Citrus Sinensis ID: 039231

---

Local Sequence Feature Prediction

Residue Number Marker
--------10--------20--------30--------40--------50--------60--------70--------80--------90-------100-------110-------120-------130-------140-------150-------160-------170-------180-------190-------200-------210-------220-------230-------240-------250-------260-------270-------280-------290-------300-------310-------320-------330-------340-------350-------360-------370-------380-------390-------400-------410-------420-------430-------440-------450-------460-------470-------480-------490-------500------
Protein Sequence
MACYSFLVFLVISRLLLLSSAEEESELNKICPYSFPPCGNLGQFTFPFTDPKHPECGLMAVDNCIEPVQRIRLGKAGPFYNILNIAQDVSITLEDQVFQNHLNERSCESFENLTLPTSASLSFRIKSNLSLFRCTDKLDNNFISFNSTCNSSSFIYYNHPDDDLPSILPPNCSLIQLPVNKTRKSGDLFNMLTSVFSLQVEVHRVCYECRWRGGQCQSDSEGNFQCAETRECNDCLKKRGRCHIDDKGNFQCKIEWTGASAFAIGILIFIAFYFKRKLSSYNSTASCLNIETFLRNYRSLSPKRYGYADIKKMTNSFKYKLGQGGYGSVYKGKLLDGSNVAVKVLNDSKGNGKEFINEVASISRTSHVNVVALLGFCLRVAEELSSTIGIARGLEYLHLGCSTRILHFDIKPHNILLDEDFCPKISDFGLAKICNRKESIISMTGARGTVGYIAPEVFCRNIGEVSYKSDVYNYGMMIFEMTGGRKNVDVVDNGSTALDLQASRKG
Secondary Structure (PSIPRED)
ccHHHHHHHHHHHHHHHHHccccccccccccccccccccccccccccccccccccccccccccccccccEEEEcccccEEEEEEEcccEEEEEEccccccccccccccccccccccccccccccccccEEEccccccccccccccccccccccEEEEEccccccccccccccEEEEEEcccccccccHHHHHcccEEEEEEEccccccccccccEEccccccccccccccccccccccccccccccccccEEEEEEHHHHHHHHHHHHHHHHHHHHHcccccccccHHHHHHHHHHccccccccccHHHHHHHHHHHHHHccccccEEEEEEEEccccEEEEEEcccccccHHHHHHHHHHHHccccccEEEEEcccccHHHHHHHHHHHHHHHHHccccccccEEEEccccccccccccccccccccccccccccccccEEEccccccccccccccccccccccccccccccHHHHHHHHHccccccccccccccEEEccccccc
Secondary Structure Prediction (SSPRO)
ccHHHHHHHHHHHHHHHcccccccccccccccccccccccccccEccEcccccccccccccccccccccEEEEEcccEEEEEEEEEccEEEEEEccccccccccccccccccccccccccccccccccEEEEcccccccccccccccccccccEEEEEcccccccccccccccEEEEEcccccccccHHHHccccEEEEEcccccccccccccccccccccccEEEcccccccccccccccccccccccHHHHHHHHHHHHHHHHHHHHHHHHHHHHHccccccccccccHHHHHHcccccccEEcHHHHHHHHccHHHHcccccccEEEEEEcccccEEEEEEEccccccHHHHHHHHHHHHHHHcHHHHHEEcccccHHHHHHHHHHHHHHHHHHHcccccEEEcccccHHHEEEcccccEEEccccccHHcccccccEEEEEEccccccccHHHHHHHccccccccHHHHHHHHHHHHHcccccccccccccccHHHHccccc
Coil and Loop (DISEMBL)
MACYSFLVFLVISRLLLLSSAEEEselnkicpysfppcgnlgqftfpftdpkhpecglmavdnciepvqrirlgkagpfyniLNIAQDVSITLEDQVFQNhlnerscesfenltlptsaslsfriksnlslfrctdkldnnfisfnstcnsssfiyynhpdddlpsilppncsliqlpvnktrksgdLFNMLTSVFSLQVEVHRVCYEcrwrggqcqsdsegnfqcaetreCNDClkkrgrchiddkgnfqckiewtgaSAFAIGILIFIAFYFKRKlssynstasCLNIETFLRNYrslspkrygyADIKKMTNSFKyklgqggygsvykgklldgsNVAVKVLNDSKGNGKEFINEVASISRTSHVNVVALLGFCLRVAEELSSTIGIARGLEYLHLGCstrilhfdikphnilldedfcpkisdfglakicnrkesiismtgargtvgyiapevfcrnigevsyksdvyNYGMMIFEmtggrknvdvvdngstaldlqasrkg
Flexible Loop (DISEMBL)
MACYSFLVFLVISRLLLLSSAEEESELNKICPYSFPPCGNLGQFTFPFTDPKHPECGLMAVDNCIEPVQRIRLGKAGPFYNILNIAQDVSITLEDQVFQNHLNERSCESFENLTLPTSASLSFRIKSNLSLFRCTDKLDNNFISFNSTCNSSSFIYYNHPDDDLPSILPPNCSLIQLPVNKTRKSGDLFNMLTSVFSLQVEVHRVCYECRWRGGQCQSDSEGNFQCAETRECNDCLKKRGRCHIDDKGNFQCKIEWTGASAFAIGILIFIAFYFKRKLSSYNSTASCLNIETFLRNYRSLSPKRYGYADIKKMTNSFKYKLGQGGYGSVYKGKLLDGSNVAVKVlndskgngKEFINEVASISRTSHVNVVALLGFCLRVAEELSSTIGIARGLEYLHLGCSTRILHFDIKPHNILLDEDFCPKISDFGLAKICNRKESIismtgargtvgyiAPEVFCRNIGEVSYKSDVYNYGMMIFEMTGGRKNVDVVDNGstaldlqasrkg
Low Complexity Region (SEG)
MACYsflvflvisrllllssaeeeselNKICPYSFPPCGNLGQFTFPFTDPKHPECGLMAVDNCIEPVQRIRLGKAGPFYNILNIAQDVSITLEDQVFQNHLNERSCESFENLTLPTSASLSFRIKSNLSLFRCTDKLDNNFISFNSTCNSSSFIYYNHPDDDLPSILPPNCSLIQLPVNKTRKSGDLFNMLTSVFSLQVEVHRVCYECRWRGGQCQSDSEGNFQCAETRECNDCLKKRGRCHIDDKGNFQCKIEWTGasafaigilifiafyfKRKLSSYNSTASCLNIETFLRNYRSLSPKRYGYADIKKMTNSFKYKLGQGGYGSVYKGKLLDGSNVAVKVLNDSKGNGKEFINEVASISRTSHVNVVALLGFCLRVAEELSSTIGIARGLEYLHLGCSTRILHFDIKPHNILLDEDFCPKISDFGLAKICNRKESIISMTGARGTVGYIAPEVFCRNIGEVSYKSDVYNYGMMIFEMTGGRKNVDVVDNGSTALDLQASRKG
Disordered region (IsUnstruct)
**CYSFLVFLVISRLLLLSSAEEESELNKICPYSFPPCGNLGQFTFPFTDPKHPECGLMAVDNCIEPVQRIRLGKAGPFYNILNIAQDVSITLEDQVFQNHLNERSCESFENLTLPTSASLSFRIKSNLSLFRCTDKLDNNFISFNSTCNSSSFIYYNHPDDDLPSILPPNCSLIQLPVNKTRKSGDLFNMLTSVFSLQVEVHRVCYECRWRGGQCQSDSEGNFQCAETRECNDCLKKRGRCHIDDKGNFQCKIEWTGASAFAIGILIFIAFYFKRKLSSYNSTASCLNIETFLRNYRSLSPKRYGYADIKKMTNSFKYKLGQGGYGSVYKGKLLDGSNVAVKVLNDSKGNGKEFINEVASISRTSHVNVVALLGFCLRVAEELSSTIGIARGLEYLHLGCSTRILHFDIKPHNILLDEDFCPKISDFGLAKICNRKESIISMTGARGTVGYIAPEVFCRNIGEVSYKSDVYNYGMMIFEMTGGRKNVDVV***************
Disordered Region (DISOPRED)
***YSFLVFLVISRLLLLSSAEEES****ICPYSFPPCGNLGQFTFPFTDPKHPECGLMAVDNCIEPVQRIRLGKAGPFYNILNIAQDVSITLEDQVFQNHLNERSCESFENLTLPTSASLSFRIKSNLSLFRCTDKLDNNFISFNSTCNSSSFIYYNHPDDDLPSILPPNCSLIQLPVNKTRKSGDLFNMLTSVFSLQVEVHRVCYECRWRGGQCQSDSEGNFQCAETREC******************QCKIEWTGASAFAIGILIFIAFYFKRKLSS**************RNYRSLSPKRYGYADIKKMTNSFKYKLGQGGYGSVYKGKLLDGSNVAVKVLND*****KEFINEVASISRTSHVNVVALLGFCLRVAEELSSTIGIARGLEYLHLGCSTRILHFDIKPHNILLDEDFCPKISDFGLAKICNRKESIISMTGARGTVGYIAPEVFCRNIGEVSYKSDVYNYGMMIFEMTGG***************LQASRK*
Disordered Region (DISEMBL)
MACYSFLVFLVISRLLLLSSAEEESELNKICPYSFPPCGNLGQFTFPFTDPKHPECGLMAVDNCIEPVQRIRLGKAGPFYNILNIAQDVSITLEDQVFQNHLNERSCESFENLTLPTSASLSFRIKSNLSLFRCTDKLDNNFISFNSTCNSSSFIYYNHPDDDLPSILPPNCSLIQLPVNKTRKSGDLFNMLTSVFSLQVEVHRVCYECRWRGGQCQSDSEGNFQCAETRECNDCLKKRGRCHIDDKGNFQCKIEWTGASAFAIGILIFIAFYFKRKLSSYNSTASCLNIETFLRNYRSLSPKRYGYADIKKMTNSFKYKLGQGGYGSVYKGKLLDGSNVAVKVLNDSKGNGKEFINEVASISRTSHVNVVALLGFCLRVAEELSSTIGIARGLEYLHLGCSTRILHFDIKPHNILLDEDFCPKISDFGLAKICNRKESIISMTGARGTVGYIAPEVFCRNIGEVSYKSDVYNYGMMIFEMTGGRKNVDVVDNGSTALDLQASRKG
Disordered Region (DISPRO)
*ACYSFLVFLVISRLLLLSSAEEESELNKICPYSFPPCGNLGQFTFPFTDPKHPECGLMAVDNCIEPVQRIRLGKAGPFYNILNIAQDVSITLEDQVFQNHLNERSCESFENLTLPTSASLSFRIKSNLSLFRCTDKLDNNFISFNSTCNSSSFIYYNHPDDDLPSILPPNCSLIQLPVNKTRKSGDLFNMLTSVFSLQVEVHRVCYECRWRGGQCQSDSEGNFQCAETRECNDC*KKRGRCH*DDKGNFQCKIEWTGASAFAIGILIFIAFYFKRKLSS*******LNIETFLRNYRSLSPKRYGYADIKKMTNSFKYKLGQGGYGSVYKGKLLDGSNVAVKVLNDSKGNGKEFINEVASISRTSHVNVVALLGFCLRVAEELSSTIGIARGLEYLHLGCSTRILHFDIKPHNILLDEDFCPKISDFGLAKICNRKESIISMTGARGTVGYIAPEVFCRNIGEVSYKSDVYNYGMMIFEMTGGRKNV******************
Transmembrane Helix (TMHMM)
oooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooHHHHHHHHHHHHHHHHHHHiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiii
Transmembrane Helix (HMMTOP)
oooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooo
Transmembrane Helix (MEMSAT)
oooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooHHHHHHHHHHHHHHHHHHHHiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiii
TM Helix, Signal Peptide (MEMSAT_SVM)
ooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooHHHHHHHHHHHHHHHHHHHHHHiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiii
TM Helix, Signal Peptide (Phobius)
SSSSSSSSSSSSSSSSSSSSSooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooHHHHHHHHHHHHHHHHHHHiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiii
Signal Peptide (SignalP HMM Mode)
SSSSSSSSSSSSSSSSSSSSSSoooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooo
Signal Peptide (SignalP NN Mode)
xxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxx
Coiled Coils (COILS)
MACYSFLVFLVISRLLLLSSAEEESELNKICPYSFPPCGNLGQFTFPFTDPKHPECGLMAVDNCIEPVQRIRLGKAGPFYNILNIAQDVSITLEDQVFQNHLNERSCESFENLTLPTSASLSFRIKSNLSLFRCTDKLDNNFISFNSTCNSSSFIYYNHPDDDLPSILPPNCSLIQLPVNKTRKSGDLFNMLTSVFSLQVEVHRVCYECRWRGGQCQSDSEGNFQCAETRECNDCLKKRGRCHIDDKGNFQCKIEWTGASAFAIGILIFIAFYFKRKLSSYNSTASCLNIETFLRNYRSLSPKRYGYADIKKMTNSFKYKLGQGGYGSVYKGKLLDGSNVAVKVLNDSKGNGKEFINEVASISRTSHVNVVALLGFCLRVAEELSSTIGIARGLEYLHLGCSTRILHFDIKPHNILLDEDFCPKISDFGLAKICNRKESIISMTGARGTVGYIAPEVFCRNIGEVSYKSDVYNYGMMIFEMTGGRKNVDVVDNGSTALDLQASRKG
Positional Conservation
no confident homologs detected

---

Close Homologs for Annotation Transfer

Close Homologs in SWISS-PROT Database Detected by BLAST

Original result of BLAST against SWISS-PROT Database

ID	Length	Definition	RBH(Q2H)	RBH(H2Q)	Q cover	H cover	Identity	E-value
Query	506	2.2.26 [Sep-21-2011]
Q9FID6	813	Probable receptor-like pr	no	no	0.385	0.239	0.533	7e-64
Q3ECH2	892	Probable receptor-like pr	no	no	0.545	0.309	0.440	2e-62
Q9FID5	806	Probable receptor-like pr	no	no	0.381	0.239	0.508	2e-61
Q8RWZ5	821	G-type lectin S-receptor-	no	no	0.432	0.266	0.419	1e-43
Q9XID3	829	G-type lectin S-receptor-	no	no	0.389	0.237	0.406	1e-39
O65238	872	G-type lectin S-receptor-	no	no	0.361	0.209	0.402	2e-38
Q9FLV4	872	G-type lectin S-receptor-	no	no	0.369	0.214	0.391	6e-38
O64477	828	G-type lectin S-receptor-	no	no	0.367	0.224	0.411	9e-38
Q94C25	452	Probable receptor-like pr	no	no	0.415	0.464	0.367	2e-37
P17801	817	Putative receptor protein	N/A	no	0.444	0.275	0.353	4e-35

>sp|Q9FID6|Y5392_ARATH Probable receptor-like protein kinase At5g39020 OS=Arabidopsis thaliana GN=At5g39020 PE=2 SV=1

 Score =  245 bits (625), Expect = 7e-64,   Method: Compositional matrix adjust.
 Identities = 120/225 (53%), Positives = 157/225 (69%), Gaps = 30/225 (13%)

Query: 303 KRYGYADIKKMTNSFKYKLGQGGYGSVYKGKLLDGSNVAVKVLNDSKGNGKEFINEVASI 362
           K+Y YA++KK+T SF + +G+GG+G+VY+G L +G  VAVKVL D KGNG +FINEV S+
Sbjct: 484 KQYIYAELKKITKSFSHTVGKGGFGTVYRGNLSNGRTVAVKVLKDLKGNGDDFINEVTSM 543

Query: 363 SRTSHVNVVALLGFCLR------VAEELSS-----------------------TIGIARG 393
           S+TSHVN+V+LLGFC        ++E L                          +GIARG
Sbjct: 544 SQTSHVNIVSLLGFCYEGSKRAIISEFLEHGSLDQFISRNKSLTPNVTTLYGIALGIARG 603

Query: 394 LEYLHLGCSTRILHFDIKPHNILLDEDFCPKISDFGLAKICNRKESIISMTGARGTVGYI 453
           LEYLH GC TRI+HFDIKP NILLD++FCPK++DFGLAK+C ++ESI+S+   RGT+GYI
Sbjct: 604 LEYLHYGCKTRIVHFDIKPQNILLDDNFCPKVADFGLAKLCEKRESILSLIDTRGTIGYI 663

Query: 454 APEVFCRNIGEVSYKSDVYNYGMMIFEMTGGRKNVDVVD-NGSTA 497
           APEV  R  G +S+KSDVY+YGM++ +M G R  V+    NGSTA
Sbjct: 664 APEVVSRMYGGISHKSDVYSYGMLVLDMIGARNKVETTTCNGSTA 708

Arabidopsis thaliana (taxid: 3702)
EC: 2EC: .EC: 7EC: .EC: 1EC: 1EC: .EC: -

>sp|Q3ECH2|Y1670_ARATH Probable receptor-like protein kinase At1g67000 OS=Arabidopsis thaliana GN=At1g67000 PE=2 SV=2

 Score =  240 bits (612), Expect = 2e-62,   Method: Compositional matrix adjust.
 Identities = 140/318 (44%), Positives = 186/318 (58%), Gaps = 42/318 (13%)

Query: 206 CYECRWRGGQC---QSDSEGNFQCAETR---ECNDCLKKRGRCHIDDKGNFQCKIEWTGA 259
           C  CR  GG C   Q+ S     C + +   E +D   +R R  I     +   I     
Sbjct: 445 CERCRGSGGACGYNQTSSGFGCYCKDGKCGYEYDDGFFRRHRRFIATLVRYTF-IALGAL 503

Query: 260 SAFAIGILIFIAFYFKRKLSSYNSTASCLNIETFLRNYRSLSP-KRYGYADIKKMTNSFK 318
           +   I  L+ +   F+ ++     T+     E  L+  ++L P K Y YA++KKMT SF 
Sbjct: 504 TGVVIVFLVLLCPCFRVQIFRKRKTSD----EVRLQKLKALIPLKHYTYAEVKKMTKSFT 559

Query: 319 YKLGQGGYGSVYKGKLLDGSNVAVKVLNDSKG-NGKEFINEVASISRTSHVNVVALLGFC 377
             +G+GG+G VY G L D S VAVKVL DSKG +G++FINEVAS+S+TSHVN+V+LLGFC
Sbjct: 560 EVVGRGGFGIVYSGTLSDSSMVAVKVLKDSKGTDGEDFINEVASMSQTSHVNIVSLLGFC 619

Query: 378 -----------------------------LRVAEELSSTIGIARGLEYLHLGCSTRILHF 408
                                        L +       +G+ARGLEYLH GC TRI+HF
Sbjct: 620 CEGSRRAIIYEFLGNGSLDKFISDKSSVNLDLKTLYGIALGVARGLEYLHYGCKTRIVHF 679

Query: 409 DIKPHNILLDEDFCPKISDFGLAKICNRKESIISMTGARGTVGYIAPEVFCRNIGEVSYK 468
           DIKP N+LLD++ CPK+SDFGLAK+C +KESI+S+   RGT+GYIAPE+  R  G VS+K
Sbjct: 680 DIKPQNVLLDDNLCPKVSDFGLAKLCEKKESILSLLDTRGTIGYIAPEMISRLYGSVSHK 739

Query: 469 SDVYNYGMMIFEMTGGRK 486
           SDVY+YGM++ EM G RK
Sbjct: 740 SDVYSYGMLVLEMIGARK 757

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q9FID5|Y5393_ARATH Probable receptor-like protein kinase At5g39030 OS=Arabidopsis thaliana GN=At5g39030 PE=2 SV=1

 Score =  237 bits (604), Expect = 2e-61,   Method: Compositional matrix adjust.
 Identities = 114/224 (50%), Positives = 157/224 (70%), Gaps = 31/224 (13%)

Query: 305 YGYADIKKMTNSFKYKLGQGGYGSVYKGKLLDGSNVAVKVLNDSKGNGKEFINEVASISR 364
           Y YA++KK+T SF Y +G+GG+G+VY G L +G  VAVKVL D KG+ ++FINEVAS+S+
Sbjct: 488 YTYAELKKITKSFSYIIGKGGFGTVYGGNLSNGRKVAVKVLKDLKGSAEDFINEVASMSQ 547

Query: 365 TSHVNVVALLGFCLR-------------------------VAEELSS----TIGIARGLE 395
           TSHVN+V+LLGFC                           + +++++     +GIARGLE
Sbjct: 548 TSHVNIVSLLGFCFEGSKRAIVYEFLENGSLDQFMSRNKSLTQDVTTLYGIALGIARGLE 607

Query: 396 YLHLGCSTRILHFDIKPHNILLDEDFCPKISDFGLAKICNRKESIISMTGARGTVGYIAP 455
           YLH GC TRI+HFDIKP NILLD + CPK+SDFGLAK+C ++ES++S+   RGT+GYIAP
Sbjct: 608 YLHYGCKTRIVHFDIKPQNILLDGNLCPKVSDFGLAKLCEKRESVLSLMDTRGTIGYIAP 667

Query: 456 EVFCRNIGEVSYKSDVYNYGMMIFEMTGGRKN--VDVVDNGSTA 497
           EVF R  G VS+KSDVY++GM++ +M G R    V+ VD+ +++
Sbjct: 668 EVFSRMYGRVSHKSDVYSFGMLVIDMIGARSKEIVETVDSAASS 711

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: -

>sp|Q8RWZ5|SD25_ARATH G-type lectin S-receptor-like serine/threonine-protein kinase SD2-5 OS=Arabidopsis thaliana GN=SD25 PE=1 SV=1

 Score =  178 bits (451), Expect = 1e-43,   Method: Compositional matrix adjust.
 Identities = 107/255 (41%), Positives = 139/255 (54%), Gaps = 36/255 (14%)

Query: 267 LIFIAFYF-KRKLSSYNSTASCLNIETFLRNYRSLSPKRYGYADIKKMTNSFKYKLGQGG 325
           LIF+AF   KRK     +       + FL N   + P R+ Y D++  TN+F  KLGQGG
Sbjct: 445 LIFVAFRIHKRKKMILEAPQESSEEDNFLENLSGM-PIRFAYKDLQSATNNFSVKLGQGG 503

Query: 326 YGSVYKGKLLDGSNVAVKVLNDSKGNGKEFINEVASISRTSHVNVVALLGFCLRVAEELS 385
           +GSVY+G L DGS +AVK L       KEF  EV+ I    H+++V L GFC   A  L 
Sbjct: 504 FGSVYEGTLPDGSRLAVKKLEGIGQGKKEFRAEVSIIGSIHHLHLVRLRGFCAEGAHRLL 563

Query: 386 S-------------------------------TIGIARGLEYLHLGCSTRILHFDIKPHN 414
           +                                +G A+GL YLH  C  RI+H DIKP N
Sbjct: 564 AYEFLSKGSLERWIFRKKDGDVLLDWDTRFNIALGTAKGLAYLHEDCDARIVHCDIKPEN 623

Query: 415 ILLDEDFCPKISDFGLAKICNRKESIISMTGARGTVGYIAPEVFCRNIGEVSYKSDVYNY 474
           ILLD++F  K+SDFGLAK+  R++S +  T  RGT GY+APE        +S KSDVY+Y
Sbjct: 624 ILLDDNFNAKVSDFGLAKLMTREQSHV-FTTMRGTRGYLAPEWITNY--AISEKSDVYSY 680

Query: 475 GMMIFEMTGGRKNVD 489
           GM++ E+ GGRKN D
Sbjct: 681 GMVLLELIGGRKNYD 695

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q9XID3|Y1343_ARATH G-type lectin S-receptor-like serine/threonine-protein kinase At1g34300 OS=Arabidopsis thaliana GN=At1g34300 PE=1 SV=1

 Score =  164 bits (416), Expect = 1e-39,   Method: Compositional matrix adjust.
 Identities = 93/229 (40%), Positives = 138/229 (60%), Gaps = 32/229 (13%)

Query: 294 LRNYRSLSPKRYGYADIKKMTNSFKYKLGQGGYGSVYKGKLLDGSNVAVKVLNDSKGNGK 353
           L  Y S +P ++ Y ++++ T SFK KLG GG+G+VY+G L + + VAVK L   +   K
Sbjct: 463 LLEYASGAPVQFTYKELQRCTKSFKEKLGAGGFGTVYRGVLTNRTVVAVKQLEGIEQGEK 522

Query: 354 EFINEVASISRTSHVNVVALLGFC------LRVAEELSS--------------------- 386
           +F  EVA+IS T H+N+V L+GFC      L V E + +                     
Sbjct: 523 QFRMEVATISSTHHLNLVRLIGFCSQGRHRLLVYEFMRNGSLDNFLFTTDSAKFLTWEYR 582

Query: 387 ---TIGIARGLEYLHLGCSTRILHFDIKPHNILLDEDFCPKISDFGLAKICNRKESIISM 443
               +G A+G+ YLH  C   I+H DIKP NIL+D++F  K+SDFGLAK+ N K++  +M
Sbjct: 583 FNIALGTAKGITYLHEECRDCIVHCDIKPENILVDDNFAAKVSDFGLAKLLNPKDNRYNM 642

Query: 444 TGARGTVGYIAPEVFCRNIGEVSYKSDVYNYGMMIFEMTGGRKNVDVVD 492
           +  RGT GY+APE +  N+  ++ KSDVY+YGM++ E+  G++N DV +
Sbjct: 643 SSVRGTRGYLAPE-WLANL-PITSKSDVYSYGMVLLELVSGKRNFDVSE 689

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|O65238|Y5537_ARATH G-type lectin S-receptor-like serine/threonine-protein kinase At5g35370 OS=Arabidopsis thaliana GN=At5g35370 PE=2 SV=2

 Score =  160 bits (405), Expect = 2e-38,   Method: Compositional matrix adjust.
 Identities = 87/216 (40%), Positives = 124/216 (57%), Gaps = 33/216 (15%)

Query: 302 PKRYGYADIKKMTNSFKYKLGQGGYGSVYKGKLLDGSNVAVKVLNDSKGNGK-EFINEVA 360
           P+++ + ++++ T +FK ++G GG+GSVYKG L D + +AVK + +   +G+ EF  E+A
Sbjct: 502 PQKFEFEELEQATENFKMQIGSGGFGSVYKGTLPDETLIAVKKITNHGLHGRQEFCTEIA 561

Query: 361 SISRTSHVNVVALLGFCLR-----------------------------VAEELSSTIGIA 391
            I    H N+V L GFC R                               E     +G A
Sbjct: 562 IIGNIRHTNLVKLRGFCARGRQLLLVYEYMNHGSLEKTLFSGNGPVLEWQERFDIALGTA 621

Query: 392 RGLEYLHLGCSTRILHFDIKPHNILLDEDFCPKISDFGLAKICNRKESIISMTGARGTVG 451
           RGL YLH GC  +I+H D+KP NILL + F PKISDFGL+K+ N++ES +  T  RGT G
Sbjct: 622 RGLAYLHSGCDQKIIHCDVKPENILLHDHFQPKISDFGLSKLLNQEESSL-FTTMRGTRG 680

Query: 452 YIAPEVFCRNIGEVSYKSDVYNYGMMIFEMTGGRKN 487
           Y+APE        +S K+DVY+YGM++ E+  GRKN
Sbjct: 681 YLAPEWITN--AAISEKADVYSYGMVLLELVSGRKN 714

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q9FLV4|Y5248_ARATH G-type lectin S-receptor-like serine/threonine-protein kinase At5g24080 OS=Arabidopsis thaliana GN=At5g24080 PE=2 SV=1

 Score =  159 bits (401), Expect = 6e-38,   Method: Compositional matrix adjust.
 Identities = 87/222 (39%), Positives = 126/222 (56%), Gaps = 35/222 (15%)

Query: 301 SPKRYGYADIKKMTNSFKYKLGQGGYGSVYKGKLLDGSNVAVKVLNDSKGNG-KEFINEV 359
           SP  + Y D++  TN+F   LG GG+G+VYKG +   + VAVK L+ +  +G +EFI EV
Sbjct: 516 SPVSFTYRDLQNCTNNFSQLLGSGGFGTVYKGTVAGETLVAVKRLDRALSHGEREFITEV 575

Query: 360 ASISRTSHVNVVALLGFCLRVAEEL-------------------------------SSTI 388
            +I    H+N+V L G+C   +  L                                  +
Sbjct: 576 NTIGSMHHMNLVRLCGYCSEDSHRLLVYEYMINGSLDKWIFSSEQTANLLDWRTRFEIAV 635

Query: 389 GIARGLEYLHLGCSTRILHFDIKPHNILLDEDFCPKISDFGLAKICNRKESIISMTGARG 448
             A+G+ Y H  C  RI+H DIKP NILLD++FCPK+SDFGLAK+  R+ S + +T  RG
Sbjct: 636 ATAQGIAYFHEQCRNRIIHCDIKPENILLDDNFCPKVSDFGLAKMMGREHSHV-VTMIRG 694

Query: 449 TVGYIAPEVFCRNIGEVSYKSDVYNYGMMIFEMTGGRKNVDV 490
           T GY+APE        ++ K+DVY+YGM++ E+ GGR+N+D+
Sbjct: 695 TRGYLAPEWVSNR--PITVKADVYSYGMLLLEIVGGRRNLDM 734

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|O64477|Y2913_ARATH G-type lectin S-receptor-like serine/threonine-protein kinase At2g19130 OS=Arabidopsis thaliana GN=At2g19130 PE=2 SV=1

 Score =  158 bits (400), Expect = 9e-38,   Method: Compositional matrix adjust.
 Identities = 91/221 (41%), Positives = 122/221 (55%), Gaps = 35/221 (15%)

Query: 305 YGYADIKKMTNSFKYKLGQGGYGSVYKGKLLDGSNVAVKVLNDSKGNGKEFINEVASISR 364
           + Y +++  T +F  KLG GG+GSV+KG L D S++AVK L       K+F  EV +I  
Sbjct: 483 FSYRELQNATKNFSDKLGGGGFGSVFKGALPDSSDIAVKRLEGISQGEKQFRTEVVTIGT 542

Query: 365 TSHVNVVALLGFC-----------------------LRVAEE---------LSSTIGIAR 392
             HVN+V L GFC                       L   EE             +G AR
Sbjct: 543 IQHVNLVRLRGFCSEGSKKLLVYDYMPNGSLDSHLFLNQVEEKIVLGWKLRFQIALGTAR 602

Query: 393 GLEYLHLGCSTRILHFDIKPHNILLDEDFCPKISDFGLAKICNRKESIISMTGARGTVGY 452
           GL YLH  C   I+H DIKP NILLD  FCPK++DFGLAK+  R  S + +T  RGT GY
Sbjct: 603 GLAYLHDECRDCIIHCDIKPENILLDSQFCPKVADFGLAKLVGRDFSRV-LTTMRGTRGY 661

Query: 453 IAPEVFCRNIGEVSYKSDVYNYGMMIFEMTGGRKNVDVVDN 493
           +APE +   +  ++ K+DVY+YGMM+FE+  GR+N +  +N
Sbjct: 662 LAPE-WISGVA-ITAKADVYSYGMMLFELVSGRRNTEQSEN 700

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q94C25|Y5005_ARATH Probable receptor-like protein kinase At5g20050 OS=Arabidopsis thaliana GN=At5g20050 PE=2 SV=1

 Score =  157 bits (397), Expect = 2e-37,   Method: Compositional matrix adjust.
 Identities = 94/256 (36%), Positives = 139/256 (54%), Gaps = 46/256 (17%)

Query: 275 KRKL--SSYNSTASCLNIE-TFLRNYRSLSPKRYGYADIKKMTNSFKYKLGQGGYGSVYK 331
           +RKL  S + S    L IE +FLR    + P ++   D+++ T+ F+  +G+GG GSV+K
Sbjct: 61  ERKLLVSRFASEGRELRIEYSFLRKVAGV-PTKFKLEDLEEATDGFRSLIGKGGSGSVFK 119

Query: 332 GKLLDGSNVAVKVLNDSKGNGKEFINEVASISRTSHVNVVALLGF--------------- 376
           G L DGS VAVK +   +   +EF +EVA+I+   H N+V L G+               
Sbjct: 120 GVLKDGSQVAVKRIEGEEKGEREFRSEVAAIASVQHKNLVRLYGYSSSTSANRPRFLVYD 179

Query: 377 ------------------------CLRVAEELSSTIGIARGLEYLHLGCSTRILHFDIKP 412
                                   CL   +     I +A+ L YLH  C ++ILH D+KP
Sbjct: 180 YIVNSSLDIWIFPDRGNRGRSGGGCLSWEQRYQVAIDVAKALAYLHHDCRSKILHLDVKP 239

Query: 413 HNILLDEDFCPKISDFGLAKICNRKESIISMTGARGTVGYIAPEVFCRNIGEVSYKSDVY 472
            NILLDE+F   ++DFGL+K+  R ES + +T  RGT GY+APE    +   +S KSDVY
Sbjct: 240 ENILLDENFRAVVTDFGLSKLIARDESRV-LTDIRGTRGYLAPEWLLEH--GISEKSDVY 296

Query: 473 NYGMMIFEMTGGRKNV 488
           +YG+++ EM GGR+++
Sbjct: 297 SYGIVLLEMIGGRRSI 312

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|P17801|KPRO_MAIZE Putative receptor protein kinase ZmPK1 OS=Zea mays GN=PK1 PE=2 SV=2

 Score =  149 bits (377), Expect = 4e-35,   Method: Compositional matrix adjust.
 Identities = 94/266 (35%), Positives = 143/266 (53%), Gaps = 41/266 (15%)

Query: 260 SAFAIGILIFIAFYF----KRKLSSYNSTASCLNIETFLRNYRSLSPKRYGYADIKKMTN 315
           +AF +  + FI+F +    KR+L      AS    +    N+R     RY Y ++ K T 
Sbjct: 480 AAFFVVEVSFISFAWFFVLKRELRPSELWASEKGYKAMTSNFR-----RYSYRELVKATR 534

Query: 316 SFKYKLGQGGYGSVYKGKLLDGSNVAVKVLNDSKGNGKEFINEVASISRTSHVNVVALLG 375
            FK +LG+G  G+VYKG L D  +VAVK L + +   + F  E++ I R +H+N+V + G
Sbjct: 535 KFKVELGRGESGTVYKGVLEDDRHVAVKKLENVRQGKEVFQAELSVIGRINHMNLVRIWG 594

Query: 376 FC------LRVAEELSS------------------------TIGIARGLEYLHLGCSTRI 405
           FC      L V+E + +                         +G+A+GL YLH  C   +
Sbjct: 595 FCSEGSHRLLVSEYVENGSLANILFSEGGNILLDWEGRFNIALGVAKGLAYLHHECLEWV 654

Query: 406 LHFDIKPHNILLDEDFCPKISDFGLAKICNRKESIISMTGARGTVGYIAPEVFCRNIGEV 465
           +H D+KP NILLD+ F PKI+DFGL K+ NR  S  +++  RGT+GYIAPE        +
Sbjct: 655 IHCDVKPENILLDQAFEPKITDFGLVKLLNRGGSTQNVSHVRGTLGYIAPEWVSSL--PI 712

Query: 466 SYKSDVYNYGMMIFEMTGGRKNVDVV 491
           + K DVY+YG+++ E+  G +  ++V
Sbjct: 713 TAKVDVYSYGVVLLELLTGTRVSELV 738

Probable receptor. Interaction with a ligand in the extracellular domain triggers the protein kinase activity of the cytoplasmic domain.

Zea mays (taxid: 4577)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

Close Homologs in the Non-Redundant Database Detected by BLAST

Original result of BLAST against Nonredundant Database

GI	Length	Definition	Q cover	H cover	Identity	E-value
Query	506
359472674	637	PREDICTED: probable receptor-like protei	0.924	0.734	0.466	1e-120
147795963	624	hypothetical protein VITISV_039936 [Viti	0.924	0.75	0.466	1e-120
145839451	627	receptor-like protein kinase [Capsicum a	0.883	0.712	0.464	1e-112
147769927	1001	hypothetical protein VITISV_010117 [Viti	0.788	0.398	0.474	1e-110
356574202	694	PREDICTED: probable receptor-like protei	0.913	0.665	0.424	2e-99
356574204	736	PREDICTED: G-type lectin S-receptor-like	0.915	0.629	0.420	5e-99
356574212	621	PREDICTED: probable receptor-like protei	0.897	0.731	0.433	1e-95
357444697	642	Protein kinase-coding resistance protein	0.885	0.697	0.418	1e-94
356574208	587	PREDICTED: probable receptor-like protei	0.859	0.741	0.411	3e-91
356574206	619	PREDICTED: probable receptor-like protei	0.877	0.717	0.412	3e-91

>gi|359472674|ref|XP_002279652.2| PREDICTED: probable receptor-like protein kinase At1g67000-like [Vitis vinifera]

 Score =  437 bits (1124), Expect = e-120,   Method: Compositional matrix adjust.
 Identities = 255/547 (46%), Positives = 341/547 (62%), Gaps = 79/547 (14%)

Query: 1   MACYSFLVFLVISRLLLLSSAEEESELNKICPYSFPPCGNLGQFTFPFTDPKHPECGLMA 60
           M   SFLV  ++S  +LLSSAEEE +    CP  F  C  LG+  FPF +  + ECGL  
Sbjct: 14  MGSVSFLVLFLLSHSVLLSSAEEERKHPPTCP-PFD-CEKLGRLHFPFKNETNSECGLCT 71

Query: 61  VDNCIEPVQRIRLGKAGPFYNILNIAQDVSITLEDQVFQNHLNERSCESFENLTLPTSAS 120
           +  C E + RI+L + G ++ + NI+Q  +I ++D+  Q HL    CE  +NLT   S S
Sbjct: 72  IVRCTEELPRIQLERGGRYFGLKNISQADTIVIQDERLQEHLQRGICEFIDNLTRFRSPS 131

Query: 121 LSFRIK---SNLSLFRCTDKLDNNFISFNSTCNSSSFI-YYNHPDDDLPSILPP------ 170
           +SF+     + L+LF+C   L+ +  + ++      +I +YNHP+    S+LPP      
Sbjct: 132 VSFKPVPPLAELTLFKCHRNLNIDLTTDHTYTGCQDYIIHYNHPNHT--SLLPPLPHNQP 189

Query: 171 ------------NCSLIQLPVNKTRKSGDLFNMLTSVFSLQVEVHRVCYECRWRGGQCQS 218
                       +CS+IQ P+N +    +L  +LTS  +L+V + R C +C + GGQC+ 
Sbjct: 190 NHTPTLPAPPPLDCSIIQYPINMSLGMDNLVALLTSDITLEVHLSRECRKCHFSGGQCRD 249

Query: 219 DSEGNFQCAETRECNDCLKKRGRCHIDDKGNFQCKIEWTGASAFAIGILIFIAFYFKRKL 278
           D EG F+CA T   ND   K               I  TG     IGI + + FYF +K 
Sbjct: 250 D-EGKFRCAHT--GNDKTLKLA---------LGLAISITG-----IGIPLALTFYFSKKF 292

Query: 279 SSY---NSTASCLNIETFLRNYRSLSPKRYGYADIKKMTNSFKYKLGQGGYGSVYKGKLL 335
            S      T + LN+ETFLRN+ SL+PKRY Y++++KMT+SFK ++G+GGYG+VYKGKLL
Sbjct: 293 RSIFKEKQTGNHLNVETFLRNHESLAPKRYRYSEVQKMTSSFKDRVGEGGYGAVYKGKLL 352

Query: 336 DGSNVAVKVLNDSKGNGKEFINEVASISRTSHVNVVALLGFCLR---------------- 379
           +G  VAVKVL+++KGNG+EFINE+ASISRTSHVN+V+LLGFC +                
Sbjct: 353 NGDLVAVKVLSETKGNGEEFINEIASISRTSHVNIVSLLGFCFQGSKRALIYEFMPNGSL 412

Query: 380 ---VAEELSS--------------TIGIARGLEYLHLGCSTRILHFDIKPHNILLDEDFC 422
              + ++ SS               IGIARGLEYLH GC+TRILH DIKPHNILL++DFC
Sbjct: 413 EKFIYDKNSSMTYDKLGWETLYNIAIGIARGLEYLHRGCNTRILHLDIKPHNILLNQDFC 472

Query: 423 PKISDFGLAKICNRKESIISMTGARGTVGYIAPEVFCRNIGEVSYKSDVYNYGMMIFEMT 482
           PKISDFGL+K+C RKESI+SM+GARGT GYIAPEVFCRN G+VS KSDVY+YGMM+ EM 
Sbjct: 473 PKISDFGLSKLCTRKESIVSMSGARGTAGYIAPEVFCRNFGDVSPKSDVYSYGMMVLEMV 532

Query: 483 GGRKNVD 489
           GGRKN+D
Sbjct: 533 GGRKNID 539

Source: Vitis vinifera

Species: Vitis vinifera

Genus: Vitis

Family: Vitaceae

Order: Vitales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|147795963|emb|CAN69599.1| hypothetical protein VITISV_039936 [Vitis vinifera]

 Score =  437 bits (1123), Expect = e-120,   Method: Compositional matrix adjust.
 Identities = 255/547 (46%), Positives = 341/547 (62%), Gaps = 79/547 (14%)

Query: 1   MACYSFLVFLVISRLLLLSSAEEESELNKICPYSFPPCGNLGQFTFPFTDPKHPECGLMA 60
           M   SFLV  ++S  +LLSSAEEE +    CP  F  C  LG+  FPF +  + ECGL  
Sbjct: 1   MGSVSFLVLFLLSHSVLLSSAEEERKHPPTCP-PFD-CEKLGRLHFPFKNETNSECGLCT 58

Query: 61  VDNCIEPVQRIRLGKAGPFYNILNIAQDVSITLEDQVFQNHLNERSCESFENLTLPTSAS 120
           +  C E + RI+L + G ++ + NI+Q  +I ++D+  Q HL    CE  +NLT   S S
Sbjct: 59  IVRCTEELPRIQLERGGRYFGLKNISQADTIVIQDERLQEHLQRGICEFIDNLTRFRSPS 118

Query: 121 LSFRIK---SNLSLFRCTDKLDNNFISFNSTCNSSSFI-YYNHPDDDLPSILPP------ 170
           +SF+     + L+LF+C   L+ +  + ++      +I +YNHP+    S+LPP      
Sbjct: 119 VSFKPVPPLAELTLFKCHRNLNIDLTTDHTYTGCQDYIIHYNHPNHT--SLLPPLPHNQP 176

Query: 171 ------------NCSLIQLPVNKTRKSGDLFNMLTSVFSLQVEVHRVCYECRWRGGQCQS 218
                       +CS+IQ P+N +    +L  +LTS  +L+V + R C +C + GGQC+ 
Sbjct: 177 NHTPTLPAPPPLDCSIIQYPINMSLGMDNLVALLTSDITLEVHLSRECRKCHFSGGQCRD 236

Query: 219 DSEGNFQCAETRECNDCLKKRGRCHIDDKGNFQCKIEWTGASAFAIGILIFIAFYFKRKL 278
           D EG F+CA T   ND   K               I  TG     IGI + + FYF +K 
Sbjct: 237 D-EGKFRCAHT--GNDKTLKLA---------LGLAISITG-----IGIPLALTFYFSKKF 279

Query: 279 SSY---NSTASCLNIETFLRNYRSLSPKRYGYADIKKMTNSFKYKLGQGGYGSVYKGKLL 335
            S      T + LN+ETFLRN+ SL+PKRY Y++++KMT+SFK ++G+GGYG+VYKGKLL
Sbjct: 280 RSIFKEKQTGNHLNVETFLRNHESLAPKRYRYSEVQKMTSSFKDRVGEGGYGAVYKGKLL 339

Query: 336 DGSNVAVKVLNDSKGNGKEFINEVASISRTSHVNVVALLGFCLR---------------- 379
           +G  VAVKVL+++KGNG+EFINE+ASISRTSHVN+V+LLGFC +                
Sbjct: 340 NGDLVAVKVLSETKGNGEEFINEIASISRTSHVNIVSLLGFCFQGSKRALIYEFMPNGSL 399

Query: 380 ---VAEELSS--------------TIGIARGLEYLHLGCSTRILHFDIKPHNILLDEDFC 422
              + ++ SS               IGIARGLEYLH GC+TRILH DIKPHNILL++DFC
Sbjct: 400 EKFIYDKNSSMTYDKLGWETLYNIAIGIARGLEYLHRGCNTRILHLDIKPHNILLNQDFC 459

Query: 423 PKISDFGLAKICNRKESIISMTGARGTVGYIAPEVFCRNIGEVSYKSDVYNYGMMIFEMT 482
           PKISDFGL+K+C RKESI+SM+GARGT GYIAPEVFCRN G+VS KSDVY+YGMM+ EM 
Sbjct: 460 PKISDFGLSKLCTRKESIVSMSGARGTAGYIAPEVFCRNFGDVSPKSDVYSYGMMVLEMV 519

Query: 483 GGRKNVD 489
           GGRKN+D
Sbjct: 520 GGRKNID 526

Source: Vitis vinifera

Species: Vitis vinifera

Genus: Vitis

Family: Vitaceae

Order: Vitales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|145839451|gb|ABP96804.1| receptor-like protein kinase [Capsicum annuum]

 Score =  412 bits (1059), Expect = e-112,   Method: Compositional matrix adjust.
 Identities = 239/515 (46%), Positives = 309/515 (60%), Gaps = 68/515 (13%)

Query: 28  NKICPYSFPPCGNLGQFTFPFTDPKHPECGLMAVDNCIE-PVQRIRLGKAGPFYNILNIA 86
           +  CP SF  CGN    +FPF+    PECG++ +  C + P  +IRL     +Y  L   
Sbjct: 25  DSTCPKSFS-CGNFTNLSFPFSLSAQPECGILRMSGCDDKPFPKIRLLPGRDWYYALQ-Q 82

Query: 87  QDVSITLEDQVFQNHLNERSCESF-ENLTLPTSASLSFRIKSNLSLFRC--TDKLDNNFI 143
            D S+ L DQ  Q  L +  C++F +N +LP S S+SF + +  +  +C  T K ++ F 
Sbjct: 83  HDSSVWLGDQKLQTTLTQHKCQAFNKNFSLPNSPSISFNMININNFIKCSSTQKKNDRFA 142

Query: 144 SFNSTCNSSSF-IYYNHPDDDLPSI----LPPNCSLIQLPVNKTRKSGDLFNMLTSVFSL 198
            +N       F IYY    DD  +I    LP NCSLI+LP++K    GDLFN L   F +
Sbjct: 143 GYNMYNGCEGFSIYYKLTRDDDKNIEAHNLPTNCSLIKLPIHKN--DGDLFNRLGPEFLV 200

Query: 199 QVEVHRVCYECRWRGGQCQSDSEGNFQC----AETRECNDCLKKRGRCHIDDKGNFQCKI 254
           + ++   C EC   GG+CQ+D    F C    AE  +    + KR              +
Sbjct: 201 EWKLSDDCSECHHYGGRCQTDKTNKFYCLKDVAEVSKLPAGISKRFWF-----------L 249

Query: 255 EWTGASAFAIGILIFIAFYFKRKLSSY-------NSTASCLNIETFLRNYRSLSPKRYGY 307
             TGAS F +G+L+ + F+F+ K+  Y       +      NIE FL+NY S +PKRY Y
Sbjct: 250 AATGASLFTVGLLVLL-FFFRNKVLWYKYIRLWGSKVEDHRNIEEFLKNYGSYAPKRYNY 308

Query: 308 ADIKKMTNSFKYKLGQGGYGSVYKGKLLDGSNVAVKVLNDSKGNGKEFINEVASISRTSH 367
            DIK++T+ FK KL QGG+G+VY+G L +GS VAVKVLN+ KG+G+ FINEVASISRTSH
Sbjct: 309 TDIKRITSRFKNKLVQGGFGTVYRGSLGNGSQVAVKVLNELKGSGENFINEVASISRTSH 368

Query: 368 VNVVALLGFCLR-------------------VAEELSSTI-------------GIARGLE 395
           VNVV+L+GFC                     + EE S T+             GIARGLE
Sbjct: 369 VNVVSLVGFCFEGRKRALVYEFMPNGSLEKFIYEERSDTVRQLGWPTLYKIALGIARGLE 428

Query: 396 YLHLGCSTRILHFDIKPHNILLDEDFCPKISDFGLAKICNRKESIISMTGARGTVGYIAP 455
           YLH GC+TRILHFDIKPHNILLDEDFCPKISDFGLAK+C + ESI+SM GARGT+GYIAP
Sbjct: 429 YLHRGCTTRILHFDIKPHNILLDEDFCPKISDFGLAKLCMKNESIVSMLGARGTIGYIAP 488

Query: 456 EVFCRNIGEVSYKSDVYNYGMMIFEMTGGRKNVDV 490
           E+ CRN+G VS+KSD Y+YGMM+ EM GGRKNVD 
Sbjct: 489 EIVCRNLGGVSHKSDAYSYGMMVLEMIGGRKNVDA 523

Source: Capsicum annuum

Species: Capsicum annuum

Genus: Capsicum

Family: Solanaceae

Order: Solanales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|147769927|emb|CAN76446.1| hypothetical protein VITISV_010117 [Vitis vinifera]

 Score =  404 bits (1038), Expect = e-110,   Method: Compositional matrix adjust.
 Identities = 226/476 (47%), Positives = 300/476 (63%), Gaps = 77/476 (16%)

Query: 72  RLGKAGPFYNILNIAQDVSITLEDQVFQNHLNERSCESFENLTLPTSASLSFRIK---SN 128
           +L + G ++ + NI+Q  +I ++D+  Q HL    CE  +NLT   S S+SF+     + 
Sbjct: 447 QLERGGRYFGVKNISQADTIVIQDEWLQEHLQRGICEFIDNLTRFRSPSVSFKPVPPLAE 506

Query: 129 LSLFRCTDKLDNNFISFNSTCNSSSFI-YYNHPDDDLPSILPP----------------- 170
           L+LF+C   L+ +  + ++      +I +YNHP+    S+LPP                 
Sbjct: 507 LTLFKCHRNLNIHLTTDHTYTGCQDYIIHYNHPNHT--SLLPPLPHNQPNHTPTLPAPPP 564

Query: 171 -NCSLIQLPVNKTRKSGDLFNMLTSVFSLQVEVHRVCYECRWRGGQCQSDSEGNFQCAET 229
            +CS+IQ P+N +    +L  +LTS  +L+V + R C EC + GGQC+ D EG F+CA T
Sbjct: 565 LDCSIIQYPINMSLGMDNLVALLTSDITLEVHLSRECRECHFSGGQCR-DEEGKFRCAHT 623

Query: 230 RECNDCLKKRGRCHIDDKGNFQCKIEWTGASAFAIGILIFIAFYFKRKLSSY---NSTAS 286
              ND   K               I  TG     IGI + + FYF +K  S      T +
Sbjct: 624 --GNDKTLKLA---------LGLAISITG-----IGIPLALTFYFSKKFRSIFKEKQTGN 667

Query: 287 CLNIETFLRNYRSLSPKRYGYADIKKMTNSFKYKLGQGGYGSVYKGKLLDGSNVAVKVLN 346
            LN+ETFLRN+ SL+PKRY Y++++KMT+SFK ++G+GGYG+VYKGKLL+G  VAVKVL+
Sbjct: 668 HLNVETFLRNHESLAPKRYRYSEVQKMTSSFKDRVGEGGYGAVYKGKLLNGDLVAVKVLS 727

Query: 347 DSKGNGKEFINEVASISRTSHVNVVALLGFCLR-------------------VAEELSS- 386
           ++KGNG+EFINE+ASISRTSHVN+V+LLGFC +                   + ++ SS 
Sbjct: 728 ETKGNGEEFINEIASISRTSHVNIVSLLGFCFQGSKRALIYEFMPNGSLEKFIYDKNSSM 787

Query: 387 -------------TIGIARGLEYLHLGCSTRILHFDIKPHNILLDEDFCPKISDFGLAKI 433
                         IGIARGLEYLH GC+TRILH DIKPHNILL++DFCPKISDFGL+K+
Sbjct: 788 TYHKLGWETLYNIAIGIARGLEYLHRGCNTRILHLDIKPHNILLNQDFCPKISDFGLSKL 847

Query: 434 CNRKESIISMTGARGTVGYIAPEVFCRNIGEVSYKSDVYNYGMMIFEMTGGRKNVD 489
           C RKESIISM+GARGT GYIAPEVFCRN G+VS KSDVY+YGMM+ EM GGRKN D
Sbjct: 848 CTRKESIISMSGARGTAGYIAPEVFCRNFGDVSPKSDVYSYGMMVLEMVGGRKNTD 903

Source: Vitis vinifera

Species: Vitis vinifera

Genus: Vitis

Family: Vitaceae

Order: Vitales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|356574202|ref|XP_003555240.1| PREDICTED: probable receptor-like protein kinase At1g67000-like [Glycine max]

 Score =  369 bits (947), Expect = 2e-99,   Method: Compositional matrix adjust.
 Identities = 231/544 (42%), Positives = 307/544 (56%), Gaps = 82/544 (15%)

Query: 1   MACYSFLVFLVISRLLLLSSAEEESELNKICPYSFPPCGNLGQFTFPFTDPKHPECGLMA 60
           MA      FL+   L+L+ SA   +  ++ CP+SF  CGNLG F +PFT  + P+CGL+A
Sbjct: 1   MAIVDLFCFLLFCHLVLILSAGYGNG-HQDCPHSFT-CGNLGTFHYPFTKAEKPDCGLIA 58

Query: 61  VDNCIEPVQR---IRLGKAGPFYNILNIAQDVSITLEDQVFQNHLNERSCESFEN-LTLP 116
           + +C  P Q    I+L K G    +  +AQ  +I++ D+ F   L +  C + +N  +LP
Sbjct: 59  IHDCDNPHQHRKMIQLEKNGKSIVLTGVAQQNAISILDEDFHKLLQQDPCGTLKNNYSLP 118

Query: 117 TSASL-SFRIKSNLSLFRCTDKLDNNFIS--FNSTCNSSSFIYYNH----PDDDLPSILP 169
           +  SL S  IK N++LFRC   L     +  FN +C    +  Y      P+D     L 
Sbjct: 119 SPFSLYSIHIKFNVTLFRCKHSLKMKPPAHYFNHSCPDYDYDIYYDSLPSPNDKEVHSLF 178

Query: 170 PNCSLIQLPVNKTRKSGDLFNMLTSVFSLQVEVHRVCYEC--RWRGGQCQSDSEGNFQCA 227
            +CS+IQ+       + D+ + +++   LQV +   C +C  RW GGQC+ D+   F C 
Sbjct: 179 SSCSVIQISSKDLTNTNDILSFVSAEMVLQVVLSNDCDQCYNRW-GGQCRLDANQEFYCE 237

Query: 228 ETRECNDCLKKRGRCHIDDKGNFQCKIEWTGASAFAIGILIFIAFYFKRKLSSYNSTASC 287
           +                              A   A+ +L+ +  Y  R     N T   
Sbjct: 238 K------------------------------AVTIAL-LLVMVMIYHTRWKKKQNPTNQ- 265

Query: 288 LNIETFLRNYRSLSPKRYGYADIKKMTNSFKYKLGQGGYGSVYKGKLLDGSNVAVKVLND 347
             I+ FL     L  KRY Y++IKK+TNSF+ KLGQGG+GSVYKGKL DG  VAVK+L++
Sbjct: 266 -QIKIFLERQGPLQTKRYDYSEIKKVTNSFRNKLGQGGFGSVYKGKLPDGRYVAVKILSE 324

Query: 348 SKGNGKEFINEVASISRTSHVNVVALLGFCLR------VAEELSS--------------- 386
            K NG++FINEVA+ISRTSH+N+V LLGFC        V E +S+               
Sbjct: 325 LKDNGEDFINEVATISRTSHINIVNLLGFCCEGSKRALVYEFMSNGSLEKFIFEENVVKT 384

Query: 387 ------------TIGIARGLEYLHLGCSTRILHFDIKPHNILLDEDFCPKISDFGLAKIC 434
                        +G+ARGLEYLH GC+TRILHFDIKPHNILLDE+F PKISDFGLAKIC
Sbjct: 385 DRQLDCQTIYHIAVGVARGLEYLHQGCNTRILHFDIKPHNILLDENFNPKISDFGLAKIC 444

Query: 435 NRKESIISMTGARGTVGYIAPEVFCRNIGEVSYKSDVYNYGMMIFEMTGGRKNVDVVDNG 494
            RKES+IS+ GARGT GYIAPEVF RN G VS+KSDVY+YGMMI EM G RKN+    N 
Sbjct: 445 TRKESMISIFGARGTAGYIAPEVFSRNFGAVSHKSDVYSYGMMILEMVGRRKNIKTEVNR 504

Query: 495 STAL 498
           S+ +
Sbjct: 505 SSEI 508

Source: Glycine max

Species: Glycine max

Genus: Glycine

Family: Fabaceae

Order: Fabales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|356574204|ref|XP_003555241.1| PREDICTED: G-type lectin S-receptor-like serine/threonine-protein kinase At1g61480-like [Glycine max]

 Score =  368 bits (944), Expect = 5e-99,   Method: Compositional matrix adjust.
 Identities = 229/544 (42%), Positives = 303/544 (55%), Gaps = 81/544 (14%)

Query: 1   MACYSFLVFLVISRLLLLSSAEEESELNKICPYSFPPCGNLGQFTFPFTDPKHPECGLMA 60
           MA      FL+   L+L+ SA   +  ++ CP+SF  CGNLG F +PFT  + P+CGL+A
Sbjct: 1   MAIVDLFCFLLFCHLVLILSAGYGNG-HQDCPHSFT-CGNLGTFHYPFTKAEKPDCGLLA 58

Query: 61  VDNCIEPVQR---IRLGKAGPFYNILNIAQDVSITLEDQVFQNHLNERSCESFEN---LT 114
           + +C  P Q    I+L   G    ++ +AQ  +I++ D+ F   L +  C + +N   L 
Sbjct: 59  IHDCDNPHQHRKMIQLELNGKGIVLIGVAQQNAISILDEDFHKRLQQNPCGTLKNNYSLP 118

Query: 115 LPTSASLSFRIKSNLSLFRCTDKLDNNFIS--FNSTCNSSSF-IYYNH---PDDDLPSIL 168
            P S+  S  IK N++LF+C   L     +  FN  C    + IYY+    P+      L
Sbjct: 119 SPFSSLYSIHIKFNVTLFKCKQSLKMKPPTHYFNHPCPEYDYDIYYDSLPTPNSKEAHSL 178

Query: 169 PPNCSLIQLPVNKTRKSGDLFNMLTSVFSLQVEVHRVCYEC-RWRGGQCQSDSEGNFQCA 227
             +CS+IQ+       + D+ + +++   LQV +   C +C   RGGQ            
Sbjct: 179 FSSCSVIQISTKDLTDTNDILSFVSAEMVLQVVLSNDCDQCYNHRGGQ------------ 226

Query: 228 ETRECNDCLKKRGRCHIDDKGNFQCKIEWTGASAFAIGILIFIAFYFKRKLSSYNSTASC 287
                         C +D    F CK   T A      +L+ +  Y  R     N T   
Sbjct: 227 --------------CRLDANQKFYCKEAVTIAL-----LLVMVMIYHTRWKQKQNPTNQ- 266

Query: 288 LNIETFLRNYRSLSPKRYGYADIKKMTNSFKYKLGQGGYGSVYKGKLLDGSNVAVKVLND 347
             I+ FL     L  KRY Y++IKK+TNSF+ KLGQGG+GSVYKGKL DG  VAVK+L++
Sbjct: 267 -QIKIFLERQGPLQTKRYDYSEIKKVTNSFRNKLGQGGFGSVYKGKLPDGRYVAVKILSE 325

Query: 348 SKGNGKEFINEVASISRTSHVNVVALLGFCLR------VAEELSS--------------- 386
            K NG++FINEVA+ISRTSH+N+V LLGFC        V E +S+               
Sbjct: 326 LKDNGEDFINEVATISRTSHINIVNLLGFCCEGSKRALVYEFMSNGSLEKFIFEENVGKT 385

Query: 387 ------------TIGIARGLEYLHLGCSTRILHFDIKPHNILLDEDFCPKISDFGLAKIC 434
                        +G+ARGLEYLH GC+TRILHFDIKPHNILLDE+F PKISDFGLAKIC
Sbjct: 386 DRQLDCQTIYHIAVGVARGLEYLHQGCNTRILHFDIKPHNILLDENFNPKISDFGLAKIC 445

Query: 435 NRKESIISMTGARGTVGYIAPEVFCRNIGEVSYKSDVYNYGMMIFEMTGGRKNVDVVDNG 494
            RKES+IS+ GARGT GYIAPEVF RN G VS+KSDVY+YGMMI EM G RKN+    N 
Sbjct: 446 TRKESMISIFGARGTAGYIAPEVFSRNFGAVSHKSDVYSYGMMILEMAGRRKNIKTEVNR 505

Query: 495 STAL 498
           S+ +
Sbjct: 506 SSEI 509

Source: Glycine max

Species: Glycine max

Genus: Glycine

Family: Fabaceae

Order: Fabales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|356574212|ref|XP_003555245.1| PREDICTED: probable receptor-like protein kinase At5g39020-like [Glycine max]

 Score =  356 bits (914), Expect = 1e-95,   Method: Compositional matrix adjust.
 Identities = 225/519 (43%), Positives = 289/519 (55%), Gaps = 65/519 (12%)

Query: 31  CPYSFPPCGNLGQFTFPFTDPKHPECGLMAVDNCIEPVQ--RIRLGKAGPFYNILNIAQD 88
           CP SFP CG L   +FPFT  + P+CGL+ + NC +P++   I+L K G ++ ++ + Q 
Sbjct: 29  CPPSFP-CGYLSNISFPFTLTERPDCGLLPIRNCDDPLKPIMIQLHKNGVWFQLVRVTQH 87

Query: 89  --------VSITLEDQVFQNHLNERSCESFEN-LTLPTSASL---SFRIKSNLSLFRCTD 136
                    +    D+   + L   SCE+F N  TLP   S    SF I  N +LFRC  
Sbjct: 88  FRSPTTPLTTFHFRDKNLYDLLQNESCEAFRNNYTLPFPHSFHFASFHIHYNTTLFRCNR 147

Query: 137 KLDNNFIS---FNSTCNSSSFIYYNHPDDDLPSILPPNCSLIQLPVNKTRKSGDLFNMLT 193
            L  + ++     + C      Y N+P  +  S+    C+   LP+     + + F  +T
Sbjct: 148 SLHVSPLTSMYHYTKCPDYDLYYNNNPKAEDASLRA--CTKALLPIKDVPDANNPFTFVT 205

Query: 194 SVFSLQVEVHRVCYECRWR-GGQCQSDSEGNFQCAETRECNDCLKKRGRCHIDDKGNFQC 252
           +  S  V +   C  C +R GGQCQ DS   F CA        L       I     F  
Sbjct: 206 ADISTIVVLTDECAACHYRRGGQCQLDSREIFFCATANSI--ALLSHPYIII-----FLI 258

Query: 253 KIEWTGASAFAIGILIFIAFYFKRKLSSYNSTASCLNIETFLRNYRSLSPKRYGYADIKK 312
            I  + A   A  +L+ +  Y  R     N T     I+ FL     L  KRY Y++IKK
Sbjct: 259 PIT-SPAVTIAALLLVMVKIYHTR-WKKQNPTNQ--QIKIFLEREGPLQTKRYDYSEIKK 314

Query: 313 MTNSFKYKLGQGGYGSVYKGKLLDGSNVAVKVLNDSKGNGKEFINEVASISRTSHVNVVA 372
           +TNSF+ KLGQGG+GSVYKGKL DG  VAVK+L++ K NG++FINEVA+ISRTSH+N+V 
Sbjct: 315 VTNSFRNKLGQGGFGSVYKGKLPDGRYVAVKILSELKDNGEDFINEVATISRTSHINIVN 374

Query: 373 LLGFCLR------VAEELSS---------------------------TIGIARGLEYLHL 399
           LLGFC        V E +S+                            IG+ARGLEYLH 
Sbjct: 375 LLGFCCEGSKRALVYEFMSNGSLEKFIFEENVIKTDRQLDCETIYHIAIGVARGLEYLHQ 434

Query: 400 GCSTRILHFDIKPHNILLDEDFCPKISDFGLAKICNRKESIISMTGARGTVGYIAPEVFC 459
           GC+TRILHFDIKPHNILLDE+F PKISDFGLAKIC RKES+IS+ GARGT GYIAPEVF 
Sbjct: 435 GCNTRILHFDIKPHNILLDENFNPKISDFGLAKICTRKESMISIFGARGTAGYIAPEVFS 494

Query: 460 RNIGEVSYKSDVYNYGMMIFEMTGGRKNVDVVDNGSTAL 498
           RN G VS+KSDVY+YGMMI EM G RKN+    N S+ +
Sbjct: 495 RNFGAVSHKSDVYSYGMMILEMVGRRKNIKTEVNRSSEI 533

Source: Glycine max

Species: Glycine max

Genus: Glycine

Family: Fabaceae

Order: Fabales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|357444697|ref|XP_003592626.1| Protein kinase-coding resistance protein [Medicago truncatula] gi|355481674|gb|AES62877.1| Protein kinase-coding resistance protein [Medicago truncatula]

 Score =  353 bits (905), Expect = 1e-94,   Method: Compositional matrix adjust.
 Identities = 225/537 (41%), Positives = 305/537 (56%), Gaps = 89/537 (16%)

Query: 6   FLVFLVISRLLLLSSAEEESELNKICPYSFPPCGNLGQFTFPFTDPKHPECGLMAVDNC- 64
           FL   ++ + LLLSS         ICP S   CG LG+  FPFT  +HP+CG++ +  C 
Sbjct: 7   FLFSCLLIKQLLLSSC--------ICPSSIT-CGFLGEIEFPFTSTQHPDCGMLVIHGCE 57

Query: 65  -IEPVQRIRLGKAGPFYNILNIAQDVSITLEDQVFQNHLNERSCE--SFENLTLPTSASL 121
             EP  +  +     +++IL I +  +IT++D    + L ++SC+  +++++ +  +  +
Sbjct: 58  DYEPQSKKTIQNNKRWFDILKI-EPFTITIKDDQLHDLLLQKSCDILTYDSMFMVNTPLV 116

Query: 122 SFRIKSNLSLFRCTDKLDNNFISFNSTCNSSSF------IYYNHPDDDLPS--------- 166
           S R++  +++F C      +   + S  NSSS         Y   D D+ S         
Sbjct: 117 SSRLEYYVTVFGCNSNNSLDLQQYYSVSNSSSICREDTTTLYGVSDSDIKSNKTIVVVTD 176

Query: 167 -ILPPN----CSLIQLPVNKT---RKSGDLFNMLTSVFSLQVEVHRVCYECR-WRGGQCQ 217
            +   N    CS ++LP        +  DLF +L+   S++++V + C  C    GGQC 
Sbjct: 177 SVSNSNHLKGCSNVELPTYSKVDRLEPADLFKVLSGEISIKLQVSQNCSSCHDLYGGQCL 236

Query: 218 SDSEGNFQCAETRECNDCLKKRGRCHIDDKGNFQCKIEW-TGASAFAIGILIFIAFYFKR 276
            D+ G F C + +     LK              C   W TG+S F      F +++ +R
Sbjct: 237 LDNNGQFYCKQEKSKKTRLKVTAGI---------CIFCWSTGSSDF------FWSWFLRR 281

Query: 277 KLSSYNSTASCLNIETFLRNYRSLSPKRYGYADIKKMTNSFKYKLGQGGYGSVYKGKLLD 336
              + N       IE FL+N+  L+ KRY YA+IKK TNSFKYKLGQGGYGSVYKGKL D
Sbjct: 282 HYFN-NKNPPYQIIELFLKNHGHLAAKRYTYAEIKKATNSFKYKLGQGGYGSVYKGKLQD 340

Query: 337 GSNVAVKVLNDSKGNGKEFINEVASISRTSHVNVVALLGFC------------------- 377
           GS VAVKVL++S+GNG+EFINEVASIS TSHVN+V LLGF                    
Sbjct: 341 GSLVAVKVLSESEGNGEEFINEVASISVTSHVNIVGLLGFYLEGSKRALIYDYMPNGSLE 400

Query: 378 ---------LRVAEELSS------TIGIARGLEYLHLGCSTRILHFDIKPHNILLDEDFC 422
                    L++  +LS        IG+ARGLEYLH GC+T+ILHFDIKPHNILLD+DFC
Sbjct: 401 KFIYENKDPLKLNLQLSCKTVYNIAIGVARGLEYLHKGCNTKILHFDIKPHNILLDDDFC 460

Query: 423 PKISDFGLAKICNRKESIISMTGARGTVGYIAPEVFCRNIGEVSYKSDVYNYGMMIF 479
           PK+SDFGLAK+C RKESIIS+ GARGT GYIAPEVF RN G VS+KSDVY+YGMM+ 
Sbjct: 461 PKVSDFGLAKVCPRKESIISLLGARGTAGYIAPEVFSRNFGGVSHKSDVYSYGMMVL 517

Source: Medicago truncatula

Species: Medicago truncatula

Genus: Medicago

Family: Fabaceae

Order: Fabales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|356574208|ref|XP_003555243.1| PREDICTED: probable receptor-like protein kinase At1g67000-like [Glycine max]

 Score =  342 bits (876), Expect = 3e-91,   Method: Compositional matrix adjust.
 Identities = 214/520 (41%), Positives = 283/520 (54%), Gaps = 85/520 (16%)

Query: 31  CPYSFPPCGNLGQFTFPFTDPKHPECGLMAVDNCIEPVQ--RIRLGKAGPFYNILNIAQD 88
           CP SFP CG L   +FPFT  + P+CGL+ + NC +P++   I+L K G ++ ++ +AQ 
Sbjct: 13  CPPSFP-CGYLDNISFPFTLTERPDCGLLPISNCDDPLKPKMIQLHKNGLWFPLVRVAQL 71

Query: 89  VS--------ITLEDQVFQNHLNERSCESF-ENLTLPTSASLSFR----IKSNLSLFRCT 135
            S            D    + L   +CE+F  N TLP   S  F     I+   +LFRC 
Sbjct: 72  FSSPTTSLTAFQFRDTNLYHLLLNENCEAFGNNYTLPFPHSSGFAASLYIQYYTTLFRCN 131

Query: 136 DKLD----NNFISFNSTCNSSSFIYYNHPDDDLPSILPPNCSLIQLPVNKTRKSGDLFNM 191
             L      N  ++ + C      Y ++P  +  S+    C+ + LP+     + + F  
Sbjct: 132 RSLHVSPPTNMHNY-TKCPDYDLYYNDNPKAEDASLRA--CTKVLLPIKDAPDANNPFTF 188

Query: 192 LTSVFSLQVEVHRVCYECRWRGGQCQSDSEGNFQCAETRECNDCLKKRGRCHIDDKGNFQ 251
            T+    +VE+   C  C +R G                         G+C +D +  F 
Sbjct: 189 ATADIFTKVELTDECAACHYRRG-------------------------GQCQLDSREIFF 223

Query: 252 CKIEWTGASAFAIGILIFIAFYFKRKLSSYNSTASCLNIETFLRNYRSLSPKRYGYADIK 311
           C      + A  I +L+ +   +  +    N T     I  FL     L  KRY Y++IK
Sbjct: 224 CAT--ANSIAVTIALLLVMVKIYHTRWKKQNPTNQ--QIRIFLEREGPLQTKRYDYSEIK 279

Query: 312 KMTNSFKYKLGQGGYGSVYKGKLLDGSNVAVKVLNDSKGNGKEFINEVASISRTSHVNVV 371
           K+TNSF+ KLGQGG+GSVYKGKL DG  VAVK+L++ K NG++FINEVA+ISRTSH+N+V
Sbjct: 280 KVTNSFRNKLGQGGFGSVYKGKLPDGRYVAVKILSELKDNGEDFINEVATISRTSHINIV 339

Query: 372 ALLGFCLR------VAEELSS---------------------------TIGIARGLEYLH 398
            LLGFC        V E +S+                            IG+ARGLEYLH
Sbjct: 340 NLLGFCCEGSKRALVYEFMSNGSLEKFIFEENVIKTDRQLDCQTIYHIAIGVARGLEYLH 399

Query: 399 LGCSTRILHFDIKPHNILLDEDFCPKISDFGLAKICNRKESIISMTGARGTVGYIAPEVF 458
            GC+TRILHFDIKPHNILLDE+F PKISDFGLAKIC RKES+IS+ GARGT GYIAPEVF
Sbjct: 400 QGCNTRILHFDIKPHNILLDENFNPKISDFGLAKICTRKESMISIFGARGTAGYIAPEVF 459

Query: 459 CRNIGEVSYKSDVYNYGMMIFEMTGGRKNVDVVDNGSTAL 498
            RN G VS+KSDVY+YGMMI EM G RKN+    N S+ +
Sbjct: 460 SRNFGTVSHKSDVYSYGMMILEMVGRRKNIKTEVNCSSEI 499

Source: Glycine max

Species: Glycine max

Genus: Glycine

Family: Fabaceae

Order: Fabales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|356574206|ref|XP_003555242.1| PREDICTED: probable receptor-like protein kinase At1g67000-like [Glycine max]

 Score =  342 bits (876), Expect = 3e-91,   Method: Compositional matrix adjust.
 Identities = 208/504 (41%), Positives = 288/504 (57%), Gaps = 60/504 (11%)

Query: 44  FTFPFTDPKHPECGLMAVDNC--IEPVQRIRLGKAGPFYNILNIAQDVSITLEDQVFQNH 101
            TFPFT+  H +CG++ +  C   EP  +  +     +++++ + Q  +IT++D    + 
Sbjct: 12  ITFPFTNTLHQDCGILVIHGCDDKEPGAKKTIKCNNTWFDVVGLDQ-FTITIKDDKLHDL 70

Query: 102 LNERSCESFE---NLTLPTSASLSFRIKSNLSLFRCTDKLDN---NFISFNSTCNSSSFI 155
           L +RSC++F      T+ +    + R+K  L + RC   L +     +S N+ C + +  
Sbjct: 71  LLQRSCDTFSYSSTFTVSSPLLKASRLKHYLEILRCNHTLGHPPKKSVSNNTLCKNETLY 130

Query: 156 YYNHPDDDLPSILPPN-CSLIQLPV-------NKTRKSGDLFNMLTSVFSLQVEVHRVCY 207
               P+         N CS++ +P        +    S D F  +T   ++++E+   C 
Sbjct: 131 SMVDPNPSGSGYSHHNGCSMLLIPTCLQLLDRHGHLYSSDPFEFITDNIAVEIELSPDCS 190

Query: 208 ECRW-RGGQCQSDSEGNFQCAETRECNDCLKKRGRCHIDD----KGNFQCKI--EWTGAS 260
            C +  GGQC+ D+   F C +  + +  L     C        +  F   I      ++
Sbjct: 191 TCIYAHGGQCRLDNTQKFYCYKGNK-STLLIAASMCVFKSTYAARHYFLSSIINNVVASA 249

Query: 261 AFAIGILIFIAFYFKRKLSSYNSTASCLNIETFLRNYRSLSPKRYGYADIKKMTNSFKYK 320
             A+G +IF+ +  +R+     +    + IE FL  +  L+ KRY Y++IKK TNSF+YK
Sbjct: 250 GGALGAMIFLIWCIRRRFYKKKNPTHQI-IEMFLNTHGHLAAKRYSYSEIKKATNSFRYK 308

Query: 321 LGQGGYGSVYKGKLLDGSNVAVKVLNDSKGNGKEFINEVASISRTSHVNVVALLGFCLRV 380
           LG GGYGSVYKGKL DGS VAVKVL+DS GNG+EFINEVASIS TSHVN+V+LLGFCL  
Sbjct: 309 LGHGGYGSVYKGKLQDGSLVAVKVLSDSIGNGEEFINEVASISVTSHVNIVSLLGFCLEG 368

Query: 381 AE----------------------------ELSS------TIGIARGLEYLHLGCSTRIL 406
           ++                            +LS        IG+ARGLEYLH GC+T+IL
Sbjct: 369 SKRALIYKYMPNGSLEKFIYEDKDPLKLNLQLSCKTIYNIAIGVARGLEYLHRGCNTKIL 428

Query: 407 HFDIKPHNILLDEDFCPKISDFGLAKICNRKESIISMTGARGTVGYIAPEVFCRNIGEVS 466
           HFDIKPHNILLDEDFCPKISDFGLAKIC +KESI+S+ G RGT GYIAPEVF RN GEVS
Sbjct: 429 HFDIKPHNILLDEDFCPKISDFGLAKICPKKESIVSLLGTRGTAGYIAPEVFSRNFGEVS 488

Query: 467 YKSDVYNYGMMIFEMTGGRKNVDV 490
           +KSDVY+YGMM+ EM G R N +V
Sbjct: 489 HKSDVYSYGMMVLEMVGERVNNNV 512

Source: Glycine max

Species: Glycine max

Genus: Glycine

Family: Fabaceae

Order: Fabales

Phylum: Streptophyta

Superkingdom: Eukaryota

---

Prediction of Gene Ontology (GO) Terms

Close Homologs with Gene Ontology terms Detected by BLAST

Original result of BLAST against Gene Ontology (AMIGO)

ID	Length	Definition	Q cover	H cover	Identity	E-value
Query	506
TAIR|locus:2176717	638	AT5G38260 [Arabidopsis thalian	0.213	0.169	0.623	1.3e-66
TAIR|locus:2176737	665	PR5K "PR5-like receptor kinase	0.211	0.160	0.669	2.3e-66
TAIR|locus:2141862	853	AT4G18250 [Arabidopsis thalian	0.203	0.120	0.689	2.3e-65
TAIR|locus:2204480	666	AT1G66910 [Arabidopsis thalian	0.215	0.163	0.614	5.7e-64
TAIR|locus:2019688	674	AT1G66930 [Arabidopsis thalian	0.195	0.146	0.656	1.3e-63
TAIR|locus:2020583	799	AT1G70250 [Arabidopsis thalian	0.213	0.135	0.645	3.7e-61
TAIR|locus:2177142	813	AT5G39020 [Arabidopsis thalian	0.217	0.135	0.639	4.4e-61
TAIR|locus:2177152	806	AT5G39030 [Arabidopsis thalian	0.217	0.136	0.607	1.3e-58
TAIR|locus:2019713	892	AT1G67000 [Arabidopsis thalian	0.274	0.155	0.503	4.5e-40
TAIR|locus:2176707	579	AT5G38250 [Arabidopsis thalian	0.252	0.221	0.535	7.3e-40

TAIR|locus:2176717 AT5G38260 [Arabidopsis thaliana (taxid:3702)]

 Score = 386 (140.9 bits), Expect = 1.3e-66, Sum P(4) = 1.3e-66
 Identities = 68/109 (62%), Positives = 89/109 (81%)

Query:   388 IGIARGLEYLHLGCSTRILHFDIKPHNILLDEDFCPKISDFGLAKICNRKESIISMTGAR 447
             +G+ARGL+YLH GC TRI+HFDIKP NILLD+ FCPK+SDFGLAK+C ++ESI+S+  AR
Sbjct:   423 LGVARGLDYLHHGCKTRIVHFDIKPQNILLDDTFCPKVSDFGLAKLCEKRESILSLLDAR 482

Query:   448 GTVGYIAPEVFCRNIGEVSYKSDVYNYGMMIFEMTGGRKNVDVVDNGST 496
             GT+GYIAPEVF    G VS+KSDVY+YGM++ EM G  KN ++ +  ++
Sbjct:   483 GTIGYIAPEVFSGMYGRVSHKSDVYSYGMLVLEMIGA-KNKEIEETAAS 530

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005886 "plasma membrane" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

TAIR|locus:2176737 PR5K "PR5-like receptor kinase" [Arabidopsis thaliana (taxid:3702)]

 Score = 386 (140.9 bits), Expect = 2.3e-66, Sum P(3) = 2.3e-66
 Identities = 73/109 (66%), Positives = 89/109 (81%)

Query:   388 IGIARGLEYLHLGCSTRILHFDIKPHNILLDEDFCPKISDFGLAKICNRKESIISMTGAR 447
             +GI+RGLEYLH  C TRI+HFDIKP NIL+DE+ CPKISDFGLAK+C  KESIISM   R
Sbjct:   434 VGISRGLEYLHNRCVTRIVHFDIKPQNILMDENLCPKISDFGLAKLCKNKESIISMLHMR 493

Query:   448 GTVGYIAPEVFCRNIGEVSYKSDVYNYGMMIFEMTGGRKNVDVVD-NGS 495
             GT GYIAPE+F +N G VS+KSDVY+YGM++ EM G  KN++ V+ +GS
Sbjct:   494 GTFGYIAPEMFSKNFGAVSHKSDVYSYGMVVLEMIGA-KNIEKVEYSGS 541

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005886 "plasma membrane" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0009506 "plasmodesma" evidence=IDA

GO:0009691 "cytokinin biosynthetic process" evidence=RCA

GO:0004675 "transmembrane receptor protein serine/threonine kinase activity" evidence=ISS

GO:0009620 "response to fungus" evidence=ISS

TAIR|locus:2141862 AT4G18250 [Arabidopsis thaliana (taxid:3702)]

 Score = 394 (143.8 bits), Expect = 2.3e-65, Sum P(4) = 2.3e-65
 Identities = 71/103 (68%), Positives = 86/103 (83%)

Query:   388 IGIARGLEYLHLGCSTRILHFDIKPHNILLDEDFCPKISDFGLAKICNRKESIISMTGAR 447
             +G+ARGLEYLH  C ++I+HFDIKP NIL+DED CPKISDFGLAK+C +KESIISM  AR
Sbjct:   623 VGVARGLEYLHNSCVSKIVHFDIKPQNILIDEDLCPKISDFGLAKLCKKKESIISMLDAR 682

Query:   448 GTVGYIAPEVFCRNIGEVSYKSDVYNYGMMIFEMTGGRKNVDV 490
             GTVGYIAPE+F +N G VS+KSDVY+YGM++ EM G  K  +V
Sbjct:   683 GTVGYIAPEMFSKNYGGVSHKSDVYSYGMVVLEMIGATKREEV 725

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0004675 "transmembrane receptor protein serine/threonine kinase activity" evidence=ISS

GO:0004713 "protein tyrosine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

TAIR|locus:2204480 AT1G66910 [Arabidopsis thaliana (taxid:3702)]

 Score = 379 (138.5 bits), Expect = 5.7e-64, Sum P(3) = 5.7e-64
 Identities = 67/109 (61%), Positives = 85/109 (77%)

Query:   388 IGIARGLEYLHLGCSTRILHFDIKPHNILLDEDFCPKISDFGLAKICNRKESIISMTGAR 447
             +G+ARGLEYLH GC TRI+HFDIKP N+LLD++  PK+SDFGLAK+C RKESI+S+   R
Sbjct:   450 LGVARGLEYLHHGCRTRIVHFDIKPQNVLLDDNLSPKVSDFGLAKLCERKESILSLMDTR 509

Query:   448 GTVGYIAPEVFCRNIGEVSYKSDVYNYGMMIFEMTGGRKNVDVVDNGST 496
             GT+GYIAPEVF R  G VS+KSDVY+YGM++ ++ G R      D  S+
Sbjct:   510 GTIGYIAPEVFSRVYGRVSHKSDVYSYGMLVLDIIGARNKTSTEDTTSS 558

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0004713 "protein tyrosine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005886 "plasma membrane" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

TAIR|locus:2019688 AT1G66930 [Arabidopsis thaliana (taxid:3702)]

 Score = 379 (138.5 bits), Expect = 1.3e-63, Sum P(4) = 1.3e-63
 Identities = 65/99 (65%), Positives = 83/99 (83%)

Query:   388 IGIARGLEYLHLGCSTRILHFDIKPHNILLDEDFCPKISDFGLAKICNRKESIISMTGAR 447
             +G+ARGLEYLH GC TRI+HFDIKP N+LLD++  PK+SDFGLAK+C +KES++S+   R
Sbjct:   449 LGVARGLEYLHYGCKTRIVHFDIKPQNVLLDDNLSPKVSDFGLAKLCEKKESVMSLMDTR 508

Query:   448 GTVGYIAPEVFCRNIGEVSYKSDVYNYGMMIFEMTGGRK 486
             GT+GYIAPE+  R  G VS+KSDVY+YGM++FEM G RK
Sbjct:   509 GTIGYIAPEMISRVYGSVSHKSDVYSYGMLVFEMIGARK 547

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0004713 "protein tyrosine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005886 "plasma membrane" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

TAIR|locus:2020583 AT1G70250 [Arabidopsis thaliana (taxid:3702)]

 Score = 376 (137.4 bits), Expect = 3.7e-61, Sum P(3) = 3.7e-61
 Identities = 71/110 (64%), Positives = 86/110 (78%)

Query:   388 IGIARGLEYLHLGCSTRILHFDIKPHNILLDEDFCPKISDFGLAKICNRKESIISMTGAR 447
             +G++ GLEYLH  C +RI+HFDIKP NIL+D D CPKISDFGLAK+C   ESIISM  AR
Sbjct:   562 VGVSHGLEYLHSHCVSRIVHFDIKPQNILIDGDLCPKISDFGLAKLCKNNESIISMLHAR 621

Query:   448 GTVGYIAPEVFCRNIGEVSYKSDVYNYGMMIFEMTGGRKNVDVVDN-GST 496
             GT+GYIAPEVF +N G VS+KSDVY+YGM++ EM G R N+    N GS+
Sbjct:   622 GTIGYIAPEVFSQNFGGVSHKSDVYSYGMVVLEMIGAR-NIGRAQNAGSS 670

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0004675 "transmembrane receptor protein serine/threonine kinase activity" evidence=ISS

GO:0004713 "protein tyrosine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005886 "plasma membrane" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

TAIR|locus:2177142 AT5G39020 [Arabidopsis thaliana (taxid:3702)]

 Score = 400 (145.9 bits), Expect = 4.4e-61, Sum P(2) = 4.4e-61
 Identities = 71/111 (63%), Positives = 90/111 (81%)

Query:   388 IGIARGLEYLHLGCSTRILHFDIKPHNILLDEDFCPKISDFGLAKICNRKESIISMTGAR 447
             +GIARGLEYLH GC TRI+HFDIKP NILLD++FCPK++DFGLAK+C ++ESI+S+   R
Sbjct:   598 LGIARGLEYLHYGCKTRIVHFDIKPQNILLDDNFCPKVADFGLAKLCEKRESILSLIDTR 657

Query:   448 GTVGYIAPEVFCRNIGEVSYKSDVYNYGMMIFEMTGGRKNVDVVD-NGSTA 497
             GT+GYIAPEV  R  G +S+KSDVY+YGM++ +M G R  V+    NGSTA
Sbjct:   658 GTIGYIAPEVVSRMYGGISHKSDVYSYGMLVLDMIGARNKVETTTCNGSTA 708

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0000165 "MAPK cascade" evidence=RCA

GO:0002237 "response to molecule of bacterial origin" evidence=RCA

GO:0006355 "regulation of transcription, DNA-dependent" evidence=RCA

GO:0006612 "protein targeting to membrane" evidence=RCA

GO:0009581 "detection of external stimulus" evidence=RCA

GO:0009595 "detection of biotic stimulus" evidence=RCA

GO:0009617 "response to bacterium" evidence=RCA

GO:0009625 "response to insect" evidence=RCA

GO:0009697 "salicylic acid biosynthetic process" evidence=RCA

GO:0009862 "systemic acquired resistance, salicylic acid mediated signaling pathway" evidence=RCA

GO:0009863 "salicylic acid mediated signaling pathway" evidence=RCA

GO:0009867 "jasmonic acid mediated signaling pathway" evidence=RCA

GO:0010200 "response to chitin" evidence=RCA

GO:0010310 "regulation of hydrogen peroxide metabolic process" evidence=RCA

GO:0010363 "regulation of plant-type hypersensitive response" evidence=RCA

GO:0031348 "negative regulation of defense response" evidence=RCA

GO:0035304 "regulation of protein dephosphorylation" evidence=RCA

GO:0042742 "defense response to bacterium" evidence=RCA

GO:0043069 "negative regulation of programmed cell death" evidence=RCA

GO:0043900 "regulation of multi-organism process" evidence=RCA

GO:0045088 "regulation of innate immune response" evidence=RCA

GO:0050832 "defense response to fungus" evidence=RCA

GO:0051707 "response to other organism" evidence=RCA

TAIR|locus:2177152 AT5G39030 [Arabidopsis thaliana (taxid:3702)]

 Score = 386 (140.9 bits), Expect = 1.3e-58, Sum P(2) = 1.3e-58
 Identities = 68/112 (60%), Positives = 90/112 (80%)

Query:   388 IGIARGLEYLHLGCSTRILHFDIKPHNILLDEDFCPKISDFGLAKICNRKESIISMTGAR 447
             +GIARGLEYLH GC TRI+HFDIKP NILLD + CPK+SDFGLAK+C ++ES++S+   R
Sbjct:   600 LGIARGLEYLHYGCKTRIVHFDIKPQNILLDGNLCPKVSDFGLAKLCEKRESVLSLMDTR 659

Query:   448 GTVGYIAPEVFCRNIGEVSYKSDVYNYGMMIFEMTGGRKN--VDVVDNGSTA 497
             GT+GYIAPEVF R  G VS+KSDVY++GM++ +M G R    V+ VD+ +++
Sbjct:   660 GTIGYIAPEVFSRMYGRVSHKSDVYSFGMLVIDMIGARSKEIVETVDSAASS 711

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005576 "extracellular region" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

TAIR|locus:2019713 AT1G67000 [Arabidopsis thaliana (taxid:3702)]

 Score = 387 (141.3 bits), Expect = 4.5e-40, Sum P(3) = 4.5e-40
 Identities = 79/157 (50%), Positives = 108/157 (68%)

Query:   332 GKLLDGSNVAVKVLNDSKGNGK--EFINEVASISRTSHVNVVALLGFCLRVAEELSSTIG 389
             G   +GS  A+  + +  GNG   +FI++ +S++    +++  L G  L          G
Sbjct:   617 GFCCEGSRRAI--IYEFLGNGSLDKFISDKSSVN----LDLKTLYGIAL----------G 660

Query:   390 IARGLEYLHLGCSTRILHFDIKPHNILLDEDFCPKISDFGLAKICNRKESIISMTGARGT 449
             +ARGLEYLH GC TRI+HFDIKP N+LLD++ CPK+SDFGLAK+C +KESI+S+   RGT
Sbjct:   661 VARGLEYLHYGCKTRIVHFDIKPQNVLLDDNLCPKVSDFGLAKLCEKKESILSLLDTRGT 720

Query:   450 VGYIAPEVFCRNIGEVSYKSDVYNYGMMIFEMTGGRK 486
             +GYIAPE+  R  G VS+KSDVY+YGM++ EM G RK
Sbjct:   721 IGYIAPEMISRLYGSVSHKSDVYSYGMLVLEMIGARK 757

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005576 "extracellular region" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

TAIR|locus:2176707 AT5G38250 [Arabidopsis thaliana (taxid:3702)]

 Score = 376 (137.4 bits), Expect = 7.3e-40, Sum P(2) = 7.3e-40
 Identities = 75/140 (53%), Positives = 100/140 (71%)

Query:   354 EFINEVASISRTSHVNVVALLGFCLRVAEELSSTIGIARGLEYLHLGCSTRILHFDIKPH 413
             EF+ E  S+ ++ +++V  L G  L          G+ARGLEYLH GC TRI+HFDIKP 
Sbjct:   346 EFL-ENGSLDQSLNLDVSTLYGIAL----------GVARGLEYLHYGCKTRIVHFDIKPQ 394

Query:   414 NILLDEDFCPKISDFGLAKICNRKESIISMTGARGTVGYIAPEVFCRNIGEVSYKSDVYN 473
             N+LLDE+  PK++DFGLAK+C ++ESI+S+   RGT+GYIAPE+F R  G VS+KSDVY+
Sbjct:   395 NVLLDENLRPKVADFGLAKLCEKQESILSLLDTRGTIGYIAPELFSRMYGSVSHKSDVYS 454

Query:   474 YGMMIFEMTGGRKNVDVVDN 493
             YGM++ EM G R N + V N
Sbjct:   455 YGMLVLEMIGAR-NKERVQN 473

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0004713 "protein tyrosine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005886 "plasma membrane" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

---

Prediction of Enzyme Commission (EC) Number

EC Number Prediction by Annotation Transfer from SWISS-PROT Entries

Original result of BLAST against SWISS-PROT

No confident hit for EC number transfering in SWISSPROT detected by BLAST

EC Number Prediction by Ezypred Server

Original result from Ezypred Server

Fail to connect to Ezypred Server

EC Number Prediction by EFICAz Software

Prediction Level	EC number	Confidence of Prediction
4th Layer	2.7.11.1	0.737
3rd Layer	2.7.11	0.691

---

Prediction of Functionally Associated Proteins

Functionally Associated Proteins Detected by STRING

Original result from the STRING server

Fail to connect to STRING server

---

Conserved Domains and Related Protein Families

Conserved Domains Detected by RPS-BLAST

Original result of RPS-BLAST against CDD database part I

ID	Length	Definition	E-value
Query	506
cd00180	215	cd00180, PKc, Catalytic domain of Protein Kinases	3e-35
pfam00069	260	pfam00069, Pkinase, Protein kinase domain	2e-34
smart00219	257	smart00219, TyrKc, Tyrosine kinase, catalytic doma	7e-33
smart00221	258	smart00221, STYKc, Protein kinase; unclassified sp	2e-31
smart00220	254	smart00220, S_TKc, Serine/Threonine protein kinase	2e-31
cd00192	262	cd00192, PTKc, Catalytic domain of Protein Tyrosin	3e-30
pfam07714	258	pfam07714, Pkinase_Tyr, Protein tyrosine kinase	6e-30
cd06606	260	cd06606, STKc_MAPKKK, Catalytic domain of the Prot	7e-30
cd05122	253	cd05122, PKc_STE, Catalytic domain of STE family P	2e-28
cd05057	279	cd05057, PTKc_EGFR_like, Catalytic domain of Epide	4e-23
cd05148	261	cd05148, PTKc_Srm_Brk, Catalytic domain of the Pro	1e-22
cd05060	257	cd05060, PTKc_Syk_like, Catalytic domain of Spleen	5e-21
cd05039	256	cd05039, PTKc_Csk_like, Catalytic domain of C-term	6e-21
cd06612	256	cd06612, STKc_MST1_2, Catalytic domain of the Prot	7e-20
cd08215	258	cd08215, STKc_Nek, Catalytic domain of the Protein	8e-20
cd06623	264	cd06623, PKc_MAPKK_plant_like, Catalytic domain of	1e-19
cd05059	256	cd05059, PTKc_Tec_like, Catalytic domain of Tec-li	2e-19
cd05038	284	cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domai	6e-19
cd06632	258	cd06632, STKc_MEKK1_plant, Catalytic domain of the	2e-18
cd05083	254	cd05083, PTKc_Chk, Catalytic domain of the Protein	2e-18
cd06627	254	cd06627, STKc_Cdc7_like, Catalytic domain of Cell	2e-18
COG0515	384	COG0515, SPS1, Serine/threonine protein kinase [Ge	4e-18
cd06614	286	cd06614, STKc_PAK, Catalytic domain of the Protein	4e-18
cd05052	263	cd05052, PTKc_Abl, Catalytic domain of the Protein	9e-18
cd05123	250	cd05123, STKc_AGC, Catalytic domain of AGC family	1e-17
cd07838	287	cd07838, STKc_CDK4_6_like, Catalytic domain of Cyc	2e-17
cd06613	262	cd06613, STKc_MAP4K3_like, Catalytic domain of Mit	2e-17
cd06626	264	cd06626, STKc_MEKK4, Catalytic domain of the Prote	3e-17
cd07832	286	cd07832, STKc_CCRK, Catalytic domain of the Serine	5e-17
cd05034	261	cd05034, PTKc_Src_like, Catalytic domain of Src ki	6e-17
cd05113	256	cd05113, PTKc_Btk_Bmx, Catalytic domain of the Pro	7e-17
cd05110	303	cd05110, PTKc_HER4, Catalytic domain of the Protei	1e-16
cd05578	258	cd05578, STKc_Yank1, Catalytic domain of the Prote	2e-16
cd06629	272	cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain o	2e-16
cd05058	262	cd05058, PTKc_Met_Ron, Catalytic domain of the Pro	2e-16
cd05112	256	cd05112, PTKc_Itk, Catalytic domain of the Protein	4e-16
cd05581	280	cd05581, STKc_PDK1, Catalytic domain of the Protei	4e-16
cd05041	251	cd05041, PTKc_Fes_like, Catalytic domain of Fes-li	5e-16
cd05040	257	cd05040, PTKc_Ack_like, Catalytic domain of the Pr	6e-16
cd05108	316	cd05108, PTKc_EGFR, Catalytic domain of the Protei	6e-16
cd08217	265	cd08217, STKc_Nek2, Catalytic domain of the Protei	7e-16
cd05109	279	cd05109, PTKc_HER2, Catalytic domain of the Protei	8e-16
cd08530	256	cd08530, STKc_CNK2-like, Catalytic domain of the P	1e-15
cd05068	261	cd05068, PTKc_Frk_like, Catalytic domain of Fyn-re	2e-15
cd07829	282	cd07829, STKc_CDK_like, Catalytic domain of Cyclin	2e-15
cd07841	298	cd07841, STKc_CDK7, Catalytic domain of the Serine	4e-15
cd06608	275	cd06608, STKc_myosinIII_like, Catalytic domain of	4e-15
cd06631	265	cd06631, STKc_YSK4, Catalytic domain of the Protei	7e-15
cd05118	283	cd05118, STKc_CMGC, Catalytic domain of CMGC famil	2e-14
cd06621	287	cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of	2e-14
cd05114	256	cd05114, PTKc_Tec_Rlk, Catalytic domain of the Pro	2e-14
cd06647	293	cd06647, STKc_PAK_I, Catalytic domain of the Prote	3e-14
cd05577	277	cd05577, STKc_GRK, Catalytic domain of the Protein	5e-14
cd05067	260	cd05067, PTKc_Lck_Blk, Catalytic domain of the Pro	5e-14
cd05035	273	cd05035, PTKc_Axl_like, Catalytic Domain of Axl-li	7e-14
cd08224	267	cd08224, STKc_Nek6_Nek7, Catalytic domain of the P	1e-13
cd05085	250	cd05085, PTKc_Fer, Catalytic domain of the Protein	2e-13
cd05033	266	cd05033, PTKc_EphR, Catalytic domain of Ephrin Rec	2e-13
cd05084	252	cd05084, PTKc_Fes, Catalytic domain of the Protein	2e-13
cd07833	288	cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dep	2e-13
cd05071	262	cd05071, PTKc_Src, Catalytic domain of the Protein	3e-13
cd07863	288	cd07863, STKc_CDK4, Catalytic domain of the Serine	5e-13
cd05053	293	cd05053, PTKc_FGFR, Catalytic domain of the Protei	5e-13
cd07870	291	cd07870, STKc_PFTAIRE2, Catalytic domain of the Se	6e-13
cd06610	267	cd06610, STKc_OSR1_SPAK, Catalytic domain of the P	6e-13
cd07830	283	cd07830, STKc_MAK_like, Catalytic domain of Male g	9e-13
cd08529	256	cd08529, STKc_FA2-like, Catalytic domain of the Pr	1e-12
cd05032	277	cd05032, PTKc_InsR_like, Catalytic domain of Insul	1e-12
cd07840	287	cd07840, STKc_CDK9_like, Catalytic domain of Cycli	1e-12
cd06625	263	cd06625, STKc_MEKK3_like, Catalytic domain of MAP/	2e-12
cd05072	261	cd05072, PTKc_Lyn, Catalytic domain of the Protein	2e-12
cd07844	291	cd07844, STKc_PCTAIRE_like, Catalytic domain of PC	2e-12
cd05582	318	cd05582, STKc_RSK_N, N-terminal catalytic domain o	2e-12
cd06628	267	cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain o	2e-12
cd07853	372	cd07853, STKc_NLK, Catalytic domain of the Serine/	3e-12
cd05070	260	cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Pro	4e-12
cd08221	256	cd08221, STKc_Nek9, Catalytic domain of the Protei	5e-12
cd05605	285	cd05605, STKc_GRK4_like, Catalytic domain of G pro	5e-12
cd05069	260	cd05069, PTKc_Yes, Catalytic domain of the Protein	5e-12
cd05101	304	cd05101, PTKc_FGFR2, Catalytic domain of the Prote	7e-12
cd06644	292	cd06644, STKc_STK10_LOK, Catalytic domain of the P	8e-12
cd06648	285	cd06648, STKc_PAK_II, Catalytic domain of the Prot	8e-12
cd07871	288	cd07871, STKc_PCTAIRE3, Catalytic domain of the Se	8e-12
cd07851	343	cd07851, STKc_p38, Catalytic domain of the Serine/	1e-11
cd05048	283	cd05048, PTKc_Ror, Catalytic Domain of the Protein	1e-11
cd06917	277	cd06917, STKc_NAK1_like, Catalytic domain of Funga	1e-11
cd05579	265	cd05579, STKc_MAST_like, Catalytic domain of Micro	1e-11
cd06656	297	cd06656, STKc_PAK3, Catalytic domain of the Protei	1e-11
cd07861	285	cd07861, STKc_CDK1_euk, Catalytic domain of the Se	2e-11
cd07869	303	cd07869, STKc_PFTAIRE1, Catalytic domain of the Se	2e-11
cd06607	307	cd06607, STKc_TAO, Catalytic domain of the Protein	2e-11
cd05082	256	cd05082, PTKc_Csk, Catalytic domain of the Protein	3e-11
cd06654	296	cd06654, STKc_PAK1, Catalytic domain of the Protei	3e-11
cd07856	328	cd07856, STKc_Sty1_Hog1, Catalytic domain of the S	3e-11
cd07860	284	cd07860, STKc_CDK2_3, Catalytic domain of the Seri	3e-11
cd05111	279	cd05111, PTK_HER3, Pseudokinase domain of the Prot	4e-11
cd07835	283	cd07835, STKc_CDK1_like, Catalytic domain of Cycli	4e-11
cd07836	284	cd07836, STKc_Pho85, Catalytic domain of the Serin	5e-11
cd05088	303	cd05088, PTKc_Tie2, Catalytic domain of the Protei	6e-11
cd06659	297	cd06659, STKc_PAK6, Catalytic domain of the Protei	7e-11
cd06637	272	cd06637, STKc_TNIK, Catalytic domain of the Protei	8e-11
cd07862	290	cd07862, STKc_CDK6, Catalytic domain of the Serine	9e-11
cd07842	316	cd07842, STKc_CDK8_like, Catalytic domain of Cycli	9e-11
cd06624	268	cd06624, STKc_ASK, Catalytic domain of the Protein	9e-11
cd05630	285	cd05630, STKc_GRK6, Catalytic domain of the Protei	1e-10
cd07872	309	cd07872, STKc_PCTAIRE2, Catalytic domain of the Se	1e-10
cd07834	330	cd07834, STKc_MAPK, Catalytic domain of the Serine	1e-10
cd05100	334	cd05100, PTKc_FGFR3, Catalytic domain of the Prote	1e-10
cd05099	314	cd05099, PTKc_FGFR4, Catalytic domain of the Prote	1e-10
cd05074	273	cd05074, PTKc_Tyro3, Catalytic domain of the Prote	2e-10
cd06636	282	cd06636, STKc_MAP4K4_6, Catalytic domain of the Pr	2e-10
cd06605	265	cd06605, PKc_MAPKK, Catalytic domain of the dual-s	2e-10
cd05632	285	cd05632, STKc_GRK5, Catalytic domain of the Protei	2e-10
cd08528	269	cd08528, STKc_Nek10, Catalytic domain of the Prote	2e-10
cd05036	277	cd05036, PTKc_ALK_LTK, Catalytic domain of the Pro	2e-10
cd05608	280	cd05608, STKc_GRK1, Catalytic domain of the Protei	3e-10
cd05073	260	cd05073, PTKc_Hck, Catalytic domain of the Protein	3e-10
cd05098	307	cd05098, PTKc_FGFR1, Catalytic domain of the Prote	3e-10
cd07873	301	cd07873, STKc_PCTAIRE1, Catalytic domain of the Se	3e-10
cd06635	317	cd06635, STKc_TAO1, Catalytic domain of the Protei	4e-10
TIGR03903	1266	TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclas	4e-10
cd07846	286	cd07846, STKc_CDKL2_3, Catalytic domain of the Ser	4e-10
cd08223	257	cd08223, STKc_Nek4, Catalytic domain of the Protei	4e-10
cd05049	280	cd05049, PTKc_Trk, Catalytic domain of the Protein	4e-10
cd05075	272	cd05075, PTKc_Axl, Catalytic domain of the Protein	5e-10
cd06655	296	cd06655, STKc_PAK2, Catalytic domain of the Protei	5e-10
cd07855	334	cd07855, STKc_ERK5, Catalytic domain of the Serine	5e-10
cd05580	290	cd05580, STKc_PKA, Catalytic domain of the Protein	6e-10
cd05631	285	cd05631, STKc_GRK4, Catalytic domain of the Protei	6e-10
cd05056	270	cd05056, PTKc_FAK, Catalytic domain of the Protein	7e-10
cd05044	269	cd05044, PTKc_c-ros, Catalytic domain of the Prote	7e-10
cd05045	290	cd05045, PTKc_RET, Catalytic domain of the Protein	7e-10
cd05612	291	cd05612, STKc_PRKX_like, Catalytic domain of PRKX-	9e-10
cd05063	268	cd05063, PTKc_EphR_A2, Catalytic domain of the Pro	9e-10
cd05061	288	cd05061, PTKc_InsR, Catalytic domain of the Protei	1e-09
cd07857	332	cd07857, STKc_MPK1, Catalytic domain of the Serine	1e-09
cd06634	308	cd06634, STKc_TAO2, Catalytic domain of the Protei	1e-09
cd05081	284	cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2)	1e-09
cd05115	257	cd05115, PTKc_Zap-70, Catalytic domain of the Prot	1e-09
cd05116	257	cd05116, PTKc_Syk, Catalytic domain of the Protein	2e-09
cd05611	260	cd05611, STKc_Rim15_like, Catalytic domain of fung	2e-09
cd08229	267	cd08229, STKc_Nek7, Catalytic domain of the Protei	2e-09
cd05055	302	cd05055, PTKc_PDGFR, Catalytic domain of the Prote	2e-09
cd06630	268	cd06630, STKc_MEKK1, Catalytic domain of the Prote	2e-09
cd06658	292	cd06658, STKc_PAK5, Catalytic domain of the Protei	2e-09
cd07865	310	cd07865, STKc_CDK9, Catalytic domain of the Serine	2e-09
PLN00113	968	PLN00113, PLN00113, leucine-rich repeat receptor-l	3e-09
cd08225	257	cd08225, STKc_Nek5, Catalytic domain of the Protei	3e-09
cd06643	282	cd06643, STKc_SLK, Catalytic domain of the Protein	3e-09
cd05091	283	cd05091, PTKc_Ror2, Catalytic domain of the Protei	4e-09
cd05573	350	cd05573, STKc_ROCK_NDR_like, Catalytic domain of R	4e-09
cd05062	277	cd05062, PTKc_IGF-1R, Catalytic domain of the Prot	5e-09
cd05065	269	cd05065, PTKc_EphR_B, Catalytic domain of the Prot	5e-09
cd07877	345	cd07877, STKc_p38alpha_MAPK14, Catalytic domain of	5e-09
cd05606	278	cd05606, STKc_beta_ARK, Catalytic domain of the Pr	5e-09
cd06609	274	cd06609, STKc_MST3_like, Catalytic domain of Mamma	5e-09
cd05572	262	cd05572, STKc_cGK_PKG, Catalytic domain of the Pro	5e-09
cd07858	337	cd07858, STKc_TEY_MAPK_plant, Catalytic domain of	6e-09
cd06657	292	cd06657, STKc_PAK4, Catalytic domain of the Protei	6e-09
cd08218	256	cd08218, STKc_Nek1, Catalytic domain of the Protei	7e-09
cd05607	277	cd05607, STKc_GRK7, Catalytic domain of the Protei	8e-09
cd05046	275	cd05046, PTK_CCK4, Pseudokinase domain of the Prot	8e-09
cd06611	280	cd06611, STKc_SLK_like, Catalytic domain of Ste20-	9e-09
PHA03209	357	PHA03209, PHA03209, serine/threonine kinase US3; P	9e-09
cd06633	313	cd06633, STKc_TAO3, Catalytic domain of the Protei	9e-09
cd07849	336	cd07849, STKc_ERK1_2_like, Catalytic domain of Ext	9e-09
cd07866	311	cd07866, STKc_BUR1, Catalytic domain of the Serine	1e-08
cd06642	277	cd06642, STKc_STK25-YSK1, Catalytic domain of the	1e-08
cd05066	267	cd05066, PTKc_EphR_A, Catalytic domain of the Prot	1e-08
cd07845	309	cd07845, STKc_CDK10, Catalytic domain of the Serin	2e-08
cd05570	318	cd05570, STKc_PKC, Catalytic domain of the Protein	2e-08
cd07880	343	cd07880, STKc_p38gamma_MAPK12, Catalytic domain of	2e-08
cd07852	337	cd07852, STKc_MAPK15, Catalytic domain of the Seri	2e-08
cd08228	267	cd08228, STKc_Nek6, Catalytic domain of the Protei	2e-08
PLN00034	353	PLN00034, PLN00034, mitogen-activated protein kina	2e-08
cd07879	342	cd07879, STKc_p38delta_MAPK13, Catalytic domain of	3e-08
cd05587	324	cd05587, STKc_cPKC, Catalytic domain of the Protei	3e-08
cd05633	279	cd05633, STKc_GRK3, Catalytic domain of the Protei	4e-08
cd05054	337	cd05054, PTKc_VEGFR, Catalytic domain of the Prote	4e-08
cd05595	323	cd05595, STKc_PKB_beta, Catalytic domain of the Pr	5e-08
cd05584	323	cd05584, STKc_p70S6K, Catalytic domain of the Prot	5e-08
cd07837	295	cd07837, STKc_CdkB_plant, Catalytic domain of the	5e-08
cd06639	291	cd06639, STKc_myosinIIIB, Catalytic domain of the	6e-08
cd07878	343	cd07878, STKc_p38beta_MAPK11, Catalytic domain of	6e-08
cd06646	267	cd06646, STKc_MAP4K5, Catalytic domain of the Prot	7e-08
cd05047	270	cd05047, PTKc_Tie, Catalytic domain of Tie Protein	7e-08
cd05102	338	cd05102, PTKc_VEGFR3, Catalytic domain of the Prot	7e-08
cd05600	333	cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fun	7e-08
cd05080	283	cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) doma	8e-08
cd06616	288	cd06616, PKc_MKK4, Catalytic domain of the dual-sp	9e-08
cd05090	283	cd05090, PTKc_Ror1, Catalytic domain of the Protei	9e-08
cd05089	297	cd05089, PTKc_Tie1, Catalytic domain of the Protei	9e-08
PLN00009	294	PLN00009, PLN00009, cyclin-dependent kinase A; Pro	9e-08
PTZ00426	340	PTZ00426, PTZ00426, cAMP-dependent protein kinase	9e-08
cd05103	343	cd05103, PTKc_VEGFR2, Catalytic domain of the Prot	1e-07
cd06641	277	cd06641, STKc_MST3, Catalytic domain of the Protei	1e-07
cd07847	286	cd07847, STKc_CDKL1_4, Catalytic domain of the Ser	1e-07
cd05104	375	cd05104, PTKc_Kit, Catalytic domain of the Protein	1e-07
cd06617	283	cd06617, PKc_MKK3_6, Catalytic domain of the dual-	2e-07
cd06651	266	cd06651, STKc_MEKK3, Catalytic domain of the Prote	2e-07
cd07839	284	cd07839, STKc_CDK5, Catalytic domain of the Serine	2e-07
cd05571	323	cd05571, STKc_PKB, Catalytic domain of the Protein	2e-07
cd05105	400	cd05105, PTKc_PDGFR_alpha, Catalytic domain of the	2e-07
cd05593	328	cd05593, STKc_PKB_gamma, Catalytic domain of the P	3e-07
cd06649	331	cd06649, PKc_MEK2, Catalytic domain of the dual-sp	3e-07
cd05619	316	cd05619, STKc_nPKC_theta, Catalytic domain of the	3e-07
cd06615	308	cd06615, PKc_MEK, Catalytic domain of the dual-spe	3e-07
cd06619	279	cd06619, PKc_MKK5, Catalytic domain of the dual-sp	3e-07
cd05583	288	cd05583, STKc_MSK_N, N-terminal catalytic domain o	3e-07
cd08220	256	cd08220, STKc_Nek8, Catalytic domain of the Protei	3e-07
cd07850	353	cd07850, STKc_JNK, Catalytic domain of the Serine/	4e-07
PRK13184	932	PRK13184, pknD, serine/threonine-protein kinase; R	5e-07
cd05588	329	cd05588, STKc_aPKC, Catalytic domain of the Protei	6e-07
cd06652	265	cd06652, STKc_MEKK2, Catalytic domain of the Prote	6e-07
cd07859	338	cd07859, STKc_TDY_MAPK_plant, Catalytic domain of	8e-07
cd06640	277	cd06640, STKc_MST4, Catalytic domain of the Protei	9e-07
cd05586	330	cd05586, STKc_Sck1_like, Catalytic domain of Suppr	9e-07
cd06645	267	cd06645, STKc_MAP4K3, Catalytic domain of the Prot	1e-06
cd06653	264	cd06653, STKc_MEKK3_like_1, Catalytic domain of MA	1e-06
cd05620	316	cd05620, STKc_nPKC_delta, Catalytic domain of the	1e-06
cd05622	371	cd05622, STKc_ROCK1, Catalytic domain of the Prote	1e-06
cd05618	329	cd05618, STKc_aPKC_iota, Catalytic domain of the P	1e-06
cd05617	327	cd05617, STKc_aPKC_zeta, Catalytic domain of the P	1e-06
cd07854	342	cd07854, STKc_MAPK4_6, Catalytic domain of the Ser	1e-06
cd05594	325	cd05594, STKc_PKB_alpha, Catalytic domain of the P	1e-06
cd05050	288	cd05050, PTKc_Musk, Catalytic domain of the Protei	1e-06
cd05097	295	cd05097, PTKc_DDR_like, Catalytic domain of Discoi	1e-06
cd05614	332	cd05614, STKc_MSK2_N, N-terminal catalytic domain	2e-06
PTZ00263	329	PTZ00263, PTZ00263, protein kinase A catalytic sub	2e-06
cd06620	284	cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of	2e-06
cd07831	282	cd07831, STKc_MOK, Catalytic domain of the Serine/	2e-06
cd05592	316	cd05592, STKc_nPKC_theta_delta, Catalytic domain o	2e-06
cd05615	323	cd05615, STKc_cPKC_alpha, Catalytic domain of the	3e-06
cd06650	333	cd06650, PKc_MEK1, Catalytic domain of the dual-sp	3e-06
cd06618	296	cd06618, PKc_MKK7, Catalytic domain of the dual-sp	4e-06
cd05096	304	cd05096, PTKc_DDR1, Catalytic domain of the Protei	4e-06
cd05575	323	cd05575, STKc_SGK, Catalytic domain of the Protein	5e-06
cd05589	324	cd05589, STKc_PKN, Catalytic domain of the Protein	5e-06
cd05107	401	cd05107, PTKc_PDGFR_beta, Catalytic domain of the	6e-06
cd05106	374	cd05106, PTKc_CSF-1R, Catalytic domain of the Prot	8e-06
cd05042	269	cd05042, PTKc_Aatyk, Catalytic domain of the Prote	8e-06
cd05596	370	cd05596, STKc_ROCK, Catalytic domain of the Protei	9e-06
cd05609	305	cd05609, STKc_MAST, Catalytic domain of the Protei	1e-05
cd07876	359	cd07876, STKc_JNK2, Catalytic domain of the Serine	1e-05
cd05051	296	cd05051, PTKc_DDR, Catalytic domain of the Protein	2e-05
cd05621	370	cd05621, STKc_ROCK2, Catalytic domain of the Prote	2e-05
cd05616	323	cd05616, STKc_cPKC_beta, Catalytic domain of the P	2e-05
cd06638	286	cd06638, STKc_myosinIIIA, Catalytic domain of the	2e-05
cd05613	290	cd05613, STKc_MSK1_N, N-terminal catalytic domain	2e-05
cd05590	320	cd05590, STKc_nPKC_eta, Catalytic domain of the Pr	3e-05
cd07864	302	cd07864, STKc_CDK12, Catalytic domain of the Serin	4e-05
cd07867	317	cd07867, STKc_CDC2L6, Catalytic domain of Serine/T	4e-05
PTZ00036	440	PTZ00036, PTZ00036, glycogen synthase kinase; Prov	4e-05
cd07868	317	cd07868, STKc_CDK8, Catalytic domain of the Serine	4e-05
cd07875	364	cd07875, STKc_JNK1, Catalytic domain of the Serine	5e-05
cd05591	321	cd05591, STKc_nPKC_epsilon, Catalytic domain of th	6e-05
cd05087	269	cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of t	6e-05
cd05603	321	cd05603, STKc_SGK2, Catalytic domain of the Protei	6e-05
PTZ00283	496	PTZ00283, PTZ00283, serine/threonine protein kinas	7e-05
cd07874	355	cd07874, STKc_JNK3, Catalytic domain of the Serine	7e-05
cd05599	364	cd05599, STKc_NDR_like, Catalytic domain of Nuclea	7e-05
cd05602	325	cd05602, STKc_SGK1, Catalytic domain of the Protei	8e-05
PHA03211	461	PHA03211, PHA03211, serine/threonine kinase US3; P	9e-05
cd05604	325	cd05604, STKc_SGK3, Catalytic domain of the Protei	9e-05
cd05093	288	cd05093, PTKc_TrkB, Catalytic domain of the Protei	1e-04
cd05624	331	cd05624, STKc_MRCK_beta, Catalytic domain of the P	1e-04
PTZ00267	478	PTZ00267, PTZ00267, NIMA-related protein kinase; P	1e-04
cd05574	316	cd05574, STKc_phototropin_like, Catalytic domain o	2e-04
cd05601	330	cd05601, STKc_CRIK, Catalytic domain of the Protei	2e-04
cd08222	260	cd08222, STKc_Nek11, Catalytic domain of the Prote	2e-04
cd05092	280	cd05092, PTKc_TrkA, Catalytic domain of the Protei	2e-04
PTZ00024	335	PTZ00024, PTZ00024, cyclin-dependent protein kinas	3e-04
cd06622	286	cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of	3e-04
PHA03212	391	PHA03212, PHA03212, serine/threonine kinase US3; P	3e-04
cd07843	293	cd07843, STKc_CDC2L1, Catalytic domain of the Seri	3e-04
cd05095	296	cd05095, PTKc_DDR2, Catalytic domain of the Protei	4e-04
cd05079	284	cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) doma	4e-04
cd05585	312	cd05585, STKc_YPK1_like, Catalytic domain of Yeast	4e-04
cd08219	255	cd08219, STKc_Nek3, Catalytic domain of the Protei	5e-04
cd05598	376	cd05598, STKc_LATS, Catalytic domain of the Protei	0.001
PTZ00266	1021	PTZ00266, PTZ00266, NIMA-related protein kinase; P	0.002
cd05627	360	cd05627, STKc_NDR2, Catalytic domain of the Protei	0.002
cd05610	669	cd05610, STKc_MASTL, Catalytic domain of the Prote	0.002
PHA03207	392	PHA03207, PHA03207, serine/threonine kinase US3; P	0.002
cd05628	363	cd05628, STKc_NDR1, Catalytic domain of the Protei	0.002
cd05094	291	cd05094, PTKc_TrkC, Catalytic domain of the Protei	0.004
cd05597	331	cd05597, STKc_DMPK_like, Catalytic domain of Myoto	0.004
cd07848	287	cd07848, STKc_CDKL5, Catalytic domain of the Serin	0.004

>gnl|CDD|173623 cd00180, PKc, Catalytic domain of Protein Kinases

 Score =  130 bits (329), Expect = 3e-35
 Identities = 62/193 (32%), Positives = 96/193 (49%), Gaps = 38/193 (19%)

Query: 321 LGQGGYGSVYKGK-LLDGSNVAVKVLN--DSKGNGKEFINEVASISRTSHVNVVALLGFC 377
           LG+GG+G+VY  +    G  VA+K++   DS    +E + E+  + + +H N+V L G  
Sbjct: 1   LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSSLLEELLREIEILKKLNHPNIVKLYGVF 60

Query: 378 L----------------------RVAEELSST------IGIARGLEYLHLGCSTRILHFD 409
                                      +LS        + I  GLEYLH   S  I+H D
Sbjct: 61  EDENHLYLVMEYCEGGSLKDLLKENEGKLSEDEILRILLQILEGLEYLH---SNGIIHRD 117

Query: 410 IKPHNILLDED-FCPKISDFGLAKICNRKESIISMTGARGTVGYIAPEVFCRNIGEVSYK 468
           +KP NILLD D    K++DFGL+K+    +S+  +    GT  Y+APEV     G  S K
Sbjct: 118 LKPENILLDSDNGKVKLADFGLSKLLTSDKSL--LKTIVGTPAYMAPEVL-LGKGYYSEK 174

Query: 469 SDVYNYGMMIFEM 481
           SD+++ G++++E+
Sbjct: 175 SDIWSLGVILYEL 187

Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which one kinase activates a second kinase, which in turn, may act on other kinases; this sequential action transmits a signal from the cell surface to target proteins, which results in cellular responses. The PK family is one of the largest known protein families with more than 100 homologous yeast enzymes and 550 human proteins. A fraction of PK family members are pseudokinases that lack crucial residues for catalytic activity. The mutiplicity of kinases allows for specific regulation according to substrate, tissue distribution, and cellular localization. PKs regulate many cellular processes including proliferation, division, differentiation, motility, survival, metabolism, cell-cycle progression, cytoskeletal rearrangement, immunity, and neuronal functions. Many kinases are implicated in the development of various human diseases including different types of cancer. Length = 215

>gnl|CDD|215690 pfam00069, Pkinase, Protein kinase domain

 Score =  130 bits (328), Expect = 2e-34
 Identities = 68/197 (34%), Positives = 96/197 (48%), Gaps = 37/197 (18%)

Query: 320 KLGQGGYGSVYKGKLL-DGSNVAVKVLN---DSKGNGKEFINEVASISRTSHVNVVALLG 375
           KLG G +G+VYK K    G  VAVK+L    +     +    E+  + R SH N+V L+ 
Sbjct: 6   KLGSGSFGTVYKAKHKGTGKIVAVKILKKRSEKSKKDQTARREIRILRRLSHPNIVRLID 65

Query: 376 FCLR-------------------------VAEELSSTI--GIARGLEYLHLGCSTRILHF 408
                                        ++E+ +  I   I RGLEYLH   S  I+H 
Sbjct: 66  AFEDKDHLYLVMEYCEGGDLFDYLSRGGPLSEDEAKKIALQILRGLEYLH---SNGIIHR 122

Query: 409 DIKPHNILLDEDFCPKISDFGLAKICNRKESIISMTGARGTVGYIAPEVFCRNIGEVSYK 468
           D+KP NILLDE+   KI+DFGLAK   +  S  S+T   GT  Y+APEV          K
Sbjct: 123 DLKPENILLDENGVVKIADFGLAKKLLKSSS--SLTTFVGTPWYMAPEV-LLGGNGYGPK 179

Query: 469 SDVYNYGMMIFEMTGGR 485
            DV++ G++++E+  G+
Sbjct: 180 VDVWSLGVILYELLTGK 196

Length = 260

>gnl|CDD|197581 smart00219, TyrKc, Tyrosine kinase, catalytic domain

 Score =  125 bits (316), Expect = 7e-33
 Identities = 63/203 (31%), Positives = 97/203 (47%), Gaps = 42/203 (20%)

Query: 320 KLGQGGYGSVYKGKLLDGS-----NVAVKVLNDSKGNG--KEFINEVASISRTSHVNVVA 372
           KLG+G +G VYKGKL          VAVK L +       +EF+ E   + +  H NVV 
Sbjct: 6   KLGEGAFGEVYKGKLKGKGGKKKVEVAVKTLKEDASEQQIEEFLREARIMRKLDHPNVVK 65

Query: 373 LLGFC----------------------------LRVAEELSSTIGIARGLEYLHLGCSTR 404
           LLG C                            L +++ LS  + IARG+EYL    S  
Sbjct: 66  LLGVCTEEEPLYIVMEYMEGGDLLSYLRKNRPKLSLSDLLSFALQIARGMEYLE---SKN 122

Query: 405 ILHFDIKPHNILLDEDFCPKISDFGLAKICNRKESIISMTGARGTVGYIAPEVFCRNIGE 464
            +H D+   N L+ E+   KISDFGL++     +      G +  + ++APE      G+
Sbjct: 123 FIHRDLAARNCLVGENLVVKISDFGLSRDLYDDD-YYRKRGGKLPIRWMAPESLKE--GK 179

Query: 465 VSYKSDVYNYGMMIFEM-TGGRK 486
            + KSDV+++G++++E+ T G +
Sbjct: 180 FTSKSDVWSFGVLLWEIFTLGEQ 202

Phosphotransferases. Tyrosine-specific kinase subfamily. Length = 257

>gnl|CDD|214568 smart00221, STYKc, Protein kinase; unclassified specificity

 Score =  121 bits (306), Expect = 2e-31
 Identities = 62/204 (30%), Positives = 95/204 (46%), Gaps = 43/204 (21%)

Query: 320 KLGQGGYGSVYKGKLLDGS-----NVAVKVLNDSKGNG--KEFINEVASISRTSHVNVVA 372
           KLG+G +G VYKG L          VAVK L +       +EF+ E   + +  H N+V 
Sbjct: 6   KLGEGAFGEVYKGTLKGKGDGKEVEVAVKTLKEDASEQQIEEFLREARIMRKLDHPNIVK 65

Query: 373 LLGFC---------------------LRVAEE--------LSSTIGIARGLEYLHLGCST 403
           LLG C                     LR            LS  + IARG+EYL    S 
Sbjct: 66  LLGVCTEEEPLMIVMEYMPGGDLLDYLRKNRPKELSLSDLLSFALQIARGMEYLE---SK 122

Query: 404 RILHFDIKPHNILLDEDFCPKISDFGLAKICNRKESIISMTGARGTVGYIAPEVFCRNIG 463
             +H D+   N L+ E+   KISDFGL++     +    + G +  + ++APE      G
Sbjct: 123 NFIHRDLAARNCLVGENLVVKISDFGLSRDLYDDD-YYKVKGGKLPIRWMAPESLKE--G 179

Query: 464 EVSYKSDVYNYGMMIFEM-TGGRK 486
           + + KSDV+++G++++E+ T G +
Sbjct: 180 KFTSKSDVWSFGVLLWEIFTLGEE 203

Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. Length = 258

>gnl|CDD|214567 smart00220, S_TKc, Serine/Threonine protein kinases, catalytic domain

 Score =  121 bits (305), Expect = 2e-31
 Identities = 57/196 (29%), Positives = 89/196 (45%), Gaps = 38/196 (19%)

Query: 320 KLGQGGYGSVYKGKLLD-GSNVAVKVLNDSKGNGKE--FINEVASISRTSHVNVVALLGF 376
           KLG+G +G VY  +    G  VA+KV+   K        + E+  + +  H N+V L   
Sbjct: 6   KLGEGSFGKVYLARDKKTGKLVAIKVIKKKKIKKDRERILREIKILKKLKHPNIVRLYDV 65

Query: 377 CL-------------------------RVAEELSSTIG--IARGLEYLHLGCSTRILHFD 409
                                      R++E+ +      I   LEYLH   S  I+H D
Sbjct: 66  FEDEDKLYLVMEYCEGGDLFDLLKKRGRLSEDEARFYLRQILSALEYLH---SKGIVHRD 122

Query: 410 IKPHNILLDEDFCPKISDFGLAKICNRKESIISMTGARGTVGYIAPEVFCRNIGEVSYKS 469
           +KP NILLDED   K++DFGLA+  +  E + +     GT  Y+APEV            
Sbjct: 123 LKPENILLDEDGHVKLADFGLARQLDPGEKLTTFV---GTPEYMAPEVLLGK--GYGKAV 177

Query: 470 DVYNYGMMIFEMTGGR 485
           D+++ G++++E+  G+
Sbjct: 178 DIWSLGVILYELLTGK 193

Phosphotransferases. Serine or threonine-specific kinase subfamily. Length = 254

>gnl|CDD|173624 cd00192, PTKc, Catalytic domain of Protein Tyrosine Kinases

 Score =  118 bits (298), Expect = 3e-30
 Identities = 65/210 (30%), Positives = 95/210 (45%), Gaps = 48/210 (22%)

Query: 320 KLGQGGYGSVYKGKLLDGSN----VAVKVLNDSKGNG--KEFINEVASISRTSHVNVVAL 373
           KLG+G +G VYKGKL         VAVK L +       K+F+ E   + +  H NVV L
Sbjct: 2   KLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEEERKDFLKEARVMKKLGHPNVVRL 61

Query: 374 LGFC------------------------------------LRVAEELSSTIGIARGLEYL 397
           LG C                                    L + + LS  I IA+G+EYL
Sbjct: 62  LGVCTEEEPLYLVLEYMEGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEYL 121

Query: 398 HLGCSTRILHFDIKPHNILLDEDFCPKISDFGLAKICNRKESIISMTGARGTVGYIAPEV 457
               S + +H D+   N L+ ED   KISDFGL++     +     TG +  + ++APE 
Sbjct: 122 A---SKKFVHRDLAARNCLVGEDLVVKISDFGLSRDVYDDDYYRKKTGGKLPIRWMAPES 178

Query: 458 FCRNIGEVSYKSDVYNYGMMIFE-MTGGRK 486
               I   + KSDV+++G++++E  T G  
Sbjct: 179 LKDGI--FTSKSDVWSFGVLLWEIFTLGAT 206

Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain, leading to intracellular signaling. Some RTKs are orphan receptors with no known ligands. Non-receptor (or cytoplasmic) tyr kinases are distributed in different intracellular compartments and are usually multi-domain proteins containing a catalytic tyr kinase domain as well as various regulatory domains such as SH3 and SH2. PTKs are usually autoinhibited and require a mechanism for activation. In many PTKs, the phosphorylation of tyr residues in the activation loop is essential for optimal activity. Aberrant expression of PTKs is associated with many development abnormalities and cancers. Length = 262

>gnl|CDD|219530 pfam07714, Pkinase_Tyr, Protein tyrosine kinase

 Score =  117 bits (295), Expect = 6e-30
 Identities = 60/203 (29%), Positives = 96/203 (47%), Gaps = 41/203 (20%)

Query: 320 KLGQGGYGSVYKGKLLDGSN-----VAVKVLNDSKG--NGKEFINEVASISRTSHVNVVA 372
           KLG+G +G VYKG L          VAVK L +       +EF+ E + + + SH N+V 
Sbjct: 6   KLGEGAFGEVYKGTLKGDGEGTETKVAVKTLKEGASEEEREEFLEEASIMKKLSHPNIVR 65

Query: 373 LLGFC----------------------------LRVAEELSSTIGIARGLEYLHLGCSTR 404
           LLG C                            L + + L   + IA+G+EYL    S  
Sbjct: 66  LLGVCTQGEPLYIVTEYMPGGDLLDFLRKHGEKLTLKDLLQMALQIAKGMEYLE---SKN 122

Query: 405 ILHFDIKPHNILLDEDFCPKISDFGLAKICNRKESIISMTGARGTVGYIAPEVFCRNIGE 464
            +H D+   N L+ E+   KISDFGL++     +      G +  + ++APE      G+
Sbjct: 123 FVHRDLAARNCLVTENLVVKISDFGLSRDIYEDDYYRKRGGGKLPIKWMAPESL--KDGK 180

Query: 465 VSYKSDVYNYGMMIFEM-TGGRK 486
            + KSDV+++G++++E+ T G +
Sbjct: 181 FTSKSDVWSFGVLLWEIFTLGEQ 203

Length = 258

>gnl|CDD|173724 cd06606, STKc_MAPKKK, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase

 Score =  117 bits (295), Expect = 7e-30
 Identities = 62/199 (31%), Positives = 85/199 (42%), Gaps = 38/199 (19%)

Query: 320 KLGQGGYGSVYKGKLLD-GSNVAVKVLNDSKGNGKE---FINEVASISRTSHVNVVALLG 375
            LG+G +GSVY     D G  +AVK +  S  + +E      E+  +S   H N+V   G
Sbjct: 7   LLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQHPNIVRYYG 66

Query: 376 F-------CLRVAEELSS----------------------TIGIARGLEYLHLGCSTRIL 406
                    L +  E  S                      T  I  GL YLH   S  I+
Sbjct: 67  SERDEEKNTLNIFLEYVSGGSLSSLLKKFGKLPEPVIRKYTRQILEGLAYLH---SNGIV 123

Query: 407 HFDIKPHNILLDEDFCPKISDFGLAKICNRKESIISMTGARGTVGYIAPEVFCRNIGEVS 466
           H DIK  NIL+D D   K++DFG AK     E+       RGT  ++APEV  R   E  
Sbjct: 124 HRDIKGANILVDSDGVVKLADFGCAKRLGDIETGEGTGSVRGTPYWMAPEV-IRG-EEYG 181

Query: 467 YKSDVYNYGMMIFEMTGGR 485
             +D+++ G  + EM  G+
Sbjct: 182 RAADIWSLGCTVIEMATGK 200

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKKK5) and ASK2 (or MAPKKK6), MEKK1, MEKK2, MEKK3, MEKK4, as well as plant and fungal MAPKKKs. Also included in this subfamily are the cell division control proteins Schizosaccharomyces pombe Cdc7 and Saccharomyces cerevisiae Cdc15. Length = 260

>gnl|CDD|173659 cd05122, PKc_STE, Catalytic domain of STE family Protein Kinases

 Score =  113 bits (284), Expect = 2e-28
 Identities = 65/200 (32%), Positives = 94/200 (47%), Gaps = 38/200 (19%)

Query: 316 SFKYKLGQGGYGSVYKGK-LLDGSNVAVKVLNDSKGNGKEFI-NEVASISRTSHVNVVAL 373
               K+G+GG+G VYK +    G  VA+KV+       KE I NE+  + +  H N+V  
Sbjct: 3   EILEKIGKGGFGEVYKARHKRTGKEVAIKVIKLESKEKKEKIINEIQILKKCKHPNIVKY 62

Query: 374 LG-------------FCLR--VAEELSSTIG------IA-------RGLEYLHLGCSTRI 405
            G             FC    + + L ST        IA       +GLEYLH   S  I
Sbjct: 63  YGSYLKKDELWIVMEFCSGGSLKDLLKSTNQTLTESQIAYVCKELLKGLEYLH---SNGI 119

Query: 406 LHFDIKPHNILLDEDFCPKISDFGLAKICNRKESIISMTGARGTVGYIAPEVFCRNIGEV 465
           +H DIK  NILL  D   K+ DFGL+   +  ++  +M    GT  ++APEV   N    
Sbjct: 120 IHRDIKAANILLTSDGEVKLIDFGLSAQLSDTKARNTMV---GTPYWMAPEVI--NGKPY 174

Query: 466 SYKSDVYNYGMMIFEMTGGR 485
            YK+D+++ G+   E+  G+
Sbjct: 175 DYKADIWSLGITAIELAEGK 194

Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPKK, which itself is phosphorylated and activated by a MAPKKK. Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAPKKK to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. Other STE family members include p21-activated kinases (PAKs) and class III myosins, among others. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain, which can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, as well as autophosphorylate the C-terminal motor domain. They play an important role in maintaining the structural integrity of photoreceptor cell microvilli. Length = 253

>gnl|CDD|173636 cd05057, PTKc_EGFR_like, Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases

 Score = 98.6 bits (246), Expect = 4e-23
 Identities = 66/222 (29%), Positives = 100/222 (45%), Gaps = 44/222 (19%)

Query: 310 IKKMTNSFKYK-LGQGGYGSVYKGKLL-DGSN----VAVKVLNDSKG--NGKEFINEVAS 361
           I K T   K K LG G +G+VYKG  + +G      VA+KVL +       KE ++E   
Sbjct: 3   ILKETELEKIKVLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETSPKANKEILDEAYV 62

Query: 362 ISRTSHVNVVALLGFC-----------------LRVAEELSSTIG----------IARGL 394
           ++   H +VV LLG C                 L         IG          IA+G+
Sbjct: 63  MASVDHPHVVRLLGICLSSQVQLITQLMPLGCLLDYVRNHKDNIGSQYLLNWCVQIAKGM 122

Query: 395 EYLHLGCSTRILHFDIKPHNILLDEDFCPKISDFGLAKICNRKESIISMTGARGTVGYIA 454
            YL      R++H D+   N+L+      KI+DFGLAK+ +  E      G +  + ++A
Sbjct: 123 SYLE---EKRLVHRDLAARNVLVKTPQHVKITDFGLAKLLDVDEKEYHAEGGKVPIKWMA 179

Query: 455 PEVFCRNIGEVSYKSDVYNYGMMIFE-MTGGRK---NVDVVD 492
            E         ++KSDV++YG+ ++E MT G K    +  V+
Sbjct: 180 LE--SILHRIYTHKSDVWSYGVTVWELMTFGAKPYEGIPAVE 219

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, resulting in the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Collectively, they can recognize a variety of ligands including EGF, TGFalpha, and neuregulins, among others. All four subfamily members can form homo- or heterodimers. HER3 contains an impaired kinase domain and depends on its heterodimerization partner for activation. EGFR subfamily members are involved in signaling pathways leading to a broad range of cellular responses including cell proliferation, differentiation, migration, growth inhibition, and apoptosis. Gain of function alterations, through their overexpression, deletions, or point mutations in their kinase domains, have been implicated in various cancers. These receptors are targets of many small molecule inhibitors and monoclonal antibodies used in cancer therapy. Length = 279

>gnl|CDD|133248 cd05148, PTKc_Srm_Brk, Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk

 Score = 96.7 bits (241), Expect = 1e-22
 Identities = 55/193 (28%), Positives = 93/193 (48%), Gaps = 37/193 (19%)

Query: 320 KLGQGGYGSVYKGKLLDGSNVAVKVL-NDSKGNGKEFINEVASISRTSHVNVVALLGFC- 377
           KLG G +G V++G   +   VA+K+L +D     ++F  EV ++ R  H ++++L   C 
Sbjct: 13  KLGSGYFGEVWEGLWKNRVRVAIKILKSDDLLKQQDFQKEVQALKRLRHKHLISLFAVCS 72

Query: 378 --------------------LRVAEE----LSSTIGI----ARGLEYLHLGCSTRILHFD 409
                               LR  E     ++S I +    A G+ YL        +H D
Sbjct: 73  VGEPVYIITELMEKGSLLAFLRSPEGQVLPVASLIDMACQVAEGMAYLE---EQNSIHRD 129

Query: 410 IKPHNILLDEDFCPKISDFGLAKICNRKESIISMTGARGTVGYIAPEVFCRNIGEVSYKS 469
           +   NIL+ ED   K++DFGLA++   KE +   +  +    + APE    + G  S KS
Sbjct: 130 LAARNILVGEDLVCKVADFGLARLI--KEDVYLSSDKKIPYKWTAPEAA--SHGTFSTKS 185

Query: 470 DVYNYGMMIFEMT 482
           DV+++G++++EM 
Sbjct: 186 DVWSFGILLYEMF 198

Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Srm and Brk however, lack the N-terminal myristylation sites. Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Brk has been found to be overexpressed in a majority of breast tumors. Length = 261

>gnl|CDD|133191 cd05060, PTKc_Syk_like, Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases

 Score = 92.0 bits (229), Expect = 5e-21
 Identities = 60/211 (28%), Positives = 89/211 (42%), Gaps = 45/211 (21%)

Query: 321 LGQGGYGSVYKGKLL--DGS--NVAVKVL--NDSKGNGKEFINEVASISRTSHVNVVALL 374
           LG G +GSV KG  L   G    VAVK L         KEF+ E + +++  H  +V L+
Sbjct: 3   LGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIAAGKKEFLREASVMAQLDHPCIVRLI 62

Query: 375 GFCL--------------------------RVAEELSSTIGIARGLEYLHLGCSTRILHF 408
           G C                            V++       +A G+ YL    S   +H 
Sbjct: 63  GVCKGEPLMLVMELAPLGPLLKYLKKRREIPVSDLKELAHQVAMGMAYLE---SKHFVHR 119

Query: 409 DIKPHNILLDEDFCPKISDFGLAKICNRKESII-SMTGARGTVGYIAPEVFCRNIGEVSY 467
           D+   N+LL      KISDFG+++          + T  R  + + APE  C N G+ S 
Sbjct: 120 DLAARNVLLVNRHQAKISDFGMSRALGAGSDYYRATTAGRWPLKWYAPE--CINYGKFSS 177

Query: 468 KSDVYNYGMMIFEMT-------GGRKNVDVV 491
           KSDV++YG+ ++E         G  K  +V+
Sbjct: 178 KSDVWSYGVTLWEAFSYGAKPYGEMKGAEVI 208

Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. Syk is important in B-cell receptor (BCR) signaling, while Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Syk also plays a central role in Fc receptor-mediated phagocytosis in the adaptive immune system. Shark is exclusively expressed in ectodermally derived epithelia, and is localized preferentially to the apical surface of the epithelial cells, it may play a role in a signaling pathway for epithelial cell polarity. Length = 257

>gnl|CDD|133171 cd05039, PTKc_Csk_like, Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases

 Score = 92.1 bits (229), Expect = 6e-21
 Identities = 56/194 (28%), Positives = 85/194 (43%), Gaps = 40/194 (20%)

Query: 317 FKYKLGQGGYGSVYKGKLLDGSNVAVKVLNDSKGNGKEFINEVASISRTSHVNVVALLGF 376
               +G+G +G V  G    G  VAVK L D     + F+ E + ++   H N+V LLG 
Sbjct: 10  LGATIGKGEFGDVMLG-DYRGQKVAVKCLKDDSTAAQAFLAEASVMTTLRHPNLVQLLGV 68

Query: 377 CL-------------------------RVAEELSSTIGIAR----GLEYLHLGCSTRILH 407
            L                         R    L+  +G A     G+EYL        +H
Sbjct: 69  VLQGNPLYIVTEYMAKGSLVDYLRSRGRAVITLAQQLGFALDVCEGMEYLE---EKNFVH 125

Query: 408 FDIKPHNILLDEDFCPKISDFGLAKICNRKESIISMTGARGTVGYIAPEVFCRNIGEVSY 467
            D+   N+L+ ED   K+SDFGLA     KE+       +  V + APE   R   + S 
Sbjct: 126 RDLAARNVLVSEDLVAKVSDFGLA-----KEASQGQDSGKLPVKWTAPEAL-RE-KKFST 178

Query: 468 KSDVYNYGMMIFEM 481
           KSDV+++G++++E+
Sbjct: 179 KSDVWSFGILLWEI 192

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As negative regulators of Src kinases, Csk and Chk play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Length = 256

>gnl|CDD|132943 cd06612, STKc_MST1_2, Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2

 Score = 88.9 bits (221), Expect = 7e-20
 Identities = 60/204 (29%), Positives = 97/204 (47%), Gaps = 49/204 (24%)

Query: 317 FKYKLGQGGYGSVYKGKLLD-GSNVAVKVLNDSKGNGKEFINEVASISRTSHVNVVALLG 375
              KLG+G YGSVYK    + G  VA+KV+   + + +E I E++ + +     +V   G
Sbjct: 7   ILEKLGEGSYGSVYKAIHKETGQVVAIKVVP-VEEDLQEIIKEISILKQCDSPYIVKYYG 65

Query: 376 -------------FC-------------LRVAEELSSTI--GIARGLEYLHLGCSTRILH 407
                        +C               + EE  + I     +GLEYLH   S + +H
Sbjct: 66  SYFKNTDLWIVMEYCGAGSVSDIMKITNKTLTEEEIAAILYQTLKGLEYLH---SNKKIH 122

Query: 408 FDIKPHNILLDEDFCPKISDFGLAKICN----RKESIISMTGARGTVGYIAPEVFCRNIG 463
            DIK  NILL+E+   K++DFG++        ++ ++I      GT  ++APEV    I 
Sbjct: 123 RDIKAGNILLNEEGQAKLADFGVSGQLTDTMAKRNTVI------GTPFWMAPEV----IQ 172

Query: 464 EVSY--KSDVYNYGMMIFEMTGGR 485
           E+ Y  K+D+++ G+   EM  G+
Sbjct: 173 EIGYNNKADIWSLGITAIEMAEGK 196

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a MAPK kinase) and MEKK1 (a MAPK kinase kinase) by acting as a MAPK kinase kinase kinase (MAPKKKK). Activation of JNK by MST1 leads to caspase activation and apoptosis. MST1 has also been implicated in cell proliferation and differentiation. Krs1 may regulate cell growth arrest and apoptosis in response to cellular stress. Length = 256

>gnl|CDD|173755 cd08215, STKc_Nek, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase

 Score = 88.7 bits (221), Expect = 8e-20
 Identities = 51/205 (24%), Positives = 94/205 (45%), Gaps = 48/205 (23%)

Query: 320 KLGQGGYGSVYKGK-LLDGSNVAVKVLNDSKGNGKE---FINEVASISRTSHVNVVAL-- 373
           ++G+G +G VY  +   DG    +K ++ S  + KE    +NEV  + + +H N++    
Sbjct: 7   QIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDALNEVKILKKLNHPNIIKYYE 66

Query: 374 -----------LGFC------------------LRVAEELSSTIGIARGLEYLHLGCSTR 404
                      + +                       + L   + +   L+YLH   S +
Sbjct: 67  SFEEKGKLCIVMEYADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLALKYLH---SRK 123

Query: 405 ILHFDIKPHNILLDEDFCPKISDFGLAKICNRKESIISMTGARGTVG---YIAPEVFCRN 461
           ILH DIKP NI L  +   K+ DFG++K+ +    +     A+  VG   Y++PE+ C+N
Sbjct: 124 ILHRDIKPQNIFLTSNGLVKLGDFGISKVLSSTVDL-----AKTVVGTPYYLSPEL-CQN 177

Query: 462 IGEVSYKSDVYNYGMMIFEMTGGRK 486
               +YKSD+++ G +++E+   + 
Sbjct: 178 KP-YNYKSDIWSLGCVLYELCTLKH 201

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Length = 258

>gnl|CDD|132954 cd06623, PKc_MAPKK_plant_like, Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins

 Score = 88.4 bits (220), Expect = 1e-19
 Identities = 52/201 (25%), Positives = 86/201 (42%), Gaps = 46/201 (22%)

Query: 320 KLGQGGYGSVYKGKL-LDGSNVAVKVLN--DSKGNGKEFINEVASISRTSHVNVVALLG- 375
            LGQG  G VYK +    G   A+K ++    +   K+ + E+ ++       VV   G 
Sbjct: 8   VLGQGSSGVVYKVRHKPTGKIYALKKIHVDGDEEFRKQLLRELKTLRSCESPYVVKCYGA 67

Query: 376 FC----LRVAEE------LSS----------------TIGIARGLEYLHLGCSTRILHFD 409
           F     + +  E      L+                    I +GL+YLH      I+H D
Sbjct: 68  FYKEGEISIVLEYMDGGSLADLLKKVGKIPEPVLAYIARQILKGLDYLHT--KRHIIHRD 125

Query: 410 IKPHNILLDEDFCPKISDFGLAKICNRKESIISMTGAR-----GTVGYIAPEVFCRNIGE 464
           IKP N+L++     KI+DFG++K       ++  T  +     GTV Y++PE        
Sbjct: 126 IKPSNLLINSKGEVKIADFGISK-------VLENTLDQCNTFVGTVTYMSPERI--QGES 176

Query: 465 VSYKSDVYNYGMMIFEMTGGR 485
            SY +D+++ G+ + E   G+
Sbjct: 177 YSYAADIWSLGLTLLECALGK 197

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include MAPKKs from plants, kinetoplastids, alveolates, and mycetozoa. The MAPKK, LmxPK4, from Leishmania mexicana, is important in differentiation and virulence. Dictyostelium discoideum MEK1 is required for proper chemotaxis. MEK1 null mutants display severe defects in cell polarization and directional movement. Plants contain multiple MAPKKs like other eukaryotes. The Arabidopsis genome encodes for 10 MAPKKs while poplar and rice contain 13 MAPKKs each. The functions of these proteins have not been fully elucidated. There is evidence to suggest that MAPK cascades are involved in plant stress responses. In Arabidopsis, MKK3 plays a role in pathogen signaling, MKK2 is involved in cold and salt stress signaling, MKK4/MKK5 participates in innate immunity, and MKK7 regulates basal and systemic acquired resistance. Length = 264

>gnl|CDD|173637 cd05059, PTKc_Tec_like, Catalytic domain of Tec-like Protein Tyrosine Kinases

 Score = 87.5 bits (217), Expect = 2e-19
 Identities = 62/226 (27%), Positives = 100/226 (44%), Gaps = 41/226 (18%)

Query: 310 IKKMTNSFKYKLGQGGYGSVYKGKLLDGSNVAVKVLNDSKGNGKEFINEVASISRTSHVN 369
           I     +F  +LG G +G V+ GK     +VA+K++ +   +  +FI E   + + SH N
Sbjct: 1   IDPSELTFLKELGSGQFGVVHLGKWRGKIDVAIKMIREGAMSEDDFIEEAKVMMKLSHPN 60

Query: 370 VVALLGFC---------------------LRVAEE-------LSSTIGIARGLEYLHLGC 401
           +V L G C                     LR  +        L     +   +EYL    
Sbjct: 61  LVQLYGVCTKQRPIFIVTEYMANGCLLNYLRERKGKLGTEWLLDMCSDVCEAMEYLE--- 117

Query: 402 STRILHFDIKPHNILLDEDFCPKISDFGLAKICNRKESIISMTGARGTVGYIAPEVFCRN 461
           S   +H D+   N L+ ED   K+SDFGLA+     +   S  G +  V +  PEVF  +
Sbjct: 118 SNGFIHRDLAARNCLVGEDNVVKVSDFGLARYVLDDQYTSS-QGTKFPVKWAPPEVF--D 174

Query: 462 IGEVSYKSDVYNYGMMIFEM-TGG------RKNVDVVDNGSTALDL 500
               S KSDV+++G++++E+ + G        N +VV++ S    L
Sbjct: 175 YSRFSSKSDVWSFGVLMWEVFSEGKMPYERFSNSEVVESVSAGYRL 220

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, some members contain the Tec homology (TH) domain, which contains proline-rich and zinc-binding regions. Tec kinases form the second largest subfamily of nRTKs and are expressed mainly by haematopoietic cells, although Tec and Bmx are also found in endothelial cells. B-cells express Btk and Tec, while T-cells express Itk, Txk, and Tec. Collectively, Tec kinases are expressed in a variety of myeloid cells such as mast cells, platelets, macrophages, and dendritic cells. Each Tec kinase shows a distinct cell-type pattern of expression. The function of Tec kinases in lymphoid cells have been studied extensively. They play important roles in the development, differentiation, maturation, regulation, survival, and function of B-cells and T-cells. Mutations in Btk cause the severe B-cell immunodeficiency, X-linked agammaglobulinaemia (XLA). Length = 256

>gnl|CDD|173628 cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases

 Score = 86.7 bits (215), Expect = 6e-19
 Identities = 57/207 (27%), Positives = 88/207 (42%), Gaps = 44/207 (21%)

Query: 320 KLGQGGYGSVYKGKLL-----DGSNVAVKVLNDSKGNG--KEFINEVASISRTSHVNVVA 372
           +LG+G +G V   +        G  VAVK LN S       +F  E+  +    H N+V 
Sbjct: 11  QLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEEQHRSDFEREIEILRTLDHENIVK 70

Query: 373 LLGFC-------LRVAEE-----------------------LSSTIGIARGLEYLHLGCS 402
             G C       LR+  E                       L  +  I +G++YL    S
Sbjct: 71  YKGVCEKPGGRSLRLIMEYLPSGSLRDYLQRHRDQINLKRLLLFSSQICKGMDYLG---S 127

Query: 403 TRILHFDIKPHNILLDEDFCPKISDFGLAKICNR-KESIISMTGARGTVGYIAPEVFCRN 461
            R +H D+   NIL++ +   KISDFGLAK+    K+           + + APE  C  
Sbjct: 128 QRYIHRDLAARNILVESEDLVKISDFGLAKVLPEDKDYYYVKEPGESPIFWYAPE--CLR 185

Query: 462 IGEVSYKSDVYNYGMMIFEM-TGGRKN 487
             + S  SDV+++G+ ++E+ T G  +
Sbjct: 186 TSKFSSASDVWSFGVTLYELFTYGDPS 212

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 284

>gnl|CDD|132963 cd06632, STKc_MEKK1_plant, Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1

 Score = 84.8 bits (210), Expect = 2e-18
 Identities = 60/199 (30%), Positives = 87/199 (43%), Gaps = 41/199 (20%)

Query: 321 LGQGGYGSVYKG-KLLDGSNVAVKVLN------DSKGNGKEFINEVASISRTSHVNVVAL 373
           LG G +GSVY+G  L DG   AVK ++        +   K+   E+A +S+  H N+V  
Sbjct: 8   LGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQY 67

Query: 374 LGFC-----LRVAEELSS----------------------TIGIARGLEYLHLGCSTRIL 406
           LG       L +  EL                        T  I  GLEYLH       +
Sbjct: 68  LGTEREEDNLYIFLELVPGGSLAKLLKKYGSFPEPVIRLYTRQILLGLEYLH---DRNTV 124

Query: 407 HFDIKPHNILLDEDFCPKISDFGLAKICNRKESIISMTGARGTVGYIAPEVFCRNIGEVS 466
           H DIK  NIL+D +   K++DFG+AK         S    +G+  ++APEV     G   
Sbjct: 125 HRDIKGANILVDTNGVVKLADFGMAKQVVEFSFAKSF---KGSPYWMAPEV-IAQQGGYG 180

Query: 467 YKSDVYNYGMMIFEMTGGR 485
             +D+++ G  + EM  G+
Sbjct: 181 LAADIWSLGCTVLEMATGK 199

Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidopsis thaliana MEKK1 activates MPK4, a MAPK that regulates systemic acquired resistance. MEKK1 also participates in the regulation of temperature-sensitive and tissue-specific cell death. Length = 258

>gnl|CDD|133214 cd05083, PTKc_Chk, Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase

 Score = 84.6 bits (209), Expect = 2e-18
 Identities = 53/190 (27%), Positives = 93/190 (48%), Gaps = 40/190 (21%)

Query: 320 KLGQGGYGSVYKGKLLDGSNVAVKVLNDSKGNGKEFINEVASISRTSHVNVVALLG---- 375
            +G+G +G+V +G+   G  VAVK +       + F+ E A +++  H N+V LLG    
Sbjct: 13  IIGEGEFGAVLQGEYT-GQKVAVKNIK-CDVTAQAFLEETAVMTKLHHKNLVRLLGVILH 70

Query: 376 ------------------------FCLRVAEELSSTIGIARGLEYLHLGCSTRILHFDIK 411
                                     + V + L  ++ +A G+EYL    S +++H D+ 
Sbjct: 71  NGLYIVMELMSKGNLVNFLRTRGRALVSVIQLLQFSLDVAEGMEYLE---SKKLVHRDLA 127

Query: 412 PHNILLDEDFCPKISDFGLAKICNRKESIISMTGARGTVGYIAPEVFCRNIGEVSYKSDV 471
             NIL+ ED   K+SDFGLA++ +       +  ++  V + APE       + S KSDV
Sbjct: 128 ARNILVSEDGVAKVSDFGLARVGSM-----GVDNSKLPVKWTAPEALKHK--KFSSKSDV 180

Query: 472 YNYGMMIFEM 481
           ++YG++++E+
Sbjct: 181 WSYGVLLWEV 190

Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As a negative regulator of Src kinases, Chk may play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Chk is expressed in brain and hematopoietic cells. Studies in mice reveal that Chk is not functionally redundant with Csk and that it plays an important role as a regulator of immune responses. Chk also plays a role in neural differentiation in a manner independent of Src by enhancing Mapk activation via Ras-mediated signaling. Length = 254

>gnl|CDD|173731 cd06627, STKc_Cdc7_like, Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases

 Score = 84.6 bits (210), Expect = 2e-18
 Identities = 55/196 (28%), Positives = 82/196 (41%), Gaps = 39/196 (19%)

Query: 320 KLGQGGYGSVYKG-KLLDGSNVAVK---VLNDSKGNGKEFINEVASISRTSHVNVVALLG 375
            +G+G +G VYKG  L  G  VA+K   +    +   K  + E+  +    H N+V  +G
Sbjct: 7   LIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPNIVKYIG 66

Query: 376 F---------CLRVAEE--LSSTIG----------------IARGLEYLHLGCSTRILHF 408
                      L  AE   L   I                 + +GL YLH      ++H 
Sbjct: 67  SIETSDSLYIILEYAENGSLRQIIKKFGPFPESLVAVYVYQVLQGLAYLH---EQGVIHR 123

Query: 409 DIKPHNILLDEDFCPKISDFGLAKICNRKESIISMTGARGTVGYIAPEVFCRNIGEVSYK 468
           DIK  NIL  +D   K++DFG+A   N            GT  ++APEV    +   S  
Sbjct: 124 DIKAANILTTKDGVVKLADFGVATKLNDVSK--DDASVVGTPYWMAPEVI--EMSGASTA 179

Query: 469 SDVYNYGMMIFEM-TG 483
           SD+++ G  + E+ TG
Sbjct: 180 SDIWSLGCTVIELLTG 195

Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Cdc7 is essential for cell division by playing a key role in the initiation of septum formation and cytokinesis. Budding yeast Cdc15 functions to coordinate mitotic exit with cytokinesis. Arabidopsis MAPKKK epsilon is required for pollen development in the plasma membrane. Length = 254

>gnl|CDD|223589 COG0515, SPS1, Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair]

 Score = 85.9 bits (211), Expect = 4e-18
 Identities = 63/207 (30%), Positives = 91/207 (43%), Gaps = 46/207 (22%)

Query: 320 KLGQGGYGSVYKGKLLDGSNVAVKVL----NDSKGNGKEFINEVASISRTSH-VNVVALL 374
           KLG+G +G VY  +  D   VA+KVL           + F+ E+  ++  +H  N+V L 
Sbjct: 7   KLGEGSFGEVYLAR--DRKLVALKVLAKKLESKSKEVERFLREIQILASLNHPPNIVKLY 64

Query: 375 GF------------------------------CLRVAEELSSTIGIARGLEYLHLGCSTR 404
            F                               L  +E L     I   LEYLH   S  
Sbjct: 65  DFFQDEGSLYLVMEYVDGGSLEDLLKKIGRKGPLSESEALFILAQILSALEYLH---SKG 121

Query: 405 ILHFDIKPHNILLDED-FCPKISDFGLAKI----CNRKESIISMTGARGTVGYIAPEVF- 458
           I+H DIKP NILLD D    K+ DFGLAK+     +        + + GT GY+APEV  
Sbjct: 122 IIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPGSTSSIPALPSTSVGTPGYMAPEVLL 181

Query: 459 CRNIGEVSYKSDVYNYGMMIFEMTGGR 485
             ++   S  SD+++ G+ ++E+  G 
Sbjct: 182 GLSLAYASSSSDIWSLGITLYELLTGL 208

Length = 384

>gnl|CDD|173728 cd06614, STKc_PAK, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase

 Score = 84.2 bits (209), Expect = 4e-18
 Identities = 62/195 (31%), Positives = 88/195 (45%), Gaps = 38/195 (19%)

Query: 320 KLGQGGYGSVYKGK-LLDGSNVAVKVLNDSKGNGKEFINEVASISRTSHVNVVA-----L 373
           K+G+G  G VYK      G  VA+K +   K N +  INE+  +    H N+V      L
Sbjct: 26  KIGEGASGEVYKATDRATGKEVAIKKMRLRKQNKELIINEILIMKDCKHPNIVDYYDSYL 85

Query: 374 LGFCLRVAEEL------------------SSTIG-----IARGLEYLHLGCSTRILHFDI 410
           +G  L V  E                      I      + +GLEYLH   S  ++H DI
Sbjct: 86  VGDELWVVMEYMDGGSLTDIITQNFVRMNEPQIAYVCREVLQGLEYLH---SQNVIHRDI 142

Query: 411 KPHNILLDEDFCPKISDFGL-AKICNRKESIISMTGARGTVGYIAPEVFCRNIGEVSYKS 469
           K  NILL +D   K++DFG  A++   K    S+    GT  ++APEV  R   +   K 
Sbjct: 143 KSDNILLSKDGSVKLADFGFAAQLTKEKSKRNSVV---GTPYWMAPEVIKRK--DYGPKV 197

Query: 470 DVYNYGMMIFEMTGG 484
           D+++ G+M  EM  G
Sbjct: 198 DIWSLGIMCIEMAEG 212

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). Group II PAKs contain a PBD and a catalytic domain, but lack other motifs found in group I PAKs. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. Group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX; no such binding has been demonstrated for group II PAKs. Length = 286

>gnl|CDD|173633 cd05052, PTKc_Abl, Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase

 Score = 83.0 bits (205), Expect = 9e-18
 Identities = 56/196 (28%), Positives = 94/196 (47%), Gaps = 36/196 (18%)

Query: 316 SFKYKLGQGGYGSVYKGKLLDGSN-VAVKVLNDSKGNGKEFINEVASISRTSHVNVVALL 374
           + K+KLG G YG VY+G     S  VAVK L +     +EF+ E A +    H N+V LL
Sbjct: 9   TMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLL 68

Query: 375 GFCLRVA-----------------------EELSSTI------GIARGLEYLHLGCSTRI 405
           G C R                         +E+++ +       I+  +EYL        
Sbjct: 69  GVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLE---KKNF 125

Query: 406 LHFDIKPHNILLDEDFCPKISDFGLAKICNRKESIISMTGARGTVGYIAPEVFCRNIGEV 465
           +H D+   N L+ E+   K++DFGL+++    ++  +  GA+  + + APE    N  + 
Sbjct: 126 IHRDLAARNCLVGENHLVKVADFGLSRLM-TGDTYTAHAGAKFPIKWTAPESLAYN--KF 182

Query: 466 SYKSDVYNYGMMIFEM 481
           S KSDV+ +G++++E+
Sbjct: 183 SIKSDVWAFGVLLWEI 198

Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays a role in cell proliferation and survival. In response to DNA damage or oxidative stress, Abl is transported to the nucleus where it induces apoptosis. In chronic myelogenous leukemia (CML) patients, an aberrant translocation results in the replacement of the first exon of Abl with the BCR (breakpoint cluster region) gene. The resulting BCR-Abl fusion protein is constitutively active and associates into tetramers, resulting in a hyperactive kinase sending a continuous signal. This leads to uncontrolled proliferation, morphological transformation and anti-apoptotic effects. BCR-Abl is the target of selective inhibitors, such as imatinib (Gleevec), used in the treatment of CML. Abl2, also known as ARG (Abelson-related gene), is thought to play a cooperative role with Abl in the proper development of the nervous system. The Tel-ARG fusion protein, resulting from reciprocal translocation between chromosomes 1 and 12, is associated with acute myeloid leukemia (AML). The TEL gene is a frequent fusion partner of other tyr kinase oncogenes, including Tel/Abl, Tel/PDGFRbeta, and Tel/Jak2, found in patients with leukemia and myeloproliferative disorders. Length = 263

>gnl|CDD|173660 cd05123, STKc_AGC, Catalytic domain of AGC family Protein Serine/Threonine Kinases

 Score = 82.2 bits (204), Expect = 1e-17
 Identities = 58/204 (28%), Positives = 85/204 (41%), Gaps = 53/204 (25%)

Query: 321 LGQGGYGSVYKGKLLDGSNV-AVKVLNDSKGNGKEFI----------NEVASISRTSHVN 369
           LG+G +G V   +  D   + A+KVL       K+ I           E   +SR +H  
Sbjct: 1   LGKGSFGKVLLVRKKDTGKLYAMKVLK------KKKIIKRKEVEHTLTERNILSRINHPF 54

Query: 370 VVAL-------------LGFC------------LRVAEELSSTIG--IARGLEYLHLGCS 402
           +V L             L +              R +EE +      I   LEYLH   S
Sbjct: 55  IVKLHYAFQTEEKLYLVLEYAPGGELFSHLSKEGRFSEERARFYAAEIVLALEYLH---S 111

Query: 403 TRILHFDIKPHNILLDEDFCPKISDFGLAKI-CNRKESIISMTGARGTVGYIAPEVFCRN 461
             I++ D+KP NILLD D   K++DFGLAK   +      +     GT  Y+APEV    
Sbjct: 112 LGIIYRDLKPENILLDADGHIKLTDFGLAKELSSEGSRTNTFC---GTPEYLAPEVL--L 166

Query: 462 IGEVSYKSDVYNYGMMIFEMTGGR 485
                   D ++ G++++EM  G+
Sbjct: 167 GKGYGKAVDWWSLGVLLYEMLTGK 190

Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the turn motif. Phosphorylation at the A-loop is required of most AGC kinases, which results in a disorder-to-order transition of the A-loop. The ordered conformation results in the access of substrates and ATP to the active site. A subset of AGC kinases with C-terminal extensions containing the HM also requires phosphorylation at this site. Phosphorylation at the HM allows the C-terminal extension to form an ordered structure that packs into the hydrophobic pocket of the catalytic domain, which then reconfigures the kinase into an active bi-lobed state. In addition, growth factor-activated AGC kinases such as PKB, p70S6K, RSK, MSK, PKC, and SGK, require phosphorylation at the turn motif (also called tail or zipper site), located N-terminal to the HM at the C-terminal extension. AGC kinases regulate many cellular processes including division, growth, survival, metabolism, motility, and differentiation. Many are implicated in the development of various human diseases. Length = 250

>gnl|CDD|173739 cd07838, STKc_CDK4_6_like, Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases

 Score = 82.7 bits (205), Expect = 2e-17
 Identities = 62/203 (30%), Positives = 95/203 (46%), Gaps = 52/203 (25%)

Query: 321 LGQGGYGSVYKGK-LLDGSNVAVK---VLNDSKGNGKEFINEVA---SISRTSHVNVVAL 373
           +G+G YG+VYK + L  G  VA+K   V    +G     + E+A    +    H N+V L
Sbjct: 7   IGEGAYGTVYKARDLNTGRFVALKKVRVPLSEEGIPLSTLREIALLKQLESFEHPNIVRL 66

Query: 374 LGFCL--RVAEELSSTI-------------------GIA------------RGLEYLHLG 400
           L  C   R   EL  T+                   G+             RG+++LH  
Sbjct: 67  LDVCHGPRTDRELKLTLVFEHVDQDLATYLSKCPKPGLPPETIKDLMRQLLRGVDFLH-- 124

Query: 401 CSTRILHFDIKPHNILLDEDFCPKISDFGLAKICNRKESIISMTGARGTVGYIAPEVFCR 460
            S RI+H D+KP NIL+  D   KI+DFGLA+I + +   +++T    T+ Y APEV  +
Sbjct: 125 -SHRIVHRDLKPQNILVTSDGQVKIADFGLARIYSFE---MALTSVVVTLWYRAPEVLLQ 180

Query: 461 NIGEVSYKS--DVYNYGMMIFEM 481
                SY +  D+++ G +  E+
Sbjct: 181 ----SSYATPVDMWSVGCIFAEL 199

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both expressed ubiquitously, associate with all three D cyclins (D1, D2 and D3), and phosphorylate the retinoblastoma (pRb) protein. They are also regulated by the INK4 family of inhibitors which associate with either the CDK alone or the CDK/cyclin complex. CDK4 and CDK6 show differences in subcellular localization, sensitivity to some inhibitors, timing in activation, tumor selectivity, and possibly substrate profiles. Although CDK4 and CDK6 seem to show some redundancy, they also have discrete, nonoverlapping functions. CDK6 plays an important role in cell differentiation. Length = 287

>gnl|CDD|173727 cd06613, STKc_MAP4K3_like, Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases

 Score = 81.6 bits (202), Expect = 2e-17
 Identities = 61/198 (30%), Positives = 91/198 (45%), Gaps = 46/198 (23%)

Query: 320 KLGQGGYGSVYKGK-LLDGSNVAVKVLNDSKGNGKEFI-NEVASISRTSHVNVVALLGFC 377
           ++G G YG VYK + +  G  VA+KV+    G+  E I  E++ +    H N+VA  G  
Sbjct: 10  RIGSGTYGDVYKARDIATGELVAIKVIKLEPGDDFEIIQQEISMLKECRHPNIVAYFGSY 69

Query: 378 LR---------------VAEELSSTIG------IA-------RGLEYLHLGCSTRILHFD 409
           LR               + +    T G      IA       +GL YLH    T  +H D
Sbjct: 70  LRRDKLWIVMEYCGGGSLQDIYQVTRGPLSELQIAYVCRETLKGLAYLH---ETGKIHRD 126

Query: 410 IKPHNILLDEDFCPKISDFGL-AKICN---RKESIISMTGARGTVGYIAPEVFCRNIGEV 465
           IK  NILL ED   K++DFG+ A++     +++S I      GT  ++APEV      + 
Sbjct: 127 IKGANILLTEDGDVKLADFGVSAQLTATIAKRKSFI------GTPYWMAPEVAAVER-KG 179

Query: 466 SY--KSDVYNYGMMIFEM 481
            Y  K D++  G+   E+
Sbjct: 180 GYDGKCDIWALGITAIEL 197

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K1, also called haematopoietic progenitor kinase 1 (HPK1), is a hematopoietic-specific STK involved in many cellular signaling cascades including MAPK, antigen receptor, apoptosis, growth factor, and cytokine signaling. It participates in the regulation of T cell receptor signaling and T cell-mediated immune responses. MAP4K2 was referred to as germinal center (GC) kinase because of its preferred location in GC B cells. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. It is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). Length = 262

>gnl|CDD|132957 cd06626, STKc_MEKK4, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4

 Score = 81.2 bits (201), Expect = 3e-17
 Identities = 57/201 (28%), Positives = 87/201 (43%), Gaps = 37/201 (18%)

Query: 320 KLGQGGYGSVYKGKLLD-GSNVAVKVLNDSKG---NGKEFINEVASISRTSHVNVVALLG 375
           K+G G +G VY    LD G  +AVK +          KE  +E+  +    H N+V   G
Sbjct: 7   KIGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIKEIADEMKVLELLKHPNLVKYYG 66

Query: 376 -------------FCL-----------RVAEEL---SSTIGIARGLEYLHLGCSTRILHF 408
                        +C            R+ +E      T+ +  GL YLH   S  I+H 
Sbjct: 67  VEVHREKVYIFMEYCSGGTLEELLEHGRILDEHVIRVYTLQLLEGLAYLH---SHGIVHR 123

Query: 409 DIKPHNILLDEDFCPKISDFGLAKICNRKESII--SMTGARGTVGYIAPEVFCRNIGEVS 466
           DIKP NI LD +   K+ DFG A       + +   +    GT  Y+APEV     G+  
Sbjct: 124 DIKPANIFLDHNGVIKLGDFGCAVKLKNNTTTMGEEVQSLAGTPAYMAPEVITGGKGKGH 183

Query: 467 YKS-DVYNYGMMIFEMTGGRK 486
            ++ D+++ G ++ EM  G++
Sbjct: 184 GRAADIWSLGCVVLEMATGKR 204

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. MEKK4 also plays roles in the re-polarization of the actin cytoskeleton in response to osmotic stress, in the proper closure of the neural tube, in cardiovascular development, and in immune responses. Length = 264

>gnl|CDD|173736 cd07832, STKc_CCRK, Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase

 Score = 81.2 bits (201), Expect = 5e-17
 Identities = 51/199 (25%), Positives = 88/199 (44%), Gaps = 40/199 (20%)

Query: 320 KLGQGGYGSVYKGKLLD-GSNVAVKVLNDSKGNG---KEFINEVASISRTSHVNVVALL- 374
           ++G+G +G V+K K  + G  VA+K +   +  G    + + E+ ++    H  VV LL 
Sbjct: 7   RIGEGAHGIVFKAKDRETGETVALKKVALRRLEGGIPNQALREIKALQACQHPYVVKLLD 66

Query: 375 ------GFCL---RVAEELSSTIG-----------------IARGLEYLHLGCSTRILHF 408
                 GF L    +  +LS  +                  + +G+ Y+H   +  I+H 
Sbjct: 67  VFPHGSGFVLVMEYMPSDLSEVLRDEERPLPEAQVKSYMRMLLKGVAYMH---ANGIMHR 123

Query: 409 DIKPHNILLDEDFCPKISDFGLAKICNRKESIISMTGARGTVGYIAPEVF--CRNIGEVS 466
           D+KP N+L+  D   KI+DFGLA++ + +E     +    T  Y APE+    R      
Sbjct: 124 DLKPANLLISADGVLKIADFGLARLFS-EEEPRLYSHQVATRWYRAPELLYGARKYDP-- 180

Query: 467 YKSDVYNYGMMIFEMTGGR 485
              D++  G +  E+  G 
Sbjct: 181 -GVDLWAVGCIFAELLNGS 198

Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of heart failure. Length = 286

>gnl|CDD|173626 cd05034, PTKc_Src_like, Catalytic domain of Src kinase-like Protein Tyrosine Kinases

 Score = 80.4 bits (199), Expect = 6e-17
 Identities = 56/196 (28%), Positives = 87/196 (44%), Gaps = 36/196 (18%)

Query: 320 KLGQGGYGSVYKGKLLDGSNVAVKVLNDSKGNGKEFINEVASISRTSHVNVVALLGFC-- 377
           KLG G +G V+ G     + VAVK L     + + F+ E   + +  H  +V L   C  
Sbjct: 13  KLGAGQFGEVWMGTWNGTTKVAVKTLKPGTMSPEAFLQEAQIMKKLRHDKLVQLYAVCSE 72

Query: 378 ---------------------------LRVAEELSSTIGIARGLEYLHLGCSTRILHFDI 410
                                      LR+ + +     IA G+ YL    S   +H D+
Sbjct: 73  EEPIYIVTEYMSKGSLLDFLKSGEGKKLRLPQLVDMAAQIAEGMAYLE---SRNYIHRDL 129

Query: 411 KPHNILLDEDFCPKISDFGLAKICNRKESIISMTGARGTVGYIAPEVFCRNIGEVSYKSD 470
              NIL+ E+   KI+DFGLA++    E      GA+  + + APE    N G  + KSD
Sbjct: 130 AARNILVGENLVCKIADFGLARLIEDDEYTARE-GAKFPIKWTAPEAA--NYGRFTIKSD 186

Query: 471 VYNYGMMIFE-MTGGR 485
           V+++G+++ E +T GR
Sbjct: 187 VWSFGILLTEIVTYGR 202

Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. They were identified as the first proto-oncogene products, and they regulate cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Src kinases are overexpressed in a variety of human cancers, making them attractive targets for therapy. They are also implicated in acute inflammatory responses and osteoclast function. Src, Fyn, Yes, and Yrk are widely expressed, while Blk, Lck, Hck, Fgr, and Lyn show a limited expression pattern. Length = 261

>gnl|CDD|173657 cd05113, PTKc_Btk_Bmx, Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome

 Score = 80.3 bits (198), Expect = 7e-17
 Identities = 55/219 (25%), Positives = 98/219 (44%), Gaps = 35/219 (15%)

Query: 316 SFKYKLGQGGYGSVYKGKLLDGSNVAVKVLNDSKGNGKEFINEVASISRTSHVNVVALLG 375
           +F  +LG G +G V  GK     +VA+K++ +   +  EFI E   + + SH  +V L G
Sbjct: 7   TFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSEDEFIEEAKVMMKLSHEKLVQLYG 66

Query: 376 FC----------------------------LRVAEELSSTIGIARGLEYLHLGCSTRILH 407
            C                             + ++ L     +  G+ YL    S + +H
Sbjct: 67  VCTKQRPIYIVTEYMSNGCLLNYLREHGKRFQPSQLLEMCKDVCEGMAYLE---SKQFIH 123

Query: 408 FDIKPHNILLDEDFCPKISDFGLAKICNRKESIISMTGARGTVGYIAPEVFCRNIGEVSY 467
            D+   N L+D+  C K+SDFGL++     E   S+ G++  V +  PEV      + S 
Sbjct: 124 RDLAARNCLVDDQGCVKVSDFGLSRYVLDDEYTSSV-GSKFPVRWSPPEVL--LYSKFSS 180

Query: 468 KSDVYNYGMMIFEM-TGGRKNVDVVDNGSTALDLQASRK 505
           KSDV+ +G++++E+ + G+   +  +N  T   +    +
Sbjct: 181 KSDVWAFGVLMWEVYSLGKMPYERFNNSETVEKVSQGLR 219

Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Btk contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Btk is expressed in B-cells, and a variety of myeloid cells including mast cells, platelets, neutrophils, and dendrictic cells. It interacts with a variety of partners, from cytosolic proteins to nuclear transcription factors, suggesting a diversity of functions. Stimulation of a diverse array of cell surface receptors, including antigen engagement of the B-cell receptor (BCR), leads to PH-mediated membrane translocation of Btk and subsequent phosphorylation by Src kinase and activation. Btk plays an important role in the life cycle of B-cells including their development, differentiation, proliferation, survival, and apoptosis. Mutations in Btk cause the primary immunodeficiency disease, X-linked agammaglobulinaemia (XLA) in humans. Bmx is primarily expressed in bone marrow and the arterial endothelium, and plays an important role in ischemia-induced angiogenesis. It facilitates arterial growth, capillary formation, vessel maturation, and bone marrow-derived endothelial progenitor cell mobilization. Length = 256

>gnl|CDD|173655 cd05110, PTKc_HER4, Catalytic domain of the Protein Tyrosine Kinase, HER4

 Score = 80.1 bits (197), Expect = 1e-16
 Identities = 62/204 (30%), Positives = 100/204 (49%), Gaps = 40/204 (19%)

Query: 321 LGQGGYGSVYKGKLL-DGSNV----AVKVLNDSKG--NGKEFINEVASISRTSHVNVVAL 373
           LG G +G+VYKG  + +G  V    A+K+LN++ G     EF++E   ++   H ++V L
Sbjct: 15  LGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHLVRL 74

Query: 374 LGFCL-----------------RVAEELSSTIG----------IARGLEYLHLGCSTRIL 406
           LG CL                     E    IG          IA+G+ YL      R++
Sbjct: 75  LGVCLSPTIQLVTQLMPHGCLLDYVHEHKDNIGSQLLLNWCVQIAKGMMYLE---ERRLV 131

Query: 407 HFDIKPHNILLDEDFCPKISDFGLAKICNRKESIISMTGARGTVGYIAPEVFCRNIGEVS 466
           H D+   N+L+      KI+DFGLA++    E   +  G +  + ++A E  C +  + +
Sbjct: 132 HRDLAARNVLVKSPNHVKITDFGLARLLEGDEKEYNADGGKMPIKWMALE--CIHYRKFT 189

Query: 467 YKSDVYNYGMMIFE-MTGGRKNVD 489
           ++SDV++YG+ I+E MT G K  D
Sbjct: 190 HQSDVWSYGVTIWELMTFGGKPYD 213

Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands that bind HER4 fall into two groups, the neuregulins (or heregulins) and some EGFR (HER1) ligands including betacellulin, HBEGF, and epiregulin. All four neuregulins (NRG1-4) interact with HER4. Upon ligand binding, HER4 forms homo- or heterodimers with other HER proteins. HER4 is essential in embryonic development. It is implicated in mammary gland, cardiac, and neural development. As a postsynaptic receptor of NRG1, HER4 plays an important role in synaptic plasticity and maturation. The impairment of NRG1/HER4 signaling may contribute to schizophrenia. Length = 303

>gnl|CDD|173669 cd05578, STKc_Yank1, Catalytic domain of the Protein Serine/Threonine Kinase, Yank1

 Score = 78.9 bits (195), Expect = 2e-16
 Identities = 60/203 (29%), Positives = 85/203 (41%), Gaps = 40/203 (19%)

Query: 316 SFKYKLGQGGYGSVYKGKLLDGSNV-AVKVLN----DSKGNGKEFINEVASISRTSH--- 367
                +G+G +G V   +  D   + A+K +N      KG+ +  +NE   +   +H   
Sbjct: 3   ELLRVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHPFL 62

Query: 368 VN-------------VVALLG-----FCLRVAEELSSTIG------IARGLEYLHLGCST 403
           VN             VV LL      + L    + S          I   LEYLH   S 
Sbjct: 63  VNLWYSFQDEENMYLVVDLLLGGDLRYHLSQKVKFSEEQVKFWICEIVLALEYLH---SK 119

Query: 404 RILHFDIKPHNILLDEDFCPKISDFGLAKICNRKESIISMTGARGTVGYIAPEVFCRNIG 463
            I+H DIKP NILLDE     I+DF +A          S +   GT GY+APEV CR   
Sbjct: 120 GIIHRDIKPDNILLDEQGHVHITDFNIATKVTPDTLTTSTS---GTPGYMAPEVLCRQ-- 174

Query: 464 EVSYKSDVYNYGMMIFEMTGGRK 486
             S   D ++ G+  +E   G++
Sbjct: 175 GYSVAVDWWSLGVTAYECLRGKR 197

Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. Length = 258

>gnl|CDD|132960 cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases

 Score = 79.1 bits (195), Expect = 2e-16
 Identities = 60/205 (29%), Positives = 89/205 (43%), Gaps = 42/205 (20%)

Query: 321 LGQGGYGSVYKGKLLD-GSNVAVK---VLNDSKGNGKEFI--------NEVASISRTSHV 368
           +G+G YG VY    +  G  +AVK   +     G              +E+ ++    H+
Sbjct: 9   IGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDHL 68

Query: 369 NVVALLGF---------------------CLR----VAEELSS--TIGIARGLEYLHLGC 401
           N+V  LGF                     CLR      E+L    T  +  GL YLH   
Sbjct: 69  NIVQYLGFETTEEYLSIFLEYVPGGSIGSCLRTYGRFEEQLVRFFTEQVLEGLAYLH--- 125

Query: 402 STRILHFDIKPHNILLDEDFCPKISDFGLAKICNRKESIISMTGARGTVGYIAPEVFCRN 461
           S  ILH D+K  N+L+D D   KISDFG++K  +           +G+V ++APEV    
Sbjct: 126 SKGILHRDLKADNLLVDADGICKISDFGISKKSDDIYDNDQNMSMQGSVFWMAPEVIHSY 185

Query: 462 IGEVSYKSDVYNYGMMIFEMTGGRK 486
               S K D+++ G ++ EM  GR+
Sbjct: 186 SQGYSAKVDIWSLGCVVLEMFAGRR 210

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell integrity MAPK pathway, which is activated by stresses and aggressions to the cell wall. The MAPKKK Bck1, MAPKKs Mkk1 and Mkk2, and the MAPK Slt2 make up the cascade that is important in the maintenance of cell wall homeostasis. Fission yeast Mkh1 is involved in MAPK cascades regulating cell morphology, cell wall integrity, salt resistance, and filamentous growth in response to stress. Length = 272

>gnl|CDD|133189 cd05058, PTKc_Met_Ron, Catalytic domain of the Protein Tyrosine Kinases, Met and Ron

 Score = 78.7 bits (194), Expect = 2e-16
 Identities = 62/202 (30%), Positives = 100/202 (49%), Gaps = 43/202 (21%)

Query: 321 LGQGGYGSVYKGKLLDGS----NVAVKVLN--DSKGNGKEFINEVASISRTSHVNVVALL 374
           +G+G +G VY G L+D      + AVK LN        ++F+ E   +   SH NV++LL
Sbjct: 3   IGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRITDLEEVEQFLKEGIIMKDFSHPNVLSLL 62

Query: 375 GFCLR-----------------------------VAEELSSTIGIARGLEYLHLGCSTRI 405
           G CL                              V + +   + +A+G+EYL    S + 
Sbjct: 63  GICLPSEGSPLVVLPYMKHGDLRNFIRSETHNPTVKDLIGFGLQVAKGMEYL---ASKKF 119

Query: 406 LHFDIKPHNILLDEDFCPKISDFGLAKICNRKE--SIISMTGARGTVGYIAPEVFCRNIG 463
           +H D+   N +LDE F  K++DFGLA+    KE  S+ + TGA+  V ++A E       
Sbjct: 120 VHRDLAARNCMLDESFTVKVADFGLARDIYDKEYYSVHNHTGAKLPVKWMALESL--QTQ 177

Query: 464 EVSYKSDVYNYGMMIFE-MTGG 484
           + + KSDV+++G++++E MT G
Sbjct: 178 KFTTKSDVWSFGVLLWELMTRG 199

Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also called the HGF receptor. HGF/Met signaling plays a role in growth, transformation, cell motility, invasion, metastasis, angiogenesis, wound healing, and tissue regeneration. Aberrant expression of Met through mutations or gene amplification is associated with many human cancers including hereditary papillary renal and gastric carcinomas. The ligand for Ron is macrophage stimulating protein (MSP). Ron signaling is important in regulating cell motility, adhesion, proliferation, and apoptosis. Aberrant Ron expression is implicated in tumorigenesis and metastasis. Length = 262

>gnl|CDD|133243 cd05112, PTKc_Itk, Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase

 Score = 78.1 bits (192), Expect = 4e-16
 Identities = 54/224 (24%), Positives = 100/224 (44%), Gaps = 41/224 (18%)

Query: 316 SFKYKLGQGGYGSVYKGKLLDGSNVAVKVLNDSKGNGKEFINEVASISRTSHVNVVALLG 375
           +   ++G G +G V+ G  L+   VA+K + +   + ++FI E   + + SH  +V L G
Sbjct: 7   TLVQEIGSGQFGLVWLGYWLEKRKVAIKTIREGAMSEEDFIEEAQVMMKLSHPKLVQLYG 66

Query: 376 FCLR---------------VAEELSSTIG-------------IARGLEYLHLGCSTRILH 407
            C                 +++ L +  G             +  G+ YL       ++H
Sbjct: 67  VCTERSPICLVFEFMEHGCLSDYLRAQRGKFSQETLLGMCLDVCEGMAYLESSN---VIH 123

Query: 408 FDIKPHNILLDEDFCPKISDFGLAKICNRKESIISMTGARGTVGYIAPEVFCRNIGEVSY 467
            D+   N L+ E+   K+SDFG+ +     +   S TG +  V + +PEVF  +  + S 
Sbjct: 124 RDLAARNCLVGENQVVKVSDFGMTRFV-LDDQYTSSTGTKFPVKWSSPEVF--SFSKYSS 180

Query: 468 KSDVYNYGMMIFEMTG-------GRKNVDVVDNGSTALDLQASR 504
           KSDV+++G++++E+          R N +VV+  +    L   R
Sbjct: 181 KSDVWSFGVLMWEVFSEGKTPYENRSNSEVVETINAGFRLYKPR 224

Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Itk contains the Tec homology (TH) domain containing one proline-rich region and a zinc-binding region. Tec kinases are expressed mainly by haematopoietic cells. Itk is expressed in T-cells and mast cells, and is important in their development and differentiation. Of the three Tec kinases expressed in T-cells, Itk plays the predominant role in T-cell receptor (TCR) signaling. It is activated by phosphorylation upon TCR crosslinking and is involved in the pathway resulting in phospholipase C-gamma1 activation and actin polymerization. It also plays a role in the downstream signaling of the T-cell costimulatory receptor CD28, the T-cell surface receptor CD2, and the chemokine receptor CXCR4. In addition, Itk is crucial for the development of T-helper(Th)2 effector responses. Length = 256

>gnl|CDD|173672 cd05581, STKc_PDK1, Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1

 Score = 78.4 bits (194), Expect = 4e-16
 Identities = 55/222 (24%), Positives = 81/222 (36%), Gaps = 68/222 (30%)

Query: 321 LGQGGYGSVYKGKLL-DGSNVAVKVLNDSKGNGKEFI---NEVASISR--------TSHV 368
           +G+G + +V   K        A+K+L+      K  +    +V  +            H 
Sbjct: 9   IGEGSFSTVVLAKEKETNKEYAIKILD------KRQLIKEKKVKYVKIEKEVLTRLNGHP 62

Query: 369 NVVALLG---------FCLRVAE--ELSSTIG----------------IARGLEYLHLGC 401
            ++ L           F L  A   EL   I                 I   LEYLH   
Sbjct: 63  GIIKLYYTFQDEENLYFVLEYAPNGELLQYIRKYGSLDEKCTRFYAAEILLALEYLH--- 119

Query: 402 STRILHFDIKPHNILLDEDFCPKISDFGLAKI--------------CNRKESIISMTGAR 447
           S  I+H D+KP NILLD+D   KI+DFG AK+               N    I       
Sbjct: 120 SKGIIHRDLKPENILLDKDMHIKITDFGTAKVLDPNSSPESNKGDATNIDSQIEKNRRRF 179

Query: 448 ----GTVGYIAPEVFCRNIGEVSYKSDVYNYGMMIFEMTGGR 485
               GT  Y++PE+           SD++  G +I++M  G+
Sbjct: 180 ASFVGTAEYVSPELLNEKP--AGKSSDLWALGCIIYQMLTGK 219

Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to autophosphorylate and is constitutively active in mammalian cells. PDK1 is essential for normal embryo development and is important in regulating cell volume. Length = 280

>gnl|CDD|173629 cd05041, PTKc_Fes_like, Catalytic domain of Fes-like Protein Tyrosine Kinases

 Score = 77.5 bits (191), Expect = 5e-16
 Identities = 56/195 (28%), Positives = 89/195 (45%), Gaps = 43/195 (22%)

Query: 320 KLGQGGYGSVYKGKLLDGSNVAVKV--LNDSKGNGKEFINEVASISRTSHVNVVALLGFC 377
           K+G+G +G VYKG L   + VAVK           ++F+ E   + +  H N+V L+G C
Sbjct: 2   KIGKGNFGDVYKGVLKGNTEVAVKTCRSTLPPDLKRKFLQEAEILKQYDHPNIVKLIGVC 61

Query: 378 ----------------------------LRVAEELSSTIGIARGLEYLHLGCSTRILHFD 409
                                       L V + L  ++  A G+EYL    S   +H D
Sbjct: 62  VQKQPIYIVMELVPGGSLLTFLRKKKNRLTVKKLLQMSLDAAAGMEYLE---SKNCIHRD 118

Query: 410 IKPHNILLDEDFCPKISDFGLAKICNRKESIISMTGARGT----VGYIAPEVFCRNIGEV 465
           +   N L+ E+   KISDFG++    R+E     T + G     + + APE    N G  
Sbjct: 119 LAARNCLVGENNVLKISDFGMS----REEEGGIYTVSDGLKQIPIKWTAPEAL--NYGRY 172

Query: 466 SYKSDVYNYGMMIFE 480
           + +SDV++YG++++E
Sbjct: 173 TSESDVWSYGILLWE 187

Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes and Fer kinases play roles in haematopoiesis, inflammation and immunity, growth factor signaling, cytoskeletal regulation, cell migration and adhesion, and the regulation of cell-cell interactions. Fes and Fer show redundancy in their biological functions. Length = 251

>gnl|CDD|133172 cd05040, PTKc_Ack_like, Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase

 Score = 77.4 bits (191), Expect = 6e-16
 Identities = 57/197 (28%), Positives = 78/197 (39%), Gaps = 40/197 (20%)

Query: 320 KLGQGGYGSVYKGKLLDGS----NVAVKVLNDSK--GNGKEFINEVASISRTSHVNVVAL 373
           KLG G +G V +G+          VAVK L   K      +F+ E A +    H N++ L
Sbjct: 2   KLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLSDIMDDFLKEAAIMHSLDHENLIRL 61

Query: 374 LGFCLR-----VAE--ELSS---------------------TIGIARGLEYLHLGCSTRI 405
            G  L      V E   L S                      + IA G+ YL    S R 
Sbjct: 62  YGVVLTHPLMMVTELAPLGSLLDRLRKDALGHFLISTLCDYAVQIANGMRYLE---SKRF 118

Query: 406 LHFDIKPHNILLDEDFCPKISDFGLAKICNRKESIISMTGARGT-VGYIAPEVFCRNIGE 464
           +H D+   NILL  D   KI DFGL +   + E    M         + APE        
Sbjct: 119 IHRDLAARNILLASDDKVKIGDFGLMRALPQNEDHYVMEEHLKVPFAWCAPE--SLRTRT 176

Query: 465 VSYKSDVYNYGMMIFEM 481
            S+ SDV+ +G+ ++EM
Sbjct: 177 FSHASDVWMFGVTLWEM 193

Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with androgen-independent prostate cancer progression. Tnk1 regulates TNFalpha signaling and may play an important role in cell death. Length = 257

>gnl|CDD|173654 cd05108, PTKc_EGFR, Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor

 Score = 78.5 bits (193), Expect = 6e-16
 Identities = 64/217 (29%), Positives = 101/217 (46%), Gaps = 43/217 (19%)

Query: 310 IKKMTNSFKYK-LGQGGYGSVYKGKLL-DGSN----VAVKVLNDS---KGNGKEFINEVA 360
           I K T   K K LG G +G+VYKG  + +G      VA+K L ++   K N KE ++E  
Sbjct: 3   ILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKAN-KEILDEAY 61

Query: 361 SISRTSHVNVVALLGFCLRVAEELSST---------------------------IGIARG 393
            ++   + +V  LLG CL    +L +                            + IA+G
Sbjct: 62  VMASVDNPHVCRLLGICLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKG 121

Query: 394 LEYLHLGCSTRILHFDIKPHNILLDEDFCPKISDFGLAKICNRKESIISMTGARGTVGYI 453
           + YL      R++H D+   N+L+      KI+DFGLAK+    E      G +  + ++
Sbjct: 122 MNYLE---ERRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGADEKEYHAEGGKVPIKWM 178

Query: 454 APEVFCRNIGEVSYKSDVYNYGMMIFE-MTGGRKNVD 489
           A E     I   +++SDV++YG+ ++E MT G K  D
Sbjct: 179 ALESILHRI--YTHQSDVWSYGVTVWELMTFGSKPYD 213

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands for EGFR include EGF, heparin binding EGF-like growth factor (HBEGF), epiregulin, amphiregulin, TGFalpha, and betacellulin. Upon ligand binding, EGFR can form homo- or heterodimers with other EGFR subfamily members. The EGFR signaling pathway is one of the most important pathways regulating cell proliferation, differentiation, survival, and growth. Overexpression and mutation in the kinase domain of EGFR have been implicated in the development and progression of a variety of cancers. A number of monoclonal antibodies and small molecule inhibitors have been developed that target EGFR, including the antibodies Cetuximab and Panitumumab, which are used in combination with other therapies for the treatment of colorectal cancer and non-small cell lung carcinoma (NSCLC). The small molecule inhibitors Gefitinib (Iressa) and Erlotinib (Tarceva), already used for NSCLC, are undergoing clinical trials for other types of cancer including gastrointestinal, breast, head and neck, and bladder. Length = 316

>gnl|CDD|173757 cd08217, STKc_Nek2, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2

 Score = 77.3 bits (191), Expect = 7e-16
 Identities = 52/204 (25%), Positives = 83/204 (40%), Gaps = 47/204 (23%)

Query: 319 YKLGQGGYGSVYKGKLL-DGSNVAVKVLNDSKGNGKE---FINEVASISRTSHVNVVALL 374
             +G+G +G+V K +   DG  +  K ++      KE    ++EV  +    H N+V   
Sbjct: 6   ETIGKGSFGTVRKVRRKSDGKILVWKEIDYGNMTEKEKQQLVSEVNILRELKHPNIVRYY 65

Query: 375 G---------------FC----------------LRVAEE--LSSTIGIARGLEYLHLGC 401
                           +C                  + EE        +   L   H   
Sbjct: 66  DRIIDRSNQTLYIVMEYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLALYECHNRS 125

Query: 402 --STRILHFDIKPHNILLDEDFCPKISDFGLAKICNRKESIISMTGARGTVGYIAPEVFC 459
                +LH D+KP NI LD +   K+ DFGLAKI    +S  + T   GT  Y++PE   
Sbjct: 126 DPGNTVLHRDLKPANIFLDANNNVKLGDFGLAKILGH-DSSFAKTYV-GTPYYMSPEQ-- 181

Query: 460 RNIGEVSY--KSDVYNYGMMIFEM 481
             +  +SY  KSD+++ G +I+E+
Sbjct: 182 --LNHMSYDEKSDIWSLGCLIYEL 203

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exit. NIMA is involved in nuclear membrane fission. Vertebrate Nek2 is a cell cycle-regulated STK, localized in centrosomes and kinetochores, that regulates centrosome splitting at the G2/M phase. It also interacts with other mitotic kinases such as Polo-like kinase 1 and may play a role in spindle checkpoint. An increase in the expression of the human NEK2 gene is strongly associated with the progression of non-Hodgkin lymphoma. Length = 265

>gnl|CDD|133240 cd05109, PTKc_HER2, Catalytic domain of the Protein Tyrosine Kinase, HER2

 Score = 77.4 bits (190), Expect = 8e-16
 Identities = 61/204 (29%), Positives = 97/204 (47%), Gaps = 40/204 (19%)

Query: 321 LGQGGYGSVYKGKLL-DGSN----VAVKVL--NDSKGNGKEFINEVASISRTSHVNVVAL 373
           LG G +G+VYKG  + DG N    VA+KVL  N S    KE ++E   ++      V  L
Sbjct: 15  LGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAYVMAGVGSPYVCRL 74

Query: 374 LGFCL-------------------------RVAEE--LSSTIGIARGLEYLHLGCSTRIL 406
           LG CL                         R+  +  L+  + IA+G+ YL      R++
Sbjct: 75  LGICLTSTVQLVTQLMPYGCLLDYVRENKDRIGSQDLLNWCVQIAKGMSYLE---EVRLV 131

Query: 407 HFDIKPHNILLDEDFCPKISDFGLAKICNRKESIISMTGARGTVGYIAPEVFCRNIGEVS 466
           H D+   N+L+      KI+DFGLA++ +  E+     G +  + ++A E         +
Sbjct: 132 HRDLAARNVLVKSPNHVKITDFGLARLLDIDETEYHADGGKVPIKWMALESILHR--RFT 189

Query: 467 YKSDVYNYGMMIFE-MTGGRKNVD 489
           ++SDV++YG+ ++E MT G K  D
Sbjct: 190 HQSDVWSYGVTVWELMTFGAKPYD 213

Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER2 does not bind to any known EGFR subfamily ligands, but contributes to the kinase activity of all possible heterodimers. It acts as the preferred partner with other ligand-bound EGFR proteins and functions as a signal amplifier, with the HER2-HER3 heterodimer being the most potent pair in mitogenic signaling. HER2 plays an important role in cell development, proliferation, survival and motility. Overexpression of HER2 results in its activation and downstream signaling, even in the absence of ligand. HER2 overexpression, mainly due to gene amplification, has been shown in a variety of human cancers. Its role in breast cancer is especially well-documented. HER2 is up-regulated in about 25% of breast tumors and is associated with increases in tumor aggressiveness, recurrence and mortality. HER2 is a target for monoclonal antibodies and small molecule inhibitors, which are being developed as treatments for cancer. The first humanized antibody approved for clinical use is Trastuzumab (Herceptin), which is being used in combination with other therapies to improve the survival rates of patients with HER2-overexpressing breast cancer. Length = 279

>gnl|CDD|173772 cd08530, STKc_CNK2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains

 Score = 76.7 bits (189), Expect = 1e-15
 Identities = 62/204 (30%), Positives = 93/204 (45%), Gaps = 50/204 (24%)

Query: 320 KLGQGGYGSVYKGK-LLDGSNVAVKVLNDSKGNGKE---FINEVASISRTSHVNVVA--- 372
           KLG+G YGSVYK K L D    A+K ++    + KE    +NE+  ++  +H N+++   
Sbjct: 7   KLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAVNEIRILASVNHPNIISYKE 66

Query: 373 --LLGFCLRVAEEL--------------------------SSTIGIARGLEYLHLGCSTR 404
             L G  L +  E                              I + RGL+ LH     +
Sbjct: 67  AFLDGNKLCIVMEYAPFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQALH---EQK 123

Query: 405 ILHFDIKPHNILLDEDFCPKISDFGLAKICNR---KESIISMTGARGTVGYIAPEVFCRN 461
           ILH D+K  NILL  +   KI D G++K+  +   K  I       GT  Y+APEV+   
Sbjct: 124 ILHRDLKSANILLVANDLVKIGDLGISKVLKKNMAKTQI-------GTPHYMAPEVWKGR 176

Query: 462 IGEVSYKSDVYNYGMMIFEMTGGR 485
               SYKSD+++ G +++EM    
Sbjct: 177 --PYSYKSDIWSLGCLLYEMATFA 198

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, and it regulates cell size, through influencing the size threshold at which cells commit to mitosis. Length = 256

>gnl|CDD|133199 cd05068, PTKc_Frk_like, Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases

 Score = 76.3 bits (188), Expect = 2e-15
 Identities = 57/208 (27%), Positives = 96/208 (46%), Gaps = 38/208 (18%)

Query: 309 DIKKMTNSFKYKLGQGGYGSVYKGKLLDGSNVAVKVLNDSKGNGKEFINEVASISRTSHV 368
           +I + +     KLG G +G V++G   + + VAVK L     + K+F+ E   + +  H 
Sbjct: 2   EIDRTSIQLLRKLGAGQFGEVWEGLWNNTTPVAVKTLKPGTMDPKDFLAEAQIMKKLRHP 61

Query: 369 NVVALLGFCLR------VAE-------------------ELSSTIG----IARGLEYLHL 399
            ++ L   C        V E                   +L   I     +A G+ YL  
Sbjct: 62  KLIQLYAVCTLEEPIYIVTELMKYGSLLEYLQGGAGRALKLPQLIDMAAQVASGMAYLE- 120

Query: 400 GCSTRILHFDIKPHNILLDEDFCPKISDFGLAKICNRKESII-SMTGARGTVGYIAPEVF 458
             +   +H D+   N+L+ E+   K++DFGLA++   KE I  +  GA+  + + APE  
Sbjct: 121 --AQNYIHRDLAARNVLVGENNICKVADFGLARVI--KEDIYEAREGAKFPIKWTAPEAA 176

Query: 459 CRNIGEVSYKSDVYNYGMMIFE-MTGGR 485
             N    S KSDV+++G+++ E +T GR
Sbjct: 177 LYN--RFSIKSDVWSFGILLTEIVTYGR 202

Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Frk, also known as Rak, is specifically expressed in liver, lung, kidney, intestine, mammary glands, and the islets of Langerhans. Rodent homologs were previously referred to as GTK (gastrointestinal tyr kinase), BSK (beta-cell Src-like kinase), or IYK (intestinal tyr kinase). Studies in mice reveal that Frk is not essential for viability. It plays a role in the signaling that leads to cytokine-induced beta-cell death in Type I diabetes. It also regulates beta-cell number during embryogenesis and early in life. Length = 261

>gnl|CDD|173733 cd07829, STKc_CDK_like, Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases

 Score = 76.0 bits (188), Expect = 2e-15
 Identities = 49/147 (33%), Positives = 70/147 (47%), Gaps = 34/147 (23%)

Query: 320 KLGQGGYGSVYKGK-LLDGSNVAVKVL---NDSKGNGKEFINEVASISRTSHVNVVALL- 374
           KLG+G YG VYK +    G  VA+K +   N+ +G     + E++ +    H N+V LL 
Sbjct: 6   KLGEGTYGVVYKARDKKTGEIVALKKIRLDNEEEGIPSTALREISLLKELKHPNIVKLLD 65

Query: 375 ------------GFC---LRV-----AEELS-STIG-----IARGLEYLHLGCSTRILHF 408
                        +C   L+         LS + I      + RGL Y H   S RILH 
Sbjct: 66  VIHTERKLYLVFEYCDMDLKKYLDKRPGPLSPNLIKSIMYQLLRGLAYCH---SHRILHR 122

Query: 409 DIKPHNILLDEDFCPKISDFGLAKICN 435
           D+KP NIL++ D   K++DFGLA+   
Sbjct: 123 DLKPQNILINRDGVLKLADFGLARAFG 149

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the early G1 phase by CDK4 or CDK6, the G1/S phase transition by CDK2, or the entry of mitosis by CDK1. They also exhibit overlapping cyclin specificity and functions in certain conditions. Knockout mice with a single CDK deleted remain viable with specific phenotypes, showing that some CDKs can compensate for each other. For example, CDK4 can compensate for the loss of CDK6, however, double knockout mice with both CDK4 and CDK6 deleted die in utero. CDK8 and CDK9 are mainly involved in transcription while CDK5 is implicated in neuronal function. CDK7 plays essential roles in both the cell cycle as a CDK-Activating Kinase (CAK) and in transcription as a component of the general transcription factor TFIIH. Length = 282

>gnl|CDD|143346 cd07841, STKc_CDK7, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7

 Score = 75.7 bits (187), Expect = 4e-15
 Identities = 57/176 (32%), Positives = 77/176 (43%), Gaps = 45/176 (25%)

Query: 320 KLGQGGYGSVYKGK-LLDGSNVAVK-VLNDSKGNGKEFIN-----EVASISRTSHVNVVA 372
           KLG+G Y  VYK +    G  VA+K +    +   K+ IN     E+  +    H N++ 
Sbjct: 7   KLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELKHPNIIG 66

Query: 373 LLG-FC--------------------------LRVAEELSSTIGIARGLEYLHLGCSTRI 405
           LL  F                           L  A+  S  +   RGLEYLH   S  I
Sbjct: 67  LLDVFGHKSNINLVFEFMETDLEKVIKDKSIVLTPADIKSYMLMTLRGLEYLH---SNWI 123

Query: 406 LHFDIKPHNILLDEDFCPKISDFGLAKIC---NRKESIISMTGARGTVGYIAPEVF 458
           LH D+KP+N+L+  D   K++DFGLA+     NRK     MT    T  Y APE+ 
Sbjct: 124 LHRDLKPNNLLIASDGVLKLADFGLARSFGSPNRK-----MTHQVVTRWYRAPELL 174

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is also a component of the general transcription factor TFIIH, which phosphorylates the C-terminal domain (CTD) of RNA polymerase II when it is bound with unphosphorylated DNA, as present in the pre-initiation complex. Following phosphorylation, the CTD dissociates from the DNA which allows transcription initiation. Length = 298

>gnl|CDD|173725 cd06608, STKc_myosinIII_like, Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases

 Score = 75.0 bits (185), Expect = 4e-15
 Identities = 59/211 (27%), Positives = 92/211 (43%), Gaps = 57/211 (27%)

Query: 321 LGQGGYGSVYKGKLLD-GSNVAVKVLNDSKGNGKEFINEVASISR--TSHVNVVALLG-- 375
           +G+G YG VYK +    G  VA+K++ D   + +E I E  +I R  ++H N+    G  
Sbjct: 14  IGEGTYGKVYKARHKKTGQLVAIKIM-DIIEDEEEEIKEEYNILRKYSNHPNIATFYGAF 72

Query: 376 -------------FCL--------------------RVAEELSSTI--GIARGLEYLHLG 400
                          +                    R+ EE  + I     RGL YLH  
Sbjct: 73  IKKNPPGNDDQLWLVMELCGGGSVTDLVKGLRKKGKRLKEEWIAYILRETLRGLAYLH-- 130

Query: 401 CSTRILHFDIKPHNILLDEDFCPKISDFGLAKICNRKESIISMTGARGT-VG---YIAPE 456
              +++H DIK  NILL ++   K+ DFG++   +         G R T +G   ++APE
Sbjct: 131 -ENKVIHRDIKGQNILLTKNAEVKLVDFGVSAQLDSTL------GRRNTFIGTPYWMAPE 183

Query: 457 VF-CRNIGEVSY--KSDVYNYGMMIFEMTGG 484
           V  C    + SY  +SDV++ G+   E+  G
Sbjct: 184 VIACDEQPDASYDARSDVWSLGITAIELADG 214

Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin III may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. It may also function as a cargo carrier during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. The Drosophila class III myosin, called NinaC (Neither inactivation nor afterpotential protein C), is critical in normal adaptation and termination of photoresponse. Vertebrates contain two isoforms of class III myosin, IIIA and IIIB. This subfamily also includes mammalian NIK-like embryo-specific kinase (NESK), Traf2- and Nck-interacting kinase (TNIK), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6). MAP4Ks are involved in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Length = 275

>gnl|CDD|132962 cd06631, STKc_YSK4, Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4

 Score = 74.2 bits (182), Expect = 7e-15
 Identities = 62/209 (29%), Positives = 93/209 (44%), Gaps = 55/209 (26%)

Query: 321 LGQGGYGSVYKGKLLDGSNVAVKVL----NDSKGNGKEFIN---EVASISRTSHVNVVAL 373
           LG+G YG+VY G    G  +AVK +    ++     KE+     EV  +    HVN+V  
Sbjct: 8   LGKGAYGTVYCGLTNQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIVQY 67

Query: 374 LGFCLR---------------VAEELSS------------TIGIARGLEYLHLGCSTRIL 406
           LG CL                ++  L+             T  I  G+ YLH  C   ++
Sbjct: 68  LGTCLDDNTISIFMEFVPGGSISSILNRFGPLPEPVFCKYTKQILDGVAYLHNNC---VV 124

Query: 407 HFDIKPHNILLDEDFCPKISDFGLAKICNRKESIISMTGA--------RGTVGYIAPEVF 458
           H DIK +N++L  +   K+ DFG    C R+ + + + G          GT  ++APEV 
Sbjct: 125 HRDIKGNNVMLMPNGIIKLIDFG----CARRLAWVGLHGTHSNMLKSMHGTPYWMAPEV- 179

Query: 459 CRNIGEVSY--KSDVYNYGMMIFEMTGGR 485
              I E  Y  KSD+++ G  +FEM  G+
Sbjct: 180 ---INESGYGRKSDIWSIGCTVFEMATGK 205

Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Length = 265

>gnl|CDD|143333 cd05118, STKc_CMGC, Catalytic domain of CMGC family Serine/Threonine Kinases

 Score = 73.5 bits (181), Expect = 2e-14
 Identities = 54/197 (27%), Positives = 86/197 (43%), Gaps = 37/197 (18%)

Query: 320 KLGQGGYGSVYKGK-LLDGSNVAVKVLN---DSKGNGKEFINEVASISRTSHVNVVALLG 375
           K+G+G YG VYK +  L G  VA+K +    +S+G  K  + E+  +   +H N++ LL 
Sbjct: 6   KIGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTALREIKLLKELNHPNIIKLLD 65

Query: 376 -------------FCLRVAEEL--------------SSTIGIARGLEYLHLGCSTRILHF 408
                        F      +L              S    + +GL + H   S  ILH 
Sbjct: 66  VFRHKGDLYLVFEFMDTDLYKLIKDRQRGLPESLIKSYLYQLLQGLAFCH---SHGILHR 122

Query: 409 DIKPHNILLDEDFCPKISDFGLAKICNRKESIISMTGARGTVGYIAPEVFCRNIGEVSYK 468
           D+KP N+L++ +   K++DFGLA+           T    T  Y APE+   + G  S  
Sbjct: 123 DLKPENLLINTEGVLKLADFGLARSFGSPVRP--YTHYVVTRWYRAPELLLGDKG-YSTP 179

Query: 469 SDVYNYGMMIFEMTGGR 485
            D+++ G +  E+   R
Sbjct: 180 VDIWSVGCIFAELLSRR 196

Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Length = 283

>gnl|CDD|132952 cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases

 Score = 73.6 bits (181), Expect = 2e-14
 Identities = 60/207 (28%), Positives = 88/207 (42%), Gaps = 55/207 (26%)

Query: 320 KLGQGGYGSVYKGKLLDGSNV-AVKVLNDSKGNG--KEFINEVASISRTSHVNVVALLGF 376
           +LG+G  GSV K +L +   + A+K +         K+ + E+          +V   G 
Sbjct: 8   RLGEGAGGSVTKCRLKNTGMIFALKTITTDPNPDLQKQILRELEINKSCKSPYIVKYYGA 67

Query: 377 CLRVAEELSSTIGIA------------------------------------RGLEYLHLG 400
            L   +E SS+IGIA                                    +GL YLH  
Sbjct: 68  FL---DESSSSIGIAMEYCEGGSLDSIYKKVKKRGGRIGEKVLGKIAESVLKGLSYLH-- 122

Query: 401 CSTRILHFDIKPHNILLDEDFCPKISDFGLAKICNRKESIISMTGA-RGTVGYIAPEVFC 459
            S +I+H DIKP NILL      K+ DFG++      E + S+ G   GT  Y+APE   
Sbjct: 123 -SRKIIHRDIKPSNILLTRKGQVKLCDFGVS-----GELVNSLAGTFTGTSFYMAPE--- 173

Query: 460 RNIGE-VSYKSDVYNYGMMIFEMTGGR 485
           R  G+  S  SDV++ G+ + E+   R
Sbjct: 174 RIQGKPYSITSDVWSLGLTLLEVAQNR 200

Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Pek1/Skh1 from Schizosaccharomyces pombe and MKK2 from Saccharomyces cerevisiae, and related proteins. Both fission yeast Pek1 and baker's yeast MKK2 are components of the cell integrity MAPK pathway. In fission yeast, Pek1 phosphorylates and activates the MAPK Pmk1/Spm1 and is regulated by the MAPKKK Mkh1. In baker's yeast, the pathway involves the MAPK Slt2, the MAPKKs MKK1 and MKK2, and the MAPKKK Bck1. The cell integrity MAPK cascade is activated by multiple stress conditions, and is essential in cell wall construction, morphogenesis, cytokinesis, and ion homeostasis. Length = 287

>gnl|CDD|173658 cd05114, PTKc_Tec_Rlk, Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase

 Score = 73.0 bits (179), Expect = 2e-14
 Identities = 60/212 (28%), Positives = 97/212 (45%), Gaps = 41/212 (19%)

Query: 316 SFKYKLGQGGYGSVYKGKLLDGSNVAVKVLNDSKGNGKEFINEVASISRTSHVNVVALLG 375
           +F  +LG G +G V+ GK      VA+K +N+   + ++FI E   + + SH  +V L G
Sbjct: 7   TFMKELGSGQFGVVHLGKWRAQIKVAIKAINEGAMSEEDFIEEAKVMMKLSHPKLVQLYG 66

Query: 376 FCLR------VAE----------------------ELSSTIGIARGLEYLHLGCSTRILH 407
            C +      V E                       LS    +  G+EYL        +H
Sbjct: 67  VCTQQKPLYIVTEFMENGCLLNYLRQRQGKLSKDMLLSMCQDVCEGMEYLE---RNSFIH 123

Query: 408 FDIKPHNILLDEDFCPKISDFGLAKICNRKESIISMTGARGTVGYIAPEVFCRNIGEVSY 467
            D+   N L+      K+SDFG+ +     E   S +GA+  V +  PEVF  N  + S 
Sbjct: 124 RDLAARNCLVSSTGVVKVSDFGMTRYVLDDE-YTSSSGAKFPVKWSPPEVF--NFSKYSS 180

Query: 468 KSDVYNYGMMIFEM-TGGR------KNVDVVD 492
           KSDV+++G++++E+ T G+       N +VV+
Sbjct: 181 KSDVWSFGVLMWEVFTEGKMPFEKKSNYEVVE 212

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. Instead of PH, Rlk contains an N-terminal cysteine-rich region. In addition to PH, Tec also contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Tec is more widely-expressed than other Tec subfamily kinases. It is found in endothelial cells, both B- and T-cells, and a variety of myeloid cells including mast cells, erythroid cells, platelets, macrophages and neutrophils. Rlk is expressed in T-cells and mast cell lines. Tec and Rlk are both key components of T-cell receptor (TCR) signaling. They are important in TCR-stimulated proliferation, IL-2 production and phopholipase C-gamma1 activation. Length = 256

>gnl|CDD|132978 cd06647, STKc_PAK_I, Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase

 Score = 73.0 bits (179), Expect = 3e-14
 Identities = 65/206 (31%), Positives = 92/206 (44%), Gaps = 40/206 (19%)

Query: 309 DIKKMTNSFKYKLGQGGYGSVYKG-KLLDGSNVAVKVLNDSKGNGKEFI-NEVASISRTS 366
           D KK    F+ K+GQG  G+VY    +  G  VA+K +N  +   KE I NE+  +    
Sbjct: 16  DPKKKYTRFE-KIGQGASGTVYTAIDVATGQEVAIKQMNLQQQPKKELIINEILVMRENK 74

Query: 367 HVNVVALLGFCLRVAEELSSTIGIARG---------------------------LEYLHL 399
           H N+V  L   L V +EL   +    G                           LE+LH 
Sbjct: 75  HPNIVNYLDSYL-VGDELWVVMEYLAGGSLTDVVTETCMDEGQIAAVCRECLQALEFLH- 132

Query: 400 GCSTRILHFDIKPHNILLDEDFCPKISDFGL-AKICNRKESIISMTGARGTVGYIAPEVF 458
             S +++H DIK  NILL  D   K++DFG  A+I   +    +M    GT  ++APEV 
Sbjct: 133 --SNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMV---GTPYWMAPEVV 187

Query: 459 CRNIGEVSYKSDVYNYGMMIFEMTGG 484
            R       K D+++ G+M  EM  G
Sbjct: 188 TRK--AYGPKVDIWSLGIMAIEMVEG 211

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs, also called conventional PAKs, include PAK1, PAK2, and PAK3. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). They interact with the SH3 domain containing proteins Nck, Grb2 and PIX. Binding of group I PAKs to activated GTPases leads to conformational changes that destabilize the AID, allowing autophosphorylation and full activation of the kinase domain. Known group I PAK substrates include MLCK, Bad, Raf, MEK1, LIMK, Merlin, Vimentin, Myc, Stat5a, and Aurora A, among others. Length = 293

>gnl|CDD|173668 cd05577, STKc_GRK, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase

 Score = 72.1 bits (177), Expect = 5e-14
 Identities = 37/96 (38%), Positives = 50/96 (52%), Gaps = 8/96 (8%)

Query: 390 IARGLEYLHLGCSTRILHFDIKPHNILLDEDFCPKISDFGLAKICNRKESIISMTGARGT 449
           I  GLE+LH     RI++ D+KP N+LLD+    +ISD GLA      + I    G  GT
Sbjct: 104 IICGLEHLH---QRRIVYRDLKPENVLLDDHGNVRISDLGLAVELKGGKKI---KGRAGT 157

Query: 450 VGYIAPEVFCRNIGEVSYKSDVYNYGMMIFEMTGGR 485
            GY+APEV         +  D +  G  ++EM  GR
Sbjct: 158 PGYMAPEVLQG--EVYDFSVDWFALGCTLYEMIAGR 191

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of G protein signaling) homology (RH) domain and several motifs. The C-terminus diverges among different groups of GRKs. There are seven types of GRKs, named GRK1 to GRK7. They are subdivided into three main groups: visual (GRK1/7); beta-adrenergic receptor kinases (GRK2/3); and GRK4-like (GRK4/5/6). Expression of GRK2/3/5/6 is widespread while GRK1/4/7 show a limited tissue distribution. The substrate spectrum of the widely expressed GRKs partially overlaps. GRKs play important roles in the cardiovascular, immune, respiratory, skeletal, and nervous systems. Length = 277

>gnl|CDD|173640 cd05067, PTKc_Lck_Blk, Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk

 Score = 71.8 bits (176), Expect = 5e-14
 Identities = 53/209 (25%), Positives = 90/209 (43%), Gaps = 41/209 (19%)

Query: 320 KLGQGGYGSVYKGKLLDGSNVAVKVLNDSKGNGKEFINEVASISRTSHVNVVALL----- 374
           KLG G +G V+ G     + VA+K L     + + F+ E   + +  H  +V L      
Sbjct: 13  KLGAGQFGEVWMGYYNGHTKVAIKSLKQGSMSPEAFLAEANLMKQLQHPRLVRLYAVVTQ 72

Query: 375 -----------------------GFCLRVAEELSSTIGIARGLEYLHLGCSTRILHFDIK 411
                                  G  L + + +     IA G+ ++        +H D++
Sbjct: 73  EPIYIITEYMENGSLVDFLKTPEGIKLTINKLIDMAAQIAEGMAFIE---RKNYIHRDLR 129

Query: 412 PHNILLDEDFCPKISDFGLAKICNRKESIISMTGARGTVGYIAPEVFCRNIGEVSYKSDV 471
             NIL+ E  C KI+DFGLA++    E   +  GA+  + + APE    N G  + KSDV
Sbjct: 130 AANILVSETLCCKIADFGLARLIEDNE-YTAREGAKFPIKWTAPEAI--NYGTFTIKSDV 186

Query: 472 YNYGMMIFEMTG-------GRKNVDVVDN 493
           +++G+++ E+         G  N +V+ N
Sbjct: 187 WSFGILLTEIVTYGRIPYPGMTNPEVIQN 215

Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lck is expressed in T-cells and natural killer (NK) cells. It plays a critical role in T-cell maturation, activation, and T-cell receptor (TCR) signaling. Lck phosphorylates ITAM (immunoreceptor tyr activation motif) sequences on several subunits of TCRs, leading to the activation of different second messenger cascades. Phosphorylated ITAMs serve as binding sites for other signaling factor such as Syk and ZAP-70, leading to their activation and propagation of downstream events. In addition, Lck regulates drug-induced apoptosis by interfering with the mitochondrial death pathway. The apototic role of Lck is independent of its primary function in T-cell signaling. Blk is expressed specifically in B-cells. It is involved in pre-BCR (B-cell receptor) signaling. Length = 260

>gnl|CDD|133167 cd05035, PTKc_Axl_like, Catalytic Domain of Axl-like Protein Tyrosine Kinases

 Score = 71.4 bits (175), Expect = 7e-14
 Identities = 61/216 (28%), Positives = 93/216 (43%), Gaps = 62/216 (28%)

Query: 321 LGQGGYGSVYKGKLL--DGS--NVAVKVL---NDSKGNGKEFINEVASISRTSHVNVVAL 373
           LG+G +GSV +G+L   DGS   VAVK +     +    +EF++E A +    H NV+ L
Sbjct: 7   LGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFDHPNVMKL 66

Query: 374 LGFCLRVAEE----------------------LSSTIG-----------------IARGL 394
           +G C   +                        L S +G                 IA G+
Sbjct: 67  IGVCFEASSLQKIPKPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALGM 126

Query: 395 EYLHLGCSTRILHFDIKPHNILLDEDFCPKISDFGLA-KICN----RKESIISMTGARGT 449
           EYL    +   +H D+   N +L ED    ++DFGL+ KI +    R+  I  M      
Sbjct: 127 EYL---SNRNFIHRDLAARNCMLREDMTVCVADFGLSKKIYSGDYYRQGRIAKM-----P 178

Query: 450 VGYIAPEVFCRNIGEVSYKSDVYNYGMMIFE-MTGG 484
           V +IA E     +   + KSDV+ +G+ ++E  T G
Sbjct: 179 VKWIAIESLADRV--YTSKSDVWAFGVTMWEIATRG 212

Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellular effects including survival, proliferation, migration, and phagocytosis. They are also associated with several types of cancer as well as inflammatory, autoimmune, vascular, and kidney diseases. Mer is named after its original reported expression pattern (monocytes, epithelial, and reproductive tissues). It is required for the ingestion of apoptotic cells by phagocytes such as macrophages, retinal pigment epithelial cells, and dendritic cells. Mer is also important in maintaining immune homeostasis. Length = 273

>gnl|CDD|173764 cd08224, STKc_Nek6_Nek7, Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7

 Score = 70.5 bits (173), Expect = 1e-13
 Identities = 58/204 (28%), Positives = 89/204 (43%), Gaps = 55/204 (26%)

Query: 320 KLGQGGYGSVYKGK-LLDGSNVAVKVLN-----DSKGNGKEFINEVASISRTSHVNVVAL 373
           K+G+G +  VYK   LLDG  VA+K +      D+K   ++ + E+  + +  H NV+  
Sbjct: 9   KIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKAR-QDCLKEIDLLKQLDHPNVIKY 67

Query: 374 LG-----------FCLRVAEELSSTIG--------------------IARGLEYLHLGCS 402
           L              L  A +LS  I                     +   LE++H   S
Sbjct: 68  LASFIENNELNIVLELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSALEHMH---S 124

Query: 403 TRILHFDIKPHNILLDEDFCPKISDFGLAKICNRKESIISMTGARGTVG---YIAPEVFC 459
            RI+H DIKP N+ +      K+ D GL +  + K      T A   VG   Y++PE   
Sbjct: 125 KRIMHRDIKPANVFITATGVVKLGDLGLGRFFSSK-----TTAAHSLVGTPYYMSPER-- 177

Query: 460 RNIGEVSY--KSDVYNYGMMIFEM 481
             I E  Y  KSD+++ G +++EM
Sbjct: 178 --IHENGYNFKSDIWSLGCLLYEM 199

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may also be regulators of the p70 ribosomal S6 kinase. Length = 267

>gnl|CDD|133216 cd05085, PTKc_Fer, Catalytic domain of the Protein Tyrosine Kinase, Fer

 Score = 70.0 bits (171), Expect = 2e-13
 Identities = 55/191 (28%), Positives = 90/191 (47%), Gaps = 38/191 (19%)

Query: 321 LGQGGYGSVYKGKLLDGSNVAVKVLN-DSKGNGK-EFINEVASISRTSHVNVVALLGFC- 377
           LG+G +G V+KG L D + VAVK    D     K +F++E   + +  H N+V L+G C 
Sbjct: 3   LGKGNFGEVFKGTLKDKTPVAVKTCKEDLPQELKIKFLSEARILKQYDHPNIVKLIGVCT 62

Query: 378 ---------------------------LRVAEELSSTIGIARGLEYLHLGCSTRILHFDI 410
                                      L+  + +   +  A G+ YL    S   +H D+
Sbjct: 63  QRQPIYIVMELVPGGDFLSFLRKKKDELKTKQLVKFALDAAAGMAYLE---SKNCIHRDL 119

Query: 411 KPHNILLDEDFCPKISDFGLAKICNRKESIISMTGARGT-VGYIAPEVFCRNIGEVSYKS 469
              N L+ E+   KISDFG+++     + I S +G +   + + APE    N G  S +S
Sbjct: 120 AARNCLVGENNVLKISDFGMSR--QEDDGIYSSSGLKQIPIKWTAPEAL--NYGRYSSES 175

Query: 470 DVYNYGMMIFE 480
           DV++YG++++E
Sbjct: 176 DVWSYGILLWE 186

Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-cell interactions mediated by adherens junctions and focal adhesions. Fer kinase also regulates cell cycle progression in malignant cells. Length = 250

>gnl|CDD|133165 cd05033, PTKc_EphR, Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases

 Score = 70.4 bits (173), Expect = 2e-13
 Identities = 52/218 (23%), Positives = 95/218 (43%), Gaps = 56/218 (25%)

Query: 321 LGQGGYGSVYKGKLLDGS----NVAVKVLND--SKGNGKEFINEVASISRTSHVNVVALL 374
           +G G +G V +G+L        +VA+K L    S     +F+ E + + +  H N++ L 
Sbjct: 12  IGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGSSDKQRLDFLTEASIMGQFDHPNIIRLE 71

Query: 375 GFC---------------------LRVAEELSSTI-------GIARGLEYLHLGCSTRIL 406
           G                       LR  +   +         GIA G++YL        +
Sbjct: 72  GVVTKSRPVMIITEYMENGSLDKFLRENDGKFTVGQLVGMLRGIASGMKYLSEMNY---V 128

Query: 407 HFDIKPHNILLDEDFCPKISDFGLAKICNRKESIISMTGARGTVGYIAPEVFCRNIGEVS 466
           H D+   NIL++ +   K+SDFGL++     E+  +  G +  + + APE        ++
Sbjct: 129 HRDLAARNILVNSNLVCKVSDFGLSRRLEDSEATYTTKGGKIPIRWTAPEA-------IA 181

Query: 467 YK-----SDVYNYGMMIFE-MTGGRK------NVDVVD 492
           Y+     SDV+++G++++E M+ G +      N DV+ 
Sbjct: 182 YRKFTSASDVWSFGIVMWEVMSYGERPYWDMSNQDVIK 219

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. This allows ephrin/EphR dimers to form, leading to the activation of the intracellular tyr kinase domain. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). The main effect of ephrin/EphR interaction is cell-cell repulsion or adhesion. Ephrin/EphR signaling is important in neural development and plasticity, cell morphogenesis and proliferation, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266

>gnl|CDD|173645 cd05084, PTKc_Fes, Catalytic domain of the Protein Tyrosine Kinase, Fes

 Score = 69.7 bits (170), Expect = 2e-13
 Identities = 54/194 (27%), Positives = 92/194 (47%), Gaps = 40/194 (20%)

Query: 320 KLGQGGYGSVYKGKL-LDGSNVAVKVLNDS--KGNGKEFINEVASISRTSHVNVVALLGF 376
           ++G+G +G V+ G+L  D + VAVK   ++       +F+ E   + + SH N+V L+G 
Sbjct: 2   RIGRGNFGEVFSGRLRADNTPVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGV 61

Query: 377 C----------------------------LRVAEELSSTIGIARGLEYLHLGCSTRILHF 408
           C                            L+V E +      A G+EYL    S   +H 
Sbjct: 62  CTQKQPIYIVMELVQGGDFLTFLRTEGPRLKVKELIQMVENAAAGMEYLE---SKHCIHR 118

Query: 409 DIKPHNILLDEDFCPKISDFGLAKICNRKESIISMTGA--RGTVGYIAPEVFCRNIGEVS 466
           D+   N L+ E    KISDFG+++    ++ + + TG   +  V + APE    N G  S
Sbjct: 119 DLAARNCLVTEKNVLKISDFGMSR--EEEDGVYASTGGMKQIPVKWTAPEAL--NYGRYS 174

Query: 467 YKSDVYNYGMMIFE 480
            +SDV+++G++++E
Sbjct: 175 SESDVWSFGILLWE 188

Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular endothelial, epithelial, and neuronal cells. It plays important roles in cell growth and differentiation, angiogenesis, inflammation and immunity, and cytoskeletal regulation. A recent study implicates Fes kinase as a tumor suppressor in colorectal cancer. Length = 252

>gnl|CDD|143338 cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases

 Score = 70.4 bits (173), Expect = 2e-13
 Identities = 57/206 (27%), Positives = 87/206 (42%), Gaps = 46/206 (22%)

Query: 318 KYK----LGQGGYGSVYKGKLLD-GSNVAVKVLNDSKGNG---KEFINEVASISRTSHVN 369
           KY+    +G+G YG V K +    G  VA+K   +S+ +    K  + EV  + +  H N
Sbjct: 2   KYEVLGVVGEGAYGVVLKCRNKATGEIVAIKKFKESEDDEDVKKTALREVKVLRQLRHEN 61

Query: 370 VVALLGFCLR--------------VAEEL-------------SSTIGIARGLEYLHLGCS 402
           +V L     R              + E L             S    + + + Y H   S
Sbjct: 62  IVNLKEAFRRKGRLYLVFEYVERTLLELLEASPGGLPPDAVRSYIWQLLQAIAYCH---S 118

Query: 403 TRILHFDIKPHNILLDEDFCPKISDFGLAK-ICNRKESIISMTGARGTVGYIAPEVFCRN 461
             I+H DIKP NIL+ E    K+ DFG A+ +  R  S   +T    T  Y APE+    
Sbjct: 119 HNIIHRDIKPENILVSESGVLKLCDFGFARALRARPAS--PLTDYVATRWYRAPELL--- 173

Query: 462 IGEVSYKS--DVYNYGMMIFEMTGGR 485
           +G+ +Y    DV+  G ++ E+  G 
Sbjct: 174 VGDTNYGKPVDVWAIGCIMAELLDGE 199

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning and memory. Length = 288

>gnl|CDD|133202 cd05071, PTKc_Src, Catalytic domain of the Protein Tyrosine Kinase, Src

 Score = 69.7 bits (170), Expect = 3e-13
 Identities = 54/206 (26%), Positives = 95/206 (46%), Gaps = 35/206 (16%)

Query: 309 DIKKMTNSFKYKLGQGGYGSVYKGKLLDGSNVAVKVLNDSKGNGKEFINEVASISRTSHV 368
           +I + +   + KLGQG +G V+ G     + VA+K L     + + F+ E   + +  H 
Sbjct: 2   EIPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQEAQVMKKLRHE 61

Query: 369 NVV---------------------ALLGFC-------LRVAEELSSTIGIARGLEYLHLG 400
            +V                     +LL F        LR+ + +     IA G+ Y+   
Sbjct: 62  KLVQLYAVVSEEPIYIVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVE-- 119

Query: 401 CSTRILHFDIKPHNILLDEDFCPKISDFGLAKICNRKESIISMTGARGTVGYIAPEVFCR 460
                +H D++  NIL+ E+   K++DFGLA++    E   +  GA+  + + APE    
Sbjct: 120 -RMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNE-YTARQGAKFPIKWTAPEAAL- 176

Query: 461 NIGEVSYKSDVYNYGMMIFEM-TGGR 485
             G  + KSDV+++G+++ E+ T GR
Sbjct: 177 -YGRFTIKSDVWSFGILLTELTTKGR 201

Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Src also play a role in regulating cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Elevated levels of Src kinase activity have been reported in a variety of human cancers. Several inhibitors of Src have been developed as anti-cancer drugs. Src is also implicated in acute inflammatory responses and osteoclast function. Length = 262

>gnl|CDD|143368 cd07863, STKc_CDK4, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4

 Score = 69.2 bits (169), Expect = 5e-13
 Identities = 58/204 (28%), Positives = 91/204 (44%), Gaps = 52/204 (25%)

Query: 320 KLGQGGYGSVYKGKLLD-GSNVA---VKVLNDSKGNGKEFINEVASISRTS---HVNVVA 372
           ++G G YG+VYK +    G  VA   V+V  +  G     + EVA + R     H N+V 
Sbjct: 7   EIGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGLPLSTVREVALLKRLEAFDHPNIVR 66

Query: 373 LLGFC--LRVAEELSSTI-------------------------------GIARGLEYLHL 399
           L+  C   R   E   T+                                  RGL++LH 
Sbjct: 67  LMDVCATSRTDRETKVTLVFEHVDQDLRTYLDKVPPPGLPAETIKDLMRQFLRGLDFLHA 126

Query: 400 GCSTRILHFDIKPHNILLDEDFCPKISDFGLAKICNRKESIISMTGARGTVGYIAPEVFC 459
            C   I+H D+KP NIL+      K++DFGLA+I + +   +++T    T+ Y APEV  
Sbjct: 127 NC---IVHRDLKPENILVTSGGQVKLADFGLARIYSCQ---MALTPVVVTLWYRAPEVLL 180

Query: 460 RNIGEVSYKS--DVYNYGMMIFEM 481
           ++    +Y +  D+++ G +  EM
Sbjct: 181 QS----TYATPVDMWSVGCIFAEM 200

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the nucleus. CDK4 also shows kinase activity towards Smad3, a signal transducer of transforming growth factor (TGF)-beta signaling which modulates transcription and plays a role in cell proliferation and apoptosis. CDK4 is inhibited by the p21 inhibitor and is specifically mutated in human melanoma. Length = 288

>gnl|CDD|173634 cd05053, PTKc_FGFR, Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors

 Score = 69.4 bits (170), Expect = 5e-13
 Identities = 56/218 (25%), Positives = 93/218 (42%), Gaps = 60/218 (27%)

Query: 321 LGQGGYGSVYKGKLLD------GSNVAVKVLNDSKGNGKEFINEVASISRTS----HVNV 370
           LG+G +G V K + +        S VAVK+L D     K+  + V+ +        H N+
Sbjct: 20  LGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDA-TEKDLSDLVSEMEMMKMIGKHKNI 78

Query: 371 VALLGFCL------------------------RVAEELSSTIG----------------- 389
           + LLG C                         R   E +S                    
Sbjct: 79  INLLGVCTQEGPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSFA 138

Query: 390 --IARGLEYLHLGCSTRILHFDIKPHNILLDEDFCPKISDFGLAKICNRKESIISMTGAR 447
             +ARG+E+L    S + +H D+   N+L+ ED   KI+DFGLA+  +  +     T  R
Sbjct: 139 YQVARGMEFL---ASKKCIHRDLAARNVLVTEDHVMKIADFGLARDIHHIDYYRKTTNGR 195

Query: 448 GTVGYIAPEVFCRNIGEVSYKSDVYNYGMMIFE-MTGG 484
             V ++APE     +   +++SDV+++G++++E  T G
Sbjct: 196 LPVKWMAPEALFDRV--YTHQSDVWSFGVLLWEIFTLG 231

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, and intracellular signaling. There are at least 23 FGFs and four types of FGFRs. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. FGF/FGFR signaling is important in the regulation of embryonic development, homeostasis, and regenerative processes. Depending on the cell type and stage, FGFR signaling produces diverse cellular responses including proliferation, growth arrest, differentiation, and apoptosis. Aberrant signaling leads to many human diseases such as skeletal, olfactory, and metabolic disorders, as well as cancer. Length = 293

>gnl|CDD|143375 cd07870, STKc_PFTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase

 Score = 69.2 bits (169), Expect = 6e-13
 Identities = 62/200 (31%), Positives = 91/200 (45%), Gaps = 44/200 (22%)

Query: 320 KLGQGGYGSVYKG-KLLDGSNVAVKVLNDSKGNGKEF--INEVASISRTSHVNVVAL--- 373
           KLG+G Y +VYKG   ++G  VA+KV++     G  F  I E + +    H N+V L   
Sbjct: 12  KLGEGSYATVYKGISRINGQLVALKVISMKTEEGVPFTAIREASLLKGLKHANIVLLHDI 71

Query: 374 ------LGFCLR-----VAEELSSTIG-------------IARGLEYLHLGCSTRILHFD 409
                 L F        +A+ +    G             + RGL Y+H      ILH D
Sbjct: 72  IHTKETLTFVFEYMHTDLAQYMIQHPGGLHPYNVRLFMFQLLRGLAYIH---GQHILHRD 128

Query: 410 IKPHNILLDEDFCPKISDFGLAKICNRKESIISMTGARG--TVGYIAPEVFCRNIGEVSY 467
           +KP N+L+      K++DFGLA    R +SI S T +    T+ Y  P+V    +G   Y
Sbjct: 129 LKPQNLLISYLGELKLADFGLA----RAKSIPSQTYSSEVVTLWYRPPDVL---LGATDY 181

Query: 468 KS--DVYNYGMMIFEMTGGR 485
            S  D++  G +  EM  G+
Sbjct: 182 SSALDIWGAGCIFIEMLQGQ 201

Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recessive form of juvenile ALS. The function of PFTAIRE-2 is not yet known. Length = 291

>gnl|CDD|173726 cd06610, STKc_OSR1_SPAK, Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase

 Score = 68.5 bits (168), Expect = 6e-13
 Identities = 59/208 (28%), Positives = 91/208 (43%), Gaps = 47/208 (22%)

Query: 319 YKL----GQGGYGSVYKGKLLDGS-NVAVKVLNDSKGNG--KEFINEVASISRTSHVNVV 371
           Y+L    G G    VY    L  +  VA+K ++  K      E   EV ++S+ +H NVV
Sbjct: 3   YELIEVIGVGATAVVYAAICLPNNEKVAIKRIDLEKCQTSVDELRKEVQAMSQCNHPNVV 62

Query: 372 A----------------LL--GFCLRVA----------EELSSTI--GIARGLEYLHLGC 401
                             L  G  L +           E + +T+   + +GLEYLH   
Sbjct: 63  KYYTSFVVGDELWLVMPYLSGGSLLDIMKSSYPRGGLDEAIIATVLKEVLKGLEYLH--- 119

Query: 402 STRILHFDIKPHNILLDEDFCPKISDFGLAKICNRKESIISMTGAR----GTVGYIAPEV 457
           S   +H DIK  NILL ED   KI+DFG++   +  +        R    GT  ++APEV
Sbjct: 120 SNGQIHRDIKAGNILLGEDGSVKIADFGVS--ASLADGGDRTRKVRKTFVGTPCWMAPEV 177

Query: 458 FCRNIGEVSYKSDVYNYGMMIFEMTGGR 485
             +  G   +K+D++++G+   E+  G 
Sbjct: 178 MEQVHG-YDFKADIWSFGITAIELATGA 204

Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 and SPAK contain a conserved C-terminal (CCT) domain, which recognizes a unique motif ([RK]FX[VI]) present in their activating kinases (WNK1/WNK4) and their substrates. Length = 267

>gnl|CDD|173734 cd07830, STKc_MAK_like, Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases

 Score = 68.3 bits (168), Expect = 9e-13
 Identities = 58/202 (28%), Positives = 87/202 (43%), Gaps = 47/202 (23%)

Query: 320 KLGQGGYGSVYKGKLLD-GSNVAVKVLNDSKGNGKEFIN--EVASISR-TSHVNVVALLG 375
           +LG G +GSVY  +  + G  VA+K +     + +E +N  EV S+ +   H N+V L  
Sbjct: 6   QLGDGTFGSVYLARNKETGELVAIKKMKKKFYSWEECMNLREVKSLRKLNEHPNIVKLKE 65

Query: 376 FCLRVAEEL------------------------SSTI-----GIARGLEYLHLGCSTRIL 406
              R  +EL                         S I      I +GL ++H        
Sbjct: 66  V-FRENDELYFVFEYMEGNLYQLMKDRKGKPFSESVIRSIIYQILQGLAHIH---KHGFF 121

Query: 407 HFDIKPHNILLDEDFCPKISDFGLAK-ICNRKESIISMTGARGTVGYIAPEVFCRNIGEV 465
           H D+KP N+L+      KI+DFGLA+ I +R       T    T  Y APE+  R+    
Sbjct: 122 HRDLKPENLLVSGPEVVKIADFGLAREIRSRP----PYTDYVSTRWYRAPEILLRS---T 174

Query: 466 SYKS--DVYNYGMMIFEMTGGR 485
           SY S  D++  G ++ E+   R
Sbjct: 175 SYSSPVDIWALGCIMAELYTLR 196

Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertility. It functions as a coactivator of the androgen receptor in prostate cells. MRK, also called Intestinal Cell Kinase (ICK), is expressed ubiquitously, with highest expression in the ovary and uterus. A missense mutation in MRK causes endocrine-cerebro-osteodysplasia (ECO), suggesting that this protein plays an important role in the development of many organs. MAK and MRK may be involved in regulating cell cycle and cell fate. Ime2p is a meiosis-specific kinase that is important during meiotic initiation and during the later stages of meiosis. Mde3 functions downstream of the transcription factor Mei-4 which is essential for meiotic prophase I. Length = 283

>gnl|CDD|173771 cd08529, STKc_FA2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains

 Score = 67.9 bits (166), Expect = 1e-12
 Identities = 55/213 (25%), Positives = 95/213 (44%), Gaps = 44/213 (20%)

Query: 318 KYKLGQGGYGSVYKG-KLLDGSNVAVKVLNDSKGNGK---EFINEVASISRTSHVNVVA- 372
             K+G+G +G V+K  +  D    A+K ++ SK N +   E I+E   +++     ++  
Sbjct: 5   LNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSYIIRY 64

Query: 373 ------------LLGFC--------------LRVAEEL--SSTIGIARGLEYLHLGCSTR 404
                       ++ +                 + E+      I I  GL +LH   S +
Sbjct: 65  YESFLDKGKLNIVMEYAENGDLHKLLKMQRGRPLPEDQVWRFFIQILLGLAHLH---SKK 121

Query: 405 ILHFDIKPHNILLDEDFCPKISDFGLAKICNRKESIISMTGARGTVGYIAPEVFCRNIGE 464
           ILH DIK  N+ LD     KI D G+AK+ +   +  + T   GT  Y++PE+ C    +
Sbjct: 122 ILHRDIKSLNLFLDAYDNVKIGDLGVAKLLS-DNTNFANT-IVGTPYYLSPEL-CE---D 175

Query: 465 VSY--KSDVYNYGMMIFEMTGGRKNVDVVDNGS 495
             Y  KSDV+  G++++E   G+   D  + G+
Sbjct: 176 KPYNEKSDVWALGVVLYECCTGKHPFDANNQGA 208

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cycle progression. No cellular function has yet been ascribed to CNK4. Length = 256

>gnl|CDD|173625 cd05032, PTKc_InsR_like, Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases

 Score = 67.8 bits (166), Expect = 1e-12
 Identities = 54/209 (25%), Positives = 87/209 (41%), Gaps = 54/209 (25%)

Query: 321 LGQGGYGSVYKGKLLD------GSNVAVKVLNDSKGNGK--EFINEVASISR--TSHVNV 370
           LGQG +G VY+G           + VA+K +N++    +  EF+NE AS+ +    H +V
Sbjct: 14  LGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENASMRERIEFLNE-ASVMKEFNCH-HV 71

Query: 371 VALLGFCLR-----VAEELSS--------------------------------TIGIARG 393
           V LLG         V  EL +                                   IA G
Sbjct: 72  VRLLGVVSTGQPTLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADG 131

Query: 394 LEYLHLGCSTRILHFDIKPHNILLDEDFCPKISDFGLAKICNRKESIISMTGARGTVGYI 453
           + YL    + + +H D+   N ++ ED   KI DFG+ +     +           V ++
Sbjct: 132 MAYLA---AKKFVHRDLAARNCMVAEDLTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWM 188

Query: 454 APEVFCRNIGEVSYKSDVYNYGMMIFEMT 482
           APE      G  + KSDV+++G++++EM 
Sbjct: 189 APESL--KDGVFTTKSDVWSFGVVLWEMA 215

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR and IGF-1R, which share 84% sequence identity in their kinase domains, display physiologically distinct yet overlapping functions in cell growth, differentiation, and metabolism. InsR activation leads primarily to metabolic effects while IGF-1R activation stimulates mitogenic pathways. In cells expressing both receptors, InsR/IGF-1R hybrids are found together with classical receptors. Both receptors can interact with common adaptor molecules such as IRS-1 and IRS-2. Length = 277

>gnl|CDD|143345 cd07840, STKc_CDK9_like, Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases

 Score = 68.0 bits (167), Expect = 1e-12
 Identities = 59/203 (29%), Positives = 89/203 (43%), Gaps = 46/203 (22%)

Query: 320 KLGQGGYGSVYKGK-LLDGSNVAVKVLNDSKGNGKE-----FINEVASISRTSHVNVVAL 373
           ++G+G YG VYK +    G  VA+K +     N KE      I E+  + +  H N+V L
Sbjct: 6   QIGEGTYGQVYKARNKKTGELVALKKIRME--NEKEGFPITAIREIKLLQKLRHPNIVRL 63

Query: 374 L--------GFCLRVAE----ELSS---------TIG--------IARGLEYLHLGCSTR 404
                    G    V E    +L+          T          +  GL+YLH   S  
Sbjct: 64  KEIVTSKGKGSIYMVFEYMDHDLTGLLDSPEVKFTESQIKCYMKQLLEGLQYLH---SNG 120

Query: 405 ILHFDIKPHNILLDEDFCPKISDFGLAKICNRKESIISMTGARGTVGYIAPEVFCRNIGE 464
           ILH DIK  NIL++ D   K++DFGLA+    K +    T    T+ Y  PE+    +G 
Sbjct: 121 ILHRDIKGSNILINNDGVLKLADFGLARPYT-KRNSADYTNRVITLWYRPPELL---LGA 176

Query: 465 VSYKS--DVYNYGMMIFEMTGGR 485
             Y    D+++ G ++ E+  G+
Sbjct: 177 TRYGPEVDMWSVGCILAELFLGK 199

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA polymerase II and participate in regulating mutliple steps of gene expression including transcription elongation and RNA processing. CDK9 and CdkC associate with T-type cyclins while BUR1 associates with the cyclin BUR2. CDK12 is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 interacts with cyclins L1 and L2, and participates in regulating transcription and alternative splicing. Length = 287

>gnl|CDD|132956 cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

 Score = 67.5 bits (165), Expect = 2e-12
 Identities = 66/202 (32%), Positives = 87/202 (43%), Gaps = 52/202 (25%)

Query: 321 LGQGGYGSVYKGKLLD-GSNVAVKVLN---DSKGNGKE---FINEVASISRTSHVNVVAL 373
           LGQG +G VY    +D G  +AVK +    DS    KE      E+  +    H  +V  
Sbjct: 10  LGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIVQY 69

Query: 374 LGFCLRVAEELS----------------------------STIGIARGLEYLHLGCSTRI 405
            G CLR  E LS                             T  I  G+EYLH   S  I
Sbjct: 70  YG-CLRDDETLSIFMEYMPGGSVKDQLKAYGALTETVTRKYTRQILEGVEYLH---SNMI 125

Query: 406 LHFDIKPHNILLDEDFCPKISDFGLAK----ICNRKESIISMTGARGTVGYIAPEVFCRN 461
           +H DIK  NIL D     K+ DFG +K    IC+    + S+T   GT  +++PEV    
Sbjct: 126 VHRDIKGANILRDSAGNVKLGDFGASKRLQTICSSGTGMKSVT---GTPYWMSPEVI--- 179

Query: 462 IGEVSY--KSDVYNYGMMIFEM 481
            GE  Y  K+DV++ G  + EM
Sbjct: 180 SGE-GYGRKADVWSVGCTVVEM 200

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 263

>gnl|CDD|173641 cd05072, PTKc_Lyn, Catalytic domain of the Protein Tyrosine Kinase, Lyn

 Score = 67.0 bits (163), Expect = 2e-12
 Identities = 52/208 (25%), Positives = 95/208 (45%), Gaps = 42/208 (20%)

Query: 320 KLGQGGYGSVYKGKLLDGSNVAVKVLNDSKGNGKEFINEV---------------ASISR 364
           KLG G +G V+ G   + + VAVK L     + + F+ E                A +++
Sbjct: 13  KLGAGQFGEVWMGYYNNSTKVAVKTLKPGTMSVQAFLEEANLMKTLQHDKLVRLYAVVTK 72

Query: 365 TSHVNVV-------ALLGFC-------LRVAEELSSTIGIARGLEYLHLGCSTRILHFDI 410
              + ++       +LL F        + + + +  +  IA G+ Y+        +H D+
Sbjct: 73  EEPIYIITEYMAKGSLLDFLKSDEGGKVLLPKLIDFSAQIAEGMAYIE---RKNYIHRDL 129

Query: 411 KPHNILLDEDFCPKISDFGLAKICNRKESIISMTGARGTVGYIAPEVFCRNIGEVSYKSD 470
           +  N+L+ E    KI+DFGLA++    E   +  GA+  + + APE    N G  + KSD
Sbjct: 130 RAANVLVSESLMCKIADFGLARVIEDNE-YTAREGAKFPIKWTAPEAI--NFGSFTIKSD 186

Query: 471 VYNYGMMIFEMTG-------GRKNVDVV 491
           V+++G++++E+         G  N DV+
Sbjct: 187 VWSFGILLYEIVTYGKIPYPGMSNSDVM 214

Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lyn is expressed in B lymphocytes and myeloid cells. It exhibits both positive and negative regulatory roles in B cell receptor (BCR) signaling. Lyn, as well as Fyn and Blk, promotes B cell activation by phosphorylating ITAMs (immunoreceptor tyr activation motifs) in CD19 and in Ig components of BCR. It negatively regulates signaling by its unique ability to phosphorylate ITIMs (immunoreceptor tyr inhibition motifs) in cell surface receptors like CD22 and CD5. Lyn also plays an important role in G-CSF receptor signaling by phosphorylating a variety of adaptor molecules. Length = 261

>gnl|CDD|143349 cd07844, STKc_PCTAIRE_like, Catalytic domain of PCTAIRE-like Serine/Threonine Kinases

 Score = 67.4 bits (165), Expect = 2e-12
 Identities = 60/200 (30%), Positives = 89/200 (44%), Gaps = 44/200 (22%)

Query: 320 KLGQGGYGSVYKGK-LLDGSNVAVKV--LNDSKGNGKEFINEVASISRTSHVNVVAL--- 373
           KLG+G Y +VYKG+  L G  VA+K   L   +G     I E + +    H N+V L   
Sbjct: 12  KLGEGSYATVYKGRSKLTGQLVALKEIRLEHEEGAPFTAIREASLLKDLKHANIVTLHDI 71

Query: 374 ------LGFCLR-VAEELSSTIG-----------------IARGLEYLHLGCSTRILHFD 409
                 L      +  +L   +                  + RGL Y H     R+LH D
Sbjct: 72  IHTKKTLTLVFEYLDTDLKQYMDDCGGGLSMHNVRLFLFQLLRGLAYCH---QRRVLHRD 128

Query: 410 IKPHNILLDEDFCPKISDFGLAKICNRKESIISMTGARG--TVGYIAPEVFCRNIGEVSY 467
           +KP N+L+ E    K++DFGLA    R +S+ S T +    T+ Y  P+V    +G   Y
Sbjct: 129 LKPQNLLISERGELKLADFGLA----RAKSVPSKTYSNEVVTLWYRPPDVL---LGSTEY 181

Query: 468 KS--DVYNYGMMIFEMTGGR 485
            +  D++  G + +EM  GR
Sbjct: 182 STSLDMWGVGCIFYEMATGR 201

Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the membrane-associated cyclin Y. PCTAIRE-like proteins show unusual expression patterns with high levels in post-mitotic tissues, suggesting that they may be involved in regulating post-mitotic cellular events. Length = 291

>gnl|CDD|173673 cd05582, STKc_RSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase

 Score = 67.5 bits (165), Expect = 2e-12
 Identities = 41/98 (41%), Positives = 60/98 (61%), Gaps = 13/98 (13%)

Query: 390 IARGLEYLHLGCSTRILHFDIKPHNILLDEDFCPKISDFGLAKICNRKESIISMTGAR-- 447
           +A  L++LH   S  I++ D+KP NILLDE+   K++DFGL+     KESI     A   
Sbjct: 107 LALALDHLH---SLGIIYRDLKPENILLDEEGHIKLTDFGLS-----KESIDHEKKAYSF 158

Query: 448 -GTVGYIAPEVFCRNIGEVSYKSDVYNYGMMIFEMTGG 484
            GTV Y+APEV  R  G  +  +D +++G+++FEM  G
Sbjct: 159 CGTVEYMAPEVVNRR-GH-TQSADWWSFGVLMFEMLTG 194

Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylates all known RSK substrates. RSKs act as downstream effectors of mitogen-activated protein kinase (MAPK) and play key roles in mitogen-activated cell growth, differentiation, and survival. Mammals possess four RSK isoforms (RSK1-4) from distinct genes. RSK proteins are also referred to as MAP kinase-activated protein kinases (MAPKAPKs), p90-RSKs, or p90S6Ks. Length = 318

>gnl|CDD|173732 cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases

 Score = 66.8 bits (163), Expect = 2e-12
 Identities = 63/210 (30%), Positives = 92/210 (43%), Gaps = 53/210 (25%)

Query: 321 LGQGGYGSVYKG-KLLDGSNVAVK------VLNDSKGNGKEFIN----EVASISRTSHVN 369
           +G G +GSVY G     G  +AVK      V   SK   +  ++    E+A +    H N
Sbjct: 8   IGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHEN 67

Query: 370 VVALLGFCLRVAEELS---------STIG-------------------IARGLEYLHLGC 401
           +V  LG     A+ L+         S                      I +GL YLH   
Sbjct: 68  IVQYLG-SSLDADHLNIFLEYVPGGSVAALLNNYGAFEETLVRNFVRQILKGLNYLH--- 123

Query: 402 STRILHFDIKPHNILLDEDFCPKISDFGLAKICNRKESIISMTGAR----GTVGYIAPEV 457
           +  I+H DIK  NIL+D     KISDFG++K            GAR    G+V ++APEV
Sbjct: 124 NRGIIHRDIKGANILVDNKGGIKISDFGISKKLEANSLSTKTNGARPSLQGSVFWMAPEV 183

Query: 458 FCRNIGEVSY--KSDVYNYGMMIFEMTGGR 485
               + + SY  K+D+++ G ++ EM  G+
Sbjct: 184 ----VKQTSYTRKADIWSLGCLVVEMLTGK 209

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Byr2 is regulated by Ras1. It responds to pheromone signaling and controls mating through the MAPK pathway. Budding yeast Ste11 functions in MAPK cascades that regulate mating, high osmolarity glycerol, and filamentous growth responses. Length = 267

>gnl|CDD|173748 cd07853, STKc_NLK, Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase

 Score = 67.8 bits (166), Expect = 3e-12
 Identities = 41/98 (41%), Positives = 55/98 (56%), Gaps = 9/98 (9%)

Query: 390 IARGLEYLHLGCSTRILHFDIKPHNILLDEDFCPKISDFGLAKICNRKESIISMTGARGT 449
           I RGL+YLH   S  ILH DIKP N+L++ +   KI DFGLA++    ES   MT    T
Sbjct: 112 ILRGLKYLH---SAGILHRDIKPGNLLVNSNCVLKICDFGLARVEEPDESKH-MTQEVVT 167

Query: 450 VGYIAPEVFCRNIGEVSYKS--DVYNYGMMIFEMTGGR 485
             Y APE+    +G   Y S  D+++ G +  E+ G R
Sbjct: 168 QYYRAPEIL---MGSRHYTSAVDIWSVGCIFAELLGRR 202

Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription factors from the TCF/LEF family, inhibiting their ability to activate the transcription of target genes. In prostate cancer cells, NLK is involved in regulating androgen receptor-mediated transcription and its expression is altered during cancer progression. Length = 372

>gnl|CDD|133201 cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk

 Score = 66.2 bits (161), Expect = 4e-12
 Identities = 50/195 (25%), Positives = 85/195 (43%), Gaps = 35/195 (17%)

Query: 320 KLGQGGYGSVYKGKLLDGSNVAVKVLNDSKGNGKEFINEVASISRTSHVNVVALL----- 374
           KLG G +G V+ G     + VAVK L     + + F+ E   + +  H  +V L      
Sbjct: 13  KLGNGQFGEVWMGTWNGNTKVAVKTLKPGTMSPESFLEEAQIMKKLRHDKLVQLYAVVSE 72

Query: 375 -----------------------GFCLRVAEELSSTIGIARGLEYLHLGCSTRILHFDIK 411
                                  G  L++   +     +A G+ Y+        +H D++
Sbjct: 73  EPIYIVTEYMSKGSLLDFLKDGEGRALKLPNLVDMAAQVAAGMAYIE---RMNYIHRDLR 129

Query: 412 PHNILLDEDFCPKISDFGLAKICNRKESIISMTGARGTVGYIAPEVFCRNIGEVSYKSDV 471
             NIL+ +    KI+DFGLA++    E   +  GA+  + + APE      G  + KSDV
Sbjct: 130 SANILVGDGLVCKIADFGLARLIEDNE-YTARQGAKFPIKWTAPEAAL--YGRFTIKSDV 186

Query: 472 YNYGMMIFEM-TGGR 485
           +++G+++ E+ T GR
Sbjct: 187 WSFGILLTELVTKGR 201

Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Fyn, together with Lck, plays a critical role in T-cell signal transduction by phosphorylating ITAM (immunoreceptor tyr activation motif) sequences on T-cell receptors, ultimately leading to the proliferation and differentiation of T-cells. In addition, Fyn is involved in the myelination of neurons, and is implicated in Alzheimer's and Parkinson's diseases. Yrk has been detected only in chickens. It is primarily found in neuronal and epithelial cells and in macrophages. It may play a role in inflammation and in response to injury. Length = 260

>gnl|CDD|173761 cd08221, STKc_Nek9, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9

 Score = 65.9 bits (161), Expect = 5e-12
 Identities = 50/198 (25%), Positives = 90/198 (45%), Gaps = 48/198 (24%)

Query: 321 LGQGGYGS--VYKGKLLDGSNVAVKVLNDSKGNGKE---FINEVASISRTSHVNVVALLG 375
           LG+G +G   +Y+ +  D S V  K +N ++ + KE    +NE+  +S   H N++A   
Sbjct: 8   LGKGAFGEATLYR-RTEDDSLVVWKEVNLTRLSEKERRDALNEIVILSLLQHPNIIAYYN 66

Query: 376 FCLR---------------VAEELSSTIG--------------IARGLEYLHLGCSTRIL 406
             +                + +++    G              I   + Y+H      IL
Sbjct: 67  HFMDDNTLLIEMEYANGGTLYDKIVRQKGQLFEEEMVLWYLFQIVSAVSYIH---KAGIL 123

Query: 407 HFDIKPHNILLDEDFCPKISDFGLAKICNRKESIISMTGARGTVG---YIAPEVFCRNIG 463
           H DIK  NI L +    K+ DFG++KI   + S      A   VG   Y++PE+ C+ + 
Sbjct: 124 HRDIKTLNIFLTKAGLIKLGDFGISKILGSEYS-----MAETVVGTPYYMSPEL-CQGV- 176

Query: 464 EVSYKSDVYNYGMMIFEM 481
           + ++KSD++  G +++E+
Sbjct: 177 KYNFKSDIWALGCVLYEL 194

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associates with FACT (FAcilitates Chromatin Transcription) and modulates interphase progression. It also interacts with Nek6, and Nek7, during mitosis, resulting in their activation. Length = 256

>gnl|CDD|173696 cd05605, STKc_GRK4_like, Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases

 Score = 66.0 bits (161), Expect = 5e-12
 Identities = 40/96 (41%), Positives = 53/96 (55%), Gaps = 8/96 (8%)

Query: 390 IARGLEYLHLGCSTRILHFDIKPHNILLDEDFCPKISDFGLAKICNRKESIISMTGARGT 449
           I  GLE LH     RI++ D+KP NILLD+    +ISD GLA      E+I    G  GT
Sbjct: 111 ITCGLEDLH---RERIVYRDLKPENILLDDYGHIRISDLGLAVEIPEGETI---RGRVGT 164

Query: 450 VGYIAPEVFCRNIGEVSYKSDVYNYGMMIFEMTGGR 485
           VGY+APEV        ++  D +  G +I+EM  G+
Sbjct: 165 VGYMAPEVV--KNERYTFSPDWWGLGCLIYEMIEGK 198

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, GRK6, and similar GRKs. GRKs in this group contain an N-terminal RGS homology (RH) domain and a catalytic domain, but lack a G protein betagamma-subunit binding domain. They are localized to the plasma membrane through post-translational lipid modification or direct binding to PIP2. Length = 285

>gnl|CDD|133200 cd05069, PTKc_Yes, Catalytic domain of the Protein Tyrosine Kinase, Yes

 Score = 65.8 bits (160), Expect = 5e-12
 Identities = 53/206 (25%), Positives = 93/206 (45%), Gaps = 35/206 (16%)

Query: 309 DIKKMTNSFKYKLGQGGYGSVYKGKLLDGSNVAVKVLNDSKGNGKEFINEVASISRTSHV 368
           +I + +     KLGQG +G V+ G     + VA+K L       + F+ E   + +  H 
Sbjct: 2   EIPRESLRLDVKLGQGCFGEVWMGTWNGTTKVAIKTLKPGTMMPEAFLQEAQIMKKLRHD 61

Query: 369 NVV---------------------ALLGFC-------LRVAEELSSTIGIARGLEYLHLG 400
            +V                     +LL F        L++ + +     IA G+ Y+   
Sbjct: 62  KLVPLYAVVSEEPIYIVTEFMGKGSLLDFLKEGDGKYLKLPQLVDMAAQIADGMAYIE-- 119

Query: 401 CSTRILHFDIKPHNILLDEDFCPKISDFGLAKICNRKESIISMTGARGTVGYIAPEVFCR 460
                +H D++  NIL+ ++   KI+DFGLA++    E   +  GA+  + + APE    
Sbjct: 120 -RMNYIHRDLRAANILVGDNLVCKIADFGLARLIEDNE-YTARQGAKFPIKWTAPEAAL- 176

Query: 461 NIGEVSYKSDVYNYGMMIFEM-TGGR 485
             G  + KSDV+++G+++ E+ T GR
Sbjct: 177 -YGRFTIKSDVWSFGILLTELVTKGR 201

Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. c-Yes kinase is the cellular homolog of the oncogenic protein (v-Yes) encoded by the Yamaguchi 73 and Esh sarcoma viruses. It displays functional overlap with other Src subfamily members, particularly Src. It also shows some unique functions such as binding to occludins, transmembrane proteins that regulate extracellular interactions in tight junctions. Yes also associates with a number of proteins in different cell types that Src does not interact with, like JAK2 and gp130 in pre-adipocytes, and Pyk2 in treated pulmonary vein endothelial cells. Although the biological function of Yes remains unclear, it appears to have a role in regulating cell-cell interactions and vesicle trafficking in polarized cells. Length = 260

>gnl|CDD|133232 cd05101, PTKc_FGFR2, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2

 Score = 66.2 bits (161), Expect = 7e-12
 Identities = 56/215 (26%), Positives = 97/215 (45%), Gaps = 59/215 (27%)

Query: 321 LGQGGYGSVY--------KGKLLDGSNVAVKVLND--SKGNGKEFINEVASISRTS-HVN 369
           LG+G +G V         K K  +   VAVK+L D  ++ +  + ++E+  +     H N
Sbjct: 23  LGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 82

Query: 370 VVALLGFCL------------------------------------RVAEE-------LSS 386
           ++ LLG C                                     RV +E       +S 
Sbjct: 83  IINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVSC 142

Query: 387 TIGIARGLEYLHLGCSTRILHFDIKPHNILLDEDFCPKISDFGLAKICNRKESIISMTGA 446
           T  +ARG+EYL    S + +H D+   N+L+ E+   KI+DFGLA+  N  +     T  
Sbjct: 143 TYQVARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIADFGLARDVNNIDYYKKTTNG 199

Query: 447 RGTVGYIAPEVFCRNIGEVSYKSDVYNYGMMIFEM 481
           R  V ++APE     +   +++SDV+++G++++E+
Sbjct: 200 RLPVKWMAPEALFDRV--YTHQSDVWSFGVLMWEI 232

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. There are many splice variants of FGFR2 which show differential expression and binding to FGF ligands. Disruption of either FGFR2 or FGFR2b is lethal in mice, due to defects in the placenta or severe impairment of tissue development including lung, limb, and thyroid, respectively. Disruption of FGFR2c in mice results in defective bone and skull development. Genetic alterations of FGFR2 are associated with many human skeletal disorders including Apert syndrome, Crouzon syndrome, Jackson-Weiss syndrome, and Pfeiffer syndrome. Length = 304

>gnl|CDD|132975 cd06644, STKc_STK10_LOK, Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase

 Score = 65.8 bits (160), Expect = 8e-12
 Identities = 57/197 (28%), Positives = 96/197 (48%), Gaps = 42/197 (21%)

Query: 320 KLGQGGYGSVYKGKLLD-GSNVAVKVLN-DSKGNGKEFINEVASISRTSHVNVVALLG-- 375
           +LG G +G VYK K  + G+  A KV+   S+   ++++ E+  ++  +H  +V LLG  
Sbjct: 19  ELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYMVEIEILATCNHPYIVKLLGAF 78

Query: 376 -----------FCLRVAEELSSTIGIARG-------------LEYLHLGCSTRILHFDIK 411
                      FC   A + +  + + RG             LE L    S +I+H D+K
Sbjct: 79  YWDGKLWIMIEFCPGGAVD-AIMLELDRGLTEPQIQVICRQMLEALQYLHSMKIIHRDLK 137

Query: 412 PHNILLDEDFCPKISDFGLA----KICNRKESIISMTGARGTVGYIAPE-VFCRNIGEV- 465
             N+LL  D   K++DFG++    K   R++S I      GT  ++APE V C  + +  
Sbjct: 138 AGNVLLTLDGDIKLADFGVSAKNVKTLQRRDSFI------GTPYWMAPEVVMCETMKDTP 191

Query: 466 -SYKSDVYNYGMMIFEM 481
             YK+D+++ G+ + EM
Sbjct: 192 YDYKADIWSLGITLIEM 208

Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. Length = 292

>gnl|CDD|132979 cd06648, STKc_PAK_II, Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase

 Score = 65.5 bits (160), Expect = 8e-12
 Identities = 57/199 (28%), Positives = 92/199 (46%), Gaps = 47/199 (23%)

Query: 320 KLGQGGYGSVYKG-KLLDGSNVAVKVLNDSKGNGKEFI-NEVASISRTSHVNVVALLGFC 377
           K+G+G  G V        G  VAVK ++  K   +E + NEV  +    H N+V +    
Sbjct: 26  KIGEGSTGIVCIATDKSTGRQVAVKKMDLRKQQRRELLFNEVVIMRDYQHPNIVEMYSSY 85

Query: 378 L------------------------RVAEELSSTIGIA--RGLEYLHLGCSTRILHFDIK 411
           L                        R+ EE  +T+ +A  + L +LH   +  ++H DIK
Sbjct: 86  LVGDELWVVMEFLEGGALTDIVTHTRMNEEQIATVCLAVLKALSFLH---AQGVIHRDIK 142

Query: 412 PHNILLDEDFCPKISDFG----LAKICNRKESIISMTGARGTVGYIAPEVFCRNIGEVSY 467
             +ILL  D   K+SDFG    ++K   R++S++      GT  ++APEV  R    + Y
Sbjct: 143 SDSILLTSDGRVKLSDFGFCAQVSKEVPRRKSLV------GTPYWMAPEVISR----LPY 192

Query: 468 KS--DVYNYGMMIFEMTGG 484
            +  D+++ G+M+ EM  G
Sbjct: 193 GTEVDIWSLGIMVIEMVDG 211

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs found in group I PAKs, such as an AID (autoinhibitory domain) and SH3 binding sites. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. While group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX, no such binding has been demonstrated for group II PAKs. Some known substrates of group II PAKs are also substrates of group I PAKs such as Raf, BAD, LIMK and GEFH1. Unique group II substrates include MARK/Par-1 and PDZ-RhoGEF. Group II PAKs play important roles in filopodia formation, neuron extension, cytoskeletal organization, and cell survival. Length = 285

>gnl|CDD|143376 cd07871, STKc_PCTAIRE3, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase

 Score = 65.4 bits (159), Expect = 8e-12
 Identities = 62/200 (31%), Positives = 94/200 (47%), Gaps = 44/200 (22%)

Query: 320 KLGQGGYGSVYKGKL-LDGSNVAVKV--LNDSKGNGKEFINEVASISRTSHVNVVAL--- 373
           KLG+G Y +V+KG+  L  + VA+K   L   +G     I EV+ +    H N+V L   
Sbjct: 12  KLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKNLKHANIVTLHDI 71

Query: 374 --LGFCLR-VAEELSSTIG---------------------IARGLEYLHLGCSTRILHFD 409
                CL  V E L S +                      + RGL Y H     +ILH D
Sbjct: 72  IHTERCLTLVFEYLDSDLKQYLDNCGNLMSMHNVKIFMFQLLRGLSYCH---KRKILHRD 128

Query: 410 IKPHNILLDEDFCPKISDFGLAKICNRKESIISMTGARG--TVGYIAPEVFCRNIGEVSY 467
           +KP N+L++E    K++DFGLA    R +S+ + T +    T+ Y  P+V    +G   Y
Sbjct: 129 LKPQNLLINEKGELKLADFGLA----RAKSVPTKTYSNEVVTLWYRPPDVL---LGSTEY 181

Query: 468 KS--DVYNYGMMIFEMTGGR 485
            +  D++  G +++EM  GR
Sbjct: 182 STPIDMWGVGCILYEMATGR 201

Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filaments (PHFs) and stimulate Tau phosphorylation. As AD progresses, phosphorylated Tau aggregates and forms PHFs, which leads to the formation of neurofibrillary tangles (NFTs). In human glioma cells, PCTAIRE-3 induces cell cycle arrest and cell death. Length = 288

>gnl|CDD|143356 cd07851, STKc_p38, Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase

 Score = 65.8 bits (161), Expect = 1e-11
 Identities = 52/172 (30%), Positives = 73/172 (42%), Gaps = 43/172 (25%)

Query: 321 LGQGGYGSVYKGKL-LDGSNVAVKVLN---DSKGNGKEFINEVASISRTSHVNVVALLG- 375
           +G G YG V        G  VA+K L+    S  + K    E+  +    H NV+ LL  
Sbjct: 23  VGSGAYGQVCSAFDTKTGRKVAIKKLSRPFQSAIHAKRTYRELRLLKHMDHENVIGLLDV 82

Query: 376 FCLRVAEE---------------LSSTIG---------------IARGLEYLHLGCSTRI 405
           F    + E               L++ +                I RGL+Y+H   S  I
Sbjct: 83  FTPASSLEDFQDVYLVTHLMGADLNNIVKCQKLSDDHIQFLVYQILRGLKYIH---SAGI 139

Query: 406 LHFDIKPHNILLDEDFCPKISDFGLAKICNRKESIISMTGARGTVGYIAPEV 457
           +H D+KP NI ++ED   KI DFGLA+  + +     MTG   T  Y APE+
Sbjct: 140 IHRDLKPSNIAVNEDCELKILDFGLARHTDDE-----MTGYVATRWYRAPEI 186

Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. p38 substrates include other protein kinases and factors that regulate transcription, nuclear export, mRNA stability and translation. p38 kinases are drug targets for the inflammatory diseases psoriasis, rheumatoid arthritis, and chronic pulmonary disease. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta, which show varying substrate specificity and expression patterns. p38alpha and p38beta are ubiquitously expressed, p38gamma is predominantly found in skeletal muscle, and p38delta is found in the heart, lung, testis, pancreas, and small intestine. Length = 343

>gnl|CDD|133179 cd05048, PTKc_Ror, Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors

 Score = 65.2 bits (159), Expect = 1e-11
 Identities = 56/217 (25%), Positives = 91/217 (41%), Gaps = 58/217 (26%)

Query: 317 FKYKLGQGGYGSVYKGKLLDGSN------VAVKVLNDSKGNGK---EFINEVASISRTSH 367
           F  +LG+G +G VYKG+L   +       VA+K L ++    K   EF  E   +S   H
Sbjct: 9   FLEELGEGAFGKVYKGELTGPNERLSATSVAIKTLKEN-AEPKVQQEFRQEAELMSDLQH 67

Query: 368 VNVVALLGFC-------------------------------------------LRVAEEL 384
            N+V LLG C                                           L  ++ L
Sbjct: 68  PNIVCLLGVCTKEQPTCMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFL 127

Query: 385 SSTIGIARGLEYLHLGCSTRILHFDIKPHNILLDEDFCPKISDFGLAKICNRKESIISMT 444
              I IA G+EYL    S   +H D+   N L+ E    KISDFGL++     +     +
Sbjct: 128 HIAIQIAAGMEYL---SSHHFVHRDLAARNCLVGEGLTVKISDFGLSRDIYSADYYRVQS 184

Query: 445 GARGTVGYIAPEVFCRNIGEVSYKSDVYNYGMMIFEM 481
            +   V ++ PE      G+ + +SD++++G++++E+
Sbjct: 185 KSLLPVRWMPPEAIL--YGKFTTESDIWSFGVVLWEI 219

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. They play important roles in bone and heart formation. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Drosophila Ror is expressed only in the developing nervous system during neurite outgrowth and neuronal differentiation, suggesting a role for Drosophila Ror in neural development. More recently, mouse Ror1 and Ror2 have also been found to play an important role in regulating neurite growth in central neurons. Ror1 and Ror2 are believed to have some overlapping and redundant functions. Length = 283

>gnl|CDD|132991 cd06917, STKc_NAK1_like, Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases

 Score = 64.8 bits (158), Expect = 1e-11
 Identities = 53/201 (26%), Positives = 84/201 (41%), Gaps = 48/201 (23%)

Query: 321 LGQGGYGSVYKGK-LLDGSNVAVKVLN-DSKGNGKEFI-NEVASISRTSHV---NVVALL 374
           +G+G YG+VY+GK +  G  VA+K++N D+  +    I  EVA +S+       N+    
Sbjct: 9   IGRGAYGAVYRGKHVPTGRVVALKIINLDTPDDDVSDIQREVALLSQLRQSQPPNITKYY 68

Query: 375 GFCLRVAEELSSTIGIARG---------------------------LEYLHLGCSTRILH 407
           G        L   +  A G                           L+Y+H      ++H
Sbjct: 69  G-SYLKGPRLWIIMEYAEGGSVRTLMKAGPIAEKYISVIIREVLVALKYIH---KVGVIH 124

Query: 408 FDIKPHNILLDEDFCPKISDFGLAKICNRKESIISMTGAR----GTVGYIAPEVFCRNIG 463
            DIK  NIL+      K+ DFG+A        +   +  R    GT  ++APEV      
Sbjct: 125 RDIKAANILVTNTGNVKLCDFGVAA------LLNQNSSKRSTFVGTPYWMAPEVI-TEGK 177

Query: 464 EVSYKSDVYNYGMMIFEMTGG 484
               K+D+++ G+ I+EM  G
Sbjct: 178 YYDTKADIWSLGITIYEMATG 198

Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of centrin, and phosphorylates substrates in a Cdc31p-dependent manner. Length = 277

>gnl|CDD|173670 cd05579, STKc_MAST_like, Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins

 Score = 64.6 bits (158), Expect = 1e-11
 Identities = 55/198 (27%), Positives = 86/198 (43%), Gaps = 43/198 (21%)

Query: 321 LGQGGYGSVYKG-KLLDGSNVAVKVLNDSKGNGKEFINEVAS----ISRTSHVNVVAL-- 373
           + +G YG V+   K   G   A+KV+  +    K  +++V +    +S+     VV L  
Sbjct: 1   ISKGAYGRVFLAKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKLYY 60

Query: 374 -------------------LGFCLR---VAEELSSTIGIAR---GLEYLHLGCSTRILHF 408
                              L   L      +E  + I IA     LEYLH   S  I+H 
Sbjct: 61  SFQGKKNLYLVMEYLPGGDLASLLENVGSLDEDVARIYIAEIVLALEYLH---SNGIIHR 117

Query: 409 DIKPHNILLDEDFCPKISDFGLAKI-CNRKESIISMTGAR-----GTVGYIAPEVFCRNI 462
           D+KP NIL+D +   K++DFGL+K+   R++  ++          GT  YIAPEV     
Sbjct: 118 DLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINLNDDEKEDKRIVGTPDYIAPEVILGQ- 176

Query: 463 GEVSYKSDVYNYGMMIFE 480
              S   D ++ G +++E
Sbjct: 177 -GHSKTVDWWSLGCILYE 193

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert relative to other kinases. The fungal kinases in this subfamily harbor other domains in addition to a central catalytic domain, which also contains an insert relative to MAST kinases like MASTL. Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. The fungal proteins Rim15 and cek1 are involved in the regulation of meiosis and mitosis, respectively. Length = 265

>gnl|CDD|132987 cd06656, STKc_PAK3, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3

 Score = 65.1 bits (158), Expect = 1e-11
 Identities = 67/224 (29%), Positives = 97/224 (43%), Gaps = 44/224 (19%)

Query: 291 ETFLRNYRSLSPKRYGYADIKKMTNSFKYKLGQGGYGSVYKG-KLLDGSNVAVKVLNDSK 349
           E  L   RS+        D KK    F+ K+GQG  G+VY    +  G  VA+K +N  +
Sbjct: 2   EEILEKLRSI----VSVGDPKKKYTRFE-KIGQGASGTVYTAIDIATGQEVAIKQMNLQQ 56

Query: 350 GNGKEFI-NEVASISRTSHVNVVALLGFCLRVAEELSSTIGIARG--------------- 393
              KE I NE+  +    + N+V  L   L V +EL   +    G               
Sbjct: 57  QPKKELIINEILVMRENKNPNIVNYLDSYL-VGDELWVVMEYLAGGSLTDVVTETCMDEG 115

Query: 394 ------------LEYLHLGCSTRILHFDIKPHNILLDEDFCPKISDFGL-AKICNRKESI 440
                       L++LH   S +++H DIK  NILL  D   K++DFG  A+I   +   
Sbjct: 116 QIAAVCRECLQALDFLH---SNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKR 172

Query: 441 ISMTGARGTVGYIAPEVFCRNIGEVSYKSDVYNYGMMIFEMTGG 484
            +M    GT  ++APEV  R       K D+++ G+M  EM  G
Sbjct: 173 STMV---GTPYWMAPEVVTRK--AYGPKVDIWSLGIMAIEMVEG 211

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK3 is highly expressed in the brain. It is implicated in neuronal plasticity, synapse formation, dendritic spine morphogenesis, cell cycle progression, neuronal migration, and apoptosis. Inactivating mutations in the PAK3 gene cause X-linked non-syndromic mental retardation, the severity of which depends on the site of the mutation. Length = 297

>gnl|CDD|173752 cd07861, STKc_CDK1_euk, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like

 Score = 64.4 bits (157), Expect = 2e-11
 Identities = 58/197 (29%), Positives = 93/197 (47%), Gaps = 43/197 (21%)

Query: 320 KLGQGGYGSVYKGK-LLDGSNVAVKVL---NDSKGNGKEFINEVASISRTSHVNVVALLG 375
           K+G+G YG VYKG+    G  VA+K +   ++ +G     I E++ +    H N+V L  
Sbjct: 7   KIGEGTYGVVYKGRNKKTGQIVAMKKIRLESEEEGVPSTAIREISLLKELQHPNIVCLQD 66

Query: 376 FCLR------VAEELS-------STIGIARGLE------YLH------LGC-STRILHFD 409
             ++      + E LS        ++   + ++      YL+      L C S R+LH D
Sbjct: 67  VLMQESRLYLIFEFLSMDLKKYLDSLPKGQYMDAELVKSYLYQILQGILFCHSRRVLHRD 126

Query: 410 IKPHNILLDEDFCPKISDFGLAK---ICNRKESIISMTGARGTVGYIAPEVFCRNIGEVS 466
           +KP N+L+D     K++DFGLA+   I  R       T    T+ Y APEV    +G   
Sbjct: 127 LKPQNLLIDNKGVIKLADFGLARAFGIPVR-----VYTHEVVTLWYRAPEVL---LGSPR 178

Query: 467 YKS--DVYNYGMMIFEM 481
           Y +  D+++ G +  EM
Sbjct: 179 YSTPVDIWSIGTIFAEM 195

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression. CDK1/cyclin A2 has also been implicated as an important regulator of S phase events. The CDK1/cyclin B complex is critical for G2 to M phase transition. It induces mitosis by activating nuclear enzymes that regulate chromatin condensation, nuclear membrane degradation, mitosis-specific microtubule and cytoskeletal reorganization. CDK1 also associates with cyclin E and plays a role in the entry into S phase. CDK1 transcription is stable throughout the cell cycle but is modulated in some pathological conditions. It may play a role in regulating apoptosis under these conditions. In breast cancer cells, HER2 can mediate apoptosis by inactivating CDK1. Activation of CDK1 may contribute to HIV-1 induced apoptosis and neuronal apoptosis in neurodegenerative diseases. Length = 285

>gnl|CDD|143374 cd07869, STKc_PFTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase

 Score = 64.3 bits (156), Expect = 2e-11
 Identities = 60/200 (30%), Positives = 90/200 (45%), Gaps = 46/200 (23%)

Query: 320 KLGQGGYGSVYKGKL-LDGSNVAVKVLNDSKGNGKEF--INEVASISRTSHVNVVALLGF 376
           KLG+G Y +VYKGK  ++G  VA+KV+   +  G  F  I E + +    H N+V LL  
Sbjct: 12  KLGEGSYATVYKGKSKVNGKLVALKVIRLQEEEGTPFTAIREASLLKGLKHANIV-LLHD 70

Query: 377 CLRVAEELSSTI----------------------------GIARGLEYLHLGCSTRILHF 408
            +   E L+                                + RGL Y+H      ILH 
Sbjct: 71  IIHTKETLTLVFEYVHTDLCQYMDKHPGGLHPENVKLFLFQLLRGLSYIH---QRYILHR 127

Query: 409 DIKPHNILLDEDFCPKISDFGLAKICNRKESIISMTGARG--TVGYIAPEVFCRNIGEVS 466
           D+KP N+L+ +    K++DFGLA    R +S+ S T +    T+ Y  P+V    +G   
Sbjct: 128 DLKPQNLLISDTGELKLADFGLA----RAKSVPSHTYSNEVVTLWYRPPDVL---LGSTE 180

Query: 467 YKS--DVYNYGMMIFEMTGG 484
           Y +  D++  G +  EM  G
Sbjct: 181 YSTCLDMWGVGCIFVEMIQG 200

Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 and is inhibited by the p21 cell cycle inhibitor. It has also been shown to interact with the membrane-associated cyclin Y, which recruits the protein to the plasma membrane. Length = 303

>gnl|CDD|132938 cd06607, STKc_TAO, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins

 Score = 64.4 bits (157), Expect = 2e-11
 Identities = 53/195 (27%), Positives = 84/195 (43%), Gaps = 42/195 (21%)

Query: 320 KLGQGGYGSVYKGK-LLDGSNVAVKVLNDSKGNGKE----FINEVASISRTSHVNVVALL 374
           ++G G +G+VY  + +     VA+K ++ S     E     I EV  + +  H N +   
Sbjct: 22  EIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHPNTIEYK 81

Query: 375 G-------------FCLRVAEEL--------------SSTIGIARGLEYLHLGCSTRILH 407
           G             +CL  A ++              +   G  +GL YLH   S   +H
Sbjct: 82  GCYLREHTAWLVMEYCLGSASDILEVHKKPLQEVEIAAICHGALQGLAYLH---SHERIH 138

Query: 408 FDIKPHNILLDEDFCPKISDFGLAKICNRKESIISMTGARGTVGYIAPEV-FCRNIGEVS 466
            DIK  NILL E    K++DFG A + +   S +      GT  ++APEV    + G+  
Sbjct: 139 RDIKAGNILLTEPGTVKLADFGSASLVSPANSFV------GTPYWMAPEVILAMDEGQYD 192

Query: 467 YKSDVYNYGMMIFEM 481
            K DV++ G+   E+
Sbjct: 193 GKVDVWSLGITCIEL 207

Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily members, named TAO1, TAO2, and TAO3. Length = 307

>gnl|CDD|133213 cd05082, PTKc_Csk, Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase

 Score = 63.5 bits (154), Expect = 3e-11
 Identities = 52/192 (27%), Positives = 90/192 (46%), Gaps = 44/192 (22%)

Query: 321 LGQGGYGSVYKGKLLDGSNVAVKVL-NDSKGNGKEFINEVASISRTSHVNVVALLGFCLR 379
           +G+G +G V  G    G+ VAVK + ND+    + F+ E + +++  H N+V LLG  + 
Sbjct: 14  IGKGEFGDVMLGDY-RGNKVAVKCIKNDA--TAQAFLAEASVMTQLRHSNLVQLLGVIVE 70

Query: 380 -------VAEELS-------------STIG----------IARGLEYLHLGCSTRILHFD 409
                  V E ++             S +G          +   +EYL    +   +H D
Sbjct: 71  EKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLE---ANNFVHRD 127

Query: 410 IKPHNILLDEDFCPKISDFGLAKICNRKESIISMTGARGTVGYIAPEVFCRNIGEVSYKS 469
           +   N+L+ ED   K+SDFGL      KE+  +    +  V + APE       + S KS
Sbjct: 128 LAARNVLVSEDNVAKVSDFGLT-----KEASSTQDTGKLPVKWTAPEALREK--KFSTKS 180

Query: 470 DVYNYGMMIFEM 481
           DV+++G++++E+
Sbjct: 181 DVWSFGILLWEI 192

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Csk is expressed in a wide variety of tissues. As a negative regulator of Src, Csk plays a role in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. In addition, Csk also shows Src-independent functions. It is a critical component in G-protein signaling, and plays a role in cytoskeletal reorganization and cell migration. Length = 256

>gnl|CDD|132985 cd06654, STKc_PAK1, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1

 Score = 64.0 bits (155), Expect = 3e-11
 Identities = 67/224 (29%), Positives = 97/224 (43%), Gaps = 44/224 (19%)

Query: 291 ETFLRNYRSLSPKRYGYADIKKMTNSFKYKLGQGGYGSVYKG-KLLDGSNVAVKVLNDSK 349
           E  L   RS+        D KK    F+ K+GQG  G+VY    +  G  VA++ +N  +
Sbjct: 3   EEILEKLRSI----VSVGDPKKKYTRFE-KIGQGASGTVYTAMDVATGQEVAIRQMNLQQ 57

Query: 350 GNGKEFI-NEVASISRTSHVNVVALLGFCLRVAEELSSTIGIARG--------------- 393
              KE I NE+  +    + N+V  L   L V +EL   +    G               
Sbjct: 58  QPKKELIINEILVMRENKNPNIVNYLDSYL-VGDELWVVMEYLAGGSLTDVVTETCMDEG 116

Query: 394 ------------LEYLHLGCSTRILHFDIKPHNILLDEDFCPKISDFGL-AKICNRKESI 440
                       LE+LH   S +++H DIK  NILL  D   K++DFG  A+I   +   
Sbjct: 117 QIAAVCRECLQALEFLH---SNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKR 173

Query: 441 ISMTGARGTVGYIAPEVFCRNIGEVSYKSDVYNYGMMIFEMTGG 484
            +M    GT  ++APEV  R       K D+++ G+M  EM  G
Sbjct: 174 STMV---GTPYWMAPEVVTRK--AYGPKVDIWSLGIMAIEMIEG 212

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK1 is important in the regulation of many cellular processes including cytoskeletal dynamics, cell motility, growth, and proliferation. Although PAK1 has been regarded mainly as a cytosolic protein, recent reports indicate that PAK1 also exists in significant amounts in the nucleus, where it is involved in transcription modulation and in cell cycle regulatory events. PAK1 is also involved in transformation and tumorigenesis. Its overexpression, hyperactivation and increased nuclear accumulation is correlated to breast cancer invasiveness and progression. Nuclear accumulation is also linked to tamoxifen resistance in breast cancer cells. Length = 296

>gnl|CDD|143361 cd07856, STKc_Sty1_Hog1, Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1

 Score = 64.5 bits (157), Expect = 3e-11
 Identities = 55/197 (27%), Positives = 86/197 (43%), Gaps = 43/197 (21%)

Query: 321 LGQGGYGSVYKGK-LLDGSNVAVKVLND---SKGNGKEFINEVASISRTSHVNVVALLGF 376
           +G G +G V   +  L G NVA+K +     +    K    E+  +    H N+++L   
Sbjct: 18  VGMGAFGLVCSARDQLTGQNVAIKKIMKPFSTPVLAKRTYRELKLLKHLRHENIISLSDI 77

Query: 377 CLRVAE------ELSST--------------------IGIARGLEYLHLGCSTRILHFDI 410
            +   E      EL  T                      I RGL+Y+H   S  ++H D+
Sbjct: 78  FISPLEDIYFVTELLGTDLHRLLTSRPLEKQFIQYFLYQILRGLKYVH---SAGVVHRDL 134

Query: 411 KPHNILLDEDFCPKISDFGLAKICNRKESIISMTGARGTVGYIAPEVFC--RNIGEVSYK 468
           KP NIL++E+   KI DFGLA+I + +     MTG   T  Y APE+    +       +
Sbjct: 135 KPSNILINENCDLKICDFGLARIQDPQ-----MTGYVSTRYYRAPEIMLTWQKYDV---E 186

Query: 469 SDVYNYGMMIFEMTGGR 485
            D+++ G +  EM  G+
Sbjct: 187 VDIWSAGCIFAEMLEGK 203

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and UV radiation. Sty1 is regulated by the MAP2K Wis1, which is activated by the MAP3Ks Wis4 and Win1, which receive signals of the stress condition from membrane-spanning histidine kinases Mak1-3. Activated Sty1 stabilizes the Atf1 transcription factor and induces transcription of Atf1-dependent genes of the core environmetal stress response (CESR). Hog1 is the key element in the high osmolarity glycerol (HOG) pathway and is activated upon hyperosmotic stress. Activated Hog1 accumulates in the nucleus and regulates stress-induced transcription. The HOG pathway is mediated by two transmembrane osmosensors, Sln1 and Sho1. Length = 328

>gnl|CDD|173751 cd07860, STKc_CDK2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3

 Score = 63.7 bits (155), Expect = 3e-11
 Identities = 55/196 (28%), Positives = 91/196 (46%), Gaps = 42/196 (21%)

Query: 320 KLGQGGYGSVYKGK-LLDGSNVAVKVL---NDSKGNGKEFINEVASISRTSHVNVVALLG 375
           K+G+G YG VYK +  L G  VA+K +    +++G     I E++ +   +H N+V LL 
Sbjct: 7   KIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLD 66

Query: 376 FC----------------LRVAEELSSTIGIA------------RGLEYLHLGCSTRILH 407
                             L+   + S   GI             +GL + H   S R+LH
Sbjct: 67  VIHTENKLYLVFEFLHQDLKKFMDASPLSGIPLPLIKSYLFQLLQGLAFCH---SHRVLH 123

Query: 408 FDIKPHNILLDEDFCPKISDFGLAKICNRKESIISMTGARGTVGYIAPEVFCRNIGEVSY 467
            D+KP N+L++ +   K++DFGLA+       + + T    T+ Y APE+    +G   Y
Sbjct: 124 RDLKPQNLLINTEGAIKLADFGLARAFGV--PVRTYTHEVVTLWYRAPEIL---LGCKYY 178

Query: 468 KS--DVYNYGMMIFEM 481
            +  D+++ G +  EM
Sbjct: 179 STAVDIWSLGCIFAEM 194

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. CDK2, together with CDK4, also regulates embryonic cell proliferation. Despite these important roles, mice deleted for the cdk2 gene are viable and normal except for being sterile. This may be due to compensation provided by CDK1 (also called Cdc2), which can also bind cyclin E and drive the G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 284

>gnl|CDD|173656 cd05111, PTK_HER3, Pseudokinase domain of the Protein Tyrosine Kinase, HER3

 Score = 63.4 bits (154), Expect = 4e-11
 Identities = 56/209 (26%), Positives = 98/209 (46%), Gaps = 40/209 (19%)

Query: 308 ADIKKMTNSFKYK-LGQGGYGSVYKGKLL-DGSN----VAVKVLNDSKGNG--KEFINEV 359
           A I K T   K K LG G +G+V+KG  + +G +    VA+K + D  G    +E  + +
Sbjct: 1   ARILKETELRKLKLLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRSGRQTFQEITDHM 60

Query: 360 ASISRTSHVNVVALLGFC----LRVAEELSS-----------------------TIGIAR 392
            ++    H  +V LLG C    L++  +LS                         + IA+
Sbjct: 61  LAMGSLDHAYIVRLLGICPGASLQLVTQLSPLGSLLDHVRQHRDSLDPQRLLNWCVQIAK 120

Query: 393 GLEYLHLGCSTRILHFDIKPHNILLDEDFCPKISDFGLAKICNRKESIISMTGARGTVGY 452
           G+ YL      R++H ++   NILL  D   +I+DFG+A +    +     +  +  + +
Sbjct: 121 GMYYLE---EHRMVHRNLAARNILLKSDSIVQIADFGVADLLYPDDKKYFYSEHKTPIKW 177

Query: 453 IAPEVFCRNIGEVSYKSDVYNYGMMIFEM 481
           +A E      G  +++SDV++YG+ ++EM
Sbjct: 178 MALESI--LFGRYTHQSDVWSYGVTVWEM 204

Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER3 binds the neuregulin ligands, NRG1 and NRG2. HER3 contains an impaired tyr kinase domain and relies on its heterodimerization partners for activity following ligand binding. The HER2-HER3 heterodimer constitutes a high affinity co-receptor capable of potent mitogenic signaling. HER3 participates in a signaling pathway involved in the proliferation, survival, adhesion, and motility of tumor cells. Length = 279

>gnl|CDD|173738 cd07835, STKc_CDK1_like, Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases

 Score = 63.5 bits (155), Expect = 4e-11
 Identities = 54/205 (26%), Positives = 89/205 (43%), Gaps = 52/205 (25%)

Query: 320 KLGQGGYGSVYKGK-LLDGSNVAVKVL---NDSKGNGKEFINEVASISRTSHVNVVALL- 374
           K+G+G YG VYK +  L G  VA+K +    + +G     I E++ +   +H N+V LL 
Sbjct: 6   KIGEGTYGVVYKARDKLTGEIVALKKIRLETEDEGVPSTAIREISLLKELNHPNIVRLLD 65

Query: 375 -----------------------------GFCLRVAEELSSTIGIARGLEYLHLGCSTRI 405
                                        G    + +     +   +G+ Y H   S R+
Sbjct: 66  VVHSENKLYLVFEFLDLDLKKYMDSSPLTGLDPPLIKSYLYQL--LQGIAYCH---SHRV 120

Query: 406 LHFDIKPHNILLDEDFCPKISDFGLAKICNRKESIISM---TGARGTVGYIAPEVFCRNI 462
           LH D+KP N+L+D +   K++DFGLA+        + +   T    T+ Y APE+    +
Sbjct: 121 LHRDLKPQNLLIDREGALKLADFGLARAFG-----VPVRTYTHEVVTLWYRAPEIL---L 172

Query: 463 GEVSYKS--DVYNYGMMIFEMTGGR 485
           G   Y +  D+++ G +  EM   R
Sbjct: 173 GSRQYSTPVDIWSIGCIFAEMVNRR 197

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression while the CDK1/cyclin B complex is critical for G2 to M phase transition. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. Studies in knockout mice revealed that CDK1 can compensate for the loss of the cdk2 gene as it can also bind cyclin E and drive G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 283

>gnl|CDD|143341 cd07836, STKc_Pho85, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85

 Score = 63.3 bits (154), Expect = 5e-11
 Identities = 56/200 (28%), Positives = 92/200 (46%), Gaps = 42/200 (21%)

Query: 320 KLGQGGYGSVYKGK-LLDGSNVAVKVLN-DS-KGNGKEFINEVASISRTSHVNVVAL--- 373
           KLG+G Y +VYKG+    G  VA+K ++ D+ +G     I E++ +    H N+V L   
Sbjct: 7   KLGEGTYATVYKGRNRTTGEIVALKEIHLDAEEGTPSTAIREISLMKELKHENIVRLHDV 66

Query: 374 --------LGF------------------CLRVAEELSSTIGIARGLEYLHLGCSTRILH 407
                   L F                   L      S T  + +G+ + H     R+LH
Sbjct: 67  IHTENKLMLVFEYMDKDLKKYMDTHGVRGALDPNTVKSFTYQLLKGIAFCH---ENRVLH 123

Query: 408 FDIKPHNILLDEDFCPKISDFGLAKICNRKESIISMTGARGTVGYIAPEVFCRNIGEVSY 467
            D+KP N+L+++    K++DFGLA+      +  S      T+ Y AP+V    +G  +Y
Sbjct: 124 RDLKPQNLLINKRGELKLADFGLARAFGIPVNTFSNEVV--TLWYRAPDVL---LGSRTY 178

Query: 468 KS--DVYNYGMMIFEMTGGR 485
            +  D+++ G ++ EM  GR
Sbjct: 179 STSIDIWSVGCIMAEMITGR 198

Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. It is not essential for yeast viability and is the functional homolog of mammalian CDK5, which plays a role in central nervous system development. Length = 284

>gnl|CDD|133219 cd05088, PTKc_Tie2, Catalytic domain of the Protein Tyrosine Kinase, Tie2

 Score = 63.1 bits (153), Expect = 6e-11
 Identities = 58/224 (25%), Positives = 104/224 (46%), Gaps = 62/224 (27%)

Query: 307 YADIKKMTNSFKYKLGQGGYGSVYKGKLL-DG--SNVAVKVLND--SKGNGKEFINEVAS 361
           + DIK     F+  +G+G +G V K ++  DG   + A+K + +  SK + ++F  E+  
Sbjct: 6   WNDIK-----FQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEV 60

Query: 362 ISRTS-HVNVVALLGFC---------------------LR------------VAEELSST 387
           + +   H N++ LLG C                     LR            +A   +ST
Sbjct: 61  LCKLGHHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTAST 120

Query: 388 IG----------IARGLEYLHLGCSTRILHFDIKPHNILLDEDFCPKISDFGLAKICNRK 437
           +           +ARG++YL      + +H D+   NIL+ E++  KI+DFGL++    +
Sbjct: 121 LSSQQLLHFAADVARGMDYL---SQKQFIHRDLAARNILVGENYVAKIADFGLSR---GQ 174

Query: 438 ESIISMTGARGTVGYIAPEVFCRNIGEVSYKSDVYNYGMMIFEM 481
           E  +  T  R  V ++A E    N    +  SDV++YG++++E+
Sbjct: 175 EVYVKKTMGRLPVRWMAIESL--NYSVYTTNSDVWSYGVLLWEI 216

Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. Tie2 signaling plays key regulatory roles in vascular integrity and quiescence, and in inflammation. Length = 303

>gnl|CDD|132990 cd06659, STKc_PAK6, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6

 Score = 62.7 bits (152), Expect = 7e-11
 Identities = 59/197 (29%), Positives = 93/197 (47%), Gaps = 43/197 (21%)

Query: 320 KLGQGGYGSVYKGK-LLDGSNVAVKVLNDSKGNGKEFI-NEVASISRTSHVNVV-----A 372
           K+G+G  G V   +    G  VAVK+++  K   +E + NEV  +    H NVV      
Sbjct: 28  KIGEGSTGIVCIAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHQNVVEMYKSY 87

Query: 373 LLGFCL-------------------RVAEELSSTI--GIARGLEYLHLGCSTRILHFDIK 411
           L+G  L                   R+ EE  +T+   + + L YLH   S  ++H DIK
Sbjct: 88  LVGEELWVLMEFLQGGALTDIVSQTRLNEEQIATVCESVLQALCYLH---SQGVIHRDIK 144

Query: 412 PHNILLDEDFCPKISDFG----LAKICNRKESIISMTGARGTVGYIAPEVFCRNIGEVSY 467
             +ILL  D   K+SDFG    ++K   +++S++      GT  ++APEV  R       
Sbjct: 145 SDSILLTLDGRVKLSDFGFCAQISKDVPKRKSLV------GTPYWMAPEVISRTP--YGT 196

Query: 468 KSDVYNYGMMIFEMTGG 484
           + D+++ G+M+ EM  G
Sbjct: 197 EVDIWSLGIMVIEMVDG 213

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role in stress responses through its activation by the mitogen-activated protein kinase (MAPK) p38 and MAPK kinase 6 (MKK6) pathway. PAK6 is highly expressed in the brain. It is not required for viability, but together with PAK5, it is required for normal levels of locomotion and activity, and for learning and memory. Increased expression of PAK6 is found in primary and metastatic prostate cancer. PAK6 may play a role in the regulation of motility. Length = 297

>gnl|CDD|132968 cd06637, STKc_TNIK, Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase

 Score = 62.4 bits (151), Expect = 8e-11
 Identities = 58/208 (27%), Positives = 93/208 (44%), Gaps = 53/208 (25%)

Query: 321 LGQGGYGSVYKGKLLD-GSNVAVKVLNDSKGNGKEFINEVASISRTSHVNVVA------- 372
           +G G YG VYKG+ +  G   A+KV++ +    +E   E+  + + SH   +A       
Sbjct: 14  VGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDEEEEIKQEINMLKKYSHHRNIATYYGAFI 73

Query: 373 -------------LLGFCL--RVAEELSSTIG--------------IARGLEYLHLGCST 403
                        ++ FC    V + + +T G              I RGL +LH     
Sbjct: 74  KKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLH---QH 130

Query: 404 RILHFDIKPHNILLDEDFCPKISDFG----LAKICNRKESIISMTGARGTVGYIAPEVF- 458
           +++H DIK  N+LL E+   K+ DFG    L +   R+ + I      GT  ++APEV  
Sbjct: 131 KVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRRNTFI------GTPYWMAPEVIA 184

Query: 459 CRNIGEVSY--KSDVYNYGMMIFEMTGG 484
           C    + +Y  KSD+++ G+   EM  G
Sbjct: 185 CDENPDATYDFKSDLWSLGITAIEMAEG 212

Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activates the c-Jun N-terminal kinase (JNK) pathway and plays a role in regulating the actin cytoskeleton. Length = 272

>gnl|CDD|143367 cd07862, STKc_CDK6, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6

 Score = 62.3 bits (151), Expect = 9e-11
 Identities = 59/205 (28%), Positives = 94/205 (45%), Gaps = 53/205 (25%)

Query: 320 KLGQGGYGSVYKGKLLD--GSNVA---VKVLNDSKGNGKEFINEVASISRTS---HVNVV 371
           ++G+G YG V+K + L   G  VA   V+V    +G     I EVA +       H NVV
Sbjct: 8   EIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVV 67

Query: 372 ALLGFCL---------------RVAEELSSTIGIA------------------RGLEYLH 398
            L   C                 V ++L++ +                     RGL++LH
Sbjct: 68  RLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLH 127

Query: 399 LGCSTRILHFDIKPHNILLDEDFCPKISDFGLAKICNRKESIISMTGARGTVGYIAPEVF 458
              S R++H D+KP NIL+      K++DFGLA+I + + ++ S+     T+ Y APEV 
Sbjct: 128 ---SHRVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMALTSVV---VTLWYRAPEVL 181

Query: 459 CRNIGEVSYKS--DVYNYGMMIFEM 481
            ++    SY +  D+++ G +  EM
Sbjct: 182 LQS----SYATPVDLWSVGCIFAEM 202

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytoplasm. It is also present in the ruffling edge of spreading fibroblasts and may play a role in cell spreading. It binds to the p21 inhibitor without any effect on its own activity and it is overexpressed in squamous cell carcinomas and neuroblastomas. CDK6 has also been shown to inhibit cell differentiation in many cell types. Length = 290

>gnl|CDD|173740 cd07842, STKc_CDK8_like, Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases

 Score = 62.7 bits (153), Expect = 9e-11
 Identities = 44/163 (26%), Positives = 62/163 (38%), Gaps = 47/163 (28%)

Query: 317 FKYKLGQGGYGSVYKGKLLDGSN---VAVKVLNDSKGNGKEF----INEVASISRTSHVN 369
            +  +G+G YG VYK K  +G +    A+K     K            E+A +    H N
Sbjct: 4   IEGCIGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLRELKHEN 63

Query: 370 VVALLGFCLRVAEEL---------------------------------SSTIGIARGLEY 396
           VV+L+   L  A++                                  S    I  G+ Y
Sbjct: 64  VVSLVEVFLEHADKSVYLLFDYAEHDLWQIIKFHRQAKRVSIPPSMVKSLLWQILNGVHY 123

Query: 397 LHLGCSTRILHFDIKPHNILL----DEDFCPKISDFGLAKICN 435
           LH   S  +LH D+KP NIL+     E    KI D GLA++ N
Sbjct: 124 LH---SNWVLHRDLKPANILVMGEGPERGVVKIGDLGLARLFN 163

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDC2L6 also associates with Mediator in complexes lacking CDK8. In VP16-dependent transcriptional activation, CDK8 and CDC2L6 exerts opposing effects by positive and negative regulation, respectively, in similar conditions. Length = 316

>gnl|CDD|173730 cd06624, STKc_ASK, Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase

 Score = 62.2 bits (151), Expect = 9e-11
 Identities = 61/200 (30%), Positives = 88/200 (44%), Gaps = 42/200 (21%)

Query: 321 LGQGGYGSVYKGKLLDGS-NVAVKVL--NDSKGNGKEFINEVASISRTSHVNVVALLGFC 377
           LG+G YG VY  + L     +A+K +   DS+   +    E+A  S   H N+V  LG  
Sbjct: 16  LGKGTYGIVYAARDLSTQVRIAIKEIPERDSR-YVQPLHEEIALHSYLKHRNIVQYLGSD 74

Query: 378 L-----RVAEE------LSS--------------TIG-----IARGLEYLHLGCSTRILH 407
                 ++  E      LS+              TI      I  GL+YLH     +I+H
Sbjct: 75  SENGFFKIFMEQVPGGSLSALLRSKWGPLKDNEQTIIFYTKQILEGLKYLH---DNQIVH 131

Query: 408 FDIKPHNILLDE-DFCPKISDFGLAKICNRKESIISMTGA-RGTVGYIAPEVFCRNIGEV 465
            DIK  N+L++      KISDFG +K   R   I   T    GT+ Y+APEV  +     
Sbjct: 132 RDIKGDNVLVNTYSGVVKISDFGTSK---RLAGINPCTETFTGTLQYMAPEVIDKGPRGY 188

Query: 466 SYKSDVYNYGMMIFEMTGGR 485
              +D+++ G  I EM  G+
Sbjct: 189 GAPADIWSLGCTIVEMATGK 208

Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. It plays important roles in cytokine and stress responses, as well as in reactive oxygen species (ROS)-mediated cellular responses. ASK1 is implicated in various diseases mediated by oxidative stress including inschemic heart disease, hypertension, vessel injury, brain ischemia, Fanconi anemia, asthma, and pulmonary edema, among others. ASK2 (also called MAPKKK6) functions only in a heteromeric complex with ASK1, and can activate ASK1 by direct phosphorylation. The function of MAPKKK15 is still unknown. Length = 268

>gnl|CDD|173719 cd05630, STKc_GRK6, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6

 Score = 62.3 bits (151), Expect = 1e-10
 Identities = 39/96 (40%), Positives = 55/96 (57%), Gaps = 8/96 (8%)

Query: 390 IARGLEYLHLGCSTRILHFDIKPHNILLDEDFCPKISDFGLAKICNRKESIISMTGARGT 449
           I  GLE LH     RI++ D+KP NILLD+    +ISD GLA      ++I    G  GT
Sbjct: 111 ICCGLEDLH---QERIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQTI---KGRVGT 164

Query: 450 VGYIAPEVFCRNIGEVSYKSDVYNYGMMIFEMTGGR 485
           VGY+APEV  +N    ++  D +  G +++EM  G+
Sbjct: 165 VGYMAPEV-VKN-ERYTFSPDWWALGCLLYEMIAGQ 198

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK6 plays important roles in the regulation of dopamine, M3 muscarinic, opioid, and chemokine receptor signaling. It also plays maladaptive roles in addiction and Parkinson's disease. GRK6-deficient mice exhibit altered dopamine receptor regulation, decreased lymphocyte chemotaxis, and increased acute inflammation and neutrophil chemotaxis. Length = 285

>gnl|CDD|143377 cd07872, STKc_PCTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase

 Score = 62.3 bits (151), Expect = 1e-10
 Identities = 60/198 (30%), Positives = 90/198 (45%), Gaps = 40/198 (20%)

Query: 320 KLGQGGYGSVYKGKL-LDGSNVAVKV--LNDSKGNGKEFINEVASISRTSHVNVVALLGF 376
           KLG+G Y +V+KG+  L  + VA+K   L   +G     I EV+ +    H N+V L   
Sbjct: 13  KLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDI 72

Query: 377 C------LRVAEELSSTIG---------------------IARGLEYLHLGCSTRILHFD 409
                    V E L   +                      I RGL Y H     ++LH D
Sbjct: 73  VHTDKSLTLVFEYLDKDLKQYMDDCGNIMSMHNVKIFLYQILRGLAYCH---RRKVLHRD 129

Query: 410 IKPHNILLDEDFCPKISDFGLAKICNRKESIISMTGARG--TVGYIAPEVFCRNIGEVSY 467
           +KP N+L++E    K++DFGLA    R +S+ + T +    T+ Y  P+V   +  E S 
Sbjct: 130 LKPQNLLINERGELKLADFGLA----RAKSVPTKTYSNEVVTLWYRPPDVLLGS-SEYST 184

Query: 468 KSDVYNYGMMIFEMTGGR 485
           + D++  G + FEM  GR
Sbjct: 185 QIDMWGVGCIFFEMASGR 202

Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play a role in regulating mitochondrial function in neurons. Length = 309

>gnl|CDD|173737 cd07834, STKc_MAPK, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase

 Score = 62.5 bits (153), Expect = 1e-10
 Identities = 49/201 (24%), Positives = 82/201 (40%), Gaps = 40/201 (19%)

Query: 321 LGQGGYGSVYKGK-LLDGSNVAVKVLN---DSKGNGKEFINEVASISRTSHVNVVAL--- 373
           +G G YG V        G  VA+K ++   D   + K  + E+  +    H N++ L   
Sbjct: 8   IGSGAYGVVCSAVDKRTGRKVAIKKISNVFDDLIDAKRILREIKLLRHLRHENIIGLLDI 67

Query: 374 ----------------------LGFCLRVAEELSS------TIGIARGLEYLHLGCSTRI 405
                                 L   ++  + L+          I RGL+YLH   S  +
Sbjct: 68  LRPPSPEDFNDVYIVTELMETDLHKVIKSPQPLTDDHIQYFLYQILRGLKYLH---SANV 124

Query: 406 LHFDIKPHNILLDEDFCPKISDFGLAKICNRKESIIS-MTGARGTVGYIAPEVFCRNIGE 464
           +H D+KP NIL++ +   KI DFGLA+  +  E     +T    T  Y APE+   +   
Sbjct: 125 IHRDLKPSNILVNSNCDLKICDFGLARGVDPDEDEKGFLTEYVVTRWYRAPELLL-SSSR 183

Query: 465 VSYKSDVYNYGMMIFEMTGGR 485
            +   D+++ G +  E+   +
Sbjct: 184 YTKAIDIWSVGCIFAELLTRK 204

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPK kinase (MAP2K or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAP3K or MKKK). Each cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. There are three main typical MAPK subfamilies: Extracellular signal-Regulated Kinase (ERK), c-Jun N-terminal Kinase (JNK), and p38. Some MAPKs are atypical in that they are not regulated by MAP2Ks. These include MAPK4, MAPK6, NLK, and ERK7. Length = 330

>gnl|CDD|173652 cd05100, PTKc_FGFR3, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3

 Score = 62.7 bits (152), Expect = 1e-10
 Identities = 39/134 (29%), Positives = 70/134 (52%), Gaps = 5/134 (3%)

Query: 348 SKGNGKEFINEVASISRTSHVNVVALLGFCLRVAEELSSTIGIARGLEYLHLGCSTRILH 407
           SKGN +E++            +   L    L   + +S    +ARG+EYL    S + +H
Sbjct: 101 SKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSCAYQVARGMEYL---ASQKCIH 157

Query: 408 FDIKPHNILLDEDFCPKISDFGLAKICNRKESIISMTGARGTVGYIAPEVFCRNIGEVSY 467
            D+   N+L+ ED   KI+DFGLA+  +  +     T  R  V ++APE     +   ++
Sbjct: 158 RDLAARNVLVTEDNVMKIADFGLARDVHNIDYYKKTTNGRLPVKWMAPEALFDRV--YTH 215

Query: 468 KSDVYNYGMMIFEM 481
           +SDV+++G++++E+
Sbjct: 216 QSDVWSFGVLLWEI 229

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Many FGFR3 splice variants have been reported with the IIIb and IIIc isoforms being the predominant forms. FGFR3 IIIc is the isoform expressed in chondrocytes, the cells affected in dwarfism, while IIIb is expressed in epithelial cells. FGFR3 ligands include FGF1, FGF2, FGF4, FGF8, FGF9, and FGF23. It is a negative regulator of long bone growth. In the cochlear duct and in the lens, FGFR3 is involved in differentiation while it appears to have a role in cell proliferation in epithelial cells. Germline mutations in FGFR3 are associated with skeletal disorders including several forms of dwarfism. Some missense mutations are associated with multiple myeloma and carcinomas of the bladder and cervix. Overexpression of FGFR3 is found in thyroid carcinoma. Length = 334

>gnl|CDD|133230 cd05099, PTKc_FGFR4, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4

 Score = 62.3 bits (151), Expect = 1e-10
 Identities = 55/216 (25%), Positives = 95/216 (43%), Gaps = 61/216 (28%)

Query: 321 LGQGGYGSVYKGKL--LDGSN------VAVKVLNDSKGNGKEFINEVASISRTS----HV 368
           LG+G +G V + +   +D S       VAVK+L D+    K+  + ++ +        H 
Sbjct: 20  LGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDN-ATDKDLADLISEMELMKLIGKHK 78

Query: 369 NVVALLGFCL------------------------------------RVAEEL-------S 385
           N++ LLG C                                     +V EE        S
Sbjct: 79  NIINLLGVCTQEGPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVS 138

Query: 386 STIGIARGLEYLHLGCSTRILHFDIKPHNILLDEDFCPKISDFGLAKICNRKESIISMTG 445
               +ARG+EYL    S R +H D+   N+L+ ED   KI+DFGLA+  +  +     + 
Sbjct: 139 CAYQVARGMEYLE---SRRCIHRDLAARNVLVTEDNVMKIADFGLARGVHDIDYYKKTSN 195

Query: 446 ARGTVGYIAPEVFCRNIGEVSYKSDVYNYGMMIFEM 481
            R  V ++APE     +   +++SDV+++G++++E+
Sbjct: 196 GRLPVKWMAPEALFDRV--YTHQSDVWSFGILMWEI 229

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Unlike other FGFRs, there is only one splice form of FGFR4. It binds FGF1, FGF2, FGF6, FGF19, and FGF23. FGF19 is a selective ligand for FGFR4. Although disruption of FGFR4 in mice causes no obvious phenotype, in vivo inhibition of FGFR4 in cultured skeletal muscle cells resulted in an arrest of muscle progenitor differentiation. FGF6 and FGFR4 are uniquely expressed in myofibers and satellite cells. FGF6/FGFR4 signaling appears to play a key role in the regulation of muscle regeneration. A polymorphism in FGFR4 is found in head and neck squamous cell carcinoma. Length = 314

>gnl|CDD|133205 cd05074, PTKc_Tyro3, Catalytic domain of the Protein Tyrosine Kinase, Tyro3

 Score = 61.5 bits (149), Expect = 2e-10
 Identities = 62/220 (28%), Positives = 95/220 (43%), Gaps = 52/220 (23%)

Query: 321 LGQGGYGSVYKG--KLLDGS--NVAVKVLN---DSKGNGKEFINEVASISRTSHVNVVAL 373
           LG+G +GSV +   K  DGS   VAVK+L     S  + +EF+ E A +    H NV+ L
Sbjct: 7   LGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIEEFLREAACMKEFDHPNVIKL 66

Query: 374 LGFCLRVAEE----------------------LSSTIG-----------------IARGL 394
           +G  LR   +                      L S IG                 IA G+
Sbjct: 67  IGVSLRSRAKGRLPIPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIASGM 126

Query: 395 EYLHLGCSTRILHFDIKPHNILLDEDFCPKISDFGLAKICNRKESIISMTGARGTVGYIA 454
           EYL    S   +H D+   N +L+E+    ++DFGL+K     +       ++  V ++A
Sbjct: 127 EYLS---SKNFIHRDLAARNCMLNENMTVCVADFGLSKKIYSGDYYRQGCASKLPVKWLA 183

Query: 455 PEVFCRNIGEVSYKSDVYNYGMMIFE-MTGGRKNVDVVDN 493
            E    N+      SDV+ +G+ ++E MT G+     V+N
Sbjct: 184 LESLADNVYTT--HSDVWAFGVTMWEIMTRGQTPYAGVEN 221

Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic factor. It is also expressed in osteoclasts and has a role in bone resorption. Length = 273

>gnl|CDD|132967 cd06636, STKc_MAP4K4_6, Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6

 Score = 61.6 bits (149), Expect = 2e-10
 Identities = 57/208 (27%), Positives = 95/208 (45%), Gaps = 53/208 (25%)

Query: 321 LGQGGYGSVYKGKLLD-GSNVAVKVLNDSKGNGKEFINEVASISRTSHVNVVA------- 372
           +G G YG VYKG+ +  G   A+KV++ ++   +E   E+  + + SH   +A       
Sbjct: 24  VGNGTYGQVYKGRHVKTGQLAAIKVMDVTEDEEEEIKLEINMLKKYSHHRNIATYYGAFI 83

Query: 373 -------------LLGFCL--RVAEELSSTIG--------------IARGLEYLHLGCST 403
                        ++ FC    V + + +T G              I RGL +LH   + 
Sbjct: 84  KKSPPGHDDQLWLVMEFCGAGSVTDLVKNTKGNALKEDWIAYICREILRGLAHLH---AH 140

Query: 404 RILHFDIKPHNILLDEDFCPKISDFG----LAKICNRKESIISMTGARGTVGYIAPEVF- 458
           +++H DIK  N+LL E+   K+ DFG    L +   R+ + I      GT  ++APEV  
Sbjct: 141 KVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRRNTFI------GTPYWMAPEVIA 194

Query: 459 CRNIGEVS--YKSDVYNYGMMIFEMTGG 484
           C    + +  Y+SD+++ G+   EM  G
Sbjct: 195 CDENPDATYDYRSDIWSLGITAIEMAEG 222

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K4 is also called Nck Interacting kinase (NIK). It facilitates the activation of the MAPKs, extracellular signal-regulated kinase (ERK) 1, ERK2, and c-Jun N-terminal kinase (JNK), by phosphorylating and activating MEKK1. MAP4K4 plays a role in tumor necrosis factor (TNF) alpha-induced insulin resistance. MAP4K4 silencing in skeletal muscle cells from type II diabetic patients restores insulin-mediated glucose uptake. MAP4K4, through JNK, also plays a broad role in cell motility, which impacts inflammation, homeostasis, as well as the invasion and spread of cancer. MAP4K4 is found to be highly expressed in most tumor cell lines relative to normal tissue. MAP4K6 (also called MINK for Misshapen/NIKs-related kinase) is activated after Ras induction and mediates activation of p38 MAPK. MAP4K6 plays a role in cell cycle arrest, cytoskeleton organization, cell adhesion, and cell motility. Length = 282

>gnl|CDD|173723 cd06605, PKc_MAPKK, Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase

 Score = 61.2 bits (149), Expect = 2e-10
 Identities = 50/200 (25%), Positives = 82/200 (41%), Gaps = 45/200 (22%)

Query: 320 KLGQGGYGSVYKGKLL-DGSNVAVKV--LNDSKGNGKEFINEVASISRTSHVNVVALLGF 376
           +LG G  G V K      G  +AVK   L  ++   K+ + E+  + + +   +V   G 
Sbjct: 8   ELGAGNSGVVSKVLHRPTGKIMAVKTIRLEINEAIQKQILRELDILHKCNSPYIVGFYGA 67

Query: 377 CLR-----VAEELSS-----------------------TIGIARGLEYLHLGCSTR-ILH 407
                   +  E                           + + +GL YLH       I+H
Sbjct: 68  FYNNGDISICMEYMDGGSLDKILKEVQGRIPERILGKIAVAVLKGLTYLH---EKHKIIH 124

Query: 408 FDIKPHNILLDEDFCPKISDFGLAKICNRKESIISMTGAR-GTVGYIAPEVFCRNIGEV- 465
            D+KP NIL++     K+ DFG++      + + S+     GT  Y+APE   R  G   
Sbjct: 125 RDVKPSNILVNSRGQIKLCDFGVS-----GQLVNSLAKTFVGTSSYMAPE---RIQGNDY 176

Query: 466 SYKSDVYNYGMMIFEMTGGR 485
           S KSD+++ G+ + E+  GR
Sbjct: 177 SVKSDIWSLGLSLIELATGR 196

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity PKs that phosphorylate their downstream targets, MAPKs, at specific threonine and tyrosine residues. There are three MAPK subfamilies: extracellular signal-regulated kinase (ERK), c-Jun N-terminal kinase (JNK), and p38. In mammalian cells, there are seven MAPKKs (named MKK1-7) and 20 MAPKKKs. Each MAPK subfamily can be activated by at least two cognate MAPKKs and by multiple MAPKKKs. Length = 265

>gnl|CDD|173721 cd05632, STKc_GRK5, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5

 Score = 61.5 bits (149), Expect = 2e-10
 Identities = 39/93 (41%), Positives = 50/93 (53%), Gaps = 8/93 (8%)

Query: 393 GLEYLHLGCSTRILHFDIKPHNILLDEDFCPKISDFGLAKICNRKESIISMTGARGTVGY 452
           GLE LH       ++ D+KP NILLD+    +ISD GLA      ESI    G  GTVGY
Sbjct: 114 GLEDLH---RENTVYRDLKPENILLDDYGHIRISDLGLAVKIPEGESI---RGRVGTVGY 167

Query: 453 IAPEVFCRNIGEVSYKSDVYNYGMMIFEMTGGR 485
           +APEV   N    +   D +  G +I+EM  G+
Sbjct: 168 MAPEVL--NNQRYTLSPDYWGLGCLIYEMIEGQ 198

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with the membrane though an N-terminal PIP2 binding domain and also binds phospholipids via its C-terminus. GRK5 deficiency is associated with early Alzheimer's disease in humans and mouse models. GRK5 also plays a crucial role in the pathogenesis of sporadic Parkinson's disease. It participates in the regulation and desensitization of PDGFRbeta, a receptor tyrosine kinase involved in a variety of downstream cellular effects including cell growth, chemotaxis, apoptosis, and angiogenesis. GRK5 also regulates Toll-like receptor 4, which is involved in innate and adaptive immunity. Length = 285

>gnl|CDD|173770 cd08528, STKc_Nek10, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10

 Score = 61.0 bits (148), Expect = 2e-10
 Identities = 55/208 (26%), Positives = 83/208 (39%), Gaps = 56/208 (26%)

Query: 321 LGQGGYGSVYK-------GKLLDGSNVAVKVLNDSKG------NGKEFINEVASISRT-S 366
           LG G +G VYK         LL    + V      K       +  + ++EV  I     
Sbjct: 8   LGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQLR 67

Query: 367 HVNVVALLGFCLR---------------VAEELSST----------------IGIARGLE 395
           H N+V      L                + E  +S                 + +   L 
Sbjct: 68  HPNIVRYYKTFLENDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQMVLALR 127

Query: 396 YLHLGCSTRILHFDIKPHNILLDEDFCPKISDFGLAKICNRKESIISMTGARGTVGYIAP 455
           YLH     RI+H D+ P+NI+L ED    I+DFGLAK    +     +T   GT+ Y  P
Sbjct: 128 YLHK--EKRIVHRDLTPNNIMLGEDDKVTITDFGLAKQKQPES---KLTSVVGTILYSCP 182

Query: 456 EVFCRNI--GEVSYKSDVYNYGMMIFEM 481
           E+  +N   GE   K+DV+ +G ++++M
Sbjct: 183 EIV-KNEPYGE---KADVWAFGCILYQM 206

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. Length = 269

>gnl|CDD|133168 cd05036, PTKc_ALK_LTK, Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase

 Score = 61.3 bits (149), Expect = 2e-10
 Identities = 58/227 (25%), Positives = 92/227 (40%), Gaps = 63/227 (27%)

Query: 321 LGQGGYGSVYKGKL--LDGSN----VAVKVLNDSKGNGKE--FINEVASISRTSHVNVVA 372
           LG G +G VY+G     DG      VAVK L +S     E  F+ E   +S+ +H N+V 
Sbjct: 14  LGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSEQDESDFLMEALIMSKFNHQNIVR 73

Query: 373 LLGFC----------------------------------LRVAEELSSTIGIARGLEYLH 398
           L+G                                    L + + L     +A+G +YL 
Sbjct: 74  LIGVSFERLPRFILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGCKYLE 133

Query: 399 LGCSTRILHFDIKPHNILLDEDFCP------KISDFGLAKICNRKESIISMTGARGTVGY 452
                  +H DI   N LL    C       KI+DFG+A+   R         A   + +
Sbjct: 134 ---ENHFIHRDIAARNCLLT---CKGPGRVAKIADFGMARDIYRASYYRKGGRAMLPIKW 187

Query: 453 IAPEVFCRNIGEVSYKSDVYNYGMMIFEMTG-------GRKNVDVVD 492
           + PE F   I   + K+DV+++G++++E+         GR N +V++
Sbjct: 188 MPPEAFLDGI--FTSKTDVWSFGVLLWEIFSLGYMPYPGRTNQEVME 232

Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well as visceral muscle differentiation in Drosophila. ALK is aberrantly expressed as fusion proteins, due to chromosomal translocations, in about 60% of anaplastic large cell lymphomas (ALCLs). ALK fusion proteins are also found in rare cases of diffuse large B cell lymphomas (DLBCLs). LTK is mainly expressed in B lymphocytes and neuronal tissues. It is important in cell proliferation and survival. Transgenic mice expressing TLK display retarded growth and high mortality rate. In addition, a polymorphism in mouse and human LTK is implicated in the pathogenesis of systemic lupus erythematosus. Length = 277

>gnl|CDD|173699 cd05608, STKc_GRK1, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1

 Score = 61.0 bits (148), Expect = 3e-10
 Identities = 37/99 (37%), Positives = 52/99 (52%), Gaps = 7/99 (7%)

Query: 387 TIGIARGLEYLHLGCSTRILHFDIKPHNILLDEDFCPKISDFGLAKICNRKESIISMTGA 446
           T  I  GLE+LH     RI++ D+KP N+LLD D   +ISD GLA     K+      G 
Sbjct: 103 TAQIISGLEHLH---QRRIIYRDLKPENVLLDNDGNVRISDLGLA--VELKDGQSKTKGY 157

Query: 447 RGTVGYIAPEVFCRNIGEVSYKSDVYNYGMMIFEMTGGR 485
            GT G++APE+      E  +  D +  G+ ++EM   R
Sbjct: 158 AGTPGFMAPELLQGE--EYDFSVDYFALGVTLYEMIAAR 194

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual group of GRKs and is expressed in retinal cells. It phosphorylates rhodopsin in rod cells, which leads to termination of the phototransduction cascade. Mutations in GRK1 are associated to a recessively inherited form of stationary nightblindness called Oguchi disease. Length = 280

>gnl|CDD|133204 cd05073, PTKc_Hck, Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase

 Score = 60.8 bits (147), Expect = 3e-10
 Identities = 51/206 (24%), Positives = 89/206 (43%), Gaps = 35/206 (16%)

Query: 309 DIKKMTNSFKYKLGQGGYGSVYKGKLLDGSNVAVKVLNDSKGNGKEFINEVASISRTSHV 368
           +I + +   + KLG G +G V+       + VAVK +     + + F+ E   +    H 
Sbjct: 2   EIPRESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPGSMSVEAFLAEANVMKTLQHD 61

Query: 369 NVVALLGFCLR--------------VAEELSSTIG--------------IARGLEYLHLG 400
            +V L     +              + + L S  G              IA G+ ++   
Sbjct: 62  KLVKLHAVVTKEPIYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIE-- 119

Query: 401 CSTRILHFDIKPHNILLDEDFCPKISDFGLAKICNRKESIISMTGARGTVGYIAPEVFCR 460
                +H D++  NIL+      KI+DFGLA++    E   +  GA+  + + APE    
Sbjct: 120 -QRNYIHRDLRAANILVSASLVCKIADFGLARVIEDNE-YTAREGAKFPIKWTAPEAI-- 175

Query: 461 NIGEVSYKSDVYNYGMMIFEM-TGGR 485
           N G  + KSDV+++G+++ E+ T GR
Sbjct: 176 NFGSFTIKSDVWSFGILLMEIVTYGR 201

Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Hck is present in myeloid and lymphoid cells that play a role in the development of cancer. It may be important in the oncogenic signaling of the protein Tel-Abl, which induces a chronic myelogenous leukemia (CML)-like disease. Hck also acts as a negative regulator of granulocyte colony-stimulating factor (G-CSF)-induced proliferation of granulocytic precursors, suggesting a possible role in the development of acute myeloid leukemia (AML). In addition, Hck is essential in regulating the degranulation of polymorphonuclear leukocytes (PMNs). Genetic polymorphisms affect the expression level of Hck, which affects PMN mediator release and influences the development of chronic obstructive pulmonary disease (COPD). Length = 260

>gnl|CDD|133229 cd05098, PTKc_FGFR1, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1

 Score = 61.2 bits (148), Expect = 3e-10
 Identities = 34/104 (32%), Positives = 60/104 (57%), Gaps = 5/104 (4%)

Query: 378 LRVAEELSSTIGIARGLEYLHLGCSTRILHFDIKPHNILLDEDFCPKISDFGLAKICNRK 437
           L   + +S    +ARG+EYL    S + +H D+   N+L+ ED   KI+DFGLA+  +  
Sbjct: 137 LSFKDLVSCAYQVARGMEYL---ASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHI 193

Query: 438 ESIISMTGARGTVGYIAPEVFCRNIGEVSYKSDVYNYGMMIFEM 481
           +     T  R  V ++APE     I   +++SDV+++G++++E+
Sbjct: 194 DYYKKTTNGRLPVKWMAPEALFDRI--YTHQSDVWSFGVLLWEI 235

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Alternative splicing of FGFR1 transcripts produces a variety of isoforms, which are differentially expressed in cells. FGFR1 binds the ligands, FGF1 and FGF2, with high affinity and has also been reported to bind FGF4, FGF6, and FGF9. FGFR1 signaling is critical in the control of cell migration during embryo development. It promotes cell proliferation in fibroblasts. Nuclear FGFR1 plays a role in the regulation of transcription. Mutations, insertions or deletions of FGFR1 have been identified in patients with Kallman's syndrome (KS), an inherited disorder characterized by hypogonadotropic hypogonadism and loss of olfaction. Aberrant FGFR1 expression has been found in some human cancers including 8P11 myeloproliferative syndrome (EMS), breast cancer, and pancreatic adenocarcinoma. Length = 307

>gnl|CDD|143378 cd07873, STKc_PCTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase

 Score = 60.8 bits (147), Expect = 3e-10
 Identities = 59/200 (29%), Positives = 91/200 (45%), Gaps = 44/200 (22%)

Query: 320 KLGQGGYGSVYKGKL-LDGSNVAVKV--LNDSKGNGKEFINEVASISRTSHVNVVALLGF 376
           KLG+G Y +VYKG+  L  + VA+K   L   +G     I EV+ +    H N+V L   
Sbjct: 13  KLGEGTYATVYKGRSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDI 72

Query: 377 C------LRVAEELSSTIG---------------------IARGLEYLHLGCSTRILHFD 409
                    V E L   +                      + RGL Y H     ++LH D
Sbjct: 73  IHTEKSLTLVFEYLDKDLKQYLDDCGNSINMHNVKLFLFQLLRGLNYCH---RRKVLHRD 129

Query: 410 IKPHNILLDEDFCPKISDFGLAKICNRKESIISMTGARG--TVGYIAPEVFCRNIGEVSY 467
           +KP N+L++E    K++DFGLA    R +SI + T +    T+ Y  P++    +G   Y
Sbjct: 130 LKPQNLLINERGELKLADFGLA----RAKSIPTKTYSNEVVTLWYRPPDIL---LGSTDY 182

Query: 468 KS--DVYNYGMMIFEMTGGR 485
            +  D++  G + +EM+ GR
Sbjct: 183 STQIDMWGVGCIFYEMSTGR 202

Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may play a role in regulating neurite outgrowth. It can also associate with Trap (Tudor repeat associator with PCTAIRE-2), a physiological partner of PCTAIRE-2; with p11, a small dimeric protein with similarity to S100; and with 14-3-3 proteins, mediators of phosphorylation-dependent interactions in many different proteins. Length = 301

>gnl|CDD|132966 cd06635, STKc_TAO1, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1

 Score = 60.9 bits (147), Expect = 4e-10
 Identities = 57/195 (29%), Positives = 87/195 (44%), Gaps = 42/195 (21%)

Query: 320 KLGQGGYGSVYKGKLLDGSNV-AVKVLNDSKGNGKE----FINEVASISRTSHVNVVALL 374
           ++G G +G+VY  + +  + V A+K ++ S     E     I EV  + R  H N +   
Sbjct: 32  EIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPNSIEYK 91

Query: 375 G-------------FCLRVAEEL--------------SSTIGIARGLEYLHLGCSTRILH 407
           G             +CL  A +L              + T G  +GL YLH   S  ++H
Sbjct: 92  GCYLREHTAWLVMEYCLGSASDLLEVHKKPLQEVEIAAITHGALQGLAYLH---SHNMIH 148

Query: 408 FDIKPHNILLDEDFCPKISDFGLAKICNRKESIISMTGARGTVGYIAPEV-FCRNIGEVS 466
            DIK  NILL E    K++DFG A I +   S +      GT  ++APEV    + G+  
Sbjct: 149 RDIKAGNILLTEPGQVKLADFGSASIASPANSFV------GTPYWMAPEVILAMDEGQYD 202

Query: 467 YKSDVYNYGMMIFEM 481
            K DV++ G+   E+
Sbjct: 203 GKVDVWSLGITCIEL 217

Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuronal apoptosis. TAO1 interacts with the checkpoint proteins BubR1 and Mad2, and plays an important role in regulating mitotic progression, which is required for both chromosome congression and checkpoint-induced anaphase delay. TAO1 may play a role in protecting genomic stability. Length = 317

>gnl|CDD|234389 TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclase fusion protein

 Score = 62.6 bits (152), Expect = 4e-10
 Identities = 58/200 (29%), Positives = 78/200 (39%), Gaps = 46/200 (23%)

Query: 337 GSNVAVKVLNDSKGNG----KEFINEVASISRTSHVNVVALL-------GFCLRVAE--- 382
           G  VA+K+L             F  E A  +R  H N+VALL       G    V E   
Sbjct: 3   GHEVAIKLLRTDAPEEEHQRARFRRETALCARLYHPNIVALLDSGEAPPGLLFAVFEYVP 62

Query: 383 -----ELSSTIGIARGLEYLHL--------GCSTR--ILHFDIKPHNILL---DEDFCPK 424
                E+ +  G     E   L         C+    I+H D+KP NI++         K
Sbjct: 63  GRTLREVLAADGALPAGETGRLMLQVLDALACAHNQGIVHRDLKPQNIMVSQTGVRPHAK 122

Query: 425 ISDFGLAKICNRKESIISMTGAR-----GTVGYIAPEVFCRNIGE-VSYKSDVYNYGMMI 478
           + DFG+  +          T  R     GT  Y APE   R  GE V+  SD+Y +G++ 
Sbjct: 123 VLDFGIGTLLPGVRDADVATLTRTTEVLGTPTYCAPEQL-R--GEPVTPNSDLYAWGLIF 179

Query: 479 FE-MTGGRKNVDVVDNGSTA 497
            E +TG R    VV   S A
Sbjct: 180 LECLTGQR----VVQGASVA 195

This model represents proteins of 1350 in length, in multiple species of Burkholderia, in Acidovorax avenae subsp. citrulli AAC00-1 and Delftia acidovorans SPH-1, and in multiple copies in Sorangium cellulosum, in genomic neighborhoods that include a cyclodehydratase/docking scaffold fusion protein (TIGR03882) and a member of the thiazole/oxazole modified metabolite (TOMM) precursor family TIGR03795. It has a kinase domain in the N-terminal 300 amino acids, followed by a cyclase homology domain, followed by regions without named domain definitions. It is a probable bacteriocin-like metabolite biosynthesis protein [Cellular processes, Toxin production and resistance]. Length = 1266

>gnl|CDD|173743 cd07846, STKc_CDKL2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3

 Score = 60.5 bits (147), Expect = 4e-10
 Identities = 56/198 (28%), Positives = 83/198 (41%), Gaps = 41/198 (20%)

Query: 320 KLGQGGYGSVYKGKLLD-GSNVAVKVL---NDSKGNGKEFINEVASISRTSHVNVVALLG 375
            +G+G YG V K K  + G  VA+K      D K   K  + E+  + +  H N+V L+ 
Sbjct: 8   LVGEGSYGMVMKCKHKETGQIVAIKKFLESEDDKMVKKIAMREIRMLKQLRHENLVNLIE 67

Query: 376 FCLR------VAEELSSTI---------------------GIARGLEYLHLGCSTRILHF 408
              R      V E +  T+                      I RG+E+ H   S  I+H 
Sbjct: 68  VFRRKKRLYLVFEFVDHTVLDDLEKYPNGLDESRVRKYLFQILRGIEFCH---SHNIIHR 124

Query: 409 DIKPHNILLDEDFCPKISDFGLAKICNRKESIISMTGARGTVGYIAPEVFCRNIGEVSYK 468
           DIKP NIL+ +    K+ DFG A+       +   T    T  Y APE+    +G+  Y 
Sbjct: 125 DIKPENILVSQSGVVKLCDFGFARTLAAPGEV--YTDYVATRWYRAPELL---VGDTKYG 179

Query: 469 S--DVYNYGMMIFEMTGG 484
              D++  G ++ EM  G
Sbjct: 180 RAVDIWAVGCLVTEMLTG 197

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKIAMRE (NKIATRE in rat), by translocation is associated with mild mental retardation. It has been reported that CDKL3 is lost in leukemic cells having a chromosome arm 5q deletion, and may contribute to the transformed phenotype. Length = 286

>gnl|CDD|173763 cd08223, STKc_Nek4, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4

 Score = 60.0 bits (145), Expect = 4e-10
 Identities = 55/199 (27%), Positives = 87/199 (43%), Gaps = 49/199 (24%)

Query: 321 LGQGGYGSVYKGK-LLDGSNVAVKVLN---DSKGNGKEFINEVASISRTSHVNVVA---- 372
           +G+G YG V   +   DG    +K LN    S+   K    E   +S+  H N+VA    
Sbjct: 8   VGKGSYGEVSLVRHRTDGKQYVIKKLNLRNASRRERKAAEQEAQLLSQLKHPNIVAYRES 67

Query: 373 ----------LLGFC------LRVAEE----------LSSTIGIARGLEYLHLGCSTRIL 406
                     ++GFC       ++ E+          +   + IA  L+YLH      IL
Sbjct: 68  WEGEDGLLYIVMGFCEGGDLYHKLKEQKGKLLPENQVVEWFVQIAMALQYLH---EKHIL 124

Query: 407 HFDIKPHNILLDEDFCPKISDFGLAKI----CNRKESIISMTGARGTVGYIAPEVFCRNI 462
           H D+K  N+ L      K+ D G+A++    C+   ++I      GT  Y++PE+F    
Sbjct: 125 HRDLKTQNVFLTRTNIIKVGDLGIARVLENQCDMASTLI------GTPYYMSPELFSNK- 177

Query: 463 GEVSYKSDVYNYGMMIFEM 481
              +YKSDV+  G  ++EM
Sbjct: 178 -PYNYKSDVWALGCCVYEM 195

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. Length = 257

>gnl|CDD|133180 cd05049, PTKc_Trk, Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases

 Score = 60.5 bits (147), Expect = 4e-10
 Identities = 40/172 (23%), Positives = 64/172 (37%), Gaps = 52/172 (30%)

Query: 310 IKKMTNSFKYKLGQGGYGSVYKGKLLDGSN------VAVKVLNDSKGNG--KEFINEVAS 361
           +++ T   K +LG+G +G V+ G+            VAVK L ++  N   K+F  E   
Sbjct: 2   VQRDTIVLKRELGEGAFGKVFLGECYHLEPENDKELVAVKTLKETASNDARKDFEREAEL 61

Query: 362 ISRTSHVNVVALLGFCLR---------------VAEELSS-------------------- 386
           ++   H N+V   G C                 + + L S                    
Sbjct: 62  LTNFQHENIVKFYGVCTEGDPPIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTL 121

Query: 387 ------TIGIARGLEYLHLGCSTRILHFDIKPHNILLDEDFCPKISDFGLAK 432
                  + IA G+ YL    S   +H D+   N L+  D   KI DFG+++
Sbjct: 122 SQLLQIAVQIASGMVYL---ASQHFVHRDLATRNCLVGYDLVVKIGDFGMSR 170

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalytic domain. Trk receptors are mainly expressed in the peripheral and central nervous systems. They play important roles in cell fate determination, neuronal survival and differentiation, as well as in the regulation of synaptic plasticity. Altered expression of Trk receptors is associated with many human diseases. Length = 280

>gnl|CDD|173642 cd05075, PTKc_Axl, Catalytic domain of the Protein Tyrosine Kinase, Axl

 Score = 60.0 bits (145), Expect = 5e-10
 Identities = 57/219 (26%), Positives = 97/219 (44%), Gaps = 51/219 (23%)

Query: 321 LGQGGYGSVYKGKLLDGSN---VAVKVLND---SKGNGKEFINEVASISRTSHVNVVALL 374
           LG+G +GSV +G+L    +   VAVK +     ++   ++F++E   +    H NV+ L+
Sbjct: 7   LGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFDHPNVMRLI 66

Query: 375 GFCLRVAEE----------------------LSSTIG-----------------IARGLE 395
           G CL+  E                       L S +G                 IA G+E
Sbjct: 67  GVCLQTVESEGYPSPVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGME 126

Query: 396 YLHLGCSTRILHFDIKPHNILLDEDFCPKISDFGLAKICNRKESIISMTGARGTVGYIAP 455
           YL    S   +H D+   N +L+E+    ++DFGL+K     +       A+  V +IA 
Sbjct: 127 YL---SSKSFIHRDLAARNCMLNENMNVCVADFGLSKKIYNGDYYRQGRIAKMPVKWIAI 183

Query: 456 EVFCRNIGEVSYKSDVYNYGMMIFEM-TGGRKNVDVVDN 493
           E     +   + KSDV+++G+ ++E+ T G+     V+N
Sbjct: 184 ESLADRV--YTTKSDVWSFGVTMWEIATRGQTPYPGVEN 220

Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transformed cells. Axl signaling is important in many cellular functions such as survival, anti-apoptosis, proliferation, migration, and adhesion. Axl was originally isolated from patients with chronic myelogenous leukemia and a chronic myeloproliferative disorder. Axl is overexpressed in many human cancers including colon, squamous cell, thyroid, breast, and lung carcinomas. Length = 272

>gnl|CDD|132986 cd06655, STKc_PAK2, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2

 Score = 60.1 bits (145), Expect = 5e-10
 Identities = 61/207 (29%), Positives = 93/207 (44%), Gaps = 40/207 (19%)

Query: 308 ADIKKMTNSFKYKLGQGGYGSVYKGK-LLDGSNVAVKVLNDSKGNGKEFI-NEVASISRT 365
            D KK    ++ K+GQG  G+V+    +  G  VA+K +N  K   KE I NE+  +   
Sbjct: 15  GDPKKKYTRYE-KIGQGASGTVFTAIDVATGQEVAIKQINLQKQPKKELIINEILVMKEL 73

Query: 366 SHVNVVALLGFCLRVAEEL-----------------------SSTIGIAR----GLEYLH 398
            + N+V  L   L V +EL                       +    + R     LE+LH
Sbjct: 74  KNPNIVNFLDSFL-VGDELFVVMEYLAGGSLTDVVTETCMDEAQIAAVCRECLQALEFLH 132

Query: 399 LGCSTRILHFDIKPHNILLDEDFCPKISDFGL-AKICNRKESIISMTGARGTVGYIAPEV 457
              + +++H DIK  N+LL  D   K++DFG  A+I   +    +M    GT  ++APEV
Sbjct: 133 ---ANQVIHRDIKSDNVLLGMDGSVKLTDFGFCAQITPEQSKRSTMV---GTPYWMAPEV 186

Query: 458 FCRNIGEVSYKSDVYNYGMMIFEMTGG 484
             R       K D+++ G+M  EM  G
Sbjct: 187 VTRK--AYGPKVDIWSLGIMAIEMVEG 211

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK2 plays a role in pro-apoptotic signaling. It is cleaved and activated by caspases leading to morphological changes during apoptosis. PAK2 is also activated in response to a variety of stresses including DNA damage, hyperosmolarity, serum starvation, and contact inhibition, and may play a role in coordinating the stress response. PAK2 also contributes to cancer cell invasion through a mechanism distinct from that of PAK1. Length = 296

>gnl|CDD|173749 cd07855, STKc_ERK5, Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5

 Score = 60.4 bits (147), Expect = 5e-10
 Identities = 34/98 (34%), Positives = 56/98 (57%), Gaps = 6/98 (6%)

Query: 390 IARGLEYLHLGCSTRILHFDIKPHNILLDEDFCPKISDFGLAK-ICNR-KESIISMTGAR 447
           + RGL+Y+H   S  ++H D+KP N+L++ED   +I DFG+A+ + +   E    MT   
Sbjct: 116 LLRGLKYIH---SANVIHRDLKPSNLLVNEDCELRIGDFGMARGLSSSPTEHKYFMTEYV 172

Query: 448 GTVGYIAPEVFCRNIGEVSYKSDVYNYGMMIFEMTGGR 485
            T  Y APE+   ++ E +   D+++ G +  EM G R
Sbjct: 173 ATRWYRAPELLL-SLPEYTTAIDMWSVGCIFAEMLGRR 209

Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the MAP2K MEK5, which in turn is regulated by the MAP3Ks MEKK2 and MEKK3. Activated ERK5 phosphorylates its targets including myocyte enhancer factor 2 (MEF2), Sap1a, c-Myc, and RSK. It plays a role in EGF-induced cell proliferation during the G1/S phase transition. Studies on knockout mice revealed that ERK5 is essential for cardiovascular development and plays an important role in angiogenesis. It is also critical for neural differentiation and survival. The ERK5 pathway has been implicated in the pathogenesis of many diseases including cancer, cardiac hypertrophy, and atherosclerosis. Length = 334

>gnl|CDD|173671 cd05580, STKc_PKA, Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase

 Score = 59.9 bits (146), Expect = 6e-10
 Identities = 55/206 (26%), Positives = 83/206 (40%), Gaps = 62/206 (30%)

Query: 321 LGQGGYGSVYKGKLLDGSNV-AVKVLNDSK----GNGKEFINEVASISRTSHVNVVALLG 375
           LG G +G V   +        A+K+L+ +K       +  +NE   +    H  +V L G
Sbjct: 9   LGTGSFGRVMLVRHKGSGKYYALKILSKAKIVKLKQVEHVLNEKRILQSIRHPFLVNLYG 68

Query: 376 -------------FC--------LRVAEELSSTIG------IARGLEYLHLGCSTRILHF 408
                        +         LR +      +       +   LEYLH   S  I++ 
Sbjct: 69  SFQDDSNLYLVMEYVPGGELFSHLRKSGRFPEPVARFYAAQVVLALEYLH---SLDIVYR 125

Query: 409 DIKPHNILLDEDFCPKISDFGLAK--------ICNRKESIISMTGARGTVGYIAPEVFCR 460
           D+KP N+LLD D   KI+DFG AK        +C             GT  Y+APE+   
Sbjct: 126 DLKPENLLLDSDGYIKITDFGFAKRVKGRTYTLC-------------GTPEYLAPEII-L 171

Query: 461 NIGEVSY-KS-DVYNYGMMIFEMTGG 484
           + G   Y K+ D +  G++I+EM  G
Sbjct: 172 SKG---YGKAVDWWALGILIYEMLAG 194

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubiquitously in cells and interacts with many different downstream targets. It plays a role in the regulation of diverse processes such as growth, development, memory, metabolism, gene expression, immunity, and lipolysis. Length = 290

>gnl|CDD|173720 cd05631, STKc_GRK4, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4

 Score = 60.0 bits (145), Expect = 6e-10
 Identities = 38/93 (40%), Positives = 53/93 (56%), Gaps = 8/93 (8%)

Query: 393 GLEYLHLGCSTRILHFDIKPHNILLDEDFCPKISDFGLAKICNRKESIISMTGARGTVGY 452
           GLE L      RI++ D+KP NILLD+    +ISD GLA      E++    G  GTVGY
Sbjct: 114 GLEDLQ---RERIVYRDLKPENILLDDRGHIRISDLGLAVQIPEGETV---RGRVGTVGY 167

Query: 453 IAPEVFCRNIGEVSYKSDVYNYGMMIFEMTGGR 485
           +APEV   N  + ++  D +  G +I+EM  G+
Sbjct: 168 MAPEVI--NNEKYTFSPDWWGLGCLIYEMIQGQ 198

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found in the testis, but is also present in the cerebellum and kidney. It is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK4 polymorphisms are associated with hypertension and salt sensitivity, as they cause hyperphosphorylation, desensitization, and internalization of the dopamine 1 (D1) receptor while increasing the expression of the angiotensin II type 1 receptor. GRK4 plays a crucial role in the D1 receptor regulation of sodium excretion and blood pressure. Length = 285

>gnl|CDD|133187 cd05056, PTKc_FAK, Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase

 Score = 59.7 bits (145), Expect = 7e-10
 Identities = 58/223 (26%), Positives = 92/223 (41%), Gaps = 49/223 (21%)

Query: 316 SFKYKLGQGGYGSVYKGKLLDGS----NVAVKVL-NDSKGNGKEFINEVASISRT-SHVN 369
           +    +G+G +G VY+G  +        VAVK   N +  + +E   + A I R   H +
Sbjct: 9   TLGRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSPSVREKFLQEAYIMRQFDHPH 68

Query: 370 VVALLGFC----------------LRV-----AEELSSTI------GIARGLEYLHLGCS 402
           +V L+G                  LR         L           ++  L YL    S
Sbjct: 69  IVKLIGVITENPVWIVMELAPLGELRSYLQVNKYSLDLASLILYSYQLSTALAYLE---S 125

Query: 403 TRILHFDIKPHNILLDEDFCPKISDFGLAKICNRKESIISMTGARGTVGYIAPEVFCRNI 462
            R +H DI   N+L+    C K+ DFGL++     ES    +  +  + ++APE    N 
Sbjct: 126 KRFVHRDIAARNVLVSSPDCVKLGDFGLSRYLE-DESYYKASKGKLPIKWMAPESI--NF 182

Query: 463 GEVSYKSDVYNYGMMIFE--MTG-----GRKNVDVV---DNGS 495
              +  SDV+ +G+ ++E  M G     G KN DV+   +NG 
Sbjct: 183 RRFTSASDVWMFGVCMWEILMLGVKPFQGVKNNDVIGRIENGE 225

Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions and at growth factor receptors. Through diverse molecular interactions, FAK functions as a biosensor or integrator to control cell motility. It is a key regulator of cell survival, proliferation, migration and invasion, and thus plays an important role in the development and progression of cancer. Src binds to autophosphorylated FAK forming the FAK-Src dual kinase complex, which is activated in a wide variety of tumor cells and generates signals promoting growth and metastasis. FAK is being developed as a target for cancer therapy. Length = 270

>gnl|CDD|173630 cd05044, PTKc_c-ros, Catalytic domain of the Protein Tyrosine Kinase, C-ros

 Score = 59.5 bits (144), Expect = 7e-10
 Identities = 60/228 (26%), Positives = 91/228 (39%), Gaps = 64/228 (28%)

Query: 321 LGQGGYGSVYKGKLLD-------GSNVAVKVLNDSKGNG----KEFINEVASISRTSHVN 369
           LG G +G VY+G   D          VAVK L   KG      KEF+ E   +S  +H N
Sbjct: 3   LGSGAFGEVYEGTATDILGPGSGPIRVAVKTLR--KGATDQEKKEFLKEAHLMSNFNHPN 60

Query: 370 VVALLGFC----------------------------------LRVAEELSSTIGIARGLE 395
           +V LLG C                                  L + E L   + +A+G  
Sbjct: 61  IVKLLGVCLLNEPQYIIMELMEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCV 120

Query: 396 YLHLGCSTRILHFDIKPHNILLDED--FCP---KISDFGLAKICNRKESIISMTGARGTV 450
           YL        +H D+   N L+ E         KI DFGLA+   + +           V
Sbjct: 121 YLE---QMHFIHRDLAARNCLVSEKGYDADRVVKIGDFGLARDIYKSDYYRKEGEGLLPV 177

Query: 451 GYIAPEVFCRNIGEVSYKSDVYNYGMMIFE-MTGG------RKNVDVV 491
            ++APE      G+ + +SDV+++G++++E +T G        N +V+
Sbjct: 178 RWMAPESLLD--GKFTTQSDVWSFGVLMWEILTLGQQPYPALNNQEVL 223

Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male mice bearing inactive mutations of c-ros lack the initial segment of the epididymis and are infertile. The Drosophila protein, Sevenless, is required for the specification of the R7 photoreceptor cell during eye development. Length = 269

>gnl|CDD|173631 cd05045, PTKc_RET, Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein

 Score = 59.6 bits (144), Expect = 7e-10
 Identities = 53/220 (24%), Positives = 95/220 (43%), Gaps = 64/220 (29%)

Query: 321 LGQGGYGSVYKG-----KLLDG-SNVAVKVL--NDSKGNGKEFINEVASISRTSHVNVVA 372
           LG+G +G V K      K   G + VAVK+L  N S    ++ ++E   + + +H +V+ 
Sbjct: 8   LGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENASSSELRDLLSEFNLLKQVNHPHVIK 67

Query: 373 LLGFC-----------------LRVAEELSSTIG-------------------------- 389
           L G C                 LR     S  +G                          
Sbjct: 68  LYGACSQDGPLLLIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTMG 127

Query: 390 --------IARGLEYLHLGCSTRILHFDIKPHNILLDEDFCPKISDFGLAKICNRKESII 441
                   I+RG++YL      +++H D+   N+L+ E    KISDFGL++    ++S +
Sbjct: 128 DLISFAWQISRGMQYL---AEMKLVHRDLAARNVLVAEGRKMKISDFGLSRDVYEEDSYV 184

Query: 442 SMTGARGTVGYIAPEVFCRNIGEVSYKSDVYNYGMMIFEM 481
             +  R  V ++A E    +I   + +SDV+++G++++E+
Sbjct: 185 KRSKGRIPVKWMAIESLFDHI--YTTQSDVWSFGVLLWEI 222

Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leading to autophosphorylation, activation, and intracellular signaling. RET is essential for the development of the sympathetic, parasympathetic and enteric nervous systems, and the kidney. RET disruption by germline mutations causes diseases in humans including congenital aganglionosis of the gastrointestinal tract (Hirschsprung's disease) and three related inherited cancers: multiple endocrine neoplasia type 2A (MEN2A), MEN2B, and familial medullary thyroid carcinoma (FMTC). Length = 290

>gnl|CDD|173703 cd05612, STKc_PRKX_like, Catalytic domain of PRKX-like Protein Serine/Threonine Kinases

 Score = 59.4 bits (144), Expect = 9e-10
 Identities = 41/116 (35%), Positives = 61/116 (52%), Gaps = 22/116 (18%)

Query: 378 LRVAEELSSTIG------IARGLEYLHLGCSTRILHFDIKPHNILLDEDFCPKISDFGLA 431
           LR +   S++ G      I   LEYLH   S  I++ D+KP NILLD++   K++DFG A
Sbjct: 92  LRNSGRFSNSTGLFYASEIVCALEYLH---SKEIVYRDLKPENILLDKEGHIKLTDFGFA 148

Query: 432 K-ICNRKESIISMTGARGTVGYIAPEVFCRNIGEVSYKS--DVYNYGMMIFEMTGG 484
           K + +R  ++       GT  Y+APEV    I    +    D +  G++I+EM  G
Sbjct: 149 KKLRDRTWTLC------GTPEYLAPEV----IQSKGHNKAVDWWALGILIYEMLVG 194

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyte/macrophage lineage differentiation, renal cell epithelial migration, and tubular morphogenesis in the developing kidney. Length = 291

>gnl|CDD|133194 cd05063, PTKc_EphR_A2, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2

 Score = 59.2 bits (143), Expect = 9e-10
 Identities = 52/207 (25%), Positives = 100/207 (48%), Gaps = 51/207 (24%)

Query: 321 LGQGGYGSVYKGKL-LDG---SNVAVKVLND--SKGNGKEFINEVASISRTSHVNVVALL 374
           +G G +G V++G L + G     VA+K L    ++   ++F++E + + + SH N++ L 
Sbjct: 13  IGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYTEKQRQDFLSEASIMGQFSHHNIIRLE 72

Query: 375 GFCLR------VAE----------------ELSSTI------GIARGLEYLHLGCSTRIL 406
           G   +      + E                E SS        GIA G++YL        +
Sbjct: 73  GVVTKFKPAMIITEYMENGALDKYLRDHDGEFSSYQLVGMLRGIAAGMKYL---SDMNYV 129

Query: 407 HFDIKPHNILLDEDFCPKISDFGLAKIC-NRKESIISMTGARGTVGYIAPEVFCRNIGEV 465
           H D+   NIL++ +   K+SDFGL+++  +  E   + +G +  + + APE        +
Sbjct: 130 HRDLAARNILVNSNLECKVSDFGLSRVLEDDPEGTYTTSGGKIPIRWTAPEA-------I 182

Query: 466 SYK-----SDVYNYGMMIFE-MTGGRK 486
           +Y+     SDV+++G++++E M+ G +
Sbjct: 183 AYRKFTSASDVWSFGIVMWEVMSFGER 209

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. The EphA2 receptor is overexpressed in tumor cells and tumor blood vessels in a variety of cancers including breast, prostate, lung, and colon. As a result, it is an attractive target for drug design since its inhibition could affect several aspects of tumor progression. Length = 268

>gnl|CDD|133192 cd05061, PTKc_InsR, Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor

 Score = 59.2 bits (143), Expect = 1e-09
 Identities = 55/210 (26%), Positives = 94/210 (44%), Gaps = 54/210 (25%)

Query: 320 KLGQGGYGSVYKGKLLD------GSNVAVKVLNDSKGNGK--EFINEVASISRTSHVNVV 371
           +LGQG +G VY+G   D       + VAVK +N+S    +  EF+NE + +   +  +VV
Sbjct: 13  ELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVV 72

Query: 372 ALLGF------------------------CLR-------------VAEELSSTIGIARGL 394
            LLG                          LR             + E +     IA G+
Sbjct: 73  RLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGM 132

Query: 395 EYLHLGCSTRILHFDIKPHNILLDEDFCPKISDFGLAKICNRKESIISMTGARG--TVGY 452
            YL+   + + +H D+   N ++  DF  KI DFG+ +  +  E+     G +G   V +
Sbjct: 133 AYLN---AKKFVHRDLAARNCMVAHDFTVKIGDFGMTR--DIYETDYYRKGGKGLLPVRW 187

Query: 453 IAPEVFCRNIGEVSYKSDVYNYGMMIFEMT 482
           +APE      G  +  SD++++G++++E+T
Sbjct: 188 MAPESL--KDGVFTTSSDMWSFGVVLWEIT 215

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein metabolism, ion and amino acid transport, cell cycle and proliferation, cell differentiation, gene transcription, and nitric oxide synthesis. Insulin resistance, caused by abnormalities in InsR signaling, has been described in diabetes, hypertension, cardiovascular disease, metabolic syndrome, heart failure, and female infertility. Length = 288

>gnl|CDD|173750 cd07857, STKc_MPK1, Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1

 Score = 59.3 bits (144), Expect = 1e-09
 Identities = 39/108 (36%), Positives = 56/108 (51%), Gaps = 9/108 (8%)

Query: 390 IARGLEYLHLGCSTRILHFDIKPHNILLDEDFCPKISDFGLAKIC--NRKESIISMTGAR 447
           I  GL+Y+H   S  +LH D+KP N+L++ D   KI DFGLA+    N  E+   MT   
Sbjct: 114 ILCGLKYIH---SANVLHRDLKPGNLLVNADCELKICDFGLARGFSENPGENAGFMTEYV 170

Query: 448 GTVGYIAPEVFCRNIGEVSYKSDVYNYGMMIFEMTGGR---KNVDVVD 492
            T  Y APE+        +   DV++ G ++ E+ G +   K  D VD
Sbjct: 171 ATRWYRAPEIMLSF-QSYTKAIDVWSVGCILAELLGRKPVFKGKDYVD 217

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall construction, morphogenesis, and ion homeostasis. MPK1 is activated in response to cell wall stress including heat stimulation, osmotic shock, UV irradiation, and any agents that interfere with cell wall biogenesis such as chitin antagonists, caffeine, or zymolase. MPK1 is regulated by the MAP2Ks Mkk1/2, which are regulated by the MAP3K Bck1. Pmk1 is also activated by multiple stresses including elevated temperatures, hyper- or hypotonic stress, glucose deprivation, exposure to cell-wall damaging compounds, and oxidative stress. It is regulated by the MAP2K Pek1, which is regulated by the MAP3K Mkh1. Length = 332

>gnl|CDD|132965 cd06634, STKc_TAO2, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2

 Score = 59.3 bits (143), Expect = 1e-09
 Identities = 56/200 (28%), Positives = 86/200 (43%), Gaps = 43/200 (21%)

Query: 320 KLGQGGYGSVYKGK-LLDGSNVAVKVLNDSKGNGKE----FINEVASISRTSHVNVVALL 374
           ++G G +G+VY  + + +   VA+K ++ S     E     I EV  + +  H N +   
Sbjct: 22  EIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYR 81

Query: 375 G-------------FCLRVAEEL--------------SSTIGIARGLEYLHLGCSTRILH 407
           G             +CL  A +L              + T G  +GL YLH   S  ++H
Sbjct: 82  GCYLREHTAWLVMEYCLGSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLH---SHNMIH 138

Query: 408 FDIKPHNILLDEDFCPKISDFGLAKICNRKESIISMTGARGTVGYIAPEV-FCRNIGEVS 466
            D+K  NILL E    K+ DFG A I       +      GT  ++APEV    + G+  
Sbjct: 139 RDVKAGNILLSEPGLVKLGDFGSASIMAPANXFV------GTPYWMAPEVILAMDEGQYD 192

Query: 467 YKSDVYNYGMMIFEMTGGRK 486
            K DV++ G+   E+   RK
Sbjct: 193 GKVDVWSLGITCIEL-AERK 211

Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. TAO2 contains a long C-terminal extension with autoinhibitory segments. It is activated by the release of this inhibition and the phosphorylation of its activation loop serine. TAO2 functions as a regulator of actin cytoskeletal and microtubule organization. In addition, it regulates the transforming growth factor-activated kinase 1 (TAK1), which is a MAPKKK that plays an essential role in the signaling pathways of tumor necrosis factor (TNF), interleukin 1 (IL-1), and Toll-like receptor (TLR). Length = 308

>gnl|CDD|133212 cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

 Score = 59.0 bits (143), Expect = 1e-09
 Identities = 55/199 (27%), Positives = 88/199 (44%), Gaps = 44/199 (22%)

Query: 321 LGQGGYGSVYKGK---LLD--GSNVAVKVL-NDSKGNGKEFINEVASISRTSHVNVVALL 374
           LG+G +GSV   +   L D  G  VAVK L + +  + ++F  E+  +    H N+V   
Sbjct: 12  LGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHSTAEHLRDFEREIEILKSLQHDNIVKYK 71

Query: 375 GFC-------LRVAEE-----------------------LSSTIGIARGLEYLHLGCSTR 404
           G C       LR+  E                       L     I +G+EYL    S R
Sbjct: 72  GVCYSAGRRNLRLVMEYLPYGSLRDYLQKHRERLDHRKLLLYASQICKGMEYLG---SKR 128

Query: 405 ILHFDIKPHNILLDEDFCPKISDFGLAKI--CNRKESIISMTGARGTVGYIAPEVFCRNI 462
            +H D+   NIL++ +   KI DFGL K+   +++   +   G      Y APE    + 
Sbjct: 129 YVHRDLATRNILVESENRVKIGDFGLTKVLPQDKEYYKVREPGESPIFWY-APESLTESK 187

Query: 463 GEVSYKSDVYNYGMMIFEM 481
              S  SDV+++G++++E+
Sbjct: 188 --FSVASDVWSFGVVLYEL 204

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 284

>gnl|CDD|133246 cd05115, PTKc_Zap-70, Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa

 Score = 58.8 bits (142), Expect = 1e-09
 Identities = 53/194 (27%), Positives = 90/194 (46%), Gaps = 38/194 (19%)

Query: 320 KLGQGGYGSVYKG------KLLDGSNVAVKVL--NDSKGNGKEFINEVASISRTSHVNVV 371
           +LG G +G V KG      K +D   VA+KVL   + K    E + E   + +  +  +V
Sbjct: 2   ELGSGNFGCVKKGVYKMRKKQID---VAIKVLKNENEKSVRDEMMREAEIMHQLDNPYIV 58

Query: 372 ALLGFC----LRVAEELSS-------------TIGIARGLEYLH---LGCS----TRILH 407
            ++G C    L +  E++S              I ++  +E +H   +G         +H
Sbjct: 59  RMIGVCEAEALMLVMEMASGGPLNKFLSGKKDEITVSNVVELMHQVSMGMKYLEGKNFVH 118

Query: 408 FDIKPHNILLDEDFCPKISDFGLAKICNRKESII-SMTGARGTVGYIAPEVFCRNIGEVS 466
            D+   N+LL      KISDFGL+K     +S   + +  +  + + APE  C N  + S
Sbjct: 119 RDLAARNVLLVNQHYAKISDFGLSKALGADDSYYKARSAGKWPLKWYAPE--CINFRKFS 176

Query: 467 YKSDVYNYGMMIFE 480
            +SDV++YG+ ++E
Sbjct: 177 SRSDVWSYGITMWE 190

Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its phosphorylation and activation. It then phosphorylates target proteins, which propagate the signals to downstream pathways. Zap-70 is hardly detected in normal peripheral B-cells, but is present in some B-cell malignancies. It is used as a diagnostic marker for chronic lymphocytic leukemia (CLL) as it is associated with the more aggressive subtype of the disease. Length = 257

>gnl|CDD|133247 cd05116, PTKc_Syk, Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase

 Score = 58.4 bits (141), Expect = 2e-09
 Identities = 54/196 (27%), Positives = 90/196 (45%), Gaps = 42/196 (21%)

Query: 320 KLGQGGYGSVYKG--KLLDGSN-VAVKVLNDSKGNGK---EFINEVASISRTSHVNVVAL 373
           +LG G +G+V KG  K+      VAVK+L +   +     E + E   + +  +  +V +
Sbjct: 2   ELGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNNDPALKDELLREANVMQQLDNPYIVRM 61

Query: 374 LGFC--------LRVAE--------------------ELSSTIGIARGLEYLHLGCSTRI 405
           +G C        + +AE                    EL   + +  G++YL     T  
Sbjct: 62  IGICEAESWMLVMELAELGPLNKFLQKNKHVTEKNITELVHQVSM--GMKYLE---ETNF 116

Query: 406 LHFDIKPHNILLDEDFCPKISDFGLAKICNRKESII-SMTGARGTVGYIAPEVFCRNIGE 464
           +H D+   N+LL      KISDFGL+K     E+   + T  +  V + APE  C N  +
Sbjct: 117 VHRDLAARNVLLVTQHYAKISDFGLSKALGADENYYKAKTHGKWPVKWYAPE--CMNYYK 174

Query: 465 VSYKSDVYNYGMMIFE 480
            S KSDV+++G++++E
Sbjct: 175 FSSKSDVWSFGVLMWE 190

Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. More recently, Syk expression has been detected in other cell types (including epithelial cells, vascular endothelial cells, neurons, hepatocytes, and melanocytes), suggesting a variety of biological functions in non-immune cells. Syk plays a critical role in maintaining vascular integrity and in wound healing during embryogenesis. It also regulates Vav3, which is important in osteoclast function including bone development. In breast epithelial cells, where Syk acts as a negative regulator for epidermal growth factor receptor (EGFR) signaling, loss of Syk expression is associated with abnormal proliferation during cancer development suggesting a potential role as a tumor suppressor. In mice, Syk has been shown to inhibit malignant transformation of mammary epithelial cells induced with murine mammary tumor virus (MMTV). Length = 257

>gnl|CDD|173702 cd05611, STKc_Rim15_like, Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases

 Score = 58.3 bits (141), Expect = 2e-09
 Identities = 53/199 (26%), Positives = 78/199 (39%), Gaps = 52/199 (26%)

Query: 323 QGGYGSVYKG-KLLDGSNVAVKVLNDSKGNGKEFINEVASISRTSHV-----NVVALL-- 374
           +G +GSVY   K   G   A+KVL  S    K  +  V +      +      V  L   
Sbjct: 6   KGAFGSVYLAKKRSTGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVAKLYYS 65

Query: 375 ----------------GFCLRVAEELSSTIG-------------IARGLEYLHLGCSTRI 405
                           G C      L  T+G             +  G+E LH      I
Sbjct: 66  FQSKDYLYLVMEYLNGGDC----ASLIKTLGGLPEDWAKQYIAEVVLGVEDLH---QRGI 118

Query: 406 LHFDIKPHNILLDEDFCPKISDFGLAKICNRKESIISMTGARGTVGYIAPEVFCRNIGEV 465
           +H DIKP N+L+D+    K++DFGL++     +  +      GT  Y+APE     +G+ 
Sbjct: 119 IHRDIKPENLLIDQTGHLKLTDFGLSRNGLENKKFV------GTPDYLAPETI-LGVGDD 171

Query: 466 SYKSDVYNYGMMIFEMTGG 484
              SD ++ G +IFE   G
Sbjct: 172 K-MSDWWSLGCVIFEFLFG 189

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a downstream effector of PKA and regulates entry into stationary phase (G0). Thus, it plays a crucial role in regulating yeast proliferation, differentiation, and aging. Cek1 may facilitate progression of mitotic anaphase. Length = 260

>gnl|CDD|173769 cd08229, STKc_Nek7, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7

 Score = 58.1 bits (140), Expect = 2e-09
 Identities = 56/202 (27%), Positives = 91/202 (45%), Gaps = 51/202 (25%)

Query: 320 KLGQGGYGSVYKGK-LLDGSNVAVKV-----LNDSKGNGKEFINEVASISRTSHVNVVAL 373
           K+G+G +  VY+   LLDG  VA+K      L D+K    + I E+  + + +H NV+  
Sbjct: 9   KIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKAR-ADCIKEIDLLKQLNHPNVIKY 67

Query: 374 ---------LGFCLRVAE--ELSSTI--------------------GIARGLEYLHLGCS 402
                    L   L +A+  +LS  I                     +   LE++H   S
Sbjct: 68  YASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALEHMH---S 124

Query: 403 TRILHFDIKPHNILLDEDFCPKISDFGLAKICNRKESIISMTGARGTVG---YIAPEVFC 459
            R++H DIKP N+ +      K+ D GL +  + K      T A   VG   Y++PE   
Sbjct: 125 RRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSK-----TTAAHSLVGTPYYMSPERIH 179

Query: 460 RNIGEVSYKSDVYNYGMMIFEM 481
            N    ++KSD+++ G +++EM
Sbjct: 180 EN--GYNFKSDIWSLGCLLYEM 199

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. Length = 267

>gnl|CDD|133186 cd05055, PTKc_PDGFR, Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors

 Score = 58.7 bits (142), Expect = 2e-09
 Identities = 56/204 (27%), Positives = 92/204 (45%), Gaps = 43/204 (21%)

Query: 316 SFKYKLGQGGYGSVYKGKLLDGSN------VAVKVLNDS-KGNGKE-FINEVASISRT-S 366
           SF   LG G +G V +      S       VAVK+L  +   + +E  ++E+  +S   +
Sbjct: 38  SFGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAHSSEREALMSELKIMSHLGN 97

Query: 367 HVNVVALLGFC---------------------LRVAEE--------LSSTIGIARGLEYL 397
           H N+V LLG C                     LR   E        LS +  +A+G+ +L
Sbjct: 98  HENIVNLLGACTIGGPILVITEYCCYGDLLNFLRRKRESFLTLEDLLSFSYQVAKGMAFL 157

Query: 398 HLGCSTRILHFDIKPHNILLDEDFCPKISDFGLAKICNRKESIISMTGARGTVGYIAPEV 457
               S   +H D+   N+LL      KI DFGLA+      + +    AR  V ++APE 
Sbjct: 158 ---ASKNCIHRDLAARNVLLTHGKIVKICDFGLARDIMNDSNYVVKGNARLPVKWMAPES 214

Query: 458 FCRNIGEVSYKSDVYNYGMMIFEM 481
               +   +++SDV++YG++++E+
Sbjct: 215 IFNCV--YTFESDVWSYGILLWEI 236

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR subfamily receptors are important in the development of a variety of cells. PDGFRs are expressed in a many cells including fibroblasts, neurons, endometrial cells, mammary epithelial cells, and vascular smooth muscle cells. PDGFR signaling is critical in normal embryonic development, angiogenesis, and wound healing. PDGFRs transduce mitogenic signals for connective tissue cells and are important for cell shape and motility. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. Mammalian FLT3 plays an important role in the survival, proliferation, and differentiation of stem cells. Length = 302

>gnl|CDD|132961 cd06630, STKc_MEKK1, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1

 Score = 58.0 bits (140), Expect = 2e-09
 Identities = 56/212 (26%), Positives = 89/212 (41%), Gaps = 61/212 (28%)

Query: 321 LGQGGYGSVYKGK-LLDGSNVAVKVLNDSKGNGKE-------FINEVASISRTSHVNVVA 372
           LG G + S Y+ + +  G+ +AVK +   +    E          E+  ++R +H +++ 
Sbjct: 8   LGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHIIR 67

Query: 373 LLGFCLR---------------VAEELSS------------TIGIARGLEYLHLGCSTRI 405
           +LG                   V+  LS             T  + RGL YLH     +I
Sbjct: 68  MLGATCEDSHFNLFVEWMAGGSVSHLLSKYGAFKEAVIINYTEQLLRGLSYLH---ENQI 124

Query: 406 LHFDIKPHNILLD---EDFCPKISDFGLAKICNRKESIISMTGAR-------GTVGYIAP 455
           +H D+K  N+L+D   +    +I+DFG A     K      TGA        GT+ ++AP
Sbjct: 125 IHRDVKGANLLIDSTGQRL--RIADFGAAARLAAK-----GTGAGEFQGQLLGTIAFMAP 177

Query: 456 EVFCRNIGEVSY--KSDVYNYGMMIFEMTGGR 485
           EV     GE  Y    DV++ G +I EM   +
Sbjct: 178 EVL---RGE-QYGRSCDVWSVGCVIIEMATAK 205

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their respective MAPKKs, MEK1/2 and MKK4/MKK7, respectively. MEKK1 is important in regulating cell survival and apoptosis. MEKK1 also plays a role in cell migration, tissue maintenance and homeostasis, and wound healing. Length = 268

>gnl|CDD|132989 cd06658, STKc_PAK5, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5

 Score = 58.1 bits (140), Expect = 2e-09
 Identities = 61/211 (28%), Positives = 98/211 (46%), Gaps = 48/211 (22%)

Query: 308 ADIKKMTNSFKYKLGQGGYGSV-YKGKLLDGSNVAVKVLNDSKGNGKEFI-NEVASISRT 365
            D ++  +SF  K+G+G  G V    +   G  VAVK ++  K   +E + NEV  +   
Sbjct: 18  GDPREYLDSF-IKIGEGSTGIVCIATEKHTGKQVAVKKMDLRKQQRRELLFNEVVIMRDY 76

Query: 366 SHVNVVALLGFCL------------------------RVAEELSSTI--GIARGLEYLHL 399
            H NVV +    L                        R+ EE  +T+   + R L YLH 
Sbjct: 77  HHENVVDMYNSYLVGDELWVVMEFLEGGALTDIVTHTRMNEEQIATVCLSVLRALSYLH- 135

Query: 400 GCSTRILHFDIKPHNILLDEDFCPKISDFG----LAKICNRKESIISMTGARGTVGYIAP 455
             +  ++H DIK  +ILL  D   K+SDFG    ++K   +++S++      GT  ++AP
Sbjct: 136 --NQGVIHRDIKSDSILLTSDGRIKLSDFGFCAQVSKEVPKRKSLV------GTPYWMAP 187

Query: 456 EVFCRNIGEVSYKS--DVYNYGMMIFEMTGG 484
           EV  R    + Y +  D+++ G+M+ EM  G
Sbjct: 188 EVISR----LPYGTEVDIWSLGIMVIEMIDG 214

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly expressed in the brain. It is not required for viability, but together with PAK6, it is required for normal levels of locomotion and activity, and for learning and memory. PAK5 cooperates with Inca (induced in neural crest by AP2) in the regulation of cell adhesion and cytoskeletal organization in the embryo and in neural crest cells during craniofacial development. PAK5 may also play a role in controlling the signaling of Raf-1, an effector of Ras, at the mitochondria. Length = 292

>gnl|CDD|173754 cd07865, STKc_CDK9, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9

 Score = 58.5 bits (142), Expect = 2e-09
 Identities = 52/205 (25%), Positives = 81/205 (39%), Gaps = 49/205 (23%)

Query: 320 KLGQGGYGSVYKGK-LLDGSNVAVK---VLNDSKGNGKEFINEVASISRTSHVNVVAL-- 373
           K+GQG +G V+K +       VA+K   + N+ +G     + E+  +    H NVV L  
Sbjct: 19  KIGQGTFGEVFKARHKKTKQIVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIE 78

Query: 374 -------------------LGFCLRVAEELSSTIGIA--------------RGLEYLHLG 400
                                FC      L S   +                GL Y+H  
Sbjct: 79  ICRTKATPYNRYKGSFYLVFEFCEHDLAGLLSNKNVKFTLSEIKKVMKMLLNGLYYIH-- 136

Query: 401 CSTRILHFDIKPHNILLDEDFCPKISDFGLAK--ICNRKESIISMTGARGTVGYIAPEVF 458
              +ILH D+K  NIL+ +D   K++DFGLA+    ++       T    T+ Y  PE+ 
Sbjct: 137 -RNKILHRDMKAANILITKDGILKLADFGLARAFSLSKNSKPNRYTNRVVTLWYRPPELL 195

Query: 459 --CRNIGEVSYKSDVYNYGMMIFEM 481
              R+ G      D++  G ++ EM
Sbjct: 196 LGERDYGP---PIDMWGAGCIMAEM 217

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multiple steps of gene expression including transcription elongation, mRNA synthesis, processing, export, and translation. It also plays a role in mediating cytokine induced transcription networks such as IL6-induced STAT3 signaling. In addition, the CDK9/cyclin T2a complex promotes muscle differentiation and enhances the function of some myogenic regulatory factors. Length = 310

>gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional

 Score = 59.5 bits (144), Expect = 3e-09
 Identities = 50/195 (25%), Positives = 87/195 (44%), Gaps = 37/195 (18%)

Query: 321 LGQGGYGSVYKGKLL-DGSNVAVKVLNDSKGNGKEFINEVASISRTSHVNVVALLGFCL- 378
           + +G  G+ YKGK + +G    VK +ND         +E+A + +  H N+V L+G C  
Sbjct: 698 ISRGKKGASYKGKSIKNGMQFVVKEINDVNSIPS---SEIADMGKLQHPNIVKLIGLCRS 754

Query: 379 --------------RVAEELSS---------TIGIARGLEYLHLGCSTRILHFDIKPHNI 415
                          ++E L +          IGIA+ L +LH  CS  ++  ++ P  I
Sbjct: 755 EKGAYLIHEYIEGKNLSEVLRNLSWERRRKIAIGIAKALRFLHCRCSPAVVVGNLSPEKI 814

Query: 416 LLDEDFCPKISDFGLAKICNRKESIISMTGARGTVGYIAPEVFCRNIGEVSYKSDVYNYG 475
           ++D    P +       +C   +  IS         Y+APE   R   +++ KSD+Y +G
Sbjct: 815 IIDGKDEPHLRLSLPGLLCTDTKCFIS-------SAYVAPET--RETKDITEKSDIYGFG 865

Query: 476 MMIFEMTGGRKNVDV 490
           +++ E+  G+   D 
Sbjct: 866 LILIELLTGKSPADA 880

Length = 968

>gnl|CDD|173765 cd08225, STKc_Nek5, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5

 Score = 57.7 bits (139), Expect = 3e-09
 Identities = 53/200 (26%), Positives = 91/200 (45%), Gaps = 49/200 (24%)

Query: 320 KLGQGGYGSVY--KGKLLDGSNVAVKVLNDSKGNGKE---FINEVASISRTSHVNVVALL 374
           K+G+G +G +Y  K K  D  +  +K ++ +K   KE      EV  +++  H N+V   
Sbjct: 7   KIGEGSFGKIYLAKAKS-DSEHCVIKEIDLTKMPVKEKEASKKEVILLAKMKHPNIVTFF 65

Query: 375 -----------------------------GFCLRVAEELSSTIGIARGLEYLHLGCSTRI 405
                                        G      + LS  + I+ GL+++H     +I
Sbjct: 66  ASFQENGRLFIVMEYCDGGDLMKRINRQRGVLFSEDQILSWFVQISLGLKHIH---DRKI 122

Query: 406 LHFDIKPHNILLDED-FCPKISDFGLAKICNRKESIISMTGARGTVG---YIAPEVFCRN 461
           LH DIK  NI L ++    K+ DFG+A+  N      SM  A   VG   Y++PE+ C+N
Sbjct: 123 LHRDIKSQNIFLSKNGMVAKLGDFGIARQLND-----SMELAYTCVGTPYYLSPEI-CQN 176

Query: 462 IGEVSYKSDVYNYGMMIFEM 481
               + K+D+++ G +++E+
Sbjct: 177 -RPYNNKTDIWSLGCVLYEL 195

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. Length = 257

>gnl|CDD|132974 cd06643, STKc_SLK, Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase

 Score = 57.7 bits (139), Expect = 3e-09
 Identities = 54/199 (27%), Positives = 90/199 (45%), Gaps = 46/199 (23%)

Query: 320 KLGQGGYGSVYKGKLLDGSNVAVKVLNDSKGNG--KEFINEVASISRTSHVNVVALLG-- 375
           +LG G +G VYK +  +   +A   + D+K     ++++ E+  ++   H N+V LL   
Sbjct: 12  ELGDGAFGKVYKAQNKETGVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAF 71

Query: 376 -----------FC---------LRVAEELS-STIGIA-----RGLEYLHLGCSTRILHFD 409
                      FC         L +   L+   I +        L YLH     +I+H D
Sbjct: 72  YYENNLWILIEFCAGGAVDAVMLELERPLTEPQIRVVCKQTLEALNYLH---ENKIIHRD 128

Query: 410 IKPHNILLDEDFCPKISDFGLA----KICNRKESIISMTGARGTVGYIAPE-VFCRNIGE 464
           +K  NIL   D   K++DFG++    +   R++S I      GT  ++APE V C    +
Sbjct: 129 LKAGNILFTLDGDIKLADFGVSAKNTRTIQRRDSFI------GTPYWMAPEVVMCETSKD 182

Query: 465 --VSYKSDVYNYGMMIFEM 481
               YK+DV++ G+ + EM
Sbjct: 183 RPYDYKADVWSLGITLIEM 201

Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. Length = 282

>gnl|CDD|173647 cd05091, PTKc_Ror2, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2

 Score = 57.3 bits (138), Expect = 4e-09
 Identities = 62/243 (25%), Positives = 100/243 (41%), Gaps = 65/243 (26%)

Query: 309 DIKKMTNSFKYKLGQGGYGSVYKGKLLDGS------NVAVKVLNDSKGNG---KEFINEV 359
           +I   T  F  +LG+  +G VYKG L   +       VA+K L D K  G   +EF +E 
Sbjct: 1   EINLSTVRFMEELGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKD-KAEGPLREEFKHEA 59

Query: 360 ASISRTSHVNVVALLG-------------FC----------------------------- 377
              SR  H N+V LLG             +C                             
Sbjct: 60  MMRSRLQHPNIVCLLGVVTKEQPLSMIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKS 119

Query: 378 -LRVAEELSSTIGIARGLEYLHLGCSTRILHFDIKPHNILLDEDFCPKISDFGLAKICNR 436
            L  A+ +     IA G+E+L    S  ++H D+   N+L+ +    KISD GL +    
Sbjct: 120 TLEPADFVHIVTQIAAGMEFLS---SHHVVHKDLATRNVLVFDKLNVKISDLGLFREVYA 176

Query: 437 KESIISMTGARGTVGYIAPEVFCRNIGEVSYKSDVYNYGMMIFEMTG-------GRKNVD 489
            +    M  +   + +++PE      G+ S  SD+++YG++++E+         G  N D
Sbjct: 177 ADYYKLMGNSLLPIRWMSPEAIM--YGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSNQD 234

Query: 490 VVD 492
           V++
Sbjct: 235 VIE 237

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror2 plays important roles in skeletal and heart formation. Ror2-deficient mice show widespread bone abnormalities, ventricular defects in the heart, and respiratory dysfunction. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Ror2 is also implicated in neural development. Length = 283

>gnl|CDD|173664 cd05573, STKc_ROCK_NDR_like, Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases

 Score = 58.1 bits (141), Expect = 4e-09
 Identities = 33/116 (28%), Positives = 48/116 (41%), Gaps = 34/116 (29%)

Query: 394 LEYLH-LGCSTRILHFDIKPHNILLDEDFCPKISDFGLAKICNRKESIISMTGAR----- 447
           L+ +H LG     +H DIKP NIL+D D   K++DFGL K  N+ +              
Sbjct: 114 LDSVHKLGF----IHRDIKPDNILIDADGHIKLADFGLCKKMNKAKDREYYLNDSHNLLF 169

Query: 448 ----------------------GTVGYIAPEVFCRNIGEVSYKSDVYNYGMMIFEM 481
                                 GT  YIAPEV          + D ++ G++++EM
Sbjct: 170 RDNVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRGT--PYGLECDWWSLGVILYEM 223

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Proteins in this subfamily are involved in regulating many cellular functions including contraction, motility, division, proliferation, apoptosis, morphogenesis, and cytokinesis. Length = 350

>gnl|CDD|133193 cd05062, PTKc_IGF-1R, Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor

 Score = 57.4 bits (138), Expect = 5e-09
 Identities = 53/209 (25%), Positives = 93/209 (44%), Gaps = 54/209 (25%)

Query: 320 KLGQGGYGSVYKG------KLLDGSNVAVKVLNDSKGNGK--EFINEVASISRTSHVNVV 371
           +LGQG +G VY+G      K    + VA+K +N++    +  EF+NE + +   +  +VV
Sbjct: 13  ELGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVV 72

Query: 372 ALLGFC------------------------LRVAEELSSTIG-------------IARGL 394
            LLG                          LR   E +                 IA G+
Sbjct: 73  RLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADGM 132

Query: 395 EYLHLGCSTRILHFDIKPHNILLDEDFCPKISDFGLAKICNRKESIISMTGARG--TVGY 452
            YL+   + + +H D+   N ++ EDF  KI DFG+ +  +  E+     G +G   V +
Sbjct: 133 AYLN---ANKFVHRDLAARNCMVAEDFTVKIGDFGMTR--DIYETDYYRKGGKGLLPVRW 187

Query: 453 IAPEVFCRNIGEVSYKSDVYNYGMMIFEM 481
           ++PE      G  +  SDV+++G++++E+
Sbjct: 188 MSPESL--KDGVFTTYSDVWSFGVVLWEI 214

Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, where it is frequently overexpressed, IGF-1R is implicated in proliferation, the suppression of apoptosis, invasion, and metastasis. IGF-1R is being developed as a therapeutic target in cancer treatment. Length = 277

>gnl|CDD|173638 cd05065, PTKc_EphR_B, Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors

 Score = 56.8 bits (137), Expect = 5e-09
 Identities = 56/221 (25%), Positives = 101/221 (45%), Gaps = 59/221 (26%)

Query: 321 LGQGGYGSVYKGKL-LDGSN---VAVKVLND--SKGNGKEFINEVASISRTSHVNVVALL 374
           +G G +G V +G+L L G     VA+K L    ++   ++F++E + + +  H N++ L 
Sbjct: 12  IGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNIIHLE 71

Query: 375 GFC---------------------LRVAEELSSTI-------GIARGLEYLHLGCSTRIL 406
           G                       LR  +   + I       GIA G++YL        +
Sbjct: 72  GVVTKSRPVMIITEFMENGALDSFLRQNDGQFTVIQLVGMLRGIAAGMKYL---SEMNYV 128

Query: 407 HFDIKPHNILLDEDFCPKISDFGLAKICNRKESIISMTGARG---TVGYIAPEVFCRNIG 463
           H D+   NIL++ +   K+SDFGL++      S  + T + G    + + APE       
Sbjct: 129 HRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSSLGGKIPIRWTAPEA------ 182

Query: 464 EVSYK-----SDVYNYGMMIFE-MTGGRK------NVDVVD 492
            ++Y+     SDV++YG++++E M+ G +      N DV++
Sbjct: 183 -IAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQDVIN 222

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion. EphBRs play important roles in synapse formation and plasticity, spine morphogenesis, axon guidance, and angiogenesis. In the intestinal epithelium, EphBRs are Wnt signaling target genes that control cell compartmentalization. They function as suppressors of color cancer progression. Length = 269

>gnl|CDD|143382 cd07877, STKc_p38alpha_MAPK14, Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase

 Score = 57.7 bits (139), Expect = 5e-09
 Identities = 36/96 (37%), Positives = 54/96 (56%), Gaps = 9/96 (9%)

Query: 390 IARGLEYLHLGCSTRILHFDIKPHNILLDEDFCPKISDFGLAKICNRKESIISMTGARGT 449
           I RGL+Y+H   S  I+H D+KP N+ ++ED   KI DFGLA+  + +     MTG   T
Sbjct: 129 ILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDE-----MTGYVAT 180

Query: 450 VGYIAPEVFCRNIGEVSYKSDVYNYGMMIFEMTGGR 485
             Y APE+   N    +   D+++ G ++ E+  GR
Sbjct: 181 RWYRAPEIML-NWMHYNQTVDIWSVGCIMAELLTGR 215

Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14, is expressed in most tissues and is the major isoform involved in the immune and inflammatory response. It is the central p38 MAPK involved in myogenesis. It plays a role in regulating cell cycle check-point transition and promoting cell differentiation. p38alpha also regulates cell proliferation and death through crosstalk with the JNK pathway. Its substrates include MAPK activated protein kinase 2 (MK2), MK5, and the transcription factors ATF2 and Mitf. Length = 345

>gnl|CDD|173697 cd05606, STKc_beta_ARK, Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase

 Score = 57.3 bits (138), Expect = 5e-09
 Identities = 38/97 (39%), Positives = 58/97 (59%), Gaps = 12/97 (12%)

Query: 390 IARGLEYLHLGCSTRILHFDIKPHNILLDEDFCPKISDFGLAKICNRKESIISMTGARGT 449
           I  GLE++H   +  +++ D+KP NILLDE    +ISD GLA   ++K+   S+    GT
Sbjct: 106 IILGLEHMH---NRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHASV----GT 158

Query: 450 VGYIAPEVFCRNIGEVSYKS--DVYNYGMMIFEMTGG 484
            GY+APEV  +    V+Y S  D ++ G M+F++  G
Sbjct: 159 HGYMAPEVLQKG---VAYDSSADWFSLGCMLFKLLRG 192

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is composed of GRK2, GRK3, and similar proteins. GRK2 and GRK3 are both widely expressed in many tissues, although GRK2 is present at higher levels. They contain an N-terminal RGS homology (RH) domain, a central catalytic domain, and C-terminal pleckstrin homology (PH) domain that mediates PIP2 and G protein betagamma-subunit translocation to the membrane. GRK2 (also called beta-ARK or beta-ARK1) is important in regulating several cardiac receptor responses. It plays a role in cardiac development and in hypertension. Deletion of GRK2 in mice results in embryonic lethality, caused by hypoplasia of the ventricular myocardium. GRK2 also plays important roles in the liver (as a regulator of portal blood pressure), in immune cells, and in the nervous system. Altered GRK2 expression has been reported in several disorders including major depression, schizophrenia, bipolar disorder, and Parkinsonism. Length = 278

>gnl|CDD|132940 cd06609, STKc_MST3_like, Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases

 Score = 56.9 bits (138), Expect = 5e-09
 Identities = 50/199 (25%), Positives = 86/199 (43%), Gaps = 46/199 (23%)

Query: 320 KLGQGGYGSVYKGKLLD-GSNVAVKVLN-DSKGNGKEFIN-EVASISRTSHVNVVALLG- 375
            +G+G +G VYK         VA+KV++ +   +  E I  E+  +S+     +    G 
Sbjct: 8   CIGKGSFGEVYKAIDKRTNQVVAIKVIDLEEAEDEIEDIQQEIQFLSQCRSPYITKYYGS 67

Query: 376 ------------FC--------LR---VAEELSSTI--GIARGLEYLHLGCSTRILHFDI 410
                       +C        L+   + E   + I   +  GLEYLH       +H DI
Sbjct: 68  FLKGSKLWIIMEYCGGGSCLDLLKPGKLDETYIAFILREVLLGLEYLH---EEGKIHRDI 124

Query: 411 KPHNILLDEDFCPKISDFGLAKICNRKESIISMTGAR-----GTVGYIAPEVFCRNIGEV 465
           K  NILL E+   K++DFG++         ++ T ++     GT  ++APEV  +     
Sbjct: 125 KAANILLSEEGDVKLADFGVS-------GQLTSTMSKRNTFVGTPFWMAPEVIKQ--SGY 175

Query: 466 SYKSDVYNYGMMIFEMTGG 484
             K+D+++ G+   E+  G
Sbjct: 176 DEKADIWSLGITAIELAKG 194

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) signaling pathway, and plays a role in cytokinesis. SPS1 plays a role in regulating proteins required for spore wall formation. MST4 plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. STK25 may play a role in the regulation of cell migration and polarization. Length = 274

>gnl|CDD|173663 cd05572, STKc_cGK_PKG, Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase

 Score = 56.9 bits (138), Expect = 5e-09
 Identities = 31/95 (32%), Positives = 50/95 (52%), Gaps = 15/95 (15%)

Query: 394 LEYLHLGCSTRILHFDIKPHNILLDEDFCPKISDFGLAKICNRKE---SIISMTGARGTV 450
            EYLH   +  I++ D+KP N+LLD +   K+ DFG AK     +   +        GT 
Sbjct: 106 FEYLH---NRGIIYRDLKPENLLLDSNGYVKLVDFGFAKKLKSGQKTWTFC------GTP 156

Query: 451 GYIAPEVFCRNIGEVSYKSDVYNYGMMIFE-MTGG 484
            Y+APE+   N G   +  D ++ G++++E +TG 
Sbjct: 157 EYVAPEI-ILNKGY-DFSVDYWSLGILLYELLTGR 189

Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowing autophosphorylation and activation of the kinase. cGKI is a soluble protein expressed in all smooth muscles, platelets, cerebellum, and kidney. It is also expressed at lower concentrations in other tissues. cGKII is a membrane-bound protein that is most abundantly expressed in the intestine. It is also present in the brain nuclei, adrenal cortex, kidney, lung, and prostate. cGKI is involved in the regulation of smooth muscle tone, smooth cell proliferation, and platelet activation. cGKII plays a role in the regulation of secretion, such as renin secretion by the kidney and aldosterone secretion by the adrenal. It also regulates bone growth and the circadian rhythm. Length = 262

>gnl|CDD|143363 cd07858, STKc_TEY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants

 Score = 57.4 bits (139), Expect = 6e-09
 Identities = 39/97 (40%), Positives = 53/97 (54%), Gaps = 7/97 (7%)

Query: 390 IARGLEYLHLGCSTRILHFDIKPHNILLDEDFCPKISDFGLAKICNRKESIISMTGARGT 449
           + RGL+Y+H   S  +LH D+KP N+LL+ +   KI DFGLA+  + K     MT    T
Sbjct: 117 LLRGLKYIH---SANVLHRDLKPSNLLLNANCDLKICDFGLARTTSEKGDF--MTEYVVT 171

Query: 450 VGYIAPEVFCRNIGEVSYKSDVYNYGMMIFEMTGGRK 486
             Y APE+   N  E +   DV++ G  IF    GRK
Sbjct: 172 RWYRAPELLL-NCSEYTTAIDVWSVG-CIFAELLGRK 206

Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. This subfamily represents the TEY subtype and is further subdivided into three groups (A, B, and C). Group A is represented by AtMPK3, AtMPK6, Nicotiana tabacum BTF4 (NtNTF4), among others. They are mostly involved in environmental and hormonal responses. AtMPK3 and AtMPK6 are also key regulators for stomatal development and patterning. Group B is represented by AtMPK4, AtMPK13, and NtNTF6, among others. They may be involved in both cell division and environmental stress response. AtMPK4 also participates in regulating innate immunity. Group C is represented by AtMPK1, AtMPK2, NtNTF3, Oryza sativa MAPK4 (OsMAPK4), among others. They may also be involved in stress responses. AtMPK1 and AtMPK2 are activated following mechanical injury and in the presence of stress chemicals such as jasmonic acid, hydrogen peroxide and abscisic acid. OsMAPK4 is also called OsMSRMK3 for Multiple Stress-Responsive MAPK3. Length = 337

>gnl|CDD|132988 cd06657, STKc_PAK4, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4

 Score = 57.0 bits (137), Expect = 6e-09
 Identities = 56/199 (28%), Positives = 91/199 (45%), Gaps = 47/199 (23%)

Query: 320 KLGQGGYGSVYKGKL-LDGSNVAVKVLNDSKGNGKEFI-NEVASISRTSHVNVVALLGFC 377
           K+G+G  G V    +   G  VAVK ++  K   +E + NEV  +    H NVV +    
Sbjct: 27  KIGEGSTGIVCIATVKSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSY 86

Query: 378 L------------------------RVAEELSSTIGIA--RGLEYLHLGCSTRILHFDIK 411
           L                        R+ EE  + + +A  + L  LH   +  ++H DIK
Sbjct: 87  LVGDELWVVMEFLEGGALTDIVTHTRMNEEQIAAVCLAVLKALSVLH---AQGVIHRDIK 143

Query: 412 PHNILLDEDFCPKISDFG----LAKICNRKESIISMTGARGTVGYIAPEVFCRNIGEVSY 467
             +ILL  D   K+SDFG    ++K   R++S++      GT  ++APE+  R    + Y
Sbjct: 144 SDSILLTHDGRVKLSDFGFCAQVSKEVPRRKSLV------GTPYWMAPELISR----LPY 193

Query: 468 --KSDVYNYGMMIFEMTGG 484
             + D+++ G+M+ EM  G
Sbjct: 194 GPEVDIWSLGIMVIEMVDG 212

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell morphology and cytoskeletal organization. It is essential for embryonic viability and proper neural development. Mice lacking PAK4 die due to defects in the fetal heart. In addition, their spinal cord motor neurons showed failure to differentiate and migrate. PAK4 also plays a role in cell survival and tumorigenesis. It is overexpressed in many primary tumors including colon, esophageal, and mammary tumors. PAK4 has also been implicated in viral and bacterial infection pathways. Length = 292

>gnl|CDD|173758 cd08218, STKc_Nek1, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1

 Score = 56.4 bits (136), Expect = 7e-09
 Identities = 56/199 (28%), Positives = 92/199 (46%), Gaps = 46/199 (23%)

Query: 320 KLGQGGYG-SVYKGKLLDGSNVAVKVLNDSKGNGKE---FINEVASISRTSHVNVVA--- 372
           K+G+G +G ++      DG    +K +N SK + KE      EVA +S   H N+V    
Sbjct: 7   KIGEGSFGKAILVKSKEDGKQYVIKEINISKMSPKEREESRKEVAVLSNMKHPNIVQYQE 66

Query: 373 ----------LLGFC--------------LRVAEE--LSSTIGIARGLEYLHLGCSTRIL 406
                     ++ +C              +   E+  L   + I   L+++H     +IL
Sbjct: 67  SFEENGNLYIVMDYCEGGDLYKKINAQRGVLFPEDQILDWFVQICLALKHVH---DRKIL 123

Query: 407 HFDIKPHNILLDEDFCPKISDFGLAKICNRKESIISMTGAR---GTVGYIAPEVFCRNIG 463
           H DIK  NI L +D   K+ DFG+A++ N      ++  AR   GT  Y++PE+ C N  
Sbjct: 124 HRDIKSQNIFLTKDGTIKLGDFGIARVLNS-----TVELARTCIGTPYYLSPEI-CEN-R 176

Query: 464 EVSYKSDVYNYGMMIFEMT 482
             + KSD++  G +++EM 
Sbjct: 177 PYNNKSDIWALGCVLYEMC 195

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycystic kidney disease, which is characterized by benign polycystic tumors formed by abnormal overgrowth of renal epithelial cells. It appears also to be involved in DNA damage response, and may be important for both correct DNA damage checkpoint activation and DNA repair. Length = 256

>gnl|CDD|173698 cd05607, STKc_GRK7, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7

 Score = 56.5 bits (136), Expect = 8e-09
 Identities = 36/96 (37%), Positives = 51/96 (53%), Gaps = 8/96 (8%)

Query: 390 IARGLEYLHLGCSTRILHFDIKPHNILLDEDFCPKISDFGLAKICNRKESIISMTGARGT 449
           I  G+ +LH   S  I++ D+KP N+LLD+    ++SD GLA      ++I   T   GT
Sbjct: 104 ITCGILHLH---SMDIVYRDMKPENVLLDDQGNCRLSDLGLAVELKDGKTI---TQRAGT 157

Query: 450 VGYIAPEVFCRNIGEVSYKSDVYNYGMMIFEMTGGR 485
            GY+APE+        SY  D +  G  I+EM  GR
Sbjct: 158 NGYMAPEILKEEP--YSYPVDWFAMGCSIYEMVAGR 191

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual group of GRKs. It is primarily found in the retina and plays a role in the regulation of opsin light receptors. GRK7 is located in retinal cone outer segments and plays an important role in regulating photoresponse of the cones. Length = 277

>gnl|CDD|133178 cd05046, PTK_CCK4, Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4

 Score = 56.3 bits (136), Expect = 8e-09
 Identities = 49/205 (23%), Positives = 83/205 (40%), Gaps = 50/205 (24%)

Query: 321 LGQGGYGSVYKGKL--LDGSN----VAVKVLNDSKGNG--KEFINEVASISRTSHVNVVA 372
           LG+G +G V+  K   ++       V VK L  +K      EF  E+    + SH NVV 
Sbjct: 13  LGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTKDENLQSEFRRELDMFRKLSHKNVVR 72

Query: 373 LLGFC------------------------------------LRVAEELSSTIGIARGLEY 396
           LLG C                                    L   ++++    IA G+++
Sbjct: 73  LLGLCREAEPHYMILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGMDH 132

Query: 397 LHLGCSTRILHFDIKPHNILLDEDFCPKISDFGLAKICNRKESIISMTGARGTVGYIAPE 456
           L    + R +H D+   N L+      K+S   L+K     E    +  A   + ++APE
Sbjct: 133 LS---NARFVHRDLAARNCLVSSQREVKVSLLSLSKDVYNSE-YYKLRNALIPLRWLAPE 188

Query: 457 VFCRNIGEVSYKSDVYNYGMMIFEM 481
                  + S KSDV+++G++++E+
Sbjct: 189 --AVQEDDFSTKSDVWSFGVLMWEV 211

Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is still unknown. Other pseudokinases such as HER3 rely on the activity of partner RTKs. Length = 275

>gnl|CDD|132942 cd06611, STKc_SLK_like, Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases

 Score = 56.3 bits (136), Expect = 9e-09
 Identities = 52/202 (25%), Positives = 88/202 (43%), Gaps = 46/202 (22%)

Query: 321 LGQGGYGSVYKGKLLD-GSNVAVKVLN-DSKGNGKEFINEVASISRTSHVNVVALLG--- 375
           LG G +G VYK +  + G   A K++  +S+   ++F+ E+  +S   H N+V L     
Sbjct: 13  LGDGAFGKVYKAQHKETGLFAAAKIIQIESEEELEDFMVEIDILSECKHPNIVGLYEAYF 72

Query: 376 ----------FC-------LRVAEELSSTIGIAR--------GLEYLHLGCSTRILHFDI 410
                     FC       + +  E   T    R         L +LH   S +++H D+
Sbjct: 73  YENKLWILIEFCDGGALDSIMLELERGLTEPQIRYVCRQMLEALNFLH---SHKVIHRDL 129

Query: 411 KPHNILLDEDFCPKISDFG----LAKICNRKESIISMTGARGTVGYIAPEVF-CRNIGEV 465
           K  NILL  D   K++DFG          ++++ I      GT  ++APEV  C    + 
Sbjct: 130 KAGNILLTLDGDVKLADFGVSAKNKSTLQKRDTFI------GTPYWMAPEVVACETFKDN 183

Query: 466 SY--KSDVYNYGMMIFEMTGGR 485
            Y  K+D+++ G+ + E+    
Sbjct: 184 PYDYKADIWSLGITLIELAQME 205

Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. SmSLK is capable of activating the MAPK Jun N-terminal kinase (JNK) pathway in human embryonic kidney (HEK) cells as well as in Xenopus oocytes. It may participate in regulating MAPK cascades during host-parasite interactions. Length = 280

>gnl|CDD|177557 PHA03209, PHA03209, serine/threonine kinase US3; Provisional

 Score = 56.8 bits (137), Expect = 9e-09
 Identities = 32/92 (34%), Positives = 50/92 (54%), Gaps = 8/92 (8%)

Query: 390 IARGLEYLHLGCSTRILHFDIKPHNILLDEDFCPKISDFGLAKICNRKESIISMTGARGT 449
           I  GL YLH   + RI+H D+K  NI +++     I D G A+         +  G  GT
Sbjct: 166 ILEGLRYLH---AQRIIHRDVKTENIFINDVDQVCIGDLGAAQ-FPVVAP--AFLGLAGT 219

Query: 450 VGYIAPEVFCRNIGEVSYKSDVYNYGMMIFEM 481
           V   APEV  R+  + + K+D+++ G+++FEM
Sbjct: 220 VETNAPEVLARD--KYNSKADIWSAGIVLFEM 249

Length = 357

>gnl|CDD|132964 cd06633, STKc_TAO3, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3

 Score = 56.6 bits (136), Expect = 9e-09
 Identities = 55/196 (28%), Positives = 83/196 (42%), Gaps = 42/196 (21%)

Query: 319 YKLGQGGYGSVY-KGKLLDGSNVAVKVLNDSKGNGKE----FINEVASISRTSHVNVVAL 373
           +++G G +G+VY          VAVK ++ S     E     I EV  + +  H N +  
Sbjct: 27  HEIGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPNTIEY 86

Query: 374 LG-------------FCLRVAEEL--------------SSTIGIARGLEYLHLGCSTRIL 406
            G             +CL  A +L              + T G  +GL YLH      ++
Sbjct: 87  KGCYLKEHTAWLVMEYCLGSASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSHN---MI 143

Query: 407 HFDIKPHNILLDEDFCPKISDFGLAKICNRKESIISMTGARGTVGYIAPEV-FCRNIGEV 465
           H DIK  NILL E    K++DFG A   +   S +      GT  ++APEV    + G+ 
Sbjct: 144 HRDIKAGNILLTEPGQVKLADFGSASKSSPANSFV------GTPYWMAPEVILAMDEGQY 197

Query: 466 SYKSDVYNYGMMIFEM 481
             K DV++ G+   E+
Sbjct: 198 DGKVDVWSLGITCIEL 213

Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a component of the RAM (regulation of Ace2p activity and cellular morphogenesis) signaling pathway. TAO3 is upregulated in retinal ganglion cells after axotomy, and may play a role in apoptosis. Length = 313

>gnl|CDD|143354 cd07849, STKc_ERK1_2_like, Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases

 Score = 56.5 bits (137), Expect = 9e-09
 Identities = 35/97 (36%), Positives = 52/97 (53%), Gaps = 5/97 (5%)

Query: 390 IARGLEYLHLGCSTRILHFDIKPHNILLDEDFCPKISDFGLAKIC-NRKESIISMTGARG 448
           I RGL+Y+H   S  +LH D+KP N+LL+ +   KI DFGLA+I     +    +T    
Sbjct: 115 ILRGLKYIH---SANVLHRDLKPSNLLLNTNCDLKICDFGLARIADPEHDHTGFLTEYVA 171

Query: 449 TVGYIAPEVFCRNIGEVSYKSDVYNYGMMIFEMTGGR 485
           T  Y APE+   N    +   D+++ G ++ EM   R
Sbjct: 172 TRWYRAPEIML-NSKGYTKAIDIWSVGCILAEMLSNR 207

Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase kinase from the Raf family. ERK1/2 have numerous substrates, many of which are nuclear and participate in transcriptional regulation of many cellular processes. They regulate cell growth, cell proliferation, and cell cycle progression from G1 to S phase. Although the distinct roles of ERK1 and ERK2 have not been fully determined, it is known that ERK2 can maintain most functions in the absence of ERK1, and that the deletion of ERK2 is embryonically lethal. The MAPK, Fus3, regulates yeast mating processes including mating-specific gene expression, G1 arrest, mating projection, and cell fusion. Length = 336

>gnl|CDD|143371 cd07866, STKc_BUR1, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins

 Score = 56.2 bits (136), Expect = 1e-08
 Identities = 42/153 (27%), Positives = 62/153 (40%), Gaps = 42/153 (27%)

Query: 320 KLGQGGYGSVYKG-KLLDGSNVAVK---VLNDSKGNGKEFINEVASISRTSHVNVVALLG 375
           KLG+G +G VYK  ++  G  VA+K   + N+  G     + E+  + +  H NVV L+ 
Sbjct: 15  KLGEGTFGEVYKARQIKTGRVVALKKILMHNEKDGFPITALREIKILKKLKHPNVVPLID 74

Query: 376 FCLRVAEELSSTIG-----------------------------------IARGLEYLHLG 400
             +   ++     G                                   +  G+ YLH  
Sbjct: 75  MAVERPDKSKRKRGSVYMVTPYMDHDLSGLLENPSVKLTESQIKCYMLQLLEGINYLH-- 132

Query: 401 CSTRILHFDIKPHNILLDEDFCPKISDFGLAKI 433
               ILH DIK  NIL+D     KI+DFGLA+ 
Sbjct: 133 -ENHILHRDIKAANILIDNQGILKIADFGLARP 164

Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic screen as factors involved in general transcription. The BUR1/BUR2 complex phosphorylates the C-terminal domain of RNA polymerase II. In addition, this complex regulates histone modification by phosporylating Rad6 and mediating the association of the Paf1 complex with chromatin. Length = 311

>gnl|CDD|132973 cd06642, STKc_STK25-YSK1, Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1

 Score = 55.8 bits (134), Expect = 1e-08
 Identities = 52/196 (26%), Positives = 91/196 (46%), Gaps = 40/196 (20%)

Query: 320 KLGQGGYGSVYKGKLLDGSN---VAVKV--LNDSKGNGKEFINEVASISRTSHVNVVALL 374
           ++G+G +G VYKG  +D      VA+K+  L +++   ++   E+  +S+     +    
Sbjct: 11  RIGKGSFGEVYKG--IDNRTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYITRYY 68

Query: 375 GFCLR------------------------VAEELSSTI--GIARGLEYLHLGCSTRILHF 408
           G  L+                        + E   +TI   I +GL+YLH   S R +H 
Sbjct: 69  GSYLKGTKLWIIMEYLGGGSALDLLKPGPLEETYIATILREILKGLDYLH---SERKIHR 125

Query: 409 DIKPHNILLDEDFCPKISDFGLAKICNRKESIISMTGARGTVGYIAPEVFCRNIGEVSYK 468
           DIK  N+LL E    K++DFG+A      ++ I      GT  ++APEV  ++     +K
Sbjct: 126 DIKAANVLLSEQGDVKLADFGVAG--QLTDTQIKRNTFVGTPFWMAPEVIKQS--AYDFK 181

Query: 469 SDVYNYGMMIFEMTGG 484
           +D+++ G+   E+  G
Sbjct: 182 ADIWSLGITAIELAKG 197

Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 is a candidate gene responsible for pseudopseudohypoparathyroidism (PPHP), a disease that shares features with the Albright hereditary osteodystrophy (AHO) phenotype. Length = 277

>gnl|CDD|173639 cd05066, PTKc_EphR_A, Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors

 Score = 55.3 bits (133), Expect = 1e-08
 Identities = 54/213 (25%), Positives = 101/213 (47%), Gaps = 47/213 (22%)

Query: 321 LGQGGYGSVYKGKL-LDGSN---VAVKVLND--SKGNGKEFINEVASISRTSHVNVVALL 374
           +G G +G V  G+L L G     VA+K L    ++   ++F++E + + +  H N++ L 
Sbjct: 12  IGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIHLE 71

Query: 375 GFCLR------VAEELSS--------------TI--------GIARGLEYLHLGCSTRIL 406
           G   +      V E + +              T+        GIA G++YL        +
Sbjct: 72  GVVTKSKPVMIVTEYMENGSLDAFLRKHDGQFTVIQLVGMLRGIASGMKYL---SDMGYV 128

Query: 407 HFDIKPHNILLDEDFCPKISDFGLAKIC-NRKESIISMTGARGTVGYIAPEVFCRNIGEV 465
           H D+   NIL++ +   K+SDFGL+++  +  E+  +  G +  + + APE       + 
Sbjct: 129 HRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTAPEAIAYR--KF 186

Query: 466 SYKSDVYNYGMMIFE-MTGGRK------NVDVV 491
           +  SDV++YG++++E M+ G +      N DV+
Sbjct: 187 TSASDVWSYGIVMWEVMSYGERPYWEMSNQDVI 219

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. EphARs and ephrin-A ligands are expressed in multiple areas of the developing brain, especially in the retina and tectum. They are part of a system controlling retinotectal mapping. Length = 267

>gnl|CDD|173742 cd07845, STKc_CDK10, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10

 Score = 55.8 bits (135), Expect = 2e-08
 Identities = 48/173 (27%), Positives = 76/173 (43%), Gaps = 42/173 (24%)

Query: 320 KLGQGGYGSVYKGKLLD-GSNVAVK-VLNDSKGNGKEF--INEVASISRTSHVNVVALL- 374
           ++G+G YG VY+ +    G  VA+K V  D++ +G     + E+  +    H N+V L  
Sbjct: 14  RIGEGTYGIVYRARDTTSGEIVALKKVRMDNERDGIPISSLREITLLLNLRHPNIVELKE 73

Query: 375 --------------GFC----LRVAEELSSTIGIA----------RGLEYLHLGCSTRIL 406
                          +C      + + + +    +          RGL+YLH      I+
Sbjct: 74  VVVGKHLDSIFLVMEYCEQDLASLLDNMPTPFSESQVKCLMLQLLRGLQYLHENF---II 130

Query: 407 HFDIKPHNILLDEDFCPKISDFGLAKICNRKESII--SMTGARGTVGYIAPEV 457
           H D+K  N+LL +  C KI+DFGLA    R   +    MT    T+ Y APE+
Sbjct: 131 HRDLKVSNLLLTDKGCLKIADFGLA----RTYGLPAKPMTPKVVTLWYRAPEL 179

Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing increases the transcription of c-RAF and the activation of the p42/p44 MAPK pathway, which leads to antiestrogen resistance. Patients who express low levels of CDK10 relapse early on tamoxifen. Length = 309

>gnl|CDD|173661 cd05570, STKc_PKC, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C

 Score = 55.8 bits (135), Expect = 2e-08
 Identities = 33/107 (30%), Positives = 53/107 (49%), Gaps = 15/107 (14%)

Query: 390 IARGLEYLHLGCSTRILHFDIKPHNILLDEDFCPKISDFGLAK--ICNRKESIISMTGAR 447
           I  GL++LH      I++ D+K  N+LLD +   KI+DFG+ K  I     +    +   
Sbjct: 105 IVLGLQFLH---ERGIIYRDLKLDNVLLDSEGHIKIADFGMCKEGILGGVTT----STFC 157

Query: 448 GTVGYIAPEVFCRNIGEVSYKSDV--YNYGMMIFEMTGGRKNVDVVD 492
           GT  YIAPE+    +    Y   V  +  G++++EM  G+   +  D
Sbjct: 158 GTPDYIAPEI----LSYQPYGPAVDWWALGVLLYEMLAGQSPFEGDD 200

Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only require PS. PKCs phosphorylate and modify the activities of a wide variety of cellular proteins including receptors, enzymes, cytoskeletal proteins, transcription factors, and other kinases. They play a central role in signal transduction pathways that regulate cell migration and polarity, proliferation, differentiation, and apoptosis. Also included in this subfamily are the PKC-like proteins, called PKNs. Length = 318

>gnl|CDD|143385 cd07880, STKc_p38gamma_MAPK12, Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase

 Score = 55.7 bits (134), Expect = 2e-08
 Identities = 34/96 (35%), Positives = 54/96 (56%), Gaps = 9/96 (9%)

Query: 390 IARGLEYLHLGCSTRILHFDIKPHNILLDEDFCPKISDFGLAKICNRKESIISMTGARGT 449
           + +GL+Y+H   +  I+H D+KP N+ ++ED   KI DFGLA+  + +     MTG   T
Sbjct: 127 MLKGLKYIH---AAGIIHRDLKPGNLAVNEDCELKILDFGLARQTDSE-----MTGYVVT 178

Query: 450 VGYIAPEVFCRNIGEVSYKSDVYNYGMMIFEMTGGR 485
             Y APEV   N    +   D+++ G ++ EM  G+
Sbjct: 179 RWYRAPEVIL-NWMHYTQTVDIWSVGCIMAEMLTGK 213

Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12, is predominantly expressed in skeletal muscle. Unlike p38alpha and p38beta, p38gamma is insensitive to pyridinylimidazoles. It displays an antagonizing function compared to p38alpha. p38gamma inhibits, while p38alpha stimulates, c-Jun phosphorylation and AP-1 mediated transcription. p38gamma also plays a role in the signaling between Ras and the estrogen receptor and has been implicated to increase cell invasion and breast cancer progression. In Xenopus, p38gamma is critical in the meiotic maturation of oocytes. Length = 343

>gnl|CDD|173747 cd07852, STKc_MAPK15, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15

 Score = 55.7 bits (135), Expect = 2e-08
 Identities = 33/99 (33%), Positives = 54/99 (54%), Gaps = 11/99 (11%)

Query: 392 RGLEYLHLGCSTRILHFDIKPHNILLDEDFCPKISDFGLAK-ICNRKE--SIISMTGARG 448
           + L+Y+H   S  ++H D+KP NILL+ D   K++DFGLA+ +   +E      +T    
Sbjct: 118 KALKYIH---SGNVIHRDLKPSNILLNSDCRVKLADFGLARSLSELEENPENPVLTDYVA 174

Query: 449 TVGYIAPEVFCRNIGEVSYKS--DVYNYGMMIFEMTGGR 485
           T  Y APE+    +G   Y    D+++ G ++ EM  G+
Sbjct: 175 TRWYRAPEIL---LGSTRYTKGVDMWSVGCILGEMLLGK 210

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimuli whereas ERK8 shows low basal activity and is activated by DNA-damaging agents. ERK7 and ERK8 also have different substrate profiles. Genome analysis shows that they are orthologs with similar gene structures. ERK7 and ERK 8 may be involved in the signaling of some nuclear receptor transcription factors. ERK7 regulates hormone-dependent degradation of estrogen receptor alpha while ERK8 down-regulates the transcriptional co-activation androgen and glucocorticoid receptors. Length = 337

>gnl|CDD|173768 cd08228, STKc_Nek6, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6

 Score = 55.0 bits (132), Expect = 2e-08
 Identities = 51/202 (25%), Positives = 90/202 (44%), Gaps = 51/202 (25%)

Query: 320 KLGQGGYGSVYKGK-LLDGSNVAVKVLN-----DSKGNGKEFINEVASISRTSHVNVVAL 373
           K+G+G +  VY+   LLD   VA+K +      D+K   ++ + E+  + + +H NV+  
Sbjct: 9   KIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKAR-QDCVKEIDLLKQLNHPNVIKY 67

Query: 374 L-GFC----LRVAEELSST--------------------------IGIARGLEYLHLGCS 402
           L  F     L +  EL+                            + +   +E++H   S
Sbjct: 68  LDSFIEDNELNIVLELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVEHMH---S 124

Query: 403 TRILHFDIKPHNILLDEDFCPKISDFGLAKICNRKESIISMTGARGTVG---YIAPEVFC 459
            R++H DIKP N+ +      K+ D GL +  + K      T A   VG   Y++PE   
Sbjct: 125 RRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSK-----TTAAHSLVGTPYYMSPERIH 179

Query: 460 RNIGEVSYKSDVYNYGMMIFEM 481
            N    ++KSD+++ G +++EM
Sbjct: 180 EN--GYNFKSDIWSLGCLLYEM 199

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase and anaphase, and to the midbody during cytokinesis. Length = 267

>gnl|CDD|215036 PLN00034, PLN00034, mitogen-activated protein kinase kinase; Provisional

 Score = 55.6 bits (134), Expect = 2e-08
 Identities = 31/99 (31%), Positives = 54/99 (54%), Gaps = 8/99 (8%)

Query: 390 IARGLEYLHLGCSTRILHFDIKPHNILLDEDFCPKISDFGLAKICNRKESIISMTGARGT 449
           I  G+ YLH      I+H DIKP N+L++     KI+DFG+++I    +++     + GT
Sbjct: 177 ILSGIAYLH---RRHIVHRDIKPSNLLINSAKNVKIADFGVSRILA--QTMDPCNSSVGT 231

Query: 450 VGYIAPEVFCRNIGEVSYK---SDVYNYGMMIFEMTGGR 485
           + Y++PE    ++   +Y     D+++ G+ I E   GR
Sbjct: 232 IAYMSPERINTDLNHGAYDGYAGDIWSLGVSILEFYLGR 270

Length = 353

>gnl|CDD|143384 cd07879, STKc_p38delta_MAPK13, Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase

 Score = 55.3 bits (133), Expect = 3e-08
 Identities = 61/209 (29%), Positives = 90/209 (43%), Gaps = 46/209 (22%)

Query: 321 LGQGGYGSVYKG-KLLDGSNVAVKVLN---DSKGNGKEFINEVASISRTSHVNVVALL-- 374
           +G G YGSV        G  VA+K L+    S+   K    E+  +    H NV+ LL  
Sbjct: 23  VGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQSEIFAKRAYRELTLLKHMQHENVIGLLDV 82

Query: 375 -----------GFCL---RVAEELSSTIG--------------IARGLEYLHLGCSTRIL 406
                       F L    +  +L   +G              +  GL+Y+H   S  I+
Sbjct: 83  FTSAVSGDEFQDFYLVMPYMQTDLQKIMGHPLSEDKVQYLVYQMLCGLKYIH---SAGII 139

Query: 407 HFDIKPHNILLDEDFCPKISDFGLAKICNRKESIISMTGARGTVGYIAPEVFCRNIGEVS 466
           H D+KP N+ ++ED   KI DFGLA+  + +     MTG   T  Y APEV   N    +
Sbjct: 140 HRDLKPGNLAVNEDCELKILDFGLARHADAE-----MTGYVVTRWYRAPEVIL-NWMHYN 193

Query: 467 YKSDVYNYGMMIFEMTGGR---KNVDVVD 492
              D+++ G ++ EM  G+   K  D +D
Sbjct: 194 QTVDIWSVGCIMAEMLTGKTLFKGKDYLD 222

Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13, is found in skeletal muscle, heart, lung, testis, pancreas, and small intestine. It regulates microtubule function by phosphorylating Tau. It activates the c-jun promoter and plays a role in G2 cell cycle arrest. It also controls the degration of c-Myb, which is associated with myeloid leukemia and poor prognosis in colorectal cancer. p38delta is the main isoform involved in regulating the differentiation and apoptosis of keratinocytes. Length = 342

>gnl|CDD|173678 cd05587, STKc_cPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C

 Score = 55.2 bits (133), Expect = 3e-08
 Identities = 40/111 (36%), Positives = 60/111 (54%), Gaps = 23/111 (20%)

Query: 390 IARGLEYLHLGCSTRILHFDIKPHNILLDEDFCPKISDFGLAKICNRKESIISMTGAR-- 447
           IA GL +LH   S  I++ D+K  N++LD +   KI+DFG+   C  KE+I      R  
Sbjct: 110 IAIGLFFLH---SKGIIYRDLKLDNVMLDAEGHIKIADFGM---C--KENIFGGKTTRTF 161

Query: 448 -GTVGYIAPEVFCRNIGEVSY----KS-DVYNYGMMIFEMTGGRKNVDVVD 492
            GT  YIAPE+       ++Y    KS D + +G++++EM  G+   D  D
Sbjct: 162 CGTPDYIAPEI-------IAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGED 205

Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory domain. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. cPKCs are potent kinases for histones, myelin basic protein, and protamine. PKC-gamma is mainly expressed in neuronal tissues. It plays a role in protection from ischemia. Length = 324

>gnl|CDD|173722 cd05633, STKc_GRK3, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3

 Score = 54.2 bits (130), Expect = 4e-08
 Identities = 36/95 (37%), Positives = 56/95 (58%), Gaps = 8/95 (8%)

Query: 390 IARGLEYLHLGCSTRILHFDIKPHNILLDEDFCPKISDFGLAKICNRKESIISMTGARGT 449
           I  GLE++H   +  +++ D+KP NILLDE    +ISD GLA   ++K+   S+    GT
Sbjct: 106 IILGLEHMH---NRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHASV----GT 158

Query: 450 VGYIAPEVFCRNIGEVSYKSDVYNYGMMIFEMTGG 484
            GY+APEV  +     S  +D ++ G M+F++  G
Sbjct: 159 HGYMAPEVLQKGTAYDS-SADWFSLGCMLFKLLRG 192

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is widely expressed in many tissues. GRK3-deficient mice show a lack of olfactory receptor desensitization and altered regulation of the M2 muscarinic airway. GRK3 is involved in modulating the cholinergic response of airway smooth muscles. It also plays a role in dopamine receptor regulation. GRK3 promoter polymorphisms may be associated with bipolar disorder. Length = 279

>gnl|CDD|173635 cd05054, PTKc_VEGFR, Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors

 Score = 54.9 bits (132), Expect = 4e-08
 Identities = 31/98 (31%), Positives = 57/98 (58%), Gaps = 5/98 (5%)

Query: 384 LSSTIGIARGLEYLHLGCSTRILHFDIKPHNILLDEDFCPKISDFGLAKICNRKESIISM 443
           +S +  +ARG+E+L    S + +H D+   NILL E+   KI DFGLA+   +    +  
Sbjct: 176 ISYSFQVARGMEFL---ASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRK 232

Query: 444 TGARGTVGYIAPEVFCRNIGEVSYKSDVYNYGMMIFEM 481
             AR  + ++APE     +   + +SDV+++G++++E+
Sbjct: 233 GDARLPLKWMAPESIFDKV--YTTQSDVWSFGVLLWEI 268

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. There are five VEGF ligands in mammals, which bind, in an overlapping pattern to the three VEGFRs, which can form homo or heterodimers. VEGFRs regulate the cardiovascular system. They are critical for vascular development during embryogenesis and blood vessel formation in adults. They induce cellular functions common to other growth factor receptors such as cell migration, survival, and proliferation. VEGFR1 binds VEGFA, VEGFB, and placenta growth factor (PLGF). It regulates monocyte and macrophage migration, vascular permeability, haematopoiesis, and the recruitment of haematopietic progenitor cells from the bone marrow. Length = 337

>gnl|CDD|173686 cd05595, STKc_PKB_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta

 Score = 54.6 bits (131), Expect = 5e-08
 Identities = 36/96 (37%), Positives = 52/96 (54%), Gaps = 7/96 (7%)

Query: 390 IARGLEYLHLGCSTRILHFDIKPHNILLDEDFCPKISDFGLAKICNRKESIISMTGARGT 449
           I   LEYLH   S  +++ DIK  N++LD+D   KI+DFGL K      +  +M    GT
Sbjct: 104 IVSALEYLH---SRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGA--TMKTFCGT 158

Query: 450 VGYIAPEVFCRNIGEVSYKSDVYNYGMMIFEMTGGR 485
             Y+APEV   N  +     D +  G++++EM  GR
Sbjct: 159 PEYLAPEVLEDN--DYGRAVDWWGLGVVMYEMMCGR 192

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in PKB-beta display normal growth weights but exhibit severe insulin resistance and diabetes, accompanied by lipoatrophy and B-cell failure. Length = 323

>gnl|CDD|173675 cd05584, STKc_p70S6K, Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase

 Score = 54.4 bits (131), Expect = 5e-08
 Identities = 62/206 (30%), Positives = 96/206 (46%), Gaps = 54/206 (26%)

Query: 321 LGQGGYGSVYKGKLLDGSN----VAVKVLNDSK--GNGKEFINEVAS---ISRTSHVNVV 371
           LG+GGYG V++ + + G++     A+KVL  +    N K+  +  A    +    H  +V
Sbjct: 4   LGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHPFIV 63

Query: 372 ALL------GFCLRVAEELS-----------------------STIGIARGLEYLHLGCS 402
            L+      G    + E LS                       S I +A  LE+LH    
Sbjct: 64  DLIYAFQTGGKLYLILEYLSGGELFMHLEREGIFMEDTACFYLSEISLA--LEHLH---Q 118

Query: 403 TRILHFDIKPHNILLDEDFCPKISDFGLAKICNRKESII--SMTGAR-GTVGYIAPEVFC 459
             I++ D+KP NILLD     K++DFGL   C  KESI   ++T    GT+ Y+APE+  
Sbjct: 119 QGIIYRDLKPENILLDAQGHVKLTDFGL---C--KESIHEGTVTHTFCGTIEYMAPEILM 173

Query: 460 RNIGEVSYKSDVYNYGMMIFEM-TGG 484
           R+ G      D ++ G ++++M TG 
Sbjct: 174 RS-GH-GKAVDWWSLGALMYDMLTGA 197

Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the insulin receptor substrate IRS-1, among others. Mammals contain two isoforms of p70S6K, named S6K1 and S6K2 (or S6K-beta). Length = 323

>gnl|CDD|143342 cd07837, STKc_CdkB_plant, Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase

 Score = 54.0 bits (130), Expect = 5e-08
 Identities = 57/209 (27%), Positives = 86/209 (41%), Gaps = 48/209 (22%)

Query: 320 KLGQGGYGSVYKGK-LLDGSNVAVK---VLNDSKGNGKEFINEVASISRTSHVN-VVALL 374
           K+G+G YG VYK +    G  VA+K   +  D +G     + E++ +   S    +V LL
Sbjct: 8   KIGEGTYGKVYKARDKNTGKLVALKKTRLEMDEEGIPPTALREISLLQMLSESIYIVRLL 67

Query: 375 GF----------CLR-VAEELSSTI---------GIARGLE---------YLHLGC---- 401
                        L  V E L S +         G  R L           L  G     
Sbjct: 68  DVEHVEEKNGKPSLYLVFEYLDSDLKKFMDSNGRGPGRPLPAKTIKSFMYQLLKGVAHCH 127

Query: 402 STRILHFDIKPHNILLDED-FCPKISDFGLAKICNRKESIISMTGARGTVGYIAPEVFCR 460
              ++H D+KP N+L+D+     KI+D GL +       + S T    T+ Y APEV   
Sbjct: 128 KHGVMHRDLKPQNLLVDKQKGLLKIADLGLGR--AFSIPVKSYTHEIVTLWYRAPEVL-- 183

Query: 461 NIGEVSYKS--DVYNYGMMIFEMTGGRKN 487
            +G   Y +  D+++ G +  EM+  RK 
Sbjct: 184 -LGSTHYSTPVDIWSVGCIFAEMS--RKQ 209

Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developmental pathways, such as stomata and leaf development. CdkB has been shown to associate with both cyclin B, which controls G2/M transition, and cyclin D, which acts as a mediator in linking extracellular signals to the cell cycle. Length = 295

>gnl|CDD|132970 cd06639, STKc_myosinIIIB, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin

 Score = 53.9 bits (129), Expect = 6e-08
 Identities = 59/212 (27%), Positives = 87/212 (41%), Gaps = 60/212 (28%)

Query: 321 LGQGGYGSVYK-GKLLDGSNVAVKVLNDSKGNGKEFINEVASI-SRTSHVNVVALLG--- 375
           +G+G YG VYK     DGS  AVK+L+      +E   E   + S  +H NVV   G   
Sbjct: 30  IGKGTYGKVYKVTNKKDGSLAAVKILDPISDVDEEIEAEYNILQSLPNHPNVVKFYGMFY 89

Query: 376 ---------------FC------------LRVAEELSSTI------GIARGLEYLHLGCS 402
                           C            L   + L   +      G   GL++LH   +
Sbjct: 90  KADKLVGGQLWLVLELCNGGSVTELVKGLLICGQRLDEAMISYILYGALLGLQHLH---N 146

Query: 403 TRILHFDIKPHNILLDEDFCPKISDFGLAKICNRKESIISMTGAR-------GTVGYIAP 455
            RI+H D+K +NILL  +   K+ DFG++           +T  R       GT  ++AP
Sbjct: 147 NRIIHRDVKGNNILLTTEGGVKLVDFGVSA---------QLTSTRLRRNTSVGTPFWMAP 197

Query: 456 EVF-CRNIGEVSY--KSDVYNYGMMIFEMTGG 484
           EV  C    + SY  + DV++ G+   E+  G
Sbjct: 198 EVIACEQQYDYSYDARCDVWSLGITAIELGDG 229

Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also present in the brain and testis. The human class IIIB myosin gene maps to a region that overlaps the locus for Bardet-Biedl syndrome, which is characterized by dysmorphic extremities, retinal dystrophy, obesity, male hypogenitalism, and renal abnormalities. Length = 291

>gnl|CDD|143383 cd07878, STKc_p38beta_MAPK11, Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase

 Score = 54.3 bits (130), Expect = 6e-08
 Identities = 55/202 (27%), Positives = 89/202 (44%), Gaps = 48/202 (23%)

Query: 321 LGQGGYGSV---YKGKLLDGSNVAVKVLN---DSKGNGKEFINEVASISRTSHVNVVALL 374
           +G G YGSV   Y  +L     VAVK L+    S  + +    E+  +    H NV+ LL
Sbjct: 23  VGSGAYGSVCSAYDTRLR--QKVAVKKLSRPFQSLIHARRTYRELRLLKHMKHENVIGLL 80

Query: 375 GF-----------------------------CLRVAEELSSTI--GIARGLEYLHLGCST 403
                                          C ++++E    +   + RGL+Y+H   S 
Sbjct: 81  DVFTPATSIENFNEVYLVTNLMGADLNNIVKCQKLSDEHVQFLIYQLLRGLKYIH---SA 137

Query: 404 RILHFDIKPHNILLDEDFCPKISDFGLAKICNRKESIISMTGARGTVGYIAPEVFCRNIG 463
            I+H D+KP N+ ++ED   +I DFGLA+  + +     MTG   T  Y APE+   N  
Sbjct: 138 GIIHRDLKPSNVAVNEDCELRILDFGLARQADDE-----MTGYVATRWYRAPEIML-NWM 191

Query: 464 EVSYKSDVYNYGMMIFEMTGGR 485
             +   D+++ G ++ E+  G+
Sbjct: 192 HYNQTVDIWSVGCIMAELLKGK 213

Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is widely expressed in tissues and shows more similarity with p38alpha than with the other isoforms. Both are sensitive to pyridinylimidazoles and share some common substrates such as MAPK activated protein kinase 2 (MK2) and the transcription factors ATF2, c-Fos and, ELK-1. p38beta is involved in regulating the activation of the cyclooxygenase-2 promoter and the expression of TGFbeta-induced alpha-smooth muscle cell actin. Length = 343

>gnl|CDD|132977 cd06646, STKc_MAP4K5, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5

 Score = 53.5 bits (128), Expect = 7e-08
 Identities = 53/175 (30%), Positives = 74/175 (42%), Gaps = 50/175 (28%)

Query: 320 KLGQGGYGSVYKG-KLLDGSNVAVKVLNDSKGNGKEFIN-EVASISRTSHVNVVALLG-- 375
           ++G G YG VYK   L  G   AVK++    G+    I  E+  +    H N+VA  G  
Sbjct: 16  RVGSGTYGDVYKARNLHTGELAAVKIIKLEPGDDFSLIQQEIFMVKECKHCNIVAYFGSY 75

Query: 376 -----------FC-----------------LRVAEELSSTIGIARGLEYLHLGCSTRILH 407
                      +C                 L++A     T+   +GL YLH   S   +H
Sbjct: 76  LSREKLWICMEYCGGGSLQDIYHVTGPLSELQIAYVCRETL---QGLAYLH---SKGKMH 129

Query: 408 FDIKPHNILLDEDFCPKISDFGL-----AKICNRKESIISMTGARGTVGYIAPEV 457
            DIK  NILL ++   K++DFG+     A I  RK  I       GT  ++APEV
Sbjct: 130 RDIKGANILLTDNGDVKLADFGVAAKITATIAKRKSFI-------GTPYWMAPEV 177

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). MAP4K5 also facilitates Wnt signaling in B cells, and may therefore be implicated in the control of cell fate, proliferation, and polarity. Length = 267

>gnl|CDD|88330 cd05047, PTKc_Tie, Catalytic domain of Tie Protein Tyrosine Kinases

 Score = 53.5 bits (128), Expect = 7e-08
 Identities = 51/210 (24%), Positives = 93/210 (44%), Gaps = 57/210 (27%)

Query: 321 LGQGGYGSVYKGKLL-DG--SNVAVKVLND--SKGNGKEFINEVASISRTSH-VNVVALL 374
           +G+G +G V K ++  DG   + A+K + +  SK + ++F  E+  + +  H  N++ LL
Sbjct: 3   IGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLL 62

Query: 375 GFC---------------------LRVAEELSSTIGIAR--------------------- 392
           G C                     LR +  L +    A                      
Sbjct: 63  GACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVA 122

Query: 393 -GLEYLHLGCSTRILHFDIKPHNILLDEDFCPKISDFGLAKICNRKESIISMTGARGTVG 451
            G++YL      + +H D+   NIL+ E++  KI+DFGL++    +E  +  T  R  V 
Sbjct: 123 RGMDYLS---QKQFIHRDLAARNILVGENYVAKIADFGLSR---GQEVYVKKTMGRLPVR 176

Query: 452 YIAPEVFCRNIGEVSYKSDVYNYGMMIFEM 481
           ++A E    N    +  SDV++YG++++E+
Sbjct: 177 WMAIESL--NYSVYTTNSDVWSYGVLLWEI 204

Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific ligand has been identified for Tie1. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. In vivo studies of Tie1 show that it is critical in vascular development. Length = 270

>gnl|CDD|133233 cd05102, PTKc_VEGFR3, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3

 Score = 53.9 bits (129), Expect = 7e-08
 Identities = 30/92 (32%), Positives = 54/92 (58%), Gaps = 5/92 (5%)

Query: 390 IARGLEYLHLGCSTRILHFDIKPHNILLDEDFCPKISDFGLAKICNRKESIISMTGARGT 449
           +ARG+E+L    S + +H D+   NILL E+   KI DFGLA+   +    +    AR  
Sbjct: 183 VARGMEFL---ASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGSARLP 239

Query: 450 VGYIAPEVFCRNIGEVSYKSDVYNYGMMIFEM 481
           + ++APE     +   + +SDV+++G++++E+
Sbjct: 240 LKWMAPESIFDKV--YTTQSDVWSFGVLLWEI 269

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. VEGFR3 preferentially binds the ligands VEGFC and VEGFD. VEGFR3 is essential for lymphatic endothelial cell (EC) development and function. It has been shown to regulate adaptive immunity during corneal transplantation. VEGFR3 is upregulated on blood vascular ECs in pathological conditions such as vascular tumors and the periphery of solid tumors. It plays a role in cancer progression and lymph node metastasis. Missense mutations in the VEGFR3 gene are associated with primary human lymphedema. Length = 338

>gnl|CDD|173691 cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases

 Score = 53.9 bits (130), Expect = 7e-08
 Identities = 57/199 (28%), Positives = 88/199 (44%), Gaps = 46/199 (23%)

Query: 320 KLGQGGYGSVYKGKLLD-GSNVAVKVLNDS----KGNGKEFINEVASISRTSHVNVVALL 374
           ++GQGGYG V+  K  D G  VA+K +  S        +  + E   ++ T    +V LL
Sbjct: 8   QVGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKSEWLVKLL 67

Query: 375 -GF----CLRVAEE---------LSSTIGI-----AR--------GLEYLH-LGCSTRIL 406
             F     L +A E         L + +G+     AR         ++ LH LG     +
Sbjct: 68  YAFQDDEYLYLAMEYVPGGDFRTLLNNLGVLSEDHARFYMAEMFEAVDALHELG----YI 123

Query: 407 HFDIKPHNILLDEDFCPKISDFGLAK-ICNRKESIISMTGARGTVGYIAPEVFCRNIGEV 465
           H D+KP N L+D     K++DFGL+K I     S++      G+  Y+APEV        
Sbjct: 124 HRDLKPENFLIDASGHIKLTDFGLSKGIVTYANSVV------GSPDYMAPEVL--RGKGY 175

Query: 466 SYKSDVYNYGMMIFEMTGG 484
            +  D ++ G M++E   G
Sbjct: 176 DFTVDYWSLGCMLYEFLCG 194

Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. Dbf2p is important in regulating the mitotic exit network (MEN) and in cytokinesis. Length = 333

>gnl|CDD|133211 cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2

 Score = 53.4 bits (128), Expect = 8e-08
 Identities = 55/197 (27%), Positives = 77/197 (39%), Gaps = 41/197 (20%)

Query: 321 LGQGGYGSV----YKGKLLD-GSNVAVKVLNDSKGNGKE--FINEVASISRTSHVNVVAL 373
           LG+G +G V    Y       G  VAVK L    G      +  E+  +    H N+V  
Sbjct: 12  LGEGHFGKVSLYCYDPANDGTGEMVAVKTLKRECGQQNTSGWKKEINILKTLYHENIVKY 71

Query: 374 LGFC----------------------------LRVAEELSSTIGIARGLEYLHLGCSTRI 405
            G C                            L +A+ L     I  G+ YLH   S   
Sbjct: 72  KGCCSEQGGKGLQLIMEYVPLGSLRDYLPKHKLNLAQLLLFAQQICEGMAYLH---SQHY 128

Query: 406 LHFDIKPHNILLDEDFCPKISDFGLAK-ICNRKESIISMTGARGTVGYIAPEVFCRNIGE 464
           +H D+   N+LLD D   KI DFGLAK +    E           V + A E  C    +
Sbjct: 129 IHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWYAVE--CLKENK 186

Query: 465 VSYKSDVYNYGMMIFEM 481
            SY SDV+++G+ ++E+
Sbjct: 187 FSYASDVWSFGVTLYEL 203

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 283

>gnl|CDD|132947 cd06616, PKc_MKK4, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4

 Score = 53.5 bits (129), Expect = 9e-08
 Identities = 32/101 (31%), Positives = 52/101 (51%), Gaps = 8/101 (7%)

Query: 387 TIGIARGLEYLHLGCSTRILHFDIKPHNILLDEDFCPKISDFGLAKICNRKESIISMTGA 446
            +   + L YL      +I+H D+KP NILLD +   K+ DFG   I  +    I+ T  
Sbjct: 113 AVATVKALNYLKE--ELKIIHRDVKPSNILLDRNGNIKLCDFG---ISGQLVDSIAKTRD 167

Query: 447 RGTVGYIAPEVFCRNIGEVSY--KSDVYNYGMMIFEMTGGR 485
            G   Y+APE    +  +  Y  +SDV++ G+ ++E+  G+
Sbjct: 168 AGCRPYMAPERIDPSARD-GYDVRSDVWSLGITLYEVATGK 207

Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates the downstream targets, c-Jun N-terminal kinase (JNK) and p38 MAPK, on specific threonine and tyrosine residues. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. Their activation is associated with the induction of cell death. Mice deficient in MKK4 die during embryogenesis and display anemia, severe liver hemorrhage, and abnormal hepatogenesis. MKK4 may also play roles in the immune system and in cardiac hypertrophy. It plays a major role in cancer as a tumor and metastasis suppressor. Under certain conditions, MKK4 is pro-oncogenic. Length = 288

>gnl|CDD|133221 cd05090, PTKc_Ror1, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1

 Score = 53.5 bits (128), Expect = 9e-08
 Identities = 55/216 (25%), Positives = 88/216 (40%), Gaps = 56/216 (25%)

Query: 317 FKYKLGQGGYGSVYKGKL-LDGSN----VAVKVLND--SKGNGKEFINEVASISRTSHVN 369
           F  +LG+  +G +YKG L L G +    VA+K L D  +     EF  E + ++   H N
Sbjct: 9   FMEELGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDINNPQQWGEFQQEASLMAELHHPN 68

Query: 370 VVALLG-------FC-------------------------------------LRVAEELS 385
           +V LLG        C                                     L   + L 
Sbjct: 69  IVCLLGVVTQEQPVCMLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLH 128

Query: 386 STIGIARGLEYLHLGCSTRILHFDIKPHNILLDEDFCPKISDFGLAKICNRKESIISMTG 445
             I IA G+EYL    S   +H D+   NIL+ E    KISD GL++     +       
Sbjct: 129 IAIQIAAGMEYL---SSHFFVHKDLAARNILIGEQLHVKISDLGLSREIYSADYYRVQPK 185

Query: 446 ARGTVGYIAPEVFCRNIGEVSYKSDVYNYGMMIFEM 481
           +   + ++ PE      G+ S  SD++++G++++E+
Sbjct: 186 SLLPIRWMPPEAIM--YGKFSSDSDIWSFGVVLWEI 219

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. Avian Ror1 was found to be involved in late limb development. Studies in mice reveal that Ror1 is important in the regulation of neurite growth in central neurons, as well as in respiratory development. Loss of Ror1 also enhances the heart and skeletal abnormalities found in Ror2-deficient mice. Length = 283

>gnl|CDD|133220 cd05089, PTKc_Tie1, Catalytic domain of the Protein Tyrosine Kinase, Tie1

 Score = 53.5 bits (128), Expect = 9e-08
 Identities = 53/215 (24%), Positives = 97/215 (45%), Gaps = 57/215 (26%)

Query: 316 SFKYKLGQGGYGSVYKGKLL-DGS--NVAVKVLND--SKGNGKEFINEVASISRTS-HVN 369
            F+  +G+G +G V +  +  DG   N A+K+L +  S+ + ++F  E+  + +   H N
Sbjct: 5   KFEDVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFASENDHRDFAGELEVLCKLGHHPN 64

Query: 370 VVALLGFC---------------------LR----------------VAEELSS------ 386
           ++ LLG C                     LR                 A  L+S      
Sbjct: 65  IINLLGACENRGYLYIAIEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQF 124

Query: 387 TIGIARGLEYLHLGCSTRILHFDIKPHNILLDEDFCPKISDFGLAKICNRKESIISMTGA 446
              +A G++YL      + +H D+   N+L+ E+   KI+DFGL++    +E  +  T  
Sbjct: 125 ASDVATGMQYL---SEKQFIHRDLAARNVLVGENLASKIADFGLSR---GEEVYVKKTMG 178

Query: 447 RGTVGYIAPEVFCRNIGEVSYKSDVYNYGMMIFEM 481
           R  V ++A E    N    + KSDV+++G++++E+
Sbjct: 179 RLPVRWMAIESL--NYSVYTTKSDVWSFGVLLWEI 211

Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. In vivo studies of Tie1 show that it is critical in vascular development. Length = 297

>gnl|CDD|177649 PLN00009, PLN00009, cyclin-dependent kinase A; Provisional

 Score = 53.3 bits (128), Expect = 9e-08
 Identities = 56/204 (27%), Positives = 91/204 (44%), Gaps = 49/204 (24%)

Query: 320 KLGQGGYGSVYKGK-LLDGSNVAVKVL---NDSKGNGKEFINEVASISRTSHVNVVAL-- 373
           K+G+G YG VYK +  +    +A+K +    + +G     I E++ +    H N+V L  
Sbjct: 9   KIGEGTYGVVYKARDRVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVRLQD 68

Query: 374 ---------LGF---CLRVAEELSST--------------IGIARGLEYLHLGCSTRILH 407
                    L F    L + + + S+                I RG+ Y H   S R+LH
Sbjct: 69  VVHSEKRLYLVFEYLDLDLKKHMDSSPDFAKNPRLIKTYLYQILRGIAYCH---SHRVLH 125

Query: 408 FDIKPHNILLDEDFCP-KISDFGLAK---ICNRKESIISMTGARGTVGYIAPEVFCRNIG 463
            D+KP N+L+D      K++DFGLA+   I  R     + T    T+ Y APE+    +G
Sbjct: 126 RDLKPQNLLIDRRTNALKLADFGLARAFGIPVR-----TFTHEVVTLWYRAPEIL---LG 177

Query: 464 EVSYKS--DVYNYGMMIFEMTGGR 485
              Y +  D+++ G +  EM   +
Sbjct: 178 SRHYSTPVDIWSVGCIFAEMVNQK 201

Length = 294

>gnl|CDD|173616 PTZ00426, PTZ00426, cAMP-dependent protein kinase catalytic subunit; Provisional

 Score = 53.4 bits (128), Expect = 9e-08
 Identities = 33/91 (36%), Positives = 51/91 (56%), Gaps = 10/91 (10%)

Query: 394 LEYLHLGCSTRILHFDIKPHNILLDEDFCPKISDFGLAKICNRKESIISMTGARGTVGYI 453
            EYL    S  I++ D+KP N+LLD+D   K++DFG AK+ + +   +      GT  YI
Sbjct: 144 FEYLQ---SLNIVYRDLKPENLLLDKDGFIKMTDFGFAKVVDTRTYTLC-----GTPEYI 195

Query: 454 APEVFCRNIGEVSYKSDVYNYGMMIFEMTGG 484
           APE+   N+G     +D +  G+ I+E+  G
Sbjct: 196 APEILL-NVGH-GKAADWWTLGIFIYEILVG 224

Length = 340

>gnl|CDD|133234 cd05103, PTKc_VEGFR2, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2

 Score = 53.5 bits (128), Expect = 1e-07
 Identities = 29/92 (31%), Positives = 54/92 (58%), Gaps = 5/92 (5%)

Query: 390 IARGLEYLHLGCSTRILHFDIKPHNILLDEDFCPKISDFGLAKICNRKESIISMTGARGT 449
           +A+G+E+L    S + +H D+   NILL E+   KI DFGLA+   +    +    AR  
Sbjct: 188 VAKGMEFL---ASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARLP 244

Query: 450 VGYIAPEVFCRNIGEVSYKSDVYNYGMMIFEM 481
           + ++APE     +   + +SDV+++G++++E+
Sbjct: 245 LKWMAPETIFDRV--YTIQSDVWSFGVLLWEI 274

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosphorylation and activation. VEGFR2 binds the ligands VEGFA, VEGFC, VEGFD and VEGFE. VEGFR2 signaling is implicated in all aspects of normal and pathological vascular endothelial cell biology. It induces a variety of cellular effects including migration, survival, and proliferation. It is critical in regulating embryonic vascular development and angiogenesis. VEGFR2 is the major signal transducer in pathological angiogenesis including cancer and diabetic retinopathy, and is a target for inhibition in cancer therapy. Length = 343

>gnl|CDD|132972 cd06641, STKc_MST3, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3

 Score = 52.8 bits (126), Expect = 1e-07
 Identities = 54/198 (27%), Positives = 92/198 (46%), Gaps = 44/198 (22%)

Query: 320 KLGQGGYGSVYKGKLLDGSN---VAVKV--LNDSKGNGKEFINEVASISRTSHVNVVALL 374
           K+G+G +G V+KG  +D      VA+K+  L +++   ++   E+  +S+     V    
Sbjct: 11  KIGKGSFGEVFKG--IDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYY 68

Query: 375 GFCLR------------------------VAEELSSTI--GIARGLEYLHLGCSTRILHF 408
           G  L+                        + E   +TI   I +GL+YLH   S + +H 
Sbjct: 69  GSYLKDTKLWIIMEYLGGGSALDLLEPGPLDETQIATILREILKGLDYLH---SEKKIHR 125

Query: 409 DIKPHNILLDEDFCPKISDFGLAKICNRKESIISMTGARGTVGYIAPEVFCRNIGEVSY- 467
           DIK  N+LL E    K++DFG+A      ++ I      GT  ++APEV    I + +Y 
Sbjct: 126 DIKAANVLLSEHGEVKLADFGVAG--QLTDTQIKRNTFVGTPFWMAPEV----IKQSAYD 179

Query: 468 -KSDVYNYGMMIFEMTGG 484
            K+D+++ G+   E+  G
Sbjct: 180 SKADIWSLGITAIELAKG 197

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and intrauterine growth retardation. Length = 277

>gnl|CDD|173744 cd07847, STKc_CDKL1_4, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4

 Score = 52.8 bits (127), Expect = 1e-07
 Identities = 53/209 (25%), Positives = 86/209 (41%), Gaps = 47/209 (22%)

Query: 320 KLGQGGYGSVYKGKLLD-GSNVAVKVLNDSKGN---GKEFINEVASISRTSHVNVVALL- 374
           K+G+G YG V+K +  + G  VA+K   +S+ +    K  + E+  + +  H N+V L+ 
Sbjct: 8   KIGEGSYGVVFKCRNRETGQIVAIKKFVESEDDPVIKKIALREIRMLKQLKHPNLVNLIE 67

Query: 375 ------------GFC-LRVAEEL-------------SSTIGIARGLEYLHLGCSTRILHF 408
                        +C   V  EL                    + + + H       +H 
Sbjct: 68  VFRRKRKLHLVFEYCDHTVLNELEKNPRGVPEHLIKKIIWQTLQAVNFCH---KHNCIHR 124

Query: 409 DIKPHNILLDEDFCPKISDFGLAKICNRKESIISMTGARGTVGYIAPEVFCRNIGEVSYK 468
           D+KP NIL+ +    K+ DFG A+I          T    T  Y APE+    +G+  Y 
Sbjct: 125 DVKPENILITKQGQIKLCDFGFARILTGPGD--DYTDYVATRWYRAPELL---VGDTQYG 179

Query: 469 S--DVYNYGMMIFEM-TG-----GRKNVD 489
              DV+  G +  E+ TG     G+ +VD
Sbjct: 180 PPVDVWAIGCVFAELLTGQPLWPGKSDVD 208

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The function of CDKL4 is unknown. Length = 286

>gnl|CDD|133235 cd05104, PTKc_Kit, Catalytic domain of the Protein Tyrosine Kinase, Kit

 Score = 53.4 bits (128), Expect = 1e-07
 Identities = 34/109 (31%), Positives = 56/109 (51%), Gaps = 9/109 (8%)

Query: 375 GFCLRVAEELSSTIGIARGLEYLHLGCSTRILHFDIKPHNILLDEDFCPKISDFGLAKIC 434
              L   + LS +  +A+G+ +L    S   +H D+   NILL      KI DFGLA+  
Sbjct: 208 ELALDTEDLLSFSYQVAKGMSFL---ASKNCIHRDLAARNILLTHGRITKICDFGLARDI 264

Query: 435 NRKESIISMTGARGTVGYIAPEVFCRNIGEVSY--KSDVYNYGMMIFEM 481
               + +    AR  V ++APE    +I    Y  +SDV++YG++++E+
Sbjct: 265 RNDSNYVVKGNARLPVKWMAPE----SIFNCVYTFESDVWSYGILLWEI 309

Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. Kit signaling is involved in major cellular functions including cell survival, proliferation, differentiation, adhesion, and chemotaxis. Mutations in Kit, which result in constitutive ligand-independent activation, are found in human cancers such as gastrointestinal stromal tumor (GIST) and testicular germ cell tumor (TGCT). The aberrant expression of Kit and/or SCF is associated with other tumor types such as systemic mastocytosis and cancers of the breast, neurons, lung, prostate, colon, and rectum. Although the structure of the human Kit catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 375

>gnl|CDD|173729 cd06617, PKc_MKK3_6, Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6

 Score = 52.4 bits (126), Expect = 2e-07
 Identities = 53/203 (26%), Positives = 84/203 (41%), Gaps = 45/203 (22%)

Query: 321 LGQGGYGSVYKGK-LLDGSNVAVK----VLNDSKGNGKEFINEVASISRTSH-VNVVALL 374
           LG+G YG V K + +  G+ +AVK     +N  +   K  + ++    R+      V   
Sbjct: 9   LGRGAYGVVDKMRHVPTGTIMAVKRIRATVNSQEQ--KRLLMDLDISMRSVDCPYTVTFY 66

Query: 375 G---------FC-------------------LRVAEELSSTI--GIARGLEYLHLGCSTR 404
           G          C                   L + E++   I   I + LEYLH   S  
Sbjct: 67  GALFREGDVWICMEVMDTSLDKFYKKVYDKGLTIPEDILGKIAVSIVKALEYLHSKLS-- 124

Query: 405 ILHFDIKPHNILLDEDFCPKISDFGLAKICNRKESIISMTGARGTVGYIAPEVF--CRNI 462
           ++H D+KP N+L++ +   K+ DFG   I       ++ T   G   Y+APE      N 
Sbjct: 125 VIHRDVKPSNVLINRNGQVKLCDFG---ISGYLVDSVAKTIDAGCKPYMAPERINPELNQ 181

Query: 463 GEVSYKSDVYNYGMMIFEMTGGR 485
                KSDV++ G+ + E+  GR
Sbjct: 182 KGYDVKSDVWSLGITMIELATGR 204

Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs that phosphorylate and activate their downstream target, p38 MAPK, on specific threonine and tyrosine residues. MKK3/6 plays roles in the regulation of cell cycle progression, cytokine- and stress-induced apoptosis, oncogenic transformation, and adult tissue regeneration. In addition, MKK6 plays a critical role in osteoclast survival in inflammatory disease while MKK3 is associated with tumor invasion, progression, and poor patient survival in glioma. Length = 283

>gnl|CDD|132982 cd06651, STKc_MEKK3, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3

 Score = 52.4 bits (125), Expect = 2e-07
 Identities = 62/203 (30%), Positives = 85/203 (41%), Gaps = 52/203 (25%)

Query: 321 LGQGGYGSVYKGKLLD-GSNVAVKVLN---DSKGNGKEFIN---EVASISRTSHVNVVAL 373
           LGQG +G VY    +D G  +A K +    +S    KE      E+  +    H  +V  
Sbjct: 10  LGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERIVQY 69

Query: 374 LGFCLRVAEELSSTI------------------------------GIARGLEYLHLGCST 403
            G CLR   E + TI                               I  G+ YLH   S 
Sbjct: 70  YG-CLRDRAEKTLTIFMEYMPGGSVKDQLKAYGALTESVTRKYTRQILEGMSYLH---SN 125

Query: 404 RILHFDIKPHNILLDEDFCPKISDFGLAKICNRKESI-ISMTGARGTVG---YIAPEVFC 459
            I+H DIK  NIL D     K+ DFG +K   R ++I +S TG R   G   +++PEV  
Sbjct: 126 MIVHRDIKGANILRDSAGNVKLGDFGASK---RLQTICMSGTGIRSVTGTPYWMSPEVIS 182

Query: 460 RNIGE-VSYKSDVYNYGMMIFEM 481
              GE    K+DV++ G  + EM
Sbjct: 183 ---GEGYGRKADVWSLGCTVVEM 202

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. In addition, MEKK3 is involved in interleukin-1 receptor and Toll-like receptor 4 signaling. It is also a specific regulator of the proinflammatory cytokines IL-6 and GM-CSF in some immune cells. MEKK3 also regulates calcineurin, which plays a critical role in T cell activation, apoptosis, skeletal myocyte differentiation, and cardiac hypertrophy. Length = 266

>gnl|CDD|143344 cd07839, STKc_CDK5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5

 Score = 52.4 bits (126), Expect = 2e-07
 Identities = 37/144 (25%), Positives = 65/144 (45%), Gaps = 34/144 (23%)

Query: 320 KLGQGGYGSVYKGKLLD-GSNVAVKVL---NDSKGNGKEFINEVASISRTSHVNVVAL-- 373
           K+G+G YG+V+K K  +    VA+K +   +D +G     + E+  +    H N+V L  
Sbjct: 7   KIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLYD 66

Query: 374 -----------LGFC--------------LRVAEELSSTIGIARGLEYLHLGCSTRILHF 408
                        +C              +      S    + +GL + H   S  +LH 
Sbjct: 67  VLHSDKKLTLVFEYCDQDLKKYFDSCNGDIDPEIVKSFMFQLLKGLAFCH---SHNVLHR 123

Query: 409 DIKPHNILLDEDFCPKISDFGLAK 432
           D+KP N+L++++   K++DFGLA+
Sbjct: 124 DLKPQNLLINKNGELKLADFGLAR 147

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also important in synaptic plasticity and learning. CDK5 also participates in protecting against cell death and promoting angiogenesis. Impaired CDK5 activity is implicated in Alzheimer's disease, amyotrophic lateral sclerosis, Parkinson's disease, Huntington's disease and acute neuronal injury. Length = 284

>gnl|CDD|173662 cd05571, STKc_PKB, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B

 Score = 52.5 bits (126), Expect = 2e-07
 Identities = 37/99 (37%), Positives = 53/99 (53%), Gaps = 13/99 (13%)

Query: 390 IARGLEYLHLGCSTRILHFDIKPHNILLDEDFCPKISDFGLAKICNRKESII---SMTGA 446
           I   L YLH   S  +++ D+K  N++LD+D   KI+DFGL   C  KE I    +M   
Sbjct: 104 IVSALGYLH---SCDVVYRDLKLENLMLDKDGHIKITDFGL---C--KEGISDGATMKTF 155

Query: 447 RGTVGYIAPEVFCRNIGEVSYKSDVYNYGMMIFEMTGGR 485
            GT  Y+APEV   N  +     D +  G++++EM  GR
Sbjct: 156 CGTPEYLAPEVLEDN--DYGRAVDWWGLGVVMYEMMCGR 192

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having been implicated in tumor initiation, progression, and metastasis. Length = 323

>gnl|CDD|173653 cd05105, PTKc_PDGFR_alpha, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha

 Score = 52.7 bits (126), Expect = 2e-07
 Identities = 34/104 (32%), Positives = 56/104 (53%), Gaps = 5/104 (4%)

Query: 378 LRVAEELSSTIGIARGLEYLHLGCSTRILHFDIKPHNILLDEDFCPKISDFGLAKICNRK 437
           L   + LS T  +ARG+E+L    S   +H D+   N+LL +    KI DFGLA+     
Sbjct: 234 LTTLDLLSFTYQVARGMEFL---ASKNCVHRDLAARNVLLAQGKIVKICDFGLARDIMHD 290

Query: 438 ESIISMTGARGTVGYIAPEVFCRNIGEVSYKSDVYNYGMMIFEM 481
            + +S       V ++APE    N+   +  SDV++YG++++E+
Sbjct: 291 SNYVSKGSTFLPVKWMAPESIFDNL--YTTLSDVWSYGILLWEI 332

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-AB, and PDGF-CC induce PDGFR alpha homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR alpha signaling is important in the formation of lung alveoli, intestinal villi, mesenchymal dermis, and hair follicles, as well as in the development of oligodendrocytes, retinal astrocytes, neural crest cells, and testicular cells. Aberrant PDGFR alpha expression is associated with some human cancers. Mutations in PDGFR alpha have been found within a subset of gastrointestinal stromal tumors (GISTs). An active fusion protein FIP1L1-PDGFR alpha, derived from interstitial deletion, is associated with idiopathic hypereosinophilic syndrome (HES) and chronic eosinophilic leukemia (CEL). Length = 400

>gnl|CDD|173684 cd05593, STKc_PKB_gamma, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma

 Score = 52.4 bits (125), Expect = 3e-07
 Identities = 37/99 (37%), Positives = 54/99 (54%), Gaps = 13/99 (13%)

Query: 390 IARGLEYLHLGCSTRILHFDIKPHNILLDEDFCPKISDFGLAKICNRKESII---SMTGA 446
           I   L+YLH G   +I++ D+K  N++LD+D   KI+DFGL      KE I    +M   
Sbjct: 104 IVSALDYLHSG---KIVYRDLKLENLMLDKDGHIKITDFGLC-----KEGITDAATMKTF 155

Query: 447 RGTVGYIAPEVFCRNIGEVSYKSDVYNYGMMIFEMTGGR 485
            GT  Y+APEV   N  +     D +  G++++EM  GR
Sbjct: 156 CGTPEYLAPEVLEDN--DYGRAVDWWGLGVVMYEMMCGR 192

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulated in estrogen-deficient breast cancer cells, androgen-independent prostate cancer cells, and primary ovarian tumors. It acts as a key mediator in the genesis of ovarian cancer. Length = 328

>gnl|CDD|132980 cd06649, PKc_MEK2, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2

 Score = 52.4 bits (125), Expect = 3e-07
 Identities = 39/111 (35%), Positives = 61/111 (54%), Gaps = 14/111 (12%)

Query: 379 RVAEELSSTIGIA--RGLEYLHLGCSTRILHFDIKPHNILLDEDFCPKISDFGLAKICNR 436
           R+ EE+   + IA  RGL YL      +I+H D+KP NIL++     K+ DFG++     
Sbjct: 99  RIPEEILGKVSIAVLRGLAYLRE--KHQIMHRDVKPSNILVNSRGEIKLCDFGVS----- 151

Query: 437 KESIISMTGA-RGTVGYIAPEVFCRNIG-EVSYKSDVYNYGMMIFEMTGGR 485
            + I SM  +  GT  Y++PE   R  G   S +SD+++ G+ + E+  GR
Sbjct: 152 GQLIDSMANSFVGTRSYMSPE---RLQGTHYSVQSDIWSMGLSLVELAIGR 199

Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 331

>gnl|CDD|173709 cd05619, STKc_nPKC_theta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta

 Score = 51.9 bits (124), Expect = 3e-07
 Identities = 35/100 (35%), Positives = 57/100 (57%), Gaps = 15/100 (15%)

Query: 390 IARGLEYLHLGCSTRILHFDIKPHNILLDEDFCPKISDFGLAKICNRKESIISMTGAR-- 447
           I  GL++LH   S  I++ D+K  NILLD D   KI+DFG+      KE+++        
Sbjct: 105 IICGLQFLH---SKGIVYRDLKLDNILLDTDGHIKIADFGMC-----KENMLGDAKTCTF 156

Query: 448 -GTVGYIAPEVFCRNIGE-VSYKSDVYNYGMMIFEMTGGR 485
            GT  YIAPE+    +G+  +   D +++G++++EM  G+
Sbjct: 157 CGTPDYIAPEIL---LGQKYNTSVDWWSFGVLLYEMLIGQ 193

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. Although T-cells also express other PKC isoforms, PKC-theta is unique in that upon antigen stimulation, it is translocated to the plasma membrane at the immunological synapse, where it mediates signals essential for T-cell activation. It is essential for TCR-induced proliferation, cytokine production, T-cell survival, and the differentiation and effector function of T-helper (Th) cells, particularly Th2 and Th17. PKC-theta is being developed as a therapeutic target for Th2-mediated allergic inflammation and Th17-mediated autoimmune diseases. Length = 316

>gnl|CDD|132946 cd06615, PKc_MEK, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase

 Score = 51.7 bits (124), Expect = 3e-07
 Identities = 40/114 (35%), Positives = 61/114 (53%), Gaps = 20/114 (17%)

Query: 379 RVAEELSSTIGIA--RGLEYL---HLGCSTRILHFDIKPHNILLDEDFCPKISDFGLAKI 433
           R+ E +   I IA  RGL YL   H     +I+H D+KP NIL++     K+ DFG++  
Sbjct: 95  RIPENILGKISIAVLRGLTYLREKH-----KIMHRDVKPSNILVNSRGEIKLCDFGVS-- 147

Query: 434 CNRKESIISMTGA-RGTVGYIAPEVFCRNIG-EVSYKSDVYNYGMMIFEMTGGR 485
               + I SM  +  GT  Y++PE   R  G   + +SD+++ G+ + EM  GR
Sbjct: 148 ---GQLIDSMANSFVGTRSYMSPE---RLQGTHYTVQSDIWSLGLSLVEMAIGR 195

Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the downstream targets, ERK(extracellular signal-regulated kinase) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1/2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. This cascade has also been implicated in synaptic plasticity, migration, morphological determination, and stress response immunological reactions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1/2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 308

>gnl|CDD|132950 cd06619, PKc_MKK5, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5

 Score = 51.4 bits (123), Expect = 3e-07
 Identities = 57/193 (29%), Positives = 90/193 (46%), Gaps = 39/193 (20%)

Query: 321 LGQGGYGSVYKG-KLLDGSNVAVKV--LNDSKGNGKEFINEVASISRTSHVNVVALLG-- 375
           LG G  G+VYK   LL    +AVKV  L+ +    K+ ++E+  + +     ++   G  
Sbjct: 9   LGHGNGGTVYKAYHLLTRRILAVKVIPLDITVELQKQIMSELEILYKCDSPYIIGFYGAF 68

Query: 376 -------FCL------------RVAEELSSTIGIA--RGLEYLHLGCSTRILHFDIKPHN 414
                   C             ++ E +   I +A  +GL YL    S +ILH D+KP N
Sbjct: 69  FVENRISICTEFMDGGSLDVYRKIPEHVLGRIAVAVVKGLTYL---WSLKILHRDVKPSN 125

Query: 415 ILLDEDFCPKISDFGLA-KICNRKESIISMTGARGTVGYIAPEVFCRNIGE-VSYKSDVY 472
           +L++     K+ DFG++ ++ N     I+ T   GT  Y+APE   R  GE     SDV+
Sbjct: 126 MLVNTRGQVKLCDFGVSTQLVNS----IAKTYV-GTNAYMAPE---RISGEQYGIHSDVW 177

Query: 473 NYGMMIFEMTGGR 485
           + G+   E+  GR
Sbjct: 178 SLGISFMELALGR 190

Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that phosphorylates its downstream target, extracellular signal-regulated kinase 5 (ERK5), on specific threonine and tyrosine residues. MKK5 is activated by MEKK2 and MEKK3 in response to mitogenic and stress stimuli. The ERK5 cascade promotes cell proliferation, differentiation, neuronal survival, and neuroprotection. This cascade plays an essential role in heart development. Mice deficient in either ERK5 or MKK5 die around embryonic day 10 due to cardiovascular defects including underdevelopment of the myocardium. In addition, MKK5 is associated with metastasis and unfavorable prognosis in prostate cancer. Length = 279

>gnl|CDD|173674 cd05583, STKc_MSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase

 Score = 51.7 bits (124), Expect = 3e-07
 Identities = 35/98 (35%), Positives = 51/98 (52%), Gaps = 10/98 (10%)

Query: 390 IARGLEYLH-LGCSTRILHFDIKPHNILLDEDFCPKISDFGLAKI--CNRKESIISMTGA 446
           I   L++LH LG    I++ DIK  NILLD +    ++DFGL+K      +E   S    
Sbjct: 114 IVLALDHLHQLG----IIYRDIKLENILLDSEGHVVLTDFGLSKEFLAEEEERAYSFC-- 167

Query: 447 RGTVGYIAPEVFCRNIGEVSYKSDVYNYGMMIFEMTGG 484
            GT+ Y+APEV     G      D ++ G++ FE+  G
Sbjct: 168 -GTIEYMAPEVIRGGSGGHDKAVDWWSLGVLTFELLTG 204

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines. This triggers phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) in the C-terminal extension of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSKs are predominantly nuclear proteins. They are widely expressed in many tissues including heart, brain, lung, liver, kidney, and pancreas. There are two isoforms of MSK, called MSK1 and MSK2. Length = 288

>gnl|CDD|173760 cd08220, STKc_Nek8, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8

 Score = 51.4 bits (123), Expect = 3e-07
 Identities = 48/196 (24%), Positives = 80/196 (40%), Gaps = 42/196 (21%)

Query: 321 LGQGGYGSVYKGKLLDGSN-VAVKVLNDSKGNGKE---FINEVASISRTSHVNVVAL--- 373
           +G+G +G V+  +       V +K +   +    E     NE   +   SH N++     
Sbjct: 8   VGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTKDERLAAQNECQVLKLLSHPNIIEYYEN 67

Query: 374 ------LGFCLRVAEE--------------------LSSTIGIARGLEYLHLGCSTRILH 407
                 L   +  A                      L   + I   L ++H   +  ILH
Sbjct: 68  FLEDKALMIVMEYAPGGTLAEYIQKRCNSLLDEDTILHFFVQILLALHHVH---TKLILH 124

Query: 408 FDIKPHNILLDE-DFCPKISDFGLAKICNRKESIISMTGARGTVGYIAPEVFCRNIGEVS 466
            D+K  NILLD+     KI DFG++KI + K    ++    GT  YI+PE+ C      +
Sbjct: 125 RDLKTQNILLDKHKMVVKIGDFGISKILSSKSKAYTVV---GTPCYISPEL-CEG-KPYN 179

Query: 467 YKSDVYNYGMMIFEMT 482
            KSD++  G +++E+ 
Sbjct: 180 QKSDIWALGCVLYELA 195

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with a rare form of juvenile renal cystic disease, nephronophthisis type 9. It has been suggested that a defect in the ciliary localization of Nek8 contributes to the development of cysts manifested by these diseases. Length = 256

>gnl|CDD|173746 cd07850, STKc_JNK, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase

 Score = 52.0 bits (125), Expect = 4e-07
 Identities = 35/95 (36%), Positives = 50/95 (52%), Gaps = 12/95 (12%)

Query: 393 GLEYLHLGCSTRILHFDIKPHNILLDEDFCPKISDFGLAKICNRKESIISMTGARGTVGY 452
           G+++LH   S  I+H D+KP NI++  D   KI DFGLA+      +   MT    T  Y
Sbjct: 130 GIKHLH---SAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAG---TSFMMTPYVVTRYY 183

Query: 453 IAPEVFCRNIGEVSYKS--DVYNYGMMIFEMTGGR 485
            APEV    I  + YK   D+++ G ++ EM  G 
Sbjct: 184 RAPEV----ILGMGYKENVDIWSVGCIMGEMIRGT 214

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3) that are alternatively spliced to produce at least 10 isoforms. JNKs are specifically activated by the MAPK kinases MKK4 and MKK7, which are in turn activated by upstream MAPK kinase kinases as a result of different stimuli including stresses such as ultraviolet (UV) irradiation, hyperosmolarity, heat shock, or cytokines. JNKs activate a large number of different substrates based on specific stimulus, cell type, and cellular condition, and may be implicated in seemingly contradictory functions. Length = 353

>gnl|CDD|183880 PRK13184, pknD, serine/threonine-protein kinase; Reviewed

 Score = 52.1 bits (125), Expect = 5e-07
 Identities = 35/119 (29%), Positives = 51/119 (42%), Gaps = 23/119 (19%)

Query: 380 VAEELSSTIGIARGLEYLHLGCSTRILHFDIKPHNILLDEDFCPKISDFGLAKICNRKES 439
           V   LS    I   +EY+H   S  +LH D+KP NILL       I D+G A     +E 
Sbjct: 112 VGAFLSIFHKICATIEYVH---SKGVLHRDLKPDNILLGLFGEVVILDWGAAIFKKLEEE 168

Query: 440 I-----ISMTGAR-----------GTVGYIAPEVFCRNIG-EVSYKSDVYNYGMMIFEM 481
                 +                 GT  Y+APE   R +G   S  +D+Y  G+++++M
Sbjct: 169 DLLDIDVDERNICYSSMTIPGKIVGTPDYMAPE---RLLGVPASESTDIYALGVILYQM 224

Length = 932

>gnl|CDD|173679 cd05588, STKc_aPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C

 Score = 51.0 bits (122), Expect = 6e-07
 Identities = 35/109 (32%), Positives = 55/109 (50%), Gaps = 9/109 (8%)

Query: 385 SSTIGIARGLEYLHLGCSTRILHFDIKPHNILLDEDFCPKISDFGLAKICNRKESIISMT 444
           S+ I +A  L +LH      I++ D+K  N+LLD +   K++D+G+ K   R     S  
Sbjct: 102 SAEISLA--LNFLH---ERGIIYRDLKLDNVLLDAEGHIKLTDYGMCKEGIRPGDTTSTF 156

Query: 445 GARGTVGYIAPEVFCRNIGEVSYKSDVYNYGMMIFEMTGGRKNVDVVDN 493
              GT  YIAPE+      +  +  D +  G+++FEM  GR   D+V  
Sbjct: 157 C--GTPNYIAPEILRGE--DYGFSVDWWALGVLMFEMMAGRSPFDIVGM 201

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions including proliferation, migration, apoptosis, polarity maintenance and cytoskeletal regulation. They also play a critical role in the regulation of glucose metabolism and in the pathogenesis of type 2 diabetes. Length = 329

>gnl|CDD|132983 cd06652, STKc_MEKK2, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2

 Score = 50.4 bits (120), Expect = 6e-07
 Identities = 61/204 (29%), Positives = 85/204 (41%), Gaps = 54/204 (26%)

Query: 321 LGQGGYGSVYKGKLLD-GSNVAVKVLN---DSKGNGKEFIN----EVASISRTSHVNVVA 372
           LGQG +G VY     D G  +AVK +    +S    KE +N    E+  +    H  +V 
Sbjct: 10  LGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKE-VNALECEIQLLKNLLHERIVQ 68

Query: 373 LLGFCLRVAEELSSTI------------------------------GIARGLEYLHLGCS 402
             G CLR   E + +I                               I  G+ YLH   S
Sbjct: 69  YYG-CLRDPMERTLSIFMEHMPGGSIKDQLKSYGALTENVTRKYTRQILEGVSYLH---S 124

Query: 403 TRILHFDIKPHNILLDEDFCPKISDFGLAK----ICNRKESIISMTGARGTVGYIAPEVF 458
             I+H DIK  NIL D     K+ DFG +K    IC     + S+T   GT  +++PEV 
Sbjct: 125 NMIVHRDIKGANILRDSVGNVKLGDFGASKRLQTICLSGTGMKSVT---GTPYWMSPEVI 181

Query: 459 CRNIGE-VSYKSDVYNYGMMIFEM 481
               GE    K+D+++ G  + EM
Sbjct: 182 S---GEGYGRKADIWSVGCTVVEM 202

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their respective MAPKKs MEK1/2, JNK-activating kinase 2 (JNKK2), and MKK3/6. MEKK2 plays roles in T cell receptor signaling, immune synapse formation, cytokine gene expression, as well as in EGF and FGF receptor signaling. Length = 265

>gnl|CDD|143364 cd07859, STKc_TDY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants

 Score = 50.5 bits (121), Expect = 8e-07
 Identities = 34/103 (33%), Positives = 52/103 (50%), Gaps = 9/103 (8%)

Query: 392 RGLEYLHLGCSTRILHFDIKPHNILLDEDFCPKISDFGLAKIC-NRKESIISMTGARGTV 450
           R L+Y+H   +  + H D+KP NIL + D   KI DFGLA++  N   + I  T    T 
Sbjct: 114 RALKYIH---TANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYVATR 170

Query: 451 GYIAPEVFCRNIGEVSYKSDVYNYGMMIFEMTGGR-----KNV 488
            Y APE+      + +   D+++ G +  E+  G+     KNV
Sbjct: 171 WYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNV 213

Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. Arabidopsis thaliana contains more TEY-type MAPKs than TDY-type, whereas the reverse is true for Oryza sativa. This subfamily represents the TDY subtype and is composed of Group D plant MAPKs including Arabidopsis thaliana MPK18 (AtMPK18), Oryza sativa Blast- and Wound-induced MAPK1 (OsBWMK1), OsWJUMK1 (Wound- and JA-Uninducible MAPK1), Zea mays MPK6, and the Medicago sativa TDY1 gene product. OsBWMK1 enhances resistance to pathogenic infections. It mediates stress-activated defense responses by activating a transcription factor that affects the expression of stress-related genes. AtMPK18 is involved in microtubule-related functions. Length = 338

>gnl|CDD|132971 cd06640, STKc_MST4, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4

 Score = 50.1 bits (119), Expect = 9e-07
 Identities = 52/198 (26%), Positives = 90/198 (45%), Gaps = 44/198 (22%)

Query: 320 KLGQGGYGSVYKGKLLDG---SNVAVKV--LNDSKGNGKEFINEVASISRTSHVNVVALL 374
           ++G+G +G V+KG  +D      VA+K+  L +++   ++   E+  +S+     V    
Sbjct: 11  RIGKGSFGEVFKG--IDNRTQQVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYY 68

Query: 375 GFCLR------VAEELSSTIG--------------------IARGLEYLHLGCSTRILHF 408
           G  L+      + E L                         I +GL+YLH   S + +H 
Sbjct: 69  GSYLKGTKLWIIMEYLGGGSALDLLRAGPFDEFQIATMLKEILKGLDYLH---SEKKIHR 125

Query: 409 DIKPHNILLDEDFCPKISDFGLAKICNRKESIISMTGARGTVGYIAPEVFCRNIGEVSY- 467
           DIK  N+LL E    K++DFG+A      ++ I      GT  ++APEV    I + +Y 
Sbjct: 126 DIKAANVLLSEQGDVKLADFGVAG--QLTDTQIKRNTFVGTPFWMAPEV----IQQSAYD 179

Query: 468 -KSDVYNYGMMIFEMTGG 484
            K+D+++ G+   E+  G
Sbjct: 180 SKADIWSLGITAIELAKG 197

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by interacting with the Golgi matrix protein GM130 and may play a role in cell migration. Length = 277

>gnl|CDD|173677 cd05586, STKc_Sck1_like, Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases

 Score = 50.3 bits (120), Expect = 9e-07
 Identities = 34/91 (37%), Positives = 50/91 (54%), Gaps = 6/91 (6%)

Query: 394 LEYLHLGCSTRILHFDIKPHNILLDEDFCPKISDFGLAKICNRKESIISMTGARGTVGYI 453
           LE+LH      I++ D+KP NILLD      + DFGL+K  N  ++  + T   GT  Y+
Sbjct: 109 LEHLH---KYDIVYRDLKPENILLDATGHIALCDFGLSK-ANLTDNKTTNTFC-GTTEYL 163

Query: 454 APEVFCRNIGEVSYKSDVYNYGMMIFEMTGG 484
           APEV     G  +   D ++ G+++FEM  G
Sbjct: 164 APEVLLDEKG-YTKHVDFWSLGVLVFEMCCG 193

Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of yeast to environmental changes. Length = 330

>gnl|CDD|132976 cd06645, STKc_MAP4K3, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3

 Score = 50.1 bits (119), Expect = 1e-06
 Identities = 53/172 (30%), Positives = 74/172 (43%), Gaps = 44/172 (25%)

Query: 320 KLGQGGYGSVYKGKLLD-GSNVAVKVLNDSKGNGKEFIN-EVASISRTSHVNVVALLGFC 377
           ++G G YG VYK + ++ G   A+KV+    G     +  E+  +    H N+VA  G  
Sbjct: 16  RIGSGTYGDVYKARNVNTGELAAIKVIKLEPGEDFAVVQQEIIMMKDCKHSNIVAYFGSY 75

Query: 378 LR-----VAEELS---------------STIGIA-------RGLEYLHLGCSTRILHFDI 410
           LR     +  E                 S   IA       +GL YLH   S   +H DI
Sbjct: 76  LRRDKLWICMEFCGGGSLQDIYHVTGPLSESQIAYVSRETLQGLYYLH---SKGKMHRDI 132

Query: 411 KPHNILLDEDFCPKISDFGL-----AKICNRKESIISMTGARGTVGYIAPEV 457
           K  NILL ++   K++DFG+     A I  RK  I       GT  ++APEV
Sbjct: 133 KGANILLTDNGHVKLADFGVSAQITATIAKRKSFI-------GTPYWMAPEV 177

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. MAP4K3 is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. mTOR regulates ribosome biogenesis and protein translation, and is frequently deregulated in cancer. Length = 267

>gnl|CDD|132984 cd06653, STKc_MEKK3_like_1, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

 Score = 50.0 bits (119), Expect = 1e-06
 Identities = 63/204 (30%), Positives = 86/204 (42%), Gaps = 54/204 (26%)

Query: 321 LGQGGYGSVYKGKLLD-GSNVAVKVLN---DSKGNGKEFIN----EVASISRTSHVNVVA 372
           LG+G +G VY     D G  +AVK +    DS+   KE +N    E+  +    H  +V 
Sbjct: 10  LGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKE-VNALECEIQLLKNLRHDRIVQ 68

Query: 373 LLGFCLRVAEELSSTI------------------------------GIARGLEYLHLGCS 402
             G CLR  EE   +I                               I +G+ YLH   S
Sbjct: 69  YYG-CLRDPEEKKLSIFVEYMPGGSIKDQLKAYGALTENVTRRYTRQILQGVSYLH---S 124

Query: 403 TRILHFDIKPHNILLDEDFCPKISDFGLAK----ICNRKESIISMTGARGTVGYIAPEVF 458
             I+H DIK  NIL D     K+ DFG +K    IC     I S+T   GT  +++PEV 
Sbjct: 125 NMIVHRDIKGANILRDSAGNVKLGDFGASKRIQTICMSGTGIKSVT---GTPYWMSPEVI 181

Query: 459 CRNIGE-VSYKSDVYNYGMMIFEM 481
               GE    K+DV++    + EM
Sbjct: 182 S---GEGYGRKADVWSVACTVVEM 202

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 264

>gnl|CDD|173710 cd05620, STKc_nPKC_delta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta

 Score = 50.3 bits (120), Expect = 1e-06
 Identities = 32/96 (33%), Positives = 55/96 (57%), Gaps = 13/96 (13%)

Query: 393 GLEYLHLGCSTRILHFDIKPHNILLDEDFCPKISDFGLAKICNRKESIISMTGAR---GT 449
           GL++LH   S  I++ D+K  N++LD D   KI+DFG+      KE++     A    GT
Sbjct: 108 GLQFLH---SKGIIYRDLKLDNVMLDRDGHIKIADFGMC-----KENVFGDNRASTFCGT 159

Query: 450 VGYIAPEVFCRNIGEVSYKSDVYNYGMMIFEMTGGR 485
             YIAPE+      + ++  D +++G++++EM  G+
Sbjct: 160 PDYIAPEILQGL--KYTFSVDWWSFGVLLYEMLIGQ 193

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. It slows down cell proliferation, inducing cell cycle arrest and enhancing cell differentiation. PKC-delta is also involved in the regulation of transcription as well as immune and inflammatory responses. It plays a central role in the genotoxic stress response that leads to DNA damaged-induced apoptosis. Length = 316

>gnl|CDD|173712 cd05622, STKc_ROCK1, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1

 Score = 50.4 bits (120), Expect = 1e-06
 Identities = 34/100 (34%), Positives = 53/100 (53%), Gaps = 6/100 (6%)

Query: 387 TIGIARGLEYLHLGCSTRILHFDIKPHNILLDEDFCPKISDFGLAKICNRKESIISMTGA 446
           T  +   L+ +H   S   +H D+KP N+LLD+    K++DFG     N KE ++    A
Sbjct: 148 TAEVVLALDAIH---SMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMN-KEGMVRCDTA 203

Query: 447 RGTVGYIAPEVFCRNIGEVSY--KSDVYNYGMMIFEMTGG 484
            GT  YI+PEV     G+  Y  + D ++ G+ ++EM  G
Sbjct: 204 VGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVG 243

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, and kidney. It mediates signaling from Rho to the actin cytoskeleton. It is implicated in the development of cardiac fibrosis, cardiomyocyte apoptosis, and hyperglycemia. Mice deficient with ROCK1 display eyelids open at birth (EOB) and omphalocele phenotypes due to the disorganization of actin filaments in the eyelids and the umbilical ring. Length = 371

>gnl|CDD|88519 cd05618, STKc_aPKC_iota, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota

 Score = 50.1 bits (119), Expect = 1e-06
 Identities = 36/103 (34%), Positives = 53/103 (51%), Gaps = 9/103 (8%)

Query: 390 IARGLEYLHLGCSTRILHFDIKPHNILLDEDFCPKISDFGLAKICNRKESIISMTGARGT 449
           I+  L YLH      I++ D+K  N+LLD +   K++D+G+ K   R     S     GT
Sbjct: 105 ISLALNYLH---ERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTTSTFC--GT 159

Query: 450 VGYIAPEVFCRNIGE-VSYKSDVYNYGMMIFEMTGGRKNVDVV 491
             YIAPE+     GE   +  D +  G+++FEM  GR   D+V
Sbjct: 160 PNYIAPEIL---RGEDYGFSVDWWALGVLMFEMMAGRSPFDIV 199

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target of tumor-specific gene amplification in many human cancers, and has been identified as a human oncogene. In addition to its role in transformed growth, PKC-iota also promotes invasion, chemoresistance, and tumor cell survival. Expression profiling of PKC-iota is a prognostic marker of poor clinical outcome in several human cancers. PKC-iota also plays a role in establishing cell polarity, and has critical embryonic functions. Length = 329

>gnl|CDD|173708 cd05617, STKc_aPKC_zeta, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta

 Score = 50.0 bits (119), Expect = 1e-06
 Identities = 35/105 (33%), Positives = 52/105 (49%), Gaps = 8/105 (7%)

Query: 390 IARGLEYLHLGCSTRILHFDIKPHNILLDEDFCPKISDFGLAKICNRKESIISMTGARGT 449
           I   L +LH      I++ D+K  N+LLD D   K++D+G+ K         S     GT
Sbjct: 105 ICIALNFLH---ERGIIYRDLKLDNVLLDADGHIKLTDYGMCKEGLGPGDTTSTFC--GT 159

Query: 450 VGYIAPEVFCRNIGEVSYKSDVYNYGMMIFEMTGGRKNVDVV-DN 493
             YIAPE+      E  +  D +  G+++FEM  GR   D++ DN
Sbjct: 160 PNYIAPEILRGE--EYGFSVDWWALGVLMFEMMAGRSPFDIITDN 202

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways. PKC-zeta also plays a central role in maintaining cell polarity in yeast and mammalian cells. In addition, it affects actin remodeling in muscle cells. Length = 327

>gnl|CDD|143359 cd07854, STKc_MAPK4_6, Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6

 Score = 50.2 bits (120), Expect = 1e-06
 Identities = 22/43 (51%), Positives = 30/43 (69%), Gaps = 4/43 (9%)

Query: 392 RGLEYLHLGCSTRILHFDIKPHNILLD-EDFCPKISDFGLAKI 433
           RGL+Y+H   S  +LH D+KP N+ ++ ED   KI DFGLA+I
Sbjct: 125 RGLKYIH---SANVLHRDLKPANVFINTEDLVLKIGDFGLARI 164

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progression in certain conditions. It may also play a role in glucose-induced insulin secretion. MAPK6 and MAPK4 cooperate to regulate the activity of MAPK-activated protein kinase 5 (MK5), leading to its relocation to the cytoplasm and exclusion from the nucleus. The MAPK6/MK5 and MAPK4/MK5 pathways may play critical roles in embryonic and post-natal development. Length = 342

>gnl|CDD|173685 cd05594, STKc_PKB_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha

 Score = 50.0 bits (119), Expect = 1e-06
 Identities = 35/99 (35%), Positives = 52/99 (52%), Gaps = 12/99 (12%)

Query: 390 IARGLEYLHLGCSTRILHFDIKPHNILLDEDFCPKISDFGLAKICNRKESI---ISMTGA 446
           I   L+YLH      +++ D+K  N++LD+D   KI+DFGL      KE I    +M   
Sbjct: 104 IVSALDYLH--SEKNVVYRDLKLENLMLDKDGHIKITDFGLC-----KEGIKDGATMKTF 156

Query: 447 RGTVGYIAPEVFCRNIGEVSYKSDVYNYGMMIFEMTGGR 485
            GT  Y+APEV   N  +     D +  G++++EM  GR
Sbjct: 157 CGTPEYLAPEVLEDN--DYGRAVDWWGLGVVMYEMMCGR 193

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficient in PKB-alpha exhibit perinatal morbidity, growth retardation, reduction in body weight accompanied by reduced sizes of multiple organs, and enhanced apoptosis in some cell types. PKB-alpha activity has been reported to be frequently elevated in breast and prostate cancers. In some cancer cells, PKB-alpha may act as a suppressor of metastasis. Length = 325

>gnl|CDD|133181 cd05050, PTKc_Musk, Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase

 Score = 49.8 bits (119), Expect = 1e-06
 Identities = 50/224 (22%), Positives = 87/224 (38%), Gaps = 74/224 (33%)

Query: 321 LGQGGYGSVYKGKLL------DGSNVAVKVLND--SKGNGKEFINEVASISRTSHVNVVA 372
           +GQG +G V++ +          + VAVK+L +  S     +F  E A ++   H N+V 
Sbjct: 13  IGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDHPNIVK 72

Query: 373 LLGFC-------------------------------------------------LRVAEE 383
           LLG C                                                 L   E+
Sbjct: 73  LLGVCAVGKPMCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQ 132

Query: 384 LSSTIGIARGLEYLHLGCSTRILHFDIKPHNILLDEDFCPKISDFGLAKICNRKESIISM 443
           L     +A G+ YL      + +H D+   N L+ E+   KI+DFGL++      +I S 
Sbjct: 133 LCIAKQVAAGMAYL---SERKFVHRDLATRNCLVGENMVVKIADFGLSR------NIYSA 183

Query: 444 TGARGT------VGYIAPEVFCRNIGEVSYKSDVYNYGMMIFEM 481
              + +      + ++ PE    N    + +SDV+ YG++++E+
Sbjct: 184 DYYKASENDAIPIRWMPPESIFYN--RYTTESDVWAYGVVLWEI 225

Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates Musk autophosphorylation and activation, leading to the clustering of acetylcholine receptors (AChRs). To date, there is no evidence to suggest that agrin binds directly to Musk. Mutations in AChR, Musk and other partners are responsible for diseases of the NMJ, such as the autoimmune syndrome myasthenia gravis. Length = 288

>gnl|CDD|133228 cd05097, PTKc_DDR_like, Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases

 Score = 49.6 bits (118), Expect = 1e-06
 Identities = 51/221 (23%), Positives = 91/221 (41%), Gaps = 61/221 (27%)

Query: 317 FKYKLGQGGYGSVYKGK-------LLDGSN--------VAVKVLN-DSKGNGK-EFINEV 359
            K KLG+G +G V+  +       L +G+         VAVK+L  D     + +F+ E+
Sbjct: 9   LKEKLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADVTKTARNDFLKEI 68

Query: 360 ASISRTSHVNVVALLGFCLR---------------------------------------V 380
             +SR  + N++ LLG C+                                        +
Sbjct: 69  KIMSRLKNPNIIRLLGVCVSDDPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSI 128

Query: 381 AEELSSTIGIARGLEYLHLGCSTRILHFDIKPHNILLDEDFCPKISDFGLAKICNRKESI 440
           A  L   + IA G++YL    S   +H D+   N L+   +  KI+DFG+++     +  
Sbjct: 129 ANLLYMAVQIASGMKYL---ASLNFVHRDLATRNCLVGNHYTIKIADFGMSRNLYSGDYY 185

Query: 441 ISMTGARGTVGYIAPEVFCRNIGEVSYKSDVYNYGMMIFEM 481
                A   + ++A E     +G+ +  SDV+ +G+ ++EM
Sbjct: 186 RIQGRAVLPIRWMAWESIL--LGKFTTASDVWAFGVTLWEM 224

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 295

>gnl|CDD|173705 cd05614, STKc_MSK2_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2

 Score = 49.6 bits (118), Expect = 2e-06
 Identities = 38/98 (38%), Positives = 54/98 (55%), Gaps = 11/98 (11%)

Query: 390 IARGLEYLH-LGCSTRILHFDIKPHNILLDEDFCPKISDFGLAK--ICNRKESIISMTGA 446
           I   LE+LH LG    I++ DIK  NILLD +    ++DFGL+K  +   KE   S    
Sbjct: 114 IILALEHLHKLG----IVYRDIKLENILLDSEGHVVLTDFGLSKEFLSEEKERTYSFC-- 167

Query: 447 RGTVGYIAPEVFCRNIGEVSYKSDVYNYGMMIFEMTGG 484
            GT+ Y+APE+  R  G      D ++ G++IFE+  G
Sbjct: 168 -GTIEYMAPEII-RGKGGHGKAVDWWSLGILIFELLTG 203

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK2 and MSK1 play nonredundant roles in activating histone H3 kinases, which play pivotal roles in compaction of the chromatin fiber. MSK2 is the required H3 kinase in response to stress stimuli and activation of the p38 MAPK pathway. MSK2 also plays a role in the pathogenesis of psoriasis. Length = 332

>gnl|CDD|140289 PTZ00263, PTZ00263, protein kinase A catalytic subunit; Provisional

 Score = 49.4 bits (118), Expect = 2e-06
 Identities = 32/92 (34%), Positives = 50/92 (54%), Gaps = 14/92 (15%)

Query: 395 EYLHLGCSTRILHFDIKPHNILLDEDFCPKISDFGLAK-ICNRKESIISMTGARGTVGYI 453
           EYLH   S  I++ D+KP N+LLD     K++DFG AK + +R  ++       GT  Y+
Sbjct: 132 EYLH---SKDIIYRDLKPENLLLDNKGHVKVTDFGFAKKVPDRTFTLC------GTPEYL 182

Query: 454 APEVF-CRNIGEVSYKSDVYNYGMMIFEMTGG 484
           APEV   +  G+     D +  G++++E   G
Sbjct: 183 APEVIQSKGHGKA---VDWWTMGVLLYEFIAG 211

Length = 329

>gnl|CDD|132951 cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases

 Score = 49.0 bits (117), Expect = 2e-06
 Identities = 35/100 (35%), Positives = 54/100 (54%), Gaps = 10/100 (10%)

Query: 387 TIGIARGLEYLHLGCSTRILHFDIKPHNILLDEDFCPKISDFGLAKICNRKESIISMTGA 446
            + +  GL YL+     RI+H DIKP NIL++     K+ DFG++      E I S+   
Sbjct: 109 AVAVVEGLTYLYN--VHRIMHRDIKPSNILVNSRGQIKLCDFGVS-----GELINSIADT 161

Query: 447 -RGTVGYIAPEVFCRNIGEVSYKSDVYNYGMMIFEMTGGR 485
             GT  Y++PE      G+ + KSDV++ G+ I E+  G+
Sbjct: 162 FVGTSTYMSPERI--QGGKYTVKSDVWSLGISIIELALGK 199

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Byr1 from Schizosaccharomyces pombe, FUZ7 from Ustilago maydis, and related proteins. Byr1 phosphorylates its downstream target, the MAPK Spk1, and is regulated by the MAPKKK Byr2. The Spk1 cascade is pheromone-responsive and is essential for sporulation and sexual differentiation in fission yeast. FUZ7 phosphorylates and activates its target, the MAPK Crk1, which is required in mating and virulence in U. maydis. Length = 284

>gnl|CDD|173735 cd07831, STKc_MOK, Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase

 Score = 49.2 bits (118), Expect = 2e-06
 Identities = 47/200 (23%), Positives = 76/200 (38%), Gaps = 49/200 (24%)

Query: 320 KLGQGGYGSVYKGK-LLDGSNVAVKVLNDSKGNGKEFINEVASI----SRTSHVNVVALL 374
           K+G+G +  V K +    G   A+K +        E +N +  I      + H N++ L+
Sbjct: 6   KIGEGTFSEVLKAQSRKTGKYYAIKCMKK-HFKSLEQVNNLREIQALRRLSPHPNILRLI 64

Query: 375 GF-------CLRVAEEL-----------------SSTIG-----IARGLEYLHLGCSTRI 405
                     L +  EL                    +      + + L+++H      I
Sbjct: 65  EVLFDRKTGRLALVFELMDMNLYELIKGRKRPLPEKRVKSYMYQLLKSLDHMH---RNGI 121

Query: 406 LHFDIKPHNILLDEDFCPKISDFGLAKICNRKE---SIISMTGARGTVGYIAPEVFCRNI 462
            H DIKP NIL+ +D   K++DFG  +    K      IS      T  Y APE    + 
Sbjct: 122 FHRDIKPENILIKDD-ILKLADFGSCRGIYSKPPYTEYIS------TRWYRAPECLLTD- 173

Query: 463 GEVSYKSDVYNYGMMIFEMT 482
           G    K D++  G + FE+ 
Sbjct: 174 GYYGPKMDIWAVGCVFFEIL 193

Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. Length = 282

>gnl|CDD|173683 cd05592, STKc_nPKC_theta_delta, Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta

 Score = 49.4 bits (118), Expect = 2e-06
 Identities = 35/100 (35%), Positives = 57/100 (57%), Gaps = 15/100 (15%)

Query: 390 IARGLEYLHLGCSTRILHFDIKPHNILLDEDFCPKISDFGLAKICNRKESIISMTGAR-- 447
           I  GL++LH      I++ D+K  N+LLD+D   KI+DFG+      KE++     A   
Sbjct: 105 IICGLQFLH---KKGIIYRDLKLDNVLLDKDGHIKIADFGMC-----KENMNGEGKASTF 156

Query: 448 -GTVGYIAPEVFCRNIGEVSYKS-DVYNYGMMIFEMTGGR 485
            GT  YIAPE+     G+   +S D +++G++++EM  G+
Sbjct: 157 CGTPDYIAPEIL---KGQKYNESVDWWSFGVLLYEMLIGQ 193

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. Length = 316

>gnl|CDD|173706 cd05615, STKc_cPKC_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha

 Score = 48.8 bits (116), Expect = 3e-06
 Identities = 35/111 (31%), Positives = 57/111 (51%), Gaps = 23/111 (20%)

Query: 390 IARGLEYLHLGCSTRILHFDIKPHNILLDEDFCPKISDFGLAKICNRKESIISMTGAR-- 447
           I+ GL +LH      I++ D+K  N++LD +   KI+DFG+      KE ++     R  
Sbjct: 110 ISVGLFFLH---RRGIIYRDLKLDNVMLDSEGHIKIADFGMC-----KEHMVDGVTTRTF 161

Query: 448 -GTVGYIAPEVFCRNIGEVSYKS-----DVYNYGMMIFEMTGGRKNVDVVD 492
            GT  YIAPE+       ++Y+      D + YG++++EM  G+   D  D
Sbjct: 162 CGTPDYIAPEI-------IAYQPYGKSVDWWAYGVLLYEMLAGQPPFDGED 205

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. PKC-alpha is expressed in many tissues and is associated with cell proliferation, apoptosis, and cell motility. It plays a role in the signaling of the growth factors PDGF, VEGF, EGF, and FGF. Abnormal levels of PKC-alpha have been detected in many transformed cell lines and several human tumors. In addition, PKC-alpha is required for HER2 dependent breast cancer invasion. Length = 323

>gnl|CDD|132981 cd06650, PKc_MEK1, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1

 Score = 48.9 bits (116), Expect = 3e-06
 Identities = 38/111 (34%), Positives = 61/111 (54%), Gaps = 14/111 (12%)

Query: 379 RVAEELSSTIGIA--RGLEYLHLGCSTRILHFDIKPHNILLDEDFCPKISDFGLAKICNR 436
           R+ E++   + IA  +GL YL      +I+H D+KP NIL++     K+ DFG++     
Sbjct: 99  RIPEQILGKVSIAVIKGLTYLRE--KHKIMHRDVKPSNILVNSRGEIKLCDFGVS----- 151

Query: 437 KESIISMTGA-RGTVGYIAPEVFCRNIG-EVSYKSDVYNYGMMIFEMTGGR 485
            + I SM  +  GT  Y++PE   R  G   S +SD+++ G+ + EM  GR
Sbjct: 152 GQLIDSMANSFVGTRSYMSPE---RLQGTHYSVQSDIWSMGLSLVEMAIGR 199

Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. MEK1 also plays a role in cell cycle control. Length = 333

>gnl|CDD|132949 cd06618, PKc_MKK7, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7

 Score = 48.1 bits (115), Expect = 4e-06
 Identities = 33/104 (31%), Positives = 50/104 (48%), Gaps = 13/104 (12%)

Query: 387 TIGIARGLEYL---HLGCSTRILHFDIKPHNILLDEDFCPKISDFGLAKICNRKESIISM 443
           T+ I + L YL   H      ++H D+KP NILLD     K+ DFG   I  R     + 
Sbjct: 120 TVAIVKALHYLKEKH-----GVIHRDVKPSNILLDASGNVKLCDFG---ISGRLVDSKAK 171

Query: 444 TGARGTVGYIAPEVFCRNIGEVSY--KSDVYNYGMMIFEMTGGR 485
           T + G   Y+APE          Y  ++DV++ G+ + E+  G+
Sbjct: 172 TRSAGCAAYMAPERIDPPDPNPKYDIRADVWSLGISLVELATGQ 215

Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates its downstream target, c-Jun N-terminal kinase (JNK), on specific threonine and tyrosine residues. Although MKK7 is capable of dual phosphorylation, it prefers to phosphorylate the threonine residue of JNK. Thus, optimal activation of JNK requires both MKK4 (not included in this subfamily) and MKK7. MKK7 is primarily activated by cytokines. MKK7 is essential for liver formation during embryogenesis. It plays roles in G2/M cell cycle arrest and cell growth. In addition, it is involved in the control of programmed cell death, which is crucial in oncogenesis, cancer chemoresistance, and antagonism to TNFalpha-induced killing, through its inhibition by Gadd45beta and the subsequent suppression of the JNK cascade. Length = 296

>gnl|CDD|133227 cd05096, PTKc_DDR1, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1

 Score = 48.4 bits (115), Expect = 4e-06
 Identities = 55/233 (23%), Positives = 94/233 (40%), Gaps = 76/233 (32%)

Query: 317 FKYKLGQGGYGSVY--------------------KGKLLDGSNVAVKVLN-DSKGNGK-E 354
           FK KLG+G +G V+                    KG+ L    VAVK+L  D+  N + +
Sbjct: 9   FKEKLGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPL---LVAVKILRPDANKNARND 65

Query: 355 FINEVASISRTSHVNVVALLGFCL-----------------------RVAEE-------- 383
           F+ EV  +SR    N++ LLG C+                          ++        
Sbjct: 66  FLKEVKILSRLKDPNIIRLLGVCVDEDPLCMITEYMENGDLNQFLSSHHLDDKEENGNDA 125

Query: 384 ---------------LSSTIGIARGLEYLHLGCSTRILHFDIKPHNILLDEDFCPKISDF 428
                          L   + IA G++YL    S   +H D+   N L+ E+   KI+DF
Sbjct: 126 VPPAHCLPAISYSSLLHVALQIASGMKYL---SSLNFVHRDLATRNCLVGENLTIKIADF 182

Query: 429 GLAKICNRKESIISMTGARGTVGYIAPEVFCRNIGEVSYKSDVYNYGMMIFEM 481
           G+++     +       A   + ++A E  C  +G+ +  SDV+ +G+ ++E+
Sbjct: 183 GMSRNLYAGDYYRIQGRAVLPIRWMAWE--CILMGKFTTASDVWAFGVTLWEI 233

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in keratinocytes, colonic mucosa epithelium, lung epithelium, thyroid follicles, and the islets of Langerhans. During embryonic development, it is found in the developing neuroectoderm. DDR1 is a key regulator of cell morphogenesis, differentiation and proliferation. It is important in the development of the mammary gland, the vasculator and the kidney. DDR1 is also found in human leukocytes, where it facilitates cell adhesion, migration, maturation, and cytokine production. Length = 304

>gnl|CDD|173666 cd05575, STKc_SGK, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase

 Score = 48.2 bits (115), Expect = 5e-06
 Identities = 39/107 (36%), Positives = 54/107 (50%), Gaps = 19/107 (17%)

Query: 381 AEELSSTIGIARGLEYLHLGCSTRILHFDIKPHNILLDEDFCPKISDFGLAKICNRKESI 440
           A E++S +G      YLH   S  I++ D+KP NILLD      ++DFGL   C  KE I
Sbjct: 102 AAEIASALG------YLH---SLNIIYRDLKPENILLDSQGHVVLTDFGL---C--KEGI 147

Query: 441 -ISMTGAR--GTVGYIAPEVFCRNIGEVSYKSDVYNYGMMIFEMTGG 484
             S T +   GT  Y+APEV  +         D +  G +++EM  G
Sbjct: 148 EHSKTTSTFCGTPEYLAPEVLRKQ--PYDRTVDWWCLGAVLYEMLYG 192

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell proliferation, and apoptosis. Length = 323

>gnl|CDD|173680 cd05589, STKc_PKN, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N

 Score = 48.1 bits (115), Expect = 5e-06
 Identities = 34/92 (36%), Positives = 49/92 (53%), Gaps = 13/92 (14%)

Query: 393 GLEYLHLGCSTRILHFDIKPHNILLDEDFCPKISDFGLAKICNRKESIISMTGAR-GTVG 451
           GL+YLH     +I++ D+K  N+LLD +   KI+DFGL   C         T    GT  
Sbjct: 113 GLQYLH---ENKIVYRDLKLDNLLLDTEGFVKIADFGL---CKEGMGFGDRTSTFCGTPE 166

Query: 452 YIAPEVFCRNIGEVSYKSDV--YNYGMMIFEM 481
           ++APEV    + E SY   V  +  G++I+EM
Sbjct: 167 FLAPEV----LTETSYTRAVDWWGLGVLIYEM 194

Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved in many biological processes including cytokeletal regulation, cell adhesion, vesicle transport, glucose transport, regulation of meiotic maturation and embryonic cell cycles, signaling to the nucleus, and tumorigenesis. Length = 324

>gnl|CDD|133238 cd05107, PTKc_PDGFR_beta, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta

 Score = 48.1 bits (114), Expect = 6e-06
 Identities = 34/120 (28%), Positives = 62/120 (51%), Gaps = 15/120 (12%)

Query: 362 ISRTSHVNVVALLGFCLRVAEELSSTIGIARGLEYLHLGCSTRILHFDIKPHNILLDEDF 421
           I+ +  ++ + L+GF  +VA           G+E+L    S   +H D+   N+L+ E  
Sbjct: 230 INESPALSYMDLVGFSYQVA----------NGMEFL---ASKNCVHRDLAARNVLICEGK 276

Query: 422 CPKISDFGLAKICNRKESIISMTGARGTVGYIAPEVFCRNIGEVSYKSDVYNYGMMIFEM 481
             KI DFGLA+   R  + IS       + ++APE    N+   +  SDV+++G++++E+
Sbjct: 277 LVKICDFGLARDIMRDSNYISKGSTFLPLKWMAPESIFNNL--YTTLSDVWSFGILLWEI 334

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-DD induce PDGFR beta homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR beta signaling leads to a variety of cellular effects including the stimulation of cell growth and chemotaxis, as well as the inhibition of apoptosis and GAP junctional communication. It is critical in normal angiogenesis as it is involved in the recruitment of pericytes and smooth muscle cells essential for vessel stability. Aberrant PDGFR beta expression is associated with some human cancers. The continuously-active fusion proteins of PDGFR beta with COL1A1 and TEL are associated with dermatofibrosarcoma protuberans (DFSP) and a subset of chronic myelomonocytic leukemia (CMML), respectively. Length = 401

>gnl|CDD|133237 cd05106, PTKc_CSF-1R, Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor

 Score = 47.9 bits (114), Expect = 8e-06
 Identities = 31/100 (31%), Positives = 56/100 (56%), Gaps = 9/100 (9%)

Query: 384 LSSTIGIARGLEYLHLGCSTRILHFDIKPHNILLDEDFCPKISDFGLAKICNRKESIISM 443
           L  +  +A+G+++L    S   +H D+   N+LL +    KI DFGLA+      + +  
Sbjct: 215 LRFSSQVAQGMDFL---ASKNCIHRDVAARNVLLTDGRVAKICDFGLARDIMNDSNYVVK 271

Query: 444 TGARGTVGYIAPEVFCRNIGEVSY--KSDVYNYGMMIFEM 481
             AR  V ++APE    +I +  Y  +SDV++YG++++E+
Sbjct: 272 GNARLPVKWMAPE----SIFDCVYTVQSDVWSYGILLWEI 307

Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. It leads to increases in gene transcription and protein translation, and induces cytoskeletal remodeling. CSF-1R signaling leads to a variety of cellular responses including survival, proliferation, and differentiation of target cells. It plays an important role in innate immunity, tissue development and function, and the pathogenesis of some diseases including atherosclerosis and cancer. CSF-1R signaling is also implicated in mammary gland development during pregnancy and lactation. Aberrant CSF-1/CSF-1R expression correlates with tumor cell invasiveness, poor clinical prognosis, and bone metastasis in breast cancer. Although the structure of the human CSF-1R catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 374

>gnl|CDD|133174 cd05042, PTKc_Aatyk, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases

 Score = 47.2 bits (112), Expect = 8e-06
 Identities = 46/205 (22%), Positives = 81/205 (39%), Gaps = 47/205 (22%)

Query: 320 KLGQGGYGSVYKGKLLDGSNVA---VKVLNDSKGNGKE---FINEVASISRTSHVNVVAL 373
           ++G G +G V  G+   G + A   VK L  S     E   F+ EV      +H NV+  
Sbjct: 2   EIGNGWFGKVLLGEAHRGMSKARVVVKELRAS-ATPDEQLLFLQEVQPYRELNHPNVLQC 60

Query: 374 LGFCL------------------------RVAEELSS--------TIGIARGLEYLHLGC 401
           LG C+                        R      +           +A GL +LH   
Sbjct: 61  LGQCIESIPYLLVLEFCPLGDLKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLH--- 117

Query: 402 STRILHFDIKPHNILLDEDFCPKISDFGLAKICNRKESIISMTGARGTVGYIAPEV---F 458
               +H D+   N  L  D   KI D+GLA     ++  I+       + ++APE+    
Sbjct: 118 QADFIHSDLALRNCQLTADLSVKIGDYGLALEQYPEDYYITKDCHAVPLRWLAPELVEIR 177

Query: 459 CRNI--GEVSYKSDVYNYGMMIFEM 481
            +++   + + KS++++ G+ ++E+
Sbjct: 178 GQDLLPKDQTKKSNIWSLGVTMWEL 202

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kinases based on overall sequence similarity and the phylogenetic tree. However, analysis of catalytic residues suggests that Aatyk proteins may be multispecific kinases, functioning also as serine/threonine kinases. They are involved in neural differentiation, nerve growth factor (NGF) signaling, apoptosis, and spermatogenesis. Length = 269

>gnl|CDD|173687 cd05596, STKc_ROCK, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase

 Score = 47.5 bits (113), Expect = 9e-06
 Identities = 32/102 (31%), Positives = 52/102 (50%), Gaps = 10/102 (9%)

Query: 387 TIGIARGLEYLHLGCSTRILHFDIKPHNILLDEDFCPKISDFGLAKICNR--KESIISMT 444
           T  +   L+ +H   S   +H D+KP N+LLD+    K++DFG    C +     ++   
Sbjct: 148 TAEVVLALDAIH---SMGFIHRDVKPDNMLLDKSGHLKLADFG---TCMKMDANGMVRCD 201

Query: 445 GARGTVGYIAPEVFCRNIGEVSY--KSDVYNYGMMIFEMTGG 484
            A GT  YI+PEV     G+  Y  + D ++ G+ ++EM  G
Sbjct: 202 TAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVG 243

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via interaction with Rho GTPases and is involved in many cellular functions including contraction, adhesion, migration, motility, proliferation, and apoptosis. The ROCK subfamily consists of two isoforms, ROCK1 and ROCK2, which may be functionally redundant in some systems, but exhibit different tissue distributions. Both isoforms are ubiquitously expressed in most tissues, but ROCK2 is more prominent in brain and skeletal muscle while ROCK1 is more pronounced in the liver, testes, and kidney. Studies in knockout mice result in different phenotypes, suggesting that the two isoforms do not compensate for each other during embryonic development. Length = 370

>gnl|CDD|173700 cd05609, STKc_MAST, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase

 Score = 46.7 bits (111), Expect = 1e-05
 Identities = 31/85 (36%), Positives = 42/85 (49%), Gaps = 26/85 (30%)

Query: 394 LEYLHLGCSTRILHFDIKPHNILLDEDFCPKISDFGLAKICNRKESIISMT--------- 444
           LEYLH   +  I+H D+KP N+L+      K++DFGL+KI      ++S+T         
Sbjct: 114 LEYLH---NYGIVHRDLKPDNLLITSMGHIKLTDFGLSKI-----GLMSLTTNLYEGHIE 165

Query: 445 -GAR--------GTVGYIAPEVFCR 460
              R        GT  YIAPEV  R
Sbjct: 166 KDTREFLDKQVCGTPEYIAPEVILR 190

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. MAST1, MAST2, and MAST3 bind and phosphorylate the tumor suppressor PTEN, and may contribute to the regulation and stabilization of PTEN. MAST2 is involved in the regulation of the Fc-gamma receptor of the innate immune response in macrophages, and may also be involved in the regulation of the Na+/H+ exchanger NHE3. Length = 305

>gnl|CDD|143381 cd07876, STKc_JNK2, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2

 Score = 46.9 bits (111), Expect = 1e-05
 Identities = 37/109 (33%), Positives = 55/109 (50%), Gaps = 16/109 (14%)

Query: 393 GLEYLHLGCSTRILHFDIKPHNILLDEDFCPKISDFGLAKICNRKESIISMTGARGTVGY 452
           G+++LH   S  I+H D+KP NI++  D   KI DFGLA+          MT    T  Y
Sbjct: 135 GIKHLH---SAGIIHRDLKPSNIVVKSDCTLKILDFGLARTACTN---FMMTPYVVTRYY 188

Query: 453 IAPEVFCRNIGEVSYKS--DVYNYGMMIFEMTGGRKNVDVVDNGSTALD 499
            APEV    I  + YK   D+++ G ++ E+  G     V+  G+  +D
Sbjct: 189 RAPEV----ILGMGYKENVDIWSVGCIMGELVKG----SVIFQGTDHID 229

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK2 is specifically translocated to the mitochondria during dopaminergic cell death. Specific substrates include the microtubule-associated proteins DCX and Tau, as well as TIF-IA which is involved in ribosomal RNA synthesis regulation. Mice deficient in Jnk2 show protection against arthritis, type 1 diabetes, atherosclerosis, abdominal aortic aneurysm, cardiac cell death, TNF-induced liver damage, and tumor growth, indicating that JNK2 may play roles in the pathogenesis of these diseases. Length = 359

>gnl|CDD|173632 cd05051, PTKc_DDR, Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors

 Score = 46.6 bits (111), Expect = 2e-05
 Identities = 44/171 (25%), Positives = 64/171 (37%), Gaps = 60/171 (35%)

Query: 316 SFKYKLGQGGYGSVY------------KGKLLDGSN-----VAVKVL--NDSKGNGKEFI 356
           +F  KLG+G +G V+            K    + +      VAVKVL  + S    ++F+
Sbjct: 8   NFVEKLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDASDNAREDFL 67

Query: 357 NEVASISRTSHVNVVALLGFCLR-----------------------VAEELSSTIG---- 389
            EV  +SR S  N+  LLG C                         VAE           
Sbjct: 68  KEVKILSRLSDPNIARLLGVCTVDPPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSL 127

Query: 390 -----------IARGLEYLHLGCSTRILHFDIKPHNILLDEDFCPKISDFG 429
                      IA G+ YL    S   +H D+   N L+ +++  KI+DFG
Sbjct: 128 SFSTLLYMATQIASGMRYLE---SLNFVHRDLATRNCLVGKNYTIKIADFG 175

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 296

>gnl|CDD|173711 cd05621, STKc_ROCK2, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2

 Score = 46.6 bits (110), Expect = 2e-05
 Identities = 33/102 (32%), Positives = 54/102 (52%), Gaps = 10/102 (9%)

Query: 387 TIGIARGLEYLHLGCSTRILHFDIKPHNILLDEDFCPKISDFGLAKICNRKES--IISMT 444
           T  +   L+ +H   S  ++H D+KP N+LLD+    K++DFG    C + +   ++   
Sbjct: 148 TAEVVLALDAIH---SMGLIHRDVKPDNMLLDKHGHLKLADFG---TCMKMDETGMVRCD 201

Query: 445 GARGTVGYIAPEVFCRNIGEVSY--KSDVYNYGMMIFEMTGG 484
            A GT  YI+PEV     G+  Y  + D ++ G+ +FEM  G
Sbjct: 202 TAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVG 243

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found to play a role in stress fiber and focal adhesion formation. It is prominently expressed in the brain, heart, and skeletal muscles. It is implicated in vascular and neurological disorders, such as hypertension and vasospasm of the coronary and cerebral arteries. ROCK2 is also activated by caspase-2 cleavage, resulting in thrombin-induced microparticle generation in response to cell activation. Mice deficient in ROCK2 show intrauterine growth retardation and embryonic lethality because of placental dysfunction. Length = 370

>gnl|CDD|173707 cd05616, STKc_cPKC_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta

 Score = 46.1 bits (109), Expect = 2e-05
 Identities = 34/101 (33%), Positives = 57/101 (56%), Gaps = 17/101 (16%)

Query: 390 IARGLEYLHLGCSTRILHFDIKPHNILLDEDFCPKISDFGLAKICNRKESIISMTGARGT 449
           IA GL +LH   S  I++ D+K  N++LD +   KI+DFG+ K  N  + + + T   GT
Sbjct: 110 IAIGLFFLH---SKGIIYRDLKLDNVMLDSEGHIKIADFGMCKE-NMWDGVTTKTFC-GT 164

Query: 450 VGYIAPEVFCRNIGEVSYKS-----DVYNYGMMIFEMTGGR 485
             YIAPE+       ++Y+      D + +G++++EM  G+
Sbjct: 165 PDYIAPEI-------IAYQPYGKSVDWWAFGVLLYEMLAGQ 198

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. The PKC beta isoforms (I and II), generated by alternative splicing of a single gene, are preferentially activated by hyperglycemia-induced DAG in retinal tissues. This is implicated in diabetic microangiopathy such as ischemia, neovascularization, and abnormal vasodilator function. PKC-beta also plays an important role in VEGF signaling. In addition, glucose regulates proliferation in retinal endothelial cells via PKC-betaI. PKC-beta is also being explored as a therapeutic target in cancer. It contributes to tumor formation and is involved in the tumor host mechanisms of inflammation and angiogenesis. Length = 323

>gnl|CDD|132969 cd06638, STKc_myosinIIIA, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin

 Score = 45.8 bits (108), Expect = 2e-05
 Identities = 55/207 (26%), Positives = 89/207 (42%), Gaps = 50/207 (24%)

Query: 321 LGQGGYGSVYK-GKLLDGSNVAVKVLNDSKGNGKEFINEVASISRTS-HVNVVALLG--- 375
           +G+G YG V+K     +GS  AVK+L+      +E   E   +   S H NVV   G   
Sbjct: 26  IGKGTYGKVFKVLNKKNGSKAAVKILDPIHDIDEEIEAEYNILKALSDHPNVVKFYGMYY 85

Query: 376 ---------------FC------------LRVAEELSSTIGIA-------RGLEYLHLGC 401
                           C            L+  E +   I IA        GL++LH   
Sbjct: 86  KKDVKNGDQLWLVLELCNGGSVTDLVKGFLKRGERMEEPI-IAYILHEALMGLQHLH--- 141

Query: 402 STRILHFDIKPHNILLDEDFCPKISDFGL-AKICNRKESIISMTGARGTVGYIAPEVF-C 459
             + +H D+K +NILL  +   K+ DFG+ A++ + +   +    + GT  ++APEV  C
Sbjct: 142 VNKTIHRDVKGNNILLTTEGGVKLVDFGVSAQLTSTR---LRRNTSVGTPFWMAPEVIAC 198

Query: 460 RNIGEVSY--KSDVYNYGMMIFEMTGG 484
               + +Y  + DV++ G+   E+  G
Sbjct: 199 EQQLDSTYDARCDVWSLGITAIELGDG 225

Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear hair cells. It is localized to the distal ends of actin-bundled structures. Mutations in human myosin IIIA are responsible for progressive nonsyndromic hearing loss. Human myosin IIIA possesses ATPase and kinase activities, and the ability to move actin filaments in a motility assay. It may function as a cellular transporter capable of moving along actin bundles in sensory cells. Length = 286

>gnl|CDD|173704 cd05613, STKc_MSK1_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1

 Score = 45.8 bits (108), Expect = 2e-05
 Identities = 34/99 (34%), Positives = 53/99 (53%), Gaps = 11/99 (11%)

Query: 390 IARGLEYLH-LGCSTRILHFDIKPHNILLDEDFCPKISDFGLAK--ICNRKESIISMTGA 446
           I   LE+LH LG    I++ DIK  NILLD +    ++DFGL+K    +  E   S    
Sbjct: 114 IVLALEHLHKLG----IIYRDIKLENILLDSNGHVVLTDFGLSKEFHEDEVERAYSFC-- 167

Query: 447 RGTVGYIAPEVFCRNIGEVSYKSDVYNYGMMIFE-MTGG 484
            GT+ Y+AP++     G      D ++ G++++E +TG 
Sbjct: 168 -GTIEYMAPDIVRGGDGGHDKAVDWWSMGVLMYELLTGA 205

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK1 plays a role in the regulation of translational control and transcriptional activation. It phosphorylates the transcription factors, CREB and NFkappaB. It also phosphorylates the nucleosomal proteins H3 and HMG-14. Increased phosphorylation of MEK1 is associated with the development of cerebral ischemic/hypoxic preconditioning. Length = 290

>gnl|CDD|173681 cd05590, STKc_nPKC_eta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta

 Score = 45.7 bits (108), Expect = 3e-05
 Identities = 33/99 (33%), Positives = 51/99 (51%), Gaps = 15/99 (15%)

Query: 390 IARGLEYLHLGCSTRILHFDIKPHNILLDEDFCPKISDFGLAK--ICNRKESIISMTGAR 447
           I   L +LH      I++ D+K  N+LLD +   K++DFG+ K  I N      + T   
Sbjct: 105 ITSALMFLH---DKGIIYRDLKLDNVLLDHEGHCKLADFGMCKEGIFN---GKTTSTFC- 157

Query: 448 GTVGYIAPEVFCRNIGEVSYKSDV--YNYGMMIFEMTGG 484
           GT  YIAPE+    + E+ Y   V  +  G++++EM  G
Sbjct: 158 GTPDYIAPEI----LQEMLYGPSVDWWAMGVLLYEMLCG 192

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signaling of cell-type specific differentiation. It is also expressed in pro-B cells and early-stage thymocytes, and acts as a key regulator in early B-cell development. PKC-eta increases glioblastoma multiforme (GBM) proliferation and resistance to radiation, and is being developed as a therapeutic target for the management of GBM. Length = 320

>gnl|CDD|173753 cd07864, STKc_CDK12, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12

 Score = 45.2 bits (107), Expect = 4e-05
 Identities = 33/91 (36%), Positives = 46/91 (50%), Gaps = 9/91 (9%)

Query: 393 GLEYLHLGCSTRILHFDIKPHNILLDEDFCPKISDFGLAKICNRKESIISMTGARGTVGY 452
           GL Y H       LH DIK  NILL+     K++DFGLA++ N  E     T    T+ Y
Sbjct: 128 GLNYCH---KKNFLHRDIKCSNILLNNKGQIKLADFGLARLYN-SEESRPYTNKVITLWY 183

Query: 453 IAPEVFCRNIGEVSYKS--DVYNYGMMIFEM 481
             PE+    +GE  Y    DV++ G ++ E+
Sbjct: 184 RPPELL---LGEERYGPAIDVWSCGCILGEL 211

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely expressed in tissues. It interacts with cyclins L1 and L2, and plays roles in regulating transcription and alternative splicing. Length = 302

>gnl|CDD|143372 cd07867, STKc_CDC2L6, Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6

 Score = 45.4 bits (107), Expect = 4e-05
 Identities = 55/214 (25%), Positives = 84/214 (39%), Gaps = 55/214 (25%)

Query: 317 FKY---KLGQGGYGSVYKGKLLDGSNVAVKVLNDSKGNGKEF--INEVASISRTSHVNVV 371
           F+Y   K+G+G YG VYK K  DG +     L   +G G       E+A +    H NV+
Sbjct: 2   FEYEGCKVGRGTYGHVYKAKRKDGKDEKEYALKQIEGTGISMSACREIALLRELKHPNVI 61

Query: 372 ALLGFCL-------------------------RVAEELSSTIGIAR------------GL 394
           AL    L                         R ++     + + R            G+
Sbjct: 62  ALQKVFLSHSDRKVWLLFDYAEHDLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGI 121

Query: 395 EYLHLGCSTRILHFDIKPHNILL----DEDFCPKISDFGLAKICNRK-ESIISMTGARGT 449
            YLH   +  +LH D+KP NIL+     E    KI+D G A++ N   + +  +     T
Sbjct: 122 HYLH---ANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVVT 178

Query: 450 VGYIAPEVFCRNIGEVSYKS--DVYNYGMMIFEM 481
             Y APE+    +G   Y    D++  G +  E+
Sbjct: 179 FWYRAPELL---LGARHYTKAIDIWAIGCIFAEL 209

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as the caspase-processed CDK11(p46). CDK11(p110), CDK11(p58), and CDK11(p46)do not belong to this subfamily. CDC2L6 is an associated protein of Mediator, a multiprotein complex that provides a platform to connect transcriptional and chromatin regulators and cofactors, in order to activate and mediate RNA polymerase II transcription. CDC2L6 is localized mainly in the nucleus amd exerts an opposing effect to CDK8 in VP16-dependent transcriptional activation by being a negative regulator. Length = 317

>gnl|CDD|173333 PTZ00036, PTZ00036, glycogen synthase kinase; Provisional

 Score = 45.4 bits (107), Expect = 4e-05
 Identities = 62/247 (25%), Positives = 101/247 (40%), Gaps = 79/247 (31%)

Query: 298 RSLSPKRYGYADIKKM-------TNSFKYKLGQ----GGYGSVYKGKLLDGS-NVAVK-V 344
           RS +       D +KM       + +  YKLG     G +G VY+   +D S  VA+K V
Sbjct: 40  RSHNNNAGEDEDEEKMIDNDINRSPNKSYKLGNIIGNGSFGVVYEAICIDTSEKVAIKKV 99

Query: 345 LNDSKGNGKEFINEVASISRTSHVNVVALLGF----CLR----------VAEELSSTI-- 388
           L D +   +E +     +   +H+N++ L  +    C +          V E +  T+  
Sbjct: 100 LQDPQYKNRELL----IMKNLNHINIIFLKDYYYTECFKKNEKNIFLNVVMEFIPQTVHK 155

Query: 389 ----------------------GIARGLEYLHLGCSTRILHFDIKPHNILLDED-FCPKI 425
                                  + R L Y+H   S  I H D+KP N+L+D +    K+
Sbjct: 156 YMKHYARNNHALPLFLVKLYSYQLCRALAYIH---SKFICHRDLKPQNLLIDPNTHTLKL 212

Query: 426 SDFGLAKICNRKESIISMTGARGTVGYI------APEVFCRNIGEVSYKS--DVYNYGMM 477
            DFG AK         ++   + +V YI      APE+    +G  +Y +  D+++ G +
Sbjct: 213 CDFGSAK---------NLLAGQRSVSYICSRFYRAPELM---LGATNYTTHIDLWSLGCI 260

Query: 478 IFEMTGG 484
           I EM  G
Sbjct: 261 IAEMILG 267

Length = 440

>gnl|CDD|143373 cd07868, STKc_CDK8, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8

 Score = 45.0 bits (106), Expect = 4e-05
 Identities = 54/214 (25%), Positives = 84/214 (39%), Gaps = 55/214 (25%)

Query: 317 FKY---KLGQGGYGSVYKGKLLDGSNVAVKVLNDSKGNGKEF--INEVASISRTSHVNVV 371
           F+Y   K+G+G YG VYK K  DG +     L   +G G       E+A +    H NV+
Sbjct: 2   FEYEGCKVGRGTYGHVYKAKRKDGKDDRDYALKQIEGTGISMSACREIALLRELKHPNVI 61

Query: 372 ALLGFCL-------------------------RVAEELSSTIGIARGL------------ 394
           +L    L                         R ++     + + RG+            
Sbjct: 62  SLQKVFLSHADRKVWLLFDYAEHDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGI 121

Query: 395 EYLHLGCSTRILHFDIKPHNILL----DEDFCPKISDFGLAKICNRK-ESIISMTGARGT 449
            YLH   +  +LH D+KP NIL+     E    KI+D G A++ N   + +  +     T
Sbjct: 122 HYLH---ANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVVT 178

Query: 450 VGYIAPEVFCRNIGEVSYKS--DVYNYGMMIFEM 481
             Y APE+    +G   Y    D++  G +  E+
Sbjct: 179 FWYRAPELL---LGARHYTKAIDIWAIGCIFAEL 209

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDK8 phosphorylates cyclin H, a subunit of the general transcription factor TFIIH, which results in the inhibition of TFIIH-dependent phosphorylation of the C-terminal domain (CTD) of RNAP II, facilitating the inhibition of transcription. It has also been shown to promote transcription by a mechanism that is likely to involve RNAP II phosphorylation. CDK8 also functions as a stimulus-specific positive coregulator of p53 transcriptional responses. Length = 317

>gnl|CDD|143380 cd07875, STKc_JNK1, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1

 Score = 45.4 bits (107), Expect = 5e-05
 Identities = 35/95 (36%), Positives = 50/95 (52%), Gaps = 12/95 (12%)

Query: 393 GLEYLHLGCSTRILHFDIKPHNILLDEDFCPKISDFGLAKICNRKESIISMTGARGTVGY 452
           G+++LH   S  I+H D+KP NI++  D   KI DFGLA+      +   MT    T  Y
Sbjct: 138 GIKHLH---SAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAG---TSFMMTPYVVTRYY 191

Query: 453 IAPEVFCRNIGEVSYKS--DVYNYGMMIFEMTGGR 485
            APEV    I  + YK   D+++ G ++ EM  G 
Sbjct: 192 RAPEV----ILGMGYKENVDIWSVGCIMGEMIKGG 222

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK1 specifically binds with JAMP (JNK1-associated membrane protein), which regulates the duration of JNK1 activity in response to stimuli. Specific JNK1 substrates include Itch and SG10, which are implicated in Th2 responses and airway inflammation, and microtubule dynamics and axodendritic length, respectively. Mice deficient in Jnk1 are protected against arthritis, obesity, type 2 diabetes, cardiac cell death, and non-alcoholic liver disease, suggesting that JNK1 may play roles in the pathogenesis of these diseases. Length = 364

>gnl|CDD|173682 cd05591, STKc_nPKC_epsilon, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon

 Score = 44.8 bits (106), Expect = 6e-05
 Identities = 32/97 (32%), Positives = 52/97 (53%), Gaps = 17/97 (17%)

Query: 394 LEYLHLGCSTRILHFDIKPHNILLDEDFCPKISDFGLAKICNRKESI---ISMTGARGTV 450
           L +LH      +++ D+K  NILLD +   K++DFG+      KE I   ++ T   GT 
Sbjct: 109 LMFLH---RHGVIYRDLKLDNILLDAEGHCKLADFGMC-----KEGILNGVTTTTFCGTP 160

Query: 451 GYIAPEVFCRNIGEVSYKSDV--YNYGMMIFEMTGGR 485
            YIAPE+    + E+ Y   V  +  G++++EM  G+
Sbjct: 161 DYIAPEI----LQELEYGPSVDWWALGVLMYEMMAGQ 193

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to neoplastic transformation depending on the cell type. It contributes to oncogenesis by inducing disordered cell growth and inhibiting cell death. It also plays a role in tumor invasion and metastasis. PKC-epsilon has also been found to confer cardioprotection against ischemia and reperfusion-mediated damage. Other cellular functions include the regulation of gene expression, cell adhesion, and cell motility. Length = 321

>gnl|CDD|173646 cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3

 Score = 44.5 bits (105), Expect = 6e-05
 Identities = 48/204 (23%), Positives = 81/204 (39%), Gaps = 45/204 (22%)

Query: 320 KLGQGGYGSVYKGKLLDGSN---VAVKVLNDSKG--NGKEFINEVASISRTSHVNVVALL 374
           ++G G +G V  G++  G     V VK L  S       +F+ E        H N++  L
Sbjct: 2   EIGNGWFGKVILGEVNSGYTPAQVVVKELRVSASVQEQMKFLEEAQPYRSLQHSNLLQCL 61

Query: 375 GFCL------------------------RVAEELSS--------TIGIARGLEYLHLGCS 402
           G C                         R AE ++            IA GL +LH    
Sbjct: 62  GQCTEVTPYLLVMEFCPLGDLKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLH---K 118

Query: 403 TRILHFDIKPHNILLDEDFCPKISDFGLAKICNRKESIISMTGARGTVGYIAPEVFCRNI 462
              +H D+   N LL  D   KI D+GL+    +++  ++       + +IAPE+     
Sbjct: 119 NNFIHSDLALRNCLLTADLTVKIGDYGLSHNKYKEDYYVTPDQLWVPLRWIAPELVDEVH 178

Query: 463 GEV-----SYKSDVYNYGMMIFEM 481
           G +     + +S+V++ G+ I+E+
Sbjct: 179 GNLLVVDQTKESNVWSLGVTIWEL 202

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells. Aatyk1 has been implicated in neural differentiation, and is a regulator of the Na-K-2Cl cotransporter, a membrane protein involved in cell proliferation and survival, epithelial transport, and blood pressure control. The function of Aatyk3 is still unknown. Length = 269

>gnl|CDD|173694 cd05603, STKc_SGK2, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2

 Score = 44.6 bits (105), Expect = 6e-05
 Identities = 37/104 (35%), Positives = 50/104 (48%), Gaps = 13/104 (12%)

Query: 381 AEELSSTIGIARGLEYLHLGCSTRILHFDIKPHNILLDEDFCPKISDFGLAKICNRKESI 440
           A E++S IG      YLH   S  I++ D+KP NILLD      ++DFGL K     E  
Sbjct: 102 AAEVASAIG------YLH---SLNIIYRDLKPENILLDSQGHVVLTDFGLCKEGVEPEET 152

Query: 441 ISMTGARGTVGYIAPEVFCRNIGEVSYKSDVYNYGMMIFEMTGG 484
            S     GT  Y+APEV  +         D +  G +++EM  G
Sbjct: 153 TSTFC--GTPEYLAPEVLRKE--PYDRTVDWWCLGAVLYEMLYG 192

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. Length = 321

>gnl|CDD|240344 PTZ00283, PTZ00283, serine/threonine protein kinase; Provisional

 Score = 44.9 bits (106), Expect = 7e-05
 Identities = 30/99 (30%), Positives = 54/99 (54%), Gaps = 8/99 (8%)

Query: 397 LHLGCSTRILHFDIKPHNILLDEDFCPKISDFGLAKICNRKESIISMTGAR---GTVGYI 453
           +H   S  ++H DIK  NILL  +   K+ DFG +K+     + +S    R   GT  Y+
Sbjct: 156 VHHVHSKHMIHRDIKSANILLCSNGLVKLGDFGFSKM---YAATVSDDVGRTFCGTPYYV 212

Query: 454 APEVFCRNIGEVSYKSDVYNYGMMIFEMTGGRKNVDVVD 492
           APE++ R     S K+D+++ G++++E+   ++  D  +
Sbjct: 213 APEIWRRK--PYSKKADMFSLGVLLYELLTLKRPFDGEN 249

Length = 496

>gnl|CDD|143379 cd07874, STKc_JNK3, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3

 Score = 44.7 bits (105), Expect = 7e-05
 Identities = 34/91 (37%), Positives = 49/91 (53%), Gaps = 12/91 (13%)

Query: 393 GLEYLHLGCSTRILHFDIKPHNILLDEDFCPKISDFGLAKICNRKESIISMTGARGTVGY 452
           G+++LH   S  I+H D+KP NI++  D   KI DFGLA+      +   MT    T  Y
Sbjct: 131 GIKHLH---SAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAG---TSFMMTPYVVTRYY 184

Query: 453 IAPEVFCRNIGEVSYKS--DVYNYGMMIFEM 481
            APEV    I  + YK   D+++ G ++ EM
Sbjct: 185 RAPEV----ILGMGYKENVDIWSVGCIMGEM 211

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, stroke, sciatic axotomy neural death, and neuronal death due to NGF deprivation, oxidative stress, or exposure to beta-amyloid peptide. This suggests that JNK3 may play roles in the pathogenesis of these diseases. Length = 355

>gnl|CDD|173690 cd05599, STKc_NDR_like, Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

 Score = 44.7 bits (106), Expect = 7e-05
 Identities = 32/115 (27%), Positives = 46/115 (40%), Gaps = 38/115 (33%)

Query: 406 LHFDIKPHNILLDEDFCPKISDFGLAK-------------------------IC---NRK 437
           +H DIKP N+LLD     K+SDFGL                           I    + K
Sbjct: 123 IHRDIKPDNLLLDAKGHIKLSDFGLCTGLKKSHRTEFYRILSHALPSNFLDFISKPMSSK 182

Query: 438 ESIISMTGAR--------GTVGYIAPEVFCRNIGEVSYKSDVYNYGMMIFEMTGG 484
               +    R        GT  YIAPEVF +     + + D ++ G++++EM  G
Sbjct: 183 RKAETWKRNRRALAYSTVGTPDYIAPEVFLQT--GYNKECDWWSLGVIMYEMLVG 235

Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplication. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. This subfamily also contains fungal NDR-like kinases. Length = 364

>gnl|CDD|173693 cd05602, STKc_SGK1, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1

 Score = 44.2 bits (104), Expect = 8e-05
 Identities = 37/110 (33%), Positives = 52/110 (47%), Gaps = 13/110 (11%)

Query: 390 IARGLEYLHLGCSTRILHFDIKPHNILLDEDFCPKISDFGLAKICNRKESIISMTGARGT 449
           IA  L YLH   S  I++ D+KP NILLD      ++DFGL K     E   + +   GT
Sbjct: 105 IASALGYLH---SLNIVYRDLKPENILLDSQGHIVLTDFGLCK--ENIEHNGTTSTFCGT 159

Query: 450 VGYIAPEVFCRNIGEVSYKSDVYNYGMMIFEMTGG------RKNVDVVDN 493
             Y+APEV  +         D +  G +++EM  G      R   ++ DN
Sbjct: 160 PEYLAPEVLHKQ--PYDRTVDWWCLGAVLYEMLYGLPPFYSRNTAEMYDN 207

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt sensitivity, memory consolidation, and cardiac repolarization. A common SGK1 variant is associated with increased blood pressure and body weight. SGK1 may also contribute to tumor growth, neurodegeneration, fibrosing disease, and ischemia. Length = 325

>gnl|CDD|223009 PHA03211, PHA03211, serine/threonine kinase US3; Provisional

 Score = 44.5 bits (105), Expect = 9e-05
 Identities = 37/104 (35%), Positives = 51/104 (49%), Gaps = 17/104 (16%)

Query: 380 VAEELSSTIGIARGLEYLHLGCSTRILHFDIKPHNILLD--EDFCPKISDFGLAKICNRK 437
           VA +L S I      +Y+H      I+H DIK  N+L++  ED C  + DFG A      
Sbjct: 265 VARQLLSAI------DYIH---GEGIIHRDIKTENVLVNGPEDIC--LGDFGAACFARGS 313

Query: 438 ESIISMTGARGTVGYIAPEVFCRNIGEVSYKS-DVYNYGMMIFE 480
            S     G  GTV   APEV     G+    S D+++ G++IFE
Sbjct: 314 WSTPFHYGIAGTVDTNAPEVLA---GDPYTPSVDIWSAGLVIFE 354

Length = 461

>gnl|CDD|173695 cd05604, STKc_SGK3, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3

 Score = 44.2 bits (104), Expect = 9e-05
 Identities = 34/96 (35%), Positives = 46/96 (47%), Gaps = 9/96 (9%)

Query: 390 IARGLEYLHLGCSTRILHFDIKPHNILLDEDFCPKISDFGLAKICNRKESIISMTGAR-G 448
           IA  L YLH   S  I++ D+KP NILLD      ++DFGL   C    +    T    G
Sbjct: 105 IASALGYLH---SINIVYRDLKPENILLDSQGHVVLTDFGL---CKEGIAQSDTTTTFCG 158

Query: 449 TVGYIAPEVFCRNIGEVSYKSDVYNYGMMIFEMTGG 484
           T  Y+APEV  +         D +  G +++EM  G
Sbjct: 159 TPEYLAPEVIRKQ--PYDNTVDWWCLGAVLYEMLYG 192

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, and receptors. It plays a critical role in hair follicle morphogenesis and hair cycling. Length = 325

>gnl|CDD|173649 cd05093, PTKc_TrkB, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B

 Score = 43.9 bits (103), Expect = 1e-04
 Identities = 48/219 (21%), Positives = 84/219 (38%), Gaps = 52/219 (23%)

Query: 310 IKKMTNSFKYKLGQGGYGSVYKGKLL------DGSNVAVKVLNDSKGNG-KEFINEVASI 362
           IK+     K +LG+G +G V+  +        D   VAVK L D+  N  K+F  E   +
Sbjct: 2   IKRHNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELL 61

Query: 363 SRTSHVNVVALLGFC----------------------------------------LRVAE 382
           +   H ++V   G C                                        L  ++
Sbjct: 62  TNLQHEHIVKFYGVCVEGDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQ 121

Query: 383 ELSSTIGIARGLEYLHLGCSTRILHFDIKPHNILLDEDFCPKISDFGLAKICNRKESIIS 442
            L     IA G+ YL    S   +H D+   N L+ E+   KI DFG+++     +    
Sbjct: 122 MLHIAQQIAAGMVYL---ASQHFVHRDLATRNCLVGENLLVKIGDFGMSRDVYSTDYYRV 178

Query: 443 MTGARGTVGYIAPEVFCRNIGEVSYKSDVYNYGMMIFEM 481
                  + ++ PE       + + +SDV++ G++++E+
Sbjct: 179 GGHTMLPIRWMPPESIMYR--KFTTESDVWSLGVVLWEI 215

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly expressed in the nervous system and in some non-neural tissues. It plays important roles in cell proliferation, differentiation, and survival. BDNF/Trk signaling plays a key role in regulating activity-dependent synaptic plasticity. TrkB also contributes to protection against gp120-induced neuronal cell death. TrkB overexpression is associated with poor prognosis in neuroblastoma (NB) and other human cancers. It acts as a suppressor of anoikis (detachment-induced apoptosis) and contributes to tumor metastasis. Length = 288

>gnl|CDD|173713 cd05624, STKc_MRCK_beta, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta

 Score = 43.8 bits (103), Expect = 1e-04
 Identities = 26/84 (30%), Positives = 46/84 (54%), Gaps = 4/84 (4%)

Query: 404 RILHFDIKPHNILLDEDFCPKISDFGLAKICNRKESIISMTGARGTVGYIAPEVFCR--- 460
             +H DIKP N+LLD +   +++DFG     N ++  +  + A GT  YI+PE+      
Sbjct: 122 HYVHRDIKPDNVLLDMNGHIRLADFGSCLKMN-QDGTVQSSVAVGTPDYISPEILQAMED 180

Query: 461 NIGEVSYKSDVYNYGMMIFEMTGG 484
            +G+   + D ++ G+ ++EM  G
Sbjct: 181 GMGKYGPECDWWSLGVCMYEMLYG 204

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. Length = 331

>gnl|CDD|140293 PTZ00267, PTZ00267, NIMA-related protein kinase; Provisional

 Score = 44.2 bits (104), Expect = 1e-04
 Identities = 28/92 (30%), Positives = 51/92 (55%), Gaps = 5/92 (5%)

Query: 390 IARGLEYLHLGCSTRILHFDIKPHNILLDEDFCPKISDFGLAKICNRKESIISMTGARGT 449
           I   L+ +H   S +++H D+K  NI L      K+ DFG +K  +   S+   +   GT
Sbjct: 178 IVLALDEVH---SRKMMHRDLKSANIFLMPTGIIKLGDFGFSKQYSDSVSLDVASSFCGT 234

Query: 450 VGYIAPEVFCRNIGEVSYKSDVYNYGMMIFEM 481
             Y+APE++ R     S K+D+++ G++++E+
Sbjct: 235 PYYLAPELWERK--RYSKKADMWSLGVILYEL 264

Length = 478

>gnl|CDD|173665 cd05574, STKc_phototropin_like, Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases

 Score = 43.4 bits (103), Expect = 2e-04
 Identities = 39/123 (31%), Positives = 52/123 (42%), Gaps = 38/123 (30%)

Query: 393 GLEYLH-LGCSTRILHFDIKPHNILLDEDFCPKISDFGLAKICN---RKESIISMTGAR- 447
            LEYLH LG    I++ D+KP NILL E     +SDF L+K  +      S     G+R 
Sbjct: 115 ALEYLHLLG----IVYRDLKPENILLHESGHIMLSDFDLSKQSDVEPPPVSKALRKGSRR 170

Query: 448 -----------------------GTVGYIAPEVFCRNIGEVSYKSDV--YNYGMMIFEMT 482
                                  GT  YIAPEV    I    + S V  +  G++++EM 
Sbjct: 171 SSVNSIPSETFSEEPSFRSNSFVGTEEYIAPEV----ISGDGHGSAVDWWTLGILLYEML 226

Query: 483 GGR 485
            G 
Sbjct: 227 YGT 229

Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-terminal photosensory domain and a C-terminal catalytic domain. The N-terminal domain contains two LOV (Light, Oxygen or Voltage) domains that binds FMN. Photoexcitation of the LOV domains results in autophosphorylation at multiple sites and activation of the catalytic domain. Neurospora crassa nrc-2 plays a role in growth and development by controlling entry into the conidiation program. Length = 316

>gnl|CDD|173692 cd05601, STKc_CRIK, Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase

 Score = 43.3 bits (102), Expect = 2e-04
 Identities = 30/84 (35%), Positives = 45/84 (53%), Gaps = 5/84 (5%)

Query: 406 LHFDIKPHNILLDEDFCPKISDFGLAKICNRKESIISMTGARGTVGYIAPEVFC--RNIG 463
           +H DIKP N+L+D     K++DFG A      + + S     GT  YIAPEV       G
Sbjct: 124 VHRDIKPENVLIDRTGHIKLADFGSAARLTANKMVNSKLPV-GTPDYIAPEVLTTMNGDG 182

Query: 464 EVSY--KSDVYNYGMMIFEMTGGR 485
           + +Y  + D ++ G++ +EM  GR
Sbjct: 183 KGTYGVECDWWSLGVIAYEMIYGR 206

Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnormal cytokinesis and massive apoptosis in neuronal precursors. A Down syndrome critical region protein TTC3 interacts with CRIK and inhibits CRIK-dependent neuronal differentiation and neurite extension. Length = 330

>gnl|CDD|173762 cd08222, STKc_Nek11, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11

 Score = 42.6 bits (100), Expect = 2e-04
 Identities = 32/89 (35%), Positives = 48/89 (53%), Gaps = 8/89 (8%)

Query: 393 GLEYLHLGCSTRILHFDIKPHNILLDEDFCPKISDFGLAKICNRKESIISMTGARGTVGY 452
           G+ Y+H     RILH D+K  NI L  +   KI DFG++       S    T   GT  Y
Sbjct: 118 GVHYMH---QRRILHRDLKAKNIFLKNNLL-KIGDFGVS--RLLMGSCDLATTFTGTPYY 171

Query: 453 IAPEVFCRNIGEVSYKSDVYNYGMMIFEM 481
           ++PE   ++ G  S KSD+++ G +++EM
Sbjct: 172 MSPEAL-KHQGYDS-KSDIWSLGCILYEM 198

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M checkpoint. Nek11 may also play a role in the S-phase checkpoint as well as in DNA replication and genotoxic stress responses. Length = 260

>gnl|CDD|173648 cd05092, PTKc_TrkA, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A

 Score = 42.7 bits (100), Expect = 2e-04
 Identities = 50/228 (21%), Positives = 93/228 (40%), Gaps = 68/228 (29%)

Query: 310 IKKMTNSFKYKLGQGGYGSVYKGK---LL---DGSNVAVKVLNDSKGNGK-EFINEVASI 362
           IK+     K++LG+G +G V+  +   LL   D   VAVK L ++  + + +F  E   +
Sbjct: 2   IKRRDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELL 61

Query: 363 SRTSHVNVVALLGFC------------------------------------------LRV 380
           +   H ++V   G C                                          L +
Sbjct: 62  TVLQHQHIVRFYGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTL 121

Query: 381 AEELSSTIGIARGLEYLHLGCSTRILHFDIKPHNILLDEDFCPKISDFGLAKICNRKESI 440
            + L+    IA G+ YL    S   +H D+   N L+ +    KI DFG+++       I
Sbjct: 122 GQMLAIASQIASGMVYL---ASLHFVHRDLATRNCLVGQGLVVKIGDFGMSR------DI 172

Query: 441 ISM----TGARGT--VGYIAPE-VFCRNIGEVSYKSDVYNYGMMIFEM 481
            S      G R    + ++ PE +  R   + + +SD++++G++++E+
Sbjct: 173 YSTDYYRVGGRTMLPIRWMPPESILYR---KFTTESDIWSFGVVLWEI 217

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory and sympathetic neurons of the peripheral nervous system, and in basal forebrain cholinergic neurons of the central nervous system. It is critical for neuronal growth, differentiation and survival. Alternative TrkA splicing has been implicated as a pivotal regulator of neuroblastoma (NB) behavior. Normal TrkA expression is associated with better NB prognosis, while the hypoxia-regulated TrkAIII splice variant promotes NB pathogenesis and progression. Aberrant TrkA expression has also been demonstrated in non-neural tumors including prostate, breast, lung, and pancreatic cancers. Length = 280

>gnl|CDD|240233 PTZ00024, PTZ00024, cyclin-dependent protein kinase; Provisional

 Score = 42.8 bits (101), Expect = 3e-04
 Identities = 52/221 (23%), Positives = 86/221 (38%), Gaps = 62/221 (28%)

Query: 321 LGQGGYGSVYKGK-LLDGSNVAVKVLNDSKGN-------------GKEF--INEVASISR 364
           LG+G YG V K    L G  VA+K +   + +             G  F  + E+  ++ 
Sbjct: 17  LGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIMNE 76

Query: 365 TSHVNVVALLG-FC-----------------------LRVAEELSSTI--GIARGLEYLH 398
             H N++ L+  +                        +R+ E     I   I  GL  LH
Sbjct: 77  IKHENIMGLVDVYVEGDFINLVMDIMASDLKKVVDRKIRLTESQVKCILLQILNGLNVLH 136

Query: 399 LGCSTRILHFDIKPHNILLDEDFCPKISDFGLAK---------ICNRKESIIS---MTGA 446
                  +H D+ P NI ++     KI+DFGLA+           ++ E++     MT  
Sbjct: 137 ---KWYFMHRDLSPANIFINSKGICKIADFGLARRYGYPPYSDTLSKDETMQRREEMTSK 193

Query: 447 RGTVGYIAPEVFCRNIGEVSYKS--DVYNYGMMIFEMTGGR 485
             T+ Y APE+    +G   Y    D+++ G +  E+  G+
Sbjct: 194 VVTLWYRAPELL---MGAEKYHFAVDMWSVGCIFAELLTGK 231

Length = 335

>gnl|CDD|132953 cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases

 Score = 42.5 bits (100), Expect = 3e-04
 Identities = 26/85 (30%), Positives = 44/85 (51%), Gaps = 8/85 (9%)

Query: 405 ILHFDIKPHNILLDEDFCPKISDFGLAKICNRKESIISMTGARGTVGYIAPEVF----CR 460
           I+H D+KP N+L++ +   K+ DFG++       + ++ T   G   Y+APE        
Sbjct: 124 IIHRDVKPTNVLVNGNGQVKLCDFGVS---GNLVASLAKTNI-GCQSYMAPERIKSGGPN 179

Query: 461 NIGEVSYKSDVYNYGMMIFEMTGGR 485
                + +SDV++ G+ I EM  GR
Sbjct: 180 QNPTYTVQSDVWSLGLSILEMALGR 204

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Polymyxin B resistance protein 2 (PBS2) from Saccharomyces cerevisiae, Wis1 from Schizosaccharomyces pombe, and related proteins. PBS2 and Wis1 are components of stress-activated MAPK cascades in budding and fission yeast, respectively. PBS2 is the specific activator of the MAPK Hog1, which plays a central role in the response of budding yeast to stress including exposure to arsenite and hyperosmotic environments. Wis1 phosphorylates and activates the MAPK Sty1 (also called Spc1 or Phh1), which stimulates a transcriptional response to a wide range of cellular insults through the bZip transcription factors Atf1, Pcr1, and Pap1. Length = 286

>gnl|CDD|165478 PHA03212, PHA03212, serine/threonine kinase US3; Provisional

 Score = 42.7 bits (100), Expect = 3e-04
 Identities = 33/117 (28%), Positives = 55/117 (47%), Gaps = 18/117 (15%)

Query: 378 LRVAEELSSTIGIARGLEYLHLGCSTRILHFDIKPHNILLDE--DFCPKISDFGLA---- 431
           + + + L+    + R ++YLH     RI+H DIK  NI ++   D C  + DFG A    
Sbjct: 179 IAICDILAIERSVLRAIQYLH---ENRIIHRDIKAENIFINHPGDVC--LGDFGAACFPV 233

Query: 432 KICNRKESIISMTGARGTVGYIAPEVFCRNIGEVSYKSDVYNYGMMIFEMTGGRKNV 488
            I   K       G  GT+   APE+  R+        D+++ G+++FEM     ++
Sbjct: 234 DINANK-----YYGWAGTIATNAPELLARD--PYGPAVDIWSAGIVLFEMATCHDSL 283

Length = 391

>gnl|CDD|173741 cd07843, STKc_CDC2L1, Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1

 Score = 42.2 bits (100), Expect = 3e-04
 Identities = 27/78 (34%), Positives = 37/78 (47%), Gaps = 12/78 (15%)

Query: 392 RGLEYLHLGCSTRILHFDIKPHNILLDEDFCPKISDFGLAKICNRK--ESIISMTGARGT 449
            G+ +LH      ILH D+K  N+LL+     KI DFGLA    R+    +   T    T
Sbjct: 117 SGVAHLH---DNWILHRDLKTSNLLLNNRGILKICDFGLA----REYGSPLKPYTQLVVT 169

Query: 450 VGYIAPEVFCRNIGEVSY 467
           + Y APE+    +G   Y
Sbjct: 170 LWYRAPELL---LGAKEY 184

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the major isoform, associates with cyclin L and is expressed throughout the cell cycle. It is involved in RNA processing and the regulation of transcription. CDK11(p58) associates with cyclin D3 and is expressed during the G2/M phase of the cell cycle. It plays roles in spindle morphogenesis, centrosome maturation, sister chromatid cohesion, and the completion of mitosis. CDK11(p46) is formed from the larger isoforms by caspases during TNFalpha- and Fas-induced apoptosis. It functions as a downstream effector kinase in apoptotic signaling pathways and interacts with eukaryotic initiation factor 3f (eIF3f), p21-activated kinase (PAK1), and Ran-binding protein (RanBPM). Length = 293

>gnl|CDD|173651 cd05095, PTKc_DDR2, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2

 Score = 42.2 bits (99), Expect = 4e-04
 Identities = 44/174 (25%), Positives = 71/174 (40%), Gaps = 60/174 (34%)

Query: 316 SFKYKLGQGGYGSVY------------KGKLLDGSN-----VAVKVLN-DSKGNGK-EFI 356
           +FK KLG+G +G V+            K   LD S      VAVK+L  D+  N + +F+
Sbjct: 8   TFKEKLGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDANKNARNDFL 67

Query: 357 NEVASISRTSHVNVVALLGFCL----------------------------RVAEELSSTI 388
            E+  +SR    N++ LL  C+                               +    TI
Sbjct: 68  KEIKIMSRLKDPNIIRLLAVCITSDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTI 127

Query: 389 G----------IARGLEYLHLGCSTRILHFDIKPHNILLDEDFCPKISDFGLAK 432
                      IA G++YL    S   +H D+   N L+ +++  KI+DFG+++
Sbjct: 128 SYSTLIFMATQIASGMKYL---SSLNFVHRDLATRNCLVGKNYTIKIADFGMSR 178

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues with the highest levels found in skeletal muscle, skin, kidney and lung. It is important in cell proliferation and development. Mice, with a deletion of DDR2, suffer from dwarfism and delayed healing of epidermal wounds. DDR2 also contributes to collagen (type I) regulation by inhibiting fibrillogenesis and altering the morphology of collagen fibers. It is also expressed in immature dendritic cells (DCs), where it plays a role in DC activation and function. Length = 296

>gnl|CDD|173644 cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1

 Score = 41.8 bits (98), Expect = 4e-04
 Identities = 49/201 (24%), Positives = 80/201 (39%), Gaps = 47/201 (23%)

Query: 321 LGQGGYGSVYKGKL-----LDGSNVAVKVLNDSKGNGKEFIN----EVASISRTSHVNVV 371
           LG+G +G V   +        G  VAVK L     +G   I     E+  +    H N+V
Sbjct: 12  LGEGHFGKVELCRYDPEGDNTGEQVAVKSLK--PESGGNHIADLKKEIEILRNLYHENIV 69

Query: 372 ALLGFC------------------------------LRVAEELSSTIGIARGLEYLHLGC 401
              G C                              + + ++L   + I +G++YL    
Sbjct: 70  KYKGICTEDGGNGIKLIMEFLPSGSLKEYLPRNKNKINLKQQLKYAVQICKGMDYLG--- 126

Query: 402 STRILHFDIKPHNILLDEDFCPKISDFGLAK-ICNRKESIISMTGARGTVGYIAPEVFCR 460
           S + +H D+   N+L++ +   KI DFGL K I   KE           V + APE  C 
Sbjct: 127 SRQYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEYYTVKDDLDSPVFWYAPE--CL 184

Query: 461 NIGEVSYKSDVYNYGMMIFEM 481
              +    SDV+++G+ ++E+
Sbjct: 185 IQSKFYIASDVWSFGVTLYEL 205

Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 284

>gnl|CDD|173676 cd05585, STKc_YPK1_like, Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases

 Score = 42.2 bits (99), Expect = 4e-04
 Identities = 33/92 (35%), Positives = 50/92 (54%), Gaps = 9/92 (9%)

Query: 394 LEYLHLGCSTRILHFDIKPHNILLDEDFCPKISDFGLAKICNRKESIISMTGARGTVGYI 453
           LE LH      +++ D+KP NILLD      + DFGL K+ N K+   + T   GT  Y+
Sbjct: 106 LENLH---KFNVIYRDLKPENILLDYQGHIALCDFGLCKL-NMKDDDKTNTFC-GTPEYL 160

Query: 454 APEVFCRNIGEVSYKS-DVYNYGMMIFEMTGG 484
           APE+    +G    K+ D +  G++++EM  G
Sbjct: 161 APELL---LGHGYTKAVDWWTLGVLLYEMLTG 189

Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It plays a role in cell growth and sexual development. Length = 312

>gnl|CDD|173759 cd08219, STKc_Nek3, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3

 Score = 41.5 bits (97), Expect = 5e-04
 Identities = 27/89 (30%), Positives = 50/89 (56%), Gaps = 7/89 (7%)

Query: 393 GLEYLHLGCSTRILHFDIKPHNILLDEDFCPKISDFGLAKICNRKESIISMTGARGTVGY 452
           G++++H     R+LH DIK  NI L ++   K+ DFG A++     +        GT  Y
Sbjct: 112 GVQHIH---EKRVLHRDIKSKNIFLTQNGKVKLGDFGSARLLTSPGAYACTY--VGTPYY 166

Query: 453 IAPEVFCRNIGEVSYKSDVYNYGMMIFEM 481
           + PE++  N+   + KSD+++ G +++E+
Sbjct: 167 VPPEIW-ENM-PYNNKSDIWSLGCILYEL 193

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activation of Vav2 and contributes to prolactin-mediated motility of breast cancer cells. Length = 255

>gnl|CDD|173689 cd05598, STKc_LATS, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor

 Score = 40.9 bits (96), Expect = 0.001
 Identities = 32/123 (26%), Positives = 47/123 (38%), Gaps = 47/123 (38%)

Query: 406 LHFDIKPHNILLDEDFCPKISDFGL------------------------------AKICN 435
           +H DIKP NIL+D D   K++DFGL                              ++I  
Sbjct: 123 IHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYYQKGDHHRQDSMEPSEEWSEIDR 182

Query: 436 RKESIISMTGAR-----------GTVGYIAPEVFCRNIGEVSYKS--DVYNYGMMIFEMT 482
            +   +     R           GT  YIAPEV  R      Y    D ++ G++++EM 
Sbjct: 183 CRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLR----TGYTQLCDWWSVGVILYEML 238

Query: 483 GGR 485
            G+
Sbjct: 239 VGQ 241

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Length = 376

>gnl|CDD|173502 PTZ00266, PTZ00266, NIMA-related protein kinase; Provisional

 Score = 40.9 bits (95), Expect = 0.002
 Identities = 33/110 (30%), Positives = 45/110 (40%), Gaps = 22/110 (20%)

Query: 404 RILHFDIKPHNILLDEDF-----------------CPKISDFGLAKICNRKESIISMT-G 445
           R+LH D+KP NI L                       KI DFGL+K       I SM   
Sbjct: 145 RVLHRDLKPQNIFLSTGIRHIGKITAQANNLNGRPIAKIGDFGLSK----NIGIESMAHS 200

Query: 446 ARGTVGYIAPEVFCRNIGEVSYKSDVYNYGMMIFEMTGGRKNVDVVDNGS 495
             GT  Y +PE+          KSD++  G +I+E+  G+      +N S
Sbjct: 201 CVGTPYYWSPELLLHETKSYDDKSDMWALGCIIYELCSGKTPFHKANNFS 250

Length = 1021

>gnl|CDD|173716 cd05627, STKc_NDR2, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2

 Score = 40.4 bits (94), Expect = 0.002
 Identities = 36/114 (31%), Positives = 48/114 (42%), Gaps = 39/114 (34%)

Query: 406 LHFDIKPHNILLDEDFCPKISDFGLA---KICNRKE-------------SIISMTGAR-- 447
           +H DIKP N+LLD     K+SDFGL    K  +R E             S  +M   R  
Sbjct: 123 IHRDIKPDNLLLDAKGHVKLSDFGLCTGLKKAHRTEFYRNLTHNPPSDFSFQNMNSKRKA 182

Query: 448 ---------------GTVGYIAPEVFCRNIGEVSYKS--DVYNYGMMIFEMTGG 484
                          GT  YIAPEVF     +  Y    D ++ G++++EM  G
Sbjct: 183 ETWKKNRRQLAYSTVGTPDYIAPEVFM----QTGYNKLCDWWSLGVIMYEMLIG 232

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regulating neuronal growth and differentiation, as well as in facilitating neurite outgrowth. It is also implicated in fear conditioning as it contributes to the coupling of neuronal morphological changes with fear-memory consolidation. NDR2 is also referred to as STK38-like. Length = 360

>gnl|CDD|173701 cd05610, STKc_MASTL, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase

 Score = 40.6 bits (95), Expect = 0.002
 Identities = 19/49 (38%), Positives = 31/49 (63%), Gaps = 3/49 (6%)

Query: 390 IARGLEYLHLGCSTRILHFDIKPHNILLDEDFCPKISDFGLAKICNRKE 438
           +A  L+YLH      I+H D+KP N+L+  +   K++DFGL+K+   +E
Sbjct: 113 VALALDYLH---RHGIIHRDLKPDNMLISNEGHIKLTDFGLSKVTLNRE 158

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ14813 is associated with autosomal dominant thrombocytopenia. To date, the function of MASTL is unknown. Length = 669

>gnl|CDD|165473 PHA03207, PHA03207, serine/threonine kinase US3; Provisional

 Score = 40.2 bits (94), Expect = 0.002
 Identities = 33/104 (31%), Positives = 48/104 (46%), Gaps = 13/104 (12%)

Query: 384 LSSTIGIARGL----EYLHLGCSTRILHFDIKPHNILLDEDFCPKISDFGLAKICNRKES 439
           L   I I R L     YLH      I+H D+K  NI LDE     + DFG A  C     
Sbjct: 184 LEQAITIQRRLLEALAYLH---GRGIIHRDVKTENIFLDEPENAVLGDFGAA--CKLDAH 238

Query: 440 IISMT--GARGTVGYIAPEVFCRNIGEVSYKSDVYNYGMMIFEM 481
             +    G  GT+   +PE+    +     K+D+++ G+++FEM
Sbjct: 239 PDTPQCYGWSGTLETNSPELLA--LDPYCAKTDIWSAGLVLFEM 280

Length = 392

>gnl|CDD|173717 cd05628, STKc_NDR1, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1

 Score = 40.0 bits (93), Expect = 0.002
 Identities = 35/114 (30%), Positives = 48/114 (42%), Gaps = 39/114 (34%)

Query: 406 LHFDIKPHNILLDEDFCPKISDFGLA---KICNRKE-------------SIISMTGAR-- 447
           +H DIKP N+LLD     K+SDFGL    K  +R E             +  +M   R  
Sbjct: 123 IHRDIKPDNLLLDSKGHVKLSDFGLCTGLKKAHRTEFYRNLNHSLPSDFTFQNMNSKRKA 182

Query: 448 ---------------GTVGYIAPEVFCRNIGEVSYKS--DVYNYGMMIFEMTGG 484
                          GT  YIAPEVF +      Y    D ++ G++++EM  G
Sbjct: 183 ETWKRNRRQLAFSTVGTPDYIAPEVFMQT----GYNKLCDWWSLGVIMYEMLIG 232

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, muscle, lung and spleen. It is not an essential protein because mice deficient of NDR1 remain viable and fertile. However, these mice develop T-cell lymphomas and appear to be hypersenstive to carcinogenic treatment. NDR1 appears to act as a tumor suppressor. NDR1 is also called STK38. Length = 363

>gnl|CDD|173650 cd05094, PTKc_TrkC, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C

 Score = 39.2 bits (91), Expect = 0.004
 Identities = 46/222 (20%), Positives = 84/222 (37%), Gaps = 55/222 (24%)

Query: 310 IKKMTNSFKYKLGQGGYGSVYKGKLLDGSN------VAVKVLNDSKGNG-KEFINEVASI 362
           IK+     K +LG+G +G V+  +  + S       VAVK L D      K+F  E   +
Sbjct: 2   IKRRDIVLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELL 61

Query: 363 SRTSHVNVVALLGFC-------------------------------------------LR 379
           +   H ++V   G C                                           L 
Sbjct: 62  TNLQHEHIVKFYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELG 121

Query: 380 VAEELSSTIGIARGLEYLHLGCSTRILHFDIKPHNILLDEDFCPKISDFGLAKICNRKES 439
           +++ L     IA G+ YL    S   +H D+   N L+  +   KI DFG+++     + 
Sbjct: 122 LSQMLHIASQIASGMVYL---ASQHFVHRDLATRNCLVGANLLVKIGDFGMSRDVYSTDY 178

Query: 440 IISMTGARGTVGYIAPEVFCRNIGEVSYKSDVYNYGMMIFEM 481
                     + ++ PE       + + +SDV+++G++++E+
Sbjct: 179 YRVGGHTMLPIRWMPPESIMYR--KFTTESDVWSFGVILWEI 218

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some non-neural tissues including the developing heart. NT3/TrkC signaling plays an important role in the innervation of the cardiac conducting system and the development of smooth muscle cells. Mice deficient with NT3 and TrkC have multiple heart defects. NT3/TrkC signaling is also critical for the development and maintenance of enteric neurons that are important for the control of gut peristalsis. Length = 291

>gnl|CDD|173688 cd05597, STKc_DMPK_like, Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases

 Score = 39.0 bits (91), Expect = 0.004
 Identities = 27/84 (32%), Positives = 45/84 (53%), Gaps = 4/84 (4%)

Query: 404 RILHFDIKPHNILLDEDFCPKISDFGLAKICNRKESIISMTGARGTVGYIAPEVF-CRNI 462
             +H DIKP N+LLD++   +++DFG         ++ S   A GT  YI+PE+      
Sbjct: 122 GYVHRDIKPDNVLLDKNGHIRLADFGSCLRLLADGTVQSNV-AVGTPDYISPEILQAMED 180

Query: 463 GEVSY--KSDVYNYGMMIFEMTGG 484
           G+  Y  + D ++ G+ ++EM  G
Sbjct: 181 GKGRYGPECDWWSLGVCMYEMLYG 204

Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, and cardiac conduction defects. The genetic basis for DM1 is the mutational expansion of a CTG repeat in the 3'-UTR of DMPK. DMPK is expressed in skeletal and cardiac muscles, and in central nervous tissues. The functional role of DMPK is not fully understood. It may play a role in the signal transduction and homeostasis of calcium. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKgamma is expressed in heart and skeletal muscles, unlike MRCKalpha and MRCKbeta, which are expressed ubiquitously. Length = 331

>gnl|CDD|173745 cd07848, STKc_CDKL5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5

 Score = 38.8 bits (90), Expect = 0.004
 Identities = 50/195 (25%), Positives = 88/195 (45%), Gaps = 35/195 (17%)

Query: 321 LGQGGYGSVYKGKLLDGSN-VAVKVLNDSKGN---GKEFINEVASISRTSHVNVVAL--- 373
           +G+G YG V K +  +    VA+K   DS+ N    +  + E+  +      N+V L   
Sbjct: 9   VGEGAYGVVLKCRHKETKEIVAIKKFKDSEENEEVKETTLRELKMLRTLKQENIVELKEA 68

Query: 374 --------LGF------CLRVAEELSSTIG-------IARGLEYLHLGCSTRILHFDIKP 412
                   L F       L + EE+ + +        I + ++ +H      I+H DIKP
Sbjct: 69  FRRRGKLYLVFEYVEKNMLELLEEMPNGVPPEKVRSYIYQLIKAIHWCHKNDIVHRDIKP 128

Query: 413 HNILLDEDFCPKISDFGLAKICNRKE-SIISMTGARGTVGYIAPEVFCRNIGEVSYKS-D 470
            N+L+  +   K+ DFG A+  N  E S  + T    T  Y +PE+    +G    K+ D
Sbjct: 129 ENLLISHNDVLKLCDFGFAR--NLSEGSNANYTEYVATRWYRSPELL---LGAPYGKAVD 183

Query: 471 VYNYGMMIFEMTGGR 485
           +++ G ++ E++ G+
Sbjct: 184 MWSVGCILGELSDGQ 198

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes cause a phenotype similar to Rett syndrome (RTT), a progressive neurodevelopmental disorder. These pathogenic mutations are located in the N-terminal portion of the protein within the kinase domain. Length = 287

Conserved Domains Detected by HHsearch

Original result of HHsearch against CDD database

ID	Length	Definition	Probability
Query	506
KOG1187	361	consensus Serine/threonine protein kinase [Signal	100.0
KOG0595	429	consensus Serine/threonine-protein kinase involved	100.0
KOG0575	592	consensus Polo-like serine/threonine protein kinas	100.0
KOG0192	362	consensus Tyrosine kinase specific for activated (	100.0
KOG0615	475	consensus Serine/threonine protein kinase Chk2 and	100.0
KOG0598	357	consensus Ribosomal protein S6 kinase and related	100.0
KOG0591	375	consensus NIMA (never in mitosis)-related G2-speci	100.0
KOG0197	468	consensus Tyrosine kinases [Signal transduction me	100.0
KOG0593	396	consensus Predicted protein kinase KKIAMRE [Genera	100.0
KOG0581	364	consensus Mitogen-activated protein kinase kinase	100.0
KOG0600	560	consensus Cdc2-related protein kinase [Cell cycle	100.0
KOG0193	678	consensus Serine/threonine protein kinase RAF [Sig	100.0
KOG0616	355	consensus cAMP-dependent protein kinase catalytic	100.0
KOG0659	318	consensus Cdk activating kinase (CAK)/RNA polymera	100.0
KOG0592	604	consensus 3-phosphoinositide-dependent protein kin	100.0
KOG1026	774	consensus Nerve growth factor receptor TRKA and re	100.0
KOG0661	538	consensus MAPK related serine/threonine protein ki	100.0
KOG0658	364	consensus Glycogen synthase kinase-3 [Carbohydrate	100.0
KOG0196	996	consensus Tyrosine kinase, EPH (ephrin) receptor f	100.0
KOG0597	808	consensus Serine-threonine protein kinase FUSED [G	100.0
KOG0663	419	consensus Protein kinase PITSLRE and related kinas	100.0
KOG4721	904	consensus Serine/threonine protein kinase, contain	100.0
KOG3653	534	consensus Transforming growth factor beta/activin	99.98
KOG0594	323	consensus Protein kinase PCTAIRE and related kinas	99.98
KOG0605	550	consensus NDR and related serine/threonine kinases	99.98
KOG0694	694	consensus Serine/threonine protein kinase [Signal	99.98
KOG0583	370	consensus Serine/threonine protein kinase [Signal	99.97
KOG1095	1025	consensus Protein tyrosine kinase [Signal transduc	99.97
KOG1094	807	consensus Discoidin domain receptor DDR1 [Signal t	99.97
KOG0660	359	consensus Mitogen-activated protein kinase [Signal	99.97
KOG0585	576	consensus Ca2+/calmodulin-dependent protein kinase	99.97
KOG1025	1177	consensus Epidermal growth factor receptor EGFR an	99.97
KOG0582	516	consensus Ste20-like serine/threonine protein kina	99.97
KOG0578	550	consensus p21-activated serine/threonine protein k	99.97
KOG0198	313	consensus MEKK and related serine/threonine protei	99.97
cd05631	285	STKc_GRK4 Catalytic domain of the Protein Serine/T	99.97
cd05102	338	PTKc_VEGFR3 Catalytic domain of the Protein Tyrosi	99.97
KOG0580	281	consensus Serine/threonine protein kinase [Cell cy	99.97
cd07869	303	STKc_PFTAIRE1 Catalytic domain of the Serine/Threo	99.97
cd07871	288	STKc_PCTAIRE3 Catalytic domain of the Serine/Threo	99.97
cd05628	363	STKc_NDR1 Catalytic domain of the Protein Serine/T	99.97
PTZ00263	329	protein kinase A catalytic subunit; Provisional	99.97
KOG0588	786	consensus Serine/threonine protein kinase [Cell cy	99.97
cd05612	291	STKc_PRKX_like Catalytic domain of PRKX-like Prote	99.97
KOG0611	668	consensus Predicted serine/threonine protein kinas	99.97
cd05571	323	STKc_PKB Catalytic domain of the Protein Serine/Th	99.97
cd05585	312	STKc_YPK1_like Catalytic domain of Yeast Protein K	99.97
cd05595	323	STKc_PKB_beta Catalytic domain of the Protein Seri	99.97
cd07859	338	STKc_TDY_MAPK_plant Catalytic domain of the Serine	99.97
PTZ00426	340	cAMP-dependent protein kinase catalytic subunit; P	99.97
cd05626	381	STKc_LATS2 Catalytic domain of the Protein Serine/	99.97
cd07862	290	STKc_CDK6 Catalytic domain of the Serine/Threonine	99.97
cd05621	370	STKc_ROCK2 Catalytic domain of the Protein Serine/	99.97
cd05593	328	STKc_PKB_gamma Catalytic domain of the Protein Ser	99.97
cd07868	317	STKc_CDK8 Catalytic domain of the Serine/Threonine	99.97
cd05584	323	STKc_p70S6K Catalytic domain of the Protein Serine	99.97
cd05599	364	STKc_NDR_like Catalytic domain of Nuclear Dbf2-Rel	99.97
PLN00034	353	mitogen-activated protein kinase kinase; Provision	99.97
PHA02988	283	hypothetical protein; Provisional	99.97
cd05108	316	PTKc_EGFR Catalytic domain of the Protein Tyrosine	99.97
cd07848	287	STKc_CDKL5 Catalytic domain of the Serine/Threonin	99.97
PTZ00036	440	glycogen synthase kinase; Provisional	99.97
PHA03212	391	serine/threonine kinase US3; Provisional	99.97
cd05629	377	STKc_NDR_like_fungal Catalytic domain of Fungal Nu	99.97
cd05600	333	STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p-	99.97
KOG0194	474	consensus Protein tyrosine kinase [Signal transduc	99.97
KOG0201	467	consensus Serine/threonine protein kinase [Signal	99.97
cd07876	359	STKc_JNK2 Catalytic domain of the Serine/Threonine	99.96
cd05598	376	STKc_LATS Catalytic domain of the Protein Serine/T	99.96
cd05622	371	STKc_ROCK1 Catalytic domain of the Protein Serine/	99.96
cd05625	382	STKc_LATS1 Catalytic domain of the Protein Serine/	99.96
cd05596	370	STKc_ROCK Catalytic domain of the Protein Serine/T	99.96
cd05592	316	STKc_nPKC_theta_delta Catalytic domain of the Prot	99.96
cd05591	321	STKc_nPKC_epsilon Catalytic domain of the Protein	99.96
cd05589	324	STKc_PKN Catalytic domain of the Protein Serine/Th	99.96
KOG4250	732	consensus TANK binding protein kinase TBK1 [Signal	99.96
PHA03207	392	serine/threonine kinase US3; Provisional	99.96
cd05594	325	STKc_PKB_alpha Catalytic domain of the Protein Ser	99.96
cd07853	372	STKc_NLK Catalytic domain of the Serine/Threonine	99.96
cd05614	332	STKc_MSK2_N N-terminal catalytic domain of the Pro	99.96
cd07867	317	STKc_CDC2L6 Catalytic domain of Serine/Threonine K	99.96
cd07872	309	STKc_PCTAIRE2 Catalytic domain of the Serine/Threo	99.96
cd05590	320	STKc_nPKC_eta Catalytic domain of the Protein Seri	99.96
cd07874	355	STKc_JNK3 Catalytic domain of the Serine/Threonine	99.96
cd05616	323	STKc_cPKC_beta Catalytic domain of the Protein Ser	99.96
KOG0577	948	consensus Serine/threonine protein kinase [Signal	99.96
cd07875	364	STKc_JNK1 Catalytic domain of the Serine/Threonine	99.96
cd05096	304	PTKc_DDR1 Catalytic domain of the Protein Tyrosine	99.96
cd07878	343	STKc_p38beta_MAPK11 Catalytic domain of the Serine	99.96
cd05608	280	STKc_GRK1 Catalytic domain of the Protein Serine/T	99.96
cd05587	324	STKc_cPKC Catalytic domain of the Protein Serine/T	99.96
cd05619	316	STKc_nPKC_theta Catalytic domain of the Protein Se	99.96
cd05104	375	PTKc_Kit Catalytic domain of the Protein Tyrosine	99.96
cd05620	316	STKc_nPKC_delta Catalytic domain of the Protein Se	99.96
KOG0584	632	consensus Serine/threonine protein kinase [General	99.96
cd05068	261	PTKc_Frk_like Catalytic domain of Fyn-related kina	99.96
cd05106	374	PTKc_CSF-1R Catalytic domain of the Protein Tyrosi	99.96
cd05573	350	STKc_ROCK_NDR_like Catalytic domain of ROCK- and N	99.96
cd05588	329	STKc_aPKC Catalytic domain of the Protein Serine/T	99.96
cd05627	360	STKc_NDR2 Catalytic domain of the Protein Serine/T	99.96
KOG0667	586	consensus Dual-specificity tyrosine-phosphorylatio	99.96
cd05618	329	STKc_aPKC_iota Catalytic domain of the Protein Ser	99.96
cd05067	260	PTKc_Lck_Blk Catalytic domain of the Protein Tyros	99.96
cd07863	288	STKc_CDK4 Catalytic domain of the Serine/Threonine	99.96
cd05604	325	STKc_SGK3 Catalytic domain of the Protein Serine/T	99.96
cd05575	323	STKc_SGK Catalytic domain of the Protein Serine/Th	99.96
cd05603	321	STKc_SGK2 Catalytic domain of the Protein Serine/T	99.96
PTZ00283	496	serine/threonine protein kinase; Provisional	99.96
PTZ00284	467	protein kinase; Provisional	99.96
cd05597	331	STKc_DMPK_like Catalytic domain of Myotonic Dystro	99.96
cd05602	325	STKc_SGK1 Catalytic domain of the Protein Serine/T	99.96
PF07714	259	Pkinase_Tyr: Protein tyrosine kinase Protein kinas	99.96
cd05114	256	PTKc_Tec_Rlk Catalytic domain of the Protein Tyros	99.96
PHA03211	461	serine/threonine kinase US3; Provisional	99.96
cd05582	318	STKc_RSK_N N-terminal catalytic domain of the Prot	99.96
cd05072	261	PTKc_Lyn Catalytic domain of the Protein Tyrosine	99.96
cd05570	318	STKc_PKC Catalytic domain of the Protein Serine/Th	99.96
cd05607	277	STKc_GRK7 Catalytic domain of the Protein Serine/T	99.96
cd05617	327	STKc_aPKC_zeta Catalytic domain of the Protein Ser	99.96
cd05615	323	STKc_cPKC_alpha Catalytic domain of the Protein Se	99.96
KOG0599	411	consensus Phosphorylase kinase gamma subunit [Carb	99.96
cd05091	283	PTKc_Ror2 Catalytic domain of the Protein Tyrosine	99.96
PLN00113	968	leucine-rich repeat receptor-like protein kinase;	99.96
cd06649	331	PKc_MEK2 Catalytic domain of the dual-specificity	99.96
cd05064	266	PTKc_EphR_A10 Catalytic domain of the Protein Tyro	99.96
cd05605	285	STKc_GRK4_like Catalytic domain of G protein-coupl	99.96
cd05601	330	STKc_CRIK Catalytic domain of the Protein Serine/T	99.96
cd05113	256	PTKc_Btk_Bmx Catalytic domain of the Protein Tyros	99.96
KOG0033	355	consensus Ca2+/calmodulin-dependent protein kinase	99.96
cd05059	256	PTKc_Tec_like Catalytic domain of Tec-like Protein	99.96
cd05624	331	STKc_MRCK_beta Catalytic domain of the Protein Ser	99.96
cd05623	332	STKc_MRCK_alpha Catalytic domain of the Protein Se	99.96
cd05070	260	PTKc_Fyn_Yrk Catalytic domain of the Protein Tyros	99.96
cd05071	262	PTKc_Src Catalytic domain of the Protein Tyrosine	99.96
PTZ00267	478	NIMA-related protein kinase; Provisional	99.96
KOG0983	391	consensus Mitogen-activated protein kinase (MAPK)	99.96
cd05111	279	PTK_HER3 Pseudokinase domain of the Protein Tyrosi	99.96
KOG0032	382	consensus Ca2+/calmodulin-dependent protein kinase	99.96
cd06650	333	PKc_MEK1 Catalytic domain of the dual-specificity	99.96
cd05052	263	PTKc_Abl Catalytic domain of the Protein Tyrosine	99.96
cd05109	279	PTKc_HER2 Catalytic domain of the Protein Tyrosine	99.96
KOG0589	426	consensus Serine/threonine protein kinase [General	99.96
KOG4717	864	consensus Serine/threonine protein kinase [Signal	99.96
cd05075	272	PTKc_Axl Catalytic domain of the Protein Tyrosine	99.96
cd05049	280	PTKc_Trk Catalytic domain of the Protein Tyrosine	99.96
cd05054	337	PTKc_VEGFR Catalytic domain of the Protein Tyrosin	99.96
cd05116	257	PTKc_Syk Catalytic domain of the Protein Tyrosine	99.96
KOG4257	974	consensus Focal adhesion tyrosine kinase FAK, cont	99.96
cd05069	260	PTKc_Yes Catalytic domain of the Protein Tyrosine	99.96
cd05043	280	PTK_Ryk Pseudokinase domain of Ryk (Receptor relat	99.96
KOG4279	1226	consensus Serine/threonine protein kinase [Signal	99.96
cd05042	269	PTKc_Aatyk Catalytic domain of the Protein Tyrosin	99.96
cd05048	283	PTKc_Ror Catalytic Domain of the Protein Tyrosine	99.96
cd06619	279	PKc_MKK5 Catalytic domain of the dual-specificity	99.96
KOG0986	591	consensus G protein-coupled receptor kinase [Signa	99.96
cd05090	283	PTKc_Ror1 Catalytic domain of the Protein Tyrosine	99.96
cd05632	285	STKc_GRK5 Catalytic domain of the Protein Serine/T	99.96
cd07873	301	STKc_PCTAIRE1 Catalytic domain of the Serine/Threo	99.96
PRK13184	932	pknD serine/threonine-protein kinase; Reviewed	99.95
PTZ00266	1021	NIMA-related protein kinase; Provisional	99.95
PHA02882	294	putative serine/threonine kinase; Provisional	99.95
cd05034	261	PTKc_Src_like Catalytic domain of Src kinase-like	99.95
KOG2052	513	consensus Activin A type IB receptor, serine/threo	99.95
cd05093	288	PTKc_TrkB Catalytic domain of the Protein Tyrosine	99.95
KOG1989	738	consensus ARK protein kinase family [Signal transd	99.95
cd05115	257	PTKc_Zap-70 Catalytic domain of the Protein Tyrosi	99.95
cd05084	252	PTKc_Fes Catalytic domain of the Protein Tyrosine	99.95
cd05586	330	STKc_Sck1_like Catalytic domain of Suppressor of l	99.95
cd05087	269	PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein	99.95
cd05035	273	PTKc_Axl_like Catalytic Domain of Axl-like Protein	99.95
cd06637	272	STKc_TNIK Catalytic domain of the Protein Serine/T	99.95
cd05630	285	STKc_GRK6 Catalytic domain of the Protein Serine/T	99.95
cd05033	266	PTKc_EphR Catalytic domain of Ephrin Receptor Prot	99.95
KOG0666	438	consensus Cyclin C-dependent kinase CDK8 [Transcri	99.95
cd07861	285	STKc_CDK1_euk Catalytic domain of the Serine/Threo	99.95
cd05105	400	PTKc_PDGFR_alpha Catalytic domain of the Protein T	99.95
cd05062	277	PTKc_IGF-1R Catalytic domain of the Protein Tyrosi	99.95
KOG1035	1351	consensus eIF-2alpha kinase GCN2 [Translation, rib	99.95
PHA03209	357	serine/threonine kinase US3; Provisional	99.95
KOG2345	302	consensus Serine/threonine protein kinase/TGF-beta	99.95
PHA03210	501	serine/threonine kinase US3; Provisional	99.95
cd05073	260	PTKc_Hck Catalytic domain of the Protein Tyrosine	99.95
cd05085	250	PTKc_Fer Catalytic domain of the Protein Tyrosine	99.95
cd05148	261	PTKc_Srm_Brk Catalytic domain of the Protein Tyros	99.95
KOG4236	888	consensus Serine/threonine protein kinase PKC mu/P	99.95
KOG0610	459	consensus Putative serine/threonine protein kinase	99.95
KOG0586	596	consensus Serine/threonine protein kinase [General	99.95
cd07847	286	STKc_CDKL1_4 Catalytic domain of the Serine/Threon	99.95
cd05060	257	PTKc_Syk_like Catalytic domain of Spleen Tyrosine	99.95
KOG0664	449	consensus Nemo-like MAPK-related serine/threonine	99.95
KOG1006	361	consensus Mitogen-activated protein kinase (MAPK)	99.95
cd06625	263	STKc_MEKK3_like Catalytic domain of MAP/ERK kinase	99.95
cd07839	284	STKc_CDK5 Catalytic domain of the Serine/Threonine	99.95
cd06643	282	STKc_SLK Catalytic domain of the Protein Serine/Th	99.95
cd05080	283	PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the	99.95
cd06644	292	STKc_STK10_LOK Catalytic domain of the Protein Ser	99.95
PF00069	260	Pkinase: Protein kinase domain Protein kinase; unc	99.95
cd08529	256	STKc_FA2-like Catalytic domain of the Protein Seri	99.95
cd05032	277	PTKc_InsR_like Catalytic domain of Insulin Recepto	99.95
cd05055	302	PTKc_PDGFR Catalytic domain of the Protein Tyrosin	99.95
cd05112	256	PTKc_Itk Catalytic domain of the Protein Tyrosine	99.95
KOG4278	1157	consensus Protein tyrosine kinase [Signal transduc	99.95
cd05110	303	PTKc_HER4 Catalytic domain of the Protein Tyrosine	99.95
cd05057	279	PTKc_EGFR_like Catalytic domain of Epidermal Growt	99.95
cd06654	296	STKc_PAK1 Catalytic domain of the Protein Serine/T	99.95
KOG0662	292	consensus Cyclin-dependent kinase CDK5 [Intracellu	99.95
KOG0199	1039	consensus ACK and related non-receptor tyrosine ki	99.95
cd06612	256	STKc_MST1_2 Catalytic domain of the Protein Serine	99.95
cd05103	343	PTKc_VEGFR2 Catalytic domain of the Protein Tyrosi	99.95
cd06624	268	STKc_ASK Catalytic domain of the Protein Serine/Th	99.95
cd05036	277	PTKc_ALK_LTK Catalytic domain of the Protein Tyros	99.95
cd05074	273	PTKc_Tyro3 Catalytic domain of the Protein Tyrosin	99.95
cd06652	265	STKc_MEKK2 Catalytic domain of the Protein Serine/	99.95
cd07870	291	STKc_PFTAIRE2 Catalytic domain of the Serine/Threo	99.95
cd06646	267	STKc_MAP4K5 Catalytic domain of the Protein Serine	99.95
cd05077	262	PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of th	99.95
cd06651	266	STKc_MEKK3 Catalytic domain of the Protein Serine/	99.95
cd05094	291	PTKc_TrkC Catalytic domain of the Protein Tyrosine	99.95
cd05092	280	PTKc_TrkA Catalytic domain of the Protein Tyrosine	99.95
cd06655	296	STKc_PAK2 Catalytic domain of the Protein Serine/T	99.95
cd06645	267	STKc_MAP4K3 Catalytic domain of the Protein Serine	99.95
cd07860	284	STKc_CDK2_3 Catalytic domain of the Serine/Threoni	99.95
cd05082	256	PTKc_Csk Catalytic domain of the Protein Tyrosine	99.95
cd08228	267	STKc_Nek6 Catalytic domain of the Protein Serine/T	99.95
cd07844	291	STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like	99.95
cd06639	291	STKc_myosinIIIB Catalytic domain of the Protein Se	99.95
cd07877	345	STKc_p38alpha_MAPK14 Catalytic domain of the Serin	99.95
cd06609	274	STKc_MST3_like Catalytic domain of Mammalian Ste20	99.95
cd05097	295	PTKc_DDR_like Catalytic domain of Discoidin Domain	99.95
cd08227	327	PK_STRAD_alpha Pseudokinase domain of STE20-relate	99.95
cd05056	270	PTKc_FAK Catalytic domain of the Protein Tyrosine	99.95
cd05045	290	PTKc_RET Catalytic domain of the Protein Tyrosine	99.95
cd05101	304	PTKc_FGFR2 Catalytic domain of the Protein Tyrosin	99.95
cd06656	297	STKc_PAK3 Catalytic domain of the Protein Serine/T	99.95
cd05040	257	PTKc_Ack_like Catalytic domain of the Protein Tyro	99.95
cd05058	262	PTKc_Met_Ron Catalytic domain of the Protein Tyros	99.95
cd06631	265	STKc_YSK4 Catalytic domain of the Protein Serine/T	99.95
cd06607	307	STKc_TAO Catalytic domain of the Protein Serine/Th	99.95
cd06628	267	STKc_MAPKKK_Byr2_like Catalytic domain of fungal B	99.95
cd06636	282	STKc_MAP4K4_6 Catalytic domain of the Protein Seri	99.95
cd05041	251	PTKc_Fes_like Catalytic domain of Fes-like Protein	99.95
KOG4645	1509	consensus MAPKKK (MAP kinase kinase kinase) SSK2 a	99.95
cd07842	316	STKc_CDK8_like Catalytic domain of Cyclin-Dependen	99.95
cd00192	262	PTKc Catalytic domain of Protein Tyrosine Kinases.	99.95
cd07849	336	STKc_ERK1_2_like Catalytic domain of Extracellular	99.95
cd06642	277	STKc_STK25-YSK1 Catalytic domain of the Protein Se	99.95
cd05580	290	STKc_PKA Catalytic domain of the Protein Serine/Th	99.95
cd07852	337	STKc_MAPK15 Catalytic domain of the Serine/Threoni	99.95
cd05051	296	PTKc_DDR Catalytic domain of the Protein Tyrosine	99.95
cd05098	307	PTKc_FGFR1 Catalytic domain of the Protein Tyrosin	99.95
cd07850	353	STKc_JNK Catalytic domain of the Serine/Threonine	99.95
cd07879	342	STKc_p38delta_MAPK13 Catalytic domain of the Serin	99.95
cd06659	297	STKc_PAK6 Catalytic domain of the Protein Serine/T	99.95
cd07843	293	STKc_CDC2L1 Catalytic domain of the Serine/Threoni	99.95
cd06653	264	STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kina	99.95
cd05061	288	PTKc_InsR Catalytic domain of the Protein Tyrosine	99.95
cd05039	256	PTKc_Csk_like Catalytic domain of C-terminal Src k	99.95
cd05053	293	PTKc_FGFR Catalytic domain of the Protein Tyrosine	99.95
cd05044	269	PTKc_c-ros Catalytic domain of the Protein Tyrosin	99.95
cd06615	308	PKc_MEK Catalytic domain of the dual-specificity P	99.95
cd05107	401	PTKc_PDGFR_beta Catalytic domain of the Protein Ty	99.95
cd05100	334	PTKc_FGFR3 Catalytic domain of the Protein Tyrosin	99.95
cd08223	257	STKc_Nek4 Catalytic domain of the Protein Serine/T	99.95
KOG0984	282	consensus Mitogen-activated protein kinase (MAPK)	99.95
cd05065	269	PTKc_EphR_B Catalytic domain of the Protein Tyrosi	99.94
cd05099	314	PTKc_FGFR4 Catalytic domain of the Protein Tyrosin	99.94
cd05086	268	PTKc_Aatyk2 Catalytic domain of the Protein Tyrosi	99.94
cd06616	288	PKc_MKK4 Catalytic domain of the dual-specificity	99.94
cd05037	259	PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the	99.94
cd07845	309	STKc_CDK10 Catalytic domain of the Serine/Threonin	99.94
cd07846	286	STKc_CDKL2_3 Catalytic domain of the Serine/Threon	99.94
cd08219	255	STKc_Nek3 Catalytic domain of the Protein Serine/T	99.94
cd05063	268	PTKc_EphR_A2 Catalytic domain of the Protein Tyros	99.94
cd06611	280	STKc_SLK_like Catalytic domain of Ste20-like kinas	99.94
cd06613	262	STKc_MAP4K3_like Catalytic domain of Mitogen-activ	99.94
cd06622	286	PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS	99.94
cd06638	286	STKc_myosinIIIA Catalytic domain of the Protein Se	99.94
cd07865	310	STKc_CDK9 Catalytic domain of the Serine/Threonine	99.94
cd05089	297	PTKc_Tie1 Catalytic domain of the Protein Tyrosine	99.94
cd07864	302	STKc_CDK12 Catalytic domain of the Serine/Threonin	99.94
cd05066	267	PTKc_EphR_A Catalytic domain of the Protein Tyrosi	99.94
cd08229	267	STKc_Nek7 Catalytic domain of the Protein Serine/T	99.94
cd08224	267	STKc_Nek6_Nek7 Catalytic domain of the Protein Ser	99.94
cd06629	272	STKc_MAPKKK_Bck1_like Catalytic domain of fungal B	99.94
cd07832	286	STKc_CCRK Catalytic domain of the Serine/Threonine	99.94
cd06635	317	STKc_TAO1 Catalytic domain of the Protein Serine/T	99.94
cd05081	284	PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of	99.94
cd05088	303	PTKc_Tie2 Catalytic domain of the Protein Tyrosine	99.94
cd06632	258	STKc_MEKK1_plant Catalytic domain of the Protein S	99.94
PLN00009	294	cyclin-dependent kinase A; Provisional	99.94
cd05095	296	PTKc_DDR2 Catalytic domain of the Protein Tyrosine	99.94
cd07841	298	STKc_CDK7 Catalytic domain of the Serine/Threonine	99.94
PTZ00024	335	cyclin-dependent protein kinase; Provisional	99.94
KOG0696	683	consensus Serine/threonine protein kinase [Signal	99.94
cd05079	284	PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the	99.94
cd07836	284	STKc_Pho85 Catalytic domain of the Serine/Threonin	99.94
cd06617	283	PKc_MKK3_6 Catalytic domain of the dual-specificit	99.94
cd07835	283	STKc_CDK1_like Catalytic domain of Cyclin-Dependen	99.94
cd05083	254	PTKc_Chk Catalytic domain of the Protein Tyrosine	99.94
cd05050	288	PTKc_Musk Catalytic domain of the Protein Tyrosine	99.94
cd05613	290	STKc_MSK1_N N-terminal catalytic domain of the Pro	99.94
KOG0690	516	consensus Serine/threonine protein kinase [Signal	99.94
cd07831	282	STKc_MOK Catalytic domain of the Serine/Threonine	99.94
cd05047	270	PTKc_Tie Catalytic domain of Tie Protein Tyrosine	99.94
cd06640	277	STKc_MST4 Catalytic domain of the Protein Serine/T	99.94
cd06658	292	STKc_PAK5 Catalytic domain of the Protein Serine/T	99.94
KOG0574	502	consensus STE20-like serine/threonine kinase MST [	99.94
KOG0614	732	consensus cGMP-dependent protein kinase [Signal tr	99.94
KOG0596	677	consensus Dual specificity; serine/threonine and t	99.94
cd05574	316	STKc_phototropin_like Catalytic domain of Phototro	99.94
cd08221	256	STKc_Nek9 Catalytic domain of the Protein Serine/T	99.94
cd07840	287	STKc_CDK9_like Catalytic domain of Cyclin-Dependen	99.94
cd07833	288	STKc_CDKL Catalytic domain of Cyclin-Dependent pro	99.94
cd06626	264	STKc_MEKK4 Catalytic domain of the Protein Serine/	99.94
cd06608	275	STKc_myosinIII_like Catalytic domain of Class III	99.94
cd06620	284	PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr	99.94
cd06610	267	STKc_OSR1_SPAK Catalytic domain of the Protein Ser	99.94
smart00219	258	TyrKc Tyrosine kinase, catalytic domain. Phosphotr	99.94
cd05577	277	STKc_GRK Catalytic domain of the Protein Serine/Th	99.94
cd05076	274	PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of th	99.94
KOG0579	1187	consensus Ste20-like serine/threonine protein kina	99.94
cd06641	277	STKc_MST3 Catalytic domain of the Protein Serine/T	99.94
KOG1151	775	consensus Tousled-like protein kinase [Signal tran	99.94
cd07866	311	STKc_BUR1 Catalytic domain of the Serine/Threonine	99.94
cd07837	295	STKc_CdkB_plant Catalytic domain of the Serine/Thr	99.94
cd06917	277	STKc_NAK1_like Catalytic domain of Fungal Nak1-lik	99.94
cd06647	293	STKc_PAK_I Catalytic domain of the Protein Serine/	99.94
cd05633	279	STKc_GRK3 Catalytic domain of the Protein Serine/T	99.94
KOG0607	463	consensus MAP kinase-interacting kinase and relate	99.94
cd07855	334	STKc_ERK5 Catalytic domain of the Serine/Threonine	99.94
cd05038	284	PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the P	99.94
cd05578	258	STKc_Yank1 Catalytic domain of the Protein Serine/	99.94
cd07857	332	STKc_MPK1 Catalytic domain of the Serine/Threonine	99.94
cd07880	343	STKc_p38gamma_MAPK12 Catalytic domain of the Serin	99.94
cd06618	296	PKc_MKK7 Catalytic domain of the dual-specificity	99.94
cd08217	265	STKc_Nek2 Catalytic domain of the Protein Serine/T	99.94
cd08218	256	STKc_Nek1 Catalytic domain of the Protein Serine/T	99.94
cd05572	262	STKc_cGK_PKG Catalytic domain of the Protein Serin	99.94
cd05609	305	STKc_MAST Catalytic domain of the Protein Serine/T	99.94
cd06630	268	STKc_MEKK1 Catalytic domain of the Protein Serine/	99.94
cd06614	286	STKc_PAK Catalytic domain of the Protein Serine/Th	99.94
cd05606	278	STKc_beta_ARK Catalytic domain of the Protein Seri	99.94
cd06648	285	STKc_PAK_II Catalytic domain of the Protein Serine	99.94
cd06623	264	PKc_MAPKK_plant_like Catalytic domain of Plant dua	99.94
cd06605	265	PKc_MAPKK Catalytic domain of the dual-specificity	99.93
cd08220	256	STKc_Nek8 Catalytic domain of the Protein Serine/T	99.93
cd05579	265	STKc_MAST_like Catalytic domain of Microtubule-ass	99.93
cd06634	308	STKc_TAO2 Catalytic domain of the Protein Serine/T	99.93
cd07858	337	STKc_TEY_MAPK_plant Catalytic domain of the Serine	99.93
cd07856	328	STKc_Sty1_Hog1 Catalytic domain of the Serine/Thre	99.93
cd07838	287	STKc_CDK4_6_like Catalytic domain of Cyclin-Depend	99.93
KOG0669	376	consensus Cyclin T-dependent kinase CDK9 [Cell cyc	99.93
cd08528	269	STKc_Nek10 Catalytic domain of the Protein Serine/	99.93
cd06621	287	PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek	99.93
cd05122	253	PKc_STE Catalytic domain of STE family Protein Kin	99.93
cd06633	313	STKc_TAO3 Catalytic domain of the Protein Serine/T	99.93
cd08226	328	PK_STRAD_beta Pseudokinase domain of STE20-related	99.93
cd05078	258	PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain	99.93
cd05046	275	PTK_CCK4 Pseudokinase domain of the Protein Tyrosi	99.93
cd06657	292	STKc_PAK4 Catalytic domain of the Protein Serine/T	99.93
KOG0612	1317	consensus Rho-associated, coiled-coil containing p	99.93
cd05611	260	STKc_Rim15_like Catalytic domain of fungal Rim15-l	99.93
cd07854	342	STKc_MAPK4_6 Catalytic domain of the Serine/Threon	99.93
cd06606	260	STKc_MAPKKK Catalytic domain of the Protein Serine	99.93
cd07834	330	STKc_MAPK Catalytic domain of the Serine/Threonine	99.93
cd07830	283	STKc_MAK_like Catalytic domain of Male germ cell-A	99.93
cd08225	257	STKc_Nek5 Catalytic domain of the Protein Serine/T	99.93
cd05118	283	STKc_CMGC Catalytic domain of CMGC family Serine/T	99.93
cd06627	254	STKc_Cdc7_like Catalytic domain of Cell division c	99.93
cd08216	314	PK_STRAD Pseudokinase domain of STE20-related kina	99.93
KOG0608	1034	consensus Warts/lats-like serine threonine kinases	99.93
KOG0668	338	consensus Casein kinase II, alpha subunit [Signal	99.93
KOG1024	563	consensus Receptor-like protein tyrosine kinase RY	99.93
KOG1152	772	consensus Signal transduction serine/threonine kin	99.93
cd05583	288	STKc_MSK_N N-terminal catalytic domain of the Prot	99.93
cd07829	282	STKc_CDK_like Catalytic domain of Cyclin-Dependent	99.93
PHA03390	267	pk1 serine/threonine-protein kinase 1; Provisional	99.92
cd07851	343	STKc_p38 Catalytic domain of the Serine/Threonine	99.92
cd05581	280	STKc_PDK1 Catalytic domain of the Protein Serine/T	99.92
cd08530	256	STKc_CNK2-like Catalytic domain of the Protein Ser	99.92
KOG0200	609	consensus Fibroblast/platelet-derived growth facto	99.92
KOG0603	612	consensus Ribosomal protein S6 kinase [Signal tran	99.92
cd08215	258	STKc_Nek Catalytic domain of the Protein Serine/Th	99.92
KOG0604	400	consensus MAP kinase-activated protein kinase 2 [S	99.92
cd05123	250	STKc_AGC Catalytic domain of AGC family Protein Se	99.92
KOG0671	415	consensus LAMMER dual specificity kinases [Signal	99.91
cd08222	260	STKc_Nek11 Catalytic domain of the Protein Serine/	99.91
cd05576	237	STKc_RPK118_like Catalytic domain of the Protein S	99.9
cd05610	669	STKc_MASTL Catalytic domain of the Protein Serine/	99.9
smart00221	225	STYKc Protein kinase; unclassified specificity. Ph	99.9
KOG0695	593	consensus Serine/threonine protein kinase [Signal	99.9
KOG1027	903	consensus Serine/threonine protein kinase and endo	99.9
KOG0665	369	consensus Jun-N-terminal kinase (JNK) [Signal tran	99.89
KOG0587	953	consensus Traf2- and Nck-interacting kinase and re	99.89
PLN03225	566	Serine/threonine-protein kinase SNT7; Provisional	99.89
PLN03224	507	probable serine/threonine protein kinase; Provisio	99.89
smart00220	244	S_TKc Serine/Threonine protein kinases, catalytic	99.89
KOG0670	752	consensus U4/U6-associated splicing factor PRP4 [R	99.88
KOG1345	378	consensus Serine/threonine kinase [Signal transduc	99.86
KOG1167	418	consensus Serine/threonine protein kinase of the C	99.84
KOG1290	590	consensus Serine/threonine protein kinase [Signal	99.82
cd00180	215	PKc Catalytic domain of Protein Kinases. Protein K	99.82
PRK09188	365	serine/threonine protein kinase; Provisional	99.8
PLN00181	793	protein SPA1-RELATED; Provisional	99.77
KOG0576	829	consensus Mitogen-activated protein kinase kinase	99.77
smart00750	176	KIND kinase non-catalytic C-lobe domain. It is an	99.75
KOG1164	322	consensus Casein kinase (serine/threonine/tyrosine	99.75
KOG1165	449	consensus Casein kinase (serine/threonine/tyrosine	99.73
PF13947	106	GUB_WAK_bind: Wall-associated receptor kinase gala	99.72
KOG0195	448	consensus Integrin-linked kinase [Signal transduct	99.72
COG0515	384	SPS1 Serine/threonine protein kinase [General func	99.71
PRK12274	218	serine/threonine protein kinase; Provisional	99.7
KOG1163	341	consensus Casein kinase (serine/threonine/tyrosine	99.7
cd05145	190	RIO1_like RIO kinase family; RIO1, RIO3 and simila	99.68
cd05147	190	RIO1_euk RIO kinase family; eukaryotic RIO1, catal	99.67
PF14531	288	Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_	99.64
PRK10359	232	lipopolysaccharide core biosynthesis protein; Prov	99.64
KOG0603	612	consensus Ribosomal protein S6 kinase [Signal tran	99.61
KOG1240	1431	consensus Protein kinase containing WD40 repeats [	99.6
KOG0606	1205	consensus Microtubule-associated serine/threonine	99.59
KOG0590	601	consensus Checkpoint kinase and related serine/thr	99.59
KOG1033	516	consensus eIF-2alpha kinase PEK/EIF2AK3 [Translati	99.57
PRK10345	210	hypothetical protein; Provisional	99.54
KOG1166	974	consensus Mitotic checkpoint serine/threonine prot	99.52
cd05144	198	RIO2_C RIO kinase family; RIO2, C-terminal catalyt	99.52
smart00090	237	RIO RIO-like kinase.	99.52
PF14380	94	WAK_assoc: Wall-associated receptor kinase C-termi	99.49
cd05119	187	RIO RIO kinase family, catalytic domain. The RIO k	99.44
KOG4158	598	consensus BRPK/PTEN-induced protein kinase [Signal	99.44
PRK14879	211	serine/threonine protein kinase; Provisional	99.4
PRK09605	535	bifunctional UGMP family protein/serine/threonine	99.38
KOG1023	484	consensus Natriuretic peptide receptor, guanylate	99.38
TIGR03724	199	arch_bud32 Kae1-associated kinase Bud32. Members o	99.37
cd05120	155	APH_ChoK_like Aminoglycoside 3'-phosphotransferase	99.29
PRK01723	239	3-deoxy-D-manno-octulosonic-acid kinase; Reviewed	99.23
KOG0590	601	consensus Checkpoint kinase and related serine/thr	99.2
TIGR01982	437	UbiB 2-polyprenylphenol 6-hydroxylase. This model	98.95
cd05151	170	ChoK Choline Kinase (ChoK). The ChoK subfamily is	98.95
KOG1243	690	consensus Protein kinase [General function predict	98.87
KOG0601	524	consensus Cyclin-dependent kinase WEE1 [Cell cycle	98.82
cd05146	197	RIO3_euk RIO kinase family; eukaryotic RIO3, catal	98.64
PRK04750	537	ubiB putative ubiquinone biosynthesis protein UbiB	98.58
KOG1266	458	consensus Protein kinase [Signal transduction mech	98.47
cd05154	223	ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 an	98.43
KOG0601	524	consensus Cyclin-dependent kinase WEE1 [Cell cycle	98.39
PF01163	188	RIO1: RIO1 family; InterPro: IPR018934 Protein pho	98.35
KOG2137	700	consensus Protein kinase [Signal transduction mech	98.34
COG3642	204	Mn2+-dependent serine/threonine protein kinase [Si	98.31
COG4248	637	Uncharacterized protein with protein kinase and he	98.24
KOG3087	229	consensus Serine/threonine protein kinase [General	98.17
KOG0606	1205	consensus Microtubule-associated serine/threonine	98.13
COG0478	304	RIO-like serine/threonine protein kinase fused to	98.08
KOG3741	655	consensus Poly(A) ribonuclease subunit [RNA proces	98.01
PRK15123	268	lipopolysaccharide core heptose(I) kinase RfaP; Pr	97.85
PRK09902	216	hypothetical protein; Provisional	97.84
COG0661	517	AarF Predicted unusual protein kinase [General fun	97.55
COG1718	268	RIO1 Serine/threonine protein kinase involved in c	97.51
KOG0576	829	consensus Mitogen-activated protein kinase kinase	97.38
PF06293	206	Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family;	97.21
PF12260	188	PIP49_C: Protein-kinase domain of FAM69; InterPro:	97.1
TIGR02172	226	Fb_sc_TIGR02172 Fibrobacter succinogenes paralogou	97.04
COG2112	201	Predicted Ser/Thr protein kinase [Signal transduct	96.92
PF13095	207	FTA2: Kinetochore Sim4 complex subunit FTA2	96.86
PF01636	239	APH: Phosphotransferase enzyme family This family	96.78
PF06176	229	WaaY: Lipopolysaccharide core biosynthesis protein	96.58
KOG1235	538	consensus Predicted unusual protein kinase [Genera	96.57
cd05157	235	ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes.	96.49
cd05150	244	APH Aminoglycoside 3'-phosphotransferase (APH). Th	96.46
PF10707	199	YrbL-PhoP_reg: PhoP regulatory network protein Yrb	96.45
TIGR02721	256	ycfN_thiK thiamine kinase. Members of this family	96.11
cd05155	235	APH_ChoK_like_1 Uncharacterized bacterial proteins	95.99
cd05156	302	ChoK_euk Choline Kinase (ChoK) in eukaryotes. The	95.78
PRK09550	401	mtnK methylthioribose kinase; Reviewed	95.72
PLN02876	822	acyl-CoA dehydrogenase	95.66
KOG1035	1351	consensus eIF-2alpha kinase GCN2 [Translation, rib	95.63
KOG2268	465	consensus Serine/threonine protein kinase [Signal	95.26
PLN02236	344	choline kinase	95.26
PRK05231	319	homoserine kinase; Provisional	95.12
cd05153	296	HomoserineK_II Homoserine Kinase, type II. Homoser	94.63
PRK10593	297	hypothetical protein; Provisional	94.38
PF07387	308	Seadorna_VP7: Seadornavirus VP7; InterPro: IPR0099	94.36
PLN02421	330	phosphotransferase, alcohol group as acceptor/kina	94.23
PF01633	211	Choline_kinase: Choline/ethanolamine kinase; Inter	94.09
cd05152	276	MPH2' Macrolide 2'-Phosphotransferase (MPH2'). MPH	94.04
TIGR01767	370	MTRK 5-methylthioribose kinase. This enzyme is inv	93.89
PRK12396	409	5-methylribose kinase; Reviewed	93.61
COG5072	488	ALK1 Serine/threonine kinase of the haspin family	92.48
PLN02756	418	S-methyl-5-thioribose kinase	92.15
PF03109	119	ABC1: ABC1 family; InterPro: IPR004147 This entry	92.06
PRK11768	325	serine/threonine protein kinase; Provisional	91.26
TIGR00938	307	thrB_alt homoserine kinase, Neisseria type. Homose	91.17
PRK06148	1013	hypothetical protein; Provisional	90.83
COG0510	269	ycfN Thiamine kinase and related kinases [Coenzyme	90.32
PF03881	288	Fructosamin_kin: Fructosamine kinase; InterPro: IP	90.09
KOG2270	520	consensus Serine/threonine protein kinase involved	89.74
PRK10271	188	thiK thiamine kinase; Provisional	89.06
PF04655	253	APH_6_hur: Aminoglycoside/hydroxyurea antibiotic r	89.01
KOG1826	2724	consensus Ras GTPase activating protein RasGAP/neu	88.99
PF01102	122	Glycophorin_A: Glycophorin A; InterPro: IPR001195	88.42
PTZ00384	383	choline kinase; Provisional	88.26

>KOG1187 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.1e-40  Score=333.12  Aligned_cols=187  Identities=48%  Similarity=0.849  Sum_probs=167.3

Q ss_pred             CCCccCHHHHHHHHhhhc--cccCccCceEEEEEEEcCCCEEEEEEeccCCCC-chhhHHHHHHhhccCccceeEEEEEe
Q 039231          301 SPKRYGYADIKKMTNSFK--YKLGQGGYGSVYKGKLLDGSNVAVKVLNDSKGN-GKEFINEVASISRTSHVNVVALLGFC  377 (506)
Q Consensus       301 ~~~~~~~~el~~~~~~~~--~~ig~G~~g~V~~~~~~~~~~vavK~l~~~~~~-~~~~~~E~~~l~~l~h~niv~l~g~~  377 (506)
                      ..+.|++.|+.++|++|.  +.||+|+||.||+|.+.+|+.||||++...... .++|.+|++++.+++|||+|+|+|||
T Consensus        61 ~~~~fs~~el~~AT~~Fs~~~~ig~Ggfg~VYkG~l~~~~~vAVK~~~~~~~~~~~eF~~Ei~~ls~l~H~Nlv~LlGyC  140 (361)
T KOG1187|consen   61 PLRSFSYDELRKATNNFSESNLIGEGGFGTVYKGVLSDGTVVAVKRLSSNSGQGEREFLNEVEILSRLRHPNLVKLLGYC  140 (361)
T ss_pred             CcceeeHHHHHHHHhCCchhcceecCCCeEEEEEEECCCCEEEEEEecCCCCcchhHHHHHHHHHhcCCCcCcccEEEEE
Confidence            567899999999999997  689999999999999999999999999876555 67799999999999999999999999


Q ss_pred             e------------------------------ccchhhhHHHHHHHHHHHHhhcCCCCeEecCcCCCcEEECCCCcEEEee
Q 039231          378 L------------------------------RVAEELSSTIGIARGLEYLHLGCSTRILHFDIKPHNILLDEDFCPKISD  427 (506)
Q Consensus       378 ~------------------------------~~~~~l~i~~~i~~gl~~LH~~~~~~ivH~dlkp~Nill~~~~~~ki~d  427 (506)
                      .                              +|..|++|+.++|+||+|||+.+.++|+||||||+|||||+++++||+|
T Consensus       141 ~e~~~~~~LVYEym~nGsL~d~L~~~~~~~L~W~~R~kIa~g~A~gL~yLH~~~~~~iiHrDiKssNILLD~~~~aKlsD  220 (361)
T KOG1187|consen  141 LEGGEHRLLVYEYMPNGSLEDHLHGKKGEPLDWETRLKIALGAARGLAYLHEGCPPPIIHRDIKSSNILLDEDFNAKLSD  220 (361)
T ss_pred             ecCCceEEEEEEccCCCCHHHHhCCCCCCCCCHHHHHHHHHHHHHHHHHHccCCCCCEecCCCCHHHeeECCCCCEEccC
Confidence            2                              5777899999999999999998888999999999999999999999999


Q ss_pred             cCCCccccC-CCcceecccC-CCCcccccccccccccCCCCccccHHHHHHHHHHHHcCCCCCCCCC
Q 039231          428 FGLAKICNR-KESIISMTGA-RGTVGYIAPEVFCRNIGEVSYKSDVYNYGMMIFEMTGGRKNVDVVD  492 (506)
Q Consensus       428 fg~a~~~~~-~~~~~~~~~~-~gt~~y~aPE~l~~~~~~~s~~~Dv~s~G~il~elltg~~pf~~~~  492 (506)
                      ||+|+.... ....   ... .||.+|+|||++..  +..+.|+|||||||+|+||+||++|.+...
T Consensus       221 FGLa~~~~~~~~~~---~~~~~gt~gY~~PEy~~~--g~lt~KsDVySFGVvllElitgr~~~d~~~  282 (361)
T KOG1187|consen  221 FGLAKLGPEGDTSV---STTVMGTFGYLAPEYAST--GKLTEKSDVYSFGVVLLELITGRKAVDQSR  282 (361)
T ss_pred             ccCcccCCccccce---eeecCCCCccCChhhhcc--CCcCcccccccchHHHHHHHhCCcccCCCC
Confidence            999976654 3322   112 89999999999854  689999999999999999999999998765

>KOG0595 consensus Serine/threonine-protein kinase involved in autophagy [Posttranslational modification, protein turnover, chaperones; Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms]

Probab=100.00  E-value=1.5e-37  Score=296.93  Aligned_cols=173  Identities=29%  Similarity=0.468  Sum_probs=146.4

Q ss_pred             ccccCccCceEEEEEEEcC-CCEEEEEEeccCCC---CchhhHHHHHHhhccCccceeEEEEEe----------------
Q 039231          318 KYKLGQGGYGSVYKGKLLD-GSNVAVKVLNDSKG---NGKEFINEVASISRTSHVNVVALLGFC----------------  377 (506)
Q Consensus       318 ~~~ig~G~~g~V~~~~~~~-~~~vavK~l~~~~~---~~~~~~~E~~~l~~l~h~niv~l~g~~----------------  377 (506)
                      .++||+|+|++||+|++++ +..||||.+....-   ..+-+..|+.+|+.++|||||++++++                
T Consensus        15 ~~~iG~GsfavVykg~h~~~~~~VAIK~i~~~~l~~k~~e~L~~Ei~iLkel~H~nIV~l~d~~~~~~~i~lVMEyC~gG   94 (429)
T KOG0595|consen   15 SREIGSGSFAVVYKGRHKKSGTEVAIKCIAKKKLNKKLVELLLSEIKILKELKHPNIVRLLDCIEDDDFIYLVMEYCNGG   94 (429)
T ss_pred             hhhccCcceEEEEEeEeccCCceEEeeeehhhccCHHHHHHHHHHHHHHHhcCCcceeeEEEEEecCCeEEEEEEeCCCC
Confidence            4569999999999999864 89999999976542   235578899999999999999999877                


Q ss_pred             -----------eccchhhhHHHHHHHHHHHHhhcCCCCeEecCcCCCcEEECCC------CcEEEeecCCCccccCCCcc
Q 039231          378 -----------LRVAEELSSTIGIARGLEYLHLGCSTRILHFDIKPHNILLDED------FCPKISDFGLAKICNRKESI  440 (506)
Q Consensus       378 -----------~~~~~~l~i~~~i~~gl~~LH~~~~~~ivH~dlkp~Nill~~~------~~~ki~dfg~a~~~~~~~~~  440 (506)
                                 +.+.....++.|+|.||++||   +++||||||||+||||+..      -.+||+|||+|+.+..... 
T Consensus        95 DLs~yi~~~~~l~e~t~r~Fm~QLA~alq~L~---~~~IiHRDLKPQNiLLs~~~~~~~~~~LKIADFGfAR~L~~~~~-  170 (429)
T KOG0595|consen   95 DLSDYIRRRGRLPEATARHFMQQLASALQFLH---ENNIIHRDLKPQNILLSTTARNDTSPVLKIADFGFARFLQPGSM-  170 (429)
T ss_pred             CHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHH---HCCeeeccCCcceEEeccCCCCCCCceEEecccchhhhCCchhH-
Confidence                       233345678899999999999   9999999999999999764      4689999999999876543 


Q ss_pred             eecccCCCCcccccccccccccCCCCccccHHHHHHHHHHHHcCCCCCCCCCCCcchh
Q 039231          441 ISMTGARGTVGYIAPEVFCRNIGEVSYKSDVYNYGMMIFEMTGGRKNVDVVDNGSTAL  498 (506)
Q Consensus       441 ~~~~~~~gt~~y~aPE~l~~~~~~~s~~~Dv~s~G~il~elltg~~pf~~~~~~~~~~  498 (506)
                        .....|++.|||||++..  ..|+.|+|+||+|+|||+|++|+.||+.....+...
T Consensus       171 --a~tlcGSplYMAPEV~~~--~~YdAKADLWSiG~Ilyq~l~g~~Pf~a~t~~eL~~  224 (429)
T KOG0595|consen  171 --AETLCGSPLYMAPEVIMS--QQYDAKADLWSIGTILYQCLTGKPPFDAETPKELLL  224 (429)
T ss_pred             --HHHhhCCccccCHHHHHh--ccccchhhHHHHHHHHHHHHhCCCCccccCHHHHHH
Confidence              356789999999999964  489999999999999999999999999766555444

>KOG0575 consensus Polo-like serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=7.3e-37  Score=305.86  Aligned_cols=179  Identities=30%  Similarity=0.444  Sum_probs=156.1

Q ss_pred             hhhccccCccCceEEEEEEE-cCCCEEEEEEecc----CCCCchhhHHHHHHhhccCccceeEEEEEe------------
Q 039231          315 NSFKYKLGQGGYGSVYKGKL-LDGSNVAVKVLND----SKGNGKEFINEVASISRTSHVNVVALLGFC------------  377 (506)
Q Consensus       315 ~~~~~~ig~G~~g~V~~~~~-~~~~~vavK~l~~----~~~~~~~~~~E~~~l~~l~h~niv~l~g~~------------  377 (506)
                      +...+.||+|||+.+|+++. ..|..||+|++.+    .....+.+.+|+++.++++|||||++++++            
T Consensus        20 Y~~g~~LGkGgFA~cYe~~~~~tge~~A~KvVpk~~l~k~~~reKv~~EIeIHr~L~HpnIV~f~~~FEDs~nVYivLEL   99 (592)
T KOG0575|consen   20 YKRGRFLGKGGFARCYEARDLDTGEVVAVKVVPKKLLKKPKQREKVLNEIEIHRSLKHPNIVQFYHFFEDSNNVYIVLEL   99 (592)
T ss_pred             eeeeeeeccCcceEEEEEEEcCCCcEEEEEEeehHHhcCcchHHHHHHHHHHHHhcCCCcEEeeeeEeecCCceEEEEEe
Confidence            34456799999999999998 7799999999976    445557899999999999999999999998            


Q ss_pred             ---------------eccchhhhHHHHHHHHHHHHhhcCCCCeEecCcCCCcEEECCCCcEEEeecCCCccccCCCccee
Q 039231          378 ---------------LRVAEELSSTIGIARGLEYLHLGCSTRILHFDIKPHNILLDEDFCPKISDFGLAKICNRKESIIS  442 (506)
Q Consensus       378 ---------------~~~~~~l~i~~~i~~gl~~LH~~~~~~ivH~dlkp~Nill~~~~~~ki~dfg~a~~~~~~~~~~~  442 (506)
                                     +++.++..+..||+.||.|||   +++|+|||||..|+||+++.++||+|||+|..+..+...  
T Consensus       100 C~~~sL~el~Krrk~ltEpEary~l~QIv~GlkYLH---~~~IiHRDLKLGNlfL~~~~~VKIgDFGLAt~le~~~Er--  174 (592)
T KOG0575|consen  100 CHRGSLMELLKRRKPLTEPEARYFLRQIVEGLKYLH---SLGIIHRDLKLGNLFLNENMNVKIGDFGLATQLEYDGER--  174 (592)
T ss_pred             cCCccHHHHHHhcCCCCcHHHHHHHHHHHHHHHHHH---hcCceecccchhheeecCcCcEEecccceeeeecCcccc--
Confidence                           556668889999999999999   999999999999999999999999999999988755332  


Q ss_pred             cccCCCCcccccccccccccCCCCccccHHHHHHHHHHHHcCCCCCCCCCCCcchhhh
Q 039231          443 MTGARGTVGYIAPEVFCRNIGEVSYKSDVYNYGMMIFEMTGGRKNVDVVDNGSTALDL  500 (506)
Q Consensus       443 ~~~~~gt~~y~aPE~l~~~~~~~s~~~Dv~s~G~il~elltg~~pf~~~~~~~~~~~~  500 (506)
                      ..+..|||-|+|||++.+.  .++..+||||+||++|.||.|++||+..+-.+....|
T Consensus       175 k~TlCGTPNYIAPEVl~k~--gHsfEvDiWSlGcvmYtLL~G~PPFetk~vkety~~I  230 (592)
T KOG0575|consen  175 KKTLCGTPNYIAPEVLNKS--GHSFEVDIWSLGCVMYTLLVGRPPFETKTVKETYNKI  230 (592)
T ss_pred             cceecCCCcccChhHhccC--CCCCchhhhhhhhHHHhhhhCCCCcccchHHHHHHHH
Confidence            2567899999999999755  7899999999999999999999999987655544443

>KOG0192 consensus Tyrosine kinase specific for activated (GTP-bound) p21cdc42Hs [Signal transduction mechanisms]

Probab=100.00  E-value=2.2e-36  Score=300.07  Aligned_cols=178  Identities=37%  Similarity=0.573  Sum_probs=149.4

Q ss_pred             ccccCccCceEEEEEEEcCCCEEEEEEeccCCCC---chhhHHHHHHhhccCccceeEEEEEeec---------------
Q 039231          318 KYKLGQGGYGSVYKGKLLDGSNVAVKVLNDSKGN---GKEFINEVASISRTSHVNVVALLGFCLR---------------  379 (506)
Q Consensus       318 ~~~ig~G~~g~V~~~~~~~~~~vavK~l~~~~~~---~~~~~~E~~~l~~l~h~niv~l~g~~~~---------------  379 (506)
                      .+.||+|+||+||+|.++....||||++......   .++|.+|+.+|.+++|||||+++|+|.+               
T Consensus        46 ~~~iG~G~~g~V~~~~~~g~~~vavK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~f~G~~~~~~~~~~iVtEy~~~G  125 (362)
T KOG0192|consen   46 EEVLGSGSFGTVYKGKWRGTDVVAVKIISDPDFDDESRKAFRREASLLSRLRHPNIVQFYGACTSPPGSLCIVTEYMPGG  125 (362)
T ss_pred             hhhcccCCceeEEEEEeCCceeEEEEEecchhcChHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCceEEEEEeCCCC
Confidence            3459999999999999965555999999764432   4589999999999999999999999833               


Q ss_pred             ---------------cchhhhHHHHHHHHHHHHhhcCCCC-eEecCcCCCcEEECCCC-cEEEeecCCCccccCCCccee
Q 039231          380 ---------------VAEELSSTIGIARGLEYLHLGCSTR-ILHFDIKPHNILLDEDF-CPKISDFGLAKICNRKESIIS  442 (506)
Q Consensus       380 ---------------~~~~l~i~~~i~~gl~~LH~~~~~~-ivH~dlkp~Nill~~~~-~~ki~dfg~a~~~~~~~~~~~  442 (506)
                                     +..++.++.|||+||+|||   +++ ||||||||+|||++.++ ++||+|||+++......  ..
T Consensus       126 sL~~~l~~~~~~~l~~~~~l~~aldiArGm~YLH---~~~~iIHrDLK~~NiLv~~~~~~~KI~DFGlsr~~~~~~--~~  200 (362)
T KOG0192|consen  126 SLSVLLHKKRKRKLPLKVRLRIALDIARGMEYLH---SEGPIIHRDLKSDNILVDLKGKTLKIADFGLSREKVISK--TS  200 (362)
T ss_pred             cHHHHHhhcccCCCCHHHHHHHHHHHHHHHHHHh---cCCCeeecccChhhEEEcCCCCEEEECCCccceeecccc--cc
Confidence                           2336789999999999999   788 99999999999999997 99999999998765432  22


Q ss_pred             cccCCCCcccccccccccccCCCCccccHHHHHHHHHHHHcCCCCCCCCCCCcchhhh
Q 039231          443 MTGARGTVGYIAPEVFCRNIGEVSYKSDVYNYGMMIFEMTGGRKNVDVVDNGSTALDL  500 (506)
Q Consensus       443 ~~~~~gt~~y~aPE~l~~~~~~~s~~~Dv~s~G~il~elltg~~pf~~~~~~~~~~~~  500 (506)
                      .+...||..|||||++.+....++.|+||||||++||||+||+.||......+....+
T Consensus       201 ~~~~~GT~~wMAPEv~~~~~~~~~~K~DvySFgIvlWEl~t~~~Pf~~~~~~~~~~~v  258 (362)
T KOG0192|consen  201 MTSVAGTYRWMAPEVLRGEKSPYTEKSDVYSFGIVLWELLTGEIPFEDLAPVQVASAV  258 (362)
T ss_pred             ccCCCCCccccChhhhcCCCCcCCccchhhhHHHHHHHHHHCCCCCCCCCHHHHHHHH
Confidence            3557899999999999642247999999999999999999999999998874444433

>KOG0615 consensus Serine/threonine protein kinase Chk2 and related proteins [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=1e-36  Score=290.80  Aligned_cols=179  Identities=31%  Similarity=0.442  Sum_probs=147.1

Q ss_pred             HHHhhhccccCccCceEEEEEEE-cCCCEEEEEEeccCCC--------CchhhHHHHHHhhccCccceeEEEEEee----
Q 039231          312 KMTNSFKYKLGQGGYGSVYKGKL-LDGSNVAVKVLNDSKG--------NGKEFINEVASISRTSHVNVVALLGFCL----  378 (506)
Q Consensus       312 ~~~~~~~~~ig~G~~g~V~~~~~-~~~~~vavK~l~~~~~--------~~~~~~~E~~~l~~l~h~niv~l~g~~~----  378 (506)
                      +..+-..+.+|+|+||.|-+|.. ++|+.||||++++...        ....+.+|+++|++++|||||++.+++-    
T Consensus       171 ~d~yii~~~LGsGafg~Vkla~e~~tgk~vAiKIi~krk~~~~s~~~~~~~~v~~EieILkkL~HP~IV~~~d~f~~~ds  250 (475)
T KOG0615|consen  171 NDYYIISKTLGSGAFGLVKLAYEKKTGKQVAIKIINKRKSTGCSRAIAKTRDVQNEIEILKKLSHPNIVRIKDFFEVPDS  250 (475)
T ss_pred             cceeEeeeeecCCceeEEEEEEEcccCcEEEeeeeehhhcccccccccchhhhHHHHHHHHhcCCCCEEEEeeeeecCCc
Confidence            33444567899999999999976 4699999999975321        2234679999999999999999999882    


Q ss_pred             -----------------------ccchhhhHHHHHHHHHHHHhhcCCCCeEecCcCCCcEEECCC---CcEEEeecCCCc
Q 039231          379 -----------------------RVAEELSSTIGIARGLEYLHLGCSTRILHFDIKPHNILLDED---FCPKISDFGLAK  432 (506)
Q Consensus       379 -----------------------~~~~~l~i~~~i~~gl~~LH~~~~~~ivH~dlkp~Nill~~~---~~~ki~dfg~a~  432 (506)
                                             .+..-..++.|++.|+.|||   ++||+||||||+|||+..+   ..+||+|||+|+
T Consensus       251 ~YmVlE~v~GGeLfd~vv~nk~l~ed~~K~~f~Qll~avkYLH---~~GI~HRDiKPeNILl~~~~e~~llKItDFGlAK  327 (475)
T KOG0615|consen  251 SYMVLEYVEGGELFDKVVANKYLREDLGKLLFKQLLTAVKYLH---SQGIIHRDIKPENILLSNDAEDCLLKITDFGLAK  327 (475)
T ss_pred             eEEEEEEecCccHHHHHHhccccccchhHHHHHHHHHHHHHHH---HcCcccccCCcceEEeccCCcceEEEecccchhh
Confidence                                   22334558899999999999   9999999999999999765   789999999999


Q ss_pred             cccCCCcceecccCCCCcccccccccccccCCC-CccccHHHHHHHHHHHHcCCCCCCCCCCCcc
Q 039231          433 ICNRKESIISMTGARGTVGYIAPEVFCRNIGEV-SYKSDVYNYGMMIFEMTGGRKNVDVVDNGST  496 (506)
Q Consensus       433 ~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~-s~~~Dv~s~G~il~elltg~~pf~~~~~~~~  496 (506)
                      ..+...   .+.+..||+.|.|||++..+...+ ..++|+||+||+||-+++|.+||+.......
T Consensus       328 ~~g~~s---fm~TlCGTpsYvAPEVl~~kg~~~~~~kVDiWSlGcvLfvcLsG~pPFS~~~~~~s  389 (475)
T KOG0615|consen  328 VSGEGS---FMKTLCGTPSYVAPEVLASKGVEYYPSKVDIWSLGCVLFVCLSGYPPFSEEYTDPS  389 (475)
T ss_pred             ccccce---ehhhhcCCccccChhheecCCeecccchheeeeccceEEEEeccCCCcccccCCcc
Confidence            887443   346789999999999997653333 4589999999999999999999998766553

>KOG0598 consensus Ribosomal protein S6 kinase and related proteins [General function prediction only; Signal transduction mechanisms]

Probab=100.00  E-value=5.7e-36  Score=283.77  Aligned_cols=173  Identities=29%  Similarity=0.383  Sum_probs=146.2

Q ss_pred             ccccCccCceEEEEEEEcC-CCEEEEEEeccCC----CCchhhHHHHHHhhccCccceeEEEEEe---------------
Q 039231          318 KYKLGQGGYGSVYKGKLLD-GSNVAVKVLNDSK----GNGKEFINEVASISRTSHVNVVALLGFC---------------  377 (506)
Q Consensus       318 ~~~ig~G~~g~V~~~~~~~-~~~vavK~l~~~~----~~~~~~~~E~~~l~~l~h~niv~l~g~~---------------  377 (506)
                      -+.||+|+||+||+++.++ ++.+|+|++++..    ...+...+|..+|.+++||.||++.-.+               
T Consensus        30 lkviGkG~fGkV~~Vrk~dt~kiYAmKvl~K~~iv~~~e~~~~~~Er~IL~~v~hPFiv~l~ysFQt~~kLylVld~~~G  109 (357)
T KOG0598|consen   30 LKVIGKGSFGKVFQVRKKDTGKIYAMKVLKKKKIVEKKEVRHTKAERNILSKIKHPFIVKLIYSFQTEEKLYLVLDYLNG  109 (357)
T ss_pred             eeeeeccCCceEEEEEEcccCceeehhhhhhhHhhhhhhHHHHHHHHHHHHhCCCCcEeeeEEecccCCeEEEEEeccCC
Confidence            4689999999999998754 8999999997642    3446788999999999999999998665               


Q ss_pred             ------------eccchhhhHHHHHHHHHHHHhhcCCCCeEecCcCCCcEEECCCCcEEEeecCCCccccCCCcceeccc
Q 039231          378 ------------LRVAEELSSTIGIARGLEYLHLGCSTRILHFDIKPHNILLDEDFCPKISDFGLAKICNRKESIISMTG  445 (506)
Q Consensus       378 ------------~~~~~~l~i~~~i~~gl~~LH~~~~~~ivH~dlkp~Nill~~~~~~ki~dfg~a~~~~~~~~~~~~~~  445 (506)
                                  +.+..+..++..|+.||.|||   +++||||||||+|||||++|+++|+|||+++..-.....  ...
T Consensus       110 GeLf~hL~~eg~F~E~~arfYlaEi~lAL~~LH---~~gIiyRDlKPENILLd~~GHi~LtDFgL~k~~~~~~~~--t~t  184 (357)
T KOG0598|consen  110 GELFYHLQREGRFSEDRARFYLAEIVLALGYLH---SKGIIYRDLKPENILLDEQGHIKLTDFGLCKEDLKDGDA--TRT  184 (357)
T ss_pred             ccHHHHHHhcCCcchhHHHHHHHHHHHHHHHHH---hCCeeeccCCHHHeeecCCCcEEEeccccchhcccCCCc--ccc
Confidence                        223335557889999999999   999999999999999999999999999999965443321  245


Q ss_pred             CCCCcccccccccccccCCCCccccHHHHHHHHHHHHcCCCCCCCCCCCcch
Q 039231          446 ARGTVGYIAPEVFCRNIGEVSYKSDVYNYGMMIFEMTGGRKNVDVVDNGSTA  497 (506)
Q Consensus       446 ~~gt~~y~aPE~l~~~~~~~s~~~Dv~s~G~il~elltg~~pf~~~~~~~~~  497 (506)
                      ..||+.|||||++.+.  .++..+|+||+|+++|||++|.+||...+.....
T Consensus       185 fcGT~eYmAPEil~~~--gy~~~vDWWsLGillYeML~G~pPF~~~~~~~~~  234 (357)
T KOG0598|consen  185 FCGTPEYMAPEILLGK--GYDKAVDWWSLGILLYEMLTGKPPFYAEDVKKMY  234 (357)
T ss_pred             ccCCccccChHHHhcC--CCCcccchHhHHHHHHHHhhCCCCCcCccHHHHH
Confidence            7899999999999776  8999999999999999999999999887654433

>KOG0591 consensus NIMA (never in mitosis)-related G2-specific serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=1.4e-36  Score=276.59  Aligned_cols=172  Identities=27%  Similarity=0.448  Sum_probs=147.0

Q ss_pred             hhhccccCccCceEEEEEE-EcCCCEEEEEEeccCC---CCchhhHHHHHHhhccCccceeEEEEEe-------------
Q 039231          315 NSFKYKLGQGGYGSVYKGK-LLDGSNVAVKVLNDSK---GNGKEFINEVASISRTSHVNVVALLGFC-------------  377 (506)
Q Consensus       315 ~~~~~~ig~G~~g~V~~~~-~~~~~~vavK~l~~~~---~~~~~~~~E~~~l~~l~h~niv~l~g~~-------------  377 (506)
                      +.+.++||+|.||.||++. +.+|..+|.|.++-..   ...++...|+.+|++++|||||++++..             
T Consensus        21 y~Il~~IG~GsFg~vykv~~~~~g~l~a~K~i~f~~md~k~rq~~v~Ei~lLkQL~HpNIVqYy~~~f~~~~evlnivmE  100 (375)
T KOG0591|consen   21 YQILKKIGRGSFGEVYKVQCLLDGKLVALKKIQFGMMDAKARQDCVKEISLLKQLNHPNIVQYYAHSFIEDNEVLNIVME  100 (375)
T ss_pred             HHHHHHHcCCcchheEEeeeccCcchhhhhhcchhhccHHHHHHHHHHHHHHHhcCCchHHHHHHHhhhccchhhHHHHH
Confidence            3345679999999999997 4679999999987432   2336789999999999999999998743             


Q ss_pred             --------------------eccchhhhHHHHHHHHHHHHhhcCCCC--eEecCcCCCcEEECCCCcEEEeecCCCcccc
Q 039231          378 --------------------LRVAEELSSTIGIARGLEYLHLGCSTR--ILHFDIKPHNILLDEDFCPKISDFGLAKICN  435 (506)
Q Consensus       378 --------------------~~~~~~l~i~~~i~~gl~~LH~~~~~~--ivH~dlkp~Nill~~~~~~ki~dfg~a~~~~  435 (506)
                                          +++..+|+++.|++.||..+|... +.  |+||||||.||+|+.+|.+||+|||+++.+.
T Consensus       101 ~c~~GDLsqmIk~~K~qkr~ipE~~Vwk~f~QL~~AL~~cH~~~-~r~~VmHRDIKPaNIFl~~~gvvKLGDfGL~r~l~  179 (375)
T KOG0591|consen  101 LCDAGDLSQMIKHFKKQKRLIPEKTVWKYFVQLCRALYHCHSKI-PRGTVMHRDIKPANIFLTANGVVKLGDFGLGRFLS  179 (375)
T ss_pred             hhcccCHHHHHHHHHhccccCchHHHHHHHHHHHHHHHHHhccc-cccceeeccCcchheEEcCCCceeeccchhHhHhc
Confidence                                344457889999999999999321 44  9999999999999999999999999999988


Q ss_pred             CCCcceecccCCCCcccccccccccccCCCCccccHHHHHHHHHHHHcCCCCCCCC
Q 039231          436 RKESIISMTGARGTVGYIAPEVFCRNIGEVSYKSDVYNYGMMIFEMTGGRKNVDVV  491 (506)
Q Consensus       436 ~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~s~~~Dv~s~G~il~elltg~~pf~~~  491 (506)
                      +....  ....+|||.||+||.+.+.  .|+.||||||+||++|||+.-+.||...
T Consensus       180 s~~tf--A~S~VGTPyYMSPE~i~~~--~Y~~kSDiWslGCllyEMcaL~~PF~g~  231 (375)
T KOG0591|consen  180 SKTTF--AHSLVGTPYYMSPERIHES--GYNFKSDIWSLGCLLYEMCALQSPFYGD  231 (375)
T ss_pred             chhHH--HHhhcCCCcccCHHHHhcC--CCCcchhHHHHHHHHHHHHhcCCCcccc
Confidence            76653  3568999999999999765  8999999999999999999999999876

>KOG0197 consensus Tyrosine kinases [Signal transduction mechanisms]

Probab=100.00  E-value=6e-36  Score=296.30  Aligned_cols=188  Identities=31%  Similarity=0.539  Sum_probs=161.0

Q ss_pred             HHHHHHhhhccccCccCceEEEEEEEcCCCEEEEEEeccCCCCchhhHHHHHHhhccCccceeEEEEEeec---------
Q 039231          309 DIKKMTNSFKYKLGQGGYGSVYKGKLLDGSNVAVKVLNDSKGNGKEFINEVASISRTSHVNVVALLGFCLR---------  379 (506)
Q Consensus       309 el~~~~~~~~~~ig~G~~g~V~~~~~~~~~~vavK~l~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~---------  379 (506)
                      ++.+....+.++||+|-||.||.|+++....||+|.++......++|.+|+++|++|+|+|||+++|+|..         
T Consensus       202 ei~r~~l~l~~~LG~G~FG~V~~g~~~~~~~vavk~ik~~~m~~~~f~~Ea~iMk~L~H~~lV~l~gV~~~~~piyIVtE  281 (468)
T KOG0197|consen  202 EIPREELKLIRELGSGQFGEVWLGKWNGSTKVAVKTIKEGSMSPEAFLREAQIMKKLRHEKLVKLYGVCTKQEPIYIVTE  281 (468)
T ss_pred             eecHHHHHHHHHhcCCccceEEEEEEcCCCcccceEEeccccChhHHHHHHHHHHhCcccCeEEEEEEEecCCceEEEEE
Confidence            44555556677899999999999999888899999999887777999999999999999999999999932         


Q ss_pred             --------------------cchhhhHHHHHHHHHHHHhhcCCCCeEecCcCCCcEEECCCCcEEEeecCCCccccCCCc
Q 039231          380 --------------------VAEELSSTIGIARGLEYLHLGCSTRILHFDIKPHNILLDEDFCPKISDFGLAKICNRKES  439 (506)
Q Consensus       380 --------------------~~~~l~i~~~i~~gl~~LH~~~~~~ivH~dlkp~Nill~~~~~~ki~dfg~a~~~~~~~~  439 (506)
                                          ..+.+.++.|||+||+||+   ++++|||||.++|||++++..+||+|||+|+....+..
T Consensus       282 ~m~~GsLl~yLr~~~~~~l~~~~Ll~~a~qIaeGM~YLe---s~~~IHRDLAARNiLV~~~~~vKIsDFGLAr~~~d~~Y  358 (468)
T KOG0197|consen  282 YMPKGSLLDYLRTREGGLLNLPQLLDFAAQIAEGMAYLE---SKNYIHRDLAARNILVDEDLVVKISDFGLARLIGDDEY  358 (468)
T ss_pred             ecccCcHHHHhhhcCCCccchHHHHHHHHHHHHHHHHHH---hCCccchhhhhhheeeccCceEEEcccccccccCCCce
Confidence                                2336779999999999999   99999999999999999999999999999995554443


Q ss_pred             ceecccCCCCcccccccccccccCCCCccccHHHHHHHHHHHHc-CCCCCCCCCCCcchhhhhh
Q 039231          440 IISMTGARGTVGYIAPEVFCRNIGEVSYKSDVYNYGMMIFEMTG-GRKNVDVVDNGSTALDLQA  502 (506)
Q Consensus       440 ~~~~~~~~gt~~y~aPE~l~~~~~~~s~~~Dv~s~G~il~ellt-g~~pf~~~~~~~~~~~~~~  502 (506)
                      . ......-+..|.|||.+..  +.++.|||||||||+||||+| |+.||......+....+.+
T Consensus       359 ~-~~~~~kfPIkWtAPEa~~~--~~FS~kSDVWSFGVlL~E~fT~G~~py~~msn~ev~~~le~  419 (468)
T KOG0197|consen  359 T-ASEGGKFPIKWTAPEALNY--GKFSSKSDVWSFGVLLWELFTYGRVPYPGMSNEEVLELLER  419 (468)
T ss_pred             e-ecCCCCCCceecCHHHHhh--CCcccccceeehhhhHHHHhccCCCCCCCCCHHHHHHHHhc
Confidence            3 3345667889999999954  589999999999999999998 9999998877766555443

>KOG0593 consensus Predicted protein kinase KKIAMRE [General function prediction only]

Probab=100.00  E-value=4.6e-36  Score=275.77  Aligned_cols=178  Identities=24%  Similarity=0.353  Sum_probs=154.8

Q ss_pred             ccCccCceEEEEEEEcC-CCEEEEEEeccCCCCc---hhhHHHHHHhhccCccceeEEEEEe------------------
Q 039231          320 KLGQGGYGSVYKGKLLD-GSNVAVKVLNDSKGNG---KEFINEVASISRTSHVNVVALLGFC------------------  377 (506)
Q Consensus       320 ~ig~G~~g~V~~~~~~~-~~~vavK~l~~~~~~~---~~~~~E~~~l~~l~h~niv~l~g~~------------------  377 (506)
                      ++|+|+||.||+++.++ |+.||||++..++.+.   +-.++|+++|++++|+|+|.++.+|                  
T Consensus         9 kvGEGSYGvV~KCrnk~TgqIVAIKkF~Esedd~~VkKIAlREIrmLKqLkH~NLVnLiEVFrrkrklhLVFE~~dhTvL   88 (396)
T KOG0593|consen    9 KVGEGSYGVVMKCRNKDTGQIVAIKKFVESEDDPVVKKIALREIRMLKQLKHENLVNLIEVFRRKRKLHLVFEYCDHTVL   88 (396)
T ss_pred             ccccCcceEEEEeccCCcccEEEEEeeccCCccHHHHHHHHHHHHHHHhcccchHHHHHHHHHhcceeEEEeeecchHHH
Confidence            59999999999999876 9999999998765532   4578999999999999999887655                  


Q ss_pred             ---------eccchhhhHHHHHHHHHHHHhhcCCCCeEecCcCCCcEEECCCCcEEEeecCCCccccCCCcceecccCCC
Q 039231          378 ---------LRVAEELSSTIGIARGLEYLHLGCSTRILHFDIKPHNILLDEDFCPKISDFGLAKICNRKESIISMTGARG  448 (506)
Q Consensus       378 ---------~~~~~~l~i~~~i~~gl~~LH~~~~~~ivH~dlkp~Nill~~~~~~ki~dfg~a~~~~~~~~~~~~~~~~g  448 (506)
                               ++......+..|++.|+.|+|   +++++||||||+||||+.++.+||+|||+|+.+......  .+..+.
T Consensus        89 ~eLe~~p~G~~~~~vk~~l~Q~l~ai~~cH---k~n~IHRDIKPENILit~~gvvKLCDFGFAR~L~~pgd~--YTDYVA  163 (396)
T KOG0593|consen   89 HELERYPNGVPSELVKKYLYQLLKAIHFCH---KNNCIHRDIKPENILITQNGVVKLCDFGFARTLSAPGDN--YTDYVA  163 (396)
T ss_pred             HHHHhccCCCCHHHHHHHHHHHHHHhhhhh---hcCeecccCChhheEEecCCcEEeccchhhHhhcCCcch--hhhhhh
Confidence                     233346679999999999999   999999999999999999999999999999988743322  366788


Q ss_pred             CcccccccccccccCCCCccccHHHHHHHHHHHHcCCCCCCCCCCCcchhhhhhh
Q 039231          449 TVGYIAPEVFCRNIGEVSYKSDVYNYGMMIFEMTGGRKNVDVVDNGSTALDLQAS  503 (506)
Q Consensus       449 t~~y~aPE~l~~~~~~~s~~~Dv~s~G~il~elltg~~pf~~~~~~~~~~~~~~~  503 (506)
                      |..|.|||++.+++ .|+..+||||+||++.||++|.+.|....+-++.+.|++.
T Consensus       164 TRWYRaPELLvGDt-qYG~pVDiWAiGCv~aEl~~G~pL~PG~SDiDQLy~I~kt  217 (396)
T KOG0593|consen  164 TRWYRAPELLVGDT-QYGKPVDIWAIGCVFAELLTGEPLWPGRSDIDQLYLIRKT  217 (396)
T ss_pred             hhhccChhhhcccC-cCCCcccchhhhHHHHHHhcCCcCCCCcchHHHHHHHHHH
Confidence            99999999998863 7899999999999999999999999999888888877764

>KOG0581 consensus Mitogen-activated protein kinase kinase (MAP2K) [Signal transduction mechanisms]

Probab=100.00  E-value=4.8e-35  Score=277.57  Aligned_cols=175  Identities=29%  Similarity=0.411  Sum_probs=150.3

Q ss_pred             ccCHHHHHHHHhhhccccCccCceEEEEEEEcC-CCEEEEEEecc--CCCCchhhHHHHHHhhccCccceeEEEEEeecc
Q 039231          304 RYGYADIKKMTNSFKYKLGQGGYGSVYKGKLLD-GSNVAVKVLND--SKGNGKEFINEVASISRTSHVNVVALLGFCLRV  380 (506)
Q Consensus       304 ~~~~~el~~~~~~~~~~ig~G~~g~V~~~~~~~-~~~vavK~l~~--~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~  380 (506)
                      ..+..|+++.     ..||+|+.|+||+++++. ++.+|+|++..  .....+++.+|++++.+.+||+||.++|.|...
T Consensus        75 ~i~~~dle~~-----~~lG~G~gG~V~kv~Hk~t~~i~AlK~I~~~~~~~~~~Qi~rEl~il~~~~spyIV~~ygaF~~~  149 (364)
T KOG0581|consen   75 GISLSDLERL-----GVLGSGNGGTVYKVRHKPTGKIYALKVILLNIDPALQKQILRELEILRSCQSPYIVGFYGAFYSN  149 (364)
T ss_pred             ccCHHHhhhh-----hhcccCCCcEEEEEEEcCCCeEEEEEeecccCCHHHHHHHHHHHHHHhhCCCCCeeeEeEEEEeC
Confidence            4556666654     369999999999999864 78899999943  334458899999999999999999999998554


Q ss_pred             ch----------------------------hhhHHHHHHHHHHHHhhcCCCCeEecCcCCCcEEECCCCcEEEeecCCCc
Q 039231          381 AE----------------------------ELSSTIGIARGLEYLHLGCSTRILHFDIKPHNILLDEDFCPKISDFGLAK  432 (506)
Q Consensus       381 ~~----------------------------~l~i~~~i~~gl~~LH~~~~~~ivH~dlkp~Nill~~~~~~ki~dfg~a~  432 (506)
                      .+                            .-.|+.+|++||.|||+  +++||||||||+|||++..|.+||+|||.++
T Consensus       150 ~~~isI~mEYMDgGSLd~~~k~~g~i~E~~L~~ia~~VL~GL~YLh~--~~~IIHRDIKPsNlLvNskGeVKicDFGVS~  227 (364)
T KOG0581|consen  150 GEEISICMEYMDGGSLDDILKRVGRIPEPVLGKIARAVLRGLSYLHE--ERKIIHRDIKPSNLLVNSKGEVKICDFGVSG  227 (364)
T ss_pred             CceEEeehhhcCCCCHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhh--ccCeeeccCCHHHeeeccCCCEEeccccccH
Confidence            42                            23588999999999994  4999999999999999999999999999998


Q ss_pred             cccCCCcceecccCCCCcccccccccccccCCCCccccHHHHHHHHHHHHcCCCCCCCC
Q 039231          433 ICNRKESIISMTGARGTVGYIAPEVFCRNIGEVSYKSDVYNYGMMIFEMTGGRKNVDVV  491 (506)
Q Consensus       433 ~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~s~~~Dv~s~G~il~elltg~~pf~~~  491 (506)
                      .+....    .....||..|||||.+.+.  .|+.++||||||+.++|+++|+.||...
T Consensus       228 ~lvnS~----a~tfvGT~~YMsPERi~g~--~Ys~~sDIWSLGLsllE~a~GrfP~~~~  280 (364)
T KOG0581|consen  228 ILVNSI----ANTFVGTSAYMSPERISGE--SYSVKSDIWSLGLSLLELAIGRFPYPPP  280 (364)
T ss_pred             Hhhhhh----cccccccccccChhhhcCC--cCCcccceecccHHHHHHhhCCCCCCCc
Confidence            876542    3668899999999999765  8999999999999999999999999886

>KOG0600 consensus Cdc2-related protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=4.1e-35  Score=286.52  Aligned_cols=179  Identities=28%  Similarity=0.378  Sum_probs=154.4

Q ss_pred             cccCccCceEEEEEEE-cCCCEEEEEEeccCC---CCchhhHHHHHHhhccCccceeEEEEEe-----------------
Q 039231          319 YKLGQGGYGSVYKGKL-LDGSNVAVKVLNDSK---GNGKEFINEVASISRTSHVNVVALLGFC-----------------  377 (506)
Q Consensus       319 ~~ig~G~~g~V~~~~~-~~~~~vavK~l~~~~---~~~~~~~~E~~~l~~l~h~niv~l~g~~-----------------  377 (506)
                      ++||+|.||.||+|+. .+|+.||+|++.-+.   ....-..+|+.+|++++||||++|.+..                 
T Consensus       123 ~kIGeGTyg~VYkAr~~~tgkivALKKvr~d~~~~~~~~t~~REI~ILr~l~HpNIikL~eivt~~~~~siYlVFeYMdh  202 (560)
T KOG0600|consen  123 EKIGEGTYGQVYKARDLETGKIVALKKVRFDNEKEGFPITAIREIKILRRLDHPNIIKLEEIVTSKLSGSIYLVFEYMDH  202 (560)
T ss_pred             HHhcCcchhheeEeeecccCcEEEEEEeecccCCCcchHHHHHHHHHHHhcCCCcccceeeEEEecCCceEEEEEecccc
Confidence            4699999999999985 569999999996433   3346788999999999999999998765                 


Q ss_pred             ------------eccchhhhHHHHHHHHHHHHhhcCCCCeEecCcCCCcEEECCCCcEEEeecCCCccccCCCcceeccc
Q 039231          378 ------------LRVAEELSSTIGIARGLEYLHLGCSTRILHFDIKPHNILLDEDFCPKISDFGLAKICNRKESIISMTG  445 (506)
Q Consensus       378 ------------~~~~~~l~i~~~i~~gl~~LH~~~~~~ivH~dlkp~Nill~~~~~~ki~dfg~a~~~~~~~~~~~~~~  445 (506)
                                  +...+...++.|++.||+|+|   .++|+|||||.+|||||++|.+||+|||+|++....... ..+.
T Consensus       203 DL~GLl~~p~vkft~~qIKc~mkQLl~Gl~~cH---~~gvlHRDIK~SNiLidn~G~LKiaDFGLAr~y~~~~~~-~~T~  278 (560)
T KOG0600|consen  203 DLSGLLSSPGVKFTEPQIKCYMKQLLEGLEYCH---SRGVLHRDIKGSNILIDNNGVLKIADFGLARFYTPSGSA-PYTS  278 (560)
T ss_pred             hhhhhhcCCCcccChHHHHHHHHHHHHHHHHHh---hcCeeeccccccceEEcCCCCEEeccccceeeccCCCCc-cccc
Confidence                        445557779999999999999   999999999999999999999999999999987665533 2466


Q ss_pred             CCCCcccccccccccccCCCCccccHHHHHHHHHHHHcCCCCCCCCCCCcchhhhhh
Q 039231          446 ARGTVGYIAPEVFCRNIGEVSYKSDVYNYGMMIFEMTGGRKNVDVVDNGSTALDLQA  502 (506)
Q Consensus       446 ~~gt~~y~aPE~l~~~~~~~s~~~Dv~s~G~il~elltg~~pf~~~~~~~~~~~~~~  502 (506)
                      .+-|+.|.|||+|.+. -.|+.++|+||.||||.||++|++.|....+-++.-.|.+
T Consensus       279 rVvTLWYRpPELLLG~-t~Yg~aVDlWS~GCIl~El~~gkPI~~G~tEveQl~kIfk  334 (560)
T KOG0600|consen  279 RVVTLWYRPPELLLGA-TSYGTAVDLWSVGCILAELFLGKPILQGRTEVEQLHKIFK  334 (560)
T ss_pred             ceEEeeccChHHhcCC-cccccceeehhhhHHHHHHHcCCCCcCCccHHHHHHHHHH
Confidence            7789999999999987 4799999999999999999999999998887776655543

>KOG0193 consensus Serine/threonine protein kinase RAF [Signal transduction mechanisms]

Probab=100.00  E-value=1.1e-35  Score=296.24  Aligned_cols=179  Identities=32%  Similarity=0.605  Sum_probs=148.9

Q ss_pred             hccccCccCceEEEEEEEcCCCEEEEEEeccC---CCCchhhHHHHHHhhccCccceeEEEEEe----------------
Q 039231          317 FKYKLGQGGYGSVYKGKLLDGSNVAVKVLNDS---KGNGKEFINEVASISRTSHVNVVALLGFC----------------  377 (506)
Q Consensus       317 ~~~~ig~G~~g~V~~~~~~~~~~vavK~l~~~---~~~~~~~~~E~~~l~~l~h~niv~l~g~~----------------  377 (506)
                      +.+.||+|.||+||+|++..  .||||+++-.   .++.+.|++|+..+++.+|.||+-++|+|                
T Consensus       396 l~~rIGsGsFGtV~Rg~whG--dVAVK~Lnv~~pt~~qlqaFKnEVa~lkkTRH~NIlLFMG~~~~p~~AIiTqwCeGsS  473 (678)
T KOG0193|consen  396 LGERIGSGSFGTVYRGRWHG--DVAVKLLNVDDPTPEQLQAFKNEVAVLKKTRHENILLFMGACMNPPLAIITQWCEGSS  473 (678)
T ss_pred             ccceeccccccceeeccccc--ceEEEEEecCCCCHHHHHHHHHHHHHHhhcchhhheeeehhhcCCceeeeehhccCch
Confidence            45689999999999999854  7999999743   34558899999999999999999999998                


Q ss_pred             -----------eccchhhhHHHHHHHHHHHHhhcCCCCeEecCcCCCcEEECCCCcEEEeecCCCccccCCCcceecccC
Q 039231          378 -----------LRVAEELSSTIGIARGLEYLHLGCSTRILHFDIKPHNILLDEDFCPKISDFGLAKICNRKESIISMTGA  446 (506)
Q Consensus       378 -----------~~~~~~l~i~~~i~~gl~~LH~~~~~~ivH~dlkp~Nill~~~~~~ki~dfg~a~~~~~~~~~~~~~~~  446 (506)
                                 ++....+.|+.||++||.|||   .++|||||||+.||+|.+++++||+|||++..-............
T Consensus       474 LY~hlHv~etkfdm~~~idIAqQiaqGM~YLH---AK~IIHrDLKSnNIFl~~~~kVkIgDFGLatvk~~w~g~~q~~qp  550 (678)
T KOG0193|consen  474 LYTHLHVQETKFDMNTTIDIAQQIAQGMDYLH---AKNIIHRDLKSNNIFLHEDLKVKIGDFGLATVKTRWSGEQQLEQP  550 (678)
T ss_pred             hhhhccchhhhhhHHHHHHHHHHHHHhhhhhh---hhhhhhhhccccceEEccCCcEEEecccceeeeeeeccccccCCC
Confidence                       233346789999999999999   999999999999999999999999999999765443332334556


Q ss_pred             CCCccccccccccc-ccCCCCccccHHHHHHHHHHHHcCCCCCCCCCCCcchhhh
Q 039231          447 RGTVGYIAPEVFCR-NIGEVSYKSDVYNYGMMIFEMTGGRKNVDVVDNGSTALDL  500 (506)
Q Consensus       447 ~gt~~y~aPE~l~~-~~~~~s~~~Dv~s~G~il~elltg~~pf~~~~~~~~~~~~  500 (506)
                      .|...|||||++.. +..+++.++||||||+++|||++|..||.....+.+.+.+
T Consensus       551 ~gsilwmAPEvIRmqd~nPfS~qSDVYaFGiV~YELltg~lPysi~~~dqIifmV  605 (678)
T KOG0193|consen  551 HGSLLWMAPEVIRMQDDNPFSFQSDVYAFGIVWYELLTGELPYSIQNRDQIIFMV  605 (678)
T ss_pred             ccchhhhcHHHHhhcccCCCCcccchhhhhHHHHHHHhCcCCcCCCChhheEEEe
Confidence            78899999999853 3347899999999999999999999999955555544433

>KOG0616 consensus cAMP-dependent protein kinase catalytic subunit (PKA) [Signal transduction mechanisms]

Probab=100.00  E-value=2.3e-34  Score=264.08  Aligned_cols=180  Identities=30%  Similarity=0.386  Sum_probs=152.9

Q ss_pred             cCHHHHHHHHhhhccccCccCceEEEEEEEc-CCCEEEEEEeccCC----CCchhhHHHHHHhhccCccceeEEEEEe--
Q 039231          305 YGYADIKKMTNSFKYKLGQGGYGSVYKGKLL-DGSNVAVKVLNDSK----GNGKEFINEVASISRTSHVNVVALLGFC--  377 (506)
Q Consensus       305 ~~~~el~~~~~~~~~~ig~G~~g~V~~~~~~-~~~~vavK~l~~~~----~~~~~~~~E~~~l~~l~h~niv~l~g~~--  377 (506)
                      +++++.+.     .+.||.|+||.|.+++.+ +|..+|+|++++.+    .+.+...+|..+|+.+.||.++++.+-+  
T Consensus        41 ~~l~dfe~-----~~tlGtGSFGrV~LVr~k~~g~yYAmKvL~k~~vVklKQveH~~nEk~vL~~v~~PFlv~l~~t~~d  115 (355)
T KOG0616|consen   41 YSLQDFER-----LKTLGTGSFGRVHLVREKHSGNYYAMKVLDKQKVVKLKQVEHTHNEKRVLKAVSHPFLVKLYGTFKD  115 (355)
T ss_pred             cchhhhhh-----eeeeccCccceEEEEEEccCCceeehhhcCHHHHHHHHHHHHHhhHHHHHhhccCceeEEEEEeecc
Confidence            56655442     357999999999999975 47889999997643    2346678999999999999999999776  


Q ss_pred             -------------------------eccchhhhHHHHHHHHHHHHhhcCCCCeEecCcCCCcEEECCCCcEEEeecCCCc
Q 039231          378 -------------------------LRVAEELSSTIGIARGLEYLHLGCSTRILHFDIKPHNILLDEDFCPKISDFGLAK  432 (506)
Q Consensus       378 -------------------------~~~~~~l~i~~~i~~gl~~LH~~~~~~ivH~dlkp~Nill~~~~~~ki~dfg~a~  432 (506)
                                               +++..+..++.||+.||+|||   +.+|++|||||+|||||.+|.+||+|||+|+
T Consensus       116 ~~~lymvmeyv~GGElFS~Lrk~~rF~e~~arFYAAeivlAleylH---~~~iiYRDLKPENiLlD~~G~iKitDFGFAK  192 (355)
T KOG0616|consen  116 NSNLYMVMEYVPGGELFSYLRKSGRFSEPHARFYAAEIVLALEYLH---SLDIIYRDLKPENLLLDQNGHIKITDFGFAK  192 (355)
T ss_pred             CCeEEEEEeccCCccHHHHHHhcCCCCchhHHHHHHHHHHHHHHHH---hcCeeeccCChHHeeeccCCcEEEEeccceE
Confidence                                     444556779999999999999   9999999999999999999999999999999


Q ss_pred             cccCCCcceecccCCCCcccccccccccccCCCCccccHHHHHHHHHHHHcCCCCCCCCCCCcchhh
Q 039231          433 ICNRKESIISMTGARGTVGYIAPEVFCRNIGEVSYKSDVYNYGMMIFEMTGGRKNVDVVDNGSTALD  499 (506)
Q Consensus       433 ~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~s~~~Dv~s~G~il~elltg~~pf~~~~~~~~~~~  499 (506)
                      .....     ..+..|||.|+|||++..+  .+..++|+|||||++|||+.|.+||...+......+
T Consensus       193 ~v~~r-----T~TlCGTPeYLAPEii~sk--~ynkavDWWalGVLIYEMlaG~pPF~~~~~~~iY~K  252 (355)
T KOG0616|consen  193 RVSGR-----TWTLCGTPEYLAPEIIQSK--GYNKAVDWWALGVLIYEMLAGYPPFYDDNPIQIYEK  252 (355)
T ss_pred             EecCc-----EEEecCCccccChHHhhcC--CCCcchhHHHHHHHHHHHHcCCCCCcCCChHHHHHH
Confidence            87654     2567899999999999765  789999999999999999999999998877444333

>KOG0659 consensus Cdk activating kinase (CAK)/RNA polymerase II transcription initiation/nucleotide excision repair factor TFIIH/TFIIK, kinase subunit CDK7 [Cell cycle control, cell division, chromosome partitioning; Transcription; Replication, recombination and repair]

Probab=100.00  E-value=3.9e-34  Score=258.85  Aligned_cols=179  Identities=28%  Similarity=0.378  Sum_probs=152.0

Q ss_pred             ccccCccCceEEEEEEE-cCCCEEEEEEeccCCCC---chhhHHHHHHhhccCccceeEEEEEe----------------
Q 039231          318 KYKLGQGGYGSVYKGKL-LDGSNVAVKVLNDSKGN---GKEFINEVASISRTSHVNVVALLGFC----------------  377 (506)
Q Consensus       318 ~~~ig~G~~g~V~~~~~-~~~~~vavK~l~~~~~~---~~~~~~E~~~l~~l~h~niv~l~g~~----------------  377 (506)
                      .+++|+|.||.||+|++ ..|+.||||+++..+..   .....+|++.|+.++|+||+.+++++                
T Consensus         7 ~~~lGEG~~gvVyka~d~~t~~~VAIKKIkl~~~kdGi~~talREIK~Lqel~h~nIi~LiD~F~~~~~l~lVfEfm~td   86 (318)
T KOG0659|consen    7 LEKLGEGTYGVVYKARDTETGKRVAIKKIKLGNAKDGINRTALREIKLLQELKHPNIIELIDVFPHKSNLSLVFEFMPTD   86 (318)
T ss_pred             hhhhcCcceEEEEEEEecCCCcEEEEEEeeccccccCccHHHHHHHHHHHHccCcchhhhhhhccCCCceEEEEEecccc
Confidence            45799999999999986 45999999999754332   36789999999999999999999887                


Q ss_pred             -----------eccchhhhHHHHHHHHHHHHhhcCCCCeEecCcCCCcEEECCCCcEEEeecCCCccccCCCcceecccC
Q 039231          378 -----------LRVAEELSSTIGIARGLEYLHLGCSTRILHFDIKPHNILLDEDFCPKISDFGLAKICNRKESIISMTGA  446 (506)
Q Consensus       378 -----------~~~~~~l~i~~~i~~gl~~LH~~~~~~ivH~dlkp~Nill~~~~~~ki~dfg~a~~~~~~~~~~~~~~~  446 (506)
                                 +...+...++.++++||+|+|   .+.|+||||||.|+|++++|.+||+|||+|+.........  +..
T Consensus        87 Le~vIkd~~i~l~pa~iK~y~~m~LkGl~y~H---~~~IlHRDlKPnNLLis~~g~lKiADFGLAr~f~~p~~~~--~~~  161 (318)
T KOG0659|consen   87 LEVVIKDKNIILSPADIKSYMLMTLKGLAYCH---SKWILHRDLKPNNLLISSDGQLKIADFGLARFFGSPNRIQ--THQ  161 (318)
T ss_pred             HHHHhcccccccCHHHHHHHHHHHHHHHHHHH---hhhhhcccCCccceEEcCCCcEEeecccchhccCCCCccc--ccc
Confidence                       223336678999999999999   9999999999999999999999999999999987655432  334


Q ss_pred             CCCcccccccccccccCCCCccccHHHHHHHHHHHHcCCCCCCCCCCCcchhhhhh
Q 039231          447 RGTVGYIAPEVFCRNIGEVSYKSDVYNYGMMIFEMTGGRKNVDVVDNGSTALDLQA  502 (506)
Q Consensus       447 ~gt~~y~aPE~l~~~~~~~s~~~Dv~s~G~il~elltg~~pf~~~~~~~~~~~~~~  502 (506)
                      +-|..|.|||++.+. ..|+..+||||.|||+.||+-|.+-|....+-++.-.+.+
T Consensus       162 V~TRWYRAPELLfGs-r~Yg~~VDmWavGCI~AELllr~P~fpG~sDidQL~~If~  216 (318)
T KOG0659|consen  162 VVTRWYRAPELLFGS-RQYGTGVDMWAVGCIFAELLLRVPFFPGDSDIDQLSKIFR  216 (318)
T ss_pred             eeeeeccChHHhccc-hhcCCcchhhhHHHHHHHHHccCCCCCCCchHHHHHHHHH
Confidence            679999999999886 5899999999999999999999998888777766555443

>KOG0592 consensus 3-phosphoinositide-dependent protein kinase (PDK1) [Signal transduction mechanisms]

Probab=100.00  E-value=4.1e-34  Score=281.73  Aligned_cols=182  Identities=30%  Similarity=0.425  Sum_probs=152.2

Q ss_pred             hhccccCccCceEEEEEEEc-CCCEEEEEEeccC----CCCchhhHHHHHHhhcc-CccceeEEEEEeec----------
Q 039231          316 SFKYKLGQGGYGSVYKGKLL-DGSNVAVKVLNDS----KGNGKEFINEVASISRT-SHVNVVALLGFCLR----------  379 (506)
Q Consensus       316 ~~~~~ig~G~~g~V~~~~~~-~~~~vavK~l~~~----~~~~~~~~~E~~~l~~l-~h~niv~l~g~~~~----------  379 (506)
                      .|.+.||.|+|++|++|+.. .++.+|||++.+.    +...+.+.+|-++|.+| .||.|++|+--+.+          
T Consensus        76 ~Fg~~lGeGSYStV~~A~~~~t~keYAiKVl~K~~Iike~KvkYV~~Ek~~l~~L~~hPgivkLy~TFQD~~sLYFvLe~  155 (604)
T KOG0592|consen   76 KFGKILGEGSYSTVVLAREKATGKEYAIKVLDKRYIIKEKKVKYVTREKEALTQLSGHPGIVKLYFTFQDEESLYFVLEY  155 (604)
T ss_pred             chhheeccccceeEEEeeecCCCceeeHhhhhHHHHHhhcccchhhHHHHHHHHhhCCCCeEEEEEEeecccceEEEEEe
Confidence            45678999999999999865 4899999999653    33446788999999999 79999999876633          


Q ss_pred             -----------------cchhhhHHHHHHHHHHHHhhcCCCCeEecCcCCCcEEECCCCcEEEeecCCCccccCCCcc--
Q 039231          380 -----------------VAEELSSTIGIARGLEYLHLGCSTRILHFDIKPHNILLDEDFCPKISDFGLAKICNRKESI--  440 (506)
Q Consensus       380 -----------------~~~~l~i~~~i~~gl~~LH~~~~~~ivH~dlkp~Nill~~~~~~ki~dfg~a~~~~~~~~~--  440 (506)
                                       +......+.+|+.||+|||   +.|||||||||+|||||+++++||+|||.|+.+......  
T Consensus       156 A~nGdll~~i~K~Gsfde~caR~YAAeIldAleylH---~~GIIHRDlKPENILLd~dmhikITDFGsAK~l~~~~~~~~  232 (604)
T KOG0592|consen  156 APNGDLLDLIKKYGSFDETCARFYAAEILDALEYLH---SNGIIHRDLKPENILLDKDGHIKITDFGSAKILSPSQKSQE  232 (604)
T ss_pred             cCCCcHHHHHHHhCcchHHHHHHHHHHHHHHHHHHH---hcCceeccCChhheeEcCCCcEEEeeccccccCChhhcccc
Confidence                             2234568899999999999   999999999999999999999999999999988643322  


Q ss_pred             -------ee--cccCCCCcccccccccccccCCCCccccHHHHHHHHHHHHcCCCCCCCCCCCcchhhhhh
Q 039231          441 -------IS--MTGARGTVGYIAPEVFCRNIGEVSYKSDVYNYGMMIFEMTGGRKNVDVVDNGSTALDLQA  502 (506)
Q Consensus       441 -------~~--~~~~~gt~~y~aPE~l~~~~~~~s~~~Dv~s~G~il~elltg~~pf~~~~~~~~~~~~~~  502 (506)
                             ..  ....+||..|.+||+|...  ..+..+|+|+||||||+|+.|.+||...++=-.+.+|++
T Consensus       233 ~~~~~~~a~s~~~SFVGTAeYVSPElL~~~--~~~~~sDiWAlGCilyQmlaG~PPFra~NeyliFqkI~~  301 (604)
T KOG0592|consen  233 NPVDPNQASSRRSSFVGTAEYVSPELLNDS--PAGPSSDLWALGCILYQMLAGQPPFRAANEYLIFQKIQA  301 (604)
T ss_pred             CccCcccccCcccceeeeecccCHHHhcCC--CCCcccchHHHHHHHHHHhcCCCCCccccHHHHHHHHHH
Confidence                   11  1447899999999999654  789999999999999999999999998887666665554

>KOG1026 consensus Nerve growth factor receptor TRKA and related tyrosine kinases [Signal transduction mechanisms; Intracellular trafficking, secretion, and vesicular transport]

Probab=100.00  E-value=1.1e-34  Score=300.76  Aligned_cols=189  Identities=30%  Similarity=0.505  Sum_probs=158.5

Q ss_pred             HHHHHHhhhccccCccCceEEEEEEEc------CCCEEEEEEeccCCCC--chhhHHHHHHhhccCccceeEEEEEe---
Q 039231          309 DIKKMTNSFKYKLGQGGYGSVYKGKLL------DGSNVAVKVLNDSKGN--GKEFINEVASISRTSHVNVVALLGFC---  377 (506)
Q Consensus       309 el~~~~~~~~~~ig~G~~g~V~~~~~~------~~~~vavK~l~~~~~~--~~~~~~E~~~l~~l~h~niv~l~g~~---  377 (506)
                      ++......+.++||+|+||.||+|+..      +.+.||||.+++....  .++|.+|++.+..++|||||+++|+|   
T Consensus       482 ~i~r~~i~~~~eLGegaFGkVf~a~~~~l~p~~~~~lVAVK~LKd~a~~~~~~dF~REaeLla~l~H~nIVrLlGVC~~~  561 (774)
T KOG1026|consen  482 EIPRSDIVFKEELGEGAFGKVFLAEAYGLLPGQDEQLVAVKALKDKAENQARQDFRREAELLAELQHPNIVRLLGVCREG  561 (774)
T ss_pred             EechhheeehhhhcCchhhhhhhhhccCCCCCccceehhHhhhcccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEccC
Confidence            334444445678999999999999853      3568999999876544  47899999999999999999999999   


Q ss_pred             --------------------------------------eccchhhhHHHHHHHHHHHHhhcCCCCeEecCcCCCcEEECC
Q 039231          378 --------------------------------------LRVAEELSSTIGIARGLEYLHLGCSTRILHFDIKPHNILLDE  419 (506)
Q Consensus       378 --------------------------------------~~~~~~l~i~~~i~~gl~~LH~~~~~~ivH~dlkp~Nill~~  419 (506)
                                                            +...+.+.|+.|||.||+||-   ++.+|||||..+|.||.+
T Consensus       562 ~P~~MvFEYm~~GDL~eFLra~sP~a~~~~~g~~~~~~L~~~q~L~iA~QIAaGM~YLs---~~~FVHRDLATRNCLVge  638 (774)
T KOG1026|consen  562 DPLCMVFEYMDHGDLHEFLRARSPKADKLASGQDTPPPLSTSQFLHIATQIAAGMEYLS---SHHFVHRDLATRNCLVGE  638 (774)
T ss_pred             CeeEEEEEecccccHHHHHHhhCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHH---hCcccccchhhhhceecc
Confidence                                                  223457889999999999999   999999999999999999


Q ss_pred             CCcEEEeecCCCccccCCCcceecccCCCCcccccccccccccCCCCccccHHHHHHHHHHHHc-CCCCCCCCCCCcchh
Q 039231          420 DFCPKISDFGLAKICNRKESIISMTGARGTVGYIAPEVFCRNIGEVSYKSDVYNYGMMIFEMTG-GRKNVDVVDNGSTAL  498 (506)
Q Consensus       420 ~~~~ki~dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~s~~~Dv~s~G~il~ellt-g~~pf~~~~~~~~~~  498 (506)
                      +..+||+|||+++..-..+.+.-.....-.++|||||.+..  +.+|.+||||||||+|||+++ |+.||....++|...
T Consensus       639 ~l~VKIsDfGLsRdiYssDYYk~~~~t~lPIRWMppEsIly--~kFTteSDVWs~GVvLWEIFsyG~QPy~glSn~EVIe  716 (774)
T KOG1026|consen  639 NLVVKISDFGLSRDIYSSDYYKVRGNTLLPIRWMPPESILY--GKFTTESDVWSFGVVLWEIFSYGKQPYYGLSNQEVIE  716 (774)
T ss_pred             ceEEEecccccchhhhhhhhhcccCCceeeeecCCHHHhhc--CcccchhhhhhhhhhhhhhhccccCcccccchHHHHH
Confidence            99999999999998766655443334456889999999965  489999999999999999998 999999998887665


Q ss_pred             hhhh
Q 039231          499 DLQA  502 (506)
Q Consensus       499 ~~~~  502 (506)
                      .+++
T Consensus       717 ~i~~  720 (774)
T KOG1026|consen  717 CIRA  720 (774)
T ss_pred             HHHc
Confidence            5544

>KOG0661 consensus MAPK related serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=3.1e-34  Score=278.42  Aligned_cols=182  Identities=29%  Similarity=0.374  Sum_probs=157.9

Q ss_pred             HhhhccccCccCceEEEEEEE-cCCCEEEEEEeccCCCCchhh--HHHHHHhhccC-ccceeEEEEEe------------
Q 039231          314 TNSFKYKLGQGGYGSVYKGKL-LDGSNVAVKVLNDSKGNGKEF--INEVASISRTS-HVNVVALLGFC------------  377 (506)
Q Consensus       314 ~~~~~~~ig~G~~g~V~~~~~-~~~~~vavK~l~~~~~~~~~~--~~E~~~l~~l~-h~niv~l~g~~------------  377 (506)
                      +|...++||.|.||.||+|+. .+|..||||++++.-..-++.  .||++.|++++ |||||+|..++            
T Consensus        11 RY~~i~klGDGTfGsV~la~~~~~~~~VAIK~MK~Kf~s~ee~~nLREvksL~kln~hpniikL~Evi~d~~~~L~fVfE   90 (538)
T KOG0661|consen   11 RYTVIRKLGDGTFGSVYLAKSKETGELVAIKKMKKKFYSWEECMNLREVKSLRKLNPHPNIIKLKEVIRDNDRILYFVFE   90 (538)
T ss_pred             HHHHHHHhcCCcceeEEEeeecCCCceeeHHHHHhhhccHHHHHHHHHHHHHHhcCCCCcchhhHHHhhccCceEeeeHH
Confidence            445557899999999999985 458999999998765555554  58999999999 99999997665            


Q ss_pred             ----------------eccchhhhHHHHHHHHHHHHhhcCCCCeEecCcCCCcEEECCCCcEEEeecCCCccccCCCcce
Q 039231          378 ----------------LRVAEELSSTIGIARGLEYLHLGCSTRILHFDIKPHNILLDEDFCPKISDFGLAKICNRKESII  441 (506)
Q Consensus       378 ----------------~~~~~~l~i~~~i~~gl~~LH~~~~~~ivH~dlkp~Nill~~~~~~ki~dfg~a~~~~~~~~~~  441 (506)
                                      +.+.+...|+.||++||+|+|   ++|+.|||+||+|||+..+..+||+|||+|+...+...  
T Consensus        91 ~Md~NLYqLmK~R~r~fse~~irnim~QilqGL~hiH---k~GfFHRDlKPENiLi~~~~~iKiaDFGLARev~SkpP--  165 (538)
T KOG0661|consen   91 FMDCNLYQLMKDRNRLFSESDIRNIMYQILQGLAHIH---KHGFFHRDLKPENILISGNDVIKIADFGLAREVRSKPP--  165 (538)
T ss_pred             hhhhhHHHHHhhcCCcCCHHHHHHHHHHHHHHHHHHH---hcCcccccCChhheEecccceeEecccccccccccCCC--
Confidence                            334446779999999999999   99999999999999999889999999999998876654  


Q ss_pred             ecccCCCCcccccccccccccCCCCccccHHHHHHHHHHHHcCCCCCCCCCCCcchhhhhh
Q 039231          442 SMTGARGTVGYIAPEVFCRNIGEVSYKSDVYNYGMMIFEMTGGRKNVDVVDNGSTALDLQA  502 (506)
Q Consensus       442 ~~~~~~gt~~y~aPE~l~~~~~~~s~~~Dv~s~G~il~elltg~~pf~~~~~~~~~~~~~~  502 (506)
                       .+..+.|..|.|||+|.+. +.|+.+.||||+|||++|+.+-++.|.+.++-++.++|-.
T Consensus       166 -YTeYVSTRWYRAPEvLLrs-~~Ys~pvD~wA~GcI~aEl~sLrPLFPG~sE~Dqi~KIc~  224 (538)
T KOG0661|consen  166 -YTEYVSTRWYRAPEVLLRS-GYYSSPVDMWAVGCIMAELYSLRPLFPGASEIDQIYKICE  224 (538)
T ss_pred             -cchhhhcccccchHHhhhc-cccCCchHHHHHHHHHHHHHHhcccCCCCcHHHHHHHHHH
Confidence             3778899999999999886 6899999999999999999999999999988887776644

>KOG0658 consensus Glycogen synthase kinase-3 [Carbohydrate transport and metabolism]

Probab=100.00  E-value=2.2e-33  Score=265.68  Aligned_cols=174  Identities=32%  Similarity=0.410  Sum_probs=146.0

Q ss_pred             cccCccCceEEEEEEEcC-CCEEEEEEeccCCCCchhhHHHHHHhhccCccceeEEEEEeeccch---------------
Q 039231          319 YKLGQGGYGSVYKGKLLD-GSNVAVKVLNDSKGNGKEFINEVASISRTSHVNVVALLGFCLRVAE---------------  382 (506)
Q Consensus       319 ~~ig~G~~g~V~~~~~~~-~~~vavK~l~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~---------------  382 (506)
                      +.+|+|+||.||+|.+.. +..||||+.-.++.   .-.+|+++|++++|||||+|+-++....+               
T Consensus        30 ~liG~GsFg~Vyq~~~~e~~~~vAIKKv~~d~r---~knrEl~im~~l~HpNIV~L~~~f~~~~~~d~~~lnlVleymP~  106 (364)
T KOG0658|consen   30 RLIGSGSFGVVYQAKLRETEEEVAIKKVLQDKR---YKNRELQIMRKLDHPNIVRLLYFFSSSTESDEVYLNLVLEYMPE  106 (364)
T ss_pred             EEEeecccceEEEEEEcCCCceeEEEEecCCCC---cCcHHHHHHHhcCCcCeeeEEEEEEecCCCchhHHHHHHHhchH
Confidence            579999999999999754 79999998865432   33569999999999999999988832211               


Q ss_pred             --------------------hhhHHHHHHHHHHHHhhcCCCCeEecCcCCCcEEECCC-CcEEEeecCCCccccCCCcce
Q 039231          383 --------------------ELSSTIGIARGLEYLHLGCSTRILHFDIKPHNILLDED-FCPKISDFGLAKICNRKESII  441 (506)
Q Consensus       383 --------------------~l~i~~~i~~gl~~LH~~~~~~ivH~dlkp~Nill~~~-~~~ki~dfg~a~~~~~~~~~~  441 (506)
                                          ...+..||.+||+|||   +.+|+||||||+|+|+|.+ +.+||+|||.|+.+..++...
T Consensus       107 tL~~~~r~~~~~~~~mp~~~iKLYt~Qlfrgl~yLh---~~~IcHRDIKPqNlLvD~~tg~LKicDFGSAK~L~~~epni  183 (364)
T KOG0658|consen  107 TLYRVIRHYTRANQRMPLLEIKLYTYQLFRGLAYLH---SHGICHRDIKPQNLLVDPDTGVLKICDFGSAKVLVKGEPNI  183 (364)
T ss_pred             HHHHHHHHHhhcCCCCceeeeHHHHHHHHHHHHHHH---hcCcccCCCChheEEEcCCCCeEEeccCCcceeeccCCCce
Confidence                                2336789999999999   8999999999999999876 899999999999987766543


Q ss_pred             ecccCCCCcccccccccccccCCCCccccHHHHHHHHHHHHcCCCCCCCCCCCcchhhhhh
Q 039231          442 SMTGARGTVGYIAPEVFCRNIGEVSYKSDVYNYGMMIFEMTGGRKNVDVVDNGSTALDLQA  502 (506)
Q Consensus       442 ~~~~~~gt~~y~aPE~l~~~~~~~s~~~Dv~s~G~il~elltg~~pf~~~~~~~~~~~~~~  502 (506)
                         ...-|..|.|||++.+. ..|+.+.||||.||++.||+-|++-|.+.+..++..++.+
T Consensus       184 ---SYicSRyYRaPELifga-~~Yt~~IDiWSaGCV~aELl~g~plFpG~s~~dQL~eIik  240 (364)
T KOG0658|consen  184 ---SYICSRYYRAPELIFGA-TEYTTSIDIWSAGCVMAELLKGQPLFPGDSSVDQLVEIIK  240 (364)
T ss_pred             ---eEEEeccccCHHHHcCc-cccCceeEEhhhhHHHHHHhcCCcccCCCCHHHHHHHHHH
Confidence               34458899999999886 5899999999999999999999999999777676666654

>KOG0196 consensus Tyrosine kinase, EPH (ephrin) receptor family [Signal transduction mechanisms]

Probab=100.00  E-value=6.1e-34  Score=290.01  Aligned_cols=196  Identities=25%  Similarity=0.478  Sum_probs=162.8

Q ss_pred             CCccCHHHHHHHHhhh-----------ccccCccCceEEEEEEEcC----CCEEEEEEeccC--CCCchhhHHHHHHhhc
Q 039231          302 PKRYGYADIKKMTNSF-----------KYKLGQGGYGSVYKGKLLD----GSNVAVKVLNDS--KGNGKEFINEVASISR  364 (506)
Q Consensus       302 ~~~~~~~el~~~~~~~-----------~~~ig~G~~g~V~~~~~~~----~~~vavK~l~~~--~~~~~~~~~E~~~l~~  364 (506)
                      ..+++|+|--++...|           +++||.|.||.|++|+++.    ...||||.|+..  +.+..+|+.|+.+|.+
T Consensus       607 iDP~TYEDPnqAvreFakEId~s~i~Ie~VIGaGEFGEVc~GrLk~pgkre~~VAIKTLK~GytekqrrdFL~EAsIMGQ  686 (996)
T KOG0196|consen  607 IDPHTYEDPNQAVREFAKEIDPSCVKIEKVIGAGEFGEVCSGRLKLPGKREITVAIKTLKAGYTEKQRRDFLSEASIMGQ  686 (996)
T ss_pred             cCCccccCccHHHHHhhhhcChhheEEEEEEecccccceecccccCCCCcceeEEEeeeccCccHHHHhhhhhhhhhccc
Confidence            3467788777776666           3569999999999999853    467999999874  4455789999999999


Q ss_pred             cCccceeEEEEEe----------------------------eccchhhhHHHHHHHHHHHHhhcCCCCeEecCcCCCcEE
Q 039231          365 TSHVNVVALLGFC----------------------------LRVAEELSSTIGIARGLEYLHLGCSTRILHFDIKPHNIL  416 (506)
Q Consensus       365 l~h~niv~l~g~~----------------------------~~~~~~l~i~~~i~~gl~~LH~~~~~~ivH~dlkp~Nil  416 (506)
                      ++||||++|.|+.                            +.+.+...+.++||.||+||-   ++++|||||..+|||
T Consensus       687 FdHPNIIrLEGVVTks~PvMIiTEyMENGsLDsFLR~~DGqftviQLVgMLrGIAsGMkYLs---dm~YVHRDLAARNIL  763 (996)
T KOG0196|consen  687 FDHPNIIRLEGVVTKSKPVMIITEYMENGSLDSFLRQNDGQFTVIQLVGMLRGIASGMKYLS---DMNYVHRDLAARNIL  763 (996)
T ss_pred             CCCCcEEEEEEEEecCceeEEEhhhhhCCcHHHHHhhcCCceEeehHHHHHHHHHHHhHHHh---hcCchhhhhhhhhee
Confidence            9999999999987                            445567778999999999999   999999999999999


Q ss_pred             ECCCCcEEEeecCCCccccCCC-cceecccCCCCcccccccccccccCCCCccccHHHHHHHHHHHHc-CCCCCCCCCCC
Q 039231          417 LDEDFCPKISDFGLAKICNRKE-SIISMTGARGTVGYIAPEVFCRNIGEVSYKSDVYNYGMMIFEMTG-GRKNVDVVDNG  494 (506)
Q Consensus       417 l~~~~~~ki~dfg~a~~~~~~~-~~~~~~~~~gt~~y~aPE~l~~~~~~~s~~~Dv~s~G~il~ellt-g~~pf~~~~~~  494 (506)
                      ++.+..+||+|||+++.+..+. ...+.....-+++|.|||.+.-  ..++.+|||||||+++||.++ |+.||=.+.+.
T Consensus       764 VNsnLvCKVsDFGLSRvledd~~~~ytt~GGKIPiRWTAPEAIa~--RKFTsASDVWSyGIVmWEVmSyGERPYWdmSNQ  841 (996)
T KOG0196|consen  764 VNSNLVCKVSDFGLSRVLEDDPEAAYTTLGGKIPIRWTAPEAIAY--RKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQ  841 (996)
T ss_pred             eccceEEEeccccceeecccCCCccccccCCccceeecChhHhhh--cccCchhhccccceEEEEecccCCCcccccchH
Confidence            9999999999999999886554 2222233455789999999953  489999999999999999987 99999888877


Q ss_pred             cchhhhhh
Q 039231          495 STALDLQA  502 (506)
Q Consensus       495 ~~~~~~~~  502 (506)
                      +....+..
T Consensus       842 dVIkaIe~  849 (996)
T KOG0196|consen  842 DVIKAIEQ  849 (996)
T ss_pred             HHHHHHHh
Confidence            76655543

>KOG0597 consensus Serine-threonine protein kinase FUSED [General function prediction only]

Probab=100.00  E-value=1.2e-33  Score=278.55  Aligned_cols=167  Identities=33%  Similarity=0.509  Sum_probs=146.4

Q ss_pred             ccccCccCceEEEEEEEc-CCCEEEEEEeccCCCCc---hhhHHHHHHhhccCccceeEEEEEe----------------
Q 039231          318 KYKLGQGGYGSVYKGKLL-DGSNVAVKVLNDSKGNG---KEFINEVASISRTSHVNVVALLGFC----------------  377 (506)
Q Consensus       318 ~~~ig~G~~g~V~~~~~~-~~~~vavK~l~~~~~~~---~~~~~E~~~l~~l~h~niv~l~g~~----------------  377 (506)
                      .+.||+|.||.||||+-+ +.+.||+|.+.+.....   +.+.+|++++++++|||||.++.++                
T Consensus         7 ~e~iG~Gsfg~VYKgrrK~t~~~vAik~i~K~gr~~k~l~~l~~ev~i~r~lkHpniv~m~esfEt~~~~~vVte~a~g~   86 (808)
T KOG0597|consen    7 YEMIGEGSFGRVYKGRRKYTIQVVAIKFIDKSGRNEKELKNLRQEVRILRSLKHPNIVEMLESFETSAHLWVVTEYAVGD   86 (808)
T ss_pred             HHHhcCCccceeeecccccceeEEEEEEehhcCCchHHHHHHHHHHHHHHhcCCcchhhHHHhhcccceEEEEehhhhhh
Confidence            356999999999999854 57899999997654443   5578999999999999999998766                


Q ss_pred             ----------eccchhhhHHHHHHHHHHHHhhcCCCCeEecCcCCCcEEECCCCcEEEeecCCCccccCCCcceecccCC
Q 039231          378 ----------LRVAEELSSTIGIARGLEYLHLGCSTRILHFDIKPHNILLDEDFCPKISDFGLAKICNRKESIISMTGAR  447 (506)
Q Consensus       378 ----------~~~~~~l~i~~~i~~gl~~LH~~~~~~ivH~dlkp~Nill~~~~~~ki~dfg~a~~~~~~~~~~~~~~~~  447 (506)
                                +.++.+..++.|++.||.|||   +.+|+|||+||+|||++..+.+|++|||+|+.+..+...  .+...
T Consensus        87 L~~il~~d~~lpEe~v~~~a~~LVsaL~yLh---s~rilhrd~kPqniLl~~~~~~KlcdFg~Ar~m~~~t~v--ltsik  161 (808)
T KOG0597|consen   87 LFTILEQDGKLPEEQVRAIAYDLVSALYYLH---SNRILHRDMKPQNILLEKGGTLKLCDFGLARAMSTNTSV--LTSIK  161 (808)
T ss_pred             HHHHHHhccCCCHHHHHHHHHHHHHHHHHHH---hcCcccccCCcceeeecCCCceeechhhhhhhcccCcee--eeecc
Confidence                      455667889999999999999   999999999999999999999999999999988775543  36689


Q ss_pred             CCcccccccccccccCCCCccccHHHHHHHHHHHHcCCCCCCCC
Q 039231          448 GTVGYIAPEVFCRNIGEVSYKSDVYNYGMMIFEMTGGRKNVDVV  491 (506)
Q Consensus       448 gt~~y~aPE~l~~~~~~~s~~~Dv~s~G~il~elltg~~pf~~~  491 (506)
                      |||.|||||+..+  ..|+..+|+||+|||+|||++|++||-..
T Consensus       162 GtPlYmAPElv~e--~pyd~~sDlWslGcilYE~~~G~PPF~a~  203 (808)
T KOG0597|consen  162 GTPLYMAPELVEE--QPYDHTSDLWSLGCILYELYVGQPPFYAR  203 (808)
T ss_pred             CcccccCHHHHcC--CCccchhhHHHHHHHHHHHhcCCCCchHH
Confidence            9999999999865  48999999999999999999999999643

>KOG0663 consensus Protein kinase PITSLRE and related kinases [General function prediction only]

Probab=100.00  E-value=1e-32  Score=256.88  Aligned_cols=178  Identities=26%  Similarity=0.307  Sum_probs=151.4

Q ss_pred             cccCccCceEEEEEEEc-CCCEEEEEEeccCCCCc---hhhHHHHHHhhccCccceeEEEEEe-----------------
Q 039231          319 YKLGQGGYGSVYKGKLL-DGSNVAVKVLNDSKGNG---KEFINEVASISRTSHVNVVALLGFC-----------------  377 (506)
Q Consensus       319 ~~ig~G~~g~V~~~~~~-~~~~vavK~l~~~~~~~---~~~~~E~~~l~~l~h~niv~l~g~~-----------------  377 (506)
                      +.|++|.||.||+|+++ ++..||+|+++-++...   -..++|+.+|.+++|||||.+-.+.                 
T Consensus        82 nrI~EGtyGiVYRakdk~t~eIVALKr~kmekek~GFPItsLREIniLl~~~H~NIV~vkEVVvG~~~d~iy~VMe~~Eh  161 (419)
T KOG0663|consen   82 NRIEEGTYGVVYRAKDKKTDEIVALKRLKMEKEKEGFPITSLREINILLKARHPNIVEVKEVVVGSNMDKIYIVMEYVEH  161 (419)
T ss_pred             hhcccCcceeEEEeccCCcceeEEeeecccccccCCCcchhHHHHHHHHhcCCCCeeeeEEEEeccccceeeeeHHHHHh
Confidence            46999999999999975 58899999998654322   4578999999999999999987654                 


Q ss_pred             ------------eccchhhhHHHHHHHHHHHHhhcCCCCeEecCcCCCcEEECCCCcEEEeecCCCccccCCCcceeccc
Q 039231          378 ------------LRVAEELSSTIGIARGLEYLHLGCSTRILHFDIKPHNILLDEDFCPKISDFGLAKICNRKESIISMTG  445 (506)
Q Consensus       378 ------------~~~~~~l~i~~~i~~gl~~LH~~~~~~ivH~dlkp~Nill~~~~~~ki~dfg~a~~~~~~~~~~~~~~  445 (506)
                                  +...++..+..|+++|++|||   ...|+|||||++|+|++..|.+||+|||+|+.++.....  ++.
T Consensus       162 DLksl~d~m~q~F~~~evK~L~~QlL~glk~lH---~~wilHRDLK~SNLLm~~~G~lKiaDFGLAR~ygsp~k~--~T~  236 (419)
T KOG0663|consen  162 DLKSLMETMKQPFLPGEVKTLMLQLLRGLKHLH---DNWILHRDLKTSNLLLSHKGILKIADFGLAREYGSPLKP--YTP  236 (419)
T ss_pred             hHHHHHHhccCCCchHHHHHHHHHHHHHHHHHh---hceeEecccchhheeeccCCcEEecccchhhhhcCCccc--Ccc
Confidence                        233446678899999999999   999999999999999999999999999999988776432  466


Q ss_pred             CCCCcccccccccccccCCCCccccHHHHHHHHHHHHcCCCCCCCCCCCcchhhhhh
Q 039231          446 ARGTVGYIAPEVFCRNIGEVSYKSDVYNYGMMIFEMTGGRKNVDVVDNGSTALDLQA  502 (506)
Q Consensus       446 ~~gt~~y~aPE~l~~~~~~~s~~~Dv~s~G~il~elltg~~pf~~~~~~~~~~~~~~  502 (506)
                      .+-|..|.|||++.+. ..|+...|+||+|||+.||+++++.|....+-++...|.+
T Consensus       237 lVVTLWYRaPELLLG~-~tyst~iDMWSvGCI~aE~l~~kPlf~G~sE~dQl~~If~  292 (419)
T KOG0663|consen  237 LVVTLWYRAPELLLGA-KTYSTAVDMWSVGCIFAELLTQKPLFPGKSEIDQLDKIFK  292 (419)
T ss_pred             eEEEeeecCHHHhcCC-cccCcchhhhhHHHHHHHHHhcCCCCCCCchHHHHHHHHH
Confidence            7779999999999886 6899999999999999999999999998877666555543

>KOG4721 consensus Serine/threonine protein kinase, contains leucine zipper domain [Signal transduction mechanisms]

Probab=100.00  E-value=1.2e-33  Score=278.58  Aligned_cols=177  Identities=32%  Similarity=0.545  Sum_probs=148.0

Q ss_pred             ccCHHHHHHHHhhhccccCccCceEEEEEEEcCCCEEEEEEeccCCCCchhhHHHHHHhhccCccceeEEEEEee-----
Q 039231          304 RYGYADIKKMTNSFKYKLGQGGYGSVYKGKLLDGSNVAVKVLNDSKGNGKEFINEVASISRTSHVNVVALLGFCL-----  378 (506)
Q Consensus       304 ~~~~~el~~~~~~~~~~ig~G~~g~V~~~~~~~~~~vavK~l~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~-----  378 (506)
                      .+.+++|.+..     -||+|+.|.||+|++ .++.||||+++.-+      ..+++-|++|+||||+.+.|+|-     
T Consensus       120 eiPFe~IsELe-----WlGSGaQGAVF~Grl-~netVAVKKV~elk------ETdIKHLRkLkH~NII~FkGVCtqsPcy  187 (904)
T KOG4721|consen  120 EIPFEEISELE-----WLGSGAQGAVFLGRL-HNETVAVKKVRELK------ETDIKHLRKLKHPNIITFKGVCTQSPCY  187 (904)
T ss_pred             cCCHHHhhhhh-----hhccCcccceeeeec-cCceehhHHHhhhh------hhhHHHHHhccCcceeeEeeeecCCcee
Confidence            44566665443     399999999999999 56899999875432      23889999999999999999981     


Q ss_pred             ----------------------ccchhhhHHHHHHHHHHHHhhcCCCCeEecCcCCCcEEECCCCcEEEeecCCCccccC
Q 039231          379 ----------------------RVAEELSSTIGIARGLEYLHLGCSTRILHFDIKPHNILLDEDFCPKISDFGLAKICNR  436 (506)
Q Consensus       379 ----------------------~~~~~l~i~~~i~~gl~~LH~~~~~~ivH~dlkp~Nill~~~~~~ki~dfg~a~~~~~  436 (506)
                                            ...-...|..+||.||+|||   .+.|||||||+-||||+.+..+||+|||-++....
T Consensus       188 CIiMEfCa~GqL~~VLka~~~itp~llv~Wsk~IA~GM~YLH---~hKIIHRDLKSPNiLIs~~d~VKIsDFGTS~e~~~  264 (904)
T KOG4721|consen  188 CIIMEFCAQGQLYEVLKAGRPITPSLLVDWSKGIAGGMNYLH---LHKIIHRDLKSPNILISYDDVVKISDFGTSKELSD  264 (904)
T ss_pred             EEeeeccccccHHHHHhccCccCHHHHHHHHHHhhhhhHHHH---HhhHhhhccCCCceEeeccceEEeccccchHhhhh
Confidence                                  11224568899999999999   89999999999999999999999999999987765


Q ss_pred             CCcceecccCCCCcccccccccccccCCCCccccHHHHHHHHHHHHcCCCCCCCCCCCcchhhh
Q 039231          437 KESIISMTGARGTVGYIAPEVFCRNIGEVSYKSDVYNYGMMIFEMTGGRKNVDVVDNGSTALDL  500 (506)
Q Consensus       437 ~~~~~~~~~~~gt~~y~aPE~l~~~~~~~s~~~Dv~s~G~il~elltg~~pf~~~~~~~~~~~~  500 (506)
                      ..+   ...+.||..|||||++.+.  ..++|+|||||||||||||||..||...+...+.+.+
T Consensus       265 ~ST---kMSFaGTVaWMAPEvIrne--PcsEKVDIwSfGVVLWEmLT~EiPYkdVdssAIIwGV  323 (904)
T KOG4721|consen  265 KST---KMSFAGTVAWMAPEVIRNE--PCSEKVDIWSFGVVLWEMLTGEIPYKDVDSSAIIWGV  323 (904)
T ss_pred             hhh---hhhhhhhHhhhCHHHhhcC--CcccccceehhHHHHHHHHhcCCCccccchheeEEec
Confidence            533   3558899999999999665  8899999999999999999999999988876665544

>KOG3653 consensus Transforming growth factor beta/activin receptor subfamily of serine/threonine kinases [Signal transduction mechanisms]

Probab=99.98  E-value=3.1e-32  Score=264.36  Aligned_cols=170  Identities=31%  Similarity=0.457  Sum_probs=139.2

Q ss_pred             ccccCccCceEEEEEEEcCCCEEEEEEeccCCCCchhhHHHHHHhh--ccCccceeEEEEEe------------------
Q 039231          318 KYKLGQGGYGSVYKGKLLDGSNVAVKVLNDSKGNGKEFINEVASIS--RTSHVNVVALLGFC------------------  377 (506)
Q Consensus       318 ~~~ig~G~~g~V~~~~~~~~~~vavK~l~~~~~~~~~~~~E~~~l~--~l~h~niv~l~g~~------------------  377 (506)
                      .++||+|.||.||+|++ +++.||||++...  +.+.+.+|-++.+  .++|+||+++++.-                  
T Consensus       215 ~eli~~Grfg~V~KaqL-~~~~VAVKifp~~--~kqs~~~Ek~Iy~lp~m~h~nIl~Fi~~ekr~t~~~~eywLVt~fh~  291 (534)
T KOG3653|consen  215 LELIGRGRFGCVWKAQL-DNRLVAVKIFPEQ--EKQSFQNEKNIYSLPGMKHENILQFIGAEKRGTADRMEYWLVTEFHP  291 (534)
T ss_pred             HHHhhcCccceeehhhc-cCceeEEEecCHH--HHHHHHhHHHHHhccCccchhHHHhhchhccCCccccceeEEeeecc
Confidence            45699999999999999 5599999999643  3356777766655  46799999998643                  


Q ss_pred             ------------eccchhhhHHHHHHHHHHHHhhc------CCCCeEecCcCCCcEEECCCCcEEEeecCCCccccCCCc
Q 039231          378 ------------LRVAEELSSTIGIARGLEYLHLG------CSTRILHFDIKPHNILLDEDFCPKISDFGLAKICNRKES  439 (506)
Q Consensus       378 ------------~~~~~~l~i~~~i~~gl~~LH~~------~~~~ivH~dlkp~Nill~~~~~~ki~dfg~a~~~~~~~~  439 (506)
                                  .+|.+..+|+..+++||+|||+.      .+++|+|||||++|||+.+|++..|+|||+|..+.....
T Consensus       292 kGsL~dyL~~ntisw~~~cria~SmarGLa~LHee~p~~d~~Kp~IaHRDlkSkNVLvK~DlTccIaDFGLAl~~~p~~~  371 (534)
T KOG3653|consen  292 KGSLCDYLKANTISWNSLCRIAESMARGLAHLHEELPRGDHHKPPIAHRDLKSKNVLVKNDLTCCIADFGLALRLEPGKP  371 (534)
T ss_pred             CCcHHHHHHhccccHHHHHHHHHHHHHHHHHhcccCCcCCCCCCccccccccccceEEccCCcEEeeccceeEEecCCCC
Confidence                        56777889999999999999973      467899999999999999999999999999998876665


Q ss_pred             ceecccCCCCcccccccccccccC----CCCccccHHHHHHHHHHHHcCCCCCCC
Q 039231          440 IISMTGARGTVGYIAPEVFCRNIG----EVSYKSDVYNYGMMIFEMTGGRKNVDV  490 (506)
Q Consensus       440 ~~~~~~~~gt~~y~aPE~l~~~~~----~~s~~~Dv~s~G~il~elltg~~pf~~  490 (506)
                      .......+||.+|||||+|.+...    ..-.+.||||+|.|||||+++-.-++.
T Consensus       372 ~~d~~~qVGT~RYMAPEvLEgainl~d~~Afkr~DvYamgLVLWEi~SRC~~~~~  426 (534)
T KOG3653|consen  372 QGDTHGQVGTRRYMAPEVLEGAINLQDRDAFKRIDVYAMGLVLWEIASRCTDADP  426 (534)
T ss_pred             CcchhhhhhhhhhcCHHHHhhhcccccHHHHHHHHHHHHHHHHHHHHhhcccccC
Confidence            555556899999999999965321    122468999999999999998776653

>KOG0594 consensus Protein kinase PCTAIRE and related kinases [General function prediction only]

Probab=99.98  E-value=5.1e-32  Score=256.75  Aligned_cols=178  Identities=31%  Similarity=0.373  Sum_probs=150.6

Q ss_pred             cccCccCceEEEEEEEc-CCCEEEEEEeccCCC---CchhhHHHHHHhhccCccc-eeEEEEEeeccc------------
Q 039231          319 YKLGQGGYGSVYKGKLL-DGSNVAVKVLNDSKG---NGKEFINEVASISRTSHVN-VVALLGFCLRVA------------  381 (506)
Q Consensus       319 ~~ig~G~~g~V~~~~~~-~~~~vavK~l~~~~~---~~~~~~~E~~~l~~l~h~n-iv~l~g~~~~~~------------  381 (506)
                      ++||+|+||+||+|+.. +|+.||+|++.-+..   --....+|+.++.+++|+| ||+|.+++.+..            
T Consensus        17 eklGeGtyg~Vykar~~~~g~~VALKkirl~~~~EG~P~taiREisllk~L~~~~~iv~L~dv~~~~~~~~~~~~l~lvf   96 (323)
T KOG0594|consen   17 EKLGEGTYGVVYKARSKRTGKFVALKKIRLEFEEEGVPSTAIREISLLKRLSHANHIVRLHDVIHTSNNHRGIGKLYLVF   96 (323)
T ss_pred             HHhCCCCceEEEEEEEecCCCEEEEEEEeccccccCCCchhhHHHHHHHHhCCCcceEEEEeeeeecccccccceEEEEE
Confidence            35999999999999864 589999999975433   3366799999999999999 999998873322            


Q ss_pred             ------------------------hhhhHHHHHHHHHHHHhhcCCCCeEecCcCCCcEEECCCCcEEEeecCCCccccCC
Q 039231          382 ------------------------EELSSTIGIARGLEYLHLGCSTRILHFDIKPHNILLDEDFCPKISDFGLAKICNRK  437 (506)
Q Consensus       382 ------------------------~~l~i~~~i~~gl~~LH~~~~~~ivH~dlkp~Nill~~~~~~ki~dfg~a~~~~~~  437 (506)
                                              ....++.||++||+|||   +++|+||||||+||||+++|.+||+|||+|+...-.
T Consensus        97 e~~d~DL~~ymd~~~~~~~g~~~~~ik~~m~Qll~gl~~~H---~~~IlHRDLKPQNlLi~~~G~lKlaDFGlAra~~ip  173 (323)
T KOG0594|consen   97 EFLDRDLKKYMDSLPKKPQGLPPRLIKSFMRQLLRGLAFLH---SHGILHRDLKPQNLLISSSGVLKLADFGLARAFSIP  173 (323)
T ss_pred             EeecccHHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHH---hCCeecccCCcceEEECCCCcEeeeccchHHHhcCC
Confidence                                    14568899999999999   999999999999999999999999999999966533


Q ss_pred             CcceecccCCCCcccccccccccccCCCCccccHHHHHHHHHHHHcCCCCCCCCCCCcchhhhhh
Q 039231          438 ESIISMTGARGTVGYIAPEVFCRNIGEVSYKSDVYNYGMMIFEMTGGRKNVDVVDNGSTALDLQA  502 (506)
Q Consensus       438 ~~~~~~~~~~gt~~y~aPE~l~~~~~~~s~~~Dv~s~G~il~elltg~~pf~~~~~~~~~~~~~~  502 (506)
                      ..  ..+..+.|..|.|||++.+.+ .|+...||||+|||+.||++++..|....+.++...|.+
T Consensus       174 ~~--~yt~evvTlWYRaPEvLlGs~-~Ys~~vDiWs~GcIfaEm~~~~~LFpG~se~~ql~~If~  235 (323)
T KOG0594|consen  174 MR--TYTPEVVTLWYRAPEVLLGST-SYSTSVDIWSLGCIFAEMFTRRPLFPGDSEIDQLFRIFR  235 (323)
T ss_pred             cc--cccccEEEeeccCHHHhcCCC-cCCCCcchHhHHHHHHHHHhCCCCCCCCcHHHHHHHHHH
Confidence            22  236678899999999998873 689999999999999999999999999888666655544

>KOG0605 consensus NDR and related serine/threonine kinases [General function prediction only]

Probab=99.98  E-value=3.1e-32  Score=268.67  Aligned_cols=182  Identities=26%  Similarity=0.301  Sum_probs=152.5

Q ss_pred             cccCccCceEEEEEEEcC-CCEEEEEEeccCC----CCchhhHHHHHHhhccCccceeEEEEEe----------------
Q 039231          319 YKLGQGGYGSVYKGKLLD-GSNVAVKVLNDSK----GNGKEFINEVASISRTSHVNVVALLGFC----------------  377 (506)
Q Consensus       319 ~~ig~G~~g~V~~~~~~~-~~~vavK~l~~~~----~~~~~~~~E~~~l~~l~h~niv~l~g~~----------------  377 (506)
                      .+||+|+||.||+|+-++ |..+|+|+++++.    .+.+.+..|-.+|...++|+||+|+-.+                
T Consensus       147 k~IgkGAfGeVrLarKk~Tg~iyAmK~LkKS~M~~~~Qv~hV~aERdiL~~~ds~~vVKLyYsFQD~~~LYLiMEylPGG  226 (550)
T KOG0605|consen  147 KVIGKGAFGEVRLARKKDTGEIYAMKILKKSEMLKKNQVEHVRAERDILAEVDSPWVVKLYYSFQDKEYLYLIMEYLPGG  226 (550)
T ss_pred             eeeccccceeEEEEEEccCCcEEeeecccHHHHHhhhhHHHHHHHHHHhhhcCCCcEEEEEEEecCCCeeEEEEEecCCc
Confidence            479999999999998654 9999999998753    4557789999999999999999999766                


Q ss_pred             -----------eccchhhhHHHHHHHHHHHHhhcCCCCeEecCcCCCcEEECCCCcEEEeecCCCccccC----------
Q 039231          378 -----------LRVAEELSSTIGIARGLEYLHLGCSTRILHFDIKPHNILLDEDFCPKISDFGLAKICNR----------  436 (506)
Q Consensus       378 -----------~~~~~~l~i~~~i~~gl~~LH~~~~~~ivH~dlkp~Nill~~~~~~ki~dfg~a~~~~~----------  436 (506)
                                 ++++.....+.+++.||+.||   +.|+|||||||+|+|||..|++||+|||++.-+..          
T Consensus       227 D~mTLL~~~~~L~e~~arfYiaE~vlAI~~iH---~~gyIHRDIKPdNlLiD~~GHiKLSDFGLs~gl~~~~~~~~~~~~  303 (550)
T KOG0605|consen  227 DMMTLLMRKDTLTEDWARFYIAETVLAIESIH---QLGYIHRDIKPDNLLIDAKGHIKLSDFGLSTGLDKKHRIESYRLD  303 (550)
T ss_pred             cHHHHHHhcCcCchHHHHHHHHHHHHHHHHHH---HcCcccccCChhheeecCCCCEeeccccccchhhhhhhhhhhcch
Confidence                       445556678889999999999   99999999999999999999999999999843211          


Q ss_pred             ------------CCcc-----ee------------------cccCCCCcccccccccccccCCCCccccHHHHHHHHHHH
Q 039231          437 ------------KESI-----IS------------------MTGARGTVGYIAPEVFCRNIGEVSYKSDVYNYGMMIFEM  481 (506)
Q Consensus       437 ------------~~~~-----~~------------------~~~~~gt~~y~aPE~l~~~~~~~s~~~Dv~s~G~il~el  481 (506)
                                  .+..     ..                  ....+|||.|||||++.++  .|+..+|+||+|||+|||
T Consensus       304 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~w~~nrr~~a~StVGTPDYiAPEVll~k--gY~~~cDwWSLG~ImyEm  381 (550)
T KOG0605|consen  304 EQMQINLSEAKPSDFPKFNTPRSTMSRREQLQTWKRNRRQLAYSTVGTPDYIAPEVLLGK--GYGKECDWWSLGCIMYEM  381 (550)
T ss_pred             hhhhhhhccCCCccccccccccchhhHHHHHHHHHhhhhhhhhcccCCccccchHHHhcC--CCCccccHHHHHHHHHHH
Confidence                        0000     00                  0123499999999999886  589999999999999999


Q ss_pred             HcCCCCCCCCCCCcchhhhhhhcC
Q 039231          482 TGGRKNVDVVDNGSTALDLQASRK  505 (506)
Q Consensus       482 ltg~~pf~~~~~~~~~~~~~~~~~  505 (506)
                      |.|-+||...+..+.-..|..++.
T Consensus       382 LvGyPPF~s~tp~~T~rkI~nwr~  405 (550)
T KOG0605|consen  382 LVGYPPFCSETPQETYRKIVNWRE  405 (550)
T ss_pred             HhCCCCCCCCCHHHHHHHHHHHhh
Confidence            999999999999888888877653

>KOG0694 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.98  E-value=3.7e-32  Score=275.21  Aligned_cols=180  Identities=24%  Similarity=0.353  Sum_probs=152.4

Q ss_pred             hhccccCccCceEEEEEEEcC-CCEEEEEEeccC----CCCchhhHHHHHHhhccC-ccceeEEEEEe------------
Q 039231          316 SFKYKLGQGGYGSVYKGKLLD-GSNVAVKVLNDS----KGNGKEFINEVASISRTS-HVNVVALLGFC------------  377 (506)
Q Consensus       316 ~~~~~ig~G~~g~V~~~~~~~-~~~vavK~l~~~----~~~~~~~~~E~~~l~~l~-h~niv~l~g~~------------  377 (506)
                      .|..+||+|.||+|+++.++. ++.+|||.+++.    +...+..+.|.+++...+ ||-++.++..+            
T Consensus       371 ~~l~vLGkGsFGkV~lae~k~~~e~yAIK~LKK~~Il~~d~Ve~~~~EkrI~~la~~HPFL~~L~~~fQT~~~l~fvmey  450 (694)
T KOG0694|consen  371 RLLAVLGRGSFGKVLLAELKGTNEYYAIKVLKKGDILQRDEVESLMCEKRIFELANRHPFLVNLFSCFQTKEHLFFVMEY  450 (694)
T ss_pred             EEEEEeccCcCceEEEEEEcCCCcEEEEEEeeccceeccccHHHHHHHHHHHHHhccCCeEeecccccccCCeEEEEEEe
Confidence            345789999999999999864 789999999875    344567888888888776 99999998766            


Q ss_pred             --------------eccchhhhHHHHHHHHHHHHhhcCCCCeEecCcCCCcEEECCCCcEEEeecCCCccccCCCcceec
Q 039231          378 --------------LRVAEELSSTIGIARGLEYLHLGCSTRILHFDIKPHNILLDEDFCPKISDFGLAKICNRKESIISM  443 (506)
Q Consensus       378 --------------~~~~~~l~i~~~i~~gl~~LH~~~~~~ivH~dlkp~Nill~~~~~~ki~dfg~a~~~~~~~~~~~~  443 (506)
                                    +++.....++..|+.||+|||   +++|||||||.+|||||.+|++||+|||+++..-....  ..
T Consensus       451 ~~Ggdm~~~~~~~~F~e~rarfyaAev~l~L~fLH---~~~IIYRDlKLdNiLLD~eGh~kiADFGlcKe~m~~g~--~T  525 (694)
T KOG0694|consen  451 VAGGDLMHHIHTDVFSEPRARFYAAEVVLGLQFLH---ENGIIYRDLKLDNLLLDTEGHVKIADFGLCKEGMGQGD--RT  525 (694)
T ss_pred             cCCCcEEEEEecccccHHHHHHHHHHHHHHHHHHH---hcCceeeecchhheEEcccCcEEecccccccccCCCCC--cc
Confidence                          233345668899999999999   99999999999999999999999999999987543222  24


Q ss_pred             ccCCCCcccccccccccccCCCCccccHHHHHHHHHHHHcCCCCCCCCCCCcchhhhhh
Q 039231          444 TGARGTVGYIAPEVFCRNIGEVSYKSDVYNYGMMIFEMTGGRKNVDVVDNGSTALDLQA  502 (506)
Q Consensus       444 ~~~~gt~~y~aPE~l~~~~~~~s~~~Dv~s~G~il~elltg~~pf~~~~~~~~~~~~~~  502 (506)
                      .+..||+.|||||++.+.  .|+..+|+|||||+||||+.|..||...++++..-.|..
T Consensus       526 sTfCGTpey~aPEil~e~--~Yt~aVDWW~lGVLlyeML~Gq~PF~gddEee~FdsI~~  582 (694)
T KOG0694|consen  526 STFCGTPEFLAPEVLTEQ--SYTRAVDWWGLGVLLYEMLVGESPFPGDDEEEVFDSIVN  582 (694)
T ss_pred             ccccCChhhcChhhhccC--cccchhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHhc
Confidence            678999999999999765  899999999999999999999999999888876655543

>KOG0583 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.97  E-value=6.4e-32  Score=270.55  Aligned_cols=173  Identities=29%  Similarity=0.445  Sum_probs=145.2

Q ss_pred             hhccccCccCceEEEEEEEc-CCCEEEEEEeccC----CC--CchhhHHHHHHhhccC-ccceeEEEEEe----------
Q 039231          316 SFKYKLGQGGYGSVYKGKLL-DGSNVAVKVLNDS----KG--NGKEFINEVASISRTS-HVNVVALLGFC----------  377 (506)
Q Consensus       316 ~~~~~ig~G~~g~V~~~~~~-~~~~vavK~l~~~----~~--~~~~~~~E~~~l~~l~-h~niv~l~g~~----------  377 (506)
                      .+.+.||+|+||+|+.|+.. .+..||+|++...    ..  ..+.+.+|+.++++++ ||||++++.+.          
T Consensus        20 ~~~~~lG~GsfgkV~~a~~~~t~~~vAiKii~~~~~~~~~~~~~~~i~rEi~~~~~~~~HpnI~~l~ev~~t~~~~~ivm   99 (370)
T KOG0583|consen   20 ELGRTLGSGSFGKVKLAKHRLTGEKVAIKIIDRKKVSSKSQKLDELIKREISILRRLRSHPNIIRLLEVFATPTKIYIVM   99 (370)
T ss_pred             eeeeeecCCCCeeEEEeeeccCCCeEEEEEechhcccccccccchhhHHHHHHHHHhccCCCEeEEEEEEecCCeEEEEE
Confidence            34567999999999999764 5899999987653    22  2356778999999999 99999999876          


Q ss_pred             -----------------eccchhhhHHHHHHHHHHHHhhcCCCCeEecCcCCCcEEECCC-CcEEEeecCCCcccc-CCC
Q 039231          378 -----------------LRVAEELSSTIGIARGLEYLHLGCSTRILHFDIKPHNILLDED-FCPKISDFGLAKICN-RKE  438 (506)
Q Consensus       378 -----------------~~~~~~l~i~~~i~~gl~~LH~~~~~~ivH~dlkp~Nill~~~-~~~ki~dfg~a~~~~-~~~  438 (506)
                                       +.+.+...++.|++.|++|+|   +++|+||||||+|||++.+ +++||+|||++.... .+.
T Consensus       100 Ey~~gGdL~~~i~~~g~l~E~~ar~~F~Qlisav~y~H---~~gi~HRDLK~ENilld~~~~~~Kl~DFG~s~~~~~~~~  176 (370)
T KOG0583|consen  100 EYCSGGDLFDYIVNKGRLKEDEARKYFRQLISAVAYCH---SRGIVHRDLKPENILLDGNEGNLKLSDFGLSAISPGEDG  176 (370)
T ss_pred             EecCCccHHHHHHHcCCCChHHHHHHHHHHHHHHHHHH---hCCEeeCCCCHHHEEecCCCCCEEEeccccccccCCCCC
Confidence                             334456779999999999999   9999999999999999999 999999999999874 322


Q ss_pred             cceecccCCCCcccccccccccccCCCCccccHHHHHHHHHHHHcCCCCCCCCCCC
Q 039231          439 SIISMTGARGTVGYIAPEVFCRNIGEVSYKSDVYNYGMMIFEMTGGRKNVDVVDNG  494 (506)
Q Consensus       439 ~~~~~~~~~gt~~y~aPE~l~~~~~~~s~~~Dv~s~G~il~elltg~~pf~~~~~~  494 (506)
                         ......||+.|+|||++.+.....+.++||||+||+||.|++|+.||+..+..
T Consensus       177 ---~l~t~cGsp~Y~aPEvl~~~~~Y~g~~aDvWS~GViLy~ml~G~~PF~d~~~~  229 (370)
T KOG0583|consen  177 ---LLKTFCGSPAYAAPEVLSGKGTYSGKAADVWSLGVILYVLLCGRLPFDDSNVP  229 (370)
T ss_pred             ---cccCCCCCcccCCHHHhCCCCCcCCchhhhhhhHHHHHHHHhCCCCCCCccHH
Confidence               24678899999999999775224568999999999999999999999985433

>KOG1095 consensus Protein tyrosine kinase [Signal transduction mechanisms]

Probab=99.97  E-value=2.3e-32  Score=293.42  Aligned_cols=188  Identities=32%  Similarity=0.538  Sum_probs=155.5

Q ss_pred             HHHHHhhhccccCccCceEEEEEEEcC--CC----EEEEEEeccC--CCCchhhHHHHHHhhccCccceeEEEEEeec--
Q 039231          310 IKKMTNSFKYKLGQGGYGSVYKGKLLD--GS----NVAVKVLNDS--KGNGKEFINEVASISRTSHVNVVALLGFCLR--  379 (506)
Q Consensus       310 l~~~~~~~~~~ig~G~~g~V~~~~~~~--~~----~vavK~l~~~--~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~--  379 (506)
                      +....-.+.+.||+|+||.||+|...+  |.    .||||.++..  .+...+|.+|..+|+.++|||||+++|+|++  
T Consensus       689 v~~~~v~l~~~lG~G~FG~VY~g~~~~~~~~~~~~~vaiK~l~~~~~~~~~~~Fl~Ea~~m~~f~HpNiv~liGv~l~~~  768 (1025)
T KOG1095|consen  689 VPRKNVTLLRVLGKGAFGEVYEGTYSDVPGSVSPIQVAVKSLKRLSSEQEVSDFLKEALLMSKFDHPNIVSLIGVCLDSG  768 (1025)
T ss_pred             CChhheEeeeeeccccccceEEEEEecCCCCccceEEEEEeccccCCHHHHHHHHHHHHHHhcCCCcceeeEEEeecCCC
Confidence            444444566789999999999998754  43    4899999764  3445789999999999999999999999944  


Q ss_pred             --------------------------------cchhhhHHHHHHHHHHHHhhcCCCCeEecCcCCCcEEECCCCcEEEee
Q 039231          380 --------------------------------VAEELSSTIGIARGLEYLHLGCSTRILHFDIKPHNILLDEDFCPKISD  427 (506)
Q Consensus       380 --------------------------------~~~~l~i~~~i~~gl~~LH~~~~~~ivH~dlkp~Nill~~~~~~ki~d  427 (506)
                                                      ..+.+.++.|||+|++||+   +++.|||||..+|+||++...+||+|
T Consensus       769 ~~~i~leyM~gGDL~sflr~~r~~~~~~~~L~~~dLl~~a~dvA~G~~YLe---~~~fvHRDLAaRNCLL~~~r~VKIaD  845 (1025)
T KOG1095|consen  769 PPLILLEYMEGGDLLSFLRESRPAPFQPSNLSMRDLLAFALDVAKGMNYLE---SKHFVHRDLAARNCLLDERRVVKIAD  845 (1025)
T ss_pred             CcEEEehhcccCcHHHHHHhcccccCCCCCCCHHHHHHHHHHHhhhhHHHH---hCCCcCcchhhhheeecccCcEEEcc
Confidence                                            2236779999999999999   99999999999999999999999999


Q ss_pred             cCCCccccCCCcceecccCCCCcccccccccccccCCCCccccHHHHHHHHHHHHc-CCCCCCCCCCCcchhhhhh
Q 039231          428 FGLAKICNRKESIISMTGARGTVGYIAPEVFCRNIGEVSYKSDVYNYGMMIFEMTG-GRKNVDVVDNGSTALDLQA  502 (506)
Q Consensus       428 fg~a~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~s~~~Dv~s~G~il~ellt-g~~pf~~~~~~~~~~~~~~  502 (506)
                      ||+|+.+...+.+...........|||||.+..  +.++.|+|||||||+|||++| |..||...++.+......+
T Consensus       846 FGlArDiy~~~yyr~~~~a~lPvkWm~PEsl~d--~iFtskSDvWsFGVllWEifslG~~PY~~~~n~~v~~~~~~  919 (1025)
T KOG1095|consen  846 FGLARDIYDKDYYRKHGEAMLPVKWMPPESLKD--GIFTSKSDVWSFGVLLWEIFSLGATPYPSRSNFEVLLDVLE  919 (1025)
T ss_pred             cchhHhhhhchheeccCccccceecCCHHHHhh--cccccccchhhhHHHHHHHHhCCCCCCCCcchHHHHHHHHh
Confidence            999996655554433222355679999999964  589999999999999999998 9999998888777664443

>KOG1094 consensus Discoidin domain receptor DDR1 [Signal transduction mechanisms]

Probab=99.97  E-value=1.1e-31  Score=265.65  Aligned_cols=187  Identities=27%  Similarity=0.442  Sum_probs=158.2

Q ss_pred             HHHHHHHHhhhccccCccCceEEEEEEEcCCCEEEEEEeccCCC--CchhhHHHHHHhhccCccceeEEEEEeec-----
Q 039231          307 YADIKKMTNSFKYKLGQGGYGSVYKGKLLDGSNVAVKVLNDSKG--NGKEFINEVASISRTSHVNVVALLGFCLR-----  379 (506)
Q Consensus       307 ~~el~~~~~~~~~~ig~G~~g~V~~~~~~~~~~vavK~l~~~~~--~~~~~~~E~~~l~~l~h~niv~l~g~~~~-----  379 (506)
                      ..|..+..-.|.++||+|-||.|.++....+..||||+++....  ..++|.+|+++|.+++|||||+|+|+|..     
T Consensus       532 l~EfPRs~L~~~ekiGeGqFGEVhLCeveg~lkVAVK~Lr~~a~~~~r~~F~kEIkiLsqLkhPNIveLvGVC~~DePic  611 (807)
T KOG1094|consen  532 LVEFPRSRLRFKEKIGEGQFGEVHLCEVEGPLKVAVKILRPDATKNARNDFLKEIKILSRLKHPNIVELLGVCVQDDPLC  611 (807)
T ss_pred             hhhcchhheehhhhhcCcccceeEEEEecCceEEEEeecCcccchhHHHHHHHHHHHHhccCCCCeeEEEeeeecCCchH
Confidence            34555555556789999999999999998889999999986432  34789999999999999999999999832     


Q ss_pred             ------------------------cchhhhHHHHHHHHHHHHhhcCCCCeEecCcCCCcEEECCCCcEEEeecCCCcccc
Q 039231          380 ------------------------VAEELSSTIGIARGLEYLHLGCSTRILHFDIKPHNILLDEDFCPKISDFGLAKICN  435 (506)
Q Consensus       380 ------------------------~~~~l~i~~~i~~gl~~LH~~~~~~ivH~dlkp~Nill~~~~~~ki~dfg~a~~~~  435 (506)
                                              ....+.|+.||+.||+||.   +.++|||||.++|+|++.++++||+|||+++-+-
T Consensus       612 mI~EYmEnGDLnqFl~aheapt~~t~~~vsi~tqiasgmaYLe---s~nfVHrd~a~rNcLv~~e~~iKiadfgmsR~ly  688 (807)
T KOG1094|consen  612 MITEYMENGDLNQFLSAHELPTAETAPGVSICTQIASGMAYLE---SLNFVHRDLATRNCLVDGEFTIKIADFGMSRNLY  688 (807)
T ss_pred             HHHHHHhcCcHHHHHHhccCcccccchhHHHHHHHHHHHHHHH---hhchhhccccccceeecCcccEEecCcccccccc
Confidence                                    2225679999999999999   9999999999999999999999999999999776


Q ss_pred             CCCcceecccCCCCcccccccccccccCCCCccccHHHHHHHHHHHH--cCCCCCCCCCCCcchh
Q 039231          436 RKESIISMTGARGTVGYIAPEVFCRNIGEVSYKSDVYNYGMMIFEMT--GGRKNVDVVDNGSTAL  498 (506)
Q Consensus       436 ~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~s~~~Dv~s~G~il~ell--tg~~pf~~~~~~~~~~  498 (506)
                      ..+.+........+++|||||.+..  +.++.++|+|+||+.+||++  +...||+...+++..-
T Consensus       689 sg~yy~vqgr~vlpiRwmawEsill--gkFttaSDvWafgvTlwE~~~~C~e~Py~~lt~e~vve  751 (807)
T KOG1094|consen  689 SGDYYRVQGRAVLPIRWMAWESILL--GKFTTASDVWAFGVTLWEVFMLCREQPYSQLTDEQVVE  751 (807)
T ss_pred             cCCceeeecceeeeeeehhHHHHHh--ccccchhhhhhhHHHHHHHHHHHhhCchhhhhHHHHHH
Confidence            6665544455677899999999865  48999999999999999986  5999999887765443

>KOG0660 consensus Mitogen-activated protein kinase [Signal transduction mechanisms]

Probab=99.97  E-value=3.1e-32  Score=257.37  Aligned_cols=178  Identities=29%  Similarity=0.393  Sum_probs=150.5

Q ss_pred             cccCccCceEEEEEEEc-CCCEEEEEEeccC---CCCchhhHHHHHHhhccCccceeEEEEEeec---------------
Q 039231          319 YKLGQGGYGSVYKGKLL-DGSNVAVKVLNDS---KGNGKEFINEVASISRTSHVNVVALLGFCLR---------------  379 (506)
Q Consensus       319 ~~ig~G~~g~V~~~~~~-~~~~vavK~l~~~---~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~---------------  379 (506)
                      +.||+|++|.|..|... +|..||||++.+.   ....++..+|++.|+.++|+||+.+.++...               
T Consensus        28 ~~iG~GAyGvVcsA~~~~t~~~VAIKKi~~~F~~~~~akRtlRElklLr~~~HeNIi~l~di~~p~~~~~f~DvYiV~el  107 (359)
T KOG0660|consen   28 EPIGRGAYGVVCSAKDKRTGEKVAIKKILNPFENQIDAKRTLRELKLLRHLRHENIIGLLDIFRPPSRDKFNDVYLVFEL  107 (359)
T ss_pred             ccccCcceeeEEEEEEcCCCCEeehhhhhhhhhchHHHHHHHHHHHHHHHhcCCCcceEEeecccccccccceeEEehhH
Confidence            45999999999999874 5899999999743   3344788999999999999999999987732               


Q ss_pred             ----------------cchhhhHHHHHHHHHHHHhhcCCCCeEecCcCCCcEEECCCCcEEEeecCCCccccCCCcceec
Q 039231          380 ----------------VAEELSSTIGIARGLEYLHLGCSTRILHFDIKPHNILLDEDFCPKISDFGLAKICNRKESIISM  443 (506)
Q Consensus       380 ----------------~~~~l~i~~~i~~gl~~LH~~~~~~ivH~dlkp~Nill~~~~~~ki~dfg~a~~~~~~~~~~~~  443 (506)
                                      ......+..|+++||.|+|   +.+|+||||||+|++++.+...||+|||+|+..........+
T Consensus       108 MetDL~~iik~~~~L~d~H~q~f~YQiLrgLKyiH---SAnViHRDLKPsNll~n~~c~lKI~DFGLAR~~~~~~~~~~m  184 (359)
T KOG0660|consen  108 METDLHQIIKSQQDLTDDHAQYFLYQILRGLKYIH---SANVIHRDLKPSNLLLNADCDLKICDFGLARYLDKFFEDGFM  184 (359)
T ss_pred             HhhHHHHHHHcCccccHHHHHHHHHHHHHhcchhh---cccccccccchhheeeccCCCEEeccccceeeccccCcccch
Confidence                            2223447789999999999   999999999999999999999999999999988654333345


Q ss_pred             ccCCCCcccccccccccccCCCCccccHHHHHHHHHHHHcCCCCCCCCCCCcchhhh
Q 039231          444 TGARGTVGYIAPEVFCRNIGEVSYKSDVYNYGMMIFEMTGGRKNVDVVDNGSTALDL  500 (506)
Q Consensus       444 ~~~~gt~~y~aPE~l~~~~~~~s~~~Dv~s~G~il~elltg~~pf~~~~~~~~~~~~  500 (506)
                      +....|..|.|||++... ..|+.+.||||.|||+.||++|++.|.+.+.-++...|
T Consensus       185 TeYVaTRWYRAPElll~~-~~Yt~aiDiWSvGCI~AEmL~gkplFpG~d~v~Ql~lI  240 (359)
T KOG0660|consen  185 TEYVATRWYRAPELLLNS-SEYTKAIDIWSVGCILAEMLTGKPLFPGKDYVHQLQLI  240 (359)
T ss_pred             hcceeeeeecCHHHHhcc-ccccchhhhhhhhHHHHHHHcCCCCCCCCchHHHHHHH
Confidence            778899999999999654 68999999999999999999999999988766554443

>KOG0585 consensus Ca2+/calmodulin-dependent protein kinase kinase beta and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=99.97  E-value=5.3e-32  Score=262.63  Aligned_cols=178  Identities=28%  Similarity=0.355  Sum_probs=144.5

Q ss_pred             hccccCccCceEEEEEEEc-CCCEEEEEEeccCCC---------------CchhhHHHHHHhhccCccceeEEEEEe---
Q 039231          317 FKYKLGQGGYGSVYKGKLL-DGSNVAVKVLNDSKG---------------NGKEFINEVASISRTSHVNVVALLGFC---  377 (506)
Q Consensus       317 ~~~~ig~G~~g~V~~~~~~-~~~~vavK~l~~~~~---------------~~~~~~~E~~~l~~l~h~niv~l~g~~---  377 (506)
                      +.+.||+|.||.|-+|+.. +++.||||++.+.+.               ..+.+.+|+.+|++++|||||+|+.+.   
T Consensus       101 l~~eiG~G~yGkVkLar~~~~~~l~AiKil~K~~~~~~~~~~~~~a~~~~~~ekv~~EIailKkl~H~nVV~LiEvLDDP  180 (576)
T KOG0585|consen  101 LIKEIGSGQYGKVKLARDEVDGKLYAIKILPKKELRRQYGFPRQPAMKLMPIEKVRREIAILKKLHHPNVVKLIEVLDDP  180 (576)
T ss_pred             hhhhhcCCccceEEEEeecCCCcEEEEEeechhhhhhhcccccccccccCcHHHHHHHHHHHHhcCCcCeeEEEEeecCc
Confidence            3467999999999999974 589999999964321               114788999999999999999998765   


Q ss_pred             --------------------------eccchhhhHHHHHHHHHHHHhhcCCCCeEecCcCCCcEEECCCCcEEEeecCCC
Q 039231          378 --------------------------LRVAEELSSTIGIARGLEYLHLGCSTRILHFDIKPHNILLDEDFCPKISDFGLA  431 (506)
Q Consensus       378 --------------------------~~~~~~l~i~~~i~~gl~~LH~~~~~~ivH~dlkp~Nill~~~~~~ki~dfg~a  431 (506)
                                                +...++..++.+++.||+|||   .++|+||||||+|+||+++|++||+|||.+
T Consensus       181 ~s~~~YlVley~s~G~v~w~p~d~~els~~~Ar~ylrDvv~GLEYLH---~QgiiHRDIKPsNLLl~~~g~VKIsDFGVs  257 (576)
T KOG0585|consen  181 ESDKLYLVLEYCSKGEVKWCPPDKPELSEQQARKYLRDVVLGLEYLH---YQGIIHRDIKPSNLLLSSDGTVKISDFGVS  257 (576)
T ss_pred             ccCceEEEEEeccCCccccCCCCcccccHHHHHHHHHHHHHHHHHHH---hcCeeccccchhheEEcCCCcEEeecccee
Confidence                                      334457889999999999999   999999999999999999999999999999


Q ss_pred             ccccCC---CcceecccCCCCccccccccccccc--CCCCccccHHHHHHHHHHHHcCCCCCCCCCCCcch
Q 039231          432 KICNRK---ESIISMTGARGTVGYIAPEVFCRNI--GEVSYKSDVYNYGMMIFEMTGGRKNVDVVDNGSTA  497 (506)
Q Consensus       432 ~~~~~~---~~~~~~~~~~gt~~y~aPE~l~~~~--~~~s~~~Dv~s~G~il~elltg~~pf~~~~~~~~~  497 (506)
                      ......   .....+....|||.|+|||......  ...+.+.||||+||.||-|+.|+.||.....-+..
T Consensus       258 ~~~~~~~~~~~d~~L~~tvGTPAF~APE~c~~~~~~~~~g~a~DiWalGVTLYCllfG~~PF~~~~~~~l~  328 (576)
T KOG0585|consen  258 NEFPQGSDEGSDDQLSRTVGTPAFFAPELCSGGNSFSYSGFALDIWALGVTLYCLLFGQLPFFDDFELELF  328 (576)
T ss_pred             eecccCCccccHHHHhhcCCCccccchHhhcCCCCccccchhhhhhhhhhhHHHhhhccCCcccchHHHHH
Confidence            766322   1122234578999999999986522  23467889999999999999999999876544433

>KOG1025 consensus Epidermal growth factor receptor EGFR and related tyrosine kinases [Signal transduction mechanisms]

Probab=99.97  E-value=1.1e-31  Score=274.43  Aligned_cols=176  Identities=31%  Similarity=0.504  Sum_probs=151.4

Q ss_pred             ccccCccCceEEEEEEE-cC----CCEEEEEEeccCC--CCchhhHHHHHHhhccCccceeEEEEEeec-----------
Q 039231          318 KYKLGQGGYGSVYKGKL-LD----GSNVAVKVLNDSK--GNGKEFINEVASISRTSHVNVVALLGFCLR-----------  379 (506)
Q Consensus       318 ~~~ig~G~~g~V~~~~~-~~----~~~vavK~l~~~~--~~~~~~~~E~~~l~~l~h~niv~l~g~~~~-----------  379 (506)
                      .++||+|+||+||+|.+ .+    +-+||||++....  ...+++.+|+-.|.+++|||+++|+|+|+.           
T Consensus       701 ~kvLGsgAfGtV~kGiw~Pege~vKipVaiKvl~~~t~~~~s~e~LdeAl~masldHpnl~RLLgvc~~s~~qlvtq~mP  780 (1177)
T KOG1025|consen  701 DKVLGSGAFGTVYKGIWIPEGENVKIPVAIKVLIEFTSPKASIELLDEALRMASLDHPNLLRLLGVCMLSTLQLVTQLMP  780 (1177)
T ss_pred             hceeccccceeEEeeeEecCCceecceeEEEEeeccCCchhhHHHHHHHHHHhcCCCchHHHHhhhcccchHHHHHHhcc
Confidence            46799999999999975 33    4578999997543  345899999999999999999999999932           


Q ss_pred             ----------------cchhhhHHHHHHHHHHHHhhcCCCCeEecCcCCCcEEECCCCcEEEeecCCCccccCCCcceec
Q 039231          380 ----------------VAEELSSTIGIARGLEYLHLGCSTRILHFDIKPHNILLDEDFCPKISDFGLAKICNRKESIISM  443 (506)
Q Consensus       380 ----------------~~~~l~i~~~i~~gl~~LH~~~~~~ivH~dlkp~Nill~~~~~~ki~dfg~a~~~~~~~~~~~~  443 (506)
                                      ..+.+.|..|||+||.|||   .+++|||||..+|||+.+...+||.|||+++.+..+......
T Consensus       781 ~G~LlDyvr~hr~~igsq~lLnw~~QIAkgM~YLe---~qrlVHrdLaaRNVLVksP~hvkitdfgla~ll~~d~~ey~~  857 (1177)
T KOG1025|consen  781 LGCLLDYVREHRDNIGSQDLLNWCYQIAKGMKYLE---EQRLVHRDLAARNVLVKSPNHVKITDFGLAKLLAPDEKEYSA  857 (1177)
T ss_pred             cchHHHHHHHhhccccHHHHHHHHHHHHHHHHHHH---hcchhhhhhhhhheeecCCCeEEEEecchhhccCcccccccc
Confidence                            2336779999999999999   999999999999999999999999999999999887766665


Q ss_pred             ccCCCCcccccccccccccCCCCccccHHHHHHHHHHHHc-CCCCCCCCCCCcchh
Q 039231          444 TGARGTVGYIAPEVFCRNIGEVSYKSDVYNYGMMIFEMTG-GRKNVDVVDNGSTAL  498 (506)
Q Consensus       444 ~~~~gt~~y~aPE~l~~~~~~~s~~~Dv~s~G~il~ellt-g~~pf~~~~~~~~~~  498 (506)
                      ....-.+.|||-|.+..  +.++.++|||||||.+||++| |..|++....++..-
T Consensus       858 ~~gK~pikwmale~i~~--~~~thqSDVWsfGVtiWElmTFGa~Py~gi~~~eI~d  911 (1177)
T KOG1025|consen  858 PGGKVPIKWMALESIRI--RKYTHQSDVWSFGVTIWELMTFGAKPYDGIPAEEIPD  911 (1177)
T ss_pred             cccccCcHHHHHHHhhc--cCCCchhhhhhhhhhHHHHHhcCCCccCCCCHHHhhH
Confidence            66667889999999854  489999999999999999998 999999877665543

>KOG0582 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.97  E-value=1.4e-31  Score=258.21  Aligned_cols=176  Identities=25%  Similarity=0.377  Sum_probs=146.7

Q ss_pred             hhhccccCccCceEEEEEEE-cCCCEEEEEEeccCC--CCchhhHHHHHHhhccCccceeEEEEEe--------------
Q 039231          315 NSFKYKLGQGGYGSVYKGKL-LDGSNVAVKVLNDSK--GNGKEFINEVASISRTSHVNVVALLGFC--------------  377 (506)
Q Consensus       315 ~~~~~~ig~G~~g~V~~~~~-~~~~~vavK~l~~~~--~~~~~~~~E~~~l~~l~h~niv~l~g~~--------------  377 (506)
                      +.+.++||.|..++||+|+. ..+..||||+++-++  ...+.+.+|+..|+.++||||+++.-.|              
T Consensus        28 YeL~e~IG~G~sa~V~~A~c~p~~e~VAIK~inLEkc~~~ld~l~kE~~~msl~~HPNIv~~~~sFvv~~~LWvVmpfMa  107 (516)
T KOG0582|consen   28 YELQEVIGVGASAVVYLARCIPTNEVVAIKIINLEKCNNDLDALRKEVQTMSLIDHPNIVTYHCSFVVDSELWVVMPFMA  107 (516)
T ss_pred             eeEEEEEeccceeEeeeeeecccCCEEEEEEeehhhhhhhHHHHHHHHHHhhhcCCCCcceEEEEEEecceeEEeehhhc
Confidence            44567899999999999985 458999999997433  3357899999999999999999998766              


Q ss_pred             ---------------eccchhhhHHHHHHHHHHHHhhcCCCCeEecCcCCCcEEECCCCcEEEeecCCCccccCCCccee
Q 039231          378 ---------------LRVAEELSSTIGIARGLEYLHLGCSTRILHFDIKPHNILLDEDFCPKISDFGLAKICNRKESIIS  442 (506)
Q Consensus       378 ---------------~~~~~~l~i~~~i~~gl~~LH~~~~~~ivH~dlkp~Nill~~~~~~ki~dfg~a~~~~~~~~~~~  442 (506)
                                     +++.....|..++++||.|||   .+|.||||||+.||||+.+|.+||+|||.+..+........
T Consensus       108 ~GS~ldIik~~~~~Gl~E~~Ia~iLre~LkaL~YLH---~~G~IHRdvKAgnILi~~dG~VkLadFgvsa~l~~~G~R~~  184 (516)
T KOG0582|consen  108 GGSLLDIIKTYYPDGLEEASIATILREVLKALDYLH---QNGHIHRDVKAGNILIDSDGTVKLADFGVSASLFDSGDRQV  184 (516)
T ss_pred             CCcHHHHHHHHccccccHHHHHHHHHHHHHHHHHHH---hcCceecccccccEEEcCCCcEEEcCceeeeeecccCceee
Confidence                           223334557889999999999   99999999999999999999999999998766544332211


Q ss_pred             --cccCCCCcccccccccccccCCCCccccHHHHHHHHHHHHcCCCCCCCCCC
Q 039231          443 --MTGARGTVGYIAPEVFCRNIGEVSYKSDVYNYGMMIFEMTGGRKNVDVVDN  493 (506)
Q Consensus       443 --~~~~~gt~~y~aPE~l~~~~~~~s~~~Dv~s~G~il~elltg~~pf~~~~~  493 (506)
                        .....||+.|||||++......|+.|+||||||+...||.+|..||...-+
T Consensus       185 ~rf~tfvgtp~wmAPEvl~q~~~GYdfKaDIwSfGITA~ELA~G~aPf~k~pP  237 (516)
T KOG0582|consen  185 TRFNTFVGTPCWMAPEVLMQQLHGYDFKADIWSFGITACELAHGHAPFSKYPP  237 (516)
T ss_pred             EeeccccCcccccChHHhhhcccCccchhhhhhhhHHHHHHhcCCCCcccCCh
Confidence              255789999999999766666899999999999999999999999987653

>KOG0578 consensus p21-activated serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.97  E-value=8.5e-32  Score=267.50  Aligned_cols=168  Identities=30%  Similarity=0.437  Sum_probs=146.5

Q ss_pred             cccCccCceEEEEEEE-cCCCEEEEEEeccCCCCc-hhhHHHHHHhhccCccceeEEEEEe-------------------
Q 039231          319 YKLGQGGYGSVYKGKL-LDGSNVAVKVLNDSKGNG-KEFINEVASISRTSHVNVVALLGFC-------------------  377 (506)
Q Consensus       319 ~~ig~G~~g~V~~~~~-~~~~~vavK~l~~~~~~~-~~~~~E~~~l~~l~h~niv~l~g~~-------------------  377 (506)
                      ++||+|+.|.||.|+. ..++.||||++....+.. +-+++|+.+|+..+|+|||.++.-+                   
T Consensus       279 ~kigqgaSG~vy~A~~~~~~~~VaiK~m~l~~Q~~keLilnEi~Vm~~~~H~NiVnfl~Sylv~deLWVVMEym~ggsLT  358 (550)
T KOG0578|consen  279 KKIGQGATGGVYVARKISTKQEVAIKRMDLRKQPKKELLLNEILVMRDLHHPNIVNFLDSYLVGDELWVVMEYMEGGSLT  358 (550)
T ss_pred             hhhccccccceeeeeeccCCceEEEEEEEeccCCchhhhHHHHHHHHhccchHHHHHHHHhcccceeEEEEeecCCCchh
Confidence            4699999999999975 568999999998766555 4578999999999999999887543                   


Q ss_pred             -------eccchhhhHHHHHHHHHHHHhhcCCCCeEecCcCCCcEEECCCCcEEEeecCCCccccCCCcceecccCCCCc
Q 039231          378 -------LRVAEELSSTIGIARGLEYLHLGCSTRILHFDIKPHNILLDEDFCPKISDFGLAKICNRKESIISMTGARGTV  450 (506)
Q Consensus       378 -------~~~~~~l~i~~~i~~gl~~LH~~~~~~ivH~dlkp~Nill~~~~~~ki~dfg~a~~~~~~~~~~~~~~~~gt~  450 (506)
                             +++.+...|.++++.||+|||   .++|+|||||.+|||++.++.+||+|||++..+...+..  .....||+
T Consensus       359 DvVt~~~~~E~qIA~Icre~l~aL~fLH---~~gIiHrDIKSDnILL~~~g~vKltDFGFcaqi~~~~~K--R~TmVGTP  433 (550)
T KOG0578|consen  359 DVVTKTRMTEGQIAAICREILQGLKFLH---ARGIIHRDIKSDNILLTMDGSVKLTDFGFCAQISEEQSK--RSTMVGTP  433 (550)
T ss_pred             hhhhcccccHHHHHHHHHHHHHHHHHHH---hcceeeeccccceeEeccCCcEEEeeeeeeeccccccCc--cccccCCC
Confidence                   445567778999999999999   999999999999999999999999999999888766643  36688999


Q ss_pred             ccccccccccccCCCCccccHHHHHHHHHHHHcCCCCCCCCCC
Q 039231          451 GYIAPEVFCRNIGEVSYKSDVYNYGMMIFEMTGGRKNVDVVDN  493 (506)
Q Consensus       451 ~y~aPE~l~~~~~~~s~~~Dv~s~G~il~elltg~~pf~~~~~  493 (506)
                      .|||||+..++  .|+.|+||||||++++||+-|++||-..+.
T Consensus       434 YWMAPEVvtrk--~YG~KVDIWSLGIMaIEMveGEPPYlnE~P  474 (550)
T KOG0578|consen  434 YWMAPEVVTRK--PYGPKVDIWSLGIMAIEMVEGEPPYLNENP  474 (550)
T ss_pred             Cccchhhhhhc--ccCccccchhhhhHHHHHhcCCCCccCCCh
Confidence            99999999765  899999999999999999999999976433

>KOG0198 consensus MEKK and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=99.97  E-value=1.2e-31  Score=258.57  Aligned_cols=170  Identities=35%  Similarity=0.462  Sum_probs=140.8

Q ss_pred             ccccCccCceEEEEEEEcC-CCEEEEEEeccCCC-CchhhHHHHHHhhccCccceeEEEEE--------e----------
Q 039231          318 KYKLGQGGYGSVYKGKLLD-GSNVAVKVLNDSKG-NGKEFINEVASISRTSHVNVVALLGF--------C----------  377 (506)
Q Consensus       318 ~~~ig~G~~g~V~~~~~~~-~~~vavK~l~~~~~-~~~~~~~E~~~l~~l~h~niv~l~g~--------~----------  377 (506)
                      .+.||+|+||+||++...+ |...|||....... ..+.+.+|+++|.+++|||||+.+|.        +          
T Consensus        22 ~~~lG~Gs~G~V~l~~~~~~g~~~AvK~v~~~~~~~~~~l~~Ei~iL~~l~~p~IV~~~G~~~~~~~~~~~i~mEy~~~G  101 (313)
T KOG0198|consen   22 GKLLGRGSFGSVYLATNKKTGELMAVKSVELEDSPTSESLEREIRILSRLNHPNIVQYYGSSSSRENDEYNIFMEYAPGG  101 (313)
T ss_pred             hccccCccceEEEEEEecCCCcceeeeeeecccchhHHHHHHHHHHHHhCCCCCEEeeCCccccccCeeeEeeeeccCCC
Confidence            4579999999999998755 89999999865421 24678999999999999999999994        2          


Q ss_pred             ------------eccchhhhHHHHHHHHHHHHhhcCCCCeEecCcCCCcEEECC-CCcEEEeecCCCccccCCCcc-eec
Q 039231          378 ------------LRVAEELSSTIGIARGLEYLHLGCSTRILHFDIKPHNILLDE-DFCPKISDFGLAKICNRKESI-ISM  443 (506)
Q Consensus       378 ------------~~~~~~l~i~~~i~~gl~~LH~~~~~~ivH~dlkp~Nill~~-~~~~ki~dfg~a~~~~~~~~~-~~~  443 (506)
                                  +++........||++||+|||   +++|+|+||||+|||++. ++.+||+|||+++........ ...
T Consensus       102 sL~~~~~~~g~~l~E~~v~~ytr~iL~GL~ylH---s~g~vH~DiK~~NiLl~~~~~~~KlaDFG~a~~~~~~~~~~~~~  178 (313)
T KOG0198|consen  102 SLSDLIKRYGGKLPEPLVRRYTRQILEGLAYLH---SKGIVHCDIKPANILLDPSNGDVKLADFGLAKKLESKGTKSDSE  178 (313)
T ss_pred             cHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHH---hCCEeccCcccceEEEeCCCCeEEeccCcccccccccccccccc
Confidence                        234446778999999999999   999999999999999999 799999999999877641111 122


Q ss_pred             ccCCCCcccccccccccccCCCCccccHHHHHHHHHHHHcCCCCCCCC
Q 039231          444 TGARGTVGYIAPEVFCRNIGEVSYKSDVYNYGMMIFEMTGGRKNVDVV  491 (506)
Q Consensus       444 ~~~~gt~~y~aPE~l~~~~~~~s~~~Dv~s~G~il~elltg~~pf~~~  491 (506)
                      ....||+.|||||++.. ......++||||+||++.||+||+.||...
T Consensus       179 ~~~~Gtp~~maPEvi~~-g~~~~~~sDiWSlGCtVvEM~Tg~~PW~~~  225 (313)
T KOG0198|consen  179 LSVQGTPNYMAPEVIRN-GEVARRESDIWSLGCTVVEMLTGKPPWSEF  225 (313)
T ss_pred             ccccCCccccCchhhcC-CCcCCccchhhhcCCEEEeccCCCCcchhh
Confidence            45789999999999964 223446999999999999999999999874

>cd05631 STKc_GRK4 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4

Probab=99.97  E-value=1e-30  Score=256.00  Aligned_cols=169  Identities=31%  Similarity=0.451  Sum_probs=140.6

Q ss_pred             ccccCccCceEEEEEEE-cCCCEEEEEEeccCC----CCchhhHHHHHHhhccCccceeEEEEEe---------------
Q 039231          318 KYKLGQGGYGSVYKGKL-LDGSNVAVKVLNDSK----GNGKEFINEVASISRTSHVNVVALLGFC---------------  377 (506)
Q Consensus       318 ~~~ig~G~~g~V~~~~~-~~~~~vavK~l~~~~----~~~~~~~~E~~~l~~l~h~niv~l~g~~---------------  377 (506)
                      .+.||+|+||.||+|.. .+++.||+|++....    .....+.+|++++.+++|+||+++.+.+               
T Consensus         5 ~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~iv~~~~~~~~~~~~~lv~e~~~~   84 (285)
T cd05631           5 YRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKRILEKVNSRFVVSLAYAYETKDALCLVLTIMNG   84 (285)
T ss_pred             EEEEecCCCEEEEEEEEecCCceEEEEEeeHhhhhhhhhHHHHHHHHHHHHhcCCCcEEEEEEEEccCCeEEEEEEecCC
Confidence            46799999999999986 468999999986432    2224578899999999999999998765               


Q ss_pred             --------------eccchhhhHHHHHHHHHHHHhhcCCCCeEecCcCCCcEEECCCCcEEEeecCCCccccCCCcceec
Q 039231          378 --------------LRVAEELSSTIGIARGLEYLHLGCSTRILHFDIKPHNILLDEDFCPKISDFGLAKICNRKESIISM  443 (506)
Q Consensus       378 --------------~~~~~~l~i~~~i~~gl~~LH~~~~~~ivH~dlkp~Nill~~~~~~ki~dfg~a~~~~~~~~~~~~  443 (506)
                                    +++...+.++.|++.||+|||   +++|+||||||+|||+++++.+||+|||++........   .
T Consensus        85 g~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH---~~~iiH~dikp~Nill~~~~~~kl~Dfg~~~~~~~~~~---~  158 (285)
T cd05631          85 GDLKFHIYNMGNPGFDEQRAIFYAAELCCGLEDLQ---RERIVYRDLKPENILLDDRGHIRISDLGLAVQIPEGET---V  158 (285)
T ss_pred             CcHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHH---hCCEEeCCCCHHHEEECCCCCEEEeeCCCcEEcCCCCe---e
Confidence                          122335668899999999999   89999999999999999999999999999987543322   2


Q ss_pred             ccCCCCcccccccccccccCCCCccccHHHHHHHHHHHHcCCCCCCCCCCC
Q 039231          444 TGARGTVGYIAPEVFCRNIGEVSYKSDVYNYGMMIFEMTGGRKNVDVVDNG  494 (506)
Q Consensus       444 ~~~~gt~~y~aPE~l~~~~~~~s~~~Dv~s~G~il~elltg~~pf~~~~~~  494 (506)
                      ....|+..|+|||.+.+.  .++.++|||||||++|||++|+.||...+..
T Consensus       159 ~~~~g~~~y~aPE~~~~~--~~~~~~DvwslGvil~el~~g~~pf~~~~~~  207 (285)
T cd05631         159 RGRVGTVGYMAPEVINNE--KYTFSPDWWGLGCLIYEMIQGQSPFRKRKER  207 (285)
T ss_pred             cCCCCCCCccCHhhhcCC--CCCcccCchhHHHHHHHHHhCCCCCCCCCcc
Confidence            345689999999999654  7899999999999999999999999876543

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found i

>cd05102 PTKc_VEGFR3 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3

Probab=99.97  E-value=7.1e-31  Score=263.59  Aligned_cols=176  Identities=30%  Similarity=0.504  Sum_probs=140.6

Q ss_pred             HhhhccccCccCceEEEEEEE------cCCCEEEEEEeccCCC--CchhhHHHHHHhhcc-CccceeEEEEEeecc----
Q 039231          314 TNSFKYKLGQGGYGSVYKGKL------LDGSNVAVKVLNDSKG--NGKEFINEVASISRT-SHVNVVALLGFCLRV----  380 (506)
Q Consensus       314 ~~~~~~~ig~G~~g~V~~~~~------~~~~~vavK~l~~~~~--~~~~~~~E~~~l~~l-~h~niv~l~g~~~~~----  380 (506)
                      .+.+.++||+|+||.||+|..      .+++.||||+++....  ..+.+.+|++++.++ +||||+++++++...    
T Consensus         8 ~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~~   87 (338)
T cd05102           8 RLRLGKVLGHGAFGKVVEASAFGIDKKSSCNTVAVKMLKEGATASEHKALMSELKILIHIGNHLNVVNLLGACTKPNGPL   87 (338)
T ss_pred             HceeeeEeccCCcceEEEEEEeccCCcccchhhheeccccccchHHHHHHHHHHHHHHHhccCcceeeEEeEecCCCCce
Confidence            345567899999999999974      2256899999975432  235688999999999 899999999876221    


Q ss_pred             --------------------------------------------------------------------------------
Q 039231          381 --------------------------------------------------------------------------------  380 (506)
Q Consensus       381 --------------------------------------------------------------------------------  380 (506)
                                                                                                      
T Consensus        88 ~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  167 (338)
T cd05102          88 MVIVEFCKYGNLSNFLRAKREFFSPYREKSPKQRGRFRAMVEQSRVDRRIEAGQASVLFSRFQPSTSGSTNPPQETDDLW  167 (338)
T ss_pred             EEEEecCCCCcHHHHHHhcchhcccccccchhhhhhhhhhhhhhccccccccccCCccccccccccCcccccchhccccc
Confidence                                                                                            


Q ss_pred             ------chhhhHHHHHHHHHHHHhhcCCCCeEecCcCCCcEEECCCCcEEEeecCCCccccCCCcceecccCCCCccccc
Q 039231          381 ------AEELSSTIGIARGLEYLHLGCSTRILHFDIKPHNILLDEDFCPKISDFGLAKICNRKESIISMTGARGTVGYIA  454 (506)
Q Consensus       381 ------~~~l~i~~~i~~gl~~LH~~~~~~ivH~dlkp~Nill~~~~~~ki~dfg~a~~~~~~~~~~~~~~~~gt~~y~a  454 (506)
                            .+.+.++.||++||+|||   +++|+||||||+|||+++++.+||+|||+++...............+++.|+|
T Consensus       168 ~~~l~~~~~~~~~~qi~~aL~~LH---~~~ivHrDiKp~Nil~~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~~~y~a  244 (338)
T cd05102         168 KSPLTMEDLICYSFQVARGMEFLA---SRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGSARLPLKWMA  244 (338)
T ss_pred             cCCCCHHHHHHHHHHHHHHHHHHH---HCCEECCCCccceEEEcCCCcEEEeecccccccccCcchhcccCCCCCccccC
Confidence                  112457789999999999   89999999999999999999999999999986544332222233456788999


Q ss_pred             ccccccccCCCCccccHHHHHHHHHHHHc-CCCCCCCCCCC
Q 039231          455 PEVFCRNIGEVSYKSDVYNYGMMIFEMTG-GRKNVDVVDNG  494 (506)
Q Consensus       455 PE~l~~~~~~~s~~~Dv~s~G~il~ellt-g~~pf~~~~~~  494 (506)
                      ||++.+.  .++.++||||||+++|||++ |+.||......
T Consensus       245 PE~~~~~--~~~~~sDiwslG~il~el~~~g~~pf~~~~~~  283 (338)
T cd05102         245 PESIFDK--VYTTQSDVWSFGVLLWEIFSLGASPYPGVQIN  283 (338)
T ss_pred             cHHhhcC--CCCcccCHHHHHHHHHHHHhCCCCCCCCCCcc
Confidence            9998654  78999999999999999997 99999876543

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. V

>KOG0580 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=99.97  E-value=6.9e-32  Score=240.95  Aligned_cols=187  Identities=26%  Similarity=0.369  Sum_probs=156.9

Q ss_pred             CccCHHHHHHHHhhhccccCccCceEEEEEEEcC-CCEEEEEEeccCC----CCchhhHHHHHHhhccCccceeEEEEEe
Q 039231          303 KRYGYADIKKMTNSFKYKLGQGGYGSVYKGKLLD-GSNVAVKVLNDSK----GNGKEFINEVASISRTSHVNVVALLGFC  377 (506)
Q Consensus       303 ~~~~~~el~~~~~~~~~~ig~G~~g~V~~~~~~~-~~~vavK~l~~~~----~~~~~~~~E~~~l~~l~h~niv~l~g~~  377 (506)
                      +.++++++     ++.+.||+|-||.||.|+.+. +..||+|++.+++    .-.+++.+|+++-+.++||||+++++++
T Consensus        17 ~~~~l~df-----eigr~LgkgkFG~vYlarekks~~IvalKVlfKsqi~~~~v~~qlrREiEIqs~L~hpnilrlY~~f   91 (281)
T KOG0580|consen   17 KTWTLDDF-----EIGRPLGKGKFGNVYLAREKKSLFIVALKVLFKSQILKTQVEHQLRREIEIQSHLRHPNILRLYGYF   91 (281)
T ss_pred             cccchhhc-----cccccccCCccccEeEeeeccCCcEEEEeeeeHHHHHHhcchhhhhheeEeecccCCccHHhhhhhe
Confidence            44555543     345789999999999998754 7789999997643    2337899999999999999999999998


Q ss_pred             ec-----------------------------cchhhhHHHHHHHHHHHHhhcCCCCeEecCcCCCcEEECCCCcEEEeec
Q 039231          378 LR-----------------------------VAEELSSTIGIARGLEYLHLGCSTRILHFDIKPHNILLDEDFCPKISDF  428 (506)
Q Consensus       378 ~~-----------------------------~~~~l~i~~~i~~gl~~LH~~~~~~ivH~dlkp~Nill~~~~~~ki~df  428 (506)
                      .+                             +.....++.|+|.||.|+|   .++++||||||+|+|++.++.+||+||
T Consensus        92 hd~~riyLilEya~~gel~k~L~~~~~~~f~e~~~a~Yi~q~A~Al~y~h---~k~VIhRdiKpenlLlg~~~~lkiAdf  168 (281)
T KOG0580|consen   92 HDSKRIYLILEYAPRGELYKDLQEGRMKRFDEQRAATYIKQLANALLYCH---LKRVIHRDIKPENLLLGSAGELKIADF  168 (281)
T ss_pred             eccceeEEEEEecCCchHHHHHHhcccccccccchhHHHHHHHHHHHHhc---cCCcccCCCCHHHhccCCCCCeeccCC
Confidence            32                             3335668899999999999   999999999999999999999999999


Q ss_pred             CCCccccCCCcceecccCCCCcccccccccccccCCCCccccHHHHHHHHHHHHcCCCCCCCCCCCcchhhhhhh
Q 039231          429 GLAKICNRKESIISMTGARGTVGYIAPEVFCRNIGEVSYKSDVYNYGMMIFEMTGGRKNVDVVDNGSTALDLQAS  503 (506)
Q Consensus       429 g~a~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~s~~~Dv~s~G~il~elltg~~pf~~~~~~~~~~~~~~~  503 (506)
                      |.+...+...    .....||..|.|||...+.  .++..+|+|++|++.||++.|.+||+....++...+|.+.
T Consensus       169 GwsV~~p~~k----R~tlcgt~dyl~pEmv~~~--~hd~~Vd~w~lgvl~yeflvg~ppFes~~~~etYkrI~k~  237 (281)
T KOG0580|consen  169 GWSVHAPSNK----RKTLCGTLDYLPPEMVEGR--GHDKFVDLWSLGVLCYEFLVGLPPFESQSHSETYKRIRKV  237 (281)
T ss_pred             CceeecCCCC----ceeeecccccCCHhhcCCC--CccchhhHHHHHHHHHHHHhcCCchhhhhhHHHHHHHHHc
Confidence            9998765333    2567899999999998654  7899999999999999999999999998877776666654

>cd07869 STKc_PFTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase

Probab=99.97  E-value=1.2e-30  Score=257.81  Aligned_cols=172  Identities=30%  Similarity=0.412  Sum_probs=141.5

Q ss_pred             hhccccCccCceEEEEEEEc-CCCEEEEEEeccCCC--CchhhHHHHHHhhccCccceeEEEEEee--------------
Q 039231          316 SFKYKLGQGGYGSVYKGKLL-DGSNVAVKVLNDSKG--NGKEFINEVASISRTSHVNVVALLGFCL--------------  378 (506)
Q Consensus       316 ~~~~~ig~G~~g~V~~~~~~-~~~~vavK~l~~~~~--~~~~~~~E~~~l~~l~h~niv~l~g~~~--------------  378 (506)
                      .+.++||+|+||.||+|+.. +++.+|||+++....  ....+.+|++++++++||||+++++++.              
T Consensus         8 ~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~   87 (303)
T cd07869           8 EKLEKLGEGSYATVYKGKSKVNGKLVALKVIRLQEEEGTPFTAIREASLLKGLKHANIVLLHDIIHTKETLTLVFEYVHT   87 (303)
T ss_pred             eEeeeEEecCCEEEEEEEECCCCCEEEEEEeccccccccchhHHHHHHHHhhCCCCCcCeEEEEEecCCeEEEEEECCCc
Confidence            34567999999999999976 588999999975432  2356789999999999999999998761              


Q ss_pred             -------------ccchhhhHHHHHHHHHHHHhhcCCCCeEecCcCCCcEEECCCCcEEEeecCCCccccCCCcceeccc
Q 039231          379 -------------RVAEELSSTIGIARGLEYLHLGCSTRILHFDIKPHNILLDEDFCPKISDFGLAKICNRKESIISMTG  445 (506)
Q Consensus       379 -------------~~~~~l~i~~~i~~gl~~LH~~~~~~ivH~dlkp~Nill~~~~~~ki~dfg~a~~~~~~~~~~~~~~  445 (506)
                                   ...+...++.|++.||+|||   +++|+||||||+|||+++++.+||+|||+++.......  ....
T Consensus        88 ~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH---~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~--~~~~  162 (303)
T cd07869          88 DLCQYMDKHPGGLHPENVKLFLFQLLRGLSYIH---QRYILHRDLKPQNLLISDTGELKLADFGLARAKSVPSH--TYSN  162 (303)
T ss_pred             CHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHEEECCCCCEEECCCCcceeccCCCc--cCCC
Confidence                         22335668899999999999   89999999999999999999999999999875433221  1234


Q ss_pred             CCCCcccccccccccccCCCCccccHHHHHHHHHHHHcCCCCCCCCCC
Q 039231          446 ARGTVGYIAPEVFCRNIGEVSYKSDVYNYGMMIFEMTGGRKNVDVVDN  493 (506)
Q Consensus       446 ~~gt~~y~aPE~l~~~~~~~s~~~Dv~s~G~il~elltg~~pf~~~~~  493 (506)
                      ..+++.|+|||++.+. ..++.++||||+||++|||++|+.||....+
T Consensus       163 ~~~~~~y~aPE~~~~~-~~~~~~~DiwslG~il~~l~~g~~pf~~~~~  209 (303)
T cd07869         163 EVVTLWYRPPDVLLGS-TEYSTCLDMWGVGCIFVEMIQGVAAFPGMKD  209 (303)
T ss_pred             CcccCCCCChHHHcCC-CCCCcHHHHHHHHHHHHHHHhCCCCCCCCcc
Confidence            5678999999998553 3578899999999999999999999987544

Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 an

>cd07871 STKc_PCTAIRE3 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase

Probab=99.97  E-value=1.2e-30  Score=256.05  Aligned_cols=174  Identities=29%  Similarity=0.417  Sum_probs=142.0

Q ss_pred             hhccccCccCceEEEEEEEc-CCCEEEEEEeccCC--CCchhhHHHHHHhhccCccceeEEEEEee--------------
Q 039231          316 SFKYKLGQGGYGSVYKGKLL-DGSNVAVKVLNDSK--GNGKEFINEVASISRTSHVNVVALLGFCL--------------  378 (506)
Q Consensus       316 ~~~~~ig~G~~g~V~~~~~~-~~~~vavK~l~~~~--~~~~~~~~E~~~l~~l~h~niv~l~g~~~--------------  378 (506)
                      .+.++||+|+||.||+|+.. +++.||+|+++...  .....+.+|++++++++||||+++++++.              
T Consensus         8 ~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~   87 (288)
T cd07871           8 VKLDKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKNLKHANIVTLHDIIHTERCLTLVFEYLDS   87 (288)
T ss_pred             eEeeEEecCCCEEEEEEEECCCCCEEEEEEecccccCCcchhHHHHHHHHHhCCCCCEeeEEEEEcCCCeEEEEEeCCCc
Confidence            34567999999999999875 58899999986532  23356789999999999999999998761              


Q ss_pred             -------------ccchhhhHHHHHHHHHHHHhhcCCCCeEecCcCCCcEEECCCCcEEEeecCCCccccCCCcceeccc
Q 039231          379 -------------RVAEELSSTIGIARGLEYLHLGCSTRILHFDIKPHNILLDEDFCPKISDFGLAKICNRKESIISMTG  445 (506)
Q Consensus       379 -------------~~~~~l~i~~~i~~gl~~LH~~~~~~ivH~dlkp~Nill~~~~~~ki~dfg~a~~~~~~~~~~~~~~  445 (506)
                                   ...+...++.||+.||+|||   +++|+||||||+|||+++++.+||+|||+++.......  ....
T Consensus        88 ~l~~~l~~~~~~~~~~~~~~~~~qi~~aL~~LH---~~~ivH~dlkp~Nil~~~~~~~kl~DfG~~~~~~~~~~--~~~~  162 (288)
T cd07871          88 DLKQYLDNCGNLMSMHNVKIFMFQLLRGLSYCH---KRKILHRDLKPQNLLINEKGELKLADFGLARAKSVPTK--TYSN  162 (288)
T ss_pred             CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCCHHHEEECCCCCEEECcCcceeeccCCCc--cccC
Confidence                         12234668899999999999   89999999999999999999999999999976543221  1234


Q ss_pred             CCCCcccccccccccccCCCCccccHHHHHHHHHHHHcCCCCCCCCCCCc
Q 039231          446 ARGTVGYIAPEVFCRNIGEVSYKSDVYNYGMMIFEMTGGRKNVDVVDNGS  495 (506)
Q Consensus       446 ~~gt~~y~aPE~l~~~~~~~s~~~Dv~s~G~il~elltg~~pf~~~~~~~  495 (506)
                      ..+++.|+|||.+.+. ..++.++||||+|+++|||++|+.||...+..+
T Consensus       163 ~~~~~~y~aPE~~~~~-~~~~~~~DiwslG~~l~~l~~g~~pf~~~~~~~  211 (288)
T cd07871         163 EVVTLWYRPPDVLLGS-TEYSTPIDMWGVGCILYEMATGRPMFPGSTVKE  211 (288)
T ss_pred             ceecccccChHHhcCC-cccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHH
Confidence            5678999999998643 467899999999999999999999998665433

Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filament

>cd05628 STKc_NDR1 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1

Probab=99.97  E-value=7e-31  Score=266.23  Aligned_cols=175  Identities=25%  Similarity=0.308  Sum_probs=141.6

Q ss_pred             hccccCccCceEEEEEEEc-CCCEEEEEEeccCC----CCchhhHHHHHHhhccCccceeEEEEEe--------------
Q 039231          317 FKYKLGQGGYGSVYKGKLL-DGSNVAVKVLNDSK----GNGKEFINEVASISRTSHVNVVALLGFC--------------  377 (506)
Q Consensus       317 ~~~~ig~G~~g~V~~~~~~-~~~~vavK~l~~~~----~~~~~~~~E~~~l~~l~h~niv~l~g~~--------------  377 (506)
                      +.+.||+|+||+||+|+.. +++.+|||++....    .....+.+|++++.+++|+||+++++.+              
T Consensus         5 ~~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~~~~~~iv~~~~~~~~~~~~~lv~E~~~   84 (363)
T cd05628           5 SLKVIGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDILVEADSLWVVKMFYSFQDKLNLYLIMEFLP   84 (363)
T ss_pred             EeEEEEeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHhCCCCCcceEEEEEecCCeEEEEEcCCC
Confidence            3467999999999999875 48999999996532    2335678899999999999999998776              


Q ss_pred             -------------eccchhhhHHHHHHHHHHHHhhcCCCCeEecCcCCCcEEECCCCcEEEeecCCCccccCCCcc----
Q 039231          378 -------------LRVAEELSSTIGIARGLEYLHLGCSTRILHFDIKPHNILLDEDFCPKISDFGLAKICNRKESI----  440 (506)
Q Consensus       378 -------------~~~~~~l~i~~~i~~gl~~LH~~~~~~ivH~dlkp~Nill~~~~~~ki~dfg~a~~~~~~~~~----  440 (506)
                                   +.+.+...++.|++.||+|||   +++|+||||||+|||+++++.+||+|||+++........    
T Consensus        85 gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~lH---~~givHrDlKp~NILi~~~~~vkL~DFGla~~~~~~~~~~~~~  161 (363)
T cd05628          85 GGDMMTLLMKKDTLTEEETQFYIAETVLAIDSIH---QLGFIHRDIKPDNLLLDSKGHVKLSDFGLCTGLKKAHRTEFYR  161 (363)
T ss_pred             CCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH---hCCeEecCCCHHHeEECCCCCEEEeeccCcccccccccccccc
Confidence                         223335668899999999999   899999999999999999999999999998764321100    


Q ss_pred             -----------------------------eecccCCCCcccccccccccccCCCCccccHHHHHHHHHHHHcCCCCCCCC
Q 039231          441 -----------------------------ISMTGARGTVGYIAPEVFCRNIGEVSYKSDVYNYGMMIFEMTGGRKNVDVV  491 (506)
Q Consensus       441 -----------------------------~~~~~~~gt~~y~aPE~l~~~~~~~s~~~Dv~s~G~il~elltg~~pf~~~  491 (506)
                                                   .......||+.|+|||++.+.  .++.++|||||||++|||++|+.||...
T Consensus       162 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~--~~~~~~DvwSlGvil~ell~G~~Pf~~~  239 (363)
T cd05628         162 NLNHSLPSDFTFQNMNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQT--GYNKLCDWWSLGVIMYEMLIGYPPFCSE  239 (363)
T ss_pred             cccccccccccccccccccccchhhhccccccccccCCccccCHHHHcCC--CCCCchhhhhhHHHHHHHHhCCCCCCCC
Confidence                                         001234689999999998654  6889999999999999999999999866


Q ss_pred             CCCcc
Q 039231          492 DNGST  496 (506)
Q Consensus       492 ~~~~~  496 (506)
                      ...+.
T Consensus       240 ~~~~~  244 (363)
T cd05628         240 TPQET  244 (363)
T ss_pred             CHHHH
Confidence            54443

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, mus

>PTZ00263 protein kinase A catalytic subunit; Provisional

Probab=99.97  E-value=4.1e-31  Score=264.26  Aligned_cols=168  Identities=26%  Similarity=0.349  Sum_probs=141.0

Q ss_pred             hhccccCccCceEEEEEEEc-CCCEEEEEEeccCC----CCchhhHHHHHHhhccCccceeEEEEEee------------
Q 039231          316 SFKYKLGQGGYGSVYKGKLL-DGSNVAVKVLNDSK----GNGKEFINEVASISRTSHVNVVALLGFCL------------  378 (506)
Q Consensus       316 ~~~~~ig~G~~g~V~~~~~~-~~~~vavK~l~~~~----~~~~~~~~E~~~l~~l~h~niv~l~g~~~------------  378 (506)
                      .+.+.||+|+||.||+|+.. +++.||+|+++...    ...+.+.+|++++++++||||+++++.+.            
T Consensus        21 ~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~  100 (329)
T PTZ00263         21 EMGETLGTGSFGRVRIAKHKGTGEYYAIKCLKKREILKMKQVQHVAQEKSILMELSHPFIVNMMCSFQDENRVYFLLEFV  100 (329)
T ss_pred             EEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCcEEEEEEcCCEEEEEEcCC
Confidence            44578999999999999985 48899999996432    23367889999999999999999998762            


Q ss_pred             ---------------ccchhhhHHHHHHHHHHHHhhcCCCCeEecCcCCCcEEECCCCcEEEeecCCCccccCCCcceec
Q 039231          379 ---------------RVAEELSSTIGIARGLEYLHLGCSTRILHFDIKPHNILLDEDFCPKISDFGLAKICNRKESIISM  443 (506)
Q Consensus       379 ---------------~~~~~l~i~~~i~~gl~~LH~~~~~~ivH~dlkp~Nill~~~~~~ki~dfg~a~~~~~~~~~~~~  443 (506)
                                     .+.....++.|++.||+|||   +++|+||||||+|||+++++.+||+|||+++......     
T Consensus       101 ~~~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH---~~~ivH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~-----  172 (329)
T PTZ00263        101 VGGELFTHLRKAGRFPNDVAKFYHAELVLAFEYLH---SKDIIYRDLKPENLLLDNKGHVKVTDFGFAKKVPDRT-----  172 (329)
T ss_pred             CCChHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHH---HCCeeecCCCHHHEEECCCCCEEEeeccCceEcCCCc-----
Confidence                           22224557889999999999   8999999999999999999999999999998664332     


Q ss_pred             ccCCCCcccccccccccccCCCCccccHHHHHHHHHHHHcCCCCCCCCCC
Q 039231          444 TGARGTVGYIAPEVFCRNIGEVSYKSDVYNYGMMIFEMTGGRKNVDVVDN  493 (506)
Q Consensus       444 ~~~~gt~~y~aPE~l~~~~~~~s~~~Dv~s~G~il~elltg~~pf~~~~~  493 (506)
                      ....||+.|+|||.+.+.  .++.++|||||||++|||++|+.||...+.
T Consensus       173 ~~~~gt~~y~aPE~~~~~--~~~~~~DiwslG~il~elltg~~pf~~~~~  220 (329)
T PTZ00263        173 FTLCGTPEYLAPEVIQSK--GHGKAVDWWTMGVLLYEFIAGYPPFFDDTP  220 (329)
T ss_pred             ceecCChhhcCHHHHcCC--CCCCcceeechHHHHHHHHcCCCCCCCCCH
Confidence            235689999999998654  678999999999999999999999976543

>KOG0588 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=99.97  E-value=6.6e-31  Score=264.26  Aligned_cols=170  Identities=28%  Similarity=0.380  Sum_probs=147.6

Q ss_pred             ccccCccCceEEEEEEEc-CCCEEEEEEeccC----CCCchhhHHHHHHhhccCccceeEEEEEe---------------
Q 039231          318 KYKLGQGGYGSVYKGKLL-DGSNVAVKVLNDS----KGNGKEFINEVASISRTSHVNVVALLGFC---------------  377 (506)
Q Consensus       318 ~~~ig~G~~g~V~~~~~~-~~~~vavK~l~~~----~~~~~~~~~E~~~l~~l~h~niv~l~g~~---------------  377 (506)
                      .+.||+|+.|.|-.|++. .|+.+|||++.+.    ......+.+|+-+|+-+.|||++++++++               
T Consensus        17 gkTLG~Gstg~vrlakh~~TGqlaaiKii~k~~~~s~s~~~~IerEIviMkLi~HpnVl~LydVwe~~~~lylvlEyv~g   96 (786)
T KOG0588|consen   17 GKTLGKGSTGCVRLAKHAETGQLAAIKIIPKRSELSSSQPAGIEREIVIMKLIEHPNVLRLYDVWENKQHLYLVLEYVPG   96 (786)
T ss_pred             cccccCCCCceehhhhcccccceeEEEeeccccccccccccchhhhhHHHHHhcCCCeeeeeeeeccCceEEEEEEecCC
Confidence            456999999999999874 6999999999654    23335688999999999999999999987               


Q ss_pred             ------------eccchhhhHHHHHHHHHHHHhhcCCCCeEecCcCCCcEEECCCCcEEEeecCCCccccCCCcceeccc
Q 039231          378 ------------LRVAEELSSTIGIARGLEYLHLGCSTRILHFDIKPHNILLDEDFCPKISDFGLAKICNRKESIISMTG  445 (506)
Q Consensus       378 ------------~~~~~~l~i~~~i~~gl~~LH~~~~~~ivH~dlkp~Nill~~~~~~ki~dfg~a~~~~~~~~~~~~~~  445 (506)
                                  +.+.+..+.+.||+.|+.|+|   ..+|+||||||+|+|||..+++||+|||+|.+...+..   +.+
T Consensus        97 GELFdylv~kG~l~e~eaa~ff~QIi~gv~yCH---~~~icHRDLKpENlLLd~~~nIKIADFGMAsLe~~gkl---LeT  170 (786)
T KOG0588|consen   97 GELFDYLVRKGPLPEREAAHFFRQILDGVSYCH---AFNICHRDLKPENLLLDVKNNIKIADFGMASLEVPGKL---LET  170 (786)
T ss_pred             chhHHHHHhhCCCCCHHHHHHHHHHHHHHHHHh---hhcceeccCCchhhhhhcccCEeeeccceeecccCCcc---ccc
Confidence                        455667889999999999999   99999999999999999999999999999987665543   356


Q ss_pred             CCCCcccccccccccccCCCCccccHHHHHHHHHHHHcCCCCCCCCCCC
Q 039231          446 ARGTVGYIAPEVFCRNIGEVSYKSDVYNYGMMIFEMTGGRKNVDVVDNG  494 (506)
Q Consensus       446 ~~gt~~y~aPE~l~~~~~~~s~~~Dv~s~G~il~elltg~~pf~~~~~~  494 (506)
                      -.|++.|+|||++.+. .+.+.++||||.|||||.||||+.||++++-+
T Consensus       171 SCGSPHYA~PEIV~G~-pYdG~~sDVWSCGVILfALLtG~LPFdDdNir  218 (786)
T KOG0588|consen  171 SCGSPHYAAPEIVSGR-PYDGRPSDVWSCGVILFALLTGKLPFDDDNIR  218 (786)
T ss_pred             cCCCcccCCchhhcCC-CCCCCccccchhHHHHHHHHhCCCCCCCccHH
Confidence            7899999999999876 56788999999999999999999999954433

>cd05612 STKc_PRKX_like Catalytic domain of PRKX-like Protein Serine/Threonine Kinases

Probab=99.97  E-value=4.7e-31  Score=259.21  Aligned_cols=168  Identities=29%  Similarity=0.327  Sum_probs=140.3

Q ss_pred             hccccCccCceEEEEEEEc-CCCEEEEEEeccCC----CCchhhHHHHHHhhccCccceeEEEEEe--------------
Q 039231          317 FKYKLGQGGYGSVYKGKLL-DGSNVAVKVLNDSK----GNGKEFINEVASISRTSHVNVVALLGFC--------------  377 (506)
Q Consensus       317 ~~~~ig~G~~g~V~~~~~~-~~~~vavK~l~~~~----~~~~~~~~E~~~l~~l~h~niv~l~g~~--------------  377 (506)
                      +.+.||+|+||.||+|+.. +++.+|+|++....    ...+.+.+|++++++++||||+++++++              
T Consensus         5 ~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~   84 (291)
T cd05612           5 RIKTVGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVSHPFIIRLFWTEHDQRFLYMLMEYVP   84 (291)
T ss_pred             eeeeeecCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhhHHHHHHHHHHHHHHhCCCCcHhhhHhhhccCCeEEEEEeCCC
Confidence            4567999999999999975 58999999986432    2335688999999999999999987654              


Q ss_pred             -------------eccchhhhHHHHHHHHHHHHhhcCCCCeEecCcCCCcEEECCCCcEEEeecCCCccccCCCcceecc
Q 039231          378 -------------LRVAEELSSTIGIARGLEYLHLGCSTRILHFDIKPHNILLDEDFCPKISDFGLAKICNRKESIISMT  444 (506)
Q Consensus       378 -------------~~~~~~l~i~~~i~~gl~~LH~~~~~~ivH~dlkp~Nill~~~~~~ki~dfg~a~~~~~~~~~~~~~  444 (506)
                                   +.+...+.++.|++.||+|||   +++|+||||||+|||+++++.+||+|||+++......     .
T Consensus        85 ~~~L~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dlkp~NIli~~~~~~kl~Dfg~~~~~~~~~-----~  156 (291)
T cd05612          85 GGELFSYLRNSGRFSNSTGLFYASEIVCALEYLH---SKEIVYRDLKPENILLDKEGHIKLTDFGFAKKLRDRT-----W  156 (291)
T ss_pred             CCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHH---HCCeeecCCCHHHeEECCCCCEEEEecCcchhccCCc-----c
Confidence                         123335668899999999999   8999999999999999999999999999998654322     2


Q ss_pred             cCCCCcccccccccccccCCCCccccHHHHHHHHHHHHcCCCCCCCCCCC
Q 039231          445 GARGTVGYIAPEVFCRNIGEVSYKSDVYNYGMMIFEMTGGRKNVDVVDNG  494 (506)
Q Consensus       445 ~~~gt~~y~aPE~l~~~~~~~s~~~Dv~s~G~il~elltg~~pf~~~~~~  494 (506)
                      ...|++.|+|||.+.+.  .++.++||||||+++|||++|+.||...+..
T Consensus       157 ~~~gt~~y~aPE~~~~~--~~~~~~DiwSlG~il~~l~~g~~pf~~~~~~  204 (291)
T cd05612         157 TLCGTPEYLAPEVIQSK--GHNKAVDWWALGILIYEMLVGYPPFFDDNPF  204 (291)
T ss_pred             cccCChhhcCHHHHcCC--CCCchhhHHHHHHHHHHHHhCCCCCCCCCHH
Confidence            35689999999998654  6789999999999999999999999876543

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyt

>KOG0611 consensus Predicted serine/threonine protein kinase [General function prediction only]

Probab=99.97  E-value=3.4e-31  Score=251.93  Aligned_cols=184  Identities=24%  Similarity=0.342  Sum_probs=157.4

Q ss_pred             cCHHHHHHHHhhhccccCccCceEEEEEEE-cCCCEEEEEEeccCC----CCchhhHHHHHHhhccCccceeEEEEEe--
Q 039231          305 YGYADIKKMTNSFKYKLGQGGYGSVYKGKL-LDGSNVAVKVLNDSK----GNGKEFINEVASISRTSHVNVVALLGFC--  377 (506)
Q Consensus       305 ~~~~el~~~~~~~~~~ig~G~~g~V~~~~~-~~~~~vavK~l~~~~----~~~~~~~~E~~~l~~l~h~niv~l~g~~--  377 (506)
                      -+...-.+.++.|.+.||+|.||.|-+|.. ..|+.||||.+++++    ++.-.+.+|+++|+.++||||++++.+|  
T Consensus        45 hhhkhnlkHRyE~~etLGkGTYGKVk~A~e~~sgR~VAiKsIrKdkIkdeqDlvhIRREIeIMSsLNHPhII~IyEVFEN  124 (668)
T KOG0611|consen   45 HHHKHNLKHRYEITETLGKGTYGKVKLAYEHKSGREVAIKSIRKDKIKDEQDLVHIRREIEIMSSLNHPHIIQIYEVFEN  124 (668)
T ss_pred             cCcccchhhHHHHHHHhcCCcccceeehhhccCCcEeehhhhhhhhcccHHHHHHHHHHHHHHhhcCCCceeehhhhhcC
Confidence            334445566777888999999999999985 569999999997643    2334578999999999999999999877  


Q ss_pred             -------------------------eccchhhhHHHHHHHHHHHHhhcCCCCeEecCcCCCcEEECCCCcEEEeecCCCc
Q 039231          378 -------------------------LRVAEELSSTIGIARGLEYLHLGCSTRILHFDIKPHNILLDEDFCPKISDFGLAK  432 (506)
Q Consensus       378 -------------------------~~~~~~l~i~~~i~~gl~~LH~~~~~~ivH~dlkp~Nill~~~~~~ki~dfg~a~  432 (506)
                                               +.+.+...++.||.+|+.|+|   +++++|||||.+|||||.++++||+|||++.
T Consensus       125 kdKIvivMEYaS~GeLYDYiSer~~LsErEaRhfFRQIvSAVhYCH---knrVvHRDLKLENILLD~N~NiKIADFGLSN  201 (668)
T KOG0611|consen  125 KDKIVIVMEYASGGELYDYISERGSLSEREARHFFRQIVSAVHYCH---KNRVVHRDLKLENILLDQNNNIKIADFGLSN  201 (668)
T ss_pred             CceEEEEEEecCCccHHHHHHHhccccHHHHHHHHHHHHHHHHHHh---hccceecccchhheeecCCCCeeeeccchhh
Confidence                                     455567789999999999999   9999999999999999999999999999998


Q ss_pred             cccCCCcceecccCCCCcccccccccccccCCCCccccHHHHHHHHHHHHcCCCCCCCCCCCc
Q 039231          433 ICNRKESIISMTGARGTVGYIAPEVFCRNIGEVSYKSDVYNYGMMIFEMTGGRKNVDVVDNGS  495 (506)
Q Consensus       433 ~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~s~~~Dv~s~G~il~elltg~~pf~~~~~~~  495 (506)
                      ++..+..   +....|++.|.+||+..+. ..-++.+|-||+||+||.|+.|..||+..+...
T Consensus       202 ly~~~kf---LqTFCGSPLYASPEIvNG~-PY~GPEVDsWsLGvLLYtLVyGtMPFDG~Dhk~  260 (668)
T KOG0611|consen  202 LYADKKF---LQTFCGSPLYASPEIVNGT-PYKGPEVDSWSLGVLLYTLVYGTMPFDGRDHKR  260 (668)
T ss_pred             hhccccH---HHHhcCCcccCCccccCCC-CCCCCccchhhHHHHHHHHhhcccccCCchHHH
Confidence            8776553   3668899999999999765 456889999999999999999999999876543

>cd05571 STKc_PKB Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B

Probab=99.97  E-value=6.5e-31  Score=262.17  Aligned_cols=167  Identities=29%  Similarity=0.374  Sum_probs=138.2

Q ss_pred             ccCccCceEEEEEEEc-CCCEEEEEEeccCC----CCchhhHHHHHHhhccCccceeEEEEEe-----------------
Q 039231          320 KLGQGGYGSVYKGKLL-DGSNVAVKVLNDSK----GNGKEFINEVASISRTSHVNVVALLGFC-----------------  377 (506)
Q Consensus       320 ~ig~G~~g~V~~~~~~-~~~~vavK~l~~~~----~~~~~~~~E~~~l~~l~h~niv~l~g~~-----------------  377 (506)
                      .||+|+||.||+++.. +|+.+|+|+++...    .....+.+|++++++++||||+++.+.+                 
T Consensus         2 ~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e~~~~~~   81 (323)
T cd05571           2 LLGKGTFGKVILVREKATGKYYAMKILKKEVIIAKDEVAHTLTESRVLQNTRHPFLTALKYSFQTHDRLCFVMEYANGGE   81 (323)
T ss_pred             eeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCCEEEEEEcCCEEEEEEeCCCCCc
Confidence            5999999999999875 58999999997532    2335678899999999999999998766                 


Q ss_pred             ----------eccchhhhHHHHHHHHHHHHhhcCCCCeEecCcCCCcEEECCCCcEEEeecCCCccccCCCcceecccCC
Q 039231          378 ----------LRVAEELSSTIGIARGLEYLHLGCSTRILHFDIKPHNILLDEDFCPKISDFGLAKICNRKESIISMTGAR  447 (506)
Q Consensus       378 ----------~~~~~~l~i~~~i~~gl~~LH~~~~~~ivH~dlkp~Nill~~~~~~ki~dfg~a~~~~~~~~~~~~~~~~  447 (506)
                                +.+.+...++.||+.||+|||   +.+|+||||||+|||++.++.+||+|||+++.......  ......
T Consensus        82 L~~~l~~~~~~~~~~~~~~~~qi~~~L~~lH---~~~ivHrDlkp~NIll~~~~~~kl~DfG~a~~~~~~~~--~~~~~~  156 (323)
T cd05571          82 LFFHLSRERVFSEDRARFYGAEIVSALGYLH---SCDVVYRDLKLENLMLDKDGHIKITDFGLCKEGISDGA--TMKTFC  156 (323)
T ss_pred             HHHHHHHcCCCCHHHHHHHHHHHHHHHHHHH---hCCeEeCCCCHHHEEECCCCCEEEeeCCCCcccccCCC--ccccee
Confidence                      223335568899999999999   89999999999999999999999999999875432221  123456


Q ss_pred             CCcccccccccccccCCCCccccHHHHHHHHHHHHcCCCCCCCCCC
Q 039231          448 GTVGYIAPEVFCRNIGEVSYKSDVYNYGMMIFEMTGGRKNVDVVDN  493 (506)
Q Consensus       448 gt~~y~aPE~l~~~~~~~s~~~Dv~s~G~il~elltg~~pf~~~~~  493 (506)
                      ||+.|+|||.+.+.  .++.++|||||||++|||++|+.||...+.
T Consensus       157 gt~~y~aPE~~~~~--~~~~~~DiwSlG~il~elltg~~Pf~~~~~  200 (323)
T cd05571         157 GTPEYLAPEVLEDN--DYGRAVDWWGLGVVMYEMMCGRLPFYNQDH  200 (323)
T ss_pred             cCccccChhhhcCC--CCCccccCcccchhhhhhhcCCCCCCCCCH
Confidence            89999999998654  688999999999999999999999976543

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having be

>cd05585 STKc_YPK1_like Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases

Probab=99.97  E-value=1.3e-30  Score=258.83  Aligned_cols=166  Identities=23%  Similarity=0.329  Sum_probs=138.2

Q ss_pred             cCccCceEEEEEEEc-CCCEEEEEEeccC----CCCchhhHHHHHHhhccCccceeEEEEEe------------------
Q 039231          321 LGQGGYGSVYKGKLL-DGSNVAVKVLNDS----KGNGKEFINEVASISRTSHVNVVALLGFC------------------  377 (506)
Q Consensus       321 ig~G~~g~V~~~~~~-~~~~vavK~l~~~----~~~~~~~~~E~~~l~~l~h~niv~l~g~~------------------  377 (506)
                      ||+|+||.||+|+.. +++.||+|+++..    ......+.+|++++.+++||||+++++++                  
T Consensus         1 lg~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L   80 (312)
T cd05585           1 IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQVNCPFIVPLKFSFQSPEKLYLVLAFINGGEL   80 (312)
T ss_pred             CCcCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCcEeceeeEEecCCeEEEEEcCCCCCcH
Confidence            699999999999875 4789999998642    23335678899999999999999998776                  


Q ss_pred             ---------eccchhhhHHHHHHHHHHHHhhcCCCCeEecCcCCCcEEECCCCcEEEeecCCCccccCCCcceecccCCC
Q 039231          378 ---------LRVAEELSSTIGIARGLEYLHLGCSTRILHFDIKPHNILLDEDFCPKISDFGLAKICNRKESIISMTGARG  448 (506)
Q Consensus       378 ---------~~~~~~l~i~~~i~~gl~~LH~~~~~~ivH~dlkp~Nill~~~~~~ki~dfg~a~~~~~~~~~~~~~~~~g  448 (506)
                               +++.+...++.|++.||+|||   +++|+||||||+|||++.++.+||+|||+++........  .....|
T Consensus        81 ~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH---~~~i~HrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~~--~~~~~g  155 (312)
T cd05585          81 FHHLQREGRFDLSRARFYTAELLCALENLH---KFNVIYRDLKPENILLDYQGHIALCDFGLCKLNMKDDDK--TNTFCG  155 (312)
T ss_pred             HHHHHhcCCCCHHHHHHHHHHHHHHHHHHH---hCCeEeCCCCHHHeEECCCCcEEEEECcccccCccCCCc--cccccC
Confidence                     223335668899999999999   899999999999999999999999999999864332221  234568


Q ss_pred             CcccccccccccccCCCCccccHHHHHHHHHHHHcCCCCCCCCCC
Q 039231          449 TVGYIAPEVFCRNIGEVSYKSDVYNYGMMIFEMTGGRKNVDVVDN  493 (506)
Q Consensus       449 t~~y~aPE~l~~~~~~~s~~~Dv~s~G~il~elltg~~pf~~~~~  493 (506)
                      |+.|+|||.+.+.  .++.++|||||||++|||++|+.||...+.
T Consensus       156 t~~y~aPE~~~~~--~~~~~~DvwslGvil~el~tg~~pf~~~~~  198 (312)
T cd05585         156 TPEYLAPELLLGH--GYTKAVDWWTLGVLLYEMLTGLPPFYDENV  198 (312)
T ss_pred             CcccCCHHHHcCC--CCCCccceechhHHHHHHHhCCCCcCCCCH
Confidence            9999999998654  689999999999999999999999976543

Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It pl

>cd05595 STKc_PKB_beta Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta

Probab=99.97  E-value=1.7e-30  Score=259.13  Aligned_cols=168  Identities=31%  Similarity=0.392  Sum_probs=139.2

Q ss_pred             ccCccCceEEEEEEEc-CCCEEEEEEeccC----CCCchhhHHHHHHhhccCccceeEEEEEe-----------------
Q 039231          320 KLGQGGYGSVYKGKLL-DGSNVAVKVLNDS----KGNGKEFINEVASISRTSHVNVVALLGFC-----------------  377 (506)
Q Consensus       320 ~ig~G~~g~V~~~~~~-~~~~vavK~l~~~----~~~~~~~~~E~~~l~~l~h~niv~l~g~~-----------------  377 (506)
                      .||+|+||.||+++.. +|+.||+|+++..    ......+.+|++++++++||||+++++.+                 
T Consensus         2 ~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~i~~~~~~~~~~~~~~lv~E~~~~~~   81 (323)
T cd05595           2 LLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVMEYANGGE   81 (323)
T ss_pred             eeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCcceeeEEecCCEEEEEEeCCCCCc
Confidence            5999999999999875 5899999999753    22335677899999999999999998766                 


Q ss_pred             ----------eccchhhhHHHHHHHHHHHHhhcCCCCeEecCcCCCcEEECCCCcEEEeecCCCccccCCCcceecccCC
Q 039231          378 ----------LRVAEELSSTIGIARGLEYLHLGCSTRILHFDIKPHNILLDEDFCPKISDFGLAKICNRKESIISMTGAR  447 (506)
Q Consensus       378 ----------~~~~~~l~i~~~i~~gl~~LH~~~~~~ivH~dlkp~Nill~~~~~~ki~dfg~a~~~~~~~~~~~~~~~~  447 (506)
                                +.+...+.++.||+.||+|||   +++|+||||||+|||+++++.+||+|||+++.......  ......
T Consensus        82 L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH---~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~~--~~~~~~  156 (323)
T cd05595          82 LFFHLSRERVFTEERARFYGAEIVSALEYLH---SRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGA--TMKTFC  156 (323)
T ss_pred             HHHHHHHcCCCCHHHHHHHHHHHHHHHHHHH---HCCeEecCCCHHHEEEcCCCCEEecccHHhccccCCCC--cccccc
Confidence                      223345678899999999999   89999999999999999999999999999875432221  123456


Q ss_pred             CCcccccccccccccCCCCccccHHHHHHHHHHHHcCCCCCCCCCCC
Q 039231          448 GTVGYIAPEVFCRNIGEVSYKSDVYNYGMMIFEMTGGRKNVDVVDNG  494 (506)
Q Consensus       448 gt~~y~aPE~l~~~~~~~s~~~Dv~s~G~il~elltg~~pf~~~~~~  494 (506)
                      ||+.|+|||++.+.  .++.++||||||+++|||++|+.||...+..
T Consensus       157 gt~~y~aPE~~~~~--~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~  201 (323)
T cd05595         157 GTPEYLAPEVLEDN--DYGRAVDWWGLGVVMYEMMCGRLPFYNQDHE  201 (323)
T ss_pred             CCcCcCCcccccCC--CCCchhchhhhHHHHHHHHhCCCCCCCCCHH
Confidence            89999999998553  7889999999999999999999999766543

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in

>cd07859 STKc_TDY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants

Probab=99.97  E-value=1.6e-30  Score=260.77  Aligned_cols=174  Identities=26%  Similarity=0.391  Sum_probs=141.4

Q ss_pred             hhccccCccCceEEEEEEEc-CCCEEEEEEeccCC---CCchhhHHHHHHhhccCccceeEEEEEee-------------
Q 039231          316 SFKYKLGQGGYGSVYKGKLL-DGSNVAVKVLNDSK---GNGKEFINEVASISRTSHVNVVALLGFCL-------------  378 (506)
Q Consensus       316 ~~~~~ig~G~~g~V~~~~~~-~~~~vavK~l~~~~---~~~~~~~~E~~~l~~l~h~niv~l~g~~~-------------  378 (506)
                      .+.++||+|+||.||+|+.. ++..||||+++...   ....++.+|++++++++||||+++++++.             
T Consensus         3 ~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~~lv   82 (338)
T cd07859           3 KIQEVIGKGSYGVVCSAIDTHTGEKVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKDIYVV   82 (338)
T ss_pred             EEEEEEeecCCeEEEEEEECCCCCEEEEEEechhhccchhHHHHHHHHHHHHhCCCCCEeeecceEeccCCCCCceEEEE
Confidence            34578999999999999875 58999999987432   23356889999999999999999987642             


Q ss_pred             ------------------ccchhhhHHHHHHHHHHHHhhcCCCCeEecCcCCCcEEECCCCcEEEeecCCCccccCCCc-
Q 039231          379 ------------------RVAEELSSTIGIARGLEYLHLGCSTRILHFDIKPHNILLDEDFCPKISDFGLAKICNRKES-  439 (506)
Q Consensus       379 ------------------~~~~~l~i~~~i~~gl~~LH~~~~~~ivH~dlkp~Nill~~~~~~ki~dfg~a~~~~~~~~-  439 (506)
                                        .+.....++.||++||+|||   +++|+||||||+|||+++++.+||+|||+++....... 
T Consensus        83 ~e~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH---~~~ivH~dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~~~  159 (338)
T cd07859          83 FELMESDLHQVIKANDDLTPEHHQFFLYQLLRALKYIH---TANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPT  159 (338)
T ss_pred             EecCCCCHHHHHHhcccCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHeEECCCCcEEEccCccccccccccCc
Confidence                              22335668899999999999   89999999999999999999999999999986433221 


Q ss_pred             ceecccCCCCcccccccccccccCCCCccccHHHHHHHHHHHHcCCCCCCCCC
Q 039231          440 IISMTGARGTVGYIAPEVFCRNIGEVSYKSDVYNYGMMIFEMTGGRKNVDVVD  492 (506)
Q Consensus       440 ~~~~~~~~gt~~y~aPE~l~~~~~~~s~~~Dv~s~G~il~elltg~~pf~~~~  492 (506)
                      ........+|+.|+|||++.+....++.++||||||+++|||++|+.||...+
T Consensus       160 ~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~DvwSlGvvl~el~tg~~pf~~~~  212 (338)
T cd07859         160 AIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKN  212 (338)
T ss_pred             cccccCCCCCCCcCCHHHHhccccccCchhHHHHHHHHHHHHHcCCCCCCCCC
Confidence            11123456899999999985533478899999999999999999999997654

Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phos

>PTZ00426 cAMP-dependent protein kinase catalytic subunit; Provisional

Probab=99.97  E-value=8.2e-31  Score=262.99  Aligned_cols=169  Identities=28%  Similarity=0.365  Sum_probs=141.1

Q ss_pred             hhhccccCccCceEEEEEEEcC--CCEEEEEEeccC----CCCchhhHHHHHHhhccCccceeEEEEEee----------
Q 039231          315 NSFKYKLGQGGYGSVYKGKLLD--GSNVAVKVLNDS----KGNGKEFINEVASISRTSHVNVVALLGFCL----------  378 (506)
Q Consensus       315 ~~~~~~ig~G~~g~V~~~~~~~--~~~vavK~l~~~----~~~~~~~~~E~~~l~~l~h~niv~l~g~~~----------  378 (506)
                      +.+.+.||+|+||.||+|+..+  +..||+|++...    ....+.+.+|++++..++||||+++++++.          
T Consensus        32 y~~~~~ig~G~~g~Vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lv~E  111 (340)
T PTZ00426         32 FNFIRTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQVDHVFSERKILNYINHPFCVNLYGSFKDESYLYLVLE  111 (340)
T ss_pred             cEEEEEEeecCCeEEEEEEEECCCCeEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCCcceEEEEEeCCEEEEEEe
Confidence            4456789999999999998644  368999998643    223457889999999999999999998762          


Q ss_pred             -----------------ccchhhhHHHHHHHHHHHHhhcCCCCeEecCcCCCcEEECCCCcEEEeecCCCccccCCCcce
Q 039231          379 -----------------RVAEELSSTIGIARGLEYLHLGCSTRILHFDIKPHNILLDEDFCPKISDFGLAKICNRKESII  441 (506)
Q Consensus       379 -----------------~~~~~l~i~~~i~~gl~~LH~~~~~~ivH~dlkp~Nill~~~~~~ki~dfg~a~~~~~~~~~~  441 (506)
                                       ++.....++.|++.||+|||   +++|+||||||+|||++.++.+||+|||+++......   
T Consensus       112 y~~~g~L~~~i~~~~~~~~~~~~~~~~qi~~aL~~LH---~~~ivHrDLkp~NILl~~~~~ikL~DFG~a~~~~~~~---  185 (340)
T PTZ00426        112 FVIGGEFFTFLRRNKRFPNDVGCFYAAQIVLIFEYLQ---SLNIVYRDLKPENLLLDKDGFIKMTDFGFAKVVDTRT---  185 (340)
T ss_pred             CCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHH---HCCeEccCCCHHHEEECCCCCEEEecCCCCeecCCCc---
Confidence                             22335668899999999999   8999999999999999999999999999998654322   


Q ss_pred             ecccCCCCcccccccccccccCCCCccccHHHHHHHHHHHHcCCCCCCCCCC
Q 039231          442 SMTGARGTVGYIAPEVFCRNIGEVSYKSDVYNYGMMIFEMTGGRKNVDVVDN  493 (506)
Q Consensus       442 ~~~~~~gt~~y~aPE~l~~~~~~~s~~~Dv~s~G~il~elltg~~pf~~~~~  493 (506)
                        ....||+.|+|||++.+.  .++.++|||||||++|||++|+.||...+.
T Consensus       186 --~~~~gt~~y~aPE~~~~~--~~~~~~DiwSlGvil~ell~G~~Pf~~~~~  233 (340)
T PTZ00426        186 --YTLCGTPEYIAPEILLNV--GHGKAADWWTLGIFIYEILVGCPPFYANEP  233 (340)
T ss_pred             --ceecCChhhcCHHHHhCC--CCCccccccchhhHHHHHhcCCCCCCCCCH
Confidence              345689999999998654  678999999999999999999999986544

>cd05626 STKc_LATS2 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2

Probab=99.97  E-value=1.1e-30  Score=266.36  Aligned_cols=177  Identities=26%  Similarity=0.292  Sum_probs=140.9

Q ss_pred             ccccCccCceEEEEEEEc-CCCEEEEEEeccCC----CCchhhHHHHHHhhccCccceeEEEEEee--------------
Q 039231          318 KYKLGQGGYGSVYKGKLL-DGSNVAVKVLNDSK----GNGKEFINEVASISRTSHVNVVALLGFCL--------------  378 (506)
Q Consensus       318 ~~~ig~G~~g~V~~~~~~-~~~~vavK~l~~~~----~~~~~~~~E~~~l~~l~h~niv~l~g~~~--------------  378 (506)
                      .++||+|+||+||+|+.. +++.+|||++....    ...+.+.+|++++.+++||||+++++.+.              
T Consensus         6 ~~~LG~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~~~~~lv~E~~~g   85 (381)
T cd05626           6 IKTLGIGAFGEVCLACKVDTHALYAMKTLRKKDVLNRNQVAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVMDYIPG   85 (381)
T ss_pred             EEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhcCCCCeeeeEEEEecCCEEEEEEecCCC
Confidence            467999999999999874 48899999996532    22356889999999999999999998762              


Q ss_pred             -------------ccchhhhHHHHHHHHHHHHhhcCCCCeEecCcCCCcEEECCCCcEEEeecCCCccccCCCcc-----
Q 039231          379 -------------RVAEELSSTIGIARGLEYLHLGCSTRILHFDIKPHNILLDEDFCPKISDFGLAKICNRKESI-----  440 (506)
Q Consensus       379 -------------~~~~~l~i~~~i~~gl~~LH~~~~~~ivH~dlkp~Nill~~~~~~ki~dfg~a~~~~~~~~~-----  440 (506)
                                   .+.....++.||+.||+|||   +.+|+||||||+|||++.++.+||+|||+++........     
T Consensus        86 g~L~~~l~~~~~~~e~~~~~~~~qi~~aL~~LH---~~givHrDlKp~Nili~~~~~~kL~DFGl~~~~~~~~~~~~~~~  162 (381)
T cd05626          86 GDMMSLLIRMEVFPEVLARFYIAELTLAIESVH---KMGFIHRDIKPDNILIDLDGHIKLTDFGLCTGFRWTHNSKYYQK  162 (381)
T ss_pred             CcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH---hCCeeecCCcHHHEEECCCCCEEEeeCcCCcccccccccccccc
Confidence                         12224557889999999999   899999999999999999999999999997643210000     


Q ss_pred             ----------------------------------------eecccCCCCcccccccccccccCCCCccccHHHHHHHHHH
Q 039231          441 ----------------------------------------ISMTGARGTVGYIAPEVFCRNIGEVSYKSDVYNYGMMIFE  480 (506)
Q Consensus       441 ----------------------------------------~~~~~~~gt~~y~aPE~l~~~~~~~s~~~Dv~s~G~il~e  480 (506)
                                                              .......||+.|+|||++.+.  .++.++|||||||++||
T Consensus       163 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~--~~~~~~DiwSlG~il~e  240 (381)
T cd05626         163 GSHIRQDSMEPSDLWDDVSNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLRK--GYTQLCDWWSVGVILFE  240 (381)
T ss_pred             cccccccccCcccccccccccccccccchhhccccccccccccccccCCccccCHHHHcCC--CCCCccceeehhhHHHH
Confidence                                                    000134689999999998654  68899999999999999


Q ss_pred             HHcCCCCCCCCCCCcchhh
Q 039231          481 MTGGRKNVDVVDNGSTALD  499 (506)
Q Consensus       481 lltg~~pf~~~~~~~~~~~  499 (506)
                      |++|+.||...+..+....
T Consensus       241 lltG~~Pf~~~~~~~~~~~  259 (381)
T cd05626         241 MLVGQPPFLAPTPTETQLK  259 (381)
T ss_pred             HHhCCCCCcCCCHHHHHHH
Confidence            9999999987665544433

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with po

>cd07862 STKc_CDK6 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6

Probab=99.97  E-value=3.2e-30  Score=252.93  Aligned_cols=173  Identities=31%  Similarity=0.463  Sum_probs=139.3

Q ss_pred             hhccccCccCceEEEEEEEc--CCCEEEEEEeccCCC---CchhhHHHHHHhhcc---CccceeEEEEEee---------
Q 039231          316 SFKYKLGQGGYGSVYKGKLL--DGSNVAVKVLNDSKG---NGKEFINEVASISRT---SHVNVVALLGFCL---------  378 (506)
Q Consensus       316 ~~~~~ig~G~~g~V~~~~~~--~~~~vavK~l~~~~~---~~~~~~~E~~~l~~l---~h~niv~l~g~~~---------  378 (506)
                      .+.++||+|+||.||+|+..  +++.||+|+++....   ....+.+|+++++++   +||||+++++++.         
T Consensus         4 ~~~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~hpniv~~~~~~~~~~~~~~~~   83 (290)
T cd07862           4 ECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTDRETK   83 (290)
T ss_pred             ceeeEeccCCCeEEEEEEEcCCCCeEEEEEEEecccCCCCchHHHHHHHHHHHhhcccCCCCcceEEEEEecccCCCCCc
Confidence            34567999999999999873  468899999864322   224566777777665   6999999998752         


Q ss_pred             ------------------------ccchhhhHHHHHHHHHHHHhhcCCCCeEecCcCCCcEEECCCCcEEEeecCCCccc
Q 039231          379 ------------------------RVAEELSSTIGIARGLEYLHLGCSTRILHFDIKPHNILLDEDFCPKISDFGLAKIC  434 (506)
Q Consensus       379 ------------------------~~~~~l~i~~~i~~gl~~LH~~~~~~ivH~dlkp~Nill~~~~~~ki~dfg~a~~~  434 (506)
                                              ++.+.+.++.|++.||+|||   +++|+||||||+|||+++++.+||+|||+++..
T Consensus        84 ~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH---~~~iiH~dlkp~Nil~~~~~~~kl~Dfg~~~~~  160 (290)
T cd07862          84 LTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLH---SHRVVHRDLKPQNILVTSSGQIKLADFGLARIY  160 (290)
T ss_pred             EEEEEccCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHH---HCCeeeCCCCHHHEEEcCCCCEEEccccceEec
Confidence                                    12235678999999999999   899999999999999999999999999999865


Q ss_pred             cCCCcceecccCCCCcccccccccccccCCCCccccHHHHHHHHHHHHcCCCCCCCCCCCcc
Q 039231          435 NRKESIISMTGARGTVGYIAPEVFCRNIGEVSYKSDVYNYGMMIFEMTGGRKNVDVVDNGST  496 (506)
Q Consensus       435 ~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~s~~~Dv~s~G~il~elltg~~pf~~~~~~~~  496 (506)
                      ....   ......+++.|+|||.+.+.  .++.++||||||+++|||++|+.||....+.+.
T Consensus       161 ~~~~---~~~~~~~~~~y~aPE~~~~~--~~~~~~DiwslG~il~el~~g~~~f~~~~~~~~  217 (290)
T cd07862         161 SFQM---ALTSVVVTLWYRAPEVLLQS--SYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQ  217 (290)
T ss_pred             cCCc---ccccccccccccChHHHhCC--CCCCccchHHHHHHHHHHHcCCCCcCCCCHHHH
Confidence            4332   12345689999999998553  688899999999999999999999987665443

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytopla

>cd05621 STKc_ROCK2 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2

Probab=99.97  E-value=1.1e-30  Score=265.04  Aligned_cols=175  Identities=25%  Similarity=0.299  Sum_probs=142.4

Q ss_pred             hhccccCccCceEEEEEEEc-CCCEEEEEEeccC----CCCchhhHHHHHHhhccCccceeEEEEEee------------
Q 039231          316 SFKYKLGQGGYGSVYKGKLL-DGSNVAVKVLNDS----KGNGKEFINEVASISRTSHVNVVALLGFCL------------  378 (506)
Q Consensus       316 ~~~~~ig~G~~g~V~~~~~~-~~~~vavK~l~~~----~~~~~~~~~E~~~l~~l~h~niv~l~g~~~------------  378 (506)
                      .+.+.||+|+||.||+++.. +++.+|+|++.+.    ....+.+.+|+.+++.++||||+++++.+.            
T Consensus        46 ~~~~~lG~G~fg~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~~~~~~lv~Ey~  125 (370)
T cd05621          46 DVVKVIGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFCAFQDDKYLYMVMEYM  125 (370)
T ss_pred             eEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEEcCC
Confidence            34567999999999999975 4789999998642    223355788999999999999999998762            


Q ss_pred             --------------ccchhhhHHHHHHHHHHHHhhcCCCCeEecCcCCCcEEECCCCcEEEeecCCCccccCCCcceecc
Q 039231          379 --------------RVAEELSSTIGIARGLEYLHLGCSTRILHFDIKPHNILLDEDFCPKISDFGLAKICNRKESIISMT  444 (506)
Q Consensus       379 --------------~~~~~l~i~~~i~~gl~~LH~~~~~~ivH~dlkp~Nill~~~~~~ki~dfg~a~~~~~~~~~~~~~  444 (506)
                                    +......++.||+.||+|||   +++|+||||||+|||+++++.+||+|||+++........ ...
T Consensus       126 ~gg~L~~~l~~~~~~~~~~~~~~~qil~aL~~LH---~~~IvHrDLKp~NILl~~~~~~kL~DFG~a~~~~~~~~~-~~~  201 (370)
T cd05621         126 PGGDLVNLMSNYDVPEKWAKFYTAEVVLALDAIH---SMGLIHRDVKPDNMLLDKHGHLKLADFGTCMKMDETGMV-RCD  201 (370)
T ss_pred             CCCcHHHHHHhcCCCHHHHHHHHHHHHHHHHHHH---HCCeEecCCCHHHEEECCCCCEEEEecccceecccCCce-ecc
Confidence                          22335668899999999999   899999999999999999999999999999876433221 123


Q ss_pred             cCCCCccccccccccccc--CCCCccccHHHHHHHHHHHHcCCCCCCCCCCC
Q 039231          445 GARGTVGYIAPEVFCRNI--GEVSYKSDVYNYGMMIFEMTGGRKNVDVVDNG  494 (506)
Q Consensus       445 ~~~gt~~y~aPE~l~~~~--~~~s~~~Dv~s~G~il~elltg~~pf~~~~~~  494 (506)
                      ...||+.|+|||++.+..  +.++.++||||+||++|||++|+.||...+..
T Consensus       202 ~~~gt~~Y~aPE~~~~~~~~~~~~~~~DiwSlG~ilyell~G~~Pf~~~~~~  253 (370)
T cd05621         202 TAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVGDTPFYADSLV  253 (370)
T ss_pred             cCCCCcccCCHHHHhccCCCCCCCcccCEEeehHHHHHHHhCCCCCCCCCHH
Confidence            567999999999986532  24788999999999999999999999866543

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found

>cd05593 STKc_PKB_gamma Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma

Probab=99.97  E-value=1.9e-30  Score=259.33  Aligned_cols=167  Identities=30%  Similarity=0.397  Sum_probs=139.1

Q ss_pred             ccCccCceEEEEEEEc-CCCEEEEEEeccC----CCCchhhHHHHHHhhccCccceeEEEEEe-----------------
Q 039231          320 KLGQGGYGSVYKGKLL-DGSNVAVKVLNDS----KGNGKEFINEVASISRTSHVNVVALLGFC-----------------  377 (506)
Q Consensus       320 ~ig~G~~g~V~~~~~~-~~~~vavK~l~~~----~~~~~~~~~E~~~l~~l~h~niv~l~g~~-----------------  377 (506)
                      .||+|+||.||+++.. +++.+|+|++...    ......+.+|++++++++||||+++.+.+                 
T Consensus         2 ~lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~Ey~~~g~   81 (328)
T cd05593           2 LLGKGTFGKVILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTSLKYSFQTKDRLCFVMEYVNGGE   81 (328)
T ss_pred             eeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCEEEEEEeCCCCCC
Confidence            5899999999999875 5899999999753    22335678899999999999999998766                 


Q ss_pred             ----------eccchhhhHHHHHHHHHHHHhhcCCCCeEecCcCCCcEEECCCCcEEEeecCCCccccCCCcceecccCC
Q 039231          378 ----------LRVAEELSSTIGIARGLEYLHLGCSTRILHFDIKPHNILLDEDFCPKISDFGLAKICNRKESIISMTGAR  447 (506)
Q Consensus       378 ----------~~~~~~l~i~~~i~~gl~~LH~~~~~~ivH~dlkp~Nill~~~~~~ki~dfg~a~~~~~~~~~~~~~~~~  447 (506)
                                +.+.+...++.||+.||+|||   +++|+||||||+|||+++++.+||+|||+++.......  ......
T Consensus        82 L~~~l~~~~~l~~~~~~~~~~qi~~aL~~LH---~~~ivHrDikp~NIll~~~~~~kL~DfG~~~~~~~~~~--~~~~~~  156 (328)
T cd05593          82 LFFHLSRERVFSEDRTRFYGAEIVSALDYLH---SGKIVYRDLKLENLMLDKDGHIKITDFGLCKEGITDAA--TMKTFC  156 (328)
T ss_pred             HHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH---hCCeEecccCHHHeEECCCCcEEEecCcCCccCCCccc--cccccc
Confidence                      223345678899999999999   89999999999999999999999999999875432221  123456


Q ss_pred             CCcccccccccccccCCCCccccHHHHHHHHHHHHcCCCCCCCCCC
Q 039231          448 GTVGYIAPEVFCRNIGEVSYKSDVYNYGMMIFEMTGGRKNVDVVDN  493 (506)
Q Consensus       448 gt~~y~aPE~l~~~~~~~s~~~Dv~s~G~il~elltg~~pf~~~~~  493 (506)
                      ||+.|+|||.+.+.  .++.++|||||||++|||++|+.||...+.
T Consensus       157 gt~~y~aPE~~~~~--~~~~~~DiwslGvil~elltG~~Pf~~~~~  200 (328)
T cd05593         157 GTPEYLAPEVLEDN--DYGRAVDWWGLGVVMYEMMCGRLPFYNQDH  200 (328)
T ss_pred             CCcCccChhhhcCC--CCCccCCccccchHHHHHhhCCCCCCCCCH
Confidence            89999999998654  678999999999999999999999976544

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulate

>cd07868 STKc_CDK8 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8

Probab=99.97  E-value=5.1e-30  Score=254.93  Aligned_cols=170  Identities=28%  Similarity=0.384  Sum_probs=137.6

Q ss_pred             cccCccCceEEEEEEEc---CCCEEEEEEeccCCCCchhhHHHHHHhhccCccceeEEEEEeec----------------
Q 039231          319 YKLGQGGYGSVYKGKLL---DGSNVAVKVLNDSKGNGKEFINEVASISRTSHVNVVALLGFCLR----------------  379 (506)
Q Consensus       319 ~~ig~G~~g~V~~~~~~---~~~~vavK~l~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~----------------  379 (506)
                      .+||+|+||.||+|+..   +++.+|+|.+.... ....+.+|++++++++||||+++++++..                
T Consensus         7 ~~lG~G~~g~Vy~~~~~~~~~~~~~aiK~~~~~~-~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~~~~~   85 (317)
T cd07868           7 CKVGRGTYGHVYKAKRKDGKDDRDYALKQIEGTG-ISMSACREIALLRELKHPNVISLQKVFLSHADRKVWLLFDYAEHD   85 (317)
T ss_pred             cccccCCCeEEEEEEEccCCCCceEEEEEECCCC-CcHHHHHHHHHHHhcCCCCCcceeeeEecCCCcEEEEEEeccCCC
Confidence            57999999999999864   46789999986543 23567899999999999999999876521                


Q ss_pred             ---------------------cchhhhHHHHHHHHHHHHhhcCCCCeEecCcCCCcEEE----CCCCcEEEeecCCCccc
Q 039231          380 ---------------------VAEELSSTIGIARGLEYLHLGCSTRILHFDIKPHNILL----DEDFCPKISDFGLAKIC  434 (506)
Q Consensus       380 ---------------------~~~~l~i~~~i~~gl~~LH~~~~~~ivH~dlkp~Nill----~~~~~~ki~dfg~a~~~  434 (506)
                                           ......++.||+.||+|||   +++|+||||||+|||+    +.++.+||+|||+++..
T Consensus        86 l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH---~~~ivHrDlkp~Nil~~~~~~~~~~~kl~DfG~a~~~  162 (317)
T cd07868          86 LWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLH---ANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLF  162 (317)
T ss_pred             HHHHHHhcccccccCCcccCCHHHHHHHHHHHHHHHHHHH---hCCEEcCCCCHHHEEEecCCCCcCcEEEeecCceecc
Confidence                                 1113568899999999999   8999999999999999    45678999999999876


Q ss_pred             cCCCcc-eecccCCCCcccccccccccccCCCCccccHHHHHHHHHHHHcCCCCCCCCCC
Q 039231          435 NRKESI-ISMTGARGTVGYIAPEVFCRNIGEVSYKSDVYNYGMMIFEMTGGRKNVDVVDN  493 (506)
Q Consensus       435 ~~~~~~-~~~~~~~gt~~y~aPE~l~~~~~~~s~~~Dv~s~G~il~elltg~~pf~~~~~  493 (506)
                      ...... .......+|+.|+|||++.+. ..++.++||||+||++|||++|+.||....+
T Consensus       163 ~~~~~~~~~~~~~~~t~~y~aPE~~~~~-~~~~~~~DiwslG~il~el~~g~~~f~~~~~  221 (317)
T cd07868         163 NSPLKPLADLDPVVVTFWYRAPELLLGA-RHYTKAIDIWAIGCIFAELLTSEPIFHCRQE  221 (317)
T ss_pred             CCCCccccccCCccccccccCCHHHcCC-CCcCchhhHHHHHHHHHHHHhCCCCccCCcc
Confidence            543211 112346789999999998653 3578899999999999999999999976543

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA p

>cd05584 STKc_p70S6K Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase

Probab=99.97  E-value=2.8e-30  Score=257.61  Aligned_cols=169  Identities=28%  Similarity=0.396  Sum_probs=137.7

Q ss_pred             cccCccCceEEEEEEE----cCCCEEEEEEeccCC-----CCchhhHHHHHHhhccCccceeEEEEEeec----------
Q 039231          319 YKLGQGGYGSVYKGKL----LDGSNVAVKVLNDSK-----GNGKEFINEVASISRTSHVNVVALLGFCLR----------  379 (506)
Q Consensus       319 ~~ig~G~~g~V~~~~~----~~~~~vavK~l~~~~-----~~~~~~~~E~~~l~~l~h~niv~l~g~~~~----------  379 (506)
                      +.||+|+||.||+++.    .+++.+|+|+++...     .....+.+|++++++++||||+++++++..          
T Consensus         2 ~~lg~G~~g~V~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~e~   81 (323)
T cd05584           2 KVLGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHPFIVDLIYAFQTGGKLYLILEY   81 (323)
T ss_pred             ceeeecCCeEEEEEEEcccCCCCCEEEEEEEEHHHHHhhhhhHHHHHHHHHHHHhCCCCchhceeeEEecCCeEEEEEeC
Confidence            4699999999999985    347899999996431     223467789999999999999999877621          


Q ss_pred             -----------------cchhhhHHHHHHHHHHHHhhcCCCCeEecCcCCCcEEECCCCcEEEeecCCCccccCCCccee
Q 039231          380 -----------------VAEELSSTIGIARGLEYLHLGCSTRILHFDIKPHNILLDEDFCPKISDFGLAKICNRKESIIS  442 (506)
Q Consensus       380 -----------------~~~~l~i~~~i~~gl~~LH~~~~~~ivH~dlkp~Nill~~~~~~ki~dfg~a~~~~~~~~~~~  442 (506)
                                       +.....++.|++.||+|||   +++|+||||||+|||+++++.+||+|||+++........  
T Consensus        82 ~~~~~L~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH---~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~--  156 (323)
T cd05584          82 LSGGELFMHLEREGIFMEDTACFYLSEISLALEHLH---QQGIIYRDLKPENILLDAQGHVKLTDFGLCKESIHEGTV--  156 (323)
T ss_pred             CCCchHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHeEECCCCCEEEeeCcCCeecccCCCc--
Confidence                             2224557889999999999   899999999999999999999999999998754322211  


Q ss_pred             cccCCCCcccccccccccccCCCCccccHHHHHHHHHHHHcCCCCCCCCCCC
Q 039231          443 MTGARGTVGYIAPEVFCRNIGEVSYKSDVYNYGMMIFEMTGGRKNVDVVDNG  494 (506)
Q Consensus       443 ~~~~~gt~~y~aPE~l~~~~~~~s~~~Dv~s~G~il~elltg~~pf~~~~~~  494 (506)
                      .....|++.|+|||++.+.  .++.++||||||+++|||++|+.||...+..
T Consensus       157 ~~~~~gt~~y~aPE~~~~~--~~~~~~DiwslG~il~ell~G~~pf~~~~~~  206 (323)
T cd05584         157 THTFCGTIEYMAPEILMRS--GHGKAVDWWSLGALMYDMLTGAPPFTAENRK  206 (323)
T ss_pred             ccccCCCccccChhhccCC--CCCCcceecccHHHHHHHhcCCCCCCCCCHH
Confidence            1335689999999998654  6788999999999999999999999876543

Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the in

>cd05599 STKc_NDR_like Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

Probab=99.97  E-value=1.5e-30  Score=264.05  Aligned_cols=172  Identities=26%  Similarity=0.306  Sum_probs=140.3

Q ss_pred             ccccCccCceEEEEEEEc-CCCEEEEEEeccC----CCCchhhHHHHHHhhccCccceeEEEEEe---------------
Q 039231          318 KYKLGQGGYGSVYKGKLL-DGSNVAVKVLNDS----KGNGKEFINEVASISRTSHVNVVALLGFC---------------  377 (506)
Q Consensus       318 ~~~ig~G~~g~V~~~~~~-~~~~vavK~l~~~----~~~~~~~~~E~~~l~~l~h~niv~l~g~~---------------  377 (506)
                      .+.||+|+||.||+|+.. +++.||||++...    ......+.+|++++..++||||+++++.+               
T Consensus         6 ~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~E~~~~   85 (364)
T cd05599           6 IKVIGRGAFGEVRLVQKKDTGHIYAMKKLRKSEMLEKEQVAHVRAERDILAEADNPWVVKLYYSFQDENYLYLIMEYLPG   85 (364)
T ss_pred             EEEEEecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCeEEEEECCCCC
Confidence            467999999999999975 5899999999753    22335678899999999999999999876               


Q ss_pred             ------------eccchhhhHHHHHHHHHHHHhhcCCCCeEecCcCCCcEEECCCCcEEEeecCCCccccCCCcce----
Q 039231          378 ------------LRVAEELSSTIGIARGLEYLHLGCSTRILHFDIKPHNILLDEDFCPKISDFGLAKICNRKESII----  441 (506)
Q Consensus       378 ------------~~~~~~l~i~~~i~~gl~~LH~~~~~~ivH~dlkp~Nill~~~~~~ki~dfg~a~~~~~~~~~~----  441 (506)
                                  +.+.+...++.|++.||+|||   +++|+||||||+|||++.++.+||+|||+++.........    
T Consensus        86 g~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~lH---~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~  162 (364)
T cd05599          86 GDMMTLLMKKDTFTEEETRFYIAETILAIDSIH---KLGYIHRDIKPDNLLLDAKGHIKLSDFGLCTGLKKSHRTEFYRI  162 (364)
T ss_pred             cHHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHH---HCCeEeccCCHHHeEECCCCCEEEeecccceecccccccccccc
Confidence                        223345678899999999999   8999999999999999999999999999987543211100    


Q ss_pred             --------------------------------ecccCCCCcccccccccccccCCCCccccHHHHHHHHHHHHcCCCCCC
Q 039231          442 --------------------------------SMTGARGTVGYIAPEVFCRNIGEVSYKSDVYNYGMMIFEMTGGRKNVD  489 (506)
Q Consensus       442 --------------------------------~~~~~~gt~~y~aPE~l~~~~~~~s~~~Dv~s~G~il~elltg~~pf~  489 (506)
                                                      ......||+.|+|||++.+.  .++.++|||||||++|||++|+.||.
T Consensus       163 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~~DiwSlG~il~el~~G~~Pf~  240 (364)
T cd05599         163 LSHALPSNFLDFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQT--GYNKECDWWSLGVIMYEMLVGYPPFC  240 (364)
T ss_pred             ccccccccccccccccccccccccchhhcccccccccccCccccCHHHHcCC--CCCCeeeeecchhHHHHhhcCCCCCC
Confidence                                            00124589999999998654  68899999999999999999999998


Q ss_pred             CCCCC
Q 039231          490 VVDNG  494 (506)
Q Consensus       490 ~~~~~  494 (506)
                      ..+..
T Consensus       241 ~~~~~  245 (364)
T cd05599         241 SDNPQ  245 (364)
T ss_pred             CCCHH
Confidence            66543

Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplica

>PLN00034 mitogen-activated protein kinase kinase; Provisional

Probab=99.97  E-value=1e-29  Score=256.74  Aligned_cols=170  Identities=28%  Similarity=0.412  Sum_probs=138.8

Q ss_pred             ccccCccCceEEEEEEEc-CCCEEEEEEeccCCC--CchhhHHHHHHhhccCccceeEEEEEee----------------
Q 039231          318 KYKLGQGGYGSVYKGKLL-DGSNVAVKVLNDSKG--NGKEFINEVASISRTSHVNVVALLGFCL----------------  378 (506)
Q Consensus       318 ~~~ig~G~~g~V~~~~~~-~~~~vavK~l~~~~~--~~~~~~~E~~~l~~l~h~niv~l~g~~~----------------  378 (506)
                      .++||+|+||.||+|+.. +++.||||++.....  ..+.+.+|++++++++|+||+++++++.                
T Consensus        79 ~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~  158 (353)
T PLN00034         79 VNRIGSGAGGTVYKVIHRPTGRLYALKVIYGNHEDTVRRQICREIEILRDVNHPNVVKCHDMFDHNGEIQVLLEFMDGGS  158 (353)
T ss_pred             hhhccCCCCeEEEEEEECCCCCEEEEEEEecCCcHHHHHHHHHHHHHHHhCCCCCcceeeeEeccCCeEEEEEecCCCCc
Confidence            357999999999999875 589999999965432  2367889999999999999999998762                


Q ss_pred             -------ccchhhhHHHHHHHHHHHHhhcCCCCeEecCcCCCcEEECCCCcEEEeecCCCccccCCCcceecccCCCCcc
Q 039231          379 -------RVAEELSSTIGIARGLEYLHLGCSTRILHFDIKPHNILLDEDFCPKISDFGLAKICNRKESIISMTGARGTVG  451 (506)
Q Consensus       379 -------~~~~~l~i~~~i~~gl~~LH~~~~~~ivH~dlkp~Nill~~~~~~ki~dfg~a~~~~~~~~~~~~~~~~gt~~  451 (506)
                             .+.....++.||+.||+|||   +++|+||||||+|||+++++.+||+|||+++.......  ......||..
T Consensus       159 L~~~~~~~~~~~~~i~~qi~~aL~~LH---~~~ivHrDlkp~NIll~~~~~~kL~DfG~~~~~~~~~~--~~~~~~gt~~  233 (353)
T PLN00034        159 LEGTHIADEQFLADVARQILSGIAYLH---RRHIVHRDIKPSNLLINSAKNVKIADFGVSRILAQTMD--PCNSSVGTIA  233 (353)
T ss_pred             ccccccCCHHHHHHHHHHHHHHHHHHH---HCCEeecCCCHHHEEEcCCCCEEEcccccceecccccc--cccccccCcc
Confidence                   12224578999999999999   89999999999999999999999999999987643321  1234578999


Q ss_pred             cccccccccc---cCCCCccccHHHHHHHHHHHHcCCCCCCCCC
Q 039231          452 YIAPEVFCRN---IGEVSYKSDVYNYGMMIFEMTGGRKNVDVVD  492 (506)
Q Consensus       452 y~aPE~l~~~---~~~~s~~~Dv~s~G~il~elltg~~pf~~~~  492 (506)
                      |+|||.+...   ....+.++|||||||++|||++|+.||....
T Consensus       234 y~aPE~~~~~~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~  277 (353)
T PLN00034        234 YMSPERINTDLNHGAYDGYAGDIWSLGVSILEFYLGRFPFGVGR  277 (353)
T ss_pred             ccCccccccccccCcCCCcchhHHHHHHHHHHHHhCCCCCCCCC
Confidence            9999987432   1234568999999999999999999998443

>PHA02988 hypothetical protein; Provisional

Probab=99.97  E-value=3.8e-30  Score=251.71  Aligned_cols=181  Identities=21%  Similarity=0.327  Sum_probs=146.3

Q ss_pred             CccCHHHHHHHHhhhccccCccCceEEEEEEEcCCCEEEEEEeccCCCCc----hhhHHHHHHhhccCccceeEEEEEee
Q 039231          303 KRYGYADIKKMTNSFKYKLGQGGYGSVYKGKLLDGSNVAVKVLNDSKGNG----KEFINEVASISRTSHVNVVALLGFCL  378 (506)
Q Consensus       303 ~~~~~~el~~~~~~~~~~ig~G~~g~V~~~~~~~~~~vavK~l~~~~~~~----~~~~~E~~~l~~l~h~niv~l~g~~~  378 (506)
                      +.++.++++...   ...|++|+++.||+|.+ +|+.||||+++......    +.+.+|+++|.+++|||||+++|++.
T Consensus        13 ~~i~~~~i~~~~---~~~i~~g~~~~v~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~g~~~   88 (283)
T PHA02988         13 KCIESDDIDKYT---SVLIKENDQNSIYKGIF-NNKEVIIRTFKKFHKGHKVLIDITENEIKNLRRIDSNNILKIYGFII   88 (283)
T ss_pred             eecCHHHcCCCC---CeEEeeCCceEEEEEEE-CCEEEEEEeccccccccHHHHHHHHHHHHHHHhcCCCCEEEEeeeEE
Confidence            445555553221   13599999999999998 78999999997654333    56679999999999999999998764


Q ss_pred             c-------------------------------cchhhhHHHHHHHHHHHHhhcCC-CCeEecCcCCCcEEECCCCcEEEe
Q 039231          379 R-------------------------------VAEELSSTIGIARGLEYLHLGCS-TRILHFDIKPHNILLDEDFCPKIS  426 (506)
Q Consensus       379 ~-------------------------------~~~~l~i~~~i~~gl~~LH~~~~-~~ivH~dlkp~Nill~~~~~~ki~  426 (506)
                      +                               +...+.++.|++.||+|||   + .+++||||||+||++++++.+||+
T Consensus        89 ~~~~~~~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~i~~~i~~~l~~lH---~~~~~~Hrdlkp~nill~~~~~~kl~  165 (283)
T PHA02988         89 DIVDDLPRLSLILEYCTRGYLREVLDKEKDLSFKTKLDMAIDCCKGLYNLY---KYTNKPYKNLTSVSFLVTENYKLKII  165 (283)
T ss_pred             ecccCCCceEEEEEeCCCCcHHHHHhhCCCCChhHHHHHHHHHHHHHHHHH---hcCCCCCCcCChhhEEECCCCcEEEc
Confidence            3                               1224678899999999999   5 588999999999999999999999


Q ss_pred             ecCCCccccCCCcceecccCCCCcccccccccccccCCCCccccHHHHHHHHHHHHcCCCCCCCCCCCc
Q 039231          427 DFGLAKICNRKESIISMTGARGTVGYIAPEVFCRNIGEVSYKSDVYNYGMMIFEMTGGRKNVDVVDNGS  495 (506)
Q Consensus       427 dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~s~~~Dv~s~G~il~elltg~~pf~~~~~~~  495 (506)
                      |||+++......     ....++..|+|||.+.+....++.++|||||||++|||++|+.||+..+..+
T Consensus       166 dfg~~~~~~~~~-----~~~~~~~~y~aPE~~~~~~~~~~~k~Di~SlGvil~el~~g~~Pf~~~~~~~  229 (283)
T PHA02988        166 CHGLEKILSSPP-----FKNVNFMVYFSYKMLNDIFSEYTIKDDIYSLGVVLWEIFTGKIPFENLTTKE  229 (283)
T ss_pred             ccchHhhhcccc-----ccccCcccccCHHHhhhccccccchhhhhHHHHHHHHHHHCCCCCCCCCHHH
Confidence            999998654322     2346789999999986533578999999999999999999999998765443

>cd05108 PTKc_EGFR Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor

Probab=99.97  E-value=4.5e-30  Score=255.34  Aligned_cols=172  Identities=31%  Similarity=0.540  Sum_probs=139.8

Q ss_pred             hhccccCccCceEEEEEEEcC-CC----EEEEEEeccCC--CCchhhHHHHHHhhccCccceeEEEEEeec---------
Q 039231          316 SFKYKLGQGGYGSVYKGKLLD-GS----NVAVKVLNDSK--GNGKEFINEVASISRTSHVNVVALLGFCLR---------  379 (506)
Q Consensus       316 ~~~~~ig~G~~g~V~~~~~~~-~~----~vavK~l~~~~--~~~~~~~~E~~~l~~l~h~niv~l~g~~~~---------  379 (506)
                      ...+.||+|+||.||+|++.. +.    .||+|+++...  ...+++.+|+.+++.++||||++++|++..         
T Consensus        10 ~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~g~~~~~~~~~v~e~   89 (316)
T cd05108          10 KKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTSTVQLITQL   89 (316)
T ss_pred             eeeeeeecCCCceEEEEEEecCCCccceeEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEcCCCceeeeec
Confidence            334679999999999998643 33    48999987532  233678899999999999999999998721         


Q ss_pred             ------------------cchhhhHHHHHHHHHHHHhhcCCCCeEecCcCCCcEEECCCCcEEEeecCCCccccCCCcce
Q 039231          380 ------------------VAEELSSTIGIARGLEYLHLGCSTRILHFDIKPHNILLDEDFCPKISDFGLAKICNRKESII  441 (506)
Q Consensus       380 ------------------~~~~l~i~~~i~~gl~~LH~~~~~~ivH~dlkp~Nill~~~~~~ki~dfg~a~~~~~~~~~~  441 (506)
                                        +...+.++.||+.||+|||   +++|+||||||+|||+++++.+||+|||+++.........
T Consensus        90 ~~~g~l~~~l~~~~~~~~~~~~~~~~~qi~~~L~~LH---~~~iiH~dlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~~  166 (316)
T cd05108          90 MPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLE---ERRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGADEKEY  166 (316)
T ss_pred             CCCCCHHHHHHhccccCCHHHHHHHHHHHHHHHHHHH---hcCeeccccchhheEecCCCcEEEccccccccccCCCcce
Confidence                              2235678899999999999   8999999999999999999999999999998776544332


Q ss_pred             ecccCCCCcccccccccccccCCCCccccHHHHHHHHHHHHc-CCCCCCCCC
Q 039231          442 SMTGARGTVGYIAPEVFCRNIGEVSYKSDVYNYGMMIFEMTG-GRKNVDVVD  492 (506)
Q Consensus       442 ~~~~~~gt~~y~aPE~l~~~~~~~s~~~Dv~s~G~il~ellt-g~~pf~~~~  492 (506)
                      .......+..|+|||.+.+.  .++.++||||||+++|||++ |+.||+...
T Consensus       167 ~~~~~~~~~~y~apE~~~~~--~~~~~~Di~slGv~l~el~t~g~~p~~~~~  216 (316)
T cd05108         167 HAEGGKVPIKWMALESILHR--IYTHQSDVWSYGVTVWELMTFGSKPYDGIP  216 (316)
T ss_pred             eccCCccceeecChHHhccC--CCCchhhhHHHHHHHHHHHcCCCCCCCCCC
Confidence            22333456789999998553  78999999999999999998 999997654

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphor

>cd07848 STKc_CDKL5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5

Probab=99.97  E-value=4e-30  Score=251.89  Aligned_cols=174  Identities=22%  Similarity=0.310  Sum_probs=143.1

Q ss_pred             hhccccCccCceEEEEEEEc-CCCEEEEEEeccCC---CCchhhHHHHHHhhccCccceeEEEEEe--------------
Q 039231          316 SFKYKLGQGGYGSVYKGKLL-DGSNVAVKVLNDSK---GNGKEFINEVASISRTSHVNVVALLGFC--------------  377 (506)
Q Consensus       316 ~~~~~ig~G~~g~V~~~~~~-~~~~vavK~l~~~~---~~~~~~~~E~~~l~~l~h~niv~l~g~~--------------  377 (506)
                      .+.+.||+|+||.||+|+.+ +++.+|+|+++...   ...+.+.+|++++++++||||+++++++              
T Consensus         4 ~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~   83 (287)
T cd07848           4 EVLGVVGEGAYGVVLKCRHKETKEIVAIKKFKDSEENEEVKETTLRELKMLRTLKQENIVELKEAFRRRGKLYLVFEYVE   83 (287)
T ss_pred             eEEEEecccCCEEEEEEEECCCCcEEEEEEEecccccccchhhHHHHHHHHHhCCCccccchhhhEecCCEEEEEEecCC
Confidence            34567999999999999986 47899999997543   2335688999999999999999998765              


Q ss_pred             -------------eccchhhhHHHHHHHHHHHHhhcCCCCeEecCcCCCcEEECCCCcEEEeecCCCccccCCCcceecc
Q 039231          378 -------------LRVAEELSSTIGIARGLEYLHLGCSTRILHFDIKPHNILLDEDFCPKISDFGLAKICNRKESIISMT  444 (506)
Q Consensus       378 -------------~~~~~~l~i~~~i~~gl~~LH~~~~~~ivH~dlkp~Nill~~~~~~ki~dfg~a~~~~~~~~~~~~~  444 (506)
                                   +.+...+.++.|++.||+|||   +.+++||||||+||+++.++.+||+|||+++........ ...
T Consensus        84 ~~~l~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH---~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~-~~~  159 (287)
T cd07848          84 KNMLELLEEMPNGVPPEKVRSYIYQLIKAIHWCH---KNDIVHRDIKPENLLISHNDVLKLCDFGFARNLSEGSNA-NYT  159 (287)
T ss_pred             CCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHEEEcCCCcEEEeeccCcccccccccc-ccc
Confidence                         122335678999999999999   899999999999999999999999999999876433221 123


Q ss_pred             cCCCCcccccccccccccCCCCccccHHHHHHHHHHHHcCCCCCCCCCCCc
Q 039231          445 GARGTVGYIAPEVFCRNIGEVSYKSDVYNYGMMIFEMTGGRKNVDVVDNGS  495 (506)
Q Consensus       445 ~~~gt~~y~aPE~l~~~~~~~s~~~Dv~s~G~il~elltg~~pf~~~~~~~  495 (506)
                      ...+++.|+|||++.+.  .++.++|||||||++|||++|+.||...+..+
T Consensus       160 ~~~~~~~y~aPE~~~~~--~~~~~~DiwslGvil~el~~g~~pf~~~~~~~  208 (287)
T cd07848         160 EYVATRWYRSPELLLGA--PYGKAVDMWSVGCILGELSDGQPLFPGESEID  208 (287)
T ss_pred             ccccccccCCcHHHcCC--CCCCchhHHhHHHHHHHHHhCCCCCCCCCHHH
Confidence            45689999999998654  68899999999999999999999998765433

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes

>PTZ00036 glycogen synthase kinase; Provisional

Probab=99.97  E-value=4.6e-30  Score=266.10  Aligned_cols=171  Identities=24%  Similarity=0.332  Sum_probs=137.3

Q ss_pred             hhccccCccCceEEEEEEEc-CCCEEEEEEeccCCCCchhhHHHHHHhhccCccceeEEEEEeec---------------
Q 039231          316 SFKYKLGQGGYGSVYKGKLL-DGSNVAVKVLNDSKGNGKEFINEVASISRTSHVNVVALLGFCLR---------------  379 (506)
Q Consensus       316 ~~~~~ig~G~~g~V~~~~~~-~~~~vavK~l~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~---------------  379 (506)
                      .+.++||+|+||.||+|+.. .++.||||++....   ....+|+.++++++|||||++.+++..               
T Consensus        69 ~~~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~---~~~~~Ei~il~~l~h~niv~l~~~~~~~~~~~~~~~~~l~lv  145 (440)
T PTZ00036         69 KLGNIIGNGSFGVVYEAICIDTSEKVAIKKVLQDP---QYKNRELLIMKNLNHINIIFLKDYYYTECFKKNEKNIFLNVV  145 (440)
T ss_pred             EEeEEEEeCCCEEEEEEEECCCCCEEEEEEEecCc---chHHHHHHHHHhcCCCCCcceeeeEeecccccCCCceEEEEE
Confidence            34568999999999999875 58899999885432   334579999999999999998765411               


Q ss_pred             -----------------------cchhhhHHHHHHHHHHHHhhcCCCCeEecCcCCCcEEECCCC-cEEEeecCCCcccc
Q 039231          380 -----------------------VAEELSSTIGIARGLEYLHLGCSTRILHFDIKPHNILLDEDF-CPKISDFGLAKICN  435 (506)
Q Consensus       380 -----------------------~~~~l~i~~~i~~gl~~LH~~~~~~ivH~dlkp~Nill~~~~-~~ki~dfg~a~~~~  435 (506)
                                             +.....++.||+.||+|||   +++|+||||||+|||++.++ .+||+|||+++...
T Consensus       146 mE~~~~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~gL~yLH---~~~IiHrDLKp~NILl~~~~~~vkL~DFGla~~~~  222 (440)
T PTZ00036        146 MEFIPQTVHKYMKHYARNNHALPLFLVKLYSYQLCRALAYIH---SKFICHRDLKPQNLLIDPNTHTLKLCDFGSAKNLL  222 (440)
T ss_pred             EecCCccHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHH---HCCEecCCcCHHHEEEcCCCCceeeeccccchhcc
Confidence                                   1123457789999999999   89999999999999998664 79999999998765


Q ss_pred             CCCcceecccCCCCcccccccccccccCCCCccccHHHHHHHHHHHHcCCCCCCCCCCCcc
Q 039231          436 RKESIISMTGARGTVGYIAPEVFCRNIGEVSYKSDVYNYGMMIFEMTGGRKNVDVVDNGST  496 (506)
Q Consensus       436 ~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~s~~~Dv~s~G~il~elltg~~pf~~~~~~~~  496 (506)
                      .....   ....+|+.|+|||++.+. ..++.++|||||||++|||++|.+||......+.
T Consensus       223 ~~~~~---~~~~~t~~y~aPE~~~~~-~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~  279 (440)
T PTZ00036        223 AGQRS---VSYICSRFYRAPELMLGA-TNYTTHIDLWSLGCIIAEMILGYPIFSGQSSVDQ  279 (440)
T ss_pred             CCCCc---ccCCCCcCccCHHHhcCC-CCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHH
Confidence            43321   345679999999998653 3688999999999999999999999987654433

>PHA03212 serine/threonine kinase US3; Provisional

Probab=99.97  E-value=4.2e-30  Score=262.30  Aligned_cols=166  Identities=23%  Similarity=0.314  Sum_probs=137.1

Q ss_pred             hhhccccCccCceEEEEEEEc-CCCEEEEEEeccCCCCchhhHHHHHHhhccCccceeEEEEEe----------------
Q 039231          315 NSFKYKLGQGGYGSVYKGKLL-DGSNVAVKVLNDSKGNGKEFINEVASISRTSHVNVVALLGFC----------------  377 (506)
Q Consensus       315 ~~~~~~ig~G~~g~V~~~~~~-~~~~vavK~l~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~----------------  377 (506)
                      +.+.+.||+|+||.||++... .++.||+|...     .+.+.+|++++++++|||||++++++                
T Consensus        94 y~~~~~lg~G~~g~V~~~~d~~~~~~vaiK~~~-----~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~lv~e~~~~~  168 (391)
T PHA03212         94 FSILETFTPGAEGFAFACIDNKTCEHVVIKAGQ-----RGGTATEAHILRAINHPSIIQLKGTFTYNKFTCLILPRYKTD  168 (391)
T ss_pred             cEEEEEEcCCCCeEEEEEEECCCCCEEEEechh-----hhhhHHHHHHHHhCCCCCCCCEeEEEEECCeeEEEEecCCCC
Confidence            334567999999999999875 58899999653     24578999999999999999999876                


Q ss_pred             ----------eccchhhhHHHHHHHHHHHHhhcCCCCeEecCcCCCcEEECCCCcEEEeecCCCccccCCCcceecccCC
Q 039231          378 ----------LRVAEELSSTIGIARGLEYLHLGCSTRILHFDIKPHNILLDEDFCPKISDFGLAKICNRKESIISMTGAR  447 (506)
Q Consensus       378 ----------~~~~~~l~i~~~i~~gl~~LH~~~~~~ivH~dlkp~Nill~~~~~~ki~dfg~a~~~~~~~~~~~~~~~~  447 (506)
                                +.+.+.+.++.||+.||+|||   +++|+||||||+|||++.++.+||+|||+++........ ......
T Consensus       169 L~~~l~~~~~l~~~~~~~i~~qi~~aL~ylH---~~~IvHrDiKP~NIll~~~~~vkL~DFG~a~~~~~~~~~-~~~~~~  244 (391)
T PHA03212        169 LYCYLAAKRNIAICDILAIERSVLRAIQYLH---ENRIIHRDIKAENIFINHPGDVCLGDFGAACFPVDINAN-KYYGWA  244 (391)
T ss_pred             HHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCChHhEEEcCCCCEEEEeCCccccccccccc-cccccc
Confidence                      223346778899999999999   899999999999999999999999999999754322111 123457


Q ss_pred             CCcccccccccccccCCCCccccHHHHHHHHHHHHcCCCCCCCC
Q 039231          448 GTVGYIAPEVFCRNIGEVSYKSDVYNYGMMIFEMTGGRKNVDVV  491 (506)
Q Consensus       448 gt~~y~aPE~l~~~~~~~s~~~Dv~s~G~il~elltg~~pf~~~  491 (506)
                      ||+.|+|||++.+.  .++.++|||||||++|||++|+.||...
T Consensus       245 gt~~y~aPE~~~~~--~~~~~~DiwSlGvil~elltg~~p~~~~  286 (391)
T PHA03212        245 GTIATNAPELLARD--PYGPAVDIWSAGIVLFEMATCHDSLFEK  286 (391)
T ss_pred             CccCCCChhhhcCC--CCCcHHHHHHHHHHHHHHHHCCCCcCCc
Confidence            89999999998654  7899999999999999999999887543

>cd05629 STKc_NDR_like_fungal Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

Probab=99.97  E-value=1.9e-30  Score=264.51  Aligned_cols=173  Identities=25%  Similarity=0.282  Sum_probs=138.4

Q ss_pred             hccccCccCceEEEEEEEc-CCCEEEEEEeccCC----CCchhhHHHHHHhhccCccceeEEEEEee-------------
Q 039231          317 FKYKLGQGGYGSVYKGKLL-DGSNVAVKVLNDSK----GNGKEFINEVASISRTSHVNVVALLGFCL-------------  378 (506)
Q Consensus       317 ~~~~ig~G~~g~V~~~~~~-~~~~vavK~l~~~~----~~~~~~~~E~~~l~~l~h~niv~l~g~~~-------------  378 (506)
                      +.++||+|+||.||+++.. +++.||||++....    ...+.+.+|++++++++||||+++++++.             
T Consensus         5 ~~~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~E~~~   84 (377)
T cd05629           5 TVKVIGKGAFGEVRLVQKKDTGKIYAMKTLLKSEMFKKDQLAHVKAERDVLAESDSPWVVSLYYSFQDAQYLYLIMEFLP   84 (377)
T ss_pred             EeEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHHHHhHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCeeEEEEeCCC
Confidence            3467999999999999874 58999999986432    22356788999999999999999998762             


Q ss_pred             --------------ccchhhhHHHHHHHHHHHHhhcCCCCeEecCcCCCcEEECCCCcEEEeecCCCccccCCCcc----
Q 039231          379 --------------RVAEELSSTIGIARGLEYLHLGCSTRILHFDIKPHNILLDEDFCPKISDFGLAKICNRKESI----  440 (506)
Q Consensus       379 --------------~~~~~l~i~~~i~~gl~~LH~~~~~~ivH~dlkp~Nill~~~~~~ki~dfg~a~~~~~~~~~----  440 (506)
                                    .+.....++.|++.||+|||   +.+|+||||||+|||++.++.+||+|||+++........    
T Consensus        85 gg~L~~~l~~~~~~~~~~~~~~~~ql~~aL~~LH---~~givHrDlkp~NIll~~~~~~kl~DfGla~~~~~~~~~~~~~  161 (377)
T cd05629          85 GGDLMTMLIKYDTFSEDVTRFYMAECVLAIEAVH---KLGFIHRDIKPDNILIDRGGHIKLSDFGLSTGFHKQHDSAYYQ  161 (377)
T ss_pred             CCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH---hCCeeccCCCHHHEEECCCCCEEEeeccccccccccccccccc
Confidence                          12234557899999999999   999999999999999999999999999998633210000    


Q ss_pred             --------e---------------------------------ecccCCCCcccccccccccccCCCCccccHHHHHHHHH
Q 039231          441 --------I---------------------------------SMTGARGTVGYIAPEVFCRNIGEVSYKSDVYNYGMMIF  479 (506)
Q Consensus       441 --------~---------------------------------~~~~~~gt~~y~aPE~l~~~~~~~s~~~Dv~s~G~il~  479 (506)
                              .                                 ......||+.|+|||++.+.  .++.++|||||||++|
T Consensus       162 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~~DiwSlGvil~  239 (377)
T cd05629         162 KLLQGKSNKNRIDNRNSVAVDSINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIFLQQ--GYGQECDWWSLGAIMF  239 (377)
T ss_pred             ccccccccccccccccccccccccccccchhhhhhhhhcccccccccCCCccccCHHHHccC--CCCCceeeEecchhhh
Confidence                    0                                 00124689999999998654  6899999999999999


Q ss_pred             HHHcCCCCCCCCCCC
Q 039231          480 EMTGGRKNVDVVDNG  494 (506)
Q Consensus       480 elltg~~pf~~~~~~  494 (506)
                      ||++|+.||...+..
T Consensus       240 elltG~~Pf~~~~~~  254 (377)
T cd05629         240 ECLIGWPPFCSENSH  254 (377)
T ss_pred             hhhcCCCCCCCCCHH
Confidence            999999999765543

Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of

>cd05600 STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases

Probab=99.97  E-value=2e-30  Score=259.83  Aligned_cols=169  Identities=27%  Similarity=0.388  Sum_probs=142.2

Q ss_pred             hccccCccCceEEEEEEEcC-CCEEEEEEeccCC----CCchhhHHHHHHhhccCccceeEEEEEe--------------
Q 039231          317 FKYKLGQGGYGSVYKGKLLD-GSNVAVKVLNDSK----GNGKEFINEVASISRTSHVNVVALLGFC--------------  377 (506)
Q Consensus       317 ~~~~ig~G~~g~V~~~~~~~-~~~vavK~l~~~~----~~~~~~~~E~~~l~~l~h~niv~l~g~~--------------  377 (506)
                      +.++||+|+||.||+|+..+ ++.||+|+++...    ...+.+.+|++++.+++||||+++++++              
T Consensus         5 ~~~~ig~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~~~   84 (333)
T cd05600           5 ILTQVGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKSEWLVKLLYAFQDDEYLYLAMEYVP   84 (333)
T ss_pred             EEEEEeecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhCCCCCCccEEEEEEcCCEEEEEEeCCC
Confidence            45679999999999999864 8899999997532    2335688999999999999999999776              


Q ss_pred             -------------eccchhhhHHHHHHHHHHHHhhcCCCCeEecCcCCCcEEECCCCcEEEeecCCCccccCCCcceecc
Q 039231          378 -------------LRVAEELSSTIGIARGLEYLHLGCSTRILHFDIKPHNILLDEDFCPKISDFGLAKICNRKESIISMT  444 (506)
Q Consensus       378 -------------~~~~~~l~i~~~i~~gl~~LH~~~~~~ivH~dlkp~Nill~~~~~~ki~dfg~a~~~~~~~~~~~~~  444 (506)
                                   +.+.....++.|++.||+|||   +++|+||||||+|||+++++.+||+|||+++.....     ..
T Consensus        85 g~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~lH---~~~ivH~dlkp~Nil~~~~~~~kL~Dfg~a~~~~~~-----~~  156 (333)
T cd05600          85 GGDFRTLLNNLGVLSEDHARFYMAEMFEAVDALH---ELGYIHRDLKPENFLIDASGHIKLTDFGLSKGIVTY-----AN  156 (333)
T ss_pred             CCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHH---HCCccccCCCHHHEEECCCCCEEEEeCcCCcccccc-----cC
Confidence                         123335668899999999999   899999999999999999999999999999765431     24


Q ss_pred             cCCCCcccccccccccccCCCCccccHHHHHHHHHHHHcCCCCCCCCCCCc
Q 039231          445 GARGTVGYIAPEVFCRNIGEVSYKSDVYNYGMMIFEMTGGRKNVDVVDNGS  495 (506)
Q Consensus       445 ~~~gt~~y~aPE~l~~~~~~~s~~~Dv~s~G~il~elltg~~pf~~~~~~~  495 (506)
                      ...||+.|+|||.+.+.  .++.++||||||+++|||++|+.||...+..+
T Consensus       157 ~~~gt~~y~aPE~~~~~--~~~~~~DvwslG~il~ell~g~~pf~~~~~~~  205 (333)
T cd05600         157 SVVGSPDYMAPEVLRGK--GYDFTVDYWSLGCMLYEFLCGFPPFSGSTPNE  205 (333)
T ss_pred             CcccCccccChhHhcCC--CCCCccceecchHHHhhhhhCCCCCCCCCHHH
Confidence            46789999999998654  78899999999999999999999998765443

Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis.

>KOG0194 consensus Protein tyrosine kinase [Signal transduction mechanisms]

Probab=99.97  E-value=5.5e-31  Score=265.08  Aligned_cols=177  Identities=35%  Similarity=0.524  Sum_probs=145.9

Q ss_pred             hccccCccCceEEEEEEEcC--C--CE-EEEEEeccC----CCCchhhHHHHHHhhccCccceeEEEEEe----------
Q 039231          317 FKYKLGQGGYGSVYKGKLLD--G--SN-VAVKVLNDS----KGNGKEFINEVASISRTSHVNVVALLGFC----------  377 (506)
Q Consensus       317 ~~~~ig~G~~g~V~~~~~~~--~--~~-vavK~l~~~----~~~~~~~~~E~~~l~~l~h~niv~l~g~~----------  377 (506)
                      +.++||+|+||.||+|++..  +  .. ||||..+.+    .....++.+|+++|++++|||||+++|++          
T Consensus       161 l~kkLGeGaFGeV~~G~l~~~~~~~~~~VAvK~~k~~~~~~~~~~~e~m~EArvMr~l~H~NVVr~yGVa~~~~Pl~ivm  240 (474)
T KOG0194|consen  161 LGKKLGEGAFGEVFKGKLKLKNGFKVVPVAVKTTKGSSELTKEQIKEFMKEARVMRQLNHPNVVRFYGVAVLEEPLMLVM  240 (474)
T ss_pred             ccceeecccccEEEEEEEEecCCceeeeeEEEeecccccccHHHHHHHHHHHHHHHhCCCCCEEEEEEEEcCCCccEEEE
Confidence            34789999999999998753  2  23 899998742    33447899999999999999999999988          


Q ss_pred             ------------------eccchhhhHHHHHHHHHHHHhhcCCCCeEecCcCCCcEEECCCCcEEEeecCCCccccCCCc
Q 039231          378 ------------------LRVAEELSSTIGIARGLEYLHLGCSTRILHFDIKPHNILLDEDFCPKISDFGLAKICNRKES  439 (506)
Q Consensus       378 ------------------~~~~~~l~i~~~i~~gl~~LH~~~~~~ivH~dlkp~Nill~~~~~~ki~dfg~a~~~~~~~~  439 (506)
                                        ++..+.+.++.+.|.||+|||   +++++||||..+|+|++.++.+||+|||+++.......
T Consensus       241 El~~gGsL~~~L~k~~~~v~~~ek~~~~~~AA~Gl~YLh---~k~~IHRDIAARNcL~~~~~~vKISDFGLs~~~~~~~~  317 (474)
T KOG0194|consen  241 ELCNGGSLDDYLKKNKKSLPTLEKLRFCYDAARGLEYLH---SKNCIHRDIAARNCLYSKKGVVKISDFGLSRAGSQYVM  317 (474)
T ss_pred             EecCCCcHHHHHHhCCCCCCHHHHHHHHHHHHhHHHHHH---HCCCcchhHhHHHheecCCCeEEeCccccccCCcceee
Confidence                              234457889999999999999   99999999999999999999999999999876542111


Q ss_pred             ceecccCCCCcccccccccccccCCCCccccHHHHHHHHHHHHc-CCCCCCCCCCCcchhhh
Q 039231          440 IISMTGARGTVGYIAPEVFCRNIGEVSYKSDVYNYGMMIFEMTG-GRKNVDVVDNGSTALDL  500 (506)
Q Consensus       440 ~~~~~~~~gt~~y~aPE~l~~~~~~~s~~~Dv~s~G~il~ellt-g~~pf~~~~~~~~~~~~  500 (506)
                      .  ......+..|+|||.+..  +.++.++|||||||++||+++ |..||......+....+
T Consensus       318 ~--~~~~klPirWLAPEtl~~--~~~s~kTDV~sfGV~~~Eif~~g~~Py~g~~~~~v~~kI  375 (474)
T KOG0194|consen  318 K--KFLKKLPIRWLAPETLNT--GIFSFKTDVWSFGVLLWEIFENGAEPYPGMKNYEVKAKI  375 (474)
T ss_pred             c--cccccCcceecChhhhcc--CccccccchhheeeeEEeeeccCCCCCCCCCHHHHHHHH
Confidence            1  112346789999999954  489999999999999999998 89999988776655555

>KOG0201 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.97  E-value=1.3e-30  Score=251.39  Aligned_cols=175  Identities=26%  Similarity=0.368  Sum_probs=149.0

Q ss_pred             cccCccCceEEEEEEEc-CCCEEEEEEeccC--CCCchhhHHHHHHhhccCccceeEEEEEee-----------------
Q 039231          319 YKLGQGGYGSVYKGKLL-DGSNVAVKVLNDS--KGNGKEFINEVASISRTSHVNVVALLGFCL-----------------  378 (506)
Q Consensus       319 ~~ig~G~~g~V~~~~~~-~~~~vavK~l~~~--~~~~~~~~~E~~~l~~l~h~niv~l~g~~~-----------------  378 (506)
                      +.||+|.||.||+|.+. .++.||+|++.-.  +...+++.+|+.+|.+++++||.+++|.++                 
T Consensus        19 ~~IgrGsfG~Vyk~~d~~t~k~vAiKii~Le~~~deIediqqei~~Ls~~~~~~it~yygsyl~g~~LwiiMey~~gGsv   98 (467)
T KOG0201|consen   19 ELIGRGSFGEVYKAIDNKTKKVVAIKIIDLEEAEDEIEDIQQEISVLSQCDSPNITEYYGSYLKGTKLWIIMEYCGGGSV   98 (467)
T ss_pred             hhccccccceeeeeeeccccceEEEEEechhhcchhhHHHHHHHHHHHhcCcchHHhhhhheeecccHHHHHHHhcCcch
Confidence            56999999999999875 4899999999743  344578999999999999999999998763                 


Q ss_pred             ----------ccchhhhHHHHHHHHHHHHhhcCCCCeEecCcCCCcEEECCCCcEEEeecCCCccccCCCcceecccCCC
Q 039231          379 ----------RVAEELSSTIGIARGLEYLHLGCSTRILHFDIKPHNILLDEDFCPKISDFGLAKICNRKESIISMTGARG  448 (506)
Q Consensus       379 ----------~~~~~l~i~~~i~~gl~~LH~~~~~~ivH~dlkp~Nill~~~~~~ki~dfg~a~~~~~~~~~~~~~~~~g  448 (506)
                                ++.+..-+.++++.|+.|||   .++.+|||||+.|||+.++|.+|++|||.+..+.......  ...+|
T Consensus        99 ~~lL~~~~~~~E~~i~~ilre~l~~l~ylH---~~~kiHrDIKaanil~s~~g~vkl~DfgVa~ql~~~~~rr--~tfvG  173 (467)
T KOG0201|consen   99 LDLLKSGNILDEFEIAVILREVLKGLDYLH---SEKKIHRDIKAANILLSESGDVKLADFGVAGQLTNTVKRR--KTFVG  173 (467)
T ss_pred             hhhhccCCCCccceeeeehHHHHHHhhhhh---hcceecccccccceeEeccCcEEEEecceeeeeechhhcc--ccccc
Confidence                      23334457789999999999   9999999999999999999999999999998776655432  66899


Q ss_pred             CcccccccccccccCCCCccccHHHHHHHHHHHHcCCCCCCCCCCCcchhhh
Q 039231          449 TVGYIAPEVFCRNIGEVSYKSDVYNYGMMIFEMTGGRKNVDVVDNGSTALDL  500 (506)
Q Consensus       449 t~~y~aPE~l~~~~~~~s~~~Dv~s~G~il~elltg~~pf~~~~~~~~~~~~  500 (506)
                      |+.|||||++...  .|+.|+||||||++.+||++|.+|+....+-...+-|
T Consensus       174 TPfwMAPEVI~~~--~Y~~KADIWSLGITaiEla~GePP~s~~hPmrvlflI  223 (467)
T KOG0201|consen  174 TPFWMAPEVIKQS--GYDTKADIWSLGITAIELAKGEPPHSKLHPMRVLFLI  223 (467)
T ss_pred             cccccchhhhccc--cccchhhhhhhhHHHHHHhcCCCCCcccCcceEEEec
Confidence            9999999999754  7999999999999999999999999988775544433

>cd07876 STKc_JNK2 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2

Probab=99.96  E-value=8.2e-30  Score=258.05  Aligned_cols=169  Identities=29%  Similarity=0.320  Sum_probs=140.8

Q ss_pred             hccccCccCceEEEEEEEc-CCCEEEEEEeccCC---CCchhhHHHHHHhhccCccceeEEEEEee--------------
Q 039231          317 FKYKLGQGGYGSVYKGKLL-DGSNVAVKVLNDSK---GNGKEFINEVASISRTSHVNVVALLGFCL--------------  378 (506)
Q Consensus       317 ~~~~ig~G~~g~V~~~~~~-~~~~vavK~l~~~~---~~~~~~~~E~~~l~~l~h~niv~l~g~~~--------------  378 (506)
                      ..+.||+|+||.||+++.. .|..+|+|++....   ...+.+.+|+.+++.++||||+++++++.              
T Consensus        25 ~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~~lv  104 (359)
T cd07876          25 QLKPIGSGAQGIVCAAFDTVLGINVAVKKLSRPFQNQTHAKRAYRELVLLKCVNHKNIISLLNVFTPQKSLEEFQDVYLV  104 (359)
T ss_pred             EEEEeecCCCEEEEEEEEcCCCceeEEEEecccccchhHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCCccccceeEEE
Confidence            3567999999999999875 48999999996532   23367889999999999999999998652              


Q ss_pred             ----------------ccchhhhHHHHHHHHHHHHhhcCCCCeEecCcCCCcEEECCCCcEEEeecCCCccccCCCccee
Q 039231          379 ----------------RVAEELSSTIGIARGLEYLHLGCSTRILHFDIKPHNILLDEDFCPKISDFGLAKICNRKESIIS  442 (506)
Q Consensus       379 ----------------~~~~~l~i~~~i~~gl~~LH~~~~~~ivH~dlkp~Nill~~~~~~ki~dfg~a~~~~~~~~~~~  442 (506)
                                      +..+...++.|++.||+|||   +.+|+||||||+|||++.++.+||+|||+++.......   
T Consensus       105 ~e~~~~~l~~~~~~~~~~~~~~~~~~qi~~~L~~LH---~~~ivHrDlkp~NIl~~~~~~~kl~Dfg~a~~~~~~~~---  178 (359)
T cd07876         105 MELMDANLCQVIHMELDHERMSYLLYQMLCGIKHLH---SAGIIHRDLKPSNIVVKSDCTLKILDFGLARTACTNFM---  178 (359)
T ss_pred             EeCCCcCHHHHHhccCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCCHHHEEECCCCCEEEecCCCccccccCcc---
Confidence                            12234568899999999999   89999999999999999999999999999976433221   


Q ss_pred             cccCCCCcccccccccccccCCCCccccHHHHHHHHHHHHcCCCCCCCCCC
Q 039231          443 MTGARGTVGYIAPEVFCRNIGEVSYKSDVYNYGMMIFEMTGGRKNVDVVDN  493 (506)
Q Consensus       443 ~~~~~gt~~y~aPE~l~~~~~~~s~~~Dv~s~G~il~elltg~~pf~~~~~  493 (506)
                      .....+|+.|+|||.+.+.  .++.++||||||+++|||++|+.||...+.
T Consensus       179 ~~~~~~t~~y~aPE~~~~~--~~~~~~DiwSlG~il~el~tg~~pf~~~~~  227 (359)
T cd07876         179 MTPYVVTRYYRAPEVILGM--GYKENVDIWSVGCIMGELVKGSVIFQGTDH  227 (359)
T ss_pred             CCCCcccCCCCCchhccCC--CCCcchhhHHHHHHHHHHHhCCCCCCCCCH
Confidence            2345789999999998654  788999999999999999999999987654

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn

>cd05598 STKc_LATS Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor

Probab=99.96  E-value=2e-30  Score=264.16  Aligned_cols=175  Identities=25%  Similarity=0.302  Sum_probs=139.6

Q ss_pred             hccccCccCceEEEEEEEc-CCCEEEEEEeccC----CCCchhhHHHHHHhhccCccceeEEEEEee-------------
Q 039231          317 FKYKLGQGGYGSVYKGKLL-DGSNVAVKVLNDS----KGNGKEFINEVASISRTSHVNVVALLGFCL-------------  378 (506)
Q Consensus       317 ~~~~ig~G~~g~V~~~~~~-~~~~vavK~l~~~----~~~~~~~~~E~~~l~~l~h~niv~l~g~~~-------------  378 (506)
                      +.+.||+|+||.||+|+.. +++.+|||++...    ......+.+|++++++++|+||+++++.+.             
T Consensus         5 ~~~~lG~G~~g~V~~a~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~E~~~   84 (376)
T cd05598           5 KIKTIGIGAFGEVCLVRKVDTNALYAMKTLRKADVLMRNQAAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVMDYIP   84 (376)
T ss_pred             EEEEEEeCCCeEEEEEEECCCCCEEEEEEEcHHHHHhhhhHHHHHHHHHHHHhCCCCCcceEEEEEEcCCEEEEEEeCCC
Confidence            3467999999999999875 4899999998642    223466889999999999999999988761             


Q ss_pred             --------------ccchhhhHHHHHHHHHHHHhhcCCCCeEecCcCCCcEEECCCCcEEEeecCCCccccCCCc-----
Q 039231          379 --------------RVAEELSSTIGIARGLEYLHLGCSTRILHFDIKPHNILLDEDFCPKISDFGLAKICNRKES-----  439 (506)
Q Consensus       379 --------------~~~~~l~i~~~i~~gl~~LH~~~~~~ivH~dlkp~Nill~~~~~~ki~dfg~a~~~~~~~~-----  439 (506)
                                    .......++.||+.||+|||   +++|+||||||+|||++.++.+||+|||++........     
T Consensus        85 ~g~L~~~i~~~~~~~~~~~~~~~~qi~~al~~lH---~~~ivHrDlkp~Nill~~~~~ikL~DFG~a~~~~~~~~~~~~~  161 (376)
T cd05598          85 GGDMMSLLIRLGIFEEDLARFYIAELTCAIESVH---KMGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYYQ  161 (376)
T ss_pred             CCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH---HCCeEeCCCCHHHEEECCCCCEEEEeCCCCccccccccccccc
Confidence                          12224557889999999999   89999999999999999999999999999753210000     


Q ss_pred             ------------------------------------ceecccCCCCcccccccccccccCCCCccccHHHHHHHHHHHHc
Q 039231          440 ------------------------------------IISMTGARGTVGYIAPEVFCRNIGEVSYKSDVYNYGMMIFEMTG  483 (506)
Q Consensus       440 ------------------------------------~~~~~~~~gt~~y~aPE~l~~~~~~~s~~~Dv~s~G~il~ellt  483 (506)
                                                          ........||+.|+|||++.+.  .++.++|||||||++|||++
T Consensus       162 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~~DiwSlGvilyell~  239 (376)
T cd05598         162 KGDHHRQDSMEPSEEWSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRT--GYTQLCDWWSVGVILYEMLV  239 (376)
T ss_pred             cccccccccccccccccccccccccchhhhhhhhcccccccccCCCccccCHHHHcCC--CCCcceeeeeccceeeehhh
Confidence                                                0001134689999999998654  68899999999999999999


Q ss_pred             CCCCCCCCCCCcc
Q 039231          484 GRKNVDVVDNGST  496 (506)
Q Consensus       484 g~~pf~~~~~~~~  496 (506)
                      |+.||...+..+.
T Consensus       240 G~~Pf~~~~~~~~  252 (376)
T cd05598         240 GQPPFLADTPAET  252 (376)
T ss_pred             CCCCCCCCCHHHH
Confidence            9999987665443

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation.

>cd05622 STKc_ROCK1 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1

Probab=99.96  E-value=3.7e-30  Score=261.40  Aligned_cols=175  Identities=25%  Similarity=0.300  Sum_probs=141.7

Q ss_pred             hhhccccCccCceEEEEEEEc-CCCEEEEEEeccC----CCCchhhHHHHHHhhccCccceeEEEEEee-----------
Q 039231          315 NSFKYKLGQGGYGSVYKGKLL-DGSNVAVKVLNDS----KGNGKEFINEVASISRTSHVNVVALLGFCL-----------  378 (506)
Q Consensus       315 ~~~~~~ig~G~~g~V~~~~~~-~~~~vavK~l~~~----~~~~~~~~~E~~~l~~l~h~niv~l~g~~~-----------  378 (506)
                      +.+.+.||+|+||.||+++.. +++.+|+|++...    ....+.+.+|+.+++.++||||+++++.+.           
T Consensus        45 y~i~~~lG~G~fg~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~~~~~~lv~Ey  124 (371)
T cd05622          45 YEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQDDRYLYMVMEY  124 (371)
T ss_pred             cEEEEEEeecCCeEEEEEEECCCCcEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEcCCEEEEEEcC
Confidence            344578999999999999876 4789999998642    122345788999999999999999998761           


Q ss_pred             ---------------ccchhhhHHHHHHHHHHHHhhcCCCCeEecCcCCCcEEECCCCcEEEeecCCCccccCCCcceec
Q 039231          379 ---------------RVAEELSSTIGIARGLEYLHLGCSTRILHFDIKPHNILLDEDFCPKISDFGLAKICNRKESIISM  443 (506)
Q Consensus       379 ---------------~~~~~l~i~~~i~~gl~~LH~~~~~~ivH~dlkp~Nill~~~~~~ki~dfg~a~~~~~~~~~~~~  443 (506)
                                     .......++.||+.||+|||   +++|+||||||+|||+++++.+||+|||+++........ ..
T Consensus       125 ~~gg~L~~~~~~~~~~~~~~~~~~~qi~~aL~~LH---~~~ivHrDLkp~NIll~~~~~ikL~DfG~a~~~~~~~~~-~~  200 (371)
T cd05622         125 MPGGDLVNLMSNYDVPEKWARFYTAEVVLALDAIH---SMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMV-RC  200 (371)
T ss_pred             CCCCcHHHHHHhcCCCHHHHHHHHHHHHHHHHHHH---HCCEEeCCCCHHHEEECCCCCEEEEeCCceeEcCcCCcc-cc
Confidence                           12234567889999999999   999999999999999999999999999999876543221 12


Q ss_pred             ccCCCCccccccccccccc--CCCCccccHHHHHHHHHHHHcCCCCCCCCCC
Q 039231          444 TGARGTVGYIAPEVFCRNI--GEVSYKSDVYNYGMMIFEMTGGRKNVDVVDN  493 (506)
Q Consensus       444 ~~~~gt~~y~aPE~l~~~~--~~~s~~~Dv~s~G~il~elltg~~pf~~~~~  493 (506)
                      ....||+.|+|||++....  +.++.++|||||||++|||++|+.||...+.
T Consensus       201 ~~~~gt~~y~aPE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~  252 (371)
T cd05622         201 DTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSL  252 (371)
T ss_pred             cCcccCccccCHHHHhccCCCccCCCccceeehhHHHHHHHhCCCCCCCCCH
Confidence            3467899999999986432  2478899999999999999999999986544

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, an

>cd05625 STKc_LATS1 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1

Probab=99.96  E-value=2.4e-30  Score=264.14  Aligned_cols=175  Identities=25%  Similarity=0.289  Sum_probs=139.2

Q ss_pred             ccccCccCceEEEEEEEc-CCCEEEEEEeccCC----CCchhhHHHHHHhhccCccceeEEEEEee--------------
Q 039231          318 KYKLGQGGYGSVYKGKLL-DGSNVAVKVLNDSK----GNGKEFINEVASISRTSHVNVVALLGFCL--------------  378 (506)
Q Consensus       318 ~~~ig~G~~g~V~~~~~~-~~~~vavK~l~~~~----~~~~~~~~E~~~l~~l~h~niv~l~g~~~--------------  378 (506)
                      .++||+|+||.||+|+.. +++.+|+|++....    ...+.+.+|++++++++|+||+++++.+.              
T Consensus         6 ~~~LG~G~~g~Vy~a~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~~~h~~iv~~~~~~~~~~~~~lv~E~~~g   85 (382)
T cd05625           6 IKTLGIGAFGEVCLARKVDTKALYAMKTLRKKDVLLRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLYFVMDYIPG   85 (382)
T ss_pred             EEEEEeCCCEEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhCCCCcCCeEEEEEEeCCEEEEEEeCCCC
Confidence            467999999999999874 58899999996532    22356889999999999999999998762              


Q ss_pred             -------------ccchhhhHHHHHHHHHHHHhhcCCCCeEecCcCCCcEEECCCCcEEEeecCCCccccCCCc------
Q 039231          379 -------------RVAEELSSTIGIARGLEYLHLGCSTRILHFDIKPHNILLDEDFCPKISDFGLAKICNRKES------  439 (506)
Q Consensus       379 -------------~~~~~l~i~~~i~~gl~~LH~~~~~~ivH~dlkp~Nill~~~~~~ki~dfg~a~~~~~~~~------  439 (506)
                                   .+.....++.||+.||+|||   +++|+||||||+|||++.++.+||+|||++........      
T Consensus        86 g~L~~~l~~~~~~~e~~~~~~~~qi~~al~~lH---~~~ivHrDlKp~NILl~~~g~~kL~DFGla~~~~~~~~~~~~~~  162 (382)
T cd05625          86 GDMMSLLIRMGIFPEDLARFYIAELTCAVESVH---KMGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYYQS  162 (382)
T ss_pred             CcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEECCCCCEEEeECCCCcccccccccccccc
Confidence                         12224557889999999999   89999999999999999999999999999753211000      


Q ss_pred             ---------------------------------------ceecccCCCCcccccccccccccCCCCccccHHHHHHHHHH
Q 039231          440 ---------------------------------------IISMTGARGTVGYIAPEVFCRNIGEVSYKSDVYNYGMMIFE  480 (506)
Q Consensus       440 ---------------------------------------~~~~~~~~gt~~y~aPE~l~~~~~~~s~~~Dv~s~G~il~e  480 (506)
                                                             ........||+.|+|||++.+.  .++.++|||||||++||
T Consensus       163 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~--~~~~~~DiwSlGvil~e  240 (382)
T cd05625         163 GDHVRQDSMDFSNEWGDPANCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLRT--GYTQLCDWWSVGVILYE  240 (382)
T ss_pred             ccccccccccccccccccccccccccccchhhhhccccccccccccccCcccCCHHHhcCC--CCCCeeeEEechHHHHH
Confidence                                                   0001124689999999998654  68899999999999999


Q ss_pred             HHcCCCCCCCCCCCcch
Q 039231          481 MTGGRKNVDVVDNGSTA  497 (506)
Q Consensus       481 lltg~~pf~~~~~~~~~  497 (506)
                      |++|+.||...+..+..
T Consensus       241 lltG~~Pf~~~~~~~~~  257 (382)
T cd05625         241 MLVGQPPFLAQTPLETQ  257 (382)
T ss_pred             HHhCCCCCCCCCHHHHH
Confidence            99999999876544433

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype an

>cd05596 STKc_ROCK Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase

Probab=99.96  E-value=4.5e-30  Score=260.71  Aligned_cols=176  Identities=23%  Similarity=0.278  Sum_probs=142.3

Q ss_pred             hhhccccCccCceEEEEEEEc-CCCEEEEEEeccC----CCCchhhHHHHHHhhccCccceeEEEEEee-----------
Q 039231          315 NSFKYKLGQGGYGSVYKGKLL-DGSNVAVKVLNDS----KGNGKEFINEVASISRTSHVNVVALLGFCL-----------  378 (506)
Q Consensus       315 ~~~~~~ig~G~~g~V~~~~~~-~~~~vavK~l~~~----~~~~~~~~~E~~~l~~l~h~niv~l~g~~~-----------  378 (506)
                      +.+.+.||+|+||.||+++.. +++.+|+|+++..    ......+.+|+.+++.++||||+++++++.           
T Consensus        45 y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~h~~iv~~~~~~~~~~~~~lv~Ey  124 (370)
T cd05596          45 FDVIKVIGRGAFGEVQLVRHKSSKQVYAMKLLSKFEMIKRSDSAFFWEERDIMAHANSEWIVQLHYAFQDDKYLYMVMEY  124 (370)
T ss_pred             cEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCcceEEEEEecCCEEEEEEcC
Confidence            344578999999999999875 4889999999642    223345778999999999999999998762           


Q ss_pred             ---------------ccchhhhHHHHHHHHHHHHhhcCCCCeEecCcCCCcEEECCCCcEEEeecCCCccccCCCcceec
Q 039231          379 ---------------RVAEELSSTIGIARGLEYLHLGCSTRILHFDIKPHNILLDEDFCPKISDFGLAKICNRKESIISM  443 (506)
Q Consensus       379 ---------------~~~~~l~i~~~i~~gl~~LH~~~~~~ivH~dlkp~Nill~~~~~~ki~dfg~a~~~~~~~~~~~~  443 (506)
                                     +......++.|++.||+|||   +++|+||||||+|||+++++.+||+|||+++........ ..
T Consensus       125 ~~gg~L~~~l~~~~l~~~~~~~~~~qi~~aL~~LH---~~~ivHrDLkp~NILl~~~~~~kL~DfG~~~~~~~~~~~-~~  200 (370)
T cd05596         125 MPGGDLVNLMSNYDIPEKWARFYTAEVVLALDAIH---SMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMDANGMV-RC  200 (370)
T ss_pred             CCCCcHHHHHHhcCCCHHHHHHHHHHHHHHHHHHH---HCCeeccCCCHHHEEEcCCCCEEEEeccceeeccCCCcc-cC
Confidence                           12234557889999999999   899999999999999999999999999999866433221 12


Q ss_pred             ccCCCCccccccccccccc--CCCCccccHHHHHHHHHHHHcCCCCCCCCCCC
Q 039231          444 TGARGTVGYIAPEVFCRNI--GEVSYKSDVYNYGMMIFEMTGGRKNVDVVDNG  494 (506)
Q Consensus       444 ~~~~gt~~y~aPE~l~~~~--~~~s~~~Dv~s~G~il~elltg~~pf~~~~~~  494 (506)
                      ....||+.|+|||.+....  ..++.++|||||||++|||++|+.||...+..
T Consensus       201 ~~~~gt~~y~aPE~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~  253 (370)
T cd05596         201 DTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLV  253 (370)
T ss_pred             CCCCCCcCeECHHHhccCCCCCCCCCceeeeehhHHHHHHHhCCCCcCCCCHH
Confidence            3467899999999985431  34788999999999999999999999876543

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via in

>cd05592 STKc_nPKC_theta_delta Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta

Probab=99.96  E-value=9.3e-30  Score=253.01  Aligned_cols=168  Identities=27%  Similarity=0.376  Sum_probs=135.6

Q ss_pred             ccCccCceEEEEEEEc-CCCEEEEEEeccCC----CCchhhHHHHHHhhc-cCccceeEEEEEe----------------
Q 039231          320 KLGQGGYGSVYKGKLL-DGSNVAVKVLNDSK----GNGKEFINEVASISR-TSHVNVVALLGFC----------------  377 (506)
Q Consensus       320 ~ig~G~~g~V~~~~~~-~~~~vavK~l~~~~----~~~~~~~~E~~~l~~-l~h~niv~l~g~~----------------  377 (506)
                      +||+|+||.||+|+.. +++.||+|+++...    ...+.+..|..++.. .+||||+++++++                
T Consensus         2 ~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~~~~~lv~e~~~gg   81 (316)
T cd05592           2 VLGKGSFGKVMLAELKGTNEFFAIKALKKDVVLEDDDVECTMVERRVLALAWEHPFLTHLFCTFQTKEHLFFVMEYLNGG   81 (316)
T ss_pred             eeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCCC
Confidence            5999999999999875 47899999997532    233455667777765 4799999999775                


Q ss_pred             -----------eccchhhhHHHHHHHHHHHHhhcCCCCeEecCcCCCcEEECCCCcEEEeecCCCccccCCCcceecccC
Q 039231          378 -----------LRVAEELSSTIGIARGLEYLHLGCSTRILHFDIKPHNILLDEDFCPKISDFGLAKICNRKESIISMTGA  446 (506)
Q Consensus       378 -----------~~~~~~l~i~~~i~~gl~~LH~~~~~~ivH~dlkp~Nill~~~~~~ki~dfg~a~~~~~~~~~~~~~~~  446 (506)
                                 ++..+...++.|++.||+|||   +++|+||||||+|||++.++.+||+|||+++.......  .....
T Consensus        82 ~L~~~~~~~~~~~~~~~~~~~~qi~~al~~LH---~~~ivH~dlkp~Nill~~~~~~kL~Dfg~a~~~~~~~~--~~~~~  156 (316)
T cd05592          82 DLMFHIQSSGRFDEARARFYAAEIICGLQFLH---KKGIIYRDLKLDNVLLDKDGHIKIADFGMCKENMNGEG--KASTF  156 (316)
T ss_pred             cHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHH---HCCEEeCCCCHHHeEECCCCCEEEccCcCCeECCCCCC--ccccc
Confidence                       122335568899999999999   89999999999999999999999999999976433221  12345


Q ss_pred             CCCcccccccccccccCCCCccccHHHHHHHHHHHHcCCCCCCCCCCC
Q 039231          447 RGTVGYIAPEVFCRNIGEVSYKSDVYNYGMMIFEMTGGRKNVDVVDNG  494 (506)
Q Consensus       447 ~gt~~y~aPE~l~~~~~~~s~~~Dv~s~G~il~elltg~~pf~~~~~~  494 (506)
                      .||+.|+|||.+.+.  .++.++||||||+++|||++|+.||...+..
T Consensus       157 ~gt~~y~aPE~~~~~--~~~~~~DvwslG~il~ell~G~~Pf~~~~~~  202 (316)
T cd05592         157 CGTPDYIAPEILKGQ--KYNESVDWWSFGVLLYEMLIGQSPFHGEDED  202 (316)
T ss_pred             cCCccccCHHHHcCC--CCCCcccchhHHHHHHHHHhCCCCCCCCCHH
Confidence            689999999998654  6889999999999999999999999866543

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an imp

>cd05591 STKc_nPKC_epsilon Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon

Probab=99.96  E-value=6.3e-30  Score=254.82  Aligned_cols=170  Identities=25%  Similarity=0.337  Sum_probs=138.4

Q ss_pred             cccCccCceEEEEEEEcC-CCEEEEEEeccC----CCCchhhHHHHHHhhcc-CccceeEEEEEee--------------
Q 039231          319 YKLGQGGYGSVYKGKLLD-GSNVAVKVLNDS----KGNGKEFINEVASISRT-SHVNVVALLGFCL--------------  378 (506)
Q Consensus       319 ~~ig~G~~g~V~~~~~~~-~~~vavK~l~~~----~~~~~~~~~E~~~l~~l-~h~niv~l~g~~~--------------  378 (506)
                      ++||+|+||.||+|+... ++.+|+|+++..    ....+.+..|.+++..+ +||||+++++++.              
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~   80 (321)
T cd05591           1 KVLGKGSFGKVMLAELKGTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAAKHPFLTALHCCFQTKDRLFFVMEYVNG   80 (321)
T ss_pred             CccccCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCeEEEEEeCCCC
Confidence            359999999999998754 789999999753    22335577888888866 7999999998761              


Q ss_pred             -------------ccchhhhHHHHHHHHHHHHhhcCCCCeEecCcCCCcEEECCCCcEEEeecCCCccccCCCcceeccc
Q 039231          379 -------------RVAEELSSTIGIARGLEYLHLGCSTRILHFDIKPHNILLDEDFCPKISDFGLAKICNRKESIISMTG  445 (506)
Q Consensus       379 -------------~~~~~l~i~~~i~~gl~~LH~~~~~~ivH~dlkp~Nill~~~~~~ki~dfg~a~~~~~~~~~~~~~~  445 (506)
                                   ++.....++.|++.||+|||   +++|+||||||+|||+++++.+||+|||+++........  ...
T Consensus        81 ~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH---~~~ivHrDikp~Nill~~~~~~kL~Dfg~~~~~~~~~~~--~~~  155 (321)
T cd05591          81 GDLMFQIQRSRKFDEPRSRFYAAEVTLALMFLH---RHGVIYRDLKLDNILLDAEGHCKLADFGMCKEGILNGVT--TTT  155 (321)
T ss_pred             CcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHH---HCCeeccCCCHHHeEECCCCCEEEeecccceecccCCcc--ccc
Confidence                         22335668899999999999   899999999999999999999999999998754322211  234


Q ss_pred             CCCCcccccccccccccCCCCccccHHHHHHHHHHHHcCCCCCCCCCCCc
Q 039231          446 ARGTVGYIAPEVFCRNIGEVSYKSDVYNYGMMIFEMTGGRKNVDVVDNGS  495 (506)
Q Consensus       446 ~~gt~~y~aPE~l~~~~~~~s~~~Dv~s~G~il~elltg~~pf~~~~~~~  495 (506)
                      ..||+.|+|||++.+.  .++.++||||||+++|||++|+.||...+..+
T Consensus       156 ~~gt~~y~aPE~~~~~--~~~~~~DvwslG~il~el~tg~~Pf~~~~~~~  203 (321)
T cd05591         156 FCGTPDYIAPEILQEL--EYGPSVDWWALGVLMYEMMAGQPPFEADNEDD  203 (321)
T ss_pred             cccCccccCHHHHcCC--CCCCccceechhHHHHHHhcCCCCCCCCCHHH
Confidence            5689999999998653  68899999999999999999999998765443

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to

>cd05589 STKc_PKN Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N

Probab=99.96  E-value=7.8e-30  Score=254.50  Aligned_cols=172  Identities=26%  Similarity=0.372  Sum_probs=138.5

Q ss_pred             hccccCccCceEEEEEEEc-CCCEEEEEEeccCC----CCchhhHHHHHHh---hccCccceeEEEEEe-----------
Q 039231          317 FKYKLGQGGYGSVYKGKLL-DGSNVAVKVLNDSK----GNGKEFINEVASI---SRTSHVNVVALLGFC-----------  377 (506)
Q Consensus       317 ~~~~ig~G~~g~V~~~~~~-~~~~vavK~l~~~~----~~~~~~~~E~~~l---~~l~h~niv~l~g~~-----------  377 (506)
                      +.+.||+|+||.||+|+.. +++.||||+++...    ...+.+.+|++++   .+++||||+++++++           
T Consensus         3 i~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~l~~e~~~~~~~~~l~hp~i~~~~~~~~~~~~~~lv~E   82 (324)
T cd05589           3 CLAVLGRGHFGKVLLAEYKKTGELYAIKALKKGDIIARDEVESLMCEKRIFETANSERHPFLVNLFACFQTEDHVCFVME   82 (324)
T ss_pred             EEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccccCCCChhceeeEEEcCCEEEEEEc
Confidence            3567999999999999875 58999999997432    2234566666554   567899999999876           


Q ss_pred             ---------------eccchhhhHHHHHHHHHHHHhhcCCCCeEecCcCCCcEEECCCCcEEEeecCCCccccCCCccee
Q 039231          378 ---------------LRVAEELSSTIGIARGLEYLHLGCSTRILHFDIKPHNILLDEDFCPKISDFGLAKICNRKESIIS  442 (506)
Q Consensus       378 ---------------~~~~~~l~i~~~i~~gl~~LH~~~~~~ivH~dlkp~Nill~~~~~~ki~dfg~a~~~~~~~~~~~  442 (506)
                                     +++.+.+.++.|++.||+|||   +++++||||||+||++++++.+||+|||+++.......  .
T Consensus        83 ~~~~~~L~~~~~~~~l~~~~~~~~~~qi~~al~~lH---~~~ivHrdlkp~Nill~~~~~~kL~Dfg~~~~~~~~~~--~  157 (324)
T cd05589          83 YAAGGDLMMHIHTDVFSEPRAVFYAACVVLGLQYLH---ENKIVYRDLKLDNLLLDTEGFVKIADFGLCKEGMGFGD--R  157 (324)
T ss_pred             CCCCCcHHHHhhcCCCCHHHHHHHHHHHHHHHHHHH---hCCeEecCCCHHHeEECCCCcEEeCcccCCccCCCCCC--c
Confidence                           233446778999999999999   89999999999999999999999999999875332221  1


Q ss_pred             cccCCCCcccccccccccccCCCCccccHHHHHHHHHHHHcCCCCCCCCCCCc
Q 039231          443 MTGARGTVGYIAPEVFCRNIGEVSYKSDVYNYGMMIFEMTGGRKNVDVVDNGS  495 (506)
Q Consensus       443 ~~~~~gt~~y~aPE~l~~~~~~~s~~~Dv~s~G~il~elltg~~pf~~~~~~~  495 (506)
                      .....|++.|+|||.+.+.  .++.++||||||+++|||++|+.||...+..+
T Consensus       158 ~~~~~g~~~y~aPE~~~~~--~~~~~~DiwslG~il~el~~G~~pf~~~~~~~  208 (324)
T cd05589         158 TSTFCGTPEFLAPEVLTET--SYTRAVDWWGLGVLIYEMLVGESPFPGDDEEE  208 (324)
T ss_pred             ccccccCccccCHhHhcCC--CCCcccchhhHHHHHHHHHhCCCCCCCCCHHH
Confidence            2346689999999998654  68899999999999999999999998765433

Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved

>KOG4250 consensus TANK binding protein kinase TBK1 [Signal transduction mechanisms]

Probab=99.96  E-value=2.3e-30  Score=262.89  Aligned_cols=169  Identities=29%  Similarity=0.485  Sum_probs=145.2

Q ss_pred             cccCccCceEEEEEEEc-CCCEEEEEEeccCC--CCchhhHHHHHHhhccCccceeEEEEEe------------------
Q 039231          319 YKLGQGGYGSVYKGKLL-DGSNVAVKVLNDSK--GNGKEFINEVASISRTSHVNVVALLGFC------------------  377 (506)
Q Consensus       319 ~~ig~G~~g~V~~~~~~-~~~~vavK~l~~~~--~~~~~~~~E~~~l~~l~h~niv~l~g~~------------------  377 (506)
                      +.||+||||.||+|+.+ .|+.||||.++...  ...+...+|+++|++++|+|||++++.-                  
T Consensus        19 e~LG~Ga~g~V~rgrnketG~~vAvK~~~~~~~~r~~e~~~~EieilkKLnh~NIVk~f~iee~~~~~~~~~~~vlvmEy   98 (732)
T KOG4250|consen   19 ERLGKGAFGNVYRGRNKETGRLVAVKTFNKESSLRPRERWCREIEILKKLNHPNIVKLFDIEETKFLGLVTRLPVLVMEY   98 (732)
T ss_pred             hhhcCCccceeeeecccccccchhHHhhhhhcccchHHHHHHHHHHHHHcCchhhhhhcccCCccccCcccccceEEEee
Confidence            46999999999999965 59999999997643  3446788999999999999999987642                  


Q ss_pred             ------------------eccchhhhHHHHHHHHHHHHhhcCCCCeEecCcCCCcEEEC--CCC--cEEEeecCCCcccc
Q 039231          378 ------------------LRVAEELSSTIGIARGLEYLHLGCSTRILHFDIKPHNILLD--EDF--CPKISDFGLAKICN  435 (506)
Q Consensus       378 ------------------~~~~~~l~i~~~i~~gl~~LH~~~~~~ivH~dlkp~Nill~--~~~--~~ki~dfg~a~~~~  435 (506)
                                        +++.+.+.+..++..||.|||   +.+|+||||||.||++-  ++|  .-||+|||.|+...
T Consensus        99 C~gGsL~~~L~~PEN~~GLpE~e~l~lL~d~~~al~~Lr---En~IvHRDlKP~NIvl~~Gedgq~IyKLtDfG~Arel~  175 (732)
T KOG4250|consen   99 CSGGSLRKVLNSPENAYGLPESEFLDLLSDLVSALRHLR---ENGIVHRDLKPGNIVLQIGEDGQSIYKLTDFGAARELD  175 (732)
T ss_pred             cCCCcHHHHhcCcccccCCCHHHHHHHHHHHHHHHHHHH---HcCceeccCCCCcEEEeecCCCceEEeeecccccccCC
Confidence                              556668889999999999999   89999999999999983  333  46999999999888


Q ss_pred             CCCcceecccCCCCcccccccccccccCCCCccccHHHHHHHHHHHHcCCCCCCCCCCC
Q 039231          436 RKESIISMTGARGTVGYIAPEVFCRNIGEVSYKSDVYNYGMMIFEMTGGRKNVDVVDNG  494 (506)
Q Consensus       436 ~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~s~~~Dv~s~G~il~elltg~~pf~~~~~~  494 (506)
                      .+..   .....||..|++||.+.+. +.++..+|.|||||++||.+||..||......
T Consensus       176 d~s~---~~S~vGT~~YLhPel~E~q-~~y~~tVDLWS~GvtlY~caTG~lPF~p~~~p  230 (732)
T KOG4250|consen  176 DNSL---FTSLVGTEEYLHPELYERQ-KKYTATVDLWSFGVTLYECATGELPFIPFGGP  230 (732)
T ss_pred             CCCe---eeeecCchhhcChHHHhhc-cCcCceeehhhhhhHHHHHhccCCCCCcCCCc
Confidence            7763   4678999999999999752 58999999999999999999999999876544

>PHA03207 serine/threonine kinase US3; Provisional

Probab=99.96  E-value=8.9e-30  Score=260.68  Aligned_cols=174  Identities=25%  Similarity=0.337  Sum_probs=143.4

Q ss_pred             HHhhhccccCccCceEEEEEEEc---CCCEEEEEEeccCCCCchhhHHHHHHhhccCccceeEEEEEe------------
Q 039231          313 MTNSFKYKLGQGGYGSVYKGKLL---DGSNVAVKVLNDSKGNGKEFINEVASISRTSHVNVVALLGFC------------  377 (506)
Q Consensus       313 ~~~~~~~~ig~G~~g~V~~~~~~---~~~~vavK~l~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~------------  377 (506)
                      ..+.+.+.||+|+||.||++...   .+..||+|.+...    +...+|++++++++||||+++++++            
T Consensus        92 ~~y~i~~~Lg~G~~g~Vy~~~~~~~~~~~~v~vK~~~~~----~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~e~  167 (392)
T PHA03207         92 MQYNILSSLTPGSEGEVFVCTKHGDEQRKKVIVKAVTGG----KTPGREIDILKTISHRAIINLIHAYRWKSTVCMVMPK  167 (392)
T ss_pred             CceEEEEeecCCCCeEEEEEEEcCCccceeEEEEecccc----ccHHHHHHHHHhcCCCCccceeeeEeeCCEEEEEehh
Confidence            34555678999999999999753   3578999988643    3457899999999999999998765            


Q ss_pred             --------------eccchhhhHHHHHHHHHHHHhhcCCCCeEecCcCCCcEEECCCCcEEEeecCCCccccCCCcceec
Q 039231          378 --------------LRVAEELSSTIGIARGLEYLHLGCSTRILHFDIKPHNILLDEDFCPKISDFGLAKICNRKESIISM  443 (506)
Q Consensus       378 --------------~~~~~~l~i~~~i~~gl~~LH~~~~~~ivH~dlkp~Nill~~~~~~ki~dfg~a~~~~~~~~~~~~  443 (506)
                                    +.+.+++.++.||+.||+|||   +++|+||||||+|||++.++.+||+|||+++...........
T Consensus       168 ~~~~l~~~l~~~~~l~~~~~~~i~~ql~~aL~~LH---~~givHrDlkp~Nill~~~~~~~l~DfG~a~~~~~~~~~~~~  244 (392)
T PHA03207        168 YKCDLFTYVDRSGPLPLEQAITIQRRLLEALAYLH---GRGIIHRDVKTENIFLDEPENAVLGDFGAACKLDAHPDTPQC  244 (392)
T ss_pred             cCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH---HCCccccCCCHHHEEEcCCCCEEEccCccccccCcccccccc
Confidence                          233446789999999999999   899999999999999999999999999999766544332223


Q ss_pred             ccCCCCcccccccccccccCCCCccccHHHHHHHHHHHHcCCCCCCCCCCCc
Q 039231          444 TGARGTVGYIAPEVFCRNIGEVSYKSDVYNYGMMIFEMTGGRKNVDVVDNGS  495 (506)
Q Consensus       444 ~~~~gt~~y~aPE~l~~~~~~~s~~~Dv~s~G~il~elltg~~pf~~~~~~~  495 (506)
                      ....||+.|+|||++...  .++.++|||||||++|||++|+.||.......
T Consensus       245 ~~~~gt~~y~aPE~~~~~--~~~~~~DvwslGvil~el~~g~~pf~~~~~~~  294 (392)
T PHA03207        245 YGWSGTLETNSPELLALD--PYCAKTDIWSAGLVLFEMSVKNVTLFGKQVKS  294 (392)
T ss_pred             cccccccCccCHhHhcCC--CCCchhhHHHHHHHHHHHHHCCCCCCCCCCCC
Confidence            346789999999998654  68899999999999999999999998765443

>cd05594 STKc_PKB_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha

Probab=99.96  E-value=4.3e-30  Score=256.46  Aligned_cols=167  Identities=29%  Similarity=0.385  Sum_probs=137.9

Q ss_pred             ccCccCceEEEEEEEc-CCCEEEEEEeccCC----CCchhhHHHHHHhhccCccceeEEEEEe-----------------
Q 039231          320 KLGQGGYGSVYKGKLL-DGSNVAVKVLNDSK----GNGKEFINEVASISRTSHVNVVALLGFC-----------------  377 (506)
Q Consensus       320 ~ig~G~~g~V~~~~~~-~~~~vavK~l~~~~----~~~~~~~~E~~~l~~l~h~niv~l~g~~-----------------  377 (506)
                      .||+|+||.||+++.. +++.+|+|+++...    .....+.+|++++..++||||+++.+++                 
T Consensus         2 ~lG~G~~g~V~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~~~   81 (325)
T cd05594           2 LLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFVMEYANGGE   81 (325)
T ss_pred             eeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCCceEEEEEcCCEEEEEEeCCCCCc
Confidence            5899999999999874 58999999997532    2335678899999999999999998766                 


Q ss_pred             ----------eccchhhhHHHHHHHHHHHHhhcCC-CCeEecCcCCCcEEECCCCcEEEeecCCCccccCCCcceecccC
Q 039231          378 ----------LRVAEELSSTIGIARGLEYLHLGCS-TRILHFDIKPHNILLDEDFCPKISDFGLAKICNRKESIISMTGA  446 (506)
Q Consensus       378 ----------~~~~~~l~i~~~i~~gl~~LH~~~~-~~ivH~dlkp~Nill~~~~~~ki~dfg~a~~~~~~~~~~~~~~~  446 (506)
                                +.+.+...++.||+.||+|||   + .+|+||||||+|||+++++.+||+|||+++.......  .....
T Consensus        82 L~~~l~~~~~l~~~~~~~~~~qi~~aL~~lH---~~~~ivHrDikp~NIll~~~~~~kL~Dfg~~~~~~~~~~--~~~~~  156 (325)
T cd05594          82 LFFHLSRERVFSEDRARFYGAEIVSALDYLH---SEKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGA--TMKTF  156 (325)
T ss_pred             HHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH---hcCCEEecCCCCCeEEECCCCCEEEecCCCCeecCCCCc--ccccc
Confidence                      223345678899999999999   6 7999999999999999999999999999875432221  12345


Q ss_pred             CCCcccccccccccccCCCCccccHHHHHHHHHHHHcCCCCCCCCCC
Q 039231          447 RGTVGYIAPEVFCRNIGEVSYKSDVYNYGMMIFEMTGGRKNVDVVDN  493 (506)
Q Consensus       447 ~gt~~y~aPE~l~~~~~~~s~~~Dv~s~G~il~elltg~~pf~~~~~  493 (506)
                      .||+.|+|||++.+.  .++.++||||||+++|||++|+.||...+.
T Consensus       157 ~gt~~y~aPE~~~~~--~~~~~~DiwslG~il~el~tG~~Pf~~~~~  201 (325)
T cd05594         157 CGTPEYLAPEVLEDN--DYGRAVDWWGLGVVMYEMMCGRLPFYNQDH  201 (325)
T ss_pred             cCCcccCCHHHHccC--CCCCccccccccceeeeeccCCCCCCCCCH
Confidence            689999999998553  788999999999999999999999976544

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficien

>cd07853 STKc_NLK Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase

Probab=99.96  E-value=1e-29  Score=258.55  Aligned_cols=173  Identities=31%  Similarity=0.406  Sum_probs=141.4

Q ss_pred             ccccCccCceEEEEEEEc-CCCEEEEEEeccCCC---CchhhHHHHHHhhccCccceeEEEEEee---------------
Q 039231          318 KYKLGQGGYGSVYKGKLL-DGSNVAVKVLNDSKG---NGKEFINEVASISRTSHVNVVALLGFCL---------------  378 (506)
Q Consensus       318 ~~~ig~G~~g~V~~~~~~-~~~~vavK~l~~~~~---~~~~~~~E~~~l~~l~h~niv~l~g~~~---------------  378 (506)
                      .++||+|+||.||+|+.. +++.||||++.....   ..+++.+|+++++.++|+||+++++++.               
T Consensus         5 ~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e   84 (372)
T cd07853           5 DRPIGYGAFGVVWSVTDPRDGKRVALKKMPNVFQNLVSCKRVFRELKMLCFFKHDNVLSALDILQPPHIDPFEEIYVVTE   84 (372)
T ss_pred             cceeeeCCCEEEEEEEECCCCCEEEEEeccccccchHHHHHHHHHHHHHHhCCCCCcCCHhheecCCCccccceEEEEee
Confidence            467999999999999874 689999999865322   2367889999999999999999887652               


Q ss_pred             ----------------ccchhhhHHHHHHHHHHHHhhcCCCCeEecCcCCCcEEECCCCcEEEeecCCCccccCCCccee
Q 039231          379 ----------------RVAEELSSTIGIARGLEYLHLGCSTRILHFDIKPHNILLDEDFCPKISDFGLAKICNRKESIIS  442 (506)
Q Consensus       379 ----------------~~~~~l~i~~~i~~gl~~LH~~~~~~ivH~dlkp~Nill~~~~~~ki~dfg~a~~~~~~~~~~~  442 (506)
                                      .+.+...++.||+.||+|||   +++++||||||+|||+++++.+||+|||+++........ .
T Consensus        85 ~~~~~l~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH---~~~ivH~dlkp~Nili~~~~~~kL~Dfg~a~~~~~~~~~-~  160 (372)
T cd07853          85 LMQSDLHKIIVSPQPLSSDHVKVFLYQILRGLKYLH---SAGILHRDIKPGNLLVNSNCVLKICDFGLARVEEPDESK-H  160 (372)
T ss_pred             ccccCHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH---hCCeeCCCCChHHEEECCCCCEEeccccceeecccCccc-c
Confidence                            22235568899999999999   899999999999999999999999999999865433221 1


Q ss_pred             cccCCCCcccccccccccccCCCCccccHHHHHHHHHHHHcCCCCCCCCCCCc
Q 039231          443 MTGARGTVGYIAPEVFCRNIGEVSYKSDVYNYGMMIFEMTGGRKNVDVVDNGS  495 (506)
Q Consensus       443 ~~~~~gt~~y~aPE~l~~~~~~~s~~~Dv~s~G~il~elltg~~pf~~~~~~~  495 (506)
                      .....+++.|+|||.+.+. ..++.++|||||||++|||++|+.||...+..+
T Consensus       161 ~~~~~~~~~y~aPE~~~~~-~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~  212 (372)
T cd07853         161 MTQEVVTQYYRAPEILMGS-RHYTSAVDIWSVGCIFAELLGRRILFQAQSPIQ  212 (372)
T ss_pred             CCCCCcCCCcCCHHHHcCC-CCCCcHHHHHhHHHHHHHHHcCCCCCCCCCHHH
Confidence            2345678999999998653 357889999999999999999999998765443

Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription

>cd05614 STKc_MSK2_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2

Probab=99.96  E-value=1.1e-29  Score=254.36  Aligned_cols=173  Identities=28%  Similarity=0.316  Sum_probs=139.3

Q ss_pred             hccccCccCceEEEEEEE----cCCCEEEEEEeccC-----CCCchhhHHHHHHhhccC-ccceeEEEEEe---------
Q 039231          317 FKYKLGQGGYGSVYKGKL----LDGSNVAVKVLNDS-----KGNGKEFINEVASISRTS-HVNVVALLGFC---------  377 (506)
Q Consensus       317 ~~~~ig~G~~g~V~~~~~----~~~~~vavK~l~~~-----~~~~~~~~~E~~~l~~l~-h~niv~l~g~~---------  377 (506)
                      +.++||+|+||.||+++.    .+++.+|+|++.+.     ....+.+.+|++++.+++ |+||+++++++         
T Consensus         4 ~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~lv   83 (332)
T cd05614           4 LLKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEHVRQSPFLVTLHYAFQTEAKLHLI   83 (332)
T ss_pred             EEEEEeecCCEEEEEEEEcccCCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHHhccCCCCcccEEEEEecCCEEEEE
Confidence            456799999999999975    35789999998642     122356788999999995 99999998765         


Q ss_pred             ------------------eccchhhhHHHHHHHHHHHHhhcCCCCeEecCcCCCcEEECCCCcEEEeecCCCccccCCCc
Q 039231          378 ------------------LRVAEELSSTIGIARGLEYLHLGCSTRILHFDIKPHNILLDEDFCPKISDFGLAKICNRKES  439 (506)
Q Consensus       378 ------------------~~~~~~l~i~~~i~~gl~~LH~~~~~~ivH~dlkp~Nill~~~~~~ki~dfg~a~~~~~~~~  439 (506)
                                        +.+.+...++.||+.||+|||   +++|+||||||+|||++.++.+||+|||+++.......
T Consensus        84 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH---~~~ivHrDlkp~Nili~~~~~~kl~DfG~~~~~~~~~~  160 (332)
T cd05614          84 LDYVSGGEMFTHLYQRDNFSEDEVRFYSGEIILALEHLH---KLGIVYRDIKLENILLDSEGHVVLTDFGLSKEFLSEEK  160 (332)
T ss_pred             EeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHH---HCCcEecCCCHHHeEECCCCCEEEeeCcCCccccccCC
Confidence                              223335668889999999999   89999999999999999999999999999986543322


Q ss_pred             ceecccCCCCcccccccccccccCCCCccccHHHHHHHHHHHHcCCCCCCCCCCC
Q 039231          440 IISMTGARGTVGYIAPEVFCRNIGEVSYKSDVYNYGMMIFEMTGGRKNVDVVDNG  494 (506)
Q Consensus       440 ~~~~~~~~gt~~y~aPE~l~~~~~~~s~~~Dv~s~G~il~elltg~~pf~~~~~~  494 (506)
                      .. .....||+.|+|||.+.+. ..++.++||||||+++|||++|+.||......
T Consensus       161 ~~-~~~~~gt~~y~aPE~~~~~-~~~~~~~DiwslG~il~elltg~~pf~~~~~~  213 (332)
T cd05614         161 ER-TYSFCGTIEYMAPEIIRGK-GGHGKAVDWWSLGILIFELLTGASPFTLEGER  213 (332)
T ss_pred             Cc-cccccCCccccCHHHhcCC-CCCCCccccccchhhhhhhhcCCCCCCCCCCC
Confidence            11 1345689999999998643 34788999999999999999999999765443

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph

>cd07867 STKc_CDC2L6 Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6

Probab=99.96  E-value=2.3e-29  Score=250.15  Aligned_cols=169  Identities=29%  Similarity=0.385  Sum_probs=137.1

Q ss_pred             cccCccCceEEEEEEEcC---CCEEEEEEeccCCCCchhhHHHHHHhhccCccceeEEEEEeec----------------
Q 039231          319 YKLGQGGYGSVYKGKLLD---GSNVAVKVLNDSKGNGKEFINEVASISRTSHVNVVALLGFCLR----------------  379 (506)
Q Consensus       319 ~~ig~G~~g~V~~~~~~~---~~~vavK~l~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~----------------  379 (506)
                      .+||+|+||.||+|+..+   +..+|+|.+.... ....+.+|++++++++||||+++++++..                
T Consensus         7 ~~lG~G~~g~Vy~~~~~~~~~~~~~a~k~~~~~~-~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~~~~~   85 (317)
T cd07867           7 CKVGRGTYGHVYKAKRKDGKDEKEYALKQIEGTG-ISMSACREIALLRELKHPNVIALQKVFLSHSDRKVWLLFDYAEHD   85 (317)
T ss_pred             eEeccCCCeeEEEEEecCCCccceEEEEEecCCC-CcHHHHHHHHHHHhCCCCCeeeEEEEEeccCCCeEEEEEeeeCCc
Confidence            469999999999998753   5789999886543 23568899999999999999999887621                


Q ss_pred             ---------------------cchhhhHHHHHHHHHHHHhhcCCCCeEecCcCCCcEEE----CCCCcEEEeecCCCccc
Q 039231          380 ---------------------VAEELSSTIGIARGLEYLHLGCSTRILHFDIKPHNILL----DEDFCPKISDFGLAKIC  434 (506)
Q Consensus       380 ---------------------~~~~l~i~~~i~~gl~~LH~~~~~~ivH~dlkp~Nill----~~~~~~ki~dfg~a~~~  434 (506)
                                           +.....++.|++.||+|||   +++|+||||||+|||+    ++++.+||+|||+++..
T Consensus        86 l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH---~~~ivH~Dlkp~Nil~~~~~~~~~~~kl~DfG~a~~~  162 (317)
T cd07867          86 LWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYLH---ANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLF  162 (317)
T ss_pred             HHHHHHhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHH---hCCEEcCCCCHHHEEEccCCCCCCcEEEeeccceecc
Confidence                                 1114568899999999999   8999999999999999    56678999999999876


Q ss_pred             cCCCcc-eecccCCCCcccccccccccccCCCCccccHHHHHHHHHHHHcCCCCCCCCC
Q 039231          435 NRKESI-ISMTGARGTVGYIAPEVFCRNIGEVSYKSDVYNYGMMIFEMTGGRKNVDVVD  492 (506)
Q Consensus       435 ~~~~~~-~~~~~~~gt~~y~aPE~l~~~~~~~s~~~Dv~s~G~il~elltg~~pf~~~~  492 (506)
                      ...... .......+|+.|+|||.+.+. ..++.++||||||+++|||+||+.||....
T Consensus       163 ~~~~~~~~~~~~~~~t~~y~aPE~~~~~-~~~~~~~DiwSlG~il~el~tg~~~f~~~~  220 (317)
T cd07867         163 NSPLKPLADLDPVVVTFWYRAPELLLGA-RHYTKAIDIWAIGCIFAELLTSEPIFHCRQ  220 (317)
T ss_pred             CCCcccccccCcceecccccCcHHhcCC-CccCcHHHHHhHHHHHHHHHhCCCCccccc
Confidence            543221 112345679999999998653 357899999999999999999999997654

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as

>cd07872 STKc_PCTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase

Probab=99.96  E-value=1.9e-29  Score=249.96  Aligned_cols=173  Identities=30%  Similarity=0.422  Sum_probs=141.4

Q ss_pred             hccccCccCceEEEEEEEc-CCCEEEEEEeccCC--CCchhhHHHHHHhhccCccceeEEEEEee---------------
Q 039231          317 FKYKLGQGGYGSVYKGKLL-DGSNVAVKVLNDSK--GNGKEFINEVASISRTSHVNVVALLGFCL---------------  378 (506)
Q Consensus       317 ~~~~ig~G~~g~V~~~~~~-~~~~vavK~l~~~~--~~~~~~~~E~~~l~~l~h~niv~l~g~~~---------------  378 (506)
                      ..++||+|+||.||+|+.. +++.+|+|.++...  .....+.+|++++++++||||+++++++.               
T Consensus        10 ~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~   89 (309)
T cd07872          10 KLEKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIVHTDKSLTLVFEYLDKD   89 (309)
T ss_pred             EEEEecccCCEEEEEEEecCCCCeEEEEEeeccccCCcchhHHHHHHHHHhCCCCCcceEEEEEeeCCeEEEEEeCCCCC
Confidence            3467999999999999875 57889999987433  23356789999999999999999998872               


Q ss_pred             ------------ccchhhhHHHHHHHHHHHHhhcCCCCeEecCcCCCcEEECCCCcEEEeecCCCccccCCCcceecccC
Q 039231          379 ------------RVAEELSSTIGIARGLEYLHLGCSTRILHFDIKPHNILLDEDFCPKISDFGLAKICNRKESIISMTGA  446 (506)
Q Consensus       379 ------------~~~~~l~i~~~i~~gl~~LH~~~~~~ivH~dlkp~Nill~~~~~~ki~dfg~a~~~~~~~~~~~~~~~  446 (506)
                                  ...+...++.|++.||+|||   +++|+||||||+||++++++.+||+|||+++........  ....
T Consensus        90 l~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH---~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~--~~~~  164 (309)
T cd07872          90 LKQYMDDCGNIMSMHNVKIFLYQILRGLAYCH---RRKVLHRDLKPQNLLINERGELKLADFGLARAKSVPTKT--YSNE  164 (309)
T ss_pred             HHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHEEECCCCCEEECccccceecCCCccc--cccc
Confidence                        12234557889999999999   899999999999999999999999999999765433221  1334


Q ss_pred             CCCcccccccccccccCCCCccccHHHHHHHHHHHHcCCCCCCCCCCCc
Q 039231          447 RGTVGYIAPEVFCRNIGEVSYKSDVYNYGMMIFEMTGGRKNVDVVDNGS  495 (506)
Q Consensus       447 ~gt~~y~aPE~l~~~~~~~s~~~Dv~s~G~il~elltg~~pf~~~~~~~  495 (506)
                      .+++.|+|||.+.+. ..++.++||||||+++|||++|+.||...+..+
T Consensus       165 ~~~~~y~aPE~~~~~-~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~  212 (309)
T cd07872         165 VVTLWYRPPDVLLGS-SEYSTQIDMWGVGCIFFEMASGRPLFPGSTVED  212 (309)
T ss_pred             cccccccCCHHHhCC-CCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHH
Confidence            678999999998543 467889999999999999999999998765443

Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play

>cd05590 STKc_nPKC_eta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta

Probab=99.96  E-value=1.2e-29  Score=252.69  Aligned_cols=168  Identities=27%  Similarity=0.364  Sum_probs=137.6

Q ss_pred             ccCccCceEEEEEEEc-CCCEEEEEEeccC----CCCchhhHHHHHHhhcc-CccceeEEEEEe----------------
Q 039231          320 KLGQGGYGSVYKGKLL-DGSNVAVKVLNDS----KGNGKEFINEVASISRT-SHVNVVALLGFC----------------  377 (506)
Q Consensus       320 ~ig~G~~g~V~~~~~~-~~~~vavK~l~~~----~~~~~~~~~E~~~l~~l-~h~niv~l~g~~----------------  377 (506)
                      .||+|+||.||+|+.. +++.||||+++..    ....+.+.+|.+++..+ +||||+++++++                
T Consensus         2 ~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~~~~~iv~Ey~~~g   81 (320)
T cd05590           2 VLGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLYCCFQTPDRLFFVMEFVNGG   81 (320)
T ss_pred             eeeeCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhccCCCchhceeeEEEcCCEEEEEEcCCCCc
Confidence            5999999999999975 4889999998643    22335677888888876 699999998876                


Q ss_pred             -----------eccchhhhHHHHHHHHHHHHhhcCCCCeEecCcCCCcEEECCCCcEEEeecCCCccccCCCcceecccC
Q 039231          378 -----------LRVAEELSSTIGIARGLEYLHLGCSTRILHFDIKPHNILLDEDFCPKISDFGLAKICNRKESIISMTGA  446 (506)
Q Consensus       378 -----------~~~~~~l~i~~~i~~gl~~LH~~~~~~ivH~dlkp~Nill~~~~~~ki~dfg~a~~~~~~~~~~~~~~~  446 (506)
                                 +++...+.++.|++.||+|||   +++++||||||+|||+++++.+||+|||+++........  ....
T Consensus        82 ~L~~~i~~~~~l~~~~~~~~~~ql~~~L~~lH---~~~ivH~dlkp~NIli~~~~~~kL~DfG~~~~~~~~~~~--~~~~  156 (320)
T cd05590          82 DLMFHIQKSRRFDEARARFYAAEITSALMFLH---DKGIIYRDLKLDNVLLDHEGHCKLADFGMCKEGIFNGKT--TSTF  156 (320)
T ss_pred             hHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHH---HCCeEeCCCCHHHeEECCCCcEEEeeCCCCeecCcCCCc--cccc
Confidence                       222335668899999999999   899999999999999999999999999998754322211  2345


Q ss_pred             CCCcccccccccccccCCCCccccHHHHHHHHHHHHcCCCCCCCCCCC
Q 039231          447 RGTVGYIAPEVFCRNIGEVSYKSDVYNYGMMIFEMTGGRKNVDVVDNG  494 (506)
Q Consensus       447 ~gt~~y~aPE~l~~~~~~~s~~~Dv~s~G~il~elltg~~pf~~~~~~  494 (506)
                      .||+.|+|||.+.+.  .++.++||||||+++|||++|+.||...+..
T Consensus       157 ~gt~~y~aPE~~~~~--~~~~~~DiwslG~il~el~~g~~Pf~~~~~~  202 (320)
T cd05590         157 CGTPDYIAPEILQEM--LYGPSVDWWAMGVLLYEMLCGHAPFEAENED  202 (320)
T ss_pred             ccCccccCHHHHcCC--CCCCccchhhhHHHHHHHhhCCCCCCCCCHH
Confidence            689999999998654  6888999999999999999999999876543

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signal

>cd07874 STKc_JNK3 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3

Probab=99.96  E-value=1.2e-29  Score=256.37  Aligned_cols=168  Identities=28%  Similarity=0.301  Sum_probs=140.1

Q ss_pred             ccccCccCceEEEEEEEc-CCCEEEEEEeccCCC---CchhhHHHHHHhhccCccceeEEEEEee---------------
Q 039231          318 KYKLGQGGYGSVYKGKLL-DGSNVAVKVLNDSKG---NGKEFINEVASISRTSHVNVVALLGFCL---------------  378 (506)
Q Consensus       318 ~~~ig~G~~g~V~~~~~~-~~~~vavK~l~~~~~---~~~~~~~E~~~l~~l~h~niv~l~g~~~---------------  378 (506)
                      .+.||+|+||.||++... .++.+|||++.....   ..+.+.+|+.+++.++||||+++++++.               
T Consensus        22 ~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~~lv~  101 (355)
T cd07874          22 LKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKSLEEFQDVYLVM  101 (355)
T ss_pred             EEEeeecCCEEEEEEEecCCCceEEEEEeCCcccChHHHHHHHHHHHHHHHhCCCchhceeeeeeccccccccceeEEEh
Confidence            467999999999999864 488999999975432   2356788999999999999999998652               


Q ss_pred             ---------------ccchhhhHHHHHHHHHHHHhhcCCCCeEecCcCCCcEEECCCCcEEEeecCCCccccCCCcceec
Q 039231          379 ---------------RVAEELSSTIGIARGLEYLHLGCSTRILHFDIKPHNILLDEDFCPKISDFGLAKICNRKESIISM  443 (506)
Q Consensus       379 ---------------~~~~~l~i~~~i~~gl~~LH~~~~~~ivH~dlkp~Nill~~~~~~ki~dfg~a~~~~~~~~~~~~  443 (506)
                                     +......++.|+++||+|||   +++|+||||||+|||++.++.+||+|||+++.......   .
T Consensus       102 e~~~~~l~~~~~~~l~~~~~~~~~~qi~~aL~~LH---~~givHrDikp~Nill~~~~~~kl~Dfg~~~~~~~~~~---~  175 (355)
T cd07874         102 ELMDANLCQVIQMELDHERMSYLLYQMLCGIKHLH---SAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFM---M  175 (355)
T ss_pred             hhhcccHHHHHhhcCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCChHHEEECCCCCEEEeeCcccccCCCccc---c
Confidence                           12224568899999999999   89999999999999999999999999999986543321   2


Q ss_pred             ccCCCCcccccccccccccCCCCccccHHHHHHHHHHHHcCCCCCCCCCC
Q 039231          444 TGARGTVGYIAPEVFCRNIGEVSYKSDVYNYGMMIFEMTGGRKNVDVVDN  493 (506)
Q Consensus       444 ~~~~gt~~y~aPE~l~~~~~~~s~~~Dv~s~G~il~elltg~~pf~~~~~  493 (506)
                      ....+|+.|+|||++.+.  .++.++||||||+++|||++|+.||...+.
T Consensus       176 ~~~~~t~~y~aPE~~~~~--~~~~~~DiwslG~il~el~~g~~pf~~~~~  223 (355)
T cd07874         176 TPYVVTRYYRAPEVILGM--GYKENVDIWSVGCIMGEMVRHKILFPGRDY  223 (355)
T ss_pred             CCccccCCccCHHHHcCC--CCCchhhHHHHHHHHHHHHhCCCCCCCCCH
Confidence            345789999999998654  688999999999999999999999986543

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, strok

>cd05616 STKc_cPKC_beta Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta

Probab=99.96  E-value=1.3e-29  Score=252.88  Aligned_cols=172  Identities=25%  Similarity=0.364  Sum_probs=138.7

Q ss_pred             hccccCccCceEEEEEEEc-CCCEEEEEEeccCC----CCchhhHHHHHHhhcc-CccceeEEEEEe-------------
Q 039231          317 FKYKLGQGGYGSVYKGKLL-DGSNVAVKVLNDSK----GNGKEFINEVASISRT-SHVNVVALLGFC-------------  377 (506)
Q Consensus       317 ~~~~ig~G~~g~V~~~~~~-~~~~vavK~l~~~~----~~~~~~~~E~~~l~~l-~h~niv~l~g~~-------------  377 (506)
                      +.+.||+|+||.||+|+.. +++.+|+|+++...    ...+.+..|.+++..+ +|++|+++.+++             
T Consensus         4 ~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~E~~   83 (323)
T cd05616           4 FLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALSGKPPFLTQLHSCFQTMDRLYFVMEYV   83 (323)
T ss_pred             EEEEEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCeEeeEEEEEecCCEEEEEEcCC
Confidence            4567999999999999875 47899999997532    2224567788888777 488888888765             


Q ss_pred             --------------eccchhhhHHHHHHHHHHHHhhcCCCCeEecCcCCCcEEECCCCcEEEeecCCCccccCCCcceec
Q 039231          378 --------------LRVAEELSSTIGIARGLEYLHLGCSTRILHFDIKPHNILLDEDFCPKISDFGLAKICNRKESIISM  443 (506)
Q Consensus       378 --------------~~~~~~l~i~~~i~~gl~~LH~~~~~~ivH~dlkp~Nill~~~~~~ki~dfg~a~~~~~~~~~~~~  443 (506)
                                    +++.+.+.++.|++.||+|||   +++|+||||||+|||+++++.+||+|||+++.......  ..
T Consensus        84 ~~g~L~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH---~~~ivHrDlkp~Nill~~~~~~kL~DfG~~~~~~~~~~--~~  158 (323)
T cd05616          84 NGGDLMYQIQQVGRFKEPHAVFYAAEIAIGLFFLH---SKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENMWDGV--TT  158 (323)
T ss_pred             CCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHH---HCCEEecCCCHHHeEECCCCcEEEccCCCceecCCCCC--cc
Confidence                          223346678999999999999   89999999999999999999999999999975432221  12


Q ss_pred             ccCCCCcccccccccccccCCCCccccHHHHHHHHHHHHcCCCCCCCCCCCc
Q 039231          444 TGARGTVGYIAPEVFCRNIGEVSYKSDVYNYGMMIFEMTGGRKNVDVVDNGS  495 (506)
Q Consensus       444 ~~~~gt~~y~aPE~l~~~~~~~s~~~Dv~s~G~il~elltg~~pf~~~~~~~  495 (506)
                      ....||+.|+|||++.+.  .++.++|||||||++|||++|+.||...+..+
T Consensus       159 ~~~~gt~~y~aPE~~~~~--~~~~~~DiwSlGvil~elltg~~Pf~~~~~~~  208 (323)
T cd05616         159 KTFCGTPDYIAPEIIAYQ--PYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDE  208 (323)
T ss_pred             ccCCCChhhcCHHHhcCC--CCCCccchhchhHHHHHHHhCCCCCCCCCHHH
Confidence            345689999999998654  78999999999999999999999998765443

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and

>KOG0577 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.96  E-value=4e-30  Score=254.66  Aligned_cols=172  Identities=30%  Similarity=0.434  Sum_probs=147.2

Q ss_pred             ccCccCceEEEEEEE-cCCCEEEEEEeccCCCCc----hhhHHHHHHhhccCccceeEEEEEeeccch------------
Q 039231          320 KLGQGGYGSVYKGKL-LDGSNVAVKVLNDSKGNG----KEFINEVASISRTSHVNVVALLGFCLRVAE------------  382 (506)
Q Consensus       320 ~ig~G~~g~V~~~~~-~~~~~vavK~l~~~~~~~----~~~~~E~~~l~~l~h~niv~l~g~~~~~~~------------  382 (506)
                      .||.|+||.||-|++ ++...||||++..+..+.    ++++.|+..|.+++|||+|.+-|+++....            
T Consensus        33 EIGHGSFGAVYfArd~~n~evVAIKKMsySGKQs~EKWqDIlKEVrFL~~l~HPntieYkgCyLre~TaWLVMEYClGSA  112 (948)
T KOG0577|consen   33 EIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDILKEVRFLRQLRHPNTIEYKGCYLREHTAWLVMEYCLGSA  112 (948)
T ss_pred             HhcCCccceeEEeeccCccceeeeeeccccccccHHHHHHHHHHHHHHHhccCCCcccccceeeccchHHHHHHHHhccH
Confidence            599999999999986 457889999997543332    679999999999999999999999855433            


Q ss_pred             ---------------hhhHHHHHHHHHHHHhhcCCCCeEecCcCCCcEEECCCCcEEEeecCCCccccCCCcceecccCC
Q 039231          383 ---------------ELSSTIGIARGLEYLHLGCSTRILHFDIKPHNILLDEDFCPKISDFGLAKICNRKESIISMTGAR  447 (506)
Q Consensus       383 ---------------~l~i~~~i~~gl~~LH~~~~~~ivH~dlkp~Nill~~~~~~ki~dfg~a~~~~~~~~~~~~~~~~  447 (506)
                                     ...|..+.+.||+|||   +.+.||||||..||||++.|.+||+|||.|....+.      ..++
T Consensus       113 sDlleVhkKplqEvEIAAi~~gaL~gLaYLH---S~~~IHRDiKAGNILLse~g~VKLaDFGSAsi~~PA------nsFv  183 (948)
T KOG0577|consen  113 SDLLEVHKKPLQEVEIAAITHGALQGLAYLH---SHNRIHRDIKAGNILLSEPGLVKLADFGSASIMAPA------NSFV  183 (948)
T ss_pred             HHHHHHHhccchHHHHHHHHHHHHHHHHHHH---HhhHHhhhccccceEecCCCeeeeccccchhhcCch------hccc
Confidence                           4457789999999999   999999999999999999999999999999877654      4578


Q ss_pred             CCcccccccccc-cccCCCCccccHHHHHHHHHHHHcCCCCCCCCCCCcchhhh
Q 039231          448 GTVGYIAPEVFC-RNIGEVSYKSDVYNYGMMIFEMTGGRKNVDVVDNGSTALDL  500 (506)
Q Consensus       448 gt~~y~aPE~l~-~~~~~~s~~~Dv~s~G~il~elltg~~pf~~~~~~~~~~~~  500 (506)
                      |||.|||||++. .+.|.|+-++||||+|+...||..+++|+..++.-+..+.|
T Consensus       184 GTPywMAPEVILAMDEGqYdgkvDvWSLGITCIELAERkPPlFnMNAMSALYHI  237 (948)
T KOG0577|consen  184 GTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHI  237 (948)
T ss_pred             CCccccchhHheeccccccCCccceeeccchhhhhhhcCCCccCchHHHHHHHH
Confidence            999999999984 34478999999999999999999999999887765544443

>cd07875 STKc_JNK1 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1

Probab=99.96  E-value=1.4e-29  Score=256.74  Aligned_cols=171  Identities=28%  Similarity=0.295  Sum_probs=141.9

Q ss_pred             hhccccCccCceEEEEEEEc-CCCEEEEEEeccCC---CCchhhHHHHHHhhccCccceeEEEEEee-------------
Q 039231          316 SFKYKLGQGGYGSVYKGKLL-DGSNVAVKVLNDSK---GNGKEFINEVASISRTSHVNVVALLGFCL-------------  378 (506)
Q Consensus       316 ~~~~~ig~G~~g~V~~~~~~-~~~~vavK~l~~~~---~~~~~~~~E~~~l~~l~h~niv~l~g~~~-------------  378 (506)
                      .+.+.||+|+||.||+++.. .++.||||++....   ...+.+.+|+.+++.++||||+++++++.             
T Consensus        27 ~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~~~~~~~~~~~~l  106 (364)
T cd07875          27 QNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQDVYI  106 (364)
T ss_pred             eEEEEeecCCCeEEEEEEECCCCcEEEEEEeCccccCchhHHHHHHHHHHHHhcCCCCccccceeecccccccccCeEEE
Confidence            34567999999999999875 48899999997532   23357889999999999999999987642             


Q ss_pred             -----------------ccchhhhHHHHHHHHHHHHhhcCCCCeEecCcCCCcEEECCCCcEEEeecCCCccccCCCcce
Q 039231          379 -----------------RVAEELSSTIGIARGLEYLHLGCSTRILHFDIKPHNILLDEDFCPKISDFGLAKICNRKESII  441 (506)
Q Consensus       379 -----------------~~~~~l~i~~~i~~gl~~LH~~~~~~ivH~dlkp~Nill~~~~~~ki~dfg~a~~~~~~~~~~  441 (506)
                                       ++.....++.|++.||+|||   +++|+||||||+|||++.++.+||+|||+++.......  
T Consensus       107 v~e~~~~~l~~~~~~~~~~~~~~~~~~qi~~aL~~LH---~~~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~~~~--  181 (364)
T cd07875         107 VMELMDANLCQVIQMELDHERMSYLLYQMLCGIKHLH---SAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFM--  181 (364)
T ss_pred             EEeCCCCCHHHHHHhcCCHHHHHHHHHHHHHHHHHHh---hCCeecCCCCHHHEEECCCCcEEEEeCCCccccCCCCc--
Confidence                             22335568899999999999   89999999999999999999999999999986543321  


Q ss_pred             ecccCCCCcccccccccccccCCCCccccHHHHHHHHHHHHcCCCCCCCCCCC
Q 039231          442 SMTGARGTVGYIAPEVFCRNIGEVSYKSDVYNYGMMIFEMTGGRKNVDVVDNG  494 (506)
Q Consensus       442 ~~~~~~gt~~y~aPE~l~~~~~~~s~~~Dv~s~G~il~elltg~~pf~~~~~~  494 (506)
                       .....+|+.|+|||++.+.  .++.++|||||||++|||++|+.||...+..
T Consensus       182 -~~~~~~t~~y~aPE~~~~~--~~~~~~DiwSlG~il~ell~g~~pf~~~~~~  231 (364)
T cd07875         182 -MTPYVVTRYYRAPEVILGM--GYKENVDIWSVGCIMGEMIKGGVLFPGTDHI  231 (364)
T ss_pred             -ccCCcccCCcCCHHHHhCC--CCCchhhHHhHHHHHHHHHhCCCCCCCCCHH
Confidence             2345789999999998654  7889999999999999999999999876543

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn

>cd05096 PTKc_DDR1 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1

Probab=99.96  E-value=2e-29  Score=249.25  Aligned_cols=175  Identities=28%  Similarity=0.452  Sum_probs=139.0

Q ss_pred             HhhhccccCccCceEEEEEEEcC-----------------CCEEEEEEeccCCC--CchhhHHHHHHhhccCccceeEEE
Q 039231          314 TNSFKYKLGQGGYGSVYKGKLLD-----------------GSNVAVKVLNDSKG--NGKEFINEVASISRTSHVNVVALL  374 (506)
Q Consensus       314 ~~~~~~~ig~G~~g~V~~~~~~~-----------------~~~vavK~l~~~~~--~~~~~~~E~~~l~~l~h~niv~l~  374 (506)
                      .+.+.++||+|+||.||++.+++                 +..||+|.+.....  ...++.+|++++.+++||||++++
T Consensus         6 ~~~~~~~lg~G~fg~V~~~~~~~~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~   85 (304)
T cd05096           6 HLLFKEKLGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDANKNARNDFLKEVKILSRLKDPNIIRLL   85 (304)
T ss_pred             hCeeeeEecccCCeEEEEEEeccCcccccccccccccCCcceEEEEEEecCCCCHHHHHHHHHHHHHHhhcCCCCeeEEE
Confidence            34456789999999999997532                 33699999875432  235789999999999999999999


Q ss_pred             EEeecc----------------------------------------------chhhhHHHHHHHHHHHHhhcCCCCeEec
Q 039231          375 GFCLRV----------------------------------------------AEELSSTIGIARGLEYLHLGCSTRILHF  408 (506)
Q Consensus       375 g~~~~~----------------------------------------------~~~l~i~~~i~~gl~~LH~~~~~~ivH~  408 (506)
                      +++.+.                                              ...+.++.||+.||+|||   +.+|+||
T Consensus        86 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH---~~~ivH~  162 (304)
T cd05096          86 GVCVDEDPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYLS---SLNFVHR  162 (304)
T ss_pred             EEEecCCceEEEEecCCCCcHHHHHHhccccccccccccccccccccccccHHHHHHHHHHHHHHHHHHH---HCCcccc
Confidence            876210                                              123578999999999999   8999999


Q ss_pred             CcCCCcEEECCCCcEEEeecCCCccccCCCcceecccCCCCcccccccccccccCCCCccccHHHHHHHHHHHHc--CCC
Q 039231          409 DIKPHNILLDEDFCPKISDFGLAKICNRKESIISMTGARGTVGYIAPEVFCRNIGEVSYKSDVYNYGMMIFEMTG--GRK  486 (506)
Q Consensus       409 dlkp~Nill~~~~~~ki~dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~s~~~Dv~s~G~il~ellt--g~~  486 (506)
                      ||||+|||+++++.+||+|||+++...............++..|+|||.+..  +.++.++||||||+++|||++  +..
T Consensus       163 dlkp~Nill~~~~~~kl~DfG~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~--~~~~~~~Dv~slG~~l~el~~~~~~~  240 (304)
T cd05096         163 DLATRNCLVGENLTIKIADFGMSRNLYAGDYYRIQGRAVLPIRWMAWECILM--GKFTTASDVWAFGVTLWEILMLCKEQ  240 (304)
T ss_pred             CcchhheEEcCCccEEECCCccceecccCceeEecCcCCCCccccCHHHHhc--CCCCchhhhHHHHHHHHHHHHccCCC
Confidence            9999999999999999999999986644332222233455788999999854  378999999999999999986  667


Q ss_pred             CCCCCCC
Q 039231          487 NVDVVDN  493 (506)
Q Consensus       487 pf~~~~~  493 (506)
                      ||.....
T Consensus       241 p~~~~~~  247 (304)
T cd05096         241 PYGELTD  247 (304)
T ss_pred             CCCcCCH
Confidence            8876543

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in k

>cd07878 STKc_p38beta_MAPK11 Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase

Probab=99.96  E-value=1.2e-29  Score=255.12  Aligned_cols=167  Identities=30%  Similarity=0.404  Sum_probs=139.2

Q ss_pred             ccccCccCceEEEEEEEc-CCCEEEEEEeccCCC---CchhhHHHHHHhhccCccceeEEEEEe----------------
Q 039231          318 KYKLGQGGYGSVYKGKLL-DGSNVAVKVLNDSKG---NGKEFINEVASISRTSHVNVVALLGFC----------------  377 (506)
Q Consensus       318 ~~~ig~G~~g~V~~~~~~-~~~~vavK~l~~~~~---~~~~~~~E~~~l~~l~h~niv~l~g~~----------------  377 (506)
                      .+.||+|+||.||+|... +++.||||++.....   ..+.+.+|++++++++||||+++++++                
T Consensus        20 ~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~~~~   99 (343)
T cd07878          20 LTPVGSGAYGSVCSAYDTRLRQKVAVKKLSRPFQSLIHARRTYRELRLLKHMKHENVIGLLDVFTPATSIENFNEVYLVT   99 (343)
T ss_pred             heecccCCCeEEEEEEECCCCCEEEEEEeCchhhhhHHHHHHHHHHHHHHhcCCCchhhhhhhhcccccccccCcEEEEe
Confidence            467999999999999864 578999999875422   235678899999999999999988654                


Q ss_pred             ---------------eccchhhhHHHHHHHHHHHHhhcCCCCeEecCcCCCcEEECCCCcEEEeecCCCccccCCCccee
Q 039231          378 ---------------LRVAEELSSTIGIARGLEYLHLGCSTRILHFDIKPHNILLDEDFCPKISDFGLAKICNRKESIIS  442 (506)
Q Consensus       378 ---------------~~~~~~l~i~~~i~~gl~~LH~~~~~~ivH~dlkp~Nill~~~~~~ki~dfg~a~~~~~~~~~~~  442 (506)
                                     +++.+...++.|++.||+|||   +++|+||||||+||++++++.+||+|||+++......    
T Consensus       100 ~~~~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH---~~~ivHrdikp~Nil~~~~~~~kl~Dfg~~~~~~~~~----  172 (343)
T cd07878         100 NLMGADLNNIVKCQKLSDEHVQFLIYQLLRGLKYIH---SAGIIHRDLKPSNVAVNEDCELRILDFGLARQADDEM----  172 (343)
T ss_pred             ecCCCCHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH---HCCeecccCChhhEEECCCCCEEEcCCccceecCCCc----
Confidence                           223335678999999999999   8999999999999999999999999999998654322    


Q ss_pred             cccCCCCcccccccccccccCCCCccccHHHHHHHHHHHHcCCCCCCCCCC
Q 039231          443 MTGARGTVGYIAPEVFCRNIGEVSYKSDVYNYGMMIFEMTGGRKNVDVVDN  493 (506)
Q Consensus       443 ~~~~~gt~~y~aPE~l~~~~~~~s~~~Dv~s~G~il~elltg~~pf~~~~~  493 (506)
                       ....+|+.|+|||.+.+. ..++.++||||||+++|||++|+.||...+.
T Consensus       173 -~~~~~t~~y~aPE~~~~~-~~~~~~~DiwslG~il~el~~g~~pf~~~~~  221 (343)
T cd07878         173 -TGYVATRWYRAPEIMLNW-MHYNQTVDIWSVGCIMAELLKGKALFPGNDY  221 (343)
T ss_pred             -CCccccccccCchHhcCC-ccCCchhhhHhHHHHHHHHHHCCCCCCCCCH
Confidence             345689999999998653 3678899999999999999999999976543

Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is

>cd05608 STKc_GRK1 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1

Probab=99.96  E-value=3.2e-29  Score=244.82  Aligned_cols=166  Identities=31%  Similarity=0.434  Sum_probs=137.5

Q ss_pred             cCccCceEEEEEEEc-CCCEEEEEEeccCCC----CchhhHHHHHHhhccCccceeEEEEEe------------------
Q 039231          321 LGQGGYGSVYKGKLL-DGSNVAVKVLNDSKG----NGKEFINEVASISRTSHVNVVALLGFC------------------  377 (506)
Q Consensus       321 ig~G~~g~V~~~~~~-~~~~vavK~l~~~~~----~~~~~~~E~~~l~~l~h~niv~l~g~~------------------  377 (506)
                      ||+|+||+||++... +++.+|+|++.....    ..+.+..|++++++++|+||+++.+++                  
T Consensus         1 lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~g~L   80 (280)
T cd05608           1 LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKVHSRFIVSLAYAFQTKTDLCLVMTIMNGGDL   80 (280)
T ss_pred             CCCCCceeEEEEEEccCCcEEEEEeeeHHHHhhhHHHHHHHHHHHHHHhCCCCcEeeeeEEEcCCCeEEEEEeCCCCCCH
Confidence            699999999999875 588999999864321    225677899999999999999998765                  


Q ss_pred             -------------eccchhhhHHHHHHHHHHHHhhcCCCCeEecCcCCCcEEECCCCcEEEeecCCCccccCCCcceecc
Q 039231          378 -------------LRVAEELSSTIGIARGLEYLHLGCSTRILHFDIKPHNILLDEDFCPKISDFGLAKICNRKESIISMT  444 (506)
Q Consensus       378 -------------~~~~~~l~i~~~i~~gl~~LH~~~~~~ivH~dlkp~Nill~~~~~~ki~dfg~a~~~~~~~~~~~~~  444 (506)
                                   +++...+.++.||+.||+|||   +.+|+||||||+||++++++.+||+|||++.........  ..
T Consensus        81 ~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH---~~~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~~--~~  155 (280)
T cd05608          81 RYHIYNVDEENPGFPEPRACFYTAQIISGLEHLH---QRRIIYRDLKPENVLLDNDGNVRISDLGLAVELKDGQSK--TK  155 (280)
T ss_pred             HHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCHHHEEECCCCCEEEeeCccceecCCCCcc--cc
Confidence                         112234568899999999999   899999999999999999999999999999766543321  23


Q ss_pred             cCCCCcccccccccccccCCCCccccHHHHHHHHHHHHcCCCCCCCCCC
Q 039231          445 GARGTVGYIAPEVFCRNIGEVSYKSDVYNYGMMIFEMTGGRKNVDVVDN  493 (506)
Q Consensus       445 ~~~gt~~y~aPE~l~~~~~~~s~~~Dv~s~G~il~elltg~~pf~~~~~  493 (506)
                      ...|++.|+|||.+.+.  .++.++||||||+++|||++|+.||.....
T Consensus       156 ~~~g~~~y~aPE~~~~~--~~~~~~DvwslG~il~el~~g~~pf~~~~~  202 (280)
T cd05608         156 GYAGTPGFMAPELLQGE--EYDFSVDYFALGVTLYEMIAARGPFRARGE  202 (280)
T ss_pred             ccCCCcCccCHHHhcCC--CCCccccHHHHHHHHHHHHhCCCCCCCCCc
Confidence            45789999999998654  788999999999999999999999986543

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual g

>cd05587 STKc_cPKC Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C

Probab=99.96  E-value=1.9e-29  Score=251.73  Aligned_cols=172  Identities=26%  Similarity=0.369  Sum_probs=137.9

Q ss_pred             hhccccCccCceEEEEEEEcC-CCEEEEEEeccC----CCCchhhHHHHHHhhccCcc-ceeEEEEEe------------
Q 039231          316 SFKYKLGQGGYGSVYKGKLLD-GSNVAVKVLNDS----KGNGKEFINEVASISRTSHV-NVVALLGFC------------  377 (506)
Q Consensus       316 ~~~~~ig~G~~g~V~~~~~~~-~~~vavK~l~~~----~~~~~~~~~E~~~l~~l~h~-niv~l~g~~------------  377 (506)
                      .+.+.||+|+||.||+|+..+ ++.||+|++...    ....+.+..|.+++..++|+ +|+++.+++            
T Consensus         3 ~~~~~lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~E~   82 (324)
T cd05587           3 NFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYFVMEY   82 (324)
T ss_pred             eEEEEEeeccCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhcCCCCceeeeEEEEEcCCEEEEEEcC
Confidence            345689999999999998754 789999999753    22345678899999999865 577777655            


Q ss_pred             ---------------eccchhhhHHHHHHHHHHHHhhcCCCCeEecCcCCCcEEECCCCcEEEeecCCCccccCCCccee
Q 039231          378 ---------------LRVAEELSSTIGIARGLEYLHLGCSTRILHFDIKPHNILLDEDFCPKISDFGLAKICNRKESIIS  442 (506)
Q Consensus       378 ---------------~~~~~~l~i~~~i~~gl~~LH~~~~~~ivH~dlkp~Nill~~~~~~ki~dfg~a~~~~~~~~~~~  442 (506)
                                     +.+...+.++.||+.||+|||   +++|+||||||+|||+++++.+||+|||+++.......  .
T Consensus        83 ~~~g~L~~~~~~~~~~~~~~~~~~~~qi~~al~~lH---~~~ivH~dlkp~Nill~~~~~~kL~Dfg~~~~~~~~~~--~  157 (324)
T cd05587          83 VNGGDLMYHIQQVGKFKEPHAVFYAAEIAIGLFFLH---SKGIIYRDLKLDNVMLDAEGHIKIADFGMCKENIFGGK--T  157 (324)
T ss_pred             CCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHH---HCCeEecCCCHHHeEEcCCCCEEEeecCcceecCCCCC--c
Confidence                           123335668899999999999   89999999999999999999999999999875322221  1


Q ss_pred             cccCCCCcccccccccccccCCCCccccHHHHHHHHHHHHcCCCCCCCCCCC
Q 039231          443 MTGARGTVGYIAPEVFCRNIGEVSYKSDVYNYGMMIFEMTGGRKNVDVVDNG  494 (506)
Q Consensus       443 ~~~~~gt~~y~aPE~l~~~~~~~s~~~Dv~s~G~il~elltg~~pf~~~~~~  494 (506)
                      .....||+.|+|||++.+.  .++.++||||+|+++|||++|+.||...+..
T Consensus       158 ~~~~~gt~~y~aPE~~~~~--~~~~~~DiwslGvil~elltG~~pf~~~~~~  207 (324)
T cd05587         158 TRTFCGTPDYIAPEIIAYQ--PYGKSVDWWAFGVLLYEMLAGQPPFDGEDED  207 (324)
T ss_pred             eeeecCCccccChhhhcCC--CCCcccchhhhHHHHHHHHhCCCCCCCCCHH
Confidence            2345689999999998654  6889999999999999999999999866543

Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory

>cd05619 STKc_nPKC_theta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta

Probab=99.96  E-value=2e-29  Score=250.61  Aligned_cols=168  Identities=28%  Similarity=0.383  Sum_probs=136.7

Q ss_pred             cccCccCceEEEEEEEcC-CCEEEEEEeccC----CCCchhhHHHHHHhhc-cCccceeEEEEEe---------------
Q 039231          319 YKLGQGGYGSVYKGKLLD-GSNVAVKVLNDS----KGNGKEFINEVASISR-TSHVNVVALLGFC---------------  377 (506)
Q Consensus       319 ~~ig~G~~g~V~~~~~~~-~~~vavK~l~~~----~~~~~~~~~E~~~l~~-l~h~niv~l~g~~---------------  377 (506)
                      +.||+|+||.||+|+..+ ++.||||+++..    ....+....|..++.. ++||||+++++++               
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~ey~~~   80 (316)
T cd05619           1 KMLGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHLYCTFQTKENLFFVMEYLNG   80 (316)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCcCcceEEEEEeCCEEEEEEeCCCC
Confidence            359999999999999754 789999999753    2233556778888876 4899999999876               


Q ss_pred             ------------eccchhhhHHHHHHHHHHHHhhcCCCCeEecCcCCCcEEECCCCcEEEeecCCCccccCCCcceeccc
Q 039231          378 ------------LRVAEELSSTIGIARGLEYLHLGCSTRILHFDIKPHNILLDEDFCPKISDFGLAKICNRKESIISMTG  445 (506)
Q Consensus       378 ------------~~~~~~l~i~~~i~~gl~~LH~~~~~~ivH~dlkp~Nill~~~~~~ki~dfg~a~~~~~~~~~~~~~~  445 (506)
                                  +++.+...++.|++.||+|||   +++|+||||||+|||+++++.+||+|||+++........  ...
T Consensus        81 g~L~~~l~~~~~~~~~~~~~~~~qi~~al~~LH---~~~ivHrdikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~--~~~  155 (316)
T cd05619          81 GDLMFHIQSCHKFDLPRATFYAAEIICGLQFLH---SKGIVYRDLKLDNILLDTDGHIKIADFGMCKENMLGDAK--TCT  155 (316)
T ss_pred             CcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHH---hCCeEeCCCCHHHEEECCCCCEEEccCCcceECCCCCCc--eee
Confidence                        223335678899999999999   899999999999999999999999999998753222211  134


Q ss_pred             CCCCcccccccccccccCCCCccccHHHHHHHHHHHHcCCCCCCCCCC
Q 039231          446 ARGTVGYIAPEVFCRNIGEVSYKSDVYNYGMMIFEMTGGRKNVDVVDN  493 (506)
Q Consensus       446 ~~gt~~y~aPE~l~~~~~~~s~~~Dv~s~G~il~elltg~~pf~~~~~  493 (506)
                      ..||+.|+|||.+.+.  .++.++|||||||++|||++|+.||...+.
T Consensus       156 ~~gt~~y~aPE~~~~~--~~~~~~DvwslG~il~el~~G~~pf~~~~~  201 (316)
T cd05619         156 FCGTPDYIAPEILLGQ--KYNTSVDWWSFGVLLYEMLIGQSPFHGHDE  201 (316)
T ss_pred             ecCCccccCHHHHcCC--CCCchhhhhhHHHHHHHHHhCCCCCCCCCH
Confidence            5689999999998654  688999999999999999999999986554

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in

>cd05104 PTKc_Kit Catalytic domain of the Protein Tyrosine Kinase, Kit

Probab=99.96  E-value=2.9e-29  Score=255.32  Aligned_cols=176  Identities=31%  Similarity=0.498  Sum_probs=140.2

Q ss_pred             HhhhccccCccCceEEEEEEE------cCCCEEEEEEeccCCC--CchhhHHHHHHhhcc-CccceeEEEEEeec-----
Q 039231          314 TNSFKYKLGQGGYGSVYKGKL------LDGSNVAVKVLNDSKG--NGKEFINEVASISRT-SHVNVVALLGFCLR-----  379 (506)
Q Consensus       314 ~~~~~~~ig~G~~g~V~~~~~------~~~~~vavK~l~~~~~--~~~~~~~E~~~l~~l-~h~niv~l~g~~~~-----  379 (506)
                      .+.+.+.||+|+||.||+|+.      ..+..||||+++....  ..+.+.+|++++..+ +||||+++++++..     
T Consensus        36 ~~~~~~~LG~G~fG~V~~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~il~~l~~HpnIv~l~~~~~~~~~~~  115 (375)
T cd05104          36 RLSFGKTLGAGAFGKVVEATAYGLFKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHINIVNLLGACTVGGPTL  115 (375)
T ss_pred             HeehhheecCCccceEEEEEEeccccCccceeEEEEeccCCcCcHHHHHHHHHHHHHHHhcCCcceeeeeeeeccCCcce
Confidence            345567899999999999974      2356899999975432  235688999999999 89999999987621     


Q ss_pred             --------------------------------------------------------------------------------
Q 039231          380 --------------------------------------------------------------------------------  379 (506)
Q Consensus       380 --------------------------------------------------------------------------------  379 (506)
                                                                                                      
T Consensus       116 lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  195 (375)
T cd05104         116 VITEYCCYGDLLNFLRRKRDSFICPKHEDHAEAALYKNLLHQREMSCDSLNEYMDMKPGVSYVVPTKADKRRSVRSGSYI  195 (375)
T ss_pred             eeehhccCCcHHHHHHhcccccccccccchhhhHHHHhhhhhhcccchhhhhhhhcCCCcccccccccccccccccceec
Confidence                                                                                            


Q ss_pred             -----------------cchhhhHHHHHHHHHHHHhhcCCCCeEecCcCCCcEEECCCCcEEEeecCCCccccCCCccee
Q 039231          380 -----------------VAEELSSTIGIARGLEYLHLGCSTRILHFDIKPHNILLDEDFCPKISDFGLAKICNRKESIIS  442 (506)
Q Consensus       380 -----------------~~~~l~i~~~i~~gl~~LH~~~~~~ivH~dlkp~Nill~~~~~~ki~dfg~a~~~~~~~~~~~  442 (506)
                                       +...+.++.||++||+|||   +++|+||||||+|||+++++.+||+|||+++..........
T Consensus       196 ~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH---~~~ivH~Dlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~~~  272 (375)
T cd05104         196 DQDVTSEILEEDELALDTEDLLSFSYQVAKGMSFLA---SKNCIHRDLAARNILLTHGRITKICDFGLARDIRNDSNYVV  272 (375)
T ss_pred             ccccHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHH---HCCeeccCCchhhEEEECCCcEEEecCccceeccCcccccc
Confidence                             1224567889999999999   89999999999999999999999999999987654332211


Q ss_pred             cccCCCCcccccccccccccCCCCccccHHHHHHHHHHHHc-CCCCCCCCCCC
Q 039231          443 MTGARGTVGYIAPEVFCRNIGEVSYKSDVYNYGMMIFEMTG-GRKNVDVVDNG  494 (506)
Q Consensus       443 ~~~~~gt~~y~aPE~l~~~~~~~s~~~Dv~s~G~il~ellt-g~~pf~~~~~~  494 (506)
                      .....++..|+|||.+.+.  .++.++||||||+++|||++ |..||......
T Consensus       273 ~~~~~~~~~y~aPE~~~~~--~~~~~sDi~slG~~l~ellt~g~~p~~~~~~~  323 (375)
T cd05104         273 KGNARLPVKWMAPESIFNC--VYTFESDVWSYGILLWEIFSLGSSPYPGMPVD  323 (375)
T ss_pred             cCCCCCCcceeChhHhcCC--CCCCCCCHHHHHHHHHHHHhcCCCCCCCCCch
Confidence            1224456789999998654  78999999999999999997 99999765443

Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem ce

>cd05620 STKc_nPKC_delta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta

Probab=99.96  E-value=1.8e-29  Score=250.88  Aligned_cols=168  Identities=27%  Similarity=0.390  Sum_probs=136.5

Q ss_pred             cccCccCceEEEEEEEc-CCCEEEEEEeccC----CCCchhhHHHHHHhhcc-CccceeEEEEEe---------------
Q 039231          319 YKLGQGGYGSVYKGKLL-DGSNVAVKVLNDS----KGNGKEFINEVASISRT-SHVNVVALLGFC---------------  377 (506)
Q Consensus       319 ~~ig~G~~g~V~~~~~~-~~~~vavK~l~~~----~~~~~~~~~E~~~l~~l-~h~niv~l~g~~---------------  377 (506)
                      ++||+|+||.||+|+.. +|..||+|+++..    ....+....|.+++... +||||+++++++               
T Consensus         1 ~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~E~~~~   80 (316)
T cd05620           1 KVLGKGSFGKVLLAELKGKGEYFAVKALKKDVVLIDDDVECTMVEKRVLALAWENPFLTHLYCTFQTKEHLFFVMEFLNG   80 (316)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCCccCeeEEEEeCCEEEEEECCCCC
Confidence            35999999999999975 4889999999753    22335567788888754 899999999876               


Q ss_pred             ------------eccchhhhHHHHHHHHHHHHhhcCCCCeEecCcCCCcEEECCCCcEEEeecCCCccccCCCcceeccc
Q 039231          378 ------------LRVAEELSSTIGIARGLEYLHLGCSTRILHFDIKPHNILLDEDFCPKISDFGLAKICNRKESIISMTG  445 (506)
Q Consensus       378 ------------~~~~~~l~i~~~i~~gl~~LH~~~~~~ivH~dlkp~Nill~~~~~~ki~dfg~a~~~~~~~~~~~~~~  445 (506)
                                  ++..+...++.|++.||+|||   +++|+||||||+|||+++++.+||+|||+++.......  ....
T Consensus        81 g~L~~~i~~~~~~~~~~~~~~~~qi~~~l~~lH---~~~ivHrDlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~--~~~~  155 (316)
T cd05620          81 GDLMFHIQDKGRFDLYRATFYAAEIVCGLQFLH---SKGIIYRDLKLDNVMLDRDGHIKIADFGMCKENVFGDN--RAST  155 (316)
T ss_pred             CcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHH---HCCeEecCCCHHHeEECCCCCEEeCccCCCeecccCCC--ceec
Confidence                        122335568899999999999   89999999999999999999999999999875322221  1234


Q ss_pred             CCCCcccccccccccccCCCCccccHHHHHHHHHHHHcCCCCCCCCCC
Q 039231          446 ARGTVGYIAPEVFCRNIGEVSYKSDVYNYGMMIFEMTGGRKNVDVVDN  493 (506)
Q Consensus       446 ~~gt~~y~aPE~l~~~~~~~s~~~Dv~s~G~il~elltg~~pf~~~~~  493 (506)
                      ..||+.|+|||++.+.  .++.++||||||+++|||++|+.||...+.
T Consensus       156 ~~gt~~y~aPE~~~~~--~~~~~~DiwslGvil~el~~g~~Pf~~~~~  201 (316)
T cd05620         156 FCGTPDYIAPEILQGL--KYTFSVDWWSFGVLLYEMLIGQSPFHGDDE  201 (316)
T ss_pred             cCCCcCccCHHHHcCC--CCCcccchhhhHHHHHHHHhCCCCCCCCCH
Confidence            6689999999998654  788999999999999999999999976544

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. I

>KOG0584 consensus Serine/threonine protein kinase [General function prediction only]

Probab=99.96  E-value=1.9e-30  Score=260.38  Aligned_cols=177  Identities=27%  Similarity=0.374  Sum_probs=145.4

Q ss_pred             hccccCccCceEEEEEEEc-CCCEEEEEEec-----cCCCCchhhHHHHHHhhccCccceeEEEEEeeccch--------
Q 039231          317 FKYKLGQGGYGSVYKGKLL-DGSNVAVKVLN-----DSKGNGKEFINEVASISRTSHVNVVALLGFCLRVAE--------  382 (506)
Q Consensus       317 ~~~~ig~G~~g~V~~~~~~-~~~~vavK~l~-----~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~--------  382 (506)
                      |..+||+|+|-+||+|.+. +|..||.-.++     .+....++|..|+.+|+.|+|||||+++..+.+...        
T Consensus        44 ~~evLGrGafKtVYka~De~~giEVAWnqvk~~d~~q~~~~leR~~~Ev~lLKsL~H~NIirfy~SW~d~~n~~in~iTE  123 (632)
T KOG0584|consen   44 FDEVLGRGAFKTVYKAFDEEEGIEVAWNQVKIRDVTQSPEELERLYSEVHLLKSLKHPNIIRFYDSWVDTDNKTINFITE  123 (632)
T ss_pred             hhhhcccccceeeeeccccccchhhHHHHHhHHHhhcChHHHHHHHHHHHHHccCCCCceeeeeeheecCCCceeeeeee
Confidence            4567999999999999874 37777753332     233444889999999999999999999998843222        


Q ss_pred             ---------------------hhhHHHHHHHHHHHHhhcCCCCeEecCcCCCcEEECC-CCcEEEeecCCCccccCCCcc
Q 039231          383 ---------------------ELSSTIGIARGLEYLHLGCSTRILHFDIKPHNILLDE-DFCPKISDFGLAKICNRKESI  440 (506)
Q Consensus       383 ---------------------~l~i~~~i~~gl~~LH~~~~~~ivH~dlkp~Nill~~-~~~~ki~dfg~a~~~~~~~~~  440 (506)
                                           ...|++||++||.|||+. .++|+|||||.+||+|+. .|.+||+|+|+|..+..... 
T Consensus       124 L~TSGtLr~Y~kk~~~vn~kaik~W~RQILkGL~yLHs~-~PPIIHRDLKCDNIFinG~~G~VKIGDLGLAtl~r~s~a-  201 (632)
T KOG0584|consen  124 LFTSGTLREYRKKHRRVNIKAIKSWCRQILKGLVYLHSQ-DPPIIHRDLKCDNIFVNGNLGEVKIGDLGLATLLRKSHA-  201 (632)
T ss_pred             cccCCcHHHHHHHhccCCHHHHHHHHHHHHHHhhhhhcC-CCCccccccccceEEEcCCcCceeecchhHHHHhhcccc-
Confidence                                 456999999999999964 789999999999999975 58999999999998765442 


Q ss_pred             eecccCCCCcccccccccccccCCCCccccHHHHHHHHHHHHcCCCCCCCCCCCcchhhhh
Q 039231          441 ISMTGARGTVGYIAPEVFCRNIGEVSYKSDVYNYGMMIFEMTGGRKNVDVVDNGSTALDLQ  501 (506)
Q Consensus       441 ~~~~~~~gt~~y~aPE~l~~~~~~~s~~~Dv~s~G~il~elltg~~pf~~~~~~~~~~~~~  501 (506)
                         ....|||.|||||.+..   .|.+.+||||||+.++||+|+..||..-.+..+.++-.
T Consensus       202 ---ksvIGTPEFMAPEmYEE---~YnE~VDVYaFGMCmLEMvT~eYPYsEC~n~AQIYKKV  256 (632)
T KOG0584|consen  202 ---KSVIGTPEFMAPEMYEE---NYNELVDVYAFGMCMLEMVTSEYPYSECTNPAQIYKKV  256 (632)
T ss_pred             ---ceeccCccccChHHHhh---hcchhhhhhhhhHHHHHHHhccCChhhhCCHHHHHHHH
Confidence               44789999999999853   69999999999999999999999998876665555443

>cd05068 PTKc_Frk_like Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases

Probab=99.96  E-value=3.1e-29  Score=242.12  Aligned_cols=177  Identities=28%  Similarity=0.510  Sum_probs=145.7

Q ss_pred             HHHhhhccccCccCceEEEEEEEcCCCEEEEEEeccCCCCchhhHHHHHHhhccCccceeEEEEEe--------------
Q 039231          312 KMTNSFKYKLGQGGYGSVYKGKLLDGSNVAVKVLNDSKGNGKEFINEVASISRTSHVNVVALLGFC--------------  377 (506)
Q Consensus       312 ~~~~~~~~~ig~G~~g~V~~~~~~~~~~vavK~l~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~--------------  377 (506)
                      .....+.+.||+|++|.||+|...+++.||+|.++......+++.+|++++++++||||+++.+++              
T Consensus         5 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~v~iK~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~   84 (261)
T cd05068           5 RTSIQLLRKLGAGQFGEVWEGLWNNTTPVAVKTLKPGTMDPKDFLAEAQIMKKLRHPKLIQLYAVCTLEEPIYIVTELMK   84 (261)
T ss_pred             hhheeeEEEecccCCccEEEEEecCCeEEEEEeeCCCcccHHHHHHHHHHHHHCCCCCccceeEEEecCCCeeeeeeccc
Confidence            344556688999999999999987888999999987665667899999999999999999999876              


Q ss_pred             ---------------eccchhhhHHHHHHHHHHHHhhcCCCCeEecCcCCCcEEECCCCcEEEeecCCCccccCCCccee
Q 039231          378 ---------------LRVAEELSSTIGIARGLEYLHLGCSTRILHFDIKPHNILLDEDFCPKISDFGLAKICNRKESIIS  442 (506)
Q Consensus       378 ---------------~~~~~~l~i~~~i~~gl~~LH~~~~~~ivH~dlkp~Nill~~~~~~ki~dfg~a~~~~~~~~~~~  442 (506)
                                     +++.+.+.++.|++.||.|||   +.+++|+||||+||++++++.+||+|||+++........ .
T Consensus        85 ~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~~~-~  160 (261)
T cd05068          85 YGSLLEYLQGGAGRALKLPQLIDMAAQVASGMAYLE---AQNYIHRDLAARNVLVGENNICKVADFGLARVIKEDIYE-A  160 (261)
T ss_pred             CCcHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHH---hCCeeeccCCcceEEEcCCCCEEECCcceEEEccCCccc-c
Confidence                           122335678899999999999   899999999999999999999999999999876532211 1


Q ss_pred             cccCCCCcccccccccccccCCCCccccHHHHHHHHHHHHc-CCCCCCCCCCC
Q 039231          443 MTGARGTVGYIAPEVFCRNIGEVSYKSDVYNYGMMIFEMTG-GRKNVDVVDNG  494 (506)
Q Consensus       443 ~~~~~gt~~y~aPE~l~~~~~~~s~~~Dv~s~G~il~ellt-g~~pf~~~~~~  494 (506)
                      ......+..|+|||.+.+.  .++.++||||||+++|||++ |+.||......
T Consensus       161 ~~~~~~~~~y~aPE~~~~~--~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~  211 (261)
T cd05068         161 REGAKFPIKWTAPEAALYN--RFSIKSDVWSFGILLTEIVTYGRMPYPGMTNA  211 (261)
T ss_pred             cCCCcCceeccCccccccC--CCCchhhHHHHHHHHHHHHhcCCCCCCCCCHH
Confidence            1222335689999988543  78899999999999999999 99999765543

Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins a

>cd05106 PTKc_CSF-1R Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor

Probab=99.96  E-value=3.1e-29  Score=254.91  Aligned_cols=177  Identities=29%  Similarity=0.492  Sum_probs=140.4

Q ss_pred             HhhhccccCccCceEEEEEEEc------CCCEEEEEEeccCCC--CchhhHHHHHHhhcc-CccceeEEEEEeec-----
Q 039231          314 TNSFKYKLGQGGYGSVYKGKLL------DGSNVAVKVLNDSKG--NGKEFINEVASISRT-SHVNVVALLGFCLR-----  379 (506)
Q Consensus       314 ~~~~~~~ig~G~~g~V~~~~~~------~~~~vavK~l~~~~~--~~~~~~~E~~~l~~l-~h~niv~l~g~~~~-----  379 (506)
                      .+.+.+.||+|+||.||+|+..      ++..||+|+++....  ....+.+|+++++.+ +|+|||++++.+..     
T Consensus        39 ~~~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~~h~nIv~~~~~~~~~~~~~  118 (374)
T cd05106          39 NLQFGKTLGAGAFGKVVEATAFGLGKEDNVLRVAVKMLKASAHTDEREALMSELKILSHLGQHKNIVNLLGACTHGGPVL  118 (374)
T ss_pred             HceehheecCCCcccEEEEEEecCCcccccceeEEEeccCCCCHHHHHHHHHHHHHHHhhccCCceeeEeeEecCCCCeE
Confidence            3445678999999999999742      245799999975432  235688999999999 89999999997621     


Q ss_pred             --------------------------------------------------------------------------------
Q 039231          380 --------------------------------------------------------------------------------  379 (506)
Q Consensus       380 --------------------------------------------------------------------------------  379 (506)
                                                                                                      
T Consensus       119 lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  198 (374)
T cd05106         119 VITEYCCYGDLLNFLRKKAETFLNFVMALPEISETSSDYKNITLEKKYIRSDSGFSSQGSDTYVEMRPVSSSSSQSSDSK  198 (374)
T ss_pred             EeHhhccCCcHHHHHHhhhhhhccccccccccccccccccccchhcccccccccccccccccccccCCcccccccccccc
Confidence                                                                                            


Q ss_pred             ------------cchhhhHHHHHHHHHHHHhhcCCCCeEecCcCCCcEEECCCCcEEEeecCCCccccCCCcceecccCC
Q 039231          380 ------------VAEELSSTIGIARGLEYLHLGCSTRILHFDIKPHNILLDEDFCPKISDFGLAKICNRKESIISMTGAR  447 (506)
Q Consensus       380 ------------~~~~l~i~~~i~~gl~~LH~~~~~~ivH~dlkp~Nill~~~~~~ki~dfg~a~~~~~~~~~~~~~~~~  447 (506)
                                  +.+.+.++.||+.||+|||   +++|+||||||+|||+++++.+||+|||+++...............
T Consensus       199 ~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH---~~giiHrDLkp~Nil~~~~~~~kL~DfGla~~~~~~~~~~~~~~~~  275 (374)
T cd05106         199 DEEDTEDSWPLDLDDLLRFSSQVAQGMDFLA---SKNCIHRDVAARNVLLTDGRVAKICDFGLARDIMNDSNYVVKGNAR  275 (374)
T ss_pred             chhccCCCCCcCHHHHHHHHHHHHHHHHHHH---HCCEEeccCchheEEEeCCCeEEEeeceeeeeccCCcceeeccCCC
Confidence                        1123568899999999999   8999999999999999999999999999997654433221112234


Q ss_pred             CCcccccccccccccCCCCccccHHHHHHHHHHHHc-CCCCCCCCCCCc
Q 039231          448 GTVGYIAPEVFCRNIGEVSYKSDVYNYGMMIFEMTG-GRKNVDVVDNGS  495 (506)
Q Consensus       448 gt~~y~aPE~l~~~~~~~s~~~Dv~s~G~il~ellt-g~~pf~~~~~~~  495 (506)
                      ++..|+|||++.+.  .++.++||||||+++|||++ |+.||.......
T Consensus       276 ~~~~y~aPE~~~~~--~~~~~~DvwSlGvil~ellt~G~~Pf~~~~~~~  322 (374)
T cd05106         276 LPVKWMAPESIFDC--VYTVQSDVWSYGILLWEIFSLGKSPYPGILVNS  322 (374)
T ss_pred             CccceeCHHHhcCC--CCCccccHHHHHHHHHHHHhCCCCCCccccccH
Confidence            56789999998543  78999999999999999997 999998765544

Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is criti

>cd05573 STKc_ROCK_NDR_like Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases

Probab=99.96  E-value=3.9e-30  Score=259.45  Aligned_cols=175  Identities=26%  Similarity=0.338  Sum_probs=144.1

Q ss_pred             hccccCccCceEEEEEEEc-CCCEEEEEEeccCC----CCchhhHHHHHHhhccCccceeEEEEEe--------------
Q 039231          317 FKYKLGQGGYGSVYKGKLL-DGSNVAVKVLNDSK----GNGKEFINEVASISRTSHVNVVALLGFC--------------  377 (506)
Q Consensus       317 ~~~~ig~G~~g~V~~~~~~-~~~~vavK~l~~~~----~~~~~~~~E~~~l~~l~h~niv~l~g~~--------------  377 (506)
                      +.+.||+|+||.||+|+.. +++.||||+++...    .....+.+|++++..++|+||+++++.+              
T Consensus         5 ~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~   84 (350)
T cd05573           5 VIKVIGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMIKRNQIAHVRAERDILADADSPWIVKLYYSFQDEEHLYLVMEYMP   84 (350)
T ss_pred             EEEEEEeCCcEEEEEEEECCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhcCCCCccchhhheecCCeEEEEEcCCC
Confidence            4567999999999999975 58999999997532    3346788999999999999999998655              


Q ss_pred             -------------eccchhhhHHHHHHHHHHHHhhcCCCCeEecCcCCCcEEECCCCcEEEeecCCCccccCCC------
Q 039231          378 -------------LRVAEELSSTIGIARGLEYLHLGCSTRILHFDIKPHNILLDEDFCPKISDFGLAKICNRKE------  438 (506)
Q Consensus       378 -------------~~~~~~l~i~~~i~~gl~~LH~~~~~~ivH~dlkp~Nill~~~~~~ki~dfg~a~~~~~~~------  438 (506)
                                   ++....+.++.|++.||+|||   +++|+||||||+|||++.++.+||+|||+++......      
T Consensus        85 ~~~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH---~~giiH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~  161 (350)
T cd05573          85 GGDLMNLLIRKDVFPEETARFYIAELVLALDSVH---KLGFIHRDIKPDNILIDADGHIKLADFGLCKKMNKAKDREYYL  161 (350)
T ss_pred             CCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHH---HCCeeccCCCHHHeEECCCCCEEeecCCCCccCcccCcccccc
Confidence                         223335668899999999999   8999999999999999999999999999998665433      


Q ss_pred             ---------------------cceecccCCCCcccccccccccccCCCCccccHHHHHHHHHHHHcCCCCCCCCCCCcc
Q 039231          439 ---------------------SIISMTGARGTVGYIAPEVFCRNIGEVSYKSDVYNYGMMIFEMTGGRKNVDVVDNGST  496 (506)
Q Consensus       439 ---------------------~~~~~~~~~gt~~y~aPE~l~~~~~~~s~~~Dv~s~G~il~elltg~~pf~~~~~~~~  496 (506)
                                           .........||+.|+|||.+.+.  .++.++|||||||++|||++|+.||...+..+.
T Consensus       162 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~~DiwSlG~il~ell~g~~Pf~~~~~~~~  238 (350)
T cd05573         162 NDSHNLLFRDNVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRGT--PYGLECDWWSLGVILYEMLYGFPPFYSDTLQET  238 (350)
T ss_pred             cccccccccccccccccccccccccccccccCccccCHHHHcCC--CCCCceeeEecchhhhhhccCCCCCCCCCHHHH
Confidence                                 00112345689999999999654  789999999999999999999999987664443

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the

>cd05588 STKc_aPKC Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C

Probab=99.96  E-value=1.9e-29  Score=252.17  Aligned_cols=166  Identities=27%  Similarity=0.394  Sum_probs=137.0

Q ss_pred             cccCccCceEEEEEEEc-CCCEEEEEEeccCC----CCchhhHHHHHHhhcc-CccceeEEEEEe---------------
Q 039231          319 YKLGQGGYGSVYKGKLL-DGSNVAVKVLNDSK----GNGKEFINEVASISRT-SHVNVVALLGFC---------------  377 (506)
Q Consensus       319 ~~ig~G~~g~V~~~~~~-~~~~vavK~l~~~~----~~~~~~~~E~~~l~~l-~h~niv~l~g~~---------------  377 (506)
                      ++||+|+||.||+|+.. +++.||+|+++...    ...+.+.+|..++.++ +||||+++++++               
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~il~~~~~hp~Iv~~~~~~~~~~~~~lv~e~~~~   80 (329)
T cd05588           1 RVIGRGSYAKVLLVELKKTRRIYAMKVIKKELVNDDEDIDWVQTEKHVFETASNHPFLVGLHSCFQTESRLFFVIEFVSG   80 (329)
T ss_pred             CeEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCCCCceEEEEEcCCEEEEEEeCCCC
Confidence            35899999999999875 58899999997532    2235578899999998 699999999876               


Q ss_pred             ------------eccchhhhHHHHHHHHHHHHhhcCCCCeEecCcCCCcEEECCCCcEEEeecCCCccccCCCcceeccc
Q 039231          378 ------------LRVAEELSSTIGIARGLEYLHLGCSTRILHFDIKPHNILLDEDFCPKISDFGLAKICNRKESIISMTG  445 (506)
Q Consensus       378 ------------~~~~~~l~i~~~i~~gl~~LH~~~~~~ivH~dlkp~Nill~~~~~~ki~dfg~a~~~~~~~~~~~~~~  445 (506)
                                  +.+..++.++.|++.||+|||   +++++||||||+|||+++++.+||+|||+++.......  ....
T Consensus        81 g~L~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH---~~~ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~~~~--~~~~  155 (329)
T cd05588          81 GDLMFHMQRQRKLPEEHARFYSAEISLALNFLH---ERGIIYRDLKLDNVLLDAEGHIKLTDYGMCKEGIRPGD--TTST  155 (329)
T ss_pred             CCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHH---HCCeEecCCCHHHeEECCCCCEEECcCccccccccCCC--cccc
Confidence                        223345678899999999999   89999999999999999999999999999875322111  1234


Q ss_pred             CCCCcccccccccccccCCCCccccHHHHHHHHHHHHcCCCCCCCC
Q 039231          446 ARGTVGYIAPEVFCRNIGEVSYKSDVYNYGMMIFEMTGGRKNVDVV  491 (506)
Q Consensus       446 ~~gt~~y~aPE~l~~~~~~~s~~~Dv~s~G~il~elltg~~pf~~~  491 (506)
                      ..||+.|+|||++.+.  .++.++||||||+++|||++|+.||+..
T Consensus       156 ~~gt~~y~aPE~~~~~--~~~~~~DiwslG~~l~el~~g~~Pf~~~  199 (329)
T cd05588         156 FCGTPNYIAPEILRGE--DYGFSVDWWALGVLMFEMMAGRSPFDIV  199 (329)
T ss_pred             ccCCccccCHHHHcCC--CCCCccceechHHHHHHHHHCCCCcccc
Confidence            5789999999998654  6889999999999999999999999743

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions incl

>cd05627 STKc_NDR2 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2

Probab=99.96  E-value=8.5e-30  Score=258.02  Aligned_cols=173  Identities=24%  Similarity=0.294  Sum_probs=140.3

Q ss_pred             ccccCccCceEEEEEEEc-CCCEEEEEEeccC----CCCchhhHHHHHHhhccCccceeEEEEEee--------------
Q 039231          318 KYKLGQGGYGSVYKGKLL-DGSNVAVKVLNDS----KGNGKEFINEVASISRTSHVNVVALLGFCL--------------  378 (506)
Q Consensus       318 ~~~ig~G~~g~V~~~~~~-~~~~vavK~l~~~----~~~~~~~~~E~~~l~~l~h~niv~l~g~~~--------------  378 (506)
                      .+.||+|+||.||+++.. +++.+|+|+++..    ......+.+|++++.+++|+||+++++.+.              
T Consensus         6 ~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~lv~E~~~g   85 (360)
T cd05627           6 LKVIGRGAFGEVRLVQKKDTGHIYAMKILRKADMLEKEQVAHIRAERDILVEADGAWVVKMFYSFQDKRNLYLIMEFLPG   85 (360)
T ss_pred             EEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEEeCCCC
Confidence            467999999999999875 4899999999642    223356788999999999999999987661              


Q ss_pred             -------------ccchhhhHHHHHHHHHHHHhhcCCCCeEecCcCCCcEEECCCCcEEEeecCCCccccCCCcc-----
Q 039231          379 -------------RVAEELSSTIGIARGLEYLHLGCSTRILHFDIKPHNILLDEDFCPKISDFGLAKICNRKESI-----  440 (506)
Q Consensus       379 -------------~~~~~l~i~~~i~~gl~~LH~~~~~~ivH~dlkp~Nill~~~~~~ki~dfg~a~~~~~~~~~-----  440 (506)
                                   ++.....++.|++.||+|||   +++|+||||||+|||++.++.+||+|||+++........     
T Consensus        86 g~L~~~l~~~~~l~~~~~~~~~~qi~~~L~~lH---~~givHrDLkp~NIli~~~~~vkL~DfG~~~~~~~~~~~~~~~~  162 (360)
T cd05627          86 GDMMTLLMKKDTLSEEATQFYIAETVLAIDAIH---QLGFIHRDIKPDNLLLDAKGHVKLSDFGLCTGLKKAHRTEFYRN  162 (360)
T ss_pred             ccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH---HCCeEccCCCHHHEEECCCCCEEEeeccCCcccccccccccccc
Confidence                         22335568899999999999   999999999999999999999999999998754321100     


Q ss_pred             ----------------------------eecccCCCCcccccccccccccCCCCccccHHHHHHHHHHHHcCCCCCCCCC
Q 039231          441 ----------------------------ISMTGARGTVGYIAPEVFCRNIGEVSYKSDVYNYGMMIFEMTGGRKNVDVVD  492 (506)
Q Consensus       441 ----------------------------~~~~~~~gt~~y~aPE~l~~~~~~~s~~~Dv~s~G~il~elltg~~pf~~~~  492 (506)
                                                  .......||+.|+|||++.+.  .++.++|||||||++|||++|+.||....
T Consensus       163 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~--~~~~~~DiwSlGvilyel~tG~~Pf~~~~  240 (360)
T cd05627         163 LTHNPPSDFSFQNMNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQT--GYNKLCDWWSLGVIMYEMLIGYPPFCSET  240 (360)
T ss_pred             cccCCcccccccccccccccccccccccccccccCCCccccCHHHHcCC--CCCCcceeccccceeeecccCCCCCCCCC
Confidence                                        001134689999999998654  68899999999999999999999998765


Q ss_pred             CCc
Q 039231          493 NGS  495 (506)
Q Consensus       493 ~~~  495 (506)
                      ..+
T Consensus       241 ~~~  243 (360)
T cd05627         241 PQE  243 (360)
T ss_pred             HHH
Confidence            543

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regul

>KOG0667 consensus Dual-specificity tyrosine-phosphorylation regulated kinase [General function prediction only]

Probab=99.96  E-value=9.3e-30  Score=257.68  Aligned_cols=179  Identities=24%  Similarity=0.295  Sum_probs=150.2

Q ss_pred             HhhhccccCccCceEEEEEEEc-CCCEEEEEEeccCCCCchhhHHHHHHhhccC-c-----cceeEEEEEe---------
Q 039231          314 TNSFKYKLGQGGYGSVYKGKLL-DGSNVAVKVLNDSKGNGKEFINEVASISRTS-H-----VNVVALLGFC---------  377 (506)
Q Consensus       314 ~~~~~~~ig~G~~g~V~~~~~~-~~~~vavK~l~~~~~~~~~~~~E~~~l~~l~-h-----~niv~l~g~~---------  377 (506)
                      ++...+.||+|+||.|-+|.+. +++.||||++++...-.++...|+.+|..++ |     -|+|++++++         
T Consensus       187 rY~V~e~LGkGtFGQVvk~~d~~T~e~VAIKIiKN~k~f~~Q~~~Ei~iL~~ln~~d~~~~~n~Vrm~d~F~fr~HlciV  266 (586)
T KOG0667|consen  187 RYEVLEVLGKGSFGQVVKAYDHKTGEIVAIKIIKNKKRFLRQAQIEIRILELLNKHDPDDKYNIVRMLDYFYFRNHLCIV  266 (586)
T ss_pred             EEEEEEEecccccceeEEEEecCCCcEEEEEeeccChHHHHHHHHHHHHHHHHhccCCCCCeeEEEeeeccccccceeee
Confidence            3444678999999999999875 4999999999998888888899999999997 3     3699999988         


Q ss_pred             -------------------eccchhhhHHHHHHHHHHHHhhcCCCCeEecCcCCCcEEECCC--CcEEEeecCCCccccC
Q 039231          378 -------------------LRVAEELSSTIGIARGLEYLHLGCSTRILHFDIKPHNILLDED--FCPKISDFGLAKICNR  436 (506)
Q Consensus       378 -------------------~~~~~~l~i~~~i~~gl~~LH~~~~~~ivH~dlkp~Nill~~~--~~~ki~dfg~a~~~~~  436 (506)
                                         +.......++.||+.||.+||   +.+|||+||||+||||.+.  ..+||+|||.+.....
T Consensus       267 fELL~~NLYellK~n~f~Glsl~~ir~~~~Qil~~L~~L~---~l~IIHcDLKPENILL~~~~r~~vKVIDFGSSc~~~q  343 (586)
T KOG0667|consen  267 FELLSTNLYELLKNNKFRGLSLPLVRKFAQQILTALLFLH---ELGIIHCDLKPENILLKDPKRSRIKVIDFGSSCFESQ  343 (586)
T ss_pred             ehhhhhhHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHH---hCCeeeccCChhheeeccCCcCceeEEecccccccCC
Confidence                               223335678999999999999   9999999999999999543  3799999999976544


Q ss_pred             CCcceecccCCCCcccccccccccccCCCCccccHHHHHHHHHHHHcCCCCCCCCCCCcchhhhhh
Q 039231          437 KESIISMTGARGTVGYIAPEVFCRNIGEVSYKSDVYNYGMMIFEMTGGRKNVDVVDNGSTALDLQA  502 (506)
Q Consensus       437 ~~~~~~~~~~~gt~~y~aPE~l~~~~~~~s~~~Dv~s~G~il~elltg~~pf~~~~~~~~~~~~~~  502 (506)
                      .-     ....-+..|.|||++.+-  .|+.+.||||||||+.||++|.+.|...++.++...|++
T Consensus       344 ~v-----ytYiQSRfYRAPEVILGl--pY~~~IDmWSLGCIlAEL~tG~PLfpG~ne~DQl~~I~e  402 (586)
T KOG0667|consen  344 RV-----YTYIQSRFYRAPEVILGL--PYDTAIDMWSLGCILAELFTGEPLFPGDNEYDQLARIIE  402 (586)
T ss_pred             cc-----eeeeeccccccchhhccC--CCCCccceeehhhhHHhHhcCccccCCCCHHHHHHHHHH
Confidence            32     245568899999999875  899999999999999999999888888877776665554

>cd05618 STKc_aPKC_iota Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota

Probab=99.96  E-value=2e-29  Score=251.99  Aligned_cols=165  Identities=27%  Similarity=0.389  Sum_probs=135.4

Q ss_pred             cccCccCceEEEEEEEc-CCCEEEEEEeccCC----CCchhhHHHHHHhhcc-CccceeEEEEEee--------------
Q 039231          319 YKLGQGGYGSVYKGKLL-DGSNVAVKVLNDSK----GNGKEFINEVASISRT-SHVNVVALLGFCL--------------  378 (506)
Q Consensus       319 ~~ig~G~~g~V~~~~~~-~~~~vavK~l~~~~----~~~~~~~~E~~~l~~l-~h~niv~l~g~~~--------------  378 (506)
                      +.||+|+||.||+|+.. +++.+|+|+++...    ...+.+.+|+.++.++ +||||+++++++.              
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~E~~~~   80 (329)
T cd05618           1 RVIGRGSYAKVLLVRLKKTERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFVIEYVNG   80 (329)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEhhHhcchhHHHHHHHHHHHHHhcCCCCcCCceeeEEEeCCEEEEEEeCCCC
Confidence            35999999999999975 47899999997532    2234577888888877 7999999998761              


Q ss_pred             -------------ccchhhhHHHHHHHHHHHHhhcCCCCeEecCcCCCcEEECCCCcEEEeecCCCccccCCCcceeccc
Q 039231          379 -------------RVAEELSSTIGIARGLEYLHLGCSTRILHFDIKPHNILLDEDFCPKISDFGLAKICNRKESIISMTG  445 (506)
Q Consensus       379 -------------~~~~~l~i~~~i~~gl~~LH~~~~~~ivH~dlkp~Nill~~~~~~ki~dfg~a~~~~~~~~~~~~~~  445 (506)
                                   .+.....++.|++.||+|||   +++|+||||||+||+++.++.+||+|||+++.......  ....
T Consensus        81 ~~L~~~~~~~~~l~~~~~~~i~~qi~~~l~~lH---~~~ivH~Dikp~Nili~~~~~~kL~DfG~~~~~~~~~~--~~~~  155 (329)
T cd05618          81 GDLMFHMQRQRKLPEEHARFYSAEISLALNYLH---ERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGD--TTST  155 (329)
T ss_pred             CCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHH---HCCeeeCCCCHHHEEECCCCCEEEeeCCccccccCCCC--cccc
Confidence                         22335668899999999999   89999999999999999999999999999875332221  1234


Q ss_pred             CCCCcccccccccccccCCCCccccHHHHHHHHHHHHcCCCCCCC
Q 039231          446 ARGTVGYIAPEVFCRNIGEVSYKSDVYNYGMMIFEMTGGRKNVDV  490 (506)
Q Consensus       446 ~~gt~~y~aPE~l~~~~~~~s~~~Dv~s~G~il~elltg~~pf~~  490 (506)
                      ..||+.|+|||++.+.  .++.++||||||+++|||++|+.||..
T Consensus       156 ~~gt~~y~aPE~~~~~--~~~~~~DiwslG~il~el~~g~~Pf~~  198 (329)
T cd05618         156 FCGTPNYIAPEILRGE--DYGFSVDWWALGVLMFEMMAGRSPFDI  198 (329)
T ss_pred             ccCCccccCHHHHcCC--CCCCccceecccHHHHHHhhCCCCCcc
Confidence            5689999999998654  788999999999999999999999964

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target o

>cd05067 PTKc_Lck_Blk Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk

Probab=99.96  E-value=4.8e-29  Score=240.64  Aligned_cols=178  Identities=29%  Similarity=0.516  Sum_probs=148.2

Q ss_pred             HHHHHhhhccccCccCceEEEEEEEcCCCEEEEEEeccCCCCchhhHHHHHHhhccCccceeEEEEEe------------
Q 039231          310 IKKMTNSFKYKLGQGGYGSVYKGKLLDGSNVAVKVLNDSKGNGKEFINEVASISRTSHVNVVALLGFC------------  377 (506)
Q Consensus       310 l~~~~~~~~~~ig~G~~g~V~~~~~~~~~~vavK~l~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~------------  377 (506)
                      +....+.+.++||+|+||.||+|...+++.+|+|.+........++.+|+.++++++|+||++++++.            
T Consensus         3 ~~~~~~~~~~~ig~G~~g~v~~~~~~~~~~~a~K~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~v~e~~   82 (260)
T cd05067           3 VPRETLKLVKKLGAGQFGEVWMGYYNGHTKVAIKSLKQGSMSPEAFLAEANLMKQLQHPRLVRLYAVVTQEPIYIITEYM   82 (260)
T ss_pred             cchHHceeeeeeccCccceEEeeecCCCceEEEEEecCCCCcHHHHHHHHHHHHhcCCcCeeeEEEEEccCCcEEEEEcC
Confidence            44556667789999999999999988899999999987666667899999999999999999999875            


Q ss_pred             ----------------eccchhhhHHHHHHHHHHHHhhcCCCCeEecCcCCCcEEECCCCcEEEeecCCCccccCCCcce
Q 039231          378 ----------------LRVAEELSSTIGIARGLEYLHLGCSTRILHFDIKPHNILLDEDFCPKISDFGLAKICNRKESII  441 (506)
Q Consensus       378 ----------------~~~~~~l~i~~~i~~gl~~LH~~~~~~ivH~dlkp~Nill~~~~~~ki~dfg~a~~~~~~~~~~  441 (506)
                                      +++.+.+.++.|++.||+|||   +.+++|+||||+||++++++.++|+|||++......... 
T Consensus        83 ~~~~L~~~~~~~~~~~~~~~~~~~i~~~i~~al~~LH---~~~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~~~-  158 (260)
T cd05067          83 ENGSLVDFLKTPEGIKLTINKLIDMAAQIAEGMAFIE---RKNYIHRDLRAANILVSETLCCKIADFGLARLIEDNEYT-  158 (260)
T ss_pred             CCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHh---cCCeecccccHHhEEEcCCCCEEEccCcceeecCCCCcc-
Confidence                            122335668899999999999   899999999999999999999999999999766532221 


Q ss_pred             ecccCCCCcccccccccccccCCCCccccHHHHHHHHHHHHc-CCCCCCCCCC
Q 039231          442 SMTGARGTVGYIAPEVFCRNIGEVSYKSDVYNYGMMIFEMTG-GRKNVDVVDN  493 (506)
Q Consensus       442 ~~~~~~gt~~y~aPE~l~~~~~~~s~~~Dv~s~G~il~ellt-g~~pf~~~~~  493 (506)
                      ......++..|+|||.+..  ..++.++||||||+++|||++ |+.||...+.
T Consensus       159 ~~~~~~~~~~y~~pe~~~~--~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~  209 (260)
T cd05067         159 AREGAKFPIKWTAPEAINY--GTFTIKSDVWSFGILLTEIVTYGRIPYPGMTN  209 (260)
T ss_pred             cccCCcccccccCHHHhcc--CCcCcccchHHHHHHHHHHHhCCCCCCCCCCh
Confidence            1123345678999999854  367889999999999999998 9999976554

Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Sr

>cd07863 STKc_CDK4 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4

Probab=99.96  E-value=4e-29  Score=244.84  Aligned_cols=170  Identities=31%  Similarity=0.431  Sum_probs=137.3

Q ss_pred             hccccCccCceEEEEEEEc-CCCEEEEEEeccCC---CCchhhHHHHHHhhcc---CccceeEEEEEee-----------
Q 039231          317 FKYKLGQGGYGSVYKGKLL-DGSNVAVKVLNDSK---GNGKEFINEVASISRT---SHVNVVALLGFCL-----------  378 (506)
Q Consensus       317 ~~~~ig~G~~g~V~~~~~~-~~~~vavK~l~~~~---~~~~~~~~E~~~l~~l---~h~niv~l~g~~~-----------  378 (506)
                      ..+.||+|+||.||+|+.. +++.||+|.++...   .....+.+|+++++++   +||||+++++++.           
T Consensus         4 ~~~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~ni~~~~~~~~~~~~~~~~~~~   83 (288)
T cd07863           4 PVAEIGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGLPLSTVREVALLKRLEAFDHPNIVRLMDVCATSRTDRETKVT   83 (288)
T ss_pred             EeeEEeecCCeEEEEEEECCCCcEEEEEEeccCcCCCCCchHHHHHHHHHHHhhhcCCCCeeeeeeeeccccCCCCceEE
Confidence            3467999999999999875 58899999987532   2224566777777665   6999999987641           


Q ss_pred             ----------------------ccchhhhHHHHHHHHHHHHhhcCCCCeEecCcCCCcEEECCCCcEEEeecCCCccccC
Q 039231          379 ----------------------RVAEELSSTIGIARGLEYLHLGCSTRILHFDIKPHNILLDEDFCPKISDFGLAKICNR  436 (506)
Q Consensus       379 ----------------------~~~~~l~i~~~i~~gl~~LH~~~~~~ivH~dlkp~Nill~~~~~~ki~dfg~a~~~~~  436 (506)
                                            ++.+...++.|++.||+|||   +++++||||||+||++++++.+||+|||+++....
T Consensus        84 lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH---~~~ivH~dikp~Nili~~~~~~kl~dfg~~~~~~~  160 (288)
T cd07863          84 LVFEHVDQDLRTYLDKVPPPGLPAETIKDLMRQFLRGLDFLH---ANCIVHRDLKPENILVTSGGQVKLADFGLARIYSC  160 (288)
T ss_pred             EEEcccccCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEECCCCCEEECccCccccccC
Confidence                                  12235668899999999999   89999999999999999999999999999986643


Q ss_pred             CCcceecccCCCCcccccccccccccCCCCccccHHHHHHHHHHHHcCCCCCCCCCCC
Q 039231          437 KESIISMTGARGTVGYIAPEVFCRNIGEVSYKSDVYNYGMMIFEMTGGRKNVDVVDNG  494 (506)
Q Consensus       437 ~~~~~~~~~~~gt~~y~aPE~l~~~~~~~s~~~Dv~s~G~il~elltg~~pf~~~~~~  494 (506)
                      ...   .....++..|+|||.+.+.  .++.++||||+||++|||++|+.||......
T Consensus       161 ~~~---~~~~~~~~~y~aPE~~~~~--~~~~~~DiwslG~~l~~l~~g~~~f~~~~~~  213 (288)
T cd07863         161 QMA---LTPVVVTLWYRAPEVLLQS--TYATPVDMWSVGCIFAEMFRRKPLFCGNSEA  213 (288)
T ss_pred             ccc---CCCccccccccCchHhhCC--CCCCcchhhhHHHHHHHHHhCCcCcCCCCHH
Confidence            322   1345678999999998654  6899999999999999999999999765443

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitou

>cd05604 STKc_SGK3 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3

Probab=99.96  E-value=1.3e-29  Score=252.98  Aligned_cols=169  Identities=31%  Similarity=0.378  Sum_probs=135.4

Q ss_pred             cccCccCceEEEEEEEc-CCCEEEEEEeccCC----CCchhhHHHHH-HhhccCccceeEEEEEe---------------
Q 039231          319 YKLGQGGYGSVYKGKLL-DGSNVAVKVLNDSK----GNGKEFINEVA-SISRTSHVNVVALLGFC---------------  377 (506)
Q Consensus       319 ~~ig~G~~g~V~~~~~~-~~~~vavK~l~~~~----~~~~~~~~E~~-~l~~l~h~niv~l~g~~---------------  377 (506)
                      +.||+|+||.||+|+.. +|+.+|+|++....    ...+++.+|.. +++.++||||+++++.+               
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~hp~iv~~~~~~~~~~~~~lv~e~~~~   80 (325)
T cd05604           1 KVIGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTTEKLYFVLDFVNG   80 (325)
T ss_pred             CceeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHHhCCCCCCccEEEEEecCCEEEEEEcCCCC
Confidence            35999999999999874 58999999996431    22244555554 46779999999998765               


Q ss_pred             ------------eccchhhhHHHHHHHHHHHHhhcCCCCeEecCcCCCcEEECCCCcEEEeecCCCccccCCCcceeccc
Q 039231          378 ------------LRVAEELSSTIGIARGLEYLHLGCSTRILHFDIKPHNILLDEDFCPKISDFGLAKICNRKESIISMTG  445 (506)
Q Consensus       378 ------------~~~~~~l~i~~~i~~gl~~LH~~~~~~ivH~dlkp~Nill~~~~~~ki~dfg~a~~~~~~~~~~~~~~  445 (506)
                                  +.+.+...++.||+.||+|||   +.+|+||||||+|||+++++.+||+|||+++.......  ....
T Consensus        81 ~~L~~~l~~~~~~~~~~~~~~~~qi~~al~~lH---~~givH~Dlkp~NIll~~~~~~kL~DfG~~~~~~~~~~--~~~~  155 (325)
T cd05604          81 GELFFHLQRERSFPEPRARFYAAEIASALGYLH---SINIVYRDLKPENILLDSQGHVVLTDFGLCKEGIAQSD--TTTT  155 (325)
T ss_pred             CCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHH---HCCeeecCCCHHHeEECCCCCEEEeecCCcccCCCCCC--Cccc
Confidence                        223335668899999999999   89999999999999999999999999999875322221  1234


Q ss_pred             CCCCcccccccccccccCCCCccccHHHHHHHHHHHHcCCCCCCCCCCC
Q 039231          446 ARGTVGYIAPEVFCRNIGEVSYKSDVYNYGMMIFEMTGGRKNVDVVDNG  494 (506)
Q Consensus       446 ~~gt~~y~aPE~l~~~~~~~s~~~Dv~s~G~il~elltg~~pf~~~~~~  494 (506)
                      ..||+.|+|||.+.+.  .++.++||||||+++|||++|+.||...+..
T Consensus       156 ~~gt~~y~aPE~~~~~--~~~~~~DvwslG~il~el~~G~~pf~~~~~~  202 (325)
T cd05604         156 FCGTPEYLAPEVIRKQ--PYDNTVDWWCLGAVLYEMLYGLPPFYCRDVA  202 (325)
T ss_pred             ccCChhhCCHHHHcCC--CCCCcCccccccceehhhhcCCCCCCCCCHH
Confidence            5689999999998654  6889999999999999999999999865443

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels,

>cd05575 STKc_SGK Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase

Probab=99.96  E-value=1.5e-29  Score=252.38  Aligned_cols=167  Identities=31%  Similarity=0.383  Sum_probs=134.3

Q ss_pred             ccCccCceEEEEEEEc-CCCEEEEEEeccCC----CCchhhHHHHH-HhhccCccceeEEEEEee---------------
Q 039231          320 KLGQGGYGSVYKGKLL-DGSNVAVKVLNDSK----GNGKEFINEVA-SISRTSHVNVVALLGFCL---------------  378 (506)
Q Consensus       320 ~ig~G~~g~V~~~~~~-~~~~vavK~l~~~~----~~~~~~~~E~~-~l~~l~h~niv~l~g~~~---------------  378 (506)
                      .||+|+||+||+|+.. +|+.||+|++....    ...+++.+|.. .++.++||||+++++.+.               
T Consensus         2 ~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~g   81 (323)
T cd05575           2 VIGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTADKLYFVLDYVNGG   81 (323)
T ss_pred             eeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhhCCCCCCCCeeEEEEeCCEEEEEEcCCCCC
Confidence            5999999999999975 58999999996432    22244555554 567899999999987651               


Q ss_pred             ------------ccchhhhHHHHHHHHHHHHhhcCCCCeEecCcCCCcEEECCCCcEEEeecCCCccccCCCcceecccC
Q 039231          379 ------------RVAEELSSTIGIARGLEYLHLGCSTRILHFDIKPHNILLDEDFCPKISDFGLAKICNRKESIISMTGA  446 (506)
Q Consensus       379 ------------~~~~~l~i~~~i~~gl~~LH~~~~~~ivH~dlkp~Nill~~~~~~ki~dfg~a~~~~~~~~~~~~~~~  446 (506)
                                  .+.....++.||+.||+|||   +++|+||||||+|||+++++.+||+|||+++.......  .....
T Consensus        82 ~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH---~~givH~dikp~NIll~~~~~~kl~Dfg~~~~~~~~~~--~~~~~  156 (323)
T cd05575          82 ELFFHLQRERSFPEPRARFYAAEIASALGYLH---SLNIIYRDLKPENILLDSQGHVVLTDFGLCKEGIEHSK--TTSTF  156 (323)
T ss_pred             CHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH---HCCeEeCCCCHHHeEECCCCcEEEeccCCCcccccCCC--ccccc
Confidence                        22234568899999999999   89999999999999999999999999999875432221  12345


Q ss_pred             CCCcccccccccccccCCCCccccHHHHHHHHHHHHcCCCCCCCCCC
Q 039231          447 RGTVGYIAPEVFCRNIGEVSYKSDVYNYGMMIFEMTGGRKNVDVVDN  493 (506)
Q Consensus       447 ~gt~~y~aPE~l~~~~~~~s~~~Dv~s~G~il~elltg~~pf~~~~~  493 (506)
                      .||+.|+|||++.+.  .++.++||||||+++|||++|+.||...+.
T Consensus       157 ~gt~~y~aPE~~~~~--~~~~~~DvwslG~il~ell~g~~pf~~~~~  201 (323)
T cd05575         157 CGTPEYLAPEVLRKQ--PYDRTVDWWCLGAVLYEMLYGLPPFYSRDT  201 (323)
T ss_pred             cCChhhcChhhhcCC--CCCccccccccchhhhhhhcCCCCCCCCCH
Confidence            689999999998653  688999999999999999999999986543

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell pr

>cd05603 STKc_SGK2 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2

Probab=99.96  E-value=1.6e-29  Score=251.97  Aligned_cols=166  Identities=30%  Similarity=0.381  Sum_probs=133.7

Q ss_pred             ccCccCceEEEEEEEc-CCCEEEEEEeccCC----CCchhhHHHHH-HhhccCccceeEEEEEee---------------
Q 039231          320 KLGQGGYGSVYKGKLL-DGSNVAVKVLNDSK----GNGKEFINEVA-SISRTSHVNVVALLGFCL---------------  378 (506)
Q Consensus       320 ~ig~G~~g~V~~~~~~-~~~~vavK~l~~~~----~~~~~~~~E~~-~l~~l~h~niv~l~g~~~---------------  378 (506)
                      +||+|+||.||+|+.. +++.+|+|++....    ....++.+|.. +++.++||||+++++.+.               
T Consensus         2 ~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~~~~~   81 (321)
T cd05603           2 VIGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVGLHYSFQTAEKLYFVLDYVNGG   81 (321)
T ss_pred             eeeeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHHhCCCCCccceeeEEEcCCEEEEEEcCCCCC
Confidence            5999999999999975 58899999986432    22244555554 578899999999987651               


Q ss_pred             ------------ccchhhhHHHHHHHHHHHHhhcCCCCeEecCcCCCcEEECCCCcEEEeecCCCccccCCCcceecccC
Q 039231          379 ------------RVAEELSSTIGIARGLEYLHLGCSTRILHFDIKPHNILLDEDFCPKISDFGLAKICNRKESIISMTGA  446 (506)
Q Consensus       379 ------------~~~~~l~i~~~i~~gl~~LH~~~~~~ivH~dlkp~Nill~~~~~~ki~dfg~a~~~~~~~~~~~~~~~  446 (506)
                                  ...+...++.||+.||+|||   +.+|+||||||+||+++.++.+||+|||+++.......  .....
T Consensus        82 ~L~~~l~~~~~~~~~~~~~~~~qi~~~L~~lH---~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~--~~~~~  156 (321)
T cd05603          82 ELFFHLQRERCFLEPRARFYAAEVASAIGYLH---SLNIIYRDLKPENILLDSQGHVVLTDFGLCKEGVEPEE--TTSTF  156 (321)
T ss_pred             CHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHH---HCCeEeccCCHHHeEECCCCCEEEccCCCCccCCCCCC--ccccc
Confidence                        12234568899999999999   89999999999999999999999999999875322221  12345


Q ss_pred             CCCcccccccccccccCCCCccccHHHHHHHHHHHHcCCCCCCCCC
Q 039231          447 RGTVGYIAPEVFCRNIGEVSYKSDVYNYGMMIFEMTGGRKNVDVVD  492 (506)
Q Consensus       447 ~gt~~y~aPE~l~~~~~~~s~~~Dv~s~G~il~elltg~~pf~~~~  492 (506)
                      .||+.|+|||.+.+.  .++.++|||||||++|||++|+.||...+
T Consensus       157 ~gt~~y~aPE~~~~~--~~~~~~DiwslG~il~el~~g~~pf~~~~  200 (321)
T cd05603         157 CGTPEYLAPEVLRKE--PYDRTVDWWCLGAVLYEMLYGLPPFYSRD  200 (321)
T ss_pred             cCCcccCCHHHhcCC--CCCCcCcccccchhhhhhhcCCCCCCCCC
Confidence            689999999998653  68899999999999999999999997654

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1.

>PTZ00283 serine/threonine protein kinase; Provisional

Probab=99.96  E-value=3e-29  Score=263.24  Aligned_cols=173  Identities=27%  Similarity=0.334  Sum_probs=140.2

Q ss_pred             hhccccCccCceEEEEEEEc-CCCEEEEEEeccCCC---CchhhHHHHHHhhccCccceeEEEEEe--------------
Q 039231          316 SFKYKLGQGGYGSVYKGKLL-DGSNVAVKVLNDSKG---NGKEFINEVASISRTSHVNVVALLGFC--------------  377 (506)
Q Consensus       316 ~~~~~ig~G~~g~V~~~~~~-~~~~vavK~l~~~~~---~~~~~~~E~~~l~~l~h~niv~l~g~~--------------  377 (506)
                      .+.+.||+|+||+||+|+.. +++.||||++.....   ....+.+|+..+..++|+||+++...+              
T Consensus        35 ~i~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~~l~~~~h~~iv~~~~~~~~~~~~~~~~~~~i  114 (496)
T PTZ00283         35 WISRVLGSGATGTVLCAKRVSDGEPFAVKVVDMEGMSEADKNRAQAEVCCLLNCDFFSIVKCHEDFAKKDPRNPENVLMI  114 (496)
T ss_pred             EEEEEEecCCCEEEEEEEEcCCCCEEEEEEEecccCCHHHHHHHHHHHHHHhcCCCCcEEEeecceecccccCcccceEE
Confidence            44678999999999999864 689999999865432   235678899999999999999865432              


Q ss_pred             -------------------------eccchhhhHHHHHHHHHHHHhhcCCCCeEecCcCCCcEEECCCCcEEEeecCCCc
Q 039231          378 -------------------------LRVAEELSSTIGIARGLEYLHLGCSTRILHFDIKPHNILLDEDFCPKISDFGLAK  432 (506)
Q Consensus       378 -------------------------~~~~~~l~i~~~i~~gl~~LH~~~~~~ivH~dlkp~Nill~~~~~~ki~dfg~a~  432 (506)
                                               +.+.+...++.|++.||+|||   +++|+||||||+|||+++++.+||+|||+++
T Consensus       115 ~lV~Ey~~~gsL~~~l~~~~~~~~~l~e~~~~~i~~qll~aL~~lH---~~~IiHrDLKP~NILl~~~~~vkL~DFGls~  191 (496)
T PTZ00283        115 ALVLDYANAGDLRQEIKSRAKTNRTFREHEAGLLFIQVLLAVHHVH---SKHMIHRDIKSANILLCSNGLVKLGDFGFSK  191 (496)
T ss_pred             EEEEeCCCCCcHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHH---hCCEecCCCCHHHEEEeCCCCEEEEecccCe
Confidence                                     112224557899999999999   8999999999999999999999999999998


Q ss_pred             cccCCCcceecccCCCCcccccccccccccCCCCccccHHHHHHHHHHHHcCCCCCCCCCC
Q 039231          433 ICNRKESIISMTGARGTVGYIAPEVFCRNIGEVSYKSDVYNYGMMIFEMTGGRKNVDVVDN  493 (506)
Q Consensus       433 ~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~s~~~Dv~s~G~il~elltg~~pf~~~~~  493 (506)
                      ...............||+.|+|||++.+.  .++.++||||||+++|||++|+.||...+.
T Consensus       192 ~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~--~~s~k~DVwSlGvilyeLltG~~Pf~~~~~  250 (496)
T PTZ00283        192 MYAATVSDDVGRTFCGTPYYVAPEIWRRK--PYSKKADMFSLGVLLYELLTLKRPFDGENM  250 (496)
T ss_pred             eccccccccccccccCCcceeCHHHhCCC--CCCcHHHHHHHHHHHHHHHHCCCCCCCCCH
Confidence            76543222222446789999999999654  689999999999999999999999976543

>PTZ00284 protein kinase; Provisional

Probab=99.96  E-value=2.4e-29  Score=263.34  Aligned_cols=170  Identities=22%  Similarity=0.313  Sum_probs=134.6

Q ss_pred             hhccccCccCceEEEEEEEc-CCCEEEEEEeccCCCCchhhHHHHHHhhccCcc------ceeEEEEEee----------
Q 039231          316 SFKYKLGQGGYGSVYKGKLL-DGSNVAVKVLNDSKGNGKEFINEVASISRTSHV------NVVALLGFCL----------  378 (506)
Q Consensus       316 ~~~~~ig~G~~g~V~~~~~~-~~~~vavK~l~~~~~~~~~~~~E~~~l~~l~h~------niv~l~g~~~----------  378 (506)
                      .+.++||+|+||+||+|+.. .++.||||+++......++...|++++.+++|.      +++++++++.          
T Consensus       132 ~i~~~lG~G~fg~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~i~~i~~~~~~~~~~~~iv~  211 (467)
T PTZ00284        132 KILSLLGEGTFGKVVEAWDRKRKEYCAVKIVRNVPKYTRDAKIEIQFMEKVRQADPADRFPLMKIQRYFQNETGHMCIVM  211 (467)
T ss_pred             EEEEEEEeccCEEEEEEEEcCCCeEEEEEEEecchhhHHHHHHHHHHHHHHhhcCcccCcceeeeEEEEEcCCceEEEEE
Confidence            34568999999999999875 478899999976444445667788887777654      4777776552          


Q ss_pred             -----------------ccchhhhHHHHHHHHHHHHhhcCC-CCeEecCcCCCcEEECCCC----------------cEE
Q 039231          379 -----------------RVAEELSSTIGIARGLEYLHLGCS-TRILHFDIKPHNILLDEDF----------------CPK  424 (506)
Q Consensus       379 -----------------~~~~~l~i~~~i~~gl~~LH~~~~-~~ivH~dlkp~Nill~~~~----------------~~k  424 (506)
                                       .+.+...++.||+.||+|||   + .+|+||||||+|||++.++                .+|
T Consensus       212 ~~~g~~l~~~l~~~~~l~~~~~~~i~~qi~~aL~yLH---~~~gIiHrDlKP~NILl~~~~~~~~~~~~~~~~~~~~~vk  288 (467)
T PTZ00284        212 PKYGPCLLDWIMKHGPFSHRHLAQIIFQTGVALDYFH---TELHLMHTDLKPENILMETSDTVVDPVTNRALPPDPCRVR  288 (467)
T ss_pred             eccCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHH---hcCCeecCCCCHHHEEEecCCcccccccccccCCCCceEE
Confidence                             22235678899999999999   6 5999999999999998765                499


Q ss_pred             EeecCCCccccCCCcceecccCCCCcccccccccccccCCCCccccHHHHHHHHHHHHcCCCCCCCCCCCc
Q 039231          425 ISDFGLAKICNRKESIISMTGARGTVGYIAPEVFCRNIGEVSYKSDVYNYGMMIFEMTGGRKNVDVVDNGS  495 (506)
Q Consensus       425 i~dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~s~~~Dv~s~G~il~elltg~~pf~~~~~~~  495 (506)
                      |+|||.+......     .....||+.|+|||++.+.  .++.++|||||||++|||++|+.||+..++.+
T Consensus       289 l~DfG~~~~~~~~-----~~~~~gt~~Y~APE~~~~~--~~~~~~DiwSlGvil~elltG~~pf~~~~~~~  352 (467)
T PTZ00284        289 ICDLGGCCDERHS-----RTAIVSTRHYRSPEVVLGL--GWMYSTDMWSMGCIIYELYTGKLLYDTHDNLE  352 (467)
T ss_pred             ECCCCccccCccc-----cccccCCccccCcHHhhcC--CCCcHHHHHHHHHHHHHHHhCCCCCCCCChHH
Confidence            9999987643221     2446789999999999654  78999999999999999999999998765543

>cd05597 STKc_DMPK_like Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases

Probab=99.96  E-value=1.9e-29  Score=252.37  Aligned_cols=172  Identities=23%  Similarity=0.288  Sum_probs=139.4

Q ss_pred             hccccCccCceEEEEEEEc-CCCEEEEEEeccC----CCCchhhHHHHHHhhccCccceeEEEEEee-------------
Q 039231          317 FKYKLGQGGYGSVYKGKLL-DGSNVAVKVLNDS----KGNGKEFINEVASISRTSHVNVVALLGFCL-------------  378 (506)
Q Consensus       317 ~~~~ig~G~~g~V~~~~~~-~~~~vavK~l~~~----~~~~~~~~~E~~~l~~l~h~niv~l~g~~~-------------  378 (506)
                      +.+.||+|+||.||+++.. +++.||+|++...    ....+.+.+|+.++..++|+||+++++++.             
T Consensus         5 ~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~   84 (331)
T cd05597           5 ILKVIGRGAFGEVAVVKMKNTGQVYAMKILNKWEMLKRAETACFREERDVLVNGDRRWITNLHYAFQDENNLYLVMDYYV   84 (331)
T ss_pred             EEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCceEEEEecCCeEEEEEecCC
Confidence            4567999999999999975 4899999999642    223356888999999999999999987661             


Q ss_pred             ---------------ccchhhhHHHHHHHHHHHHhhcCCCCeEecCcCCCcEEECCCCcEEEeecCCCccccCCCcceec
Q 039231          379 ---------------RVAEELSSTIGIARGLEYLHLGCSTRILHFDIKPHNILLDEDFCPKISDFGLAKICNRKESIISM  443 (506)
Q Consensus       379 ---------------~~~~~l~i~~~i~~gl~~LH~~~~~~ivH~dlkp~Nill~~~~~~ki~dfg~a~~~~~~~~~~~~  443 (506)
                                     .+.....++.||+.||+|||   +++|+||||||+|||++.++.+||+|||++.......... .
T Consensus        85 g~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH---~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~-~  160 (331)
T cd05597          85 GGDLLTLLSKFEDRLPEDMARFYLAEMVLAIDSVH---QLGYVHRDIKPDNVLLDKNGHIRLADFGSCLRLLADGTVQ-S  160 (331)
T ss_pred             CCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH---hCCeEECCCCHHHEEECCCCCEEEEECCceeecCCCCCcc-c
Confidence                           12235568889999999999   9999999999999999999999999999987654333211 1


Q ss_pred             ccCCCCcccccccccccc---cCCCCccccHHHHHHHHHHHHcCCCCCCCCC
Q 039231          444 TGARGTVGYIAPEVFCRN---IGEVSYKSDVYNYGMMIFEMTGGRKNVDVVD  492 (506)
Q Consensus       444 ~~~~gt~~y~aPE~l~~~---~~~~s~~~Dv~s~G~il~elltg~~pf~~~~  492 (506)
                      ....||+.|+|||++...   .+.++.++|||||||++|||++|+.||...+
T Consensus       161 ~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~  212 (331)
T cd05597         161 NVAVGTPDYISPEILQAMEDGKGRYGPECDWWSLGVCMYEMLYGETPFYAES  212 (331)
T ss_pred             cceeccccccCHHHHhhccccccCCCCcceeehhhhHHHHHhhCCCCCCCCC
Confidence            234689999999998531   2357889999999999999999999997654

Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy,

>cd05602 STKc_SGK1 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1

Probab=99.96  E-value=2e-29  Score=251.64  Aligned_cols=167  Identities=28%  Similarity=0.356  Sum_probs=133.2

Q ss_pred             ccCccCceEEEEEEEc-CCCEEEEEEeccCC----CCchhhHHHHH-HhhccCccceeEEEEEee---------------
Q 039231          320 KLGQGGYGSVYKGKLL-DGSNVAVKVLNDSK----GNGKEFINEVA-SISRTSHVNVVALLGFCL---------------  378 (506)
Q Consensus       320 ~ig~G~~g~V~~~~~~-~~~~vavK~l~~~~----~~~~~~~~E~~-~l~~l~h~niv~l~g~~~---------------  378 (506)
                      .||+|+||.||+|+.. +++.+|+|++....    ....++.+|.. .++.++||||+++++.+.               
T Consensus         2 ~lg~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~Iv~~~~~~~~~~~~~lv~e~~~~~   81 (325)
T cd05602           2 VIGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYFVLDYINGG   81 (325)
T ss_pred             eeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHHhhhHHHHHHHHHHHHHHhCCCCCCCceeEEEEcCCeEEEEEeCCCCC
Confidence            5999999999999875 47889999986432    22234444444 567889999999987761               


Q ss_pred             ------------ccchhhhHHHHHHHHHHHHhhcCCCCeEecCcCCCcEEECCCCcEEEeecCCCccccCCCcceecccC
Q 039231          379 ------------RVAEELSSTIGIARGLEYLHLGCSTRILHFDIKPHNILLDEDFCPKISDFGLAKICNRKESIISMTGA  446 (506)
Q Consensus       379 ------------~~~~~l~i~~~i~~gl~~LH~~~~~~ivH~dlkp~Nill~~~~~~ki~dfg~a~~~~~~~~~~~~~~~  446 (506)
                                  .......++.||++||+|||   +.+|+||||||+|||++.++.+||+|||+++.......  .....
T Consensus        82 ~L~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH---~~giiHrDlkp~Nili~~~~~~kl~DfG~a~~~~~~~~--~~~~~  156 (325)
T cd05602          82 ELFYHLQRERCFLEPRARFYAAEIASALGYLH---SLNIVYRDLKPENILLDSQGHIVLTDFGLCKENIEHNG--TTSTF  156 (325)
T ss_pred             cHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH---HCCeEecCCCHHHeEECCCCCEEEccCCCCcccccCCC--Ccccc
Confidence                        12224557899999999999   89999999999999999999999999999975432221  12345


Q ss_pred             CCCcccccccccccccCCCCccccHHHHHHHHHHHHcCCCCCCCCCC
Q 039231          447 RGTVGYIAPEVFCRNIGEVSYKSDVYNYGMMIFEMTGGRKNVDVVDN  493 (506)
Q Consensus       447 ~gt~~y~aPE~l~~~~~~~s~~~Dv~s~G~il~elltg~~pf~~~~~  493 (506)
                      .||+.|+|||++.+.  .++.++||||||+++|||++|+.||...+.
T Consensus       157 ~gt~~y~aPE~~~~~--~~~~~~DiwslG~il~el~~g~~pf~~~~~  201 (325)
T cd05602         157 CGTPEYLAPEVLHKQ--PYDRTVDWWCLGAVLYEMLYGLPPFYSRNT  201 (325)
T ss_pred             cCCccccCHHHHcCC--CCCCccccccccHHHHHHhcCCCCCCCCCH
Confidence            689999999998654  788999999999999999999999986543

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt

>PF07714 Pkinase_Tyr: Protein tyrosine kinase Protein kinase; unclassified specificity

Probab=99.96  E-value=1.4e-29  Score=244.54  Aligned_cols=174  Identities=37%  Similarity=0.637  Sum_probs=141.7

Q ss_pred             hccccCccCceEEEEEEEc-----CCCEEEEEEeccCCC--CchhhHHHHHHhhccCccceeEEEEEee-----------
Q 039231          317 FKYKLGQGGYGSVYKGKLL-----DGSNVAVKVLNDSKG--NGKEFINEVASISRTSHVNVVALLGFCL-----------  378 (506)
Q Consensus       317 ~~~~ig~G~~g~V~~~~~~-----~~~~vavK~l~~~~~--~~~~~~~E~~~l~~l~h~niv~l~g~~~-----------  378 (506)
                      +.+.||.|.||.||+|.+.     .+..|+||+++....  ..+++.+|++.+++++||||++++|++.           
T Consensus         3 ~~~~ig~G~fg~v~~~~~~~~~~~~~~~V~vk~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~g~~~~~~~~~lv~e~   82 (259)
T PF07714_consen    3 LIKQIGEGSFGKVYRAEWKQKDNDKNQPVAVKILKPSSSEEEEEEFLNEIQILRKLRHPNIVKLYGFCIENEPLFLVMEY   82 (259)
T ss_dssp             EEEEEEEESSEEEEEEEEESTTTSSEEEEEEEEESTTSSHHHHHHHHHHHHHHHTHSBTTBE-EEEEEESSSSEEEEEE-
T ss_pred             EeeEEccCCCcEEEEEEEEcccCCCCEEEEEEEeccccccccceeeeecccccccccccccccccccccccccccccccc
Confidence            3467999999999999987     267899999965433  2478999999999999999999999983           


Q ss_pred             ------------------ccchhhhHHHHHHHHHHHHhhcCCCCeEecCcCCCcEEECCCCcEEEeecCCCccccCCCcc
Q 039231          379 ------------------RVAEELSSTIGIARGLEYLHLGCSTRILHFDIKPHNILLDEDFCPKISDFGLAKICNRKESI  440 (506)
Q Consensus       379 ------------------~~~~~l~i~~~i~~gl~~LH~~~~~~ivH~dlkp~Nill~~~~~~ki~dfg~a~~~~~~~~~  440 (506)
                                        ++..++.|+.||++||+|||   +.+++|+||+++||++++++.+||+|||+++........
T Consensus        83 ~~~g~L~~~L~~~~~~~~~~~~~~~i~~~i~~~l~~Lh---~~~iiH~~l~~~nill~~~~~~Kl~~f~~~~~~~~~~~~  159 (259)
T PF07714_consen   83 CPGGSLDDYLKSKNKEPLSEQQRLSIAIQIAEALSYLH---SNNIIHGNLSPSNILLDSNGQVKLSDFGLSRPISEKSKY  159 (259)
T ss_dssp             -TTEBHHHHHHHTCTTTSBHHHHHHHHHHHHHHHHHHH---HTTEEEST-SGGGEEEETTTEEEEESTTTGEETTTSSSE
T ss_pred             cccccccccccccccccccccccccccccccccccccc---ccccccccccccccccccccccccccccccccccccccc
Confidence                              22336779999999999999   889999999999999999999999999999877433332


Q ss_pred             eecccCCCCcccccccccccccCCCCccccHHHHHHHHHHHHc-CCCCCCCCCCCc
Q 039231          441 ISMTGARGTVGYIAPEVFCRNIGEVSYKSDVYNYGMMIFEMTG-GRKNVDVVDNGS  495 (506)
Q Consensus       441 ~~~~~~~gt~~y~aPE~l~~~~~~~s~~~Dv~s~G~il~ellt-g~~pf~~~~~~~  495 (506)
                      ...........|+|||.+...  .++.++||||||+++|||++ |+.||...+..+
T Consensus       160 ~~~~~~~~~~~~~aPE~~~~~--~~~~ksDVysfG~~l~ei~~~~~~p~~~~~~~~  213 (259)
T PF07714_consen  160 KNDSSQQLPLRYLAPEVLKDG--EYTKKSDVYSFGMLLYEILTLGKFPFSDYDNEE  213 (259)
T ss_dssp             EESTTSESGGGGS-HHHHHHS--EESHHHHHHHHHHHHHHHHTTSSGTTTTSCHHH
T ss_pred             ccccccccccccccccccccc--ccccccccccccccccccccccccccccccccc
Confidence            223445578899999998654  58999999999999999999 789998775444

Tyrosine kinase, catalytic domain; InterPro: IPR001245 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Tyrosine-protein kinases can transfer a phosphate group from ATP to a tyrosine residue in a protein. These enzymes can be divided into two main groups []: Receptor tyrosine kinases (RTK), which are transmembrane proteins involved in signal transduction; they play key roles in growth, differentiation, metabolism, adhesion, motility, death and oncogenesis []. RTKs are composed of 3 domains: an extracellular domain (binds ligand), a transmembrane (TM) domain, and an intracellular catalytic domain (phosphorylates substrate). The TM domain plays an important role in the dimerisation process necessary for signal transduction []. Cytoplasmic / non-receptor tyrosine kinases, which act as regulatory proteins, playing key roles in cell differentiation, motility, proliferation, and survival. For example, the Src-family of protein-tyrosine kinases []. ; GO: 0004672 protein kinase activity, 0006468 protein phosphorylation; PDB: 2HYY_C 1OPL_A 2V7A_A 2G2H_B 2G1T_A 3PYY_A 3CS9_D 2HZI_A 2E2B_A 2HIW_A ....

>cd05114 PTKc_Tec_Rlk Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase

Probab=99.96  E-value=4.9e-29  Score=239.99  Aligned_cols=173  Identities=32%  Similarity=0.516  Sum_probs=143.4

Q ss_pred             hhccccCccCceEEEEEEEcCCCEEEEEEeccCCCCchhhHHHHHHhhccCccceeEEEEEe------------------
Q 039231          316 SFKYKLGQGGYGSVYKGKLLDGSNVAVKVLNDSKGNGKEFINEVASISRTSHVNVVALLGFC------------------  377 (506)
Q Consensus       316 ~~~~~ig~G~~g~V~~~~~~~~~~vavK~l~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~------------------  377 (506)
                      .+.+.||+|+||.||++++.++..+|+|.+.......+++.+|++++++++||||+++++++                  
T Consensus         7 ~~~~~lg~G~~~~vy~~~~~~~~~~a~K~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv~e~~~~~~L   86 (256)
T cd05114           7 TFMKELGSGQFGVVHLGKWRAQIKVAIKAINEGAMSEEDFIEEAKVMMKLSHPKLVQLYGVCTQQKPLYIVTEFMENGCL   86 (256)
T ss_pred             EEeeEecCCcCceEEEEEeccCceEEEEecccCCccHHHHHHHHHHHHHCCCCCceeEEEEEccCCCEEEEEEcCCCCcH
Confidence            34567999999999999998888999999876655567899999999999999999999886                  


Q ss_pred             ----------eccchhhhHHHHHHHHHHHHhhcCCCCeEecCcCCCcEEECCCCcEEEeecCCCccccCCCcceecccCC
Q 039231          378 ----------LRVAEELSSTIGIARGLEYLHLGCSTRILHFDIKPHNILLDEDFCPKISDFGLAKICNRKESIISMTGAR  447 (506)
Q Consensus       378 ----------~~~~~~l~i~~~i~~gl~~LH~~~~~~ivH~dlkp~Nill~~~~~~ki~dfg~a~~~~~~~~~~~~~~~~  447 (506)
                                +++...+.++.|++.||+|||   +++++|+||||+||++++++.+||+|||.++........ ......
T Consensus        87 ~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dl~p~ni~i~~~~~~kl~d~g~~~~~~~~~~~-~~~~~~  162 (256)
T cd05114          87 LNYLRQRQGKLSKDMLLSMCQDVCEGMEYLE---RNSFIHRDLAARNCLVSSTGVVKVSDFGMTRYVLDDEYT-SSSGAK  162 (256)
T ss_pred             HHHHHhCccCCCHHHHHHHHHHHHHHHHHHH---HCCccccccCcceEEEcCCCeEEECCCCCccccCCCcee-ccCCCC
Confidence                      122335678899999999999   899999999999999999999999999999865433221 112334


Q ss_pred             CCcccccccccccccCCCCccccHHHHHHHHHHHHc-CCCCCCCCCCC
Q 039231          448 GTVGYIAPEVFCRNIGEVSYKSDVYNYGMMIFEMTG-GRKNVDVVDNG  494 (506)
Q Consensus       448 gt~~y~aPE~l~~~~~~~s~~~Dv~s~G~il~ellt-g~~pf~~~~~~  494 (506)
                      ++..|+|||.+...  .++.++||||||+++|||++ |+.||...+..
T Consensus       163 ~~~~y~aPE~~~~~--~~~~~~Di~s~G~~l~el~~~g~~p~~~~~~~  208 (256)
T cd05114         163 FPVKWSPPEVFNFS--KYSSKSDVWSFGVLMWEVFTEGKMPFEKKSNY  208 (256)
T ss_pred             CchhhCChhhcccC--ccchhhhhHHHHHHHHHHHcCCCCCCCCCCHH
Confidence            56789999998543  68889999999999999999 99999766543

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin h

>PHA03211 serine/threonine kinase US3; Provisional

Probab=99.96  E-value=5.9e-29  Score=257.38  Aligned_cols=165  Identities=27%  Similarity=0.338  Sum_probs=136.3

Q ss_pred             hhccccCccCceEEEEEEEcC-CCEEEEEEeccCCCCchhhHHHHHHhhccCccceeEEEEEe-----------------
Q 039231          316 SFKYKLGQGGYGSVYKGKLLD-GSNVAVKVLNDSKGNGKEFINEVASISRTSHVNVVALLGFC-----------------  377 (506)
Q Consensus       316 ~~~~~ig~G~~g~V~~~~~~~-~~~vavK~l~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~-----------------  377 (506)
                      .+.+.||+|+||.||+|+... ++.||||...     ...+.+|++++++++|+|||++++++                 
T Consensus       172 ~i~~~Lg~G~~G~Vy~a~~~~~~~~vavK~~~-----~~~~~~E~~iL~~L~HpnIv~l~~~~~~~~~~~lv~e~~~~~L  246 (461)
T PHA03211        172 AIHRALTPGSEGCVFESSHPDYPQRVVVKAGW-----YASSVHEARLLRRLSHPAVLALLDVRVVGGLTCLVLPKYRSDL  246 (461)
T ss_pred             EEEEEEccCCCeEEEEEEECCCCCEEEEeccc-----ccCHHHHHHHHHHCCCCCCCcEEEEEEECCEEEEEEEccCCCH
Confidence            345679999999999998754 7889999532     24567899999999999999999875                 


Q ss_pred             ----------eccchhhhHHHHHHHHHHHHhhcCCCCeEecCcCCCcEEECCCCcEEEeecCCCccccCCCcceecccCC
Q 039231          378 ----------LRVAEELSSTIGIARGLEYLHLGCSTRILHFDIKPHNILLDEDFCPKISDFGLAKICNRKESIISMTGAR  447 (506)
Q Consensus       378 ----------~~~~~~l~i~~~i~~gl~~LH~~~~~~ivH~dlkp~Nill~~~~~~ki~dfg~a~~~~~~~~~~~~~~~~  447 (506)
                                +++.+++.++.|++.||+|||   +++|+||||||+|||++.++.+||+|||+++...............
T Consensus       247 ~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH---~~gIvHrDLKP~NILl~~~~~vkL~DFGla~~~~~~~~~~~~~~~~  323 (461)
T PHA03211        247 YTYLGARLRPLGLAQVTAVARQLLSAIDYIH---GEGIIHRDIKTENVLVNGPEDICLGDFGAACFARGSWSTPFHYGIA  323 (461)
T ss_pred             HHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH---HCCEEECcCCHHHEEECCCCCEEEcccCCceecccccccccccccC
Confidence                      223346779999999999999   8999999999999999999999999999998764432221123456


Q ss_pred             CCcccccccccccccCCCCccccHHHHHHHHHHHHcCCCCCCC
Q 039231          448 GTVGYIAPEVFCRNIGEVSYKSDVYNYGMMIFEMTGGRKNVDV  490 (506)
Q Consensus       448 gt~~y~aPE~l~~~~~~~s~~~Dv~s~G~il~elltg~~pf~~  490 (506)
                      ||+.|+|||++.+.  .++.++|||||||+||||++|..|+..
T Consensus       324 GT~~Y~APE~~~~~--~~~~~sDvwSlGviL~El~~g~~~lf~  364 (461)
T PHA03211        324 GTVDTNAPEVLAGD--PYTPSVDIWSAGLVIFEAAVHTASLFS  364 (461)
T ss_pred             CCcCCcCHHHHcCC--CCCchHHHHHHHHHHHHHHHcCCCccc
Confidence            89999999998654  689999999999999999998876643

>cd05582 STKc_RSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase

Probab=99.96  E-value=8.2e-30  Score=253.67  Aligned_cols=169  Identities=31%  Similarity=0.394  Sum_probs=139.4

Q ss_pred             cccCccCceEEEEEEE----cCCCEEEEEEeccCC---CCchhhHHHHHHhhccCccceeEEEEEe--------------
Q 039231          319 YKLGQGGYGSVYKGKL----LDGSNVAVKVLNDSK---GNGKEFINEVASISRTSHVNVVALLGFC--------------  377 (506)
Q Consensus       319 ~~ig~G~~g~V~~~~~----~~~~~vavK~l~~~~---~~~~~~~~E~~~l~~l~h~niv~l~g~~--------------  377 (506)
                      +.||+|+||.||+++.    .+|+.+|+|+++...   .....+.+|++++++++||||+++++++              
T Consensus         2 ~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~   81 (318)
T cd05582           2 KVLGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLKVRDRVRTKMERDILAEVNHPFIVKLHYAFQTEGKLYLILDFLR   81 (318)
T ss_pred             ceeeeCCCEEEEEEEEeccCCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhCCCCCcccEEEEEEcCCEEEEEEcCCC
Confidence            4699999999999975    357899999997532   2335577899999999999999998876              


Q ss_pred             -------------eccchhhhHHHHHHHHHHHHhhcCCCCeEecCcCCCcEEECCCCcEEEeecCCCccccCCCcceecc
Q 039231          378 -------------LRVAEELSSTIGIARGLEYLHLGCSTRILHFDIKPHNILLDEDFCPKISDFGLAKICNRKESIISMT  444 (506)
Q Consensus       378 -------------~~~~~~l~i~~~i~~gl~~LH~~~~~~ivH~dlkp~Nill~~~~~~ki~dfg~a~~~~~~~~~~~~~  444 (506)
                                   +++.+.+.++.||+.||+|||   +++|+||||||+||++++++.+||+|||+++........  ..
T Consensus        82 ~~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~lH---~~~i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~~~~~--~~  156 (318)
T cd05582          82 GGDLFTRLSKEVMFTEEDVKFYLAELALALDHLH---SLGIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKK--AY  156 (318)
T ss_pred             CCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHH---HCCEecCCCCHHHeEECCCCcEEEeeccCCcccCCCCCc--ee
Confidence                         223345678999999999999   899999999999999999999999999999765433211  23


Q ss_pred             cCCCCcccccccccccccCCCCccccHHHHHHHHHHHHcCCCCCCCCCCC
Q 039231          445 GARGTVGYIAPEVFCRNIGEVSYKSDVYNYGMMIFEMTGGRKNVDVVDNG  494 (506)
Q Consensus       445 ~~~gt~~y~aPE~l~~~~~~~s~~~Dv~s~G~il~elltg~~pf~~~~~~  494 (506)
                      ...|++.|+|||.+.+.  .++.++||||||+++|||++|+.||...+..
T Consensus       157 ~~~g~~~y~aPE~~~~~--~~~~~~DiwslG~il~el~tg~~p~~~~~~~  204 (318)
T cd05582         157 SFCGTVEYMAPEVVNRR--GHTQSADWWSFGVLMFEMLTGSLPFQGKDRK  204 (318)
T ss_pred             cccCChhhcCHHHHcCC--CCCCccceeccceEeeeeccCCCCCCCCCHH
Confidence            45689999999998653  6788999999999999999999999865543

Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylate

>cd05072 PTKc_Lyn Catalytic domain of the Protein Tyrosine Kinase, Lyn

Probab=99.96  E-value=4.1e-29  Score=241.15  Aligned_cols=173  Identities=28%  Similarity=0.502  Sum_probs=143.3

Q ss_pred             hhccccCccCceEEEEEEEcCCCEEEEEEeccCCCCchhhHHHHHHhhccCccceeEEEEEee-----------------
Q 039231          316 SFKYKLGQGGYGSVYKGKLLDGSNVAVKVLNDSKGNGKEFINEVASISRTSHVNVVALLGFCL-----------------  378 (506)
Q Consensus       316 ~~~~~ig~G~~g~V~~~~~~~~~~vavK~l~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~-----------------  378 (506)
                      .+.++||+|++|.||+|...++..||+|.+.......+.+.+|+.++++++|+||+++++.+.                 
T Consensus         9 ~~~~~lg~g~~g~v~~~~~~~~~~v~iK~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L   88 (261)
T cd05072           9 KLVKKLGAGQFGEVWMGYYNNSTKVAVKTLKPGTMSVQAFLEEANLMKTLQHDKLVRLYAVVTKEEPIYIITEYMAKGSL   88 (261)
T ss_pred             EEeeecCCcCCceEEEEEecCCceEEEEEccCCchhHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCcEEEEecCCCCcH
Confidence            345789999999999999888889999998765555678999999999999999999988751                 


Q ss_pred             ------------ccchhhhHHHHHHHHHHHHhhcCCCCeEecCcCCCcEEECCCCcEEEeecCCCccccCCCcceecccC
Q 039231          379 ------------RVAEELSSTIGIARGLEYLHLGCSTRILHFDIKPHNILLDEDFCPKISDFGLAKICNRKESIISMTGA  446 (506)
Q Consensus       379 ------------~~~~~l~i~~~i~~gl~~LH~~~~~~ivH~dlkp~Nill~~~~~~ki~dfg~a~~~~~~~~~~~~~~~  446 (506)
                                  .+...+.++.|++.||+|||   +.+++|+||||+||++++++.+||+|||+++........ .....
T Consensus        89 ~~~l~~~~~~~~~~~~~~~~~~~l~~~l~~LH---~~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~~~-~~~~~  164 (261)
T cd05072          89 LDFLKSDEGGKVLLPKLIDFSAQIAEGMAYIE---RKNYIHRDLRAANVLVSESLMCKIADFGLARVIEDNEYT-AREGA  164 (261)
T ss_pred             HHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH---HCCeeccccchhhEEecCCCcEEECCCccceecCCCcee-ccCCC
Confidence                        12234668899999999999   899999999999999999999999999999876543221 11234


Q ss_pred             CCCcccccccccccccCCCCccccHHHHHHHHHHHHc-CCCCCCCCCCC
Q 039231          447 RGTVGYIAPEVFCRNIGEVSYKSDVYNYGMMIFEMTG-GRKNVDVVDNG  494 (506)
Q Consensus       447 ~gt~~y~aPE~l~~~~~~~s~~~Dv~s~G~il~ellt-g~~pf~~~~~~  494 (506)
                      .++..|+|||.+..  +.++.++||||||+++|||++ |+.||......
T Consensus       165 ~~~~~y~aPE~~~~--~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~~  211 (261)
T cd05072         165 KFPIKWTAPEAINF--GSFTIKSDVWSFGILLYEIVTYGKIPYPGMSNS  211 (261)
T ss_pred             ccceecCCHHHhcc--CCCChhhhhhhhHHHHHHHHccCCCCCCCCCHH
Confidence            45778999999854  368889999999999999998 99999765443

Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth fa

>cd05570 STKc_PKC Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C

Probab=99.96  E-value=3.4e-29  Score=249.24  Aligned_cols=168  Identities=27%  Similarity=0.366  Sum_probs=137.8

Q ss_pred             cccCccCceEEEEEEEcC-CCEEEEEEeccC----CCCchhhHHHHHHhhcc-CccceeEEEEEe---------------
Q 039231          319 YKLGQGGYGSVYKGKLLD-GSNVAVKVLNDS----KGNGKEFINEVASISRT-SHVNVVALLGFC---------------  377 (506)
Q Consensus       319 ~~ig~G~~g~V~~~~~~~-~~~vavK~l~~~----~~~~~~~~~E~~~l~~l-~h~niv~l~g~~---------------  377 (506)
                      +.||+|+||.||+|+... ++.+|||+++..    ......+.+|.+++..+ +||||+++++++               
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~   80 (318)
T cd05570           1 KVLGKGSFGKVLLAELKGTDELYAVKVLKKDVILQDDDVECTMTEKRVLALAGKHPFLTQLHSCFQTKDRLFFVMEYVNG   80 (318)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence            359999999999998764 789999999753    22335677898998888 699999999875               


Q ss_pred             ------------eccchhhhHHHHHHHHHHHHhhcCCCCeEecCcCCCcEEECCCCcEEEeecCCCccccCCCcceeccc
Q 039231          378 ------------LRVAEELSSTIGIARGLEYLHLGCSTRILHFDIKPHNILLDEDFCPKISDFGLAKICNRKESIISMTG  445 (506)
Q Consensus       378 ------------~~~~~~l~i~~~i~~gl~~LH~~~~~~ivH~dlkp~Nill~~~~~~ki~dfg~a~~~~~~~~~~~~~~  445 (506)
                                  +++.+...++.|++.||+|||   +++|+||||||+||++++++.+||+|||+++........  ...
T Consensus        81 ~~L~~~~~~~~~l~~~~~~~~~~qi~~~l~~LH---~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~--~~~  155 (318)
T cd05570          81 GDLMFHIQRSGRFDEPRARFYAAEIVLGLQFLH---ERGIIYRDLKLDNVLLDSEGHIKIADFGMCKEGILGGVT--TST  155 (318)
T ss_pred             CCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHH---hCCeEccCCCHHHeEECCCCcEEecccCCCeecCcCCCc--ccc
Confidence                        223345678899999999999   899999999999999999999999999998753222211  133


Q ss_pred             CCCCcccccccccccccCCCCccccHHHHHHHHHHHHcCCCCCCCCCC
Q 039231          446 ARGTVGYIAPEVFCRNIGEVSYKSDVYNYGMMIFEMTGGRKNVDVVDN  493 (506)
Q Consensus       446 ~~gt~~y~aPE~l~~~~~~~s~~~Dv~s~G~il~elltg~~pf~~~~~  493 (506)
                      ..|++.|+|||.+.+.  .++.++|||||||++|||++|+.||...+.
T Consensus       156 ~~g~~~y~aPE~~~~~--~~~~~~DiwslGvil~~l~~G~~pf~~~~~  201 (318)
T cd05570         156 FCGTPDYIAPEILSYQ--PYGPAVDWWALGVLLYEMLAGQSPFEGDDE  201 (318)
T ss_pred             eecCccccCHHHhcCC--CCCcchhhhhHHHHHHHHhhCCCCCCCCCH
Confidence            5689999999998654  788999999999999999999999976543

Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only re

>cd05607 STKc_GRK7 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7

Probab=99.96  E-value=1.3e-28  Score=240.06  Aligned_cols=165  Identities=30%  Similarity=0.435  Sum_probs=136.1

Q ss_pred             cCccCceEEEEEEEc-CCCEEEEEEeccCC----CCchhhHHHHHHhhccCccceeEEEEEee-----------------
Q 039231          321 LGQGGYGSVYKGKLL-DGSNVAVKVLNDSK----GNGKEFINEVASISRTSHVNVVALLGFCL-----------------  378 (506)
Q Consensus       321 ig~G~~g~V~~~~~~-~~~~vavK~l~~~~----~~~~~~~~E~~~l~~l~h~niv~l~g~~~-----------------  378 (506)
                      ||+|+||.||+++.. +|+.+|+|++....    ...+.+..|++++++++||||+++.+.+.                 
T Consensus         1 lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~il~~l~hp~i~~~~~~~~~~~~~~lv~e~~~g~~L   80 (277)
T cd05607           1 LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEILEKVNSPFIVNLAYAFESKTHLCLVMSLMNGGDL   80 (277)
T ss_pred             CCCCCceEEEEEEEccCCcEEEEEEEcHHHhhcchhhHHHHHHHHHHHhcCCCcEEEEEEEEecCCeEEEEEecCCCCCH
Confidence            699999999999875 48999999986422    12245567999999999999999987661                 


Q ss_pred             ------------ccchhhhHHHHHHHHHHHHhhcCCCCeEecCcCCCcEEECCCCcEEEeecCCCccccCCCcceecccC
Q 039231          379 ------------RVAEELSSTIGIARGLEYLHLGCSTRILHFDIKPHNILLDEDFCPKISDFGLAKICNRKESIISMTGA  446 (506)
Q Consensus       379 ------------~~~~~l~i~~~i~~gl~~LH~~~~~~ivH~dlkp~Nill~~~~~~ki~dfg~a~~~~~~~~~~~~~~~  446 (506)
                                  ++...+.++.|++.||+|||   +.+++||||||+||++++++.+||+|||++........   ....
T Consensus        81 ~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH---~~~ivH~dikp~Nili~~~~~~~l~Dfg~~~~~~~~~~---~~~~  154 (277)
T cd05607          81 KYHIYNVGERGLEMERVIHYSAQITCGILHLH---SMDIVYRDMKPENVLLDDQGNCRLSDLGLAVELKDGKT---ITQR  154 (277)
T ss_pred             HHHHHhccccCCCHHHHHHHHHHHHHHHHHHH---HCCEEEccCChHhEEEcCCCCEEEeeceeeeecCCCce---eecc
Confidence                        12224567889999999999   89999999999999999999999999999876654322   1345


Q ss_pred             CCCcccccccccccccCCCCccccHHHHHHHHHHHHcCCCCCCCCCC
Q 039231          447 RGTVGYIAPEVFCRNIGEVSYKSDVYNYGMMIFEMTGGRKNVDVVDN  493 (506)
Q Consensus       447 ~gt~~y~aPE~l~~~~~~~s~~~Dv~s~G~il~elltg~~pf~~~~~  493 (506)
                      .++..|+|||++.+.  .++.++||||+||++|||++|+.||.....
T Consensus       155 ~~~~~y~aPE~~~~~--~~~~~~DvwslGv~l~el~~g~~p~~~~~~  199 (277)
T cd05607         155 AGTNGYMAPEILKEE--PYSYPVDWFAMGCSIYEMVAGRTPFKDHKE  199 (277)
T ss_pred             CCCCCccCHHHHccC--CCCCchhHHHHHHHHHHHHhCCCCCCCCcc
Confidence            689999999998654  589999999999999999999999976543

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual gr

>cd05617 STKc_aPKC_zeta Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta

Probab=99.96  E-value=4.5e-29  Score=249.32  Aligned_cols=165  Identities=27%  Similarity=0.395  Sum_probs=136.5

Q ss_pred             ccCccCceEEEEEEEc-CCCEEEEEEeccCC----CCchhhHHHHHHhhcc-CccceeEEEEEe----------------
Q 039231          320 KLGQGGYGSVYKGKLL-DGSNVAVKVLNDSK----GNGKEFINEVASISRT-SHVNVVALLGFC----------------  377 (506)
Q Consensus       320 ~ig~G~~g~V~~~~~~-~~~~vavK~l~~~~----~~~~~~~~E~~~l~~l-~h~niv~l~g~~----------------  377 (506)
                      .||+|+||.||+|+.. +++.+|+|+++...    ...+.+.+|+.++.++ +||||+++++++                
T Consensus         2 ~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~   81 (327)
T cd05617           2 VIGRGSYAKVLLVRLKKNDQIYAMKVVKKELVHDDEDIDWVQTEKHVFEQASSNPFLVGLHSCFQTTSRLFLVIEYVNGG   81 (327)
T ss_pred             eeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhhcCCCCEeeEEEEEEeCCEEEEEEeCCCCC
Confidence            5999999999999875 47899999997532    2235678899999888 599999998876                


Q ss_pred             -----------eccchhhhHHHHHHHHHHHHhhcCCCCeEecCcCCCcEEECCCCcEEEeecCCCccccCCCcceecccC
Q 039231          378 -----------LRVAEELSSTIGIARGLEYLHLGCSTRILHFDIKPHNILLDEDFCPKISDFGLAKICNRKESIISMTGA  446 (506)
Q Consensus       378 -----------~~~~~~l~i~~~i~~gl~~LH~~~~~~ivH~dlkp~Nill~~~~~~ki~dfg~a~~~~~~~~~~~~~~~  446 (506)
                                 +++.+++.++.|++.||+|||   +++|+||||||+|||+++++.+||+|||+++.......  .....
T Consensus        82 ~L~~~~~~~~~l~~~~~~~~~~qi~~al~~lH---~~~ivHrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~--~~~~~  156 (327)
T cd05617          82 DLMFHMQRQRKLPEEHARFYAAEICIALNFLH---ERGIIYRDLKLDNVLLDADGHIKLTDYGMCKEGLGPGD--TTSTF  156 (327)
T ss_pred             cHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHH---HCCeeccCCCHHHEEEeCCCCEEEeccccceeccCCCC--ceecc
Confidence                       223345678999999999999   89999999999999999999999999999875322211  12345


Q ss_pred             CCCcccccccccccccCCCCccccHHHHHHHHHHHHcCCCCCCCC
Q 039231          447 RGTVGYIAPEVFCRNIGEVSYKSDVYNYGMMIFEMTGGRKNVDVV  491 (506)
Q Consensus       447 ~gt~~y~aPE~l~~~~~~~s~~~Dv~s~G~il~elltg~~pf~~~  491 (506)
                      .||+.|+|||++.+.  .++.++||||||+++|||++|+.||+..
T Consensus       157 ~gt~~y~aPE~~~~~--~~~~~~DiwslGvil~ell~g~~pf~~~  199 (327)
T cd05617         157 CGTPNYIAPEILRGE--EYGFSVDWWALGVLMFEMMAGRSPFDII  199 (327)
T ss_pred             cCCcccCCHHHHCCC--CCCchheeehhHHHHHHHHhCCCCCCcc
Confidence            689999999998654  7889999999999999999999999753

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways

>cd05615 STKc_cPKC_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha

Probab=99.96  E-value=3.3e-29  Score=249.84  Aligned_cols=172  Identities=25%  Similarity=0.375  Sum_probs=138.5

Q ss_pred             hhccccCccCceEEEEEEEc-CCCEEEEEEeccC----CCCchhhHHHHHHhhccCc-cceeEEEEEe------------
Q 039231          316 SFKYKLGQGGYGSVYKGKLL-DGSNVAVKVLNDS----KGNGKEFINEVASISRTSH-VNVVALLGFC------------  377 (506)
Q Consensus       316 ~~~~~ig~G~~g~V~~~~~~-~~~~vavK~l~~~----~~~~~~~~~E~~~l~~l~h-~niv~l~g~~------------  377 (506)
                      ++.+.||+|+||.||+|+.. +++.||+|+++..    ....+.+..|.+++..+.| ++|+++.+++            
T Consensus         3 ~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~Ey   82 (323)
T cd05615           3 NFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALQDKPPFLTQLHSCFQTVDRLYFVMEY   82 (323)
T ss_pred             eEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCchhheeeEEecCCEEEEEEcC
Confidence            45678999999999999875 5889999999753    2233567788999988864 6677777654            


Q ss_pred             ---------------eccchhhhHHHHHHHHHHHHhhcCCCCeEecCcCCCcEEECCCCcEEEeecCCCccccCCCccee
Q 039231          378 ---------------LRVAEELSSTIGIARGLEYLHLGCSTRILHFDIKPHNILLDEDFCPKISDFGLAKICNRKESIIS  442 (506)
Q Consensus       378 ---------------~~~~~~l~i~~~i~~gl~~LH~~~~~~ivH~dlkp~Nill~~~~~~ki~dfg~a~~~~~~~~~~~  442 (506)
                                     +++.+.+.++.|++.||+|||   +++|+||||||+|||+++++.+||+|||+++.......  .
T Consensus        83 ~~~g~L~~~i~~~~~l~~~~~~~i~~qi~~al~~lH---~~~ivHrDikp~Nill~~~~~ikL~Dfg~~~~~~~~~~--~  157 (323)
T cd05615          83 VNGGDLMYHIQQVGKFKEPQAVFYAAEISVGLFFLH---RRGIIYRDLKLDNVMLDSEGHIKIADFGMCKEHMVDGV--T  157 (323)
T ss_pred             CCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHH---HCCeeccCCCHHHeEECCCCCEEEeccccccccCCCCc--c
Confidence                           233446778999999999999   89999999999999999999999999999875432221  1


Q ss_pred             cccCCCCcccccccccccccCCCCccccHHHHHHHHHHHHcCCCCCCCCCCC
Q 039231          443 MTGARGTVGYIAPEVFCRNIGEVSYKSDVYNYGMMIFEMTGGRKNVDVVDNG  494 (506)
Q Consensus       443 ~~~~~gt~~y~aPE~l~~~~~~~s~~~Dv~s~G~il~elltg~~pf~~~~~~  494 (506)
                      .....||+.|+|||++.+.  .++.++||||||+++|||++|+.||...+..
T Consensus       158 ~~~~~gt~~y~aPE~~~~~--~~~~~~DiwslGvil~elltG~~pf~~~~~~  207 (323)
T cd05615         158 TRTFCGTPDYIAPEIIAYQ--PYGKSVDWWAYGVLLYEMLAGQPPFDGEDED  207 (323)
T ss_pred             ccCccCCccccCHHHHcCC--CCCCccchhhhHHHHHHHHhCCCCCCCCCHH
Confidence            2345689999999998653  6889999999999999999999999876543

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, a

>KOG0599 consensus Phosphorylase kinase gamma subunit [Carbohydrate transport and metabolism]

Probab=99.96  E-value=1.7e-29  Score=229.32  Aligned_cols=165  Identities=29%  Similarity=0.419  Sum_probs=140.3

Q ss_pred             cccCccCceEEEEEEEc-CCCEEEEEEeccCC-----CCc----hhhHHHHHHhhccC-ccceeEEEEEe----------
Q 039231          319 YKLGQGGYGSVYKGKLL-DGSNVAVKVLNDSK-----GNG----KEFINEVASISRTS-HVNVVALLGFC----------  377 (506)
Q Consensus       319 ~~ig~G~~g~V~~~~~~-~~~~vavK~l~~~~-----~~~----~~~~~E~~~l~~l~-h~niv~l~g~~----------  377 (506)
                      +.||+|..+.|-+...+ .|+..|+|++....     .+.    +.-.+|+.+|+++. ||+|+.+.+++          
T Consensus        23 eilgrgvss~vrRci~k~t~~e~a~kii~~~at~~~~e~~~~~~EaT~~Ev~ILRqv~GHP~II~l~D~yes~sF~FlVF  102 (411)
T KOG0599|consen   23 EILGRGVSSVVRRCIHKETGKEFAVKIIDVTATTESGETPYEMREATRQEISILRQVMGHPYIIDLQDVYESDAFVFLVF  102 (411)
T ss_pred             HHhcccchhhhhhhhhcccccceeEEEEEecccccCCccHHHHHHHHHHHHHHHHHhcCCCcEEEeeeeccCcchhhhhh
Confidence            46999999999998765 48899999985321     112    33457899999986 99999999877          


Q ss_pred             -----------------eccchhhhHHHHHHHHHHHHhhcCCCCeEecCcCCCcEEECCCCcEEEeecCCCccccCCCcc
Q 039231          378 -----------------LRVAEELSSTIGIARGLEYLHLGCSTRILHFDIKPHNILLDEDFCPKISDFGLAKICNRKESI  440 (506)
Q Consensus       378 -----------------~~~~~~l~i~~~i~~gl~~LH~~~~~~ivH~dlkp~Nill~~~~~~ki~dfg~a~~~~~~~~~  440 (506)
                                       +.+.+...|+.|+.+|+.|||   ...||||||||+|||++++.++||+|||++..+.+++. 
T Consensus       103 dl~prGELFDyLts~VtlSEK~tR~iMrqlfegVeylH---a~~IVHRDLKpENILlddn~~i~isDFGFa~~l~~Gek-  178 (411)
T KOG0599|consen  103 DLMPRGELFDYLTSKVTLSEKETRRIMRQLFEGVEYLH---ARNIVHRDLKPENILLDDNMNIKISDFGFACQLEPGEK-  178 (411)
T ss_pred             hhcccchHHHHhhhheeecHHHHHHHHHHHHHHHHHHH---HhhhhhcccChhheeeccccceEEeccceeeccCCchh-
Confidence                             455567789999999999999   99999999999999999999999999999998877664 


Q ss_pred             eecccCCCCcccccccccc----cccCCCCccccHHHHHHHHHHHHcCCCCCC
Q 039231          441 ISMTGARGTVGYIAPEVFC----RNIGEVSYKSDVYNYGMMIFEMTGGRKNVD  489 (506)
Q Consensus       441 ~~~~~~~gt~~y~aPE~l~----~~~~~~s~~~Dv~s~G~il~elltg~~pf~  489 (506)
                        .....|||+|+|||.+.    .+...|+..+|+||+|||+|.|+.|.+||-
T Consensus       179 --LrelCGTPgYLAPEtikC~m~e~~pGYs~EVD~Wa~GVImyTLLaGcpPFw  229 (411)
T KOG0599|consen  179 --LRELCGTPGYLAPETIKCSMYENHPGYSKEVDEWACGVIMYTLLAGCPPFW  229 (411)
T ss_pred             --HHHhcCCCcccChhheeeecccCCCCccchhhHHHHHHHHHHHHcCCCchh
Confidence              36688999999999983    233568999999999999999999999995

>cd05091 PTKc_Ror2 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2

Probab=99.96  E-value=4.6e-29  Score=243.86  Aligned_cols=175  Identities=31%  Similarity=0.494  Sum_probs=139.9

Q ss_pred             hhhccccCccCceEEEEEEEcC------CCEEEEEEeccCCCC--chhhHHHHHHhhccCccceeEEEEEeec-------
Q 039231          315 NSFKYKLGQGGYGSVYKGKLLD------GSNVAVKVLNDSKGN--GKEFINEVASISRTSHVNVVALLGFCLR-------  379 (506)
Q Consensus       315 ~~~~~~ig~G~~g~V~~~~~~~------~~~vavK~l~~~~~~--~~~~~~E~~~l~~l~h~niv~l~g~~~~-------  379 (506)
                      +.+.++||+|+||.||+|+..+      ++.||+|+++.....  .+.+.+|+.++..++||||+++++++.+       
T Consensus         7 ~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~~~   86 (283)
T cd05091           7 VRFMEELGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKAEGPLREEFKHEAMMRSRLQHPNIVCLLGVVTKEQPLSMI   86 (283)
T ss_pred             HHHHHHhCCCCCCeEEEEEEecCCCCCceeEEEEEEccCCCCHHHHHHHHHHHHHHhcCCCCCcCeEEEEEcCCCceEEE
Confidence            4455679999999999998632      578999999754332  2568899999999999999999986511       


Q ss_pred             ------------------------------------cchhhhHHHHHHHHHHHHhhcCCCCeEecCcCCCcEEECCCCcE
Q 039231          380 ------------------------------------VAEELSSTIGIARGLEYLHLGCSTRILHFDIKPHNILLDEDFCP  423 (506)
Q Consensus       380 ------------------------------------~~~~l~i~~~i~~gl~~LH~~~~~~ivH~dlkp~Nill~~~~~~  423 (506)
                                                          +...+.++.|++.||+|||   +++++||||||+||++++++.+
T Consensus        87 ~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~aL~~lH---~~gi~H~dlkp~Nil~~~~~~~  163 (283)
T cd05091          87 FSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIVTQIAAGMEFLS---SHHVVHKDLATRNVLVFDKLNV  163 (283)
T ss_pred             EEcCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHH---HcCccccccchhheEecCCCce
Confidence                                                1124567889999999999   8999999999999999999999


Q ss_pred             EEeecCCCccccCCCcceecccCCCCcccccccccccccCCCCccccHHHHHHHHHHHHc-CCCCCCCCCCC
Q 039231          424 KISDFGLAKICNRKESIISMTGARGTVGYIAPEVFCRNIGEVSYKSDVYNYGMMIFEMTG-GRKNVDVVDNG  494 (506)
Q Consensus       424 ki~dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~s~~~Dv~s~G~il~ellt-g~~pf~~~~~~  494 (506)
                      ||+|||+++...............+++.|+|||.+..  +.++.++||||||+++|||++ |..||......
T Consensus       164 kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~--~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~  233 (283)
T cd05091         164 KISDLGLFREVYAADYYKLMGNSLLPIRWMSPEAIMY--GKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSNQ  233 (283)
T ss_pred             EecccccccccccchheeeccCccCCccccCHHHHhc--CCCCcchhHHHHHHHHHHHHcCCCCCCCCCCHH
Confidence            9999999886644332222233456789999999854  368899999999999999998 88898765443

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly

>PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional

Probab=99.96  E-value=2.1e-28  Score=278.47  Aligned_cols=175  Identities=28%  Similarity=0.490  Sum_probs=139.5

Q ss_pred             ccCHHHHHHHHhhhccccCccCceEEEEEEE-cCCCEEEEEEeccCCCCchhhHHHHHHhhccCccceeEEEEEe-----
Q 039231          304 RYGYADIKKMTNSFKYKLGQGGYGSVYKGKL-LDGSNVAVKVLNDSKGNGKEFINEVASISRTSHVNVVALLGFC-----  377 (506)
Q Consensus       304 ~~~~~el~~~~~~~~~~ig~G~~g~V~~~~~-~~~~~vavK~l~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~-----  377 (506)
                      .++++++.+. ....+.||+|+||.||+|+. .++..||||+++.....   ..+|++.+++++|||||+++|++     
T Consensus       682 ~~~~~~~~~~-~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~---~~~~~~~l~~l~HpnIv~~~~~~~~~~~  757 (968)
T PLN00113        682 SITINDILSS-LKEENVISRGKKGASYKGKSIKNGMQFVVKEINDVNSI---PSSEIADMGKLQHPNIVKLIGLCRSEKG  757 (968)
T ss_pred             hhhHHHHHhh-CCcccEEccCCCeeEEEEEECCCCcEEEEEEccCCccc---cHHHHHHHhhCCCCCcceEEEEEEcCCC
Confidence            3455555443 22346799999999999987 46899999998754322   23568899999999999999988     


Q ss_pred             -------------------eccchhhhHHHHHHHHHHHHhhcCCCCeEecCcCCCcEEECCCCcEEEeecCCCccccCCC
Q 039231          378 -------------------LRVAEELSSTIGIARGLEYLHLGCSTRILHFDIKPHNILLDEDFCPKISDFGLAKICNRKE  438 (506)
Q Consensus       378 -------------------~~~~~~l~i~~~i~~gl~~LH~~~~~~ivH~dlkp~Nill~~~~~~ki~dfg~a~~~~~~~  438 (506)
                                         +++.++..++.|+++||+|||+.++++|+||||||+||+++.++.+++. |+.+...... 
T Consensus       758 ~~lv~Ey~~~g~L~~~l~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlkp~Nil~~~~~~~~~~-~~~~~~~~~~-  835 (968)
T PLN00113        758 AYLIHEYIEGKNLSEVLRNLSWERRRKIAIGIAKALRFLHCRCSPAVVVGNLSPEKIIIDGKDEPHLR-LSLPGLLCTD-  835 (968)
T ss_pred             CEEEEeCCCCCcHHHHHhcCCHHHHHHHHHHHHHHHHHhccCCCCCeecCCCCHHhEEECCCCceEEE-eccccccccC-
Confidence                               2445577899999999999997777899999999999999999888876 6655433221 


Q ss_pred             cceecccCCCCcccccccccccccCCCCccccHHHHHHHHHHHHcCCCCCCCC
Q 039231          439 SIISMTGARGTVGYIAPEVFCRNIGEVSYKSDVYNYGMMIFEMTGGRKNVDVV  491 (506)
Q Consensus       439 ~~~~~~~~~gt~~y~aPE~l~~~~~~~s~~~Dv~s~G~il~elltg~~pf~~~  491 (506)
                           ....+++.|+|||++.+.  .++.++|||||||++|||+||+.||+..
T Consensus       836 -----~~~~~t~~y~aPE~~~~~--~~~~~sDv~S~Gvvl~el~tg~~p~~~~  881 (968)
T PLN00113        836 -----TKCFISSAYVAPETRETK--DITEKSDIYGFGLILIELLTGKSPADAE  881 (968)
T ss_pred             -----CCccccccccCcccccCC--CCCcccchhhHHHHHHHHHhCCCCCCcc
Confidence                 223678999999998653  7899999999999999999999999653

>cd06649 PKc_MEK2 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2

Probab=99.96  E-value=4.7e-29  Score=249.60  Aligned_cols=167  Identities=26%  Similarity=0.357  Sum_probs=138.7

Q ss_pred             hccccCccCceEEEEEEEc-CCCEEEEEEeccCCC--CchhhHHHHHHhhccCccceeEEEEEee---------------
Q 039231          317 FKYKLGQGGYGSVYKGKLL-DGSNVAVKVLNDSKG--NGKEFINEVASISRTSHVNVVALLGFCL---------------  378 (506)
Q Consensus       317 ~~~~ig~G~~g~V~~~~~~-~~~~vavK~l~~~~~--~~~~~~~E~~~l~~l~h~niv~l~g~~~---------------  378 (506)
                      ..+.||+|+||.||+++.. ++..+|+|++.....  ..+++.+|++++++++||||+++++++.               
T Consensus         9 ~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~   88 (331)
T cd06649           9 RISELGAGNGGVVTKVQHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGG   88 (331)
T ss_pred             EEEeecCCCCEEEEEEEECCCCcEEEEEEeecccCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEEEeecCCCC
Confidence            3467999999999999975 478899999875422  2357899999999999999999998762               


Q ss_pred             ------------ccchhhhHHHHHHHHHHHHhhcCCC-CeEecCcCCCcEEECCCCcEEEeecCCCccccCCCcceeccc
Q 039231          379 ------------RVAEELSSTIGIARGLEYLHLGCST-RILHFDIKPHNILLDEDFCPKISDFGLAKICNRKESIISMTG  445 (506)
Q Consensus       379 ------------~~~~~l~i~~~i~~gl~~LH~~~~~-~ivH~dlkp~Nill~~~~~~ki~dfg~a~~~~~~~~~~~~~~  445 (506)
                                  .+.....++.|++.||.|||   +. +|+||||||+|||+++++.+||+|||+++......    ...
T Consensus        89 ~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH---~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~----~~~  161 (331)
T cd06649          89 SLDQVLKEAKRIPEEILGKVSIAVLRGLAYLR---EKHQIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSM----ANS  161 (331)
T ss_pred             cHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHh---hcCCEEcCCCChhhEEEcCCCcEEEccCcccccccccc----ccc
Confidence                        12224578899999999999   54 69999999999999999999999999997654322    134


Q ss_pred             CCCCcccccccccccccCCCCccccHHHHHHHHHHHHcCCCCCCCCC
Q 039231          446 ARGTVGYIAPEVFCRNIGEVSYKSDVYNYGMMIFEMTGGRKNVDVVD  492 (506)
Q Consensus       446 ~~gt~~y~aPE~l~~~~~~~s~~~Dv~s~G~il~elltg~~pf~~~~  492 (506)
                      ..+++.|+|||++.+.  .++.++||||||+++|||++|+.||...+
T Consensus       162 ~~g~~~y~aPE~~~~~--~~~~~~DiwslG~il~el~tg~~p~~~~~  206 (331)
T cd06649         162 FVGTRSYMSPERLQGT--HYSVQSDIWSMGLSLVELAIGRYPIPPPD  206 (331)
T ss_pred             CCCCcCcCCHhHhcCC--CCCchHhHHHHHHHHHHHHhCCCCCCCCC
Confidence            5689999999998654  68899999999999999999999997544

Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downst

>cd05064 PTKc_EphR_A10 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10

Probab=99.96  E-value=4.6e-29  Score=241.78  Aligned_cols=176  Identities=23%  Similarity=0.393  Sum_probs=140.8

Q ss_pred             HHhhhccccCccCceEEEEEEEc----CCCEEEEEEeccCCC--CchhhHHHHHHhhccCccceeEEEEEe---------
Q 039231          313 MTNSFKYKLGQGGYGSVYKGKLL----DGSNVAVKVLNDSKG--NGKEFINEVASISRTSHVNVVALLGFC---------  377 (506)
Q Consensus       313 ~~~~~~~~ig~G~~g~V~~~~~~----~~~~vavK~l~~~~~--~~~~~~~E~~~l~~l~h~niv~l~g~~---------  377 (506)
                      ..+.+.+.||+|+||.||+|.++    .+..||+|+++....  ....+.+|+..+.+++||||++++|++         
T Consensus         5 ~~~~~~~~ig~G~fg~V~~~~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv   84 (266)
T cd05064           5 KSIKIERILGTGRFGELCRGCLKLPSKRELPVAIHTLRAGCSDKQRRGFLAEALTLGQFDHSNIVRLEGVITRGNTMMIV   84 (266)
T ss_pred             HHeEEeeeecccCCCeEEEEEEecCCCceeeEEEEecCCCCCHHHHHHHHHHHHHHhcCCCCCcCeEEEEEecCCCcEEE
Confidence            34456678999999999999763    357899999976432  235688999999999999999999986         


Q ss_pred             -------------------eccchhhhHHHHHHHHHHHHhhcCCCCeEecCcCCCcEEECCCCcEEEeecCCCccccCCC
Q 039231          378 -------------------LRVAEELSSTIGIARGLEYLHLGCSTRILHFDIKPHNILLDEDFCPKISDFGLAKICNRKE  438 (506)
Q Consensus       378 -------------------~~~~~~l~i~~~i~~gl~~LH~~~~~~ivH~dlkp~Nill~~~~~~ki~dfg~a~~~~~~~  438 (506)
                                         +.+.+.+.++.|++.||+|||   +++++||||||+||+++.++.+|++|||.+.......
T Consensus        85 ~e~~~~~~L~~~l~~~~~~l~~~~~~~~~~~i~~al~~lH---~~~iiH~dikp~nili~~~~~~~l~dfg~~~~~~~~~  161 (266)
T cd05064          85 TEYMSNGALDSFLRKHEGQLVAGQLMGMLPGLASGMKYLS---EMGYVHKGLAAHKVLVNSDLVCKISGFRRLQEDKSEA  161 (266)
T ss_pred             EEeCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHH---HCCEeeccccHhhEEEcCCCcEEECCCcccccccccc
Confidence                               233346788999999999999   8999999999999999999999999999876543221


Q ss_pred             cceecccCCCCcccccccccccccCCCCccccHHHHHHHHHHHHc-CCCCCCCCCCC
Q 039231          439 SIISMTGARGTVGYIAPEVFCRNIGEVSYKSDVYNYGMMIFEMTG-GRKNVDVVDNG  494 (506)
Q Consensus       439 ~~~~~~~~~gt~~y~aPE~l~~~~~~~s~~~Dv~s~G~il~ellt-g~~pf~~~~~~  494 (506)
                      .. ......++..|+|||.+.+  ..++.++||||||+++||+++ |+.||......
T Consensus       162 ~~-~~~~~~~~~~y~aPE~~~~--~~~~~~~Di~slG~~l~ell~~g~~p~~~~~~~  215 (266)
T cd05064         162 IY-TTMSGKSPVLWAAPEAIQY--HHFSSASDVWSFGIVMWEVMSYGERPYWDMSGQ  215 (266)
T ss_pred             hh-cccCCCCceeecCHHHHhh--CCccchhHHHHHHHHHHHHhcCCCCCcCcCCHH
Confidence            11 1122345678999999855  378899999999999999875 99999866543

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchor

>cd05605 STKc_GRK4_like Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases

Probab=99.96  E-value=6.7e-29  Score=243.18  Aligned_cols=168  Identities=32%  Similarity=0.458  Sum_probs=139.4

Q ss_pred             ccccCccCceEEEEEEEc-CCCEEEEEEeccCC----CCchhhHHHHHHhhccCccceeEEEEEe---------------
Q 039231          318 KYKLGQGGYGSVYKGKLL-DGSNVAVKVLNDSK----GNGKEFINEVASISRTSHVNVVALLGFC---------------  377 (506)
Q Consensus       318 ~~~ig~G~~g~V~~~~~~-~~~~vavK~l~~~~----~~~~~~~~E~~~l~~l~h~niv~l~g~~---------------  377 (506)
                      .++||+|+||.||++... +++.||+|++....    .....+.+|++++++++||||+++++.+               
T Consensus         5 ~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~   84 (285)
T cd05605           5 YRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLTLMNG   84 (285)
T ss_pred             EEEEecCCCeEEEEEEEcCCCceEEEEEEehhhhhhhhhHHHHHHHHHHHHhcCCCCEeeeeeeecCCCeEEEEEeccCC
Confidence            467999999999999874 58999999986432    1224577899999999999999998765               


Q ss_pred             --------------eccchhhhHHHHHHHHHHHHhhcCCCCeEecCcCCCcEEECCCCcEEEeecCCCccccCCCcceec
Q 039231          378 --------------LRVAEELSSTIGIARGLEYLHLGCSTRILHFDIKPHNILLDEDFCPKISDFGLAKICNRKESIISM  443 (506)
Q Consensus       378 --------------~~~~~~l~i~~~i~~gl~~LH~~~~~~ivH~dlkp~Nill~~~~~~ki~dfg~a~~~~~~~~~~~~  443 (506)
                                    +++.....++.|++.||.|||   +.+++||||||+||++++++.++|+|||+++.......   .
T Consensus        85 ~~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH---~~~ivH~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~~~---~  158 (285)
T cd05605          85 GDLKFHIYNMGNPGFDEERAVFYAAEITCGLEDLH---RERIVYRDLKPENILLDDYGHIRISDLGLAVEIPEGET---I  158 (285)
T ss_pred             CcHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHH---HCCcEecCCCHHHEEECCCCCEEEeeCCCceecCCCCc---c
Confidence                          122235668899999999999   89999999999999999999999999999987543332   1


Q ss_pred             ccCCCCcccccccccccccCCCCccccHHHHHHHHHHHHcCCCCCCCCCC
Q 039231          444 TGARGTVGYIAPEVFCRNIGEVSYKSDVYNYGMMIFEMTGGRKNVDVVDN  493 (506)
Q Consensus       444 ~~~~gt~~y~aPE~l~~~~~~~s~~~Dv~s~G~il~elltg~~pf~~~~~  493 (506)
                      ....|++.|+|||.+.+.  .++.++||||+|+++|||++|+.||.....
T Consensus       159 ~~~~~~~~y~aPE~~~~~--~~~~~~Diws~G~~l~el~~g~~pf~~~~~  206 (285)
T cd05605         159 RGRVGTVGYMAPEVVKNE--RYTFSPDWWGLGCLIYEMIEGKSPFRQRKE  206 (285)
T ss_pred             ccccCCCCccCcHHhcCC--CCCccccchhHHHHHHHHHHCCCCCCCCch
Confidence            335689999999998653  688999999999999999999999987544

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5,

>cd05601 STKc_CRIK Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase

Probab=99.96  E-value=8.9e-30  Score=254.77  Aligned_cols=175  Identities=25%  Similarity=0.288  Sum_probs=142.2

Q ss_pred             hhccccCccCceEEEEEEEc-CCCEEEEEEeccCC----CCchhhHHHHHHhhccCccceeEEEEEee------------
Q 039231          316 SFKYKLGQGGYGSVYKGKLL-DGSNVAVKVLNDSK----GNGKEFINEVASISRTSHVNVVALLGFCL------------  378 (506)
Q Consensus       316 ~~~~~ig~G~~g~V~~~~~~-~~~~vavK~l~~~~----~~~~~~~~E~~~l~~l~h~niv~l~g~~~------------  378 (506)
                      .+.+.||+|+||.||+++.. +++.+|+|+++...    ...+.+.+|+.+++.++|+||+++++++.            
T Consensus         4 ~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~~~~i~~~~~~~~~~~~~~lv~e~~   83 (330)
T cd05601           4 DVKSLVGRGHFGEVQVVREKATGDIYAMKVMKKSVLLAQETVSFFEEERDILSISNSPWIPQLQYAFQDKDNLYLVMEYQ   83 (330)
T ss_pred             eEEEEEEeccCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceeeEEecCCeEEEEECCC
Confidence            34568999999999999875 58999999997532    23356788999999999999999987651            


Q ss_pred             ----------------ccchhhhHHHHHHHHHHHHhhcCCCCeEecCcCCCcEEECCCCcEEEeecCCCccccCCCccee
Q 039231          379 ----------------RVAEELSSTIGIARGLEYLHLGCSTRILHFDIKPHNILLDEDFCPKISDFGLAKICNRKESIIS  442 (506)
Q Consensus       379 ----------------~~~~~l~i~~~i~~gl~~LH~~~~~~ivH~dlkp~Nill~~~~~~ki~dfg~a~~~~~~~~~~~  442 (506)
                                      ++.....++.|++.||+|||   +.+|+||||||+|||++.++.+||+|||+++........ .
T Consensus        84 ~~~~L~~~l~~~~~~l~~~~~~~~~~qi~~aL~~lH---~~~i~H~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~~~~-~  159 (330)
T cd05601          84 PGGDLLSLLNRYEDQFDEDMAQFYLAELVLAIHSVH---QMGYVHRDIKPENVLIDRTGHIKLADFGSAARLTANKMV-N  159 (330)
T ss_pred             CCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH---HCCeEcccCchHheEECCCCCEEeccCCCCeECCCCCce-e
Confidence                            22234567889999999999   899999999999999999999999999999876544332 1


Q ss_pred             cccCCCCcccccccccccc----cCCCCccccHHHHHHHHHHHHcCCCCCCCCCCC
Q 039231          443 MTGARGTVGYIAPEVFCRN----IGEVSYKSDVYNYGMMIFEMTGGRKNVDVVDNG  494 (506)
Q Consensus       443 ~~~~~gt~~y~aPE~l~~~----~~~~s~~~Dv~s~G~il~elltg~~pf~~~~~~  494 (506)
                      .....||+.|+|||++...    ...++.++||||||+++|||++|+.||......
T Consensus       160 ~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~  215 (330)
T cd05601         160 SKLPVGTPDYIAPEVLTTMNGDGKGTYGVECDWWSLGVIAYEMIYGRSPFHEGTSA  215 (330)
T ss_pred             eecccCCccccCHHHhccccccccCCCCCcceeecccceeeeeccCCCCCCCCCHH
Confidence            2345789999999998531    235788999999999999999999999765443

Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnor

>cd05113 PTKc_Btk_Bmx Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome

Probab=99.96  E-value=8.1e-29  Score=238.63  Aligned_cols=173  Identities=31%  Similarity=0.565  Sum_probs=143.6

Q ss_pred             hhccccCccCceEEEEEEEcCCCEEEEEEeccCCCCchhhHHHHHHhhccCccceeEEEEEe------------------
Q 039231          316 SFKYKLGQGGYGSVYKGKLLDGSNVAVKVLNDSKGNGKEFINEVASISRTSHVNVVALLGFC------------------  377 (506)
Q Consensus       316 ~~~~~ig~G~~g~V~~~~~~~~~~vavK~l~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~------------------  377 (506)
                      .+.+.||+|++|.||+|+..++..+|+|.++.......++.+|++++.+++||||+++++++                  
T Consensus         7 ~~~~~lg~G~~~~vy~~~~~~~~~~aik~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~l   86 (256)
T cd05113           7 TFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSEDEFIEEAKVMMKLSHEKLVQLYGVCTKQRPIYIVTEYMSNGCL   86 (256)
T ss_pred             EEeeEecCcccceEEEEEecCCCcEEEEEcCCCcccHHHHHHHHHHHhcCCCCCeeeEEEEEccCCCcEEEEEcCCCCcH
Confidence            45567999999999999987777899999876555557899999999999999999999886                  


Q ss_pred             ----------eccchhhhHHHHHHHHHHHHhhcCCCCeEecCcCCCcEEECCCCcEEEeecCCCccccCCCcceecccCC
Q 039231          378 ----------LRVAEELSSTIGIARGLEYLHLGCSTRILHFDIKPHNILLDEDFCPKISDFGLAKICNRKESIISMTGAR  447 (506)
Q Consensus       378 ----------~~~~~~l~i~~~i~~gl~~LH~~~~~~ivH~dlkp~Nill~~~~~~ki~dfg~a~~~~~~~~~~~~~~~~  447 (506)
                                +++...+.++.|++.||+|||   +.+++|+||||+||++++++.+||+|||.++........ ......
T Consensus        87 ~~~i~~~~~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dl~p~nili~~~~~~kl~d~g~~~~~~~~~~~-~~~~~~  162 (256)
T cd05113          87 LNYLREHGKRFQPSQLLEMCKDVCEGMAYLE---SKQFIHRDLAARNCLVDDQGCVKVSDFGLSRYVLDDEYT-SSVGSK  162 (256)
T ss_pred             HHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH---hCCeeccccCcceEEEcCCCCEEECCCccceecCCCcee-ecCCCc
Confidence                      122335779999999999999   899999999999999999999999999998865443221 112234


Q ss_pred             CCcccccccccccccCCCCccccHHHHHHHHHHHHc-CCCCCCCCCCC
Q 039231          448 GTVGYIAPEVFCRNIGEVSYKSDVYNYGMMIFEMTG-GRKNVDVVDNG  494 (506)
Q Consensus       448 gt~~y~aPE~l~~~~~~~s~~~Dv~s~G~il~ellt-g~~pf~~~~~~  494 (506)
                      ++..|+|||.+...  .++.++||||||+++|||++ |+.||......
T Consensus       163 ~~~~y~~pe~~~~~--~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~~  208 (256)
T cd05113         163 FPVRWSPPEVLLYS--KFSSKSDVWAFGVLMWEVYSLGKMPYERFNNS  208 (256)
T ss_pred             cChhhCCHHHHhcC--cccchhHHHHHHHHHHHHhcCCCCCcCcCCHH
Confidence            56789999998543  68889999999999999998 99999866543

Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds

>KOG0033 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms]

Probab=99.96  E-value=1.3e-30  Score=233.09  Aligned_cols=179  Identities=28%  Similarity=0.398  Sum_probs=143.3

Q ss_pred             hhhccccCccCceEEEEEEE-cCCCEEEEEEecc---CCCCchhhHHHHHHhhccCccceeEEEEEe-------------
Q 039231          315 NSFKYKLGQGGYGSVYKGKL-LDGSNVAVKVLND---SKGNGKEFINEVASISRTSHVNVVALLGFC-------------  377 (506)
Q Consensus       315 ~~~~~~ig~G~~g~V~~~~~-~~~~~vavK~l~~---~~~~~~~~~~E~~~l~~l~h~niv~l~g~~-------------  377 (506)
                      +.+.+.||+|+|+.|++... ..|+.+|+|+++-   +....+++.+|+++-+.++|||||+|..-.             
T Consensus        13 y~l~e~igkG~FSvVrRc~~~~tg~~fa~kiin~~k~~~~~~e~l~rEarIC~~LqHP~IvrL~~ti~~~~~~ylvFe~m   92 (355)
T KOG0033|consen   13 YDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVFDLV   92 (355)
T ss_pred             hhHHHHHccCchHHHHHHHhccchHHHHHHHhhhhhhccccHHHHHHHHHHHHhcCCCcEeehhhhhcccceeEEEEecc
Confidence            34456799999999999965 4589999998853   233457899999999999999999997533             


Q ss_pred             --------------eccchhhhHHHHHHHHHHHHhhcCCCCeEecCcCCCcEEECC---CCcEEEeecCCCccccCCCcc
Q 039231          378 --------------LRVAEELSSTIGIARGLEYLHLGCSTRILHFDIKPHNILLDE---DFCPKISDFGLAKICNRKESI  440 (506)
Q Consensus       378 --------------~~~~~~l~i~~~i~~gl~~LH~~~~~~ivH~dlkp~Nill~~---~~~~ki~dfg~a~~~~~~~~~  440 (506)
                                    +.+...-..+.||++||.|+|   .++|||||+||+|++|.+   .--+||+|||+|..++...  
T Consensus        93 ~G~dl~~eIV~R~~ySEa~aSH~~rQiLeal~yCH---~n~IvHRDvkP~nllLASK~~~A~vKL~~FGvAi~l~~g~--  167 (355)
T KOG0033|consen   93 TGGELFEDIVAREFYSEADASHCIQQILEALAYCH---SNGIVHRDLKPENLLLASKAKGAAVKLADFGLAIEVNDGE--  167 (355)
T ss_pred             cchHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH---hcCceeccCChhheeeeeccCCCceeecccceEEEeCCcc--
Confidence                          112223446789999999999   999999999999999953   3358999999999887332  


Q ss_pred             eecccCCCCcccccccccccccCCCCccccHHHHHHHHHHHHcCCCCCCCCCCCcchhhhh
Q 039231          441 ISMTGARGTVGYIAPEVFCRNIGEVSYKSDVYNYGMMIFEMTGGRKNVDVVDNGSTALDLQ  501 (506)
Q Consensus       441 ~~~~~~~gt~~y~aPE~l~~~~~~~s~~~Dv~s~G~il~elltg~~pf~~~~~~~~~~~~~  501 (506)
                       ......|||+|||||++.++  +++..+|||+.|||||-|+.|.+||...+......+|+
T Consensus       168 -~~~G~~GtP~fmaPEvvrkd--py~kpvDiW~cGViLfiLL~G~~PF~~~~~~rlye~I~  225 (355)
T KOG0033|consen  168 -AWHGFAGTPGYLSPEVLKKD--PYSKPVDIWACGVILYILLVGYPPFWDEDQHRLYEQIK  225 (355)
T ss_pred             -ccccccCCCcccCHHHhhcC--CCCCcchhhhhhHHHHHHHhCCCCCCCccHHHHHHHHh
Confidence             23567899999999999665  89999999999999999999999998755544444443

>cd05059 PTKc_Tec_like Catalytic domain of Tec-like Protein Tyrosine Kinases

Probab=99.96  E-value=9.1e-29  Score=238.19  Aligned_cols=174  Identities=32%  Similarity=0.531  Sum_probs=142.7

Q ss_pred             hhccccCccCceEEEEEEEcCCCEEEEEEeccCCCCchhhHHHHHHhhccCccceeEEEEEe------------------
Q 039231          316 SFKYKLGQGGYGSVYKGKLLDGSNVAVKVLNDSKGNGKEFINEVASISRTSHVNVVALLGFC------------------  377 (506)
Q Consensus       316 ~~~~~ig~G~~g~V~~~~~~~~~~vavK~l~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~------------------  377 (506)
                      .+.+.||+|++|.||+|..+++..+|+|++........++.+|++++++++||||+++++++                  
T Consensus         7 ~~~~~lg~G~~~~v~~~~~~~~~~~~iK~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L   86 (256)
T cd05059           7 TFLKELGSGQFGVVHLGKWRGKIDVAIKMIREGAMSEDDFIEEAKVMMKLSHPNLVQLYGVCTKQRPIFIVTEYMANGCL   86 (256)
T ss_pred             chhhhhccCCCceEEEeEecCCccEEEEEeccCCCCHHHHHHHHHHHHhCCCCCEEEEEEEEcCCCceEEEEecCCCCCH
Confidence            45667999999999999987778899999876555557889999999999999999998875                  


Q ss_pred             ----------eccchhhhHHHHHHHHHHHHhhcCCCCeEecCcCCCcEEECCCCcEEEeecCCCccccCCCcceecccCC
Q 039231          378 ----------LRVAEELSSTIGIARGLEYLHLGCSTRILHFDIKPHNILLDEDFCPKISDFGLAKICNRKESIISMTGAR  447 (506)
Q Consensus       378 ----------~~~~~~l~i~~~i~~gl~~LH~~~~~~ivH~dlkp~Nill~~~~~~ki~dfg~a~~~~~~~~~~~~~~~~  447 (506)
                                +++...+.++.|++.||+|||   +.+++||||||+||++++++.+||+|||+++........ ......
T Consensus        87 ~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH---~~~i~H~dl~p~ni~i~~~~~~kl~dfg~~~~~~~~~~~-~~~~~~  162 (256)
T cd05059          87 LNYLRERKGKLGTEWLLDMCSDVCEAMEYLE---SNGFIHRDLAARNCLVGEDNVVKVSDFGLARYVLDDQYT-SSQGTK  162 (256)
T ss_pred             HHHHHhcccCCCHHHHHHHHHHHHHHHHHHH---HCCcccccccHhhEEECCCCcEEECCcccceeccccccc-ccCCCC
Confidence                      122235678999999999999   899999999999999999999999999999865433221 112223


Q ss_pred             CCcccccccccccccCCCCccccHHHHHHHHHHHHc-CCCCCCCCCCCc
Q 039231          448 GTVGYIAPEVFCRNIGEVSYKSDVYNYGMMIFEMTG-GRKNVDVVDNGS  495 (506)
Q Consensus       448 gt~~y~aPE~l~~~~~~~s~~~Dv~s~G~il~ellt-g~~pf~~~~~~~  495 (506)
                      ++..|+|||.+.+.  .++.++||||||+++|||++ |+.||+..++.+
T Consensus       163 ~~~~y~~Pe~~~~~--~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~  209 (256)
T cd05059         163 FPVKWAPPEVFDYS--RFSSKSDVWSFGVLMWEVFSEGKMPYERFSNSE  209 (256)
T ss_pred             CCccccCHHHhccC--CCCchhhHHHHHHHHHHHhccCCCCCCCCCHHH
Confidence            45679999998654  68889999999999999999 899998665443

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows

>cd05624 STKc_MRCK_beta Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta

Probab=99.96  E-value=2.4e-29  Score=251.69  Aligned_cols=173  Identities=23%  Similarity=0.281  Sum_probs=139.8

Q ss_pred             hccccCccCceEEEEEEEc-CCCEEEEEEeccC----CCCchhhHHHHHHhhccCccceeEEEEEee-------------
Q 039231          317 FKYKLGQGGYGSVYKGKLL-DGSNVAVKVLNDS----KGNGKEFINEVASISRTSHVNVVALLGFCL-------------  378 (506)
Q Consensus       317 ~~~~ig~G~~g~V~~~~~~-~~~~vavK~l~~~----~~~~~~~~~E~~~l~~l~h~niv~l~g~~~-------------  378 (506)
                      +.++||+|+||.||+++.. +++.+|+|++...    ......+.+|..++..++|+||+++.+++.             
T Consensus         5 i~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~l~~~~~~~~~~~lv~Ey~~   84 (331)
T cd05624           5 IIKVIGRGAFGEVAVVKMKHTERIYAMKILNKWEMLKRAETACFREERNVLVNGDCQWITTLHYAFQDENYLYLVMDYYV   84 (331)
T ss_pred             EEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHHHhhHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEEeCCC
Confidence            4568999999999999875 4788999998642    122345788999999999999999987761             


Q ss_pred             ---------------ccchhhhHHHHHHHHHHHHhhcCCCCeEecCcCCCcEEECCCCcEEEeecCCCccccCCCcceec
Q 039231          379 ---------------RVAEELSSTIGIARGLEYLHLGCSTRILHFDIKPHNILLDEDFCPKISDFGLAKICNRKESIISM  443 (506)
Q Consensus       379 ---------------~~~~~l~i~~~i~~gl~~LH~~~~~~ivH~dlkp~Nill~~~~~~ki~dfg~a~~~~~~~~~~~~  443 (506)
                                     .+.....++.|++.||+|||   +++|+||||||+|||++.++.+||+|||+++......... .
T Consensus        85 gg~L~~~l~~~~~~l~~~~~~~~~~qi~~~L~~lH---~~~iiHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~~-~  160 (331)
T cd05624          85 GGDLLTLLSKFEDRLPEDMARFYIAEMVLAIHSIH---QLHYVHRDIKPDNVLLDMNGHIRLADFGSCLKMNQDGTVQ-S  160 (331)
T ss_pred             CCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH---HCCeeeccCchHHEEEcCCCCEEEEeccceeeccCCCcee-e
Confidence                           12224567889999999999   8999999999999999999999999999998765433221 1


Q ss_pred             ccCCCCccccccccccccc---CCCCccccHHHHHHHHHHHHcCCCCCCCCCC
Q 039231          444 TGARGTVGYIAPEVFCRNI---GEVSYKSDVYNYGMMIFEMTGGRKNVDVVDN  493 (506)
Q Consensus       444 ~~~~gt~~y~aPE~l~~~~---~~~s~~~Dv~s~G~il~elltg~~pf~~~~~  493 (506)
                      ....|++.|+|||++....   +.++.++||||||+++|||++|+.||...+.
T Consensus       161 ~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~  213 (331)
T cd05624         161 SVAVGTPDYISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETPFYAESL  213 (331)
T ss_pred             ccccCCcccCCHHHHhccccCCCCCCCcccEEeeehhhhhhhhCCCCccCCCH
Confidence            3356899999999985421   3578899999999999999999999976543

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues.

>cd05623 STKc_MRCK_alpha Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha

Probab=99.96  E-value=3.6e-29  Score=250.58  Aligned_cols=173  Identities=23%  Similarity=0.293  Sum_probs=139.3

Q ss_pred             hccccCccCceEEEEEEEcC-CCEEEEEEeccC----CCCchhhHHHHHHhhccCccceeEEEEEee-------------
Q 039231          317 FKYKLGQGGYGSVYKGKLLD-GSNVAVKVLNDS----KGNGKEFINEVASISRTSHVNVVALLGFCL-------------  378 (506)
Q Consensus       317 ~~~~ig~G~~g~V~~~~~~~-~~~vavK~l~~~----~~~~~~~~~E~~~l~~l~h~niv~l~g~~~-------------  378 (506)
                      +.++||+|+||.||+++.+. ++.+|+|++.+.    ....+.+.+|+.++..++|+||+++.+.+.             
T Consensus         5 ~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ey~~   84 (332)
T cd05623           5 ILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDNQWITTLHYAFQDENNLYLVMDYYV   84 (332)
T ss_pred             EEEEEEeCCCeEEEEEEECCCCCEEEEEEEeHHHHHHhhHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCEEEEEEeccC
Confidence            45689999999999999764 788999998642    222345788999999999999999987651             


Q ss_pred             ---------------ccchhhhHHHHHHHHHHHHhhcCCCCeEecCcCCCcEEECCCCcEEEeecCCCccccCCCcceec
Q 039231          379 ---------------RVAEELSSTIGIARGLEYLHLGCSTRILHFDIKPHNILLDEDFCPKISDFGLAKICNRKESIISM  443 (506)
Q Consensus       379 ---------------~~~~~l~i~~~i~~gl~~LH~~~~~~ivH~dlkp~Nill~~~~~~ki~dfg~a~~~~~~~~~~~~  443 (506)
                                     .+.....++.|++.||+|||   +++|+||||||+|||++.++.+||+|||+++........ ..
T Consensus        85 ~g~L~~~l~~~~~~l~~~~~~~~~~qi~~al~~lH---~~~iiHrDlkp~Nili~~~~~~kL~DfG~a~~~~~~~~~-~~  160 (332)
T cd05623          85 GGDLLTLLSKFEDRLPEDMARFYLAEMVIAIDSVH---QLHYVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGTV-QS  160 (332)
T ss_pred             CCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH---HCCeEecCCCHHHEEECCCCCEEEeecchheecccCCcc-ee
Confidence                           12234567889999999999   899999999999999999999999999998765433221 11


Q ss_pred             ccCCCCccccccccccc---ccCCCCccccHHHHHHHHHHHHcCCCCCCCCCC
Q 039231          444 TGARGTVGYIAPEVFCR---NIGEVSYKSDVYNYGMMIFEMTGGRKNVDVVDN  493 (506)
Q Consensus       444 ~~~~gt~~y~aPE~l~~---~~~~~s~~~Dv~s~G~il~elltg~~pf~~~~~  493 (506)
                      ....||+.|+|||++..   ..+.++.++|||||||++|||++|+.||...+.
T Consensus       161 ~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwSlGvil~ell~g~~Pf~~~~~  213 (332)
T cd05623         161 SVAVGTPDYISPEILQAMEDGKGKYGPECDWWSLGVCMYEMLYGETPFYAESL  213 (332)
T ss_pred             cccccCccccCHHHHhccccCCCCCCCcCCEEeeHHHHHHHhcCCCCCCCCCH
Confidence            33568999999999853   123578899999999999999999999986543

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathw

>cd05070 PTKc_Fyn_Yrk Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk

Probab=99.96  E-value=1.2e-28  Score=237.97  Aligned_cols=176  Identities=28%  Similarity=0.499  Sum_probs=145.1

Q ss_pred             HhhhccccCccCceEEEEEEEcCCCEEEEEEeccCCCCchhhHHHHHHhhccCccceeEEEEEe----------------
Q 039231          314 TNSFKYKLGQGGYGSVYKGKLLDGSNVAVKVLNDSKGNGKEFINEVASISRTSHVNVVALLGFC----------------  377 (506)
Q Consensus       314 ~~~~~~~ig~G~~g~V~~~~~~~~~~vavK~l~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~----------------  377 (506)
                      .+.+.++||+|++|.||+|...++..+|+|.+.......+.+.+|+.++++++|+|++++++++                
T Consensus         7 ~~~~~~~ig~g~~~~v~~~~~~~~~~~~~k~~~~~~~~~~~~~~E~~~l~~l~~~~i~~~~~~~~~~~~~lv~e~~~~~~   86 (260)
T cd05070           7 SLQLIKKLGNGQFGEVWMGTWNGNTKVAVKTLKPGTMSPESFLEEAQIMKKLRHDKLVQLYAVVSEEPIYIVTEYMSKGS   86 (260)
T ss_pred             HhhhhheeccccCceEEEEEecCCceeEEEEecCCCCCHHHHHHHHHHHHhcCCCceEEEEeEECCCCcEEEEEecCCCc
Confidence            3455678999999999999988888999999987665667899999999999999999999875                


Q ss_pred             ------------eccchhhhHHHHHHHHHHHHhhcCCCCeEecCcCCCcEEECCCCcEEEeecCCCccccCCCcceeccc
Q 039231          378 ------------LRVAEELSSTIGIARGLEYLHLGCSTRILHFDIKPHNILLDEDFCPKISDFGLAKICNRKESIISMTG  445 (506)
Q Consensus       378 ------------~~~~~~l~i~~~i~~gl~~LH~~~~~~ivH~dlkp~Nill~~~~~~ki~dfg~a~~~~~~~~~~~~~~  445 (506)
                                  +++.+.+.++.|++.||+|||   +.+++|+||||+||++++++.+||+|||++.......... ...
T Consensus        87 L~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH---~~~i~H~di~p~Nili~~~~~~~l~dfg~~~~~~~~~~~~-~~~  162 (260)
T cd05070          87 LLDFLKDGEGRALKLPNLVDMAAQVAAGMAYIE---RMNYIHRDLRSANILVGDGLVCKIADFGLARLIEDNEYTA-RQG  162 (260)
T ss_pred             HHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCccceEEEeCCceEEeCCceeeeeccCccccc-ccC
Confidence                        122235778999999999999   8999999999999999999999999999998664433211 122


Q ss_pred             CCCCcccccccccccccCCCCccccHHHHHHHHHHHHc-CCCCCCCCCCCc
Q 039231          446 ARGTVGYIAPEVFCRNIGEVSYKSDVYNYGMMIFEMTG-GRKNVDVVDNGS  495 (506)
Q Consensus       446 ~~gt~~y~aPE~l~~~~~~~s~~~Dv~s~G~il~ellt-g~~pf~~~~~~~  495 (506)
                      ..++..|+|||.+.+  ..++.++||||||+++|||++ |+.||...+..+
T Consensus       163 ~~~~~~y~aPE~~~~--~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~~~  211 (260)
T cd05070         163 AKFPIKWTAPEAALY--GRFTIKSDVWSFGILLTELVTKGRVPYPGMNNRE  211 (260)
T ss_pred             CCCCccccChHHHhc--CCCcchhhhHHHHHHHHHHHhcCCCCCCCCCHHH
Confidence            345678999998854  368899999999999999999 999997655443

Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that r

>cd05071 PTKc_Src Catalytic domain of the Protein Tyrosine Kinase, Src

Probab=99.96  E-value=8.7e-29  Score=239.28  Aligned_cols=176  Identities=30%  Similarity=0.505  Sum_probs=144.8

Q ss_pred             HHhhhccccCccCceEEEEEEEcCCCEEEEEEeccCCCCchhhHHHHHHhhccCccceeEEEEEe---------------
Q 039231          313 MTNSFKYKLGQGGYGSVYKGKLLDGSNVAVKVLNDSKGNGKEFINEVASISRTSHVNVVALLGFC---------------  377 (506)
Q Consensus       313 ~~~~~~~~ig~G~~g~V~~~~~~~~~~vavK~l~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~---------------  377 (506)
                      ..+.+.++||+|++|.||+|+..+...||+|+++......+++.+|++++++++||||+++++.+               
T Consensus         6 ~~~~~~~~lg~g~~~~v~~~~~~~~~~valK~~~~~~~~~~~~~~E~~~l~~l~~~~i~~~~~~~~~~~~~lv~e~~~~~   85 (262)
T cd05071           6 ESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVSEEPIYIVTEYMSKG   85 (262)
T ss_pred             HHeeEeeecCCCCCCcEEEEEecCCceEEEEecccCccCHHHHHHHHHHHHhCCCCCcceEEEEECCCCcEEEEEcCCCC
Confidence            34566788999999999999987777899999987555557899999999999999999998764               


Q ss_pred             -------------eccchhhhHHHHHHHHHHHHhhcCCCCeEecCcCCCcEEECCCCcEEEeecCCCccccCCCcceecc
Q 039231          378 -------------LRVAEELSSTIGIARGLEYLHLGCSTRILHFDIKPHNILLDEDFCPKISDFGLAKICNRKESIISMT  444 (506)
Q Consensus       378 -------------~~~~~~l~i~~~i~~gl~~LH~~~~~~ivH~dlkp~Nill~~~~~~ki~dfg~a~~~~~~~~~~~~~  444 (506)
                                   +++...+.++.|++.||+|||   +.+++|+||||+||++++++.+||+|||.++......... ..
T Consensus        86 ~L~~~~~~~~~~~~~~~~~~~~~~~l~~aL~~lH---~~~i~H~dl~p~Nill~~~~~~~L~dfg~~~~~~~~~~~~-~~  161 (262)
T cd05071          86 SLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVE---RMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTA-RQ  161 (262)
T ss_pred             cHHHHHhhccccCCCHHHHHHHHHHHHHHHHHHH---HCCccccccCcccEEEcCCCcEEeccCCceeecccccccc-cc
Confidence                         122335678899999999999   8999999999999999999999999999997664433211 12


Q ss_pred             cCCCCcccccccccccccCCCCccccHHHHHHHHHHHHc-CCCCCCCCCCC
Q 039231          445 GARGTVGYIAPEVFCRNIGEVSYKSDVYNYGMMIFEMTG-GRKNVDVVDNG  494 (506)
Q Consensus       445 ~~~gt~~y~aPE~l~~~~~~~s~~~Dv~s~G~il~ellt-g~~pf~~~~~~  494 (506)
                      ...++..|+|||.+.+  ..++.++||||||+++|||++ |+.||......
T Consensus       162 ~~~~~~~y~~PE~~~~--~~~~~~~DvwslG~~l~ellt~g~~p~~~~~~~  210 (262)
T cd05071         162 GAKFPIKWTAPEAALY--GRFTIKSDVWSFGILLTELTTKGRVPYPGMVNR  210 (262)
T ss_pred             CCcccceecCHhHhcc--CCCCchhhHHHHHHHHHHHHcCCCCCCCCCChH
Confidence            3446778999998854  368999999999999999999 89999765443

Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is invo

>PTZ00267 NIMA-related protein kinase; Provisional

Probab=99.96  E-value=7.2e-29  Score=260.01  Aligned_cols=174  Identities=21%  Similarity=0.256  Sum_probs=140.5

Q ss_pred             hhhccccCccCceEEEEEEEc-C-CCEEEEEEeccCCC-CchhhHHHHHHhhccCccceeEEEEEee-------------
Q 039231          315 NSFKYKLGQGGYGSVYKGKLL-D-GSNVAVKVLNDSKG-NGKEFINEVASISRTSHVNVVALLGFCL-------------  378 (506)
Q Consensus       315 ~~~~~~ig~G~~g~V~~~~~~-~-~~~vavK~l~~~~~-~~~~~~~E~~~l~~l~h~niv~l~g~~~-------------  378 (506)
                      +.+.+.||+|++|.||+|... + +..||+|.+..... ....+.+|+++++.++|||||++++++.             
T Consensus        69 y~~~~~lg~G~~g~vy~a~~~~~~~~~vv~K~~~~~~~~~~~~~~~E~~~l~~l~Hpniv~~~~~~~~~~~~~lv~E~~~  148 (478)
T PTZ00267         69 YVLTTLVGRNPTTAAFVATRGSDPKEKVVAKFVMLNDERQAAYARSELHCLAACDHFGIVKHFDDFKSDDKLLLIMEYGS  148 (478)
T ss_pred             EEEEEEEEeCCCcEEEEEEEcCCCCeEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeEEEEEEEECCEEEEEEECCC
Confidence            445678999999999999753 3 57788887654332 2346778999999999999999998771             


Q ss_pred             ------------------ccchhhhHHHHHHHHHHHHhhcCCCCeEecCcCCCcEEECCCCcEEEeecCCCccccCCCcc
Q 039231          379 ------------------RVAEELSSTIGIARGLEYLHLGCSTRILHFDIKPHNILLDEDFCPKISDFGLAKICNRKESI  440 (506)
Q Consensus       379 ------------------~~~~~l~i~~~i~~gl~~LH~~~~~~ivH~dlkp~Nill~~~~~~ki~dfg~a~~~~~~~~~  440 (506)
                                        .+.+...++.|++.||+|||   +++|+||||||+|||++.++.+||+|||+++........
T Consensus       149 gg~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH---~~~ivHrDlkp~NIll~~~~~~kL~DFgla~~~~~~~~~  225 (478)
T PTZ00267        149 GGDLNKQIKQRLKEHLPFQEYEVGLLFYQIVLALDEVH---SRKMMHRDLKSANIFLMPTGIIKLGDFGFSKQYSDSVSL  225 (478)
T ss_pred             CCCHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHH---hCCEEECCcCHHhEEECCCCcEEEEeCcCceecCCcccc
Confidence                              11224457889999999999   899999999999999999999999999999876543322


Q ss_pred             eecccCCCCcccccccccccccCCCCccccHHHHHHHHHHHHcCCCCCCCCCC
Q 039231          441 ISMTGARGTVGYIAPEVFCRNIGEVSYKSDVYNYGMMIFEMTGGRKNVDVVDN  493 (506)
Q Consensus       441 ~~~~~~~gt~~y~aPE~l~~~~~~~s~~~Dv~s~G~il~elltg~~pf~~~~~  493 (506)
                      .......||+.|+|||++.+.  .++.++||||||+++|||++|+.||...+.
T Consensus       226 ~~~~~~~gt~~y~aPE~~~~~--~~~~~~Dv~slG~~l~el~tg~~Pf~~~~~  276 (478)
T PTZ00267        226 DVASSFCGTPYYLAPELWERK--RYSKKADMWSLGVILYELLTLHRPFKGPSQ  276 (478)
T ss_pred             ccccccCCCccccCHhHhCCC--CCCcHHhHHHHHHHHHHHHhCCCCCCCCCH
Confidence            122345689999999998653  789999999999999999999999976543

>KOG0983 consensus Mitogen-activated protein kinase (MAPK) kinase MKK7/JNKK2 [Signal transduction mechanisms]

Probab=99.96  E-value=1.3e-28  Score=223.68  Aligned_cols=170  Identities=25%  Similarity=0.428  Sum_probs=140.3

Q ss_pred             ccCccCceEEEEEEEcC-CCEEEEEEeccCC--CCchhhHHHHHHhhccC-ccceeEEEEEeeccch-------------
Q 039231          320 KLGQGGYGSVYKGKLLD-GSNVAVKVLNDSK--GNGKEFINEVASISRTS-HVNVVALLGFCLRVAE-------------  382 (506)
Q Consensus       320 ~ig~G~~g~V~~~~~~~-~~~vavK~l~~~~--~~~~~~~~E~~~l~~l~-h~niv~l~g~~~~~~~-------------  382 (506)
                      .||.|..|.|++++.+. |..+|||.+..+.  ++.+++++.++++..-+ .|.||+.+|++....+             
T Consensus        99 dlGsGtcG~V~k~~~rs~~~iiAVK~M~rt~Nkee~kRILmDldvv~~s~dcpyIV~c~GyFi~n~dV~IcMelMs~C~e  178 (391)
T KOG0983|consen   99 DLGSGTCGQVWKMRFRSTGHIIAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVQCFGYFITNTDVFICMELMSTCAE  178 (391)
T ss_pred             hhcCCCccceEEEEEcccceEEEEEeecccCCHHHHHHHHHhhhHHhhccCCCeeeeeeeEEeeCchHHHHHHHHHHHHH
Confidence            59999999999999865 8999999997643  34467888888776665 8999999999954333             


Q ss_pred             --------------hhhHHHHHHHHHHHHhhcCCCCeEecCcCCCcEEECCCCcEEEeecCCCccccCCCcceecccCCC
Q 039231          383 --------------ELSSTIGIARGLEYLHLGCSTRILHFDIKPHNILLDEDFCPKISDFGLAKICNRKESIISMTGARG  448 (506)
Q Consensus       383 --------------~l~i~~~i~~gl~~LH~~~~~~ivH~dlkp~Nill~~~~~~ki~dfg~a~~~~~~~~~~~~~~~~g  448 (506)
                                    .-++...+++||.||.+  +++|+|||+||+|||+|+.|++|++|||++..+-....+   +...|
T Consensus       179 kLlkrik~piPE~ilGk~tva~v~AL~YLKe--KH~viHRDvKPSNILlDe~GniKlCDFGIsGrlvdSkAh---trsAG  253 (391)
T KOG0983|consen  179 KLLKRIKGPIPERILGKMTVAIVKALYYLKE--KHGVIHRDVKPSNILLDERGNIKLCDFGISGRLVDSKAH---TRSAG  253 (391)
T ss_pred             HHHHHhcCCchHHhhhhhHHHHHHHHHHHHH--hcceeecccCccceEEccCCCEEeecccccceeeccccc---ccccC
Confidence                          12355678999999987  899999999999999999999999999999776554433   45678


Q ss_pred             Ccccccccccccc-cCCCCccccHHHHHHHHHHHHcCCCCCCCCCCC
Q 039231          449 TVGYIAPEVFCRN-IGEVSYKSDVYNYGMMIFEMTGGRKNVDVVDNG  494 (506)
Q Consensus       449 t~~y~aPE~l~~~-~~~~s~~~Dv~s~G~il~elltg~~pf~~~~~~  494 (506)
                      .+.|||||.+.-. ...|+-.+||||||+.|+||.||+.||...+.+
T Consensus       254 C~~YMaPERidp~~~~kYDiRaDVWSlGITlveLaTg~yPy~~c~td  300 (391)
T KOG0983|consen  254 CAAYMAPERIDPPDKPKYDIRADVWSLGITLVELATGQYPYKGCKTD  300 (391)
T ss_pred             CccccCccccCCCCCCccchhhhhhhhccchhhhhcccCCCCCCCcc
Confidence            9999999999643 346888999999999999999999999986544

>cd05111 PTK_HER3 Pseudokinase domain of the Protein Tyrosine Kinase, HER3

Probab=99.96  E-value=1.2e-28  Score=240.60  Aligned_cols=171  Identities=29%  Similarity=0.516  Sum_probs=137.8

Q ss_pred             ccccCccCceEEEEEEEc-CCC----EEEEEEeccCCC--CchhhHHHHHHhhccCccceeEEEEEe-------------
Q 039231          318 KYKLGQGGYGSVYKGKLL-DGS----NVAVKVLNDSKG--NGKEFINEVASISRTSHVNVVALLGFC-------------  377 (506)
Q Consensus       318 ~~~ig~G~~g~V~~~~~~-~~~----~vavK~l~~~~~--~~~~~~~E~~~l~~l~h~niv~l~g~~-------------  377 (506)
                      .+.||+|+||.||+|++. +++    .+++|.+.....  ..+++..|+..+++++||||+++++++             
T Consensus        12 ~~~lg~G~~~~vy~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~l~~l~h~~iv~~~~~~~~~~~~~i~e~~~   91 (279)
T cd05111          12 LKLLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRSGRQTFQEITDHMLAMGSLDHAYIVRLLGICPGASLQLVTQLSP   91 (279)
T ss_pred             ccccCccCCcceEEEEEcCCCCceeeEEEEeecccccchHHHHHHHHHHHHHhcCCCCCcceEEEEECCCccEEEEEeCC
Confidence            467999999999999874 344    477787754322  225677888899999999999999886             


Q ss_pred             --------------eccchhhhHHHHHHHHHHHHhhcCCCCeEecCcCCCcEEECCCCcEEEeecCCCccccCCCcceec
Q 039231          378 --------------LRVAEELSSTIGIARGLEYLHLGCSTRILHFDIKPHNILLDEDFCPKISDFGLAKICNRKESIISM  443 (506)
Q Consensus       378 --------------~~~~~~l~i~~~i~~gl~~LH~~~~~~ivH~dlkp~Nill~~~~~~ki~dfg~a~~~~~~~~~~~~  443 (506)
                                    +++...+.++.|++.||+|||   +++++|+||||+||++++++.+||+|||+++...........
T Consensus        92 ~gsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH---~~~iiH~dlkp~nili~~~~~~kl~Dfg~~~~~~~~~~~~~~  168 (279)
T cd05111          92 LGSLLDHVRQHRDSLDPQRLLNWCVQIAKGMYYLE---EHRMVHRNLAARNILLKSDSIVQIADFGVADLLYPDDKKYFY  168 (279)
T ss_pred             CCcHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHH---HCCEeccccCcceEEEcCCCcEEEcCCccceeccCCCccccc
Confidence                          123345678999999999999   899999999999999999999999999999876543332223


Q ss_pred             ccCCCCcccccccccccccCCCCccccHHHHHHHHHHHHc-CCCCCCCCCC
Q 039231          444 TGARGTVGYIAPEVFCRNIGEVSYKSDVYNYGMMIFEMTG-GRKNVDVVDN  493 (506)
Q Consensus       444 ~~~~gt~~y~aPE~l~~~~~~~s~~~Dv~s~G~il~ellt-g~~pf~~~~~  493 (506)
                      ....++..|+|||.+..  +.++.++||||||+++|||++ |+.||.....
T Consensus       169 ~~~~~~~~y~~pE~~~~--~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~  217 (279)
T cd05111         169 SEHKTPIKWMALESILF--GRYTHQSDVWSYGVTVWEMMSYGAEPYAGMRP  217 (279)
T ss_pred             CCCCCcccccCHHHhcc--CCcCchhhHHHHHHHHHHHHcCCCCCCCCCCH
Confidence            34557788999999854  378999999999999999998 9999976543

Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr r

>KOG0032 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms]

Probab=99.96  E-value=1.1e-28  Score=247.20  Aligned_cols=181  Identities=29%  Similarity=0.398  Sum_probs=152.2

Q ss_pred             HhhhccccCccCceEEEEEEEcC-CCEEEEEEeccCCC----CchhhHHHHHHhhccC-ccceeEEEEEe----------
Q 039231          314 TNSFKYKLGQGGYGSVYKGKLLD-GSNVAVKVLNDSKG----NGKEFINEVASISRTS-HVNVVALLGFC----------  377 (506)
Q Consensus       314 ~~~~~~~ig~G~~g~V~~~~~~~-~~~vavK~l~~~~~----~~~~~~~E~~~l~~l~-h~niv~l~g~~----------  377 (506)
                      .+.+.+.||+|.||.||+++.+. |+.+|+|++++...    ....+.+|+++|+++. |||||.+.+.+          
T Consensus        36 ~Y~l~~~lG~G~Fg~v~~~~~~~tg~~~A~K~i~k~~~~~~~~~~~v~~Ev~il~~l~~hpniv~l~~~~e~~~~~~lvm  115 (382)
T KOG0032|consen   36 KYELGRELGRGQFGVVYLCREKSTGKEVACKVIPKRKLRGKEDREDVRREVAILQQLSGHPNIVQLKDAFEDPDSVYLVM  115 (382)
T ss_pred             cEEehhhhCCCCceEEEEEEecCCCceeEEEEeehhhccccccHHHHHHHHHHHHhccCCCCEEEEEEEEEcCCeEEEEE
Confidence            34555789999999999999865 99999999976443    2358999999999999 99999999887          


Q ss_pred             ----------------eccchhhhHHHHHHHHHHHHhhcCCCCeEecCcCCCcEEECCC----CcEEEeecCCCccccCC
Q 039231          378 ----------------LRVAEELSSTIGIARGLEYLHLGCSTRILHFDIKPHNILLDED----FCPKISDFGLAKICNRK  437 (506)
Q Consensus       378 ----------------~~~~~~l~i~~~i~~gl~~LH~~~~~~ivH~dlkp~Nill~~~----~~~ki~dfg~a~~~~~~  437 (506)
                                      +.+.+...++.|++.|++|||   +.+|+||||||+|+|+...    +.+|++|||++......
T Consensus       116 EL~~GGeLfd~i~~~~~sE~da~~~~~~il~av~~lH---~~gvvHrDlKpEN~L~~~~~~~~~~ik~~DFGla~~~~~~  192 (382)
T KOG0032|consen  116 ELCEGGELFDRIVKKHYSERDAAGIIRQILEAVKYLH---SLGVVHRDLKPENLLLASKDEGSGRIKLIDFGLAKFIKPG  192 (382)
T ss_pred             EecCCchHHHHHHHccCCHHHHHHHHHHHHHHHHHHH---hCCceeccCCHHHeeeccccCCCCcEEEeeCCCceEccCC
Confidence                            223335668899999999999   8999999999999999533    57999999999988762


Q ss_pred             CcceecccCCCCcccccccccccccCCCCccccHHHHHHHHHHHHcCCCCCCCCCCCcchhhhhh
Q 039231          438 ESIISMTGARGTVGYIAPEVFCRNIGEVSYKSDVYNYGMMIFEMTGGRKNVDVVDNGSTALDLQA  502 (506)
Q Consensus       438 ~~~~~~~~~~gt~~y~aPE~l~~~~~~~s~~~Dv~s~G~il~elltg~~pf~~~~~~~~~~~~~~  502 (506)
                      .   ......||+.|+|||++...  .++.++||||+|+++|.|++|..||....+.+....+.+
T Consensus       193 ~---~~~~~~Gtp~y~APEvl~~~--~y~~~~DiWS~Gvi~yiLL~G~~PF~~~~~~~~~~~i~~  252 (382)
T KOG0032|consen  193 E---RLHTIVGTPEYVAPEVLGGR--PYGDEVDVWSIGVILYILLSGVPPFWGETEFEIFLAILR  252 (382)
T ss_pred             c---eEeeecCCccccCchhhcCC--CCCcccchhHHHHHHHHHhhCCCCCcCCChhHHHHHHHc
Confidence            2   24678999999999999643  799999999999999999999999998887776665443

>cd06650 PKc_MEK1 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1

Probab=99.96  E-value=1.2e-28  Score=246.82  Aligned_cols=173  Identities=25%  Similarity=0.340  Sum_probs=140.6

Q ss_pred             HHhhhccccCccCceEEEEEEEc-CCCEEEEEEeccCCC--CchhhHHHHHHhhccCccceeEEEEEeec----------
Q 039231          313 MTNSFKYKLGQGGYGSVYKGKLL-DGSNVAVKVLNDSKG--NGKEFINEVASISRTSHVNVVALLGFCLR----------  379 (506)
Q Consensus       313 ~~~~~~~~ig~G~~g~V~~~~~~-~~~~vavK~l~~~~~--~~~~~~~E~~~l~~l~h~niv~l~g~~~~----------  379 (506)
                      ..+.+.++||+|+||.||+++.. ++..+|+|++.....  ...++.+|++++++++|+||+++++++.+          
T Consensus         5 ~~y~~~~~lg~g~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~   84 (333)
T cd06650           5 DDFEKISELGAGNGGVVFKVSHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEH   84 (333)
T ss_pred             hhhheeccccCCCCEEEEEEEECCCCcEEEEEEeecccCHHHHHHHHHHHHHHHHCCCCcccceeEEEEECCEEEEEEec
Confidence            34445678999999999999986 478899998865422  23568899999999999999999988722          


Q ss_pred             -----------------cchhhhHHHHHHHHHHHHhhcCCCCeEecCcCCCcEEECCCCcEEEeecCCCccccCCCccee
Q 039231          380 -----------------VAEELSSTIGIARGLEYLHLGCSTRILHFDIKPHNILLDEDFCPKISDFGLAKICNRKESIIS  442 (506)
Q Consensus       380 -----------------~~~~l~i~~~i~~gl~~LH~~~~~~ivH~dlkp~Nill~~~~~~ki~dfg~a~~~~~~~~~~~  442 (506)
                                       +.....++.|++.||+|||+  ..+++|+||||+|||+++++.+||+|||++.......    
T Consensus        85 ~~~~~L~~~l~~~~~~~~~~~~~~~~~l~~~l~~lH~--~~~ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~~~----  158 (333)
T cd06650          85 MDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLRE--KHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSM----  158 (333)
T ss_pred             CCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHh--cCCEEecCCChhhEEEcCCCCEEEeeCCcchhhhhhc----
Confidence                             12245688899999999993  2479999999999999999999999999987553321    


Q ss_pred             cccCCCCcccccccccccccCCCCccccHHHHHHHHHHHHcCCCCCCCCCC
Q 039231          443 MTGARGTVGYIAPEVFCRNIGEVSYKSDVYNYGMMIFEMTGGRKNVDVVDN  493 (506)
Q Consensus       443 ~~~~~gt~~y~aPE~l~~~~~~~s~~~Dv~s~G~il~elltg~~pf~~~~~  493 (506)
                      .....++..|+|||.+.+.  .++.++|||||||++|||++|+.||.....
T Consensus       159 ~~~~~~~~~y~aPE~~~~~--~~~~~~DvwslG~il~~l~~g~~p~~~~~~  207 (333)
T cd06650         159 ANSFVGTRSYMSPERLQGT--HYSVQSDIWSMGLSLVEMAIGRYPIPPPDA  207 (333)
T ss_pred             cccCCCCccccCHHHhcCC--CCCcHHHHHHHHHHHHHHHHCCCCCCCcch
Confidence            1335689999999998654  688999999999999999999999976543

Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downst

>cd05052 PTKc_Abl Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase

Probab=99.96  E-value=9.1e-29  Score=239.18  Aligned_cols=173  Identities=32%  Similarity=0.543  Sum_probs=142.0

Q ss_pred             hhhccccCccCceEEEEEEEc-CCCEEEEEEeccCCCCchhhHHHHHHhhccCccceeEEEEEe----------------
Q 039231          315 NSFKYKLGQGGYGSVYKGKLL-DGSNVAVKVLNDSKGNGKEFINEVASISRTSHVNVVALLGFC----------------  377 (506)
Q Consensus       315 ~~~~~~ig~G~~g~V~~~~~~-~~~~vavK~l~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~----------------  377 (506)
                      ..+.++||+|++|.||+|... .++.+|+|+++......+++.+|++.+++++|+||+++++++                
T Consensus         8 ~~~~~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~   87 (263)
T cd05052           8 ITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYG   87 (263)
T ss_pred             eEEeeecCCcccceEEEEEEecCCceEEEEEecCCchHHHHHHHHHHHHHhCCCCChhheEEEEcCCCCcEEEEEeCCCC
Confidence            345678999999999999875 488999999986655567889999999999999999999876                


Q ss_pred             -------------eccchhhhHHHHHHHHHHHHhhcCCCCeEecCcCCCcEEECCCCcEEEeecCCCccccCCCcceecc
Q 039231          378 -------------LRVAEELSSTIGIARGLEYLHLGCSTRILHFDIKPHNILLDEDFCPKISDFGLAKICNRKESIISMT  444 (506)
Q Consensus       378 -------------~~~~~~l~i~~~i~~gl~~LH~~~~~~ivH~dlkp~Nill~~~~~~ki~dfg~a~~~~~~~~~~~~~  444 (506)
                                   +++...+.++.|+++||+|||   +.+++||||||+||++++++.+||+|||++.......... ..
T Consensus        88 ~L~~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH---~~~i~H~dlkp~nil~~~~~~~kl~df~~~~~~~~~~~~~-~~  163 (263)
T cd05052          88 NLLDYLRECNRQEVNAVVLLYMATQISSAMEYLE---KKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTA-HA  163 (263)
T ss_pred             cHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHH---hCCEeecccCcceEEEcCCCcEEeCCCccccccccceeec-cC
Confidence                         122235668899999999999   8999999999999999999999999999998765432211 12


Q ss_pred             cCCCCcccccccccccccCCCCccccHHHHHHHHHHHHc-CCCCCCCCCC
Q 039231          445 GARGTVGYIAPEVFCRNIGEVSYKSDVYNYGMMIFEMTG-GRKNVDVVDN  493 (506)
Q Consensus       445 ~~~gt~~y~aPE~l~~~~~~~s~~~Dv~s~G~il~ellt-g~~pf~~~~~  493 (506)
                      ....+..|+|||.+...  .++.++||||||+++|||++ |..||...+.
T Consensus       164 ~~~~~~~y~aPE~~~~~--~~~~~~Dv~slG~il~el~t~g~~p~~~~~~  211 (263)
T cd05052         164 GAKFPIKWTAPESLAYN--KFSIKSDVWAFGVLLWEIATYGMSPYPGIDL  211 (263)
T ss_pred             CCCCccccCCHHHhccC--CCCchhHHHHHHHHHHHHHcCCCCCCCCCCH
Confidence            23346689999988543  78889999999999999998 9999976543

Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays

>cd05109 PTKc_HER2 Catalytic domain of the Protein Tyrosine Kinase, HER2

Probab=99.96  E-value=1.2e-28  Score=240.40  Aligned_cols=173  Identities=32%  Similarity=0.568  Sum_probs=139.2

Q ss_pred             hhccccCccCceEEEEEEEc-CCC----EEEEEEeccCCC--CchhhHHHHHHhhccCccceeEEEEEee----------
Q 039231          316 SFKYKLGQGGYGSVYKGKLL-DGS----NVAVKVLNDSKG--NGKEFINEVASISRTSHVNVVALLGFCL----------  378 (506)
Q Consensus       316 ~~~~~ig~G~~g~V~~~~~~-~~~----~vavK~l~~~~~--~~~~~~~E~~~l~~l~h~niv~l~g~~~----------  378 (506)
                      .+.++||+|+||.||+|++. ++.    .||+|+++....  ..+++.+|+.++..++|+||+++++++.          
T Consensus        10 ~~~~~lg~G~~g~vy~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~l~~~~   89 (279)
T cd05109          10 KKVKVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAYVMAGVGSPYVCRLLGICLTSTVQLVTQL   89 (279)
T ss_pred             eeeeecCCCCCceEEEEEEecCCCccceEEEEEEecCCCCHHHHHHHHHHHHHHHhcCCCCCceEEEEEcCCCcEEEEEc
Confidence            34567999999999999853 344    489999865322  2367889999999999999999998762          


Q ss_pred             -----------------ccchhhhHHHHHHHHHHHHhhcCCCCeEecCcCCCcEEECCCCcEEEeecCCCccccCCCcce
Q 039231          379 -----------------RVAEELSSTIGIARGLEYLHLGCSTRILHFDIKPHNILLDEDFCPKISDFGLAKICNRKESII  441 (506)
Q Consensus       379 -----------------~~~~~l~i~~~i~~gl~~LH~~~~~~ivH~dlkp~Nill~~~~~~ki~dfg~a~~~~~~~~~~  441 (506)
                                       .+...+.++.|++.||+|||   +++++||||||+||++++++.+||+|||+++.........
T Consensus        90 ~~~g~l~~~l~~~~~~~~~~~~~~~~~qi~~~L~~lH---~~~iiH~dlkp~Nil~~~~~~~kL~dfG~~~~~~~~~~~~  166 (279)
T cd05109          90 MPYGCLLDYVRENKDRIGSQDLLNWCVQIAKGMSYLE---EVRLVHRDLAARNVLVKSPNHVKITDFGLARLLDIDETEY  166 (279)
T ss_pred             CCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHH---HCCeeccccccceEEEcCCCcEEECCCCceeeccccccee
Confidence                             22235678999999999999   8999999999999999999999999999998765443322


Q ss_pred             ecccCCCCcccccccccccccCCCCccccHHHHHHHHHHHHc-CCCCCCCCCC
Q 039231          442 SMTGARGTVGYIAPEVFCRNIGEVSYKSDVYNYGMMIFEMTG-GRKNVDVVDN  493 (506)
Q Consensus       442 ~~~~~~gt~~y~aPE~l~~~~~~~s~~~Dv~s~G~il~ellt-g~~pf~~~~~  493 (506)
                      ......++..|+|||.+.+.  .++.++||||||+++|||++ |..||+....
T Consensus       167 ~~~~~~~~~~y~~PE~~~~~--~~~~~~Di~slG~~l~el~t~g~~p~~~~~~  217 (279)
T cd05109         167 HADGGKVPIKWMALESILHR--RFTHQSDVWSYGVTVWELMTFGAKPYDGIPA  217 (279)
T ss_pred             ecCCCccchhhCCHHHhccC--CCCchhHHHHHHHHHHHHHcCCCCCCCCCCH
Confidence            22233456789999998543  68899999999999999998 9999976543

Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve

>KOG0589 consensus Serine/threonine protein kinase [General function prediction only]

Probab=99.96  E-value=1.4e-29  Score=250.34  Aligned_cols=178  Identities=28%  Similarity=0.404  Sum_probs=152.7

Q ss_pred             ccccCccCceEEEEEEEc-CCCEEEEEEeccCC---CCchhhHHHHHHhhccCccceeEEEEEe----------------
Q 039231          318 KYKLGQGGYGSVYKGKLL-DGSNVAVKVLNDSK---GNGKEFINEVASISRTSHVNVVALLGFC----------------  377 (506)
Q Consensus       318 ~~~ig~G~~g~V~~~~~~-~~~~vavK~l~~~~---~~~~~~~~E~~~l~~l~h~niv~l~g~~----------------  377 (506)
                      -++||+|+||.++..+.+ +++.+++|++.-..   ...+...+|+.++++++|||||.+.+.+                
T Consensus         9 ~~~iG~GafG~a~lvrhk~~~~~~vlK~I~l~~~t~~~r~~A~~E~~lis~~~hP~iv~y~ds~~~~~~~l~Ivm~Y~eG   88 (426)
T KOG0589|consen    9 LRQVGRGAFGSALLVRHKSDDKLYVLKKINLEKLTEPERRSAIQEMDLLSKLLHPNIVEYKDSFEEDGQLLCIVMEYCEG   88 (426)
T ss_pred             hhhcCccccchhhhhhhccCCceEEEEEEeccccCchhhHHHHHHHHHHHhccCCCeeeeccchhcCCceEEEEEeecCC
Confidence            457999999999999864 57899999986433   2335678999999999999999987655                


Q ss_pred             --------------eccchhhhHHHHHHHHHHHHhhcCCCCeEecCcCCCcEEECCCCcEEEeecCCCccccCCCcceec
Q 039231          378 --------------LRVAEELSSTIGIARGLEYLHLGCSTRILHFDIKPHNILLDEDFCPKISDFGLAKICNRKESIISM  443 (506)
Q Consensus       378 --------------~~~~~~l~i~~~i~~gl~~LH~~~~~~ivH~dlkp~Nill~~~~~~ki~dfg~a~~~~~~~~~~~~  443 (506)
                                    ++++..+.++.|++.|++|||   +..|+|||||+.||+++.+..+||+|||+|+.+......  .
T Consensus        89 g~l~~~i~~~k~~~f~E~~i~~~~~Q~~~av~ylH---~~~iLHRDlK~~Nifltk~~~VkLgDfGlaK~l~~~~~~--a  163 (426)
T KOG0589|consen   89 GDLAQLIKEQKGVLFPEERILKWFVQILLAVNYLH---ENRVLHRDLKCANIFLTKDKKVKLGDFGLAKILNPEDSL--A  163 (426)
T ss_pred             CCHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHH---hhhhhcccchhhhhhccccCceeecchhhhhhcCCchhh--h
Confidence                          445557789999999999999   999999999999999999999999999999999877633  2


Q ss_pred             ccCCCCcccccccccccccCCCCccccHHHHHHHHHHHHcCCCCCCCCCCCcchhhhhh
Q 039231          444 TGARGTVGYIAPEVFCRNIGEVSYKSDVYNYGMMIFEMTGGRKNVDVVDNGSTALDLQA  502 (506)
Q Consensus       444 ~~~~gt~~y~aPE~l~~~~~~~s~~~Dv~s~G~il~elltg~~pf~~~~~~~~~~~~~~  502 (506)
                      ....||+.||.||++.+.  +|..|+|||||||++|||++-+++|+..+-.....++..
T Consensus       164 ~tvvGTp~YmcPEil~d~--pYn~KSDiWsLGC~~yEm~~lk~aF~a~~m~~Li~ki~~  220 (426)
T KOG0589|consen  164 STVVGTPYYMCPEILSDI--PYNEKSDIWSLGCCLYEMCTLKPAFKASNMSELILKINR  220 (426)
T ss_pred             heecCCCcccCHHHhCCC--CCCccCcchhhcchHHHHHhcccccCccchHHHHHHHhh
Confidence            568899999999999765  899999999999999999999999998877666555543

>KOG4717 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.96  E-value=4.3e-29  Score=243.89  Aligned_cols=180  Identities=22%  Similarity=0.403  Sum_probs=152.1

Q ss_pred             hhhccccCccCceEEEEEEE-cCCCEEEEEEeccCCCC---chhhHHHHHHhhccCccceeEEEEEe-------------
Q 039231          315 NSFKYKLGQGGYGSVYKGKL-LDGSNVAVKVLNDSKGN---GKEFINEVASISRTSHVNVVALLGFC-------------  377 (506)
Q Consensus       315 ~~~~~~ig~G~~g~V~~~~~-~~~~~vavK~l~~~~~~---~~~~~~E~~~l~~l~h~niv~l~g~~-------------  377 (506)
                      |++++.||+|-|..|.+|++ -.|..||||++.+.+.+   ...+.+|++.|+-++|||||+|+.+.             
T Consensus        20 YDLekTlG~GHFAVVKLArHVFTGekVAVKviDKTKlD~~st~hlfqEVRCMKLVQHpNiVRLYEViDTQTKlyLiLELG   99 (864)
T KOG4717|consen   20 YDLEKTLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDTLSTGHLFQEVRCMKLVQHPNIVRLYEVIDTQTKLYLILELG   99 (864)
T ss_pred             ehhhhhhcCCceehhhhhhhhcccceeEEEEecccccchhhhhHHHHHHHHHHHhcCcCeeeeeehhcccceEEEEEEec
Confidence            34456799999999999975 47999999999876543   36789999999999999999999765             


Q ss_pred             ---------------eccchhhhHHHHHHHHHHHHhhcCCCCeEecCcCCCcEEE-CCCCcEEEeecCCCccccCCCcce
Q 039231          378 ---------------LRVAEELSSTIGIARGLEYLHLGCSTRILHFDIKPHNILL-DEDFCPKISDFGLAKICNRKESII  441 (506)
Q Consensus       378 ---------------~~~~~~l~i~~~i~~gl~~LH~~~~~~ivH~dlkp~Nill-~~~~~~ki~dfg~a~~~~~~~~~~  441 (506)
                                     +.++-..+++.||+.|+.|+|   +..+|||||||+|+.+ ..-|.+||.|||++..+.+.+.  
T Consensus       100 D~GDl~DyImKHe~Gl~E~La~kYF~QI~~AI~YCH---qLHVVHRDLKPENVVFFEKlGlVKLTDFGFSNkf~PG~k--  174 (864)
T KOG4717|consen  100 DGGDLFDYIMKHEEGLNEDLAKKYFAQIVHAISYCH---QLHVVHRDLKPENVVFFEKLGLVKLTDFGFSNKFQPGKK--  174 (864)
T ss_pred             CCchHHHHHHhhhccccHHHHHHHHHHHHHHHHHHh---hhhhhcccCCcceeEEeeecCceEeeeccccccCCCcch--
Confidence                           122225568899999999999   8999999999999976 5668999999999988776654  


Q ss_pred             ecccCCCCcccccccccccccCCCCccccHHHHHHHHHHHHcCCCCCCCCCCCcchhhhh
Q 039231          442 SMTGARGTVGYIAPEVFCRNIGEVSYKSDVYNYGMMIFEMTGGRKNVDVVDNGSTALDLQ  501 (506)
Q Consensus       442 ~~~~~~gt~~y~aPE~l~~~~~~~s~~~Dv~s~G~il~elltg~~pf~~~~~~~~~~~~~  501 (506)
                       +....|++.|-|||++.++ .+..+++||||+|||||.|++|+.||+..++.|..--|+
T Consensus       175 -L~TsCGSLAYSAPEILLGD-sYDAPAVDiWSLGVILyMLVCGq~PFqeANDSETLTmIm  232 (864)
T KOG4717|consen  175 -LTTSCGSLAYSAPEILLGD-SYDAPAVDIWSLGVILYMLVCGQPPFQEANDSETLTMIM  232 (864)
T ss_pred             -hhcccchhhccCchhhhcC-ccCCcchhhhHHHHHHHHHHhCCCccccccchhhhhhhh
Confidence             3667899999999999887 355778999999999999999999999998888765544

>cd05075 PTKc_Axl Catalytic domain of the Protein Tyrosine Kinase, Axl

Probab=99.96  E-value=1.2e-28  Score=239.29  Aligned_cols=172  Identities=31%  Similarity=0.499  Sum_probs=137.7

Q ss_pred             hccccCccCceEEEEEEEcCC-C--EEEEEEeccCC---CCchhhHHHHHHhhccCccceeEEEEEeec-----------
Q 039231          317 FKYKLGQGGYGSVYKGKLLDG-S--NVAVKVLNDSK---GNGKEFINEVASISRTSHVNVVALLGFCLR-----------  379 (506)
Q Consensus       317 ~~~~ig~G~~g~V~~~~~~~~-~--~vavK~l~~~~---~~~~~~~~E~~~l~~l~h~niv~l~g~~~~-----------  379 (506)
                      +.++||+|+||.||+|+..+. .  .+|+|.++...   ...+.+.+|++++++++|+||+++++++..           
T Consensus         3 i~~~ig~G~~g~V~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~   82 (272)
T cd05075           3 LGKTLGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFDHPNVMRLIGVCLQTVESEGYPSPV   82 (272)
T ss_pred             cccccCcccCceEEEeEEccCCCeeeEEEEecccCcCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEccCCcccCCCCcE
Confidence            456799999999999997553 2  68999887542   233578889999999999999999986521           


Q ss_pred             ----------------------------cchhhhHHHHHHHHHHHHhhcCCCCeEecCcCCCcEEECCCCcEEEeecCCC
Q 039231          380 ----------------------------VAEELSSTIGIARGLEYLHLGCSTRILHFDIKPHNILLDEDFCPKISDFGLA  431 (506)
Q Consensus       380 ----------------------------~~~~l~i~~~i~~gl~~LH~~~~~~ivH~dlkp~Nill~~~~~~ki~dfg~a  431 (506)
                                                  +...+.++.|++.||+|||   +++|+||||||+|||+++++.+||+|||++
T Consensus        83 ~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~  159 (272)
T cd05075          83 VILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGMEYLS---SKSFIHRDLAARNCMLNENMNVCVADFGLS  159 (272)
T ss_pred             EEEEeCCCCcHHHHHHHhcccCCcccCCHHHHHHHHHHHHHHHHHHH---HCCeeccccchhheEEcCCCCEEECCCCcc
Confidence                                        1224567889999999999   899999999999999999999999999999


Q ss_pred             ccccCCCcceecccCCCCcccccccccccccCCCCccccHHHHHHHHHHHHc-CCCCCCCCCC
Q 039231          432 KICNRKESIISMTGARGTVGYIAPEVFCRNIGEVSYKSDVYNYGMMIFEMTG-GRKNVDVVDN  493 (506)
Q Consensus       432 ~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~s~~~Dv~s~G~il~ellt-g~~pf~~~~~  493 (506)
                      +...............+++.|+|||.+.+.  .++.++||||||+++|||++ |+.||.....
T Consensus       160 ~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~--~~~~~~Di~slG~il~el~~~g~~p~~~~~~  220 (272)
T cd05075         160 KKIYNGDYYRQGRIAKMPVKWIAIESLADR--VYTTKSDVWSFGVTMWEIATRGQTPYPGVEN  220 (272)
T ss_pred             cccCcccceecCCcccCCcccCCHHHccCC--CcChHHHHHHHHHHHHHHHcCCCCCCCCCCH
Confidence            876543322111233457789999998553  68899999999999999999 8999976543

Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transfor

>cd05049 PTKc_Trk Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases

Probab=99.96  E-value=1.2e-28  Score=240.35  Aligned_cols=178  Identities=27%  Similarity=0.467  Sum_probs=143.0

Q ss_pred             HHhhhccccCccCceEEEEEEEcC------CCEEEEEEeccCCCC--chhhHHHHHHhhccCccceeEEEEEeec-----
Q 039231          313 MTNSFKYKLGQGGYGSVYKGKLLD------GSNVAVKVLNDSKGN--GKEFINEVASISRTSHVNVVALLGFCLR-----  379 (506)
Q Consensus       313 ~~~~~~~~ig~G~~g~V~~~~~~~------~~~vavK~l~~~~~~--~~~~~~E~~~l~~l~h~niv~l~g~~~~-----  379 (506)
                      ..+.+.+.||+|+||.||+|+..+      +..||||+++.....  .+++.+|++++++++|+||+++++++..     
T Consensus         5 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~   84 (280)
T cd05049           5 DTIVLKRELGEGAFGKVFLGECYHLEPENDKELVAVKTLKETASNDARKDFEREAELLTNFQHENIVKFYGVCTEGDPPI   84 (280)
T ss_pred             HHhhHHhhccccCCceEeeeeeccccCcCCcceEEEEeecccCCHHHHHHHHHHHHHHHhcCCCCchheeeEEecCCCeE
Confidence            345566789999999999998643      478999999765433  3678999999999999999999987621     


Q ss_pred             ------------------------------------cchhhhHHHHHHHHHHHHhhcCCCCeEecCcCCCcEEECCCCcE
Q 039231          380 ------------------------------------VAEELSSTIGIARGLEYLHLGCSTRILHFDIKPHNILLDEDFCP  423 (506)
Q Consensus       380 ------------------------------------~~~~l~i~~~i~~gl~~LH~~~~~~ivH~dlkp~Nill~~~~~~  423 (506)
                                                          +.+.+.++.|++.||+|||   +++++||||||+||+++.++.+
T Consensus        85 lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH---~~~i~h~dlkp~nili~~~~~~  161 (280)
T cd05049          85 MVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIASGMVYLA---SQHFVHRDLATRNCLVGYDLVV  161 (280)
T ss_pred             EEEecCCCCCHHHHHHhcCCchhhhcccccccccccHHHHHHHHHHHHHHHHHHh---hCCeeccccccceEEEcCCCeE
Confidence                                                1224567899999999999   8999999999999999999999


Q ss_pred             EEeecCCCccccCCCcceecccCCCCcccccccccccccCCCCccccHHHHHHHHHHHHc-CCCCCCCCCCCc
Q 039231          424 KISDFGLAKICNRKESIISMTGARGTVGYIAPEVFCRNIGEVSYKSDVYNYGMMIFEMTG-GRKNVDVVDNGS  495 (506)
Q Consensus       424 ki~dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~s~~~Dv~s~G~il~ellt-g~~pf~~~~~~~  495 (506)
                      ||+|||+++...............+++.|+|||.+.+  +.++.++||||||+++|||++ |+.||...+..+
T Consensus       162 kl~d~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~--~~~~~~~Di~slG~il~e~~~~g~~p~~~~~~~~  232 (280)
T cd05049         162 KIGDFGMSRDVYTTDYYRVGGHTMLPIRWMPPESIMY--RKFTTESDVWSFGVVLWEIFTYGKQPWYGLSNEE  232 (280)
T ss_pred             EECCcccceecccCcceecCCCCcccceecChhhhcc--CCcchhhhHHHHHHHHHHHHhcCCCCCCCCCHHH
Confidence            9999999976543322111123445788999999865  378999999999999999998 999997655443

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalyt

>cd05054 PTKc_VEGFR Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors

Probab=99.96  E-value=1.3e-28  Score=246.78  Aligned_cols=175  Identities=30%  Similarity=0.517  Sum_probs=140.5

Q ss_pred             HhhhccccCccCceEEEEEEEc------CCCEEEEEEeccCCCC--chhhHHHHHHhhcc-CccceeEEEEEeec-----
Q 039231          314 TNSFKYKLGQGGYGSVYKGKLL------DGSNVAVKVLNDSKGN--GKEFINEVASISRT-SHVNVVALLGFCLR-----  379 (506)
Q Consensus       314 ~~~~~~~ig~G~~g~V~~~~~~------~~~~vavK~l~~~~~~--~~~~~~E~~~l~~l-~h~niv~l~g~~~~-----  379 (506)
                      .+.+.+.||+|+||.||+|+..      .++.||+|+++.....  .+.+.+|++++.++ +|+||+++++++..     
T Consensus         8 ~~~i~~~lG~G~fg~Vy~a~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~E~~~~~~l~~h~niv~~~~~~~~~~~~~   87 (337)
T cd05054           8 RLKLGKPLGRGAFGKVIQASAFGIEKSASCRTVAVKMLKEGATASEYKALMTELKILIHIGHHLNVVNLLGACTKPGGPL   87 (337)
T ss_pred             HhhhhcccccCcCceEEeccccccccccccceeeeeeccCCCCHHHHHHHHHHHHHHHhhccCcchhheeeeEecCCCCE
Confidence            4556678999999999999642      2478999998754322  25678899999999 79999999987632     


Q ss_pred             --------------------------------------------------------------------------------
Q 039231          380 --------------------------------------------------------------------------------  379 (506)
Q Consensus       380 --------------------------------------------------------------------------------  379 (506)
                                                                                                      
T Consensus        88 ~~v~ey~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  167 (337)
T cd05054          88 MVIVEYCKFGNLSNYLRSKRECFSPYRNKSTRKREMKQKEGKKQRLDSVSSSQSSASSGFIEDKSLSDVEEDEEGDELYK  167 (337)
T ss_pred             EEEEecCCCCCHHHHHHhccccccccccccccccccccccccccccccCCccccccccccccCcchhhcccchhhhHHhh
Confidence                                                                                            


Q ss_pred             ----cchhhhHHHHHHHHHHHHhhcCCCCeEecCcCCCcEEECCCCcEEEeecCCCccccCCCcceecccCCCCcccccc
Q 039231          380 ----VAEELSSTIGIARGLEYLHLGCSTRILHFDIKPHNILLDEDFCPKISDFGLAKICNRKESIISMTGARGTVGYIAP  455 (506)
Q Consensus       380 ----~~~~l~i~~~i~~gl~~LH~~~~~~ivH~dlkp~Nill~~~~~~ki~dfg~a~~~~~~~~~~~~~~~~gt~~y~aP  455 (506)
                          +...+.++.||+.||+|||   +.+|+||||||+|||+++++.+||+|||+++...............++..|+||
T Consensus       168 ~~l~~~~~~~~~~qi~~aL~~lH---~~~ivHrDikp~Nill~~~~~vkL~DfG~a~~~~~~~~~~~~~~~~~~~~y~aP  244 (337)
T cd05054         168 EPLTLEDLISYSFQVARGMEFLA---SRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAP  244 (337)
T ss_pred             cCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCcceEEEeCCCcEEEeccccchhcccCcchhhccCCCCCccccCc
Confidence                1123457889999999999   899999999999999999999999999999876443332222345567889999


Q ss_pred             cccccccCCCCccccHHHHHHHHHHHHc-CCCCCCCCCC
Q 039231          456 EVFCRNIGEVSYKSDVYNYGMMIFEMTG-GRKNVDVVDN  493 (506)
Q Consensus       456 E~l~~~~~~~s~~~Dv~s~G~il~ellt-g~~pf~~~~~  493 (506)
                      |++.+.  .++.++|||||||++|||++ |..||.....
T Consensus       245 E~~~~~--~~~~~~Di~SlGv~l~el~t~g~~p~~~~~~  281 (337)
T cd05054         245 ESIFDK--VYTTQSDVWSFGVLLWEIFSLGASPYPGVQI  281 (337)
T ss_pred             HHhcCC--CCCccccHHHHHHHHHHHHHcCCCCCCCCCc
Confidence            998654  78999999999999999997 9999976543

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to recepto

>cd05116 PTKc_Syk Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase

Probab=99.96  E-value=2.7e-28  Score=235.04  Aligned_cols=170  Identities=29%  Similarity=0.494  Sum_probs=138.5

Q ss_pred             ccCccCceEEEEEEEc---CCCEEEEEEeccCCC---CchhhHHHHHHhhccCccceeEEEEEe----------------
Q 039231          320 KLGQGGYGSVYKGKLL---DGSNVAVKVLNDSKG---NGKEFINEVASISRTSHVNVVALLGFC----------------  377 (506)
Q Consensus       320 ~ig~G~~g~V~~~~~~---~~~~vavK~l~~~~~---~~~~~~~E~~~l~~l~h~niv~l~g~~----------------  377 (506)
                      +||+|+||.||+|.++   ++..+|+|+++....   ..+++.+|+.++++++||||+++++++                
T Consensus         2 ~lg~G~~g~v~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~lv~e~~~~~~   81 (257)
T cd05116           2 ELGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNNDPALKDELLREANVMQQLDNPYIVRMIGICEAESWMLVMELAELGP   81 (257)
T ss_pred             cCCCcCCcceEEeEEecCCCceEEEEEEccCCCCcHHHHHHHHHHHHHHHhCCCCCcceEEEEEcCCCcEEEEecCCCCc
Confidence            5899999999999753   478899999865432   236788999999999999999999876                


Q ss_pred             ----------eccchhhhHHHHHHHHHHHHhhcCCCCeEecCcCCCcEEECCCCcEEEeecCCCccccCCCccee-cccC
Q 039231          378 ----------LRVAEELSSTIGIARGLEYLHLGCSTRILHFDIKPHNILLDEDFCPKISDFGLAKICNRKESIIS-MTGA  446 (506)
Q Consensus       378 ----------~~~~~~l~i~~~i~~gl~~LH~~~~~~ivH~dlkp~Nill~~~~~~ki~dfg~a~~~~~~~~~~~-~~~~  446 (506)
                                +++...+.++.|++.||+|||   +++++||||||+||++++++.+||+|||+++.......... ....
T Consensus        82 L~~~l~~~~~~~~~~~~~i~~qi~~al~~lH---~~~i~H~dlkp~nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~  158 (257)
T cd05116          82 LNKFLQKNKHVTEKNITELVHQVSMGMKYLE---ETNFVHRDLAARNVLLVTQHYAKISDFGLSKALGADENYYKAKTHG  158 (257)
T ss_pred             HHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH---HCCEeecccchhhEEEcCCCeEEECCCccccccCCCCCeeeecCCC
Confidence                      223346778999999999999   89999999999999999999999999999987654433211 1223


Q ss_pred             CCCcccccccccccccCCCCccccHHHHHHHHHHHHc-CCCCCCCCCCC
Q 039231          447 RGTVGYIAPEVFCRNIGEVSYKSDVYNYGMMIFEMTG-GRKNVDVVDNG  494 (506)
Q Consensus       447 ~gt~~y~aPE~l~~~~~~~s~~~Dv~s~G~il~ellt-g~~pf~~~~~~  494 (506)
                      .++..|+|||.+..  ..++.++||||||+++|||++ |+.||......
T Consensus       159 ~~~~~y~aPE~~~~--~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~  205 (257)
T cd05116         159 KWPVKWYAPECMNY--YKFSSKSDVWSFGVLMWEAFSYGQKPYKGMKGN  205 (257)
T ss_pred             CCCccccCHhHhcc--CCcCchhHHHHHHHHHHHHHhCCCCCCCCCCHH
Confidence            34678999998854  367889999999999999998 99999876543

Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferatio

>KOG4257 consensus Focal adhesion tyrosine kinase FAK, contains FERM domain [Signal transduction mechanisms]

Probab=99.96  E-value=3.8e-29  Score=249.19  Aligned_cols=188  Identities=27%  Similarity=0.512  Sum_probs=155.3

Q ss_pred             HHHHHHhhhccccCccCceEEEEEEEcC---C--CEEEEEEeccC--CCCchhhHHHHHHhhccCccceeEEEEEeec--
Q 039231          309 DIKKMTNSFKYKLGQGGYGSVYKGKLLD---G--SNVAVKVLNDS--KGNGKEFINEVASISRTSHVNVVALLGFCLR--  379 (506)
Q Consensus       309 el~~~~~~~~~~ig~G~~g~V~~~~~~~---~--~~vavK~l~~~--~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~--  379 (506)
                      +|.++...+.+.||.|-||.||+|...+   |  -.||||.-+.+  ..+.+.|+.|+-+|++++|||||+|+|+|.+  
T Consensus       385 el~Re~Itl~r~iG~GqFGdVy~gvYt~~~kge~iaVAvKtCK~d~t~d~tekflqEa~iMrnfdHphIikLIGv~~e~P  464 (974)
T KOG4257|consen  385 ELRRELITLKRLIGEGQFGDVYKGVYTDPEKGERIAVAVKTCKTDCTPDDTEKFLQEASIMRNFDHPHIIKLIGVCVEQP  464 (974)
T ss_pred             eeehhhccHHHhhcCCcccceeeeEecccccCcceeeeeehhccCCChhhHHHHHHHHHHHHhCCCcchhheeeeeeccc
Confidence            3444444556789999999999998532   3  45889988763  3456789999999999999999999999922  


Q ss_pred             -------------------------cchhhhHHHHHHHHHHHHhhcCCCCeEecCcCCCcEEECCCCcEEEeecCCCccc
Q 039231          380 -------------------------VAEELSSTIGIARGLEYLHLGCSTRILHFDIKPHNILLDEDFCPKISDFGLAKIC  434 (506)
Q Consensus       380 -------------------------~~~~l~i~~~i~~gl~~LH~~~~~~ivH~dlkp~Nill~~~~~~ki~dfg~a~~~  434 (506)
                                               .......+.||..||+|||   +...|||||..+|||+...-.+||+|||+++.+
T Consensus       465 ~WivmEL~~~GELr~yLq~nk~sL~l~tL~ly~~Qi~talaYLe---SkrfVHRDIAaRNiLVsSp~CVKLaDFGLSR~~  541 (974)
T KOG4257|consen  465 MWIVMELAPLGELREYLQQNKDSLPLRTLTLYCYQICTALAYLE---SKRFVHRDIAARNILVSSPQCVKLADFGLSRYL  541 (974)
T ss_pred             eeEEEecccchhHHHHHHhccccchHHHHHHHHHHHHHHHHHHH---hhchhhhhhhhhheeecCcceeeecccchhhhc
Confidence                                     1224457889999999999   999999999999999999999999999999998


Q ss_pred             cCCCcceecccCCCCcccccccccccccCCCCccccHHHHHHHHHHHHc-CCCCCCCCCCCcchhhhhh
Q 039231          435 NRKESIISMTGARGTVGYIAPEVFCRNIGEVSYKSDVYNYGMMIFEMTG-GRKNVDVVDNGSTALDLQA  502 (506)
Q Consensus       435 ~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~s~~~Dv~s~G~il~ellt-g~~pf~~~~~~~~~~~~~~  502 (506)
                      ..+..+.. +....++.|||||.+  +...++.++|||-|||.+||++. |.+||....+.+....|..
T Consensus       542 ed~~yYka-S~~kLPIKWmaPESI--NfRrFTtASDVWMFgVCmWEIl~lGvkPfqgvkNsDVI~~iEn  607 (974)
T KOG4257|consen  542 EDDAYYKA-SRGKLPIKWMAPESI--NFRRFTTASDVWMFGVCMWEILSLGVKPFQGVKNSDVIGHIEN  607 (974)
T ss_pred             cccchhhc-cccccceeecCcccc--chhcccchhhHHHHHHHHHHHHHhcCCccccccccceEEEecC
Confidence            77655433 456678899999998  44589999999999999999986 9999999988887665543

>cd05069 PTKc_Yes Catalytic domain of the Protein Tyrosine Kinase, Yes

Probab=99.96  E-value=2.2e-28  Score=236.01  Aligned_cols=175  Identities=29%  Similarity=0.502  Sum_probs=143.6

Q ss_pred             HhhhccccCccCceEEEEEEEcCCCEEEEEEeccCCCCchhhHHHHHHhhccCccceeEEEEEe----------------
Q 039231          314 TNSFKYKLGQGGYGSVYKGKLLDGSNVAVKVLNDSKGNGKEFINEVASISRTSHVNVVALLGFC----------------  377 (506)
Q Consensus       314 ~~~~~~~ig~G~~g~V~~~~~~~~~~vavK~l~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~----------------  377 (506)
                      .+.+.++||+|++|.||+|....+..+|+|++.......+.+.+|++++++++|+|++++++++                
T Consensus         7 ~~~~~~~ig~g~~~~v~~~~~~~~~~~~lK~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~v~e~~~~~~   86 (260)
T cd05069           7 SLRLDVKLGQGCFGEVWMGTWNGTTKVAIKTLKPGTMMPEAFLQEAQIMKKLRHDKLVPLYAVVSEEPIYIVTEFMGKGS   86 (260)
T ss_pred             HeeeeeeecCcCCCeEEEEEEcCCceEEEEEcccCCccHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCcEEEEEcCCCCC
Confidence            3445678999999999999987777899999876555557789999999999999999998875                


Q ss_pred             ------------eccchhhhHHHHHHHHHHHHhhcCCCCeEecCcCCCcEEECCCCcEEEeecCCCccccCCCcceeccc
Q 039231          378 ------------LRVAEELSSTIGIARGLEYLHLGCSTRILHFDIKPHNILLDEDFCPKISDFGLAKICNRKESIISMTG  445 (506)
Q Consensus       378 ------------~~~~~~l~i~~~i~~gl~~LH~~~~~~ivH~dlkp~Nill~~~~~~ki~dfg~a~~~~~~~~~~~~~~  445 (506)
                                  +++..++.++.|++.||+|||   +.+++|+||||+||++++++.+||+|||+++........ ....
T Consensus        87 L~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH---~~~i~H~dl~~~Nill~~~~~~~l~dfg~~~~~~~~~~~-~~~~  162 (260)
T cd05069          87 LLDFLKEGDGKYLKLPQLVDMAAQIADGMAYIE---RMNYIHRDLRAANILVGDNLVCKIADFGLARLIEDNEYT-ARQG  162 (260)
T ss_pred             HHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHH---hCCEeecccCcceEEEcCCCeEEECCCccceEccCCccc-ccCC
Confidence                        122235678899999999999   899999999999999999999999999999766433221 1123


Q ss_pred             CCCCcccccccccccccCCCCccccHHHHHHHHHHHHc-CCCCCCCCCCC
Q 039231          446 ARGTVGYIAPEVFCRNIGEVSYKSDVYNYGMMIFEMTG-GRKNVDVVDNG  494 (506)
Q Consensus       446 ~~gt~~y~aPE~l~~~~~~~s~~~Dv~s~G~il~ellt-g~~pf~~~~~~  494 (506)
                      ..++..|+|||.+.+  ..++.++||||||+++|||++ |+.||....+.
T Consensus       163 ~~~~~~y~~Pe~~~~--~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~  210 (260)
T cd05069         163 AKFPIKWTAPEAALY--GRFTIKSDVWSFGILLTELVTKGRVPYPGMVNR  210 (260)
T ss_pred             CccchhhCCHHHhcc--CCcChHHHHHHHHHHHHHHHhCCCCCCCCCCHH
Confidence            345678999998854  368899999999999999999 99999765443

Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine an

>cd05043 PTK_Ryk Pseudokinase domain of Ryk (Receptor related to tyrosine kinase)

Probab=99.96  E-value=1.6e-28  Score=239.58  Aligned_cols=176  Identities=26%  Similarity=0.422  Sum_probs=142.9

Q ss_pred             HHhhhccccCccCceEEEEEEEcC-----CCEEEEEEeccCCC--CchhhHHHHHHhhccCccceeEEEEEeec------
Q 039231          313 MTNSFKYKLGQGGYGSVYKGKLLD-----GSNVAVKVLNDSKG--NGKEFINEVASISRTSHVNVVALLGFCLR------  379 (506)
Q Consensus       313 ~~~~~~~~ig~G~~g~V~~~~~~~-----~~~vavK~l~~~~~--~~~~~~~E~~~l~~l~h~niv~l~g~~~~------  379 (506)
                      ..+.+.+.||+|+||.||+|...+     +..|++|++.....  ..+.+.+|+.++++++|+||+++++++..      
T Consensus         6 ~~~~~~~~i~~g~~g~V~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~~   85 (280)
T cd05043           6 DRVTLSDLLQEGTFGRIFYGILIDEKPGKEEEVFVKTVKDHASEIQVTLLLQESCLLYGLSHQNILPILHVCIEDGEPPF   85 (280)
T ss_pred             hheEEeeeecccCCceEEEEEEecCCCCceeEEEEEEccCCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCCCCCE
Confidence            344556789999999999999765     68899999875422  23668899999999999999999997622      


Q ss_pred             ------------------------------cchhhhHHHHHHHHHHHHhhcCCCCeEecCcCCCcEEECCCCcEEEeecC
Q 039231          380 ------------------------------VAEELSSTIGIARGLEYLHLGCSTRILHFDIKPHNILLDEDFCPKISDFG  429 (506)
Q Consensus       380 ------------------------------~~~~l~i~~~i~~gl~~LH~~~~~~ivH~dlkp~Nill~~~~~~ki~dfg  429 (506)
                                                    +...+.++.|++.||+|||   +.+++|+||||+||++++++.+||+|||
T Consensus        86 ~~~~~~~~~~L~~~l~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH---~~~i~H~di~p~nil~~~~~~~kl~d~g  162 (280)
T cd05043          86 VLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIACGMSYLH---KRGVIHKDIAARNCVIDEELQVKITDNA  162 (280)
T ss_pred             EEEEcCCCCcHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHH---HCCEeecccCHhhEEEcCCCcEEECCCC
Confidence                                          1224568889999999999   8999999999999999999999999999


Q ss_pred             CCccccCCCcceecccCCCCcccccccccccccCCCCccccHHHHHHHHHHHHc-CCCCCCCCCC
Q 039231          430 LAKICNRKESIISMTGARGTVGYIAPEVFCRNIGEVSYKSDVYNYGMMIFEMTG-GRKNVDVVDN  493 (506)
Q Consensus       430 ~a~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~s~~~Dv~s~G~il~ellt-g~~pf~~~~~  493 (506)
                      +++.+.............++..|+|||.+.+.  .++.++||||||+++||+++ |+.||...+.
T Consensus       163 ~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~--~~~~~~Di~slG~~l~el~~~g~~p~~~~~~  225 (280)
T cd05043         163 LSRDLFPMDYHCLGDNENRPVKWMALESLVNK--EYSSASDVWSFGVLLWELMTLGQTPYVEIDP  225 (280)
T ss_pred             CcccccCCceEEeCCCCCcchhccCHHHHhcC--CCCchhhHHHhHHHHHHHhcCCCCCcCcCCH
Confidence            99876544332222334567789999998654  68899999999999999999 9999976543

Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It

>KOG4279 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.96  E-value=1.1e-29  Score=255.45  Aligned_cols=169  Identities=31%  Similarity=0.447  Sum_probs=142.0

Q ss_pred             ccCccCceEEEEEEEcC-CCEEEEEEeccC-CCCchhhHHHHHHhhccCccceeEEEEEeec------------------
Q 039231          320 KLGQGGYGSVYKGKLLD-GSNVAVKVLNDS-KGNGKEFINEVASISRTSHVNVVALLGFCLR------------------  379 (506)
Q Consensus       320 ~ig~G~~g~V~~~~~~~-~~~vavK~l~~~-~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~------------------  379 (506)
                      ++|+|.||+||.|++.+ ...+|||.+... ....+.+.+|+...++++|.|||+++|.+-+                  
T Consensus       582 VLGKGTYG~VYA~RD~~tqvrIaIKEIpekdsr~~QPLhEEIaLH~~LrHkNIVrYLGs~senGf~kIFMEqVPGGSLSs  661 (1226)
T KOG4279|consen  582 VLGKGTYGTVYAARDMDTQVRIAIKEIPEKDSREVQPLHEEIALHSTLRHKNIVRYLGSVSENGFFKIFMEQVPGGSLSS  661 (1226)
T ss_pred             EeecCceeEEEeeccccceeEEEeeecccccchhhccHHHHHHHHHHHhhHhHHHHhhccCCCCeEEEEeecCCCCcHHH
Confidence            59999999999999765 667999998653 3445789999999999999999999987611                  


Q ss_pred             ------------cchhhhHHHHHHHHHHHHhhcCCCCeEecCcCCCcEEEC-CCCcEEEeecCCCccccCCCcceecccC
Q 039231          380 ------------VAEELSSTIGIARGLEYLHLGCSTRILHFDIKPHNILLD-EDFCPKISDFGLAKICNRKESIISMTGA  446 (506)
Q Consensus       380 ------------~~~~l~i~~~i~~gl~~LH~~~~~~ivH~dlkp~Nill~-~~~~~ki~dfg~a~~~~~~~~~~~~~~~  446 (506)
                                  +...-....||++||.|||   ++.|||||||-+|+|++ -.|.+||+|||-++.+......  ....
T Consensus       662 LLrskWGPlKDNEstm~fYtkQILeGLkYLH---en~IVHRDIKGDNVLvNTySGvlKISDFGTsKRLAginP~--TETF  736 (1226)
T KOG4279|consen  662 LLRSKWGPLKDNESTMNFYTKQILEGLKYLH---ENKIVHRDIKGDNVLVNTYSGVLKISDFGTSKRLAGINPC--TETF  736 (1226)
T ss_pred             HHHhccCCCccchhHHHHHHHHHHHHhhhhh---hcceeeccccCCcEEEeeccceEEecccccchhhccCCcc--cccc
Confidence                        1113346789999999999   99999999999999995 6789999999999877654432  2457


Q ss_pred             CCCcccccccccccccCCCCccccHHHHHHHHHHHHcCCCCCCCCCC
Q 039231          447 RGTVGYIAPEVFCRNIGEVSYKSDVYNYGMMIFEMTGGRKNVDVVDN  493 (506)
Q Consensus       447 ~gt~~y~aPE~l~~~~~~~s~~~Dv~s~G~il~elltg~~pf~~~~~  493 (506)
                      .||..|||||++......|+.++|||||||.+.||.||++||-....
T Consensus       737 TGTLQYMAPEvIDqG~RGYG~aADIWS~GCT~vEMATGrPPF~Elgs  783 (1226)
T KOG4279|consen  737 TGTLQYMAPEVIDQGPRGYGKAADIWSFGCTMVEMATGRPPFVELGS  783 (1226)
T ss_pred             ccchhhhChHhhccCCcCCCchhhhhhccceeEeeccCCCCeeecCC
Confidence            89999999999977666799999999999999999999999976543

>cd05042 PTKc_Aatyk Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases

Probab=99.96  E-value=2.3e-28  Score=237.07  Aligned_cols=172  Identities=25%  Similarity=0.384  Sum_probs=134.2

Q ss_pred             ccCccCceEEEEEEEcC---CCEEEEEEeccCCC--CchhhHHHHHHhhccCccceeEEEEEee----------------
Q 039231          320 KLGQGGYGSVYKGKLLD---GSNVAVKVLNDSKG--NGKEFINEVASISRTSHVNVVALLGFCL----------------  378 (506)
Q Consensus       320 ~ig~G~~g~V~~~~~~~---~~~vavK~l~~~~~--~~~~~~~E~~~l~~l~h~niv~l~g~~~----------------  378 (506)
                      +||+|+||.||+|+..+   ...+++|.+.....  ....+.+|++.++.++|+||+++++.+.                
T Consensus         2 ~lg~G~fg~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~h~nii~~~~~~~~~~~~~lv~e~~~~g~   81 (269)
T cd05042           2 EIGNGWFGKVLLGEAHRGMSKARVVVKELRASATPDEQLLFLQEVQPYRELNHPNVLQCLGQCIESIPYLLVLEFCPLGD   81 (269)
T ss_pred             cCCccCCceEEEEEEecCCCCeEEEEeecCccCChHHHHHHHHHHHHHHhCCCCCcceEEEEECCCCceEEEEEeCCCCc
Confidence            59999999999997643   35688887764332  2256789999999999999999998761                


Q ss_pred             ----------------ccchhhhHHHHHHHHHHHHhhcCCCCeEecCcCCCcEEECCCCcEEEeecCCCccccCCCccee
Q 039231          379 ----------------RVAEELSSTIGIARGLEYLHLGCSTRILHFDIKPHNILLDEDFCPKISDFGLAKICNRKESIIS  442 (506)
Q Consensus       379 ----------------~~~~~l~i~~~i~~gl~~LH~~~~~~ivH~dlkp~Nill~~~~~~ki~dfg~a~~~~~~~~~~~  442 (506)
                                      ++...+.++.||+.||+|||   +++|+||||||+||++++++.+||+|||+++..........
T Consensus        82 L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH---~~~ivH~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~~~~  158 (269)
T cd05042          82 LKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLH---QADFIHSDLALRNCQLTADLSVKIGDYGLALEQYPEDYYIT  158 (269)
T ss_pred             HHHHHHhccccccccccHHHHHHHHHHHHHHHHHHH---hcCEecccccHhheEecCCCcEEEeccccccccccchheec
Confidence                            11224568899999999999   89999999999999999999999999999875443322222


Q ss_pred             cccCCCCcccccccccccc-----cCCCCccccHHHHHHHHHHHHc-CCCCCCCCCCC
Q 039231          443 MTGARGTVGYIAPEVFCRN-----IGEVSYKSDVYNYGMMIFEMTG-GRKNVDVVDNG  494 (506)
Q Consensus       443 ~~~~~gt~~y~aPE~l~~~-----~~~~s~~~Dv~s~G~il~ellt-g~~pf~~~~~~  494 (506)
                      .....+++.|+|||++...     ...++.++||||||+++|||++ |+.||....+.
T Consensus       159 ~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~  216 (269)
T cd05042         159 KDCHAVPLRWLAPELVEIRGQDLLPKDQTKKSNIWSLGVTMWELFTAADQPYPDLSDE  216 (269)
T ss_pred             cCCCCCcccccCHHHHhhccccccccccchhhHHHHHHHHHHHHHhCCCCCCCcCCHH
Confidence            2334457789999987431     1256889999999999999998 88899766543

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kina

>cd05048 PTKc_Ror Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors

Probab=99.96  E-value=1.8e-28  Score=239.53  Aligned_cols=175  Identities=32%  Similarity=0.550  Sum_probs=140.2

Q ss_pred             hhccccCccCceEEEEEEEcC------CCEEEEEEeccCCC--CchhhHHHHHHhhccCccceeEEEEEeec--------
Q 039231          316 SFKYKLGQGGYGSVYKGKLLD------GSNVAVKVLNDSKG--NGKEFINEVASISRTSHVNVVALLGFCLR--------  379 (506)
Q Consensus       316 ~~~~~ig~G~~g~V~~~~~~~------~~~vavK~l~~~~~--~~~~~~~E~~~l~~l~h~niv~l~g~~~~--------  379 (506)
                      .+.+.||+|+||.||+|....      ...||+|.++....  ...++.+|++.+.+++||||+++++++..        
T Consensus         8 ~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~v~~K~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~   87 (283)
T cd05048           8 RFLEELGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEPKVQQEFRQEAELMSDLQHPNIVCLLGVCTKEQPTCMLF   87 (283)
T ss_pred             chhhcccCccCCcEEEEEEecCCCCcceeeEEEEecccCCCHHHHHHHHHHHHHHHhcCCcccceEEEEEcCCCceEEEE
Confidence            345679999999999998643      25799999875432  23568899999999999999999987621        


Q ss_pred             -----------------------------------cchhhhHHHHHHHHHHHHhhcCCCCeEecCcCCCcEEECCCCcEE
Q 039231          380 -----------------------------------VAEELSSTIGIARGLEYLHLGCSTRILHFDIKPHNILLDEDFCPK  424 (506)
Q Consensus       380 -----------------------------------~~~~l~i~~~i~~gl~~LH~~~~~~ivH~dlkp~Nill~~~~~~k  424 (506)
                                                         +.+.+.++.|++.||+|||   +.+++|+||||+||++++++.+|
T Consensus        88 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~al~~lH---~~~i~H~dlkp~Nil~~~~~~~~  164 (283)
T cd05048          88 EYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAIQIAAGMEYLS---SHHFVHRDLAARNCLVGEGLTVK  164 (283)
T ss_pred             ecCCCCcHHHHHHhcCCCcccccccccccccCCCCHHHHHHHHHHHHHHHHHHH---hCCeeccccccceEEEcCCCcEE
Confidence                                               1123568999999999999   89999999999999999999999


Q ss_pred             EeecCCCccccCCCcceecccCCCCcccccccccccccCCCCccccHHHHHHHHHHHHc-CCCCCCCCCCCc
Q 039231          425 ISDFGLAKICNRKESIISMTGARGTVGYIAPEVFCRNIGEVSYKSDVYNYGMMIFEMTG-GRKNVDVVDNGS  495 (506)
Q Consensus       425 i~dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~s~~~Dv~s~G~il~ellt-g~~pf~~~~~~~  495 (506)
                      |+|||+++...............+++.|+|||.+.+  +.++.++||||||+++|||++ |..||......+
T Consensus       165 L~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~--~~~~~~sDv~slG~il~el~~~g~~p~~~~~~~~  234 (283)
T cd05048         165 ISDFGLSRDIYSADYYRVQSKSLLPVRWMPPEAILY--GKFTTESDIWSFGVVLWEIFSYGLQPYYGFSNQE  234 (283)
T ss_pred             ECCCcceeeccccccccccCCCcccccccCHHHhcc--CcCchhhhHHHHHHHHHHHHcCCCCCCCCCCHHH
Confidence            999999986544332222233456788999999854  378999999999999999998 999998765544

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimer

>cd06619 PKc_MKK5 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5

Probab=99.96  E-value=3.8e-28  Score=237.05  Aligned_cols=167  Identities=27%  Similarity=0.407  Sum_probs=140.1

Q ss_pred             hccccCccCceEEEEEEE-cCCCEEEEEEeccCCC--CchhhHHHHHHhhccCccceeEEEEEee---------------
Q 039231          317 FKYKLGQGGYGSVYKGKL-LDGSNVAVKVLNDSKG--NGKEFINEVASISRTSHVNVVALLGFCL---------------  378 (506)
Q Consensus       317 ~~~~ig~G~~g~V~~~~~-~~~~~vavK~l~~~~~--~~~~~~~E~~~l~~l~h~niv~l~g~~~---------------  378 (506)
                      +.+.||+|++|.||+|+. .+++.+|+|++.....  ..+++.+|++++.+++||||+++++.+.               
T Consensus         5 ~~~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~   84 (279)
T cd06619           5 YQEILGHGNGGTVYKAYHLLTRRILAVKVIPLDITVELQKQIMSELEILYKCDSPYIIGFYGAFFVENRISICTEFMDGG   84 (279)
T ss_pred             heeeeccCCCeEEEEEEEcCCCcEEEEEEEecCCChHHHHHHHHHHHHHHhCCCCCeeeEEEEEEECCEEEEEEecCCCC
Confidence            346799999999999986 4588999999865422  2357889999999999999999998762               


Q ss_pred             --------ccchhhhHHHHHHHHHHHHhhcCCCCeEecCcCCCcEEECCCCcEEEeecCCCccccCCCcceecccCCCCc
Q 039231          379 --------RVAEELSSTIGIARGLEYLHLGCSTRILHFDIKPHNILLDEDFCPKISDFGLAKICNRKESIISMTGARGTV  450 (506)
Q Consensus       379 --------~~~~~l~i~~~i~~gl~~LH~~~~~~ivH~dlkp~Nill~~~~~~ki~dfg~a~~~~~~~~~~~~~~~~gt~  450 (506)
                              ++.....++.|++.||+|||   +.+|+|+||||+||+++.++.+||+|||++.......    .....++.
T Consensus        85 ~l~~~~~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dlkp~Nill~~~~~~~l~dfg~~~~~~~~~----~~~~~~~~  157 (279)
T cd06619          85 SLDVYRKIPEHVLGRIAVAVVKGLTYLW---SLKILHRDVKPSNMLVNTRGQVKLCDFGVSTQLVNSI----AKTYVGTN  157 (279)
T ss_pred             ChHHhhcCCHHHHHHHHHHHHHHHHHHH---HCCEeeCCCCHHHEEECCCCCEEEeeCCcceeccccc----ccCCCCCh
Confidence                    22235678999999999999   8999999999999999999999999999997654322    13457899


Q ss_pred             ccccccccccccCCCCccccHHHHHHHHHHHHcCCCCCCCCC
Q 039231          451 GYIAPEVFCRNIGEVSYKSDVYNYGMMIFEMTGGRKNVDVVD  492 (506)
Q Consensus       451 ~y~aPE~l~~~~~~~s~~~Dv~s~G~il~elltg~~pf~~~~  492 (506)
                      .|+|||.+.+.  .++.++||||||+++|||++|+.||....
T Consensus       158 ~y~aPE~~~~~--~~~~~~DvwslG~~l~~l~~g~~pf~~~~  197 (279)
T cd06619         158 AYMAPERISGE--QYGIHSDVWSLGISFMELALGRFPYPQIQ  197 (279)
T ss_pred             hhcCceeecCC--CCCCcchHHHHHHHHHHHHhCCCCchhhc
Confidence            99999998654  68899999999999999999999997643

Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that p

>KOG0986 consensus G protein-coupled receptor kinase [Signal transduction mechanisms]

Probab=99.96  E-value=3.5e-29  Score=241.58  Aligned_cols=170  Identities=31%  Similarity=0.449  Sum_probs=146.3

Q ss_pred             cccCccCceEEEEEEEc-CCCEEEEEEeccC----CCCchhhHHHHHHhhccCccceeEEEEEe----------------
Q 039231          319 YKLGQGGYGSVYKGKLL-DGSNVAVKVLNDS----KGNGKEFINEVASISRTSHVNVVALLGFC----------------  377 (506)
Q Consensus       319 ~~ig~G~~g~V~~~~~~-~~~~vavK~l~~~----~~~~~~~~~E~~~l~~l~h~niv~l~g~~----------------  377 (506)
                      ++||+|+||.||-.+.+ .|+.+|.|++.+.    +....-.++|-.+|++++.+-||.+-..+                
T Consensus       191 RvlGkGGFGEV~acqvraTGKMYAcKkL~KKRiKkr~ge~maLnEk~iL~kV~s~FiVslaYAfeTkd~LClVLtlMNGG  270 (591)
T KOG0986|consen  191 RVLGKGGFGEVCACQVRATGKMYACKKLDKKRIKKRKGETMALNEKQILEKVSSPFIVSLAYAFETKDALCLVLTLMNGG  270 (591)
T ss_pred             EEEecccccceeEEEEecchhhHHHHHHHHHHHHHhhhhHHhhHHHHHHHHhccCcEEEEeeeecCCCceEEEEEeecCC
Confidence            57999999999999875 4999999998643    22334568899999999999999886444                


Q ss_pred             -------------eccchhhhHHHHHHHHHHHHhhcCCCCeEecCcCCCcEEECCCCcEEEeecCCCccccCCCcceecc
Q 039231          378 -------------LRVAEELSSTIGIARGLEYLHLGCSTRILHFDIKPHNILLDEDFCPKISDFGLAKICNRKESIISMT  444 (506)
Q Consensus       378 -------------~~~~~~l~i~~~i~~gl~~LH~~~~~~ivH~dlkp~Nill~~~~~~ki~dfg~a~~~~~~~~~~~~~  444 (506)
                                   +++..++..+.+|+.||++||   +.+||+|||||+|||||+.|+++|+|+|+|..+...+..   .
T Consensus       271 DLkfHiyn~g~~gF~e~ra~FYAAEi~cGLehlH---~~~iVYRDLKPeNILLDd~GhvRISDLGLAvei~~g~~~---~  344 (591)
T KOG0986|consen  271 DLKFHIYNHGNPGFDEQRARFYAAEIICGLEHLH---RRRIVYRDLKPENILLDDHGHVRISDLGLAVEIPEGKPI---R  344 (591)
T ss_pred             ceeEEeeccCCCCCchHHHHHHHHHHHhhHHHHH---hcceeeccCChhheeeccCCCeEeeccceEEecCCCCcc---c
Confidence                         556667889999999999999   999999999999999999999999999999998877754   4


Q ss_pred             cCCCCcccccccccccccCCCCccccHHHHHHHHHHHHcCCCCCCCCCCCcc
Q 039231          445 GARGTVGYIAPEVFCRNIGEVSYKSDVYNYGMMIFEMTGGRKNVDVVDNGST  496 (506)
Q Consensus       445 ~~~gt~~y~aPE~l~~~~~~~s~~~Dv~s~G~il~elltg~~pf~~~~~~~~  496 (506)
                      ..+||.+|||||++.+.  .|+...|+||+||+||||+.|+.||....+...
T Consensus       345 ~rvGT~GYMAPEvl~ne--~Y~~s~Dwf~lGCllYemi~G~sPFr~~KeKvk  394 (591)
T KOG0986|consen  345 GRVGTVGYMAPEVLQNE--VYDFSPDWFSLGCLLYEMIAGHSPFRQRKEKVK  394 (591)
T ss_pred             cccCcccccCHHHHcCC--cccCCccHHHHHhHHHHHHcccCchhhhhhhhh
Confidence            45899999999999665  699999999999999999999999987655433

>cd05090 PTKc_Ror1 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1

Probab=99.96  E-value=2.1e-28  Score=239.31  Aligned_cols=174  Identities=30%  Similarity=0.470  Sum_probs=139.2

Q ss_pred             hhhccccCccCceEEEEEEE-----cCCCEEEEEEeccCCCC--chhhHHHHHHhhccCccceeEEEEEeec--------
Q 039231          315 NSFKYKLGQGGYGSVYKGKL-----LDGSNVAVKVLNDSKGN--GKEFINEVASISRTSHVNVVALLGFCLR--------  379 (506)
Q Consensus       315 ~~~~~~ig~G~~g~V~~~~~-----~~~~~vavK~l~~~~~~--~~~~~~E~~~l~~l~h~niv~l~g~~~~--------  379 (506)
                      ..+.++||+|+||.||+|+.     ..+..+++|.+......  ..++.+|++++++++||||+++++++..        
T Consensus         7 ~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~   86 (283)
T cd05090           7 VRFMEELGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDINNPQQWGEFQQEASLMAELHHPNIVCLLGVVTQEQPVCMLF   86 (283)
T ss_pred             ceeeeeccccCCcceEEEEEecCCCCCcceEEEEeccCCCCHHHHHHHHHHHHHHhhCCCCCeeeEEEEEecCCceEEEE
Confidence            34567899999999999985     24678999999753322  2568899999999999999999987511        


Q ss_pred             ------------------------------------cchhhhHHHHHHHHHHHHhhcCCCCeEecCcCCCcEEECCCCcE
Q 039231          380 ------------------------------------VAEELSSTIGIARGLEYLHLGCSTRILHFDIKPHNILLDEDFCP  423 (506)
Q Consensus       380 ------------------------------------~~~~l~i~~~i~~gl~~LH~~~~~~ivH~dlkp~Nill~~~~~~  423 (506)
                                                          +.+.+.++.|++.||+|||   +++++|+||||+||++++++.+
T Consensus        87 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH---~~~i~H~dlkp~nili~~~~~~  163 (283)
T cd05090          87 EYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAIQIAAGMEYLS---SHFFVHKDLAARNILIGEQLHV  163 (283)
T ss_pred             EcCCCCcHHHHHHhcCCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHH---hcCeehhccccceEEEcCCCcE
Confidence                                                1123558899999999999   8999999999999999999999


Q ss_pred             EEeecCCCccccCCCcceecccCCCCcccccccccccccCCCCccccHHHHHHHHHHHHc-CCCCCCCCCC
Q 039231          424 KISDFGLAKICNRKESIISMTGARGTVGYIAPEVFCRNIGEVSYKSDVYNYGMMIFEMTG-GRKNVDVVDN  493 (506)
Q Consensus       424 ki~dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~s~~~Dv~s~G~il~ellt-g~~pf~~~~~  493 (506)
                      ||+|||+++...............++..|+|||.+.+.  .++.++||||||+++|||++ |..||.....
T Consensus       164 kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~--~~~~~~Dv~slG~il~el~~~g~~p~~~~~~  232 (283)
T cd05090         164 KISDLGLSREIYSADYYRVQPKSLLPIRWMPPEAIMYG--KFSSDSDIWSFGVVLWEIFSFGLQPYYGFSN  232 (283)
T ss_pred             EeccccccccccCCcceecccCCCccceecChHHhccC--CCCchhhhHHHHHHHHHHHcCCCCCCCCCCH
Confidence            99999999866443322222334457789999998543  68899999999999999998 9999976543

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly

>cd05632 STKc_GRK5 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5

Probab=99.96  E-value=2.9e-28  Score=238.64  Aligned_cols=168  Identities=32%  Similarity=0.429  Sum_probs=139.0

Q ss_pred             ccccCccCceEEEEEEEc-CCCEEEEEEeccCCC----CchhhHHHHHHhhccCccceeEEEEEe---------------
Q 039231          318 KYKLGQGGYGSVYKGKLL-DGSNVAVKVLNDSKG----NGKEFINEVASISRTSHVNVVALLGFC---------------  377 (506)
Q Consensus       318 ~~~ig~G~~g~V~~~~~~-~~~~vavK~l~~~~~----~~~~~~~E~~~l~~l~h~niv~l~g~~---------------  377 (506)
                      .+.||+|+||+||+|+.. +++.+|+|.+.....    ....+.+|++++++++|+||+++.+.+               
T Consensus         5 ~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~   84 (285)
T cd05632           5 YRVLGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQFVVNLAYAYETKDALCLVLTIMNG   84 (285)
T ss_pred             EEEEecCCCeEEEEEEECCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHHcCCcCceeEEEEEecCCEEEEEEEeccC
Confidence            357999999999999874 588999999865321    224578899999999999999998765               


Q ss_pred             --------------eccchhhhHHHHHHHHHHHHhhcCCCCeEecCcCCCcEEECCCCcEEEeecCCCccccCCCcceec
Q 039231          378 --------------LRVAEELSSTIGIARGLEYLHLGCSTRILHFDIKPHNILLDEDFCPKISDFGLAKICNRKESIISM  443 (506)
Q Consensus       378 --------------~~~~~~l~i~~~i~~gl~~LH~~~~~~ivH~dlkp~Nill~~~~~~ki~dfg~a~~~~~~~~~~~~  443 (506)
                                    +++...+.++.|++.||.|||   +++|+||||||+||++++++.+||+|||++........   .
T Consensus        85 ~~L~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH---~~~iiH~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~~---~  158 (285)
T cd05632          85 GDLKFHIYNMGNPGFEEERALFYAAEILCGLEDLH---RENTVYRDLKPENILLDDYGHIRISDLGLAVKIPEGES---I  158 (285)
T ss_pred             ccHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH---hCCeeecCCCHHHEEECCCCCEEEecCCcceecCCCCc---c
Confidence                          123345678899999999999   89999999999999999999999999999976543222   1


Q ss_pred             ccCCCCcccccccccccccCCCCccccHHHHHHHHHHHHcCCCCCCCCCC
Q 039231          444 TGARGTVGYIAPEVFCRNIGEVSYKSDVYNYGMMIFEMTGGRKNVDVVDN  493 (506)
Q Consensus       444 ~~~~gt~~y~aPE~l~~~~~~~s~~~Dv~s~G~il~elltg~~pf~~~~~  493 (506)
                      ....|+..|+|||.+.+.  .++.++|+||||+++|||++|+.||....+
T Consensus       159 ~~~~g~~~~~aPE~~~~~--~~~~~~Di~slG~~l~~l~~g~~P~~~~~~  206 (285)
T cd05632         159 RGRVGTVGYMAPEVLNNQ--RYTLSPDYWGLGCLIYEMIEGQSPFRGRKE  206 (285)
T ss_pred             cCCCCCcCccChHHhcCC--CCCcccchHHHHHHHHHHHhCCCCCCCCCH
Confidence            345689999999998653  688999999999999999999999986544

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with

>cd07873 STKc_PCTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase

Probab=99.96  E-value=2.4e-28  Score=241.07  Aligned_cols=171  Identities=29%  Similarity=0.428  Sum_probs=139.8

Q ss_pred             hccccCccCceEEEEEEEc-CCCEEEEEEeccCC--CCchhhHHHHHHhhccCccceeEEEEEee---------------
Q 039231          317 FKYKLGQGGYGSVYKGKLL-DGSNVAVKVLNDSK--GNGKEFINEVASISRTSHVNVVALLGFCL---------------  378 (506)
Q Consensus       317 ~~~~ig~G~~g~V~~~~~~-~~~~vavK~l~~~~--~~~~~~~~E~~~l~~l~h~niv~l~g~~~---------------  378 (506)
                      +.++||+|+||.||+|+.. +++.||+|.++...  .....+.+|++++++++||||+++++++.               
T Consensus        10 ~~~~lg~g~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~nI~~~~~~~~~~~~~~lv~e~~~~~   89 (301)
T cd07873          10 KLDKLGEGTYATVYKGRSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTLVFEYLDKD   89 (301)
T ss_pred             EeeEeccCcCEEEEEEEEcCCCcEEEEEEEecccccCchhHHHHHHHHHHhcCCCCcceEEEEEecCCeEEEEEeccccC
Confidence            3467999999999999875 47899999986432  23356789999999999999999998762               


Q ss_pred             ------------ccchhhhHHHHHHHHHHHHhhcCCCCeEecCcCCCcEEECCCCcEEEeecCCCccccCCCcceecccC
Q 039231          379 ------------RVAEELSSTIGIARGLEYLHLGCSTRILHFDIKPHNILLDEDFCPKISDFGLAKICNRKESIISMTGA  446 (506)
Q Consensus       379 ------------~~~~~l~i~~~i~~gl~~LH~~~~~~ivH~dlkp~Nill~~~~~~ki~dfg~a~~~~~~~~~~~~~~~  446 (506)
                                  .+.....++.|++.||+|||   +.+++|+||||+||++++++.+||+|||++........  .....
T Consensus        90 l~~~l~~~~~~~~~~~~~~~~~qi~~aL~~lH---~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~--~~~~~  164 (301)
T cd07873          90 LKQYLDDCGNSINMHNVKLFLFQLLRGLNYCH---RRKVLHRDLKPQNLLINERGELKLADFGLARAKSIPTK--TYSNE  164 (301)
T ss_pred             HHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH---hCCeeCCCCCHHHEEECCCCcEEECcCcchhccCCCCC--ccccc
Confidence                        12235568899999999999   89999999999999999999999999999976433221  11334


Q ss_pred             CCCcccccccccccccCCCCccccHHHHHHHHHHHHcCCCCCCCCCC
Q 039231          447 RGTVGYIAPEVFCRNIGEVSYKSDVYNYGMMIFEMTGGRKNVDVVDN  493 (506)
Q Consensus       447 ~gt~~y~aPE~l~~~~~~~s~~~Dv~s~G~il~elltg~~pf~~~~~  493 (506)
                      .+++.|+|||.+.+. ..++.++||||||+++|||++|+.||...+.
T Consensus       165 ~~~~~y~~PE~~~~~-~~~~~~~Dv~slG~~l~el~tg~~~f~~~~~  210 (301)
T cd07873         165 VVTLWYRPPDILLGS-TDYSTQIDMWGVGCIFYEMSTGRPLFPGSTV  210 (301)
T ss_pred             ceeecccCcHHHhCC-CCCccHHHHHHHHHHHHHHHhCCCCCCCCCH
Confidence            568899999998653 3578899999999999999999999986554

Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may pl

>PRK13184 pknD serine/threonine-protein kinase; Reviewed

Probab=99.95  E-value=2.7e-28  Score=263.94  Aligned_cols=172  Identities=27%  Similarity=0.329  Sum_probs=139.2

Q ss_pred             hccccCccCceEEEEEEEc-CCCEEEEEEeccCCC----CchhhHHHHHHhhccCccceeEEEEEeecc-----------
Q 039231          317 FKYKLGQGGYGSVYKGKLL-DGSNVAVKVLNDSKG----NGKEFINEVASISRTSHVNVVALLGFCLRV-----------  380 (506)
Q Consensus       317 ~~~~ig~G~~g~V~~~~~~-~~~~vavK~l~~~~~----~~~~~~~E~~~l~~l~h~niv~l~g~~~~~-----------  380 (506)
                      +.++||+|+||.||+|+.. .++.||+|++.....    ..+++.+|++++++++||||+++++++.+.           
T Consensus         6 Ii~~LGkGgfG~VYlA~d~~tg~~VAIK~I~~~l~~~e~~~~rflrEi~ILs~L~HPNIVkl~~v~~d~~~lyLVMEY~e   85 (932)
T PRK13184          6 IIRLIGKGGMGEVYLAYDPVCSRRVALKKIREDLSENPLLKKRFLREAKIAADLIHPGIVPVYSICSDGDPVYYTMPYIE   85 (932)
T ss_pred             EEEEEecCCCEEEEEEEECCCCcEEEEEEECcccccCHHHHHHHHHHHHHHHhCCCcCcCeEEEEEeeCCEEEEEEEcCC
Confidence            3468999999999999875 489999999975322    235688999999999999999999876110           


Q ss_pred             ---------------------------chhhhHHHHHHHHHHHHhhcCCCCeEecCcCCCcEEECCCCcEEEeecCCCcc
Q 039231          381 ---------------------------AEELSSTIGIARGLEYLHLGCSTRILHFDIKPHNILLDEDFCPKISDFGLAKI  433 (506)
Q Consensus       381 ---------------------------~~~l~i~~~i~~gl~~LH~~~~~~ivH~dlkp~Nill~~~~~~ki~dfg~a~~  433 (506)
                                                 ...+.++.||++||+|||   +++|+||||||+||+++.++.+||+|||+++.
T Consensus        86 GGSL~~lL~s~~~~~~l~e~~~~~lsv~~iL~I~~QIa~AL~yLH---s~GIIHRDLKPeNILLd~dg~vKLiDFGLAk~  162 (932)
T PRK13184         86 GYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKICATIEYVH---SKGVLHRDLKPDNILLGLFGEVVILDWGAAIF  162 (932)
T ss_pred             CCCHHHHHHHhhhccccchhhhcccCHHHHHHHHHHHHHHHHHHH---HCCccccCCchheEEEcCCCCEEEEecCccee
Confidence                                       123567889999999999   89999999999999999999999999999986


Q ss_pred             ccCCCcc----------------eecccCCCCcccccccccccccCCCCccccHHHHHHHHHHHHcCCCCCCCCCC
Q 039231          434 CNRKESI----------------ISMTGARGTVGYIAPEVFCRNIGEVSYKSDVYNYGMMIFEMTGGRKNVDVVDN  493 (506)
Q Consensus       434 ~~~~~~~----------------~~~~~~~gt~~y~aPE~l~~~~~~~s~~~Dv~s~G~il~elltg~~pf~~~~~  493 (506)
                      .......                .......||+.|+|||.+.+.  .++.++|||||||++|||++|+.||...+.
T Consensus       163 i~~~~~~~~~l~~~~~~s~~s~~t~~g~~vGT~~YmAPE~l~g~--~~S~kSDIWSLGVILyELLTG~~PF~~~~~  236 (932)
T PRK13184        163 KKLEEEDLLDIDVDERNICYSSMTIPGKIVGTPDYMAPERLLGV--PASESTDIYALGVILYQMLTLSFPYRRKKG  236 (932)
T ss_pred             cccccccccccccccccccccccccCCCCCCCCCCCCHHHhcCC--CCCcHhHHHHHHHHHHHHHHCCCCCCCcch
Confidence            6211100                001124689999999998654  689999999999999999999999976443

>PTZ00266 NIMA-related protein kinase; Provisional

Probab=99.95  E-value=1.5e-28  Score=266.97  Aligned_cols=182  Identities=25%  Similarity=0.362  Sum_probs=141.9

Q ss_pred             HHHHHHhhhccccCccCceEEEEEEEcC-CCEEEEEEeccCC---CCchhhHHHHHHhhccCccceeEEEEEeec-----
Q 039231          309 DIKKMTNSFKYKLGQGGYGSVYKGKLLD-GSNVAVKVLNDSK---GNGKEFINEVASISRTSHVNVVALLGFCLR-----  379 (506)
Q Consensus       309 el~~~~~~~~~~ig~G~~g~V~~~~~~~-~~~vavK~l~~~~---~~~~~~~~E~~~l~~l~h~niv~l~g~~~~-----  379 (506)
                      ++....+.+.++||+|+||.||+|+... +..+|+|++....   .....+..|+.++++++|||||++++++..     
T Consensus         9 e~~l~~YeIl~kLG~GgFGtVYLAkdk~tg~~vAlKvIk~~~l~e~~~~~~~~EI~IL~~L~HPNIVrl~d~f~de~~~~   88 (1021)
T PTZ00266          9 ESRLNEYEVIKKIGNGRFGEVFLVKHKRTQEFFCWKAISYRGLKEREKSQLVIEVNVMRELKHKNIVRYIDRFLNKANQK   88 (1021)
T ss_pred             ccccCCEEEEEEEecCCCeEEEEEEECCCCeEEEEEEEeccccCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEecCCCE
Confidence            3333344556789999999999998754 7789999986432   223568899999999999999999986521     


Q ss_pred             ----------------------------cchhhhHHHHHHHHHHHHhhcC----CCCeEecCcCCCcEEECC--------
Q 039231          380 ----------------------------VAEELSSTIGIARGLEYLHLGC----STRILHFDIKPHNILLDE--------  419 (506)
Q Consensus       380 ----------------------------~~~~l~i~~~i~~gl~~LH~~~----~~~ivH~dlkp~Nill~~--------  419 (506)
                                                  +...+.|+.||+.||+|||...    .++|+||||||+||||+.        
T Consensus        89 lyIVMEY~~gGSL~~lL~k~~~~~g~L~E~~Il~Ia~QIL~ALaYLHs~g~~~~~k~IVHRDLKPeNILL~s~~~~lg~i  168 (1021)
T PTZ00266         89 LYILMEFCDAGDLSRNIQKCYKMFGKIEEHAIVDITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIGKI  168 (1021)
T ss_pred             EEEEEeCCCCCcHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhcccccccCCceeccCcHHHeEeecCccccccc
Confidence                                        1224668899999999999321    146999999999999964        


Q ss_pred             ---------CCcEEEeecCCCccccCCCcceecccCCCCcccccccccccccCCCCccccHHHHHHHHHHHHcCCCCCCC
Q 039231          420 ---------DFCPKISDFGLAKICNRKESIISMTGARGTVGYIAPEVFCRNIGEVSYKSDVYNYGMMIFEMTGGRKNVDV  490 (506)
Q Consensus       420 ---------~~~~ki~dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~s~~~Dv~s~G~il~elltg~~pf~~  490 (506)
                               ...+||+|||+++.......   .....||+.|+|||++......++.++|||||||+||||++|+.||..
T Consensus       169 ~~~~~n~ng~~iVKLsDFGlAr~l~~~s~---~~s~vGTp~YmAPEvL~ge~~~~s~KSDVWSLG~ILYELLTGk~PF~~  245 (1021)
T PTZ00266        169 TAQANNLNGRPIAKIGDFGLSKNIGIESM---AHSCVGTPYYWSPELLLHETKSYDDKSDMWALGCIIYELCSGKTPFHK  245 (1021)
T ss_pred             cccccccCCCCceEEccCCcccccccccc---ccccCCCccccCHHHHhccCCCCCchhHHHHHHHHHHHHHHCCCCCCc
Confidence                     23589999999986643322   134578999999999865445688999999999999999999999976


Q ss_pred             CCC
Q 039231          491 VDN  493 (506)
Q Consensus       491 ~~~  493 (506)
                      .+.
T Consensus       246 ~~~  248 (1021)
T PTZ00266        246 ANN  248 (1021)
T ss_pred             CCc
Confidence            544

>PHA02882 putative serine/threonine kinase; Provisional

Probab=99.95  E-value=1.9e-28  Score=241.12  Aligned_cols=176  Identities=22%  Similarity=0.258  Sum_probs=131.6

Q ss_pred             HhhhccccCccCceEEEEEEEcC----CCEEEEEEeccCCCCc------------hhhHHHHHHhhccCccceeEEEEEe
Q 039231          314 TNSFKYKLGQGGYGSVYKGKLLD----GSNVAVKVLNDSKGNG------------KEFINEVASISRTSHVNVVALLGFC  377 (506)
Q Consensus       314 ~~~~~~~ig~G~~g~V~~~~~~~----~~~vavK~l~~~~~~~------------~~~~~E~~~l~~l~h~niv~l~g~~  377 (506)
                      .+.+.++||+|+||.||+|+..+    +..+|+|+........            .....+...+..++|+||+++++++
T Consensus        13 ~y~i~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~k~~~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~~   92 (294)
T PHA02882         13 EWKIDKLIGCGGFGCVYETQCASDHCINNQAVAKIENLENETIVMETLVYNNIYDIDKIALWKNIHNIDHLGIPKYYGCG   92 (294)
T ss_pred             ceEEeeEEecCCCceEEEEEEcCCcccccceEEEeccccCCchhhHHHHHHhhhhHHHHHHHHHhccCCCCCCCcEEEee
Confidence            34456789999999999998754    3456666543222111            1122344556677899999988753


Q ss_pred             e------------------------------ccchhhhHHHHHHHHHHHHhhcCCCCeEecCcCCCcEEECCCCcEEEee
Q 039231          378 L------------------------------RVAEELSSTIGIARGLEYLHLGCSTRILHFDIKPHNILLDEDFCPKISD  427 (506)
Q Consensus       378 ~------------------------------~~~~~l~i~~~i~~gl~~LH~~~~~~ivH~dlkp~Nill~~~~~~ki~d  427 (506)
                      .                              .+...+.++.|++.||+|||   +++|+||||||+|||++.++.+||+|
T Consensus        93 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH---~~~iiHrDiKp~Nill~~~~~~~l~D  169 (294)
T PHA02882         93 SFKRCRMYYRFILLEKLVENTKEIFKRIKCKNKKLIKNIMKDMLTTLEYIH---EHGISHGDIKPENIMVDGNNRGYIID  169 (294)
T ss_pred             eEecCCceEEEEEEehhccCHHHHHHhhccCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEEcCCCcEEEEE
Confidence            1                              11224568999999999999   89999999999999999999999999


Q ss_pred             cCCCccccCCCcce-----ecccCCCCcccccccccccccCCCCccccHHHHHHHHHHHHcCCCCCCCCCCC
Q 039231          428 FGLAKICNRKESII-----SMTGARGTVGYIAPEVFCRNIGEVSYKSDVYNYGMMIFEMTGGRKNVDVVDNG  494 (506)
Q Consensus       428 fg~a~~~~~~~~~~-----~~~~~~gt~~y~aPE~l~~~~~~~s~~~Dv~s~G~il~elltg~~pf~~~~~~  494 (506)
                      ||+++.........     ......||+.|+|||++.+.  .++.++||||||+++|||++|+.||......
T Consensus       170 FGla~~~~~~~~~~~~~~~~~~~~~gt~~y~ape~~~~~--~~~~~~DiwSlG~~l~el~~g~~P~~~~~~~  239 (294)
T PHA02882        170 YGIASHFIIHGKHIEYSKEQKDLHRGTLYYAGLDAHNGA--CVTRRGDLESLGYCMLKWAGIKLPWKGFGHN  239 (294)
T ss_pred             cCCceeeccCCcccccccccccccCCCccccCHHHhCCC--CCCcHHHHHHHHHHHHHHHhCCCCCCccccc
Confidence            99998764322111     11234689999999998654  6899999999999999999999999877443

>cd05034 PTKc_Src_like Catalytic domain of Src kinase-like Protein Tyrosine Kinases

Probab=99.95  E-value=2.8e-28  Score=235.26  Aligned_cols=177  Identities=30%  Similarity=0.513  Sum_probs=145.8

Q ss_pred             HHHhhhccccCccCceEEEEEEEcCCCEEEEEEeccCCCCchhhHHHHHHhhccCccceeEEEEEee-------------
Q 039231          312 KMTNSFKYKLGQGGYGSVYKGKLLDGSNVAVKVLNDSKGNGKEFINEVASISRTSHVNVVALLGFCL-------------  378 (506)
Q Consensus       312 ~~~~~~~~~ig~G~~g~V~~~~~~~~~~vavK~l~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~-------------  378 (506)
                      +..+.+.++||+|++|.||+|..++++.+|||.+.......+++.+|++++++++|+||+++++++.             
T Consensus         5 ~~~~~i~~~ig~g~~~~v~~~~~~~~~~~~vK~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~   84 (261)
T cd05034           5 RESLKLERKLGAGQFGEVWMGTWNGTTKVAVKTLKPGTMSPEAFLQEAQIMKKLRHDKLVQLYAVCSEEEPIYIVTEYMS   84 (261)
T ss_pred             hhheeeeeeeccCcceEEEEEEEcCCceEEEEEecCCccCHHHHHHHHHHHhhCCCCCEeeeeeeeecCCceEEEEeccC
Confidence            3344556789999999999999888889999999876666688999999999999999999998761             


Q ss_pred             ----------------ccchhhhHHHHHHHHHHHHhhcCCCCeEecCcCCCcEEECCCCcEEEeecCCCccccCCCccee
Q 039231          379 ----------------RVAEELSSTIGIARGLEYLHLGCSTRILHFDIKPHNILLDEDFCPKISDFGLAKICNRKESIIS  442 (506)
Q Consensus       379 ----------------~~~~~l~i~~~i~~gl~~LH~~~~~~ivH~dlkp~Nill~~~~~~ki~dfg~a~~~~~~~~~~~  442 (506)
                                      ++.+.+.++.|++.||+|||   +.+++|+||||+||++++++.+||+|||+++........ .
T Consensus        85 ~~~L~~~i~~~~~~~~~~~~~~~~~~~i~~al~~lh---~~~i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~~~~-~  160 (261)
T cd05034          85 KGSLLDFLKSGEGKKLRLPQLVDMAAQIAEGMAYLE---SRNYIHRDLAARNILVGENLVCKIADFGLARLIEDDEYT-A  160 (261)
T ss_pred             CCCHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHH---hCCcccCCcchheEEEcCCCCEEECccccceeccchhhh-h
Confidence                            22335678899999999999   899999999999999999999999999999866532211 1


Q ss_pred             cccCCCCcccccccccccccCCCCccccHHHHHHHHHHHHc-CCCCCCCCCCC
Q 039231          443 MTGARGTVGYIAPEVFCRNIGEVSYKSDVYNYGMMIFEMTG-GRKNVDVVDNG  494 (506)
Q Consensus       443 ~~~~~gt~~y~aPE~l~~~~~~~s~~~Dv~s~G~il~ellt-g~~pf~~~~~~  494 (506)
                      ......+..|+|||.+.+.  .++.++||||||+++|||++ |+.||......
T Consensus       161 ~~~~~~~~~y~~PE~~~~~--~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~  211 (261)
T cd05034         161 REGAKFPIKWTAPEAANYG--RFTIKSDVWSFGILLTEIVTYGRVPYPGMTNR  211 (261)
T ss_pred             hhccCCCccccCHHHhccC--CcCchhHHHHHHHHHHHHHhCCCCCCCCCCHH
Confidence            1223346789999998653  68899999999999999998 99999765443

Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-t

>KOG2052 consensus Activin A type IB receptor, serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.95  E-value=1.8e-28  Score=236.61  Aligned_cols=178  Identities=26%  Similarity=0.457  Sum_probs=139.3

Q ss_pred             hccccCccCceEEEEEEEcCCCEEEEEEeccCCCCchhhHHHHHHhhc--cCccceeEEEEEe-----------------
Q 039231          317 FKYKLGQGGYGSVYKGKLLDGSNVAVKVLNDSKGNGKEFINEVASISR--TSHVNVVALLGFC-----------------  377 (506)
Q Consensus       317 ~~~~ig~G~~g~V~~~~~~~~~~vavK~l~~~~~~~~~~~~E~~~l~~--l~h~niv~l~g~~-----------------  377 (506)
                      +.+.||+|.||.||+|++ .|..||||++...  +++.+.+|.++.+.  ++|+||+.+++.-                 
T Consensus       215 L~e~IGkGRyGEVwrG~w-rGe~VAVKiF~sr--dE~SWfrEtEIYqTvmLRHENILgFIaaD~~~~gs~TQLwLvTdYH  291 (513)
T KOG2052|consen  215 LQEIIGKGRFGEVWRGRW-RGEDVAVKIFSSR--DERSWFRETEIYQTVMLRHENILGFIAADNKDNGSWTQLWLVTDYH  291 (513)
T ss_pred             EEEEecCccccceeeccc-cCCceEEEEeccc--chhhhhhHHHHHHHHHhccchhhhhhhccccCCCceEEEEEeeecc
Confidence            357799999999999999 6789999999654  34568888888877  4899999888643                 


Q ss_pred             -------------eccchhhhHHHHHHHHHHHHhhc-----CCCCeEecCcCCCcEEECCCCcEEEeecCCCccccCCCc
Q 039231          378 -------------LRVAEELSSTIGIARGLEYLHLG-----CSTRILHFDIKPHNILLDEDFCPKISDFGLAKICNRKES  439 (506)
Q Consensus       378 -------------~~~~~~l~i~~~i~~gl~~LH~~-----~~~~ivH~dlkp~Nill~~~~~~ki~dfg~a~~~~~~~~  439 (506)
                                   ++.+..++++..+|.||++||-+     .++.|.|||||++|||+.+++..-|+|+|+|........
T Consensus       292 e~GSL~DyL~r~tv~~~~ml~LalS~AsGLaHLH~eI~GTqgKPaIAHRDlKSKNILVKkn~~C~IADLGLAv~h~~~t~  371 (513)
T KOG2052|consen  292 EHGSLYDYLNRNTVTTEGMLKLALSIASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSDTD  371 (513)
T ss_pred             cCCcHHHHHhhccCCHHHHHHHHHHHhhhHHHHHHHHhcCCCCchhhccccccccEEEccCCcEEEeeceeeEEecccCC
Confidence                         44555788999999999999953     367899999999999999999999999999977655432


Q ss_pred             ce--ecccCCCCcccccccccccccC----CCCccccHHHHHHHHHHHHcC----------CCCCCCCCCCcch
Q 039231          440 II--SMTGARGTVGYIAPEVFCRNIG----EVSYKSDVYNYGMMIFEMTGG----------RKNVDVVDNGSTA  497 (506)
Q Consensus       440 ~~--~~~~~~gt~~y~aPE~l~~~~~----~~s~~~Dv~s~G~il~elltg----------~~pf~~~~~~~~~  497 (506)
                      ..  .....+||.+|||||+|...-.    +.-..+||||||.|+||++-+          ..||...-+.+..
T Consensus       372 ~idi~~N~rVGTKRYMAPEvLdetin~~~Fesyk~ADIYafgLVlWEiarRc~~ggi~eey~~Pyyd~Vp~DPs  445 (513)
T KOG2052|consen  372 TIDIPPNPRVGTKRYMAPEVLDETINMKHFESYKRADIYAFGLVLWEIARRCESGGIVEEYQLPYYDVVPSDPS  445 (513)
T ss_pred             cccCCCCCccceeeccChHHhhhhcChhhhhhhhHHHHHHHHHHHHHHHHHhhcCCEehhhcCCcccCCCCCCC
Confidence            22  2345789999999999954311    112358999999999999753          4677665554433

>cd05093 PTKc_TrkB Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B

Probab=99.95  E-value=2.8e-28  Score=239.11  Aligned_cols=177  Identities=26%  Similarity=0.447  Sum_probs=141.3

Q ss_pred             HHhhhccccCccCceEEEEEEEc------CCCEEEEEEeccCCC-CchhhHHHHHHhhccCccceeEEEEEee-------
Q 039231          313 MTNSFKYKLGQGGYGSVYKGKLL------DGSNVAVKVLNDSKG-NGKEFINEVASISRTSHVNVVALLGFCL-------  378 (506)
Q Consensus       313 ~~~~~~~~ig~G~~g~V~~~~~~------~~~~vavK~l~~~~~-~~~~~~~E~~~l~~l~h~niv~l~g~~~-------  378 (506)
                      ..+.+.+.||+|+||.||++...      ++..+|+|.+..... ..+.+.+|++++++++||||+++++++.       
T Consensus         5 ~~~~~~~~lg~G~~~~v~~~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l   84 (288)
T cd05093           5 HNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKFYGVCVEGDPLIM   84 (288)
T ss_pred             HHeeeccccCCcCCeeEEeeEeccCCCCCcceEEEEEecCCcCHHHHHHHHHHHHHHHhCCCCCcceEEEEEecCCccEE
Confidence            33445678999999999999752      245689998875432 3467899999999999999999998761       


Q ss_pred             ---------------------------------ccchhhhHHHHHHHHHHHHhhcCCCCeEecCcCCCcEEECCCCcEEE
Q 039231          379 ---------------------------------RVAEELSSTIGIARGLEYLHLGCSTRILHFDIKPHNILLDEDFCPKI  425 (506)
Q Consensus       379 ---------------------------------~~~~~l~i~~~i~~gl~~LH~~~~~~ivH~dlkp~Nill~~~~~~ki  425 (506)
                                                       ++...+.++.|++.||+|||   +++++||||||+||++++++.+||
T Consensus        85 v~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~lH---~~~i~H~dlkp~Nili~~~~~~kl  161 (288)
T cd05093          85 VFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAAGMVYLA---SQHFVHRDLATRNCLVGENLLVKI  161 (288)
T ss_pred             EEEcCCCCCHHHHHHHcCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHH---hCCeeecccCcceEEEccCCcEEe
Confidence                                             12234668899999999999   899999999999999999999999


Q ss_pred             eecCCCccccCCCcceecccCCCCcccccccccccccCCCCccccHHHHHHHHHHHHc-CCCCCCCCCCC
Q 039231          426 SDFGLAKICNRKESIISMTGARGTVGYIAPEVFCRNIGEVSYKSDVYNYGMMIFEMTG-GRKNVDVVDNG  494 (506)
Q Consensus       426 ~dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~s~~~Dv~s~G~il~ellt-g~~pf~~~~~~  494 (506)
                      +|||+++...............+++.|+|||.+...  .++.++||||||+++|||++ |+.||......
T Consensus       162 ~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~--~~~~~sDiwslG~il~~l~t~g~~p~~~~~~~  229 (288)
T cd05093         162 GDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYR--KFTTESDVWSLGVVLWEIFTYGKQPWYQLSNN  229 (288)
T ss_pred             ccCCccccccCCceeecCCCCCccccccCHHHhccC--CCCchhhHHHHHHHHHHHHhCCCCCCCCCCHH
Confidence            999999866443322212234457789999998543  68899999999999999998 99999766543

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly

>KOG1989 consensus ARK protein kinase family [Signal transduction mechanisms]

Probab=99.95  E-value=1.1e-28  Score=257.37  Aligned_cols=174  Identities=22%  Similarity=0.278  Sum_probs=142.5

Q ss_pred             hccccCccCceEEEEEEEcCC-CEEEEEEecc-CCCCchhhHHHHHHhhccC-ccceeEEEEEe----------------
Q 039231          317 FKYKLGQGGYGSVYKGKLLDG-SNVAVKVLND-SKGNGKEFINEVASISRTS-HVNVVALLGFC----------------  377 (506)
Q Consensus       317 ~~~~ig~G~~g~V~~~~~~~~-~~vavK~l~~-~~~~~~~~~~E~~~l~~l~-h~niv~l~g~~----------------  377 (506)
                      .++.|.+|||+.||.|++..+ ..+|+|++-- ++...+.+.+|+++|++|+ |+|||.+++-.                
T Consensus        41 V~~vLAEGGFa~VYla~~~~~~~~~AlKrm~~~de~~L~~v~~EI~~MK~L~gh~nIV~yidss~~~~~~~~~~~EvllL  120 (738)
T KOG1989|consen   41 VEKVLAEGGFAQVYLAQDVKGGKKYALKRMYVNDEEALNAVKREIDIMKLLSGHKNIVSYIDSSAINRSSNNGVWEVLLL  120 (738)
T ss_pred             EEEEEccCCcEEEEEEEecCCCceeeeeeeecCCHHHHHHHHHHHHHHHHhcCCCceeeEeccccccccCCCceeEEEee
Confidence            356799999999999998776 9999998854 4445588999999999998 99999999722                


Q ss_pred             --------------------eccchhhhHHHHHHHHHHHHhhcCCCCeEecCcCCCcEEECCCCcEEEeecCCCccccCC
Q 039231          378 --------------------LRVAEELSSTIGIARGLEYLHLGCSTRILHFDIKPHNILLDEDFCPKISDFGLAKICNRK  437 (506)
Q Consensus       378 --------------------~~~~~~l~i~~~i~~gl~~LH~~~~~~ivH~dlkp~Nill~~~~~~ki~dfg~a~~~~~~  437 (506)
                                          +.+.++|+|+.|+++|+++||.. +.+|||||||-+||||+.+++.||+|||.|.-.-..
T Consensus       121 mEyC~gg~Lvd~mn~Rlq~~lte~eVLkIf~dv~~AVa~mH~~-~pPiIHRDLKiENvLls~~g~~KLCDFGSatt~~~~  199 (738)
T KOG1989|consen  121 MEYCKGGSLVDFMNTRLQTRLTEDEVLKIFYDVCEAVAAMHYL-KPPIIHRDLKIENVLLSADGNYKLCDFGSATTKILS  199 (738)
T ss_pred             hhhccCCcHHHHHHHHHhccCChHHHHHHHHHHHHHHHHHhcC-CCccchhhhhhhheEEcCCCCEEeCcccccccccCC
Confidence                                56778999999999999999943 677999999999999999999999999998543211


Q ss_pred             C-cceec------ccCCCCccccccccccc-ccCCCCccccHHHHHHHHHHHHcCCCCCCCC
Q 039231          438 E-SIISM------TGARGTVGYIAPEVFCR-NIGEVSYKSDVYNYGMMIFEMTGGRKNVDVV  491 (506)
Q Consensus       438 ~-~~~~~------~~~~gt~~y~aPE~l~~-~~~~~s~~~Dv~s~G~il~elltg~~pf~~~  491 (506)
                      . .....      -...-|+.|.|||.+.- ....+++|+|||||||+||-|+....||+..
T Consensus       200 ~~~~~e~~~ve~eI~k~TTp~YRsPEMIDlysg~pI~eKsDIWALGclLYkLCy~t~PFe~s  261 (738)
T KOG1989|consen  200 PTSAQEVNYVEEEIEKYTTPQYRSPEMIDLYSGLPIGEKSDIWALGCLLYKLCYFTTPFEES  261 (738)
T ss_pred             CccHHHHHHHHHHHHhhCCccccChHHHhhhcCCCCcchhHHHHHHHHHHHHHHhCCCcCcC
Confidence            1 10000      11235999999999832 2237899999999999999999999999876

>cd05115 PTKc_Zap-70 Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa

Probab=99.95  E-value=5.6e-28  Score=232.97  Aligned_cols=170  Identities=28%  Similarity=0.505  Sum_probs=137.1

Q ss_pred             ccCccCceEEEEEEEc---CCCEEEEEEeccCCC--CchhhHHHHHHhhccCccceeEEEEEe-----------------
Q 039231          320 KLGQGGYGSVYKGKLL---DGSNVAVKVLNDSKG--NGKEFINEVASISRTSHVNVVALLGFC-----------------  377 (506)
Q Consensus       320 ~ig~G~~g~V~~~~~~---~~~~vavK~l~~~~~--~~~~~~~E~~~l~~l~h~niv~l~g~~-----------------  377 (506)
                      .||+|+||.||+|.+.   ++..||+|++.....  ..+++.+|++++++++||||+++++++                 
T Consensus         2 ~ig~G~~g~v~~~~~~~~~~~~~vavk~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~~~~~lv~e~~~~~~L   81 (257)
T cd05115           2 ELGSGNFGCVKKGVYKMRKKQIDVAIKVLKNENEKSVRDEMMREAEIMHQLDNPYIVRMIGVCEAEALMLVMEMASGGPL   81 (257)
T ss_pred             ccCCCCcccEEEEEEecCCCceeEEEEEcccccChHHHHHHHHHHHHHHhcCCCCeEEEEEEEcCCCeEEEEEeCCCCCH
Confidence            3899999999999764   355799999875432  235688999999999999999999886                 


Q ss_pred             ----------eccchhhhHHHHHHHHHHHHhhcCCCCeEecCcCCCcEEECCCCcEEEeecCCCccccCCCccee-cccC
Q 039231          378 ----------LRVAEELSSTIGIARGLEYLHLGCSTRILHFDIKPHNILLDEDFCPKISDFGLAKICNRKESIIS-MTGA  446 (506)
Q Consensus       378 ----------~~~~~~l~i~~~i~~gl~~LH~~~~~~ivH~dlkp~Nill~~~~~~ki~dfg~a~~~~~~~~~~~-~~~~  446 (506)
                                +++.+.+.++.|++.||+|||   +++++||||||+||+++.++.+||+|||+++.......... ....
T Consensus        82 ~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~  158 (257)
T cd05115          82 NKFLSGKKDEITVSNVVELMHQVSMGMKYLE---GKNFVHRDLAARNVLLVNQHYAKISDFGLSKALGADDSYYKARSAG  158 (257)
T ss_pred             HHHHHhCCCCCCHHHHHHHHHHHHHHHHHHH---hcCeeecccchheEEEcCCCcEEeccCCccccccCCccceeccCCC
Confidence                      223345778999999999999   89999999999999999999999999999986544332211 1223


Q ss_pred             CCCcccccccccccccCCCCccccHHHHHHHHHHHHc-CCCCCCCCCCC
Q 039231          447 RGTVGYIAPEVFCRNIGEVSYKSDVYNYGMMIFEMTG-GRKNVDVVDNG  494 (506)
Q Consensus       447 ~gt~~y~aPE~l~~~~~~~s~~~Dv~s~G~il~ellt-g~~pf~~~~~~  494 (506)
                      .++..|+|||.+...  .++.++||||||+++|||++ |..||......
T Consensus       159 ~~~~~y~aPE~~~~~--~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~  205 (257)
T cd05115         159 KWPLKWYAPECINFR--KFSSRSDVWSYGITMWEAFSYGQKPYKKMKGP  205 (257)
T ss_pred             CCCcccCCHHHHccC--CCCchhhHHHHHHHHHHHhcCCCCCcCcCCHH
Confidence            346789999998543  67889999999999999996 99999866543

Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its pho

>cd05084 PTKc_Fes Catalytic domain of the Protein Tyrosine Kinase, Fes

Probab=99.95  E-value=3.9e-28  Score=233.09  Aligned_cols=170  Identities=31%  Similarity=0.513  Sum_probs=136.2

Q ss_pred             cccCccCceEEEEEEEc-CCCEEEEEEeccCC--CCchhhHHHHHHhhccCccceeEEEEEe------------------
Q 039231          319 YKLGQGGYGSVYKGKLL-DGSNVAVKVLNDSK--GNGKEFINEVASISRTSHVNVVALLGFC------------------  377 (506)
Q Consensus       319 ~~ig~G~~g~V~~~~~~-~~~~vavK~l~~~~--~~~~~~~~E~~~l~~l~h~niv~l~g~~------------------  377 (506)
                      ++||+|+||.||+|+.. +++.+|+|.+....  .....+.+|++++++++||||+++++++                  
T Consensus         1 ~~lg~g~~g~vy~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L   80 (252)
T cd05084           1 ERIGRGNFGEVFSGRLRADNTPVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIVMELVQGGDF   80 (252)
T ss_pred             CccCcccCccEEEEEEecCCceEEEEecCccCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEcCCCCeEEEEeeccCCcH
Confidence            36999999999999875 68999999886432  2235789999999999999999999886                  


Q ss_pred             ----------eccchhhhHHHHHHHHHHHHhhcCCCCeEecCcCCCcEEECCCCcEEEeecCCCccccCCCcceecccCC
Q 039231          378 ----------LRVAEELSSTIGIARGLEYLHLGCSTRILHFDIKPHNILLDEDFCPKISDFGLAKICNRKESIISMTGAR  447 (506)
Q Consensus       378 ----------~~~~~~l~i~~~i~~gl~~LH~~~~~~ivH~dlkp~Nill~~~~~~ki~dfg~a~~~~~~~~~~~~~~~~  447 (506)
                                +++.+.+.++.|++.||+|||   +++++|+||||+||+++.++.+||+|||++................
T Consensus        81 ~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH---~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~  157 (252)
T cd05084          81 LTFLRTEGPRLKVKELIQMVENAAAGMEYLE---SKHCIHRDLAARNCLVTEKNVLKISDFGMSREEEDGVYASTGGMKQ  157 (252)
T ss_pred             HHHHHhCCCCCCHHHHHHHHHHHHHHHHHHH---hCCccccccchheEEEcCCCcEEECccccCcccccccccccCCCCC
Confidence                      122335678899999999999   8999999999999999999999999999987654322111111122


Q ss_pred             CCcccccccccccccCCCCccccHHHHHHHHHHHHc-CCCCCCCCCC
Q 039231          448 GTVGYIAPEVFCRNIGEVSYKSDVYNYGMMIFEMTG-GRKNVDVVDN  493 (506)
Q Consensus       448 gt~~y~aPE~l~~~~~~~s~~~Dv~s~G~il~ellt-g~~pf~~~~~  493 (506)
                      .+..|+|||.+.+  +.++.++||||||+++|||++ |..||.....
T Consensus       158 ~~~~y~aPE~~~~--~~~~~~~Dv~slG~il~e~~~~~~~p~~~~~~  202 (252)
T cd05084         158 IPVKWTAPEALNY--GRYSSESDVWSFGILLWEAFSLGAVPYANLSN  202 (252)
T ss_pred             CceeecCchhhcC--CCCChHHHHHHHHHHHHHHHhCCCCCccccCH
Confidence            3567999999854  368889999999999999997 9999976544

Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular

>cd05586 STKc_Sck1_like Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases

Probab=99.95  E-value=6e-29  Score=248.79  Aligned_cols=167  Identities=28%  Similarity=0.360  Sum_probs=133.1

Q ss_pred             cCccCceEEEEEEEc-CCCEEEEEEeccCC----CCchhhHHHHHHhhcc---CccceeEEEEEe---------------
Q 039231          321 LGQGGYGSVYKGKLL-DGSNVAVKVLNDSK----GNGKEFINEVASISRT---SHVNVVALLGFC---------------  377 (506)
Q Consensus       321 ig~G~~g~V~~~~~~-~~~~vavK~l~~~~----~~~~~~~~E~~~l~~l---~h~niv~l~g~~---------------  377 (506)
                      ||+|+||.||+|+.. +++.||||++....    .......+|..++.+.   +||||+++++.+               
T Consensus         1 lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~p~i~~~~~~~~~~~~~~lv~e~~~~   80 (330)
T cd05586           1 IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEIVAKKEVAHTIGERNILVRTLLDESPFIVGLKFSFQTDSDLYLVTDYMSG   80 (330)
T ss_pred             CCCCCceEEEEEEECCCCCEEEEEEEeHHHHhhhhHHHHHHHHHHHHHHhccCCCCcCcceEEEEecCCeEEEEEcCCCC
Confidence            799999999999875 48999999986432    1223455677777665   699999998765               


Q ss_pred             ------------eccchhhhHHHHHHHHHHHHhhcCCCCeEecCcCCCcEEECCCCcEEEeecCCCccccCCCcceeccc
Q 039231          378 ------------LRVAEELSSTIGIARGLEYLHLGCSTRILHFDIKPHNILLDEDFCPKISDFGLAKICNRKESIISMTG  445 (506)
Q Consensus       378 ------------~~~~~~l~i~~~i~~gl~~LH~~~~~~ivH~dlkp~Nill~~~~~~ki~dfg~a~~~~~~~~~~~~~~  445 (506)
                                  +++.+...++.||++||+|||   +++|+||||||+|||+++++.+||+|||+++........  ...
T Consensus        81 g~L~~~l~~~~~~~~~~~~~~~~qil~al~~LH---~~~ivHrDlkp~Nili~~~~~~kl~Dfg~a~~~~~~~~~--~~~  155 (330)
T cd05586          81 GELFWHLQKEGRFSEDRAKFYIAELVLALEHLH---KYDIVYRDLKPENILLDATGHIALCDFGLSKANLTDNKT--TNT  155 (330)
T ss_pred             ChHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH---HCCeEeccCCHHHeEECCCCCEEEecCCcCcCCCCCCCC--ccC
Confidence                        223335668899999999999   899999999999999999999999999998754332211  234


Q ss_pred             CCCCcccccccccccccCCCCccccHHHHHHHHHHHHcCCCCCCCCCC
Q 039231          446 ARGTVGYIAPEVFCRNIGEVSYKSDVYNYGMMIFEMTGGRKNVDVVDN  493 (506)
Q Consensus       446 ~~gt~~y~aPE~l~~~~~~~s~~~Dv~s~G~il~elltg~~pf~~~~~  493 (506)
                      ..||+.|+|||.+.+. ..++.++|||||||++|||++|+.||...+.
T Consensus       156 ~~gt~~y~aPE~~~~~-~~~~~~~DvwslGvil~elltG~~Pf~~~~~  202 (330)
T cd05586         156 FCGTTEYLAPEVLLDE-KGYTKHVDFWSLGVLVFEMCCGWSPFYAEDT  202 (330)
T ss_pred             ccCCccccCHHHHcCC-CCCCCccceeccccEEEEeccCCCCCCCCCH
Confidence            5689999999998543 3578899999999999999999999976543

Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of

>cd05087 PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3

Probab=99.95  E-value=7.1e-28  Score=233.72  Aligned_cols=172  Identities=26%  Similarity=0.407  Sum_probs=135.8

Q ss_pred             ccCccCceEEEEEEEcC---CCEEEEEEeccCCCC--chhhHHHHHHhhccCccceeEEEEEeec---------------
Q 039231          320 KLGQGGYGSVYKGKLLD---GSNVAVKVLNDSKGN--GKEFINEVASISRTSHVNVVALLGFCLR---------------  379 (506)
Q Consensus       320 ~ig~G~~g~V~~~~~~~---~~~vavK~l~~~~~~--~~~~~~E~~~l~~l~h~niv~l~g~~~~---------------  379 (506)
                      .||+|+||.||+|...+   +..+|+|.++.....  ...+.+|+.++++++||||+++++++.+               
T Consensus         2 ~lg~G~~g~Vy~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g~   81 (269)
T cd05087           2 EIGNGWFGKVILGEVNSGYTPAQVVVKELRVSASVQEQMKFLEEAQPYRSLQHSNLLQCLGQCTEVTPYLLVMEFCPLGD   81 (269)
T ss_pred             cccccCCceEEEEEEcCCCCceEEEEEecCCCCChHHHHHHHHHHHHHHhCCCCCEeeEEEEEcCCCCcEEEEECCCCCc
Confidence            58999999999998643   457899988754332  2468889999999999999999987611               


Q ss_pred             -----------------cchhhhHHHHHHHHHHHHhhcCCCCeEecCcCCCcEEECCCCcEEEeecCCCccccCCCccee
Q 039231          380 -----------------VAEELSSTIGIARGLEYLHLGCSTRILHFDIKPHNILLDEDFCPKISDFGLAKICNRKESIIS  442 (506)
Q Consensus       380 -----------------~~~~l~i~~~i~~gl~~LH~~~~~~ivH~dlkp~Nill~~~~~~ki~dfg~a~~~~~~~~~~~  442 (506)
                                       +...+.++.|++.||+|||   +.+++|+||||+||++++++.+||+|||+++..........
T Consensus        82 L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH---~~~i~H~dlkp~nil~~~~~~~kL~dfg~~~~~~~~~~~~~  158 (269)
T cd05087          82 LKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLH---KNNFIHSDLALRNCLLTADLTVKIGDYGLSHNKYKEDYYVT  158 (269)
T ss_pred             HHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHH---HCCEeccccCcceEEEcCCCcEEECCccccccccCcceeec
Confidence                             1123457889999999999   89999999999999999999999999999976544332222


Q ss_pred             cccCCCCcccccccccccccC-----CCCccccHHHHHHHHHHHHc-CCCCCCCCCCC
Q 039231          443 MTGARGTVGYIAPEVFCRNIG-----EVSYKSDVYNYGMMIFEMTG-GRKNVDVVDNG  494 (506)
Q Consensus       443 ~~~~~gt~~y~aPE~l~~~~~-----~~s~~~Dv~s~G~il~ellt-g~~pf~~~~~~  494 (506)
                      .....++..|+|||++.+...     .++.++||||||+++|||++ |+.||....+.
T Consensus       159 ~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~~  216 (269)
T cd05087         159 PDQLWVPLRWIAPELVDEVHGNLLVVDQTKESNVWSLGVTIWELFELGSQPYRHLSDE  216 (269)
T ss_pred             CCCcCCcccccCHhHhccccccccccCCCccchhHHHHHHHHHHHhCCCCCCCCCChH
Confidence            233456788999999854211     35789999999999999996 99999765443

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells

>cd05035 PTKc_Axl_like Catalytic Domain of Axl-like Protein Tyrosine Kinases

Probab=99.95  E-value=5.8e-28  Score=234.46  Aligned_cols=173  Identities=31%  Similarity=0.481  Sum_probs=138.3

Q ss_pred             hccccCccCceEEEEEEEcC----CCEEEEEEeccCCCC---chhhHHHHHHhhccCccceeEEEEEeec----------
Q 039231          317 FKYKLGQGGYGSVYKGKLLD----GSNVAVKVLNDSKGN---GKEFINEVASISRTSHVNVVALLGFCLR----------  379 (506)
Q Consensus       317 ~~~~ig~G~~g~V~~~~~~~----~~~vavK~l~~~~~~---~~~~~~E~~~l~~l~h~niv~l~g~~~~----------  379 (506)
                      +.+.||+|+||.||+|+...    +..+|+|+++.....   ..++.+|++.++.++||||+++++++..          
T Consensus         3 ~~~~lg~G~~g~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~   82 (273)
T cd05035           3 LGKILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFDHPNVMKLIGVCFEASSLQKIPKP   82 (273)
T ss_pred             cccccCcCCCceEEEEEEecCCCCcceEEEEEeccCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEeeeccCCccccCccc
Confidence            45679999999999998743    367999998754322   3578899999999999999999986522          


Q ss_pred             -----------------------------cchhhhHHHHHHHHHHHHhhcCCCCeEecCcCCCcEEECCCCcEEEeecCC
Q 039231          380 -----------------------------VAEELSSTIGIARGLEYLHLGCSTRILHFDIKPHNILLDEDFCPKISDFGL  430 (506)
Q Consensus       380 -----------------------------~~~~l~i~~~i~~gl~~LH~~~~~~ivH~dlkp~Nill~~~~~~ki~dfg~  430 (506)
                                                   +...+.++.|++.||+|||   +.+++||||||+||++++++.+||+|||+
T Consensus        83 ~~v~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~aL~~lH---~~~i~H~dlkp~Nil~~~~~~~kl~dfg~  159 (273)
T cd05035          83 MVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALGMEYLS---NRNFIHRDLAARNCMLREDMTVCVADFGL  159 (273)
T ss_pred             EEEEeccCCCCHHHHHHHhhccCCcccCCHHHHHHHHHHHHHHHHHHH---hCCeeccccchheEEECCCCeEEECCccc
Confidence                                         1123557899999999999   89999999999999999999999999999


Q ss_pred             CccccCCCcceecccCCCCcccccccccccccCCCCccccHHHHHHHHHHHHc-CCCCCCCCCCC
Q 039231          431 AKICNRKESIISMTGARGTVGYIAPEVFCRNIGEVSYKSDVYNYGMMIFEMTG-GRKNVDVVDNG  494 (506)
Q Consensus       431 a~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~s~~~Dv~s~G~il~ellt-g~~pf~~~~~~  494 (506)
                      ++................+..|+|||.+..  ..++.++||||||+++|||++ |..||....+.
T Consensus       160 ~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~--~~~~~~~Dv~SlG~il~el~~~g~~p~~~~~~~  222 (273)
T cd05035         160 SKKIYSGDYYRQGRIAKMPVKWIAIESLAD--RVYTSKSDVWAFGVTMWEIATRGQTPYPGVENH  222 (273)
T ss_pred             eeeccccccccccccccCCccccCHhhccc--CCCCcccchHHHHHHHHHHHhCCCCCCCCCCHH
Confidence            987654433222222345678999999854  378899999999999999999 99999765443

Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellu

>cd06637 STKc_TNIK Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase

Probab=99.95  E-value=4.9e-28  Score=235.05  Aligned_cols=170  Identities=29%  Similarity=0.450  Sum_probs=140.3

Q ss_pred             ccccCccCceEEEEEEEc-CCCEEEEEEeccCCCCchhhHHHHHHhhcc-CccceeEEEEEeec----------------
Q 039231          318 KYKLGQGGYGSVYKGKLL-DGSNVAVKVLNDSKGNGKEFINEVASISRT-SHVNVVALLGFCLR----------------  379 (506)
Q Consensus       318 ~~~ig~G~~g~V~~~~~~-~~~~vavK~l~~~~~~~~~~~~E~~~l~~l-~h~niv~l~g~~~~----------------  379 (506)
                      .+.||+|+||.||+|+.. +++.+|+|++........++.+|+.++.++ +|+||+++++++..                
T Consensus        11 ~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~~~~~iv~e~   90 (272)
T cd06637          11 VELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDEEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGMDDQLWLVMEF   90 (272)
T ss_pred             HHheeecCCeEEEEEEEcCCCcEEEEEEEEcCCccHHHHHHHHHHHHHhcCCCCeeeEeeEEeecCCCCCCcEEEEEEEc
Confidence            457999999999999875 488999999977665667889999999998 69999999987521                


Q ss_pred             -------------------cchhhhHHHHHHHHHHHHhhcCCCCeEecCcCCCcEEECCCCcEEEeecCCCccccCCCcc
Q 039231          380 -------------------VAEELSSTIGIARGLEYLHLGCSTRILHFDIKPHNILLDEDFCPKISDFGLAKICNRKESI  440 (506)
Q Consensus       380 -------------------~~~~l~i~~~i~~gl~~LH~~~~~~ivH~dlkp~Nill~~~~~~ki~dfg~a~~~~~~~~~  440 (506)
                                         +...+.++.|++.||+|||   +++|+|+||||+||++++++.+||+|||++........ 
T Consensus        91 ~~~~~L~~~l~~~~~~~l~~~~~~~~~~qi~~~l~~LH---~~~ivh~dl~~~nili~~~~~~~l~Dfg~~~~~~~~~~-  166 (272)
T cd06637          91 CGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLH---QHKVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVG-  166 (272)
T ss_pred             CCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHH---HCCCccCCCCHHHEEECCCCCEEEccCCCceecccccc-
Confidence                               1124558889999999999   89999999999999999999999999999986543222 


Q ss_pred             eecccCCCCcccccccccccc---cCCCCccccHHHHHHHHHHHHcCCCCCCCCC
Q 039231          441 ISMTGARGTVGYIAPEVFCRN---IGEVSYKSDVYNYGMMIFEMTGGRKNVDVVD  492 (506)
Q Consensus       441 ~~~~~~~gt~~y~aPE~l~~~---~~~~s~~~Dv~s~G~il~elltg~~pf~~~~  492 (506)
                       ......|++.|+|||++...   ...++.++||||||+++|||++|+.||....
T Consensus       167 -~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGv~l~el~~g~~p~~~~~  220 (272)
T cd06637         167 -RRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMH  220 (272)
T ss_pred             -cCCcccccccccCHhHhccccCcCCCCCchhhHHHHHHHHHHHHhCCCCccccC
Confidence             12345688999999998532   2357889999999999999999999997544

Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activ

>cd05630 STKc_GRK6 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6

Probab=99.95  E-value=6.3e-28  Score=236.30  Aligned_cols=168  Identities=31%  Similarity=0.460  Sum_probs=138.6

Q ss_pred             ccccCccCceEEEEEEEc-CCCEEEEEEeccCCC----CchhhHHHHHHhhccCccceeEEEEEe---------------
Q 039231          318 KYKLGQGGYGSVYKGKLL-DGSNVAVKVLNDSKG----NGKEFINEVASISRTSHVNVVALLGFC---------------  377 (506)
Q Consensus       318 ~~~ig~G~~g~V~~~~~~-~~~~vavK~l~~~~~----~~~~~~~E~~~l~~l~h~niv~l~g~~---------------  377 (506)
                      .+.||+|+||.||++... +++.+|+|.+.....    ..+.+.+|+.++++++|+||+++.+.+               
T Consensus         5 ~~~ig~G~~g~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~~~g   84 (285)
T cd05630           5 YRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLTLMNG   84 (285)
T ss_pred             eEEeecCCCeEEEEEEEcCCCceEEEEEEehhhccchHHHHHHHHHHHHHHhCCCCCeeeeeEEEecCCEEEEEEEecCC
Confidence            467999999999999875 588999999864321    124567899999999999999998765               


Q ss_pred             --------------eccchhhhHHHHHHHHHHHHhhcCCCCeEecCcCCCcEEECCCCcEEEeecCCCccccCCCcceec
Q 039231          378 --------------LRVAEELSSTIGIARGLEYLHLGCSTRILHFDIKPHNILLDEDFCPKISDFGLAKICNRKESIISM  443 (506)
Q Consensus       378 --------------~~~~~~l~i~~~i~~gl~~LH~~~~~~ivH~dlkp~Nill~~~~~~ki~dfg~a~~~~~~~~~~~~  443 (506)
                                    +.+...+.++.|++.||.|||   +.+|+||||||+||++++++.++|+|||++........   .
T Consensus        85 ~~L~~~l~~~~~~~l~~~~~~~~~~qi~~~l~~lH---~~~iiH~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~~---~  158 (285)
T cd05630          85 GDLKFHIYHMGEAGFEEGRAVFYAAEICCGLEDLH---QERIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQT---I  158 (285)
T ss_pred             CcHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHH---hCCEEeCCCCHHHEEECCCCCEEEeeccceeecCCCcc---c
Confidence                          122235568899999999999   89999999999999999999999999999876543332   1


Q ss_pred             ccCCCCcccccccccccccCCCCccccHHHHHHHHHHHHcCCCCCCCCCC
Q 039231          444 TGARGTVGYIAPEVFCRNIGEVSYKSDVYNYGMMIFEMTGGRKNVDVVDN  493 (506)
Q Consensus       444 ~~~~gt~~y~aPE~l~~~~~~~s~~~Dv~s~G~il~elltg~~pf~~~~~  493 (506)
                      ....|+..|+|||.+.+.  .++.++||||||+++|||++|+.||.....
T Consensus       159 ~~~~g~~~y~aPE~~~~~--~~~~~~DiwslG~~l~~l~~g~~Pf~~~~~  206 (285)
T cd05630         159 KGRVGTVGYMAPEVVKNE--RYTFSPDWWALGCLLYEMIAGQSPFQQRKK  206 (285)
T ss_pred             cCCCCCccccChHHHcCC--CCCCccccHHHHHHHHHHHhCCCCCCCCCc
Confidence            335689999999998653  688999999999999999999999986543

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as

>cd05033 PTKc_EphR Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases

Probab=99.95  E-value=5e-28  Score=234.36  Aligned_cols=175  Identities=26%  Similarity=0.505  Sum_probs=141.1

Q ss_pred             hhhccccCccCceEEEEEEEcC----CCEEEEEEeccCCC--CchhhHHHHHHhhccCccceeEEEEEe-----------
Q 039231          315 NSFKYKLGQGGYGSVYKGKLLD----GSNVAVKVLNDSKG--NGKEFINEVASISRTSHVNVVALLGFC-----------  377 (506)
Q Consensus       315 ~~~~~~ig~G~~g~V~~~~~~~----~~~vavK~l~~~~~--~~~~~~~E~~~l~~l~h~niv~l~g~~-----------  377 (506)
                      +.+.+.||+|+||.||+|++..    ...||||+++....  ...++.+|+..+++++||||+++++++           
T Consensus         6 ~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv~e   85 (266)
T cd05033           6 VTIEKVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGSSDKQRLDFLTEASIMGQFDHPNIIRLEGVVTKSRPVMIITE   85 (266)
T ss_pred             ceeeeEecCCccceEEEEEEccCCCCcceEEEEEcCCCCChHHHHHHHHHHHHHHhCCCCCcceEeEEEecCCceEEEEE
Confidence            3456789999999999998743    45799999875433  235788999999999999999999875           


Q ss_pred             -----------------eccchhhhHHHHHHHHHHHHhhcCCCCeEecCcCCCcEEECCCCcEEEeecCCCccccCCCcc
Q 039231          378 -----------------LRVAEELSSTIGIARGLEYLHLGCSTRILHFDIKPHNILLDEDFCPKISDFGLAKICNRKESI  440 (506)
Q Consensus       378 -----------------~~~~~~l~i~~~i~~gl~~LH~~~~~~ivH~dlkp~Nill~~~~~~ki~dfg~a~~~~~~~~~  440 (506)
                                       +++.+.+.++.|++.||+|||   +.+|+|+||||+||++++++.+||+|||+++........
T Consensus        86 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~Lh---~~~i~H~di~p~nili~~~~~~~l~dfg~~~~~~~~~~~  162 (266)
T cd05033          86 YMENGSLDKFLRENDGKFTVGQLVGMLRGIASGMKYLS---EMNYVHRDLAARNILVNSNLVCKVSDFGLSRRLEDSEAT  162 (266)
T ss_pred             cCCCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCCcceEEEcCCCCEEECccchhhcccccccc
Confidence                             123345678899999999999   899999999999999999999999999999877532222


Q ss_pred             eecccCCCCcccccccccccccCCCCccccHHHHHHHHHHHHc-CCCCCCCCCCC
Q 039231          441 ISMTGARGTVGYIAPEVFCRNIGEVSYKSDVYNYGMMIFEMTG-GRKNVDVVDNG  494 (506)
Q Consensus       441 ~~~~~~~gt~~y~aPE~l~~~~~~~s~~~Dv~s~G~il~ellt-g~~pf~~~~~~  494 (506)
                      .......+++.|+|||.+...  .++.++||||||+++|||++ |..||......
T Consensus       163 ~~~~~~~~~~~y~~Pe~~~~~--~~~~~~Dv~slG~~l~~l~~~g~~p~~~~~~~  215 (266)
T cd05033         163 YTTKGGKIPIRWTAPEAIAYR--KFTSASDVWSFGIVMWEVMSYGERPYWDMSNQ  215 (266)
T ss_pred             eeccCCCCCccccChhhhccC--CCccccchHHHHHHHHHHHccCCCCCCCCCHH
Confidence            222234456789999998653  68899999999999999998 99999765433

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment

>KOG0666 consensus Cyclin C-dependent kinase CDK8 [Transcription]

Probab=99.95  E-value=2.5e-29  Score=232.03  Aligned_cols=172  Identities=30%  Similarity=0.372  Sum_probs=141.6

Q ss_pred             ccccCccCceEEEEEEEcC-----CCEEEEEEeccCCC---CchhhHHHHHHhhccCccceeEEEEEeecc---------
Q 039231          318 KYKLGQGGYGSVYKGKLLD-----GSNVAVKVLNDSKG---NGKEFINEVASISRTSHVNVVALLGFCLRV---------  380 (506)
Q Consensus       318 ~~~ig~G~~g~V~~~~~~~-----~~~vavK~l~~~~~---~~~~~~~E~~~l~~l~h~niv~l~g~~~~~---------  380 (506)
                      ...||+|.+|.||+|.-.+     ...+|||+++.++.   -.....+|+..++.++|||++.|..+++..         
T Consensus        29 ig~Ig~GTYG~VykA~~~~~n~kr~k~yAiKkfk~~kd~tGiS~SAcREiaL~REl~h~nvi~Lv~Vfl~~d~~v~l~fd  108 (438)
T KOG0666|consen   29 IGKIGRGTYGKVYKAVRKNTNDKRTKEYAIKKFKGEKDGTGISMSACREIALLRELKHPNVISLVKVFLSHDKKVWLLFD  108 (438)
T ss_pred             cceecccccceeeEeeeccCCcccchhhHHHHHhccCCCCCcCHHHHHHHHHHHHhcCCcchhHHHHHhccCceEEEEeh
Confidence            4569999999999995322     23789999976533   236789999999999999999988766431         


Q ss_pred             -----------------------chhhhHHHHHHHHHHHHhhcCCCCeEecCcCCCcEEECCC----CcEEEeecCCCcc
Q 039231          381 -----------------------AEELSSTIGIARGLEYLHLGCSTRILHFDIKPHNILLDED----FCPKISDFGLAKI  433 (506)
Q Consensus       381 -----------------------~~~l~i~~~i~~gl~~LH~~~~~~ivH~dlkp~Nill~~~----~~~ki~dfg~a~~  433 (506)
                                             .....|..||+.|+.|||   +.-|+||||||.|||+..+    |.+||+|+|+++.
T Consensus       109 YAEhDL~~II~fHr~~~~~~lp~~mvKsilwQil~Gv~YLH---~NWvlHRDLKPaNIlvmgdgperG~VKIaDlGlaR~  185 (438)
T KOG0666|consen  109 YAEHDLWHIIKFHRASKAKQLPRSMVKSILWQILDGVHYLH---SNWVLHRDLKPANILVMGDGPERGRVKIADLGLARL  185 (438)
T ss_pred             hhhhhHHHHHHHhccchhccCCHHHHHHHHHHHHhhhHHHh---hhheeeccCCcceEEEeccCCccCeeEeecccHHHH
Confidence                                   114568889999999999   8999999999999999777    8999999999998


Q ss_pred             ccCCCcce-ecccCCCCcccccccccccccCCCCccccHHHHHHHHHHHHcCCCCCCCCCC
Q 039231          434 CNRKESII-SMTGARGTVGYIAPEVFCRNIGEVSYKSDVYNYGMMIFEMTGGRKNVDVVDN  493 (506)
Q Consensus       434 ~~~~~~~~-~~~~~~gt~~y~aPE~l~~~~~~~s~~~Dv~s~G~il~elltg~~pf~~~~~  493 (506)
                      +...-... +....+-|..|.|||++.+. ..|+.+.||||.|||..||+|-++.|.....
T Consensus       186 ~~~plkpl~s~d~VVVTiWYRAPELLLGa-~hYT~AiDvWAiGCIfaElLtl~PlF~g~E~  245 (438)
T KOG0666|consen  186 FNNPLKPLASLDPVVVTIWYRAPELLLGA-RHYTKAIDVWAIGCIFAELLTLEPLFKGREE  245 (438)
T ss_pred             hhccccccccCCceEEEEEecChHHhccc-ccccchhhhHHHHHHHHHHHccCccccchhh
Confidence            76543222 34556779999999999886 5899999999999999999999999987644

>cd07861 STKc_CDK1_euk Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like

Probab=99.95  E-value=6.4e-28  Score=235.88  Aligned_cols=171  Identities=30%  Similarity=0.408  Sum_probs=139.7

Q ss_pred             hccccCccCceEEEEEEEc-CCCEEEEEEeccCC---CCchhhHHHHHHhhccCccceeEEEEEee--------------
Q 039231          317 FKYKLGQGGYGSVYKGKLL-DGSNVAVKVLNDSK---GNGKEFINEVASISRTSHVNVVALLGFCL--------------  378 (506)
Q Consensus       317 ~~~~ig~G~~g~V~~~~~~-~~~~vavK~l~~~~---~~~~~~~~E~~~l~~l~h~niv~l~g~~~--------------  378 (506)
                      +.+.||+|++|.||+|+.. ++..||+|+++...   ...+.+.+|+.++++++||||+++++++.              
T Consensus         4 ~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~   83 (285)
T cd07861           4 KIEKIGEGTYGVVYKGRNKKTGQIVAMKKIRLESEEEGVPSTAIREISLLKELQHPNIVCLQDVLMQESRLYLIFEFLSM   83 (285)
T ss_pred             EeeEecccCceEEEEEEECCCCcEEEEEEeccccccCCchHHHHHHHHHHHhcCCCCEeeeEEEEeeCCeEEEEEecCCC
Confidence            3467999999999999875 58999999986432   22367889999999999999999998872              


Q ss_pred             ---------------ccchhhhHHHHHHHHHHHHhhcCCCCeEecCcCCCcEEECCCCcEEEeecCCCccccCCCcceec
Q 039231          379 ---------------RVAEELSSTIGIARGLEYLHLGCSTRILHFDIKPHNILLDEDFCPKISDFGLAKICNRKESIISM  443 (506)
Q Consensus       379 ---------------~~~~~l~i~~~i~~gl~~LH~~~~~~ivH~dlkp~Nill~~~~~~ki~dfg~a~~~~~~~~~~~~  443 (506)
                                     ++.+.+.++.|++.||+|||   +++++|+||+|+||++++++.+||+|||++........  ..
T Consensus        84 ~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH---~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~--~~  158 (285)
T cd07861          84 DLKKYLDSLPKGQYMDAELVKSYLYQILQGILFCH---SRRVLHRDLKPQNLLIDNKGVIKLADFGLARAFGIPVR--VY  158 (285)
T ss_pred             CHHHHHhcCCCCCcCCHHHHHHHHHHHHHHHHHHH---hCCeeecCCCHHHEEEcCCCcEEECcccceeecCCCcc--cc
Confidence                           12224568899999999999   89999999999999999999999999999876543221  11


Q ss_pred             ccCCCCcccccccccccccCCCCccccHHHHHHHHHHHHcCCCCCCCCCC
Q 039231          444 TGARGTVGYIAPEVFCRNIGEVSYKSDVYNYGMMIFEMTGGRKNVDVVDN  493 (506)
Q Consensus       444 ~~~~gt~~y~aPE~l~~~~~~~s~~~Dv~s~G~il~elltg~~pf~~~~~  493 (506)
                      ....+++.|+|||.+.+. ..++.++||||||+++|||++|+.||.....
T Consensus       159 ~~~~~~~~y~aPE~~~~~-~~~~~~~Dv~slG~il~~l~tg~~~~~~~~~  207 (285)
T cd07861         159 THEVVTLWYRAPEVLLGS-PRYSTPVDIWSIGTIFAEMATKKPLFHGDSE  207 (285)
T ss_pred             cCCcccccccChHHhcCC-CCcCcHHHHHHHHHHHHHHHHCCCCCCCCCH
Confidence            334568899999988553 3578899999999999999999999986543

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2

>cd05105 PTKc_PDGFR_alpha Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha

Probab=99.95  E-value=5e-28  Score=247.37  Aligned_cols=174  Identities=30%  Similarity=0.477  Sum_probs=138.6

Q ss_pred             hhccccCccCceEEEEEEEcC------CCEEEEEEeccCCC--CchhhHHHHHHhhccC-ccceeEEEEEeecc------
Q 039231          316 SFKYKLGQGGYGSVYKGKLLD------GSNVAVKVLNDSKG--NGKEFINEVASISRTS-HVNVVALLGFCLRV------  380 (506)
Q Consensus       316 ~~~~~ig~G~~g~V~~~~~~~------~~~vavK~l~~~~~--~~~~~~~E~~~l~~l~-h~niv~l~g~~~~~------  380 (506)
                      .+.+.||+|+||.||+|+...      +..||||+++....  ..+.+.+|++++++++ ||||+++++++.+.      
T Consensus        40 ~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~~l~~l~~HpnIv~l~~~~~~~~~~~lv  119 (400)
T cd05105          40 VLGRILGSGAFGKVVEGTAYGLSRSQPVMKVAVKMLKPTARSSEKQALMSELKIMTHLGPHLNIVNLLGACTKSGPIYII  119 (400)
T ss_pred             ehhheecCCCCceEEEEEEcccCCCCCceEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCCCeeeEEEEEccCCceEEE
Confidence            345679999999999998532      34799999975432  2357899999999996 99999999887211      


Q ss_pred             --------------------------------------------------------------------------------
Q 039231          381 --------------------------------------------------------------------------------  380 (506)
Q Consensus       381 --------------------------------------------------------------------------------  380 (506)
                                                                                                      
T Consensus       120 ~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  199 (400)
T cd05105         120 TEYCFYGDLVNYLHKNRDNFLSRHPEKPKKDLDIFGINPADESTRSYVILSFENKGDYMDMKQADTTQYVPMLEIKEASK  199 (400)
T ss_pred             EEecCCCcHHHHHHHhhhhhhccccccccccccccCCCcccccccchhhhhhcccccccccccccccccchhhhhhhhhh
Confidence                                                                                            


Q ss_pred             -------------------------------------chhhhHHHHHHHHHHHHhhcCCCCeEecCcCCCcEEECCCCcE
Q 039231          381 -------------------------------------AEELSSTIGIARGLEYLHLGCSTRILHFDIKPHNILLDEDFCP  423 (506)
Q Consensus       381 -------------------------------------~~~l~i~~~i~~gl~~LH~~~~~~ivH~dlkp~Nill~~~~~~  423 (506)
                                                           .+.+.++.|+++||+|||   +.+|+|+||||+|||+++++.+
T Consensus       200 ~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH---~~~ivH~dikp~Nill~~~~~~  276 (400)
T cd05105         200 YSDIQRSNYDRPASYKGSNDSEVKNLLSDDGSEGLTTLDLLSFTYQVARGMEFLA---SKNCVHRDLAARNVLLAQGKIV  276 (400)
T ss_pred             hhhcccCcccccccccCcchhhHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHH---hCCeeCCCCChHhEEEeCCCEE
Confidence                                                 012457889999999999   8999999999999999999999


Q ss_pred             EEeecCCCccccCCCcceecccCCCCcccccccccccccCCCCccccHHHHHHHHHHHHc-CCCCCCCCCCC
Q 039231          424 KISDFGLAKICNRKESIISMTGARGTVGYIAPEVFCRNIGEVSYKSDVYNYGMMIFEMTG-GRKNVDVVDNG  494 (506)
Q Consensus       424 ki~dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~s~~~Dv~s~G~il~ellt-g~~pf~~~~~~  494 (506)
                      ||+|||+++...............++..|+|||.+.+.  .++.++||||||+++|||++ |..||......
T Consensus       277 kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~--~~~~~~DiwSlGvil~ellt~g~~P~~~~~~~  346 (400)
T cd05105         277 KICDFGLARDIMHDSNYVSKGSTFLPVKWMAPESIFDN--LYTTLSDVWSYGILLWEIFSLGGTPYPGMIVD  346 (400)
T ss_pred             EEEeCCcceeccccccccccCCcCCCcceEChhhhcCC--CCCchhhHHHHHHHHHHHHHCCCCCCcccchh
Confidence            99999999866443322222334567889999998553  68899999999999999997 99999875443

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-

>cd05062 PTKc_IGF-1R Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor

Probab=99.95  E-value=5.8e-28  Score=235.41  Aligned_cols=174  Identities=27%  Similarity=0.477  Sum_probs=138.2

Q ss_pred             hhhccccCccCceEEEEEEEc------CCCEEEEEEeccCCC--CchhhHHHHHHhhccCccceeEEEEEeec-------
Q 039231          315 NSFKYKLGQGGYGSVYKGKLL------DGSNVAVKVLNDSKG--NGKEFINEVASISRTSHVNVVALLGFCLR-------  379 (506)
Q Consensus       315 ~~~~~~ig~G~~g~V~~~~~~------~~~~vavK~l~~~~~--~~~~~~~E~~~l~~l~h~niv~l~g~~~~-------  379 (506)
                      +.+.+.||+|++|.||+|...      .+..+|+|+++....  ...++.+|+.++++++||||+++++++.+       
T Consensus         8 ~~~~~~ig~G~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~lv   87 (277)
T cd05062           8 ITMSRELGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQPTLVI   87 (277)
T ss_pred             ceeeeeeccccCCeEEEEEeccCCCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCeEEE
Confidence            445678999999999999753      246799999864322  23568899999999999999999987611       


Q ss_pred             ------------------------------cchhhhHHHHHHHHHHHHhhcCCCCeEecCcCCCcEEECCCCcEEEeecC
Q 039231          380 ------------------------------VAEELSSTIGIARGLEYLHLGCSTRILHFDIKPHNILLDEDFCPKISDFG  429 (506)
Q Consensus       380 ------------------------------~~~~l~i~~~i~~gl~~LH~~~~~~ivH~dlkp~Nill~~~~~~ki~dfg  429 (506)
                                                    +...+.++.|++.||+|||   +.+++|+||||+||++++++.+||+|||
T Consensus        88 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH---~~~~vH~dlkp~Nil~~~~~~~~l~dfg  164 (277)
T cd05062          88 MELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADGMAYLN---ANKFVHRDLAARNCMVAEDFTVKIGDFG  164 (277)
T ss_pred             EecCCCCCHHHHHHHcCccccccccccCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCcchheEEEcCCCCEEECCCC
Confidence                                          1124567889999999999   8999999999999999999999999999


Q ss_pred             CCccccCCCcceecccCCCCcccccccccccccCCCCccccHHHHHHHHHHHHc-CCCCCCCCCC
Q 039231          430 LAKICNRKESIISMTGARGTVGYIAPEVFCRNIGEVSYKSDVYNYGMMIFEMTG-GRKNVDVVDN  493 (506)
Q Consensus       430 ~a~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~s~~~Dv~s~G~il~ellt-g~~pf~~~~~  493 (506)
                      +++...............+++.|+|||.+.+  +.++.++||||||+++|||++ |..||.....
T Consensus       165 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~--~~~~~~~Di~slG~~l~el~~~~~~p~~~~~~  227 (277)
T cd05062         165 MTRDIYETDYYRKGGKGLLPVRWMSPESLKD--GVFTTYSDVWSFGVVLWEIATLAEQPYQGMSN  227 (277)
T ss_pred             CccccCCcceeecCCCCccCHhhcChhHhhc--CCcCchhHHHHHHHHHHHHHcCCCCCCCCCCH
Confidence            9876544332221123345778999999854  368999999999999999998 7899976543

Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, wh

>KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis]

Probab=99.95  E-value=1.5e-28  Score=261.79  Aligned_cols=175  Identities=33%  Similarity=0.463  Sum_probs=139.0

Q ss_pred             HHhhhc--cccCccCceEEEEEEEc-CCCEEEEEEeccC--CCCchhhHHHHHHhhccCccceeEEEEEee---------
Q 039231          313 MTNSFK--YKLGQGGYGSVYKGKLL-DGSNVAVKVLNDS--KGNGKEFINEVASISRTSHVNVVALLGFCL---------  378 (506)
Q Consensus       313 ~~~~~~--~~ig~G~~g~V~~~~~~-~~~~vavK~l~~~--~~~~~~~~~E~~~l~~l~h~niv~l~g~~~---------  378 (506)
                      ...+|+  +.||+||||.||+++.+ ||+.+|||++.-.  ......+.+|++.|++++|||||+++..+.         
T Consensus       477 Y~~DFEEL~lLGkGGFG~VvkVRNKlDGr~YAIKKIpl~~s~~~~skI~rEVk~LArLnHpNVVRYysAWVEs~~~~~~~  556 (1351)
T KOG1035|consen  477 YLNDFEELELLGKGGFGSVVKVRNKLDGREYAIKKIPLKASDKLYSKILREVKLLARLNHPNVVRYYSAWVESTAELTVL  556 (1351)
T ss_pred             HhhhhHHHHHhcCCCCceEEEEeecccchhhhhhhccCchHHHHHHHHHHHHHHHhhcCCcceeeeehhhhccCCccccc
Confidence            344454  36999999999999975 7999999999654  333467899999999999999999986550         


Q ss_pred             --------------------------------------------------------------------------------
Q 039231          379 --------------------------------------------------------------------------------  378 (506)
Q Consensus       379 --------------------------------------------------------------------------------  378 (506)
                                                                                                      
T Consensus       557 ei~~~~~~~~sQs~s~~~~~~~~~q~t~~p~~~~~~~~~~~~dd~sss~~~~~~~~~~~~d~e~~d~dedg~~~S~tS~~  636 (1351)
T KOG1035|consen  557 EIVASDSESRSQSASKYNGVDIRYQPTSSPSLTLSELDSEDEDDKSSSYTTRKASYESSTDEENDDSDEDGRNLSNTSDS  636 (1351)
T ss_pred             cccccchhhhcccCCCcccceeeeccCCCcccCcchhhccccCccccccccccccccccCCccccccccccccccccccc
Confidence                                                                                            


Q ss_pred             ----------------------------------------------------------ccchhhhHHHHHHHHHHHHhhc
Q 039231          379 ----------------------------------------------------------RVAEELSSTIGIARGLEYLHLG  400 (506)
Q Consensus       379 ----------------------------------------------------------~~~~~l~i~~~i~~gl~~LH~~  400 (506)
                                                                                .....++++.+|++||+|+|  
T Consensus       637 e~~~~~d~~~ess~s~~~~~n~~e~~~~~q~~~~LYIQMEyCE~~ll~~iI~~N~~~~~~d~~wrLFreIlEGLaYIH--  714 (1351)
T KOG1035|consen  637 EGSVILDDTSESSESIPKTENSSEPMVPVQKPLILYIQMEYCEKTLLRDIIRRNHFNSQRDEAWRLFREILEGLAYIH--  714 (1351)
T ss_pred             CCccccCcchhhhhhccccCCccccccccccceEEEEEHhhhhhhHHHHHHHhcccchhhHHHHHHHHHHHHHHHHHH--
Confidence                                                                      00115678999999999999  


Q ss_pred             CCCCeEecCcCCCcEEECCCCcEEEeecCCCcccc----------------CCCcceecccCCCCcccccccccccccC-
Q 039231          401 CSTRILHFDIKPHNILLDEDFCPKISDFGLAKICN----------------RKESIISMTGARGTVGYIAPEVFCRNIG-  463 (506)
Q Consensus       401 ~~~~ivH~dlkp~Nill~~~~~~ki~dfg~a~~~~----------------~~~~~~~~~~~~gt~~y~aPE~l~~~~~-  463 (506)
                       +++||||||||.||+|+++..+||+|||+|....                ........+...||.-|+|||++.+... 
T Consensus       715 -~~giIHRDLKP~NIFLd~~~~VKIGDFGLAt~~~~~~~~~d~~~~~~~~~~g~~~~~~Ts~VGTalYvAPEll~~~~~~  793 (1351)
T KOG1035|consen  715 -DQGIIHRDLKPRNIFLDSRNSVKIGDFGLATDLKENLESIDQDLSFSTNRAGSNDGDLTSQVGTALYVAPELLSDTSSN  793 (1351)
T ss_pred             -hCceeeccCCcceeEEcCCCCeeecccccchhhhhhhhhHhhccCccccccCCCCcccccccceeeeecHHHhcccccc
Confidence             9999999999999999999999999999998721                0111112356789999999999966532 


Q ss_pred             CCCccccHHHHHHHHHHHHcCCCCCCCCCC
Q 039231          464 EVSYKSDVYNYGMMIFEMTGGRKNVDVVDN  493 (506)
Q Consensus       464 ~~s~~~Dv~s~G~il~elltg~~pf~~~~~  493 (506)
                      .|+.|+|+||+|||++||+   .||....+
T Consensus       794 ~Yn~KiDmYSLGIVlFEM~---yPF~TsME  820 (1351)
T KOG1035|consen  794 KYNSKIDMYSLGIVLFEML---YPFGTSME  820 (1351)
T ss_pred             cccchhhhHHHHHHHHHHh---ccCCchHH
Confidence            6999999999999999998   34654433

>PHA03209 serine/threonine kinase US3; Provisional

Probab=99.95  E-value=4.6e-28  Score=244.93  Aligned_cols=162  Identities=27%  Similarity=0.380  Sum_probs=133.1

Q ss_pred             hhhccccCccCceEEEEEEEcC-CCEEEEEEeccCCCCchhhHHHHHHhhccCccceeEEEEEe----------------
Q 039231          315 NSFKYKLGQGGYGSVYKGKLLD-GSNVAVKVLNDSKGNGKEFINEVASISRTSHVNVVALLGFC----------------  377 (506)
Q Consensus       315 ~~~~~~ig~G~~g~V~~~~~~~-~~~vavK~l~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~----------------  377 (506)
                      +.+.+.||+|+||.||+|+... +..||+|+...     .....|+.++++++|+||+++++++                
T Consensus        68 y~~~~~lg~G~~g~Vy~~~~~~~~~~valK~~~~-----~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~  142 (357)
T PHA03209         68 YTVIKTLTPGSEGRVFVATKPGQPDPVVLKIGQK-----GTTLIEAMLLQNVNHPSVIRMKDTLVSGAITCMVLPHYSSD  142 (357)
T ss_pred             cEEEEEecCCCCeEEEEEEECCCCceEEEEeCCc-----cccHHHHHHHHhCCCCCCcChhheEEeCCeeEEEEEccCCc
Confidence            3445789999999999998754 68899997532     2346799999999999999998876                


Q ss_pred             -----------eccchhhhHHHHHHHHHHHHhhcCCCCeEecCcCCCcEEECCCCcEEEeecCCCccccCCCcceecccC
Q 039231          378 -----------LRVAEELSSTIGIARGLEYLHLGCSTRILHFDIKPHNILLDEDFCPKISDFGLAKICNRKESIISMTGA  446 (506)
Q Consensus       378 -----------~~~~~~l~i~~~i~~gl~~LH~~~~~~ivH~dlkp~Nill~~~~~~ki~dfg~a~~~~~~~~~~~~~~~  446 (506)
                                 +.+.+++.++.||+.||+|||   +++|+||||||+|||++.++.+||+|||+++.......   ....
T Consensus       143 l~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH---~~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~~---~~~~  216 (357)
T PHA03209        143 LYTYLTKRSRPLPIDQALIIEKQILEGLRYLH---AQRIIHRDVKTENIFINDVDQVCIGDLGAAQFPVVAPA---FLGL  216 (357)
T ss_pred             HHHHHHhccCCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHEEECCCCCEEEecCccccccccCcc---cccc
Confidence                       233446778999999999999   89999999999999999999999999999975432221   1345


Q ss_pred             CCCcccccccccccccCCCCccccHHHHHHHHHHHHcCCCCCC
Q 039231          447 RGTVGYIAPEVFCRNIGEVSYKSDVYNYGMMIFEMTGGRKNVD  489 (506)
Q Consensus       447 ~gt~~y~aPE~l~~~~~~~s~~~Dv~s~G~il~elltg~~pf~  489 (506)
                      .||+.|+|||++.+.  .++.++|||||||++|||+++..|+.
T Consensus       217 ~gt~~y~aPE~~~~~--~~~~~~DiwSlGvvl~ell~~~~~~f  257 (357)
T PHA03209        217 AGTVETNAPEVLARD--KYNSKADIWSAGIVLFEMLAYPSTIF  257 (357)
T ss_pred             cccccccCCeecCCC--CCCchhhHHHHHHHHHHHHHcCCccc
Confidence            689999999998654  68999999999999999998655553

>KOG2345 consensus Serine/threonine protein kinase/TGF-beta stimulated factor [Transcription; Lipid transport and metabolism; Signal transduction mechanisms]

Probab=99.95  E-value=3.5e-29  Score=224.68  Aligned_cols=178  Identities=28%  Similarity=0.366  Sum_probs=143.1

Q ss_pred             HhhhccccCccCceEEEEEE-EcCCCEEEEEEeccCC-CCchhhHHHHHHhhccCccceeEEEEEe--------------
Q 039231          314 TNSFKYKLGQGGYGSVYKGK-LLDGSNVAVKVLNDSK-GNGKEFINEVASISRTSHVNVVALLGFC--------------  377 (506)
Q Consensus       314 ~~~~~~~ig~G~~g~V~~~~-~~~~~~vavK~l~~~~-~~~~~~~~E~~~l~~l~h~niv~l~g~~--------------  377 (506)
                      ++.+.+.+|.|||+-||.++ ..++..+|+|++.-.. ++.+..++|++..++++|||+++++++.              
T Consensus        22 Ryri~~~LgeGGfsfv~LV~~~s~~~~YAlKkI~c~~~~~~e~~~rEid~~rkf~s~~vl~l~dh~l~~~~D~~~~~yll  101 (302)
T KOG2345|consen   22 RYRIQRLLGEGGFSFVDLVKGLSTGHLYALKKILCHSQEDIEEALREIDNHRKFNSPNVLRLVDHQLREEKDGKHEAYLL  101 (302)
T ss_pred             eEEEeeeecCCCceeeeeecccCcccchhhheeeccchHHHHHHHHHHHHHHhhCCcchHHHHHHHHHhhccCceeEEEE
Confidence            44567789999999999998 4678999999987544 5567889999999999999999887543              


Q ss_pred             ----------------------eccchhhhHHHHHHHHHHHHhhcCCCCeEecCcCCCcEEECCCCcEEEeecCCCcccc
Q 039231          378 ----------------------LRVAEELSSTIGIARGLEYLHLGCSTRILHFDIKPHNILLDEDFCPKISDFGLAKICN  435 (506)
Q Consensus       378 ----------------------~~~~~~l~i~~~i~~gl~~LH~~~~~~ivH~dlkp~Nill~~~~~~ki~dfg~a~~~~  435 (506)
                                            +++.+.+.|+.+|++||++||+. ..++.||||||.|||+.+++.++|.|||.+....
T Consensus       102 ~Pyy~~Gsl~d~i~~~k~kg~~~sE~~iL~if~gic~gL~~lH~~-~~~yAH~DiKP~NILls~~~~~vl~D~GS~~~a~  180 (302)
T KOG2345|consen  102 LPYYKRGSLLDEIERLKIKGNFVSEAQILWIFLGICRGLEALHEK-EPPYAHRDIKPANILLSDSGLPVLMDLGSATQAP  180 (302)
T ss_pred             eehhccccHHHHHHHHhhcCCccCHHHHHHHHHHHHHHHHHHhcc-CCcccccCCCcceeEecCCCceEEEeccCccccc
Confidence                                  34555788999999999999943 3359999999999999999999999999987643


Q ss_pred             CCC-------cceecccCCCCccccccccccccc-CCCCccccHHHHHHHHHHHHcCCCCCCCCC
Q 039231          436 RKE-------SIISMTGARGTVGYIAPEVFCRNI-GEVSYKSDVYNYGMMIFEMTGGRKNVDVVD  492 (506)
Q Consensus       436 ~~~-------~~~~~~~~~gt~~y~aPE~l~~~~-~~~s~~~Dv~s~G~il~elltg~~pf~~~~  492 (506)
                      -.-       .........-|..|.|||++.-+. ...++++|||||||+||+|+.|..||+...
T Consensus       181 i~i~~~~~a~~lQe~a~e~Ct~pyRAPELf~vk~~~ti~ertDIWSLGCtLYa~mf~~sPfe~~~  245 (302)
T KOG2345|consen  181 IQIEGSRQALRLQEWAEERCTIPYRAPELFNVKSHCTITERTDIWSLGCTLYAMMFGESPFERIY  245 (302)
T ss_pred             eEeechHHHHHHHHHHHHhCCCcccCchheecccCcccccccchhhhhHHHHHHHHcCCcchHHh
Confidence            110       000113345689999999985332 357899999999999999999999998643

>PHA03210 serine/threonine kinase US3; Provisional

Probab=99.95  E-value=1.7e-28  Score=258.30  Aligned_cols=170  Identities=20%  Similarity=0.304  Sum_probs=130.4

Q ss_pred             HhhhccccCccCceEEEEEEEcC--CCEEEEE------------------EeccCCCCchhhHHHHHHhhccCccceeEE
Q 039231          314 TNSFKYKLGQGGYGSVYKGKLLD--GSNVAVK------------------VLNDSKGNGKEFINEVASISRTSHVNVVAL  373 (506)
Q Consensus       314 ~~~~~~~ig~G~~g~V~~~~~~~--~~~vavK------------------~l~~~~~~~~~~~~E~~~l~~l~h~niv~l  373 (506)
                      .+.+.++||+|+||+||++.++.  +...++|                  .+.........+.+|++++++++|||||++
T Consensus       149 ~Y~ii~~LG~G~fG~Vyl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l  228 (501)
T PHA03210        149 HFRVIDDLPAGAFGKIFICALRASTEEAEARRGVNSTNQGKPKCERLIAKRVKAGSRAAIQLENEILALGRLNHENILKI  228 (501)
T ss_pred             ccEEEeEecCCCCcceEEEEEeccchhhhhhhccccccccchhhhhhHhHHhhcchHHHHHHHHHHHHHHhCCCCCcCcE
Confidence            34455789999999999987543  2222222                  111222223567899999999999999999


Q ss_pred             EEEeec-------------------------------cchhhhHHHHHHHHHHHHhhcCCCCeEecCcCCCcEEECCCCc
Q 039231          374 LGFCLR-------------------------------VAEELSSTIGIARGLEYLHLGCSTRILHFDIKPHNILLDEDFC  422 (506)
Q Consensus       374 ~g~~~~-------------------------------~~~~l~i~~~i~~gl~~LH~~~~~~ivH~dlkp~Nill~~~~~  422 (506)
                      ++++..                               ..+...++.||+.||+|||   +++|+||||||+|||++.++.
T Consensus       229 ~~~~~~~~~~~lv~e~~~~~l~~~l~~~~~~~~~~~~~~~~~~i~~ql~~aL~yLH---~~gIiHrDLKP~NILl~~~~~  305 (501)
T PHA03210        229 EEILRSEANTYMITQKYDFDLYSFMYDEAFDWKDRPLLKQTRAIMKQLLCAVEYIH---DKKLIHRDIKLENIFLNCDGK  305 (501)
T ss_pred             eEEEEECCeeEEEEeccccCHHHHHhhccccccccccHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEECCCCC
Confidence            987611                               1123458899999999999   899999999999999999999


Q ss_pred             EEEeecCCCccccCCCcceecccCCCCcccccccccccccCCCCccccHHHHHHHHHHHHcCCCCCC
Q 039231          423 PKISDFGLAKICNRKESIISMTGARGTVGYIAPEVFCRNIGEVSYKSDVYNYGMMIFEMTGGRKNVD  489 (506)
Q Consensus       423 ~ki~dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~s~~~Dv~s~G~il~elltg~~pf~  489 (506)
                      +||+|||+++......... .....||..|+|||++.+.  .++.++|||||||++|||++|..++.
T Consensus       306 vkL~DFGla~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~--~~~~~~DiwSlGvil~ell~~~~~p~  369 (501)
T PHA03210        306 IVLGDFGTAMPFEKEREAF-DYGWVGTVATNSPEILAGD--GYCEITDIWSCGLILLDMLSHDFCPI  369 (501)
T ss_pred             EEEEeCCCceecCcccccc-cccccCCcCCCCchhhcCC--CCCcHHHHHHHHHHHHHHHHCCCCCc
Confidence            9999999998765433221 1345789999999998654  68899999999999999999886543

>cd05073 PTKc_Hck Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase

Probab=99.95  E-value=4.3e-28  Score=234.02  Aligned_cols=176  Identities=26%  Similarity=0.468  Sum_probs=144.6

Q ss_pred             HHHhhhccccCccCceEEEEEEEcCCCEEEEEEeccCCCCchhhHHHHHHhhccCccceeEEEEEee-------------
Q 039231          312 KMTNSFKYKLGQGGYGSVYKGKLLDGSNVAVKVLNDSKGNGKEFINEVASISRTSHVNVVALLGFCL-------------  378 (506)
Q Consensus       312 ~~~~~~~~~ig~G~~g~V~~~~~~~~~~vavK~l~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~-------------  378 (506)
                      ...+.+.++||+|+||.||+|...++..+++|.+.......+.+.+|++++++++|+||+++.+.+.             
T Consensus         5 ~~~~~~~~~lg~g~~~~vy~~~~~~~~~~~iK~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~v~e~~~~   84 (260)
T cd05073           5 RESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPGSMSVEAFLAEANVMKTLQHDKLVKLHAVVTKEPIYIITEFMAK   84 (260)
T ss_pred             ccceeEEeEecCccceEEEEEEecCCccEEEEecCCChhHHHHHHHHHHHHHhcCCCCcceEEEEEcCCCeEEEEEeCCC
Confidence            3445567889999999999999888888999998765555578999999999999999999988751             


Q ss_pred             ---------------ccchhhhHHHHHHHHHHHHhhcCCCCeEecCcCCCcEEECCCCcEEEeecCCCccccCCCcceec
Q 039231          379 ---------------RVAEELSSTIGIARGLEYLHLGCSTRILHFDIKPHNILLDEDFCPKISDFGLAKICNRKESIISM  443 (506)
Q Consensus       379 ---------------~~~~~l~i~~~i~~gl~~LH~~~~~~ivH~dlkp~Nill~~~~~~ki~dfg~a~~~~~~~~~~~~  443 (506)
                                     ++.+++.++.|++.||.|||   +.+++|+||||+||+++.++.+||+|||.+......... ..
T Consensus        85 ~~L~~~~~~~~~~~~~~~~~~~~~~~l~~aL~~lH---~~~i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~~-~~  160 (260)
T cd05073          85 GSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIE---QRNYIHRDLRAANILVSASLVCKIADFGLARVIEDNEYT-AR  160 (260)
T ss_pred             CcHHHHHHhCCccccCHHHHHHHHHHHHHHHHHHH---hCCccccccCcceEEEcCCCcEEECCCcceeeccCCCcc-cc
Confidence                           22235668899999999999   899999999999999999999999999999765433221 11


Q ss_pred             ccCCCCcccccccccccccCCCCccccHHHHHHHHHHHHc-CCCCCCCCCC
Q 039231          444 TGARGTVGYIAPEVFCRNIGEVSYKSDVYNYGMMIFEMTG-GRKNVDVVDN  493 (506)
Q Consensus       444 ~~~~gt~~y~aPE~l~~~~~~~s~~~Dv~s~G~il~ellt-g~~pf~~~~~  493 (506)
                      ....++..|+|||.+..  +.++.++|+||||+++|||++ |+.||...+.
T Consensus       161 ~~~~~~~~y~~PE~~~~--~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~  209 (260)
T cd05073         161 EGAKFPIKWTAPEAINF--GSFTIKSDVWSFGILLMEIVTYGRIPYPGMSN  209 (260)
T ss_pred             cCCcccccccCHhHhcc--CCcCccccchHHHHHHHHHHhcCCCCCCCCCH
Confidence            23345678999999854  368889999999999999998 9999976543

Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pa

>cd05085 PTKc_Fer Catalytic domain of the Protein Tyrosine Kinase, Fer

Probab=99.95  E-value=9.2e-28  Score=230.12  Aligned_cols=169  Identities=30%  Similarity=0.497  Sum_probs=138.1

Q ss_pred             ccCccCceEEEEEEEcCCCEEEEEEeccCCCC--chhhHHHHHHhhccCccceeEEEEEe--------------------
Q 039231          320 KLGQGGYGSVYKGKLLDGSNVAVKVLNDSKGN--GKEFINEVASISRTSHVNVVALLGFC--------------------  377 (506)
Q Consensus       320 ~ig~G~~g~V~~~~~~~~~~vavK~l~~~~~~--~~~~~~E~~~l~~l~h~niv~l~g~~--------------------  377 (506)
                      +||+|+||.||+|...+++.+|+|+++.....  ...+.+|++.+++++||||+++++++                    
T Consensus         2 ~ig~g~~g~vy~~~~~~~~~~a~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~   81 (250)
T cd05085           2 LLGKGNFGEVFKGTLKDKTPVAVKTCKEDLPQELKIKFLSEARILKQYDHPNIVKLIGVCTQRQPIYIVMELVPGGDFLS   81 (250)
T ss_pred             ccCCCCCceEEEEEecCCcEEEEEecCCcCCHHHHHHHHHHHHHHHhCCCCCcCeEEEEEecCCccEEEEECCCCCcHHH
Confidence            69999999999999888999999998754322  24688999999999999999999876                    


Q ss_pred             --------eccchhhhHHHHHHHHHHHHhhcCCCCeEecCcCCCcEEECCCCcEEEeecCCCccccCCCcceecccCCCC
Q 039231          378 --------LRVAEELSSTIGIARGLEYLHLGCSTRILHFDIKPHNILLDEDFCPKISDFGLAKICNRKESIISMTGARGT  449 (506)
Q Consensus       378 --------~~~~~~l~i~~~i~~gl~~LH~~~~~~ivH~dlkp~Nill~~~~~~ki~dfg~a~~~~~~~~~~~~~~~~gt  449 (506)
                              +++...+.++.|++.||.|||   +++++|+||||+||++++++.+||+|||++.......... .....++
T Consensus        82 ~~~~~~~~~~~~~~~~~~~~i~~~l~~lH---~~~~~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~~~-~~~~~~~  157 (250)
T cd05085          82 FLRKKKDELKTKQLVKFALDAAAGMAYLE---SKNCIHRDLAARNCLVGENNVLKISDFGMSRQEDDGIYSS-SGLKQIP  157 (250)
T ss_pred             HHHhcCCCCCHHHHHHHHHHHHHHHHHHH---hCCeeecccChheEEEcCCCeEEECCCccceecccccccc-CCCCCCc
Confidence                    123335678899999999999   8999999999999999999999999999987543322111 1123446


Q ss_pred             cccccccccccccCCCCccccHHHHHHHHHHHHc-CCCCCCCCCCC
Q 039231          450 VGYIAPEVFCRNIGEVSYKSDVYNYGMMIFEMTG-GRKNVDVVDNG  494 (506)
Q Consensus       450 ~~y~aPE~l~~~~~~~s~~~Dv~s~G~il~ellt-g~~pf~~~~~~  494 (506)
                      +.|+|||++..  +.++.++||||||+++|||++ |..||......
T Consensus       158 ~~y~aPE~~~~--~~~~~~~Di~slG~ll~~~~~~g~~p~~~~~~~  201 (250)
T cd05085         158 IKWTAPEALNY--GRYSSESDVWSYGILLWETFSLGVCPYPGMTNQ  201 (250)
T ss_pred             ccccCHHHhcc--CCCCchhHHHHHHHHHHHHhcCCCCCCCCCCHH
Confidence            77999999854  468899999999999999998 99999765443

Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-c

>cd05148 PTKc_Srm_Brk Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk

Probab=99.95  E-value=7e-28  Score=232.48  Aligned_cols=174  Identities=29%  Similarity=0.540  Sum_probs=144.7

Q ss_pred             hhhccccCccCceEEEEEEEcCCCEEEEEEeccCCC-CchhhHHHHHHhhccCccceeEEEEEe----------------
Q 039231          315 NSFKYKLGQGGYGSVYKGKLLDGSNVAVKVLNDSKG-NGKEFINEVASISRTSHVNVVALLGFC----------------  377 (506)
Q Consensus       315 ~~~~~~ig~G~~g~V~~~~~~~~~~vavK~l~~~~~-~~~~~~~E~~~l~~l~h~niv~l~g~~----------------  377 (506)
                      +.+.++||.|++|.||+|...++..+++|.+..... ...++.+|++++++++|+||+++++++                
T Consensus         8 y~~~~~ig~g~~~~vy~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~   87 (261)
T cd05148           8 FTLERKLGSGYFGEVWEGLWKNRVRVAIKILKSDDLLKQQDFQKEVQALKRLRHKHLISLFAVCSVGEPVYIITELMEKG   87 (261)
T ss_pred             HHHhhhhccCCCccEEEeEecCCCcEEEEeccccchhhHHHHHHHHHHHhcCCCcchhheeeeEecCCCeEEEEeecccC
Confidence            445678999999999999998899999999976544 457789999999999999999999875                


Q ss_pred             -------------eccchhhhHHHHHHHHHHHHhhcCCCCeEecCcCCCcEEECCCCcEEEeecCCCccccCCCcceecc
Q 039231          378 -------------LRVAEELSSTIGIARGLEYLHLGCSTRILHFDIKPHNILLDEDFCPKISDFGLAKICNRKESIISMT  444 (506)
Q Consensus       378 -------------~~~~~~l~i~~~i~~gl~~LH~~~~~~ivH~dlkp~Nill~~~~~~ki~dfg~a~~~~~~~~~~~~~  444 (506)
                                   +++.+.+.++.|++.||+|||   +++++|+||+|+||++++++.+||+|||.+.........  ..
T Consensus        88 ~L~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH---~~~i~h~dl~~~nilv~~~~~~kl~d~g~~~~~~~~~~~--~~  162 (261)
T cd05148          88 SLLAFLRSPEGQVLPVASLIDMACQVAEGMAYLE---EQNSIHRDLAARNILVGEDLVCKVADFGLARLIKEDVYL--SS  162 (261)
T ss_pred             CHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHH---HCCeeccccCcceEEEcCCceEEEccccchhhcCCcccc--cc
Confidence                         122335678899999999999   899999999999999999999999999999766433221  12


Q ss_pred             cCCCCcccccccccccccCCCCccccHHHHHHHHHHHHc-CCCCCCCCCCCc
Q 039231          445 GARGTVGYIAPEVFCRNIGEVSYKSDVYNYGMMIFEMTG-GRKNVDVVDNGS  495 (506)
Q Consensus       445 ~~~gt~~y~aPE~l~~~~~~~s~~~Dv~s~G~il~ellt-g~~pf~~~~~~~  495 (506)
                      ...++..|+|||.+.+.  .++.++||||||+++|||++ |+.||......+
T Consensus       163 ~~~~~~~~~~PE~~~~~--~~~~~~DiwslG~~l~~l~~~g~~p~~~~~~~~  212 (261)
T cd05148         163 DKKIPYKWTAPEAASHG--TFSTKSDVWSFGILLYEMFTYGQVPYPGMNNHE  212 (261)
T ss_pred             CCCCceEecCHHHHccC--CCCchhhHHHHHHHHHHHHcCCCCCCCcCCHHH
Confidence            34457789999998543  68889999999999999998 899997765443

Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase dom

>KOG4236 consensus Serine/threonine protein kinase PKC mu/PKD and related proteins [Signal transduction mechanisms]

Probab=99.95  E-value=8.6e-29  Score=242.35  Aligned_cols=171  Identities=30%  Similarity=0.439  Sum_probs=143.4

Q ss_pred             ccccCccCceEEEEEEEc-CCCEEEEEEeccC---CCCchhhHHHHHHhhccCccceeEEEEEeeccc------------
Q 039231          318 KYKLGQGGYGSVYKGKLL-DGSNVAVKVLNDS---KGNGKEFINEVASISRTSHVNVVALLGFCLRVA------------  381 (506)
Q Consensus       318 ~~~ig~G~~g~V~~~~~~-~~~~vavK~l~~~---~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~------------  381 (506)
                      ++.||+|-||+||-|+++ +|+.||||++.+-   ..+..++.+|+.+|++++||.||.+.-.|-..+            
T Consensus       569 devLGSGQFG~VYgg~hRktGrdVAvKvIdKlrFp~kqesqlR~EVaILq~l~HPGiV~le~M~ET~ervFVVMEKl~GD  648 (888)
T KOG4236|consen  569 DEVLGSGQFGTVYGGKHRKTGRDVAVKVIDKLRFPTKQESQLRNEVAILQNLHHPGIVNLECMFETPERVFVVMEKLHGD  648 (888)
T ss_pred             HhhccCCcceeeecceecccCceeeeeeeecccCCCchHHHHHHHHHHHHhcCCCCeeEEEEeecCCceEEEEehhhcch
Confidence            467999999999999885 5999999999753   334478999999999999999999886662111            


Q ss_pred             ----------------hhhhHHHHHHHHHHHHhhcCCCCeEecCcCCCcEEECCC---CcEEEeecCCCccccCCCccee
Q 039231          382 ----------------EELSSTIGIARGLEYLHLGCSTRILHFDIKPHNILLDED---FCPKISDFGLAKICNRKESIIS  442 (506)
Q Consensus       382 ----------------~~l~i~~~i~~gl~~LH~~~~~~ivH~dlkp~Nill~~~---~~~ki~dfg~a~~~~~~~~~~~  442 (506)
                                      ....++.||+.||.|||   .++|+|.||||+||||.+.   -.+||+|||+|+.++.....  
T Consensus       649 MLEMILSsEkgRL~er~TkFlvtQIL~ALr~LH---~knIvHCDLKPENVLLas~~~FPQvKlCDFGfARiIgEksFR--  723 (888)
T KOG4236|consen  649 MLEMILSSEKGRLPERITKFLVTQILVALRYLH---FKNIVHCDLKPENVLLASASPFPQVKLCDFGFARIIGEKSFR--  723 (888)
T ss_pred             HHHHHHHhhcccchHHHHHHHHHHHHHHHHHhh---hcceeeccCCchheeeccCCCCCceeeccccceeecchhhhh--
Confidence                            12336779999999999   9999999999999999644   36899999999999876643  


Q ss_pred             cccCCCCcccccccccccccCCCCccccHHHHHHHHHHHHcCCCCCCCCCCCcc
Q 039231          443 MTGARGTVGYIAPEVFCRNIGEVSYKSDVYNYGMMIFEMTGGRKNVDVVDNGST  496 (506)
Q Consensus       443 ~~~~~gt~~y~aPE~l~~~~~~~s~~~Dv~s~G~il~elltg~~pf~~~~~~~~  496 (506)
                       ....||+.|+|||++.++  .|...-|+||.|||+|--++|..||....+...
T Consensus       724 -rsVVGTPAYLaPEVLrnk--GyNrSLDMWSVGVIiYVsLSGTFPFNEdEdInd  774 (888)
T KOG4236|consen  724 -RSVVGTPAYLAPEVLRNK--GYNRSLDMWSVGVIIYVSLSGTFPFNEDEDIND  774 (888)
T ss_pred             -hhhcCCccccCHHHHhhc--cccccccceeeeEEEEEEecccccCCCccchhH
Confidence             568999999999999765  688899999999999999999999987655433

>KOG0610 consensus Putative serine/threonine protein kinase [General function prediction only]

Probab=99.95  E-value=9e-28  Score=230.14  Aligned_cols=178  Identities=27%  Similarity=0.336  Sum_probs=146.7

Q ss_pred             cccCccCceEEEEEEEcC-CCEEEEEEeccCC----CCchhhHHHHHHhhccCccceeEEEEEe----------------
Q 039231          319 YKLGQGGYGSVYKGKLLD-GSNVAVKVLNDSK----GNGKEFINEVASISRTSHVNVVALLGFC----------------  377 (506)
Q Consensus       319 ~~ig~G~~g~V~~~~~~~-~~~vavK~l~~~~----~~~~~~~~E~~~l~~l~h~niv~l~g~~----------------  377 (506)
                      +.||+|.-|+||++++++ +...|+|++.+..    ....+...|-++|+.++||-+..|++.+                
T Consensus        83 k~LG~GdiG~VyL~~l~~t~~~fAmKVmdK~~l~~rkKl~Ra~tE~eIL~~lDHPFlPTLYa~fet~~~~cl~meyCpGG  162 (459)
T KOG0610|consen   83 KRLGCGDIGTVYLVELRGTNCLFAMKVMDKESLASRKKLKRAQTEREILSLLDHPFLPTLYASFETDKYSCLVMEYCPGG  162 (459)
T ss_pred             HHcCCCCceeEEEEEecCCCceEEEEEecHHHHhhhhHHHHHHHHHHHHHhcCCCccchhhheeeccceeEEEEecCCCc
Confidence            469999999999999876 5899999997643    2335677899999999999999998655                


Q ss_pred             -------------eccchhhhHHHHHHHHHHHHhhcCCCCeEecCcCCCcEEECCCCcEEEeecCCCccccC--------
Q 039231          378 -------------LRVAEELSSTIGIARGLEYLHLGCSTRILHFDIKPHNILLDEDFCPKISDFGLAKICNR--------  436 (506)
Q Consensus       378 -------------~~~~~~l~i~~~i~~gl~~LH~~~~~~ivH~dlkp~Nill~~~~~~ki~dfg~a~~~~~--------  436 (506)
                                   +.+..+..++..|+.||+|||   ..|||+|||||+||||.++|++-|+||.++.....        
T Consensus       163 dL~~LrqkQp~~~fse~~aRFYaAEvl~ALEYLH---mlGivYRDLKPENILvredGHIMLsDFDLS~~~~~~Pt~~~s~  239 (459)
T KOG0610|consen  163 DLHSLRQKQPGKRFSESAARFYAAEVLLALEYLH---MLGIVYRDLKPENILVREDGHIMLSDFDLSLRCPVSPTLVKSS  239 (459)
T ss_pred             cHHHHHhhCCCCccchhhHHHHHHHHHHHHHHHH---hhceeeccCCcceeEEecCCcEEeeeccccccCCCCCeeeccC
Confidence                         344456678999999999999   99999999999999999999999999998744311        


Q ss_pred             -------------------------CCcc---------------------eecccCCCCcccccccccccccCCCCcccc
Q 039231          437 -------------------------KESI---------------------ISMTGARGTVGYIAPEVFCRNIGEVSYKSD  470 (506)
Q Consensus       437 -------------------------~~~~---------------------~~~~~~~gt~~y~aPE~l~~~~~~~s~~~D  470 (506)
                                               ....                     ......+||-.|+|||++.++  ..+.++|
T Consensus       240 ~~~~~~~~~~~~~~~~s~f~~r~~~~~~~~~k~~~~~~~~~p~~~aep~~~RSnSFVGThEYlAPEvI~G~--GHgsAVD  317 (459)
T KOG0610|consen  240 SPRSSGSQPSCRSRQPSCFSPRCLSSSKKRKKKDESASRSLPELVAEPTGARSNSFVGTHEYLAPEVIRGE--GHGSAVD  317 (459)
T ss_pred             CCCCCCCCcccccccccccccchhccccccccccccccccchhhhcCCCCccccccccccccccceeeecC--CCCchhh
Confidence                                     0000                     001235699999999999776  6788999


Q ss_pred             HHHHHHHHHHHHcCCCCCCCCCCCcchhhhh
Q 039231          471 VYNYGMMIFEMTGGRKNVDVVDNGSTALDLQ  501 (506)
Q Consensus       471 v~s~G~il~elltg~~pf~~~~~~~~~~~~~  501 (506)
                      +|+|||+||||+.|+.||...+.+++...+.
T Consensus       318 WWtfGIflYEmLyG~TPFKG~~~~~Tl~NIv  348 (459)
T KOG0610|consen  318 WWTFGIFLYEMLYGTTPFKGSNNKETLRNIV  348 (459)
T ss_pred             HHHHHHHHHHHHhCCCCcCCCCchhhHHHHh
Confidence            9999999999999999999999888876654

>KOG0586 consensus Serine/threonine protein kinase [General function prediction only]

Probab=99.95  E-value=2.4e-28  Score=245.06  Aligned_cols=172  Identities=26%  Similarity=0.434  Sum_probs=147.9

Q ss_pred             hccccCccCceEEEEEEEc-CCCEEEEEEeccCCCCc---hhhHHHHHHhhccCccceeEEEEEee--------------
Q 039231          317 FKYKLGQGGYGSVYKGKLL-DGSNVAVKVLNDSKGNG---KEFINEVASISRTSHVNVVALLGFCL--------------  378 (506)
Q Consensus       317 ~~~~ig~G~~g~V~~~~~~-~~~~vavK~l~~~~~~~---~~~~~E~~~l~~l~h~niv~l~g~~~--------------  378 (506)
                      +...||+|.|+.|..|++. .+..||||++.++..+.   +.+.+|+++|..++|||||+++.+..              
T Consensus        60 i~~tig~g~f~~V~La~~~~t~~~VaiK~idkt~ln~~~~~k~~rev~imk~l~HPnIvkl~~v~~t~~~lylV~eya~~  139 (596)
T KOG0586|consen   60 IIKTIGKGNFAKVKLARHILTGTEVAIKIIDKTQLNPSKRQKLGREVDIMKSLNHPNIVKLFSVIETEATLYLVMEYASG  139 (596)
T ss_pred             eeeeeccceeEEEEeeEecCCCceEEEEEehhcccChHHHHHHHHHHHHHHhcCCcceeeeeeeeeecceeEEEEEeccC
Confidence            3567999999999999875 58999999998765443   45889999999999999999998762              


Q ss_pred             -------------ccchhhhHHHHHHHHHHHHhhcCCCCeEecCcCCCcEEECCCCcEEEeecCCCccccCCCcceeccc
Q 039231          379 -------------RVAEELSSTIGIARGLEYLHLGCSTRILHFDIKPHNILLDEDFCPKISDFGLAKICNRKESIISMTG  445 (506)
Q Consensus       379 -------------~~~~~l~i~~~i~~gl~~LH~~~~~~ivH~dlkp~Nill~~~~~~ki~dfg~a~~~~~~~~~~~~~~  445 (506)
                                   .+.+...++.|+.+|++|+|   ++.|+|||||.+||||+.+.++||+|||++..+.....   ...
T Consensus       140 ge~~~yl~~~gr~~e~~ar~~F~q~vsaveYcH---~k~ivHrdLk~eNilL~~~mnikIaDfgfS~~~~~~~~---lqt  213 (596)
T KOG0586|consen  140 GELFDYLVKHGRMKEKEARAKFRQIVSAVEYCH---SKNIVHRDLKAENILLDENMNIKIADFGFSTFFDYGLM---LQT  213 (596)
T ss_pred             chhHHHHHhcccchhhhhhhhhHHHHHHHHHHh---hcceeccccchhhcccccccceeeeccccceeeccccc---ccc
Confidence                         22335568899999999999   99999999999999999999999999999998875443   356


Q ss_pred             CCCCcccccccccccccCCCCccccHHHHHHHHHHHHcCCCCCCCCCCCc
Q 039231          446 ARGTVGYIAPEVFCRNIGEVSYKSDVYNYGMMIFEMTGGRKNVDVVDNGS  495 (506)
Q Consensus       446 ~~gt~~y~aPE~l~~~~~~~s~~~Dv~s~G~il~elltg~~pf~~~~~~~  495 (506)
                      ..|++.|.|||++.+. ...++++|+||+|++||.|+.|..||+..+-.+
T Consensus       214 ~cgsppyAaPEl~~g~-~y~gpe~D~Wslgvvly~LV~GsLPFDG~~lk~  262 (596)
T KOG0586|consen  214 FCGSPPYAAPELFNGK-KYDGPEVDIWSLGVVLYALVEGSLPFDGQNLKE  262 (596)
T ss_pred             cCCCCCccChHhhcCc-ccCCcceehhhhhhhheeeeecccccCCccccc
Confidence            7899999999999876 477899999999999999999999999765443

>cd07847 STKc_CDKL1_4 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4

Probab=99.95  E-value=1.4e-27  Score=233.61  Aligned_cols=174  Identities=25%  Similarity=0.315  Sum_probs=143.2

Q ss_pred             hccccCccCceEEEEEEEc-CCCEEEEEEeccCC---CCchhhHHHHHHhhccCccceeEEEEEe---------------
Q 039231          317 FKYKLGQGGYGSVYKGKLL-DGSNVAVKVLNDSK---GNGKEFINEVASISRTSHVNVVALLGFC---------------  377 (506)
Q Consensus       317 ~~~~ig~G~~g~V~~~~~~-~~~~vavK~l~~~~---~~~~~~~~E~~~l~~l~h~niv~l~g~~---------------  377 (506)
                      +.+.||+|++|.||+|+.. +++.+|+|++....   ...+.+.+|++++++++|+||+++++++               
T Consensus         5 ~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~e~~~~   84 (286)
T cd07847           5 KLSKIGEGSYGVVFKCRNRETGQIVAIKKFVESEDDPVIKKIALREIRMLKQLKHPNLVNLIEVFRRKRKLHLVFEYCDH   84 (286)
T ss_pred             eeeeecccCCeEEEEEEECCCCcEEEEEEEeecccCccccHHHHHHHHHHHhCCCCCEeeeeeEEeeCCEEEEEEeccCc
Confidence            3467999999999999986 48999999986532   2235678999999999999999999876               


Q ss_pred             ------------eccchhhhHHHHHHHHHHHHhhcCCCCeEecCcCCCcEEECCCCcEEEeecCCCccccCCCcceeccc
Q 039231          378 ------------LRVAEELSSTIGIARGLEYLHLGCSTRILHFDIKPHNILLDEDFCPKISDFGLAKICNRKESIISMTG  445 (506)
Q Consensus       378 ------------~~~~~~l~i~~~i~~gl~~LH~~~~~~ivH~dlkp~Nill~~~~~~ki~dfg~a~~~~~~~~~~~~~~  445 (506)
                                  +++...+.++.|++.||+|||   +++++|+||||+||++++++.+||+|||++.........  ...
T Consensus        85 ~~l~~~~~~~~~~~~~~~~~~~~ql~~~l~~LH---~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~~--~~~  159 (286)
T cd07847          85 TVLNELEKNPRGVPEHLIKKIIWQTLQAVNFCH---KHNCIHRDVKPENILITKQGQIKLCDFGFARILTGPGDD--YTD  159 (286)
T ss_pred             cHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHH---HCCceecCCChhhEEEcCCCcEEECccccceecCCCccc--ccC
Confidence                        233346779999999999999   899999999999999999999999999999876543321  123


Q ss_pred             CCCCcccccccccccccCCCCccccHHHHHHHHHHHHcCCCCCCCCCCCcc
Q 039231          446 ARGTVGYIAPEVFCRNIGEVSYKSDVYNYGMMIFEMTGGRKNVDVVDNGST  496 (506)
Q Consensus       446 ~~gt~~y~aPE~l~~~~~~~s~~~Dv~s~G~il~elltg~~pf~~~~~~~~  496 (506)
                      ..++..|+|||.+.+. ..++.++||||||+++|||++|+.||....+.+.
T Consensus       160 ~~~~~~~~aPE~~~~~-~~~~~~~Di~slG~i~~~l~~g~~p~~~~~~~~~  209 (286)
T cd07847         160 YVATRWYRAPELLVGD-TQYGPPVDVWAIGCVFAELLTGQPLWPGKSDVDQ  209 (286)
T ss_pred             cccccccCCHHHHhCC-CCcCchhhhHHHHHHHHHHHhCCCCCCCCChHHH
Confidence            4578899999998543 3578899999999999999999999987655433

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The functio

>cd05060 PTKc_Syk_like Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases

Probab=99.95  E-value=1.3e-27  Score=230.20  Aligned_cols=170  Identities=32%  Similarity=0.523  Sum_probs=138.7

Q ss_pred             cccCccCceEEEEEEEcC----CCEEEEEEeccCCC--CchhhHHHHHHhhccCccceeEEEEEe---------------
Q 039231          319 YKLGQGGYGSVYKGKLLD----GSNVAVKVLNDSKG--NGKEFINEVASISRTSHVNVVALLGFC---------------  377 (506)
Q Consensus       319 ~~ig~G~~g~V~~~~~~~----~~~vavK~l~~~~~--~~~~~~~E~~~l~~l~h~niv~l~g~~---------------  377 (506)
                      ++||+|+||.||+|+...    +..+|+|.+.....  ..+++.+|++++++++|+||+++++++               
T Consensus         1 ~~ig~G~~g~v~~~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~v~e~~~~~   80 (257)
T cd05060           1 KELGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIAAGKKEFLREASVMAQLDHPCIVRLIGVCKGEPLMLVMELAPLG   80 (257)
T ss_pred             CccCccCceeEEEeEeeccCCCcceEEEEecccccchHHHHHHHHHHHHHHhcCCCCeeeEEEEEcCCceEEEEEeCCCC
Confidence            369999999999997532    26899999976544  346789999999999999999999876               


Q ss_pred             -----------eccchhhhHHHHHHHHHHHHhhcCCCCeEecCcCCCcEEECCCCcEEEeecCCCccccCCCccee-ccc
Q 039231          378 -----------LRVAEELSSTIGIARGLEYLHLGCSTRILHFDIKPHNILLDEDFCPKISDFGLAKICNRKESIIS-MTG  445 (506)
Q Consensus       378 -----------~~~~~~l~i~~~i~~gl~~LH~~~~~~ivH~dlkp~Nill~~~~~~ki~dfg~a~~~~~~~~~~~-~~~  445 (506)
                                 +++..++.++.|++.||+|||   ..+++|+||||+||+++.++.+||+|||+++.......... ...
T Consensus        81 ~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lh---~~~i~H~di~p~nili~~~~~~kl~df~~~~~~~~~~~~~~~~~~  157 (257)
T cd05060          81 PLLKYLKKRREIPVSDLKELAHQVAMGMAYLE---SKHFVHRDLAARNVLLVNRHQAKISDFGMSRALGAGSDYYRATTA  157 (257)
T ss_pred             cHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHh---hcCeeccCcccceEEEcCCCcEEeccccccceeecCCcccccccC
Confidence                       223345779999999999999   89999999999999999999999999999987654432211 112


Q ss_pred             CCCCcccccccccccccCCCCccccHHHHHHHHHHHHc-CCCCCCCCCC
Q 039231          446 ARGTVGYIAPEVFCRNIGEVSYKSDVYNYGMMIFEMTG-GRKNVDVVDN  493 (506)
Q Consensus       446 ~~gt~~y~aPE~l~~~~~~~s~~~Dv~s~G~il~ellt-g~~pf~~~~~  493 (506)
                      ..++..|+|||.+...  .++.++||||||+++|||++ |..||...+.
T Consensus       158 ~~~~~~y~aPE~~~~~--~~~~~~Di~slG~~l~~~~~~g~~p~~~~~~  204 (257)
T cd05060         158 GRWPLKWYAPECINYG--KFSSKSDVWSYGVTLWEAFSYGAKPYGEMKG  204 (257)
T ss_pred             ccccccccCHHHhcCC--CCCccchHHHHHHHHHHHHcCCCCCcccCCH
Confidence            2345689999998543  68899999999999999998 9999976654

Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, mi

>KOG0664 consensus Nemo-like MAPK-related serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.95  E-value=1.6e-29  Score=229.48  Aligned_cols=179  Identities=28%  Similarity=0.412  Sum_probs=148.3

Q ss_pred             ccCccCceEEEEEEE-cCCCEEEEEEeccCCC---CchhhHHHHHHhhccCccceeEEEEEe------------------
Q 039231          320 KLGQGGYGSVYKGKL-LDGSNVAVKVLNDSKG---NGKEFINEVASISRTSHVNVVALLGFC------------------  377 (506)
Q Consensus       320 ~ig~G~~g~V~~~~~-~~~~~vavK~l~~~~~---~~~~~~~E~~~l~~l~h~niv~l~g~~------------------  377 (506)
                      -||-|+||.||..++ ++|+.||.|++.+-..   ..+.+.+|+++|..++|.|++..++..                  
T Consensus        60 PIGYGAFGVVWsVTDPRdgrrvalkK~pnvfq~L~s~krvFre~kmLcfFkHdNVLSaLDILQPph~dfFqEiYV~TELm  139 (449)
T KOG0664|consen   60 PIGYGAFGVVWSVTDPRSGKRVALKKMPNVFQNLASCKRVFREIKMLSSFRHDNVLSLLDILQPANPSFFQELYVLTELM  139 (449)
T ss_pred             cccccceeEEEeccCCCCccchhHhhcchHHHHHHHHHHHHHHHHHHHhhccccHHHHHHhcCCCCchHHHHHHHHHHHH
Confidence            499999999999987 5699999999876433   337899999999999999999988765                  


Q ss_pred             -------------eccchhhhHHHHHHHHHHHHhhcCCCCeEecCcCCCcEEECCCCcEEEeecCCCccccCCCcceecc
Q 039231          378 -------------LRVAEELSSTIGIARGLEYLHLGCSTRILHFDIKPHNILLDEDFCPKISDFGLAKICNRKESIISMT  444 (506)
Q Consensus       378 -------------~~~~~~l~i~~~i~~gl~~LH~~~~~~ivH~dlkp~Nill~~~~~~ki~dfg~a~~~~~~~~~~~~~  444 (506)
                                   +..+...-+..||++||+|||   +.+|+||||||.|.|++++..+||+|||+++.-..++.. -++
T Consensus       140 QSDLHKIIVSPQ~Ls~DHvKVFlYQILRGLKYLH---sA~ILHRDIKPGNLLVNSNCvLKICDFGLARvee~d~~~-hMT  215 (449)
T KOG0664|consen  140 QSDLHKIIVSPQALTPDHVKVFVYQILRGLKYLH---TANILHRDIKPGNLLVNSNCILKICDFGLARTWDQRDRL-NMT  215 (449)
T ss_pred             HhhhhheeccCCCCCcchhhhhHHHHHhhhHHHh---hcchhhccCCCccEEeccCceEEecccccccccchhhhh-hhH
Confidence                         223334457789999999999   999999999999999999999999999999876544432 245


Q ss_pred             cCCCCcccccccccccccCCCCccccHHHHHHHHHHHHcCCCCCCCCCCCcchhhhhhhc
Q 039231          445 GARGTVGYIAPEVFCRNIGEVSYKSDVYNYGMMIFEMTGGRKNVDVVDNGSTALDLQASR  504 (506)
Q Consensus       445 ~~~gt~~y~aPE~l~~~~~~~s~~~Dv~s~G~il~elltg~~pf~~~~~~~~~~~~~~~~  504 (506)
                      ...-|..|.|||++.+. ..|+.+.||||.|||+.||+.++..|+..++-++ ++++...
T Consensus       216 qEVVTQYYRAPEiLMGa-RhYs~AvDiWSVGCIFaELLgRrILFQAq~PiqQ-L~lItdL  273 (449)
T KOG0664|consen  216 HEVVTQYYRAPELLMGA-RRYTGAVDIWSVGCIFAELLQRKILFQAAGPIEQ-LQMIIDL  273 (449)
T ss_pred             HHHHHHHhccHHHhhcc-hhhcCccceehhhHHHHHHHhhhhhhhccChHHH-HHHHHHH
Confidence            56678999999999886 5799999999999999999999999998776553 4444433

>KOG1006 consensus Mitogen-activated protein kinase (MAPK) kinase MKK4 [Signal transduction mechanisms]

Probab=99.95  E-value=9.6e-30  Score=230.22  Aligned_cols=180  Identities=25%  Similarity=0.390  Sum_probs=143.0

Q ss_pred             ccCHHHHHHHHhhhccccCccCceEEEEEEEcC-CCEEEEEEeccCC--CCchhhHHHHHHhhcc-CccceeEEEEEeec
Q 039231          304 RYGYADIKKMTNSFKYKLGQGGYGSVYKGKLLD-GSNVAVKVLNDSK--GNGKEFINEVASISRT-SHVNVVALLGFCLR  379 (506)
Q Consensus       304 ~~~~~el~~~~~~~~~~ig~G~~g~V~~~~~~~-~~~vavK~l~~~~--~~~~~~~~E~~~l~~l-~h~niv~l~g~~~~  379 (506)
                      .|+-.+|+...     .||.|+||+|++-.++. |+..|||++....  .+.+++..|.++..+- +-||||+++|.++.
T Consensus        60 ~F~~~~Lqdlg-----~iG~G~fG~V~KM~hk~sg~~mAVKrIr~~n~~keq~rll~e~d~~mks~~cp~IVkfyGa~F~  134 (361)
T KOG1006|consen   60 TFTSDNLQDLG-----EIGNGAFGTVNKMLHKPSGKLMAVKRIRSNNIEKEQKRLLMEHDTVMKSSNCPNIVKFYGALFS  134 (361)
T ss_pred             ccccchHHHHH-----HhcCCcchhhhhhhcCccCcEEEEEEeeeccchHHHHHHHHHHHHHHhhcCCcHHHHHhhhhhc
Confidence            34444444432     59999999999998764 8999999997543  3447788898876665 58999999998865


Q ss_pred             cchh-------------------------------hhHHHHHHHHHHHHhhcCCCCeEecCcCCCcEEECCCCcEEEeec
Q 039231          380 VAEE-------------------------------LSSTIGIARGLEYLHLGCSTRILHFDIKPHNILLDEDFCPKISDF  428 (506)
Q Consensus       380 ~~~~-------------------------------l~i~~~i~~gl~~LH~~~~~~ivH~dlkp~Nill~~~~~~ki~df  428 (506)
                      +...                               -.|..-++.||.||.+  ...|+|||+||+||||+..|.+||+||
T Consensus       135 EGdcWiCMELMd~SlDklYk~vy~vq~~~ipE~Ilg~ItvatV~AL~yLK~--~lkiIHRDvKPSNILldr~G~vKLCDF  212 (361)
T KOG1006|consen  135 EGDCWICMELMDISLDKLYKRVYSVQKSRIPENILGHITVATVDALDYLKE--ELKIIHRDVKPSNILLDRHGDVKLCDF  212 (361)
T ss_pred             CCceeeeHHHHhhhHHHHHHHHHHHHhccCcHhhhhheeeeehhHHHHHHH--HhhhhhccCChhheEEecCCCEeeecc
Confidence            5441                               1123346799999986  789999999999999999999999999


Q ss_pred             CCCccccCCCcceecccCCCCcccccccccccccCCCCccccHHHHHHHHHHHHcCCCCCCCCCC
Q 039231          429 GLAKICNRKESIISMTGARGTVGYIAPEVFCRNIGEVSYKSDVYNYGMMIFEMTGGRKNVDVVDN  493 (506)
Q Consensus       429 g~a~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~s~~~Dv~s~G~il~elltg~~pf~~~~~  493 (506)
                      |++..+...-   ..+...|...|||||.+......++-+|||||+|+.|||+.||+.|+...++
T Consensus       213 GIcGqLv~Si---AkT~daGCrpYmAPERi~p~~~gyDiRSDvWSLGITL~EvAtG~fPyr~w~s  274 (361)
T KOG1006|consen  213 GICGQLVDSI---AKTVDAGCRPYMAPERIDPSDKGYDIRSDVWSLGITLYEVATGNFPYRKWDS  274 (361)
T ss_pred             cchHhHHHHH---HhhhccCCccccChhccCCccCCcchhhhhhhhcceEeeeecCCCCcchHHH
Confidence            9986553321   2355778999999999976655689999999999999999999999988765

>cd06625 STKc_MEKK3_like Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

Probab=99.95  E-value=1.5e-27  Score=230.29  Aligned_cols=171  Identities=29%  Similarity=0.351  Sum_probs=139.1

Q ss_pred             ccccCccCceEEEEEEEc-CCCEEEEEEeccCCC------CchhhHHHHHHhhccCccceeEEEEEee------------
Q 039231          318 KYKLGQGGYGSVYKGKLL-DGSNVAVKVLNDSKG------NGKEFINEVASISRTSHVNVVALLGFCL------------  378 (506)
Q Consensus       318 ~~~ig~G~~g~V~~~~~~-~~~~vavK~l~~~~~------~~~~~~~E~~~l~~l~h~niv~l~g~~~------------  378 (506)
                      .+.||+|++|.||+|... +++.+|+|.+.....      ..+.+.+|++++++++||||+++++++.            
T Consensus         7 ~~~lg~g~~~~vy~~~~~~~~~~~~lk~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~   86 (263)
T cd06625           7 GKLLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIVQYYGCLRDDETLSIFMEYM   86 (263)
T ss_pred             cceecCCCceEEEEEEEcCCCcEEEEEEEeecccchhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEccCCeEEEEEEEC
Confidence            467999999999999874 589999999864321      2246888999999999999999998761            


Q ss_pred             ---------------ccchhhhHHHHHHHHHHHHhhcCCCCeEecCcCCCcEEECCCCcEEEeecCCCccccCCCccee-
Q 039231          379 ---------------RVAEELSSTIGIARGLEYLHLGCSTRILHFDIKPHNILLDEDFCPKISDFGLAKICNRKESIIS-  442 (506)
Q Consensus       379 ---------------~~~~~l~i~~~i~~gl~~LH~~~~~~ivH~dlkp~Nill~~~~~~ki~dfg~a~~~~~~~~~~~-  442 (506)
                                     .......++.|++.||+|||   +.+++|+||+|+||++++++.+||+|||+++.......... 
T Consensus        87 ~~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH---~~~i~H~dl~p~nilv~~~~~~~l~dfg~~~~~~~~~~~~~~  163 (263)
T cd06625          87 PGGSVKDQLKAYGALTETVTRKYTRQILEGVEYLH---SNMIVHRDIKGANILRDSAGNVKLGDFGASKRLQTICSSGTG  163 (263)
T ss_pred             CCCcHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEEcCCCCEEEeecccceecccccccccc
Confidence                           12234668899999999999   89999999999999999999999999999976543221111 


Q ss_pred             cccCCCCcccccccccccccCCCCccccHHHHHHHHHHHHcCCCCCCCCCC
Q 039231          443 MTGARGTVGYIAPEVFCRNIGEVSYKSDVYNYGMMIFEMTGGRKNVDVVDN  493 (506)
Q Consensus       443 ~~~~~gt~~y~aPE~l~~~~~~~s~~~Dv~s~G~il~elltg~~pf~~~~~  493 (506)
                      .....++..|+|||.+.+.  .++.++||||||+++|||++|+.||...+.
T Consensus       164 ~~~~~~~~~y~aPE~~~~~--~~~~~~Di~slG~il~el~~g~~p~~~~~~  212 (263)
T cd06625         164 MKSVTGTPYWMSPEVISGE--GYGRKADVWSVGCTVVEMLTEKPPWAEFEA  212 (263)
T ss_pred             ccCCCcCccccCcceeccC--CCCchhhhHHHHHHHHHHHhCCCCccccch
Confidence            1234578899999998654  688999999999999999999999976543

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades t

>cd07839 STKc_CDK5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5

Probab=99.95  E-value=5e-28  Score=236.57  Aligned_cols=171  Identities=25%  Similarity=0.362  Sum_probs=138.9

Q ss_pred             hccccCccCceEEEEEEEc-CCCEEEEEEeccCC---CCchhhHHHHHHhhccCccceeEEEEEe---------------
Q 039231          317 FKYKLGQGGYGSVYKGKLL-DGSNVAVKVLNDSK---GNGKEFINEVASISRTSHVNVVALLGFC---------------  377 (506)
Q Consensus       317 ~~~~ig~G~~g~V~~~~~~-~~~~vavK~l~~~~---~~~~~~~~E~~~l~~l~h~niv~l~g~~---------------  377 (506)
                      +.+.||+|++|.||+|+.. +|+.+|+|+++...   .....+.+|++++++++||||+++++++               
T Consensus         4 ~~~~l~~g~~~~vy~~~~~~~g~~~~~k~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~   83 (284)
T cd07839           4 KLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLYDVLHSDKKLTLVFEYCDQ   83 (284)
T ss_pred             eEEEecccCCeEEEEEEECCCCcEEEEEEeecccccccCccchhHHHHHHHhcCCCCeeeHHHHhccCCceEEEEecCCC
Confidence            3467999999999999975 58999999986432   2235678899999999999999987654               


Q ss_pred             ------------eccchhhhHHHHHHHHHHHHhhcCCCCeEecCcCCCcEEECCCCcEEEeecCCCccccCCCcceeccc
Q 039231          378 ------------LRVAEELSSTIGIARGLEYLHLGCSTRILHFDIKPHNILLDEDFCPKISDFGLAKICNRKESIISMTG  445 (506)
Q Consensus       378 ------------~~~~~~l~i~~~i~~gl~~LH~~~~~~ivH~dlkp~Nill~~~~~~ki~dfg~a~~~~~~~~~~~~~~  445 (506)
                                  +++...+.++.||++||.|||   +++++|+||||+||+++.++.+||+|||+++........  ...
T Consensus        84 ~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH---~~~i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~~~--~~~  158 (284)
T cd07839          84 DLKKYFDSCNGDIDPEIVKSFMFQLLKGLAFCH---SHNVLHRDLKPQNLLINKNGELKLADFGLARAFGIPVRC--YSA  158 (284)
T ss_pred             CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH---HCCEecCCCCHHHEEEcCCCcEEECccchhhccCCCCCC--cCC
Confidence                        233345778999999999999   899999999999999999999999999999865433221  233


Q ss_pred             CCCCcccccccccccccCCCCccccHHHHHHHHHHHHcCCCCCCCCCC
Q 039231          446 ARGTVGYIAPEVFCRNIGEVSYKSDVYNYGMMIFEMTGGRKNVDVVDN  493 (506)
Q Consensus       446 ~~gt~~y~aPE~l~~~~~~~s~~~Dv~s~G~il~elltg~~pf~~~~~  493 (506)
                      ..++..|+|||.+.+. ..++.++||||||+++|||++|..|+....+
T Consensus       159 ~~~~~~y~aPE~~~~~-~~~~~~~DiwslG~il~~l~tg~~p~~~~~~  205 (284)
T cd07839         159 EVVTLWYRPPDVLFGA-KLYSTSIDMWSAGCIFAELANAGRPLFPGND  205 (284)
T ss_pred             CccccCCcChHHHhCC-cccCcHHHHHHHHHHHHHHHhcCCCCcCCCC
Confidence            5678899999998553 3578899999999999999999999755443

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also

>cd06643 STKc_SLK Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase

Probab=99.95  E-value=1.8e-27  Score=232.53  Aligned_cols=174  Identities=27%  Similarity=0.390  Sum_probs=140.7

Q ss_pred             hccccCccCceEEEEEEEcC-CCEEEEEEeccCC-CCchhhHHHHHHhhccCccceeEEEEEee----------------
Q 039231          317 FKYKLGQGGYGSVYKGKLLD-GSNVAVKVLNDSK-GNGKEFINEVASISRTSHVNVVALLGFCL----------------  378 (506)
Q Consensus       317 ~~~~ig~G~~g~V~~~~~~~-~~~vavK~l~~~~-~~~~~~~~E~~~l~~l~h~niv~l~g~~~----------------  378 (506)
                      ..+.||+|+||.||+|.... +..+++|.+.... ...+.+.+|+++++.++||||+++++++.                
T Consensus         9 i~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~~v~e~~~~~~   88 (282)
T cd06643           9 IIGELGDGAFGKVYKAQNKETGVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEFCAGGA   88 (282)
T ss_pred             HHhhcccCCCeEEEEEEECCCCeEEEEEEeCCCCHHHHHHHHHHHHHHHHCCCCCeeeEEEEEeeCCEEEEEEEecCCCc
Confidence            34579999999999999764 7788999886533 23467889999999999999999998761                


Q ss_pred             ------------ccchhhhHHHHHHHHHHHHhhcCCCCeEecCcCCCcEEECCCCcEEEeecCCCccccCCCcceecccC
Q 039231          379 ------------RVAEELSSTIGIARGLEYLHLGCSTRILHFDIKPHNILLDEDFCPKISDFGLAKICNRKESIISMTGA  446 (506)
Q Consensus       379 ------------~~~~~l~i~~~i~~gl~~LH~~~~~~ivH~dlkp~Nill~~~~~~ki~dfg~a~~~~~~~~~~~~~~~  446 (506)
                                  ++...+.++.|+++||+|||   +.+++||||||+||+++.++.+||+|||++........  .....
T Consensus        89 l~~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH---~~~i~H~dlkp~nili~~~~~~kl~dfg~~~~~~~~~~--~~~~~  163 (282)
T cd06643          89 VDAVMLELERPLTEPQIRVVCKQTLEALNYLH---ENKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQ--RRDSF  163 (282)
T ss_pred             HHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH---HCCeeecCCCcccEEEccCCCEEEcccccccccccccc--ccccc
Confidence                        22335668899999999999   89999999999999999999999999999876543221  12345


Q ss_pred             CCCccccccccccc---ccCCCCccccHHHHHHHHHHHHcCCCCCCCCCCCc
Q 039231          447 RGTVGYIAPEVFCR---NIGEVSYKSDVYNYGMMIFEMTGGRKNVDVVDNGS  495 (506)
Q Consensus       447 ~gt~~y~aPE~l~~---~~~~~s~~~Dv~s~G~il~elltg~~pf~~~~~~~  495 (506)
                      .+++.|+|||.+..   ....++.++|||||||++|||++|+.||...+..+
T Consensus       164 ~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~  215 (282)
T cd06643         164 IGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAQIEPPHHELNPMR  215 (282)
T ss_pred             cccccccCHhhccccCCCCCCCCccchhhhHHHHHHHHccCCCCccccCHHH
Confidence            68899999999842   22357789999999999999999999998665433

Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration.

>cd05080 PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2

Probab=99.95  E-value=1e-27  Score=234.48  Aligned_cols=171  Identities=31%  Similarity=0.433  Sum_probs=138.2

Q ss_pred             hhccccCccCceEEEEEEE-----cCCCEEEEEEeccCCC--CchhhHHHHHHhhccCccceeEEEEEee----------
Q 039231          316 SFKYKLGQGGYGSVYKGKL-----LDGSNVAVKVLNDSKG--NGKEFINEVASISRTSHVNVVALLGFCL----------  378 (506)
Q Consensus       316 ~~~~~ig~G~~g~V~~~~~-----~~~~~vavK~l~~~~~--~~~~~~~E~~~l~~l~h~niv~l~g~~~----------  378 (506)
                      .+.+.||+|+||+||++..     .++..||+|.++....  ....+.+|++++++++||||+++++++.          
T Consensus         7 ~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~lv   86 (283)
T cd05080           7 KKIRVLGEGHFGKVSLYCYDPANDGTGEMVAVKTLKRECGQQNTSGWKKEINILKTLYHENIVKYKGCCSEQGGKGLQLI   86 (283)
T ss_pred             eeceecccCCCcEEEEeeEccccCCCCceEEEEEeccccChHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCceEEEE
Confidence            4456799999999988753     3578899999975432  3467889999999999999999998752          


Q ss_pred             ------------------ccchhhhHHHHHHHHHHHHhhcCCCCeEecCcCCCcEEECCCCcEEEeecCCCccccCCCcc
Q 039231          379 ------------------RVAEELSSTIGIARGLEYLHLGCSTRILHFDIKPHNILLDEDFCPKISDFGLAKICNRKESI  440 (506)
Q Consensus       379 ------------------~~~~~l~i~~~i~~gl~~LH~~~~~~ivH~dlkp~Nill~~~~~~ki~dfg~a~~~~~~~~~  440 (506)
                                        ++.+++.++.|++.||+|||   +++++|+||||+||++++++.+||+|||+++........
T Consensus        87 ~e~~~~~~l~~~~~~~~l~~~~~~~i~~~l~~~l~~lH---~~~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~~  163 (283)
T cd05080          87 MEYVPLGSLRDYLPKHKLNLAQLLLFAQQICEGMAYLH---SQHYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEY  163 (283)
T ss_pred             ecCCCCCCHHHHHHHcCCCHHHHHHHHHHHHHHHHHHH---HCCeeccccChheEEEcCCCcEEEeecccccccCCcchh
Confidence                              23346678999999999999   899999999999999999999999999999876543321


Q ss_pred             ee-cccCCCCcccccccccccccCCCCccccHHHHHHHHHHHHcCCCCCCCC
Q 039231          441 IS-MTGARGTVGYIAPEVFCRNIGEVSYKSDVYNYGMMIFEMTGGRKNVDVV  491 (506)
Q Consensus       441 ~~-~~~~~gt~~y~aPE~l~~~~~~~s~~~Dv~s~G~il~elltg~~pf~~~  491 (506)
                      .. .....++..|+|||.+.+.  .++.++||||||+++|||++|..||...
T Consensus       164 ~~~~~~~~~~~~~~~PE~~~~~--~~~~~~Di~slG~~l~el~tg~~p~~~~  213 (283)
T cd05080         164 YRVREDGDSPVFWYAVECLKEN--KFSYASDVWSFGVTLYELLTHCDSKQSP  213 (283)
T ss_pred             hccCCCCCCCceeeCHhHhccc--CCCcccccHHHHHHHHHHHhCCCCCCCC
Confidence            11 1223456679999998543  6889999999999999999999998654

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of sign

>cd06644 STKc_STK10_LOK Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase

Probab=99.95  E-value=1.8e-27  Score=233.74  Aligned_cols=171  Identities=28%  Similarity=0.423  Sum_probs=139.5

Q ss_pred             hccccCccCceEEEEEEEcC-CCEEEEEEeccCCC-CchhhHHHHHHhhccCccceeEEEEEe-----------------
Q 039231          317 FKYKLGQGGYGSVYKGKLLD-GSNVAVKVLNDSKG-NGKEFINEVASISRTSHVNVVALLGFC-----------------  377 (506)
Q Consensus       317 ~~~~ig~G~~g~V~~~~~~~-~~~vavK~l~~~~~-~~~~~~~E~~~l~~l~h~niv~l~g~~-----------------  377 (506)
                      +.++||+|+||.||+|+... +..+++|.+..... ..+.+.+|++.+++++|+||+++++.+                 
T Consensus        16 i~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~   95 (292)
T cd06644          16 IIGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYMVEIEILATCNHPYIVKLLGAFYWDGKLWIMIEFCPGGA   95 (292)
T ss_pred             hhheecCCCCeEEEEEEECCCCceEEEEEeccCCHHHHHHHHHHHHHHHhCCCCcEeeeEEEEEeCCeEEEEEecCCCCc
Confidence            44679999999999999854 88999999875432 346788999999999999999999875                 


Q ss_pred             -----------eccchhhhHHHHHHHHHHHHhhcCCCCeEecCcCCCcEEECCCCcEEEeecCCCccccCCCcceecccC
Q 039231          378 -----------LRVAEELSSTIGIARGLEYLHLGCSTRILHFDIKPHNILLDEDFCPKISDFGLAKICNRKESIISMTGA  446 (506)
Q Consensus       378 -----------~~~~~~l~i~~~i~~gl~~LH~~~~~~ivH~dlkp~Nill~~~~~~ki~dfg~a~~~~~~~~~~~~~~~  446 (506)
                                 +++...+.++.|++.||+|||   +.+++||||||+||+++.++.+||+|||++........  .....
T Consensus        96 l~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH---~~~i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~~~~--~~~~~  170 (292)
T cd06644          96 VDAIMLELDRGLTEPQIQVICRQMLEALQYLH---SMKIIHRDLKAGNVLLTLDGDIKLADFGVSAKNVKTLQ--RRDSF  170 (292)
T ss_pred             HHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHh---cCCeeecCCCcceEEEcCCCCEEEccCccceecccccc--cccee
Confidence                       123335678999999999999   89999999999999999999999999999875433211  11335


Q ss_pred             CCCcccccccccccc---cCCCCccccHHHHHHHHHHHHcCCCCCCCCC
Q 039231          447 RGTVGYIAPEVFCRN---IGEVSYKSDVYNYGMMIFEMTGGRKNVDVVD  492 (506)
Q Consensus       447 ~gt~~y~aPE~l~~~---~~~~s~~~Dv~s~G~il~elltg~~pf~~~~  492 (506)
                      .+++.|+|||.+...   ...++.++||||||+++|||++|+.||...+
T Consensus       171 ~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~  219 (292)
T cd06644         171 IGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELN  219 (292)
T ss_pred             cCCccccCceeeccccccCCCCCchhhhHhHHHHHHHHhcCCCCCcccc
Confidence            678899999998531   2356789999999999999999999997654

Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types.

>PF00069 Pkinase: Protein kinase domain Protein kinase; unclassified specificity

Probab=99.95  E-value=4.7e-28  Score=233.22  Aligned_cols=169  Identities=37%  Similarity=0.558  Sum_probs=141.1

Q ss_pred             hccccCccCceEEEEEEEcC-CCEEEEEEeccCCCCch---hhHHHHHHhhccCccceeEEEEEe---------------
Q 039231          317 FKYKLGQGGYGSVYKGKLLD-GSNVAVKVLNDSKGNGK---EFINEVASISRTSHVNVVALLGFC---------------  377 (506)
Q Consensus       317 ~~~~ig~G~~g~V~~~~~~~-~~~vavK~l~~~~~~~~---~~~~E~~~l~~l~h~niv~l~g~~---------------  377 (506)
                      +.+.||+|+||+||+++... ++.+|+|++........   ...+|+..+.+++||||+++++++               
T Consensus         3 ~~~~lg~G~~g~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~v~~~~~~   82 (260)
T PF00069_consen    3 LVKKLGSGGFGTVYKAKNKKNGQKVAVKIIDKSEIEEEEREENIREIKILRRLRHPNIVQILDVFQDDNYLYIVMEYCPG   82 (260)
T ss_dssp             EEEEEEEESSEEEEEEEETTTTEEEEEEEEESTTHHHHHHHHHHHHHHHHHHHTBTTBCHEEEEEEESSEEEEEEEEETT
T ss_pred             EeEEEEeCCCEEEEEEEECCCCeEEEEEEeccccccccccchhhhhhhcccccccccccccccccccccccccccccccc
Confidence            45679999999999999865 66899999987654332   345699999999999999999877               


Q ss_pred             ------------eccchhhhHHHHHHHHHHHHhhcCCCCeEecCcCCCcEEECCCCcEEEeecCCCccccCCCcceeccc
Q 039231          378 ------------LRVAEELSSTIGIARGLEYLHLGCSTRILHFDIKPHNILLDEDFCPKISDFGLAKICNRKESIISMTG  445 (506)
Q Consensus       378 ------------~~~~~~l~i~~~i~~gl~~LH~~~~~~ivH~dlkp~Nill~~~~~~ki~dfg~a~~~~~~~~~~~~~~  445 (506)
                                  ++..+.+.++.|+++||++||   +.+++|+||||+||++++++.++|+|||.+.......  .....
T Consensus        83 ~~L~~~l~~~~~~~~~~~~~~~~qi~~~L~~Lh---~~~i~H~dikp~NIl~~~~~~~~l~Dfg~~~~~~~~~--~~~~~  157 (260)
T PF00069_consen   83 GSLQDYLQKNKPLSEEEILKIAYQILEALAYLH---SKGIVHRDIKPENILLDENGEVKLIDFGSSVKLSENN--ENFNP  157 (260)
T ss_dssp             EBHHHHHHHHSSBBHHHHHHHHHHHHHHHHHHH---HTTEEESSBSGGGEEESTTSEEEESSGTTTEESTSTT--SEBSS
T ss_pred             ccccccccccccccccccccccccccccccccc---ccccccccccccccccccccccccccccccccccccc--ccccc
Confidence                        233346779999999999999   8999999999999999999999999999997642221  12355


Q ss_pred             CCCCcccccccccccccCCCCccccHHHHHHHHHHHHcCCCCCCCC
Q 039231          446 ARGTVGYIAPEVFCRNIGEVSYKSDVYNYGMMIFEMTGGRKNVDVV  491 (506)
Q Consensus       446 ~~gt~~y~aPE~l~~~~~~~s~~~Dv~s~G~il~elltg~~pf~~~  491 (506)
                      ..++..|+|||.+.. ....+.++||||+|+++|+|++|+.||...
T Consensus       158 ~~~~~~y~aPE~~~~-~~~~~~~~Di~slG~il~~l~~~~~p~~~~  202 (260)
T PF00069_consen  158 FVGTPEYMAPEVLQQ-GKKYTRKSDIWSLGIILYELLTGKLPFEES  202 (260)
T ss_dssp             SSSSGGGSCHHHHTT-TSSBSTHHHHHHHHHHHHHHHHSSSSSTTS
T ss_pred             ccccccccccccccc-cccccccccccccccccccccccccccccc
Confidence            778999999999851 247899999999999999999999999976

Serine/Threonine protein kinases, catalytic domain Tyrosine kinase, catalytic domain; InterPro: IPR017442 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Eukaryotic protein kinases [, , , , ] are enzymes that belong to a very extensive family of proteins which share a conserved catalytic core common with both serine/threonine and tyrosine protein kinases. There are a number of conserved regions in the catalytic domain of protein kinases. In the N-terminal extremity of the catalytic domain there is a glycine-rich stretch of residues in the vicinity of a lysine residue, which has been shown to be involved in ATP binding. In the central part of the catalytic domain there is a conserved aspartic acid residue which is important for the catalytic activity of the enzyme []. This entry includes protein kinases from eukaryotes and viruses and may include some bacterial hits too.; GO: 0004672 protein kinase activity, 0005524 ATP binding, 0006468 protein phosphorylation; PDB: 3GC7_A 3ZYA_A 3MPT_A 3NEW_A 3MVM_A 1R3C_A 2FST_X 3E93_A 3HV5_B 3OCG_A ....

>cd08529 STKc_FA2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains

Probab=99.95  E-value=1.2e-27  Score=229.98  Aligned_cols=170  Identities=29%  Similarity=0.408  Sum_probs=141.5

Q ss_pred             hccccCccCceEEEEEEEc-CCCEEEEEEeccC---CCCchhhHHHHHHhhccCccceeEEEEEee--------------
Q 039231          317 FKYKLGQGGYGSVYKGKLL-DGSNVAVKVLNDS---KGNGKEFINEVASISRTSHVNVVALLGFCL--------------  378 (506)
Q Consensus       317 ~~~~ig~G~~g~V~~~~~~-~~~~vavK~l~~~---~~~~~~~~~E~~~l~~l~h~niv~l~g~~~--------------  378 (506)
                      +.+.||+|++|.||+|+.. +++.+++|.+...   ....+++.+|++++++++||||+++++++.              
T Consensus         4 ~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~   83 (256)
T cd08529           4 ILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSYIIRYYESFLDKGKLNIVMEYAEN   83 (256)
T ss_pred             EeEEecCCCCeEEEEEEEcCCCcEEEEEEeehhhCCHHHHHHHHHHHHHHHhcCCCCeehheeeeccCCEEEEEEEeCCC
Confidence            4567999999999999875 5899999998643   233467889999999999999999998761              


Q ss_pred             ---------------ccchhhhHHHHHHHHHHHHhhcCCCCeEecCcCCCcEEECCCCcEEEeecCCCccccCCCcceec
Q 039231          379 ---------------RVAEELSSTIGIARGLEYLHLGCSTRILHFDIKPHNILLDEDFCPKISDFGLAKICNRKESIISM  443 (506)
Q Consensus       379 ---------------~~~~~l~i~~~i~~gl~~LH~~~~~~ivH~dlkp~Nill~~~~~~ki~dfg~a~~~~~~~~~~~~  443 (506)
                                     ++...+.++.|++.||.|||   +.+++|+||+|+||++++++.+||+|||+++........  .
T Consensus        84 ~~L~~~l~~~~~~~~~~~~~~~i~~~l~~al~~lH---~~~i~h~dl~~~nili~~~~~~~l~df~~~~~~~~~~~~--~  158 (256)
T cd08529          84 GDLHKLLKMQRGRPLPEDQVWRFFIQILLGLAHLH---SKKILHRDIKSLNLFLDAYDNVKIGDLGVAKLLSDNTNF--A  158 (256)
T ss_pred             CcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCcceEEEeCCCCEEEcccccceeccCccch--h
Confidence                           12234668899999999999   899999999999999999999999999999876543322  1


Q ss_pred             ccCCCCcccccccccccccCCCCccccHHHHHHHHHHHHcCCCCCCCCCC
Q 039231          444 TGARGTVGYIAPEVFCRNIGEVSYKSDVYNYGMMIFEMTGGRKNVDVVDN  493 (506)
Q Consensus       444 ~~~~gt~~y~aPE~l~~~~~~~s~~~Dv~s~G~il~elltg~~pf~~~~~  493 (506)
                      ....+++.|+|||++.+.  .++.++|+||||+++|||++|+.||...+.
T Consensus       159 ~~~~~~~~y~aPE~~~~~--~~~~~~Di~slG~il~~l~~g~~p~~~~~~  206 (256)
T cd08529         159 NTIVGTPYYLSPELCEDK--PYNEKSDVWALGVVLYECCTGKHPFDANNQ  206 (256)
T ss_pred             hccccCccccCHHHhcCC--CCCCccchHHHHHHHHHHHhCCCCCCCCCH
Confidence            335678899999998654  678999999999999999999999986653

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cyc

>cd05032 PTKc_InsR_like Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases

Probab=99.95  E-value=1.1e-27  Score=233.14  Aligned_cols=175  Identities=28%  Similarity=0.475  Sum_probs=140.4

Q ss_pred             HhhhccccCccCceEEEEEEEcC------CCEEEEEEeccCCC--CchhhHHHHHHhhccCccceeEEEEEee-------
Q 039231          314 TNSFKYKLGQGGYGSVYKGKLLD------GSNVAVKVLNDSKG--NGKEFINEVASISRTSHVNVVALLGFCL-------  378 (506)
Q Consensus       314 ~~~~~~~ig~G~~g~V~~~~~~~------~~~vavK~l~~~~~--~~~~~~~E~~~l~~l~h~niv~l~g~~~-------  378 (506)
                      .+.+.+.||+|+||.||+|...+      +..+|+|.+.....  ....+.+|++++..++|+||+++++++.       
T Consensus         7 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~   86 (277)
T cd05032           7 KITLIRELGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENASMRERIEFLNEASVMKEFNCHHVVRLLGVVSTGQPTLV   86 (277)
T ss_pred             HeeEEeEecCCCCceEEEEEEeccCCCCcceeEEEEecCCccCHHHHHHHHHHHHHHHhCCCCceeEEEEEEcCCCCcEE
Confidence            33445789999999999998643      36899999865432  2356889999999999999999998751       


Q ss_pred             ------------------------------ccchhhhHHHHHHHHHHHHhhcCCCCeEecCcCCCcEEECCCCcEEEeec
Q 039231          379 ------------------------------RVAEELSSTIGIARGLEYLHLGCSTRILHFDIKPHNILLDEDFCPKISDF  428 (506)
Q Consensus       379 ------------------------------~~~~~l~i~~~i~~gl~~LH~~~~~~ivH~dlkp~Nill~~~~~~ki~df  428 (506)
                                                    .+...+.++.|++.||.|||   +.+++|+||||+||++++++.+||+||
T Consensus        87 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~di~p~nill~~~~~~kl~df  163 (277)
T cd05032          87 VMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGMAYLA---AKKFVHRDLAARNCMVAEDLTVKIGDF  163 (277)
T ss_pred             EEecCCCCCHHHHHHhcccchhhccCCCCCCHHHHHHHHHHHHHHHHHHH---hCCccccccChheEEEcCCCCEEECCc
Confidence                                          11234668899999999999   899999999999999999999999999


Q ss_pred             CCCccccCCCcceecccCCCCcccccccccccccCCCCccccHHHHHHHHHHHHc-CCCCCCCCCC
Q 039231          429 GLAKICNRKESIISMTGARGTVGYIAPEVFCRNIGEVSYKSDVYNYGMMIFEMTG-GRKNVDVVDN  493 (506)
Q Consensus       429 g~a~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~s~~~Dv~s~G~il~ellt-g~~pf~~~~~  493 (506)
                      |+++...............++..|+|||.+.+  +.++.++||||||+++|||++ |+.||...+.
T Consensus       164 g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~--~~~~~~~Di~slG~il~el~t~g~~p~~~~~~  227 (277)
T cd05032         164 GMTRDIYETDYYRKGGKGLLPVRWMAPESLKD--GVFTTKSDVWSFGVVLWEMATLAEQPYQGLSN  227 (277)
T ss_pred             ccchhhccCcccccCCCCCccccccCHHHHhc--CCCCcccchHHHHHHHHHhhccCCCCCccCCH
Confidence            99986654332222233456789999999854  368899999999999999998 9999976543

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological

>cd05055 PTKc_PDGFR Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors

Probab=99.95  E-value=1.3e-27  Score=236.19  Aligned_cols=178  Identities=30%  Similarity=0.498  Sum_probs=142.1

Q ss_pred             HhhhccccCccCceEEEEEEEc------CCCEEEEEEeccCCCC--chhhHHHHHHhhcc-CccceeEEEEEe-------
Q 039231          314 TNSFKYKLGQGGYGSVYKGKLL------DGSNVAVKVLNDSKGN--GKEFINEVASISRT-SHVNVVALLGFC-------  377 (506)
Q Consensus       314 ~~~~~~~ig~G~~g~V~~~~~~------~~~~vavK~l~~~~~~--~~~~~~E~~~l~~l-~h~niv~l~g~~-------  377 (506)
                      ...+.+.||+|+||.||+|...      .+..+|+|+++.....  .+.+.+|+++++++ +||||+++++++       
T Consensus        36 ~~~~~~~ig~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~  115 (302)
T cd05055          36 NLSFGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAHSSEREALMSELKIMSHLGNHENIVNLLGACTIGGPIL  115 (302)
T ss_pred             HeEEcceeeccCCeeEEEEEEecCCCCCceeEEEEEecCccCChHHHHHHHHHHHHHHhccCCCCcceEEEEEecCCceE
Confidence            3445678999999999999742      2457999998754322  35688999999999 799999999876       


Q ss_pred             ----------------------eccchhhhHHHHHHHHHHHHhhcCCCCeEecCcCCCcEEECCCCcEEEeecCCCcccc
Q 039231          378 ----------------------LRVAEELSSTIGIARGLEYLHLGCSTRILHFDIKPHNILLDEDFCPKISDFGLAKICN  435 (506)
Q Consensus       378 ----------------------~~~~~~l~i~~~i~~gl~~LH~~~~~~ivH~dlkp~Nill~~~~~~ki~dfg~a~~~~  435 (506)
                                            +++.+.+.++.|++.||+|||   +++++|+||||+||+++.++.+||+|||+++...
T Consensus       116 lv~e~~~~~~L~~~i~~~~~~~l~~~~~~~i~~~i~~~l~~lH---~~~ivH~dlkp~Nil~~~~~~~~l~dfg~~~~~~  192 (302)
T cd05055         116 VITEYCCYGDLLNFLRRKRESFLTLEDLLSFSYQVAKGMAFLA---SKNCIHRDLAARNVLLTHGKIVKICDFGLARDIM  192 (302)
T ss_pred             EEEEcCCCCcHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHH---HCCeehhhhccceEEEcCCCeEEECCCccccccc
Confidence                                  123335678899999999999   8999999999999999999999999999998665


Q ss_pred             CCCcceecccCCCCcccccccccccccCCCCccccHHHHHHHHHHHHc-CCCCCCCCCCCcc
Q 039231          436 RKESIISMTGARGTVGYIAPEVFCRNIGEVSYKSDVYNYGMMIFEMTG-GRKNVDVVDNGST  496 (506)
Q Consensus       436 ~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~s~~~Dv~s~G~il~ellt-g~~pf~~~~~~~~  496 (506)
                      ............++..|+|||.+...  .++.++||||||+++|||++ |..||......+.
T Consensus       193 ~~~~~~~~~~~~~~~~y~aPE~~~~~--~~~~~~DiwslGvil~el~t~g~~p~~~~~~~~~  252 (302)
T cd05055         193 NDSNYVVKGNARLPVKWMAPESIFNC--VYTFESDVWSYGILLWEIFSLGSNPYPGMPVDSK  252 (302)
T ss_pred             CCCceeecCCCCcccccCCHhhhccC--CCCcHhHHHHHHHHHHHHHhCCCCCcCCCCchHH
Confidence            43322222234567889999998554  68899999999999999998 9999987655443

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to recept

>cd05112 PTKc_Itk Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase

Probab=99.95  E-value=1.5e-27  Score=229.44  Aligned_cols=173  Identities=29%  Similarity=0.556  Sum_probs=142.6

Q ss_pred             hhccccCccCceEEEEEEEcCCCEEEEEEeccCCCCchhhHHHHHHhhccCccceeEEEEEe------------------
Q 039231          316 SFKYKLGQGGYGSVYKGKLLDGSNVAVKVLNDSKGNGKEFINEVASISRTSHVNVVALLGFC------------------  377 (506)
Q Consensus       316 ~~~~~ig~G~~g~V~~~~~~~~~~vavK~l~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~------------------  377 (506)
                      .+.+.||+|+||.||+|.+.++..+|+|++........++.+|++++++++||||+++++++                  
T Consensus         7 ~~~~~ig~g~~g~v~~~~~~~~~~~~~k~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~~~L   86 (256)
T cd05112           7 TLVQEIGSGQFGLVWLGYWLEKRKVAIKTIREGAMSEEDFIEEAQVMMKLSHPKLVQLYGVCTERSPICLVFEFMEHGCL   86 (256)
T ss_pred             EEEeeecCcccceEEEEEEeCCCeEEEEECCCCCCCHHHHHHHHHHHHhCCCCCeeeEEEEEccCCceEEEEEcCCCCcH
Confidence            34578999999999999987788999999976655567899999999999999999999876                  


Q ss_pred             ----------eccchhhhHHHHHHHHHHHHhhcCCCCeEecCcCCCcEEECCCCcEEEeecCCCccccCCCcceecccCC
Q 039231          378 ----------LRVAEELSSTIGIARGLEYLHLGCSTRILHFDIKPHNILLDEDFCPKISDFGLAKICNRKESIISMTGAR  447 (506)
Q Consensus       378 ----------~~~~~~l~i~~~i~~gl~~LH~~~~~~ivH~dlkp~Nill~~~~~~ki~dfg~a~~~~~~~~~~~~~~~~  447 (506)
                                +.+...+.++.|++.||+|||   +.+++|+||||+||+++.++.+||+|||+++........ ......
T Consensus        87 ~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH---~~~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~~~-~~~~~~  162 (256)
T cd05112          87 SDYLRAQRGKFSQETLLGMCLDVCEGMAYLE---SSNVIHRDLAARNCLVGENQVVKVSDFGMTRFVLDDQYT-SSTGTK  162 (256)
T ss_pred             HHHHHhCccCCCHHHHHHHHHHHHHHHHHHH---HCCccccccccceEEEcCCCeEEECCCcceeecccCccc-ccCCCc
Confidence                      122335678889999999999   899999999999999999999999999998765433211 112233


Q ss_pred             CCcccccccccccccCCCCccccHHHHHHHHHHHHc-CCCCCCCCCCC
Q 039231          448 GTVGYIAPEVFCRNIGEVSYKSDVYNYGMMIFEMTG-GRKNVDVVDNG  494 (506)
Q Consensus       448 gt~~y~aPE~l~~~~~~~s~~~Dv~s~G~il~ellt-g~~pf~~~~~~  494 (506)
                      ++..|+|||.+.+  +.++.++||||||+++|||++ |+.||.....+
T Consensus       163 ~~~~~~aPe~~~~--~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~  208 (256)
T cd05112         163 FPVKWSSPEVFSF--SKYSSKSDVWSFGVLMWEVFSEGKTPYENRSNS  208 (256)
T ss_pred             cchhhcCHhHhcc--CCcChHHHHHHHHHHHHHHHcCCCCCCCcCCHH
Confidence            5678999999854  368889999999999999998 99999765433

Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activ

>KOG4278 consensus Protein tyrosine kinase [Signal transduction mechanisms]

Probab=99.95  E-value=9.8e-29  Score=245.89  Aligned_cols=181  Identities=31%  Similarity=0.525  Sum_probs=153.5

Q ss_pred             HHHHHHHhhhccccCccCceEEEEEEEcC-CCEEEEEEeccCCCCchhhHHHHHHhhccCccceeEEEEEeecc------
Q 039231          308 ADIKKMTNSFKYKLGQGGYGSVYKGKLLD-GSNVAVKVLNDSKGNGKEFINEVASISRTSHVNVVALLGFCLRV------  380 (506)
Q Consensus       308 ~el~~~~~~~~~~ig~G~~g~V~~~~~~~-~~~vavK~l~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~------  380 (506)
                      .|+++-.....++||-|-||.||.|.++. .-.||||.++.+....++|+.|+.+|+.++|||+|+|+|+|-.+      
T Consensus       262 WEmeRtdItMkhKLGGGQYGeVYeGvWKkyslTvAVKtLKEDtMeveEFLkEAAvMKeikHpNLVqLLGVCT~EpPFYIi  341 (1157)
T KOG4278|consen  262 WEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTHEPPFYII  341 (1157)
T ss_pred             hhccchheeeeeccCCCcccceeeeeeeccceeeehhhhhhcchhHHHHHHHHHHHHhhcCccHHHHhhhhccCCCeEEE
Confidence            34444444456889999999999999876 67899999999888889999999999999999999999999211      


Q ss_pred             -----------------------chhhhHHHHHHHHHHHHhhcCCCCeEecCcCCCcEEECCCCcEEEeecCCCccccCC
Q 039231          381 -----------------------AEELSSTIGIARGLEYLHLGCSTRILHFDIKPHNILLDEDFCPKISDFGLAKICNRK  437 (506)
Q Consensus       381 -----------------------~~~l~i~~~i~~gl~~LH~~~~~~ivH~dlkp~Nill~~~~~~ki~dfg~a~~~~~~  437 (506)
                                             --.+.++.||+.||+||.   ++.+|||||..+|.|+.++..+||+|||+++++..+
T Consensus       342 TEfM~yGNLLdYLRecnr~ev~avvLlyMAtQIsSaMeYLE---kknFIHRDLAARNCLVgEnhiVKvADFGLsRlMtgD  418 (1157)
T KOG4278|consen  342 TEFMCYGNLLDYLRECNRSEVPAVVLLYMATQISSAMEYLE---KKNFIHRDLAARNCLVGENHIVKVADFGLSRLMTGD  418 (1157)
T ss_pred             EecccCccHHHHHHHhchhhcchhHHHHHHHHHHHHHHHHH---HhhhhhhhhhhhhccccccceEEeeccchhhhhcCC
Confidence                                   115678999999999999   999999999999999999999999999999998776


Q ss_pred             CcceecccCCCCcccccccccccccCCCCccccHHHHHHHHHHHHc-CCCCCCCCCCC
Q 039231          438 ESIISMTGARGTVGYIAPEVFCRNIGEVSYKSDVYNYGMMIFEMTG-GRKNVDVVDNG  494 (506)
Q Consensus       438 ~~~~~~~~~~gt~~y~aPE~l~~~~~~~s~~~Dv~s~G~il~ellt-g~~pf~~~~~~  494 (506)
                      .... .....-.+.|.|||.+.-+  .++.|+|||+|||+||||.| |..||...+-.
T Consensus       419 TYTA-HAGAKFPIKWTAPEsLAyN--tFSiKSDVWAFGVLLWEIATYGMsPYPGidlS  473 (1157)
T KOG4278|consen  419 TYTA-HAGAKFPIKWTAPESLAYN--TFSIKSDVWAFGVLLWEIATYGMSPYPGIDLS  473 (1157)
T ss_pred             ceec-ccCccCcccccCccccccc--ccccchhhHHHHHHHHHHHhcCCCCCCCccHH
Confidence            5422 2334457789999998544  78999999999999999998 99999876543

>cd05110 PTKc_HER4 Catalytic domain of the Protein Tyrosine Kinase, HER4

Probab=99.95  E-value=1e-27  Score=236.99  Aligned_cols=170  Identities=34%  Similarity=0.602  Sum_probs=136.7

Q ss_pred             ccccCccCceEEEEEEEc-CCC----EEEEEEeccCCCC--chhhHHHHHHhhccCccceeEEEEEee------------
Q 039231          318 KYKLGQGGYGSVYKGKLL-DGS----NVAVKVLNDSKGN--GKEFINEVASISRTSHVNVVALLGFCL------------  378 (506)
Q Consensus       318 ~~~ig~G~~g~V~~~~~~-~~~----~vavK~l~~~~~~--~~~~~~E~~~l~~l~h~niv~l~g~~~------------  378 (506)
                      .+.||+|+||.||+|++. ++.    .+|+|.+......  ..++.+|+.++++++||||++++|++.            
T Consensus        12 ~~~lg~G~~g~vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~~~~~v~e~~~   91 (303)
T cd05110          12 VKVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHLVRLLGVCLSPTIQLVTQLMP   91 (303)
T ss_pred             ccccccCCCccEEEEEEecCCCcceeeEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEcCCCceeeehhcC
Confidence            357999999999999864 343    5788988654322  246889999999999999999999872            


Q ss_pred             ---------------ccchhhhHHHHHHHHHHHHhhcCCCCeEecCcCCCcEEECCCCcEEEeecCCCccccCCCcceec
Q 039231          379 ---------------RVAEELSSTIGIARGLEYLHLGCSTRILHFDIKPHNILLDEDFCPKISDFGLAKICNRKESIISM  443 (506)
Q Consensus       379 ---------------~~~~~l~i~~~i~~gl~~LH~~~~~~ivH~dlkp~Nill~~~~~~ki~dfg~a~~~~~~~~~~~~  443 (506)
                                     .+...+.++.|++.||+|||   +++|+|+||||+||++++++.+||+|||+++...........
T Consensus        92 ~g~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH---~~~ivH~dikp~Nill~~~~~~kL~Dfg~~~~~~~~~~~~~~  168 (303)
T cd05110          92 HGCLLDYVHEHKDNIGSQLLLNWCVQIAKGMMYLE---ERRLVHRDLAARNVLVKSPNHVKITDFGLARLLEGDEKEYNA  168 (303)
T ss_pred             CCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHh---hcCeeccccccceeeecCCCceEEccccccccccCccccccc
Confidence                           12235678899999999999   899999999999999999999999999999876543322222


Q ss_pred             ccCCCCcccccccccccccCCCCccccHHHHHHHHHHHHc-CCCCCCCCC
Q 039231          444 TGARGTVGYIAPEVFCRNIGEVSYKSDVYNYGMMIFEMTG-GRKNVDVVD  492 (506)
Q Consensus       444 ~~~~gt~~y~aPE~l~~~~~~~s~~~Dv~s~G~il~ellt-g~~pf~~~~  492 (506)
                      ....++..|+|||.+.+.  .++.++||||||+++|||++ |+.||....
T Consensus       169 ~~~~~~~~y~~PE~~~~~--~~~~~~DiwslG~~l~el~t~g~~p~~~~~  216 (303)
T cd05110         169 DGGKMPIKWMALECIHYR--KFTHQSDVWSYGVTIWELMTFGGKPYDGIP  216 (303)
T ss_pred             CCCccccccCCHHHhccC--CCChHHHHHHHHHHHHHHHhCCCCCCCCCC
Confidence            334457789999998543  68899999999999999997 999997643

Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as bindin

>cd05057 PTKc_EGFR_like Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases

Probab=99.95  E-value=1.4e-27  Score=232.93  Aligned_cols=175  Identities=33%  Similarity=0.543  Sum_probs=141.1

Q ss_pred             hhccccCccCceEEEEEEEcC-C----CEEEEEEeccCCC--CchhhHHHHHHhhccCccceeEEEEEee----------
Q 039231          316 SFKYKLGQGGYGSVYKGKLLD-G----SNVAVKVLNDSKG--NGKEFINEVASISRTSHVNVVALLGFCL----------  378 (506)
Q Consensus       316 ~~~~~ig~G~~g~V~~~~~~~-~----~~vavK~l~~~~~--~~~~~~~E~~~l~~l~h~niv~l~g~~~----------  378 (506)
                      .+.+.||+|+||.||+|...+ +    ..+|+|.+.....  ...++.+|++.+++++||||+++++++.          
T Consensus        10 ~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~v~e~   89 (279)
T cd05057          10 EKIKVLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETSPKANKEILDEAYVMASVDHPHVVRLLGICLSSQVQLITQL   89 (279)
T ss_pred             EEcceecCCCCccEEEEEEecCCCCcceEEEEEeccCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEecCceEEEEec
Confidence            445689999999999998643 3    2689998875543  2367889999999999999999998762          


Q ss_pred             -----------------ccchhhhHHHHHHHHHHHHhhcCCCCeEecCcCCCcEEECCCCcEEEeecCCCccccCCCcce
Q 039231          379 -----------------RVAEELSSTIGIARGLEYLHLGCSTRILHFDIKPHNILLDEDFCPKISDFGLAKICNRKESII  441 (506)
Q Consensus       379 -----------------~~~~~l~i~~~i~~gl~~LH~~~~~~ivH~dlkp~Nill~~~~~~ki~dfg~a~~~~~~~~~~  441 (506)
                                       ++...+.++.|++.||+|||   +.+++|+||||+||++++++.+||+|||+++.........
T Consensus        90 ~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~LH---~~~i~H~di~p~nil~~~~~~~kL~dfg~~~~~~~~~~~~  166 (279)
T cd05057          90 MPLGCLLDYVRNHKDNIGSQYLLNWCVQIAKGMSYLE---EKRLVHRDLAARNVLVKTPQHVKITDFGLAKLLDVDEKEY  166 (279)
T ss_pred             CCCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHH---hCCEEecccCcceEEEcCCCeEEECCCcccccccCcccce
Confidence                             23346778999999999999   8999999999999999999999999999998765443322


Q ss_pred             ecccCCCCcccccccccccccCCCCccccHHHHHHHHHHHHc-CCCCCCCCCCCc
Q 039231          442 SMTGARGTVGYIAPEVFCRNIGEVSYKSDVYNYGMMIFEMTG-GRKNVDVVDNGS  495 (506)
Q Consensus       442 ~~~~~~gt~~y~aPE~l~~~~~~~s~~~Dv~s~G~il~ellt-g~~pf~~~~~~~  495 (506)
                      ......++..|+|||.+..  ..++.++|+||||+++||+++ |+.||+.....+
T Consensus       167 ~~~~~~~~~~y~~PE~~~~--~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~  219 (279)
T cd05057         167 HAEGGKVPIKWMALESILH--RIYTHKSDVWSYGVTVWELMTFGAKPYEGIPAVE  219 (279)
T ss_pred             ecCCCcccccccCHHHhhc--CCcCchhhHHHHHHHHHHHhcCCCCCCCCCCHHH
Confidence            2222334678999998854  378899999999999999998 999998765443

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instea

>cd06654 STKc_PAK1 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1

Probab=99.95  E-value=1.6e-27  Score=234.73  Aligned_cols=169  Identities=30%  Similarity=0.430  Sum_probs=140.8

Q ss_pred             ccccCccCceEEEEEEEc-CCCEEEEEEeccCCC-CchhhHHHHHHhhccCccceeEEEEEee-----------------
Q 039231          318 KYKLGQGGYGSVYKGKLL-DGSNVAVKVLNDSKG-NGKEFINEVASISRTSHVNVVALLGFCL-----------------  378 (506)
Q Consensus       318 ~~~ig~G~~g~V~~~~~~-~~~~vavK~l~~~~~-~~~~~~~E~~~l~~l~h~niv~l~g~~~-----------------  378 (506)
                      .+.||+|++|.||+|+.. +++.+++|.+..... ..+.+.+|+.+++.++|+||+++++.+.                 
T Consensus        25 ~~~lg~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~e~~~l~~~~h~~v~~~~~~~~~~~~~~lv~e~~~~~~L  104 (296)
T cd06654          25 FEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSL  104 (296)
T ss_pred             EEEecCCCCeEEEEEEECCCCcEEEEEEEecCCcchHHHHHHHHHHHHhCCCCCEeeEEEEEEeCCEEEEeecccCCCCH
Confidence            457999999999999864 588999999875433 3467889999999999999999998762                 


Q ss_pred             ---------ccchhhhHHHHHHHHHHHHhhcCCCCeEecCcCCCcEEECCCCcEEEeecCCCccccCCCcceecccCCCC
Q 039231          379 ---------RVAEELSSTIGIARGLEYLHLGCSTRILHFDIKPHNILLDEDFCPKISDFGLAKICNRKESIISMTGARGT  449 (506)
Q Consensus       379 ---------~~~~~l~i~~~i~~gl~~LH~~~~~~ivH~dlkp~Nill~~~~~~ki~dfg~a~~~~~~~~~~~~~~~~gt  449 (506)
                               .+.+.+.++.|++.||+|||   +.+++|+||||+||+++.++.+||+|||++.........  .....++
T Consensus       105 ~~~~~~~~~~~~~~~~i~~ql~~aL~~LH---~~gi~H~dLkp~Nill~~~~~~kl~dfg~~~~~~~~~~~--~~~~~~~  179 (296)
T cd06654         105 TDVVTETCMDEGQIAAVCRECLQALEFLH---SNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSK--RSTMVGT  179 (296)
T ss_pred             HHHHHhcCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCHHHEEEcCCCCEEECccccchhccccccc--cCcccCC
Confidence                     23346678899999999999   899999999999999999999999999998765433221  1334678


Q ss_pred             cccccccccccccCCCCccccHHHHHHHHHHHHcCCCCCCCCCC
Q 039231          450 VGYIAPEVFCRNIGEVSYKSDVYNYGMMIFEMTGGRKNVDVVDN  493 (506)
Q Consensus       450 ~~y~aPE~l~~~~~~~s~~~Dv~s~G~il~elltg~~pf~~~~~  493 (506)
                      +.|+|||.+.+.  .++.++||||||+++|||++|+.||.....
T Consensus       180 ~~y~aPE~~~~~--~~~~~~Dv~s~Gvil~~l~~g~~pf~~~~~  221 (296)
T cd06654         180 PYWMAPEVVTRK--AYGPKVDIWSLGIMAIEMIEGEPPYLNENP  221 (296)
T ss_pred             ccccCHHHHcCC--CCCccchHHHHHHHHHHHHhCCCCCCCCCH
Confidence            899999998653  678999999999999999999999976554

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding

>KOG0662 consensus Cyclin-dependent kinase CDK5 [Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms]

Probab=99.95  E-value=3.8e-28  Score=207.80  Aligned_cols=177  Identities=27%  Similarity=0.373  Sum_probs=145.9

Q ss_pred             cccCccCceEEEEEEEcC-CCEEEEEEeccCC---CCchhhHHHHHHhhccCccceeEEEEEe-----------------
Q 039231          319 YKLGQGGYGSVYKGKLLD-GSNVAVKVLNDSK---GNGKEFINEVASISRTSHVNVVALLGFC-----------------  377 (506)
Q Consensus       319 ~~ig~G~~g~V~~~~~~~-~~~vavK~l~~~~---~~~~~~~~E~~~l~~l~h~niv~l~g~~-----------------  377 (506)
                      ++||+|.+|+||+|+..+ ++.||+|+..-+.   .-.....+|+-+++.++|.|||+++++.                 
T Consensus         8 ekigegtygtvfkarn~~t~eivalkrvrlddddegvpssalreicllkelkhknivrl~dvlhsdkkltlvfe~cdqdl   87 (292)
T KOG0662|consen    8 EKIGEGTYGTVFKARNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFEFCDQDL   87 (292)
T ss_pred             HhhcCCcceeeEecccCCccceEEEEEEeccCCCCCCcHHHHHHHHHHHHhhhcceeehhhhhccCceeEEeHHHhhHHH
Confidence            469999999999999755 7889999986432   2236789999999999999999998765                 


Q ss_pred             ----------eccchhhhHHHHHHHHHHHHhhcCCCCeEecCcCCCcEEECCCCcEEEeecCCCccccCCCcceecccCC
Q 039231          378 ----------LRVAEELSSTIGIARGLEYLHLGCSTRILHFDIKPHNILLDEDFCPKISDFGLAKICNRKESIISMTGAR  447 (506)
Q Consensus       378 ----------~~~~~~l~i~~~i~~gl~~LH~~~~~~ivH~dlkp~Nill~~~~~~ki~dfg~a~~~~~~~~~~~~~~~~  447 (506)
                                ++.+....++.|+++||.+.|   ++.++|||+||+|.||+.+|..|++|||+++.++-.-..  .....
T Consensus        88 kkyfdslng~~d~~~~rsfmlqllrgl~fch---shnvlhrdlkpqnllin~ngelkladfglarafgipvrc--ysaev  162 (292)
T KOG0662|consen   88 KKYFDSLNGDLDPEIVRSFMLQLLRGLGFCH---SHNVLHRDLKPQNLLINRNGELKLADFGLARAFGIPVRC--YSAEV  162 (292)
T ss_pred             HHHHHhcCCcCCHHHHHHHHHHHHhhhhhhh---hhhhhhccCCcceEEeccCCcEEecccchhhhcCCceEe--eecee
Confidence                      223335568889999999999   999999999999999999999999999999977654322  24566


Q ss_pred             CCcccccccccccccCCCCccccHHHHHHHHHHHHc-CCCCCCCCCCCcchhhhh
Q 039231          448 GTVGYIAPEVFCRNIGEVSYKSDVYNYGMMIFEMTG-GRKNVDVVDNGSTALDLQ  501 (506)
Q Consensus       448 gt~~y~aPE~l~~~~~~~s~~~Dv~s~G~il~ellt-g~~pf~~~~~~~~~~~~~  501 (506)
                      -|..|.+|.++.+. .-|+...|+||-|||+.|+.. |++.|...+-.++...|.
T Consensus       163 vtlwyrppdvlfga-kly~tsidmwsagcifaelanagrplfpg~dvddqlkrif  216 (292)
T KOG0662|consen  163 VTLWYRPPDVLFGA-KLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIF  216 (292)
T ss_pred             eeeeccCcceeeee-ehhccchHhhhcchHHHHHhhcCCCCCCCCcHHHHHHHHH
Confidence            79999999999875 578899999999999999996 777787776666555443

>KOG0199 consensus ACK and related non-receptor tyrosine kinases [Signal transduction mechanisms]

Probab=99.95  E-value=4.5e-28  Score=244.41  Aligned_cols=176  Identities=30%  Similarity=0.447  Sum_probs=147.8

Q ss_pred             hccccCccCceEEEEEEEcC--C--CEEEEEEeccCCC--CchhhHHHHHHhhccCccceeEEEEEeeccch--------
Q 039231          317 FKYKLGQGGYGSVYKGKLLD--G--SNVAVKVLNDSKG--NGKEFINEVASISRTSHVNVVALLGFCLRVAE--------  382 (506)
Q Consensus       317 ~~~~ig~G~~g~V~~~~~~~--~--~~vavK~l~~~~~--~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~--------  382 (506)
                      +-++||+|.||.|++|.+..  |  ..||||.++....  ...+|++|+.+|.+++|+|+++|+|+.++..-        
T Consensus       114 l~e~LG~GsFgvV~rg~Wt~psgk~V~VAVKclr~d~l~~~mddflrEas~M~~L~H~hliRLyGvVl~qp~mMV~ELap  193 (1039)
T KOG0199|consen  114 LYELLGEGSFGVVKRGTWTQPSGKHVNVAVKCLRDDSLNAIMDDFLREASHMLKLQHPHLIRLYGVVLDQPAMMVFELAP  193 (1039)
T ss_pred             HHHHhcCcceeeEeeccccCCCCcEEeEEEEeccCCccchhHHHHHHHHHHHHhccCcceeEEeeeeccchhhHHhhhcc
Confidence            34679999999999998753  4  4689999987654  45899999999999999999999999864211        


Q ss_pred             --------------------hhhHHHHHHHHHHHHhhcCCCCeEecCcCCCcEEECCCCcEEEeecCCCccccCCCccee
Q 039231          383 --------------------ELSSTIGIARGLEYLHLGCSTRILHFDIKPHNILLDEDFCPKISDFGLAKICNRKESIIS  442 (506)
Q Consensus       383 --------------------~l~i~~~i~~gl~~LH~~~~~~ivH~dlkp~Nill~~~~~~ki~dfg~a~~~~~~~~~~~  442 (506)
                                          .-.++.|||.||+||.   .+++|||||..+|+||.....+||+|||+.+.++.++.+..
T Consensus       194 lGSLldrLrka~~~~llv~~Lcdya~QiA~aM~YLe---skrlvHRDLAARNlllasprtVKI~DFGLmRaLg~ned~Yv  270 (1039)
T KOG0199|consen  194 LGSLLDRLRKAKKAILLVSRLCDYAMQIAKAMQYLE---SKRLVHRDLAARNLLLASPRTVKICDFGLMRALGENEDMYV  270 (1039)
T ss_pred             cchHHHHHhhccccceeHHHHHHHHHHHHHHHHHHh---hhhhhhhhhhhhhheecccceeeeecccceeccCCCCcceE
Confidence                                2347889999999999   99999999999999999999999999999999988776665


Q ss_pred             ccc-CCCCcccccccccccccCCCCccccHHHHHHHHHHHHc-CCCCCCCCCCCcch
Q 039231          443 MTG-ARGTVGYIAPEVFCRNIGEVSYKSDVYNYGMMIFEMTG-GRKNVDVVDNGSTA  497 (506)
Q Consensus       443 ~~~-~~gt~~y~aPE~l~~~~~~~s~~~Dv~s~G~il~ellt-g~~pf~~~~~~~~~  497 (506)
                      +.. ..-...|.|||.|.  .+.++.++|||+|||.||||+| |+.||-......+.
T Consensus       271 m~p~rkvPfAWCaPEsLr--h~kFShaSDvWmyGVTiWEMFtyGEePW~G~~g~qIL  325 (1039)
T KOG0199|consen  271 MAPQRKVPFAWCAPESLR--HRKFSHASDVWMYGVTIWEMFTYGEEPWVGCRGIQIL  325 (1039)
T ss_pred             ecCCCcCcccccCHhHhc--cccccccchhhhhhhhHHhhhccCCCCCCCCCHHHHH
Confidence            443 33566899999994  4589999999999999999998 99999877654443

>cd06612 STKc_MST1_2 Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2

Probab=99.95  E-value=1.4e-27  Score=229.40  Aligned_cols=171  Identities=31%  Similarity=0.446  Sum_probs=143.4

Q ss_pred             hhccccCccCceEEEEEEEcC-CCEEEEEEeccCCCCchhhHHHHHHhhccCccceeEEEEEee----------------
Q 039231          316 SFKYKLGQGGYGSVYKGKLLD-GSNVAVKVLNDSKGNGKEFINEVASISRTSHVNVVALLGFCL----------------  378 (506)
Q Consensus       316 ~~~~~ig~G~~g~V~~~~~~~-~~~vavK~l~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~----------------  378 (506)
                      .+.+.||+|++|.||+|+..+ ++.+++|.+..... .+++.+|++.+++++|+||+++++.+.                
T Consensus         6 ~~~~~i~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~-~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e~~~~~~   84 (256)
T cd06612           6 DILEKLGEGSYGSVYKAIHKETGQVVAIKVVPVEED-LQEIIKEISILKQCDSPYIVKYYGSYFKNTDLWIVMEYCGAGS   84 (256)
T ss_pred             hhhhhhcCCCCeEEEEEEEcCCCcEEEEEEeecHHH-HHHHHHHHHHHHhCCCCcEeeeeeeeecCCcEEEEEecCCCCc
Confidence            345679999999999999865 78999999875543 578999999999999999999998762                


Q ss_pred             ------------ccchhhhHHHHHHHHHHHHhhcCCCCeEecCcCCCcEEECCCCcEEEeecCCCccccCCCcceecccC
Q 039231          379 ------------RVAEELSSTIGIARGLEYLHLGCSTRILHFDIKPHNILLDEDFCPKISDFGLAKICNRKESIISMTGA  446 (506)
Q Consensus       379 ------------~~~~~l~i~~~i~~gl~~LH~~~~~~ivH~dlkp~Nill~~~~~~ki~dfg~a~~~~~~~~~~~~~~~  446 (506)
                                  ++...+.++.|++.||.|||   +.+++|+||+|+||++++++.+||+|||++.........  ....
T Consensus        85 L~~~l~~~~~~l~~~~~~~~~~~l~~~l~~lh---~~~i~H~dl~~~ni~~~~~~~~~l~dfg~~~~~~~~~~~--~~~~  159 (256)
T cd06612          85 VSDIMKITNKTLTEEEIAAILYQTLKGLEYLH---SNKKIHRDIKAGNILLNEEGQAKLADFGVSGQLTDTMAK--RNTV  159 (256)
T ss_pred             HHHHHHhCccCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCcceEEECCCCcEEEcccccchhcccCccc--cccc
Confidence                        23345678999999999999   899999999999999999999999999999876543311  1334


Q ss_pred             CCCcccccccccccccCCCCccccHHHHHHHHHHHHcCCCCCCCCCCC
Q 039231          447 RGTVGYIAPEVFCRNIGEVSYKSDVYNYGMMIFEMTGGRKNVDVVDNG  494 (506)
Q Consensus       447 ~gt~~y~aPE~l~~~~~~~s~~~Dv~s~G~il~elltg~~pf~~~~~~  494 (506)
                      .++..|+|||.+.+.  .++.++||||||+++|||++|+.||......
T Consensus       160 ~~~~~y~~PE~~~~~--~~~~~~Di~s~G~il~~l~~g~~p~~~~~~~  205 (256)
T cd06612         160 IGTPFWMAPEVIQEI--GYNNKADIWSLGITAIEMAEGKPPYSDIHPM  205 (256)
T ss_pred             cCCccccCHHHHhcC--CCCchhhHHHHHHHHHHHHhCCCCCCCcchh
Confidence            578899999998554  6889999999999999999999999865443

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a

>cd05103 PTKc_VEGFR2 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2

Probab=99.95  E-value=1.2e-27  Score=240.65  Aligned_cols=176  Identities=28%  Similarity=0.496  Sum_probs=139.2

Q ss_pred             HHhhhccccCccCceEEEEEEE------cCCCEEEEEEeccCCC--CchhhHHHHHHhhcc-CccceeEEEEEeecc---
Q 039231          313 MTNSFKYKLGQGGYGSVYKGKL------LDGSNVAVKVLNDSKG--NGKEFINEVASISRT-SHVNVVALLGFCLRV---  380 (506)
Q Consensus       313 ~~~~~~~~ig~G~~g~V~~~~~------~~~~~vavK~l~~~~~--~~~~~~~E~~~l~~l-~h~niv~l~g~~~~~---  380 (506)
                      ..+.+.+.||+|+||.||+|+.      .+++.||||+++....  ....+.+|++++.++ +||||+++++++...   
T Consensus         7 ~~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~   86 (343)
T cd05103           7 DRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGGP   86 (343)
T ss_pred             hHhcccccccCCccceEEEEeeccCCccccceeEEEEEeccCCChHHHHHHHHHHHHHHhccCCccHhhhcceeecCCCc
Confidence            3455678899999999999974      3468899999975432  235688999999999 689999998765211   


Q ss_pred             --------------------------------------------------------------------------------
Q 039231          381 --------------------------------------------------------------------------------  380 (506)
Q Consensus       381 --------------------------------------------------------------------------------  380 (506)
                                                                                                      
T Consensus        87 ~~lv~ey~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  166 (343)
T cd05103          87 LMVIVEFCKFGNLSNYLRSKRGEFVPYKTKDARFRQGKSGYGDISEDLKRRLDSITSSQSSASSGFVEEKSLSDVEEEEA  166 (343)
T ss_pred             eEEEEeccCCCcHHHHHHhcCCccccccccccccccccccccchhhhhhhhccccccccccccccccCCCccccchhhhh
Confidence                                                                                            


Q ss_pred             ------------chhhhHHHHHHHHHHHHhhcCCCCeEecCcCCCcEEECCCCcEEEeecCCCccccCCCcceecccCCC
Q 039231          381 ------------AEELSSTIGIARGLEYLHLGCSTRILHFDIKPHNILLDEDFCPKISDFGLAKICNRKESIISMTGARG  448 (506)
Q Consensus       381 ------------~~~l~i~~~i~~gl~~LH~~~~~~ivH~dlkp~Nill~~~~~~ki~dfg~a~~~~~~~~~~~~~~~~g  448 (506)
                                  ...+.++.|+++||+|||   +++|+||||||+||++++++.+||+|||+++...............+
T Consensus       167 ~~~~~~~~~~~~~~~~~~~~qi~~al~~lH---~~~i~H~dikp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~  243 (343)
T cd05103         167 EQEDLYKKVLTLEDLICYSFQVAKGMEFLA---SRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARL  243 (343)
T ss_pred             hhhhhhhccCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCccCeEEEcCCCcEEEEecccccccccCcchhhcCCCCC
Confidence                        112457889999999999   89999999999999999999999999999986543322222223445


Q ss_pred             CcccccccccccccCCCCccccHHHHHHHHHHHHc-CCCCCCCCCC
Q 039231          449 TVGYIAPEVFCRNIGEVSYKSDVYNYGMMIFEMTG-GRKNVDVVDN  493 (506)
Q Consensus       449 t~~y~aPE~l~~~~~~~s~~~Dv~s~G~il~ellt-g~~pf~~~~~  493 (506)
                      +..|+|||.+...  .++.++||||||+++|||++ |..||.....
T Consensus       244 ~~~y~aPE~~~~~--~~~~~~Di~slG~~l~el~~~g~~p~~~~~~  287 (343)
T cd05103         244 PLKWMAPETIFDR--VYTIQSDVWSFGVLLWEIFSLGASPYPGVKI  287 (343)
T ss_pred             CcceECcHHhcCC--CCCchhhHHHHHHHHHHHHHCCCCCCCCccc
Confidence            6789999998553  68899999999999999996 9999976543

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosp

>cd06624 STKc_ASK Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase

Probab=99.95  E-value=1.5e-27  Score=231.33  Aligned_cols=177  Identities=29%  Similarity=0.389  Sum_probs=141.2

Q ss_pred             HHHHhhhc--cccCccCceEEEEEEEc-CCCEEEEEEeccCCC-CchhhHHHHHHhhccCccceeEEEEEee--------
Q 039231          311 KKMTNSFK--YKLGQGGYGSVYKGKLL-DGSNVAVKVLNDSKG-NGKEFINEVASISRTSHVNVVALLGFCL--------  378 (506)
Q Consensus       311 ~~~~~~~~--~~ig~G~~g~V~~~~~~-~~~~vavK~l~~~~~-~~~~~~~E~~~l~~l~h~niv~l~g~~~--------  378 (506)
                      +.++.++.  ..||+|+||.||+|+.. ++..|++|.+..... ..+.+.+|++++++++|+||+++++++.        
T Consensus         4 ~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv   83 (268)
T cd06624           4 EYEYDENGERVVLGKGTYGIVYAARDLSTQVRIAIKEIPERDSRYVQPLHEEIALHSYLKHRNIVQYLGSDSENGFFKIF   83 (268)
T ss_pred             ccccccCCceEEEecCCceEEEEeEecCCCcEEEEEEecCCCHHHHHHHHHHHHHHHhcCCCCeeeeeeeeccCCEEEEE
Confidence            33444443  46999999999999865 578899998875433 3467899999999999999999998761        


Q ss_pred             ----------------------ccchhhhHHHHHHHHHHHHhhcCCCCeEecCcCCCcEEECC-CCcEEEeecCCCcccc
Q 039231          379 ----------------------RVAEELSSTIGIARGLEYLHLGCSTRILHFDIKPHNILLDE-DFCPKISDFGLAKICN  435 (506)
Q Consensus       379 ----------------------~~~~~l~i~~~i~~gl~~LH~~~~~~ivH~dlkp~Nill~~-~~~~ki~dfg~a~~~~  435 (506)
                                            +....+.++.|++.||+|||   +.+|+||||||+||+++. ++.+||+|||++....
T Consensus        84 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~al~~lH---~~~i~h~dl~p~nil~~~~~~~~~l~dfg~~~~~~  160 (268)
T cd06624          84 MEQVPGGSLSALLRSKWGPLKDNEQTIIFYTKQILEGLKYLH---DNQIVHRDIKGDNVLVNTYSGVVKISDFGTSKRLA  160 (268)
T ss_pred             EecCCCCCHHHHHHHhcccCCCcHHHHHHHHHHHHHHHHHHH---HCCEeecCCCHHHEEEcCCCCeEEEecchhheecc
Confidence                                  12224557889999999999   899999999999999976 6799999999987654


Q ss_pred             CCCcceecccCCCCcccccccccccccCCCCccccHHHHHHHHHHHHcCCCCCCCCC
Q 039231          436 RKESIISMTGARGTVGYIAPEVFCRNIGEVSYKSDVYNYGMMIFEMTGGRKNVDVVD  492 (506)
Q Consensus       436 ~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~s~~~Dv~s~G~il~elltg~~pf~~~~  492 (506)
                      .....  .....+++.|+|||.+.+....++.++||||||+++|||++|+.||....
T Consensus       161 ~~~~~--~~~~~~~~~~~aPE~~~~~~~~~~~~~Dv~slGvvl~~l~~g~~p~~~~~  215 (268)
T cd06624         161 GINPC--TETFTGTLQYMAPEVIDKGPRGYGAPADIWSLGCTIVEMATGKPPFIELG  215 (268)
T ss_pred             cCCCc--cccCCCCccccChhhhccccccCCchhhhHHHHHHHHHHHhCCCCCcccc
Confidence            32221  13345789999999985543357889999999999999999999997654

Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kina

>cd05036 PTKc_ALK_LTK Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase

Probab=99.95  E-value=1.6e-27  Score=232.39  Aligned_cols=173  Identities=29%  Similarity=0.474  Sum_probs=136.0

Q ss_pred             hccccCccCceEEEEEEEcC------CCEEEEEEeccCCC--CchhhHHHHHHhhccCccceeEEEEEee----------
Q 039231          317 FKYKLGQGGYGSVYKGKLLD------GSNVAVKVLNDSKG--NGKEFINEVASISRTSHVNVVALLGFCL----------  378 (506)
Q Consensus       317 ~~~~ig~G~~g~V~~~~~~~------~~~vavK~l~~~~~--~~~~~~~E~~~l~~l~h~niv~l~g~~~----------  378 (506)
                      +.+.||+|++|.||+|.+.+      +..|++|.+.....  ....+.+|+.++++++|+||+++++++.          
T Consensus        10 ~~~~lg~g~~g~vy~~~~~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e   89 (277)
T cd05036          10 LLRALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSEQDESDFLMEALIMSKFNHQNIVRLIGVSFERLPRFILLE   89 (277)
T ss_pred             eeeECCCCCCCcEEEEEEecCCCCCCceeEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCcEEEEe
Confidence            34679999999999998753      56789998864332  2356889999999999999999998751          


Q ss_pred             ------------------------ccchhhhHHHHHHHHHHHHhhcCCCCeEecCcCCCcEEECCCC---cEEEeecCCC
Q 039231          379 ------------------------RVAEELSSTIGIARGLEYLHLGCSTRILHFDIKPHNILLDEDF---CPKISDFGLA  431 (506)
Q Consensus       379 ------------------------~~~~~l~i~~~i~~gl~~LH~~~~~~ivH~dlkp~Nill~~~~---~~ki~dfg~a  431 (506)
                                              ++...+.++.||+.||+|||   +++++|+||||+||+++.++   .+||+|||++
T Consensus        90 ~~~g~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH---~~~ivH~dlkp~nil~~~~~~~~~~kl~dfg~~  166 (277)
T cd05036          90 LMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGCKYLE---ENHFIHRDIAARNCLLTCKGPGRVAKIADFGMA  166 (277)
T ss_pred             cCCCCCHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHH---HCCEeecccchheEEEeccCCCcceEeccCccc
Confidence                                    11224568899999999999   89999999999999998654   5999999999


Q ss_pred             ccccCCCcceecccCCCCcccccccccccccCCCCccccHHHHHHHHHHHHc-CCCCCCCCCCC
Q 039231          432 KICNRKESIISMTGARGTVGYIAPEVFCRNIGEVSYKSDVYNYGMMIFEMTG-GRKNVDVVDNG  494 (506)
Q Consensus       432 ~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~s~~~Dv~s~G~il~ellt-g~~pf~~~~~~  494 (506)
                      +................+..|+|||.+.+  ..++.++|||||||++|||++ |+.||+.....
T Consensus       167 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~--~~~~~~~DiwslG~il~el~~~g~~pf~~~~~~  228 (277)
T cd05036         167 RDIYRASYYRKGGRAMLPIKWMPPEAFLD--GIFTSKTDVWSFGVLLWEIFSLGYMPYPGRTNQ  228 (277)
T ss_pred             cccCCccceecCCCCCccHhhCCHHHHhc--CCcCchhHHHHHHHHHHHHHcCCCCCCCCCCHH
Confidence            87643322111122334568999999854  368999999999999999997 99999865443

Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well

>cd05074 PTKc_Tyro3 Catalytic domain of the Protein Tyrosine Kinase, Tyro3

Probab=99.95  E-value=1.9e-27  Score=231.02  Aligned_cols=172  Identities=31%  Similarity=0.480  Sum_probs=137.9

Q ss_pred             hccccCccCceEEEEEEEc----CCCEEEEEEeccCCC---CchhhHHHHHHhhccCccceeEEEEEeec----------
Q 039231          317 FKYKLGQGGYGSVYKGKLL----DGSNVAVKVLNDSKG---NGKEFINEVASISRTSHVNVVALLGFCLR----------  379 (506)
Q Consensus       317 ~~~~ig~G~~g~V~~~~~~----~~~~vavK~l~~~~~---~~~~~~~E~~~l~~l~h~niv~l~g~~~~----------  379 (506)
                      +.+.||+|+||.||+|.+.    .++.+|||++.....   ..+++.+|++++++++||||+++++++..          
T Consensus         3 ~~~~ig~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~   82 (273)
T cd05074           3 LGRMLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIEEFLREAACMKEFDHPNVIKLIGVSLRSRAKGRLPIP   82 (273)
T ss_pred             chhcccCCCCCCEEeeEeeccCCCceEEEEEEeccccCChHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCCCCcccce
Confidence            3467999999999999863    368899999975432   23568899999999999999999985411          


Q ss_pred             -----------------------------cchhhhHHHHHHHHHHHHhhcCCCCeEecCcCCCcEEECCCCcEEEeecCC
Q 039231          380 -----------------------------VAEELSSTIGIARGLEYLHLGCSTRILHFDIKPHNILLDEDFCPKISDFGL  430 (506)
Q Consensus       380 -----------------------------~~~~l~i~~~i~~gl~~LH~~~~~~ivH~dlkp~Nill~~~~~~ki~dfg~  430 (506)
                                                   +...+.++.|++.||+|||   +.+|+||||||+||++++++.+||+|||+
T Consensus        83 ~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH---~~~i~H~dikp~nili~~~~~~kl~dfg~  159 (273)
T cd05074          83 MVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIASGMEYLS---SKNFIHRDLAARNCMLNENMTVCVADFGL  159 (273)
T ss_pred             EEEEecCCCCcHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHH---hCCEeecccchhhEEEcCCCCEEECcccc
Confidence                                         1124668899999999999   89999999999999999999999999999


Q ss_pred             CccccCCCcceecccCCCCcccccccccccccCCCCccccHHHHHHHHHHHHc-CCCCCCCCCC
Q 039231          431 AKICNRKESIISMTGARGTVGYIAPEVFCRNIGEVSYKSDVYNYGMMIFEMTG-GRKNVDVVDN  493 (506)
Q Consensus       431 a~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~s~~~Dv~s~G~il~ellt-g~~pf~~~~~  493 (506)
                      ++...............+++.|++||.+...  .++.++||||||+++|||++ |+.||...+.
T Consensus       160 ~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~--~~~~~sDi~slG~il~el~~~g~~p~~~~~~  221 (273)
T cd05074         160 SKKIYSGDYYRQGCASKLPVKWLALESLADN--VYTTHSDVWAFGVTMWEIMTRGQTPYAGVEN  221 (273)
T ss_pred             cccccCCcceecCCCccCchhhcCHhHHhcC--ccchhhhhHHHHHHHHHHhhCCCCCCCCCCH
Confidence            9876543322222334456789999988543  67889999999999999999 8999876544

Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic fac

>cd06652 STKc_MEKK2 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2

Probab=99.95  E-value=2.5e-27  Score=229.30  Aligned_cols=170  Identities=28%  Similarity=0.328  Sum_probs=137.5

Q ss_pred             ccccCccCceEEEEEEEc-CCCEEEEEEeccCCC------CchhhHHHHHHhhccCccceeEEEEEeec-----------
Q 039231          318 KYKLGQGGYGSVYKGKLL-DGSNVAVKVLNDSKG------NGKEFINEVASISRTSHVNVVALLGFCLR-----------  379 (506)
Q Consensus       318 ~~~ig~G~~g~V~~~~~~-~~~~vavK~l~~~~~------~~~~~~~E~~~l~~l~h~niv~l~g~~~~-----------  379 (506)
                      .+.||+|+||.||+|+.. ++..||||.+.....      ..+.+.+|++++++++||||+++++++.+           
T Consensus         7 ~~~l~~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~v~e   86 (265)
T cd06652           7 GKLLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHERIVQYYGCLRDPMERTLSIFME   86 (265)
T ss_pred             eeEEecCCceEEEEEEEcCCCcEEEEEEeecCcCCcccHHHHHHHHHHHHHHHhcCCCCeeeEEeEeccCCCceEEEEEE
Confidence            467999999999999875 489999998853221      12467889999999999999999987522           


Q ss_pred             ------------------cchhhhHHHHHHHHHHHHhhcCCCCeEecCcCCCcEEECCCCcEEEeecCCCccccCCCcc-
Q 039231          380 ------------------VAEELSSTIGIARGLEYLHLGCSTRILHFDIKPHNILLDEDFCPKISDFGLAKICNRKESI-  440 (506)
Q Consensus       380 ------------------~~~~l~i~~~i~~gl~~LH~~~~~~ivH~dlkp~Nill~~~~~~ki~dfg~a~~~~~~~~~-  440 (506)
                                        +...+.++.|++.||+|||   +++++|+||+|+||+++.++.+||+|||+++........ 
T Consensus        87 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~l~~~l~~lH---~~~i~H~dl~p~nil~~~~~~~~l~Dfg~~~~~~~~~~~~  163 (265)
T cd06652          87 HMPGGSIKDQLKSYGALTENVTRKYTRQILEGVSYLH---SNMIVHRDIKGANILRDSVGNVKLGDFGASKRLQTICLSG  163 (265)
T ss_pred             ecCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHH---hCCEecCCCCHHHEEecCCCCEEECcCccccccccccccc
Confidence                              1224668899999999999   899999999999999999999999999998765432111 


Q ss_pred             eecccCCCCcccccccccccccCCCCccccHHHHHHHHHHHHcCCCCCCCCC
Q 039231          441 ISMTGARGTVGYIAPEVFCRNIGEVSYKSDVYNYGMMIFEMTGGRKNVDVVD  492 (506)
Q Consensus       441 ~~~~~~~gt~~y~aPE~l~~~~~~~s~~~Dv~s~G~il~elltg~~pf~~~~  492 (506)
                      .......++..|+|||.+.+.  .++.++||||||+++|||++|+.||....
T Consensus       164 ~~~~~~~~~~~y~aPE~~~~~--~~~~~~Dv~slG~il~el~~g~~p~~~~~  213 (265)
T cd06652         164 TGMKSVTGTPYWMSPEVISGE--GYGRKADIWSVGCTVVEMLTEKPPWAEFE  213 (265)
T ss_pred             cccccCCCCccccChhhhcCC--CCCcchhHHHHHHHHHHHhhCCCCCCccc
Confidence            112334578899999998653  67899999999999999999999997653

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their re

>cd07870 STKc_PFTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase

Probab=99.95  E-value=2.5e-27  Score=232.58  Aligned_cols=170  Identities=29%  Similarity=0.399  Sum_probs=138.2

Q ss_pred             ccccCccCceEEEEEEEc-CCCEEEEEEeccCCC--CchhhHHHHHHhhccCccceeEEEEEee----------------
Q 039231          318 KYKLGQGGYGSVYKGKLL-DGSNVAVKVLNDSKG--NGKEFINEVASISRTSHVNVVALLGFCL----------------  378 (506)
Q Consensus       318 ~~~ig~G~~g~V~~~~~~-~~~~vavK~l~~~~~--~~~~~~~E~~~l~~l~h~niv~l~g~~~----------------  378 (506)
                      .+.||+|+||.||+|... +++.+|+|++.....  ....+.+|++.+++++|+||+++.+++.                
T Consensus        10 ~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~e~~~~~l   89 (291)
T cd07870          10 LEKLGEGSYATVYKGISRINGQLVALKVISMKTEEGVPFTAIREASLLKGLKHANIVLLHDIIHTKETLTFVFEYMHTDL   89 (291)
T ss_pred             EEEEEecCCEEEEEEEEcCCCcEEEEEEecccCcCCCcHHHHHHHHHHHhcCCCCEeEEEEEEecCCeEEEEEecccCCH
Confidence            467999999999999874 588999999865432  2246788999999999999999998761                


Q ss_pred             -----------ccchhhhHHHHHHHHHHHHhhcCCCCeEecCcCCCcEEECCCCcEEEeecCCCccccCCCcceecccCC
Q 039231          379 -----------RVAEELSSTIGIARGLEYLHLGCSTRILHFDIKPHNILLDEDFCPKISDFGLAKICNRKESIISMTGAR  447 (506)
Q Consensus       379 -----------~~~~~l~i~~~i~~gl~~LH~~~~~~ivH~dlkp~Nill~~~~~~ki~dfg~a~~~~~~~~~~~~~~~~  447 (506)
                                 .+.+...++.|++.||+|||   +.+++|+||||+||+++.++.+||+|||+++........  .....
T Consensus        90 ~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH---~~~i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~~~~--~~~~~  164 (291)
T cd07870          90 AQYMIQHPGGLHPYNVRLFMFQLLRGLAYIH---GQHILHRDLKPQNLLISYLGELKLADFGLARAKSIPSQT--YSSEV  164 (291)
T ss_pred             HHHHHhCCCCCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCChHHEEEcCCCcEEEeccccccccCCCCCC--CCCcc
Confidence                       12234568889999999999   899999999999999999999999999998764332211  13345


Q ss_pred             CCcccccccccccccCCCCccccHHHHHHHHHHHHcCCCCCCCCCC
Q 039231          448 GTVGYIAPEVFCRNIGEVSYKSDVYNYGMMIFEMTGGRKNVDVVDN  493 (506)
Q Consensus       448 gt~~y~aPE~l~~~~~~~s~~~Dv~s~G~il~elltg~~pf~~~~~  493 (506)
                      +++.|+|||.+.+. ..++.++||||||+++|||++|+.||+..++
T Consensus       165 ~~~~y~aPE~~~~~-~~~~~~~Dv~slG~~l~~l~~g~~~f~~~~~  209 (291)
T cd07870         165 VTLWYRPPDVLLGA-TDYSSALDIWGAGCIFIEMLQGQPAFPGVSD  209 (291)
T ss_pred             ccccccCCceeecC-CCCCcHHHHHHHHHHHHHHHhCCCCCCCchh
Confidence            68899999998543 3578899999999999999999999976543

Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recess

>cd06646 STKc_MAP4K5 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5

Probab=99.95  E-value=2.5e-27  Score=229.54  Aligned_cols=172  Identities=27%  Similarity=0.362  Sum_probs=139.4

Q ss_pred             hhccccCccCceEEEEEEE-cCCCEEEEEEeccCC-CCchhhHHHHHHhhccCccceeEEEEEee---------------
Q 039231          316 SFKYKLGQGGYGSVYKGKL-LDGSNVAVKVLNDSK-GNGKEFINEVASISRTSHVNVVALLGFCL---------------  378 (506)
Q Consensus       316 ~~~~~ig~G~~g~V~~~~~-~~~~~vavK~l~~~~-~~~~~~~~E~~~l~~l~h~niv~l~g~~~---------------  378 (506)
                      .+.+.||+|+||.||+|+. .+++.+|+|++.... .....+.+|+.++++++||||+++++.+.               
T Consensus        12 ~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~~~~~~~~~~e~~~l~~~~h~~ii~~~~~~~~~~~~~iv~e~~~~~   91 (267)
T cd06646          12 ELIQRVGSGTYGDVYKARNLHTGELAAVKIIKLEPGDDFSLIQQEIFMVKECKHCNIVAYFGSYLSREKLWICMEYCGGG   91 (267)
T ss_pred             chhheeecCCCeEEEEEEECCCCeEEEEEEEecCccchHHHHHHHHHHHHhcCCCCeeeeeEEEEeCCEEEEEEeCCCCC
Confidence            3456799999999999997 458899999997543 23356788999999999999999998762               


Q ss_pred             ------------ccchhhhHHHHHHHHHHHHhhcCCCCeEecCcCCCcEEECCCCcEEEeecCCCccccCCCcceecccC
Q 039231          379 ------------RVAEELSSTIGIARGLEYLHLGCSTRILHFDIKPHNILLDEDFCPKISDFGLAKICNRKESIISMTGA  446 (506)
Q Consensus       379 ------------~~~~~l~i~~~i~~gl~~LH~~~~~~ivH~dlkp~Nill~~~~~~ki~dfg~a~~~~~~~~~~~~~~~  446 (506)
                                  ++.+...++.|++.||+|||   +.+|+||||+|+||++++++.+||+|||+++.......  .....
T Consensus        92 ~L~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dl~p~nill~~~~~~~l~dfg~~~~~~~~~~--~~~~~  166 (267)
T cd06646          92 SLQDIYHVTGPLSELQIAYVCRETLQGLAYLH---SKGKMHRDIKGANILLTDNGDVKLADFGVAAKITATIA--KRKSF  166 (267)
T ss_pred             cHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH---HCCccccCCCHHHEEECCCCCEEECcCccceeeccccc--ccCcc
Confidence                        12234568899999999999   89999999999999999999999999999986543221  11335


Q ss_pred             CCCcccccccccccc-cCCCCccccHHHHHHHHHHHHcCCCCCCCCC
Q 039231          447 RGTVGYIAPEVFCRN-IGEVSYKSDVYNYGMMIFEMTGGRKNVDVVD  492 (506)
Q Consensus       447 ~gt~~y~aPE~l~~~-~~~~s~~~Dv~s~G~il~elltg~~pf~~~~  492 (506)
                      .++..|+|||.+... ...++.++||||||+++|||++|+.||....
T Consensus       167 ~~~~~y~~PE~~~~~~~~~~~~~~Dvws~G~il~el~~g~~p~~~~~  213 (267)
T cd06646         167 IGTPYWMAPEVAAVEKNGGYNQLCDIWAVGITAIELAELQPPMFDLH  213 (267)
T ss_pred             ccCccccCHhHcccccCCCCcchhhHHHHHHHHHHHHhCCCCccccc
Confidence            678899999987432 2357789999999999999999999996544

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated

>cd05077 PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1

Probab=99.95  E-value=2.5e-27  Score=229.09  Aligned_cols=163  Identities=25%  Similarity=0.412  Sum_probs=131.2

Q ss_pred             ccCccCceEEEEEEEcC-------------CCEEEEEEeccCCCC-chhhHHHHHHhhccCccceeEEEEEee-------
Q 039231          320 KLGQGGYGSVYKGKLLD-------------GSNVAVKVLNDSKGN-GKEFINEVASISRTSHVNVVALLGFCL-------  378 (506)
Q Consensus       320 ~ig~G~~g~V~~~~~~~-------------~~~vavK~l~~~~~~-~~~~~~E~~~l~~l~h~niv~l~g~~~-------  378 (506)
                      .||+|+||.||+|+...             ...|++|.+...... ...+.+|+.++..++||||+++++++.       
T Consensus         2 ~lg~G~~~~vy~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~~~~l~~l~hp~iv~~~~~~~~~~~~~l   81 (262)
T cd05077           2 HLGRGTRTQIYAGILNYKDDDEDDGYSYEKEIKVILKVLDPSHRDISLAFFETASMMRQVSHKHIVLLYGVCVRDVENIM   81 (262)
T ss_pred             ccccCCcceEeeeecccCCCccccccchhhceeEEEeecChhhhhHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCCEE
Confidence            58999999999998532             235889988654332 357888999999999999999999762       


Q ss_pred             ---------------------ccchhhhHHHHHHHHHHHHhhcCCCCeEecCcCCCcEEECCCCc-------EEEeecCC
Q 039231          379 ---------------------RVAEELSSTIGIARGLEYLHLGCSTRILHFDIKPHNILLDEDFC-------PKISDFGL  430 (506)
Q Consensus       379 ---------------------~~~~~l~i~~~i~~gl~~LH~~~~~~ivH~dlkp~Nill~~~~~-------~ki~dfg~  430 (506)
                                           ++...+.++.||++||+|||   +++|+||||||+|||++.++.       +|++|||+
T Consensus        82 v~e~~~~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH---~~~ivH~dlkp~Nill~~~~~~~~~~~~~~l~d~g~  158 (262)
T cd05077          82 VEEFVEFGPLDLFMHRKSDVLTTPWKFKVAKQLASALSYLE---DKDLVHGNVCTKNILLAREGIDGECGPFIKLSDPGI  158 (262)
T ss_pred             EEecccCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhh---hCCeECCCCCcccEEEecCCccCCCCceeEeCCCCC
Confidence                                 22335678999999999999   999999999999999987664       89999999


Q ss_pred             CccccCCCcceecccCCCCcccccccccccccCCCCccccHHHHHHHHHHHH-cCCCCCCCCC
Q 039231          431 AKICNRKESIISMTGARGTVGYIAPEVFCRNIGEVSYKSDVYNYGMMIFEMT-GGRKNVDVVD  492 (506)
Q Consensus       431 a~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~s~~~Dv~s~G~il~ell-tg~~pf~~~~  492 (506)
                      +......      ....++..|+|||.+... ..++.++||||||+++|||+ +|+.||....
T Consensus       159 ~~~~~~~------~~~~~~~~y~aPE~~~~~-~~~~~~~DiwslG~~l~el~~~~~~p~~~~~  214 (262)
T cd05077         159 PITVLSR------QECVERIPWIAPECVEDS-KNLSIAADKWSFGTTLWEICYNGEIPLKDKT  214 (262)
T ss_pred             CccccCc------ccccccccccChhhhcCC-CCCCchhHHHHHHHHHHHHHhCCCCCCCCcc
Confidence            8754322      234568889999988532 46888999999999999998 6899987543

Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic dom

>cd06651 STKc_MEKK3 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3

Probab=99.95  E-value=2.1e-27  Score=230.01  Aligned_cols=172  Identities=27%  Similarity=0.327  Sum_probs=138.6

Q ss_pred             ccccCccCceEEEEEEEc-CCCEEEEEEeccCCC------CchhhHHHHHHhhccCccceeEEEEEeec-----------
Q 039231          318 KYKLGQGGYGSVYKGKLL-DGSNVAVKVLNDSKG------NGKEFINEVASISRTSHVNVVALLGFCLR-----------  379 (506)
Q Consensus       318 ~~~ig~G~~g~V~~~~~~-~~~~vavK~l~~~~~------~~~~~~~E~~~l~~l~h~niv~l~g~~~~-----------  379 (506)
                      .+.||+|+||.||+|... .+..+++|++.....      ..+.+.+|++++++++||||+++++++..           
T Consensus         7 ~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~l~~e   86 (266)
T cd06651           7 GKLLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERIVQYYGCLRDRAEKTLTIFME   86 (266)
T ss_pred             cceecCCCCEEEEEEEEcCCCcEEEEEEeecCcCCchhHHHHHHHHHHHHHHHHcCCCCeeeEEEEEEcCCCCEEEEEEe
Confidence            467999999999999875 589999999864321      12457889999999999999999987521           


Q ss_pred             ------------------cchhhhHHHHHHHHHHHHhhcCCCCeEecCcCCCcEEECCCCcEEEeecCCCccccCCCcc-
Q 039231          380 ------------------VAEELSSTIGIARGLEYLHLGCSTRILHFDIKPHNILLDEDFCPKISDFGLAKICNRKESI-  440 (506)
Q Consensus       380 ------------------~~~~l~i~~~i~~gl~~LH~~~~~~ivH~dlkp~Nill~~~~~~ki~dfg~a~~~~~~~~~-  440 (506)
                                        +...+.++.|++.||+|||   +.+++|+||+|+||++++++.+||+|||+++........ 
T Consensus        87 ~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~LH---~~~i~H~~l~p~nil~~~~~~~~l~dfg~~~~~~~~~~~~  163 (266)
T cd06651          87 YMPGGSVKDQLKAYGALTESVTRKYTRQILEGMSYLH---SNMIVHRDIKGANILRDSAGNVKLGDFGASKRLQTICMSG  163 (266)
T ss_pred             CCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHH---hCCeeeCCCCHHHEEECCCCCEEEccCCCccccccccccC
Confidence                              2224568899999999999   899999999999999999999999999998765432111 


Q ss_pred             eecccCCCCcccccccccccccCCCCccccHHHHHHHHHHHHcCCCCCCCCCCC
Q 039231          441 ISMTGARGTVGYIAPEVFCRNIGEVSYKSDVYNYGMMIFEMTGGRKNVDVVDNG  494 (506)
Q Consensus       441 ~~~~~~~gt~~y~aPE~l~~~~~~~s~~~Dv~s~G~il~elltg~~pf~~~~~~  494 (506)
                      .......++..|+|||.+.+.  .++.++||||||+++|||++|+.||...+..
T Consensus       164 ~~~~~~~~~~~y~aPE~~~~~--~~~~~~Dv~slG~i~~el~~g~~pf~~~~~~  215 (266)
T cd06651         164 TGIRSVTGTPYWMSPEVISGE--GYGRKADVWSLGCTVVEMLTEKPPWAEYEAM  215 (266)
T ss_pred             CccccCCccccccCHHHhCCC--CCCchhhhHHHHHHHHHHHHCCCCccccchH
Confidence            111234578899999998653  6889999999999999999999999865433

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development

>cd05094 PTKc_TrkC Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C

Probab=99.95  E-value=1.7e-27  Score=233.84  Aligned_cols=173  Identities=26%  Similarity=0.450  Sum_probs=139.8

Q ss_pred             hhccccCccCceEEEEEEEc------CCCEEEEEEeccCCC-CchhhHHHHHHhhccCccceeEEEEEee----------
Q 039231          316 SFKYKLGQGGYGSVYKGKLL------DGSNVAVKVLNDSKG-NGKEFINEVASISRTSHVNVVALLGFCL----------  378 (506)
Q Consensus       316 ~~~~~ig~G~~g~V~~~~~~------~~~~vavK~l~~~~~-~~~~~~~E~~~l~~l~h~niv~l~g~~~----------  378 (506)
                      .+.+.||+|+||.||+|+..      ++..+++|.++.... ..+.+.+|++.+++++|+||+++++++.          
T Consensus         8 ~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e   87 (291)
T cd05094           8 VLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHIVKFYGVCGDGDPLIMVFE   87 (291)
T ss_pred             EEeeeecccCCCeEEEeEeeccCCCCcceeeEEEecCCccHHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCceEEEEe
Confidence            34567999999999999753      345689998865443 2367889999999999999999998761          


Q ss_pred             ---------------------------------ccchhhhHHHHHHHHHHHHhhcCCCCeEecCcCCCcEEECCCCcEEE
Q 039231          379 ---------------------------------RVAEELSSTIGIARGLEYLHLGCSTRILHFDIKPHNILLDEDFCPKI  425 (506)
Q Consensus       379 ---------------------------------~~~~~l~i~~~i~~gl~~LH~~~~~~ivH~dlkp~Nill~~~~~~ki  425 (506)
                                                       ++...+.++.|++.||+|||   +++++||||||+||++++++.+||
T Consensus        88 ~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH---~~~i~H~dlkp~Nil~~~~~~~~l  164 (291)
T cd05094          88 YMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQIASGMVYLA---SQHFVHRDLATRNCLVGANLLVKI  164 (291)
T ss_pred             cCCCCcHHHHHHhcCcccccccccccccCcCCCCHHHHHHHHHHHHHHHHHHH---hCCeeecccCcceEEEccCCcEEE
Confidence                                             11235678999999999999   999999999999999999999999


Q ss_pred             eecCCCccccCCCcceecccCCCCcccccccccccccCCCCccccHHHHHHHHHHHHc-CCCCCCCCCC
Q 039231          426 SDFGLAKICNRKESIISMTGARGTVGYIAPEVFCRNIGEVSYKSDVYNYGMMIFEMTG-GRKNVDVVDN  493 (506)
Q Consensus       426 ~dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~s~~~Dv~s~G~il~ellt-g~~pf~~~~~  493 (506)
                      +|||+++...............++..|+|||.+...  .++.++||||||+++|||++ |+.||.....
T Consensus       165 ~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~--~~~~~~Di~slG~il~el~t~g~~p~~~~~~  231 (291)
T cd05094         165 GDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYR--KFTTESDVWSFGVILWEIFTYGKQPWFQLSN  231 (291)
T ss_pred             CCCCcccccCCCceeecCCCCCcceeecChHHhccC--CCCchhhHHHHHHHHHHHHhCCCCCCCCCCH
Confidence            999999765443322222334567889999998654  68889999999999999998 9999976554

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some n

>cd05092 PTKc_TrkA Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A

Probab=99.95  E-value=1.3e-27  Score=233.40  Aligned_cols=172  Identities=24%  Similarity=0.466  Sum_probs=137.8

Q ss_pred             hccccCccCceEEEEEEEc------CCCEEEEEEeccCCC-CchhhHHHHHHhhccCccceeEEEEEee-----------
Q 039231          317 FKYKLGQGGYGSVYKGKLL------DGSNVAVKVLNDSKG-NGKEFINEVASISRTSHVNVVALLGFCL-----------  378 (506)
Q Consensus       317 ~~~~ig~G~~g~V~~~~~~------~~~~vavK~l~~~~~-~~~~~~~E~~~l~~l~h~niv~l~g~~~-----------  378 (506)
                      +.++||+|+||.||++...      ++..+|+|.+..... ..+++.+|++++++++|+||+++++++.           
T Consensus         9 ~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~   88 (280)
T cd05092           9 LKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTVLQHQHIVRFYGVCTEGRPLLMVFEY   88 (280)
T ss_pred             eccccCCccCCeEEEeEEecCCCCCCceEEEEEecCcCCHHHHHHHHHHHHHHhcCCCCCCceEEEEEecCCceEEEEec
Confidence            4568999999999999642      356889998865432 3467899999999999999999998761           


Q ss_pred             -------------------------------ccchhhhHHHHHHHHHHHHhhcCCCCeEecCcCCCcEEECCCCcEEEee
Q 039231          379 -------------------------------RVAEELSSTIGIARGLEYLHLGCSTRILHFDIKPHNILLDEDFCPKISD  427 (506)
Q Consensus       379 -------------------------------~~~~~l~i~~~i~~gl~~LH~~~~~~ivH~dlkp~Nill~~~~~~ki~d  427 (506)
                                                     ++...+.++.|++.||+|||   +.+++|+||||+||++++++.+||+|
T Consensus        89 ~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH---~~~i~H~dlkp~nil~~~~~~~kL~d  165 (280)
T cd05092          89 MRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIASGMVYLA---SLHFVHRDLATRNCLVGQGLVVKIGD  165 (280)
T ss_pred             CCCCCHHHHHHhcCcchhhhcccccCCccccCHHHHHHHHHHHHHHHHHHH---HCCeecccccHhhEEEcCCCCEEECC
Confidence                                           11234668899999999999   89999999999999999999999999


Q ss_pred             cCCCccccCCCcceecccCCCCcccccccccccccCCCCccccHHHHHHHHHHHHc-CCCCCCCCCC
Q 039231          428 FGLAKICNRKESIISMTGARGTVGYIAPEVFCRNIGEVSYKSDVYNYGMMIFEMTG-GRKNVDVVDN  493 (506)
Q Consensus       428 fg~a~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~s~~~Dv~s~G~il~ellt-g~~pf~~~~~  493 (506)
                      ||+++...............+++.|+|||.+.+.  .++.++||||||+++|||++ |+.||.....
T Consensus       166 fg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~--~~~~~~Di~slG~il~el~~~g~~p~~~~~~  230 (280)
T cd05092         166 FGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYR--KFTTESDIWSFGVVLWEIFTYGKQPWYQLSN  230 (280)
T ss_pred             CCceeEcCCCceeecCCCccccccccCHHHhccC--CcCchhhHHHHHHHHHHHHcCCCCCCccCCH
Confidence            9999765433322111223456789999998654  68999999999999999998 9999976544

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory

>cd06655 STKc_PAK2 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2

Probab=99.95  E-value=2.5e-27  Score=233.31  Aligned_cols=170  Identities=29%  Similarity=0.412  Sum_probs=142.4

Q ss_pred             ccccCccCceEEEEEEE-cCCCEEEEEEeccCCC-CchhhHHHHHHhhccCccceeEEEEEe------------------
Q 039231          318 KYKLGQGGYGSVYKGKL-LDGSNVAVKVLNDSKG-NGKEFINEVASISRTSHVNVVALLGFC------------------  377 (506)
Q Consensus       318 ~~~ig~G~~g~V~~~~~-~~~~~vavK~l~~~~~-~~~~~~~E~~~l~~l~h~niv~l~g~~------------------  377 (506)
                      .+.||.|++|.||+|.. .+++.|++|.+..... ..+.+.+|++.++.++||||+++++.+                  
T Consensus        24 ~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L  103 (296)
T cd06655          24 YEKIGQGASGTVFTAIDVATGQEVAIKQINLQKQPKKELIINEILVMKELKNPNIVNFLDSFLVGDELFVVMEYLAGGSL  103 (296)
T ss_pred             EEEEecCCCeEEEEEEEcCCCcEEEEEEEecccCchHHHHHHHHHHHHhcCCCceeeeeeeEecCceEEEEEEecCCCcH
Confidence            45799999999999986 4689999999865433 346788999999999999999999876                  


Q ss_pred             --------eccchhhhHHHHHHHHHHHHhhcCCCCeEecCcCCCcEEECCCCcEEEeecCCCccccCCCcceecccCCCC
Q 039231          378 --------LRVAEELSSTIGIARGLEYLHLGCSTRILHFDIKPHNILLDEDFCPKISDFGLAKICNRKESIISMTGARGT  449 (506)
Q Consensus       378 --------~~~~~~l~i~~~i~~gl~~LH~~~~~~ivH~dlkp~Nill~~~~~~ki~dfg~a~~~~~~~~~~~~~~~~gt  449 (506)
                              +++.+++.++.|++.||+|||   +.+++|+||||+||+++.++.+||+|||++.........  .....++
T Consensus       104 ~~~~~~~~l~~~~~~~i~~~l~~al~~LH---~~~i~H~dL~p~Nili~~~~~~kl~dfg~~~~~~~~~~~--~~~~~~~  178 (296)
T cd06655         104 TDVVTETCMDEAQIAAVCRECLQALEFLH---ANQVIHRDIKSDNVLLGMDGSVKLTDFGFCAQITPEQSK--RSTMVGT  178 (296)
T ss_pred             HHHHHhcCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCHHHEEECCCCCEEEccCccchhccccccc--CCCcCCC
Confidence                    234456778899999999999   899999999999999999999999999998865543321  1335678


Q ss_pred             cccccccccccccCCCCccccHHHHHHHHHHHHcCCCCCCCCCCC
Q 039231          450 VGYIAPEVFCRNIGEVSYKSDVYNYGMMIFEMTGGRKNVDVVDNG  494 (506)
Q Consensus       450 ~~y~aPE~l~~~~~~~s~~~Dv~s~G~il~elltg~~pf~~~~~~  494 (506)
                      ..|+|||.+.+.  .++.++||||||+++|||++|+.||...+..
T Consensus       179 ~~y~aPE~~~~~--~~~~~~Dv~slGvil~~lltg~~pf~~~~~~  221 (296)
T cd06655         179 PYWMAPEVVTRK--AYGPKVDIWSLGIMAIEMVEGEPPYLNENPL  221 (296)
T ss_pred             ccccCcchhcCC--CCCchhhHHHHHHHHHHHHhCCCCCCCCCHH
Confidence            899999998543  6788999999999999999999999876543

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding

>cd06645 STKc_MAP4K3 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3

Probab=99.95  E-value=3.6e-27  Score=228.36  Aligned_cols=173  Identities=27%  Similarity=0.378  Sum_probs=140.5

Q ss_pred             hhhccccCccCceEEEEEEEc-CCCEEEEEEeccCCC-CchhhHHHHHHhhccCccceeEEEEEee--------------
Q 039231          315 NSFKYKLGQGGYGSVYKGKLL-DGSNVAVKVLNDSKG-NGKEFINEVASISRTSHVNVVALLGFCL--------------  378 (506)
Q Consensus       315 ~~~~~~ig~G~~g~V~~~~~~-~~~~vavK~l~~~~~-~~~~~~~E~~~l~~l~h~niv~l~g~~~--------------  378 (506)
                      +.+.++||+|+||.||+|+.. +++.+|+|.++.... ....+.+|+.+++.++||||+++++.+.              
T Consensus        11 ~~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~~~~l~h~~ii~~~~~~~~~~~~~lv~e~~~~   90 (267)
T cd06645          11 FELIQRIGSGTYGDVYKARNVNTGELAAIKVIKLEPGEDFAVVQQEIIMMKDCKHSNIVAYFGSYLRRDKLWICMEFCGG   90 (267)
T ss_pred             HHHHHHhCCCCCeEEEEEEEcCCCcEEEEEEEecCchhHHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCEEEEEEeccCC
Confidence            344567999999999999874 588999999875432 2356788999999999999999998751              


Q ss_pred             -------------ccchhhhHHHHHHHHHHHHhhcCCCCeEecCcCCCcEEECCCCcEEEeecCCCccccCCCcceeccc
Q 039231          379 -------------RVAEELSSTIGIARGLEYLHLGCSTRILHFDIKPHNILLDEDFCPKISDFGLAKICNRKESIISMTG  445 (506)
Q Consensus       379 -------------~~~~~l~i~~~i~~gl~~LH~~~~~~ivH~dlkp~Nill~~~~~~ki~dfg~a~~~~~~~~~~~~~~  445 (506)
                                   ++.+.+.++.|++.||+|||   +.+++|+||||+||+++.++.+||+|||++........  ....
T Consensus        91 ~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dlkp~nili~~~~~~~l~dfg~~~~~~~~~~--~~~~  165 (267)
T cd06645          91 GSLQDIYHVTGPLSESQIAYVSRETLQGLYYLH---SKGKMHRDIKGANILLTDNGHVKLADFGVSAQITATIA--KRKS  165 (267)
T ss_pred             CcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHEEECCCCCEEECcceeeeEccCccc--cccc
Confidence                         23345678899999999999   89999999999999999999999999999876543221  1234


Q ss_pred             CCCCccccccccccc-ccCCCCccccHHHHHHHHHHHHcCCCCCCCCC
Q 039231          446 ARGTVGYIAPEVFCR-NIGEVSYKSDVYNYGMMIFEMTGGRKNVDVVD  492 (506)
Q Consensus       446 ~~gt~~y~aPE~l~~-~~~~~s~~~Dv~s~G~il~elltg~~pf~~~~  492 (506)
                      ..|+..|+|||.+.. ....++.++|+||||+++|||++|+.||....
T Consensus       166 ~~~~~~y~aPE~~~~~~~~~~~~~~DvwSlG~il~~l~~~~~p~~~~~  213 (267)
T cd06645         166 FIGTPYWMAPEVAAVERKGGYNQLCDIWAVGITAIELAELQPPMFDLH  213 (267)
T ss_pred             ccCcccccChhhhccccCCCCCchhhhHHHHHHHHHHhcCCCCccccc
Confidence            568999999999742 12357889999999999999999999996544

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated

>cd07860 STKc_CDK2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3

Probab=99.95  E-value=1.6e-27  Score=233.09  Aligned_cols=172  Identities=30%  Similarity=0.399  Sum_probs=139.8

Q ss_pred             ccccCccCceEEEEEEEc-CCCEEEEEEeccCC---CCchhhHHHHHHhhccCccceeEEEEEee---------------
Q 039231          318 KYKLGQGGYGSVYKGKLL-DGSNVAVKVLNDSK---GNGKEFINEVASISRTSHVNVVALLGFCL---------------  378 (506)
Q Consensus       318 ~~~ig~G~~g~V~~~~~~-~~~~vavK~l~~~~---~~~~~~~~E~~~l~~l~h~niv~l~g~~~---------------  378 (506)
                      .+.||.|++|.||+|+.. +++.+|||+++...   ...+.+.+|++++++++||||+++++++.               
T Consensus         5 ~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~   84 (284)
T cd07860           5 VEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLHQD   84 (284)
T ss_pred             eeeecCCCceEEEEEEECCCCCEEEEEEccccccccccchHHHHHHHHHHhcCCCCCcchhhhcccCCcEEEEeeccccC
Confidence            457999999999999875 58999999986432   22357889999999999999999988751               


Q ss_pred             -------------ccchhhhHHHHHHHHHHHHhhcCCCCeEecCcCCCcEEECCCCcEEEeecCCCccccCCCcceeccc
Q 039231          379 -------------RVAEELSSTIGIARGLEYLHLGCSTRILHFDIKPHNILLDEDFCPKISDFGLAKICNRKESIISMTG  445 (506)
Q Consensus       379 -------------~~~~~l~i~~~i~~gl~~LH~~~~~~ivH~dlkp~Nill~~~~~~ki~dfg~a~~~~~~~~~~~~~~  445 (506)
                                   ++...+.++.|++.||+|||   +.+++|+||+|+||++++++.+||+|||+++........  ...
T Consensus        85 l~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh---~~~i~H~~l~p~nill~~~~~~~l~dfg~~~~~~~~~~~--~~~  159 (284)
T cd07860          85 LKKFMDASPLSGIPLPLIKSYLFQLLQGLAFCH---SHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRT--YTH  159 (284)
T ss_pred             HHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHEEECCCCCEEEeeccchhhcccCccc--ccc
Confidence                         22335678899999999999   899999999999999999999999999998765433211  133


Q ss_pred             CCCCcccccccccccccCCCCccccHHHHHHHHHHHHcCCCCCCCCCCCc
Q 039231          446 ARGTVGYIAPEVFCRNIGEVSYKSDVYNYGMMIFEMTGGRKNVDVVDNGS  495 (506)
Q Consensus       446 ~~gt~~y~aPE~l~~~~~~~s~~~Dv~s~G~il~elltg~~pf~~~~~~~  495 (506)
                      ..+++.|+|||.+.+. ..++.++||||||+++|||+||+.||...++.+
T Consensus       160 ~~~~~~y~aPE~~~~~-~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~  208 (284)
T cd07860         160 EVVTLWYRAPEILLGC-KYYSTAVDIWSLGCIFAEMVTRRALFPGDSEID  208 (284)
T ss_pred             ccccccccCCeEEecC-CCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHH
Confidence            4568899999988543 346889999999999999999999997665433

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex

>cd05082 PTKc_Csk Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase

Probab=99.95  E-value=2.4e-27  Score=228.21  Aligned_cols=166  Identities=29%  Similarity=0.541  Sum_probs=137.3

Q ss_pred             hhhccccCccCceEEEEEEEcCCCEEEEEEeccCCCCchhhHHHHHHhhccCccceeEEEEEee----------------
Q 039231          315 NSFKYKLGQGGYGSVYKGKLLDGSNVAVKVLNDSKGNGKEFINEVASISRTSHVNVVALLGFCL----------------  378 (506)
Q Consensus       315 ~~~~~~ig~G~~g~V~~~~~~~~~~vavK~l~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~----------------  378 (506)
                      +.+.+.||+|++|.||++.. .+..+|+|.++... ..+.+.+|+.++++++|+|++++++++.                
T Consensus         8 ~~~~~~lg~g~~~~v~~~~~-~~~~~~~k~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv~e~~~~~   85 (256)
T cd05082           8 LKLLQTIGKGEFGDVMLGDY-RGNKVAVKCIKNDA-TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAKG   85 (256)
T ss_pred             CeeeeeecccCCCeEEEEEE-cCCcEEEEEeCCCc-hHHHHHHHHHHHHhCCCCCeeeEEEEEEcCCCceEEEEECCCCC
Confidence            34457899999999999987 47889999986543 3467899999999999999999998652                


Q ss_pred             --------------ccchhhhHHHHHHHHHHHHhhcCCCCeEecCcCCCcEEECCCCcEEEeecCCCccccCCCcceecc
Q 039231          379 --------------RVAEELSSTIGIARGLEYLHLGCSTRILHFDIKPHNILLDEDFCPKISDFGLAKICNRKESIISMT  444 (506)
Q Consensus       379 --------------~~~~~l~i~~~i~~gl~~LH~~~~~~ivH~dlkp~Nill~~~~~~ki~dfg~a~~~~~~~~~~~~~  444 (506)
                                    ++...+.++.|++.||+|||   +++++||||||+||++++++.+||+|||+++......     .
T Consensus        86 ~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~-----~  157 (256)
T cd05082          86 SLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLE---ANNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQ-----D  157 (256)
T ss_pred             cHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHH---hCCEeccccchheEEEcCCCcEEecCCccceeccccC-----C
Confidence                          11234678899999999999   8999999999999999999999999999987654322     2


Q ss_pred             cCCCCcccccccccccccCCCCccccHHHHHHHHHHHHc-CCCCCCCCC
Q 039231          445 GARGTVGYIAPEVFCRNIGEVSYKSDVYNYGMMIFEMTG-GRKNVDVVD  492 (506)
Q Consensus       445 ~~~gt~~y~aPE~l~~~~~~~s~~~Dv~s~G~il~ellt-g~~pf~~~~  492 (506)
                      ....+..|+|||++...  .++.++||||||+++|||++ |+.||....
T Consensus       158 ~~~~~~~y~aPE~~~~~--~~~~~~Dv~slG~i~~~l~~~g~~p~~~~~  204 (256)
T cd05082         158 TGKLPVKWTAPEALREK--KFSTKSDVWSFGILLWEIYSFGRVPYPRIP  204 (256)
T ss_pred             CCccceeecCHHHHccC--CCCchhhhHHHHHHHHHHHhCCCCCCCCCC
Confidence            23446789999998543  68899999999999999997 999997654

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, re

>cd08228 STKc_Nek6 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6

Probab=99.95  E-value=2.7e-27  Score=229.17  Aligned_cols=170  Identities=25%  Similarity=0.432  Sum_probs=139.4

Q ss_pred             hhccccCccCceEEEEEEEc-CCCEEEEEEeccCC----CCchhhHHHHHHhhccCccceeEEEEEee------------
Q 039231          316 SFKYKLGQGGYGSVYKGKLL-DGSNVAVKVLNDSK----GNGKEFINEVASISRTSHVNVVALLGFCL------------  378 (506)
Q Consensus       316 ~~~~~ig~G~~g~V~~~~~~-~~~~vavK~l~~~~----~~~~~~~~E~~~l~~l~h~niv~l~g~~~------------  378 (506)
                      .+.++||+|+||.||+|+.. +++.+|||.++...    ....++.+|++++++++||||+++++++.            
T Consensus         5 ~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~   84 (267)
T cd08228           5 QIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHPNVIKYLDSFIEDNELNIVLELA   84 (267)
T ss_pred             eeeeeeccCCCeeEEEEEEeCCCCEEEEEEeeccccCCHHHHHHHHHHHHHHHhCCCcceeeeeeeEEECCeEEEEEEec
Confidence            34567999999999999874 68999999886422    22246889999999999999999998762            


Q ss_pred             -------------------ccchhhhHHHHHHHHHHHHhhcCCCCeEecCcCCCcEEECCCCcEEEeecCCCccccCCCc
Q 039231          379 -------------------RVAEELSSTIGIARGLEYLHLGCSTRILHFDIKPHNILLDEDFCPKISDFGLAKICNRKES  439 (506)
Q Consensus       379 -------------------~~~~~l~i~~~i~~gl~~LH~~~~~~ivH~dlkp~Nill~~~~~~ki~dfg~a~~~~~~~~  439 (506)
                                         +....+.++.|++.||+|||   +.+++|+||||+||+++.++.++|+|||++........
T Consensus        85 ~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH---~~~i~H~dl~~~nil~~~~~~~~l~d~g~~~~~~~~~~  161 (267)
T cd08228          85 DAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVEHMH---SRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTT  161 (267)
T ss_pred             CCCcHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHh---hCCeeCCCCCHHHEEEcCCCCEEECccccceeccchhH
Confidence                               11224678899999999999   89999999999999999999999999999987654332


Q ss_pred             ceecccCCCCcccccccccccccCCCCccccHHHHHHHHHHHHcCCCCCCCCC
Q 039231          440 IISMTGARGTVGYIAPEVFCRNIGEVSYKSDVYNYGMMIFEMTGGRKNVDVVD  492 (506)
Q Consensus       440 ~~~~~~~~gt~~y~aPE~l~~~~~~~s~~~Dv~s~G~il~elltg~~pf~~~~  492 (506)
                      .  .....+++.|+|||.+.+.  .++.++|+||||+++|||++|+.||....
T Consensus       162 ~--~~~~~~~~~~~aPE~~~~~--~~~~~~Di~slG~~l~el~~g~~p~~~~~  210 (267)
T cd08228         162 A--AHSLVGTPYYMSPERIHEN--GYNFKSDIWSLGCLLYEMAALQSPFYGDK  210 (267)
T ss_pred             H--HhcCCCCccccChhhhccC--CCCchhhHHHHHHHHHHHhcCCCCCcccc
Confidence            1  1335678899999998654  67889999999999999999999996543

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase

>cd07844 STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like Serine/Threonine Kinases

Probab=99.95  E-value=2.9e-27  Score=232.06  Aligned_cols=170  Identities=30%  Similarity=0.425  Sum_probs=138.1

Q ss_pred             hccccCccCceEEEEEEEc-CCCEEEEEEeccCCC--CchhhHHHHHHhhccCccceeEEEEEee---------------
Q 039231          317 FKYKLGQGGYGSVYKGKLL-DGSNVAVKVLNDSKG--NGKEFINEVASISRTSHVNVVALLGFCL---------------  378 (506)
Q Consensus       317 ~~~~ig~G~~g~V~~~~~~-~~~~vavK~l~~~~~--~~~~~~~E~~~l~~l~h~niv~l~g~~~---------------  378 (506)
                      +.+.||+|++|.||+|+.+ +++.||||.+.....  ....+.+|++++++++|+||+++++++.               
T Consensus         9 ~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~   88 (291)
T cd07844           9 KLDKLGEGSYATVYKGRSKLTGQLVALKEIRLEHEEGAPFTAIREASLLKDLKHANIVTLHDIIHTKKTLTLVFEYLDTD   88 (291)
T ss_pred             EEEEEeecCCeEEEEEEEcCCCcEEEEEEEecccccCCchhHHHHHHHHhhCCCcceeeEEEEEecCCeEEEEEecCCCC
Confidence            3467999999999999875 589999999865332  2356778999999999999999998762               


Q ss_pred             ------------ccchhhhHHHHHHHHHHHHhhcCCCCeEecCcCCCcEEECCCCcEEEeecCCCccccCCCcceecccC
Q 039231          379 ------------RVAEELSSTIGIARGLEYLHLGCSTRILHFDIKPHNILLDEDFCPKISDFGLAKICNRKESIISMTGA  446 (506)
Q Consensus       379 ------------~~~~~l~i~~~i~~gl~~LH~~~~~~ivH~dlkp~Nill~~~~~~ki~dfg~a~~~~~~~~~~~~~~~  446 (506)
                                  ++.....++.|+++||.|||   +.+++|+||||+||++++++.+||+|||+++.......  .....
T Consensus        89 L~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH---~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~--~~~~~  163 (291)
T cd07844          89 LKQYMDDCGGGLSMHNVRLFLFQLLRGLAYCH---QRRVLHRDLKPQNLLISERGELKLADFGLARAKSVPSK--TYSNE  163 (291)
T ss_pred             HHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHH---hCCeecccCCHHHEEEcCCCCEEECccccccccCCCCc--ccccc
Confidence                        22235567889999999999   89999999999999999999999999999875432211  11223


Q ss_pred             CCCcccccccccccccCCCCccccHHHHHHHHHHHHcCCCCCCCCC
Q 039231          447 RGTVGYIAPEVFCRNIGEVSYKSDVYNYGMMIFEMTGGRKNVDVVD  492 (506)
Q Consensus       447 ~gt~~y~aPE~l~~~~~~~s~~~Dv~s~G~il~elltg~~pf~~~~  492 (506)
                      .++..|+|||.+.+. ..++.++||||+|+++|||++|+.||....
T Consensus       164 ~~~~~~~aPE~~~~~-~~~~~~~Dv~slG~il~~l~~g~~~~~~~~  208 (291)
T cd07844         164 VVTLWYRPPDVLLGS-TEYSTSLDMWGVGCIFYEMATGRPLFPGST  208 (291)
T ss_pred             ccccccCCcHHhhcC-cccCcHHHHHHHHHHHHHHHhCCCCCCCCc
Confidence            468889999988543 357889999999999999999999997654

Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the

>cd06639 STKc_myosinIIIB Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin

Probab=99.95  E-value=1.8e-27  Score=233.69  Aligned_cols=185  Identities=29%  Similarity=0.383  Sum_probs=146.6

Q ss_pred             cCHHHHHHHHhhh--ccccCccCceEEEEEEEc-CCCEEEEEEeccCCCCchhhHHHHHHhhcc-CccceeEEEEEeec-
Q 039231          305 YGYADIKKMTNSF--KYKLGQGGYGSVYKGKLL-DGSNVAVKVLNDSKGNGKEFINEVASISRT-SHVNVVALLGFCLR-  379 (506)
Q Consensus       305 ~~~~el~~~~~~~--~~~ig~G~~g~V~~~~~~-~~~~vavK~l~~~~~~~~~~~~E~~~l~~l-~h~niv~l~g~~~~-  379 (506)
                      +++.++.+++.+|  .+.||+|+||.||++... +++.+|+|.+........++.+|+.+++++ +|||++++++++.. 
T Consensus        12 ~~~~~~~~~~~~y~~~~~l~~g~~~~vy~~~~~~~~~~~aik~~~~~~~~~~~~~~e~~~l~~l~~h~ni~~~~~~~~~~   91 (291)
T cd06639          12 LGLESLGDPTDTWEIIETIGKGTYGKVYKVTNKKDGSLAAVKILDPISDVDEEIEAEYNILQSLPNHPNVVKFYGMFYKA   91 (291)
T ss_pred             hhcccCCCCCCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEecccccHHHHHHHHHHHHHHhcCCCCeEEEEEEEEec
Confidence            4445555555555  367999999999999874 588999999976554456788899999999 79999999986521 


Q ss_pred             -----------------------------------cchhhhHHHHHHHHHHHHhhcCCCCeEecCcCCCcEEECCCCcEE
Q 039231          380 -----------------------------------VAEELSSTIGIARGLEYLHLGCSTRILHFDIKPHNILLDEDFCPK  424 (506)
Q Consensus       380 -----------------------------------~~~~l~i~~~i~~gl~~LH~~~~~~ivH~dlkp~Nill~~~~~~k  424 (506)
                                                         +...+.++.|++.||+|||   +.+++|+||||+||++++++.+|
T Consensus        92 ~~~~~~~~~lv~ey~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH---~~~ivH~dlkp~nili~~~~~~k  168 (291)
T cd06639          92 DKLVGGQLWLVLELCNGGSVTELVKGLLICGQRLDEAMISYILYGALLGLQHLH---NNRIIHRDVKGNNILLTTEGGVK  168 (291)
T ss_pred             cccCCCeeEEEEEECCCCcHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHH---hCCeeccCCCHHHEEEcCCCCEE
Confidence                                               1123558889999999999   89999999999999999999999


Q ss_pred             EeecCCCccccCCCcceecccCCCCccccccccccccc---CCCCccccHHHHHHHHHHHHcCCCCCCCCCCC
Q 039231          425 ISDFGLAKICNRKESIISMTGARGTVGYIAPEVFCRNI---GEVSYKSDVYNYGMMIFEMTGGRKNVDVVDNG  494 (506)
Q Consensus       425 i~dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~---~~~s~~~Dv~s~G~il~elltg~~pf~~~~~~  494 (506)
                      |+|||+++........  .....++..|+|||.+....   ..++.++||||||+++|||++|+.||...+..
T Consensus       169 l~dfg~~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slGvi~~el~~g~~p~~~~~~~  239 (291)
T cd06639         169 LVDFGVSAQLTSTRLR--RNTSVGTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIELGDGDPPLFDMHPV  239 (291)
T ss_pred             Eeecccchhccccccc--ccCccCCccccChhhhcCCCCcccccCCccchHHHHHHHHHHhhCCCCCCCCcHH
Confidence            9999998865433221  13356788999999975321   13688999999999999999999999876543

Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also pre

>cd07877 STKc_p38alpha_MAPK14 Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase

Probab=99.95  E-value=2.2e-27  Score=238.86  Aligned_cols=178  Identities=31%  Similarity=0.417  Sum_probs=143.5

Q ss_pred             HHHHHHHHhhhc--cccCccCceEEEEEEE-cCCCEEEEEEeccCCC---CchhhHHHHHHhhccCccceeEEEEEee--
Q 039231          307 YADIKKMTNSFK--YKLGQGGYGSVYKGKL-LDGSNVAVKVLNDSKG---NGKEFINEVASISRTSHVNVVALLGFCL--  378 (506)
Q Consensus       307 ~~el~~~~~~~~--~~ig~G~~g~V~~~~~-~~~~~vavK~l~~~~~---~~~~~~~E~~~l~~l~h~niv~l~g~~~--  378 (506)
                      ..++..++.+|.  +.||+|+||.||+|.. .+++.||+|+++....   ..+.+.+|++++.+++||||+++.+++.  
T Consensus         9 ~~~~~~~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~iv~~~~~~~~~   88 (345)
T cd07877           9 NKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPA   88 (345)
T ss_pred             HHHHhhccCceEEEEEeeecCCeEEEEEEEcCCCeEEEEEEecCcchhhHHHHHHHHHHHHHHHcCCCcccceeeeeeec
Confidence            445555555554  5799999999999986 4688999999975322   2356788999999999999999987652  


Q ss_pred             -----------------------------ccchhhhHHHHHHHHHHHHhhcCCCCeEecCcCCCcEEECCCCcEEEeecC
Q 039231          379 -----------------------------RVAEELSSTIGIARGLEYLHLGCSTRILHFDIKPHNILLDEDFCPKISDFG  429 (506)
Q Consensus       379 -----------------------------~~~~~l~i~~~i~~gl~~LH~~~~~~ivH~dlkp~Nill~~~~~~ki~dfg  429 (506)
                                                   .+...+.++.|+++||+|||   +.+++||||||+||++++++.+||+|||
T Consensus        89 ~~~~~~~~~~lv~~~~~~~L~~~~~~~~l~~~~~~~i~~qi~~aL~~LH---~~~ivH~dlkp~NIll~~~~~~kl~dfg  165 (345)
T cd07877          89 RSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFG  165 (345)
T ss_pred             ccccccccEEEEehhcccCHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH---HCCeeecCCChHHEEEcCCCCEEEeccc
Confidence                                         22235568899999999999   8999999999999999999999999999


Q ss_pred             CCccccCCCcceecccCCCCcccccccccccccCCCCccccHHHHHHHHHHHHcCCCCCCCCCC
Q 039231          430 LAKICNRKESIISMTGARGTVGYIAPEVFCRNIGEVSYKSDVYNYGMMIFEMTGGRKNVDVVDN  493 (506)
Q Consensus       430 ~a~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~s~~~Dv~s~G~il~elltg~~pf~~~~~  493 (506)
                      +++......     ....++..|+|||.+.+. ..++.++||||||+++|||++|+.||...+.
T Consensus       166 ~~~~~~~~~-----~~~~~~~~y~aPE~~~~~-~~~~~~~DvwslG~il~el~~g~~pf~~~~~  223 (345)
T cd07877         166 LARHTDDEM-----TGYVATRWYRAPEIMLNW-MHYNQTVDIWSVGCIMAELLTGRTLFPGTDH  223 (345)
T ss_pred             ccccccccc-----cccccCCCccCHHHHhCc-cCCCchhhHHHHHHHHHHHHhCCCCCCCCCH
Confidence            987643321     335678899999987542 3578899999999999999999999976543

Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14

>cd06609 STKc_MST3_like Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases

Probab=99.95  E-value=3.7e-27  Score=229.26  Aligned_cols=170  Identities=26%  Similarity=0.354  Sum_probs=142.7

Q ss_pred             hccccCccCceEEEEEEEc-CCCEEEEEEeccCC--CCchhhHHHHHHhhccCccceeEEEEEee---------------
Q 039231          317 FKYKLGQGGYGSVYKGKLL-DGSNVAVKVLNDSK--GNGKEFINEVASISRTSHVNVVALLGFCL---------------  378 (506)
Q Consensus       317 ~~~~ig~G~~g~V~~~~~~-~~~~vavK~l~~~~--~~~~~~~~E~~~l~~l~h~niv~l~g~~~---------------  378 (506)
                      +.+.||.|++|.||+|+.. +++.+|+|++....  .....+.+|+++++.++|+||+++.+++.               
T Consensus         5 ~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~   84 (274)
T cd06609           5 LLECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEEAEDEIEDIQQEIQFLSQCRSPYITKYYGSFLKGSKLWIIMEYCGGG   84 (274)
T ss_pred             hhhhhcCCCCeEEEEEEECCCCeEEEEEEeeccccchHHHHHHHHHHHHHHcCCCCeeeeeEEEEECCeEEEEEEeeCCC
Confidence            4467999999999999875 58899999986543  23357889999999999999999998762               


Q ss_pred             -----------ccchhhhHHHHHHHHHHHHhhcCCCCeEecCcCCCcEEECCCCcEEEeecCCCccccCCCcceecccCC
Q 039231          379 -----------RVAEELSSTIGIARGLEYLHLGCSTRILHFDIKPHNILLDEDFCPKISDFGLAKICNRKESIISMTGAR  447 (506)
Q Consensus       379 -----------~~~~~l~i~~~i~~gl~~LH~~~~~~ivH~dlkp~Nill~~~~~~ki~dfg~a~~~~~~~~~~~~~~~~  447 (506)
                                 ++...+.++.|++.||+|||   +++++|+||+|+||++++++.++|+|||+++........  .....
T Consensus        85 ~L~~~~~~~~~~~~~~~~~~~ql~~~l~~lh---~~~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~~~--~~~~~  159 (274)
T cd06609          85 SCLDLLKPGKLDETYIAFILREVLLGLEYLH---EEGKIHRDIKAANILLSEEGDVKLADFGVSGQLTSTMSK--RNTFV  159 (274)
T ss_pred             cHHHHHhhcCCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCCHHHEEECCCCCEEEcccccceeecccccc--ccccc
Confidence                       33346778999999999999   899999999999999999999999999999877644221  23456


Q ss_pred             CCcccccccccccccCCCCccccHHHHHHHHHHHHcCCCCCCCCCC
Q 039231          448 GTVGYIAPEVFCRNIGEVSYKSDVYNYGMMIFEMTGGRKNVDVVDN  493 (506)
Q Consensus       448 gt~~y~aPE~l~~~~~~~s~~~Dv~s~G~il~elltg~~pf~~~~~  493 (506)
                      +++.|+|||.+.+.  .++.++||||||+++|||++|+.||...+.
T Consensus       160 ~~~~y~~PE~~~~~--~~~~~sDv~slG~il~~l~tg~~p~~~~~~  203 (274)
T cd06609         160 GTPFWMAPEVIKQS--GYDEKADIWSLGITAIELAKGEPPLSDLHP  203 (274)
T ss_pred             CCccccChhhhccC--CCCchhhHHHHHHHHHHHHhCCCCcccCch
Confidence            78899999998654  589999999999999999999999976553

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN)

>cd05097 PTKc_DDR_like Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases

Probab=99.95  E-value=1.6e-27  Score=234.48  Aligned_cols=176  Identities=27%  Similarity=0.438  Sum_probs=138.0

Q ss_pred             HHhhhccccCccCceEEEEEEEcC---------------CCEEEEEEeccCCC--CchhhHHHHHHhhccCccceeEEEE
Q 039231          313 MTNSFKYKLGQGGYGSVYKGKLLD---------------GSNVAVKVLNDSKG--NGKEFINEVASISRTSHVNVVALLG  375 (506)
Q Consensus       313 ~~~~~~~~ig~G~~g~V~~~~~~~---------------~~~vavK~l~~~~~--~~~~~~~E~~~l~~l~h~niv~l~g  375 (506)
                      ..+.+.++||+|+||.||+++..+               ...||+|+++....  ...++.+|++++++++|+||+++++
T Consensus         5 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~   84 (295)
T cd05097           5 QQLRLKEKLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADVTKTARNDFLKEIKIMSRLKNPNIIRLLG   84 (295)
T ss_pred             HhCeehhccCCCCCceEEecccccchhhccccCcccCCCceEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCcCeEEE
Confidence            344556789999999999987532               23589999875422  2356889999999999999999998


Q ss_pred             Eee---------------------------------------ccchhhhHHHHHHHHHHHHhhcCCCCeEecCcCCCcEE
Q 039231          376 FCL---------------------------------------RVAEELSSTIGIARGLEYLHLGCSTRILHFDIKPHNIL  416 (506)
Q Consensus       376 ~~~---------------------------------------~~~~~l~i~~~i~~gl~~LH~~~~~~ivH~dlkp~Nil  416 (506)
                      ++.                                       .+...+.++.|++.||+|||   +.+++|+||||+||+
T Consensus        85 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH---~~~i~H~dlkp~Nil  161 (295)
T cd05097          85 VCVSDDPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSIANLLYMAVQIASGMKYLA---SLNFVHRDLATRNCL  161 (295)
T ss_pred             EEcCCCccEEEEecCCCCcHHHHHHhccccccccccccCCcccHHHHHHHHHHHHHHHHHHH---hcCeeccccChhhEE
Confidence            761                                       11224568899999999999   899999999999999


Q ss_pred             ECCCCcEEEeecCCCccccCCCcceecccCCCCcccccccccccccCCCCccccHHHHHHHHHHHHc--CCCCCCCCCC
Q 039231          417 LDEDFCPKISDFGLAKICNRKESIISMTGARGTVGYIAPEVFCRNIGEVSYKSDVYNYGMMIFEMTG--GRKNVDVVDN  493 (506)
Q Consensus       417 l~~~~~~ki~dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~s~~~Dv~s~G~il~ellt--g~~pf~~~~~  493 (506)
                      +++++.+||+|||+++...............++..|+|||.+.+  +.++.++||||||+++|||++  +..||.....
T Consensus       162 l~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~--~~~~~~~DvwSlG~~l~el~~~~~~~p~~~~~~  238 (295)
T cd05097         162 VGNHYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMAWESILL--GKFTTASDVWAFGVTLWEMFTLCKEQPYSLLSD  238 (295)
T ss_pred             EcCCCcEEecccccccccccCcceeccCcCcCceeecChhhhcc--CCcCchhhHHHHHHHHHHHHHcCCCCCCcccCh
Confidence            99999999999999976543322211223445778999998854  368999999999999999988  6778876544

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including

>cd08227 PK_STRAD_alpha Pseudokinase domain of STE20-related kinase adapter protein alpha

Probab=99.95  E-value=3.3e-27  Score=235.89  Aligned_cols=172  Identities=19%  Similarity=0.216  Sum_probs=135.3

Q ss_pred             ccccCcc--CceEEEEEEEc-CCCEEEEEEeccCCC---CchhhHHHHHHhhccCccceeEEEEEee-------------
Q 039231          318 KYKLGQG--GYGSVYKGKLL-DGSNVAVKVLNDSKG---NGKEFINEVASISRTSHVNVVALLGFCL-------------  378 (506)
Q Consensus       318 ~~~ig~G--~~g~V~~~~~~-~~~~vavK~l~~~~~---~~~~~~~E~~~l~~l~h~niv~l~g~~~-------------  378 (506)
                      .++||+|  +|++||+++.+ +|+.||+|+++....   ..+.+.+|+++++.++||||+++++++.             
T Consensus         3 ~~~ig~G~~~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~~   82 (327)
T cd08227           3 LTVIGRGFEDLMTVNLARYKPTGEYVTVRRINLEACTNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELWVVTSFMA   82 (327)
T ss_pred             hhhccccccceEEEEEEeecccCcEEEEEEechhhccHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEECCEEEEEEeccC
Confidence            4579999  78999999874 589999999975432   2246778999999999999999998761             


Q ss_pred             ----------------ccchhhhHHHHHHHHHHHHhhcCCCCeEecCcCCCcEEECCCCcEEEeecCCCccccCCCcce-
Q 039231          379 ----------------RVAEELSSTIGIARGLEYLHLGCSTRILHFDIKPHNILLDEDFCPKISDFGLAKICNRKESII-  441 (506)
Q Consensus       379 ----------------~~~~~l~i~~~i~~gl~~LH~~~~~~ivH~dlkp~Nill~~~~~~ki~dfg~a~~~~~~~~~~-  441 (506)
                                      ++...+.++.|++.||+|||   +++|+||||||+||+++.++.+++.||+............ 
T Consensus        83 ~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH---~~~iiH~dlkp~Nil~~~~~~~~l~~~~~~~~~~~~~~~~~  159 (327)
T cd08227          83 YGSAKDLICTHFMDGMSELAIAYILQGVLKALDYIH---HMGYVHRSVKASHILISVDGKVYLSGLRSNLSMINHGQRLR  159 (327)
T ss_pred             CCcHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHH---HCCEecCCCChhhEEEecCCcEEEcccchhhcccccccccc
Confidence                            22335678899999999999   8999999999999999999999999998654332111100 


Q ss_pred             ----ecccCCCCcccccccccccccCCCCccccHHHHHHHHHHHHcCCCCCCCCC
Q 039231          442 ----SMTGARGTVGYIAPEVFCRNIGEVSYKSDVYNYGMMIFEMTGGRKNVDVVD  492 (506)
Q Consensus       442 ----~~~~~~gt~~y~aPE~l~~~~~~~s~~~Dv~s~G~il~elltg~~pf~~~~  492 (506)
                          ......++..|+|||++.+....++.++|||||||++|||++|+.||....
T Consensus       160 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~  214 (327)
T cd08227         160 VVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMP  214 (327)
T ss_pred             ccccccccccceecccChHHhhcccCCCCchhhHHHHHHHHHHHHHCCCCCCCcc
Confidence                001234677899999986543468899999999999999999999997644

Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hype

>cd05056 PTKc_FAK Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase

Probab=99.95  E-value=2.6e-27  Score=229.88  Aligned_cols=177  Identities=26%  Similarity=0.457  Sum_probs=141.7

Q ss_pred             HHhhhccccCccCceEEEEEEEcC----CCEEEEEEeccCC--CCchhhHHHHHHhhccCccceeEEEEEe---------
Q 039231          313 MTNSFKYKLGQGGYGSVYKGKLLD----GSNVAVKVLNDSK--GNGKEFINEVASISRTSHVNVVALLGFC---------  377 (506)
Q Consensus       313 ~~~~~~~~ig~G~~g~V~~~~~~~----~~~vavK~l~~~~--~~~~~~~~E~~~l~~l~h~niv~l~g~~---------  377 (506)
                      ....+.+.||+|+||.||+|...+    ...|+||......  ...+.+.+|+.++++++||||+++++++         
T Consensus         6 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~lv~   85 (270)
T cd05056           6 EDITLGRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSPSVREKFLQEAYIMRQFDHPHIVKLIGVITENPVWIVM   85 (270)
T ss_pred             hhceeeeeeCCccceeEEEEEEecCCCCCcceEEEecCCcCCHHHHHHHHHHHHHHHhCCCCchhceeEEEcCCCcEEEE
Confidence            344556789999999999998643    2468999886543  2346789999999999999999999875         


Q ss_pred             ------------------eccchhhhHHHHHHHHHHHHhhcCCCCeEecCcCCCcEEECCCCcEEEeecCCCccccCCCc
Q 039231          378 ------------------LRVAEELSSTIGIARGLEYLHLGCSTRILHFDIKPHNILLDEDFCPKISDFGLAKICNRKES  439 (506)
Q Consensus       378 ------------------~~~~~~l~i~~~i~~gl~~LH~~~~~~ivH~dlkp~Nill~~~~~~ki~dfg~a~~~~~~~~  439 (506)
                                        +++...+.++.|++.||+|||   +.+++|+||||+||+++.++.+||+|||+++.......
T Consensus        86 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~l~~~l~~lH---~~~~~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~  162 (270)
T cd05056          86 ELAPLGELRSYLQVNKYSLDLASLILYSYQLSTALAYLE---SKRFVHRDIAARNVLVSSPDCVKLGDFGLSRYLEDESY  162 (270)
T ss_pred             EcCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHH---hCCeeccccChheEEEecCCCeEEccCceeeecccccc
Confidence                              223335678899999999999   89999999999999999999999999999987654432


Q ss_pred             ceecccCCCCcccccccccccccCCCCccccHHHHHHHHHHHHc-CCCCCCCCCCCc
Q 039231          440 IISMTGARGTVGYIAPEVFCRNIGEVSYKSDVYNYGMMIFEMTG-GRKNVDVVDNGS  495 (506)
Q Consensus       440 ~~~~~~~~gt~~y~aPE~l~~~~~~~s~~~Dv~s~G~il~ellt-g~~pf~~~~~~~  495 (506)
                      .. .....++..|+|||.+...  .++.++||||||+++|||++ |..||......+
T Consensus       163 ~~-~~~~~~~~~y~aPE~~~~~--~~~~~~Di~slG~il~el~~~g~~pf~~~~~~~  216 (270)
T cd05056         163 YK-ASKGKLPIKWMAPESINFR--RFTSASDVWMFGVCMWEILMLGVKPFQGVKNND  216 (270)
T ss_pred             ee-cCCCCccccccChhhhccC--CCCchhhhHHHHHHHHHHHHcCCCCCCCCCHHH
Confidence            21 1233445689999988543  68899999999999999996 999998765543

Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions

>cd05045 PTKc_RET Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein

Probab=99.95  E-value=2.6e-27  Score=232.38  Aligned_cols=172  Identities=27%  Similarity=0.491  Sum_probs=137.2

Q ss_pred             hccccCccCceEEEEEEEcC------CCEEEEEEeccCCC--CchhhHHHHHHhhccCccceeEEEEEee----------
Q 039231          317 FKYKLGQGGYGSVYKGKLLD------GSNVAVKVLNDSKG--NGKEFINEVASISRTSHVNVVALLGFCL----------  378 (506)
Q Consensus       317 ~~~~ig~G~~g~V~~~~~~~------~~~vavK~l~~~~~--~~~~~~~E~~~l~~l~h~niv~l~g~~~----------  378 (506)
                      +.+.||+|+||.||+|+...      ...+++|.+.....  ..+++.+|++++++++||||+++++.+.          
T Consensus         4 ~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e   83 (290)
T cd05045           4 LGKTLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENASSSELRDLLSEFNLLKQVNHPHVIKLYGACSQDGPLLLIVE   83 (290)
T ss_pred             ccccccCcCCcceEEEEEecCCCCCcceeEEEEecCCCCCHHHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCCcEEEEE
Confidence            34679999999999998632      35789998865433  2357889999999999999999998651          


Q ss_pred             -----------------------------------------ccchhhhHHHHHHHHHHHHhhcCCCCeEecCcCCCcEEE
Q 039231          379 -----------------------------------------RVAEELSSTIGIARGLEYLHLGCSTRILHFDIKPHNILL  417 (506)
Q Consensus       379 -----------------------------------------~~~~~l~i~~~i~~gl~~LH~~~~~~ivH~dlkp~Nill  417 (506)
                                                               ++...+.++.|++.||+|||   +.+++||||||+||++
T Consensus        84 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH---~~~ivH~dikp~nill  160 (290)
T cd05045          84 YAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTMGDLISFAWQISRGMQYLA---EMKLVHRDLAARNVLV  160 (290)
T ss_pred             ecCCCCHHHHHHhcCCccccccccccccccccccCccccccCHHHHHHHHHHHHHHHHHHH---HCCeehhhhhhheEEE
Confidence                                                     11223678899999999999   8999999999999999


Q ss_pred             CCCCcEEEeecCCCccccCCCcceecccCCCCcccccccccccccCCCCccccHHHHHHHHHHHHc-CCCCCCCCCC
Q 039231          418 DEDFCPKISDFGLAKICNRKESIISMTGARGTVGYIAPEVFCRNIGEVSYKSDVYNYGMMIFEMTG-GRKNVDVVDN  493 (506)
Q Consensus       418 ~~~~~~ki~dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~s~~~Dv~s~G~il~ellt-g~~pf~~~~~  493 (506)
                      ++++.+||+|||+++...............++..|+|||.+.+.  .++.++||||||+++|||++ |+.||.....
T Consensus       161 ~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~--~~~~~~Di~slG~~l~el~t~g~~p~~~~~~  235 (290)
T cd05045         161 AEGRKMKISDFGLSRDVYEEDSYVKRSKGRIPVKWMAIESLFDH--IYTTQSDVWSFGVLLWEIVTLGGNPYPGIAP  235 (290)
T ss_pred             cCCCcEEeccccccccccCccchhcccCCCCCccccCHHHHccC--CcchHhHHHHHHHHHHHHHhcCCCCCCCCCH
Confidence            99999999999999765433322222334557789999988543  68899999999999999998 9999976543

Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leadi

>cd05101 PTKc_FGFR2 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2

Probab=99.95  E-value=2.4e-27  Score=234.38  Aligned_cols=178  Identities=30%  Similarity=0.508  Sum_probs=140.0

Q ss_pred             HHHHhhhccccCccCceEEEEEEEc--------CCCEEEEEEeccCC--CCchhhHHHHHHhhcc-CccceeEEEEEeec
Q 039231          311 KKMTNSFKYKLGQGGYGSVYKGKLL--------DGSNVAVKVLNDSK--GNGKEFINEVASISRT-SHVNVVALLGFCLR  379 (506)
Q Consensus       311 ~~~~~~~~~~ig~G~~g~V~~~~~~--------~~~~vavK~l~~~~--~~~~~~~~E~~~l~~l-~h~niv~l~g~~~~  379 (506)
                      ....+.+.+.||+|+||.||+|+..        ++..+|+|.++...  ...+++.+|+..++.+ +||||+++++++..
T Consensus        13 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~   92 (304)
T cd05101          13 SRDKLTLGKPLGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQ   92 (304)
T ss_pred             cHHHeeecceeeccCCceEEEEEEeccCCCCCCcceeEEeeecccccchHHHHHHHHHHHHHHhhccCCCchheeEEEec
Confidence            3344455678999999999999741        24579999987532  2336789999999999 79999999987611


Q ss_pred             -------------------------------------------cchhhhHHHHHHHHHHHHhhcCCCCeEecCcCCCcEE
Q 039231          380 -------------------------------------------VAEELSSTIGIARGLEYLHLGCSTRILHFDIKPHNIL  416 (506)
Q Consensus       380 -------------------------------------------~~~~l~i~~~i~~gl~~LH~~~~~~ivH~dlkp~Nil  416 (506)
                                                                 +.+.+.++.||+.||+|||   +++++||||||+||+
T Consensus        93 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH---~~givH~dlkp~Nil  169 (304)
T cd05101          93 DGPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVSCTYQVARGMEYLA---SQKCIHRDLAARNVL  169 (304)
T ss_pred             CCceEEEEecCCCCcHHHHHHhcCCcccccccccccCCcccccHHHHHHHHHHHHHHHHHHH---HCCeeecccccceEE
Confidence                                                       0123557889999999999   899999999999999


Q ss_pred             ECCCCcEEEeecCCCccccCCCcceecccCCCCcccccccccccccCCCCccccHHHHHHHHHHHHc-CCCCCCCCCC
Q 039231          417 LDEDFCPKISDFGLAKICNRKESIISMTGARGTVGYIAPEVFCRNIGEVSYKSDVYNYGMMIFEMTG-GRKNVDVVDN  493 (506)
Q Consensus       417 l~~~~~~ki~dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~s~~~Dv~s~G~il~ellt-g~~pf~~~~~  493 (506)
                      +++++.+||+|||+++...............+++.|+|||.+.+.  .++.++||||||+++|||++ |..||.....
T Consensus       170 i~~~~~~kl~D~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~--~~~~~~Di~slG~~l~el~~~g~~p~~~~~~  245 (304)
T cd05101         170 VTENNVMKIADFGLARDVNNIDYYKKTTNGRLPVKWMAPEALFDR--VYTHQSDVWSFGVLMWEIFTLGGSPYPGIPV  245 (304)
T ss_pred             EcCCCcEEECCCccceecccccccccccCCCCCceeeCchhhccC--CCCchhhHHHHHHHHHHHHcCCCCCcccCCH
Confidence            999999999999999876543332222334567789999998553  68899999999999999998 8888875543

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>cd06656 STKc_PAK3 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3

Probab=99.95  E-value=4.1e-27  Score=231.92  Aligned_cols=171  Identities=30%  Similarity=0.423  Sum_probs=141.9

Q ss_pred             hhccccCccCceEEEEEEEc-CCCEEEEEEeccCCC-CchhhHHHHHHhhccCccceeEEEEEee---------------
Q 039231          316 SFKYKLGQGGYGSVYKGKLL-DGSNVAVKVLNDSKG-NGKEFINEVASISRTSHVNVVALLGFCL---------------  378 (506)
Q Consensus       316 ~~~~~ig~G~~g~V~~~~~~-~~~~vavK~l~~~~~-~~~~~~~E~~~l~~l~h~niv~l~g~~~---------------  378 (506)
                      .+.+.||+|++|.||+|+.. +++.||+|.+..... ..+.+.+|+.+++.++|+||+++++++.               
T Consensus        22 ~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~~  101 (297)
T cd06656          22 TRFEKIGQGASGTVYTAIDIATGQEVAIKQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYLAGG  101 (297)
T ss_pred             eeeeeeccCCCeEEEEEEECCCCCEEEEEEEecCccchHHHHHHHHHHHHhCCCCCEeeEEEEEecCCEEEEeecccCCC
Confidence            34567999999999999864 689999999975433 3356788999999999999999998762               


Q ss_pred             -----------ccchhhhHHHHHHHHHHHHhhcCCCCeEecCcCCCcEEECCCCcEEEeecCCCccccCCCcceecccCC
Q 039231          379 -----------RVAEELSSTIGIARGLEYLHLGCSTRILHFDIKPHNILLDEDFCPKISDFGLAKICNRKESIISMTGAR  447 (506)
Q Consensus       379 -----------~~~~~l~i~~~i~~gl~~LH~~~~~~ivH~dlkp~Nill~~~~~~ki~dfg~a~~~~~~~~~~~~~~~~  447 (506)
                                 ++.+.+.++.|++.||.|||   +.+++||||||+||+++.++.+||+|||++.........  .....
T Consensus       102 ~L~~~~~~~~~~~~~~~~~~~~l~~~L~~LH---~~~i~H~dL~p~Nili~~~~~~~l~Dfg~~~~~~~~~~~--~~~~~  176 (297)
T cd06656         102 SLTDVVTETCMDEGQIAAVCRECLQALDFLH---SNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSK--RSTMV  176 (297)
T ss_pred             CHHHHHHhCCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCHHHEEECCCCCEEECcCccceEccCCccC--cCccc
Confidence                       23346678899999999999   899999999999999999999999999999765443321  13356


Q ss_pred             CCcccccccccccccCCCCccccHHHHHHHHHHHHcCCCCCCCCCC
Q 039231          448 GTVGYIAPEVFCRNIGEVSYKSDVYNYGMMIFEMTGGRKNVDVVDN  493 (506)
Q Consensus       448 gt~~y~aPE~l~~~~~~~s~~~Dv~s~G~il~elltg~~pf~~~~~  493 (506)
                      +++.|+|||.+.+.  .++.++|+||||+++|+|++|+.||...+.
T Consensus       177 ~~~~y~aPE~~~~~--~~~~~~Di~slGvil~~l~tg~~pf~~~~~  220 (297)
T cd06656         177 GTPYWMAPEVVTRK--AYGPKVDIWSLGIMAIEMVEGEPPYLNENP  220 (297)
T ss_pred             CCccccCHHHHcCC--CCCcHHHHHHHHHHHHHHHhCCCCCCCCCc
Confidence            78899999998653  678999999999999999999999976544

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding

>cd05040 PTKc_Ack_like Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase

Probab=99.95  E-value=2.6e-27  Score=227.94  Aligned_cols=171  Identities=32%  Similarity=0.474  Sum_probs=138.6

Q ss_pred             cccCccCceEEEEEEEcC--C--CEEEEEEeccCCC--CchhhHHHHHHhhccCccceeEEEEEee--------------
Q 039231          319 YKLGQGGYGSVYKGKLLD--G--SNVAVKVLNDSKG--NGKEFINEVASISRTSHVNVVALLGFCL--------------  378 (506)
Q Consensus       319 ~~ig~G~~g~V~~~~~~~--~--~~vavK~l~~~~~--~~~~~~~E~~~l~~l~h~niv~l~g~~~--------------  378 (506)
                      ++||+|++|.||+|.+.+  +  ..+|||.+.....  ..+++.+|++.+++++||||+++++.+.              
T Consensus         1 ~~ig~g~~~~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~v~e~~~~~   80 (257)
T cd05040           1 KKLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLSDIMDDFLKEAAIMHSLDHENLIRLYGVVLTHPLMMVTELAPLG   80 (257)
T ss_pred             CcCCccCcccEEeeeEecCCCCceEEEEeecCCcccHHHHHHHHHHHHHHhhcCCCCccceeEEEcCCeEEEEEEecCCC
Confidence            368999999999998743  3  3689999976544  3467899999999999999999987652              


Q ss_pred             --------------ccchhhhHHHHHHHHHHHHhhcCCCCeEecCcCCCcEEECCCCcEEEeecCCCccccCCCccee-c
Q 039231          379 --------------RVAEELSSTIGIARGLEYLHLGCSTRILHFDIKPHNILLDEDFCPKISDFGLAKICNRKESIIS-M  443 (506)
Q Consensus       379 --------------~~~~~l~i~~~i~~gl~~LH~~~~~~ivH~dlkp~Nill~~~~~~ki~dfg~a~~~~~~~~~~~-~  443 (506)
                                    ++...+.++.|++.||+|||   +++++|+||+|+||+++.++.+||+|||+++.......... .
T Consensus        81 ~L~~~l~~~~~~~~~~~~~~~~~~qi~~~L~~lH---~~~i~H~di~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~  157 (257)
T cd05040          81 SLLDRLRKDALGHFLISTLCDYAVQIANGMRYLE---SKRFIHRDLAARNILLASDDKVKIGDFGLMRALPQNEDHYVME  157 (257)
T ss_pred             cHHHHHHhcccccCcHHHHHHHHHHHHHHHHHHH---hCCccccccCcccEEEecCCEEEeccccccccccccccceecc
Confidence                          12234668889999999999   89999999999999999999999999999987654332211 1


Q ss_pred             ccCCCCcccccccccccccCCCCccccHHHHHHHHHHHHc-CCCCCCCCCCC
Q 039231          444 TGARGTVGYIAPEVFCRNIGEVSYKSDVYNYGMMIFEMTG-GRKNVDVVDNG  494 (506)
Q Consensus       444 ~~~~gt~~y~aPE~l~~~~~~~s~~~Dv~s~G~il~ellt-g~~pf~~~~~~  494 (506)
                      ....++..|+|||.+...  .++.++||||||+++|||++ |+.||......
T Consensus       158 ~~~~~~~~y~~pE~~~~~--~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~  207 (257)
T cd05040         158 EHLKVPFAWCAPESLRTR--TFSHASDVWMFGVTLWEMFTYGEEPWAGLSGS  207 (257)
T ss_pred             cCCCCCceecCHHHhccc--CcCchhhhHHHHHHHHHHHhCCCCCCCCCCHH
Confidence            234567889999998543  68899999999999999998 99999765443

Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with and

>cd05058 PTKc_Met_Ron Catalytic domain of the Protein Tyrosine Kinases, Met and Ron

Probab=99.95  E-value=3.3e-27  Score=227.93  Aligned_cols=169  Identities=36%  Similarity=0.603  Sum_probs=132.4

Q ss_pred             cccCccCceEEEEEEEcC----CCEEEEEEeccCC--CCchhhHHHHHHhhccCccceeEEEEEeec-------------
Q 039231          319 YKLGQGGYGSVYKGKLLD----GSNVAVKVLNDSK--GNGKEFINEVASISRTSHVNVVALLGFCLR-------------  379 (506)
Q Consensus       319 ~~ig~G~~g~V~~~~~~~----~~~vavK~l~~~~--~~~~~~~~E~~~l~~l~h~niv~l~g~~~~-------------  379 (506)
                      +.||+|+||.||+|.+.+    +..+|+|.+....  ...+.+.+|+.+++.++||||+++++++..             
T Consensus         1 ~~lg~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~lv~e~~~   80 (262)
T cd05058           1 RVIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRITDLEEVEQFLKEGIIMKDFSHPNVLSLLGICLPSEGSPLVVLPYMK   80 (262)
T ss_pred             CcccccCCceEEEEEEecCCCceEEEEEEecCccCCHHHHHHHHHHHHHHccCCCCCcceEEEEeecCCCCcEEEEecCC
Confidence            358999999999998632    4579999885432  233678899999999999999999997631             


Q ss_pred             ----------------cchhhhHHHHHHHHHHHHhhcCCCCeEecCcCCCcEEECCCCcEEEeecCCCccccCCCcce--
Q 039231          380 ----------------VAEELSSTIGIARGLEYLHLGCSTRILHFDIKPHNILLDEDFCPKISDFGLAKICNRKESII--  441 (506)
Q Consensus       380 ----------------~~~~l~i~~~i~~gl~~LH~~~~~~ivH~dlkp~Nill~~~~~~ki~dfg~a~~~~~~~~~~--  441 (506)
                                      +...+.++.|+++||+|||   +.+++||||||+|||+++++.+||+|||+++.........  
T Consensus        81 ~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dlk~~nili~~~~~~kl~dfg~~~~~~~~~~~~~~  157 (262)
T cd05058          81 HGDLRNFIRSETHNPTVKDLIGFGLQVAKGMEYLA---SKKFVHRDLAARNCMLDESFTVKVADFGLARDIYDKEYYSVH  157 (262)
T ss_pred             CCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH---hCCccccccCcceEEEcCCCcEEECCccccccccCCcceeec
Confidence                            1124567889999999999   8999999999999999999999999999997654322110  


Q ss_pred             ecccCCCCcccccccccccccCCCCccccHHHHHHHHHHHHc-CCCCCCCCC
Q 039231          442 SMTGARGTVGYIAPEVFCRNIGEVSYKSDVYNYGMMIFEMTG-GRKNVDVVD  492 (506)
Q Consensus       442 ~~~~~~gt~~y~aPE~l~~~~~~~s~~~Dv~s~G~il~ellt-g~~pf~~~~  492 (506)
                      ......++..|+|||.+...  .++.++||||||+++|||++ |.+||...+
T Consensus       158 ~~~~~~~~~~y~aPE~~~~~--~~~~~~Di~slG~~l~el~~~~~~~~~~~~  207 (262)
T cd05058         158 NHTGAKLPVKWMALESLQTQ--KFTTKSDVWSFGVLLWELMTRGAPPYPDVD  207 (262)
T ss_pred             ccccCcCCccccChhHhccC--ccchHHHHHHHHHHHHHHHcCCCCCCCCCC
Confidence            11234457789999998543  68899999999999999999 566666443

Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also ca

>cd06631 STKc_YSK4 Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4

Probab=99.95  E-value=4.6e-27  Score=227.40  Aligned_cols=172  Identities=32%  Similarity=0.450  Sum_probs=140.0

Q ss_pred             ccccCccCceEEEEEEEcCCCEEEEEEeccCCCC-------chhhHHHHHHhhccCccceeEEEEEe-------------
Q 039231          318 KYKLGQGGYGSVYKGKLLDGSNVAVKVLNDSKGN-------GKEFINEVASISRTSHVNVVALLGFC-------------  377 (506)
Q Consensus       318 ~~~ig~G~~g~V~~~~~~~~~~vavK~l~~~~~~-------~~~~~~E~~~l~~l~h~niv~l~g~~-------------  377 (506)
                      .+.||+|+||.||+|...+++.+|+|.++.....       .+.+.+|++++++++|+||+++.+++             
T Consensus         5 ~~~ig~g~~~~v~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~   84 (265)
T cd06631           5 GEVLGKGAYGTVYCGLTNQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIVQYLGTCLDDNTISIFMEFV   84 (265)
T ss_pred             cceEeccCCeEEEEEEEcCCCeEEEEEeecCccchhhHHHHHHHHHHHHHHHHhcCCCCEeeEeeEeecCCeEEEEEecC
Confidence            4579999999999999888999999998643211       24578899999999999999999876             


Q ss_pred             --------------eccchhhhHHHHHHHHHHHHhhcCCCCeEecCcCCCcEEECCCCcEEEeecCCCccccCCCc----
Q 039231          378 --------------LRVAEELSSTIGIARGLEYLHLGCSTRILHFDIKPHNILLDEDFCPKISDFGLAKICNRKES----  439 (506)
Q Consensus       378 --------------~~~~~~l~i~~~i~~gl~~LH~~~~~~ivH~dlkp~Nill~~~~~~ki~dfg~a~~~~~~~~----  439 (506)
                                    +++.....++.|++.||+|||   +.+++|+||+|+||++++++.+||+|||++........    
T Consensus        85 ~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~  161 (265)
T cd06631          85 PGGSISSILNRFGPLPEPVFCKYTKQILDGVAYLH---NNCVVHRDIKGNNVMLMPNGIIKLIDFGCARRLAWVGLHGTH  161 (265)
T ss_pred             CCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH---hCCcccCCcCHHhEEECCCCeEEeccchhhHhhhhccccccc
Confidence                          122335568899999999999   89999999999999999999999999999876532111    


Q ss_pred             ceecccCCCCcccccccccccccCCCCccccHHHHHHHHHHHHcCCCCCCCCCCC
Q 039231          440 IISMTGARGTVGYIAPEVFCRNIGEVSYKSDVYNYGMMIFEMTGGRKNVDVVDNG  494 (506)
Q Consensus       440 ~~~~~~~~gt~~y~aPE~l~~~~~~~s~~~Dv~s~G~il~elltg~~pf~~~~~~  494 (506)
                      ........++..|+|||.+.+.  .++.++||||||+++|||++|+.||...+..
T Consensus       162 ~~~~~~~~~~~~~~~pe~~~~~--~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~  214 (265)
T cd06631         162 SNMLKSMHGTPYWMAPEVINES--GYGRKSDIWSIGCTVFEMATGKPPLASMDRL  214 (265)
T ss_pred             cccccccCCCccccChhhhcCC--CCcchhhHHHHHHHHHHHHhCCCccccCChH
Confidence            1111335688999999998654  6788999999999999999999999765443

Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals.

>cd06607 STKc_TAO Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins

Probab=99.95  E-value=8.7e-27  Score=230.71  Aligned_cols=169  Identities=30%  Similarity=0.427  Sum_probs=139.0

Q ss_pred             hhhccccCccCceEEEEEEEc-CCCEEEEEEeccCCC----CchhhHHHHHHhhccCccceeEEEEEeec----------
Q 039231          315 NSFKYKLGQGGYGSVYKGKLL-DGSNVAVKVLNDSKG----NGKEFINEVASISRTSHVNVVALLGFCLR----------  379 (506)
Q Consensus       315 ~~~~~~ig~G~~g~V~~~~~~-~~~~vavK~l~~~~~----~~~~~~~E~~~l~~l~h~niv~l~g~~~~----------  379 (506)
                      +...++||+|+||.||+|+.. +++.||+|++.....    ..+++.+|++++++++||||+++.+++.+          
T Consensus        17 y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~~~~~~~~~~~~~lv~e~   96 (307)
T cd06607          17 FTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHPNTIEYKGCYLREHTAWLVMEY   96 (307)
T ss_pred             hhhheeecCCCCeEEEEEEEcCCCcEEEEEEEeccccCcHHHHHHHHHHHHHHHhCCCCCEEEEEEEEEeCCeEEEEHHh
Confidence            334567999999999999875 589999999864322    22568899999999999999999988732          


Q ss_pred             -----------------cchhhhHHHHHHHHHHHHhhcCCCCeEecCcCCCcEEECCCCcEEEeecCCCccccCCCccee
Q 039231          380 -----------------VAEELSSTIGIARGLEYLHLGCSTRILHFDIKPHNILLDEDFCPKISDFGLAKICNRKESIIS  442 (506)
Q Consensus       380 -----------------~~~~l~i~~~i~~gl~~LH~~~~~~ivH~dlkp~Nill~~~~~~ki~dfg~a~~~~~~~~~~~  442 (506)
                                       +.+...++.|++.||.|||   +.+++|+||+|+||++++++.+||+|||++......     
T Consensus        97 ~~g~l~~~~~~~~~~l~~~~~~~~~~ql~~~L~~LH---~~~i~H~dl~p~nIl~~~~~~~kL~dfg~~~~~~~~-----  168 (307)
T cd06607          97 CLGSASDILEVHKKPLQEVEIAAICHGALQGLAYLH---SHERIHRDIKAGNILLTEPGTVKLADFGSASLVSPA-----  168 (307)
T ss_pred             hCCCHHHHHHHcccCCCHHHHHHHHHHHHHHHHHHH---HCCceecCCCcccEEECCCCCEEEeecCcceecCCC-----
Confidence                             2234568899999999999   899999999999999999999999999998765432     


Q ss_pred             cccCCCCccccccccccc-ccCCCCccccHHHHHHHHHHHHcCCCCCCCCC
Q 039231          443 MTGARGTVGYIAPEVFCR-NIGEVSYKSDVYNYGMMIFEMTGGRKNVDVVD  492 (506)
Q Consensus       443 ~~~~~gt~~y~aPE~l~~-~~~~~s~~~Dv~s~G~il~elltg~~pf~~~~  492 (506)
                       ....++..|+|||.+.+ ..+.++.++||||||+++|||++|+.||...+
T Consensus       169 -~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~s~G~il~el~tg~~p~~~~~  218 (307)
T cd06607         169 -NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMN  218 (307)
T ss_pred             -CCccCCccccCceeeeccCCCCCCcccchHHHHHHHHHHHcCCCCCCCcc
Confidence             23457889999998742 22467889999999999999999999997654

Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily

>cd06628 STKc_MAPKKK_Byr2_like Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases

Probab=99.95  E-value=4.2e-27  Score=227.84  Aligned_cols=172  Identities=31%  Similarity=0.430  Sum_probs=138.9

Q ss_pred             hccccCccCceEEEEEEEc-CCCEEEEEEeccCCCC----------chhhHHHHHHhhccCccceeEEEEEee-------
Q 039231          317 FKYKLGQGGYGSVYKGKLL-DGSNVAVKVLNDSKGN----------GKEFINEVASISRTSHVNVVALLGFCL-------  378 (506)
Q Consensus       317 ~~~~ig~G~~g~V~~~~~~-~~~~vavK~l~~~~~~----------~~~~~~E~~~l~~l~h~niv~l~g~~~-------  378 (506)
                      +...||+|++|.||+|... +++.+|+|.+......          .+.+.+|++++++++||||+++++++.       
T Consensus         4 ~~~~ig~g~~~~v~~a~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l   83 (267)
T cd06628           4 KGALIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHENIVQYLGSSLDADHLNI   83 (267)
T ss_pred             ccceeecCCCeEEEEEEecCCCcEEEEEEecCCCcccchhHHHHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCccEE
Confidence            4567999999999999874 5889999988643221          145778999999999999999998762       


Q ss_pred             --------------------ccchhhhHHHHHHHHHHHHhhcCCCCeEecCcCCCcEEECCCCcEEEeecCCCccccCCC
Q 039231          379 --------------------RVAEELSSTIGIARGLEYLHLGCSTRILHFDIKPHNILLDEDFCPKISDFGLAKICNRKE  438 (506)
Q Consensus       379 --------------------~~~~~l~i~~~i~~gl~~LH~~~~~~ivH~dlkp~Nill~~~~~~ki~dfg~a~~~~~~~  438 (506)
                                          +......++.|++.||+|||   +.+++|+||+|+||++++++.+||+|||.++......
T Consensus        84 v~e~~~~~~L~~~l~~~~~l~~~~~~~~~~~l~~~l~~lH---~~~ivH~di~p~nil~~~~~~~~l~dfg~~~~~~~~~  160 (267)
T cd06628          84 FLEYVPGGSVAALLNNYGAFEETLVRNFVRQILKGLNYLH---NRGIIHRDIKGANILVDNKGGIKISDFGISKKLEANS  160 (267)
T ss_pred             EEEecCCCCHHHHHHhccCccHHHHHHHHHHHHHHHHHHH---hcCcccccCCHHHEEEcCCCCEEecccCCCccccccc
Confidence                                22335578899999999999   8999999999999999999999999999998765322


Q ss_pred             ccee----cccCCCCcccccccccccccCCCCccccHHHHHHHHHHHHcCCCCCCCCCC
Q 039231          439 SIIS----MTGARGTVGYIAPEVFCRNIGEVSYKSDVYNYGMMIFEMTGGRKNVDVVDN  493 (506)
Q Consensus       439 ~~~~----~~~~~gt~~y~aPE~l~~~~~~~s~~~Dv~s~G~il~elltg~~pf~~~~~  493 (506)
                      ....    .....++..|+|||.+.+.  .++.++|+||||+++|||++|+.||...+.
T Consensus       161 ~~~~~~~~~~~~~~~~~y~~pe~~~~~--~~~~~~Dv~slG~il~~l~~g~~p~~~~~~  217 (267)
T cd06628         161 LSTKTNGARPSLQGSVFWMAPEVVKQT--SYTRKADIWSLGCLVVEMLTGKHPFPDCTQ  217 (267)
T ss_pred             ccCCccccccccCCCcCccChhHhccC--CCCchhhhHHHHHHHHHHhhCCCCCCCccH
Confidence            1110    1224578899999998653  678899999999999999999999986543

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate

>cd06636 STKc_MAP4K4_6 Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6

Probab=99.95  E-value=3.2e-27  Score=230.73  Aligned_cols=171  Identities=29%  Similarity=0.452  Sum_probs=138.8

Q ss_pred             ccccCccCceEEEEEEEc-CCCEEEEEEeccCCCCchhhHHHHHHhhcc-CccceeEEEEEeec----------------
Q 039231          318 KYKLGQGGYGSVYKGKLL-DGSNVAVKVLNDSKGNGKEFINEVASISRT-SHVNVVALLGFCLR----------------  379 (506)
Q Consensus       318 ~~~ig~G~~g~V~~~~~~-~~~~vavK~l~~~~~~~~~~~~E~~~l~~l-~h~niv~l~g~~~~----------------  379 (506)
                      .+.||+|+||.||+|+.. +++.+|+|++........++..|+.++.++ +|+||+++++++..                
T Consensus        21 ~~~lg~g~~~~v~~~~~~~~~~~~a~K~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~~~~~iv~e~  100 (282)
T cd06636          21 VEVVGNGTYGQVYKGRHVKTGQLAAIKVMDVTEDEEEEIKLEINMLKKYSHHRNIATYYGAFIKKSPPGHDDQLWLVMEF  100 (282)
T ss_pred             heeeccCCCeEEEEEEEcCCCcEEEEEEEecChHHHHHHHHHHHHHHHhcCCCcEEEEeeehhcccccCCCCEEEEEEEe
Confidence            467999999999999974 588999999876655556788999999998 69999999877521                


Q ss_pred             -------------------cchhhhHHHHHHHHHHHHhhcCCCCeEecCcCCCcEEECCCCcEEEeecCCCccccCCCcc
Q 039231          380 -------------------VAEELSSTIGIARGLEYLHLGCSTRILHFDIKPHNILLDEDFCPKISDFGLAKICNRKESI  440 (506)
Q Consensus       380 -------------------~~~~l~i~~~i~~gl~~LH~~~~~~ivH~dlkp~Nill~~~~~~ki~dfg~a~~~~~~~~~  440 (506)
                                         +...+.++.|++.||+|||   +.+++|+||+|+||++++++.++|+|||++........ 
T Consensus       101 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH---~~~ivH~dl~~~nili~~~~~~~l~dfg~~~~~~~~~~-  176 (282)
T cd06636         101 CGAGSVTDLVKNTKGNALKEDWIAYICREILRGLAHLH---AHKVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVG-  176 (282)
T ss_pred             CCCCcHHHHHHHccCCCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCHHHEEECCCCCEEEeeCcchhhhhcccc-
Confidence                               1113557789999999999   89999999999999999999999999999876543221 


Q ss_pred             eecccCCCCcccccccccccc---cCCCCccccHHHHHHHHHHHHcCCCCCCCCCC
Q 039231          441 ISMTGARGTVGYIAPEVFCRN---IGEVSYKSDVYNYGMMIFEMTGGRKNVDVVDN  493 (506)
Q Consensus       441 ~~~~~~~gt~~y~aPE~l~~~---~~~~s~~~Dv~s~G~il~elltg~~pf~~~~~  493 (506)
                       ......+++.|+|||.+...   ...++.++||||||+++|||++|+.||....+
T Consensus       177 -~~~~~~~~~~y~aPE~l~~~~~~~~~~~~~~DvwslG~~l~el~~g~~p~~~~~~  231 (282)
T cd06636         177 -RRNTFIGTPYWMAPEVIACDENPDATYDYRSDIWSLGITAIEMAEGAPPLCDMHP  231 (282)
T ss_pred             -CCCcccccccccCHhhcCcccCcCcCCCcccchhHHHHHHHHHHhCCCCccccCH
Confidence             11335688999999998532   23578899999999999999999999976543

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Ea

>cd05041 PTKc_Fes_like Catalytic domain of Fes-like Protein Tyrosine Kinases

Probab=99.95  E-value=5.3e-27  Score=224.95  Aligned_cols=170  Identities=31%  Similarity=0.526  Sum_probs=138.1

Q ss_pred             cccCccCceEEEEEEEcCCCEEEEEEeccCCC--CchhhHHHHHHhhccCccceeEEEEEee------------------
Q 039231          319 YKLGQGGYGSVYKGKLLDGSNVAVKVLNDSKG--NGKEFINEVASISRTSHVNVVALLGFCL------------------  378 (506)
Q Consensus       319 ~~ig~G~~g~V~~~~~~~~~~vavK~l~~~~~--~~~~~~~E~~~l~~l~h~niv~l~g~~~------------------  378 (506)
                      ++||+|++|.||++...+++.|++|++.....  ....+.+|++++++++|+||+++++++.                  
T Consensus         1 ~~lg~g~~g~v~~~~~~~~~~v~~K~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~~~l~   80 (251)
T cd05041           1 EKIGKGNFGDVYKGVLKGNTEVAVKTCRSTLPPDLKRKFLQEAEILKQYDHPNIVKLIGVCVQKQPIYIVMELVPGGSLL   80 (251)
T ss_pred             CccccCCCceEEEEEEeCCCcEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCeEEEEEEEecCCCeEEEEEcCCCCcHH
Confidence            36999999999999987799999999875433  3367899999999999999999998761                  


Q ss_pred             ----------ccchhhhHHHHHHHHHHHHhhcCCCCeEecCcCCCcEEECCCCcEEEeecCCCccccCCCcceecccCCC
Q 039231          379 ----------RVAEELSSTIGIARGLEYLHLGCSTRILHFDIKPHNILLDEDFCPKISDFGLAKICNRKESIISMTGARG  448 (506)
Q Consensus       379 ----------~~~~~l~i~~~i~~gl~~LH~~~~~~ivH~dlkp~Nill~~~~~~ki~dfg~a~~~~~~~~~~~~~~~~g  448 (506)
                                +....+.++.+++.||+|||   +++++||||+|+||+++.++.+||+|||+++................
T Consensus        81 ~~l~~~~~~~~~~~~~~~~~~~~~~l~~lH---~~~i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~  157 (251)
T cd05041          81 TFLRKKKNRLTVKKLLQMSLDAAAGMEYLE---SKNCIHRDLAARNCLVGENNVLKISDFGMSREEEGGIYTVSDGLKQI  157 (251)
T ss_pred             HHHHhcCCCCCHHHHHHHHHHHHHHHHHHH---hCCEehhhcCcceEEEcCCCcEEEeeccccccccCCcceeccccCcc
Confidence                      12224668889999999999   89999999999999999999999999999976543222111122334


Q ss_pred             CcccccccccccccCCCCccccHHHHHHHHHHHHc-CCCCCCCCCC
Q 039231          449 TVGYIAPEVFCRNIGEVSYKSDVYNYGMMIFEMTG-GRKNVDVVDN  493 (506)
Q Consensus       449 t~~y~aPE~l~~~~~~~s~~~Dv~s~G~il~ellt-g~~pf~~~~~  493 (506)
                      +..|+|||.+.+  +.++.++|+||||+++|||++ |..||.....
T Consensus       158 ~~~y~~PE~~~~--~~~~~~~Di~slG~i~~~l~t~~~~p~~~~~~  201 (251)
T cd05041         158 PIKWTAPEALNY--GRYTSESDVWSYGILLWETFSLGDTPYPGMSN  201 (251)
T ss_pred             eeccCChHhhcc--CCCCcchhHHHHHHHHHHHHhccCCCCccCCH
Confidence            667999999854  368899999999999999998 8999976654

Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr k

>KOG4645 consensus MAPKKK (MAP kinase kinase kinase) SSK2 and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=99.95  E-value=1.9e-28  Score=262.17  Aligned_cols=181  Identities=29%  Similarity=0.381  Sum_probs=146.2

Q ss_pred             cccCccCceEEEEEEE-cCCCEEEEEEeccC---CCCchhhHHHHHHhhccCccceeEEEEEeeccch------------
Q 039231          319 YKLGQGGYGSVYKGKL-LDGSNVAVKVLNDS---KGNGKEFINEVASISRTSHVNVVALLGFCLRVAE------------  382 (506)
Q Consensus       319 ~~ig~G~~g~V~~~~~-~~~~~vavK~l~~~---~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~------------  382 (506)
                      ..||.|.||.||.|.. ++|...|+|.++-.   ....+.+.+|+.++..++|||+|+++|+-.+.++            
T Consensus      1241 ~~Ig~G~fG~VYtavN~~tGellAvKEI~iq~~~~k~~~~i~eEm~vlE~lnHpNlV~YyGVEvHRekv~IFMEyC~~Gs 1320 (1509)
T KOG4645|consen 1241 NFIGGGTFGKVYTAVNLDTGELLAVKEIKIQDSDHKTFKLIAEEMKVLEGLNHPNLVRYYGVEVHREKVYIFMEYCEGGS 1320 (1509)
T ss_pred             cccCCcceeeeEEeecCCccchhhhhhhhcCccccccCcchHHHHHHHHhccCccccccCceeecHHHHHHHHHHhccCc
Confidence            3699999999999985 45888999988632   2233678899999999999999999997643332            


Q ss_pred             ---------------hhhHHHHHHHHHHHHhhcCCCCeEecCcCCCcEEECCCCcEEEeecCCCccccCCCcc--eeccc
Q 039231          383 ---------------ELSSTIGIARGLEYLHLGCSTRILHFDIKPHNILLDEDFCPKISDFGLAKICNRKESI--ISMTG  445 (506)
Q Consensus       383 ---------------~l~i~~~i~~gl~~LH~~~~~~ivH~dlkp~Nill~~~~~~ki~dfg~a~~~~~~~~~--~~~~~  445 (506)
                                     ...+..|++.|++|||   ++|||||||||.||+|+.+|.+|++|||.|..+...-..  .....
T Consensus      1321 La~ll~~gri~dE~vt~vyt~qll~gla~LH---~~gIVHRDIK~aNI~Ld~~g~iK~~DFGsa~ki~~~~~~~~~el~~ 1397 (1509)
T KOG4645|consen 1321 LASLLEHGRIEDEMVTRVYTKQLLEGLAYLH---EHGIVHRDIKPANILLDFNGLIKYGDFGSAVKIKNNAQTMPGELQS 1397 (1509)
T ss_pred             HHHHHHhcchhhhhHHHHHHHHHHHHHHHHH---hcCceecCCCccceeeecCCcEEeecccceeEecCchhcCCHHHHh
Confidence                           2235679999999999   999999999999999999999999999999887654311  12345


Q ss_pred             CCCCccccccccccccc-CCCCccccHHHHHHHHHHHHcCCCCCCCCCCC-cchhhhhh
Q 039231          446 ARGTVGYIAPEVFCRNI-GEVSYKSDVYNYGMMIFEMTGGRKNVDVVDNG-STALDLQA  502 (506)
Q Consensus       446 ~~gt~~y~aPE~l~~~~-~~~s~~~Dv~s~G~il~elltg~~pf~~~~~~-~~~~~~~~  502 (506)
                      ..||+.|||||++.+.. .....+.||||+|||+.||+||+.||...+++ ...+.+.+
T Consensus      1398 ~~GT~~YMAPEvit~t~~kG~~~A~DiWslGCVVlEM~tGkrPW~~~dne~aIMy~V~~ 1456 (1509)
T KOG4645|consen 1398 MMGTPMYMAPEVITGTKGKGHGGAADIWSLGCVVLEMATGKRPWAELDNEWAIMYHVAA 1456 (1509)
T ss_pred             hcCCchhcCchhhcccccCCCCcchhhhcccceEEEeecCCCchhhccchhHHHhHHhc
Confidence            77999999999997654 34567899999999999999999999988766 44444433

>cd07842 STKc_CDK8_like Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases

Probab=99.95  E-value=3.8e-27  Score=233.92  Aligned_cols=175  Identities=30%  Similarity=0.396  Sum_probs=142.1

Q ss_pred             hccccCccCceEEEEEEEc---CCCEEEEEEeccCC----CCchhhHHHHHHhhccCccceeEEEEEeecc---------
Q 039231          317 FKYKLGQGGYGSVYKGKLL---DGSNVAVKVLNDSK----GNGKEFINEVASISRTSHVNVVALLGFCLRV---------  380 (506)
Q Consensus       317 ~~~~ig~G~~g~V~~~~~~---~~~~vavK~l~~~~----~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~---------  380 (506)
                      +.++||+|++|.||+|+..   ++..+|+|.+....    ...+.+.+|++++.+++||||+++++++.+.         
T Consensus         4 ~~~~ig~g~~g~v~~~~~~~~~~~~~~alK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~lv~   83 (316)
T cd07842           4 IEGCIGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLRELKHENVVSLVEVFLEHADKSVYLLF   83 (316)
T ss_pred             EEEEeccCCcEEEEEEEecCCCCCCeEEEEEeccccccccCccHHHHHHHHHHHhcCCCCccceEEEEeCCCCceEEEEE
Confidence            4567999999999999875   47899999997632    2336788999999999999999999987333         


Q ss_pred             ------------------------chhhhHHHHHHHHHHHHhhcCCCCeEecCcCCCcEEECC----CCcEEEeecCCCc
Q 039231          381 ------------------------AEELSSTIGIARGLEYLHLGCSTRILHFDIKPHNILLDE----DFCPKISDFGLAK  432 (506)
Q Consensus       381 ------------------------~~~l~i~~~i~~gl~~LH~~~~~~ivH~dlkp~Nill~~----~~~~ki~dfg~a~  432 (506)
                                              ...+.++.|++.||+|||   +.+++||||||+||++++    ++.+||+|||+++
T Consensus        84 e~~~~~l~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH---~~~i~h~dlkp~Nil~~~~~~~~~~~kl~Dfg~~~  160 (316)
T cd07842          84 DYAEHDLWQIIKFHRQAKRVSIPPSMVKSLLWQILNGVHYLH---SNWVLHRDLKPANILVMGEGPERGVVKIGDLGLAR  160 (316)
T ss_pred             eCCCcCHHHHHHhhccCCCcCcCHHHHHHHHHHHHHHHHHHH---hCCEeeCCCCHHHEEEcCCCCccceEEECCCcccc
Confidence                                    113458889999999999   899999999999999999    9999999999998


Q ss_pred             cccCCCc-ceecccCCCCcccccccccccccCCCCccccHHHHHHHHHHHHcCCCCCCCCCCCc
Q 039231          433 ICNRKES-IISMTGARGTVGYIAPEVFCRNIGEVSYKSDVYNYGMMIFEMTGGRKNVDVVDNGS  495 (506)
Q Consensus       433 ~~~~~~~-~~~~~~~~gt~~y~aPE~l~~~~~~~s~~~Dv~s~G~il~elltg~~pf~~~~~~~  495 (506)
                      ....... ........++..|+|||.+.+. ..++.++||||||++++||++|+.||.......
T Consensus       161 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~  223 (316)
T cd07842         161 LFNAPLKPLADLDPVVVTIWYRAPELLLGA-RHYTKAIDIWAIGCIFAELLTLEPIFKGREAKI  223 (316)
T ss_pred             ccCCCcccccccCCccccccccCHHHHhCC-CCCCcHHHHHHHHHHHHHHHhcCCCCcCCcccc
Confidence            7643322 1112345678899999987543 357889999999999999999999998765543

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the

>cd00192 PTKc Catalytic domain of Protein Tyrosine Kinases

Probab=99.95  E-value=4.4e-27  Score=226.33  Aligned_cols=170  Identities=37%  Similarity=0.631  Sum_probs=142.6

Q ss_pred             cccCccCceEEEEEEEcC----CCEEEEEEeccCCCC--chhhHHHHHHhhccCccceeEEEEEee--------------
Q 039231          319 YKLGQGGYGSVYKGKLLD----GSNVAVKVLNDSKGN--GKEFINEVASISRTSHVNVVALLGFCL--------------  378 (506)
Q Consensus       319 ~~ig~G~~g~V~~~~~~~----~~~vavK~l~~~~~~--~~~~~~E~~~l~~l~h~niv~l~g~~~--------------  378 (506)
                      +.||+|+||.||+|....    +..+++|+++.....  .+++.+|++.+.+++|+||+++++++.              
T Consensus         1 ~~ig~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~   80 (262)
T cd00192           1 KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEEERKDFLKEARVMKKLGHPNVVRLLGVCTEEEPLYLVLEYMEG   80 (262)
T ss_pred             CccccCCceEEEEEEEecCCCCCceEEeEeeccccchhHHHHHHHHHHHHhhcCCCChheeeeeecCCCceEEEEEeccC
Confidence            369999999999998754    789999999765443  478899999999999999999998761              


Q ss_pred             ----------------------ccchhhhHHHHHHHHHHHHhhcCCCCeEecCcCCCcEEECCCCcEEEeecCCCccccC
Q 039231          379 ----------------------RVAEELSSTIGIARGLEYLHLGCSTRILHFDIKPHNILLDEDFCPKISDFGLAKICNR  436 (506)
Q Consensus       379 ----------------------~~~~~l~i~~~i~~gl~~LH~~~~~~ivH~dlkp~Nill~~~~~~ki~dfg~a~~~~~  436 (506)
                                            ++.+.+.++.|++.||+|||   +++++|+||+|+||++++++.+||+|||.+.....
T Consensus        81 ~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH---~~~i~H~di~p~nili~~~~~~~l~dfg~~~~~~~  157 (262)
T cd00192          81 GDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEYLA---SKKFVHRDLAARNCLVGEDLVVKISDFGLSRDVYD  157 (262)
T ss_pred             CcHHHHHhhccccccccccccCCHHHHHHHHHHHHHHHHHHH---cCCcccCccCcceEEECCCCcEEEccccccccccc
Confidence                                  12235678999999999999   89999999999999999999999999999987765


Q ss_pred             CCcceecccCCCCcccccccccccccCCCCccccHHHHHHHHHHHHc-CCCCCCCCCC
Q 039231          437 KESIISMTGARGTVGYIAPEVFCRNIGEVSYKSDVYNYGMMIFEMTG-GRKNVDVVDN  493 (506)
Q Consensus       437 ~~~~~~~~~~~gt~~y~aPE~l~~~~~~~s~~~Dv~s~G~il~ellt-g~~pf~~~~~  493 (506)
                      ...........++..|+|||.+...  .++.++||||+|+++|||++ |+.||.....
T Consensus       158 ~~~~~~~~~~~~~~~y~aPE~~~~~--~~~~~~Di~slG~il~~l~~~g~~p~~~~~~  213 (262)
T cd00192         158 DDYYRKKTGGKLPIRWMAPESLKDG--IFTSKSDVWSFGVLLWEIFTLGATPYPGLSN  213 (262)
T ss_pred             ccccccccCCCcCccccCHHHhccC--CcchhhccHHHHHHHHHHHhcCCCCCCCCCH
Confidence            4322223445678899999998654  78899999999999999999 6999987643

Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligan

>cd07849 STKc_ERK1_2_like Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases

Probab=99.95  E-value=1.8e-27  Score=238.63  Aligned_cols=172  Identities=29%  Similarity=0.421  Sum_probs=139.0

Q ss_pred             hccccCccCceEEEEEEEc-CCCEEEEEEeccCC--CCchhhHHHHHHhhccCccceeEEEEEe----------------
Q 039231          317 FKYKLGQGGYGSVYKGKLL-DGSNVAVKVLNDSK--GNGKEFINEVASISRTSHVNVVALLGFC----------------  377 (506)
Q Consensus       317 ~~~~ig~G~~g~V~~~~~~-~~~~vavK~l~~~~--~~~~~~~~E~~~l~~l~h~niv~l~g~~----------------  377 (506)
                      +.++||+|++|.||+|+.. +|+.||+|+++...  .....+.+|+.++++++|+||+++++++                
T Consensus         9 i~~~lg~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e   88 (336)
T cd07849           9 NLSYIGEGAYGMVCSATHKPTGVKVAIKKISPFEHQTFCQRTLREIKILRRFKHENIIGILDIIRPPSFESFNDVYIVQE   88 (336)
T ss_pred             EEEEEEecCCeEEEEEEEcCCCCeEEEEEecccccchhHHHHHHHHHHHHhCCCCCcCchhheeecccccccceEEEEeh
Confidence            3567999999999999864 58999999986432  2335688899999999999999998653                


Q ss_pred             --------------eccchhhhHHHHHHHHHHHHhhcCCCCeEecCcCCCcEEECCCCcEEEeecCCCccccCCCcce-e
Q 039231          378 --------------LRVAEELSSTIGIARGLEYLHLGCSTRILHFDIKPHNILLDEDFCPKISDFGLAKICNRKESII-S  442 (506)
Q Consensus       378 --------------~~~~~~l~i~~~i~~gl~~LH~~~~~~ivH~dlkp~Nill~~~~~~ki~dfg~a~~~~~~~~~~-~  442 (506)
                                    +.+.....++.|+++||+|||   +.+|+||||||+||++++++.+||+|||+++......... .
T Consensus        89 ~~~~~l~~~~~~~~l~~~~~~~i~~ql~~aL~~LH---~~~ivH~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~~~~~  165 (336)
T cd07849          89 LMETDLYKLIKTQHLSNDHIQYFLYQILRGLKYIH---SANVLHRDLKPSNLLLNTNCDLKICDFGLARIADPEHDHTGF  165 (336)
T ss_pred             hcccCHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH---hCCeeccCCCHHHEEECCCCCEEECcccceeeccccccccCC
Confidence                          122335668899999999999   8999999999999999999999999999997654332211 1


Q ss_pred             cccCCCCcccccccccccccCCCCccccHHHHHHHHHHHHcCCCCCCCCC
Q 039231          443 MTGARGTVGYIAPEVFCRNIGEVSYKSDVYNYGMMIFEMTGGRKNVDVVD  492 (506)
Q Consensus       443 ~~~~~gt~~y~aPE~l~~~~~~~s~~~Dv~s~G~il~elltg~~pf~~~~  492 (506)
                      .....++..|+|||.+.+. ..++.++||||+|+++|||++|+.||...+
T Consensus       166 ~~~~~~~~~y~aPE~~~~~-~~~~~~~DvwslGvil~el~~G~~~f~~~~  214 (336)
T cd07849         166 LTEYVATRWYRAPEIMLNS-KGYTKAIDIWSVGCILAEMLSNRPLFPGKD  214 (336)
T ss_pred             cCCcCcCCCccChHHhhCC-CCCCcHHHHHHHHHHHHHHHhCCCCCCCCC
Confidence            1235678999999987543 367889999999999999999999997543

Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase

>cd06642 STKc_STK25-YSK1 Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1

Probab=99.95  E-value=3.3e-27  Score=230.03  Aligned_cols=170  Identities=27%  Similarity=0.407  Sum_probs=140.0

Q ss_pred             hccccCccCceEEEEEEEc-CCCEEEEEEeccCC--CCchhhHHHHHHhhccCccceeEEEEEee---------------
Q 039231          317 FKYKLGQGGYGSVYKGKLL-DGSNVAVKVLNDSK--GNGKEFINEVASISRTSHVNVVALLGFCL---------------  378 (506)
Q Consensus       317 ~~~~ig~G~~g~V~~~~~~-~~~~vavK~l~~~~--~~~~~~~~E~~~l~~l~h~niv~l~g~~~---------------  378 (506)
                      ..+.||+|+||.||+|.+. ++..||+|.+....  ...+.+.+|++++++++||||+++++.+.               
T Consensus         8 ~~~~l~~g~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~   87 (277)
T cd06642           8 KLERIGKGSFGEVYKGIDNRTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYITRYYGSYLKGTKLWIIMEYLGGG   87 (277)
T ss_pred             HHHHhcCCCCeeEEEEEEcCCCeEEEEEEeccccchHHHHHHHHHHHHHHcCCCCccHhhhcccccCCceEEEEEccCCC
Confidence            3456999999999999875 47889999987433  23357889999999999999999998762               


Q ss_pred             -----------ccchhhhHHHHHHHHHHHHhhcCCCCeEecCcCCCcEEECCCCcEEEeecCCCccccCCCcceecccCC
Q 039231          379 -----------RVAEELSSTIGIARGLEYLHLGCSTRILHFDIKPHNILLDEDFCPKISDFGLAKICNRKESIISMTGAR  447 (506)
Q Consensus       379 -----------~~~~~l~i~~~i~~gl~~LH~~~~~~ivH~dlkp~Nill~~~~~~ki~dfg~a~~~~~~~~~~~~~~~~  447 (506)
                                 .+.....++.|+++||+|||   +++++|+||+|+||++++++.+||+|||++.........  .....
T Consensus        88 ~L~~~~~~~~~~~~~~~~~~~~i~~~l~~lH---~~~ivH~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~~~--~~~~~  162 (277)
T cd06642          88 SALDLLKPGPLEETYIATILREILKGLDYLH---SERKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIK--RNTFV  162 (277)
T ss_pred             cHHHHhhcCCCCHHHHHHHHHHHHHHHHHHh---cCCeeccCCChheEEEeCCCCEEEccccccccccCcchh--hhccc
Confidence                       23335678899999999999   899999999999999999999999999999766543211  12346


Q ss_pred             CCcccccccccccccCCCCccccHHHHHHHHHHHHcCCCCCCCCCC
Q 039231          448 GTVGYIAPEVFCRNIGEVSYKSDVYNYGMMIFEMTGGRKNVDVVDN  493 (506)
Q Consensus       448 gt~~y~aPE~l~~~~~~~s~~~Dv~s~G~il~elltg~~pf~~~~~  493 (506)
                      ++..|+|||.+.+.  .++.++||||||+++|||++|+.||.....
T Consensus       163 ~~~~y~aPE~~~~~--~~~~~~Dv~slG~il~el~tg~~p~~~~~~  206 (277)
T cd06642         163 GTPFWMAPEVIKQS--AYDFKADIWSLGITAIELAKGEPPNSDLHP  206 (277)
T ss_pred             CcccccCHHHhCcC--CCchhhhHHHHHHHHHHHHhCCCCCcccch
Confidence            78899999998654  678899999999999999999999976543

Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25

>cd05580 STKc_PKA Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase

Probab=99.95  E-value=3.4e-27  Score=231.60  Aligned_cols=167  Identities=31%  Similarity=0.415  Sum_probs=140.5

Q ss_pred             hhccccCccCceEEEEEEEc-CCCEEEEEEeccCC----CCchhhHHHHHHhhccCccceeEEEEEee------------
Q 039231          316 SFKYKLGQGGYGSVYKGKLL-DGSNVAVKVLNDSK----GNGKEFINEVASISRTSHVNVVALLGFCL------------  378 (506)
Q Consensus       316 ~~~~~ig~G~~g~V~~~~~~-~~~~vavK~l~~~~----~~~~~~~~E~~~l~~l~h~niv~l~g~~~------------  378 (506)
                      .+.+.||+|++|.||++... +++.+|+|++....    ...+.+.+|++++++++||||+++++++.            
T Consensus         4 ~~~~~ig~g~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~   83 (290)
T cd05580           4 EFIKTLGTGSFGRVMLVRHKGSGKYYALKILSKAKIVKLKQVEHVLNEKRILQSIRHPFLVNLYGSFQDDSNLYLVMEYV   83 (290)
T ss_pred             EEEEEeecCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCccceeeEEEcCCeEEEEEecC
Confidence            34567999999999999875 48999999986532    23366889999999999999999998762            


Q ss_pred             ---------------ccchhhhHHHHHHHHHHHHhhcCCCCeEecCcCCCcEEECCCCcEEEeecCCCccccCCCcceec
Q 039231          379 ---------------RVAEELSSTIGIARGLEYLHLGCSTRILHFDIKPHNILLDEDFCPKISDFGLAKICNRKESIISM  443 (506)
Q Consensus       379 ---------------~~~~~l~i~~~i~~gl~~LH~~~~~~ivH~dlkp~Nill~~~~~~ki~dfg~a~~~~~~~~~~~~  443 (506)
                                     +....+.++.|++.||+|||   +.+++|+||+|+||++++++.+||+|||+++......     
T Consensus        84 ~~~~L~~~~~~~~~l~~~~~~~~~~qil~~l~~lH---~~~i~H~dl~p~nili~~~~~~kl~dfg~~~~~~~~~-----  155 (290)
T cd05580          84 PGGELFSHLRKSGRFPEPVARFYAAQVVLALEYLH---SLDIVYRDLKPENLLLDSDGYIKITDFGFAKRVKGRT-----  155 (290)
T ss_pred             CCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHH---HCCEecCCCCHHHEEECCCCCEEEeeCCCccccCCCC-----
Confidence                           22335568899999999999   8999999999999999999999999999998765431     


Q ss_pred             ccCCCCcccccccccccccCCCCccccHHHHHHHHHHHHcCCCCCCCCC
Q 039231          444 TGARGTVGYIAPEVFCRNIGEVSYKSDVYNYGMMIFEMTGGRKNVDVVD  492 (506)
Q Consensus       444 ~~~~gt~~y~aPE~l~~~~~~~s~~~Dv~s~G~il~elltg~~pf~~~~  492 (506)
                      ....+++.|+|||.+...  ..+.++||||||+++|||++|+.||...+
T Consensus       156 ~~~~~~~~y~aPE~~~~~--~~~~~~Di~slG~il~~l~~g~~p~~~~~  202 (290)
T cd05580         156 YTLCGTPEYLAPEIILSK--GYGKAVDWWALGILIYEMLAGYPPFFDDN  202 (290)
T ss_pred             CCCCCCccccChhhhcCC--CCCccccHHHHHHHHHHHHhCCCCCCCCC
Confidence            334678999999998553  67889999999999999999999997655

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubi

>cd07852 STKc_MAPK15 Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15

Probab=99.95  E-value=4.3e-27  Score=236.06  Aligned_cols=175  Identities=28%  Similarity=0.385  Sum_probs=141.5

Q ss_pred             hhhccccCccCceEEEEEEEc-CCCEEEEEEeccC---CCCchhhHHHHHHhhcc-CccceeEEEEEee-----------
Q 039231          315 NSFKYKLGQGGYGSVYKGKLL-DGSNVAVKVLNDS---KGNGKEFINEVASISRT-SHVNVVALLGFCL-----------  378 (506)
Q Consensus       315 ~~~~~~ig~G~~g~V~~~~~~-~~~~vavK~l~~~---~~~~~~~~~E~~~l~~l-~h~niv~l~g~~~-----------  378 (506)
                      +.+.+.||+|+||.||+|... +++.+|+|++...   ......+.+|+.+++++ +||||+++++++.           
T Consensus         9 y~~~~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~ni~~~~~~~~~~~~~~~~lv~   88 (337)
T cd07852           9 YEILQKLGKGAYGIVWKAIDRRTKEVVALKKIFDAFRNATDAQRTFREIMFLQELGDHPNIVKLLNVIKAENDKDIYLVF   88 (337)
T ss_pred             HHHhHhhcCCCCeeEEEEEEcCCCeEEEEEeeccccCcchhhhhhhHHHHHHHHhcCCCCccceeeeeccCCCceEEEEe
Confidence            344567999999999999975 5889999988542   22335677899999999 9999999998762           


Q ss_pred             ----------------ccchhhhHHHHHHHHHHHHhhcCCCCeEecCcCCCcEEECCCCcEEEeecCCCccccCCCcc--
Q 039231          379 ----------------RVAEELSSTIGIARGLEYLHLGCSTRILHFDIKPHNILLDEDFCPKISDFGLAKICNRKESI--  440 (506)
Q Consensus       379 ----------------~~~~~l~i~~~i~~gl~~LH~~~~~~ivH~dlkp~Nill~~~~~~ki~dfg~a~~~~~~~~~--  440 (506)
                                      ++...+.++.|++.||+|||   +.+|+|+||||+||++++++.+||+|||+++........  
T Consensus        89 e~~~~~L~~~~~~~~~~~~~~~~i~~qi~~~L~~LH---~~~i~H~dl~p~nill~~~~~~kl~d~g~~~~~~~~~~~~~  165 (337)
T cd07852          89 EYMETDLHAVIRANILEDVHKRYIMYQLLKALKYIH---SGNVIHRDLKPSNILLNSDCRVKLADFGLARSLSELEENPE  165 (337)
T ss_pred             cccccCHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHEEEcCCCcEEEeeccchhcccccccccc
Confidence                            22234568899999999999   899999999999999999999999999999866443321  


Q ss_pred             -eecccCCCCcccccccccccccCCCCccccHHHHHHHHHHHHcCCCCCCCCCC
Q 039231          441 -ISMTGARGTVGYIAPEVFCRNIGEVSYKSDVYNYGMMIFEMTGGRKNVDVVDN  493 (506)
Q Consensus       441 -~~~~~~~gt~~y~aPE~l~~~~~~~s~~~Dv~s~G~il~elltg~~pf~~~~~  493 (506)
                       .......++..|+|||.+.+. ..++.++||||||+++|||++|+.||.....
T Consensus       166 ~~~~~~~~~~~~y~aPE~~~~~-~~~~~~sDi~slG~~l~el~tg~~pf~~~~~  218 (337)
T cd07852         166 NPVLTDYVATRWYRAPEILLGS-TRYTKGVDMWSVGCILGEMLLGKPLFPGTST  218 (337)
T ss_pred             CcchhcccccccccCceeeecc-ccccccchHHHHHHHHHHHHhCCCCCCCCCh
Confidence             122335678999999988553 4678899999999999999999999976543

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimul

>cd05051 PTKc_DDR Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors

Probab=99.95  E-value=3.2e-27  Score=232.32  Aligned_cols=173  Identities=28%  Similarity=0.432  Sum_probs=138.9

Q ss_pred             hhccccCccCceEEEEEEEcC-----------------CCEEEEEEeccCCC--CchhhHHHHHHhhccCccceeEEEEE
Q 039231          316 SFKYKLGQGGYGSVYKGKLLD-----------------GSNVAVKVLNDSKG--NGKEFINEVASISRTSHVNVVALLGF  376 (506)
Q Consensus       316 ~~~~~ig~G~~g~V~~~~~~~-----------------~~~vavK~l~~~~~--~~~~~~~E~~~l~~l~h~niv~l~g~  376 (506)
                      .+.++||+|+||.||+|+..+                 +..||+|++.....  ..+++.+|++++++++||||++++++
T Consensus         8 ~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~   87 (296)
T cd05051           8 NFVEKLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDASDNAREDFLKEVKILSRLSDPNIARLLGV   87 (296)
T ss_pred             cccccccCCCCccEEEEEeccCCcccccccccccccCCceeEEEEEecCccCHHHHHHHHHHHHHHHhcCCCCEeEEEEE
Confidence            445789999999999997643                 24689999875432  34678899999999999999999987


Q ss_pred             eec--------------------------------------cchhhhHHHHHHHHHHHHhhcCCCCeEecCcCCCcEEEC
Q 039231          377 CLR--------------------------------------VAEELSSTIGIARGLEYLHLGCSTRILHFDIKPHNILLD  418 (506)
Q Consensus       377 ~~~--------------------------------------~~~~l~i~~~i~~gl~~LH~~~~~~ivH~dlkp~Nill~  418 (506)
                      +..                                      +...+.++.|++.||+|||   +.+++|+||||+||+++
T Consensus        88 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~LH---~~~i~H~dlkp~Nili~  164 (296)
T cd05051          88 CTVDPPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSLSFSTLLYMATQIASGMRYLE---SLNFVHRDLATRNCLVG  164 (296)
T ss_pred             EecCCCcEEEEecCCCCCHHHHHHhcccccccccccCCCCCHHHHHHHHHHHHHHHHHHH---HcCccccccchhceeec
Confidence            611                                      1224668899999999999   89999999999999999


Q ss_pred             CCCcEEEeecCCCccccCCCcceecccCCCCcccccccccccccCCCCccccHHHHHHHHHHHHc--CCCCCCCCCC
Q 039231          419 EDFCPKISDFGLAKICNRKESIISMTGARGTVGYIAPEVFCRNIGEVSYKSDVYNYGMMIFEMTG--GRKNVDVVDN  493 (506)
Q Consensus       419 ~~~~~ki~dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~s~~~Dv~s~G~il~ellt--g~~pf~~~~~  493 (506)
                      +++.++|+|||+++...............+++.|+|||.+.+.  .++.++||||||+++|||++  +..||.....
T Consensus       165 ~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~--~~~~~~Dv~slG~~l~el~~~~~~~p~~~~~~  239 (296)
T cd05051         165 KNYTIKIADFGMSRNLYSSDYYRVQGRAPLPIRWMAWESVLLG--KFTTKSDVWAFGVTLWEILTLCREQPYEHLTD  239 (296)
T ss_pred             CCCceEEccccceeecccCcceeecCcCCCCceecCHHHhhcC--CCCccchhhhhHHHHHHHHhcCCCCCCCCcCh
Confidence            9999999999999765443322222345567899999998553  68899999999999999998  7888876543

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linke

>cd05098 PTKc_FGFR1 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1

Probab=99.95  E-value=3e-27  Score=234.05  Aligned_cols=176  Identities=30%  Similarity=0.489  Sum_probs=138.2

Q ss_pred             HHHhhhccccCccCceEEEEEEEcC--------CCEEEEEEeccCCC--CchhhHHHHHHhhcc-CccceeEEEEEee--
Q 039231          312 KMTNSFKYKLGQGGYGSVYKGKLLD--------GSNVAVKVLNDSKG--NGKEFINEVASISRT-SHVNVVALLGFCL--  378 (506)
Q Consensus       312 ~~~~~~~~~ig~G~~g~V~~~~~~~--------~~~vavK~l~~~~~--~~~~~~~E~~~l~~l-~h~niv~l~g~~~--  378 (506)
                      ...+.+.+.||+|+||.||+|+...        ...+|+|.++....  ...++.+|++++.++ +||||+++++++.  
T Consensus        17 ~~~~~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~   96 (307)
T cd05098          17 RDRLVLGKPLGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQD   96 (307)
T ss_pred             hHHeEEeeeeccCCCeeEEEeEEeccCCcccCccceEEEEeccCCCChHHHHHHHHHHHHHHHhcCCCCEeeEEEEEecC
Confidence            3445667889999999999997522        35699999975432  235688899999999 7999999998751  


Q ss_pred             -----------------------------------------ccchhhhHHHHHHHHHHHHhhcCCCCeEecCcCCCcEEE
Q 039231          379 -----------------------------------------RVAEELSSTIGIARGLEYLHLGCSTRILHFDIKPHNILL  417 (506)
Q Consensus       379 -----------------------------------------~~~~~l~i~~~i~~gl~~LH~~~~~~ivH~dlkp~Nill  417 (506)
                                                               .+.+.+.++.|++.||+|||   +.+++||||||+||++
T Consensus        97 ~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH---~~gi~H~dlkp~Nill  173 (307)
T cd05098          97 GPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSCAYQVARGMEYLA---SKKCIHRDLAARNVLV  173 (307)
T ss_pred             CceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHH---HCCcccccccHHheEE
Confidence                                                     11224568999999999999   8999999999999999


Q ss_pred             CCCCcEEEeecCCCccccCCCcceecccCCCCcccccccccccccCCCCccccHHHHHHHHHHHHc-CCCCCCCCC
Q 039231          418 DEDFCPKISDFGLAKICNRKESIISMTGARGTVGYIAPEVFCRNIGEVSYKSDVYNYGMMIFEMTG-GRKNVDVVD  492 (506)
Q Consensus       418 ~~~~~~ki~dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~s~~~Dv~s~G~il~ellt-g~~pf~~~~  492 (506)
                      +.++.+||+|||.++...............+++.|+|||.+.+.  .++.++||||||+++|||++ |+.||....
T Consensus       174 ~~~~~~kL~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~--~~~~~~DvwslG~~l~el~~~g~~p~~~~~  247 (307)
T cd05098         174 TEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDR--IYTHQSDVWSFGVLLWEIFTLGGSPYPGVP  247 (307)
T ss_pred             cCCCcEEECCCcccccccccchhhccccCCCccceeChHHhccC--CCCcHHHHHHHHHHHHHHHcCCCCCCCcCC
Confidence            99999999999998765432221111223345789999998553  68899999999999999998 889987544

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>cd07850 STKc_JNK Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase

Probab=99.95  E-value=3.8e-27  Score=237.99  Aligned_cols=168  Identities=29%  Similarity=0.340  Sum_probs=139.4

Q ss_pred             ccccCccCceEEEEEEEc-CCCEEEEEEeccCC---CCchhhHHHHHHhhccCccceeEEEEEee---------------
Q 039231          318 KYKLGQGGYGSVYKGKLL-DGSNVAVKVLNDSK---GNGKEFINEVASISRTSHVNVVALLGFCL---------------  378 (506)
Q Consensus       318 ~~~ig~G~~g~V~~~~~~-~~~~vavK~l~~~~---~~~~~~~~E~~~l~~l~h~niv~l~g~~~---------------  378 (506)
                      .+.||+|+||.||+|+.. +++.||+|++....   ...+++.+|++++++++|+||+++++++.               
T Consensus        21 ~~~lg~g~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~lv~  100 (353)
T cd07850          21 LKPIGSGAQGIVCAAYDTVTGQNVAIKKLSRPFQNVTHAKRAYRELVLMKLVNHKNIIGLLNVFTPQKSLEEFQDVYLVM  100 (353)
T ss_pred             EEEeccCCCEEEEEEEECCCCCEEEEEecCccccChhHHHHHHHHHHHHHhcCCCCCcceeeeeccCCCccccCcEEEEE
Confidence            467999999999999875 58999999986532   22356778999999999999999987652               


Q ss_pred             ---------------ccchhhhHHHHHHHHHHHHhhcCCCCeEecCcCCCcEEECCCCcEEEeecCCCccccCCCcceec
Q 039231          379 ---------------RVAEELSSTIGIARGLEYLHLGCSTRILHFDIKPHNILLDEDFCPKISDFGLAKICNRKESIISM  443 (506)
Q Consensus       379 ---------------~~~~~l~i~~~i~~gl~~LH~~~~~~ivH~dlkp~Nill~~~~~~ki~dfg~a~~~~~~~~~~~~  443 (506)
                                     +..+...++.|++.||+|||   +++++||||||+||++++++.+||+|||+++.......   .
T Consensus       101 e~~~~~l~~~~~~~l~~~~~~~~~~ql~~aL~~LH---~~gi~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~~~~---~  174 (353)
T cd07850         101 ELMDANLCQVIQMDLDHERMSYLLYQMLCGIKHLH---SAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFM---M  174 (353)
T ss_pred             eccCCCHHHHHhhcCCHHHHHHHHHHHHHHHHHHH---hCCeeeCCCCHHHEEECCCCCEEEccCccceeCCCCCC---C
Confidence                           22234557899999999999   89999999999999999999999999999986644322   2


Q ss_pred             ccCCCCcccccccccccccCCCCccccHHHHHHHHHHHHcCCCCCCCCCC
Q 039231          444 TGARGTVGYIAPEVFCRNIGEVSYKSDVYNYGMMIFEMTGGRKNVDVVDN  493 (506)
Q Consensus       444 ~~~~gt~~y~aPE~l~~~~~~~s~~~Dv~s~G~il~elltg~~pf~~~~~  493 (506)
                      ....++..|+|||.+.+.  .++.++||||||+++|+|++|+.||...+.
T Consensus       175 ~~~~~~~~y~aPE~~~~~--~~~~~~DvwslG~~l~~l~~g~~pf~~~~~  222 (353)
T cd07850         175 TPYVVTRYYRAPEVILGM--GYKENVDIWSVGCIMGEMIRGTVLFPGTDH  222 (353)
T ss_pred             CCCcccccccCHHHHhCC--CCCCchhhHhHHHHHHHHHHCCCCCCCCCH
Confidence            335678899999998654  688999999999999999999999976543

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK

>cd07879 STKc_p38delta_MAPK13 Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase

Probab=99.95  E-value=4.5e-27  Score=236.42  Aligned_cols=166  Identities=31%  Similarity=0.399  Sum_probs=137.0

Q ss_pred             ccccCccCceEEEEEEEc-CCCEEEEEEeccCC---CCchhhHHHHHHhhccCccceeEEEEEee---------------
Q 039231          318 KYKLGQGGYGSVYKGKLL-DGSNVAVKVLNDSK---GNGKEFINEVASISRTSHVNVVALLGFCL---------------  378 (506)
Q Consensus       318 ~~~ig~G~~g~V~~~~~~-~~~~vavK~l~~~~---~~~~~~~~E~~~l~~l~h~niv~l~g~~~---------------  378 (506)
                      .+.||+|++|.||+|+.. +++.||+|+++...   .....+.+|++++++++||||+++++++.               
T Consensus        20 ~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~~lv~   99 (342)
T cd07879          20 LKQVGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQSEIFAKRAYRELTLLKHMQHENVIGLLDVFTSAVSGDEFQDFYLVM   99 (342)
T ss_pred             EEEeeecCCeEEEEEEeCCCCcEEEEEEecCccccccchhHHHHHHHHHHhcCCCCccchhheecccccCCCCceEEEEe
Confidence            357999999999999864 58999999986532   22356889999999999999999987652               


Q ss_pred             ---------------ccchhhhHHHHHHHHHHHHhhcCCCCeEecCcCCCcEEECCCCcEEEeecCCCccccCCCcceec
Q 039231          379 ---------------RVAEELSSTIGIARGLEYLHLGCSTRILHFDIKPHNILLDEDFCPKISDFGLAKICNRKESIISM  443 (506)
Q Consensus       379 ---------------~~~~~l~i~~~i~~gl~~LH~~~~~~ivH~dlkp~Nill~~~~~~ki~dfg~a~~~~~~~~~~~~  443 (506)
                                     .+.....++.|++.||+|||   +.+++||||||+||+++.++.+||+|||+++......     
T Consensus       100 e~~~~~l~~~~~~~~~~~~~~~~~~qi~~aL~~LH---~~~i~H~dlkp~NIll~~~~~~kL~dfg~~~~~~~~~-----  171 (342)
T cd07879         100 PYMQTDLQKIMGHPLSEDKVQYLVYQMLCGLKYIH---SAGIIHRDLKPGNLAVNEDCELKILDFGLARHADAEM-----  171 (342)
T ss_pred             cccccCHHHHHcCCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCHHHEEECCCCCEEEeeCCCCcCCCCCC-----
Confidence                           12224558889999999999   8999999999999999999999999999987653321     


Q ss_pred             ccCCCCcccccccccccccCCCCccccHHHHHHHHHHHHcCCCCCCCCC
Q 039231          444 TGARGTVGYIAPEVFCRNIGEVSYKSDVYNYGMMIFEMTGGRKNVDVVD  492 (506)
Q Consensus       444 ~~~~gt~~y~aPE~l~~~~~~~s~~~Dv~s~G~il~elltg~~pf~~~~  492 (506)
                      ....++..|+|||.+.+. ..++.++||||||+++|||++|+.||...+
T Consensus       172 ~~~~~~~~y~aPE~~~~~-~~~~~~~Dv~slGvil~el~~g~~pf~~~~  219 (342)
T cd07879         172 TGYVVTRWYRAPEVILNW-MHYNQTVDIWSVGCIMAEMLTGKTLFKGKD  219 (342)
T ss_pred             CCceeeecccChhhhcCc-cccCchHHHHHHHHHHHHHHhCCCCCCCCC
Confidence            334568889999998542 357889999999999999999999998654

Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13

>cd06659 STKc_PAK6 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6

Probab=99.95  E-value=2.1e-27  Score=234.06  Aligned_cols=166  Identities=30%  Similarity=0.417  Sum_probs=138.9

Q ss_pred             ccCccCceEEEEEEEc-CCCEEEEEEeccCC-CCchhhHHHHHHhhccCccceeEEEEEe--------------------
Q 039231          320 KLGQGGYGSVYKGKLL-DGSNVAVKVLNDSK-GNGKEFINEVASISRTSHVNVVALLGFC--------------------  377 (506)
Q Consensus       320 ~ig~G~~g~V~~~~~~-~~~~vavK~l~~~~-~~~~~~~~E~~~l~~l~h~niv~l~g~~--------------------  377 (506)
                      +||+|+||.||+|... +++.||+|.+.... ...+.+.+|+..+..++||||+++++++                    
T Consensus        28 ~ig~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~iv~e~~~~~~L~~  107 (297)
T cd06659          28 KIGEGSTGIVCIAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHQNVVEMYKSYLVGEELWVLMEFLQGGALTD  107 (297)
T ss_pred             hcCCCCceeEEEEEEcCCCCEEEEEEEEecccchHHHHHHHHHHHHhCCCCchhhhhhheeeCCeEEEEEecCCCCCHHH
Confidence            5999999999999875 58999999986433 3346788999999999999999998865                    


Q ss_pred             ------eccchhhhHHHHHHHHHHHHhhcCCCCeEecCcCCCcEEECCCCcEEEeecCCCccccCCCcceecccCCCCcc
Q 039231          378 ------LRVAEELSSTIGIARGLEYLHLGCSTRILHFDIKPHNILLDEDFCPKISDFGLAKICNRKESIISMTGARGTVG  451 (506)
Q Consensus       378 ------~~~~~~l~i~~~i~~gl~~LH~~~~~~ivH~dlkp~Nill~~~~~~ki~dfg~a~~~~~~~~~~~~~~~~gt~~  451 (506)
                            +++...+.++.|++.||+|||   +.+++|+||+|+||++++++.+||+|||++.........  .....++..
T Consensus       108 ~~~~~~~~~~~~~~~~~qi~~~L~~LH---~~~ivH~dl~p~Nill~~~~~~kL~dfg~~~~~~~~~~~--~~~~~~~~~  182 (297)
T cd06659         108 IVSQTRLNEEQIATVCESVLQALCYLH---SQGVIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVPK--RKSLVGTPY  182 (297)
T ss_pred             HHhhcCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHeEEccCCcEEEeechhHhhccccccc--ccceecCcc
Confidence                  223346678999999999999   899999999999999999999999999998765433221  134568899


Q ss_pred             cccccccccccCCCCccccHHHHHHHHHHHHcCCCCCCCCC
Q 039231          452 YIAPEVFCRNIGEVSYKSDVYNYGMMIFEMTGGRKNVDVVD  492 (506)
Q Consensus       452 y~aPE~l~~~~~~~s~~~Dv~s~G~il~elltg~~pf~~~~  492 (506)
                      |+|||.+.+.  .++.++||||||+++|||++|+.||...+
T Consensus       183 y~aPE~~~~~--~~~~~~Dv~slG~il~el~~g~~p~~~~~  221 (297)
T cd06659         183 WMAPEVISRT--PYGTEVDIWSLGIMVIEMVDGEPPYFSDS  221 (297)
T ss_pred             ccCHHHHccC--CCCchhhHHHHHHHHHHHHhCCCCCCCCC
Confidence            9999998654  67899999999999999999999997554

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role i

>cd07843 STKc_CDC2L1 Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1

Probab=99.95  E-value=7.1e-27  Score=229.63  Aligned_cols=171  Identities=26%  Similarity=0.319  Sum_probs=140.2

Q ss_pred             hccccCccCceEEEEEEEc-CCCEEEEEEeccCCC---CchhhHHHHHHhhccCccceeEEEEEeec-------------
Q 039231          317 FKYKLGQGGYGSVYKGKLL-DGSNVAVKVLNDSKG---NGKEFINEVASISRTSHVNVVALLGFCLR-------------  379 (506)
Q Consensus       317 ~~~~ig~G~~g~V~~~~~~-~~~~vavK~l~~~~~---~~~~~~~E~~~l~~l~h~niv~l~g~~~~-------------  379 (506)
                      +.+.||+|++|.||+|..+ +++.+++|.++....   ....+.+|++++++++||||+++++++..             
T Consensus         9 ~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~~~lv~e~~   88 (293)
T cd07843           9 KLNRIEEGTYGVVYRARDKKTGEIVALKKLKMEKEKEGFPITSLREINILLKLQHPNIVTVKEVVVGSNLDKIYMVMEYV   88 (293)
T ss_pred             hhhhhcCCCCeEEEEEEECCCCcEEEEEEEeeccccccchhhHHHHHHHHHhcCCCCEEEEEEEEEecCCCcEEEEehhc
Confidence            3467999999999999986 488999999975332   22456789999999999999999887632             


Q ss_pred             ----------------cchhhhHHHHHHHHHHHHhhcCCCCeEecCcCCCcEEECCCCcEEEeecCCCccccCCCcceec
Q 039231          380 ----------------VAEELSSTIGIARGLEYLHLGCSTRILHFDIKPHNILLDEDFCPKISDFGLAKICNRKESIISM  443 (506)
Q Consensus       380 ----------------~~~~l~i~~~i~~gl~~LH~~~~~~ivH~dlkp~Nill~~~~~~ki~dfg~a~~~~~~~~~~~~  443 (506)
                                      +.+.+.++.|++.||+|||   +.+++|+||||+||++++++.+||+|||+++........  .
T Consensus        89 ~~~L~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH---~~~i~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~~--~  163 (293)
T cd07843          89 EHDLKSLMETMKQPFLQSEVKCLMLQLLSGVAHLH---DNWILHRDLKTSNLLLNNRGILKICDFGLAREYGSPLKP--Y  163 (293)
T ss_pred             CcCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHH---HCCeeeccCCHHHEEECCCCcEEEeecCceeeccCCccc--c
Confidence                            2235678999999999999   899999999999999999999999999999876543211  1


Q ss_pred             ccCCCCcccccccccccccCCCCccccHHHHHHHHHHHHcCCCCCCCCCC
Q 039231          444 TGARGTVGYIAPEVFCRNIGEVSYKSDVYNYGMMIFEMTGGRKNVDVVDN  493 (506)
Q Consensus       444 ~~~~gt~~y~aPE~l~~~~~~~s~~~Dv~s~G~il~elltg~~pf~~~~~  493 (506)
                      ....+++.|+|||.+.+. ..++.++|+||||+++|||++|+.||.....
T Consensus       164 ~~~~~~~~~~aPE~~~~~-~~~~~~~Di~slG~~l~~l~~g~~~f~~~~~  212 (293)
T cd07843         164 TQLVVTLWYRAPELLLGA-KEYSTAIDMWSVGCIFAELLTKKPLFPGKSE  212 (293)
T ss_pred             ccccccccccCchhhcCC-ccccchhhHHHHHHHHHHHHhCCCCCCCCCh
Confidence            335578899999998543 3468899999999999999999999986544

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the

>cd06653 STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

Probab=99.95  E-value=3.9e-27  Score=227.86  Aligned_cols=171  Identities=26%  Similarity=0.313  Sum_probs=138.1

Q ss_pred             hccccCccCceEEEEEEEc-CCCEEEEEEeccCC------CCchhhHHHHHHhhccCccceeEEEEEeec----------
Q 039231          317 FKYKLGQGGYGSVYKGKLL-DGSNVAVKVLNDSK------GNGKEFINEVASISRTSHVNVVALLGFCLR----------  379 (506)
Q Consensus       317 ~~~~ig~G~~g~V~~~~~~-~~~~vavK~l~~~~------~~~~~~~~E~~~l~~l~h~niv~l~g~~~~----------  379 (506)
                      +.+.||+|++|.||+|+.. ++..+|+|++....      ...+.+.+|++++++++|+||+++++++.+          
T Consensus         6 ~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~v~   85 (264)
T cd06653           6 LGKLLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRHDRIVQYYGCLRDPEEKKLSIFV   85 (264)
T ss_pred             eeeeEccCCCeEEEEEEEcCCCCEEEEEEEecCcccchhhHHHHHHHHHHHHHHHcCCCCcceEEEEEEcCCCCEEEEEE
Confidence            4568999999999999874 58999999875321      122568889999999999999999987522          


Q ss_pred             -------------------cchhhhHHHHHHHHHHHHhhcCCCCeEecCcCCCcEEECCCCcEEEeecCCCccccCCCc-
Q 039231          380 -------------------VAEELSSTIGIARGLEYLHLGCSTRILHFDIKPHNILLDEDFCPKISDFGLAKICNRKES-  439 (506)
Q Consensus       380 -------------------~~~~l~i~~~i~~gl~~LH~~~~~~ivH~dlkp~Nill~~~~~~ki~dfg~a~~~~~~~~-  439 (506)
                                         +...+.++.|++.||.|||   +.+++|+||||+||+++.++.++|+|||+++....... 
T Consensus        86 e~~~~~~L~~~~~~~~~l~~~~~~~~~~~i~~al~~LH---~~~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~~~  162 (264)
T cd06653          86 EYMPGGSIKDQLKAYGALTENVTRRYTRQILQGVSYLH---SNMIVHRDIKGANILRDSAGNVKLGDFGASKRIQTICMS  162 (264)
T ss_pred             EeCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHH---hCCEecCCCCHHHEEEcCCCCEEECcccccccccccccc
Confidence                               1224568889999999999   89999999999999999999999999999986532111 


Q ss_pred             ceecccCCCCcccccccccccccCCCCccccHHHHHHHHHHHHcCCCCCCCCC
Q 039231          440 IISMTGARGTVGYIAPEVFCRNIGEVSYKSDVYNYGMMIFEMTGGRKNVDVVD  492 (506)
Q Consensus       440 ~~~~~~~~gt~~y~aPE~l~~~~~~~s~~~Dv~s~G~il~elltg~~pf~~~~  492 (506)
                      ........++..|+|||.+.+.  .++.++|+||||+++|||++|+.||....
T Consensus       163 ~~~~~~~~~~~~y~aPE~~~~~--~~~~~~Di~slG~il~~l~~g~~p~~~~~  213 (264)
T cd06653         163 GTGIKSVTGTPYWMSPEVISGE--GYGRKADVWSVACTVVEMLTEKPPWAEYE  213 (264)
T ss_pred             CccccccCCcccccCHhhhcCC--CCCccccHHHHHHHHHHHHhCCCCCCccC
Confidence            0111235678999999998654  67889999999999999999999997654

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phospho

>cd05061 PTKc_InsR Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor

Probab=99.95  E-value=4.5e-27  Score=230.54  Aligned_cols=175  Identities=29%  Similarity=0.497  Sum_probs=137.8

Q ss_pred             HhhhccccCccCceEEEEEEEcC------CCEEEEEEeccCCCC--chhhHHHHHHhhccCccceeEEEEEeec------
Q 039231          314 TNSFKYKLGQGGYGSVYKGKLLD------GSNVAVKVLNDSKGN--GKEFINEVASISRTSHVNVVALLGFCLR------  379 (506)
Q Consensus       314 ~~~~~~~ig~G~~g~V~~~~~~~------~~~vavK~l~~~~~~--~~~~~~E~~~l~~l~h~niv~l~g~~~~------  379 (506)
                      .+.+.++||+|+||.||+|..++      +..||+|.++.....  ..++.+|+..+++++||||+++++++.+      
T Consensus         7 ~~~i~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l   86 (288)
T cd05061           7 KITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVRLLGVVSKGQPTLV   86 (288)
T ss_pred             HceeeeeecCCCCcEEEEEEEeccCCCCcceEEEEEECCCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCcEE
Confidence            34456789999999999997542      458999988654322  2467889999999999999999987610      


Q ss_pred             -------------------------------cchhhhHHHHHHHHHHHHhhcCCCCeEecCcCCCcEEECCCCcEEEeec
Q 039231          380 -------------------------------VAEELSSTIGIARGLEYLHLGCSTRILHFDIKPHNILLDEDFCPKISDF  428 (506)
Q Consensus       380 -------------------------------~~~~l~i~~~i~~gl~~LH~~~~~~ivH~dlkp~Nill~~~~~~ki~df  428 (506)
                                                     ....+.++.|++.||.|||   +++++||||||+||++++++.+||+||
T Consensus        87 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH---~~~i~H~dikp~nili~~~~~~~L~Df  163 (288)
T cd05061          87 VMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMAYLN---AKKFVHRDLAARNCMVAHDFTVKIGDF  163 (288)
T ss_pred             EEeCCCCCCHHHHHHHhccccccCCCCCCCCHHHHHHHHHHHHHHHHHHH---hCCCcCCCCChheEEEcCCCcEEECcC
Confidence                                           1123568889999999999   899999999999999999999999999


Q ss_pred             CCCccccCCCcceecccCCCCcccccccccccccCCCCccccHHHHHHHHHHHHc-CCCCCCCCCC
Q 039231          429 GLAKICNRKESIISMTGARGTVGYIAPEVFCRNIGEVSYKSDVYNYGMMIFEMTG-GRKNVDVVDN  493 (506)
Q Consensus       429 g~a~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~s~~~Dv~s~G~il~ellt-g~~pf~~~~~  493 (506)
                      |+++...............++..|+|||.+.+  +.++.++||||||+++|||++ |..||...+.
T Consensus       164 g~~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~--~~~~~~~DvwslG~~l~el~~~~~~p~~~~~~  227 (288)
T cd05061         164 GMTRDIYETDYYRKGGKGLLPVRWMAPESLKD--GVFTTSSDMWSFGVVLWEITSLAEQPYQGLSN  227 (288)
T ss_pred             CccccccccccccccCCCcccccccCHHHhcc--CCCChHhHHHHHHHHHHHHHhCCCCCCCCCCH
Confidence            99986544332221222345678999999854  368899999999999999998 7889976543

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein meta

>cd05039 PTKc_Csk_like Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases

Probab=99.95  E-value=4.1e-27  Score=226.50  Aligned_cols=168  Identities=32%  Similarity=0.592  Sum_probs=141.1

Q ss_pred             hhhccccCccCceEEEEEEEcCCCEEEEEEeccCCCCchhhHHHHHHhhccCccceeEEEEEee----------------
Q 039231          315 NSFKYKLGQGGYGSVYKGKLLDGSNVAVKVLNDSKGNGKEFINEVASISRTSHVNVVALLGFCL----------------  378 (506)
Q Consensus       315 ~~~~~~ig~G~~g~V~~~~~~~~~~vavK~l~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~----------------  378 (506)
                      ..+.+.||+|++|.||+|.. .|+.||+|.++......+++.+|+.++++++|+||+++++++.                
T Consensus         8 ~~~~~~ig~g~~g~v~~~~~-~~~~v~iK~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~~~   86 (256)
T cd05039           8 LKLGATIGKGEFGDVMLGDY-RGQKVAVKCLKDDSTAAQAFLAEASVMTTLRHPNLVQLLGVVLQGNPLYIVTEYMAKGS   86 (256)
T ss_pred             ccceeeeecCCCceEEEEEe-cCcEEEEEEeccchhHHHHHHHHHHHHHhcCCcceeeeEEEEcCCCCeEEEEEecCCCc
Confidence            34567899999999999987 4789999999876555678999999999999999999998862                


Q ss_pred             -------------ccchhhhHHHHHHHHHHHHhhcCCCCeEecCcCCCcEEECCCCcEEEeecCCCccccCCCcceeccc
Q 039231          379 -------------RVAEELSSTIGIARGLEYLHLGCSTRILHFDIKPHNILLDEDFCPKISDFGLAKICNRKESIISMTG  445 (506)
Q Consensus       379 -------------~~~~~l~i~~~i~~gl~~LH~~~~~~ivH~dlkp~Nill~~~~~~ki~dfg~a~~~~~~~~~~~~~~  445 (506)
                                   .+...+.++.|++.||.|||   +.+++|+||||+||+++.++.+||+|||.++......     ..
T Consensus        87 L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh---~~~i~H~di~p~Nili~~~~~~~l~d~g~~~~~~~~~-----~~  158 (256)
T cd05039          87 LVDYLRSRGRAVITLAQQLGFALDVCEGMEYLE---EKNFVHRDLAARNVLVSEDLVAKVSDFGLAKEASQGQ-----DS  158 (256)
T ss_pred             HHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHH---hCCccchhcccceEEEeCCCCEEEccccccccccccc-----cc
Confidence                         22235678899999999999   9999999999999999999999999999998763322     12


Q ss_pred             CCCCcccccccccccccCCCCccccHHHHHHHHHHHHc-CCCCCCCCCC
Q 039231          446 ARGTVGYIAPEVFCRNIGEVSYKSDVYNYGMMIFEMTG-GRKNVDVVDN  493 (506)
Q Consensus       446 ~~gt~~y~aPE~l~~~~~~~s~~~Dv~s~G~il~ellt-g~~pf~~~~~  493 (506)
                      ...+..|+|||.+..  +.++.++||||||+++|||++ |+.||.....
T Consensus       159 ~~~~~~~~ape~~~~--~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~  205 (256)
T cd05039         159 GKLPVKWTAPEALRE--KKFSTKSDVWSFGILLWEIYSFGRVPYPRIPL  205 (256)
T ss_pred             CCCcccccCchhhcC--CcCCcHHHHHHHHHHHHHHHhcCCCCCCCCCH
Confidence            344678999999854  368889999999999999997 9999976543

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk

>cd05053 PTKc_FGFR Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors

Probab=99.95  E-value=2.6e-27  Score=232.67  Aligned_cols=173  Identities=30%  Similarity=0.527  Sum_probs=137.9

Q ss_pred             hhccccCccCceEEEEEEEcC------CCEEEEEEeccCCC--CchhhHHHHHHhhcc-CccceeEEEEEeec-------
Q 039231          316 SFKYKLGQGGYGSVYKGKLLD------GSNVAVKVLNDSKG--NGKEFINEVASISRT-SHVNVVALLGFCLR-------  379 (506)
Q Consensus       316 ~~~~~ig~G~~g~V~~~~~~~------~~~vavK~l~~~~~--~~~~~~~E~~~l~~l-~h~niv~l~g~~~~-------  379 (506)
                      .+.+.||+|++|.||++...+      ...+|+|++.....  ...++.+|++++.++ +|+||+++++++..       
T Consensus        15 ~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~li   94 (293)
T cd05053          15 TLGKPLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGVCTQEGPLYVV   94 (293)
T ss_pred             EEeeEecccccccEEEEEEecCCCCCCceeEEEEEccCCCCHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEcCCCCeEEE
Confidence            345679999999999998642      36799999875432  225688999999999 79999999987511       


Q ss_pred             ------------------------------------cchhhhHHHHHHHHHHHHhhcCCCCeEecCcCCCcEEECCCCcE
Q 039231          380 ------------------------------------VAEELSSTIGIARGLEYLHLGCSTRILHFDIKPHNILLDEDFCP  423 (506)
Q Consensus       380 ------------------------------------~~~~l~i~~~i~~gl~~LH~~~~~~ivH~dlkp~Nill~~~~~~  423 (506)
                                                          +...+.++.|++.||+|||   +.+|+||||||+||++++++.+
T Consensus        95 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH---~~~ivH~dlkp~Nil~~~~~~~  171 (293)
T cd05053          95 VEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSFAYQVARGMEFLA---SKKCIHRDLAARNVLVTEDHVM  171 (293)
T ss_pred             EEeCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHH---HCCccccccceeeEEEcCCCeE
Confidence                                                1123568999999999999   8999999999999999999999


Q ss_pred             EEeecCCCccccCCCcceecccCCCCcccccccccccccCCCCccccHHHHHHHHHHHHc-CCCCCCCCCC
Q 039231          424 KISDFGLAKICNRKESIISMTGARGTVGYIAPEVFCRNIGEVSYKSDVYNYGMMIFEMTG-GRKNVDVVDN  493 (506)
Q Consensus       424 ki~dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~s~~~Dv~s~G~il~ellt-g~~pf~~~~~  493 (506)
                      ||+|||+++...............++..|+|||.+.+.  .++.++||||||+++|||++ |..||.....
T Consensus       172 kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~--~~~~~~Di~slG~il~el~~~g~~p~~~~~~  240 (293)
T cd05053         172 KIADFGLARDIHHIDYYRKTTNGRLPVKWMAPEALFDR--VYTHQSDVWSFGVLLWEIFTLGGSPYPGIPV  240 (293)
T ss_pred             EeCccccccccccccceeccCCCCCCccccCHHHhccC--CcCcccceeehhhHHHHHhcCCCCCCCCCCH
Confidence            99999999876543322222334456789999987543  68899999999999999997 9999976543

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation,

>cd05044 PTKc_c-ros Catalytic domain of the Protein Tyrosine Kinase, C-ros

Probab=99.95  E-value=2.2e-27  Score=230.00  Aligned_cols=169  Identities=33%  Similarity=0.562  Sum_probs=136.1

Q ss_pred             ccCccCceEEEEEEEcC-------CCEEEEEEeccCC--CCchhhHHHHHHhhccCccceeEEEEEee------------
Q 039231          320 KLGQGGYGSVYKGKLLD-------GSNVAVKVLNDSK--GNGKEFINEVASISRTSHVNVVALLGFCL------------  378 (506)
Q Consensus       320 ~ig~G~~g~V~~~~~~~-------~~~vavK~l~~~~--~~~~~~~~E~~~l~~l~h~niv~l~g~~~------------  378 (506)
                      .||+|+||.||+|+..+       +..+|||.+....  ....++.+|++++++++||||+++++++.            
T Consensus         2 ~lg~g~~g~vy~~~~~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~   81 (269)
T cd05044           2 FLGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATDQEKKEFLKEAHLMSNFNHPNIVKLLGVCLLNEPQYIIMELM   81 (269)
T ss_pred             ccccccceeEEeeeecccccCcccceeehhhhhhcccchhhHHHHHHHHHHHHhcCCCCeeeEeeeecCCCCeEEEEecc
Confidence            58999999999998643       2579999886543  34467889999999999999999998761            


Q ss_pred             ----------------------ccchhhhHHHHHHHHHHHHhhcCCCCeEecCcCCCcEEECCCC-----cEEEeecCCC
Q 039231          379 ----------------------RVAEELSSTIGIARGLEYLHLGCSTRILHFDIKPHNILLDEDF-----CPKISDFGLA  431 (506)
Q Consensus       379 ----------------------~~~~~l~i~~~i~~gl~~LH~~~~~~ivH~dlkp~Nill~~~~-----~~ki~dfg~a  431 (506)
                                            .+.+.+.++.|++.||+|||   +.+++|+||||+||+++++.     .+||+|||++
T Consensus        82 ~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH---~~~i~H~dl~p~nil~~~~~~~~~~~~~l~dfg~~  158 (269)
T cd05044          82 EGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCVYLE---QMHFIHRDLAARNCLVSEKGYDADRVVKIGDFGLA  158 (269)
T ss_pred             CCCcHHHHHHHhhhcccCCccccHHHHHHHHHHHHHHHHHHH---hCCcccCCCChheEEEecCCCCCCcceEECCcccc
Confidence                                  11334568899999999999   89999999999999999877     8999999999


Q ss_pred             ccccCCCcceecccCCCCcccccccccccccCCCCccccHHHHHHHHHHHHc-CCCCCCCCCC
Q 039231          432 KICNRKESIISMTGARGTVGYIAPEVFCRNIGEVSYKSDVYNYGMMIFEMTG-GRKNVDVVDN  493 (506)
Q Consensus       432 ~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~s~~~Dv~s~G~il~ellt-g~~pf~~~~~  493 (506)
                      +...............++..|+|||.+.+  +.++.++||||||+++|||++ |+.||...++
T Consensus       159 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~--~~~~~~~Dv~slG~il~ellt~g~~p~~~~~~  219 (269)
T cd05044         159 RDIYKSDYYRKEGEGLLPVRWMAPESLLD--GKFTTQSDVWSFGVLMWEILTLGQQPYPALNN  219 (269)
T ss_pred             cccccccccccCcccCCCccccCHHHHcc--CCcccchhHHHHHHHHHHHHHcCCCCCcccCH
Confidence            76543332222223345788999999854  478999999999999999998 9999976543

Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male

>cd06615 PKc_MEK Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase

Probab=99.95  E-value=6.1e-27  Score=231.96  Aligned_cols=167  Identities=26%  Similarity=0.346  Sum_probs=137.6

Q ss_pred             hccccCccCceEEEEEEEc-CCCEEEEEEeccCCC--CchhhHHHHHHhhccCccceeEEEEEee---------------
Q 039231          317 FKYKLGQGGYGSVYKGKLL-DGSNVAVKVLNDSKG--NGKEFINEVASISRTSHVNVVALLGFCL---------------  378 (506)
Q Consensus       317 ~~~~ig~G~~g~V~~~~~~-~~~~vavK~l~~~~~--~~~~~~~E~~~l~~l~h~niv~l~g~~~---------------  378 (506)
                      +.+.||+|+||.||+++.. ++..+|+|.++....  ..+++.+|++++.+++||||+++++.+.               
T Consensus         5 ~~~~lg~G~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ey~~~~   84 (308)
T cd06615           5 KLGELGAGNGGVVTKVLHRPSGLIMARKLIHLEIKPAIRNQIIRELKVLHECNSPYIVGFYGAFYSDGEISICMEHMDGG   84 (308)
T ss_pred             EEeeccCCCCeEEEEEEEcCCCeEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCEEEEEeeccCCC
Confidence            3467999999999999875 478899998865322  2356889999999999999999998762               


Q ss_pred             ------------ccchhhhHHHHHHHHHHHHhhcCC-CCeEecCcCCCcEEECCCCcEEEeecCCCccccCCCcceeccc
Q 039231          379 ------------RVAEELSSTIGIARGLEYLHLGCS-TRILHFDIKPHNILLDEDFCPKISDFGLAKICNRKESIISMTG  445 (506)
Q Consensus       379 ------------~~~~~l~i~~~i~~gl~~LH~~~~-~~ivH~dlkp~Nill~~~~~~ki~dfg~a~~~~~~~~~~~~~~  445 (506)
                                  ++.....++.|+++||+|||   + .+++|+||||+||++++++.+||+|||++.......    ...
T Consensus        85 ~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH---~~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~----~~~  157 (308)
T cd06615          85 SLDQVLKKAGRIPENILGKISIAVLRGLTYLR---EKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSM----ANS  157 (308)
T ss_pred             cHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH---hhCCEEECCCChHHEEEecCCcEEEccCCCcccccccc----ccc
Confidence                        22235678899999999999   5 689999999999999999999999999987553322    134


Q ss_pred             CCCCcccccccccccccCCCCccccHHHHHHHHHHHHcCCCCCCCCC
Q 039231          446 ARGTVGYIAPEVFCRNIGEVSYKSDVYNYGMMIFEMTGGRKNVDVVD  492 (506)
Q Consensus       446 ~~gt~~y~aPE~l~~~~~~~s~~~Dv~s~G~il~elltg~~pf~~~~  492 (506)
                      ..++..|+|||.+.+.  .++.++|+||||+++|||++|+.||...+
T Consensus       158 ~~~~~~~~aPE~~~~~--~~~~~~DiwslG~~l~~l~~g~~p~~~~~  202 (308)
T cd06615         158 FVGTRSYMSPERLQGT--HYTVQSDIWSLGLSLVEMAIGRYPIPPPD  202 (308)
T ss_pred             CCCCcCccChhHhcCC--CCCccchHHHHHHHHHHHHhCCCCCCCcc
Confidence            5678999999998543  68889999999999999999999997544

Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the down

>cd05107 PTKc_PDGFR_beta Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta

Probab=99.95  E-value=7.1e-27  Score=238.79  Aligned_cols=180  Identities=27%  Similarity=0.438  Sum_probs=140.8

Q ss_pred             HHHHhhhccccCccCceEEEEEEEc------CCCEEEEEEeccCCCC--chhhHHHHHHhhccC-ccceeEEEEEeeccc
Q 039231          311 KKMTNSFKYKLGQGGYGSVYKGKLL------DGSNVAVKVLNDSKGN--GKEFINEVASISRTS-HVNVVALLGFCLRVA  381 (506)
Q Consensus       311 ~~~~~~~~~~ig~G~~g~V~~~~~~------~~~~vavK~l~~~~~~--~~~~~~E~~~l~~l~-h~niv~l~g~~~~~~  381 (506)
                      ......+.++||+|+||.||+|++.      .+..||+|+++.....  .+.+.+|++++.++. ||||+++++++....
T Consensus        35 ~~~~~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l~~H~niv~~~~~~~~~~  114 (401)
T cd05107          35 PRDNLVLGRTLGSGAFGRVVEATAHGLSHSQSTMKVAVKMLKSTARSSEKQALMSELKIMSHLGPHLNIVNLLGACTKGG  114 (401)
T ss_pred             cHHHeehhhhccCCCceeEEEEEEcCCCCCCCceEEEEEecCCCCChhHHHHHHHHHHHHHhcCCCCCeEEEEEEEccCC
Confidence            3333445578999999999999863      2468999999754322  356889999999997 999999998772110


Q ss_pred             --------------------------------------------------------------------------------
Q 039231          382 --------------------------------------------------------------------------------  381 (506)
Q Consensus       382 --------------------------------------------------------------------------------  381 (506)
                                                                                                      
T Consensus       115 ~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  194 (401)
T cd05107         115 PIYIITEYCRYGDLVDYLHRNKHTFLQYYLDKNRDDGSLISGGSTPLSQRKSHVSLGSESDGGYMDMSKDESADYVPMQD  194 (401)
T ss_pred             CcEEEEeccCCCcHHHHHHhccccchhhhcccccccccccccccccccccccchhhhhccCccccccCCccccCccchhc
Confidence                                                                                            


Q ss_pred             ---------------------------------------------hhhhHHHHHHHHHHHHhhcCCCCeEecCcCCCcEE
Q 039231          382 ---------------------------------------------EELSSTIGIARGLEYLHLGCSTRILHFDIKPHNIL  416 (506)
Q Consensus       382 ---------------------------------------------~~l~i~~~i~~gl~~LH~~~~~~ivH~dlkp~Nil  416 (506)
                                                                   +.+.++.|++.||+|||   +++++||||||+|||
T Consensus       195 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH---~~~ivHrdlkp~NiL  271 (401)
T cd05107         195 MKGTVKYADIESSNYESPYDQYLPSAPERTRRDTLINESPALSYMDLVGFSYQVANGMEFLA---SKNCVHRDLAARNVL  271 (401)
T ss_pred             chhhhhhhhhhccCcCCchhhhhcccCCCcchhhhhcCCCCCCHHHHHHHHHHHHHHHHHHh---cCCcCcccCCcceEE
Confidence                                                         12346789999999999   899999999999999


Q ss_pred             ECCCCcEEEeecCCCccccCCCcceecccCCCCcccccccccccccCCCCccccHHHHHHHHHHHHc-CCCCCCCCCCCc
Q 039231          417 LDEDFCPKISDFGLAKICNRKESIISMTGARGTVGYIAPEVFCRNIGEVSYKSDVYNYGMMIFEMTG-GRKNVDVVDNGS  495 (506)
Q Consensus       417 l~~~~~~ki~dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~s~~~Dv~s~G~il~ellt-g~~pf~~~~~~~  495 (506)
                      +++++.+||+|||+++...............++..|+|||.+.+.  .++.++||||||+++|||++ |+.||......+
T Consensus       272 l~~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~--~~~~~~DvwslGvil~e~l~~g~~P~~~~~~~~  349 (401)
T cd05107         272 ICEGKLVKICDFGLARDIMRDSNYISKGSTFLPLKWMAPESIFNN--LYTTLSDVWSFGILLWEIFTLGGTPYPELPMNE  349 (401)
T ss_pred             EeCCCEEEEEecCcceecccccccccCCCcCCCCceeChHHhcCC--CCCcHhHHHHHHHHHHHHHHcCCCCCCCCCchH
Confidence            999999999999999865433221112234567889999998553  68899999999999999998 899997654433

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-D

>cd05100 PTKc_FGFR3 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3

Probab=99.95  E-value=3.6e-27  Score=236.29  Aligned_cols=179  Identities=28%  Similarity=0.500  Sum_probs=140.0

Q ss_pred             HHHHHhhhccccCccCceEEEEEEEcC--------CCEEEEEEeccCCC--CchhhHHHHHHhhcc-CccceeEEEEEee
Q 039231          310 IKKMTNSFKYKLGQGGYGSVYKGKLLD--------GSNVAVKVLNDSKG--NGKEFINEVASISRT-SHVNVVALLGFCL  378 (506)
Q Consensus       310 l~~~~~~~~~~ig~G~~g~V~~~~~~~--------~~~vavK~l~~~~~--~~~~~~~E~~~l~~l-~h~niv~l~g~~~  378 (506)
                      +...++.+.+.||+|+||.||+|+...        +..+|+|.++....  ..+++.+|++++.++ +||||+++++++.
T Consensus         9 ~~~~~~~i~~~ig~G~~g~v~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~   88 (334)
T cd05100           9 LSRTRLTLGKPLGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDATDKDLSDLVSEMEMMKMIGKHKNIINLLGACT   88 (334)
T ss_pred             cCHhHeeecceeccccCCcEEEEEEeccCCccCCcceeEEEEEcccccCHHHHHHHHHHHHHHHhhcCCCCeeeeeEEEc
Confidence            344455667889999999999997421        23689998875332  236789999999999 7999999998761


Q ss_pred             c-------------------------------------------cchhhhHHHHHHHHHHHHhhcCCCCeEecCcCCCcE
Q 039231          379 R-------------------------------------------VAEELSSTIGIARGLEYLHLGCSTRILHFDIKPHNI  415 (506)
Q Consensus       379 ~-------------------------------------------~~~~l~i~~~i~~gl~~LH~~~~~~ivH~dlkp~Ni  415 (506)
                      .                                           +.+.+.++.|++.||+|||   +++++||||||+||
T Consensus        89 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH---~~givH~dlkp~Ni  165 (334)
T cd05100          89 QDGPLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSCAYQVARGMEYLA---SQKCIHRDLAARNV  165 (334)
T ss_pred             cCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHH---HCCeeccccccceE
Confidence            1                                           1123457889999999999   89999999999999


Q ss_pred             EECCCCcEEEeecCCCccccCCCcceecccCCCCcccccccccccccCCCCccccHHHHHHHHHHHHc-CCCCCCCCCC
Q 039231          416 LLDEDFCPKISDFGLAKICNRKESIISMTGARGTVGYIAPEVFCRNIGEVSYKSDVYNYGMMIFEMTG-GRKNVDVVDN  493 (506)
Q Consensus       416 ll~~~~~~ki~dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~s~~~Dv~s~G~il~ellt-g~~pf~~~~~  493 (506)
                      ++++++.+||+|||+++...............++..|+|||.+.+.  .++.++||||||+++|||++ |..||.....
T Consensus       166 ll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~--~~~~~~Di~slG~il~el~~~g~~p~~~~~~  242 (334)
T cd05100         166 LVTEDNVMKIADFGLARDVHNIDYYKKTTNGRLPVKWMAPEALFDR--VYTHQSDVWSFGVLLWEIFTLGGSPYPGIPV  242 (334)
T ss_pred             EEcCCCcEEECCcccceecccccccccccCCCcCceEcCHHHhccC--CcCchhhhHHHHHHHHHHHhcCCCCCCCCCH
Confidence            9999999999999999866543322222233446789999998554  68889999999999999998 8999976543

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>cd08223 STKc_Nek4 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4

Probab=99.95  E-value=6.8e-27  Score=224.96  Aligned_cols=171  Identities=29%  Similarity=0.443  Sum_probs=140.2

Q ss_pred             hhccccCccCceEEEEEEEc-CCCEEEEEEeccCCC---CchhhHHHHHHhhccCccceeEEEEEee-------------
Q 039231          316 SFKYKLGQGGYGSVYKGKLL-DGSNVAVKVLNDSKG---NGKEFINEVASISRTSHVNVVALLGFCL-------------  378 (506)
Q Consensus       316 ~~~~~ig~G~~g~V~~~~~~-~~~~vavK~l~~~~~---~~~~~~~E~~~l~~l~h~niv~l~g~~~-------------  378 (506)
                      .+.+.||+|++|.||+++.. +++.+|+|++.....   ..+.+.+|++++++++|+|++++.+.+.             
T Consensus         3 ~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv~e~~   82 (257)
T cd08223           3 CFVRVVGKGSYGEVSLVRHRTDGKQYVIKKLNLRNASRRERKAAEQEAQLLSQLKHPNIVAYRESWEGEDGLLYIVMGFC   82 (257)
T ss_pred             eEEEEecCCCCeEEEEEEEcCCCcEEEEEEEehhhcCHHHHHHHHHHHHHHHhCCCCCeeeeeeeecCCCCEEEEEeccc
Confidence            34578999999999999875 478899999865332   2356888999999999999999886541             


Q ss_pred             -----------------ccchhhhHHHHHHHHHHHHhhcCCCCeEecCcCCCcEEECCCCcEEEeecCCCccccCCCcce
Q 039231          379 -----------------RVAEELSSTIGIARGLEYLHLGCSTRILHFDIKPHNILLDEDFCPKISDFGLAKICNRKESII  441 (506)
Q Consensus       379 -----------------~~~~~l~i~~~i~~gl~~LH~~~~~~ivH~dlkp~Nill~~~~~~ki~dfg~a~~~~~~~~~~  441 (506)
                                       .+.+.+.++.|++.|+++||   +.+++|+||||+||++++++.++|+|||++......... 
T Consensus        83 ~~~~l~~~l~~~~~~~l~~~~~~~~~~~l~~~l~~lH---~~~i~H~di~p~nil~~~~~~~~l~df~~~~~~~~~~~~-  158 (257)
T cd08223          83 EGGDLYHKLKEQKGKLLPENQVVEWFVQIAMALQYLH---EKHILHRDLKTQNVFLTRTNIIKVGDLGIARVLENQCDM-  158 (257)
T ss_pred             CCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH---hCCeeccCCCchhEEEecCCcEEEecccceEEecccCCc-
Confidence                             12234678899999999999   899999999999999999999999999999876433221 


Q ss_pred             ecccCCCCcccccccccccccCCCCccccHHHHHHHHHHHHcCCCCCCCCCC
Q 039231          442 SMTGARGTVGYIAPEVFCRNIGEVSYKSDVYNYGMMIFEMTGGRKNVDVVDN  493 (506)
Q Consensus       442 ~~~~~~gt~~y~aPE~l~~~~~~~s~~~Dv~s~G~il~elltg~~pf~~~~~  493 (506)
                       .....+++.|+|||.+.+.  .++.++||||||++++||++|+.||+..+.
T Consensus       159 -~~~~~~~~~y~aPE~~~~~--~~~~~~Dv~slG~il~~l~~g~~~~~~~~~  207 (257)
T cd08223         159 -ASTLIGTPYYMSPELFSNK--PYNYKSDVWALGCCVYEMATLKHAFNAKDM  207 (257)
T ss_pred             -cccccCCcCccChhHhcCC--CCCchhhhHHHHHHHHHHHcCCCCCCCCCH
Confidence             1345678999999998654  678899999999999999999999986543

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown.

>KOG0984 consensus Mitogen-activated protein kinase (MAPK) kinase MKK3/MKK6 [Signal transduction mechanisms]

Probab=99.95  E-value=1.4e-27  Score=208.74  Aligned_cols=171  Identities=29%  Similarity=0.402  Sum_probs=138.7

Q ss_pred             cccCccCceEEEEEEEc-CCCEEEEEEeccCC--CCchhhHHHHHHhhcc-CccceeEEEEEeeccch------------
Q 039231          319 YKLGQGGYGSVYKGKLL-DGSNVAVKVLNDSK--GNGKEFINEVASISRT-SHVNVVALLGFCLRVAE------------  382 (506)
Q Consensus       319 ~~ig~G~~g~V~~~~~~-~~~~vavK~l~~~~--~~~~~~~~E~~~l~~l-~h~niv~l~g~~~~~~~------------  382 (506)
                      ..||+|++|.|=+-++. +|+..|+|.+..+-  +..++..+|+.+..+. .-|.+|.++|..+++.+            
T Consensus        52 ~elGrGayG~vekmrh~~sg~imAvKri~~tvn~q~q~r~L~dldi~~r~~~CPf~V~FyGa~~regdvwIcME~M~tSl  131 (282)
T KOG0984|consen   52 EELGRGAYGVVEKMRHIQSGTIMAVKRIRATVNSQEQKRLLMDLDIIMRTVDCPFTVHFYGALFREGDVWICMELMDTSL  131 (282)
T ss_pred             hhhcCCccchhhheeeccCCeEEEEeeehhhcChHHHHHHHHhhhhhccCCCCCeEEEeehhhhccccEEEeHHHhhhhH
Confidence            35999999999888764 68999999997543  2336788899886665 68999999986643322            


Q ss_pred             ------------------hhhHHHHHHHHHHHHhhcCCCCeEecCcCCCcEEECCCCcEEEeecCCCccccCCCcceecc
Q 039231          383 ------------------ELSSTIGIARGLEYLHLGCSTRILHFDIKPHNILLDEDFCPKISDFGLAKICNRKESIISMT  444 (506)
Q Consensus       383 ------------------~l~i~~~i~~gl~~LH~~~~~~ivH~dlkp~Nill~~~~~~ki~dfg~a~~~~~~~~~~~~~  444 (506)
                                        .-+|+..++.||.|||+  +..++|||+||+||||+.+|++||+|||.+..+...-.   .+
T Consensus       132 dkfy~~v~~~g~~ipE~vlGkIa~Svv~al~~L~~--kL~vIHRDvKPsNiLIn~~GqVKiCDFGIsG~L~dSiA---kt  206 (282)
T KOG0984|consen  132 DKFYRKVLKKGGTIPEDVLGKIAVSVVHALEFLHS--KLSVIHRDVKPSNILINYDGQVKICDFGISGYLVDSIA---KT  206 (282)
T ss_pred             HHHHHHHHhcCCcCchHHhhHhHHHHHHHHHHHHH--HhhhhhccCCcceEEEccCCcEEEcccccceeehhhhH---HH
Confidence                              33588899999999997  78999999999999999999999999999987654322   23


Q ss_pred             cCCCCccccccccccccc--CCCCccccHHHHHHHHHHHHcCCCCCCCCCCC
Q 039231          445 GARGTVGYIAPEVFCRNI--GEVSYKSDVYNYGMMIFEMTGGRKNVDVVDNG  494 (506)
Q Consensus       445 ~~~gt~~y~aPE~l~~~~--~~~s~~~Dv~s~G~il~elltg~~pf~~~~~~  494 (506)
                      ...|...|||||.+....  ..|+-++||||+|+.+.||.+++.||+.....
T Consensus       207 ~daGCkpYmaPEri~~e~n~~gY~vksDvWSLGItmiElA~lr~PY~~w~tp  258 (282)
T KOG0984|consen  207 MDAGCKPYMAPERINPELNQKGYSVKSDVWSLGITMIEMAILRFPYESWGTP  258 (282)
T ss_pred             HhcCCCccCChhhcCcccCcccceeehhhhhhhhhhhhhhhccccccccCCH
Confidence            367889999999985422  36888999999999999999999999876543

>cd05065 PTKc_EphR_B Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors

Probab=99.94  E-value=2.4e-27  Score=229.93  Aligned_cols=175  Identities=27%  Similarity=0.496  Sum_probs=138.7

Q ss_pred             hhhccccCccCceEEEEEEEcC-C---CEEEEEEeccCCC--CchhhHHHHHHhhccCccceeEEEEEe-----------
Q 039231          315 NSFKYKLGQGGYGSVYKGKLLD-G---SNVAVKVLNDSKG--NGKEFINEVASISRTSHVNVVALLGFC-----------  377 (506)
Q Consensus       315 ~~~~~~ig~G~~g~V~~~~~~~-~---~~vavK~l~~~~~--~~~~~~~E~~~l~~l~h~niv~l~g~~-----------  377 (506)
                      ..+.+.||+|+||.||+|.... +   ..||||.++....  ..+++.+|++.+++++||||+++.+++           
T Consensus         6 ~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~e   85 (269)
T cd05065           6 VKIEEVIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSRPVMIITE   85 (269)
T ss_pred             eEEEeEecCCCCCeEEEEEEecCCCCceeEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCcCcceEEEEECCCCceEEEEe
Confidence            4456789999999999998753 3   3699999875422  336789999999999999999999876           


Q ss_pred             -----------------eccchhhhHHHHHHHHHHHHhhcCCCCeEecCcCCCcEEECCCCcEEEeecCCCccccCCCcc
Q 039231          378 -----------------LRVAEELSSTIGIARGLEYLHLGCSTRILHFDIKPHNILLDEDFCPKISDFGLAKICNRKESI  440 (506)
Q Consensus       378 -----------------~~~~~~l~i~~~i~~gl~~LH~~~~~~ivH~dlkp~Nill~~~~~~ki~dfg~a~~~~~~~~~  440 (506)
                                       +++.+.+.++.|++.||+|||   +++++|+||||+||+++.++.+||+|||+++........
T Consensus        86 ~~~~~~L~~~l~~~~~~~~~~~~~~i~~~l~~al~~lH---~~g~~H~dl~p~nili~~~~~~kl~dfg~~~~~~~~~~~  162 (269)
T cd05065          86 FMENGALDSFLRQNDGQFTVIQLVGMLRGIAAGMKYLS---EMNYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSD  162 (269)
T ss_pred             cCCCCcHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHH---HCCEeecccChheEEEcCCCcEEECCCccccccccCccc
Confidence                             122335778899999999999   899999999999999999999999999998765443221


Q ss_pred             eeccc---CCCCcccccccccccccCCCCccccHHHHHHHHHHHHc-CCCCCCCCCCC
Q 039231          441 ISMTG---ARGTVGYIAPEVFCRNIGEVSYKSDVYNYGMMIFEMTG-GRKNVDVVDNG  494 (506)
Q Consensus       441 ~~~~~---~~gt~~y~aPE~l~~~~~~~s~~~Dv~s~G~il~ellt-g~~pf~~~~~~  494 (506)
                      .....   ...+..|+|||.+..  ..++.++||||||+++|||++ |..||...+..
T Consensus       163 ~~~~~~~~~~~~~~y~~PE~~~~--~~~~~~~DvwslG~~l~e~l~~g~~p~~~~~~~  218 (269)
T cd05065         163 PTYTSSLGGKIPIRWTAPEAIAY--RKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQ  218 (269)
T ss_pred             cccccccCCCcceeecCHhHhcc--CcccchhhhhhhHHHHHHHhcCCCCCCCCCCHH
Confidence            11111   112457999999854  378899999999999999986 99999765443

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephr

>cd05099 PTKc_FGFR4 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4

Probab=99.94  E-value=5e-27  Score=233.20  Aligned_cols=174  Identities=30%  Similarity=0.513  Sum_probs=136.7

Q ss_pred             HhhhccccCccCceEEEEEEEc--------CCCEEEEEEeccCCC--CchhhHHHHHHhhcc-CccceeEEEEEeec---
Q 039231          314 TNSFKYKLGQGGYGSVYKGKLL--------DGSNVAVKVLNDSKG--NGKEFINEVASISRT-SHVNVVALLGFCLR---  379 (506)
Q Consensus       314 ~~~~~~~ig~G~~g~V~~~~~~--------~~~~vavK~l~~~~~--~~~~~~~E~~~l~~l-~h~niv~l~g~~~~---  379 (506)
                      ...+.++||+|+||.||+|+..        ....+|+|+++....  ...++.+|++++.++ +||||+++++++..   
T Consensus        13 ~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~   92 (314)
T cd05099          13 RLVLGKPLGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNATDKDLADLISEMELMKLIGKHKNIINLLGVCTQEGP   92 (314)
T ss_pred             HeeeeeeecCCCcccEEEeeecccCCccCCcceEEEEEecCCCCChHHHHHHHHHHHHHHhccCCCCeeeEEEEEccCCc
Confidence            4445678999999999999752        245789999875432  235688999999999 59999999987621   


Q ss_pred             ----------------------------------------cchhhhHHHHHHHHHHHHhhcCCCCeEecCcCCCcEEECC
Q 039231          380 ----------------------------------------VAEELSSTIGIARGLEYLHLGCSTRILHFDIKPHNILLDE  419 (506)
Q Consensus       380 ----------------------------------------~~~~l~i~~~i~~gl~~LH~~~~~~ivH~dlkp~Nill~~  419 (506)
                                                              +.+.+.++.|++.||+|||   +++++||||||+||++++
T Consensus        93 ~~lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH---~~gi~H~dlkp~Nill~~  169 (314)
T cd05099          93 LYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVSCAYQVARGMEYLE---SRRCIHRDLAARNVLVTE  169 (314)
T ss_pred             eEEEEecCCCCcHHHHHHhcCCCcccccccccCCcccccCHHHHHHHHHHHHHHHHHHH---HCCeeeccccceeEEEcC
Confidence                                                    1113457889999999999   899999999999999999


Q ss_pred             CCcEEEeecCCCccccCCCcceecccCCCCcccccccccccccCCCCccccHHHHHHHHHHHHc-CCCCCCCCC
Q 039231          420 DFCPKISDFGLAKICNRKESIISMTGARGTVGYIAPEVFCRNIGEVSYKSDVYNYGMMIFEMTG-GRKNVDVVD  492 (506)
Q Consensus       420 ~~~~ki~dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~s~~~Dv~s~G~il~ellt-g~~pf~~~~  492 (506)
                      ++.+||+|||+++...............++..|+|||.+.+  +.++.++||||||+++|||++ |..||....
T Consensus       170 ~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~--~~~~~~~DiwslG~~l~el~~~g~~p~~~~~  241 (314)
T cd05099         170 DNVMKIADFGLARGVHDIDYYKKTSNGRLPVKWMAPEALFD--RVYTHQSDVWSFGILMWEIFTLGGSPYPGIP  241 (314)
T ss_pred             CCcEEEccccccccccccccccccccCCCCccccCHHHHcc--CCcCccchhhHHHHHHHHHHhCCCCCCCCCC
Confidence            99999999999986653322111122334568999999854  368899999999999999999 899997654

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>cd05086 PTKc_Aatyk2 Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2

Probab=99.94  E-value=8.5e-27  Score=226.12  Aligned_cols=172  Identities=22%  Similarity=0.376  Sum_probs=130.8

Q ss_pred             ccCccCceEEEEEEEcCC---CEEEEEEeccCC--CCchhhHHHHHHhhccCccceeEEEEEeec---------------
Q 039231          320 KLGQGGYGSVYKGKLLDG---SNVAVKVLNDSK--GNGKEFINEVASISRTSHVNVVALLGFCLR---------------  379 (506)
Q Consensus       320 ~ig~G~~g~V~~~~~~~~---~~vavK~l~~~~--~~~~~~~~E~~~l~~l~h~niv~l~g~~~~---------------  379 (506)
                      +||+|+||.||+|+..++   ..+++|.++...  ...+.+.+|+..++.++||||+++++.+.+               
T Consensus         2 ~lg~G~~g~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~   81 (268)
T cd05086           2 EIGNGWFGKVLLSEIYTDTGVARVVVKELKANASSKEQNEFLQQGDPYRILQHPNILQCLGQCVEAIPYLLVFEYCELGD   81 (268)
T ss_pred             cCCCCcCceEEEEEEEcCCCcceEEEEEecCCCChHHHHHHHHHHHHHhccCCcchhheEEEecCCCccEEEEecCCCCc
Confidence            599999999999976443   345677665432  233678999999999999999999987611               


Q ss_pred             ----------------cchhhhHHHHHHHHHHHHhhcCCCCeEecCcCCCcEEECCCCcEEEeecCCCccccCCCcceec
Q 039231          380 ----------------VAEELSSTIGIARGLEYLHLGCSTRILHFDIKPHNILLDEDFCPKISDFGLAKICNRKESIISM  443 (506)
Q Consensus       380 ----------------~~~~l~i~~~i~~gl~~LH~~~~~~ivH~dlkp~Nill~~~~~~ki~dfg~a~~~~~~~~~~~~  443 (506)
                                      ....+.++.||+.||+|||   +.+++||||||+|||++.++.+||+|||++............
T Consensus        82 L~~~l~~~~~~~~~~~~~~~~~~~~~i~~al~~lH---~~~i~H~dikp~nil~~~~~~~~l~Dfg~~~~~~~~~~~~~~  158 (268)
T cd05086          82 LKSYLSQEQWHRRNSQLLLLQRMACEIAAGVTHMH---KHNFLHSDLALRNCFLTSDLTVKVGDYGIGPSRYKEDYIETE  158 (268)
T ss_pred             HHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHH---HCCeeccCCccceEEEcCCccEEecccccccccCcchhhhcc
Confidence                            0113467889999999999   899999999999999999999999999998643222111111


Q ss_pred             ccCCCCccccccccccccc-----CCCCccccHHHHHHHHHHHHc-CCCCCCCCCCC
Q 039231          444 TGARGTVGYIAPEVFCRNI-----GEVSYKSDVYNYGMMIFEMTG-GRKNVDVVDNG  494 (506)
Q Consensus       444 ~~~~gt~~y~aPE~l~~~~-----~~~s~~~Dv~s~G~il~ellt-g~~pf~~~~~~  494 (506)
                      ....++..|+|||++....     ..++.++||||||+++|||++ |..||....+.
T Consensus       159 ~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~  215 (268)
T cd05086         159 DDKCVPLRWLAPELVGEFHGGLITAEQTKPSNVWALGVTLWELFENAAQPYSHLSDR  215 (268)
T ss_pred             cCCcCcccccCchhcccccCccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCHH
Confidence            3356788999999974321     235778999999999999996 67788765443

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage

>cd06616 PKc_MKK4 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4

Probab=99.94  E-value=5.6e-27  Score=229.70  Aligned_cols=169  Identities=26%  Similarity=0.399  Sum_probs=136.5

Q ss_pred             cccCccCceEEEEEEEc-CCCEEEEEEeccCC--CCchhhHHHHHHhhccC-ccceeEEEEEeec---------------
Q 039231          319 YKLGQGGYGSVYKGKLL-DGSNVAVKVLNDSK--GNGKEFINEVASISRTS-HVNVVALLGFCLR---------------  379 (506)
Q Consensus       319 ~~ig~G~~g~V~~~~~~-~~~~vavK~l~~~~--~~~~~~~~E~~~l~~l~-h~niv~l~g~~~~---------------  379 (506)
                      ++||+|+||.||+++.. +++.+|+|.+....  .....+.+|+.++.++. |+||+++++++..               
T Consensus        10 ~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~~~~~~~iv~~~~~~~~~~~~~~~~e~~~~~l   89 (288)
T cd06616          10 GEIGRGAFGTVNKMLHKPSGTIMAVKRIRSTVDEKEQKRLLMDLDVVMRSSDCPYIVKFYGALFREGDCWICMELMDISL   89 (288)
T ss_pred             HHhCCCCceEEEEEEECCCCCEEEEEEehhccChHHHHHHHHHHHHHHHhcCCCCEeeeeeEEecCCcEEEEEecccCCH
Confidence            46999999999999875 48999999986533  23357889999999996 9999999987621               


Q ss_pred             ----------------cchhhhHHHHHHHHHHHHhhcCCCCeEecCcCCCcEEECCCCcEEEeecCCCccccCCCcceec
Q 039231          380 ----------------VAEELSSTIGIARGLEYLHLGCSTRILHFDIKPHNILLDEDFCPKISDFGLAKICNRKESIISM  443 (506)
Q Consensus       380 ----------------~~~~l~i~~~i~~gl~~LH~~~~~~ivH~dlkp~Nill~~~~~~ki~dfg~a~~~~~~~~~~~~  443 (506)
                                      +.....++.|++.||+|||+  +.+++||||||+||++++++.+||+|||+++........   
T Consensus        90 ~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~--~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~~---  164 (288)
T cd06616          90 DKFYKYVYEVLKSVIPEEILGKIAVATVKALNYLKE--ELKIIHRDVKPSNILLDRNGNIKLCDFGISGQLVDSIAK---  164 (288)
T ss_pred             HHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhh--cCCeeccCCCHHHEEEccCCcEEEeecchhHHhccCCcc---
Confidence                            11245688899999999993  359999999999999999999999999999765433221   


Q ss_pred             ccCCCCccccccccccccc-CCCCccccHHHHHHHHHHHHcCCCCCCCCC
Q 039231          444 TGARGTVGYIAPEVFCRNI-GEVSYKSDVYNYGMMIFEMTGGRKNVDVVD  492 (506)
Q Consensus       444 ~~~~gt~~y~aPE~l~~~~-~~~s~~~Dv~s~G~il~elltg~~pf~~~~  492 (506)
                      ....++..|+|||.+.... ..++.++||||||+++|||++|+.||....
T Consensus       165 ~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~  214 (288)
T cd06616         165 TRDAGCRPYMAPERIDPSARDGYDVRSDVWSLGITLYEVATGKFPYPKWN  214 (288)
T ss_pred             ccccCccCccCHHHhccccccCCcchhhhhHHHHHHHHHHhCCCCchhcc
Confidence            2345788999999985431 257889999999999999999999997653

Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates

>cd05037 PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases

Probab=99.94  E-value=5.2e-27  Score=225.95  Aligned_cols=165  Identities=25%  Similarity=0.443  Sum_probs=135.2

Q ss_pred             cccCccCceEEEEEEEcCCC-----------EEEEEEeccCCCCchhhHHHHHHhhccCccceeEEEEEee---------
Q 039231          319 YKLGQGGYGSVYKGKLLDGS-----------NVAVKVLNDSKGNGKEFINEVASISRTSHVNVVALLGFCL---------  378 (506)
Q Consensus       319 ~~ig~G~~g~V~~~~~~~~~-----------~vavK~l~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~---------  378 (506)
                      +.||+|+||.||+|.+.+..           .+++|.+.........+.+|+.++++++||||+++++++.         
T Consensus         1 ~~lg~G~~~~v~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~lv~e   80 (259)
T cd05037           1 EHLGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDHRDSLAFFETASLMSQLSHKHLVKLYGVCVRDENIMVEE   80 (259)
T ss_pred             CcccccccceEEEEEEeccCCccccCCccceeeeeeccccchhhHHHHHHHHHHHHcCCCcchhheeeEEecCCcEEEEE
Confidence            35899999999999986432           5788887655444678899999999999999999999762         


Q ss_pred             ------------------ccchhhhHHHHHHHHHHHHhhcCCCCeEecCcCCCcEEECCCC-------cEEEeecCCCcc
Q 039231          379 ------------------RVAEELSSTIGIARGLEYLHLGCSTRILHFDIKPHNILLDEDF-------CPKISDFGLAKI  433 (506)
Q Consensus       379 ------------------~~~~~l~i~~~i~~gl~~LH~~~~~~ivH~dlkp~Nill~~~~-------~~ki~dfg~a~~  433 (506)
                                        ++..++.++.|++.||+|||   +++|+||||||+||+++.++       .+||+|||++..
T Consensus        81 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~LH---~~~i~H~dlkp~Nill~~~~~~~~~~~~~kl~Dfg~a~~  157 (259)
T cd05037          81 YVKFGPLDVFLHREKNNVSLHWKLDVAKQLASALHYLE---DKKLVHGNVCGKNILVARYGLNEGYVPFIKLSDPGIPIT  157 (259)
T ss_pred             cCCCCcHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHh---hCCeecccCccceEEEecCccccCCceeEEeCCCCcccc
Confidence                              22235668899999999999   89999999999999999887       799999999986


Q ss_pred             ccCCCcceecccCCCCcccccccccccccCCCCccccHHHHHHHHHHHHc-CCCCCCCCC
Q 039231          434 CNRKESIISMTGARGTVGYIAPEVFCRNIGEVSYKSDVYNYGMMIFEMTG-GRKNVDVVD  492 (506)
Q Consensus       434 ~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~s~~~Dv~s~G~il~ellt-g~~pf~~~~  492 (506)
                      ....      ....++..|+|||++......++.++||||||+++|||++ |..||...+
T Consensus       158 ~~~~------~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~~~~~l~~~~~~p~~~~~  211 (259)
T cd05037         158 VLSR------EERVERIPWIAPECIRNGQASLTIAADKWSFGTTLLEICSNGEEPLSTLS  211 (259)
T ss_pred             cccc------cccccCCCccChhhhcCCCCCcchhhHHHHHHHHHHHHHhCCCCCcccCC
Confidence            5431      2344577899999986543468899999999999999999 688887664

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the ki

>cd07845 STKc_CDK10 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10

Probab=99.94  E-value=5e-27  Score=232.62  Aligned_cols=172  Identities=27%  Similarity=0.376  Sum_probs=139.6

Q ss_pred             hccccCccCceEEEEEEEc-CCCEEEEEEeccCCC---CchhhHHHHHHhhccCccceeEEEEEee--------------
Q 039231          317 FKYKLGQGGYGSVYKGKLL-DGSNVAVKVLNDSKG---NGKEFINEVASISRTSHVNVVALLGFCL--------------  378 (506)
Q Consensus       317 ~~~~ig~G~~g~V~~~~~~-~~~~vavK~l~~~~~---~~~~~~~E~~~l~~l~h~niv~l~g~~~--------------  378 (506)
                      +.+.||+|+||.||+|... +|+.||+|+++....   ....+.+|++++++++|+||+++++++.              
T Consensus        11 ~~~~ig~g~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~lv~e~~   90 (309)
T cd07845          11 KLNRIGEGTYGIVYRARDTTSGEIVALKKVRMDNERDGIPISSLREITLLLNLRHPNIVELKEVVVGKHLDSIFLVMEYC   90 (309)
T ss_pred             EeeeeeecCCEEEEEEEECCCCcEEEEEEEEeccCCCCCcchhhHHHHHHHhCCCCCCcceEEEEecCCCCeEEEEEecC
Confidence            3467999999999999975 489999999864322   2245678999999999999999987752              


Q ss_pred             ---------------ccchhhhHHHHHHHHHHHHhhcCCCCeEecCcCCCcEEECCCCcEEEeecCCCccccCCCcceec
Q 039231          379 ---------------RVAEELSSTIGIARGLEYLHLGCSTRILHFDIKPHNILLDEDFCPKISDFGLAKICNRKESIISM  443 (506)
Q Consensus       379 ---------------~~~~~l~i~~~i~~gl~~LH~~~~~~ivH~dlkp~Nill~~~~~~ki~dfg~a~~~~~~~~~~~~  443 (506)
                                     ++.+.+.++.|++.||+|||   +.+++||||||+||++++++.+||+|||++.........  .
T Consensus        91 ~~~l~~~l~~~~~~l~~~~~~~~~~qi~~~l~~lH---~~~i~H~dl~p~nil~~~~~~~kL~dfg~~~~~~~~~~~--~  165 (309)
T cd07845          91 EQDLASLLDNMPTPFSESQVKCLMLQLLRGLQYLH---ENFIIHRDLKVSNLLLTDKGCLKIADFGLARTYGLPAKP--M  165 (309)
T ss_pred             CCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEECCCCCEEECccceeeecCCccCC--C
Confidence                           22234668999999999999   899999999999999999999999999999876543211  1


Q ss_pred             ccCCCCcccccccccccccCCCCccccHHHHHHHHHHHHcCCCCCCCCCCC
Q 039231          444 TGARGTVGYIAPEVFCRNIGEVSYKSDVYNYGMMIFEMTGGRKNVDVVDNG  494 (506)
Q Consensus       444 ~~~~gt~~y~aPE~l~~~~~~~s~~~Dv~s~G~il~elltg~~pf~~~~~~  494 (506)
                      ....++..|+|||.+.+. ..++.++||||+|+++|||++|+.||...++.
T Consensus       166 ~~~~~~~~y~aPE~~~~~-~~~~~~~DvwslG~il~el~~g~~~f~~~~~~  215 (309)
T cd07845         166 TPKVVTLWYRAPELLLGC-TTYTTAIDMWAVGCILAELLAHKPLLPGKSEI  215 (309)
T ss_pred             CcccccccccChhhhcCC-CCcCchHHHHHHHHHHHHHHhCCCCCCCCCHH
Confidence            334457889999998653 35788999999999999999999999865543

Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing

>cd07846 STKc_CDKL2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3

Probab=99.94  E-value=1.9e-27  Score=232.64  Aligned_cols=170  Identities=29%  Similarity=0.395  Sum_probs=140.3

Q ss_pred             hccccCccCceEEEEEEEc-CCCEEEEEEeccCCC---CchhhHHHHHHhhccCccceeEEEEEe---------------
Q 039231          317 FKYKLGQGGYGSVYKGKLL-DGSNVAVKVLNDSKG---NGKEFINEVASISRTSHVNVVALLGFC---------------  377 (506)
Q Consensus       317 ~~~~ig~G~~g~V~~~~~~-~~~~vavK~l~~~~~---~~~~~~~E~~~l~~l~h~niv~l~g~~---------------  377 (506)
                      +.++||+|++|.||+|... +++.+|+|++.....   ..+.+.+|++++++++||||+++++++               
T Consensus         5 ~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~   84 (286)
T cd07846           5 NLGLVGEGSYGMVMKCKHKETGQIVAIKKFLESEDDKMVKKIAMREIRMLKQLRHENLVNLIEVFRRKKRLYLVFEFVDH   84 (286)
T ss_pred             EeeeeccCCCeEEEEEEECCCCCEEEEEeHhhccCcchhhHHHHHHHHHHHhcCCcchhhHHHhcccCCeEEEEEecCCc
Confidence            3467999999999999986 489999999864322   235688999999999999999988765               


Q ss_pred             ------------eccchhhhHHHHHHHHHHHHhhcCCCCeEecCcCCCcEEECCCCcEEEeecCCCccccCCCcceeccc
Q 039231          378 ------------LRVAEELSSTIGIARGLEYLHLGCSTRILHFDIKPHNILLDEDFCPKISDFGLAKICNRKESIISMTG  445 (506)
Q Consensus       378 ------------~~~~~~l~i~~~i~~gl~~LH~~~~~~ivH~dlkp~Nill~~~~~~ki~dfg~a~~~~~~~~~~~~~~  445 (506)
                                  +++.+.+.++.|++.||+|||   +.+++|+||+|+||++++++.+||+|||++.........  ...
T Consensus        85 ~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH---~~~i~h~~l~p~ni~~~~~~~~~l~dfg~~~~~~~~~~~--~~~  159 (286)
T cd07846          85 TVLDDLEKYPNGLDESRVRKYLFQILRGIEFCH---SHNIIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGEV--YTD  159 (286)
T ss_pred             cHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHH---HCCccccCCCHHHEEECCCCcEEEEeeeeeeeccCCccc--cCc
Confidence                        234456778999999999999   899999999999999999999999999998765443321  233


Q ss_pred             CCCCcccccccccccccCCCCccccHHHHHHHHHHHHcCCCCCCCCC
Q 039231          446 ARGTVGYIAPEVFCRNIGEVSYKSDVYNYGMMIFEMTGGRKNVDVVD  492 (506)
Q Consensus       446 ~~gt~~y~aPE~l~~~~~~~s~~~Dv~s~G~il~elltg~~pf~~~~  492 (506)
                      ..++..|+|||.+.+. ..++.++||||||+++|||++|+.||....
T Consensus       160 ~~~~~~y~aPE~~~~~-~~~~~~~Dv~slG~~l~el~~g~~~~~~~~  205 (286)
T cd07846         160 YVATRWYRAPELLVGD-TKYGRAVDIWAVGCLVTEMLTGEPLFPGDS  205 (286)
T ss_pred             ccceeeccCcHHhccc-cccCchHhHHHHHHHHHHHHcCCCCCCCCc
Confidence            5578899999998543 357789999999999999999999997554

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKI

>cd08219 STKc_Nek3 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3

Probab=99.94  E-value=4.1e-27  Score=226.39  Aligned_cols=170  Identities=22%  Similarity=0.328  Sum_probs=140.3

Q ss_pred             hccccCccCceEEEEEEEc-CCCEEEEEEeccC--CCCchhhHHHHHHhhccCccceeEEEEEee---------------
Q 039231          317 FKYKLGQGGYGSVYKGKLL-DGSNVAVKVLNDS--KGNGKEFINEVASISRTSHVNVVALLGFCL---------------  378 (506)
Q Consensus       317 ~~~~ig~G~~g~V~~~~~~-~~~~vavK~l~~~--~~~~~~~~~E~~~l~~l~h~niv~l~g~~~---------------  378 (506)
                      +.++||+|+||.||+++.. +++.+|+|.++..  ....+.+.+|+.++++++|+||+++.+.+.               
T Consensus         4 ~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~   83 (255)
T cd08219           4 VLRVVGEGSFGRALLVQHVNSDQKYAMKEIRLPKSSSAVEDSRKEAVLLAKMKHPNIVAFKESFEADGHLYIVMEYCDGG   83 (255)
T ss_pred             EEEEeeccCCeEEEEEEEcCCCceEEEEEEEcCcchHHHHHHHHHHHHHHhCCCCCcceEEEEEEECCEEEEEEeeCCCC
Confidence            4567999999999999875 5889999998643  233467889999999999999999987661               


Q ss_pred             --------------ccchhhhHHHHHHHHHHHHhhcCCCCeEecCcCCCcEEECCCCcEEEeecCCCccccCCCcceecc
Q 039231          379 --------------RVAEELSSTIGIARGLEYLHLGCSTRILHFDIKPHNILLDEDFCPKISDFGLAKICNRKESIISMT  444 (506)
Q Consensus       379 --------------~~~~~l~i~~~i~~gl~~LH~~~~~~ivH~dlkp~Nill~~~~~~ki~dfg~a~~~~~~~~~~~~~  444 (506)
                                    +....+.++.|++.||.|||   +++++|+||||+||++++++.++|+|||.+.........  ..
T Consensus        84 ~l~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH---~~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~~~--~~  158 (255)
T cd08219          84 DLMQKIKLQRGKLFPEDTILQWFVQMCLGVQHIH---EKRVLHRDIKSKNIFLTQNGKVKLGDFGSARLLTSPGAY--AC  158 (255)
T ss_pred             cHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHh---hCCcccCCCCcceEEECCCCcEEEcccCcceeecccccc--cc
Confidence                          12234568899999999999   899999999999999999999999999999766443221  13


Q ss_pred             cCCCCcccccccccccccCCCCccccHHHHHHHHHHHHcCCCCCCCCCC
Q 039231          445 GARGTVGYIAPEVFCRNIGEVSYKSDVYNYGMMIFEMTGGRKNVDVVDN  493 (506)
Q Consensus       445 ~~~gt~~y~aPE~l~~~~~~~s~~~Dv~s~G~il~elltg~~pf~~~~~  493 (506)
                      ...+++.|+|||.+.+.  .++.++|+||||+++|+|++|+.||...+.
T Consensus       159 ~~~~~~~~~aPE~~~~~--~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~  205 (255)
T cd08219         159 TYVGTPYYVPPEIWENM--PYNNKSDIWSLGCILYELCTLKHPFQANSW  205 (255)
T ss_pred             cccCCccccCHHHHccC--CcCchhhhhhhchhheehhhccCCCCCCCH
Confidence            35678899999998554  688999999999999999999999986543

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activati

>cd05063 PTKc_EphR_A2 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2

Probab=99.94  E-value=6.1e-27  Score=226.89  Aligned_cols=174  Identities=26%  Similarity=0.500  Sum_probs=138.3

Q ss_pred             hhccccCccCceEEEEEEEcC-C---CEEEEEEeccCCC--CchhhHHHHHHhhccCccceeEEEEEe------------
Q 039231          316 SFKYKLGQGGYGSVYKGKLLD-G---SNVAVKVLNDSKG--NGKEFINEVASISRTSHVNVVALLGFC------------  377 (506)
Q Consensus       316 ~~~~~ig~G~~g~V~~~~~~~-~---~~vavK~l~~~~~--~~~~~~~E~~~l~~l~h~niv~l~g~~------------  377 (506)
                      ...+.||+|++|.||+|+... +   ..+++|.++....  ..+++.+|++++.+++|+||+++.+++            
T Consensus         8 ~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~   87 (268)
T cd05063           8 TKQKVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYTEKQRQDFLSEASIMGQFSHHNIIRLEGVVTKFKPAMIITEY   87 (268)
T ss_pred             eEeeEecCCCCccEEEEEEecCCCCceEEEEEeccccCCHHHHHHHHHHHHHHhcCCCCCeeEEEEEEccCCCcEEEEEc
Confidence            345689999999999998753 3   3799999865432  235788999999999999999999886            


Q ss_pred             ----------------eccchhhhHHHHHHHHHHHHhhcCCCCeEecCcCCCcEEECCCCcEEEeecCCCccccCCCcce
Q 039231          378 ----------------LRVAEELSSTIGIARGLEYLHLGCSTRILHFDIKPHNILLDEDFCPKISDFGLAKICNRKESII  441 (506)
Q Consensus       378 ----------------~~~~~~l~i~~~i~~gl~~LH~~~~~~ivH~dlkp~Nill~~~~~~ki~dfg~a~~~~~~~~~~  441 (506)
                                      +++.+.+.++.|++.||+|||   +.+++|+||||+||++++++.+||+|||++..........
T Consensus        88 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH---~~~i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~~~~~~  164 (268)
T cd05063          88 MENGALDKYLRDHDGEFSSYQLVGMLRGIAAGMKYLS---DMNYVHRDLAARNILVNSNLECKVSDFGLSRVLEDDPEGT  164 (268)
T ss_pred             CCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH---HCCeeccccchhhEEEcCCCcEEECCCccceecccccccc
Confidence                            123345778999999999999   8999999999999999999999999999997664332211


Q ss_pred             -ecccCCCCcccccccccccccCCCCccccHHHHHHHHHHHHc-CCCCCCCCCCC
Q 039231          442 -SMTGARGTVGYIAPEVFCRNIGEVSYKSDVYNYGMMIFEMTG-GRKNVDVVDNG  494 (506)
Q Consensus       442 -~~~~~~gt~~y~aPE~l~~~~~~~s~~~Dv~s~G~il~ellt-g~~pf~~~~~~  494 (506)
                       .......+..|+|||.+...  .++.++||||||+++|||++ |+.||......
T Consensus       165 ~~~~~~~~~~~y~~PE~~~~~--~~~~~~Dv~slG~il~ell~~g~~p~~~~~~~  217 (268)
T cd05063         165 YTTSGGKIPIRWTAPEAIAYR--KFTSASDVWSFGIVMWEVMSFGERPYWDMSNH  217 (268)
T ss_pred             eeccCCCcCceecCHHHhhcC--CcChHhHHHHHHHHHHHHHhCCCCCCCcCCHH
Confidence             11122335679999998543  67899999999999999997 99999765543

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored

>cd06611 STKc_SLK_like Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases

Probab=99.94  E-value=6.6e-27  Score=228.23  Aligned_cols=173  Identities=25%  Similarity=0.380  Sum_probs=141.0

Q ss_pred             hhccccCccCceEEEEEEEc-CCCEEEEEEeccCC-CCchhhHHHHHHhhccCccceeEEEEEee---------------
Q 039231          316 SFKYKLGQGGYGSVYKGKLL-DGSNVAVKVLNDSK-GNGKEFINEVASISRTSHVNVVALLGFCL---------------  378 (506)
Q Consensus       316 ~~~~~ig~G~~g~V~~~~~~-~~~~vavK~l~~~~-~~~~~~~~E~~~l~~l~h~niv~l~g~~~---------------  378 (506)
                      .+.+.||+|++|.||+|+.. ++..+|+|.+.... ...+.+.+|++++++++|+||+++++.+.               
T Consensus         8 ~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~   87 (280)
T cd06611           8 EIIGELGDGAFGKVYKAQHKETGLFAAAKIIQIESEEELEDFMVEIDILSECKHPNIVGLYEAYFYENKLWILIEFCDGG   87 (280)
T ss_pred             HHHHHhcCCCCceEEEEEEcCCCcEEEEEEEeeCCHHHHHHHHHHHHHHHhCCCCceeEEEEEEecCCeEEEEeeccCCC
Confidence            34467999999999999875 58899999986543 23367889999999999999999998762               


Q ss_pred             -------------ccchhhhHHHHHHHHHHHHhhcCCCCeEecCcCCCcEEECCCCcEEEeecCCCccccCCCcceeccc
Q 039231          379 -------------RVAEELSSTIGIARGLEYLHLGCSTRILHFDIKPHNILLDEDFCPKISDFGLAKICNRKESIISMTG  445 (506)
Q Consensus       379 -------------~~~~~l~i~~~i~~gl~~LH~~~~~~ivH~dlkp~Nill~~~~~~ki~dfg~a~~~~~~~~~~~~~~  445 (506)
                                   ++.+.+.++.|++.||+|||   +.+|+|+||+|+||+++.++.++|+|||++.........  ...
T Consensus        88 ~L~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lh---~~~i~h~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~~--~~~  162 (280)
T cd06611          88 ALDSIMLELERGLTEPQIRYVCRQMLEALNFLH---SHKVIHRDLKAGNILLTLDGDVKLADFGVSAKNKSTLQK--RDT  162 (280)
T ss_pred             cHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCChhhEEECCCCCEEEccCccchhhcccccc--cce
Confidence                         23345678999999999999   899999999999999999999999999998765432211  133


Q ss_pred             CCCCcccccccccccc---cCCCCccccHHHHHHHHHHHHcCCCCCCCCCC
Q 039231          446 ARGTVGYIAPEVFCRN---IGEVSYKSDVYNYGMMIFEMTGGRKNVDVVDN  493 (506)
Q Consensus       446 ~~gt~~y~aPE~l~~~---~~~~s~~~Dv~s~G~il~elltg~~pf~~~~~  493 (506)
                      ..+++.|+|||.+...   ...++.++||||||+++|||++|+.||...+.
T Consensus       163 ~~~~~~y~~PE~~~~~~~~~~~~~~~sDi~slG~il~~l~~g~~p~~~~~~  213 (280)
T cd06611         163 FIGTPYWMAPEVVACETFKDNPYDYKADIWSLGITLIELAQMEPPHHELNP  213 (280)
T ss_pred             eecchhhcCHHHHhhcccCCCCCCccccHHHHHHHHHHHHhCCCCcccCCH
Confidence            5678999999997432   23567899999999999999999999986644

Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated anti

>cd06613 STKc_MAP4K3_like Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases

Probab=99.94  E-value=7.2e-27  Score=225.34  Aligned_cols=173  Identities=29%  Similarity=0.402  Sum_probs=141.6

Q ss_pred             hhccccCccCceEEEEEEEc-CCCEEEEEEeccCCC-CchhhHHHHHHhhccCccceeEEEEEe----------------
Q 039231          316 SFKYKLGQGGYGSVYKGKLL-DGSNVAVKVLNDSKG-NGKEFINEVASISRTSHVNVVALLGFC----------------  377 (506)
Q Consensus       316 ~~~~~ig~G~~g~V~~~~~~-~~~~vavK~l~~~~~-~~~~~~~E~~~l~~l~h~niv~l~g~~----------------  377 (506)
                      .+.+.||+|++|.||+|... +++.+++|++..... ..+.+.+|++++++++||||+++++.+                
T Consensus         6 ~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~l~~e~~~~~   85 (262)
T cd06613           6 ELIQRIGSGTYGDVYKARDIATGELVAIKVIKLEPGDDFEIIQQEISMLKECRHPNIVAYFGSYLRRDKLWIVMEYCGGG   85 (262)
T ss_pred             EEEEEecCCCceEEEEeEecCCCCEEEEEEEEcCchhhHHHHHHHHHHHHhCCCCChhceEEEEEeCCEEEEEEeCCCCC
Confidence            34567999999999999875 478899999975433 447889999999999999999999875                


Q ss_pred             ------------eccchhhhHHHHHHHHHHHHhhcCCCCeEecCcCCCcEEECCCCcEEEeecCCCccccCCCcceeccc
Q 039231          378 ------------LRVAEELSSTIGIARGLEYLHLGCSTRILHFDIKPHNILLDEDFCPKISDFGLAKICNRKESIISMTG  445 (506)
Q Consensus       378 ------------~~~~~~l~i~~~i~~gl~~LH~~~~~~ivH~dlkp~Nill~~~~~~ki~dfg~a~~~~~~~~~~~~~~  445 (506)
                                  ++..+.+.++.|++.||+|||   +.+++|+||+|+||++++++.+||+|||++.........  ...
T Consensus        86 ~l~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lh---~~~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~~~--~~~  160 (262)
T cd06613          86 SLQDIYQVTRGPLSELQIAYVCRETLKGLAYLH---ETGKIHRDIKGANILLTEDGDVKLADFGVSAQLTATIAK--RKS  160 (262)
T ss_pred             cHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHH---hCCceecCCChhhEEECCCCCEEECccccchhhhhhhhc--ccc
Confidence                        122335568999999999999   899999999999999999999999999998765433211  133


Q ss_pred             CCCCcccccccccccc-cCCCCccccHHHHHHHHHHHHcCCCCCCCCCC
Q 039231          446 ARGTVGYIAPEVFCRN-IGEVSYKSDVYNYGMMIFEMTGGRKNVDVVDN  493 (506)
Q Consensus       446 ~~gt~~y~aPE~l~~~-~~~~s~~~Dv~s~G~il~elltg~~pf~~~~~  493 (506)
                      ..++..|+|||.+... ...++.++|+||||+++|||++|+.||...+.
T Consensus       161 ~~~~~~y~~Pe~~~~~~~~~~~~~~Di~slG~~l~~~~tg~~p~~~~~~  209 (262)
T cd06613         161 FIGTPYWMAPEVAAVERKGGYDGKCDIWALGITAIELAELQPPMFDLHP  209 (262)
T ss_pred             ccCCccccCchhhcccccCCcCchhhhHHHHHHHHHHHhCCCCCCCCCH
Confidence            5678899999998542 12678899999999999999999999986553

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activ

>cd06622 PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases

Probab=99.94  E-value=4.8e-27  Score=229.94  Aligned_cols=173  Identities=26%  Similarity=0.361  Sum_probs=138.4

Q ss_pred             hhccccCccCceEEEEEEEc-CCCEEEEEEeccCCC--CchhhHHHHHHhhccCccceeEEEEEe---------------
Q 039231          316 SFKYKLGQGGYGSVYKGKLL-DGSNVAVKVLNDSKG--NGKEFINEVASISRTSHVNVVALLGFC---------------  377 (506)
Q Consensus       316 ~~~~~ig~G~~g~V~~~~~~-~~~~vavK~l~~~~~--~~~~~~~E~~~l~~l~h~niv~l~g~~---------------  377 (506)
                      .+.+.||+|+||.||+++.. .+..+|+|.++....  ...++.+|++++.+++|+||+++++.+               
T Consensus         4 ~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~   83 (286)
T cd06622           4 EVLDELGKGNYGSVYKVLHRPTGVTMAMKEIRLELDESKFNQIIMELDILHKAVSPYIVDFYGAFFIEGAVYMCMEYMDA   83 (286)
T ss_pred             hhhhhhcccCCeEEEEEEEcCCCcEEEEEEeecccCHHHHHHHHHHHHHHHhcCCCcHHhhhhheecCCeEEEEEeecCC
Confidence            34567999999999999986 589999998865322  235788999999999999999988754               


Q ss_pred             ---------------eccchhhhHHHHHHHHHHHHhhcCCCCeEecCcCCCcEEECCCCcEEEeecCCCccccCCCccee
Q 039231          378 ---------------LRVAEELSSTIGIARGLEYLHLGCSTRILHFDIKPHNILLDEDFCPKISDFGLAKICNRKESIIS  442 (506)
Q Consensus       378 ---------------~~~~~~l~i~~~i~~gl~~LH~~~~~~ivH~dlkp~Nill~~~~~~ki~dfg~a~~~~~~~~~~~  442 (506)
                                     +++.....++.|++.||.|||+  +.+++|+||||+||++++++.+||+|||++........   
T Consensus        84 ~~l~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~--~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~---  158 (286)
T cd06622          84 GSLDKLYAGGVATEGIPEDVLRRITYAVVKGLKFLKE--EHNIIHRDVKPTNVLVNGNGQVKLCDFGVSGNLVASLA---  158 (286)
T ss_pred             CCHHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHHh--cCCEeeCCCCHHHEEECCCCCEEEeecCCcccccCCcc---
Confidence                           1122356788999999999993  35999999999999999999999999999876533221   


Q ss_pred             cccCCCCccccccccccccc----CCCCccccHHHHHHHHHHHHcCCCCCCCCCCC
Q 039231          443 MTGARGTVGYIAPEVFCRNI----GEVSYKSDVYNYGMMIFEMTGGRKNVDVVDNG  494 (506)
Q Consensus       443 ~~~~~gt~~y~aPE~l~~~~----~~~s~~~Dv~s~G~il~elltg~~pf~~~~~~  494 (506)
                       ....++..|+|||.+.+..    ..++.++|+||||+++|||++|+.||......
T Consensus       159 -~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~  213 (286)
T cd06622         159 -KTNIGCQSYMAPERIKSGGPNQNPTYTVQSDVWSLGLSILEMALGRYPYPPETYA  213 (286)
T ss_pred             -ccCCCccCccCcchhcCCCCCccCCCCcccchHhHHHHHHHHHhCCCCCCCcchh
Confidence             3345788999999984421    23578999999999999999999999765443

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include

>cd06638 STKc_myosinIIIA Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin

Probab=99.94  E-value=7.3e-27  Score=228.60  Aligned_cols=171  Identities=26%  Similarity=0.356  Sum_probs=138.7

Q ss_pred             ccccCccCceEEEEEEEc-CCCEEEEEEeccCCCCchhhHHHHHHhhcc-CccceeEEEEEeec----------------
Q 039231          318 KYKLGQGGYGSVYKGKLL-DGSNVAVKVLNDSKGNGKEFINEVASISRT-SHVNVVALLGFCLR----------------  379 (506)
Q Consensus       318 ~~~ig~G~~g~V~~~~~~-~~~~vavK~l~~~~~~~~~~~~E~~~l~~l-~h~niv~l~g~~~~----------------  379 (506)
                      .+.||+|+||.||+++.. +++.+|+|++........++.+|+.++.++ +||||+++++++..                
T Consensus        23 ~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~~~~lv~e~~  102 (286)
T cd06638          23 IETIGKGTYGKVFKVLNKKNGSKAAVKILDPIHDIDEEIEAEYNILKALSDHPNVVKFYGMYYKKDVKNGDQLWLVLELC  102 (286)
T ss_pred             eeeeccCCCcEEEEEEECCCCceeEEEeeccccchHHHHHHHHHHHHHHhcCCCeeeeeeeeeecccCCCCeEEEEEeec
Confidence            367999999999999875 478999999876544446788999999999 69999999986521                


Q ss_pred             --------------------cchhhhHHHHHHHHHHHHhhcCCCCeEecCcCCCcEEECCCCcEEEeecCCCccccCCCc
Q 039231          380 --------------------VAEELSSTIGIARGLEYLHLGCSTRILHFDIKPHNILLDEDFCPKISDFGLAKICNRKES  439 (506)
Q Consensus       380 --------------------~~~~l~i~~~i~~gl~~LH~~~~~~ivH~dlkp~Nill~~~~~~ki~dfg~a~~~~~~~~  439 (506)
                                          +.....++.|+++||.|||   +.+++||||||+||++++++.+||+|||+++.......
T Consensus       103 ~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dlkp~nili~~~~~~kl~dfg~~~~~~~~~~  179 (286)
T cd06638         103 NGGSVTDLVKGFLKRGERMEEPIIAYILHEALMGLQHLH---VNKTIHRDVKGNNILLTTEGGVKLVDFGVSAQLTSTRL  179 (286)
T ss_pred             CCCCHHHHHHHhhccCccccHHHHHHHHHHHHHHHHHHH---hCCccccCCCHHhEEECCCCCEEEccCCceeecccCCC
Confidence                                0113347889999999999   89999999999999999999999999999986643322


Q ss_pred             ceecccCCCCcccccccccccc---cCCCCccccHHHHHHHHHHHHcCCCCCCCCCC
Q 039231          440 IISMTGARGTVGYIAPEVFCRN---IGEVSYKSDVYNYGMMIFEMTGGRKNVDVVDN  493 (506)
Q Consensus       440 ~~~~~~~~gt~~y~aPE~l~~~---~~~~s~~~Dv~s~G~il~elltg~~pf~~~~~  493 (506)
                      .  .....+++.|+|||++...   ...++.++||||+|+++|||++|+.||.....
T Consensus       180 ~--~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvi~~el~~g~~p~~~~~~  234 (286)
T cd06638         180 R--RNTSVGTPFWMAPEVIACEQQLDSTYDARCDVWSLGITAIELGDGDPPLADLHP  234 (286)
T ss_pred             c--cccccCCCcccChhhhchhhhccccccchhhhhhHHHHHHHHhcCCCCCCCCch
Confidence            1  1345689999999998432   23578899999999999999999999976544

Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear

>cd07865 STKc_CDK9 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9

Probab=99.94  E-value=8.2e-27  Score=230.79  Aligned_cols=174  Identities=26%  Similarity=0.340  Sum_probs=139.2

Q ss_pred             hhccccCccCceEEEEEEEc-CCCEEEEEEeccCCC---CchhhHHHHHHhhccCccceeEEEEEee-------------
Q 039231          316 SFKYKLGQGGYGSVYKGKLL-DGSNVAVKVLNDSKG---NGKEFINEVASISRTSHVNVVALLGFCL-------------  378 (506)
Q Consensus       316 ~~~~~ig~G~~g~V~~~~~~-~~~~vavK~l~~~~~---~~~~~~~E~~~l~~l~h~niv~l~g~~~-------------  378 (506)
                      ...++||+|+||.||+|+.. +++.||||++.....   ....+.+|++++++++||||+++++++.             
T Consensus        15 ~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~~   94 (310)
T cd07865          15 EKLAKIGQGTFGEVFKARHKKTKQIVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPYNRYKGSF   94 (310)
T ss_pred             EEEEEeecCCCEEEEEEEECCCCcEEEEEEEeccCCcCCchhHHHHHHHHHHhCCCCCccceEEEEecccccccCCCceE
Confidence            34567999999999999875 589999999864322   2245678999999999999999998641             


Q ss_pred             ----------------------ccchhhhHHHHHHHHHHHHhhcCCCCeEecCcCCCcEEECCCCcEEEeecCCCccccC
Q 039231          379 ----------------------RVAEELSSTIGIARGLEYLHLGCSTRILHFDIKPHNILLDEDFCPKISDFGLAKICNR  436 (506)
Q Consensus       379 ----------------------~~~~~l~i~~~i~~gl~~LH~~~~~~ivH~dlkp~Nill~~~~~~ki~dfg~a~~~~~  436 (506)
                                            ++.+.+.++.|++.||+|||   +++++|+||||+||++++++.+||+|||++.....
T Consensus        95 ~lv~e~~~~~l~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH---~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~  171 (310)
T cd07865          95 YLVFEFCEHDLAGLLSNKNVKFTLSEIKKVMKMLLNGLYYIH---RNKILHRDMKAANILITKDGILKLADFGLARAFSL  171 (310)
T ss_pred             EEEEcCCCcCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHH---HCCeeccCCCHHHEEECCCCcEEECcCCCcccccC
Confidence                                  22335678899999999999   89999999999999999999999999999976543


Q ss_pred             CCcc--eecccCCCCcccccccccccccCCCCccccHHHHHHHHHHHHcCCCCCCCCCC
Q 039231          437 KESI--ISMTGARGTVGYIAPEVFCRNIGEVSYKSDVYNYGMMIFEMTGGRKNVDVVDN  493 (506)
Q Consensus       437 ~~~~--~~~~~~~gt~~y~aPE~l~~~~~~~s~~~Dv~s~G~il~elltg~~pf~~~~~  493 (506)
                      ....  .......++..|+|||.+.+. ..++.++||||||+++|||++|+.||...+.
T Consensus       172 ~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~~Di~slG~~l~el~t~~~~~~~~~~  229 (310)
T cd07865         172 SKNSKPNRYTNRVVTLWYRPPELLLGE-RDYGPPIDMWGAGCIMAEMWTRSPIMQGNTE  229 (310)
T ss_pred             CcccCCCCccCcccCccccCcHHhcCC-cccCchhhhHHHHHHHHHHHhCCCCCCCCCH
Confidence            2211  111234578889999987543 3467899999999999999999999976543

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multipl

>cd05089 PTKc_Tie1 Catalytic domain of the Protein Tyrosine Kinase, Tie1

Probab=99.94  E-value=5.7e-27  Score=230.88  Aligned_cols=171  Identities=27%  Similarity=0.501  Sum_probs=133.9

Q ss_pred             hhccccCccCceEEEEEEEcC-C--CEEEEEEeccCC--CCchhhHHHHHHhhcc-CccceeEEEEEeec----------
Q 039231          316 SFKYKLGQGGYGSVYKGKLLD-G--SNVAVKVLNDSK--GNGKEFINEVASISRT-SHVNVVALLGFCLR----------  379 (506)
Q Consensus       316 ~~~~~ig~G~~g~V~~~~~~~-~--~~vavK~l~~~~--~~~~~~~~E~~~l~~l-~h~niv~l~g~~~~----------  379 (506)
                      .+.+.||+|+||.||+|...+ +  ..+++|.++...  ...+.+.+|++++.++ +||||+++++++..          
T Consensus         5 ~~~~~lg~g~~g~v~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~lv~e~   84 (297)
T cd05089           5 KFEDVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFASENDHRDFAGELEVLCKLGHHPNIINLLGACENRGYLYIAIEY   84 (297)
T ss_pred             eeeeeecCCCcceEEEEEecCCCCcceeEEEEccccCCHHHHHHHHHHHHHHHhhcCCCchhheEEEEccCCcceEEEEe
Confidence            345689999999999998754 3  347888887422  2235788999999999 79999999887511          


Q ss_pred             ---------------------------------cchhhhHHHHHHHHHHHHhhcCCCCeEecCcCCCcEEECCCCcEEEe
Q 039231          380 ---------------------------------VAEELSSTIGIARGLEYLHLGCSTRILHFDIKPHNILLDEDFCPKIS  426 (506)
Q Consensus       380 ---------------------------------~~~~l~i~~~i~~gl~~LH~~~~~~ivH~dlkp~Nill~~~~~~ki~  426 (506)
                                                       +...+.++.|++.||+|||   +.+++||||||+|||+++++.+||+
T Consensus        85 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH---~~~ivH~dlkp~Nill~~~~~~kl~  161 (297)
T cd05089          85 APYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFASDVATGMQYLS---EKQFIHRDLAARNVLVGENLASKIA  161 (297)
T ss_pred             cCCCcHHHHHHhccccccccccccccCccCCCCHHHHHHHHHHHHHHHHHHH---HCCcccCcCCcceEEECCCCeEEEC
Confidence                                             1124668899999999999   8999999999999999999999999


Q ss_pred             ecCCCccccCCCcceecccCCCCcccccccccccccCCCCccccHHHHHHHHHHHHc-CCCCCCCCCCC
Q 039231          427 DFGLAKICNRKESIISMTGARGTVGYIAPEVFCRNIGEVSYKSDVYNYGMMIFEMTG-GRKNVDVVDNG  494 (506)
Q Consensus       427 dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~s~~~Dv~s~G~il~ellt-g~~pf~~~~~~  494 (506)
                      |||++.......   .......+..|+|||.+...  .++.++||||||+++|||++ |+.||......
T Consensus       162 dfg~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~--~~~~~~DvwSlG~il~el~t~g~~pf~~~~~~  225 (297)
T cd05089         162 DFGLSRGEEVYV---KKTMGRLPVRWMAIESLNYS--VYTTKSDVWSFGVLLWEIVSLGGTPYCGMTCA  225 (297)
T ss_pred             CcCCCcccccee---ccCCCCcCccccCchhhccC--CCCchhhHHHHHHHHHHHHcCCCCCCCCCCHH
Confidence            999986432111   11122335679999998543  68899999999999999997 99999765443

Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations.

>cd07864 STKc_CDK12 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12

Probab=99.94  E-value=1.2e-26  Score=228.86  Aligned_cols=174  Identities=29%  Similarity=0.363  Sum_probs=140.3

Q ss_pred             hhhccccCccCceEEEEEEEc-CCCEEEEEEeccCC---CCchhhHHHHHHhhccCccceeEEEEEee------------
Q 039231          315 NSFKYKLGQGGYGSVYKGKLL-DGSNVAVKVLNDSK---GNGKEFINEVASISRTSHVNVVALLGFCL------------  378 (506)
Q Consensus       315 ~~~~~~ig~G~~g~V~~~~~~-~~~~vavK~l~~~~---~~~~~~~~E~~~l~~l~h~niv~l~g~~~------------  378 (506)
                      +.+.+.||+|++|.||+|... +++.||+|+++...   .....+.+|++++++++||||+++++++.            
T Consensus         9 ~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~l~h~~i~~~~~~~~~~~~~~~~~~~~   88 (302)
T cd07864           9 FDIIGQIGEGTYGQVYKARDKDTGELVALKKVRLDNEKEGFPITAIREIKILRQLNHRNIVNLKEIVTDKQDALDFKKDK   88 (302)
T ss_pred             hheeeeecccCCEEEEEEEECCCCcEEEEEEEeecccccCchHHHHHHHHHHHhCCCCCeeeeeheecCcchhhhccccC
Confidence            344678999999999999985 48899999997532   22356788999999999999999887542            


Q ss_pred             -------------------------ccchhhhHHHHHHHHHHHHhhcCCCCeEecCcCCCcEEECCCCcEEEeecCCCcc
Q 039231          379 -------------------------RVAEELSSTIGIARGLEYLHLGCSTRILHFDIKPHNILLDEDFCPKISDFGLAKI  433 (506)
Q Consensus       379 -------------------------~~~~~l~i~~~i~~gl~~LH~~~~~~ivH~dlkp~Nill~~~~~~ki~dfg~a~~  433 (506)
                                               ++.+.+.++.|++.||+|||   +.+|+|+||+|+||++++++.+||+|||++..
T Consensus        89 ~~~~lv~e~~~~~l~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH---~~~i~H~dl~p~nili~~~~~~kl~dfg~~~~  165 (302)
T cd07864          89 GAFYLVFEYMDHDLMGLLESGLVHFSEDHIKSFMKQLLEGLNYCH---KKNFLHRDIKCSNILLNNKGQIKLADFGLARL  165 (302)
T ss_pred             CcEEEEEcccCccHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEECCCCcEEeCccccccc
Confidence                                     22335678899999999999   89999999999999999999999999999986


Q ss_pred             ccCCCcceecccCCCCcccccccccccccCCCCccccHHHHHHHHHHHHcCCCCCCCCCC
Q 039231          434 CNRKESIISMTGARGTVGYIAPEVFCRNIGEVSYKSDVYNYGMMIFEMTGGRKNVDVVDN  493 (506)
Q Consensus       434 ~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~s~~~Dv~s~G~il~elltg~~pf~~~~~  493 (506)
                      ....... ......++..|+|||.+.+. ..++.++||||||+++|||++|+.||...+.
T Consensus       166 ~~~~~~~-~~~~~~~~~~y~~PE~~~~~-~~~~~~~Di~slG~~~~el~~g~~~~~~~~~  223 (302)
T cd07864         166 YNSEESR-PYTNKVITLWYRPPELLLGE-ERYGPAIDVWSCGCILGELFTKKPIFQANQE  223 (302)
T ss_pred             ccCCccc-ccccceeccCccChHHhcCC-CCCCchhHHHHHHHHHHHHHhCCCCCCCCCh
Confidence            6543321 11223457789999988543 3568899999999999999999999986543

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely

>cd05066 PTKc_EphR_A Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors

Probab=99.94  E-value=6.7e-27  Score=226.60  Aligned_cols=174  Identities=26%  Similarity=0.499  Sum_probs=138.9

Q ss_pred             hhccccCccCceEEEEEEEcC----CCEEEEEEeccCCC--CchhhHHHHHHhhccCccceeEEEEEe------------
Q 039231          316 SFKYKLGQGGYGSVYKGKLLD----GSNVAVKVLNDSKG--NGKEFINEVASISRTSHVNVVALLGFC------------  377 (506)
Q Consensus       316 ~~~~~ig~G~~g~V~~~~~~~----~~~vavK~l~~~~~--~~~~~~~E~~~l~~l~h~niv~l~g~~------------  377 (506)
                      .+.+.||+|+||.||+|+...    +..+|+|.++....  ..+.+.+|+.++.+++||||+++.+++            
T Consensus         7 ~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~   86 (267)
T cd05066           7 KIEKVIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSKPVMIVTEY   86 (267)
T ss_pred             EeeeeecccCCCceEEEEEecCCCCceEEEEEECCCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEecCCccEEEEEc
Confidence            446789999999999998642    34799999865432  235788999999999999999999876            


Q ss_pred             ----------------eccchhhhHHHHHHHHHHHHhhcCCCCeEecCcCCCcEEECCCCcEEEeecCCCccccCCCcce
Q 039231          378 ----------------LRVAEELSSTIGIARGLEYLHLGCSTRILHFDIKPHNILLDEDFCPKISDFGLAKICNRKESII  441 (506)
Q Consensus       378 ----------------~~~~~~l~i~~~i~~gl~~LH~~~~~~ivH~dlkp~Nill~~~~~~ki~dfg~a~~~~~~~~~~  441 (506)
                                      +++.+.+.++.|++.||+|||   +++++|+||||+||++++++.+||+|||+++.........
T Consensus        87 ~~~~~L~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH---~~~i~h~dlkp~nili~~~~~~~l~dfg~~~~~~~~~~~~  163 (267)
T cd05066          87 MENGSLDAFLRKHDGQFTVIQLVGMLRGIASGMKYLS---DMGYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEAA  163 (267)
T ss_pred             CCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH---HCCEeehhhchhcEEECCCCeEEeCCCCccccccccccee
Confidence                            122335778899999999999   8999999999999999999999999999998765433211


Q ss_pred             e-cccCCCCcccccccccccccCCCCccccHHHHHHHHHHHHc-CCCCCCCCCCC
Q 039231          442 S-MTGARGTVGYIAPEVFCRNIGEVSYKSDVYNYGMMIFEMTG-GRKNVDVVDNG  494 (506)
Q Consensus       442 ~-~~~~~gt~~y~aPE~l~~~~~~~s~~~Dv~s~G~il~ellt-g~~pf~~~~~~  494 (506)
                      . .....++..|+|||.+...  .++.++|+||||+++||+++ |+.||......
T Consensus       164 ~~~~~~~~~~~y~~pe~~~~~--~~~~~~Dv~slG~~l~ell~~g~~p~~~~~~~  216 (267)
T cd05066         164 YTTRGGKIPIRWTAPEAIAYR--KFTSASDVWSYGIVMWEVMSYGERPYWEMSNQ  216 (267)
T ss_pred             eecCCCccceeecCHhHhccC--ccCchhhhHHHHHHHHHHhcCCCCCcccCCHH
Confidence            1 1222345689999998543  68899999999999999886 99999766543

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellul

>cd08229 STKc_Nek7 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7

Probab=99.94  E-value=5.8e-27  Score=226.87  Aligned_cols=170  Identities=26%  Similarity=0.439  Sum_probs=139.3

Q ss_pred             hhccccCccCceEEEEEEE-cCCCEEEEEEeccCC----CCchhhHHHHHHhhccCccceeEEEEEee------------
Q 039231          316 SFKYKLGQGGYGSVYKGKL-LDGSNVAVKVLNDSK----GNGKEFINEVASISRTSHVNVVALLGFCL------------  378 (506)
Q Consensus       316 ~~~~~ig~G~~g~V~~~~~-~~~~~vavK~l~~~~----~~~~~~~~E~~~l~~l~h~niv~l~g~~~------------  378 (506)
                      .+.+.||+|++|.||+|+. .++..++||.+....    ....++.+|+++++.++|+||+++++++.            
T Consensus         5 ~~~~~ig~g~~g~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~e~~   84 (267)
T cd08229           5 RIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIVLELA   84 (267)
T ss_pred             hhhhhhcccCCeEEEEEeecCCCceEEEEeeeehhhhhHHHHHHHHHHHHHHHHccCCchhhhhheeEeCCeEEEEEEec
Confidence            3456799999999999986 468999999886432    12357889999999999999999987662            


Q ss_pred             -------------------ccchhhhHHHHHHHHHHHHhhcCCCCeEecCcCCCcEEECCCCcEEEeecCCCccccCCCc
Q 039231          379 -------------------RVAEELSSTIGIARGLEYLHLGCSTRILHFDIKPHNILLDEDFCPKISDFGLAKICNRKES  439 (506)
Q Consensus       379 -------------------~~~~~l~i~~~i~~gl~~LH~~~~~~ivH~dlkp~Nill~~~~~~ki~dfg~a~~~~~~~~  439 (506)
                                         ++...+.++.|++.||+|||   +++++|+||+|+||+++.++.++|+|||++........
T Consensus        85 ~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH---~~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~~  161 (267)
T cd08229          85 DAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALEHMH---SRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTT  161 (267)
T ss_pred             CCCCHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHEEEcCCCCEEECcchhhhccccCCc
Confidence                               12234567889999999999   89999999999999999999999999999876644332


Q ss_pred             ceecccCCCCcccccccccccccCCCCccccHHHHHHHHHHHHcCCCCCCCCC
Q 039231          440 IISMTGARGTVGYIAPEVFCRNIGEVSYKSDVYNYGMMIFEMTGGRKNVDVVD  492 (506)
Q Consensus       440 ~~~~~~~~gt~~y~aPE~l~~~~~~~s~~~Dv~s~G~il~elltg~~pf~~~~  492 (506)
                      .  .....++..|+|||.+.+.  .++.++|+||||+++|||++|..||....
T Consensus       162 ~--~~~~~~~~~~~ape~~~~~--~~~~~~Dv~slG~il~~l~~g~~p~~~~~  210 (267)
T cd08229         162 A--AHSLVGTPYYMSPERIHEN--GYNFKSDIWSLGCLLYEMAALQSPFYGDK  210 (267)
T ss_pred             c--cccccCCcCccCHHHhcCC--CccchhhHHHHHHHHHHHHhCCCCccccc
Confidence            1  1235678899999998554  67889999999999999999999997543

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase.

>cd08224 STKc_Nek6_Nek7 Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7

Probab=99.94  E-value=1.3e-26  Score=224.28  Aligned_cols=169  Identities=27%  Similarity=0.441  Sum_probs=140.0

Q ss_pred             hhccccCccCceEEEEEEEc-CCCEEEEEEeccC----CCCchhhHHHHHHhhccCccceeEEEEEee------------
Q 039231          316 SFKYKLGQGGYGSVYKGKLL-DGSNVAVKVLNDS----KGNGKEFINEVASISRTSHVNVVALLGFCL------------  378 (506)
Q Consensus       316 ~~~~~ig~G~~g~V~~~~~~-~~~~vavK~l~~~----~~~~~~~~~E~~~l~~l~h~niv~l~g~~~------------  378 (506)
                      .+.+.||+|++|.||+|... +|+.+|+|.++..    ....+.+.+|++++++++|+||+++++.+.            
T Consensus         5 ~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~ei~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~   84 (267)
T cd08224           5 KIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLDHPNVIKYLASFIENNELNIVLELA   84 (267)
T ss_pred             eeeeeeccCCceEEEEEEEcCCCCEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEEEEEecC
Confidence            45678999999999999986 6899999988632    222467889999999999999999998752            


Q ss_pred             -------------------ccchhhhHHHHHHHHHHHHhhcCCCCeEecCcCCCcEEECCCCcEEEeecCCCccccCCCc
Q 039231          379 -------------------RVAEELSSTIGIARGLEYLHLGCSTRILHFDIKPHNILLDEDFCPKISDFGLAKICNRKES  439 (506)
Q Consensus       379 -------------------~~~~~l~i~~~i~~gl~~LH~~~~~~ivH~dlkp~Nill~~~~~~ki~dfg~a~~~~~~~~  439 (506)
                                         ...+.+.++.|++.||+|||   +.+++|+||+|+||++++++.++|+|||++........
T Consensus        85 ~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh---~~~i~h~dl~p~nil~~~~~~~~l~d~~~~~~~~~~~~  161 (267)
T cd08224          85 DAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSALEHMH---SKRIMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTT  161 (267)
T ss_pred             CCCCHHHHHHHhcccCCCcCHHHHHHHHHHHHHHHHHHH---hCCEecCCcChhhEEECCCCcEEEeccceeeeccCCCc
Confidence                               12235678899999999999   89999999999999999999999999999876544322


Q ss_pred             ceecccCCCCcccccccccccccCCCCccccHHHHHHHHHHHHcCCCCCCCC
Q 039231          440 IISMTGARGTVGYIAPEVFCRNIGEVSYKSDVYNYGMMIFEMTGGRKNVDVV  491 (506)
Q Consensus       440 ~~~~~~~~gt~~y~aPE~l~~~~~~~s~~~Dv~s~G~il~elltg~~pf~~~  491 (506)
                      .  .....+++.|+|||.+.+.  .++.++||||||+++|||++|+.||...
T Consensus       162 ~--~~~~~~~~~y~apE~~~~~--~~~~~~Di~slG~il~~l~~g~~p~~~~  209 (267)
T cd08224         162 A--AHSLVGTPYYMSPERIHEN--GYNFKSDIWSLGCLLYEMAALQSPFYGD  209 (267)
T ss_pred             c--cceecCCccccCHHHhccC--CCCchhcHHHHHHHHHHHHHCCCCcccC
Confidence            1  1335678899999998543  6888999999999999999999999654

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may a

>cd06629 STKc_MAPKKK_Bck1_like Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases

Probab=99.94  E-value=1e-26  Score=225.79  Aligned_cols=173  Identities=32%  Similarity=0.431  Sum_probs=138.3

Q ss_pred             ccccCccCceEEEEEEEc-CCCEEEEEEeccCCC---C--------chhhHHHHHHhhccCccceeEEEEEee-------
Q 039231          318 KYKLGQGGYGSVYKGKLL-DGSNVAVKVLNDSKG---N--------GKEFINEVASISRTSHVNVVALLGFCL-------  378 (506)
Q Consensus       318 ~~~ig~G~~g~V~~~~~~-~~~~vavK~l~~~~~---~--------~~~~~~E~~~l~~l~h~niv~l~g~~~-------  378 (506)
                      .+.||+|++|.||+|... +++.+|+|.++....   .        .+.+.+|++++++++|+||+++++++.       
T Consensus         6 ~~~lg~g~~~~vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l   85 (272)
T cd06629           6 GELIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDHLNIVQYLGFETTEEYLSI   85 (272)
T ss_pred             cceecccCceEEEEEeecCCCceeeeeeeechhhhhcccchHHHHHHHHHHHHHHHHHhcCCCCcceEEEEeccCCceEE
Confidence            457999999999999864 589999998853211   1        135778999999999999999998761       


Q ss_pred             --------------------ccchhhhHHHHHHHHHHHHhhcCCCCeEecCcCCCcEEECCCCcEEEeecCCCccccCCC
Q 039231          379 --------------------RVAEELSSTIGIARGLEYLHLGCSTRILHFDIKPHNILLDEDFCPKISDFGLAKICNRKE  438 (506)
Q Consensus       379 --------------------~~~~~l~i~~~i~~gl~~LH~~~~~~ivH~dlkp~Nill~~~~~~ki~dfg~a~~~~~~~  438 (506)
                                          ++.....++.|++.||.|||   +++++|+||+|+||++++++.+||+|||+++......
T Consensus        86 v~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~lH---~~~i~H~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~  162 (272)
T cd06629          86 FLEYVPGGSIGSCLRTYGRFEEQLVRFFTEQVLEGLAYLH---SKGILHRDLKADNLLVDADGICKISDFGISKKSDDIY  162 (272)
T ss_pred             EEecCCCCcHHHHHhhccCCCHHHHHHHHHHHHHHHHHHh---hCCeeecCCChhhEEEcCCCeEEEeeccccccccccc
Confidence                                22235567899999999999   8999999999999999999999999999997654322


Q ss_pred             cceecccCCCCcccccccccccccCCCCccccHHHHHHHHHHHHcCCCCCCCCCC
Q 039231          439 SIISMTGARGTVGYIAPEVFCRNIGEVSYKSDVYNYGMMIFEMTGGRKNVDVVDN  493 (506)
Q Consensus       439 ~~~~~~~~~gt~~y~aPE~l~~~~~~~s~~~Dv~s~G~il~elltg~~pf~~~~~  493 (506)
                      .........++..|+|||.+......++.++|+||||+++|||++|..||...+.
T Consensus       163 ~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~  217 (272)
T cd06629         163 DNDQNMSMQGSVFWMAPEVIHSYSQGYSAKVDIWSLGCVVLEMFAGRRPWSDEEA  217 (272)
T ss_pred             cccccccccCCccccCHHHhccccCCCCccchhHHHHHHHHHHHhCCCCCcCcch
Confidence            2111234567899999999865423478899999999999999999999975443

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell inte

>cd07832 STKc_CCRK Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase

Probab=99.94  E-value=1e-26  Score=227.44  Aligned_cols=173  Identities=28%  Similarity=0.409  Sum_probs=142.4

Q ss_pred             hhccccCccCceEEEEEEEc-CCCEEEEEEeccCC---CCchhhHHHHHHhhccCccceeEEEEEe--------------
Q 039231          316 SFKYKLGQGGYGSVYKGKLL-DGSNVAVKVLNDSK---GNGKEFINEVASISRTSHVNVVALLGFC--------------  377 (506)
Q Consensus       316 ~~~~~ig~G~~g~V~~~~~~-~~~~vavK~l~~~~---~~~~~~~~E~~~l~~l~h~niv~l~g~~--------------  377 (506)
                      .+.+.||+|++|.||+|+.. +|+.|++|++....   ...+.+.+|+.++++++||||+++++++              
T Consensus         3 ~~~~~l~~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~~~   82 (286)
T cd07832           3 KILGRIGEGAHGIVFKAKDRETGETVALKKVALRRLEGGIPNQALREIKALQACQHPYVVKLLDVFPHGSGFVLVMEYMP   82 (286)
T ss_pred             eEEeecccCCCcEEEEEEECCCCceEEEEEEEcccccchhhHHHHHHHHHHHhCCCCCCcceeeEEecCCeeEEEecccC
Confidence            34567999999999999975 58999999997543   2336789999999999999999999875              


Q ss_pred             -------------eccchhhhHHHHHHHHHHHHhhcCCCCeEecCcCCCcEEECCCCcEEEeecCCCccccCCCcceecc
Q 039231          378 -------------LRVAEELSSTIGIARGLEYLHLGCSTRILHFDIKPHNILLDEDFCPKISDFGLAKICNRKESIISMT  444 (506)
Q Consensus       378 -------------~~~~~~l~i~~~i~~gl~~LH~~~~~~ivH~dlkp~Nill~~~~~~ki~dfg~a~~~~~~~~~~~~~  444 (506)
                                   +++.+.+.++.|+++||+|||   +.+++|+||||+||++++++.++|+|||++......... ...
T Consensus        83 ~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dl~p~ni~~~~~~~~~l~dfg~~~~~~~~~~~-~~~  158 (286)
T cd07832          83 SDLSEVLRDEERPLPEAQVKSYMRMLLKGVAYMH---ANGIMHRDLKPANLLISADGVLKIADFGLARLFSEEEPR-LYS  158 (286)
T ss_pred             CCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCcCHHHEEEcCCCcEEEeeeeecccccCCCCC-ccc
Confidence                         123345678899999999999   899999999999999999999999999999876543321 123


Q ss_pred             cCCCCcccccccccccccCCCCccccHHHHHHHHHHHHcCCCCCCCCCC
Q 039231          445 GARGTVGYIAPEVFCRNIGEVSYKSDVYNYGMMIFEMTGGRKNVDVVDN  493 (506)
Q Consensus       445 ~~~gt~~y~aPE~l~~~~~~~s~~~Dv~s~G~il~elltg~~pf~~~~~  493 (506)
                      ...++..|+|||.+.+. ..++.++||||+|++++||++|++||....+
T Consensus       159 ~~~~~~~y~aPE~~~~~-~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~  206 (286)
T cd07832         159 HQVATRWYRAPELLYGA-RKYDPGVDLWAVGCIFAELLNGSPLFPGEND  206 (286)
T ss_pred             cccCcccccCceeeecc-ccCCchhHHHHHHHHHHHHHcCCcCcCCCCH
Confidence            45688999999998543 3568899999999999999999888876543

Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of hea

>cd06635 STKc_TAO1 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1

Probab=99.94  E-value=2.5e-26  Score=228.53  Aligned_cols=167  Identities=32%  Similarity=0.459  Sum_probs=138.1

Q ss_pred             ccccCccCceEEEEEEEc-CCCEEEEEEeccCCC----CchhhHHHHHHhhccCccceeEEEEEee--------------
Q 039231          318 KYKLGQGGYGSVYKGKLL-DGSNVAVKVLNDSKG----NGKEFINEVASISRTSHVNVVALLGFCL--------------  378 (506)
Q Consensus       318 ~~~ig~G~~g~V~~~~~~-~~~~vavK~l~~~~~----~~~~~~~E~~~l~~l~h~niv~l~g~~~--------------  378 (506)
                      .+.||+|+||.||+|+.. ++..+|+|++.....    ..+++.+|++++++++|||++++++++.              
T Consensus        30 ~~~lg~G~~~~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~g  109 (317)
T cd06635          30 LREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPNSIEYKGCYLREHTAWLVMEYCLG  109 (317)
T ss_pred             hheeccCCCeEEEEEEEcCCCcEEEEEEEecCCCCchHHHHHHHHHHHHHHhCCCCCEEEEEEEEeeCCeEEEEEeCCCC
Confidence            456999999999999874 588999999865322    2246888999999999999999999762              


Q ss_pred             -------------ccchhhhHHHHHHHHHHHHhhcCCCCeEecCcCCCcEEECCCCcEEEeecCCCccccCCCcceeccc
Q 039231          379 -------------RVAEELSSTIGIARGLEYLHLGCSTRILHFDIKPHNILLDEDFCPKISDFGLAKICNRKESIISMTG  445 (506)
Q Consensus       379 -------------~~~~~l~i~~~i~~gl~~LH~~~~~~ivH~dlkp~Nill~~~~~~ki~dfg~a~~~~~~~~~~~~~~  445 (506)
                                   ++.++..++.|++.||.|||   +.+++|+||+|+||+++.++.+||+|||++......      ..
T Consensus       110 ~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH---~~~i~H~dL~p~Nil~~~~~~~kl~dfg~~~~~~~~------~~  180 (317)
T cd06635         110 SASDLLEVHKKPLQEVEIAAITHGALQGLAYLH---SHNMIHRDIKAGNILLTEPGQVKLADFGSASIASPA------NS  180 (317)
T ss_pred             CHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCcccEEECCCCCEEEecCCCccccCCc------cc
Confidence                         22335668899999999999   899999999999999999999999999998754332      23


Q ss_pred             CCCCccccccccccc-ccCCCCccccHHHHHHHHHHHHcCCCCCCCCCC
Q 039231          446 ARGTVGYIAPEVFCR-NIGEVSYKSDVYNYGMMIFEMTGGRKNVDVVDN  493 (506)
Q Consensus       446 ~~gt~~y~aPE~l~~-~~~~~s~~~Dv~s~G~il~elltg~~pf~~~~~  493 (506)
                      ..++..|+|||.+.. ..+.++.++||||||+++|||++|+.||...+.
T Consensus       181 ~~~~~~y~aPE~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~  229 (317)
T cd06635         181 FVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNA  229 (317)
T ss_pred             ccCCccccChhhhhcCCCCCCCccccHHHHHHHHHHHHhCCCCCCCccH
Confidence            457889999999743 224678899999999999999999999976543

Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuron

>cd05081 PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

Probab=99.94  E-value=8e-27  Score=228.12  Aligned_cols=168  Identities=30%  Similarity=0.485  Sum_probs=135.0

Q ss_pred             hccccCccCceEEEEEEEc-----CCCEEEEEEeccCCC-CchhhHHHHHHhhccCccceeEEEEEee------------
Q 039231          317 FKYKLGQGGYGSVYKGKLL-----DGSNVAVKVLNDSKG-NGKEFINEVASISRTSHVNVVALLGFCL------------  378 (506)
Q Consensus       317 ~~~~ig~G~~g~V~~~~~~-----~~~~vavK~l~~~~~-~~~~~~~E~~~l~~l~h~niv~l~g~~~------------  378 (506)
                      +.+.||+|+||.||++...     ++..||+|+++.... ..+.+.+|++++++++||||+++.+++.            
T Consensus         8 ~~~~lg~g~~g~v~~~~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~e   87 (284)
T cd05081           8 FIQQLGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHSTAEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLRLVME   87 (284)
T ss_pred             eeeeccCCCCceEEEEEecCCcCCCCcEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCeeEEEEEEccCCCCceEEEEE
Confidence            4567999999999999742     478999999875433 3467889999999999999999988651            


Q ss_pred             ------------------ccchhhhHHHHHHHHHHHHhhcCCCCeEecCcCCCcEEECCCCcEEEeecCCCccccCCCcc
Q 039231          379 ------------------RVAEELSSTIGIARGLEYLHLGCSTRILHFDIKPHNILLDEDFCPKISDFGLAKICNRKESI  440 (506)
Q Consensus       379 ------------------~~~~~l~i~~~i~~gl~~LH~~~~~~ivH~dlkp~Nill~~~~~~ki~dfg~a~~~~~~~~~  440 (506)
                                        ++...+.++.|++.||+|||   +.+++||||||+||++++++.+||+|||+++........
T Consensus        88 ~~~~~~L~~~l~~~~~~l~~~~~~~~~~~l~~aL~~LH---~~~i~H~dlkp~nili~~~~~~~l~dfg~~~~~~~~~~~  164 (284)
T cd05081          88 YLPYGSLRDYLQKHRERLDHRKLLLYASQICKGMEYLG---SKRYVHRDLATRNILVESENRVKIGDFGLTKVLPQDKEY  164 (284)
T ss_pred             ecCCCCHHHHHHhcCcCCCHHHHHHHHHHHHHHHHHHH---HCCceeccCCHhhEEECCCCeEEECCCcccccccCCCcc
Confidence                              12234668899999999999   899999999999999999999999999999876543322


Q ss_pred             eec-ccCCCCcccccccccccccCCCCccccHHHHHHHHHHHHcCCCCCC
Q 039231          441 ISM-TGARGTVGYIAPEVFCRNIGEVSYKSDVYNYGMMIFEMTGGRKNVD  489 (506)
Q Consensus       441 ~~~-~~~~gt~~y~aPE~l~~~~~~~s~~~Dv~s~G~il~elltg~~pf~  489 (506)
                      ... ....++..|+|||.+.+.  .++.++||||||+++|||++|..|+.
T Consensus       165 ~~~~~~~~~~~~y~aPE~~~~~--~~~~~~Di~slG~~l~el~~~~~~~~  212 (284)
T cd05081         165 YKVREPGESPIFWYAPESLTES--KFSVASDVWSFGVVLYELFTYSDKSC  212 (284)
T ss_pred             eeecCCCCCceEeeCHHHhccC--CcChHHHHHHHHHHHHHHhhcCCcCC
Confidence            111 122344569999998543  68899999999999999999877754

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as th

>cd05088 PTKc_Tie2 Catalytic domain of the Protein Tyrosine Kinase, Tie2

Probab=99.94  E-value=4.7e-27  Score=232.22  Aligned_cols=172  Identities=27%  Similarity=0.511  Sum_probs=134.6

Q ss_pred             hhhccccCccCceEEEEEEEcC-CC--EEEEEEeccCC--CCchhhHHHHHHhhcc-CccceeEEEEEee----------
Q 039231          315 NSFKYKLGQGGYGSVYKGKLLD-GS--NVAVKVLNDSK--GNGKEFINEVASISRT-SHVNVVALLGFCL----------  378 (506)
Q Consensus       315 ~~~~~~ig~G~~g~V~~~~~~~-~~--~vavK~l~~~~--~~~~~~~~E~~~l~~l-~h~niv~l~g~~~----------  378 (506)
                      +.+.+.||+|+||.||+|++++ +.  .+++|.++...  ...+++.+|++++.++ +|+||+++++++.          
T Consensus         9 ~~~~~~lg~G~~g~V~~a~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~Ei~~l~~l~~h~~iv~~~~~~~~~~~~~lv~e   88 (303)
T cd05088           9 IKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIE   88 (303)
T ss_pred             ceeeeeecCCCCceEEEEEEccCCceeeEEEEEecccCCHHHHHHHHHHHHHHHHhcCCCCcceEEEEECCCCCceEEEE
Confidence            3456789999999999998753 44  45777776432  2335788899999999 8999999998761          


Q ss_pred             ---------------------------------ccchhhhHHHHHHHHHHHHhhcCCCCeEecCcCCCcEEECCCCcEEE
Q 039231          379 ---------------------------------RVAEELSSTIGIARGLEYLHLGCSTRILHFDIKPHNILLDEDFCPKI  425 (506)
Q Consensus       379 ---------------------------------~~~~~l~i~~~i~~gl~~LH~~~~~~ivH~dlkp~Nill~~~~~~ki  425 (506)
                                                       ++.+.+.++.|++.||+|||   +.+++||||||+|||+++++.+||
T Consensus        89 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH---~~gi~H~dlkp~Nili~~~~~~kl  165 (303)
T cd05088          89 YAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLS---QKQFIHRDLAARNILVGENYVAKI  165 (303)
T ss_pred             eCCCCcHHHHHHhcccccccccccccccccCcCCHHHHHHHHHHHHHHHHHHH---hCCccccccchheEEecCCCcEEe
Confidence                                             12235678899999999999   899999999999999999999999


Q ss_pred             eecCCCccccCCCcceecccCCCCcccccccccccccCCCCccccHHHHHHHHHHHHc-CCCCCCCCCCC
Q 039231          426 SDFGLAKICNRKESIISMTGARGTVGYIAPEVFCRNIGEVSYKSDVYNYGMMIFEMTG-GRKNVDVVDNG  494 (506)
Q Consensus       426 ~dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~s~~~Dv~s~G~il~ellt-g~~pf~~~~~~  494 (506)
                      +|||+++......   .......+..|+|||.+...  .++.++||||||+++|||+| |..||...+..
T Consensus       166 ~dfg~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~--~~~~~~Di~slG~il~ellt~g~~p~~~~~~~  230 (303)
T cd05088         166 ADFGLSRGQEVYV---KKTMGRLPVRWMAIESLNYS--VYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCA  230 (303)
T ss_pred             CccccCcccchhh---hcccCCCcccccCHHHHhcc--CCcccccchhhhhHHHHHHhcCCCCcccCChH
Confidence            9999986432111   11223346679999988543  67899999999999999998 99999765443

Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of A

>cd06632 STKc_MEKK1_plant Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1

Probab=99.94  E-value=7.2e-27  Score=224.71  Aligned_cols=169  Identities=33%  Similarity=0.468  Sum_probs=140.5

Q ss_pred             ccccCccCceEEEEEEEc-CCCEEEEEEeccCC------CCchhhHHHHHHhhccCccceeEEEEEee------------
Q 039231          318 KYKLGQGGYGSVYKGKLL-DGSNVAVKVLNDSK------GNGKEFINEVASISRTSHVNVVALLGFCL------------  378 (506)
Q Consensus       318 ~~~ig~G~~g~V~~~~~~-~~~~vavK~l~~~~------~~~~~~~~E~~~l~~l~h~niv~l~g~~~------------  378 (506)
                      .+.||+|++|.||+|... ++..|++|.+....      ...+.+.+|++++++++|+||+++.+++.            
T Consensus         5 ~~~ig~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~   84 (258)
T cd06632           5 GELLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQYLGTEREEDNLYIFLELV   84 (258)
T ss_pred             cceeeecCCceEEEEEEcCCCcEEEEEEEEEccccccchHHHHHHHHHHHHHHhcCCCCchheeeeEecCCeEEEEEEec
Confidence            467999999999999986 68999999986432      12357889999999999999999998761            


Q ss_pred             ---------------ccchhhhHHHHHHHHHHHHhhcCCCCeEecCcCCCcEEECCCCcEEEeecCCCccccCCCcceec
Q 039231          379 ---------------RVAEELSSTIGIARGLEYLHLGCSTRILHFDIKPHNILLDEDFCPKISDFGLAKICNRKESIISM  443 (506)
Q Consensus       379 ---------------~~~~~l~i~~~i~~gl~~LH~~~~~~ivH~dlkp~Nill~~~~~~ki~dfg~a~~~~~~~~~~~~  443 (506)
                                     ++...+.++.|++.||+|||   +.+++|+||+|+||+++.++.+||+|||++........   .
T Consensus        85 ~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dl~~~ni~~~~~~~~kl~d~~~~~~~~~~~~---~  158 (258)
T cd06632          85 PGGSLAKLLKKYGSFPEPVIRLYTRQILLGLEYLH---DRNTVHRDIKGANILVDTNGVVKLADFGMAKQVVEFSF---A  158 (258)
T ss_pred             CCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCHHHEEECCCCCEEEccCccceecccccc---c
Confidence                           22335568899999999999   89999999999999999999999999999887644331   2


Q ss_pred             ccCCCCcccccccccccccCCCCccccHHHHHHHHHHHHcCCCCCCCCCC
Q 039231          444 TGARGTVGYIAPEVFCRNIGEVSYKSDVYNYGMMIFEMTGGRKNVDVVDN  493 (506)
Q Consensus       444 ~~~~gt~~y~aPE~l~~~~~~~s~~~Dv~s~G~il~elltg~~pf~~~~~  493 (506)
                      ....++..|+|||.+... ..++.++|+||||+++|||++|+.||.....
T Consensus       159 ~~~~~~~~y~~pe~~~~~-~~~~~~~D~~slG~~l~~l~~g~~pf~~~~~  207 (258)
T cd06632         159 KSFKGSPYWMAPEVIAQQ-GGYGLAADIWSLGCTVLEMATGKPPWSQLEG  207 (258)
T ss_pred             cccCCCcceeCHHHhcCC-CCCCchhhhHHHHHHHHHHHhCCCCcccCcH
Confidence            345678899999998554 2378999999999999999999999977653

Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidops

>PLN00009 cyclin-dependent kinase A; Provisional

Probab=99.94  E-value=1.2e-26  Score=228.02  Aligned_cols=171  Identities=29%  Similarity=0.402  Sum_probs=137.8

Q ss_pred             hccccCccCceEEEEEEEc-CCCEEEEEEeccCC---CCchhhHHHHHHhhccCccceeEEEEEeec-------------
Q 039231          317 FKYKLGQGGYGSVYKGKLL-DGSNVAVKVLNDSK---GNGKEFINEVASISRTSHVNVVALLGFCLR-------------  379 (506)
Q Consensus       317 ~~~~ig~G~~g~V~~~~~~-~~~~vavK~l~~~~---~~~~~~~~E~~~l~~l~h~niv~l~g~~~~-------------  379 (506)
                      +.+.||+|++|.||+|+.. +++.+|+|++....   ...+.+.+|++++++++||||+++++++..             
T Consensus         6 ~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~   85 (294)
T PLN00009          6 KVEKIGEGTYGVVYKARDRVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVRLQDVVHSEKRLYLVFEYLDL   85 (294)
T ss_pred             EEEEecCCCCEEEEEEEecCCCcEEEEEehhhccccccchHHHHHHHHHHHhccCCCEeeEEEEEecCCeEEEEEecccc
Confidence            3467999999999999875 58899999986432   223568899999999999999999988721             


Q ss_pred             ---------------cchhhhHHHHHHHHHHHHhhcCCCCeEecCcCCCcEEECC-CCcEEEeecCCCccccCCCcceec
Q 039231          380 ---------------VAEELSSTIGIARGLEYLHLGCSTRILHFDIKPHNILLDE-DFCPKISDFGLAKICNRKESIISM  443 (506)
Q Consensus       380 ---------------~~~~l~i~~~i~~gl~~LH~~~~~~ivH~dlkp~Nill~~-~~~~ki~dfg~a~~~~~~~~~~~~  443 (506)
                                     +.....++.||+.||+|||   +++++|+||+|+||++++ ++.+||+|||++........  ..
T Consensus        86 ~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH---~~~i~H~dl~p~nill~~~~~~~kl~dfg~~~~~~~~~~--~~  160 (294)
T PLN00009         86 DLKKHMDSSPDFAKNPRLIKTYLYQILRGIAYCH---SHRVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPVR--TF  160 (294)
T ss_pred             cHHHHHHhCCCCCcCHHHHHHHHHHHHHHHHHHH---hCCeeCCCCCcceEEEECCCCEEEEcccccccccCCCcc--cc
Confidence                           1223467889999999999   899999999999999985 56799999999976543221  11


Q ss_pred             ccCCCCcccccccccccccCCCCccccHHHHHHHHHHHHcCCCCCCCCCC
Q 039231          444 TGARGTVGYIAPEVFCRNIGEVSYKSDVYNYGMMIFEMTGGRKNVDVVDN  493 (506)
Q Consensus       444 ~~~~gt~~y~aPE~l~~~~~~~s~~~Dv~s~G~il~elltg~~pf~~~~~  493 (506)
                      ....+++.|+|||.+.+. ..++.++||||||+++|||++|+.||....+
T Consensus       161 ~~~~~~~~y~~PE~~~~~-~~~~~~~Dv~slG~i~~~l~tg~~pf~~~~~  209 (294)
T PLN00009        161 THEVVTLWYRAPEILLGS-RHYSTPVDIWSVGCIFAEMVNQKPLFPGDSE  209 (294)
T ss_pred             ccCceeecccCHHHHhCC-CCCCcHHHHHHHHHHHHHHHhCCCCCCCCCH
Confidence            334568899999988543 3578899999999999999999999986544

>cd05095 PTKc_DDR2 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2

Probab=99.94  E-value=6.2e-27  Score=230.50  Aligned_cols=174  Identities=25%  Similarity=0.430  Sum_probs=137.2

Q ss_pred             hhhccccCccCceEEEEEEEc-----------------CCCEEEEEEeccCCC--CchhhHHHHHHhhccCccceeEEEE
Q 039231          315 NSFKYKLGQGGYGSVYKGKLL-----------------DGSNVAVKVLNDSKG--NGKEFINEVASISRTSHVNVVALLG  375 (506)
Q Consensus       315 ~~~~~~ig~G~~g~V~~~~~~-----------------~~~~vavK~l~~~~~--~~~~~~~E~~~l~~l~h~niv~l~g  375 (506)
                      +.+.++||+|+||.||+++..                 ++..+|+|++.....  ..+++.+|++++++++|+||+++++
T Consensus         7 ~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~~~~   86 (296)
T cd05095           7 LTFKEKLGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDANKNARNDFLKEIKIMSRLKDPNIIRLLA   86 (296)
T ss_pred             ceeeeeccCCCCCeEEecccccccccccccccccCCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcceEEE
Confidence            445678999999999998532                 234689999875432  2367899999999999999999998


Q ss_pred             Eeec--------------------------------------cchhhhHHHHHHHHHHHHhhcCCCCeEecCcCCCcEEE
Q 039231          376 FCLR--------------------------------------VAEELSSTIGIARGLEYLHLGCSTRILHFDIKPHNILL  417 (506)
Q Consensus       376 ~~~~--------------------------------------~~~~l~i~~~i~~gl~~LH~~~~~~ivH~dlkp~Nill  417 (506)
                      ++..                                      +...+.++.|++.||+|||   +.+++|+||||+||++
T Consensus        87 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH---~~~i~H~dlkp~Nili  163 (296)
T cd05095          87 VCITSDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTISYSTLIFMATQIASGMKYLS---SLNFVHRDLATRNCLV  163 (296)
T ss_pred             EEecCCccEEEEEeCCCCcHHHHHHhcCcccccccccccccCHHHHHHHHHHHHHHHHHHH---HCCeecccCChheEEE
Confidence            7611                                      1135678899999999999   8999999999999999


Q ss_pred             CCCCcEEEeecCCCccccCCCcceecccCCCCcccccccccccccCCCCccccHHHHHHHHHHHHc--CCCCCCCCCC
Q 039231          418 DEDFCPKISDFGLAKICNRKESIISMTGARGTVGYIAPEVFCRNIGEVSYKSDVYNYGMMIFEMTG--GRKNVDVVDN  493 (506)
Q Consensus       418 ~~~~~~ki~dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~s~~~Dv~s~G~il~ellt--g~~pf~~~~~  493 (506)
                      ++++.+||+|||+++...............++..|+|||....  +.++.++||||||+++|||++  |..||.....
T Consensus       164 ~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~--~~~~~~~DiwSlG~~l~el~~~~~~~p~~~~~~  239 (296)
T cd05095         164 GKNYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMSWESILL--GKFTTASDVWAFGVTLWEILTLCKEQPYSQLSD  239 (296)
T ss_pred             cCCCCEEeccCcccccccCCcceeccCcCcCccccCCHHHHhc--CCccchhhhhHHHHHHHHHHHhCCCCCccccCh
Confidence            9999999999999986544332111122344678999998754  368999999999999999998  7888876543

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues wit

>cd07841 STKc_CDK7 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7

Probab=99.94  E-value=8.1e-27  Score=229.75  Aligned_cols=171  Identities=30%  Similarity=0.383  Sum_probs=139.6

Q ss_pred             hccccCccCceEEEEEEEc-CCCEEEEEEeccCCCC------chhhHHHHHHhhccCccceeEEEEEee-----------
Q 039231          317 FKYKLGQGGYGSVYKGKLL-DGSNVAVKVLNDSKGN------GKEFINEVASISRTSHVNVVALLGFCL-----------  378 (506)
Q Consensus       317 ~~~~ig~G~~g~V~~~~~~-~~~~vavK~l~~~~~~------~~~~~~E~~~l~~l~h~niv~l~g~~~-----------  378 (506)
                      +.+.||+|++|.||+|... +++.||||+++.....      ...+.+|++++++++|+||+++++++.           
T Consensus         4 ~~~~lg~g~~~~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~   83 (298)
T cd07841           4 KGKKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELKHPNIIGLLDVFGHKSNINLVFEF   83 (298)
T ss_pred             eeeeeeeccccEEEEEEECCCCcEEEEEEEeccccccccchhhHHHHHHHHHHhhcCCCCChhhhheeecCCEEEEEEcc
Confidence            4567999999999999875 5899999999754322      245678999999999999999988762           


Q ss_pred             ----------------ccchhhhHHHHHHHHHHHHhhcCCCCeEecCcCCCcEEECCCCcEEEeecCCCccccCCCccee
Q 039231          379 ----------------RVAEELSSTIGIARGLEYLHLGCSTRILHFDIKPHNILLDEDFCPKISDFGLAKICNRKESIIS  442 (506)
Q Consensus       379 ----------------~~~~~l~i~~~i~~gl~~LH~~~~~~ivH~dlkp~Nill~~~~~~ki~dfg~a~~~~~~~~~~~  442 (506)
                                      ++.+.+.++.||++||+|||   +.+++|+||+|+||+++.++.+||+|||+++........  
T Consensus        84 ~~~~L~~~i~~~~~~~~~~~~~~~~~qi~~al~~lH---~~~i~H~dl~p~nill~~~~~~~l~dfg~~~~~~~~~~~--  158 (298)
T cd07841          84 METDLEKVIKDKSIVLTPADIKSYMLMTLRGLEYLH---SNWILHRDLKPNNLLIASDGVLKLADFGLARSFGSPNRK--  158 (298)
T ss_pred             cCCCHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHH---hCCeeecCCChhhEEEcCCCCEEEccceeeeeccCCCcc--
Confidence                            23335678999999999999   899999999999999999999999999999876543221  


Q ss_pred             cccCCCCcccccccccccccCCCCccccHHHHHHHHHHHHcCCCCCCCCCC
Q 039231          443 MTGARGTVGYIAPEVFCRNIGEVSYKSDVYNYGMMIFEMTGGRKNVDVVDN  493 (506)
Q Consensus       443 ~~~~~gt~~y~aPE~l~~~~~~~s~~~Dv~s~G~il~elltg~~pf~~~~~  493 (506)
                      .....+++.|+|||.+.+. ..++.++||||||+++|||++|..||....+
T Consensus       159 ~~~~~~~~~y~aPE~~~~~-~~~~~~~Dv~slG~il~e~~~g~~~~~~~~~  208 (298)
T cd07841         159 MTHQVVTRWYRAPELLFGA-RHYGVGVDMWSVGCIFAELLLRVPFLPGDSD  208 (298)
T ss_pred             ccccccceeeeCHHHHhCC-CCCCcHHHHHHHHHHHHHHHcCCccccCCcc
Confidence            1334567889999988543 3678899999999999999999888876544

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is

>PTZ00024 cyclin-dependent protein kinase; Provisional

Probab=99.94  E-value=1.1e-26  Score=232.90  Aligned_cols=174  Identities=25%  Similarity=0.330  Sum_probs=139.6

Q ss_pred             ccccCccCceEEEEEEEc-CCCEEEEEEeccCCCCc---------------hhhHHHHHHhhccCccceeEEEEEee---
Q 039231          318 KYKLGQGGYGSVYKGKLL-DGSNVAVKVLNDSKGNG---------------KEFINEVASISRTSHVNVVALLGFCL---  378 (506)
Q Consensus       318 ~~~ig~G~~g~V~~~~~~-~~~~vavK~l~~~~~~~---------------~~~~~E~~~l~~l~h~niv~l~g~~~---  378 (506)
                      .+.||+|+||.||+|+.. +++.||||+++......               ..+.+|++++++++|+||+++++++.   
T Consensus        14 ~~~ig~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~   93 (335)
T PTZ00024         14 GAHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIMNEIKHENIMGLVDVYVEGD   93 (335)
T ss_pred             hhcccCCCceeEEEEEECCCCCeEEEEEeeccccccccccchhhhcccccchhHHHHHHHHHhCCCcceeeeeEEEecCC
Confidence            456999999999999875 58999999986432211               24778999999999999999998762   


Q ss_pred             -----------------------ccchhhhHHHHHHHHHHHHhhcCCCCeEecCcCCCcEEECCCCcEEEeecCCCcccc
Q 039231          379 -----------------------RVAEELSSTIGIARGLEYLHLGCSTRILHFDIKPHNILLDEDFCPKISDFGLAKICN  435 (506)
Q Consensus       379 -----------------------~~~~~l~i~~~i~~gl~~LH~~~~~~ivH~dlkp~Nill~~~~~~ki~dfg~a~~~~  435 (506)
                                             .....+.++.|++.||+|||   +.+++|+||+|+||+++.++.+||+|||+++...
T Consensus        94 ~~~lv~e~~~~~l~~~l~~~~~~~~~~~~~~~~ql~~aL~~LH---~~~i~H~dl~~~nill~~~~~~kl~dfg~~~~~~  170 (335)
T PTZ00024         94 FINLVMDIMASDLKKVVDRKIRLTESQVKCILLQILNGLNVLH---KWYFMHRDLSPANIFINSKGICKIADFGLARRYG  170 (335)
T ss_pred             cEEEEEeccccCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH---hCCeecccccHHHeEECCCCCEEECCccceeecc
Confidence                                   22335668999999999999   8999999999999999999999999999997654


Q ss_pred             CCC------------cceecccCCCCcccccccccccccCCCCccccHHHHHHHHHHHHcCCCCCCCCCCCc
Q 039231          436 RKE------------SIISMTGARGTVGYIAPEVFCRNIGEVSYKSDVYNYGMMIFEMTGGRKNVDVVDNGS  495 (506)
Q Consensus       436 ~~~------------~~~~~~~~~gt~~y~aPE~l~~~~~~~s~~~Dv~s~G~il~elltg~~pf~~~~~~~  495 (506)
                      ...            .........+++.|+|||.+.+. ..++.++||||||+++|||++|+.||...++.+
T Consensus       171 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~  241 (335)
T PTZ00024        171 YPPYSDTLSKDETMQRREEMTSKVVTLWYRAPELLMGA-EKYHFAVDMWSVGCIFAELLTGKPLFPGENEID  241 (335)
T ss_pred             cccccccccccccccccccccccccccCCCCChhcccC-CCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHH
Confidence            111            01111234568889999998653 357889999999999999999999998765543

>KOG0696 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.94  E-value=8.5e-28  Score=229.31  Aligned_cols=186  Identities=25%  Similarity=0.345  Sum_probs=145.1

Q ss_pred             HHHHHhhhccccCccCceEEEEEEEcC-CCEEEEEEeccCC----CCchhhHHHHHHhhccC-ccceeEEEEEe------
Q 039231          310 IKKMTNSFKYKLGQGGYGSVYKGKLLD-GSNVAVKVLNDSK----GNGKEFINEVASISRTS-HVNVVALLGFC------  377 (506)
Q Consensus       310 l~~~~~~~~~~ig~G~~g~V~~~~~~~-~~~vavK~l~~~~----~~~~~~~~E~~~l~~l~-h~niv~l~g~~------  377 (506)
                      +.....+|-.+||+|+||.|.+|.-+. ...+|||+++++-    .+.+--+.|-++|+-.. -|-++++.-++      
T Consensus       346 i~~tDFnFl~VlGKGSFGKVlLaerkgtdELyAiKiLkKDViiQdDDvectm~EKrvLAL~~kppFL~qlHScFQTmDRL  425 (683)
T KOG0696|consen  346 IKATDFNFLMVLGKGSFGKVLLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLVQLHSCFQTMDRL  425 (683)
T ss_pred             eeecccceEEEeccCccceeeeecccCcchhhhhhhhccceeeecCcccceehhhhheecCCCCchHHHHHHHhhhhhhe
Confidence            344455777899999999999997644 5789999998642    23333455666666553 33444443222      


Q ss_pred             ---------------------eccchhhhHHHHHHHHHHHHhhcCCCCeEecCcCCCcEEECCCCcEEEeecCCCccccC
Q 039231          378 ---------------------LRVAEELSSTIGIARGLEYLHLGCSTRILHFDIKPHNILLDEDFCPKISDFGLAKICNR  436 (506)
Q Consensus       378 ---------------------~~~~~~l~i~~~i~~gl~~LH~~~~~~ivH~dlkp~Nill~~~~~~ki~dfg~a~~~~~  436 (506)
                                           +.+..+...+..||-||-+||   +++|+.||||.+|||||.+|++||+|||+++.---
T Consensus       426 yFVMEyvnGGDLMyhiQQ~GkFKEp~AvFYAaEiaigLFFLh---~kgIiYRDLKLDNvmLd~eGHiKi~DFGmcKEni~  502 (683)
T KOG0696|consen  426 YFVMEYVNGGDLMYHIQQVGKFKEPVAVFYAAEIAIGLFFLH---SKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENIF  502 (683)
T ss_pred             eeEEEEecCchhhhHHHHhcccCCchhhhhhHHHHHHhhhhh---cCCeeeeeccccceEeccCCceEeeeccccccccc
Confidence                                 334446678899999999999   99999999999999999999999999999986433


Q ss_pred             CCcceecccCCCCcccccccccccccCCCCccccHHHHHHHHHHHHcCCCCCCCCCCCcchhhhhh
Q 039231          437 KESIISMTGARGTVGYIAPEVFCRNIGEVSYKSDVYNYGMMIFEMTGGRKNVDVVDNGSTALDLQA  502 (506)
Q Consensus       437 ~~~~~~~~~~~gt~~y~aPE~l~~~~~~~s~~~Dv~s~G~il~elltg~~pf~~~~~~~~~~~~~~  502 (506)
                      +.  .+.....||+.|+|||++.-.  +|+..+|+|||||+||||+.|.+||+..++++....|.+
T Consensus       503 ~~--~TTkTFCGTPdYiAPEIi~Yq--PYgksvDWWa~GVLLyEmlaGQpPFdGeDE~elF~aI~e  564 (683)
T KOG0696|consen  503 DG--VTTKTFCGTPDYIAPEIIAYQ--PYGKSVDWWAFGVLLYEMLAGQPPFDGEDEDELFQAIME  564 (683)
T ss_pred             CC--cceeeecCCCcccccceEEec--ccccchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHH
Confidence            22  234668899999999999654  899999999999999999999999999988887766654

>cd05079 PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1

Probab=99.94  E-value=9.6e-27  Score=227.68  Aligned_cols=169  Identities=25%  Similarity=0.445  Sum_probs=136.4

Q ss_pred             hhhccccCccCceEEEEEEE-----cCCCEEEEEEeccCC--CCchhhHHHHHHhhccCccceeEEEEEee---------
Q 039231          315 NSFKYKLGQGGYGSVYKGKL-----LDGSNVAVKVLNDSK--GNGKEFINEVASISRTSHVNVVALLGFCL---------  378 (506)
Q Consensus       315 ~~~~~~ig~G~~g~V~~~~~-----~~~~~vavK~l~~~~--~~~~~~~~E~~~l~~l~h~niv~l~g~~~---------  378 (506)
                      +...++||+|+||.||+++.     .++..||+|.++...  ...+.+.+|++++++++||||+++.+++.         
T Consensus         6 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~l   85 (284)
T cd05079           6 LKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNGIKL   85 (284)
T ss_pred             hhhceecCCCCceeEEEEEEccCCCCccceEEEEEcCccccHHHHHHHHHHHHHHHhCCCCCeeeeeeEEecCCCCceEE
Confidence            34456799999999999974     247889999987542  22367889999999999999999988652         


Q ss_pred             ---------------------ccchhhhHHHHHHHHHHHHhhcCCCCeEecCcCCCcEEECCCCcEEEeecCCCccccCC
Q 039231          379 ---------------------RVAEELSSTIGIARGLEYLHLGCSTRILHFDIKPHNILLDEDFCPKISDFGLAKICNRK  437 (506)
Q Consensus       379 ---------------------~~~~~l~i~~~i~~gl~~LH~~~~~~ivH~dlkp~Nill~~~~~~ki~dfg~a~~~~~~  437 (506)
                                           ++.+++.++.|++.||+|||   +++++||||||+||++++++.+||+|||+++.....
T Consensus        86 v~e~~~g~~L~~~l~~~~~~~~~~~~~~i~~~i~~aL~~lH---~~gi~H~dlkp~Nil~~~~~~~~l~dfg~~~~~~~~  162 (284)
T cd05079          86 IMEFLPSGSLKEYLPRNKNKINLKQQLKYAVQICKGMDYLG---SRQYVHRDLAARNVLVESEHQVKIGDFGLTKAIETD  162 (284)
T ss_pred             EEEccCCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHH---HCCeeecccchheEEEcCCCCEEECCCccccccccC
Confidence                                 22335678899999999999   899999999999999999999999999999876543


Q ss_pred             Cccee-cccCCCCcccccccccccccCCCCccccHHHHHHHHHHHHcCCCCC
Q 039231          438 ESIIS-MTGARGTVGYIAPEVFCRNIGEVSYKSDVYNYGMMIFEMTGGRKNV  488 (506)
Q Consensus       438 ~~~~~-~~~~~gt~~y~aPE~l~~~~~~~s~~~Dv~s~G~il~elltg~~pf  488 (506)
                      ..... .....++..|+|||.+.+.  .++.++||||||+++|||++++.|.
T Consensus       163 ~~~~~~~~~~~~~~~y~apE~~~~~--~~~~~~Di~slG~il~ellt~~~~~  212 (284)
T cd05079         163 KEYYTVKDDLDSPVFWYAPECLIQS--KFYIASDVWSFGVTLYELLTYCDSE  212 (284)
T ss_pred             ccceeecCCCCCCccccCHHHhccC--CCCccccchhhhhhhhhhhcCCCCC
Confidence            32111 1234567789999998553  6889999999999999999987765

Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers a

>cd07836 STKc_Pho85 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85

Probab=99.94  E-value=1.3e-26  Score=226.51  Aligned_cols=173  Identities=29%  Similarity=0.419  Sum_probs=141.4

Q ss_pred             hccccCccCceEEEEEEEc-CCCEEEEEEeccCCC--CchhhHHHHHHhhccCccceeEEEEEee---------------
Q 039231          317 FKYKLGQGGYGSVYKGKLL-DGSNVAVKVLNDSKG--NGKEFINEVASISRTSHVNVVALLGFCL---------------  378 (506)
Q Consensus       317 ~~~~ig~G~~g~V~~~~~~-~~~~vavK~l~~~~~--~~~~~~~E~~~l~~l~h~niv~l~g~~~---------------  378 (506)
                      +.++||+|++|.||+|+.. +|..||||+++....  ....+.+|++++++++|+||+++++++.               
T Consensus         4 ~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~   83 (284)
T cd07836           4 QLEKLGEGTYATVYKGRNRTTGEIVALKEIHLDAEEGTPSTAIREISLMKELKHENIVRLHDVIHTENKLMLVFEYMDKD   83 (284)
T ss_pred             EeeeeccCCceEEEEEEECCCCeEEEEEEecccccccchHHHHHHHHHHHhhcCCCEeeeeeeEeeCCcEEEEEecCCcc
Confidence            3467999999999999985 588999999875432  3356788999999999999999998762               


Q ss_pred             --------------ccchhhhHHHHHHHHHHHHhhcCCCCeEecCcCCCcEEECCCCcEEEeecCCCccccCCCcceecc
Q 039231          379 --------------RVAEELSSTIGIARGLEYLHLGCSTRILHFDIKPHNILLDEDFCPKISDFGLAKICNRKESIISMT  444 (506)
Q Consensus       379 --------------~~~~~l~i~~~i~~gl~~LH~~~~~~ivH~dlkp~Nill~~~~~~ki~dfg~a~~~~~~~~~~~~~  444 (506)
                                    ++...+.++.|++.||+|||   +.+++|+||+|+||++++++.+||+|||+++.......  ...
T Consensus        84 l~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH---~~~i~h~dl~p~ni~~~~~~~~~l~d~g~~~~~~~~~~--~~~  158 (284)
T cd07836          84 LKKYMDTHGVRGALDPNTVKSFTYQLLKGIAFCH---ENRVLHRDLKPQNLLINKRGELKLADFGLARAFGIPVN--TFS  158 (284)
T ss_pred             HHHHHHhcCCCCCcCHHHHHHHHHHHHHHHHHHH---HCCeeeCCCCHHHEEECCCCcEEEeecchhhhhcCCcc--ccc
Confidence                          22335678999999999999   89999999999999999999999999999976543221  113


Q ss_pred             cCCCCcccccccccccccCCCCccccHHHHHHHHHHHHcCCCCCCCCCCCc
Q 039231          445 GARGTVGYIAPEVFCRNIGEVSYKSDVYNYGMMIFEMTGGRKNVDVVDNGS  495 (506)
Q Consensus       445 ~~~gt~~y~aPE~l~~~~~~~s~~~Dv~s~G~il~elltg~~pf~~~~~~~  495 (506)
                      ...++..|+|||.+.+. ..++.++||||||+++|||++|+.||...+..+
T Consensus       159 ~~~~~~~y~~PE~~~~~-~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~  208 (284)
T cd07836         159 NEVVTLWYRAPDVLLGS-RTYSTSIDIWSVGCIMAEMITGRPLFPGTNNED  208 (284)
T ss_pred             cccccccccChHHhcCC-CCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcHH
Confidence            34568899999988543 356889999999999999999999998765443

Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment.

>cd06617 PKc_MKK3_6 Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6

Probab=99.94  E-value=1.6e-26  Score=225.77  Aligned_cols=169  Identities=27%  Similarity=0.417  Sum_probs=134.5

Q ss_pred             hccccCccCceEEEEEEEc-CCCEEEEEEeccCCC--CchhhHHHHHH-hhccCccceeEEEEEee--------------
Q 039231          317 FKYKLGQGGYGSVYKGKLL-DGSNVAVKVLNDSKG--NGKEFINEVAS-ISRTSHVNVVALLGFCL--------------  378 (506)
Q Consensus       317 ~~~~ig~G~~g~V~~~~~~-~~~~vavK~l~~~~~--~~~~~~~E~~~-l~~l~h~niv~l~g~~~--------------  378 (506)
                      +.+.||+|+||.||+|+.. +|+.||+|+++....  ...++..|+.. ++.++||||+++++++.              
T Consensus         5 ~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~iv~~~~~~~~~~~~~lv~e~~~~   84 (283)
T cd06617           5 VIEELGRGAYGVVDKMRHVPTGTIMAVKRIRATVNSQEQKRLLMDLDISMRSVDCPYTVTFYGALFREGDVWICMEVMDT   84 (283)
T ss_pred             EEEEecccCCeEEEEEEEcCCCcEEEEEEEecCCCcHHHHHHHHHHHHHHHHcCCCCeeeeeEEEecCCcEEEEhhhhcc
Confidence            3467999999999999875 589999999875432  22456667665 56678999999998761              


Q ss_pred             ----------------ccchhhhHHHHHHHHHHHHhhcCCC-CeEecCcCCCcEEECCCCcEEEeecCCCccccCCCcce
Q 039231          379 ----------------RVAEELSSTIGIARGLEYLHLGCST-RILHFDIKPHNILLDEDFCPKISDFGLAKICNRKESII  441 (506)
Q Consensus       379 ----------------~~~~~l~i~~~i~~gl~~LH~~~~~-~ivH~dlkp~Nill~~~~~~ki~dfg~a~~~~~~~~~~  441 (506)
                                      ++...+.++.|++.||+|||   ++ +++||||||+||++++++.+||+|||+++.......  
T Consensus        85 ~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH---~~~~i~h~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~~--  159 (283)
T cd06617          85 SLDKFYKKVYDKGLTIPEDILGKIAVSIVKALEYLH---SKLSVIHRDVKPSNVLINRNGQVKLCDFGISGYLVDSVA--  159 (283)
T ss_pred             cHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHh---hcCCeecCCCCHHHEEECCCCCEEEeecccccccccccc--
Confidence                            22335678999999999999   76 999999999999999999999999999986543221  


Q ss_pred             ecccCCCCccccccccccccc--CCCCccccHHHHHHHHHHHHcCCCCCCCC
Q 039231          442 SMTGARGTVGYIAPEVFCRNI--GEVSYKSDVYNYGMMIFEMTGGRKNVDVV  491 (506)
Q Consensus       442 ~~~~~~gt~~y~aPE~l~~~~--~~~s~~~Dv~s~G~il~elltg~~pf~~~  491 (506)
                       .....++..|+|||.+.+..  ..++.++|+||||+++|||++|+.||...
T Consensus       160 -~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~  210 (283)
T cd06617         160 -KTIDAGCKPYMAPERINPELNQKGYDVKSDVWSLGITMIELATGRFPYDSW  210 (283)
T ss_pred             -cccccCCccccChhhcCCcccccccCccccchhhHHHHHHHHhCCCCCCcc
Confidence             12345788999999885421  24688999999999999999999999754

Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs

>cd07835 STKc_CDK1_like Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases

Probab=99.94  E-value=8.8e-27  Score=227.66  Aligned_cols=170  Identities=31%  Similarity=0.422  Sum_probs=139.1

Q ss_pred             ccccCccCceEEEEEEEc-CCCEEEEEEeccCCC---CchhhHHHHHHhhccCccceeEEEEEe----------------
Q 039231          318 KYKLGQGGYGSVYKGKLL-DGSNVAVKVLNDSKG---NGKEFINEVASISRTSHVNVVALLGFC----------------  377 (506)
Q Consensus       318 ~~~ig~G~~g~V~~~~~~-~~~~vavK~l~~~~~---~~~~~~~E~~~l~~l~h~niv~l~g~~----------------  377 (506)
                      .++||.|++|.||+|... +|..||+|++.....   ..+.+.+|++.+++++|||++++++++                
T Consensus         4 ~~~l~~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~~~~iv~~~~~~~~~~~~~iv~e~~~~~   83 (283)
T cd07835           4 VEKIGEGTYGVVYKARDKLTGEIVALKKIRLETEDEGVPSTAIREISLLKELNHPNIVRLLDVVHSENKLYLVFEFLDLD   83 (283)
T ss_pred             heEecCCCCeEEEEEEEcCCCCEEEEEEeecccccccchhHHHHHHHHHHhcCCCCccCHhheeccCCeEEEEEeccCcC
Confidence            457999999999999875 689999999865432   235688999999999999999998776                


Q ss_pred             ------------eccchhhhHHHHHHHHHHHHhhcCCCCeEecCcCCCcEEECCCCcEEEeecCCCccccCCCcceeccc
Q 039231          378 ------------LRVAEELSSTIGIARGLEYLHLGCSTRILHFDIKPHNILLDEDFCPKISDFGLAKICNRKESIISMTG  445 (506)
Q Consensus       378 ------------~~~~~~l~i~~~i~~gl~~LH~~~~~~ivH~dlkp~Nill~~~~~~ki~dfg~a~~~~~~~~~~~~~~  445 (506)
                                  +++...+.++.|+++||+|||   +++++|+||+|+||++++++.+||+|||+++........  ...
T Consensus        84 l~~~~~~~~~~~~~~~~~~~~~~~i~~~L~~lH---~~~~~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~~--~~~  158 (283)
T cd07835          84 LKKYMDSSPLTGLDPPLIKSYLYQLLQGIAYCH---SHRVLHRDLKPQNLLIDREGALKLADFGLARAFGVPVRT--YTH  158 (283)
T ss_pred             HHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHH---HCCeeCCCCCHHHEEEcCCCcEEEeecccccccCCCccc--cCc
Confidence                        123335678999999999999   899999999999999999999999999999765432211  123


Q ss_pred             CCCCcccccccccccccCCCCccccHHHHHHHHHHHHcCCCCCCCCCC
Q 039231          446 ARGTVGYIAPEVFCRNIGEVSYKSDVYNYGMMIFEMTGGRKNVDVVDN  493 (506)
Q Consensus       446 ~~gt~~y~aPE~l~~~~~~~s~~~Dv~s~G~il~elltg~~pf~~~~~  493 (506)
                      ..++..|+|||.+.+. ..++.++||||||+++|||++|+.||...++
T Consensus       159 ~~~~~~~~aPE~~~~~-~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~  205 (283)
T cd07835         159 EVVTLWYRAPEILLGS-RQYSTPVDIWSIGCIFAEMVNRRPLFPGDSE  205 (283)
T ss_pred             cccccCCCCCceeecC-cccCcHHHHHHHHHHHHHHHhCCCCCCCCCH
Confidence            4568899999987543 3568899999999999999999999976544

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyc

>cd05083 PTKc_Chk Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase

Probab=99.94  E-value=8.5e-27  Score=224.10  Aligned_cols=167  Identities=33%  Similarity=0.574  Sum_probs=137.7

Q ss_pred             hhhccccCccCceEEEEEEEcCCCEEEEEEeccCCCCchhhHHHHHHhhccCccceeEEEEEe-----------------
Q 039231          315 NSFKYKLGQGGYGSVYKGKLLDGSNVAVKVLNDSKGNGKEFINEVASISRTSHVNVVALLGFC-----------------  377 (506)
Q Consensus       315 ~~~~~~ig~G~~g~V~~~~~~~~~~vavK~l~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~-----------------  377 (506)
                      +.+.+.||+|+||.||++.. .++.+|+|.++... ..+.+.+|+.++++++||||+++++++                 
T Consensus         8 ~~~~~~lg~g~~g~v~~~~~-~~~~~~iK~~~~~~-~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~v~e~~~~~~L   85 (254)
T cd05083           8 LTLGEIIGEGEFGAVLQGEY-TGQKVAVKNIKCDV-TAQAFLEETAVMTKLHHKNLVRLLGVILHNGLYIVMELMSKGNL   85 (254)
T ss_pred             ceeeeeeccCCCCceEeccc-CCCceEEEeecCcc-hHHHHHHHHHHHHhCCCCCcCeEEEEEcCCCcEEEEECCCCCCH
Confidence            34567899999999999975 67889999986543 336789999999999999999999876                 


Q ss_pred             -----------eccchhhhHHHHHHHHHHHHhhcCCCCeEecCcCCCcEEECCCCcEEEeecCCCccccCCCcceecccC
Q 039231          378 -----------LRVAEELSSTIGIARGLEYLHLGCSTRILHFDIKPHNILLDEDFCPKISDFGLAKICNRKESIISMTGA  446 (506)
Q Consensus       378 -----------~~~~~~l~i~~~i~~gl~~LH~~~~~~ivH~dlkp~Nill~~~~~~ki~dfg~a~~~~~~~~~~~~~~~  446 (506)
                                 +++...+.++.|++.||.|||   +.+++||||||+||+++.++.+||+|||+++......     ...
T Consensus        86 ~~~l~~~~~~~~~~~~~~~~~~qi~~al~~lH---~~~~~H~dl~p~nili~~~~~~kl~Dfg~~~~~~~~~-----~~~  157 (254)
T cd05083          86 VNFLRTRGRALVSVIQLLQFSLDVAEGMEYLE---SKKLVHRDLAARNILVSEDGVAKVSDFGLARVGSMGV-----DNS  157 (254)
T ss_pred             HHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHH---hCCeeccccCcceEEEcCCCcEEECCCccceeccccC-----CCC
Confidence                       122235678899999999999   8999999999999999999999999999987543221     223


Q ss_pred             CCCcccccccccccccCCCCccccHHHHHHHHHHHHc-CCCCCCCCCC
Q 039231          447 RGTVGYIAPEVFCRNIGEVSYKSDVYNYGMMIFEMTG-GRKNVDVVDN  493 (506)
Q Consensus       447 ~gt~~y~aPE~l~~~~~~~s~~~Dv~s~G~il~ellt-g~~pf~~~~~  493 (506)
                      ..+..|+|||.+.+  +.++.++|+||||+++|||++ |+.||.....
T Consensus       158 ~~~~~y~~pe~~~~--~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~  203 (254)
T cd05083         158 KLPVKWTAPEALKH--KKFSSKSDVWSYGVLLWEVFSYGRAPYPKMSL  203 (254)
T ss_pred             CCCceecCHHHhcc--CCcCchhhHHHHHHHHHHHHhCCCCCCccCCH
Confidence            34678999998854  478899999999999999997 9999976544

Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src ki

>cd05050 PTKc_Musk Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase

Probab=99.94  E-value=6e-27  Score=229.55  Aligned_cols=172  Identities=27%  Similarity=0.490  Sum_probs=137.2

Q ss_pred             hhccccCccCceEEEEEEEc------CCCEEEEEEeccCCC--CchhhHHHHHHhhccCccceeEEEEEeec--------
Q 039231          316 SFKYKLGQGGYGSVYKGKLL------DGSNVAVKVLNDSKG--NGKEFINEVASISRTSHVNVVALLGFCLR--------  379 (506)
Q Consensus       316 ~~~~~ig~G~~g~V~~~~~~------~~~~vavK~l~~~~~--~~~~~~~E~~~l~~l~h~niv~l~g~~~~--------  379 (506)
                      .+.+.||+|+||.||+|+..      ++..+|+|++.....  ..+++.+|++++++++||||+++++++..        
T Consensus         8 ~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~ei~~l~~l~h~~iv~~~~~~~~~~~~~lv~   87 (288)
T cd05050           8 EYVRDIGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDHPNIVKLLGVCAVGKPMCLLF   87 (288)
T ss_pred             eecccccccccccEEEEEEcccCCCCcceeEEEEecCCCcCHHHHHHHHHHHHHHHhcCCCchheEEEEEcCCCccEEEE
Confidence            34567999999999999863      467899999875432  23568899999999999999999987611        


Q ss_pred             -----------------------------------------cchhhhHHHHHHHHHHHHhhcCCCCeEecCcCCCcEEEC
Q 039231          380 -----------------------------------------VAEELSSTIGIARGLEYLHLGCSTRILHFDIKPHNILLD  418 (506)
Q Consensus       380 -----------------------------------------~~~~l~i~~~i~~gl~~LH~~~~~~ivH~dlkp~Nill~  418 (506)
                                                               +.+.+.++.|++.||+|||   +++++||||||+||+++
T Consensus        88 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~aL~~lH---~~~i~H~dl~p~nil~~  164 (288)
T cd05050          88 EYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQLCIAKQVAAGMAYLS---ERKFVHRDLATRNCLVG  164 (288)
T ss_pred             ecCCCCCHHHHHHHcCccccccccccccccccccccccccCHHHHHHHHHHHHHHHHHHH---hCCeecccccHhheEec
Confidence                                                     1123679999999999999   89999999999999999


Q ss_pred             CCCcEEEeecCCCccccCCCcceecccCCCCcccccccccccccCCCCccccHHHHHHHHHHHHc-CCCCCCCCC
Q 039231          419 EDFCPKISDFGLAKICNRKESIISMTGARGTVGYIAPEVFCRNIGEVSYKSDVYNYGMMIFEMTG-GRKNVDVVD  492 (506)
Q Consensus       419 ~~~~~ki~dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~s~~~Dv~s~G~il~ellt-g~~pf~~~~  492 (506)
                      +++.+||+|||+++................+..|+|||.+.+.  .++.++||||||+++|||++ |..||....
T Consensus       165 ~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~--~~~~~~Dv~slG~il~el~~~~~~p~~~~~  237 (288)
T cd05050         165 ENMVVKIADFGLSRNIYSADYYKASENDAIPIRWMPPESIFYN--RYTTESDVWAYGVVLWEIFSYGMQPYYGMA  237 (288)
T ss_pred             CCCceEECccccceecccCccccccCCCccChhhcCHHHHhcC--CCCchhHHHHHHHHHHHHHhCCCCCCCCCC
Confidence            9999999999998765433221111223446789999988543  78899999999999999997 888986554

Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates M

>cd05613 STKc_MSK1_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1

Probab=99.94  E-value=1.7e-26  Score=226.61  Aligned_cols=173  Identities=27%  Similarity=0.327  Sum_probs=138.4

Q ss_pred             hccccCccCceEEEEEEE----cCCCEEEEEEeccCC-----CCchhhHHHHHHhhcc-CccceeEEEEEe---------
Q 039231          317 FKYKLGQGGYGSVYKGKL----LDGSNVAVKVLNDSK-----GNGKEFINEVASISRT-SHVNVVALLGFC---------  377 (506)
Q Consensus       317 ~~~~ig~G~~g~V~~~~~----~~~~~vavK~l~~~~-----~~~~~~~~E~~~l~~l-~h~niv~l~g~~---------  377 (506)
                      +.+.||+|+||.||+++.    .+|..+|+|+++...     ...+.+.+|++++.++ +|+||+++.+.+         
T Consensus         4 ~~~~lg~G~~g~v~~~~~~~~~~~g~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~lv   83 (290)
T cd05613           4 LLKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTDTKLHLI   83 (290)
T ss_pred             eeeeeccCCcceEEEEEeccCCCCCceEEEEEeehhhhhhcchHHHHHHHHHHHHHhcccCCChhceeeEeecCCeEEEE
Confidence            346799999999999986    368899999997532     2235678899999999 599999998654         


Q ss_pred             ------------------eccchhhhHHHHHHHHHHHHhhcCCCCeEecCcCCCcEEECCCCcEEEeecCCCccccCCCc
Q 039231          378 ------------------LRVAEELSSTIGIARGLEYLHLGCSTRILHFDIKPHNILLDEDFCPKISDFGLAKICNRKES  439 (506)
Q Consensus       378 ------------------~~~~~~l~i~~~i~~gl~~LH~~~~~~ivH~dlkp~Nill~~~~~~ki~dfg~a~~~~~~~~  439 (506)
                                        +.+.....++.|++.||+|||   +.+++||||+|+||++++++.+||+|||+++.......
T Consensus        84 ~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~al~~lH---~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~  160 (290)
T cd05613          84 LDYINGGELFTHLSQRERFKEQEVQIYSGEIVLALEHLH---KLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFHEDEV  160 (290)
T ss_pred             EecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHH---hCCeeccCCCHHHeEECCCCCEEEeeCccceecccccc
Confidence                              122234556779999999999   89999999999999999999999999999986544322


Q ss_pred             ceecccCCCCcccccccccccccCCCCccccHHHHHHHHHHHHcCCCCCCCCCC
Q 039231          440 IISMTGARGTVGYIAPEVFCRNIGEVSYKSDVYNYGMMIFEMTGGRKNVDVVDN  493 (506)
Q Consensus       440 ~~~~~~~~gt~~y~aPE~l~~~~~~~s~~~Dv~s~G~il~elltg~~pf~~~~~  493 (506)
                      . ......++..|+|||.+......++.++||||||+++|||++|+.||.....
T Consensus       161 ~-~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~  213 (290)
T cd05613         161 E-RAYSFCGTIEYMAPDIVRGGDGGHDKAVDWWSMGVLMYELLTGASPFTVDGE  213 (290)
T ss_pred             c-ccccccCCcccCChhhccCCCCCCCccccHHHHHHHHHHHhcCCCCCCcCCc
Confidence            1 1123567899999999865434578899999999999999999999975443

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph

>KOG0690 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.94  E-value=1.7e-27  Score=221.15  Aligned_cols=172  Identities=28%  Similarity=0.342  Sum_probs=139.9

Q ss_pred             hccccCccCceEEEEEEEc-CCCEEEEEEeccCC----CCchhhHHHHHHhhccCccceeEEEEEe--------------
Q 039231          317 FKYKLGQGGYGSVYKGKLL-DGSNVAVKVLNDSK----GNGKEFINEVASISRTSHVNVVALLGFC--------------  377 (506)
Q Consensus       317 ~~~~ig~G~~g~V~~~~~~-~~~~vavK~l~~~~----~~~~~~~~E~~~l~~l~h~niv~l~g~~--------------  377 (506)
                      |-+.||+|.||.|-+++-+ .++.+|||++++.-    .....-..|-++|+..+||-+..|-..+              
T Consensus       172 fLKvLGkGTFGKVIL~rEKat~k~YAiKIlkKeviiakdEVAHTlTE~RVL~~~~HPFLt~LKYsFQt~drlCFVMeyan  251 (516)
T KOG0690|consen  172 FLKVLGKGTFGKVILCREKATGKLYAIKILKKEVIIAKDEVAHTLTENRVLQNCRHPFLTSLKYSFQTQDRLCFVMEYAN  251 (516)
T ss_pred             HHHHhcCCccceEEEEeecccCceeehhhhhhhheeehHHhhhhhhHHHHHHhccCcHHHHhhhhhccCceEEEEEEEcc
Confidence            4568999999999999864 58999999998643    2233456789999999999876553111              


Q ss_pred             -------------eccchhhhHHHHHHHHHHHHhhcCCCCeEecCcCCCcEEECCCCcEEEeecCCCccccCCCcceecc
Q 039231          378 -------------LRVAEELSSTIGIARGLEYLHLGCSTRILHFDIKPHNILLDEDFCPKISDFGLAKICNRKESIISMT  444 (506)
Q Consensus       378 -------------~~~~~~l~i~~~i~~gl~~LH~~~~~~ivH~dlkp~Nill~~~~~~ki~dfg~a~~~~~~~~~~~~~  444 (506)
                                   +.+.........|+.||.|||   +++||.||||.+|+|||.+|++||+|||+++.--...  ..+.
T Consensus       252 GGeLf~HLsrer~FsE~RtRFYGaEIvsAL~YLH---s~~ivYRDlKLENLlLDkDGHIKitDFGLCKE~I~~g--~t~k  326 (516)
T KOG0690|consen  252 GGELFFHLSRERVFSEDRTRFYGAEIVSALGYLH---SRNIVYRDLKLENLLLDKDGHIKITDFGLCKEEIKYG--DTTK  326 (516)
T ss_pred             CceEeeehhhhhcccchhhhhhhHHHHHHhhhhh---hCCeeeeechhhhheeccCCceEeeecccchhccccc--ceec
Confidence                         233334556778999999999   9999999999999999999999999999998543222  2346


Q ss_pred             cCCCCcccccccccccccCCCCccccHHHHHHHHHHHHcCCCCCCCCCCCc
Q 039231          445 GARGTVGYIAPEVFCRNIGEVSYKSDVYNYGMMIFEMTGGRKNVDVVDNGS  495 (506)
Q Consensus       445 ~~~gt~~y~aPE~l~~~~~~~s~~~Dv~s~G~il~elltg~~pf~~~~~~~  495 (506)
                      ...|||.|+|||++...  .|+..+|+|.+||++|||++|+.||...+.+.
T Consensus       327 TFCGTPEYLAPEVleDn--DYgraVDWWG~GVVMYEMmCGRLPFyn~dh~k  375 (516)
T KOG0690|consen  327 TFCGTPEYLAPEVLEDN--DYGRAVDWWGVGVVMYEMMCGRLPFYNKDHEK  375 (516)
T ss_pred             cccCChhhcCchhhccc--cccceeehhhhhHHHHHHHhccCcccccchhH
Confidence            78999999999999665  89999999999999999999999998766543

>cd07831 STKc_MOK Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase

Probab=99.94  E-value=1.5e-26  Score=225.83  Aligned_cols=169  Identities=25%  Similarity=0.350  Sum_probs=137.5

Q ss_pred             hccccCccCceEEEEEEEc-CCCEEEEEEeccCCC--CchhhHHHHHHhhccC-ccceeEEEEEeec-------------
Q 039231          317 FKYKLGQGGYGSVYKGKLL-DGSNVAVKVLNDSKG--NGKEFINEVASISRTS-HVNVVALLGFCLR-------------  379 (506)
Q Consensus       317 ~~~~ig~G~~g~V~~~~~~-~~~~vavK~l~~~~~--~~~~~~~E~~~l~~l~-h~niv~l~g~~~~-------------  379 (506)
                      +.++||+|+||.||+|+.. +++.+|+|+++....  ......+|+..+.++. |+||+++++++.+             
T Consensus         3 ~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~lv~e~~   82 (282)
T cd07831           3 ILGKIGEGTFSEVLKAQSRKTGKYYAIKCMKKHFKSLEQVNNLREIQALRRLSPHPNILRLIEVLFDRKTGRLALVFELM   82 (282)
T ss_pred             eEeeccccccceEEEEEEcCCCcEEEEEEehhccCCchhhhHHHHHHHHhhcCCCCCccceEEEEecCCCCcEEEEEecC
Confidence            4567999999999999875 589999999875422  2234567999999986 9999999987732             


Q ss_pred             ----------------cchhhhHHHHHHHHHHHHhhcCCCCeEecCcCCCcEEECCCCcEEEeecCCCccccCCCcceec
Q 039231          380 ----------------VAEELSSTIGIARGLEYLHLGCSTRILHFDIKPHNILLDEDFCPKISDFGLAKICNRKESIISM  443 (506)
Q Consensus       380 ----------------~~~~l~i~~~i~~gl~~LH~~~~~~ivH~dlkp~Nill~~~~~~ki~dfg~a~~~~~~~~~~~~  443 (506)
                                      +.+.+.++.|++.||+|||   +.+++||||+|+||++++ +.+||+|||+++........   
T Consensus        83 ~~~l~~~l~~~~~~~~~~~~~~~~~qi~~~L~~LH---~~~i~H~dl~p~ni~l~~-~~~kl~dfg~~~~~~~~~~~---  155 (282)
T cd07831          83 DMNLYELIKGRKRPLPEKRVKSYMYQLLKSLDHMH---RNGIFHRDIKPENILIKD-DILKLADFGSCRGIYSKPPY---  155 (282)
T ss_pred             CccHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHH---HCCceecccCHHHEEEcC-CCeEEEecccccccccCCCc---
Confidence                            2235678899999999999   899999999999999999 99999999999876443321   


Q ss_pred             ccCCCCcccccccccccccCCCCccccHHHHHHHHHHHHcCCCCCCCCCC
Q 039231          444 TGARGTVGYIAPEVFCRNIGEVSYKSDVYNYGMMIFEMTGGRKNVDVVDN  493 (506)
Q Consensus       444 ~~~~gt~~y~aPE~l~~~~~~~s~~~Dv~s~G~il~elltg~~pf~~~~~  493 (506)
                      ....++..|+|||.+... +.++.++|||||||++|||++|..||...+.
T Consensus       156 ~~~~~~~~y~aPE~~~~~-~~~~~~~Di~slGv~l~el~~~~~p~~~~~~  204 (282)
T cd07831         156 TEYISTRWYRAPECLLTD-GYYGPKMDIWAVGCVFFEILSLFPLFPGTNE  204 (282)
T ss_pred             CCCCCCcccCChhHhhcC-CCCCcchhHHHHHHHHHHHHcCCcCCCCCCH
Confidence            234578899999987443 4578899999999999999999999976544

Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation.

>cd05047 PTKc_Tie Catalytic domain of Tie Protein Tyrosine Kinases

Probab=99.94  E-value=1.6e-26  Score=224.50  Aligned_cols=165  Identities=28%  Similarity=0.529  Sum_probs=131.1

Q ss_pred             ccCccCceEEEEEEEcC-CC--EEEEEEeccCC--CCchhhHHHHHHhhcc-CccceeEEEEEee---------------
Q 039231          320 KLGQGGYGSVYKGKLLD-GS--NVAVKVLNDSK--GNGKEFINEVASISRT-SHVNVVALLGFCL---------------  378 (506)
Q Consensus       320 ~ig~G~~g~V~~~~~~~-~~--~vavK~l~~~~--~~~~~~~~E~~~l~~l-~h~niv~l~g~~~---------------  378 (506)
                      .||+|+||.||+|++.+ +.  .+++|.++...  ...+.+.+|++++.++ +||||+++++++.               
T Consensus         2 ~lg~g~~g~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~lv~e~~~~~   81 (270)
T cd05047           2 VIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPHG   81 (270)
T ss_pred             cCCCCCCceEEEEEEcCCCCeeEEEEEEccccCCHHHHHHHHHHHHHHHhhccCCCeeeEEEEEecCCCceEEEEeCCCC
Confidence            58999999999999754 43  56888887432  2336788999999999 7999999988761               


Q ss_pred             ----------------------------ccchhhhHHHHHHHHHHHHhhcCCCCeEecCcCCCcEEECCCCcEEEeecCC
Q 039231          379 ----------------------------RVAEELSSTIGIARGLEYLHLGCSTRILHFDIKPHNILLDEDFCPKISDFGL  430 (506)
Q Consensus       379 ----------------------------~~~~~l~i~~~i~~gl~~LH~~~~~~ivH~dlkp~Nill~~~~~~ki~dfg~  430 (506)
                                                  .+.+.+.++.|++.||+|||   +.+++|+||||+||++++++.+||+|||+
T Consensus        82 ~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~al~~lH---~~~i~H~dikp~nili~~~~~~kl~dfgl  158 (270)
T cd05047          82 NLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLS---QKQFIHRDLAARNILVGENYVAKIADFGL  158 (270)
T ss_pred             cHHHHHHhccccccccccccccCCcCCCCHHHHHHHHHHHHHHHHHHH---HCCEeecccccceEEEcCCCeEEECCCCC
Confidence                                        11234678899999999999   89999999999999999999999999999


Q ss_pred             CccccCCCcceecccCCCCcccccccccccccCCCCccccHHHHHHHHHHHHc-CCCCCCCCC
Q 039231          431 AKICNRKESIISMTGARGTVGYIAPEVFCRNIGEVSYKSDVYNYGMMIFEMTG-GRKNVDVVD  492 (506)
Q Consensus       431 a~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~s~~~Dv~s~G~il~ellt-g~~pf~~~~  492 (506)
                      ++......   .......+..|+|||++...  .++.++||||||+++|||++ |..||...+
T Consensus       159 ~~~~~~~~---~~~~~~~~~~y~apE~~~~~--~~~~~~Di~slG~il~el~~~g~~pf~~~~  216 (270)
T cd05047         159 SRGQEVYV---KKTMGRLPVRWMAIESLNYS--VYTTNSDVWSYGVLLWEIVSLGGTPYCGMT  216 (270)
T ss_pred             ccccchhh---hccCCCCccccCChHHHccC--CCCchhhHHHHHHHHHHHHcCCCCCccccC
Confidence            86322111   11123346679999998543  68899999999999999997 999997654

Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific l

>cd06640 STKc_MST4 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4

Probab=99.94  E-value=2.2e-26  Score=224.36  Aligned_cols=169  Identities=27%  Similarity=0.398  Sum_probs=140.1

Q ss_pred             ccccCccCceEEEEEEEc-CCCEEEEEEeccCC--CCchhhHHHHHHhhccCccceeEEEEEee----------------
Q 039231          318 KYKLGQGGYGSVYKGKLL-DGSNVAVKVLNDSK--GNGKEFINEVASISRTSHVNVVALLGFCL----------------  378 (506)
Q Consensus       318 ~~~ig~G~~g~V~~~~~~-~~~~vavK~l~~~~--~~~~~~~~E~~~l~~l~h~niv~l~g~~~----------------  378 (506)
                      .+.||+|+||.||+|... ++..+|+|.++...  ...+.+.+|++++++++|+||+++++.+.                
T Consensus         9 ~~~lg~g~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~   88 (277)
T cd06640           9 LERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKGTKLWIIMEYLGGGS   88 (277)
T ss_pred             hhhcccCCCeEEEEEEEccCCEEEEEEEEeccccHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEEEEEEecCCCCc
Confidence            356999999999999875 48899999987543  23367889999999999999999998762                


Q ss_pred             ----------ccchhhhHHHHHHHHHHHHhhcCCCCeEecCcCCCcEEECCCCcEEEeecCCCccccCCCcceecccCCC
Q 039231          379 ----------RVAEELSSTIGIARGLEYLHLGCSTRILHFDIKPHNILLDEDFCPKISDFGLAKICNRKESIISMTGARG  448 (506)
Q Consensus       379 ----------~~~~~l~i~~~i~~gl~~LH~~~~~~ivH~dlkp~Nill~~~~~~ki~dfg~a~~~~~~~~~~~~~~~~g  448 (506)
                                ++.+...++.|++.||+|||   +.+++|+||+|+||+++.++.++|+|||++.........  .....+
T Consensus        89 L~~~i~~~~l~~~~~~~~~~~l~~~l~~lh---~~~ivH~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~~~--~~~~~~  163 (277)
T cd06640          89 ALDLLRAGPFDEFQIATMLKEILKGLDYLH---SEKKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIK--RNTFVG  163 (277)
T ss_pred             HHHHHhcCCCCHHHHHHHHHHHHHHHHHHH---hCCccCcCCChhhEEEcCCCCEEEcccccceeccCCccc--cccccC
Confidence                      22234568899999999999   899999999999999999999999999999766543321  133457


Q ss_pred             CcccccccccccccCCCCccccHHHHHHHHHHHHcCCCCCCCCCC
Q 039231          449 TVGYIAPEVFCRNIGEVSYKSDVYNYGMMIFEMTGGRKNVDVVDN  493 (506)
Q Consensus       449 t~~y~aPE~l~~~~~~~s~~~Dv~s~G~il~elltg~~pf~~~~~  493 (506)
                      +..|+|||.+.+.  ..+.++|+||||+++|||++|..||.....
T Consensus       164 ~~~y~apE~~~~~--~~~~~~Dv~slG~il~el~tg~~p~~~~~~  206 (277)
T cd06640         164 TPFWMAPEVIQQS--AYDSKADIWSLGITAIELAKGEPPNSDMHP  206 (277)
T ss_pred             cccccCHhHhccC--CCccHHHHHHHHHHHHHHHHCCCCCCCcCh
Confidence            8899999998543  678999999999999999999999976543

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by inter

>cd06658 STKc_PAK5 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5

Probab=99.94  E-value=4.6e-27  Score=231.00  Aligned_cols=168  Identities=29%  Similarity=0.413  Sum_probs=138.4

Q ss_pred             cccCccCceEEEEEEEc-CCCEEEEEEeccCCC-CchhhHHHHHHhhccCccceeEEEEEe-------------------
Q 039231          319 YKLGQGGYGSVYKGKLL-DGSNVAVKVLNDSKG-NGKEFINEVASISRTSHVNVVALLGFC-------------------  377 (506)
Q Consensus       319 ~~ig~G~~g~V~~~~~~-~~~~vavK~l~~~~~-~~~~~~~E~~~l~~l~h~niv~l~g~~-------------------  377 (506)
                      ..||+|+||.||++... ++..||||.+..... ..+.+.+|+..++.++|+||+++++.+                   
T Consensus        28 ~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~lv~e~~~~~~L~  107 (292)
T cd06658          28 IKIGEGSTGIVCIATEKHTGKQVAVKKMDLRKQQRRELLFNEVVIMRDYHHENVVDMYNSYLVGDELWVVMEFLEGGALT  107 (292)
T ss_pred             hcccCCCCeEEEEEEECCCCCEEEEEEEecchHHHHHHHHHHHHHHHhCCCCcHHHHHHheecCCeEEEEEeCCCCCcHH
Confidence            35999999999999874 588999999865332 335688999999999999999988654                   


Q ss_pred             -------eccchhhhHHHHHHHHHHHHhhcCCCCeEecCcCCCcEEECCCCcEEEeecCCCccccCCCcceecccCCCCc
Q 039231          378 -------LRVAEELSSTIGIARGLEYLHLGCSTRILHFDIKPHNILLDEDFCPKISDFGLAKICNRKESIISMTGARGTV  450 (506)
Q Consensus       378 -------~~~~~~l~i~~~i~~gl~~LH~~~~~~ivH~dlkp~Nill~~~~~~ki~dfg~a~~~~~~~~~~~~~~~~gt~  450 (506)
                             +.+.+.+.++.|++.||+|||   +++++||||||+||++++++.+||+|||++.........  .....++.
T Consensus       108 ~~~~~~~l~~~~~~~~~~qi~~~l~~LH---~~~ivH~dlkp~Nill~~~~~~kL~dfg~~~~~~~~~~~--~~~~~~~~  182 (292)
T cd06658         108 DIVTHTRMNEEQIATVCLSVLRALSYLH---NQGVIHRDIKSDSILLTSDGRIKLSDFGFCAQVSKEVPK--RKSLVGTP  182 (292)
T ss_pred             HHHhcCCCCHHHHHHHHHHHHHHHHHHH---HCCEeecCCCHHHEEEcCCCCEEEccCcchhhccccccc--CceeecCc
Confidence                   233446778999999999999   899999999999999999999999999998765432211  13356789


Q ss_pred             ccccccccccccCCCCccccHHHHHHHHHHHHcCCCCCCCCCC
Q 039231          451 GYIAPEVFCRNIGEVSYKSDVYNYGMMIFEMTGGRKNVDVVDN  493 (506)
Q Consensus       451 ~y~aPE~l~~~~~~~s~~~Dv~s~G~il~elltg~~pf~~~~~  493 (506)
                      .|+|||.+.+.  .++.++||||||+++|||++|+.||...+.
T Consensus       183 ~y~aPE~~~~~--~~~~~~Dv~slGvil~el~~g~~p~~~~~~  223 (292)
T cd06658         183 YWMAPEVISRL--PYGTEVDIWSLGIMVIEMIDGEPPYFNEPP  223 (292)
T ss_pred             cccCHHHHccC--CCCchhhHHHHHHHHHHHHhCCCCCCCCCH
Confidence            99999998543  678899999999999999999999976543

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly express

>KOG0574 consensus STE20-like serine/threonine kinase MST [Signal transduction mechanisms]

Probab=99.94  E-value=1.3e-28  Score=226.24  Aligned_cols=168  Identities=31%  Similarity=0.417  Sum_probs=143.6

Q ss_pred             ccccCccCceEEEEEEEcC-CCEEEEEEeccCCCCchhhHHHHHHhhccCccceeEEEEEe-------------------
Q 039231          318 KYKLGQGGYGSVYKGKLLD-GSNVAVKVLNDSKGNGKEFINEVASISRTSHVNVVALLGFC-------------------  377 (506)
Q Consensus       318 ~~~ig~G~~g~V~~~~~~~-~~~vavK~l~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~-------------------  377 (506)
                      -.+||+|+||.||+|.++. |+.+|||...-. .+.+++++|+.++++.+.|++|+++|-+                   
T Consensus        38 ~~KLGEGSYGSV~KAIH~EsG~v~AIK~VPV~-sDLQEIIKEISIMQQC~S~yVVKYYGSYFK~sDLWIVMEYCGAGSiS  116 (502)
T KOG0574|consen   38 VGKLGEGSYGSVHKAIHRESGHVLAIKKVPVD-TDLQEIIKEISIMQQCKSKYVVKYYGSYFKHSDLWIVMEYCGAGSIS  116 (502)
T ss_pred             HHHhcCCcchHHHHHHHhccCcEEEEEecCcc-chHHHHHHHHHHHHHcCCchhhhhhhhhccCCceEeehhhcCCCcHH
Confidence            3579999999999998754 999999987543 3568999999999999999999999866                   


Q ss_pred             ---------eccchhhhHHHHHHHHHHHHhhcCCCCeEecCcCCCcEEECCCCcEEEeecCCCccccCCCcceecccCCC
Q 039231          378 ---------LRVAEELSSTIGIARGLEYLHLGCSTRILHFDIKPHNILLDEDFCPKISDFGLAKICNRKESIISMTGARG  448 (506)
Q Consensus       378 ---------~~~~~~l~i~~~i~~gl~~LH~~~~~~ivH~dlkp~Nill~~~~~~ki~dfg~a~~~~~~~~~~~~~~~~g  448 (506)
                               +.+.+...+..+.++||+|||   ...-+|||||..||||+-+|.+||+|||.|..+....  .......|
T Consensus       117 DI~R~R~K~L~E~EIs~iL~~TLKGL~YLH---~~~KIHRDIKAGNILLNT~G~AKLADFGVAGQLTDTM--AKRNTVIG  191 (502)
T KOG0574|consen  117 DIMRARRKPLSEQEISAVLRDTLKGLQYLH---DLKKIHRDIKAGNILLNTDGIAKLADFGVAGQLTDTM--AKRNTVIG  191 (502)
T ss_pred             HHHHHhcCCccHHHHHHHHHHHHhHHHHHH---HHHHHHhhcccccEEEcccchhhhhhccccchhhhhH--HhhCcccc
Confidence                     334445567889999999999   8999999999999999999999999999997654432  22366889


Q ss_pred             CcccccccccccccCCCCccccHHHHHHHHHHHHcCCCCCCCCCC
Q 039231          449 TVGYIAPEVFCRNIGEVSYKSDVYNYGMMIFEMTGGRKNVDVVDN  493 (506)
Q Consensus       449 t~~y~aPE~l~~~~~~~s~~~Dv~s~G~il~elltg~~pf~~~~~  493 (506)
                      |+.|||||++..-  .|..++||||+|+...||..|++||....+
T Consensus       192 TPFWMAPEVI~EI--GY~~~ADIWSLGITaIEMAEG~PPYsDIHP  234 (502)
T KOG0574|consen  192 TPFWMAPEVIEEI--GYDTKADIWSLGITAIEMAEGRPPYSDIHP  234 (502)
T ss_pred             CcccccHHHHHHh--ccchhhhHhhhcchhhhhhcCCCCcccccc
Confidence            9999999999664  678899999999999999999999987654

>KOG0614 consensus cGMP-dependent protein kinase [Signal transduction mechanisms]

Probab=99.94  E-value=7e-28  Score=235.27  Aligned_cols=170  Identities=26%  Similarity=0.352  Sum_probs=145.0

Q ss_pred             ccCccCceEEEEEEEcCCC-EEEEEEeccC----CCCchhhHHHHHHhhccCccceeEEEEEe-----------------
Q 039231          320 KLGQGGYGSVYKGKLLDGS-NVAVKVLNDS----KGNGKEFINEVASISRTSHVNVVALLGFC-----------------  377 (506)
Q Consensus       320 ~ig~G~~g~V~~~~~~~~~-~vavK~l~~~----~~~~~~~~~E~~~l~~l~h~niv~l~g~~-----------------  377 (506)
                      .||-|+||.|=+++.+... .+|+|++++.    ..+.+.+..|-++|...+.|.||+++.-+                 
T Consensus       427 TLGvGgFGRVELV~~~~~~~~fAlKilkK~hIVdtkQqeHv~sEr~Im~~~~s~fIvrLYrTfrd~kyvYmLmEaClGGE  506 (732)
T KOG0614|consen  427 TLGVGGFGRVELVKVNSQKATFALKILKKKHIVDTKQQEHVFSERNIMMECRSDFIVRLYRTFRDSKYVYMLMEACLGGE  506 (732)
T ss_pred             hcccCccceEEEEEecccchHHHHHHHhHhhccchhHHHHHHhHHHHHHhcCchHHHHHHHHhccchhhhhhHHhhcCch
Confidence            4999999999999886543 4899998753    23346788999999999999999987544                 


Q ss_pred             ----------eccchhhhHHHHHHHHHHHHhhcCCCCeEecCcCCCcEEECCCCcEEEeecCCCccccCCCcceecccCC
Q 039231          378 ----------LRVAEELSSTIGIARGLEYLHLGCSTRILHFDIKPHNILLDEDFCPKISDFGLAKICNRKESIISMTGAR  447 (506)
Q Consensus       378 ----------~~~~~~l~i~~~i~~gl~~LH~~~~~~ivH~dlkp~Nill~~~~~~ki~dfg~a~~~~~~~~~~~~~~~~  447 (506)
                                ++......++.-+++|++|||   .++||+|||||+|.+|+.+|-+||.|||+|+.++.....   .+..
T Consensus       507 lWTiLrdRg~Fdd~tarF~~acv~EAfeYLH---~k~iIYRDLKPENllLd~~Gy~KLVDFGFAKki~~g~KT---wTFc  580 (732)
T KOG0614|consen  507 LWTILRDRGSFDDYTARFYVACVLEAFEYLH---RKGIIYRDLKPENLLLDNRGYLKLVDFGFAKKIGSGRKT---WTFC  580 (732)
T ss_pred             hhhhhhhcCCcccchhhhhHHHHHHHHHHHH---hcCceeccCChhheeeccCCceEEeehhhHHHhccCCce---eeec
Confidence                      334445567778999999999   999999999999999999999999999999999887754   5688


Q ss_pred             CCcccccccccccccCCCCccccHHHHHHHHHHHHcCCCCCCCCCCCcch
Q 039231          448 GTVGYIAPEVFCRNIGEVSYKSDVYNYGMMIFEMTGGRKNVDVVDNGSTA  497 (506)
Q Consensus       448 gt~~y~aPE~l~~~~~~~s~~~Dv~s~G~il~elltg~~pf~~~~~~~~~  497 (506)
                      ||+.|.|||++.++  .++.++|.||+|+++|||++|++||+..++-...
T Consensus       581 GTpEYVAPEIILnK--GHD~avDyWaLGIli~ELL~G~pPFs~~dpmktY  628 (732)
T KOG0614|consen  581 GTPEYVAPEIILNK--GHDRAVDYWALGILIYELLTGSPPFSGVDPMKTY  628 (732)
T ss_pred             CCcccccchhhhcc--CcchhhHHHHHHHHHHHHHcCCCCCCCCchHHHH
Confidence            99999999999876  6788999999999999999999999988765443

>KOG0596 consensus Dual specificity; serine/threonine and tyrosine kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=99.94  E-value=3.6e-27  Score=232.90  Aligned_cols=172  Identities=24%  Similarity=0.327  Sum_probs=144.3

Q ss_pred             hccccCccCceEEEEEEEcCCCEEEEEEeccC---CCCchhhHHHHHHhhccC-ccceeEEEEEeeccc-----------
Q 039231          317 FKYKLGQGGYGSVYKGKLLDGSNVAVKVLNDS---KGNGKEFINEVASISRTS-HVNVVALLGFCLRVA-----------  381 (506)
Q Consensus       317 ~~~~ig~G~~g~V~~~~~~~~~~vavK~l~~~---~~~~~~~~~E~~~l~~l~-h~niv~l~g~~~~~~-----------  381 (506)
                      ..++||+||.+.||++...+.+.+|+|+....   .....-|.+|+..|.+++ |.+||+|++|-+...           
T Consensus       365 ilk~iG~GGSSkV~kV~~s~~~iyalkkv~~~~~D~qtl~gy~nEI~lL~KLkg~~~IIqL~DYEv~d~~lYmvmE~Gd~  444 (677)
T KOG0596|consen  365 ILKQIGSGGSSKVFKVLNSDKQIYALKKVVLLEADNQTLDGYRNEIALLNKLKGHDKIIQLYDYEVTDGYLYMVMECGDI  444 (677)
T ss_pred             HHHhhcCCCcceeeeeecCCCcchhhhHHHHhhcCHHHHHHHHHHHHHHHHhcCCceEEEEeeeeccCceEEEEeecccc
Confidence            34579999999999999988889999887543   333467999999999997 999999998762111           


Q ss_pred             ----------------hhhhHHHHHHHHHHHHhhcCCCCeEecCcCCCcEEECCCCcEEEeecCCCccccCCCcceeccc
Q 039231          382 ----------------EELSSTIGIARGLEYLHLGCSTRILHFDIKPHNILLDEDFCPKISDFGLAKICNRKESIISMTG  445 (506)
Q Consensus       382 ----------------~~l~i~~~i~~gl~~LH~~~~~~ivH~dlkp~Nill~~~~~~ki~dfg~a~~~~~~~~~~~~~~  445 (506)
                                      .+..+-.|++.|+.++|   ..||||-||||.|+|+-. |.+||+|||+|..+..+.+......
T Consensus       445 DL~kiL~k~~~~~~~~~lk~ywkqML~aV~~IH---~~gIVHSDLKPANFLlVk-G~LKLIDFGIA~aI~~DTTsI~kds  520 (677)
T KOG0596|consen  445 DLNKILKKKKSIDPDWFLKFYWKQMLLAVKTIH---QHGIVHSDLKPANFLLVK-GRLKLIDFGIANAIQPDTTSIVKDS  520 (677)
T ss_pred             cHHHHHHhccCCCchHHHHHHHHHHHHHHHHHH---HhceeecCCCcccEEEEe-eeEEeeeechhcccCccccceeecc
Confidence                            24456789999999999   999999999999999874 6899999999999988887777777


Q ss_pred             CCCCccccccccccccc---------CCCCccccHHHHHHHHHHHHcCCCCCCCCC
Q 039231          446 ARGTVGYIAPEVFCRNI---------GEVSYKSDVYNYGMMIFEMTGGRKNVDVVD  492 (506)
Q Consensus       446 ~~gt~~y~aPE~l~~~~---------~~~s~~~Dv~s~G~il~elltg~~pf~~~~  492 (506)
                      ..||+.||+||.+....         -..+.++||||+|||||+|+-|+.||....
T Consensus       521 QvGT~NYMsPEAl~~~~s~~~~~~~k~Ki~r~SDvWSLGCILYqMvYgktPf~~~~  576 (677)
T KOG0596|consen  521 QVGTVNYMSPEALTDMSSSRENGKSKIKISRKSDVWSLGCILYQMVYGKTPFGQII  576 (677)
T ss_pred             ccCcccccCHHHHhhccccccCCCcceeecCccchhhhhhHHHHHHhcCCchHHHH
Confidence            89999999999984321         126789999999999999999999997654

>cd05574 STKc_phototropin_like Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases

Probab=99.94  E-value=1.3e-26  Score=230.42  Aligned_cols=173  Identities=28%  Similarity=0.354  Sum_probs=139.9

Q ss_pred             ccccCccCceEEEEEEEcC-CCEEEEEEeccCCC----CchhhHHHHHHhhccCccceeEEEEEe---------------
Q 039231          318 KYKLGQGGYGSVYKGKLLD-GSNVAVKVLNDSKG----NGKEFINEVASISRTSHVNVVALLGFC---------------  377 (506)
Q Consensus       318 ~~~ig~G~~g~V~~~~~~~-~~~vavK~l~~~~~----~~~~~~~E~~~l~~l~h~niv~l~g~~---------------  377 (506)
                      .+.||+|++|.||+|...+ ++.+|+|.+.....    ..+.+.+|++.+.+++|+||+++++.+               
T Consensus         6 ~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~   85 (316)
T cd05574           6 IKLLGKGDVGRVFLVRLKGTGKLFALKVLDKKEMIKRNKVKRVLTEQEILATLDHPFLPTLYASFQTETYLCLVMDYCPG   85 (316)
T ss_pred             eeeecCCccEEEEEEEEcCCCcEEEEEEEeccccchHHHHHHHHHHHHHHHhCCCCCchhheeeeecCCEEEEEEEecCC
Confidence            4679999999999998764 89999999975432    235688999999999999999998775               


Q ss_pred             --------------eccchhhhHHHHHHHHHHHHhhcCCCCeEecCcCCCcEEECCCCcEEEeecCCCccccCCCcce--
Q 039231          378 --------------LRVAEELSSTIGIARGLEYLHLGCSTRILHFDIKPHNILLDEDFCPKISDFGLAKICNRKESII--  441 (506)
Q Consensus       378 --------------~~~~~~l~i~~~i~~gl~~LH~~~~~~ivH~dlkp~Nill~~~~~~ki~dfg~a~~~~~~~~~~--  441 (506)
                                    +++...+.++.|++.||+|||   +.+++|+||||+||+++.++.++|+|||++..........  
T Consensus        86 ~~L~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH---~~~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~~~~~  162 (316)
T cd05574          86 GELFRLLQRQPGKCLSEEVARFYAAEVLLALEYLH---LLGIVYRDLKPENILLHESGHIMLSDFDLSKQSDVEPPPVSK  162 (316)
T ss_pred             CCHHHHHHhCCCCccCHHHHHHHHHHHHHHHHHHH---HCCeeccCCChHHeEEcCCCCEEEeecchhhccccccccccc
Confidence                          122235567899999999999   8999999999999999999999999999987543221100  


Q ss_pred             -------------------------ecccCCCCcccccccccccccCCCCccccHHHHHHHHHHHHcCCCCCCCCCCCc
Q 039231          442 -------------------------SMTGARGTVGYIAPEVFCRNIGEVSYKSDVYNYGMMIFEMTGGRKNVDVVDNGS  495 (506)
Q Consensus       442 -------------------------~~~~~~gt~~y~aPE~l~~~~~~~s~~~Dv~s~G~il~elltg~~pf~~~~~~~  495 (506)
                                               ......|+..|+|||.+.+.  .++.++||||||+++|||++|+.||...+..+
T Consensus       163 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~--~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~  239 (316)
T cd05574         163 ALRKGSRRSSVNSIPSETFSEEPSFRSNSFVGTEEYIAPEVISGD--GHGSAVDWWTLGILLYEMLYGTTPFKGSNRDE  239 (316)
T ss_pred             ccccccccccccccchhhhcccccCCCCCCcCccCCcCHHHHcCC--CCCchHHHHHHHHHHHHHhhCCCCCCCCchHH
Confidence                                     01123578899999998654  67899999999999999999999997665443

Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-termin

>cd08221 STKc_Nek9 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9

Probab=99.94  E-value=2.1e-26  Score=221.45  Aligned_cols=172  Identities=27%  Similarity=0.390  Sum_probs=141.8

Q ss_pred             hccccCccCceEEEEEEEc-CCCEEEEEEeccC---CCCchhhHHHHHHhhccCccceeEEEEEee--------------
Q 039231          317 FKYKLGQGGYGSVYKGKLL-DGSNVAVKVLNDS---KGNGKEFINEVASISRTSHVNVVALLGFCL--------------  378 (506)
Q Consensus       317 ~~~~ig~G~~g~V~~~~~~-~~~~vavK~l~~~---~~~~~~~~~E~~~l~~l~h~niv~l~g~~~--------------  378 (506)
                      +.+.||.|+||.||.++.. +++.+++|.+...   ....+++.+|++++++++|+||+++++++.              
T Consensus         4 ~~~~ig~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~~~e~~~~   83 (256)
T cd08221           4 PIRVLGKGAFGEATLYRRTEDDSLVVWKEVNLTRLSEKERRDALNEIVILSLLQHPNIIAYYNHFMDDNTLLIEMEYANG   83 (256)
T ss_pred             EeeEecccCCceEEEEEEcCCCcEEEEEEEeecccchhHHHHHHHHHHHHHhCCCCCeeEEEeEEecCCeEEEEEEecCC
Confidence            4467999999999999864 5889999998643   233467889999999999999999998862              


Q ss_pred             ---------------ccchhhhHHHHHHHHHHHHhhcCCCCeEecCcCCCcEEECCCCcEEEeecCCCccccCCCcceec
Q 039231          379 ---------------RVAEELSSTIGIARGLEYLHLGCSTRILHFDIKPHNILLDEDFCPKISDFGLAKICNRKESIISM  443 (506)
Q Consensus       379 ---------------~~~~~l~i~~~i~~gl~~LH~~~~~~ivH~dlkp~Nill~~~~~~ki~dfg~a~~~~~~~~~~~~  443 (506)
                                     ++.+.+.++.|++.||+|||   +.+++|+||+|+||++++++.+||+|||++.........  .
T Consensus        84 ~~L~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh---~~~i~h~dl~p~ni~~~~~~~~kl~d~~~~~~~~~~~~~--~  158 (256)
T cd08221          84 GTLYDKIVRQKGQLFEEEMVLWYLFQIVSAVSYIH---KAGILHRDIKTLNIFLTKAGLIKLGDFGISKILGSEYSM--A  158 (256)
T ss_pred             CcHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHH---hCCccccCCChHhEEEeCCCCEEECcCcceEEccccccc--c
Confidence                           12234668889999999999   899999999999999999999999999999876544321  2


Q ss_pred             ccCCCCcccccccccccccCCCCccccHHHHHHHHHHHHcCCCCCCCCCCCc
Q 039231          444 TGARGTVGYIAPEVFCRNIGEVSYKSDVYNYGMMIFEMTGGRKNVDVVDNGS  495 (506)
Q Consensus       444 ~~~~gt~~y~aPE~l~~~~~~~s~~~Dv~s~G~il~elltg~~pf~~~~~~~  495 (506)
                      ....+++.|+|||.+.+.  .++.++||||||+++|||++|+.||+.....+
T Consensus       159 ~~~~~~~~y~ape~~~~~--~~~~~~Dv~slG~i~~~l~~g~~~~~~~~~~~  208 (256)
T cd08221         159 ETVVGTPYYMSPELCQGV--KYNFKSDIWALGCVLYELLTLKRTFDATNPLN  208 (256)
T ss_pred             cccCCCccccCHhhcCCC--CCCCcchhHHHHHHHHHHHHCCCCCCCCCHHH
Confidence            345689999999998654  57889999999999999999999998655443

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associa

>cd07840 STKc_CDK9_like Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases

Probab=99.94  E-value=1.4e-26  Score=226.24  Aligned_cols=172  Identities=29%  Similarity=0.406  Sum_probs=141.7

Q ss_pred             hccccCccCceEEEEEEEcC-CCEEEEEEeccCC---CCchhhHHHHHHhhccCccceeEEEEEeecc------------
Q 039231          317 FKYKLGQGGYGSVYKGKLLD-GSNVAVKVLNDSK---GNGKEFINEVASISRTSHVNVVALLGFCLRV------------  380 (506)
Q Consensus       317 ~~~~ig~G~~g~V~~~~~~~-~~~vavK~l~~~~---~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~------------  380 (506)
                      +.++||+|++|.||+|+..+ ++.+|+|++....   ...+.+.+|++++++++|+|++++++++...            
T Consensus         3 ~~~~l~~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~e~~   82 (287)
T cd07840           3 KIAQIGEGTYGQVYKARNKKTGELVALKKIRMENEKEGFPITAIREIKLLQKLRHPNIVRLKEIVTSKGKGSIYMVFEYM   82 (287)
T ss_pred             eeEEeccCCCeEEEEEEECCCCeEEEEEEEecccccccchHHHHHHHHHHHhccCCCeeeheeeEecCCCCcEEEEeccc
Confidence            34679999999999998764 8899999997653   2335688999999999999999999876433            


Q ss_pred             -----------------chhhhHHHHHHHHHHHHhhcCCCCeEecCcCCCcEEECCCCcEEEeecCCCccccCCCcceec
Q 039231          381 -----------------AEELSSTIGIARGLEYLHLGCSTRILHFDIKPHNILLDEDFCPKISDFGLAKICNRKESIISM  443 (506)
Q Consensus       381 -----------------~~~l~i~~~i~~gl~~LH~~~~~~ivH~dlkp~Nill~~~~~~ki~dfg~a~~~~~~~~~~~~  443 (506)
                                       .+.+.++.|++.||+|||   +.+++|+||+|+||++++++.+||+|||++......... ..
T Consensus        83 ~~~l~~~~~~~~~~~~~~~~~~i~~~i~~al~~LH---~~~~~h~dl~p~nil~~~~~~~~l~d~g~~~~~~~~~~~-~~  158 (287)
T cd07840          83 DHDLTGLLDSPEVKFTESQIKCYMKQLLEGLQYLH---SNGILHRDIKGSNILINNDGVLKLADFGLARPYTKRNSA-DY  158 (287)
T ss_pred             cccHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHH---HCCceeccCcHHHeEEcCCCCEEEccccceeeccCCCcc-cc
Confidence                             225678899999999999   899999999999999999999999999999876544321 12


Q ss_pred             ccCCCCcccccccccccccCCCCccccHHHHHHHHHHHHcCCCCCCCCCC
Q 039231          444 TGARGTVGYIAPEVFCRNIGEVSYKSDVYNYGMMIFEMTGGRKNVDVVDN  493 (506)
Q Consensus       444 ~~~~gt~~y~aPE~l~~~~~~~s~~~Dv~s~G~il~elltg~~pf~~~~~  493 (506)
                      ....++..|+|||.+.+. ..++.++||||||+++|||++|+.||+..+.
T Consensus       159 ~~~~~~~~y~~PE~~~~~-~~~~~~~Dv~slG~~l~el~t~~~p~~~~~~  207 (287)
T cd07840         159 TNRVITLWYRPPELLLGA-TRYGPEVDMWSVGCILAELFLGKPIFQGSTE  207 (287)
T ss_pred             cccccccccCCceeeEcc-ccCChHHHHHHHHHHHHHHHhCCCCCCCCCh
Confidence            334567889999987543 3578899999999999999999999986654

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA po

>cd07833 STKc_CDKL Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases

Probab=99.94  E-value=1.1e-26  Score=227.48  Aligned_cols=173  Identities=28%  Similarity=0.369  Sum_probs=142.7

Q ss_pred             hhccccCccCceEEEEEEEc-CCCEEEEEEeccCC---CCchhhHHHHHHhhccCccceeEEEEEee-------------
Q 039231          316 SFKYKLGQGGYGSVYKGKLL-DGSNVAVKVLNDSK---GNGKEFINEVASISRTSHVNVVALLGFCL-------------  378 (506)
Q Consensus       316 ~~~~~ig~G~~g~V~~~~~~-~~~~vavK~l~~~~---~~~~~~~~E~~~l~~l~h~niv~l~g~~~-------------  378 (506)
                      .+.+.||+|++|.||+|+.. +++.|++|+++...   ...+.+.+|++++++++|+||+++++++.             
T Consensus         4 ~~~~~i~~g~~~~v~~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e~~~   83 (288)
T cd07833           4 EVLGVVGEGAYGVVLKCRNKATGEIVAIKKFKESEDDEDVKKTALREVKVLRQLRHENIVNLKEAFRRKGRLYLVFEYVE   83 (288)
T ss_pred             eEEEEecccCCeeEEEEEeCCCCcEEEEehhhhhcccccchhHHHHHHHHHHhcCCCCeeehhheEEECCEEEEEEecCC
Confidence            34567999999999999986 47899999987532   23467899999999999999999998772             


Q ss_pred             --------------ccchhhhHHHHHHHHHHHHhhcCCCCeEecCcCCCcEEECCCCcEEEeecCCCccccCCCcceecc
Q 039231          379 --------------RVAEELSSTIGIARGLEYLHLGCSTRILHFDIKPHNILLDEDFCPKISDFGLAKICNRKESIISMT  444 (506)
Q Consensus       379 --------------~~~~~l~i~~~i~~gl~~LH~~~~~~ivH~dlkp~Nill~~~~~~ki~dfg~a~~~~~~~~~~~~~  444 (506)
                                    +..+.+.++.|++.||+|||   +.+++|+||+|+||++++++.+||+|||++......... ...
T Consensus        84 ~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH---~~~i~H~dl~~~ni~~~~~~~~kl~d~g~~~~~~~~~~~-~~~  159 (288)
T cd07833          84 RTLLELLEASPGGLPPDAVRSYIWQLLQAIAYCH---SHNIIHRDIKPENILVSESGVLKLCDFGFARALRARPAS-PLT  159 (288)
T ss_pred             CCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHeEECCCCCEEEEeeecccccCCCccc-ccc
Confidence                          23335678899999999999   899999999999999999999999999999876544321 123


Q ss_pred             cCCCCcccccccccccccCCCCccccHHHHHHHHHHHHcCCCCCCCCCC
Q 039231          445 GARGTVGYIAPEVFCRNIGEVSYKSDVYNYGMMIFEMTGGRKNVDVVDN  493 (506)
Q Consensus       445 ~~~gt~~y~aPE~l~~~~~~~s~~~Dv~s~G~il~elltg~~pf~~~~~  493 (506)
                      ...++..|+|||.+.+. ..++.++||||||+++|||++|+.||.....
T Consensus       160 ~~~~~~~~~~PE~~~~~-~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~  207 (288)
T cd07833         160 DYVATRWYRAPELLVGD-TNYGKPVDVWAIGCIMAELLDGEPLFPGDSD  207 (288)
T ss_pred             CcccccCCcCCchhcCC-CCcCchhhHHHHHHHHHHHHhCCCCCCCCCH
Confidence            45678899999998653 2678899999999999999999999976543

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning

>cd06626 STKc_MEKK4 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4

Probab=99.94  E-value=1.7e-26  Score=222.94  Aligned_cols=173  Identities=31%  Similarity=0.464  Sum_probs=142.5

Q ss_pred             hccccCccCceEEEEEEEc-CCCEEEEEEeccCCC---CchhhHHHHHHhhccCccceeEEEEEe---------------
Q 039231          317 FKYKLGQGGYGSVYKGKLL-DGSNVAVKVLNDSKG---NGKEFINEVASISRTSHVNVVALLGFC---------------  377 (506)
Q Consensus       317 ~~~~ig~G~~g~V~~~~~~-~~~~vavK~l~~~~~---~~~~~~~E~~~l~~l~h~niv~l~g~~---------------  377 (506)
                      ..+.||+|++|.||+|... +++.+++|.++....   ..+.+.+|++++++++|+||+++++.+               
T Consensus         4 ~~~~lg~G~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~   83 (264)
T cd06626           4 RGNKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIKEIADEMKVLELLKHPNLVKYYGVEVHREKVYIFMEYCSG   83 (264)
T ss_pred             eeeEeecCCCcEEEEEEECCCCcEEEEEEEECcccchHHHHHHHHHHHHHHhCCCCChhheeeeEecCCEEEEEEecCCC
Confidence            3467999999999999875 589999999976544   346789999999999999999999875               


Q ss_pred             ------------eccchhhhHHHHHHHHHHHHhhcCCCCeEecCcCCCcEEECCCCcEEEeecCCCccccCCCccee--c
Q 039231          378 ------------LRVAEELSSTIGIARGLEYLHLGCSTRILHFDIKPHNILLDEDFCPKISDFGLAKICNRKESIIS--M  443 (506)
Q Consensus       378 ------------~~~~~~l~i~~~i~~gl~~LH~~~~~~ivH~dlkp~Nill~~~~~~ki~dfg~a~~~~~~~~~~~--~  443 (506)
                                  +.+.....++.|++.||+|||   +.+++|+||+|+||++++++.+||+|||++...........  .
T Consensus        84 ~~L~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh---~~~i~H~dl~~~nil~~~~~~~kl~d~g~~~~~~~~~~~~~~~~  160 (264)
T cd06626          84 GTLEELLEHGRILDEHVIRVYTLQLLEGLAYLH---SHGIVHRDIKPANIFLDHNGVIKLGDFGCAVKLKNNTTTMGEEV  160 (264)
T ss_pred             CcHHHHHhhcCCCChHHHHHHHHHHHHHHHHHH---HCCcccCCCCHHHEEECCCCCEEEcccccccccCCCCCcccccc
Confidence                        223335668899999999999   89999999999999999999999999999987654332211  1


Q ss_pred             ccCCCCccccccccccccc-CCCCccccHHHHHHHHHHHHcCCCCCCCCC
Q 039231          444 TGARGTVGYIAPEVFCRNI-GEVSYKSDVYNYGMMIFEMTGGRKNVDVVD  492 (506)
Q Consensus       444 ~~~~gt~~y~aPE~l~~~~-~~~s~~~Dv~s~G~il~elltg~~pf~~~~  492 (506)
                      ....++..|+|||.+.... ...+.++||||||+++|||++|+.||...+
T Consensus       161 ~~~~~~~~~~~PE~~~~~~~~~~~~~~Dv~s~G~il~~l~~g~~pf~~~~  210 (264)
T cd06626         161 QSLAGTPAYMAPEVITGGKGKGHGRAADIWSLGCVVLEMATGKRPWSELD  210 (264)
T ss_pred             cCCcCCcCccChhhccCCCCCCCCcccchHHHHHHHHHHHhCCCCccCCc
Confidence            2356788999999986542 237889999999999999999999997654

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4

>cd06608 STKc_myosinIII_like Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases

Probab=99.94  E-value=1.5e-26  Score=224.51  Aligned_cols=172  Identities=27%  Similarity=0.417  Sum_probs=140.9

Q ss_pred             hccccCccCceEEEEEEEc-CCCEEEEEEeccCCCCchhhHHHHHHhhcc-CccceeEEEEEeeccc-------------
Q 039231          317 FKYKLGQGGYGSVYKGKLL-DGSNVAVKVLNDSKGNGKEFINEVASISRT-SHVNVVALLGFCLRVA-------------  381 (506)
Q Consensus       317 ~~~~ig~G~~g~V~~~~~~-~~~~vavK~l~~~~~~~~~~~~E~~~l~~l-~h~niv~l~g~~~~~~-------------  381 (506)
                      +.+.||+|++|.||+|+.. +++.+++|++.......+++.+|+++++++ +|+||+++++++....             
T Consensus        10 ~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~~~~~lv~e   89 (275)
T cd06608          10 LVEVIGEGTYGKVYKARHKKTGQLVAIKIMDIIEDEEEEIKEEYNILRKYSNHPNIATFYGAFIKKNPPGNDDQLWLVME   89 (275)
T ss_pred             heeeecCCCCeEEEEEEECCCCcEEEEEEEecCchhHHHHHHHHHHHHHhcCCCChheEEEEEEecCCCCcceEEEEEEE
Confidence            3567999999999999985 478999999987665567899999999999 6999999998763211             


Q ss_pred             ------------------------hhhhHHHHHHHHHHHHhhcCCCCeEecCcCCCcEEECCCCcEEEeecCCCccccCC
Q 039231          382 ------------------------EELSSTIGIARGLEYLHLGCSTRILHFDIKPHNILLDEDFCPKISDFGLAKICNRK  437 (506)
Q Consensus       382 ------------------------~~l~i~~~i~~gl~~LH~~~~~~ivH~dlkp~Nill~~~~~~ki~dfg~a~~~~~~  437 (506)
                                              ....++.|++.||+|||   +.+++|+||+|+||++++++.+||+|||++......
T Consensus        90 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH---~~~i~H~~l~p~ni~~~~~~~~~l~d~~~~~~~~~~  166 (275)
T cd06608          90 LCGGGSVTDLVKGLRKKGKRLKEEWIAYILRETLRGLAYLH---ENKVIHRDIKGQNILLTKNAEVKLVDFGVSAQLDST  166 (275)
T ss_pred             cCCCCcHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHh---cCCcccCCCCHHHEEEccCCeEEECCCccceecccc
Confidence                                    13457889999999999   999999999999999999999999999998765433


Q ss_pred             CcceecccCCCCcccccccccccc---cCCCCccccHHHHHHHHHHHHcCCCCCCCCCC
Q 039231          438 ESIISMTGARGTVGYIAPEVFCRN---IGEVSYKSDVYNYGMMIFEMTGGRKNVDVVDN  493 (506)
Q Consensus       438 ~~~~~~~~~~gt~~y~aPE~l~~~---~~~~s~~~Dv~s~G~il~elltg~~pf~~~~~  493 (506)
                      ...  .....++..|+|||.+...   ...++.++||||||+++|||++|+.||.....
T Consensus       167 ~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~  223 (275)
T cd06608         167 LGR--RNTFIGTPYWMAPEVIACDEQPDASYDARSDVWSLGITAIELADGKPPLCDMHP  223 (275)
T ss_pred             hhh--hcCccccccccCHhHhcccccccCCccccccHHHhHHHHHHHHhCCCCccccch
Confidence            221  2345688899999987432   23567899999999999999999999976543

Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin I

>cd06620 PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases

Probab=99.94  E-value=1.6e-26  Score=226.11  Aligned_cols=171  Identities=29%  Similarity=0.370  Sum_probs=140.2

Q ss_pred             hhhccccCccCceEEEEEEEc-CCCEEEEEEeccCC--CCchhhHHHHHHhhccCccceeEEEEEeec------------
Q 039231          315 NSFKYKLGQGGYGSVYKGKLL-DGSNVAVKVLNDSK--GNGKEFINEVASISRTSHVNVVALLGFCLR------------  379 (506)
Q Consensus       315 ~~~~~~ig~G~~g~V~~~~~~-~~~~vavK~l~~~~--~~~~~~~~E~~~l~~l~h~niv~l~g~~~~------------  379 (506)
                      +.+.++||+|++|+||++... +++.+|+|++....  ...+++.+|+++++.++||||+++++.+..            
T Consensus         7 ~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~   86 (284)
T cd06620           7 LETISDLGAGNGGSVSKVKHIPTGTVMAKKVVHIGAKSSVRKQILRELQIMHECRSPYIVSFYGAFLNENNICMCMEFMD   86 (284)
T ss_pred             HHHHHHcCCCCCeEEEEEEEcCCCcEEEEEEEEecCcchHHHHHHHHHHHHHHcCCCCcceEeeeEecCCEEEEEEecCC
Confidence            344567999999999999875 58899999886432  234678899999999999999999987721            


Q ss_pred             ---------------cchhhhHHHHHHHHHHHHhhcCCCCeEecCcCCCcEEECCCCcEEEeecCCCccccCCCcceecc
Q 039231          380 ---------------VAEELSSTIGIARGLEYLHLGCSTRILHFDIKPHNILLDEDFCPKISDFGLAKICNRKESIISMT  444 (506)
Q Consensus       380 ---------------~~~~l~i~~~i~~gl~~LH~~~~~~ivH~dlkp~Nill~~~~~~ki~dfg~a~~~~~~~~~~~~~  444 (506)
                                     +.....++.+++.||.|||+  ..+++|+||+|+||++++++.++|+|||++........    .
T Consensus        87 ~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~--~~~i~H~dl~p~nil~~~~~~~~l~d~gl~~~~~~~~~----~  160 (284)
T cd06620          87 CGSLDRIYKKGGPIPVEILGKIAVAVVEGLTYLYN--VHRIMHRDIKPSNILVNSRGQIKLCDFGVSGELINSIA----D  160 (284)
T ss_pred             CCCHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHH--hcCeeccCCCHHHEEECCCCcEEEccCCcccchhhhcc----C
Confidence                           22346788999999999993  36899999999999999999999999999865432221    2


Q ss_pred             cCCCCcccccccccccccCCCCccccHHHHHHHHHHHHcCCCCCCCCCC
Q 039231          445 GARGTVGYIAPEVFCRNIGEVSYKSDVYNYGMMIFEMTGGRKNVDVVDN  493 (506)
Q Consensus       445 ~~~gt~~y~aPE~l~~~~~~~s~~~Dv~s~G~il~elltg~~pf~~~~~  493 (506)
                      ...++..|+|||.+.+.  .++.++||||||+++|||++|+.||+....
T Consensus       161 ~~~~~~~~~aPE~~~~~--~~~~~~Di~slG~~l~~l~tg~~p~~~~~~  207 (284)
T cd06620         161 TFVGTSTYMSPERIQGG--KYTVKSDVWSLGISIIELALGKFPFAFSNI  207 (284)
T ss_pred             ccccCcccCCHHHHccC--CCCccchHHHHHHHHHHHHhCCCCCcccch
Confidence            35689999999998543  788899999999999999999999986554

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include

>cd06610 STKc_OSR1_SPAK Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase

Probab=99.94  E-value=2.9e-26  Score=221.62  Aligned_cols=174  Identities=29%  Similarity=0.391  Sum_probs=142.0

Q ss_pred             hhccccCccCceEEEEEEEc-CCCEEEEEEeccCC--CCchhhHHHHHHhhccCccceeEEEEEee--------------
Q 039231          316 SFKYKLGQGGYGSVYKGKLL-DGSNVAVKVLNDSK--GNGKEFINEVASISRTSHVNVVALLGFCL--------------  378 (506)
Q Consensus       316 ~~~~~ig~G~~g~V~~~~~~-~~~~vavK~l~~~~--~~~~~~~~E~~~l~~l~h~niv~l~g~~~--------------  378 (506)
                      .+.+.||.|++|.||+|... ++..+++|++....  ...+.+.+|++.++.++|+||+++++.+.              
T Consensus         4 ~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e~~~~   83 (267)
T cd06610           4 ELIEVIGVGATAVVYAAICLPNNEKVAIKRIDLEKCQTSVDELRKEVQAMSQCNHPNVVKYYTSFVVGDELWLVMPYLSG   83 (267)
T ss_pred             eeeeeecCCCCeEEEEEEEcCCCcEEEEEEeccCCcchHHHHHHHHHHHHHhcCCCCEEEEEEEEeeCCEEEEEEeccCC
Confidence            34567999999999999864 57899999986543  23467899999999999999999998651              


Q ss_pred             ----------------ccchhhhHHHHHHHHHHHHhhcCCCCeEecCcCCCcEEECCCCcEEEeecCCCccccCCCcce-
Q 039231          379 ----------------RVAEELSSTIGIARGLEYLHLGCSTRILHFDIKPHNILLDEDFCPKISDFGLAKICNRKESII-  441 (506)
Q Consensus       379 ----------------~~~~~l~i~~~i~~gl~~LH~~~~~~ivH~dlkp~Nill~~~~~~ki~dfg~a~~~~~~~~~~-  441 (506)
                                      ++.....++.|++.||+|||   +.+++|+||+|+||++++++.+||+|||++.......... 
T Consensus        84 ~~l~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lh---~~~i~h~~l~p~ni~~~~~~~~~l~df~~~~~~~~~~~~~~  160 (267)
T cd06610          84 GSLLDIMKSSYPRGGLDEAIIATVLKEVLKGLEYLH---SNGQIHRDIKAGNILLGEDGSVKIADFGVSASLADGGDRTR  160 (267)
T ss_pred             CcHHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHhEEEcCCCCEEEcccchHHHhccCccccc
Confidence                            12234568899999999999   9999999999999999999999999999987765443221 


Q ss_pred             -ecccCCCCcccccccccccccCCCCccccHHHHHHHHHHHHcCCCCCCCCCC
Q 039231          442 -SMTGARGTVGYIAPEVFCRNIGEVSYKSDVYNYGMMIFEMTGGRKNVDVVDN  493 (506)
Q Consensus       442 -~~~~~~gt~~y~aPE~l~~~~~~~s~~~Dv~s~G~il~elltg~~pf~~~~~  493 (506)
                       ......++..|+|||.+... ...+.++|+||||+++|||++|+.||.....
T Consensus       161 ~~~~~~~~~~~y~~Pe~~~~~-~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~  212 (267)
T cd06610         161 KVRKTFVGTPCWMAPEVMEQV-HGYDFKADIWSFGITAIELATGAAPYSKYPP  212 (267)
T ss_pred             cccccccCChhhcChHHHccc-cCcCcccchHhHhHHHHHHHhCCCCccccCh
Confidence             11334578899999998553 3678899999999999999999999976544

Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1

>smart00219 TyrKc Tyrosine kinase, catalytic domain

Probab=99.94  E-value=2.4e-26  Score=220.88  Aligned_cols=170  Identities=35%  Similarity=0.618  Sum_probs=139.9

Q ss_pred             hccccCccCceEEEEEEEcC-----CCEEEEEEeccCCC--CchhhHHHHHHhhccCccceeEEEEEee-----------
Q 039231          317 FKYKLGQGGYGSVYKGKLLD-----GSNVAVKVLNDSKG--NGKEFINEVASISRTSHVNVVALLGFCL-----------  378 (506)
Q Consensus       317 ~~~~ig~G~~g~V~~~~~~~-----~~~vavK~l~~~~~--~~~~~~~E~~~l~~l~h~niv~l~g~~~-----------  378 (506)
                      +.+.||+|+||.||+++..+     +..+|+|+++....  ..+.+.+|++.+.+++|+||+++++++.           
T Consensus         3 ~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~i~e~   82 (258)
T smart00219        3 LGKKLGEGAFGEVYKGTLKGLSGEKEVEVAVKTLKEDADEQQIEEFLREARIMRKLDHPNIVKLLGVCTEEEPLMIVMEY   82 (258)
T ss_pred             ccceeccCCCcceEEEEecCCCCCCCceEEEEEccCCCChHHHHHHHHHHHHHHhcCCCchheEEEEEcCCCeeEEEEec
Confidence            34679999999999998754     38899999976544  4578899999999999999999998762           


Q ss_pred             ------------------ccchhhhHHHHHHHHHHHHhhcCCCCeEecCcCCCcEEECCCCcEEEeecCCCccccCCCcc
Q 039231          379 ------------------RVAEELSSTIGIARGLEYLHLGCSTRILHFDIKPHNILLDEDFCPKISDFGLAKICNRKESI  440 (506)
Q Consensus       379 ------------------~~~~~l~i~~~i~~gl~~LH~~~~~~ivH~dlkp~Nill~~~~~~ki~dfg~a~~~~~~~~~  440 (506)
                                        ++...+.++.|++.||+|||   +.+++|+||+|+||++++++.++|+|||+++........
T Consensus        83 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lh---~~~~~h~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~~~  159 (258)
T smart00219       83 MEGGDLLDYLRKNRPKELSLSDLLSFALQIARGMEYLE---SKNFIHRDLAARNCLVGENLVVKISDFGLSRDLYDDDYY  159 (258)
T ss_pred             cCCCCHHHHHHhhhhccCCHHHHHHHHHHHHHHHHHHh---cCCeeecccccceEEEccCCeEEEcccCCceeccccccc
Confidence                              12224668899999999999   899999999999999999999999999999876554322


Q ss_pred             eecccCCCCcccccccccccccCCCCccccHHHHHHHHHHHHc-CCCCCCCCC
Q 039231          441 ISMTGARGTVGYIAPEVFCRNIGEVSYKSDVYNYGMMIFEMTG-GRKNVDVVD  492 (506)
Q Consensus       441 ~~~~~~~gt~~y~aPE~l~~~~~~~s~~~Dv~s~G~il~ellt-g~~pf~~~~  492 (506)
                      .. ....+++.|+|||.+..  ..++.++||||+|++++||++ |+.||...+
T Consensus       160 ~~-~~~~~~~~y~~Pe~~~~--~~~~~~~Di~slG~i~~~l~~~g~~p~~~~~  209 (258)
T smart00219      160 KK-KGGKLPIRWMAPESLKD--GKFTSKSDVWSFGVLLWEIFTLGESPYPGMS  209 (258)
T ss_pred             cc-ccCCCcccccChHHhcc--CCCCcchhHHHHHHHHHHHHhCCCCCCCCCC
Confidence            11 12346789999999843  478899999999999999998 889987643

Phosphotransferases. Tyrosine-specific kinase subfamily.

>cd05577 STKc_GRK Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase

Probab=99.94  E-value=2.6e-26  Score=223.84  Aligned_cols=165  Identities=32%  Similarity=0.470  Sum_probs=135.7

Q ss_pred             cCccCceEEEEEEEc-CCCEEEEEEeccCC----CCchhhHHHHHHhhccCccceeEEEEEe------------------
Q 039231          321 LGQGGYGSVYKGKLL-DGSNVAVKVLNDSK----GNGKEFINEVASISRTSHVNVVALLGFC------------------  377 (506)
Q Consensus       321 ig~G~~g~V~~~~~~-~~~~vavK~l~~~~----~~~~~~~~E~~~l~~l~h~niv~l~g~~------------------  377 (506)
                      ||+|+||+||++..+ +|+.+|+|.+....    ...+.+.+|++++++++||||+++++.+                  
T Consensus         1 lg~g~~g~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L   80 (277)
T cd05577           1 LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRFIVSLAYAFETKDDLCLVMTLMNGGDL   80 (277)
T ss_pred             CCCCCceeEEEEEEcCCCcEEEEEEEehhhhhhhhhhHHHHHHHHHHHhCCCCCEeeeeeEEecCCeEEEEEecCCCCcH
Confidence            689999999999864 58899999986432    2234567899999999999999998765                  


Q ss_pred             -----------eccchhhhHHHHHHHHHHHHhhcCCCCeEecCcCCCcEEECCCCcEEEeecCCCccccCCCcceecccC
Q 039231          378 -----------LRVAEELSSTIGIARGLEYLHLGCSTRILHFDIKPHNILLDEDFCPKISDFGLAKICNRKESIISMTGA  446 (506)
Q Consensus       378 -----------~~~~~~l~i~~~i~~gl~~LH~~~~~~ivH~dlkp~Nill~~~~~~ki~dfg~a~~~~~~~~~~~~~~~  446 (506)
                                 +.+.+.+.++.|++.||.|||   +.+++|+||+|+||++++++.+||+|||.+........   ....
T Consensus        81 ~~~l~~~~~~~~~~~~~~~~~~ql~~~l~~lH---~~~i~H~di~p~Nil~~~~~~~~l~dfg~~~~~~~~~~---~~~~  154 (277)
T cd05577          81 KYHIYNVGEPGFPEARAIFYAAQIICGLEHLH---QRRIVYRDLKPENVLLDDHGNVRISDLGLAVELKGGKK---IKGR  154 (277)
T ss_pred             HHHHHHcCcCCCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCCHHHEEECCCCCEEEccCcchhhhccCCc---cccc
Confidence                       112234567889999999999   89999999999999999999999999999876543221   1335


Q ss_pred             CCCcccccccccccccCCCCccccHHHHHHHHHHHHcCCCCCCCCCC
Q 039231          447 RGTVGYIAPEVFCRNIGEVSYKSDVYNYGMMIFEMTGGRKNVDVVDN  493 (506)
Q Consensus       447 ~gt~~y~aPE~l~~~~~~~s~~~Dv~s~G~il~elltg~~pf~~~~~  493 (506)
                      .++..|+|||.+.+.  .++.++||||||+++|+|++|+.||.....
T Consensus       155 ~~~~~y~~PE~~~~~--~~~~~~Di~slG~il~~l~~g~~p~~~~~~  199 (277)
T cd05577         155 AGTPGYMAPEVLQGE--VYDFSVDWFALGCTLYEMIAGRSPFRQRKE  199 (277)
T ss_pred             cCCCCcCCHHHhcCC--CCCchhhhHHHHHHHHHHhhCCCCCCCCcc
Confidence            678899999998654  588899999999999999999999977654

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of

>cd05076 PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2

Probab=99.94  E-value=1.2e-26  Score=225.88  Aligned_cols=164  Identities=26%  Similarity=0.402  Sum_probs=130.5

Q ss_pred             ccCccCceEEEEEEEcC-------------------------CCEEEEEEeccCCC-CchhhHHHHHHhhccCccceeEE
Q 039231          320 KLGQGGYGSVYKGKLLD-------------------------GSNVAVKVLNDSKG-NGKEFINEVASISRTSHVNVVAL  373 (506)
Q Consensus       320 ~ig~G~~g~V~~~~~~~-------------------------~~~vavK~l~~~~~-~~~~~~~E~~~l~~l~h~niv~l  373 (506)
                      .||+|+||.||+|++..                         ...|++|++..... ...++.+|++++++++||||+++
T Consensus         2 ~lG~G~~~~vy~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~~~~~~~l~h~niv~~   81 (274)
T cd05076           2 HLGQGTRTNIYDGRLRVEGGGEPEEDEMEDEDPLVEGNNNGRELRVVLKVLDPSHRDIALAFFETASLMSQVSHIHLAFV   81 (274)
T ss_pred             CcCcccccceecceeEeccCCCCcccccccccccccccCCCeeeeEEEEecChHHHHHHHHHHHHHHHHhcCCCCCeeeE
Confidence            59999999999997521                         13588998865432 23578889999999999999999


Q ss_pred             EEEee----------------------------ccchhhhHHHHHHHHHHHHhhcCCCCeEecCcCCCcEEECCCC----
Q 039231          374 LGFCL----------------------------RVAEELSSTIGIARGLEYLHLGCSTRILHFDIKPHNILLDEDF----  421 (506)
Q Consensus       374 ~g~~~----------------------------~~~~~l~i~~~i~~gl~~LH~~~~~~ivH~dlkp~Nill~~~~----  421 (506)
                      ++++.                            ++..++.++.|+++||+|||   +++|+||||||+||++++.+    
T Consensus        82 ~~~~~~~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH---~~~iiH~dlkp~Nill~~~~~~~~  158 (274)
T cd05076          82 HGVCVRGSENIMVEEFVEHGPLDVCLRKEKGRVPVAWKITVAQQLASALSYLE---DKNLVHGNVCAKNILLARLGLAEG  158 (274)
T ss_pred             EEEEEeCCceEEEEecCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH---cCCccCCCCCcccEEEeccCcccC
Confidence            99872                            23336778999999999999   89999999999999997643    


Q ss_pred             ---cEEEeecCCCccccCCCcceecccCCCCcccccccccccccCCCCccccHHHHHHHHHHHH-cCCCCCCCCCC
Q 039231          422 ---CPKISDFGLAKICNRKESIISMTGARGTVGYIAPEVFCRNIGEVSYKSDVYNYGMMIFEMT-GGRKNVDVVDN  493 (506)
Q Consensus       422 ---~~ki~dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~s~~~Dv~s~G~il~ell-tg~~pf~~~~~  493 (506)
                         .+|++|||++......      ....++..|+|||.+.+. ..++.++||||||+++|||+ +|+.||.....
T Consensus       159 ~~~~~kl~d~g~~~~~~~~------~~~~~~~~~~aPe~~~~~-~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~  227 (274)
T cd05076         159 TSPFIKLSDPGVSFTALSR------EERVERIPWIAPECVPGG-NSLSTAADKWSFGTTLLEICFDGEVPLKERTP  227 (274)
T ss_pred             ccceeeecCCccccccccc------cccccCCcccCchhhcCC-CCCCcHHHHHHHHHHHHHHHhCCCCCccccCh
Confidence               3799999987643222      223467889999988553 46789999999999999994 79999976544

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalyt

>KOG0579 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.94  E-value=3.7e-28  Score=242.23  Aligned_cols=179  Identities=26%  Similarity=0.380  Sum_probs=146.3

Q ss_pred             ccCccCceEEEEEEEcC-CCEEEEEEecc-CCCCchhhHHHHHHhhccCccceeEEEEEe--------------------
Q 039231          320 KLGQGGYGSVYKGKLLD-GSNVAVKVLND-SKGNGKEFINEVASISRTSHVNVVALLGFC--------------------  377 (506)
Q Consensus       320 ~ig~G~~g~V~~~~~~~-~~~vavK~l~~-~~~~~~~~~~E~~~l~~l~h~niv~l~g~~--------------------  377 (506)
                      .||.|+||.||+|..++ +-..|.|++.. +....++++-|+++|...+||+||+|++.+                    
T Consensus        39 ELGDGAFGKVyKA~nket~~lAAaKvIetkseEELEDylVEIeILa~CdHP~ivkLl~ayy~enkLwiliEFC~GGAVDa  118 (1187)
T KOG0579|consen   39 ELGDGAFGKVYKAVNKETKLLAAAKVIETKSEEELEDYLVEIEILAECDHPVIVKLLSAYYFENKLWILIEFCGGGAVDA  118 (1187)
T ss_pred             hhcCccchhhhhhhcccchhhhhhhhhcccchhHHhhhhhhhhhhhcCCChHHHHHHHHHhccCceEEEEeecCCchHhH
Confidence            48999999999998765 44557787754 444558899999999999999999988654                    


Q ss_pred             --------eccchhhhHHHHHHHHHHHHhhcCCCCeEecCcCCCcEEECCCCcEEEeecCCCccccCCCcceecccCCCC
Q 039231          378 --------LRVAEELSSTIGIARGLEYLHLGCSTRILHFDIKPHNILLDEDFCPKISDFGLAKICNRKESIISMTGARGT  449 (506)
Q Consensus       378 --------~~~~~~l~i~~~i~~gl~~LH~~~~~~ivH~dlkp~Nill~~~~~~ki~dfg~a~~~~~~~~~~~~~~~~gt  449 (506)
                              +.+.+..-+..|++.||.|||   ++.|||||||..|||++-+|.++|+|||.+.......  .......||
T Consensus       119 imlEL~r~LtE~QIqvvc~q~ldALn~LH---s~~iIHRDLKAGNiL~TldGdirLADFGVSAKn~~t~--qkRDsFIGT  193 (1187)
T KOG0579|consen  119 IMLELGRVLTEDQIQVVCYQVLDALNWLH---SQNIIHRDLKAGNILLTLDGDIRLADFGVSAKNKSTR--QKRDSFIGT  193 (1187)
T ss_pred             HHHHhccccchHHHHHHHHHHHHHHHHHh---hcchhhhhccccceEEEecCcEeeecccccccchhHH--hhhccccCC
Confidence                    344455668899999999999   9999999999999999999999999999986543322  123568899


Q ss_pred             ccccccccccc---ccCCCCccccHHHHHHHHHHHHcCCCCCCCCCCCcchhhhhhh
Q 039231          450 VGYIAPEVFCR---NIGEVSYKSDVYNYGMMIFEMTGGRKNVDVVDNGSTALDLQAS  503 (506)
Q Consensus       450 ~~y~aPE~l~~---~~~~~s~~~Dv~s~G~il~elltg~~pf~~~~~~~~~~~~~~~  503 (506)
                      |.|||||+..-   +..+|+.++||||||+.|.||.-+.+|....+.-...+.+.++
T Consensus       194 PYWMAPEVvmCET~KD~PYDykaDiWSlGITLIEMAqiEPPHhelnpMRVllKiaKS  250 (1187)
T KOG0579|consen  194 PYWMAPEVVMCETFKDQPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVLLKIAKS  250 (1187)
T ss_pred             cccccchheeeccccCCCchhhhhHHhhhhHHHHHhccCCCccccchHHHHHHHhhc
Confidence            99999999732   2247899999999999999999999999888776666655543

>cd06641 STKc_MST3 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3

Probab=99.94  E-value=4.1e-26  Score=222.36  Aligned_cols=171  Identities=27%  Similarity=0.392  Sum_probs=140.6

Q ss_pred             hhhccccCccCceEEEEEEEc-CCCEEEEEEeccCCC--CchhhHHHHHHhhccCccceeEEEEEee-------------
Q 039231          315 NSFKYKLGQGGYGSVYKGKLL-DGSNVAVKVLNDSKG--NGKEFINEVASISRTSHVNVVALLGFCL-------------  378 (506)
Q Consensus       315 ~~~~~~ig~G~~g~V~~~~~~-~~~~vavK~l~~~~~--~~~~~~~E~~~l~~l~h~niv~l~g~~~-------------  378 (506)
                      +...+.||+|+||.||+|... ++..+|+|++.....  ..+.+.+|++.+.+++||||+++++++.             
T Consensus         6 ~~~~~~ig~G~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~   85 (277)
T cd06641           6 FTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIMEYLG   85 (277)
T ss_pred             hhhheeEeecCCeEEEEEEECCCCcEEEEEEeccccchHHHHHHHHHHHHHHhcCCCCEeEEEEEEEeCCeEEEEEEeCC
Confidence            334567999999999999864 588999999864332  2356889999999999999999998762             


Q ss_pred             -------------ccchhhhHHHHHHHHHHHHhhcCCCCeEecCcCCCcEEECCCCcEEEeecCCCccccCCCcceeccc
Q 039231          379 -------------RVAEELSSTIGIARGLEYLHLGCSTRILHFDIKPHNILLDEDFCPKISDFGLAKICNRKESIISMTG  445 (506)
Q Consensus       379 -------------~~~~~l~i~~~i~~gl~~LH~~~~~~ivH~dlkp~Nill~~~~~~ki~dfg~a~~~~~~~~~~~~~~  445 (506)
                                   ++...+.++.|++.|+.|||   +.+++|+||+|+||+++.++.++|+|||++.........  ...
T Consensus        86 ~~~l~~~i~~~~~~~~~~~~~~~~l~~~l~~lh---~~~i~h~dl~p~Ni~i~~~~~~~l~dfg~~~~~~~~~~~--~~~  160 (277)
T cd06641          86 GGSALDLLEPGPLDETQIATILREILKGLDYLH---SEKKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIK--RNT  160 (277)
T ss_pred             CCcHHHHHhcCCCCHHHHHHHHHHHHHHHHHHc---cCCeecCCCCHHhEEECCCCCEEEeecccceecccchhh--hcc
Confidence                         23335678899999999999   899999999999999999999999999998766443221  133


Q ss_pred             CCCCcccccccccccccCCCCccccHHHHHHHHHHHHcCCCCCCCCC
Q 039231          446 ARGTVGYIAPEVFCRNIGEVSYKSDVYNYGMMIFEMTGGRKNVDVVD  492 (506)
Q Consensus       446 ~~gt~~y~aPE~l~~~~~~~s~~~Dv~s~G~il~elltg~~pf~~~~  492 (506)
                      ..++..|+|||.+..  ...+.++|+||||+++|||++|..||....
T Consensus       161 ~~~~~~y~~PE~~~~--~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~  205 (277)
T cd06641         161 FVGTPFWMAPEVIKQ--SAYDSKADIWSLGITAIELAKGEPPHSELH  205 (277)
T ss_pred             ccCCccccChhhhcc--CCCCchhhHHHHHHHHHHHHcCCCCCCccc
Confidence            567889999999854  367889999999999999999999997654

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and int

>KOG1151 consensus Tousled-like protein kinase [Signal transduction mechanisms]

Probab=99.94  E-value=2.7e-27  Score=227.67  Aligned_cols=181  Identities=30%  Similarity=0.402  Sum_probs=145.9

Q ss_pred             ccccCccCceEEEEEEE-cCCCEEEEEEeccCC--------CCchhhHHHHHHhhccCccceeEEEEEe-----------
Q 039231          318 KYKLGQGGYGSVYKGKL-LDGSNVAVKVLNDSK--------GNGKEFINEVASISRTSHVNVVALLGFC-----------  377 (506)
Q Consensus       318 ~~~ig~G~~g~V~~~~~-~~~~~vavK~l~~~~--------~~~~~~~~E~~~l~~l~h~niv~l~g~~-----------  377 (506)
                      -+.||+|+|+.||+|.+ ...+.||+|+-.-.+        ...+...+|.++.+.++||.||++++++           
T Consensus       468 LhLLGrGGFSEVyKAFDl~EqRYvAvKIHqlNK~WrdEKKeNYhKHAcREyrIHKeLDHpRIVKlYDyfslDtdsFCTVL  547 (775)
T KOG1151|consen  468 LHLLGRGGFSEVYKAFDLTEQRYVAVKIHQLNKNWRDEKKENYHKHACREYRIHKELDHPRIVKLYDYFSLDTDSFCTVL  547 (775)
T ss_pred             HHHhccccHHHHHHhcccchhheeeEeeehhccchhhHhhhhHHHHHHHHHhhhhccCcceeeeeeeeeeeccccceeee
Confidence            35699999999999985 457889999874211        1125578999999999999999999887           


Q ss_pred             -----------------eccchhhhHHHHHHHHHHHHhhcCCCCeEecCcCCCcEEEC---CCCcEEEeecCCCccccCC
Q 039231          378 -----------------LRVAEELSSTIGIARGLEYLHLGCSTRILHFDIKPHNILLD---EDFCPKISDFGLAKICNRK  437 (506)
Q Consensus       378 -----------------~~~~~~l~i~~~i~~gl~~LH~~~~~~ivH~dlkp~Nill~---~~~~~ki~dfg~a~~~~~~  437 (506)
                                       +.+.++..|++||+.||.||.+. +.+|||-||||.||||.   .-|.+||.|||+++.+..+
T Consensus       548 EYceGNDLDFYLKQhklmSEKEARSIiMQiVnAL~YLNEi-kpPIIHYDLKPgNILLv~GtacGeIKITDFGLSKIMddd  626 (775)
T KOG1151|consen  548 EYCEGNDLDFYLKQHKLMSEKEARSIIMQIVNALKYLNEI-KPPIIHYDLKPGNILLVNGTACGEIKITDFGLSKIMDDD  626 (775)
T ss_pred             eecCCCchhHHHHhhhhhhHHHHHHHHHHHHHHHHHHhcc-CCCeeeeccCCccEEEecCcccceeEeeecchhhhccCC
Confidence                             34556788999999999999854 89999999999999994   4578999999999998754


Q ss_pred             Ccce-----ecccCCCCcccccccccccc--cCCCCccccHHHHHHHHHHHHcCCCCCCCCCCCcchhh
Q 039231          438 ESII-----SMTGARGTVGYIAPEVFCRN--IGEVSYKSDVYNYGMMIFEMTGGRKNVDVVDNGSTALD  499 (506)
Q Consensus       438 ~~~~-----~~~~~~gt~~y~aPE~l~~~--~~~~s~~~Dv~s~G~il~elltg~~pf~~~~~~~~~~~  499 (506)
                      ....     -.....||-.|++||.+.-.  ...++.|+||||.|||+|..+.|++||.........++
T Consensus       627 Sy~~vdGmeLTSQgAGTYWYLPPEcFvVgkePPKIsnKVDVWSvGVIFyQClYGrKPFGhnqsQQdILq  695 (775)
T KOG1151|consen  627 SYNSVDGMELTSQGAGTYWYLPPECFVVGKEPPKISNKVDVWSVGVIFYQCLYGRKPFGHNQSQQDILQ  695 (775)
T ss_pred             ccCcccceeeecccCceeeecCcceeecCCCCCccccceeeEeeehhhhhhhccCCCCCCchhHHHHHh
Confidence            4321     12346799999999998432  34689999999999999999999999987765544443

>cd07866 STKc_BUR1 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins

Probab=99.94  E-value=1.3e-26  Score=229.56  Aligned_cols=173  Identities=29%  Similarity=0.402  Sum_probs=138.4

Q ss_pred             hccccCccCceEEEEEEEc-CCCEEEEEEeccCCC---CchhhHHHHHHhhccCccceeEEEEEe---------------
Q 039231          317 FKYKLGQGGYGSVYKGKLL-DGSNVAVKVLNDSKG---NGKEFINEVASISRTSHVNVVALLGFC---------------  377 (506)
Q Consensus       317 ~~~~ig~G~~g~V~~~~~~-~~~~vavK~l~~~~~---~~~~~~~E~~~l~~l~h~niv~l~g~~---------------  377 (506)
                      +.++||+|++|.||+|+.. +++.+|+|++.....   ....+.+|++++++++|+||+++++++               
T Consensus        12 ~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~~~~   91 (311)
T cd07866          12 ILGKLGEGTFGEVYKARQIKTGRVVALKKILMHNEKDGFPITALREIKILKKLKHPNVVPLIDMAVERPDKSKRKRGSVY   91 (311)
T ss_pred             EEEEeccCCCEEEEEEEECCCCcEEEEEEEEeccCCCCcchhHHHHHHHHHhcCCCCccchhhheecccccccccCceEE
Confidence            3567999999999999875 588999999864322   234678999999999999999987653               


Q ss_pred             --------------------eccchhhhHHHHHHHHHHHHhhcCCCCeEecCcCCCcEEECCCCcEEEeecCCCccccCC
Q 039231          378 --------------------LRVAEELSSTIGIARGLEYLHLGCSTRILHFDIKPHNILLDEDFCPKISDFGLAKICNRK  437 (506)
Q Consensus       378 --------------------~~~~~~l~i~~~i~~gl~~LH~~~~~~ivH~dlkp~Nill~~~~~~ki~dfg~a~~~~~~  437 (506)
                                          +++.+...++.|+++||+|||   +++++|+||||+||++++++.+||+|||+++.....
T Consensus        92 lv~~~~~~~l~~~~~~~~~~~~~~~~~~i~~~l~~al~~lH---~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~  168 (311)
T cd07866          92 MVTPYMDHDLSGLLENPSVKLTESQIKCYMLQLLEGINYLH---ENHILHRDIKAANILIDNQGILKIADFGLARPYDGP  168 (311)
T ss_pred             EEEecCCcCHHHHHhccccCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEECCCCCEEECcCccchhccCC
Confidence                                222335668899999999999   899999999999999999999999999999765432


Q ss_pred             Ccce---------ecccCCCCcccccccccccccCCCCccccHHHHHHHHHHHHcCCCCCCCCCC
Q 039231          438 ESII---------SMTGARGTVGYIAPEVFCRNIGEVSYKSDVYNYGMMIFEMTGGRKNVDVVDN  493 (506)
Q Consensus       438 ~~~~---------~~~~~~gt~~y~aPE~l~~~~~~~s~~~Dv~s~G~il~elltg~~pf~~~~~  493 (506)
                      ....         ......+++.|+|||.+.+. ..++.++||||||+++|||++|+.||...+.
T Consensus       169 ~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~~Dv~slG~il~el~~g~~~~~~~~~  232 (311)
T cd07866         169 PPNPKGGGGGGTRKYTNLVVTRWYRPPELLLGE-RRYTTAVDIWGIGCVFAEMFTRRPILQGKSD  232 (311)
T ss_pred             CcccccCCcccccccccceeccCcCChHHhhCC-CccCchhHhHHHHHHHHHHHhCCCCCCCCCH
Confidence            2111         11234567889999987543 3578899999999999999999999976544

Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic

>cd07837 STKc_CdkB_plant Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase

Probab=99.94  E-value=2.5e-26  Score=225.82  Aligned_cols=171  Identities=26%  Similarity=0.307  Sum_probs=137.3

Q ss_pred             hccccCccCceEEEEEEEc-CCCEEEEEEeccCCC---CchhhHHHHHHhhccC-ccceeEEEEEee-------------
Q 039231          317 FKYKLGQGGYGSVYKGKLL-DGSNVAVKVLNDSKG---NGKEFINEVASISRTS-HVNVVALLGFCL-------------  378 (506)
Q Consensus       317 ~~~~ig~G~~g~V~~~~~~-~~~~vavK~l~~~~~---~~~~~~~E~~~l~~l~-h~niv~l~g~~~-------------  378 (506)
                      ..+.||+|+||.||+|... +++.||+|.++....   ....+.+|++++++++ |+||+++++++.             
T Consensus         5 ~~~~lg~g~~g~vy~~~~~~~~~~v~lK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~~~~lv   84 (295)
T cd07837           5 KLEKIGEGTYGKVYKARDKNTGKLVALKKTRLEMDEEGIPPTALREISLLQMLSESIYIVRLLDVEHVEEKNGKPSLYLV   84 (295)
T ss_pred             EeeEecccCCeEEEEEEECCCCcEEEEEeehhhccccCCchHHHHHHHHHHHccCCCCccceeeeEeecCCCCCceEEEE
Confidence            3467999999999999975 589999999865322   2357889999999995 699999987541             


Q ss_pred             -----------------------ccchhhhHHHHHHHHHHHHhhcCCCCeEecCcCCCcEEECC-CCcEEEeecCCCccc
Q 039231          379 -----------------------RVAEELSSTIGIARGLEYLHLGCSTRILHFDIKPHNILLDE-DFCPKISDFGLAKIC  434 (506)
Q Consensus       379 -----------------------~~~~~l~i~~~i~~gl~~LH~~~~~~ivH~dlkp~Nill~~-~~~~ki~dfg~a~~~  434 (506)
                                             ++...+.++.||+.||+|||   +++++||||+|+||+++. ++.+||+|||+++..
T Consensus        85 ~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH---~~~i~H~dl~~~nil~~~~~~~~kl~dfg~~~~~  161 (295)
T cd07837          85 FEYLDSDLKKFMDSNGRGPGRPLPAKTIKSFMYQLLKGVAHCH---KHGVMHRDLKPQNLLVDKQKGLLKIADLGLGRAF  161 (295)
T ss_pred             eeccCcCHHHHHHHhcccCCCCCCHHHHHHHHHHHHHHHHHHH---HCCeeecCCChHHEEEecCCCeEEEeecccceec
Confidence                                   12235668899999999999   899999999999999998 889999999998765


Q ss_pred             cCCCcceecccCCCCcccccccccccccCCCCccccHHHHHHHHHHHHcCCCCCCCCCC
Q 039231          435 NRKESIISMTGARGTVGYIAPEVFCRNIGEVSYKSDVYNYGMMIFEMTGGRKNVDVVDN  493 (506)
Q Consensus       435 ~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~s~~~Dv~s~G~il~elltg~~pf~~~~~  493 (506)
                      ......  .....+++.|+|||.+.+. ..++.++||||||+++|||++|..||....+
T Consensus       162 ~~~~~~--~~~~~~~~~~~aPE~~~~~-~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~  217 (295)
T cd07837         162 SIPVKS--YTHEIVTLWYRAPEVLLGS-THYSTPVDIWSVGCIFAEMSRKQPLFPGDSE  217 (295)
T ss_pred             CCCccc--cCCcccccCCCChHHhhCC-CCCCchHHHHHHHHHHHHHHcCCCCCCCCCH
Confidence            332211  1234568889999988543 3578899999999999999999999976543

Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developm

>cd06917 STKc_NAK1_like Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases

Probab=99.94  E-value=3.1e-26  Score=223.08  Aligned_cols=170  Identities=31%  Similarity=0.445  Sum_probs=140.4

Q ss_pred             ccccCccCceEEEEEEE-cCCCEEEEEEeccC--CCCchhhHHHHHHhhccC---ccceeEEEEEee-------------
Q 039231          318 KYKLGQGGYGSVYKGKL-LDGSNVAVKVLNDS--KGNGKEFINEVASISRTS---HVNVVALLGFCL-------------  378 (506)
Q Consensus       318 ~~~ig~G~~g~V~~~~~-~~~~~vavK~l~~~--~~~~~~~~~E~~~l~~l~---h~niv~l~g~~~-------------  378 (506)
                      .+.||+|+||.||+|.. .+++.+|+|.++..  .....++.+|++++++++   |||++++++++.             
T Consensus         6 ~~~l~~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~vi~~~~~~~~~~~~~lv~e~~~   85 (277)
T cd06917           6 LELIGRGAYGAVYRGKHVPTGRVVALKIINLDTPDDDVSDIQREVALLSQLRQSQPPNITKYYGSYLKGPRLWIIMEYAE   85 (277)
T ss_pred             hhheeccCCceEEEEEEcCCCcEEEEEEecCCCCchhHHHHHHHHHHHHHhccCCCCCeeeEeeeeeeCCEEEEEEecCC
Confidence            45799999999999997 45899999998653  233467889999999997   999999998762             


Q ss_pred             -------------ccchhhhHHHHHHHHHHHHhhcCCCCeEecCcCCCcEEECCCCcEEEeecCCCccccCCCcceeccc
Q 039231          379 -------------RVAEELSSTIGIARGLEYLHLGCSTRILHFDIKPHNILLDEDFCPKISDFGLAKICNRKESIISMTG  445 (506)
Q Consensus       379 -------------~~~~~l~i~~~i~~gl~~LH~~~~~~ivH~dlkp~Nill~~~~~~ki~dfg~a~~~~~~~~~~~~~~  445 (506)
                                   ++...+.++.|++.||.|||   +.+++|+||+|+||++++++.++|+|||++.........  ...
T Consensus        86 ~~~L~~~~~~~~l~~~~~~~i~~~i~~~l~~lh---~~~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~~~--~~~  160 (277)
T cd06917          86 GGSVRTLMKAGPIAEKYISVIIREVLVALKYIH---KVGVIHRDIKAANILVTNTGNVKLCDFGVAALLNQNSSK--RST  160 (277)
T ss_pred             CCcHHHHHHccCCCHHHHHHHHHHHHHHHHHHH---hCCcccCCcCHHHEEEcCCCCEEEccCCceeecCCCccc--ccc
Confidence                         23335678899999999999   899999999999999999999999999999876544321  233


Q ss_pred             CCCCcccccccccccccCCCCccccHHHHHHHHHHHHcCCCCCCCCCC
Q 039231          446 ARGTVGYIAPEVFCRNIGEVSYKSDVYNYGMMIFEMTGGRKNVDVVDN  493 (506)
Q Consensus       446 ~~gt~~y~aPE~l~~~~~~~s~~~Dv~s~G~il~elltg~~pf~~~~~  493 (506)
                      ..++..|+|||.+.+. ..++.++|+||||+++|||++|+.||.....
T Consensus       161 ~~~~~~y~aPE~~~~~-~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~  207 (277)
T cd06917         161 FVGTPYWMAPEVITEG-KYYDTKADIWSLGITIYEMATGNPPYSDVDA  207 (277)
T ss_pred             ccCCcceeCHHHhccC-CccccchhHHHHHHHHHHHHhCCCCCCCCCh
Confidence            5688899999988542 3568899999999999999999999976543

Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of cent

>cd06647 STKc_PAK_I Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase

Probab=99.94  E-value=2.4e-26  Score=226.00  Aligned_cols=172  Identities=31%  Similarity=0.420  Sum_probs=141.5

Q ss_pred             hhccccCccCceEEEEEEEc-CCCEEEEEEeccCC-CCchhhHHHHHHhhccCccceeEEEEEee---------------
Q 039231          316 SFKYKLGQGGYGSVYKGKLL-DGSNVAVKVLNDSK-GNGKEFINEVASISRTSHVNVVALLGFCL---------------  378 (506)
Q Consensus       316 ~~~~~ig~G~~g~V~~~~~~-~~~~vavK~l~~~~-~~~~~~~~E~~~l~~l~h~niv~l~g~~~---------------  378 (506)
                      .+.+.||+|+||.||++... +++.+++|.+.... ...+.+.+|+.++++++||||+++++.+.               
T Consensus        22 ~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e~~~~~  101 (293)
T cd06647          22 TRFEKIGQGASGTVYTAIDVATGQEVAIKQMNLQQQPKKELIINEILVMRENKHPNIVNYLDSYLVGDELWVVMEYLAGG  101 (293)
T ss_pred             eeeeEecCCCCeEEEEEEEcCCCCEEEEEEeccccchHHHHHHHHHHHHhhcCCCCeeehhheeeeCCcEEEEEecCCCC
Confidence            34567999999999999864 57899999986433 33467889999999999999999988761               


Q ss_pred             -----------ccchhhhHHHHHHHHHHHHhhcCCCCeEecCcCCCcEEECCCCcEEEeecCCCccccCCCcceecccCC
Q 039231          379 -----------RVAEELSSTIGIARGLEYLHLGCSTRILHFDIKPHNILLDEDFCPKISDFGLAKICNRKESIISMTGAR  447 (506)
Q Consensus       379 -----------~~~~~l~i~~~i~~gl~~LH~~~~~~ivH~dlkp~Nill~~~~~~ki~dfg~a~~~~~~~~~~~~~~~~  447 (506)
                                 ++.+++.++.|++.||.|||   +++++|+||+|+||+++.++.+||+|||++.........  .....
T Consensus       102 ~L~~~~~~~~l~~~~~~~i~~~l~~al~~LH---~~gi~H~dL~p~Nili~~~~~~kL~dfg~~~~~~~~~~~--~~~~~  176 (293)
T cd06647         102 SLTDVVTETCMDEGQIAAVCRECLQALEFLH---SNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSK--RSTMV  176 (293)
T ss_pred             cHHHHHhhcCCCHHHHHHHHHHHHHHHHHHH---hCCEeeccCCHHHEEEcCCCCEEEccCcceecccccccc--ccccc
Confidence                       23345678899999999999   899999999999999999999999999998765443321  13346


Q ss_pred             CCcccccccccccccCCCCccccHHHHHHHHHHHHcCCCCCCCCCCC
Q 039231          448 GTVGYIAPEVFCRNIGEVSYKSDVYNYGMMIFEMTGGRKNVDVVDNG  494 (506)
Q Consensus       448 gt~~y~aPE~l~~~~~~~s~~~Dv~s~G~il~elltg~~pf~~~~~~  494 (506)
                      +++.|+|||.+...  .++.++|+||||+++|||++|+.||...+..
T Consensus       177 ~~~~y~~PE~~~~~--~~~~~~Dv~slG~ll~~ll~g~~pf~~~~~~  221 (293)
T cd06647         177 GTPYWMAPEVVTRK--AYGPKVDIWSLGIMAIEMVEGEPPYLNENPL  221 (293)
T ss_pred             CChhhcCchhhccC--CCCchhhHHHHHHHHHHHHhCCCCCCCCChh
Confidence            78899999998553  6788999999999999999999999865543

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their bi

>cd05633 STKc_GRK3 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3

Probab=99.94  E-value=4.6e-26  Score=222.39  Aligned_cols=166  Identities=30%  Similarity=0.416  Sum_probs=129.8

Q ss_pred             ccCccCceEEEEEEEc-CCCEEEEEEeccCCCC----chhhHHHHHHh---hccCccceeEEEEEe--------------
Q 039231          320 KLGQGGYGSVYKGKLL-DGSNVAVKVLNDSKGN----GKEFINEVASI---SRTSHVNVVALLGFC--------------  377 (506)
Q Consensus       320 ~ig~G~~g~V~~~~~~-~~~~vavK~l~~~~~~----~~~~~~E~~~l---~~l~h~niv~l~g~~--------------  377 (506)
                      .||+|+||.||+++.. +++.+|+|.+......    ...+.+|..++   ...+||||+++.+.+              
T Consensus         1 ~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~   80 (279)
T cd05633           1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMTYAFHTPDKLCFILDLMN   80 (279)
T ss_pred             CcccCCCeEEEEEEECCCCcEEEEEEEEccccccchHHHHHHHHHHHHHHHhhCCCCcEeEEEEEEecCCeEEEEEecCC
Confidence            3899999999999875 5899999998654321    12334444333   334799999988765              


Q ss_pred             -------------eccchhhhHHHHHHHHHHHHhhcCCCCeEecCcCCCcEEECCCCcEEEeecCCCccccCCCcceecc
Q 039231          378 -------------LRVAEELSSTIGIARGLEYLHLGCSTRILHFDIKPHNILLDEDFCPKISDFGLAKICNRKESIISMT  444 (506)
Q Consensus       378 -------------~~~~~~l~i~~~i~~gl~~LH~~~~~~ivH~dlkp~Nill~~~~~~ki~dfg~a~~~~~~~~~~~~~  444 (506)
                                   +.+.....++.|++.||+|||   +.+++|+||||+||++++++.+||+|||++........    .
T Consensus        81 ~~~L~~~i~~~~~l~~~~~~~i~~qi~~al~~lH---~~~ivH~dikp~Nil~~~~~~~~l~dfg~~~~~~~~~~----~  153 (279)
T cd05633          81 GGDLHYHLSQHGVFSEKEMRFYATEIILGLEHMH---NRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKP----H  153 (279)
T ss_pred             CCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH---HCCcCCCCCCHHHEEECCCCCEEEccCCcceeccccCc----c
Confidence                         223335668899999999999   89999999999999999999999999999875543221    2


Q ss_pred             cCCCCcccccccccccccCCCCccccHHHHHHHHHHHHcCCCCCCCCCC
Q 039231          445 GARGTVGYIAPEVFCRNIGEVSYKSDVYNYGMMIFEMTGGRKNVDVVDN  493 (506)
Q Consensus       445 ~~~gt~~y~aPE~l~~~~~~~s~~~Dv~s~G~il~elltg~~pf~~~~~  493 (506)
                      ...+++.|+|||.+.+. ..++.++||||||+++|||++|+.||.....
T Consensus       154 ~~~~~~~y~aPE~~~~~-~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~  201 (279)
T cd05633         154 ASVGTHGYMAPEVLQKG-TAYDSSADWFSLGCMLFKLLRGHSPFRQHKT  201 (279)
T ss_pred             CcCCCcCccCHHHhcCC-CCCCchhhhHHHHHHHHHHHhCCCCcCCCCC
Confidence            34689999999987532 3578899999999999999999999976543

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is wi

>KOG0607 consensus MAP kinase-interacting kinase and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=99.94  E-value=7.8e-27  Score=216.32  Aligned_cols=183  Identities=27%  Similarity=0.423  Sum_probs=145.9

Q ss_pred             HHHHHHHHhhhccccCccCceEEEEEE-EcCCCEEEEEEeccCCCC-chhhHHHHHHhhccC-ccceeEEEEEe------
Q 039231          307 YADIKKMTNSFKYKLGQGGYGSVYKGK-LLDGSNVAVKVLNDSKGN-GKEFINEVASISRTS-HVNVVALLGFC------  377 (506)
Q Consensus       307 ~~el~~~~~~~~~~ig~G~~g~V~~~~-~~~~~~vavK~l~~~~~~-~~~~~~E~~~l~~l~-h~niv~l~g~~------  377 (506)
                      ++|+-+.|   ++.||+|+++.|--+. +.+|..+|||++.+.... ..++.+|++++.+.+ |+||++|+.|+      
T Consensus        75 F~d~YkLt---~e~LGeGAyasVqtcv~i~t~~EYAVKiidKq~gHsR~RvfREVe~f~~Cqgh~nilqLiefFEdd~~F  151 (463)
T KOG0607|consen   75 FEDMYKLT---SELLGEGAYASVQTCVSIQTGKEYAVKIIDKQPGHSRSRVFREVETFYQCQGHKNILQLIEFFEDDTRF  151 (463)
T ss_pred             HHHHHHhH---HHHhcCccceeeeeeeeeccchhhhhhhhhcCCchHHHHHHHHHHHHHHhcCCccHHHHHHHhcccceE
Confidence            55555555   3569999999999886 567999999999876543 468999999999986 99999999877      


Q ss_pred             ---------------------eccchhhhHHHHHHHHHHHHhhcCCCCeEecCcCCCcEEECCCC---cEEEeecCCCcc
Q 039231          378 ---------------------LRVAEELSSTIGIARGLEYLHLGCSTRILHFDIKPHNILLDEDF---CPKISDFGLAKI  433 (506)
Q Consensus       378 ---------------------~~~~~~l~i~~~i~~gl~~LH~~~~~~ivH~dlkp~Nill~~~~---~~ki~dfg~a~~  433 (506)
                                           +.+.++-.+..+|+.||.+||   .+||.||||||+|||-....   -+||+||.++.-
T Consensus       152 YLVfEKm~GGplLshI~~~~~F~E~EAs~vvkdia~aLdFlH---~kgIAHRDlKPENiLC~~pn~vsPvKiCDfDLgSg  228 (463)
T KOG0607|consen  152 YLVFEKMRGGPLLSHIQKRKHFNEREASRVVKDIASALDFLH---TKGIAHRDLKPENILCESPNKVSPVKICDFDLGSG  228 (463)
T ss_pred             EEEEecccCchHHHHHHHhhhccHHHHHHHHHHHHHHHHHHh---hcCcccccCCccceeecCCCCcCceeeeccccccc
Confidence                                 344456678899999999999   99999999999999996544   479999988753


Q ss_pred             ccCC-----CcceecccCCCCccccccccc---ccccCCCCccccHHHHHHHHHHHHcCCCCCCCCCCCc
Q 039231          434 CNRK-----ESIISMTGARGTVGYIAPEVF---CRNIGEVSYKSDVYNYGMMIFEMTGGRKNVDVVDNGS  495 (506)
Q Consensus       434 ~~~~-----~~~~~~~~~~gt~~y~aPE~l---~~~~~~~s~~~Dv~s~G~il~elltg~~pf~~~~~~~  495 (506)
                      +...     -.......+.|+..|||||+.   .+..-.|+.+.|.||||||||-|++|-+||...-..+
T Consensus       229 ~k~~~~~spastP~L~tPvGSAEfMAPEVVd~fv~qA~~YDKrCDlwSLGvIlYImLsGYpPFvG~Cg~d  298 (463)
T KOG0607|consen  229 IKLNNDCSPASTPELLTPVGSAEFMAPEVVDVFVDQATFYDKRCDLWSLGVILYIMLSGYPPFVGHCGAD  298 (463)
T ss_pred             cccCCCCCCCCCccccCcccchhhcchhHHhhhccccccccccccHHHHHHHHHHHHhCCCCccCccCCc
Confidence            3211     112234567899999999986   2333468899999999999999999999998876544

>cd07855 STKc_ERK5 Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5

Probab=99.94  E-value=1.4e-26  Score=232.07  Aligned_cols=171  Identities=28%  Similarity=0.388  Sum_probs=139.2

Q ss_pred             ccccCccCceEEEEEEEc-CCCEEEEEEeccCC---CCchhhHHHHHHhhccCccceeEEEEEe----------------
Q 039231          318 KYKLGQGGYGSVYKGKLL-DGSNVAVKVLNDSK---GNGKEFINEVASISRTSHVNVVALLGFC----------------  377 (506)
Q Consensus       318 ~~~ig~G~~g~V~~~~~~-~~~~vavK~l~~~~---~~~~~~~~E~~~l~~l~h~niv~l~g~~----------------  377 (506)
                      .+.||+|++|.||+|+.. ++..||+|++....   ...+.+.+|+.++.+++||||+++.+++                
T Consensus        10 ~~~lg~g~~g~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~lv~e~   89 (334)
T cd07855          10 IENIGSGAYGVVCSAIDTRSGKKVAIKKIPHAFDVPTLAKRTLRELKILRHFKHDNIIAIRDILRPPGADFKDVYVVMDL   89 (334)
T ss_pred             eeeeecCCCeEEEEEEEcCCCCEEEEEEeccccccccchHHHHHHHHHHHhcCCCCccCHHHhccccCCCCceEEEEEeh
Confidence            467999999999999875 58999999987532   2336678899999999999999876543                


Q ss_pred             --------------eccchhhhHHHHHHHHHHHHhhcCCCCeEecCcCCCcEEECCCCcEEEeecCCCccccCCCcce--
Q 039231          378 --------------LRVAEELSSTIGIARGLEYLHLGCSTRILHFDIKPHNILLDEDFCPKISDFGLAKICNRKESII--  441 (506)
Q Consensus       378 --------------~~~~~~l~i~~~i~~gl~~LH~~~~~~ivH~dlkp~Nill~~~~~~ki~dfg~a~~~~~~~~~~--  441 (506)
                                    +++.....++.|++.||+|||   +++++||||||+||++++++.+||+|||+++.........  
T Consensus        90 ~~~~l~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH---~~~ivH~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~  166 (334)
T cd07855          90 MESDLHHIIHSDQPLTEEHIRYFLYQLLRGLKYIH---SANVIHRDLKPSNLLVNEDCELRIGDFGMARGLSSSPTEHKY  166 (334)
T ss_pred             hhhhHHHHhccCCCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHEEEcCCCcEEecccccceeecccCcCCCc
Confidence                          233346778899999999999   8999999999999999999999999999997654322111  


Q ss_pred             ecccCCCCcccccccccccccCCCCccccHHHHHHHHHHHHcCCCCCCCCC
Q 039231          442 SMTGARGTVGYIAPEVFCRNIGEVSYKSDVYNYGMMIFEMTGGRKNVDVVD  492 (506)
Q Consensus       442 ~~~~~~gt~~y~aPE~l~~~~~~~s~~~Dv~s~G~il~elltg~~pf~~~~  492 (506)
                      ......++..|+|||.+.+. ..++.++||||||+++|||++|+.||...+
T Consensus       167 ~~~~~~~~~~y~~PE~~~~~-~~~~~~~Di~slG~~l~el~~g~~pf~~~~  216 (334)
T cd07855         167 FMTEYVATRWYRAPELLLSL-PEYTTAIDMWSVGCIFAEMLGRRQLFPGKN  216 (334)
T ss_pred             ccccccccccccChHHhcCC-cccccccchHHHHHHHHHHHcCCCccCCCC
Confidence            11235688899999998543 357899999999999999999999997654

Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the

>cd05038 PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases

Probab=99.94  E-value=2.4e-26  Score=224.36  Aligned_cols=171  Identities=30%  Similarity=0.470  Sum_probs=139.8

Q ss_pred             hhccccCccCceEEEEEEEc-----CCCEEEEEEeccCCCC--chhhHHHHHHhhccCccceeEEEEEeec---------
Q 039231          316 SFKYKLGQGGYGSVYKGKLL-----DGSNVAVKVLNDSKGN--GKEFINEVASISRTSHVNVVALLGFCLR---------  379 (506)
Q Consensus       316 ~~~~~ig~G~~g~V~~~~~~-----~~~~vavK~l~~~~~~--~~~~~~E~~~l~~l~h~niv~l~g~~~~---------  379 (506)
                      .+.+.||+|+||.||+|++.     .+..+|||.++.....  .+++.+|++.+++++|+||+++++++..         
T Consensus         7 ~~~~~ig~g~~~~v~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~ei~~l~~l~~~~i~~~~~~~~~~~~~~~~lv   86 (284)
T cd05038           7 KFIKQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEEQHRSDFEREIEILRTLDHENIVKYKGVCEKPGGRSLRLI   86 (284)
T ss_pred             hhheeeccCCCeeEEEeeecCCCCCCceEEEEEEeccccchHHHHHHHHHHHHHHhCCCCChheEEeeeecCCCCceEEE
Confidence            34567999999999999863     3688999999865543  5789999999999999999999887522         


Q ss_pred             ---------------------cchhhhHHHHHHHHHHHHhhcCCCCeEecCcCCCcEEECCCCcEEEeecCCCccccCCC
Q 039231          380 ---------------------VAEELSSTIGIARGLEYLHLGCSTRILHFDIKPHNILLDEDFCPKISDFGLAKICNRKE  438 (506)
Q Consensus       380 ---------------------~~~~l~i~~~i~~gl~~LH~~~~~~ivH~dlkp~Nill~~~~~~ki~dfg~a~~~~~~~  438 (506)
                                           +...+.++.|++.||+|||   +.+++|+||||+||+++.++.+||+|||.+.......
T Consensus        87 ~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~l~~aL~~lH---~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~  163 (284)
T cd05038          87 MEYLPSGSLRDYLQRHRDQINLKRLLLFSSQICKGMDYLG---SQRYIHRDLAARNILVESEDLVKISDFGLAKVLPEDK  163 (284)
T ss_pred             EecCCCCCHHHHHHhCccccCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHhEEEcCCCCEEEcccccccccccCC
Confidence                                 2224678899999999999   8999999999999999999999999999998776332


Q ss_pred             ccee-cccCCCCcccccccccccccCCCCccccHHHHHHHHHHHHcCCCCCCCC
Q 039231          439 SIIS-MTGARGTVGYIAPEVFCRNIGEVSYKSDVYNYGMMIFEMTGGRKNVDVV  491 (506)
Q Consensus       439 ~~~~-~~~~~gt~~y~aPE~l~~~~~~~s~~~Dv~s~G~il~elltg~~pf~~~  491 (506)
                      .... .....++..|+|||.+...  .++.++||||||+++|||++|+.|+...
T Consensus       164 ~~~~~~~~~~~~~~~~~Pe~~~~~--~~~~~~Di~slG~~l~el~tg~~p~~~~  215 (284)
T cd05038         164 DYYYVKEPGESPIFWYAPECLRTS--KFSSASDVWSFGVTLYELFTYGDPSQSP  215 (284)
T ss_pred             cceeccCCCCCcccccCcHHHccC--CCCcccchHHHhhhhheeeccCCCcccc
Confidence            2211 1123456679999988544  6888999999999999999999998654

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by aut

>cd05578 STKc_Yank1 Catalytic domain of the Protein Serine/Threonine Kinase, Yank1

Probab=99.94  E-value=9.1e-27  Score=224.38  Aligned_cols=170  Identities=31%  Similarity=0.436  Sum_probs=142.0

Q ss_pred             hhccccCccCceEEEEEEEc-CCCEEEEEEeccCC----CCchhhHHHHHHhhccCccceeEEEEEe-------------
Q 039231          316 SFKYKLGQGGYGSVYKGKLL-DGSNVAVKVLNDSK----GNGKEFINEVASISRTSHVNVVALLGFC-------------  377 (506)
Q Consensus       316 ~~~~~ig~G~~g~V~~~~~~-~~~~vavK~l~~~~----~~~~~~~~E~~~l~~l~h~niv~l~g~~-------------  377 (506)
                      .+.++||+|+||.||+|+.. +++.+|+|++....    ...+.+.+|++.+++++||||+++++.+             
T Consensus         3 ~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~   82 (258)
T cd05578           3 ELLRVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHPFLVNLWYSFQDEENMYLVVDLL   82 (258)
T ss_pred             eEEEEeccCCCceEEEEEEccCCcEEEEEEEehhhhcchhHHHHHHHHHHHHHhCCCCChHHHHHhhcCCCeEEEEEeCC
Confidence            34578999999999999975 48999999997532    2346789999999999999999876543             


Q ss_pred             --------------eccchhhhHHHHHHHHHHHHhhcCCCCeEecCcCCCcEEECCCCcEEEeecCCCccccCCCcceec
Q 039231          378 --------------LRVAEELSSTIGIARGLEYLHLGCSTRILHFDIKPHNILLDEDFCPKISDFGLAKICNRKESIISM  443 (506)
Q Consensus       378 --------------~~~~~~l~i~~~i~~gl~~LH~~~~~~ivH~dlkp~Nill~~~~~~ki~dfg~a~~~~~~~~~~~~  443 (506)
                                    ++..+.+.++.|+++||.|||   +++++|+||+|+||++++++.++|+|||++........   .
T Consensus        83 ~~~~L~~~l~~~~~l~~~~~~~~~~~i~~~l~~lh---~~~i~h~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~~---~  156 (258)
T cd05578          83 LGGDLRYHLSQKVKFSEEQVKFWICEIVLALEYLH---SKGIIHRDIKPDNILLDEQGHVHITDFNIATKVTPDTL---T  156 (258)
T ss_pred             CCCCHHHHHHhcCCcCHHHHHHHHHHHHHHHHHHH---hCCeeccCCCHHHeEEcCCCCEEEeecccccccCCCcc---c
Confidence                          223346678999999999999   89999999999999999999999999999887654321   2


Q ss_pred             ccCCCCcccccccccccccCCCCccccHHHHHHHHHHHHcCCCCCCCCCC
Q 039231          444 TGARGTVGYIAPEVFCRNIGEVSYKSDVYNYGMMIFEMTGGRKNVDVVDN  493 (506)
Q Consensus       444 ~~~~gt~~y~aPE~l~~~~~~~s~~~Dv~s~G~il~elltg~~pf~~~~~  493 (506)
                      ....++..|+|||.+...  .++.++|+||||+++|+|++|+.||...+.
T Consensus       157 ~~~~~~~~y~~PE~~~~~--~~~~~~Di~slG~~l~~l~~g~~p~~~~~~  204 (258)
T cd05578         157 TSTSGTPGYMAPEVLCRQ--GYSVAVDWWSLGVTAYECLRGKRPYRGHSR  204 (258)
T ss_pred             cccCCChhhcCHHHHccc--CCCCcccchhhHHHHHHHHhCCCCCCCCCc
Confidence            345678899999998654  578999999999999999999999987664

Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A.

>cd07857 STKc_MPK1 Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1

Probab=99.94  E-value=2.3e-26  Score=230.35  Aligned_cols=172  Identities=30%  Similarity=0.379  Sum_probs=138.3

Q ss_pred             hccccCccCceEEEEEEEc-C--CCEEEEEEeccCC---CCchhhHHHHHHhhcc-CccceeEEEEEe------------
Q 039231          317 FKYKLGQGGYGSVYKGKLL-D--GSNVAVKVLNDSK---GNGKEFINEVASISRT-SHVNVVALLGFC------------  377 (506)
Q Consensus       317 ~~~~ig~G~~g~V~~~~~~-~--~~~vavK~l~~~~---~~~~~~~~E~~~l~~l-~h~niv~l~g~~------------  377 (506)
                      +.+.||+|+||.||+++.. .  +..+|+|++....   ...+.+.+|+++++++ +||||+++++.+            
T Consensus         4 ~~~~lg~G~~g~vy~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~~~~~~   83 (332)
T cd07857           4 LIKELGQGAYGIVCSARNAETSEEETVAIKKITNVFSKKILAKRALRELKLLRHFRGHKNITCLYDMDIVFPGNFNELYL   83 (332)
T ss_pred             EEEEccccCCeEEEEEEeCCCCcCceEEEEEeccccccchhHHHHHHHHHHHHHhcCCCChheeeeeeeeccccCCcEEE
Confidence            4567999999999999874 3  6789999986432   2235788899999999 499999998743            


Q ss_pred             ------------------eccchhhhHHHHHHHHHHHHhhcCCCCeEecCcCCCcEEECCCCcEEEeecCCCccccCCCc
Q 039231          378 ------------------LRVAEELSSTIGIARGLEYLHLGCSTRILHFDIKPHNILLDEDFCPKISDFGLAKICNRKES  439 (506)
Q Consensus       378 ------------------~~~~~~l~i~~~i~~gl~~LH~~~~~~ivH~dlkp~Nill~~~~~~ki~dfg~a~~~~~~~~  439 (506)
                                        +++.+.+.++.||+.||+|||   +++++||||||+||++++++.+||+|||+++.......
T Consensus        84 ~~e~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH---~~givH~dlkp~Nili~~~~~~kl~Dfg~a~~~~~~~~  160 (332)
T cd07857          84 YEELMEADLHQIIRSGQPLTDAHFQSFIYQILCGLKYIH---SANVLHRDLKPGNLLVNADCELKICDFGLARGFSENPG  160 (332)
T ss_pred             EEecccCCHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCCHHHeEEcCCCCEEeCcCCCceecccccc
Confidence                              122335668899999999999   89999999999999999999999999999986543221


Q ss_pred             c--eecccCCCCcccccccccccccCCCCccccHHHHHHHHHHHHcCCCCCCCCC
Q 039231          440 I--ISMTGARGTVGYIAPEVFCRNIGEVSYKSDVYNYGMMIFEMTGGRKNVDVVD  492 (506)
Q Consensus       440 ~--~~~~~~~gt~~y~aPE~l~~~~~~~s~~~Dv~s~G~il~elltg~~pf~~~~  492 (506)
                      .  .......++..|+|||.+.+. ..++.++||||+|+++|+|++|+.||...+
T Consensus       161 ~~~~~~~~~~g~~~y~aPE~~~~~-~~~~~~~Di~slGv~l~~l~~g~~pf~~~~  214 (332)
T cd07857         161 ENAGFMTEYVATRWYRAPEIMLSF-QSYTKAIDVWSVGCILAELLGRKPVFKGKD  214 (332)
T ss_pred             cccccccCcccCccccCcHHHhCC-CCCCcHHHHHHHHHHHHHHHhCCcCCCCCC
Confidence            1  111335689999999987542 357889999999999999999999997654

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall co

>cd07880 STKc_p38gamma_MAPK12 Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase

Probab=99.94  E-value=2.5e-26  Score=231.07  Aligned_cols=167  Identities=30%  Similarity=0.400  Sum_probs=137.9

Q ss_pred             ccccCccCceEEEEEEEc-CCCEEEEEEeccCCC---CchhhHHHHHHhhccCccceeEEEEEee---------------
Q 039231          318 KYKLGQGGYGSVYKGKLL-DGSNVAVKVLNDSKG---NGKEFINEVASISRTSHVNVVALLGFCL---------------  378 (506)
Q Consensus       318 ~~~ig~G~~g~V~~~~~~-~~~~vavK~l~~~~~---~~~~~~~E~~~l~~l~h~niv~l~g~~~---------------  378 (506)
                      .+.||+|++|.||+|... ++..||||++.....   ..+.+.+|++++++++||||+++++++.               
T Consensus        20 ~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~lv~   99 (343)
T cd07880          20 LKQVGSGAYGTVCSALDRRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMKHENVIGLLDVFTPDLSLDRFHDFYLVM   99 (343)
T ss_pred             EEEeeecCCeEEEEEEECCCCcEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCccceeeeecCCccccccceEEEEE
Confidence            457999999999999864 589999999864322   2246789999999999999999987542               


Q ss_pred             ----------------ccchhhhHHHHHHHHHHHHhhcCCCCeEecCcCCCcEEECCCCcEEEeecCCCccccCCCccee
Q 039231          379 ----------------RVAEELSSTIGIARGLEYLHLGCSTRILHFDIKPHNILLDEDFCPKISDFGLAKICNRKESIIS  442 (506)
Q Consensus       379 ----------------~~~~~l~i~~~i~~gl~~LH~~~~~~ivH~dlkp~Nill~~~~~~ki~dfg~a~~~~~~~~~~~  442 (506)
                                      ++...+.++.|+++||+|||   +.+|+||||||+||++++++.+||+|||++.......    
T Consensus       100 e~~~~~l~~~~~~~~l~~~~~~~i~~qi~~al~~LH---~~gi~H~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~----  172 (343)
T cd07880         100 PFMGTDLGKLMKHEKLSEDRIQFLVYQMLKGLKYIH---AAGIIHRDLKPGNLAVNEDCELKILDFGLARQTDSEM----  172 (343)
T ss_pred             ecCCCCHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEEcCCCCEEEeecccccccccCc----
Confidence                            22235568899999999999   8999999999999999999999999999998654322    


Q ss_pred             cccCCCCcccccccccccccCCCCccccHHHHHHHHHHHHcCCCCCCCCCC
Q 039231          443 MTGARGTVGYIAPEVFCRNIGEVSYKSDVYNYGMMIFEMTGGRKNVDVVDN  493 (506)
Q Consensus       443 ~~~~~gt~~y~aPE~l~~~~~~~s~~~Dv~s~G~il~elltg~~pf~~~~~  493 (506)
                       ....+++.|+|||.+.+. ..++.++|+||||+++|+|++|+.||...+.
T Consensus       173 -~~~~~~~~y~aPE~~~~~-~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~  221 (343)
T cd07880         173 -TGYVVTRWYRAPEVILNW-MHYTQTVDIWSVGCIMAEMLTGKPLFKGHDH  221 (343)
T ss_pred             -cccccCCcccCHHHHhCC-CCCCcHHHHHHHHHHHHHHHhCCCCCCCCCH
Confidence             234568899999998542 3578899999999999999999999986554

Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12

>cd06618 PKc_MKK7 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7

Probab=99.94  E-value=2.8e-26  Score=225.85  Aligned_cols=171  Identities=25%  Similarity=0.393  Sum_probs=137.1

Q ss_pred             hhccccCccCceEEEEEEEcC-CCEEEEEEeccCCC--CchhhHHHHHHhhccC-ccceeEEEEEee-------------
Q 039231          316 SFKYKLGQGGYGSVYKGKLLD-GSNVAVKVLNDSKG--NGKEFINEVASISRTS-HVNVVALLGFCL-------------  378 (506)
Q Consensus       316 ~~~~~ig~G~~g~V~~~~~~~-~~~vavK~l~~~~~--~~~~~~~E~~~l~~l~-h~niv~l~g~~~-------------  378 (506)
                      .+.+.||+|++|.||+|..++ ++.+|||.++....  ...++.+|+..+.+.. |+||+++++++.             
T Consensus        18 ~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~   97 (296)
T cd06618          18 ENLGEIGSGTCGQVYKMRFKKTGHVMAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVKCYGYFITDSDVFICMELMS   97 (296)
T ss_pred             eeeeEeeccCCeEEEEEEECCCCeEEEEEEEeccCChHHHHHHHHHHHHHHhccCCCchHhhheeeecCCeEEEEeeccC
Confidence            345689999999999999865 89999999975432  2355677887777775 999999998762             


Q ss_pred             --------------ccchhhhHHHHHHHHHHHHhhcCCCCeEecCcCCCcEEECCCCcEEEeecCCCccccCCCcceecc
Q 039231          379 --------------RVAEELSSTIGIARGLEYLHLGCSTRILHFDIKPHNILLDEDFCPKISDFGLAKICNRKESIISMT  444 (506)
Q Consensus       379 --------------~~~~~l~i~~~i~~gl~~LH~~~~~~ivH~dlkp~Nill~~~~~~ki~dfg~a~~~~~~~~~~~~~  444 (506)
                                    ++.....++.|++.||+|||+  ..+++||||+|+||++++++.+||+|||++.........   .
T Consensus        98 ~~l~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~--~~~i~H~dl~p~nill~~~~~~kL~dfg~~~~~~~~~~~---~  172 (296)
T cd06618          98 TCLDKLLKRIQGPIPEDILGKMTVAIVKALHYLKE--KHGVIHRDVKPSNILLDASGNVKLCDFGISGRLVDSKAK---T  172 (296)
T ss_pred             cCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHh--hCCEecCCCcHHHEEEcCCCCEEECccccchhccCCCcc---c
Confidence                          223345799999999999993  259999999999999999999999999998765433221   2


Q ss_pred             cCCCCccccccccccccc--CCCCccccHHHHHHHHHHHHcCCCCCCCC
Q 039231          445 GARGTVGYIAPEVFCRNI--GEVSYKSDVYNYGMMIFEMTGGRKNVDVV  491 (506)
Q Consensus       445 ~~~gt~~y~aPE~l~~~~--~~~s~~~Dv~s~G~il~elltg~~pf~~~  491 (506)
                      ...++..|+|||.+.+..  +.++.++||||||+++|||++|+.||...
T Consensus       173 ~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~  221 (296)
T cd06618         173 RSAGCAAYMAPERIDPPDPNPKYDIRADVWSLGISLVELATGQFPYKNC  221 (296)
T ss_pred             CCCCCccccCHhhcCCCCCccccccchhHHHHHHHHHHHHhCCCCCCcc
Confidence            345788999999986442  34788999999999999999999999763

Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates it

>cd08217 STKc_Nek2 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2

Probab=99.94  E-value=4.1e-26  Score=220.07  Aligned_cols=172  Identities=26%  Similarity=0.357  Sum_probs=141.2

Q ss_pred             hccccCccCceEEEEEEEc-CCCEEEEEEeccCCC---CchhhHHHHHHhhccCccceeEEEEEee--------------
Q 039231          317 FKYKLGQGGYGSVYKGKLL-DGSNVAVKVLNDSKG---NGKEFINEVASISRTSHVNVVALLGFCL--------------  378 (506)
Q Consensus       317 ~~~~ig~G~~g~V~~~~~~-~~~~vavK~l~~~~~---~~~~~~~E~~~l~~l~h~niv~l~g~~~--------------  378 (506)
                      +.+.||+|++|.||++... +++.+|+|+++....   ..+++.+|++++++++|+||+++++++.              
T Consensus         4 ~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~e~~   83 (265)
T cd08217           4 VLETIGKGSFGTVRKVRRKSDGKILVWKEIDYGNMTEKEKQQLVSEVNILRELKHPNIVRYYDRIIDRSNQTLYIVMEYC   83 (265)
T ss_pred             eeeeeccCCCeEEEEeeecCCCCEEEEEEEecccCCHHHHHHHHHHHHHHHhcCCCccceeeeeeecCCCCEEEEEehhc
Confidence            3467999999999999864 578999999865432   2356888999999999999999987552              


Q ss_pred             -------------------ccchhhhHHHHHHHHHHHHhhcC--CCCeEecCcCCCcEEECCCCcEEEeecCCCccccCC
Q 039231          379 -------------------RVAEELSSTIGIARGLEYLHLGC--STRILHFDIKPHNILLDEDFCPKISDFGLAKICNRK  437 (506)
Q Consensus       379 -------------------~~~~~l~i~~~i~~gl~~LH~~~--~~~ivH~dlkp~Nill~~~~~~ki~dfg~a~~~~~~  437 (506)
                                         ++...+.++.|++.||+|||...  +.+++|+||+|+||++++++.+||+|||++......
T Consensus        84 ~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~~~i~h~dl~p~nili~~~~~~kl~d~g~~~~~~~~  163 (265)
T cd08217          84 EGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLALYECHNRSDPGNTVLHRDLKPANIFLDANNNVKLGDFGLAKILGHD  163 (265)
T ss_pred             cCCCHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhcCccccCcceecCCCHHHEEEecCCCEEEecccccccccCC
Confidence                               12234668899999999999543  678999999999999999999999999999877554


Q ss_pred             CcceecccCCCCcccccccccccccCCCCccccHHHHHHHHHHHHcCCCCCCCCC
Q 039231          438 ESIISMTGARGTVGYIAPEVFCRNIGEVSYKSDVYNYGMMIFEMTGGRKNVDVVD  492 (506)
Q Consensus       438 ~~~~~~~~~~gt~~y~aPE~l~~~~~~~s~~~Dv~s~G~il~elltg~~pf~~~~  492 (506)
                      ...  .....+++.|+|||.+...  .++.++|+||||+++|+|++|+.||...+
T Consensus       164 ~~~--~~~~~~~~~~~~pE~~~~~--~~~~~~Dv~slG~il~~l~~g~~p~~~~~  214 (265)
T cd08217         164 SSF--AKTYVGTPYYMSPEQLNHM--SYDEKSDIWSLGCLIYELCALSPPFTARN  214 (265)
T ss_pred             ccc--ccccccCCCccChhhhcCC--CCCchhHHHHHHHHHHHHHHCCCcccCcC
Confidence            321  1345689999999998654  68889999999999999999999998764

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exi

>cd08218 STKc_Nek1 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1

Probab=99.94  E-value=3e-26  Score=220.37  Aligned_cols=170  Identities=29%  Similarity=0.397  Sum_probs=140.1

Q ss_pred             hccccCccCceEEEEEEEc-CCCEEEEEEeccC---CCCchhhHHHHHHhhccCccceeEEEEEee--------------
Q 039231          317 FKYKLGQGGYGSVYKGKLL-DGSNVAVKVLNDS---KGNGKEFINEVASISRTSHVNVVALLGFCL--------------  378 (506)
Q Consensus       317 ~~~~ig~G~~g~V~~~~~~-~~~~vavK~l~~~---~~~~~~~~~E~~~l~~l~h~niv~l~g~~~--------------  378 (506)
                      +.++||+|+||.+|+++.. +++.+|+|.+...   ....+++.+|++++++++||||+++.+++.              
T Consensus         4 ~~~~lg~g~~g~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~   83 (256)
T cd08218           4 KVKKIGEGSFGKAILVKSKEDGKQYVIKEINISKMSPKEREESRKEVAVLSNMKHPNIVQYQESFEENGNLYIVMDYCEG   83 (256)
T ss_pred             EEEEeccCCceEEEEEEEcCCCCEEEEEEEEhHhCChHHHHHHHHHHHHHHhCCCCCeeeeEeeecCCCeEEEEEecCCC
Confidence            4567999999999999874 5889999998643   223357899999999999999999998761              


Q ss_pred             ---------------ccchhhhHHHHHHHHHHHHhhcCCCCeEecCcCCCcEEECCCCcEEEeecCCCccccCCCcceec
Q 039231          379 ---------------RVAEELSSTIGIARGLEYLHLGCSTRILHFDIKPHNILLDEDFCPKISDFGLAKICNRKESIISM  443 (506)
Q Consensus       379 ---------------~~~~~l~i~~~i~~gl~~LH~~~~~~ivH~dlkp~Nill~~~~~~ki~dfg~a~~~~~~~~~~~~  443 (506)
                                     ++.+.+.++.|++.||+|||   +.+++|+||+|+||+++.++.++|+|||++.........  .
T Consensus        84 ~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh---~~~i~h~~l~~~nil~~~~~~~~l~d~~~~~~~~~~~~~--~  158 (256)
T cd08218          84 GDLYKKINAQRGVLFPEDQILDWFVQICLALKHVH---DRKILHRDIKSQNIFLTKDGTIKLGDFGIARVLNSTVEL--A  158 (256)
T ss_pred             CcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHH---hCCEecCCCCHHHEEEcCCCCEEEeeccceeecCcchhh--h
Confidence                           12235678899999999999   899999999999999999999999999999765443221  1


Q ss_pred             ccCCCCcccccccccccccCCCCccccHHHHHHHHHHHHcCCCCCCCCCC
Q 039231          444 TGARGTVGYIAPEVFCRNIGEVSYKSDVYNYGMMIFEMTGGRKNVDVVDN  493 (506)
Q Consensus       444 ~~~~gt~~y~aPE~l~~~~~~~s~~~Dv~s~G~il~elltg~~pf~~~~~  493 (506)
                      ....+++.|+|||.+.+.  ..+.++|+||||++++||++|+.||...+.
T Consensus       159 ~~~~~~~~~~~pe~~~~~--~~~~~~Dv~slG~i~~~l~~g~~~~~~~~~  206 (256)
T cd08218         159 RTCIGTPYYLSPEICENR--PYNNKSDIWALGCVLYEMCTLKHAFEAGNM  206 (256)
T ss_pred             hhccCCccccCHHHhCCC--CCCCccchhHHHHHHHHHHcCCCCccCCCH
Confidence            234578899999998553  678899999999999999999999976543

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycysti

>cd05572 STKc_cGK_PKG Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase

Probab=99.94  E-value=4.6e-26  Score=219.97  Aligned_cols=164  Identities=27%  Similarity=0.421  Sum_probs=137.9

Q ss_pred             cCccCceEEEEEEEcC-CCEEEEEEeccCC----CCchhhHHHHHHhhccCccceeEEEEEee-----------------
Q 039231          321 LGQGGYGSVYKGKLLD-GSNVAVKVLNDSK----GNGKEFINEVASISRTSHVNVVALLGFCL-----------------  378 (506)
Q Consensus       321 ig~G~~g~V~~~~~~~-~~~vavK~l~~~~----~~~~~~~~E~~~l~~l~h~niv~l~g~~~-----------------  378 (506)
                      ||.|++|.||+++... ++.+++|++....    ...+.+.+|++++++++||||+++++.+.                 
T Consensus         1 lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L   80 (262)
T cd05572           1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKLYRTFKDKKYIYMLMEYCLGGEL   80 (262)
T ss_pred             CCCCCceEEEEEEECCCCcEEEEEEEehhcchhhhHHHHHHHHHHHHHhCCCCCEeeeeeeEEcCCccEEEEecCCCCcH
Confidence            6899999999999854 8999999986532    23367899999999999999999998761                 


Q ss_pred             ----------ccchhhhHHHHHHHHHHHHhhcCCCCeEecCcCCCcEEECCCCcEEEeecCCCccccCCCcceecccCCC
Q 039231          379 ----------RVAEELSSTIGIARGLEYLHLGCSTRILHFDIKPHNILLDEDFCPKISDFGLAKICNRKESIISMTGARG  448 (506)
Q Consensus       379 ----------~~~~~l~i~~~i~~gl~~LH~~~~~~ivH~dlkp~Nill~~~~~~ki~dfg~a~~~~~~~~~~~~~~~~g  448 (506)
                                .......++.|++.||+|||   +++++|+||+|+||++++++.+||+|||+++.......   .....+
T Consensus        81 ~~~l~~~~~l~~~~~~~~~~~i~~~l~~lH---~~~~~h~dl~~~nilv~~~~~~~l~df~~~~~~~~~~~---~~~~~~  154 (262)
T cd05572          81 WTILRDRGLFDEYTARFYIACVVLAFEYLH---NRGIIYRDLKPENLLLDSNGYVKLVDFGFAKKLKSGQK---TWTFCG  154 (262)
T ss_pred             HHHHhhcCCCCHHHHHHHHHHHHHHHHHHh---hCCcccCCCCHHHEEEcCCCCEEEeeCCcccccCcccc---cccccC
Confidence                      22235568889999999999   89999999999999999999999999999987654421   123467


Q ss_pred             CcccccccccccccCCCCccccHHHHHHHHHHHHcCCCCCCCCC
Q 039231          449 TVGYIAPEVFCRNIGEVSYKSDVYNYGMMIFEMTGGRKNVDVVD  492 (506)
Q Consensus       449 t~~y~aPE~l~~~~~~~s~~~Dv~s~G~il~elltg~~pf~~~~  492 (506)
                      +..|+|||.+...  .++.++|+||||+++|||++|..||....
T Consensus       155 ~~~~~~PE~~~~~--~~~~~~Di~slG~il~~l~~g~~p~~~~~  196 (262)
T cd05572         155 TPEYVAPEIILNK--GYDFSVDYWSLGILLYELLTGRPPFGEDD  196 (262)
T ss_pred             CcCccChhHhcCC--CCCChhhhhhhHHHHHHHHhCCCCcCCCC
Confidence            8899999998543  67899999999999999999999998765

Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowi

>cd05609 STKc_MAST Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase

Probab=99.94  E-value=3.8e-26  Score=225.90  Aligned_cols=172  Identities=26%  Similarity=0.295  Sum_probs=136.8

Q ss_pred             hccccCccCceEEEEEEEcC-CCEEEEEEeccCC----CCchhhHHHHHHhhccCccceeEEEEEee-------------
Q 039231          317 FKYKLGQGGYGSVYKGKLLD-GSNVAVKVLNDSK----GNGKEFINEVASISRTSHVNVVALLGFCL-------------  378 (506)
Q Consensus       317 ~~~~ig~G~~g~V~~~~~~~-~~~vavK~l~~~~----~~~~~~~~E~~~l~~l~h~niv~l~g~~~-------------  378 (506)
                      +.+.||+|+||.||++.... ++.|++|.+....    ...+.+.+|+++++.++||||+++++.+.             
T Consensus         5 ~~~~l~~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~   84 (305)
T cd05609           5 TIKLISNGAYGAVYLVRHKETRQRFAMKKINKQNLILRNQIQQVFVERDILTFAENPFVVSMFCSFETKRHLCMVMEYVE   84 (305)
T ss_pred             EeeEeecCCCeeEEEEEECCCCcEEEEEEeehhhhhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEecCCEEEEEEecCC
Confidence            34679999999999998754 7899999986542    22356789999999999999999998651             


Q ss_pred             --------------ccchhhhHHHHHHHHHHHHhhcCCCCeEecCcCCCcEEECCCCcEEEeecCCCccccCCCc-----
Q 039231          379 --------------RVAEELSSTIGIARGLEYLHLGCSTRILHFDIKPHNILLDEDFCPKISDFGLAKICNRKES-----  439 (506)
Q Consensus       379 --------------~~~~~l~i~~~i~~gl~~LH~~~~~~ivH~dlkp~Nill~~~~~~ki~dfg~a~~~~~~~~-----  439 (506)
                                    .+.....++.|++.||+|||   +.+++||||||+||++++++.+||+|||+++.......     
T Consensus        85 g~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dl~p~NIll~~~~~~~l~dfg~~~~~~~~~~~~~~~  161 (305)
T cd05609          85 GGDCATLLKNIGALPVDMARMYFAETVLALEYLH---NYGIVHRDLKPDNLLITSMGHIKLTDFGLSKIGLMSLTTNLYE  161 (305)
T ss_pred             CCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHH---HCCccccCCchHHEEECCCCCEEEeeCCCccccCcCccccccc
Confidence                          22234567889999999999   89999999999999999999999999999874211100     


Q ss_pred             --------ceecccCCCCcccccccccccccCCCCccccHHHHHHHHHHHHcCCCCCCCCCC
Q 039231          440 --------IISMTGARGTVGYIAPEVFCRNIGEVSYKSDVYNYGMMIFEMTGGRKNVDVVDN  493 (506)
Q Consensus       440 --------~~~~~~~~gt~~y~aPE~l~~~~~~~s~~~Dv~s~G~il~elltg~~pf~~~~~  493 (506)
                              ........++..|+|||.+...  .++.++|+||||+++|||++|+.||.....
T Consensus       162 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~--~~~~~~Di~slG~vl~el~~g~~pf~~~~~  221 (305)
T cd05609         162 GHIEKDTREFLDKQVCGTPEYIAPEVILRQ--GYGKPVDWWAMGIILYEFLVGCVPFFGDTP  221 (305)
T ss_pred             cccccchhhccccCCccCccccCchhccCC--CCCchhhHHHHHHHHHHHHhCCCCCCCCCH
Confidence                    0001123568899999998653  688999999999999999999999975543

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that a

>cd06630 STKc_MEKK1 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1

Probab=99.94  E-value=4.5e-26  Score=220.64  Aligned_cols=171  Identities=27%  Similarity=0.426  Sum_probs=138.3

Q ss_pred             ccccCccCceEEEEEEE-cCCCEEEEEEeccCCC-------CchhhHHHHHHhhccCccceeEEEEEee-----------
Q 039231          318 KYKLGQGGYGSVYKGKL-LDGSNVAVKVLNDSKG-------NGKEFINEVASISRTSHVNVVALLGFCL-----------  378 (506)
Q Consensus       318 ~~~ig~G~~g~V~~~~~-~~~~~vavK~l~~~~~-------~~~~~~~E~~~l~~l~h~niv~l~g~~~-----------  378 (506)
                      .+.||+|++|.||+|+. .+++.+|+|.+.....       ..+.+.+|++.+++++|+||+++++++.           
T Consensus         5 ~~~lg~g~~~~v~~~~~~~~~~~~alk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~v~e~   84 (268)
T cd06630           5 GQQLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHIIRMLGATCEDSHFNLFVEW   84 (268)
T ss_pred             cceecCcCceEEEEEEEcCCCcEEEEEEeecccCCchhHHHHHHHHHHHHHHHHHcCCCceehhhceeccCCeEEEEEec
Confidence            45799999999999986 4589999999864321       1356889999999999999999998762           


Q ss_pred             ----------------ccchhhhHHHHHHHHHHHHhhcCCCCeEecCcCCCcEEECCCC-cEEEeecCCCccccCCCcce
Q 039231          379 ----------------RVAEELSSTIGIARGLEYLHLGCSTRILHFDIKPHNILLDEDF-CPKISDFGLAKICNRKESII  441 (506)
Q Consensus       379 ----------------~~~~~l~i~~~i~~gl~~LH~~~~~~ivH~dlkp~Nill~~~~-~~ki~dfg~a~~~~~~~~~~  441 (506)
                                      ++...+.++.|++.||+|||   +++++|+||+|+||+++.++ .+||+|||.+..........
T Consensus        85 ~~~~~L~~~l~~~~~~~~~~~~~~~~ql~~al~~LH---~~~i~H~~i~~~nil~~~~~~~~~l~dfg~~~~~~~~~~~~  161 (268)
T cd06630          85 MAGGSVSHLLSKYGAFKEAVIINYTEQLLRGLSYLH---ENQIIHRDVKGANLLIDSTGQRLRIADFGAAARLAAKGTGA  161 (268)
T ss_pred             cCCCcHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEEcCCCCEEEEcccccccccccccccC
Confidence                            22335678899999999999   89999999999999998775 59999999987765432111


Q ss_pred             --ecccCCCCcccccccccccccCCCCccccHHHHHHHHHHHHcCCCCCCCCCC
Q 039231          442 --SMTGARGTVGYIAPEVFCRNIGEVSYKSDVYNYGMMIFEMTGGRKNVDVVDN  493 (506)
Q Consensus       442 --~~~~~~gt~~y~aPE~l~~~~~~~s~~~Dv~s~G~il~elltg~~pf~~~~~  493 (506)
                        ......++..|+|||.+.+.  .++.++||||+|+++|||++|+.||.....
T Consensus       162 ~~~~~~~~~~~~~~~PE~~~~~--~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~  213 (268)
T cd06630         162 GEFQGQLLGTIAFMAPEVLRGE--QYGRSCDVWSVGCVIIEMATAKPPWNAEKH  213 (268)
T ss_pred             CccccccccccceeCHhHhccC--CCCcccchHHHHHHHHHHHhCCCCCCCCCC
Confidence              01234578899999998553  678999999999999999999999976543

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their

>cd06614 STKc_PAK Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase

Probab=99.94  E-value=5.5e-26  Score=222.53  Aligned_cols=169  Identities=33%  Similarity=0.464  Sum_probs=141.3

Q ss_pred             ccccCccCceEEEEEEEc-CCCEEEEEEeccCCCCchhhHHHHHHhhccCccceeEEEEEe-------------------
Q 039231          318 KYKLGQGGYGSVYKGKLL-DGSNVAVKVLNDSKGNGKEFINEVASISRTSHVNVVALLGFC-------------------  377 (506)
Q Consensus       318 ~~~ig~G~~g~V~~~~~~-~~~~vavK~l~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~-------------------  377 (506)
                      .+.|++|++|.||+|... ++..+++|++.......+.+.+|++.+++++|+|++++++.+                   
T Consensus        24 ~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~  103 (286)
T cd06614          24 LEKIGEGASGEVYKATDRATGKEVAIKKMRLRKQNKELIINEILIMKDCKHPNIVDYYDSYLVGDELWVVMEYMDGGSLT  103 (286)
T ss_pred             hHhccCCCCeEEEEEEEccCCcEEEEEEEecCchhHHHHHHHHHHHHHCCCCCeeEEEEEEEECCEEEEEEeccCCCcHH
Confidence            356999999999999986 589999999976554557789999999999999999999876                   


Q ss_pred             ---------eccchhhhHHHHHHHHHHHHhhcCCCCeEecCcCCCcEEECCCCcEEEeecCCCccccCCCcceecccCCC
Q 039231          378 ---------LRVAEELSSTIGIARGLEYLHLGCSTRILHFDIKPHNILLDEDFCPKISDFGLAKICNRKESIISMTGARG  448 (506)
Q Consensus       378 ---------~~~~~~l~i~~~i~~gl~~LH~~~~~~ivH~dlkp~Nill~~~~~~ki~dfg~a~~~~~~~~~~~~~~~~g  448 (506)
                               +++.+.+.++.|++.||+|||   +.+++|+||+|+||+++.++.+||+|||++........  ......+
T Consensus       104 ~~l~~~~~~l~~~~~~~i~~~i~~~L~~lH---~~gi~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~--~~~~~~~  178 (286)
T cd06614         104 DIITQNFVRMNEPQIAYVCREVLQGLEYLH---SQNVIHRDIKSDNILLSKDGSVKLADFGFAAQLTKEKS--KRNSVVG  178 (286)
T ss_pred             HHHHHhccCCCHHHHHHHHHHHHHHHHHHH---hCCeeeCCCChhhEEEcCCCCEEECccchhhhhccchh--hhccccC
Confidence                     223345678999999999999   89999999999999999999999999998875543321  1133457


Q ss_pred             CcccccccccccccCCCCccccHHHHHHHHHHHHcCCCCCCCCCC
Q 039231          449 TVGYIAPEVFCRNIGEVSYKSDVYNYGMMIFEMTGGRKNVDVVDN  493 (506)
Q Consensus       449 t~~y~aPE~l~~~~~~~s~~~Dv~s~G~il~elltg~~pf~~~~~  493 (506)
                      +..|+|||.+.+.  .++.++|+||||+++|||++|+.||...+.
T Consensus       179 ~~~y~~PE~~~~~--~~~~~~Dv~slGvil~~l~~g~~p~~~~~~  221 (286)
T cd06614         179 TPYWMAPEVIKRK--DYGPKVDIWSLGIMCIEMAEGEPPYLREPP  221 (286)
T ss_pred             CcccCCHhHhcCC--CCCCccccHHHHHHHHHHHhCCCCCCCCCH
Confidence            8899999998653  678999999999999999999999986544

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two grou

>cd05606 STKc_beta_ARK Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase

Probab=99.94  E-value=9.9e-26  Score=219.92  Aligned_cols=165  Identities=30%  Similarity=0.420  Sum_probs=130.3

Q ss_pred             ccCccCceEEEEEEEc-CCCEEEEEEeccCCCC----chhhHHHH---HHhhccCccceeEEEEEe--------------
Q 039231          320 KLGQGGYGSVYKGKLL-DGSNVAVKVLNDSKGN----GKEFINEV---ASISRTSHVNVVALLGFC--------------  377 (506)
Q Consensus       320 ~ig~G~~g~V~~~~~~-~~~~vavK~l~~~~~~----~~~~~~E~---~~l~~l~h~niv~l~g~~--------------  377 (506)
                      .||+|+||.||+|+.. +++.||+|.+......    ...+.+|.   +.+....||||+++.+.+              
T Consensus         1 ~ig~g~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~   80 (278)
T cd05606           1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLSFILDLMN   80 (278)
T ss_pred             CcccCCCeEEEEEEEecCCCEEEEEEeeccccccchhHHHHHHHHHHHHHHHhCCCCcEeeeeeeeecCCEEEEEEecCC
Confidence            3899999999999874 5889999998653221    12233443   344456799999987755              


Q ss_pred             -------------eccchhhhHHHHHHHHHHHHhhcCCCCeEecCcCCCcEEECCCCcEEEeecCCCccccCCCcceecc
Q 039231          378 -------------LRVAEELSSTIGIARGLEYLHLGCSTRILHFDIKPHNILLDEDFCPKISDFGLAKICNRKESIISMT  444 (506)
Q Consensus       378 -------------~~~~~~l~i~~~i~~gl~~LH~~~~~~ivH~dlkp~Nill~~~~~~ki~dfg~a~~~~~~~~~~~~~  444 (506)
                                   +.+.++..++.|++.||+|||   +++++||||||+||++++++.+||+|||++........    .
T Consensus        81 g~~L~~~l~~~~~l~~~~~~~~~~ql~~~l~~lH---~~~i~H~di~p~nili~~~~~~kl~dfg~~~~~~~~~~----~  153 (278)
T cd05606          81 GGDLHYHLSQHGVFSEAEMRFYAAEIILGLEHMH---NRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKP----H  153 (278)
T ss_pred             CCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH---HCCEEcCCCCHHHEEECCCCCEEEccCcCccccCccCC----c
Confidence                         233446779999999999999   89999999999999999999999999999876543221    2


Q ss_pred             cCCCCcccccccccccccCCCCccccHHHHHHHHHHHHcCCCCCCCCC
Q 039231          445 GARGTVGYIAPEVFCRNIGEVSYKSDVYNYGMMIFEMTGGRKNVDVVD  492 (506)
Q Consensus       445 ~~~gt~~y~aPE~l~~~~~~~s~~~Dv~s~G~il~elltg~~pf~~~~  492 (506)
                      ...|+..|+|||.+.+. ..++.++||||+|+++|||++|+.||....
T Consensus       154 ~~~~~~~y~aPE~~~~~-~~~~~~~Di~s~G~~l~~l~~g~~p~~~~~  200 (278)
T cd05606         154 ASVGTHGYMAPEVLQKG-VAYDSSADWFSLGCMLFKLLRGHSPFRQHK  200 (278)
T ss_pred             CcCCCcCCcCcHHhcCC-CCCCcccchHhHHHHHHHHHhCCCCCCCCC
Confidence            34689999999998542 257889999999999999999999998653

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is co

>cd06648 STKc_PAK_II Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase

Probab=99.94  E-value=7.4e-26  Score=221.60  Aligned_cols=167  Identities=28%  Similarity=0.411  Sum_probs=138.3

Q ss_pred             cccCccCceEEEEEEEc-CCCEEEEEEeccCC-CCchhhHHHHHHhhccCccceeEEEEEee------------------
Q 039231          319 YKLGQGGYGSVYKGKLL-DGSNVAVKVLNDSK-GNGKEFINEVASISRTSHVNVVALLGFCL------------------  378 (506)
Q Consensus       319 ~~ig~G~~g~V~~~~~~-~~~~vavK~l~~~~-~~~~~~~~E~~~l~~l~h~niv~l~g~~~------------------  378 (506)
                      +.||+|++|.||++... +++.+++|++.... ...+.+.+|+.++++++||||+++++++.                  
T Consensus        25 ~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~~~h~~vv~~~~~~~~~~~~~~v~e~~~~~~L~  104 (285)
T cd06648          25 VKIGEGSTGIVCIATDKSTGRQVAVKKMDLRKQQRRELLFNEVVIMRDYQHPNIVEMYSSYLVGDELWVVMEFLEGGALT  104 (285)
T ss_pred             eEeccCCCeEEEEEEECCCCCEEEEEEEeccchhHHHHHHHHHHHHHHcCCCChheEEEEEEcCCeEEEEEeccCCCCHH
Confidence            47999999999999864 68899999886433 23356889999999999999999998752                  


Q ss_pred             --------ccchhhhHHHHHHHHHHHHhhcCCCCeEecCcCCCcEEECCCCcEEEeecCCCccccCCCcceecccCCCCc
Q 039231          379 --------RVAEELSSTIGIARGLEYLHLGCSTRILHFDIKPHNILLDEDFCPKISDFGLAKICNRKESIISMTGARGTV  450 (506)
Q Consensus       379 --------~~~~~l~i~~~i~~gl~~LH~~~~~~ivH~dlkp~Nill~~~~~~ki~dfg~a~~~~~~~~~~~~~~~~gt~  450 (506)
                              +..+.+.++.|++.||+|||   +++++||||+|+||+++.++.++|+|||.+.........  .....+++
T Consensus       105 ~~~~~~~~~~~~~~~~~~ql~~~l~~lH---~~~i~H~dl~p~Nil~~~~~~~~l~d~g~~~~~~~~~~~--~~~~~~~~  179 (285)
T cd06648         105 DIVTHTRMNEEQIATVCLAVLKALSFLH---AQGVIHRDIKSDSILLTSDGRVKLSDFGFCAQVSKEVPR--RKSLVGTP  179 (285)
T ss_pred             HHHHhCCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCChhhEEEcCCCcEEEcccccchhhccCCcc--cccccCCc
Confidence                    22335678999999999999   899999999999999999999999999988755433211  13356789


Q ss_pred             ccccccccccccCCCCccccHHHHHHHHHHHHcCCCCCCCCC
Q 039231          451 GYIAPEVFCRNIGEVSYKSDVYNYGMMIFEMTGGRKNVDVVD  492 (506)
Q Consensus       451 ~y~aPE~l~~~~~~~s~~~Dv~s~G~il~elltg~~pf~~~~  492 (506)
                      .|+|||.+.+.  .++.++||||||+++|||++|+.||...+
T Consensus       180 ~y~aPE~~~~~--~~~~~~Dv~slGv~l~ell~g~~p~~~~~  219 (285)
T cd06648         180 YWMAPEVISRL--PYGTEVDIWSLGIMVIEMVDGEPPYFNEP  219 (285)
T ss_pred             cccCHHHhcCC--CCCCcccHHHHHHHHHHHHhCCCCCcCCC
Confidence            99999998553  68889999999999999999999997644

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs foun

>cd06623 PKc_MAPKK_plant_like Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins

Probab=99.94  E-value=7.3e-26  Score=218.46  Aligned_cols=169  Identities=28%  Similarity=0.399  Sum_probs=143.1

Q ss_pred             hccccCccCceEEEEEEEcC-CCEEEEEEeccCCC--CchhhHHHHHHhhccCccceeEEEEEee---------------
Q 039231          317 FKYKLGQGGYGSVYKGKLLD-GSNVAVKVLNDSKG--NGKEFINEVASISRTSHVNVVALLGFCL---------------  378 (506)
Q Consensus       317 ~~~~ig~G~~g~V~~~~~~~-~~~vavK~l~~~~~--~~~~~~~E~~~l~~l~h~niv~l~g~~~---------------  378 (506)
                      +.+.||+|++|.||+|+..+ ++.+++|++.....  ..+++.+|++.+.+++|+||+++++++.               
T Consensus         5 ~~~~i~~g~~~~v~~~~~~~~~~~~~vk~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~   84 (264)
T cd06623           5 RVKVLGQGSSGVVYKVRHKPTGKIYALKKIHVDGDEEFRKQLLRELKTLRSCESPYVVKCYGAFYKEGEISIVLEYMDGG   84 (264)
T ss_pred             eeeeeeecCCeEEEEEEEcCCCcEEEEEEeccCcchHHHHHHHHHHHHHHhcCCCCeeeEEEEEccCCeEEEEEEecCCC
Confidence            34679999999999999865 89999999876543  3477999999999999999999998762               


Q ss_pred             ------------ccchhhhHHHHHHHHHHHHhhcCC-CCeEecCcCCCcEEECCCCcEEEeecCCCccccCCCcceeccc
Q 039231          379 ------------RVAEELSSTIGIARGLEYLHLGCS-TRILHFDIKPHNILLDEDFCPKISDFGLAKICNRKESIISMTG  445 (506)
Q Consensus       379 ------------~~~~~l~i~~~i~~gl~~LH~~~~-~~ivH~dlkp~Nill~~~~~~ki~dfg~a~~~~~~~~~~~~~~  445 (506)
                                  +....+.++.|+++||+|||   + .+++|+||+|+||+++.++.++|+|||++..........  ..
T Consensus        85 ~L~~~l~~~~~l~~~~~~~~~~~l~~~l~~lh---~~~~~~H~~l~~~ni~~~~~~~~~l~df~~~~~~~~~~~~~--~~  159 (264)
T cd06623          85 SLADLLKKVGKIPEPVLAYIARQILKGLDYLH---TKRHIIHRDIKPSNLLINSKGEVKIADFGISKVLENTLDQC--NT  159 (264)
T ss_pred             cHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHh---ccCCCccCCCCHHHEEECCCCCEEEccCccceecccCCCcc--cc
Confidence                        22335678999999999999   8 999999999999999999999999999998765443321  23


Q ss_pred             CCCCcccccccccccccCCCCccccHHHHHHHHHHHHcCCCCCCCCC
Q 039231          446 ARGTVGYIAPEVFCRNIGEVSYKSDVYNYGMMIFEMTGGRKNVDVVD  492 (506)
Q Consensus       446 ~~gt~~y~aPE~l~~~~~~~s~~~Dv~s~G~il~elltg~~pf~~~~  492 (506)
                      ..++..|+|||.+...  .++.++|+||||+++|||++|+.||...+
T Consensus       160 ~~~~~~y~~pE~~~~~--~~~~~~Dv~slG~il~~l~tg~~p~~~~~  204 (264)
T cd06623         160 FVGTVTYMSPERIQGE--SYSYAADIWSLGLTLLECALGKFPFLPPG  204 (264)
T ss_pred             eeecccccCHhhhCCC--CCCchhhHHHHHHHHHHHHhCCCCCcccc
Confidence            4578899999998554  78889999999999999999999998775

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of

>cd06605 PKc_MAPKK Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase

Probab=99.93  E-value=2.1e-26  Score=222.63  Aligned_cols=167  Identities=28%  Similarity=0.397  Sum_probs=138.9

Q ss_pred             hccccCccCceEEEEEEEc-CCCEEEEEEeccCC--CCchhhHHHHHHhhccCccceeEEEEEee---------------
Q 039231          317 FKYKLGQGGYGSVYKGKLL-DGSNVAVKVLNDSK--GNGKEFINEVASISRTSHVNVVALLGFCL---------------  378 (506)
Q Consensus       317 ~~~~ig~G~~g~V~~~~~~-~~~~vavK~l~~~~--~~~~~~~~E~~~l~~l~h~niv~l~g~~~---------------  378 (506)
                      +.+.||+|++|.||++... +++.+++|++....  ...+++.+|++.+++++||||+++++.+.               
T Consensus         5 ~~~~ig~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~   84 (265)
T cd06605           5 YLGELGAGNSGVVSKVLHRPTGKIMAVKTIRLEINEAIQKQILRELDILHKCNSPYIVGFYGAFYNNGDISICMEYMDGG   84 (265)
T ss_pred             HHHHhcCCCCeEEEEEEEcCCCcEEEEEEEecccChHHHHHHHHHHHHHHHCCCCchhhhheeeecCCEEEEEEEecCCC
Confidence            3457999999999999986 58999999987643  23367899999999999999999887651               


Q ss_pred             -------------ccchhhhHHHHHHHHHHHHhhcCC-CCeEecCcCCCcEEECCCCcEEEeecCCCccccCCCcceecc
Q 039231          379 -------------RVAEELSSTIGIARGLEYLHLGCS-TRILHFDIKPHNILLDEDFCPKISDFGLAKICNRKESIISMT  444 (506)
Q Consensus       379 -------------~~~~~l~i~~~i~~gl~~LH~~~~-~~ivH~dlkp~Nill~~~~~~ki~dfg~a~~~~~~~~~~~~~  444 (506)
                                   +......++.|++.||+|||   + .+++|+||||+||++++++.+||+|||.+........    .
T Consensus        85 ~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH---~~~~i~H~dl~~~ni~~~~~~~~~l~d~g~~~~~~~~~~----~  157 (265)
T cd06605          85 SLDKILKEVQGRIPERILGKIAVAVLKGLTYLH---EKHKIIHRDVKPSNILVNSRGQIKLCDFGVSGQLVNSLA----K  157 (265)
T ss_pred             cHHHHHHHccCCCCHHHHHHHHHHHHHHHHHHc---CCCCeecCCCCHHHEEECCCCCEEEeecccchhhHHHHh----h
Confidence                         12224568899999999999   8 9999999999999999999999999999876543221    1


Q ss_pred             cCCCCcccccccccccccCCCCccccHHHHHHHHHHHHcCCCCCCCCC
Q 039231          445 GARGTVGYIAPEVFCRNIGEVSYKSDVYNYGMMIFEMTGGRKNVDVVD  492 (506)
Q Consensus       445 ~~~gt~~y~aPE~l~~~~~~~s~~~Dv~s~G~il~elltg~~pf~~~~  492 (506)
                      ...++..|+|||.+.+.  .++.++||||||+++|+|++|+.||...+
T Consensus       158 ~~~~~~~y~~PE~~~~~--~~~~~~Dv~slG~~l~~l~~g~~p~~~~~  203 (265)
T cd06605         158 TFVGTSSYMAPERIQGN--DYSVKSDIWSLGLSLIELATGRFPYPPEN  203 (265)
T ss_pred             cccCChhccCHHHHcCC--CCCchhhHHHHHHHHHHHHhCCCCCCccc
Confidence            25678899999998654  78899999999999999999999997653

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity

>cd08220 STKc_Nek8 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8

Probab=99.93  E-value=7.7e-26  Score=217.39  Aligned_cols=170  Identities=27%  Similarity=0.370  Sum_probs=138.7

Q ss_pred             hccccCccCceEEEEEEEc-CCCEEEEEEeccCC---CCchhhHHHHHHhhccCccceeEEEEEe---------------
Q 039231          317 FKYKLGQGGYGSVYKGKLL-DGSNVAVKVLNDSK---GNGKEFINEVASISRTSHVNVVALLGFC---------------  377 (506)
Q Consensus       317 ~~~~ig~G~~g~V~~~~~~-~~~~vavK~l~~~~---~~~~~~~~E~~~l~~l~h~niv~l~g~~---------------  377 (506)
                      +.+.||+|++|.||++... +++.+|+|.+....   ...+.+.+|++++++++||||+++++.+               
T Consensus         4 ~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~   83 (256)
T cd08220           4 KIRVVGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTKDERLAAQNECQVLKLLSHPNIIEYYENFLEDKALMIVMEYAPG   83 (256)
T ss_pred             EEEEecccCceEEEEEEEcCCCcEEEEEEEeccccccHHHHHHHHHHHHHhhCCCCchhheeeeEecCCEEEEEEecCCC
Confidence            4567999999999999874 58899999986532   2336788999999999999999988765               


Q ss_pred             --------------eccchhhhHHHHHHHHHHHHhhcCCCCeEecCcCCCcEEECCC-CcEEEeecCCCccccCCCccee
Q 039231          378 --------------LRVAEELSSTIGIARGLEYLHLGCSTRILHFDIKPHNILLDED-FCPKISDFGLAKICNRKESIIS  442 (506)
Q Consensus       378 --------------~~~~~~l~i~~~i~~gl~~LH~~~~~~ivH~dlkp~Nill~~~-~~~ki~dfg~a~~~~~~~~~~~  442 (506)
                                    +++...+.++.|++.||+|||   +++++|+||+|+||+++++ ..+||+|||++.........  
T Consensus        84 ~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh---~~~i~h~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~~~~--  158 (256)
T cd08220          84 GTLAEYIQKRCNSLLDEDTILHFFVQILLALHHVH---TKLILHRDLKTQNILLDKHKMVVKIGDFGISKILSSKSKA--  158 (256)
T ss_pred             CCHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEEcCCCCEEEEccCCCceecCCCccc--
Confidence                          122335668899999999999   8999999999999999855 46899999999876543321  


Q ss_pred             cccCCCCcccccccccccccCCCCccccHHHHHHHHHHHHcCCCCCCCCCCC
Q 039231          443 MTGARGTVGYIAPEVFCRNIGEVSYKSDVYNYGMMIFEMTGGRKNVDVVDNG  494 (506)
Q Consensus       443 ~~~~~gt~~y~aPE~l~~~~~~~s~~~Dv~s~G~il~elltg~~pf~~~~~~  494 (506)
                       ....++..|+|||.+.+.  .++.++||||||+++|+|++|+.||+..+..
T Consensus       159 -~~~~~~~~y~aPE~~~~~--~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~  207 (256)
T cd08220         159 -YTVVGTPCYISPELCEGK--PYNQKSDIWALGCVLYELASLKRAFEAANLP  207 (256)
T ss_pred             -cccccCCcccCchhccCC--CCCcccchHHHHHHHHHHHhCCCCcccCchH
Confidence             235678899999998653  6788999999999999999999999876543

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with

>cd05579 STKc_MAST_like Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins

Probab=99.93  E-value=2.7e-26  Score=221.35  Aligned_cols=170  Identities=29%  Similarity=0.385  Sum_probs=138.3

Q ss_pred             cCccCceEEEEEEEcC-CCEEEEEEeccCCC----CchhhHHHHHHhhccCccceeEEEEEe------------------
Q 039231          321 LGQGGYGSVYKGKLLD-GSNVAVKVLNDSKG----NGKEFINEVASISRTSHVNVVALLGFC------------------  377 (506)
Q Consensus       321 ig~G~~g~V~~~~~~~-~~~vavK~l~~~~~----~~~~~~~E~~~l~~l~h~niv~l~g~~------------------  377 (506)
                      ||+|+||.||+++..+ ++.+++|.+.....    ..+.+.+|++++++++||||+++++.+                  
T Consensus         1 lg~g~~~~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L   80 (265)
T cd05579           1 ISKGAYGRVFLAKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKLYYSFQGKKNLYLVMEYLPGGDL   80 (265)
T ss_pred             CCCCCceEEEEEEECCCCCEEEEEEecchhhhhhhHHHHHHHHHHHHHhCCCcchhHHHHheecCcEEEEEEecCCCCcH
Confidence            6899999999999865 89999999965432    346788999999999999999887543                  


Q ss_pred             ---------eccchhhhHHHHHHHHHHHHhhcCCCCeEecCcCCCcEEECCCCcEEEeecCCCccccCCCc------cee
Q 039231          378 ---------LRVAEELSSTIGIARGLEYLHLGCSTRILHFDIKPHNILLDEDFCPKISDFGLAKICNRKES------IIS  442 (506)
Q Consensus       378 ---------~~~~~~l~i~~~i~~gl~~LH~~~~~~ivH~dlkp~Nill~~~~~~ki~dfg~a~~~~~~~~------~~~  442 (506)
                               +++...+.++.|+++||+|||   +.+++|+||+|+||++++++.+||+|||++........      ...
T Consensus        81 ~~~l~~~~~~~~~~~~~i~~qi~~~L~~lH---~~~i~H~di~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~  157 (265)
T cd05579          81 ASLLENVGSLDEDVARIYIAEIVLALEYLH---SNGIIHRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINLNDDEKE  157 (265)
T ss_pred             HHHHHHcCCCCHHHHHHHHHHHHHHHHHHH---HcCeecCCCCHHHeEEcCCCCEEEEecccchhcccCccccccccccc
Confidence                     233345678999999999999   89999999999999999999999999999876543321      001


Q ss_pred             cccCCCCcccccccccccccCCCCccccHHHHHHHHHHHHcCCCCCCCCCCCc
Q 039231          443 MTGARGTVGYIAPEVFCRNIGEVSYKSDVYNYGMMIFEMTGGRKNVDVVDNGS  495 (506)
Q Consensus       443 ~~~~~gt~~y~aPE~l~~~~~~~s~~~Dv~s~G~il~elltg~~pf~~~~~~~  495 (506)
                      .....++..|+|||.+...  ..+.++||||||+++|||++|+.||......+
T Consensus       158 ~~~~~~~~~~~~Pe~~~~~--~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~  208 (265)
T cd05579         158 DKRIVGTPDYIAPEVILGQ--GHSKTVDWWSLGCILYEFLVGIPPFHGETPEE  208 (265)
T ss_pred             ccCcccCccccCHHHhcCC--CCCcchhhHHHHHHHHHHHhCCCCCCCCCHHH
Confidence            2335578899999998654  57889999999999999999999997665443

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert re

>cd06634 STKc_TAO2 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2

Probab=99.93  E-value=4.3e-26  Score=225.88  Aligned_cols=167  Identities=31%  Similarity=0.453  Sum_probs=137.0

Q ss_pred             ccccCccCceEEEEEEEc-CCCEEEEEEeccCC----CCchhhHHHHHHhhccCccceeEEEEEee--------------
Q 039231          318 KYKLGQGGYGSVYKGKLL-DGSNVAVKVLNDSK----GNGKEFINEVASISRTSHVNVVALLGFCL--------------  378 (506)
Q Consensus       318 ~~~ig~G~~g~V~~~~~~-~~~~vavK~l~~~~----~~~~~~~~E~~~l~~l~h~niv~l~g~~~--------------  378 (506)
                      .+.||+|++|.||+|+.. ++..+|+|.+....    ...+++.+|++++++++|+|++++.+++.              
T Consensus        20 ~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~   99 (308)
T cd06634          20 LREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVMEYCLG   99 (308)
T ss_pred             HHheeeCCCEEEEEEEEcCCCcEEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCcccEEEEEEcCCeeEEEEEccCC
Confidence            456999999999999975 57889999986432    12256788999999999999999998762              


Q ss_pred             -------------ccchhhhHHHHHHHHHHHHhhcCCCCeEecCcCCCcEEECCCCcEEEeecCCCccccCCCcceeccc
Q 039231          379 -------------RVAEELSSTIGIARGLEYLHLGCSTRILHFDIKPHNILLDEDFCPKISDFGLAKICNRKESIISMTG  445 (506)
Q Consensus       379 -------------~~~~~l~i~~~i~~gl~~LH~~~~~~ivH~dlkp~Nill~~~~~~ki~dfg~a~~~~~~~~~~~~~~  445 (506)
                                   ++.+.+.++.|++.||.|||   +.+++||||+|+||+++.++.+||+|||++......      ..
T Consensus       100 ~l~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH---~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~------~~  170 (308)
T cd06634         100 SASDLLEVHKKPLQEVEIAAVTHGALQGLAYLH---SHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPA------NX  170 (308)
T ss_pred             CHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCCHHhEEECCCCcEEECCcccceeecCc------cc
Confidence                         22335667889999999999   899999999999999999999999999998765432      23


Q ss_pred             CCCCccccccccccc-ccCCCCccccHHHHHHHHHHHHcCCCCCCCCCC
Q 039231          446 ARGTVGYIAPEVFCR-NIGEVSYKSDVYNYGMMIFEMTGGRKNVDVVDN  493 (506)
Q Consensus       446 ~~gt~~y~aPE~l~~-~~~~~s~~~Dv~s~G~il~elltg~~pf~~~~~  493 (506)
                      ..++..|+|||.+.. ..+..+.++||||||+++|||++|+.||...+.
T Consensus       171 ~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~  219 (308)
T cd06634         171 FVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNA  219 (308)
T ss_pred             ccCCccccCHHHHhhcccCCCCcccchHHHHHHHHHHHcCCCCCccccH
Confidence            457889999999743 123578899999999999999999999976543

Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activatin

>cd07858 STKc_TEY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants

Probab=99.93  E-value=3.1e-26  Score=229.79  Aligned_cols=169  Identities=31%  Similarity=0.442  Sum_probs=138.2

Q ss_pred             ccccCccCceEEEEEEEc-CCCEEEEEEeccC---CCCchhhHHHHHHhhccCccceeEEEEEe----------------
Q 039231          318 KYKLGQGGYGSVYKGKLL-DGSNVAVKVLNDS---KGNGKEFINEVASISRTSHVNVVALLGFC----------------  377 (506)
Q Consensus       318 ~~~ig~G~~g~V~~~~~~-~~~~vavK~l~~~---~~~~~~~~~E~~~l~~l~h~niv~l~g~~----------------  377 (506)
                      .+.||+|+||.||+|+.. +++.||||.++..   ......+.+|+.+++.++|+||+++++++                
T Consensus        10 ~~~lg~G~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~~~~~~~~~~~lv~e   89 (337)
T cd07858          10 IKPIGRGAYGIVCSAKNSETNEKVAIKKIANAFDNRIDAKRTLREIKLLRHLDHENVIAIKDIMPPPHREAFNDVYIVYE   89 (337)
T ss_pred             EEEeccCCCeEEEEEEecCCCCeEEEEEecccccccchhHHHHHHHHHHHhcCCCCccchHHheecccccccCcEEEEEe
Confidence            457999999999999874 5899999998653   22335678899999999999999887643                


Q ss_pred             ---------------eccchhhhHHHHHHHHHHHHhhcCCCCeEecCcCCCcEEECCCCcEEEeecCCCccccCCCccee
Q 039231          378 ---------------LRVAEELSSTIGIARGLEYLHLGCSTRILHFDIKPHNILLDEDFCPKISDFGLAKICNRKESIIS  442 (506)
Q Consensus       378 ---------------~~~~~~l~i~~~i~~gl~~LH~~~~~~ivH~dlkp~Nill~~~~~~ki~dfg~a~~~~~~~~~~~  442 (506)
                                     +++...+.++.|++.||.|||   +++++|+||||+||+++.++.+||+|||+++........  
T Consensus        90 ~~~~~L~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH---~~~i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~~~~~--  164 (337)
T cd07858          90 LMDTDLHQIIRSSQTLSDDHCQYFLYQLLRGLKYIH---SANVLHRDLKPSNLLLNANCDLKICDFGLARTTSEKGDF--  164 (337)
T ss_pred             CCCCCHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH---hCCEecCCCCHHHEEEcCCCCEEECcCccccccCCCccc--
Confidence                           123335678899999999999   899999999999999999999999999999866443211  


Q ss_pred             cccCCCCcccccccccccccCCCCccccHHHHHHHHHHHHcCCCCCCCCC
Q 039231          443 MTGARGTVGYIAPEVFCRNIGEVSYKSDVYNYGMMIFEMTGGRKNVDVVD  492 (506)
Q Consensus       443 ~~~~~gt~~y~aPE~l~~~~~~~s~~~Dv~s~G~il~elltg~~pf~~~~  492 (506)
                      .....++..|+|||.+.+. ..++.++||||||+++|||++|+.||...+
T Consensus       165 ~~~~~~~~~y~aPE~~~~~-~~~~~~~DiwslG~il~~l~~g~~pf~~~~  213 (337)
T cd07858         165 MTEYVVTRWYRAPELLLNC-SEYTTAIDVWSVGCIFAELLGRKPLFPGKD  213 (337)
T ss_pred             ccccccccCccChHHHhcC-CCCCCcccHHHHHHHHHHHHcCCCCCCCCC
Confidence            2345678899999988543 358889999999999999999999997543

Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activati

>cd07856 STKc_Sty1_Hog1 Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1

Probab=99.93  E-value=5.5e-26  Score=227.10  Aligned_cols=166  Identities=30%  Similarity=0.418  Sum_probs=137.2

Q ss_pred             ccccCccCceEEEEEEEc-CCCEEEEEEeccC---CCCchhhHHHHHHhhccCccceeEEEEEeec--------------
Q 039231          318 KYKLGQGGYGSVYKGKLL-DGSNVAVKVLNDS---KGNGKEFINEVASISRTSHVNVVALLGFCLR--------------  379 (506)
Q Consensus       318 ~~~ig~G~~g~V~~~~~~-~~~~vavK~l~~~---~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~--------------  379 (506)
                      .+.||+|+||.||+|+.. +++.+|+|++...   ....+.+.+|++++.+++||||+++.+++..              
T Consensus        15 ~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~lv~e~~~~   94 (328)
T cd07856          15 LQPVGMGAFGLVCSARDQLTGQNVAIKKIMKPFSTPVLAKRTYRELKLLKHLRHENIISLSDIFISPLEDIYFVTELLGT   94 (328)
T ss_pred             EEeecccCCeEEEEEEECCCCCEEEEEEecccccccchhHHHHHHHHHHHhcCCCCeeeEeeeEecCCCcEEEEeehhcc
Confidence            467999999999999865 6899999988643   2234678899999999999999999987732              


Q ss_pred             ------------cchhhhHHHHHHHHHHHHhhcCCCCeEecCcCCCcEEECCCCcEEEeecCCCccccCCCcceecccCC
Q 039231          380 ------------VAEELSSTIGIARGLEYLHLGCSTRILHFDIKPHNILLDEDFCPKISDFGLAKICNRKESIISMTGAR  447 (506)
Q Consensus       380 ------------~~~~l~i~~~i~~gl~~LH~~~~~~ivH~dlkp~Nill~~~~~~ki~dfg~a~~~~~~~~~~~~~~~~  447 (506)
                                  ......++.|+++||+|||   +.+++|+||+|+||++++++.+||+|||.+.......     ....
T Consensus        95 ~L~~~~~~~~~~~~~~~~~~~ql~~aL~~LH---~~~iiH~dl~p~Nili~~~~~~~l~dfg~~~~~~~~~-----~~~~  166 (328)
T cd07856          95 DLHRLLTSRPLEKQFIQYFLYQILRGLKYVH---SAGVVHRDLKPSNILINENCDLKICDFGLARIQDPQM-----TGYV  166 (328)
T ss_pred             CHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCCHHHEeECCCCCEEeCccccccccCCCc-----CCCc
Confidence                        1123457889999999999   8999999999999999999999999999987543221     2345


Q ss_pred             CCcccccccccccccCCCCccccHHHHHHHHHHHHcCCCCCCCCC
Q 039231          448 GTVGYIAPEVFCRNIGEVSYKSDVYNYGMMIFEMTGGRKNVDVVD  492 (506)
Q Consensus       448 gt~~y~aPE~l~~~~~~~s~~~Dv~s~G~il~elltg~~pf~~~~  492 (506)
                      ++..|+|||.+.+. ..++.++||||||+++|||++|+.||....
T Consensus       167 ~~~~y~aPE~~~~~-~~~~~~~Dv~slG~il~el~tg~~~f~~~~  210 (328)
T cd07856         167 STRYYRAPEIMLTW-QKYDVEVDIWSAGCIFAEMLEGKPLFPGKD  210 (328)
T ss_pred             ccccccCceeeecc-CCcCcHHHHHHHHHHHHHHHhCCCCCCCCC
Confidence            68889999987542 367899999999999999999999997654

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and U

>cd07838 STKc_CDK4_6_like Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases

Probab=99.93  E-value=9e-26  Score=220.70  Aligned_cols=170  Identities=32%  Similarity=0.470  Sum_probs=137.1

Q ss_pred             hccccCccCceEEEEEEEcC-CCEEEEEEeccCCCC---chhhHHHHHHhhcc---CccceeEEEEEeec----------
Q 039231          317 FKYKLGQGGYGSVYKGKLLD-GSNVAVKVLNDSKGN---GKEFINEVASISRT---SHVNVVALLGFCLR----------  379 (506)
Q Consensus       317 ~~~~ig~G~~g~V~~~~~~~-~~~vavK~l~~~~~~---~~~~~~E~~~l~~l---~h~niv~l~g~~~~----------  379 (506)
                      +.+.||+|++|.||+|+.+. ++.+|+|+++.....   ...+.+|+.++.++   +|+||+++.+++..          
T Consensus         3 ~~~~l~~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~~~~~~~~   82 (287)
T cd07838           3 ELAEIGEGAYGTVYKARDLNTGRFVALKKVRVPLSEEGIPLSTLREIALLKQLESFEHPNIVRLLDVCHGPRTDRELKLT   82 (287)
T ss_pred             EEEEecccCceEEEEEEECCCCCEEEEEEeccccccchhhhhHHHHHHHHHHhhccCCCCcceEEEEEeeccCCCCceeE
Confidence            34679999999999999865 899999999743222   24566787776665   69999999987622          


Q ss_pred             -----------------------cchhhhHHHHHHHHHHHHhhcCCCCeEecCcCCCcEEECCCCcEEEeecCCCccccC
Q 039231          380 -----------------------VAEELSSTIGIARGLEYLHLGCSTRILHFDIKPHNILLDEDFCPKISDFGLAKICNR  436 (506)
Q Consensus       380 -----------------------~~~~l~i~~~i~~gl~~LH~~~~~~ivH~dlkp~Nill~~~~~~ki~dfg~a~~~~~  436 (506)
                                             +...+.++.|++.||+|||   +.+++|+||+|+||++++++.+||+|||++.....
T Consensus        83 l~~e~~~~~l~~~l~~~~~~~l~~~~~~~~~~~i~~al~~LH---~~~i~h~~l~~~nili~~~~~~~l~dfg~~~~~~~  159 (287)
T cd07838          83 LVFEHVDQDLATYLSKCPKPGLPPETIKDLMRQLLRGVDFLH---SHRIVHRDLKPQNILVTSDGQVKIADFGLARIYSF  159 (287)
T ss_pred             EEehhcccCHHHHHHHccCCCCCHHHHHHHHHHHHHHHHHHH---HCCeeeccCChhhEEEccCCCEEEeccCcceeccC
Confidence                                   2224568899999999999   89999999999999999999999999999987654


Q ss_pred             CCcceecccCCCCcccccccccccccCCCCccccHHHHHHHHHHHHcCCCCCCCCCCC
Q 039231          437 KESIISMTGARGTVGYIAPEVFCRNIGEVSYKSDVYNYGMMIFEMTGGRKNVDVVDNG  494 (506)
Q Consensus       437 ~~~~~~~~~~~gt~~y~aPE~l~~~~~~~s~~~Dv~s~G~il~elltg~~pf~~~~~~  494 (506)
                      ....   ....++..|+|||.+.+.  .++.++|+||||+++|||++|+.||......
T Consensus       160 ~~~~---~~~~~~~~~~~PE~~~~~--~~~~~~Di~s~G~~l~~l~~~~~~~~~~~~~  212 (287)
T cd07838         160 EMAL---TSVVVTLWYRAPEVLLQS--SYATPVDMWSVGCIFAELFRRRPLFRGTSEA  212 (287)
T ss_pred             Cccc---ccccccccccChHHhccC--CCCCcchhhhHHHHHHHHHhCCCcccCCChH
Confidence            3321   234568899999998654  6888999999999999999999999865543

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both

>KOG0669 consensus Cyclin T-dependent kinase CDK9 [Cell cycle control, cell division, chromosome partitioning]

Probab=99.93  E-value=4.7e-28  Score=217.61  Aligned_cols=173  Identities=28%  Similarity=0.438  Sum_probs=141.5

Q ss_pred             cccCccCceEEEEEEEcC-CCEEEEEEecc---CCCCchhhHHHHHHhhccCccceeEEEEEe-----------------
Q 039231          319 YKLGQGGYGSVYKGKLLD-GSNVAVKVLND---SKGNGKEFINEVASISRTSHVNVVALLGFC-----------------  377 (506)
Q Consensus       319 ~~ig~G~~g~V~~~~~~~-~~~vavK~l~~---~~~~~~~~~~E~~~l~~l~h~niv~l~g~~-----------------  377 (506)
                      .+||+|.||.||+|+..+ |+.||+|+.--   ...-....++|+++|..++|+|++.++..|                 
T Consensus        23 ~kigqGtfgeVFkAr~~n~~kkvalkkvlmeneKeGfpitalreikiL~~lkHenv~nliEic~tk~Tp~~r~r~t~ylV  102 (376)
T KOG0669|consen   23 AKIGQGTFGEVFKARSKNTGKKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPTNRDRATFYLV  102 (376)
T ss_pred             HhcCCchHHHHHHHhhcCccchhHHHHHHHhccccCCcHHHHHHHHHHHHhcchhHHHHHHHHhhccCCcccccceeeee
Confidence            369999999999998754 77888886532   233346789999999999999999887655                 


Q ss_pred             ------------------eccchhhhHHHHHHHHHHHHhhcCCCCeEecCcCCCcEEECCCCcEEEeecCCCccccCCCc
Q 039231          378 ------------------LRVAEELSSTIGIARGLEYLHLGCSTRILHFDIKPHNILLDEDFCPKISDFGLAKICNRKES  439 (506)
Q Consensus       378 ------------------~~~~~~l~i~~~i~~gl~~LH~~~~~~ivH~dlkp~Nill~~~~~~ki~dfg~a~~~~~~~~  439 (506)
                                        +...+...++.++..||.|+|   ...|+|||+||.|+||+.++.+||+|||+++.+...+.
T Consensus       103 f~~cehDLaGlLsn~~vr~sls~Ikk~Mk~Lm~GL~~iH---r~kilHRDmKaaNvLIt~dgilklADFGlar~fs~~~n  179 (376)
T KOG0669|consen  103 FDFCEHDLAGLLSNRKVRFSLSEIKKVMKGLMNGLYYIH---RNKILHRDMKAANVLITKDGILKLADFGLARAFSTSKN  179 (376)
T ss_pred             HHHhhhhHHHHhcCccccccHHHHHHHHHHHHHHHHHHH---HhhHHhhcccHhhEEEcCCceEEeeccccccceecccc
Confidence                              333445668889999999999   99999999999999999999999999999987654332


Q ss_pred             c--eecccCCCCcccccccccccccCCCCccccHHHHHHHHHHHHcCCCCCCCCCCCc
Q 039231          440 I--ISMTGARGTVGYIAPEVFCRNIGEVSYKSDVYNYGMMIFEMTGGRKNVDVVDNGS  495 (506)
Q Consensus       440 ~--~~~~~~~gt~~y~aPE~l~~~~~~~s~~~Dv~s~G~il~elltg~~pf~~~~~~~  495 (506)
                      .  ...+..+-|..|.+||.+.+. ..++++.|||+-|||+.||+||.+-++...+..
T Consensus       180 ~~kprytnrvvTLwYrppEllLG~-r~yg~~iDiWgAgCimaeMwtrspimqgnteqq  236 (376)
T KOG0669|consen  180 VVKPRYTNRVVTLWYRPPELLLGD-REYGPPIDIWGAGCIMAEMWTRSPIMQGNTEQQ  236 (376)
T ss_pred             cCCCCcccceeeeecCCHHHhhcc-cccCCcchhHhHHHHHHHHHccCccccCChHHH
Confidence            1  112334559999999999886 589999999999999999999999988765543

>cd08528 STKc_Nek10 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10

Probab=99.93  E-value=7.3e-26  Score=219.46  Aligned_cols=169  Identities=29%  Similarity=0.436  Sum_probs=136.1

Q ss_pred             hccccCccCceEEEEEEEcC--CCEEEEEEeccCC-----------CCchhhHHHHHHhhc-cCccceeEEEEEee----
Q 039231          317 FKYKLGQGGYGSVYKGKLLD--GSNVAVKVLNDSK-----------GNGKEFINEVASISR-TSHVNVVALLGFCL----  378 (506)
Q Consensus       317 ~~~~ig~G~~g~V~~~~~~~--~~~vavK~l~~~~-----------~~~~~~~~E~~~l~~-l~h~niv~l~g~~~----  378 (506)
                      +.+.||+|+||.||+|....  ++.+|+|.+....           ....++.+|+.++.+ ++||||+++++++.    
T Consensus         4 ~~~~ig~G~~~~v~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~   83 (269)
T cd08528           4 VLEHLGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQLRHPNIVRYYKTFLENDR   83 (269)
T ss_pred             hhhhhcCCCCceEEEEEEcCCCCceeeeeEeeccccccccccccchHHHHHHHHHHHHHhhcCCCCCeeeEEeeEccCCe
Confidence            34679999999999999865  6889999875321           112457778888865 79999999998761    


Q ss_pred             ---------------------------ccchhhhHHHHHHHHHHHHhhcCCCCeEecCcCCCcEEECCCCcEEEeecCCC
Q 039231          379 ---------------------------RVAEELSSTIGIARGLEYLHLGCSTRILHFDIKPHNILLDEDFCPKISDFGLA  431 (506)
Q Consensus       379 ---------------------------~~~~~l~i~~~i~~gl~~LH~~~~~~ivH~dlkp~Nill~~~~~~ki~dfg~a  431 (506)
                                                 ++...+.++.|++.||.|||.  ..+++|+||+|+||++++++.+||+|||.+
T Consensus        84 ~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~--~~~i~H~dl~~~nil~~~~~~~~l~dfg~~  161 (269)
T cd08528          84 LYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQMVLALRYLHK--EKRIVHRDLTPNNIMLGEDDKVTITDFGLA  161 (269)
T ss_pred             EEEEEecCCCCcHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHhcc--CCceeecCCCHHHEEECCCCcEEEecccce
Confidence                                       122356788899999999992  268999999999999999999999999999


Q ss_pred             ccccCCCcceecccCCCCcccccccccccccCCCCccccHHHHHHHHHHHHcCCCCCCCCC
Q 039231          432 KICNRKESIISMTGARGTVGYIAPEVFCRNIGEVSYKSDVYNYGMMIFEMTGGRKNVDVVD  492 (506)
Q Consensus       432 ~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~s~~~Dv~s~G~il~elltg~~pf~~~~  492 (506)
                      .......   ......++..|+|||.+.+  +.++.++||||||+++|||++|+.||...+
T Consensus       162 ~~~~~~~---~~~~~~~~~~~~~Pe~~~~--~~~~~~~Dv~slG~ll~~l~~g~~p~~~~~  217 (269)
T cd08528         162 KQKQPES---KLTSVVGTILYSCPEIVKN--EPYGEKADVWAFGCILYQMCTLQPPFYSTN  217 (269)
T ss_pred             eeccccc---ccccccCcccCcChhhhcC--CCCchHHHHHHHHHHHHHHHhCCCcccccC
Confidence            8765443   1244568899999999864  368999999999999999999999997654

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24.

>cd06621 PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases

Probab=99.93  E-value=7e-26  Score=221.97  Aligned_cols=165  Identities=30%  Similarity=0.376  Sum_probs=137.5

Q ss_pred             ccccCccCceEEEEEEEc-CCCEEEEEEeccCCC--CchhhHHHHHHhhccCccceeEEEEEeecc--------------
Q 039231          318 KYKLGQGGYGSVYKGKLL-DGSNVAVKVLNDSKG--NGKEFINEVASISRTSHVNVVALLGFCLRV--------------  380 (506)
Q Consensus       318 ~~~ig~G~~g~V~~~~~~-~~~~vavK~l~~~~~--~~~~~~~E~~~l~~l~h~niv~l~g~~~~~--------------  380 (506)
                      .+.||.|++|.||++... +++.+|+|++.....  ...++.+|++++++++||||+++++++...              
T Consensus         6 ~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~e~~~~   85 (287)
T cd06621           6 LSRLGEGAGGSVTKCRLKNTGMIFALKTITTDPNPDLQKQILRELEINKSCKSPYIVKYYGAFLDESSSSIGIAMEYCEG   85 (287)
T ss_pred             EEEeccCCceEEEEEEECCCCeEEEEEEEecCCchHHHHHHHHHHHHHHhCCCCCeeeeeeEEEccCCCeEEEEEEecCC
Confidence            457999999999999985 588999999875433  346789999999999999999999876221              


Q ss_pred             -------------------chhhhHHHHHHHHHHHHhhcCCCCeEecCcCCCcEEECCCCcEEEeecCCCccccCCCcce
Q 039231          381 -------------------AEELSSTIGIARGLEYLHLGCSTRILHFDIKPHNILLDEDFCPKISDFGLAKICNRKESII  441 (506)
Q Consensus       381 -------------------~~~l~i~~~i~~gl~~LH~~~~~~ivH~dlkp~Nill~~~~~~ki~dfg~a~~~~~~~~~~  441 (506)
                                         ...+.++.|++.||+|||   +.+++|+||+|+||++++++.++|+|||++........  
T Consensus        86 ~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~lH---~~~i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~~--  160 (287)
T cd06621          86 GSLDSIYKKVKKRGGRIGEKVLGKIAESVLKGLSYLH---SRKIIHRDIKPSNILLTRKGQVKLCDFGVSGELVNSLA--  160 (287)
T ss_pred             CCHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCHHHEEEecCCeEEEeecccccccccccc--
Confidence                               113458899999999999   89999999999999999999999999999875543221  


Q ss_pred             ecccCCCCcccccccccccccCCCCccccHHHHHHHHHHHHcCCCCCCCC
Q 039231          442 SMTGARGTVGYIAPEVFCRNIGEVSYKSDVYNYGMMIFEMTGGRKNVDVV  491 (506)
Q Consensus       442 ~~~~~~gt~~y~aPE~l~~~~~~~s~~~Dv~s~G~il~elltg~~pf~~~  491 (506)
                        ....++..|+|||.+.+.  .++.++||||+|+++|||++|+.||+..
T Consensus       161 --~~~~~~~~y~~pE~~~~~--~~~~~~Dv~slG~il~~l~~g~~p~~~~  206 (287)
T cd06621         161 --GTFTGTSFYMAPERIQGK--PYSITSDVWSLGLTLLEVAQNRFPFPPE  206 (287)
T ss_pred             --ccccCCccccCHHHhcCC--CCCchhhHHHHHHHHHHHHhCCCCCCcc
Confidence              234568889999998543  6888999999999999999999999866

Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include

>cd05122 PKc_STE Catalytic domain of STE family Protein Kinases

Probab=99.93  E-value=1.2e-25  Score=214.96  Aligned_cols=167  Identities=33%  Similarity=0.530  Sum_probs=142.2

Q ss_pred             ccccCccCceEEEEEEEc-CCCEEEEEEeccCCC-CchhhHHHHHHhhccCccceeEEEEEee-----------------
Q 039231          318 KYKLGQGGYGSVYKGKLL-DGSNVAVKVLNDSKG-NGKEFINEVASISRTSHVNVVALLGFCL-----------------  378 (506)
Q Consensus       318 ~~~ig~G~~g~V~~~~~~-~~~~vavK~l~~~~~-~~~~~~~E~~~l~~l~h~niv~l~g~~~-----------------  378 (506)
                      .+.||+|++|.||++... ++..+++|++..... ..+++.+|++.+++++|+|++++++.+.                 
T Consensus         5 ~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l~~e~~~~~~L   84 (253)
T cd05122           5 LEKIGKGGFGEVYKARHKRTGKEVAIKVIKLESKEKKEKIINEIQILKKCKHPNIVKYYGSYLKKDELWIVMEFCSGGSL   84 (253)
T ss_pred             eeeeccCCceEEEEEEECCCCcEEEEEEecccchhHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEEEEecCCCCcH
Confidence            467999999999999985 588999999976544 4578999999999999999999998761                 


Q ss_pred             -----------ccchhhhHHHHHHHHHHHHhhcCCCCeEecCcCCCcEEECCCCcEEEeecCCCccccCCCcceecccCC
Q 039231          379 -----------RVAEELSSTIGIARGLEYLHLGCSTRILHFDIKPHNILLDEDFCPKISDFGLAKICNRKESIISMTGAR  447 (506)
Q Consensus       379 -----------~~~~~l~i~~~i~~gl~~LH~~~~~~ivH~dlkp~Nill~~~~~~ki~dfg~a~~~~~~~~~~~~~~~~  447 (506)
                                 ++.+...++.|++.||++||   ..+++|+||+|+||++++++.++|+|||.+........   .....
T Consensus        85 ~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh---~~~i~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~---~~~~~  158 (253)
T cd05122          85 KDLLKSTNQTLTESQIAYVCKELLKGLEYLH---SNGIIHRDIKAANILLTSDGEVKLIDFGLSAQLSDTKA---RNTMV  158 (253)
T ss_pred             HHHHhhcCCCCCHHHHHHHHHHHHHHHHHhh---cCCEecCCCCHHHEEEccCCeEEEeecccccccccccc---cccee
Confidence                       22335668899999999999   89999999999999999999999999999987655432   13456


Q ss_pred             CCcccccccccccccCCCCccccHHHHHHHHHHHHcCCCCCCCCC
Q 039231          448 GTVGYIAPEVFCRNIGEVSYKSDVYNYGMMIFEMTGGRKNVDVVD  492 (506)
Q Consensus       448 gt~~y~aPE~l~~~~~~~s~~~Dv~s~G~il~elltg~~pf~~~~  492 (506)
                      ++..|+|||.+...  ..+.++|+||||+++++|++|+.||...+
T Consensus       159 ~~~~~~~PE~~~~~--~~~~~~Dv~slG~il~~l~~g~~p~~~~~  201 (253)
T cd05122         159 GTPYWMAPEVINGK--PYDYKADIWSLGITAIELAEGKPPYSELP  201 (253)
T ss_pred             cCCcccCHHHHcCC--CCCccccHHHHHHHHHHHHhCCCCCCCCc
Confidence            78899999998654  57889999999999999999999998663

Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core

>cd06633 STKc_TAO3 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3

Probab=99.93  E-value=2e-25  Score=221.60  Aligned_cols=166  Identities=31%  Similarity=0.436  Sum_probs=136.7

Q ss_pred             cccCccCceEEEEEEEc-CCCEEEEEEeccCCC----CchhhHHHHHHhhccCccceeEEEEEee---------------
Q 039231          319 YKLGQGGYGSVYKGKLL-DGSNVAVKVLNDSKG----NGKEFINEVASISRTSHVNVVALLGFCL---------------  378 (506)
Q Consensus       319 ~~ig~G~~g~V~~~~~~-~~~~vavK~l~~~~~----~~~~~~~E~~~l~~l~h~niv~l~g~~~---------------  378 (506)
                      ++||+|++|.||+|+.. +++.+++|++.....    ..+.+.+|++++++++|||++++.+++.               
T Consensus        27 ~~lg~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~  106 (313)
T cd06633          27 HEIGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPNTIEYKGCYLKEHTAWLVMEYCLGS  106 (313)
T ss_pred             eeeccCCCeEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEEEEEecCCCC
Confidence            56999999999999874 588999999864322    2246788999999999999999998762               


Q ss_pred             ------------ccchhhhHHHHHHHHHHHHhhcCCCCeEecCcCCCcEEECCCCcEEEeecCCCccccCCCcceecccC
Q 039231          379 ------------RVAEELSSTIGIARGLEYLHLGCSTRILHFDIKPHNILLDEDFCPKISDFGLAKICNRKESIISMTGA  446 (506)
Q Consensus       379 ------------~~~~~l~i~~~i~~gl~~LH~~~~~~ivH~dlkp~Nill~~~~~~ki~dfg~a~~~~~~~~~~~~~~~  446 (506)
                                  ++.+.+.++.|++.||+|||   +.+++|+||+|+||++++++.+||+|||++......      ...
T Consensus       107 l~~~l~~~~~~l~~~~~~~~~~qi~~al~~LH---~~gi~H~dl~p~nili~~~~~~kL~dfg~~~~~~~~------~~~  177 (313)
T cd06633         107 ASDLLEVHKKPLQEVEIAAITHGALQGLAYLH---SHNMIHRDIKAGNILLTEPGQVKLADFGSASKSSPA------NSF  177 (313)
T ss_pred             HHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCChhhEEECCCCCEEEeecCCCcccCCC------CCc
Confidence                        22235568899999999999   899999999999999999999999999998643221      335


Q ss_pred             CCCccccccccccc-ccCCCCccccHHHHHHHHHHHHcCCCCCCCCCC
Q 039231          447 RGTVGYIAPEVFCR-NIGEVSYKSDVYNYGMMIFEMTGGRKNVDVVDN  493 (506)
Q Consensus       447 ~gt~~y~aPE~l~~-~~~~~s~~~Dv~s~G~il~elltg~~pf~~~~~  493 (506)
                      .++..|+|||.+.. ..+.++.++||||||+++|||++|..||...+.
T Consensus       178 ~~~~~y~aPE~~~~~~~~~~~~~sDv~slGvil~el~~g~~p~~~~~~  225 (313)
T cd06633         178 VGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNA  225 (313)
T ss_pred             cccccccChhhccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCh
Confidence            67889999999843 224678899999999999999999999976543

Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a co

>cd08226 PK_STRAD_beta Pseudokinase domain of STE20-related kinase adapter protein beta

Probab=99.93  E-value=7.1e-26  Score=226.35  Aligned_cols=171  Identities=23%  Similarity=0.301  Sum_probs=133.1

Q ss_pred             ccCcc--CceEEEEEEEc-CCCEEEEEEeccCCCC---chhhHHHHHHhhccCccceeEEEEEee---------------
Q 039231          320 KLGQG--GYGSVYKGKLL-DGSNVAVKVLNDSKGN---GKEFINEVASISRTSHVNVVALLGFCL---------------  378 (506)
Q Consensus       320 ~ig~G--~~g~V~~~~~~-~~~~vavK~l~~~~~~---~~~~~~E~~~l~~l~h~niv~l~g~~~---------------  378 (506)
                      .||+|  +||+||+++.. +|+.||+|++......   .+.+.+|+.+++.++||||+++++++.               
T Consensus         5 ~ig~g~~~~~~v~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~~~~~~v~e~~~~~   84 (328)
T cd08226           5 EIGRGFCNLTSVYLARHTPTGTLVTVRITDLENCTEEHLKALQNEVVLSHFFRHPNIMTSWTVFTTGSWLWVISPFMAYG   84 (328)
T ss_pred             HhCCcccCceeEEEEEEcCCCcEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcceEeeeEecCCceEEEEecccCC
Confidence            46777  99999999874 6899999998754322   356788999999999999999998861               


Q ss_pred             --------------ccchhhhHHHHHHHHHHHHhhcCCCCeEecCcCCCcEEECCCCcEEEeecCCCccccCCCccee--
Q 039231          379 --------------RVAEELSSTIGIARGLEYLHLGCSTRILHFDIKPHNILLDEDFCPKISDFGLAKICNRKESIIS--  442 (506)
Q Consensus       379 --------------~~~~~l~i~~~i~~gl~~LH~~~~~~ivH~dlkp~Nill~~~~~~ki~dfg~a~~~~~~~~~~~--  442 (506)
                                    ++.....++.|++.||+|||   +.+++||||||+||++++++.+|++||+.+...........  
T Consensus        85 ~l~~~l~~~~~~~~~~~~~~~~~~qi~~aL~~lH---~~~ivHrDlkp~Nill~~~~~~~~~~~~~~~~~~~~~~~~~~~  161 (328)
T cd08226          85 SANSLLKTYFPEGMSEALIGNILFGALRGLNYLH---QNGYIHRNIKASHILISGDGLVSLSGLSHLYSLVRNGQKAKVV  161 (328)
T ss_pred             CHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEEeCCCcEEEechHHHhhhhccCcccccc
Confidence                          11223468899999999999   89999999999999999999999999986543322111000  


Q ss_pred             ---cccCCCCcccccccccccccCCCCccccHHHHHHHHHHHHcCCCCCCCCCC
Q 039231          443 ---MTGARGTVGYIAPEVFCRNIGEVSYKSDVYNYGMMIFEMTGGRKNVDVVDN  493 (506)
Q Consensus       443 ---~~~~~gt~~y~aPE~l~~~~~~~s~~~Dv~s~G~il~elltg~~pf~~~~~  493 (506)
                         .....++..|+|||++.+....++.++||||||+++|||++|+.||.....
T Consensus       162 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~  215 (328)
T cd08226         162 YDFPQFSTSVLPWLSPELLRQDLYGYNVKSDIYSVGITACELATGRVPFQDMLR  215 (328)
T ss_pred             ccccccccCccCccChhhhcCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCcCh
Confidence               011234667999999866434578999999999999999999999987654

Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpig

>cd05078 PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

Probab=99.93  E-value=2.1e-26  Score=222.06  Aligned_cols=164  Identities=24%  Similarity=0.414  Sum_probs=129.9

Q ss_pred             cccCccCceEEEEEEEcC--------CCEEEEEEeccCCC-CchhhHHHHHHhhccCccceeEEEEEee-----------
Q 039231          319 YKLGQGGYGSVYKGKLLD--------GSNVAVKVLNDSKG-NGKEFINEVASISRTSHVNVVALLGFCL-----------  378 (506)
Q Consensus       319 ~~ig~G~~g~V~~~~~~~--------~~~vavK~l~~~~~-~~~~~~~E~~~l~~l~h~niv~l~g~~~-----------  378 (506)
                      +.||+|+||.||+|....        ...+++|.+..... ..+++.+|+.+++.++||||+++++++.           
T Consensus         1 ~~lg~G~~~~Vy~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~   80 (258)
T cd05078           1 ESLGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKSHRNYSESFFEAASMMSQLSHKHLVLNYGVCVCGDESIMVQEY   80 (258)
T ss_pred             CCCCcccchhheeeeecccccccccccchhhHHhhcchhHHHHHHHHHHHHHHHhCCCCChhheeeEEEeCCCcEEEEec
Confidence            359999999999998642        23488888765432 3367889999999999999999998872           


Q ss_pred             -----------------ccchhhhHHHHHHHHHHHHhhcCCCCeEecCcCCCcEEECCCCc--------EEEeecCCCcc
Q 039231          379 -----------------RVAEELSSTIGIARGLEYLHLGCSTRILHFDIKPHNILLDEDFC--------PKISDFGLAKI  433 (506)
Q Consensus       379 -----------------~~~~~l~i~~~i~~gl~~LH~~~~~~ivH~dlkp~Nill~~~~~--------~ki~dfg~a~~  433 (506)
                                       ++...+.++.||+.||+|||   +++|+||||||+||+++.++.        +|++|||++..
T Consensus        81 ~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH---~~~iiH~dlkp~nili~~~~~~~~~~~~~~~l~d~g~~~~  157 (258)
T cd05078          81 VKFGSLDTYLKKNKNLINISWKLEVAKQLAWALHFLE---DKGLTHGNVCAKNVLLIREEDRKTGNPPFIKLSDPGISIT  157 (258)
T ss_pred             CCCCcHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCccceEEEecccccccCCCceEEecccccccc
Confidence                             22335668899999999999   899999999999999987765        69999998865


Q ss_pred             ccCCCcceecccCCCCcccccccccccccCCCCccccHHHHHHHHHHHHcCC-CCCCCCC
Q 039231          434 CNRKESIISMTGARGTVGYIAPEVFCRNIGEVSYKSDVYNYGMMIFEMTGGR-KNVDVVD  492 (506)
Q Consensus       434 ~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~s~~~Dv~s~G~il~elltg~-~pf~~~~  492 (506)
                      ....      ....++..|+|||.+.+. ..++.++||||||+++|||++|. .||...+
T Consensus       158 ~~~~------~~~~~~~~y~aPE~~~~~-~~~~~~~DiwslG~~l~~l~~g~~~~~~~~~  210 (258)
T cd05078         158 VLPK------EILLERIPWVPPECIENP-QNLSLAADKWSFGTTLWEIFSGGDKPLSALD  210 (258)
T ss_pred             cCCc------hhccccCCccCchhccCC-CCCCchhhHHHHHHHHHHHHcCCCCChhhcc
Confidence            4332      234568899999998643 35788999999999999999984 6665443

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity

>cd05046 PTK_CCK4 Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4

Probab=99.93  E-value=8.7e-26  Score=219.67  Aligned_cols=170  Identities=29%  Similarity=0.447  Sum_probs=136.2

Q ss_pred             ccccCccCceEEEEEEEc------CCCEEEEEEeccCCCC--chhhHHHHHHhhccCccceeEEEEEee-----------
Q 039231          318 KYKLGQGGYGSVYKGKLL------DGSNVAVKVLNDSKGN--GKEFINEVASISRTSHVNVVALLGFCL-----------  378 (506)
Q Consensus       318 ~~~ig~G~~g~V~~~~~~------~~~~vavK~l~~~~~~--~~~~~~E~~~l~~l~h~niv~l~g~~~-----------  378 (506)
                      .+.||+|+||.||+|+..      +.+.+++|.+......  .+++.+|++++++++|+||+++++++.           
T Consensus        10 ~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~   89 (275)
T cd05046          10 ITTLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTKDENLQSEFRRELDMFRKLSHKNVVRLLGLCREAEPHYMILEY   89 (275)
T ss_pred             eeeecccceeEEEEEEeccCCcCCCcceEEEEccCCccchHHHHHHHHHHHHHHhcCCcceeeeEEEECCCCcceEEEEe
Confidence            356999999999999864      2467999988654433  367899999999999999999998761           


Q ss_pred             -------------------------ccchhhhHHHHHHHHHHHHhhcCCCCeEecCcCCCcEEECCCCcEEEeecCCCcc
Q 039231          379 -------------------------RVAEELSSTIGIARGLEYLHLGCSTRILHFDIKPHNILLDEDFCPKISDFGLAKI  433 (506)
Q Consensus       379 -------------------------~~~~~l~i~~~i~~gl~~LH~~~~~~ivH~dlkp~Nill~~~~~~ki~dfg~a~~  433 (506)
                                               .+..++.++.|++.||+|||   +.+|+||||||+||++++++.++|+|||+++.
T Consensus        90 ~~~~~L~~~i~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH---~~~i~H~dlkp~Nili~~~~~~~l~~~~~~~~  166 (275)
T cd05046          90 TDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGMDHLS---NARFVHRDLAARNCLVSSQREVKVSLLSLSKD  166 (275)
T ss_pred             cCCCcHHHHHHhcccccccccccCCCHHHHHHHHHHHHHHHHHhh---hcCcccCcCccceEEEeCCCcEEEcccccccc
Confidence                                     12234668899999999999   89999999999999999999999999999875


Q ss_pred             ccCCCcceecccCCCCcccccccccccccCCCCccccHHHHHHHHHHHHc-CCCCCCCCCC
Q 039231          434 CNRKESIISMTGARGTVGYIAPEVFCRNIGEVSYKSDVYNYGMMIFEMTG-GRKNVDVVDN  493 (506)
Q Consensus       434 ~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~s~~~Dv~s~G~il~ellt-g~~pf~~~~~  493 (506)
                      ...... .......++..|+|||.+.+.  ..+.++||||||+++|||++ |..||....+
T Consensus       167 ~~~~~~-~~~~~~~~~~~y~~PE~~~~~--~~~~~~Di~slG~~l~~l~~~~~~p~~~~~~  224 (275)
T cd05046         167 VYNSEY-YKLRNALIPLRWLAPEAVQED--DFSTKSDVWSFGVLMWEVFTQGELPFYGLSD  224 (275)
T ss_pred             cCcccc-cccCCceeEEeecChhhhccC--CCCchhhHHHHHHHHHHHHhCCCCCccccch
Confidence            432221 112334557789999988543  67889999999999999998 8889965443

Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is s

>cd06657 STKc_PAK4 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4

Probab=99.93  E-value=1.2e-25  Score=221.03  Aligned_cols=167  Identities=28%  Similarity=0.396  Sum_probs=137.7

Q ss_pred             cccCccCceEEEEEEEc-CCCEEEEEEeccCCC-CchhhHHHHHHhhccCccceeEEEEEee------------------
Q 039231          319 YKLGQGGYGSVYKGKLL-DGSNVAVKVLNDSKG-NGKEFINEVASISRTSHVNVVALLGFCL------------------  378 (506)
Q Consensus       319 ~~ig~G~~g~V~~~~~~-~~~~vavK~l~~~~~-~~~~~~~E~~~l~~l~h~niv~l~g~~~------------------  378 (506)
                      .+||+|+||.||++... ++..+|||++..... ....+.+|+.++++++|+||+++++.+.                  
T Consensus        26 ~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~  105 (292)
T cd06657          26 IKIGEGSTGIVCIATVKSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLEGGALT  105 (292)
T ss_pred             HHcCCCCCeEEEEEEEcCCCeEEEEEEecccchhHHHHHHHHHHHHHhcCCcchhheeeEEEeCCEEEEEEecCCCCcHH
Confidence            46999999999999874 689999999864332 3356889999999999999999998761                  


Q ss_pred             --------ccchhhhHHHHHHHHHHHHhhcCCCCeEecCcCCCcEEECCCCcEEEeecCCCccccCCCcceecccCCCCc
Q 039231          379 --------RVAEELSSTIGIARGLEYLHLGCSTRILHFDIKPHNILLDEDFCPKISDFGLAKICNRKESIISMTGARGTV  450 (506)
Q Consensus       379 --------~~~~~l~i~~~i~~gl~~LH~~~~~~ivH~dlkp~Nill~~~~~~ki~dfg~a~~~~~~~~~~~~~~~~gt~  450 (506)
                              .+...+.++.|++.||+|||   +.+++|+||+|+||++++++.++|+|||++.........  .....++.
T Consensus       106 ~~~~~~~~~~~~~~~~~~ql~~~l~~lH---~~givH~dl~p~Nilv~~~~~~~l~dfg~~~~~~~~~~~--~~~~~~~~  180 (292)
T cd06657         106 DIVTHTRMNEEQIAAVCLAVLKALSVLH---AQGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPR--RKSLVGTP  180 (292)
T ss_pred             HHHhcCCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHEEECCCCCEEEcccccceeccccccc--ccccccCc
Confidence                    22335678899999999999   899999999999999999999999999998765433211  13356788


Q ss_pred             ccccccccccccCCCCccccHHHHHHHHHHHHcCCCCCCCCC
Q 039231          451 GYIAPEVFCRNIGEVSYKSDVYNYGMMIFEMTGGRKNVDVVD  492 (506)
Q Consensus       451 ~y~aPE~l~~~~~~~s~~~Dv~s~G~il~elltg~~pf~~~~  492 (506)
                      .|+|||.+.+  ..++.++|+||+|+++|||++|..||....
T Consensus       181 ~y~~pE~~~~--~~~~~~~Dv~slGvil~el~tg~~p~~~~~  220 (292)
T cd06657         181 YWMAPELISR--LPYGPEVDIWSLGIMVIEMVDGEPPYFNEP  220 (292)
T ss_pred             cccCHHHhcC--CCCCchhhHHHHHHHHHHHHhCCCCCCCCC
Confidence            9999998854  367889999999999999999999997543

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell mo

>KOG0612 consensus Rho-associated, coiled-coil containing protein kinase [Signal transduction mechanisms]

Probab=99.93  E-value=5.3e-27  Score=248.27  Aligned_cols=176  Identities=27%  Similarity=0.323  Sum_probs=141.9

Q ss_pred             ccccCccCceEEEEEEEcC-CCEEEEEEeccC----CCCchhhHHHHHHhhccCccceeEEE-------------EEe--
Q 039231          318 KYKLGQGGYGSVYKGKLLD-GSNVAVKVLNDS----KGNGKEFINEVASISRTSHVNVVALL-------------GFC--  377 (506)
Q Consensus       318 ~~~ig~G~~g~V~~~~~~~-~~~vavK~l~~~----~~~~~~~~~E~~~l~~l~h~niv~l~-------------g~~--  377 (506)
                      -++||+|+||.|..++.+. ++.+|+|++++.    .....-|.+|-.+|..-+.+-||.+.             +|.  
T Consensus        80 lKvIGrGaFGEV~lVr~k~t~~VYAMK~lnK~eMlKr~~tA~F~EERDimv~~ns~Wiv~LhyAFQD~~~LYlVMdY~pG  159 (1317)
T KOG0612|consen   80 LKVIGRGAFGEVALVRHKSTEKVYAMKILNKWEMLKRAETACFREERDIMVFGNSEWIVQLHYAFQDERYLYLVMDYMPG  159 (1317)
T ss_pred             HHHhcccccceeEEEEeeccccchhHHHhhHHHHhhchhHHHHHHHhHHHHcCCcHHHHHHHHHhcCccceEEEEecccC
Confidence            3679999999999999854 889999999762    33445677888888777666665543             332  


Q ss_pred             ------------eccchhhhHHHHHHHHHHHHhhcCCCCeEecCcCCCcEEECCCCcEEEeecCCCccccCCCcceeccc
Q 039231          378 ------------LRVAEELSSTIGIARGLEYLHLGCSTRILHFDIKPHNILLDEDFCPKISDFGLAKICNRKESIISMTG  445 (506)
Q Consensus       378 ------------~~~~~~l~i~~~i~~gl~~LH~~~~~~ivH~dlkp~Nill~~~~~~ki~dfg~a~~~~~~~~~~~~~~  445 (506)
                                  ++++.+..++..|+.||.-||   +.|+|||||||+|||||..|++||+|||.+..+..++... ...
T Consensus       160 GDlltLlSk~~~~pE~~ArFY~aEiVlAldslH---~mgyVHRDiKPDNvLld~~GHikLADFGsClkm~~dG~V~-s~~  235 (1317)
T KOG0612|consen  160 GDLLTLLSKFDRLPEDWARFYTAEIVLALDSLH---SMGYVHRDIKPDNVLLDKSGHIKLADFGSCLKMDADGTVR-SSV  235 (1317)
T ss_pred             chHHHHHhhcCCChHHHHHHHHHHHHHHHHHHH---hccceeccCCcceeEecccCcEeeccchhHHhcCCCCcEE-ecc
Confidence                        333445567789999999999   9999999999999999999999999999998888766544 367


Q ss_pred             CCCCccccccccccc--c-cCCCCccccHHHHHHHHHHHHcCCCCCCCCCCCcch
Q 039231          446 ARGTVGYIAPEVFCR--N-IGEVSYKSDVYNYGMMIFEMTGGRKNVDVVDNGSTA  497 (506)
Q Consensus       446 ~~gt~~y~aPE~l~~--~-~~~~s~~~Dv~s~G~il~elltg~~pf~~~~~~~~~  497 (506)
                      .+|||.|++||++..  . .+.|+...|+||+||++|||+.|..||-...--++.
T Consensus       236 aVGTPDYISPEvLqs~~~~~g~yG~ecDwWSlGV~~YEMlyG~TPFYadslveTY  290 (1317)
T KOG0612|consen  236 AVGTPDYISPEVLQSQGDGKGEYGRECDWWSLGVFMYEMLYGETPFYADSLVETY  290 (1317)
T ss_pred             ccCCCCccCHHHHHhhcCCccccCCccchhhhHHHHHHHHcCCCcchHHHHHHHH
Confidence            899999999999943  2 267999999999999999999999999765543333

>cd05611 STKc_Rim15_like Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases

Probab=99.93  E-value=1.7e-25  Score=215.68  Aligned_cols=165  Identities=28%  Similarity=0.334  Sum_probs=132.0

Q ss_pred             cccCccCceEEEEEEEc-CCCEEEEEEeccCCC----CchhhHHHHHH-hhccCccceeEEEEEee--------------
Q 039231          319 YKLGQGGYGSVYKGKLL-DGSNVAVKVLNDSKG----NGKEFINEVAS-ISRTSHVNVVALLGFCL--------------  378 (506)
Q Consensus       319 ~~ig~G~~g~V~~~~~~-~~~~vavK~l~~~~~----~~~~~~~E~~~-l~~l~h~niv~l~g~~~--------------  378 (506)
                      +.||+|++|.||+|+.. +++.||+|++.....    ....+..|... ....+|+|++++++.+.              
T Consensus         2 ~~l~~g~~~~v~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~   81 (260)
T cd05611           2 KPISKGAFGSVYLAKKRSTGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVAKLYYSFQSKDYLYLVMEYLNG   81 (260)
T ss_pred             ccCCcCCCeeEEEEEecCCCCeEEEEEecchhhhHHHHHHHHHHHHHHHhhcCCCCCeeeeeeeEEcCCeEEEEEeccCC
Confidence            35899999999999875 589999999865321    11334455444 44558999999997762              


Q ss_pred             -------------ccchhhhHHHHHHHHHHHHhhcCCCCeEecCcCCCcEEECCCCcEEEeecCCCccccCCCcceeccc
Q 039231          379 -------------RVAEELSSTIGIARGLEYLHLGCSTRILHFDIKPHNILLDEDFCPKISDFGLAKICNRKESIISMTG  445 (506)
Q Consensus       379 -------------~~~~~l~i~~~i~~gl~~LH~~~~~~ivH~dlkp~Nill~~~~~~ki~dfg~a~~~~~~~~~~~~~~  445 (506)
                                   +......++.|++.||.|||   +.+++|+||+|+||++++++.+||+|||+++.....      ..
T Consensus        82 ~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~lH---~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~------~~  152 (260)
T cd05611          82 GDCASLIKTLGGLPEDWAKQYIAEVVLGVEDLH---QRGIIHRDIKPENLLIDQTGHLKLTDFGLSRNGLEN------KK  152 (260)
T ss_pred             CCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHeEECCCCcEEEeecccceecccc------cc
Confidence                         22335678999999999999   899999999999999999999999999998754331      23


Q ss_pred             CCCCcccccccccccccCCCCccccHHHHHHHHHHHHcCCCCCCCCCCC
Q 039231          446 ARGTVGYIAPEVFCRNIGEVSYKSDVYNYGMMIFEMTGGRKNVDVVDNG  494 (506)
Q Consensus       446 ~~gt~~y~aPE~l~~~~~~~s~~~Dv~s~G~il~elltg~~pf~~~~~~  494 (506)
                      ..++..|+|||.+.+.  .++.++||||||+++|||++|..||...+..
T Consensus       153 ~~~~~~y~~pe~~~~~--~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~  199 (260)
T cd05611         153 FVGTPDYLAPETILGV--GDDKMSDWWSLGCVIFEFLFGYPPFHAETPD  199 (260)
T ss_pred             CCCCcCccChhhhcCC--CCcchhhhHHHHHHHHHHHHCCCCCCCCCHH
Confidence            4578899999998654  5789999999999999999999999765543

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a do

>cd07854 STKc_MAPK4_6 Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6

Probab=99.93  E-value=6.9e-26  Score=227.78  Aligned_cols=173  Identities=28%  Similarity=0.365  Sum_probs=137.0

Q ss_pred             hccccCccCceEEEEEEEc-CCCEEEEEEeccCCC-CchhhHHHHHHhhccCccceeEEEEEe-----------------
Q 039231          317 FKYKLGQGGYGSVYKGKLL-DGSNVAVKVLNDSKG-NGKEFINEVASISRTSHVNVVALLGFC-----------------  377 (506)
Q Consensus       317 ~~~~ig~G~~g~V~~~~~~-~~~~vavK~l~~~~~-~~~~~~~E~~~l~~l~h~niv~l~g~~-----------------  377 (506)
                      +.+.||.|+||.||+|+.. +++.||+|++..... ..+.+.+|++++++++||||+++++++                 
T Consensus         9 ~~~~Lg~g~~g~vy~~~~~~~~~~v~iK~i~~~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~~~~~~   88 (342)
T cd07854           9 DLRPLGCGSNGLVFSAVDSDCDKRVAVKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVYEVLGPSGSDLTEDVGSLTEL   88 (342)
T ss_pred             EEEEecCCCCEEEEEEEECCCCcEEEEEEEecCCCchHHHHHHHHHHHHhcCCCcchhhHhhhccccccccccccccccc
Confidence            3467999999999999875 489999999865433 346788999999999999999887421                 


Q ss_pred             ----------------------eccchhhhHHHHHHHHHHHHhhcCCCCeEecCcCCCcEEEC-CCCcEEEeecCCCccc
Q 039231          378 ----------------------LRVAEELSSTIGIARGLEYLHLGCSTRILHFDIKPHNILLD-EDFCPKISDFGLAKIC  434 (506)
Q Consensus       378 ----------------------~~~~~~l~i~~~i~~gl~~LH~~~~~~ivH~dlkp~Nill~-~~~~~ki~dfg~a~~~  434 (506)
                                            +.+...+.++.|+++||+|||   +.+++||||||+||+++ +++.+||+|||.++..
T Consensus        89 ~~~~lv~e~~~~~L~~~~~~~~l~~~~~~~~~~qi~~aL~~LH---~~givH~dikp~Nili~~~~~~~kl~dfg~~~~~  165 (342)
T cd07854          89 NSVYIVQEYMETDLANVLEQGPLSEEHARLFMYQLLRGLKYIH---SANVLHRDLKPANVFINTEDLVLKIGDFGLARIV  165 (342)
T ss_pred             ceEEEEeecccccHHHHHHcCCCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCCHHHEEEcCCCceEEECCcccceec
Confidence                                  223345678899999999999   89999999999999997 4567899999999765


Q ss_pred             cCCCcce-ecccCCCCcccccccccccccCCCCccccHHHHHHHHHHHHcCCCCCCCCCC
Q 039231          435 NRKESII-SMTGARGTVGYIAPEVFCRNIGEVSYKSDVYNYGMMIFEMTGGRKNVDVVDN  493 (506)
Q Consensus       435 ~~~~~~~-~~~~~~gt~~y~aPE~l~~~~~~~s~~~Dv~s~G~il~elltg~~pf~~~~~  493 (506)
                      ....... ......++..|+|||.+.+. ..++.++||||||+++|||++|+.||...++
T Consensus       166 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~~DiwSlGvil~el~~g~~pf~~~~~  224 (342)
T cd07854         166 DPHYSHKGYLSEGLVTKWYRSPRLLLSP-NNYTKAIDMWAAGCIFAEMLTGKPLFAGAHE  224 (342)
T ss_pred             CCccccccccccccccccccCHHHHhCc-cccCchhhHHHHHHHHHHHHhCCCCCCCCCH
Confidence            3321111 11224578899999987542 3578899999999999999999999976543

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progressi

>cd06606 STKc_MAPKKK Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase

Probab=99.93  E-value=2e-25  Score=214.20  Aligned_cols=170  Identities=33%  Similarity=0.399  Sum_probs=143.2

Q ss_pred             ccccCccCceEEEEEEEc-CCCEEEEEEeccCC---CCchhhHHHHHHhhccCccceeEEEEEeecc-------------
Q 039231          318 KYKLGQGGYGSVYKGKLL-DGSNVAVKVLNDSK---GNGKEFINEVASISRTSHVNVVALLGFCLRV-------------  380 (506)
Q Consensus       318 ~~~ig~G~~g~V~~~~~~-~~~~vavK~l~~~~---~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~-------------  380 (506)
                      .+.||+|++|.||+|... +++.+++|++....   ...+.+.+|++.+++++|+||+++++.+...             
T Consensus         5 ~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~e~~~   84 (260)
T cd06606           5 GELLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQHPNIVRYYGSERDEEKNTLNIFLEYVS   84 (260)
T ss_pred             eeEeeecCceEEEEEEECCCCcEEEEEEeeccccchHHHHHHHHHHHHHHHcCCCCEeeEEEEEecCCCCeEEEEEEecC
Confidence            467999999999999986 58999999987654   3457789999999999999999998766332             


Q ss_pred             ----------------chhhhHHHHHHHHHHHHhhcCCCCeEecCcCCCcEEECCCCcEEEeecCCCccccCCCcceecc
Q 039231          381 ----------------AEELSSTIGIARGLEYLHLGCSTRILHFDIKPHNILLDEDFCPKISDFGLAKICNRKESIISMT  444 (506)
Q Consensus       381 ----------------~~~l~i~~~i~~gl~~LH~~~~~~ivH~dlkp~Nill~~~~~~ki~dfg~a~~~~~~~~~~~~~  444 (506)
                                      .+++.++.|++.||+|||   +.+++|+||+|+||+++.++.+||+|||.+.............
T Consensus        85 ~~~L~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh---~~~~~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~~~~~~  161 (260)
T cd06606          85 GGSLSSLLKKFGKLPEPVIRKYTRQILEGLAYLH---SNGIVHRDIKGANILVDSDGVVKLADFGCAKRLGDIETGEGTG  161 (260)
T ss_pred             CCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHH---HCCccccCCCHHHEEEcCCCCEEEcccccEEeccccccccccc
Confidence                            235678999999999999   8999999999999999999999999999998776554311123


Q ss_pred             cCCCCcccccccccccccCCCCccccHHHHHHHHHHHHcCCCCCCCCC
Q 039231          445 GARGTVGYIAPEVFCRNIGEVSYKSDVYNYGMMIFEMTGGRKNVDVVD  492 (506)
Q Consensus       445 ~~~gt~~y~aPE~l~~~~~~~s~~~Dv~s~G~il~elltg~~pf~~~~  492 (506)
                      ...++..|+|||.+...  ..+.++||||||+++++|++|..||...+
T Consensus       162 ~~~~~~~y~~pE~~~~~--~~~~~~Dv~slG~il~~l~~g~~p~~~~~  207 (260)
T cd06606         162 SVRGTPYWMAPEVIRGE--EYGRAADIWSLGCTVIEMATGKPPWSELG  207 (260)
T ss_pred             CCCCCccccCHhhhcCC--CCCchhhHHHHHHHHHHHHhCCCCCCCCC
Confidence            45678899999998554  58899999999999999999999998765

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKK

>cd07834 STKc_MAPK Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase

Probab=99.93  E-value=7.2e-26  Score=226.43  Aligned_cols=175  Identities=27%  Similarity=0.362  Sum_probs=143.1

Q ss_pred             hhccccCccCceEEEEEEEcC-CCEEEEEEeccCC---CCchhhHHHHHHhhccCccceeEEEEEeec------------
Q 039231          316 SFKYKLGQGGYGSVYKGKLLD-GSNVAVKVLNDSK---GNGKEFINEVASISRTSHVNVVALLGFCLR------------  379 (506)
Q Consensus       316 ~~~~~ig~G~~g~V~~~~~~~-~~~vavK~l~~~~---~~~~~~~~E~~~l~~l~h~niv~l~g~~~~------------  379 (506)
                      .+.+.||+|++|.||+|+..+ ++.+|||++....   ...+.+.+|+++++.++|+||+++.+++..            
T Consensus         3 ~i~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~lv   82 (330)
T cd07834           3 ELLKPIGSGAYGVVCSAVDKRTGRKVAIKKISNVFDDLIDAKRILREIKLLRHLRHENIIGLLDILRPPSPEDFNDVYIV   82 (330)
T ss_pred             eeeeeecCCCCeEEEEEEeCCCCcEEEEEeeccccccchhhhhHHHHHHHHHhcCCcchhhhhhhhcccCcccccceEEE
Confidence            345679999999999999754 8999999987532   334678999999999999999999875422            


Q ss_pred             -------------------cchhhhHHHHHHHHHHHHhhcCCCCeEecCcCCCcEEECCCCcEEEeecCCCccccCCCcc
Q 039231          380 -------------------VAEELSSTIGIARGLEYLHLGCSTRILHFDIKPHNILLDEDFCPKISDFGLAKICNRKESI  440 (506)
Q Consensus       380 -------------------~~~~l~i~~~i~~gl~~LH~~~~~~ivH~dlkp~Nill~~~~~~ki~dfg~a~~~~~~~~~  440 (506)
                                         +...+.++.|++.||+|||   +.+++|+||||+||++++++.++|+|||++.........
T Consensus        83 ~e~~~~~l~~~l~~~~~l~~~~~~~i~~~l~~~l~~LH---~~gi~H~dlkp~nili~~~~~~~L~dfg~~~~~~~~~~~  159 (330)
T cd07834          83 TELMETDLHKVIKSPQPLTDDHIQYFLYQILRGLKYLH---SANVIHRDLKPSNILVNSNCDLKICDFGLARGVDPDEDE  159 (330)
T ss_pred             ecchhhhHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEEcCCCCEEEcccCceEeecccccc
Confidence                               2234568899999999999   899999999999999999999999999999876544310


Q ss_pred             -eecccCCCCcccccccccccccCCCCccccHHHHHHHHHHHHcCCCCCCCCCCC
Q 039231          441 -ISMTGARGTVGYIAPEVFCRNIGEVSYKSDVYNYGMMIFEMTGGRKNVDVVDNG  494 (506)
Q Consensus       441 -~~~~~~~gt~~y~aPE~l~~~~~~~s~~~Dv~s~G~il~elltg~~pf~~~~~~  494 (506)
                       .......++..|+|||.+.+. ..++.++|+||||+++|+|++|+.||...+..
T Consensus       160 ~~~~~~~~~~~~y~aPE~~~~~-~~~~~~sDi~slG~il~~l~~g~~pf~~~~~~  213 (330)
T cd07834         160 KGFLTEYVVTRWYRAPELLLSS-SRYTKAIDIWSVGCIFAELLTRKPLFPGRDYI  213 (330)
T ss_pred             cccccccccccCcCCceeeecc-cCCCcchhHHHHHHHHHHHHcCCCCcCCCCHH
Confidence             112345678899999998654 26888999999999999999999999876543

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and

>cd07830 STKc_MAK_like Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases

Probab=99.93  E-value=8.8e-26  Score=220.51  Aligned_cols=171  Identities=28%  Similarity=0.357  Sum_probs=139.4

Q ss_pred             hccccCccCceEEEEEEEcC-CCEEEEEEeccCCCC--chhhHHHHHHhhccC-ccceeEEEEEe---------------
Q 039231          317 FKYKLGQGGYGSVYKGKLLD-GSNVAVKVLNDSKGN--GKEFINEVASISRTS-HVNVVALLGFC---------------  377 (506)
Q Consensus       317 ~~~~ig~G~~g~V~~~~~~~-~~~vavK~l~~~~~~--~~~~~~E~~~l~~l~-h~niv~l~g~~---------------  377 (506)
                      +.+.||+|++|.||+|+..+ ++.++||++......  .....+|+..+.+++ |+||+++++++               
T Consensus         3 ~~~~ig~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~   82 (283)
T cd07830           3 VIKQLGDGTFGSVYLARNKETGELVAIKKMKKKFYSWEECMNLREVKSLRKLNEHPNIVKLKEVFRENDELYFVFEYMEG   82 (283)
T ss_pred             eheeeccCCceEEEEEEECCCCcEEEEEEehhhccchhHHHHHHHHHHHHhccCCCCchhHHHHhhcCCcEEEEEecCCC
Confidence            45679999999999999864 788999998754332  234567999999999 99999988665               


Q ss_pred             -------------eccchhhhHHHHHHHHHHHHhhcCCCCeEecCcCCCcEEECCCCcEEEeecCCCccccCCCcceecc
Q 039231          378 -------------LRVAEELSSTIGIARGLEYLHLGCSTRILHFDIKPHNILLDEDFCPKISDFGLAKICNRKESIISMT  444 (506)
Q Consensus       378 -------------~~~~~~l~i~~~i~~gl~~LH~~~~~~ivH~dlkp~Nill~~~~~~ki~dfg~a~~~~~~~~~~~~~  444 (506)
                                   +.+.+.+.++.|++.+|.|||   +.+++|+||+|+||++++++.++|+|||+++.......   ..
T Consensus        83 ~l~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~Lh---~~~i~H~dl~~~ni~i~~~~~~~l~d~~~~~~~~~~~~---~~  156 (283)
T cd07830          83 NLYQLMKDRKGKPFSESVIRSIIYQILQGLAHIH---KHGFFHRDLKPENLLVSGPEVVKIADFGLAREIRSRPP---YT  156 (283)
T ss_pred             CHHHHHHhcccccCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCChhhEEEcCCCCEEEeecccceeccCCCC---cC
Confidence                         123345678899999999999   89999999999999999999999999999986644322   13


Q ss_pred             cCCCCcccccccccccccCCCCccccHHHHHHHHHHHHcCCCCCCCCCCC
Q 039231          445 GARGTVGYIAPEVFCRNIGEVSYKSDVYNYGMMIFEMTGGRKNVDVVDNG  494 (506)
Q Consensus       445 ~~~gt~~y~aPE~l~~~~~~~s~~~Dv~s~G~il~elltg~~pf~~~~~~  494 (506)
                      ...++..|+|||.+.+. ..++.++|+||||++++||++|+.||......
T Consensus       157 ~~~~~~~~~aPE~~~~~-~~~~~~~Di~s~G~~l~el~~g~~~~~~~~~~  205 (283)
T cd07830         157 DYVSTRWYRAPEILLRS-TSYSSPVDIWALGCIMAELYTLRPLFPGSSEI  205 (283)
T ss_pred             CCCCcccccCceeeecC-cCcCCccchhhHHHHHHHHHhCCCccCCCChH
Confidence            34578899999988543 45789999999999999999999999766543

Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertili

>cd08225 STKc_Nek5 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5

Probab=99.93  E-value=7.8e-26  Score=217.46  Aligned_cols=170  Identities=25%  Similarity=0.434  Sum_probs=139.2

Q ss_pred             hccccCccCceEEEEEEEc-CCCEEEEEEeccC---CCCchhhHHHHHHhhccCccceeEEEEEe---------------
Q 039231          317 FKYKLGQGGYGSVYKGKLL-DGSNVAVKVLNDS---KGNGKEFINEVASISRTSHVNVVALLGFC---------------  377 (506)
Q Consensus       317 ~~~~ig~G~~g~V~~~~~~-~~~~vavK~l~~~---~~~~~~~~~E~~~l~~l~h~niv~l~g~~---------------  377 (506)
                      +.+.||+|+||.||+|..+ +|..+|+|.+...   ....+.+.+|++++++++|+||+++++.+               
T Consensus         4 ~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~   83 (257)
T cd08225           4 IIKKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPVKEKEASKKEVILLAKMKHPNIVTFFASFQENGRLFIVMEYCDG   83 (257)
T ss_pred             EEEEecCCCcceEEEEEEcCCCceEEEEEeeHhhccchhhHHHHHHHHHHHhCCCCChhhhhheeccCCeEEEEEecCCC
Confidence            4567999999999999975 4889999998653   23346788999999999999999998775               


Q ss_pred             --------------eccchhhhHHHHHHHHHHHHhhcCCCCeEecCcCCCcEEECCCC-cEEEeecCCCccccCCCccee
Q 039231          378 --------------LRVAEELSSTIGIARGLEYLHLGCSTRILHFDIKPHNILLDEDF-CPKISDFGLAKICNRKESIIS  442 (506)
Q Consensus       378 --------------~~~~~~l~i~~~i~~gl~~LH~~~~~~ivH~dlkp~Nill~~~~-~~ki~dfg~a~~~~~~~~~~~  442 (506)
                                    +++...+.++.|++.||+|||   +.+++|+||+|+||++++++ .+||+|||.+.........  
T Consensus        84 ~~L~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh---~~~i~H~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~~~~--  158 (257)
T cd08225          84 GDLMKRINRQRGVLFSEDQILSWFVQISLGLKHIH---DRKILHRDIKSQNIFLSKNGMVAKLGDFGIARQLNDSMEL--  158 (257)
T ss_pred             CcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHH---HCCcccccCCHHHEEEcCCCCeEEecccccchhccCCccc--
Confidence                          123346678899999999999   89999999999999998875 5699999999876543321  


Q ss_pred             cccCCCCcccccccccccccCCCCccccHHHHHHHHHHHHcCCCCCCCCCC
Q 039231          443 MTGARGTVGYIAPEVFCRNIGEVSYKSDVYNYGMMIFEMTGGRKNVDVVDN  493 (506)
Q Consensus       443 ~~~~~gt~~y~aPE~l~~~~~~~s~~~Dv~s~G~il~elltg~~pf~~~~~  493 (506)
                      .....+++.|+|||.+...  .++.++|+||||+++|||++|+.||...+.
T Consensus       159 ~~~~~~~~~~~ape~~~~~--~~~~~~Dv~slG~il~~l~~g~~p~~~~~~  207 (257)
T cd08225         159 AYTCVGTPYYLSPEICQNR--PYNNKTDIWSLGCVLYELCTLKHPFEGNNL  207 (257)
T ss_pred             ccccCCCccccCHHHHcCC--CCCchhhHHHHHHHHHHHHhCCCCCCCccH
Confidence            1234688899999988543  688999999999999999999999976543

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown.

>cd05118 STKc_CMGC Catalytic domain of CMGC family Serine/Threonine Kinases

Probab=99.93  E-value=9.7e-26  Score=220.03  Aligned_cols=170  Identities=29%  Similarity=0.382  Sum_probs=140.8

Q ss_pred             ccccCccCceEEEEEEEc-CCCEEEEEEeccCCCC---chhhHHHHHHhhccCccceeEEEEEe----------------
Q 039231          318 KYKLGQGGYGSVYKGKLL-DGSNVAVKVLNDSKGN---GKEFINEVASISRTSHVNVVALLGFC----------------  377 (506)
Q Consensus       318 ~~~ig~G~~g~V~~~~~~-~~~~vavK~l~~~~~~---~~~~~~E~~~l~~l~h~niv~l~g~~----------------  377 (506)
                      .+.||+|++|.||+|... +++.+++|+++.....   ...+.+|++++++++|+||+++++++                
T Consensus         4 ~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~~   83 (283)
T cd05118           4 LGKIGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTALREIKLLKELNHPNIIKLLDVFRHKGDLYLVFEFMDTD   83 (283)
T ss_pred             ceeeecCCCceEEEEEcCCCCcEEEEEEeccccccchhHHHHHHHHHHHHHhcCCCcchHHHhhccCCCEEEEEeccCCC
Confidence            356999999999999875 5889999998754322   36788899999999999999998765                


Q ss_pred             -----------eccchhhhHHHHHHHHHHHHhhcCCCCeEecCcCCCcEEECCCCcEEEeecCCCccccCCCcceecccC
Q 039231          378 -----------LRVAEELSSTIGIARGLEYLHLGCSTRILHFDIKPHNILLDEDFCPKISDFGLAKICNRKESIISMTGA  446 (506)
Q Consensus       378 -----------~~~~~~l~i~~~i~~gl~~LH~~~~~~ivH~dlkp~Nill~~~~~~ki~dfg~a~~~~~~~~~~~~~~~  446 (506)
                                 +++.+++.++.|++.||+|||   +.+++|+||+|+||++++++.+||+|||.+........  .....
T Consensus        84 l~~~l~~~~~~~~~~~~~~~~~~i~~~l~~LH---~~~i~H~dl~p~nili~~~~~~~l~df~~~~~~~~~~~--~~~~~  158 (283)
T cd05118          84 LYKLIKDRQRGLPESLIKSYLYQLLQGLAFCH---SHGILHRDLKPENLLINTEGVLKLADFGLARSFGSPVR--PYTHY  158 (283)
T ss_pred             HHHHHHhhcccCCHHHHHHHHHHHHHHHHHHH---HCCeeecCcCHHHEEECCCCcEEEeeeeeeEecCCCcc--cccCc
Confidence                       223345678999999999999   89999999999999999999999999999987655431  12334


Q ss_pred             CCCcccccccccccccCCCCccccHHHHHHHHHHHHcCCCCCCCCCC
Q 039231          447 RGTVGYIAPEVFCRNIGEVSYKSDVYNYGMMIFEMTGGRKNVDVVDN  493 (506)
Q Consensus       447 ~gt~~y~aPE~l~~~~~~~s~~~Dv~s~G~il~elltg~~pf~~~~~  493 (506)
                      .++..|+|||.+.+. ..++.++|+||||+++|+|++|+.||...+.
T Consensus       159 ~~~~~~~~PE~~~~~-~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~  204 (283)
T cd05118         159 VVTRWYRAPELLLGD-KGYSTPVDIWSVGCIFAELLSRRPLFPGKSE  204 (283)
T ss_pred             cCcccccCcHHHhcC-CCCCchhHHHHHHHHHHHHHhCCCCCCCCCH
Confidence            578889999998553 3678999999999999999999999976654

Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They

>cd06627 STKc_Cdc7_like Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases

Probab=99.93  E-value=2.7e-25  Score=213.08  Aligned_cols=170  Identities=29%  Similarity=0.414  Sum_probs=142.1

Q ss_pred             hccccCccCceEEEEEEEc-CCCEEEEEEeccCCC---CchhhHHHHHHhhccCccceeEEEEEe---------------
Q 039231          317 FKYKLGQGGYGSVYKGKLL-DGSNVAVKVLNDSKG---NGKEFINEVASISRTSHVNVVALLGFC---------------  377 (506)
Q Consensus       317 ~~~~ig~G~~g~V~~~~~~-~~~~vavK~l~~~~~---~~~~~~~E~~~l~~l~h~niv~l~g~~---------------  377 (506)
                      +.+.||+|++|.||+|+.. +++.+++|.+.....   ..+.+.+|++++++++|+|++++++++               
T Consensus         4 ~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~   83 (254)
T cd06627           4 LGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPNIVKYIGSIETSDSLYIILEYAEN   83 (254)
T ss_pred             eeeEEcccCCeEEEEEEEcCCCcEEEEEEecccccCHHHHHHHHHHHHHHHhCCCCCccEEEEEEEeCCEEEEEEecCCC
Confidence            4567999999999999875 578999999976543   346789999999999999999998866               


Q ss_pred             ------------eccchhhhHHHHHHHHHHHHhhcCCCCeEecCcCCCcEEECCCCcEEEeecCCCccccCCCcceeccc
Q 039231          378 ------------LRVAEELSSTIGIARGLEYLHLGCSTRILHFDIKPHNILLDEDFCPKISDFGLAKICNRKESIISMTG  445 (506)
Q Consensus       378 ------------~~~~~~l~i~~~i~~gl~~LH~~~~~~ivH~dlkp~Nill~~~~~~ki~dfg~a~~~~~~~~~~~~~~  445 (506)
                                  +++...+.++.|++.||.|||   +.+++|+||+|+||+++.++.+||+|||.+.........  ...
T Consensus        84 ~~L~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH---~~~i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~~--~~~  158 (254)
T cd06627          84 GSLRQIIKKFGPFPESLVAVYVYQVLQGLAYLH---EQGVIHRDIKAANILTTKDGVVKLADFGVATKLNDVSKD--DAS  158 (254)
T ss_pred             CcHHHHHHhccCCCHHHHHHHHHHHHHHHHHHh---hCCcccCCCCHHHEEECCCCCEEEeccccceecCCCccc--ccc
Confidence                        223335678999999999999   899999999999999999999999999999876544321  133


Q ss_pred             CCCCcccccccccccccCCCCccccHHHHHHHHHHHHcCCCCCCCCCC
Q 039231          446 ARGTVGYIAPEVFCRNIGEVSYKSDVYNYGMMIFEMTGGRKNVDVVDN  493 (506)
Q Consensus       446 ~~gt~~y~aPE~l~~~~~~~s~~~Dv~s~G~il~elltg~~pf~~~~~  493 (506)
                      ..++..|+|||.+.+.  .++.++||||+|+++|||++|+.||...+.
T Consensus       159 ~~~~~~y~~pe~~~~~--~~~~~~Dv~~lG~~l~~l~~g~~p~~~~~~  204 (254)
T cd06627         159 VVGTPYWMAPEVIEMS--GASTASDIWSLGCTVIELLTGNPPYYDLNP  204 (254)
T ss_pred             cccchhhcCHhhhcCC--CCCcchhHHHHHHHHHHHHhCCCCCCCccH
Confidence            5678899999998554  578899999999999999999999976543

Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast

>cd08216 PK_STRAD Pseudokinase domain of STE20-related kinase adapter protein

Probab=99.93  E-value=1.6e-25  Score=222.28  Aligned_cols=169  Identities=20%  Similarity=0.220  Sum_probs=130.9

Q ss_pred             cCccCceEEEEEEEcCCCEEEEEEeccC---CCCchhhHHHHHHhhccCccceeEEEEEee-------------------
Q 039231          321 LGQGGYGSVYKGKLLDGSNVAVKVLNDS---KGNGKEFINEVASISRTSHVNVVALLGFCL-------------------  378 (506)
Q Consensus       321 ig~G~~g~V~~~~~~~~~~vavK~l~~~---~~~~~~~~~E~~~l~~l~h~niv~l~g~~~-------------------  378 (506)
                      +|.|+++.|++++. +++.+|||+++..   ....+.+.+|++.+++++|+||+++++++.                   
T Consensus        10 ~~~~~~v~~~~~~~-~~~~~avK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~e~~~~~~l~~   88 (314)
T cd08216          10 FEDLMIVHLAKHKP-TNTLVAVKKINLDSCSKEDLKLLQQEIITSRQLQHPNILPYVTSFIVDSELYVVSPLMAYGSCED   88 (314)
T ss_pred             hcCCceEEEEEecC-CCCEEEEEEEeccccchhHHHHHHHHHHHHHhcCCcchhhhhheeecCCeEEEEEeccCCCCHHH
Confidence            44445545555444 6899999998754   233467899999999999999999987662                   


Q ss_pred             ----------ccchhhhHHHHHHHHHHHHhhcCCCCeEecCcCCCcEEECCCCcEEEeecCCCccccCCCc-----ceec
Q 039231          379 ----------RVAEELSSTIGIARGLEYLHLGCSTRILHFDIKPHNILLDEDFCPKISDFGLAKICNRKES-----IISM  443 (506)
Q Consensus       379 ----------~~~~~l~i~~~i~~gl~~LH~~~~~~ivH~dlkp~Nill~~~~~~ki~dfg~a~~~~~~~~-----~~~~  443 (506)
                                +......++.|+++||+|||   +.+|+||||||+||+++.++.+||+|||.+........     ....
T Consensus        89 ~l~~~~~~~~~~~~~~~~~~~l~~~L~~LH---~~~ivH~dlk~~Nili~~~~~~kl~d~~~~~~~~~~~~~~~~~~~~~  165 (314)
T cd08216          89 LLKTHFPEGLPELAIAFILKDVLNALDYIH---SKGFIHRSVKASHILLSGDGKVVLSGLRYSVSMIKHGKRQRVVHDFP  165 (314)
T ss_pred             HHHHhcccCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCcceEEEecCCceEEecCccceeecccccccccccccc
Confidence                      12234568899999999999   89999999999999999999999999998865532211     0011


Q ss_pred             ccCCCCcccccccccccccCCCCccccHHHHHHHHHHHHcCCCCCCCCCC
Q 039231          444 TGARGTVGYIAPEVFCRNIGEVSYKSDVYNYGMMIFEMTGGRKNVDVVDN  493 (506)
Q Consensus       444 ~~~~gt~~y~aPE~l~~~~~~~s~~~Dv~s~G~il~elltg~~pf~~~~~  493 (506)
                      ....++..|+|||.+......++.++||||||+++|||++|+.||.....
T Consensus       166 ~~~~~~~~y~aPE~~~~~~~~~~~~~Diws~G~il~el~~g~~pf~~~~~  215 (314)
T cd08216         166 KSSVKNLPWLSPEVLQQNLQGYNEKSDIYSVGITACELANGHVPFKDMPA  215 (314)
T ss_pred             ccccccccccCHHHhcCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCH
Confidence            23456788999999865434578899999999999999999999986543

Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buc

>KOG0608 consensus Warts/lats-like serine threonine kinases [Cell cycle control, cell division, chromosome partitioning]

Probab=99.93  E-value=4.5e-26  Score=227.62  Aligned_cols=181  Identities=25%  Similarity=0.297  Sum_probs=145.4

Q ss_pred             cccCccCceEEEEEEE-cCCCEEEEEEeccCC----CCchhhHHHHHHhhccCccceeEEEEEee---------------
Q 039231          319 YKLGQGGYGSVYKGKL-LDGSNVAVKVLNDSK----GNGKEFINEVASISRTSHVNVVALLGFCL---------------  378 (506)
Q Consensus       319 ~~ig~G~~g~V~~~~~-~~~~~vavK~l~~~~----~~~~~~~~E~~~l~~l~h~niv~l~g~~~---------------  378 (506)
                      +.||-|+||.|.+++- +....+|+|.|.+..    .+...++.|-.+|...+.+-||+|+--+.               
T Consensus       635 k~iGvGAFGeV~Lv~KvDT~~lYAmKTLrKaDVl~rnQvaHVKAERDILAEADn~WVVrLyySFQDkdnLYFVMdYIPGG  714 (1034)
T KOG0608|consen  635 KTIGVGAFGEVCLVRKVDTRALYAMKTLRKADVLMRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLYFVMDYIPGG  714 (1034)
T ss_pred             eeecccccceeEEEeecchhhHHHHhhhHHHHHHhhhhhhhhhhhhhhHhhcCCcceEEEEEEeccCCceEEEEeccCCc
Confidence            3599999999999974 447789999997532    34456889999999999999999986552               


Q ss_pred             ------------ccchhhhHHHHHHHHHHHHhhcCCCCeEecCcCCCcEEECCCCcEEEeecCCCcccc---------CC
Q 039231          379 ------------RVAEELSSTIGIARGLEYLHLGCSTRILHFDIKPHNILLDEDFCPKISDFGLAKICN---------RK  437 (506)
Q Consensus       379 ------------~~~~~l~i~~~i~~gl~~LH~~~~~~ivH~dlkp~Nill~~~~~~ki~dfg~a~~~~---------~~  437 (506)
                                  +++-+..++..+..|+++.|   +.|+|||||||+|||||.+|++||.|||++.-+.         .+
T Consensus       715 DmMSLLIrmgIFeE~LARFYIAEltcAiesVH---kmGFIHRDiKPDNILIDrdGHIKLTDFGLCTGfRWTHdskYYq~g  791 (1034)
T KOG0608|consen  715 DMMSLLIRMGIFEEDLARFYIAELTCAIESVH---KMGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYYQEG  791 (1034)
T ss_pred             cHHHHHHHhccCHHHHHHHHHHHHHHHHHHHH---hccceecccCccceEEccCCceeeeeccccccceeccccccccCC
Confidence                        22223446678999999999   9999999999999999999999999999984321         10


Q ss_pred             Ccce-------------------------------ecccCCCCcccccccccccccCCCCccccHHHHHHHHHHHHcCCC
Q 039231          438 ESII-------------------------------SMTGARGTVGYIAPEVFCRNIGEVSYKSDVYNYGMMIFEMTGGRK  486 (506)
Q Consensus       438 ~~~~-------------------------------~~~~~~gt~~y~aPE~l~~~~~~~s~~~Dv~s~G~il~elltg~~  486 (506)
                      +...                               ..-..+||+.|+|||++.+.  .++...|+||.|||||||+.|+.
T Consensus       792 dH~RqDSmep~~e~~d~~~~lkvL~~ra~~~h~r~~ahslvgt~nyiapevl~r~--g~~q~cdwws~gvil~em~~g~~  869 (1034)
T KOG0608|consen  792 DHHRQDSMEPSPEWADISKCLKVLERRAMRQHQRILAHSLVGTPNYIAPEVLART--GYTQLCDWWSVGVILYEMLVGQP  869 (1034)
T ss_pred             CccccccCCCchhhccccccchHHHHHHHhhhhhhhhhhhcCCCcccChHHhccc--CccccchhhHhhHHHHHHhhCCC
Confidence            0000                               00123499999999999765  68999999999999999999999


Q ss_pred             CCCCCCCCcchhhhhhhc
Q 039231          487 NVDVVDNGSTALDLQASR  504 (506)
Q Consensus       487 pf~~~~~~~~~~~~~~~~  504 (506)
                      ||-.....+.+..++.++
T Consensus       870 pf~~~tp~~tq~kv~nw~  887 (1034)
T KOG0608|consen  870 PFLADTPGETQYKVINWR  887 (1034)
T ss_pred             CccCCCCCcceeeeeehh
Confidence            999999999888877664

>KOG0668 consensus Casein kinase II, alpha subunit [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning; Transcription]

Probab=99.93  E-value=6.5e-26  Score=201.20  Aligned_cols=179  Identities=22%  Similarity=0.343  Sum_probs=147.4

Q ss_pred             ccccCccCceEEEEEE-EcCCCEEEEEEeccCCCCchhhHHHHHHhhccC-ccceeEEEEEeec----------------
Q 039231          318 KYKLGQGGYGSVYKGK-LLDGSNVAVKVLNDSKGNGKEFINEVASISRTS-HVNVVALLGFCLR----------------  379 (506)
Q Consensus       318 ~~~ig~G~~g~V~~~~-~~~~~~vavK~l~~~~~~~~~~~~E~~~l~~l~-h~niv~l~g~~~~----------------  379 (506)
                      .+++|+|-++.||.|. ..++..++||+++.-+  .+.+.+|+.+|..++ ||||++|++...+                
T Consensus        43 vrk~GRGKYSEVFeg~~~~~~eK~ViKiLKPVk--kkKIkREikIL~nL~gg~NIi~L~DiV~Dp~SktpaLiFE~v~n~  120 (338)
T KOG0668|consen   43 VRKVGRGKYSEVFEGINITNNEKCVIKILKPVK--KKKIKREIKILQNLRGGPNIIKLLDIVKDPESKTPSLIFEYVNNT  120 (338)
T ss_pred             HHHHcCccHhhHhcccccCCCceEEEeeechHH--HHHHHHHHHHHHhccCCCCeeehhhhhcCccccCchhHhhhhccc
Confidence            4579999999999997 4568899999998643  367899999999998 9999999987632                


Q ss_pred             ----------cchhhhHHHHHHHHHHHHhhcCCCCeEecCcCCCcEEECCC-CcEEEeecCCCccccCCCcceecccCCC
Q 039231          380 ----------VAEELSSTIGIARGLEYLHLGCSTRILHFDIKPHNILLDED-FCPKISDFGLAKICNRKESIISMTGARG  448 (506)
Q Consensus       380 ----------~~~~l~i~~~i~~gl~~LH~~~~~~ivH~dlkp~Nill~~~-~~~ki~dfg~a~~~~~~~~~~~~~~~~g  448 (506)
                                ..+....+.+++.||.|+|   ++||.|||+||.|++||.. ..++|+|+|+|.........   .....
T Consensus       121 Dfk~ly~tl~d~dIryY~~elLkALdyCH---S~GImHRDVKPhNvmIdh~~rkLrlIDWGLAEFYHp~~eY---nVRVA  194 (338)
T KOG0668|consen  121 DFKQLYPTLTDYDIRYYIYELLKALDYCH---SMGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEY---NVRVA  194 (338)
T ss_pred             cHHHHhhhhchhhHHHHHHHHHHHHhHHH---hcCcccccCCcceeeechhhceeeeeecchHhhcCCCcee---eeeee
Confidence                      2224456789999999999   9999999999999999854 57999999999988776654   33456


Q ss_pred             CcccccccccccccCCCCccccHHHHHHHHHHHHcCCCCCCCCCCCcchhhhhhhcC
Q 039231          449 TVGYIAPEVFCRNIGEVSYKSDVYNYGMMIFEMTGGRKNVDVVDNGSTALDLQASRK  505 (506)
Q Consensus       449 t~~y~aPE~l~~~~~~~s~~~Dv~s~G~il~elltg~~pf~~~~~~~~~~~~~~~~~  505 (506)
                      +..|--||++..- ..++..-|+|||||+|.+|+..+.||....+...++.-++...
T Consensus       195 SRyfKGPELLVdy-~~YDYSLD~WS~GcmlA~miFrkepFFhG~dN~DQLVkIakVL  250 (338)
T KOG0668|consen  195 SRYFKGPELLVDY-QMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVKIAKVL  250 (338)
T ss_pred             hhhcCCchheeec-hhccccHHHHHHHHHHHHHHhccCcccCCCCCHHHHHHHHHHh
Confidence            7788899998653 5789999999999999999999999988777765555444433

>KOG1024 consensus Receptor-like protein tyrosine kinase RYK/derailed [Signal transduction mechanisms]

Probab=99.93  E-value=1.9e-26  Score=218.97  Aligned_cols=173  Identities=21%  Similarity=0.347  Sum_probs=145.5

Q ss_pred             cccCccCceEEEEEEEc------CCCEEEEEEeccCCC--CchhhHHHHHHhhccCccceeEEEEEeecc----------
Q 039231          319 YKLGQGGYGSVYKGKLL------DGSNVAVKVLNDSKG--NGKEFINEVASISRTSHVNVVALLGFCLRV----------  380 (506)
Q Consensus       319 ~~ig~G~~g~V~~~~~~------~~~~vavK~l~~~~~--~~~~~~~E~~~l~~l~h~niv~l~g~~~~~----------  380 (506)
                      ..+-+|.||.||+|.++      +.+.|.+|.++...+  +...+..|...+..+.|||+.++.+++.+.          
T Consensus       290 ~llqEGtFGri~~gI~~eEdt~n~~q~v~vKTvk~~AS~iQv~~~L~es~lly~~sH~nll~V~~V~ie~~~~P~V~y~~  369 (563)
T KOG1024|consen  290 CLLQEGTFGRIYRGIWREEDTYNDCQEVLVKTVKQHASQIQVNLLLQESMLLYGASHPNLLSVLGVSIEDYATPFVLYPA  369 (563)
T ss_pred             hhhhcCchhheeeeeecccCCcchHHHHHHHHHHhcccHHHHHHHHHHHHHHhcCcCCCccceeEEEeeccCcceEEEec
Confidence            45889999999999654      356788898876544  346788999999999999999999988322          


Q ss_pred             --------------------------chhhhHHHHHHHHHHHHhhcCCCCeEecCcCCCcEEECCCCcEEEeecCCCccc
Q 039231          381 --------------------------AEELSSTIGIARGLEYLHLGCSTRILHFDIKPHNILLDEDFCPKISDFGLAKIC  434 (506)
Q Consensus       381 --------------------------~~~l~i~~~i~~gl~~LH~~~~~~ivH~dlkp~Nill~~~~~~ki~dfg~a~~~  434 (506)
                                                .+...++.|++.||+|||   +.++||.||..+|.+||+...+||+|=.+++.+
T Consensus       370 ~~~gNLK~FL~~Cr~~~~~~aqtvtt~qlV~masQla~am~hlh---~~~ViHkDiAaRNCvIdd~LqVkltDsaLSRDL  446 (563)
T KOG1024|consen  370 TGVGNLKSFLQICRGDDPSYAQTVTTIQLVLMASQLAMAMEHLH---NHGVIHKDIAARNCVIDDQLQVKLTDSALSRDL  446 (563)
T ss_pred             cCcchHHHHHHHhccCCCccccchhHHHHHHHHHHHHHHHHHHH---hcCcccchhhhhcceehhheeEEeccchhcccc
Confidence                                      225568899999999999   999999999999999999999999999999987


Q ss_pred             cCCCcceecccCCCCcccccccccccccCCCCccccHHHHHHHHHHHHc-CCCCCCCCCCCcc
Q 039231          435 NRKESIISMTGARGTVGYIAPEVFCRNIGEVSYKSDVYNYGMMIFEMTG-GRKNVDVVDNGST  496 (506)
Q Consensus       435 ~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~s~~~Dv~s~G~il~ellt-g~~pf~~~~~~~~  496 (506)
                      -+.+.+.-......+..||+||.+.++  .++.++|||||||+||||+| |+.|+...++.|-
T Consensus       447 FP~DYhcLGDnEnRPvkWMslEal~n~--~yssasDvWsfGVllWELmtlg~~PyaeIDPfEm  507 (563)
T KOG1024|consen  447 FPGDYHCLGDNENRPVKWMSLEALQNS--HYSSASDVWSFGVLLWELMTLGKLPYAEIDPFEM  507 (563)
T ss_pred             CcccccccCCCCCCcccccCHHHHhhh--hhcchhhhHHHHHHHHHHHhcCCCCccccCHHHH
Confidence            766665544556668899999999765  89999999999999999998 9999987776553

>KOG1152 consensus Signal transduction serine/threonine kinase with PAS/PAC sensor domain [Signal transduction mechanisms]

Probab=99.93  E-value=2.2e-26  Score=228.06  Aligned_cols=163  Identities=25%  Similarity=0.367  Sum_probs=139.8

Q ss_pred             cccCccCceEEEEEEEcC-CCEEEEEEeccCCCC---------chhhHHHHHHhhccC---ccceeEEEEEe--------
Q 039231          319 YKLGQGGYGSVYKGKLLD-GSNVAVKVLNDSKGN---------GKEFINEVASISRTS---HVNVVALLGFC--------  377 (506)
Q Consensus       319 ~~ig~G~~g~V~~~~~~~-~~~vavK~l~~~~~~---------~~~~~~E~~~l~~l~---h~niv~l~g~~--------  377 (506)
                      +.+|.|+||.|+.|.++. ...|+||.+.+++--         .-.+-.|+++|.+++   |+||+++++++        
T Consensus       567 q~lG~GAyGkV~lai~K~n~~eVViK~I~KeRIL~DtWvrDrkLGtVp~EIqIla~l~~~sH~NIlKlLdfFEddd~yyl  646 (772)
T KOG1152|consen  567 QPLGEGAYGKVNLAIHKENNYEVVIKMIFKERILVDTWVRDRKLGTVPSEIQILATLNKHSHENILKLLDFFEDDDYYYL  646 (772)
T ss_pred             eeccccccceEEEeeecccceEEEeeehhhhhhhhhhhhcccccCccchhHHHHHHhhhcCccchhhhhheeecCCeeEE
Confidence            469999999999998864 678999998764322         134567999999998   99999999887        


Q ss_pred             --------------------eccchhhhHHHHHHHHHHHHhhcCCCCeEecCcCCCcEEECCCCcEEEeecCCCccccCC
Q 039231          378 --------------------LRVAEELSSTIGIARGLEYLHLGCSTRILHFDIKPHNILLDEDFCPKISDFGLAKICNRK  437 (506)
Q Consensus       378 --------------------~~~~~~l~i~~~i~~gl~~LH~~~~~~ivH~dlkp~Nill~~~~~~ki~dfg~a~~~~~~  437 (506)
                                          +++.+...|+.||+.|+++||   +++|||||||-+|+.++.+|-+||+|||.|......
T Consensus       647 ~te~hg~gIDLFd~IE~kp~m~E~eAk~IFkQV~agi~hlh---~~~ivhrdikdenvivd~~g~~klidfgsaa~~ksg  723 (772)
T KOG1152|consen  647 ETEVHGEGIDLFDFIEFKPRMDEPEAKLIFKQVVAGIKHLH---DQGIVHRDIKDENVIVDSNGFVKLIDFGSAAYTKSG  723 (772)
T ss_pred             EecCCCCCcchhhhhhccCccchHHHHHHHHHHHhcccccc---ccCceecccccccEEEecCCeEEEeeccchhhhcCC
Confidence                                344557779999999999999   999999999999999999999999999999876554


Q ss_pred             CcceecccCCCCcccccccccccccCCCCccccHHHHHHHHHHHHcCCCCCC
Q 039231          438 ESIISMTGARGTVGYIAPEVFCRNIGEVSYKSDVYNYGMMIFEMTGGRKNVD  489 (506)
Q Consensus       438 ~~~~~~~~~~gt~~y~aPE~l~~~~~~~s~~~Dv~s~G~il~elltg~~pf~  489 (506)
                      .    ....+||..|.|||++.+. ...+...|||++|++||.++..+.||-
T Consensus       724 p----fd~f~gtv~~aapevl~g~-~y~gk~qdiwalgillytivykenpyy  770 (772)
T KOG1152|consen  724 P----FDVFVGTVDYAAPEVLGGE-KYLGKPQDIWALGILLYTIVYKENPYY  770 (772)
T ss_pred             C----cceeeeeccccchhhhCCC-ccCCCcchhhhhhheeeEEEeccCCCc
Confidence            4    3568899999999999765 466888999999999999999999984

>cd05583 STKc_MSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase

Probab=99.93  E-value=2.1e-25  Score=218.60  Aligned_cols=171  Identities=28%  Similarity=0.322  Sum_probs=136.6

Q ss_pred             hccccCccCceEEEEEEE----cCCCEEEEEEeccCC-----CCchhhHHHHHHhhcc-CccceeEEEEEe---------
Q 039231          317 FKYKLGQGGYGSVYKGKL----LDGSNVAVKVLNDSK-----GNGKEFINEVASISRT-SHVNVVALLGFC---------  377 (506)
Q Consensus       317 ~~~~ig~G~~g~V~~~~~----~~~~~vavK~l~~~~-----~~~~~~~~E~~~l~~l-~h~niv~l~g~~---------  377 (506)
                      +.+.||+|++|.||+++.    .++..+|||+++...     ...+.+.+|++++.++ +||||+++.+.+         
T Consensus         4 ~~~~ig~G~~~~vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~~~~~~~~lv   83 (288)
T cd05583           4 LLRVLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEAVRRCPFLVTLHYAFQTDTKLHLI   83 (288)
T ss_pred             EEEEeccCCCceEEEEEEeccccCCcEEEEEEEehHHHHhhhhHHHHHHHHHHHHHhccCCcchhhhheeeecCCEEEEE
Confidence            356799999999999975    247889999986432     2235688999999999 599999987644         


Q ss_pred             ------------------eccchhhhHHHHHHHHHHHHhhcCCCCeEecCcCCCcEEECCCCcEEEeecCCCccccCCCc
Q 039231          378 ------------------LRVAEELSSTIGIARGLEYLHLGCSTRILHFDIKPHNILLDEDFCPKISDFGLAKICNRKES  439 (506)
Q Consensus       378 ------------------~~~~~~l~i~~~i~~gl~~LH~~~~~~ivH~dlkp~Nill~~~~~~ki~dfg~a~~~~~~~~  439 (506)
                                        +.+.+...++.|+++||+|||   +.+++|+||+|+||+++.++.++|+|||+++.......
T Consensus        84 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH---~~~~~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~  160 (288)
T cd05583          84 LDYVNGGELFTHLYQREHFTESEVRVYIAEIVLALDHLH---QLGIIYRDIKLENILLDSEGHVVLTDFGLSKEFLAEEE  160 (288)
T ss_pred             EecCCCCcHHHHHhhcCCcCHHHHHHHHHHHHHHHHHHH---HCCeeccCCCHHHeEECCCCCEEEEECccccccccccc
Confidence                              122335567889999999999   89999999999999999999999999999876544332


Q ss_pred             ceecccCCCCcccccccccccccCCCCccccHHHHHHHHHHHHcCCCCCCCC
Q 039231          440 IISMTGARGTVGYIAPEVFCRNIGEVSYKSDVYNYGMMIFEMTGGRKNVDVV  491 (506)
Q Consensus       440 ~~~~~~~~gt~~y~aPE~l~~~~~~~s~~~Dv~s~G~il~elltg~~pf~~~  491 (506)
                      .. .....++..|+|||.+.+.....+.++||||||+++|||++|..||...
T Consensus       161 ~~-~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~  211 (288)
T cd05583         161 ER-AYSFCGTIEYMAPEVIRGGSGGHDKAVDWWSLGVLTFELLTGASPFTVD  211 (288)
T ss_pred             cc-cccccCCccccCHHHhcCCCCCCcchhhhHHHHHHHHHHHhCCCCcccC
Confidence            11 1234578999999998654334788999999999999999999999654

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines

>cd07829 STKc_CDK_like Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases

Probab=99.93  E-value=1.8e-25  Score=218.08  Aligned_cols=170  Identities=34%  Similarity=0.446  Sum_probs=140.1

Q ss_pred             ccccCccCceEEEEEEEcC-CCEEEEEEeccCC---CCchhhHHHHHHhhccCccceeEEEEEe----------------
Q 039231          318 KYKLGQGGYGSVYKGKLLD-GSNVAVKVLNDSK---GNGKEFINEVASISRTSHVNVVALLGFC----------------  377 (506)
Q Consensus       318 ~~~ig~G~~g~V~~~~~~~-~~~vavK~l~~~~---~~~~~~~~E~~~l~~l~h~niv~l~g~~----------------  377 (506)
                      .+.||+|++|.||+|+..+ ++.+|+|++....   ...+.+.+|++++++++|+||+++.+++                
T Consensus         4 ~~~ig~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~~~~~   83 (282)
T cd07829           4 LEKLGEGTYGVVYKARDKKTGEIVALKKIRLDNEEEGIPSTALREISLLKELKHPNIVKLLDVIHTERKLYLVFEYCDMD   83 (282)
T ss_pred             ehcccccCcceEEEeeecCCCcEEEEEEeccccccccccHHHHHHHHHHHhcCCCCHHHHHhhhhcCCceEEEecCcCcC
Confidence            4569999999999998764 8999999997642   2336788999999999999999988764                


Q ss_pred             -----------eccchhhhHHHHHHHHHHHHhhcCCCCeEecCcCCCcEEECCCCcEEEeecCCCccccCCCcceecccC
Q 039231          378 -----------LRVAEELSSTIGIARGLEYLHLGCSTRILHFDIKPHNILLDEDFCPKISDFGLAKICNRKESIISMTGA  446 (506)
Q Consensus       378 -----------~~~~~~l~i~~~i~~gl~~LH~~~~~~ivH~dlkp~Nill~~~~~~ki~dfg~a~~~~~~~~~~~~~~~  446 (506)
                                 +++..++.++.|++.||+|||   +++++|+||+|+||++++++.+||+|||.++........  ....
T Consensus        84 l~~~i~~~~~~~~~~~~~~~~~~i~~~l~~LH---~~~i~H~~l~~~ni~~~~~~~~~l~d~g~~~~~~~~~~~--~~~~  158 (282)
T cd07829          84 LKKYLDKRPGPLSPNLIKSIMYQLLRGLAYCH---SHRILHRDLKPQNILINRDGVLKLADFGLARAFGIPLRT--YTHE  158 (282)
T ss_pred             HHHHHHhhccCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCChheEEEcCCCCEEEecCCcccccCCCccc--cCcc
Confidence                       223345778999999999999   899999999999999999999999999999876543321  2334


Q ss_pred             CCCcccccccccccccCCCCccccHHHHHHHHHHHHcCCCCCCCCCC
Q 039231          447 RGTVGYIAPEVFCRNIGEVSYKSDVYNYGMMIFEMTGGRKNVDVVDN  493 (506)
Q Consensus       447 ~gt~~y~aPE~l~~~~~~~s~~~Dv~s~G~il~elltg~~pf~~~~~  493 (506)
                      ..+..|+|||.+.+. ..++.++||||||+++|||++|+.||.....
T Consensus       159 ~~~~~~~aPE~~~~~-~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~  204 (282)
T cd07829         159 VVTLWYRAPEILLGS-KHYSTAVDIWSVGCIFAEMITGKPLFPGDSE  204 (282)
T ss_pred             ccCcCcCChHHhcCC-cCCCccccHHHHHHHHHHHHhCCCCCCCccH
Confidence            457789999998543 3678899999999999999999999976543

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the

>PHA03390 pk1 serine/threonine-protein kinase 1; Provisional

Probab=99.92  E-value=1.4e-24  Score=210.48  Aligned_cols=159  Identities=24%  Similarity=0.291  Sum_probs=127.2

Q ss_pred             cCccCceEEEEEEEc-CCCEEEEEEeccCCCCchhhHHHHHHhhcc-CccceeEEEEEe---------------------
Q 039231          321 LGQGGYGSVYKGKLL-DGSNVAVKVLNDSKGNGKEFINEVASISRT-SHVNVVALLGFC---------------------  377 (506)
Q Consensus       321 ig~G~~g~V~~~~~~-~~~~vavK~l~~~~~~~~~~~~E~~~l~~l-~h~niv~l~g~~---------------------  377 (506)
                      ||+|+||.||+++.. ++..+|+|.+........    |+.....+ +||||+++++.+                     
T Consensus        24 lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~----e~~~~~~~~~h~~iv~~~~~~~~~~~~~iv~e~~~~~~L~~~   99 (267)
T PHA03390         24 LIDGKFGKVSVLKHKPTQKLFVQKIIKAKNFNAI----EPMVHQLMKDNPNFIKLYYSVTTLKGHVLIMDYIKDGDLFDL   99 (267)
T ss_pred             ecCCCceEEEEEEEcCCCcEEEEEEEehhhcchh----hHHHHHHhhcCCCEEEEEEEEecCCeeEEEEEcCCCCcHHHH
Confidence            599999999999874 578899999865432211    22222212 699999999876                     


Q ss_pred             ------eccchhhhHHHHHHHHHHHHhhcCCCCeEecCcCCCcEEECCCC-cEEEeecCCCccccCCCcceecccCCCCc
Q 039231          378 ------LRVAEELSSTIGIARGLEYLHLGCSTRILHFDIKPHNILLDEDF-CPKISDFGLAKICNRKESIISMTGARGTV  450 (506)
Q Consensus       378 ------~~~~~~l~i~~~i~~gl~~LH~~~~~~ivH~dlkp~Nill~~~~-~~ki~dfg~a~~~~~~~~~~~~~~~~gt~  450 (506)
                            +++.+.+.++.|+++||+|||   +.+++||||||+||+++.++ .++|+|||+++.....      ....++.
T Consensus       100 l~~~~~l~~~~~~~~~~qi~~~l~~lH---~~~i~H~dl~p~nil~~~~~~~~~l~dfg~~~~~~~~------~~~~~~~  170 (267)
T PHA03390        100 LKKEGKLSEAEVKKIIRQLVEALNDLH---KHNIIHNDIKLENVLYDRAKDRIYLCDYGLCKIIGTP------SCYDGTL  170 (267)
T ss_pred             HHhcCCCCHHHHHHHHHHHHHHHHHHH---hCCeeeCCCCHHHEEEeCCCCeEEEecCccceecCCC------ccCCCCC
Confidence                  234446778999999999999   89999999999999999988 9999999998765432      2245789


Q ss_pred             ccccccccccccCCCCccccHHHHHHHHHHHHcCCCCCCCCCCC
Q 039231          451 GYIAPEVFCRNIGEVSYKSDVYNYGMMIFEMTGGRKNVDVVDNG  494 (506)
Q Consensus       451 ~y~aPE~l~~~~~~~s~~~Dv~s~G~il~elltg~~pf~~~~~~  494 (506)
                      .|+|||.+.+.  .++.++||||||+++|||++|+.||....++
T Consensus       171 ~y~aPE~~~~~--~~~~~~DvwslG~il~~l~~g~~p~~~~~~~  212 (267)
T PHA03390        171 DYFSPEKIKGH--NYDVSFDWWAVGVLTYELLTGKHPFKEDEDE  212 (267)
T ss_pred             cccChhhhcCC--CCCchhhHHHHHHHHHHHHHCCCCCCCCCcc
Confidence            99999998653  6788999999999999999999999855443

>cd07851 STKc_p38 Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase

Probab=99.92  E-value=1.2e-25  Score=226.13  Aligned_cols=167  Identities=32%  Similarity=0.437  Sum_probs=137.5

Q ss_pred             ccccCccCceEEEEEEEc-CCCEEEEEEeccCC---CCchhhHHHHHHhhccCccceeEEEEEe----------------
Q 039231          318 KYKLGQGGYGSVYKGKLL-DGSNVAVKVLNDSK---GNGKEFINEVASISRTSHVNVVALLGFC----------------  377 (506)
Q Consensus       318 ~~~ig~G~~g~V~~~~~~-~~~~vavK~l~~~~---~~~~~~~~E~~~l~~l~h~niv~l~g~~----------------  377 (506)
                      .+.||+|++|.||+|+.. +++.+|+|++....   ...+.+.+|+.++++++|+||+++.+++                
T Consensus        20 ~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~lv~   99 (343)
T cd07851          20 LSPVGSGAYGQVCSAFDTKTGRKVAIKKLSRPFQSAIHAKRTYRELRLLKHMDHENVIGLLDVFTPASSLEDFQDVYLVT   99 (343)
T ss_pred             EEEeccCCceEEEEEEECCCCcEEEEEecccccchhhHHHHHHHHHHHHHhccCCCHHHHHHHhhccccccccccEEEEE
Confidence            467999999999999985 47899999986532   2335677899999999999998876532                


Q ss_pred             ---------------eccchhhhHHHHHHHHHHHHhhcCCCCeEecCcCCCcEEECCCCcEEEeecCCCccccCCCccee
Q 039231          378 ---------------LRVAEELSSTIGIARGLEYLHLGCSTRILHFDIKPHNILLDEDFCPKISDFGLAKICNRKESIIS  442 (506)
Q Consensus       378 ---------------~~~~~~l~i~~~i~~gl~~LH~~~~~~ivH~dlkp~Nill~~~~~~ki~dfg~a~~~~~~~~~~~  442 (506)
                                     +++.+.+.++.|+++||+|||   +.+++|+||+|+||++++++.+||+|||++......     
T Consensus       100 e~~~~~L~~~~~~~~l~~~~~~~~~~ql~~aL~~LH---~~gi~H~dlkp~Nill~~~~~~kL~dfg~~~~~~~~-----  171 (343)
T cd07851         100 HLMGADLNNIVKCQKLSDDHIQFLVYQILRGLKYIH---SAGIIHRDLKPSNIAVNEDCELKILDFGLARHTDDE-----  171 (343)
T ss_pred             ecCCCCHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHeEECCCCCEEEcccccccccccc-----
Confidence                           233446678899999999999   899999999999999999999999999999865433     


Q ss_pred             cccCCCCcccccccccccccCCCCccccHHHHHHHHHHHHcCCCCCCCCCC
Q 039231          443 MTGARGTVGYIAPEVFCRNIGEVSYKSDVYNYGMMIFEMTGGRKNVDVVDN  493 (506)
Q Consensus       443 ~~~~~gt~~y~aPE~l~~~~~~~s~~~Dv~s~G~il~elltg~~pf~~~~~  493 (506)
                      .....++..|+|||.+.+. ..++.++||||||+++|||++|+.||.....
T Consensus       172 ~~~~~~~~~y~aPE~~~~~-~~~~~~~DvwslGv~l~elltg~~pf~~~~~  221 (343)
T cd07851         172 MTGYVATRWYRAPEIMLNW-MHYNQTVDIWSVGCIMAELLTGKTLFPGSDH  221 (343)
T ss_pred             ccCCcccccccCHHHHhCC-CCCCchHhHHHHHHHHHHHHhCCCCCCCCCh
Confidence            1345678899999998543 2578899999999999999999999976544

Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK

>cd05581 STKc_PDK1 Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1

Probab=99.92  E-value=1.9e-25  Score=217.43  Aligned_cols=172  Identities=30%  Similarity=0.444  Sum_probs=141.1

Q ss_pred             hccccCccCceEEEEEEEc-CCCEEEEEEeccCC----CCchhhHHHHHHhhccC-ccceeEEEEEe-------------
Q 039231          317 FKYKLGQGGYGSVYKGKLL-DGSNVAVKVLNDSK----GNGKEFINEVASISRTS-HVNVVALLGFC-------------  377 (506)
Q Consensus       317 ~~~~ig~G~~g~V~~~~~~-~~~~vavK~l~~~~----~~~~~~~~E~~~l~~l~-h~niv~l~g~~-------------  377 (506)
                      +.+.||+|++|.||+|+.. +++.+++|++..+.    ...+.+.+|++++.+++ |+||+++++++             
T Consensus         5 ~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~lv~e~~   84 (280)
T cd05581           5 FGKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNGHPGIIKLYYTFQDEENLYFVLEYA   84 (280)
T ss_pred             EeeeecCCCceEEEEEEEcCCCCEEEEEEechHhccchHHHHHHHHHHHHHHhcccCCCchhHHHHhcCCceEEEEEcCC
Confidence            4567999999999999875 58999999987532    22356889999999999 99999887654             


Q ss_pred             --------------eccchhhhHHHHHHHHHHHHhhcCCCCeEecCcCCCcEEECCCCcEEEeecCCCccccCCCcc---
Q 039231          378 --------------LRVAEELSSTIGIARGLEYLHLGCSTRILHFDIKPHNILLDEDFCPKISDFGLAKICNRKESI---  440 (506)
Q Consensus       378 --------------~~~~~~l~i~~~i~~gl~~LH~~~~~~ivH~dlkp~Nill~~~~~~ki~dfg~a~~~~~~~~~---  440 (506)
                                    +.+...+.++.|++.||+|||   +.+++|+||+|+||++++++.++|+|||++.........   
T Consensus        85 ~~~~L~~~l~~~~~l~~~~~~~i~~ql~~~l~~Lh---~~~~~H~dl~~~ni~i~~~~~~~l~df~~~~~~~~~~~~~~~  161 (280)
T cd05581          85 PNGELLQYIRKYGSLDEKCTRFYAAEILLALEYLH---SKGIIHRDLKPENILLDKDMHIKITDFGTAKVLDPNSSPESN  161 (280)
T ss_pred             CCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHH---HCCeeecCCCHHHeEECCCCCEEecCCccccccCCccccccC
Confidence                          234456779999999999999   899999999999999999999999999998766443211   


Q ss_pred             ---------------eecccCCCCcccccccccccccCCCCccccHHHHHHHHHHHHcCCCCCCCCCC
Q 039231          441 ---------------ISMTGARGTVGYIAPEVFCRNIGEVSYKSDVYNYGMMIFEMTGGRKNVDVVDN  493 (506)
Q Consensus       441 ---------------~~~~~~~gt~~y~aPE~l~~~~~~~s~~~Dv~s~G~il~elltg~~pf~~~~~  493 (506)
                                     .......++..|+|||.+...  .++.++||||||++++|+++|+.||.....
T Consensus       162 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~--~~~~~~Di~slG~~l~~l~~g~~p~~~~~~  227 (280)
T cd05581         162 KGDATNIDSQIEKNRRRFASFVGTAEYVSPELLNEK--PAGKSSDLWALGCIIYQMLTGKPPFRGSNE  227 (280)
T ss_pred             CCCCccccccccccccccccccCCccccCHHHhCCC--CCChhhhHHHHHHHHHHHHhCCCCCCCccH
Confidence                           111234578899999988543  688899999999999999999999987653

Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to auto

>cd08530 STKc_CNK2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains

Probab=99.92  E-value=3.3e-25  Score=212.84  Aligned_cols=168  Identities=33%  Similarity=0.486  Sum_probs=139.2

Q ss_pred             hccccCccCceEEEEEEEc-CCCEEEEEEeccCC---CCchhhHHHHHHhhccCccceeEEEEEee--------------
Q 039231          317 FKYKLGQGGYGSVYKGKLL-DGSNVAVKVLNDSK---GNGKEFINEVASISRTSHVNVVALLGFCL--------------  378 (506)
Q Consensus       317 ~~~~ig~G~~g~V~~~~~~-~~~~vavK~l~~~~---~~~~~~~~E~~~l~~l~h~niv~l~g~~~--------------  378 (506)
                      +.++||+|++|.||+++.. +++.+++|.+....   ....++.+|++++++++|+||+++.+++.              
T Consensus         4 ~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~   83 (256)
T cd08530           4 VLKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAVNEIRILASVNHPNIISYKEAFLDGNKLCIVMEYAPF   83 (256)
T ss_pred             EeeeecCCCceeEEEEEECCCCCEEEEEEEehhhccHHHHHHHHHHHHHHHhCCCCCchhhhhhhccCCEEEEEehhcCC
Confidence            3567999999999999864 57899999987532   23356788999999999999999876541              


Q ss_pred             -----------------ccchhhhHHHHHHHHHHHHhhcCCCCeEecCcCCCcEEECCCCcEEEeecCCCccccCCCcce
Q 039231          379 -----------------RVAEELSSTIGIARGLEYLHLGCSTRILHFDIKPHNILLDEDFCPKISDFGLAKICNRKESII  441 (506)
Q Consensus       379 -----------------~~~~~l~i~~~i~~gl~~LH~~~~~~ivH~dlkp~Nill~~~~~~ki~dfg~a~~~~~~~~~~  441 (506)
                                       ++...+.++.|++.||+|||   +.+++|+||+|+||++++++.+||+|||+++......   
T Consensus        84 ~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lh---~~~i~h~~l~~~ni~~~~~~~~kl~d~g~~~~~~~~~---  157 (256)
T cd08530          84 GDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQALH---EQKILHRDLKSANILLVANDLVKIGDLGISKVLKKNM---  157 (256)
T ss_pred             CCHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHh---hCCcccCCCCcceEEEecCCcEEEeeccchhhhccCC---
Confidence                             22234678889999999999   9999999999999999999999999999998765542   


Q ss_pred             ecccCCCCcccccccccccccCCCCccccHHHHHHHHHHHHcCCCCCCCCCC
Q 039231          442 SMTGARGTVGYIAPEVFCRNIGEVSYKSDVYNYGMMIFEMTGGRKNVDVVDN  493 (506)
Q Consensus       442 ~~~~~~gt~~y~aPE~l~~~~~~~s~~~Dv~s~G~il~elltg~~pf~~~~~  493 (506)
                       .....++..|+|||.+.+.  .++.++|+||||+++|||++|+.||+..+.
T Consensus       158 -~~~~~~~~~~~~Pe~~~~~--~~~~~~D~~slG~~~~~l~~g~~p~~~~~~  206 (256)
T cd08530         158 -AKTQIGTPHYMAPEVWKGR--PYSYKSDIWSLGCLLYEMATFAPPFEARSM  206 (256)
T ss_pred             -cccccCCccccCHHHHCCC--CCCchhhHHHHHHHHHHHHhCCCCCCCCCH
Confidence             1335578899999998553  678899999999999999999999986654

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, an

>KOG0200 consensus Fibroblast/platelet-derived growth factor receptor and related receptor tyrosine kinases [Signal transduction mechanisms]

Probab=99.92  E-value=3e-25  Score=237.52  Aligned_cols=179  Identities=30%  Similarity=0.498  Sum_probs=143.5

Q ss_pred             HHHHHHhhhccccCccCceEEEEEEEcC--------CCEEEEEEeccCCC--CchhhHHHHHHhhccC-ccceeEEEEEe
Q 039231          309 DIKKMTNSFKYKLGQGGYGSVYKGKLLD--------GSNVAVKVLNDSKG--NGKEFINEVASISRTS-HVNVVALLGFC  377 (506)
Q Consensus       309 el~~~~~~~~~~ig~G~~g~V~~~~~~~--------~~~vavK~l~~~~~--~~~~~~~E~~~l~~l~-h~niv~l~g~~  377 (506)
                      |+......+.+.+|+|+||.|++|....        ...||||.++....  +.+.+..|+++|..+- |+||+.++|+|
T Consensus       292 e~~~~~l~~~~~lg~g~fG~v~~~~~~~~~~~~~~~~~~VaVK~~k~~~~~~~~~~~~~El~~m~~~g~H~niv~llG~~  371 (609)
T KOG0200|consen  292 EIPRENLKLGKYLGEGAFGQVVKALLFGLSKALLSIYVTVAVKMLKENASSSEKKDLMSELNVLKELGKHPNIVNLLGAC  371 (609)
T ss_pred             eechhhccccceeecccccceEeEEEeecccccccceEEEEEEecccccCcHHHHHHHHHHHHHHHhcCCcchhhheeee
Confidence            3333333455689999999999997531        35799999986443  3478999999999995 99999999988


Q ss_pred             ec-------------------------------------------cchhhhHHHHHHHHHHHHhhcCCCCeEecCcCCCc
Q 039231          378 LR-------------------------------------------VAEELSSTIGIARGLEYLHLGCSTRILHFDIKPHN  414 (506)
Q Consensus       378 ~~-------------------------------------------~~~~l~i~~~i~~gl~~LH~~~~~~ivH~dlkp~N  414 (506)
                      -.                                           ..+.+.++.|||.||+||+   +.++|||||..+|
T Consensus       372 t~~~~~~~v~Ey~~~G~L~~~Lr~~r~~~~~~~~~~~~~~~~~L~~~dLlsfa~QIa~GMe~L~---~~~~vHRDLAaRN  448 (609)
T KOG0200|consen  372 TQDGPLYVIVEYAEHGDLLEFLRKKRVTESIDGSGVFPNERDALTTKDLLSFAYQIANGMEYLA---SVPCVHRDLAARN  448 (609)
T ss_pred             ccCCceEEEEEeccCCcHHHHHHhccccccccccCCCccccCCcCHHHHHHHHHHHHHHHHHHh---hCCccchhhhhhh
Confidence            11                                           1124678999999999999   8999999999999


Q ss_pred             EEECCCCcEEEeecCCCccccCCCcceec-ccCCCCcccccccccccccCCCCccccHHHHHHHHHHHHc-CCCCCCCCC
Q 039231          415 ILLDEDFCPKISDFGLAKICNRKESIISM-TGARGTVGYIAPEVFCRNIGEVSYKSDVYNYGMMIFEMTG-GRKNVDVVD  492 (506)
Q Consensus       415 ill~~~~~~ki~dfg~a~~~~~~~~~~~~-~~~~gt~~y~aPE~l~~~~~~~s~~~Dv~s~G~il~ellt-g~~pf~~~~  492 (506)
                      ||+.++..+||+|||+|+........... ........|||||.+..  ..++.|+|||||||+||||+| |..||....
T Consensus       449 VLi~~~~~~kIaDFGlar~~~~~~~y~~~~~~~~LP~kWmApEsl~~--~~ft~kSDVWSfGI~L~EifsLG~~PYp~~~  526 (609)
T KOG0200|consen  449 VLITKNKVIKIADFGLARDHYNKDYYRTKSSAGTLPVKWMAPESLFD--RVFTSKSDVWSFGILLWEIFTLGGTPYPGIP  526 (609)
T ss_pred             EEecCCCEEEEccccceeccCCCCceEecCCCCccceeecCHHHhcc--CcccccchhhHHHHHHHHHhhCCCCCCCCCC
Confidence            99999999999999999976655544321 11124567999999965  489999999999999999998 999998754

>KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms]

Probab=99.92  E-value=2.3e-25  Score=224.91  Aligned_cols=166  Identities=25%  Similarity=0.378  Sum_probs=137.5

Q ss_pred             hhccccCccCceEEEEEEEc-CCCEEEEEEeccCCCCchhhHHHHHHhhcc-CccceeEEEEEeecc-------------
Q 039231          316 SFKYKLGQGGYGSVYKGKLL-DGSNVAVKVLNDSKGNGKEFINEVASISRT-SHVNVVALLGFCLRV-------------  380 (506)
Q Consensus       316 ~~~~~ig~G~~g~V~~~~~~-~~~~vavK~l~~~~~~~~~~~~E~~~l~~l-~h~niv~l~g~~~~~-------------  380 (506)
                      .+...+|.|+|+.|..+... +++..++|++.+..   .+-.+|+.++.+. +||||+++.+.+.+.             
T Consensus       325 ~~~~~~~~gs~s~~~~~~~~~t~~~~~vkii~~~~---~~~~~e~~~~~~~~~h~niv~~~~v~~~~~~~~~v~e~l~g~  401 (612)
T KOG0603|consen  325 EFREELGEGSFSAVKYCESSPTDQEPAVKIISKRA---DDNQDEIPISLLVRDHPNIVKSHDVYEDGKEIYLVMELLDGG  401 (612)
T ss_pred             ccccccCCCCccceeeeeccccccchhheeccccc---cccccccchhhhhcCCCcceeecceecCCceeeeeehhcccc
Confidence            34556999999999999864 47889999997662   3345577666655 599999999887221             


Q ss_pred             -------------chhhhHHHHHHHHHHHHhhcCCCCeEecCcCCCcEEE-CCCCcEEEeecCCCccccCCCcceecccC
Q 039231          381 -------------AEELSSTIGIARGLEYLHLGCSTRILHFDIKPHNILL-DEDFCPKISDFGLAKICNRKESIISMTGA  446 (506)
Q Consensus       381 -------------~~~l~i~~~i~~gl~~LH~~~~~~ivH~dlkp~Nill-~~~~~~ki~dfg~a~~~~~~~~~~~~~~~  446 (506)
                                   .++..|+.+|+.|+.|||   .+|+|||||||+|||+ ++.++++|+|||.++.....     ....
T Consensus       402 ell~ri~~~~~~~~e~~~w~~~lv~Av~~LH---~~gvvhRDLkp~NIL~~~~~g~lrltyFG~a~~~~~~-----~~tp  473 (612)
T KOG0603|consen  402 ELLRRIRSKPEFCSEASQWAAELVSAVDYLH---EQGVVHRDLKPGNILLDGSAGHLRLTYFGFWSELERS-----CDTP  473 (612)
T ss_pred             HHHHHHHhcchhHHHHHHHHHHHHHHHHHHH---hcCeeecCCChhheeecCCCCcEEEEEechhhhCchh-----hccc
Confidence                         234469999999999999   8999999999999999 69999999999999877654     2445


Q ss_pred             CCCcccccccccccccCCCCccccHHHHHHHHHHHHcCCCCCCCCCCC
Q 039231          447 RGTVGYIAPEVFCRNIGEVSYKSDVYNYGMMIFEMTGGRKNVDVVDNG  494 (506)
Q Consensus       447 ~gt~~y~aPE~l~~~~~~~s~~~Dv~s~G~il~elltg~~pf~~~~~~  494 (506)
                      +-|..|.|||++..  ..+++++||||||++||||++|+.||....++
T Consensus       474 ~~t~~y~APEvl~~--~~yt~acD~WSLGvlLy~ML~G~tp~~~~P~~  519 (612)
T KOG0603|consen  474 ALTLQYVAPEVLAI--QEYTEACDWWSLGVLLYEMLTGRTLFAAHPAG  519 (612)
T ss_pred             chhhcccChhhhcc--CCCCcchhhHHHHHHHHHHHhCCCccccCCch
Confidence            67899999999974  48999999999999999999999999887665

>cd08215 STKc_Nek Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase

Probab=99.92  E-value=1.1e-24  Score=209.17  Aligned_cols=170  Identities=27%  Similarity=0.450  Sum_probs=140.6

Q ss_pred             hccccCccCceEEEEEEEc-CCCEEEEEEeccCC---CCchhhHHHHHHhhccCccceeEEEEEee--------------
Q 039231          317 FKYKLGQGGYGSVYKGKLL-DGSNVAVKVLNDSK---GNGKEFINEVASISRTSHVNVVALLGFCL--------------  378 (506)
Q Consensus       317 ~~~~ig~G~~g~V~~~~~~-~~~~vavK~l~~~~---~~~~~~~~E~~~l~~l~h~niv~l~g~~~--------------  378 (506)
                      +.+.||+|++|.||++... ++..+++|++....   ...+++.+|++.+++++|+|++++.+.+.              
T Consensus         4 ~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~lv~e~~~~   83 (258)
T cd08215           4 IIKQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDALNEVKILKKLNHPNIIKYYESFEEKGKLCIVMEYADG   83 (258)
T ss_pred             EEeeeccCCCeEEEEEEEcCCCcEEEEEEeecccCChHHHHHHHHHHHHHHhcCCCChhheEEEEecCCEEEEEEEecCC
Confidence            3467999999999999975 58899999997543   23467889999999999999999987651              


Q ss_pred             -----------------ccchhhhHHHHHHHHHHHHhhcCCCCeEecCcCCCcEEECCCCcEEEeecCCCccccCCCcce
Q 039231          379 -----------------RVAEELSSTIGIARGLEYLHLGCSTRILHFDIKPHNILLDEDFCPKISDFGLAKICNRKESII  441 (506)
Q Consensus       379 -----------------~~~~~l~i~~~i~~gl~~LH~~~~~~ivH~dlkp~Nill~~~~~~ki~dfg~a~~~~~~~~~~  441 (506)
                                       ++.+.+.++.+++.||+|||   +.+++|+||+|+||++++++.++|+|||++........  
T Consensus        84 ~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh---~~~~~H~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~~--  158 (258)
T cd08215          84 GDLSQKIKKQKKEGKPFPEEQILDWFVQLCLALKYLH---SRKILHRDIKPQNIFLTSNGLVKLGDFGISKVLSSTVD--  158 (258)
T ss_pred             CcHHHHHHHhhccCCCcCHHHHHHHHHHHHHHHHHHH---hCCEecccCChHHeEEcCCCcEEECCccceeecccCcc--
Confidence                             12234668899999999999   89999999999999999999999999999987654431  


Q ss_pred             ecccCCCCcccccccccccccCCCCccccHHHHHHHHHHHHcCCCCCCCCCC
Q 039231          442 SMTGARGTVGYIAPEVFCRNIGEVSYKSDVYNYGMMIFEMTGGRKNVDVVDN  493 (506)
Q Consensus       442 ~~~~~~gt~~y~aPE~l~~~~~~~s~~~Dv~s~G~il~elltg~~pf~~~~~  493 (506)
                      ......+++.|+|||.+...  .++.++|+||+|+++++|++|+.||+..+.
T Consensus       159 ~~~~~~~~~~y~~pe~~~~~--~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~  208 (258)
T cd08215         159 LAKTVVGTPYYLSPELCQNK--PYNYKSDIWSLGCVLYELCTLKHPFEGENL  208 (258)
T ss_pred             eecceeeeecccChhHhccC--CCCccccHHHHHHHHHHHHcCCCCCCCCcH
Confidence            12335678899999987554  688899999999999999999999976643

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They

>KOG0604 consensus MAP kinase-activated protein kinase 2 [Signal transduction mechanisms]

Probab=99.92  E-value=1.1e-25  Score=207.20  Aligned_cols=166  Identities=27%  Similarity=0.327  Sum_probs=138.6

Q ss_pred             cccCccCceEEEEEEEc-CCCEEEEEEeccCCCCchhhHHHHHHhhccC-ccceeEEEEEe-------------------
Q 039231          319 YKLGQGGYGSVYKGKLL-DGSNVAVKVLNDSKGNGKEFINEVASISRTS-HVNVVALLGFC-------------------  377 (506)
Q Consensus       319 ~~ig~G~~g~V~~~~~~-~~~~vavK~l~~~~~~~~~~~~E~~~l~~l~-h~niv~l~g~~-------------------  377 (506)
                      ++||-|-.|.|.....+ .++.+|+|++.++    ....+|++..-... |||||++++++                   
T Consensus        68 qvLG~GinGkV~~C~~k~T~ekfALKvL~Ds----~KARrEVeLHw~~s~h~~iV~IidVyeNs~~~rkcLLiVmE~meG  143 (400)
T KOG0604|consen   68 QVLGAGINGKVVQCVHKRTQEKFALKVLLDS----PKARREVELHWMASGHPHIVSIIDVYENSYQGRKCLLIVMECMEG  143 (400)
T ss_pred             hhhccccCCceEEEEeccchhhhHHHHHhcC----HHHHhHhhhhhhhcCCCceEEeehhhhhhccCceeeEeeeecccc
Confidence            67999999999999875 5889999999765    34567888766654 99999999876                   


Q ss_pred             --------------eccchhhhHHHHHHHHHHHHhhcCCCCeEecCcCCCcEEECC---CCcEEEeecCCCccccCCCcc
Q 039231          378 --------------LRVAEELSSTIGIARGLEYLHLGCSTRILHFDIKPHNILLDE---DFCPKISDFGLAKICNRKESI  440 (506)
Q Consensus       378 --------------~~~~~~l~i~~~i~~gl~~LH~~~~~~ivH~dlkp~Nill~~---~~~~ki~dfg~a~~~~~~~~~  440 (506)
                                    +++.++-.|+.||..|+.|||   +.+|.||||||+|+|...   |-.+||+|||+|+.-....  
T Consensus       144 GeLfsriq~~g~~afTErea~eI~~qI~~Av~~lH---~~nIAHRDlKpENLLyt~t~~na~lKLtDfGFAK~t~~~~--  218 (400)
T KOG0604|consen  144 GELFSRIQDRGDQAFTEREASEIMKQIGLAVRYLH---SMNIAHRDLKPENLLYTTTSPNAPLKLTDFGFAKETQEPG--  218 (400)
T ss_pred             hHHHHHHHHcccccchHHHHHHHHHHHHHHHHHHH---hcchhhccCChhheeeecCCCCcceEecccccccccCCCc--
Confidence                          445556779999999999999   999999999999999953   4568999999999765433  


Q ss_pred             eecccCCCCcccccccccccccCCCCccccHHHHHHHHHHHHcCCCCCCCCCCCcc
Q 039231          441 ISMTGARGTVGYIAPEVFCRNIGEVSYKSDVYNYGMMIFEMTGGRKNVDVVDNGST  496 (506)
Q Consensus       441 ~~~~~~~gt~~y~aPE~l~~~~~~~s~~~Dv~s~G~il~elltg~~pf~~~~~~~~  496 (506)
                       .+....-|+.|.|||++-..  .++...|+||+||++|-|++|-+||-.......
T Consensus       219 -~L~TPc~TPyYvaPevlg~e--KydkscdmwSlgVimYIlLCGyPPFYS~hg~ai  271 (400)
T KOG0604|consen  219 -DLMTPCFTPYYVAPEVLGPE--KYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAI  271 (400)
T ss_pred             -cccCCcccccccCHHHhCch--hcCCCCCccchhHHHHHhhcCCCcccccCCccC
Confidence             34667789999999999544  689899999999999999999999988765443

>cd05123 STKc_AGC Catalytic domain of AGC family Protein Serine/Threonine Kinases

Probab=99.92  E-value=1.1e-24  Score=208.61  Aligned_cols=166  Identities=33%  Similarity=0.424  Sum_probs=137.7

Q ss_pred             cCccCceEEEEEEEc-CCCEEEEEEeccCCC----CchhhHHHHHHhhccCccceeEEEEEe------------------
Q 039231          321 LGQGGYGSVYKGKLL-DGSNVAVKVLNDSKG----NGKEFINEVASISRTSHVNVVALLGFC------------------  377 (506)
Q Consensus       321 ig~G~~g~V~~~~~~-~~~~vavK~l~~~~~----~~~~~~~E~~~l~~l~h~niv~l~g~~------------------  377 (506)
                      ||+|++|.||++... +++.+++|++.....    ....+.+|++++++++|+||+++++.+                  
T Consensus         1 lg~G~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L   80 (250)
T cd05123           1 LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKLHYAFQTEEKLYLVLEYAPGGEL   80 (250)
T ss_pred             CCCCCceEEEEEEECCCCcEEEEEEeehhhhcchHHHHHHHHHHHHHHHcCCCcHHHHHHHeecCCeeEEEEecCCCCcH
Confidence            689999999999875 489999999875432    335788999999999999999887543                  


Q ss_pred             ---------eccchhhhHHHHHHHHHHHHhhcCCCCeEecCcCCCcEEECCCCcEEEeecCCCccccCCCcceecccCCC
Q 039231          378 ---------LRVAEELSSTIGIARGLEYLHLGCSTRILHFDIKPHNILLDEDFCPKISDFGLAKICNRKESIISMTGARG  448 (506)
Q Consensus       378 ---------~~~~~~l~i~~~i~~gl~~LH~~~~~~ivH~dlkp~Nill~~~~~~ki~dfg~a~~~~~~~~~~~~~~~~g  448 (506)
                               +++.....++.|+++||.|||   +.+++|+||+|+||++++++.++|+|||++........  ......+
T Consensus        81 ~~~l~~~~~l~~~~~~~~~~qi~~~l~~lh---~~~~~H~~l~p~ni~~~~~~~~~l~d~~~~~~~~~~~~--~~~~~~~  155 (250)
T cd05123          81 FSHLSKEGRFSEERARFYAAEIVLALEYLH---SLGIIYRDLKPENILLDADGHIKLTDFGLAKELSSEGS--RTNTFCG  155 (250)
T ss_pred             HHHHHhcCCCCHHHHHHHHHHHHHHHHHHH---HCCceecCCCcceEEEcCCCcEEEeecCcceecccCCC--cccCCcC
Confidence                     233446778899999999999   89999999999999999999999999999977654321  1234567


Q ss_pred             CcccccccccccccCCCCccccHHHHHHHHHHHHcCCCCCCCCCC
Q 039231          449 TVGYIAPEVFCRNIGEVSYKSDVYNYGMMIFEMTGGRKNVDVVDN  493 (506)
Q Consensus       449 t~~y~aPE~l~~~~~~~s~~~Dv~s~G~il~elltg~~pf~~~~~  493 (506)
                      +..|+|||.+.+.  ..+.++|+||||+++|||++|+.||...+.
T Consensus       156 ~~~~~~Pe~~~~~--~~~~~~D~~slG~~~~~l~~g~~p~~~~~~  198 (250)
T cd05123         156 TPEYLAPEVLLGK--GYGKAVDWWSLGVLLYEMLTGKPPFYAEDR  198 (250)
T ss_pred             CccccChHHhCCC--CCCchhhHHHHHHHHHHHHHCCCCCCCCCH
Confidence            8899999998654  578899999999999999999999976553

Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the

>KOG0671 consensus LAMMER dual specificity kinases [Signal transduction mechanisms]

Probab=99.91  E-value=5e-26  Score=216.19  Aligned_cols=190  Identities=22%  Similarity=0.307  Sum_probs=152.1

Q ss_pred             CccCHHHHHHHHhhhccccCccCceEEEEEEEcC-CCEEEEEEeccCCCCchhhHHHHHHhhccCc--cc----eeEEEE
Q 039231          303 KRYGYADIKKMTNSFKYKLGQGGYGSVYKGKLLD-GSNVAVKVLNDSKGNGKEFINEVASISRTSH--VN----VVALLG  375 (506)
Q Consensus       303 ~~~~~~el~~~~~~~~~~ig~G~~g~V~~~~~~~-~~~vavK~l~~~~~~~~~~~~E~~~l~~l~h--~n----iv~l~g  375 (506)
                      ..|...|.....+..-..+|+|.||.|-+..++. +..||||+++.-....+..+-|+++|+++.+  |+    +|.+.+
T Consensus        79 ~v~~~gD~l~~Ry~i~~~lGeGtFGkV~ec~D~~~~~~vAlKIik~V~kYreAa~iEi~vLqki~~~DP~g~~rcv~m~~  158 (415)
T KOG0671|consen   79 YVYQVGDILTNRYEIVDLLGEGTFGKVVECWDRETKEHVALKIIKNVDKYREAALIEIEVLQKINESDPNGKFRCVQMRD  158 (415)
T ss_pred             EEEEeccccccceehhhhhcCCcccceEEEeecCCCceehHHHHHHHHHHhhHHHHHHHHHHHHHhcCCCCceEEEeeeh
Confidence            4455666666666666789999999999998754 7899999998876666777889999999942  22    666655


Q ss_pred             Ee----------------------------eccchhhhHHHHHHHHHHHHhhcCCCCeEecCcCCCcEEECC--------
Q 039231          376 FC----------------------------LRVAEELSSTIGIARGLEYLHLGCSTRILHFDIKPHNILLDE--------  419 (506)
Q Consensus       376 ~~----------------------------~~~~~~l~i~~~i~~gl~~LH~~~~~~ivH~dlkp~Nill~~--------  419 (506)
                      ++                            ++......|+.|+++++++||   +.+++|-||||+|||+.+        
T Consensus       159 wFdyrghiCivfellG~S~~dFlk~N~y~~fpi~~ir~m~~QL~~sv~fLh---~~kl~HTDLKPENILfvss~~~~~~~  235 (415)
T KOG0671|consen  159 WFDYRGHICIVFELLGLSTFDFLKENNYIPFPIDHIRHMGYQLLESVAFLH---DLKLTHTDLKPENILFVSSEYFKTYN  235 (415)
T ss_pred             hhhccCceEEEEeccChhHHHHhccCCccccchHHHHHHHHHHHHHHHHHH---hcceeecCCChheEEEeccceEEEec
Confidence            44                            344557789999999999999   999999999999999831        


Q ss_pred             ------------CCcEEEeecCCCccccCCCcceecccCCCCcccccccccccccCCCCccccHHHHHHHHHHHHcCCCC
Q 039231          420 ------------DFCPKISDFGLAKICNRKESIISMTGARGTVGYIAPEVFCRNIGEVSYKSDVYNYGMMIFEMTGGRKN  487 (506)
Q Consensus       420 ------------~~~~ki~dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~s~~~Dv~s~G~il~elltg~~p  487 (506)
                                  +..+||+|||.|.......     ...+.|..|.|||++.+-  .++..+||||+||||.|+.||...
T Consensus       236 ~k~~~~~~r~~ks~~I~vIDFGsAtf~~e~h-----s~iVsTRHYRAPEViLgL--GwS~pCDvWSiGCIL~ElytG~~L  308 (415)
T KOG0671|consen  236 PKKKVCFIRPLKSTAIKVIDFGSATFDHEHH-----STIVSTRHYRAPEVILGL--GWSQPCDVWSIGCILVELYTGETL  308 (415)
T ss_pred             cCCccceeccCCCcceEEEecCCcceeccCc-----ceeeeccccCCchheecc--CcCCccCceeeeeEEEEeecccee
Confidence                        3458999999998765544     445679999999999886  799999999999999999999999


Q ss_pred             CCCCCCCcchhhhhhh
Q 039231          488 VDVVDNGSTALDLQAS  503 (506)
Q Consensus       488 f~~~~~~~~~~~~~~~  503 (506)
                      |+..++.|.. +++..
T Consensus       309 FqtHen~EHL-aMMer  323 (415)
T KOG0671|consen  309 FQTHENLEHL-AMMER  323 (415)
T ss_pred             cccCCcHHHH-HHHHH
Confidence            9988865543 44443

>cd08222 STKc_Nek11 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11

Probab=99.91  E-value=1.2e-24  Score=209.79  Aligned_cols=169  Identities=27%  Similarity=0.403  Sum_probs=131.8

Q ss_pred             hhccccCccCceEEEEEEEcC-CCEEEEEEeccC------CCCchhhHHHHHHhhccCccceeEEEEEe-----------
Q 039231          316 SFKYKLGQGGYGSVYKGKLLD-GSNVAVKVLNDS------KGNGKEFINEVASISRTSHVNVVALLGFC-----------  377 (506)
Q Consensus       316 ~~~~~ig~G~~g~V~~~~~~~-~~~vavK~l~~~------~~~~~~~~~E~~~l~~l~h~niv~l~g~~-----------  377 (506)
                      .+.++||+|+||.||+++... +..+++|+++..      .....++.+|+.++++++||||+++++++           
T Consensus         3 ~i~~~ig~g~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e   82 (260)
T cd08222           3 ILQQRLGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKLDHPAIVKFHASFLERDAFCIITE   82 (260)
T ss_pred             eeeeeecCCCCceEEEEEecCCCCcceEEEeccccccccCcchHHHHHHHHHHHHhCCCCcHHHHHHHHhcCCceEEEEE
Confidence            455789999999999998754 455666666532      12224567899999999999999887644           


Q ss_pred             --------------------eccchhhhHHHHHHHHHHHHhhcCCCCeEecCcCCCcEEECCCCcEEEeecCCCccccCC
Q 039231          378 --------------------LRVAEELSSTIGIARGLEYLHLGCSTRILHFDIKPHNILLDEDFCPKISDFGLAKICNRK  437 (506)
Q Consensus       378 --------------------~~~~~~l~i~~~i~~gl~~LH~~~~~~ivH~dlkp~Nill~~~~~~ki~dfg~a~~~~~~  437 (506)
                                          +++.+.+.++.|++.||+|||   +.+++|+||+|+||++++ +.+||+|||+++.....
T Consensus        83 ~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH---~~~i~h~~l~~~nili~~-~~~~l~d~g~~~~~~~~  158 (260)
T cd08222          83 YCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGVHYMH---QRRILHRDLKAKNIFLKN-NLLKIGDFGVSRLLMGS  158 (260)
T ss_pred             eCCCCCHHHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHH---HcCccccCCChhheEeec-CCEeecccCceeecCCC
Confidence                                123345678899999999999   899999999999999976 46999999998766433


Q ss_pred             CcceecccCCCCcccccccccccccCCCCccccHHHHHHHHHHHHcCCCCCCCCC
Q 039231          438 ESIISMTGARGTVGYIAPEVFCRNIGEVSYKSDVYNYGMMIFEMTGGRKNVDVVD  492 (506)
Q Consensus       438 ~~~~~~~~~~gt~~y~aPE~l~~~~~~~s~~~Dv~s~G~il~elltg~~pf~~~~  492 (506)
                      ...  .....++..|+|||.+.+.  .++.++|+||||+++|+|++|+.||....
T Consensus       159 ~~~--~~~~~~~~~~~~pe~~~~~--~~~~~~Dv~slG~~~~~l~~~~~~~~~~~  209 (260)
T cd08222         159 CDL--ATTFTGTPYYMSPEALKHQ--GYDSKSDIWSLGCILYEMCCLAHAFEGQN  209 (260)
T ss_pred             ccc--ccCCCCCcCccCHHHHccC--CCCchhhHHHHHHHHHHHHhCCCCCCCcc
Confidence            221  1345678899999988543  67889999999999999999999997543

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M check

>cd05576 STKc_RPK118_like Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins

Probab=99.90  E-value=7.8e-24  Score=201.50  Aligned_cols=154  Identities=23%  Similarity=0.237  Sum_probs=124.1

Q ss_pred             cCceEEEEEEEc-CCCEEEEEEeccCCCCchhhHHHHHHhhccCccceeEEEEEe-------------------------
Q 039231          324 GGYGSVYKGKLL-DGSNVAVKVLNDSKGNGKEFINEVASISRTSHVNVVALLGFC-------------------------  377 (506)
Q Consensus       324 G~~g~V~~~~~~-~~~~vavK~l~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~-------------------------  377 (506)
                      |.+|.||+++.. +++.+|+|++....    ...+|...+....||||+++++++                         
T Consensus         4 g~~~~v~~~~~~~~~~~~~~K~i~~~~----~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~   79 (237)
T cd05576           4 GVIDKVLLVMDTRTQQTFILKGLRKSS----EYSRERLTIIPHCVPNMVCLHKYIVSEDSVFLVLQHAEGGKLWSHISKF   79 (237)
T ss_pred             cccceEEEEEEccCCcEEEEEeecchh----hhhhHHHHHHhcCCCceeehhhheecCCeEEEEEecCCCCCHHHHHHHh
Confidence            899999999875 58899999997543    234455556666799999998765                         


Q ss_pred             --eccchhhhHHHHHHHHHHHHhhcCCCCeEecCcCCCcEEECCCCcEEEeecCCCccccCCCcceecccCCCCcccccc
Q 039231          378 --LRVAEELSSTIGIARGLEYLHLGCSTRILHFDIKPHNILLDEDFCPKISDFGLAKICNRKESIISMTGARGTVGYIAP  455 (506)
Q Consensus       378 --~~~~~~l~i~~~i~~gl~~LH~~~~~~ivH~dlkp~Nill~~~~~~ki~dfg~a~~~~~~~~~~~~~~~~gt~~y~aP  455 (506)
                        +++.....++.|+++||+|||   +++++||||||+||++++++.++++|||.+.......     ....++..|+||
T Consensus        80 ~~l~~~~~~~~~~ql~~~l~~lH---~~~i~H~dlkp~Nil~~~~~~~~l~df~~~~~~~~~~-----~~~~~~~~y~aP  151 (237)
T cd05576          80 LNIPEECVKRWAAEMVVALDALH---REGIVCRDLNPNNILLDDRGHIQLTYFSRWSEVEDSC-----DGEAVENMYCAP  151 (237)
T ss_pred             cCCCHHHHHHHHHHHHHHHHHHH---hCCeeccCCCHHHEEEcCCCCEEEecccchhcccccc-----ccCCcCccccCC
Confidence              223335678899999999999   8999999999999999999999999999886654322     234457789999


Q ss_pred             cccccccCCCCccccHHHHHHHHHHHHcCCCCCCCC
Q 039231          456 EVFCRNIGEVSYKSDVYNYGMMIFEMTGGRKNVDVV  491 (506)
Q Consensus       456 E~l~~~~~~~s~~~Dv~s~G~il~elltg~~pf~~~  491 (506)
                      |.+..  ..++.++||||+|+++|||++|+.|+...
T Consensus       152 E~~~~--~~~~~~~DvwslG~il~el~~g~~~~~~~  185 (237)
T cd05576         152 EVGGI--SEETEACDWWSLGAILFELLTGKTLVECH  185 (237)
T ss_pred             cccCC--CCCCchhhHHHHHHHHHHHHHCcchhhcC
Confidence            98854  36788999999999999999999887643

Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phospha

>cd05610 STKc_MASTL Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase

Probab=99.90  E-value=1.7e-23  Score=227.20  Aligned_cols=113  Identities=27%  Similarity=0.398  Sum_probs=96.3

Q ss_pred             hccccCccCceEEEEEEEc-CCCEEEEEEeccCCCC----chhhHHHHHHhhccCccceeEEEEEe--------------
Q 039231          317 FKYKLGQGGYGSVYKGKLL-DGSNVAVKVLNDSKGN----GKEFINEVASISRTSHVNVVALLGFC--------------  377 (506)
Q Consensus       317 ~~~~ig~G~~g~V~~~~~~-~~~~vavK~l~~~~~~----~~~~~~E~~~l~~l~h~niv~l~g~~--------------  377 (506)
                      +.++||+|+||.||+|++. +++.||||+++.....    .+.+.+|+.++..++|+||+++++.+              
T Consensus         8 i~~~LG~G~fg~Vy~a~~~~~~~~vAiKvi~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lVmEy~~   87 (669)
T cd05610           8 IVKPISRGAFGKVYLGRKKNNSKLYAVKVVKKADMINKNMVHQVQAERDALALSKSPFIVHLYYSLQSANNVYLVMEYLI   87 (669)
T ss_pred             EEEEEecCCCeEEEEEEECCCCcEEEEEEEehhhccCHHHHHHHHHHHHHHHhcCCCCcCeEEEEEEECCEEEEEEeCCC
Confidence            3567999999999999986 5899999999754321    25688899999999999999998765              


Q ss_pred             -------------eccchhhhHHHHHHHHHHHHhhcCCCCeEecCcCCCcEEECCCCcEEEeecCCCc
Q 039231          378 -------------LRVAEELSSTIGIARGLEYLHLGCSTRILHFDIKPHNILLDEDFCPKISDFGLAK  432 (506)
Q Consensus       378 -------------~~~~~~l~i~~~i~~gl~~LH~~~~~~ivH~dlkp~Nill~~~~~~ki~dfg~a~  432 (506)
                                   +.+...+.++.||+.||+|||   ..+|+||||||+|||++.++.+||+|||+++
T Consensus        88 g~~L~~li~~~~~l~~~~~~~i~~qil~aL~yLH---~~gIiHrDLKP~NILl~~~g~vkL~DFGls~  152 (669)
T cd05610          88 GGDVKSLLHIYGYFDEEMAVKYISEVALALDYLH---RHGIIHRDLKPDNMLISNEGHIKLTDFGLSK  152 (669)
T ss_pred             CCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH---hCCEEeCCccHHHEEEcCCCCEEEEeCCCCc
Confidence                         122335678899999999999   8999999999999999999999999999986

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ1481

>smart00221 STYKc Protein kinase; unclassified specificity

Probab=99.90  E-value=2.8e-23  Score=195.06  Aligned_cols=179  Identities=34%  Similarity=0.490  Sum_probs=143.8

Q ss_pred             hccccCccCceEEEEEEEcC-CCEEEEEEeccCCC--CchhhHHHHHHhhccCccceeEEEEEee---------------
Q 039231          317 FKYKLGQGGYGSVYKGKLLD-GSNVAVKVLNDSKG--NGKEFINEVASISRTSHVNVVALLGFCL---------------  378 (506)
Q Consensus       317 ~~~~ig~G~~g~V~~~~~~~-~~~vavK~l~~~~~--~~~~~~~E~~~l~~l~h~niv~l~g~~~---------------  378 (506)
                      +.+.|++|++|.||++...+ ++.+++|.+.....  ..+.+.+|++.+++++|+|++++++++.               
T Consensus         3 ~~~~i~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~~~   82 (225)
T smart00221        3 LGKKLGEGAFGKVYLARDKGTGELVAVKVLKKEKTEKQREEFLREIRILKKLKHPNIVKLYGVFEDPEPLYLVMEYCEGG   82 (225)
T ss_pred             eeeEeecCCCeEEEEEEEcCCCcEEEEEeeccccchHHHHHHHHHHHHHHhCCCCChhhheeeeecCCceEEEEeccCCC
Confidence            45679999999999999875 89999999976543  3578889999999999999999987652               


Q ss_pred             -------------ccchhhhHHHHHHHHHHHHhhcCCCCeEecCcCCCcEEECCCCcEEEeecCCCccccCCCcceeccc
Q 039231          379 -------------RVAEELSSTIGIARGLEYLHLGCSTRILHFDIKPHNILLDEDFCPKISDFGLAKICNRKESIISMTG  445 (506)
Q Consensus       379 -------------~~~~~l~i~~~i~~gl~~LH~~~~~~ivH~dlkp~Nill~~~~~~ki~dfg~a~~~~~~~~~~~~~~  445 (506)
                                   ++.....++.+++.++.+||   +.+++|+||+|+||+++.++.++|+|||.+......... ....
T Consensus        83 ~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh---~~~i~h~di~~~ni~v~~~~~~~l~d~g~~~~~~~~~~~-~~~~  158 (225)
T smart00221       83 DLFDYLRKKGGKLSEEEARFYLRQILEALEYLH---SLGIVHRDLKPENILLGMDGLVKLADFGLARFIHRDLAA-LLKT  158 (225)
T ss_pred             CHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEEcCCCCEEEeeCceeeEecCcccc-cccc
Confidence                         11224567889999999999   889999999999999999999999999999876544210 1133


Q ss_pred             CCCCcccccccccccccCCCCccccHHHHHHHHHHHHcCCCCCCC-CCCCcchhhh
Q 039231          446 ARGTVGYIAPEVFCRNIGEVSYKSDVYNYGMMIFEMTGGRKNVDV-VDNGSTALDL  500 (506)
Q Consensus       446 ~~gt~~y~aPE~l~~~~~~~s~~~Dv~s~G~il~elltg~~pf~~-~~~~~~~~~~  500 (506)
                      ..++..|++||.+. ....++.++|+|+||++++||++|+.||.. .++.....+.
T Consensus       159 ~~~~~~~~~pe~~~-~~~~~~~~~Dv~~lG~~~~~l~~g~~pf~~~~~~~~~~~~~  213 (225)
T smart00221      159 VKGTPFYLAPEVLL-GGKGYGEAVDIWSLGVILYELLWGPEPFSGEGEFTSLLSDV  213 (225)
T ss_pred             eeccCCcCCHhHhc-CCCCCCchhhHHHHHHHHHHHHHCCCCccccchhHHHHHHH
Confidence            45678899999984 334677899999999999999999999976 4444344433

Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase.

>KOG0695 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.90  E-value=7.8e-24  Score=197.48  Aligned_cols=167  Identities=26%  Similarity=0.381  Sum_probs=138.1

Q ss_pred             ccccCccCceEEEEEEEcC-CCEEEEEEeccC----CCCchhhHHHHHHhhcc-CccceeEEEEEe--------------
Q 039231          318 KYKLGQGGYGSVYKGKLLD-GSNVAVKVLNDS----KGNGKEFINEVASISRT-SHVNVVALLGFC--------------  377 (506)
Q Consensus       318 ~~~ig~G~~g~V~~~~~~~-~~~vavK~l~~~----~~~~~~~~~E~~~l~~l-~h~niv~l~g~~--------------  377 (506)
                      -++||+|+|++|-++++.. .+.+|+|++++.    .++.+-+..|-.+..+. +||.+|-+..++              
T Consensus       255 l~vigrgsyakvl~~~~~~t~qiyamkvvkkel~nddedidwvqtek~vfe~asn~pflvglhscfqtesrlffvieyv~  334 (593)
T KOG0695|consen  255 LRVIGRGSYAKVLLVRLKKTDQIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNNPFLVGLHSCFQTESRLFFVIEYVN  334 (593)
T ss_pred             eeeecCcchhhhhheehcccceeeehhhHHHHhcCCcccchhHHhhHHHHHhccCCCeEEehhhhhcccceEEEEEEEec
Confidence            3579999999999999754 678999998753    33445567777777776 599998876554              


Q ss_pred             -------------eccchhhhHHHHHHHHHHHHhhcCCCCeEecCcCCCcEEECCCCcEEEeecCCCccccCCCcceecc
Q 039231          378 -------------LRVAEELSSTIGIARGLEYLHLGCSTRILHFDIKPHNILLDEDFCPKISDFGLAKICNRKESIISMT  444 (506)
Q Consensus       378 -------------~~~~~~l~i~~~i~~gl~~LH~~~~~~ivH~dlkp~Nill~~~~~~ki~dfg~a~~~~~~~~~~~~~  444 (506)
                                   ++++.+......|..||.|||   ++||+.||||.+|+|+|..|++|+.|+|+++.--....  ...
T Consensus       335 ggdlmfhmqrqrklpeeharfys~ei~lal~flh---~rgiiyrdlkldnvlldaeghikltdygmcke~l~~gd--~ts  409 (593)
T KOG0695|consen  335 GGDLMFHMQRQRKLPEEHARFYSAEICLALNFLH---ERGIIYRDLKLDNVLLDAEGHIKLTDYGMCKEGLGPGD--TTS  409 (593)
T ss_pred             CcceeeehhhhhcCcHHHhhhhhHHHHHHHHHHh---hcCeeeeeccccceEEccCCceeecccchhhcCCCCCc--ccc
Confidence                         334445567788999999999   99999999999999999999999999999986433322  236


Q ss_pred             cCCCCcccccccccccccCCCCccccHHHHHHHHHHHHcCCCCCCCC
Q 039231          445 GARGTVGYIAPEVFCRNIGEVSYKSDVYNYGMMIFEMTGGRKNVDVV  491 (506)
Q Consensus       445 ~~~gt~~y~aPE~l~~~~~~~s~~~Dv~s~G~il~elltg~~pf~~~  491 (506)
                      ...||+.|+|||++.+.  .|...+|+|++||+++||+.|+.||+..
T Consensus       410 tfcgtpnyiapeilrge--eygfsvdwwalgvlmfemmagrspfdiv  454 (593)
T KOG0695|consen  410 TFCGTPNYIAPEILRGE--EYGFSVDWWALGVLMFEMMAGRSPFDIV  454 (593)
T ss_pred             cccCCCcccchhhhccc--ccCceehHHHHHHHHHHHHcCCCCccee
Confidence            68999999999999776  8999999999999999999999999864

>KOG1027 consensus Serine/threonine protein kinase and endoribonuclease ERN1/IRE1, sensor of the unfolded protein response pathway [Signal transduction mechanisms]

Probab=99.90  E-value=1.4e-24  Score=223.95  Aligned_cols=169  Identities=31%  Similarity=0.460  Sum_probs=136.5

Q ss_pred             cccCccCceE-EEEEEEcCCCEEEEEEeccCCCCchhhHHHHHHhhccC-ccceeEEEEEe-------------------
Q 039231          319 YKLGQGGYGS-VYKGKLLDGSNVAVKVLNDSKGNGKEFINEVASISRTS-HVNVVALLGFC-------------------  377 (506)
Q Consensus       319 ~~ig~G~~g~-V~~~~~~~~~~vavK~l~~~~~~~~~~~~E~~~l~~l~-h~niv~l~g~~-------------------  377 (506)
                      +++|.|+-|+ ||+|.. +|+.||||++-...  ..-..+|+..|+.-+ |||||++++.-                   
T Consensus       515 eilG~Gs~Gt~Vf~G~y-e~R~VAVKrll~e~--~~~A~rEi~lL~eSD~H~NviRyyc~E~d~qF~YIalELC~~sL~d  591 (903)
T KOG1027|consen  515 EILGYGSNGTVVFRGVY-EGREVAVKRLLEEF--FDFAQREIQLLQESDEHPNVIRYYCSEQDRQFLYIALELCACSLQD  591 (903)
T ss_pred             HHcccCCCCcEEEEEee-CCceehHHHHhhHh--HHHHHHHHHHHHhccCCCceEEEEeeccCCceEEEEehHhhhhHHH
Confidence            5688998875 899998 78999999885432  234578999999885 99999998643                   


Q ss_pred             -ecc----------chhhhHHHHHHHHHHHHhhcCCCCeEecCcCCCcEEECC---C--CcEEEeecCCCccccCCCcce
Q 039231          378 -LRV----------AEELSSTIGIARGLEYLHLGCSTRILHFDIKPHNILLDE---D--FCPKISDFGLAKICNRKESII  441 (506)
Q Consensus       378 -~~~----------~~~l~i~~~i~~gl~~LH~~~~~~ivH~dlkp~Nill~~---~--~~~ki~dfg~a~~~~~~~~~~  441 (506)
                       .+.          .+.+.+..|+++||++||   +.+||||||||+||||+.   +  ..++|+|||+++.+..++...
T Consensus       592 lie~~~~d~~~~~~i~~~~~l~q~~~GlaHLH---sl~iVHRDLkPQNILI~~~~~~~~~ra~iSDfglsKkl~~~~sS~  668 (903)
T KOG1027|consen  592 LIESSGLDVEMQSDIDPISVLSQIASGLAHLH---SLKIVHRDLKPQNILISVPSADGTLRAKISDFGLSKKLAGGKSSF  668 (903)
T ss_pred             HHhccccchhhcccccHHHHHHHHHHHHHHHH---hcccccccCCCceEEEEccCCCcceeEEecccccccccCCCcchh
Confidence             111          123567889999999999   899999999999999965   2  578999999999998776544


Q ss_pred             e-cccCCCCcccccccccccccCCCCccccHHHHHHHHHHHHcC-CCCCCCCCCCc
Q 039231          442 S-MTGARGTVGYIAPEVFCRNIGEVSYKSDVYNYGMMIFEMTGG-RKNVDVVDNGS  495 (506)
Q Consensus       442 ~-~~~~~gt~~y~aPE~l~~~~~~~s~~~Dv~s~G~il~elltg-~~pf~~~~~~~  495 (506)
                      . .....||-+|+|||++...  .-+.++||+|+||++|+.++| ..||...-+++
T Consensus       669 ~r~s~~sGt~GW~APE~L~~~--~~~~avDiFslGCvfyYvltgG~HpFGd~~~R~  722 (903)
T KOG1027|consen  669 SRLSGGSGTSGWQAPEQLRED--RKTQAVDIFSLGCVFYYVLTGGSHPFGDSLERQ  722 (903)
T ss_pred             hcccCCCCcccccCHHHHhcc--ccCcccchhhcCceEEEEecCCccCCCchHHhh
Confidence            4 3557899999999999765  456789999999999999985 99998775553

>KOG0665 consensus Jun-N-terminal kinase (JNK) [Signal transduction mechanisms]

Probab=99.89  E-value=1.3e-23  Score=195.36  Aligned_cols=171  Identities=27%  Similarity=0.289  Sum_probs=139.3

Q ss_pred             cCccCceEEEEEEEc-CCCEEEEEEeccCC---CCchhhHHHHHHhhccCccceeEEEEEeec-----------------
Q 039231          321 LGQGGYGSVYKGKLL-DGSNVAVKVLNDSK---GNGKEFINEVASISRTSHVNVVALLGFCLR-----------------  379 (506)
Q Consensus       321 ig~G~~g~V~~~~~~-~~~~vavK~l~~~~---~~~~~~~~E~~~l~~l~h~niv~l~g~~~~-----------------  379 (506)
                      ++.|+- .|-.|.+. .+++||+|++....   ...++..+|+..+..++|+||++++.++.+                 
T Consensus        25 ~~~g~~-~v~~a~D~v~~~~v~ikk~~~pf~n~~~akra~rel~l~~~v~~~nii~l~n~ftP~~~l~~~~e~y~v~e~m  103 (369)
T KOG0665|consen   25 IGSGAQ-IVVAAFDQVLGRPVAIKKLSRPFQNQTHAKRAYRELKLMKCVNHKNIISLLNVFTPQKTLEEFQEVYLVMELM  103 (369)
T ss_pred             cCCCCc-eEEecchhhccCceehhhhcCccccCccchhhhhhhhhhhhhcccceeeeeeccCccccHHHHHhHHHHHHhh
Confidence            677776 55555432 48899999986443   233678899999999999999999998822                 


Q ss_pred             -------------cchhhhHHHHHHHHHHHHhhcCCCCeEecCcCCCcEEECCCCcEEEeecCCCccccCCCcceecccC
Q 039231          380 -------------VAEELSSTIGIARGLEYLHLGCSTRILHFDIKPHNILLDEDFCPKISDFGLAKICNRKESIISMTGA  446 (506)
Q Consensus       380 -------------~~~~l~i~~~i~~gl~~LH~~~~~~ivH~dlkp~Nill~~~~~~ki~dfg~a~~~~~~~~~~~~~~~  446 (506)
                                   -.....|..|++.|++|||   +.+|+||||||+||++..+...||.|||+|+.....   ..++..
T Consensus       104 ~~nl~~vi~~elDH~tis~i~yq~~~~ik~lh---s~~IihRdLkPsnivv~~~~~lKi~dfg~ar~e~~~---~~mtpy  177 (369)
T KOG0665|consen  104 DANLCQVILMELDHETISYILYQMLCGIKHLH---SAGIIHRDLKPSNIVVNSDCTLKILDFGLARTEDTD---FMMTPY  177 (369)
T ss_pred             hhHHHHHHHHhcchHHHHHHHHHHHHHHHHHH---hcceeecccCcccceecchhheeeccchhhcccCcc---cccCch
Confidence                         1224458899999999999   999999999999999999999999999999865443   235677


Q ss_pred             CCCcccccccccccccCCCCccccHHHHHHHHHHHHcCCCCCCCCCCCcchhhh
Q 039231          447 RGTVGYIAPEVFCRNIGEVSYKSDVYNYGMMIFEMTGGRKNVDVVDNGSTALDL  500 (506)
Q Consensus       447 ~gt~~y~aPE~l~~~~~~~s~~~Dv~s~G~il~elltg~~pf~~~~~~~~~~~~  500 (506)
                      ..|..|.|||++.+.  .+.+.+||||.||++.||++|+.-|.+.+.-++-.++
T Consensus       178 VvtRyyrapevil~~--~~ke~vdiwSvGci~gEli~~~Vlf~g~d~idQ~~ki  229 (369)
T KOG0665|consen  178 VVTRYYRAPEVILGM--GYKENVDIWSVGCIMGELILGTVLFPGKDHIDQWNKI  229 (369)
T ss_pred             hheeeccCchheecc--CCcccchhhhhhhHHHHHhhceEEecCchHHHHHHHH
Confidence            889999999999886  4899999999999999999999999976655554443

>KOG0587 consensus Traf2- and Nck-interacting kinase and related germinal center kinase (GCK) family protein kinases [Signal transduction mechanisms]

Probab=99.89  E-value=1.9e-23  Score=216.67  Aligned_cols=181  Identities=28%  Similarity=0.411  Sum_probs=151.6

Q ss_pred             hhccccCccCceEEEEEEE-cCCCEEEEEEeccCCCCchhhHHHHHHhhccC-ccceeEEEEEe----------------
Q 039231          316 SFKYKLGQGGYGSVYKGKL-LDGSNVAVKVLNDSKGNGKEFINEVASISRTS-HVNVVALLGFC----------------  377 (506)
Q Consensus       316 ~~~~~ig~G~~g~V~~~~~-~~~~~vavK~l~~~~~~~~~~~~E~~~l~~l~-h~niv~l~g~~----------------  377 (506)
                      .|.+.||+|.+|.||+++. ++++.+|+|++.......+++..|.++|+... |||++..+|++                
T Consensus        22 ei~evig~Gtygkv~k~k~~~~~~~aa~kI~~~~~d~deEiE~eynil~~~~~hpnv~~fyg~~~k~~~~~~DqLWLVME  101 (953)
T KOG0587|consen   22 EIIEVIGNGTYGKVYKGRHVKTGQLAAIKIMDPTEDEEEEIELEYNMLKKYSHHPNVATFYGAFIKKDPGNGDQLWLVME  101 (953)
T ss_pred             EEEEEEeeccceeEEEEeeeecCceeeeEeecCCccccHHHHHHHHHHHhccCCCCcceEEEEEEEecCCCCCeEEEEee
Confidence            3457899999999999986 46899999999888777788999999999985 99999999987                


Q ss_pred             ------------------eccchhhhHHHHHHHHHHHHhhcCCCCeEecCcCCCcEEECCCCcEEEeecCCCccccCCCc
Q 039231          378 ------------------LRVAEELSSTIGIARGLEYLHLGCSTRILHFDIKPHNILLDEDFCPKISDFGLAKICNRKES  439 (506)
Q Consensus       378 ------------------~~~~~~l~i~~~i~~gl~~LH~~~~~~ivH~dlkp~Nill~~~~~~ki~dfg~a~~~~~~~~  439 (506)
                                        +++.....|.+.++.|+++||   +..++|||||-.|||++.++.+|+.|||.+..+.....
T Consensus       102 fC~gGSVTDLVKn~~g~rl~E~~IaYI~re~lrgl~HLH---~nkviHRDikG~NiLLT~e~~VKLvDFGvSaQldsT~g  178 (953)
T KOG0587|consen  102 FCGGGSVTDLVKNTKGNRLKEEWIAYILREILRGLAHLH---NNKVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDSTVG  178 (953)
T ss_pred             ccCCccHHHHHhhhcccchhhHHHHHHHHHHHHHHHHHh---hcceeeecccCceEEEeccCcEEEeeeeeeeeeecccc
Confidence                              233335568889999999999   99999999999999999999999999999987654432


Q ss_pred             ceecccCCCCcccccccccccc---cCCCCccccHHHHHHHHHHHHcCCCCCCCCCCCcchhhhh
Q 039231          440 IISMTGARGTVGYIAPEVFCRN---IGEVSYKSDVYNYGMMIFEMTGGRKNVDVVDNGSTALDLQ  501 (506)
Q Consensus       440 ~~~~~~~~gt~~y~aPE~l~~~---~~~~s~~~Dv~s~G~il~elltg~~pf~~~~~~~~~~~~~  501 (506)
                        ......||+.|||||++.-.   ...|+..+|+||||++..||.-|.+|+-.+.+-...+.|.
T Consensus       179 --rRnT~iGtP~WMAPEViac~e~~d~tyd~R~D~WsLGITaIEladG~PPl~DmHPmraLF~Ip  241 (953)
T KOG0587|consen  179 --RRNTFIGTPYWMAPEVIACDESPDATYDYRSDLWSLGITAIEMAEGAPPLCDMHPMRALFLIP  241 (953)
T ss_pred             --cccCcCCCcccccceeeecccCCCCCcccccchhhccceeehhcCCCCCccCcchhhhhccCC
Confidence              23568899999999999432   1256778999999999999999999998887665555443

>PLN03225 Serine/threonine-protein kinase SNT7; Provisional

Probab=99.89  E-value=7.3e-23  Score=217.11  Aligned_cols=102  Identities=28%  Similarity=0.320  Sum_probs=80.5

Q ss_pred             hhHHHHHHHHHHHHhhcCCCCeEecCcCCCcEEECC-CCcEEEeecCCCccccCCCcceecccCCCCccccccccccccc
Q 039231          384 LSSTIGIARGLEYLHLGCSTRILHFDIKPHNILLDE-DFCPKISDFGLAKICNRKESIISMTGARGTVGYIAPEVFCRNI  462 (506)
Q Consensus       384 l~i~~~i~~gl~~LH~~~~~~ivH~dlkp~Nill~~-~~~~ki~dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~  462 (506)
                      ..++.|++.||+|||   +++|+||||||+|||+++ ++.+||+|||+++......... .....+++.|+|||.+....
T Consensus       258 ~~i~~qll~aL~yLH---~~gIiHRDLKP~NILl~~~~~~~KL~DFGlA~~l~~~~~~~-~~~~~~t~~Y~APE~~~~~~  333 (566)
T PLN03225        258 QTIMRQILFALDGLH---STGIVHRDVKPQNIIFSEGSGSFKIIDLGAAADLRVGINYI-PKEFLLDPRYAAPEQYIMST  333 (566)
T ss_pred             HHHHHHHHHHHHHHH---HCCEEeCcCCHHHEEEeCCCCcEEEEeCCCccccccccccC-CcccccCCCccChHHhhccC
Confidence            358899999999999   899999999999999985 5799999999998664433221 23467899999999763321


Q ss_pred             C--------------------CCCccccHHHHHHHHHHHHcCCCCCC
Q 039231          463 G--------------------EVSYKSDVYNYGMMIFEMTGGRKNVD  489 (506)
Q Consensus       463 ~--------------------~~s~~~Dv~s~G~il~elltg~~pf~  489 (506)
                      .                    .++.++|||||||+||||+++..|++
T Consensus       334 ~~~~~~~~~~~~~~sp~l~~~~~~~k~DVwSlGviL~el~~~~~~~~  380 (566)
T PLN03225        334 QTPSAPSAPVATALSPVLWQLNLPDRFDIYSAGLIFLQMAFPNLRSD  380 (566)
T ss_pred             CCCCCccccccccccchhccccCCCCcccHHHHHHHHHHHhCcCCCc
Confidence            1                    23456799999999999999877654

>PLN03224 probable serine/threonine protein kinase; Provisional

Probab=99.89  E-value=6.3e-23  Score=212.52  Aligned_cols=170  Identities=23%  Similarity=0.265  Sum_probs=121.4

Q ss_pred             hccccCccCceEEEEEEE-----------------cCCCEEEEEEeccCCCC---------------chhhHHHHHHhhc
Q 039231          317 FKYKLGQGGYGSVYKGKL-----------------LDGSNVAVKVLNDSKGN---------------GKEFINEVASISR  364 (506)
Q Consensus       317 ~~~~ig~G~~g~V~~~~~-----------------~~~~~vavK~l~~~~~~---------------~~~~~~E~~~l~~  364 (506)
                      ..++||+|+||.||+|.+                 .+++.||||+++.....               .+....|+.++.+
T Consensus       149 i~~~LG~GgFG~VYkG~~~~~~~~~v~~~~~~~~~~~~r~VAVK~l~~~~~~~~~~fl~e~~~~~~~~e~~~vE~~~l~~  228 (507)
T PLN03224        149 LRDKLGGGNFGITFEGLRLQADDQGVTQRSKLTAEQKKRRVVLKRVNMDRQGVRQDFLKTGTLAKGSAETGMVEAYMCAK  228 (507)
T ss_pred             EeeEeecCCCeEEEEEEecccccchhhhhccccccccCceEEEEEecccchhhHHHHHhhhhhhhcccchhHHHHHHHHH
Confidence            457899999999999964                 23568999998643221               1233457777788


Q ss_pred             cCccce-----eEEEEEee-----------------------------------------------------------cc
Q 039231          365 TSHVNV-----VALLGFCL-----------------------------------------------------------RV  380 (506)
Q Consensus       365 l~h~ni-----v~l~g~~~-----------------------------------------------------------~~  380 (506)
                      ++|.++     +++++++.                                                           ++
T Consensus       229 l~~~~l~~~~~~~~lg~~~~~~~~g~~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~L~e~l~~g~~l~~~~~~~~~~~  308 (507)
T PLN03224        229 IKRNPIAAASCAEYLGYFTSNTADGAFTKGSQWLVWKFESDATLGDALDGKLGPFPGCLEEFMMAGKKIPDNMPQDKRDI  308 (507)
T ss_pred             hhcccchhhhhhhhhhhcccccccccccCCceEEEEEcCCCCcHHHHHhhccCCCcchHHHHHhcCCchhhhcccccCCH
Confidence            877654     44444331                                                           11


Q ss_pred             chhhhHHHHHHHHHHHHhhcCCCCeEecCcCCCcEEECCCCcEEEeecCCCccccCCCcceecccCCCCccccccccccc
Q 039231          381 AEELSSTIGIARGLEYLHLGCSTRILHFDIKPHNILLDEDFCPKISDFGLAKICNRKESIISMTGARGTVGYIAPEVFCR  460 (506)
Q Consensus       381 ~~~l~i~~~i~~gl~~LH~~~~~~ivH~dlkp~Nill~~~~~~ki~dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~l~~  460 (506)
                      .....++.|++.||+|||   +++|+||||||+|||++.++.+||+|||+++........ ......+++.|+|||.+..
T Consensus       309 ~~~~~i~~ql~~aL~~lH---~~~ivHrDLKp~NILl~~~~~~kL~DFGla~~~~~~~~~-~~~~g~~tp~Y~aPE~l~~  384 (507)
T PLN03224        309 NVIKGVMRQVLTGLRKLH---RIGIVHRDIKPENLLVTVDGQVKIIDFGAAVDMCTGINF-NPLYGMLDPRYSPPEELVM  384 (507)
T ss_pred             HHHHHHHHHHHHHHHHHH---HCCeecCCCchHhEEECCCCcEEEEeCcCccccccCCcc-CccccCCCcceeChhhhcC
Confidence            124457889999999999   899999999999999999999999999999765433221 1122345789999999853


Q ss_pred             ccC--------------------CCCccccHHHHHHHHHHHHcCCC-CCCC
Q 039231          461 NIG--------------------EVSYKSDVYNYGMMIFEMTGGRK-NVDV  490 (506)
Q Consensus       461 ~~~--------------------~~s~~~Dv~s~G~il~elltg~~-pf~~  490 (506)
                      ...                    ....+.||||+||+++||++|.. ||..
T Consensus       385 ~~~~~~~~~~~~~~~l~~~~~~yg~~~~~DvwSlGvil~em~~~~l~p~~~  435 (507)
T PLN03224        385 PQSCPRAPAPAMAALLSPFAWLYGRPDLFDSYTAGVLLMQMCVPELRPVAN  435 (507)
T ss_pred             CCCCCccchhhhhhhhhhhHHhcCCCCccchhhHHHHHHHHHhCCCCCccc
Confidence            210                    11235799999999999999875 7753

>smart00220 S_TKc Serine/Threonine protein kinases, catalytic domain

Probab=99.89  E-value=1.1e-22  Score=192.98  Aligned_cols=161  Identities=34%  Similarity=0.497  Sum_probs=134.9

Q ss_pred             CceEEEEEEEcC-CCEEEEEEeccCCCC--chhhHHHHHHhhccCccceeEEEEEee-----------------------
Q 039231          325 GYGSVYKGKLLD-GSNVAVKVLNDSKGN--GKEFINEVASISRTSHVNVVALLGFCL-----------------------  378 (506)
Q Consensus       325 ~~g~V~~~~~~~-~~~vavK~l~~~~~~--~~~~~~E~~~l~~l~h~niv~l~g~~~-----------------------  378 (506)
                      +||.||+|+..+ ++.+++|++......  .+.+.+|++.+++++|+||+++++.+.                       
T Consensus         1 ~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e~~~~~~L~~~~~~   80 (244)
T smart00220        1 SFGKVYLARDKKTGKLVAIKVIKKEKIKKKRERILREISILKKLKHPNIVRLYDVFEDEDKLYLVMEYCDGGDLFDLLKK   80 (244)
T ss_pred             CceEEEEEEECCCCcEEEEEEecccccccHHHHHHHHHHHHHhCCCCcHHHHHhheeeCCEEEEEEeCCCCCCHHHHHHh
Confidence            589999999864 899999999765433  478999999999999999998887652                       


Q ss_pred             ----ccchhhhHHHHHHHHHHHHhhcCCCCeEecCcCCCcEEECCCCcEEEeecCCCccccCCCcceecccCCCCccccc
Q 039231          379 ----RVAEELSSTIGIARGLEYLHLGCSTRILHFDIKPHNILLDEDFCPKISDFGLAKICNRKESIISMTGARGTVGYIA  454 (506)
Q Consensus       379 ----~~~~~l~i~~~i~~gl~~LH~~~~~~ivH~dlkp~Nill~~~~~~ki~dfg~a~~~~~~~~~~~~~~~~gt~~y~a  454 (506)
                          +....+.++.+++.++.+||   +.+++|+||+|+||++++++.++|+|||.+.......   ......++..|++
T Consensus        81 ~~~~~~~~~~~~~~~l~~~l~~lh---~~~i~h~~i~~~ni~~~~~~~~~l~d~~~~~~~~~~~---~~~~~~~~~~~~~  154 (244)
T smart00220       81 RGRLSEDEARFYARQILSALEYLH---SNGIIHRDLKPENILLDEDGHVKLADFGLARQLDPGG---LLTTFVGTPEYMA  154 (244)
T ss_pred             ccCCCHHHHHHHHHHHHHHHHHHH---HcCeecCCcCHHHeEECCCCcEEEccccceeeecccc---ccccccCCcCCCC
Confidence                22335678899999999999   8999999999999999999999999999998765542   1244567889999


Q ss_pred             ccccccccCCCCccccHHHHHHHHHHHHcCCCCCCCCCC
Q 039231          455 PEVFCRNIGEVSYKSDVYNYGMMIFEMTGGRKNVDVVDN  493 (506)
Q Consensus       455 PE~l~~~~~~~s~~~Dv~s~G~il~elltg~~pf~~~~~  493 (506)
                      ||.+..  ...+.++||||||+++++|++|..||....+
T Consensus       155 pE~~~~--~~~~~~~Di~slG~~l~~l~~~~~p~~~~~~  191 (244)
T smart00220      155 PEVLLG--KGYGKAVDVWSLGVILYELLTGKPPFPGDDQ  191 (244)
T ss_pred             HHHHcc--CCCCchhhHHHHHHHHHHHHhCCCCCCCCCc
Confidence            999854  3678899999999999999999999987433

Phosphotransferases. Serine or threonine-specific kinase subfamily.

>KOG0670 consensus U4/U6-associated splicing factor PRP4 [RNA processing and modification]

Probab=99.88  E-value=7.1e-24  Score=207.90  Aligned_cols=196  Identities=23%  Similarity=0.317  Sum_probs=151.7

Q ss_pred             CCCccCHHHHHHHHhhhccccCccCceEEEEEEEcC-CCEEEEEEeccCCCCchhhHHHHHHhhccC------ccceeEE
Q 039231          301 SPKRYGYADIKKMTNSFKYKLGQGGYGSVYKGKLLD-GSNVAVKVLNDSKGNGKEFINEVASISRTS------HVNVVAL  373 (506)
Q Consensus       301 ~~~~~~~~el~~~~~~~~~~ig~G~~g~V~~~~~~~-~~~vavK~l~~~~~~~~~~~~E~~~l~~l~------h~niv~l  373 (506)
                      +..++.+.|+....|...-..|+|-|++|-+|.+.. |+.||||++.+.+.-.+.=++|+++|.+|+      ..|.+++
T Consensus       420 GYYrv~igE~LD~RY~V~~~~GkGvFs~Vvra~D~~r~~~vAiKIIRnNE~M~KtGl~EleiLkKL~~AD~Edk~Hclrl  499 (752)
T KOG0670|consen  420 GYYRVRIGELLDSRYEVQGYTGKGVFSTVVRARDQARGQEVAIKIIRNNEVMHKTGLKELEILKKLNDADPEDKFHCLRL  499 (752)
T ss_pred             ceEEEehhhhhcceeEEEeccccceeeeeeeccccCCCCeeEEEEeecchHHhhhhhHHHHHHHHhhccCchhhhHHHHH
Confidence            445666778877777777779999999999998754 889999999876554455677888888773      1233333


Q ss_pred             EEEe-----------------------------eccchhhhHHHHHHHHHHHHhhcCCCCeEecCcCCCcEEECCC-CcE
Q 039231          374 LGFC-----------------------------LRVAEELSSTIGIARGLEYLHLGCSTRILHFDIKPHNILLDED-FCP  423 (506)
Q Consensus       374 ~g~~-----------------------------~~~~~~l~i~~~i~~gl~~LH~~~~~~ivH~dlkp~Nill~~~-~~~  423 (506)
                      +-.|                             +....+..++.|+.-||..|.   +.+|+|.||||+|||+++. ..+
T Consensus       500 ~r~F~hknHLClVFE~LslNLRevLKKyG~nvGL~ikaVRsYaqQLflALklLK---~c~vlHaDIKPDNiLVNE~k~iL  576 (752)
T KOG0670|consen  500 FRHFKHKNHLCLVFEPLSLNLREVLKKYGRNVGLHIKAVRSYAQQLFLALKLLK---KCGVLHADIKPDNILVNESKNIL  576 (752)
T ss_pred             HHHhhhcceeEEEehhhhchHHHHHHHhCcccceeehHHHHHHHHHHHHHHHHH---hcCeeecccCccceEeccCccee
Confidence            2211                             344446678999999999999   9999999999999999875 468


Q ss_pred             EEeecCCCccccCCCcceecccCCCCcccccccccccccCCCCccccHHHHHHHHHHHHcCCCCCCCCCCCcchhhhhhh
Q 039231          424 KISDFGLAKICNRKESIISMTGARGTVGYIAPEVFCRNIGEVSYKSDVYNYGMMIFEMTGGRKNVDVVDNGSTALDLQAS  503 (506)
Q Consensus       424 ki~dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~s~~~Dv~s~G~il~elltg~~pf~~~~~~~~~~~~~~~  503 (506)
                      ||+|||.|...+..+.    +...-+..|.|||++.+.  .|+...|+||.||.||||.||+..|....+. ..+.+...
T Consensus       577 KLCDfGSA~~~~enei----tPYLVSRFYRaPEIiLG~--~yd~~iD~WSvgctLYElYtGkIlFpG~TNN-~MLrl~me  649 (752)
T KOG0670|consen  577 KLCDFGSASFASENEI----TPYLVSRFYRAPEIILGL--PYDYPIDTWSVGCTLYELYTGKILFPGRTNN-QMLRLFME  649 (752)
T ss_pred             eeccCccccccccccc----cHHHHHHhccCcceeecC--cccCCccceeeceeeEEeeccceecCCCCcH-HHHHHHHH
Confidence            9999999988766553    344456789999999886  8899999999999999999999999876544 35555555


Q ss_pred             cCC
Q 039231          504 RKG  506 (506)
Q Consensus       504 ~~g  506 (506)
                      .||
T Consensus       650 ~KG  652 (752)
T KOG0670|consen  650 LKG  652 (752)
T ss_pred             hcC
Confidence            444

>KOG1345 consensus Serine/threonine kinase [Signal transduction mechanisms]

Probab=99.86  E-value=1.1e-22  Score=185.19  Aligned_cols=172  Identities=20%  Similarity=0.333  Sum_probs=133.8

Q ss_pred             hhhccccCccCceEEEEEEEcC-CCEEEEEEeccCCCCchhhHHHHHHhhccC-ccceeEEEEEeec-------------
Q 039231          315 NSFKYKLGQGGYGSVYKGKLLD-GSNVAVKVLNDSKGNGKEFINEVASISRTS-HVNVVALLGFCLR-------------  379 (506)
Q Consensus       315 ~~~~~~ig~G~~g~V~~~~~~~-~~~vavK~l~~~~~~~~~~~~E~~~l~~l~-h~niv~l~g~~~~-------------  379 (506)
                      +++.+.+|+|.||.+-+++++. ++.+++|-+.......++|.+|..---.|. |.||+.-+.+.++             
T Consensus        26 y~I~k~lgeG~FgkIlL~eHr~s~t~ivlKavp~p~tt~~dF~rEfhY~~~Ls~H~hIi~tY~vaFqt~d~YvF~qE~aP  105 (378)
T KOG1345|consen   26 YTINKQLGEGRFGKILLAEHRQSKTRIVLKAVPRPQTTQADFVREFHYSFFLSPHQHIIDTYEVAFQTSDAYVFVQEFAP  105 (378)
T ss_pred             hhHHHHhcccceeeEEeeeccCCceEEEeeccCcchhhHHHHHHHhccceeeccchhhhHHHHHHhhcCceEEEeeccCc
Confidence            4556789999999999999875 788999999888888899999987655554 8999876543211             


Q ss_pred             --------------cchhhhHHHHHHHHHHHHhhcCCCCeEecCcCCCcEEE-C-CCCcEEEeecCCCccccCCCcceec
Q 039231          380 --------------VAEELSSTIGIARGLEYLHLGCSTRILHFDIKPHNILL-D-EDFCPKISDFGLAKICNRKESIISM  443 (506)
Q Consensus       380 --------------~~~~l~i~~~i~~gl~~LH~~~~~~ivH~dlkp~Nill-~-~~~~~ki~dfg~a~~~~~~~~~~~~  443 (506)
                                    +.-...++.|+++||.|||   ++.+||||||.+|||| + +...+||+|||+.+..+..-.    
T Consensus       106 ~gdL~snv~~~GigE~~~K~v~~ql~SAi~fMH---sknlVHRdlK~eNiLif~~df~rvKlcDFG~t~k~g~tV~----  178 (378)
T KOG1345|consen  106 RGDLRSNVEAAGIGEANTKKVFAQLLSAIEFMH---SKNLVHRDLKAENILIFDADFYRVKLCDFGLTRKVGTTVK----  178 (378)
T ss_pred             cchhhhhcCcccccHHHHHHHHHHHHHHHHHhh---ccchhhcccccceEEEecCCccEEEeeecccccccCceeh----
Confidence                          1124568999999999999   9999999999999999 3 334799999999986554322    


Q ss_pred             ccCCCCcccccccccccc---cCCCCccccHHHHHHHHHHHHcCCCCCCCCCCC
Q 039231          444 TGARGTVGYIAPEVFCRN---IGEVSYKSDVYNYGMMIFEMTGGRKNVDVVDNG  494 (506)
Q Consensus       444 ~~~~gt~~y~aPE~l~~~---~~~~s~~~Dv~s~G~il~elltg~~pf~~~~~~  494 (506)
                       ....+..|.+||.....   .-...+.+|+|.||++++.++||+.||+.....
T Consensus       179 -~~~~~~~y~~pe~~~~~~ne~~~~~ps~D~WqfGIi~f~cltG~~PWQka~~~  231 (378)
T KOG1345|consen  179 -YLEYVNNYHAPELCDTVVNEKLVVNPSTDIWQFGIIFFYCLTGKFPWQKASIM  231 (378)
T ss_pred             -hhhhhcccCCcHHHhhccccceEecccccchheeeeeeeeecCCCcchhhhcc
Confidence             12335678999987432   124567899999999999999999999965433

>KOG1167 consensus Serine/threonine protein kinase of the CDC7 subfamily involved in DNA synthesis, repair and recombination [Replication, recombination and repair]

Probab=99.84  E-value=1.3e-21  Score=188.58  Aligned_cols=175  Identities=27%  Similarity=0.394  Sum_probs=136.7

Q ss_pred             ccccCccCceEEEEEEEc----CCCEEEEEEeccCCCCchhhHHHHHHhhccC-ccceeEEEEEe---------------
Q 039231          318 KYKLGQGGYGSVYKGKLL----DGSNVAVKVLNDSKGNGKEFINEVASISRTS-HVNVVALLGFC---------------  377 (506)
Q Consensus       318 ~~~ig~G~~g~V~~~~~~----~~~~vavK~l~~~~~~~~~~~~E~~~l~~l~-h~niv~l~g~~---------------  377 (506)
                      .++||.|.|++||+|.+.    ..+.||+|.+..... ...+.+|++.|.++. +.||+++.+++               
T Consensus        41 v~kigeGsFssv~~a~~~~~~~~~~~valk~i~~ts~-p~ri~~El~~L~~~gG~~ni~~~~~~~rnnd~v~ivlp~~~H  119 (418)
T KOG1167|consen   41 VNKIGEGSFSSVYKATDIEQDTKRRYVALKAIYRTSS-PSRILNELEMLYRLGGSDNIIKLNGCFRNNDQVAIVLPYFEH  119 (418)
T ss_pred             hccccccchhhhhhhhHhhhccccceEeeeecccccC-chHHHHHHHHHHHhccchhhhcchhhhccCCeeEEEecccCc
Confidence            367999999999999763    367899998865432 356899999999996 88999988776               


Q ss_pred             ---------eccchhhhHHHHHHHHHHHHhhcCCCCeEecCcCCCcEEECC-CCcEEEeecCCCccccCC----------
Q 039231          378 ---------LRVAEELSSTIGIARGLEYLHLGCSTRILHFDIKPHNILLDE-DFCPKISDFGLAKICNRK----------  437 (506)
Q Consensus       378 ---------~~~~~~l~i~~~i~~gl~~LH~~~~~~ivH~dlkp~Nill~~-~~~~ki~dfg~a~~~~~~----------  437 (506)
                               +...+.......+..||+++|   .+|||||||||+|+|.+. .+.-.|.|||+|......          
T Consensus       120 ~~f~~l~~~l~~~~i~~Yl~~ll~Al~~~h---~~GIvHRDiKpsNFL~n~~t~rg~LvDFgLA~~~d~~~~~~~s~~~~  196 (418)
T KOG1167|consen  120 DRFRDLYRSLSLAEIRWYLRNLLKALAHLH---KNGIVHRDIKPSNFLYNRRTQRGVLVDFGLAQRYDGYQQTEHSRSYS  196 (418)
T ss_pred             cCHHHHHhcCCHHHHHHHHHHHHHHhhhhh---ccCccccCCCccccccccccCCceEEechhHHHHHhhhhhhhhhhhh
Confidence                     233345667889999999999   999999999999999974 456789999999721000          


Q ss_pred             ---Cc-----------------------------ceecccCCCCcccccccccccccCCCCccccHHHHHHHHHHHHcCC
Q 039231          438 ---ES-----------------------------IISMTGARGTVGYIAPEVFCRNIGEVSYKSDVYNYGMMIFEMTGGR  485 (506)
Q Consensus       438 ---~~-----------------------------~~~~~~~~gt~~y~aPE~l~~~~~~~s~~~Dv~s~G~il~elltg~  485 (506)
                         ..                             ........||++|.|||++.+- +.-+.++||||.|||++-+++++
T Consensus       197 ~~~~~~~~g~~~~~~~~~~~~~p~g~~~~~~~~r~~~~anrAGT~GfRaPEvL~k~-~~QttaiDiws~GVI~Lslls~~  275 (418)
T KOG1167|consen  197 GRHATPAMGKDVHCQSVATASKPAGYYRRCNDGRPSERANRAGTPGFRAPEVLFRC-PRQTTAIDIWSAGVILLSLLSRR  275 (418)
T ss_pred             cccCCccccCcccccccccccCCCCceeccCCCccceecccCCCCCCCchHHHhhc-cCcCCccceeeccceeehhhccc
Confidence               00                             0001123499999999999765 56788999999999999999999


Q ss_pred             CCCCCCCCCcch
Q 039231          486 KNVDVVDNGSTA  497 (506)
Q Consensus       486 ~pf~~~~~~~~~  497 (506)
                      .||....++-..
T Consensus       276 ~PFf~a~dd~~a  287 (418)
T KOG1167|consen  276 YPFFKAKDDADA  287 (418)
T ss_pred             cccccCccccch
Confidence            999887665443

>KOG1290 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.82  E-value=2.6e-20  Score=182.13  Aligned_cols=121  Identities=26%  Similarity=0.353  Sum_probs=98.0

Q ss_pred             hccCCCCCccCHHHHHH-HHhhhccccCccCceEEEEEEEc-CCCEEEEEEeccCCCCchhhHHHHHHhhccC-----c-
Q 039231          296 NYRSLSPKRYGYADIKK-MTNSFKYKLGQGGYGSVYKGKLL-DGSNVAVKVLNDSKGNGKEFINEVASISRTS-----H-  367 (506)
Q Consensus       296 ~~~~~~~~~~~~~el~~-~~~~~~~~ig~G~~g~V~~~~~~-~~~~vavK~l~~~~~~~~~~~~E~~~l~~l~-----h-  367 (506)
                      .|...+.......|... .+|...++||.|-|++||++.+. +.+.||+|+.+......+..+.|+++|++++     | 
T Consensus        60 dY~kGGYHpV~IGD~F~~gRY~v~rKLGWGHFSTVWLawDtq~~r~VAlKVvKSAqhYtEaAlDEIklL~~v~~~Dp~~~  139 (590)
T KOG1290|consen   60 DYRKGGYHPVRIGDVFNGGRYHVQRKLGWGHFSTVWLAWDTQNKRYVALKVVKSAQHYTEAALDEIKLLQQVREGDPNDP  139 (590)
T ss_pred             hhhcCCCceeeccccccCceEEEEEeccccccceeEEEeeccCCeEEEEEEEehhhHHHHHHHHHHHHHHHHHhcCCCCC
Confidence            34445555666677766 67777889999999999999874 4788999999877666678899999999984     3 


Q ss_pred             --cceeEEEEEe--------------------------------eccchhhhHHHHHHHHHHHHhhcCCCCeEecCcCCC
Q 039231          368 --VNVVALLGFC--------------------------------LRVAEELSSTIGIARGLEYLHLGCSTRILHFDIKPH  413 (506)
Q Consensus       368 --~niv~l~g~~--------------------------------~~~~~~l~i~~~i~~gl~~LH~~~~~~ivH~dlkp~  413 (506)
                        .+||+|++.|                                ++...+..|+.||+.||.|||.  +.+|||-||||+
T Consensus       140 ~~~~VV~LlD~FkhsGpNG~HVCMVfEvLGdnLLklI~~s~YrGlpl~~VK~I~~qvL~GLdYLH~--ecgIIHTDlKPE  217 (590)
T KOG1290|consen  140 GKKCVVQLLDHFKHSGPNGQHVCMVFEVLGDNLLKLIKYSNYRGLPLSCVKEICRQVLTGLDYLHR--ECGIIHTDLKPE  217 (590)
T ss_pred             CCceeeeeeccceecCCCCcEEEEEehhhhhHHHHHHHHhCCCCCcHHHHHHHHHHHHHHHHHHHH--hcCccccCCCcc
Confidence              3599999877                                3334467899999999999998  679999999999


Q ss_pred             cEEEC
Q 039231          414 NILLD  418 (506)
Q Consensus       414 Nill~  418 (506)
                      |||+.
T Consensus       218 NvLl~  222 (590)
T KOG1290|consen  218 NVLLC  222 (590)
T ss_pred             eeeee
Confidence            99993

>cd00180 PKc Catalytic domain of Protein Kinases

Probab=99.82  E-value=1.5e-19  Score=166.96  Aligned_cols=155  Identities=38%  Similarity=0.661  Sum_probs=128.4

Q ss_pred             cCccCceEEEEEEEcC-CCEEEEEEeccCCCC--chhhHHHHHHhhccCccceeEEEEEee-------------------
Q 039231          321 LGQGGYGSVYKGKLLD-GSNVAVKVLNDSKGN--GKEFINEVASISRTSHVNVVALLGFCL-------------------  378 (506)
Q Consensus       321 ig~G~~g~V~~~~~~~-~~~vavK~l~~~~~~--~~~~~~E~~~l~~l~h~niv~l~g~~~-------------------  378 (506)
                      ||+|.+|.||+++..+ ++.+++|++......  .+.+.+|++.+++++|++++++++++.                   
T Consensus         1 l~~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~~~e~~~~~~l~~   80 (215)
T cd00180           1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSSLLEELLREIEILKKLNHPNIVKLYGVFEDENHLYLVMEYCEGGSLKD   80 (215)
T ss_pred             CCcCCceEEEEEEecCCCcEEEEEEeccccchhHHHHHHHHHHHHHhcCCCCeeeEeeeeecCCeEEEEEecCCCCcHHH
Confidence            6899999999999865 899999999765442  477999999999999999999997761                   


Q ss_pred             ---------ccchhhhHHHHHHHHHHHHhhcCCCCeEecCcCCCcEEECC-CCcEEEeecCCCccccCCCcceecccCCC
Q 039231          379 ---------RVAEELSSTIGIARGLEYLHLGCSTRILHFDIKPHNILLDE-DFCPKISDFGLAKICNRKESIISMTGARG  448 (506)
Q Consensus       379 ---------~~~~~l~i~~~i~~gl~~LH~~~~~~ivH~dlkp~Nill~~-~~~~ki~dfg~a~~~~~~~~~~~~~~~~g  448 (506)
                               +....+.++.++++++++||   +.+++|+||+|.||+++. ++.++|+|||.+........  ......+
T Consensus        81 ~~~~~~~~~~~~~~~~~~~~l~~~l~~lh---~~~~~H~dl~~~ni~~~~~~~~~~l~d~~~~~~~~~~~~--~~~~~~~  155 (215)
T cd00180          81 LLKENEGKLSEDEILRILLQILEGLEYLH---SNGIIHRDLKPENILLDSDNGKVKLADFGLSKLLTSDKS--LLKTIVG  155 (215)
T ss_pred             HHHhccCCCCHHHHHHHHHHHHHHHHHHH---hCCeeccCCCHhhEEEeCCCCcEEEecCCceEEccCCcc--hhhcccC
Confidence                     12235568899999999999   889999999999999999 89999999999986654321  1133557


Q ss_pred             CcccccccccccccCCCCccccHHHHHHHHHHH
Q 039231          449 TVGYIAPEVFCRNIGEVSYKSDVYNYGMMIFEM  481 (506)
Q Consensus       449 t~~y~aPE~l~~~~~~~s~~~Dv~s~G~il~el  481 (506)
                      ...|++||.+... ...+.++|+|++|+++++|
T Consensus       156 ~~~~~~pe~~~~~-~~~~~~~D~~~lg~~~~~l  187 (215)
T cd00180         156 TPAYMAPEVLLGK-GYYSEKSDIWSLGVILYEL  187 (215)
T ss_pred             CCCccChhHhccc-CCCCchhhhHHHHHHHHHH
Confidence            8889999998442 3678899999999999998

Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which

>PRK09188 serine/threonine protein kinase; Provisional

Probab=99.80  E-value=1.4e-19  Score=180.06  Aligned_cols=143  Identities=22%  Similarity=0.232  Sum_probs=108.7

Q ss_pred             hhhccccCccCceEEEEEEEc--CCCEEEEEEeccCC------CCchhhHHHHHHhhccCccceeE-EEEEe--------
Q 039231          315 NSFKYKLGQGGYGSVYKGKLL--DGSNVAVKVLNDSK------GNGKEFINEVASISRTSHVNVVA-LLGFC--------  377 (506)
Q Consensus       315 ~~~~~~ig~G~~g~V~~~~~~--~~~~vavK~l~~~~------~~~~~~~~E~~~l~~l~h~niv~-l~g~~--------  377 (506)
                      +.+.+.||+|+||+||+|++.  +++.+|||++....      ...+.+.+|+++|++++|+|++. ++++.        
T Consensus        20 Y~~~~~IG~G~fg~Vy~a~~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~E~~iL~~L~h~~iv~~l~~~~~~~LVmE~   99 (365)
T PRK09188         20 FVETAVLKRDVFSTVERGYFAGDPGTARAVRRRVSEVPWWSKPLARHLAAREIRALKTVRGIGVVPQLLATGKDGLVRGW   99 (365)
T ss_pred             ceEccEEeecCcEEEEEEEEcCCCCeEEEEEEecccccccccHHHHHHHHHHHHHHHhccCCCCCcEEEEcCCcEEEEEc
Confidence            344568999999999999875  47778999875321      12356889999999999999984 43221        


Q ss_pred             -----ec---cchhhhHHHHHHHHHHHHhhcCCCCeEecCc-CCCcEEECCCCcEEEeecCCCccccCCCccee------
Q 039231          378 -----LR---VAEELSSTIGIARGLEYLHLGCSTRILHFDI-KPHNILLDEDFCPKISDFGLAKICNRKESIIS------  442 (506)
Q Consensus       378 -----~~---~~~~l~i~~~i~~gl~~LH~~~~~~ivH~dl-kp~Nill~~~~~~ki~dfg~a~~~~~~~~~~~------  442 (506)
                           +.   ......++.|+++||+|||   +++|+|||| ||+|||++.++.+||+|||+|+..........      
T Consensus       100 ~~G~~L~~~~~~~~~~~~~~i~~aL~~lH---~~gIiHrDL~KP~NILv~~~~~ikLiDFGlA~~~~~~~~~~~~~~~~d  176 (365)
T PRK09188        100 TEGVPLHLARPHGDPAWFRSAHRALRDLH---RAGITHNDLAKPQNWLMGPDGEAAVIDFQLASVFRRRGALYRIAAYED  176 (365)
T ss_pred             cCCCCHHHhCccchHHHHHHHHHHHHHHH---HCCCeeCCCCCcceEEEcCCCCEEEEECccceecccCcchhhhhhhhh
Confidence                 10   0112467889999999999   899999999 99999999999999999999987654332111      


Q ss_pred             cccCCCCccccccccccc
Q 039231          443 MTGARGTVGYIAPEVFCR  460 (506)
Q Consensus       443 ~~~~~gt~~y~aPE~l~~  460 (506)
                      .....+++.|+|||.+..
T Consensus       177 ~~~~~~~~~~~~pe~~~~  194 (365)
T PRK09188        177 LRHLLKHKRTYAPDALTP  194 (365)
T ss_pred             hhhhhccCccCCcccCCh
Confidence            134567888999999854

>PLN00181 protein SPA1-RELATED; Provisional

Probab=99.77  E-value=1.6e-19  Score=200.70  Aligned_cols=108  Identities=19%  Similarity=0.212  Sum_probs=82.3

Q ss_pred             eccchhhhHHHHHHHHHHHHhhcCCCCeEecCcCCCcEEECC-------------------CCcEEEeecCCCccccCCC
Q 039231          378 LRVAEELSSTIGIARGLEYLHLGCSTRILHFDIKPHNILLDE-------------------DFCPKISDFGLAKICNRKE  438 (506)
Q Consensus       378 ~~~~~~l~i~~~i~~gl~~LH~~~~~~ivH~dlkp~Nill~~-------------------~~~~ki~dfg~a~~~~~~~  438 (506)
                      ++..+.+.++.||++||+|||   +++|+||||||+||||+.                   ++.+||+|||+++......
T Consensus        77 ~~~~~~~~i~~qi~~al~~lH---~~gIvHrDlKP~NiLl~~~~~~k~~d~~~~~~~~~~~~~~~ki~DfG~a~~~~~~~  153 (793)
T PLN00181         77 VDAFECFHVFRQIVEIVNAAH---SQGIVVHNVRPSCFVMSSFNHVSFIESASCSDSGSDEDATTKSREIGSSRREEILS  153 (793)
T ss_pred             ccHHHHHHHHHHHHHHHHHHH---hCCeeeccCCchhEEEcccCcEEEeeccccCcccccccCccccccccccccccccc
Confidence            455567889999999999999   999999999999999954                   4456666666665421100


Q ss_pred             c--------------ceecccCCCCcccccccccccccCCCCccccHHHHHHHHHHHHcCCCCCCC
Q 039231          439 S--------------IISMTGARGTVGYIAPEVFCRNIGEVSYKSDVYNYGMMIFEMTGGRKNVDV  490 (506)
Q Consensus       439 ~--------------~~~~~~~~gt~~y~aPE~l~~~~~~~s~~~Dv~s~G~il~elltg~~pf~~  490 (506)
                      .              ........||+.|||||++.+.  .++.++|||||||+||||++|..|+..
T Consensus       154 ~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~--~~~~~sDVwSlGviL~ELl~~~~~~~~  217 (793)
T PLN00181        154 ERRIEKLEEVKKQPFPMKQILAMEMSWYTSPEEDNGS--SSNCASDVYRLGVLLFELFCPVSSREE  217 (793)
T ss_pred             ccchhhhhccccCCCcccccccCCCcceEChhhhccC--CCCchhhhhhHHHHHHHHhhCCCchhh
Confidence            0              0000123578899999998654  689999999999999999999998764

>KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms]

Probab=99.77  E-value=5.3e-20  Score=185.90  Aligned_cols=171  Identities=28%  Similarity=0.372  Sum_probs=138.2

Q ss_pred             ccccCccCceEEEEEEEc-CCCEEEEEEeccCCC-CchhhHHHHHHhhccCccceeEEEEEe------------------
Q 039231          318 KYKLGQGGYGSVYKGKLL-DGSNVAVKVLNDSKG-NGKEFINEVASISRTSHVNVVALLGFC------------------  377 (506)
Q Consensus       318 ~~~ig~G~~g~V~~~~~~-~~~~vavK~l~~~~~-~~~~~~~E~~~l~~l~h~niv~l~g~~------------------  377 (506)
                      -+.+|+|.+|.||+|++. .+...|+|+++-... ...-+..|+-+++.-+|||||.++|-+                  
T Consensus        20 lqrvgsgTygdvyKaRd~~s~elaavkvVkLep~dd~~~iqqei~~~~dc~h~nivay~gsylr~dklwicMEycgggsl   99 (829)
T KOG0576|consen   20 LQRVGSGTYGDVYKARDKRSGELAAVKVVKLEPGDDFSGIQQEIGMLRDCRHPNIVAYFGSYLRRDKLWICMEYCGGGSL   99 (829)
T ss_pred             eeeecCCcccchhhhcccccCchhhheeeeccCCccccccccceeeeecCCCcChHHHHhhhhhhcCcEEEEEecCCCcc
Confidence            356999999999999974 589999999986543 336677899999999999999987644                  


Q ss_pred             ---------eccchhhhHHHHHHHHHHHHhhcCCCCeEecCcCCCcEEECCCCcEEEeecCCCccccCCCcceecccCCC
Q 039231          378 ---------LRVAEELSSTIGIARGLEYLHLGCSTRILHFDIKPHNILLDEDFCPKISDFGLAKICNRKESIISMTGARG  448 (506)
Q Consensus       378 ---------~~~~~~l~i~~~i~~gl~~LH~~~~~~ivH~dlkp~Nill~~~~~~ki~dfg~a~~~~~~~~~~~~~~~~g  448 (506)
                               +.+.+.....+..++|++|||   +++-+|||||-.||++++.+.+|++|||.+..+...-  .......|
T Consensus       100 Qdiy~~TgplselqiayvcRetl~gl~ylh---s~gk~hRdiKGanilltd~gDvklaDfgvsaqitati--~KrksfiG  174 (829)
T KOG0576|consen  100 QDIYHVTGPLSELQIAYVCRETLQGLKYLH---SQGKIHRDIKGANILLTDEGDVKLADFGVSAQITATI--AKRKSFIG  174 (829)
T ss_pred             cceeeecccchhHHHHHHHhhhhccchhhh---cCCcccccccccceeecccCceeecccCchhhhhhhh--hhhhcccC
Confidence                     223334456678999999999   9999999999999999999999999999986554321  12356789


Q ss_pred             Ccccccccccc-cccCCCCccccHHHHHHHHHHHHcCCCCCCCCCC
Q 039231          449 TVGYIAPEVFC-RNIGEVSYKSDVYNYGMMIFEMTGGRKNVDVVDN  493 (506)
Q Consensus       449 t~~y~aPE~l~-~~~~~~s~~~Dv~s~G~il~elltg~~pf~~~~~  493 (506)
                      |+.|||||+-. +..+.|.+++|||+.|+...|+-.-.+|.....+
T Consensus       175 tpywmapEvaaverkggynqlcdiwa~gitAiel~eLqpplfdlhp  220 (829)
T KOG0576|consen  175 TPYWMAPEVAAVERKGGYNQLCDIWALGITAIELGELQPPLFDLHP  220 (829)
T ss_pred             CccccchhHHHHHhcccccccccccccccchhhhhhcCCcccccch
Confidence            99999999863 3346789999999999999999988888765443

>smart00750 KIND kinase non-catalytic C-lobe domain

Probab=99.75  E-value=2e-18  Score=156.24  Aligned_cols=96  Identities=25%  Similarity=0.284  Sum_probs=83.0

Q ss_pred             eccchhhhHHHHHHHHHHHHhhcCCCCeEecCcCCCcEEECCCCcEEEeecCCCccccCCCcceecccCCCCcccccccc
Q 039231          378 LRVAEELSSTIGIARGLEYLHLGCSTRILHFDIKPHNILLDEDFCPKISDFGLAKICNRKESIISMTGARGTVGYIAPEV  457 (506)
Q Consensus       378 ~~~~~~l~i~~~i~~gl~~LH~~~~~~ivH~dlkp~Nill~~~~~~ki~dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~  457 (506)
                      +++.+++.++.|++.||+|||   +++      ||+|||++.++.+|+  ||+++......       ..|++.|+|||+
T Consensus        14 l~~~~~~~i~~qi~~~L~~lH---~~~------kp~Nil~~~~~~~~~--fG~~~~~~~~~-------~~g~~~y~aPE~   75 (176)
T smart00750       14 LNEEEIWAVCLQCLRALRELH---RQA------KSGNILLTWDGLLKL--DGSVAFKTPEQ-------SRVDPYFMAPEV   75 (176)
T ss_pred             CCHHHHHHHHHHHHHHHHHHH---hcC------CcccEeEcCccceee--ccceEeecccc-------CCCcccccChHH
Confidence            678889999999999999999   555      999999999999999  99988654322       357899999999


Q ss_pred             cccccCCCCccccHHHHHHHHHHHHcCCCCCCCCCC
Q 039231          458 FCRNIGEVSYKSDVYNYGMMIFEMTGGRKNVDVVDN  493 (506)
Q Consensus       458 l~~~~~~~s~~~Dv~s~G~il~elltg~~pf~~~~~  493 (506)
                      +.+.  .++.++|||||||++|||++|+.||.....
T Consensus        76 ~~~~--~~~~~~DiwSlG~il~elltg~~p~~~~~~  109 (176)
T smart00750       76 IQGQ--SYTEKADIYSLGITLYEALDYELPYNEERE  109 (176)
T ss_pred             hcCC--CCcchhhHHHHHHHHHHHHhCCCCccccch
Confidence            9654  788999999999999999999999976543

It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features

>KOG1164 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms]

Probab=99.75  E-value=9.6e-18  Score=166.87  Aligned_cols=177  Identities=23%  Similarity=0.283  Sum_probs=134.0

Q ss_pred             hhhccccCccCceEEEEEEEcCC--CEEEEEEeccCCC-CchhhHHHHHHhhccCc----cceeEEEEEe----------
Q 039231          315 NSFKYKLGQGGYGSVYKGKLLDG--SNVAVKVLNDSKG-NGKEFINEVASISRTSH----VNVVALLGFC----------  377 (506)
Q Consensus       315 ~~~~~~ig~G~~g~V~~~~~~~~--~~vavK~l~~~~~-~~~~~~~E~~~l~~l~h----~niv~l~g~~----------  377 (506)
                      +.+.++||+|+||.||++.....  ..+|+|.-..... ....+..|..++..+.+    +++..+++..          
T Consensus        20 ~~i~~~iG~G~fG~V~~v~~~~~~~~~~a~K~e~~~~~~~~~~l~~E~~vl~~l~~~~~~~~~~~~~~~G~~~~~~~~iV   99 (322)
T KOG1164|consen   20 YKLGKKIGEGGFGAVYLVSDKSEKNKEYAKKLEKKELGSKPSVLKIEIQVLKKLEKKNGPSHFPKLLDHGRSTEDFNFIV   99 (322)
T ss_pred             eEEeeeccccCCceEEEEEecCCCCeeEEEEEEEecccCCCccchhHHHHHHHHhhhcCCCCCCEEEEeccCCCceeEEE
Confidence            34467899999999999997553  4788888765432 22368888888888863    3455554333          


Q ss_pred             -------------------eccchhhhHHHHHHHHHHHHhhcCCCCeEecCcCCCcEEECCC-----CcEEEeecCCCc-
Q 039231          378 -------------------LRVAEELSSTIGIARGLEYLHLGCSTRILHFDIKPHNILLDED-----FCPKISDFGLAK-  432 (506)
Q Consensus       378 -------------------~~~~~~l~i~~~i~~gl~~LH~~~~~~ivH~dlkp~Nill~~~-----~~~ki~dfg~a~-  432 (506)
                                         +.....+.++.|++.+|++||   +.|++||||||.|+++...     ..+.|.|||+++ 
T Consensus       100 M~l~G~sL~dl~~~~~~~~fs~~T~l~ia~q~l~~l~~lH---~~G~iHRDiKp~N~~~g~~~~~~~~~~~llDfGlar~  176 (322)
T KOG1164|consen  100 MSLLGPSLEDLRKRNPPGRFSRKTVLRIAIQNLNALEDLH---SKGFIHRDIKPENFVVGQSSRSEVRTLYLLDFGLARR  176 (322)
T ss_pred             EeccCccHHHHHHhCCCCCcCHhHHHHHHHHHHHHHHHHH---hcCcccCCcCHHHeeecCCCCcccceEEEEecCCCcc
Confidence                               223346789999999999999   9999999999999999754     469999999998 


Q ss_pred             -cccCCCc---cee---cccCCCCcccccccccccccCCCCccccHHHHHHHHHHHHcCCCCCCCCCCCcc
Q 039231          433 -ICNRKES---IIS---MTGARGTVGYIAPEVFCRNIGEVSYKSDVYNYGMMIFEMTGGRKNVDVVDNGST  496 (506)
Q Consensus       433 -~~~~~~~---~~~---~~~~~gt~~y~aPE~l~~~~~~~s~~~Dv~s~G~il~elltg~~pf~~~~~~~~  496 (506)
                       .......   ...   ....+||..|.++....+.  ..+.+.|+||++.++.|++.|..||........
T Consensus       177 ~~~~~~~~~~~~~~r~~~~~~rGT~ry~S~~~H~~~--e~~r~DDles~~Y~l~el~~g~LPW~~~~~~~~  245 (322)
T KOG1164|consen  177 FKYVGDSGGNLRPPRPQKGLFRGTLRYASINVHLGI--EQGRRDDLESLFYMLLELLKGSLPWEALEMTDL  245 (322)
T ss_pred             ccccCCCCcccccCCCCccCCCCccccccHHHhCCC--ccCCchhhhhHHHHHHHHhcCCCCCccccccch
Confidence             3221111   011   1235699999999988664  789999999999999999999999987765443

>KOG1165 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms]

Probab=99.73  E-value=2.8e-17  Score=154.02  Aligned_cols=180  Identities=21%  Similarity=0.303  Sum_probs=140.2

Q ss_pred             hhhccccCccCceEEEEEE-EcCCCEEEEEEeccCCCCchhhHHHHHHhhccC-ccceeEEEEEe---------------
Q 039231          315 NSFKYKLGQGGYGSVYKGK-LLDGSNVAVKVLNDSKGNGKEFINEVASISRTS-HVNVVALLGFC---------------  377 (506)
Q Consensus       315 ~~~~~~ig~G~~g~V~~~~-~~~~~~vavK~l~~~~~~~~~~~~E~~~l~~l~-h~niv~l~g~~---------------  377 (506)
                      +...++||+|+||..+.|+ +-++++||||.- ..+...-++..|.+..+.|. -+.|...+-|-               
T Consensus        30 yrVGkKIGeGsFG~lf~G~Nl~nne~VAIKfE-PrkS~APQLrdEYr~YKlL~g~~GIP~vYYFGqeG~~NiLVidLLGP  108 (449)
T KOG1165|consen   30 YRVGKKIGEGSFGVLFLGKNLYNNEPVAIKFE-PRKSEAPQLRDEYRTYKLLGGTEGIPQVYYFGQEGKYNILVIDLLGP  108 (449)
T ss_pred             ceeccccccCcceeeecccccccCceEEEEec-cccCCcchHHHHHHHHHHHcCCCCCCceeeeccccchhhhhhhhhCc
Confidence            3446789999999999997 457999999954 33445567888888888875 45555544332               


Q ss_pred             ------------eccchhhhHHHHHHHHHHHHhhcCCCCeEecCcCCCcEEECCC-----CcEEEeecCCCccccCCCcc
Q 039231          378 ------------LRVAEELSSTIGIARGLEYLHLGCSTRILHFDIKPHNILLDED-----FCPKISDFGLAKICNRKESI  440 (506)
Q Consensus       378 ------------~~~~~~l~i~~~i~~gl~~LH~~~~~~ivH~dlkp~Nill~~~-----~~~ki~dfg~a~~~~~~~~~  440 (506)
                                  +....++.+|.|++.-++|+|   ++.+|.|||||+|+||...     ..+.|+|||+|+......+.
T Consensus       109 SLEDLFD~CgR~FSvKTV~miA~Qmi~rie~vH---~k~LIYRDIKPdNFLIGrp~~k~~n~IhiiDFGmAK~YrDp~Tk  185 (449)
T KOG1165|consen  109 SLEDLFDLCGRRFSVKTVAMIAKQMITRIEYVH---EKDLIYRDIKPDNFLIGRPGTKDANVIHIIDFGMAKEYRDPKTK  185 (449)
T ss_pred             CHHHHHHHhcCcccHHhHHHHHHHHHHHHHHHH---hcceeecccCccceeecCCCCCCCceEEEEeccchhhhcCcccc
Confidence                        455667889999999999999   9999999999999999543     35899999999987543321


Q ss_pred             -----eecccCCCCcccccccccccccCCCCccccHHHHHHHHHHHHcCCCCCCCCCCCcchhhh
Q 039231          441 -----ISMTGARGTVGYIAPEVFCRNIGEVSYKSDVYNYGMMIFEMTGGRKNVDVVDNGSTALDL  500 (506)
Q Consensus       441 -----~~~~~~~gt~~y~aPE~l~~~~~~~s~~~Dv~s~G~il~elltg~~pf~~~~~~~~~~~~  500 (506)
                           .+.....||.+||+-....+.  +.+...|+=|+|=+++..|-|..||+...........
T Consensus       186 qHIPYrE~KSLsGTARYMSINTHlGr--EQSRRDDLEaLGHvFmYFLRGsLPWQGLKA~tnK~kY  248 (449)
T KOG1165|consen  186 QHIPYREHKSLSGTARYMSINTHLGR--EQSRRDDLEALGHVFMYFLRGSLPWQGLKADTNKEKY  248 (449)
T ss_pred             ccCccccccccccceeeeEeeccccc--hhhhhhhHHHhhhhhhhhccCCCccccccCcchHHHH
Confidence                 123446799999998887665  7788999999999999999999999998765444333

>PF13947 GUB_WAK_bind: Wall-associated receptor kinase galacturonan-binding

Probab=99.72  E-value=1.5e-17  Score=137.02  Aligned_cols=101  Identities=24%  Similarity=0.395  Sum_probs=76.5

Q ss_pred             CCCCCCCCCCCCCCCCcCCCCCCCCCCCC--CcccccccCCCcceEEeecCCcEEEEEEecCc-EEEEEcccccccCCCC
Q 039231           29 KICPYSFPPCGNLGQFTFPFTDPKHPECG--LMAVDNCIEPVQRIRLGKAGPFYNILNIAQDV-SITLEDQVFQNHLNER  105 (506)
Q Consensus        29 ~~C~~~~~~CG~~~~I~yPF~l~~~~~CG--p~f~l~C~~~~~~~~~~~~~~~y~V~~I~y~~-ti~v~d~~~~~~~~~~  105 (506)
                      +.|+.   +|||+ +|+||||+++  +||  |+|+|+|+++.+.+.+.+.++.|+|++|+|++ +++|.++..+.++...
T Consensus         2 ~~C~~---~CGnv-~IpYPFgi~~--~C~~~~~F~L~C~~~~~~~~l~l~~~~~~V~~I~~~~~~i~v~~~~~~~~~~~~   75 (106)
T PF13947_consen    2 PGCPS---SCGNV-SIPYPFGIGP--GCGRDPGFELTCNNNTSPPKLLLSSGNYEVLSISYENGTIRVSDPISSNCYSSS   75 (106)
T ss_pred             CCCCC---ccCCE-eecCCCccCC--CCCCCCCcEEECCCCCCCceeEecCCcEEEEEEecCCCEEEEEeccccceecCC
Confidence            56974   79999 5999999955  699  99999999986678888889999999999999 9999887765543332


Q ss_pred             CCC-CCCcCCCCCccccccccceeEEEEccCC
Q 039231          106 SCE-SFENLTLPTSASLSFRIKSNLSLFRCTD  136 (506)
Q Consensus       106 ~C~-~~~~~~l~~~f~~s~~~~~~~~~~~C~~  136 (506)
                      .-. ...++++..||.+++.. |.++++||+.
T Consensus        76 ~~~~~~~~~~~~~~~~~s~~~-N~~~~~GC~t  106 (106)
T PF13947_consen   76 SSNSSNSNLSLNGPFFFSSSS-NKFTVVGCNT  106 (106)
T ss_pred             CCcccccEEeecCCceEccCC-cEEEEECCCC
Confidence            222 12244555578777654 4466789974

>KOG0195 consensus Integrin-linked kinase [Signal transduction mechanisms]

Probab=99.72  E-value=4.9e-18  Score=154.87  Aligned_cols=173  Identities=21%  Similarity=0.441  Sum_probs=131.7

Q ss_pred             ccccCccCceEEEEEEEcCCCEEEEEEecc---CCCCchhhHHHHHHhhccCccceeEEEEEe-----------------
Q 039231          318 KYKLGQGGYGSVYKGKLLDGSNVAVKVLND---SKGNGKEFINEVASISRTSHVNVVALLGFC-----------------  377 (506)
Q Consensus       318 ~~~ig~G~~g~V~~~~~~~~~~vavK~l~~---~~~~~~~~~~E~~~l~~l~h~niv~l~g~~-----------------  377 (506)
                      ..+|...-.|..|+|++ .|..+++|+++-   +....++|.+|.-.|+-+.||||+.++|.|                 
T Consensus       195 ~tkl~e~hsgelwrgrw-qgndivakil~vr~~t~risrdfneefp~lrifshpnilpvlgacnsppnlv~isq~mp~gs  273 (448)
T KOG0195|consen  195 ITKLAESHSGELWRGRW-QGNDIVAKILNVREVTARISRDFNEEFPALRIFSHPNILPVLGACNSPPNLVIISQYMPFGS  273 (448)
T ss_pred             hhhhccCCCcccccccc-cCcchhhhhhhhhhcchhhcchhhhhCcceeeecCCchhhhhhhccCCCCceEeeeeccchH
Confidence            34688889999999999 456677788763   334457899999999999999999999988                 


Q ss_pred             ------------eccchhhhHHHHHHHHHHHHhhcCCCCeEecCcCCCcEEECCCCcEEEeecCCCccccCCCcceeccc
Q 039231          378 ------------LRVAEELSSTIGIARGLEYLHLGCSTRILHFDIKPHNILLDEDFCPKISDFGLAKICNRKESIISMTG  445 (506)
Q Consensus       378 ------------~~~~~~l~i~~~i~~gl~~LH~~~~~~ivH~dlkp~Nill~~~~~~ki~dfg~a~~~~~~~~~~~~~~  445 (506)
                                  .+..+..+++.++++||+|||+. ++-|.-..|.++.+++|++.+++|+ .+-+++-      .....
T Consensus       274 lynvlhe~t~vvvd~sqav~faldiargmaflhsl-ep~ipr~~lns~hvmidedltaris-mad~kfs------fqe~g  345 (448)
T KOG0195|consen  274 LYNVLHEQTSVVVDHSQAVRFALDIARGMAFLHSL-EPMIPRFYLNSKHVMIDEDLTARIS-MADTKFS------FQEVG  345 (448)
T ss_pred             HHHHHhcCccEEEecchHHHHHHHHHhhHHHHhhc-chhhhhhhcccceEEecchhhhhee-cccceee------eeccc
Confidence                        34556788999999999999964 3445556799999999999988874 2222211      11122


Q ss_pred             CCCCcccccccccccccCC-CCccccHHHHHHHHHHHHcCCCCCCCCCCCcchhh
Q 039231          446 ARGTVGYIAPEVFCRNIGE-VSYKSDVYNYGMMIFEMTGGRKNVDVVDNGSTALD  499 (506)
Q Consensus       446 ~~gt~~y~aPE~l~~~~~~-~s~~~Dv~s~G~il~elltg~~pf~~~~~~~~~~~  499 (506)
                      ..-.+.||+||.+.++... .-.+.|+|||+++||||.|++.||....+-|-..+
T Consensus       346 r~y~pawmspealqrkped~n~raadmwsfaillwel~trevpfadlspmecgmk  400 (448)
T KOG0195|consen  346 RAYSPAWMSPEALQRKPEDLNIRAADMWSFAILLWELNTREVPFADLSPMECGMK  400 (448)
T ss_pred             cccCcccCCHHHHhcCchhcchhhhhHHHHHHHHHHhhccccccccCCchhhhhh
Confidence            3447889999999765322 23468999999999999999999998877665443

>COG0515 SPS1 Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair]

Probab=99.71  E-value=1.2e-16  Score=157.80  Aligned_cols=171  Identities=37%  Similarity=0.519  Sum_probs=139.0

Q ss_pred             ccccCccCceEEEEEEEcCCCEEEEEEeccCCC----CchhhHHHHHHhhccCcc-ceeEEEEEeec-------------
Q 039231          318 KYKLGQGGYGSVYKGKLLDGSNVAVKVLNDSKG----NGKEFINEVASISRTSHV-NVVALLGFCLR-------------  379 (506)
Q Consensus       318 ~~~ig~G~~g~V~~~~~~~~~~vavK~l~~~~~----~~~~~~~E~~~l~~l~h~-niv~l~g~~~~-------------  379 (506)
                      .+.||.|+|+.||++...  ..+++|.+.....    ....+.+|+..++.+.|+ +|+++.+.+..             
T Consensus         5 ~~~l~~g~~~~v~~~~~~--~~~~~k~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~   82 (384)
T COG0515           5 LRKLGEGSFGEVYLARDR--KLVALKVLAKKLESKSKEVERFLREIQILASLNHPPNIVKLYDFFQDEGSLYLVMEYVDG   82 (384)
T ss_pred             EEeecCCCCeEEEEEEec--cEEEEEeechhhccchhHHHHHHHHHHHHHHccCCcceeeEEEEEecCCEEEEEEecCCC
Confidence            456899999999999986  7899999975432    256789999999999988 79999876611             


Q ss_pred             -----------------cchhhhHHHHHHHHHHHHhhcCCCCeEecCcCCCcEEECCCC-cEEEeecCCCccccCCCcce
Q 039231          380 -----------------VAEELSSTIGIARGLEYLHLGCSTRILHFDIKPHNILLDEDF-CPKISDFGLAKICNRKESII  441 (506)
Q Consensus       380 -----------------~~~~l~i~~~i~~gl~~LH~~~~~~ivH~dlkp~Nill~~~~-~~ki~dfg~a~~~~~~~~~~  441 (506)
                                       ......+..|++.++.|+|   ..+++|||+||+||+++... .+++.|||.++.........
T Consensus        83 ~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~H---~~~~~hrd~kp~nil~~~~~~~~~l~dfg~~~~~~~~~~~~  159 (384)
T COG0515          83 GSLEDLLKKIGRKGPLSESEALFILAQILSALEYLH---SKGIIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPGSTS  159 (384)
T ss_pred             CcHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHH---hCCeeccCCCHHHeeecCCCCeEEEeccCcceecCCCCccc
Confidence                             1124457889999999999   89999999999999999988 79999999998665443221


Q ss_pred             ----ecccCCCCccccccccccccc-CCCCccccHHHHHHHHHHHHcCCCCCCCCCC
Q 039231          442 ----SMTGARGTVGYIAPEVFCRNI-GEVSYKSDVYNYGMMIFEMTGGRKNVDVVDN  493 (506)
Q Consensus       442 ----~~~~~~gt~~y~aPE~l~~~~-~~~s~~~Dv~s~G~il~elltg~~pf~~~~~  493 (506)
                          ......++..|+|||.+.... ...+...|+||+|++++++++|..||.....
T Consensus       160 ~~~~~~~~~~~t~~~~~pe~~~~~~~~~~~~~~D~~s~g~~~~~~~~~~~p~~~~~~  216 (384)
T COG0515         160 SIPALPSTSVGTPGYMAPEVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKN  216 (384)
T ss_pred             cccccccccccccccCCHHHhcCCCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCc
Confidence                235678999999999986531 3678899999999999999999999776654

>PRK12274 serine/threonine protein kinase; Provisional

Probab=99.70  E-value=8.1e-17  Score=146.14  Aligned_cols=171  Identities=18%  Similarity=0.099  Sum_probs=124.6

Q ss_pred             cccCccCceEEEEEEEcCCCEEEEEEeccCCCCc-----hhhHHHHHHhhccC-ccceeEEEEEe---ec----------
Q 039231          319 YKLGQGGYGSVYKGKLLDGSNVAVKVLNDSKGNG-----KEFINEVASISRTS-HVNVVALLGFC---LR----------  379 (506)
Q Consensus       319 ~~ig~G~~g~V~~~~~~~~~~vavK~l~~~~~~~-----~~~~~E~~~l~~l~-h~niv~l~g~~---~~----------  379 (506)
                      ..|++|+||+|+.+.- ++..++.+.++....-.     ..+.+|+++|+++. |+++.+++++.   +.          
T Consensus         8 ~~l~~~~f~~v~~~~~-~~~k~~~~~l~~~~~~~~~~~~~l~~rE~~iL~~L~~~~~vP~ll~~~~~~lvmeyI~G~~L~   86 (218)
T PRK12274          8 EPLKSDTFGRILLVRG-GERKFVRRDLSAAPWWLRGVAWWLARREALALRQLDGLPRTPRLLHWDGRHLDRSYLAGAAMY   86 (218)
T ss_pred             eeecCCCcceEEEeec-CCceeeecccccchhhhhhHHHHHHHHHHHHHHhcCCCCCCCEEEEEcCEEEEEeeecCccHH
Confidence            4699999999997765 77888888887654422     25789999999995 46777777542   10          


Q ss_pred             ---cchhhhHHHHHHHHHHHHhhcCCCCeEecCc-CCCcEEECCCCcEEEeecCCCccccCCCcc----e--e-----cc
Q 039231          380 ---VAEELSSTIGIARGLEYLHLGCSTRILHFDI-KPHNILLDEDFCPKISDFGLAKICNRKESI----I--S-----MT  444 (506)
Q Consensus       380 ---~~~~l~i~~~i~~gl~~LH~~~~~~ivH~dl-kp~Nill~~~~~~ki~dfg~a~~~~~~~~~----~--~-----~~  444 (506)
                         ......++.|++++|.++|   .+||+|||| ||.|||+++++.++|+|||++.........    .  .     ..
T Consensus        87 ~~~~~~~~~~~~qi~~~L~~lH---~~GIvHrDL~kp~NILv~~~g~i~LIDFG~A~~~~~~~~~~r~L~~rDl~~llk~  163 (218)
T PRK12274         87 QRPPRGDLAYFRAARRLLQQLH---RCGVAHNDLAKEANWLVQEDGSPAVIDFQLAVRGNPRARWMRLLAREDLRHLLKH  163 (218)
T ss_pred             hhhhhhhHHHHHHHHHHHHHHH---HCcCccCCCCCcceEEEcCCCCEEEEECCCceecCCcchHHHHHHHHHHHHHHHH
Confidence               0122457789999999999   999999999 799999999999999999999855432210    0  0     00


Q ss_pred             cCCCCcccccccccccccCCCC-ccccHHHHHHHHHHHHcCCCCCCCCCCC
Q 039231          445 GARGTVGYIAPEVFCRNIGEVS-YKSDVYNYGMMIFEMTGGRKNVDVVDNG  494 (506)
Q Consensus       445 ~~~gt~~y~aPE~l~~~~~~~s-~~~Dv~s~G~il~elltg~~pf~~~~~~  494 (506)
                      ....++.|++|+...-. ...+ ...++++-|.-+|.++||+.|.-.+.++
T Consensus       164 ~~~y~~~~l~~~~~~~l-~~~~~~~~~w~~~g~~~~~~~~~~~~~~~~~~~  213 (218)
T PRK12274        164 KRMYCPAALTPVERRVL-KRTSWIRELWFATGKPVYRFVTRRVLHWEDNEG  213 (218)
T ss_pred             HHhcCCCCCCHHHHhhh-ccchhHHHHHHHhcchHHHHHhccCCccccCCC
Confidence            12257778888764221 1222 4568889999999999999998766554

>KOG1163 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms]

Probab=99.70  E-value=2.8e-17  Score=147.65  Aligned_cols=178  Identities=21%  Similarity=0.312  Sum_probs=133.9

Q ss_pred             hhccccCccCceEEEEEE-EcCCCEEEEEEeccCCCCchhhHHHHHHhhccCcc-ceeEEEEE-----------------
Q 039231          316 SFKYKLGQGGYGSVYKGK-LLDGSNVAVKVLNDSKGNGKEFINEVASISRTSHV-NVVALLGF-----------------  376 (506)
Q Consensus       316 ~~~~~ig~G~~g~V~~~~-~~~~~~vavK~l~~~~~~~~~~~~E~~~l~~l~h~-niv~l~g~-----------------  376 (506)
                      ..-++||+|+||.+|.|. ..+|..||||.-.... ..-++..|.++...++|- .|..+..+                 
T Consensus        18 ~lvrkiGsGSFGdIy~~~~i~~ge~VAiK~Es~~a-~hpqL~yEskvY~iL~~g~GiP~i~~y~~e~~ynvlVMdLLGPs   96 (341)
T KOG1163|consen   18 KLVRKIGSGSFGDIYLGISITSGEEVAIKLESSKA-KHPQLLYESKVYRILQGGVGIPHIRHYGTEKDYNVLVMDLLGPS   96 (341)
T ss_pred             EEEEeecCCchhheeeeeeccCCceEEEEeecccC-CCcchhHHHHHHHHhccCCCCchhhhhccccccceeeeeccCcc
Confidence            345789999999999997 4679999999765432 235677888888877642 12222111                 


Q ss_pred             -------e---eccchhhhHHHHHHHHHHHHhhcCCCCeEecCcCCCcEEECC---CCcEEEeecCCCccccCCCcce--
Q 039231          377 -------C---LRVAEELSSTIGIARGLEYLHLGCSTRILHFDIKPHNILLDE---DFCPKISDFGLAKICNRKESII--  441 (506)
Q Consensus       377 -------~---~~~~~~l~i~~~i~~gl~~LH~~~~~~ivH~dlkp~Nill~~---~~~~ki~dfg~a~~~~~~~~~~--  441 (506)
                             |   +.....+.++-|++.-++|+|   .++.+||||||+|+|..-   ...+.++|||+|+......+..  
T Consensus        97 LEdLfnfC~R~ftmkTvLMLaDQml~RiEyvH---~r~fiHRDIKPdNFLMGlgrh~~kl~LIDFGLaKky~d~~t~~HI  173 (341)
T KOG1163|consen   97 LEDLFNFCSRRFTMKTVLMLADQMLSRIEYVH---LRNFIHRDIKPDNFLMGLGRHCNKLYLIDFGLAKKYRDIRTRQHI  173 (341)
T ss_pred             HHHHHHHHhhhhhHHhHHHHHHHHHHHHHHHH---hhccccccCCccceeeccccccceEEEEeccchhhhccccccccC
Confidence                   1   445567889999999999999   999999999999999843   3468899999998875433211  


Q ss_pred             ---ecccCCCCcccccccccccccCCCCccccHHHHHHHHHHHHcCCCCCCCCCCCcchhh
Q 039231          442 ---SMTGARGTVGYIAPEVFCRNIGEVSYKSDVYNYGMMIFEMTGGRKNVDVVDNGSTALD  499 (506)
Q Consensus       442 ---~~~~~~gt~~y~aPE~l~~~~~~~s~~~Dv~s~G~il~elltg~~pf~~~~~~~~~~~  499 (506)
                         .-....||.+|.+-....+.  +.+...|+=|+|.+|....-|..||+.........+
T Consensus       174 pyre~r~ltGTaRYASinAh~g~--eqSRRDDmeSvgYvLmYfnrG~LPWQglka~tk~QK  232 (341)
T KOG1163|consen  174 PYREDRNLTGTARYASINAHLGI--EQSRRDDMESVGYVLMYFNRGSLPWQGLKAATKKQK  232 (341)
T ss_pred             ccccCCccceeeeehhhhhhhhh--hhhhhhhhhhhcceeeeeecCCCcccccchhhHHHH
Confidence               12346689999998877554  567889999999999999999999999876654443

>cd05145 RIO1_like RIO kinase family; RIO1, RIO3 and similar proteins, catalytic domain

Probab=99.68  E-value=1.9e-16  Score=145.15  Aligned_cols=114  Identities=23%  Similarity=0.217  Sum_probs=89.1

Q ss_pred             cccCccCceEEEEEEEcCCCEEEEEEeccCCCC---------------------------chhhHHHHHHhhccCcccee
Q 039231          319 YKLGQGGYGSVYKGKLLDGSNVAVKVLNDSKGN---------------------------GKEFINEVASISRTSHVNVV  371 (506)
Q Consensus       319 ~~ig~G~~g~V~~~~~~~~~~vavK~l~~~~~~---------------------------~~~~~~E~~~l~~l~h~niv  371 (506)
                      ..||+|++|.||+|+..+|+.||||+++.....                           ...+.+|.+.+.++.|+++.
T Consensus         3 ~~ig~G~~~~Vy~a~~~~g~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~   82 (190)
T cd05145           3 GCISTGKEANVYHARTGDGEELAVKIYKTSTLSFKDRDKYIEGDPRFRSRYSKSNPRKLVFAWAEKEFRNLKRLYEAGVP   82 (190)
T ss_pred             ceeecCCCcEEEEEEcCCCCEEEEEEEEcCcceEeeHHHHhcCCcccccccccCCHHHHHHHHHHHHHHHHHHHHhCCCC
Confidence            469999999999999878999999999754211                           01135788999999888752


Q ss_pred             E-----------EEEEe--------------eccchhhhHHHHHHHHHHHHhhcCC-CCeEecCcCCCcEEECCCCcEEE
Q 039231          372 A-----------LLGFC--------------LRVAEELSSTIGIARGLEYLHLGCS-TRILHFDIKPHNILLDEDFCPKI  425 (506)
Q Consensus       372 ~-----------l~g~~--------------~~~~~~l~i~~~i~~gl~~LH~~~~-~~ivH~dlkp~Nill~~~~~~ki  425 (506)
                      .           ++.++              ++..+.+.++.|++.++.+||   . .+|+||||||+||+++ ++.++|
T Consensus        83 ~p~~~~~~~~~lVmE~~~g~~~~~~~l~~~~~~~~~~~~i~~~l~~~l~~lH---~~~givHrDlkP~NIll~-~~~~~l  158 (190)
T cd05145          83 VPEPILLKKNVLVMEFIGDDGSPAPRLKDVPLEEEEAEELYEQVVEQMRRLY---QEAGLVHGDLSEYNILYH-DGKPYI  158 (190)
T ss_pred             CceEEEecCCEEEEEEecCCCchhhhhhhccCCHHHHHHHHHHHHHHHHHHH---HhCCEecCCCChhhEEEE-CCCEEE
Confidence            1           22332              122345678999999999999   7 9999999999999999 789999


Q ss_pred             eecCCCccccC
Q 039231          426 SDFGLAKICNR  436 (506)
Q Consensus       426 ~dfg~a~~~~~  436 (506)
                      +|||++.....
T Consensus       159 iDFG~a~~~~~  169 (190)
T cd05145         159 IDVSQAVELDH  169 (190)
T ss_pred             EEcccceecCC
Confidence            99999986543

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. In addition, RIO3 is present in multicellular eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle pro

>cd05147 RIO1_euk RIO kinase family; eukaryotic RIO1, catalytic domain

Probab=99.67  E-value=1.3e-16  Score=145.91  Aligned_cols=112  Identities=18%  Similarity=0.228  Sum_probs=84.8

Q ss_pred             cccCccCceEEEEEEEcCCCEEEEEEeccCCC---C-------chh-----------------hHHHHHHhhccCccce-
Q 039231          319 YKLGQGGYGSVYKGKLLDGSNVAVKVLNDSKG---N-------GKE-----------------FINEVASISRTSHVNV-  370 (506)
Q Consensus       319 ~~ig~G~~g~V~~~~~~~~~~vavK~l~~~~~---~-------~~~-----------------~~~E~~~l~~l~h~ni-  370 (506)
                      ..||+|++|.||+|...+|+.||||+++....   .       ...                 ..+|++.+.++.|+++ 
T Consensus         3 ~~ig~G~~~~Vy~a~~~~g~~vAvKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~v~   82 (190)
T cd05147           3 GCISTGKEANVYHATTANGEERAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKSNPRKMVRTWAEKEMRNLKRLVTAGIP   82 (190)
T ss_pred             CccccccceEEEEEECCCCCEEEEEEEEecccccccHHHhhcCCchhhccccCCCHHHHHHHHHHHHHHHHHHHHHCCCC
Confidence            46999999999999988899999999975421   1       111                 2348899998875543 


Q ss_pred             ----eE------EEEEe--------------eccchhhhHHHHHHHHHHHH-hhcCCCCeEecCcCCCcEEECCCCcEEE
Q 039231          371 ----VA------LLGFC--------------LRVAEELSSTIGIARGLEYL-HLGCSTRILHFDIKPHNILLDEDFCPKI  425 (506)
Q Consensus       371 ----v~------l~g~~--------------~~~~~~l~i~~~i~~gl~~L-H~~~~~~ivH~dlkp~Nill~~~~~~ki  425 (506)
                          +.      ++.++              ++..+.+.++.|++.+|.+| |   +.+|+||||||+|||++ ++.++|
T Consensus        83 ~p~~~~~~~~~iVmE~i~g~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~l~H---~~giiHrDlkP~NIli~-~~~v~L  158 (190)
T cd05147          83 CPEPILLKSHVLVMEFIGDDGWAAPRLKDAPLSESKARELYLQVIQIMRILYQ---DCRLVHADLSEYNLLYH-DGKLYI  158 (190)
T ss_pred             CCcEEEecCCEEEEEEeCCCCCcchhhhcCCCCHHHHHHHHHHHHHHHHHHHH---hCCcccCCCCHHHEEEE-CCcEEE
Confidence                21      12222              12234667899999999999 7   78999999999999998 478999


Q ss_pred             eecCCCccc
Q 039231          426 SDFGLAKIC  434 (506)
Q Consensus       426 ~dfg~a~~~  434 (506)
                      +|||+|...
T Consensus       159 iDFG~a~~~  167 (190)
T cd05147         159 IDVSQSVEH  167 (190)
T ss_pred             EEccccccC
Confidence            999998743

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. This subfamily is composed of RIO1 proteins from eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle progression and c

>PF14531 Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_A 3Q5Z_A 3Q60_A

Probab=99.64  E-value=4.4e-16  Score=148.75  Aligned_cols=169  Identities=24%  Similarity=0.345  Sum_probs=111.7

Q ss_pred             ccccCccCceEEEEEEEcC-CCEEEEEEeccCC----CCchhhHHHHHHhhccCc----------cc------eeEE---
Q 039231          318 KYKLGQGGYGSVYKGKLLD-GSNVAVKVLNDSK----GNGKEFINEVASISRTSH----------VN------VVAL---  373 (506)
Q Consensus       318 ~~~ig~G~~g~V~~~~~~~-~~~vavK~l~~~~----~~~~~~~~E~~~l~~l~h----------~n------iv~l---  373 (506)
                      .+.||.|+++.||.+++.. ++.+|+|+..-..    ...+++.+|.-....+.+          -.      ++++   
T Consensus        17 ~~~i~~g~~~~v~~v~d~~t~~~~avkvf~~~~~~~~~~~~~~~~e~l~~~~~~~~~~p~~a~~~~r~l~P~d~~~i~~~   96 (288)
T PF14531_consen   17 GRIIGKGGFSIVFEVTDVETGEEFAVKVFLLPADASANEYEQLKEEQLAITLFPGVKNPKEAYRHLRFLVPLDLLRIPGK   96 (288)
T ss_dssp             EEEEEEETTEEEEEEEETTTTEEEEEEEEEESSTTHTTHHHHHHHHHHGGGGSTT--SHHHHHHHH-B---SEEEEETTS
T ss_pred             ccccccCCceEEEEEEEccCCceEEEEEEecccccchHHHHHHHHHHHHhhhhccCCCHHHHHHhceEEeeeEEEEEcCC
Confidence            3569999999999999865 8999999985322    122556666655544322          11      1111   


Q ss_pred             ---------------EEEee--c------------------------cchhhhHHHHHHHHHHHHhhcCCCCeEecCcCC
Q 039231          374 ---------------LGFCL--R------------------------VAEELSSTIGIARGLEYLHLGCSTRILHFDIKP  412 (506)
Q Consensus       374 ---------------~g~~~--~------------------------~~~~l~i~~~i~~gl~~LH~~~~~~ivH~dlkp  412 (506)
                                     ...++  +                        ..-++.+..|+++.+++||   ..|++|+||+|
T Consensus        97 ~~~~~~~~~~~~~~v~n~~~l~P~~~~dL~~~~~~l~~~~~~~~~l~~~arl~lT~Q~I~lvA~Lh---~~GlVHgdi~~  173 (288)
T PF14531_consen   97 PPFFERGPGQSIYWVLNRFLLMPRAQGDLQDLVEALFSRAQTHSPLAFAARLSLTVQMIRLVANLH---SYGLVHGDIKP  173 (288)
T ss_dssp             -SEEEECETTEEEEEESEEEEEE--SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHH---HTTEEEST-SG
T ss_pred             CcceecCCCCccceeehhhhccchhhhcHHHHHHHHhhcccccchhHHHHHHHHHHHHHHHHHHHh---hcceEecccce
Confidence                           11110  0                        0014556789999999999   89999999999


Q ss_pred             CcEEECCCCcEEEeecCCCccccCCCcceecccCCCCcccccccccccc------cCCCCccccHHHHHHHHHHHHcCCC
Q 039231          413 HNILLDEDFCPKISDFGLAKICNRKESIISMTGARGTVGYIAPEVFCRN------IGEVSYKSDVYNYGMMIFEMTGGRK  486 (506)
Q Consensus       413 ~Nill~~~~~~ki~dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~------~~~~s~~~Dv~s~G~il~elltg~~  486 (506)
                      +|++++++|.++|+||+.....+...   ..  ...+..|.+||.....      .-.++.+.|.|++|+++|.|++++.
T Consensus       174 ~nfll~~~G~v~Lg~F~~~~r~g~~~---~~--~~~~~~~~PPe~~~~~~~~~~~~~~~t~~~DaW~LG~~ly~lWC~~l  248 (288)
T PF14531_consen  174 ENFLLDQDGGVFLGDFSSLVRAGTRY---RC--SEFPVAFTPPELESCAGQFGQNNAPYTFATDAWQLGITLYSLWCGRL  248 (288)
T ss_dssp             GGEEE-TTS-EEE--GGGEEETTEEE---EG--GGS-TTTS-HHHHHHHTSCHHSEEEE-HHHHHHHHHHHHHHHHHSS-
T ss_pred             eeEEEcCCCCEEEcChHHHeecCcee---ec--cCCCcccCChhhhhhhcccCcccceeeeccCHHHHHHHHHHHHHccC
Confidence            99999999999999998766543321   11  3345779999976432      1247889999999999999999999


Q ss_pred             CCCCCCCC
Q 039231          487 NVDVVDNG  494 (506)
Q Consensus       487 pf~~~~~~  494 (506)
                      ||+....+
T Consensus       249 Pf~~~~~~  256 (288)
T PF14531_consen  249 PFGLSSPE  256 (288)
T ss_dssp             STCCCGGG
T ss_pred             CCCCCCcc
Confidence            99876443

>PRK10359 lipopolysaccharide core biosynthesis protein; Provisional

Probab=99.64  E-value=3.1e-16  Score=145.40  Aligned_cols=144  Identities=14%  Similarity=0.120  Sum_probs=106.1

Q ss_pred             hccccCccCceEEEEEEEcCCCEEEEEEeccCCCCch----------hhHHHHHHhhccCccceeEEEEEeecc------
Q 039231          317 FKYKLGQGGYGSVYKGKLLDGSNVAVKVLNDSKGNGK----------EFINEVASISRTSHVNVVALLGFCLRV------  380 (506)
Q Consensus       317 ~~~~ig~G~~g~V~~~~~~~~~~vavK~l~~~~~~~~----------~~~~E~~~l~~l~h~niv~l~g~~~~~------  380 (506)
                      ..+.++.|+||.||++.. ++..+|||.+.+.....+          .+.+|++.+.+++|++|..+..+....      
T Consensus        35 ~~~~l~~~~f~~v~l~~~-~~~~~iiKvf~~~~~~~~~~~~~f~~g~~~e~Ea~~l~rL~~~GI~~~~d~~~~~~~~~~~  113 (232)
T PRK10359         35 TIKVFRNIDDTKVSLIDT-DYGKYILKVFAPKVKRTERFLKSFVKGDYYENLIVQTDRVRSEGLASLNDFYLLAERKTLR  113 (232)
T ss_pred             EEEEecCCCceEEEEEec-CCCcEEEEEechhcCchHHHHHhhhhhHHHHHHHHHHHHHHHCCCCcceEeeeeccccccc
Confidence            346799999999999766 577899999975433222          257899999999999988777653211      


Q ss_pred             --------------chh-------hhHHHHHHHHHHHHhhcCCCCeEecCcCCCcEEECCCCcEEEeecCCCccccCCCc
Q 039231          381 --------------AEE-------LSSTIGIARGLEYLHLGCSTRILHFDIKPHNILLDEDFCPKISDFGLAKICNRKES  439 (506)
Q Consensus       381 --------------~~~-------l~i~~~i~~gl~~LH~~~~~~ivH~dlkp~Nill~~~~~~ki~dfg~a~~~~~~~~  439 (506)
                                    ...       .....+++.+|..+|   ..+++|||+||+||+++.++ ++|+|||..+.......
T Consensus       114 ~~~~~~lvmEyi~G~tL~~~~~~~~~~~~~i~~~l~~lH---~~gi~H~Dikp~Nili~~~g-i~liDfg~~~~~~e~~a  189 (232)
T PRK10359        114 YAHTYIMLIEYIEGVELNDMPEISEDVKAKIKASIESLH---QHGMVSGDPHKGNFIVSKNG-LRIIDLSGKRCTAQRKA  189 (232)
T ss_pred             ccCCeEEEEEEECCccHHHhhhccHHHHHHHHHHHHHHH---HcCCccCCCChHHEEEeCCC-EEEEECCCcccccchhh
Confidence                          001       224569999999999   99999999999999999988 99999998865432221


Q ss_pred             ceecccCCCCcccccccccccccCCCCccccHHHHHHHHHHH
Q 039231          440 IISMTGARGTVGYIAPEVFCRNIGEVSYKSDVYNYGMMIFEM  481 (506)
Q Consensus       440 ~~~~~~~~gt~~y~aPE~l~~~~~~~s~~~Dv~s~G~il~el  481 (506)
                      .              ..+....  .+..+.|+||||+.+.-.
T Consensus       190 ~--------------d~~vler--~y~~~~di~~lg~~~~~~  215 (232)
T PRK10359        190 K--------------DRIDLER--HYGIKNEIKDLGYYLLIY  215 (232)
T ss_pred             H--------------HHHHHHh--HhcccccccceeEeehHH
Confidence            1              0022222  455789999999988754

>KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms]

Probab=99.61  E-value=1.7e-16  Score=161.10  Aligned_cols=157  Identities=27%  Similarity=0.295  Sum_probs=126.8

Q ss_pred             cCccCceEEEEEE----EcCCCEEEEEEeccCCC---CchhhHHHHHHhhccC-ccceeEEEEEeeccch----------
Q 039231          321 LGQGGYGSVYKGK----LLDGSNVAVKVLNDSKG---NGKEFINEVASISRTS-HVNVVALLGFCLRVAE----------  382 (506)
Q Consensus       321 ig~G~~g~V~~~~----~~~~~~vavK~l~~~~~---~~~~~~~E~~~l~~l~-h~niv~l~g~~~~~~~----------  382 (506)
                      +|+|++|.|++.+    .+.|..+|+|.+++...   .......|..++...+ ||.+|++.-.+....+          
T Consensus         2 lg~g~~gkvfLvrk~~g~da~~~yamkvl~k~t~~~~~~~~t~~er~il~~~~~~~f~v~lhyafqt~~kl~l~ld~~rg   81 (612)
T KOG0603|consen    2 LGQGSYGKVFLVRKAGGADAGHLYAMKVLKKATLKVRDRTHTKQERIILAFVHNTPFLVKLHYAFQTDGKLYLILDFLRG   81 (612)
T ss_pred             CCcCCCcchHHHHHhccccccchhhhhcccccccccccccccccHHHHHhhccCCCceeeeeeeeccccchhHhhhhccc
Confidence            7899999999875    23478899999875321   1125567888899998 9999999876632222          


Q ss_pred             -----------------hhhHHHHHHHHHHHHhhcCCCCeEecCcCCCcEEECCCCcEEEeecCCCccccCCCcceeccc
Q 039231          383 -----------------ELSSTIGIARGLEYLHLGCSTRILHFDIKPHNILLDEDFCPKISDFGLAKICNRKESIISMTG  445 (506)
Q Consensus       383 -----------------~l~i~~~i~~gl~~LH~~~~~~ivH~dlkp~Nill~~~~~~ki~dfg~a~~~~~~~~~~~~~~  445 (506)
                                       .......++-+++++|   +.+|+|||+|++||+++.+|++|+.|||+++..-....      
T Consensus        82 g~lft~l~~~~~f~~~~~~~~~aelaLald~lh---~l~iiyrd~k~enilld~~Ghi~~tdfglske~v~~~~------  152 (612)
T KOG0603|consen   82 GDLFTRLSKEVMFDELDVAFYLAELALALDHLH---KLGIAYRDYKLENVLLLLEGHIKLTDFGLSKEAVKEKI------  152 (612)
T ss_pred             chhhhccccCCchHHHHHHHHHHHHHHHHhhcc---hhHHHHhcccccceeecccCccccCCchhhhHhHhhhh------
Confidence                             2334567899999999   99999999999999999999999999999987544332      


Q ss_pred             CCCCcccccccccccccCCCCccccHHHHHHHHHHHHcCCCCCCC
Q 039231          446 ARGTVGYIAPEVFCRNIGEVSYKSDVYNYGMMIFEMTGGRKNVDV  490 (506)
Q Consensus       446 ~~gt~~y~aPE~l~~~~~~~s~~~Dv~s~G~il~elltg~~pf~~  490 (506)
                      ..||..|||||++.    ......|.||||++++||+||..||..
T Consensus       153 ~cgt~eymApEI~~----gh~~a~D~ws~gvl~felltg~~pf~~  193 (612)
T KOG0603|consen  153 ACGTYEYRAPEIIN----GHLSAADWWSFGVLAFELLTGTLPFGG  193 (612)
T ss_pred             cccchhhhhhHhhh----ccCCcccchhhhhhHHHHhhCCCCCch
Confidence            27899999999984    357789999999999999999999987

>KOG1240 consensus Protein kinase containing WD40 repeats [Signal transduction mechanisms]

Probab=99.60  E-value=7.5e-16  Score=164.00  Aligned_cols=170  Identities=22%  Similarity=0.260  Sum_probs=125.4

Q ss_pred             hccccCccCceEEEEEEEcCCCEEEEEEeccCC--CCchhhHHHHHH--hhccCccceeEEEEEe---------------
Q 039231          317 FKYKLGQGGYGSVYKGKLLDGSNVAVKVLNDSK--GNGKEFINEVAS--ISRTSHVNVVALLGFC---------------  377 (506)
Q Consensus       317 ~~~~ig~G~~g~V~~~~~~~~~~vavK~l~~~~--~~~~~~~~E~~~--l~~l~h~niv~l~g~~---------------  377 (506)
                      +.+.+|++.|=+|.+|++++|. |+||++-+..  -..+.+.++++-  ....+|||.+.+.-+.               
T Consensus        27 ~~~~LGstRFlKv~r~k~~eG~-vVvKVFvk~~p~~sL~~~~qrL~~ik~~l~~~pn~lPfqk~~~t~kAAylvRqyvkh  105 (1431)
T KOG1240|consen   27 YVENLGSTRFLKVARAKDREGL-VVVKVFVKQDPTISLRPFKQRLEEIKFALMKAPNCLPFQKVLVTDKAAYLVRQYVKH  105 (1431)
T ss_pred             eecccCchhhhhhhhccCCCce-EEEEEEeccCCCCCchHHHHHHHHHHHHhhcCCcccchHHHHHhhHHHHHHHHHHhh
Confidence            4567999999999999998887 9999985433  233555444433  5556899988765332               


Q ss_pred             -----------eccchhhhHHHHHHHHHHHHhhcCCCCeEecCcCCCcEEECCCCcEEEeecCCCccc--cCCC---cce
Q 039231          378 -----------LRVAEELSSTIGIARGLEYLHLGCSTRILHFDIKPHNILLDEDFCPKISDFGLAKIC--NRKE---SII  441 (506)
Q Consensus       378 -----------~~~~~~l~i~~~i~~gl~~LH~~~~~~ivH~dlkp~Nill~~~~~~ki~dfg~a~~~--~~~~---~~~  441 (506)
                                 +...|...|+.|++.||..+|   +.+|+|||||.+||||+.-.-+.|+||..-+..  +.+.   ...
T Consensus       106 nLyDRlSTRPFL~~iEKkWiaFQLL~al~qcH---~~gVcHGDIKsENILiTSWNW~~LtDFAsFKPtYLPeDNPadf~f  182 (1431)
T KOG1240|consen  106 NLYDRLSTRPFLVLIEKKWIAFQLLKALSQCH---KLGVCHGDIKSENILITSWNWLYLTDFASFKPTYLPEDNPADFTF  182 (1431)
T ss_pred             hhhhhhccchHHHHHHHHHHHHHHHHHHHHHH---HcCccccccccceEEEeeechhhhhcccccCCccCCCCCcccceE
Confidence                       334445678999999999999   999999999999999999999999999876542  1111   111


Q ss_pred             ecccCCCCccccccccccccc---------CCCCccccHHHHHHHHHHHHc-CCCCCCC
Q 039231          442 SMTGARGTVGYIAPEVFCRNI---------GEVSYKSDVYNYGMMIFEMTG-GRKNVDV  490 (506)
Q Consensus       442 ~~~~~~gt~~y~aPE~l~~~~---------~~~s~~~Dv~s~G~il~ellt-g~~pf~~  490 (506)
                      ...+-.....|+|||.+....         +..+++-||||+||++.||++ |++||+-
T Consensus       183 FFDTSrRRtCYiAPERFv~~~~~~~~~q~~~~L~paMDIFS~GCViaELf~Eg~PlF~L  241 (1431)
T KOG1240|consen  183 FFDTSRRRTCYIAPERFVSALGKTSVGQDAPLLTPAMDIFSAGCVIAELFLEGRPLFTL  241 (1431)
T ss_pred             EEecCCceeeecChHhhhccccccccCCcccccChhhhhhhhhHHHHHHHhcCCCcccH
Confidence            122333455799999985421         125678999999999999997 7999964

>KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only]

Probab=99.59  E-value=6.9e-16  Score=164.11  Aligned_cols=165  Identities=27%  Similarity=0.356  Sum_probs=119.2

Q ss_pred             cccCccCceEEEEEEEcC-CCEEEEEEeccCCCCchhhHHHHHHhhccCccceeEEEEEeeccchhhh----HHHHHHHH
Q 039231          319 YKLGQGGYGSVYKGKLLD-GSNVAVKVLNDSKGNGKEFINEVASISRTSHVNVVALLGFCLRVAEELS----STIGIARG  393 (506)
Q Consensus       319 ~~ig~G~~g~V~~~~~~~-~~~vavK~l~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~l~----i~~~i~~g  393 (506)
                      +.|..|++|.||..+++. .+++|+|+=++.     .+.+-  ++.....|.+|   |=|   ...++    .=.+++.+
T Consensus        89 klisngAygavylvrh~~trqrfa~kiNkq~-----lilRn--ilt~a~npfvv---gDc---~tllk~~g~lPvdmvla  155 (1205)
T KOG0606|consen   89 KLISNGAYGAVYLVRHKETRQRFAMKINKQN-----LILRN--ILTFAGNPFVV---GDC---ATLLKNIGPLPVDMVLA  155 (1205)
T ss_pred             EeeccCCCCceeeeeccccccchhhcccccc-----hhhhc--cccccCCccee---chh---hhhcccCCCCcchhhHH
Confidence            468999999999999864 677888543221     11111  34444455554   222   11111    11245899


Q ss_pred             HHHHhhcCCCCeEecCcCCCcEEECCCCcEEEeecCCCccccCCC------------cc-eecccCCCCccccccccccc
Q 039231          394 LEYLHLGCSTRILHFDIKPHNILLDEDFCPKISDFGLAKICNRKE------------SI-ISMTGARGTVGYIAPEVFCR  460 (506)
Q Consensus       394 l~~LH~~~~~~ivH~dlkp~Nill~~~~~~ki~dfg~a~~~~~~~------------~~-~~~~~~~gt~~y~aPE~l~~  460 (506)
                      ++|||   +.+|+|||+||+|.+|+.-|++|+.|||+.+......            .+ ..-....||+.|+|||++..
T Consensus       156 ~Eylh---~ygivhrdlkpdnllIT~mGhiKlTDfgLsk~GLms~atnl~eg~I~k~t~Ef~dKqvcgTPeyiaPeVilr  232 (1205)
T KOG0606|consen  156 VEYLH---SYGIVHRDLKPDNLLITSMGHIKLTDFGLSKKGLMSLATNLKEGHIEKDTHEFQDKQVCGTPEYIAPEVILR  232 (1205)
T ss_pred             hHhhc---cCCeecCCCCCCcceeeecccccccchhhhhhhhhhccchhhhcchHHHHHHhhhccccCCccccChhhhhh
Confidence            99999   9999999999999999999999999999987642110            00 01133579999999999977


Q ss_pred             ccCCCCccccHHHHHHHHHHHHcCCCCCCCCCCCcchhhhh
Q 039231          461 NIGEVSYKSDVYNYGMMIFEMTGGRKNVDVVDNGSTALDLQ  501 (506)
Q Consensus       461 ~~~~~s~~~Dv~s~G~il~elltg~~pf~~~~~~~~~~~~~  501 (506)
                      .  .|+..+|+|++|+|+||-+.|..||.....++.+-.++
T Consensus       233 q--gygkpvdwwamGiIlyeFLVgcvpffGdtpeelfg~vi  271 (1205)
T KOG0606|consen  233 Q--GYGKPVDWWAMGIILYEFLVGCVPFFGDTPEELFGQVI  271 (1205)
T ss_pred             h--ccCCCccHHHHHHHHHHHheeeeeccCCCHHHHHhhhh
Confidence            5  78999999999999999999999999987666554443

>KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning]

Probab=99.59  E-value=4e-16  Score=165.49  Aligned_cols=176  Identities=28%  Similarity=0.333  Sum_probs=129.4

Q ss_pred             hccccCccCceEEEEEEEc-CCCEEEEEEec----cCCCCc---hhhHHHHHHhhccCccceeEEEEEe-----------
Q 039231          317 FKYKLGQGGYGSVYKGKLL-DGSNVAVKVLN----DSKGNG---KEFINEVASISRTSHVNVVALLGFC-----------  377 (506)
Q Consensus       317 ~~~~ig~G~~g~V~~~~~~-~~~~vavK~l~----~~~~~~---~~~~~E~~~l~~l~h~niv~l~g~~-----------  377 (506)
                      ....+|.|++|.|+..... .....+.|...    ......   ..+..|+.+-..++|+|++..+...           
T Consensus       322 ~~~~~g~ga~g~~~~~~~~~~~~~~~~~~~r~~~~~~~s~~~~~~~i~sE~~i~~~l~h~~~~e~l~~~~~~~~~~~~mE  401 (601)
T KOG0590|consen  322 PGRVLGSGAYGSVRIAKRRSDLKSFPEKEFRVRVKPTESERKYNYNITSEFCIGSSLSHPNIIETLDIVQEIDGILQSME  401 (601)
T ss_pred             ccceeeecccCceEEEEecCCCccchhhhhhcccCCcccHHHHhhhhhhheeecccccCCchhhhHHHHhhcccchhhhh
Confidence            3457999999988877643 23334444332    111111   1266788888889999976543221           


Q ss_pred             ---------------eccchhhhHHHHHHHHHHHHhhcCCCCeEecCcCCCcEEECCCCcEEEeecCCCccccCCCcc--
Q 039231          378 ---------------LRVAEELSSTIGIARGLEYLHLGCSTRILHFDIKPHNILLDEDFCPKISDFGLAKICNRKESI--  440 (506)
Q Consensus       378 ---------------~~~~~~l~i~~~i~~gl~~LH~~~~~~ivH~dlkp~Nill~~~~~~ki~dfg~a~~~~~~~~~--  440 (506)
                                     +...++-.++.|++.|++|||   ..||.|||+|++|++++.++.+||+|||.+....-....  
T Consensus       402 ~~~~Dlf~~~~~~~~~~~~e~~c~fKqL~~Gv~y~h---~~GiahrdlK~enll~~~~g~lki~Dfg~~~vf~~~~e~~~  478 (601)
T KOG0590|consen  402 YCPYDLFSLVMSNGKLTPLEADCFFKQLLRGVKYLH---SMGLAHRDLKLENLLVTENGILKIIDFGAASVFRYPWEKNI  478 (601)
T ss_pred             cccHHHHHHHhcccccchhhhhHHHHHHHHHHHHHH---hcCceeccCccccEEEecCCceEEeecCcceeeccCcchhh
Confidence                           222334457889999999999   999999999999999999999999999999776543332  


Q ss_pred             eecccCCCCcccccccccccccCCCCccccHHHHHHHHHHHHcCCCCCCCCCCCcc
Q 039231          441 ISMTGARGTVGYIAPEVFCRNIGEVSYKSDVYNYGMMIFEMTGGRKNVDVVDNGST  496 (506)
Q Consensus       441 ~~~~~~~gt~~y~aPE~l~~~~~~~s~~~Dv~s~G~il~elltg~~pf~~~~~~~~  496 (506)
                      .......|+..|+|||.+.+. .......||||.|+++..|++|+.||......+.
T Consensus       479 ~~~~g~~gS~pY~apE~~~~~-~ydpr~vDiwS~~ii~~~m~~~~~~Wk~a~~~~~  533 (601)
T KOG0590|consen  479 HESSGIVGSDPYLAPEVLTGK-EYDPRAVDVWSCGIIYICMILGRFPWKVAKKSDN  533 (601)
T ss_pred             hhhcCcccCCcCcCccccccc-ccCcchhhhhhccceEEEEecCCCcccccccccc
Confidence            334668899999999999765 2345568999999999999999999987655543

>KOG1033 consensus eIF-2alpha kinase PEK/EIF2AK3 [Translation, ribosomal structure and biogenesis]

Probab=99.57  E-value=2.7e-16  Score=156.70  Aligned_cols=92  Identities=35%  Similarity=0.522  Sum_probs=77.8

Q ss_pred             hhHHHHHHHHHHHHhhcCCCCeEecCcCCCcEEECCCCcEEEeecCCCccccCCC----cceecccCCCCcccccccccc
Q 039231          384 LSSTIGIARGLEYLHLGCSTRILHFDIKPHNILLDEDFCPKISDFGLAKICNRKE----SIISMTGARGTVGYIAPEVFC  459 (506)
Q Consensus       384 l~i~~~i~~gl~~LH~~~~~~ivH~dlkp~Nill~~~~~~ki~dfg~a~~~~~~~----~~~~~~~~~gt~~y~aPE~l~  459 (506)
                      +.++.|++.|++|      ++.+|+|+||.||+...+..+||+|||+........    .....+...||..||+||.+.
T Consensus       362 ~~~~~q~~~~~~y------k~~ihrdlkp~nif~~~d~q~kIgDFgl~ts~~~~~~~~~~~a~~t~~~gt~~YmsPEQi~  435 (516)
T KOG1033|consen  362 LDIFKQIAPAVEY------KGLIHRDLKPSNIFFSDDDQLKIGDFGLVTSQDKDETVAPAAASHTQQVGTLLYMSPEQIR  435 (516)
T ss_pred             HHHHHhhccchhh------ccchhhhccccccccccchhhhhhhhhheeecccCCcccchhhhhhhcccccccCCHHHHh
Confidence            4466778888877      789999999999999999999999999987765544    122345678999999999997


Q ss_pred             cccCCCCccccHHHHHHHHHHHHc
Q 039231          460 RNIGEVSYKSDVYNYGMMIFEMTG  483 (506)
Q Consensus       460 ~~~~~~s~~~Dv~s~G~il~ellt  483 (506)
                      +.  .|+.|+||||||+||+|++.
T Consensus       436 g~--~y~~kvdIyaLGlil~EL~~  457 (516)
T KOG1033|consen  436 GQ--QYSEKVDIYALGLILAELLI  457 (516)
T ss_pred             hh--hhhhhcchhhHHHHHHHHHH
Confidence            65  89999999999999999997

>PRK10345 hypothetical protein; Provisional

Probab=99.54  E-value=3.7e-14  Score=131.07  Aligned_cols=109  Identities=23%  Similarity=0.399  Sum_probs=81.4

Q ss_pred             cccCccCceEEEEEEEcCCCEEEEEEeccC-CCCchhhHHHHHHhhcc-----CccceeEEEEEeeccc-----------
Q 039231          319 YKLGQGGYGSVYKGKLLDGSNVAVKVLNDS-KGNGKEFINEVASISRT-----SHVNVVALLGFCLRVA-----------  381 (506)
Q Consensus       319 ~~ig~G~~g~V~~~~~~~~~~vavK~l~~~-~~~~~~~~~E~~~l~~l-----~h~niv~l~g~~~~~~-----------  381 (506)
                      +.||+|++|.||. .-.++.. +||++... ....+.+.+|++.+.++     +||||++++|++.+..           
T Consensus         8 ~~LG~G~~~~Vy~-hp~~~~k-~IKv~~~~~~~~~~~~~rEi~~l~~L~~~~~~h~nIvr~yg~~et~~g~g~v~~~I~e   85 (210)
T PRK10345          8 SPLGTGRHRKCYA-HPEDAQR-CIKIVYHRGDGGDKEIRRELKYYAHLSRRLIDWSGIPRYYGTVETDCGTGYVYDVIAD   85 (210)
T ss_pred             ceecCCCceEEEE-CCCCcCe-EEEEEeccccchHHHHHHHHHHHHHhhccCCCCcccceeeEEEEeCCCCeEEEEEEec
Confidence            4699999999996 2223444 68888653 23446799999999999     5799999997662210           


Q ss_pred             -------------------hhhhHHHHHHHHH-HHHhhcCCCCeEecCcCCCcEEECC----CCcEEEee-cCCCc
Q 039231          382 -------------------EELSSTIGIARGL-EYLHLGCSTRILHFDIKPHNILLDE----DFCPKISD-FGLAK  432 (506)
Q Consensus       382 -------------------~~l~i~~~i~~gl-~~LH~~~~~~ivH~dlkp~Nill~~----~~~~ki~d-fg~a~  432 (506)
                                         +...++.+++.++ +|||   +++|+||||||+|||++.    +..++|+| ||...
T Consensus        86 ~~G~~~~tL~~~l~~~~~~e~~~~~~~~L~~l~~yLh---~~~IvhrDlKp~NILl~~~~~~~~~~~LiDg~G~~~  158 (210)
T PRK10345         86 FDGKPSITLTEFAEQCRYEEDVAQLRQLLKKLKRYLL---DNRIVTMELKPQNILCQRISESEVIPVVCDNIGEST  158 (210)
T ss_pred             CCCCcchhHHHHHHcccccHhHHHHHHHHHHHHHHHH---HCCEeecCCCHHHEEEeccCCCCCcEEEEECCCCcc
Confidence                               1122466788777 9999   999999999999999974    34799999 55443

>KOG1166 consensus Mitotic checkpoint serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=99.52  E-value=2.4e-14  Score=155.20  Aligned_cols=166  Identities=24%  Similarity=0.263  Sum_probs=119.9

Q ss_pred             hhccccCccCceEEEEEEEcCCCEEEEEEeccCCCCchhhHHHHHHhhccC--------cc-------c---ee-EEE--
Q 039231          316 SFKYKLGQGGYGSVYKGKLLDGSNVAVKVLNDSKGNGKEFINEVASISRTS--------HV-------N---VV-ALL--  374 (506)
Q Consensus       316 ~~~~~ig~G~~g~V~~~~~~~~~~vavK~l~~~~~~~~~~~~E~~~l~~l~--------h~-------n---iv-~l~--  374 (506)
                      .+++.||+|+||+||+|...+|+.||+|+-+....-  +|.--.+++.||+        |-       |   +| .+.  
T Consensus       701 ~I~~e~G~g~y~~vy~a~~~~~~~~alK~e~P~~~W--EfYI~~q~~~RLk~~~~~~~~~~~~a~~~~~~S~lv~ey~~~  778 (974)
T KOG1166|consen  701 CISKEIGEGSYGSVYVATHSNGKLVALKVEKPPNPW--EFYICLQVMERLKPQMLPSIMHISSAHVFQNASVLVSEYSPY  778 (974)
T ss_pred             EEEeeeccccceEEEEeecCCCcEEEEEeecCCCce--eeeehHHHHHhhchhhhcchHHHHHHHccCCcceeeeecccc
Confidence            345679999999999999988999999987654322  2211222222222        10       0   11 011  


Q ss_pred             ----EEe-----eccchhhhHHHHHHHHHHHHhhcCCCCeEecCcCCCcEEEC-------CCCcEEEeecCCCccccCCC
Q 039231          375 ----GFC-----LRVAEELSSTIGIARGLEYLHLGCSTRILHFDIKPHNILLD-------EDFCPKISDFGLAKICNRKE  438 (506)
Q Consensus       375 ----g~~-----~~~~~~l~i~~~i~~gl~~LH~~~~~~ivH~dlkp~Nill~-------~~~~~ki~dfg~a~~~~~~~  438 (506)
                          +++     +++.-.+.++.|++.-++.||   ..+|||+||||+|.||.       ....++|+|||-+-.+.--.
T Consensus       779 Gtlld~~N~~~~m~e~lv~~~~~qml~ive~lH---~~~IIHgDiKPDNfll~~~~~~~~~~~~l~lIDfG~siDm~lfp  855 (974)
T KOG1166|consen  779 GTLLDLINTNKVMDEYLVMFFSCQMLRIVEHLH---AMGIIHGDIKPDNFLLRREICADSDSKGLYLIDFGRSIDMKLFP  855 (974)
T ss_pred             ccHHHhhccCCCCCchhhhHHHHHHHHHHHHHH---hcceecccCCcceeEeecccCCCCcccceEEEecccceeeeEcC
Confidence                111     344557789999999999999   99999999999999993       23458999999986554222


Q ss_pred             cceecccCCCCcccccccccccccCCCCccccHHHHHHHHHHHHcCCCCC
Q 039231          439 SIISMTGARGTVGYIAPEVFCRNIGEVSYKSDVYNYGMMIFEMTGGRKNV  488 (506)
Q Consensus       439 ~~~~~~~~~gt~~y~aPE~l~~~~~~~s~~~Dv~s~G~il~elltg~~pf  488 (506)
                      .........+|-.+--+|...+.  .++.+.|.|.++.+++-||.|+.-=
T Consensus       856 ~~~~F~~~~~td~f~C~EM~~gr--pWtYq~DyfGlAa~~h~mLFG~y~q  903 (974)
T KOG1166|consen  856 DGTKFKAVWHTDLFDCIEMREGR--PWTYQIDYFGLAATVHVMLFGKYME  903 (974)
T ss_pred             CCcEEeeeeccccchhHHHhcCC--CCchhhhhHHHHHHHHHHHHHHHHH
Confidence            22234667788999999998665  8999999999999999999998654

>cd05144 RIO2_C RIO kinase family; RIO2, C-terminal catalytic domain

Probab=99.52  E-value=6.3e-14  Score=129.45  Aligned_cols=118  Identities=22%  Similarity=0.210  Sum_probs=89.4

Q ss_pred             hhhccccCccCceEEEEEEEcCCCEEEEEEeccCCCC-----------------------chhhHHHHHHhhccCccc--
Q 039231          315 NSFKYKLGQGGYGSVYKGKLLDGSNVAVKVLNDSKGN-----------------------GKEFINEVASISRTSHVN--  369 (506)
Q Consensus       315 ~~~~~~ig~G~~g~V~~~~~~~~~~vavK~l~~~~~~-----------------------~~~~~~E~~~l~~l~h~n--  369 (506)
                      +...+.||+|+||.||++...+|+.||||++......                       .....+|...+..+.|++  
T Consensus        17 ~~~~~~i~~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~   96 (198)
T cd05144          17 ESLGNQIGVGKESDVYLALDPDGNPVALKFHRLGRTSFRKVKRKRDYLGDRKHASWLYLSRLAAQKEFAALKALYEEGFP   96 (198)
T ss_pred             hhcCCccccCcceEEEEEEcCCCCEEEEEEEecccchhhhhcchHHHHhccccchhHHHhHHHHHHHHHHHHHHHHcCCC
Confidence            3445789999999999999888999999987543210                       113567888888887763  


Q ss_pred             eeEEEE---------Ee-------ecc-chhhhHHHHHHHHHHHHhhcCCCCeEecCcCCCcEEECCCCcEEEeecCCCc
Q 039231          370 VVALLG---------FC-------LRV-AEELSSTIGIARGLEYLHLGCSTRILHFDIKPHNILLDEDFCPKISDFGLAK  432 (506)
Q Consensus       370 iv~l~g---------~~-------~~~-~~~l~i~~~i~~gl~~LH~~~~~~ivH~dlkp~Nill~~~~~~ki~dfg~a~  432 (506)
                      +.+.++         ++       +.. .....++.+++.++.++|   ..+++|+||+|+||++++++.++|+|||++.
T Consensus        97 v~~~~~~~~~~lv~e~~~g~~L~~~~~~~~~~~~~~~i~~~l~~lh---~~gi~H~Dl~p~Nill~~~~~~~liDfg~~~  173 (198)
T cd05144          97 VPKPIDWNRHAVVMEYIDGVELYRVRVLEDPEEVLDEILEEIVKAY---KHGIIHGDLSEFNILVDDDEKIYIIDWPQMV  173 (198)
T ss_pred             CCceeecCCceEEEEEeCCcchhhccccccHHHHHHHHHHHHHHHH---HCCCCcCCCCcccEEEcCCCcEEEEECCccc
Confidence            222222         11       111 334568899999999999   8999999999999999999999999999986


Q ss_pred             ccc
Q 039231          433 ICN  435 (506)
Q Consensus       433 ~~~  435 (506)
                      ...
T Consensus       174 ~~~  176 (198)
T cd05144         174 STD  176 (198)
T ss_pred             cCC
Confidence            443

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO2 is present in archaea and eukaryotes. It contains an N-terminal winged helix (wHTH) domain and a C-terminal RIO kinase catalytic domain. The wHTH domain is primarily seen in DNA-binding proteins, although some wHTH dom

>smart00090 RIO RIO-like kinase

Probab=99.52  E-value=5.6e-14  Score=132.96  Aligned_cols=115  Identities=19%  Similarity=0.127  Sum_probs=86.3

Q ss_pred             hccccCccCceEEEEEE--EcCCCEEEEEEeccCCCC-------------------------chhhHHHHHHhhccCccc
Q 039231          317 FKYKLGQGGYGSVYKGK--LLDGSNVAVKVLNDSKGN-------------------------GKEFINEVASISRTSHVN  369 (506)
Q Consensus       317 ~~~~ig~G~~g~V~~~~--~~~~~~vavK~l~~~~~~-------------------------~~~~~~E~~~l~~l~h~n  369 (506)
                      +.+.||+|++|.||+|.  ..+|+.||+|+++.....                         ...+.+|++.+.++.+..
T Consensus        32 i~~~Lg~G~~g~Vy~a~~~~~~g~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~L~~L~~~~  111 (237)
T smart00090       32 IGGCISTGKEANVYHALDFDGSGKERAVKIYRTGTLEFKRRDRYVDGDFRFKYRKINPRKLVRLWAEKEFRNLQRLYEAG  111 (237)
T ss_pred             hCCeeccCcceeEEEEEecCCCCcEEEEEEEEcCcceecchhhhcccchhhccCCCCHHHHHHHHHHHHHHHHHHHHhcC
Confidence            45679999999999998  467999999998753210                         012467999999987532


Q ss_pred             --eeEEEEE---------e--------------eccchhhhHHHHHHHHHHHHhhcCCCC-eEecCcCCCcEEECCCCcE
Q 039231          370 --VVALLGF---------C--------------LRVAEELSSTIGIARGLEYLHLGCSTR-ILHFDIKPHNILLDEDFCP  423 (506)
Q Consensus       370 --iv~l~g~---------~--------------~~~~~~l~i~~~i~~gl~~LH~~~~~~-ivH~dlkp~Nill~~~~~~  423 (506)
                        +.+.+++         +              .+..+...++.|++.+|++||   ..+ ++|+||||+||+++ ++.+
T Consensus       112 i~~p~~~~~~~~~lV~E~~~g~~L~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH---~~g~iiH~Dikp~NIli~-~~~i  187 (237)
T smart00090      112 VPVPKPIAWRRNVLVMEFIGGDGLPAPRLKDVEPEEEEEFELYDDILEEMRKLY---KEGELVHGDLSEYNILVH-DGKV  187 (237)
T ss_pred             CCCCeeeEecCceEEEEEecCCcccccccccCCcchHHHHHHHHHHHHHHHHHH---hcCCEEeCCCChhhEEEE-CCCE
Confidence              2222211         1              111124578999999999999   899 99999999999999 7899


Q ss_pred             EEeecCCCcccc
Q 039231          424 KISDFGLAKICN  435 (506)
Q Consensus       424 ki~dfg~a~~~~  435 (506)
                      +|+|||.+....
T Consensus       188 ~LiDFg~a~~~~  199 (237)
T smart00090      188 VIIDVSQSVELD  199 (237)
T ss_pred             EEEEChhhhccC
Confidence            999999987543

>PF14380 WAK_assoc: Wall-associated receptor kinase C-terminal

Probab=99.49  E-value=6.3e-14  Score=112.07  Aligned_cols=82  Identities=28%  Similarity=0.453  Sum_probs=65.0

Q ss_pred             ecCCCCC--ceEEecCCCCCCCCCCCCCc-eEEecccCC------CCcccHHHHhcCcEEEEEe-ecccccccccCCccc
Q 039231          147 STCNSSS--FIYYNHPDDDLPSILPPNCS-LIQLPVNKT------RKSGDLFNMLTSVFSLQVE-VHRVCYECRWRGGQC  216 (506)
Q Consensus       147 ~~C~~~~--~~~~~~~~~~~~~~~~~~C~-~~~~pv~~~------~~~~~~~~~l~~gf~l~w~-~~~~C~~C~~sgg~C  216 (506)
                      |+|..++  ..+|++...   ..+...|. .+.|||+..      ....+|.++|++||+|+|. .+.+|.+|+.|||+|
T Consensus         1 ~~C~~~~~~~~~~~v~~~---~~~~~~C~~~v~vPV~~~~~~~~~~~~~~~~~~L~~GF~L~w~~~~~~C~~C~~SgG~C   77 (94)
T PF14380_consen    1 INCSINSGNSVSYFVFRS---SDLAGSCQKSVVVPVLGSAVDSIDGSSGNYEEVLKKGFELEWNADSGDCRECEASGGRC   77 (94)
T ss_pred             CccccCCCCceeEEEeCC---cccCCcCCEEEEEEECchhhhccccchhHHHHHHhcCcEEEEeCCCCcCcChhcCCCEe
Confidence            4676533  234444433   46788999 799999883      2467899999999999999 677999999999999


Q ss_pred             cCCCC-CCeeeee-cCc
Q 039231          217 QSDSE-GNFQCAE-TRE  231 (506)
Q Consensus       217 ~~~~~-~~~~C~c-~~~  231 (506)
                      ||+.+ ..|.|+| |++
T Consensus        78 gy~~~~~~f~C~C~dg~   94 (94)
T PF14380_consen   78 GYDSNSEQFTCFCSDGP   94 (94)
T ss_pred             CCCCCCceEEEECCCCC
Confidence            99988 8999999 653

>cd05119 RIO RIO kinase family, catalytic domain

Probab=99.44  E-value=3.3e-13  Score=123.39  Aligned_cols=112  Identities=24%  Similarity=0.192  Sum_probs=81.9

Q ss_pred             cccCccCceEEEEEEEcCCCEEEEEEeccCCCCc---hhh----------------------HHHHHHhhccCccc--ee
Q 039231          319 YKLGQGGYGSVYKGKLLDGSNVAVKVLNDSKGNG---KEF----------------------INEVASISRTSHVN--VV  371 (506)
Q Consensus       319 ~~ig~G~~g~V~~~~~~~~~~vavK~l~~~~~~~---~~~----------------------~~E~~~l~~l~h~n--iv  371 (506)
                      +.||+|+||+||+|...+++.||||++.......   ..+                      ..|.+.+.++.+..  +.
T Consensus         3 ~~lg~G~~g~Vy~a~~~~~~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~   82 (187)
T cd05119           3 GPIGTGKEADVYLALDGDGEPVAVKIYRTGRTSFKKRKRYRTGDYRFGRKKSNWRYLSRLWAEKEFRNLKRLYEAGVPVP   82 (187)
T ss_pred             cccccccceeEEEEECCCCCEEEEEEEecCccchhhhhhhhHHHHHhccCCcchhhhhhHHHHHHHHHHHHHHHcCCCCC
Confidence            5699999999999998889999999986532211   111                      34566665554332  11


Q ss_pred             EEE---------EEee-------------ccchhhhHHHHHHHHHHHHhhcCC-CCeEecCcCCCcEEECCCCcEEEeec
Q 039231          372 ALL---------GFCL-------------RVAEELSSTIGIARGLEYLHLGCS-TRILHFDIKPHNILLDEDFCPKISDF  428 (506)
Q Consensus       372 ~l~---------g~~~-------------~~~~~l~i~~~i~~gl~~LH~~~~-~~ivH~dlkp~Nill~~~~~~ki~df  428 (506)
                      +.+         .+.-             ...+...++.+++.++.++|   . ++|+|+||||+||+++ ++.++|+||
T Consensus        83 ~~~~~~~~~lv~e~~~g~~~~~~~l~~~~~~~~~~~~~~~~~~~l~~lh---~~~~ivH~Dl~p~Nili~-~~~~~liDf  158 (187)
T cd05119          83 KPIDLNRHVLVMEFIGGDGIPAPRLKDVRLLEDPEELYDQILELMRKLY---REAGLVHGDLSEYNILVD-DGKVYIIDV  158 (187)
T ss_pred             ceEecCCCEEEEEEeCCCCccChhhhhhhhcccHHHHHHHHHHHHHHHh---hccCcCcCCCChhhEEEE-CCcEEEEEC
Confidence            111         1110             01456778999999999999   7 9999999999999999 889999999


Q ss_pred             CCCccc
Q 039231          429 GLAKIC  434 (506)
Q Consensus       429 g~a~~~  434 (506)
                      |.+...
T Consensus       159 g~a~~~  164 (187)
T cd05119         159 PQAVEI  164 (187)
T ss_pred             cccccc
Confidence            998643

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases present in archaea, bacteria and eukaryotes. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. RIO kinases contain a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. Most organisms contain at least two RIO kinases, RIO1 and RIO2. A third protein, RIO3, is present in multicellular eukaryotes. In yeast, RIO1 and RIO2 are essential for survival. They funct

>KOG4158 consensus BRPK/PTEN-induced protein kinase [Signal transduction mechanisms]

Probab=99.44  E-value=1.9e-13  Score=131.31  Aligned_cols=104  Identities=23%  Similarity=0.309  Sum_probs=78.2

Q ss_pred             hhHHHHHHHHHHHHhhcCCCCeEecCcCCCcEEE--CCCC--cEEEeecCCCccccCCCcceec----ccCCCCcccccc
Q 039231          384 LSSTIGIARGLEYLHLGCSTRILHFDIKPHNILL--DEDF--CPKISDFGLAKICNRKESIISM----TGARGTVGYIAP  455 (506)
Q Consensus       384 l~i~~~i~~gl~~LH~~~~~~ivH~dlkp~Nill--~~~~--~~ki~dfg~a~~~~~~~~~~~~----~~~~gt~~y~aP  455 (506)
                      ..|..|+++|+.|||   +++|.|||+|++|||+  |+|+  ...|+|||.+--..........    ...-|...-|||
T Consensus       344 ~~~laQlLEav~hL~---~hgvAhRDlKSDNiL~ElddD~~P~LVvaDFGCcLAd~~hGlqlpy~S~~Vd~GGNa~lmAP  420 (598)
T KOG4158|consen  344 RVILAQLLEAVTHLH---KHGVAHRDLKSDNILLELDDDEIPQLVVADFGCCLADDNHGLQLPYESDEVDLGGNAKLMAP  420 (598)
T ss_pred             HHHHHHHHHHHHHHH---HccchhhcccccceEEEecCCCCcEEEEcccceeeeccccccccccccccccCCCcceecch
Confidence            347889999999999   9999999999999998  4555  4678999987543332211111    123467778999


Q ss_pred             cccccccCC----CCccccHHHHHHHHHHHHcCCCCCCC
Q 039231          456 EVFCRNIGE----VSYKSDVYNYGMMIFEMTGGRKNVDV  490 (506)
Q Consensus       456 E~l~~~~~~----~s~~~Dv~s~G~il~elltg~~pf~~  490 (506)
                      |+.....|.    .-.|.|.|+.|.+.||+++...||-.
T Consensus       421 Ei~ta~PGp~avvny~kAD~WA~GalaYEIfg~~NPFY~  459 (598)
T KOG4158|consen  421 EIATAVPGPNAVVNYEKADTWAAGALAYEIFGRSNPFYK  459 (598)
T ss_pred             hhhhcCCCCceeeccchhhhhhhhhhHHHHhccCCcccc
Confidence            998543222    13489999999999999999999976

>PRK14879 serine/threonine protein kinase; Provisional

Probab=99.40  E-value=1.2e-12  Score=122.09  Aligned_cols=111  Identities=24%  Similarity=0.296  Sum_probs=86.6

Q ss_pred             cccCccCceEEEEEEEcCCCEEEEEEeccCCCC---------chhhHHHHHHhhccCccceeEEEEEeec----------
Q 039231          319 YKLGQGGYGSVYKGKLLDGSNVAVKVLNDSKGN---------GKEFINEVASISRTSHVNVVALLGFCLR----------  379 (506)
Q Consensus       319 ~~ig~G~~g~V~~~~~~~~~~vavK~l~~~~~~---------~~~~~~E~~~l~~l~h~niv~l~g~~~~----------  379 (506)
                      +.||+|++|.||+|.. +|..+++|+.......         ...+.+|++.+..++|+++.....++..          
T Consensus         2 ~~l~~G~~~~vy~~~~-~~~~~~vK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e~   80 (211)
T PRK14879          2 KLIKRGAEAEIYLGDF-LGIKAVIKWRIPKRYRHPELDERIRRERTRREARIMSRARKAGVNVPAVYFVDPENFIIVMEY   80 (211)
T ss_pred             cccccCceEEEEEEee-CCCceEEEEeCCcCCcChHHHHHHHHHHHHHHHHHHHHHHHCCCCCCeEEEEeCCCCEEEEEE
Confidence            3589999999999988 7778999986543211         1357789999999998876543333210          


Q ss_pred             -----c--------chhhhHHHHHHHHHHHHhhcCCCCeEecCcCCCcEEECCCCcEEEeecCCCccc
Q 039231          380 -----V--------AEELSSTIGIARGLEYLHLGCSTRILHFDIKPHNILLDEDFCPKISDFGLAKIC  434 (506)
Q Consensus       380 -----~--------~~~l~i~~~i~~gl~~LH~~~~~~ivH~dlkp~Nill~~~~~~ki~dfg~a~~~  434 (506)
                           .        .+...++.+++.+|.+||   +.+++|+|++|+|||++ ++.++|+|||.+...
T Consensus        81 ~~G~~L~~~~~~~~~~~~~i~~~i~~~l~~lH---~~~i~H~Dl~p~Nil~~-~~~~~liDf~~a~~~  144 (211)
T PRK14879         81 IEGEPLKDLINSNGMEELELSREIGRLVGKLH---SAGIIHGDLTTSNMILS-GGKIYLIDFGLAEFS  144 (211)
T ss_pred             eCCcCHHHHHHhccHHHHHHHHHHHHHHHHHH---hCCcccCCCCcccEEEE-CCCEEEEECCcccCC
Confidence                 0        023578899999999999   89999999999999999 788999999998753

>PRK09605 bifunctional UGMP family protein/serine/threonine protein kinase; Validated

Probab=99.38  E-value=1.4e-12  Score=138.62  Aligned_cols=113  Identities=19%  Similarity=0.242  Sum_probs=85.7

Q ss_pred             ccccCccCceEEEEEEEcCCCEEEEEE-eccCCC--------CchhhHHHHHHhhccCccceeEEEEEeeccc-------
Q 039231          318 KYKLGQGGYGSVYKGKLLDGSNVAVKV-LNDSKG--------NGKEFINEVASISRTSHVNVVALLGFCLRVA-------  381 (506)
Q Consensus       318 ~~~ig~G~~g~V~~~~~~~~~~vavK~-l~~~~~--------~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~-------  381 (506)
                      .++||+|+||.||+|.+.+.. +++|+ ..+...        ..+.+.+|++++.+++|++++....+.....       
T Consensus       338 ~~~iG~G~~g~Vy~~~~~~~~-~v~k~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~E  416 (535)
T PRK09605        338 DHLIGKGAEADIKKGEYLGRD-AVIKERVPKGYRHPELDERLRTERTRAEARLLSEARRAGVPTPVIYDVDPEEKTIVME  416 (535)
T ss_pred             cceeccCCcEEEEEEeecCcc-ceeEEEecccccchhHHHHHHHHHHHHHHHHHHhhcccCCCeeEEEEEeCCCCEEEEE
Confidence            567999999999999875544 34443 222111        1245789999999999999877554442211       


Q ss_pred             ------------hhhhHHHHHHHHHHHHhhcCCCCeEecCcCCCcEEECCCCcEEEeecCCCcccc
Q 039231          382 ------------EELSSTIGIARGLEYLHLGCSTRILHFDIKPHNILLDEDFCPKISDFGLAKICN  435 (506)
Q Consensus       382 ------------~~l~i~~~i~~gl~~LH~~~~~~ivH~dlkp~Nill~~~~~~ki~dfg~a~~~~  435 (506)
                                  ....++.+++++|.+||   +.+++||||||+|||+ +++.++|+|||+++...
T Consensus       417 ~~~g~~L~~~l~~~~~~~~~i~~~L~~lH---~~giiHrDlkp~NILl-~~~~~~liDFGla~~~~  478 (535)
T PRK09605        417 YIGGKDLKDVLEGNPELVRKVGEIVAKLH---KAGIVHGDLTTSNFIV-RDDRLYLIDFGLGKYSD  478 (535)
T ss_pred             ecCCCcHHHHHHHHHHHHHHHHHHHHHHH---hCCCccCCCChHHEEE-ECCcEEEEeCcccccCC
Confidence                        13557899999999999   8999999999999999 57789999999998643

>KOG1023 consensus Natriuretic peptide receptor, guanylate cyclase [Signal transduction mechanisms]

Probab=99.38  E-value=3.4e-13  Score=137.11  Aligned_cols=132  Identities=25%  Similarity=0.433  Sum_probs=100.0

Q ss_pred             hhccCccceeEEEEEeeccch----------------------------hhhHHHHHHHHHHHHhhcCCCCe-EecCcCC
Q 039231          362 ISRTSHVNVVALLGFCLRVAE----------------------------ELSSTIGIARGLEYLHLGCSTRI-LHFDIKP  412 (506)
Q Consensus       362 l~~l~h~niv~l~g~~~~~~~----------------------------~l~i~~~i~~gl~~LH~~~~~~i-vH~dlkp  412 (506)
                      |+.+.|.|+.+++|.+++..+                            ...++.+++.||+|||   +.+| .|+.+++
T Consensus         1 l~~l~h~n~~~f~g~~~~~~~~~~i~~~c~rGsl~D~i~~~~~~~d~~F~~s~~rdi~~Gl~ylh---~s~i~~hg~l~s   77 (484)
T KOG1023|consen    1 LRQLDHDNLNKFIGASVDGPEMIVIWEYCSRGSLLDILSNEDIKLDYFFILSFIRDISKGLAYLH---NSPIGYHGALKS   77 (484)
T ss_pred             CcccchhhhhhheeeEecCCceEEEEeeecCccHHhHHhccccCccHHHHHHHHHHHHHHHHHHh---cCcceeeeeecc
Confidence            456789999999888744322                            4557889999999999   5555 9999999


Q ss_pred             CcEEECCCCcEEEeecCCCccccCCCcceecccCCCCccccccccccccc--C---CCCccccHHHHHHHHHHHHcCCCC
Q 039231          413 HNILLDEDFCPKISDFGLAKICNRKESIISMTGARGTVGYIAPEVFCRNI--G---EVSYKSDVYNYGMMIFEMTGGRKN  487 (506)
Q Consensus       413 ~Nill~~~~~~ki~dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~--~---~~s~~~Dv~s~G~il~elltg~~p  487 (506)
                      +|.++|....+||+|||+.................-..-|.|||.+....  .   ..+++.||||||++++|+++++.|
T Consensus        78 ~nClvd~~w~lklt~~Gl~~~~~~~~~~~~~~~~~~~~lw~aPellr~~~~~~~~~~~~~~gdiYs~~ii~~ei~~r~~~  157 (484)
T KOG1023|consen   78 SNCLVDSRWVLKLTDFGLNSLLEETAEPEAHHPIRKALLWTAPELLRGALSQSLESALTQKGDIYSFGIIMYEILFRSGP  157 (484)
T ss_pred             ccceeeeeEEEEechhhhcccccccccccccchhHHHHhccCHHHhcccccccccccccccCCeehHHHHHHHHHhccCc
Confidence            99999999999999999987764311111112223456799999985521  1   157789999999999999999999


Q ss_pred             CCCCCCCcc
Q 039231          488 VDVVDNGST  496 (506)
Q Consensus       488 f~~~~~~~~  496 (506)
                      |+.....+.
T Consensus       158 ~~~~~~~~~  166 (484)
T KOG1023|consen  158 FDLRNLVED  166 (484)
T ss_pred             cccccccCC
Confidence            998655544

>TIGR03724 arch_bud32 Kae1-associated kinase Bud32

Probab=99.37  E-value=2.6e-12  Score=118.71  Aligned_cols=109  Identities=23%  Similarity=0.298  Sum_probs=83.1

Q ss_pred             cCccCceEEEEEEEcCCCEEEEEEeccCCC-C--------chhhHHHHHHhhccCcccee--EEEEEe----------ec
Q 039231          321 LGQGGYGSVYKGKLLDGSNVAVKVLNDSKG-N--------GKEFINEVASISRTSHVNVV--ALLGFC----------LR  379 (506)
Q Consensus       321 ig~G~~g~V~~~~~~~~~~vavK~l~~~~~-~--------~~~~~~E~~~l~~l~h~niv--~l~g~~----------~~  379 (506)
                      ||+|++|.||+|.+ ++..+++|....... .        ..++.+|++.+..++|+++.  .++...          .+
T Consensus         2 ig~G~~~~vy~~~~-~~~~~viK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e~~~   80 (199)
T TIGR03724         2 IAKGAEAIIYLGDF-LGLKAVIKERVPKSYRHPELDERIRRERTRNEARLLSRARKAGVNTPVVYDVDPDNKTIVMEYIE   80 (199)
T ss_pred             CCCCceEEEEEeec-CCccEEEEEecCCcCcCchHHHHHHHHHHHHHHHHHHHHHHCCCCCCEEEEEECCCCEEEEEEEC
Confidence            89999999999995 678899998653211 1        14567899999999877643  222221          00


Q ss_pred             ---cchhh-----hHHHHHHHHHHHHhhcCCCCeEecCcCCCcEEECCCCcEEEeecCCCccc
Q 039231          380 ---VAEEL-----SSTIGIARGLEYLHLGCSTRILHFDIKPHNILLDEDFCPKISDFGLAKIC  434 (506)
Q Consensus       380 ---~~~~l-----~i~~~i~~gl~~LH~~~~~~ivH~dlkp~Nill~~~~~~ki~dfg~a~~~  434 (506)
                         ..+.+     .++.+++.+|.+||   +.+++|+|++|+||+++ ++.++++|||+++..
T Consensus        81 g~~l~~~~~~~~~~~~~~i~~~l~~lH---~~gi~H~Dl~~~Nil~~-~~~~~liDfg~a~~~  139 (199)
T TIGR03724        81 GKPLKDVIEEGNDELLREIGRLVGKLH---KAGIVHGDLTTSNIIVR-DDKLYLIDFGLGKYS  139 (199)
T ss_pred             CccHHHHHhhcHHHHHHHHHHHHHHHH---HCCeecCCCCcceEEEE-CCcEEEEECCCCcCC
Confidence               00111     68999999999999   99999999999999999 789999999998764

Members of this protein family are the Bud32 protein associated with Kae1 (kinase-associated endopeptidase 1) in the Archaea. In many Archaeal genomes, Kae1 and Bud32 are fused. The complex is homologous to the Kae1 and Bud32 subunits of the eukaryotic KEOPS complex, an apparently ancient protein kinase-containing molecular machine.

>cd05120 APH_ChoK_like Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family

Probab=99.29  E-value=2e-11  Score=106.67  Aligned_cols=113  Identities=24%  Similarity=0.167  Sum_probs=90.1

Q ss_pred             cccCccCceEEEEEEEcCCCEEEEEEeccCCCCchhhHHHHHHhhccCc--cceeEEEEEee------------------
Q 039231          319 YKLGQGGYGSVYKGKLLDGSNVAVKVLNDSKGNGKEFINEVASISRTSH--VNVVALLGFCL------------------  378 (506)
Q Consensus       319 ~~ig~G~~g~V~~~~~~~~~~vavK~l~~~~~~~~~~~~E~~~l~~l~h--~niv~l~g~~~------------------  378 (506)
                      +.|++|.++.||+++..+ ..+++|....... ..++.+|+..+..++|  .++.+++++..                  
T Consensus         4 ~~i~~g~~~~v~~~~~~~-~~~~iK~~~~~~~-~~~~~~e~~~~~~l~~~~~~~p~~~~~~~~~~~~~~v~e~~~g~~~~   81 (155)
T cd05120           4 KLLKGGLTNRVYLLGTKD-EDYVLKINPSREK-GADREREVAILQLLARKGLPVPKVLASGESDGWSYLLMEWIEGETLD   81 (155)
T ss_pred             eecccccccceEEEEecC-CeEEEEecCCCCc-hhHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCccEEEEEecCCeecc
Confidence            459999999999999854 7899999866543 4678899999999976  46766665431                  


Q ss_pred             --ccchhhhHHHHHHHHHHHHhhcCCCCeEecCcCCCcEEECCCCcEEEeecCCCcc
Q 039231          379 --RVAEELSSTIGIARGLEYLHLGCSTRILHFDIKPHNILLDEDFCPKISDFGLAKI  433 (506)
Q Consensus       379 --~~~~~l~i~~~i~~gl~~LH~~~~~~ivH~dlkp~Nill~~~~~~ki~dfg~a~~  433 (506)
                        +......++.+++++|++||.....+++|+|++|+||++++.+.+++.|||.+..
T Consensus        82 ~~~~~~~~~~~~~~~~~l~~lh~~~~~~i~H~Dl~~~Nil~~~~~~~~l~Df~~~~~  138 (155)
T cd05120          82 EVSEEEKEDIAEQLAELLAKLHQLPLLVLCHGDLHPGNILVDDGKILGIIDWEYAGY  138 (155)
T ss_pred             cCCHHHHHHHHHHHHHHHHHHhCCCceEEEecCCCcceEEEECCcEEEEEecccccC
Confidence              1134567889999999999943335799999999999999989999999998864

The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves

>PRK01723 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed

Probab=99.23  E-value=4e-11  Score=113.71  Aligned_cols=112  Identities=17%  Similarity=0.198  Sum_probs=84.7

Q ss_pred             cccC-ccCceEEEEEEEcCCCEEEEEEeccCC--------------CCchhhHHHHHHhhccCccce--eEEEEEe----
Q 039231          319 YKLG-QGGYGSVYKGKLLDGSNVAVKVLNDSK--------------GNGKEFINEVASISRTSHVNV--VALLGFC----  377 (506)
Q Consensus       319 ~~ig-~G~~g~V~~~~~~~~~~vavK~l~~~~--------------~~~~~~~~E~~~l~~l~h~ni--v~l~g~~----  377 (506)
                      ..|| .|+.|+||.+.. ++..++||.+....              .....+.+|++.+.+++|++|  ++.+++.    
T Consensus        37 ~~lg~~~g~gtv~~v~~-~~~~~vlk~~~r~~~i~kv~~~~~~~~~~~~~r~~rE~~ll~~L~~~gi~vP~pl~~~~~~~  115 (239)
T PRK01723         37 RVVGSAKGRGTTWFVQT-PGVNWVLRHYRRGGLIGKLSKDRYLFTGLERTRAFAEFRLLAQLYEAGLPVPRPIAARVVRH  115 (239)
T ss_pred             ceeecCCCCccEEEEEe-CCceEEEEEeeEcchHHhhhhhcccccchhhhHHHHHHHHHHHHHhCCCCCceeEeeeeeec
Confidence            4587 899999999988 47788998874311              122467889999999998774  4444331    


Q ss_pred             ------------ecc-ch----------hhhHHHHHHHHHHHHhhcCCCCeEecCcCCCcEEECCCCcEEEeecCCCccc
Q 039231          378 ------------LRV-AE----------ELSSTIGIARGLEYLHLGCSTRILHFDIKPHNILLDEDFCPKISDFGLAKIC  434 (506)
Q Consensus       378 ------------~~~-~~----------~l~i~~~i~~gl~~LH~~~~~~ivH~dlkp~Nill~~~~~~ki~dfg~a~~~  434 (506)
                                  ++. ..          ......+++.+|.+||   +.||+|+||||.|||++.++.++|+|||.+...
T Consensus       116 ~~~~~~~lV~e~l~G~~~L~~~l~~~~l~~~~~~~i~~~l~~lH---~~GI~HrDlkp~NILv~~~~~v~LIDfg~~~~~  192 (239)
T PRK01723        116 GLFYRADILIERIEGARDLVALLQEAPLSEEQWQAIGQLIARFH---DAGVYHADLNAHNILLDPDGKFWLIDFDRGELR  192 (239)
T ss_pred             CcceeeeEEEEecCCCCCHHHHHhcCCCCHHHHHHHHHHHHHHH---HCCCCCCCCCchhEEEcCCCCEEEEECCCcccC
Confidence                        110 01          1234678999999999   999999999999999998889999999988753

>KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning]

Probab=99.20  E-value=3e-12  Score=136.05  Aligned_cols=175  Identities=26%  Similarity=0.312  Sum_probs=136.0

Q ss_pred             ccccCccCceEEEEEEEcC--CCEEEEEEeccCC---CCchhhHHHHHHhhccC-ccceeEEEEEee-------------
Q 039231          318 KYKLGQGGYGSVYKGKLLD--GSNVAVKVLNDSK---GNGKEFINEVASISRTS-HVNVVALLGFCL-------------  378 (506)
Q Consensus       318 ~~~ig~G~~g~V~~~~~~~--~~~vavK~l~~~~---~~~~~~~~E~~~l~~l~-h~niv~l~g~~~-------------  378 (506)
                      .+.||+|+++.|-......  ...+|+|.+....   ........|..+-..+. |.|++.+++...             
T Consensus        25 ~~~ig~gs~~~~~~~~~~~~~~~~~a~~~~s~~~~~~~~~~~i~~e~~~~~~~s~h~n~~~~~~~~~~~~~~~~~~~~s~  104 (601)
T KOG0590|consen   25 SRSIGKGSFSSSALASNSRDPESSSATKPISIPPKSEDSSEHIDTETDIQKKLSKHSNTVHMIEPSSSPRSYLLSLSYSD  104 (601)
T ss_pred             cccccccccchhhhhhhcCCCcceeeccCCCCCCCccchhhhcCccccccccccccccccccCCccCCCcccccccCccc
Confidence            3459999999999887633  4556777665443   22244556777777777 999999986541             


Q ss_pred             ----------------ccchhhhHHHHHHHHHHHHhhcCCCCeEecCcCCCcEEECCCC-cEEEeecCCCccccC-CCcc
Q 039231          379 ----------------RVAEELSSTIGIARGLEYLHLGCSTRILHFDIKPHNILLDEDF-CPKISDFGLAKICNR-KESI  440 (506)
Q Consensus       379 ----------------~~~~~l~i~~~i~~gl~~LH~~~~~~ivH~dlkp~Nill~~~~-~~ki~dfg~a~~~~~-~~~~  440 (506)
                                      .....-....|+..++.|+|.  ..++.|+||||+|.+++..+ ..|++|||+|..... ....
T Consensus       105 g~~~f~~i~~~~~~~~~~~~~~~~~~ql~s~l~~~H~--~~~~~h~~ikP~n~~l~~s~~~l~~~df~~At~~~~~~g~~  182 (601)
T KOG0590|consen  105 GGSLFSKISHPDSTGTSSSSASRYLPQLNSGLSYLHP--ENGVTHRDIKPSNSLLDESGSALKIADFGLATAYRNKNGAE  182 (601)
T ss_pred             ccccccccccCCccCCCCcchhhhhhhhccCccccCc--ccccccCCCCCccchhccCCCcccCCCchhhccccccCCcc
Confidence                            111234577899999999995  68999999999999999999 999999999988776 4444


Q ss_pred             eecccCCC-CcccccccccccccCCCCccccHHHHHHHHHHHHcCCCCCCCCCCCc
Q 039231          441 ISMTGARG-TVGYIAPEVFCRNIGEVSYKSDVYNYGMMIFEMTGGRKNVDVVDNGS  495 (506)
Q Consensus       441 ~~~~~~~g-t~~y~aPE~l~~~~~~~s~~~Dv~s~G~il~elltg~~pf~~~~~~~  495 (506)
                      .......| ++.|+|||...+. ....+..|+||.|+++.-+++|..|++......
T Consensus       183 ~~~~~~~g~s~~y~a~E~~~~~-~~~~~~~d~~S~g~~l~~~~~g~~p~~~~~~~~  237 (601)
T KOG0590|consen  183 RSLKDRCGSSPPYGAPEHLSGK-AYRGPSVDVWSLGIVLSAMLTGELPWDFPSRKD  237 (601)
T ss_pred             eeeecccCCCCCCCCcccccch-hhcCCCcccccccccccccccCCCCcccccccc
Confidence            44455677 9999999998664 356778999999999999999999998876554

>TIGR01982 UbiB 2-polyprenylphenol 6-hydroxylase

Probab=98.95  E-value=6e-09  Score=107.54  Aligned_cols=115  Identities=24%  Similarity=0.294  Sum_probs=78.7

Q ss_pred             cccCccCceEEEEEEEcCCCEEEEEEeccCCCC---------------------------c--------------hhhHH
Q 039231          319 YKLGQGGYGSVYKGKLLDGSNVAVKVLNDSKGN---------------------------G--------------KEFIN  357 (506)
Q Consensus       319 ~~ig~G~~g~V~~~~~~~~~~vavK~l~~~~~~---------------------------~--------------~~~~~  357 (506)
                      +.||.|++|.||+|++.+|+.||||+.+..-..                           .              -++.+
T Consensus       123 ~plasaSigQVh~A~l~~G~~VaVKv~rp~i~~~i~~Dl~~l~~~~~~~~~~~~~~~~~~~~~~~~e~~~~l~~Eldf~~  202 (437)
T TIGR01982       123 KPLAAASIAQVHRARLVDGKEVAVKVLRPGIEKTIAADIALLYRLARIVERLSPDSRRLRPTEVVKEFEKTLRRELDLRR  202 (437)
T ss_pred             cceeeeehhheEEEEecCCCEEEEEeeCCCcHHHHHHHHHHHHHHHHHHHHhCccccccCHHHHHHHHHHHHHHHHCHHH
Confidence            359999999999999999999999998542100                           0              02445


Q ss_pred             HHHHhhccC-----cccee--EE-----------EEEe----ecc--------chhhhHHHHHHH-HHHHHhhcCCCCeE
Q 039231          358 EVASISRTS-----HVNVV--AL-----------LGFC----LRV--------AEELSSTIGIAR-GLEYLHLGCSTRIL  406 (506)
Q Consensus       358 E~~~l~~l~-----h~niv--~l-----------~g~~----~~~--------~~~l~i~~~i~~-gl~~LH~~~~~~iv  406 (506)
                      |++.+.+++     ++++.  ++           +.++    +..        .+...++.+++. .+..+|   ..|++
T Consensus       203 Ea~n~~~~~~~~~~~~~v~vP~v~~~~~~~~vLvmE~i~G~~L~~~~~~~~~~~~~~~ia~~~~~~~l~ql~---~~g~~  279 (437)
T TIGR01982       203 EAANASELGENFKNDPGVYVPEVYWDRTSERVLTMEWIDGIPLSDIAALDEAGLDRKALAENLARSFLNQVL---RDGFF  279 (437)
T ss_pred             HHHHHHHHHHhcCCCCCEEeCCEehhhcCCceEEEEeECCcccccHHHHHhcCCCHHHHHHHHHHHHHHHHH---hCCce
Confidence            555555552     23322  11           1111    110        012346666665 467788   89999


Q ss_pred             ecCcCCCcEEECCCCcEEEeecCCCccccC
Q 039231          407 HFDIKPHNILLDEDFCPKISDFGLAKICNR  436 (506)
Q Consensus       407 H~dlkp~Nill~~~~~~ki~dfg~a~~~~~  436 (506)
                      |+|++|.||++++++.+++.|||++..+..
T Consensus       280 H~D~hPgNilv~~~g~i~liDfG~~~~l~~  309 (437)
T TIGR01982       280 HADLHPGNIFVLKDGKIIALDFGIVGRLSE  309 (437)
T ss_pred             eCCCCcccEEECCCCcEEEEeCCCeeECCH
Confidence            999999999999999999999999987653

This model represents the enzyme (UbiB) which catalyzes the first hydroxylation step in the ubiquinone biosynthetic pathway in bacteria. It is believed that the reaction is 2-polyprenylphenol - 6-hydroxy-2-polyprenylphenol. This model finds hits primarily in the proteobacteria. The gene is also known as AarF in certain species.

>cd05151 ChoK Choline Kinase (ChoK)

Probab=98.95  E-value=4e-09  Score=94.56  Aligned_cols=109  Identities=22%  Similarity=0.185  Sum_probs=81.1

Q ss_pred             ccCccCceEEEEEEEcCCCEEEEEEeccCCCCchhhHHHHHHhhccCcccee-EEEEEee-------cc----------c
Q 039231          320 KLGQGGYGSVYKGKLLDGSNVAVKVLNDSKGNGKEFINEVASISRTSHVNVV-ALLGFCL-------RV----------A  381 (506)
Q Consensus       320 ~ig~G~~g~V~~~~~~~~~~vavK~l~~~~~~~~~~~~E~~~l~~l~h~niv-~l~g~~~-------~~----------~  381 (506)
                      .++.|..+.||+++.. +..+++|+..........+.+|++.+..+.+.+++ +++.+.-       ++          .
T Consensus         5 ~l~~G~~~~vy~~~~~-~~~~~lK~~~~~~~~~~~~~~E~~~l~~l~~~~~~P~~~~~~~~~~~lv~e~i~G~~l~~~~~   83 (170)
T cd05151           5 PLKGGMTNKNYRVEVA-NKKYVVRIPGNGTELLINRENEAENSKLAAEAGIGPKLYYFDPETGVLITEFIEGSELLTEDF   83 (170)
T ss_pred             ecCCcccCceEEEEEC-CeEEEEEeCCCCcccccCHHHHHHHHHHHHHhCCCCceEEEeCCCCeEEEEecCCCccccccc
Confidence            4788999999999874 78899999865543334577899999888654433 3333220       00          1


Q ss_pred             hhhhHHHHHHHHHHHHhhcCCCC-----eEecCcCCCcEEECCCCcEEEeecCCCcc
Q 039231          382 EELSSTIGIARGLEYLHLGCSTR-----ILHFDIKPHNILLDEDFCPKISDFGLAKI  433 (506)
Q Consensus       382 ~~l~i~~~i~~gl~~LH~~~~~~-----ivH~dlkp~Nill~~~~~~ki~dfg~a~~  433 (506)
                      ....+..+++++|+.||   ..+     ++|+|++|.||+++ ++.++++||+.+..
T Consensus        84 ~~~~~~~~l~~~l~~LH---~~~~~~~~~~HgD~~~~Nil~~-~~~~~liDf~~a~~  136 (170)
T cd05151          84 SDPENLEKIAKLLKKLH---SSPLPDLVPCHNDLLPGNFLLD-DGRLWLIDWEYAGM  136 (170)
T ss_pred             cCHHHHHHHHHHHHHHh---CCCCCCceeecCCCCcCcEEEE-CCeEEEEecccccC
Confidence            12346789999999999   665     59999999999999 56899999998864

The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC), and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. Bacterial ChoK is also referred to as licA protein. ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major ph

>KOG1243 consensus Protein kinase [General function prediction only]

Probab=98.87  E-value=7.5e-09  Score=106.90  Aligned_cols=144  Identities=18%  Similarity=0.216  Sum_probs=104.8

Q ss_pred             EEcCCCEEEEEEeccCCC-CchhhHHHHHHhhccCccceeEEEEEeeccc----------------------hhhhHHHH
Q 039231          333 KLLDGSNVAVKVLNDSKG-NGKEFINEVASISRTSHVNVVALLGFCLRVA----------------------EELSSTIG  389 (506)
Q Consensus       333 ~~~~~~~vavK~l~~~~~-~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~----------------------~~l~i~~~  389 (506)
                      +..++.+|.|...+.... ......+-++.|+.++||||++++...-...                      ..-..+.|
T Consensus        33 ~k~~~~~vsVF~~~~~~~~~~~~~~~A~k~lKtlRHP~Il~yL~t~e~~~~~ylvTErV~Pl~~~lk~l~~~~v~~Gl~q  112 (690)
T KOG1243|consen   33 RKADGGPVSVFVYKRSNGEVTELAKRAVKRLKTLRHPNILSYLDTTEEEGTLYLVTERVRPLETVLKELGKEEVCLGLFQ  112 (690)
T ss_pred             eeccCCceEEEEEeCCCchhhHHHHHHHHHhhhccCchhhhhhhhhcccCceEEEeeccccHHHHHHHhHHHHHHHHHHH
Confidence            344688999998876554 2245778899999999999999987552111                      12235679


Q ss_pred             HHHHHHHHhhcCCCCeEecCcCCCcEEECCCCcEEEeecCCCccccCCCcceecccCCCCcccccccccccccCCCCccc
Q 039231          390 IARGLEYLHLGCSTRILHFDIKPHNILLDEDFCPKISDFGLAKICNRKESIISMTGARGTVGYIAPEVFCRNIGEVSYKS  469 (506)
Q Consensus       390 i~~gl~~LH~~~~~~ivH~dlkp~Nill~~~~~~ki~dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~s~~~  469 (506)
                      |+.||.|||.  +.+++|++|.-+.|++++.|..||++|.++........  .......-..|..|+.+...    .-..
T Consensus       113 Il~AL~FL~~--d~~lvHgNv~~~SVfVn~~GeWkLggle~v~~~~~~~~--~~~~~~~~~s~~~P~~~~~s----~~s~  184 (690)
T KOG1243|consen  113 ILAALSFLND--DCNLVHGNVCKDSVFVNESGEWKLGGLELVSKASGFNA--PAKSLYLIESFDDPEEIDPS----EWSI  184 (690)
T ss_pred             HHHHHHHHhc--cCCeeeccEeeeeEEEcCCCcEEEeeeEEEeccccCCc--ccccchhhhcccChhhcCcc----ccch
Confidence            9999999985  78999999999999999999999999988754332221  00112223346677765221    1356


Q ss_pred             cHHHHHHHHHHHHcC
Q 039231          470 DVYNYGMMIFEMTGG  484 (506)
Q Consensus       470 Dv~s~G~il~elltg  484 (506)
                      |.|-||++++|++.|
T Consensus       185 D~~~Lg~li~el~ng  199 (690)
T KOG1243|consen  185 DSWGLGCLIEELFNG  199 (690)
T ss_pred             hhhhHHHHHHHHhCc
Confidence            999999999999999

>KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning]

Probab=98.82  E-value=3e-09  Score=108.69  Aligned_cols=178  Identities=26%  Similarity=0.272  Sum_probs=134.1

Q ss_pred             HHHHHHHhhhccccCc--cCceEEEEEEE---cCCCEEEEEEeccCC---CCchhhHHHHHHhhccC-ccceeEEEEEe-
Q 039231          308 ADIKKMTNSFKYKLGQ--GGYGSVYKGKL---LDGSNVAVKVLNDSK---GNGKEFINEVASISRTS-HVNVVALLGFC-  377 (506)
Q Consensus       308 ~el~~~~~~~~~~ig~--G~~g~V~~~~~---~~~~~vavK~l~~~~---~~~~~~~~E~~~l~~l~-h~niv~l~g~~-  377 (506)
                      .+..+.+..+...+|.  |.+|.||.++.   .++..+|+|.-+...   .....=.+|+....+++ |+|.++....+ 
T Consensus       109 ~s~~~~~~~~~~~~g~~~g~~~s~~~~~~~~~~s~~~~a~k~s~~p~s~p~~~~~k~~~~~s~~~i~~~~~~v~~~~~~e  188 (524)
T KOG0601|consen  109 DSFFDQRFPISSRTGSLPGSKGSVFKSRCTNSESPHKFAVKKSKIPFSPPLDSKRKLREFLSHHKIDSHENPVRDSPAWE  188 (524)
T ss_pred             cchhhhhcccccccccCCCCCceeecccCCcccCCcccccccccCCCCCccccccccchhhcccccCccccccccCcccc
Confidence            4455555566677999  99999999986   357889999854322   23344466777777776 99999854333 


Q ss_pred             --------------------------eccchhhhHHHHHHH----HHHHHhhcCCCCeEecCcCCCcEEECCC-CcEEEe
Q 039231          378 --------------------------LRVAEELSSTIGIAR----GLEYLHLGCSTRILHFDIKPHNILLDED-FCPKIS  426 (506)
Q Consensus       378 --------------------------~~~~~~l~i~~~i~~----gl~~LH~~~~~~ivH~dlkp~Nill~~~-~~~ki~  426 (506)
                                                ++....+....+..+    |+.++|   ...++|-|+||.||++..+ ...+++
T Consensus       189 ~~~~lfiqtE~~~~sl~~~~~~~~~~~p~~~l~~~~~~~~~~~~~al~~~h---s~~~~~~~~kp~~i~~~~~~~s~~~~  265 (524)
T KOG0601|consen  189 GSGILFIQTELCGESLQSYCHTPCNFLPDNLLWNSLRDWLSRDVTALSHLH---SNNIVHDDLKPANIFTTSDWTSCKLT  265 (524)
T ss_pred             cCCcceeeeccccchhHHhhhcccccCCchhhhhHHhhhhhcccccccccC---CCcccccccchhheecccccceeecC
Confidence                                      333345667777777    999999   9999999999999999988 889999


Q ss_pred             ecCCCccccCCCcceec---ccCCCCcccccccccccccCCCCccccHHHHHHHHHHHHcCCCCCCCC
Q 039231          427 DFGLAKICNRKESIISM---TGARGTVGYIAPEVFCRNIGEVSYKSDVYNYGMMIFEMTGGRKNVDVV  491 (506)
Q Consensus       427 dfg~a~~~~~~~~~~~~---~~~~gt~~y~aPE~l~~~~~~~s~~~Dv~s~G~il~elltg~~pf~~~  491 (506)
                      |||+...++...-....   ....+...|++||.+.   +-++.++|+|++|.+..|..++-.+....
T Consensus       266 df~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~---~l~~~~~di~sl~ev~l~~~l~~~~~~~g  330 (524)
T KOG0601|consen  266 DFGLVSKISDGNFSSVFKVSKRPEGDCIYAAKELLN---GLATFASDIFSLGEVILEAILGSHLPSVG  330 (524)
T ss_pred             CcceeEEccCCccccceeeeecCCCCceEeChhhhc---cccchHhhhcchhhhhHhhHhhcccccCC
Confidence            99999887665422111   1235778899999984   46888999999999999999887766544

>cd05146 RIO3_euk RIO kinase family; eukaryotic RIO3, catalytic domain

Probab=98.64  E-value=1.9e-07  Score=85.00  Aligned_cols=111  Identities=15%  Similarity=0.111  Sum_probs=76.6

Q ss_pred             ccCccCceEEEEEEEcC-------CCEEEEEEeccCC----------------------CC-chhhH----HHHHHhhcc
Q 039231          320 KLGQGGYGSVYKGKLLD-------GSNVAVKVLNDSK----------------------GN-GKEFI----NEVASISRT  365 (506)
Q Consensus       320 ~ig~G~~g~V~~~~~~~-------~~~vavK~l~~~~----------------------~~-~~~~~----~E~~~l~~l  365 (506)
                      .|+.|--+.||.|...+       +..+|||+.+.+.                      .+ .+.+.    +|++.|.++
T Consensus         4 ~i~~GKEa~V~~~~~~~~~~~~~~~~~~avKi~r~~~~~Fk~~~~y~~~~~rf~~~~~k~~~~~~~~~wa~kE~r~L~rl   83 (197)
T cd05146           4 CISTGKESVVLHANGGSNETEQVIPTECAIKVFKTTLNEFKNRDKYIKDDYRFKDRFSKLNPRKIIRMWAEKEMHNLKRM   83 (197)
T ss_pred             ccccCcceEEEEEecCcccccccCCceEEEEEEeccceeEcChhhhccCCcccccCcCCCCHHHHHHHHHHHHHHHHHHH
Confidence            58999999999997643       4799999874210                      00 11222    788888888


Q ss_pred             Ccc--ceeEEEEEe-----------------------eccchhhhHHHHHHHHHHHH-hhcCCCCeEecCcCCCcEEECC
Q 039231          366 SHV--NVVALLGFC-----------------------LRVAEELSSTIGIARGLEYL-HLGCSTRILHFDIKPHNILLDE  419 (506)
Q Consensus       366 ~h~--niv~l~g~~-----------------------~~~~~~l~i~~~i~~gl~~L-H~~~~~~ivH~dlkp~Nill~~  419 (506)
                      ...  ++.+.+++.                       ++..+...+..+++.+|..| |   +.+++|+||++.||++++
T Consensus        84 ~~~Gv~vP~pi~~~~~~lvME~Ig~~~~~~~~Lkd~~~~~~~~~~i~~~i~~~l~~l~H---~~glVHGDLs~~NIL~~~  160 (197)
T cd05146          84 QKAGIPCPEVVVLKKHVLVMSFIGDDQVPAPKLKDAKLNDEEMKNAYYQVLSMMKQLYK---ECNLVHADLSEYNMLWHD  160 (197)
T ss_pred             HHcCCCCCeEEEecCCEEEEEEcCCCCccchhhhccccCHHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEEEC
Confidence            522  222222111                       11112345678999999998 8   889999999999999974


Q ss_pred             CCcEEEeecCCCccc
Q 039231          420 DFCPKISDFGLAKIC  434 (506)
Q Consensus       420 ~~~~ki~dfg~a~~~  434 (506)
                       +.+.|+|||.+...
T Consensus       161 -~~v~iIDF~qav~~  174 (197)
T cd05146         161 -GKVWFIDVSQSVEP  174 (197)
T ss_pred             -CcEEEEECCCceeC
Confidence             67999999988643

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO3 is present only in multicellular eukaryotes. Its function is still unknown.

>PRK04750 ubiB putative ubiquinone biosynthesis protein UbiB; Reviewed

Probab=98.58  E-value=2.4e-07  Score=96.99  Aligned_cols=35  Identities=29%  Similarity=0.409  Sum_probs=31.9

Q ss_pred             CCCeEecCcCCCcEEECCCC----cEEEeecCCCccccC
Q 039231          402 STRILHFDIKPHNILLDEDF----CPKISDFGLAKICNR  436 (506)
Q Consensus       402 ~~~ivH~dlkp~Nill~~~~----~~ki~dfg~a~~~~~  436 (506)
                      ..|++|+|+||.||+++.++    .+++.|||+...++.
T Consensus       278 ~~GffHaDpHPGNIlv~~~g~~~~~i~llDFGivg~l~~  316 (537)
T PRK04750        278 RDGFFHADMHPGNIFVSYDPPENPRYIALDFGIVGSLNK  316 (537)
T ss_pred             hCCeeeCCCChHHeEEecCCCCCCeEEEEecceEEECCH
Confidence            78999999999999999888    999999999987654

>KOG1266 consensus Protein kinase [Signal transduction mechanisms]

Probab=98.47  E-value=1.1e-07  Score=90.26  Aligned_cols=102  Identities=23%  Similarity=0.256  Sum_probs=73.7

Q ss_pred             hhhHHHHHHHHHHHHhhcCCCCeEecCcCCCcEEECCCCcEEEeecCCCccccCCCc--ceecccCCCCccccccccccc
Q 039231          383 ELSSTIGIARGLEYLHLGCSTRILHFDIKPHNILLDEDFCPKISDFGLAKICNRKES--IISMTGARGTVGYIAPEVFCR  460 (506)
Q Consensus       383 ~l~i~~~i~~gl~~LH~~~~~~ivH~dlkp~Nill~~~~~~ki~dfg~a~~~~~~~~--~~~~~~~~gt~~y~aPE~l~~  460 (506)
                      ..++..||..||.|||+ +.++|+|+++..+.|++..++-+||+--........-..  ........+-++|.|||.=..
T Consensus       178 wkkw~tqIlsal~yLhs-~~PpiihgnlTc~tifiq~ngLIkig~~ap~s~h~s~~~~~~~Ek~~~~~~~g~~a~~sg~~  256 (458)
T KOG1266|consen  178 WKKWCTQILSALSYLHS-CDPPIIHGNLTCDTIFIQHNGLIKIGSVAPDSTHPSVNSTREAEKSVNTSLPGFSAPESGTT  256 (458)
T ss_pred             HHHHHHHHHhhhhhhhc-cCCccccCCcchhheeecCCceEEecccCccccchhhhhhhHhhhhccccCCccccCCcCcc
Confidence            34588899999999994 589999999999999999999999863221111110000  001123456789999997432


Q ss_pred             ccCCCCccccHHHHHHHHHHHHcCCCC
Q 039231          461 NIGEVSYKSDVYNYGMMIFEMTGGRKN  487 (506)
Q Consensus       461 ~~~~~s~~~Dv~s~G~il~elltg~~p  487 (506)
                        -..+-.+|||+||+..+||..+..-
T Consensus       257 --tn~~~a~dIy~fgmcAlemailEiq  281 (458)
T KOG1266|consen  257 --TNTTGASDIYKFGMCALEMAILEIQ  281 (458)
T ss_pred             --cccccchhhhhhhHHHHHHHHheec
Confidence              3566789999999999999988765

>cd05154 ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 and 11, N-terminal domain, and similar proteins

Probab=98.43  E-value=2e-06  Score=80.49  Aligned_cols=114  Identities=18%  Similarity=0.195  Sum_probs=83.8

Q ss_pred             ccCccCceEEEEEEEcCCCEEEEEEeccCCC--CchhhHHHHHHhhccCccc--eeEEEEEee-----------------
Q 039231          320 KLGQGGYGSVYKGKLLDGSNVAVKVLNDSKG--NGKEFINEVASISRTSHVN--VVALLGFCL-----------------  378 (506)
Q Consensus       320 ~ig~G~~g~V~~~~~~~~~~vavK~l~~~~~--~~~~~~~E~~~l~~l~h~n--iv~l~g~~~-----------------  378 (506)
                      .|+.|..+.||++...+|..+++|+......  ...++.+|+++++.+++.+  +.+++.+.-                 
T Consensus         5 ~l~~G~~n~~~~v~~~~g~~~ilK~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~vp~~~~~~~~~~~~~~~~~v~e~i~G   84 (223)
T cd05154           5 QLSGGQSNLTYLLTAGGGRRLVLRRPPPGALLPSAHDVAREYRVLRALAGTGVPVPKVLALCEDPSVLGTPFYVMERVDG   84 (223)
T ss_pred             ecCCCccceEEEEEecCCcceEEEeCCCcccCcccccHHHHHHHHHHhhCCCCCCCCEEEECCCCCccCCceEEEEEeCC
Confidence            4889999999999987778999999865433  3467889999999986522  333333221                 


Q ss_pred             ------------ccchhhhHHHHHHHHHHHHhhcC---------------------------------------------
Q 039231          379 ------------RVAEELSSTIGIARGLEYLHLGC---------------------------------------------  401 (506)
Q Consensus       379 ------------~~~~~l~i~~~i~~gl~~LH~~~---------------------------------------------  401 (506)
                                  +..+...++.+++++|..||+..                                             
T Consensus        85 ~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  164 (223)
T cd05154          85 RVLRDRLLRPELSPEERRALARALADTLAALHSVDPAAVGLGDLGRPGGYLERQVARWRRQYDASRTDEPPAMERLLRWL  164 (223)
T ss_pred             EecCCCCCCCCCCHHHHHHHHHHHHHHHHHHhCCChhhcCCcccCCCCchHHHHHHHHHHHHHhhcccccHHHHHHHHHH
Confidence                        01123457889999999998521                                             


Q ss_pred             --------CCCeEecCcCCCcEEECC--CCcEEEeecCCCcc
Q 039231          402 --------STRILHFDIKPHNILLDE--DFCPKISDFGLAKI  433 (506)
Q Consensus       402 --------~~~ivH~dlkp~Nill~~--~~~~ki~dfg~a~~  433 (506)
                              ...++|+|++|.||+++.  ++.+.|+||+.+..
T Consensus       165 ~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~~~iID~e~~~~  206 (223)
T cd05154         165 EAHLPADSRPGLVHGDYRLGNVLFHPDEPRVVAVLDWELATL  206 (223)
T ss_pred             HhhCCCCCCcEEEECCCCcccEEEcCCCCcEEEEEecccccc
Confidence                    245799999999999998  66789999997753

This subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of bacterial and eukaryotic proteins with similarity to the N-terminal domains of vertebrate ACAD10 and ACAD11. ACADs are a family of flavoproteins that are involved in the beta-oxidation of fatty acyl-CoA derivatives. ACAD deficiency can cause metabolic disorders including muscle fatigue, hypoglycemia, and hepatic lipidosis, among them. There are at least 11 distinct ACADs, some of which show distinct substrate specificities to either straight-chain or branched-chain fatty acids. ACAD10 is widely expressed in human tissues and is highly expressed in liver, kidney, pancreas, and spleen. ACAD10 and ACAD11 contain

>KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning]

Probab=98.39  E-value=1.2e-07  Score=97.12  Aligned_cols=162  Identities=23%  Similarity=0.252  Sum_probs=112.6

Q ss_pred             cccCccCceEEEEEEEc--CCCEEEEEEeccCCCCc---hhhHHHHHHhhccC-ccceeEEEEEe---------------
Q 039231          319 YKLGQGGYGSVYKGKLL--DGSNVAVKVLNDSKGNG---KEFINEVASISRTS-HVNVVALLGFC---------------  377 (506)
Q Consensus       319 ~~ig~G~~g~V~~~~~~--~~~~vavK~l~~~~~~~---~~~~~E~~~l~~l~-h~niv~l~g~~---------------  377 (506)
                      ..|+.|.|+.|++...+  ++..+++|.+.+.-...   ..-..|+-+...+. |.++++....+               
T Consensus       271 ~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~l~~~~~di~sl~ev~l~~~l~~~~~~~g~~~~W~~~r~~~ip~e~~~~  350 (524)
T KOG0601|consen  271 SKISDGNFSSVFKVSKRPEGDCIYAAKELLNGLATFASDIFSLGEVILEAILGSHLPSVGKNSSWSQLRQGYIPLEFCEG  350 (524)
T ss_pred             EEccCCccccceeeeecCCCCceEeChhhhccccchHhhhcchhhhhHhhHhhcccccCCCCCCccccccccCchhhhcC
Confidence            46999999999998654  57888999886532211   11234444444443 66666643222               


Q ss_pred             ------------eccchhhhHHHHHHHHHHHHhhcCCCCeEecCcCCCcEEECCC-CcEEEeecCCCccccCCCcceecc
Q 039231          378 ------------LRVAEELSSTIGIARGLEYLHLGCSTRILHFDIKPHNILLDED-FCPKISDFGLAKICNRKESIISMT  444 (506)
Q Consensus       378 ------------~~~~~~l~i~~~i~~gl~~LH~~~~~~ivH~dlkp~Nill~~~-~~~ki~dfg~a~~~~~~~~~~~~~  444 (506)
                                  ++....+.+..|++.++.++|   ++.++|+|++|+||++.++ +.-+++||+.+..+.-..     .
T Consensus       351 ~s~~l~~~~~~~~d~~~~~~~~~q~~~~l~~i~---s~~~~~~d~~psni~i~~~~~~~~~~~~~~~t~~~~~~-----~  422 (524)
T KOG0601|consen  351 GSSSLRSVTSQMLDEDPRLRLTAQILTALNVIH---SKLFVHLDVKPSNILISNDGFFSKLGDFGCWTRLAFSS-----G  422 (524)
T ss_pred             cchhhhhHHHHhcCcchhhhhHHHHHhcccccc---chhhhcccccccceeeccchhhhhccccccccccceec-----c
Confidence                        445557788899999999999   9999999999999999886 788999999886422111     1


Q ss_pred             cCCCCcccc-cccccccccCCCCccccHHHHHHHHHHHHcCCCCCC
Q 039231          445 GARGTVGYI-APEVFCRNIGEVSYKSDVYNYGMMIFEMTGGRKNVD  489 (506)
Q Consensus       445 ~~~gt~~y~-aPE~l~~~~~~~s~~~Dv~s~G~il~elltg~~pf~  489 (506)
                      .....-+++ .+|.+... ..+-.+.|++|||.-+.|.+++.+--.
T Consensus       423 ~~~~~~r~~p~~~~~~e~-~~~~~~~~~~sl~~~~~e~~~~~~ls~  467 (524)
T KOG0601|consen  423 VFHHIDRLYPIAEILLED-YPHLSKADIFSLGLSVDEAITGSPLSE  467 (524)
T ss_pred             cccccccccccchhhccc-cccccccccccccccccccccCcccCc
Confidence            122233444 25555443 477889999999999999988776543

>PF01163 RIO1: RIO1 family; InterPro: IPR018934 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases

Probab=98.35  E-value=7.9e-06  Score=74.08  Aligned_cols=103  Identities=26%  Similarity=0.249  Sum_probs=68.4

Q ss_pred             EEEEEEEcCCCEEEEEEeccCC--------------C--------Cc-----hhhHHHHHHhhccCccc--eeEEEEEe-
Q 039231          328 SVYKGKLLDGSNVAVKVLNDSK--------------G--------NG-----KEFINEVASISRTSHVN--VVALLGFC-  377 (506)
Q Consensus       328 ~V~~~~~~~~~~vavK~l~~~~--------------~--------~~-----~~~~~E~~~l~~l~h~n--iv~l~g~~-  377 (506)
                      .||.|...+|..+|+|+.+...              .        ..     ....+|.+.|.++....  +.+.+.+- 
T Consensus         1 ~Vy~~~~~~~~~~a~K~~r~~~~~Fk~~~~y~~~~~r~~~~~~~~~~~~~~~~~~~~E~~~L~~l~~~Gv~vP~p~~~~~   80 (188)
T PF01163_consen    1 DVYHAIDPDGEEVAVKIYRTGRTSFKRRKKYRDYDYRFKKYRHKSSWRYLIREWAKKEFRNLKRLYEAGVPVPKPYDYNR   80 (188)
T ss_dssp             EEEEEEECTTEEEEEEEE-S---SS-HHHHHTTTSTTSTTC--G--CHHHHHHHHHHHHHHHHHCCCTT-SS--EEEEET
T ss_pred             CEEEEECCCCCEEEEEEeccCceEEEEeeeeecccchhcccccccCHHHHHHHHHHHHHHHHHHHHHCCccCCcEEEEeC
Confidence            4899999899999999974210              0        00     23567999999997542  33333322 


Q ss_pred             --------e--------------ccchhhhHHHHHHHHHHH-HhhcCCCCeEecCcCCCcEEECCCCcEEEeecCCCccc
Q 039231          378 --------L--------------RVAEELSSTIGIARGLEY-LHLGCSTRILHFDIKPHNILLDEDFCPKISDFGLAKIC  434 (506)
Q Consensus       378 --------~--------------~~~~~l~i~~~i~~gl~~-LH~~~~~~ivH~dlkp~Nill~~~~~~ki~dfg~a~~~  434 (506)
                              -              ...+...+..+++..+.. +|   ..+|+|+||++.||+++++ .+.|+|||.+...
T Consensus        81 ~~ivME~I~~~G~~~~~l~~~~~~~~~~~~~~~~il~~~~~~~~---~~givHGDLs~~NIlv~~~-~~~iIDf~qav~~  156 (188)
T PF01163_consen   81 NVIVMEYIGEDGVPLPRLKDVDLSPEEPKELLEEILEEIIKMLH---KAGIVHGDLSEYNILVDDG-KVYIIDFGQAVDS  156 (188)
T ss_dssp             TEEEEE--EETTEEGGCHHHCGGGGSTHHHHHHHHHHHHHHHHH---CTTEEESS-STTSEEEETT-CEEE--GTTEEET
T ss_pred             CEEEEEecCCCccchhhHHhccccchhHHHHHHHHHHHHHHHHH---hcCceecCCChhhEEeecc-eEEEEecCcceec
Confidence                    0              112344577788886666 57   8999999999999999987 8999999987643

Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents RIO kinase, they exhibit little sequence similarity with eukaryotic protein kinases, and are classified as atypical protein kinases []. The conformation of ATP when bound to the RIO kinases is unique when compared with ePKs, such as serine/threonine kinases or the insulin receptor tyrosine kinase, suggesting that the detailed mechanism by which the catalytic aspartate of RIO kinases participates in phosphoryl transfer may not be identical to that employed in known serine/threonine ePKs. Representatives of the RIO family are present in organisms varying from Archaea to humans, although the RIO3 proteins have only been identified in multicellular eukaryotes, to date. Yeast Rio1 and Rio2 proteins are required for proper cell cycle progression and chromosome maintenance, and are necessary for survival of the cells. These proteins are involved in the processing of 20 S pre-rRNA via late 18 S rRNA processing. ; GO: 0003824 catalytic activity, 0005524 ATP binding; PDB: 1TQP_A 1ZAR_A 1TQI_A 1ZAO_A 1TQM_A 3RE4_A 1ZTH_B 1ZP9_A 1ZTF_A.

>KOG2137 consensus Protein kinase [Signal transduction mechanisms]

Probab=98.34  E-value=1.3e-07  Score=98.30  Aligned_cols=122  Identities=20%  Similarity=0.356  Sum_probs=88.6

Q ss_pred             HhhccCccceeEEEEEeeccchhhhHHHHHHHHHHHHhhcCCCCeEecCcCCCcEEECCCCcEEEeecCCCccccCCCcc
Q 039231          361 SISRTSHVNVVALLGFCLRVAEELSSTIGIARGLEYLHLGCSTRILHFDIKPHNILLDEDFCPKISDFGLAKICNRKESI  440 (506)
Q Consensus       361 ~l~~l~h~niv~l~g~~~~~~~~l~i~~~i~~gl~~LH~~~~~~ivH~dlkp~Nill~~~~~~ki~dfg~a~~~~~~~~~  440 (506)
                      .+++++|     +-++....++...=+.+++.||.|+|.  +.++||++|.|++|.++.++..||+.|+.+.........
T Consensus        84 ~~~~lr~-----~~~vs~aTe~~f~nl~~v~dgl~flh~--sAk~VH~ni~p~~i~~na~~~wkl~Gf~f~v~~~~~~~~  156 (700)
T KOG2137|consen   84 SLQQLRG-----LDGVSKATEDGFANLGNVADGLAFLHR--SAKVVHGNIQPEAIVVNANGDWKLAGFSFCVNANGPTEY  156 (700)
T ss_pred             HHHHHhc-----ccchhhcccHhhhhhhcccchhhhhcc--CcceeecccchhheeeccCcceeeccchhhhccCCCCcc
Confidence            3455555     334445555556666778899999997  789999999999999999999999999987654432111


Q ss_pred             ee------c-ccCCCCcccccccccccccCCCCccccHHHHHHHHHHHHc-CCCCCCCC
Q 039231          441 IS------M-TGARGTVGYIAPEVFCRNIGEVSYKSDVYNYGMMIFEMTG-GRKNVDVV  491 (506)
Q Consensus       441 ~~------~-~~~~gt~~y~aPE~l~~~~~~~s~~~Dv~s~G~il~ellt-g~~pf~~~  491 (506)
                      ..      + .-......|.|||++...  ..+.++|+||+|+++|.+.. |+.-+...
T Consensus       157 p~~~yd~~lp~~~~~~~~f~apE~~~~~--~~~~~sd~fSlG~li~~i~~~gk~i~~a~  213 (700)
T KOG2137|consen  157 PFSEYDPPLPLLLQPHLNFLAPEYLLGT--TNTPASDVFSLGVLIYTIYNGGKSIIAAN  213 (700)
T ss_pred             ccccCCCCCChhhccCcccccchhhccc--cccccccceeeeeEEEEEecCCcchhhcc
Confidence            00      0 112346679999999664  56789999999999999995 44444443

>COG3642 Mn2+-dependent serine/threonine protein kinase [Signal transduction mechanisms]

Probab=98.31  E-value=4.7e-06  Score=73.69  Aligned_cols=109  Identities=20%  Similarity=0.221  Sum_probs=74.6

Q ss_pred             ccCccCceEEEEEEEcCCCEEEEEEe-ccCCCC--------chhhHHHHHHhhccCcc--ceeEEEEEeecc--------
Q 039231          320 KLGQGGYGSVYKGKLLDGSNVAVKVL-NDSKGN--------GKEFINEVASISRTSHV--NVVALLGFCLRV--------  380 (506)
Q Consensus       320 ~ig~G~~g~V~~~~~~~~~~vavK~l-~~~~~~--------~~~~~~E~~~l~~l~h~--niv~l~g~~~~~--------  380 (506)
                      .+.+|+-+.+|.+.+. |..+++|.= ++....        ...-.+|++++.+++--  +...++.+....        
T Consensus         3 ~i~~GAEa~i~~~~~~-g~~av~K~Ri~K~YR~p~LD~klrr~Rt~~Earil~~a~~~GV~~P~v~dvD~~~~~I~me~I   81 (204)
T COG3642           3 LIKQGAEAIIYLTDFL-GLPAVVKERIPKRYRHPELDEKLRRERTRREARILAKAREAGVPVPIVYDVDPDNGLIVMEYI   81 (204)
T ss_pred             hhhCCcceeEEeeecc-CcceEEEeecCcccCChHHHHHHHHHHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCEEEEEEe
Confidence            4789999999999773 344666643 222111        13466889998887522  222233322110        


Q ss_pred             ----------chhhhHHHHHHHHHHHHhhcCCCCeEecCcCCCcEEECCCCcEEEeecCCCcc
Q 039231          381 ----------AEELSSTIGIARGLEYLHLGCSTRILHFDIKPHNILLDEDFCPKISDFGLAKI  433 (506)
Q Consensus       381 ----------~~~l~i~~~i~~gl~~LH~~~~~~ivH~dlkp~Nill~~~~~~ki~dfg~a~~  433 (506)
                                .....++..+-.-+.-||   ..+|+|+||+++||++..+. +.++|||++..
T Consensus        82 ~G~~lkd~l~~~~~~~~r~vG~~vg~lH---~~givHGDLTtsNiIl~~~~-i~~IDfGLg~~  140 (204)
T COG3642          82 EGELLKDALEEARPDLLREVGRLVGKLH---KAGIVHGDLTTSNIILSGGR-IYFIDFGLGEF  140 (204)
T ss_pred             CChhHHHHHHhcchHHHHHHHHHHHHHH---hcCeecCCCccceEEEeCCc-EEEEECCcccc
Confidence                      112457778888999999   99999999999999998765 99999999974

>COG4248 Uncharacterized protein with protein kinase and helix-hairpin-helix DNA-binding domains [General function prediction only]

Probab=98.24  E-value=3.4e-06  Score=82.96  Aligned_cols=108  Identities=17%  Similarity=0.144  Sum_probs=85.6

Q ss_pred             ccchhhhHHHHHHHHHHHHhhcCCCCeEecCcCCCcEEECCCCcEEEeecCCCccccCCCcceecccCCCCccccccccc
Q 039231          379 RVAEELSSTIGIARGLEYLHLGCSTRILHFDIKPHNILLDEDFCPKISDFGLAKICNRKESIISMTGARGTVGYIAPEVF  458 (506)
Q Consensus       379 ~~~~~l~i~~~i~~gl~~LH~~~~~~ivH~dlkp~Nill~~~~~~ki~dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~l  458 (506)
                      .|.-.+..+..++.+.+-||   ..|.+-+|++++|+|+++++.+.|.|-..-.....+..   .....|...|.+||..
T Consensus       115 ~w~fllrvaRnlA~aFA~lH---~~Gh~vGDVn~~~~lVsd~~~V~LVdsDsfqi~~ng~~---~~cpVg~~eftPPElQ  188 (637)
T COG4248         115 AWDFLLRVARNLASAFATLH---EHGHVVGDVNQNSFLVSDDSKVVLVDSDSFQINANGTL---HLCPVGVSEFTPPELQ  188 (637)
T ss_pred             ccHHHHHHHHHHHHHHHHHH---hcCCcccccCccceeeecCceEEEEcccceeeccCCce---EecccCccccCCHHHh
Confidence            45557888999999999999   89999999999999999999999988654443322222   2567899999999986


Q ss_pred             c-c--ccCCCCccccHHHHHHHHHHHHcC-CCCCCCCC
Q 039231          459 C-R--NIGEVSYKSDVYNYGMMIFEMTGG-RKNVDVVD  492 (506)
Q Consensus       459 ~-~--~~~~~s~~~Dv~s~G~il~elltg-~~pf~~~~  492 (506)
                      . .  ....-+...|-|.+|+++++++.| +.||....
T Consensus       189 ~~~sf~g~~r~~~hD~FGLavLiF~lL~ggrHPysGI~  226 (637)
T COG4248         189 TLPSFVGFERTANHDNFGLAVLIFHLLFGGRHPYSGIP  226 (637)
T ss_pred             ccccccccCCCccccchhHHHHHHHHHhcCCCCCCccc
Confidence            3 1  112456789999999999999875 99998754

>KOG3087 consensus Serine/threonine protein kinase [General function prediction only]

Probab=98.17  E-value=1.2e-05  Score=70.94  Aligned_cols=111  Identities=24%  Similarity=0.307  Sum_probs=76.3

Q ss_pred             cccCccCceEEEEEEEcCCCEEEEEEec-cC--------CCCchhhHHHHHHhhccC-----ccceeEE--------EEE
Q 039231          319 YKLGQGGYGSVYKGKLLDGSNVAVKVLN-DS--------KGNGKEFINEVASISRTS-----HVNVVAL--------LGF  376 (506)
Q Consensus       319 ~~ig~G~~g~V~~~~~~~~~~vavK~l~-~~--------~~~~~~~~~E~~~l~~l~-----h~niv~l--------~g~  376 (506)
                      ..|-||+-+.|+++.+ .|+...||.-. +.        +-..++..+|++.|.++.     -|-++.+        +.+
T Consensus        13 ~likQGAEArv~~~~~-~Ge~~iIK~Rf~K~YRHP~LD~kLtr~Rt~~Ear~l~k~~~~GI~~P~l~~~D~~~~~i~ME~   91 (229)
T KOG3087|consen   13 ELIKQGAEARVPRGSF-SGEAAIIKERFSKRYRHPALDQKLTRKRTKQEARLLAKCRALGIPAPRLIFIDTYGGQIYMEF   91 (229)
T ss_pred             eeeeccceeeEeeecc-CCceeEEeecccccccchHHHHHHHHHHHHHHHHHHHHHHHhCCCCceEEEEecCCCeEEEEe
Confidence            3588999999999998 66776666432 11        112256778999888874     2333221        011


Q ss_pred             e----------------eccch-hhhHHHHHHHHHHHHhhcCCCCeEecCcCCCcEEECCCC---cEEEeecCCCcc
Q 039231          377 C----------------LRVAE-ELSSTIGIARGLEYLHLGCSTRILHFDIKPHNILLDEDF---CPKISDFGLAKI  433 (506)
Q Consensus       377 ~----------------~~~~~-~l~i~~~i~~gl~~LH~~~~~~ivH~dlkp~Nill~~~~---~~ki~dfg~a~~  433 (506)
                      .                -..++ ....+.+|-+.+.-||   ..+|+|+||..+||+|..++   .+.++|||++..
T Consensus        92 ~~g~~~vk~~i~~~~~~~~~d~~~~~~~~~iG~~igklH---~ndiiHGDLTTSNill~~~~~~~~~~lIdfgls~~  165 (229)
T KOG3087|consen   92 IDGASTVKDFILSTMEDESEDEGLAELARRIGELIGKLH---DNDIIHGDLTTSNILLRSDGNQITPILIDFGLSSV  165 (229)
T ss_pred             ccchhHHHHHHHHHccCcccchhHHHHHHHHHHHHHHhh---hCCeecccccccceEEecCCCcCceEEEeecchhc
Confidence            0                00111 2467888999999999   99999999999999996655   358999999864

>KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only]

Probab=98.13  E-value=2e-06  Score=93.19  Aligned_cols=108  Identities=25%  Similarity=0.339  Sum_probs=84.4

Q ss_pred             hHHHHHHHHHHHHhhcCCCCeEecCcCCCcEEECCCCcEEEeecCCCccccC---------------------CCcc---
Q 039231          385 SSTIGIARGLEYLHLGCSTRILHFDIKPHNILLDEDFCPKISDFGLAKICNR---------------------KESI---  440 (506)
Q Consensus       385 ~i~~~i~~gl~~LH~~~~~~ivH~dlkp~Nill~~~~~~ki~dfg~a~~~~~---------------------~~~~---  440 (506)
                      .....+..++++||   ...+.|+|++|.|++...++..++.||+.....+-                     ....   
T Consensus       908 s~i~~~vqs~e~L~---s~~r~h~~~~p~~~l~~~~gh~~l~~~~t~~~vg~~~p~~~~sg~~~~~~~~~~~~~~~~~~l  984 (1205)
T KOG0606|consen  908 SPILERVQSLESLH---SSLRKHRDLKPDSLLIAYDGHRPLTDFGTLSKVGLIPPTTDLSGPSSSGTPRRLSRSERRPQL  984 (1205)
T ss_pred             chhHHHHhhhhccc---cchhhcccccccchhhcccCCcccCccccccccccccCcCCcccccccCcccccccccccccc
Confidence            34566889999999   77799999999999999999999999984332210                     0000   


Q ss_pred             -----eecccCCCCcccccccccccccCCCCccccHHHHHHHHHHHHcCCCCCCCCCCCcch
Q 039231          441 -----ISMTGARGTVGYIAPEVFCRNIGEVSYKSDVYNYGMMIFEMTGGRKNVDVVDNGSTA  497 (506)
Q Consensus       441 -----~~~~~~~gt~~y~aPE~l~~~~~~~s~~~Dv~s~G~il~elltg~~pf~~~~~~~~~  497 (506)
                           .......+|+.|.+||.+.+.  ......|+|+.|++++|.++|..||.....+..+
T Consensus       985 ~~~~~~~~~~~~~t~~~laPe~~lg~--~hgs~ad~~~~g~~l~e~l~g~pp~na~tpq~~f 1044 (1205)
T KOG0606|consen  985 SADEARRKHAVVGTPDYLAPEILLGR--RHGSAADWWSSGVCLFEVLTGIPPFNAETPQQIF 1044 (1205)
T ss_pred             ccchhhccccccCCCcccCCcccccc--cCCCcchhhhhhhhhhhhhcCCCCCCCcchhhhh
Confidence                 001235689999999999765  6788899999999999999999999987766554

>COG0478 RIO-like serine/threonine protein kinase fused to N-terminal HTH domain [Signal transduction mechanisms]

Probab=98.08  E-value=2.3e-05  Score=73.50  Aligned_cols=114  Identities=23%  Similarity=0.177  Sum_probs=80.0

Q ss_pred             hhccccCccCceEEEEEEEcCCCEEEEEEeccCC----------------C-------CchhhHHHHHHhhccCcc--ce
Q 039231          316 SFKYKLGQGGYGSVYKGKLLDGSNVAVKVLNDSK----------------G-------NGKEFINEVASISRTSHV--NV  370 (506)
Q Consensus       316 ~~~~~ig~G~~g~V~~~~~~~~~~vavK~l~~~~----------------~-------~~~~~~~E~~~l~~l~h~--ni  370 (506)
                      .+.++||-|--+.||.|...+|.++|||.-+-..                .       ......+|.+.|.++...  .+
T Consensus        94 ~iG~~IGvGKEsdVY~~~~~~g~~~~vKfHR~GrtsFrkvk~~R~y~~~~~h~sWl~~sRl~A~rEf~~L~~L~~~G~~V  173 (304)
T COG0478          94 AIGTKIGVGKESDVYVAIDPKGRKVAVKFHRLGRTSFRKVKRNRDYLADKEHGSWLYVSRLAAEREFEALQRLYPEGVKV  173 (304)
T ss_pred             hhccccccCccceEEEEECCCCCEEEEEEeecCchhhhhhcchhhhhccccCcchhhhHHHHHHHHHHHHHHhhhcCCCC
Confidence            4457899999999999999999999999753110                0       012356889999988532  22


Q ss_pred             eEEEEEe------------------eccchhhhHHHHHHHHHHHHhhcCCCCeEecCcCCCcEEECCCCcEEEeecCCCc
Q 039231          371 VALLGFC------------------LRVAEELSSTIGIARGLEYLHLGCSTRILHFDIKPHNILLDEDFCPKISDFGLAK  432 (506)
Q Consensus       371 v~l~g~~------------------~~~~~~l~i~~~i~~gl~~LH~~~~~~ivH~dlkp~Nill~~~~~~ki~dfg~a~  432 (506)
                      .+-+++-                  ++....-.+...|++-+.-+-   ..|+||+|+++-||+++++|.+.++||--+.
T Consensus       174 P~P~~~nRHaVvMe~ieG~eL~~~r~~~en~~~il~~il~~~~~~~---~~GiVHGDlSefNIlV~~dg~~~vIDwPQ~v  250 (304)
T COG0478         174 PKPIAWNRHAVVMEYIEGVELYRLRLDVENPDEILDKILEEVRKAY---RRGIVHGDLSEFNILVTEDGDIVVIDWPQAV  250 (304)
T ss_pred             CCccccccceeeeehcccceeecccCcccCHHHHHHHHHHHHHHHH---HcCccccCCchheEEEecCCCEEEEeCcccc
Confidence            2221111                  123344445666666666665   6899999999999999999999999997554

>KOG3741 consensus Poly(A) ribonuclease subunit [RNA processing and modification]

Probab=98.01  E-value=3.2e-05  Score=78.20  Aligned_cols=138  Identities=19%  Similarity=0.288  Sum_probs=103.9

Q ss_pred             ceEEEEEEE-cCCCEEEEEEeccCCCCc-hhhHHHHHHhhccCccceeEEEEEe--------------------------
Q 039231          326 YGSVYKGKL-LDGSNVAVKVLNDSKGNG-KEFINEVASISRTSHVNVVALLGFC--------------------------  377 (506)
Q Consensus       326 ~g~V~~~~~-~~~~~vavK~l~~~~~~~-~~~~~E~~~l~~l~h~niv~l~g~~--------------------------  377 (506)
                      -.+.|++.. .||..+.+|+++..+... ..-..-++.++++.|.|+|++..++                          
T Consensus       289 ~~Ttyk~~s~~DG~~YvLkRlhg~r~~~~nk~t~lve~wkkl~h~NvV~frevf~t~tF~D~SlvlvYDYyP~s~TL~d~  368 (655)
T KOG3741|consen  289 SITTYKATSNVDGNAYVLKRLHGDRDQSTNKDTSLVEAWKKLCHTNVVPFREVFLTYTFGDLSLVLVYDYYPSSPTLYDL  368 (655)
T ss_pred             cceeEeeeeccCCceeeeeeeccccccCcccchHHHHHHHHhccCceeehhhhhhhhccCcceEEEEEecCCCCchHHHH
Confidence            457899975 479999999995433222 2344557889999999999886554                          


Q ss_pred             ---------------------eccchhhhHHHHHHHHHHHHhhcCCCCeEecCcCCCcEEECCCCcEEEeecCCCccccC
Q 039231          378 ---------------------LRVAEELSSTIGIARGLEYLHLGCSTRILHFDIKPHNILLDEDFCPKISDFGLAKICNR  436 (506)
Q Consensus       378 ---------------------~~~~~~l~i~~~i~~gl~~LH~~~~~~ivH~dlkp~Nill~~~~~~ki~dfg~a~~~~~  436 (506)
                                           ..+...|.++.|+..||.++|   +.|+.-+-|.+++|+++.+.+++|+.-|.......
T Consensus       369 ~F~~~~~t~~~n~~~~~~~~~~~e~~lW~y~~QLtaaL~sIH---ssGLAck~L~~~kIlv~G~~RIriS~C~i~Dvl~~  445 (655)
T KOG3741|consen  369 YFANPPFTKRTNSFYPSQNLKAPEEVLWSYISQLTAALYSIH---SSGLACKTLDLKKILVTGKMRIRISGCGIMDVLQE  445 (655)
T ss_pred             HccCCccccccccccccCCCCchHHHHHHHHHHHHHHHHHHH---hcCceeecccHhHeEeeCcceEEEecccceeeecC
Confidence                                 123346789999999999999   99999999999999999998999988776655433


Q ss_pred             CCcceecccCCCCcccccccccccccCCCCccccHHHHHHHHHHHHcCCCC
Q 039231          437 KESIISMTGARGTVGYIAPEVFCRNIGEVSYKSDVYNYGMMIFEMTGGRKN  487 (506)
Q Consensus       437 ~~~~~~~~~~~gt~~y~aPE~l~~~~~~~s~~~Dv~s~G~il~elltg~~p  487 (506)
                      +..                |.+     +--++-|.=.||.++.-|.||...
T Consensus       446 d~~----------------~~l-----e~~Qq~D~~~lG~ll~aLAt~~~n  475 (655)
T KOG3741|consen  446 DPT----------------EPL-----ESQQQNDLRDLGLLLLALATGTEN  475 (655)
T ss_pred             CCC----------------cch-----hHHhhhhHHHHHHHHHHHhhcccc
Confidence            320                122     112467899999999999999665

>PRK15123 lipopolysaccharide core heptose(I) kinase RfaP; Provisional

Probab=97.85  E-value=0.00012  Score=70.44  Aligned_cols=110  Identities=18%  Similarity=0.066  Sum_probs=74.0

Q ss_pred             ccCccCceEEEEEEEcCCCEEEEEEeccCC------------CCchhhHHHHHHhhccC-----ccceeEEE--------
Q 039231          320 KLGQGGYGSVYKGKLLDGSNVAVKVLNDSK------------GNGKEFINEVASISRTS-----HVNVVALL--------  374 (506)
Q Consensus       320 ~ig~G~~g~V~~~~~~~~~~vavK~l~~~~------------~~~~~~~~E~~~l~~l~-----h~niv~l~--------  374 (506)
                      .+..-....|.+..+ +|+.+.||......            .....+.+|.+.+.++.     -|.+|-+.        
T Consensus        29 ~v~~~~~rrvvr~~~-~g~~~~vKr~~~~~~~~~~k~l~~~~~p~~~a~rE~~~l~~L~~~GIptP~pVa~~e~~~~~~~  107 (268)
T PRK15123         29 VFRELEGRRTLRFEL-AGKSYFLKWHRGTGWGEIFKNLLSLRMPVLGADREWRAIHRLHEVGVDTMTGVAFGERGSNPAT  107 (268)
T ss_pred             EEecCCCceEEEEEE-CCEEEEEEEecCCcHHHHhhhhcccccccHHHHHHHHHHHHHHHcCCCCCCeeEEEEecCCCcc
Confidence            344444455777766 67889999774322            01124778888887773     34443331        


Q ss_pred             --EEe--------ec-------c-------chhhhHHHHHHHHHHHHhhcCCCCeEecCcCCCcEEECC-------CCcE
Q 039231          375 --GFC--------LR-------V-------AEELSSTIGIARGLEYLHLGCSTRILHFDIKPHNILLDE-------DFCP  423 (506)
Q Consensus       375 --g~~--------~~-------~-------~~~l~i~~~i~~gl~~LH~~~~~~ivH~dlkp~Nill~~-------~~~~  423 (506)
                        .+.        .+       +       .....++.+++..+.-||   ..||+|+|++++|||++.       +..+
T Consensus       108 ~~s~LVte~l~~~~sL~~~~~~~~~~~~~~~~~~~ll~~la~~i~~LH---~~Gi~HgDL~~~NiLl~~~~~~~~~~~~~  184 (268)
T PRK15123        108 RTSFIITEDLAPTISLEDYCADWATNPPDPRLKRMLIKRVATMVRDMH---AAGINHRDCYICHFLLHLPFPGREEDLKL  184 (268)
T ss_pred             ceeEEEEeeCCCCccHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHH---HCcCccCCCChhhEEEeccccCCCCCceE
Confidence              111        00       0       123357788999999999   999999999999999975       4679


Q ss_pred             EEeecCCCcc
Q 039231          424 KISDFGLAKI  433 (506)
Q Consensus       424 ki~dfg~a~~  433 (506)
                      .++||+.+..
T Consensus       185 ~LIDl~r~~~  194 (268)
T PRK15123        185 SVIDLHRAQI  194 (268)
T ss_pred             EEEECCcccc
Confidence            9999998864

>PRK09902 hypothetical protein; Provisional

Probab=97.84  E-value=8e-05  Score=68.17  Aligned_cols=109  Identities=15%  Similarity=0.108  Sum_probs=79.1

Q ss_pred             cCccCceEEEEEEEcCCCEEEEEEeccC-------CCCchhhHHHHHHhhccCccce--eEEEE------------Eee-
Q 039231          321 LGQGGYGSVYKGKLLDGSNVAVKVLNDS-------KGNGKEFINEVASISRTSHVNV--VALLG------------FCL-  378 (506)
Q Consensus       321 ig~G~~g~V~~~~~~~~~~vavK~l~~~-------~~~~~~~~~E~~~l~~l~h~ni--v~l~g------------~~~-  378 (506)
                      -++||.+.|++-.+ +|..+-+|.-.+.       +-....|.+|+..|.++...+|  .+...            +.+ 
T Consensus        26 ~~rgG~SgV~r~~~-~g~~~ylKrq~nhl~~s~r~P~g~ptf~rE~~~L~~L~~~GvPVP~pvf~~~~k~~~~~rA~LVT  104 (216)
T PRK09902         26 YRRNGMSGVQCVER-NGKKLYVKRMTHHLFHSVRYPFGRPTIVREVAVIKELERAGVIVPKIVFGEAVKIEGEWRALLVT  104 (216)
T ss_pred             cCCCCcceEEEEEe-CCcEEEEEeccCcccccccCCCCchHHHHHHHHHHHHHHcCCCCCccceeeeeccCCceEEEEEE
Confidence            57899999999877 4457888886521       2234679999999999864332  22221            110 


Q ss_pred             ---------------------ccchhhhHHHHHHHHHHHHhhcCCCCeEecCcCCCcEEECCCCc--EEEeecCCCcc
Q 039231          379 ---------------------RVAEELSSTIGIARGLEYLHLGCSTRILHFDIKPHNILLDEDFC--PKISDFGLAKI  433 (506)
Q Consensus       379 ---------------------~~~~~l~i~~~i~~gl~~LH~~~~~~ivH~dlkp~Nill~~~~~--~ki~dfg~a~~  433 (506)
                                           +..+...+..+++..+.-||   ..++.|+|+.+.||+++.++.  ++++||.-++.
T Consensus       105 e~L~g~~~L~~~l~~~~~~~~~~~~k~~il~~va~~ia~LH---~~Gv~Hgdly~khIll~~~g~~~v~lIDlEk~r~  179 (216)
T PRK09902        105 EDMAGFISIADWYAQHAVSPYSDEVRQAMLKAVALAFKKMH---SVNRQHGCCYVRHIYVKTEGKAEAGFLDLEKSRR  179 (216)
T ss_pred             EeCCCCccHHHHHhcCCcCCcchHHHHHHHHHHHHHHHHHH---HCCCcCCCCCHhheeecCCCCeeEEEEEhhccch
Confidence                                 01112468889999999999   999999999999999986666  99999987654

>COG0661 AarF Predicted unusual protein kinase [General function prediction only]

Probab=97.55  E-value=0.00015  Score=75.81  Aligned_cols=35  Identities=29%  Similarity=0.374  Sum_probs=31.8

Q ss_pred             CCCeEecCcCCCcEEECCCCcEEEeecCCCccccC
Q 039231          402 STRILHFDIKPHNILLDEDFCPKISDFGLAKICNR  436 (506)
Q Consensus       402 ~~~ivH~dlkp~Nill~~~~~~ki~dfg~a~~~~~  436 (506)
                      ..|++|.|.+|.||+++.++.+.+.|||+...++.
T Consensus       283 ~dgffHaDpHpGNi~v~~~g~i~~lDfGi~g~l~~  317 (517)
T COG0661         283 RDGFFHADPHPGNILVRSDGRIVLLDFGIVGRLDP  317 (517)
T ss_pred             hcCccccCCCccceEEecCCcEEEEcCcceecCCH
Confidence            57999999999999999999999999999876543

>COG1718 RIO1 Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms / Cell division and chromosome partitioning]

Probab=97.51  E-value=0.0008  Score=62.68  Aligned_cols=113  Identities=26%  Similarity=0.288  Sum_probs=78.1

Q ss_pred             ccCccCceEEEEEEEcCCCEEEEEEeccCCC--------------------Cchh-----hHHHHHHhhccC--------
Q 039231          320 KLGQGGYGSVYKGKLLDGSNVAVKVLNDSKG--------------------NGKE-----FINEVASISRTS--------  366 (506)
Q Consensus       320 ~ig~G~~g~V~~~~~~~~~~vavK~l~~~~~--------------------~~~~-----~~~E~~~l~~l~--------  366 (506)
                      .|.+|--+.||+|...++..+|+|+++....                    +.++     ..+|..-|.++.        
T Consensus        55 ~istGKEA~Vy~a~~~~~~~~avKiyr~~t~~fk~~~~Yi~gd~Rf~~~~~~rr~lv~~W~~kEf~NL~R~~eAGVrvP~  134 (268)
T COG1718          55 CISTGKEANVYLAETGDGRYVAVKIYRTSTSEFKRIRRYIQGDPRFRNSRSNRRKLVFAWARKEFRNLKRAYEAGVRVPE  134 (268)
T ss_pred             eecCCcceEEEeeccCCCceEEEEEEehhhhhhhhHHHHHhcChhhhcCCCCHHHHHHHHHHHHHHHHHHHHHcCCCCCC
Confidence            3778888899999988899999999853211                    1111     235666666662        


Q ss_pred             ---ccceeEEEEEe--------------eccchhhhHHHHHHHHHHHHhhcCCCCeEecCcCCCcEEECCCCcEEEeecC
Q 039231          367 ---HVNVVALLGFC--------------LRVAEELSSTIGIARGLEYLHLGCSTRILHFDIKPHNILLDEDFCPKISDFG  429 (506)
Q Consensus       367 ---h~niv~l~g~~--------------~~~~~~l~i~~~i~~gl~~LH~~~~~~ivH~dlkp~Nill~~~~~~ki~dfg  429 (506)
                         ..+-|-+..+.              ++..+...+..++++.|.-|-.  ..++||+||+.=|||+. ++.+.|+|++
T Consensus       135 Pi~~~~nVLvMEfIg~~g~pAP~LkDv~~e~~e~~~~~~~~v~~~~~l~~--~a~LVHgDLSEyNiL~~-~~~p~iID~~  211 (268)
T COG1718         135 PIAFRNNVLVMEFIGDDGLPAPRLKDVPLELEEAEGLYEDVVEYMRRLYK--EAGLVHGDLSEYNILVH-DGEPYIIDVS  211 (268)
T ss_pred             ceeecCCeEEEEeccCCCCCCCCcccCCcCchhHHHHHHHHHHHHHHHHH--hcCcccccchhhheEEE-CCeEEEEECc
Confidence               12222223322              2222455667788888888872  48999999999999999 7899999999


Q ss_pred             CCcccc
Q 039231          430 LAKICN  435 (506)
Q Consensus       430 ~a~~~~  435 (506)
                      -|....
T Consensus       212 QaV~~~  217 (268)
T COG1718         212 QAVTID  217 (268)
T ss_pred             cccccC
Confidence            886543

>KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms]

Probab=97.38  E-value=3.5e-05  Score=79.78  Aligned_cols=152  Identities=22%  Similarity=0.150  Sum_probs=106.6

Q ss_pred             cCccCceEEEEEEEcCCCEEEEEEeccCCCCchhhHHHHHHhhccCccc-eeEEEEEe----------------------
Q 039231          321 LGQGGYGSVYKGKLLDGSNVAVKVLNDSKGNGKEFINEVASISRTSHVN-VVALLGFC----------------------  377 (506)
Q Consensus       321 ig~G~~g~V~~~~~~~~~~vavK~l~~~~~~~~~~~~E~~~l~~l~h~n-iv~l~g~~----------------------  377 (506)
                      .+++++++++|.+....+....+.+...    ....-+++.|.+++||| .+..++-+                      
T Consensus       250 fvK~altknpKkRptaeklL~h~fvs~~----l~~rl~~eLLdK~n~P~~~v~~~~d~~~E~~~~i~~~i~s~~rs~~~~  325 (829)
T KOG0576|consen  250 FVKGALTKNPKKRPTAEKLLQHPFVSQT----LSRRLAIELLDKVNNPNPVVRYLEDYDGEDYLWIPMRICSTGRSSALE  325 (829)
T ss_pred             HHHHHhcCCCccCCChhhheeceeeccc----hhhHHHHHHHHHccCCCCcccccccCCcccccchhhhhhcCCcccccc
Confidence            6789999999888655455555555433    34456889999999999 55444322                      


Q ss_pred             -------eccchhhhHHHHHHHHHHHHhhcCCCCeEecCcCCCcEEECCCCcEEEeecCCCccccCCCcceecccCCCCc
Q 039231          378 -------LRVAEELSSTIGIARGLEYLHLGCSTRILHFDIKPHNILLDEDFCPKISDFGLAKICNRKESIISMTGARGTV  450 (506)
Q Consensus       378 -------~~~~~~l~i~~~i~~gl~~LH~~~~~~ivH~dlkp~Nill~~~~~~ki~dfg~a~~~~~~~~~~~~~~~~gt~  450 (506)
                             +...+...+.+.-.+++++||   +..-+|+|    ||+..+ +..|..||+....+.+...   .....+++
T Consensus       326 ~~~se~~~~~~~~~~~~r~et~~l~~l~---~~~~~~~d----~~l~s~-~~~~~~~~~v~~~L~~~~~---~~t~~~~~  394 (829)
T KOG0576|consen  326 MTVSEIALEQYQFAYPLRKETRPLAELH---SSYKVHRD----NILGSE-EEVKLLDFAVPPQLTRTMK---PRTAIGTP  394 (829)
T ss_pred             CChhhHhhhhhhhhhhhhhhcccccccc---cccccCcc----cccccc-cccccccccCCcccCcccc---cccCCCCC
Confidence                   001112223445668889999   55568888    777766 5789999998877665542   35577899


Q ss_pred             ccccccccccccCCCCccccHHHHHHHHHHHHcCCCCCC
Q 039231          451 GYIAPEVFCRNIGEVSYKSDVYNYGMMIFEMTGGRKNVD  489 (506)
Q Consensus       451 ~y~aPE~l~~~~~~~s~~~Dv~s~G~il~elltg~~pf~  489 (506)
                      .|+|||+..++  .+..+.|.|+.|+--.+|.-|.+|-.
T Consensus       395 ~~~~pev~~~~--~~~~~p~~~~~~~~~~~~ap~~pPr~  431 (829)
T KOG0576|consen  395 EPLAPEVIQEN--TIDGCPDSGSLAVSAIQMAPGLPPRS  431 (829)
T ss_pred             CCCCchhhccc--ccccCCCccCCCcchhhcCCCCCCCC
Confidence            99999987554  78889999999987777777776654

>PF06293 Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; InterPro: IPR010440 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases

Probab=97.21  E-value=0.00035  Score=64.77  Aligned_cols=49  Identities=29%  Similarity=0.316  Sum_probs=43.7

Q ss_pred             hhhHHHHHHHHHHHHhhcCCCCeEecCcCCCcEEECCCC---cEEEeecCCCccc
Q 039231          383 ELSSTIGIARGLEYLHLGCSTRILHFDIKPHNILLDEDF---CPKISDFGLAKIC  434 (506)
Q Consensus       383 ~l~i~~~i~~gl~~LH~~~~~~ivH~dlkp~Nill~~~~---~~ki~dfg~a~~~  434 (506)
                      ...++.+++..+.-||   ..||+|+|+++.|||++.+.   .+.++||+.++..
T Consensus       120 ~~~ll~~l~~~i~~lH---~~gi~H~Dl~~~NILv~~~~~~~~~~lIDld~~~~~  171 (206)
T PF06293_consen  120 RRELLRALARLIAKLH---DAGIYHGDLNPSNILVDPDDGQYRFYLIDLDRMRFR  171 (206)
T ss_pred             HHHHHHHHHHHHHHHH---HCcCCCCCCCcccEEEeCCCCceeEEEEcchhceeC
Confidence            4568889999999999   99999999999999998887   8999999987653

Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents lipopolysaccharide kinases which are related to protein kinases IPR000719 from INTERPRO. This family includes waaP (rfaP) gene product is required for the addition of phosphate to O-4 of the first heptose residue of the lipopolysaccharide (LPS) inner core region. It has previously been shown that WaaP is necessary for resistance to hydrophobic and polycationic antimicrobials in E. coli and that it is required for virulence in invasive strains of Salmonella enterica [].; GO: 0005524 ATP binding, 0016773 phosphotransferase activity, alcohol group as acceptor, 0009103 lipopolysaccharide biosynthetic process, 0016020 membrane

>PF12260 PIP49_C: Protein-kinase domain of FAM69; InterPro: IPR022049 Family with sequence similarity 69 has three members (A, B and C)

Probab=97.10  E-value=0.0012  Score=60.05  Aligned_cols=79  Identities=20%  Similarity=0.148  Sum_probs=66.5

Q ss_pred             HHHHHHhhccCc-cceeEEEEEe--------------------------eccchhhhHHHHHHHHHHHHhhcCCCCeEec
Q 039231          356 INEVASISRTSH-VNVVALLGFC--------------------------LRVAEELSSTIGIARGLEYLHLGCSTRILHF  408 (506)
Q Consensus       356 ~~E~~~l~~l~h-~niv~l~g~~--------------------------~~~~~~l~i~~~i~~gl~~LH~~~~~~ivH~  408 (506)
                      .+|.-+++.+.+ +++.+++|.|                          .+|..+.+|+.++++.+.+|++.....+.-.
T Consensus         7 ~~E~lll~~l~~~~~~pk~lG~CG~~~v~E~~~~~~~~~~~~~l~~~~~~~w~~R~~iA~~lL~~l~~l~~~~~~~~~lc   86 (188)
T PF12260_consen    7 NNEPLLLQLLQGSEPFPKLLGSCGRFYVVEYVGAGSLYGIYRPLSQFLQSPWEQRAKIALQLLELLEELDHGPLGFFYLC   86 (188)
T ss_pred             ccHHHHHHHcCCCCCCCCeeeECCCEEEEEeecCccccccccccccccccCHHHHHHHHHHHHHHHHHHhcCCCCcEEEe
Confidence            347788888876 5899999988                          1466688999999999999997655679999


Q ss_pred             CcCCCcEEECCCCcEEEeecCCCccc
Q 039231          409 DIKPHNILLDEDFCPKISDFGLAKIC  434 (506)
Q Consensus       409 dlkp~Nill~~~~~~ki~dfg~a~~~  434 (506)
                      |++++|+-+++++.+|+.|...+...
T Consensus        87 Dv~~~nfgv~~~~~lk~iDld~v~~~  112 (188)
T PF12260_consen   87 DVSPDNFGVNDDGRLKLIDLDDVFVE  112 (188)
T ss_pred             ecchHHeEEeCCCcEEEEechhcchh
Confidence            99999999999999999999876543

Proteins in this uncharacterised family are described as transmembrane proteins.

>TIGR02172 Fb_sc_TIGR02172 Fibrobacter succinogenes paralogous family TIGR02172

Probab=97.04  E-value=0.004  Score=58.52  Aligned_cols=109  Identities=17%  Similarity=0.173  Sum_probs=69.2

Q ss_pred             ccCccCceEEEEEEEcCCCEEEEEEeccCCCCchhhHHHHHHhhccC-----ccceeEEE------EEeecc--------
Q 039231          320 KLGQGGYGSVYKGKLLDGSNVAVKVLNDSKGNGKEFINEVASISRTS-----HVNVVALL------GFCLRV--------  380 (506)
Q Consensus       320 ~ig~G~~g~V~~~~~~~~~~vavK~l~~~~~~~~~~~~E~~~l~~l~-----h~niv~l~------g~~~~~--------  380 (506)
                      .|++|..+.||+.   .+..+++|...... ......+|.+.+..+.     .|.++.+.      +..+++        
T Consensus         8 ~i~~G~t~~~y~~---~~~~~VlR~~~~~~-~~~~i~~E~~~l~~l~~~glpvP~~~~~~~~~~~~glv~e~i~G~~~~~   83 (226)
T TIGR02172         8 QTGEGGNGESYTH---KTGKWMLKLYNPGF-DKETIKREFDASRKVFSLGIPTPHPFDLVEDGGRLGLIYELIVGKRSFS   83 (226)
T ss_pred             eecCCCCcceeEe---cCCCEEEEeCCCCC-CHHHHHHHHHHHHHHHHcCCCCCceEEEEecCCeeeeeeeecCCccchh
Confidence            5899999999983   34567788876432 3356788998888774     33333331      111111        


Q ss_pred             -------chhhhHHHHHHHHHHHHhhc----------------------------------------CCCCeEecCcCCC
Q 039231          381 -------AEELSSTIGIARGLEYLHLG----------------------------------------CSTRILHFDIKPH  413 (506)
Q Consensus       381 -------~~~l~i~~~i~~gl~~LH~~----------------------------------------~~~~ivH~dlkp~  413 (506)
                             .+...++.++++.+.-||+.                                        ....++|+|+.|.
T Consensus        84 ~~~~~~~~~~~~l~~~la~~l~~lH~~~~~~~~l~~~~~~~~~~l~~~~~~~~~~~~~l~~~l~~~~~~~~~~HgD~~~~  163 (226)
T TIGR02172        84 RIISDNPSRLEEIAKIFAEMAKKLHSTKCDTSTFQSYKEKIRKFIEEKDFVPKDYKEKARAFIKEVPDTSTCLHGDFQIG  163 (226)
T ss_pred             hhhcCCHHHHHHHHHHHHHHHHHHhCCCCCCCcHHHHHHHHHHHHHhccCCCHHHHHHHHHHHHhCCCCCceEecCCCCC
Confidence                   00112444455555545521                                        1235689999999


Q ss_pred             cEEECCCCcEEEeecCCCcc
Q 039231          414 NILLDEDFCPKISDFGLAKI  433 (506)
Q Consensus       414 Nill~~~~~~ki~dfg~a~~  433 (506)
                      ||++++++ +.|+||+.+..
T Consensus       164 Nii~~~~~-~~iIDwe~a~~  182 (226)
T TIGR02172       164 NLITSGKG-TYWIDLGDFGY  182 (226)
T ss_pred             cEEEcCCC-cEEEechhcCc
Confidence            99999888 99999998754

This model describes a paralogous family of five proteins, likely to be enzymes, in the rumen bacterium Fibrobacter succinogenes S85. Members show homology to proteins described by PFAM model pfam01636, a phosphotransferase enzyme family associated with resistance to aminoglycoside antibiotics. However, members of this family score below the current trusted and noise cutoffs for pfam01636.

>COG2112 Predicted Ser/Thr protein kinase [Signal transduction mechanisms]

Probab=96.92  E-value=0.007  Score=53.50  Aligned_cols=110  Identities=20%  Similarity=0.213  Sum_probs=74.8

Q ss_pred             cccCccCceEEEEEEEcCCCEEEEEEeccCCCCchhhHHHHHHhhccCccceeE-EEEEee--------------ccch-
Q 039231          319 YKLGQGGYGSVYKGKLLDGSNVAVKVLNDSKGNGKEFINEVASISRTSHVNVVA-LLGFCL--------------RVAE-  382 (506)
Q Consensus       319 ~~ig~G~~g~V~~~~~~~~~~vavK~l~~~~~~~~~~~~E~~~l~~l~h~niv~-l~g~~~--------------~~~~-  382 (506)
                      +.|++|.+|.||++.+. |..+|+|+-..+. ....+..|+++|..+.-.++.. ++.+-.              ++.. 
T Consensus        28 ~~L~KG~~s~Vyl~~~~-~~~~a~Kvrr~ds-~r~~l~kEakiLeil~g~~~~p~vy~yg~~~i~me~i~G~~L~~~~~~  105 (201)
T COG2112          28 KELAKGTTSVVYLGEWR-GGEVALKVRRRDS-PRRNLEKEAKILEILAGEGVTPEVYFYGEDFIRMEYIDGRPLGKLEIG  105 (201)
T ss_pred             hhhhcccccEEEEeecc-CceEEEEEecCCc-chhhHHHHHHHHHHhhhcCCCceEEEechhhhhhhhhcCcchhhhhhc
Confidence            45999999999999984 5588888765443 3467889999999887655542 332220              0111 


Q ss_pred             -hhhHHHHHHHHHHHHhhcCCCCeEecCcC-CCcEEECCCCcEEEeecCCCcc
Q 039231          383 -ELSSTIGIARGLEYLHLGCSTRILHFDIK-PHNILLDEDFCPKISDFGLAKI  433 (506)
Q Consensus       383 -~l~i~~~i~~gl~~LH~~~~~~ivH~dlk-p~Nill~~~~~~ki~dfg~a~~  433 (506)
                       ..+-...++++---|.   ..||-|+.|+ |...+|.++..+.|+||..|+.
T Consensus       106 ~~rk~l~~vlE~a~~LD---~~GI~H~El~~~~k~vlv~~~~~~iIDFd~At~  155 (201)
T COG2112         106 GDRKHLLRVLEKAYKLD---RLGIEHGELSRPWKNVLVNDRDVYIIDFDSATF  155 (201)
T ss_pred             ccHHHHHHHHHHHHHHH---HhccchhhhcCCceeEEecCCcEEEEEccchhh
Confidence             1233445666644466   7899999986 5555665566899999998874

>PF13095 FTA2: Kinetochore Sim4 complex subunit FTA2

Probab=96.86  E-value=0.0098  Score=54.17  Aligned_cols=109  Identities=27%  Similarity=0.379  Sum_probs=78.9

Q ss_pred             HhhhccccCccCc-eEEEEEEEcCCCEEEEEEecc-----C-----C------------CCchhhHHHHHHhhccC---c
Q 039231          314 TNSFKYKLGQGGY-GSVYKGKLLDGSNVAVKVLND-----S-----K------------GNGKEFINEVASISRTS---H  367 (506)
Q Consensus       314 ~~~~~~~ig~G~~-g~V~~~~~~~~~~vavK~l~~-----~-----~------------~~~~~~~~E~~~l~~l~---h  367 (506)
                      ...|-+.||.|.. |.||++++ +|+.+|+|+.+.     .     .            .....|..|.+...+++   +
T Consensus        38 ~I~flefLg~g~~~~~V~kv~I-~g~~YALKlf~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~PF~~ECRAfgRLke~~~  116 (207)
T PF13095_consen   38 DIEFLEFLGHGSHDGYVFKVEI-DGRIYALKLFRFWDYTEPDYTRERFAGHETSLSTPAHYADPFNCECRAFGRLKEAGR  116 (207)
T ss_pred             cEeeeeecCCCCceeEEEEEEE-CCeEEEEEEeeccccCCCccccccccccccccchhhhhcChHHHHHHhhHHHHhccc
Confidence            3345577999999 99999999 677999999421     0     0            11135778888888876   4


Q ss_pred             cce--eEEEEEee-ccchh-------------------------------hhHHHHHHHHHHHHhhcCCCCeEecCcCCC
Q 039231          368 VNV--VALLGFCL-RVAEE-------------------------------LSSTIGIARGLEYLHLGCSTRILHFDIKPH  413 (506)
Q Consensus       368 ~ni--v~l~g~~~-~~~~~-------------------------------l~i~~~i~~gl~~LH~~~~~~ivH~dlkp~  413 (506)
                      .++  |+.+||.+ +.++.                               ..-+.+|.+-|..+|   +.+|+-+|+++.
T Consensus       117 e~~~Avkc~Gyl~L~~~~q~~~~~~~~~~~~~~~~~aIVKD~v~~~~~~~~~~~~~~~~dl~~~~---k~gI~~~Dv~~~  193 (207)
T PF13095_consen  117 EGLWAVKCHGYLLLTEDQQFEQLRQRGSDHRPLPIRAIVKDFVPDDPPLQIRDIPQMLRDLKILH---KLGIVPRDVKPR  193 (207)
T ss_pred             cCceEEEeeEEEEEchHHHHHHhhcccccCCCCccEEEEEeecCCccccchhHHHHHHHHHHHHH---HCCeeeccCccc
Confidence            456  89999883 21111                               123457888899999   999999999999


Q ss_pred             cEEECCCCcEEEeecCCC
Q 039231          414 NILLDEDFCPKISDFGLA  431 (506)
Q Consensus       414 Nill~~~~~~ki~dfg~a  431 (506)
                      |..     .-||+|||.+
T Consensus       194 ny~-----~G~lvDfs~~  206 (207)
T PF13095_consen  194 NYR-----GGKLVDFSSS  206 (207)
T ss_pred             ccc-----CCEEEecccC
Confidence            965     3488999854

>PF01636 APH: Phosphotransferase enzyme family This family is part of the larger protein kinase superfamily

Probab=96.78  E-value=0.0032  Score=59.01  Aligned_cols=45  Identities=18%  Similarity=0.211  Sum_probs=35.5

Q ss_pred             ccCccCceEEEEEEEcCCCEEEEEEeccCCCCchhhHHHHHHhhccC
Q 039231          320 KLGQGGYGSVYKGKLLDGSNVAVKVLNDSKGNGKEFINEVASISRTS  366 (506)
Q Consensus       320 ~ig~G~~g~V~~~~~~~~~~vavK~l~~~~~~~~~~~~E~~~l~~l~  366 (506)
                      .++.|..+.||+....+ ..+++|..... .....+.+|..+++.+.
T Consensus         4 ~l~~G~~n~~~~v~~~~-~~~vlK~~~~~-~~~~~~~~e~~~~~~l~   48 (239)
T PF01636_consen    4 PLSGGFSNRVYRVTTDD-GRYVLKFYRPP-DAAERLRREAAVLRQLA   48 (239)
T ss_dssp             EEEESSSSEEEEEEETT-SEEEEEEESSH-HHHHHHHHHHHHHHHHH
T ss_pred             cCCCCCeeeEEEEEECC-cEEEEEEeCCC-CCHHHHHHHHHHHHHHH
Confidence            47889999999999877 69999987654 33467778888888775

; InterPro: IPR002575 This entry consists of bacterial antibiotic resistance proteins, which confer resistance to various aminoglycosides they include:- aminoglycoside 3'-phosphotransferase or kanamycin kinase / neomycin-kanamycin phosphotransferase and streptomycin 3''-kinase or streptomycin 3''-phosphotransferase. The aminoglycoside phosphotransferases inactivate aminoglycoside antibiotics via phosphorylation []. The proteins are found in a range of taxonomic groups.; PDB: 2PPQ_A 2Q83_B 3TDV_B 3TDW_A 3I0O_A 3I0Q_A 3I1A_B 3Q2M_A 3HAV_C 2PUI_B ....

>PF06176 WaaY: Lipopolysaccharide core biosynthesis protein (WaaY); InterPro: IPR009330 This family consists of several bacterial lipopolysaccharide core biosynthesis proteins (WaaY or RfaY)

Probab=96.58  E-value=0.012  Score=54.35  Aligned_cols=44  Identities=23%  Similarity=0.264  Sum_probs=37.9

Q ss_pred             HHHHHHHHHHHHhhcCCCCeEecCcCCCcEEECCCCcEEEeecCCCcc
Q 039231          386 STIGIARGLEYLHLGCSTRILHFDIKPHNILLDEDFCPKISDFGLAKI  433 (506)
Q Consensus       386 i~~~i~~gl~~LH~~~~~~ivH~dlkp~Nill~~~~~~ki~dfg~a~~  433 (506)
                      ++..+.++|.-||   +.|++|+|.+|.|+++++++ +++.||+..+.
T Consensus       140 ~~~ki~~~ikqlH---~~G~~HGD~hpgNFlv~~~~-i~iID~~~k~~  183 (229)
T PF06176_consen  140 LAEKIVEAIKQLH---KHGFYHGDPHPGNFLVSNNG-IRIIDTQGKRM  183 (229)
T ss_pred             HHHHHHHHHHHHH---HcCCccCCCCcCcEEEECCc-EEEEECccccc
Confidence            4567889999999   99999999999999998655 99999986653

The waaY, waaQ, and waaP genes are located in the central operon of the waa (formerly rfa) locus on the chromosome of Escherichia coli. This locus contains genes whose products are involved in the assembly of the core region of the lipopolysaccharide molecule. WaaY is the enzyme that phosphorylates HepII in this system [].; GO: 0009244 lipopolysaccharide core region biosynthetic process

>KOG1235 consensus Predicted unusual protein kinase [General function prediction only]

Probab=96.57  E-value=0.009  Score=62.55  Aligned_cols=36  Identities=31%  Similarity=0.364  Sum_probs=30.6

Q ss_pred             CCCCeEecCcCCCcEEEC----CCCcEEEeecCCCccccC
Q 039231          401 CSTRILHFDIKPHNILLD----EDFCPKISDFGLAKICNR  436 (506)
Q Consensus       401 ~~~~ivH~dlkp~Nill~----~~~~~ki~dfg~a~~~~~  436 (506)
                      ...|.+|.|=+|.||++.    .++.+.+.|||+......
T Consensus       318 f~~GffHaDPHPGNilv~~~~~~~~~ivllDhGl~~~is~  357 (538)
T KOG1235|consen  318 FKTGFFHADPHPGNILVRPNPEGDEEIVLLDHGLYAVISH  357 (538)
T ss_pred             HhcCCccCCCCCCcEEEecCCCCCccEEEEcccccccccH
Confidence            367899999999999998    367899999999876543

>cd05157 ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes

Probab=96.49  E-value=0.025  Score=53.32  Aligned_cols=31  Identities=26%  Similarity=0.306  Sum_probs=26.9

Q ss_pred             CCeEecCcCCCcEEECC-CCcEEEeecCCCcc
Q 039231          403 TRILHFDIKPHNILLDE-DFCPKISDFGLAKI  433 (506)
Q Consensus       403 ~~ivH~dlkp~Nill~~-~~~~ki~dfg~a~~  433 (506)
                      ..++|+|+.+.|||+++ +..+.|+||..|..
T Consensus       170 ~~l~H~Dl~~~Nil~~~~~~~~~lIDwe~a~~  201 (235)
T cd05157         170 IVFCHNDLLSGNIIYNEEKNSVKFIDYEYAGY  201 (235)
T ss_pred             EEEEcCCCCcCcEEEeCCCCCEEEEEcccCCc
Confidence            46899999999999997 57899999987753

ETNK is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major phospholipid, phosphatidylethanolamine (PtdEtn). Unlike ChoK, ETNK shows specific activity for its substrate, and displays negligible activity towards N-methylated derivatives of Etn. The Drosophila ETNK is implicated in development and neuronal function. Mammals contain two ETNK proteins, ETNK1 and ETNK2. ETNK1 selectively increases Etn uptake and phosphorylation, as well as PtdEtn synthesis. ETNK2 is found primarily in the liver and reproductive tissues. It plays a critical role in regulating placental hemostasis to support late embryo

>cd05150 APH Aminoglycoside 3'-phosphotransferase (APH)

Probab=96.46  E-value=0.026  Score=53.57  Aligned_cols=31  Identities=23%  Similarity=0.217  Sum_probs=27.1

Q ss_pred             CCeEecCcCCCcEEECCCCcEEEeecCCCcc
Q 039231          403 TRILHFDIKPHNILLDEDFCPKISDFGLAKI  433 (506)
Q Consensus       403 ~~ivH~dlkp~Nill~~~~~~ki~dfg~a~~  433 (506)
                      ..++|+|+.|.|||++++....|+||+.+..
T Consensus       163 ~~l~HgD~~~~Nil~~~~~~~~iIDwe~a~~  193 (244)
T cd05150         163 LVVTHGDACLPNIIVDPGKFSGFIDLGRLGV  193 (244)
T ss_pred             eEEECCCCCCccEEEeCCcEEEEEEcccccc
Confidence            3489999999999999988889999998754

The APH subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). APH catalyzes the transfer of the gamma-phosphoryl group from ATP to aminoglycoside antibiotics such as kanamycin, streptomycin, neomycin, and gentamicin, among others. The aminoglycoside antibiotics target the 30S ribosome and promote miscoding, leading to the production of defective proteins which insert into the bacterial membrane, resulting in membrane damage and the ultimate demise of the bacterium. Phosphorylation of the aminoglycoside antibiotics results in their inactivation, leading to bacterial antibiotic resistance. The APH gene is found on transposons and plasmids and is thought to have originated as a self-defense mechanism used by microorganisms that produce the antibio

>PF10707 YrbL-PhoP_reg: PhoP regulatory network protein YrbL; InterPro: IPR019647 This entry represents proteins that are activated by the protein PhoP

Probab=96.45  E-value=0.026  Score=51.65  Aligned_cols=104  Identities=20%  Similarity=0.264  Sum_probs=67.9

Q ss_pred             cccCccCceEEEEEEEcCCCEEEEEEeccCC-----------------CCchhhHHHHHHhhccC------ccceeEEEE
Q 039231          319 YKLGQGGYGSVYKGKLLDGSNVAVKVLNDSK-----------------GNGKEFINEVASISRTS------HVNVVALLG  375 (506)
Q Consensus       319 ~~ig~G~~g~V~~~~~~~~~~vavK~l~~~~-----------------~~~~~~~~E~~~l~~l~------h~niv~l~g  375 (506)
                      ..||+|+.-.||.-  .+.....||+.....                 ...++..+|+....++.      +.+|.+++|
T Consensus         7 ~~i~~G~~R~cy~H--P~dp~~cIKV~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~E~~~y~~l~~~~~~~~~~i~r~~G   84 (199)
T PF10707_consen    7 DLIAQGGERDCYQH--PDDPNLCIKVMRPDRGERRRPFKRWLKRLRPKSRYRQNRRELRYYKQLSLRRGVDWSHIPRFYG   84 (199)
T ss_pred             cccccCCCceEEEC--CCCCCeEEEEEccccccccccchhHHHhhcccchhHHHHHHHHHHHHHhhccCCcccccccEeE
Confidence            35999999999954  445567888876544                 22356777777666665      788999998


Q ss_pred             Eeeccch----------------------------hhhHHHHHHHHHHHHhhcCCCCeEecCcCCCcEEECCC--C--cE
Q 039231          376 FCLRVAE----------------------------ELSSTIGIARGLEYLHLGCSTRILHFDIKPHNILLDED--F--CP  423 (506)
Q Consensus       376 ~~~~~~~----------------------------~l~i~~~i~~gl~~LH~~~~~~ivH~dlkp~Nill~~~--~--~~  423 (506)
                      +..+...                            ...+...+-+-..||-   +..|+.+|++|+||++...  +  .+
T Consensus        85 ~veT~~G~Glv~e~I~d~dG~~s~TL~~~l~~~~~~~~~~~~L~~f~~~l~---~~~Iv~~dl~~~NIv~~~~~~~~~~l  161 (199)
T PF10707_consen   85 FVETNLGLGLVVELIRDADGNISPTLEDYLKEGGLTEELRQALDEFKRYLL---DHHIVIRDLNPHNIVVQRRDSGEFRL  161 (199)
T ss_pred             EEecCCceEEEEEEEECCCCCcCccHHHHHHcCCccHHHHHHHHHHHHHHH---HcCCeecCCCcccEEEEecCCCceEE
Confidence            8721110                            0112223333345666   7899999999999999432  2  46


Q ss_pred             EEee
Q 039231          424 KISD  427 (506)
Q Consensus       424 ki~d  427 (506)
                      .|+|
T Consensus       162 vlID  165 (199)
T PF10707_consen  162 VLID  165 (199)
T ss_pred             EEEe
Confidence            6666

PhoP controls the expression of a large number of genes that mediate adaptation to low Mg2+ environments and/or virulence in several bacterial species. YbrL is proposed to be acting in a loop activity with PhoP and PrmA analogous to the multi-component loop in Salmonella sp., where the PhoP-dependent PmrD protein activates the regulatory protein PmrA, and the activated PmrA then represses transcription from the PmrD promoter which harbours binding sites for both the PhoP and PmrA proteins. Expression of YrbL is induced in low Mg2+ in a PhoP-dependent fashion and repressed by Fe3+ in a PmrA-dependent manner [].

>TIGR02721 ycfN_thiK thiamine kinase

Probab=96.11  E-value=0.033  Score=53.39  Aligned_cols=112  Identities=15%  Similarity=0.105  Sum_probs=66.4

Q ss_pred             cCccCceEEEEEEEcCCCEEEEEEeccCCCCc-hhhHHHHHHhhccCc----cceeEEE------EEe----eccc--hh
Q 039231          321 LGQGGYGSVYKGKLLDGSNVAVKVLNDSKGNG-KEFINEVASISRTSH----VNVVALL------GFC----LRVA--EE  383 (506)
Q Consensus       321 ig~G~~g~V~~~~~~~~~~vavK~l~~~~~~~-~~~~~E~~~l~~l~h----~niv~l~------g~~----~~~~--~~  383 (506)
                      +..|-...+|+... ++..+++|+........ -...+|.++++.+..    |.++..-      .+.    ++..  ..
T Consensus         4 ~~~G~tn~~y~~~~-~~~~~vlR~~~~~~~~~~~~r~~E~~~l~~l~~~g~~P~~i~~~~~~~v~e~i~G~~~~~~~~~~   82 (256)
T TIGR02721         4 LSGGLTNRSWRIEH-PGISFVWRPQSPVCKALGVDRQREYQILQALSALGLAPKPILVNEHWLLVEWLEGEVITLDQFVA   82 (256)
T ss_pred             CCCcCcCCeEEEEe-CCccEEEeeCCcccccccCcHHHHHHHHHHHHhcCCCCceEEEeCCEEEEEeccCcccccccccC
Confidence            55677788998874 56788888765432221 245778888887753    3333211      111    1100  01


Q ss_pred             hhHHHHHHHHHHHHhhc--------------------------------------------CCCCeEecCcCCCcEEECC
Q 039231          384 LSSTIGIARGLEYLHLG--------------------------------------------CSTRILHFDIKPHNILLDE  419 (506)
Q Consensus       384 l~i~~~i~~gl~~LH~~--------------------------------------------~~~~ivH~dlkp~Nill~~  419 (506)
                      .....++++.|.-||+.                                            ....++|+|+.|.||++++
T Consensus        83 ~~~~~~la~~l~~lH~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~H~Dl~~~Nil~~~  162 (256)
T TIGR02721        83 LDLLLELAALLHQLHSQPRFGYPLSLKARIAHYWLQIDPARRTPEWLRLYKQFRSAPEPAPLPLAPLHMDVHAYNLVVTP  162 (256)
T ss_pred             chhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHHhcccccCChHHHHHHHHHHhccCCCCCCCeeecCCCCcCcEEEeC
Confidence            11233344433333321                                            1235799999999999998


Q ss_pred             CCcEEEeecCCCccc
Q 039231          420 DFCPKISDFGLAKIC  434 (506)
Q Consensus       420 ~~~~ki~dfg~a~~~  434 (506)
                      ++ +.|+||+.+...
T Consensus       163 ~~-~~lIDwE~a~~g  176 (256)
T TIGR02721       163 QG-LKLIDWEYASDG  176 (256)
T ss_pred             CC-CEEEeccccCcC
Confidence            77 789999988653

Members of this family are the ycfN gene product of Escherichia coli, now identified as the salvage enzyme thiamine kinase (thiK), and additional proteobacterial homologs taken to be orthologs with equivalent function.

>cd05155 APH_ChoK_like_1 Uncharacterized bacterial proteins with similarity to Aminoglycoside 3'-phosphotransferase (APH) and Choline kinase (ChoK) family members

Probab=95.99  E-value=0.049  Score=51.44  Aligned_cols=31  Identities=26%  Similarity=0.460  Sum_probs=26.3

Q ss_pred             CCeEecCcCCCcEEECCCCcEEEeecCCCcc
Q 039231          403 TRILHFDIKPHNILLDEDFCPKISDFGLAKI  433 (506)
Q Consensus       403 ~~ivH~dlkp~Nill~~~~~~ki~dfg~a~~  433 (506)
                      ..++|+|+.+.||+++++...-|+||+.+..
T Consensus       164 ~~l~HGD~~~~Nvlv~~~~i~giIDw~~a~~  194 (235)
T cd05155         164 PVWFHGDLAPGNLLVQDGRLSAVIDFGCLGV  194 (235)
T ss_pred             ceEEeCCCCCCcEEEECCCEEEEEeCcccCc
Confidence            3489999999999999776677999998754

The APH/ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates, such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides, and macrolides leads to their inactivation and to bacterial antibiotic resista

>cd05156 ChoK_euk Choline Kinase (ChoK) in eukaryotes

Probab=95.78  E-value=0.085  Score=51.85  Aligned_cols=33  Identities=27%  Similarity=0.221  Sum_probs=28.7

Q ss_pred             CCCeEecCcCCCcEEECCC----CcEEEeecCCCccc
Q 039231          402 STRILHFDIKPHNILLDED----FCPKISDFGLAKIC  434 (506)
Q Consensus       402 ~~~ivH~dlkp~Nill~~~----~~~ki~dfg~a~~~  434 (506)
                      ...++|+|+.+.||+++++    +.++++||..+...
T Consensus       178 ~~~lcH~Dl~~~Nil~~~~~~~~~~i~lIDwEya~~~  214 (302)
T cd05156         178 PVVFCHNDLQEGNILLLNPSSETKKLVLIDFEYASYN  214 (302)
T ss_pred             CceEEecCCCcCeEEecCCCCCCCcEEEEeeCCCCCC
Confidence            5578999999999999874    78999999988654

The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC) and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. ChoK plays an important role in cell signaling pathways and the regulation of cell growth. Along with PCho, it is involved in malignant transformation through Ras oncogenes in various human cancer

>PRK09550 mtnK methylthioribose kinase; Reviewed

Probab=95.72  E-value=0.085  Score=53.71  Aligned_cols=57  Identities=16%  Similarity=0.127  Sum_probs=39.0

Q ss_pred             ccCccCceEEEEEEEcCC-CEEEEEEeccC--------CCCchhhHHHHHHhhccC---ccceeEEEEE
Q 039231          320 KLGQGGYGSVYKGKLLDG-SNVAVKVLNDS--------KGNGKEFINEVASISRTS---HVNVVALLGF  376 (506)
Q Consensus       320 ~ig~G~~g~V~~~~~~~~-~~vavK~l~~~--------~~~~~~~~~E~~~l~~l~---h~niv~l~g~  376 (506)
                      .||.|.+..||++...+| +.+.||.-...        ....+....|.+.|..+.   ..++.+++.+
T Consensus        33 elggGn~N~VyrV~~~~g~~svIVKqa~p~~r~~g~~wpl~~eR~~~Eae~L~~l~~~~p~~VPkV~~~  101 (401)
T PRK09550         33 EIGDGNLNLVFRVSDTEGGKSVIVKQALPYVRVVGESWPLTLDRARIEAEALKIQAKYVPDLVPKVYHY  101 (401)
T ss_pred             EcCCCceEEEEEEEeCCCCeEEEEEecCcccccccccccccHHHHHHHHHHHHHHHhhCCCCCCeEEEE
Confidence            589999999999999877 48999974311        123355677888877753   2345555544

>PLN02876 acyl-CoA dehydrogenase

Probab=95.66  E-value=0.079  Score=59.70  Aligned_cols=58  Identities=12%  Similarity=0.199  Sum_probs=39.4

Q ss_pred             cccCccCceEEEEEEEcCC---CEEEEEEeccCC--CCchhhHHHHHHhhccC-ccce--eEEEEE
Q 039231          319 YKLGQGGYGSVYKGKLLDG---SNVAVKVLNDSK--GNGKEFINEVASISRTS-HVNV--VALLGF  376 (506)
Q Consensus       319 ~~ig~G~~g~V~~~~~~~~---~~vavK~l~~~~--~~~~~~~~E~~~l~~l~-h~ni--v~l~g~  376 (506)
                      +.++.|.+..+|+....++   ..+++|+.....  .....+.+|+++++.+. |.++  .+++++
T Consensus        44 ~~l~gG~sn~ty~l~~~~~~~~~~~VLR~~p~~~~~~~~~~~~rE~~~l~~L~~~~~vpVP~v~~~  109 (822)
T PLN02876         44 SQFGHGQSNPTFLLEVGNGGSVKRYVLRKKPPGKLLQSAHAVEREYQVLRALGEHTDVPVPKVYCL  109 (822)
T ss_pred             EEeCCCCcCceEEEEECCCCcceeEEEEeCCCCccCccHHHHHHHHHHHHHHhhcCCCCCCcEEEE
Confidence            3588899999999887554   467777764322  22357889999999885 5553  555544

>KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis]

Probab=95.63  E-value=0.025  Score=63.27  Aligned_cols=127  Identities=21%  Similarity=0.204  Sum_probs=89.1

Q ss_pred             HHHHHHhhccCccceeEEEEEeeccch-------------------------------hhhHHHHHHHHHHHHhhcCCCC
Q 039231          356 INEVASISRTSHVNVVALLGFCLRVAE-------------------------------ELSSTIGIARGLEYLHLGCSTR  404 (506)
Q Consensus       356 ~~E~~~l~~l~h~niv~l~g~~~~~~~-------------------------------~l~i~~~i~~gl~~LH~~~~~~  404 (506)
                      .-|++.+..+.|+|++.+++|-+....                               .+.+..+..+|+.|+|   +..
T Consensus       230 E~e~~~l~k~~~~n~~~~~~~~le~~~~g~~~~v~~~~~s~~~~~~~~q~v~~i~~~~~r~~~~~~~~GL~~~h---~~~  306 (1351)
T KOG1035|consen  230 EIELESLSKIAHDNLGGYFVYGLERLFRGIVLDVLQEICSKVELRSLLQSVGSIPLETLRILHQKLLEGLAYLH---SLS  306 (1351)
T ss_pred             HHHHHHHHhhccccccceeEEeehhhcchHHHHHHHhhcCccchHHHHhhccccCHHHHHHHHHHHhhhHHHHH---Hhc
Confidence            457778888999999999988743221                               3346678999999999   555


Q ss_pred             eEecCcCCC---cEEECCCCcEEEe--ecCCCccccCCCcceecccCCCCcccccccccccccCCCCccccHHHHHHHHH
Q 039231          405 ILHFDIKPH---NILLDEDFCPKIS--DFGLAKICNRKESIISMTGARGTVGYIAPEVFCRNIGEVSYKSDVYNYGMMIF  479 (506)
Q Consensus       405 ivH~dlkp~---Nill~~~~~~ki~--dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~s~~~Dv~s~G~il~  479 (506)
                      ..|.-+..+   +--.+.++...++  ||+..+........   .....+..|.|||....+....+...|+|.+|.++.
T Consensus       307 l~~v~L~~s~~~~~~~~~e~~~~~sl~~~~ss~~l~d~~~~---~~~~~~~~~~~~e~~~~~~~~~~r~~dL~~lgll~~  383 (1351)
T KOG1035|consen  307 LEHVVLSASSSKESTVDGEGVVAISLSDFDSSKPLPDNEKS---FSDLLAEIRNADEDLKENTAKKSRLTDLWCLGLLLL  383 (1351)
T ss_pred             cceeEEecccccccccCccceeecchhhhcccccCCCcccc---hhhcCccccccccccccccchhhhhhHHHHHHHHHh
Confidence            555555544   4444566667777  88888766554432   223446678889988665445555689999999999


Q ss_pred             HHHcCCCCC
Q 039231          480 EMTGGRKNV  488 (506)
Q Consensus       480 elltg~~pf  488 (506)
                      .+..|..+-
T Consensus       384 ~~~~~~~i~  392 (1351)
T KOG1035|consen  384 QLSQGEDIS  392 (1351)
T ss_pred             hhhhcCccc
Confidence            998876654

>KOG2268 consensus Serine/threonine protein kinase [Signal transduction mechanisms; General function prediction only]

Probab=95.26  E-value=0.024  Score=55.04  Aligned_cols=113  Identities=17%  Similarity=0.153  Sum_probs=75.2

Q ss_pred             hhccccCccCceEEEEEEEcCCCEEEEEEecc----------C-------CCCc------hhhHHHHHHhhccCc-----
Q 039231          316 SFKYKLGQGGYGSVYKGKLLDGSNVAVKVLND----------S-------KGNG------KEFINEVASISRTSH-----  367 (506)
Q Consensus       316 ~~~~~ig~G~~g~V~~~~~~~~~~vavK~l~~----------~-------~~~~------~~~~~E~~~l~~l~h-----  367 (506)
                      .+.++||-|--+.||.+-..+|++.++|.-.-          .       ....      -...+|...|+.+..     
T Consensus        95 svGnqIGVGKESDIY~v~d~~G~~~~lK~HRLGRtSFR~Vk~kRDY~r~r~~~sWlyLSRlaa~kEfafmkaL~e~gfpV  174 (465)
T KOG2268|consen   95 SVGNQIGVGKESDIYVVADEEGNPLILKLHRLGRTSFRNVKNKRDYLRKRKSGSWLYLSRLAATKEFAFMKALYERGFPV  174 (465)
T ss_pred             hhccccccccccceEEEecCCCCchhHHHHhhhhhhHHHhhhhhhhHhcCCccchhhhHHHHHHHHHHHHHHHHHcCCCC
Confidence            34678999999999999999999999986421          0       0000      123467777777631     


Q ss_pred             -------cce--eEEEEEe-----eccchhhhHHHHHHHHHHHHhhcCCCCeEecCcCCCcEEECCCCcEEEeecCCC
Q 039231          368 -------VNV--VALLGFC-----LRVAEELSSTIGIARGLEYLHLGCSTRILHFDIKPHNILLDEDFCPKISDFGLA  431 (506)
Q Consensus       368 -------~ni--v~l~g~~-----~~~~~~l~i~~~i~~gl~~LH~~~~~~ivH~dlkp~Nill~~~~~~ki~dfg~a  431 (506)
                             .|+  ..++..+     -.....-.+...+..-+.-|-   ..|+||+|..-=||+++++..++++||--.
T Consensus       175 PkpiD~~RH~Vvmelv~g~Pl~~v~~v~d~~~ly~~lm~~Iv~la---~~GlIHgDFNEFNimv~dd~~i~vIDFPQm  249 (465)
T KOG2268|consen  175 PKPIDHNRHCVVMELVDGYPLRQVRHVEDPPTLYDDLMGLIVRLA---NHGLIHGDFNEFNIMVKDDDKIVVIDFPQM  249 (465)
T ss_pred             CCcccccceeeHHHhhcccceeeeeecCChHHHHHHHHHHHHHHH---HcCceecccchheeEEecCCCEEEeechHh
Confidence                   111  1222211     112223344455555566677   899999999999999999999999999654

>PLN02236 choline kinase

Probab=95.26  E-value=0.12  Score=51.76  Aligned_cols=32  Identities=28%  Similarity=0.345  Sum_probs=27.4

Q ss_pred             CCeEecCcCCCcEEECC-CCcEEEeecCCCccc
Q 039231          403 TRILHFDIKPHNILLDE-DFCPKISDFGLAKIC  434 (506)
Q Consensus       403 ~~ivH~dlkp~Nill~~-~~~~ki~dfg~a~~~  434 (506)
                      ..++|+|+++.|||+++ ++.+.++||..+...
T Consensus       200 ~~~cH~Dl~~~Nil~~~~~~~~~lID~Eya~~~  232 (344)
T PLN02236        200 IGFCHNDLQYGNIMIDEETRAITIIDYEYASYN  232 (344)
T ss_pred             ceEEeCCCCcCcEEEeCCCCcEEEEeehhcccc
Confidence            46899999999999976 468999999988654

>PRK05231 homoserine kinase; Provisional

Probab=95.12  E-value=0.18  Score=49.91  Aligned_cols=32  Identities=25%  Similarity=0.338  Sum_probs=27.4

Q ss_pred             CCCeEecCcCCCcEEECCCCcEEEeecCCCcc
Q 039231          402 STRILHFDIKPHNILLDEDFCPKISDFGLAKI  433 (506)
Q Consensus       402 ~~~ivH~dlkp~Nill~~~~~~ki~dfg~a~~  433 (506)
                      ..+++|+|++|.||+++.+...-|+||+.+..
T Consensus       186 p~~liHgD~~~~Nil~~~~~~~~iIDf~~~~~  217 (319)
T PRK05231        186 PRGVIHADLFRDNVLFEGDRLSGFIDFYFACN  217 (319)
T ss_pred             CcccCCCCCCCCcEEEECCceEEEEecccccC
Confidence            45899999999999999776668999998854

>cd05153 HomoserineK_II Homoserine Kinase, type II

Probab=94.63  E-value=0.17  Score=49.53  Aligned_cols=31  Identities=29%  Similarity=0.404  Sum_probs=27.6

Q ss_pred             CCeEecCcCCCcEEECCCCcEEEeecCCCcc
Q 039231          403 TRILHFDIKPHNILLDEDFCPKISDFGLAKI  433 (506)
Q Consensus       403 ~~ivH~dlkp~Nill~~~~~~ki~dfg~a~~  433 (506)
                      .+++|+|+.|.||+++++..+.|.||+.+..
T Consensus       175 ~~l~HgD~~~~Nil~~~~~~~~iIDfe~a~~  205 (296)
T cd05153         175 RGVIHADLFRDNVLFDGDELSGVIDFYFACT  205 (296)
T ss_pred             CcCCccCcCcccEEEeCCceEEEeehhhhcC
Confidence            5799999999999999987789999998754

Homoserine kinase is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of unusual homoserine kinases, from a subset of bacteria, which have a PK fold. These proteins do not bear any similarity to the GHMP family homoserine kinases present in most bacteria and eukaryotes. Homoserine kinase catalyzes the transfer of the gamma-phosphoryl group from ATP to L-homoserine producing L-homoserine phosphate, an intermediate in the production of the amino acids threonine, methionine, and isoleucine.

>PRK10593 hypothetical protein; Provisional

Probab=94.38  E-value=0.51  Score=46.30  Aligned_cols=45  Identities=11%  Similarity=0.008  Sum_probs=32.6

Q ss_pred             ccCccCceEEEEEEEcCCCEEEEEEeccCCCCchhhHHHHHHhhccC
Q 039231          320 KLGQGGYGSVYKGKLLDGSNVAVKVLNDSKGNGKEFINEVASISRTS  366 (506)
Q Consensus       320 ~ig~G~~g~V~~~~~~~~~~vavK~l~~~~~~~~~~~~E~~~l~~l~  366 (506)
                      .|+.|..+.||+....++ .+.+|..+. ......+.+|.+.|+.+.
T Consensus        21 ~i~~G~~~~vy~~~~~~~-~~~~k~~~~-~~~~~~~~~Ea~~L~~L~   65 (297)
T PRK10593         21 CISEQPYAALWALYDSQG-NPMPLMARS-FSTPGVAQQEAWKLSMLA   65 (297)
T ss_pred             ecCCccceeEEEEEcCCC-CEEEEEecc-cccchHHHHHHHHHHHHc
Confidence            599999999999987566 466676433 223357888988887764

>PF07387 Seadorna_VP7: Seadornavirus VP7; InterPro: IPR009973 This family consists of several Seadornavirus specific VP7 proteins of around 305 residues in length

Probab=94.36  E-value=0.33  Score=44.81  Aligned_cols=135  Identities=19%  Similarity=0.204  Sum_probs=78.5

Q ss_pred             ceEEEEEEEcCCCEEEEEEeccCCC--CchhhHHHHHHhhccCccceeEE-----------EEEeeccchhhh-HHHHHH
Q 039231          326 YGSVYKGKLLDGSNVAVKVLNDSKG--NGKEFINEVASISRTSHVNVVAL-----------LGFCLRVAEELS-STIGIA  391 (506)
Q Consensus       326 ~g~V~~~~~~~~~~vavK~l~~~~~--~~~~~~~E~~~l~~l~h~niv~l-----------~g~~~~~~~~l~-i~~~i~  391 (506)
                      -++.-.++-+-| +..+|++...+-  ...-+.++.++++++.  .|+++           +..|.+...... ++.-=+
T Consensus        75 NsTl~~~kt~iG-~L~lKKi~slp~~~~~~~y~nky~v~Armh--GilrL~NDn~~~yGvIlE~Cy~~~i~~~N~i~agi  151 (308)
T PF07387_consen   75 NSTLLIGKTKIG-PLFLKKIRSLPCCINDALYFNKYRVFARMH--GILRLKNDNNYKYGVILERCYKIKINFSNFITAGI  151 (308)
T ss_pred             ceEEEEeccccc-hhhhhhccCCCcccchhhhhhhhhHHHHhh--heeEeecCCCceeEEEEeeccCcccchhHHHHHhH
Confidence            344444433222 344555544332  2345677888887763  23433           223333222211 222125


Q ss_pred             HHHHHHhhcCCCCeEecCcCCCcEEECCCCcEEEeecCCCccccCCCcceecccCCCCcccccccccccccCCCCccccH
Q 039231          392 RGLEYLHLGCSTRILHFDIKPHNILLDEDFCPKISDFGLAKICNRKESIISMTGARGTVGYIAPEVFCRNIGEVSYKSDV  471 (506)
Q Consensus       392 ~gl~~LH~~~~~~ivH~dlkp~Nill~~~~~~ki~dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~s~~~Dv  471 (506)
                      .+|.-.|++ ..+.+|+|-.|+||+-|..|.+||.|-+.-..              .+.-|.--|+     ...++++.+
T Consensus       152 ~~L~~fH~~-~~~~lHGD~np~NiM~D~~G~lKlVDP~~Ll~--------------~~V~~vN~~Y-----~~lT~~aE~  211 (308)
T PF07387_consen  152 KDLMDFHSE-NQHCLHGDCNPDNIMCDKFGYLKLVDPVCLLE--------------NQVNMVNIEY-----ESLTQEAEV  211 (308)
T ss_pred             HHHHHhhcc-CCCeecCCCChhheeecCCCCEEecChhhhhh--------------heeeEEeeec-----cccChHHHH
Confidence            667777854 78999999999999999999999999764321              1222443222     245777888


Q ss_pred             HHHHHHHHHHHc
Q 039231          472 YNYGMMIFEMTG  483 (506)
Q Consensus       472 ~s~G~il~ellt  483 (506)
                      =+|=.-++++..
T Consensus       212 ~~fv~s~l~~v~  223 (308)
T PF07387_consen  212 KVFVKSCLKLVE  223 (308)
T ss_pred             HHHHHHHHHHHH
Confidence            787777777765

The function of this family is unknown.

>PLN02421 phosphotransferase, alcohol group as acceptor/kinase

Probab=94.23  E-value=0.37  Score=48.03  Aligned_cols=30  Identities=23%  Similarity=0.298  Sum_probs=25.9

Q ss_pred             eEecCcCCCcEEECC-CCcEEEeecCCCccc
Q 039231          405 ILHFDIKPHNILLDE-DFCPKISDFGLAKIC  434 (506)
Q Consensus       405 ivH~dlkp~Nill~~-~~~~ki~dfg~a~~~  434 (506)
                      ..|+|+.+.|||+++ ++.++++||+.|...
T Consensus       184 ~CHnDl~~~NiL~~~~~~~l~lID~EYag~n  214 (330)
T PLN02421        184 FAHNDLLSGNLMLNEDEGKLYFIDFEYGSYS  214 (330)
T ss_pred             EEECCCCcccEEEeCCCCcEEEEcccccCCC
Confidence            699999999999974 578999999988654

>PF01633 Choline_kinase: Choline/ethanolamine kinase; InterPro: IPR002573 Choline kinase, (ATP:choline phosphotransferase, 2

Probab=94.09  E-value=0.23  Score=45.97  Aligned_cols=31  Identities=35%  Similarity=0.453  Sum_probs=21.7

Q ss_pred             CCeEecCcCCCcEEE-CCCCcEEEeecCCCcc
Q 039231          403 TRILHFDIKPHNILL-DEDFCPKISDFGLAKI  433 (506)
Q Consensus       403 ~~ivH~dlkp~Nill-~~~~~~ki~dfg~a~~  433 (506)
                      .-+.|+|+.|.|||+ +.++.++++||..|..
T Consensus       143 ~v~cHnDl~~~Nil~~~~~~~~~lIDfEya~~  174 (211)
T PF01633_consen  143 LVFCHNDLNPGNILINNKDGEVKLIDFEYAGY  174 (211)
T ss_dssp             EEEE-S--SGGGEEETSSSSCEEE--GTT-EE
T ss_pred             ceEeeccCccccEEeccCCCeEEEecHHHHhh
Confidence            357999999999999 8889999999998854

7.1.32 from EC) belongs to the choline/ethanolamine kinase family. Ethanolamine and choline are major membrane phospholipids, in the form of glycerophosphoethanolamine and glycerophosphocholine. Ethanolamine is also a component of the glycosylphosphatidylinositol (GPI) anchor, which is necessary for cell-surface protein attachment []. The de novo synthesis of these phospholipids begins with the creation of phosphoethanolamine and phosphocholine by ethanolamine and choline kinases in the first step of the CDP-ethanolamine pathway [, ]. There are two putative choline/ethanolamine kinases (C/EKs) in the Trypanosoma brucei genome. Ethanolamine kinase has no choline kinase activity [] and its activity is inhibited by ADP []. Inositol supplementation represses ethanolamine kinase, decreasing the incorporation of ethanolamine into the CDP-ethanolamine pathway and into phosphatidylethanolamine and phosphatidylcholine []. ; GO: 0016773 phosphotransferase activity, alcohol group as acceptor; PDB: 3C5I_A 2IG7_A 3LQ3_A 3FEG_A 2QG7_E 3FI8_A 1NW1_A 3MES_A 3G15_A 2CKP_B ....

>cd05152 MPH2' Macrolide 2'-Phosphotransferase (MPH2')

Probab=94.04  E-value=0.37  Score=46.74  Aligned_cols=31  Identities=35%  Similarity=0.531  Sum_probs=25.8

Q ss_pred             CeEecCcCCCcEEECCCCc-EEEeecCCCccc
Q 039231          404 RILHFDIKPHNILLDEDFC-PKISDFGLAKIC  434 (506)
Q Consensus       404 ~ivH~dlkp~Nill~~~~~-~ki~dfg~a~~~  434 (506)
                      .++|+|++|.||++++++. .-|.||+.+...
T Consensus       186 ~lvHGD~~~~Nilv~~~~~~~gviDWe~a~iG  217 (276)
T cd05152         186 VLVHGDLHPGHILIDEDARVTGLIDWTEAKVG  217 (276)
T ss_pred             eeEeCCCCCCcEEEeCCCCEEEEECcHhcccC
Confidence            4799999999999997554 569999988654

MPH2' is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). MPH2' catalyzes the transfer of the gamma-phosphoryl group from ATP to the 2'-hydroxyl of macrolide antibiotics such as erythromycin, clarithromycin, and azithromycin, among others. Macrolides penetrate the bacterial cell and bind to ribosomes, where it interrupts protein elongation, leading ultimately to the demise of the bacterium. Phosphorylation of macrolides leads to their inactivation. Based on substrate specificity and amino acid sequence, MPH2' is divided into types I and II, encoded by mphA and mphB genes, respectively. MPH2'I inactivates 14-membered ring macrolides while MPH2'II inactivates both 14- and 16-membered ring macrolides. Enzymatic inactivation of macrolides has been reported

>TIGR01767 MTRK 5-methylthioribose kinase

Probab=93.89  E-value=0.51  Score=47.22  Aligned_cols=31  Identities=26%  Similarity=0.323  Sum_probs=26.4

Q ss_pred             CCCeEecCcCCCcEEECCCCcEEEeecCCCcc
Q 039231          402 STRILHFDIKPHNILLDEDFCPKISDFGLAKI  433 (506)
Q Consensus       402 ~~~ivH~dlkp~Nill~~~~~~ki~dfg~a~~  433 (506)
                      ...++|||+.+.||+++++. ++++|+..+..
T Consensus       191 ~~~llHGDl~~gNi~~~~~~-~~~iD~e~~~~  221 (370)
T TIGR01767       191 AETLLHGDLHSGSIFVSEHE-TKVIDPEFAFY  221 (370)
T ss_pred             cceeeeccCCcccEEEcCCC-CEEEcCccccc
Confidence            56899999999999998764 78999987754

This enzyme is involved in the methionine salvage pathway in certain bacteria.

>PRK12396 5-methylribose kinase; Reviewed

Probab=93.61  E-value=0.64  Score=47.15  Aligned_cols=58  Identities=21%  Similarity=0.137  Sum_probs=38.2

Q ss_pred             ccCccCceEEEEEEEcC-CCEEEEEEecc----C---CCCchhhHHHHHHhhccC--cc-ceeEEEEEe
Q 039231          320 KLGQGGYGSVYKGKLLD-GSNVAVKVLND----S---KGNGKEFINEVASISRTS--HV-NVVALLGFC  377 (506)
Q Consensus       320 ~ig~G~~g~V~~~~~~~-~~~vavK~l~~----~---~~~~~~~~~E~~~l~~l~--h~-niv~l~g~~  377 (506)
                      .||-|.-..||++.+.+ ++.|+||.-..    .   +...++..-|.+.|+...  -| .+.+++.+-
T Consensus        36 eigdGnlN~VfrV~~~~~~~svIVKQAlp~vRv~~swpL~~~R~~~E~~aL~~~~~~~P~~VP~vy~~D  104 (409)
T PRK12396         36 EIGDGNLNYVFRVWDEQKNISVIVKQAGDTARISDEFKLSTNRIRIESDVLQLEEELAPGLVPKVYLFD  104 (409)
T ss_pred             EcCCCceEEEEEEeeCCCCceEEEEeccHhhccCCCCCCChHHHHHHHHHHHHHHhhCCCcCCeEEEEC
Confidence            58999999999999853 56899986421    1   223355666777777653  23 455566554

>COG5072 ALK1 Serine/threonine kinase of the haspin family [Cell division and chromosome partitioning]

Probab=92.48  E-value=0.37  Score=47.77  Aligned_cols=52  Identities=27%  Similarity=0.287  Sum_probs=41.3

Q ss_pred             cchhhhHHHHHHHHHHHHhhcCCCCeEecCcCCCcEEECCCCcEEEeecCCCccc
Q 039231          380 VAEELSSTIGIARGLEYLHLGCSTRILHFDIKPHNILLDEDFCPKISDFGLAKIC  434 (506)
Q Consensus       380 ~~~~l~i~~~i~~gl~~LH~~~~~~ivH~dlkp~Nill~~~~~~ki~dfg~a~~~  434 (506)
                      +++.+.++.+.+.-+.-+..  +-+.=|||+.-.||||+ +|++-|+||-+++.-
T Consensus       320 ~~e~lsff~s~~sil~~lek--kf~fehrnlt~~niLId-~GnvtLIDfklsRl~  371 (488)
T COG5072         320 SEEELSFFWSCISILDILEK--KFPFEHRNLTLDNILID-EGNVTLIDFKLSRLS  371 (488)
T ss_pred             HHHHHHHHHHHHHHHhhhhh--cCCcccccccccceeee-cCceEEEEeeeeecc
Confidence            44566677766666655553  66889999999999999 899999999999843

>PLN02756 S-methyl-5-thioribose kinase

Probab=92.15  E-value=1.2  Score=45.32  Aligned_cols=31  Identities=16%  Similarity=0.282  Sum_probs=25.9

Q ss_pred             CCCeEecCcCCCcEEECCCCcEEEeecCCCcc
Q 039231          402 STRILHFDIKPHNILLDEDFCPKISDFGLAKI  433 (506)
Q Consensus       402 ~~~ivH~dlkp~Nill~~~~~~ki~dfg~a~~  433 (506)
                      .+.++|+|+.|.||++++++ +++.|..++..
T Consensus       229 ~~~L~HGDl~~g~i~~~~~~-~~~id~ef~~~  259 (418)
T PLN02756        229 AQALVHGDLHTGSVMVTPDS-TQVIDPEFAFY  259 (418)
T ss_pred             ccceeecCCCCCcEEEcCCC-ceEecchhhcc
Confidence            67899999999999999875 88888765543

>PF03109 ABC1: ABC1 family; InterPro: IPR004147 This entry includes ABC1 from yeast [] and AarF from Escherichia coli []

Probab=92.06  E-value=0.081  Score=44.15  Aligned_cols=44  Identities=25%  Similarity=0.355  Sum_probs=33.1

Q ss_pred             ccCccCceEEEEEEEcCCCEEEEEEeccCCCCchhhHHHHHHhhcc
Q 039231          320 KLGQGGYGSVYKGKLLDGSNVAVKVLNDSKGNGKEFINEVASISRT  365 (506)
Q Consensus       320 ~ig~G~~g~V~~~~~~~~~~vavK~l~~~~~~~~~~~~E~~~l~~l  365 (506)
                      -|+.|+.|.||+|++++|+.||||+.++.-  .+.+..++.+|..+
T Consensus        18 PlasASiaQVh~a~l~~g~~VaVKV~rP~i--~~~i~~Dl~~l~~~   61 (119)
T PF03109_consen   18 PLASASIAQVHRARLKDGEEVAVKVQRPGI--EEQIEADLRILRRL   61 (119)
T ss_pred             hhhheehhhheeeeecccchhhhhhcchHH--HHHHHHHHHHHHHH
Confidence            499999999999999999999999986542  23444455555443

These proteins have a nuclear or mitochondrial subcellular location in eukaryotes. The exact molecular functions of these proteins is not clear, however yeast ABC1 suppresses a cytochrome b mRNA translation defect and is essential for the electron transfer in the bc 1 complex [] and E. coli AarF is required for ubiquinone production []. It has been suggested that members of the ABC1 family are novel chaperonins []. These proteins are unrelated to the ABC transporter proteins.

>PRK11768 serine/threonine protein kinase; Provisional

Probab=91.26  E-value=2.1  Score=42.59  Aligned_cols=42  Identities=19%  Similarity=0.119  Sum_probs=30.3

Q ss_pred             cCceEEEEEEEcCCCEEEEEEeccCCCCchhhHHHHHHhhcc
Q 039231          324 GGYGSVYKGKLLDGSNVAVKVLNDSKGNGKEFINEVASISRT  365 (506)
Q Consensus       324 G~~g~V~~~~~~~~~~vavK~l~~~~~~~~~~~~E~~~l~~l  365 (506)
                      +.-..||+....++..+++|+.........++..|++.+..+
T Consensus        36 s~eN~vy~v~~~~~~~~vlKv~r~~~~~~~~i~~E~~~l~~L   77 (325)
T PRK11768         36 SYENRVYQFGDEDGRRVVAKFYRPERWSDAQILEEHAFALEL   77 (325)
T ss_pred             cccceEEEEecCCCCEEEEEEcCcccCCHHHHHHHHHHHHHH
Confidence            344679999888888999998865444445667777776665

>TIGR00938 thrB_alt homoserine kinase, Neisseria type

Probab=91.17  E-value=0.3  Score=48.18  Aligned_cols=32  Identities=31%  Similarity=0.501  Sum_probs=28.5

Q ss_pred             CCCeEecCcCCCcEEECCCCcEEEeecCCCcc
Q 039231          402 STRILHFDIKPHNILLDEDFCPKISDFGLAKI  433 (506)
Q Consensus       402 ~~~ivH~dlkp~Nill~~~~~~ki~dfg~a~~  433 (506)
                      ..+++|+|+++.||++++++...|.||+.+..
T Consensus       186 ~~~l~HgD~~~~Nvl~~~~~~~~vIDfd~~~~  217 (307)
T TIGR00938       186 PRGVIHADLFPDNVLFDGDSVKGVIDFYFACT  217 (307)
T ss_pred             CCccCCCCCCcCcEEEECCceEEEeecccccC
Confidence            57899999999999999888778999998854

Homoserine kinase is required in the biosynthesis of threonine from aspartate.The member of this family from Pseudomonas aeruginosa was shown by direct assay and complementation to act specifically as a homoserine kinase.

>PRK06148 hypothetical protein; Provisional

Probab=90.83  E-value=1.9  Score=49.82  Aligned_cols=32  Identities=34%  Similarity=0.425  Sum_probs=26.6

Q ss_pred             CCCeEecCcCCCcEEECCCC--cEE-EeecCCCcc
Q 039231          402 STRILHFDIKPHNILLDEDF--CPK-ISDFGLAKI  433 (506)
Q Consensus       402 ~~~ivH~dlkp~Nill~~~~--~~k-i~dfg~a~~  433 (506)
                      .+++||+|+++.|||++.+.  .+. |+|||.+..
T Consensus       202 p~~vIHgDln~~NiLv~~~~~~~isGiIDFgDa~~  236 (1013)
T PRK06148        202 PAQVIHNDANDYNILVDADDGERISGLIDFGDAVH  236 (1013)
T ss_pred             CcceECCCCCcccEEEcCCCCcceEEEEECccccc
Confidence            46799999999999998775  454 999998753

>COG0510 ycfN Thiamine kinase and related kinases [Coenzyme transport and metabolism]

Probab=90.32  E-value=1.8  Score=41.77  Aligned_cols=44  Identities=25%  Similarity=0.292  Sum_probs=33.2

Q ss_pred             HHHHHHHHHhhcCCCCeEecCcCCCcEEECCCCcEEEeecCCCcc
Q 039231          389 GIARGLEYLHLGCSTRILHFDIKPHNILLDEDFCPKISDFGLAKI  433 (506)
Q Consensus       389 ~i~~gl~~LH~~~~~~ivH~dlkp~Nill~~~~~~ki~dfg~a~~  433 (506)
                      .+-.++.-.|.. ..-++|+|+.|.|++.++.+.++|+||.-|..
T Consensus       140 ~l~~~l~~~~~~-~~v~cH~Dl~~~N~l~t~~~~l~LIDWEyAg~  183 (269)
T COG0510         140 ELRRALEEVPKD-DLVPCHNDLNPGNLLLTDKGGLFLIDWEYAGL  183 (269)
T ss_pred             HHHHHhhhcCCC-ceeeecCCCCccceEEcCCCcEEEEecccCCC
Confidence            344444444421 13689999999999999989999999988764

>PF03881 Fructosamin_kin: Fructosamine kinase; InterPro: IPR016477 Ketosamines derive from a non-enzymatic reaction between a sugar and a protein []

Probab=90.09  E-value=1.7  Score=42.38  Aligned_cols=44  Identities=20%  Similarity=0.305  Sum_probs=30.5

Q ss_pred             ccCccCceEEEEEEEcCCCEEEEEEeccCCCCchhhHHHHHHhhccC
Q 039231          320 KLGQGGYGSVYKGKLLDGSNVAVKVLNDSKGNGKEFINEVASISRTS  366 (506)
Q Consensus       320 ~ig~G~~g~V~~~~~~~~~~vavK~l~~~~~~~~~~~~E~~~l~~l~  366 (506)
                      .++.|....+|+.. .+++.+.||+-.  ......|..|.+-|+.+.
T Consensus        24 ~v~GG~i~~a~~~~-~~~~~~FvK~~~--~~~~~~f~~Ea~gL~~L~   67 (288)
T PF03881_consen   24 PVSGGDINEAYRLD-TDGGSYFVKVNS--ESGRDMFEGEAEGLKALA   67 (288)
T ss_dssp             EE--SSSSEEEEEE-TTS-EEEEEEEE--GGGCCHHHHHHHHHHHHC
T ss_pred             ecCCCChhheEEEE-CCCccEEEEecC--hhhHHHHHHHHHHHHHHH
Confidence            48888889999887 578899999876  223356777888777773

Ketosamine-3-kinases (KT3K), of which fructosamine-3-kinase (FN3K) is the best-known example, catalyse the phosphorylation of the ketosamine moiety of glycated proteins. The instability of a phosphorylated ketosamine leads to its degradation, and KT3K is thus thought to be involved in protein repair []. The function of the prokaryotic members of this group has not been established. However, several lines of evidence indicate that they may function as fructosamine-3-kinases (FN3K). First, they are similar to characterised FN3K from mouse and human. Second, the Escherichia coli members are found in close proximity on the genome to fructose-6-phosphate kinase (PfkB). Last, FN3K activity has been found in a Anacystis montana (Gloeocapsa montana Kutzing 1843) [], indicating such activity-directly demonstrated in eukaryotes-is nonetheless not confined to eukaryotes. This family includes eukaryotic fructosamine-3-kinase enzymes [] which may initiate a process leading to the deglycation of fructoselysine and of glycated proteins and in the phosphorylation of 1-deoxy-1-morpholinofructose, fructoselysine, fructoseglycine, fructose and glycated lysozyme. The family also includes bacterial members that have not been characterised but probably have a similar or identical function. For additional information please see [].; PDB: 3JR1_B 3F7W_A.

>KOG2270 consensus Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning]

Probab=89.74  E-value=0.67  Score=46.14  Aligned_cols=111  Identities=21%  Similarity=0.276  Sum_probs=76.5

Q ss_pred             ccCccCceEEEEEEEcCCCEEEEEEeccC------C----------------CCchh-----hHHHHHHhhccCccc---
Q 039231          320 KLGQGGYGSVYKGKLLDGSNVAVKVLNDS------K----------------GNGKE-----FINEVASISRTSHVN---  369 (506)
Q Consensus       320 ~ig~G~~g~V~~~~~~~~~~vavK~l~~~------~----------------~~~~~-----~~~E~~~l~~l~h~n---  369 (506)
                      .|..|--+-||.|.-.+|..+|||+++.+      .                .+.+.     ...|++-|.+++...   
T Consensus       151 CiSTGKEANVYHat~~dG~~~AIKIYKTSILvFKDRdRYV~GEfRFRhgyck~NPRKMVk~WAEKE~RNLkRl~~aGIP~  230 (520)
T KOG2270|consen  151 CISTGKEANVYHATEEDGSEFAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKHNPRKMVKTWAEKEMRNLKRLNNAGIPC  230 (520)
T ss_pred             ccccCccceeEeeecCCCceEEEEEEeeeEEEEechhhhccceeeeecccccCCcHHHHHHHHHHHHHHHHHHHhcCCCC
Confidence            48888889999999999999999998522      0                01111     235777777774221   


Q ss_pred             ----ee----EEEEEe--------------eccchhhhHHHHHHHHHHHHhhcCCCCeEecCcCCCcEEECCCCcEEEee
Q 039231          370 ----VV----ALLGFC--------------LRVAEELSSTIGIARGLEYLHLGCSTRILHFDIKPHNILLDEDFCPKISD  427 (506)
Q Consensus       370 ----iv----~l~g~~--------------~~~~~~l~i~~~i~~gl~~LH~~~~~~ivH~dlkp~Nill~~~~~~ki~d  427 (506)
                          ++    -++.++              +...+...+-.|++.-|.-|-+  ..++||.||+-=|+|+.+ |.+.|+|
T Consensus       231 PePIlLk~hVLVM~FlGrdgw~aPkLKd~~ls~~ka~~~Y~~~v~~MR~lY~--~c~LVHADLSEfN~Lyhd-G~lyiID  307 (520)
T KOG2270|consen  231 PEPILLKNHVLVMEFLGRDGWAAPKLKDASLSTSKARELYQQCVRIMRRLYQ--KCRLVHADLSEFNLLYHD-GKLYIID  307 (520)
T ss_pred             CCceeeecceEeeeeccCCCCcCcccccccCChHHHHHHHHHHHHHHHHHHH--HhceeccchhhhhheEEC-CEEEEEE
Confidence                11    122222              3334455667788888888765  678999999999998874 6899999


Q ss_pred             cCCCcc
Q 039231          428 FGLAKI  433 (506)
Q Consensus       428 fg~a~~  433 (506)
                      .+-+..
T Consensus       308 VSQSVE  313 (520)
T KOG2270|consen  308 VSQSVE  313 (520)
T ss_pred             cccccc
Confidence            887654

>PRK10271 thiK thiamine kinase; Provisional

Probab=89.06  E-value=0.34  Score=43.79  Aligned_cols=32  Identities=19%  Similarity=0.220  Sum_probs=27.0

Q ss_pred             CCCeEecCcCCCcEEECCCCcEEEeecCCCccc
Q 039231          402 STRILHFDIKPHNILLDEDFCPKISDFGLAKIC  434 (506)
Q Consensus       402 ~~~ivH~dlkp~Nill~~~~~~ki~dfg~a~~~  434 (506)
                      ..-.+|+|+.|.|+++++++ ++|+||+.+...
T Consensus        76 ~~~p~H~D~~~~N~~~~~~~-~~lIDwe~a~~g  107 (188)
T PRK10271         76 RLAPLHMDVHAGNLVHSASG-LRLIDWEYAGDG  107 (188)
T ss_pred             CeeeecCCCCCccEEEECCC-EEEEeCCcccCC
Confidence            34569999999999998877 899999988643

>PF04655 APH_6_hur: Aminoglycoside/hydroxyurea antibiotic resistance kinase; InterPro: IPR006748 The aminoglycosides are a large group of biologically active bacterial secondary metabolites, best known for their antibiotic properties []

Probab=89.01  E-value=2.5  Score=40.34  Aligned_cols=56  Identities=20%  Similarity=0.151  Sum_probs=36.7

Q ss_pred             ccCccCceEEEEEEEcCCCEEEEEEeccCCCCchhhHHHHHHhhccCccceeEEEEE
Q 039231          320 KLGQGGYGSVYKGKLLDGSNVAVKVLNDSKGNGKEFINEVASISRTSHVNVVALLGF  376 (506)
Q Consensus       320 ~ig~G~~g~V~~~~~~~~~~vavK~l~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~  376 (506)
                      .+..|..+.|+.++..+|.++++|+.........+...+ ..|+..+=...|+++..
T Consensus         9 ~~~~g~~s~V~pv~~~dG~~avLKl~~p~~~~~~E~~g~-~~L~~w~G~GaVrll~~   64 (253)
T PF04655_consen    9 PPAHGSSSLVVPVRRADGTPAVLKLAPPHAEAEHEARGE-AALRWWNGRGAVRLLAA   64 (253)
T ss_pred             CCCCCcceEEEEEEcCCCCeEEEEecCCcccchhhhhHH-hHhheeCCCCceeeecc
Confidence            366788999999999999999999986543322222111 33555555556666654

Aminoglycoside phosphotransferases achieve inactivation of these enzymes by phosphorylation, utilising ATP. Likewise, hydroxyurea is inactivated by phosphorylation of the hydroxy group in the hydroxylamine moiety.; GO: 0016773 phosphotransferase activity, alcohol group as acceptor, 0006468 protein phosphorylation, 0019748 secondary metabolic process

>KOG1826 consensus Ras GTPase activating protein RasGAP/neurofibromin [Defense mechanisms]

Probab=88.99  E-value=0.081  Score=61.09  Aligned_cols=82  Identities=15%  Similarity=0.125  Sum_probs=66.0

Q ss_pred             CCeEecCcCCCcEEECCCCcEEEeecCCCccccCCCcceecccCCCCcccccccccccccCCCCccccHHHHHHHHHHHH
Q 039231          403 TRILHFDIKPHNILLDEDFCPKISDFGLAKICNRKESIISMTGARGTVGYIAPEVFCRNIGEVSYKSDVYNYGMMIFEMT  482 (506)
Q Consensus       403 ~~ivH~dlkp~Nill~~~~~~ki~dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~s~~~Dv~s~G~il~ell  482 (506)
                      .-.+|+++|+-|.+|..+..+|++++|+.+........  .....+++.|++|++..+-  .++.++|+|..|+-+|+.-
T Consensus      1359 ~T~v~~~Lkf~lpmIVtny~v~~gk~gLdKIknp~~sf--~Gl~l~sp~~v~qli~N~i--k~t~rsdilr~s~~ly~rs 1434 (2724)
T KOG1826|consen 1359 NTNVSKSLKFTLPMIVTNYNVKLGKGGLDKIKNPVLSF--FGLELCSPIYVLQLIKNEI--KFTKRSDILRRSLSLYLRS 1434 (2724)
T ss_pred             ccchhhhhhhhccceecCCcccccccccccccCchHhh--hhhhhCCHHHHHHHHHHHH--hhhhHHHHHHHHHHHHHHh
Confidence            34689999999999999999999999999943332221  2446678889999987443  6777799999999999999


Q ss_pred             cCCCCC
Q 039231          483 GGRKNV  488 (506)
Q Consensus       483 tg~~pf  488 (506)
                      -|..+|
T Consensus      1435 ~~n~~f 1440 (2724)
T KOG1826|consen 1435 DGNAYF 1440 (2724)
T ss_pred             cccHHH
Confidence            888887

>PF01102 Glycophorin_A: Glycophorin A; InterPro: IPR001195 Proteins in this group are responsible for the molecular basis of the blood group antigens, surface markers on the outside of the red blood cell membrane

Probab=88.42  E-value=0.62  Score=38.67  Aligned_cols=26  Identities=27%  Similarity=0.413  Sum_probs=11.2

Q ss_pred             hHHHHHHHHHHHHHHHHHHHHhcccC
Q 039231          255 EWTGASAFAIGILIFIAFYFKRKLSS  280 (506)
Q Consensus       255 ~~~~v~~~vl~~li~l~~~~rrk~~~  280 (506)
                      +++|+.+.++++++++++++||++++
T Consensus        69 Ii~gv~aGvIg~Illi~y~irR~~Kk   94 (122)
T PF01102_consen   69 IIFGVMAGVIGIILLISYCIRRLRKK   94 (122)
T ss_dssp             HHHHHHHHHHHHHHHHHHHHHHHS--
T ss_pred             hhHHHHHHHHHHHHHHHHHHHHHhcc
Confidence            33444444444444554555544433

Most of these markers are proteins, but some are carbohydrates attached to lipids or proteins [Reid M.E., Lomas-Francis C. The Blood Group Antigen FactsBook Academic Press, London / San Diego, (1997)]. Glycophorin A (PAS-2) and glycophorin B (PAS-3) belong to the MNS blood group system and are associated with antigens that include M/N, S/s, U, He, Mi(a), M(c), Vw, Mur, M(g), Vr, M(e), Mt(a), St(a), Ri(a), Cl(a), Ny(a), Hut, Hil, M(v), Far, Mit, Dantu, Hop, Nob, En(a), ENKT, amongst others. Glycophorin A is the major sialoglycoprotein of the erythrocyte membrane []. Structurally, glycophorin A consists of an N-terminal extracellular domain, heavily glycosylated on serine and threonine residues, followed by a transmembrane region and a C-terminal cytoplasmic domain. Other glycophorins in this entry such as Glycophorin B and Glycophorin E represent minor sialoglycoproteins in the erythrocyte membrane.; GO: 0016021 integral to membrane; PDB: 2KPF_B 1AFO_B 2KPE_A.

>PTZ00384 choline kinase; Provisional

Probab=88.26  E-value=3.6  Score=41.88  Aligned_cols=30  Identities=27%  Similarity=0.158  Sum_probs=24.8

Q ss_pred             CCeEecCcCCCcEEECCCCcEEEeecCCCcc
Q 039231          403 TRILHFDIKPHNILLDEDFCPKISDFGLAKI  433 (506)
Q Consensus       403 ~~ivH~dlkp~Nill~~~~~~ki~dfg~a~~  433 (506)
                      ....|.|+.+.||+.+++ .+.++||..|..
T Consensus       227 ~VfCHNDL~~gNIL~~~~-~l~lID~EYA~~  256 (383)
T PTZ00384        227 VLFCHNDLFFTNILDFNQ-GIYFIDFDFAGF  256 (383)
T ss_pred             eeeeeccCCcccEEecCC-CEEEEEeccccC
Confidence            456999999999997654 599999988754

---

Homologous Structure Templates

Structure Templates Detected by BLAST

Original result of BLAST against Protein Data Bank

ID	Length	Definition	E-value
Query	506
3tl8_A	349	The Avrptob-Bak1 Complex Reveals Two Structurally S		7e-33
3uim_A	326	Structural Basis For The Impact Of Phosphorylation		8e-32
2qkw_B	321	Structural Basis For Activation Of Plant Immunity B		6e-25
3hgk_A	327	Crystal Structure Of Effect Protein Avrptob Complex		2e-24
2nry_A	307	Crystal Structure Of Irak-4 Length = 307		3e-21
2nru_A	307	Crystal Structure Of Irak-4 Length = 307		4e-21
3c4c_A	280	B-Raf Kinase In Complex With Plx4720 Length = 280		5e-21
2oib_A	301	Crystal Structure Of Irak4 Kinase Domain Apo Form L		5e-21
3q96_A	282	B-Raf Kinase Domain In Complex With A Tetrahydronap		7e-21
1uwh_A	276	The Complex Of Wild Type B-Raf And Bay439006 Length		8e-21
2fb8_A	281	Structure Of The B-Raf Kinase Domain Bound To Sb-59		8e-21
4h58_A	275	Braf In Complex With Compound 3 Length = 275		8e-21
3omv_A	307	Crystal Structure Of C-Raf (Raf-1) Length = 307		8e-21
3ii5_A	306	The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimi		8e-21
4dbn_A	284	Crystal Structure Of The Kinase Domain Of Human B-R		9e-21
3d4q_A	307	Pyrazole-Based Inhibitors Of B-Raf Kinase Length =		1e-20
3og7_A	289	B-Raf Kinase V600e Oncogenic Mutant In Complex With		3e-20
4fk3_A	292	B-Raf Kinase V600e Oncogenic Mutant In Complex With		3e-20
1uwj_A	276	The Complex Of Mutant V599e B-raf And Bay439006 Len		4e-20
3idp_A	300	B-Raf V600e Kinase Domain In Complex With An Aminoi		4e-20
4g9r_A	307	B-Raf V600e Kinase Domain Bound To A Type Ii Dihydr		5e-20
2o8y_A	298	Apo Irak4 Kinase Domain Length = 298		5e-20
3p86_A	309	Crystal Structure Of Ctr1 Kinase Domain Mutant D676		5e-17
3ppz_A	309	Crystal Structure Of Ctr1 Kinase Domain In Complex		1e-16
1fpu_A	293	Crystal Structure Of Abl Kinase Domain In Complex W		2e-16
3oxz_A	284	Crystal Structure Of Abl Kinase Domain Bound With A		2e-16
3oy3_A	284	Crystal Structure Of Abl T315i Mutant Kinase Domain		2e-16
2qoh_A	288	Crystal Structure Of Abl Kinase Bound With Ppy-a Le		2e-16
3dk3_A	293	Crystal Structure Of Mutant Abl Kinase Domain In Co		3e-16
2z60_A	288	Crystal Structure Of The T315i Mutant Of Abl Kinase		3e-16
4gg5_A	319	Crystal Structure Of Cmet In Complex With Novel Inh		3e-16
2rfn_A	310	X-ray Structure Of C-met With Inhibitor. Length = 3		3e-16
3dk7_A	277	Crystal Structure Of Mutant Abl Kinase Domain In Co		4e-16
3q6w_A	307	Structure Of Dually-phosphorylated Met Receptor Kin		4e-16
3i5n_A	309	Crystal Structure Of C-Met With Triazolopyridazine		4e-16
2wd1_A	292	Human C-Met Kinase In Complex With Azaindole Inhibi		4e-16
3f66_A	298	Human C-Met Kinase In Complex With Quinoxaline Inhi		4e-16
3q6u_A	308	Structure Of The Apo Met Receptor Kinase In The Dua		4e-16
2g15_A	318	Structural Characterization Of Autoinhibited C-Met		4e-16
2wgj_A	306	X-Ray Structure Of Pf-02341066 Bound To The Kinase		4e-16
3lq8_A	302	Structure Of The Kinase Domain Of C-Met Bound To Xl		4e-16
2gqg_A	278	X-Ray Crystal Structure Of Dasatinib (Bms-354825) B		5e-16
3qri_A	277	The Crystal Structure Of Human Abl1 Kinase Domain I		5e-16
2g1t_A	287	A Src-Like Inactive Conformation In The Abl Tyrosin		5e-16
3qrj_A	277	The Crystal Structure Of Human Abl1 Kinase Domain T		6e-16
2v7a_A	286	Crystal Structure Of The T315i Abl Mutant In Comple		6e-16
2hzi_A	277	Abl Kinase Domain In Complex With Pd180970 Length =		6e-16
2f4j_A	287	Structure Of The Kinase Domain Of An Imatinib-Resis		6e-16
2e2b_A	293	Crystal Structure Of The C-Abl Kinase Domain In Com		6e-16
2hyy_A	273	Human Abl Kinase Domain In Complex With Imatinib (S		7e-16
2g2f_A	287	A Src-Like Inactive Conformation In The Abl Tyrosin		7e-16
3pyy_A	298	Discovery And Characterization Of A Cell-Permeable,		7e-16
2hiw_A	287	Crystal Structure Of Inactive Conformation Abl Kina		7e-16
2hz0_A	270	Abl Kinase Domain In Complex With Nvp-Aeg082 Length		8e-16
1opk_A	495	Structural Basis For The Auto-Inhibition Of C-Abl T		9e-16
3bbt_B	328	Crystal Structure Of The Erbb4 Kinase In Complex Wi		1e-15
3dk6_A	293	Crystal Structure Of Mutant Abl Kinase Domain In Co		1e-15
1sm2_A	264	Crystal Structure Of The Phosphorylated Interleukin		1e-15
3t9t_A	267	Crystal Structure Of Btk Mutant (F435t,K596r) Compl		1e-15
1r0p_A	312	Crystal Structure Of The Tyrosine Kinase Domain Of		1e-15
4hct_A	269	Crystal Structure Of Itk In Complex With Compound 5		1e-15
3v5j_A	266	Crystal Structure Of Interleukin-2 Inducible T-Cell		1e-15
3cth_A	314	Crystal Structure Of The Tyrosine Kinase Domain Of		1e-15
3a4p_A	319	Human C-Met Kinase Domain Complexed With 6-Benzylox		1e-15
3dkc_A	317	Sgx Clone 5698a65kfg1h1 Length = 317		1e-15
3qti_A	314	C-Met Kinase In Complex With Nvp-Bvu972 Length = 31		1e-15
2r4b_A	321	Erbb4 Kinase Domain Complexed With A Thienopyrimidi		1e-15
3sxr_A	268	Crystal Structure Of Bmx Non-Receptor Tyrosine Kina		1e-15
3c1x_A	373	Crystal Structure Of The Tyrosine Kinase Domain Of		2e-15
3dkg_A	317	Sgx Clone 5698a109kfg1h1 Length = 317		2e-15
3qgw_A	286	Crystal Structure Of Itk Kinase Bound To An Inhibit		2e-15
1opl_A	537	Structural Basis For The Auto-Inhibition Of C-Abl T		2e-15
2fo0_A	495	Organization Of The Sh3-Sh2 Unit In Active And Inac		3e-15
3gvu_A	292	The Crystal Structure Of Human Abl2 In Complex With		6e-15
3pp0_A	338	Crystal Structure Of The Kinase Domain Of Human Her		7e-15
3miy_A	266	X-Ray Crystal Structure Of Itk Complexed With Sunit		9e-15
4f0f_A	287	Crystal Structure Of The Roco4 Kinase Domain Bound		1e-14
2eva_A	307	Structural Basis For The Interaction Of Tak1 Kinase		3e-14
4gs6_A	315	Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxoz		3e-14
3dqw_A	286	C-Src Kinase Domain Thr338ile Mutant In Complex Wit		5e-14
3u4w_A	275	Src In Complex With Dna-Templated Macrocyclic Inhib		5e-14
2hwo_A	286	Crystal Structure Of Src Kinase Domain In Complex W		5e-14
3oez_A	286	Crystal Structure Of The L317i Mutant Of The Chicke		6e-14
3svv_A	286	Crystal Structure Of T338c C-Src Covalently Bound T		6e-14
2oiq_A	286	Crystal Structure Of Chicken C-Src Kinase Domain In		6e-14
3d7u_B	277	Structural Basis For The Recognition Of C-Src By It		6e-14
2qq7_A	286	Crystal Structure Of Drug Resistant Src Kinase Doma		6e-14
4f1o_A	287	Crystal Structure Of The L1180t Mutant Roco4 Kinase		6e-14
3g6h_A	286	Src Thr338ile Inhibited In The Dfg-Asp-Out Conforma		7e-14
4f1m_A	287	Crystal Structure Of The G1179s Roco4 Kinase Domain		7e-14
1yoj_A	283	Crystal Structure Of Src Kinase Domain Length = 283		8e-14
1yi6_A	276	C-Term Tail Segment Of Human Tyrosine Kinase (258-5		9e-14
1yol_A	283	Crystal Structure Of Src Kinase Domain In Complex W		1e-13
1ksw_A	452	Structure Of Human C-Src Tyrosine Kinase (Thr338gly		1e-13
1y57_A	452	Structure Of Unphosphorylated C-Src In Complex With		1e-13
1fmk_A	452	Crystal Structure Of Human Tyrosine-Protein Kinase		1e-13
3geq_A	286	Structural Basis For The Chemical Rescue Of Src Kin		1e-13
2bdf_A	279	Src Kinase In Complex With Inhibitor Ap23451 Length		1e-13
2h8h_A	535	Src Kinase In Complex With A Quinazoline Inhibitor		1e-13
2ptk_A	453	Chicken Src Tyrosine Kinase Length = 453		2e-13
4hjo_A	337	Crystal Structure Of The Inactive Egfr Tyrosine Kin		3e-13
1m14_A	333	Tyrosine Kinase Domain From Epidermal Growth Factor		4e-13
2j5e_A	327	Crystal Structure Of Egfr Kinase Domain In Complex		4e-13
3bel_A	315	X-Ray Structure Of Egfr In Complex With Oxime Inhib		4e-13
2j5f_A	327	Crystal Structure Of Egfr Kinase Domain In Complex		4e-13
2gs7_A	330	Crystal Structure Of The Inactive Egfr Kinase Domai		4e-13
1xkk_A	352	Egfr Kinase Domain Complexed With A Quinazoline Inh		4e-13
4i23_A	329	Crystal Structure Of The Wild-type Egfr Kinase Doma		4e-13
4g5j_A	330	Crystal Structure Of Egfr Kinase In Complex With Bi		5e-13
2gs2_A	330	Crystal Structure Of The Active Egfr Kinase Domain		5e-13
3vjo_A	334	Crystal Structure Of The Wild-Type Egfr Kinase Doma		5e-13
3lzb_A	327	Egfr Kinase Domain Complexed With An Imidazo[2,1-B]		5e-13
3gop_A	361	Crystal Structure Of The Egf Receptor Juxtamembrane		7e-13
2jiv_A	328	Crystal Structure Of Egfr Kinase Domain T790m Mutat		7e-13
2jiu_A	328	Crystal Structure Of Egfr Kinase Domain T790m Mutat		7e-13
3ika_A	331	Crystal Structure Of Egfr 696-1022 T790m Mutant Cov		7e-13
2jit_A	327	Crystal Structure Of Egfr Kinase Domain T790m Mutat		7e-13
4i24_A	329	Structure Of T790m Egfr Kinase Domain Co-crystalliz		8e-13
4g5p_A	330	Crystal Structure Of Egfr Kinase T790m In Complex W		8e-13
2rfd_A	324	Crystal Structure Of The Complex Between The Egfr K		8e-13
3dtc_A	271	Crystal Structure Of Mixed-Lineage Kinase Mlk1 Comp		2e-12
2itn_A	327	Crystal Structure Of Egfr Kinase Domain G719s Mutat		2e-12
3a4o_X	286	Lyn Kinase Domain Length = 286		2e-12
2eb2_A	334	Crystal Structure Of Mutated Egfr Kinase Domain (G7		2e-12
2pvf_A	334	Crystal Structure Of Tyrosine Phosphorylated Activa		2e-12
4i20_A	329	Crystal Structure Of Monomeric (v948r) Primary Onco		2e-12
3cly_A	334	Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase		2e-12
2itt_A	327	Crystal Structure Of Egfr Kinase Domain L858r Mutat		3e-12
2eb3_A	334	Crystal Structure Of Mutated Egfr Kinase Domain (L8		3e-12
2pz5_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		3e-12
3k54_A	283	Structures Of Human Bruton's Tyrosine Kinase In Act		4e-12
4i1z_A	329	Crystal Structure Of The Monomeric (v948r) Form Of		4e-12
4i21_A	329	Crystal Structure Of L858r + T790m Egfr Kinase Doma		4e-12
3w2o_A	331	Egfr Kinase Domain T790m/l858r Mutant With Tak-285		4e-12
2pwl_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		4e-12
3ug1_A	334	Crystal Structure Of The Mutated Egfr Kinase Domain		5e-12
2q0b_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		5e-12
2pvy_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		5e-12
3gen_A	283	The 1.6 A Crystal Structure Of Human Bruton's Tyros		6e-12
2pzp_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		6e-12
2py3_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		6e-12
3pix_A	274	Crystal Structure Of Btk Kinase Domain Complexed Wi		7e-12
2pzr_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		1e-11
1f3m_C	297	Crystal Structure Of Human SerineTHREONINE KINASE P		1e-11
2psq_A	370	Crystal Structure Of Unphosphorylated Unactivated W		1e-11
4eqm_A	294	Structural Analysis Of Staphylococcus Aureus Serine		1e-11
1yhv_A	297	Crystal Structure Of Pak1 Kinase Domain With Two Po		1e-11
3b2t_A	311	Structure Of Phosphotransferase Length = 311		2e-11
3ri1_A	313	Crystal Structure Of The Catalytic Domain Of Fgfr2		2e-11
3fxz_A	297	Crystal Structure Of Pak1 Kinase Domain With Ruthen		2e-11
3q52_A	306	Structure Of Phosphorylated Pak1 Kinase Domain Leng		2e-11
2zv7_A	279	Lyn Tyrosine Kinase Domain, Apo Form Length = 279		2e-11
1gjo_A	316	The Fgfr2 Tyrosine Kinase Domain Length = 316		2e-11
2zm1_A	285	Crystal Structure Of Imidazo Pyrazin 1 Bound To The		2e-11
3kxz_A	287	The Complex Crystal Structure Of Lck With A Probe M		2e-11
3kmm_A	288	Structure Of Human Lck Kinase With A Small Molecule		2e-11
3cd3_A	377	Crystal Structure Of Phosphorylated Human Feline Sa		2e-11
2qkr_A	313	Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5		2e-11
3niz_A	311	Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5		2e-11
3bkb_A	377	Crystal Structure Of Human Feline Sarcoma Viral Onc		3e-11
3p08_A	267	Crystal Structure Of The Human Btk Kinase Domain Le		3e-11
1qpe_A	279	Structural Analysis Of The Lymphocyte-Specific Kina		3e-11
1k2p_A	263	Crystal Structure Of Bruton's Tyrosine Kinase Domai		3e-11
2ofu_A	273	X-Ray Crystal Structure Of 2-Aminopyrimidine Carbam		3e-11
2pl0_A	289	Lck Bound To Imatinib Length = 289		3e-11
3ocs_A	271	Crystal Structure Of Bruton's Tyrosine Kinase In Co		3e-11
3bys_A	277	Co-Crystal Structure Of Lck And Aminopyrimidine Ami		3e-11
3bym_A	272	X-Ray Co-Crystal Structure Aminobenzimidazole Triaz		4e-11
2ofv_A	277	Crystal Structure Of Aminoquinazoline 1 Bound To Lc		4e-11
3lck_A	271	The Kinase Domain Of Human Lymphocyte Kinase (Lck),		4e-11
3oct_A	265	Crystal Structure Of Bruton's Tyrosine Kinase Mutan		4e-11
3pls_A	298	Ron In Complex With Ligand Amp-Pnp Length = 298		5e-11
2of2_A	271	Crystal Structure Of Furanopyrimidine 8 Bound To Lc		5e-11
2og8_A	265	Crystal Structure Of Aminoquinazoline 36 Bound To L		7e-11
2z7q_A	321	Crystal Structure Of The N-Terminal Kinase Domain O		7e-11
1qpd_A	279	Structural Analysis Of The Lymphocyte-specific Kina		9e-11
3q4z_A	306	Structure Of Unphosphorylated Pak1 Kinase Domain Le		1e-10
1zyc_A	303	Crystal Structure Of Eif2alpha Protein Kinase Gcn2:		1e-10
2dq7_X	283	Crystal Structure Of Fyn Kinase Domain Complexed Wi		1e-10
1zy4_A	303	Crystal Structure Of Eif2alpha Protein Kinase Gcn2:		2e-10
3gqi_A	326	Crystal Structure Of Activated Receptor Tyrosine Ki		2e-10
2w9f_B	306	Crystal Structure Of Cdk4 In Complex With A D-Type		2e-10
2c30_A	321	Crystal Structure Of The Human P21-Activated Kinase		2e-10
1bi8_A	326	Mechanism Of G1 Cyclin Dependent Kinase Inhibition		2e-10
2p0c_A	313	Catalytic Domain Of The Proto-Oncogene Tyrosine-Pro		2e-10
2w99_B	306	Crystal Structure Of Cdk4 In Complex With A D-Type		2e-10
3c4f_A	302	Fgfr Tyrosine Kinase Domain In Complex With 3-(3- M		2e-10
1jow_B	308	Crystal Structure Of A Complex Of Human Cdk6 And A		2e-10
3pwy_A	311	Crystal Structure Of An Extender (Spd28345)-Modifie		3e-10
3rhx_B	306	Crystal Structure Of The Catalytic Domain Of Fgfr1		3e-10
3mpm_A	267	Lck Complexed With A Pyrazolopyrimidine Length = 26		3e-10
3nup_A	307	Cdk6 (Monomeric) In Complex With Inhibitor Length =		3e-10
3kxx_A	317	Structure Of The Mutant Fibroblast Growth Factor Re		3e-10
1fgk_A	310	Crystal Structure Of The Tyrosine Kinase Domain Of		3e-10
4f63_A	309	Crystal Structure Of Human Fibroblast Growth Factor		3e-10
3com_A	314	Crystal Structure Of Mst1 Kinase Length = 314		3e-10
1gz8_A	299	Human Cyclin Dependent Kinase 2 Complexed With The		3e-10
1gii_A	298	Human Cyclin Dependent Kinase 2 Complexed With The		3e-10
3js2_A	317	Crystal Structure Of Minimal Kinase Domain Of Fibro		3e-10
4erw_A	306	Cdk2 In Complex With Staurosporine Length = 306		3e-10
2x7f_A	326	Crystal Structure Of The Kinase Domain Of Human Tra		3e-10
3gql_A	326	Crystal Structure Of Activated Receptor Tyrosine Ki		3e-10
2w96_B	306	Crystal Structure Of Cdk4 In Complex With A D-Type		3e-10
3g51_A	325	Structural Diversity Of The Active Conformation Of		4e-10
4fr4_A	384	Crystal Structure Of Human SerineTHREONINE-Protein		4e-10
3tt0_A	382	Co-Structure Of Fibroblast Growth Factor Receptor 1		4e-10
1h1w_A	289	High Resolution Crystal Structure Of The Human Pdk1		5e-10
4el9_A	305	Structure Of N-Terminal Kinase Domain Of Rsk2 With		5e-10
3ubd_A	304	Structure Of N-Terminal Domain Of Rsk2 Kinase In Co		5e-10
1oit_A	299	Imidazopyridines: A Potent And Selective Class Of C		6e-10
1pf8_A	298	Crystal Structure Of Human Cyclin-dependent Kinase		6e-10
2hk5_A	270	Hck Kinase In Complex With Lck Targetted Inhibitor		6e-10
4a07_A	311	Human Pdk1 Kinase Domain In Complex With Allosteric		6e-10
2w17_A	299	Cdk2 In Complex With The Imidazole Pyrimidine Amide		6e-10
1fin_A	298	Cyclin A-Cyclin-Dependent Kinase 2 Complex Length =		6e-10
1vyw_A	309	Structure Of Cdk2CYCLIN A WITH PNU-292137 Length =		6e-10
1uu9_A	286	Structure Of Human Pdk1 Kinase Domain In Complex Wi		6e-10
3pxf_A	306	Cdk2 In Complex With Two Molecules Of 8-Anilino-1-N		6e-10
1mqb_A	333	Crystal Structure Of Ephrin A2 (Epha2) Receptor Pro		7e-10
3pj8_A	299	Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]		7e-10
3nus_A	286	Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fra		7e-10
1z5m_A	286	Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrr		7e-10
3ezr_A	300	Cdk-2 With Indazole Inhibitor 17 Bound At Its Activ		7e-10
1qcf_A	454	Crystal Structure Of Hck In Complex With A Src Fami		7e-10
2baq_A	365	P38alpha Bound To Ro3201195 Length = 365		1e-09
4gt4_A	308	Structure Of Unliganded, Inactive Ror2 Kinase Domai		1e-09
2biy_A	310	Structure Of Pdk1-S241a Mutant Kinase Domain Length		1e-09
3d83_A	360	Crystal Structure Of P38 Kinase In Complex With A B		1e-09
1oir_A	299	Imidazopyridines: A Potent And Selective Class Of C		1e-09
1h01_A	298	Cdk2 In Complex With A Disubstituted 2, 4-Bis Anili		1e-09
2bal_A	365	P38alpha Map Kinase Bound To Pyrazoloamine Length =		1e-09
3orx_A	316	Pdk1 Mutant Bound To Allosteric Disulfide Fragment		1e-09
3e92_A	371	Crystal Structure Of P38 Kinase In Complex With A B		1e-09
2iw6_A	302	Structure Of Human Thr160-Phospho Cdk2-Cyclin A Com		1e-09
2r7b_A	312	Crystal Structure Of The Phosphoinositide-Dependent		2e-09
2j7t_A	302	Crystal Structure Of Human Serine Threonine Kinase-		2e-09
2y8o_A	362	Crystal Structure Of Human P38alpha Complexed With		2e-09
1ove_A	366	The Structure Of P38 Alpha In Complex With A Dihydr		2e-09
2oza_B	366	Structure Of P38alpha Complex Length = 366		2e-09
3oht_A	389	Crystal Structure Of Salmo Salar P38alpha Length =		2e-09
3nax_A	311	Pdk1 In Complex With Inhibitor Mp7 Length = 311		2e-09
3p4k_A	370	The Third Conformation Of P38a Map Kinase Observed		2e-09
1lew_A	360	Crystal Structure Of Map Kinase P38 Complexed To Th		2e-09
4bc6_A	293	Crystal Structure Of Human Serine Threonine Kinase-		2e-09
3c4x_A	543	Crystal Structure Of G Protein Coupled Receptor Kin		2e-09
3zzw_A	289	Crystal Structure Of The Kinase Domain Of Ror2 Leng		2e-09
3c4w_A	543	Crystal Structure Of G Protein Coupled Receptor Kin		2e-09
3t8o_A	543	Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolu		2e-09
3nnx_A	354	Crystal Structure Of Phosphorylated P38 Alpha In Co		2e-09
2gtm_A	348	Mutated Mouse P38 Map Kinase Domain In Complex With		2e-09
2xck_A	309	Crystal Structure Of Pdk1 In Complex With A Pyrazol		2e-09
3rwp_A	311	Discovery Of A Novel, Potent And Selective Inhibito		2e-09
3sc1_A	311	Novel Isoquinolone Pdk1 Inhibitors Discovered Throu		2e-09
3h9o_A	311	Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1)		2e-09
1uu3_A	310	Structure Of Human Pdk1 Kinase Domain In Complex Wi		2e-09
2xch_A	309	Crystal Structure Of Pdk1 In Complex With A Pyrazol		2e-09
3qc9_A	543	Crystal Structure Of Cross-Linked Bovine Grk1 T8cN4		2e-09
3iop_A	312	Pdk-1 In Complex With The Inhibitor Compound-8i Len		2e-09
2rei_A	318	Kinase Domain Of Human Ephrin Type-a Receptor 7 (ep		2e-09
3mtl_A	324	Crystal Structure Of The Pctaire1 Kinase In Complex		2e-09
3qc4_A	314	Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length =		2e-09
3hrc_A	311	Crystal Structure Of A Mutant Of Human Pdk1 Kinase		2e-09
3nun_A	292	Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lea		2e-09
3lij_A	494	Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820)		2e-09
1w98_A	298	The Structural Basis Of Cdk2 Activation By Cyclin E		2e-09
3nay_A	311	Pdk1 In Complex With Inhibitor Mp6 Length = 311		2e-09
2puu_A	348	Crystal Structure Of P38 Complex With 1-(5-Tert-But		2e-09
3ody_X	360	Crystal Structure Of P38alpha Y323q Active Mutant L		2e-09
3od6_X	360	Crystal Structure Of P38alpha Y323t Active Mutant L		2e-09
1jst_A	298	Phosphorylated Cyclin-Dependent Kinase-2 Bound To C		2e-09
4i3z_A	296	Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNES		2e-09
1qmz_A	299	Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Com		2e-09
2jgz_A	289	Crystal Structure Of Phospho-Cdk2 In Complex With C		2e-09
1bmk_A	379	The Complex Structure Of The Map Kinase P38SB218655		2e-09
1ian_A	366	Human P38 Map Kinase Inhibitor Complex Length = 366		2e-09
2wqm_A	310	Structure Of Apo Human Nek7 Length = 310		2e-09
3odz_X	360	Crystal Structure Of P38alpha Y323r Active Mutant L		3e-09
2baj_A	365	P38alpha Bound To Pyrazolourea Length = 365		3e-09
3tg1_A	380	Crystal Structure Of P38alpha In Complex With A Map		3e-09
3hrb_A	359	P38 Kinase Crystal Structure In Complex With Small		3e-09
2npq_A	367	A Novel Lipid Binding Site In The P38 Alpha Map Kin		3e-09
2oo8_X	317	Synthesis, Structural Analysis, And Sar Studies Of		3e-09
1e9h_A	297	Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex		3e-09
4eos_A	300	Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co		3e-09
1di9_A	360	The Structure Of P38 Mitogen-Activated Protein Kina		3e-09
4e5a_X	360	The W197a Mutant Of P38a Map Kinase Length = 360		3e-09
3oef_X	360	Crystal Structure Of Y323f Inactive Mutant Of P38al		3e-09
2lgc_A	359	Joint Nmr And X-Ray Refinement Reveals The Structur		3e-09
3d7z_A	360	Crystal Structure Of P38 Kinase In Complex With A B		3e-09
3s3i_A	349	P38 Kinase Crystal Structure In Complex With Small		3e-09
3qhr_A	298	Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic		3e-09
1zzl_A	351	Crystal Structure Of P38 With Triazolopyridine Leng		3e-09
1m7q_A	366	Crystal Structure Of P38 Map Kinase In Complex With		3e-09
3gcu_A	360	Human P38 Map Kinase In Complex With Rl48 Length =		3e-09
3k3j_A	362	P38alpha Bound To Novel Dfg-Out Compound Pf-0041612		3e-09
3hec_A	348	P38 In Complex With Imatinib Length = 348		3e-09
3nnu_A	354	Crystal Structure Of P38 Alpha In Complex With Dp13		3e-09
3hvc_A	362	Crystal Structure Of Human P38alpha Map Kinase Leng		3e-09
1fvr_A	327	Tie2 Kinase Domain Length = 327		3e-09
1ogu_A	302	Structure Of Human Thr160-phospho Cdk2/cyclin A Com		3e-09
4eoq_A	301	Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co		3e-09
4bcq_A	301	Structure Of Cdk2 In Complex With Cyclin A And A 2-		3e-09
3bht_A	300	Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN		3e-09
3zsg_A	362	X-Ray Structure Of P38alpha Bound To Tak-715 Length		3e-09
2iw8_A	302	Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82		3e-09
1h1p_A	303	Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMP		3e-09
3fi4_A	372	P38 Kinase Crystal Structure In Complex With Ro4499		3e-09
2acx_A	576	Crystal Structure Of G Protein Coupled Receptor Kin		3e-09
3k3i_A	350	P38alpha Bound To Novel Dgf-Out Compound Pf-0021595		3e-09
4eop_A	300	Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3		3e-09
4eoj_A	302	Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma		3e-09
1oz1_A	372	P38 Mitogen-Activated Kinase In Complex With 4-Azai		3e-09
2gfs_A	372	P38 Kinase Crystal Structure In Complex With Ro3201		3e-09
4eom_A	301	Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum		3e-09
3mpt_A	371	Crystal Structure Of P38 Kinase In Complex With A P		3e-09
3kq7_A	380	Structure Of Human P38alpha With N-[4-Methyl-3-(6-{		3e-09
4eon_A	300	Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum		3e-09
2fst_X	367	Mitogen Activated Protein Kinase P38alpha (d176a+f3		3e-09
4eoo_A	299	Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3		3e-09
3nyn_A	576	Crystal Structure Of G Protein-Coupled Receptor Kin		4e-09
1bl6_A	379	The Complex Structure Of The Map Kinase P38SB216995		4e-09
2fsl_X	367	Mitogen Activated Protein Kinase P38alpha (D176a+f3		4e-09
1zxe_A	303	Crystal Structure Of Eif2alpha Protein Kinase Gcn2:		4e-09
3dt1_A	383	P38 Complexed With A Quinazoline Inhibitor Length =		4e-09
4eok_A	300	Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma		4e-09
3is5_A	285	Crystal Structure Of Cdpk Kinase Domain From Toxopl		4e-09
2fso_X	367	Mitogen Activated Protein Kinase P38alpha (D176a) A		4e-09
1k9a_A	450	Crystal Structure Analysis Of Full-Length Carboxyl-		4e-09
3d7u_A	263	Structural Basis For The Recognition Of C-Src By It		4e-09
2j51_A	325	Crystal Structure Of Human Ste20-Like Kinase Bound		4e-09
4eoi_A	299	Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyc		4e-09
3hng_A	360	Crystal Structure Of Vegfr1 In Complex With N-(4-ch		4e-09
3cjf_A	309	Crystal Structure Of Vegfr2 In Complex With A 3,4,5		5e-09
2jfm_A	325	Crystal Structure Of Human Ste20-Like Kinase (Unlig		5e-09
1u5q_A	348	Crystal Structure Of The Tao2 Kinase Domain: Activa		5e-09
1byg_A	278	Kinase Domain Of Human C-Terminal Src Kinase (Csk)		5e-09
3mh2_A	360	Mutagenesis Of P38 Map Kinase Establishes Key Roles		6e-09
1ad5_A	438	Src Family Kinase Hck-Amp-Pnp Complex Length = 438		6e-09
2gcd_A	309	Tao2 Kinase Domain-Staurosporine Structure Length =		6e-09
2jc6_A	334	Crystal Structure Of Human Calmodulin-Dependent Pro		6e-09
2wei_A	287	Crystal Structure Of The Kinase Domain Of Cryptospo		6e-09
3dfa_A	286	Crystal Structure Of Kinase Domain Of Calcium-depen		7e-09
1ywr_A	360	Crystal Structure Analysis Of Inactive P38 Kinase D		7e-09
3py3_A	380	Crystal Structure Of Phosphorylated P38alpha Map Ki		7e-09
1yw2_A	360	Mutated Mus Musculus P38 Kinase (Mp38) Length = 360		7e-09
3lmg_A	344	Crystal Structure Of The Erbb3 Kinase Domain In Com		7e-09
2ghl_A	348	Mutant Mus Musculus P38 Kinase Domain In Complex Wi		8e-09
3d7t_A	269	Structural Basis For The Recognition Of C-Src By It		8e-09
3c7q_A	316	Structure Of Vegfr2 Kinase Domain In Complex With B		9e-09
3kex_A	325	Crystal Structure Of The Catalytically Inactive Kin		9e-09
3g33_A	308	Crystal Structure Of Cdk4CYCLIN D3 Length = 308		1e-08
3igo_A	486	Crystal Structure Of Cryptosporidium Parvum Cdpk1,		1e-08
2wqb_A	324	Structure Of The Tie2 Kinase Domain In Complex With		1e-08
3gcp_A	360	Human P38 Map Kinase In Complex With Sb203580 Lengt		1e-08
3cjg_A	309	Crystal Structure Of Vegfr2 In Complex With A 3,4,5		1e-08
4ewq_A	383	Human P38 Alpha Mapk In Complex With A Pyridazine B		1e-08
3gp0_A	348	Crystal Structure Of Human Mitogen Activated Protei		1e-08
3qd2_B	332	Crsytal Structure Of Mouse Perk Kinase Domain Lengt		1e-08
3gc8_A	370	The Structure Of P38beta C162s In Complex With A Di		1e-08
3gi3_A	360	Crystal Structure Of A N-Phenyl-N'-Naphthylurea Ana		1e-08
2z8c_A	303	Phosphorylated Insulin Receptor Tyrosine Kinase In		2e-08
2jfl_A	325	Crystal Structure Of Human Ste20-Like Kinase ( Diph		2e-08
1ir3_A	306	Phosphorylated Insulin Receptor Tyrosine Kinase In		2e-08
1rqq_A	306	Crystal Structure Of The Insulin Receptor Kinase In		2e-08
3rvg_A	303	Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido		2e-08
2b7a_A	293	The Structural Basis Of Janus Kinase 2 Inhibition B		2e-08
2xa4_A	298	Inhibitors Of Jak2 Kinase Domain Length = 298		2e-08
4hge_A	300	Jak2 Kinase (Jh1 Domain) In Complex With Compound 8		2e-08
3e62_A	293	Fragment Based Discovery Of Jak-2 Inhibitors Length		2e-08
4e6d_A	298	Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex W		2e-08
1u59_A	287	Crystal Structure Of The Zap-70 Kinase Domain In Co		2e-08
3q32_A	301	Structure Of Janus Kinase 2 With A Pyrrolotriazine		2e-08
4aqc_A	301	Triazolopyridine-Based Inhibitor Of Janus Kinase 2		2e-08
3tjc_A	298	Co-Crystal Structure Of Jak2 With Thienopyridine 8		2e-08
1omw_A	689	Crystal Structure Of The Complex Between G Protein-		2e-08
3psc_A	695	Bovine Grk2 In Complex With Gbetagamma Subunits Len		2e-08
2buj_A	317	Crystal Structure Of The Human Serine-Threonine Kin		2e-08
2w1i_A	326	Structure Determination Of Aurora Kinase In Complex		2e-08
4e4m_A	302	Jak2 Kinase (Jh1 Domain) In Complex With Compound 3		2e-08
3krw_A	688	Human Grk2 In Complex With Gbetgamma Subunits And B		2e-08
3cik_A	689	Human Grk2 In Complex With Gbetagamma Subunits Leng		2e-08
3lpb_A	295	Crystal Structure Of Jak2 Complexed With A Potent 2		2e-08
3jy9_A	311	Janus Kinase 2 Inhibitors Length = 311		2e-08
1i44_A	306	Crystallographic Studies Of An Activation Loop Muta		2e-08
3gc9_A	370	The Structure Of P38beta C119s, C162s In Complex Wi		2e-08
3io7_A	313	2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Sel		3e-08
3hzt_A	467	Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme4		3e-08
3dxn_A	287	Crystal Structure Of The Calcium-dependent Kinase F		3e-08
2f57_A	317	Crystal Structure Of The Human P21-activated Kinase		3e-08
3o8p_A	360	Conformational Plasticity Of P38 Map Kinase Dfg Mot		3e-08
3f69_A	311	Crystal Structure Of The Mycobacterium Tuberculosis		3e-08
3mh0_A	360	Mutagenesis Of P38 Map Kinase Eshtablishes Key Role		3e-08
3ugc_A	295	Structural Basis Of Jak2 Inhibition By The Type Ii		3e-08
2qok_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		3e-08
4fob_A	353	Crystal Structure Of Human Anaplastic Lymphoma Kina		3e-08
1ywn_A	316	Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]p		3e-08
3say_A	430	Crystal Structure Of Human Glycogen Synthase Kinase		3e-08
3q4t_A	322	Crystal Structure Of Activin Receptor Type-Iia (Acv		3e-08
4b99_A	398	Crystal Structure Of Mapk7 (Erk5) With Inhibitor Le		3e-08
3mh3_A	360	Mutagenesis Of P38 Map Kinase Establishes Key Roles		3e-08
4g31_A	299	Crystal Structure Of Gsk6414 Bound To Perk (R587-R1		3e-08
1i09_A	420	Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Len		3e-08
4ic7_A	442	Crystal Structure Of The Erk5 Kinase Domain In Comp		3e-08
4afj_A	367	5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selec		3e-08
3f61_A	311	Crystal Structure Of M. Tuberculosis Pknb Leu33aspV		3e-08
1q5k_A	414	Crystal Structure Of Glycogen Synthase Kinase 3 In		3e-08
1v0o_A	288	Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulpho		3e-08
3f88_A	349	Glycogen Synthase Kinase 3beta Inhibitor Complex Le		3e-08
2p2h_A	314	Crystal Structure Of The Vegfr2 Kinase Domain In Co		3e-08
3ori_A	311	Mycobacterium Tuberculosis Pknb Kinase Domain L33d		3e-08
1v0b_A	288	Crystal Structure Of The T198a Mutant Of Pfpk5 Leng		3e-08
1gng_A	378	Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With		3e-08
1pyx_A	422	Gsk-3 Beta Complexed With Amp-Pnp Length = 422		3e-08
4fsz_A	279	Crystal Structure Of The Chk1 Length = 279		3e-08
2p2i_A	314	Crystal Structure Of The Vegfr2 Kinase Domain In Co		4e-08
3f7z_A	350	X-ray Co-crystal Structure Of Glycogen Synthase Kin		4e-08
3zdi_A	350	Glycogen Synthase Kinase 3 Beta Complexed With Axin		4e-08
4apc_A	350	Crystal Structure Of Human Nima-Related Kinase 1 (N		4e-08
3zrk_A	371	Identification Of 2-(4-Pyridyl)thienopyridinones As		4e-08
2oh4_A	316	Crystal Structure Of Vegfr2 With A Benzimidazole-Ur		4e-08
1ob3_A	288	Structure Of P. Falciparum Pfpk5 Length = 288		4e-08
2ydj_A	276	Discovery Of Checkpoint Kinase Inhibitor Azd7762 By		4e-08
2ow3_A	352	Glycogen Synthase Kinase-3 Beta In Complex With Bis		4e-08
1q3d_A	424	Gsk-3 Beta Complexed With Staurosporine Length = 42		4e-08
4dit_A	382	Crystal Structure Of Gsk3beta In Complex With A Imi		4e-08
2o5k_A	372	Crystal Structure Of Gsk3beta In Complex With A Ben		4e-08
1irk_A	306	Crystal Structure Of The Tyrosine Kinase Domain Of		4e-08
3u6j_A	314	Crystal Structure Of The Vegfr2 Kinase Domain In Co		4e-08
3sd0_A	350	Identification Of A Glycogen Synthase Kinase-3b Inh		4e-08
4acc_A	465	Gsk3b In Complex With Inhibitor Length = 465		4e-08
2xir_A	316	Crystal Structure Of The Vegfr2 Kinase Domain In Co		4e-08
1vr2_A	316	Human Vascular Endothelial Growth Factor Receptor 2		4e-08
1r0e_A	391	Glycogen Synthase Kinase-3 Beta In Complex With 3-I		4e-08
1jpa_A	312	Crystal Structure Of Unphosphorylated Ephb2 Recepto		4e-08
3ewh_A	314	Crystal Structure Of The Vegfr2 Kinase Domain In Co		5e-08
3coi_A	353	Crystal Structure Of P38delta Kinase Length = 353		5e-08
3gb2_A	353	Gsk3beta Inhibitor Complex Length = 353		5e-08
3mh1_A	360	Mutagenesis Of P38 Map Kinase Establishes Key Roles		5e-08
4aw5_A	291	Complex Of The Ephb4 Kinase Domain With An Oxindole		5e-08
2qoo_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		5e-08
2j0l_A	276	Crystal Structure Of A The Active Conformation Of T		5e-08
1o9u_A	350	Glycogen Synthase Kinase 3 Beta Complexed With Axin		5e-08
4fsw_A	279	Crystal Structure Of The Chk1 Length = 279		6e-08
1h8f_A	352	Glycogen Synthase Kinase 3 Beta. Length = 352		6e-08
3eta_A	317	Kinase Domain Of Insulin Receptor Complexed With A		6e-08
1uv5_A	350	Glycogen Synthase Kinase 3 Beta Complexed With 6-Br		6e-08
2vwu_A	302	Ephb4 Kinase Domain Inhibitor Complex Length = 302		6e-08
2qon_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		6e-08
4agc_A	353	Crystal Structure Of Vegfr2 (Juxtamembrane And Kina		6e-08
2ozo_A	613	Autoinhibited Intact Human Zap-70 Length = 613		6e-08
4ft3_A	279	Crystal Structure Of The Chk1 Length = 279		6e-08
1fot_A	318	Structure Of The Unliganded Camp-Dependent Protein		6e-08
4fst_A	269	Crystal Structure Of The Chk1 Length = 269		6e-08
3g2f_A	336	Crystal Structure Of The Kinase Domain Of Bone Morp		6e-08
4fg9_A	320	Crystal Structure Of Human Calcium/calmodulin-depen		7e-08
4exu_A	371	Mapk13, Inactive Form Length = 371		7e-08
4fsy_A	279	Crystal Structure Of The Chk1 Length = 279		7e-08
3fxx_A	371	Human Epha3 Kinase And Juxtamembrane Region Bound T		7e-08
3qup_A	323	Inhibitor Bound Structure Of The Kinase Domain Of T		7e-08
3lvp_A	336	Crystal Structure Of Bisphosphorylated Igf1-R Kinas		7e-08
4fg8_A	315	Crystal Structure Of Human Calcium/calmodulin-depen		8e-08
2qoi_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		8e-08
2qof_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f		8e-08
2qod_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y602f		8e-08
2j0j_A	656	Crystal Structure Of A Fragment Of Focal Adhesion K		8e-08
2gsf_A	373	The Human Epha3 Receptor Tyrosine Kinase And Juxtam		8e-08
2qo7_A	373	Human Epha3 Kinase And Juxtamembrane Region, Dephos		8e-08
2ivt_A	314	Crystal Structure Of Phosphorylated Ret Tyrosine Ki		8e-08
4dce_A	333	Crystal Structure Of Human Anaplastic Lymphoma Kina		8e-08
3dzq_A	361	Human Epha3 Kinase Domain In Complex With Inhibitor		8e-08
2r2p_A	295	Kinase Domain Of Human Ephrin Type-A Receptor 5 (Ep		8e-08
3d5u_A	317	Crystal Structure Of A Wildtype Polo-Like Kinase 1		8e-08
4fg7_A	293	Crystal Structure Of Human Calcium/calmodulin-depen		8e-08
1a06_A	332	Calmodulin-Dependent Protein Kinase From Rat Length		8e-08
3i79_A	484	Calcium-Dependent Protein Kinase 1 From Toxoplasma		8e-08
3d5v_A	317	Crystal Structure Of An Activated (Thr->asp) Polo-L		8e-08
3aox_A	344	X-Ray Crystal Structure Of Human Anaplastic Lymphom		9e-08
3d5w_A	317	Crystal Structure Of A Phosphorylated Polo-Like Kin		9e-08
3vnt_A	318	Crystal Structure Of The Kinase Domain Of Human Veg		9e-08
2qob_A	344	Human Epha3 Kinase Domain, Base Structure Length =		9e-08
2ivs_A	314	Crystal Structure Of Non-Phosphorylated Ret Tyrosin		9e-08
2qoc_A	344	Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp		9e-08
2qol_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596:y		9e-08
4fsn_A	278	Crystal Structure Of The Chk1 Length = 278		9e-08
2x8e_A	276	Discovery Of A Novel Class Of Triazolones As Checkp		9e-08
2ghg_A	269	H-Chk1 Complexed With A431994 Length = 269		1e-07
2jkk_A	276	Focal Adhesion Kinase Catalytic Domain In Complex W		1e-07
2ayp_A	269	Crystal Structure Of Chk1 With An Indol Inhibitor L		1e-07
4fnw_A	327	Crystal Structure Of The Apo F1174l Anaplastic Lymp		1e-07
3ma6_A	298	Crystal Structure Of Kinase Domain Of Tgcdpk1 In Pr		1e-07
2e9v_A	268	Structure Of H-Chk1 Complexed With A859017 Length =		1e-07
3db6_A	301	Crystal Structure Of An Activated (Thr->asp) Polo-L		1e-07
4fsm_A	279	Crystal Structure Of The Chk1 Length = 279		1e-07
3aln_A	327	Crystal Structure Of Human Non-Phosphorylated Mkk4		1e-07
2pk9_A	317	Structure Of The Pho85-pho80 Cdk-cyclin Complex Of		1e-07
2yjr_A	342	Structure Of F1174l Mutant Anaplastic Lymphoma Kina		1e-07
2clq_A	295	Structure Of Mitogen-Activated Protein Kinase Kinas		1e-07
3jvr_A	271	Characterization Of The Chk1 Allosteric Inhibitor B		1e-07
3ot3_A	273	X-Ray Crystal Structure Of Compound 22k Bound To Hu		1e-07
1yvj_A	290	Crystal Structure Of The Jak3 Kinase Domain In Comp		1e-07
4bbe_A	298	Aminoalkylpyrimidine Inhibitor Complexes With Jak2		1e-07
1y6a_A	366	Crystal Structure Of Vegfr2 In Complex With A 2-Ani		1e-07
3vhk_A	368	Crystal Structure Of The Vegfr2 Kinase Domain In Co		1e-07
2br1_A	297	Structure-Based Design Of Novel Chk1 Inhibitors: In		1e-07
1ia8_A	289	The 1.7 A Crystal Structure Of Human Cell Cycle Che		1e-07
4fnz_A	327	Crystal Structure Of Human Anaplastic Lymphoma Kina		1e-07
1zlt_A	295	Crystal Structure Of Chk1 Complexed With A Hymenald		1e-07
2hog_A	322	Crystal Structure Of Chek1 In Complex With Inhibito		1e-07
3vhe_A	359	Crystal Structure Of Human Vegfr2 Kinase Domain Wit		1e-07
2r0u_A	323	Crystal Structure Of Chek1 In Complex With Inhibito		1e-07
2xp2_A	327	Structure Of The Human Anaplastic Lymphoma Kinase I		1e-07
1zys_A	273	Co-Crystal Structure Of Checkpoint Kinase Chk1 With		1e-07
3ku2_A	507	Crystal Structure Of Inactivated Form Of Cdpk1 From		1e-07
3vid_A	356	Crystal Structure Of Human Vegfr2 Kinase Domain Wit		1e-07
2yfx_A	327	Structure Of L1196m Mutant Anaplastic Lymphoma Kina		1e-07
4hzs_A	341	Crystal Structure Of Ack1 Kinase Domain With C-term		1e-07
2j0k_A	656	Crystal Structure Of A Fragment Of Focal Adhesion K		1e-07
4fnx_A	327	Crystal Structure Of The Apo R1275q Anaplastic Lymp		1e-07
3bz3_A	276	Crystal Structure Analysis Of Focal Adhesion Kinase		2e-07
2jkm_A	276	Focal Adhesion Kinase Catalytic Domain In Complex W		2e-07
2j0m_B	276	Crystal Structure A Two-Chain Complex Between The F		2e-07
4ewh_B	275	Co-Crystal Structure Of Ack1 With Inhibitor Length		2e-07
3l9p_A	367	Crystal Structure Of The Anaplastic Lymphoma Kinase		2e-07
4id7_A	273	Ack1 Kinase In Complex With The Inhibitor Cis-3-[8-		2e-07
2yhv_A	342	Structure Of L1196m Mutant Anaplastic Lymphoma Kina		2e-07
4hvd_A	314	Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h		2e-07
3eqp_B	276	Crystal Structure Of Ack1 With Compound T95 Length		2e-07
3lct_A	344	Crystal Structure Of The Anaplastic Lymphoma Kinase		2e-07
2yjs_A	342	Structure Of C1156y Mutant Anaplastic Lymphoma Kina		2e-07
3hx4_A	508	Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tg		2e-07
4ebw_A	304	Structure Of Focal Adhesion Kinase Catalytic Domain		2e-07
2etm_A	281	Crystal Structure Of Focal Adhesion Kinase Domain C		2e-07
3sa0_A	360	Complex Of Erk2 With Norathyriol Length = 360		2e-07
2xb7_A	315	Structure Of Human Anaplastic Lymphoma Kinase In Co		2e-07
3lxk_A	327	Structural And Thermodynamic Characterization Of Th		2e-07
1p14_A	306	Crystal Structure Of A Catalytic-Loop Mutant Of The		2e-07
3pjc_A	315	Crystal Structure Of Jak3 Complexed With A Potent A		2e-07
3pxk_A	282	Focal Adhesion Kinase Catalytic Domain In Complex W		2e-07
1u54_A	291	Crystal Structures Of The Phosphorylated And Unphos		2e-07
3vw6_A	269	Crystal Structure Of Human Apoptosis Signal-Regulat		2e-07
3lcd_A	329	Inhibitor Bound To A Dfg-In Structure Of The Kinase		2e-07
3ekk_A	307	Insulin Receptor Kinase Complexed With An Inhibitor		2e-07
1p4o_A	322	Structure Of Apo Unactivated Igf-1r Kinase Domain A		2e-07
3qbn_A	281	Structure Of Human Aurora A In Complex With A Diami		2e-07
2ivv_A	314	Crystal Structure Of Phosphorylated Ret Tyrosine Ki		2e-07
1u46_A	291	Crystal Structure Of The Unphosphorylated Kinase Do		2e-07
1m7n_A	322	Crystal Structure Of Unactivated Apo Insulin-Like G		2e-07
4hzr_A	277	Crystal Structure Of Ack1 Kinase Domain Length = 27		2e-07
1mp8_A	281	Crystal Structure Of Focal Adhesion Kinase (Fak) Le		2e-07
2ogv_A	317	Crystal Structure Of The Autoinhibited Human C-Fms		2e-07
4fsu_A	279	Crystal Structure Of The Chk1 Length = 279		2e-07
4e7w_A	394	Structure Of Gsk3 From Ustilago Maydis Length = 394		2e-07
4fux_A	360	Crystal Structure Of The Erk2 Complexed With E75 Le		2e-07
3qyw_A	364	Crystal Structure Of Erk2 In Complex With An Inhibi		3e-07
1k3a_A	299	Structure Of The Insulin-Like Growth Factor 1 Recep		3e-07
3kul_B	325	Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep		3e-07
4fie_A	423	Full-Length Human Pak4 Length = 423		3e-07
2zm3_A	308	Complex Structure Of Insulin-Like Growth Factor Rec		3e-07
2hel_A	306	Crystal Structure Of A Mutant Epha4 Kinase Domain (		3e-07
4fv7_A	360	Crystal Structure Of The Erk2 Complexed With E94 Le		3e-07
4gsb_A	364	Monoclinic Crystal Form Of The Apo-Erk2 Length = 36		3e-07
3kul_A	325	Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep		3e-07
2xik_A	294	Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related K		3e-07
2uv2_A	287	Crystal Structure Of Human Ste20-Like Kinase Bound		3e-07
1pme_A	380	Structure Of Penta Mutant Human Erk2 Map Kinase Com		3e-07
1ua2_A	346	Crystal Structure Of Human Cdk7 Length = 346		3e-07
2zoq_A	382	Structural Dissection Of Human Mitogen-Activated Ki		3e-07
2y6m_A	291	Crystal Structure Of Epha4 Kinase Domain Length = 2		3e-07
3rzf_A	677	Crystal Structure Of Inhibitor Of Kappab Kinase Bet		3e-07
3qa8_A	676	Crystal Structure Of Inhibitor Of Kappa B Kinase Be		3e-07
2a19_B	284	Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Leng		4e-07
4aaa_A	331	Crystal Structure Of The Human Cdkl2 Kinase Domain		4e-07
2jdo_A	342	Structure Of Pkb-Beta (Akt2) Complexed With Isoquin		4e-07
2yac_A	311	Crystal Structure Of Polo-Like Kinase 1 In Complex		4e-07
3thb_A	333	Structure Of Plk1 Kinase Domain In Complex With A B		4e-07
2y4i_B	319	Ksr2-Mek1 Heterodimer Length = 319		4e-07
2ou7_A	335	Structure Of The Catalytic Domain Of Human Polo-Lik		4e-07
2hen_A	286	Crystal Structure Of The Ephb2 Receptor Kinase Doma		4e-07
4h3q_A	362	Crystal Structure Of Human Erk2 Complexed With A Ma		4e-07
3kb7_A	311	Crystal Structure Of Polo-Like Kinase 1 In Complex		4e-07
2xyu_A	285	Crystal Structure Of Epha4 Kinase Domain In Complex		4e-07
2q0n_A	301	Structure Of Human P21 Activating Kinase 4 (Pak4) I		4e-07
2v5q_A	315	Crystal Structure Of Wild-type Plk-1 Kinase Domain		4e-07
2cdz_A	303	Crystal Structure Of The Human P21-Activated Kinase		4e-07
3uiu_A	306	Crystal Structure Of Apo-Pkr Kinase Domain Length =		4e-07
3fe3_A	328	Crystal Structure Of The Kinase Mark3PAR-1: T211a-S		5e-07
2gph_A	364	Docking Motif Interactions In The Map Kinase Erk2 L		5e-07
2rku_A	294	Structure Of Plk1 In Complex With Bi2536 Length = 2		5e-07
2bva_A	292	Crystal Structure Of The Human P21-Activated Kinase		5e-07
3tei_A	362	Crystal Structure Of Human Erk2 Complexed With A Ma		5e-07
1wzy_A	368	Crystal Structure Of Human Erk2 Complexed With A Py		5e-07
1tvo_A	368	The Structure Of Erk2 In Complex With A Small Molec		5e-07
4f4p_A	273	Syk In Complex With Ligand Lasw836 Length = 273		5e-07
4fv6_A	360	Crystal Structure Of The Erk2 Complexed With E57 Le		5e-07
3o71_A	358	Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length		5e-07
1gol_A	364	Coordinates Of Rat Map Kinase Erk2 With An Arginine		5e-07
2y9q_A	362	Crystal Structure Of Human Erk2 Complexed With A Ma		5e-07
1mru_A	311	Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycob		5e-07
3zu7_A	365	Crystal Structure Of A Designed Selected Ankyrin Re		5e-07
3r63_A	358	Structure Of Erk2 (Spe) Mutant (S246e) Length = 358		5e-07
3orm_A	311	Mycobacterium Tuberculosis Pknb Kinase Domain D76a		5e-07
2z7l_A	366	Unphosphorylated Mitogen Activated Protein Kinase E		5e-07
3c9w_A	357	Crystal Structure Of Erk-2 With Hypothemycin Covale		5e-07
2fys_B	364	Crystal Structure Of Erk2 Complex With Kim Peptide		5e-07
4dfl_A	274	Crystal Structure Of Spleen Tyrosine Kinase Complex		6e-07
3o23_A	305	Human Unphosphorylated Igf1-R Kinase Domain In Comp		6e-07
3srv_A	277	Crystal Structure Of Spleen Tyrosine Kinase (Syk) I		6e-07
3srv_B	277	Crystal Structure Of Spleen Tyrosine Kinase (Syk) I		6e-07
2ojg_A	380	Crystal Structure Of Erk2 In Complex With N,n-dimet		6e-07
2x4z_A	296	Crystal Structure Of The Human P21-Activated Kinase		6e-07
4fif_A	346	Catalytic Domain Of Human Pak4 With Rpkplvdp Peptid		6e-07
3q5i_A	504	Crystal Structure Of Pbanka_031420 Length = 504		6e-07
4fl2_A	636	Structural And Biophysical Characterization Of The		6e-07
4fl3_A	635	Structural And Biophysical Characterization Of The		6e-07
1jqh_A	308	Igf-1 Receptor Kinase Domain Length = 308		6e-07
3qqu_A	301	Cocrystal Structure Of Unphosphorylated Igf With Py		6e-07
1xba_A	291	Crystal Structure Of Apo Syk Tyrosine Kinase Domain		6e-07
3lw0_A	304	Igf-1rk In Complex With Ligand Msc1609119a-1 Length		6e-07
3emg_A	291	Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylami		6e-07
2oj9_A	307	Structure Of Igf-1r Kinase Domain Complexed With A		6e-07
3tub_A	293	Crystal Structure Of Syk Kinase Domain With 1-(5-(6		7e-07
3vf8_A	299	Crystal Structure Of Spleen Tyrosine Kinase Syk Cat		7e-07
3i81_A	315	Crystal Structure Of Insulin-Like Growth Factor 1 R		7e-07
2zv2_A	298	Crystal Structure Of Human CalciumCALMODULIN-Depend		7e-07
2y94_A	476	Structure Of An Active Form Of Mammalian Ampk Lengt		7e-07
2i0v_A	335	C-Fms Tyrosine Kinase In Complex With A Quinolone I		8e-07
3unz_A	279	Aurora A In Complex With Rpm1679 Length = 279		8e-07
1o6y_A	299	Catalytic Domain Of Pknb Kinase From Mycobacterium		8e-07
1cm8_A	367	Phosphorylated Map Kinase P38-Gamma Length = 367		8e-07
2i1m_A	333	Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An		9e-07
3lco_A	324	Inhibitor Bound To A Dfg-Out Structure Of The Kinas		9e-07
3v8s_A	410	Human Rho-Associated Protein Kinase 1 (Rock 1) In C		9e-07
2esm_A	415	Crystal Structure Of Rock 1 Bound To Fasudil Length		9e-07
2j4z_A	306	Structure Of Aurora-2 In Complex With Pha-680626 Le		1e-06
2bmc_A	306	Aurora-2 T287d T288d Complexed With Pha-680632 Leng		1e-06
3bea_A	333	Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A P		1e-06
2v55_A	406	Mechanism Of Multi-site Phosphorylation From A Rock		1e-06
1muo_A	297	Crystal Structure Of Aurora-2, An Oncogenic Serine-		1e-06
3g0f_A	336	Kit Kinase Domain Mutant D816h In Complex With Suni		1e-06
3daj_A	272	Crystal Structure Of Aurora A Complexed With An Inh		1e-06
1rjb_A	344	Crystal Structure Of Flt3 Length = 344		1e-06
1t46_A	313	Structural Basis For The Autoinhibition And Sti-571		1e-06
1t45_A	331	Structural Basis For The Autoinhibition And Sti-571		1e-06
3g0e_A	336	Kit Kinase Domain In Complex With Sunitinib Length		1e-06
1mrv_A	339	Crystal Structure Of An Inactive Akt2 Kinase Domain		1e-06
2xng_A	283	Structure Of Aurora-A Bound To A Selective Imidazop		1e-06
2vwi_A	303	Structure Of The Osr1 Kinase, A Hypertension Drug T		1e-06
1ol5_A	282	Structure Of Aurora-A 122-403, Phosphorylated On Th		1e-06
1pkg_A	329	Structure Of A C-kit Kinase Product Complex Length		2e-06
3fdn_A	279	Structure-Based Drug Design Of Novel Aurora Kinase		2e-06
3zuv_A	364	Crystal Structure Of A Designed Selected Ankyrin Re		2e-06
2j50_A	280	Structure Of Aurora-2 In Complex With Pha-739358 Le		2e-06
2erk_A	365	Phosphorylated Map Kinase Erk2 Length = 365		2e-06
2c6d_A	275	Aurora A Kinase Activated Mutant (T287d) In Complex		2e-06
2xru_A	280	Aurora-A T288e Complexed With Pha-828300 Length = 2		2e-06
2x6d_A	285	Aurora-A Bound To An Inhibitor Length = 285		2e-06
3dak_A	290	Crystal Structure Of Domain-Swapped Osr1 Kinase Dom		2e-06
3d94_A	301	Crystal Structure Of The Insulin-Like Growth Factor		2e-06
3p23_A	432	Crystal Structure Of The Human Kinase And Rnase Dom		2e-06
2c6e_A	283	Aurora A Kinase Activated Mutant (T287d) In Complex		2e-06
1gzn_A	335	Structure Of Pkb Kinase Domain Length = 335		2e-06
3lau_A	287	Crystal Structure Of Aurora2 Kinase In Complex With		2e-06
1gzk_A	315	Molecular Mechanism For The Regulation Of Protein K		2e-06
3nrm_A	283	Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibito		2e-06
3i7c_A	484	Calcium-Dependent Protein Kinase 1 From Toxoplasma		2e-06
3cc6_A	281	Crystal Structure Of Kinase Domain Of Protein Tyros		2e-06
1o6l_A	337	Crystal Structure Of An Activated Akt/protein Kinas		2e-06
3ggf_A	301	Crystal Structure Of Human SerineTHREONINE-Protein		2e-06
3e87_A	335	Crystal Structures Of The Kinase Domain Of Akt2 In		2e-06
3d14_A	272	Crystal Structure Of Mouse Aurora A (Asn186->gly, L		2e-06
1o6k_A	336	Structure Of Activated Form Of Pkb Kinase Domain S4		2e-06
2x4f_A	373	The Crystal Structure Of The Human Myosin Light Cha		2e-06
1s9i_A	354	X-Ray Structure Of The Human Mitogen-Activated Prot		2e-06
3lxn_A	318	Structural And Thermodynamic Characterization Of Th		2e-06
3r21_A	271	Design, Synthesis, And Biological Evaluation Of Pyr		2e-06
3o50_A	267	Crystal Structure Of Benzamide 9 Bound To Auroraa L		2e-06
3h0y_A	268	Aurora A In Complex With A Bisanilinopyrimidine Len		2e-06
3fzo_A	277	Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosin		2e-06
1zrz_A	364	Crystal Structure Of The Catalytic Domain Of Atypic		3e-06
2w1c_A	275	Structure Determination Of Aurora Kinase In Complex		3e-06
2w1d_A	275	Structure Determination Of Aurora Kinase In Complex		3e-06
4dc2_A	396	Structure Of Pkc In Complex With A Substrate Peptid		3e-06
2ya9_A	361	Crystal Structure Of The Autoinhibited Form Of Mous		3e-06
4h1j_A	293	Crystal Structure Of Pyk2 With The Pyrazole 13a Len		3e-06
3ha6_A	268	Crystal Structure Of Aurora A In Complex With Tpx2		3e-06
1mq4_A	272	Crystal Structure Of Aurora-A Protein Kinase Length		3e-06
3a8w_A	345	Crystal Structure Of Pkciota Kinase Domain Length =		3e-06
2wtw_A	285	Aurora-A Inhibitor Structure (2nd Crystal Form) Len		3e-06
3e5a_A	268	Crystal Structure Of Aurora A In Complex With Vx-68		3e-06
4e1z_A	291	Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda		3e-06
2jed_A	352	The Crystal Structure Of The Kinase Domain Of The P		3e-06
4e20_A	290	Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda		3e-06
1xjd_A	345	Crystal Structure Of Pkc-Theta Complexed With Staur		3e-06
2qlu_A	314	Crystal Structure Of Activin Receptor Type Ii Kinas		3e-06
3zh8_A	349	A Novel Small Molecule Apkc Inhibitor Length = 349		3e-06
2wtv_A	285	Aurora-A Inhibitor Structure Length = 285		3e-06
3a7f_A	303	Human Mst3 Kinase Length = 303		3e-06
1wmk_A	321	Human Death-Associated Kinase Drp-1, Mutant S308d D		3e-06
3ckw_A	304	Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3		4e-06
3ckx_A	304	Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3		4e-06
2a2a_A	321	High-resolution Crystallographic Analysis Of The Au		4e-06
2wnt_A	330	Crystal Structure Of The Human Ribosomal Protein S6		4e-06
2jav_A	279	Human Kinase With Pyrrole-Indolinone Ligand Length		4e-06
1z9x_A	321	Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal		4e-06
4a4x_A	279	Nek2-Ede Bound To Cct248662 Length = 279		4e-06
3rny_A	346	Crystal Structure Of Human Rsk1 C-Terminal Kinase D		4e-06
2a27_A	321	Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal		4e-06
2dwb_A	285	Aurora-A Kinase Complexed With Amppnp Length = 285		4e-06
4dym_A	301	Crystal Structure Of The Acvr1 Kinase Domain In Com		4e-06
3zhp_C	294	Human Mst3 (stk24) In Complex With Mo25beta Length		4e-06
3mtf_A	301	Crystal Structure Of The Acvr1 Kinase In Complex Wi		4e-06
3a62_A	327	Crystal Structure Of Phosphorylated P70s6k1 Length		4e-06
3a60_A	327	Crystal Structure Of Unphosphorylated P70s6k1 (Form		4e-06
3fhi_A	350	Crystal Structure Of A Complex Between The Catalyti		4e-06
2wqe_A	262	Structure Of S155r Aurora-A Somatic Mutant Length =		4e-06
3cok_A	278	Crystal Structure Of Plk4 Kinase Length = 278		5e-06
1xh9_A	350	Crystal Structures Of Protein Kinase B Selective In		5e-06
1zws_A	288	Crystal Structure Of The Catalytic Domain Of Human		5e-06
2y7j_A	365	Structure Of Human Phosphorylase Kinase, Gamma 2 Le		5e-06
3h9r_A	330	Crystal Structure Of The Kinase Domain Of Type I Ac		5e-06
3e3p_A	360	Glycogen Synthase Kinase From Leishmania Major Leng		5e-06
3nyx_A	302	Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-T		6e-06
2y4i_C	395	Ksr2-Mek1 Heterodimer Length = 395		6e-06
2w5a_A	279	Human Nek2 Kinase Adp-Bound Length = 279		6e-06
1ol6_A	282	Structure Of Unphosphorylated D274n Mutant Of Auror		6e-06
1yrp_A	278	Catalytic Domain Of Human Zip Kinase Phosphorylated		6e-06
3bhy_A	283	Crystal Structure Of Human Death Associated Protein		7e-06
3ama_A	351	Protein Kinase A Sixfold Mutant Model Of Aurora B W		7e-06
2j90_A	304	Crystal Structure Of Human Zip Kinase In Complex Wi		7e-06
3eyg_A	290	Crystal Structures Of Jak1 And Jak2 Inhibitor Compl		7e-06
2gnf_A	350	Protein Kinase A Fivefold Mutant Model Of Rho-Kinas		7e-06
2gng_A	350	Protein Kinase A Fivefold Mutant Model Of Rho-Kinas		8e-06
2gnj_A	350	Pka Three Fold Mutant Model Of Rho-Kinase With Y-27		8e-06
1j3h_A	350	Crystal Structure Of Apoenzyme Camp-Dependent Prote		8e-06
3sls_A	304	Crystal Structure Of Human Mek-1 Kinase In Complex		8e-06
2gu8_A	337	Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel		8e-06
4e4l_A	302	Jak1 Kinase (Jh1 Domain) In Complex With Compound 3		8e-06
2xk9_A	322	Structural Analysis Of Checkpoint Kinase 2 (Chk2) I		8e-06
3eqc_A	360	X-Ray Structure Of The Human Mitogen-Activated Prot		8e-06
2ycr_A	323	Crystal Structure Of Checkpoint Kinase 2 In Complex		9e-06
2w0j_A	323	Crystal Structure Of Chk2 In Complex With Nsc 10955		9e-06
2ycf_A	322	Crystal Structure Of Checkpoint Kinase 2 In Complex		9e-06
2xne_A	272	Structure Of Aurora-A Bound To An Imidazopyrazine I		9e-06
2cn5_A	329	Crystal Structure Of Human Chk2 In Complex With Adp		9e-06
2jam_A	304	Crystal Structure Of Human Calmodulin-Dependent Pro		9e-06
3o96_A	446	Crystal Structure Of Human Akt1 With An Allosteric		1e-05
4ejn_A	446	Crystal Structure Of Autoinhibited Form Of Akt1 In		1e-05
4ec8_A	373	Structure Of Full Length Cdk9 In Complex With Cycli		1e-05
3lm0_A	327	Crystal Structure Of Human SerineTHREONINE KINASE 1		1e-05
3orn_A	307	Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In		1e-05
3nz0_A	302	Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 3		1e-05
3cqu_A	342	Crystal Structure Of Akt-1 Complexed With Substrate		1e-05
4gv1_A	340	Pkb Alpha In Complex With Azd5363 Length = 340		1e-05
1smh_A	350	Protein Kinase A Variant Complex With Completely Or		1e-05
2p55_A	333	X-Ray Structure Of The Human Mitogen-Activated Prot		1e-05
1s9j_A	341	X-Ray Structure Of The Human Mitogen-Activated Prot		1e-05
2f2u_A	402	Crystal Structure Of The Rho-Kinase Kinase Domain L		1e-05
3i6w_A	443	Structure And Activation Mechanism Of The Chk2 Dna-		1e-05
3ocb_A	341	Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor		1e-05
3coh_A	268	Crystal Structure Of Aurora-A In Complex With A Pen		1e-05
3i6u_A	419	Structure And Activation Mechanism Of The Chk2 Dna-		1e-05
2vo0_A	351	Structure Of Pka-Pkb Chimera Complexed With C-(4-(4		1e-05
2uvy_A	351	Structure Of Pka-pkb Chimera Complexed With Methyl-		1e-05
2xuu_A	334	Crystal Structure Of A Dap-Kinase 1 Mutant Length =		1e-05
2jdt_A	351	Structure Of Pka-Pkb Chimera Complexed With Isoquin		1e-05
1q61_A	350	Pka Triple Mutant Model Of Pkb Length = 350		1e-05
1szm_A	350	Dual Binding Mode Of Bisindolylmaleimide 2 To Prote		1e-05
3mbl_A	328	Crystal Structure Of The Human Mitogen-Activated Pr		1e-05
3dv3_A	322	Mek1 With Pf-04622664 Bound Length = 322		1e-05
3l9m_A	351	Crystal Structure Of Pkab3 (Pka Triple Mutant V123a		1e-05
3vul_A	370	Crystal Structure Of A Cysteine-deficient Mutant M1		1e-05
3vum_A	370	Crystal Structure Of A Cysteine-deficient Mutant M7		1e-05
3mi9_A	351	Crystal Structure Of Hiv-1 Tat Complexed With Human		1e-05
2qur_A	350	Crystal Structure Of F327aK285P MUTANT OF CAMP-Depe		2e-05
2f7e_E	351	Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoqu		2e-05
3blh_A	331	Crystal Structure Of Human Cdk9CYCLINT1 Length = 33		2e-05
3qal_E	350	Crystal Structure Of Arg280ala Mutant Of Catalytic		2e-05
1fmo_E	350	Crystal Structure Of A Polyhistidine-Tagged Recombi		2e-05
1apm_E	350	2.0 Angstrom Refined Crystal Structure Of The Catal		2e-05
2qcs_A	350	A Complex Structure Between The Catalytic And Regul		2e-05
1bkx_A	350	A Binary Complex Of The Catalytic Subunit Of Camp-D		2e-05
2erz_E	351	Crystal Structure Of C-amp Dependent Kinase (pka) B		2e-05
1l3r_E	350	Crystal Structure Of A Transition State Mimic Of Th		2e-05
1jbp_E	350	Crystal Structure Of The Catalytic Subunit Of Camp-		2e-05
4dfx_E	350	Crystal Structure Of Myristoylated K7c Catalytic Su		2e-05
4dg3_E	371	Crystal Structure Of R336a Mutant Of Camp-dependent		2e-05
3my0_A	305	Crystal Structure Of The Acvrl1 (Alk1) Kinase Domai		2e-05
1ctp_E	350	Structure Of The Mammalian Catalytic Subunit Of Cam		2e-05
1q8w_A	350	The Catalytic Subunit Of Camp-Dependent Protein Kin		2e-05
3nx8_A	351	Human Camp Dependent Protein Kinase In Complex With		2e-05
1stc_E	350	Camp-Dependent Protein Kinase, Alpha-Catalytic Subu		2e-05
1b6c_B	342	Crystal Structure Of The Cytoplasmic Domain Of The		2e-05
1svh_A	350	Crystal Structure Of Protein Kinase A In Complex Wi		2e-05
1cdk_A	350	Camp-Dependent Protein Kinase Catalytic Subunit (E.		2e-05
3pvb_A	345	Crystal Structure Of (73-244)ria:c Holoenzyme Of Ca		2e-05
3agm_A	351	Complex Of Pka With The Bisubstrate Protein Kinase		2e-05
1cmk_E	350	Crystal Structures Of The Myristylated Catalytic Su		2e-05
2c1a_A	351	Structure Of Camp-Dependent Protein Kinase Complexe		2e-05
4ae6_A	343	Structure And Function Of The Human Sperm-specific		2e-05
2uzt_A	336	Pka Structures Of Akt, Indazole-Pyridine Inhibitors		2e-05
2jds_A	351	Structure Of Camp-Dependent Protein Kinase Complexe		2e-05
3agl_A	351	Complex Of Pka With The Bisubstrate Protein Kinase		2e-05
1ydt_E	350	Structure Of Camp-Dependent Protein Kinase, Alpha-C		2e-05
3dnd_A	350	Camp-Dependent Protein Kinase Pka Catalytic Subunit		2e-05
1xh7_A	350	Crystal Structures Of Protein Kinase B Selective In		2e-05
4bcf_A	331	Structure Of Cdk9 In Complex With Cyclin T And A 2-		2e-05
3mvj_A	371	Human Cyclic Amp-Dependent Protein Kinase Pka Inhib		2e-05
4ae9_A	343	Structure And Function Of The Human Sperm-specific		2e-05
2pml_X	348	Crystal Structure Of Pfpk7 In Complex With An Atp A		2e-05
3kk8_A	284	Camkii Substrate Complex A Length = 284		2e-05
1rw8_A	301	Crystal Structure Of Tgf-Beta Receptor I Kinase Wit		2e-05
2qr8_A	342	2.0a X-ray Structure Of C-terminal Kinase Domain Of		2e-05
1py5_A	326	Crystal Structure Of Tgf-Beta Receptor I Kinase Wit		2e-05
3kk9_A	282	Camkii Substrate Complex B Length = 282		2e-05
1vjy_A	303	Crystal Structure Of A Naphthyridine Inhibitor Of H		2e-05
3kl8_A	269	Camkiintide Inhibitor Complex Length = 269		2e-05
3iw4_A	360	Crystal Structure Of Pkc Alpha In Complex With Nvp-		2e-05
2bdw_A	362	Crystal Structure Of The Auto-Inhibited Kinase Doma		2e-05
2x0g_A	334	X-ray Structure Of A Dap-kinase Calmodulin Complex		2e-05
2wot_A	306	Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl)		3e-05
3tzm_A	309	Tgf-Beta Receptor Type 1 In Complex With Sb431542 L		3e-05
3dls_A	335	Crystal Structure Of Human Pas Kinase Bound To Adp		3e-05
3h4j_B	336	Crystal Structure Of Pombe Ampk Kdaid Fragment Leng		3e-05
3kmw_A	271	Crystal Structure Of The IlkALPHA-Parvin Core Compl		3e-05
1p4f_A	293	Death Associated Protein Kinase Catalytic Domain Wi		3e-05
1ig1_A	294	1.8a X-Ray Structure Of Ternary Complex Of A Cataly		3e-05
4dfy_A	371	Crystal Structure Of R194a Mutant Of Camp-Dependent		3e-05
2xzs_A	312	Death Associated Protein Kinase 1 Residues 1-312 Le		3e-05
1q24_A	350	Pka Double Mutant Model Of Pkb In Complex With Mgat		3e-05
3f5u_A	295	Crystal Structure Of The Death Associated Protein K		3e-05
3gu8_A	295	Crystal Structure Of Dapkl93g With N6-Cyclopentylad		3e-05
3gu4_A	295	Crystal Structure Of Dapkq23v-Amppnp Length = 295		3e-05
3s95_A	310	Crystal Structure Of The Human Limk1 Kinase Domain		3e-05
2w4k_A	302	X-Ray Structure Of A Dap-Kinase 2-302 Length = 302		3e-05
3dfc_B	295	Crystal Structure Of A Glycine-Rich Loop Mutant Of		3e-05
2y0a_A	326	Structure Of Dapk1 Construct Residues 1-304 Length		3e-05
3o7l_B	350	Crystal Structure Of Phospholamban (1-19):pka C-Sub		3e-05
2yak_A	285	Structure Of Death-Associated Protein Kinase 1 (Dap		3e-05
2qnj_A	328	Kinase And Ubiquitin-Associated Domains Of Mark3PAR		3e-05
2w4j_A	277	X-Ray Structure Of A Dap-Kinase 2-277 Length = 277		4e-05
1wvw_A	278	Crystal Structures Of Kinase Domain Of Dap Kinase I		4e-05
1syk_A	350	Crystal Structure Of E230q Mutant Of Camp-Dependent		4e-05
4asz_A	299	Crystal Structure Of Apo Trkb Kinase Domain Length		4e-05
2h34_A	309	Apoenzyme Crystal Structure Of The Tuberculosis Ser		4e-05
1ql6_A	298	The Catalytic Mechanism Of Phosphorylase Kinase Pro		4e-05
2wtk_C	305	Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo2		4e-05
1h4l_A	292	Structure And Regulation Of The Cdk5-P25(Nck5a) Com		4e-05
1zmw_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		4e-05
4agu_A	311	Crystal Structure Of The Human Cdkl1 Kinase Domain		5e-05
3vuh_A	370	Crystal Structure Of A Cysteine-deficient Mutant M3		5e-05
3vui_A	370	Crystal Structure Of A Cysteine-deficient Mutant M2		5e-05
3v3v_A	379	Structural And Functional Analysis Of Quercetagetin		5e-05
3hyh_A	275	Crystal Structure Of The Protein Kinase Domain Of Y		5e-05
3vuk_A	370	Crystal Structure Of A Cysteine-deficient Mutant M5		5e-05
4an2_A	301	Crystal Structures Of Human Mek1 With Carboxamide-B		5e-05
3dae_A	283	Crystal Structure Of Phosphorylated Snf1 Kinase Dom		5e-05
2fh9_A	274	Structure And Dimerization Of The Kinase Domain Fro		5e-05
3mn3_A	271	An Inhibited Conformation For The Protein Kinase Do		6e-05
2iwi_A	312	Crystal Structure Of The Human Pim2 In Complex With		7e-05
1kob_A	387	Twitchin Kinase Fragment (Aplysia), Autoregulated P		7e-05
2i6l_A	320	Crystal Structure Of Human Mitogen Activated Protei		7e-05
3vn9_A	340	Rifined Crystal Structure Of Non-Phosphorylated Map		7e-05
1ukh_A	369	Structural Basis For The Selective Inhibition Of Jn		8e-05
2xrw_A	371	Linear Binding Motifs For Jnk And For Calcineurin A		8e-05
3vud_A	370	Crystal Structure Of A Cysteine-deficient Mutant M1		8e-05
2h6d_A	276	Protein Kinase Domain Of The Human 5'-Amp-Activated		8e-05
3qam_E	350	Crystal Structure Of Glu208ala Mutant Of Catalytic		8e-05
2yza_A	276	Crystal Structure Of Kinase Domain Of Human 5'-Amp-		8e-05
3vug_A	370	Crystal Structure Of A Cysteine-deficient Mutant M2		8e-05
3mdy_A	337	Crystal Structure Of The Cytoplasmic Domain Of The		9e-05
2r5t_A	373	Crystal Structure Of Inactive Serum And Glucocortic		9e-05
3fi2_A	353	Crystal Structure Of Jnk3 With Amino-Pyrazole Inhib		1e-04
2xs0_A	386	Linear Binding Motifs For Jnk And For Calcineurin A		1e-04
2r0i_A	327	Crystal Structure Of A Kinase Mark2PAR-1 Mutant Len		1e-04
3fv8_A	355	Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Le		1e-04
3gbz_A	329	Structure Of The Cmgc Cdk Kinase From Giardia Lambl		1e-04
1phk_A	298	Two Structures Of The Catalytic Domain Of Phosphory		1e-04
1zmu_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		1e-04
2phk_A	277	The Crystal Structure Of A Phosphorylase Kinase Pep		1e-04
3fi3_A	364	Crystal Structure Of Jnk3 With Indazole Inhibitor,		1e-04
3e7o_A	360	Crystal Structure Of Jnk2 Length = 360		1e-04
3oz6_A	388	Crystal Structure Of Mapk From Cryptosporidium Parv		1e-04
2w4o_A	349	Crystal Structure Of Human Camk4 In Complex With 4-		1e-04
3iec_A	319	Helicobacter Pylori Caga Inhibits Par1MARK FAMILY K		1e-04
2r9s_A	356	C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Qu		1e-04
3kvx_A	364	Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Le		1e-04
1luf_A	343	Crystal Structure Of The Musk Tyrosine Kinase: Insi		1e-04
2hak_A	328	Catalytic And Ubiqutin-Associated Domains Of Mark1P		1e-04
1rdq_E	350	Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of		2e-04
1ung_A	292	Structural Mechanism For The Inhibition Of Cdk5-P25		2e-04
3zgw_A	347	Crystal Structure Of Maternal Embryonic Leucine Zip		2e-04
3pfq_A	674	Crystal Structure And Allosteric Activation Of Prot		2e-04
3ttj_A	464	Crystal Structure Of Jnk3 Complexed With Cc-359, A		2e-04
1zmv_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		2e-04
4gt5_A	306	Crystal Structure Of The Inactive Trka Kinase Domai		2e-04
1jnk_A	423	The C-Jun N-Terminal Kinase (Jnk3s) Complexed With		2e-04
4f0i_A	300	Crystal Structure Of Apo Trka Length = 300		2e-04
1kwp_A	400	Crystal Structure Of Mapkap2 Length = 400		2e-04
2i0e_A	353	Structure Of Catalytic Domain Of Human Protein Kina		2e-04
3oxi_A	362	Design And Synthesis Of Disubstituted Thiophene And		2e-04
2jbo_A	326	Protein Kinase Mk2 In Complex With An Inhibitor (Cr		2e-04
1pmn_A	364	Crystal Structure Of Jnk3 In Complex With An Imidaz		2e-04
3ptg_A	363	Design And Synthesis Of A Novel, Orally Efficacious		2e-04
2ok1_A	365	Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3		2e-04
2pzy_A	324	Structure Of Mk2 Complexed With Compound 76 Length		3e-04
2onl_C	406	Crystal Structure Of The P38a-Mapkap Kinase 2 Heter		3e-04
1y8g_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		3e-04
2o0u_A	364	Crystal Structure Of Human Jnk3 Complexed With N-{3		3e-04
3r2y_A	319	Mk2 Kinase Bound To Compound 1 Length = 319		3e-04
2b1p_A	355	Inhibitor Complex Of Jnk3 Length = 355		3e-04
4h36_A	356	Crystal Structure Of Jnk3 In Complex With Atf2 Pept		3e-04
3r2b_A	318	Mk2 Kinase Bound To Compound 5b Length = 318		3e-04
3fpm_A	325	Crystal Structure Of A Squarate Inhibitor Bound To		3e-04
2oza_A	356	Structure Of P38alpha Complex Length = 356		3e-04
2exc_X	356	Inhibitor Complex Of Jnk3 Length = 356		3e-04
3gok_A	334	Binding Site Mapping Of Protein Ligands Length = 33		3e-04
2hw6_A	307	Crystal Structure Of Mnk1 Catalytic Domain Length =		3e-04
2p3g_X	327	Crystal Structure Of A Pyrrolopyridine Inhibitor Bo		3e-04
4aoj_A	329	Human Trka In Complex With The Inhibitor Az-23 Leng		3e-04
2wzj_A	327	Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82		3e-04
3ka0_A	320	Mk2 Complex With Inhibitor 6-(5-(2-Aminopyrimidin-4		3e-04
3mfr_A	351	Cask-4m Cam Kinase Domain, Native Length = 351		4e-04
3elj_A	369	Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine		4e-04
2dyl_A	318	Crystal Structure Of Human Mitogen-Activated Protei		4e-04
3r1n_A	317	Mk3 Kinase Bound To Compound 5b Length = 317		5e-04
1nxk_A	400	Crystal Structure Of Staurosporine Bound To Map Kap		5e-04
1koa_A	491	Twitchin Kinase Fragment (C.Elegans), Autoregulated		5e-04
3pze_A	358	Jnk1 In Complex With Inhibitor Length = 358		5e-04
4g3d_A	371	Crystal Structure Of Human Nf-kappab Inducing Kinas		5e-04
2vz6_A	313	Structure Of Human Calcium Calmodulin Dependent Pro		5e-04
3fhr_A	336	High Resolution Crystal Structure Of Mitogen-Activa		5e-04
2qr7_A	342	2.0a X-Ray Structure Of C-Terminal Kinase Domain Of		5e-04
3rp9_A	458	Crystal Structure Of The Apo Mapk From Toxoplasma G		6e-04
3npc_A	364	Crystal Structure Of Jnk2 Complexed With Birb796 Le		6e-04
2f9g_A	353	Crystal Structure Of Fus3 Phosphorylated On Tyr182		6e-04
2wel_A	327	Crystal Structure Of Su6656-Bound CalciumCALMODULIN		6e-04
3uto_A	573	Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-		6e-04
2vn9_A	301	Crystal Structure Of Human Calcium Calmodulin Depen		7e-04
2b9f_A	353	Crystal Structure Of Non-Phosphorylated Fus3 Length		7e-04
3fme_A	290	Crystal Structure Of Human Mitogen-Activated Protei		7e-04
4dn5_A	356	Crystal Structure Of Nf-kb-inducing Kinase (nik) Le		8e-04
3o17_A	370	Crystal Structure Of Jnk1-Alpha1 Isoform Length = 3		8e-04
1vzo_A	355	The Structure Of The N-Terminal Kinase Domain Of Ms		9e-04

>pdb|3TL8|A Chain A, The Avrptob-Bak1 Complex Reveals Two Structurally Similar Kinaseinteracting Domains In A Single Type Iii Effector Length = 349

Iteration: 1
 Score =  138 bits (347), Expect = 7e-33,   Method: Compositional matrix adjust.
 Identities = 82/224 (36%), Positives = 120/224 (53%), Gaps = 38/224 (16%)
Query: 303 KRYGYADIKKMTNSFKYK--LGQGGYGSVYKGKLLDGSNVAVKVLNDSKGNGKE--FINE 358
           KR+   +++  +++F  K  LG+GG+G VYKG+L DG+ VAVK L + +  G E  F  E
Sbjct: 26  KRFSLRELQVASDNFSNKNILGRGGFGKVYKGRLADGTLVAVKRLKEERXQGGELQFQTE 85
Query: 359 VASISRTSHVNVVALLGFCLRVAEEL-------------------------------SST 387
           V  IS   H N++ L GFC+   E L                                  
Sbjct: 86  VEMISMAVHRNLLRLRGFCMTPTERLLVYPYMANGSVASCLRERPESQPPLDWPKRQRIA 145
Query: 388 IGIARGLEYLHLGCSTRILHFDIKPHNILLDEDFCPKISDFGLAKICNRKESIISMTGAR 447
           +G ARGL YLH  C  +I+H D+K  NILLDE+F   + DFGLAK+ + K+  +     R
Sbjct: 146 LGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDXHVX-XAVR 204
Query: 448 GTVGYIAPEVFCRNIGEVSYKSDVYNYGMMIFEMTGGRKNVDVV 491
           GT+G+IAPE    + G+ S K+DV+ YG+M+ E+  G++  D+ 
Sbjct: 205 GTIGHIAPEYL--STGKSSEKTDVFGYGVMLLELITGQRAFDLA 246

>pdb|3UIM|A Chain A, Structural Basis For The Impact Of Phosphorylation On Plant Receptor- Like Kinase Bak1 Activation Length = 326

Iteration: 1
 Score =  135 bits (339), Expect = 8e-32,   Method: Compositional matrix adjust.
 Identities = 81/223 (36%), Positives = 118/223 (52%), Gaps = 38/223 (17%)
Query: 303 KRYGYADIKKMTNSFKYK--LGQGGYGSVYKGKLLDGSNVAVKVLNDSKGNGKE--FINE 358
           KR+   +++  +++F  K  LG+GG+G VYKG+L DG  VAVK L + +  G E  F  E
Sbjct: 18  KRFSLRELQVASDNFXNKNILGRGGFGKVYKGRLADGXLVAVKRLKEERTQGGELQFQTE 77
Query: 359 VASISRTSHVNVVALLGFCLRVAEEL-------------------------------SST 387
           V  IS   H N++ L GFC+   E L                                  
Sbjct: 78  VEMISMAVHRNLLRLRGFCMTPTERLLVYPYMANGSVASCLRERPESQPPLDWPKRQRIA 137
Query: 388 IGIARGLEYLHLGCSTRILHFDIKPHNILLDEDFCPKISDFGLAKICNRKESIISMTGAR 447
           +G ARGL YLH  C  +I+H D+K  NILLDE+F   + DFGLAK+ + K+  +     R
Sbjct: 138 LGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDXHVX-XAVR 196
Query: 448 GTVGYIAPEVFCRNIGEVSYKSDVYNYGMMIFEMTGGRKNVDV 490
           G +G+IAPE    + G+ S K+DV+ YG+M+ E+  G++  D+
Sbjct: 197 GXIGHIAPEYL--STGKSSEKTDVFGYGVMLLELITGQRAFDL 237

>pdb|2QKW|B Chain B, Structural Basis For Activation Of Plant Immunity By Bacterial Effector Protein Avrpto Length = 321

Iteration: 1
 Score =  112 bits (279), Expect = 6e-25,   Method: Compositional matrix adjust.
 Identities = 74/219 (33%), Positives = 110/219 (50%), Gaps = 39/219 (17%)
Query: 304 RYGYADIKKMTNSFKYK--LGQGGYGSVYKGKLLDGSNVAVKVLNDSKGNGKEFINEVAS 361
           R    D+++ TN+F +K  +G G +G VYKG L DG+ VA+K        G E       
Sbjct: 28  RVPLVDLEEATNNFDHKFLIGHGVFGKVYKGVLRDGAKVALKRRTPESSQGIEEFETEIE 87
Query: 362 -ISRTSHVNVVALLGFC-------------------------------LRVAEELSSTIG 389
            +S   H ++V+L+GFC                               +   + L   IG
Sbjct: 88  TLSFCRHPHLVSLIGFCDERNEMILIYKYMENGNLKRHLYGSDLPTMSMSWEQRLEICIG 147
Query: 390 IARGLEYLHLGCSTRILHFDIKPHNILLDEDFCPKISDFGLAKICNRKESIISMTGARGT 449
            ARGL YLH   +  I+H D+K  NILLDE+F PKI+DFG++K     +        +GT
Sbjct: 148 AARGLHYLH---TRAIIHRDVKSINILLDENFVPKITDFGISKKGTELDQTHLXXVVKGT 204
Query: 450 VGYIAPEVFCRNIGEVSYKSDVYNYGMMIFEMTGGRKNV 488
           +GYI PE F +  G ++ KSDVY++G+++FE+   R  +
Sbjct: 205 LGYIDPEYFIK--GRLTEKSDVYSFGVVLFEVLCARSAI 241

>pdb|3HGK|A Chain A, Crystal Structure Of Effect Protein Avrptob Complexed With Kinase Pto Length = 327

Iteration: 1
 Score =  110 bits (275), Expect = 2e-24,   Method: Compositional matrix adjust.
 Identities = 74/219 (33%), Positives = 109/219 (49%), Gaps = 39/219 (17%)
Query: 304 RYGYADIKKMTNSFKYK--LGQGGYGSVYKGKLLDGSNVAVKVLNDSKGNGKEFINEVAS 361
           R    D+++ TN+F +K  +G G +G VYKG L DG+ VA+K        G E       
Sbjct: 28  RVPLVDLEEATNNFDHKFLIGHGVFGKVYKGVLRDGAKVALKRRTPESSQGIEEFETEIE 87
Query: 362 -ISRTSHVNVVALLGFC-------------------------------LRVAEELSSTIG 389
            +S   H ++V+L+GFC                               +   + L   IG
Sbjct: 88  TLSFCRHPHLVSLIGFCDERNEMILIYKYMENGNLKRHLYGSDLPTMSMSWEQRLEICIG 147
Query: 390 IARGLEYLHLGCSTRILHFDIKPHNILLDEDFCPKISDFGLAKICNRKESIISMTGARGT 449
            ARGL YLH   +  I+H D+K  NILLDE+F PKI+DFG++K              +GT
Sbjct: 148 AARGLHYLH---TRAIIHRDVKSINILLDENFVPKITDFGISKKGTELGQTHLXXVVKGT 204
Query: 450 VGYIAPEVFCRNIGEVSYKSDVYNYGMMIFEMTGGRKNV 488
           +GYI PE F +  G ++ KSDVY++G+++FE+   R  +
Sbjct: 205 LGYIDPEYFIK--GRLTEKSDVYSFGVVLFEVLCARSAI 241

>pdb|2NRY|A Chain A, Crystal Structure Of Irak-4 Length = 307

Iteration: 1
 Score =  100 bits (248), Expect = 3e-21,   Method: Compositional matrix adjust.
 Identities = 72/228 (31%), Positives = 111/228 (48%), Gaps = 50/228 (21%)
Query: 305 YGYADIKKMTNSFKY--------KLGQGGYGSVYKGKLLDGSNVAVKVLN-----DSKGN 351
           + + ++K +TN+F          K+G+GG+G VYKG  ++ + VAVK L       ++  
Sbjct: 15  FSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKG-YVNNTTVAVKKLAAMVDITTEEL 73
Query: 352 GKEFINEVASISRTSHVNVVALLGF------------------------CLRVAEELSST 387
            ++F  E+  +++  H N+V LLGF                        CL     LS  
Sbjct: 74  KQQFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLDGTPPLSWH 133
Query: 388 I------GIARGLEYLHLGCSTRILHFDIKPHNILLDEDFCPKISDFGLAKICNRKESII 441
           +      G A G+ +LH       +H DIK  NILLDE F  KISDFGLA+   +    +
Sbjct: 134 MRCKIAQGAANGINFLH---ENHHIHRDIKSANILLDEAFTAKISDFGLARASEKFAQTV 190
Query: 442 SMTGARGTVGYIAPEVFCRNIGEVSYKSDVYNYGMMIFEMTGGRKNVD 489
             +   GT  Y+APE      GE++ KSD+Y++G+++ E+  G   VD
Sbjct: 191 MXSRIVGTTAYMAPEALR---GEITPKSDIYSFGVVLLEIITGLPAVD 235

>pdb|2NRU|A Chain A, Crystal Structure Of Irak-4 Length = 307

Iteration: 1
 Score = 99.4 bits (246), Expect = 4e-21,   Method: Compositional matrix adjust.
 Identities = 72/228 (31%), Positives = 110/228 (48%), Gaps = 50/228 (21%)
Query: 305 YGYADIKKMTNSFKY--------KLGQGGYGSVYKGKLLDGSNVAVKVLN-----DSKGN 351
           + + ++K +TN+F          K+G+GG+G VYKG  ++ + VAVK L       ++  
Sbjct: 15  FSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKG-YVNNTTVAVKKLAAMVDITTEEL 73
Query: 352 GKEFINEVASISRTSHVNVVALLGF------------------------CLRVAEELSST 387
            ++F  E+  +++  H N+V LLGF                        CL     LS  
Sbjct: 74  KQQFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLDGTPPLSWH 133
Query: 388 I------GIARGLEYLHLGCSTRILHFDIKPHNILLDEDFCPKISDFGLAKICNRKESII 441
           +      G A G+ +LH       +H DIK  NILLDE F  KISDFGLA+   +    +
Sbjct: 134 MRCKIAQGAANGINFLH---ENHHIHRDIKSANILLDEAFTAKISDFGLARASEKFAQTV 190
Query: 442 SMTGARGTVGYIAPEVFCRNIGEVSYKSDVYNYGMMIFEMTGGRKNVD 489
                 GT  Y+APE      GE++ KSD+Y++G+++ E+  G   VD
Sbjct: 191 MXXRIVGTTAYMAPEALR---GEITPKSDIYSFGVVLLEIITGLPAVD 235

>pdb|3C4C|A Chain A, B-Raf Kinase In Complex With Plx4720 Length = 280

Iteration: 1
 Score = 99.0 bits (245), Expect = 5e-21,   Method: Compositional matrix adjust.
 Identities = 70/226 (30%), Positives = 115/226 (50%), Gaps = 46/226 (20%)
Query: 320 KLGQGGYGSVYKGKLLDGSNVAVKVLNDSKGNGKE---FINEVASISRTSHVNVVALLGF 376
           ++G G +G+VYKGK     +VAVK+LN +    ++   F NEV  + +T HVN++  +G+
Sbjct: 19  RIGSGSFGTVYKGKW--HGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGY 76
Query: 377 C--------------------LRVAE---ELSSTIGIAR----GLEYLHLGCSTRILHFD 409
                                L  +E   E+   I IAR    G++YLH   +  I+H D
Sbjct: 77  STKPQLAIVTQWCEGSSLYHHLHASETKFEMKKLIDIARQTARGMDYLH---AKSIIHRD 133
Query: 410 IKPHNILLDEDFCPKISDFGLAKICNRKESIISMTGARGTVGYIAPEVF-CRNIGEVSYK 468
           +K +NI L ED   KI DFGLA + +R           G++ ++APEV   ++    S++
Sbjct: 134 LKSNNIFLHEDNTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQDSNPYSFQ 193
Query: 469 SDVYNYGMMIFEMTGGR----------KNVDVVDNGSTALDLQASR 504
           SDVY +G++++E+  G+          + +++V  GS + DL   R
Sbjct: 194 SDVYAFGIVLYELMTGQLPYSNINNRDQIIEMVGRGSLSPDLSKVR 239

>pdb|2OIB|A Chain A, Crystal Structure Of Irak4 Kinase Domain Apo Form Length = 301

Iteration: 1
 Score = 99.0 bits (245), Expect = 5e-21,   Method: Compositional matrix adjust.
 Identities = 72/228 (31%), Positives = 110/228 (48%), Gaps = 50/228 (21%)
Query: 305 YGYADIKKMTNSFKY--------KLGQGGYGSVYKGKLLDGSNVAVKVLN-----DSKGN 351
           + + ++K +TN+F          K+G+GG+G VYKG  ++ + VAVK L       ++  
Sbjct: 9   FSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKG-YVNNTTVAVKKLAAMVDITTEEL 67
Query: 352 GKEFINEVASISRTSHVNVVALLGF------------------------CLRVAEELSST 387
            ++F  E+  +++  H N+V LLGF                        CL     LS  
Sbjct: 68  KQQFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLDGTPPLSWH 127
Query: 388 I------GIARGLEYLHLGCSTRILHFDIKPHNILLDEDFCPKISDFGLAKICNRKESII 441
           +      G A G+ +LH       +H DIK  NILLDE F  KISDFGLA+   +    +
Sbjct: 128 MRCKIAQGAANGINFLH---ENHHIHRDIKSANILLDEAFTAKISDFGLARASEKFAQXV 184
Query: 442 SMTGARGTVGYIAPEVFCRNIGEVSYKSDVYNYGMMIFEMTGGRKNVD 489
                 GT  Y+APE      GE++ KSD+Y++G+++ E+  G   VD
Sbjct: 185 MXXRIVGTTAYMAPEALR---GEITPKSDIYSFGVVLLEIITGLPAVD 229

>pdb|3Q96|A Chain A, B-Raf Kinase Domain In Complex With A Tetrahydronaphthalene Inhibitor Length = 282

Iteration: 1
 Score = 98.6 bits (244), Expect = 7e-21,   Method: Compositional matrix adjust.
 Identities = 64/197 (32%), Positives = 104/197 (52%), Gaps = 36/197 (18%)
Query: 320 KLGQGGYGSVYKGKLLDGSNVAVKVLNDSKGNGKE---FINEVASISRTSHVNVVALLGF 376
           ++G G +G+VYKGK     +VAVK+LN +    ++   F NEV  + +T HVN++  +G+
Sbjct: 17  RIGSGSFGTVYKGKW--HGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGY 74
Query: 377 C--------------------LRVAE---ELSSTIGIAR----GLEYLHLGCSTRILHFD 409
                                L + E   E+   I IAR    G++YLH   +  I+H D
Sbjct: 75  STKPQLAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLH---AKSIIHRD 131
Query: 410 IKPHNILLDEDFCPKISDFGLAKICNRKESIISMTGARGTVGYIAPEVF-CRNIGEVSYK 468
           +K +NI L ED   KI DFGLA + +R           G++ ++APEV   ++    S++
Sbjct: 132 LKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQDKNPYSFQ 191
Query: 469 SDVYNYGMMIFEMTGGR 485
           SDVY +G++++E+  G+
Sbjct: 192 SDVYAFGIVLYELMTGQ 208

>pdb|1UWH|A Chain A, The Complex Of Wild Type B-Raf And Bay439006 Length = 276

Iteration: 1
 Score = 98.6 bits (244), Expect = 8e-21,   Method: Compositional matrix adjust.
 Identities = 64/197 (32%), Positives = 104/197 (52%), Gaps = 36/197 (18%)
Query: 320 KLGQGGYGSVYKGKLLDGSNVAVKVLNDSKGNGKE---FINEVASISRTSHVNVVALLGF 376
           ++G G +G+VYKGK     +VAVK+LN +    ++   F NEV  + +T HVN++  +G+
Sbjct: 15  RIGSGSFGTVYKGKW--HGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGY 72
Query: 377 C--------------------LRVAE---ELSSTIGIAR----GLEYLHLGCSTRILHFD 409
                                L + E   E+   I IAR    G++YLH   +  I+H D
Sbjct: 73  STAPQLAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLH---AKSIIHRD 129
Query: 410 IKPHNILLDEDFCPKISDFGLAKICNRKESIISMTGARGTVGYIAPEVF-CRNIGEVSYK 468
           +K +NI L ED   KI DFGLA + +R           G++ ++APEV   ++    S++
Sbjct: 130 LKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQDKNPYSFQ 189
Query: 469 SDVYNYGMMIFEMTGGR 485
           SDVY +G++++E+  G+
Sbjct: 190 SDVYAFGIVLYELMTGQ 206

>pdb|2FB8|A Chain A, Structure Of The B-Raf Kinase Domain Bound To Sb-590885 Length = 281

Iteration: 1
 Score = 98.6 bits (244), Expect = 8e-21,   Method: Compositional matrix adjust.
 Identities = 64/197 (32%), Positives = 104/197 (52%), Gaps = 36/197 (18%)
Query: 320 KLGQGGYGSVYKGKLLDGSNVAVKVLNDSKGNGKE---FINEVASISRTSHVNVVALLGF 376
           ++G G +G+VYKGK     +VAVK+LN +    ++   F NEV  + +T HVN++  +G+
Sbjct: 20  RIGSGSFGTVYKGKW--HGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGY 77
Query: 377 C--------------------LRVAE---ELSSTIGIAR----GLEYLHLGCSTRILHFD 409
                                L + E   E+   I IAR    G++YLH   +  I+H D
Sbjct: 78  STKPQLAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLH---AKSIIHRD 134
Query: 410 IKPHNILLDEDFCPKISDFGLAKICNRKESIISMTGARGTVGYIAPEVF-CRNIGEVSYK 468
           +K +NI L ED   KI DFGLA + +R           G++ ++APEV   ++    S++
Sbjct: 135 LKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQDKNPYSFQ 194
Query: 469 SDVYNYGMMIFEMTGGR 485
           SDVY +G++++E+  G+
Sbjct: 195 SDVYAFGIVLYELMTGQ 211

>pdb|4H58|A Chain A, Braf In Complex With Compound 3 Length = 275

Iteration: 1
 Score = 98.6 bits (244), Expect = 8e-21,   Method: Compositional matrix adjust.
 Identities = 64/197 (32%), Positives = 104/197 (52%), Gaps = 36/197 (18%)
Query: 320 KLGQGGYGSVYKGKLLDGSNVAVKVLNDSKGNGKE---FINEVASISRTSHVNVVALLGF 376
           ++G G +G+VYKGK     +VAVK+LN +    ++   F NEV  + +T HVN++  +G+
Sbjct: 15  RIGSGSFGTVYKGKW--HGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGY 72
Query: 377 C--------------------LRVAE---ELSSTIGIAR----GLEYLHLGCSTRILHFD 409
                                L + E   E+   I IAR    G++YLH   +  I+H D
Sbjct: 73  STKPQLAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLH---AKSIIHRD 129
Query: 410 IKPHNILLDEDFCPKISDFGLAKICNRKESIISMTGARGTVGYIAPEVF-CRNIGEVSYK 468
           +K +NI L ED   KI DFGLA + +R           G++ ++APEV   ++    S++
Sbjct: 130 LKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQDKNPYSFQ 189
Query: 469 SDVYNYGMMIFEMTGGR 485
           SDVY +G++++E+  G+
Sbjct: 190 SDVYAFGIVLYELMTGQ 206

>pdb|3OMV|A Chain A, Crystal Structure Of C-Raf (Raf-1) Length = 307

Iteration: 1
 Score = 98.6 bits (244), Expect = 8e-21,   Method: Compositional matrix adjust.
 Identities = 67/209 (32%), Positives = 108/209 (51%), Gaps = 36/209 (17%)
Query: 307 YADIKKMTNSFKYKLGQGGYGSVYKGKLLDGSNVAVKVL---NDSKGNGKEFINEVASIS 363
           Y +I+        ++G G +G+VYKGK     +VAVK+L   + +    + F NEVA + 
Sbjct: 30  YWEIEASEVMLSTRIGSGSFGTVYKGKW--HGDVAVKILKVVDPTPEQFQAFRNEVAVLR 87
Query: 364 RTSHVNVVALLGFC--------------------LRVAE---ELSSTIGIAR----GLEY 396
           +T HVN++  +G+                     L V E   ++   I IAR    G++Y
Sbjct: 88  KTRHVNILLFMGYMTKDNLAIVTQWCEGSSLYKHLHVQETKFQMFQLIDIARQTAQGMDY 147
Query: 397 LHLGCSTRILHFDIKPHNILLDEDFCPKISDFGLAKICNRKESIISMTGARGTVGYIAPE 456
           LH   +  I+H D+K +NI L E    KI DFGLA + +R      +    G+V ++APE
Sbjct: 148 LH---AKNIIHRDMKSNNIFLHEGLTVKIGDFGLATVKSRWSGSQQVEQPTGSVLWMAPE 204
Query: 457 VF-CRNIGEVSYKSDVYNYGMMIFEMTGG 484
           V   ++    S++SDVY+YG++++E+  G
Sbjct: 205 VIRMQDNNPFSFQSDVYSYGIVLYELMTG 233

>pdb|3II5|A Chain A, The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimidine Inhibitor Length = 306

Iteration: 1
 Score = 98.2 bits (243), Expect = 8e-21,   Method: Compositional matrix adjust.
 Identities = 64/197 (32%), Positives = 104/197 (52%), Gaps = 36/197 (18%)
Query: 320 KLGQGGYGSVYKGKLLDGSNVAVKVLNDSKGNGKE---FINEVASISRTSHVNVVALLGF 376
           ++G G +G+VYKGK     +VAVK+LN +    ++   F NEV  + +T HVN++  +G+
Sbjct: 42  RIGSGSFGTVYKGKW--HGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGY 99
Query: 377 C--------------------LRVAE---ELSSTIGIAR----GLEYLHLGCSTRILHFD 409
                                L + E   E+   I IAR    G++YLH   +  I+H D
Sbjct: 100 STKPQLAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLH---AKSIIHRD 156
Query: 410 IKPHNILLDEDFCPKISDFGLAKICNRKESIISMTGARGTVGYIAPEVF-CRNIGEVSYK 468
           +K +NI L ED   KI DFGLA + +R           G++ ++APEV   ++    S++
Sbjct: 157 LKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQDKNPYSFQ 216
Query: 469 SDVYNYGMMIFEMTGGR 485
           SDVY +G++++E+  G+
Sbjct: 217 SDVYAFGIVLYELMTGQ 233

>pdb|4DBN|A Chain A, Crystal Structure Of The Kinase Domain Of Human B-Raf With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 284

Iteration: 1
 Score = 98.2 bits (243), Expect = 9e-21,   Method: Compositional matrix adjust.
 Identities = 64/197 (32%), Positives = 104/197 (52%), Gaps = 36/197 (18%)
Query: 320 KLGQGGYGSVYKGKLLDGSNVAVKVLNDSKGNGKE---FINEVASISRTSHVNVVALLGF 376
           ++G G +G+VYKGK     +VAVK+LN +    ++   F NEV  + +T HVN++  +G+
Sbjct: 20  RIGSGSFGTVYKGKW--HGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGY 77
Query: 377 C--------------------LRVAE---ELSSTIGIAR----GLEYLHLGCSTRILHFD 409
                                L + E   E+   I IAR    G++YLH   +  I+H D
Sbjct: 78  STKPQLAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLH---AKSIIHRD 134
Query: 410 IKPHNILLDEDFCPKISDFGLAKICNRKESIISMTGARGTVGYIAPEVF-CRNIGEVSYK 468
           +K +NI L ED   KI DFGLA + +R           G++ ++APEV   ++    S++
Sbjct: 135 LKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQDKNPYSFQ 194
Query: 469 SDVYNYGMMIFEMTGGR 485
           SDVY +G++++E+  G+
Sbjct: 195 SDVYAFGIVLYELMTGQ 211

>pdb|3D4Q|A Chain A, Pyrazole-Based Inhibitors Of B-Raf Kinase Length = 307

Iteration: 1
 Score = 98.2 bits (243), Expect = 1e-20,   Method: Compositional matrix adjust.
 Identities = 64/197 (32%), Positives = 104/197 (52%), Gaps = 36/197 (18%)
Query: 320 KLGQGGYGSVYKGKLLDGSNVAVKVLNDSKGNGKE---FINEVASISRTSHVNVVALLGF 376
           ++G G +G+VYKGK     +VAVK+LN +    ++   F NEV  + +T HVN++  +G+
Sbjct: 43  RIGSGSFGTVYKGKW--HGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGY 100
Query: 377 C--------------------LRVAE---ELSSTIGIAR----GLEYLHLGCSTRILHFD 409
                                L + E   E+   I IAR    G++YLH   +  I+H D
Sbjct: 101 STKPQLAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLH---AKSIIHRD 157
Query: 410 IKPHNILLDEDFCPKISDFGLAKICNRKESIISMTGARGTVGYIAPEVF-CRNIGEVSYK 468
           +K +NI L ED   KI DFGLA + +R           G++ ++APEV   ++    S++
Sbjct: 158 LKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQDKNPYSFQ 217
Query: 469 SDVYNYGMMIFEMTGGR 485
           SDVY +G++++E+  G+
Sbjct: 218 SDVYAFGIVLYELMTGQ 234

>pdb|3OG7|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx4032 Length = 289

Iteration: 1
 Score = 96.3 bits (238), Expect = 3e-20,   Method: Compositional matrix adjust.
 Identities = 70/226 (30%), Positives = 114/226 (50%), Gaps = 46/226 (20%)
Query: 320 KLGQGGYGSVYKGKLLDGSNVAVKVLNDSKGNGKE---FINEVASISRTSHVNVVALLGF 376
           ++G G +G+VYKGK     +VAVK+LN +    ++   F NEV  + +T HVN++  +G+
Sbjct: 31  RIGSGSFGTVYKGKW--HGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGY 88
Query: 377 C--------------------LRVAE---ELSSTIGIAR----GLEYLHLGCSTRILHFD 409
                                L  +E   E+   I IAR    G++YLH   +  I+H D
Sbjct: 89  STAPQLAIVTQWCEGSSLYHHLHASETKFEMKKLIDIARQTARGMDYLH---AKSIIHRD 145
Query: 410 IKPHNILLDEDFCPKISDFGLAKICNRKESIISMTGARGTVGYIAPEVF-CRNIGEVSYK 468
           +K +NI L ED   KI DFGLA   +R           G++ ++APEV   ++    S++
Sbjct: 146 LKSNNIFLHEDNTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIRMQDSNPYSFQ 205
Query: 469 SDVYNYGMMIFEMTGGR----------KNVDVVDNGSTALDLQASR 504
           SDVY +G++++E+  G+          + +++V  GS + DL   R
Sbjct: 206 SDVYAFGIVLYELMTGQLPYSNINNRDQIIEMVGRGSLSPDLSKVR 251

>pdb|4FK3|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx3203 Length = 292

Iteration: 1
 Score = 96.3 bits (238), Expect = 3e-20,   Method: Compositional matrix adjust.
 Identities = 70/226 (30%), Positives = 114/226 (50%), Gaps = 46/226 (20%)
Query: 320 KLGQGGYGSVYKGKLLDGSNVAVKVLNDSKGNGKE---FINEVASISRTSHVNVVALLGF 376
           ++G G +G+VYKGK     +VAVK+LN +    ++   F NEV  + +T HVN++  +G+
Sbjct: 31  RIGSGSFGTVYKGKW--HGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGY 88
Query: 377 C--------------------LRVAE---ELSSTIGIAR----GLEYLHLGCSTRILHFD 409
                                L  +E   E+   I IAR    G++YLH   +  I+H D
Sbjct: 89  STKPQLAIVTQWCEGSSLYHHLHASETKFEMKKLIDIARQTARGMDYLH---AKSIIHRD 145
Query: 410 IKPHNILLDEDFCPKISDFGLAKICNRKESIISMTGARGTVGYIAPEVF-CRNIGEVSYK 468
           +K +NI L ED   KI DFGLA   +R           G++ ++APEV   ++    S++
Sbjct: 146 LKSNNIFLHEDNTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIRMQDSNPYSFQ 205
Query: 469 SDVYNYGMMIFEMTGGR----------KNVDVVDNGSTALDLQASR 504
           SDVY +G++++E+  G+          + +++V  GS + DL   R
Sbjct: 206 SDVYAFGIVLYELMTGQLPYSNINNRDQIIEMVGRGSLSPDLSKVR 251

>pdb|1UWJ|A Chain A, The Complex Of Mutant V599e B-raf And Bay439006 Length = 276

Iteration: 1
 Score = 95.9 bits (237), Expect = 4e-20,   Method: Compositional matrix adjust.
 Identities = 64/197 (32%), Positives = 103/197 (52%), Gaps = 36/197 (18%)
Query: 320 KLGQGGYGSVYKGKLLDGSNVAVKVLNDSKGNGKE---FINEVASISRTSHVNVVALLGF 376
           ++G G +G+VYKGK     +VAVK+LN +    ++   F NEV  + +T HVN++  +G+
Sbjct: 15  RIGSGSFGTVYKGKW--HGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGY 72
Query: 377 C--------------------LRVAE---ELSSTIGIAR----GLEYLHLGCSTRILHFD 409
                                L + E   E+   I IAR    G++YLH   +  I+H D
Sbjct: 73  STKPQLAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLH---AKSIIHRD 129
Query: 410 IKPHNILLDEDFCPKISDFGLAKICNRKESIISMTGARGTVGYIAPEVF-CRNIGEVSYK 468
           +K +NI L ED   KI DFGLA   +R           G++ ++APEV   ++    S++
Sbjct: 130 LKSNNIFLHEDLTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIRMQDKNPYSFQ 189
Query: 469 SDVYNYGMMIFEMTGGR 485
           SDVY +G++++E+  G+
Sbjct: 190 SDVYAFGIVLYELMTGQ 206

>pdb|3IDP|A Chain A, B-Raf V600e Kinase Domain In Complex With An Aminoisoquinoline Inhibitor Length = 300

Iteration: 1
 Score = 95.9 bits (237), Expect = 4e-20,   Method: Compositional matrix adjust.
 Identities = 64/197 (32%), Positives = 103/197 (52%), Gaps = 36/197 (18%)
Query: 320 KLGQGGYGSVYKGKLLDGSNVAVKVLNDSKGNGKE---FINEVASISRTSHVNVVALLGF 376
           ++G G +G+VYKGK     +VAVK+LN +    ++   F NEV  + +T HVN++  +G+
Sbjct: 35  RIGSGSFGTVYKGKW--HGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGY 92
Query: 377 C--------------------LRVAE---ELSSTIGIAR----GLEYLHLGCSTRILHFD 409
                                L + E   E+   I IAR    G++YLH   +  I+H D
Sbjct: 93  STKPQLAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLH---AKSIIHRD 149
Query: 410 IKPHNILLDEDFCPKISDFGLAKICNRKESIISMTGARGTVGYIAPEVF-CRNIGEVSYK 468
           +K +NI L ED   KI DFGLA   +R           G++ ++APEV   ++    S++
Sbjct: 150 LKSNNIFLHEDLTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIRMQDKNPYSFQ 209
Query: 469 SDVYNYGMMIFEMTGGR 485
           SDVY +G++++E+  G+
Sbjct: 210 SDVYAFGIVLYELMTGQ 226

>pdb|4G9R|A Chain A, B-Raf V600e Kinase Domain Bound To A Type Ii Dihydroquinazoline Inhibitor Length = 307

Iteration: 1
 Score = 95.9 bits (237), Expect = 5e-20,   Method: Compositional matrix adjust.
 Identities = 64/197 (32%), Positives = 103/197 (52%), Gaps = 36/197 (18%)
Query: 320 KLGQGGYGSVYKGKLLDGSNVAVKVLNDSKGNGKE---FINEVASISRTSHVNVVALLGF 376
           ++G G +G+VYKGK     +VAVK+LN +    ++   F NEV  + +T HVN++  +G+
Sbjct: 43  RIGSGSFGTVYKGKW--HGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGY 100
Query: 377 C--------------------LRVAE---ELSSTIGIAR----GLEYLHLGCSTRILHFD 409
                                L + E   E+   I IAR    G++YLH   +  I+H D
Sbjct: 101 STKPQLAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLH---AKSIIHRD 157
Query: 410 IKPHNILLDEDFCPKISDFGLAKICNRKESIISMTGARGTVGYIAPEVF-CRNIGEVSYK 468
           +K +NI L ED   KI DFGLA   +R           G++ ++APEV   ++    S++
Sbjct: 158 LKSNNIFLHEDLTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIRMQDKNPYSFQ 217
Query: 469 SDVYNYGMMIFEMTGGR 485
           SDVY +G++++E+  G+
Sbjct: 218 SDVYAFGIVLYELMTGQ 234

>pdb|2O8Y|A Chain A, Apo Irak4 Kinase Domain Length = 298

Iteration: 1
 Score = 95.9 bits (237), Expect = 5e-20,   Method: Compositional matrix adjust.
 Identities = 72/228 (31%), Positives = 107/228 (46%), Gaps = 50/228 (21%)
Query: 305 YGYADIKKMTNSFKY--------KLGQGGYGSVYKGKLLDGSNVAVKVLN-----DSKGN 351
           + + ++K +TN+F          K G+GG+G VYKG  ++ + VAVK L       ++  
Sbjct: 6   FSFYELKNVTNNFDERPISVGGNKXGEGGFGVVYKG-YVNNTTVAVKKLAAMVDITTEEL 64
Query: 352 GKEFINEVASISRTSHVNVVALLGF------------------------CLRVAEELSS- 386
            ++F  E+   ++  H N+V LLGF                        CL     LS  
Sbjct: 65  KQQFDQEIKVXAKCQHENLVELLGFSSDGDDLCLVYVYXPNGSLLDRLSCLDGTPPLSWH 124
Query: 387 -----TIGIARGLEYLHLGCSTRILHFDIKPHNILLDEDFCPKISDFGLAKICNRKESII 441
                  G A G+ +LH       +H DIK  NILLDE F  KISDFGLA+   +    +
Sbjct: 125 XRCKIAQGAANGINFLH---ENHHIHRDIKSANILLDEAFTAKISDFGLARASEKFAQXV 181
Query: 442 SMTGARGTVGYIAPEVFCRNIGEVSYKSDVYNYGMMIFEMTGGRKNVD 489
             +   GT  Y APE      GE++ KSD+Y++G+++ E+  G   VD
Sbjct: 182 XXSRIVGTTAYXAPEALR---GEITPKSDIYSFGVVLLEIITGLPAVD 226

>pdb|3P86|A Chain A, Crystal Structure Of Ctr1 Kinase Domain Mutant D676n In Complex With Staurosporine Length = 309

Iteration: 1
 Score = 85.9 bits (211), Expect = 5e-17,   Method: Compositional matrix adjust.
 Identities = 60/207 (28%), Positives = 105/207 (50%), Gaps = 39/207 (18%)
Query: 309 DIKKMTNSFKYKLGQGGYGSVYKGKLLDGSNVAVKVLNDSKGNGK---EFINEVASISRT 365
           DI     + K K+G G +G+V++ +   GS+VAVK+L +   + +   EF+ EVA + R 
Sbjct: 33  DIPWCDLNIKEKIGAGSFGTVHRAEW-HGSDVAVKILMEQDFHAERVNEFLREVAIMKRL 91
Query: 366 SHVNVVALLGFC-----LRVAEE-------------------------LSSTIGIARGLE 395
            H N+V  +G       L +  E                         LS    +A+G+ 
Sbjct: 92  RHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMN 151
Query: 396 YLHLGCSTRILHFDIKPHNILLDEDFCPKISDFGLAKICNRKESIISMTGARGTVGYIAP 455
           YLH   +  I+H ++K  N+L+D+ +  K+ DFGL+++  +  + +S   A GT  ++AP
Sbjct: 152 YLH-NRNPPIVHRNLKSPNLLVDKKYTVKVCDFGLSRL--KASTFLSSKSAAGTPEWMAP 208
Query: 456 EVFCRNIGEVSYKSDVYNYGMMIFEMT 482
           EV        + KSDVY++G++++E+ 
Sbjct: 209 EVLRDEPS--NEKSDVYSFGVILWELA 233

>pdb|3PPZ|A Chain A, Crystal Structure Of Ctr1 Kinase Domain In Complex With Staurosporine Length = 309

Iteration: 1
 Score = 84.7 bits (208), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 60/207 (28%), Positives = 103/207 (49%), Gaps = 39/207 (18%)
Query: 309 DIKKMTNSFKYKLGQGGYGSVYKGKLLDGSNVAVKVLNDSKGNGK---EFINEVASISRT 365
           DI     + K K+G G +G+V++ +   GS+VAVK+L +   + +   EF+ EVA + R 
Sbjct: 33  DIPWCDLNIKEKIGAGSFGTVHRAEW-HGSDVAVKILMEQDFHAERVNEFLREVAIMKRL 91
Query: 366 SHVNVVALLGFC-----LRVAEE-------------------------LSSTIGIARGLE 395
            H N+V  +G       L +  E                         LS    +A+G+ 
Sbjct: 92  RHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMN 151
Query: 396 YLHLGCSTRILHFDIKPHNILLDEDFCPKISDFGLAKICNRKESIISMTGARGTVGYIAP 455
           YLH   +  I+H D+K  N+L+D+ +  K+ DFGL+++  +    +    A GT  ++AP
Sbjct: 152 YLH-NRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRL--KASXFLXSKXAAGTPEWMAP 208
Query: 456 EVFCRNIGEVSYKSDVYNYGMMIFEMT 482
           EV        + KSDVY++G++++E+ 
Sbjct: 209 EVLRDEPS--NEKSDVYSFGVILWELA 233

>pdb|1FPU|A Chain A, Crystal Structure Of Abl Kinase Domain In Complex With A Small Molecule Inhibitor Length = 293

Iteration: 1
 Score = 84.0 bits (206), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 59/212 (27%), Positives = 100/212 (47%), Gaps = 36/212 (16%)
Query: 301 SPKRYGYADIKKMTNSFKYKLGQGGYGSVYKGKLLDGS-NVAVKVLNDSKGNGKEFINEV 359
           S   Y   ++++   + K+KLG G YG VY+G     S  VAVK L +     +EF+ E 
Sbjct: 6   SSPNYDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEA 65
Query: 360 ASISRTSHVNVVALLGFCLRVA-----------------------EELSSTI------GI 390
           A +    H N+V LLG C R                         +E+S+ +       I
Sbjct: 66  AVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQI 125
Query: 391 ARGLEYLHLGCSTRILHFDIKPHNILLDEDFCPKISDFGLAKICNRKESIISMTGARGTV 450
           +  +EYL        +H D+   N L+ E+   K++DFGL+++    ++  +  GA+  +
Sbjct: 126 SSAMEYLE---KKNFIHRDLAARNCLVGENHLVKVADFGLSRLMT-GDTYTAHAGAKFPI 181
Query: 451 GYIAPEVFCRNIGEVSYKSDVYNYGMMIFEMT 482
            + APE    N  + S KSDV+ +G++++E+ 
Sbjct: 182 KWTAPESLAYN--KFSIKSDVWAFGVLLWEIA 211

>pdb|3OXZ|A Chain A, Crystal Structure Of Abl Kinase Domain Bound With A Dfg-Out Inhibitor Ap24534 Length = 284

Iteration: 1
 Score = 83.6 bits (205), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 58/208 (27%), Positives = 99/208 (47%), Gaps = 36/208 (17%)
Query: 305 YGYADIKKMTNSFKYKLGQGGYGSVYKGKLLDGS-NVAVKVLNDSKGNGKEFINEVASIS 363
           Y   ++++   + K+KLG G YG VY+G     S  VAVK L +     +EF+ E A + 
Sbjct: 5   YDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMK 64
Query: 364 RTSHVNVVALLGFCLRVA-----------------------EELSSTI------GIARGL 394
              H N+V LLG C R                         +E+S+ +       I+  +
Sbjct: 65  EIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAM 124
Query: 395 EYLHLGCSTRILHFDIKPHNILLDEDFCPKISDFGLAKICNRKESIISMTGARGTVGYIA 454
           EYL        +H D+   N L+ E+   K++DFGL+++    ++  +  GA+  + + A
Sbjct: 125 EYLE---KKNFIHRDLAARNCLVGENHLVKVADFGLSRLMT-GDTYTAHAGAKFPIKWTA 180
Query: 455 PEVFCRNIGEVSYKSDVYNYGMMIFEMT 482
           PE    N  + S KSDV+ +G++++E+ 
Sbjct: 181 PESLAYN--KFSIKSDVWAFGVLLWEIA 206

>pdb|3OY3|A Chain A, Crystal Structure Of Abl T315i Mutant Kinase Domain Bound With A Dfg- Out Inhibitor Ap24589 Length = 284

Iteration: 1
 Score = 83.6 bits (205), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 58/208 (27%), Positives = 99/208 (47%), Gaps = 36/208 (17%)
Query: 305 YGYADIKKMTNSFKYKLGQGGYGSVYKGKLLDGS-NVAVKVLNDSKGNGKEFINEVASIS 363
           Y   ++++   + K+KLG G YG VY+G     S  VAVK L +     +EF+ E A + 
Sbjct: 5   YDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMK 64
Query: 364 RTSHVNVVALLGFCLRVA-----------------------EELSSTI------GIARGL 394
              H N+V LLG C R                         +E+S+ +       I+  +
Sbjct: 65  EIKHPNLVQLLGVCTREPPFYIIIEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAM 124
Query: 395 EYLHLGCSTRILHFDIKPHNILLDEDFCPKISDFGLAKICNRKESIISMTGARGTVGYIA 454
           EYL        +H D+   N L+ E+   K++DFGL+++    ++  +  GA+  + + A
Sbjct: 125 EYLE---KKNFIHRDLAARNCLVGENHLVKVADFGLSRLMT-GDTYTAHAGAKFPIKWTA 180
Query: 455 PEVFCRNIGEVSYKSDVYNYGMMIFEMT 482
           PE    N  + S KSDV+ +G++++E+ 
Sbjct: 181 PESLAYN--KFSIKSDVWAFGVLLWEIA 206

>pdb|2QOH|A Chain A, Crystal Structure Of Abl Kinase Bound With Ppy-a Length = 288

Iteration: 1
 Score = 83.6 bits (205), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 58/208 (27%), Positives = 99/208 (47%), Gaps = 36/208 (17%)
Query: 305 YGYADIKKMTNSFKYKLGQGGYGSVYKGKLLDGS-NVAVKVLNDSKGNGKEFINEVASIS 363
           Y   ++++   + K+KLG G YG VY+G     S  VAVK L +     +EF+ E A + 
Sbjct: 5   YDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMK 64
Query: 364 RTSHVNVVALLGFCLRVA-----------------------EELSSTI------GIARGL 394
              H N+V LLG C R                         +E+S+ +       I+  +
Sbjct: 65  EIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAM 124
Query: 395 EYLHLGCSTRILHFDIKPHNILLDEDFCPKISDFGLAKICNRKESIISMTGARGTVGYIA 454
           EYL        +H D+   N L+ E+   K++DFGL+++    ++  +  GA+  + + A
Sbjct: 125 EYLE---KKNFIHRDLAARNCLVGENHLVKVADFGLSRLMT-GDTYTAHAGAKFPIKWTA 180
Query: 455 PEVFCRNIGEVSYKSDVYNYGMMIFEMT 482
           PE    N  + S KSDV+ +G++++E+ 
Sbjct: 181 PESLAYN--KFSIKSDVWAFGVLLWEIA 206

>pdb|3DK3|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293

Iteration: 1
 Score = 83.2 bits (204), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 57/204 (27%), Positives = 98/204 (48%), Gaps = 36/204 (17%)
Query: 309 DIKKMTNSFKYKLGQGGYGSVYKGKLLDGS-NVAVKVLNDSKGNGKEFINEVASISRTSH 367
           ++++   + K+KLG G YG VY+G     S  VAVK L +     +EF+ E A +    H
Sbjct: 7   EMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKH 66
Query: 368 VNVVALLGFCLRVA-----------------------EELSSTI------GIARGLEYLH 398
            N+V LLG C R                         +E+S+ +       I+  +EYL 
Sbjct: 67  PNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLE 126
Query: 399 LGCSTRILHFDIKPHNILLDEDFCPKISDFGLAKICNRKESIISMTGARGTVGYIAPEVF 458
                  +H D+   N L+ E+   K++DFGL+++    ++  +  GA+  + + APE  
Sbjct: 127 ---KKNFIHRDLAARNCLVGENHLVKVADFGLSRLMT-GDTFTAHAGAKFPIKWTAPESL 182
Query: 459 CRNIGEVSYKSDVYNYGMMIFEMT 482
             N  + S KSDV+ +G++++E+ 
Sbjct: 183 AYN--KFSIKSDVWAFGVLLWEIA 204

>pdb|2Z60|A Chain A, Crystal Structure Of The T315i Mutant Of Abl Kinase Bound With Ppy-A Length = 288

Iteration: 1
 Score = 83.2 bits (204), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 58/208 (27%), Positives = 99/208 (47%), Gaps = 36/208 (17%)
Query: 305 YGYADIKKMTNSFKYKLGQGGYGSVYKGKLLDGS-NVAVKVLNDSKGNGKEFINEVASIS 363
           Y   ++++   + K+KLG G YG VY+G     S  VAVK L +     +EF+ E A + 
Sbjct: 5   YDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMK 64
Query: 364 RTSHVNVVALLGFCLRVA-----------------------EELSSTI------GIARGL 394
              H N+V LLG C R                         +E+S+ +       I+  +
Sbjct: 65  EIKHPNLVQLLGVCTREPPFYIIIEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAM 124
Query: 395 EYLHLGCSTRILHFDIKPHNILLDEDFCPKISDFGLAKICNRKESIISMTGARGTVGYIA 454
           EYL        +H D+   N L+ E+   K++DFGL+++    ++  +  GA+  + + A
Sbjct: 125 EYLE---KKNFIHRDLAARNCLVGENHLVKVADFGLSRLMT-GDTYTAHAGAKFPIKWTA 180
Query: 455 PEVFCRNIGEVSYKSDVYNYGMMIFEMT 482
           PE    N  + S KSDV+ +G++++E+ 
Sbjct: 181 PESLAYN--KFSIKSDVWAFGVLLWEIA 206

>pdb|4GG5|A Chain A, Crystal Structure Of Cmet In Complex With Novel Inhibitor Length = 319

Iteration: 1
 Score = 83.2 bits (204), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 70/227 (30%), Positives = 108/227 (47%), Gaps = 44/227 (19%)
Query: 317 FKYKLGQGGYGSVYKGKLLD--GSNV--AVKVLN--DSKGNGKEFINEVASISRTSHVNV 370
           F   +G+G +G VY G LLD  G  +  AVK LN     G   +F+ E   +   SH NV
Sbjct: 53  FNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNV 112
Query: 371 VALLGFCLR-----------------------------VAEELSSTIGIARGLEYLHLGC 401
           ++LLG CLR                             V + +   + +A+G++YL    
Sbjct: 113 LSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYL---A 169
Query: 402 STRILHFDIKPHNILLDEDFCPKISDFGLAKICNRKE--SIISMTGARGTVGYIAPEVFC 459
           S + +H D+   N +LDE F  K++DFGLA+    KE  S+ + TGA+  V ++A E   
Sbjct: 170 SKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALESL- 228
Query: 460 RNIGEVSYKSDVYNYGMMIFEMT--GGRKNVDVVDNGSTALDLQASR 504
               + + KSDV+++G++++E+   G     DV     T   LQ  R
Sbjct: 229 -QTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGRR 274

>pdb|2RFN|A Chain A, X-ray Structure Of C-met With Inhibitor. Length = 310

Iteration: 1
 Score = 83.2 bits (204), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 70/227 (30%), Positives = 108/227 (47%), Gaps = 44/227 (19%)
Query: 317 FKYKLGQGGYGSVYKGKLLD--GSNV--AVKVLN--DSKGNGKEFINEVASISRTSHVNV 370
           F   +G+G +G VY G LLD  G  +  AVK LN     G   +F+ E   +   SH NV
Sbjct: 34  FNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNV 93
Query: 371 VALLGFCLR-----------------------------VAEELSSTIGIARGLEYLHLGC 401
           ++LLG CLR                             V + +   + +A+G++YL    
Sbjct: 94  LSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYL---A 150
Query: 402 STRILHFDIKPHNILLDEDFCPKISDFGLAKICNRKE--SIISMTGARGTVGYIAPEVFC 459
           S + +H D+   N +LDE F  K++DFGLA+    KE  S+ + TGA+  V ++A E   
Sbjct: 151 SKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALESL- 209
Query: 460 RNIGEVSYKSDVYNYGMMIFEMT--GGRKNVDVVDNGSTALDLQASR 504
               + + KSDV+++G++++E+   G     DV     T   LQ  R
Sbjct: 210 -QTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGRR 255

>pdb|3DK7|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 277

Iteration: 1
 Score = 83.2 bits (204), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 57/204 (27%), Positives = 98/204 (48%), Gaps = 36/204 (17%)
Query: 309 DIKKMTNSFKYKLGQGGYGSVYKGKLLDGS-NVAVKVLNDSKGNGKEFINEVASISRTSH 367
           ++++   + K+KLG G YG VY+G     S  VAVK L +     +EF+ E A +    H
Sbjct: 7   EMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKH 66
Query: 368 VNVVALLGFCLRVA-----------------------EELSSTI------GIARGLEYLH 398
            N+V LLG C R                         +E+S+ +       I+  +EYL 
Sbjct: 67  PNLVQLLGVCTREPPFYIIIEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLE 126
Query: 399 LGCSTRILHFDIKPHNILLDEDFCPKISDFGLAKICNRKESIISMTGARGTVGYIAPEVF 458
                  +H D+   N L+ E+   K++DFGL+++    ++  +  GA+  + + APE  
Sbjct: 127 ---KKNFIHRDLAARNCLVGENHLVKVADFGLSRLMT-GDTXTAHAGAKFPIKWTAPESL 182
Query: 459 CRNIGEVSYKSDVYNYGMMIFEMT 482
             N  + S KSDV+ +G++++E+ 
Sbjct: 183 AYN--KFSIKSDVWAFGVLLWEIA 204

>pdb|3Q6W|A Chain A, Structure Of Dually-phosphorylated Met Receptor Kinase In Complex With An Mk-2461 Analog With Specificity For The Activated Receptor Length = 307

Iteration: 1
 Score = 83.2 bits (204), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 70/227 (30%), Positives = 108/227 (47%), Gaps = 44/227 (19%)
Query: 317 FKYKLGQGGYGSVYKGKLLD--GSNV--AVKVLN--DSKGNGKEFINEVASISRTSHVNV 370
           F   +G+G +G VY G LLD  G  +  AVK LN     G   +F+ E   +   SH NV
Sbjct: 33  FNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNV 92
Query: 371 VALLGFCLR-----------------------------VAEELSSTIGIARGLEYLHLGC 401
           ++LLG CLR                             V + +   + +A+G++YL    
Sbjct: 93  LSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYL---A 149
Query: 402 STRILHFDIKPHNILLDEDFCPKISDFGLAKICNRKE--SIISMTGARGTVGYIAPEVFC 459
           S + +H D+   N +LDE F  K++DFGLA+    KE  S+ + TGA+  V ++A E   
Sbjct: 150 SKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEXXSVHNKTGAKLPVKWMALESL- 208
Query: 460 RNIGEVSYKSDVYNYGMMIFEMT--GGRKNVDVVDNGSTALDLQASR 504
               + + KSDV+++G++++E+   G     DV     T   LQ  R
Sbjct: 209 -QTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGRR 254

>pdb|3I5N|A Chain A, Crystal Structure Of C-Met With Triazolopyridazine Inhibitor 13 Length = 309

Iteration: 1
 Score = 83.2 bits (204), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 70/227 (30%), Positives = 108/227 (47%), Gaps = 44/227 (19%)
Query: 317 FKYKLGQGGYGSVYKGKLLD--GSNV--AVKVLN--DSKGNGKEFINEVASISRTSHVNV 370
           F   +G+G +G VY G LLD  G  +  AVK LN     G   +F+ E   +   SH NV
Sbjct: 33  FNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNV 92
Query: 371 VALLGFCLR-----------------------------VAEELSSTIGIARGLEYLHLGC 401
           ++LLG CLR                             V + +   + +A+G++YL    
Sbjct: 93  LSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYL---A 149
Query: 402 STRILHFDIKPHNILLDEDFCPKISDFGLAKICNRKE--SIISMTGARGTVGYIAPEVFC 459
           S + +H D+   N +LDE F  K++DFGLA+    KE  S+ + TGA+  V ++A E   
Sbjct: 150 SKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALESL- 208
Query: 460 RNIGEVSYKSDVYNYGMMIFEMT--GGRKNVDVVDNGSTALDLQASR 504
               + + KSDV+++G++++E+   G     DV     T   LQ  R
Sbjct: 209 -QTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGRR 254

>pdb|2WD1|A Chain A, Human C-Met Kinase In Complex With Azaindole Inhibitor Length = 292

Iteration: 1
 Score = 82.8 bits (203), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 70/227 (30%), Positives = 108/227 (47%), Gaps = 44/227 (19%)
Query: 317 FKYKLGQGGYGSVYKGKLLD--GSNV--AVKVLN--DSKGNGKEFINEVASISRTSHVNV 370
           F   +G+G +G VY G LLD  G  +  AVK LN     G   +F+ E   +   SH NV
Sbjct: 26  FNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNV 85
Query: 371 VALLGFCLR-----------------------------VAEELSSTIGIARGLEYLHLGC 401
           ++LLG CLR                             V + +   + +A+G++YL    
Sbjct: 86  LSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYL---A 142
Query: 402 STRILHFDIKPHNILLDEDFCPKISDFGLAKICNRKE--SIISMTGARGTVGYIAPEVFC 459
           S + +H D+   N +LDE F  K++DFGLA+    KE  S+ + TGA+  V ++A E   
Sbjct: 143 SKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALESL- 201
Query: 460 RNIGEVSYKSDVYNYGMMIFEMT--GGRKNVDVVDNGSTALDLQASR 504
               + + KSDV+++G++++E+   G     DV     T   LQ  R
Sbjct: 202 -QTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGRR 247

>pdb|3F66|A Chain A, Human C-Met Kinase In Complex With Quinoxaline Inhibitor Length = 298

Iteration: 1
 Score = 82.8 bits (203), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 70/227 (30%), Positives = 108/227 (47%), Gaps = 44/227 (19%)
Query: 317 FKYKLGQGGYGSVYKGKLLD--GSNV--AVKVLN--DSKGNGKEFINEVASISRTSHVNV 370
           F   +G+G +G VY G LLD  G  +  AVK LN     G   +F+ E   +   SH NV
Sbjct: 29  FNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNV 88
Query: 371 VALLGFCLR-----------------------------VAEELSSTIGIARGLEYLHLGC 401
           ++LLG CLR                             V + +   + +A+G++YL    
Sbjct: 89  LSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYL---A 145
Query: 402 STRILHFDIKPHNILLDEDFCPKISDFGLAKICNRKE--SIISMTGARGTVGYIAPEVFC 459
           S + +H D+   N +LDE F  K++DFGLA+    KE  S+ + TGA+  V ++A E   
Sbjct: 146 SKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALESL- 204
Query: 460 RNIGEVSYKSDVYNYGMMIFEMT--GGRKNVDVVDNGSTALDLQASR 504
               + + KSDV+++G++++E+   G     DV     T   LQ  R
Sbjct: 205 -QTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGRR 250

>pdb|3Q6U|A Chain A, Structure Of The Apo Met Receptor Kinase In The Dually-Phosphorylated, Activated State Length = 308

Iteration: 1
 Score = 82.8 bits (203), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 70/227 (30%), Positives = 108/227 (47%), Gaps = 44/227 (19%)
Query: 317 FKYKLGQGGYGSVYKGKLLD--GSNV--AVKVLN--DSKGNGKEFINEVASISRTSHVNV 370
           F   +G+G +G VY G LLD  G  +  AVK LN     G   +F+ E   +   SH NV
Sbjct: 34  FNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNV 93
Query: 371 VALLGFCLR-----------------------------VAEELSSTIGIARGLEYLHLGC 401
           ++LLG CLR                             V + +   + +A+G++YL    
Sbjct: 94  LSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYL---A 150
Query: 402 STRILHFDIKPHNILLDEDFCPKISDFGLAKICNRKE--SIISMTGARGTVGYIAPEVFC 459
           S + +H D+   N +LDE F  K++DFGLA+    KE  S+ + TGA+  V ++A E   
Sbjct: 151 SKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALESL- 209
Query: 460 RNIGEVSYKSDVYNYGMMIFEMT--GGRKNVDVVDNGSTALDLQASR 504
               + + KSDV+++G++++E+   G     DV     T   LQ  R
Sbjct: 210 -QTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGRR 255

>pdb|2G15|A Chain A, Structural Characterization Of Autoinhibited C-Met Kinase Length = 318

Iteration: 1
 Score = 82.8 bits (203), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 70/227 (30%), Positives = 108/227 (47%), Gaps = 44/227 (19%)
Query: 317 FKYKLGQGGYGSVYKGKLLD--GSNV--AVKVLN--DSKGNGKEFINEVASISRTSHVNV 370
           F   +G+G +G VY G LLD  G  +  AVK LN     G   +F+ E   +   SH NV
Sbjct: 52  FNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNV 111
Query: 371 VALLGFCLR-----------------------------VAEELSSTIGIARGLEYLHLGC 401
           ++LLG CLR                             V + +   + +A+G++YL    
Sbjct: 112 LSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYL---A 168
Query: 402 STRILHFDIKPHNILLDEDFCPKISDFGLAKICNRKE--SIISMTGARGTVGYIAPEVFC 459
           S + +H D+   N +LDE F  K++DFGLA+    KE  S+ + TGA+  V ++A E   
Sbjct: 169 SKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALESL- 227
Query: 460 RNIGEVSYKSDVYNYGMMIFEMT--GGRKNVDVVDNGSTALDLQASR 504
               + + KSDV+++G++++E+   G     DV     T   LQ  R
Sbjct: 228 -QTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGRR 273

>pdb|2WGJ|A Chain A, X-Ray Structure Of Pf-02341066 Bound To The Kinase Domain Of C-Met Length = 306

Iteration: 1
 Score = 82.8 bits (203), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 70/227 (30%), Positives = 108/227 (47%), Gaps = 44/227 (19%)
Query: 317 FKYKLGQGGYGSVYKGKLLD--GSNV--AVKVLN--DSKGNGKEFINEVASISRTSHVNV 370
           F   +G+G +G VY G LLD  G  +  AVK LN     G   +F+ E   +   SH NV
Sbjct: 31  FNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNV 90
Query: 371 VALLGFCLR-----------------------------VAEELSSTIGIARGLEYLHLGC 401
           ++LLG CLR                             V + +   + +A+G++YL    
Sbjct: 91  LSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYL---A 147
Query: 402 STRILHFDIKPHNILLDEDFCPKISDFGLAKICNRKE--SIISMTGARGTVGYIAPEVFC 459
           S + +H D+   N +LDE F  K++DFGLA+    KE  S+ + TGA+  V ++A E   
Sbjct: 148 SKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALESL- 206
Query: 460 RNIGEVSYKSDVYNYGMMIFEMT--GGRKNVDVVDNGSTALDLQASR 504
               + + KSDV+++G++++E+   G     DV     T   LQ  R
Sbjct: 207 -QTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGRR 252

>pdb|3LQ8|A Chain A, Structure Of The Kinase Domain Of C-Met Bound To Xl880 (Gsk1 Length = 302

Iteration: 1
 Score = 82.8 bits (203), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 70/227 (30%), Positives = 108/227 (47%), Gaps = 44/227 (19%)
Query: 317 FKYKLGQGGYGSVYKGKLLD--GSNV--AVKVLN--DSKGNGKEFINEVASISRTSHVNV 370
           F   +G+G +G VY G LLD  G  +  AVK LN     G   +F+ E   +   SH NV
Sbjct: 32  FNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNV 91
Query: 371 VALLGFCLR-----------------------------VAEELSSTIGIARGLEYLHLGC 401
           ++LLG CLR                             V + +   + +A+G++YL    
Sbjct: 92  LSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYL---A 148
Query: 402 STRILHFDIKPHNILLDEDFCPKISDFGLAKICNRKE--SIISMTGARGTVGYIAPEVFC 459
           S + +H D+   N +LDE F  K++DFGLA+    KE  S+ + TGA+  V ++A E   
Sbjct: 149 SKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALESL- 207
Query: 460 RNIGEVSYKSDVYNYGMMIFEMT--GGRKNVDVVDNGSTALDLQASR 504
               + + KSDV+++G++++E+   G     DV     T   LQ  R
Sbjct: 208 -QTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGRR 253

>pdb|2GQG|A Chain A, X-Ray Crystal Structure Of Dasatinib (Bms-354825) Bound To Activated Abl Kinase Domain Length = 278

Iteration: 1
 Score = 82.4 bits (202), Expect = 5e-16,   Method: Compositional matrix adjust.
 Identities = 58/212 (27%), Positives = 100/212 (47%), Gaps = 36/212 (16%)
Query: 301 SPKRYGYADIKKMTNSFKYKLGQGGYGSVYKGKLLDGS-NVAVKVLNDSKGNGKEFINEV 359
           S   Y   ++++   + K+KLG G YG VY+G     S  VAVK L +     +EF+ E 
Sbjct: 6   SSPNYDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEA 65
Query: 360 ASISRTSHVNVVALLGFCLRVA-----------------------EELSSTI------GI 390
           A +    H N+V LLG C R                         +E+++ +       I
Sbjct: 66  AVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQI 125
Query: 391 ARGLEYLHLGCSTRILHFDIKPHNILLDEDFCPKISDFGLAKICNRKESIISMTGARGTV 450
           +  +EYL        +H D+   N L+ E+   K++DFGL+++    ++  +  GA+  +
Sbjct: 126 SSAMEYLE---KKNFIHRDLAARNCLVGENHLVKVADFGLSRLMT-GDTXTAHAGAKFPI 181
Query: 451 GYIAPEVFCRNIGEVSYKSDVYNYGMMIFEMT 482
            + APE    N  + S KSDV+ +G++++E+ 
Sbjct: 182 KWTAPESLAYN--KFSIKSDVWAFGVLLWEIA 211

>pdb|3QRI|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain In Complex With Dcc- 2036 Length = 277

Iteration: 1
 Score = 82.4 bits (202), Expect = 5e-16,   Method: Compositional matrix adjust.
 Identities = 58/212 (27%), Positives = 100/212 (47%), Gaps = 36/212 (16%)
Query: 301 SPKRYGYADIKKMTNSFKYKLGQGGYGSVYKGKLLDGS-NVAVKVLNDSKGNGKEFINEV 359
           S   Y   ++++   + K+KLG G YG VY+G     S  VAVK L +     +EF+ E 
Sbjct: 6   SSPNYDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEA 65
Query: 360 ASISRTSHVNVVALLGFCLRVA-----------------------EELSSTI------GI 390
           A +    H N+V LLG C R                         +E+++ +       I
Sbjct: 66  AVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQI 125
Query: 391 ARGLEYLHLGCSTRILHFDIKPHNILLDEDFCPKISDFGLAKICNRKESIISMTGARGTV 450
           +  +EYL        +H D+   N L+ E+   K++DFGL+++    ++  +  GA+  +
Sbjct: 126 SSAMEYLE---KKNFIHRDLAARNCLVGENHLVKVADFGLSRLMT-GDTYTAHAGAKFPI 181
Query: 451 GYIAPEVFCRNIGEVSYKSDVYNYGMMIFEMT 482
            + APE    N  + S KSDV+ +G++++E+ 
Sbjct: 182 KWTAPESLAYN--KFSIKSDVWAFGVLLWEIA 211

>pdb|2G1T|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287

Iteration: 1
 Score = 82.4 bits (202), Expect = 5e-16,   Method: Compositional matrix adjust.
 Identities = 59/213 (27%), Positives = 102/213 (47%), Gaps = 37/213 (17%)
Query: 300 LSPKRYGYADIKKMTNSFKYKLGQGGYGSVYKGKLLDGS-NVAVKVLNDSKGNGKEFINE 358
           +SP  Y   ++++   + K+KLG G YG VY+G     S  VAVK L +     +EF+ E
Sbjct: 3   MSP-NYDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKE 61
Query: 359 VASISRTSHVNVVALLGFCLRVA-----------------------EELSSTI------G 389
            A +    H N+V LLG C R                         +E+++ +       
Sbjct: 62  AAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQ 121
Query: 390 IARGLEYLHLGCSTRILHFDIKPHNILLDEDFCPKISDFGLAKICNRKESIISMTGARGT 449
           I+  +EYL        +H D+   N L+ E+   K++DFGL+++    ++  +  GA+  
Sbjct: 122 ISSAMEYLE---KKNFIHRDLAARNCLVGENHLVKVADFGLSRLMT-GDTYTAHAGAKFP 177
Query: 450 VGYIAPEVFCRNIGEVSYKSDVYNYGMMIFEMT 482
           + + APE    N  + S KSDV+ +G++++E+ 
Sbjct: 178 IKWTAPESLAYN--KFSIKSDVWAFGVLLWEIA 208

>pdb|3QRJ|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain T315i Mutant In Complex With Dcc-2036 Length = 277

Iteration: 1
 Score = 82.4 bits (202), Expect = 6e-16,   Method: Compositional matrix adjust.
 Identities = 58/212 (27%), Positives = 100/212 (47%), Gaps = 36/212 (16%)
Query: 301 SPKRYGYADIKKMTNSFKYKLGQGGYGSVYKGKLLDGS-NVAVKVLNDSKGNGKEFINEV 359
           S   Y   ++++   + K+KLG G YG VY+G     S  VAVK L +     +EF+ E 
Sbjct: 6   SSPNYDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEA 65
Query: 360 ASISRTSHVNVVALLGFCLRVA-----------------------EELSSTI------GI 390
           A +    H N+V LLG C R                         +E+++ +       I
Sbjct: 66  AVMKEIKHPNLVQLLGVCTREPPFYIIIEFMTYGNLLDYLRECNRQEVNAVVLLYMATQI 125
Query: 391 ARGLEYLHLGCSTRILHFDIKPHNILLDEDFCPKISDFGLAKICNRKESIISMTGARGTV 450
           +  +EYL        +H D+   N L+ E+   K++DFGL+++    ++  +  GA+  +
Sbjct: 126 SSAMEYLE---KKNFIHRDLAARNCLVGENHLVKVADFGLSRLMT-GDTYTAHAGAKFPI 181
Query: 451 GYIAPEVFCRNIGEVSYKSDVYNYGMMIFEMT 482
            + APE    N  + S KSDV+ +G++++E+ 
Sbjct: 182 KWTAPESLAYN--KFSIKSDVWAFGVLLWEIA 211

>pdb|2V7A|A Chain A, Crystal Structure Of The T315i Abl Mutant In Complex With The Inhibitor Pha-739358 Length = 286

Iteration: 1
 Score = 82.4 bits (202), Expect = 6e-16,   Method: Compositional matrix adjust.
 Identities = 57/208 (27%), Positives = 99/208 (47%), Gaps = 36/208 (17%)
Query: 305 YGYADIKKMTNSFKYKLGQGGYGSVYKGKLLDGS-NVAVKVLNDSKGNGKEFINEVASIS 363
           Y   ++++   + K+KLG G YG VY+G     S  VAVK L +     +EF+ E A + 
Sbjct: 6   YDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMK 65
Query: 364 RTSHVNVVALLGFCLRVA-----------------------EELSSTI------GIARGL 394
              H N+V LLG C R                         +E+++ +       I+  +
Sbjct: 66  EIKHPNLVQLLGVCTREPPFYIIIEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAM 125
Query: 395 EYLHLGCSTRILHFDIKPHNILLDEDFCPKISDFGLAKICNRKESIISMTGARGTVGYIA 454
           EYL        +H D+   N L+ E+   K++DFGL+++    ++  +  GA+  + + A
Sbjct: 126 EYLE---KKNFIHRDLAARNCLVGENHLVKVADFGLSRLMT-GDTXTAHAGAKFPIKWTA 181
Query: 455 PEVFCRNIGEVSYKSDVYNYGMMIFEMT 482
           PE    N  + S KSDV+ +G++++E+ 
Sbjct: 182 PESLAYN--KFSIKSDVWAFGVLLWEIA 207

>pdb|2HZI|A Chain A, Abl Kinase Domain In Complex With Pd180970 Length = 277

Iteration: 1
 Score = 82.4 bits (202), Expect = 6e-16,   Method: Compositional matrix adjust.
 Identities = 57/208 (27%), Positives = 99/208 (47%), Gaps = 36/208 (17%)
Query: 305 YGYADIKKMTNSFKYKLGQGGYGSVYKGKLLDGS-NVAVKVLNDSKGNGKEFINEVASIS 363
           Y   ++++   + K+KLG G YG VY+G     S  VAVK L +     +EF+ E A + 
Sbjct: 9   YDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMK 68
Query: 364 RTSHVNVVALLGFCLRVA-----------------------EELSSTI------GIARGL 394
              H N+V LLG C R                         +E+++ +       I+  +
Sbjct: 69  EIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAM 128
Query: 395 EYLHLGCSTRILHFDIKPHNILLDEDFCPKISDFGLAKICNRKESIISMTGARGTVGYIA 454
           EYL        +H D+   N L+ E+   K++DFGL+++    ++  +  GA+  + + A
Sbjct: 129 EYLE---KKNFIHRDLAARNCLVGENHLVKVADFGLSRLMT-GDTYTAHAGAKFPIKWTA 184
Query: 455 PEVFCRNIGEVSYKSDVYNYGMMIFEMT 482
           PE    N  + S KSDV+ +G++++E+ 
Sbjct: 185 PESLAYN--KFSIKSDVWAFGVLLWEIA 210

>pdb|2F4J|A Chain A, Structure Of The Kinase Domain Of An Imatinib-Resistant Abl Mutant In Complex With The Aurora Kinase Inhibitor Vx-680 Length = 287

Iteration: 1
 Score = 82.0 bits (201), Expect = 6e-16,   Method: Compositional matrix adjust.
 Identities = 59/213 (27%), Positives = 102/213 (47%), Gaps = 37/213 (17%)
Query: 300 LSPKRYGYADIKKMTNSFKYKLGQGGYGSVYKGKLLDGS-NVAVKVLNDSKGNGKEFINE 358
           +SP  Y   ++++   + K+KLG G YG VY+G     S  VAVK L +     +EF+ E
Sbjct: 2   MSP-NYDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKE 60
Query: 359 VASISRTSHVNVVALLGFCLRVA-----------------------EELSSTI------G 389
            A +    H N+V LLG C R                         +E+++ +       
Sbjct: 61  AAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQ 120
Query: 390 IARGLEYLHLGCSTRILHFDIKPHNILLDEDFCPKISDFGLAKICNRKESIISMTGARGT 449
           I+  +EYL        +H D+   N L+ E+   K++DFGL+++    ++  +  GA+  
Sbjct: 121 ISSAMEYLE---KKNFIHRDLAARNCLVGENHLVKVADFGLSRLMT-GDTYTAPAGAKFP 176
Query: 450 VGYIAPEVFCRNIGEVSYKSDVYNYGMMIFEMT 482
           + + APE    N  + S KSDV+ +G++++E+ 
Sbjct: 177 IKWTAPESLAYN--KFSIKSDVWAFGVLLWEIA 207

>pdb|2E2B|A Chain A, Crystal Structure Of The C-Abl Kinase Domain In Complex With Inno-406 Length = 293

Iteration: 1
 Score = 82.0 bits (201), Expect = 6e-16,   Method: Compositional matrix adjust.
 Identities = 58/212 (27%), Positives = 100/212 (47%), Gaps = 36/212 (16%)
Query: 301 SPKRYGYADIKKMTNSFKYKLGQGGYGSVYKGKLLDGS-NVAVKVLNDSKGNGKEFINEV 359
           S   Y   ++++   + K+KLG G YG VY+G     S  VAVK L +     +EF+ E 
Sbjct: 6   SSPNYDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEA 65
Query: 360 ASISRTSHVNVVALLGFCLRVA-----------------------EELSSTI------GI 390
           A +    H N+V LLG C R                         +E+++ +       I
Sbjct: 66  AVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQI 125
Query: 391 ARGLEYLHLGCSTRILHFDIKPHNILLDEDFCPKISDFGLAKICNRKESIISMTGARGTV 450
           +  +EYL        +H D+   N L+ E+   K++DFGL+++    ++  +  GA+  +
Sbjct: 126 SSAMEYLE---KKNFIHRDLAARNCLVGENHLVKVADFGLSRLMT-GDTYTAHAGAKFPI 181
Query: 451 GYIAPEVFCRNIGEVSYKSDVYNYGMMIFEMT 482
            + APE    N  + S KSDV+ +G++++E+ 
Sbjct: 182 KWTAPESLAYN--KFSIKSDVWAFGVLLWEIA 211

>pdb|2HYY|A Chain A, Human Abl Kinase Domain In Complex With Imatinib (Sti571, Glivec) Length = 273

Iteration: 1
 Score = 82.0 bits (201), Expect = 7e-16,   Method: Compositional matrix adjust.
 Identities = 57/208 (27%), Positives = 99/208 (47%), Gaps = 36/208 (17%)
Query: 305 YGYADIKKMTNSFKYKLGQGGYGSVYKGKLLDGS-NVAVKVLNDSKGNGKEFINEVASIS 363
           Y   ++++   + K+KLG G YG VY+G     S  VAVK L +     +EF+ E A + 
Sbjct: 5   YDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMK 64
Query: 364 RTSHVNVVALLGFCLRVA-----------------------EELSSTI------GIARGL 394
              H N+V LLG C R                         +E+++ +       I+  +
Sbjct: 65  EIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAM 124
Query: 395 EYLHLGCSTRILHFDIKPHNILLDEDFCPKISDFGLAKICNRKESIISMTGARGTVGYIA 454
           EYL        +H D+   N L+ E+   K++DFGL+++    ++  +  GA+  + + A
Sbjct: 125 EYLE---KKNFIHRDLAARNCLVGENHLVKVADFGLSRLMT-GDTYTAHAGAKFPIKWTA 180
Query: 455 PEVFCRNIGEVSYKSDVYNYGMMIFEMT 482
           PE    N  + S KSDV+ +G++++E+ 
Sbjct: 181 PESLAYN--KFSIKSDVWAFGVLLWEIA 206

>pdb|2G2F|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287

Iteration: 1
 Score = 82.0 bits (201), Expect = 7e-16,   Method: Compositional matrix adjust.
 Identities = 59/213 (27%), Positives = 102/213 (47%), Gaps = 37/213 (17%)
Query: 300 LSPKRYGYADIKKMTNSFKYKLGQGGYGSVYKGKLLDGS-NVAVKVLNDSKGNGKEFINE 358
           +SP  Y   ++++   + K+KLG G YG VY+G     S  VAVK L +     +EF+ E
Sbjct: 3   MSP-NYDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKE 61
Query: 359 VASISRTSHVNVVALLGFCLRVA-----------------------EELSSTI------G 389
            A +    H N+V LLG C R                         +E+++ +       
Sbjct: 62  AAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQ 121
Query: 390 IARGLEYLHLGCSTRILHFDIKPHNILLDEDFCPKISDFGLAKICNRKESIISMTGARGT 449
           I+  +EYL        +H D+   N L+ E+   K++DFGL+++    ++  +  GA+  
Sbjct: 122 ISSAMEYLE---KKNFIHRDLAARNCLVGENHLVKVADFGLSRLMT-GDTYTAPAGAKFP 177
Query: 450 VGYIAPEVFCRNIGEVSYKSDVYNYGMMIFEMT 482
           + + APE    N  + S KSDV+ +G++++E+ 
Sbjct: 178 IKWTAPESLAYN--KFSIKSDVWAFGVLLWEIA 208

>pdb|3PYY|A Chain A, Discovery And Characterization Of A Cell-Permeable, Small-Molecule C- Abl Kinase Activator That Binds To The Myristoyl Binding Site Length = 298

Iteration: 1
 Score = 82.0 bits (201), Expect = 7e-16,   Method: Compositional matrix adjust.
 Identities = 57/208 (27%), Positives = 99/208 (47%), Gaps = 36/208 (17%)
Query: 305 YGYADIKKMTNSFKYKLGQGGYGSVYKGKLLDGS-NVAVKVLNDSKGNGKEFINEVASIS 363
           Y   ++++   + K+KLG G YG VY+G     S  VAVK L +     +EF+ E A + 
Sbjct: 18  YDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMK 77
Query: 364 RTSHVNVVALLGFCLRVA-----------------------EELSSTI------GIARGL 394
              H N+V LLG C R                         +E+++ +       I+  +
Sbjct: 78  EIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAM 137
Query: 395 EYLHLGCSTRILHFDIKPHNILLDEDFCPKISDFGLAKICNRKESIISMTGARGTVGYIA 454
           EYL        +H D+   N L+ E+   K++DFGL+++    ++  +  GA+  + + A
Sbjct: 138 EYLE---KKNFIHRDLAARNCLVGENHLVKVADFGLSRLMT-GDTYTAHAGAKFPIKWTA 193
Query: 455 PEVFCRNIGEVSYKSDVYNYGMMIFEMT 482
           PE    N  + S KSDV+ +G++++E+ 
Sbjct: 194 PESLAYN--KFSIKSDVWAFGVLLWEIA 219

>pdb|2HIW|A Chain A, Crystal Structure Of Inactive Conformation Abl Kinase Catalytic Domain Complexed With Type Ii Inhibitor Length = 287

Iteration: 1
 Score = 82.0 bits (201), Expect = 7e-16,   Method: Compositional matrix adjust.
 Identities = 57/208 (27%), Positives = 99/208 (47%), Gaps = 36/208 (17%)
Query: 305 YGYADIKKMTNSFKYKLGQGGYGSVYKGKLLDGS-NVAVKVLNDSKGNGKEFINEVASIS 363
           Y   ++++   + K+KLG G YG VY+G     S  VAVK L +     +EF+ E A + 
Sbjct: 7   YDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMK 66
Query: 364 RTSHVNVVALLGFCLRVA-----------------------EELSSTI------GIARGL 394
              H N+V LLG C R                         +E+++ +       I+  +
Sbjct: 67  EIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAM 126
Query: 395 EYLHLGCSTRILHFDIKPHNILLDEDFCPKISDFGLAKICNRKESIISMTGARGTVGYIA 454
           EYL        +H D+   N L+ E+   K++DFGL+++    ++  +  GA+  + + A
Sbjct: 127 EYLE---KKNFIHRDLAARNCLVGENHLVKVADFGLSRLMT-GDTYTAHAGAKFPIKWTA 182
Query: 455 PEVFCRNIGEVSYKSDVYNYGMMIFEMT 482
           PE    N  + S KSDV+ +G++++E+ 
Sbjct: 183 PESLAYN--KFSIKSDVWAFGVLLWEIA 208

>pdb|2HZ0|A Chain A, Abl Kinase Domain In Complex With Nvp-Aeg082 Length = 270

Iteration: 1
 Score = 82.0 bits (201), Expect = 8e-16,   Method: Compositional matrix adjust.
 Identities = 57/208 (27%), Positives = 99/208 (47%), Gaps = 36/208 (17%)
Query: 305 YGYADIKKMTNSFKYKLGQGGYGSVYKGKLLDGS-NVAVKVLNDSKGNGKEFINEVASIS 363
           Y   ++++   + K+KLG G YG VY+G     S  VAVK L +     +EF+ E A + 
Sbjct: 5   YDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMK 64
Query: 364 RTSHVNVVALLGFCLRVA-----------------------EELSSTI------GIARGL 394
              H N+V LLG C R                         +E+++ +       I+  +
Sbjct: 65  EIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAM 124
Query: 395 EYLHLGCSTRILHFDIKPHNILLDEDFCPKISDFGLAKICNRKESIISMTGARGTVGYIA 454
           EYL        +H D+   N L+ E+   K++DFGL+++    ++  +  GA+  + + A
Sbjct: 125 EYLE---KKNFIHRDLAARNCLVGENHLVKVADFGLSRLMT-GDTYTAHAGAKFPIKWTA 180
Query: 455 PEVFCRNIGEVSYKSDVYNYGMMIFEMT 482
           PE    N  + S KSDV+ +G++++E+ 
Sbjct: 181 PESLAYN--KFSIKSDVWAFGVLLWEIA 206

>pdb|1OPK|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 495

Iteration: 1
 Score = 81.6 bits (200), Expect = 9e-16,   Method: Compositional matrix adjust.
 Identities = 57/208 (27%), Positives = 99/208 (47%), Gaps = 36/208 (17%)
Query: 305 YGYADIKKMTNSFKYKLGQGGYGSVYKGKLLDGS-NVAVKVLNDSKGNGKEFINEVASIS 363
           Y   ++++   + K+KLG G YG VY+G     S  VAVK L +     +EF+ E A + 
Sbjct: 212 YDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMK 271
Query: 364 RTSHVNVVALLGFCLRVA-----------------------EELSSTI------GIARGL 394
              H N+V LLG C R                         +E+S+ +       I+  +
Sbjct: 272 EIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAM 331
Query: 395 EYLHLGCSTRILHFDIKPHNILLDEDFCPKISDFGLAKICNRKESIISMTGARGTVGYIA 454
           EYL        +H ++   N L+ E+   K++DFGL+++    ++  +  GA+  + + A
Sbjct: 332 EYLE---KKNFIHRNLAARNCLVGENHLVKVADFGLSRLMT-GDTYTAHAGAKFPIKWTA 387
Query: 455 PEVFCRNIGEVSYKSDVYNYGMMIFEMT 482
           PE    N  + S KSDV+ +G++++E+ 
Sbjct: 388 PESLAYN--KFSIKSDVWAFGVLLWEIA 413

>pdb|3BBT|B Chain B, Crystal Structure Of The Erbb4 Kinase In Complex With Lapatinib Length = 328

Iteration: 1
 Score = 81.6 bits (200), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 60/204 (29%), Positives = 101/204 (49%), Gaps = 40/204 (19%)
Query: 321 LGQGGYGSVYKGKLL-DGSNV----AVKVLNDSKGNGK--EFINEVASISRTSHVNVVAL 373
           LG G +G+VYKG  + +G  V    A+K+LN++ G     EF++E   ++   H ++V L
Sbjct: 23  LGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHLVRL 82
Query: 374 LGFCLRVAEELSST---------------------------IGIARGLEYLHLGCSTRIL 406
           LG CL    +L +                            + IA+G+ YL      R++
Sbjct: 83  LGVCLSPTIQLVTQLMPHGCLLEYVHEHKDNIGSQLLLNWCVQIAKGMMYLE---ERRLV 139
Query: 407 HFDIKPHNILLDEDFCPKISDFGLAKICNRKESIISMTGARGTVGYIAPEVFCRNIGEVS 466
           H D+   N+L+      KI+DFGLA++    E   +  G +  + ++A E  C +  + +
Sbjct: 140 HRDLAARNVLVKSPNHVKITDFGLARLLEGDEKEYNADGGKMPIKWMALE--CIHYRKFT 197
Query: 467 YKSDVYNYGMMIFE-MTGGRKNVD 489
           ++SDV++YG+ I+E MT G K  D
Sbjct: 198 HQSDVWSYGVTIWELMTFGGKPYD 221

>pdb|3DK6|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293

Iteration: 1
 Score = 81.6 bits (200), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 56/204 (27%), Positives = 98/204 (48%), Gaps = 36/204 (17%)
Query: 309 DIKKMTNSFKYKLGQGGYGSVYKGKLLDGS-NVAVKVLNDSKGNGKEFINEVASISRTSH 367
           ++++   + K+KLG G +G VY+G     S  VAVK L +     +EF+ E A +    H
Sbjct: 7   EMERTDITMKHKLGGGQFGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKH 66
Query: 368 VNVVALLGFCLRVA-----------------------EELSSTI------GIARGLEYLH 398
            N+V LLG C R                         +E+S+ +       I+  +EYL 
Sbjct: 67  PNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLE 126
Query: 399 LGCSTRILHFDIKPHNILLDEDFCPKISDFGLAKICNRKESIISMTGARGTVGYIAPEVF 458
                  +H D+   N L+ E+   K++DFGL+++    ++  +  GA+  + + APE  
Sbjct: 127 ---KKNFIHRDLAARNCLVGENHLVKVADFGLSRLMT-GDTXTAHAGAKFPIKWTAPESL 182
Query: 459 CRNIGEVSYKSDVYNYGMMIFEMT 482
             N  + S KSDV+ +G++++E+ 
Sbjct: 183 AYN--KFSIKSDVWAFGVLLWEIA 204

>pdb|1SM2|A Chain A, Crystal Structure Of The Phosphorylated Interleukin-2 Tyrosine Kinase Catalytic Domain Length = 264

Iteration: 1
 Score = 81.6 bits (200), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 59/224 (26%), Positives = 101/224 (45%), Gaps = 41/224 (18%)
Query: 316 SFKYKLGQGGYGSVYKGKLLDGSNVAVKVLNDSKGNGKEFINEVASISRTSHVNVVALLG 375
           +F  ++G G +G V+ G  L+   VA+K + +   + ++FI E   + + SH  +V L G
Sbjct: 8   TFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAMSEEDFIEEAEVMMKLSHPKLVQLYG 67
Query: 376 FCLRVA----------------------------EELSSTIGIARGLEYLHLGCSTRILH 407
            CL  A                              L   + +  G+ YL   C   ++H
Sbjct: 68  VCLEQAPICLVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEAC---VIH 124
Query: 408 FDIKPHNILLDEDFCPKISDFGLAKICNRKESIISMTGARGTVGYIAPEVFCRNIGEVSY 467
            D+   N L+ E+   K+SDFG+ +     +   S TG +  V + +PEVF  +    S 
Sbjct: 125 RDLAARNCLVGENQVIKVSDFGMTRFV-LDDQYTSSTGTKFPVKWASPEVF--SFSRYSS 181
Query: 468 KSDVYNYGMMIFEMTG-------GRKNVDVVDNGSTALDLQASR 504
           KSDV+++G++++E+          R N +VV++ ST   L   R
Sbjct: 182 KSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTGFRLYKPR 225

>pdb|3T9T|A Chain A, Crystal Structure Of Btk Mutant (F435t,K596r) Complexed With Imidazo[1,5-A]quinoxaline Length = 267

Iteration: 1
 Score = 81.3 bits (199), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 60/224 (26%), Positives = 102/224 (45%), Gaps = 41/224 (18%)
Query: 316 SFKYKLGQGGYGSVYKGKLLDGSNVAVKVLNDSKGNGKEFINEVASISRTSHVNVVALLG 375
           +F  ++G G +G V+ G  L+   VA+K + +   + ++FI E   + + SH  +V L G
Sbjct: 11  TFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAMSEEDFIEEAEVMMKLSHPKLVQLYG 70
Query: 376 FCLR---------------------------VAEELSST-IGIARGLEYLHLGCSTRILH 407
            CL                             AE L    + +  G+ YL   C   ++H
Sbjct: 71  VCLEQAPICLVTEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEAC---VIH 127
Query: 408 FDIKPHNILLDEDFCPKISDFGLAKICNRKESIISMTGARGTVGYIAPEVFCRNIGEVSY 467
            D+   N L+ E+   K+SDFG+ +     +   S TG +  V + +PEVF  +    S 
Sbjct: 128 RDLAARNCLVGENQVIKVSDFGMTRFV-LDDQYTSSTGTKFPVKWASPEVF--SFSRYSS 184
Query: 468 KSDVYNYGMMIFEMTG-------GRKNVDVVDNGSTALDLQASR 504
           KSDV+++G++++E+          R N +VV++ ST   L   R
Sbjct: 185 KSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTGFRLYKPR 228

>pdb|1R0P|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With The Microbial Alkaloid K-252a Length = 312

Iteration: 1
 Score = 81.3 bits (199), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 69/227 (30%), Positives = 108/227 (47%), Gaps = 44/227 (19%)
Query: 317 FKYKLGQGGYGSVYKGKLLD--GSNV--AVKVLN--DSKGNGKEFINEVASISRTSHVNV 370
           F   +G+G +G VY G LLD  G  +  AVK LN     G   +F+ E   +   SH NV
Sbjct: 32  FNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNV 91
Query: 371 VALLGFCLR-----------------------------VAEELSSTIGIARGLEYLHLGC 401
           ++LLG CLR                             V + +   + +A+G+++L    
Sbjct: 92  LSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFL---A 148
Query: 402 STRILHFDIKPHNILLDEDFCPKISDFGLAKICNRKE--SIISMTGARGTVGYIAPEVFC 459
           S + +H D+   N +LDE F  K++DFGLA+    KE  S+ + TGA+  V ++A E   
Sbjct: 149 SKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALESL- 207
Query: 460 RNIGEVSYKSDVYNYGMMIFEMT--GGRKNVDVVDNGSTALDLQASR 504
               + + KSDV+++G++++E+   G     DV     T   LQ  R
Sbjct: 208 -QTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGRR 253

>pdb|4HCT|A Chain A, Crystal Structure Of Itk In Complex With Compound 52 Length = 269

Iteration: 1
 Score = 81.3 bits (199), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 60/224 (26%), Positives = 102/224 (45%), Gaps = 41/224 (18%)
Query: 316 SFKYKLGQGGYGSVYKGKLLDGSNVAVKVLNDSKGNGKEFINEVASISRTSHVNVVALLG 375
           +F  ++G G +G V+ G  L+   VA+K + +   + ++FI E   + + SH  +V L G
Sbjct: 13  TFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAMSEEDFIEEAEVMMKLSHPKLVQLYG 72
Query: 376 FCLR---------------------------VAEELSST-IGIARGLEYLHLGCSTRILH 407
            CL                             AE L    + +  G+ YL   C   ++H
Sbjct: 73  VCLEQAPICLVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEAC---VIH 129
Query: 408 FDIKPHNILLDEDFCPKISDFGLAKICNRKESIISMTGARGTVGYIAPEVFCRNIGEVSY 467
            D+   N L+ E+   K+SDFG+ +     +   S TG +  V + +PEVF  +    S 
Sbjct: 130 RDLAARNCLVGENQVIKVSDFGMTRFV-LDDQYTSSTGTKFPVKWASPEVF--SFSRYSS 186
Query: 468 KSDVYNYGMMIFEMTG-------GRKNVDVVDNGSTALDLQASR 504
           KSDV+++G++++E+          R N +VV++ ST   L   R
Sbjct: 187 KSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTGFRLYKPR 230

>pdb|3V5J|A Chain A, Crystal Structure Of Interleukin-2 Inducible T-Cell Kinase Itk Catalytic Domain With Thienopyrazolylindole Inhibitor 090 Length = 266

Iteration: 1
 Score = 81.3 bits (199), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 59/224 (26%), Positives = 101/224 (45%), Gaps = 41/224 (18%)
Query: 316 SFKYKLGQGGYGSVYKGKLLDGSNVAVKVLNDSKGNGKEFINEVASISRTSHVNVVALLG 375
           +F  ++G G +G V+ G  L+   VA+K + +   + ++FI E   + + SH  +V L G
Sbjct: 10  TFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAMSEEDFIEEAEVMMKLSHPKLVQLYG 69
Query: 376 FCLRVA----------------------------EELSSTIGIARGLEYLHLGCSTRILH 407
            CL  A                              L   + +  G+ YL   C   ++H
Sbjct: 70  VCLEQAPICLVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEAC---VIH 126
Query: 408 FDIKPHNILLDEDFCPKISDFGLAKICNRKESIISMTGARGTVGYIAPEVFCRNIGEVSY 467
            D+   N L+ E+   K+SDFG+ +     +   S TG +  V + +PEVF  +    S 
Sbjct: 127 RDLAARNCLVGENQVIKVSDFGMTRFV-LDDQYTSSTGTKFPVKWASPEVF--SFSRYSS 183
Query: 468 KSDVYNYGMMIFEMTG-------GRKNVDVVDNGSTALDLQASR 504
           KSDV+++G++++E+          R N +VV++ ST   L   R
Sbjct: 184 KSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTGFRLYKPR 227

>pdb|3CTH|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Aminopyridine Based Inhibitor Length = 314

Iteration: 1
 Score = 81.3 bits (199), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 69/227 (30%), Positives = 108/227 (47%), Gaps = 44/227 (19%)
Query: 317 FKYKLGQGGYGSVYKGKLLD--GSNV--AVKVLN--DSKGNGKEFINEVASISRTSHVNV 370
           F   +G+G +G VY G LLD  G  +  AVK LN     G   +F+ E   +   SH NV
Sbjct: 34  FNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNV 93
Query: 371 VALLGFCLR-----------------------------VAEELSSTIGIARGLEYLHLGC 401
           ++LLG CLR                             V + +   + +A+G+++L    
Sbjct: 94  LSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFL---A 150
Query: 402 STRILHFDIKPHNILLDEDFCPKISDFGLAKICNRKE--SIISMTGARGTVGYIAPEVFC 459
           S + +H D+   N +LDE F  K++DFGLA+    KE  S+ + TGA+  V ++A E   
Sbjct: 151 SKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALESL- 209
Query: 460 RNIGEVSYKSDVYNYGMMIFEMT--GGRKNVDVVDNGSTALDLQASR 504
               + + KSDV+++G++++E+   G     DV     T   LQ  R
Sbjct: 210 -QTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGRR 255

>pdb|3A4P|A Chain A, Human C-Met Kinase Domain Complexed With 6-Benzyloxyquinoline Inhibitor Length = 319

Iteration: 1
 Score = 81.3 bits (199), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 69/227 (30%), Positives = 108/227 (47%), Gaps = 44/227 (19%)
Query: 317 FKYKLGQGGYGSVYKGKLLD--GSNV--AVKVLN--DSKGNGKEFINEVASISRTSHVNV 370
           F   +G+G +G VY G LLD  G  +  AVK LN     G   +F+ E   +   SH NV
Sbjct: 39  FNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNV 98
Query: 371 VALLGFCLR-----------------------------VAEELSSTIGIARGLEYLHLGC 401
           ++LLG CLR                             V + +   + +A+G+++L    
Sbjct: 99  LSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFL---A 155
Query: 402 STRILHFDIKPHNILLDEDFCPKISDFGLAKICNRKE--SIISMTGARGTVGYIAPEVFC 459
           S + +H D+   N +LDE F  K++DFGLA+    KE  S+ + TGA+  V ++A E   
Sbjct: 156 SKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALESL- 214
Query: 460 RNIGEVSYKSDVYNYGMMIFEMT--GGRKNVDVVDNGSTALDLQASR 504
               + + KSDV+++G++++E+   G     DV     T   LQ  R
Sbjct: 215 -QTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGRR 260

>pdb|3DKC|A Chain A, Sgx Clone 5698a65kfg1h1 Length = 317

Iteration: 1
 Score = 81.3 bits (199), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 69/227 (30%), Positives = 108/227 (47%), Gaps = 44/227 (19%)
Query: 317 FKYKLGQGGYGSVYKGKLLD--GSNV--AVKVLN--DSKGNGKEFINEVASISRTSHVNV 370
           F   +G+G +G VY G LLD  G  +  AVK LN     G   +F+ E   +   SH NV
Sbjct: 35  FNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNV 94
Query: 371 VALLGFCLR-----------------------------VAEELSSTIGIARGLEYLHLGC 401
           ++LLG CLR                             V + +   + +A+G+++L    
Sbjct: 95  LSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFL---A 151
Query: 402 STRILHFDIKPHNILLDEDFCPKISDFGLAKICNRKE--SIISMTGARGTVGYIAPEVFC 459
           S + +H D+   N +LDE F  K++DFGLA+    KE  S+ + TGA+  V ++A E   
Sbjct: 152 SKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALESL- 210
Query: 460 RNIGEVSYKSDVYNYGMMIFEMT--GGRKNVDVVDNGSTALDLQASR 504
               + + KSDV+++G++++E+   G     DV     T   LQ  R
Sbjct: 211 -QTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGRR 256

>pdb|3QTI|A Chain A, C-Met Kinase In Complex With Nvp-Bvu972 Length = 314

Iteration: 1
 Score = 81.3 bits (199), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 69/227 (30%), Positives = 108/227 (47%), Gaps = 44/227 (19%)
Query: 317 FKYKLGQGGYGSVYKGKLLD--GSNV--AVKVLN--DSKGNGKEFINEVASISRTSHVNV 370
           F   +G+G +G VY G LLD  G  +  AVK LN     G   +F+ E   +   SH NV
Sbjct: 34  FNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNV 93
Query: 371 VALLGFCLR-----------------------------VAEELSSTIGIARGLEYLHLGC 401
           ++LLG CLR                             V + +   + +A+G+++L    
Sbjct: 94  LSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFL---A 150
Query: 402 STRILHFDIKPHNILLDEDFCPKISDFGLAKICNRKE--SIISMTGARGTVGYIAPEVFC 459
           S + +H D+   N +LDE F  K++DFGLA+    KE  S+ + TGA+  V ++A E   
Sbjct: 151 SKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALESL- 209
Query: 460 RNIGEVSYKSDVYNYGMMIFEMT--GGRKNVDVVDNGSTALDLQASR 504
               + + KSDV+++G++++E+   G     DV     T   LQ  R
Sbjct: 210 -QTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGRR 255

>pdb|2R4B|A Chain A, Erbb4 Kinase Domain Complexed With A Thienopyrimidine Inhibitor Length = 321

Iteration: 1
 Score = 81.3 bits (199), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 60/204 (29%), Positives = 101/204 (49%), Gaps = 40/204 (19%)
Query: 321 LGQGGYGSVYKGKLL-DGSNV----AVKVLNDSKGNGK--EFINEVASISRTSHVNVVAL 373
           LG G +G+VYKG  + +G  V    A+K+LN++ G     EF++E   ++   H ++V L
Sbjct: 46  LGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHLVRL 105
Query: 374 LGFCLRVAEELSST---------------------------IGIARGLEYLHLGCSTRIL 406
           LG CL    +L +                            + IA+G+ YL      R++
Sbjct: 106 LGVCLSPTIQLVTQLMPHGCLLEYVHEHKDNIGSQLLLNWCVQIAKGMMYLE---ERRLV 162
Query: 407 HFDIKPHNILLDEDFCPKISDFGLAKICNRKESIISMTGARGTVGYIAPEVFCRNIGEVS 466
           H D+   N+L+      KI+DFGLA++    E   +  G +  + ++A E  C +  + +
Sbjct: 163 HRDLAARNVLVKSPNHVKITDFGLARLLEGDEKEYNADGGKMPIKWMALE--CIHYRKFT 220
Query: 467 YKSDVYNYGMMIFE-MTGGRKNVD 489
           ++SDV++YG+ I+E MT G K  D
Sbjct: 221 HQSDVWSYGVTIWELMTFGGKPYD 244

>pdb|3SXR|A Chain A, Crystal Structure Of Bmx Non-Receptor Tyrosine Kinase Complex With Dasatinib Length = 268

Iteration: 1
 Score = 80.9 bits (198), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 57/229 (24%), Positives = 103/229 (44%), Gaps = 35/229 (15%)
Query: 306 GYADIKKMTNSFKYKLGQGGYGSVYKGKLLDGSNVAVKVLNDSKGNGKEFINEVASISRT 365
           G+ ++K+   +   +LG G +G V  GK     +VAVK++ +   +  EF  E  ++ + 
Sbjct: 1   GHMELKREEITLLKELGSGQFGVVKLGKWKGQYDVAVKMIKEGSMSEDEFFQEAQTMMKL 60
Query: 366 SHVNVVALLGFC----------------------------LRVAEELSSTIGIARGLEYL 397
           SH  +V   G C                            L  ++ L     +  G+ +L
Sbjct: 61  SHPKLVKFYGVCSKEYPIYIVTEYISNGCLLNYLRSHGKGLEPSQLLEMCYDVCEGMAFL 120
Query: 398 HLGCSTRILHFDIKPHNILLDEDFCPKISDFGLAKICNRKESIISMTGARGTVGYIAPEV 457
               S + +H D+   N L+D D C K+SDFG+ +     +  +S  G +  V + APEV
Sbjct: 121 E---SHQFIHRDLAARNCLVDRDLCVKVSDFGMTRYV-LDDQYVSSVGTKFPVKWSAPEV 176
Query: 458 FCRNIGEVSYKSDVYNYGMMIFEM-TGGRKNVDVVDNGSTALDLQASRK 505
           F  +  + S KSDV+ +G++++E+ + G+   D+  N    L +    +
Sbjct: 177 F--HYFKYSSKSDVWAFGILMWEVFSLGKMPYDLYTNSEVVLKVSQGHR 223

>pdb|3C1X|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Pyrrolotriazine Based Inhibitor Length = 373

Iteration: 1
 Score = 80.9 bits (198), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 69/227 (30%), Positives = 108/227 (47%), Gaps = 44/227 (19%)
Query: 317 FKYKLGQGGYGSVYKGKLLD--GSNV--AVKVLN--DSKGNGKEFINEVASISRTSHVNV 370
           F   +G+G +G VY G LLD  G  +  AVK LN     G   +F+ E   +   SH NV
Sbjct: 93  FNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNV 152
Query: 371 VALLGFCLR-----------------------------VAEELSSTIGIARGLEYLHLGC 401
           ++LLG CLR                             V + +   + +A+G+++L    
Sbjct: 153 LSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFL---A 209
Query: 402 STRILHFDIKPHNILLDEDFCPKISDFGLAKICNRKE--SIISMTGARGTVGYIAPEVFC 459
           S + +H D+   N +LDE F  K++DFGLA+    KE  S+ + TGA+  V ++A E   
Sbjct: 210 SKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALESL- 268
Query: 460 RNIGEVSYKSDVYNYGMMIFEMT--GGRKNVDVVDNGSTALDLQASR 504
               + + KSDV+++G++++E+   G     DV     T   LQ  R
Sbjct: 269 -QTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGRR 314

>pdb|3DKG|A Chain A, Sgx Clone 5698a109kfg1h1 Length = 317

Iteration: 1
 Score = 80.9 bits (198), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 69/227 (30%), Positives = 108/227 (47%), Gaps = 44/227 (19%)
Query: 317 FKYKLGQGGYGSVYKGKLLD--GSNV--AVKVLN--DSKGNGKEFINEVASISRTSHVNV 370
           F   +G+G +G VY G LLD  G  +  AVK LN     G   +F+ E   +   SH NV
Sbjct: 35  FNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNV 94
Query: 371 VALLGFCLR-----------------------------VAEELSSTIGIARGLEYLHLGC 401
           ++LLG CLR                             V + +   + +A+G+++L    
Sbjct: 95  LSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFL---A 151
Query: 402 STRILHFDIKPHNILLDEDFCPKISDFGLAKICNRKE--SIISMTGARGTVGYIAPEVFC 459
           S + +H D+   N +LDE F  K++DFGLA+    KE  S+ + TGA+  V ++A E   
Sbjct: 152 SKKFVHRDLAARNCMLDEKFTVKVADFGLARDMLDKEFDSVHNKTGAKLPVKWMALESL- 210
Query: 460 RNIGEVSYKSDVYNYGMMIFEMT--GGRKNVDVVDNGSTALDLQASR 504
               + + KSDV+++G++++E+   G     DV     T   LQ  R
Sbjct: 211 -QTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGRR 256

>pdb|3QGW|A Chain A, Crystal Structure Of Itk Kinase Bound To An Inhibitor Length = 286

Iteration: 1
 Score = 80.5 bits (197), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 62/240 (25%), Positives = 105/240 (43%), Gaps = 41/240 (17%)
Query: 300 LSPKRYGYADIKKMTNSFKYKLGQGGYGSVYKGKLLDGSNVAVKVLNDSKGNGKEFINEV 359
           L P+   +  I     +F  ++G G +G V+ G  L+   VA+K + +   +  +FI E 
Sbjct: 14  LVPRGSLHMVIDPSELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIKEGSMSEDDFIEEA 73
Query: 360 ASISRTSHVNVVALLGFCLRVA----------------------------EELSSTIGIA 391
             + + SH  +V L G CL  A                              L   + + 
Sbjct: 74  EVMMKLSHPKLVQLYGVCLEQAPICLVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVC 133
Query: 392 RGLEYLHLGCSTRILHFDIKPHNILLDEDFCPKISDFGLAKICNRKESIISMTGARGTVG 451
            G+ YL   C   ++H D+   N L+ E+   K+SDFG+ +     +   S TG +  V 
Sbjct: 134 EGMAYLEEAC---VIHRDLAARNCLVGENQVIKVSDFGMTRFV-LDDQYTSSTGTKFPVK 189
Query: 452 YIAPEVFCRNIGEVSYKSDVYNYGMMIFEMTG-------GRKNVDVVDNGSTALDLQASR 504
           + +PEVF  +    S KSDV+++G++++E+          R N +VV++ ST   L   R
Sbjct: 190 WASPEVF--SFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTGFRLYKPR 247

>pdb|1OPL|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 537

Iteration: 1
 Score = 80.1 bits (196), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 56/208 (26%), Positives = 99/208 (47%), Gaps = 36/208 (17%)
Query: 305 YGYADIKKMTNSFKYKLGQGGYGSVYKGKLLDGS-NVAVKVLNDSKGNGKEFINEVASIS 363
           Y   ++++   + K+KLG G YG VY+G     S  VAVK L +     +EF+ E A + 
Sbjct: 251 YDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMK 310
Query: 364 RTSHVNVVALLGFCLRVA-----------------------EELSSTI------GIARGL 394
              H N+V LLG C R                         +E+++ +       I+  +
Sbjct: 311 EIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAM 370
Query: 395 EYLHLGCSTRILHFDIKPHNILLDEDFCPKISDFGLAKICNRKESIISMTGARGTVGYIA 454
           EYL        +H ++   N L+ E+   K++DFGL+++    ++  +  GA+  + + A
Sbjct: 371 EYLE---KKNFIHRNLAARNCLVGENHLVKVADFGLSRLMT-GDTYTAHAGAKFPIKWTA 426
Query: 455 PEVFCRNIGEVSYKSDVYNYGMMIFEMT 482
           PE    N  + S KSDV+ +G++++E+ 
Sbjct: 427 PESLAYN--KFSIKSDVWAFGVLLWEIA 452

>pdb|3GVU|A Chain A, The Crystal Structure Of Human Abl2 In Complex With Gleevec Length = 292

Iteration: 1
 Score = 79.0 bits (193), Expect = 6e-15,   Method: Compositional matrix adjust.
 Identities = 58/204 (28%), Positives = 97/204 (47%), Gaps = 36/204 (17%)
Query: 309 DIKKMTNSFKYKLGQGGYGSVYKGKLLDGS-NVAVKVLNDSKGNGKEFINEVASISRTSH 367
           ++++   + K+KLG G YG VY G     S  VAVK L +     +EF+ E A +    H
Sbjct: 28  EMERTDITMKHKLGGGQYGEVYVGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKH 87
Query: 368 VNVVALLGFC---------------------LRV--AEELSSTI------GIARGLEYLH 398
            N+V LLG C                     LR    EE+++ +       I+  +EYL 
Sbjct: 88  PNLVQLLGVCTLEPPFYIVTEYMPYGNLLDYLRECNREEVTAVVLLYMATQISSAMEYLE 147
Query: 399 LGCSTRILHFDIKPHNILLDEDFCPKISDFGLAKICNRKESIISMTGARGTVGYIAPEVF 458
                  +H D+   N L+ E+   K++DFGL+++    ++  +  GA+  + + APE  
Sbjct: 148 ---KKNFIHRDLAARNCLVGENHVVKVADFGLSRLMT-GDTYTAHAGAKFPIKWTAPESL 203
Query: 459 CRNIGEVSYKSDVYNYGMMIFEMT 482
             N    S KSDV+ +G++++E+ 
Sbjct: 204 AYNT--FSIKSDVWAFGVLLWEIA 225

>pdb|3PP0|A Chain A, Crystal Structure Of The Kinase Domain Of Human Her2 (Erbb2). Length = 338

Iteration: 1
 Score = 79.0 bits (193), Expect = 7e-15,   Method: Compositional matrix adjust.
 Identities = 66/216 (30%), Positives = 101/216 (46%), Gaps = 41/216 (18%)
Query: 310 IKKMTNSFKYK-LGQGGYGSVYKGKLL-DGSNV----AVKVL--NDSKGNGKEFINEVAS 361
           I K T   K K LG G +G+VYKG  + DG NV    A+KVL  N S    KE ++E   
Sbjct: 13  ILKETELRKVKVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAYV 72
Query: 362 ISRTSHVNVVALLGFCLRVAEELSSTI---------------------------GIARGL 394
           ++      V  LLG CL    +L + +                            IA+G+
Sbjct: 73  MAGVGSPYVSRLLGICLTSTVQLVTQLMPYGCLLDHVRENRGRLGSQDLLNWCMQIAKGM 132
Query: 395 EYLHLGCSTRILHFDIKPHNILLDEDFCPKISDFGLAKICNRKESIISMTGARGTVGYIA 454
            YL      R++H D+   N+L+      KI+DFGLA++ +  E+     G +  + ++A
Sbjct: 133 SYLE---DVRLVHRDLAARNVLVKSPNHVKITDFGLARLLDIDETEYHADGGKVPIKWMA 189
Query: 455 PEVFCRNIGEVSYKSDVYNYGMMIFE-MTGGRKNVD 489
            E   R     +++SDV++YG+ ++E MT G K  D
Sbjct: 190 LESILRR--RFTHQSDVWSYGVTVWELMTFGAKPYD 223

>pdb|3MIY|A Chain A, X-Ray Crystal Structure Of Itk Complexed With Sunitinib Length = 266

Iteration: 1
 Score = 78.2 bits (191), Expect = 9e-15,   Method: Compositional matrix adjust.
 Identities = 62/221 (28%), Positives = 102/221 (46%), Gaps = 35/221 (15%)
Query: 316 SFKYKLGQGGYGSVYKGKLLDGSNVAVKVLNDSKGNGKEFINEVASISRTSHVNVVALLG 375
           +F  ++G G +G V+ G  L+   VA+K + +   + ++FI E   + + SH  +V L G
Sbjct: 10  TFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAMSEEDFIEEAEVMMKLSHPKLVQLYG 69
Query: 376 FCLRVAEE-----------LSSTIGIARGL---EYLHLGC-----------STRILHFDI 410
            CL  A             LS  +   RGL   E L   C              ++H D+
Sbjct: 70  VCLEQAPICLVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEASVIHRDL 129
Query: 411 KPHNILLDEDFCPKISDFGLAKICNRKESIISMTGARGTVGYIAPEVFCRNIGEVSYKSD 470
              N L+ E+   K+SDFG+ +     +   S TG +  V + +PEVF  +    S KSD
Sbjct: 130 AARNCLVGENQVIKVSDFGMTRFV-LDDQYTSSTGTKFPVKWASPEVF--SFSRYSSKSD 186
Query: 471 VYNYGMMIFEMTG-------GRKNVDVVDNGSTALDLQASR 504
           V+++G++++E+          R N +VV++ ST   L   R
Sbjct: 187 VWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTGFRLYKPR 227

>pdb|4F0F|A Chain A, Crystal Structure Of The Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287

Iteration: 1
 Score = 77.8 bits (190), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 60/214 (28%), Positives = 106/214 (49%), Gaps = 46/214 (21%)
Query: 316 SFKYKLGQGGYGSVYKGKLL-DGSNVAVK--VLNDSKGNG------KEFINEVASISRTS 366
            ++ ++G+GG+G V+KG+L+ D S VA+K  +L DS+G        +EF  EV  +S  +
Sbjct: 22  EYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLN 81
Query: 367 HVNVVALLGFC--------------------------LRVAEELSSTIGIARGLEYLHLG 400
           H N+V L G                            ++ + +L   + IA G+EY+   
Sbjct: 82  HPNIVKLYGLMHNPPRMVMEFVPCGDLYHRLLDKAHPIKWSVKLRLMLDIALGIEYMQ-N 140
Query: 401 CSTRILHFDIKPHNILL---DED--FCPKISDFGLAKICNRKESIISMTGARGTVGYIAP 455
            +  I+H D++  NI L   DE+   C K++DFGL++     +S+ S++G  G   ++AP
Sbjct: 141 QNPPIVHRDLRSPNIFLQSLDENAPVCAKVADFGLSQ-----QSVHSVSGLLGNFQWMAP 195
Query: 456 EVFCRNIGEVSYKSDVYNYGMMIFEMTGGRKNVD 489
           E         + K+D Y++ M+++ +  G    D
Sbjct: 196 ETIGAEEESYTEKADTYSFAMILYTILTGEGPFD 229

>pdb|2EVA|A Chain A, Structural Basis For The Interaction Of Tak1 Kinase With Its Activating Protein Tab1 Length = 307

Iteration: 1
 Score = 76.6 bits (187), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 60/200 (30%), Positives = 96/200 (48%), Gaps = 38/200 (19%)
Query: 321 LGQGGYGSVYKGKLLDGSNVAVKVLNDSKGNGKEFINEVASISRTSHVNVVALLGFCLR- 379
           +G+G +G V K K     +VA+K + +S+   K FI E+  +SR +H N+V L G CL  
Sbjct: 16  VGRGAFGVVCKAKW-RAKDVAIKQI-ESESERKAFIVELRQLSRVNHPNIVKLYGACLNP 73
Query: 380 ---------------------------VAEELSSTIGIARGLEYLHLGCSTRILHFDIKP 412
                                       A  +S  +  ++G+ YLH      ++H D+KP
Sbjct: 74  VCLVMEYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHSMQPKALIHRDLKP 133
Query: 413 HNILLDE-DFCPKISDFGLAKICNRKESIISMTGARGTVGYIAPEVFCRNIGEVSYKSDV 471
            N+LL       KI DFG A  C+ +     MT  +G+  ++APEVF       S K DV
Sbjct: 134 PNLLLVAGGTVLKICDFGTA--CDIQ---THMTNNKGSAAWMAPEVF--EGSNYSEKCDV 186
Query: 472 YNYGMMIFEMTGGRKNVDVV 491
           +++G++++E+   RK  D +
Sbjct: 187 FSWGIILWEVITRRKPFDEI 206

>pdb|4GS6|A Chain A, Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxozeaenol Length = 315

Iteration: 1
 Score = 76.6 bits (187), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 60/200 (30%), Positives = 96/200 (48%), Gaps = 38/200 (19%)
Query: 321 LGQGGYGSVYKGKLLDGSNVAVKVLNDSKGNGKEFINEVASISRTSHVNVVALLGFCLR- 379
           +G+G +G V K K     +VA+K + +S+   K FI E+  +SR +H N+V L G CL  
Sbjct: 17  VGRGAFGVVCKAKW-RAKDVAIKQI-ESESERKAFIVELRQLSRVNHPNIVKLYGACLNP 74
Query: 380 ---------------------------VAEELSSTIGIARGLEYLHLGCSTRILHFDIKP 412
                                       A  +S  +  ++G+ YLH      ++H D+KP
Sbjct: 75  VCLVMEYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHSMQPKALIHRDLKP 134
Query: 413 HNILLDE-DFCPKISDFGLAKICNRKESIISMTGARGTVGYIAPEVFCRNIGEVSYKSDV 471
            N+LL       KI DFG A  C+ +     MT  +G+  ++APEVF       S K DV
Sbjct: 135 PNLLLVAGGTVLKICDFGTA--CDIQ---THMTNNKGSAAWMAPEVF--EGSNYSEKCDV 187
Query: 472 YNYGMMIFEMTGGRKNVDVV 491
           +++G++++E+   RK  D +
Sbjct: 188 FSWGIILWEVITRRKPFDEI 207

>pdb|3DQW|A Chain A, C-Src Kinase Domain Thr338ile Mutant In Complex With Atpgs Length = 286

Iteration: 1
 Score = 75.9 bits (185), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 55/220 (25%), Positives = 98/220 (44%), Gaps = 41/220 (18%)
Query: 309 DIKKMTNSFKYKLGQGGYGSVYKGKLLDGSNVAVKVLNDSKGNGKEFINEVASISRTSHV 368
           +I + +   + KLGQG +G V+ G     + VA+K L     + + F+ E   + +  H 
Sbjct: 14  EIPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQEAQVMKKLRHE 73
Query: 369 NVVAL----------------------------LGFCLRVAEELSSTIGIARGLEYLHLG 400
            +V L                            +G  LR+ + +     IA G+ Y+   
Sbjct: 74  KLVQLYAVVSEEPIYIVIEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVE-- 131
Query: 401 CSTRILHFDIKPHNILLDEDFCPKISDFGLAKICNRKESIISMTGARGTVGYIAPEVFCR 460
                +H D++  NIL+ E+   K++DFGLA++    E   +  GA+  + + APE    
Sbjct: 132 -RMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEX-TARQGAKFPIKWTAPEAAL- 188
Query: 461 NIGEVSYKSDVYNYGMMIFEMTG-------GRKNVDVVDN 493
             G  + KSDV+++G+++ E+T        G  N +V+D 
Sbjct: 189 -YGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQ 227

>pdb|3U4W|A Chain A, Src In Complex With Dna-Templated Macrocyclic Inhibitor Mc4b Length = 275

Iteration: 1
 Score = 75.9 bits (185), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 55/220 (25%), Positives = 98/220 (44%), Gaps = 41/220 (18%)
Query: 309 DIKKMTNSFKYKLGQGGYGSVYKGKLLDGSNVAVKVLNDSKGNGKEFINEVASISRTSHV 368
           +I + +   + KLGQG +G V+ G     + VA+K L     + + F+ E   + +  H 
Sbjct: 3   EIPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQEAQVMKKLRHE 62
Query: 369 NVVAL----------------------------LGFCLRVAEELSSTIGIARGLEYLHLG 400
            +V L                            +G  LR+ + +     IA G+ Y+   
Sbjct: 63  KLVQLYAVVSEEPIYIVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVE-- 120
Query: 401 CSTRILHFDIKPHNILLDEDFCPKISDFGLAKICNRKESIISMTGARGTVGYIAPEVFCR 460
                +H D++  NIL+ E+   K++DFGLA++    E   +  GA+  + + APE    
Sbjct: 121 -RMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNE-YTARQGAKFPIKWTAPEAAL- 177
Query: 461 NIGEVSYKSDVYNYGMMIFEMTG-------GRKNVDVVDN 493
             G  + KSDV+++G+++ E+T        G  N +V+D 
Sbjct: 178 -YGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQ 216

>pdb|2HWO|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Covalent Inhibitor Length = 286

Iteration: 1
 Score = 75.9 bits (185), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 55/220 (25%), Positives = 98/220 (44%), Gaps = 41/220 (18%)
Query: 309 DIKKMTNSFKYKLGQGGYGSVYKGKLLDGSNVAVKVLNDSKGNGKEFINEVASISRTSHV 368
           +I + +   + KLGQG +G V+ G     + VA+K L     + + F+ E   + +  H 
Sbjct: 14  EIPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQEAQVMKKLRHE 73
Query: 369 NVVAL----------------------------LGFCLRVAEELSSTIGIARGLEYLHLG 400
            +V L                            +G  LR+ + +     IA G+ Y+   
Sbjct: 74  KLVQLYAVVSEEPIYIVTEYMSKGCLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVE-- 131
Query: 401 CSTRILHFDIKPHNILLDEDFCPKISDFGLAKICNRKESIISMTGARGTVGYIAPEVFCR 460
                +H D++  NIL+ E+   K++DFGLA++    E   +  GA+  + + APE    
Sbjct: 132 -RMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNE-YTARQGAKFPIKWTAPEAAL- 188
Query: 461 NIGEVSYKSDVYNYGMMIFEMTG-------GRKNVDVVDN 493
             G  + KSDV+++G+++ E+T        G  N +V+D 
Sbjct: 189 -YGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQ 227

>pdb|3OEZ|A Chain A, Crystal Structure Of The L317i Mutant Of The Chicken C-Src Tyrosine Kinase Domain Complexed With Imatinib Length = 286

Iteration: 1
 Score = 75.9 bits (185), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 55/220 (25%), Positives = 98/220 (44%), Gaps = 41/220 (18%)
Query: 309 DIKKMTNSFKYKLGQGGYGSVYKGKLLDGSNVAVKVLNDSKGNGKEFINEVASISRTSHV 368
           +I + +   + KLGQG +G V+ G     + VA+K L     + + F+ E   + +  H 
Sbjct: 14  EIPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQEAQVMKKIRHE 73
Query: 369 NVVAL----------------------------LGFCLRVAEELSSTIGIARGLEYLHLG 400
            +V L                            +G  LR+ + +     IA G+ Y+   
Sbjct: 74  KLVQLYAVVSEEPIYIVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVE-- 131
Query: 401 CSTRILHFDIKPHNILLDEDFCPKISDFGLAKICNRKESIISMTGARGTVGYIAPEVFCR 460
                +H D++  NIL+ E+   K++DFGLA++    E   +  GA+  + + APE    
Sbjct: 132 -RMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNE-YTARQGAKFPIKWTAPEAAL- 188
Query: 461 NIGEVSYKSDVYNYGMMIFEMTG-------GRKNVDVVDN 493
             G  + KSDV+++G+++ E+T        G  N +V+D 
Sbjct: 189 -YGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQ 227

>pdb|3SVV|A Chain A, Crystal Structure Of T338c C-Src Covalently Bound To Vinylsulfonamide- Pyrazolopyrimidine 9 Length = 286

Iteration: 1
 Score = 75.9 bits (185), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 55/220 (25%), Positives = 98/220 (44%), Gaps = 41/220 (18%)
Query: 309 DIKKMTNSFKYKLGQGGYGSVYKGKLLDGSNVAVKVLNDSKGNGKEFINEVASISRTSHV 368
           +I + +   + KLGQG +G V+ G     + VA+K L     + + F+ E   + +  H 
Sbjct: 14  EIPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQEAQVMKKLRHE 73
Query: 369 NVVAL----------------------------LGFCLRVAEELSSTIGIARGLEYLHLG 400
            +V L                            +G  LR+ + +     IA G+ Y+   
Sbjct: 74  KLVQLYAVVSEEPIYIVCEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVE-- 131
Query: 401 CSTRILHFDIKPHNILLDEDFCPKISDFGLAKICNRKESIISMTGARGTVGYIAPEVFCR 460
                +H D++  NIL+ E+   K++DFGLA++    E   +  GA+  + + APE    
Sbjct: 132 -RMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNE-YTARQGAKFPIKWTAPEAAL- 188
Query: 461 NIGEVSYKSDVYNYGMMIFEMTG-------GRKNVDVVDN 493
             G  + KSDV+++G+++ E+T        G  N +V+D 
Sbjct: 189 -YGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQ 227

>pdb|2OIQ|A Chain A, Crystal Structure Of Chicken C-Src Kinase Domain In Complex With The Cancer Drug Imatinib. Length = 286

Iteration: 1
 Score = 75.9 bits (185), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 55/220 (25%), Positives = 98/220 (44%), Gaps = 41/220 (18%)
Query: 309 DIKKMTNSFKYKLGQGGYGSVYKGKLLDGSNVAVKVLNDSKGNGKEFINEVASISRTSHV 368
           +I + +   + KLGQG +G V+ G     + VA+K L     + + F+ E   + +  H 
Sbjct: 14  EIPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQEAQVMKKLRHE 73
Query: 369 NVVAL----------------------------LGFCLRVAEELSSTIGIARGLEYLHLG 400
            +V L                            +G  LR+ + +     IA G+ Y+   
Sbjct: 74  KLVQLYAVVSEEPIYIVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVE-- 131
Query: 401 CSTRILHFDIKPHNILLDEDFCPKISDFGLAKICNRKESIISMTGARGTVGYIAPEVFCR 460
                +H D++  NIL+ E+   K++DFGLA++    E   +  GA+  + + APE    
Sbjct: 132 -RMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNE-YTARQGAKFPIKWTAPEAAL- 188
Query: 461 NIGEVSYKSDVYNYGMMIFEMTG-------GRKNVDVVDN 493
             G  + KSDV+++G+++ E+T        G  N +V+D 
Sbjct: 189 -YGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQ 227

>pdb|3D7U|B Chain B, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 277

Iteration: 1
 Score = 75.9 bits (185), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 55/220 (25%), Positives = 98/220 (44%), Gaps = 41/220 (18%)
Query: 309 DIKKMTNSFKYKLGQGGYGSVYKGKLLDGSNVAVKVLNDSKGNGKEFINEVASISRTSHV 368
           +I + +   + KLGQG +G V+ G     + VA+K L     + + F+ E   + +  H 
Sbjct: 5   EIPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQEAQVMKKLRHE 64
Query: 369 NVVAL----------------------------LGFCLRVAEELSSTIGIARGLEYLHLG 400
            +V L                            +G  LR+ + +     IA G+ Y+   
Sbjct: 65  KLVQLYAVVSEEPIYIVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVE-- 122
Query: 401 CSTRILHFDIKPHNILLDEDFCPKISDFGLAKICNRKESIISMTGARGTVGYIAPEVFCR 460
                +H D++  NIL+ E+   K++DFGLA++    E   +  GA+  + + APE    
Sbjct: 123 -RMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNE-YTARQGAKFPIKWTAPEAAL- 179
Query: 461 NIGEVSYKSDVYNYGMMIFEMTG-------GRKNVDVVDN 493
             G  + KSDV+++G+++ E+T        G  N +V+D 
Sbjct: 180 -YGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQ 218

>pdb|2QQ7|A Chain A, Crystal Structure Of Drug Resistant Src Kinase Domain With Irreversible Inhibitor Length = 286

Iteration: 1
 Score = 75.9 bits (185), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 55/220 (25%), Positives = 98/220 (44%), Gaps = 41/220 (18%)
Query: 309 DIKKMTNSFKYKLGQGGYGSVYKGKLLDGSNVAVKVLNDSKGNGKEFINEVASISRTSHV 368
           +I + +   + KLGQG +G V+ G     + VA+K L     + + F+ E   + +  H 
Sbjct: 14  EIPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQEAQVMKKLRHE 73
Query: 369 NVVAL----------------------------LGFCLRVAEELSSTIGIARGLEYLHLG 400
            +V L                            +G  LR+ + +     IA G+ Y+   
Sbjct: 74  KLVQLYAVVSEEPIYIVMEYMSKGCLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVE-- 131
Query: 401 CSTRILHFDIKPHNILLDEDFCPKISDFGLAKICNRKESIISMTGARGTVGYIAPEVFCR 460
                +H D++  NIL+ E+   K++DFGLA++    E   +  GA+  + + APE    
Sbjct: 132 -RMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNE-YTARQGAKFPIKWTAPEAAL- 188
Query: 461 NIGEVSYKSDVYNYGMMIFEMTG-------GRKNVDVVDN 493
             G  + KSDV+++G+++ E+T        G  N +V+D 
Sbjct: 189 -YGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQ 227

>pdb|4F1O|A Chain A, Crystal Structure Of The L1180t Mutant Roco4 Kinase Domain From D. Discoideum Bound To Appcp Length = 287

Iteration: 1
 Score = 75.5 bits (184), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 59/214 (27%), Positives = 105/214 (49%), Gaps = 46/214 (21%)
Query: 316 SFKYKLGQGGYGSVYKGKLL-DGSNVAVK--VLNDSKGNG------KEFINEVASISRTS 366
            ++ ++G+GG+G V+KG+L+ D S VA+K  +L DS+G        +EF  EV  +S  +
Sbjct: 22  EYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLN 81
Query: 367 HVNVVALLGFC--------------------------LRVAEELSSTIGIARGLEYLHLG 400
           H N+V L G                            ++ + +L   + IA G+EY+   
Sbjct: 82  HPNIVKLYGLMHNPPRMVMEFVPCGDLYHRLLDKAHPIKWSVKLRLMLDIALGIEYMQ-N 140
Query: 401 CSTRILHFDIKPHNILL---DED--FCPKISDFGLAKICNRKESIISMTGARGTVGYIAP 455
            +  I+H D++  NI L   DE+   C K++DFG ++     +S+ S++G  G   ++AP
Sbjct: 141 QNPPIVHRDLRSPNIFLQSLDENAPVCAKVADFGTSQ-----QSVHSVSGLLGNFQWMAP 195
Query: 456 EVFCRNIGEVSYKSDVYNYGMMIFEMTGGRKNVD 489
           E         + K+D Y++ M+++ +  G    D
Sbjct: 196 ETIGAEEESYTEKADTYSFAMILYTILTGEGPFD 229

>pdb|3G6H|A Chain A, Src Thr338ile Inhibited In The Dfg-Asp-Out Conformation Length = 286

Iteration: 1
 Score = 75.5 bits (184), Expect = 7e-14,   Method: Compositional matrix adjust.
 Identities = 55/220 (25%), Positives = 98/220 (44%), Gaps = 41/220 (18%)
Query: 309 DIKKMTNSFKYKLGQGGYGSVYKGKLLDGSNVAVKVLNDSKGNGKEFINEVASISRTSHV 368
           +I + +   + KLGQG +G V+ G     + VA+K L     + + F+ E   + +  H 
Sbjct: 14  EIPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQEAQVMKKLRHE 73
Query: 369 NVVAL----------------------------LGFCLRVAEELSSTIGIARGLEYLHLG 400
            +V L                            +G  LR+ + +     IA G+ Y+   
Sbjct: 74  KLVQLYAVVSEEPIYIVIEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVE-- 131
Query: 401 CSTRILHFDIKPHNILLDEDFCPKISDFGLAKICNRKESIISMTGARGTVGYIAPEVFCR 460
                +H D++  NIL+ E+   K++DFGLA++    E   +  GA+  + + APE    
Sbjct: 132 -RMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNE-YTARQGAKFPIKWTAPEAAL- 188
Query: 461 NIGEVSYKSDVYNYGMMIFEMTG-------GRKNVDVVDN 493
             G  + KSDV+++G+++ E+T        G  N +V+D 
Sbjct: 189 -YGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQ 227

>pdb|4F1M|A Chain A, Crystal Structure Of The G1179s Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287

Iteration: 1
 Score = 75.5 bits (184), Expect = 7e-14,   Method: Compositional matrix adjust.
 Identities = 59/214 (27%), Positives = 105/214 (49%), Gaps = 46/214 (21%)
Query: 316 SFKYKLGQGGYGSVYKGKLL-DGSNVAVK--VLNDSKGNG------KEFINEVASISRTS 366
            ++ ++G+GG+G V+KG+L+ D S VA+K  +L DS+G        +EF  EV  +S  +
Sbjct: 22  EYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLN 81
Query: 367 HVNVVALLGFC--------------------------LRVAEELSSTIGIARGLEYLHLG 400
           H N+V L G                            ++ + +L   + IA G+EY+   
Sbjct: 82  HPNIVKLYGLMHNPPRMVMEFVPCGDLYHRLLDKAHPIKWSVKLRLMLDIALGIEYMQ-N 140
Query: 401 CSTRILHFDIKPHNILL---DED--FCPKISDFGLAKICNRKESIISMTGARGTVGYIAP 455
            +  I+H D++  NI L   DE+   C K++DF L++     +S+ S++G  G   ++AP
Sbjct: 141 QNPPIVHRDLRSPNIFLQSLDENAPVCAKVADFSLSQ-----QSVHSVSGLLGNFQWMAP 195
Query: 456 EVFCRNIGEVSYKSDVYNYGMMIFEMTGGRKNVD 489
           E         + K+D Y++ M+++ +  G    D
Sbjct: 196 ETIGAEEESYTEKADTYSFAMILYTILTGEGPFD 229

>pdb|1YOJ|A Chain A, Crystal Structure Of Src Kinase Domain Length = 283

Iteration: 1
 Score = 75.1 bits (183), Expect = 8e-14,   Method: Compositional matrix adjust.
 Identities = 55/220 (25%), Positives = 98/220 (44%), Gaps = 41/220 (18%)
Query: 309 DIKKMTNSFKYKLGQGGYGSVYKGKLLDGSNVAVKVLNDSKGNGKEFINEVASISRTSHV 368
           +I + +   + KLGQG +G V+ G     + VA+K L     + + F+ E   + +  H 
Sbjct: 11  EIPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQEAQVMKKLRHE 70
Query: 369 NVVALL----------------------------GFCLRVAEELSSTIGIARGLEYLHLG 400
            +V L                             G  LR+ + +  +  IA G+ Y+   
Sbjct: 71  KLVQLYAVVSEEPIYIVTEYMNKGSLLDFLKGETGKYLRLPQLVDMSAQIASGMAYVE-- 128
Query: 401 CSTRILHFDIKPHNILLDEDFCPKISDFGLAKICNRKESIISMTGARGTVGYIAPEVFCR 460
                +H D++  NIL+ E+   K++DFGLA++    E   +  GA+  + + APE    
Sbjct: 129 -RMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNE-WTARQGAKFPIKWTAPEAAL- 185
Query: 461 NIGEVSYKSDVYNYGMMIFEMTG-------GRKNVDVVDN 493
             G  + KSDV+++G+++ E+T        G  N +V+D 
Sbjct: 186 -YGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQ 224

>pdb|1YI6|A Chain A, C-Term Tail Segment Of Human Tyrosine Kinase (258-533) Length = 276

Iteration: 1
 Score = 75.1 bits (183), Expect = 9e-14,   Method: Compositional matrix adjust.
 Identities = 55/220 (25%), Positives = 97/220 (44%), Gaps = 41/220 (18%)
Query: 309 DIKKMTNSFKYKLGQGGYGSVYKGKLLDGSNVAVKVLNDSKGNGKEFINEVASISRTSHV 368
           +I + +   + KLGQG +G V+ G     + VA+K L     + + F+ E   + +  H 
Sbjct: 4   EIPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQEAQVMKKLRHE 63
Query: 369 NVVALL----------------------------GFCLRVAEELSSTIGIARGLEYLHLG 400
            +V L                             G  LR+ + +     IA G+ Y+   
Sbjct: 64  KLVQLYAVVSEEPIXIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVE-- 121
Query: 401 CSTRILHFDIKPHNILLDEDFCPKISDFGLAKICNRKESIISMTGARGTVGYIAPEVFCR 460
                +H D++  NIL+ E+   K++DFGLA++    E   +  GA+  + + APE    
Sbjct: 122 -RMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEX-TARQGAKFPIKWTAPEAAL- 178
Query: 461 NIGEVSYKSDVYNYGMMIFEMTG-------GRKNVDVVDN 493
             G  + KSDV+++G+++ E+T        G  N +V+D 
Sbjct: 179 -YGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQ 217

>pdb|1YOL|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Cgp77675 Length = 283

Iteration: 1
 Score = 74.7 bits (182), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 55/220 (25%), Positives = 98/220 (44%), Gaps = 41/220 (18%)
Query: 309 DIKKMTNSFKYKLGQGGYGSVYKGKLLDGSNVAVKVLNDSKGNGKEFINEVASISRTSHV 368
           +I + +   + KLGQG +G V+ G     + VA+K L     + + F+ E   + +  H 
Sbjct: 11  EIPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQEAQVMKKLRHE 70
Query: 369 NVVALL----------------------------GFCLRVAEELSSTIGIARGLEYLHLG 400
            +V L                             G  LR+ + +  +  IA G+ Y+   
Sbjct: 71  KLVQLYAVVSEEPIYIVTEYMNKGSLLDFLKGETGKYLRLPQLVDMSAQIASGMAYVE-- 128
Query: 401 CSTRILHFDIKPHNILLDEDFCPKISDFGLAKICNRKESIISMTGARGTVGYIAPEVFCR 460
                +H D++  NIL+ E+   K++DFGLA++    E   +  GA+  + + APE    
Sbjct: 129 -RMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNE-YTARQGAKFPIKWTAPEAAL- 185
Query: 461 NIGEVSYKSDVYNYGMMIFEMTG-------GRKNVDVVDN 493
             G  + KSDV+++G+++ E+T        G  N +V+D 
Sbjct: 186 -YGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQ 224

>pdb|1KSW|A Chain A, Structure Of Human C-Src Tyrosine Kinase (Thr338gly Mutant) In Complex With N6-Benzyl Adp Length = 452

Iteration: 1
 Score = 74.3 bits (181), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 55/220 (25%), Positives = 97/220 (44%), Gaps = 41/220 (18%)
Query: 309 DIKKMTNSFKYKLGQGGYGSVYKGKLLDGSNVAVKVLNDSKGNGKEFINEVASISRTSHV 368
           +I + +   + KLGQG +G V+ G     + VA+K L     + + F+ E   + +  H 
Sbjct: 180 EIPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQEAQVMKKLRHE 239
Query: 369 NVVALL----------------------------GFCLRVAEELSSTIGIARGLEYLHLG 400
            +V L                             G  LR+ + +     IA G+ Y+   
Sbjct: 240 KLVQLYAVVSEEPIYIVGEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVE-- 297
Query: 401 CSTRILHFDIKPHNILLDEDFCPKISDFGLAKICNRKESIISMTGARGTVGYIAPEVFCR 460
                +H D++  NIL+ E+   K++DFGLA++    E   +  GA+  + + APE    
Sbjct: 298 -RMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNE-YTARQGAKFPIKWTAPEAAL- 354
Query: 461 NIGEVSYKSDVYNYGMMIFEMTG-------GRKNVDVVDN 493
             G  + KSDV+++G+++ E+T        G  N +V+D 
Sbjct: 355 -YGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQ 393

>pdb|1Y57|A Chain A, Structure Of Unphosphorylated C-Src In Complex With An Inhibitor Length = 452

Iteration: 1
 Score = 74.3 bits (181), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 55/220 (25%), Positives = 97/220 (44%), Gaps = 41/220 (18%)
Query: 309 DIKKMTNSFKYKLGQGGYGSVYKGKLLDGSNVAVKVLNDSKGNGKEFINEVASISRTSHV 368
           +I + +   + KLGQG +G V+ G     + VA+K L     + + F+ E   + +  H 
Sbjct: 180 EIPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQEAQVMKKLRHE 239
Query: 369 NVVALL----------------------------GFCLRVAEELSSTIGIARGLEYLHLG 400
            +V L                             G  LR+ + +     IA G+ Y+   
Sbjct: 240 KLVQLYAVVSEEPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVE-- 297
Query: 401 CSTRILHFDIKPHNILLDEDFCPKISDFGLAKICNRKESIISMTGARGTVGYIAPEVFCR 460
                +H D++  NIL+ E+   K++DFGLA++    E   +  GA+  + + APE    
Sbjct: 298 -RMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNE-YTARQGAKFPIKWTAPEAAL- 354
Query: 461 NIGEVSYKSDVYNYGMMIFEMTG-------GRKNVDVVDN 493
             G  + KSDV+++G+++ E+T        G  N +V+D 
Sbjct: 355 -YGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQ 393

>pdb|1FMK|A Chain A, Crystal Structure Of Human Tyrosine-Protein Kinase C-Src Length = 452

Iteration: 1
 Score = 74.3 bits (181), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 55/220 (25%), Positives = 97/220 (44%), Gaps = 41/220 (18%)
Query: 309 DIKKMTNSFKYKLGQGGYGSVYKGKLLDGSNVAVKVLNDSKGNGKEFINEVASISRTSHV 368
           +I + +   + KLGQG +G V+ G     + VA+K L     + + F+ E   + +  H 
Sbjct: 180 EIPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQEAQVMKKLRHE 239
Query: 369 NVVALL----------------------------GFCLRVAEELSSTIGIARGLEYLHLG 400
            +V L                             G  LR+ + +     IA G+ Y+   
Sbjct: 240 KLVQLYAVVSEEPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVE-- 297
Query: 401 CSTRILHFDIKPHNILLDEDFCPKISDFGLAKICNRKESIISMTGARGTVGYIAPEVFCR 460
                +H D++  NIL+ E+   K++DFGLA++    E   +  GA+  + + APE    
Sbjct: 298 -RMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNE-YTARQGAKFPIKWTAPEAAL- 354
Query: 461 NIGEVSYKSDVYNYGMMIFEMTG-------GRKNVDVVDN 493
             G  + KSDV+++G+++ E+T        G  N +V+D 
Sbjct: 355 -YGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQ 393

>pdb|3GEQ|A Chain A, Structural Basis For The Chemical Rescue Of Src Kinase Activity Length = 286

Iteration: 1
 Score = 74.3 bits (181), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 55/220 (25%), Positives = 97/220 (44%), Gaps = 41/220 (18%)
Query: 309 DIKKMTNSFKYKLGQGGYGSVYKGKLLDGSNVAVKVLNDSKGNGKEFINEVASISRTSHV 368
           +I + +   + KLGQG +G V+ G     + VA+K L     + + F+ E   + +  H 
Sbjct: 14  EIPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQEAQVMKKLRHE 73
Query: 369 NVVAL----------------------------LGFCLRVAEELSSTIGIARGLEYLHLG 400
            +V L                            +G  LR+ + +     IA G+ Y+   
Sbjct: 74  KLVQLYAVVSEEPIYIVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVE-- 131
Query: 401 CSTRILHFDIKPHNILLDEDFCPKISDFGLAKICNRKESIISMTGARGTVGYIAPEVFCR 460
                +H D+   NIL+ E+   K++DFGLA++    E   +  GA+  + + APE    
Sbjct: 132 -RMNYVHRDLAAANILVGENLVCKVADFGLARLIEDNE-YTARQGAKFPIKWTAPEAAL- 188
Query: 461 NIGEVSYKSDVYNYGMMIFEMTG-------GRKNVDVVDN 493
             G  + KSDV+++G+++ E+T        G  N +V+D 
Sbjct: 189 -YGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQ 227

>pdb|2BDF|A Chain A, Src Kinase In Complex With Inhibitor Ap23451 Length = 279

Iteration: 1
 Score = 74.3 bits (181), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 55/220 (25%), Positives = 97/220 (44%), Gaps = 41/220 (18%)
Query: 309 DIKKMTNSFKYKLGQGGYGSVYKGKLLDGSNVAVKVLNDSKGNGKEFINEVASISRTSHV 368
           +I + +   + KLGQG +G V+ G     + VA+K L     + + F+ E   + +  H 
Sbjct: 7   EIPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQEAQVMKKLRHE 66
Query: 369 NVVALL----------------------------GFCLRVAEELSSTIGIARGLEYLHLG 400
            +V L                             G  LR+ + +     IA G+ Y+   
Sbjct: 67  KLVQLYAVVSEEPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVE-- 124
Query: 401 CSTRILHFDIKPHNILLDEDFCPKISDFGLAKICNRKESIISMTGARGTVGYIAPEVFCR 460
                +H D++  NIL+ E+   K++DFGLA++    E   +  GA+  + + APE    
Sbjct: 125 -RMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNE-YTARQGAKFPIKWTAPEAAL- 181
Query: 461 NIGEVSYKSDVYNYGMMIFEMTG-------GRKNVDVVDN 493
             G  + KSDV+++G+++ E+T        G  N +V+D 
Sbjct: 182 -YGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQ 220

>pdb|2H8H|A Chain A, Src Kinase In Complex With A Quinazoline Inhibitor Length = 535

Iteration: 1
 Score = 74.3 bits (181), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 51/202 (25%), Positives = 91/202 (45%), Gaps = 34/202 (16%)
Query: 309 DIKKMTNSFKYKLGQGGYGSVYKGKLLDGSNVAVKVLNDSKGNGKEFINEVASISRTSHV 368
           +I + +   + KLGQG +G V+ G     + VA+K L     + + F+ E   + +  H 
Sbjct: 263 EIPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQEAQVMKKLRHE 322
Query: 369 NVVALL----------------------------GFCLRVAEELSSTIGIARGLEYLHLG 400
            +V L                             G  LR+ + +     IA G+ Y+   
Sbjct: 323 KLVQLYAVVSEEPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVE-- 380
Query: 401 CSTRILHFDIKPHNILLDEDFCPKISDFGLAKICNRKESIISMTGARGTVGYIAPEVFCR 460
                +H D++  NIL+ E+   K++DFGLA++    E   +  GA+  + + APE    
Sbjct: 381 -RMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNE-YTARQGAKFPIKWTAPEAAL- 437
Query: 461 NIGEVSYKSDVYNYGMMIFEMT 482
             G  + KSDV+++G+++ E+T
Sbjct: 438 -YGRFTIKSDVWSFGILLTELT 458

>pdb|2PTK|A Chain A, Chicken Src Tyrosine Kinase Length = 453

Iteration: 1
 Score = 73.9 bits (180), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 54/220 (24%), Positives = 97/220 (44%), Gaps = 41/220 (18%)
Query: 309 DIKKMTNSFKYKLGQGGYGSVYKGKLLDGSNVAVKVLNDSKGNGKEFINEVASISRTSHV 368
           +I + +   + KLGQG +G V+ G     + VA+K L     + + F+ E   + +  H 
Sbjct: 181 EIPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGNMSPEAFLQEAQVMKKLRHE 240
Query: 369 NVVAL----------------------------LGFCLRVAEELSSTIGIARGLEYLHLG 400
            +V L                            +G  LR+ + +     IA G+ Y+   
Sbjct: 241 KLVQLYAVVSEEPIYIVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVE-- 298
Query: 401 CSTRILHFDIKPHNILLDEDFCPKISDFGLAKICNRKESIISMTGARGTVGYIAPEVFCR 460
                +H D++  NIL+ E+   K++DFGL ++    E   +  GA+  + + APE    
Sbjct: 299 -RMNYVHRDLRAANILVGENLVCKVADFGLGRLIEDNE-YTARQGAKFPIKWTAPEAAL- 355
Query: 461 NIGEVSYKSDVYNYGMMIFEMTG-------GRKNVDVVDN 493
             G  + KSDV+++G+++ E+T        G  N +V+D 
Sbjct: 356 -YGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQ 394

>pdb|4HJO|A Chain A, Crystal Structure Of The Inactive Egfr Tyrosine Kinase Domain With Erlotinib Length = 337

Iteration: 1
 Score = 73.2 bits (178), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 58/204 (28%), Positives = 95/204 (46%), Gaps = 40/204 (19%)
Query: 321 LGQGGYGSVYKGKLL-DGSNV----AVKVLND--SKGNGKEFINEVASISRTSHVNVVAL 373
           LG G +G+VYKG  + +G  V    A+K L +  S    KE ++E   ++   + +V  L
Sbjct: 33  LGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRL 92
Query: 374 LGFCLRVAEELSST---------------------------IGIARGLEYLHLGCSTRIL 406
           LG CL    +L +                            + IA+G+ YL      R++
Sbjct: 93  LGICLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLE---DRRLV 149
Query: 407 HFDIKPHNILLDEDFCPKISDFGLAKICNRKESIISMTGARGTVGYIAPEVFCRNIGEVS 466
           H D+   N+L+      KI+DFGLAK+   +E      G +  + ++A E     I   +
Sbjct: 150 HRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRI--YT 207
Query: 467 YKSDVYNYGMMIFE-MTGGRKNVD 489
           ++SDV++YG+ ++E MT G K  D
Sbjct: 208 HQSDVWSYGVTVWELMTFGSKPYD 231

>pdb|1M14|A Chain A, Tyrosine Kinase Domain From Epidermal Growth Factor Receptor Length = 333

Iteration: 1
 Score = 72.8 bits (177), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 58/204 (28%), Positives = 95/204 (46%), Gaps = 40/204 (19%)
Query: 321 LGQGGYGSVYKGKLL-DGSNV----AVKVLND--SKGNGKEFINEVASISRTSHVNVVAL 373
           LG G +G+VYKG  + +G  V    A+K L +  S    KE ++E   ++   + +V  L
Sbjct: 29  LGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRL 88
Query: 374 LGFCLRVAEELSST---------------------------IGIARGLEYLHLGCSTRIL 406
           LG CL    +L +                            + IA+G+ YL      R++
Sbjct: 89  LGICLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLE---DRRLV 145
Query: 407 HFDIKPHNILLDEDFCPKISDFGLAKICNRKESIISMTGARGTVGYIAPEVFCRNIGEVS 466
           H D+   N+L+      KI+DFGLAK+   +E      G +  + ++A E     I   +
Sbjct: 146 HRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRI--YT 203
Query: 467 YKSDVYNYGMMIFE-MTGGRKNVD 489
           ++SDV++YG+ ++E MT G K  D
Sbjct: 204 HQSDVWSYGVTVWELMTFGSKPYD 227

>pdb|2J5E|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 13-Jab Length = 327

Iteration: 1
 Score = 72.8 bits (177), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 58/204 (28%), Positives = 95/204 (46%), Gaps = 40/204 (19%)
Query: 321 LGQGGYGSVYKGKLL-DGSNV----AVKVLND--SKGNGKEFINEVASISRTSHVNVVAL 373
           LG G +G+VYKG  + +G  V    A+K L +  S    KE ++E   ++   + +V  L
Sbjct: 23  LGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRL 82
Query: 374 LGFCLRVAEELSST---------------------------IGIARGLEYLHLGCSTRIL 406
           LG CL    +L +                            + IA+G+ YL      R++
Sbjct: 83  LGICLTSTVQLITQLMPFGXLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLE---DRRLV 139
Query: 407 HFDIKPHNILLDEDFCPKISDFGLAKICNRKESIISMTGARGTVGYIAPEVFCRNIGEVS 466
           H D+   N+L+      KI+DFGLAK+   +E      G +  + ++A E     I   +
Sbjct: 140 HRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRI--YT 197
Query: 467 YKSDVYNYGMMIFE-MTGGRKNVD 489
           ++SDV++YG+ ++E MT G K  D
Sbjct: 198 HQSDVWSYGVTVWELMTFGSKPYD 221

>pdb|3BEL|A Chain A, X-Ray Structure Of Egfr In Complex With Oxime Inhibitor Length = 315

Iteration: 1
 Score = 72.8 bits (177), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 58/204 (28%), Positives = 95/204 (46%), Gaps = 40/204 (19%)
Query: 321 LGQGGYGSVYKGKLL-DGSNV----AVKVLND--SKGNGKEFINEVASISRTSHVNVVAL 373
           LG G +G+VYKG  + +G  V    A+K L +  S    KE ++E   ++   + +V  L
Sbjct: 17  LGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRL 76
Query: 374 LGFCLRVAEELSST---------------------------IGIARGLEYLHLGCSTRIL 406
           LG CL    +L +                            + IA+G+ YL      R++
Sbjct: 77  LGICLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLE---DRRLV 133
Query: 407 HFDIKPHNILLDEDFCPKISDFGLAKICNRKESIISMTGARGTVGYIAPEVFCRNIGEVS 466
           H D+   N+L+      KI+DFGLAK+   +E      G +  + ++A E     I   +
Sbjct: 134 HRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRI--YT 191
Query: 467 YKSDVYNYGMMIFE-MTGGRKNVD 489
           ++SDV++YG+ ++E MT G K  D
Sbjct: 192 HQSDVWSYGVTVWELMTFGSKPYD 215

>pdb|2J5F|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 34-Jab Length = 327

Iteration: 1
 Score = 72.8 bits (177), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 58/204 (28%), Positives = 95/204 (46%), Gaps = 40/204 (19%)
Query: 321 LGQGGYGSVYKGKLL-DGSNV----AVKVLND--SKGNGKEFINEVASISRTSHVNVVAL 373
           LG G +G+VYKG  + +G  V    A+K L +  S    KE ++E   ++   + +V  L
Sbjct: 23  LGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRL 82
Query: 374 LGFCLRVAEELSST---------------------------IGIARGLEYLHLGCSTRIL 406
           LG CL    +L +                            + IA+G+ YL      R++
Sbjct: 83  LGICLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLE---DRRLV 139
Query: 407 HFDIKPHNILLDEDFCPKISDFGLAKICNRKESIISMTGARGTVGYIAPEVFCRNIGEVS 466
           H D+   N+L+      KI+DFGLAK+   +E      G +  + ++A E     I   +
Sbjct: 140 HRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRI--YT 197
Query: 467 YKSDVYNYGMMIFE-MTGGRKNVD 489
           ++SDV++YG+ ++E MT G K  D
Sbjct: 198 HQSDVWSYGVTVWELMTFGSKPYD 221

>pdb|2GS7|A Chain A, Crystal Structure Of The Inactive Egfr Kinase Domain In Complex With Amp-Pnp Length = 330

Iteration: 1
 Score = 72.8 bits (177), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 58/204 (28%), Positives = 95/204 (46%), Gaps = 40/204 (19%)
Query: 321 LGQGGYGSVYKGKLL-DGSNV----AVKVLND--SKGNGKEFINEVASISRTSHVNVVAL 373
           LG G +G+VYKG  + +G  V    A+K L +  S    KE ++E   ++   + +V  L
Sbjct: 26  LGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRL 85
Query: 374 LGFCLRVAEELSST---------------------------IGIARGLEYLHLGCSTRIL 406
           LG CL    +L +                            + IA+G+ YL      R++
Sbjct: 86  LGICLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLE---DRRLV 142
Query: 407 HFDIKPHNILLDEDFCPKISDFGLAKICNRKESIISMTGARGTVGYIAPEVFCRNIGEVS 466
           H D+   N+L+      KI+DFGLAK+   +E      G +  + ++A E     I   +
Sbjct: 143 HRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRI--YT 200
Query: 467 YKSDVYNYGMMIFE-MTGGRKNVD 489
           ++SDV++YG+ ++E MT G K  D
Sbjct: 201 HQSDVWSYGVTVWELMTFGSKPYD 224

>pdb|1XKK|A Chain A, Egfr Kinase Domain Complexed With A Quinazoline Inhibitor- Gw572016 Length = 352

Iteration: 1
 Score = 72.8 bits (177), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 58/204 (28%), Positives = 95/204 (46%), Gaps = 40/204 (19%)
Query: 321 LGQGGYGSVYKGKLL-DGSNV----AVKVLND--SKGNGKEFINEVASISRTSHVNVVAL 373
           LG G +G+VYKG  + +G  V    A+K L +  S    KE ++E   ++   + +V  L
Sbjct: 48  LGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRL 107
Query: 374 LGFCLRVAEELSST---------------------------IGIARGLEYLHLGCSTRIL 406
           LG CL    +L +                            + IA+G+ YL      R++
Sbjct: 108 LGICLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLE---DRRLV 164
Query: 407 HFDIKPHNILLDEDFCPKISDFGLAKICNRKESIISMTGARGTVGYIAPEVFCRNIGEVS 466
           H D+   N+L+      KI+DFGLAK+   +E      G +  + ++A E     I   +
Sbjct: 165 HRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRI--YT 222
Query: 467 YKSDVYNYGMMIFE-MTGGRKNVD 489
           ++SDV++YG+ ++E MT G K  D
Sbjct: 223 HQSDVWSYGVTVWELMTFGSKPYD 246

>pdb|4I23|A Chain A, Crystal Structure Of The Wild-type Egfr Kinase Domain In Complex With Dacomitinib (soaked) Length = 329

Iteration: 1
 Score = 72.8 bits (177), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 58/204 (28%), Positives = 95/204 (46%), Gaps = 40/204 (19%)
Query: 321 LGQGGYGSVYKGKLL-DGSNV----AVKVLND--SKGNGKEFINEVASISRTSHVNVVAL 373
           LG G +G+VYKG  + +G  V    A+K L +  S    KE ++E   ++   + +V  L
Sbjct: 25  LGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRL 84
Query: 374 LGFCLRVAEELSST---------------------------IGIARGLEYLHLGCSTRIL 406
           LG CL    +L +                            + IA+G+ YL      R++
Sbjct: 85  LGICLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLE---DRRLV 141
Query: 407 HFDIKPHNILLDEDFCPKISDFGLAKICNRKESIISMTGARGTVGYIAPEVFCRNIGEVS 466
           H D+   N+L+      KI+DFGLAK+   +E      G +  + ++A E     I   +
Sbjct: 142 HRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRI--YT 199
Query: 467 YKSDVYNYGMMIFE-MTGGRKNVD 489
           ++SDV++YG+ ++E MT G K  D
Sbjct: 200 HQSDVWSYGVTVWELMTFGSKPYD 223

>pdb|4G5J|A Chain A, Crystal Structure Of Egfr Kinase In Complex With Bibw2992 Length = 330

Iteration: 1
 Score = 72.8 bits (177), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 58/204 (28%), Positives = 95/204 (46%), Gaps = 40/204 (19%)
Query: 321 LGQGGYGSVYKGKLL-DGSNV----AVKVLND--SKGNGKEFINEVASISRTSHVNVVAL 373
           LG G +G+VYKG  + +G  V    A+K L +  S    KE ++E   ++   + +V  L
Sbjct: 26  LGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRL 85
Query: 374 LGFCLRVAEELSST---------------------------IGIARGLEYLHLGCSTRIL 406
           LG CL    +L +                            + IA+G+ YL      R++
Sbjct: 86  LGICLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLE---DRRLV 142
Query: 407 HFDIKPHNILLDEDFCPKISDFGLAKICNRKESIISMTGARGTVGYIAPEVFCRNIGEVS 466
           H D+   N+L+      KI+DFGLAK+   +E      G +  + ++A E     I   +
Sbjct: 143 HRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRI--YT 200
Query: 467 YKSDVYNYGMMIFE-MTGGRKNVD 489
           ++SDV++YG+ ++E MT G K  D
Sbjct: 201 HQSDVWSYGVTVWELMTFGSKPYD 224

>pdb|2GS2|A Chain A, Crystal Structure Of The Active Egfr Kinase Domain Length = 330

Iteration: 1
 Score = 72.8 bits (177), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 58/204 (28%), Positives = 95/204 (46%), Gaps = 40/204 (19%)
Query: 321 LGQGGYGSVYKGKLL-DGSNV----AVKVLND--SKGNGKEFINEVASISRTSHVNVVAL 373
           LG G +G+VYKG  + +G  V    A+K L +  S    KE ++E   ++   + +V  L
Sbjct: 26  LGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRL 85
Query: 374 LGFCLRVAEELSST---------------------------IGIARGLEYLHLGCSTRIL 406
           LG CL    +L +                            + IA+G+ YL      R++
Sbjct: 86  LGICLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLE---DRRLV 142
Query: 407 HFDIKPHNILLDEDFCPKISDFGLAKICNRKESIISMTGARGTVGYIAPEVFCRNIGEVS 466
           H D+   N+L+      KI+DFGLAK+   +E      G +  + ++A E     I   +
Sbjct: 143 HRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRI--YT 200
Query: 467 YKSDVYNYGMMIFE-MTGGRKNVD 489
           ++SDV++YG+ ++E MT G K  D
Sbjct: 201 HQSDVWSYGVTVWELMTFGSKPYD 224

>pdb|3VJO|A Chain A, Crystal Structure Of The Wild-Type Egfr Kinase Domain In Complex With Amppnp Length = 334

Iteration: 1
 Score = 72.4 bits (176), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 58/204 (28%), Positives = 95/204 (46%), Gaps = 40/204 (19%)
Query: 321 LGQGGYGSVYKGKLL-DGSNV----AVKVLND--SKGNGKEFINEVASISRTSHVNVVAL 373
           LG G +G+VYKG  + +G  V    A+K L +  S    KE ++E   ++   + +V  L
Sbjct: 30  LGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRL 89
Query: 374 LGFCLRVAEELSST---------------------------IGIARGLEYLHLGCSTRIL 406
           LG CL    +L +                            + IA+G+ YL      R++
Sbjct: 90  LGICLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLE---DRRLV 146
Query: 407 HFDIKPHNILLDEDFCPKISDFGLAKICNRKESIISMTGARGTVGYIAPEVFCRNIGEVS 466
           H D+   N+L+      KI+DFGLAK+   +E      G +  + ++A E     I   +
Sbjct: 147 HRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRI--YT 204
Query: 467 YKSDVYNYGMMIFE-MTGGRKNVD 489
           ++SDV++YG+ ++E MT G K  D
Sbjct: 205 HQSDVWSYGVTVWELMTFGSKPYD 228

>pdb|3LZB|A Chain A, Egfr Kinase Domain Complexed With An Imidazo[2,1-B]thiazole Inhibitor Length = 327

Iteration: 1
 Score = 72.4 bits (176), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 58/204 (28%), Positives = 95/204 (46%), Gaps = 40/204 (19%)
Query: 321 LGQGGYGSVYKGKLL-DGSNV----AVKVLND--SKGNGKEFINEVASISRTSHVNVVAL 373
           LG G +G+VYKG  + +G  V    A+K L +  S    KE ++E   ++   + +V  L
Sbjct: 23  LGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRL 82
Query: 374 LGFCLRVAEELSST---------------------------IGIARGLEYLHLGCSTRIL 406
           LG CL    +L +                            + IA+G+ YL      R++
Sbjct: 83  LGICLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLE---DRRLV 139
Query: 407 HFDIKPHNILLDEDFCPKISDFGLAKICNRKESIISMTGARGTVGYIAPEVFCRNIGEVS 466
           H D+   N+L+      KI+DFGLAK+   +E      G +  + ++A E     I   +
Sbjct: 140 HRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRI--YT 197
Query: 467 YKSDVYNYGMMIFE-MTGGRKNVD 489
           ++SDV++YG+ ++E MT G K  D
Sbjct: 198 HQSDVWSYGVTVWELMTFGSKPYD 221

>pdb|3GOP|A Chain A, Crystal Structure Of The Egf Receptor Juxtamembrane And Kinase Domains Length = 361

Iteration: 1
 Score = 72.0 bits (175), Expect = 7e-13,   Method: Compositional matrix adjust.
 Identities = 56/204 (27%), Positives = 92/204 (45%), Gaps = 40/204 (19%)
Query: 321 LGQGGYGSVYKGKLL-DGSNVAVKVL------NDSKGNGKEFINEVASISRTSHVNVVAL 373
           LG G +G+VYKG  + +G  V + V         S    KE ++E   ++   + +V  L
Sbjct: 57  LGSGAFGTVYKGLWIPEGEKVKIPVAIMELREATSPKANKEILDEAYVMASVDNPHVCRL 116
Query: 374 LGFCLRVAEELSST---------------------------IGIARGLEYLHLGCSTRIL 406
           LG CL    +L +                            + IA+G+ YL      R++
Sbjct: 117 LGICLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLE---DRRLV 173
Query: 407 HFDIKPHNILLDEDFCPKISDFGLAKICNRKESIISMTGARGTVGYIAPEVFCRNIGEVS 466
           H D+   N+L+      KI+DFGLAK+   +E      G +  + ++A E     I   +
Sbjct: 174 HRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRI--YT 231
Query: 467 YKSDVYNYGMMIFE-MTGGRKNVD 489
           ++SDV++YG+ ++E MT G K  D
Sbjct: 232 HQSDVWSYGVTVWELMTFGSKPYD 255

>pdb|2JIV|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Compex With Hki-272 Length = 328

Iteration: 1
 Score = 72.0 bits (175), Expect = 7e-13,   Method: Compositional matrix adjust.
 Identities = 60/204 (29%), Positives = 95/204 (46%), Gaps = 40/204 (19%)
Query: 321 LGQGGYGSVYKGKLL-DGSNV----AVKVLND--SKGNGKEFINEVASISRTSHVNVVAL 373
           LG G +G+VYKG  + +G  V    A+K L +  S    KE ++E   ++   + +V  L
Sbjct: 24  LGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRL 83
Query: 374 LGFCLRVAEEL-----------------SSTIG----------IARGLEYLHLGCSTRIL 406
           LG CL    +L                    IG          IA+G+ YL      R++
Sbjct: 84  LGICLTSTVQLIMQLMPFGXLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLE---DRRLV 140
Query: 407 HFDIKPHNILLDEDFCPKISDFGLAKICNRKESIISMTGARGTVGYIAPEVFCRNIGEVS 466
           H D+   N+L+      KI+DFGLAK+   +E      G +  + ++A E     I   +
Sbjct: 141 HRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRI--YT 198
Query: 467 YKSDVYNYGMMIFE-MTGGRKNVD 489
           ++SDV++YG+ ++E MT G K  D
Sbjct: 199 HQSDVWSYGVTVWELMTFGSKPYD 222

>pdb|2JIU|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Complex With Aee788 Length = 328

Iteration: 1
 Score = 72.0 bits (175), Expect = 7e-13,   Method: Compositional matrix adjust.
 Identities = 60/204 (29%), Positives = 95/204 (46%), Gaps = 40/204 (19%)
Query: 321 LGQGGYGSVYKGKLL-DGSNV----AVKVLND--SKGNGKEFINEVASISRTSHVNVVAL 373
           LG G +G+VYKG  + +G  V    A+K L +  S    KE ++E   ++   + +V  L
Sbjct: 24  LGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRL 83
Query: 374 LGFCLRVAEEL-----------------SSTIG----------IARGLEYLHLGCSTRIL 406
           LG CL    +L                    IG          IA+G+ YL      R++
Sbjct: 84  LGICLTSTVQLIMQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLE---DRRLV 140
Query: 407 HFDIKPHNILLDEDFCPKISDFGLAKICNRKESIISMTGARGTVGYIAPEVFCRNIGEVS 466
           H D+   N+L+      KI+DFGLAK+   +E      G +  + ++A E     I   +
Sbjct: 141 HRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRI--YT 198
Query: 467 YKSDVYNYGMMIFE-MTGGRKNVD 489
           ++SDV++YG+ ++E MT G K  D
Sbjct: 199 HQSDVWSYGVTVWELMTFGSKPYD 222

>pdb|3IKA|A Chain A, Crystal Structure Of Egfr 696-1022 T790m Mutant Covalently Binding To Wz4002 Length = 331

Iteration: 1
 Score = 72.0 bits (175), Expect = 7e-13,   Method: Compositional matrix adjust.
 Identities = 60/204 (29%), Positives = 95/204 (46%), Gaps = 40/204 (19%)
Query: 321 LGQGGYGSVYKGKLL-DGSNV----AVKVLND--SKGNGKEFINEVASISRTSHVNVVAL 373
           LG G +G+VYKG  + +G  V    A+K L +  S    KE ++E   ++   + +V  L
Sbjct: 27  LGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRL 86
Query: 374 LGFCLRVAEEL-----------------SSTIG----------IARGLEYLHLGCSTRIL 406
           LG CL    +L                    IG          IA+G+ YL      R++
Sbjct: 87  LGICLTSTVQLIMQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLE---DRRLV 143
Query: 407 HFDIKPHNILLDEDFCPKISDFGLAKICNRKESIISMTGARGTVGYIAPEVFCRNIGEVS 466
           H D+   N+L+      KI+DFGLAK+   +E      G +  + ++A E     I   +
Sbjct: 144 HRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRI--YT 201
Query: 467 YKSDVYNYGMMIFE-MTGGRKNVD 489
           ++SDV++YG+ ++E MT G K  D
Sbjct: 202 HQSDVWSYGVTVWELMTFGSKPYD 225

>pdb|2JIT|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation Length = 327

Iteration: 1
 Score = 72.0 bits (175), Expect = 7e-13,   Method: Compositional matrix adjust.
 Identities = 60/204 (29%), Positives = 95/204 (46%), Gaps = 40/204 (19%)
Query: 321 LGQGGYGSVYKGKLL-DGSNV----AVKVLND--SKGNGKEFINEVASISRTSHVNVVAL 373
           LG G +G+VYKG  + +G  V    A+K L +  S    KE ++E   ++   + +V  L
Sbjct: 23  LGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRL 82
Query: 374 LGFCLRVAEEL-----------------SSTIG----------IARGLEYLHLGCSTRIL 406
           LG CL    +L                    IG          IA+G+ YL      R++
Sbjct: 83  LGICLTSTVQLIMQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLE---DRRLV 139
Query: 407 HFDIKPHNILLDEDFCPKISDFGLAKICNRKESIISMTGARGTVGYIAPEVFCRNIGEVS 466
           H D+   N+L+      KI+DFGLAK+   +E      G +  + ++A E     I   +
Sbjct: 140 HRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRI--YT 197
Query: 467 YKSDVYNYGMMIFE-MTGGRKNVD 489
           ++SDV++YG+ ++E MT G K  D
Sbjct: 198 HQSDVWSYGVTVWELMTFGSKPYD 221

>pdb|4I24|A Chain A, Structure Of T790m Egfr Kinase Domain Co-crystallized With Dacomitinib Length = 329

Iteration: 1
 Score = 72.0 bits (175), Expect = 8e-13,   Method: Compositional matrix adjust.
 Identities = 60/204 (29%), Positives = 95/204 (46%), Gaps = 40/204 (19%)
Query: 321 LGQGGYGSVYKGKLL-DGSNV----AVKVLND--SKGNGKEFINEVASISRTSHVNVVAL 373
           LG G +G+VYKG  + +G  V    A+K L +  S    KE ++E   ++   + +V  L
Sbjct: 25  LGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRL 84
Query: 374 LGFCLRVAEEL-----------------SSTIG----------IARGLEYLHLGCSTRIL 406
           LG CL    +L                    IG          IA+G+ YL      R++
Sbjct: 85  LGICLTSTVQLIMQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLE---DRRLV 141
Query: 407 HFDIKPHNILLDEDFCPKISDFGLAKICNRKESIISMTGARGTVGYIAPEVFCRNIGEVS 466
           H D+   N+L+      KI+DFGLAK+   +E      G +  + ++A E     I   +
Sbjct: 142 HRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRI--YT 199
Query: 467 YKSDVYNYGMMIFE-MTGGRKNVD 489
           ++SDV++YG+ ++E MT G K  D
Sbjct: 200 HQSDVWSYGVTVWELMTFGSKPYD 223

>pdb|4G5P|A Chain A, Crystal Structure Of Egfr Kinase T790m In Complex With Bibw2992 Length = 330

Iteration: 1
 Score = 72.0 bits (175), Expect = 8e-13,   Method: Compositional matrix adjust.
 Identities = 60/204 (29%), Positives = 95/204 (46%), Gaps = 40/204 (19%)
Query: 321 LGQGGYGSVYKGKLL-DGSNV----AVKVLND--SKGNGKEFINEVASISRTSHVNVVAL 373
           LG G +G+VYKG  + +G  V    A+K L +  S    KE ++E   ++   + +V  L
Sbjct: 26  LGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRL 85
Query: 374 LGFCLRVAEEL-----------------SSTIG----------IARGLEYLHLGCSTRIL 406
           LG CL    +L                    IG          IA+G+ YL      R++
Sbjct: 86  LGICLTSTVQLIMQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLE---DRRLV 142
Query: 407 HFDIKPHNILLDEDFCPKISDFGLAKICNRKESIISMTGARGTVGYIAPEVFCRNIGEVS 466
           H D+   N+L+      KI+DFGLAK+   +E      G +  + ++A E     I   +
Sbjct: 143 HRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRI--YT 200
Query: 467 YKSDVYNYGMMIFE-MTGGRKNVD 489
           ++SDV++YG+ ++E MT G K  D
Sbjct: 201 HQSDVWSYGVTVWELMTFGSKPYD 224

>pdb|2RFD|A Chain A, Crystal Structure Of The Complex Between The Egfr Kinase Domain And A Mig6 Peptide Length = 324

Iteration: 1
 Score = 71.6 bits (174), Expect = 8e-13,   Method: Compositional matrix adjust.
 Identities = 58/204 (28%), Positives = 94/204 (46%), Gaps = 40/204 (19%)
Query: 321 LGQGGYGSVYKGKLL-DGSNV----AVKVLND--SKGNGKEFINEVASISRTSHVNVVAL 373
           LG G +G+VYKG  + +G  V    A+K L +  S    KE ++E   ++   + +V  L
Sbjct: 20  LGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRL 79
Query: 374 LGFCLRVAEELSST---------------------------IGIARGLEYLHLGCSTRIL 406
           LG CL    +L +                            + IA G+ YL      R++
Sbjct: 80  LGICLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAEGMNYLE---DRRLV 136
Query: 407 HFDIKPHNILLDEDFCPKISDFGLAKICNRKESIISMTGARGTVGYIAPEVFCRNIGEVS 466
           H D+   N+L+      KI+DFGLAK+   +E      G +  + ++A E     I   +
Sbjct: 137 HRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRI--YT 194
Query: 467 YKSDVYNYGMMIFE-MTGGRKNVD 489
           ++SDV++YG+ ++E MT G K  D
Sbjct: 195 HQSDVWSYGVTVWELMTFGSKPYD 218

>pdb|3DTC|A Chain A, Crystal Structure Of Mixed-Lineage Kinase Mlk1 Complexed With Compound 16 Length = 271

Iteration: 1
 Score = 70.9 bits (172), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 59/216 (27%), Positives = 94/216 (43%), Gaps = 46/216 (21%)
Query: 321 LGQGGYGSVYKGKLLDGSNVAVKVL-----NDSKGNGKEFINEVASISRTSHVNVVALLG 375
           +G GG+G VY+   + G  VAVK        D     +    E    +   H N++AL G
Sbjct: 15  IGIGGFGKVYRAFWI-GDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNIIALRG 73
Query: 376 FCL------------------------RVAEEL--SSTIGIARGLEYLHLGCSTRILHFD 409
            CL                        R+  ++  +  + IARG+ YLH      I+H D
Sbjct: 74  VCLKEPNLCLVMEFARGGPLNRVLSGKRIPPDILVNWAVQIARGMNYLHDEAIVPIIHRD 133
Query: 410 IKPHNILLDEDF--------CPKISDFGLAKICNRKESIISMTGARGTVGYIAPEVFCRN 461
           +K  NIL+ +            KI+DFGLA+  +R   +     A G   ++APEV   +
Sbjct: 134 LKSSNILILQKVENGDLSNKILKITDFGLAREWHRTTKM----SAAGAYAWMAPEVIRAS 189
Query: 462 IGEVSYKSDVYNYGMMIFEMTGGRKNVDVVDNGSTA 497
           +   S  SDV++YG++++E+  G      +D  + A
Sbjct: 190 M--FSKGSDVWSYGVLLWELLTGEVPFRGIDGLAVA 223

>pdb|2ITN|A Chain A, Crystal Structure Of Egfr Kinase Domain G719s Mutation In Complex With Amp-Pnp Length = 327

Iteration: 1
 Score = 70.9 bits (172), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 57/204 (27%), Positives = 94/204 (46%), Gaps = 40/204 (19%)
Query: 321 LGQGGYGSVYKGKLL-DGSNV----AVKVLND--SKGNGKEFINEVASISRTSHVNVVAL 373
           L  G +G+VYKG  + +G  V    A+K L +  S    KE ++E   ++   + +V  L
Sbjct: 23  LSSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRL 82
Query: 374 LGFCLRVAEELSST---------------------------IGIARGLEYLHLGCSTRIL 406
           LG CL    +L +                            + IA+G+ YL      R++
Sbjct: 83  LGICLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLE---DRRLV 139
Query: 407 HFDIKPHNILLDEDFCPKISDFGLAKICNRKESIISMTGARGTVGYIAPEVFCRNIGEVS 466
           H D+   N+L+      KI+DFGLAK+   +E      G +  + ++A E     I   +
Sbjct: 140 HRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRI--YT 197
Query: 467 YKSDVYNYGMMIFE-MTGGRKNVD 489
           ++SDV++YG+ ++E MT G K  D
Sbjct: 198 HQSDVWSYGVTVWELMTFGSKPYD 221

>pdb|3A4O|X Chain X, Lyn Kinase Domain Length = 286

Iteration: 1
 Score = 70.5 bits (171), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 53/208 (25%), Positives = 91/208 (43%), Gaps = 42/208 (20%)
Query: 320 KLGQGGYGSVYKGKLLDGSNVAVKVLNDSKGNGKEFINEVASISRTSHVNVVALLGFCLR 379
           +LG G +G V+ G   + + VAVK L     + + F+ E   +    H  +V L     R
Sbjct: 20  RLGAGQFGEVWMGYYNNSTKVAVKTLKPGTMSVQAFLEEANLMKTLQHDKLVRLYAVVTR 79
Query: 380 ------VAEELSS-----------------------TIGIARGLEYLHLGCSTRILHFDI 410
                 + E ++                        +  IA G+ Y+        +H D+
Sbjct: 80  EEPIYIITEYMAKGSLLDFLKSDEGGKVLLPKLIDFSAQIAEGMAYIE---RKNYIHRDL 136
Query: 411 KPHNILLDEDFCPKISDFGLAKICNRKESIISMTGARGTVGYIAPEVFCRNIGEVSYKSD 470
           +  N+L+ E    KI+DFGLA++    E   +  GA+  + + APE    N G  + KSD
Sbjct: 137 RAANVLVSESLMCKIADFGLARVIEDNE-YTAREGAKFPIKWTAPEAI--NFGCFTIKSD 193
Query: 471 VYNYGMMIFEMTG-------GRKNVDVV 491
           V+++G++++E+         GR N DV+
Sbjct: 194 VWSFGILLYEIVTYGKIPYPGRTNADVM 221

>pdb|2EB2|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (G719s) Length = 334

Iteration: 1
 Score = 70.5 bits (171), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 57/204 (27%), Positives = 94/204 (46%), Gaps = 40/204 (19%)
Query: 321 LGQGGYGSVYKGKLL-DGSNV----AVKVLND--SKGNGKEFINEVASISRTSHVNVVAL 373
           L  G +G+VYKG  + +G  V    A+K L +  S    KE ++E   ++   + +V  L
Sbjct: 30  LSSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRL 89
Query: 374 LGFCLRVAEELSST---------------------------IGIARGLEYLHLGCSTRIL 406
           LG CL    +L +                            + IA+G+ YL      R++
Sbjct: 90  LGICLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLE---DRRLV 146
Query: 407 HFDIKPHNILLDEDFCPKISDFGLAKICNRKESIISMTGARGTVGYIAPEVFCRNIGEVS 466
           H D+   N+L+      KI+DFGLAK+   +E      G +  + ++A E     I   +
Sbjct: 147 HRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRI--YT 204
Query: 467 YKSDVYNYGMMIFE-MTGGRKNVD 489
           ++SDV++YG+ ++E MT G K  D
Sbjct: 205 HQSDVWSYGVTVWELMTFGSKPYD 228

>pdb|2PVF|A Chain A, Crystal Structure Of Tyrosine Phosphorylated Activated Fgf Receptor 2 (Fgfr2) Kinase Domain In Complex With Atp Analog And Substrate Peptide Length = 334

Iteration: 1
 Score = 70.5 bits (171), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 57/215 (26%), Positives = 97/215 (45%), Gaps = 59/215 (27%)
Query: 321 LGQGGYGSVY--------KGKLLDGSNVAVKVLND--SKGNGKEFINEVASISRT-SHVN 369
           LG+G +G V         K K  +   VAVK+L D  ++ +  + ++E+  +     H N
Sbjct: 43  LGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 102
Query: 370 VVALLGFCL------------------------------------RVAEE-------LSS 386
           ++ LLG C                                     RV EE       +S 
Sbjct: 103 IINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEXSYDINRVPEEQMTFKDLVSC 162
Query: 387 TIGIARGLEYLHLGCSTRILHFDIKPHNILLDEDFCPKISDFGLAKICNRKESIISMTGA 446
           T  +ARG+EYL    S + +H D+   N+L+ E+   KI+DFGLA+  N  +     T  
Sbjct: 163 TYQLARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDXXKKTTNG 219
Query: 447 RGTVGYIAPEVFCRNIGEVSYKSDVYNYGMMIFEM 481
           R  V ++APE     +   +++SDV+++G++++E+
Sbjct: 220 RLPVKWMAPEALFDRV--YTHQSDVWSFGVLMWEI 252

>pdb|4I20|A Chain A, Crystal Structure Of Monomeric (v948r) Primary Oncogenic Mutant L858r Egfr Kinase Domain Length = 329

Iteration: 1
 Score = 70.5 bits (171), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 57/204 (27%), Positives = 94/204 (46%), Gaps = 40/204 (19%)
Query: 321 LGQGGYGSVYKGKLL-DGSNV----AVKVLND--SKGNGKEFINEVASISRTSHVNVVAL 373
           LG G +G+VYKG  + +G  V    A+K L +  S    KE ++E   ++   + +V  L
Sbjct: 25  LGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRL 84
Query: 374 LGFCLRVAEELSST---------------------------IGIARGLEYLHLGCSTRIL 406
           LG CL    +L +                            + IA+G+ YL      R++
Sbjct: 85  LGICLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLE---DRRLV 141
Query: 407 HFDIKPHNILLDEDFCPKISDFGLAKICNRKESIISMTGARGTVGYIAPEVFCRNIGEVS 466
           H D+   N+L+      KI+DFG AK+   +E      G +  + ++A E     I   +
Sbjct: 142 HRDLAARNVLVKTPQHVKITDFGRAKLLGAEEKEYHAEGGKVPIKWMALESILHRI--YT 199
Query: 467 YKSDVYNYGMMIFE-MTGGRKNVD 489
           ++SDV++YG+ ++E MT G K  D
Sbjct: 200 HQSDVWSYGVTVWELMTFGSKPYD 223

>pdb|3CLY|A Chain A, Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase Domains Trapped In Trans-Phosphorylation Reaction Length = 334

Iteration: 1
 Score = 70.5 bits (171), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 57/215 (26%), Positives = 97/215 (45%), Gaps = 59/215 (27%)
Query: 321 LGQGGYGSVY--------KGKLLDGSNVAVKVLND--SKGNGKEFINEVASISRT-SHVN 369
           LG+G +G V         K K  +   VAVK+L D  ++ +  + ++E+  +     H N
Sbjct: 43  LGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 102
Query: 370 VVALLGFCL------------------------------------RVAEE-------LSS 386
           ++ LLG C                                     RV EE       +S 
Sbjct: 103 IINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSC 162
Query: 387 TIGIARGLEYLHLGCSTRILHFDIKPHNILLDEDFCPKISDFGLAKICNRKESIISMTGA 446
           T  +ARG+EYL    S + +H D+   N+L+ E+   KI+DFGLA+  N  +     T  
Sbjct: 163 TYQLARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDXXKKTTNG 219
Query: 447 RGTVGYIAPEVFCRNIGEVSYKSDVYNYGMMIFEM 481
           R  V ++APE     +   +++SDV+++G++++E+
Sbjct: 220 RLPVKWMAPEALFDRV--YTHQSDVWSFGVLMWEI 252

>pdb|2ITT|A Chain A, Crystal Structure Of Egfr Kinase Domain L858r Mutation In Complex With Aee788 Length = 327

Iteration: 1
 Score = 70.1 bits (170), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 57/204 (27%), Positives = 94/204 (46%), Gaps = 40/204 (19%)
Query: 321 LGQGGYGSVYKGKLL-DGSNV----AVKVLND--SKGNGKEFINEVASISRTSHVNVVAL 373
           LG G +G+VYKG  + +G  V    A+K L +  S    KE ++E   ++   + +V  L
Sbjct: 23  LGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRL 82
Query: 374 LGFCLRVAEELSST---------------------------IGIARGLEYLHLGCSTRIL 406
           LG CL    +L +                            + IA+G+ YL      R++
Sbjct: 83  LGICLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLE---DRRLV 139
Query: 407 HFDIKPHNILLDEDFCPKISDFGLAKICNRKESIISMTGARGTVGYIAPEVFCRNIGEVS 466
           H D+   N+L+      KI+DFG AK+   +E      G +  + ++A E     I   +
Sbjct: 140 HRDLAARNVLVKTPQHVKITDFGRAKLLGAEEKEYHAEGGKVPIKWMALESILHRI--YT 197
Query: 467 YKSDVYNYGMMIFE-MTGGRKNVD 489
           ++SDV++YG+ ++E MT G K  D
Sbjct: 198 HQSDVWSYGVTVWELMTFGSKPYD 221

>pdb|2EB3|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (L858r) In Complex With Amppnp Length = 334

Iteration: 1
 Score = 70.1 bits (170), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 57/204 (27%), Positives = 94/204 (46%), Gaps = 40/204 (19%)
Query: 321 LGQGGYGSVYKGKLL-DGSNV----AVKVLND--SKGNGKEFINEVASISRTSHVNVVAL 373
           LG G +G+VYKG  + +G  V    A+K L +  S    KE ++E   ++   + +V  L
Sbjct: 30  LGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRL 89
Query: 374 LGFCLRVAEELSST---------------------------IGIARGLEYLHLGCSTRIL 406
           LG CL    +L +                            + IA+G+ YL      R++
Sbjct: 90  LGICLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLE---DRRLV 146
Query: 407 HFDIKPHNILLDEDFCPKISDFGLAKICNRKESIISMTGARGTVGYIAPEVFCRNIGEVS 466
           H D+   N+L+      KI+DFG AK+   +E      G +  + ++A E     I   +
Sbjct: 147 HRDLAARNVLVKTPQHVKITDFGRAKLLGAEEKEYHAEGGKVPIKWMALESILHRI--YT 204
Query: 467 YKSDVYNYGMMIFE-MTGGRKNVD 489
           ++SDV++YG+ ++E MT G K  D
Sbjct: 205 HQSDVWSYGVTVWELMTFGSKPYD 228

>pdb|2PZ5|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549t Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score = 70.1 bits (170), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 57/215 (26%), Positives = 97/215 (45%), Gaps = 59/215 (27%)
Query: 321 LGQGGYGSVY--------KGKLLDGSNVAVKVLND--SKGNGKEFINEVASISRT-SHVN 369
           LG+G +G V         K K  +   VAVK+L D  ++ +  + ++E+  +     H N
Sbjct: 43  LGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 102
Query: 370 VVALLGFCL------------------------------------RVAEE-------LSS 386
           ++ LLG C                                     RV EE       +S 
Sbjct: 103 IITLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSC 162
Query: 387 TIGIARGLEYLHLGCSTRILHFDIKPHNILLDEDFCPKISDFGLAKICNRKESIISMTGA 446
           T  +ARG+EYL    S + +H D+   N+L+ E+   KI+DFGLA+  N  +     T  
Sbjct: 163 TYQLARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTTNG 219
Query: 447 RGTVGYIAPEVFCRNIGEVSYKSDVYNYGMMIFEM 481
           R  V ++APE     +   +++SDV+++G++++E+
Sbjct: 220 RLPVKWMAPEALFDRV--YTHQSDVWSFGVLMWEI 252

>pdb|3K54|A Chain A, Structures Of Human Bruton's Tyrosine Kinase In Active And Inactive Conformations Suggests A Mechanism Of Activation For Tec Family Kinases Length = 283

Iteration: 1
 Score = 69.7 bits (169), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 57/222 (25%), Positives = 96/222 (43%), Gaps = 35/222 (15%)
Query: 305 YGYADIKKMTNSFKYKLGQGGYGSVYKGKLLDGSNVAVKVLNDSKGNGKEFINEVASISR 364
           YG  +I     +F  +LG G +G V  GK     +VA+K++ +   +  EFI E   +  
Sbjct: 16  YGSWEIDPKDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSEDEFIEEAKVMMN 75
Query: 365 TSHVNVVALLGFC----------------------------LRVAEELSSTIGIARGLEY 396
            SH  +V L G C                             +  + L     +   +EY
Sbjct: 76  LSHEKLVQLYGVCTKQRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEY 135
Query: 397 LHLGCSTRILHFDIKPHNILLDEDFCPKISDFGLAKICNRKESIISMTGARGTVGYIAPE 456
           L    S + LH D+   N L+++    K+SDFGL++     E   S  G++  V +  PE
Sbjct: 136 LE---SKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEE-TSSVGSKFPVRWSPPE 191
Query: 457 VFCRNIGEVSYKSDVYNYGMMIFEMTG-GRKNVDVVDNGSTA 497
           V   +  + S KSD++ +G++++E+   G+   +   N  TA
Sbjct: 192 VLMYS--KFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETA 231

>pdb|4I1Z|A Chain A, Crystal Structure Of The Monomeric (v948r) Form Of The Gefitinib/erlotinib Resistant Egfr Kinase Domain L858r+t790m Length = 329

Iteration: 1
 Score = 69.3 bits (168), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 59/204 (28%), Positives = 94/204 (46%), Gaps = 40/204 (19%)
Query: 321 LGQGGYGSVYKGKLL-DGSNV----AVKVLND--SKGNGKEFINEVASISRTSHVNVVAL 373
           LG G +G+VYKG  + +G  V    A+K L +  S    KE ++E   ++   + +V  L
Sbjct: 25  LGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRL 84
Query: 374 LGFCLRVAEEL-----------------SSTIG----------IARGLEYLHLGCSTRIL 406
           LG CL    +L                    IG          IA+G+ YL      R++
Sbjct: 85  LGICLTSTVQLIMQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLE---DRRLV 141
Query: 407 HFDIKPHNILLDEDFCPKISDFGLAKICNRKESIISMTGARGTVGYIAPEVFCRNIGEVS 466
           H D+   N+L+      KI+DFG AK+   +E      G +  + ++A E     I   +
Sbjct: 142 HRDLAARNVLVKTPQHVKITDFGRAKLLGAEEKEYHAEGGKVPIKWMALESILHRI--YT 199
Query: 467 YKSDVYNYGMMIFE-MTGGRKNVD 489
           ++SDV++YG+ ++E MT G K  D
Sbjct: 200 HQSDVWSYGVTVWELMTFGSKPYD 223

>pdb|4I21|A Chain A, Crystal Structure Of L858r + T790m Egfr Kinase Domain In Complex With Mig6 Peptide Length = 329

Iteration: 1
 Score = 69.3 bits (168), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 59/204 (28%), Positives = 94/204 (46%), Gaps = 40/204 (19%)
Query: 321 LGQGGYGSVYKGKLL-DGSNV----AVKVLND--SKGNGKEFINEVASISRTSHVNVVAL 373
           LG G +G+VYKG  + +G  V    A+K L +  S    KE ++E   ++   + +V  L
Sbjct: 25  LGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRL 84
Query: 374 LGFCLRVAEEL-----------------SSTIG----------IARGLEYLHLGCSTRIL 406
           LG CL    +L                    IG          IA+G+ YL      R++
Sbjct: 85  LGICLTSTVQLIMQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLE---DRRLV 141
Query: 407 HFDIKPHNILLDEDFCPKISDFGLAKICNRKESIISMTGARGTVGYIAPEVFCRNIGEVS 466
           H D+   N+L+      KI+DFG AK+   +E      G +  + ++A E     I   +
Sbjct: 142 HRDLAARNVLVKTPQHVKITDFGRAKLLGAEEKEYHAEGGKVPIKWMALESILHRI--YT 199
Query: 467 YKSDVYNYGMMIFE-MTGGRKNVD 489
           ++SDV++YG+ ++E MT G K  D
Sbjct: 200 HQSDVWSYGVTVWELMTFGSKPYD 223

>pdb|3W2O|A Chain A, Egfr Kinase Domain T790m/l858r Mutant With Tak-285 Length = 331

Iteration: 1
 Score = 69.3 bits (168), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 59/204 (28%), Positives = 94/204 (46%), Gaps = 40/204 (19%)
Query: 321 LGQGGYGSVYKGKLL-DGSNV----AVKVLND--SKGNGKEFINEVASISRTSHVNVVAL 373
           LG G +G+VYKG  + +G  V    A+K L +  S    KE ++E   ++   + +V  L
Sbjct: 27  LGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRL 86
Query: 374 LGFCLRVAEEL-----------------SSTIG----------IARGLEYLHLGCSTRIL 406
           LG CL    +L                    IG          IA+G+ YL      R++
Sbjct: 87  LGICLTSTVQLIMQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLE---DRRLV 143
Query: 407 HFDIKPHNILLDEDFCPKISDFGLAKICNRKESIISMTGARGTVGYIAPEVFCRNIGEVS 466
           H D+   N+L+      KI+DFG AK+   +E      G +  + ++A E     I   +
Sbjct: 144 HRDLAARNVLVKTPQHVKITDFGRAKLLGAEEKEYHAEGGKVPIKWMALESILHRI--YT 201
Query: 467 YKSDVYNYGMMIFE-MTGGRKNVD 489
           ++SDV++YG+ ++E MT G K  D
Sbjct: 202 HQSDVWSYGVTVWELMTFGSKPYD 225

>pdb|2PWL|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549h Mutation Responsible For Crouzon Syndrome. Length = 324

Iteration: 1
 Score = 69.3 bits (168), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 57/215 (26%), Positives = 97/215 (45%), Gaps = 59/215 (27%)
Query: 321 LGQGGYGSVY--------KGKLLDGSNVAVKVLND--SKGNGKEFINEVASISRT-SHVN 369
           LG+G +G V         K K  +   VAVK+L D  ++ +  + ++E+  +     H N
Sbjct: 43  LGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 102
Query: 370 VVALLGFCL------------------------------------RVAEE-------LSS 386
           ++ LLG C                                     RV EE       +S 
Sbjct: 103 IIHLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSC 162
Query: 387 TIGIARGLEYLHLGCSTRILHFDIKPHNILLDEDFCPKISDFGLAKICNRKESIISMTGA 446
           T  +ARG+EYL    S + +H D+   N+L+ E+   KI+DFGLA+  N  +     T  
Sbjct: 163 TYQLARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTTNG 219
Query: 447 RGTVGYIAPEVFCRNIGEVSYKSDVYNYGMMIFEM 481
           R  V ++APE     +   +++SDV+++G++++E+
Sbjct: 220 RLPVKWMAPEALFDRV--YTHQSDVWSFGVLMWEI 252

>pdb|3UG1|A Chain A, Crystal Structure Of The Mutated Egfr Kinase Domain (G719sT790M) IN The Apo Form Length = 334

Iteration: 1
 Score = 69.3 bits (168), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 59/204 (28%), Positives = 94/204 (46%), Gaps = 40/204 (19%)
Query: 321 LGQGGYGSVYKGKLL-DGSNV----AVKVLND--SKGNGKEFINEVASISRTSHVNVVAL 373
           L  G +G+VYKG  + +G  V    A+K L +  S    KE ++E   ++   + +V  L
Sbjct: 30  LSSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRL 89
Query: 374 LGFCLRVAEEL-----------------SSTIG----------IARGLEYLHLGCSTRIL 406
           LG CL    +L                    IG          IA+G+ YL      R++
Sbjct: 90  LGICLTSTVQLIMQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLE---DRRLV 146
Query: 407 HFDIKPHNILLDEDFCPKISDFGLAKICNRKESIISMTGARGTVGYIAPEVFCRNIGEVS 466
           H D+   N+L+      KI+DFGLAK+   +E      G +  + ++A E     I   +
Sbjct: 147 HRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRI--YT 204
Query: 467 YKSDVYNYGMMIFE-MTGGRKNVD 489
           ++SDV++YG+ ++E MT G K  D
Sbjct: 205 HQSDVWSYGVTVWELMTFGSKPYD 228

>pdb|2Q0B|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565a Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score = 69.3 bits (168), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 57/215 (26%), Positives = 97/215 (45%), Gaps = 59/215 (27%)
Query: 321 LGQGGYGSVY--------KGKLLDGSNVAVKVLND--SKGNGKEFINEVASISRT-SHVN 369
           LG+G +G V         K K  +   VAVK+L D  ++ +  + ++E+  +     H N
Sbjct: 43  LGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 102
Query: 370 VVALLGFCL------------------------------------RVAEE-------LSS 386
           ++ LLG C                                     RV EE       +S 
Sbjct: 103 IINLLGACTQDGPLYVIVAYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSC 162
Query: 387 TIGIARGLEYLHLGCSTRILHFDIKPHNILLDEDFCPKISDFGLAKICNRKESIISMTGA 446
           T  +ARG+EYL    S + +H D+   N+L+ E+   KI+DFGLA+  N  +     T  
Sbjct: 163 TYQLARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTTNG 219
Query: 447 RGTVGYIAPEVFCRNIGEVSYKSDVYNYGMMIFEM 481
           R  V ++APE     +   +++SDV+++G++++E+
Sbjct: 220 RLPVKWMAPEALFDRV--YTHQSDVWSFGVLMWEI 252

>pdb|2PVY|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K659n Mutation Responsible For An Unclassified Craniosynostosis Syndrome. Length = 324

Iteration: 1
 Score = 69.3 bits (168), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 57/215 (26%), Positives = 98/215 (45%), Gaps = 59/215 (27%)
Query: 321 LGQGGYGSVY--------KGKLLDGSNVAVKVLND--SKGNGKEFINEVASISRT-SHVN 369
           LG+G +G V         K K  +   VAVK+L D  ++ +  + ++E+  +     H N
Sbjct: 43  LGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 102
Query: 370 VVALLGFCL------------------------------------RVAEE-------LSS 386
           ++ LLG C                                     RV EE       +S 
Sbjct: 103 IINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSC 162
Query: 387 TIGIARGLEYLHLGCSTRILHFDIKPHNILLDEDFCPKISDFGLAKICNRKESIISMTGA 446
           T  +ARG+EYL    S + +H D+   N+L+ E+   KI+DFGLA+  N  +   + T  
Sbjct: 163 TYQLARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKNTTNG 219
Query: 447 RGTVGYIAPEVFCRNIGEVSYKSDVYNYGMMIFEM 481
           R  V ++APE     +   +++SDV+++G++++E+
Sbjct: 220 RLPVKWMAPEALFDRV--YTHQSDVWSFGVLMWEI 252

>pdb|3GEN|A Chain A, The 1.6 A Crystal Structure Of Human Bruton's Tyrosine Kinase Bound To A Pyrrolopyrimidine-Containing Compound Length = 283

Iteration: 1
 Score = 68.9 bits (167), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 57/222 (25%), Positives = 96/222 (43%), Gaps = 35/222 (15%)
Query: 305 YGYADIKKMTNSFKYKLGQGGYGSVYKGKLLDGSNVAVKVLNDSKGNGKEFINEVASISR 364
           YG  +I     +F  +LG G +G V  GK     +VA+K++ +   +  EFI E   +  
Sbjct: 16  YGSWEIDPKDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSEDEFIEEAKVMMN 75
Query: 365 TSHVNVVALLGFC----------------------------LRVAEELSSTIGIARGLEY 396
            SH  +V L G C                             +  + L     +   +EY
Sbjct: 76  LSHEKLVQLYGVCTKQRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEY 135
Query: 397 LHLGCSTRILHFDIKPHNILLDEDFCPKISDFGLAKICNRKESIISMTGARGTVGYIAPE 456
           L    S + LH D+   N L+++    K+SDFGL++     E   S  G++  V +  PE
Sbjct: 136 LE---SKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDE-YTSSVGSKFPVRWSPPE 191
Query: 457 VFCRNIGEVSYKSDVYNYGMMIFEMTG-GRKNVDVVDNGSTA 497
           V   +  + S KSD++ +G++++E+   G+   +   N  TA
Sbjct: 192 VLMYS--KFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETA 231

>pdb|2PZP|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K526e Mutation Responsible For Crouzon Syndrome Length = 324

Iteration: 1
 Score = 68.9 bits (167), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 57/215 (26%), Positives = 97/215 (45%), Gaps = 59/215 (27%)
Query: 321 LGQGGYGSVY--------KGKLLDGSNVAVKVLND--SKGNGKEFINEVASISRT-SHVN 369
           LG+G +G V         K K  +   VAVK+L D  ++ +  + ++E+  +     H N
Sbjct: 43  LGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEEDLSDLVSEMEMMKMIGKHKN 102
Query: 370 VVALLGFCL------------------------------------RVAEE-------LSS 386
           ++ LLG C                                     RV EE       +S 
Sbjct: 103 IINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSC 162
Query: 387 TIGIARGLEYLHLGCSTRILHFDIKPHNILLDEDFCPKISDFGLAKICNRKESIISMTGA 446
           T  +ARG+EYL    S + +H D+   N+L+ E+   KI+DFGLA+  N  +     T  
Sbjct: 163 TYQLARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTTNG 219
Query: 447 RGTVGYIAPEVFCRNIGEVSYKSDVYNYGMMIFEM 481
           R  V ++APE     +   +++SDV+++G++++E+
Sbjct: 220 RLPVKWMAPEALFDRV--YTHQSDVWSFGVLMWEI 252

>pdb|2PY3|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565g Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score = 68.9 bits (167), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 57/215 (26%), Positives = 97/215 (45%), Gaps = 59/215 (27%)
Query: 321 LGQGGYGSVY--------KGKLLDGSNVAVKVLND--SKGNGKEFINEVASISRT-SHVN 369
           LG+G +G V         K K  +   VAVK+L D  ++ +  + ++E+  +     H N
Sbjct: 43  LGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 102
Query: 370 VVALLGFCL------------------------------------RVAEE-------LSS 386
           ++ LLG C                                     RV EE       +S 
Sbjct: 103 IINLLGACTQDGPLYVIVGYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSC 162
Query: 387 TIGIARGLEYLHLGCSTRILHFDIKPHNILLDEDFCPKISDFGLAKICNRKESIISMTGA 446
           T  +ARG+EYL    S + +H D+   N+L+ E+   KI+DFGLA+  N  +     T  
Sbjct: 163 TYQLARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTTNG 219
Query: 447 RGTVGYIAPEVFCRNIGEVSYKSDVYNYGMMIFEM 481
           R  V ++APE     +   +++SDV+++G++++E+
Sbjct: 220 RLPVKWMAPEALFDRV--YTHQSDVWSFGVLMWEI 252

>pdb|3PIX|A Chain A, Crystal Structure Of Btk Kinase Domain Complexed With 2-Isopropyl-7- (4-Methyl-Piperazin-1-Yl)-4-(5-Methyl-2h-Pyrazol-3- Ylamino)-2h- Phthalazin-1-One Length = 274

Iteration: 1
 Score = 68.9 bits (167), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 57/222 (25%), Positives = 96/222 (43%), Gaps = 35/222 (15%)
Query: 305 YGYADIKKMTNSFKYKLGQGGYGSVYKGKLLDGSNVAVKVLNDSKGNGKEFINEVASISR 364
           YG  +I     +F  +LG G +G V  GK     +VA+K++ +   +  EFI E   +  
Sbjct: 7   YGSWEIDPKDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSEDEFIEEAKVMMN 66
Query: 365 TSHVNVVALLGFC----------------------------LRVAEELSSTIGIARGLEY 396
            SH  +V L G C                             +  + L     +   +EY
Sbjct: 67  LSHEKLVQLYGVCTKQRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEY 126
Query: 397 LHLGCSTRILHFDIKPHNILLDEDFCPKISDFGLAKICNRKESIISMTGARGTVGYIAPE 456
           L    S + LH D+   N L+++    K+SDFGL++     E   S  G++  V +  PE
Sbjct: 127 LE---SKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDE-YTSSVGSKFPVRWSPPE 182
Query: 457 VFCRNIGEVSYKSDVYNYGMMIFEMTG-GRKNVDVVDNGSTA 497
           V   +  + S KSD++ +G++++E+   G+   +   N  TA
Sbjct: 183 VLMYS--KFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETA 222

>pdb|2PZR|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K641r Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score = 68.2 bits (165), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 56/215 (26%), Positives = 97/215 (45%), Gaps = 59/215 (27%)
Query: 321 LGQGGYGSVY--------KGKLLDGSNVAVKVLND--SKGNGKEFINEVASISRT-SHVN 369
           LG+G +G V         K K  +   VAVK+L D  ++ +  + ++E+  +     H N
Sbjct: 43  LGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 102
Query: 370 VVALLGFCL------------------------------------RVAEE-------LSS 386
           ++ LLG C                                     RV EE       +S 
Sbjct: 103 IINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSC 162
Query: 387 TIGIARGLEYLHLGCSTRILHFDIKPHNILLDEDFCPKISDFGLAKICNRKESIISMTGA 446
           T  +ARG+EYL    S + +H D+   N+L+ E+   +I+DFGLA+  N  +     T  
Sbjct: 163 TYQLARGMEYL---ASQKCIHRDLAARNVLVTENNVMRIADFGLARDINNIDYYKKTTNG 219
Query: 447 RGTVGYIAPEVFCRNIGEVSYKSDVYNYGMMIFEM 481
           R  V ++APE     +   +++SDV+++G++++E+
Sbjct: 220 RLPVKWMAPEALFDRV--YTHQSDVWSFGVLMWEI 252

>pdb|1F3M|C Chain C, Crystal Structure Of Human SerineTHREONINE KINASE PAK1 Length = 297

Iteration: 1
 Score = 68.2 bits (165), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 67/225 (29%), Positives = 97/225 (43%), Gaps = 44/225 (19%)
Query: 291 ETFLRNYRSLSPKRYGYADIKKMTNSFKYKLGQGGYGSVYKG-KLLDGSNVAVKVLNDSK 349
           E  L   RS+        D KK    F+ K+GQG  G+VY    +  G  VA++ +N  +
Sbjct: 3   EEILEKLRSI----VSVGDPKKKYTRFE-KIGQGASGTVYTAMDVATGQEVAIRQMNLQQ 57
Query: 350 GNGKEFI-NEVASISRTSHVNVVALLGFCLRVAEELSSTIGIARG--------------- 393
              KE I NE+  +    + N+V  L   L V +EL   +    G               
Sbjct: 58  QPKKELIINEILVMRENKNPNIVNYLDSYL-VGDELWVVMEYLAGGSLTDVVTETCMDEG 116
Query: 394 ------------LEYLHLGCSTRILHFDIKPHNILLDEDFCPKISDFGL-AKICNRKESI 440
                       LE+LH   S +++H DIK  NILL  D   K++DFG  A+I   +   
Sbjct: 117 QIAAVCRECLQALEFLH---SNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKR 173
Query: 441 ISMTGARGTVGYIAPEVFCRNIGEVSYKSDVYNYGMMIFEMTGGR 485
            +M    GT  ++APEV  R       K D+++ G+M  EM  G 
Sbjct: 174 STMV---GTPYWMAPEVVTRK--AYGPKVDIWSLGIMAIEMIEGE 213

>pdb|2PSQ|A Chain A, Crystal Structure Of Unphosphorylated Unactivated Wild Type Fgf Receptor 2 (Fgfr2) Kinase Domain Length = 370

Iteration: 1
 Score = 67.8 bits (164), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 57/215 (26%), Positives = 97/215 (45%), Gaps = 59/215 (27%)
Query: 321 LGQGGYGSVY--------KGKLLDGSNVAVKVLND--SKGNGKEFINEVASISRT-SHVN 369
           LG+G +G V         K K  +   VAVK+L D  ++ +  + ++E+  +     H N
Sbjct: 89  LGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 148
Query: 370 VVALLGFCL------------------------------------RVAEE-------LSS 386
           ++ LLG C                                     RV EE       +S 
Sbjct: 149 IINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSC 208
Query: 387 TIGIARGLEYLHLGCSTRILHFDIKPHNILLDEDFCPKISDFGLAKICNRKESIISMTGA 446
           T  +ARG+EYL    S + +H D+   N+L+ E+   KI+DFGLA+  N  +     T  
Sbjct: 209 TYQLARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTTNG 265
Query: 447 RGTVGYIAPEVFCRNIGEVSYKSDVYNYGMMIFEM 481
           R  V ++APE     +   +++SDV+++G++++E+
Sbjct: 266 RLPVKWMAPEALFDRV--YTHQSDVWSFGVLMWEI 298

>pdb|4EQM|A Chain A, Structural Analysis Of Staphylococcus Aureus SerineTHREONINE KINASE Pknb Length = 294

Iteration: 1
 Score = 67.8 bits (164), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 62/214 (28%), Positives = 99/214 (46%), Gaps = 44/214 (20%)
Query: 320 KLGQGGYGSVYKGK-LLDGSNVAVKVL----NDSKGNGKEFINEVASISRTSHVNVVALL 374
           KLG GG  +VY  +  +    VA+K +     + +   K F  EV + S+ SH N+V+++
Sbjct: 18  KLGGGGMSTVYLAEDTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQNIVSMI 77
Query: 375 GF---------------------------CLRVAEELSSTIGIARGLEYLHLGCSTRILH 407
                                         L V   ++ T  I  G+++ H     RI+H
Sbjct: 78  DVDEEDDCYYLVMEYIEGPTLSEYIESHGPLSVDTAINFTNQILDGIKHAH---DMRIVH 134
Query: 408 FDIKPHNILLDEDFCPKISDFGLAKICNRKESIISMTGARGTVGYIAPEVFCRNIGEVSY 467
            DIKP NIL+D +   KI DFG+AK  +   S+       GTV Y +PE   +  GE + 
Sbjct: 135 RDIKPQNILIDSNKTLKIFDFGIAKALSET-SLTQTNHVLGTVQYFSPE---QAKGEATD 190
Query: 468 K-SDVYNYGMMIFEMTGGRKNVDVVDNGSTALDL 500
           + +D+Y+ G++++EM  G        NG TA+ +
Sbjct: 191 ECTDIYSIGIVLYEMLVGEPPF----NGETAVSI 220

>pdb|1YHV|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Two Point Mutations (K299r, T423e) Length = 297

Iteration: 1
 Score = 67.8 bits (164), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 67/225 (29%), Positives = 96/225 (42%), Gaps = 44/225 (19%)
Query: 291 ETFLRNYRSLSPKRYGYADIKKMTNSFKYKLGQGGYGSVYKG-KLLDGSNVAVKVLNDSK 349
           E  L   RS+        D KK    F+ K+GQG  G+VY    +  G  VA++ +N  +
Sbjct: 3   EEILEKLRSI----VSVGDPKKKYTRFE-KIGQGASGTVYTAMDVATGQEVAIRQMNLQQ 57
Query: 350 GNGKEFI-NEVASISRTSHVNVVALLGFCLRVAEELSSTIGIARG--------------- 393
              KE I NE+  +    + N+V  L   L V +EL   +    G               
Sbjct: 58  QPKKELIINEILVMRENKNPNIVNYLDSYL-VGDELWVVMEYLAGGSLTDVVTETCMDEG 116
Query: 394 ------------LEYLHLGCSTRILHFDIKPHNILLDEDFCPKISDFGL-AKICNRKESI 440
                       LE+LH   S +++H DIK  NILL  D   K++DFG  A+I   +   
Sbjct: 117 QIAAVCRECLQALEFLH---SNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKR 173
Query: 441 ISMTGARGTVGYIAPEVFCRNIGEVSYKSDVYNYGMMIFEMTGGR 485
             M    GT  ++APEV  R       K D+++ G+M  EM  G 
Sbjct: 174 SEMV---GTPYWMAPEVVTRK--AYGPKVDIWSLGIMAIEMIEGE 213

>pdb|3B2T|A Chain A, Structure Of Phosphotransferase Length = 311

Iteration: 1
 Score = 67.4 bits (163), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 57/215 (26%), Positives = 97/215 (45%), Gaps = 59/215 (27%)
Query: 321 LGQGGYGSVY--------KGKLLDGSNVAVKVLND--SKGNGKEFINEVASISRT-SHVN 369
           LG+G +G V         K K  +   VAVK+L D  ++ +  + ++E+  +     H N
Sbjct: 30  LGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 89
Query: 370 VVALLGFCL------------------------------------RVAEE-------LSS 386
           ++ LLG C                                     RV EE       +S 
Sbjct: 90  IINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSC 149
Query: 387 TIGIARGLEYLHLGCSTRILHFDIKPHNILLDEDFCPKISDFGLAKICNRKESIISMTGA 446
           T  +ARG+EYL    S + +H D+   N+L+ E+   KI+DFGLA+  N  +     T  
Sbjct: 150 TYQLARGMEYL---ASQKCIHRDLTARNVLVTENNVMKIADFGLARDINNIDYYKKTTNG 206
Query: 447 RGTVGYIAPEVFCRNIGEVSYKSDVYNYGMMIFEM 481
           R  V ++APE     +   +++SDV+++G++++E+
Sbjct: 207 RLPVKWMAPEALFDRV--YTHQSDVWSFGVLMWEI 239

>pdb|3RI1|A Chain A, Crystal Structure Of The Catalytic Domain Of Fgfr2 Kinase In Complex With Arq 069 Length = 313

Iteration: 1
 Score = 67.4 bits (163), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 57/215 (26%), Positives = 97/215 (45%), Gaps = 59/215 (27%)
Query: 321 LGQGGYGSVY--------KGKLLDGSNVAVKVLND--SKGNGKEFINEVASISRT-SHVN 369
           LG+G +G V         K K  +   VAVK+L D  ++ +  + ++E+  +     H N
Sbjct: 32  LGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 91
Query: 370 VVALLGFCL------------------------------------RVAEE-------LSS 386
           ++ LLG C                                     RV EE       +S 
Sbjct: 92  IINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSC 151
Query: 387 TIGIARGLEYLHLGCSTRILHFDIKPHNILLDEDFCPKISDFGLAKICNRKESIISMTGA 446
           T  +ARG+EYL    S + +H D+   N+L+ E+   KI+DFGLA+  N  +     T  
Sbjct: 152 TYQLARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTTNG 208
Query: 447 RGTVGYIAPEVFCRNIGEVSYKSDVYNYGMMIFEM 481
           R  V ++APE     +   +++SDV+++G++++E+
Sbjct: 209 RLPVKWMAPEALFDRV--YTHQSDVWSFGVLMWEI 241

>pdb|3FXZ|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Ruthenium Complex Lambda-Fl172 Length = 297

Iteration: 1
 Score = 67.4 bits (163), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 67/225 (29%), Positives = 96/225 (42%), Gaps = 44/225 (19%)
Query: 291 ETFLRNYRSLSPKRYGYADIKKMTNSFKYKLGQGGYGSVYKG-KLLDGSNVAVKVLNDSK 349
           E  L   RS+        D KK    F+ K+GQG  G+VY    +  G  VA++ +N  +
Sbjct: 3   EEILEKLRSI----VSVGDPKKKYTRFE-KIGQGASGTVYTAMDVATGQEVAIRQMNLQQ 57
Query: 350 GNGKEFI-NEVASISRTSHVNVVALLGFCLRVAEELSSTIGIARG--------------- 393
              KE I NE+  +    + N+V  L   L V +EL   +    G               
Sbjct: 58  QPKKELIINEILVMRENKNPNIVNYLDSYL-VGDELWVVMEYLAGGSLTDVVTETCMDEG 116
Query: 394 ------------LEYLHLGCSTRILHFDIKPHNILLDEDFCPKISDFGL-AKICNRKESI 440
                       LE+LH   S +++H DIK  NILL  D   K++DFG  A+I   +   
Sbjct: 117 QIAAVCRECLQALEFLH---SNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKR 173
Query: 441 ISMTGARGTVGYIAPEVFCRNIGEVSYKSDVYNYGMMIFEMTGGR 485
             M    GT  ++APEV  R       K D+++ G+M  EM  G 
Sbjct: 174 SXMV---GTPYWMAPEVVTRK--AYGPKVDIWSLGIMAIEMIEGE 213

>pdb|3Q52|A Chain A, Structure Of Phosphorylated Pak1 Kinase Domain Length = 306

Iteration: 1
 Score = 67.4 bits (163), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 67/225 (29%), Positives = 96/225 (42%), Gaps = 44/225 (19%)
Query: 291 ETFLRNYRSLSPKRYGYADIKKMTNSFKYKLGQGGYGSVYKG-KLLDGSNVAVKVLNDSK 349
           E  L   RS+        D KK    F+ K+GQG  G+VY    +  G  VA++ +N  +
Sbjct: 4   EEILEKLRSI----VSVGDPKKKYTRFE-KIGQGASGTVYTAMDVATGQEVAIRQMNLQQ 58
Query: 350 GNGKEFI-NEVASISRTSHVNVVALLGFCLRVAEELSSTIGIARG--------------- 393
              KE I NE+  +    + N+V  L   L V +EL   +    G               
Sbjct: 59  QPKKELIINEILVMRENKNPNIVNYLDSYL-VGDELWVVMEYLAGGSLTDVVTETCMDEG 117
Query: 394 ------------LEYLHLGCSTRILHFDIKPHNILLDEDFCPKISDFGL-AKICNRKESI 440
                       LE+LH   S +++H DIK  NILL  D   K++DFG  A+I   +   
Sbjct: 118 QIAAVCRECLQALEFLH---SNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKR 174
Query: 441 ISMTGARGTVGYIAPEVFCRNIGEVSYKSDVYNYGMMIFEMTGGR 485
             M    GT  ++APEV  R       K D+++ G+M  EM  G 
Sbjct: 175 SXMV---GTPYWMAPEVVTRK--AYGPKVDIWSLGIMAIEMIEGE 214

>pdb|2ZV7|A Chain A, Lyn Tyrosine Kinase Domain, Apo Form Length = 279

Iteration: 1
 Score = 67.4 bits (163), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 54/208 (25%), Positives = 91/208 (43%), Gaps = 42/208 (20%)
Query: 320 KLGQGGYGSVYKGKLLDGSNVAVKVLNDSKGNGKEFINEVASISRTSHVNVVALLGFCLR 379
           KLG G +G V+ G   + + VAVK L     + + F+ E   +    H  +V L     +
Sbjct: 19  KLGAGQFGEVWMGYYNNSTKVAVKTLKPGTMSVQAFLEEANLMKTLQHDKLVRLYAVVTK 78
Query: 380 ---------------VAEELSSTIG--------------IARGLEYLHLGCSTRILHFDI 410
                          + + L S  G              IA G+ Y+        +H D+
Sbjct: 79  EEPIYIITEFMAKGSLLDFLKSDEGGKVLLPKLIDFSAQIAEGMAYIE---RKNYIHRDL 135
Query: 411 KPHNILLDEDFCPKISDFGLAKICNRKESIISMTGARGTVGYIAPEVFCRNIGEVSYKSD 470
           +  N+L+ E    KI+DFGLA++    E   +  GA+  + + APE    N G  + KS+
Sbjct: 136 RAANVLVSESLMCKIADFGLARVIEDNE-YTAREGAKFPIKWTAPEAI--NFGCFTIKSN 192
Query: 471 VYNYGMMIFEMTG-------GRKNVDVV 491
           V+++G++++E+         GR N DV+
Sbjct: 193 VWSFGILLYEIVTYGKIPYPGRTNADVM 220

>pdb|1GJO|A Chain A, The Fgfr2 Tyrosine Kinase Domain Length = 316

Iteration: 1
 Score = 67.4 bits (163), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 57/215 (26%), Positives = 97/215 (45%), Gaps = 59/215 (27%)
Query: 321 LGQGGYGSVY--------KGKLLDGSNVAVKVLND--SKGNGKEFINEVASISRT-SHVN 369
           LG+G +G V         K K  +   VAVK+L D  ++ +  + ++E+  +     H N
Sbjct: 35  LGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 94
Query: 370 VVALLGFCL------------------------------------RVAEE-------LSS 386
           ++ LLG C                                     RV EE       +S 
Sbjct: 95  IINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSC 154
Query: 387 TIGIARGLEYLHLGCSTRILHFDIKPHNILLDEDFCPKISDFGLAKICNRKESIISMTGA 446
           T  +ARG+EYL    S + +H D+   N+L+ E+   KI+DFGLA+  N  +     T  
Sbjct: 155 TYQLARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTTNG 211
Query: 447 RGTVGYIAPEVFCRNIGEVSYKSDVYNYGMMIFEM 481
           R  V ++APE     +   +++SDV+++G++++E+
Sbjct: 212 RLPVKWMAPEALFDRV--YTHQSDVWSFGVLMWEI 244

>pdb|2ZM1|A Chain A, Crystal Structure Of Imidazo Pyrazin 1 Bound To The Kinase Domain Of Human Lck, (Auto-Phosphorylated On Tyr394) Length = 285

Iteration: 1
 Score = 67.4 bits (163), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 57/234 (24%), Positives = 100/234 (42%), Gaps = 44/234 (18%)
Query: 298 RSLSPKRYGYAD---IKKMTNSFKYKLGQGGYGSVYKGKLLDGSNVAVKVLNDSKGNGKE 354
           ++  P++  + D   + + T     +LG G +G V+ G     + VAVK L     +   
Sbjct: 1   QTQKPQKPWWEDEWEVPRETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPDA 60
Query: 355 FINEVASISRTSHVNVVALL----------------------------GFCLRVAEELSS 386
           F+ E   + +  H  +V L                             G  L + + L  
Sbjct: 61  FLAEANLMKQLQHQRLVRLYAVVTQEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDM 120
Query: 387 TIGIARGLEYLHLGCSTRILHFDIKPHNILLDEDFCPKISDFGLAKICNRKESIISMTGA 446
              IA G+ ++        +H D++  NIL+ +    KI+DFGLA++    E   +  GA
Sbjct: 121 AAQIAEGMAFIE---ERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEX-TAREGA 176
Query: 447 RGTVGYIAPEVFCRNIGEVSYKSDVYNYGMMIFEM-TGGR------KNVDVVDN 493
           +  + + APE    N G  + KSDV+++G+++ E+ T GR       N +V+ N
Sbjct: 177 KFPIKWTAPEAI--NYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQN 228

>pdb|3KXZ|A Chain A, The Complex Crystal Structure Of Lck With A Probe Molecule W259 Length = 287

Iteration: 1
 Score = 67.4 bits (163), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 57/234 (24%), Positives = 100/234 (42%), Gaps = 44/234 (18%)
Query: 298 RSLSPKRYGYAD---IKKMTNSFKYKLGQGGYGSVYKGKLLDGSNVAVKVLNDSKGNGKE 354
           ++  P++  + D   + + T     +LG G +G V+ G     + VAVK L     +   
Sbjct: 3   QTQKPQKPWWEDEWEVPRETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPDA 62
Query: 355 FINEVASISRTSHVNVVALL----------------------------GFCLRVAEELSS 386
           F+ E   + +  H  +V L                             G  L + + L  
Sbjct: 63  FLAEANLMKQLQHQRLVRLYAVVTQEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDM 122
Query: 387 TIGIARGLEYLHLGCSTRILHFDIKPHNILLDEDFCPKISDFGLAKICNRKESIISMTGA 446
              IA G+ ++        +H D++  NIL+ +    KI+DFGLA++    E   +  GA
Sbjct: 123 AAQIAEGMAFIE---ERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEX-TAREGA 178
Query: 447 RGTVGYIAPEVFCRNIGEVSYKSDVYNYGMMIFEM-TGGR------KNVDVVDN 493
           +  + + APE    N G  + KSDV+++G+++ E+ T GR       N +V+ N
Sbjct: 179 KFPIKWTAPEAI--NYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQN 230

>pdb|3KMM|A Chain A, Structure Of Human Lck Kinase With A Small Molecule Inhibitor Length = 288

Iteration: 1
 Score = 67.0 bits (162), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 57/230 (24%), Positives = 98/230 (42%), Gaps = 44/230 (19%)
Query: 302 PKRYGYAD---IKKMTNSFKYKLGQGGYGSVYKGKLLDGSNVAVKVLNDSKGNGKEFINE 358
           P++  + D   + + T     +LG G +G V+ G     + VAVK L     +   F+ E
Sbjct: 8   PQKPWWEDEWEVPRETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPDAFLAE 67
Query: 359 VASISRTSHVNVVALL----------------------------GFCLRVAEELSSTIGI 390
              + +  H  +V L                             G  L + + L     I
Sbjct: 68  ANLMKQLQHQRLVRLYAVVTQEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQI 127
Query: 391 ARGLEYLHLGCSTRILHFDIKPHNILLDEDFCPKISDFGLAKICNRKESIISMTGARGTV 450
           A G+ ++        +H D++  NIL+ +    KI+DFGLA++    E   +  GA+  +
Sbjct: 128 AEGMAFIE---ERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEX-TAREGAKFPI 183
Query: 451 GYIAPEVFCRNIGEVSYKSDVYNYGMMIFEM-TGGR------KNVDVVDN 493
            + APE    N G  + KSDV+++G+++ E+ T GR       N +V+ N
Sbjct: 184 KWTAPEAI--NYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQN 231

>pdb|3CD3|A Chain A, Crystal Structure Of Phosphorylated Human Feline Sarcoma Viral Oncogene Homologue (V-Fes) In Complex With Staurosporine And A Consensus Peptide Length = 377

Iteration: 1
 Score = 67.0 bits (162), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 54/194 (27%), Positives = 90/194 (46%), Gaps = 40/194 (20%)
Query: 320 KLGQGGYGSVYKGKL-LDGSNVAVKVLNDS--KGNGKEFINEVASISRTSHVNVVALLGF 376
           ++G+G +G V+ G+L  D + VAVK   ++       +F+ E   + + SH N+V L+G 
Sbjct: 121 QIGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGV 180
Query: 377 C----------------------------LRVAEELSSTIGIARGLEYLHLGCSTRILHF 408
           C                            LRV   L      A G+EYL   C    +H 
Sbjct: 181 CTQKQPIYIVMELVQGGDFLTFLRTEGARLRVKTLLQMVGDAAAGMEYLESKCC---IHR 237
Query: 409 DIKPHNILLDEDFCPKISDFGLAKICNRKESIISMTGA--RGTVGYIAPEVFCRNIGEVS 466
           D+   N L+ E    KISDFG+++     + + + +G   +  V + APE    N G  S
Sbjct: 238 DLAARNCLVTEKNVLKISDFGMSR--EEADGVXAASGGLRQVPVKWTAPEAL--NYGRYS 293
Query: 467 YKSDVYNYGMMIFE 480
            +SDV+++G++++E
Sbjct: 294 SESDVWSFGILLWE 307

>pdb|2QKR|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Indirubin 3'-Monoxime Bound Length = 313

Iteration: 1
 Score = 67.0 bits (162), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 59/198 (29%), Positives = 91/198 (45%), Gaps = 40/198 (20%)
Query: 320 KLGQGGYGSVYKGKLLDGSNVAVKVLN---DSKGNGKEFINEVASISRTSHVNVVALLGF 376
           K+G+G YG VYK K   G  VA+K +    + +G     I E++ +    H N+V+L+  
Sbjct: 28  KVGEGTYGVVYKAKDSQGRIVALKRIRLDAEDEGIPSTAIREISLLKELHHPNIVSLIDV 87
Query: 377 -----CLRVAEEL-----------------SSTIGI-----ARGLEYLHLGCSTRILHFD 409
                CL +  E                   S I I      RG+ + H     RILH D
Sbjct: 88  IHSERCLTLVFEFMEKDLKKVLDENKTGLQDSQIKIYLYQLLRGVAHCH---QHRILHRD 144
Query: 410 IKPHNILLDEDFCPKISDFGLAKICNRKESIISMTGARGTVGYIAPEVFCRNIGEVSYKS 469
           +KP N+L++ D   K++DFGLA+       + S T    T+ Y AP+V    +G   Y +
Sbjct: 145 LKPQNLLINSDGALKLADFGLARAFGI--PVRSYTHEVVTLWYRAPDVL---MGSKKYST 199
Query: 470 --DVYNYGMMIFEMTGGR 485
             D+++ G +  EM  G+
Sbjct: 200 SVDIWSIGCIFAEMITGK 217

>pdb|3NIZ|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Adp Bound Length = 311

Iteration: 1
 Score = 67.0 bits (162), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 59/198 (29%), Positives = 91/198 (45%), Gaps = 40/198 (20%)
Query: 320 KLGQGGYGSVYKGKLLDGSNVAVKVLN---DSKGNGKEFINEVASISRTSHVNVVALLGF 376
           K+G+G YG VYK K   G  VA+K +    + +G     I E++ +    H N+V+L+  
Sbjct: 28  KVGEGTYGVVYKAKDSQGRIVALKRIRLDAEDEGIPSTAIREISLLKELHHPNIVSLIDV 87
Query: 377 -----CLRVAEEL-----------------SSTIGI-----ARGLEYLHLGCSTRILHFD 409
                CL +  E                   S I I      RG+ + H     RILH D
Sbjct: 88  IHSERCLTLVFEFMEKDLKKVLDENKTGLQDSQIKIYLYQLLRGVAHCH---QHRILHRD 144
Query: 410 IKPHNILLDEDFCPKISDFGLAKICNRKESIISMTGARGTVGYIAPEVFCRNIGEVSYKS 469
           +KP N+L++ D   K++DFGLA+       + S T    T+ Y AP+V    +G   Y +
Sbjct: 145 LKPQNLLINSDGALKLADFGLARAFGI--PVRSYTHEVVTLWYRAPDVL---MGSKKYST 199
Query: 470 --DVYNYGMMIFEMTGGR 485
             D+++ G +  EM  G+
Sbjct: 200 SVDIWSIGCIFAEMITGK 217

>pdb|3BKB|A Chain A, Crystal Structure Of Human Feline Sarcoma Viral Oncogene Homologue (V- Fes) Length = 377

Iteration: 1
 Score = 67.0 bits (162), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 54/194 (27%), Positives = 90/194 (46%), Gaps = 40/194 (20%)
Query: 320 KLGQGGYGSVYKGKL-LDGSNVAVKVLNDS--KGNGKEFINEVASISRTSHVNVVALLGF 376
           ++G+G +G V+ G+L  D + VAVK   ++       +F+ E   + + SH N+V L+G 
Sbjct: 121 QIGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGV 180
Query: 377 C----------------------------LRVAEELSSTIGIARGLEYLHLGCSTRILHF 408
           C                            LRV   L      A G+EYL   C    +H 
Sbjct: 181 CTQKQPIYIVMELVQGGDFLTFLRTEGARLRVKTLLQMVGDAAAGMEYLESKCC---IHR 237
Query: 409 DIKPHNILLDEDFCPKISDFGLAKICNRKESIISMTGA--RGTVGYIAPEVFCRNIGEVS 466
           D+   N L+ E    KISDFG+++     + + + +G   +  V + APE    N G  S
Sbjct: 238 DLAARNCLVTEKNVLKISDFGMSR--EEADGVYAASGGLRQVPVKWTAPEAL--NYGRYS 293
Query: 467 YKSDVYNYGMMIFE 480
            +SDV+++G++++E
Sbjct: 294 SESDVWSFGILLWE 307

>pdb|3P08|A Chain A, Crystal Structure Of The Human Btk Kinase Domain Length = 267

Iteration: 1
 Score = 67.0 bits (162), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 56/221 (25%), Positives = 95/221 (42%), Gaps = 35/221 (15%)
Query: 306 GYADIKKMTNSFKYKLGQGGYGSVYKGKLLDGSNVAVKVLNDSKGNGKEFINEVASISRT 365
           G  +I     +F  +LG G +G V  GK     +VA+K++ +   +  EFI E   +   
Sbjct: 1   GSWEIDPKDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSEDEFIEEAKVMMNL 60
Query: 366 SHVNVVALLGFC----------------------------LRVAEELSSTIGIARGLEYL 397
           SH  +V L G C                             +  + L     +   +EYL
Sbjct: 61  SHEKLVQLYGVCTKQRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYL 120
Query: 398 HLGCSTRILHFDIKPHNILLDEDFCPKISDFGLAKICNRKESIISMTGARGTVGYIAPEV 457
               S + LH D+   N L+++    K+SDFGL++     E   S  G++  V +  PEV
Sbjct: 121 E---SKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDE-YTSSVGSKFPVRWSPPEV 176
Query: 458 FCRNIGEVSYKSDVYNYGMMIFEMTG-GRKNVDVVDNGSTA 497
              +  + S KSD++ +G++++E+   G+   +   N  TA
Sbjct: 177 LMYS--KFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETA 215

>pdb|1QPE|A Chain A, Structural Analysis Of The Lymphocyte-Specific Kinase Lck In Complex With Non-Selective And Src Family Selective Kinase Inhibitors Length = 279

Iteration: 1
 Score = 66.6 bits (161), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 55/220 (25%), Positives = 94/220 (42%), Gaps = 41/220 (18%)
Query: 309 DIKKMTNSFKYKLGQGGYGSVYKGKLLDGSNVAVKVLNDSKGNGKEFINEVASISRTSHV 368
           ++ + T     +LG G +G V+ G     + VAVK L     +   F+ E   + +  H 
Sbjct: 9   EVPRETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPDAFLAEANLMKQLQHQ 68
Query: 369 NVVALL----------------------------GFCLRVAEELSSTIGIARGLEYLHLG 400
            +V L                             G  L + + L     IA G+ ++   
Sbjct: 69  RLVRLYAVVTQEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIE-- 126
Query: 401 CSTRILHFDIKPHNILLDEDFCPKISDFGLAKICNRKESIISMTGARGTVGYIAPEVFCR 460
                +H D++  NIL+ +    KI+DFGLA++    E   +  GA+  + + APE    
Sbjct: 127 -ERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEX-TAREGAKFPIKWTAPEAI-- 182
Query: 461 NIGEVSYKSDVYNYGMMIFEM-TGGR------KNVDVVDN 493
           N G  + KSDV+++G+++ E+ T GR       N +V+ N
Sbjct: 183 NYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQN 222

>pdb|1K2P|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Domain Length = 263

Iteration: 1
 Score = 66.6 bits (161), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 54/211 (25%), Positives = 92/211 (43%), Gaps = 35/211 (16%)
Query: 316 SFKYKLGQGGYGSVYKGKLLDGSNVAVKVLNDSKGNGKEFINEVASISRTSHVNVVALLG 375
           +F  +LG G +G V  GK     +VA+K++ +   +  EFI E   +   SH  +V L G
Sbjct: 7   TFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSEDEFIEEAKVMMNLSHEKLVQLYG 66
Query: 376 FC----------------------------LRVAEELSSTIGIARGLEYLHLGCSTRILH 407
            C                             +  + L     +   +EYL    S + LH
Sbjct: 67  VCTKQRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLE---SKQFLH 123
Query: 408 FDIKPHNILLDEDFCPKISDFGLAKICNRKESIISMTGARGTVGYIAPEVFCRNIGEVSY 467
            D+   N L+++    K+SDFGL++     E   S  G++  V +  PEV   +  + S 
Sbjct: 124 RDLAARNCLVNDQGVVKVSDFGLSRYVLDDE-YTSSVGSKFPVRWSPPEVLMYS--KFSS 180
Query: 468 KSDVYNYGMMIFEMTG-GRKNVDVVDNGSTA 497
           KSD++ +G++++E+   G+   +   N  TA
Sbjct: 181 KSDIWAFGVLMWEIYSLGKMPYERFTNSETA 211

>pdb|2OFU|A Chain A, X-Ray Crystal Structure Of 2-Aminopyrimidine Carbamate 43 Bound To Lck Length = 273

Iteration: 1
 Score = 66.6 bits (161), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 57/230 (24%), Positives = 98/230 (42%), Gaps = 44/230 (19%)
Query: 302 PKRYGYAD---IKKMTNSFKYKLGQGGYGSVYKGKLLDGSNVAVKVLNDSKGNGKEFINE 358
           P++  + D   + + T     +LG G +G V+ G     + VAVK L     +   F+ E
Sbjct: 1   PQKPWWEDEWEVPRETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPDAFLAE 60
Query: 359 VASISRTSHVNVVALL----------------------------GFCLRVAEELSSTIGI 390
              + +  H  +V L                             G  L + + L     I
Sbjct: 61  ANLMKQLQHQRLVRLYAVVTQEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQI 120
Query: 391 ARGLEYLHLGCSTRILHFDIKPHNILLDEDFCPKISDFGLAKICNRKESIISMTGARGTV 450
           A G+ ++        +H D++  NIL+ +    KI+DFGLA++    E   +  GA+  +
Sbjct: 121 AEGMAFIE---ERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEX-TAREGAKFPI 176
Query: 451 GYIAPEVFCRNIGEVSYKSDVYNYGMMIFEM-TGGR------KNVDVVDN 493
            + APE    N G  + KSDV+++G+++ E+ T GR       N +V+ N
Sbjct: 177 KWTAPEAI--NYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQN 224

>pdb|2PL0|A Chain A, Lck Bound To Imatinib Length = 289

Iteration: 1
 Score = 66.6 bits (161), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 57/234 (24%), Positives = 100/234 (42%), Gaps = 44/234 (18%)
Query: 298 RSLSPKRYGYAD---IKKMTNSFKYKLGQGGYGSVYKGKLLDGSNVAVKVLNDSKGNGKE 354
           ++  P++  + D   + + T     +LG G +G V+ G     + VAVK L     +   
Sbjct: 5   QTQKPQKPWWEDEWEVPRETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPDA 64
Query: 355 FINEVASISRTSHVNVVALL----------------------------GFCLRVAEELSS 386
           F+ E   + +  H  +V L                             G  L + + L  
Sbjct: 65  FLAEANLMKQLQHQRLVRLYAVVTQEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDM 124
Query: 387 TIGIARGLEYLHLGCSTRILHFDIKPHNILLDEDFCPKISDFGLAKICNRKESIISMTGA 446
              IA G+ ++        +H D++  NIL+ +    KI+DFGLA++    E   +  GA
Sbjct: 125 AAQIAEGMAFIE---ERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNE-YTAREGA 180
Query: 447 RGTVGYIAPEVFCRNIGEVSYKSDVYNYGMMIFEM-TGGR------KNVDVVDN 493
           +  + + APE    N G  + KSDV+++G+++ E+ T GR       N +V+ N
Sbjct: 181 KFPIKWTAPEAI--NYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQN 232

>pdb|3OCS|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase In Complex With Inhibitor Cgi1746 Length = 271

Iteration: 1
 Score = 66.6 bits (161), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 56/221 (25%), Positives = 95/221 (42%), Gaps = 35/221 (15%)
Query: 306 GYADIKKMTNSFKYKLGQGGYGSVYKGKLLDGSNVAVKVLNDSKGNGKEFINEVASISRT 365
           G  +I     +F  +LG G +G V  GK     +VA+K++ +   +  EFI E   +   
Sbjct: 2   GSWEIDPKDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSEDEFIEEAKVMMNL 61
Query: 366 SHVNVVALLGFC----------------------------LRVAEELSSTIGIARGLEYL 397
           SH  +V L G C                             +  + L     +   +EYL
Sbjct: 62  SHEKLVQLYGVCTKQRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYL 121
Query: 398 HLGCSTRILHFDIKPHNILLDEDFCPKISDFGLAKICNRKESIISMTGARGTVGYIAPEV 457
               S + LH D+   N L+++    K+SDFGL++     E   S  G++  V +  PEV
Sbjct: 122 E---SKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDE-YTSSVGSKFPVRWSPPEV 177
Query: 458 FCRNIGEVSYKSDVYNYGMMIFEMTG-GRKNVDVVDNGSTA 497
              +  + S KSD++ +G++++E+   G+   +   N  TA
Sbjct: 178 LMYS--KFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETA 216

>pdb|3BYS|A Chain A, Co-Crystal Structure Of Lck And Aminopyrimidine Amide 10b Length = 277

Iteration: 1
 Score = 66.6 bits (161), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 57/234 (24%), Positives = 100/234 (42%), Gaps = 44/234 (18%)
Query: 298 RSLSPKRYGYAD---IKKMTNSFKYKLGQGGYGSVYKGKLLDGSNVAVKVLNDSKGNGKE 354
           ++  P++  + D   + + T     +LG G +G V+ G     + VAVK L     +   
Sbjct: 1   QTQKPQKPWWEDEWEVPRETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPDA 60
Query: 355 FINEVASISRTSHVNVVALL----------------------------GFCLRVAEELSS 386
           F+ E   + +  H  +V L                             G  L + + L  
Sbjct: 61  FLAEANLMKQLQHQRLVRLYAVVTQEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDM 120
Query: 387 TIGIARGLEYLHLGCSTRILHFDIKPHNILLDEDFCPKISDFGLAKICNRKESIISMTGA 446
              IA G+ ++        +H D++  NIL+ +    KI+DFGLA++    E   +  GA
Sbjct: 121 AAQIAEGMAFIE---ERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNE-YTAREGA 176
Query: 447 RGTVGYIAPEVFCRNIGEVSYKSDVYNYGMMIFEM-TGGR------KNVDVVDN 493
           +  + + APE    N G  + KSDV+++G+++ E+ T GR       N +V+ N
Sbjct: 177 KFPIKWTAPEAI--NYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQN 228

>pdb|3BYM|A Chain A, X-Ray Co-Crystal Structure Aminobenzimidazole Triazine 1 Bound To Lck Length = 272

Iteration: 1
 Score = 66.2 bits (160), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 55/220 (25%), Positives = 94/220 (42%), Gaps = 41/220 (18%)
Query: 309 DIKKMTNSFKYKLGQGGYGSVYKGKLLDGSNVAVKVLNDSKGNGKEFINEVASISRTSHV 368
           ++ + T     +LG G +G V+ G     + VAVK L     +   F+ E   + +  H 
Sbjct: 10  EVPRETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPDAFLAEANLMKQLQHQ 69
Query: 369 NVVALL----------------------------GFCLRVAEELSSTIGIARGLEYLHLG 400
            +V L                             G  L + + L     IA G+ ++   
Sbjct: 70  RLVRLYAVVTQEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIE-- 127
Query: 401 CSTRILHFDIKPHNILLDEDFCPKISDFGLAKICNRKESIISMTGARGTVGYIAPEVFCR 460
                +H D++  NIL+ +    KI+DFGLA++    E   +  GA+  + + APE    
Sbjct: 128 -ERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEX-TAREGAKFPIKWTAPEAI-- 183
Query: 461 NIGEVSYKSDVYNYGMMIFEM-TGGR------KNVDVVDN 493
           N G  + KSDV+++G+++ E+ T GR       N +V+ N
Sbjct: 184 NYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQN 223

>pdb|2OFV|A Chain A, Crystal Structure Of Aminoquinazoline 1 Bound To Lck Length = 277

Iteration: 1
 Score = 66.2 bits (160), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 57/230 (24%), Positives = 98/230 (42%), Gaps = 44/230 (19%)
Query: 302 PKRYGYAD---IKKMTNSFKYKLGQGGYGSVYKGKLLDGSNVAVKVLNDSKGNGKEFINE 358
           P++  + D   + + T     +LG G +G V+ G     + VAVK L     +   F+ E
Sbjct: 4   PQKPWWEDEWEVPRETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPDAFLAE 63
Query: 359 VASISRTSHVNVVALL----------------------------GFCLRVAEELSSTIGI 390
              + +  H  +V L                             G  L + + L     I
Sbjct: 64  ANLMKQLQHQRLVRLYAVVTQEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQI 123
Query: 391 ARGLEYLHLGCSTRILHFDIKPHNILLDEDFCPKISDFGLAKICNRKESIISMTGARGTV 450
           A G+ ++        +H D++  NIL+ +    KI+DFGLA++    E   +  GA+  +
Sbjct: 124 AEGMAFIE---ERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNE-YTAREGAKFPI 179
Query: 451 GYIAPEVFCRNIGEVSYKSDVYNYGMMIFEM-TGGR------KNVDVVDN 493
            + APE    N G  + KSDV+++G+++ E+ T GR       N +V+ N
Sbjct: 180 KWTAPEAI--NYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQN 227

>pdb|3LCK|A Chain A, The Kinase Domain Of Human Lymphocyte Kinase (Lck), Activated Form (Auto-Phosphorylated On Tyr394) Length = 271

Iteration: 1
 Score = 66.2 bits (160), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 55/220 (25%), Positives = 94/220 (42%), Gaps = 41/220 (18%)
Query: 309 DIKKMTNSFKYKLGQGGYGSVYKGKLLDGSNVAVKVLNDSKGNGKEFINEVASISRTSHV 368
           ++ + T     +LG G +G V+ G     + VAVK L     +   F+ E   + +  H 
Sbjct: 9   EVPRETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPDAFLAEANLMKQLQHQ 68
Query: 369 NVVALL----------------------------GFCLRVAEELSSTIGIARGLEYLHLG 400
            +V L                             G  L + + L     IA G+ ++   
Sbjct: 69  RLVRLYAVVTQEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIE-- 126
Query: 401 CSTRILHFDIKPHNILLDEDFCPKISDFGLAKICNRKESIISMTGARGTVGYIAPEVFCR 460
                +H D++  NIL+ +    KI+DFGLA++    E   +  GA+  + + APE    
Sbjct: 127 -ERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEX-TAREGAKFPIKWTAPEAI-- 182
Query: 461 NIGEVSYKSDVYNYGMMIFEM-TGGR------KNVDVVDN 493
           N G  + KSDV+++G+++ E+ T GR       N +V+ N
Sbjct: 183 NYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQN 222

>pdb|3OCT|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Mutant V555r In Complex With Dasatinib Length = 265

Iteration: 1
 Score = 66.2 bits (160), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 56/221 (25%), Positives = 95/221 (42%), Gaps = 35/221 (15%)
Query: 306 GYADIKKMTNSFKYKLGQGGYGSVYKGKLLDGSNVAVKVLNDSKGNGKEFINEVASISRT 365
           G  +I     +F  +LG G +G V  GK     +VA+K++ +   +  EFI E   +   
Sbjct: 2   GSWEIDPKDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSEDEFIEEAKVMMNL 61
Query: 366 SHVNVVALLGFC----------------------------LRVAEELSSTIGIARGLEYL 397
           SH  +V L G C                             +  + L     +   +EYL
Sbjct: 62  SHEKLVQLYGVCTKQRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYL 121
Query: 398 HLGCSTRILHFDIKPHNILLDEDFCPKISDFGLAKICNRKESIISMTGARGTVGYIAPEV 457
               S + LH D+   N L+++    K+SDFGL++     E   S  G++  V +  PEV
Sbjct: 122 E---SKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDE-YTSSRGSKFPVRWSPPEV 177
Query: 458 FCRNIGEVSYKSDVYNYGMMIFEMTG-GRKNVDVVDNGSTA 497
              +  + S KSD++ +G++++E+   G+   +   N  TA
Sbjct: 178 LMYS--KFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETA 216

>pdb|3PLS|A Chain A, Ron In Complex With Ligand Amp-Pnp Length = 298

Iteration: 1
 Score = 65.9 bits (159), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 54/198 (27%), Positives = 93/198 (46%), Gaps = 42/198 (21%)
Query: 321 LGQGGYGSVYKGKLLDGSN----VAVKVLN--DSKGNGKEFINEVASISRTSHVNVVALL 374
           +G+G +G VY G+ +D +      A+K L+        + F+ E   +   +H NV+AL+
Sbjct: 29  IGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEAFLREGLLMRGLNHPNVLALI 88
Query: 375 GFCL-----------------------------RVAEELSSTIGIARGLEYLHLGCSTRI 405
           G  L                              V + +S  + +ARG+EYL      + 
Sbjct: 89  GIMLPPEGLPHVLLPYMCHGDLLQFIRSPQRNPTVKDLISFGLQVARGMEYL---AEQKF 145
Query: 406 LHFDIKPHNILLDEDFCPKISDFGLAK-ICNRK-ESIISMTGARGTVGYIAPEVFCRNIG 463
           +H D+   N +LDE F  K++DFGLA+ I +R+  S+     AR  V + A E       
Sbjct: 146 VHRDLAARNCMLDESFTVKVADFGLARDILDREYYSVQQHRHARLPVKWTALESL--QTY 203
Query: 464 EVSYKSDVYNYGMMIFEM 481
             + KSDV+++G++++E+
Sbjct: 204 RFTTKSDVWSFGVLLWEL 221

>pdb|2OF2|A Chain A, Crystal Structure Of Furanopyrimidine 8 Bound To Lck Length = 271

Iteration: 1
 Score = 65.9 bits (159), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 55/220 (25%), Positives = 94/220 (42%), Gaps = 41/220 (18%)
Query: 309 DIKKMTNSFKYKLGQGGYGSVYKGKLLDGSNVAVKVLNDSKGNGKEFINEVASISRTSHV 368
           ++ + T     +LG G +G V+ G     + VAVK L     +   F+ E   + +  H 
Sbjct: 9   EVPRETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPDAFLAEANLMKQLQHQ 68
Query: 369 NVVALL----------------------------GFCLRVAEELSSTIGIARGLEYLHLG 400
            +V L                             G  L + + L     IA G+ ++   
Sbjct: 69  RLVRLYAVVTQEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIE-- 126
Query: 401 CSTRILHFDIKPHNILLDEDFCPKISDFGLAKICNRKESIISMTGARGTVGYIAPEVFCR 460
                +H D++  NIL+ +    KI+DFGLA++    E   +  GA+  + + APE    
Sbjct: 127 -ERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNE-YTAREGAKFPIKWTAPEAI-- 182
Query: 461 NIGEVSYKSDVYNYGMMIFEM-TGGR------KNVDVVDN 493
           N G  + KSDV+++G+++ E+ T GR       N +V+ N
Sbjct: 183 NYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQN 222

>pdb|2OG8|A Chain A, Crystal Structure Of Aminoquinazoline 36 Bound To Lck Length = 265

Iteration: 1
 Score = 65.5 bits (158), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 55/220 (25%), Positives = 94/220 (42%), Gaps = 41/220 (18%)
Query: 309 DIKKMTNSFKYKLGQGGYGSVYKGKLLDGSNVAVKVLNDSKGNGKEFINEVASISRTSHV 368
           ++ + T     +LG G +G V+ G     + VAVK L     +   F+ E   + +  H 
Sbjct: 4   EVPRETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPDAFLAEANLMKQLQHQ 63
Query: 369 NVVALL----------------------------GFCLRVAEELSSTIGIARGLEYLHLG 400
            +V L                             G  L + + L     IA G+ ++   
Sbjct: 64  RLVRLYAVVTQEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIE-- 121
Query: 401 CSTRILHFDIKPHNILLDEDFCPKISDFGLAKICNRKESIISMTGARGTVGYIAPEVFCR 460
                +H D++  NIL+ +    KI+DFGLA++    E   +  GA+  + + APE    
Sbjct: 122 -ERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNE-YTAREGAKFPIKWTAPEAI-- 177
Query: 461 NIGEVSYKSDVYNYGMMIFEM-TGGR------KNVDVVDN 493
           N G  + KSDV+++G+++ E+ T GR       N +V+ N
Sbjct: 178 NYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQN 217

>pdb|2Z7Q|A Chain A, Crystal Structure Of The N-Terminal Kinase Domain Of Human Rsk-1 Bound To Amp-Pcp Length = 321

Iteration: 1
 Score = 65.5 bits (158), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 43/98 (43%), Positives = 62/98 (63%), Gaps = 13/98 (13%)
Query: 390 IARGLEYLHLGCSTRILHFDIKPHNILLDEDFCPKISDFGLAKICNRKESIISMTGAR-- 447
           +A GL++LH   S  I++ D+KP NILLDE+   K++DFGL+     KE+I     A   
Sbjct: 139 LALGLDHLH---SLGIIYRDLKPENILLDEEGHIKLTDFGLS-----KEAIDHEKKAYSF 190
Query: 448 -GTVGYIAPEVFCRNIGEVSYKSDVYNYGMMIFEMTGG 484
            GTV Y+APEV  R  G  S+ +D ++YG+++FEM  G
Sbjct: 191 CGTVEYMAPEVVNRQ-GH-SHSADWWSYGVLMFEMLTG 226

>pdb|1QPD|A Chain A, Structural Analysis Of The Lymphocyte-specific Kinase Lck In Complex With Non-selective And Src Family Selective Kinase Inhibitors Length = 279

Iteration: 1
 Score = 65.1 bits (157), Expect = 9e-11,   Method: Compositional matrix adjust.
 Identities = 55/220 (25%), Positives = 93/220 (42%), Gaps = 41/220 (18%)
Query: 309 DIKKMTNSFKYKLGQGGYGSVYKGKLLDGSNVAVKVLNDSKGNGKEFINEVASISRTSHV 368
           ++ + T     +LG G  G V+ G     + VAVK L     +   F+ E   + +  H 
Sbjct: 9   EVPRETLKLVERLGAGQAGEVWMGYYNGHTKVAVKSLKQGSMSPDAFLAEANLMKQLQHQ 68
Query: 369 NVVALL----------------------------GFCLRVAEELSSTIGIARGLEYLHLG 400
            +V L                             G  L + + L     IA G+ ++   
Sbjct: 69  RLVRLYAVVTQEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIE-- 126
Query: 401 CSTRILHFDIKPHNILLDEDFCPKISDFGLAKICNRKESIISMTGARGTVGYIAPEVFCR 460
                +H D++  NIL+ +    KI+DFGLA++    E   +  GA+  + + APE    
Sbjct: 127 -ERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDAEX-TAREGAKFPIKWTAPEAI-- 182
Query: 461 NIGEVSYKSDVYNYGMMIFEM-TGGR------KNVDVVDN 493
           N G  + KSDV+++G+++ E+ T GR       N +V+ N
Sbjct: 183 NYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQN 222

>pdb|3Q4Z|A Chain A, Structure Of Unphosphorylated Pak1 Kinase Domain Length = 306

Iteration: 1
 Score = 64.7 bits (156), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 62/207 (29%), Positives = 92/207 (44%), Gaps = 40/207 (19%)
Query: 309 DIKKMTNSFKYKLGQGGYGSVYKG-KLLDGSNVAVKVLNDSKGNGKEFI-NEVASISRTS 366
           D KK    F+ K+GQG  G+VY    +  G  VA++ +N  +   KE I NE+  +    
Sbjct: 18  DPKKKYTRFE-KIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENK 76
Query: 367 HVNVVALLGFCLRVAEELSSTIGIARG---------------------------LEYLHL 399
           + N+V  L   L V +EL   +    G                           LE+LH 
Sbjct: 77  NPNIVNYLDSYL-VGDELWVVMEYLAGGSLTDVVTETCMDEGQIAAVCRECLQALEFLH- 134
Query: 400 GCSTRILHFDIKPHNILLDEDFCPKISDFGL-AKICNRKESIISMTGARGTVGYIAPEVF 458
             S +++H +IK  NILL  D   K++DFG  A+I   +    +M    GT  ++APEV 
Sbjct: 135 --SNQVIHRNIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMV---GTPYWMAPEVV 189
Query: 459 CRNIGEVSYKSDVYNYGMMIFEMTGGR 485
            R       K D+++ G+M  EM  G 
Sbjct: 190 TRK--AYGPKVDIWSLGIMAIEMIEGE 214

>pdb|1ZYC|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: Wild- Type In Apo Form. Length = 303

Iteration: 1
 Score = 64.3 bits (155), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 60/215 (27%), Positives = 87/215 (40%), Gaps = 58/215 (26%)
Query: 321 LGQGGYGSVYKGK-LLDGSNVAVKVLNDSKGNGKEFINEVASISRTSHVNVVALLGFCLR 379
           LGQG +G V K +  LD    A+K +  ++      ++EV  ++  +H  VV      L 
Sbjct: 14  LGQGAFGQVVKARNALDSRYYAIKKIRHTEEKLSTILSEVMLLASLNHQYVVRYYAAWLE 73
Query: 380 --------VAEELSSTI---------------------------------GIARGLEYLH 398
                    A +  ST+                                  I   L Y+H
Sbjct: 74  RRNFVKPMTAVKKKSTLFIQMEYCENRTLYDLIHSENLNQQRDEYWRLFRQILEALSYIH 133
Query: 399 LGCSTRILHFDIKPHNILLDEDFCPKISDFGLAKICNRKESII------------SMTGA 446
              S  I+H D+KP NI +DE    KI DFGLAK  +R   I+            ++T A
Sbjct: 134 ---SQGIIHRDLKPMNIFIDESRNVKIGDFGLAKNVHRSLDILKLDSQNLPGSSDNLTSA 190
Query: 447 RGTVGYIAPEVFCRNIGEVSYKSDVYNYGMMIFEM 481
            GT  Y+A EV     G  + K D+Y+ G++ FEM
Sbjct: 191 IGTAMYVATEVLD-GTGHYNEKIDMYSLGIIFFEM 224

>pdb|2DQ7|X Chain X, Crystal Structure Of Fyn Kinase Domain Complexed With Staurosporine Length = 283

Iteration: 1
 Score = 64.3 bits (155), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 48/195 (24%), Positives = 84/195 (43%), Gaps = 35/195 (17%)
Query: 320 KLGQGGYGSVYKGKLLDGSNVAVKVLNDSKGNGKEFINEVASISRTSHVNVVALL----- 374
           +LG G +G V+ G     + VA+K L     + + F+ E   + +  H  +V L      
Sbjct: 16  RLGNGQFGEVWMGTWNGNTKVAIKTLKPGTMSPESFLEEAQIMKKLKHDKLVQLYAVVSE 75
Query: 375 -----------------------GFCLRVAEELSSTIGIARGLEYLHLGCSTRILHFDIK 411
                                  G  L++   +     +A G+ Y+        +H D++
Sbjct: 76  EPIYIVTEYMNKGSLLDFLKDGEGRALKLPNLVDMAAQVAAGMAYIE---RMNYIHRDLR 132
Query: 412 PHNILLDEDFCPKISDFGLAKICNRKESIISMTGARGTVGYIAPEVFCRNIGEVSYKSDV 471
             NIL+      KI+DFGLA++    E   +  GA+  + + APE      G  + KSDV
Sbjct: 133 SANILVGNGLICKIADFGLARLIEDNEX-TARQGAKFPIKWTAPEAAL--YGRFTIKSDV 189
Query: 472 YNYGMMIFEM-TGGR 485
           +++G+++ E+ T GR
Sbjct: 190 WSFGILLTELVTKGR 204

>pdb|1ZY4|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: R794g Hyperactivating Mutant In Apo Form. Length = 303

Iteration: 1
 Score = 64.3 bits (155), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 60/215 (27%), Positives = 87/215 (40%), Gaps = 58/215 (26%)
Query: 321 LGQGGYGSVYKGK-LLDGSNVAVKVLNDSKGNGKEFINEVASISRTSHVNVVALLGFCLR 379
           LGQG +G V K +  LD    A+K +  ++      ++EV  ++  +H  VV      L 
Sbjct: 14  LGQGAFGQVVKARNALDSRYYAIKKIRHTEEKLSTILSEVMLLASLNHQYVVRYYAAWLE 73
Query: 380 --------VAEELSSTI---------------------------------GIARGLEYLH 398
                    A +  ST+                                  I   L Y+H
Sbjct: 74  RRNFVKPMTAVKKKSTLFIQMEYCENGTLYDLIHSENLNQQRDEYWRLFRQILEALSYIH 133
Query: 399 LGCSTRILHFDIKPHNILLDEDFCPKISDFGLAKICNRKESII------------SMTGA 446
              S  I+H D+KP NI +DE    KI DFGLAK  +R   I+            ++T A
Sbjct: 134 ---SQGIIHRDLKPMNIFIDESRNVKIGDFGLAKNVHRSLDILKLDSQNLPGSSDNLTSA 190
Query: 447 RGTVGYIAPEVFCRNIGEVSYKSDVYNYGMMIFEM 481
            GT  Y+A EV     G  + K D+Y+ G++ FEM
Sbjct: 191 IGTAMYVATEVLD-GTGHYNEKIDMYSLGIIFFEM 224

>pdb|3GQI|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326

Iteration: 1
 Score = 64.3 bits (155), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 56/215 (26%), Positives = 97/215 (45%), Gaps = 59/215 (27%)
Query: 321 LGQGGYGSVYKGKLL----DGSN----VAVKVL--NDSKGNGKEFINEVASISRT-SHVN 369
           LG+G +G V   + +    D  N    VAVK+L  + ++ +  + I+E+  +     H N
Sbjct: 36  LGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKN 95
Query: 370 VVALLGFCLR-------------------------------------VAEELSS------ 386
           ++ LLG C +                                       E+LSS      
Sbjct: 96  IINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEFSFNPSHNPEEQLSSKDLVSC 155
Query: 387 TIGIARGLEYLHLGCSTRILHFDIKPHNILLDEDFCPKISDFGLAKICNRKESIISMTGA 446
              +ARG+EYL    S + +H D+   N+L+ ED   KI+DFGLA+  +  +     T  
Sbjct: 156 AYQVARGMEYL---ASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDXXKKTTNG 212
Query: 447 RGTVGYIAPEVFCRNIGEVSYKSDVYNYGMMIFEM 481
           R  V ++APE     I   +++SDV+++G++++E+
Sbjct: 213 RLPVKWMAPEALFDRI--YTHQSDVWSFGVLLWEI 245

>pdb|2W9F|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306

Iteration: 1
 Score = 63.9 bits (154), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 58/202 (28%), Positives = 90/202 (44%), Gaps = 48/202 (23%)
Query: 320 KLGQGGYGSVYKGK-LLDGSNVA---VKVLNDSKGNGKEFINEVASISRTS---HVNVVA 372
           ++G G YG+VYK +    G  VA   V+V N  +G     + EVA + R     H NVV 
Sbjct: 11  EIGVGAYGTVYKARDPHSGHFVALKSVRVPNGEEGLPISTVREVALLRRLEAFEHPNVVR 70
Query: 373 LLGFCL--RVAEELSSTI-------------------------------GIARGLEYLHL 399
           L+  C   R   E+  T+                                  RGL++LH 
Sbjct: 71  LMDVCATSRTDREIKVTLVFEHVDQDLRTYLDKAPPPGLPAETIKDLMRQFLRGLDFLHA 130
Query: 400 GCSTRILHFDIKPHNILLDEDFCPKISDFGLAKICNRKESIISMTGARGTVGYIAPEVFC 459
            C   I+H D+KP NIL+      K++DFGLA+I + + ++  +     T+ Y APEV  
Sbjct: 131 NC---IVHRDLKPENILVTSGGTVKLADFGLARIYSYQMALFPVV---VTLWYRAPEVLL 184
Query: 460 RNIGEVSYKSDVYNYGMMIFEM 481
           ++    +   D+++ G +  EM
Sbjct: 185 QST--YATPVDMWSVGCIFAEM 204

>pdb|2C30|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 6 Length = 321

Iteration: 1
 Score = 63.9 bits (154), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 58/208 (27%), Positives = 101/208 (48%), Gaps = 44/208 (21%)
Query: 309 DIKKMTNSFKYKLGQGGYGSV-YKGKLLDGSNVAVKVLNDSKGNGKEFI-NEVASISRTS 366
           D + + +S+  K+G+G  G V    +   G  VAVK+++  K   +E + NEV  +    
Sbjct: 42  DPRLLLDSY-VKIGEGSTGIVCLAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQ 100
Query: 367 HVNVV-------------ALLGFC-----------LRVAEELSSTI--GIARGLEYLHLG 400
           H NVV              L+ F            +R+ EE  +T+   + + L YLH  
Sbjct: 101 HFNVVEMYKSYLVGEELWVLMEFLQGGALTDIVSQVRLNEEQIATVCEAVLQALAYLH-- 158
Query: 401 CSTRILHFDIKPHNILLDEDFCPKISDFG----LAKICNRKESIISMTGARGTVGYIAPE 456
            +  ++H DIK  +ILL  D   K+SDFG    ++K   +++ ++      GT  ++APE
Sbjct: 159 -AQGVIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVPKRKXLV------GTPYWMAPE 211
Query: 457 VFCRNIGEVSYKSDVYNYGMMIFEMTGG 484
           V  R++   + + D+++ G+M+ EM  G
Sbjct: 212 VISRSL--YATEVDIWSLGIMVIEMVDG 237

>pdb|1BI8|A Chain A, Mechanism Of G1 Cyclin Dependent Kinase Inhibition From The Structures Cdk6-P19ink4d Inhibitor Complex Length = 326

Iteration: 1
 Score = 63.9 bits (154), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 59/205 (28%), Positives = 95/205 (46%), Gaps = 53/205 (25%)
Query: 320 KLGQGGYGSVYKGKLLD--GSNVA---VKVLNDSKGNGKEFINEVASISRTS---HVNVV 371
           ++G+G YG V+K + L   G  VA   V+V    +G     I EVA +       H NVV
Sbjct: 18  EIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVV 77
Query: 372 ALLGFCL---------------RVAEELSSTIG------------------IARGLEYLH 398
            L   C                 V ++L++ +                   + RGL++LH
Sbjct: 78  RLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLH 137
Query: 399 LGCSTRILHFDIKPHNILLDEDFCPKISDFGLAKICNRKESIISMTGARGTVGYIAPEVF 458
              S R++H D+KP NIL+      K++DFGLA+I + +   +++T    T+ Y APEV 
Sbjct: 138 ---SHRVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQ---MALTSVVVTLWYRAPEVL 191
Query: 459 CRNIGEVSYKS--DVYNYGMMIFEM 481
            ++    SY +  D+++ G +  EM
Sbjct: 192 LQS----SYATPVDLWSVGCIFAEM 212

>pdb|2P0C|A Chain A, Catalytic Domain Of The Proto-Oncogene Tyrosine-Protein Kina Length = 313

Iteration: 1
 Score = 63.9 bits (154), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 57/207 (27%), Positives = 93/207 (44%), Gaps = 50/207 (24%)
Query: 321 LGQGGYGSVYKGKLL--DGSN--VAVKVL---NDSKGNGKEFINEVASISRTSHVNVVAL 373
           LG+G +GSV +G L   DG++  VAVK +   N S+   +EF++E A +   SH NV+ L
Sbjct: 42  LGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSHPNVIRL 101
Query: 374 LGFCLRVAEE--------------------------------------LSSTIGIARGLE 395
           LG C+ ++ +                                      L   + IA G+E
Sbjct: 102 LGVCIEMSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALGME 161
Query: 396 YLHLGCSTRILHFDIKPHNILLDEDFCPKISDFGLAKICNRKESIISMTGARGTVGYIAP 455
           YL    +   LH D+   N +L +D    ++DFGL+K     +       A+  V +IA 
Sbjct: 162 YL---SNRNFLHRDLAARNCMLRDDMTVCVADFGLSKKIYSGDYYRQGRIAKMPVKWIAI 218
Query: 456 EVFCRNIGEVSYKSDVYNYGMMIFEMT 482
           E     +   + KSDV+ +G+ ++E+ 
Sbjct: 219 ESLADRV--YTSKSDVWAFGVTMWEIA 243

>pdb|2W99|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306

Iteration: 1
 Score = 63.5 bits (153), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 58/202 (28%), Positives = 90/202 (44%), Gaps = 48/202 (23%)
Query: 320 KLGQGGYGSVYKGK-LLDGSNVA---VKVLNDSKGNGKEFINEVASISRTS---HVNVVA 372
           ++G G YG+VYK +    G  VA   V+V N  +G     + EVA + R     H NVV 
Sbjct: 11  EIGVGAYGTVYKARDPHSGHFVALKSVRVPNGEEGLPISTVREVALLRRLEAFEHPNVVR 70
Query: 373 LLGFCL--RVAEELSSTI-------------------------------GIARGLEYLHL 399
           L+  C   R   E+  T+                                  RGL++LH 
Sbjct: 71  LMDVCATSRTDREIKVTLVFEHVDQDLRTYLDKAPPPGLPAETIKDLMRQFLRGLDFLHA 130
Query: 400 GCSTRILHFDIKPHNILLDEDFCPKISDFGLAKICNRKESIISMTGARGTVGYIAPEVFC 459
            C   I+H D+KP NIL+      K++DFGLA+I + +   +++     T+ Y APEV  
Sbjct: 131 NC---IVHRDLKPENILVTSGGTVKLADFGLARIYSYQ---MALAPVVVTLWYRAPEVLL 184
Query: 460 RNIGEVSYKSDVYNYGMMIFEM 481
           ++    +   D+++ G +  EM
Sbjct: 185 QST--YATPVDMWSVGCIFAEM 204

>pdb|3C4F|A Chain A, Fgfr Tyrosine Kinase Domain In Complex With 3-(3- Methoxybenzyl)-7-Azaindole Length = 302

Iteration: 1
 Score = 63.5 bits (153), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 56/215 (26%), Positives = 97/215 (45%), Gaps = 59/215 (27%)
Query: 321 LGQGGYGSVYKGKLL----DGSN----VAVKVL--NDSKGNGKEFINEVASISRT-SHVN 369
           LG+G +G V   + +    D  N    VAVK+L  + ++ +  + I+E+  +     H N
Sbjct: 21  LGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKN 80
Query: 370 VVALLGFCLR-------------------------------------VAEELSS------ 386
           ++ LLG C +                                       E+LSS      
Sbjct: 81  IINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYCYNPSHNPEEQLSSKDLVSC 140
Query: 387 TIGIARGLEYLHLGCSTRILHFDIKPHNILLDEDFCPKISDFGLAKICNRKESIISMTGA 446
              +ARG+EYL    S + +H D+   N+L+ ED   KI+DFGLA+  +  +     T  
Sbjct: 141 AYQVARGMEYL---ASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNG 197
Query: 447 RGTVGYIAPEVFCRNIGEVSYKSDVYNYGMMIFEM 481
           R  V ++APE     I   +++SDV+++G++++E+
Sbjct: 198 RLPVKWMAPEALFDRI--YTHQSDVWSFGVLLWEI 230

>pdb|1JOW|B Chain B, Crystal Structure Of A Complex Of Human Cdk6 And A Viral Cyclin Length = 308

Iteration: 1
 Score = 63.5 bits (153), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 59/205 (28%), Positives = 95/205 (46%), Gaps = 53/205 (25%)
Query: 320 KLGQGGYGSVYKGKLLD--GSNVA---VKVLNDSKGNGKEFINEVASISRTS---HVNVV 371
           ++G+G YG V+K + L   G  VA   V+V    +G     I EVA +       H NVV
Sbjct: 18  EIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVV 77
Query: 372 ALLGFCL---------------RVAEELSSTIG------------------IARGLEYLH 398
            L   C                 V ++L++ +                   + RGL++LH
Sbjct: 78  RLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLH 137
Query: 399 LGCSTRILHFDIKPHNILLDEDFCPKISDFGLAKICNRKESIISMTGARGTVGYIAPEVF 458
              S R++H D+KP NIL+      K++DFGLA+I + +   +++T    T+ Y APEV 
Sbjct: 138 ---SHRVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQ---MALTSVVVTLWYRAPEVL 191
Query: 459 CRNIGEVSYKS--DVYNYGMMIFEM 481
            ++    SY +  D+++ G +  EM
Sbjct: 192 LQS----SYATPVDLWSVGCIFAEM 212

>pdb|3PWY|A Chain A, Crystal Structure Of An Extender (Spd28345)-Modified Human Pdk1 Complex 2 Length = 311

Iteration: 1
 Score = 63.5 bits (153), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 35/98 (35%), Positives = 52/98 (53%), Gaps = 5/98 (5%)
Query: 387 TIGIARGLEYLHLGCSTRILHFDIKPHNILLDEDFCPKISDFGLAKICNRKESIISMTGA 446
           T  I   LEYLH      I+H D+KP NILL+ED   +I+DFG AK+ + +         
Sbjct: 138 TAEIVSALEYLH---GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSF 194
Query: 447 RGTVGYIAPEVFCRNIGEVSYKSDVYNYGMMIFEMTGG 484
            GT  Y++PE+        S  SD++  G +I+++  G
Sbjct: 195 VGTAQYVSPELLTEK--SASKSSDLWALGCIIYQLVAG 230

>pdb|3RHX|B Chain B, Crystal Structure Of The Catalytic Domain Of Fgfr1 Kinase In Complex With Arq 069 Length = 306

Iteration: 1
 Score = 63.5 bits (153), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 56/215 (26%), Positives = 97/215 (45%), Gaps = 59/215 (27%)
Query: 321 LGQGGYGSVYKGKLL----DGSN----VAVKVL--NDSKGNGKEFINEVASISRT-SHVN 369
           LG+G +G V   + +    D  N    VAVK+L  + ++ +  + I+E+  +     H N
Sbjct: 25  LGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKN 84
Query: 370 VVALLGFCLR-------------------------------------VAEELSS------ 386
           ++ LLG C +                                       E+LSS      
Sbjct: 85  IINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSC 144
Query: 387 TIGIARGLEYLHLGCSTRILHFDIKPHNILLDEDFCPKISDFGLAKICNRKESIISMTGA 446
              +ARG+EYL    S + +H D+   N+L+ ED   KI+DFGLA+  +  +     T  
Sbjct: 145 AYQVARGMEYL---ASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNG 201
Query: 447 RGTVGYIAPEVFCRNIGEVSYKSDVYNYGMMIFEM 481
           R  V ++APE     I   +++SDV+++G++++E+
Sbjct: 202 RLPVKWMAPEALFDRI--YTHQSDVWSFGVLLWEI 234

>pdb|3MPM|A Chain A, Lck Complexed With A Pyrazolopyrimidine Length = 267

Iteration: 1
 Score = 63.5 bits (153), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 54/220 (24%), Positives = 94/220 (42%), Gaps = 41/220 (18%)
Query: 309 DIKKMTNSFKYKLGQGGYGSVYKGKLLDGSNVAVKVLNDSKGNGKEFINEVASISRTSHV 368
           ++ + T     +LG G +G V+ G     + VAVK L     +   F+ E   + +  H 
Sbjct: 5   EVPRETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPDAFLAEANLMKQLQHQ 64
Query: 369 NVVALL----------------------------GFCLRVAEELSSTIGIARGLEYLHLG 400
            +V L                             G  L + + L     IA G+ ++   
Sbjct: 65  RLVRLYAVVTQEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIE-- 122
Query: 401 CSTRILHFDIKPHNILLDEDFCPKISDFGLAKICNRKESIISMTGARGTVGYIAPEVFCR 460
                +H +++  NIL+ +    KI+DFGLA++    E   +  GA+  + + APE    
Sbjct: 123 -ERNYIHRNLRAANILVSDTLSCKIADFGLARLIEDNE-YTAREGAKFPIKWTAPEAI-- 178
Query: 461 NIGEVSYKSDVYNYGMMIFEM-TGGR------KNVDVVDN 493
           N G  + KSDV+++G+++ E+ T GR       N +V+ N
Sbjct: 179 NYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQN 218

>pdb|3NUP|A Chain A, Cdk6 (Monomeric) In Complex With Inhibitor Length = 307

Iteration: 1
 Score = 63.5 bits (153), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 59/205 (28%), Positives = 95/205 (46%), Gaps = 53/205 (25%)
Query: 320 KLGQGGYGSVYKGKLLD--GSNVA---VKVLNDSKGNGKEFINEVASISRTS---HVNVV 371
           ++G+G YG V+K + L   G  VA   V+V    +G     I EVA +       H NVV
Sbjct: 18  EIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVV 77
Query: 372 ALLGFCL---------------RVAEELSSTIG------------------IARGLEYLH 398
            L   C                 V ++L++ +                   + RGL++LH
Sbjct: 78  RLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLH 137
Query: 399 LGCSTRILHFDIKPHNILLDEDFCPKISDFGLAKICNRKESIISMTGARGTVGYIAPEVF 458
              S R++H D+KP NIL+      K++DFGLA+I + +   +++T    T+ Y APEV 
Sbjct: 138 ---SHRVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQ---MALTSVVVTLWYRAPEVL 191
Query: 459 CRNIGEVSYKS--DVYNYGMMIFEM 481
            ++    SY +  D+++ G +  EM
Sbjct: 192 LQS----SYATPVDLWSVGCIFAEM 212

>pdb|3KXX|A Chain A, Structure Of The Mutant Fibroblast Growth Factor Receptor 1 Length = 317

Iteration: 1
 Score = 63.5 bits (153), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 56/215 (26%), Positives = 97/215 (45%), Gaps = 59/215 (27%)
Query: 321 LGQGGYGSVYKGKLL----DGSN----VAVKVL--NDSKGNGKEFINEVASISRT-SHVN 369
           LG+G +G V   + +    D  N    VAVK+L  + ++ +  + I+E+  +     H N
Sbjct: 36  LGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKN 95
Query: 370 VVALLGFCLR-------------------------------------VAEELSS------ 386
           ++ LLG C +                                       E+LSS      
Sbjct: 96  IINLLGACTQDGPLYVIVEYASKGNLREYLQAREPPGLEYSYNPSHNPEEQLSSKDLVSC 155
Query: 387 TIGIARGLEYLHLGCSTRILHFDIKPHNILLDEDFCPKISDFGLAKICNRKESIISMTGA 446
              +ARG+EYL    S + +H D+   N+L+ ED   KI+DFGLA+  +  +     T  
Sbjct: 156 AYQVARGMEYL---ASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNG 212
Query: 447 RGTVGYIAPEVFCRNIGEVSYKSDVYNYGMMIFEM 481
           R  V ++APE     I   +++SDV+++G++++E+
Sbjct: 213 RLPVKWMAPEALFDRI--YTHQSDVWSFGVLLWEI 245

>pdb|1FGK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of Fibroblast Growth Factor Receptor 1 Length = 310

Iteration: 1
 Score = 63.5 bits (153), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 56/215 (26%), Positives = 97/215 (45%), Gaps = 59/215 (27%)
Query: 321 LGQGGYGSVYKGKLL----DGSN----VAVKVL--NDSKGNGKEFINEVASISRT-SHVN 369
           LG+G +G V   + +    D  N    VAVK+L  + ++ +  + I+E+  +     H N
Sbjct: 29  LGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKN 88
Query: 370 VVALLGFCLR-------------------------------------VAEELSS------ 386
           ++ LLG C +                                       E+LSS      
Sbjct: 89  IINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSC 148
Query: 387 TIGIARGLEYLHLGCSTRILHFDIKPHNILLDEDFCPKISDFGLAKICNRKESIISMTGA 446
              +ARG+EYL    S + +H D+   N+L+ ED   KI+DFGLA+  +  +     T  
Sbjct: 149 AYQVARGMEYL---ASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNG 205
Query: 447 RGTVGYIAPEVFCRNIGEVSYKSDVYNYGMMIFEM 481
           R  V ++APE     I   +++SDV+++G++++E+
Sbjct: 206 RLPVKWMAPEALFDRI--YTHQSDVWSFGVLLWEI 238

>pdb|4F63|A Chain A, Crystal Structure Of Human Fibroblast Growth Factor Receptor 1 Kinase Domain In Complex With Compound 1 Length = 309

Iteration: 1
 Score = 63.5 bits (153), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 56/215 (26%), Positives = 97/215 (45%), Gaps = 59/215 (27%)
Query: 321 LGQGGYGSVYKGKLL----DGSN----VAVKVL--NDSKGNGKEFINEVASISRT-SHVN 369
           LG+G +G V   + +    D  N    VAVK+L  + ++ +  + I+E+  +     H N
Sbjct: 28  LGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKN 87
Query: 370 VVALLGFCLR-------------------------------------VAEELSS------ 386
           ++ LLG C +                                       E+LSS      
Sbjct: 88  IINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSC 147
Query: 387 TIGIARGLEYLHLGCSTRILHFDIKPHNILLDEDFCPKISDFGLAKICNRKESIISMTGA 446
              +ARG+EYL    S + +H D+   N+L+ ED   KI+DFGLA+  +  +     T  
Sbjct: 148 AYQVARGMEYL---ASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNG 204
Query: 447 RGTVGYIAPEVFCRNIGEVSYKSDVYNYGMMIFEM 481
           R  V ++APE     I   +++SDV+++G++++E+
Sbjct: 205 RLPVKWMAPEALFDRI--YTHQSDVWSFGVLLWEI 237

>pdb|3COM|A Chain A, Crystal Structure Of Mst1 Kinase Length = 314

Iteration: 1
 Score = 63.2 bits (152), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 61/200 (30%), Positives = 94/200 (47%), Gaps = 47/200 (23%)
Query: 320 KLGQGGYGSVYKGKLLD-GSNVAVKVLNDSKGNGKEFINEVASISRTSHVNVVALLG--- 375
           KLG+G YGSVYK    + G  VA+K +   + + +E I E++ + +    +VV   G   
Sbjct: 36  KLGEGSYGSVYKAIHKETGQIVAIKQV-PVESDLQEIIKEISIMQQCDSPHVVKYYGSYF 94
Query: 376 ----------FC----------LR--------VAEELSSTIGIARGLEYLHLGCSTRILH 407
                     +C          LR        +A  L ST+   +GLEYLH     R +H
Sbjct: 95  KNTDLWIVMEYCGAGSVSDIIRLRNKTLTEDEIATILQSTL---KGLEYLHF---MRKIH 148
Query: 408 FDIKPHNILLDEDFCPKISDFGLAKICNRKESIISMTGARGTVGYIAPEVFCRNIGEVSY 467
            DIK  NILL+ +   K++DFG+A      + +       GT  ++APEV    I E+ Y
Sbjct: 149 RDIKAGNILLNTEGHAKLADFGVA--GQLTDXMAKRNXVIGTPFWMAPEV----IQEIGY 202
Query: 468 K--SDVYNYGMMIFEMTGGR 485
              +D+++ G+   EM  G+
Sbjct: 203 NCVADIWSLGITAIEMAEGK 222

>pdb|1GZ8|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Inhibitor 2-Amino-6-(3'-Methyl-2'-Oxo)butoxypurine Length = 299

Iteration: 1
 Score = 63.2 bits (152), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 56/200 (28%), Positives = 93/200 (46%), Gaps = 42/200 (21%)
Query: 320 KLGQGGYGSVYKGK-LLDGSNVAVKVL---NDSKGNGKEFINEVASISRTSHVNVVALLG 375
           K+G+G YG VYK +  L G  VA+K +    +++G     I E++ +   +H N+V LL 
Sbjct: 10  KIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLD 69
Query: 376 FC----------------LRVAEELSSTIGIA------------RGLEYLHLGCSTRILH 407
                             L+   + S+  GI             +GL + H   S R+LH
Sbjct: 70  VIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCH---SHRVLH 126
Query: 408 FDIKPHNILLDEDFCPKISDFGLAKICNRKESIISMTGARGTVGYIAPEVFCRNIGEVSY 467
            D+KP N+L++ +   K++DFGLA+       + + T    T+ Y APE+    +G   Y
Sbjct: 127 RDLKPQNLLINTEGAIKLADFGLARAFG--VPVRTYTHEVVTLWYRAPEIL---LGXKYY 181
Query: 468 KS--DVYNYGMMIFEMTGGR 485
            +  D+++ G +  EM   R
Sbjct: 182 STAVDIWSLGCIFAEMVTRR 201

>pdb|1GII|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Cdk4 Inhibitor Length = 298

Iteration: 1
 Score = 63.2 bits (152), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 56/200 (28%), Positives = 92/200 (46%), Gaps = 42/200 (21%)
Query: 320 KLGQGGYGSVYKGK-LLDGSNVAVKVL---NDSKGNGKEFINEVASISRTSHVNVVALLG 375
           K+G+G YG VYK +  L G  VA+K +    +++G     I E++ +   +H N+V LL 
Sbjct: 9   KIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLD 68
Query: 376 FC----------------LRVAEELSSTIGIA------------RGLEYLHLGCSTRILH 407
                             L+   + S+  GI             +GL + H   S R+LH
Sbjct: 69  VIHTENKLYLVFEHVHQDLKTFMDASALTGIPLPLIKSYLFQLLQGLAFCH---SHRVLH 125
Query: 408 FDIKPHNILLDEDFCPKISDFGLAKICNRKESIISMTGARGTVGYIAPEVF--CRNIGEV 465
            D+KP N+L++ +   K++DFGLA+       + + T    T+ Y APE+   C+     
Sbjct: 126 RDLKPQNLLINTEGAIKLADFGLARAFG--VPVRTYTHEVVTLWYRAPEILLGCKY---Y 180
Query: 466 SYKSDVYNYGMMIFEMTGGR 485
           S   D+++ G +  EM   R
Sbjct: 181 STAVDIWSLGCIFAEMVTRR 200

>pdb|3JS2|A Chain A, Crystal Structure Of Minimal Kinase Domain Of Fibroblast Growth Factor Receptor 1 In Complex With 5-(2-Thienyl) Nicotinic Acid Length = 317

Iteration: 1
 Score = 63.2 bits (152), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 56/215 (26%), Positives = 97/215 (45%), Gaps = 59/215 (27%)
Query: 321 LGQGGYGSVYKGKLL----DGSN----VAVKVL--NDSKGNGKEFINEVASISRT-SHVN 369
           LG+G +G V   + +    D  N    VAVK+L  + ++ +  + I+E+  +     H N
Sbjct: 36  LGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKN 95
Query: 370 VVALLGFCLR-------------------------------------VAEELSS------ 386
           ++ LLG C +                                       E+LSS      
Sbjct: 96  IINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSC 155
Query: 387 TIGIARGLEYLHLGCSTRILHFDIKPHNILLDEDFCPKISDFGLAKICNRKESIISMTGA 446
              +ARG+EYL    S + +H D+   N+L+ ED   KI+DFGLA+  +  +     T  
Sbjct: 156 AYQVARGMEYL---ASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNG 212
Query: 447 RGTVGYIAPEVFCRNIGEVSYKSDVYNYGMMIFEM 481
           R  V ++APE     I   +++SDV+++G++++E+
Sbjct: 213 RLPVKWMAPEALFDRI--YTHQSDVWSFGVLLWEI 245

>pdb|4ERW|A Chain A, Cdk2 In Complex With Staurosporine Length = 306

Iteration: 1
 Score = 63.2 bits (152), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 56/200 (28%), Positives = 93/200 (46%), Gaps = 42/200 (21%)
Query: 320 KLGQGGYGSVYKGK-LLDGSNVAVKVL---NDSKGNGKEFINEVASISRTSHVNVVALLG 375
           K+G+G YG VYK +  L G  VA+K +    +++G     I E++ +   +H N+V LL 
Sbjct: 17  KIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLD 76
Query: 376 FC----------------LRVAEELSSTIGIA------------RGLEYLHLGCSTRILH 407
                             L+   + S+  GI             +GL + H   S R+LH
Sbjct: 77  VIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCH---SHRVLH 133
Query: 408 FDIKPHNILLDEDFCPKISDFGLAKICNRKESIISMTGARGTVGYIAPEVFCRNIGEVSY 467
            D+KP N+L++ +   K++DFGLA+       + + T    T+ Y APE+    +G   Y
Sbjct: 134 RDLKPQNLLINTEGAIKLADFGLARAFG--VPVRTYTHEVVTLWYRAPEIL---LGXKYY 188
Query: 468 KS--DVYNYGMMIFEMTGGR 485
            +  D+++ G +  EM   R
Sbjct: 189 STAVDIWSLGCIFAEMVTRR 208

>pdb|2X7F|A Chain A, Crystal Structure Of The Kinase Domain Of Human Traf2- And Nck-Interacting Kinase With Wee1chk1 Inhibitor Length = 326

Iteration: 1
 Score = 63.2 bits (152), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 58/208 (27%), Positives = 93/208 (44%), Gaps = 53/208 (25%)
Query: 321 LGQGGYGSVYKGKLLD-GSNVAVKVLNDSKGNGKEFINEVASISRTSHVNVVA------- 372
           +G G YG VYKG+ +  G   A+KV++ +    +E   E+  + + SH   +A       
Sbjct: 32  VGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDEEEEIKQEINMLKKYSHHRNIATYYGAFI 91
Query: 373 -------------LLGFCL--RVAEELSSTIG--------------IARGLEYLHLGCST 403
                        ++ FC    V + + +T G              I RGL +LH     
Sbjct: 92  KKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLH---QH 148
Query: 404 RILHFDIKPHNILLDEDFCPKISDFG----LAKICNRKESIISMTGARGTVGYIAPEVF- 458
           +++H DIK  N+LL E+   K+ DFG    L +   R+ + I      GT  ++APEV  
Sbjct: 149 KVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRRNTFI------GTPYWMAPEVIA 202
Query: 459 CRNIGEVSY--KSDVYNYGMMIFEMTGG 484
           C    + +Y  KSD+++ G+   EM  G
Sbjct: 203 CDENPDATYDFKSDLWSLGITAIEMAEG 230

>pdb|3GQL|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326

Iteration: 1
 Score = 63.2 bits (152), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 56/215 (26%), Positives = 97/215 (45%), Gaps = 59/215 (27%)
Query: 321 LGQGGYGSVYKGKLL----DGSN----VAVKVL--NDSKGNGKEFINEVASISRT-SHVN 369
           LG+G +G V   + +    D  N    VAVK+L  + ++ +  + I+E+  +     H N
Sbjct: 36  LGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKN 95
Query: 370 VVALLGFCLR-------------------------------------VAEELSS------ 386
           ++ LLG C +                                       E+LSS      
Sbjct: 96  IINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYCYNPSHNPEEQLSSKDLVSC 155
Query: 387 TIGIARGLEYLHLGCSTRILHFDIKPHNILLDEDFCPKISDFGLAKICNRKESIISMTGA 446
              +ARG+EYL    S + +H D+   N+L+ ED   KI+DFGLA+  +  +     T  
Sbjct: 156 AYQVARGMEYL---ASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNG 212
Query: 447 RGTVGYIAPEVFCRNIGEVSYKSDVYNYGMMIFEM 481
           R  V ++APE     I   +++SDV+++G++++E+
Sbjct: 213 RLPVKWMAPEALFDRI--YTHQSDVWSFGVLLWEI 245

>pdb|2W96|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306

Iteration: 1
 Score = 63.2 bits (152), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 58/202 (28%), Positives = 90/202 (44%), Gaps = 48/202 (23%)
Query: 320 KLGQGGYGSVYKGK-LLDGSNVA---VKVLNDSKGNGKEFINEVASISRTS---HVNVVA 372
           ++G G YG+VYK +    G  VA   V+V N  +G     + EVA + R     H NVV 
Sbjct: 11  EIGVGAYGTVYKARDPHSGHFVALKSVRVPNGEEGLPISTVREVALLRRLEAFEHPNVVR 70
Query: 373 LLGFCL--RVAEELSSTI-------------------------------GIARGLEYLHL 399
           L+  C   R   E+  T+                                  RGL++LH 
Sbjct: 71  LMDVCATSRTDREIKVTLVFEHVDQDLRTYLDKAPPPGLPAETIKDLMRQFLRGLDFLHA 130
Query: 400 GCSTRILHFDIKPHNILLDEDFCPKISDFGLAKICNRKESIISMTGARGTVGYIAPEVFC 459
            C   I+H D+KP NIL+      K++DFGLA+I + +   +++     T+ Y APEV  
Sbjct: 131 NC---IVHRDLKPENILVTSGGTVKLADFGLARIYSYQ---MALDPVVVTLWYRAPEVLL 184
Query: 460 RNIGEVSYKSDVYNYGMMIFEM 481
           ++    +   D+++ G +  EM
Sbjct: 185 QST--YATPVDMWSVGCIFAEM 204

>pdb|3G51|A Chain A, Structural Diversity Of The Active Conformation Of The N- Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 Length = 325

Iteration: 1
 Score = 63.2 bits (152), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 63/201 (31%), Positives = 97/201 (48%), Gaps = 47/201 (23%)
Query: 321 LGQGGYGSVYKGKLLDGSNV----AVKVLNDSKGNGKEFIN---EVASISRTSHVNVVAL 373
           LGQG +G V+  K + GS+     A+KVL  +    ++ +    E   +   +H  +V L
Sbjct: 32  LGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDILVEVNHPFIVKL 91
Query: 374 -------------LGFC------LRVAEELSST--------IGIARGLEYLHLGCSTRIL 406
                        L F        R+++E+  T          +A  L++LH   S  I+
Sbjct: 92  HYAFQTEGKLYLILDFLRGGDLFTRLSKEVMFTEEDVKFYLAELALALDHLH---SLGII 148
Query: 407 HFDIKPHNILLDEDFCPKISDFGLAKICNRKESIISMTGAR---GTVGYIAPEVFCRNIG 463
           + D+KP NILLDE+   K++DFGL+     KESI     A    GTV Y+APEV  R   
Sbjct: 149 YRDLKPENILLDEEGHIKLTDFGLS-----KESIDHEKKAYSFCGTVEYMAPEVVNRRGH 203
Query: 464 EVSYKSDVYNYGMMIFEMTGG 484
             S  +D +++G+++FEM  G
Sbjct: 204 TQS--ADWWSFGVLMFEMLTG 222

>pdb|4FR4|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase 32a (Yank1) Length = 384

Iteration: 1
 Score = 62.8 bits (151), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 36/98 (36%), Positives = 55/98 (56%), Gaps = 7/98 (7%)
Query: 390 IARGLEYLHLGCSTRILHFDIKPHNILLDEDFCPKISDFGLAKICNRKESIISMTGARGT 449
           +   L+YL    + RI+H D+KP NILLDE     I+DF +A +  R+  I +M    GT
Sbjct: 124 LVMALDYLQ---NQRIIHRDMKPDNILLDEHGHVHITDFNIAAMLPRETQITTMA---GT 177
Query: 450 VGYIAPEVFCRNIGE-VSYKSDVYNYGMMIFEMTGGRK 486
             Y+APE+F    G   S+  D ++ G+  +E+  GR+
Sbjct: 178 KPYMAPEMFSSRKGAGYSFAVDWWSLGVTAYELLRGRR 215

>pdb|3TT0|A Chain A, Co-Structure Of Fibroblast Growth Factor Receptor 1 Kinase Domain With 3-(2,6-Dichloro-3, 5-Dimethoxy-Phenyl)-1-{6-[4-(4-Ethyl-Piperazin-1- Yl)-Phenylamino]-Pyrimidin-4-Yl}-1-Methyl-Urea (Bgj398) Length = 382

Iteration: 1
 Score = 62.8 bits (151), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 56/215 (26%), Positives = 97/215 (45%), Gaps = 59/215 (27%)
Query: 321 LGQGGYGSVYKGKLL----DGSN----VAVKVL--NDSKGNGKEFINEVASISRT-SHVN 369
           LG+G +G V   + +    D  N    VAVK+L  + ++ +  + I+E+  +     H N
Sbjct: 77  LGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKN 136
Query: 370 VVALLGFCLR-------------------------------------VAEELSS------ 386
           ++ LLG C +                                       E+LSS      
Sbjct: 137 IINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSC 196
Query: 387 TIGIARGLEYLHLGCSTRILHFDIKPHNILLDEDFCPKISDFGLAKICNRKESIISMTGA 446
              +ARG+EYL    S + +H D+   N+L+ ED   KI+DFGLA+  +  +     T  
Sbjct: 197 AYQVARGMEYL---ASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNG 253
Query: 447 RGTVGYIAPEVFCRNIGEVSYKSDVYNYGMMIFEM 481
           R  V ++APE     I   +++SDV+++G++++E+
Sbjct: 254 RLPVKWMAPEALFDRI--YTHQSDVWSFGVLLWEI 286

>pdb|1H1W|A Chain A, High Resolution Crystal Structure Of The Human Pdk1 Catalytic Domain Length = 289

Iteration: 1
 Score = 62.4 bits (150), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 59/208 (28%), Positives = 89/208 (42%), Gaps = 39/208 (18%)
Query: 311 KKMTNSFKYK--LGQGGYGSVYKGKLLDGS-NVAVKVLNDS---KGNGKEFIN-EVASIS 363
           KK    FK+   LG+G + +V   + L  S   A+K+L      K N   ++  E   +S
Sbjct: 6   KKRPEDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMS 65
Query: 364 RTSHVNVVALL------------------GFCLRVAEELSS---------TIGIARGLEY 396
           R  H   V L                   G  L+   ++ S         T  I   LEY
Sbjct: 66  RLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEY 125
Query: 397 LHLGCSTRILHFDIKPHNILLDEDFCPKISDFGLAKICNRKESIISMTGARGTVGYIAPE 456
           LH      I+H D+KP NILL+ED   +I+DFG AK+ + +          GT  Y++PE
Sbjct: 126 LH---GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPE 182
Query: 457 VFCRNIGEVSYKSDVYNYGMMIFEMTGG 484
           +        S  SD++  G +I+++  G
Sbjct: 183 LLTEKSACKS--SDLWALGCIIYQLVAG 208

>pdb|4EL9|A Chain A, Structure Of N-Terminal Kinase Domain Of Rsk2 With Afzelin Length = 305

Iteration: 1
 Score = 62.4 bits (150), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 63/201 (31%), Positives = 97/201 (48%), Gaps = 47/201 (23%)
Query: 321 LGQGGYGSVYKGKLLDGSNV----AVKVLNDSKGNGKEFIN---EVASISRTSHVNVVAL 373
           LGQG +G V+  K + GS+     A+KVL  +    ++ +    E   +   +H  +V L
Sbjct: 33  LGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDILVEVNHPFIVKL 92
Query: 374 -------------LGFC------LRVAEELSST--------IGIARGLEYLHLGCSTRIL 406
                        L F        R+++E+  T          +A  L++LH   S  I+
Sbjct: 93  HYAFQTEGKLYLILDFLRGGDLFTRLSKEVMFTEEDVKFYLAELALALDHLH---SLGII 149
Query: 407 HFDIKPHNILLDEDFCPKISDFGLAKICNRKESIISMTGAR---GTVGYIAPEVFCRNIG 463
           + D+KP NILLDE+   K++DFGL+     KESI     A    GTV Y+APEV  R   
Sbjct: 150 YRDLKPENILLDEEGHIKLTDFGLS-----KESIDHEKKAYSFCGTVEYMAPEVVNRRGH 204
Query: 464 EVSYKSDVYNYGMMIFEMTGG 484
             S  +D +++G+++FEM  G
Sbjct: 205 TQS--ADWWSFGVLMFEMLTG 223

>pdb|3UBD|A Chain A, Structure Of N-Terminal Domain Of Rsk2 Kinase In Complex With Flavonoid Glycoside Sl0101 Length = 304

Iteration: 1
 Score = 62.4 bits (150), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 63/201 (31%), Positives = 97/201 (48%), Gaps = 47/201 (23%)
Query: 321 LGQGGYGSVYKGKLLDGSNV----AVKVLNDSKGNGKEFIN---EVASISRTSHVNVVAL 373
           LGQG +G V+  K + GS+     A+KVL  +    ++ +    E   +   +H  +V L
Sbjct: 32  LGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDILVEVNHPFIVKL 91
Query: 374 -------------LGFC------LRVAEELSST--------IGIARGLEYLHLGCSTRIL 406
                        L F        R+++E+  T          +A  L++LH   S  I+
Sbjct: 92  HYAFQTEGKLYLILDFLRGGDLFTRLSKEVMFTEEDVKFYLAELALALDHLH---SLGII 148
Query: 407 HFDIKPHNILLDEDFCPKISDFGLAKICNRKESIISMTGAR---GTVGYIAPEVFCRNIG 463
           + D+KP NILLDE+   K++DFGL+     KESI     A    GTV Y+APEV  R   
Sbjct: 149 YRDLKPENILLDEEGHIKLTDFGLS-----KESIDHEKKAYSFCGTVEYMAPEVVNRRGH 203
Query: 464 EVSYKSDVYNYGMMIFEMTGG 484
             S  +D +++G+++FEM  G
Sbjct: 204 TQS--ADWWSFGVLMFEMLTG 222

>pdb|1OIT|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-dependent Kinase Inhibitors Identified Through Structure-based Hybridisation Length = 299

Iteration: 1
 Score = 62.4 bits (150), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 56/200 (28%), Positives = 92/200 (46%), Gaps = 42/200 (21%)
Query: 320 KLGQGGYGSVYKGK-LLDGSNVAVKVL---NDSKGNGKEFINEVASISRTSHVNVVALLG 375
           K+G+G YG VYK +  L G  VA+K +    +++G     I E++ +   +H N+V LL 
Sbjct: 10  KIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLD 69
Query: 376 FC----------------LRVAEELSSTIGIA------------RGLEYLHLGCSTRILH 407
                             L+   + S+  GI             +GL + H   S R+LH
Sbjct: 70  VIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLSFCH---SHRVLH 126
Query: 408 FDIKPHNILLDEDFCPKISDFGLAKICNRKESIISMTGARGTVGYIAPEVF--CRNIGEV 465
            D+KP N+L++ +   K++DFGLA+       + + T    T+ Y APE+   C+     
Sbjct: 127 RDLKPQNLLINTEGAIKLADFGLARAFG--VPVRTYTHEVVTLWYRAPEILLGCKY---Y 181
Query: 466 SYKSDVYNYGMMIFEMTGGR 485
           S   D+++ G +  EM   R
Sbjct: 182 STAVDIWSLGCIFAEMVTRR 201

>pdb|1PF8|A Chain A, Crystal Structure Of Human Cyclin-dependent Kinase 2 Complexed With A Nucleoside Inhibitor Length = 298

Iteration: 1
 Score = 62.4 bits (150), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 56/200 (28%), Positives = 92/200 (46%), Gaps = 42/200 (21%)
Query: 320 KLGQGGYGSVYKGK-LLDGSNVAVKVL---NDSKGNGKEFINEVASISRTSHVNVVALLG 375
           K+G+G YG VYK +  L G  VA+K +    +++G     I E++ +   +H N+V LL 
Sbjct: 9   KIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLD 68
Query: 376 FC----------------LRVAEELSSTIGIA------------RGLEYLHLGCSTRILH 407
                             L+   + S+  GI             +GL + H   S R+LH
Sbjct: 69  VIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCH---SHRVLH 125
Query: 408 FDIKPHNILLDEDFCPKISDFGLAKICNRKESIISMTGARGTVGYIAPEVF--CRNIGEV 465
            D+KP N+L++ +   K++DFGLA+       + + T    T+ Y APE+   C+     
Sbjct: 126 RDLKPQNLLINTEGAIKLADFGLARAFG--VPVRTYTHEVVTLWYRAPEILLGCKY---Y 180
Query: 466 SYKSDVYNYGMMIFEMTGGR 485
           S   D+++ G +  EM   R
Sbjct: 181 STAVDIWSLGCIFAEMVTRR 200

>pdb|2HK5|A Chain A, Hck Kinase In Complex With Lck Targetted Inhibitor Pg- 1009247 Length = 270

Iteration: 1
 Score = 62.4 bits (150), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 51/206 (24%), Positives = 89/206 (43%), Gaps = 35/206 (16%)
Query: 309 DIKKMTNSFKYKLGQGGYGSVYKGKLLDGSNVAVKVLNDSKGNGKEFINEVASISRTSHV 368
           +I + +   + KLG G +G V+       + VAVK +     + + F+ E   +    H 
Sbjct: 11  EIPRESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPGSMSVEAFLAEANVMKTLQHD 70
Query: 369 NVVALLGFCLR--------------VAEELSSTIG--------------IARGLEYLHLG 400
            +V L     +              + + L S  G              IA G+ ++   
Sbjct: 71  KLVKLHAVVTKEPIYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIE-- 128
Query: 401 CSTRILHFDIKPHNILLDEDFCPKISDFGLAKICNRKESIISMTGARGTVGYIAPEVFCR 460
                +H D++  NIL+      KI+DFGLA++    E   +  GA+  + + APE    
Sbjct: 129 -QRNYIHRDLRAANILVSASLVCKIADFGLARVIEDNE-YTAREGAKFPIKWTAPEAI-- 184
Query: 461 NIGEVSYKSDVYNYGMMIFEM-TGGR 485
           N G  + KSDV+++G+++ E+ T GR
Sbjct: 185 NFGSFTIKSDVWSFGILLMEIVTYGR 210

>pdb|4A07|A Chain A, Human Pdk1 Kinase Domain In Complex With Allosteric Activator Ps171 Bound To The Pif-Pocket Length = 311

Iteration: 1
 Score = 62.4 bits (150), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 35/98 (35%), Positives = 52/98 (53%), Gaps = 5/98 (5%)
Query: 387 TIGIARGLEYLHLGCSTRILHFDIKPHNILLDEDFCPKISDFGLAKICNRKESIISMTGA 446
           T  I   LEYLH      I+H D+KP NILL+ED   +I+DFG AK+ + +         
Sbjct: 138 TAEIVSALEYLH---GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXF 194
Query: 447 RGTVGYIAPEVFCRNIGEVSYKSDVYNYGMMIFEMTGG 484
            GT  Y++PE+        S  SD++  G +I+++  G
Sbjct: 195 VGTAQYVSPELLTEKSAXKS--SDLWALGCIIYQLVAG 230

>pdb|2W17|A Chain A, Cdk2 In Complex With The Imidazole Pyrimidine Amide, Compound (S)-8b Length = 299

Iteration: 1
 Score = 62.4 bits (150), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 56/200 (28%), Positives = 92/200 (46%), Gaps = 42/200 (21%)
Query: 320 KLGQGGYGSVYKGK-LLDGSNVAVKVL---NDSKGNGKEFINEVASISRTSHVNVVALLG 375
           K+G+G YG VYK +  L G  VA+K +    +++G     I E++ +   +H N+V LL 
Sbjct: 10  KIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLD 69
Query: 376 FC----------------LRVAEELSSTIGIA------------RGLEYLHLGCSTRILH 407
                             L+   + S+  GI             +GL + H   S R+LH
Sbjct: 70  VIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCH---SHRVLH 126
Query: 408 FDIKPHNILLDEDFCPKISDFGLAKICNRKESIISMTGARGTVGYIAPEVF--CRNIGEV 465
            D+KP N+L++ +   K++DFGLA+       + + T    T+ Y APE+   C+     
Sbjct: 127 RDLKPQNLLINTEGAIKLADFGLARAFG--VPVRTYTHEVVTLWYRAPEILLGCKY---Y 181
Query: 466 SYKSDVYNYGMMIFEMTGGR 485
           S   D+++ G +  EM   R
Sbjct: 182 STAVDIWSLGCIFAEMVTRR 201

>pdb|1FIN|A Chain A, Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = 298

Iteration: 1
 Score = 62.4 bits (150), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 56/200 (28%), Positives = 92/200 (46%), Gaps = 42/200 (21%)
Query: 320 KLGQGGYGSVYKGK-LLDGSNVAVKVL---NDSKGNGKEFINEVASISRTSHVNVVALLG 375
           K+G+G YG VYK +  L G  VA+K +    +++G     I E++ +   +H N+V LL 
Sbjct: 9   KIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLD 68
Query: 376 FC----------------LRVAEELSSTIGIA------------RGLEYLHLGCSTRILH 407
                             L+   + S+  GI             +GL + H   S R+LH
Sbjct: 69  VIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCH---SHRVLH 125
Query: 408 FDIKPHNILLDEDFCPKISDFGLAKICNRKESIISMTGARGTVGYIAPEVF--CRNIGEV 465
            D+KP N+L++ +   K++DFGLA+       + + T    T+ Y APE+   C+     
Sbjct: 126 RDLKPQNLLINTEGAIKLADFGLARAFG--VPVRTYTHEVVTLWYRAPEILLGCKY---Y 180
Query: 466 SYKSDVYNYGMMIFEMTGGR 485
           S   D+++ G +  EM   R
Sbjct: 181 STAVDIWSLGCIFAEMVTRR 200

>pdb|1VYW|A Chain A, Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = 309

Iteration: 1
 Score = 62.4 bits (150), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 56/200 (28%), Positives = 92/200 (46%), Gaps = 42/200 (21%)
Query: 320 KLGQGGYGSVYKGK-LLDGSNVAVKVL---NDSKGNGKEFINEVASISRTSHVNVVALLG 375
           K+G+G YG VYK +  L G  VA+K +    +++G     I E++ +   +H N+V LL 
Sbjct: 14  KIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLD 73
Query: 376 FC----------------LRVAEELSSTIGIA------------RGLEYLHLGCSTRILH 407
                             L+   + S+  GI             +GL + H   S R+LH
Sbjct: 74  VIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCH---SHRVLH 130
Query: 408 FDIKPHNILLDEDFCPKISDFGLAKICNRKESIISMTGARGTVGYIAPEVF--CRNIGEV 465
            D+KP N+L++ +   K++DFGLA+       + + T    T+ Y APE+   C+     
Sbjct: 131 RDLKPQNLLINTEGAIKLADFGLARAFG--VPVRTYTHEVVTLWYRAPEILLGCKY---Y 185
Query: 466 SYKSDVYNYGMMIFEMTGGR 485
           S   D+++ G +  EM   R
Sbjct: 186 STAVDIWSLGCIFAEMVTRR 205

>pdb|1UU9|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Bim-3 Length = 286

Iteration: 1
 Score = 62.4 bits (150), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 59/208 (28%), Positives = 89/208 (42%), Gaps = 39/208 (18%)
Query: 311 KKMTNSFKYK--LGQGGYGSVYKGKLLDGS-NVAVKVLNDS---KGNGKEFIN-EVASIS 363
           KK    FK+   LG+G + +V   + L  S   A+K+L      K N   ++  E   +S
Sbjct: 5   KKRPEDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMS 64
Query: 364 RTSHVNVVALL------------------GFCLRVAEELSS---------TIGIARGLEY 396
           R  H   V L                   G  L+   ++ S         T  I   LEY
Sbjct: 65  RLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEY 124
Query: 397 LHLGCSTRILHFDIKPHNILLDEDFCPKISDFGLAKICNRKESIISMTGARGTVGYIAPE 456
           LH      I+H D+KP NILL+ED   +I+DFG AK+ + +          GT  Y++PE
Sbjct: 125 LH---GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPE 181
Query: 457 VFCRNIGEVSYKSDVYNYGMMIFEMTGG 484
           +        S  SD++  G +I+++  G
Sbjct: 182 LLTEKSACKS--SDLWALGCIIYQLVAG 207

>pdb|3PXF|A Chain A, Cdk2 In Complex With Two Molecules Of 8-Anilino-1-Naphthalene Sulfonate Length = 306

Iteration: 1
 Score = 62.4 bits (150), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 56/200 (28%), Positives = 92/200 (46%), Gaps = 42/200 (21%)
Query: 320 KLGQGGYGSVYKGK-LLDGSNVAVKVL---NDSKGNGKEFINEVASISRTSHVNVVALLG 375
           K+G+G YG VYK +  L G  VA+K +    +++G     I E++ +   +H N+V LL 
Sbjct: 17  KIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLD 76
Query: 376 FC----------------LRVAEELSSTIGIA------------RGLEYLHLGCSTRILH 407
                             L+   + S+  GI             +GL + H   S R+LH
Sbjct: 77  VIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCH---SHRVLH 133
Query: 408 FDIKPHNILLDEDFCPKISDFGLAKICNRKESIISMTGARGTVGYIAPEVF--CRNIGEV 465
            D+KP N+L++ +   K++DFGLA+       + + T    T+ Y APE+   C+     
Sbjct: 134 RDLKPQNLLINTEGAIKLADFGLARAFG--VPVRTYTHEVVTLWYRAPEILLGCKY---Y 188
Query: 466 SYKSDVYNYGMMIFEMTGGR 485
           S   D+++ G +  EM   R
Sbjct: 189 STAVDIWSLGCIFAEMVTRR 208

>pdb|1MQB|A Chain A, Crystal Structure Of Ephrin A2 (Epha2) Receptor Protein Kinase Length = 333

Iteration: 1
 Score = 62.0 bits (149), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 51/203 (25%), Positives = 94/203 (46%), Gaps = 42/203 (20%)
Query: 321 LGQGGYGSVYKGKLLDGSN-----VAVKVLND--SKGNGKEFINEVASISRTSHVNVVAL 373
           +G G +G VYKG L   S      VA+K L    ++    +F+ E   + + SH N++ L
Sbjct: 52  IGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRL 111
Query: 374 LGFCLR----------------------------VAEELSSTIGIARGLEYLHLGCSTRI 405
            G   +                            V + +    GIA G++YL    +   
Sbjct: 112 EGVISKYKPMMIITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAGMKYL---ANMNY 168
Query: 406 LHFDIKPHNILLDEDFCPKISDFGLAKIC-NRKESIISMTGARGTVGYIAPEVFCRNIGE 464
           +H D+   NIL++ +   K+SDFGL+++  +  E+  + +G +  + + APE       +
Sbjct: 169 VHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGGKIPIRWTAPEAISYR--K 226
Query: 465 VSYKSDVYNYGMMIFE-MTGGRK 486
            +  SDV+++G++++E MT G +
Sbjct: 227 FTSASDVWSFGIVMWEVMTYGER 249

>pdb|3PJ8|A Chain A, Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]pyrimidine Bioisostere Of Roscovitine Length = 299

Iteration: 1
 Score = 62.0 bits (149), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 56/200 (28%), Positives = 92/200 (46%), Gaps = 42/200 (21%)
Query: 320 KLGQGGYGSVYKGK-LLDGSNVAVKVL---NDSKGNGKEFINEVASISRTSHVNVVALLG 375
           K+G+G YG VYK +  L G  VA+K +    +++G     I E++ +   +H N+V LL 
Sbjct: 10  KIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLD 69
Query: 376 FC----------------LRVAEELSSTIGIA------------RGLEYLHLGCSTRILH 407
                             L+   + S+  GI             +GL + H   S R+LH
Sbjct: 70  VIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCH---SHRVLH 126
Query: 408 FDIKPHNILLDEDFCPKISDFGLAKICNRKESIISMTGARGTVGYIAPEVF--CRNIGEV 465
            D+KP N+L++ +   K++DFGLA+       + + T    T+ Y APE+   C+     
Sbjct: 127 RDLKPQNLLINTEGAIKLADFGLARAFG--VPVRTYTHEVVTLWYRAPEILLGCKY---Y 181
Query: 466 SYKSDVYNYGMMIFEMTGGR 485
           S   D+++ G +  EM   R
Sbjct: 182 STAVDIWSLGCIFAEMVTRR 201

>pdb|3NUS|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fragment8 Length = 286

Iteration: 1
 Score = 62.0 bits (149), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 59/208 (28%), Positives = 89/208 (42%), Gaps = 39/208 (18%)
Query: 311 KKMTNSFKYK--LGQGGYGSVYKGKLLDGS-NVAVKVLNDS---KGNGKEFIN-EVASIS 363
           KK    FK+   LG+G + +V   + L  S   A+K+L      K N   ++  E   +S
Sbjct: 4   KKRPEDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMS 63
Query: 364 RTSHVNVVALL------------------GFCLRVAEELSS---------TIGIARGLEY 396
           R  H   V L                   G  L+   ++ S         T  I   LEY
Sbjct: 64  RLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEY 123
Query: 397 LHLGCSTRILHFDIKPHNILLDEDFCPKISDFGLAKICNRKESIISMTGARGTVGYIAPE 456
           LH      I+H D+KP NILL+ED   +I+DFG AK+ + +          GT  Y++PE
Sbjct: 124 LH---GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPE 180
Query: 457 VFCRNIGEVSYKSDVYNYGMMIFEMTGG 484
           +        S  SD++  G +I+++  G
Sbjct: 181 LLTEKSACKS--SDLWALGCIIYQLVAG 206

>pdb|1Z5M|A Chain A, Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrrolidinylcarbonyl) Amino]phenyl]amino]-4-pyrimidinyl]amino]propyl]-2,2- Dimethylpropanediamide Complexed With Human Pdk1 Length = 286

Iteration: 1
 Score = 62.0 bits (149), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 59/208 (28%), Positives = 89/208 (42%), Gaps = 39/208 (18%)
Query: 311 KKMTNSFKYK--LGQGGYGSVYKGKLLDGS-NVAVKVLNDS---KGNGKEFIN-EVASIS 363
           KK    FK+   LG+G + +V   + L  S   A+K+L      K N   ++  E   +S
Sbjct: 3   KKRPEDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMS 62
Query: 364 RTSHVNVVALL------------------GFCLRVAEELSS---------TIGIARGLEY 396
           R  H   V L                   G  L+   ++ S         T  I   LEY
Sbjct: 63  RLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEY 122
Query: 397 LHLGCSTRILHFDIKPHNILLDEDFCPKISDFGLAKICNRKESIISMTGARGTVGYIAPE 456
           LH      I+H D+KP NILL+ED   +I+DFG AK+ + +          GT  Y++PE
Sbjct: 123 LH---GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPE 179
Query: 457 VFCRNIGEVSYKSDVYNYGMMIFEMTGG 484
           +        S  SD++  G +I+++  G
Sbjct: 180 LLTEKSACKS--SDLWALGCIIYQLVAG 205

>pdb|3EZR|A Chain A, Cdk-2 With Indazole Inhibitor 17 Bound At Its Active Site Length = 300

Iteration: 1
 Score = 62.0 bits (149), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 56/200 (28%), Positives = 92/200 (46%), Gaps = 42/200 (21%)
Query: 320 KLGQGGYGSVYKGK-LLDGSNVAVKVL---NDSKGNGKEFINEVASISRTSHVNVVALLG 375
           K+G+G YG VYK +  L G  VA+K +    +++G     I E++ +   +H N+V LL 
Sbjct: 11  KIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLD 70
Query: 376 FC----------------LRVAEELSSTIGIA------------RGLEYLHLGCSTRILH 407
                             L+   + S+  GI             +GL + H   S R+LH
Sbjct: 71  VIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCH---SHRVLH 127
Query: 408 FDIKPHNILLDEDFCPKISDFGLAKICNRKESIISMTGARGTVGYIAPEVF--CRNIGEV 465
            D+KP N+L++ +   K++DFGLA+       + + T    T+ Y APE+   C+     
Sbjct: 128 RDLKPQNLLINTEGAIKLADFGLARAFG--VPVRTYTHEVVTLWYRAPEILLGCKY---Y 182
Query: 466 SYKSDVYNYGMMIFEMTGGR 485
           S   D+++ G +  EM   R
Sbjct: 183 STAVDIWSLGCIFAEMVTRR 202

>pdb|1QCF|A Chain A, Crystal Structure Of Hck In Complex With A Src Family- Selective Tyrosine Kinase Inhibitor Length = 454

Iteration: 1
 Score = 62.0 bits (149), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 51/206 (24%), Positives = 89/206 (43%), Gaps = 35/206 (16%)
Query: 309 DIKKMTNSFKYKLGQGGYGSVYKGKLLDGSNVAVKVLNDSKGNGKEFINEVASISRTSHV 368
           +I + +   + KLG G +G V+       + VAVK +     + + F+ E   +    H 
Sbjct: 184 EIPRESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPGSMSVEAFLAEANVMKTLQHD 243
Query: 369 NVVALLGFCLR--------------VAEELSSTIG--------------IARGLEYLHLG 400
            +V L     +              + + L S  G              IA G+ ++   
Sbjct: 244 KLVKLHAVVTKEPIYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIE-- 301
Query: 401 CSTRILHFDIKPHNILLDEDFCPKISDFGLAKICNRKESIISMTGARGTVGYIAPEVFCR 460
                +H D++  NIL+      KI+DFGLA++    E   +  GA+  + + APE    
Sbjct: 302 -QRNYIHRDLRAANILVSASLVCKIADFGLARVIEDNE-YTAREGAKFPIKWTAPEAI-- 357
Query: 461 NIGEVSYKSDVYNYGMMIFEM-TGGR 485
           N G  + KSDV+++G+++ E+ T GR
Sbjct: 358 NFGSFTIKSDVWSFGILLMEIVTYGR 383

>pdb|2BAQ|A Chain A, P38alpha Bound To Ro3201195 Length = 365

Iteration: 1
 Score = 61.6 bits (148), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 61/202 (30%), Positives = 89/202 (44%), Gaps = 48/202 (23%)
Query: 321 LGQGGYGSV---YKGKLLDGSNVAVKVLN---DSKGNGKEFINEVASISRTSHVNVVALL 374
           +G G YGSV   +  K   G  VAVK L+    S  + K    E+  +    H NV+ LL
Sbjct: 35  IGSGAYGSVCAAFDTK--TGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLL 92
Query: 375 GFCL--RVAEE------LSSTIG-----------------------IARGLEYLHLGCST 403
                 R  EE      ++  +G                       I RGL+Y+H   S 
Sbjct: 93  DVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIH---SA 149
Query: 404 RILHFDIKPHNILLDEDFCPKISDFGLAKICNRKESIISMTGARGTVGYIAPEVFCRNIG 463
            I+H D+KP N+ ++ED   KI DFGLA+  + +     MTG   T  Y APE+   N  
Sbjct: 150 DIIHRDLKPSNLAVNEDXELKILDFGLARHTDDE-----MTGYVATRWYRAPEIML-NWM 203
Query: 464 EVSYKSDVYNYGMMIFEMTGGR 485
             +   D+++ G ++ E+  GR
Sbjct: 204 HYNQTVDIWSVGCIMAELLTGR 225

>pdb|4GT4|A Chain A, Structure Of Unliganded, Inactive Ror2 Kinase Domain Length = 308

Iteration: 1
 Score = 61.6 bits (148), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 65/247 (26%), Positives = 102/247 (41%), Gaps = 68/247 (27%)
Query: 308 ADIKKMTNS---FKYKLGQGGYGSVYKGKLL------DGSNVAVKVLNDSKGNG---KEF 355
           A +K+++ S   F  +LG+  +G VYKG L           VA+K L D K  G   +EF
Sbjct: 18  AKLKEISLSAVRFMEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKD-KAEGPLREEF 76
Query: 356 INEVASISRTSHVNVVALLGFCLR--------------------VAEELSSTIG------ 389
            +E    +R  H NVV LLG   +                    V     S +G      
Sbjct: 77  RHEAMLRARLQHPNVVCLLGVVTKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDR 136
Query: 390 -----------------IARGLEYLHLGCSTRILHFDIKPHNILLDEDFCPKISDFGLAK 432
                            IA G+EYL    S  ++H D+   N+L+ +    KISD GL +
Sbjct: 137 TVKSALEPPDFVHLVAQIAAGMEYL---SSHHVVHKDLATRNVLVYDKLNVKISDLGLFR 193
Query: 433 ICNRKESIISMTGARGTVGYIAPEVFCRNIGEVSYKSDVYNYGMMIFEMTG-------GR 485
                +    +  +   + ++APE      G+ S  SD+++YG++++E+         G 
Sbjct: 194 EVYAADYYKLLGNSLLPIRWMAPEAIM--YGKFSIDSDIWSYGVVLWEVFSYGLQPYCGY 251
Query: 486 KNVDVVD 492
            N DVV+
Sbjct: 252 SNQDVVE 258

>pdb|2BIY|A Chain A, Structure Of Pdk1-S241a Mutant Kinase Domain Length = 310

Iteration: 1
 Score = 61.6 bits (148), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 35/98 (35%), Positives = 52/98 (53%), Gaps = 5/98 (5%)
Query: 387 TIGIARGLEYLHLGCSTRILHFDIKPHNILLDEDFCPKISDFGLAKICNRKESIISMTGA 446
           T  I   LEYLH      I+H D+KP NILL+ED   +I+DFG AK+ + +         
Sbjct: 136 TAEIVSALEYLH---GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANAF 192
Query: 447 RGTVGYIAPEVFCRNIGEVSYKSDVYNYGMMIFEMTGG 484
            GT  Y++PE+        S  SD++  G +I+++  G
Sbjct: 193 VGTAQYVSPELLTEKSACKS--SDLWALGCIIYQLVAG 228

>pdb|3D83|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360

Iteration: 1
 Score = 61.2 bits (147), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 61/202 (30%), Positives = 89/202 (44%), Gaps = 48/202 (23%)
Query: 321 LGQGGYGSV---YKGKLLDGSNVAVKVLN---DSKGNGKEFINEVASISRTSHVNVVALL 374
           +G G YGSV   +  K   G  VAVK L+    S  + K    E+  +    H NV+ LL
Sbjct: 30  VGSGAYGSVCAAFDTK--TGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLL 87
Query: 375 GFCL--RVAEE------LSSTIG-----------------------IARGLEYLHLGCST 403
                 R  EE      ++  +G                       I RGL+Y+H   S 
Sbjct: 88  DVFTPARSLEEFNDVYLVTHLMGADLNNIVKXQKLTDDHVQFLIYQILRGLKYIH---SA 144
Query: 404 RILHFDIKPHNILLDEDFCPKISDFGLAKICNRKESIISMTGARGTVGYIAPEVFCRNIG 463
            I+H D+KP N+ ++ED   KI DFGLA+  + +     MTG   T  Y APE+   N  
Sbjct: 145 DIIHRDLKPSNLAVNEDXELKILDFGLARHTDDE-----MTGYVATRWYRAPEIML-NWM 198
Query: 464 EVSYKSDVYNYGMMIFEMTGGR 485
             +   D+++ G ++ E+  GR
Sbjct: 199 HYNQTVDIWSVGCIMAELLTGR 220

>pdb|1OIR|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-Dependent Kinase Inhibitors Identified Through Structure-Based Hybridisation Length = 299

Iteration: 1
 Score = 61.2 bits (147), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 55/200 (27%), Positives = 92/200 (46%), Gaps = 42/200 (21%)
Query: 320 KLGQGGYGSVYKGK-LLDGSNVA---VKVLNDSKGNGKEFINEVASISRTSHVNVVALLG 375
           K+G+G YG VYK +  L G  VA   +++  +++G     I E++ +   +H N+V LL 
Sbjct: 10  KIGEGTYGVVYKARNKLTGEVVALXKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLD 69
Query: 376 FC----------------LRVAEELSSTIGIA------------RGLEYLHLGCSTRILH 407
                             L+   + S+  GI             +GL + H   S R+LH
Sbjct: 70  VIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCH---SHRVLH 126
Query: 408 FDIKPHNILLDEDFCPKISDFGLAKICNRKESIISMTGARGTVGYIAPEVF--CRNIGEV 465
            D+KP N+L++ +   K++DFGLA+       + + T    T+ Y APE+   C+     
Sbjct: 127 RDLKPQNLLINTEGAIKLADFGLARAFG--VPVRTYTHEVVTLWYRAPEILLGCKY---Y 181
Query: 466 SYKSDVYNYGMMIFEMTGGR 485
           S   D+++ G +  EM   R
Sbjct: 182 STAVDIWSLGCIFAEMVTRR 201

>pdb|1H01|A Chain A, Cdk2 In Complex With A Disubstituted 2, 4-Bis Anilino Pyrimidine Cdk4 Inhibitor Length = 298

Iteration: 1
 Score = 61.2 bits (147), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 55/200 (27%), Positives = 92/200 (46%), Gaps = 42/200 (21%)
Query: 320 KLGQGGYGSVYKGK-LLDGSNVA---VKVLNDSKGNGKEFINEVASISRTSHVNVVALLG 375
           K+G+G YG VYK +  L G  VA   +++  +++G     I E++ +   +H N+V LL 
Sbjct: 9   KIGEGTYGVVYKARNKLTGEVVALXKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLD 68
Query: 376 FC----------------LRVAEELSSTIGIA------------RGLEYLHLGCSTRILH 407
                             L+   + S+  GI             +GL + H   S R+LH
Sbjct: 69  VIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCH---SHRVLH 125
Query: 408 FDIKPHNILLDEDFCPKISDFGLAKICNRKESIISMTGARGTVGYIAPEVF--CRNIGEV 465
            D+KP N+L++ +   K++DFGLA+       + + T    T+ Y APE+   C+     
Sbjct: 126 RDLKPQNLLINTEGAIKLADFGLARAFG--VPVRTYTHEVVTLWYRAPEILLGCKY---Y 180
Query: 466 SYKSDVYNYGMMIFEMTGGR 485
           S   D+++ G +  EM   R
Sbjct: 181 STAVDIWSLGCIFAEMVTRR 200

>pdb|2BAL|A Chain A, P38alpha Map Kinase Bound To Pyrazoloamine Length = 365

Iteration: 1
 Score = 61.2 bits (147), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 61/202 (30%), Positives = 89/202 (44%), Gaps = 48/202 (23%)
Query: 321 LGQGGYGSV---YKGKLLDGSNVAVKVLN---DSKGNGKEFINEVASISRTSHVNVVALL 374
           +G G YGSV   +  K   G  VAVK L+    S  + K    E+  +    H NV+ LL
Sbjct: 35  VGSGAYGSVCAAFDTK--TGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLL 92
Query: 375 GFCL--RVAEE------LSSTIG-----------------------IARGLEYLHLGCST 403
                 R  EE      ++  +G                       I RGL+Y+H   S 
Sbjct: 93  DVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIH---SA 149
Query: 404 RILHFDIKPHNILLDEDFCPKISDFGLAKICNRKESIISMTGARGTVGYIAPEVFCRNIG 463
            I+H D+KP N+ ++ED   KI DFGLA+  + +     MTG   T  Y APE+   N  
Sbjct: 150 DIIHRDLKPSNLAVNEDXELKILDFGLARHTDDE-----MTGYVATRWYRAPEIML-NWM 203
Query: 464 EVSYKSDVYNYGMMIFEMTGGR 485
             +   D+++ G ++ E+  GR
Sbjct: 204 HYNQTVDIWSVGCIMAELLTGR 225

>pdb|3ORX|A Chain A, Pdk1 Mutant Bound To Allosteric Disulfide Fragment Inhibitor 1f8 Length = 316

Iteration: 1
 Score = 61.2 bits (147), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 56/197 (28%), Positives = 84/197 (42%), Gaps = 39/197 (19%)
Query: 321 LGQGGYGSVYKGKLLDGS-NVAVKVLNDS---KGNGKEFIN-EVASISRTSHVNVVALLG 375
           LG+G + +V   + L  S   A+K+L      K N   ++  E   +SR  H   V L  
Sbjct: 45  LGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLY- 103
Query: 376 FCLRVAEELS----------------------------STIGIARGLEYLHLGCSTRILH 407
           FC +  E+L                              T  I   LEYLH      I+H
Sbjct: 104 FCFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLH---GKGIIH 160
Query: 408 FDIKPHNILLDEDFCPKISDFGLAKICNRKESIISMTGARGTVGYIAPEVFCRNIGEVSY 467
            D+KP NILL+ED   +I+DFG AK+ + +          GT  Y++PE+        S 
Sbjct: 161 RDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLTEKSACKS- 219
Query: 468 KSDVYNYGMMIFEMTGG 484
            SD++  G +I+++  G
Sbjct: 220 -SDLWALGCIIYQLVAG 235

>pdb|3E92|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biaryl Amide Inhibitor Length = 371

Iteration: 1
 Score = 60.8 bits (146), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 60/202 (29%), Positives = 86/202 (42%), Gaps = 48/202 (23%)
Query: 321 LGQGGYGSV---YKGKLLDGSNVAVKVLN---DSKGNGKEFINEVASISRTSHVNVVALL 374
           +G G YGSV   +  K   G  VAVK L+    S  + K    E+  +    H NV+ LL
Sbjct: 41  VGSGAYGSVCAAFDTK--TGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLL 98
Query: 375 GFCL--RVAEELSSTI-----------------------------GIARGLEYLHLGCST 403
                 R  EE +                                 I RGL+Y+H   S 
Sbjct: 99  DVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIH---SA 155
Query: 404 RILHFDIKPHNILLDEDFCPKISDFGLAKICNRKESIISMTGARGTVGYIAPEVFCRNIG 463
            I+H D+KP N+ ++ED   KI DFGLA+  + +     MTG   T  Y APE+   N  
Sbjct: 156 DIIHRDLKPSNLAVNEDXELKILDFGLARHTDDE-----MTGYVATRWYRAPEIML-NWM 209
Query: 464 EVSYKSDVYNYGMMIFEMTGGR 485
             +   D+++ G ++ E+  GR
Sbjct: 210 HYNQTVDIWSVGCIMAELLTGR 231

>pdb|2IW6|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A Complexed With A Bisanilinopyrimidine Inhibitor Length = 302

Iteration: 1
 Score = 60.8 bits (146), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 55/200 (27%), Positives = 91/200 (45%), Gaps = 42/200 (21%)
Query: 320 KLGQGGYGSVYKGK-LLDGSNVAVKVL---NDSKGNGKEFINEVASISRTSHVNVVALLG 375
           K+G+G YG VYK +  L G  VA+K +    +++G     I E++ +   +H N+V LL 
Sbjct: 13  KIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLD 72
Query: 376 FC----------------LRVAEELSSTIGIA------------RGLEYLHLGCSTRILH 407
                             L+   + S+  GI             +GL + H   S R+LH
Sbjct: 73  VIHTENKLYLVFEFLHQDLKTFMDASALTGIPLPLIKSYLFQLLQGLAFCH---SHRVLH 129
Query: 408 FDIKPHNILLDEDFCPKISDFGLAKICNRKESIISMTGARGTVGYIAPEVF--CRNIGEV 465
            D+KP N+L++ +   K++DFGLA+       + +      T+ Y APE+   C+     
Sbjct: 130 RDLKPQNLLINTEGAIKLADFGLARAFG--VPVRTYXHEVVTLWYRAPEILLGCKY---Y 184
Query: 466 SYKSDVYNYGMMIFEMTGGR 485
           S   D+++ G +  EM   R
Sbjct: 185 STAVDIWSLGCIFAEMVTRR 204

>pdb|2R7B|A Chain A, Crystal Structure Of The Phosphoinositide-Dependent Kinase- 1 (Pdk-1)catalytic Domain Bound To A Dibenzonaphthyridine Inhibitor Length = 312

Iteration: 1
 Score = 60.8 bits (146), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 35/98 (35%), Positives = 52/98 (53%), Gaps = 5/98 (5%)
Query: 387 TIGIARGLEYLHLGCSTRILHFDIKPHNILLDEDFCPKISDFGLAKICNRKESIISMTGA 446
           T  I   LEYLH      I+H D+KP NILL+ED   +I+DFG AK+ + +         
Sbjct: 139 TAEIVSALEYLH---GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSF 195
Query: 447 RGTVGYIAPEVFCRNIGEVSYKSDVYNYGMMIFEMTGG 484
            GT  Y++PE+        S  SD++  G +I+++  G
Sbjct: 196 VGTAQYVSPELLTEKSACKS--SDLWALGCIIYQLVAG 231

>pdb|2J7T|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Su11274 Length = 302

Iteration: 1
 Score = 60.8 bits (146), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 55/198 (27%), Positives = 96/198 (48%), Gaps = 42/198 (21%)
Query: 320 KLGQGGYGSVYKGKLLD-GSNVAVKVLN-DSKGNGKEFINEVASISRTSHVNVVALLG-- 375
           +LG G +G VYK K  + G+  A KV+   S+   +++I E+  ++   H  +V LLG  
Sbjct: 26  ELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYIVEIEILATCDHPYIVKLLGAY 85
Query: 376 -----------FCLRVAEELSSTIGIARG-------------LEYLHLGCSTRILHFDIK 411
                      FC   A + +  + + RG             LE L+   S RI+H D+K
Sbjct: 86  YHDGKLWIMIEFCPGGAVD-AIMLELDRGLTEPQIQVVCRQMLEALNFLHSKRIIHRDLK 144
Query: 412 PHNILLDEDFCPKISDFGLA----KICNRKESIISMTGARGTVGYIAPE-VFCRNIGEV- 465
             N+L+  +   +++DFG++    K   +++S I      GT  ++APE V C  + +  
Sbjct: 145 AGNVLMTLEGDIRLADFGVSAKNLKTLQKRDSFI------GTPYWMAPEVVMCETMKDTP 198
Query: 466 -SYKSDVYNYGMMIFEMT 482
             YK+D+++ G+ + EM 
Sbjct: 199 YDYKADIWSLGITLIEMA 216

>pdb|2Y8O|A Chain A, Crystal Structure Of Human P38alpha Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score = 60.8 bits (146), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 61/202 (30%), Positives = 89/202 (44%), Gaps = 48/202 (23%)
Query: 321 LGQGGYGSV---YKGKLLDGSNVAVKVLN---DSKGNGKEFINEVASISRTSHVNVVALL 374
           +G G YGSV   +  K   G  VAVK L+    S  + K    E+  +    H NV+ LL
Sbjct: 32  VGSGAYGSVCAAFDTK--TGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLL 89
Query: 375 GFCL--RVAEE------LSSTIG-----------------------IARGLEYLHLGCST 403
                 R  EE      ++  +G                       I RGL+Y+H   S 
Sbjct: 90  DVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIH---SA 146
Query: 404 RILHFDIKPHNILLDEDFCPKISDFGLAKICNRKESIISMTGARGTVGYIAPEVFCRNIG 463
            I+H D+KP N+ ++ED   KI DFGLA+  + +     MTG   T  Y APE+   N  
Sbjct: 147 DIIHRDLKPSNLAVNEDSELKILDFGLARHTDDE-----MTGYVATRWYRAPEIML-NWM 200
Query: 464 EVSYKSDVYNYGMMIFEMTGGR 485
             +   D+++ G ++ E+  GR
Sbjct: 201 HYNQTVDIWSVGCIMAELLTGR 222

>pdb|1OVE|A Chain A, The Structure Of P38 Alpha In Complex With A Dihydroquinolinone Length = 366

Iteration: 1
 Score = 60.8 bits (146), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 61/202 (30%), Positives = 89/202 (44%), Gaps = 48/202 (23%)
Query: 321 LGQGGYGSV---YKGKLLDGSNVAVKVLN---DSKGNGKEFINEVASISRTSHVNVVALL 374
           +G G YGSV   +  K   G  VAVK L+    S  + K    E+  +    H NV+ LL
Sbjct: 36  VGSGAYGSVCAAFDTK--TGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLL 93
Query: 375 GFCL--RVAEE------LSSTIG-----------------------IARGLEYLHLGCST 403
                 R  EE      ++  +G                       I RGL+Y+H   S 
Sbjct: 94  DVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIH---SA 150
Query: 404 RILHFDIKPHNILLDEDFCPKISDFGLAKICNRKESIISMTGARGTVGYIAPEVFCRNIG 463
            I+H D+KP N+ ++ED   KI DFGLA+  + +     MTG   T  Y APE+   N  
Sbjct: 151 DIIHRDLKPSNLAVNEDSELKILDFGLARHTDDE-----MTGYVATRWYRAPEIML-NWM 204
Query: 464 EVSYKSDVYNYGMMIFEMTGGR 485
             +   D+++ G ++ E+  GR
Sbjct: 205 HYNQTVDIWSVGCIMAELLTGR 226

>pdb|2OZA|B Chain B, Structure Of P38alpha Complex Length = 366

Iteration: 1
 Score = 60.8 bits (146), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 61/202 (30%), Positives = 89/202 (44%), Gaps = 48/202 (23%)
Query: 321 LGQGGYGSV---YKGKLLDGSNVAVKVLN---DSKGNGKEFINEVASISRTSHVNVVALL 374
           +G G YGSV   +  K   G  VAVK L+    S  + K    E+  +    H NV+ LL
Sbjct: 36  VGSGAYGSVCAAFDTK--TGHRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLL 93
Query: 375 GFCL--RVAEE------LSSTIG-----------------------IARGLEYLHLGCST 403
                 R  EE      ++  +G                       I RGL+Y+H   S 
Sbjct: 94  DVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIH---SA 150
Query: 404 RILHFDIKPHNILLDEDFCPKISDFGLAKICNRKESIISMTGARGTVGYIAPEVFCRNIG 463
            I+H D+KP N+ ++ED   KI DFGLA+  + +     MTG   T  Y APE+   N  
Sbjct: 151 DIIHRDLKPSNLAVNEDCELKILDFGLARHTDDE-----MTGYVATRWYRAPEIML-NWM 204
Query: 464 EVSYKSDVYNYGMMIFEMTGGR 485
             +   D+++ G ++ E+  GR
Sbjct: 205 HYNQTVDIWSVGCIMAELLTGR 226

>pdb|3OHT|A Chain A, Crystal Structure Of Salmo Salar P38alpha Length = 389

Iteration: 1
 Score = 60.8 bits (146), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 58/202 (28%), Positives = 88/202 (43%), Gaps = 48/202 (23%)
Query: 321 LGQGGYGSV---YKGKLLDGSNVAVKVLN---DSKGNGKEFINEVASISRTSHVNVVALL 374
           +G G YGSV   Y  K   G  +AVK L+    S  + K    E+  +    H NV+ LL
Sbjct: 59  VGSGAYGSVCSSYDVK--SGLKIAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLL 116
Query: 375 GF-----------------------------CLRVAEELSSTI--GIARGLEYLHLGCST 403
                                          C ++ ++    +   I RGL+Y+H   S 
Sbjct: 117 DVFTPATSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIH---SA 173
Query: 404 RILHFDIKPHNILLDEDFCPKISDFGLAKICNRKESIISMTGARGTVGYIAPEVFCRNIG 463
            I+H D+KP N+ ++ED   KI DFGLA+  + +     MTG   T  Y APE+   N  
Sbjct: 174 DIIHRDLKPSNLAVNEDCELKILDFGLARHTDDE-----MTGYVATRWYRAPEIML-NWM 227
Query: 464 EVSYKSDVYNYGMMIFEMTGGR 485
             +   D+++ G ++ E+  GR
Sbjct: 228 HYNMTVDIWSVGCIMAELLTGR 249

>pdb|3NAX|A Chain A, Pdk1 In Complex With Inhibitor Mp7 Length = 311

Iteration: 1
 Score = 60.8 bits (146), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 35/98 (35%), Positives = 52/98 (53%), Gaps = 5/98 (5%)
Query: 387 TIGIARGLEYLHLGCSTRILHFDIKPHNILLDEDFCPKISDFGLAKICNRKESIISMTGA 446
           T  I   LEYLH      I+H D+KP NILL+ED   +I+DFG AK+ + +         
Sbjct: 135 TAEIVSALEYLH---GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSF 191
Query: 447 RGTVGYIAPEVFCRNIGEVSYKSDVYNYGMMIFEMTGG 484
            GT  Y++PE+        S  SD++  G +I+++  G
Sbjct: 192 VGTAQYVSPELLTEKSACKS--SDLWALGCIIYQLVAG 227

>pdb|3P4K|A Chain A, The Third Conformation Of P38a Map Kinase Observed In Phosphorylated P38a And In Solution Length = 370

Iteration: 1
 Score = 60.8 bits (146), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 60/202 (29%), Positives = 86/202 (42%), Gaps = 48/202 (23%)
Query: 321 LGQGGYGSV---YKGKLLDGSNVAVKVLN---DSKGNGKEFINEVASISRTSHVNVVALL 374
           +G G YGSV   +  K   G  VAVK L+    S  + K    E+  +    H NV+ LL
Sbjct: 40  VGSGAYGSVCAAFDTK--TGHRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLL 97
Query: 375 GFCL--RVAEELSSTI-----------------------------GIARGLEYLHLGCST 403
                 R  EE +                                 I RGL+Y+H   S 
Sbjct: 98  DVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIH---SA 154
Query: 404 RILHFDIKPHNILLDEDFCPKISDFGLAKICNRKESIISMTGARGTVGYIAPEVFCRNIG 463
            I+H D+KP N+ ++ED   KI DFGLA+  + +     MTG   T  Y APE+   N  
Sbjct: 155 DIIHRDLKPSNLAVNEDCELKILDFGLARHTDDE-----MTGYVATRWYRAPEIML-NWM 208
Query: 464 EVSYKSDVYNYGMMIFEMTGGR 485
             +   D+++ G ++ E+  GR
Sbjct: 209 HYNQTVDIWSVGCIMAELLTGR 230

>pdb|1LEW|A Chain A, Crystal Structure Of Map Kinase P38 Complexed To The Docking Site On Its Nuclear Substrate Mef2a Length = 360

Iteration: 1
 Score = 60.8 bits (146), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 60/202 (29%), Positives = 86/202 (42%), Gaps = 48/202 (23%)
Query: 321 LGQGGYGSV---YKGKLLDGSNVAVKVLN---DSKGNGKEFINEVASISRTSHVNVVALL 374
           +G G YGSV   +  K   G  VAVK L+    S  + K    E+  +    H NV+ LL
Sbjct: 30  VGSGAYGSVCAAFDTK--TGHRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLL 87
Query: 375 GFCL--RVAEELSSTI-----------------------------GIARGLEYLHLGCST 403
                 R  EE +                                 I RGL+Y+H   S 
Sbjct: 88  DVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIH---SA 144
Query: 404 RILHFDIKPHNILLDEDFCPKISDFGLAKICNRKESIISMTGARGTVGYIAPEVFCRNIG 463
            I+H D+KP N+ ++ED   KI DFGLA+  + +     MTG   T  Y APE+   N  
Sbjct: 145 DIIHRDLKPSNLAVNEDCELKILDFGLARHTDDE-----MTGYVATRWYRAPEIML-NWM 198
Query: 464 EVSYKSDVYNYGMMIFEMTGGR 485
             +   D+++ G ++ E+  GR
Sbjct: 199 HYNQTVDIWSVGCIMAELLTGR 220

>pdb|4BC6|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Novel Bosutinib Isoform 1, Previously Thought To Be Bosutinib Length = 293

Iteration: 1
 Score = 60.8 bits (146), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 55/198 (27%), Positives = 96/198 (48%), Gaps = 42/198 (21%)
Query: 320 KLGQGGYGSVYKGKLLD-GSNVAVKVL-NDSKGNGKEFINEVASISRTSHVNVVALLG-- 375
           +LG G +G VYK K  + G+  A KV+   S+   +++I E+  ++   H  +V LLG  
Sbjct: 18  ELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYIVEIEILATCDHPYIVKLLGAY 77
Query: 376 -----------FCLRVAEELSSTIGIARG-------------LEYLHLGCSTRILHFDIK 411
                      FC   A + +  + + RG             LE L+   S RI+H D+K
Sbjct: 78  YHDGKLWIMIEFCPGGAVD-AIMLELDRGLTEPQIQVVCRQMLEALNFLHSKRIIHRDLK 136
Query: 412 PHNILLDEDFCPKISDFGLA----KICNRKESIISMTGARGTVGYIAPE-VFCRNIGEV- 465
             N+L+  +   +++DFG++    K   +++S I      GT  ++APE V C  + +  
Sbjct: 137 AGNVLMTLEGDIRLADFGVSAKNLKTLQKRDSFI------GTPYWMAPEVVMCETMKDTP 190
Query: 466 -SYKSDVYNYGMMIFEMT 482
             YK+D+++ G+ + EM 
Sbjct: 191 YDYKADIWSLGITLIEMA 208

>pdb|3C4X|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.9a Length = 543

Iteration: 1
 Score = 60.8 bits (146), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 36/99 (36%), Positives = 51/99 (51%), Gaps = 7/99 (7%)
Query: 387 TIGIARGLEYLHLGCSTRILHFDIKPHNILLDEDFCPKISDFGLAKICNRKESIISMTGA 446
           T  I  GLE+LH      I++ D+KP N+LLD+D   +ISD GLA     K       G 
Sbjct: 295 TAQIVSGLEHLH---QRNIIYRDLKPENVLLDDDGNVRISDLGLA--VELKAGQTKTKGY 349
Query: 447 RGTVGYIAPEVFCRNIGEVSYKSDVYNYGMMIFEMTGGR 485
            GT G++APE+      E  +  D +  G+ ++EM   R
Sbjct: 350 AGTPGFMAPELLLGE--EYDFSVDYFALGVTLYEMIAAR 386

>pdb|3ZZW|A Chain A, Crystal Structure Of The Kinase Domain Of Ror2 Length = 289

Iteration: 1
 Score = 60.8 bits (146), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 62/235 (26%), Positives = 95/235 (40%), Gaps = 65/235 (27%)
Query: 317 FKYKLGQGGYGSVYKGKLL------DGSNVAVKVLNDSKGNG---KEFINEVASISRTSH 367
           F  +LG+  +G VYKG L           VA+K L D K  G   +EF +E    +R  H
Sbjct: 13  FMEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKD-KAEGPLREEFRHEAMLRARLQH 71
Query: 368 VNVVALLGFCLR--------------------VAEELSSTIG------------------ 389
            NVV LLG   +                    V     S +G                  
Sbjct: 72  PNVVCLLGVVTKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFV 131
Query: 390 -----IARGLEYLHLGCSTRILHFDIKPHNILLDEDFCPKISDFGLAKICNRKESIISMT 444
                IA G+EYL    S  ++H D+   N+L+ +    KISD GL +     +    + 
Sbjct: 132 HLVAQIAAGMEYL---SSHHVVHKDLATRNVLVYDKLNVKISDLGLFREVYAADYYKLLG 188
Query: 445 GARGTVGYIAPEVFCRNIGEVSYKSDVYNYGMMIFEMTG-------GRKNVDVVD 492
            +   + ++APE      G+ S  SD+++YG++++E+         G  N DVV+
Sbjct: 189 NSLLPIRWMAPEAIM--YGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSNQDVVE 241

>pdb|3C4W|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.7a Length = 543

Iteration: 1
 Score = 60.8 bits (146), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 36/99 (36%), Positives = 51/99 (51%), Gaps = 7/99 (7%)
Query: 387 TIGIARGLEYLHLGCSTRILHFDIKPHNILLDEDFCPKISDFGLAKICNRKESIISMTGA 446
           T  I  GLE+LH      I++ D+KP N+LLD+D   +ISD GLA     K       G 
Sbjct: 295 TAQIVSGLEHLH---QRNIIYRDLKPENVLLDDDGNVRISDLGLA--VELKAGQTKTKGY 349
Query: 447 RGTVGYIAPEVFCRNIGEVSYKSDVYNYGMMIFEMTGGR 485
            GT G++APE+      E  +  D +  G+ ++EM   R
Sbjct: 350 AGTPGFMAPELLLGE--EYDFSVDYFALGVTLYEMIAAR 386

>pdb|3T8O|A Chain A, Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolution Length = 543

Iteration: 1
 Score = 60.5 bits (145), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 36/99 (36%), Positives = 51/99 (51%), Gaps = 7/99 (7%)
Query: 387 TIGIARGLEYLHLGCSTRILHFDIKPHNILLDEDFCPKISDFGLAKICNRKESIISMTGA 446
           T  I  GLE+LH      I++ D+KP N+LLD+D   +ISD GLA     K       G 
Sbjct: 295 TAQIVSGLEHLH---QRNIIYRDLKPENVLLDDDGNVRISDLGLA--VELKAGQTKTKGY 349
Query: 447 RGTVGYIAPEVFCRNIGEVSYKSDVYNYGMMIFEMTGGR 485
            GT G++APE+      E  +  D +  G+ ++EM   R
Sbjct: 350 AGTPGFMAPELLLGE--EYDFSVDYFALGVTLYEMIAAR 386

>pdb|3NNX|A Chain A, Crystal Structure Of Phosphorylated P38 Alpha In Complex With Dp802 Length = 354

Iteration: 1
 Score = 60.5 bits (145), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 61/202 (30%), Positives = 89/202 (44%), Gaps = 48/202 (23%)
Query: 321 LGQGGYGSV---YKGKLLDGSNVAVKVLN---DSKGNGKEFINEVASISRTSHVNVVALL 374
           +G G YGSV   +  K   G  VAVK L+    S  + K    E+  +    H NV+ LL
Sbjct: 30  VGSGAYGSVCAAFDTK--TGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLL 87
Query: 375 GFCL--RVAEE------LSSTIG-----------------------IARGLEYLHLGCST 403
                 R  EE      ++  +G                       I RGL+Y+H   S 
Sbjct: 88  DVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIH---SA 144
Query: 404 RILHFDIKPHNILLDEDFCPKISDFGLAKICNRKESIISMTGARGTVGYIAPEVFCRNIG 463
            I+H D+KP N+ ++ED   KI DFGLA+  + +     MTG   T  Y APE+   N  
Sbjct: 145 DIIHRDLKPSNLAVNEDCELKILDFGLARHTDDE-----MTGXVATRWYRAPEIML-NWM 198
Query: 464 EVSYKSDVYNYGMMIFEMTGGR 485
             +   D+++ G ++ E+  GR
Sbjct: 199 HYNQTVDIWSVGCIMAELLTGR 220

>pdb|2GTM|A Chain A, Mutated Mouse P38 Map Kinase Domain In Complex With Inhibitor Pg-892579 Length = 348

Iteration: 1
 Score = 60.5 bits (145), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 60/202 (29%), Positives = 86/202 (42%), Gaps = 48/202 (23%)
Query: 321 LGQGGYGSV---YKGKLLDGSNVAVKVLN---DSKGNGKEFINEVASISRTSHVNVVALL 374
           +G G YGSV   +  K   G  VAVK L+    S  + K    E+  +    H NV+ LL
Sbjct: 26  VGSGAYGSVCAAFDTK--TGHRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLL 83
Query: 375 GFCL--RVAEELSSTI-----------------------------GIARGLEYLHLGCST 403
                 R  EE +                                 I RGL+Y+H   S 
Sbjct: 84  DVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIH---SA 140
Query: 404 RILHFDIKPHNILLDEDFCPKISDFGLAKICNRKESIISMTGARGTVGYIAPEVFCRNIG 463
            I+H D+KP N+ ++ED   KI DFGLA+  + +     MTG   T  Y APE+   N  
Sbjct: 141 DIIHRDLKPSNLAVNEDCELKILDFGLARHTDDE-----MTGYVATRWYRAPEIML-NWM 194
Query: 464 EVSYKSDVYNYGMMIFEMTGGR 485
             +   D+++ G ++ E+  GR
Sbjct: 195 HYNQTVDIWSVGCIMAELLTGR 216

>pdb|2XCK|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309

Iteration: 1
 Score = 60.5 bits (145), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 35/98 (35%), Positives = 52/98 (53%), Gaps = 5/98 (5%)
Query: 387 TIGIARGLEYLHLGCSTRILHFDIKPHNILLDEDFCPKISDFGLAKICNRKESIISMTGA 446
           T  I   LEYLH      I+H D+KP NILL+ED   +I+DFG AK+ + +         
Sbjct: 136 TAEIVSALEYLH---GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXF 192
Query: 447 RGTVGYIAPEVFCRNIGEVSYKSDVYNYGMMIFEMTGG 484
            GT  Y++PE+        S  SD++  G +I+++  G
Sbjct: 193 VGTAQYVSPELLTEKSACKS--SDLWALGCIIYQLVAG 228

>pdb|3RWP|A Chain A, Discovery Of A Novel, Potent And Selective Inhibitor Of 3- Phosphoinositide Dependent Kinase (Pdk1) Length = 311

Iteration: 1
 Score = 60.5 bits (145), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 35/98 (35%), Positives = 52/98 (53%), Gaps = 5/98 (5%)
Query: 387 TIGIARGLEYLHLGCSTRILHFDIKPHNILLDEDFCPKISDFGLAKICNRKESIISMTGA 446
           T  I   LEYLH      I+H D+KP NILL+ED   +I+DFG AK+ + +         
Sbjct: 138 TAEIVSALEYLH---GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXF 194
Query: 447 RGTVGYIAPEVFCRNIGEVSYKSDVYNYGMMIFEMTGG 484
            GT  Y++PE+        S  SD++  G +I+++  G
Sbjct: 195 VGTAQYVSPELLTEKSACKS--SDLWALGCIIYQLVAG 230

>pdb|3SC1|A Chain A, Novel Isoquinolone Pdk1 Inhibitors Discovered Through Fragment-Based Lead Discovery Length = 311

Iteration: 1
 Score = 60.5 bits (145), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 35/98 (35%), Positives = 52/98 (53%), Gaps = 5/98 (5%)
Query: 387 TIGIARGLEYLHLGCSTRILHFDIKPHNILLDEDFCPKISDFGLAKICNRKESIISMTGA 446
           T  I   LEYLH      I+H D+KP NILL+ED   +I+DFG AK+ + +         
Sbjct: 138 TAEIVSALEYLH---GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXF 194
Query: 447 RGTVGYIAPEVFCRNIGEVSYKSDVYNYGMMIFEMTGG 484
            GT  Y++PE+        S  SD++  G +I+++  G
Sbjct: 195 VGTAQYVSPELLTEKSACKS--SDLWALGCIIYQLVAG 230

>pdb|3H9O|A Chain A, Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) In Complex With Compound 9 Length = 311

Iteration: 1
 Score = 60.5 bits (145), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 35/98 (35%), Positives = 52/98 (53%), Gaps = 5/98 (5%)
Query: 387 TIGIARGLEYLHLGCSTRILHFDIKPHNILLDEDFCPKISDFGLAKICNRKESIISMTGA 446
           T  I   LEYLH      I+H D+KP NILL+ED   +I+DFG AK+ + +         
Sbjct: 138 TAEIVSALEYLH---GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXF 194
Query: 447 RGTVGYIAPEVFCRNIGEVSYKSDVYNYGMMIFEMTGG 484
            GT  Y++PE+        S  SD++  G +I+++  G
Sbjct: 195 VGTAQYVSPELLTEKSACKS--SDLWALGCIIYQLVAG 230

>pdb|1UU3|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Ly333531 Length = 310

Iteration: 1
 Score = 60.5 bits (145), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 35/98 (35%), Positives = 52/98 (53%), Gaps = 5/98 (5%)
Query: 387 TIGIARGLEYLHLGCSTRILHFDIKPHNILLDEDFCPKISDFGLAKICNRKESIISMTGA 446
           T  I   LEYLH      I+H D+KP NILL+ED   +I+DFG AK+ + +         
Sbjct: 136 TAEIVSALEYLH---GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXF 192
Query: 447 RGTVGYIAPEVFCRNIGEVSYKSDVYNYGMMIFEMTGG 484
            GT  Y++PE+        S  SD++  G +I+++  G
Sbjct: 193 VGTAQYVSPELLTEKSACKS--SDLWALGCIIYQLVAG 228

>pdb|2XCH|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309

Iteration: 1
 Score = 60.5 bits (145), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 35/98 (35%), Positives = 52/98 (53%), Gaps = 5/98 (5%)
Query: 387 TIGIARGLEYLHLGCSTRILHFDIKPHNILLDEDFCPKISDFGLAKICNRKESIISMTGA 446
           T  I   LEYLH      I+H D+KP NILL+ED   +I+DFG AK+ + +         
Sbjct: 136 TAEIVSALEYLH---GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXF 192
Query: 447 RGTVGYIAPEVFCRNIGEVSYKSDVYNYGMMIFEMTGG 484
            GT  Y++PE+        S  SD++  G +I+++  G
Sbjct: 193 VGTAQYVSPELLTEKSACKS--SDLWALGCIIYQLVAG 228

>pdb|3QC9|A Chain A, Crystal Structure Of Cross-Linked Bovine Grk1 T8cN480C DOUBLE MUTANT Complexed With Adp And Mg Length = 543

Iteration: 1
 Score = 60.5 bits (145), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 36/99 (36%), Positives = 51/99 (51%), Gaps = 7/99 (7%)
Query: 387 TIGIARGLEYLHLGCSTRILHFDIKPHNILLDEDFCPKISDFGLAKICNRKESIISMTGA 446
           T  I  GLE+LH      I++ D+KP N+LLD+D   +ISD GLA     K       G 
Sbjct: 295 TAQIVSGLEHLH---QRNIIYRDLKPENVLLDDDGNVRISDLGLA--VELKAGQTKTKGY 349
Query: 447 RGTVGYIAPEVFCRNIGEVSYKSDVYNYGMMIFEMTGGR 485
            GT G++APE+      E  +  D +  G+ ++EM   R
Sbjct: 350 AGTPGFMAPELLLGE--EYDFSVDYFALGVTLYEMIAAR 386

>pdb|3IOP|A Chain A, Pdk-1 In Complex With The Inhibitor Compound-8i Length = 312

Iteration: 1
 Score = 60.5 bits (145), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 35/98 (35%), Positives = 52/98 (53%), Gaps = 5/98 (5%)
Query: 387 TIGIARGLEYLHLGCSTRILHFDIKPHNILLDEDFCPKISDFGLAKICNRKESIISMTGA 446
           T  I   LEYLH      I+H D+KP NILL+ED   +I+DFG AK+ + +         
Sbjct: 139 TAEIVSALEYLH---GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXF 195
Query: 447 RGTVGYIAPEVFCRNIGEVSYKSDVYNYGMMIFEMTGG 484
            GT  Y++PE+        S  SD++  G +I+++  G
Sbjct: 196 VGTAQYVSPELLTEKSACKS--SDLWALGCIIYQLVAG 231

>pdb|2REI|A Chain A, Kinase Domain Of Human Ephrin Type-a Receptor 7 (epha7) Length = 318

Iteration: 1
 Score = 60.5 bits (145), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 52/196 (26%), Positives = 91/196 (46%), Gaps = 40/196 (20%)
Query: 321 LGQGGYGSVYKGKL-LDGSN---VAVKVLND--SKGNGKEFINEVASISRTSHVNVVALL 374
           +G G +G V  G+L L G     VA+K L    ++   ++F+ E + + +  H NVV L 
Sbjct: 51  IGAGEFGEVCSGRLKLPGKRDVAVAIKTLKVGYTEKQRRDFLCEASIMGQFDHPNVVHLE 110
Query: 375 GFCLR----------------------------VAEELSSTIGIARGLEYLHLGCSTRIL 406
           G   R                            V + +    GIA G+ YL        +
Sbjct: 111 GVVTRGKPVMIVIEFMENGALDAFLRKHDGQFTVIQLVGMLRGIAAGMRYL---ADMGYV 167
Query: 407 HFDIKPHNILLDEDFCPKISDFGLAKIC-NRKESIISMTGARGTVGYIAPEVFCRNIGEV 465
           H D+   NIL++ +   K+SDFGL+++  +  E++ + TG +  V + APE       + 
Sbjct: 168 HRDLAARNILVNSNLVCKVSDFGLSRVIEDDPEAVYTTTGGKIPVRWTAPEAI--QYRKF 225
Query: 466 SYKSDVYNYGMMIFEM 481
           +  SDV++YG++++E+
Sbjct: 226 TSASDVWSYGIVMWEV 241

>pdb|3MTL|A Chain A, Crystal Structure Of The Pctaire1 Kinase In Complex With Ind E804 Length = 324

Iteration: 1
 Score = 60.5 bits (145), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 60/200 (30%), Positives = 89/200 (44%), Gaps = 44/200 (22%)
Query: 320 KLGQGGYGSVYKGK-LLDGSNVAVKV--LNDSKGNGKEFINEVASISRTSHVNVVALLGF 376
           KLG+G Y +VYKGK  L  + VA+K   L   +G     I EV+ +    H N+V L   
Sbjct: 9   KLGEGTYATVYKGKSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDI 68
Query: 377 ------CLRVAEELSSTIG---------------------IARGLEYLHLGCSTRILHFD 409
                    V E L   +                      + RGL Y H     ++LH D
Sbjct: 69  IHTEKSLTLVFEYLDKDLKQYLDDCGNIINMHNVKLFLFQLLRGLAYCH---RQKVLHRD 125
Query: 410 IKPHNILLDEDFCPKISDFGLAKICNRKESIISMT--GARGTVGYIAPEVFCRNIGEVSY 467
           +KP N+L++E    K++DFGLA    R +SI + T      T+ Y  P++    +G   Y
Sbjct: 126 LKPQNLLINERGELKLADFGLA----RAKSIPTKTYDNEVVTLWYRPPDIL---LGSTDY 178
Query: 468 KS--DVYNYGMMIFEMTGGR 485
            +  D++  G + +EM  GR
Sbjct: 179 STQIDMWGVGCIFYEMATGR 198

>pdb|3QC4|A Chain A, Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = 314

Iteration: 1
 Score = 60.5 bits (145), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 34/98 (34%), Positives = 51/98 (52%), Gaps = 5/98 (5%)
Query: 387 TIGIARGLEYLHLGCSTRILHFDIKPHNILLDEDFCPKISDFGLAKICNRKESIISMTGA 446
           T  I   LEYLH      I+H D+KP NILL+ED   +I+DFG AK+ + +         
Sbjct: 141 TAEIVSALEYLH---GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXF 197
Query: 447 RGTVGYIAPEVFCRNIGEVSYKSDVYNYGMMIFEMTGG 484
            GT  Y++PE+           SD++  G +I+++  G
Sbjct: 198 VGTAQYVSPELLTEK--SACKSSDLWALGCIIYQLVAG 233

>pdb|3HRC|A Chain A, Crystal Structure Of A Mutant Of Human Pdk1 Kinase Domain In Complex With Atp Length = 311

Iteration: 1
 Score = 60.5 bits (145), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 34/98 (34%), Positives = 51/98 (52%), Gaps = 5/98 (5%)
Query: 387 TIGIARGLEYLHLGCSTRILHFDIKPHNILLDEDFCPKISDFGLAKICNRKESIISMTGA 446
           T  I   LEYLH      I+H D+KP NILL+ED   +I+DFG AK+ + +         
Sbjct: 138 TAEIVSALEYLH---GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXF 194
Query: 447 RGTVGYIAPEVFCRNIGEVSYKSDVYNYGMMIFEMTGG 484
            GT  Y++PE+           SD++  G +I+++  G
Sbjct: 195 VGTAQYVSPELLTEK--SACKSSDLWALGCIIYQLVAG 230

>pdb|3NUN|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lead Compound Length = 292

Iteration: 1
 Score = 60.5 bits (145), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 35/98 (35%), Positives = 52/98 (53%), Gaps = 5/98 (5%)
Query: 387 TIGIARGLEYLHLGCSTRILHFDIKPHNILLDEDFCPKISDFGLAKICNRKESIISMTGA 446
           T  I   LEYLH      I+H D+KP NILL+ED   +I+DFG AK+ + +         
Sbjct: 120 TAEIVSALEYLH---GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXF 176
Query: 447 RGTVGYIAPEVFCRNIGEVSYKSDVYNYGMMIFEMTGG 484
            GT  Y++PE+        S  SD++  G +I+++  G
Sbjct: 177 VGTAQYVSPELLTEKSACKS--SDLWALGCIIYQLVAG 212

>pdb|3LIJ|A Chain A, Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) In Complex With Ca2+ And Amppnp Length = 494

Iteration: 1
 Score = 60.5 bits (145), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 57/200 (28%), Positives = 90/200 (45%), Gaps = 45/200 (22%)
Query: 320 KLGQGGYGSVY--KGKLLDGSNVAVKVLND---SKGNGKEFINEVASISRTSHVNVVALL 374
           KLG G YG V   + K+      A+K++     S  +  + + EVA +    H N++ L 
Sbjct: 44  KLGSGAYGEVLLCRDKVTHVER-AIKIIRKTSVSTSSNSKLLEEVAVLKLLDHPNIMKLY 102
Query: 375 GF------------CLRVAE------------ELSSTIGIAR---GLEYLHLGCSTRILH 407
            F            C +  E            E+ + + I +   G+ YLH      I+H
Sbjct: 103 DFFEDKRNYYLVMECYKGGELFDEIIHRMKFNEVDAAVIIKQVLSGVTYLH---KHNIVH 159
Query: 408 FDIKPHNILL---DEDFCPKISDFGLAKICNRKESIISMTGARGTVGYIAPEVFCRNIGE 464
            D+KP N+LL   ++D   KI DFGL+ +   ++    M    GT  YIAPEV  +   E
Sbjct: 160 RDLKPENLLLESKEKDALIKIVDFGLSAVFENQK---KMKERLGTAYYIAPEVLRKKYDE 216
Query: 465 VSYKSDVYNYGMMIFEMTGG 484
              K DV++ G+++F +  G
Sbjct: 217 ---KCDVWSIGVILFILLAG 233

>pdb|1W98|A Chain A, The Structural Basis Of Cdk2 Activation By Cyclin E Length = 298

Iteration: 1
 Score = 60.5 bits (145), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 55/200 (27%), Positives = 91/200 (45%), Gaps = 42/200 (21%)
Query: 320 KLGQGGYGSVYKGK-LLDGSNVAVKVL---NDSKGNGKEFINEVASISRTSHVNVVALLG 375
           K+G+G YG VYK +  L G  VA+K +    +++G     I E++ +   +H N+V LL 
Sbjct: 10  KIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLD 69
Query: 376 FC----------------LRVAEELSSTIGIA------------RGLEYLHLGCSTRILH 407
                             L+   + S+  GI             +GL + H   S R+LH
Sbjct: 70  VIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCH---SHRVLH 126
Query: 408 FDIKPHNILLDEDFCPKISDFGLAKICNRKESIISMTGARGTVGYIAPEVF--CRNIGEV 465
            D+KP N+L++ +   K++DFGLA+       + +      T+ Y APE+   C+     
Sbjct: 127 RDLKPQNLLINTEGAIKLADFGLARAFG--VPVRTYXHEVVTLWYRAPEILLGCKY---Y 181
Query: 466 SYKSDVYNYGMMIFEMTGGR 485
           S   D+++ G +  EM   R
Sbjct: 182 STAVDIWSLGCIFAEMVTRR 201

>pdb|3NAY|A Chain A, Pdk1 In Complex With Inhibitor Mp6 Length = 311

Iteration: 1
 Score = 60.5 bits (145), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 35/98 (35%), Positives = 52/98 (53%), Gaps = 5/98 (5%)
Query: 387 TIGIARGLEYLHLGCSTRILHFDIKPHNILLDEDFCPKISDFGLAKICNRKESIISMTGA 446
           T  I   LEYLH      I+H D+KP NILL+ED   +I+DFG AK+ + +         
Sbjct: 135 TAEIVSALEYLH---GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXF 191
Query: 447 RGTVGYIAPEVFCRNIGEVSYKSDVYNYGMMIFEMTGG 484
            GT  Y++PE+        S  SD++  G +I+++  G
Sbjct: 192 VGTAQYVSPELLTEKSACKS--SDLWALGCIIYQLVAG 227

>pdb|2PUU|A Chain A, Crystal Structure Of P38 Complex With 1-(5-Tert-Butyl-2-P- Tolyl-2h-Pyrazol-3-Yl)-3-[4-(6-Morpholin-4-Ylmethyl- Pyridin-3-Yl)naphthalen-1-Yl]urea Length = 348

Iteration: 1
 Score = 60.5 bits (145), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 61/202 (30%), Positives = 89/202 (44%), Gaps = 48/202 (23%)
Query: 321 LGQGGYGSV---YKGKLLDGSNVAVKVLN---DSKGNGKEFINEVASISRTSHVNVVALL 374
           +G G YGSV   +  K   G  VAVK L+    S  + K    E+  +    H NV+ LL
Sbjct: 26  VGSGAYGSVCAAFDTK--TGHRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLL 83
Query: 375 GFCL--RVAEE------LSSTIG-----------------------IARGLEYLHLGCST 403
                 R  EE      ++  +G                       I RGL+Y+H   S 
Sbjct: 84  DVFTPARSLEEFNDVYLVTHLMGADLNNIVKCAKLTDDHVQFLIYQILRGLKYIH---SA 140
Query: 404 RILHFDIKPHNILLDEDFCPKISDFGLAKICNRKESIISMTGARGTVGYIAPEVFCRNIG 463
            I+H D+KP N+ ++ED   KI DFGLA+  + +     MTG   T  Y APE+   N  
Sbjct: 141 DIIHRDLKPSNLAVNEDCELKILDFGLARHTDDE-----MTGYVATRWYRAPEIML-NWM 194
Query: 464 EVSYKSDVYNYGMMIFEMTGGR 485
             +   D+++ G ++ E+  GR
Sbjct: 195 HYNQTVDIWSVGCIMAELLTGR 216

>pdb|3ODY|X Chain X, Crystal Structure Of P38alpha Y323q Active Mutant Length = 360

Iteration: 1
 Score = 60.5 bits (145), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 61/202 (30%), Positives = 89/202 (44%), Gaps = 48/202 (23%)
Query: 321 LGQGGYGSV---YKGKLLDGSNVAVKVLN---DSKGNGKEFINEVASISRTSHVNVVALL 374
           +G G YGSV   +  K   G  VAVK L+    S  + K    E+  +    H NV+ LL
Sbjct: 30  VGSGAYGSVCAAFDTK--TGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLL 87
Query: 375 GFCL--RVAEE------LSSTIG-----------------------IARGLEYLHLGCST 403
                 R  EE      ++  +G                       I RGL+Y+H   S 
Sbjct: 88  DVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIH---SA 144
Query: 404 RILHFDIKPHNILLDEDFCPKISDFGLAKICNRKESIISMTGARGTVGYIAPEVFCRNIG 463
            I+H D+KP N+ ++ED   KI DFGLA+  + +     MTG   T  Y APE+   N  
Sbjct: 145 DIIHRDLKPSNLAVNEDCELKILDFGLARHTDDE-----MTGYVATRWYRAPEIML-NWM 198
Query: 464 EVSYKSDVYNYGMMIFEMTGGR 485
             +   D+++ G ++ E+  GR
Sbjct: 199 HYNQTVDIWSVGCIMAELLTGR 220

>pdb|3OD6|X Chain X, Crystal Structure Of P38alpha Y323t Active Mutant Length = 360

Iteration: 1
 Score = 60.5 bits (145), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 61/202 (30%), Positives = 89/202 (44%), Gaps = 48/202 (23%)
Query: 321 LGQGGYGSV---YKGKLLDGSNVAVKVLN---DSKGNGKEFINEVASISRTSHVNVVALL 374
           +G G YGSV   +  K   G  VAVK L+    S  + K    E+  +    H NV+ LL
Sbjct: 30  VGSGAYGSVCAAFDTK--TGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLL 87
Query: 375 GFCL--RVAEE------LSSTIG-----------------------IARGLEYLHLGCST 403
                 R  EE      ++  +G                       I RGL+Y+H   S 
Sbjct: 88  DVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIH---SA 144
Query: 404 RILHFDIKPHNILLDEDFCPKISDFGLAKICNRKESIISMTGARGTVGYIAPEVFCRNIG 463
            I+H D+KP N+ ++ED   KI DFGLA+  + +     MTG   T  Y APE+   N  
Sbjct: 145 DIIHRDLKPSNLAVNEDCELKILDFGLARHTDDE-----MTGYVATRWYRAPEIML-NWM 198
Query: 464 EVSYKSDVYNYGMMIFEMTGGR 485
             +   D+++ G ++ E+  GR
Sbjct: 199 HYNQTVDIWSVGCIMAELLTGR 220

>pdb|1JST|A Chain A, Phosphorylated Cyclin-Dependent Kinase-2 Bound To Cyclin A Length = 298

Iteration: 1
 Score = 60.5 bits (145), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 55/200 (27%), Positives = 91/200 (45%), Gaps = 42/200 (21%)
Query: 320 KLGQGGYGSVYKGK-LLDGSNVAVKVL---NDSKGNGKEFINEVASISRTSHVNVVALLG 375
           K+G+G YG VYK +  L G  VA+K +    +++G     I E++ +   +H N+V LL 
Sbjct: 9   KIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLD 68
Query: 376 FC----------------LRVAEELSSTIGIA------------RGLEYLHLGCSTRILH 407
                             L+   + S+  GI             +GL + H   S R+LH
Sbjct: 69  VIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCH---SHRVLH 125
Query: 408 FDIKPHNILLDEDFCPKISDFGLAKICNRKESIISMTGARGTVGYIAPEVF--CRNIGEV 465
            D+KP N+L++ +   K++DFGLA+       + +      T+ Y APE+   C+     
Sbjct: 126 RDLKPQNLLINTEGAIKLADFGLARAFG--VPVRTYXHEVVTLWYRAPEILLGCKY---Y 180
Query: 466 SYKSDVYNYGMMIFEMTGGR 485
           S   D+++ G +  EM   R
Sbjct: 181 STAVDIWSLGCIFAEMVTRR 200

>pdb|4I3Z|A Chain A, Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNESIUM IONS Length = 296

Iteration: 1
 Score = 60.5 bits (145), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 55/200 (27%), Positives = 91/200 (45%), Gaps = 42/200 (21%)
Query: 320 KLGQGGYGSVYKGK-LLDGSNVAVKVL---NDSKGNGKEFINEVASISRTSHVNVVALLG 375
           K+G+G YG VYK +  L G  VA+K +    +++G     I E++ +   +H N+V LL 
Sbjct: 9   KIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLD 68
Query: 376 FC----------------LRVAEELSSTIGIA------------RGLEYLHLGCSTRILH 407
                             L+   + S+  GI             +GL + H   S R+LH
Sbjct: 69  VIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCH---SHRVLH 125
Query: 408 FDIKPHNILLDEDFCPKISDFGLAKICNRKESIISMTGARGTVGYIAPEVF--CRNIGEV 465
            D+KP N+L++ +   K++DFGLA+       + +      T+ Y APE+   C+     
Sbjct: 126 RDLKPQNLLINTEGAIKLADFGLARAFG--VPVRTYXHEVVTLWYRAPEILLGCKY---Y 180
Query: 466 SYKSDVYNYGMMIFEMTGGR 485
           S   D+++ G +  EM   R
Sbjct: 181 STAVDIWSLGCIFAEMVTRR 200

>pdb|1QMZ|A Chain A, Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Complex Length = 299

Iteration: 1
 Score = 60.5 bits (145), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 55/200 (27%), Positives = 91/200 (45%), Gaps = 42/200 (21%)
Query: 320 KLGQGGYGSVYKGK-LLDGSNVAVKVL---NDSKGNGKEFINEVASISRTSHVNVVALLG 375
           K+G+G YG VYK +  L G  VA+K +    +++G     I E++ +   +H N+V LL 
Sbjct: 10  KIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLD 69
Query: 376 FC----------------LRVAEELSSTIGIA------------RGLEYLHLGCSTRILH 407
                             L+   + S+  GI             +GL + H   S R+LH
Sbjct: 70  VIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCH---SHRVLH 126
Query: 408 FDIKPHNILLDEDFCPKISDFGLAKICNRKESIISMTGARGTVGYIAPEVF--CRNIGEV 465
            D+KP N+L++ +   K++DFGLA+       + +      T+ Y APE+   C+     
Sbjct: 127 RDLKPQNLLINTEGAIKLADFGLARAFG--VPVRTYXHEVVTLWYRAPEILLGCKY---Y 181
Query: 466 SYKSDVYNYGMMIFEMTGGR 485
           S   D+++ G +  EM   R
Sbjct: 182 STAVDIWSLGCIFAEMVTRR 201

>pdb|2JGZ|A Chain A, Crystal Structure Of Phospho-Cdk2 In Complex With Cyclin B Length = 289

Iteration: 1
 Score = 60.5 bits (145), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 55/200 (27%), Positives = 91/200 (45%), Gaps = 42/200 (21%)
Query: 320 KLGQGGYGSVYKGK-LLDGSNVAVKVL---NDSKGNGKEFINEVASISRTSHVNVVALLG 375
           K+G+G YG VYK +  L G  VA+K +    +++G     I E++ +   +H N+V LL 
Sbjct: 10  KIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLD 69
Query: 376 FC----------------LRVAEELSSTIGIA------------RGLEYLHLGCSTRILH 407
                             L+   + S+  GI             +GL + H   S R+LH
Sbjct: 70  VIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCH---SHRVLH 126
Query: 408 FDIKPHNILLDEDFCPKISDFGLAKICNRKESIISMTGARGTVGYIAPEVF--CRNIGEV 465
            D+KP N+L++ +   K++DFGLA+       + +      T+ Y APE+   C+     
Sbjct: 127 RDLKPQNLLINTEGAIKLADFGLARAFG--VPVRTYXHEVVTLWYRAPEILLGCKY---Y 181
Query: 466 SYKSDVYNYGMMIFEMTGGR 485
           S   D+++ G +  EM   R
Sbjct: 182 STAVDIWSLGCIFAEMVTRR 201

>pdb|1BMK|A Chain A, The Complex Structure Of The Map Kinase P38SB218655 Length = 379

Iteration: 1
 Score = 60.5 bits (145), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 61/202 (30%), Positives = 89/202 (44%), Gaps = 48/202 (23%)
Query: 321 LGQGGYGSV---YKGKLLDGSNVAVKVLN---DSKGNGKEFINEVASISRTSHVNVVALL 374
           +G G YGSV   +  K   G  VAVK L+    S  + K    E+  +    H NV+ LL
Sbjct: 49  VGSGAYGSVCAAFDTK--TGHRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLL 106
Query: 375 GFCL--RVAEE------LSSTIG-----------------------IARGLEYLHLGCST 403
                 R  EE      ++  +G                       I RGL+Y+H   S 
Sbjct: 107 DVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIH---SA 163
Query: 404 RILHFDIKPHNILLDEDFCPKISDFGLAKICNRKESIISMTGARGTVGYIAPEVFCRNIG 463
            I+H D+KP N+ ++ED   KI DFGLA+  + +     MTG   T  Y APE+   N  
Sbjct: 164 DIIHRDLKPSNLAVNEDCELKILDFGLARHTDDE-----MTGYVATRWYRAPEIML-NWM 217
Query: 464 EVSYKSDVYNYGMMIFEMTGGR 485
             +   D+++ G ++ E+  GR
Sbjct: 218 HYNQTVDIWSVGCIMAELLTGR 239

>pdb|1IAN|A Chain A, Human P38 Map Kinase Inhibitor Complex Length = 366

Iteration: 1
 Score = 60.1 bits (144), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 61/202 (30%), Positives = 89/202 (44%), Gaps = 48/202 (23%)
Query: 321 LGQGGYGSV---YKGKLLDGSNVAVKVLN---DSKGNGKEFINEVASISRTSHVNVVALL 374
           +G G YGSV   +  K   G  VAVK L+    S  + K    E+  +    H NV+ LL
Sbjct: 36  VGSGAYGSVCAAFDTK--TGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLL 93
Query: 375 GFCL--RVAEE------LSSTIG-----------------------IARGLEYLHLGCST 403
                 R  EE      ++  +G                       I RGL+Y+H   S 
Sbjct: 94  DVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIH---SA 150
Query: 404 RILHFDIKPHNILLDEDFCPKISDFGLAKICNRKESIISMTGARGTVGYIAPEVFCRNIG 463
            I+H D+KP N+ ++ED   KI DFGLA+  + +     MTG   T  Y APE+   N  
Sbjct: 151 DIIHRDLKPSNLAVNEDCELKILDFGLARHTDDE-----MTGYVATRWYRAPEIML-NWM 204
Query: 464 EVSYKSDVYNYGMMIFEMTGGR 485
             +   D+++ G ++ E+  GR
Sbjct: 205 HYNQTVDIWSVGCIMAELLTGR 226

>pdb|2WQM|A Chain A, Structure Of Apo Human Nek7 Length = 310

Iteration: 1
 Score = 60.1 bits (144), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 54/201 (26%), Positives = 91/201 (45%), Gaps = 45/201 (22%)
Query: 320 KLGQGGYGSVYKGK-LLDGSNVAVKV-----LNDSKGNGKEFINEVASISRTSHVNVVAL 373
           K+G+G +  VY+   LLDG  VA+K      L D+K    + I E+  + + +H NV+  
Sbjct: 39  KIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARA-DCIKEIDLLKQLNHPNVIKY 97
Query: 374 ---------LGFCLRVAE--ELSSTIG--------------------IARGLEYLHLGCS 402
                    L   L +A+  +LS  I                     +   LE++H   S
Sbjct: 98  YASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEHMH---S 154
Query: 403 TRILHFDIKPHNILLDEDFCPKISDFGLAKICNRKESIISMTGARGTVGYIAPEVFCRNI 462
            R++H DIKP N+ +      K+ D GL +  + K +  +     GT  Y++PE    N 
Sbjct: 155 RRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTT--AAHSLVGTPYYMSPERIHEN- 211
Query: 463 GEVSYKSDVYNYGMMIFEMTG 483
              ++KSD+++ G +++EM  
Sbjct: 212 -GYNFKSDIWSLGCLLYEMAA 231

>pdb|3ODZ|X Chain X, Crystal Structure Of P38alpha Y323r Active Mutant Length = 360

Iteration: 1
 Score = 60.1 bits (144), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 60/202 (29%), Positives = 86/202 (42%), Gaps = 48/202 (23%)
Query: 321 LGQGGYGSV---YKGKLLDGSNVAVKVLN---DSKGNGKEFINEVASISRTSHVNVVALL 374
           +G G YGSV   +  K   G  VAVK L+    S  + K    E+  +    H NV+ LL
Sbjct: 30  VGSGAYGSVCAAFDTK--TGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLL 87
Query: 375 GFCL--RVAEELSSTI-----------------------------GIARGLEYLHLGCST 403
                 R  EE +                                 I RGL+Y+H   S 
Sbjct: 88  DVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIH---SA 144
Query: 404 RILHFDIKPHNILLDEDFCPKISDFGLAKICNRKESIISMTGARGTVGYIAPEVFCRNIG 463
            I+H D+KP N+ ++ED   KI DFGLA+  + +     MTG   T  Y APE+   N  
Sbjct: 145 DIIHRDLKPSNLAVNEDCELKILDFGLARHTDDE-----MTGYVATRWYRAPEIML-NWM 198
Query: 464 EVSYKSDVYNYGMMIFEMTGGR 485
             +   D+++ G ++ E+  GR
Sbjct: 199 HYNQTVDIWSVGCIMAELLTGR 220

>pdb|2BAJ|A Chain A, P38alpha Bound To Pyrazolourea Length = 365

Iteration: 1
 Score = 60.1 bits (144), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 60/202 (29%), Positives = 86/202 (42%), Gaps = 48/202 (23%)
Query: 321 LGQGGYGSV---YKGKLLDGSNVAVKVLN---DSKGNGKEFINEVASISRTSHVNVVALL 374
           +G G YGSV   +  K   G  VAVK L+    S  + K    E+  +    H NV+ LL
Sbjct: 35  VGSGAYGSVCAAFDTK--TGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLL 92
Query: 375 GFCL--RVAEELSSTI-----------------------------GIARGLEYLHLGCST 403
                 R  EE +                                 I RGL+Y+H   S 
Sbjct: 93  DVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIH---SA 149
Query: 404 RILHFDIKPHNILLDEDFCPKISDFGLAKICNRKESIISMTGARGTVGYIAPEVFCRNIG 463
            I+H D+KP N+ ++ED   KI DFGLA+  + +     MTG   T  Y APE+   N  
Sbjct: 150 DIIHRDLKPSNLAVNEDCELKILDFGLARHTDDE-----MTGYVATRWYRAPEIML-NWM 203
Query: 464 EVSYKSDVYNYGMMIFEMTGGR 485
             +   D+++ G ++ E+  GR
Sbjct: 204 HYNQTVDIWSVGCIMAELLTGR 225

>pdb|3TG1|A Chain A, Crystal Structure Of P38alpha In Complex With A Mapk Docking Partner Length = 380

Iteration: 1
 Score = 60.1 bits (144), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 61/202 (30%), Positives = 89/202 (44%), Gaps = 48/202 (23%)
Query: 321 LGQGGYGSV---YKGKLLDGSNVAVKVLN---DSKGNGKEFINEVASISRTSHVNVVALL 374
           +G G YGSV   +  K   G  VAVK L+    S  + K    E+  +    H NV+ LL
Sbjct: 50  VGSGAYGSVCAAFDTK--TGHRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLL 107
Query: 375 GFCL--RVAEE------LSSTIG-----------------------IARGLEYLHLGCST 403
                 R  EE      ++  +G                       I RGL+Y+H   S 
Sbjct: 108 DVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIH---SA 164
Query: 404 RILHFDIKPHNILLDEDFCPKISDFGLAKICNRKESIISMTGARGTVGYIAPEVFCRNIG 463
            I+H D+KP N+ ++ED   KI DFGLA+  + +     MTG   T  Y APE+   N  
Sbjct: 165 DIIHRDLKPSNLAVNEDCELKILDFGLARHTDDE-----MTGYVATRWYRAPEIML-NWM 218
Query: 464 EVSYKSDVYNYGMMIFEMTGGR 485
             +   D+++ G ++ E+  GR
Sbjct: 219 HYNQTVDIWSVGCIMAELLTGR 240

>pdb|3HRB|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 359

Iteration: 1
 Score = 60.1 bits (144), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 60/202 (29%), Positives = 86/202 (42%), Gaps = 48/202 (23%)
Query: 321 LGQGGYGSV---YKGKLLDGSNVAVKVLN---DSKGNGKEFINEVASISRTSHVNVVALL 374
           +G G YGSV   +  K   G  VAVK L+    S  + K    E+  +    H NV+ LL
Sbjct: 29  VGSGAYGSVCAAFDTK--TGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLL 86
Query: 375 GFCL--RVAEELSSTI-----------------------------GIARGLEYLHLGCST 403
                 R  EE +                                 I RGL+Y+H   S 
Sbjct: 87  DVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIH---SA 143
Query: 404 RILHFDIKPHNILLDEDFCPKISDFGLAKICNRKESIISMTGARGTVGYIAPEVFCRNIG 463
            I+H D+KP N+ ++ED   KI DFGLA+  + +     MTG   T  Y APE+   N  
Sbjct: 144 DIIHRDLKPSNLAVNEDCELKILDFGLARHTDDE-----MTGYVATRWYRAPEIML-NWM 197
Query: 464 EVSYKSDVYNYGMMIFEMTGGR 485
             +   D+++ G ++ E+  GR
Sbjct: 198 HYNQTVDIWSVGCIMAELLTGR 219

>pdb|2NPQ|A Chain A, A Novel Lipid Binding Site In The P38 Alpha Map Kinase Length = 367

Iteration: 1
 Score = 60.1 bits (144), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 61/202 (30%), Positives = 89/202 (44%), Gaps = 48/202 (23%)
Query: 321 LGQGGYGSV---YKGKLLDGSNVAVKVLN---DSKGNGKEFINEVASISRTSHVNVVALL 374
           +G G YGSV   +  K   G  VAVK L+    S  + K    E+  +    H NV+ LL
Sbjct: 37  VGSGAYGSVCAAFDTK--TGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLL 94
Query: 375 GFCL--RVAEE------LSSTIG-----------------------IARGLEYLHLGCST 403
                 R  EE      ++  +G                       I RGL+Y+H   S 
Sbjct: 95  DVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIH---SA 151
Query: 404 RILHFDIKPHNILLDEDFCPKISDFGLAKICNRKESIISMTGARGTVGYIAPEVFCRNIG 463
            I+H D+KP N+ ++ED   KI DFGLA+  + +     MTG   T  Y APE+   N  
Sbjct: 152 DIIHRDLKPSNLAVNEDCELKILDFGLARHTDDE-----MTGYVATRWYRAPEIML-NWM 205
Query: 464 EVSYKSDVYNYGMMIFEMTGGR 485
             +   D+++ G ++ E+  GR
Sbjct: 206 HYNQTVDIWSVGCIMAELLTGR 227

>pdb|2OO8|X Chain X, Synthesis, Structural Analysis, And Sar Studies Of Triazine Derivatives As Potent, Selective Tie-2 Inhibitors Length = 317

Iteration: 1
 Score = 60.1 bits (144), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 55/215 (25%), Positives = 100/215 (46%), Gaps = 57/215 (26%)
Query: 317 FKYKLGQGGYGSVYKGKLL-DG--SNVAVKVLND--SKGNGKEFINEVASISRTSH-VNV 370
           F+  +G+G +G V K ++  DG   + A+K + +  SK + ++F  E+  + +  H  N+
Sbjct: 19  FQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNI 78
Query: 371 VALLGFC---------------------LR------------VAEELSSTIG-------- 389
           + LLG C                     LR            +A   +ST+         
Sbjct: 79  INLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFA 138
Query: 390 --IARGLEYLHLGCSTRILHFDIKPHNILLDEDFCPKISDFGLAKICNRKESIISMTGAR 447
             +ARG++YL      + +H D+   NIL+ E++  KI+DFGL++    +E  +  T  R
Sbjct: 139 ADVARGMDYL---SQKQFIHRDLAARNILVGENYVAKIADFGLSR---GQEVYVKKTMGR 192
Query: 448 GTVGYIAPEVFCRNIGEVSYKSDVYNYGMMIFEMT 482
             V ++A E    N    +  SDV++YG++++E+ 
Sbjct: 193 LPVRWMAIESL--NYSVYTTNSDVWSYGVLLWEIV 225

>pdb|1E9H|A Chain A, Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex With The Inhibitor Indirubin-5-Sulphonate Bound Length = 297

Iteration: 1
 Score = 60.1 bits (144), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 55/200 (27%), Positives = 91/200 (45%), Gaps = 42/200 (21%)
Query: 320 KLGQGGYGSVYKGK-LLDGSNVAVKVL---NDSKGNGKEFINEVASISRTSHVNVVALLG 375
           K+G+G YG VYK +  L G  VA+K +    +++G     I E++ +   +H N+V LL 
Sbjct: 10  KIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLD 69
Query: 376 FC----------------LRVAEELSSTIGIA------------RGLEYLHLGCSTRILH 407
                             L+   + S+  GI             +GL + H   S R+LH
Sbjct: 70  VIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCH---SHRVLH 126
Query: 408 FDIKPHNILLDEDFCPKISDFGLAKICNRKESIISMTGARGTVGYIAPEVF--CRNIGEV 465
            D+KP N+L++ +   K++DFGLA+       + +      T+ Y APE+   C+     
Sbjct: 127 RDLKPQNLLINTEGAIKLADFGLARAFG--VPVRTYXHEVVTLWYRAPEILLGCKY---Y 181
Query: 466 SYKSDVYNYGMMIFEMTGGR 485
           S   D+++ G +  EM   R
Sbjct: 182 STAVDIWSLGCIFAEMVTRR 201

>pdb|4EOS|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300

Iteration: 1
 Score = 60.1 bits (144), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 55/200 (27%), Positives = 91/200 (45%), Gaps = 42/200 (21%)
Query: 320 KLGQGGYGSVYKGK-LLDGSNVAVKVL---NDSKGNGKEFINEVASISRTSHVNVVALLG 375
           K+G+G YG VYK +  L G  VA+K +    +++G     I E++ +   +H N+V LL 
Sbjct: 12  KIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLD 71
Query: 376 FC----------------LRVAEELSSTIGIA------------RGLEYLHLGCSTRILH 407
                             L+   + S+  GI             +GL + H   S R+LH
Sbjct: 72  VIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCH---SHRVLH 128
Query: 408 FDIKPHNILLDEDFCPKISDFGLAKICNRKESIISMTGARGTVGYIAPEVF--CRNIGEV 465
            D+KP N+L++ +   K++DFGLA+       + +      T+ Y APE+   C+     
Sbjct: 129 RDLKPQNLLINTEGAIKLADFGLARAFG--VPVRTYXHEVVTLWYRAPEILLGCKY---Y 183
Query: 466 SYKSDVYNYGMMIFEMTGGR 485
           S   D+++ G +  EM   R
Sbjct: 184 STAVDIWSLGCIFAEMVTRR 203

>pdb|1DI9|A Chain A, The Structure Of P38 Mitogen-Activated Protein Kinase In Complex With 4-[3-Methylsulfanylanilino]-6,7- Dimethoxyquinazoline Length = 360

Iteration: 1
 Score = 60.1 bits (144), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 60/202 (29%), Positives = 86/202 (42%), Gaps = 48/202 (23%)
Query: 321 LGQGGYGSV---YKGKLLDGSNVAVKVLN---DSKGNGKEFINEVASISRTSHVNVVALL 374
           +G G YGSV   +  K   G  VAVK L+    S  + K    E+  +    H NV+ LL
Sbjct: 30  VGSGAYGSVCAAFDTK--TGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLL 87
Query: 375 GFCL--RVAEELSSTI-----------------------------GIARGLEYLHLGCST 403
                 R  EE +                                 I RGL+Y+H   S 
Sbjct: 88  DVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIH---SA 144
Query: 404 RILHFDIKPHNILLDEDFCPKISDFGLAKICNRKESIISMTGARGTVGYIAPEVFCRNIG 463
            I+H D+KP N+ ++ED   KI DFGLA+  + +     MTG   T  Y APE+   N  
Sbjct: 145 DIIHRDLKPSNLAVNEDCELKILDFGLARHTDDE-----MTGYVATRWYRAPEIML-NWM 198
Query: 464 EVSYKSDVYNYGMMIFEMTGGR 485
             +   D+++ G ++ E+  GR
Sbjct: 199 HYNQTVDIWSVGCIMAELLTGR 220

>pdb|4E5A|X Chain X, The W197a Mutant Of P38a Map Kinase Length = 360

Iteration: 1
 Score = 60.1 bits (144), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 61/202 (30%), Positives = 89/202 (44%), Gaps = 48/202 (23%)
Query: 321 LGQGGYGSV---YKGKLLDGSNVAVKVLN---DSKGNGKEFINEVASISRTSHVNVVALL 374
           +G G YGSV   +  K   G  VAVK L+    S  + K    E+  +    H NV+ LL
Sbjct: 30  VGSGAYGSVCAAFDTK--TGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLL 87
Query: 375 GFCL--RVAEE------LSSTIG-----------------------IARGLEYLHLGCST 403
                 R  EE      ++  +G                       I RGL+Y+H   S 
Sbjct: 88  DVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIH---SA 144
Query: 404 RILHFDIKPHNILLDEDFCPKISDFGLAKICNRKESIISMTGARGTVGYIAPEVFCRNIG 463
            I+H D+KP N+ ++ED   KI DFGLA+  + +     MTG   T  Y APE+   N  
Sbjct: 145 DIIHRDLKPSNLAVNEDCELKILDFGLARHTDDE-----MTGYVATRWYRAPEIML-NAM 198
Query: 464 EVSYKSDVYNYGMMIFEMTGGR 485
             +   D+++ G ++ E+  GR
Sbjct: 199 HYNQTVDIWSVGCIMAELLTGR 220

>pdb|3OEF|X Chain X, Crystal Structure Of Y323f Inactive Mutant Of P38alpha Map Kinase Length = 360

Iteration: 1
 Score = 60.1 bits (144), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 60/202 (29%), Positives = 86/202 (42%), Gaps = 48/202 (23%)
Query: 321 LGQGGYGSV---YKGKLLDGSNVAVKVLN---DSKGNGKEFINEVASISRTSHVNVVALL 374
           +G G YGSV   +  K   G  VAVK L+    S  + K    E+  +    H NV+ LL
Sbjct: 30  VGSGAYGSVCAAFDTK--TGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLL 87
Query: 375 GFCL--RVAEELSSTI-----------------------------GIARGLEYLHLGCST 403
                 R  EE +                                 I RGL+Y+H   S 
Sbjct: 88  DVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIH---SA 144
Query: 404 RILHFDIKPHNILLDEDFCPKISDFGLAKICNRKESIISMTGARGTVGYIAPEVFCRNIG 463
            I+H D+KP N+ ++ED   KI DFGLA+  + +     MTG   T  Y APE+   N  
Sbjct: 145 DIIHRDLKPSNLAVNEDCELKILDFGLARHTDDE-----MTGYVATRWYRAPEIML-NWM 198
Query: 464 EVSYKSDVYNYGMMIFEMTGGR 485
             +   D+++ G ++ E+  GR
Sbjct: 199 HYNQTVDIWSVGCIMAELLTGR 220

>pdb|2LGC|A Chain A, Joint Nmr And X-Ray Refinement Reveals The Structure Of A Novel Dibenzo[a,D]cycloheptenone InhibitorP38 MAP KINASE COMPLEX IN Solution Length = 359

Iteration: 1
 Score = 60.1 bits (144), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 61/202 (30%), Positives = 89/202 (44%), Gaps = 48/202 (23%)
Query: 321 LGQGGYGSV---YKGKLLDGSNVAVKVLN---DSKGNGKEFINEVASISRTSHVNVVALL 374
           +G G YGSV   +  K   G  VAVK L+    S  + K    E+  +    H NV+ LL
Sbjct: 35  VGSGAYGSVCAAFDTK--TGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLL 92
Query: 375 GFCL--RVAEE------LSSTIG-----------------------IARGLEYLHLGCST 403
                 R  EE      ++  +G                       I RGL+Y+H   S 
Sbjct: 93  DVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIH---SA 149
Query: 404 RILHFDIKPHNILLDEDFCPKISDFGLAKICNRKESIISMTGARGTVGYIAPEVFCRNIG 463
            I+H D+KP N+ ++ED   KI DFGLA+  + +     MTG   T  Y APE+   N  
Sbjct: 150 DIIHRDLKPSNLAVNEDCELKILDFGLARHTDDE-----MTGYVATRWYRAPEIML-NWM 203
Query: 464 EVSYKSDVYNYGMMIFEMTGGR 485
             +   D+++ G ++ E+  GR
Sbjct: 204 HYNQTVDIWSVGCIMAELLTGR 225

>pdb|3D7Z|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360

Iteration: 1
 Score = 60.1 bits (144), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 61/202 (30%), Positives = 89/202 (44%), Gaps = 48/202 (23%)
Query: 321 LGQGGYGSV---YKGKLLDGSNVAVKVLN---DSKGNGKEFINEVASISRTSHVNVVALL 374
           +G G YGSV   +  K   G  VAVK L+    S  + K    E+  +    H NV+ LL
Sbjct: 30  VGSGAYGSVCAAFDTK--TGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLL 87
Query: 375 GFCL--RVAEE------LSSTIG-----------------------IARGLEYLHLGCST 403
                 R  EE      ++  +G                       I RGL+Y+H   S 
Sbjct: 88  DVFTPARSLEEFNDVYLVTHLMGADLNNIVKXQKLTDDHVQFLIYQILRGLKYIH---SA 144
Query: 404 RILHFDIKPHNILLDEDFCPKISDFGLAKICNRKESIISMTGARGTVGYIAPEVFCRNIG 463
            I+H D+KP N+ ++ED   KI DFGLA+  + +     MTG   T  Y APE+   N  
Sbjct: 145 DIIHRDLKPSNLAVNEDCELKILDFGLARHTDDE-----MTGYVATRWYRAPEIML-NWM 198
Query: 464 EVSYKSDVYNYGMMIFEMTGGR 485
             +   D+++ G ++ E+  GR
Sbjct: 199 HYNQTVDIWSVGCIMAELLTGR 220

>pdb|3S3I|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 349

Iteration: 1
 Score = 60.1 bits (144), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 60/202 (29%), Positives = 86/202 (42%), Gaps = 48/202 (23%)
Query: 321 LGQGGYGSV---YKGKLLDGSNVAVKVLN---DSKGNGKEFINEVASISRTSHVNVVALL 374
           +G G YGSV   +  K   G  VAVK L+    S  + K    E+  +    H NV+ LL
Sbjct: 27  VGSGAYGSVCAAFDTK--TGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLL 84
Query: 375 GFCL--RVAEELSSTI-----------------------------GIARGLEYLHLGCST 403
                 R  EE +                                 I RGL+Y+H   S 
Sbjct: 85  DVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIH---SA 141
Query: 404 RILHFDIKPHNILLDEDFCPKISDFGLAKICNRKESIISMTGARGTVGYIAPEVFCRNIG 463
            I+H D+KP N+ ++ED   KI DFGLA+  + +     MTG   T  Y APE+   N  
Sbjct: 142 DIIHRDLKPSNLAVNEDCELKILDFGLARHTDDE-----MTGYVATRWYRAPEIML-NWM 195
Query: 464 EVSYKSDVYNYGMMIFEMTGGR 485
             +   D+++ G ++ E+  GR
Sbjct: 196 HYNQTVDIWSVGCIMAELLTGR 217

>pdb|3QHR|A Chain A, Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic Length = 298

Iteration: 1
 Score = 60.1 bits (144), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 55/200 (27%), Positives = 91/200 (45%), Gaps = 42/200 (21%)
Query: 320 KLGQGGYGSVYKGK-LLDGSNVAVKVL---NDSKGNGKEFINEVASISRTSHVNVVALLG 375
           K+G+G YG VYK +  L G  VA+K +    +++G     I E++ +   +H N+V LL 
Sbjct: 11  KIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLD 70
Query: 376 FC----------------LRVAEELSSTIGIA------------RGLEYLHLGCSTRILH 407
                             L+   + S+  GI             +GL + H   S R+LH
Sbjct: 71  VIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCH---SHRVLH 127
Query: 408 FDIKPHNILLDEDFCPKISDFGLAKICNRKESIISMTGARGTVGYIAPEVF--CRNIGEV 465
            D+KP N+L++ +   K++DFGLA+       + +      T+ Y APE+   C+     
Sbjct: 128 RDLKPQNLLINTEGAIKLADFGLARAFG--VPVRTYXHEVVTLWYRAPEILLGCKY---Y 182
Query: 466 SYKSDVYNYGMMIFEMTGGR 485
           S   D+++ G +  EM   R
Sbjct: 183 STAVDIWSLGCIFAEMVTRR 202

>pdb|1ZZL|A Chain A, Crystal Structure Of P38 With Triazolopyridine Length = 351

Iteration: 1
 Score = 60.1 bits (144), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 60/202 (29%), Positives = 86/202 (42%), Gaps = 48/202 (23%)
Query: 321 LGQGGYGSV---YKGKLLDGSNVAVKVLN---DSKGNGKEFINEVASISRTSHVNVVALL 374
           +G G YGSV   +  K   G  VAVK L+    S  + K    E+  +    H NV+ LL
Sbjct: 27  VGSGAYGSVCAAFDTK--TGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLL 84
Query: 375 GFCL--RVAEELSSTI-----------------------------GIARGLEYLHLGCST 403
                 R  EE +                                 I RGL+Y+H   S 
Sbjct: 85  DVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIH---SA 141
Query: 404 RILHFDIKPHNILLDEDFCPKISDFGLAKICNRKESIISMTGARGTVGYIAPEVFCRNIG 463
            I+H D+KP N+ ++ED   KI DFGLA+  + +     MTG   T  Y APE+   N  
Sbjct: 142 DIIHRDLKPSNLAVNEDCELKILDFGLARHTDDE-----MTGYVATRWYRAPEIML-NWM 195
Query: 464 EVSYKSDVYNYGMMIFEMTGGR 485
             +   D+++ G ++ E+  GR
Sbjct: 196 HYNQTVDIWSVGCIMAELLTGR 217

>pdb|1M7Q|A Chain A, Crystal Structure Of P38 Map Kinase In Complex With A Dihydroquinazolinone Inhibitor Length = 366

Iteration: 1
 Score = 60.1 bits (144), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 61/202 (30%), Positives = 89/202 (44%), Gaps = 48/202 (23%)
Query: 321 LGQGGYGSV---YKGKLLDGSNVAVKVLN---DSKGNGKEFINEVASISRTSHVNVVALL 374
           +G G YGSV   +  K   G  VAVK L+    S  + K    E+  +    H NV+ LL
Sbjct: 36  VGSGAYGSVCAAFDTK--TGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLL 93
Query: 375 GFCL--RVAEE------LSSTIG-----------------------IARGLEYLHLGCST 403
                 R  EE      ++  +G                       I RGL+Y+H   S 
Sbjct: 94  DVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIH---SA 150
Query: 404 RILHFDIKPHNILLDEDFCPKISDFGLAKICNRKESIISMTGARGTVGYIAPEVFCRNIG 463
            I+H D+KP N+ ++ED   KI DFGLA+  + +     MTG   T  Y APE+   N  
Sbjct: 151 DIIHRDLKPSNLAVNEDCELKILDFGLARHTDDE-----MTGYVATRWYRAPEIML-NWM 204
Query: 464 EVSYKSDVYNYGMMIFEMTGGR 485
             +   D+++ G ++ E+  GR
Sbjct: 205 HYNQTVDIWSVGCIMAELLTGR 226

>pdb|3GCU|A Chain A, Human P38 Map Kinase In Complex With Rl48 Length = 360

Iteration: 1
 Score = 60.1 bits (144), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 60/202 (29%), Positives = 86/202 (42%), Gaps = 48/202 (23%)
Query: 321 LGQGGYGSV---YKGKLLDGSNVAVKVLN---DSKGNGKEFINEVASISRTSHVNVVALL 374
           +G G YGSV   +  K   G  VAVK L+    S  + K    E+  +    H NV+ LL
Sbjct: 30  VGSGAYGSVCAAFDTK--TGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLL 87
Query: 375 GFCL--RVAEELSSTI-----------------------------GIARGLEYLHLGCST 403
                 R  EE +                                 I RGL+Y+H   S 
Sbjct: 88  DVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIH---SA 144
Query: 404 RILHFDIKPHNILLDEDFCPKISDFGLAKICNRKESIISMTGARGTVGYIAPEVFCRNIG 463
            I+H D+KP N+ ++ED   KI DFGLA+  + +     MTG   T  Y APE+   N  
Sbjct: 145 DIIHRDLKPSNLAVNEDCELKILDFGLARHTDDE-----MTGYVATRWYRAPEIML-NWM 198
Query: 464 EVSYKSDVYNYGMMIFEMTGGR 485
             +   D+++ G ++ E+  GR
Sbjct: 199 HYNQTVDIWSVGCIMAELLTGR 220

>pdb|3K3J|A Chain A, P38alpha Bound To Novel Dfg-Out Compound Pf-00416121 Length = 362

Iteration: 1
 Score = 60.1 bits (144), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 60/202 (29%), Positives = 86/202 (42%), Gaps = 48/202 (23%)
Query: 321 LGQGGYGSV---YKGKLLDGSNVAVKVLN---DSKGNGKEFINEVASISRTSHVNVVALL 374
           +G G YGSV   +  K   G  VAVK L+    S  + K    E+  +    H NV+ LL
Sbjct: 32  VGSGAYGSVCAAFDTK--TGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLL 89
Query: 375 GFCL--RVAEELSSTI-----------------------------GIARGLEYLHLGCST 403
                 R  EE +                                 I RGL+Y+H   S 
Sbjct: 90  DVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIH---SA 146
Query: 404 RILHFDIKPHNILLDEDFCPKISDFGLAKICNRKESIISMTGARGTVGYIAPEVFCRNIG 463
            I+H D+KP N+ ++ED   KI DFGLA+  + +     MTG   T  Y APE+   N  
Sbjct: 147 DIIHRDLKPSNLAVNEDCELKILDFGLARHTDDE-----MTGYVATRWYRAPEIML-NWM 200
Query: 464 EVSYKSDVYNYGMMIFEMTGGR 485
             +   D+++ G ++ E+  GR
Sbjct: 201 HYNQTVDIWSVGCIMAELLTGR 222

>pdb|3HEC|A Chain A, P38 In Complex With Imatinib Length = 348

Iteration: 1
 Score = 60.1 bits (144), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 60/202 (29%), Positives = 86/202 (42%), Gaps = 48/202 (23%)
Query: 321 LGQGGYGSV---YKGKLLDGSNVAVKVLN---DSKGNGKEFINEVASISRTSHVNVVALL 374
           +G G YGSV   +  K   G  VAVK L+    S  + K    E+  +    H NV+ LL
Sbjct: 26  VGSGAYGSVCAAFDTK--TGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLL 83
Query: 375 GFCL--RVAEELSSTI-----------------------------GIARGLEYLHLGCST 403
                 R  EE +                                 I RGL+Y+H   S 
Sbjct: 84  DVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIH---SA 140
Query: 404 RILHFDIKPHNILLDEDFCPKISDFGLAKICNRKESIISMTGARGTVGYIAPEVFCRNIG 463
            I+H D+KP N+ ++ED   KI DFGLA+  + +     MTG   T  Y APE+   N  
Sbjct: 141 DIIHRDLKPSNLAVNEDCELKILDFGLARHTDDE-----MTGYVATRWYRAPEIML-NWM 194
Query: 464 EVSYKSDVYNYGMMIFEMTGGR 485
             +   D+++ G ++ E+  GR
Sbjct: 195 HYNQTVDIWSVGCIMAELLTGR 216

>pdb|3NNU|A Chain A, Crystal Structure Of P38 Alpha In Complex With Dp1376 Length = 354

Iteration: 1
 Score = 60.1 bits (144), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 61/202 (30%), Positives = 89/202 (44%), Gaps = 48/202 (23%)
Query: 321 LGQGGYGSV---YKGKLLDGSNVAVKVLN---DSKGNGKEFINEVASISRTSHVNVVALL 374
           +G G YGSV   +  K   G  VAVK L+    S  + K    E+  +    H NV+ LL
Sbjct: 30  VGSGAYGSVCAAFDTK--TGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLL 87
Query: 375 GFCL--RVAEE------LSSTIG-----------------------IARGLEYLHLGCST 403
                 R  EE      ++  +G                       I RGL+Y+H   S 
Sbjct: 88  DVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIH---SA 144
Query: 404 RILHFDIKPHNILLDEDFCPKISDFGLAKICNRKESIISMTGARGTVGYIAPEVFCRNIG 463
            I+H D+KP N+ ++ED   KI DFGLA+  + +     MTG   T  Y APE+   N  
Sbjct: 145 DIIHRDLKPSNLAVNEDCELKILDFGLARHTDDE-----MTGYVATRWYRAPEIML-NWM 198
Query: 464 EVSYKSDVYNYGMMIFEMTGGR 485
             +   D+++ G ++ E+  GR
Sbjct: 199 HYNQTVDIWSVGCIMAELLTGR 220

>pdb|3HVC|A Chain A, Crystal Structure Of Human P38alpha Map Kinase Length = 362

Iteration: 1
 Score = 60.1 bits (144), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 60/202 (29%), Positives = 86/202 (42%), Gaps = 48/202 (23%)
Query: 321 LGQGGYGSV---YKGKLLDGSNVAVKVLN---DSKGNGKEFINEVASISRTSHVNVVALL 374
           +G G YGSV   +  K   G  VAVK L+    S  + K    E+  +    H NV+ LL
Sbjct: 32  VGSGAYGSVCAAFDTK--TGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLL 89
Query: 375 GFCL--RVAEELSSTI-----------------------------GIARGLEYLHLGCST 403
                 R  EE +                                 I RGL+Y+H   S 
Sbjct: 90  DVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIH---SA 146
Query: 404 RILHFDIKPHNILLDEDFCPKISDFGLAKICNRKESIISMTGARGTVGYIAPEVFCRNIG 463
            I+H D+KP N+ ++ED   KI DFGLA+  + +     MTG   T  Y APE+   N  
Sbjct: 147 DIIHRDLKPSNLAVNEDCELKILDFGLARHTDDE-----MTGYVATRWYRAPEIML-NWM 200
Query: 464 EVSYKSDVYNYGMMIFEMTGGR 485
             +   D+++ G ++ E+  GR
Sbjct: 201 HYNQTVDIWSVGCIMAELLTGR 222

>pdb|1FVR|A Chain A, Tie2 Kinase Domain Length = 327

Iteration: 1
 Score = 60.1 bits (144), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 55/215 (25%), Positives = 100/215 (46%), Gaps = 57/215 (26%)
Query: 317 FKYKLGQGGYGSVYKGKLL-DG--SNVAVKVLND--SKGNGKEFINEVASISRTSH-VNV 370
           F+  +G+G +G V K ++  DG   + A+K + +  SK + ++F  E+  + +  H  N+
Sbjct: 29  FQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNI 88
Query: 371 VALLGFC---------------------LR------------VAEELSSTIG-------- 389
           + LLG C                     LR            +A   +ST+         
Sbjct: 89  INLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFA 148
Query: 390 --IARGLEYLHLGCSTRILHFDIKPHNILLDEDFCPKISDFGLAKICNRKESIISMTGAR 447
             +ARG++YL      + +H D+   NIL+ E++  KI+DFGL++    +E  +  T  R
Sbjct: 149 ADVARGMDYL---SQKQFIHRDLAARNILVGENYVAKIADFGLSR---GQEVYVKKTMGR 202
Query: 448 GTVGYIAPEVFCRNIGEVSYKSDVYNYGMMIFEMT 482
             V ++A E    N    +  SDV++YG++++E+ 
Sbjct: 203 LPVRWMAIESL--NYSVYTTNSDVWSYGVLLWEIV 235

>pdb|1OGU|A Chain A, Structure Of Human Thr160-phospho Cdk2/cyclin A Complexed With A 2-arylamino-4-cyclohexylmethyl-5-nitroso-6- aminopyrimidine Inhibitor Length = 302

Iteration: 1
 Score = 60.1 bits (144), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 55/200 (27%), Positives = 91/200 (45%), Gaps = 42/200 (21%)
Query: 320 KLGQGGYGSVYKGK-LLDGSNVAVKVL---NDSKGNGKEFINEVASISRTSHVNVVALLG 375
           K+G+G YG VYK +  L G  VA+K +    +++G     I E++ +   +H N+V LL 
Sbjct: 13  KIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLD 72
Query: 376 FC----------------LRVAEELSSTIGIA------------RGLEYLHLGCSTRILH 407
                             L+   + S+  GI             +GL + H   S R+LH
Sbjct: 73  VIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCH---SHRVLH 129
Query: 408 FDIKPHNILLDEDFCPKISDFGLAKICNRKESIISMTGARGTVGYIAPEVF--CRNIGEV 465
            D+KP N+L++ +   K++DFGLA+       + +      T+ Y APE+   C+     
Sbjct: 130 RDLKPQNLLINTEGAIKLADFGLARAFG--VPVRTYXHEVVTLWYRAPEILLGCKY---Y 184
Query: 466 SYKSDVYNYGMMIFEMTGGR 485
           S   D+++ G +  EM   R
Sbjct: 185 STAVDIWSLGCIFAEMVTRR 204

>pdb|4EOQ|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With Atp Length = 301

Iteration: 1
 Score = 60.1 bits (144), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 55/200 (27%), Positives = 91/200 (45%), Gaps = 42/200 (21%)
Query: 320 KLGQGGYGSVYKGK-LLDGSNVAVKVL---NDSKGNGKEFINEVASISRTSHVNVVALLG 375
           K+G+G YG VYK +  L G  VA+K +    +++G     I E++ +   +H N+V LL 
Sbjct: 13  KIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLD 72
Query: 376 FC----------------LRVAEELSSTIGIA------------RGLEYLHLGCSTRILH 407
                             L+   + S+  GI             +GL + H   S R+LH
Sbjct: 73  VIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCH---SHRVLH 129
Query: 408 FDIKPHNILLDEDFCPKISDFGLAKICNRKESIISMTGARGTVGYIAPEVF--CRNIGEV 465
            D+KP N+L++ +   K++DFGLA+       + +      T+ Y APE+   C+     
Sbjct: 130 RDLKPQNLLINTEGAIKLADFGLARAFG--VPVRTYXHEVVTLWYRAPEILLGCKY---Y 184
Query: 466 SYKSDVYNYGMMIFEMTGGR 485
           S   D+++ G +  EM   R
Sbjct: 185 STAVDIWSLGCIFAEMVTRR 204

>pdb|4BCQ|A Chain A, Structure Of Cdk2 In Complex With Cyclin A And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 301

Iteration: 1
 Score = 60.1 bits (144), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 55/200 (27%), Positives = 91/200 (45%), Gaps = 42/200 (21%)
Query: 320 KLGQGGYGSVYKGK-LLDGSNVAVKVL---NDSKGNGKEFINEVASISRTSHVNVVALLG 375
           K+G+G YG VYK +  L G  VA+K +    +++G     I E++ +   +H N+V LL 
Sbjct: 12  KIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLD 71
Query: 376 FC----------------LRVAEELSSTIGIA------------RGLEYLHLGCSTRILH 407
                             L+   + S+  GI             +GL + H   S R+LH
Sbjct: 72  VIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCH---SHRVLH 128
Query: 408 FDIKPHNILLDEDFCPKISDFGLAKICNRKESIISMTGARGTVGYIAPEVF--CRNIGEV 465
            D+KP N+L++ +   K++DFGLA+       + +      T+ Y APE+   C+     
Sbjct: 129 RDLKPQNLLINTEGAIKLADFGLARAFG--VPVRTYXHEVVTLWYRAPEILLGCKY---Y 183
Query: 466 SYKSDVYNYGMMIFEMTGGR 485
           S   D+++ G +  EM   R
Sbjct: 184 STAVDIWSLGCIFAEMVTRR 203

>pdb|3BHT|A Chain A, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX WITH THE Inhibitor Meriolin 3 Length = 300

Iteration: 1
 Score = 60.1 bits (144), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 55/200 (27%), Positives = 91/200 (45%), Gaps = 42/200 (21%)
Query: 320 KLGQGGYGSVYKGK-LLDGSNVAVKVL---NDSKGNGKEFINEVASISRTSHVNVVALLG 375
           K+G+G YG VYK +  L G  VA+K +    +++G     I E++ +   +H N+V LL 
Sbjct: 11  KIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLD 70
Query: 376 FC----------------LRVAEELSSTIGIA------------RGLEYLHLGCSTRILH 407
                             L+   + S+  GI             +GL + H   S R+LH
Sbjct: 71  VIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCH---SHRVLH 127
Query: 408 FDIKPHNILLDEDFCPKISDFGLAKICNRKESIISMTGARGTVGYIAPEVF--CRNIGEV 465
            D+KP N+L++ +   K++DFGLA+       + +      T+ Y APE+   C+     
Sbjct: 128 RDLKPQNLLINTEGAIKLADFGLARAFG--VPVRTYXHEVVTLWYRAPEILLGCKY---Y 182
Query: 466 SYKSDVYNYGMMIFEMTGGR 485
           S   D+++ G +  EM   R
Sbjct: 183 STAVDIWSLGCIFAEMVTRR 202

>pdb|3ZSG|A Chain A, X-Ray Structure Of P38alpha Bound To Tak-715 Length = 362

Iteration: 1
 Score = 60.1 bits (144), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 60/202 (29%), Positives = 86/202 (42%), Gaps = 48/202 (23%)
Query: 321 LGQGGYGSV---YKGKLLDGSNVAVKVLN---DSKGNGKEFINEVASISRTSHVNVVALL 374
           +G G YGSV   +  K   G  VAVK L+    S  + K    E+  +    H NV+ LL
Sbjct: 32  VGSGAYGSVCAAFDTK--TGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLL 89
Query: 375 GFCL--RVAEELSSTI-----------------------------GIARGLEYLHLGCST 403
                 R  EE +                                 I RGL+Y+H   S 
Sbjct: 90  DVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIH---SA 146
Query: 404 RILHFDIKPHNILLDEDFCPKISDFGLAKICNRKESIISMTGARGTVGYIAPEVFCRNIG 463
            I+H D+KP N+ ++ED   KI DFGLA+  + +     MTG   T  Y APE+   N  
Sbjct: 147 DIIHRDLKPSNLAVNEDCELKILDFGLARHTDDE-----MTGYVATRWYRAPEIML-NWM 200
Query: 464 EVSYKSDVYNYGMMIFEMTGGR 485
             +   D+++ G ++ E+  GR
Sbjct: 201 HYNQTVDIWSVGCIMAELLTGR 222

>pdb|2IW8|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82h-L83v- H84d Mutant With An O6-Cyclohexylmethylguanine Inhibitor Length = 302

Iteration: 1
 Score = 60.1 bits (144), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 55/200 (27%), Positives = 91/200 (45%), Gaps = 42/200 (21%)
Query: 320 KLGQGGYGSVYKGK-LLDGSNVAVKVL---NDSKGNGKEFINEVASISRTSHVNVVALLG 375
           K+G+G YG VYK +  L G  VA+K +    +++G     I E++ +   +H N+V LL 
Sbjct: 13  KIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLD 72
Query: 376 FC----------------LRVAEELSSTIGIA------------RGLEYLHLGCSTRILH 407
                             L+   + S+  GI             +GL + H   S R+LH
Sbjct: 73  VIHTENKLYLVFEHVDQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCH---SHRVLH 129
Query: 408 FDIKPHNILLDEDFCPKISDFGLAKICNRKESIISMTGARGTVGYIAPEVF--CRNIGEV 465
            D+KP N+L++ +   K++DFGLA+       + +      T+ Y APE+   C+     
Sbjct: 130 RDLKPQNLLINTEGAIKLADFGLARAFG--VPVRTYXHEVVTLWYRAPEILLGCKY---Y 184
Query: 466 SYKSDVYNYGMMIFEMTGGR 485
           S   D+++ G +  EM   R
Sbjct: 185 STAVDIWSLGCIFAEMVTRR 204

>pdb|1H1P|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED With The Inhibitor Nu2058 Length = 303

Iteration: 1
 Score = 60.1 bits (144), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 55/200 (27%), Positives = 91/200 (45%), Gaps = 42/200 (21%)
Query: 320 KLGQGGYGSVYKGK-LLDGSNVAVKVL---NDSKGNGKEFINEVASISRTSHVNVVALLG 375
           K+G+G YG VYK +  L G  VA+K +    +++G     I E++ +   +H N+V LL 
Sbjct: 14  KIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLD 73
Query: 376 FC----------------LRVAEELSSTIGIA------------RGLEYLHLGCSTRILH 407
                             L+   + S+  GI             +GL + H   S R+LH
Sbjct: 74  VIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCH---SHRVLH 130
Query: 408 FDIKPHNILLDEDFCPKISDFGLAKICNRKESIISMTGARGTVGYIAPEVF--CRNIGEV 465
            D+KP N+L++ +   K++DFGLA+       + +      T+ Y APE+   C+     
Sbjct: 131 RDLKPQNLLINTEGAIKLADFGLARAFG--VPVRTYXHEVVTLWYRAPEILLGCKY---Y 185
Query: 466 SYKSDVYNYGMMIFEMTGGR 485
           S   D+++ G +  EM   R
Sbjct: 186 STAVDIWSLGCIFAEMVTRR 205

>pdb|3FI4|A Chain A, P38 Kinase Crystal Structure In Complex With Ro4499 Length = 372

Iteration: 1
 Score = 60.1 bits (144), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 61/202 (30%), Positives = 89/202 (44%), Gaps = 48/202 (23%)
Query: 321 LGQGGYGSV---YKGKLLDGSNVAVKVLN---DSKGNGKEFINEVASISRTSHVNVVALL 374
           +G G YGSV   +  K   G  VAVK L+    S  + K    E+  +    H NV+ LL
Sbjct: 42  VGSGAYGSVCAAFDTK--TGLRVAVKKLSKPFQSIIHAKRTYRELRLLKHMKHENVIGLL 99
Query: 375 GFCL--RVAEE------LSSTIG-----------------------IARGLEYLHLGCST 403
                 R  EE      ++  +G                       I RGL+Y+H   S 
Sbjct: 100 DVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIH---SA 156
Query: 404 RILHFDIKPHNILLDEDFCPKISDFGLAKICNRKESIISMTGARGTVGYIAPEVFCRNIG 463
            I+H D+KP N+ ++ED   KI DFGLA+  + +     MTG   T  Y APE+   N  
Sbjct: 157 DIIHRDLKPSNLAVNEDCELKILDFGLARHTDDE-----MTGYVATRWYRAPEIML-NWM 210
Query: 464 EVSYKSDVYNYGMMIFEMTGGR 485
             +   D+++ G ++ E+  GR
Sbjct: 211 HYNQTVDIWSVGCIMAELLTGR 232

>pdb|2ACX|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 6 Bound To Amppnp Length = 576

Iteration: 1
 Score = 60.1 bits (144), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 37/93 (39%), Positives = 52/93 (55%), Gaps = 8/93 (8%)
Query: 393 GLEYLHLGCSTRILHFDIKPHNILLDEDFCPKISDFGLAKICNRKESIISMTGARGTVGY 452
           GLE LH     RI++ D+KP NILLD+    +ISD GLA      ++I    G  GTVGY
Sbjct: 298 GLEDLH---RERIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQTI---KGRVGTVGY 351
Query: 453 IAPEVFCRNIGEVSYKSDVYNYGMMIFEMTGGR 485
           +APEV        ++  D +  G +++EM  G+
Sbjct: 352 MAPEVVKNE--RYTFSPDWWALGCLLYEMIAGQ 382

>pdb|3K3I|A Chain A, P38alpha Bound To Novel Dgf-Out Compound Pf-00215955 Length = 350

Iteration: 1
 Score = 60.1 bits (144), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 61/202 (30%), Positives = 89/202 (44%), Gaps = 48/202 (23%)
Query: 321 LGQGGYGSV---YKGKLLDGSNVAVKVLN---DSKGNGKEFINEVASISRTSHVNVVALL 374
           +G G YGSV   +  K   G  VAVK L+    S  + K    E+  +    H NV+ LL
Sbjct: 28  VGSGAYGSVCAAFDTK--TGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLL 85
Query: 375 GFCL--RVAEE------LSSTIG-----------------------IARGLEYLHLGCST 403
                 R  EE      ++  +G                       I RGL+Y+H   S 
Sbjct: 86  DVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIH---SA 142
Query: 404 RILHFDIKPHNILLDEDFCPKISDFGLAKICNRKESIISMTGARGTVGYIAPEVFCRNIG 463
            I+H D+KP N+ ++ED   KI DFGLA+  + +     MTG   T  Y APE+   N  
Sbjct: 143 DIIHRDLKPSNLAVNEDCELKILDFGLARHTDDE-----MTGYVATRWYRAPEIML-NWM 196
Query: 464 EVSYKSDVYNYGMMIFEMTGGR 485
             +   D+++ G ++ E+  GR
Sbjct: 197 HYNQTVDIWSVGCIMAELLTGR 218

>pdb|4EOP|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300

Iteration: 1
 Score = 59.7 bits (143), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 55/200 (27%), Positives = 91/200 (45%), Gaps = 42/200 (21%)
Query: 320 KLGQGGYGSVYKGK-LLDGSNVAVKVL---NDSKGNGKEFINEVASISRTSHVNVVALLG 375
           K+G+G YG VYK +  L G  VA+K +    +++G     I E++ +   +H N+V LL 
Sbjct: 12  KIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLD 71
Query: 376 FC----------------LRVAEELSSTIGIA------------RGLEYLHLGCSTRILH 407
                             L+   + S+  GI             +GL + H   S R+LH
Sbjct: 72  VIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCH---SHRVLH 128
Query: 408 FDIKPHNILLDEDFCPKISDFGLAKICNRKESIISMTGARGTVGYIAPEVF--CRNIGEV 465
            D+KP N+L++ +   K++DFGLA+       + +      T+ Y APE+   C+     
Sbjct: 129 RDLKPENLLINTEGAIKLADFGLARAFG--VPVRTYXHEVVTLWYRAPEILLGCKY---Y 183
Query: 466 SYKSDVYNYGMMIFEMTGGR 485
           S   D+++ G +  EM   R
Sbjct: 184 STAVDIWSLGCIFAEMVTRR 203

>pdb|4EOJ|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With Atp Length = 302

Iteration: 1
 Score = 59.7 bits (143), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 55/200 (27%), Positives = 91/200 (45%), Gaps = 42/200 (21%)
Query: 320 KLGQGGYGSVYKGK-LLDGSNVAVKVL---NDSKGNGKEFINEVASISRTSHVNVVALLG 375
           K+G+G YG VYK +  L G  VA+K +    +++G     I E++ +   +H N+V LL 
Sbjct: 13  KIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLD 72
Query: 376 FC----------------LRVAEELSSTIGIA------------RGLEYLHLGCSTRILH 407
                             L+   + S+  GI             +GL + H   S R+LH
Sbjct: 73  VIHTENKLYLVFEFLSMDLKDFMDASALTGIPLPLIKSYLFQLLQGLAFCH---SHRVLH 129
Query: 408 FDIKPHNILLDEDFCPKISDFGLAKICNRKESIISMTGARGTVGYIAPEVF--CRNIGEV 465
            D+KP N+L++ +   K++DFGLA+       + +      T+ Y APE+   C+     
Sbjct: 130 RDLKPQNLLINTEGAIKLADFGLARAFG--VPVRTYXHEVVTLWYRAPEILLGCKY---Y 184
Query: 466 SYKSDVYNYGMMIFEMTGGR 485
           S   D+++ G +  EM   R
Sbjct: 185 STAVDIWSLGCIFAEMVTRR 204

>pdb|1OZ1|A Chain A, P38 Mitogen-Activated Kinase In Complex With 4-Azaindole Inhibitor Length = 372

Iteration: 1
 Score = 59.7 bits (143), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 60/202 (29%), Positives = 86/202 (42%), Gaps = 48/202 (23%)
Query: 321 LGQGGYGSV---YKGKLLDGSNVAVKVLN---DSKGNGKEFINEVASISRTSHVNVVALL 374
           +G G YGSV   +  K   G  VAVK L+    S  + K    E+  +    H NV+ LL
Sbjct: 42  VGSGAYGSVCAAFDTK--TGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLL 99
Query: 375 GFCL--RVAEELSSTI-----------------------------GIARGLEYLHLGCST 403
                 R  EE +                                 I RGL+Y+H   S 
Sbjct: 100 DVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIH---SA 156
Query: 404 RILHFDIKPHNILLDEDFCPKISDFGLAKICNRKESIISMTGARGTVGYIAPEVFCRNIG 463
            I+H D+KP N+ ++ED   KI DFGLA+  + +     MTG   T  Y APE+   N  
Sbjct: 157 DIIHRDLKPSNLAVNEDCELKILDFGLARHTDDE-----MTGYVATRWYRAPEIML-NWM 210
Query: 464 EVSYKSDVYNYGMMIFEMTGGR 485
             +   D+++ G ++ E+  GR
Sbjct: 211 HYNQTVDIWSVGCIMAELLTGR 232

>pdb|2GFS|A Chain A, P38 Kinase Crystal Structure In Complex With Ro3201195 Length = 372

Iteration: 1
 Score = 59.7 bits (143), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 60/202 (29%), Positives = 86/202 (42%), Gaps = 48/202 (23%)
Query: 321 LGQGGYGSV---YKGKLLDGSNVAVKVLN---DSKGNGKEFINEVASISRTSHVNVVALL 374
           +G G YGSV   +  K   G  VAVK L+    S  + K    E+  +    H NV+ LL
Sbjct: 42  VGSGAYGSVCAAFDTK--TGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLL 99
Query: 375 GFCL--RVAEELSSTI-----------------------------GIARGLEYLHLGCST 403
                 R  EE +                                 I RGL+Y+H   S 
Sbjct: 100 DVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIH---SA 156
Query: 404 RILHFDIKPHNILLDEDFCPKISDFGLAKICNRKESIISMTGARGTVGYIAPEVFCRNIG 463
            I+H D+KP N+ ++ED   KI DFGLA+  + +     MTG   T  Y APE+   N  
Sbjct: 157 DIIHRDLKPSNLAVNEDCELKILDFGLARHTDDE-----MTGYVATRWYRAPEIML-NWM 210
Query: 464 EVSYKSDVYNYGMMIFEMTGGR 485
             +   D+++ G ++ E+  GR
Sbjct: 211 HYNQTVDIWSVGCIMAELLTGR 232

>pdb|4EOM|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With Atp Length = 301

Iteration: 1
 Score = 59.7 bits (143), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 55/200 (27%), Positives = 91/200 (45%), Gaps = 42/200 (21%)
Query: 320 KLGQGGYGSVYKGK-LLDGSNVAVKVL---NDSKGNGKEFINEVASISRTSHVNVVALLG 375
           K+G+G YG VYK +  L G  VA+K +    +++G     I E++ +   +H N+V LL 
Sbjct: 13  KIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLD 72
Query: 376 FC----------------LRVAEELSSTIGIA------------RGLEYLHLGCSTRILH 407
                             L+   + S+  GI             +GL + H   S R+LH
Sbjct: 73  VIHTENKLYLVFEFLSMDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCH---SHRVLH 129
Query: 408 FDIKPHNILLDEDFCPKISDFGLAKICNRKESIISMTGARGTVGYIAPEVF--CRNIGEV 465
            D+KP N+L++ +   K++DFGLA+       + +      T+ Y APE+   C+     
Sbjct: 130 RDLKPENLLINTEGAIKLADFGLARAFG--VPVRTYXHEVVTLWYRAPEILLGCKY---Y 184
Query: 466 SYKSDVYNYGMMIFEMTGGR 485
           S   D+++ G +  EM   R
Sbjct: 185 STAVDIWSLGCIFAEMVTRR 204

>pdb|3MPT|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Pyrrole-2- Carboxamide Inhibitor Length = 371

Iteration: 1
 Score = 59.7 bits (143), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 61/202 (30%), Positives = 89/202 (44%), Gaps = 48/202 (23%)
Query: 321 LGQGGYGSV---YKGKLLDGSNVAVKVLN---DSKGNGKEFINEVASISRTSHVNVVALL 374
           +G G YGSV   +  K   G  VAVK L+    S  + K    E+  +    H NV+ LL
Sbjct: 41  VGSGAYGSVCAAFDTK--TGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLL 98
Query: 375 GFCL--RVAEE------LSSTIG-----------------------IARGLEYLHLGCST 403
                 R  EE      ++  +G                       I RGL+Y+H   S 
Sbjct: 99  DVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIH---SA 155
Query: 404 RILHFDIKPHNILLDEDFCPKISDFGLAKICNRKESIISMTGARGTVGYIAPEVFCRNIG 463
            I+H D+KP N+ ++ED   KI DFGLA+  + +     MTG   T  Y APE+   N  
Sbjct: 156 DIIHRDLKPSNLAVNEDCELKILDFGLARHTDDE-----MTGYVATRWYRAPEIML-NWM 209
Query: 464 EVSYKSDVYNYGMMIFEMTGGR 485
             +   D+++ G ++ E+  GR
Sbjct: 210 HYNQTVDIWSVGCIMAELLTGR 231

>pdb|3KQ7|A Chain A, Structure Of Human P38alpha With N-[4-Methyl-3-(6-{[2-(1- Methylpyrrolidin-2-Yl)ethyl]amino}pyridine-3- Amido)phenyl]- 2-(Morpholin-4-Yl)pyridine-4-Carboxamide Length = 380

Iteration: 1
 Score = 59.7 bits (143), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 61/202 (30%), Positives = 89/202 (44%), Gaps = 48/202 (23%)
Query: 321 LGQGGYGSV---YKGKLLDGSNVAVKVLN---DSKGNGKEFINEVASISRTSHVNVVALL 374
           +G G YGSV   +  K   G  VAVK L+    S  + K    E+  +    H NV+ LL
Sbjct: 50  VGSGAYGSVCAAFDTK--TGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLL 107
Query: 375 GFCL--RVAEE------LSSTIG-----------------------IARGLEYLHLGCST 403
                 R  EE      ++  +G                       I RGL+Y+H   S 
Sbjct: 108 DVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIH---SA 164
Query: 404 RILHFDIKPHNILLDEDFCPKISDFGLAKICNRKESIISMTGARGTVGYIAPEVFCRNIG 463
            I+H D+KP N+ ++ED   KI DFGLA+  + +     MTG   T  Y APE+   N  
Sbjct: 165 DIIHRDLKPSNLAVNEDCELKILDFGLARHTDDE-----MTGYVATRWYRAPEIML-NWM 218
Query: 464 EVSYKSDVYNYGMMIFEMTGGR 485
             +   D+++ G ++ E+  GR
Sbjct: 219 HYNQTVDIWSVGCIMAELLTGR 240

>pdb|4EON|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300

Iteration: 1
 Score = 59.7 bits (143), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 55/200 (27%), Positives = 91/200 (45%), Gaps = 42/200 (21%)
Query: 320 KLGQGGYGSVYKGK-LLDGSNVAVKVL---NDSKGNGKEFINEVASISRTSHVNVVALLG 375
           K+G+G YG VYK +  L G  VA+K +    +++G     I E++ +   +H N+V LL 
Sbjct: 11  KIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLD 70
Query: 376 FC----------------LRVAEELSSTIGIA------------RGLEYLHLGCSTRILH 407
                             L+   + S+  GI             +GL + H   S R+LH
Sbjct: 71  VIHTENKLYLVFEFLSMDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCH---SHRVLH 127
Query: 408 FDIKPHNILLDEDFCPKISDFGLAKICNRKESIISMTGARGTVGYIAPEVF--CRNIGEV 465
            D+KP N+L++ +   K++DFGLA+       + +      T+ Y APE+   C+     
Sbjct: 128 RDLKPENLLINTEGAIKLADFGLARAFG--VPVRTYXHEVVTLWYRAPEILLGCKY---Y 182
Query: 466 SYKSDVYNYGMMIFEMTGGR 485
           S   D+++ G +  EM   R
Sbjct: 183 STAVDIWSLGCIFAEMVTRR 202

>pdb|2FST|X Chain X, Mitogen Activated Protein Kinase P38alpha (d176a+f327l) Activating Mutant Length = 367

Iteration: 1
 Score = 59.7 bits (143), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 61/202 (30%), Positives = 88/202 (43%), Gaps = 48/202 (23%)
Query: 321 LGQGGYGSV---YKGKLLDGSNVAVKVLN---DSKGNGKEFINEVASISRTSHVNVVALL 374
           +G G YGSV   +  K   G  VAVK L+    S  + K    E+  +    H NV+ LL
Sbjct: 37  VGSGAYGSVCAAFDTK--TGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLL 94
Query: 375 GFCL--RVAEE------LSSTIG-----------------------IARGLEYLHLGCST 403
                 R  EE      ++  +G                       I RGL+Y+H   S 
Sbjct: 95  DVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIH---SA 151
Query: 404 RILHFDIKPHNILLDEDFCPKISDFGLAKICNRKESIISMTGARGTVGYIAPEVFCRNIG 463
            I+H D+KP N+ ++ED   KI DFGLA     + +   MTG   T  Y APE+   N  
Sbjct: 152 DIIHRDLKPSNLAVNEDCELKILDFGLA-----RHTADEMTGYVATRWYRAPEIML-NWM 205
Query: 464 EVSYKSDVYNYGMMIFEMTGGR 485
             +   D+++ G ++ E+  GR
Sbjct: 206 HYNQTVDIWSVGCIMAELLTGR 227

>pdb|4EOO|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With Atp Length = 299

Iteration: 1
 Score = 59.7 bits (143), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 55/200 (27%), Positives = 91/200 (45%), Gaps = 42/200 (21%)
Query: 320 KLGQGGYGSVYKGK-LLDGSNVAVKVL---NDSKGNGKEFINEVASISRTSHVNVVALLG 375
           K+G+G YG VYK +  L G  VA+K +    +++G     I E++ +   +H N+V LL 
Sbjct: 11  KIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLD 70
Query: 376 FC----------------LRVAEELSSTIGIA------------RGLEYLHLGCSTRILH 407
                             L+   + S+  GI             +GL + H   S R+LH
Sbjct: 71  VIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCH---SHRVLH 127
Query: 408 FDIKPHNILLDEDFCPKISDFGLAKICNRKESIISMTGARGTVGYIAPEVF--CRNIGEV 465
            D+KP N+L++ +   K++DFGLA+       + +      T+ Y APE+   C+     
Sbjct: 128 RDLKPENLLINTEGAIKLADFGLARAFG--VPVRTYXHEVVTLWYRAPEILLGCKY---Y 182
Query: 466 SYKSDVYNYGMMIFEMTGGR 485
           S   D+++ G +  EM   R
Sbjct: 183 STAVDIWSLGCIFAEMVTRR 202

>pdb|3NYN|A Chain A, Crystal Structure Of G Protein-Coupled Receptor Kinase 6 In Complex With Sangivamycin Length = 576

Iteration: 1
 Score = 59.7 bits (143), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 37/93 (39%), Positives = 52/93 (55%), Gaps = 8/93 (8%)
Query: 393 GLEYLHLGCSTRILHFDIKPHNILLDEDFCPKISDFGLAKICNRKESIISMTGARGTVGY 452
           GLE LH     RI++ D+KP NILLD+    +ISD GLA      ++I    G  GTVGY
Sbjct: 298 GLEDLH---RERIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQTI---KGRVGTVGY 351
Query: 453 IAPEVFCRNIGEVSYKSDVYNYGMMIFEMTGGR 485
           +APEV        ++  D +  G +++EM  G+
Sbjct: 352 MAPEVVKNE--RYTFSPDWWALGCLLYEMIAGQ 382

>pdb|1BL6|A Chain A, The Complex Structure Of The Map Kinase P38SB216995 Length = 379

Iteration: 1
 Score = 59.7 bits (143), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 61/202 (30%), Positives = 89/202 (44%), Gaps = 48/202 (23%)
Query: 321 LGQGGYGSV---YKGKLLDGSNVAVKVLN---DSKGNGKEFINEVASISRTSHVNVVALL 374
           +G G YGSV   +  K   G  VAVK L+    S  + K    E+  +    H NV+ LL
Sbjct: 49  VGSGAYGSVCAAFDTK--TGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLL 106
Query: 375 GFCL--RVAEE------LSSTIG-----------------------IARGLEYLHLGCST 403
                 R  EE      ++  +G                       I RGL+Y+H   S 
Sbjct: 107 DVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIH---SA 163
Query: 404 RILHFDIKPHNILLDEDFCPKISDFGLAKICNRKESIISMTGARGTVGYIAPEVFCRNIG 463
            I+H D+KP N+ ++ED   KI DFGLA+  + +     MTG   T  Y APE+   N  
Sbjct: 164 DIIHRDLKPSNLAVNEDCELKILDFGLARHTDDE-----MTGYVATRWYRAPEIML-NWM 217
Query: 464 EVSYKSDVYNYGMMIFEMTGGR 485
             +   D+++ G ++ E+  GR
Sbjct: 218 HYNQTVDIWSVGCIMAELLTGR 239

>pdb|2FSL|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a+f327s) Activating Mutant Form-A Length = 367

Iteration: 1
 Score = 59.7 bits (143), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 61/202 (30%), Positives = 88/202 (43%), Gaps = 48/202 (23%)
Query: 321 LGQGGYGSV---YKGKLLDGSNVAVKVLN---DSKGNGKEFINEVASISRTSHVNVVALL 374
           +G G YGSV   +  K   G  VAVK L+    S  + K    E+  +    H NV+ LL
Sbjct: 37  VGSGAYGSVCAAFDTK--TGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLL 94
Query: 375 GFCL--RVAEE------LSSTIG-----------------------IARGLEYLHLGCST 403
                 R  EE      ++  +G                       I RGL+Y+H   S 
Sbjct: 95  DVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIH---SA 151
Query: 404 RILHFDIKPHNILLDEDFCPKISDFGLAKICNRKESIISMTGARGTVGYIAPEVFCRNIG 463
            I+H D+KP N+ ++ED   KI DFGLA     + +   MTG   T  Y APE+   N  
Sbjct: 152 DIIHRDLKPSNLAVNEDCELKILDFGLA-----RHTADEMTGYVATRWYRAPEIML-NWM 205
Query: 464 EVSYKSDVYNYGMMIFEMTGGR 485
             +   D+++ G ++ E+  GR
Sbjct: 206 HYNQTVDIWSVGCIMAELLTGR 227

>pdb|1ZXE|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: D835n Inactivating Mutant In Apo Form Length = 303

Iteration: 1
 Score = 59.7 bits (143), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 58/214 (27%), Positives = 85/214 (39%), Gaps = 58/214 (27%)
Query: 321 LGQGGYGSVYKGK-LLDGSNVAVKVLNDSKGNGKEFINEVASISRTSHVNVVALLGFCLR 379
           LGQG +G V K +  LD    A+K +  ++      ++EV  ++  +H  VV      L 
Sbjct: 14  LGQGAFGQVVKARNALDSRYYAIKKIRHTEEKLSTILSEVXLLASLNHQYVVRYYAAWLE 73
Query: 380 --------VAEELSSTI---------------------------------GIARGLEYLH 398
                    A +  ST+                                  I   L Y+H
Sbjct: 74  RRNFVKPXTAVKKKSTLFIQXEYCENRTLYDLIHSENLNQQRDEYWRLFRQILEALSYIH 133
Query: 399 LGCSTRILHFDIKPHNILLDEDFCPKISDFGLAKICNRKESII------------SMTGA 446
              S  I+H ++KP NI +DE    KI DFGLAK  +R   I+            ++T A
Sbjct: 134 ---SQGIIHRNLKPXNIFIDESRNVKIGDFGLAKNVHRSLDILKLDSQNLPGSSDNLTSA 190
Query: 447 RGTVGYIAPEVFCRNIGEVSYKSDVYNYGMMIFE 480
            GT  Y+A EV     G  + K D Y+ G++ FE
Sbjct: 191 IGTAXYVATEVLD-GTGHYNEKIDXYSLGIIFFE 223

>pdb|3DT1|A Chain A, P38 Complexed With A Quinazoline Inhibitor Length = 383

Iteration: 1
 Score = 59.7 bits (143), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 61/202 (30%), Positives = 89/202 (44%), Gaps = 48/202 (23%)
Query: 321 LGQGGYGSV---YKGKLLDGSNVAVKVLN---DSKGNGKEFINEVASISRTSHVNVVALL 374
           +G G YGSV   +  K   G  VAVK L+    S  + K    E+  +    H NV+ LL
Sbjct: 53  VGSGAYGSVCAAFDTK--TGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLL 110
Query: 375 GFCL--RVAEE------LSSTIG-----------------------IARGLEYLHLGCST 403
                 R  EE      ++  +G                       I RGL+Y+H   S 
Sbjct: 111 DVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIH---SA 167
Query: 404 RILHFDIKPHNILLDEDFCPKISDFGLAKICNRKESIISMTGARGTVGYIAPEVFCRNIG 463
            I+H D+KP N+ ++ED   KI DFGLA+  + +     MTG   T  Y APE+   N  
Sbjct: 168 DIIHRDLKPSNLAVNEDCELKILDFGLARHTDDE-----MTGYVATRWYRAPEIML-NWM 221
Query: 464 EVSYKSDVYNYGMMIFEMTGGR 485
             +   D+++ G ++ E+  GR
Sbjct: 222 HYNQTVDIWSVGCIMAELLTGR 243

>pdb|4EOK|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With The Inhibitor Nu6102 Length = 300

Iteration: 1
 Score = 59.7 bits (143), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 55/200 (27%), Positives = 91/200 (45%), Gaps = 42/200 (21%)
Query: 320 KLGQGGYGSVYKGK-LLDGSNVAVKVL---NDSKGNGKEFINEVASISRTSHVNVVALLG 375
           K+G+G YG VYK +  L G  VA+K +    +++G     I E++ +   +H N+V LL 
Sbjct: 12  KIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLD 71
Query: 376 FC----------------LRVAEELSSTIGIA------------RGLEYLHLGCSTRILH 407
                             L+   + S+  GI             +GL + H   S R+LH
Sbjct: 72  VIHTENKLYLVFEFLSMDLKDFMDASALTGIPLPLIKSYLFQLLQGLAFCH---SHRVLH 128
Query: 408 FDIKPHNILLDEDFCPKISDFGLAKICNRKESIISMTGARGTVGYIAPEVF--CRNIGEV 465
            D+KP N+L++ +   K++DFGLA+       + +      T+ Y APE+   C+     
Sbjct: 129 RDLKPQNLLINTEGAIKLADFGLARAFG--VPVRTYXHEVVTLWYRAPEILLGCKY---Y 183
Query: 466 SYKSDVYNYGMMIFEMTGGR 485
           S   D+++ G +  EM   R
Sbjct: 184 STAVDIWSLGCIFAEMVTRR 203

>pdb|3IS5|A Chain A, Crystal Structure Of Cdpk Kinase Domain From Toxoplasma Gondii, Tgme49_018720 Length = 285

Iteration: 1
 Score = 59.7 bits (143), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 61/206 (29%), Positives = 91/206 (44%), Gaps = 49/206 (23%)
Query: 317 FKYKLGQGGYGSVY-KGKLLDGSNVAVKVLNDSKGN--GKEFINEVASISRTSHVNVVAL 373
           FK KLG G +G V+   +   G    +K +N  +     ++   E+  +    H N++ +
Sbjct: 26  FKRKLGSGAFGDVHLVEERSSGLERVIKTINKDRSQVPMEQIEAEIEVLKSLDHPNIIKI 85
Query: 374 ---------LGFCLRVAE--ELSSTI--GIARG------------------LEYLHLGCS 402
                    +   +   E  EL   I    ARG                  L Y H   S
Sbjct: 86  FEVFEDYHNMYIVMETCEGGELLERIVSAQARGKALSEGYVAELMKQMMNALAYFH---S 142
Query: 403 TRILHFDIKPHNILLDEDFCP----KISDFGLAKICNRKESIISMTGARGTVGYIAPEVF 458
             ++H D+KP NIL  +D  P    KI DFGLA++    E     T A GT  Y+APEVF
Sbjct: 143 QHVVHKDLKPENILF-QDTSPHSPIKIIDFGLAELFKSDEH---STNAAGTALYMAPEVF 198
Query: 459 CRNIGEVSYKSDVYNYG-MMIFEMTG 483
            R+   V++K D+++ G +M F +TG
Sbjct: 199 KRD---VTFKCDIWSAGVVMYFLLTG 221

>pdb|2FSO|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a) Activating Mutant Length = 367

Iteration: 1
 Score = 59.7 bits (143), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 61/202 (30%), Positives = 88/202 (43%), Gaps = 48/202 (23%)
Query: 321 LGQGGYGSV---YKGKLLDGSNVAVKVLN---DSKGNGKEFINEVASISRTSHVNVVALL 374
           +G G YGSV   +  K   G  VAVK L+    S  + K    E+  +    H NV+ LL
Sbjct: 37  VGSGAYGSVCAAFDTK--TGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLL 94
Query: 375 GFCL--RVAEE------LSSTIG-----------------------IARGLEYLHLGCST 403
                 R  EE      ++  +G                       I RGL+Y+H   S 
Sbjct: 95  DVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIH---SA 151
Query: 404 RILHFDIKPHNILLDEDFCPKISDFGLAKICNRKESIISMTGARGTVGYIAPEVFCRNIG 463
            I+H D+KP N+ ++ED   KI DFGLA     + +   MTG   T  Y APE+   N  
Sbjct: 152 DIIHRDLKPSNLAVNEDCELKILDFGLA-----RHTADEMTGYVATRWYRAPEIML-NWM 205
Query: 464 EVSYKSDVYNYGMMIFEMTGGR 485
             +   D+++ G ++ E+  GR
Sbjct: 206 HYNQTVDIWSVGCIMAELLTGR 227

>pdb|1K9A|A Chain A, Crystal Structure Analysis Of Full-Length Carboxyl-Terminal Src Kinase At 2.5 A Resolution Length = 450

Iteration: 1
 Score = 59.7 bits (143), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 50/192 (26%), Positives = 88/192 (45%), Gaps = 44/192 (22%)
Query: 321 LGQGGYGSVYKGKLLDGSNVAVK-VLNDSKGNGKEFINEVASISRTSHVNVVALLGFCLR 379
           +G+G +G V  G    G+ VAVK + ND+    + F+ E + +++  H N+V LLG  + 
Sbjct: 201 IGKGEFGDVMLGDY-RGNKVAVKCIKNDA--TAQAFLAEASVMTQLRHSNLVQLLGVIVE 257
Query: 380 -------VAEELSS-----------------------TIGIARGLEYLHLGCSTRILHFD 409
                  V E ++                        ++ +   +EYL        +H D
Sbjct: 258 EKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLE---GNNFVHRD 314
Query: 410 IKPHNILLDEDFCPKISDFGLAKICNRKESIISMTGARGTVGYIAPEVFCRNIGEVSYKS 469
           +   N+L+ ED   K+SDFGL      KE+  +    +  V + APE       + S KS
Sbjct: 315 LAARNVLVSEDNVAKVSDFGLT-----KEASSTQDTGKLPVKWTAPEALREK--KFSTKS 367
Query: 470 DVYNYGMMIFEM 481
           DV+++G++++E+
Sbjct: 368 DVWSFGILLWEI 379

>pdb|3D7U|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 263

Iteration: 1
 Score = 59.7 bits (143), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 50/192 (26%), Positives = 88/192 (45%), Gaps = 44/192 (22%)
Query: 321 LGQGGYGSVYKGKLLDGSNVAVK-VLNDSKGNGKEFINEVASISRTSHVNVVALLGFCLR 379
           +G+G +G V  G    G+ VAVK + ND+    + F+ E + +++  H N+V LLG  + 
Sbjct: 14  IGKGEFGDVMLGDY-RGNKVAVKCIKNDA--TAQAFLAEASVMTQLRHSNLVQLLGVIVE 70
Query: 380 -------VAEELSS-----------------------TIGIARGLEYLHLGCSTRILHFD 409
                  V E ++                        ++ +   +EYL        +H D
Sbjct: 71  EKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLE---GNNFVHRD 127
Query: 410 IKPHNILLDEDFCPKISDFGLAKICNRKESIISMTGARGTVGYIAPEVFCRNIGEVSYKS 469
           +   N+L+ ED   K+SDFGL      KE+  +    +  V + APE       + S KS
Sbjct: 128 LAARNVLVSEDNVAKVSDFGLT-----KEASSTQDTGKLPVKWTAPEALREK--KFSTKS 180
Query: 470 DVYNYGMMIFEM 481
           DV+++G++++E+
Sbjct: 181 DVWSFGILLWEI 192

>pdb|2J51|A Chain A, Crystal Structure Of Human Ste20-Like Kinase Bound To 5- Amino-3-((4-(Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2,4-Triazole-1-Carbothioamide Length = 325

Iteration: 1
 Score = 59.7 bits (143), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 56/200 (28%), Positives = 92/200 (46%), Gaps = 46/200 (23%)
Query: 320 KLGQGGYGSVYKGKLLDGSNVAVKVLNDSKGNGK--EFINEVASISRTSHVNVVALLG-- 375
           +LG G +G VYK +  + S +A   + D+K   +  +++ E+  ++   H N+V LL   
Sbjct: 44  ELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAF 103
Query: 376 -----------FC---------LRVAEELS-STIGIA-----RGLEYLHLGCSTRILHFD 409
                      FC         L +   L+ S I +        L YLH     +I+H D
Sbjct: 104 YYENNLWILIEFCAGGAVDAVMLELERPLTESQIQVVCKQTLDALNYLH---DNKIIHRD 160
Query: 410 IKPHNILLDEDFCPKISDFGLA----KICNRKESIISMTGARGTVGYIAPE-VFCRNIGE 464
           +K  NIL   D   K++DFG++    +   R++S I      GT  ++APE V C    +
Sbjct: 161 LKAGNILFTLDGDIKLADFGVSAKNTRTIQRRDSFI------GTPYWMAPEVVMCETSKD 214
Query: 465 --VSYKSDVYNYGMMIFEMT 482
               YK+DV++ G+ + EM 
Sbjct: 215 RPYDYKADVWSLGITLIEMA 234

>pdb|4EOI|A Chain A, Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 299

Iteration: 1
 Score = 59.3 bits (142), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 55/200 (27%), Positives = 91/200 (45%), Gaps = 42/200 (21%)
Query: 320 KLGQGGYGSVYKGK-LLDGSNVAVKVL---NDSKGNGKEFINEVASISRTSHVNVVALLG 375
           K+G+G YG VYK +  L G  VA+K +    +++G     I E++ +   +H N+V LL 
Sbjct: 10  KIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLD 69
Query: 376 FC----------------LRVAEELSSTIGIA------------RGLEYLHLGCSTRILH 407
                             L+   + S+  GI             +GL + H   S R+LH
Sbjct: 70  VIHTENKLYLVFEFLHQDLKDFMDASALTGIPLPLIKSYLFQLLQGLAFCH---SHRVLH 126
Query: 408 FDIKPHNILLDEDFCPKISDFGLAKICNRKESIISMTGARGTVGYIAPEVF--CRNIGEV 465
            D+KP N+L++ +   K++DFGLA+       + +      T+ Y APE+   C+     
Sbjct: 127 RDLKPENLLINTEGAIKLADFGLARAFG--VPVRTYXHEVVTLWYRAPEILLGCKY---Y 181
Query: 466 SYKSDVYNYGMMIFEMTGGR 485
           S   D+++ G +  EM   R
Sbjct: 182 STAVDIWSLGCIFAEMVTRR 201

>pdb|3HNG|A Chain A, Crystal Structure Of Vegfr1 In Complex With N-(4-chlorophenyl)-2- ((pyridin-4-ylmethyl)amino)benzamide Length = 360

Iteration: 1
 Score = 59.3 bits (142), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 34/98 (34%), Positives = 56/98 (57%), Gaps = 5/98 (5%)
Query: 384 LSSTIGIARGLEYLHLGCSTRILHFDIKPHNILLDEDFCPKISDFGLAKICNRKESIISM 443
           +S +  +ARG+E+L    S + +H D+   NILL E+   KI DFGLA+   +    +  
Sbjct: 202 ISYSFQVARGMEFL---SSRKCIHRDLAARNILLSENNVVKICDFGLARDIYKNPDYVRK 258
Query: 444 TGARGTVGYIAPEVFCRNIGEVSYKSDVYNYGMMIFEM 481
              R  + ++APE     I   S KSDV++YG++++E+
Sbjct: 259 GDTRLPLKWMAPESIFDKI--YSTKSDVWSYGVLLWEI 294

>pdb|3CJF|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309

Iteration: 1
 Score = 59.3 bits (142), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 50/210 (23%), Positives = 89/210 (42%), Gaps = 54/210 (25%)
Query: 321 LGQGGYGSVYKG------KLLDGSNVAVKVLND--SKGNGKEFINEVASISRTSH-VNVV 371
           LG+G +G V +       K      VAVK+L +  +    +  ++E+  +    H +NVV
Sbjct: 35  LGRGAFGQVIEADAFGIDKTATXRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVV 94
Query: 372 ALLGFC----------------------------------------LRVAEELSSTIGIA 391
            LLG C                                        L +   +  +  +A
Sbjct: 95  NLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKDLYKDFLTLEHLIXYSFQVA 154
Query: 392 RGLEYLHLGCSTRILHFDIKPHNILLDEDFCPKISDFGLAKICNRKESIISMTGARGTVG 451
           +G+E+L    S + +H D+   NILL E    KI DFGLA+   +    +    AR  + 
Sbjct: 155 KGMEFL---ASRKXIHRDLAARNILLSEKNVVKIXDFGLARDIYKDPDYVRKGDARLPLK 211
Query: 452 YIAPEVFCRNIGEVSYKSDVYNYGMMIFEM 481
           ++APE     +   + +SDV+++G++++E+
Sbjct: 212 WMAPETIFDRV--YTIQSDVWSFGVLLWEI 239

>pdb|2JFM|A Chain A, Crystal Structure Of Human Ste20-Like Kinase (Unliganded Form) Length = 325

Iteration: 1
 Score = 59.3 bits (142), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 56/200 (28%), Positives = 92/200 (46%), Gaps = 46/200 (23%)
Query: 320 KLGQGGYGSVYKGKLLDGSNVAVKVLNDSKGNGK--EFINEVASISRTSHVNVVALLG-- 375
           +LG G +G VYK +  + S +A   + D+K   +  +++ E+  ++   H N+V LL   
Sbjct: 44  ELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAF 103
Query: 376 -----------FC---------LRVAEELS-STIGIA-----RGLEYLHLGCSTRILHFD 409
                      FC         L +   L+ S I +        L YLH     +I+H D
Sbjct: 104 YYENNLWILIEFCAGGAVDAVMLELERPLTESQIQVVCKQTLDALNYLH---DNKIIHRD 160
Query: 410 IKPHNILLDEDFCPKISDFGLA----KICNRKESIISMTGARGTVGYIAPE-VFCRNIGE 464
           +K  NIL   D   K++DFG++    +   R++S I      GT  ++APE V C    +
Sbjct: 161 LKAGNILFTLDGDIKLADFGVSAKNTRXIQRRDSFI------GTPYWMAPEVVMCETSKD 214
Query: 465 --VSYKSDVYNYGMMIFEMT 482
               YK+DV++ G+ + EM 
Sbjct: 215 RPYDYKADVWSLGITLIEMA 234

>pdb|1U5Q|A Chain A, Crystal Structure Of The Tao2 Kinase Domain: Activation And Specifity Of A Ste20p Map3k Length = 348

Iteration: 1
 Score = 59.3 bits (142), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 56/207 (27%), Positives = 91/207 (43%), Gaps = 43/207 (20%)
Query: 309 DIKKMTNSFKYKLGQGGYGSVYKGKLLDGSNV-AVKVLN----DSKGNGKEFINEVASIS 363
           D +K+ +  + ++G G +G+VY  + +  S V A+K ++     S    ++ I EV  + 
Sbjct: 51  DPEKLFSDLR-EIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQ 109
Query: 364 RTSHVNVVALLG-------------FCLRVAEEL--------------SSTIGIARGLEY 396
           +  H N +   G             +CL  A +L              + T G  +GL Y
Sbjct: 110 KLRHPNTIQYRGCYLREHTAWLVMEYCLGSASDLLEVHKKPLQEVEIAAVTHGALQGLAY 169
Query: 397 LHLGCSTRILHFDIKPHNILLDEDFCPKISDFGLAKICNRKESIISMTGARGTVGYIAPE 456
           LH   S  ++H D+K  NILL E    K+ DFG A I       +      GT  ++APE
Sbjct: 170 LH---SHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPANXFV------GTPYWMAPE 220
Query: 457 V-FCRNIGEVSYKSDVYNYGMMIFEMT 482
           V    + G+   K DV++ G+   E+ 
Sbjct: 221 VILAMDEGQYDGKVDVWSLGITCIELA 247

>pdb|1BYG|A Chain A, Kinase Domain Of Human C-Terminal Src Kinase (Csk) In Complex With Inhibitor Staurosporine Length = 278

Iteration: 1
 Score = 59.3 bits (142), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 50/192 (26%), Positives = 88/192 (45%), Gaps = 44/192 (22%)
Query: 321 LGQGGYGSVYKGKLLDGSNVAVK-VLNDSKGNGKEFINEVASISRTSHVNVVALLGFCLR 379
           +G+G +G V  G    G+ VAVK + ND+    + F+ E + +++  H N+V LLG  + 
Sbjct: 29  IGKGEFGDVMLGDY-RGNKVAVKCIKNDA--TAQAFLAEASVMTQLRHSNLVQLLGVIVE 85
Query: 380 -------VAEELSS-----------------------TIGIARGLEYLHLGCSTRILHFD 409
                  V E ++                        ++ +   +EYL        +H D
Sbjct: 86  EKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLE---GNNFVHRD 142
Query: 410 IKPHNILLDEDFCPKISDFGLAKICNRKESIISMTGARGTVGYIAPEVFCRNIGEVSYKS 469
           +   N+L+ ED   K+SDFGL      KE+  +    +  V + APE       + S KS
Sbjct: 143 LAARNVLVSEDNVAKVSDFGLT-----KEASSTQDTGKLPVKWTAPEALREK--KFSTKS 195
Query: 470 DVYNYGMMIFEM 481
           DV+++G++++E+
Sbjct: 196 DVWSFGILLWEI 207

>pdb|3MH2|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score = 58.9 bits (141), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 59/202 (29%), Positives = 86/202 (42%), Gaps = 48/202 (23%)
Query: 321 LGQGGYGSV---YKGKLLDGSNVAVKVLN---DSKGNGKEFINEVASISRTSHVNVVALL 374
           +G G YGSV   +  K   G  VAVK L+    S  + K    E+  +    H NV+ LL
Sbjct: 30  VGSGAYGSVCAAFDTK--TGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLL 87
Query: 375 GFCL--RVAEELSSTI-----------------------------GIARGLEYLHLGCST 403
                 R  EE +                                 I RGL+Y+H   S 
Sbjct: 88  DVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIH---SA 144
Query: 404 RILHFDIKPHNILLDEDFCPKISDFGLAKICNRKESIISMTGARGTVGYIAPEVFCRNIG 463
            I+H D+KP N+ ++ED   KI D+GLA+  + +     MTG   T  Y APE+   N  
Sbjct: 145 DIIHRDLKPSNLAVNEDCELKILDYGLARHTDDE-----MTGYVATRWYRAPEIML-NWM 198
Query: 464 EVSYKSDVYNYGMMIFEMTGGR 485
             +   D+++ G ++ E+  GR
Sbjct: 199 HYNQTVDIWSVGCIMAELLTGR 220

>pdb|1AD5|A Chain A, Src Family Kinase Hck-Amp-Pnp Complex Length = 438

Iteration: 1
 Score = 58.9 bits (141), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 50/206 (24%), Positives = 87/206 (42%), Gaps = 45/206 (21%)
Query: 309 DIKKMTNSFKYKLGQGGYGSVYKGKLLDGSNVAVKVLNDSKGNGKEFINEVASISRTSHV 368
           +I + +   + KLG G +G V+       + VAVK +     + + F+ E   +    H 
Sbjct: 178 EIPRESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPGSMSVEAFLAEANVMKTLQHD 237
Query: 369 NVVALLGFCLR--------------VAEELSSTIG--------------IARGLEYLHLG 400
            +V L     +              + + L S  G              IA G+ ++   
Sbjct: 238 KLVKLHAVVTKEPIYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIE-- 295
Query: 401 CSTRILHFDIKPHNILLDEDFCPKISDFGLAKICNRKESIISMTGARGTVGYIAPEVFCR 460
                +H D++  NIL+      KI+DFGLA++           GA+  + + APE    
Sbjct: 296 -QRNYIHRDLRAANILVSASLVCKIADFGLARV-----------GAKFPIKWTAPEAI-- 341
Query: 461 NIGEVSYKSDVYNYGMMIFEM-TGGR 485
           N G  + KSDV+++G+++ E+ T GR
Sbjct: 342 NFGSFTIKSDVWSFGILLMEIVTYGR 367

>pdb|2GCD|A Chain A, Tao2 Kinase Domain-Staurosporine Structure Length = 309

Iteration: 1
 Score = 58.9 bits (141), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 54/196 (27%), Positives = 85/196 (43%), Gaps = 42/196 (21%)
Query: 320 KLGQGGYGSVYKGKLLDGSNV-AVKVLN----DSKGNGKEFINEVASISRTSHVNVVALL 374
           ++G G +G+VY  + +  S V A+K ++     S    ++ I EV  + +  H N +   
Sbjct: 22  EIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYR 81
Query: 375 G-------------FCLRVAEEL--------------SSTIGIARGLEYLHLGCSTRILH 407
           G             +CL  A +L              + T G  +GL YLH   S  ++H
Sbjct: 82  GCYLREHTAWLVMEYCLGSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLH---SHNMIH 138
Query: 408 FDIKPHNILLDEDFCPKISDFGLAKICNRKESIISMTGARGTVGYIAPEV-FCRNIGEVS 466
            D+K  NILL E    K+ DFG A I       +      GT  ++APEV    + G+  
Sbjct: 139 RDVKAGNILLSEPGLVKLGDFGSASIMAPANXFV------GTPYWMAPEVILAMDEGQYD 192
Query: 467 YKSDVYNYGMMIFEMT 482
            K DV++ G+   E+ 
Sbjct: 193 GKVDVWSLGITCIELA 208

>pdb|2JC6|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase 1d Length = 334

Iteration: 1
 Score = 58.9 bits (141), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 61/199 (30%), Positives = 90/199 (45%), Gaps = 44/199 (22%)
Query: 309 DIKKMTNSFKYKLGQGGYGSVYKGK-LLDGSNVAVKVLNDSKGNGKE--FINEVASISRT 365
           DIKK+   FK  LG G +  V   +    G   AVK +      GKE    NE+A + + 
Sbjct: 19  DIKKIFE-FKETLGTGAFSEVVLAEEKATGKLFAVKCIPKKALKGKESSIENEIAVLRKI 77
Query: 366 SHVNVVAL---------LGFCL----------RVAE-----ELSSTIGIARGLEYLHLGC 401
            H N+VAL         L   +          R+ E     E  ++  I + L+ ++   
Sbjct: 78  KHENIVALEDIYESPNHLYLVMQLVSGGELFDRIVEKGFYTEKDASTLIRQVLDAVYYLH 137
Query: 402 STRILHFDIKPHNILL---DEDFCPKISDFGLAKICNRKESIISMTGARGTVGYIAPEVF 458
              I+H D+KP N+L    DE+    ISDFGL+K+  + +    M+ A GT GY+APEV 
Sbjct: 138 RMGIVHRDLKPENLLYYSQDEESKIMISDFGLSKMEGKGDV---MSTACGTPGYVAPEVL 194
Query: 459 ----------CRNIGEVSY 467
                     C +IG ++Y
Sbjct: 195 AQKPYSKAVDCWSIGVIAY 213

>pdb|2WEI|A Chain A, Crystal Structure Of The Kinase Domain Of Cryptosporidium Parvum Calcium Dependent Protein Kinase In Complex With 3- Mb-Pp1 Length = 287

Iteration: 1
 Score = 58.9 bits (141), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 63/227 (27%), Positives = 98/227 (43%), Gaps = 52/227 (22%)
Query: 321 LGQGGYGSVYKGK-LLDGSNVAVKVLNDSKGNGKE---FINEVASISRTSHVNVVALLGF 376
           LG+G +G V K K  +     AVKV+N +    K+    + EV  + +  H N++ L   
Sbjct: 30  LGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEI 89
Query: 377 C-------------------------LRVAEELSSTI--GIARGLEYLHLGCSTRILHFD 409
                                      R +E  ++ I   +  G+ Y+H      I+H D
Sbjct: 90  LEDSSSFYIVGELYTGGELFDEIIKRKRFSEHDAARIIKQVFSGITYMH---KHNIVHRD 146
Query: 410 IKPHNILL---DEDFCPKISDFGLAKICNRKESIISMTGARGTVGYIAPEVFCRNIGEVS 466
           +KP NILL   ++D   KI DFGL+  C ++ +   M    GT  YIAPEV     G   
Sbjct: 147 LKPENILLESKEKDCDIKIIDFGLS-TCFQQNT--KMKDRIGTAYYIAPEVLR---GTYD 200
Query: 467 YKSDVYNYGMMIFEMTG------GRKNVDV---VDNGSTALDLQASR 504
            K DV++ G++++ +        G+   D+   V+ G  A DL   R
Sbjct: 201 EKCDVWSAGVILYILLSGTPPFYGKNEYDILKRVETGKYAFDLPQWR 247

>pdb|3DFA|A Chain A, Crystal Structure Of Kinase Domain Of Calcium-dependent Protein Kinase Cgd3_920 From Cryptosporidium Parvum Length = 286

Iteration: 1
 Score = 58.9 bits (141), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 63/227 (27%), Positives = 98/227 (43%), Gaps = 52/227 (22%)
Query: 321 LGQGGYGSVYKGK-LLDGSNVAVKVLNDSKGNGKE---FINEVASISRTSHVNVVALLGF 376
           LG+G +G V K K  +     AVKV+N +    K+    + EV  + +  H N++ L   
Sbjct: 30  LGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEI 89
Query: 377 C-------------------------LRVAEELSSTI--GIARGLEYLHLGCSTRILHFD 409
                                      R +E  ++ I   +  G+ Y+H      I+H D
Sbjct: 90  LEDSSSFYIVGELYTGGELFDEIIKRKRFSEHDAARIIKQVFSGITYMH---KHNIVHRD 146
Query: 410 IKPHNILL---DEDFCPKISDFGLAKICNRKESIISMTGARGTVGYIAPEVFCRNIGEVS 466
           +KP NILL   ++D   KI DFGL+  C ++ +   M    GT  YIAPEV     G   
Sbjct: 147 LKPENILLESKEKDCDIKIIDFGLS-TCFQQNT--KMKDRIGTAYYIAPEVLR---GTYD 200
Query: 467 YKSDVYNYGMMIFEMTG------GRKNVDV---VDNGSTALDLQASR 504
            K DV++ G++++ +        G+   D+   V+ G  A DL   R
Sbjct: 201 EKCDVWSAGVILYILLSGTPPFYGKNEYDILKRVETGKYAFDLPQWR 247

>pdb|1YWR|A Chain A, Crystal Structure Analysis Of Inactive P38 Kinase Domain In Complex With A Monocyclic Pyrazolone Inhibitor Length = 360

Iteration: 1
 Score = 58.9 bits (141), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 59/202 (29%), Positives = 85/202 (42%), Gaps = 48/202 (23%)
Query: 321 LGQGGYGSV---YKGKLLDGSNVAVKVLN---DSKGNGKEFINEVASISRTSHVNVVALL 374
           +G G YGSV   +  K   G  VAVK L+    S  + K    E+  +    H NV+ LL
Sbjct: 30  VGSGAYGSVCAAFDTK--TGHRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLL 87
Query: 375 GFCL--RVAEELSSTI-----------------------------GIARGLEYLHLGCST 403
                 R  EE +                                 I RGL+Y+H   S 
Sbjct: 88  DVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIH---SA 144
Query: 404 RILHFDIKPHNILLDEDFCPKISDFGLAKICNRKESIISMTGARGTVGYIAPEVFCRNIG 463
            I+H D+KP N+ ++ED   KI DFGLA+  + +     M G   T  Y APE+   N  
Sbjct: 145 DIIHRDLKPSNLAVNEDCELKILDFGLARHTDDE-----MAGFVATRWYRAPEIML-NWM 198
Query: 464 EVSYKSDVYNYGMMIFEMTGGR 485
             +   D+++ G ++ E+  GR
Sbjct: 199 HYNQTVDIWSVGCIMAELLTGR 220

>pdb|3PY3|A Chain A, Crystal Structure Of Phosphorylated P38alpha Map Kinase Length = 380

Iteration: 1
 Score = 58.9 bits (141), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 60/202 (29%), Positives = 88/202 (43%), Gaps = 48/202 (23%)
Query: 321 LGQGGYGSV---YKGKLLDGSNVAVKVLN---DSKGNGKEFINEVASISRTSHVNVVALL 374
           +G G YGSV   +  K   G  VAVK L+    S  + K    E+  +    H NV+ LL
Sbjct: 50  VGSGAYGSVCAAFDTK--TGHRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLL 107
Query: 375 GFCL--RVAEE------LSSTIG-----------------------IARGLEYLHLGCST 403
                 R  EE      ++  +G                       I RGL+Y+H   S 
Sbjct: 108 DVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIH---SA 164
Query: 404 RILHFDIKPHNILLDEDFCPKISDFGLAKICNRKESIISMTGARGTVGYIAPEVFCRNIG 463
            I+H D+KP N+ ++ED   KI DFGLA+  + +     M G   T  Y APE+   N  
Sbjct: 165 DIIHRDLKPSNLAVNEDCELKILDFGLARHTDDE-----MXGXVATRWYRAPEIML-NWM 218
Query: 464 EVSYKSDVYNYGMMIFEMTGGR 485
             +   D+++ G ++ E+  GR
Sbjct: 219 HYNQTVDIWSVGCIMAELLTGR 240

>pdb|1YW2|A Chain A, Mutated Mus Musculus P38 Kinase (Mp38) Length = 360

Iteration: 1
 Score = 58.5 bits (140), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 59/202 (29%), Positives = 85/202 (42%), Gaps = 48/202 (23%)
Query: 321 LGQGGYGSV---YKGKLLDGSNVAVKVLN---DSKGNGKEFINEVASISRTSHVNVVALL 374
           +G G YGSV   +  K   G  VAVK L+    S  + K    E+  +    H NV+ LL
Sbjct: 30  VGSGAYGSVCAAFDTK--TGHRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLL 87
Query: 375 GFCL--RVAEELSSTI-----------------------------GIARGLEYLHLGCST 403
                 R  EE +                                 I RGL+Y+H   S 
Sbjct: 88  DVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIH---SA 144
Query: 404 RILHFDIKPHNILLDEDFCPKISDFGLAKICNRKESIISMTGARGTVGYIAPEVFCRNIG 463
            I+H D+KP N+ ++ED   KI DFGLA+  + +     M G   T  Y APE+   N  
Sbjct: 145 DIIHRDLKPSNLAVNEDCELKILDFGLARHTDDE-----MAGFVATRWYRAPEIML-NWM 198
Query: 464 EVSYKSDVYNYGMMIFEMTGGR 485
             +   D+++ G ++ E+  GR
Sbjct: 199 HYNQTVDIWSVGCIMAELLTGR 220

>pdb|3LMG|A Chain A, Crystal Structure Of The Erbb3 Kinase Domain In Complex With Amp-Pnp Length = 344

Iteration: 1
 Score = 58.5 bits (140), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 50/209 (23%), Positives = 100/209 (47%), Gaps = 40/209 (19%)
Query: 308 ADIKKMTNSFKYK-LGQGGYGSVYKGKLL-DGSNVAV----KVLNDSKGNG--KEFINEV 359
           A I K T   K K LG G +G+V+KG  + +G ++ +    KV+ D  G    +   + +
Sbjct: 25  ARIFKETELRKLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHM 84
Query: 360 ASISRTSHVNVVALLGFC----LRVAEE-----------------------LSSTIGIAR 392
            +I    H ++V LLG C    L++  +                       L+  + IA+
Sbjct: 85  LAIGSLDHAHIVRLLGLCPGSSLQLVTQYLPLGSLLDHVRQHRGALGPQLLLNWGVQIAK 144
Query: 393 GLEYLHLGCSTRILHFDIKPHNILLDEDFCPKISDFGLAKICNRKESIISMTGARGTVGY 452
           G+ YL       ++H ++   N+LL      +++DFG+A +    +  +  + A+  + +
Sbjct: 145 GMYYLE---EHGMVHRNLAARNVLLKSPSQVQVADFGVADLLPPDDKQLLYSEAKTPIKW 201
Query: 453 IAPEVFCRNIGEVSYKSDVYNYGMMIFEM 481
           +A E    + G+ +++SDV++YG+ ++E+
Sbjct: 202 MALESI--HFGKYTHQSDVWSYGVTVWEL 228

>pdb|2GHL|A Chain A, Mutant Mus Musculus P38 Kinase Domain In Complex With Inhibitor Pg-874743 Length = 348

Iteration: 1
 Score = 58.5 bits (140), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 59/202 (29%), Positives = 85/202 (42%), Gaps = 48/202 (23%)
Query: 321 LGQGGYGSV---YKGKLLDGSNVAVKVLN---DSKGNGKEFINEVASISRTSHVNVVALL 374
           +G G YGSV   +  K   G  VAVK L+    S  + K    E+  +    H NV+ LL
Sbjct: 26  VGSGAYGSVCAAFDTK--TGHRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLL 83
Query: 375 GFCL--RVAEELSSTI-----------------------------GIARGLEYLHLGCST 403
                 R  EE +                                 I RGL+Y+H   S 
Sbjct: 84  DVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIH---SA 140
Query: 404 RILHFDIKPHNILLDEDFCPKISDFGLAKICNRKESIISMTGARGTVGYIAPEVFCRNIG 463
            I+H D+KP N+ ++ED   KI DFGLA+  + +     M G   T  Y APE+   N  
Sbjct: 141 DIIHRDLKPSNLAVNEDCELKILDFGLARHTDDE-----MAGFVATRWYRAPEIML-NWM 194
Query: 464 EVSYKSDVYNYGMMIFEMTGGR 485
             +   D+++ G ++ E+  GR
Sbjct: 195 HYNQTVDIWSVGCIMAELLTGR 216

>pdb|3D7T|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 269

Iteration: 1
 Score = 58.5 bits (140), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 50/192 (26%), Positives = 87/192 (45%), Gaps = 44/192 (22%)
Query: 321 LGQGGYGSVYKGKLLDGSNVAVK-VLNDSKGNGKEFINEVASISRTSHVNVVALLGFCLR 379
           +G+G +G V  G    G+ VAVK + ND+    + F+ E + +++  H N+V LLG  + 
Sbjct: 20  IGKGEFGDVMLGDY-RGNKVAVKCIKNDA--TAQAFLAEASVMTQLRHSNLVQLLGVIVE 76
Query: 380 -------VAEELSS-----------------------TIGIARGLEYLHLGCSTRILHFD 409
                  V E ++                        ++ +   +EYL        +H D
Sbjct: 77  EKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLE---GNNFVHRD 133
Query: 410 IKPHNILLDEDFCPKISDFGLAKICNRKESIISMTGARGTVGYIAPEVFCRNIGEVSYKS 469
           +   N+L+ ED   K+SDFGL      KE+  +    +  V + APE         S KS
Sbjct: 134 LAARNVLVSEDNVAKVSDFGLT-----KEASSTQDTGKLPVKWTAPEALRE--AAFSTKS 186
Query: 470 DVYNYGMMIFEM 481
           DV+++G++++E+
Sbjct: 187 DVWSFGILLWEI 198

>pdb|3C7Q|A Chain A, Structure Of Vegfr2 Kinase Domain In Complex With Bibf1120 Length = 316

Iteration: 1
 Score = 58.5 bits (140), Expect = 9e-09,   Method: Compositional matrix adjust.
 Identities = 50/212 (23%), Positives = 89/212 (41%), Gaps = 56/212 (26%)
Query: 321 LGQGGYGSVYKG------KLLDGSNVAVKVLND--SKGNGKEFINEVASISRTSH-VNVV 371
           LG+G +G V +       K      VAVK+L +  +    +  ++E+  +    H +NVV
Sbjct: 37  LGRGAFGQVIEADAFGIDKTATXRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVV 96
Query: 372 ALLGFC------------------------------------------LRVAEELSSTIG 389
            LLG C                                          L +   +  +  
Sbjct: 97  NLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKPEDLYKDFLTLEHLIXYSFQ 156
Query: 390 IARGLEYLHLGCSTRILHFDIKPHNILLDEDFCPKISDFGLAKICNRKESIISMTGARGT 449
           +A+G+E+L    S + +H D+   NILL E    KI DFGLA+   +    +    AR  
Sbjct: 157 VAKGMEFL---ASRKXIHRDLAARNILLSEKNVVKICDFGLARDIXKDPDXVRKGDARLP 213
Query: 450 VGYIAPEVFCRNIGEVSYKSDVYNYGMMIFEM 481
           + ++APE     +   + +SDV+++G++++E+
Sbjct: 214 LKWMAPETIFDRV--YTIQSDVWSFGVLLWEI 243

>pdb|3KEX|A Chain A, Crystal Structure Of The Catalytically Inactive Kinase Domain Of The Human Epidermal Growth Factor Receptor 3 (Her3) Length = 325

Iteration: 1
 Score = 58.5 bits (140), Expect = 9e-09,   Method: Compositional matrix adjust.
 Identities = 50/209 (23%), Positives = 100/209 (47%), Gaps = 40/209 (19%)
Query: 308 ADIKKMTNSFKYK-LGQGGYGSVYKGKLL-DGSNVAV----KVLNDSKGNG--KEFINEV 359
           A I K T   K K LG G +G+V+KG  + +G ++ +    KV+ D  G    +   + +
Sbjct: 7   ARIFKETELRKLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHM 66
Query: 360 ASISRTSHVNVVALLGFC----LRVAEE-----------------------LSSTIGIAR 392
            +I    H ++V LLG C    L++  +                       L+  + IA+
Sbjct: 67  LAIGSLDHAHIVRLLGLCPGSSLQLVTQYLPLGSLLDHVRQHRGALGPQLLLNWGVQIAK 126
Query: 393 GLEYLHLGCSTRILHFDIKPHNILLDEDFCPKISDFGLAKICNRKESIISMTGARGTVGY 452
           G+ YL       ++H ++   N+LL      +++DFG+A +    +  +  + A+  + +
Sbjct: 127 GMYYLE---EHGMVHRNLAARNVLLKSPSQVQVADFGVADLLPPDDKQLLYSEAKTPIKW 183
Query: 453 IAPEVFCRNIGEVSYKSDVYNYGMMIFEM 481
           +A E    + G+ +++SDV++YG+ ++E+
Sbjct: 184 MALESI--HFGKYTHQSDVWSYGVTVWEL 210

>pdb|3G33|A Chain A, Crystal Structure Of Cdk4CYCLIN D3 Length = 308

Iteration: 1
 Score = 58.2 bits (139), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 58/205 (28%), Positives = 90/205 (43%), Gaps = 51/205 (24%)
Query: 320 KLGQGGYGSVYKGK-LLDGSNVAVKVLNDSKGNGKEF------INEVASISRTS---HVN 369
           ++G G YG+VYK +    G  VA+K +    G G         + EVA + R     H N
Sbjct: 16  EIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLRRLEAFEHPN 75
Query: 370 VVALLGFCL--RVAEELSSTI-------------------------------GIARGLEY 396
           VV L+  C   R   E+  T+                                  RGL++
Sbjct: 76  VVRLMDVCATSRTDREIKVTLVFEHVDQDLRTYLDKAPPPGLPAETIKDLMRQFLRGLDF 135
Query: 397 LHLGCSTRILHFDIKPHNILLDEDFCPKISDFGLAKICNRKESIISMTGARGTVGYIAPE 456
           LH  C   I+H D+KP NIL+      K++DFGLA+I + +   +++T    T+ Y APE
Sbjct: 136 LHANC---IVHRDLKPENILVTSGGTVKLADFGLARIYSYQ---MALTPVVVTLWYRAPE 189
Query: 457 VFCRNIGEVSYKSDVYNYGMMIFEM 481
           V  ++    +   D+++ G +  EM
Sbjct: 190 VLLQST--YATPVDMWSVGCIFAEM 212

>pdb|3IGO|A Chain A, Crystal Structure Of Cryptosporidium Parvum Cdpk1, Cgd3_920 Length = 486

Iteration: 1
 Score = 58.2 bits (139), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 63/227 (27%), Positives = 98/227 (43%), Gaps = 52/227 (22%)
Query: 321 LGQGGYGSVYKGK-LLDGSNVAVKVLNDSKGNGKE---FINEVASISRTSHVNVVALLGF 376
           LG+G +G V K K  +     AVKV+N +    K+    + EV  + +  H N++ L   
Sbjct: 30  LGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEI 89
Query: 377 C-------------------------LRVAEELSSTI--GIARGLEYLHLGCSTRILHFD 409
                                      R +E  ++ I   +  G+ Y+H      I+H D
Sbjct: 90  LEDSSSFYIVGELYTGGELFDEIIKRKRFSEHDAARIIKQVFSGITYMH---KHNIVHRD 146
Query: 410 IKPHNILL---DEDFCPKISDFGLAKICNRKESIISMTGARGTVGYIAPEVFCRNIGEVS 466
           +KP NILL   ++D   KI DFGL+  C ++ +   M    GT  YIAPEV     G   
Sbjct: 147 LKPENILLESKEKDCDIKIIDFGLS-TCFQQNT--KMKDRIGTAYYIAPEVLR---GTYD 200
Query: 467 YKSDVYNYGMMIFEMTG------GRKNVDV---VDNGSTALDLQASR 504
            K DV++ G++++ +        G+   D+   V+ G  A DL   R
Sbjct: 201 EKCDVWSAGVILYILLSGTPPFYGKNEYDILKRVETGKYAFDLPQWR 247

>pdb|2WQB|A Chain A, Structure Of The Tie2 Kinase Domain In Complex With A Thiazolopyrimidine Inhibitor Length = 324

Iteration: 1
 Score = 58.2 bits (139), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 57/225 (25%), Positives = 104/225 (46%), Gaps = 62/225 (27%)
Query: 307 YADIKKMTNSFKYKLGQGGYGSVYKGKLL-DG--SNVAVKVLND--SKGNGKEFINEVAS 361
           + DIK     F+  +G+G +G V K ++  DG   + A+K + +  SK + ++F  E+  
Sbjct: 21  WNDIK-----FQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEV 75
Query: 362 ISRTSH-VNVVALLGFC---------------------LR------------VAEELSST 387
           + +  H  N++ LLG C                     LR            +A   +ST
Sbjct: 76  LCKLGHHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTAST 135
Query: 388 IG----------IARGLEYLHLGCSTRILHFDIKPHNILLDEDFCPKISDFGLAKICNRK 437
           +           +ARG++YL      + +H ++   NIL+ E++  KI+DFGL++    +
Sbjct: 136 LSSQQLLHFAADVARGMDYL---SQKQFIHRNLAARNILVGENYVAKIADFGLSR---GQ 189
Query: 438 ESIISMTGARGTVGYIAPEVFCRNIGEVSYKSDVYNYGMMIFEMT 482
           E  +  T  R  V ++A E    N    +  SDV++YG++++E+ 
Sbjct: 190 EVYVKKTMGRLPVRWMAIESL--NYSVYTTNSDVWSYGVLLWEIV 232

>pdb|3GCP|A Chain A, Human P38 Map Kinase In Complex With Sb203580 Length = 360

Iteration: 1
 Score = 58.2 bits (139), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 61/202 (30%), Positives = 87/202 (43%), Gaps = 48/202 (23%)
Query: 321 LGQGGYGSV---YKGKLLDGSNVAVKVLN---DSKGNGKEFINEVASISRTSHVNVVALL 374
           +G G YGSV   +  K   G  VAVK L+    S  + K    E+  +    H NV+ LL
Sbjct: 30  VGSGAYGSVCAAFDTK--TGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLL 87
Query: 375 GFCL--RVAEE------LSSTIG-----------------------IARGLEYLHLGCST 403
                 R  EE      ++  +G                       I RGL+Y+H   S 
Sbjct: 88  DVFTPARSLEEFNDVYLVTHLMGADLNNIVKSQKLTDDHVQFLIYQILRGLKYIH---SA 144
Query: 404 RILHFDIKPHNILLDEDFCPKISDFGLAKICNRKESIISMTGARGTVGYIAPEVFCRNIG 463
            I+H D+KP N+ ++ED   KI DFGL   C   +    MTG   T  Y APE+   N  
Sbjct: 145 DIIHRDLKPSNLAVNEDSELKILDFGL---CRHTDD--EMTGYVATRWYRAPEIML-NWM 198
Query: 464 EVSYKSDVYNYGMMIFEMTGGR 485
             +   D+++ G ++ E+  GR
Sbjct: 199 HYNQTVDIWSVGCIMAELLTGR 220

>pdb|3CJG|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309

Iteration: 1
 Score = 58.2 bits (139), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 50/210 (23%), Positives = 88/210 (41%), Gaps = 54/210 (25%)
Query: 321 LGQGGYGSVYKG------KLLDGSNVAVKVLND--SKGNGKEFINEVASISRTSH-VNVV 371
           LG+G +G V +       K      VAVK+L +  +    +  ++E+  +    H +NVV
Sbjct: 35  LGRGAFGQVIEADAFGIDKTATXRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVV 94
Query: 372 ALLGFCLRVAEELSSTI----------------------------------------GIA 391
            LLG C +    L   +                                         +A
Sbjct: 95  NLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKDLYKDFLTLEHLICYSFQVA 154
Query: 392 RGLEYLHLGCSTRILHFDIKPHNILLDEDFCPKISDFGLAKICNRKESIISMTGARGTVG 451
           +G+E+L    S + +H D+   NILL E    KI DFGLA+   +    +    AR  + 
Sbjct: 155 KGMEFL---ASRKXIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLK 211
Query: 452 YIAPEVFCRNIGEVSYKSDVYNYGMMIFEM 481
           ++APE     +   + +SDV+++G++++E+
Sbjct: 212 WMAPETIFDRV--YTIQSDVWSFGVLLWEI 239

>pdb|4EWQ|A Chain A, Human P38 Alpha Mapk In Complex With A Pyridazine Based Inhibitor Length = 383

Iteration: 1
 Score = 57.8 bits (138), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 59/202 (29%), Positives = 85/202 (42%), Gaps = 48/202 (23%)
Query: 321 LGQGGYGSV---YKGKLLDGSNVAVKVLN---DSKGNGKEFINEVASISRTSHVNVVALL 374
           +G G YGSV   +  K   G  VAVK L+    S  + K    E+  +    H NV+ LL
Sbjct: 53  VGSGAYGSVCAAFDTK--TGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLL 110
Query: 375 GFCL--RVAEELSSTI-----------------------------GIARGLEYLHLGCST 403
                 R  EE +                                 I RGL+Y+H   S 
Sbjct: 111 DVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIH---SA 167
Query: 404 RILHFDIKPHNILLDEDFCPKISDFGLAKICNRKESIISMTGARGTVGYIAPEVFCRNIG 463
            I+H D+KP N+ ++ED   KI DFGLA+  + +     M G   T  Y APE+   N  
Sbjct: 168 DIIHRDLKPSNLAVNEDCELKILDFGLARHTDDE-----MXGYVATRWYRAPEIML-NWM 221
Query: 464 EVSYKSDVYNYGMMIFEMTGGR 485
             +   D+++ G ++ E+  GR
Sbjct: 222 HYNQTVDIWSVGCIMAELLTGR 243

>pdb|3GP0|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 11 (p38 Beta) In Complex With Nilotinib Length = 348

Iteration: 1
 Score = 57.8 bits (138), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 55/202 (27%), Positives = 88/202 (43%), Gaps = 48/202 (23%)
Query: 321 LGQGGYGSV---YKGKLLDGSNVAVKVLN---DSKGNGKEFINEVASISRTSHVNVVALL 374
           +G G YGSV   Y  +L     VAVK L+    S  + +    E+  +    H NV+ LL
Sbjct: 28  VGSGAYGSVCSAYDARL--RQKVAVKKLSRPFQSLIHARRTYRELRLLKHLKHENVIGLL 85
Query: 375 GF-----------------------------CLRVAEELSSTI--GIARGLEYLHLGCST 403
                                          C  +++E    +   + RGL+Y+H   S 
Sbjct: 86  DVFTPATSIEDFSEVYLVTTLMGADLNNIVKCQALSDEHVQFLVYQLLRGLKYIH---SA 142
Query: 404 RILHFDIKPHNILLDEDFCPKISDFGLAKICNRKESIISMTGARGTVGYIAPEVFCRNIG 463
            I+H D+KP N+ ++ED   +I DFGLA+  + +     MTG   T  Y APE+   N  
Sbjct: 143 GIIHRDLKPSNVAVNEDCELRILDFGLARQADEE-----MTGYVATRWYRAPEIML-NWM 196
Query: 464 EVSYKSDVYNYGMMIFEMTGGR 485
             +   D+++ G ++ E+  G+
Sbjct: 197 HYNQTVDIWSVGCIMAELLQGK 218

>pdb|3QD2|B Chain B, Crsytal Structure Of Mouse Perk Kinase Domain Length = 332

Iteration: 1
 Score = 57.8 bits (138), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 42/143 (29%), Positives = 67/143 (46%), Gaps = 28/143 (19%)
Query: 349 KGNGKEFINEVASISRTSHVNVVALLGFCLRVAEELSSTIGIARGLEYLHLGCSTRILHF 408
           K N K+++N   S+    H       G CL +       I IA  +E+LH   S  ++H 
Sbjct: 145 KENLKDWMNRRCSLEDREH-------GVCLHIF------IQIAEAVEFLH---SKGLMHR 188
Query: 409 DIKPHNILLDEDFCPKISDFGLAKICNRKE----------SIISMTGARGTVGYIAPEVF 458
           D+KP NI    D   K+ DFGL    ++ E          +  +  G  GT  Y++PE  
Sbjct: 189 DLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHXGQVGTKLYMSPEQI 248
Query: 459 CRNIGEVSYKSDVYNYGMMIFEM 481
             N    S+K D+++ G+++FE+
Sbjct: 249 HGN--NYSHKVDIFSLGLILFEL 269

>pdb|3GC8|A Chain A, The Structure Of P38beta C162s In Complex With A Dihydroquinazolinone Length = 370

Iteration: 1
 Score = 57.8 bits (138), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 55/202 (27%), Positives = 88/202 (43%), Gaps = 48/202 (23%)
Query: 321 LGQGGYGSV---YKGKLLDGSNVAVKVLN---DSKGNGKEFINEVASISRTSHVNVVALL 374
           +G G YGSV   Y  +L     VAVK L+    S  + +    E+  +    H NV+ LL
Sbjct: 36  VGSGAYGSVCSAYDARL--RQKVAVKKLSRPFQSLIHARRTYRELRLLKHLKHENVIGLL 93
Query: 375 GF-----------------------------CLRVAEELSSTI--GIARGLEYLHLGCST 403
                                          C  +++E    +   + RGL+Y+H   S 
Sbjct: 94  DVFTPATSIEDFSEVYLVTTLMGADLNNIVKCQALSDEHVQFLVYQLLRGLKYIH---SA 150
Query: 404 RILHFDIKPHNILLDEDFCPKISDFGLAKICNRKESIISMTGARGTVGYIAPEVFCRNIG 463
            I+H D+KP N+ ++ED   +I DFGLA+  + +     MTG   T  Y APE+   N  
Sbjct: 151 GIIHRDLKPSNVAVNEDSELRILDFGLARQADEE-----MTGYVATRWYRAPEIML-NWM 204
Query: 464 EVSYKSDVYNYGMMIFEMTGGR 485
             +   D+++ G ++ E+  G+
Sbjct: 205 HYNQTVDIWSVGCIMAELLQGK 226

>pdb|3GI3|A Chain A, Crystal Structure Of A N-Phenyl-N'-Naphthylurea Analog In Complex With P38 Map Kinase Length = 360

Iteration: 1
 Score = 57.8 bits (138), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 59/202 (29%), Positives = 85/202 (42%), Gaps = 48/202 (23%)
Query: 321 LGQGGYGSV---YKGKLLDGSNVAVKVLN---DSKGNGKEFINEVASISRTSHVNVVALL 374
           +G G YGSV   +  K   G  VAVK L+    S  + K    E+  +    H NV+ LL
Sbjct: 30  VGSGAYGSVCAAFDTK--TGHRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLL 87
Query: 375 GFCL--RVAEELSSTI-----------------------------GIARGLEYLHLGCST 403
                 R  EE +                                 I RGL+Y+H   S 
Sbjct: 88  DVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIH---SA 144
Query: 404 RILHFDIKPHNILLDEDFCPKISDFGLAKICNRKESIISMTGARGTVGYIAPEVFCRNIG 463
            I+H D+KP N+ ++ED   KI DF LA+  + +     MTG   T  Y APE+   N  
Sbjct: 145 DIIHRDLKPSNLAVNEDCELKILDFYLARHTDDE-----MTGYVATRWYRAPEIML-NWM 198
Query: 464 EVSYKSDVYNYGMMIFEMTGGR 485
             +   D+++ G ++ E+  GR
Sbjct: 199 HYNQTVDIWSVGCIMAELLTGR 220

>pdb|2Z8C|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin-2- Yl]amino}phenyl)acetic Acid Length = 303

Iteration: 1
 Score = 57.8 bits (138), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 53/210 (25%), Positives = 93/210 (44%), Gaps = 54/210 (25%)
Query: 320 KLGQGGYGSVYKGKLLD------GSNVAVKVLNDSKGNGK--EFINEVASISRTSHVNVV 371
           +LGQG +G VY+G   D       + VAVK +N+S    +  EF+NE + +   +  +VV
Sbjct: 21  ELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVV 80
Query: 372 ALLGFCLR-------------------------------------VAEELSSTIGIARGL 394
            LLG   +                                     + E +     IA G+
Sbjct: 81  RLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGM 140
Query: 395 EYLHLGCSTRILHFDIKPHNILLDEDFCPKISDFGLAKICNRKESIISMTGARG--TVGY 452
            YL+   + + +H D+   N ++  DF  KI DFG+ +  +  E+     G +G   V +
Sbjct: 141 AYLN---AKKFVHRDLAARNCMVAHDFTVKIGDFGMTR--DIXETDXXRKGGKGLLPVRW 195
Query: 453 IAPEVFCRNIGEVSYKSDVYNYGMMIFEMT 482
           +APE      G  +  SD++++G++++E+T
Sbjct: 196 MAPESL--KDGVFTTSSDMWSFGVVLWEIT 223

>pdb|2JFL|A Chain A, Crystal Structure Of Human Ste20-Like Kinase ( Diphosphorylated Form) Bound To 5- Amino-3-((4-( Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2, 4-Triazole-1-Carbothioamide Length = 325

Iteration: 1
 Score = 57.4 bits (137), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 55/200 (27%), Positives = 91/200 (45%), Gaps = 46/200 (23%)
Query: 320 KLGQGGYGSVYKGKLLDGSNVAVKVLNDSKGNGK--EFINEVASISRTSHVNVVALLG-- 375
           +LG G +G VYK +  + S +A   + D+K   +  +++ E+  ++   H N+V LL   
Sbjct: 44  ELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAF 103
Query: 376 -----------FC---------LRVAEELS-STIGIA-----RGLEYLHLGCSTRILHFD 409
                      FC         L +   L+ S I +        L YLH     +I+H D
Sbjct: 104 YYENNLWILIEFCAGGAVDAVMLELERPLTESQIQVVCKQTLDALNYLH---DNKIIHRD 160
Query: 410 IKPHNILLDEDFCPKISDFGLA----KICNRKESIISMTGARGTVGYIAPE-VFCRNIGE 464
           +K  NIL   D   K++DFG++    +   R++  I      GT  ++APE V C    +
Sbjct: 161 LKAGNILFTLDGDIKLADFGVSAKNTRXIQRRDXFI------GTPYWMAPEVVMCETSKD 214
Query: 465 --VSYKSDVYNYGMMIFEMT 482
               YK+DV++ G+ + EM 
Sbjct: 215 RPYDYKADVWSLGITLIEMA 234

>pdb|1IR3|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With Peptide Substrate And Atp Analog Length = 306

Iteration: 1
 Score = 57.4 bits (137), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 53/210 (25%), Positives = 93/210 (44%), Gaps = 54/210 (25%)
Query: 320 KLGQGGYGSVYKGKLLD------GSNVAVKVLNDSKGNGK--EFINEVASISRTSHVNVV 371
           +LGQG +G VY+G   D       + VAVK +N+S    +  EF+NE + +   +  +VV
Sbjct: 24  ELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVV 83
Query: 372 ALLGFCLR-------------------------------------VAEELSSTIGIARGL 394
            LLG   +                                     + E +     IA G+
Sbjct: 84  RLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGM 143
Query: 395 EYLHLGCSTRILHFDIKPHNILLDEDFCPKISDFGLAKICNRKESIISMTGARG--TVGY 452
            YL+   + + +H D+   N ++  DF  KI DFG+ +  +  E+     G +G   V +
Sbjct: 144 AYLN---AKKFVHRDLAARNCMVAHDFTVKIGDFGMTR--DIXETDXXRKGGKGLLPVRW 198
Query: 453 IAPEVFCRNIGEVSYKSDVYNYGMMIFEMT 482
           +APE      G  +  SD++++G++++E+T
Sbjct: 199 MAPESL--KDGVFTTSSDMWSFGVVLWEIT 226

>pdb|1RQQ|A Chain A, Crystal Structure Of The Insulin Receptor Kinase In Complex With The Sh2 Domain Of Aps Length = 306

Iteration: 1
 Score = 57.4 bits (137), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 53/210 (25%), Positives = 93/210 (44%), Gaps = 54/210 (25%)
Query: 320 KLGQGGYGSVYKGKLLD------GSNVAVKVLNDSKGNGK--EFINEVASISRTSHVNVV 371
           +LGQG +G VY+G   D       + VAVK +N+S    +  EF+NE + +   +  +VV
Sbjct: 24  ELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVV 83
Query: 372 ALLGFCLR-------------------------------------VAEELSSTIGIARGL 394
            LLG   +                                     + E +     IA G+
Sbjct: 84  RLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGM 143
Query: 395 EYLHLGCSTRILHFDIKPHNILLDEDFCPKISDFGLAKICNRKESIISMTGARG--TVGY 452
            YL+   + + +H D+   N ++  DF  KI DFG+ +  +  E+     G +G   V +
Sbjct: 144 AYLN---AKKFVHRDLAARNCMVAHDFTVKIGDFGMTR--DIXETDXXRKGGKGLLPVRW 198
Query: 453 IAPEVFCRNIGEVSYKSDVYNYGMMIFEMT 482
           +APE      G  +  SD++++G++++E+T
Sbjct: 199 MAPESL--KDGVFTTSSDMWSFGVVLWEIT 226

>pdb|3RVG|A Chain A, Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido[4,3-B]indol-4- Carboxamide Inhibitor Length = 303

Iteration: 1
 Score = 57.4 bits (137), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 56/203 (27%), Positives = 91/203 (44%), Gaps = 42/203 (20%)
Query: 316 SFKYKLGQGGYGSVYKGK---LLD--GSNVAVKVLNDS-KGNGKEFINEVASISRTSHVN 369
            F  +LG+G +GSV   +   L D  G  VAVK L  S + + ++F  E+  +    H N
Sbjct: 17  KFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDN 76
Query: 370 VVALLGFC-------LRVAEE-----------------------LSSTIGIARGLEYLHL 399
           +V   G C       L++  E                       L  T  I +G+EYL  
Sbjct: 77  IVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYL-- 134
Query: 400 GCSTRILHFDIKPHNILLDEDFCPKISDFGLAKICNR-KESIISMTGARGTVGYIAPEVF 458
             + R +H D+   NIL++ +   KI DFGL K+  + KE           + + APE  
Sbjct: 135 -GTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESL 193
Query: 459 CRNIGEVSYKSDVYNYGMMIFEM 481
             +  + S  SDV+++G++++E+
Sbjct: 194 TES--KFSVASDVWSFGVVLYEL 214

>pdb|2B7A|A Chain A, The Structural Basis Of Janus Kinase 2 Inhibition By A Potent And Specific Pan-Janus Kinase Inhibitor Length = 293

Iteration: 1
 Score = 57.4 bits (137), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 56/203 (27%), Positives = 91/203 (44%), Gaps = 42/203 (20%)
Query: 316 SFKYKLGQGGYGSVYKGK---LLD--GSNVAVKVLNDS-KGNGKEFINEVASISRTSHVN 369
            F  +LG+G +GSV   +   L D  G  VAVK L  S + + ++F  E+  +    H N
Sbjct: 11  KFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDN 70
Query: 370 VVALLGFC-------LRVAEE-----------------------LSSTIGIARGLEYLHL 399
           +V   G C       L++  E                       L  T  I +G+EYL  
Sbjct: 71  IVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYL-- 128
Query: 400 GCSTRILHFDIKPHNILLDEDFCPKISDFGLAKICNR-KESIISMTGARGTVGYIAPEVF 458
             + R +H D+   NIL++ +   KI DFGL K+  + KE           + + APE  
Sbjct: 129 -GTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESL 187
Query: 459 CRNIGEVSYKSDVYNYGMMIFEM 481
             +  + S  SDV+++G++++E+
Sbjct: 188 TES--KFSVASDVWSFGVVLYEL 208

>pdb|2XA4|A Chain A, Inhibitors Of Jak2 Kinase Domain Length = 298

Iteration: 1
 Score = 57.4 bits (137), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 56/203 (27%), Positives = 91/203 (44%), Gaps = 42/203 (20%)
Query: 316 SFKYKLGQGGYGSVYKGK---LLD--GSNVAVKVLNDS-KGNGKEFINEVASISRTSHVN 369
            F  +LG+G +GSV   +   L D  G  VAVK L  S + + ++F  E+  +    H N
Sbjct: 16  KFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDN 75
Query: 370 VVALLGFC-------LRVAEE-----------------------LSSTIGIARGLEYLHL 399
           +V   G C       L++  E                       L  T  I +G+EYL  
Sbjct: 76  IVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQAHAERIDHIKLLQYTSQICKGMEYL-- 133
Query: 400 GCSTRILHFDIKPHNILLDEDFCPKISDFGLAKICNR-KESIISMTGARGTVGYIAPEVF 458
             + R +H D+   NIL++ +   KI DFGL K+  + KE           + + APE  
Sbjct: 134 -GTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESL 192
Query: 459 CRNIGEVSYKSDVYNYGMMIFEM 481
             +  + S  SDV+++G++++E+
Sbjct: 193 TES--KFSVASDVWSFGVVLYEL 213

>pdb|4HGE|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 Length = 300

Iteration: 1
 Score = 57.4 bits (137), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 56/203 (27%), Positives = 91/203 (44%), Gaps = 42/203 (20%)
Query: 316 SFKYKLGQGGYGSVYKGK---LLD--GSNVAVKVLNDS-KGNGKEFINEVASISRTSHVN 369
            F  +LG+G +GSV   +   L D  G  VAVK L  S + + ++F  E+  +    H N
Sbjct: 18  KFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDN 77
Query: 370 VVALLGFC-------LRVAEE-----------------------LSSTIGIARGLEYLHL 399
           +V   G C       L++  E                       L  T  I +G+EYL  
Sbjct: 78  IVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYL-- 135
Query: 400 GCSTRILHFDIKPHNILLDEDFCPKISDFGLAKICNR-KESIISMTGARGTVGYIAPEVF 458
             + R +H D+   NIL++ +   KI DFGL K+  + KE           + + APE  
Sbjct: 136 -GTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESL 194
Query: 459 CRNIGEVSYKSDVYNYGMMIFEM 481
             +  + S  SDV+++G++++E+
Sbjct: 195 TES--KFSVASDVWSFGVVLYEL 215

>pdb|3E62|A Chain A, Fragment Based Discovery Of Jak-2 Inhibitors Length = 293

Iteration: 1
 Score = 57.4 bits (137), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 56/203 (27%), Positives = 91/203 (44%), Gaps = 42/203 (20%)
Query: 316 SFKYKLGQGGYGSVYKGK---LLD--GSNVAVKVLNDS-KGNGKEFINEVASISRTSHVN 369
            F  +LG+G +GSV   +   L D  G  VAVK L  S + + ++F  E+  +    H N
Sbjct: 12  KFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDN 71
Query: 370 VVALLGFC-------LRVAEE-----------------------LSSTIGIARGLEYLHL 399
           +V   G C       L++  E                       L  T  I +G+EYL  
Sbjct: 72  IVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYL-- 129
Query: 400 GCSTRILHFDIKPHNILLDEDFCPKISDFGLAKICNR-KESIISMTGARGTVGYIAPEVF 458
             + R +H D+   NIL++ +   KI DFGL K+  + KE           + + APE  
Sbjct: 130 -GTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESL 188
Query: 459 CRNIGEVSYKSDVYNYGMMIFEM 481
             +  + S  SDV+++G++++E+
Sbjct: 189 TES--KFSVASDVWSFGVVLYEL 209

>pdb|4E6D|A Chain A, Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex With Compound 7 Length = 298

Iteration: 1
 Score = 57.4 bits (137), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 56/203 (27%), Positives = 91/203 (44%), Gaps = 42/203 (20%)
Query: 316 SFKYKLGQGGYGSVYKGK---LLD--GSNVAVKVLNDS-KGNGKEFINEVASISRTSHVN 369
            F  +LG+G +GSV   +   L D  G  VAVK L  S + + ++F  E+  +    H N
Sbjct: 16  KFLRQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDN 75
Query: 370 VVALLGFC-------LRVAEE-----------------------LSSTIGIARGLEYLHL 399
           +V   G C       L++  E                       L  T  I +G+EYL  
Sbjct: 76  IVKYKGVCYSAGRRNLKLIMEFLPYGSLREYLQKHKERIDHIKLLQYTSQICKGMEYL-- 133
Query: 400 GCSTRILHFDIKPHNILLDEDFCPKISDFGLAKICNR-KESIISMTGARGTVGYIAPEVF 458
             + R +H D+   NIL++ +   KI DFGL K+  + KE           + + APE  
Sbjct: 134 -GTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESL 192
Query: 459 CRNIGEVSYKSDVYNYGMMIFEM 481
             +  + S  SDV+++G++++E+
Sbjct: 193 TES--KFSVASDVWSFGVVLYEL 213

>pdb|1U59|A Chain A, Crystal Structure Of The Zap-70 Kinase Domain In Complex With Staurosporine Length = 287

Iteration: 1
 Score = 57.4 bits (137), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 55/194 (28%), Positives = 90/194 (46%), Gaps = 38/194 (19%)
Query: 320 KLGQGGYGSVYKG------KLLDGSNVAVKVLND--SKGNGKEFINEVASISRTSHVNVV 371
           +LG G +GSV +G      K +D   VA+KVL     K + +E + E   + +  +  +V
Sbjct: 17  ELGCGNFGSVRQGVYRMRKKQID---VAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIV 73
Query: 372 ALLGFC----LRVAEELS-------------STIGIARGLEYLH---LGC----STRILH 407
            L+G C    L +  E++               I ++   E LH   +G         +H
Sbjct: 74  RLIGVCQAEALMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKNFVH 133
Query: 408 FDIKPHNILLDEDFCPKISDFGLAKICNRKESIISMTGA-RGTVGYIAPEVFCRNIGEVS 466
            D+   N+LL      KISDFGL+K     +S  +   A +  + + APE  C N  + S
Sbjct: 134 RDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPE--CINFRKFS 191
Query: 467 YKSDVYNYGMMIFE 480
            +SDV++YG+ ++E
Sbjct: 192 SRSDVWSYGVTMWE 205

>pdb|3Q32|A Chain A, Structure Of Janus Kinase 2 With A Pyrrolotriazine Inhibitor Length = 301

Iteration: 1
 Score = 57.4 bits (137), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 56/203 (27%), Positives = 91/203 (44%), Gaps = 42/203 (20%)
Query: 316 SFKYKLGQGGYGSVYKGK---LLD--GSNVAVKVLNDS-KGNGKEFINEVASISRTSHVN 369
            F  +LG+G +GSV   +   L D  G  VAVK L  S + + ++F  E+  +    H N
Sbjct: 13  KFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDN 72
Query: 370 VVALLGFC-------LRVAEE-----------------------LSSTIGIARGLEYLHL 399
           +V   G C       L++  E                       L  T  I +G+EYL  
Sbjct: 73  IVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYL-- 130
Query: 400 GCSTRILHFDIKPHNILLDEDFCPKISDFGLAKICNR-KESIISMTGARGTVGYIAPEVF 458
             + R +H D+   NIL++ +   KI DFGL K+  + KE           + + APE  
Sbjct: 131 -GTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESL 189
Query: 459 CRNIGEVSYKSDVYNYGMMIFEM 481
             +  + S  SDV+++G++++E+
Sbjct: 190 TES--KFSVASDVWSFGVVLYEL 210

>pdb|4AQC|A Chain A, Triazolopyridine-Based Inhibitor Of Janus Kinase 2 Length = 301

Iteration: 1
 Score = 57.4 bits (137), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 56/203 (27%), Positives = 91/203 (44%), Gaps = 42/203 (20%)
Query: 316 SFKYKLGQGGYGSVYKGK---LLD--GSNVAVKVLNDS-KGNGKEFINEVASISRTSHVN 369
            F  +LG+G +GSV   +   L D  G  VAVK L  S + + ++F  E+  +    H N
Sbjct: 19  KFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDN 78
Query: 370 VVALLGFC-------LRVAEE-----------------------LSSTIGIARGLEYLHL 399
           +V   G C       L++  E                       L  T  I +G+EYL  
Sbjct: 79  IVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYL-- 136
Query: 400 GCSTRILHFDIKPHNILLDEDFCPKISDFGLAKICNR-KESIISMTGARGTVGYIAPEVF 458
             + R +H D+   NIL++ +   KI DFGL K+  + KE           + + APE  
Sbjct: 137 -GTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESL 195
Query: 459 CRNIGEVSYKSDVYNYGMMIFEM 481
             +  + S  SDV+++G++++E+
Sbjct: 196 TES--KFSVASDVWSFGVVLYEL 216

>pdb|3TJC|A Chain A, Co-Crystal Structure Of Jak2 With Thienopyridine 8 Length = 298

Iteration: 1
 Score = 57.4 bits (137), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 56/203 (27%), Positives = 91/203 (44%), Gaps = 42/203 (20%)
Query: 316 SFKYKLGQGGYGSVYKGK---LLD--GSNVAVKVLNDS-KGNGKEFINEVASISRTSHVN 369
            F  +LG+G +GSV   +   L D  G  VAVK L  S + + ++F  E+  +    H N
Sbjct: 16  KFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDN 75
Query: 370 VVALLGFC-------LRVAEE-----------------------LSSTIGIARGLEYLHL 399
           +V   G C       L++  E                       L  T  I +G+EYL  
Sbjct: 76  IVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYL-- 133
Query: 400 GCSTRILHFDIKPHNILLDEDFCPKISDFGLAKICNR-KESIISMTGARGTVGYIAPEVF 458
             + R +H D+   NIL++ +   KI DFGL K+  + KE           + + APE  
Sbjct: 134 -GTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESL 192
Query: 459 CRNIGEVSYKSDVYNYGMMIFEM 481
             +  + S  SDV+++G++++E+
Sbjct: 193 TES--KFSVASDVWSFGVVLYEL 213

>pdb|1OMW|A Chain A, Crystal Structure Of The Complex Between G Protein-Coupled Receptor Kinase 2 And Heterotrimeric G Protein Beta 1 And Gamma 2 Subunits Length = 689

Iteration: 1
 Score = 57.4 bits (137), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 54/199 (27%), Positives = 92/199 (46%), Gaps = 43/199 (21%)
Query: 321 LGQGGYGSVYKGKLLD-GSNVAVKVLNDSKGNGKE----FINE--VASISRTSHVNVVAL 373
           +G+GG+G VY  +  D G   A+K L+  +   K+     +NE  + S+  T     +  
Sbjct: 197 IGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVC 256
Query: 374 LGFCLRVAEELSSTIG----------------------------IARGLEYLHLGCSTRI 405
           + +     ++LS  +                             I  GLE++H   +  +
Sbjct: 257 MSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEADMRFYAAEIILGLEHMH---NRFV 313
Query: 406 LHFDIKPHNILLDEDFCPKISDFGLAKICNRKESIISMTGARGTVGYIAPEVFCRNIGEV 465
           ++ D+KP NILLDE    +ISD GLA   ++K+   S+    GT GY+APEV  + +   
Sbjct: 314 VYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHASV----GTHGYMAPEVLQKGVAYD 369
Query: 466 SYKSDVYNYGMMIFEMTGG 484
           S  +D ++ G M+F++  G
Sbjct: 370 S-SADWFSLGCMLFKLLRG 387

>pdb|3PSC|A Chain A, Bovine Grk2 In Complex With Gbetagamma Subunits Length = 695

Iteration: 1
 Score = 57.4 bits (137), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 54/199 (27%), Positives = 92/199 (46%), Gaps = 43/199 (21%)
Query: 321 LGQGGYGSVYKGKLLD-GSNVAVKVLNDSKGNGKE----FINE--VASISRTSHVNVVAL 373
           +G+GG+G VY  +  D G   A+K L+  +   K+     +NE  + S+  T     +  
Sbjct: 197 IGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVC 256
Query: 374 LGFCLRVAEELSSTIG----------------------------IARGLEYLHLGCSTRI 405
           + +     ++LS  +                             I  GLE++H   +  +
Sbjct: 257 MSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEADMRFYAAEIILGLEHMH---NRFV 313
Query: 406 LHFDIKPHNILLDEDFCPKISDFGLAKICNRKESIISMTGARGTVGYIAPEVFCRNIGEV 465
           ++ D+KP NILLDE    +ISD GLA   ++K+   S+    GT GY+APEV  + +   
Sbjct: 314 VYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHASV----GTHGYMAPEVLQKGVAYD 369
Query: 466 SYKSDVYNYGMMIFEMTGG 484
           S  +D ++ G M+F++  G
Sbjct: 370 S-SADWFSLGCMLFKLLRG 387

>pdb|2BUJ|A Chain A, Crystal Structure Of The Human Serine-Threonine Kinase 16 In Complex With Staurosporine Length = 317

Iteration: 1
 Score = 57.4 bits (137), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 61/232 (26%), Positives = 100/232 (43%), Gaps = 50/232 (21%)
Query: 317 FKYKLGQGGYGSV-YKGKLLDGSNVAVKVLNDSKGNGKEFINEVASISRT-SHVNVVALL 374
           F  KLG+GG+  V     L DG   A+K +   +   +E     A + R  +H N++ L+
Sbjct: 33  FIQKLGEGGFSYVDLVEGLHDGHFYALKRILCHEQQDREEAQREADMHRLFNHPNILRLV 92
Query: 375 GFCLR---------------------------------VAEE--LSSTIGIARGLEYLHL 399
            +CLR                                 + E+  L   +GI RGLE +H 
Sbjct: 93  AYCLRERGAKHEAWLLLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGLEAIH- 151
Query: 400 GCSTRILHFDIKPHNILLDEDFCPKISDFG-LAKICNRKE------SIISMTGARGTVGY 452
             +    H D+KP NILL ++  P + D G + + C   E      ++      R T+ Y
Sbjct: 152 --AKGYAHRDLKPTNILLGDEGQPVLMDLGSMNQACIHVEGSRQALTLQDWAAQRCTISY 209
Query: 453 IAPEVF-CRNIGEVSYKSDVYNYGMMIFEMTGGRKNVDVV--DNGSTALDLQ 501
            APE+F  ++   +  ++DV++ G +++ M  G    D+V     S AL +Q
Sbjct: 210 RAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGPYDMVFQKGDSVALAVQ 261

>pdb|2W1I|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 326

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 56/202 (27%), Positives = 91/202 (45%), Gaps = 42/202 (20%)
Query: 317 FKYKLGQGGYGSVYKGK---LLD--GSNVAVKVLNDS-KGNGKEFINEVASISRTSHVNV 370
           F  +LG+G +GSV   +   L D  G  VAVK L  S + + ++F  E+  +    H N+
Sbjct: 45  FLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNI 104
Query: 371 VALLGFC-------LRVAEE-----------------------LSSTIGIARGLEYLHLG 400
           V   G C       L++  E                       L  T  I +G+EYL   
Sbjct: 105 VKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYL--- 161
Query: 401 CSTRILHFDIKPHNILLDEDFCPKISDFGLAKICNR-KESIISMTGARGTVGYIAPEVFC 459
            + R +H D+   NIL++ +   KI DFGL K+  + KE           + + APE   
Sbjct: 162 GTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESLT 221
Query: 460 RNIGEVSYKSDVYNYGMMIFEM 481
            +  + S  SDV+++G++++E+
Sbjct: 222 ES--KFSVASDVWSFGVVLYEL 241

>pdb|4E4M|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 56/202 (27%), Positives = 91/202 (45%), Gaps = 42/202 (20%)
Query: 317 FKYKLGQGGYGSVYKGK---LLD--GSNVAVKVLNDS-KGNGKEFINEVASISRTSHVNV 370
           F  +LG+G +GSV   +   L D  G  VAVK L  S + + ++F  E+  +    H N+
Sbjct: 21  FLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNI 80
Query: 371 VALLGFC-------LRVAEE-----------------------LSSTIGIARGLEYLHLG 400
           V   G C       L++  E                       L  T  I +G+EYL   
Sbjct: 81  VKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYL--- 137
Query: 401 CSTRILHFDIKPHNILLDEDFCPKISDFGLAKICNR-KESIISMTGARGTVGYIAPEVFC 459
            + R +H D+   NIL++ +   KI DFGL K+  + KE           + + APE   
Sbjct: 138 GTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESLT 197
Query: 460 RNIGEVSYKSDVYNYGMMIFEM 481
            +  + S  SDV+++G++++E+
Sbjct: 198 ES--KFSVASDVWSFGVVLYEL 217

>pdb|3KRW|A Chain A, Human Grk2 In Complex With Gbetgamma Subunits And Balanol (Soak) Length = 688

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 54/199 (27%), Positives = 92/199 (46%), Gaps = 43/199 (21%)
Query: 321 LGQGGYGSVYKGKLLD-GSNVAVKVLNDSKGNGKE----FINE--VASISRTSHVNVVAL 373
           +G+GG+G VY  +  D G   A+K L+  +   K+     +NE  + S+  T     +  
Sbjct: 196 IGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVC 255
Query: 374 LGFCLRVAEELSSTIG----------------------------IARGLEYLHLGCSTRI 405
           + +     ++LS  +                             I  GLE++H   +  +
Sbjct: 256 MSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEADMRFYAAEIILGLEHMH---NRFV 312
Query: 406 LHFDIKPHNILLDEDFCPKISDFGLAKICNRKESIISMTGARGTVGYIAPEVFCRNIGEV 465
           ++ D+KP NILLDE    +ISD GLA   ++K+   S+    GT GY+APEV  + +   
Sbjct: 313 VYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHASV----GTHGYMAPEVLQKGVAYD 368
Query: 466 SYKSDVYNYGMMIFEMTGG 484
           S  +D ++ G M+F++  G
Sbjct: 369 S-SADWFSLGCMLFKLLRG 386

>pdb|3CIK|A Chain A, Human Grk2 In Complex With Gbetagamma Subunits Length = 689

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 54/199 (27%), Positives = 92/199 (46%), Gaps = 43/199 (21%)
Query: 321 LGQGGYGSVYKGKLLD-GSNVAVKVLNDSKGNGKE----FINE--VASISRTSHVNVVAL 373
           +G+GG+G VY  +  D G   A+K L+  +   K+     +NE  + S+  T     +  
Sbjct: 197 IGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVC 256
Query: 374 LGFCLRVAEELSSTIG----------------------------IARGLEYLHLGCSTRI 405
           + +     ++LS  +                             I  GLE++H   +  +
Sbjct: 257 MSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEADMRFYAAEIILGLEHMH---NRFV 313
Query: 406 LHFDIKPHNILLDEDFCPKISDFGLAKICNRKESIISMTGARGTVGYIAPEVFCRNIGEV 465
           ++ D+KP NILLDE    +ISD GLA   ++K+   S+    GT GY+APEV  + +   
Sbjct: 314 VYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHASV----GTHGYMAPEVLQKGVAYD 369
Query: 466 SYKSDVYNYGMMIFEMTGG 484
           S  +D ++ G M+F++  G
Sbjct: 370 S-SADWFSLGCMLFKLLRG 387

>pdb|3LPB|A Chain A, Crystal Structure Of Jak2 Complexed With A Potent 2,8-Diaryl Quinoxaline Inhibitor Length = 295

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 56/203 (27%), Positives = 91/203 (44%), Gaps = 42/203 (20%)
Query: 316 SFKYKLGQGGYGSVYKGK---LLD--GSNVAVKVLNDS-KGNGKEFINEVASISRTSHVN 369
            F  +LG+G +GSV   +   L D  G  VAVK L  S + + ++F  E+  +    H N
Sbjct: 13  KFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDN 72
Query: 370 VVALLGFC-------LRVAEE-----------------------LSSTIGIARGLEYLHL 399
           +V   G C       L++  E                       L  T  I +G+EYL  
Sbjct: 73  IVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYL-- 130
Query: 400 GCSTRILHFDIKPHNILLDEDFCPKISDFGLAKICNR-KESIISMTGARGTVGYIAPEVF 458
             + R +H D+   NIL++ +   KI DFGL K+  + KE           + + APE  
Sbjct: 131 -GTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESL 189
Query: 459 CRNIGEVSYKSDVYNYGMMIFEM 481
             +  + S  SDV+++G++++E+
Sbjct: 190 TES--KFSVASDVWSFGVVLYEL 210

>pdb|3JY9|A Chain A, Janus Kinase 2 Inhibitors Length = 311

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 56/203 (27%), Positives = 91/203 (44%), Gaps = 42/203 (20%)
Query: 316 SFKYKLGQGGYGSVYKGK---LLD--GSNVAVKVLNDS-KGNGKEFINEVASISRTSHVN 369
            F  +LG+G +GSV   +   L D  G  VAVK L  S + + ++F  E+  +    H N
Sbjct: 31  KFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDN 90
Query: 370 VVALLGFC-------LRVAEE-----------------------LSSTIGIARGLEYLHL 399
           +V   G C       L++  E                       L  T  I +G+EYL  
Sbjct: 91  IVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYL-- 148
Query: 400 GCSTRILHFDIKPHNILLDEDFCPKISDFGLAKICNR-KESIISMTGARGTVGYIAPEVF 458
             + R +H D+   NIL++ +   KI DFGL K+  + KE           + + APE  
Sbjct: 149 -GTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESL 207
Query: 459 CRNIGEVSYKSDVYNYGMMIFEM 481
             +  + S  SDV+++G++++E+
Sbjct: 208 TES--KFSVASDVWSFGVVLYEL 228

>pdb|1I44|A Chain A, Crystallographic Studies Of An Activation Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 53/210 (25%), Positives = 93/210 (44%), Gaps = 54/210 (25%)
Query: 320 KLGQGGYGSVYKGKLLD------GSNVAVKVLNDSKGNGK--EFINEVASISRTSHVNVV 371
           +LGQG +G VY+G   D       + VAVK +N+S    +  EF+NE + +   +  +VV
Sbjct: 24  ELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVV 83
Query: 372 ALLGFCLR-------------------------------------VAEELSSTIGIARGL 394
            LLG   +                                     + E +     IA G+
Sbjct: 84  RLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGM 143
Query: 395 EYLHLGCSTRILHFDIKPHNILLDEDFCPKISDFGLAKICNRKESIISMTGARG--TVGY 452
            YL+   + + +H D+   N ++  DF  KI DFG+ +  +  E+     G +G   V +
Sbjct: 144 AYLN---AKKFVHRDLAARNCMVAHDFTVKIGDFGMTR--DIYETAYYRKGGKGLLPVRW 198
Query: 453 IAPEVFCRNIGEVSYKSDVYNYGMMIFEMT 482
           +APE      G  +  SD++++G++++E+T
Sbjct: 199 MAPESL--KDGVFTTSSDMWSFGVVLWEIT 226

>pdb|3GC9|A Chain A, The Structure Of P38beta C119s, C162s In Complex With A Dihydroquinazolinone Inhibitor Length = 370

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 56/202 (27%), Positives = 90/202 (44%), Gaps = 48/202 (23%)
Query: 321 LGQGGYGSV---YKGKLLDGSNVAVKVLN---DSKGNGKEFINEVASISRTSHVNVVALL 374
           +G G YGSV   Y  +L     VAVK L+    S  + +    E+  +    H NV+ LL
Sbjct: 36  VGSGAYGSVCSAYDARL--RQKVAVKKLSRPFQSLIHARRTYRELRLLKHLKHENVIGLL 93
Query: 375 G-FCLRVAEE-------LSSTIG-----------------------IARGLEYLHLGCST 403
             F    + E       +++ +G                       + RGL+Y+H   S 
Sbjct: 94  DVFTPATSIEDFSEVYLVTTLMGADLNNIVKSQALSDEHVQFLVYQLLRGLKYIH---SA 150
Query: 404 RILHFDIKPHNILLDEDFCPKISDFGLAKICNRKESIISMTGARGTVGYIAPEVFCRNIG 463
            I+H D+KP N+ ++ED   +I DFGLA+  + +     MTG   T  Y APE+   N  
Sbjct: 151 GIIHRDLKPSNVAVNEDSELRILDFGLARQADEE-----MTGYVATRWYRAPEIML-NWM 204
Query: 464 EVSYKSDVYNYGMMIFEMTGGR 485
             +   D+++ G ++ E+  G+
Sbjct: 205 HYNQTVDIWSVGCIMAELLQGK 226

>pdb|3IO7|A Chain A, 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Selective Inhibitors Of Jak2 Length = 313

Iteration: 1
 Score = 57.0 bits (136), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 56/203 (27%), Positives = 91/203 (44%), Gaps = 42/203 (20%)
Query: 316 SFKYKLGQGGYGSVYKGK---LLD--GSNVAVKVLNDS-KGNGKEFINEVASISRTSHVN 369
            F  +LG+G +GSV   +   L D  G  VAVK L  S + + ++F  E+  +    H N
Sbjct: 31  KFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDN 90
Query: 370 VVALLGFC-------LRVAEE-----------------------LSSTIGIARGLEYLHL 399
           +V   G C       L++  E                       L  T  I +G+EYL  
Sbjct: 91  IVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYL-- 148
Query: 400 GCSTRILHFDIKPHNILLDEDFCPKISDFGLAKICNR-KESIISMTGARGTVGYIAPEVF 458
             + R +H D+   NIL++ +   KI DFGL K+  + KE           + + APE  
Sbjct: 149 -GTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESL 207
Query: 459 CRNIGEVSYKSDVYNYGMMIFEM 481
             +  + S  SDV+++G++++E+
Sbjct: 208 TES--KFSVASDVWSFGVVLYEL 228

>pdb|3HZT|A Chain A, Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme49_105860 Length = 467

Iteration: 1
 Score = 57.0 bits (136), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 59/196 (30%), Positives = 82/196 (41%), Gaps = 46/196 (23%)
Query: 320 KLGQGGYGSVY--KGKLLDGSNVAVKVLNDSK----GNGKEFINEVASISRTSHVNVVAL 373
           KLG G YG V   K KL  G+  A+K++  S      N    ++EVA + +  H N++ L
Sbjct: 11  KLGSGAYGEVLLCKDKLT-GAERAIKIIKKSSVTTTSNSGALLDEVAVLKQLDHPNIMKL 69
Query: 374 LGF------------CLRVAEELSSTI---------------GIARGLEYLHLGCSTRIL 406
             F              R  E     I                +  G  YLH      I+
Sbjct: 70  YEFFEDKRNYYLVMEVYRGGELFDEIILRQKFSEVDAAVIMKQVLSGTTYLH---KHNIV 126
Query: 407 HFDIKPHNILLD---EDFCPKISDFGLAKICNRKESIISMTGARGTVGYIAPEVFCRNIG 463
           H D+KP N+LL+    D   KI DFGL+      E    M    GT  YIAPEV  +   
Sbjct: 127 HRDLKPENLLLESKSRDALIKIVDFGLSA---HFEVGGKMKERLGTAYYIAPEVLRKKYD 183
Query: 464 EVSYKSDVYNYGMMIF 479
           E   K DV++ G++++
Sbjct: 184 E---KCDVWSCGVILY 196

>pdb|3DXN|A Chain A, Crystal Structure Of The Calcium-dependent Kinase From Toxoplasma Gondii, 541.m00134, Kinase Domain Length = 287

Iteration: 1
 Score = 57.0 bits (136), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 63/224 (28%), Positives = 93/224 (41%), Gaps = 53/224 (23%)
Query: 320 KLGQGGYGSVYKGK-LLDGSNVAVKVLNDSK----GNGKEFINEVASISRTSHVNVVALL 374
           KLG G YG V   K  L G+  A+K++  S      N    ++EVA + +  H N++ L 
Sbjct: 28  KLGSGAYGEVLLCKDKLTGAERAIKIIKKSSVTTTSNSGALLDEVAVLKQLDHPNIMKLY 87
Query: 375 GF------------CLRVAEELSSTI---------------GIARGLEYLHLGCSTRILH 407
            F              R  E     I                +  G  YLH      I+H
Sbjct: 88  EFFEDKRNYYLVMEVYRGGELFDEIILRQKFSEVDAAVIMKQVLSGTTYLH---KHNIVH 144
Query: 408 FDIKPHNILLD---EDFCPKISDFGLAKICNRKESIISMTGARGTVGYIAPEVFCRNIGE 464
            D+KP N+LL+    D   KI DFGL+      E    M    GT  YIAPEV  +   E
Sbjct: 145 RDLKPENLLLESKSRDALIKIVDFGLS---AHFEVGGKMKERLGTAYYIAPEVLRKKYDE 201
Query: 465 VSYKSDVYNYGMMIFEMT------GGRKNVDV---VDNGSTALD 499
              K DV++ G++++ +       GG+ + ++   V+ G  + D
Sbjct: 202 ---KCDVWSCGVILYILLCGYPPFGGQTDQEILKRVEKGKFSFD 242

>pdb|2F57|A Chain A, Crystal Structure Of The Human P21-activated Kinase 5 Length = 317

Iteration: 1
 Score = 57.0 bits (136), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 57/199 (28%), Positives = 91/199 (45%), Gaps = 47/199 (23%)
Query: 320 KLGQGGYGSV-YKGKLLDGSNVAVKVLNDSKGNGKEFI-NEVASISRTSHVNVVALLGFC 377
           K+G+G  G V    +   G  VAVK ++  K   +E + NEV  +    H NVV +    
Sbjct: 52  KIGEGSTGIVCIATEKHTGKQVAVKKMDLRKQQRRELLFNEVVIMRDYHHDNVVDMYSSY 111
Query: 378 L------------------------RVAEELSSTI--GIARGLEYLHLGCSTRILHFDIK 411
           L                        R+ EE  +T+   + R L YLH   +  ++H DIK
Sbjct: 112 LVGDELWVVMEFLEGGALTDIVTHTRMNEEQIATVCLSVLRALSYLH---NQGVIHRDIK 168
Query: 412 PHNILLDEDFCPKISDFG----LAKICNRKESIISMTGARGTVGYIAPEVFCRNIGEVSY 467
             +ILL  D   K+SDFG    ++K   +++ ++      GT  ++APEV  R    + Y
Sbjct: 169 SDSILLTSDGRIKLSDFGFCAQVSKEVPKRKXLV------GTPYWMAPEVISR----LPY 218
Query: 468 --KSDVYNYGMMIFEMTGG 484
             + D+++ G+M+ EM  G
Sbjct: 219 GTEVDIWSLGIMVIEMIDG 237

>pdb|3O8P|A Chain A, Conformational Plasticity Of P38 Map Kinase Dfg Motif Mutants In Response To Inhibitor Binding Length = 360

Iteration: 1
 Score = 57.0 bits (136), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 60/202 (29%), Positives = 88/202 (43%), Gaps = 48/202 (23%)
Query: 321 LGQGGYGSV---YKGKLLDGSNVAVKVLN---DSKGNGKEFINEVASISRTSHVNVVALL 374
           +G G YGSV   +  K   G  VAVK L+    S  + K    E+  +    H NV+ LL
Sbjct: 30  VGSGAYGSVCAAFDTK--TGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLL 87
Query: 375 GFCL--RVAEE------LSSTIG-----------------------IARGLEYLHLGCST 403
                 R  EE      ++  +G                       I RGL+Y+H   S 
Sbjct: 88  DVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIH---SA 144
Query: 404 RILHFDIKPHNILLDEDFCPKISDFGLAKICNRKESIISMTGARGTVGYIAPEVFCRNIG 463
            I+H D+KP N+ ++ED   KI  FGLA+  + +     MTG   T  Y APE+   N  
Sbjct: 145 DIIHRDLKPSNLAVNEDCELKILGFGLARHTDDE-----MTGYVATRWYRAPEIML-NWM 198
Query: 464 EVSYKSDVYNYGMMIFEMTGGR 485
             +   D+++ G ++ E+  GR
Sbjct: 199 HYNQTVDIWSVGCIMAELLTGR 220

>pdb|3F69|A Chain A, Crystal Structure Of The Mycobacterium Tuberculosis Pknb Mutant Kinase Domain In Complex With Kt5720 Length = 311

Iteration: 1
 Score = 57.0 bits (136), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 54/207 (26%), Positives = 85/207 (41%), Gaps = 40/207 (19%)
Query: 316 SFKYKLGQ----GGYGSVYKGK-LLDGSNVAVKVLNDSKGNGKEFI----NEVASISRTS 366
           S +Y+LG+    GG   V+  + L D  +VAVKVL         F      E  + +  +
Sbjct: 11  SDRYELGEILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALN 70
Query: 367 HVNVVALL---------------------GFCLRVAEELSSTIGIARGLEYLHLGCSTR- 404
           H  +VA+                      G  LR        +   R +E +   C    
Sbjct: 71  HPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGPMTPKRAIEVIADACQALN 130
Query: 405 ------ILHFDIKPHNILLDEDFCPKISDFGLAK-ICNRKESIISMTGARGTVGYIAPEV 457
                 I+H D+KP NIL+      K+ DFG+A+ I +   S+       GT  Y++PE 
Sbjct: 131 FSHQNGIIHRDVKPANILISATNAVKVVDFGIARAIADSGNSVXQTAAVIGTAQYLSPEQ 190
Query: 458 FCRNIGEVSYKSDVYNYGMMIFEMTGG 484
              +   V  +SDVY+ G +++E+  G
Sbjct: 191 ARGD--SVDARSDVYSLGCVLYEVLTG 215

>pdb|3MH0|A Chain A, Mutagenesis Of P38 Map Kinase Eshtablishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score = 57.0 bits (136), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 60/202 (29%), Positives = 88/202 (43%), Gaps = 48/202 (23%)
Query: 321 LGQGGYGSV---YKGKLLDGSNVAVKVLN---DSKGNGKEFINEVASISRTSHVNVVALL 374
           +G G YGSV   +  K   G  VAVK L+    S  + K    E+  +    H NV+ LL
Sbjct: 30  VGSGAYGSVCAAFDTK--TGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLL 87
Query: 375 GFCL--RVAEE------LSSTIG-----------------------IARGLEYLHLGCST 403
                 R  EE      ++  +G                       I RGL+Y+H   S 
Sbjct: 88  DVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIH---SA 144
Query: 404 RILHFDIKPHNILLDEDFCPKISDFGLAKICNRKESIISMTGARGTVGYIAPEVFCRNIG 463
            I+H D+KP N+ ++ED   KI D GLA+  + +     MTG   T  Y APE+   N  
Sbjct: 145 DIIHRDLKPSNLAVNEDCELKILDAGLARHTDDE-----MTGYVATRWYRAPEIML-NWM 198
Query: 464 EVSYKSDVYNYGMMIFEMTGGR 485
             +   D+++ G ++ E+  GR
Sbjct: 199 HYNQTVDIWSVGCIMAELLTGR 220

>pdb|3UGC|A Chain A, Structural Basis Of Jak2 Inhibition By The Type Ii Inhibtor Nvp-Bbt594 Length = 295

Iteration: 1
 Score = 56.6 bits (135), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 56/203 (27%), Positives = 91/203 (44%), Gaps = 42/203 (20%)
Query: 316 SFKYKLGQGGYGSVYKGK---LLD--GSNVAVKVLNDS-KGNGKEFINEVASISRTSHVN 369
            F  +LG+G +GSV   +   L D  G  VAVK L  S + + ++F  E+  +    H N
Sbjct: 13  KFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDN 72
Query: 370 VVALLGFC-------LRVAEE-----------------------LSSTIGIARGLEYLHL 399
           +V   G C       L++  E                       L  T  I +G+EYL  
Sbjct: 73  IVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYL-- 130
Query: 400 GCSTRILHFDIKPHNILLDEDFCPKISDFGLAKICNR-KESIISMTGARGTVGYIAPEVF 458
             + R +H D+   NIL++ +   KI DFGL K+  + KE           + + APE  
Sbjct: 131 -GTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEFFKVKEPGESPIFWYAPESL 189
Query: 459 CRNIGEVSYKSDVYNYGMMIFEM 481
             +  + S  SDV+++G++++E+
Sbjct: 190 TES--KFSVASDVWSFGVVLYEL 210

>pdb|2QOK|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:s768a Triple Mutant Length = 373

Iteration: 1
 Score = 56.6 bits (135), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 46/196 (23%), Positives = 90/196 (45%), Gaps = 40/196 (20%)
Query: 321 LGQGGYGSVYKGKLLDGS----NVAVKVLND--SKGNGKEFINEVASISRTSHVNVVALL 374
           +G G +G V  G+L   S    +VA+K L    ++   ++F+ E + + +  H N++ L 
Sbjct: 53  VGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRLE 112
Query: 375 GFCLR----------------------------VAEELSSTIGIARGLEYLHLGCSTRIL 406
           G   +                            V + +    GIA G++YL        +
Sbjct: 113 GVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTVIQLVGMLRGIASGMKYL---SDMGYV 169
Query: 407 HFDIKPHNILLDEDFCPKISDFGLAKIC-NRKESIISMTGARGTVGYIAPEVFCRNIGEV 465
           H D+   NIL++ +   K+SDFGLA++  +  E+  +  G +  + + +PE       + 
Sbjct: 170 HRDLAARNILINSNLVCKVSDFGLARVLEDDPEAAYTTRGGKIPIRWTSPEAIAYR--KF 227
Query: 466 SYKSDVYNYGMMIFEM 481
           +  SDV++YG++++E+
Sbjct: 228 TSASDVWSYGIVLWEV 243

>pdb|4FOB|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Acyliminobenzimidazole Inhibitor 1 Length = 353

Iteration: 1
 Score = 56.6 bits (135), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 66/258 (25%), Positives = 109/258 (42%), Gaps = 56/258 (21%)
Query: 275 KRKLSSYNSTASCLNIETFLRNYR---SLSPKRYGYADIKKMTN---SFKYKLGQGGYGS 328
           + +L S     S L   T + +Y    S + K    +D+K++     +    LG G +G 
Sbjct: 13  QMELQSPEYKLSKLRTSTIMTDYNPNYSFAGKTSSISDLKEVPRKNITLIRGLGHGAFGE 72
Query: 329 VYKGKLLDGSN------VAVKVLND--SKGNGKEFINEVASISRTSHVNVVALLGFCLR- 379
           VY+G++    N      VAVK L +  S+ +  +F+ E   IS+ +H N+V  +G  L+ 
Sbjct: 73  VYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQS 132
Query: 380 ----------VAEELSSTIGIARG----------LEYLHL------GCS----TRILHFD 409
                        +L S +   R           L+ LH+      GC        +H D
Sbjct: 133 LPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENHFIHRD 192
Query: 410 IKPHNILLDEDFCP------KISDFGLAKICNRKESIISMTGARGTVGYIAPEVFCRNIG 463
           I   N LL    CP      KI DFG+A+   R         A   V ++ PE F   I 
Sbjct: 193 IAARNCLLT---CPGPGRVAKIGDFGMARDIYRASYYRKGGCAMLPVKWMPPEAFMEGI- 248
Query: 464 EVSYKSDVYNYGMMIFEM 481
             + K+D +++G++++E+
Sbjct: 249 -FTSKTDTWSFGVLLWEI 265

>pdb|1YWN|A Chain A, Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]pyrimidine Length = 316

Iteration: 1
 Score = 56.6 bits (135), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 52/214 (24%), Positives = 91/214 (42%), Gaps = 58/214 (27%)
Query: 321 LGQGGYGSVYKG------KLLDGSNVAVKVLND--SKGNGKEFINEVASISRTSH-VNVV 371
           LG+G +G V +       K      VAVK+L +  +    +  ++E+  +    H +NVV
Sbjct: 35  LGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVV 94
Query: 372 ALLGFC--------------------------------LRVAEE------------LSST 387
            LLG C                                 +VA E            +  +
Sbjct: 95  NLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYS 154
Query: 388 IGIARGLEYLHLGCSTRILHFDIKPHNILLDEDFCPKISDFGLAKICNRKESIISMTGAR 447
             +A+G+E+L    S + +H D+   NILL E    KI DFGLA+   +    +    AR
Sbjct: 155 FQVAKGMEFL---ASRKCIHRDLAARNILLSEKNVVKICDFGLARDIXKDPDXVRKGDAR 211
Query: 448 GTVGYIAPEVFCRNIGEVSYKSDVYNYGMMIFEM 481
             + ++APE     +   + +SDV+++G++++E+
Sbjct: 212 LPLKWMAPETIFDRV--YTIQSDVWSFGVLLWEI 243

>pdb|3SAY|A Chain A, Crystal Structure Of Human Glycogen Synthase Kinase 3 Beta (Gsk3b) In Complex With Inhibitor 142 Length = 430

Iteration: 1
 Score = 56.6 bits (135), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 71/226 (31%), Positives = 94/226 (41%), Gaps = 64/226 (28%)
Query: 302 PKRYGYADIKKMTNSFKYKLGQGGYGSVYKGKLLD-GSNVAVK-VLNDSKGNGKEFIN-E 358
           P+   Y D K         +G G +G VY+ KL D G  VA+K VL D     K F N E
Sbjct: 51  PQEVSYTDTKV--------IGNGSFGVVYQAKLCDSGELVAIKKVLQD-----KRFKNRE 97
Query: 359 VASISRTSHVNVVALLGF-----------------------CLRVAEELS---STIGIA- 391
           +  + +  H N+V L  F                         RVA   S    T+ +  
Sbjct: 98  LQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIY 157
Query: 392 ---------RGLEYLHLGCSTRILHFDIKPHNILLDEDFCP-KISDFGLAKICNRKESII 441
                    R L Y+H   S  I H DIKP N+LLD D    K+ DFG AK   R E  +
Sbjct: 158 VKLYMYQLFRSLAYIH---SFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNV 214
Query: 442 SMTGARGTVGYIAPEVFCRNIGEVSYKS--DVYNYGMMIFEMTGGR 485
           S   +R    Y APE+     G   Y S  DV++ G ++ E+  G+
Sbjct: 215 SXICSR---YYRAPELI---FGATDYTSSIDVWSAGCVLAELLLGQ 254

>pdb|3Q4T|A Chain A, Crystal Structure Of Activin Receptor Type-Iia (Acvr2a) Kinase Domain In Complex With Dorsomorphin Length = 322

Iteration: 1
 Score = 56.6 bits (135), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 56/203 (27%), Positives = 88/203 (43%), Gaps = 45/203 (22%)
Query: 322 GQGGYGSVYKGKLLDGSNVAVKV--LNDSKGNGKEFINEVASISRTSHVNVVALLGFCLR 379
            +G +G V+K +LL+   VAVK+  + D +    E+  EV S+    H N++  +G   R
Sbjct: 33  ARGRFGCVWKAQLLN-EYVAVKIFPIQDKQSWQNEY--EVYSLPGMKHENILQFIGAEKR 89
Query: 380 -------------------VAEELSSTI-----------GIARGLEYLHL-------GCS 402
                              +++ L + +            +ARGL YLH        G  
Sbjct: 90  GTSVDVDLWLITAFHEKGSLSDFLKANVVSWNELCHIAETMARGLAYLHEDIPGLKDGHK 149
Query: 403 TRILHFDIKPHNILLDEDFCPKISDFGLAKICNRKESIISMTGARGTVGYIAPEVFCRNI 462
             I H DIK  N+LL  +    I+DFGLA      +S     G  GT  Y+APEV    I
Sbjct: 150 PAISHRDIKSKNVLLKNNLTACIADFGLALKFEAGKSAGDTHGQVGTRRYMAPEVLEGAI 209
Query: 463 G---EVSYKSDVYNYGMMIFEMT 482
               +   + D+Y  G++++E+ 
Sbjct: 210 NFQRDAFLRIDMYAMGLVLWELA 232

>pdb|4B99|A Chain A, Crystal Structure Of Mapk7 (Erk5) With Inhibitor Length = 398

Iteration: 1
 Score = 56.6 bits (135), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 55/204 (26%), Positives = 91/204 (44%), Gaps = 42/204 (20%)
Query: 321 LGQGGYGSVYKGKL-LDGSNVAVKVLN---DSKGNGKEFINEVASISRTSHVNVVAL--- 373
           +G G YG V   +  L G  VA+K +    D   N K  + E+  +    H N++A+   
Sbjct: 62  IGNGAYGVVSSARRRLTGQQVAIKKIPNAFDVVTNAKRTLRELKILKHFKHDNIIAIKDI 121
Query: 374 ------------LGFCLRVAE-ELSSTI----------------GIARGLEYLHLGCSTR 404
                       +   L + E +L   I                 + RGL+Y+H   S +
Sbjct: 122 LRPTVPYGEFKSVYVVLDLMESDLHQIIHSSQPLTLEHVRYFLYQLLRGLKYMH---SAQ 178
Query: 405 ILHFDIKPHNILLDEDFCPKISDFGLAK-ICNR-KESIISMTGARGTVGYIAPEVFCRNI 462
           ++H D+KP N+L++E+   KI DFG+A+ +C    E    MT    T  Y APE+   ++
Sbjct: 179 VIHRDLKPSNLLVNENCELKIGDFGMARGLCTSPAEHQYFMTEYVATRWYRAPELML-SL 237
Query: 463 GEVSYKSDVYNYGMMIFEMTGGRK 486
            E +   D+++ G +  EM   R+
Sbjct: 238 HEYTQAIDLWSVGCIFGEMLARRQ 261

>pdb|3MH3|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score = 56.6 bits (135), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 60/202 (29%), Positives = 88/202 (43%), Gaps = 48/202 (23%)
Query: 321 LGQGGYGSV---YKGKLLDGSNVAVKVLN---DSKGNGKEFINEVASISRTSHVNVVALL 374
           +G G YGSV   +  K   G  VAVK L+    S  + K    E+  +    H NV+ LL
Sbjct: 30  VGSGAYGSVCAAFDTK--TGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLL 87
Query: 375 GFCL--RVAEE------LSSTIG-----------------------IARGLEYLHLGCST 403
                 R  EE      ++  +G                       I RGL+Y+H   S 
Sbjct: 88  DVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIH---SA 144
Query: 404 RILHFDIKPHNILLDEDFCPKISDFGLAKICNRKESIISMTGARGTVGYIAPEVFCRNIG 463
            I+H D+KP N+ ++ED   KI D GLA+  + +     MTG   T  Y APE+   N  
Sbjct: 145 DIIHRDLKPSNLAVNEDCELKILDRGLARHTDDE-----MTGYVATRWYRAPEIML-NWM 198
Query: 464 EVSYKSDVYNYGMMIFEMTGGR 485
             +   D+++ G ++ E+  GR
Sbjct: 199 HYNQTVDIWSVGCIMAELLTGR 220

>pdb|4G31|A Chain A, Crystal Structure Of Gsk6414 Bound To Perk (R587-R1092, Delete A660- T867) At 2.28 A Resolution Length = 299

Iteration: 1
 Score = 56.6 bits (135), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 52/216 (24%), Positives = 90/216 (41%), Gaps = 60/216 (27%)
Query: 321 LGQGGYGSVYKGK-LLDGSNVAVKV--LNDSKGNGKEFINEVASISRTSHVNVVALLGFC 377
           LG+GG+G V++ K  +D  N A+K   L + +   ++ + EV ++++  H  +V      
Sbjct: 13  LGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAW 72
Query: 378 LR--VAEELSST----------------------------------------IGIARGLE 395
           L     E+L  +                                        + IA  +E
Sbjct: 73  LEKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHIFLQIAEAVE 132
Query: 396 YLHLGCSTRILHFDIKPHNILLDEDFCPKISDFGLAKICNRKE----------SIISMTG 445
           +LH   S  ++H D+KP NI    D   K+ DFGL    ++ E          +    TG
Sbjct: 133 FLH---SKGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYARHTG 189
Query: 446 ARGTVGYIAPEVFCRNIGEVSYKSDVYNYGMMIFEM 481
             GT  Y++PE    N    S+K D+++ G+++FE+
Sbjct: 190 QVGTKLYMSPEQIHGN--SYSHKVDIFSLGLILFEL 223

>pdb|1I09|A Chain A, Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Length = 420

Iteration: 1
 Score = 56.6 bits (135), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 71/226 (31%), Positives = 94/226 (41%), Gaps = 64/226 (28%)
Query: 302 PKRYGYADIKKMTNSFKYKLGQGGYGSVYKGKLLD-GSNVAVK-VLNDSKGNGKEFIN-E 358
           P+   Y D K         +G G +G VY+ KL D G  VA+K VL D     K F N E
Sbjct: 51  PQEVSYTDTKV--------IGNGSFGVVYQAKLCDSGELVAIKKVLQD-----KRFKNRE 97
Query: 359 VASISRTSHVNVVALLGF-----------------------CLRVAEELS---STIGIA- 391
           +  + +  H N+V L  F                         RVA   S    T+ +  
Sbjct: 98  LQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIY 157
Query: 392 ---------RGLEYLHLGCSTRILHFDIKPHNILLDEDFCP-KISDFGLAKICNRKESII 441
                    R L Y+H   S  I H DIKP N+LLD D    K+ DFG AK   R E  +
Sbjct: 158 VKLYMYQLFRSLAYIH---SFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNV 214
Query: 442 SMTGARGTVGYIAPEVFCRNIGEVSYKS--DVYNYGMMIFEMTGGR 485
           S   +R    Y APE+     G   Y S  DV++ G ++ E+  G+
Sbjct: 215 SYICSR---YYRAPELI---FGATDYTSSIDVWSAGCVLAELLLGQ 254

>pdb|4IC7|A Chain A, Crystal Structure Of The Erk5 Kinase Domain In Complex With An Mkk5 Binding Fragment Length = 442

Iteration: 1
 Score = 56.6 bits (135), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 55/204 (26%), Positives = 91/204 (44%), Gaps = 42/204 (20%)
Query: 321 LGQGGYGSVYKGKL-LDGSNVAVKVLN---DSKGNGKEFINEVASISRTSHVNVVAL--- 373
           +G G YG V   +  L G  VA+K +    D   N K  + E+  +    H N++A+   
Sbjct: 63  IGNGAYGVVSSARRRLTGQQVAIKKIPNAFDVVTNAKRTLRELKILKHFKHDNIIAIKDI 122
Query: 374 ------------LGFCLRVAE-ELSSTI----------------GIARGLEYLHLGCSTR 404
                       +   L + E +L   I                 + RGL+Y+H   S +
Sbjct: 123 LRPTVPYGEFKSVYVVLDLMESDLHQIIHSSQPLTLEHVRYFLYQLLRGLKYMH---SAQ 179
Query: 405 ILHFDIKPHNILLDEDFCPKISDFGLAK-ICNRK-ESIISMTGARGTVGYIAPEVFCRNI 462
           ++H D+KP N+L++E+   KI DFG+A+ +C    E    MT    T  Y APE+   ++
Sbjct: 180 VIHRDLKPSNLLVNENCELKIGDFGMARGLCTSPAEHQYFMTEYVATRWYRAPELML-SL 238
Query: 463 GEVSYKSDVYNYGMMIFEMTGGRK 486
            E +   D+++ G +  EM   R+
Sbjct: 239 HEYTQAIDLWSVGCIFGEMLARRQ 262

>pdb|4AFJ|A Chain A, 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selective Gsk-3 Inhibitors Length = 367

Iteration: 1
 Score = 56.6 bits (135), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 68/225 (30%), Positives = 93/225 (41%), Gaps = 62/225 (27%)
Query: 302 PKRYGYADIKKMTNSFKYKLGQGGYGSVYKGKLLD-GSNVAVK-VLNDSKGNGKEFINEV 359
           P+   Y D K         +G G +G VY+ KL D G  VA+K VL D +   +E    +
Sbjct: 25  PQEVSYTDTKV--------IGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNRE----L 72
Query: 360 ASISRTSHVNVVALLGF-----------------------CLRVAEELS---STIGIA-- 391
             + +  H N+V L  F                         RVA   S    T+ +   
Sbjct: 73  QIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYV 132
Query: 392 --------RGLEYLHLGCSTRILHFDIKPHNILLDEDFCP-KISDFGLAKICNRKESIIS 442
                   R L Y+H   S  I H DIKP N+LLD D    K+ DFG AK   R E  +S
Sbjct: 133 KLYMYQLFRSLAYIH---SFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVS 189
Query: 443 MTGARGTVGYIAPEVFCRNIGEVSYKS--DVYNYGMMIFEMTGGR 485
              +R    Y APE+     G   Y S  DV++ G ++ E+  G+
Sbjct: 190 XICSR---YYRAPELI---FGATDYTSSIDVWSAGCVLAELLLGQ 228

>pdb|3F61|A Chain A, Crystal Structure Of M. Tuberculosis Pknb Leu33aspVAL222ASP DOUBLE MUTANT IN COMPLEX WITH ADP Length = 311

Iteration: 1
 Score = 56.6 bits (135), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 53/207 (25%), Positives = 85/207 (41%), Gaps = 40/207 (19%)
Query: 316 SFKYKLGQ----GGYGSVYKGK-LLDGSNVAVKVLNDSKGNGKEFI----NEVASISRTS 366
           S +Y+LG+    GG   V+  + L D  +VAVKVL         F      E  + +  +
Sbjct: 11  SDRYELGEILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALN 70
Query: 367 HVNVVALL---------------------GFCLRVAEELSSTIGIARGLEYLHLGCSTR- 404
           H  +VA+                      G  LR        +   R +E +   C    
Sbjct: 71  HPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGPMTPKRAIEVIADACQALN 130
Query: 405 ------ILHFDIKPHNILLDEDFCPKISDFGLAK-ICNRKESIISMTGARGTVGYIAPEV 457
                 I+H D+KP NI++      K+ DFG+A+ I +   S+       GT  Y++PE 
Sbjct: 131 FSHQNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQ 190
Query: 458 FCRNIGEVSYKSDVYNYGMMIFEMTGG 484
              +   V  +SDVY+ G +++E+  G
Sbjct: 191 ARGD--SVDARSDVYSLGCVLYEVLTG 215

>pdb|1Q5K|A Chain A, Crystal Structure Of Glycogen Synthase Kinase 3 In Complexed With Inhibitor Length = 414

Iteration: 1
 Score = 56.6 bits (135), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 71/226 (31%), Positives = 94/226 (41%), Gaps = 64/226 (28%)
Query: 302 PKRYGYADIKKMTNSFKYKLGQGGYGSVYKGKLLD-GSNVAVK-VLNDSKGNGKEFIN-E 358
           P+   Y D K         +G G +G VY+ KL D G  VA+K VL D     K F N E
Sbjct: 45  PQEVSYTDTKV--------IGNGSFGVVYQAKLCDSGELVAIKKVLQD-----KRFKNRE 91
Query: 359 VASISRTSHVNVVALLGF-----------------------CLRVAEELS---STIGIA- 391
           +  + +  H N+V L  F                         RVA   S    T+ +  
Sbjct: 92  LQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIY 151
Query: 392 ---------RGLEYLHLGCSTRILHFDIKPHNILLDEDFCP-KISDFGLAKICNRKESII 441
                    R L Y+H   S  I H DIKP N+LLD D    K+ DFG AK   R E  +
Sbjct: 152 VKLYMYQLFRSLAYIH---SFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNV 208
Query: 442 SMTGARGTVGYIAPEVFCRNIGEVSYKS--DVYNYGMMIFEMTGGR 485
           S   +R    Y APE+     G   Y S  DV++ G ++ E+  G+
Sbjct: 209 SYICSR---YYRAPELI---FGATDYTSSIDVWSAGCVLAELLLGQ 248

>pdb|1V0O|A Chain A, Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulphonate Ligand Complex Length = 288

Iteration: 1
 Score = 56.6 bits (135), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 56/200 (28%), Positives = 86/200 (43%), Gaps = 46/200 (23%)
Query: 320 KLGQGGYGSVYKGKLLDGSNVAVKVL---NDSKGNGKEFINEVASISRTSHVNVVAL--- 373
           K+G+G YG VYK +   G   A+K +    + +G     I E++ +    H N+V L   
Sbjct: 9   KIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDV 68
Query: 374 ---------------------LGFC---LRVAEELSSTIGIARGLEYLHLGCSTRILHFD 409
                                L  C   L      S  + +  G+ Y H     R+LH D
Sbjct: 69  IHTKKRLVLVFEHLDQDLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCH---DRRVLHRD 125
Query: 410 IKPHNILLDEDFCPKISDFGLAK---ICNRKESIISMTGARGTVGYIAPEVFCRNIGEVS 466
           +KP N+L++ +   KI+DFGLA+   I  RK      T    T+ Y AP+V    +G   
Sbjct: 126 LKPQNLLINREGELKIADFGLARAFGIPVRK-----YTHEVVTLWYRAPDVL---MGSKK 177
Query: 467 YKS--DVYNYGMMIFEMTGG 484
           Y +  D+++ G +  EM  G
Sbjct: 178 YSTTIDIWSVGCIFAEMVNG 197

>pdb|3F88|A Chain A, Glycogen Synthase Kinase 3beta Inhibitor Complex Length = 349

Iteration: 1
 Score = 56.6 bits (135), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 68/225 (30%), Positives = 93/225 (41%), Gaps = 62/225 (27%)
Query: 302 PKRYGYADIKKMTNSFKYKLGQGGYGSVYKGKLLD-GSNVAVK-VLNDSKGNGKEFINEV 359
           P+   Y D K         +G G +G VY+ KL D G  VA+K VL D +   +E    +
Sbjct: 17  PQEVSYTDTKV--------IGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNRE----L 64
Query: 360 ASISRTSHVNVVALLGF-----------------------CLRVAEELS---STIGIA-- 391
             + +  H N+V L  F                         RVA   S    T+ +   
Sbjct: 65  QIMRKLDHCNIVRLRYFFYSSGEKKDVVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYV 124
Query: 392 --------RGLEYLHLGCSTRILHFDIKPHNILLDEDFCP-KISDFGLAKICNRKESIIS 442
                   R L Y+H   S  I H DIKP N+LLD D    K+ DFG AK   R E  +S
Sbjct: 125 KLYMYQLFRSLAYIH---SFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVS 181
Query: 443 MTGARGTVGYIAPEVFCRNIGEVSYKS--DVYNYGMMIFEMTGGR 485
              +R    Y APE+     G   Y S  DV++ G ++ E+  G+
Sbjct: 182 XICSR---YYRAPELI---FGATDYTSSIDVWSAGCVLAELLLGQ 220

>pdb|2P2H|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridinyl-Triazine Inhibitor Length = 314

Iteration: 1
 Score = 56.6 bits (135), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 52/214 (24%), Positives = 91/214 (42%), Gaps = 58/214 (27%)
Query: 321 LGQGGYGSVYKG------KLLDGSNVAVKVLND--SKGNGKEFINEVASISRTSH-VNVV 371
           LG+G +G V +       K      VAVK+L +  +    +  ++E+  +    H +NVV
Sbjct: 26  LGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVV 85
Query: 372 ALLGFC--------------------------------LRVAEE------------LSST 387
            LLG C                                 +VA E            +  +
Sbjct: 86  NLLGACTKPGGPLMVITEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYS 145
Query: 388 IGIARGLEYLHLGCSTRILHFDIKPHNILLDEDFCPKISDFGLAKICNRKESIISMTGAR 447
             +A+G+E+L    S + +H D+   NILL E    KI DFGLA+   +    +    AR
Sbjct: 146 FQVAKGMEFL---ASRKCIHRDLAARNILLSEKNVVKICDFGLARDIXKDPDXVRKGDAR 202
Query: 448 GTVGYIAPEVFCRNIGEVSYKSDVYNYGMMIFEM 481
             + ++APE     +   + +SDV+++G++++E+
Sbjct: 203 LPLKWMAPETIFDRV--YTIQSDVWSFGVLLWEI 234

>pdb|3ORI|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain L33d Mutant (Crystal Form 1) Length = 311

Iteration: 1
 Score = 56.6 bits (135), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 53/207 (25%), Positives = 85/207 (41%), Gaps = 40/207 (19%)
Query: 316 SFKYKLGQ----GGYGSVYKGK-LLDGSNVAVKVLNDSKGNGKEFI----NEVASISRTS 366
           S +Y+LG+    GG   V+  + L D  +VAVKVL         F      E  + +  +
Sbjct: 11  SDRYELGEILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALN 70
Query: 367 HVNVVALL---------------------GFCLRVAEELSSTIGIARGLEYLHLGCSTR- 404
           H  +VA+                      G  LR        +   R +E +   C    
Sbjct: 71  HPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGPMTPKRAIEVIADACQALN 130
Query: 405 ------ILHFDIKPHNILLDEDFCPKISDFGLAK-ICNRKESIISMTGARGTVGYIAPEV 457
                 I+H D+KP NI++      K+ DFG+A+ I +   S+       GT  Y++PE 
Sbjct: 131 FSHQNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQ 190
Query: 458 FCRNIGEVSYKSDVYNYGMMIFEMTGG 484
              +   V  +SDVY+ G +++E+  G
Sbjct: 191 ARGD--SVDARSDVYSLGCVLYEVLTG 215

>pdb|1V0B|A Chain A, Crystal Structure Of The T198a Mutant Of Pfpk5 Length = 288

Iteration: 1
 Score = 56.6 bits (135), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 56/200 (28%), Positives = 86/200 (43%), Gaps = 46/200 (23%)
Query: 320 KLGQGGYGSVYKGKLLDGSNVAVKVL---NDSKGNGKEFINEVASISRTSHVNVVAL--- 373
           K+G+G YG VYK +   G   A+K +    + +G     I E++ +    H N+V L   
Sbjct: 9   KIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDV 68
Query: 374 ---------------------LGFC---LRVAEELSSTIGIARGLEYLHLGCSTRILHFD 409
                                L  C   L      S  + +  G+ Y H     R+LH D
Sbjct: 69  IHTKKRLVLVFEHLDQDLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCH---DRRVLHRD 125
Query: 410 IKPHNILLDEDFCPKISDFGLAK---ICNRKESIISMTGARGTVGYIAPEVFCRNIGEVS 466
           +KP N+L++ +   KI+DFGLA+   I  RK      T    T+ Y AP+V    +G   
Sbjct: 126 LKPQNLLINREGELKIADFGLARAFGIPVRK-----YTHEVVTLWYRAPDVL---MGSKK 177
Query: 467 YKS--DVYNYGMMIFEMTGG 484
           Y +  D+++ G +  EM  G
Sbjct: 178 YSTTIDIWSVGCIFAEMVNG 197

>pdb|1GNG|A Chain A, Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With Frattide Peptide Length = 378

Iteration: 1
 Score = 56.6 bits (135), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 68/225 (30%), Positives = 93/225 (41%), Gaps = 62/225 (27%)
Query: 302 PKRYGYADIKKMTNSFKYKLGQGGYGSVYKGKLLD-GSNVAVK-VLNDSKGNGKEFINEV 359
           P+   Y D K         +G G +G VY+ KL D G  VA+K VL D +   +E    +
Sbjct: 36  PQEVSYTDTKV--------IGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNRE----L 83
Query: 360 ASISRTSHVNVVALLGF-----------------------CLRVAEELS---STIGIA-- 391
             + +  H N+V L  F                         RVA   S    T+ +   
Sbjct: 84  QIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYV 143
Query: 392 --------RGLEYLHLGCSTRILHFDIKPHNILLDEDFCP-KISDFGLAKICNRKESIIS 442
                   R L Y+H   S  I H DIKP N+LLD D    K+ DFG AK   R E  +S
Sbjct: 144 KLYMYQLFRSLAYIH---SFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVS 200
Query: 443 MTGARGTVGYIAPEVFCRNIGEVSYKS--DVYNYGMMIFEMTGGR 485
              +R    Y APE+     G   Y S  DV++ G ++ E+  G+
Sbjct: 201 XICSR---YYRAPELI---FGATDYTSSIDVWSAGCVLAELLLGQ 239

>pdb|1PYX|A Chain A, Gsk-3 Beta Complexed With Amp-Pnp Length = 422

Iteration: 1
 Score = 56.6 bits (135), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 71/226 (31%), Positives = 94/226 (41%), Gaps = 64/226 (28%)
Query: 302 PKRYGYADIKKMTNSFKYKLGQGGYGSVYKGKLLD-GSNVAVK-VLNDSKGNGKEFIN-E 358
           P+   Y D K         +G G +G VY+ KL D G  VA+K VL D     K F N E
Sbjct: 53  PQEVSYTDTKV--------IGNGSFGVVYQAKLCDSGELVAIKKVLQD-----KRFKNRE 99
Query: 359 VASISRTSHVNVVALLGF-----------------------CLRVAEELS---STIGIA- 391
           +  + +  H N+V L  F                         RVA   S    T+ +  
Sbjct: 100 LQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIY 159
Query: 392 ---------RGLEYLHLGCSTRILHFDIKPHNILLDEDFCP-KISDFGLAKICNRKESII 441
                    R L Y+H   S  I H DIKP N+LLD D    K+ DFG AK   R E  +
Sbjct: 160 VKLYMYQLFRSLAYIH---SFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNV 216
Query: 442 SMTGARGTVGYIAPEVFCRNIGEVSYKS--DVYNYGMMIFEMTGGR 485
           S   +R    Y APE+     G   Y S  DV++ G ++ E+  G+
Sbjct: 217 SYICSR---YYRAPELI---FGATDYTSSIDVWSAGCVLAELLLGQ 256

>pdb|4FSZ|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 56.6 bits (135), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 58/196 (29%), Positives = 89/196 (45%), Gaps = 38/196 (19%)
Query: 321 LGQGGYGSVYKG-KLLDGSNVAVKVLNDSKG-NGKEFINEVASISRT-SHVNVVALLG-- 375
           LG+G YG V      +    VAVK+++  +  +  E I +   I++  +H NVV   G  
Sbjct: 14  LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEIXINKMLNHENVVKFYGHR 73
Query: 376 -----------FCL--RVAEELSSTIGIAR------------GLEYLHLGCSTRILHFDI 410
                      +C    + + +   IG+              G+ YLH      I H DI
Sbjct: 74  REGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLH---GIGITHRDI 130
Query: 411 KPHNILLDEDFCPKISDFGLAKI--CNRKESIISMTGARGTVGYIAPEVFCRNIGEVSYK 468
           KP N+LLDE    KISDFGLA +   N +E +++     GT+ Y+APE+  R        
Sbjct: 131 KPENLLLDERDNLKISDFGLATVFRYNNRERLLNKM--XGTLPYVAPELLKRREFHAE-P 187
Query: 469 SDVYNYGMMIFEMTGG 484
            DV++ G+++  M  G
Sbjct: 188 VDVWSCGIVLTAMLAG 203

>pdb|2P2I|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Nicotinamide Inhibitor Length = 314

Iteration: 1
 Score = 56.6 bits (135), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 52/214 (24%), Positives = 91/214 (42%), Gaps = 58/214 (27%)
Query: 321 LGQGGYGSVYKG------KLLDGSNVAVKVLND--SKGNGKEFINEVASISRTSH-VNVV 371
           LG+G +G V +       K      VAVK+L +  +    +  ++E+  +    H +NVV
Sbjct: 26  LGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVV 85
Query: 372 ALLGFC--------------------------------LRVAEE------------LSST 387
            LLG C                                 +VA E            +  +
Sbjct: 86  NLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYS 145
Query: 388 IGIARGLEYLHLGCSTRILHFDIKPHNILLDEDFCPKISDFGLAKICNRKESIISMTGAR 447
             +A+G+E+L    S + +H D+   NILL E    KI DFGLA+   +    +    AR
Sbjct: 146 FQVAKGMEFL---ASRKCIHRDLAARNILLSEKNVVKICDFGLARDIXKDPDXVRKGDAR 202
Query: 448 GTVGYIAPEVFCRNIGEVSYKSDVYNYGMMIFEM 481
             + ++APE     +   + +SDV+++G++++E+
Sbjct: 203 LPLKWMAPETIFDRV--YTIQSDVWSFGVLLWEI 234

>pdb|3F7Z|A Chain A, X-ray Co-crystal Structure Of Glycogen Synthase Kinase 3beta In Complex With An Inhibitor Length = 350

Iteration: 1
 Score = 56.2 bits (134), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 68/225 (30%), Positives = 93/225 (41%), Gaps = 62/225 (27%)
Query: 302 PKRYGYADIKKMTNSFKYKLGQGGYGSVYKGKLLD-GSNVAVK-VLNDSKGNGKEFINEV 359
           P+   Y D K         +G G +G VY+ KL D G  VA+K VL D +   +E    +
Sbjct: 18  PQEVSYTDTKV--------IGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNRE----L 65
Query: 360 ASISRTSHVNVVALLGF-----------------------CLRVAEELS---STIGIA-- 391
             + +  H N+V L  F                         RVA   S    T+ +   
Sbjct: 66  QIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYV 125
Query: 392 --------RGLEYLHLGCSTRILHFDIKPHNILLDEDFCP-KISDFGLAKICNRKESIIS 442
                   R L Y+H   S  I H DIKP N+LLD D    K+ DFG AK   R E  +S
Sbjct: 126 KLYMYQLFRSLAYIH---SFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVS 182
Query: 443 MTGARGTVGYIAPEVFCRNIGEVSYKS--DVYNYGMMIFEMTGGR 485
              +R    Y APE+     G   Y S  DV++ G ++ E+  G+
Sbjct: 183 XICSR---YYRAPELI---FGATDYTSSIDVWSAGCVLAELLLGQ 221

>pdb|3ZDI|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide And Inhibitor 7d Length = 350

Iteration: 1
 Score = 56.2 bits (134), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 68/225 (30%), Positives = 93/225 (41%), Gaps = 62/225 (27%)
Query: 302 PKRYGYADIKKMTNSFKYKLGQGGYGSVYKGKLLD-GSNVAVK-VLNDSKGNGKEFINEV 359
           P+   Y D K         +G G +G VY+ KL D G  VA+K VL D +   +E    +
Sbjct: 17  PQEVSYTDTKV--------IGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNRE----L 64
Query: 360 ASISRTSHVNVVALLGF-----------------------CLRVAEELS---STIGIA-- 391
             + +  H N+V L  F                         RVA   S    T+ +   
Sbjct: 65  QIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYV 124
Query: 392 --------RGLEYLHLGCSTRILHFDIKPHNILLDEDFCP-KISDFGLAKICNRKESIIS 442
                   R L Y+H   S  I H DIKP N+LLD D    K+ DFG AK   R E  +S
Sbjct: 125 KLYMYQLFRSLAYIH---SFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVS 181
Query: 443 MTGARGTVGYIAPEVFCRNIGEVSYKS--DVYNYGMMIFEMTGGR 485
              +R    Y APE+     G   Y S  DV++ G ++ E+  G+
Sbjct: 182 XICSR---YYRAPELI---FGATDYTSSIDVWSAGCVLAELLLGQ 220

>pdb|4APC|A Chain A, Crystal Structure Of Human Nima-Related Kinase 1 (Nek1) Length = 350

Iteration: 1
 Score = 56.2 bits (134), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 52/196 (26%), Positives = 89/196 (45%), Gaps = 42/196 (21%)
Query: 320 KLGQGGYG-SVYKGKLLDGSNVAVKVLNDSKGNGKEFIN---EVASISRTSHVNVV---- 371
           K+G+G +G ++      DG    +K +N S+ + KE      EVA ++   H N+V    
Sbjct: 31  KIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLANMKHPNIVQYRE 90
Query: 372 -------------------------ALLGFCLRVAEELSSTIGIARGLEYLHLGCSTRIL 406
                                    A  G   +  + L   + I   L+++H     +IL
Sbjct: 91  SFEENGSLYIVMDYCEGGDLFKRINAQKGVLFQEDQILDWFVQICLALKHVH---DRKIL 147
Query: 407 HFDIKPHNILLDEDFCPKISDFGLAKICNRKESIISMTGA-RGTVGYIAPEVFCRNIGEV 465
           H DIK  NI L +D   ++ DFG+A++ N   S + +  A  GT  Y++PE+ C N    
Sbjct: 148 HRDIKSQNIFLTKDGTVQLGDFGIARVLN---STVELARACIGTPYYLSPEI-CEN-KPY 202
Query: 466 SYKSDVYNYGMMIFEM 481
           + KSD++  G +++E+
Sbjct: 203 NNKSDIWALGCVLYEL 218

>pdb|3ZRK|A Chain A, Identification Of 2-(4-Pyridyl)thienopyridinones As Gsk-3beta Inhibitors Length = 371

Iteration: 1
 Score = 56.2 bits (134), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 68/225 (30%), Positives = 93/225 (41%), Gaps = 62/225 (27%)
Query: 302 PKRYGYADIKKMTNSFKYKLGQGGYGSVYKGKLLD-GSNVAVK-VLNDSKGNGKEFINEV 359
           P+   Y D K         +G G +G VY+ KL D G  VA+K VL D +   +E    +
Sbjct: 29  PQEVSYTDTKV--------IGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNRE----L 76
Query: 360 ASISRTSHVNVVALLGF-----------------------CLRVAEELS---STIGIA-- 391
             + +  H N+V L  F                         RVA   S    T+ +   
Sbjct: 77  QIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYV 136
Query: 392 --------RGLEYLHLGCSTRILHFDIKPHNILLDEDFCP-KISDFGLAKICNRKESIIS 442
                   R L Y+H   S  I H DIKP N+LLD D    K+ DFG AK   R E  +S
Sbjct: 137 KLYMYQLFRSLAYIH---SFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVS 193
Query: 443 MTGARGTVGYIAPEVFCRNIGEVSYKS--DVYNYGMMIFEMTGGR 485
              +R    Y APE+     G   Y S  DV++ G ++ E+  G+
Sbjct: 194 XICSR---YYRAPELI---FGATDYTSSIDVWSAGCVLAELLLGQ 232

>pdb|2OH4|A Chain A, Crystal Structure Of Vegfr2 With A Benzimidazole-Urea Inhibitor Length = 316

Iteration: 1
 Score = 56.2 bits (134), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 50/213 (23%), Positives = 88/213 (41%), Gaps = 57/213 (26%)
Query: 321 LGQGGYGSVYKG------KLLDGSNVAVKVLND--SKGNGKEFINEVASISRTSH-VNVV 371
           LG+G +G V +       K      VAVK+L +  +    +  ++E+  +    H +NVV
Sbjct: 36  LGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVV 95
Query: 372 ALLGFCLRVAEELSSTI------------------------------------------- 388
            LLG C +    L   +                                           
Sbjct: 96  NLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTPEDLYKDFLTLEHLICYSF 155
Query: 389 GIARGLEYLHLGCSTRILHFDIKPHNILLDEDFCPKISDFGLAKICNRKESIISMTGARG 448
            +A+G+E+L    S + +H D+   NILL E    KI DFGLA+   +    +    AR 
Sbjct: 156 QVAKGMEFL---ASRKCIHRDLAARNILLSEKNVVKICDFGLARDIXKDPDXVRKGDARL 212
Query: 449 TVGYIAPEVFCRNIGEVSYKSDVYNYGMMIFEM 481
            + ++APE     +   + +SDV+++G++++E+
Sbjct: 213 PLKWMAPETIFDRV--YTIQSDVWSFGVLLWEI 243

>pdb|1OB3|A Chain A, Structure Of P. Falciparum Pfpk5 Length = 288

Iteration: 1
 Score = 56.2 bits (134), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 56/200 (28%), Positives = 86/200 (43%), Gaps = 46/200 (23%)
Query: 320 KLGQGGYGSVYKGKLLDGSNVAVKVL---NDSKGNGKEFINEVASISRTSHVNVVAL--- 373
           K+G+G YG VYK +   G   A+K +    + +G     I E++ +    H N+V L   
Sbjct: 9   KIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDV 68
Query: 374 ---------------------LGFC---LRVAEELSSTIGIARGLEYLHLGCSTRILHFD 409
                                L  C   L      S  + +  G+ Y H     R+LH D
Sbjct: 69  IHTKKRLVLVFEHLDQDLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCH---DRRVLHRD 125
Query: 410 IKPHNILLDEDFCPKISDFGLAK---ICNRKESIISMTGARGTVGYIAPEVFCRNIGEVS 466
           +KP N+L++ +   KI+DFGLA+   I  RK      T    T+ Y AP+V    +G   
Sbjct: 126 LKPQNLLINREGELKIADFGLARAFGIPVRK-----YTHEIVTLWYRAPDVL---MGSKK 177
Query: 467 YKS--DVYNYGMMIFEMTGG 484
           Y +  D+++ G +  EM  G
Sbjct: 178 YSTTIDIWSVGCIFAEMVNG 197

>pdb|2YDJ|A Chain A, Discovery Of Checkpoint Kinase Inhibitor Azd7762 By Structure Based Design And Optimization Of Thiophene Carboxamide Ureas Length = 276

Iteration: 1
 Score = 56.2 bits (134), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 58/196 (29%), Positives = 89/196 (45%), Gaps = 38/196 (19%)
Query: 321 LGQGGYGSVYKG-KLLDGSNVAVKVLNDSKG-NGKEFINEVASISRT-SHVNVVALLG-- 375
           LG+G YG V      +    VAVK+++  +  +  E I +   I++  +H NVV   G  
Sbjct: 15  LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEIXINKMLNHENVVKFYGHR 74
Query: 376 -----------FCL--RVAEELSSTIGIAR------------GLEYLHLGCSTRILHFDI 410
                      +C    + + +   IG+              G+ YLH      I H DI
Sbjct: 75  REGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLH---GIGITHRDI 131
Query: 411 KPHNILLDEDFCPKISDFGLAKI--CNRKESIISMTGARGTVGYIAPEVFCRNIGEVSYK 468
           KP N+LLDE    KISDFGLA +   N +E +++     GT+ Y+APE+  R        
Sbjct: 132 KPENLLLDERDNLKISDFGLATVFRYNNRERLLNKM--XGTLPYVAPELLKRREFHAE-P 188
Query: 469 SDVYNYGMMIFEMTGG 484
            DV++ G+++  M  G
Sbjct: 189 VDVWSCGIVLTAMLAG 204

>pdb|2OW3|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With Bis- (Indole)maleimide Pyridinophane Inhibitor Length = 352

Iteration: 1
 Score = 56.2 bits (134), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 68/225 (30%), Positives = 93/225 (41%), Gaps = 62/225 (27%)
Query: 302 PKRYGYADIKKMTNSFKYKLGQGGYGSVYKGKLLD-GSNVAVK-VLNDSKGNGKEFINEV 359
           P+   Y D K         +G G +G VY+ KL D G  VA+K VL D +   +E    +
Sbjct: 17  PQEVSYTDTKV--------IGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNRE----L 64
Query: 360 ASISRTSHVNVVALLGF-----------------------CLRVAEELS---STIGIA-- 391
             + +  H N+V L  F                         RVA   S    T+ +   
Sbjct: 65  QIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYV 124
Query: 392 --------RGLEYLHLGCSTRILHFDIKPHNILLDEDFCP-KISDFGLAKICNRKESIIS 442
                   R L Y+H   S  I H DIKP N+LLD D    K+ DFG AK   R E  +S
Sbjct: 125 KLYMYQLFRSLAYIH---SFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVS 181
Query: 443 MTGARGTVGYIAPEVFCRNIGEVSYKS--DVYNYGMMIFEMTGGR 485
              +R    Y APE+     G   Y S  DV++ G ++ E+  G+
Sbjct: 182 XICSR---YYRAPELI---FGATDYTSSIDVWSAGCVLAELLLGQ 220

>pdb|1Q3D|A Chain A, Gsk-3 Beta Complexed With Staurosporine Length = 424

Iteration: 1
 Score = 56.2 bits (134), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 71/226 (31%), Positives = 94/226 (41%), Gaps = 64/226 (28%)
Query: 302 PKRYGYADIKKMTNSFKYKLGQGGYGSVYKGKLLD-GSNVAVK-VLNDSKGNGKEFIN-E 358
           P+   Y D K         +G G +G VY+ KL D G  VA+K VL D     K F N E
Sbjct: 55  PQEVSYTDTKV--------IGNGSFGVVYQAKLCDSGELVAIKKVLQD-----KRFKNRE 101
Query: 359 VASISRTSHVNVVALLGF-----------------------CLRVAEELS---STIGIA- 391
           +  + +  H N+V L  F                         RVA   S    T+ +  
Sbjct: 102 LQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIY 161
Query: 392 ---------RGLEYLHLGCSTRILHFDIKPHNILLDEDFCP-KISDFGLAKICNRKESII 441
                    R L Y+H   S  I H DIKP N+LLD D    K+ DFG AK   R E  +
Sbjct: 162 VKLYMYQLFRSLAYIH---SFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNV 218
Query: 442 SMTGARGTVGYIAPEVFCRNIGEVSYKS--DVYNYGMMIFEMTGGR 485
           S   +R    Y APE+     G   Y S  DV++ G ++ E+  G+
Sbjct: 219 SYICSR---YYRAPELI---FGATDYTSSIDVWSAGCVLAELLLGQ 258

>pdb|4DIT|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Imidazopyridine Inhibitor Length = 382

Iteration: 1
 Score = 56.2 bits (134), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 68/225 (30%), Positives = 93/225 (41%), Gaps = 62/225 (27%)
Query: 302 PKRYGYADIKKMTNSFKYKLGQGGYGSVYKGKLLD-GSNVAVK-VLNDSKGNGKEFINEV 359
           P+   Y D K         +G G +G VY+ KL D G  VA+K VL D +   +E    +
Sbjct: 29  PQEVSYTDTKV--------IGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNRE----L 76
Query: 360 ASISRTSHVNVVALLGF-----------------------CLRVAEELS---STIGIA-- 391
             + +  H N+V L  F                         RVA   S    T+ +   
Sbjct: 77  QIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYV 136
Query: 392 --------RGLEYLHLGCSTRILHFDIKPHNILLDEDFCP-KISDFGLAKICNRKESIIS 442
                   R L Y+H   S  I H DIKP N+LLD D    K+ DFG AK   R E  +S
Sbjct: 137 KLYMYQLFRSLAYIH---SFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVS 193
Query: 443 MTGARGTVGYIAPEVFCRNIGEVSYKS--DVYNYGMMIFEMTGGR 485
              +R    Y APE+     G   Y S  DV++ G ++ E+  G+
Sbjct: 194 XICSR---YYRAPELI---FGATDYTSSIDVWSAGCVLAELLLGQ 232

>pdb|2O5K|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Benzoimidazol Inhibitor Length = 372

Iteration: 1
 Score = 56.2 bits (134), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 68/225 (30%), Positives = 93/225 (41%), Gaps = 62/225 (27%)
Query: 302 PKRYGYADIKKMTNSFKYKLGQGGYGSVYKGKLLD-GSNVAVK-VLNDSKGNGKEFINEV 359
           P+   Y D K         +G G +G VY+ KL D G  VA+K VL D +   +E    +
Sbjct: 30  PQEVSYTDTKV--------IGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNRE----L 77
Query: 360 ASISRTSHVNVVALLGF-----------------------CLRVAEELS---STIGIA-- 391
             + +  H N+V L  F                         RVA   S    T+ +   
Sbjct: 78  QIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYV 137
Query: 392 --------RGLEYLHLGCSTRILHFDIKPHNILLDEDFCP-KISDFGLAKICNRKESIIS 442
                   R L Y+H   S  I H DIKP N+LLD D    K+ DFG AK   R E  +S
Sbjct: 138 KLYMYQLFRSLAYIH---SFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVS 194
Query: 443 MTGARGTVGYIAPEVFCRNIGEVSYKS--DVYNYGMMIFEMTGGR 485
              +R    Y APE+     G   Y S  DV++ G ++ E+  G+
Sbjct: 195 YICSR---YYRAPELI---FGATDYTSSIDVWSAGCVLAELLLGQ 233

>pdb|1IRK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Human Insulin Receptor Length = 306

Iteration: 1
 Score = 56.2 bits (134), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 53/210 (25%), Positives = 93/210 (44%), Gaps = 54/210 (25%)
Query: 320 KLGQGGYGSVYKGKLLD------GSNVAVKVLNDSKGNGK--EFINEVASISRTSHVNVV 371
           +LGQG +G VY+G   D       + VAVK +N+S    +  EF+NE + +   +  +VV
Sbjct: 24  ELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVV 83
Query: 372 ALLGFCLR-------------------------------------VAEELSSTIGIARGL 394
            LLG   +                                     + E +     IA G+
Sbjct: 84  RLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGM 143
Query: 395 EYLHLGCSTRILHFDIKPHNILLDEDFCPKISDFGLAKICNRKESIISMTGARG--TVGY 452
            YL+   + + +H D+   N ++  DF  KI DFG+ +  +  E+     G +G   V +
Sbjct: 144 AYLN---AKKFVHRDLAARNCMVAHDFTVKIGDFGMTR--DIYETDYYRKGGKGLLPVRW 198
Query: 453 IAPEVFCRNIGEVSYKSDVYNYGMMIFEMT 482
           +APE      G  +  SD++++G++++E+T
Sbjct: 199 MAPESL--KDGVFTTSSDMWSFGVVLWEIT 226

>pdb|3U6J|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyrazolone Inhibitor Length = 314

Iteration: 1
 Score = 56.2 bits (134), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 52/214 (24%), Positives = 91/214 (42%), Gaps = 58/214 (27%)
Query: 321 LGQGGYGSVYKG------KLLDGSNVAVKVLND--SKGNGKEFINEVASISRTSH-VNVV 371
           LG+G +G V +       K      VAVK+L +  +    +  ++E+  +    H +NVV
Sbjct: 26  LGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVV 85
Query: 372 ALLGFC--------------------------------LRVAEE------------LSST 387
            LLG C                                 +VA E            +  +
Sbjct: 86  NLLGACTKPGGPLMVITEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYS 145
Query: 388 IGIARGLEYLHLGCSTRILHFDIKPHNILLDEDFCPKISDFGLAKICNRKESIISMTGAR 447
             +A+G+E+L    S + +H D+   NILL E    KI DFGLA+   +    +    AR
Sbjct: 146 FQVAKGMEFL---ASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDAR 202
Query: 448 GTVGYIAPEVFCRNIGEVSYKSDVYNYGMMIFEM 481
             + ++APE     +   + +SDV+++G++++E+
Sbjct: 203 LPLKWMAPETIFDRV--YTIQSDVWSFGVLLWEI 234

>pdb|3SD0|A Chain A, Identification Of A Glycogen Synthase Kinase-3b Inhibitor That Attenuates Hyperactivity In Clock Mutant Mice Length = 350

Iteration: 1
 Score = 56.2 bits (134), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 68/225 (30%), Positives = 93/225 (41%), Gaps = 62/225 (27%)
Query: 302 PKRYGYADIKKMTNSFKYKLGQGGYGSVYKGKLLD-GSNVAVK-VLNDSKGNGKEFINEV 359
           P+   Y D K         +G G +G VY+ KL D G  VA+K VL D +   +E    +
Sbjct: 17  PQEVSYTDTKV--------IGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNRE----L 64
Query: 360 ASISRTSHVNVVALLGF-----------------------CLRVAEELS---STIGIA-- 391
             + +  H N+V L  F                         RVA   S    T+ +   
Sbjct: 65  QIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYV 124
Query: 392 --------RGLEYLHLGCSTRILHFDIKPHNILLDEDFCP-KISDFGLAKICNRKESIIS 442
                   R L Y+H   S  I H DIKP N+LLD D    K+ DFG AK   R E  +S
Sbjct: 125 KLYMYQLFRSLAYIH---SFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVS 181
Query: 443 MTGARGTVGYIAPEVFCRNIGEVSYKS--DVYNYGMMIFEMTGGR 485
              +R    Y APE+     G   Y S  DV++ G ++ E+  G+
Sbjct: 182 YICSR---YYRAPELI---FGATDYTSSIDVWSAGCVLAELLLGQ 220

>pdb|4ACC|A Chain A, Gsk3b In Complex With Inhibitor Length = 465

Iteration: 1
 Score = 56.2 bits (134), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 71/226 (31%), Positives = 94/226 (41%), Gaps = 64/226 (28%)
Query: 302 PKRYGYADIKKMTNSFKYKLGQGGYGSVYKGKLLD-GSNVAVK-VLNDSKGNGKEFIN-E 358
           P+   Y D K         +G G +G VY+ KL D G  VA+K VL D     K F N E
Sbjct: 96  PQEVSYTDTKV--------IGNGSFGVVYQAKLCDSGELVAIKKVLQD-----KRFKNRE 142
Query: 359 VASISRTSHVNVVALLGF-----------------------CLRVAEELS---STIGIA- 391
           +  + +  H N+V L  F                         RVA   S    T+ +  
Sbjct: 143 LQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIY 202
Query: 392 ---------RGLEYLHLGCSTRILHFDIKPHNILLDEDFCP-KISDFGLAKICNRKESII 441
                    R L Y+H   S  I H DIKP N+LLD D    K+ DFG AK   R E  +
Sbjct: 203 VKLYMYQLFRSLAYIH---SFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNV 259
Query: 442 SMTGARGTVGYIAPEVFCRNIGEVSYKS--DVYNYGMMIFEMTGGR 485
           S   +R    Y APE+     G   Y S  DV++ G ++ E+  G+
Sbjct: 260 SYICSR---YYRAPELI---FGATDYTSSIDVWSAGCVLAELLLGQ 299

>pdb|2XIR|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With Pf-00337210 (N,2-Dimethyl-6-(7-(2-Morpholinoethoxy) Quinolin-4-Yloxy)benzofuran-3-Carboxamide) Length = 316

Iteration: 1
 Score = 56.2 bits (134), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 52/214 (24%), Positives = 91/214 (42%), Gaps = 58/214 (27%)
Query: 321 LGQGGYGSVYKG------KLLDGSNVAVKVLND--SKGNGKEFINEVASISRTSH-VNVV 371
           LG+G +G V +       K      VAVK+L +  +    +  ++E+  +    H +NVV
Sbjct: 35  LGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVV 94
Query: 372 ALLGFC--------------------------------LRVAEE------------LSST 387
            LLG C                                 +VA E            +  +
Sbjct: 95  NLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYS 154
Query: 388 IGIARGLEYLHLGCSTRILHFDIKPHNILLDEDFCPKISDFGLAKICNRKESIISMTGAR 447
             +A+G+E+L    S + +H D+   NILL E    KI DFGLA+   +    +    AR
Sbjct: 155 FQVAKGMEFL---ASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDAR 211
Query: 448 GTVGYIAPEVFCRNIGEVSYKSDVYNYGMMIFEM 481
             + ++APE     +   + +SDV+++G++++E+
Sbjct: 212 LPLKWMAPETIFDRV--YTIQSDVWSFGVLLWEI 243

>pdb|1VR2|A Chain A, Human Vascular Endothelial Growth Factor Receptor 2 (Kdr) Kinase Domain Length = 316

Iteration: 1
 Score = 56.2 bits (134), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 52/214 (24%), Positives = 91/214 (42%), Gaps = 58/214 (27%)
Query: 321 LGQGGYGSVYKG------KLLDGSNVAVKVLND--SKGNGKEFINEVASISRTSH-VNVV 371
           LG+G +G V +       K      VAVK+L +  +    +  ++E+  +    H +NVV
Sbjct: 35  LGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVV 94
Query: 372 ALLGFC--------------------------------LRVAEE------------LSST 387
            LLG C                                 +VA E            +  +
Sbjct: 95  NLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYS 154
Query: 388 IGIARGLEYLHLGCSTRILHFDIKPHNILLDEDFCPKISDFGLAKICNRKESIISMTGAR 447
             +A+G+E+L    S + +H D+   NILL E    KI DFGLA+   +    +    AR
Sbjct: 155 FQVAKGMEFL---ASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDXVRKGDAR 211
Query: 448 GTVGYIAPEVFCRNIGEVSYKSDVYNYGMMIFEM 481
             + ++APE     +   + +SDV+++G++++E+
Sbjct: 212 LPLKWMAPETIFDRV--YTIQSDVWSFGVLLWEI 243

>pdb|1R0E|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With 3-Indolyl-4- Arylmaleimide Inhibitor Length = 391

Iteration: 1
 Score = 56.2 bits (134), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 71/226 (31%), Positives = 94/226 (41%), Gaps = 64/226 (28%)
Query: 302 PKRYGYADIKKMTNSFKYKLGQGGYGSVYKGKLLD-GSNVAVK-VLNDSKGNGKEFIN-E 358
           P+   Y D K         +G G +G VY+ KL D G  VA+K VL D     K F N E
Sbjct: 22  PQEVSYTDTKV--------IGNGSFGVVYQAKLCDSGELVAIKKVLQD-----KRFKNRE 68
Query: 359 VASISRTSHVNVVALLGF-----------------------CLRVAEELS---STIGIA- 391
           +  + +  H N+V L  F                         RVA   S    T+ +  
Sbjct: 69  LQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIY 128
Query: 392 ---------RGLEYLHLGCSTRILHFDIKPHNILLDEDFCP-KISDFGLAKICNRKESII 441
                    R L Y+H   S  I H DIKP N+LLD D    K+ DFG AK   R E  +
Sbjct: 129 VKLYMYQLFRSLAYIH---SFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNV 185
Query: 442 SMTGARGTVGYIAPEVFCRNIGEVSYKS--DVYNYGMMIFEMTGGR 485
           S   +R    Y APE+     G   Y S  DV++ G ++ E+  G+
Sbjct: 186 SYICSR---YYRAPELI---FGATDYTSSIDVWSAGCVLAELLLGQ 225

>pdb|1JPA|A Chain A, Crystal Structure Of Unphosphorylated Ephb2 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 312

Iteration: 1
 Score = 56.2 bits (134), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 50/198 (25%), Positives = 88/198 (44%), Gaps = 42/198 (21%)
Query: 321 LGQGGYGSVYKGKL-LDGSN---VAVKVLND--SKGNGKEFINEVASISRTSHVNVVALL 374
           +G G +G V  G L L G     VA+K L    ++   ++F++E + + +  H NV+ L 
Sbjct: 41  IGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNVIHLE 100
Query: 375 GFCLR----------------------------VAEELSSTIGIARGLEYLHLGCSTRIL 406
           G   +                            V + +    GIA G++YL        +
Sbjct: 101 GVVTKSTPVMIITEFMENGSLDSFLRQNDGQFTVIQLVGMLRGIAAGMKYL---ADMNYV 157
Query: 407 HFDIKPHNILLDEDFCPKISDFGLAKICNRKESIISMTGARG---TVGYIAPEVFCRNIG 463
           H D+   NIL++ +   K+SDFGL++      S  + T A G    + + APE       
Sbjct: 158 HRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSALGGKIPIRWTAPEAI--QYR 215
Query: 464 EVSYKSDVYNYGMMIFEM 481
           + +  SDV++YG++++E+
Sbjct: 216 KFTSASDVWSYGIVMWEV 233

>pdb|3EWH|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridyl-Pyrimidine Benzimidazole Inhibitor Length = 314

Iteration: 1
 Score = 56.2 bits (134), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 52/214 (24%), Positives = 91/214 (42%), Gaps = 58/214 (27%)
Query: 321 LGQGGYGSVYKG------KLLDGSNVAVKVLND--SKGNGKEFINEVASISRTSH-VNVV 371
           LG+G +G V +       K      VAVK+L +  +    +  ++E+  +    H +NVV
Sbjct: 26  LGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVV 85
Query: 372 ALLGFC--------------------------------LRVAEE------------LSST 387
            LLG C                                 +VA E            +  +
Sbjct: 86  NLLGACTKPGGPLMVITEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYS 145
Query: 388 IGIARGLEYLHLGCSTRILHFDIKPHNILLDEDFCPKISDFGLAKICNRKESIISMTGAR 447
             +A+G+E+L    S + +H D+   NILL E    KI DFGLA+   +    +    AR
Sbjct: 146 FQVAKGMEFL---ASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDAR 202
Query: 448 GTVGYIAPEVFCRNIGEVSYKSDVYNYGMMIFEM 481
             + ++APE     +   + +SDV+++G++++E+
Sbjct: 203 LPLKWMAPETIFDRV--YTIQSDVWSFGVLLWEI 234

>pdb|3COI|A Chain A, Crystal Structure Of P38delta Kinase Length = 353

Iteration: 1
 Score = 56.2 bits (134), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 61/219 (27%), Positives = 96/219 (43%), Gaps = 50/219 (22%)
Query: 321 LGQGGYGSVYKGKLLD---GSNVAVKVLN---DSKGNGKEFINEVASISRTSHVNVVALL 374
           +G G YGSV     +D   G  VA+K L+    S+   K    E+  +    H NV+ LL
Sbjct: 32  VGSGAYGSVCSA--IDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLL 89
Query: 375 GF-----CLR-----------VAEELSSTIGIA--------------RGLEYLHLGCSTR 404
                   LR           +  +L   +G+               +GL+Y+H   S  
Sbjct: 90  DVFTPASSLRNFYDFYLVMPFMQTDLQKIMGLKFSEEKIQYLVYQMLKGLKYIH---SAG 146
Query: 405 ILHFDIKPHNILLDEDFCPKISDFGLAKICNRKESIISMTGARGTVGYIAPEVFCRNIGE 464
           ++H D+KP N+ ++ED   KI DFGLA+  + +     MTG   T  Y APEV    +  
Sbjct: 147 VVHRDLKPGNLAVNEDCELKILDFGLARHADAE-----MTGYVVTRWYRAPEVILSWM-H 200
Query: 465 VSYKSDVYNYGMMIFEMTGGR---KNVDVVDNGSTALDL 500
            +   D+++ G ++ EM  G+   K  D +D  +  L +
Sbjct: 201 YNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKV 239

>pdb|3GB2|A Chain A, Gsk3beta Inhibitor Complex Length = 353

Iteration: 1
 Score = 56.2 bits (134), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 68/225 (30%), Positives = 93/225 (41%), Gaps = 62/225 (27%)
Query: 302 PKRYGYADIKKMTNSFKYKLGQGGYGSVYKGKLLD-GSNVAVK-VLNDSKGNGKEFINEV 359
           P+   Y D K         +G G +G VY+ KL D G  VA+K VL D +   +E    +
Sbjct: 21  PQEVSYTDTKV--------IGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNRE----L 68
Query: 360 ASISRTSHVNVVALLGF-----------------------CLRVAEELS---STIGIA-- 391
             + +  H N+V L  F                         RVA   S    T+ +   
Sbjct: 69  QIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYV 128
Query: 392 --------RGLEYLHLGCSTRILHFDIKPHNILLDEDFCP-KISDFGLAKICNRKESIIS 442
                   R L Y+H   S  I H DIKP N+LLD D    K+ DFG AK   R E  +S
Sbjct: 129 KLYMYQLFRSLAYIH---SFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVS 185
Query: 443 MTGARGTVGYIAPEVFCRNIGEVSYKS--DVYNYGMMIFEMTGGR 485
              +R    Y APE+     G   Y S  DV++ G ++ E+  G+
Sbjct: 186 XICSR---YYRAPELI---FGATDYTSSIDVWSAGCVLAELLLGQ 224

>pdb|3MH1|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score = 56.2 bits (134), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 60/202 (29%), Positives = 88/202 (43%), Gaps = 48/202 (23%)
Query: 321 LGQGGYGSV---YKGKLLDGSNVAVKVLN---DSKGNGKEFINEVASISRTSHVNVVALL 374
           +G G YGSV   +  K   G  VAVK L+    S  + K    E+  +    H NV+ LL
Sbjct: 30  VGSGAYGSVCAAFDTK--TGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLL 87
Query: 375 GFCL--RVAEE------LSSTIG-----------------------IARGLEYLHLGCST 403
                 R  EE      ++  +G                       I RGL+Y+H   S 
Sbjct: 88  DVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIH---SA 144
Query: 404 RILHFDIKPHNILLDEDFCPKISDFGLAKICNRKESIISMTGARGTVGYIAPEVFCRNIG 463
            I+H D+KP N+ ++ED   KI D GLA+  + +     MTG   T  Y APE+   N  
Sbjct: 145 DIIHRDLKPSNLAVNEDCELKILDGGLARHTDDE-----MTGYVATRWYRAPEIML-NWM 198
Query: 464 EVSYKSDVYNYGMMIFEMTGGR 485
             +   D+++ G ++ E+  GR
Sbjct: 199 HYNQTVDIWSVGCIMAELLTGR 220

>pdb|4AW5|A Chain A, Complex Of The Ephb4 Kinase Domain With An Oxindole Inhibitor Length = 291

Iteration: 1
 Score = 55.8 bits (133), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 49/198 (24%), Positives = 89/198 (44%), Gaps = 42/198 (21%)
Query: 321 LGQGGYGSVYKGKLL----DGSNVAVKVLND--SKGNGKEFINEVASISRTSHVNVVALL 374
           +G G +G V +G+L       S VA+K L    ++   +EF++E + + +  H N++ L 
Sbjct: 22  IGAGEFGEVCRGRLKAPGKKESCVAIKTLKGGYTERQRREFLSEASIMGQFEHPNIIRLE 81
Query: 375 GFC---------------------LRVAEELSSTI-------GIARGLEYLHLGCSTRIL 406
           G                       LR+ +   + I       GIA G+ YL        +
Sbjct: 82  GVVTNSMPVMILTEFMENGALDSFLRLNDGQFTVIQLVGMLRGIASGMRYL---AEMSYV 138
Query: 407 HFDIKPHNILLDEDFCPKISDFGLAKICNRKESIISMT---GARGTVGYIAPEVFCRNIG 463
           H D+   NIL++ +   K+SDFGL++      S  + T   G +  + + APE       
Sbjct: 139 HRDLAARNILVNSNLVCKVSDFGLSRFLEENSSDPTYTSSLGGKIPIRWTAPEAIA--FR 196
Query: 464 EVSYKSDVYNYGMMIFEM 481
           + +  SD ++YG++++E+
Sbjct: 197 KFTSASDAWSYGIVMWEV 214

>pdb|2QOO|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742f Triple Mutant Length = 373

Iteration: 1
 Score = 55.8 bits (133), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 45/196 (22%), Positives = 90/196 (45%), Gaps = 40/196 (20%)
Query: 321 LGQGGYGSVYKGKLLDGS----NVAVKVLND--SKGNGKEFINEVASISRTSHVNVVALL 374
           +G G +G V  G+L   S    +VA+K L    ++   ++F+ E + + +  H N++ L 
Sbjct: 53  VGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRLE 112
Query: 375 GFCLR----------------------------VAEELSSTIGIARGLEYLHLGCSTRIL 406
           G   +                            V + +    GIA G++YL        +
Sbjct: 113 GVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTVIQLVGMLRGIASGMKYL---SDMGFV 169
Query: 407 HFDIKPHNILLDEDFCPKISDFGLAKIC-NRKESIISMTGARGTVGYIAPEVFCRNIGEV 465
           H D+   NIL++ +   K+SDFGL+++  +  E+  +  G +  + + +PE       + 
Sbjct: 170 HRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTSPEAIAYR--KF 227
Query: 466 SYKSDVYNYGMMIFEM 481
           +  SDV++YG++++E+
Sbjct: 228 TSASDVWSYGIVLWEV 243

>pdb|2J0L|A Chain A, Crystal Structure Of A The Active Conformation Of The Kinase Domain Of Focal Adhesion Kinase With A Phosphorylated Activation Loop Length = 276

Iteration: 1
 Score = 55.8 bits (133), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 51/211 (24%), Positives = 92/211 (43%), Gaps = 46/211 (21%)
Query: 321 LGQGGYGSVYKGKLLDGSN----VAVKVLND--SKGNGKEFINEVASISRTSHVNVVALL 374
           +G+G +G V++G  +   N    VA+K   +  S    ++F+ E  ++ +  H ++V L+
Sbjct: 18  IGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLI 77
Query: 375 G---------------------------FCLRVAEELSSTIGIARGLEYLHLGCSTRILH 407
           G                           F L +A  +     ++  L YL    S R +H
Sbjct: 78  GVITENPVWIIMELCTLGELRSFLQVRKFSLDLASLILYAYQLSTALAYLE---SKRFVH 134
Query: 408 FDIKPHNILLDEDFCPKISDFGLAKICNRKESIISMTGARGTVGYIAPEVFCRNIGEVSY 467
            DI   N+L+  + C K+ DFGL++      +    +  +  + ++APE    N    + 
Sbjct: 135 RDIAARNVLVSSNDCVKLGDFGLSRYME-DSTXXKASKGKLPIKWMAPESI--NFRRFTS 191
Query: 468 KSDVYNYGMMIFE--MTG-----GRKNVDVV 491
            SDV+ +G+ ++E  M G     G KN DV+
Sbjct: 192 ASDVWMFGVCMWEILMHGVKPFQGVKNNDVI 222

>pdb|1O9U|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide Length = 350

Iteration: 1
 Score = 55.8 bits (133), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 69/225 (30%), Positives = 93/225 (41%), Gaps = 62/225 (27%)
Query: 302 PKRYGYADIKKMTNSFKYKLGQGGYGSVYKGKLLD-GSNVAVKVLNDSKGNGKEFIN-EV 359
           P+   Y D K         +G G +G VY+ KL D G  VA+K +      GK F N E+
Sbjct: 17  PQEVSYTDTKV--------IGNGSFGVVYQAKLCDSGELVAIKKVL----QGKAFKNREL 64
Query: 360 ASISRTSHVNVVALLGF-----------------------CLRVAEELS---STIGIA-- 391
             + +  H N+V L  F                         RVA   S    T+ +   
Sbjct: 65  QIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPATVYRVARHYSRAKQTLPVIYV 124
Query: 392 --------RGLEYLHLGCSTRILHFDIKPHNILLDEDFCP-KISDFGLAKICNRKESIIS 442
                   R L Y+H   S  I H DIKP N+LLD D    K+ DFG AK   R E  +S
Sbjct: 125 KLYMYQLFRSLAYIH---SFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVS 181
Query: 443 MTGARGTVGYIAPEVFCRNIGEVSYKS--DVYNYGMMIFEMTGGR 485
              +R    Y APE+     G   Y S  DV++ G ++ E+  G+
Sbjct: 182 XICSR---YYRAPELI---FGATDYTSSIDVWSAGCVLAELLLGQ 220

>pdb|4FSW|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 55.8 bits (133), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 58/196 (29%), Positives = 89/196 (45%), Gaps = 38/196 (19%)
Query: 321 LGQGGYGSVYKG-KLLDGSNVAVKVLNDSKG-NGKEFINEVASISRT-SHVNVVALLG-- 375
           LG+G YG V      +    VAVK+++  +  +  E I +   I++  +H NVV   G  
Sbjct: 14  LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHR 73
Query: 376 -----------FCL--RVAEELSSTIGIAR------------GLEYLHLGCSTRILHFDI 410
                      +C    + + +   IG+              G+ YLH      I H DI
Sbjct: 74  REGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLH---GIGITHRDI 130
Query: 411 KPHNILLDEDFCPKISDFGLAKI--CNRKESIISMTGARGTVGYIAPEVFCRNIGEVSYK 468
           KP N+LLDE    KISDFGLA +   N +E +++     GT+ Y+APE+  R        
Sbjct: 131 KPENLLLDERDNLKISDFGLATVFRYNNRERLLNKM--XGTLPYVAPELLKRREFHAE-P 187
Query: 469 SDVYNYGMMIFEMTGG 484
            DV++ G+++  M  G
Sbjct: 188 VDVWSCGIVLTAMLAG 203

>pdb|1H8F|A Chain A, Glycogen Synthase Kinase 3 Beta. Length = 352

Iteration: 1
 Score = 55.8 bits (133), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 69/225 (30%), Positives = 93/225 (41%), Gaps = 62/225 (27%)
Query: 302 PKRYGYADIKKMTNSFKYKLGQGGYGSVYKGKLLD-GSNVAVKVLNDSKGNGKEFIN-EV 359
           P+   Y D K         +G G +G VY+ KL D G  VA+K +      GK F N E+
Sbjct: 17  PQEVSYTDTKV--------IGNGSFGVVYQAKLCDSGELVAIKKVL----QGKAFKNREL 64
Query: 360 ASISRTSHVNVVALLGF-----------------------CLRVAEELS---STIGIA-- 391
             + +  H N+V L  F                         RVA   S    T+ +   
Sbjct: 65  QIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYV 124
Query: 392 --------RGLEYLHLGCSTRILHFDIKPHNILLDEDFCP-KISDFGLAKICNRKESIIS 442
                   R L Y+H   S  I H DIKP N+LLD D    K+ DFG AK   R E  +S
Sbjct: 125 KLYMYQLFRSLAYIH---SFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVS 181
Query: 443 MTGARGTVGYIAPEVFCRNIGEVSYKS--DVYNYGMMIFEMTGGR 485
              +R    Y APE+     G   Y S  DV++ G ++ E+  G+
Sbjct: 182 YICSR---YYRAPELI---FGATDYTSSIDVWSAGCVLAELLLGQ 220

>pdb|3ETA|A Chain A, Kinase Domain Of Insulin Receptor Complexed With A Pyrrolo Pyridine Inhibitor Length = 317

Iteration: 1
 Score = 55.8 bits (133), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 53/210 (25%), Positives = 93/210 (44%), Gaps = 54/210 (25%)
Query: 320 KLGQGGYGSVYKGKLLD------GSNVAVKVLNDSKGNGK--EFINEVASISRTSHVNVV 371
           +LGQG +G VY+G   D       + VAVK +N+S    +  EF+NE + +   +  +VV
Sbjct: 23  ELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVV 82
Query: 372 ALLGFCLR-------------------------------------VAEELSSTIGIARGL 394
            LLG   +                                     + E +     IA G+
Sbjct: 83  RLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGM 142
Query: 395 EYLHLGCSTRILHFDIKPHNILLDEDFCPKISDFGLAKICNRKESIISMTGARG--TVGY 452
            YL+   + + +H D+   N ++  DF  KI DFG+ +  +  E+     G +G   V +
Sbjct: 143 AYLN---AKKFVHRDLAARNCMVAHDFTVKIGDFGMTR--DIYETDYYRKGGKGLLPVRW 197
Query: 453 IAPEVFCRNIGEVSYKSDVYNYGMMIFEMT 482
           +APE      G  +  SD++++G++++E+T
Sbjct: 198 MAPESL--KDGVFTTSSDMWSFGVVLWEIT 225

>pdb|1UV5|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With 6-Bromoindirubin-3'-Oxime Length = 350

Iteration: 1
 Score = 55.8 bits (133), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 69/225 (30%), Positives = 93/225 (41%), Gaps = 62/225 (27%)
Query: 302 PKRYGYADIKKMTNSFKYKLGQGGYGSVYKGKLLD-GSNVAVKVLNDSKGNGKEFIN-EV 359
           P+   Y D K         +G G +G VY+ KL D G  VA+K +      GK F N E+
Sbjct: 17  PQEVSYTDTKV--------IGNGSFGVVYQAKLCDSGELVAIKKVL----QGKAFKNREL 64
Query: 360 ASISRTSHVNVVALLGF-----------------------CLRVAEELS---STIGIA-- 391
             + +  H N+V L  F                         RVA   S    T+ +   
Sbjct: 65  QIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYV 124
Query: 392 --------RGLEYLHLGCSTRILHFDIKPHNILLDEDFCP-KISDFGLAKICNRKESIIS 442
                   R L Y+H   S  I H DIKP N+LLD D    K+ DFG AK   R E  +S
Sbjct: 125 KLYMYQLFRSLAYIH---SFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVS 181
Query: 443 MTGARGTVGYIAPEVFCRNIGEVSYKS--DVYNYGMMIFEMTGGR 485
              +R    Y APE+     G   Y S  DV++ G ++ E+  G+
Sbjct: 182 YICSR---YYRAPELI---FGATDYTSSIDVWSAGCVLAELLLGQ 220

>pdb|2VWU|A Chain A, Ephb4 Kinase Domain Inhibitor Complex Length = 302

Iteration: 1
 Score = 55.8 bits (133), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 49/198 (24%), Positives = 89/198 (44%), Gaps = 42/198 (21%)
Query: 321 LGQGGYGSVYKGKLL----DGSNVAVKVLND--SKGNGKEFINEVASISRTSHVNVVALL 374
           +G G +G V +G+L       S VA+K L    ++   +EF++E + + +  H N++ L 
Sbjct: 24  IGAGEFGEVCRGRLKAPGKKESCVAIKTLKGGYTERQRREFLSEASIMGQFEHPNIIRLE 83
Query: 375 GFC---------------------LRVAEELSSTI-------GIARGLEYLHLGCSTRIL 406
           G                       LR+ +   + I       GIA G+ YL        +
Sbjct: 84  GVVTNSMPVMILTEFMENGALDSFLRLNDGQFTVIQLVGMLRGIASGMRYL---AEMSYV 140
Query: 407 HFDIKPHNILLDEDFCPKISDFGLAKICNRKESIISMT---GARGTVGYIAPEVFCRNIG 463
           H D+   NIL++ +   K+SDFGL++      S  + T   G +  + + APE       
Sbjct: 141 HRDLAARNILVNSNLVCKVSDFGLSRFLEENSSDPTETSSLGGKIPIRWTAPEAIA--FR 198
Query: 464 EVSYKSDVYNYGMMIFEM 481
           + +  SD ++YG++++E+
Sbjct: 199 KFTSASDAWSYGIVMWEV 216

>pdb|2QON|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742a Triple Mutant Length = 373

Iteration: 1
 Score = 55.8 bits (133), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 46/197 (23%), Positives = 92/197 (46%), Gaps = 42/197 (21%)
Query: 321 LGQGGYGSVYKGKLLDGS----NVAVKVLND--SKGNGKEFINEVASISRTSHVNVVALL 374
           +G G +G V  G+L   S    +VA+K L    ++   ++F+ E + + +  H N++ L 
Sbjct: 53  VGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRLE 112
Query: 375 GFCLR----------------------------VAEELSSTIGIARGLEYL-HLGCSTRI 405
           G   +                            V + +    GIA G++YL  +G     
Sbjct: 113 GVVTKSKPVMIVTEXMENGSLDSFLRKHDAQFTVIQLVGMLRGIASGMKYLSDMGA---- 168
Query: 406 LHFDIKPHNILLDEDFCPKISDFGLAKIC-NRKESIISMTGARGTVGYIAPEVFCRNIGE 464
           +H D+   NIL++ +   K+SDFGL+++  +  E+  +  G +  + + +PE       +
Sbjct: 169 VHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTSPEAIAYR--K 226
Query: 465 VSYKSDVYNYGMMIFEM 481
            +  SDV++YG++++E+
Sbjct: 227 FTSASDVWSYGIVLWEV 243

>pdb|4AGC|A Chain A, Crystal Structure Of Vegfr2 (Juxtamembrane And Kinase Domains) In Complex With Axitinib (Ag-013736) (N-Methyl-2-( 3-((E)-2-Pyridin-2-Yl-Vinyl)-1h-Indazol-6-Ylsulfanyl)- Benzamide) Length = 353

Iteration: 1
 Score = 55.8 bits (133), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 52/214 (24%), Positives = 91/214 (42%), Gaps = 58/214 (27%)
Query: 321 LGQGGYGSVYKG------KLLDGSNVAVKVLND--SKGNGKEFINEVASISRTSH-VNVV 371
           LG+G +G V +       K      VAVK+L +  +    +  ++E+  +    H +NVV
Sbjct: 72  LGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVV 131
Query: 372 ALLGFC--------------------------------LRVAEE------------LSST 387
            LLG C                                 +VA E            +  +
Sbjct: 132 NLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYS 191
Query: 388 IGIARGLEYLHLGCSTRILHFDIKPHNILLDEDFCPKISDFGLAKICNRKESIISMTGAR 447
             +A+G+E+L    S + +H D+   NILL E    KI DFGLA+   +    +    AR
Sbjct: 192 FQVAKGMEFL---ASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDAR 248
Query: 448 GTVGYIAPEVFCRNIGEVSYKSDVYNYGMMIFEM 481
             + ++APE     +   + +SDV+++G++++E+
Sbjct: 249 LPLKWMAPETIFDRV--YTIQSDVWSFGVLLWEI 280

>pdb|2OZO|A Chain A, Autoinhibited Intact Human Zap-70 Length = 613

Iteration: 1
 Score = 55.8 bits (133), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 54/194 (27%), Positives = 90/194 (46%), Gaps = 38/194 (19%)
Query: 320 KLGQGGYGSVYKG------KLLDGSNVAVKVLND--SKGNGKEFINEVASISRTSHVNVV 371
           +LG G +GSV +G      K +D   VA+KVL     K + +E + E   + +  +  +V
Sbjct: 343 ELGCGNFGSVRQGVYRMRKKQID---VAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIV 399
Query: 372 ALLGFC----LRVAEELS-------------STIGIARGLEYLH---LGC----STRILH 407
            L+G C    L +  E++               I ++   E LH   +G         +H
Sbjct: 400 RLIGVCQAEALMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKNFVH 459
Query: 408 FDIKPHNILLDEDFCPKISDFGLAKICNRKESIISMTGA-RGTVGYIAPEVFCRNIGEVS 466
            ++   N+LL      KISDFGL+K     +S  +   A +  + + APE  C N  + S
Sbjct: 460 RNLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPE--CINFRKFS 517
Query: 467 YKSDVYNYGMMIFE 480
            +SDV++YG+ ++E
Sbjct: 518 SRSDVWSYGVTMWE 531

>pdb|4FT3|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 55.5 bits (132), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 58/196 (29%), Positives = 89/196 (45%), Gaps = 38/196 (19%)
Query: 321 LGQGGYGSVYKG-KLLDGSNVAVKVLNDSKG-NGKEFINEVASISRT-SHVNVVALLG-- 375
           LG+G YG V      +    VAVK+++  +  +  E I +   I++  +H NVV   G  
Sbjct: 14  LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHR 73
Query: 376 -----------FCL--RVAEELSSTIGIAR------------GLEYLHLGCSTRILHFDI 410
                      +C    + + +   IG+              G+ YLH      I H DI
Sbjct: 74  REGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLH---GIGITHRDI 130
Query: 411 KPHNILLDEDFCPKISDFGLAKI--CNRKESIISMTGARGTVGYIAPEVFCRNIGEVSYK 468
           KP N+LLDE    KISDFGLA +   N +E +++     GT+ Y+APE+  R        
Sbjct: 131 KPENLLLDERDNLKISDFGLATVFRYNNRERLLNKM--XGTLPYVAPELLKRREFHAE-P 187
Query: 469 SDVYNYGMMIFEMTGG 484
            DV++ G+++  M  G
Sbjct: 188 VDVWSCGIVLTAMLAG 203

>pdb|1FOT|A Chain A, Structure Of The Unliganded Camp-Dependent Protein Kinase Catalytic Subunit From Saccharomyces Cerevisiae Length = 318

Iteration: 1
 Score = 55.5 bits (132), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 37/92 (40%), Positives = 50/92 (54%), Gaps = 10/92 (10%)
Query: 393 GLEYLHLGCSTRILHFDIKPHNILLDEDFCPKISDFGLAKICNRKESIISMTGARGTVGY 452
            LEYLH   S  I++ D+KP NILLD++   KI+DFG AK        +      GT  Y
Sbjct: 118 ALEYLH---SKDIIYRDLKPENILLDKNGHIKITDFGFAKYVPDVTYXLC-----GTPDY 169
Query: 453 IAPEVFCRNIGEVSYKSDVYNYGMMIFEMTGG 484
           IAPEV        S   D +++G++I+EM  G
Sbjct: 170 IAPEVVSTKPYNKS--IDWWSFGILIYEMLAG 199

>pdb|4FST|A Chain A, Crystal Structure Of The Chk1 Length = 269

Iteration: 1
 Score = 55.5 bits (132), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 58/196 (29%), Positives = 89/196 (45%), Gaps = 38/196 (19%)
Query: 321 LGQGGYGSVYKG-KLLDGSNVAVKVLNDSKG-NGKEFINEVASISRT-SHVNVVALLG-- 375
           LG+G YG V      +    VAVK+++  +  +  E I +   I++  +H NVV   G  
Sbjct: 14  LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHR 73
Query: 376 -----------FCL--RVAEELSSTIGIAR------------GLEYLHLGCSTRILHFDI 410
                      +C    + + +   IG+              G+ YLH      I H DI
Sbjct: 74  REGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLH---GIGITHRDI 130
Query: 411 KPHNILLDEDFCPKISDFGLAKI--CNRKESIISMTGARGTVGYIAPEVFCRNIGEVSYK 468
           KP N+LLDE    KISDFGLA +   N +E +++     GT+ Y+APE+  R        
Sbjct: 131 KPENLLLDERDNLKISDFGLATVFRYNNRERLLNKM--XGTLPYVAPELLKRREFHAE-P 187
Query: 469 SDVYNYGMMIFEMTGG 484
            DV++ G+++  M  G
Sbjct: 188 VDVWSCGIVLTAMLAG 203

>pdb|3G2F|A Chain A, Crystal Structure Of The Kinase Domain Of Bone Morphogenetic Protein Receptor Type Ii (Bmpr2) At 2.35 A Resolution Length = 336

Iteration: 1
 Score = 55.5 bits (132), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 57/211 (27%), Positives = 85/211 (40%), Gaps = 53/211 (25%)
Query: 321 LGQGGYGSVYKGKLLDGSNVAVKVLNDSKGNGKEFINE--VASISRTSHVNVVALLG--- 375
           +G+G YG+VYKG L D   VAVKV   S  N + FINE  +  +    H N+   +    
Sbjct: 21  IGRGRYGAVYKGSL-DERPVAVKVF--SFANRQNFINEKNIYRVPLMEHDNIARFIVGDE 77
Query: 376 -------------------------FCLRVAEELSS---TIGIARGLEYLHLGC------ 401
                                      L  ++ +SS      + RGL YLH         
Sbjct: 78  RVTADGRMEYLLVMEYYPNGSLXKYLSLHTSDWVSSCRLAHSVTRGLAYLHTELPRGDHY 137
Query: 402 STRILHFDIKPHNILLDEDFCPKISDFGLA------KICNRKESIISMTGARGTVGYIAP 455
              I H D+   N+L+  D    ISDFGL+      ++    E   +     GT+ Y+AP
Sbjct: 138 KPAISHRDLNSRNVLVKNDGTCVISDFGLSMRLTGNRLVRPGEEDNAAISEVGTIRYMAP 197
Query: 456 EVF-----CRNIGEVSYKSDVYNYGMMIFEM 481
           EV       R+      + D+Y  G++ +E+
Sbjct: 198 EVLEGAVNLRDXESALKQVDMYALGLIYWEI 228

>pdb|4FG9|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-320 In Complex With Atp Length = 320

Iteration: 1
 Score = 55.5 bits (132), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 65/210 (30%), Positives = 93/210 (44%), Gaps = 52/210 (24%)
Query: 302 PKRYGYADIKKMTNSFKYKLGQGGYGSVYKGKLLDGSN-VAVKVLNDSKGNGKE--FINE 358
           P+     DI+ + + F+  LG G +  V   +       VA+K +      GKE    NE
Sbjct: 8   PRWKQAEDIRDIYD-FRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKEALEGKEGSMENE 66
Query: 359 VASISRTSHVNVVAL-----------LGFCLRVAEELSSTI----------------GIA 391
           +A + +  H N+VAL           L   L    EL   I                 + 
Sbjct: 67  IAVLHKIKHPNIVALDDIYESGGHLYLIMQLVSGGELFDRIVEKGFYTERDASRLIFQVL 126
Query: 392 RGLEYLH-LGCSTRILHFDIKPHNIL---LDEDFCPKISDFGLAKICNRKESIISMTGAR 447
             ++YLH LG    I+H D+KP N+L   LDED    ISDFGL+K+ +   S++S   A 
Sbjct: 127 DAVKYLHDLG----IVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPG-SVLST--AC 179
Query: 448 GTVGYIAPEVF----------CRNIGEVSY 467
           GT GY+APEV           C +IG ++Y
Sbjct: 180 GTPGYVAPEVLAQKPYSKAVDCWSIGVIAY 209

>pdb|4EXU|A Chain A, Mapk13, Inactive Form Length = 371

Iteration: 1
 Score = 55.5 bits (132), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 61/219 (27%), Positives = 96/219 (43%), Gaps = 50/219 (22%)
Query: 321 LGQGGYGSVYKGKLLD---GSNVAVKVLN---DSKGNGKEFINEVASISRTSHVNVVALL 374
           +G G YGSV     +D   G  VA+K L+    S+   K    E+  +    H NV+ LL
Sbjct: 50  VGSGAYGSVCSA--IDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLL 107
Query: 375 GF-----CLR-----------VAEELSSTIGIA--------------RGLEYLHLGCSTR 404
                   LR           +  +L   +G+               +GL+Y+H   S  
Sbjct: 108 DVFTPASSLRNFYDFYLVMPFMQTDLQKIMGMEFSEEKIQYLVYQMLKGLKYIH---SAG 164
Query: 405 ILHFDIKPHNILLDEDFCPKISDFGLAKICNRKESIISMTGARGTVGYIAPEVFCRNIGE 464
           ++H D+KP N+ ++ED   KI DFGLA+  + +     MTG   T  Y APEV    +  
Sbjct: 165 VVHRDLKPGNLAVNEDCELKILDFGLARHADAE-----MTGYVVTRWYRAPEVILSWM-H 218
Query: 465 VSYKSDVYNYGMMIFEMTGGR---KNVDVVDNGSTALDL 500
            +   D+++ G ++ EM  G+   K  D +D  +  L +
Sbjct: 219 YNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKV 257

>pdb|4FSY|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 55.5 bits (132), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 58/196 (29%), Positives = 89/196 (45%), Gaps = 38/196 (19%)
Query: 321 LGQGGYGSVYKG-KLLDGSNVAVKVLNDSKG-NGKEFINEVASISRT-SHVNVVALLG-- 375
           LG+G YG V      +    VAVK+++  +  +  E I +   I++  +H NVV   G  
Sbjct: 14  LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEIXINKMLNHENVVKFYGHR 73
Query: 376 -----------FCL--RVAEELSSTIGIAR------------GLEYLHLGCSTRILHFDI 410
                      +C    + + +   IG+              G+ YLH      I H DI
Sbjct: 74  REGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLH---GIGITHRDI 130
Query: 411 KPHNILLDEDFCPKISDFGLAKI--CNRKESIISMTGARGTVGYIAPEVFCRNIGEVSYK 468
           KP N+LLDE    KISDFGLA +   N +E +++     GT+ Y+APE+  R        
Sbjct: 131 KPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMC--GTLPYVAPELLKRREFHAE-P 187
Query: 469 SDVYNYGMMIFEMTGG 484
            DV++ G+++  M  G
Sbjct: 188 VDVWSCGIVLTAMLAG 203

>pdb|3FXX|A Chain A, Human Epha3 Kinase And Juxtamembrane Region Bound To Substrate Kqwdnye[ptyr]iw Length = 371

Iteration: 1
 Score = 55.5 bits (132), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 45/196 (22%), Positives = 90/196 (45%), Gaps = 40/196 (20%)
Query: 321 LGQGGYGSVYKGKLLDGS----NVAVKVLND--SKGNGKEFINEVASISRTSHVNVVALL 374
           +G G +G V  G+L   S    +VA+K L    ++   ++F+ E + + +  H N++ L 
Sbjct: 51  VGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRLE 110
Query: 375 GFCLR----------------------------VAEELSSTIGIARGLEYLHLGCSTRIL 406
           G   +                            V + +    GIA G++YL        +
Sbjct: 111 GVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTVIQLVGMLRGIASGMKYL---SDMGYV 167
Query: 407 HFDIKPHNILLDEDFCPKISDFGLAKIC-NRKESIISMTGARGTVGYIAPEVFCRNIGEV 465
           H D+   NIL++ +   K+SDFGL+++  +  E+  +  G +  + + +PE       + 
Sbjct: 168 HRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTSPEAIAYR--KF 225
Query: 466 SYKSDVYNYGMMIFEM 481
           +  SDV++YG++++E+
Sbjct: 226 TSASDVWSYGIVLWEV 241

>pdb|3QUP|A Chain A, Inhibitor Bound Structure Of The Kinase Domain Of The Murine Receptor Tyrosine Kinase Tyro3 (Sky) Length = 323

Iteration: 1
 Score = 55.5 bits (132), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 60/221 (27%), Positives = 96/221 (43%), Gaps = 52/221 (23%)
Query: 321 LGQGGYGSVYKGKLL--DGS--NVAVKVLND---SKGNGKEFINEVASISRTSHVNVVAL 373
           LG+G +GSV + +L   DGS   VAVK+L     +  + +EF+ E A +    H +V  L
Sbjct: 31  LGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEFDHPHVAKL 90
Query: 374 LGFCLRVAEE----------------------LSSTIG-----------------IARGL 394
           +G  LR   +                      L+S IG                 IA G+
Sbjct: 91  VGVSLRSRAKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIACGM 150
Query: 395 EYLHLGCSTRILHFDIKPHNILLDEDFCPKISDFGLAKICNRKESIISMTGARGTVGYIA 454
           EYL    S   +H D+   N +L ED    ++DFGL++     +       ++  V ++A
Sbjct: 151 EYL---SSRNFIHRDLAARNCMLAEDMTVCVADFGLSRKIYSGDYYRQGCASKLPVKWLA 207
Query: 455 PEVFCRNIGEVSYKSDVYNYGMMIFE-MTGGRKNVDVVDNG 494
            E    N+  V   SDV+ +G+ ++E MT G+     ++N 
Sbjct: 208 LESLADNLYTV--HSDVWAFGVTMWEIMTRGQTPYAGIENA 246

>pdb|3LVP|A Chain A, Crystal Structure Of Bisphosphorylated Igf1-R Kinase Domain (2p) In Complex With A Bis-Azaindole Inhibitor Length = 336

Iteration: 1
 Score = 55.5 bits (132), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 64/243 (26%), Positives = 110/243 (45%), Gaps = 66/243 (27%)
Query: 297 YRSLSPKRYGYADI----------KKMTNSFKYKLGQGGYGSVYKG------KLLDGSNV 340
           Y S++P+ +  AD+          +K+T S   +LGQG +G VY+G      K    + V
Sbjct: 23  YASVNPEYFSAADVYVPDEWEVAREKITMS--RELGQGSFGMVYEGVAKGVVKDEPETRV 80
Query: 341 AVKVLNDSKGNGK--EFINEVASISRTSHVNVVALLGFC--------------------- 377
           A+K +N++    +  EF+NE + +   +  +VV LLG                       
Sbjct: 81  AIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSY 140
Query: 378 ---LRVAEE---------LSSTIG----IARGLEYLHLGCSTRILHFDIKPHNILLDEDF 421
              LR   E         LS  I     IA G+ YL+   + + +H D+   N ++ EDF
Sbjct: 141 LRSLRPEMENNPVLAPPSLSKMIQMAGEIADGMAYLN---ANKFVHRDLAARNCMVAEDF 197
Query: 422 CPKISDFGLAKICNRKESIISMTGARG--TVGYIAPEVFCRNIGEVSYKSDVYNYGMMIF 479
             KI DFG+ +  +  E+     G +G   V +++PE      G  +  SDV+++G++++
Sbjct: 198 TVKIGDFGMTR--DIYETDYYRKGGKGLLPVRWMSPESL--KDGVFTTYSDVWSFGVVLW 253
Query: 480 EMT 482
           E+ 
Sbjct: 254 EIA 256

>pdb|4FG8|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-315 In Complex With Atp Length = 315

Iteration: 1
 Score = 55.5 bits (132), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 65/210 (30%), Positives = 93/210 (44%), Gaps = 52/210 (24%)
Query: 302 PKRYGYADIKKMTNSFKYKLGQGGYGSVYKGKLLDGSN-VAVKVLNDSKGNGKE--FINE 358
           P+     DI+ + + F+  LG G +  V   +       VA+K +      GKE    NE
Sbjct: 8   PRWKQAEDIRDIYD-FRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKEALEGKEGSMENE 66
Query: 359 VASISRTSHVNVVAL-----------LGFCLRVAEELSSTI----------------GIA 391
           +A + +  H N+VAL           L   L    EL   I                 + 
Sbjct: 67  IAVLHKIKHPNIVALDDIYESGGHLYLIMQLVSGGELFDRIVEKGFYTERDASRLIFQVL 126
Query: 392 RGLEYLH-LGCSTRILHFDIKPHNIL---LDEDFCPKISDFGLAKICNRKESIISMTGAR 447
             ++YLH LG    I+H D+KP N+L   LDED    ISDFGL+K+ +   S++S   A 
Sbjct: 127 DAVKYLHDLG----IVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPG-SVLST--AC 179
Query: 448 GTVGYIAPEVF----------CRNIGEVSY 467
           GT GY+APEV           C +IG ++Y
Sbjct: 180 GTPGYVAPEVLAQKPYSKAVDCWSIGVIAY 209

>pdb|2QOI|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f Double Mutant Length = 373

Iteration: 1
 Score = 55.5 bits (132), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 45/196 (22%), Positives = 90/196 (45%), Gaps = 40/196 (20%)
Query: 321 LGQGGYGSVYKGKLLDGS----NVAVKVLND--SKGNGKEFINEVASISRTSHVNVVALL 374
           +G G +G V  G+L   S    +VA+K L    ++   ++F+ E + + +  H N++ L 
Sbjct: 53  VGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRLE 112
Query: 375 GFCLR----------------------------VAEELSSTIGIARGLEYLHLGCSTRIL 406
           G   +                            V + +    GIA G++YL        +
Sbjct: 113 GVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTVIQLVGMLRGIASGMKYL---SDMGYV 169
Query: 407 HFDIKPHNILLDEDFCPKISDFGLAKIC-NRKESIISMTGARGTVGYIAPEVFCRNIGEV 465
           H D+   NIL++ +   K+SDFGL+++  +  E+  +  G +  + + +PE       + 
Sbjct: 170 HRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTSPEAIAYR--KF 227
Query: 466 SYKSDVYNYGMMIFEM 481
           +  SDV++YG++++E+
Sbjct: 228 TSASDVWSYGIVLWEV 243

>pdb|2QOF|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f Mutant Length = 373

Iteration: 1
 Score = 55.5 bits (132), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 45/196 (22%), Positives = 90/196 (45%), Gaps = 40/196 (20%)
Query: 321 LGQGGYGSVYKGKLLDGS----NVAVKVLND--SKGNGKEFINEVASISRTSHVNVVALL 374
           +G G +G V  G+L   S    +VA+K L    ++   ++F+ E + + +  H N++ L 
Sbjct: 53  VGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRLE 112
Query: 375 GFCLR----------------------------VAEELSSTIGIARGLEYLHLGCSTRIL 406
           G   +                            V + +    GIA G++YL        +
Sbjct: 113 GVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTVIQLVGMLRGIASGMKYL---SDMGYV 169
Query: 407 HFDIKPHNILLDEDFCPKISDFGLAKIC-NRKESIISMTGARGTVGYIAPEVFCRNIGEV 465
           H D+   NIL++ +   K+SDFGL+++  +  E+  +  G +  + + +PE       + 
Sbjct: 170 HRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTSPEAIAYR--KF 227
Query: 466 SYKSDVYNYGMMIFEM 481
           +  SDV++YG++++E+
Sbjct: 228 TSASDVWSYGIVLWEV 243

>pdb|2QOD|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y602f Mutant Length = 373

Iteration: 1
 Score = 55.5 bits (132), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 45/196 (22%), Positives = 90/196 (45%), Gaps = 40/196 (20%)
Query: 321 LGQGGYGSVYKGKLLDGS----NVAVKVLND--SKGNGKEFINEVASISRTSHVNVVALL 374
           +G G +G V  G+L   S    +VA+K L    ++   ++F+ E + + +  H N++ L 
Sbjct: 53  VGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRLE 112
Query: 375 GFCLR----------------------------VAEELSSTIGIARGLEYLHLGCSTRIL 406
           G   +                            V + +    GIA G++YL        +
Sbjct: 113 GVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTVIQLVGMLRGIASGMKYL---SDMGYV 169
Query: 407 HFDIKPHNILLDEDFCPKISDFGLAKIC-NRKESIISMTGARGTVGYIAPEVFCRNIGEV 465
           H D+   NIL++ +   K+SDFGL+++  +  E+  +  G +  + + +PE       + 
Sbjct: 170 HRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTSPEAIAYR--KF 227
Query: 466 SYKSDVYNYGMMIFEM 481
           +  SDV++YG++++E+
Sbjct: 228 TSASDVWSYGIVLWEV 243

>pdb|2J0J|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains Length = 656

Iteration: 1
 Score = 55.5 bits (132), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 51/211 (24%), Positives = 92/211 (43%), Gaps = 46/211 (21%)
Query: 321 LGQGGYGSVYKGKLLDGSN----VAVKVLND--SKGNGKEFINEVASISRTSHVNVVALL 374
           +G+G +G V++G  +   N    VA+K   +  S    ++F+ E  ++ +  H ++V L+
Sbjct: 398 IGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLI 457
Query: 375 G---------------------------FCLRVAEELSSTIGIARGLEYLHLGCSTRILH 407
           G                           F L +A  +     ++  L YL    S R +H
Sbjct: 458 GVITENPVWIIMELCTLGELRSFLQVRKFSLDLASLILYAYQLSTALAYLE---SKRFVH 514
Query: 408 FDIKPHNILLDEDFCPKISDFGLAKICNRKESIISMTGARGTVGYIAPEVFCRNIGEVSY 467
            DI   N+L+  + C K+ DFGL++      +    +  +  + ++APE    N    + 
Sbjct: 515 RDIAARNVLVSSNDCVKLGDFGLSRYME-DSTYYKASKGKLPIKWMAPESI--NFRRFTS 571
Query: 468 KSDVYNYGMMIFE--MTG-----GRKNVDVV 491
            SDV+ +G+ ++E  M G     G KN DV+
Sbjct: 572 ASDVWMFGVCMWEILMHGVKPFQGVKNNDVI 602

>pdb|2GSF|A Chain A, The Human Epha3 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 373

Iteration: 1
 Score = 55.5 bits (132), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 45/196 (22%), Positives = 90/196 (45%), Gaps = 40/196 (20%)
Query: 321 LGQGGYGSVYKGKLLDGS----NVAVKVLND--SKGNGKEFINEVASISRTSHVNVVALL 374
           +G G +G V  G+L   S    +VA+K L    ++   ++F+ E + + +  H N++ L 
Sbjct: 53  VGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRLE 112
Query: 375 GFCLR----------------------------VAEELSSTIGIARGLEYLHLGCSTRIL 406
           G   +                            V + +    GIA G++YL        +
Sbjct: 113 GVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTVIQLVGMLRGIASGMKYL---SDMGYV 169
Query: 407 HFDIKPHNILLDEDFCPKISDFGLAKIC-NRKESIISMTGARGTVGYIAPEVFCRNIGEV 465
           H D+   NIL++ +   K+SDFGL+++  +  E+  +  G +  + + +PE       + 
Sbjct: 170 HRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTSPEAIAYR--KF 227
Query: 466 SYKSDVYNYGMMIFEM 481
           +  SDV++YG++++E+
Sbjct: 228 TSASDVWSYGIVLWEV 243

>pdb|2QO7|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Dephosphorylated, Amp-Pnp Bound Length = 373

Iteration: 1
 Score = 55.5 bits (132), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 45/196 (22%), Positives = 90/196 (45%), Gaps = 40/196 (20%)
Query: 321 LGQGGYGSVYKGKLLDGS----NVAVKVLND--SKGNGKEFINEVASISRTSHVNVVALL 374
           +G G +G V  G+L   S    +VA+K L    ++   ++F+ E + + +  H N++ L 
Sbjct: 53  VGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRLE 112
Query: 375 GFCLR----------------------------VAEELSSTIGIARGLEYLHLGCSTRIL 406
           G   +                            V + +    GIA G++YL        +
Sbjct: 113 GVVTKSKPVMIVTEXMENGSLDSFLRKHDAQFTVIQLVGMLRGIASGMKYL---SDMGYV 169
Query: 407 HFDIKPHNILLDEDFCPKISDFGLAKIC-NRKESIISMTGARGTVGYIAPEVFCRNIGEV 465
           H D+   NIL++ +   K+SDFGL+++  +  E+  +  G +  + + +PE       + 
Sbjct: 170 HRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTSPEAIAYR--KF 227
Query: 466 SYKSDVYNYGMMIFEM 481
           +  SDV++YG++++E+
Sbjct: 228 TSASDVWSYGIVLWEV 243

>pdb|2IVT|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Length = 314

Iteration: 1
 Score = 55.5 bits (132), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 53/221 (23%), Positives = 97/221 (43%), Gaps = 64/221 (28%)
Query: 321 LGQGGYGSVYKGKL--LDG----SNVAVKVL--NDSKGNGKEFINEVASISRTSHVNVVA 372
           LG+G +G V K     L G    + VAVK+L  N S    ++ ++E   + + +H +V+ 
Sbjct: 31  LGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQVNHPHVIK 90
Query: 373 LLGFC-------------------------------------------LRVAEELSSTIG 389
           L G C                                           L   +E + T+G
Sbjct: 91  LYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMG 150
Query: 390 --------IARGLEYLHLGCSTRILHFDIKPHNILLDEDFCPKISDFGLAKICNRKESII 441
                   I++G++YL      +++H D+   NIL+ E    KISDFGL++    ++S +
Sbjct: 151 DLISFAWQISQGMQYL---AEMKLVHRDLAARNILVAEGRKMKISDFGLSRDVYEEDSXV 207
Query: 442 SMTGARGTVGYIAPEVFCRNIGEVSYKSDVYNYGMMIFEMT 482
             +  R  V ++A E    +I   + +SDV+++G++++E+ 
Sbjct: 208 KRSQGRIPVKWMAIESLFDHI--YTTQSDVWSFGVLLWEIV 246

>pdb|4DCE|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With A Piperidine-Carboxamide Inhibitor Length = 333

Iteration: 1
 Score = 55.5 bits (132), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 64/247 (25%), Positives = 105/247 (42%), Gaps = 56/247 (22%)
Query: 286 SCLNIETFLRNYR---SLSPKRYGYADIKKMTN---SFKYKLGQGGYGSVYKGKLLDGSN 339
           S L   T + +Y    S + K    +D+K++     +    LG G +G VY+G++    N
Sbjct: 4   SKLRTSTIMTDYNPNYSFAGKTSSISDLKEVPRKNITLIRGLGHGAFGEVYEGQVSGMPN 63
Query: 340 ------VAVKVLND--SKGNGKEFINEVASISRTSHVNVVALLGFCLR-----------V 380
                 VAVK L +  S+ +  +F+ E   IS+ +H N+V  +G  L+            
Sbjct: 64  DPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQSLPRFILLELMA 123
Query: 381 AEELSSTIGIARG----------LEYLHL------GCS----TRILHFDIKPHNILLDED 420
             +L S +   R           L+ LH+      GC        +H DI   N LL   
Sbjct: 124 GGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENHFIHRDIAARNCLLT-- 181
Query: 421 FCP------KISDFGLAKICNRKESIISMTGARGTVGYIAPEVFCRNIGEVSYKSDVYNY 474
            CP      KI DFG+A+   R         A   V ++ PE F   I   + K+D +++
Sbjct: 182 -CPGPGRVAKIGDFGMARDIYRASYYRKGGCAMLPVKWMPPEAFMEGI--FTSKTDTWSF 238
Query: 475 GMMIFEM 481
           G++++E+
Sbjct: 239 GVLLWEI 245

>pdb|3DZQ|A Chain A, Human Epha3 Kinase Domain In Complex With Inhibitor Awl-Ii- 38.3 Length = 361

Iteration: 1
 Score = 55.1 bits (131), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 45/196 (22%), Positives = 90/196 (45%), Gaps = 40/196 (20%)
Query: 321 LGQGGYGSVYKGKLLDGS----NVAVKVLND--SKGNGKEFINEVASISRTSHVNVVALL 374
           +G G +G V  G+L   S    +VA+K L    ++   ++F+ E + + +  H N++ L 
Sbjct: 41  VGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRLE 100
Query: 375 GFCLR----------------------------VAEELSSTIGIARGLEYLHLGCSTRIL 406
           G   +                            V + +    GIA G++YL        +
Sbjct: 101 GVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTVIQLVGMLRGIASGMKYL---SDMGYV 157
Query: 407 HFDIKPHNILLDEDFCPKISDFGLAKIC-NRKESIISMTGARGTVGYIAPEVFCRNIGEV 465
           H D+   NIL++ +   K+SDFGL+++  +  E+  +  G +  + + +PE       + 
Sbjct: 158 HRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTSPEAIAYR--KF 215
Query: 466 SYKSDVYNYGMMIFEM 481
           +  SDV++YG++++E+
Sbjct: 216 TSASDVWSYGIVLWEV 231

>pdb|2R2P|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 5 (Epha5) Length = 295

Iteration: 1
 Score = 55.1 bits (131), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 46/197 (23%), Positives = 90/197 (45%), Gaps = 40/197 (20%)
Query: 321 LGQGGYGSVYKGKL-LDGSN---VAVKVLND--SKGNGKEFINEVASISRTSHVNVVALL 374
           +G G +G V  G+L L G     VA+K L    ++   ++F+ E + + +  H N++ L 
Sbjct: 30  IGAGEFGEVCSGRLKLPGKRELPVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIHLE 89
Query: 375 GFCLR----------------------------VAEELSSTIGIARGLEYLHLGCSTRIL 406
           G   +                            V + +    GI+ G++YL        +
Sbjct: 90  GVVTKSKPVMIVTEYMENGSLDTFLKKNDGQFTVIQLVGMLRGISAGMKYL---SDMGYV 146
Query: 407 HFDIKPHNILLDEDFCPKISDFGLAKIC-NRKESIISMTGARGTVGYIAPEVFCRNIGEV 465
           H D+   NIL++ +   K+SDFGL+++  +  E+  +  G +  + + APE       + 
Sbjct: 147 HRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTAPEAIA--FRKF 204
Query: 466 SYKSDVYNYGMMIFEMT 482
           +  SDV++YG++++E+ 
Sbjct: 205 TSASDVWSYGIVMWEVV 221

>pdb|3D5U|A Chain A, Crystal Structure Of A Wildtype Polo-Like Kinase 1 (Plk1) Catalytic Domain Length = 317

Iteration: 1
 Score = 55.1 bits (131), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 35/99 (35%), Positives = 57/99 (57%), Gaps = 17/99 (17%)
Query: 392 RGLEYLHLGCSTRILHFDIKPHNILLDEDFCPKISDFGLAKICNRKESIISMTGAR---- 447
           +G++YLH   + R++H D+K  N+ L++D   KI DFGLA       + I   G R    
Sbjct: 153 QGVQYLH---NNRVIHRDLKLGNLFLNDDMDVKIGDFGLA-------TKIEFDGERKKTL 202
Query: 448 -GTVGYIAPEVFCRNIGEVSYKSDVYNYGMMIFEMTGGR 485
            GT  YIAPEV C+  G  S++ D+++ G +++ +  G+
Sbjct: 203 CGTPNYIAPEVLCKK-GH-SFEVDIWSLGCILYTLLVGK 239

>pdb|4FG7|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-293 In Complex With Atp Length = 293

Iteration: 1
 Score = 55.1 bits (131), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 65/210 (30%), Positives = 93/210 (44%), Gaps = 52/210 (24%)
Query: 302 PKRYGYADIKKMTNSFKYKLGQGGYGSVYKGKLLDGSN-VAVKVLNDSKGNGKE--FINE 358
           P+     DI+ + + F+  LG G +  V   +       VA+K +      GKE    NE
Sbjct: 8   PRWKQAEDIRDIYD-FRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKEALEGKEGSMENE 66
Query: 359 VASISRTSHVNVVAL-----------LGFCLRVAEELSSTI----------------GIA 391
           +A + +  H N+VAL           L   L    EL   I                 + 
Sbjct: 67  IAVLHKIKHPNIVALDDIYESGGHLYLIMQLVSGGELFDRIVEKGFYTERDASRLIFQVL 126
Query: 392 RGLEYLH-LGCSTRILHFDIKPHNIL---LDEDFCPKISDFGLAKICNRKESIISMTGAR 447
             ++YLH LG    I+H D+KP N+L   LDED    ISDFGL+K+ +   S++S   A 
Sbjct: 127 DAVKYLHDLG----IVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPG-SVLST--AC 179
Query: 448 GTVGYIAPEVF----------CRNIGEVSY 467
           GT GY+APEV           C +IG ++Y
Sbjct: 180 GTPGYVAPEVLAQKPYSKAVDCWSIGVIAY 209

>pdb|1A06|A Chain A, Calmodulin-Dependent Protein Kinase From Rat Length = 332

Iteration: 1
 Score = 55.1 bits (131), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 65/210 (30%), Positives = 93/210 (44%), Gaps = 52/210 (24%)
Query: 302 PKRYGYADIKKMTNSFKYKLGQGGYGSVYKGKLLDGSN-VAVKVLNDSKGNGKE--FINE 358
           P+     DI+ + + F+  LG G +  V   +       VA+K +      GKE    NE
Sbjct: 8   PRWKQAEDIRDIYD-FRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSMENE 66
Query: 359 VASISRTSHVNVVAL-----------LGFCLRVAEELSSTI----------------GIA 391
           +A + +  H N+VAL           L   L    EL   I                 + 
Sbjct: 67  IAVLHKIKHPNIVALDDIYESGGHLYLIMQLVSGGELFDRIVEKGFYTERDASRLIFQVL 126
Query: 392 RGLEYLH-LGCSTRILHFDIKPHNIL---LDEDFCPKISDFGLAKICNRKESIISMTGAR 447
             ++YLH LG    I+H D+KP N+L   LDED    ISDFGL+K+ +   S++S   A 
Sbjct: 127 DAVKYLHDLG----IVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPG-SVLST--AC 179
Query: 448 GTVGYIAPEVF----------CRNIGEVSY 467
           GT GY+APEV           C +IG ++Y
Sbjct: 180 GTPGYVAPEVLAQKPYSKAVDCWSIGVIAY 209

>pdb|3I79|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) Length = 484

Iteration: 1
 Score = 55.1 bits (131), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 57/200 (28%), Positives = 90/200 (45%), Gaps = 46/200 (23%)
Query: 321 LGQGGYGSVY--KGKLLDGSNVAVKVLND----SKGNGKEFINEVASISRTSHVNVVALL 374
           LG+G +G V   K K+  G   AVKV++      K + +  + EV  + +  H N++ L 
Sbjct: 34  LGKGSFGEVILCKDKIT-GQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMKLY 92
Query: 375 ------GFCLRVAEELS--------------STIGIAR-------GLEYLHLGCSTRILH 407
                 G+   V E  +              S +  AR       G+ Y+H     +I+H
Sbjct: 93  EFFEDKGYFYLVGEVYTGGELFDEIISRKRFSEVDAARIIRQVLSGITYMH---KNKIVH 149
Query: 408 FDIKPHNILLD---EDFCPKISDFGLAKICNRKESIISMTGARGTVGYIAPEVFCRNIGE 464
            D+KP N+LL+   +D   +I DFGL+      E+   M    GT  YIAPEV     G 
Sbjct: 150 RDLKPENLLLESKSKDANIRIIDFGLS---THFEASKKMKDKIGTAYYIAPEVLH---GT 203
Query: 465 VSYKSDVYNYGMMIFEMTGG 484
              K DV++ G++++ +  G
Sbjct: 204 YDEKCDVWSTGVILYILLSG 223

>pdb|3D5V|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain. Length = 317

Iteration: 1
 Score = 55.1 bits (131), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 35/99 (35%), Positives = 57/99 (57%), Gaps = 17/99 (17%)
Query: 392 RGLEYLHLGCSTRILHFDIKPHNILLDEDFCPKISDFGLAKICNRKESIISMTGAR---- 447
           +G++YLH   + R++H D+K  N+ L++D   KI DFGLA       + I   G R    
Sbjct: 153 QGVQYLH---NNRVIHRDLKLGNLFLNDDMDVKIGDFGLA-------TKIEFDGERKKDL 202
Query: 448 -GTVGYIAPEVFCRNIGEVSYKSDVYNYGMMIFEMTGGR 485
            GT  YIAPEV C+  G  S++ D+++ G +++ +  G+
Sbjct: 203 CGTPNYIAPEVLCKK-GH-SFEVDIWSLGCILYTLLVGK 239

>pdb|3AOX|A Chain A, X-Ray Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Ch5424802 Length = 344

Iteration: 1
 Score = 55.1 bits (131), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 65/258 (25%), Positives = 108/258 (41%), Gaps = 56/258 (21%)
Query: 275 KRKLSSYNSTASCLNIETFLRNYRS---LSPKRYGYADIKKMTN---SFKYKLGQGGYGS 328
           + +L S     S L   T + +Y      + K    +D+K++     +    LG G +G 
Sbjct: 3   QMELQSPEYKLSKLRTSTIMTDYNPNYCFAGKTSSISDLKEVPRKNITLIRGLGHGAFGE 62
Query: 329 VYKGKLLDGSN------VAVKVLND--SKGNGKEFINEVASISRTSHVNVVALLGFCLR- 379
           VY+G++    N      VAVK L +  S+ +  +F+ E   IS+ +H N+V  +G  L+ 
Sbjct: 63  VYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQS 122
Query: 380 ----------VAEELSSTIGIARG----------LEYLHL------GCS----TRILHFD 409
                        +L S +   R           L+ LH+      GC        +H D
Sbjct: 123 LPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENHFIHRD 182
Query: 410 IKPHNILLDEDFCP------KISDFGLAKICNRKESIISMTGARGTVGYIAPEVFCRNIG 463
           I   N LL    CP      KI DFG+A+   R         A   V ++ PE F   I 
Sbjct: 183 IAARNCLLT---CPGPGRVAKIGDFGMARDIYRASYYRKGGCAMLPVKWMPPEAFMEGI- 238
Query: 464 EVSYKSDVYNYGMMIFEM 481
             + K+D +++G++++E+
Sbjct: 239 -FTSKTDTWSFGVLLWEI 255

>pdb|3D5W|A Chain A, Crystal Structure Of A Phosphorylated Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Adp Length = 317

Iteration: 1
 Score = 55.1 bits (131), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 35/99 (35%), Positives = 57/99 (57%), Gaps = 17/99 (17%)
Query: 392 RGLEYLHLGCSTRILHFDIKPHNILLDEDFCPKISDFGLAKICNRKESIISMTGAR---- 447
           +G++YLH   + R++H D+K  N+ L++D   KI DFGLA       + I   G R    
Sbjct: 153 QGVQYLH---NNRVIHRDLKLGNLFLNDDMDVKIGDFGLA-------TKIEFDGERKKXL 202
Query: 448 -GTVGYIAPEVFCRNIGEVSYKSDVYNYGMMIFEMTGGR 485
            GT  YIAPEV C+  G  S++ D+++ G +++ +  G+
Sbjct: 203 CGTPNYIAPEVLCKK-GH-SFEVDIWSLGCILYTLLVGK 239

>pdb|3VNT|A Chain A, Crystal Structure Of The Kinase Domain Of Human Vegfr2 With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 318

Iteration: 1
 Score = 55.1 bits (131), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 50/214 (23%), Positives = 89/214 (41%), Gaps = 58/214 (27%)
Query: 321 LGQGGYGSVYKG------KLLDGSNVAVKVLND--SKGNGKEFINEVASISRTSH-VNVV 371
           LG+G +G V +       K      VAVK+L +  +    +  ++E+  +    H +NVV
Sbjct: 37  LGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVV 96
Query: 372 ALLGFC--------------------------------------------LRVAEELSST 387
            LLG C                                            L +   +  +
Sbjct: 97  NLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKEAPEDLYKDFLTLEHLICYS 156
Query: 388 IGIARGLEYLHLGCSTRILHFDIKPHNILLDEDFCPKISDFGLAKICNRKESIISMTGAR 447
             +A+G+E+L    S + +H D+   NILL E    KI DFGLA+   +    +    AR
Sbjct: 157 FQVAKGMEFL---ASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDAR 213
Query: 448 GTVGYIAPEVFCRNIGEVSYKSDVYNYGMMIFEM 481
             + ++APE     +   + +SDV+++G++++E+
Sbjct: 214 LPLKWMAPETIFDRV--YTIQSDVWSFGVLLWEI 245

>pdb|2QOB|A Chain A, Human Epha3 Kinase Domain, Base Structure Length = 344

Iteration: 1
 Score = 55.1 bits (131), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 45/196 (22%), Positives = 90/196 (45%), Gaps = 40/196 (20%)
Query: 321 LGQGGYGSVYKGKLLDGS----NVAVKVLND--SKGNGKEFINEVASISRTSHVNVVALL 374
           +G G +G V  G+L   S    +VA+K L    ++   ++F+ E + + +  H N++ L 
Sbjct: 24  VGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRLE 83
Query: 375 GFCLR----------------------------VAEELSSTIGIARGLEYLHLGCSTRIL 406
           G   +                            V + +    GIA G++YL        +
Sbjct: 84  GVVTKSKPVMIVTEXMENGSLDSFLRKHDAQFTVIQLVGMLRGIASGMKYL---SDMGYV 140
Query: 407 HFDIKPHNILLDEDFCPKISDFGLAKIC-NRKESIISMTGARGTVGYIAPEVFCRNIGEV 465
           H D+   NIL++ +   K+SDFGL+++  +  E+  +  G +  + + +PE       + 
Sbjct: 141 HRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTSPEAIAYR--KF 198
Query: 466 SYKSDVYNYGMMIFEM 481
           +  SDV++YG++++E+
Sbjct: 199 TSASDVWSYGIVLWEV 214

>pdb|2IVS|A Chain A, Crystal Structure Of Non-Phosphorylated Ret Tyrosine Kinase Domain Length = 314

Iteration: 1
 Score = 55.1 bits (131), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 53/221 (23%), Positives = 97/221 (43%), Gaps = 64/221 (28%)
Query: 321 LGQGGYGSVYKGKL--LDG----SNVAVKVL--NDSKGNGKEFINEVASISRTSHVNVVA 372
           LG+G +G V K     L G    + VAVK+L  N S    ++ ++E   + + +H +V+ 
Sbjct: 31  LGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQVNHPHVIK 90
Query: 373 LLGFC-------------------------------------------LRVAEELSSTIG 389
           L G C                                           L   +E + T+G
Sbjct: 91  LYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMG 150
Query: 390 --------IARGLEYLHLGCSTRILHFDIKPHNILLDEDFCPKISDFGLAKICNRKESII 441
                   I++G++YL      +++H D+   NIL+ E    KISDFGL++    ++S +
Sbjct: 151 DLISFAWQISQGMQYL---AEMKLVHRDLAARNILVAEGRKMKISDFGLSRDVYEEDSYV 207
Query: 442 SMTGARGTVGYIAPEVFCRNIGEVSYKSDVYNYGMMIFEMT 482
             +  R  V ++A E    +I   + +SDV+++G++++E+ 
Sbjct: 208 KRSQGRIPVKWMAIESLFDHI--YTTQSDVWSFGVLLWEIV 246

>pdb|2QOC|A Chain A, Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp Bound Structure Length = 344

Iteration: 1
 Score = 55.1 bits (131), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 45/196 (22%), Positives = 90/196 (45%), Gaps = 40/196 (20%)
Query: 321 LGQGGYGSVYKGKLLDGS----NVAVKVLND--SKGNGKEFINEVASISRTSHVNVVALL 374
           +G G +G V  G+L   S    +VA+K L    ++   ++F+ E + + +  H N++ L 
Sbjct: 24  VGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRLE 83
Query: 375 GFCLR----------------------------VAEELSSTIGIARGLEYLHLGCSTRIL 406
           G   +                            V + +    GIA G++YL        +
Sbjct: 84  GVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTVIQLVGMLRGIASGMKYL---SDMGYV 140
Query: 407 HFDIKPHNILLDEDFCPKISDFGLAKIC-NRKESIISMTGARGTVGYIAPEVFCRNIGEV 465
           H D+   NIL++ +   K+SDFGL+++  +  E+  +  G +  + + +PE       + 
Sbjct: 141 HRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTSPEAIAYR--KF 198
Query: 466 SYKSDVYNYGMMIFEM 481
           +  SDV++YG++++E+
Sbjct: 199 TSASDVWSYGIVLWEV 214

>pdb|2QOL|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596:y602:s768g Triple Mutant Length = 373

Iteration: 1
 Score = 55.1 bits (131), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 45/196 (22%), Positives = 89/196 (45%), Gaps = 40/196 (20%)
Query: 321 LGQGGYGSVYKGKLLDGS----NVAVKVLND--SKGNGKEFINEVASISRTSHVNVVALL 374
           +G G +G V  G+L   S    +VA+K L    ++   ++F+ E + + +  H N++ L 
Sbjct: 53  VGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRLE 112
Query: 375 GFCLR----------------------------VAEELSSTIGIARGLEYLHLGCSTRIL 406
           G   +                            V + +    GIA G++YL        +
Sbjct: 113 GVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTVIQLVGMLRGIASGMKYL---SDMGYV 169
Query: 407 HFDIKPHNILLDEDFCPKISDFGLAKIC-NRKESIISMTGARGTVGYIAPEVFCRNIGEV 465
           H D+   NIL++ +   K+SDFGL ++  +  E+  +  G +  + + +PE       + 
Sbjct: 170 HRDLAARNILINSNLVCKVSDFGLGRVLEDDPEAAYTTRGGKIPIRWTSPEAIAYR--KF 227
Query: 466 SYKSDVYNYGMMIFEM 481
           +  SDV++YG++++E+
Sbjct: 228 TSASDVWSYGIVLWEV 243

>pdb|4FSN|A Chain A, Crystal Structure Of The Chk1 Length = 278

Iteration: 1
 Score = 55.1 bits (131), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 58/196 (29%), Positives = 89/196 (45%), Gaps = 38/196 (19%)
Query: 321 LGQGGYGSVYKG-KLLDGSNVAVKVLNDSKG-NGKEFINEVASISRT-SHVNVVALLG-- 375
           LG+G YG V      +    VAVK+++  +  +  E I +   I++  +H NVV   G  
Sbjct: 13  LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHR 72
Query: 376 -----------FCL--RVAEELSSTIGIAR------------GLEYLHLGCSTRILHFDI 410
                      +C    + + +   IG+              G+ YLH      I H DI
Sbjct: 73  REGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLH---GIGITHRDI 129
Query: 411 KPHNILLDEDFCPKISDFGLAKI--CNRKESIISMTGARGTVGYIAPEVFCRNIGEVSYK 468
           KP N+LLDE    KISDFGLA +   N +E +++     GT+ Y+APE+  R        
Sbjct: 130 KPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMC--GTLPYVAPELLKRREFHAE-P 186
Query: 469 SDVYNYGMMIFEMTGG 484
            DV++ G+++  M  G
Sbjct: 187 VDVWSCGIVLTAMLAG 202

>pdb|2X8E|A Chain A, Discovery Of A Novel Class Of Triazolones As Checkpoint Kinase Inhibitors - Hit To Lead Exploration Length = 276

Iteration: 1
 Score = 55.1 bits (131), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 58/196 (29%), Positives = 89/196 (45%), Gaps = 38/196 (19%)
Query: 321 LGQGGYGSVYKG-KLLDGSNVAVKVLNDSKG-NGKEFINEVASISRT-SHVNVVALLG-- 375
           LG+G YG V      +    VAVK+++  +  +  E I +   I++  +H NVV   G  
Sbjct: 15  LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHR 74
Query: 376 -----------FCL--RVAEELSSTIGIAR------------GLEYLHLGCSTRILHFDI 410
                      +C    + + +   IG+              G+ YLH      I H DI
Sbjct: 75  REGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLH---GIGITHRDI 131
Query: 411 KPHNILLDEDFCPKISDFGLAKI--CNRKESIISMTGARGTVGYIAPEVFCRNIGEVSYK 468
           KP N+LLDE    KISDFGLA +   N +E +++     GT+ Y+APE+  R        
Sbjct: 132 KPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMC--GTLPYVAPELLKRREFHAE-P 188
Query: 469 SDVYNYGMMIFEMTGG 484
            DV++ G+++  M  G
Sbjct: 189 VDVWSCGIVLTAMLAG 204

>pdb|2GHG|A Chain A, H-Chk1 Complexed With A431994 Length = 269

Iteration: 1
 Score = 55.1 bits (131), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 58/196 (29%), Positives = 89/196 (45%), Gaps = 38/196 (19%)
Query: 321 LGQGGYGSVYKG-KLLDGSNVAVKVLNDSKG-NGKEFINEVASISRT-SHVNVVALLG-- 375
           LG+G YG V      +    VAVK+++  +  +  E I +   I++  +H NVV   G  
Sbjct: 14  LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHR 73
Query: 376 -----------FCL--RVAEELSSTIGIAR------------GLEYLHLGCSTRILHFDI 410
                      +C    + + +   IG+              G+ YLH      I H DI
Sbjct: 74  REGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLH---GIGITHRDI 130
Query: 411 KPHNILLDEDFCPKISDFGLAKI--CNRKESIISMTGARGTVGYIAPEVFCRNIGEVSYK 468
           KP N+LLDE    KISDFGLA +   N +E +++     GT+ Y+APE+  R        
Sbjct: 131 KPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMC--GTLPYVAPELLKRREFHAE-P 187
Query: 469 SDVYNYGMMIFEMTGG 484
            DV++ G+++  M  G
Sbjct: 188 VDVWSCGIVLTAMLAG 203

>pdb|2JKK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276

Iteration: 1
 Score = 55.1 bits (131), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 51/211 (24%), Positives = 91/211 (43%), Gaps = 46/211 (21%)
Query: 321 LGQGGYGSVYKGKLLDGSN----VAVKVLND--SKGNGKEFINEVASISRTSHVNVVALL 374
           +G+G +G V++G  +   N    VA+K   +  S    ++F+ E  ++ +  H ++V L+
Sbjct: 18  IGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLI 77
Query: 375 G---------------------------FCLRVAEELSSTIGIARGLEYLHLGCSTRILH 407
           G                           F L +A  +     ++  L YL    S R +H
Sbjct: 78  GVITENPVWIIMELCTLGELRSFLQVRKFSLDLASLILYAYQLSTALAYLE---SKRFVH 134
Query: 408 FDIKPHNILLDEDFCPKISDFGLAKICNRKESIISMTGARGTVGYIAPEVFCRNIGEVSY 467
            DI   N+L+    C K+ DFGL++      +    +  +  + ++APE    N    + 
Sbjct: 135 RDIAARNVLVSATDCVKLGDFGLSRYME-DSTYYKASKGKLPIKWMAPESI--NFRRFTS 191
Query: 468 KSDVYNYGMMIFE--MTG-----GRKNVDVV 491
            SDV+ +G+ ++E  M G     G KN DV+
Sbjct: 192 ASDVWMFGVCMWEILMHGVKPFQGVKNNDVI 222

>pdb|2AYP|A Chain A, Crystal Structure Of Chk1 With An Indol Inhibitor Length = 269

Iteration: 1
 Score = 55.1 bits (131), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 59/201 (29%), Positives = 90/201 (44%), Gaps = 38/201 (18%)
Query: 321 LGQGGYGSVYKG-KLLDGSNVAVKVLNDSKG-NGKEFINEVASISRT-SHVNVVALLG-- 375
           LG+G YG V      +    VAVK+++  +  +  E I +   I++  +H NVV   G  
Sbjct: 15  LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHR 74
Query: 376 -----------FCL--RVAEELSSTIGIAR------------GLEYLHLGCSTRILHFDI 410
                      +C    + + +   IG+              G+ YLH      I H DI
Sbjct: 75  REGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLH---GIGITHRDI 131
Query: 411 KPHNILLDEDFCPKISDFGLAKI--CNRKESIISMTGARGTVGYIAPEVFCRNIGEVSYK 468
           KP N+LLDE    KISDFGLA +   N +E +++     GT+ Y+APE+  R        
Sbjct: 132 KPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMC--GTLPYVAPELLKRREFHAE-P 188
Query: 469 SDVYNYGMMIFEMTGGRKNVD 489
            DV++ G+++  M  G    D
Sbjct: 189 VDVWSCGIVLTAMLAGELPWD 209

>pdb|4FNW|A Chain A, Crystal Structure Of The Apo F1174l Anaplastic Lymphoma Kinase Catalytic Domain Length = 327

Iteration: 1
 Score = 55.1 bits (131), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 56/206 (27%), Positives = 89/206 (43%), Gaps = 50/206 (24%)
Query: 321 LGQGGYGSVYKGKLLDGSN------VAVKVLND--SKGNGKEFINEVASISRTSHVNVVA 372
           LG G +G VY+G++    N      VAVK L +  S+ +  +F+ E   IS+ +H N+V 
Sbjct: 39  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKLNHQNIVR 98
Query: 373 LLGFCLR-----------VAEELSSTIGIARG----------LEYLHL------GCS--- 402
            +G  L+              +L S +   R           L+ LH+      GC    
Sbjct: 99  CIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLE 158
Query: 403 -TRILHFDIKPHNILLDEDFCP------KISDFGLAKICNRKESIISMTGARGTVGYIAP 455
               +H DI   N LL    CP      KI DFG+A+   R         A   V ++ P
Sbjct: 159 ENHFIHRDIAARNCLLT---CPGPGRVAKIGDFGMARDIYRASYYRKGGCAMLPVKWMPP 215
Query: 456 EVFCRNIGEVSYKSDVYNYGMMIFEM 481
           E F   I   + K+D +++G++++E+
Sbjct: 216 EAFMEGI--FTSKTDTWSFGVLLWEI 239

>pdb|3MA6|A Chain A, Crystal Structure Of Kinase Domain Of Tgcdpk1 In Presence Of 3brb-Pp1 Length = 298

Iteration: 1
 Score = 55.1 bits (131), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 57/200 (28%), Positives = 90/200 (45%), Gaps = 46/200 (23%)
Query: 321 LGQGGYGSVY--KGKLLDGSNVAVKVLND----SKGNGKEFINEVASISRTSHVNVVALL 374
           LG+G +G V   K K+  G   AVKV++      K + +  + EV  + +  H N++ L 
Sbjct: 40  LGKGSFGEVILCKDKI-TGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMKLY 98
Query: 375 ------GFCLRVAEELS--------------STIGIAR-------GLEYLHLGCSTRILH 407
                 G+   V E  +              S +  AR       G+ Y+H     +I+H
Sbjct: 99  EFFEDKGYFYLVGEVYTGGELFDEIISRKRFSEVDAARIIRQVLSGITYMH---KNKIVH 155
Query: 408 FDIKPHNILLD---EDFCPKISDFGLAKICNRKESIISMTGARGTVGYIAPEVFCRNIGE 464
            D+KP N+LL+   +D   +I DFGL+      E+   M    GT  YIAPEV     G 
Sbjct: 156 RDLKPENLLLESKSKDANIRIIDFGLS---THFEASKKMKDKIGTAYYIAPEVLH---GT 209
Query: 465 VSYKSDVYNYGMMIFEMTGG 484
              K DV++ G++++ +  G
Sbjct: 210 YDEKCDVWSTGVILYILLSG 229

>pdb|2E9V|A Chain A, Structure Of H-Chk1 Complexed With A859017 Length = 268

Iteration: 1
 Score = 55.1 bits (131), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 59/201 (29%), Positives = 90/201 (44%), Gaps = 38/201 (18%)
Query: 321 LGQGGYGSVYKG-KLLDGSNVAVKVLNDSKG-NGKEFINEVASISRT-SHVNVVALLG-- 375
           LG+G YG V      +    VAVK+++  +  +  E I +   I++  +H NVV   G  
Sbjct: 14  LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHR 73
Query: 376 -----------FCL--RVAEELSSTIGIAR------------GLEYLHLGCSTRILHFDI 410
                      +C    + + +   IG+              G+ YLH      I H DI
Sbjct: 74  REGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLH---GIGITHRDI 130
Query: 411 KPHNILLDEDFCPKISDFGLAKI--CNRKESIISMTGARGTVGYIAPEVFCRNIGEVSYK 468
           KP N+LLDE    KISDFGLA +   N +E +++     GT+ Y+APE+  R        
Sbjct: 131 KPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMC--GTLPYVAPELLKRREFHAE-P 187
Query: 469 SDVYNYGMMIFEMTGGRKNVD 489
            DV++ G+++  M  G    D
Sbjct: 188 VDVWSCGIVLTAMLAGELPWD 208

>pdb|3DB6|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Compound 902 Length = 301

Iteration: 1
 Score = 55.1 bits (131), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 35/99 (35%), Positives = 57/99 (57%), Gaps = 17/99 (17%)
Query: 392 RGLEYLHLGCSTRILHFDIKPHNILLDEDFCPKISDFGLAKICNRKESIISMTGAR---- 447
           +G++YLH   + R++H D+K  N+ L++D   KI DFGLA       + I   G R    
Sbjct: 137 QGVQYLH---NNRVIHRDLKLGNLFLNDDMDVKIGDFGLA-------TKIEFDGERKKDL 186
Query: 448 -GTVGYIAPEVFCRNIGEVSYKSDVYNYGMMIFEMTGGR 485
            GT  YIAPEV C+  G  S++ D+++ G +++ +  G+
Sbjct: 187 CGTPNYIAPEVLCKK-GH-SFEVDIWSLGCILYTLLVGK 223

>pdb|4FSM|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 54.7 bits (130), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 58/196 (29%), Positives = 89/196 (45%), Gaps = 38/196 (19%)
Query: 321 LGQGGYGSVYKG-KLLDGSNVAVKVLNDSKG-NGKEFINEVASISRT-SHVNVVALLG-- 375
           LG+G YG V      +    VAVK+++  +  +  E I +   I++  +H NVV   G  
Sbjct: 14  LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHR 73
Query: 376 -----------FCL--RVAEELSSTIGIAR------------GLEYLHLGCSTRILHFDI 410
                      +C    + + +   IG+              G+ YLH      I H DI
Sbjct: 74  REGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLH---GIGITHRDI 130
Query: 411 KPHNILLDEDFCPKISDFGLAKI--CNRKESIISMTGARGTVGYIAPEVFCRNIGEVSYK 468
           KP N+LLDE    KISDFGLA +   N +E +++     GT+ Y+APE+  R        
Sbjct: 131 KPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMC--GTLPYVAPELLKRREFHAE-P 187
Query: 469 SDVYNYGMMIFEMTGG 484
            DV++ G+++  M  G
Sbjct: 188 VDVWSCGIVLTAMLAG 203

>pdb|3ALN|A Chain A, Crystal Structure Of Human Non-Phosphorylated Mkk4 Kinase Domain Complexed With Amp-Pnp Length = 327

Iteration: 1
 Score = 54.7 bits (130), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 37/108 (34%), Positives = 55/108 (50%), Gaps = 5/108 (4%)
Query: 380 VAEELSSTIGIARGLEYLHLGCSTRILHFDIKPHNILLDEDFCPKISDFGLAKICNRKES 439
           + EE+   I +A      HL  + +I+H DIKP NILLD     K+ DFG   I  +   
Sbjct: 122 IPEEILGKITLATVKALNHLKENLKIIHRDIKPSNILLDRSGNIKLCDFG---ISGQLVD 178
Query: 440 IISMTGARGTVGYIAPEVFCRNIGEVSY--KSDVYNYGMMIFEMTGGR 485
            I+ T   G   Y+APE    +     Y  +SDV++ G+ ++E+  GR
Sbjct: 179 SIAKTRDAGCRPYMAPERIDPSASRQGYDVRSDVWSLGITLYELATGR 226

>pdb|2PK9|A Chain A, Structure Of The Pho85-pho80 Cdk-cyclin Complex Of The Phosphate-responsive Signal Transduction Pathway Length = 317

Iteration: 1
 Score = 54.7 bits (130), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 57/200 (28%), Positives = 89/200 (44%), Gaps = 39/200 (19%)
Query: 320 KLGQGGYGSVYKG-KLLDGSNVAVK--VLNDSKGNGKEFINEVASISRTSHVNVVALLGF 376
           KLG G Y +VYKG     G  VA+K   L+  +G     I E++ +    H N+V L   
Sbjct: 12  KLGNGTYATVYKGLNKTTGVYVALKEVKLDSEEGTPSTAIREISLMKELKHENIVRLYDV 71
Query: 377 C-----LRVAEEL----------SSTIG-IARGLEY-------------LHLGCSTRILH 407
                 L +  E           S T+G   RGLE              L      +ILH
Sbjct: 72  IHTENKLTLVFEFMDNDLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGLAFCHENKILH 131
Query: 408 FDIKPHNILLDEDFCPKISDFGLAKICNRKESIISMTGARGTVGYIAPEVFCRNIGEVSY 467
            D+KP N+L+++    K+ DFGLA+       + + +    T+ Y AP+V    +G  +Y
Sbjct: 132 RDLKPQNLLINKRGQLKLGDFGLARAFGI--PVNTFSSEVVTLWYRAPDVL---MGSRTY 186
Query: 468 KS--DVYNYGMMIFEMTGGR 485
            +  D+++ G ++ EM  G+
Sbjct: 187 STSIDIWSCGCILAEMITGK 206

>pdb|2YJR|A Chain A, Structure Of F1174l Mutant Anaplastic Lymphoma Kinase Length = 342

Iteration: 1
 Score = 54.7 bits (130), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 56/206 (27%), Positives = 89/206 (43%), Gaps = 50/206 (24%)
Query: 321 LGQGGYGSVYKGKLLDGSN------VAVKVLND--SKGNGKEFINEVASISRTSHVNVVA 372
           LG G +G VY+G++    N      VAVK L +  S+ +  +F+ E   IS+ +H N+V 
Sbjct: 53  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKLNHQNIVR 112
Query: 373 LLGFCLR-----------VAEELSSTIGIARG----------LEYLHL------GCS--- 402
            +G  L+              +L S +   R           L+ LH+      GC    
Sbjct: 113 CIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLE 172
Query: 403 -TRILHFDIKPHNILLDEDFCP------KISDFGLAKICNRKESIISMTGARGTVGYIAP 455
               +H DI   N LL    CP      KI DFG+A+   R         A   V ++ P
Sbjct: 173 ENHFIHRDIAARNCLLT---CPGPGRVAKIGDFGMARDIYRASYYRKGGCAMLPVKWMPP 229
Query: 456 EVFCRNIGEVSYKSDVYNYGMMIFEM 481
           E F   I   + K+D +++G++++E+
Sbjct: 230 EAFMEGI--FTSKTDTWSFGVLLWEI 253

>pdb|2CLQ|A Chain A, Structure Of Mitogen-Activated Protein Kinase Kinase Kinase 5 Length = 295

Iteration: 1
 Score = 54.7 bits (130), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 58/199 (29%), Positives = 87/199 (43%), Gaps = 40/199 (20%)
Query: 321 LGQGGYGSVYKGKLLDGS-NVAVKVLNDSKGNGKEFINE-VASISRTSHVNVVALLG--- 375
           LG+G YG VY G+ L     +A+K + +      + ++E +A      H N+V  LG   
Sbjct: 30  LGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPLHEEIALHKHLKHKNIVQYLGSFS 89
Query: 376 ---FCLRVAEEL-------------------SSTIG-----IARGLEYLHLGCSTRILHF 408
              F     E++                     TIG     I  GL+YLH     +I+H 
Sbjct: 90  ENGFIKIFMEQVPGGSLSALLRSKWGPLKDNEQTIGFYTKQILEGLKYLH---DNQIVHR 146
Query: 409 DIKPHNILLDE-DFCPKISDFGLAKICNRKESIISMTGA-RGTVGYIAPEVFCRNIGEVS 466
           DIK  N+L++      KISDFG +K   R   I   T    GT+ Y+APE+  +      
Sbjct: 147 DIKGDNVLINTYSGVLKISDFGTSK---RLAGINPCTETFTGTLQYMAPEIIDKGPRGYG 203
Query: 467 YKSDVYNYGMMIFEMTGGR 485
             +D+++ G  I EM  G+
Sbjct: 204 KAADIWSLGCTIIEMATGK 222

>pdb|3JVR|A Chain A, Characterization Of The Chk1 Allosteric Inhibitor Binding Site Length = 271

Iteration: 1
 Score = 54.7 bits (130), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 58/196 (29%), Positives = 89/196 (45%), Gaps = 38/196 (19%)
Query: 321 LGQGGYGSVYKG-KLLDGSNVAVKVLNDSKG-NGKEFINEVASISRT-SHVNVVALLG-- 375
           LG+G YG V      +    VAVK+++  +  +  E I +   I++  +H NVV   G  
Sbjct: 14  LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHR 73
Query: 376 -----------FCL--RVAEELSSTIGIAR------------GLEYLHLGCSTRILHFDI 410
                      +C    + + +   IG+              G+ YLH      I H DI
Sbjct: 74  REGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLH---GIGITHRDI 130
Query: 411 KPHNILLDEDFCPKISDFGLAKI--CNRKESIISMTGARGTVGYIAPEVFCRNIGEVSYK 468
           KP N+LLDE    KISDFGLA +   N +E +++     GT+ Y+APE+  R        
Sbjct: 131 KPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMC--GTLPYVAPELLKRREFHAE-P 187
Query: 469 SDVYNYGMMIFEMTGG 484
            DV++ G+++  M  G
Sbjct: 188 VDVWSCGIVLTAMLAG 203

>pdb|3OT3|A Chain A, X-Ray Crystal Structure Of Compound 22k Bound To Human Chk1 Kinase Domain Length = 273

Iteration: 1
 Score = 54.7 bits (130), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 58/196 (29%), Positives = 89/196 (45%), Gaps = 38/196 (19%)
Query: 321 LGQGGYGSVYKG-KLLDGSNVAVKVLNDSKG-NGKEFINEVASISRT-SHVNVVALLG-- 375
           LG+G YG V      +    VAVK+++  +  +  E I +   I++  +H NVV   G  
Sbjct: 14  LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHR 73
Query: 376 -----------FCL--RVAEELSSTIGIAR------------GLEYLHLGCSTRILHFDI 410
                      +C    + + +   IG+              G+ YLH      I H DI
Sbjct: 74  REGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLH---GIGITHRDI 130
Query: 411 KPHNILLDEDFCPKISDFGLAKI--CNRKESIISMTGARGTVGYIAPEVFCRNIGEVSYK 468
           KP N+LLDE    KISDFGLA +   N +E +++     GT+ Y+APE+  R        
Sbjct: 131 KPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMC--GTLPYVAPELLKRREFHAE-P 187
Query: 469 SDVYNYGMMIFEMTGG 484
            DV++ G+++  M  G
Sbjct: 188 VDVWSCGIVLTAMLAG 203

>pdb|1YVJ|A Chain A, Crystal Structure Of The Jak3 Kinase Domain In Complex With A Staurosporine Analogue Length = 290

Iteration: 1
 Score = 54.7 bits (130), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 32/93 (34%), Positives = 55/93 (59%), Gaps = 6/93 (6%)
Query: 390 IARGLEYLHLGCSTRILHFDIKPHNILLDEDFCPKISDFGLAKICN-RKESIISMTGARG 448
           I +G+EYL    S R +H D+   NIL++ +   KI+DFGLAK+    K+  +     + 
Sbjct: 120 ICKGMEYLG---SRRCVHRDLAARNILVESEAHVKIADFGLAKLLPLDKDXXVVREPGQS 176
Query: 449 TVGYIAPEVFCRNIGEVSYKSDVYNYGMMIFEM 481
            + + APE    NI   S +SDV+++G++++E+
Sbjct: 177 PIFWYAPESLSDNI--FSRQSDVWSFGVVLYEL 207

>pdb|4BBE|A Chain A, Aminoalkylpyrimidine Inhibitor Complexes With Jak2 Length = 298

Iteration: 1
 Score = 54.7 bits (130), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 55/203 (27%), Positives = 91/203 (44%), Gaps = 42/203 (20%)
Query: 316 SFKYKLGQGGYGSVYKGK---LLD--GSNVAVKVLNDS-KGNGKEFINEVASISRTSHVN 369
            F  +LG+G +GSV   +   L D  G  VAVK L  S + + ++F  E+  +    H N
Sbjct: 14  KFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDN 73
Query: 370 VVALLGFC-------LRVAEE-----------------------LSSTIGIARGLEYLHL 399
           +V   G C       L++  E                       L  T  I +G+EYL  
Sbjct: 74  IVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYL-- 131
Query: 400 GCSTRILHFDIKPHNILLDEDFCPKISDFGLAKICNR-KESIISMTGARGTVGYIAPEVF 458
             + R +H ++   NIL++ +   KI DFGL K+  + KE           + + APE  
Sbjct: 132 -GTKRYIHRNLATRNILVENENRVKIGDFGLTKVLPQDKEYYKVKEPGESPIFWYAPESL 190
Query: 459 CRNIGEVSYKSDVYNYGMMIFEM 481
             +  + S  SDV+++G++++E+
Sbjct: 191 TES--KFSVASDVWSFGVVLYEL 211

>pdb|1Y6A|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 2-Anilino-5-Aryl-Oxazole Inhibitor Length = 366

Iteration: 1
 Score = 54.7 bits (130), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 29/92 (31%), Positives = 53/92 (57%), Gaps = 5/92 (5%)
Query: 390 IARGLEYLHLGCSTRILHFDIKPHNILLDEDFCPKISDFGLAKICNRKESIISMTGARGT 449
           +A+G+E+L    S + +H D+   NILL E    KI DFGLA+   +    +    AR  
Sbjct: 207 VAKGMEFL---ASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLP 263
Query: 450 VGYIAPEVFCRNIGEVSYKSDVYNYGMMIFEM 481
           + ++APE     +   + +SDV+++G++++E+
Sbjct: 264 LKWMAPETIFDRV--YTIQSDVWSFGVLLWEI 293

>pdb|3VHK|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Back Pocket Binder Length = 368

Iteration: 1
 Score = 54.7 bits (130), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 29/92 (31%), Positives = 53/92 (57%), Gaps = 5/92 (5%)
Query: 390 IARGLEYLHLGCSTRILHFDIKPHNILLDEDFCPKISDFGLAKICNRKESIISMTGARGT 449
           +A+G+E+L    S + +H D+   NILL E    KI DFGLA+   +    +    AR  
Sbjct: 209 VAKGMEFL---ASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLP 265
Query: 450 VGYIAPEVFCRNIGEVSYKSDVYNYGMMIFEM 481
           + ++APE     +   + +SDV+++G++++E+
Sbjct: 266 LKWMAPETIFDRV--YTIQSDVWSFGVLLWEI 295

>pdb|2BR1|A Chain A, Structure-Based Design Of Novel Chk1 Inhibitors: Insights Into Hydrogen Bonding And Protein-Ligand Affinity Length = 297

Iteration: 1
 Score = 54.7 bits (130), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 58/196 (29%), Positives = 89/196 (45%), Gaps = 38/196 (19%)
Query: 321 LGQGGYGSVYKG-KLLDGSNVAVKVLNDSKG-NGKEFINEVASISRT-SHVNVVALLG-- 375
           LG+G YG V      +    VAVK+++  +  +  E I +   I++  +H NVV   G  
Sbjct: 15  LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHR 74
Query: 376 -----------FCL--RVAEELSSTIGIAR------------GLEYLHLGCSTRILHFDI 410
                      +C    + + +   IG+              G+ YLH      I H DI
Sbjct: 75  REGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLH---GIGITHRDI 131
Query: 411 KPHNILLDEDFCPKISDFGLAKI--CNRKESIISMTGARGTVGYIAPEVFCRNIGEVSYK 468
           KP N+LLDE    KISDFGLA +   N +E +++     GT+ Y+APE+  R        
Sbjct: 132 KPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMC--GTLPYVAPELLKRREFHAE-P 188
Query: 469 SDVYNYGMMIFEMTGG 484
            DV++ G+++  M  G
Sbjct: 189 VDVWSCGIVLTAMLAG 204

>pdb|1IA8|A Chain A, The 1.7 A Crystal Structure Of Human Cell Cycle Checkpoint Kinase Chk1 Length = 289

Iteration: 1
 Score = 54.7 bits (130), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 58/196 (29%), Positives = 89/196 (45%), Gaps = 38/196 (19%)
Query: 321 LGQGGYGSVYKG-KLLDGSNVAVKVLNDSKG-NGKEFINEVASISRT-SHVNVVALLG-- 375
           LG+G YG V      +    VAVK+++  +  +  E I +   I++  +H NVV   G  
Sbjct: 15  LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHR 74
Query: 376 -----------FCL--RVAEELSSTIGIAR------------GLEYLHLGCSTRILHFDI 410
                      +C    + + +   IG+              G+ YLH      I H DI
Sbjct: 75  REGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLH---GIGITHRDI 131
Query: 411 KPHNILLDEDFCPKISDFGLAKI--CNRKESIISMTGARGTVGYIAPEVFCRNIGEVSYK 468
           KP N+LLDE    KISDFGLA +   N +E +++     GT+ Y+APE+  R        
Sbjct: 132 KPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMC--GTLPYVAPELLKRREFHAE-P 188
Query: 469 SDVYNYGMMIFEMTGG 484
            DV++ G+++  M  G
Sbjct: 189 VDVWSCGIVLTAMLAG 204

>pdb|4FNZ|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Piperidine-Carboxamide Inhibitor 2 Length = 327

Iteration: 1
 Score = 54.7 bits (130), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 56/206 (27%), Positives = 89/206 (43%), Gaps = 50/206 (24%)
Query: 321 LGQGGYGSVYKGKLLDGSN------VAVKVLND--SKGNGKEFINEVASISRTSHVNVVA 372
           LG G +G VY+G++    N      VAVK L +  S+ +  +F+ E   IS+ +H N+V 
Sbjct: 39  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVR 98
Query: 373 LLGFCLR-----------VAEELSSTIGIARG----------LEYLHL------GCS--- 402
            +G  L+              +L S +   R           L+ LH+      GC    
Sbjct: 99  CIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLE 158
Query: 403 -TRILHFDIKPHNILLDEDFCP------KISDFGLAKICNRKESIISMTGARGTVGYIAP 455
               +H DI   N LL    CP      KI DFG+A+   R         A   V ++ P
Sbjct: 159 ENHFIHRDIAARNCLLT---CPGPGRVAKIGDFGMARDIYRASYYRKGGCAMLPVKWMPP 215
Query: 456 EVFCRNIGEVSYKSDVYNYGMMIFEM 481
           E F   I   + K+D +++G++++E+
Sbjct: 216 EAFMEGI--FTSKTDTWSFGVLLWEI 239

>pdb|1ZLT|A Chain A, Crystal Structure Of Chk1 Complexed With A Hymenaldisine Analog Length = 295

Iteration: 1
 Score = 54.7 bits (130), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 58/196 (29%), Positives = 89/196 (45%), Gaps = 38/196 (19%)
Query: 321 LGQGGYGSVYKG-KLLDGSNVAVKVLNDSKG-NGKEFINEVASISRT-SHVNVVALLG-- 375
           LG+G YG V      +    VAVK+++  +  +  E I +   I++  +H NVV   G  
Sbjct: 15  LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHR 74
Query: 376 -----------FCL--RVAEELSSTIGIAR------------GLEYLHLGCSTRILHFDI 410
                      +C    + + +   IG+              G+ YLH      I H DI
Sbjct: 75  REGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLH---GIGITHRDI 131
Query: 411 KPHNILLDEDFCPKISDFGLAKI--CNRKESIISMTGARGTVGYIAPEVFCRNIGEVSYK 468
           KP N+LLDE    KISDFGLA +   N +E +++     GT+ Y+APE+  R        
Sbjct: 132 KPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMC--GTLPYVAPELLKRREFHAE-P 188
Query: 469 SDVYNYGMMIFEMTGG 484
            DV++ G+++  M  G
Sbjct: 189 VDVWSCGIVLTAMLAG 204

>pdb|2HOG|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 20 Length = 322

Iteration: 1
 Score = 54.7 bits (130), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 59/201 (29%), Positives = 90/201 (44%), Gaps = 38/201 (18%)
Query: 321 LGQGGYGSVYKG-KLLDGSNVAVKVLNDSKG-NGKEFINEVASISRT-SHVNVVALLG-- 375
           LG+G YG V      +    VAVK+++  +  +  E I +   I++  +H NVV   G  
Sbjct: 14  LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHR 73
Query: 376 -----------FCL--RVAEELSSTIGIAR------------GLEYLHLGCSTRILHFDI 410
                      +C    + + +   IG+              G+ YLH      I H DI
Sbjct: 74  REGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLH---GIGITHRDI 130
Query: 411 KPHNILLDEDFCPKISDFGLAKI--CNRKESIISMTGARGTVGYIAPEVFCRNIGEVSYK 468
           KP N+LLDE    KISDFGLA +   N +E +++     GT+ Y+APE+  R        
Sbjct: 131 KPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMC--GTLPYVAPELLKRREFHAE-P 187
Query: 469 SDVYNYGMMIFEMTGGRKNVD 489
            DV++ G+++  M  G    D
Sbjct: 188 VDVWSCGIVLTAMLAGELPWD 208

>pdb|3VHE|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With A Novel Pyrrolopyrimidine Inhibitor Length = 359

Iteration: 1
 Score = 54.3 bits (129), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 29/92 (31%), Positives = 53/92 (57%), Gaps = 5/92 (5%)
Query: 390 IARGLEYLHLGCSTRILHFDIKPHNILLDEDFCPKISDFGLAKICNRKESIISMTGARGT 449
           +A+G+E+L    S + +H D+   NILL E    KI DFGLA+   +    +    AR  
Sbjct: 202 VAKGMEFL---ASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLP 258
Query: 450 VGYIAPEVFCRNIGEVSYKSDVYNYGMMIFEM 481
           + ++APE     +   + +SDV+++G++++E+
Sbjct: 259 LKWMAPETIFDRV--YTIQSDVWSFGVLLWEI 288

>pdb|2R0U|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 54 Length = 323

Iteration: 1
 Score = 54.3 bits (129), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 59/201 (29%), Positives = 90/201 (44%), Gaps = 38/201 (18%)
Query: 321 LGQGGYGSVYKG-KLLDGSNVAVKVLNDSKG-NGKEFINEVASISRT-SHVNVVALLG-- 375
           LG+G YG V      +    VAVK+++  +  +  E I +   I++  +H NVV   G  
Sbjct: 15  LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHR 74
Query: 376 -----------FCL--RVAEELSSTIGIAR------------GLEYLHLGCSTRILHFDI 410
                      +C    + + +   IG+              G+ YLH      I H DI
Sbjct: 75  REGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLH---GIGITHRDI 131
Query: 411 KPHNILLDEDFCPKISDFGLAKI--CNRKESIISMTGARGTVGYIAPEVFCRNIGEVSYK 468
           KP N+LLDE    KISDFGLA +   N +E +++     GT+ Y+APE+  R        
Sbjct: 132 KPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMC--GTLPYVAPELLKRREFHAE-P 188
Query: 469 SDVYNYGMMIFEMTGGRKNVD 489
            DV++ G+++  M  G    D
Sbjct: 189 VDVWSCGIVLTAMLAGELPWD 209

>pdb|2XP2|A Chain A, Structure Of The Human Anaplastic Lymphoma Kinase In Complex With Crizotinib (Pf-02341066) Length = 327

Iteration: 1
 Score = 54.3 bits (129), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 56/206 (27%), Positives = 89/206 (43%), Gaps = 50/206 (24%)
Query: 321 LGQGGYGSVYKGKLLDGSN------VAVKVLND--SKGNGKEFINEVASISRTSHVNVVA 372
           LG G +G VY+G++    N      VAVK L +  S+ +  +F+ E   IS+ +H N+V 
Sbjct: 38  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVR 97
Query: 373 LLGFCLR-----------VAEELSSTIGIARG----------LEYLHL------GCS--- 402
            +G  L+              +L S +   R           L+ LH+      GC    
Sbjct: 98  CIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLE 157
Query: 403 -TRILHFDIKPHNILLDEDFCP------KISDFGLAKICNRKESIISMTGARGTVGYIAP 455
               +H DI   N LL    CP      KI DFG+A+   R         A   V ++ P
Sbjct: 158 ENHFIHRDIAARNCLLT---CPGPGRVAKIGDFGMARDIYRASYYRKGGCAMLPVKWMPP 214
Query: 456 EVFCRNIGEVSYKSDVYNYGMMIFEM 481
           E F   I   + K+D +++G++++E+
Sbjct: 215 EAFMEGI--FTSKTDTWSFGVLLWEI 238

>pdb|1ZYS|A Chain A, Co-Crystal Structure Of Checkpoint Kinase Chk1 With A Pyrrolo-Pyridine Inhibitor Length = 273

Iteration: 1
 Score = 54.3 bits (129), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 57/201 (28%), Positives = 87/201 (43%), Gaps = 38/201 (18%)
Query: 321 LGQGGYGSVYKG-KLLDGSNVAVKVLNDSKGNG--KEFINEVASISRTSHVNVVALLG-- 375
           LG+G YG V      +    VAVK+++  +     +    E+   +  +H NVV   G  
Sbjct: 15  LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINAMLNHENVVKFYGHR 74
Query: 376 -----------FCL--RVAEELSSTIGIAR------------GLEYLHLGCSTRILHFDI 410
                      +C    + + +   IG+              G+ YLH      I H DI
Sbjct: 75  REGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLH---GIGITHRDI 131
Query: 411 KPHNILLDEDFCPKISDFGLAKI--CNRKESIISMTGARGTVGYIAPEVFCRNIGEVSYK 468
           KP N+LLDE    KISDFGLA +   N +E +++     GT+ Y+APE+  R        
Sbjct: 132 KPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMC--GTLPYVAPELLKRREFHAE-P 188
Query: 469 SDVYNYGMMIFEMTGGRKNVD 489
            DV++ G+++  M  G    D
Sbjct: 189 VDVWSCGIVLTAMLAGELPWD 209

>pdb|3KU2|A Chain A, Crystal Structure Of Inactivated Form Of Cdpk1 From Toxoplasma Gondii, Tgme49.101440 Length = 507

Iteration: 1
 Score = 54.3 bits (129), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 57/200 (28%), Positives = 90/200 (45%), Gaps = 46/200 (23%)
Query: 321 LGQGGYGSVY--KGKLLDGSNVAVKVLND----SKGNGKEFINEVASISRTSHVNVVALL 374
           LG+G +G V   K K+  G   AVKV++      K + +  + EV  + +  H N++ L 
Sbjct: 57  LGKGSFGEVILCKDKIT-GQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMKLY 115
Query: 375 ------GFCLRVAEELS--------------STIGIAR-------GLEYLHLGCSTRILH 407
                 G+   V E  +              S +  AR       G+ Y+H     +I+H
Sbjct: 116 EFFEDKGYFYLVGEVYTGGELFDEIISRKRFSEVDAARIIRQVLSGITYMH---KNKIVH 172
Query: 408 FDIKPHNILLD---EDFCPKISDFGLAKICNRKESIISMTGARGTVGYIAPEVFCRNIGE 464
            D+KP N+LL+   +D   +I DFGL+      E+   M    GT  YIAPEV     G 
Sbjct: 173 RDLKPENLLLESKSKDANIRIIDFGLS---THFEASKKMKDKIGTAYYIAPEVLH---GT 226
Query: 465 VSYKSDVYNYGMMIFEMTGG 484
              K DV++ G++++ +  G
Sbjct: 227 YDEKCDVWSTGVILYILLSG 246

>pdb|3VID|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With Compound A Length = 356

Iteration: 1
 Score = 54.3 bits (129), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 29/92 (31%), Positives = 53/92 (57%), Gaps = 5/92 (5%)
Query: 390 IARGLEYLHLGCSTRILHFDIKPHNILLDEDFCPKISDFGLAKICNRKESIISMTGARGT 449
           +A+G+E+L    S + +H D+   NILL E    KI DFGLA+   +    +    AR  
Sbjct: 200 VAKGMEFL---ASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLP 256
Query: 450 VGYIAPEVFCRNIGEVSYKSDVYNYGMMIFEM 481
           + ++APE     +   + +SDV+++G++++E+
Sbjct: 257 LKWMAPETIFDRV--YTIQSDVWSFGVLLWEI 286

>pdb|2YFX|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase In Complex With Crizotinib Length = 327

Iteration: 1
 Score = 54.3 bits (129), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 56/206 (27%), Positives = 89/206 (43%), Gaps = 50/206 (24%)
Query: 321 LGQGGYGSVYKGKLLDGSN------VAVKVLND--SKGNGKEFINEVASISRTSHVNVVA 372
           LG G +G VY+G++    N      VAVK L +  S+ +  +F+ E   IS+ +H N+V 
Sbjct: 38  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVR 97
Query: 373 LLGFCLR-----------VAEELSSTIGIARG----------LEYLHL------GCS--- 402
            +G  L+              +L S +   R           L+ LH+      GC    
Sbjct: 98  CIGVSLQSLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLE 157
Query: 403 -TRILHFDIKPHNILLDEDFCP------KISDFGLAKICNRKESIISMTGARGTVGYIAP 455
               +H DI   N LL    CP      KI DFG+A+   R         A   V ++ P
Sbjct: 158 ENHFIHRDIAARNCLLT---CPGPGRVAKIGDFGMARDIYRASYYRKGGCAMLPVKWMPP 214
Query: 456 EVFCRNIGEVSYKSDVYNYGMMIFEM 481
           E F   I   + K+D +++G++++E+
Sbjct: 215 EAFMEGI--FTSKTDTWSFGVLLWEI 238

>pdb|4HZS|A Chain A, Crystal Structure Of Ack1 Kinase Domain With C-terminal Sh3 Domain Length = 341

Iteration: 1
 Score = 54.3 bits (129), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 57/215 (26%), Positives = 87/215 (40%), Gaps = 41/215 (19%)
Query: 320 KLGQGGYGSVYKGKLLDGS----NVAVKVLNDSKGNGKE----FINEVASISRTSHVNVV 371
           KLG G +G V +G+    S    +VAVK L     +  E    FI EV ++    H N++
Sbjct: 19  KLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLI 78
Query: 372 ALLGFCL----RVAEELSS-----------------------TIGIARGLEYLHLGCSTR 404
            L G  L    ++  EL+                         + +A G+ YL    S R
Sbjct: 79  RLYGVVLTPPMKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLE---SKR 135
Query: 405 ILHFDIKPHNILLDEDFCPKISDFGLAKICNRKESIISMTGARGT-VGYIAPEVFCRNIG 463
            +H D+   N+LL      KI DFGL +   + +    M   R     + APE       
Sbjct: 136 FIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPESL--KTR 193
Query: 464 EVSYKSDVYNYGMMIFEMTGGRKNVDVVDNGSTAL 498
             S+ SD + +G+ ++EM    +   +  NGS  L
Sbjct: 194 TFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQIL 228

>pdb|2J0K|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains. Length = 656

Iteration: 1
 Score = 54.3 bits (129), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 51/211 (24%), Positives = 91/211 (43%), Gaps = 46/211 (21%)
Query: 321 LGQGGYGSVYKGKLLDGSN----VAVKVLND--SKGNGKEFINEVASISRTSHVNVVALL 374
           +G+G +G V++G  +   N    VA+K   +  S    ++F+ E  ++ +  H ++V L+
Sbjct: 398 IGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLI 457
Query: 375 G---------------------------FCLRVAEELSSTIGIARGLEYLHLGCSTRILH 407
           G                           F L +A  +     ++  L YL    S R +H
Sbjct: 458 GVITENPVWIIMELCTLGELRSFLQVRKFSLDLASLILYAYQLSTALAYLE---SKRFVH 514
Query: 408 FDIKPHNILLDEDFCPKISDFGLAKICNRKESIISMTGARGTVGYIAPEVFCRNIGEVSY 467
            DI   N+L+    C K+ DFGL++      +    +  +  + ++APE    N    + 
Sbjct: 515 RDIAARNVLVSATDCVKLGDFGLSRYME-DSTYYKASKGKLPIKWMAPESI--NFRRFTS 571
Query: 468 KSDVYNYGMMIFE--MTG-----GRKNVDVV 491
            SDV+ +G+ ++E  M G     G KN DV+
Sbjct: 572 ASDVWMFGVCMWEILMHGVKPFQGVKNNDVI 602

>pdb|4FNX|A Chain A, Crystal Structure Of The Apo R1275q Anaplastic Lymphoma Kinase Catalytic Domain Length = 327

Iteration: 1
 Score = 54.3 bits (129), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 56/206 (27%), Positives = 89/206 (43%), Gaps = 50/206 (24%)
Query: 321 LGQGGYGSVYKGKLLDGSN------VAVKVLND--SKGNGKEFINEVASISRTSHVNVVA 372
           LG G +G VY+G++    N      VAVK L +  S+ +  +F+ E   IS+ +H N+V 
Sbjct: 39  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVR 98
Query: 373 LLGFCLR-----------VAEELSSTIGIARG----------LEYLHL------GCS--- 402
            +G  L+              +L S +   R           L+ LH+      GC    
Sbjct: 99  CIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLE 158
Query: 403 -TRILHFDIKPHNILLDEDFCP------KISDFGLAKICNRKESIISMTGARGTVGYIAP 455
               +H DI   N LL    CP      KI DFG+A+   R         A   V ++ P
Sbjct: 159 ENHFIHRDIAARNCLLT---CPGPGRVAKIGDFGMAQDIYRASYYRKGGCAMLPVKWMPP 215
Query: 456 EVFCRNIGEVSYKSDVYNYGMMIFEM 481
           E F   I   + K+D +++G++++E+
Sbjct: 216 EAFMEGI--FTSKTDTWSFGVLLWEI 239

>pdb|3BZ3|A Chain A, Crystal Structure Analysis Of Focal Adhesion Kinase With A Methanesulfonamide Diaminopyrimidine Inhibitor Length = 276

Iteration: 1
 Score = 54.3 bits (129), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 50/211 (23%), Positives = 92/211 (43%), Gaps = 46/211 (21%)
Query: 321 LGQGGYGSVYKGKLLDGSN----VAVKVLND--SKGNGKEFINEVASISRTSHVNVVALL 374
           +G+G +G V++G  +   N    VA+K   +  S    ++F+ E  ++ +  H ++V L+
Sbjct: 15  IGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLI 74
Query: 375 G---------------------------FCLRVAEELSSTIGIARGLEYLHLGCSTRILH 407
           G                           + L +A  +     ++  L YL    S R +H
Sbjct: 75  GVITENPVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLE---SKRFVH 131
Query: 408 FDIKPHNILLDEDFCPKISDFGLAKICNRKESIISMTGARGTVGYIAPEVFCRNIGEVSY 467
            DI   N+L+  + C K+ DFGL++      +    +  +  + ++APE    N    + 
Sbjct: 132 RDIAARNVLVSSNDCVKLGDFGLSRYME-DSTYYKASKGKLPIKWMAPESI--NFRRFTS 188
Query: 468 KSDVYNYGMMIFE--MTG-----GRKNVDVV 491
            SDV+ +G+ ++E  M G     G KN DV+
Sbjct: 189 ASDVWMFGVCMWEILMHGVKPFQGVKNNDVI 219

>pdb|2JKM|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276

Iteration: 1
 Score = 54.3 bits (129), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 50/211 (23%), Positives = 92/211 (43%), Gaps = 46/211 (21%)
Query: 321 LGQGGYGSVYKGKLLDGSN----VAVKVLND--SKGNGKEFINEVASISRTSHVNVVALL 374
           +G+G +G V++G  +   N    VA+K   +  S    ++F+ E  ++ +  H ++V L+
Sbjct: 18  IGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLI 77
Query: 375 G---------------------------FCLRVAEELSSTIGIARGLEYLHLGCSTRILH 407
           G                           + L +A  +     ++  L YL    S R +H
Sbjct: 78  GVITENPVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLE---SKRFVH 134
Query: 408 FDIKPHNILLDEDFCPKISDFGLAKICNRKESIISMTGARGTVGYIAPEVFCRNIGEVSY 467
            DI   N+L+  + C K+ DFGL++      +    +  +  + ++APE    N    + 
Sbjct: 135 RDIAARNVLVSSNDCVKLGDFGLSRYME-DSTYYKASKGKLPIKWMAPESI--NFRRFTS 191
Query: 468 KSDVYNYGMMIFE--MTG-----GRKNVDVV 491
            SDV+ +G+ ++E  M G     G KN DV+
Sbjct: 192 ASDVWMFGVCMWEILMHGVKPFQGVKNNDVI 222

>pdb|2J0M|B Chain B, Crystal Structure A Two-Chain Complex Between The Ferm And Kinase Domains Of Focal Adhesion Kinase. Length = 276

Iteration: 1
 Score = 54.3 bits (129), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 50/211 (23%), Positives = 92/211 (43%), Gaps = 46/211 (21%)
Query: 321 LGQGGYGSVYKGKLLDGSN----VAVKVLND--SKGNGKEFINEVASISRTSHVNVVALL 374
           +G+G +G V++G  +   N    VA+K   +  S    ++F+ E  ++ +  H ++V L+
Sbjct: 18  IGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLI 77
Query: 375 G---------------------------FCLRVAEELSSTIGIARGLEYLHLGCSTRILH 407
           G                           + L +A  +     ++  L YL    S R +H
Sbjct: 78  GVITENPVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLE---SKRFVH 134
Query: 408 FDIKPHNILLDEDFCPKISDFGLAKICNRKESIISMTGARGTVGYIAPEVFCRNIGEVSY 467
            DI   N+L+  + C K+ DFGL++      +    +  +  + ++APE    N    + 
Sbjct: 135 RDIAARNVLVSSNDCVKLGDFGLSRYME-DSTYYKASKGKLPIKWMAPESI--NFRRFTS 191
Query: 468 KSDVYNYGMMIFE--MTG-----GRKNVDVV 491
            SDV+ +G+ ++E  M G     G KN DV+
Sbjct: 192 ASDVWMFGVCMWEILMHGVKPFQGVKNNDVI 222

>pdb|4EWH|B Chain B, Co-Crystal Structure Of Ack1 With Inhibitor Length = 275

Iteration: 1
 Score = 54.3 bits (129), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 57/215 (26%), Positives = 87/215 (40%), Gaps = 41/215 (19%)
Query: 320 KLGQGGYGSVYKGKLLDGS----NVAVKVLNDSKGNGKE----FINEVASISRTSHVNVV 371
           KLG G +G V +G+    S    +VAVK L     +  E    FI EV ++    H N++
Sbjct: 15  KLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLI 74
Query: 372 ALLGFCL----RVAEELSS-----------------------TIGIARGLEYLHLGCSTR 404
            L G  L    ++  EL+                         + +A G+ YL    S R
Sbjct: 75  RLYGVVLTPPMKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLE---SKR 131
Query: 405 ILHFDIKPHNILLDEDFCPKISDFGLAKICNRKESIISMTGARGT-VGYIAPEVFCRNIG 463
            +H D+   N+LL      KI DFGL +   + +    M   R     + APE       
Sbjct: 132 FIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHXVMQEHRKVPFAWCAPESL--KTR 189
Query: 464 EVSYKSDVYNYGMMIFEMTGGRKNVDVVDNGSTAL 498
             S+ SD + +G+ ++EM    +   +  NGS  L
Sbjct: 190 TFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQIL 224

>pdb|3L9P|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 367

Iteration: 1
 Score = 54.3 bits (129), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 65/256 (25%), Positives = 107/256 (41%), Gaps = 56/256 (21%)
Query: 277 KLSSYNSTASCLNIETFLRNYRS---LSPKRYGYADIKKMTN---SFKYKLGQGGYGSVY 330
           +L S     S L   T + +Y      + K    +D+K++     +    LG G +G VY
Sbjct: 29  ELQSPEYKLSKLRTSTIMTDYNPNYCFAGKTSSISDLKEVPRKNITLIRGLGHGAFGEVY 88
Query: 331 KGKLLDGSN------VAVKVLND--SKGNGKEFINEVASISRTSHVNVVALLGFCLR--- 379
           +G++    N      VAVK L +  S+ +  +F+ E   IS+ +H N+V  +G  L+   
Sbjct: 89  EGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQSLP 148
Query: 380 --------VAEELSSTIGIARG----------LEYLHL------GCS----TRILHFDIK 411
                      +L S +   R           L+ LH+      GC        +H DI 
Sbjct: 149 RFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENHFIHRDIA 208
Query: 412 PHNILLDEDFCP------KISDFGLAKICNRKESIISMTGARGTVGYIAPEVFCRNIGEV 465
             N LL    CP      KI DFG+A+   R         A   V ++ PE F   I   
Sbjct: 209 ARNCLLT---CPGPGRVAKIGDFGMARDIYRAGYYRKGGCAMLPVKWMPPEAFMEGI--F 263
Query: 466 SYKSDVYNYGMMIFEM 481
           + K+D +++G++++E+
Sbjct: 264 TSKTDTWSFGVLLWEI 279

>pdb|4ID7|A Chain A, Ack1 Kinase In Complex With The Inhibitor Cis-3-[8-amino-1-(4- Phenoxyphenyl)imidazo[1,5-a]pyrazin-3-yl]cyclobutanol Length = 273

Iteration: 1
 Score = 54.3 bits (129), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 57/215 (26%), Positives = 87/215 (40%), Gaps = 41/215 (19%)
Query: 320 KLGQGGYGSVYKGKLLDGS----NVAVKVLNDSKGNGKE----FINEVASISRTSHVNVV 371
           KLG G +G V +G+    S    +VAVK L     +  E    FI EV ++    H N++
Sbjct: 15  KLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLI 74
Query: 372 ALLGFCL----RVAEELSS-----------------------TIGIARGLEYLHLGCSTR 404
            L G  L    ++  EL+                         + +A G+ YL    S R
Sbjct: 75  RLYGVVLTPPMKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLE---SKR 131
Query: 405 ILHFDIKPHNILLDEDFCPKISDFGLAKICNRKESIISMTGARGT-VGYIAPEVFCRNIG 463
            +H D+   N+LL      KI DFGL +   + +    M   R     + APE       
Sbjct: 132 FIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPESL--KTR 189
Query: 464 EVSYKSDVYNYGMMIFEMTGGRKNVDVVDNGSTAL 498
             S+ SD + +G+ ++EM    +   +  NGS  L
Sbjct: 190 TFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQIL 224

>pdb|2YHV|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase Length = 342

Iteration: 1
 Score = 54.3 bits (129), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 56/206 (27%), Positives = 89/206 (43%), Gaps = 50/206 (24%)
Query: 321 LGQGGYGSVYKGKLLDGSN------VAVKVLND--SKGNGKEFINEVASISRTSHVNVVA 372
           LG G +G VY+G++    N      VAVK L +  S+ +  +F+ E   IS+ +H N+V 
Sbjct: 53  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVR 112
Query: 373 LLGFCLR-----------VAEELSSTIGIARG----------LEYLHL------GCS--- 402
            +G  L+              +L S +   R           L+ LH+      GC    
Sbjct: 113 CIGVSLQSLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLE 172
Query: 403 -TRILHFDIKPHNILLDEDFCP------KISDFGLAKICNRKESIISMTGARGTVGYIAP 455
               +H DI   N LL    CP      KI DFG+A+   R         A   V ++ P
Sbjct: 173 ENHFIHRDIAARNCLLT---CPGPGRVAKIGDFGMARDIYRASYYRKGGCAMLPVKWMPP 229
Query: 456 EVFCRNIGEVSYKSDVYNYGMMIFEM 481
           E F   I   + K+D +++G++++E+
Sbjct: 230 EAFMEGI--FTSKTDTWSFGVLLWEI 253

>pdb|4HVD|A Chain A, Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h-pyrrolo[2,3- B]pyrazine-7-carboxylic Acid ((s)-1,2,2-trimethyl-propyl)-amide Length = 314

Iteration: 1
 Score = 54.3 bits (129), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 32/93 (34%), Positives = 55/93 (59%), Gaps = 6/93 (6%)
Query: 390 IARGLEYLHLGCSTRILHFDIKPHNILLDEDFCPKISDFGLAKICN-RKESIISMTGARG 448
           I +G+EYL    S R +H D+   NIL++ +   KI+DFGLAK+    K+  +     + 
Sbjct: 123 ICKGMEYL---GSRRCVHRDLAARNILVESEAHVKIADFGLAKLLPLDKDYYVVREPGQS 179
Query: 449 TVGYIAPEVFCRNIGEVSYKSDVYNYGMMIFEM 481
            + + APE    NI   S +SDV+++G++++E+
Sbjct: 180 PIFWYAPESLSDNI--FSRQSDVWSFGVVLYEL 210

>pdb|3EQP|B Chain B, Crystal Structure Of Ack1 With Compound T95 Length = 276

Iteration: 1
 Score = 54.3 bits (129), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 57/215 (26%), Positives = 87/215 (40%), Gaps = 41/215 (19%)
Query: 320 KLGQGGYGSVYKGKLLDGS----NVAVKVLNDSKGNGKE----FINEVASISRTSHVNVV 371
           KLG G +G V +G+    S    +VAVK L     +  E    FI EV ++    H N++
Sbjct: 15  KLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLI 74
Query: 372 ALLGFCL----RVAEELSS-----------------------TIGIARGLEYLHLGCSTR 404
            L G  L    ++  EL+                         + +A G+ YL    S R
Sbjct: 75  RLYGVVLTPPMKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLE---SKR 131
Query: 405 ILHFDIKPHNILLDEDFCPKISDFGLAKICNRKESIISMTGARGT-VGYIAPEVFCRNIG 463
            +H D+   N+LL      KI DFGL +   + +    M   R     + APE       
Sbjct: 132 FIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPESL--KTR 189
Query: 464 EVSYKSDVYNYGMMIFEMTGGRKNVDVVDNGSTAL 498
             S+ SD + +G+ ++EM    +   +  NGS  L
Sbjct: 190 TFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQIL 224

>pdb|3LCT|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 344

Iteration: 1
 Score = 54.3 bits (129), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 65/256 (25%), Positives = 107/256 (41%), Gaps = 56/256 (21%)
Query: 277 KLSSYNSTASCLNIETFLRNYRS---LSPKRYGYADIKKMTN---SFKYKLGQGGYGSVY 330
           +L S     S L   T + +Y      + K    +D+K++     +    LG G +G VY
Sbjct: 6   ELQSPEYKLSKLRTSTIMTDYNPNYCFAGKTSSISDLKEVPRKNITLIRGLGHGAFGEVY 65
Query: 331 KGKLLDGSN------VAVKVLND--SKGNGKEFINEVASISRTSHVNVVALLGFCLR--- 379
           +G++    N      VAVK L +  S+ +  +F+ E   IS+ +H N+V  +G  L+   
Sbjct: 66  EGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQSLP 125
Query: 380 --------VAEELSSTIGIARG----------LEYLHL------GCS----TRILHFDIK 411
                      +L S +   R           L+ LH+      GC        +H DI 
Sbjct: 126 RFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENHFIHRDIA 185
Query: 412 PHNILLDEDFCP------KISDFGLAKICNRKESIISMTGARGTVGYIAPEVFCRNIGEV 465
             N LL    CP      KI DFG+A+   R         A   V ++ PE F   I   
Sbjct: 186 ARNCLLT---CPGPGRVAKIGDFGMARDIYRAGYYRKGGCAMLPVKWMPPEAFMEGI--F 240
Query: 466 SYKSDVYNYGMMIFEM 481
           + K+D +++G++++E+
Sbjct: 241 TSKTDTWSFGVLLWEI 256

>pdb|2YJS|A Chain A, Structure Of C1156y Mutant Anaplastic Lymphoma Kinase Length = 342

Iteration: 1
 Score = 54.3 bits (129), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 56/206 (27%), Positives = 89/206 (43%), Gaps = 50/206 (24%)
Query: 321 LGQGGYGSVYKGKLLDGSN------VAVKVLND--SKGNGKEFINEVASISRTSHVNVVA 372
           LG G +G VY+G++    N      VAVK L +  S+ +  +F+ E   IS+ +H N+V 
Sbjct: 53  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVYSEQDELDFLMEALIISKFNHQNIVR 112
Query: 373 LLGFCLR-----------VAEELSSTIGIARG----------LEYLHL------GCS--- 402
            +G  L+              +L S +   R           L+ LH+      GC    
Sbjct: 113 CIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLE 172
Query: 403 -TRILHFDIKPHNILLDEDFCP------KISDFGLAKICNRKESIISMTGARGTVGYIAP 455
               +H DI   N LL    CP      KI DFG+A+   R         A   V ++ P
Sbjct: 173 ENHFIHRDIAARNCLLT---CPGPGRVAKIGDFGMARDIYRASYYRKGGCAMLPVKWMPP 229
Query: 456 EVFCRNIGEVSYKSDVYNYGMMIFEM 481
           E F   I   + K+D +++G++++E+
Sbjct: 230 EAFMEGI--FTSKTDTWSFGVLLWEI 253

>pdb|3HX4|A Chain A, Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tgme49_101440, In Presence Of Calcium Length = 508

Iteration: 1
 Score = 54.3 bits (129), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 57/200 (28%), Positives = 90/200 (45%), Gaps = 46/200 (23%)
Query: 321 LGQGGYGSVY--KGKLLDGSNVAVKVLND----SKGNGKEFINEVASISRTSHVNVVALL 374
           LG+G +G V   K K+  G   AVKV++      K + +  + EV  + +  H N++ L 
Sbjct: 58  LGKGSFGEVILCKDKIT-GQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMKLY 116
Query: 375 ------GFCLRVAEELS--------------STIGIAR-------GLEYLHLGCSTRILH 407
                 G+   V E  +              S +  AR       G+ Y+H     +I+H
Sbjct: 117 EFFEDKGYFYLVGEVYTGGELFDEIISRKRFSEVDAARIIRQVLSGITYMH---KNKIVH 173
Query: 408 FDIKPHNILLD---EDFCPKISDFGLAKICNRKESIISMTGARGTVGYIAPEVFCRNIGE 464
            D+KP N+LL+   +D   +I DFGL+      E+   M    GT  YIAPEV     G 
Sbjct: 174 RDLKPENLLLESKSKDANIRIIDFGLS---THFEASKKMKDKIGTAYYIAPEVLH---GT 227
Query: 465 VSYKSDVYNYGMMIFEMTGG 484
              K DV++ G++++ +  G
Sbjct: 228 YDEKCDVWSTGVILYILLSG 247

>pdb|4EBW|A Chain A, Structure Of Focal Adhesion Kinase Catalytic Domain In Complex With Novel Allosteric Inhibitor Length = 304

Iteration: 1
 Score = 54.3 bits (129), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 50/211 (23%), Positives = 92/211 (43%), Gaps = 46/211 (21%)
Query: 321 LGQGGYGSVYKGKLLDGSN----VAVKVLND--SKGNGKEFINEVASISRTSHVNVVALL 374
           +G+G +G V++G  +   N    VA+K   +  S    ++F+ E  ++ +  H ++V L+
Sbjct: 46  IGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLI 105
Query: 375 G---------------------------FCLRVAEELSSTIGIARGLEYLHLGCSTRILH 407
           G                           + L +A  +     ++  L YL    S R +H
Sbjct: 106 GVITENPVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLE---SKRFVH 162
Query: 408 FDIKPHNILLDEDFCPKISDFGLAKICNRKESIISMTGARGTVGYIAPEVFCRNIGEVSY 467
            DI   N+L+  + C K+ DFGL++      +    +  +  + ++APE    N    + 
Sbjct: 163 RDIAARNVLVSSNDCVKLGDFGLSRYME-DSTYYKASKGKLPIKWMAPESI--NFRRFTS 219
Query: 468 KSDVYNYGMMIFE--MTG-----GRKNVDVV 491
            SDV+ +G+ ++E  M G     G KN DV+
Sbjct: 220 ASDVWMFGVCMWEILMHGVKPFQGVKNNDVI 250

>pdb|2ETM|A Chain A, Crystal Structure Of Focal Adhesion Kinase Domain Complexed With 7h-Pyrrolo [2,3-D] Pyrimidine Derivative Length = 281

Iteration: 1
 Score = 54.3 bits (129), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 50/211 (23%), Positives = 92/211 (43%), Gaps = 46/211 (21%)
Query: 321 LGQGGYGSVYKGKLLDGSN----VAVKVLND--SKGNGKEFINEVASISRTSHVNVVALL 374
           +G+G +G V++G  +   N    VA+K   +  S    ++F+ E  ++ +  H ++V L+
Sbjct: 20  IGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLI 79
Query: 375 G---------------------------FCLRVAEELSSTIGIARGLEYLHLGCSTRILH 407
           G                           + L +A  +     ++  L YL    S R +H
Sbjct: 80  GVITENPVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLE---SKRFVH 136
Query: 408 FDIKPHNILLDEDFCPKISDFGLAKICNRKESIISMTGARGTVGYIAPEVFCRNIGEVSY 467
            DI   N+L+  + C K+ DFGL++      +    +  +  + ++APE    N    + 
Sbjct: 137 RDIAARNVLVSSNDCVKLGDFGLSRYME-DSTYYKASKGKLPIKWMAPESI--NFRRFTS 193
Query: 468 KSDVYNYGMMIFE--MTG-----GRKNVDVV 491
            SDV+ +G+ ++E  M G     G KN DV+
Sbjct: 194 ASDVWMFGVCMWEILMHGVKPFQGVKNNDVI 224

>pdb|3SA0|A Chain A, Complex Of Erk2 With Norathyriol Length = 360

Iteration: 1
 Score = 54.3 bits (129), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 34/97 (35%), Positives = 52/97 (53%), Gaps = 5/97 (5%)
Query: 390 IARGLEYLHLGCSTRILHFDIKPHNILLDEDFCPKISDFGLAKICNRKESIIS-MTGARG 448
           I RGL+Y+H   S  +LH D+KP N+LL+     KI DFGLA++ +        +T    
Sbjct: 133 ILRGLKYIH---SANVLHRDLKPSNLLLNTTXDLKIXDFGLARVADPDHDHTGFLTEYVA 189
Query: 449 TVGYIAPEVFCRNIGEVSYKSDVYNYGMMIFEMTGGR 485
           T  Y APE+   + G  +   D+++ G ++ EM   R
Sbjct: 190 TRWYRAPEIMLNSKG-YTKSIDIWSVGCILAEMLSNR 225

>pdb|2XB7|A Chain A, Structure Of Human Anaplastic Lymphoma Kinase In Complex With Nvp- Tae684 Length = 315

Iteration: 1
 Score = 54.3 bits (129), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 56/206 (27%), Positives = 89/206 (43%), Gaps = 50/206 (24%)
Query: 321 LGQGGYGSVYKGKLLDGSN------VAVKVLND--SKGNGKEFINEVASISRTSHVNVVA 372
           LG G +G VY+G++    N      VAVK L +  S+ +  +F+ E   IS+ +H N+V 
Sbjct: 30  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVR 89
Query: 373 LLGFCLR-----------VAEELSSTIGIARG----------LEYLHL------GCS--- 402
            +G  L+              +L S +   R           L+ LH+      GC    
Sbjct: 90  CIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLE 149
Query: 403 -TRILHFDIKPHNILLDEDFCP------KISDFGLAKICNRKESIISMTGARGTVGYIAP 455
               +H DI   N LL    CP      KI DFG+A+   R         A   V ++ P
Sbjct: 150 ENHFIHRDIAARNCLLT---CPGPGRVAKIGDFGMARDIYRASYYRKGGCAMLPVKWMPP 206
Query: 456 EVFCRNIGEVSYKSDVYNYGMMIFEM 481
           E F   I   + K+D +++G++++E+
Sbjct: 207 EAFMEGI--FTSKTDTWSFGVLLWEI 230

>pdb|3LXK|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 327

Iteration: 1
 Score = 54.3 bits (129), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 32/93 (34%), Positives = 55/93 (59%), Gaps = 6/93 (6%)
Query: 390 IARGLEYLHLGCSTRILHFDIKPHNILLDEDFCPKISDFGLAKICN-RKESIISMTGARG 448
           I +G+EYL    S R +H D+   NIL++ +   KI+DFGLAK+    K+  +     + 
Sbjct: 136 ICKGMEYL---GSRRCVHRDLAARNILVESEAHVKIADFGLAKLLPLDKDYYVVREPGQS 192
Query: 449 TVGYIAPEVFCRNIGEVSYKSDVYNYGMMIFEM 481
            + + APE    NI   S +SDV+++G++++E+
Sbjct: 193 PIFWYAPESLSDNI--FSRQSDVWSFGVVLYEL 223

>pdb|1P14|A Chain A, Crystal Structure Of A Catalytic-Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306

Iteration: 1
 Score = 54.3 bits (129), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 52/210 (24%), Positives = 93/210 (44%), Gaps = 54/210 (25%)
Query: 320 KLGQGGYGSVYKGKLLD------GSNVAVKVLNDSKGNGK--EFINEVASISRTSHVNVV 371
           +LGQG +G VY+G   D       + VAVK +N+S    +  EF+NE + +   +  +VV
Sbjct: 24  ELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVV 83
Query: 372 ALLGFCLR-------------------------------------VAEELSSTIGIARGL 394
            LLG   +                                     + E +     IA G+
Sbjct: 84  RLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGM 143
Query: 395 EYLHLGCSTRILHFDIKPHNILLDEDFCPKISDFGLAKICNRKESIISMTGARG--TVGY 452
            YL+   + + +H ++   N ++  DF  KI DFG+ +  +  E+     G +G   V +
Sbjct: 144 AYLN---AKKFVHRNLAARNCMVAHDFTVKIGDFGMTR--DIYETDYYRKGGKGLLPVRW 198
Query: 453 IAPEVFCRNIGEVSYKSDVYNYGMMIFEMT 482
           +APE      G  +  SD++++G++++E+T
Sbjct: 199 MAPESL--KDGVFTTSSDMWSFGVVLWEIT 226

>pdb|3PJC|A Chain A, Crystal Structure Of Jak3 Complexed With A Potent Atp Site Inhibitor Showing High Selectivity Within The Janus Kinase Family Length = 315

Iteration: 1
 Score = 54.3 bits (129), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 32/93 (34%), Positives = 55/93 (59%), Gaps = 6/93 (6%)
Query: 390 IARGLEYLHLGCSTRILHFDIKPHNILLDEDFCPKISDFGLAKICN-RKESIISMTGARG 448
           I +G+EYL    S R +H D+   NIL++ +   KI+DFGLAK+    K+  +     + 
Sbjct: 124 ICKGMEYL---GSRRCVHRDLAARNILVESEAHVKIADFGLAKLLPLDKDYYVVREPGQS 180
Query: 449 TVGYIAPEVFCRNIGEVSYKSDVYNYGMMIFEM 481
            + + APE    NI   S +SDV+++G++++E+
Sbjct: 181 PIFWYAPESLSDNI--FSRQSDVWSFGVVLYEL 211

>pdb|3PXK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Pyrrolo[2,3- D]thiazole Length = 282

Iteration: 1
 Score = 54.3 bits (129), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 50/211 (23%), Positives = 92/211 (43%), Gaps = 46/211 (21%)
Query: 321 LGQGGYGSVYKGKLLDGSN----VAVKVLND--SKGNGKEFINEVASISRTSHVNVVALL 374
           +G+G +G V++G  +   N    VA+K   +  S    ++F+ E  ++ +  H ++V L+
Sbjct: 21  IGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLI 80
Query: 375 G---------------------------FCLRVAEELSSTIGIARGLEYLHLGCSTRILH 407
           G                           + L +A  +     ++  L YL    S R +H
Sbjct: 81  GVITENPVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLE---SKRFVH 137
Query: 408 FDIKPHNILLDEDFCPKISDFGLAKICNRKESIISMTGARGTVGYIAPEVFCRNIGEVSY 467
            DI   N+L+  + C K+ DFGL++      +    +  +  + ++APE    N    + 
Sbjct: 138 RDIAARNVLVSSNDCVKLGDFGLSRYME-DSTYYKASKGKLPIKWMAPESI--NFRRFTS 194
Query: 468 KSDVYNYGMMIFE--MTG-----GRKNVDVV 491
            SDV+ +G+ ++E  M G     G KN DV+
Sbjct: 195 ASDVWMFGVCMWEILMHGVKPFQGVKNNDVI 225

>pdb|1U54|A Chain A, Crystal Structures Of The Phosphorylated And Unphosphorylated Kinase Domains Of The Cdc42-Associated Tyrosine Kinase Ack1 Bound To Amp-Pcp Length = 291

Iteration: 1
 Score = 53.9 bits (128), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 57/215 (26%), Positives = 87/215 (40%), Gaps = 41/215 (19%)
Query: 320 KLGQGGYGSVYKGKLLDGS----NVAVKVLNDSKGNGKE----FINEVASISRTSHVNVV 371
           KLG G +G V +G+    S    +VAVK L     +  E    FI EV ++    H N++
Sbjct: 25  KLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLI 84
Query: 372 ALLGFCL----RVAEELSS-----------------------TIGIARGLEYLHLGCSTR 404
            L G  L    ++  EL+                         + +A G+ YL    S R
Sbjct: 85  RLYGVVLTPPMKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLE---SKR 141
Query: 405 ILHFDIKPHNILLDEDFCPKISDFGLAKICNRKESIISMTGARGT-VGYIAPEVFCRNIG 463
            +H D+   N+LL      KI DFGL +   + +    M   R     + APE       
Sbjct: 142 FIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHXVMQEHRKVPFAWCAPESL--KTR 199
Query: 464 EVSYKSDVYNYGMMIFEMTGGRKNVDVVDNGSTAL 498
             S+ SD + +G+ ++EM    +   +  NGS  L
Sbjct: 200 TFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQIL 234

>pdb|3VW6|A Chain A, Crystal Structure Of Human Apoptosis Signal-Regulating Kinase 1 (Ask1) With Imidazopyridine Inhibitor Length = 269

Iteration: 1
 Score = 53.9 bits (128), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 58/199 (29%), Positives = 87/199 (43%), Gaps = 40/199 (20%)
Query: 321 LGQGGYGSVYKGKLLDGS-NVAVKVLNDSKGNGKEFINE-VASISRTSHVNVVALLG--- 375
           LG+G YG VY G+ L     +A+K + +      + ++E +A      H N+V  LG   
Sbjct: 16  LGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPLHEEIALHKHLKHKNIVQYLGSFS 75
Query: 376 ---FCLRVAEEL-------------------SSTIG-----IARGLEYLHLGCSTRILHF 408
              F     E++                     TIG     I  GL+YLH     +I+H 
Sbjct: 76  ENGFIKIFMEQVPGGSLSALLRSKWGPLKDNEQTIGFYTKQILEGLKYLH---DNQIVHR 132
Query: 409 DIKPHNILLDE-DFCPKISDFGLAKICNRKESIISMTGA-RGTVGYIAPEVFCRNIGEVS 466
           DIK  N+L++      KISDFG +K   R   I   T    GT+ Y+APE+  +      
Sbjct: 133 DIKGDNVLINTYSGVLKISDFGTSK---RLAGINPCTETFTGTLQYMAPEIIDKGPRGYG 189
Query: 467 YKSDVYNYGMMIFEMTGGR 485
             +D+++ G  I EM  G+
Sbjct: 190 KAADIWSLGCTIIEMATGK 208

>pdb|3LCD|A Chain A, Inhibitor Bound To A Dfg-In Structure Of The Kinase Domain Of Csf-1r Length = 329

Iteration: 1
 Score = 53.9 bits (128), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 56/212 (26%), Positives = 89/212 (41%), Gaps = 51/212 (24%)
Query: 316 SFKYKLGQGGYGSVYK------GKLLDGSNVAVKVLND-SKGNGKE-FINEVASISRT-S 366
            F   LG G +G V +      GK      VAVK+L   +  + KE  ++E+  +S    
Sbjct: 49  QFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQ 108
Query: 367 HVNVVALLGFC-------------------------------------LRVAEELSSTIG 389
           H N+V LLG C                                     L + + L  +  
Sbjct: 109 HENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKAEADLDKEDGRPLELRDLLHFSSQ 168
Query: 390 IARGLEYLHLGCSTRILHFDIKPHNILLDEDFCPKISDFGLAKICNRKESIISMTGARGT 449
           +A+G+ +L    S   +H D+   N+LL      KI DFGLA+      + I    AR  
Sbjct: 169 VAQGMAFL---ASKNCIHRDVAARNVLLTNGHVAKIGDFGLARDIMNDSNYIVKGNARLP 225
Query: 450 VGYIAPEVFCRNIGEVSYKSDVYNYGMMIFEM 481
           V ++APE     +  V  +SDV++YG++++E+
Sbjct: 226 VKWMAPESIFDCVYTV--QSDVWSYGILLWEI 255

>pdb|3EKK|A Chain A, Insulin Receptor Kinase Complexed With An Inhibitor Length = 307

Iteration: 1
 Score = 53.9 bits (128), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 52/210 (24%), Positives = 93/210 (44%), Gaps = 54/210 (25%)
Query: 320 KLGQGGYGSVYKGKLLD------GSNVAVKVLNDSKGNGK--EFINEVASISRTSHVNVV 371
           +LGQG +G VY+G   D       + VAVK +N+S    +  EF+NE + +   +  +VV
Sbjct: 25  ELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVV 84
Query: 372 ALLGFCLR-------------------------------------VAEELSSTIGIARGL 394
            LLG   +                                     + E +     IA G+
Sbjct: 85  RLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGM 144
Query: 395 EYLHLGCSTRILHFDIKPHNILLDEDFCPKISDFGLAKICNRKESIISMTGARG--TVGY 452
            YL+   + + +H ++   N ++  DF  KI DFG+ +  +  E+     G +G   V +
Sbjct: 145 AYLN---AKKFVHRNLAARNCMVAHDFTVKIGDFGMTR--DIYETDYYRKGGKGLLPVRW 199
Query: 453 IAPEVFCRNIGEVSYKSDVYNYGMMIFEMT 482
           +APE      G  +  SD++++G++++E+T
Sbjct: 200 MAPESL--KDGVFTTSSDMWSFGVVLWEIT 227

>pdb|1P4O|A Chain A, Structure Of Apo Unactivated Igf-1r Kinase Domain At 1.5a Resolution. Length = 322

Iteration: 1
 Score = 53.9 bits (128), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 63/241 (26%), Positives = 109/241 (45%), Gaps = 66/241 (27%)
Query: 299 SLSPKRYGYADI----------KKMTNSFKYKLGQGGYGSVYKG------KLLDGSNVAV 342
           S++P+ +  AD+          +K+T S   +LGQG +G VY+G      K    + VA+
Sbjct: 3   SVNPEYFSAADVYVPDEWEVAREKITMS--RELGQGSFGMVYEGVAKGVVKDEPETRVAI 60
Query: 343 KVLNDSKGNGK--EFINEVASISRTSHVNVVALLGFC----------------------- 377
           K +N++    +  EF+NE + +   +  +VV LLG                         
Sbjct: 61  KTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLR 120
Query: 378 -LRVA---------EELSSTIG----IARGLEYLHLGCSTRILHFDIKPHNILLDEDFCP 423
            LR A           LS  I     IA G+ YL+   + + +H D+   N ++ EDF  
Sbjct: 121 SLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLN---ANKFVHRDLAARNCMVAEDFTV 177
Query: 424 KISDFGLAKICNRKESIISMTGARG--TVGYIAPEVFCRNIGEVSYKSDVYNYGMMIFEM 481
           KI DFG+ +  +  E+     G +G   V +++PE      G  +  SDV+++G++++E+
Sbjct: 178 KIGDFGMTR--DIYETDYYRKGGKGLLPVRWMSPESL--KDGVFTTYSDVWSFGVVLWEI 233
Query: 482 T 482
Sbjct: 234 A 234

>pdb|3QBN|A Chain A, Structure Of Human Aurora A In Complex With A Diaminopyrimidine Length = 281

Iteration: 1
 Score = 53.9 bits (128), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 52/197 (26%), Positives = 83/197 (42%), Gaps = 41/197 (20%)
Query: 321 LGQGGYGSVY-----KGKLLDGSNVAVKVLNDSKGNGKEFINEVASISRTSHVNVVALLG 375
           LG+G +G+VY     + K +    V  K   +  G   +   EV   S   H N++ L G
Sbjct: 17  LGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYG 76
Query: 376 F------------------CLRVAEELSS---------TIGIARGLEYLHLGCSTRILHF 408
           +                    R  ++LS             +A  L Y H   S R++H 
Sbjct: 77  YFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCH---SKRVIHR 133
Query: 409 DIKPHNILLDEDFCPKISDFGLAKICNRKESIISMTGARGTVGYIAPEVFCRNIGEVSYK 468
           DIKP N+LL      KI+DFG +  C+   S    T   GT+ Y+ PE+    + +   K
Sbjct: 134 DIKPENLLLGSAGELKIADFGWS--CHAPSS--RRTTLSGTLDYLPPEMIEGRMHDE--K 187
Query: 469 SDVYNYGMMIFEMTGGR 485
            D+++ G++ +E   G+
Sbjct: 188 VDLWSLGVLCYEFLVGK 204

>pdb|2IVV|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Complexed With The Inhibitor Pp1 Length = 314

Iteration: 1
 Score = 53.9 bits (128), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 53/221 (23%), Positives = 96/221 (43%), Gaps = 64/221 (28%)
Query: 321 LGQGGYGSVYKGKL--LDG----SNVAVKVL--NDSKGNGKEFINEVASISRTSHVNVVA 372
           LG+G +G V K     L G    + VAVK+L  N S    ++ ++E   + + +H +V+ 
Sbjct: 31  LGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQVNHPHVIK 90
Query: 373 LLGFC-------------------------------------------LRVAEELSSTIG 389
           L G C                                           L   +E + T+G
Sbjct: 91  LYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMG 150
Query: 390 --------IARGLEYLHLGCSTRILHFDIKPHNILLDEDFCPKISDFGLAKICNRKESII 441
                   I++G++YL       ++H D+   NIL+ E    KISDFGL++    ++S +
Sbjct: 151 DLISFAWQISQGMQYL---AEMSLVHRDLAARNILVAEGRKMKISDFGLSRDVYEEDSXV 207
Query: 442 SMTGARGTVGYIAPEVFCRNIGEVSYKSDVYNYGMMIFEMT 482
             +  R  V ++A E    +I   + +SDV+++G++++E+ 
Sbjct: 208 KRSQGRIPVKWMAIESLFDHI--YTTQSDVWSFGVLLWEIV 246

>pdb|1U46|A Chain A, Crystal Structure Of The Unphosphorylated Kinase Domain Of The Tyrosine Kinase Ack1 Length = 291

Iteration: 1
 Score = 53.9 bits (128), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 57/215 (26%), Positives = 87/215 (40%), Gaps = 41/215 (19%)
Query: 320 KLGQGGYGSVYKGKLLDGS----NVAVKVLNDSKGNGKE----FINEVASISRTSHVNVV 371
           KLG G +G V +G+    S    +VAVK L     +  E    FI EV ++    H N++
Sbjct: 25  KLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLI 84
Query: 372 ALLGFCL----RVAEELSS-----------------------TIGIARGLEYLHLGCSTR 404
            L G  L    ++  EL+                         + +A G+ YL    S R
Sbjct: 85  RLYGVVLTPPMKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLE---SKR 141
Query: 405 ILHFDIKPHNILLDEDFCPKISDFGLAKICNRKESIISMTGARGT-VGYIAPEVFCRNIG 463
            +H D+   N+LL      KI DFGL +   + +    M   R     + APE       
Sbjct: 142 FIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPESL--KTR 199
Query: 464 EVSYKSDVYNYGMMIFEMTGGRKNVDVVDNGSTAL 498
             S+ SD + +G+ ++EM    +   +  NGS  L
Sbjct: 200 TFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQIL 234

>pdb|1M7N|A Chain A, Crystal Structure Of Unactivated Apo Insulin-Like Growth Factor-1 Receptor Kinase Domain Length = 322

Iteration: 1
 Score = 53.9 bits (128), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 63/241 (26%), Positives = 109/241 (45%), Gaps = 66/241 (27%)
Query: 299 SLSPKRYGYADI----------KKMTNSFKYKLGQGGYGSVYKG------KLLDGSNVAV 342
           S++P+ +  AD+          +K+T S   +LGQG +G VY+G      K    + VA+
Sbjct: 3   SVNPEYFSAADVYVPDEWEVAREKITMS--RELGQGSFGMVYEGVAKGVVKDEPETRVAI 60
Query: 343 KVLNDSKGNGK--EFINEVASISRTSHVNVVALLGFC----------------------- 377
           K +N++    +  EF+NE + +   +  +VV LLG                         
Sbjct: 61  KTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLR 120
Query: 378 -LRVAEE---------LSSTIG----IARGLEYLHLGCSTRILHFDIKPHNILLDEDFCP 423
            LR   E         LS  I     IA G+ YL+   + + +H D+   N ++ EDF  
Sbjct: 121 SLRPEMENNPVLAPPSLSKMIQMAGEIADGMAYLN---ANKFVHRDLAARNCMVAEDFTV 177
Query: 424 KISDFGLAKICNRKESIISMTGARG--TVGYIAPEVFCRNIGEVSYKSDVYNYGMMIFEM 481
           KI DFG+ +  +  E+     G +G   V +++PE      G  +  SDV+++G++++E+
Sbjct: 178 KIGDFGMTR--DIYETDYYRKGGKGLLPVRWMSPESL--KDGVFTTYSDVWSFGVVLWEI 233
Query: 482 T 482
Sbjct: 234 A 234

>pdb|4HZR|A Chain A, Crystal Structure Of Ack1 Kinase Domain Length = 277

Iteration: 1
 Score = 53.9 bits (128), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 57/215 (26%), Positives = 87/215 (40%), Gaps = 41/215 (19%)
Query: 320 KLGQGGYGSVYKGKLLDGS----NVAVKVLNDSKGNGKE----FINEVASISRTSHVNVV 371
           KLG G +G V +G+    S    +VAVK L     +  E    FI EV ++    H N++
Sbjct: 19  KLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLI 78
Query: 372 ALLGFCL----RVAEELSS-----------------------TIGIARGLEYLHLGCSTR 404
            L G  L    ++  EL+                         + +A G+ YL    S R
Sbjct: 79  RLYGVVLTPPMKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLE---SKR 135
Query: 405 ILHFDIKPHNILLDEDFCPKISDFGLAKICNRKESIISMTGARGT-VGYIAPEVFCRNIG 463
            +H D+   N+LL      KI DFGL +   + +    M   R     + APE       
Sbjct: 136 FIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPESL--KTR 193
Query: 464 EVSYKSDVYNYGMMIFEMTGGRKNVDVVDNGSTAL 498
             S+ SD + +G+ ++EM    +   +  NGS  L
Sbjct: 194 TFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQIL 228

>pdb|1MP8|A Chain A, Crystal Structure Of Focal Adhesion Kinase (Fak) Length = 281

Iteration: 1
 Score = 53.9 bits (128), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 50/211 (23%), Positives = 92/211 (43%), Gaps = 46/211 (21%)
Query: 321 LGQGGYGSVYKGKLLDGSN----VAVKVLND--SKGNGKEFINEVASISRTSHVNVVALL 374
           +G+G +G V++G  +   N    VA+K   +  S    ++F+ E  ++ +  H ++V L+
Sbjct: 23  IGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLI 82
Query: 375 G---------------------------FCLRVAEELSSTIGIARGLEYLHLGCSTRILH 407
           G                           + L +A  +     ++  L YL    S R +H
Sbjct: 83  GVITENPVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLE---SKRFVH 139
Query: 408 FDIKPHNILLDEDFCPKISDFGLAKICNRKESIISMTGARGTVGYIAPEVFCRNIGEVSY 467
            DI   N+L+  + C K+ DFGL++      +    +  +  + ++APE    N    + 
Sbjct: 140 RDIAARNVLVSSNDCVKLGDFGLSRYME-DSTYYKASKGKLPIKWMAPESI--NFRRFTS 196
Query: 468 KSDVYNYGMMIFE--MTG-----GRKNVDVV 491
            SDV+ +G+ ++E  M G     G KN DV+
Sbjct: 197 ASDVWMFGVCMWEILMHGVKPFQGVKNNDVI 227

>pdb|2OGV|A Chain A, Crystal Structure Of The Autoinhibited Human C-Fms Kinase Domain Length = 317

Iteration: 1
 Score = 53.9 bits (128), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 56/212 (26%), Positives = 89/212 (41%), Gaps = 51/212 (24%)
Query: 316 SFKYKLGQGGYGSVYK------GKLLDGSNVAVKVLND-SKGNGKE-FINEVASISRT-S 366
            F   LG G +G V +      GK      VAVK+L   +  + KE  ++E+  +S    
Sbjct: 41  QFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQ 100
Query: 367 HVNVVALLGFC-------------------------------------LRVAEELSSTIG 389
           H N+V LLG C                                     L + + L  +  
Sbjct: 101 HENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKAEADLDKEDGRPLELRDLLHFSSQ 160
Query: 390 IARGLEYLHLGCSTRILHFDIKPHNILLDEDFCPKISDFGLAKICNRKESIISMTGARGT 449
           +A+G+ +L    S   +H D+   N+LL      KI DFGLA+      + I    AR  
Sbjct: 161 VAQGMAFL---ASKNCIHRDVAARNVLLTNGHVAKIGDFGLARDIMNDSNYIVKGNARLP 217
Query: 450 VGYIAPEVFCRNIGEVSYKSDVYNYGMMIFEM 481
           V ++APE     +  V  +SDV++YG++++E+
Sbjct: 218 VKWMAPESIFDCVYTV--QSDVWSYGILLWEI 247

>pdb|4FSU|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 53.5 bits (127), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 37/94 (39%), Positives = 52/94 (55%), Gaps = 8/94 (8%)
Query: 393 GLEYLHLGCSTRILHFDIKPHNILLDEDFCPKISDFGLAKI--CNRKESIISMTGARGTV 450
           G+ YLH      I H DIKP N+LLDE    KISDFGLA +   N +E +++     GT+
Sbjct: 116 GVVYLH---GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMC--GTL 170
Query: 451 GYIAPEVFCRNIGEVSYKSDVYNYGMMIFEMTGG 484
            Y+APE+  R         DV++ G+++  M  G
Sbjct: 171 PYVAPELLKRREFHAE-PVDVWSCGIVLTAMLAG 203

>pdb|4E7W|A Chain A, Structure Of Gsk3 From Ustilago Maydis Length = 394

Iteration: 1
 Score = 53.5 bits (127), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 61/206 (29%), Positives = 86/206 (41%), Gaps = 55/206 (26%)
Query: 321 LGQGGYGSVYKGKLLDGSNVAVK-VLNDSKGNGKEFINEVASISR-TSHVNVVALLGFCL 378
           +G G +G V++ KL++   VA+K VL D     K F N    I R   H NVV L  F  
Sbjct: 48  IGNGSFGVVFQAKLVESDEVAIKKVLQD-----KRFKNRELQIMRIVKHPNVVDLKAFFY 102
Query: 379 R------------VAEELSSTI------------------------GIARGLEYLHLGCS 402
                        V E +  T+                         + R L Y+H   S
Sbjct: 103 SNGDKKDEVFLNLVLEYVPETVYRASRHYAKLKQTMPMLLIKLYMYQLLRSLAYIH---S 159
Query: 403 TRILHFDIKPHNILLDEDF-CPKISDFGLAKICNRKESIISMTGARGTVGYIAPEVFCRN 461
             I H DIKP N+LLD      K+ DFG AKI    E  +S   +R    Y APE+    
Sbjct: 160 IGICHRDIKPQNLLLDPPSGVLKLIDFGSAKILIAGEPNVSXICSR---YYRAPELI--- 213
Query: 462 IGEVSYKS--DVYNYGMMIFEMTGGR 485
            G  +Y +  D+++ G ++ E+  G+
Sbjct: 214 FGATNYTTNIDIWSTGCVMAELMQGQ 239

>pdb|4FUX|A Chain A, Crystal Structure Of The Erk2 Complexed With E75 Length = 360

Iteration: 1
 Score = 53.5 bits (127), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 34/97 (35%), Positives = 52/97 (53%), Gaps = 5/97 (5%)
Query: 390 IARGLEYLHLGCSTRILHFDIKPHNILLDEDFCPKISDFGLAKICNRKESIIS-MTGARG 448
           I RGL+Y+H   S  +LH D+KP N+LL+     KI DFGLA++ +        +T    
Sbjct: 133 ILRGLKYIH---SANVLHRDLKPSNLLLNTTXDLKICDFGLARVADPDHDHTGFLTEYVA 189
Query: 449 TVGYIAPEVFCRNIGEVSYKSDVYNYGMMIFEMTGGR 485
           T  Y APE+   + G  +   D+++ G ++ EM   R
Sbjct: 190 TRWYRAPEIMLNSKG-YTKSIDIWSVGCILAEMLSNR 225

>pdb|3QYW|A Chain A, Crystal Structure Of Erk2 In Complex With An Inhibitor Length = 364

Iteration: 1
 Score = 53.5 bits (127), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 34/97 (35%), Positives = 52/97 (53%), Gaps = 5/97 (5%)
Query: 390 IARGLEYLHLGCSTRILHFDIKPHNILLDEDFCPKISDFGLAKICNRKESIIS-MTGARG 448
           I RGL+Y+H   S  +LH D+KP N+LL+     KI DFGLA++ +        +T    
Sbjct: 137 ILRGLKYIH---SANVLHRDLKPSNLLLNTTXDLKICDFGLARVADPDHDHTGFLTEYVA 193
Query: 449 TVGYIAPEVFCRNIGEVSYKSDVYNYGMMIFEMTGGR 485
           T  Y APE+   + G  +   D+++ G ++ EM   R
Sbjct: 194 TRWYRAPEIMLNSKG-YTKSIDIWSVGCILAEMLSNR 229

>pdb|1K3A|A Chain A, Structure Of The Insulin-Like Growth Factor 1 Receptor Kinase Length = 299

Iteration: 1
 Score = 53.5 bits (127), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 56/210 (26%), Positives = 95/210 (45%), Gaps = 54/210 (25%)
Query: 320 KLGQGGYGSVYKG------KLLDGSNVAVKVLNDSKGNGK--EFINEVASISRTSHVNVV 371
           +LGQG +G VY+G      K    + VA+K +N++    +  EF+NE + +   +  +VV
Sbjct: 17  ELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVV 76
Query: 372 ALLGFC------------------------LRVAEE---------LSSTIG----IARGL 394
            LLG                          LR   E         LS  I     IA G+
Sbjct: 77  RLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLSKMIQMAGEIADGM 136
Query: 395 EYLHLGCSTRILHFDIKPHNILLDEDFCPKISDFGLAKICNRKESIISMTGARG--TVGY 452
            YL+   + + +H D+   N ++ EDF  KI DFG+ +  +  E+     G +G   V +
Sbjct: 137 AYLN---ANKFVHRDLAARNCMVAEDFTVKIGDFGMTR--DIXETDXXRKGGKGLLPVRW 191
Query: 453 IAPEVFCRNIGEVSYKSDVYNYGMMIFEMT 482
           ++PE      G  +  SDV+++G++++E+ 
Sbjct: 192 MSPESL--KDGVFTTYSDVWSFGVVLWEIA 219

>pdb|3KUL|B Chain B, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325

Iteration: 1
 Score = 53.5 bits (127), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 54/219 (24%), Positives = 102/219 (46%), Gaps = 45/219 (20%)
Query: 302 PKRYGYADIKKMTNS---FKYKLGQGGYGSVYKGKL-LDGSN---VAVKVLND--SKGNG 352
           P R G +  +++  S    +  +G G  G V  G+L + G     VA+K L    ++   
Sbjct: 35  PGRAGRSFTREIEASRIHIEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQR 94
Query: 353 KEFINEVASISRTSHVNVVALLGFCLR------VAEELSS--------------TI---- 388
           ++F++E + + +  H N++ L G   R      V E + +              TI    
Sbjct: 95  RDFLSEASIMGQFDHPNIIRLEGVVTRGRLAMIVTEYMENGSLDTFLRTHDGQFTIMQLV 154
Query: 389 ----GIARGLEYLH-LGCSTRILHFDIKPHNILLDEDFCPKISDFGLAKIC-NRKESIIS 442
               G+  G+ YL  LG     +H D+   N+L+D +   K+SDFGL+++  +  ++  +
Sbjct: 155 GMLRGVGAGMRYLSDLGY----VHRDLAARNVLVDSNLVCKVSDFGLSRVLEDDPDAAXT 210
Query: 443 MTGARGTVGYIAPEVFCRNIGEVSYKSDVYNYGMMIFEM 481
            TG +  + + APE         S  SDV+++G++++E+
Sbjct: 211 TTGGKIPIRWTAPEAIA--FRTFSSASDVWSFGVVMWEV 247

>pdb|4FIE|A Chain A, Full-Length Human Pak4 Length = 423

Iteration: 1
 Score = 53.5 bits (127), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 55/199 (27%), Positives = 92/199 (46%), Gaps = 47/199 (23%)
Query: 320 KLGQGGYGSVYKGKLLD-GSNVAVKVLNDSKGNGKEFI-NEVASISRTSHVNVVA----- 372
           K+G+G  G V    +   G  VAVK ++  K   +E + NEV  +    H NVV      
Sbjct: 158 KIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSY 217
Query: 373 LLGFCLRVA--------------------EELSST-IGIARGLEYLHLGCSTRILHFDIK 411
           L+G  L V                     E++++  + + + L  LH   +  ++H DIK
Sbjct: 218 LVGDELWVVMEFLEGGALTDIVTHTRMNEEQIAAVCLAVLQALSVLH---AQGVIHRDIK 274
Query: 412 PHNILLDEDFCPKISDFG----LAKICNRKESIISMTGARGTVGYIAPEVFCRNIGEVSY 467
             +ILL  D   K+SDFG    ++K   R++ ++      GT  ++APE+  R    + Y
Sbjct: 275 SDSILLTHDGRVKLSDFGFCAQVSKEVPRRKXLV------GTPYWMAPELISR----LPY 324
Query: 468 --KSDVYNYGMMIFEMTGG 484
             + D+++ G+M+ EM  G
Sbjct: 325 GPEVDIWSLGIMVIEMVDG 343

>pdb|2ZM3|A Chain A, Complex Structure Of Insulin-Like Growth Factor Receptor And Isoquinolinedione Inhibitor Length = 308

Iteration: 1
 Score = 53.5 bits (127), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 56/210 (26%), Positives = 95/210 (45%), Gaps = 54/210 (25%)
Query: 320 KLGQGGYGSVYKG------KLLDGSNVAVKVLNDSKGNGK--EFINEVASISRTSHVNVV 371
           +LGQG +G VY+G      K    + VA+K +N++    +  EF+NE + +   +  +VV
Sbjct: 26  ELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVV 85
Query: 372 ALLGFC------------------------LRVAEE---------LSSTIG----IARGL 394
            LLG                          LR   E         LS  I     IA G+
Sbjct: 86  RLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLSKMIQMAGEIADGM 145
Query: 395 EYLHLGCSTRILHFDIKPHNILLDEDFCPKISDFGLAKICNRKESIISMTGARG--TVGY 452
            YL+   + + +H D+   N ++ EDF  KI DFG+ +  +  E+     G +G   V +
Sbjct: 146 AYLN---ANKFVHRDLAARNCMVAEDFTVKIGDFGMTR--DIXETDXXRKGGKGLLPVRW 200
Query: 453 IAPEVFCRNIGEVSYKSDVYNYGMMIFEMT 482
           ++PE      G  +  SDV+++G++++E+ 
Sbjct: 201 MSPESL--KDGVFTTYSDVWSFGVVLWEIA 228

>pdb|2HEL|A Chain A, Crystal Structure Of A Mutant Epha4 Kinase Domain (Y742a) Length = 306

Iteration: 1
 Score = 53.5 bits (127), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 44/196 (22%), Positives = 89/196 (45%), Gaps = 40/196 (20%)
Query: 321 LGQGGYGSVYKGKL-LDGSN---VAVKVLND--SKGNGKEFINEVASISRTSHVNVVALL 374
           +G G +G V  G+L + G     VA+K L    +    ++F++E + + +  H N++ L 
Sbjct: 37  IGVGEFGEVCSGRLKVPGKREICVAIKTLKAGYTDKQRRDFLSEASIMGQFDHPNIIHLE 96
Query: 375 GFCLR----------------------------VAEELSSTIGIARGLEYLHLGCSTRIL 406
           G   +                            V + +    GI  G++YL        +
Sbjct: 97  GVVTKCKPVMIITEYMENGSLDAFLRKNDGRFTVIQLVGMLRGIGSGMKYL---SDMSAV 153
Query: 407 HFDIKPHNILLDEDFCPKISDFGLAKIC-NRKESIISMTGARGTVGYIAPEVFCRNIGEV 465
           H D+   NIL++ +   K+SDFG++++  +  E+  +  G +  + + APE       + 
Sbjct: 154 HRDLAARNILVNSNLVCKVSDFGMSRVLEDDPEAAYTTRGGKIPIRWTAPEAIAYR--KF 211
Query: 466 SYKSDVYNYGMMIFEM 481
           +  SDV++YG++++E+
Sbjct: 212 TSASDVWSYGIVMWEV 227

>pdb|4FV7|A Chain A, Crystal Structure Of The Erk2 Complexed With E94 Length = 360

Iteration: 1
 Score = 53.5 bits (127), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 34/97 (35%), Positives = 52/97 (53%), Gaps = 5/97 (5%)
Query: 390 IARGLEYLHLGCSTRILHFDIKPHNILLDEDFCPKISDFGLAKICNRKESIIS-MTGARG 448
           I RGL+Y+H   S  +LH D+KP N+LL+     KI DFGLA++ +        +T    
Sbjct: 133 ILRGLKYIH---SANVLHRDLKPSNLLLNTTXDLKICDFGLARVADPDHDHTGFLTEYVA 189
Query: 449 TVGYIAPEVFCRNIGEVSYKSDVYNYGMMIFEMTGGR 485
           T  Y APE+   + G  +   D+++ G ++ EM   R
Sbjct: 190 TRWYRAPEIMLNSKG-YTKSIDIWSVGCILAEMLSNR 225

>pdb|4GSB|A Chain A, Monoclinic Crystal Form Of The Apo-Erk2 Length = 364

Iteration: 1
 Score = 53.5 bits (127), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 34/97 (35%), Positives = 52/97 (53%), Gaps = 5/97 (5%)
Query: 390 IARGLEYLHLGCSTRILHFDIKPHNILLDEDFCPKISDFGLAKICNRKESIIS-MTGARG 448
           I RGL+Y+H   S  +LH D+KP N+LL+     KI DFGLA++ +        +T    
Sbjct: 137 ILRGLKYIH---SANVLHRDLKPSNLLLNTTXDLKICDFGLARVADPDHDHTGFLTEYVA 193
Query: 449 TVGYIAPEVFCRNIGEVSYKSDVYNYGMMIFEMTGGR 485
           T  Y APE+   + G  +   D+++ G ++ EM   R
Sbjct: 194 TRWYRAPEIMLNSKG-YTKSIDIWSVGCILAEMLSNR 229

>pdb|3KUL|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325

Iteration: 1
 Score = 53.5 bits (127), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 50/197 (25%), Positives = 93/197 (47%), Gaps = 42/197 (21%)
Query: 321 LGQGGYGSVYKGKL-LDGSN---VAVKVLND--SKGNGKEFINEVASISRTSHVNVVALL 374
           +G G  G V  G+L + G     VA+K L    ++   ++F++E + + +  H N++ L 
Sbjct: 57  IGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDFLSEASIMGQFDHPNIIRLE 116
Query: 375 GFCLR------VAEELSS--------------TI--------GIARGLEYLH-LGCSTRI 405
           G   R      V E + +              TI        G+  G+ YL  LG     
Sbjct: 117 GVVTRGRLAMIVTEYMENGSLDTFLRTHDGQFTIMQLVGMLRGVGAGMRYLSDLGY---- 172
Query: 406 LHFDIKPHNILLDEDFCPKISDFGLAKIC-NRKESIISMTGARGTVGYIAPEVFCRNIGE 464
           +H D+   N+L+D +   K+SDFGL+++  +  ++  + TG +  + + APE        
Sbjct: 173 VHRDLAARNVLVDSNLVCKVSDFGLSRVLEDDPDAAYTTTGGKIPIRWTAPEAIA--FRT 230
Query: 465 VSYKSDVYNYGMMIFEM 481
            S  SDV+++G++++E+
Sbjct: 231 FSSASDVWSFGVVMWEV 247

>pdb|2XIK|A Chain A, Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related Kinase 1) Length = 294

Iteration: 1
 Score = 53.5 bits (127), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 52/196 (26%), Positives = 91/196 (46%), Gaps = 40/196 (20%)
Query: 320 KLGQGGYGSVYKGKLLDGSN---VAVKV--LNDSKGNGKEFINEVASISRTSHVNVVALL 374
           ++G+G +G VYKG  +D      VA+K+  L +++   ++   E+  +S+     +    
Sbjct: 26  RIGKGSFGEVYKG--IDNHTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYITRYF 83
Query: 375 GFCLR------------------------VAEELSSTI--GIARGLEYLHLGCSTRILHF 408
           G  L+                        + E   +TI   I +GL+YLH   S R +H 
Sbjct: 84  GSYLKSTKLWIIMEYLGGGSALDLLKPGPLEETYIATILREILKGLDYLH---SERKIHR 140
Query: 409 DIKPHNILLDEDFCPKISDFGLAKICNRKESIISMTGARGTVGYIAPEVFCRNIGEVSYK 468
           DIK  N+LL E    K++DFG+A      ++ I      GT  ++APEV  ++     +K
Sbjct: 141 DIKAANVLLSEQGDVKLADFGVA--GQLTDTQIKRNXFVGTPFWMAPEVIKQS--AYDFK 196
Query: 469 SDVYNYGMMIFEMTGG 484
           +D+++ G+   E+  G
Sbjct: 197 ADIWSLGITAIELAKG 212

>pdb|1PME|A Chain A, Structure Of Penta Mutant Human Erk2 Map Kinase Complexed With A Specific Inhibitor Of Human P38 Map Kinase Length = 380

Iteration: 1
 Score = 53.1 bits (126), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 34/97 (35%), Positives = 52/97 (53%), Gaps = 5/97 (5%)
Query: 390 IARGLEYLHLGCSTRILHFDIKPHNILLDEDFCPKISDFGLAKICNRKESIIS-MTGARG 448
           I RGL+Y+H   S  +LH D+KP N+LL+     KI DFGLA++ +        +T    
Sbjct: 153 ILRGLKYIH---SANVLHRDLKPSNLLLNTTXDLKICDFGLARVADPDHDHTGFLTEYVA 209
Query: 449 TVGYIAPEVFCRNIGEVSYKSDVYNYGMMIFEMTGGR 485
           T  Y APE+   + G  +   D+++ G ++ EM   R
Sbjct: 210 TRWYRAPEIMLNSKG-YTKSIDIWSVGCILAEMLSNR 245

>pdb|1UA2|A Chain A, Crystal Structure Of Human Cdk7 Length = 346

Iteration: 1
 Score = 53.1 bits (126), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 41/146 (28%), Positives = 65/146 (44%), Gaps = 37/146 (25%)
Query: 321 LGQGGYGSVYKGKLLDGSNVAV--KVLNDSKGNGKEFIN-----EVASISRTSHVNVVAL 373
           LG+G + +VYK +  + + +    K+    +   K+ IN     E+  +   SH N++ L
Sbjct: 18  LGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGL 77
Query: 374 L---------------------------GFCLRVAEELSSTIGIARGLEYLHLGCSTRIL 406
           L                              L  +   +  +   +GLEYLH      IL
Sbjct: 78  LDAFGHKSNISLVFDFMETDLEVIIKDNSLVLTPSHIKAYMLMTLQGLEYLH---QHWIL 134
Query: 407 HFDIKPHNILLDEDFCPKISDFGLAK 432
           H D+KP+N+LLDE+   K++DFGLAK
Sbjct: 135 HRDLKPNNLLLDENGVLKLADFGLAK 160

>pdb|2ZOQ|A Chain A, Structural Dissection Of Human Mitogen-Activated Kinase Erk1 Length = 382

Iteration: 1
 Score = 53.1 bits (126), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 34/97 (35%), Positives = 53/97 (54%), Gaps = 5/97 (5%)
Query: 390 IARGLEYLHLGCSTRILHFDIKPHNILLDEDFCPKISDFGLAKICNRKESIIS-MTGARG 448
           I RGL+Y+H   S  +LH D+KP N+L++     KI DFGLA+I + +      +T    
Sbjct: 153 ILRGLKYIH---SANVLHRDLKPSNLLINTTCDLKICDFGLARIADPEHDHTGFLTEXVA 209
Query: 449 TVGYIAPEVFCRNIGEVSYKSDVYNYGMMIFEMTGGR 485
           T  Y APE+   + G  +   D+++ G ++ EM   R
Sbjct: 210 TRWYRAPEIMLNSKG-YTKSIDIWSVGCILAEMLSNR 245

>pdb|2Y6M|A Chain A, Crystal Structure Of Epha4 Kinase Domain Length = 291

Iteration: 1
 Score = 53.1 bits (126), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 44/196 (22%), Positives = 89/196 (45%), Gaps = 40/196 (20%)
Query: 321 LGQGGYGSVYKGKL-LDGSN---VAVKVLND--SKGNGKEFINEVASISRTSHVNVVALL 374
           +G G +G V  G+L + G     VA+K L    +    ++F++E + + +  H N++ L 
Sbjct: 22  IGVGEFGEVCSGRLKVPGKREICVAIKTLKAGYTDKQRRDFLSEASIMGQFDHPNIIHLE 81
Query: 375 GFCLR----------------------------VAEELSSTIGIARGLEYLHLGCSTRIL 406
           G   +                            V + +    GI  G++YL        +
Sbjct: 82  GVVTKCKPVMIITEYMENGSLDAFLRKNDGRFTVIQLVGMLRGIGSGMKYL---SDMSYV 138
Query: 407 HFDIKPHNILLDEDFCPKISDFGLAKIC-NRKESIISMTGARGTVGYIAPEVFCRNIGEV 465
           H D+   NIL++ +   K+SDFG++++  +  E+  +  G +  + + APE       + 
Sbjct: 139 HRDLAARNILVNSNLVCKVSDFGMSRVLEDDPEAAYTTRGGKIPIRWTAPEAIAYR--KF 196
Query: 466 SYKSDVYNYGMMIFEM 481
           +  SDV++YG++++E+
Sbjct: 197 TSASDVWSYGIVMWEV 212

>pdb|3RZF|A Chain A, Crystal Structure Of Inhibitor Of Kappab Kinase Beta (I4122) Length = 677

Iteration: 1
 Score = 53.1 bits (126), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 59/213 (27%), Positives = 89/213 (41%), Gaps = 51/213 (23%)
Query: 316 SFKYKLGQGGYGSVYKGKLLD-GSNVAVKVLND--SKGNGKEFINEVASISRTSHVNVVA 372
             K +LG GG+G V +    D G  VA+K      S  N + +  E+  + + +H NVV+
Sbjct: 18  EMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKLNHPNVVS 77
Query: 373 -----------------LLGF-----------------CLRVAEELSSTI--GIARGLEY 396
                            LL                   C  + E    T+   I+  L Y
Sbjct: 78  AREVPDGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISSALRY 137
Query: 397 LHLGCSTRILHFDIKPHNILLD---EDFCPKISDFGLAKICNRKESIISMTGARGTVGYI 453
           LH     RI+H D+KP NI+L    +    KI D G AK  ++ E         GT+ Y+
Sbjct: 138 LH---ENRIIHRDLKPENIVLQPGPQRLIHKIIDLGYAKELDQGELCTEFV---GTLQYL 191
Query: 454 APEVFCRNIGEVSYKSDVYNYGMMIFE-MTGGR 485
           APE+  +    V+   D +++G + FE +TG R
Sbjct: 192 APELLEQKKYTVTV--DYWSFGTLAFECITGFR 222

>pdb|3QA8|A Chain A, Crystal Structure Of Inhibitor Of Kappa B Kinase Beta Length = 676

Iteration: 1
 Score = 53.1 bits (126), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 59/213 (27%), Positives = 89/213 (41%), Gaps = 51/213 (23%)
Query: 316 SFKYKLGQGGYGSVYKGKLLD-GSNVAVKVLND--SKGNGKEFINEVASISRTSHVNVVA 372
             K +LG GG+G V +    D G  VA+K      S  N + +  E+  + + +H NVV+
Sbjct: 17  EMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKLNHPNVVS 76
Query: 373 -----------------LLGF-----------------CLRVAEELSSTI--GIARGLEY 396
                            LL                   C  + E    T+   I+  L Y
Sbjct: 77  AREVPDGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISSALRY 136
Query: 397 LHLGCSTRILHFDIKPHNILLD---EDFCPKISDFGLAKICNRKESIISMTGARGTVGYI 453
           LH     RI+H D+KP NI+L    +    KI D G AK  ++ E         GT+ Y+
Sbjct: 137 LH---ENRIIHRDLKPENIVLQPGPQRLIHKIIDLGYAKELDQGELCTEFV---GTLQYL 190
Query: 454 APEVFCRNIGEVSYKSDVYNYGMMIFE-MTGGR 485
           APE+  +    V+   D +++G + FE +TG R
Sbjct: 191 APELLEQKKYTVTV--DYWSFGTLAFECITGFR 221

>pdb|2A19|B Chain B, Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Length = 284

Iteration: 1
 Score = 53.1 bits (126), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 53/212 (25%), Positives = 93/212 (43%), Gaps = 67/212 (31%)
Query: 321 LGQGGYGSVYKGK-LLDGSNVAVKVLNDSKGNGKEFINEVASISRTSHVNVVALLG---- 375
           +G GG+G V+K K  +DG    +K +   K N ++   EV ++++  HVN+V   G    
Sbjct: 19  IGSGGFGQVFKAKHRIDGKTYVIKRV---KYNNEKAEREVKALAKLDHVNIVHYNGCWDG 75
Query: 376 -------------------------FC----------LRVAEELSSTIG------IARGL 394
                                    FC           R  E+L   +       I +G+
Sbjct: 76  FDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLDKVLALELFEQITKGV 135
Query: 395 EYLHLGCSTRILHFDIKPHNILLDEDFCPKISDFGLAKICNRKESIISMTGAR----GTV 450
           +Y+H   S ++++ D+KP NI L +    KI DFGL        + +   G R    GT+
Sbjct: 136 DYIH---SKKLINRDLKPSNIFLVDTKQVKIGDFGLV-------TSLKNDGKRXRSKGTL 185
Query: 451 GYIAPE-VFCRNIGEVSYKSDVYNYGMMIFEM 481
            Y++PE +  ++ G+   + D+Y  G+++ E+
Sbjct: 186 RYMSPEQISSQDYGK---EVDLYALGLILAEL 214

>pdb|4AAA|A Chain A, Crystal Structure Of The Human Cdkl2 Kinase Domain Length = 331

Iteration: 1
 Score = 53.1 bits (126), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 58/197 (29%), Positives = 84/197 (42%), Gaps = 41/197 (20%)
Query: 321 LGQGGYGSVYKGKLLD-GSNVAVKVL---NDSKGNGKEFINEVASISRTSHVNVVALLGF 376
           +G+G YG V K +  D G  VA+K     +D K   K  + E+  + +  H N+V LL  
Sbjct: 33  VGEGSYGMVMKCRNKDTGRIVAIKKFLESDDDKMVKKIAMREIKLLKQLRHENLVNLLEV 92
Query: 377 CLR------VAEELSSTI---------------------GIARGLEYLHLGCSTRILHFD 409
           C +      V E +  TI                      I  G+ + H   S  I+H D
Sbjct: 93  CKKKKRWYLVFEFVDHTILDDLELFPNGLDYQVVQKYLFQIINGIGFCH---SHNIIHRD 149
Query: 410 IKPHNILLDEDFCPKISDFGLAKICNRKESIISMTGARGTVGYIAPEVFCRNIGEVSY-- 467
           IKP NIL+ +    K+ DFG A+       +     A  T  Y APE+    +G+V Y  
Sbjct: 150 IKPENILVSQSGVVKLCDFGFARTLAAPGEVYDDEVA--TRWYRAPELL---VGDVKYGK 204
Query: 468 KSDVYNYGMMIFEMTGG 484
             DV+  G ++ EM  G
Sbjct: 205 AVDVWAIGCLVTEMFMG 221

>pdb|2JDO|A Chain A, Structure Of Pkb-Beta (Akt2) Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 342

Iteration: 1
 Score = 53.1 bits (126), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 66/217 (30%), Positives = 92/217 (42%), Gaps = 47/217 (21%)
Query: 306 GYADIKKMTNSFKYK--LGQGGYGSVYKGK-LLDGSNVAVKVLNDSKGNGKEFINEVASI 362
           G  D K   N F Y   LG+G +G V   +    G   A+K+L       K+ +    + 
Sbjct: 1   GAMDPKVTMNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTE 60
Query: 363 SR----TSHVNVVAL---------LGFCLRVA----------------EELSSTIG--IA 391
           SR    T H  + AL         L F +  A                EE +   G  I 
Sbjct: 61  SRVLQNTRHPFLTALKYAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARFYGAEIV 120
Query: 392 RGLEYLHLGCSTRILHFDIKPHNILLDEDFCPKISDFGLAKICNRKESI---ISMTGARG 448
             LEYLH   S  +++ DIK  N++LD+D   KI+DFGL      KE I    +M    G
Sbjct: 121 SALEYLH---SRDVVYRDIKLENLMLDKDGHIKITDFGLC-----KEGISDGATMKXFCG 172
Query: 449 TVGYIAPEVFCRNIGEVSYKSDVYNYGMMIFEMTGGR 485
           T  Y+APEV   N  +     D +  G++++EM  GR
Sbjct: 173 TPEYLAPEVLEDN--DYGRAVDWWGLGVVMYEMMCGR 207

>pdb|2YAC|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With Nms-P937 Length = 311

Iteration: 1
 Score = 53.1 bits (126), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 57/202 (28%), Positives = 88/202 (43%), Gaps = 49/202 (24%)
Query: 321 LGQGGYGSVYKGKLLDGSNV-AVKVLNDS---KGNGKEFINEVASISRT-SHVNVVALLG 375
           LG+GG+   ++    D   V A K++  S   K + +E ++   SI R+ +H +VV   G
Sbjct: 25  LGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHG 84
Query: 376 F---------------------------CLRVAEELSSTIGIARGLEYLHLGCSTRILHF 408
           F                            L   E       I  G +YLH     R++H 
Sbjct: 85  FFEDNDFVFVVLELCRRRSLLELHKRRKALTEPEARYYLRQIVLGCQYLH---RNRVIHR 141
Query: 409 DIKPHNILLDEDFCPKISDFGLAKICNRKESIISMTGAR-----GTVGYIAPEVFCRNIG 463
           D+K  N+ L+ED   KI DFGLA       + +   G R     GT  YIAPEV  +  G
Sbjct: 142 DLKLGNLFLNEDLEVKIGDFGLA-------TKVEYDGERKKTLCGTPNYIAPEVLSKK-G 193
Query: 464 EVSYKSDVYNYGMMIFEMTGGR 485
             S++ DV++ G +++ +  G+
Sbjct: 194 H-SFEVDVWSIGCIMYTLLVGK 214

>pdb|3THB|A Chain A, Structure Of Plk1 Kinase Domain In Complex With A Benzolactam-Derived Inhibitor Length = 333

Iteration: 1
 Score = 53.1 bits (126), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 57/202 (28%), Positives = 88/202 (43%), Gaps = 49/202 (24%)
Query: 321 LGQGGYGSVYKGKLLDGSNV-AVKVLNDS---KGNGKEFINEVASISRT-SHVNVVALLG 375
           LG+GG+   ++    D   V A K++  S   K + +E ++   SI R+ +H +VV   G
Sbjct: 47  LGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHG 106
Query: 376 F---------------------------CLRVAEELSSTIGIARGLEYLHLGCSTRILHF 408
           F                            L   E       I  G +YLH     R++H 
Sbjct: 107 FFEDNDFVFVVLELCRRRSLLELHKRRKALTEPEARYYLRQIVLGCQYLH---RNRVIHR 163
Query: 409 DIKPHNILLDEDFCPKISDFGLAKICNRKESIISMTGAR-----GTVGYIAPEVFCRNIG 463
           D+K  N+ L+ED   KI DFGLA       + +   G R     GT  YIAPEV  +  G
Sbjct: 164 DLKLGNLFLNEDLEVKIGDFGLA-------TKVEYDGERKKVLCGTPNYIAPEVLSKK-G 215
Query: 464 EVSYKSDVYNYGMMIFEMTGGR 485
             S++ DV++ G +++ +  G+
Sbjct: 216 H-SFEVDVWSIGCIMYTLLVGK 236

>pdb|2Y4I|B Chain B, Ksr2-Mek1 Heterodimer Length = 319

Iteration: 1
 Score = 53.1 bits (126), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 53/205 (25%), Positives = 91/205 (44%), Gaps = 53/205 (25%)
Query: 321 LGQGGYGSVYKGKLLDGSNVAVKVLN---DSKGNGKEFINEVASISRTSHVNVVALLGFC 377
           +G+G +G VY G+      VA+++++   D++   K F  EV +  +T H NVV  +G C
Sbjct: 41  IGKGRFGQVYHGRW--HGEVAIRLIDIERDNEDQLKAFKREVMAYRQTRHENVVLFMGAC 98
Query: 378 L------------------------RVAEELSSTIGIA----RGLEYLHLGCSTRILHFD 409
           +                        ++  +++ T  IA    +G+ YLH   +  ILH D
Sbjct: 99  MSPPHLAIITSLCKGRTLYSVVRDAKIVLDVNKTRQIAQEIVKGMGYLH---AKGILHKD 155
Query: 410 IKPHNILLDEDFCPKISDFGLAKI-----CNRKESIISMTGARGTVGYIAPEVFCRNIG- 463
           +K  N+  D      I+DFGL  I       R+E  + +    G + ++APE+  R +  
Sbjct: 156 LKSKNVFYDNGKV-VITDFGLFSISGVLQAGRREDKLRIQN--GWLCHLAPEI-IRQLSP 211
Query: 464 -------EVSYKSDVYNYGMMIFEM 481
                    S  SDV+  G + +E+
Sbjct: 212 DTEEDKLPFSKHSDVFALGTIWYEL 236

>pdb|2OU7|A Chain A, Structure Of The Catalytic Domain Of Human Polo-Like Kinase 1 Length = 335

Iteration: 1
 Score = 53.1 bits (126), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 57/202 (28%), Positives = 88/202 (43%), Gaps = 49/202 (24%)
Query: 321 LGQGGYGSVYKGKLLDGSNV-AVKVLNDS---KGNGKEFINEVASISRT-SHVNVVALLG 375
           LG+GG+   ++    D   V A K++  S   K + +E ++   SI R+ +H +VV   G
Sbjct: 49  LGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHG 108
Query: 376 F---------------------------CLRVAEELSSTIGIARGLEYLHLGCSTRILHF 408
           F                            L   E       I  G +YLH     R++H 
Sbjct: 109 FFEDNDFVFVVLELCRRRSLLELHKRRKALTEPEARYYLRQIVLGCQYLH---RNRVIHR 165
Query: 409 DIKPHNILLDEDFCPKISDFGLAKICNRKESIISMTGAR-----GTVGYIAPEVFCRNIG 463
           D+K  N+ L+ED   KI DFGLA       + +   G R     GT  YIAPEV  +  G
Sbjct: 166 DLKLGNLFLNEDLEVKIGDFGLA-------TKVEYDGERKKVLCGTPNYIAPEVLSKK-G 217
Query: 464 EVSYKSDVYNYGMMIFEMTGGR 485
             S++ DV++ G +++ +  G+
Sbjct: 218 H-SFEVDVWSIGCIMYTLLVGK 238

>pdb|2HEN|A Chain A, Crystal Structure Of The Ephb2 Receptor Kinase Domain In Complex With Adp Length = 286

Iteration: 1
 Score = 53.1 bits (126), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 49/198 (24%), Positives = 87/198 (43%), Gaps = 42/198 (21%)
Query: 321 LGQGGYGSVYKGKL-LDGSN---VAVKVLND--SKGNGKEFINEVASISRTSHVNVVALL 374
           +G G +G V  G L L G     VA+K L    ++   ++F++E + + +  H NV+ L 
Sbjct: 15  IGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNVIHLE 74
Query: 375 GFCLR----------------------------VAEELSSTIGIARGLEYLHLGCSTRIL 406
           G   +                            V + +    GIA G++YL        +
Sbjct: 75  GVVTKSTPVMIITEFMENGSLDSFLRQNDGQFTVIQLVGMLRGIAAGMKYL---ADMNYV 131
Query: 407 HFDIKPHNILLDEDFCPKISDFGLAKICNRKESIISMTGARG---TVGYIAPEVFCRNIG 463
           H  +   NIL++ +   K+SDFGL++      S  + T A G    + + APE       
Sbjct: 132 HRALAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSALGGKIPIRWTAPEAI--QYR 189
Query: 464 EVSYKSDVYNYGMMIFEM 481
           + +  SDV++YG++++E+
Sbjct: 190 KFTSASDVWSYGIVMWEV 207

>pdb|4H3Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score = 53.1 bits (126), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 34/97 (35%), Positives = 52/97 (53%), Gaps = 5/97 (5%)
Query: 390 IARGLEYLHLGCSTRILHFDIKPHNILLDEDFCPKISDFGLAKICNRKESIIS-MTGARG 448
           I RGL+Y+H   S  +LH D+KP N+LL+     KI DFGLA++ +        +T    
Sbjct: 135 ILRGLKYIH---SANVLHRDLKPSNLLLNTTSDLKICDFGLARVADPDHDHTGFLTEYVA 191
Query: 449 TVGYIAPEVFCRNIGEVSYKSDVYNYGMMIFEMTGGR 485
           T  Y APE+   + G  +   D+++ G ++ EM   R
Sbjct: 192 TRWYRAPEIMLNSKG-YTKSIDIWSVGCILAEMLSNR 227

>pdb|3KB7|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 311

Iteration: 1
 Score = 53.1 bits (126), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 57/202 (28%), Positives = 88/202 (43%), Gaps = 49/202 (24%)
Query: 321 LGQGGYGSVYKGKLLDGSNV-AVKVLNDS---KGNGKEFINEVASISRT-SHVNVVALLG 375
           LG+GG+   ++    D   V A K++  S   K + +E ++   SI R+ +H +VV   G
Sbjct: 25  LGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHG 84
Query: 376 F---------------------------CLRVAEELSSTIGIARGLEYLHLGCSTRILHF 408
           F                            L   E       I  G +YLH     R++H 
Sbjct: 85  FFEDNDFVFVVLELCRRRSLLELHKRRKALTEPEARYYLRQIVLGCQYLH---RNRVIHR 141
Query: 409 DIKPHNILLDEDFCPKISDFGLAKICNRKESIISMTGAR-----GTVGYIAPEVFCRNIG 463
           D+K  N+ L+ED   KI DFGLA       + +   G R     GT  YIAPEV  +  G
Sbjct: 142 DLKLGNLFLNEDLEVKIGDFGLA-------TKVEYDGERKKTLCGTPNYIAPEVLSKK-G 193
Query: 464 EVSYKSDVYNYGMMIFEMTGGR 485
             S++ DV++ G +++ +  G+
Sbjct: 194 H-SFEVDVWSIGCIMYTLLVGK 214

>pdb|2XYU|A Chain A, Crystal Structure Of Epha4 Kinase Domain In Complex With Vuf 12058 Length = 285

Iteration: 1
 Score = 53.1 bits (126), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 44/196 (22%), Positives = 89/196 (45%), Gaps = 40/196 (20%)
Query: 321 LGQGGYGSVYKGKL-LDGSN---VAVKVLND--SKGNGKEFINEVASISRTSHVNVVALL 374
           +G G +G V  G+L + G     VA+K L    +    ++F++E + + +  H N++ L 
Sbjct: 16  IGVGEFGEVCSGRLKVPGKREICVAIKTLKAGYTDKQRRDFLSEASIMGQFDHPNIIHLE 75
Query: 375 GFCLR----------------------------VAEELSSTIGIARGLEYLHLGCSTRIL 406
           G   +                            V + +    GI  G++YL        +
Sbjct: 76  GVVTKCKPVMIITEYMENGSLDAFLRKNDGRFTVIQLVGMLRGIGSGMKYL---SDMSYV 132
Query: 407 HFDIKPHNILLDEDFCPKISDFGLAKIC-NRKESIISMTGARGTVGYIAPEVFCRNIGEV 465
           H D+   NIL++ +   K+SDFG++++  +  E+  +  G +  + + APE       + 
Sbjct: 133 HRDLAARNILVNSNLVCKVSDFGMSRVLEDDPEAAYTTRGGKIPIRWTAPEAIAYR--KF 190
Query: 466 SYKSDVYNYGMMIFEM 481
           +  SDV++YG++++E+
Sbjct: 191 TSASDVWSYGIVMWEV 206

>pdb|2Q0N|A Chain A, Structure Of Human P21 Activating Kinase 4 (Pak4) In Complex With A Consensus Peptide Length = 301

Iteration: 1
 Score = 53.1 bits (126), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 55/199 (27%), Positives = 92/199 (46%), Gaps = 47/199 (23%)
Query: 320 KLGQGGYGSVYKGKLLD-GSNVAVKVLNDSKGNGKEFI-NEVASISRTSHVNVVA----- 372
           K+G+G  G V    +   G  VAVK ++  K   +E + NEV  +    H NVV      
Sbjct: 36  KIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSY 95
Query: 373 LLGFCLRVA--------------------EELSST-IGIARGLEYLHLGCSTRILHFDIK 411
           L+G  L V                     E++++  + + + L  LH   +  ++H DIK
Sbjct: 96  LVGDELWVVMEFLEGGALTDIVTHTRMNEEQIAAVCLAVLQALSVLH---AQGVIHRDIK 152
Query: 412 PHNILLDEDFCPKISDFG----LAKICNRKESIISMTGARGTVGYIAPEVFCRNIGEVSY 467
             +ILL  D   K+SDFG    ++K   R++ ++      GT  ++APE+  R    + Y
Sbjct: 153 SDSILLTHDGRVKLSDFGFCAQVSKEVPRRKXLV------GTPYWMAPELISR----LPY 202
Query: 468 --KSDVYNYGMMIFEMTGG 484
             + D+++ G+M+ EM  G
Sbjct: 203 GPEVDIWSLGIMVIEMVDG 221

>pdb|2V5Q|A Chain A, Crystal Structure Of Wild-type Plk-1 Kinase Domain In Complex With A Selective Darpin Length = 315

Iteration: 1
 Score = 52.8 bits (125), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 57/202 (28%), Positives = 88/202 (43%), Gaps = 49/202 (24%)
Query: 321 LGQGGYGSVYKGKLLDGSNV-AVKVLNDS---KGNGKEFINEVASISRT-SHVNVVALLG 375
           LG+GG+   ++    D   V A K++  S   K + +E ++   SI R+ +H +VV   G
Sbjct: 29  LGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHG 88
Query: 376 F---------------------------CLRVAEELSSTIGIARGLEYLHLGCSTRILHF 408
           F                            L   E       I  G +YLH     R++H 
Sbjct: 89  FFEDNDFVFVVLELCRRRSLLELHKRRKALTEPEARYYLRQIVLGCQYLH---RNRVIHR 145
Query: 409 DIKPHNILLDEDFCPKISDFGLAKICNRKESIISMTGAR-----GTVGYIAPEVFCRNIG 463
           D+K  N+ L+ED   KI DFGLA       + +   G R     GT  YIAPEV  +  G
Sbjct: 146 DLKLGNLFLNEDLEVKIGDFGLA-------TKVEYDGERKKTLCGTPNYIAPEVLSKK-G 197
Query: 464 EVSYKSDVYNYGMMIFEMTGGR 485
             S++ DV++ G +++ +  G+
Sbjct: 198 H-SFEVDVWSIGCIMYTLLVGK 218

>pdb|2CDZ|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Cgp74514a Length = 303

Iteration: 1
 Score = 52.8 bits (125), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 55/199 (27%), Positives = 92/199 (46%), Gaps = 47/199 (23%)
Query: 320 KLGQGGYGSVYKGKLLD-GSNVAVKVLNDSKGNGKEFI-NEVASISRTSHVNVVA----- 372
           K+G+G  G V    +   G  VAVK ++  K   +E + NEV  +    H NVV      
Sbjct: 38  KIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSY 97
Query: 373 LLGFCLRVA--------------------EELSST-IGIARGLEYLHLGCSTRILHFDIK 411
           L+G  L V                     E++++  + + + L  LH   +  ++H DIK
Sbjct: 98  LVGDELWVVMEFLEGGALTDIVTHTRMNEEQIAAVCLAVLQALSVLH---AQGVIHRDIK 154
Query: 412 PHNILLDEDFCPKISDFG----LAKICNRKESIISMTGARGTVGYIAPEVFCRNIGEVSY 467
             +ILL  D   K+SDFG    ++K   R++ ++      GT  ++APE+  R    + Y
Sbjct: 155 SDSILLTHDGRVKLSDFGFCAQVSKEVPRRKXLV------GTPYWMAPELISR----LPY 204
Query: 468 --KSDVYNYGMMIFEMTGG 484
             + D+++ G+M+ EM  G
Sbjct: 205 GPEVDIWSLGIMVIEMVDG 223

>pdb|3UIU|A Chain A, Crystal Structure Of Apo-Pkr Kinase Domain Length = 306

Iteration: 1
 Score = 52.8 bits (125), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 52/221 (23%), Positives = 92/221 (41%), Gaps = 72/221 (32%)
Query: 321 LGQGGYGSVYKGK-LLDGSNVAVKVLNDSKGNGKEFINEVASISRTSHVNVVALLG---- 375
           +G GG+G V+K K  +DG    ++ +   K N ++   EV ++++  HVN+V   G    
Sbjct: 20  IGSGGFGQVFKAKHRIDGKTYVIRRV---KYNNEKAEREVKALAKLDHVNIVHYNGCWDG 76
Query: 376 --------------------------------------FC----------LRVAEELSST 387
                                                 FC           R  E+L   
Sbjct: 77  FDYDPETSDDSLESSDYDPENSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLDKV 136
Query: 388 IG------IARGLEYLHLGCSTRILHFDIKPHNILLDEDFCPKISDFGLAKICNRKESII 441
           +       I +G++Y+H   S +++H D+KP NI L +    KI DFGL           
Sbjct: 137 LALELFEQITKGVDYIH---SKKLIHRDLKPSNIFLVDTKQVKIGDFGLVTSLKNDG--- 190
Query: 442 SMTGARGTVGYIAPE-VFCRNIGEVSYKSDVYNYGMMIFEM 481
             T ++GT+ Y++PE +  ++ G+   + D+Y  G+++ E+
Sbjct: 191 KRTRSKGTLRYMSPEQISSQDYGK---EVDLYALGLILAEL 228

>pdb|3FE3|A Chain A, Crystal Structure Of The Kinase Mark3PAR-1: T211a-S215a Double Mutant Length = 328

Iteration: 1
 Score = 52.8 bits (125), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 55/234 (23%), Positives = 95/234 (40%), Gaps = 56/234 (23%)
Query: 282 NSTASCLNIETFLRNYRSLSPKRYGYADIKKMTNSFKYKLGQGGYGSVYKGK-LLDGSNV 340
           NS ASC + +  + NYR L                    +G+G +  V   + +L G  V
Sbjct: 2   NSIASCADEQPHIGNYRLLKT------------------IGKGNFAKVKLARHILTGREV 43
Query: 341 AVKVLNDSKGNG---KEFINEVASISRTSHVNVVALLGFC-------------------- 377
           A+K+++ ++ N    ++   EV  +   +H N+V L                        
Sbjct: 44  AIKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVKLFEVIETEKTLYLIMEYASGGEVFD 103
Query: 378 -------LRVAEELSSTIGIARGLEYLHLGCSTRILHFDIKPHNILLDEDFCPKISDFGL 430
                  ++  E  S    I   ++Y H     RI+H D+K  N+LLD D   KI+DFG 
Sbjct: 104 YLVAHGRMKEKEARSKFRQIVSAVQYCH---QKRIVHRDLKAENLLLDADMNIKIADFGF 160
Query: 431 AKICNRKESIISMTGARGTVGYIAPEVFCRNIGEVSYKSDVYNYGMMIFEMTGG 484
           +        + +  GA     Y APE+F     +   + DV++ G++++ +  G
Sbjct: 161 SNEFTVGGKLDAFCGAP---PYAAPELFQGKKYD-GPEVDVWSLGVILYTLVSG 210

>pdb|2GPH|A Chain A, Docking Motif Interactions In The Map Kinase Erk2 Length = 364

Iteration: 1
 Score = 52.8 bits (125), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 34/97 (35%), Positives = 52/97 (53%), Gaps = 5/97 (5%)
Query: 390 IARGLEYLHLGCSTRILHFDIKPHNILLDEDFCPKISDFGLAKICNRKESIIS-MTGARG 448
           I RGL+Y+H   S  +LH D+KP N+LL+     KI DFGLA++ +        +T    
Sbjct: 137 ILRGLKYIH---SANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVA 193
Query: 449 TVGYIAPEVFCRNIGEVSYKSDVYNYGMMIFEMTGGR 485
           T  Y APE+   + G  +   D+++ G ++ EM   R
Sbjct: 194 TRWYRAPEIMLNSKG-YTKSIDIWSVGCILAEMLSNR 229

>pdb|2RKU|A Chain A, Structure Of Plk1 In Complex With Bi2536 Length = 294

Iteration: 1
 Score = 52.8 bits (125), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 57/202 (28%), Positives = 88/202 (43%), Gaps = 49/202 (24%)
Query: 321 LGQGGYGSVYKGKLLDGSNV-AVKVLNDS---KGNGKEFINEVASISRT-SHVNVVALLG 375
           LG+GG+   ++    D   V A K++  S   K + +E ++   SI R+ +H +VV   G
Sbjct: 23  LGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHG 82
Query: 376 F---------------------------CLRVAEELSSTIGIARGLEYLHLGCSTRILHF 408
           F                            L   E       I  G +YLH     R++H 
Sbjct: 83  FFEDNDFVFVVLELCRRRSLLELHKRRKALTEPEARYYLRQIVLGCQYLH---RNRVIHR 139
Query: 409 DIKPHNILLDEDFCPKISDFGLAKICNRKESIISMTGAR-----GTVGYIAPEVFCRNIG 463
           D+K  N+ L+ED   KI DFGLA       + +   G R     GT  YIAPEV  +  G
Sbjct: 140 DLKLGNLFLNEDLEVKIGDFGLA-------TKVEYDGERKKVLCGTPNYIAPEVLSKK-G 191
Query: 464 EVSYKSDVYNYGMMIFEMTGGR 485
             S++ DV++ G +++ +  G+
Sbjct: 192 H-SFEVDVWSIGCIMYTLLVGK 212

>pdb|2BVA|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 Length = 292

Iteration: 1
 Score = 52.8 bits (125), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 55/199 (27%), Positives = 92/199 (46%), Gaps = 47/199 (23%)
Query: 320 KLGQGGYGSVYKGKLLD-GSNVAVKVLNDSKGNGKEFI-NEVASISRTSHVNVVA----- 372
           K+G+G  G V    +   G  VAVK ++  K   +E + NEV  +    H NVV      
Sbjct: 27  KIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSY 86
Query: 373 LLGFCLRVA--------------------EELSST-IGIARGLEYLHLGCSTRILHFDIK 411
           L+G  L V                     E++++  + + + L  LH   +  ++H DIK
Sbjct: 87  LVGDELWVVMEFLEGGALTDIVTHTRMNEEQIAAVCLAVLQALSVLH---AQGVIHRDIK 143
Query: 412 PHNILLDEDFCPKISDFG----LAKICNRKESIISMTGARGTVGYIAPEVFCRNIGEVSY 467
             +ILL  D   K+SDFG    ++K   R++ ++      GT  ++APE+  R    + Y
Sbjct: 144 SDSILLTHDGRVKLSDFGFCAQVSKEVPRRKXLV------GTPYWMAPELISR----LPY 193
Query: 468 --KSDVYNYGMMIFEMTGG 484
             + D+++ G+M+ EM  G
Sbjct: 194 GPEVDIWSLGIMVIEMVDG 212

>pdb|3TEI|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score = 52.8 bits (125), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 34/97 (35%), Positives = 52/97 (53%), Gaps = 5/97 (5%)
Query: 390 IARGLEYLHLGCSTRILHFDIKPHNILLDEDFCPKISDFGLAKICNRKESIIS-MTGARG 448
           I RGL+Y+H   S  +LH D+KP N+LL+     KI DFGLA++ +        +T    
Sbjct: 135 ILRGLKYIH---SANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVA 191
Query: 449 TVGYIAPEVFCRNIGEVSYKSDVYNYGMMIFEMTGGR 485
           T  Y APE+   + G  +   D+++ G ++ EM   R
Sbjct: 192 TRWYRAPEIMLNSKG-YTKSIDIWSVGCILAEMLSNR 227

>pdb|1WZY|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Pyrazolopyridazine Derivative Length = 368

Iteration: 1
 Score = 52.8 bits (125), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 34/97 (35%), Positives = 52/97 (53%), Gaps = 5/97 (5%)
Query: 390 IARGLEYLHLGCSTRILHFDIKPHNILLDEDFCPKISDFGLAKICNRKESIIS-MTGARG 448
           I RGL+Y+H   S  +LH D+KP N+LL+     KI DFGLA++ +        +T    
Sbjct: 141 ILRGLKYIH---SANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVA 197
Query: 449 TVGYIAPEVFCRNIGEVSYKSDVYNYGMMIFEMTGGR 485
           T  Y APE+   + G  +   D+++ G ++ EM   R
Sbjct: 198 TRWYRAPEIMLNSKG-YTKSIDIWSVGCILAEMLSNR 233

>pdb|1TVO|A Chain A, The Structure Of Erk2 In Complex With A Small Molecule Inhibitor Length = 368

Iteration: 1
 Score = 52.8 bits (125), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 34/97 (35%), Positives = 52/97 (53%), Gaps = 5/97 (5%)
Query: 390 IARGLEYLHLGCSTRILHFDIKPHNILLDEDFCPKISDFGLAKICNRKESIIS-MTGARG 448
           I RGL+Y+H   S  +LH D+KP N+LL+     KI DFGLA++ +        +T    
Sbjct: 133 ILRGLKYIH---SANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVA 189
Query: 449 TVGYIAPEVFCRNIGEVSYKSDVYNYGMMIFEMTGGR 485
           T  Y APE+   + G  +   D+++ G ++ EM   R
Sbjct: 190 TRWYRAPEIMLNSKG-YTKSIDIWSVGCILAEMLSNR 225

>pdb|4F4P|A Chain A, Syk In Complex With Ligand Lasw836 Length = 273

Iteration: 1
 Score = 52.4 bits (124), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 31/92 (33%), Positives = 52/92 (56%), Gaps = 6/92 (6%)
Query: 390 IARGLEYLHLGCSTRILHFDIKPHNILLDEDFCPKISDFGLAKICNRKESII-SMTGARG 448
           ++ G++YL     +  +H D+   N+LL      KISDFGL+K     E+   + T  + 
Sbjct: 114 VSMGMKYLE---ESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKW 170
Query: 449 TVGYIAPEVFCRNIGEVSYKSDVYNYGMMIFE 480
            V + APE  C N  + S KSDV+++G++++E
Sbjct: 171 PVKWYAPE--CINYYKFSSKSDVWSFGVLMWE 200

>pdb|4FV6|A Chain A, Crystal Structure Of The Erk2 Complexed With E57 Length = 360

Iteration: 1
 Score = 52.4 bits (124), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 34/97 (35%), Positives = 52/97 (53%), Gaps = 5/97 (5%)
Query: 390 IARGLEYLHLGCSTRILHFDIKPHNILLDEDFCPKISDFGLAKICNRKESIIS-MTGARG 448
           I RGL+Y+H   S  +LH D+KP N+LL+     KI DFGLA++ +        +T    
Sbjct: 133 ILRGLKYIH---SANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVA 189
Query: 449 TVGYIAPEVFCRNIGEVSYKSDVYNYGMMIFEMTGGR 485
           T  Y APE+   + G  +   D+++ G ++ EM   R
Sbjct: 190 TRWYRAPEIMLNSKG-YTKSIDIWSVGCILAEMLSNR 225

>pdb|3O71|A Chain A, Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length = 358

Iteration: 1
 Score = 52.4 bits (124), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 34/97 (35%), Positives = 52/97 (53%), Gaps = 5/97 (5%)
Query: 390 IARGLEYLHLGCSTRILHFDIKPHNILLDEDFCPKISDFGLAKICNRKESIIS-MTGARG 448
           I RGL+Y+H   S  +LH D+KP N+LL+     KI DFGLA++ +        +T    
Sbjct: 131 ILRGLKYIH---SANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVA 187
Query: 449 TVGYIAPEVFCRNIGEVSYKSDVYNYGMMIFEMTGGR 485
           T  Y APE+   + G  +   D+++ G ++ EM   R
Sbjct: 188 TRWYRAPEIMLNSKG-YTKSIDIWSVGCILAEMLSNR 223

>pdb|1GOL|A Chain A, Coordinates Of Rat Map Kinase Erk2 With An Arginine Mutation At Position 52 Length = 364

Iteration: 1
 Score = 52.4 bits (124), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 34/97 (35%), Positives = 52/97 (53%), Gaps = 5/97 (5%)
Query: 390 IARGLEYLHLGCSTRILHFDIKPHNILLDEDFCPKISDFGLAKICNRKESIIS-MTGARG 448
           I RGL+Y+H   S  +LH D+KP N+LL+     KI DFGLA++ +        +T    
Sbjct: 137 ILRGLKYIH---SANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVA 193
Query: 449 TVGYIAPEVFCRNIGEVSYKSDVYNYGMMIFEMTGGR 485
           T  Y APE+   + G  +   D+++ G ++ EM   R
Sbjct: 194 TRWYRAPEIMLNSKG-YTKSIDIWSVGCILAEMLSNR 229

>pdb|2Y9Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score = 52.4 bits (124), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 34/97 (35%), Positives = 52/97 (53%), Gaps = 5/97 (5%)
Query: 390 IARGLEYLHLGCSTRILHFDIKPHNILLDEDFCPKISDFGLAKICNRKESIIS-MTGARG 448
           I RGL+Y+H   S  +LH D+KP N+LL+     KI DFGLA++ +        +T    
Sbjct: 135 ILRGLKYIH---SANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVA 191
Query: 449 TVGYIAPEVFCRNIGEVSYKSDVYNYGMMIFEMTGGR 485
           T  Y APE+   + G  +   D+++ G ++ EM   R
Sbjct: 192 TRWYRAPEIMLNSKG-YTKSIDIWSVGCILAEMLSNR 227

>pdb|1MRU|A Chain A, Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycobacterium Tuberculosis Pknb. Length = 311

Iteration: 1
 Score = 52.4 bits (124), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 52/207 (25%), Positives = 84/207 (40%), Gaps = 40/207 (19%)
Query: 316 SFKYKLGQ----GGYGSVYKGKLLD-GSNVAVKVLNDSKGNGKEFI----NEVASISRTS 366
           S +Y+LG+    GG   V+  + L    +VAVKVL         F      E  + +  +
Sbjct: 11  SDRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALN 70
Query: 367 HVNVVALL---------------------GFCLRVAEELSSTIGIARGLEYLHLGCSTR- 404
           H  +VA+                      G  LR        +   R +E +   C    
Sbjct: 71  HPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGPMTPKRAIEVIADACQALN 130
Query: 405 ------ILHFDIKPHNILLDEDFCPKISDFGLAK-ICNRKESIISMTGARGTVGYIAPEV 457
                 I+H D+KP NI++      K+ DFG+A+ I +   S+       GT  Y++PE 
Sbjct: 131 FSHQNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQ 190
Query: 458 FCRNIGEVSYKSDVYNYGMMIFEMTGG 484
              +   V  +SDVY+ G +++E+  G
Sbjct: 191 ARGD--SVDARSDVYSLGCVLYEVLTG 215

>pdb|3ZU7|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Map Kinase Erk2 Length = 365

Iteration: 1
 Score = 52.4 bits (124), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 34/97 (35%), Positives = 52/97 (53%), Gaps = 5/97 (5%)
Query: 390 IARGLEYLHLGCSTRILHFDIKPHNILLDEDFCPKISDFGLAKICNRKESIIS-MTGARG 448
           I RGL+Y+H   S  +LH D+KP N+LL+     KI DFGLA++ +        +T    
Sbjct: 138 ILRGLKYIH---SANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVA 194
Query: 449 TVGYIAPEVFCRNIGEVSYKSDVYNYGMMIFEMTGGR 485
           T  Y APE+   + G  +   D+++ G ++ EM   R
Sbjct: 195 TRWYRAPEIMLNSKG-YTKSIDIWSVGCILAEMLSNR 230

>pdb|3R63|A Chain A, Structure Of Erk2 (Spe) Mutant (S246e) Length = 358

Iteration: 1
 Score = 52.4 bits (124), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 34/97 (35%), Positives = 52/97 (53%), Gaps = 5/97 (5%)
Query: 390 IARGLEYLHLGCSTRILHFDIKPHNILLDEDFCPKISDFGLAKICNRKESIIS-MTGARG 448
           I RGL+Y+H   S  +LH D+KP N+LL+     KI DFGLA++ +        +T    
Sbjct: 131 ILRGLKYIH---SANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVA 187
Query: 449 TVGYIAPEVFCRNIGEVSYKSDVYNYGMMIFEMTGGR 485
           T  Y APE+   + G  +   D+++ G ++ EM   R
Sbjct: 188 TRWYRAPEIMLNSKG-YTKSIDIWSVGCILAEMLSNR 223

>pdb|3ORM|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain D76a Mutant Length = 311

Iteration: 1
 Score = 52.4 bits (124), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 52/207 (25%), Positives = 84/207 (40%), Gaps = 40/207 (19%)
Query: 316 SFKYKLGQ----GGYGSVYKGKLLD-GSNVAVKVLNDSKGNGKEFI----NEVASISRTS 366
           S +Y+LG+    GG   V+  + L    +VAVKVL         F      E  + +  +
Sbjct: 11  SDRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALN 70
Query: 367 HVNVVALL---------------------GFCLRVAEELSSTIGIARGLEYLHLGCSTR- 404
           H  +VA+                      G  LR        +   R +E +   C    
Sbjct: 71  HPAIVAVYATGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGPMTPKRAIEVIADACQALN 130
Query: 405 ------ILHFDIKPHNILLDEDFCPKISDFGLAK-ICNRKESIISMTGARGTVGYIAPEV 457
                 I+H D+KP NI++      K+ DFG+A+ I +   S+       GT  Y++PE 
Sbjct: 131 FSHQNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQ 190
Query: 458 FCRNIGEVSYKSDVYNYGMMIFEMTGG 484
              +   V  +SDVY+ G +++E+  G
Sbjct: 191 ARGD--SVDARSDVYSLGCVLYEVLTG 215

>pdb|2Z7L|A Chain A, Unphosphorylated Mitogen Activated Protein Kinase Erk2 In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin 2-Yl]amino}phenyl)acetic Acid Length = 366

Iteration: 1
 Score = 52.4 bits (124), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 34/97 (35%), Positives = 52/97 (53%), Gaps = 5/97 (5%)
Query: 390 IARGLEYLHLGCSTRILHFDIKPHNILLDEDFCPKISDFGLAKICNRKESIIS-MTGARG 448
           I RGL+Y+H   S  +LH D+KP N+LL+     KI DFGLA++ +        +T    
Sbjct: 139 ILRGLKYIH---SANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVA 195
Query: 449 TVGYIAPEVFCRNIGEVSYKSDVYNYGMMIFEMTGGR 485
           T  Y APE+   + G  +   D+++ G ++ EM   R
Sbjct: 196 TRWYRAPEIMLNSKG-YTKSIDIWSVGCILAEMLSNR 231

>pdb|3C9W|A Chain A, Crystal Structure Of Erk-2 With Hypothemycin Covalently Bound Length = 357

Iteration: 1
 Score = 52.4 bits (124), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 34/97 (35%), Positives = 52/97 (53%), Gaps = 5/97 (5%)
Query: 390 IARGLEYLHLGCSTRILHFDIKPHNILLDEDFCPKISDFGLAKICNRKESIIS-MTGARG 448
           I RGL+Y+H   S  +LH D+KP N+LL+     KI DFGLA++ +        +T    
Sbjct: 130 ILRGLKYIH---SANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVA 186
Query: 449 TVGYIAPEVFCRNIGEVSYKSDVYNYGMMIFEMTGGR 485
           T  Y APE+   + G  +   D+++ G ++ EM   R
Sbjct: 187 TRWYRAPEIMLNSKG-YTKSIDIWSVGCILAEMLSNR 222

>pdb|2FYS|B Chain B, Crystal Structure Of Erk2 Complex With Kim Peptide Derived From Mkp3 Length = 364

Iteration: 1
 Score = 52.4 bits (124), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 34/97 (35%), Positives = 52/97 (53%), Gaps = 5/97 (5%)
Query: 390 IARGLEYLHLGCSTRILHFDIKPHNILLDEDFCPKISDFGLAKICNRKESIIS-MTGARG 448
           I RGL+Y+H   S  +LH D+KP N+LL+     KI DFGLA++ +        +T    
Sbjct: 137 ILRGLKYIH---SANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVA 193
Query: 449 TVGYIAPEVFCRNIGEVSYKSDVYNYGMMIFEMTGGR 485
           T  Y APE+   + G  +   D+++ G ++ EM   R
Sbjct: 194 TRWYRAPEIMLNSKG-YTKSIDIWSVGCILAEMLSNR 229

>pdb|4DFL|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Complexed With A Sulfonamidopyrazine Piperidine Inhibitor Length = 274

Iteration: 1
 Score = 52.4 bits (124), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 31/92 (33%), Positives = 52/92 (56%), Gaps = 6/92 (6%)
Query: 390 IARGLEYLHLGCSTRILHFDIKPHNILLDEDFCPKISDFGLAKICNRKESII-SMTGARG 448
           ++ G++YL     +  +H D+   N+LL      KISDFGL+K     E+   + T  + 
Sbjct: 116 VSMGMKYLE---ESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKW 172
Query: 449 TVGYIAPEVFCRNIGEVSYKSDVYNYGMMIFE 480
            V + APE  C N  + S KSDV+++G++++E
Sbjct: 173 PVKWYAPE--CINYYKFSSKSDVWSFGVLMWE 202

>pdb|3O23|A Chain A, Human Unphosphorylated Igf1-R Kinase Domain In Complex With An Hydantoin Inhibitor Length = 305

Iteration: 1
 Score = 52.4 bits (124), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 56/210 (26%), Positives = 95/210 (45%), Gaps = 54/210 (25%)
Query: 320 KLGQGGYGSVYKG------KLLDGSNVAVKVLNDSKGNGK--EFINEVASISRTSHVNVV 371
           +LGQG +G VY+G      K    + VA+K +N++    +  EF+NE + +   +  +VV
Sbjct: 23  ELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVV 82
Query: 372 ALLGFC------------------------LRVAEE---------LSSTIG----IARGL 394
            LLG                          LR   E         LS  I     IA G+
Sbjct: 83  RLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLSKMIQMAGEIADGM 142
Query: 395 EYLHLGCSTRILHFDIKPHNILLDEDFCPKISDFGLAKICNRKESIISMTGARG--TVGY 452
            YL+   + + +H D+   N ++ EDF  KI DFG+ +  +  E+     G +G   V +
Sbjct: 143 AYLN---ANKFVHRDLAARNCMVAEDFTVKIGDFGMTR--DIYETDYYRKGGKGLLPVRW 197
Query: 453 IAPEVFCRNIGEVSYKSDVYNYGMMIFEMT 482
           ++PE      G  +  SDV+++G++++E+ 
Sbjct: 198 MSPESL--KDGVFTTYSDVWSFGVVLWEIA 225

>pdb|3SRV|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277

Iteration: 1
 Score = 52.4 bits (124), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 31/92 (33%), Positives = 52/92 (56%), Gaps = 6/92 (6%)
Query: 390 IARGLEYLHLGCSTRILHFDIKPHNILLDEDFCPKISDFGLAKICNRKESII-SMTGARG 448
           ++ G++YL     +  +H D+   N+LL      KISDFGL+K     E+   + T  + 
Sbjct: 120 VSMGMKYLE---ESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENXYKAQTHGKW 176
Query: 449 TVGYIAPEVFCRNIGEVSYKSDVYNYGMMIFE 480
            V + APE  C N  + S KSDV+++G++++E
Sbjct: 177 PVKWYAPE--CINYYKFSSKSDVWSFGVLMWE 206

>pdb|3SRV|B Chain B, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277

Iteration: 1
 Score = 52.4 bits (124), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 31/92 (33%), Positives = 52/92 (56%), Gaps = 6/92 (6%)
Query: 390 IARGLEYLHLGCSTRILHFDIKPHNILLDEDFCPKISDFGLAKICNRKESII-SMTGARG 448
           ++ G++YL     +  +H D+   N+LL      KISDFGL+K     E+   + T  + 
Sbjct: 120 VSMGMKYLE---ESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKW 176
Query: 449 TVGYIAPEVFCRNIGEVSYKSDVYNYGMMIFE 480
            V + APE  C N  + S KSDV+++G++++E
Sbjct: 177 PVKWYAPE--CINYYKFSSKSDVWSFGVLMWE 206

>pdb|2OJG|A Chain A, Crystal Structure Of Erk2 In Complex With N,n-dimethyl-4-(4- Phenyl-1h-pyrazol-3-yl)-1h-pyrrole-2-carboxamide Length = 380

Iteration: 1
 Score = 52.4 bits (124), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 34/97 (35%), Positives = 52/97 (53%), Gaps = 5/97 (5%)
Query: 390 IARGLEYLHLGCSTRILHFDIKPHNILLDEDFCPKISDFGLAKICNRKESIIS-MTGARG 448
           I RGL+Y+H   S  +LH D+KP N+LL+     KI DFGLA++ +        +T    
Sbjct: 153 ILRGLKYIH---SANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVA 209
Query: 449 TVGYIAPEVFCRNIGEVSYKSDVYNYGMMIFEMTGGR 485
           T  Y APE+   + G  +   D+++ G ++ EM   R
Sbjct: 210 TRWYRAPEIMLNSKG-YTKSIDIWSVGCILAEMLSNR 245

>pdb|2X4Z|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Pf-03758309 Length = 296

Iteration: 1
 Score = 52.4 bits (124), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 55/199 (27%), Positives = 92/199 (46%), Gaps = 47/199 (23%)
Query: 320 KLGQGGYGSVYKGKLLD-GSNVAVKVLNDSKGNGKEFI-NEVASISRTSHVNVVA----- 372
           K+G+G  G V    +   G  VAVK ++  K   +E + NEV  +    H NVV      
Sbjct: 31  KIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSY 90
Query: 373 LLGFCLRVA--------------------EELSST-IGIARGLEYLHLGCSTRILHFDIK 411
           L+G  L V                     E++++  + + + L  LH   +  ++H DIK
Sbjct: 91  LVGDELWVVMEFLEGGALTDIVTHTRMNEEQIAAVCLAVLQALSVLH---AQGVIHRDIK 147
Query: 412 PHNILLDEDFCPKISDFG----LAKICNRKESIISMTGARGTVGYIAPEVFCRNIGEVSY 467
             +ILL  D   K+SDFG    ++K   R++ ++      GT  ++APE+  R    + Y
Sbjct: 148 SDSILLTHDGRVKLSDFGFCAQVSKEVPRRKXLV------GTPYWMAPELISR----LPY 197
Query: 468 --KSDVYNYGMMIFEMTGG 484
             + D+++ G+M+ EM  G
Sbjct: 198 GPEVDIWSLGIMVIEMVDG 216

>pdb|4FIF|A Chain A, Catalytic Domain Of Human Pak4 With Rpkplvdp Peptide Length = 346

Iteration: 1
 Score = 52.4 bits (124), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 55/199 (27%), Positives = 92/199 (46%), Gaps = 47/199 (23%)
Query: 320 KLGQGGYGSVYKGKLLD-GSNVAVKVLNDSKGNGKEFI-NEVASISRTSHVNVVA----- 372
           K+G+G  G V    +   G  VAVK ++  K   +E + NEV  +    H NVV      
Sbjct: 81  KIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSY 140
Query: 373 LLGFCLRVA--------------------EELSST-IGIARGLEYLHLGCSTRILHFDIK 411
           L+G  L V                     E++++  + + + L  LH   +  ++H DIK
Sbjct: 141 LVGDELWVVMEFLEGGALTDIVTHTRMNEEQIAAVCLAVLQALSVLH---AQGVIHRDIK 197
Query: 412 PHNILLDEDFCPKISDFG----LAKICNRKESIISMTGARGTVGYIAPEVFCRNIGEVSY 467
             +ILL  D   K+SDFG    ++K   R++ ++      GT  ++APE+  R    + Y
Sbjct: 198 SDSILLTHDGRVKLSDFGFCAQVSKEVPRRKXLV------GTPYWMAPELISR----LPY 247
Query: 468 --KSDVYNYGMMIFEMTGG 484
             + D+++ G+M+ EM  G
Sbjct: 248 GPEVDIWSLGIMVIEMVDG 266

>pdb|3Q5I|A Chain A, Crystal Structure Of Pbanka_031420 Length = 504

Iteration: 1
 Score = 52.4 bits (124), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 62/223 (27%), Positives = 93/223 (41%), Gaps = 60/223 (26%)
Query: 320 KLGQGGYGSVYKGKLLDG-SNVAVKVLNDSKGNG--------------KEFINEVASISR 364
           KLG G YG V   K  +G S  A+KV+  S+ +               +E  NE++ +  
Sbjct: 43  KLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKS 102
Query: 365 TSHVNVVALLG------FCLRVAE-----ELSSTI----------------GIARGLEYL 397
             H N++ L        +   V E     EL   I                 I  G+ YL
Sbjct: 103 LDHPNIIKLFDVFEDKKYFYLVTEFYEGGELFEQIINRHKFDECDAANIMKQILSGICYL 162
Query: 398 HLGCSTRILHFDIKPHNILLDED---FCPKISDFGLAKICNRKESIISMTGARGTVGYIA 454
           H      I+H DIKP NILL+        KI DFGL+   ++      +    GT  YIA
Sbjct: 163 H---KHNIVHRDIKPENILLENKNSLLNIKIVDFGLSSFFSKD---YKLRDRLGTAYYIA 216
Query: 455 PEVFCRNIGEVSYKSDVYNYGMMIFEMT------GGRKNVDVV 491
           PEV  +   E   K DV++ G++++ +       GG+ + D++
Sbjct: 217 PEVLKKKYNE---KCDVWSCGVIMYILLCGYPPFGGQNDQDII 256

>pdb|4FL2|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 636

Iteration: 1
 Score = 52.4 bits (124), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 31/92 (33%), Positives = 52/92 (56%), Gaps = 6/92 (6%)
Query: 390 IARGLEYLHLGCSTRILHFDIKPHNILLDEDFCPKISDFGLAKICNRKESII-SMTGARG 448
           ++ G++YL     +  +H D+   N+LL      KISDFGL+K     E+   + T  + 
Sbjct: 479 VSMGMKYLE---ESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKW 535
Query: 449 TVGYIAPEVFCRNIGEVSYKSDVYNYGMMIFE 480
            V + APE  C N  + S KSDV+++G++++E
Sbjct: 536 PVKWYAPE--CINYYKFSSKSDVWSFGVLMWE 565

>pdb|4FL3|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 635

Iteration: 1
 Score = 52.4 bits (124), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 31/92 (33%), Positives = 52/92 (56%), Gaps = 6/92 (6%)
Query: 390 IARGLEYLHLGCSTRILHFDIKPHNILLDEDFCPKISDFGLAKICNRKESII-SMTGARG 448
           ++ G++YL     +  +H D+   N+LL      KISDFGL+K     E+   + T  + 
Sbjct: 478 VSMGMKYLE---ESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKW 534
Query: 449 TVGYIAPEVFCRNIGEVSYKSDVYNYGMMIFE 480
            V + APE  C N  + S KSDV+++G++++E
Sbjct: 535 PVKWYAPE--CINYYKFSSKSDVWSFGVLMWE 564

>pdb|1JQH|A Chain A, Igf-1 Receptor Kinase Domain Length = 308

Iteration: 1
 Score = 52.4 bits (124), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 56/210 (26%), Positives = 95/210 (45%), Gaps = 54/210 (25%)
Query: 320 KLGQGGYGSVYKG------KLLDGSNVAVKVLNDSKGNGK--EFINEVASISRTSHVNVV 371
           +LGQG +G VY+G      K    + VA+K +N++    +  EF+NE + +   +  +VV
Sbjct: 26  ELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVV 85
Query: 372 ALLGFC------------------------LRVAEE---------LSSTIG----IARGL 394
            LLG                          LR   E         LS  I     IA G+
Sbjct: 86  RLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLSKMIQMAGEIADGM 145
Query: 395 EYLHLGCSTRILHFDIKPHNILLDEDFCPKISDFGLAKICNRKESIISMTGARG--TVGY 452
            YL+   + + +H D+   N ++ EDF  KI DFG+ +  +  E+     G +G   V +
Sbjct: 146 AYLN---ANKFVHRDLAARNCMVAEDFTVKIGDFGMTR--DIYETDYYRKGGKGLLPVRW 200
Query: 453 IAPEVFCRNIGEVSYKSDVYNYGMMIFEMT 482
           ++PE      G  +  SDV+++G++++E+ 
Sbjct: 201 MSPESL--KDGVFTTYSDVWSFGVVLWEIA 228

>pdb|3QQU|A Chain A, Cocrystal Structure Of Unphosphorylated Igf With Pyrimidine 8 Length = 301

Iteration: 1
 Score = 52.4 bits (124), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 56/210 (26%), Positives = 95/210 (45%), Gaps = 54/210 (25%)
Query: 320 KLGQGGYGSVYKG------KLLDGSNVAVKVLNDSKGNGK--EFINEVASISRTSHVNVV 371
           +LGQG +G VY+G      K    + VA+K +N++    +  EF+NE + +   +  +VV
Sbjct: 19  ELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVV 78
Query: 372 ALLGFC------------------------LRVAEE---------LSSTIG----IARGL 394
            LLG                          LR   E         LS  I     IA G+
Sbjct: 79  RLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLSKMIQMAGEIADGM 138
Query: 395 EYLHLGCSTRILHFDIKPHNILLDEDFCPKISDFGLAKICNRKESIISMTGARG--TVGY 452
            YL+   + + +H D+   N ++ EDF  KI DFG+ +  +  E+     G +G   V +
Sbjct: 139 AYLN---ANKFVHRDLAARNCMVAEDFTVKIGDFGMTR--DIYETDYYRKGGKGLLPVRW 193
Query: 453 IAPEVFCRNIGEVSYKSDVYNYGMMIFEMT 482
           ++PE      G  +  SDV+++G++++E+ 
Sbjct: 194 MSPESL--KDGVFTTYSDVWSFGVVLWEIA 221

>pdb|1XBA|A Chain A, Crystal Structure Of Apo Syk Tyrosine Kinase Domain Length = 291

Iteration: 1
 Score = 52.4 bits (124), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 31/92 (33%), Positives = 52/92 (56%), Gaps = 6/92 (6%)
Query: 390 IARGLEYLHLGCSTRILHFDIKPHNILLDEDFCPKISDFGLAKICNRKESII-SMTGARG 448
           ++ G++YL     +  +H D+   N+LL      KISDFGL+K     E+   + T  + 
Sbjct: 126 VSMGMKYLE---ESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKW 182
Query: 449 TVGYIAPEVFCRNIGEVSYKSDVYNYGMMIFE 480
            V + APE  C N  + S KSDV+++G++++E
Sbjct: 183 PVKWYAPE--CINYYKFSSKSDVWSFGVLMWE 212

>pdb|3LW0|A Chain A, Igf-1rk In Complex With Ligand Msc1609119a-1 Length = 304

Iteration: 1
 Score = 52.4 bits (124), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 56/210 (26%), Positives = 95/210 (45%), Gaps = 54/210 (25%)
Query: 320 KLGQGGYGSVYKG------KLLDGSNVAVKVLNDSKGNGK--EFINEVASISRTSHVNVV 371
           +LGQG +G VY+G      K    + VA+K +N++    +  EF+NE + +   +  +VV
Sbjct: 22  ELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVV 81
Query: 372 ALLGFC------------------------LRVA---------EELSSTIG----IARGL 394
            LLG                          LR A           LS  I     IA G+
Sbjct: 82  RLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGM 141
Query: 395 EYLHLGCSTRILHFDIKPHNILLDEDFCPKISDFGLAKICNRKESIISMTGARG--TVGY 452
            YL+   + + +H D+   N ++ EDF  KI DFG+ +  +  E+     G +G   V +
Sbjct: 142 AYLN---ANKFVHRDLAARNCMVAEDFTVKIGDFGMTR--DIYETDYYRKGGKGLLPVRW 196
Query: 453 IAPEVFCRNIGEVSYKSDVYNYGMMIFEMT 482
           ++PE      G  +  SDV+++G++++E+ 
Sbjct: 197 MSPESL--KDGVFTTYSDVWSFGVVLWEIA 224

>pdb|3EMG|A Chain A, Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylaminopyrimidines As Potent Inhibitors Of Spleen Tyrosine Kinase (Syk) Length = 291

Iteration: 1
 Score = 52.4 bits (124), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 31/92 (33%), Positives = 52/92 (56%), Gaps = 6/92 (6%)
Query: 390 IARGLEYLHLGCSTRILHFDIKPHNILLDEDFCPKISDFGLAKICNRKESII-SMTGARG 448
           ++ G++YL     +  +H D+   N+LL      KISDFGL+K     E+   + T  + 
Sbjct: 134 VSMGMKYLE---ESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKW 190
Query: 449 TVGYIAPEVFCRNIGEVSYKSDVYNYGMMIFE 480
            V + APE  C N  + S KSDV+++G++++E
Sbjct: 191 PVKWYAPE--CINYYKFSSKSDVWSFGVLMWE 220

>pdb|2OJ9|A Chain A, Structure Of Igf-1r Kinase Domain Complexed With A Benzimidazole Inhibitor Length = 307

Iteration: 1
 Score = 52.4 bits (124), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 56/210 (26%), Positives = 95/210 (45%), Gaps = 54/210 (25%)
Query: 320 KLGQGGYGSVYKG------KLLDGSNVAVKVLNDSKGNGK--EFINEVASISRTSHVNVV 371
           +LGQG +G VY+G      K    + VA+K +N++    +  EF+NE + +   +  +VV
Sbjct: 25  ELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVV 84
Query: 372 ALLGFC------------------------LRVAEE---------LSSTIG----IARGL 394
            LLG                          LR   E         LS  I     IA G+
Sbjct: 85  RLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLSKMIQMAGEIADGM 144
Query: 395 EYLHLGCSTRILHFDIKPHNILLDEDFCPKISDFGLAKICNRKESIISMTGARG--TVGY 452
            YL+   + + +H D+   N ++ EDF  KI DFG+ +  +  E+     G +G   V +
Sbjct: 145 AYLN---ANKFVHRDLAARNCMVAEDFTVKIGDFGMTR--DIYETDYYRKGGKGLLPVRW 199
Query: 453 IAPEVFCRNIGEVSYKSDVYNYGMMIFEMT 482
           ++PE      G  +  SDV+++G++++E+ 
Sbjct: 200 MSPESL--KDGVFTTYSDVWSFGVVLWEIA 227

>pdb|3TUB|A Chain A, Crystal Structure Of Syk Kinase Domain With 1-(5-(6,7- Dimethoxyquinolin-4-Yloxy)pyridin-2-Yl)-3-((1r,2s)-2- Phenylcyclopropyl)urea Length = 293

Iteration: 1
 Score = 52.4 bits (124), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 31/92 (33%), Positives = 52/92 (56%), Gaps = 6/92 (6%)
Query: 390 IARGLEYLHLGCSTRILHFDIKPHNILLDEDFCPKISDFGLAKICNRKESII-SMTGARG 448
           ++ G++YL     +  +H D+   N+LL      KISDFGL+K     E+   + T  + 
Sbjct: 136 VSMGMKYLE---ESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKW 192
Query: 449 TVGYIAPEVFCRNIGEVSYKSDVYNYGMMIFE 480
            V + APE  C N  + S KSDV+++G++++E
Sbjct: 193 PVKWYAPE--CINYYKFSSKSDVWSFGVLMWE 222

>pdb|3VF8|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Syk Catalytic Domain With Pyrazolylbenzimidazole Inhibitor 416 Length = 299

Iteration: 1
 Score = 52.4 bits (124), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 31/92 (33%), Positives = 52/92 (56%), Gaps = 6/92 (6%)
Query: 390 IARGLEYLHLGCSTRILHFDIKPHNILLDEDFCPKISDFGLAKICNRKESII-SMTGARG 448
           ++ G++YL     +  +H D+   N+LL      KISDFGL+K     E+   + T  + 
Sbjct: 136 VSMGMKYLE---ESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKW 192
Query: 449 TVGYIAPEVFCRNIGEVSYKSDVYNYGMMIFE 480
            V + APE  C N  + S KSDV+++G++++E
Sbjct: 193 PVKWYAPE--CINYYKFSSKSDVWSFGVLMWE 222

>pdb|3I81|A Chain A, Crystal Structure Of Insulin-Like Growth Factor 1 Receptor (Igf-1r-Wt) Complex With Bms-754807 [1-(4-((5-Cyclopropyl- 1h-Pyrazol-3-Yl)amino)pyrrolo[2,1-F][1,2, 4]triazin-2-Yl)-N- (6-Fluoro-3-Pyridinyl)-2-Methyl-L-Prolinamide] Length = 315

Iteration: 1
 Score = 52.4 bits (124), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 56/210 (26%), Positives = 95/210 (45%), Gaps = 54/210 (25%)
Query: 320 KLGQGGYGSVYKG------KLLDGSNVAVKVLNDSKGNGK--EFINEVASISRTSHVNVV 371
           +LGQG +G VY+G      K    + VA+K +N++    +  EF+NE + +   +  +VV
Sbjct: 25  ELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVV 84
Query: 372 ALLGFC------------------------LRVAEE---------LSSTIG----IARGL 394
            LLG                          LR   E         LS  I     IA G+
Sbjct: 85  RLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLSKMIQMAGEIADGM 144
Query: 395 EYLHLGCSTRILHFDIKPHNILLDEDFCPKISDFGLAKICNRKESIISMTGARG--TVGY 452
            YL+   + + +H D+   N ++ EDF  KI DFG+ +  +  E+     G +G   V +
Sbjct: 145 AYLN---ANKFVHRDLAARNCMVAEDFTVKIGDFGMTR--DIYETDYYRKGGKGLLPVRW 199
Query: 453 IAPEVFCRNIGEVSYKSDVYNYGMMIFEMT 482
           ++PE      G  +  SDV+++G++++E+ 
Sbjct: 200 MSPESL--KDGVFTTYSDVWSFGVVLWEIA 227

>pdb|2ZV2|A Chain A, Crystal Structure Of Human CalciumCALMODULIN-Dependent Protein Kinase Kinase 2, Beta, Camkk2 Kinase Domain In Complex With Sto-609 Length = 298

Iteration: 1
 Score = 52.4 bits (124), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 32/91 (35%), Positives = 53/91 (58%), Gaps = 6/91 (6%)
Query: 390 IARGLEYLHLGCSTRILHFDIKPHNILLDEDFCPKISDFGLAKICNRKESIISMTGARGT 449
           + +G+EYLH     +I+H DIKP N+L+ ED   KI+DFG++      ++++S T   GT
Sbjct: 146 LIKGIEYLHY---QKIIHRDIKPSNLLVGEDGHIKIADFGVSNEFKGSDALLSNT--VGT 200
Query: 450 VGYIAPEVFCRNIGEVSYKS-DVYNYGMMIF 479
             ++APE         S K+ DV+  G+ ++
Sbjct: 201 PAFMAPESLSETRKIFSGKALDVWAMGVTLY 231

>pdb|2Y94|A Chain A, Structure Of An Active Form Of Mammalian Ampk Length = 476

Iteration: 1
 Score = 52.0 bits (123), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 50/196 (25%), Positives = 86/196 (43%), Gaps = 39/196 (19%)
Query: 321 LGQGGYGSVYKGKL-LDGSNVAVKVLNDSKGNGKEFI----NEVASISRTSHVNVVALLG 375
           LG G +G V  GK  L G  VAVK+LN  K    + +     E+ ++    H +++ L  
Sbjct: 24  LGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHIIKLYQ 83
Query: 376 FCL-------------------------RVAEELSSTI--GIARGLEYLHLGCSTRILHF 408
                                       R+ E+ S  +   I  G++Y H      ++H 
Sbjct: 84  VISTPSDIFMVMEYVSGGELFDYICKNGRLDEKESRRLFQQILSGVDYCH---RHMVVHR 140
Query: 409 DIKPHNILLDEDFCPKISDFGLAKICNRKESIISMTGARGTVGYIAPEVFCRNIGEVSYK 468
           D+KP N+LLD     KI+DFGL+ + +  E    +  + G+  Y APEV    +     +
Sbjct: 141 DLKPENVLLDAHMNAKIADFGLSNMMSDGE---FLRXSCGSPNYAAPEVISGRL-YAGPE 196
Query: 469 SDVYNYGMMIFEMTGG 484
            D+++ G++++ +  G
Sbjct: 197 VDIWSSGVILYALLCG 212

>pdb|2I0V|A Chain A, C-Fms Tyrosine Kinase In Complex With A Quinolone Inhibitor Length = 335

Iteration: 1
 Score = 52.0 bits (123), Expect = 8e-07,   Method: Compositional matrix adjust.
 Identities = 60/218 (27%), Positives = 92/218 (42%), Gaps = 57/218 (26%)
Query: 316 SFKYKLGQGGYGSVYK------GKLLDGSNVAVKVLND-SKGNGKE-FINEVASISRT-S 366
            F   LG G +G V +      GK      VAVK+L   +  + KE  ++E+  +S    
Sbjct: 49  QFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQ 108
Query: 367 HVNVVALLGFC---------------------LR----------------VAEELSS--- 386
           H N+V LLG C                     LR                  E+LSS   
Sbjct: 109 HENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKRPPGLEYSYNPSHNPEEQLSSRDL 168
Query: 387 ---TIGIARGLEYLHLGCSTRILHFDIKPHNILLDEDFCPKISDFGLAKICNRKESIISM 443
              +  +A+G+ +L    S   +H D+   N+LL      KI DFGLA+      + I  
Sbjct: 169 LHFSSQVAQGMAFL---ASKNCIHRDVAARNVLLTNGHVAKIGDFGLARDIMNDSNYIVK 225
Query: 444 TGARGTVGYIAPEVFCRNIGEVSYKSDVYNYGMMIFEM 481
             AR  V ++APE     +  V  +SDV++YG++++E+
Sbjct: 226 GNARLPVKWMAPESIFDCVYTV--QSDVWSYGILLWEI 261

>pdb|3UNZ|A Chain A, Aurora A In Complex With Rpm1679 Length = 279

Iteration: 1
 Score = 52.0 bits (123), Expect = 8e-07,   Method: Compositional matrix adjust.
 Identities = 50/199 (25%), Positives = 85/199 (42%), Gaps = 45/199 (22%)
Query: 321 LGQGGYGSVY-----KGKLLDGSNVAVKVLNDSKGNGKEFINEVASISRTSHVNVVALLG 375
           LG+G +G+VY     + K +    V  K   +  G   +   EV   S   H N++ L G
Sbjct: 17  LGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYG 76
Query: 376 F------------------CLRVAEELSS---------TIGIARGLEYLHLGCSTRILHF 408
           +                    R  ++LS             +A  L Y H   S R++H 
Sbjct: 77  YFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCH---SKRVIHR 133
Query: 409 DIKPHNILLDEDFCPKISDFGLA--KICNRKESIISMTGARGTVGYIAPEVFCRNIGEVS 466
           DIKP N+LL      KI+DFG +     +R++++       GT+ Y+ PE+    + +  
Sbjct: 134 DIKPENLLLGSAGELKIADFGWSVHAPSSRRDTLC------GTLDYLPPEMIEGRMHDE- 186
Query: 467 YKSDVYNYGMMIFEMTGGR 485
            K D+++ G++ +E   G+
Sbjct: 187 -KVDLWSLGVLCYEFLVGK 204

>pdb|1O6Y|A Chain A, Catalytic Domain Of Pknb Kinase From Mycobacterium Tuberculosis Length = 299

Iteration: 1
 Score = 52.0 bits (123), Expect = 8e-07,   Method: Compositional matrix adjust.
 Identities = 52/207 (25%), Positives = 84/207 (40%), Gaps = 40/207 (19%)
Query: 316 SFKYKLGQ----GGYGSVYKGKLLD-GSNVAVKVLNDSKGNGKEFI----NEVASISRTS 366
           S +Y+LG+    GG   V+  + L    +VAVKVL         F      E  + +  +
Sbjct: 28  SDRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALN 87
Query: 367 HVNVVALL---------------------GFCLRVAEELSSTIGIARGLEYLHLGCSTR- 404
           H  +VA+                      G  LR        +   R +E +   C    
Sbjct: 88  HPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGPMTPKRAIEVIADACQALN 147
Query: 405 ------ILHFDIKPHNILLDEDFCPKISDFGLAK-ICNRKESIISMTGARGTVGYIAPEV 457
                 I+H D+KP NI++      K+ DFG+A+ I +   S+       GT  Y++PE 
Sbjct: 148 FSHQNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQ 207
Query: 458 FCRNIGEVSYKSDVYNYGMMIFEMTGG 484
              +   V  +SDVY+ G +++E+  G
Sbjct: 208 ARGD--SVDARSDVYSLGCVLYEVLTG 232

>pdb|1CM8|A Chain A, Phosphorylated Map Kinase P38-Gamma Length = 367

Iteration: 1
 Score = 52.0 bits (123), Expect = 8e-07,   Method: Compositional matrix adjust.
 Identities = 56/203 (27%), Positives = 87/203 (42%), Gaps = 50/203 (24%)
Query: 321 LGQGGYGSV---YKGKLLDGSNVAVKVLN---DSKGNGKEFINEVASISRTSHVNVVALL 374
           +G G YG+V     G+   G+ VA+K L     S+   K    E+  +    H NV+ LL
Sbjct: 33  VGSGAYGAVCSAVDGRT--GAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLL 90
Query: 375 G-------------FCLRVAEELSSTIG-------------------IARGLEYLHLGCS 402
                         F L V   + + +G                   + +GL Y+H   +
Sbjct: 91  DVFTPDETLDDFTDFYL-VMPFMGTDLGKLMKHEKLGEDRIQFLVYQMLKGLRYIH---A 146
Query: 403 TRILHFDIKPHNILLDEDFCPKISDFGLAKICNRKESIISMTGARGTVGYIAPEVFCRNI 462
             I+H D+KP N+ ++ED   KI DFGLA+  + +     M G   T  Y APEV   N 
Sbjct: 147 AGIIHRDLKPGNLAVNEDCELKILDFGLARQADSE-----MXGXVVTRWYRAPEVIL-NW 200
Query: 463 GEVSYKSDVYNYGMMIFEMTGGR 485
              +   D+++ G ++ EM  G+
Sbjct: 201 MRYTQTVDIWSVGCIMAEMITGK 223

>pdb|2I1M|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An Arylamide Inhibitor Length = 333

Iteration: 1
 Score = 51.6 bits (122), Expect = 9e-07,   Method: Compositional matrix adjust.
 Identities = 58/216 (26%), Positives = 89/216 (41%), Gaps = 55/216 (25%)
Query: 316 SFKYKLGQGGYGSVYK------GKLLDGSNVAVKVLNDSK-GNGKE-FINEVASISRT-S 366
            F   LG G +G V +      GK      VAVK+L  +   + KE  ++E+  +S    
Sbjct: 49  QFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQ 108
Query: 367 HVNVVALLGFCL-------------------------RVAEE----------------LS 385
           H N+V LLG C                          RV E                 L 
Sbjct: 109 HENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLH 168
Query: 386 STIGIARGLEYLHLGCSTRILHFDIKPHNILLDEDFCPKISDFGLAKICNRKESIISMTG 445
            +  +A+G+ +L    S   +H D+   N+LL      KI DFGLA+      + I    
Sbjct: 169 FSSQVAQGMAFL---ASKNCIHRDVAARNVLLTNGHVAKIGDFGLARDIMNDSNYIVKGN 225
Query: 446 ARGTVGYIAPEVFCRNIGEVSYKSDVYNYGMMIFEM 481
           AR  V ++APE     +  V  +SDV++YG++++E+
Sbjct: 226 ARLPVKWMAPESIFDCVYTV--QSDVWSYGILLWEI 259

>pdb|3LCO|A Chain A, Inhibitor Bound To A Dfg-Out Structure Of The Kinase Domain Of Csf-1r Length = 324

Iteration: 1
 Score = 51.6 bits (122), Expect = 9e-07,   Method: Compositional matrix adjust.
 Identities = 33/107 (30%), Positives = 56/107 (52%), Gaps = 5/107 (4%)
Query: 375 GFCLRVAEELSSTIGIARGLEYLHLGCSTRILHFDIKPHNILLDEDFCPKISDFGLAKIC 434
           G  L + + L  +  +A+G+ +L    S   +H D+   N+LL      KI DFGLA+  
Sbjct: 152 GRPLELRDLLHFSSQVAQGMAFL---ASKNCIHRDVAARNVLLTNGHVAKIGDFGLARDI 208
Query: 435 NRKESIISMTGARGTVGYIAPEVFCRNIGEVSYKSDVYNYGMMIFEM 481
               + I    AR  V ++APE     +  V  +SDV++YG++++E+
Sbjct: 209 MNDSNYIVKGNARLPVKWMAPESIFDCVYTV--QSDVWSYGILLWEI 253

>pdb|3V8S|A Chain A, Human Rho-Associated Protein Kinase 1 (Rock 1) In Complex With Indazole Derivative (Compound 18) Length = 410

Iteration: 1
 Score = 51.6 bits (122), Expect = 9e-07,   Method: Compositional matrix adjust.
 Identities = 34/100 (34%), Positives = 53/100 (53%), Gaps = 6/100 (6%)
Query: 387 TIGIARGLEYLHLGCSTRILHFDIKPHNILLDEDFCPKISDFGLAKICNRKESIISMTGA 446
           T  +   L+ +H   S   +H D+KP N+LLD+    K++DFG     N KE ++    A
Sbjct: 174 TAEVVLALDAIH---SMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMN-KEGMVRCDTA 229
Query: 447 RGTVGYIAPEVFCRNIGEVSY--KSDVYNYGMMIFEMTGG 484
            GT  YI+PEV     G+  Y  + D ++ G+ ++EM  G
Sbjct: 230 VGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVG 269

>pdb|2ESM|A Chain A, Crystal Structure Of Rock 1 Bound To Fasudil Length = 415

Iteration: 1
 Score = 51.6 bits (122), Expect = 9e-07,   Method: Compositional matrix adjust.
 Identities = 34/100 (34%), Positives = 53/100 (53%), Gaps = 6/100 (6%)
Query: 387 TIGIARGLEYLHLGCSTRILHFDIKPHNILLDEDFCPKISDFGLAKICNRKESIISMTGA 446
           T  +   L+ +H   S   +H D+KP N+LLD+    K++DFG     N KE ++    A
Sbjct: 179 TAEVVLALDAIH---SMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMN-KEGMVRCDTA 234
Query: 447 RGTVGYIAPEVFCRNIGEVSY--KSDVYNYGMMIFEMTGG 484
            GT  YI+PEV     G+  Y  + D ++ G+ ++EM  G
Sbjct: 235 VGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVG 274

>pdb|2J4Z|A Chain A, Structure Of Aurora-2 In Complex With Pha-680626 Length = 306

Iteration: 1
 Score = 51.6 bits (122), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 52/201 (25%), Positives = 83/201 (41%), Gaps = 49/201 (24%)
Query: 321 LGQGGYGSVY-----KGKLLDGSNVAVKVLNDSKGNGKEFINEVASISRTSHVNVVAL-- 373
           LG+G +G+VY     + K +    V  K   +  G   +   EV   S   H N++ L  
Sbjct: 42  LGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYG 101
Query: 374 ----------------LGFCLRVAEELSS---------TIGIARGLEYLHLGCSTRILHF 408
                           LG   R  ++LS             +A  L Y H   S R++H 
Sbjct: 102 YFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCH---SKRVIHR 158
Query: 409 DIKPHNILLDEDFCPKISDFGLAKICNRKESIISMTGAR----GTVGYIAPEVFCRNIGE 464
           DIKP N+LL      KI+DFG         S+ + +  R    GT+ Y+ PE+    + +
Sbjct: 159 DIKPENLLLGSAGELKIADFGW--------SVHAPSSRRTTLCGTLDYLPPEMIEGRMHD 210
Query: 465 VSYKSDVYNYGMMIFEMTGGR 485
              K D+++ G++ +E   G+
Sbjct: 211 E--KVDLWSLGVLCYEFLVGK 229

>pdb|2BMC|A Chain A, Aurora-2 T287d T288d Complexed With Pha-680632 Length = 306

Iteration: 1
 Score = 51.6 bits (122), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 51/199 (25%), Positives = 84/199 (42%), Gaps = 45/199 (22%)
Query: 321 LGQGGYGSVY-----KGKLLDGSNVAVKVLNDSKGNGKEFINEVASISRTSHVNVVAL-- 373
           LG+G +G+VY     + K +    V  K   +  G   +   EV   S   H N++ L  
Sbjct: 42  LGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYG 101
Query: 374 ----------------LGFCLRVAEELSS---------TIGIARGLEYLHLGCSTRILHF 408
                           LG   R  ++LS             +A  L Y H   S R++H 
Sbjct: 102 YFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCH---SKRVIHR 158
Query: 409 DIKPHNILLDEDFCPKISDFGLA--KICNRKESIISMTGARGTVGYIAPEVFCRNIGEVS 466
           DIKP N+LL      KI+DFG +     +R++ +       GT+ Y+ PE+    + +  
Sbjct: 159 DIKPENLLLGSAGELKIADFGWSVHAPSSRRDDLC------GTLDYLPPEMIEGRMHDE- 211
Query: 467 YKSDVYNYGMMIFEMTGGR 485
            K D+++ G++ +E   G+
Sbjct: 212 -KVDLWSLGVLCYEFLVGK 229

>pdb|3BEA|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A Pyrimidinopyridone Inhibitor Length = 333

Iteration: 1
 Score = 51.6 bits (122), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 58/216 (26%), Positives = 89/216 (41%), Gaps = 55/216 (25%)
Query: 316 SFKYKLGQGGYGSVYK------GKLLDGSNVAVKVLNDSK-GNGKE-FINEVASISRT-S 366
            F   LG G +G V +      GK      VAVK+L  +   + KE  ++E+  +S    
Sbjct: 49  QFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQ 108
Query: 367 HVNVVALLGFCL-------------------------RVAEE----------------LS 385
           H N+V LLG C                          RV E                 L 
Sbjct: 109 HENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTLSTRDLLH 168
Query: 386 STIGIARGLEYLHLGCSTRILHFDIKPHNILLDEDFCPKISDFGLAKICNRKESIISMTG 445
            +  +A+G+ +L    S   +H D+   N+LL      KI DFGLA+      + I    
Sbjct: 169 FSSQVAQGMAFL---ASKNCIHRDVAARNVLLTNGHVAKIGDFGLARDIMNDSNYIVKGN 225
Query: 446 ARGTVGYIAPEVFCRNIGEVSYKSDVYNYGMMIFEM 481
           AR  V ++APE     +  V  +SDV++YG++++E+
Sbjct: 226 ARLPVKWMAPESIFDCVYTV--QSDVWSYGILLWEI 259

>pdb|2V55|A Chain A, Mechanism Of Multi-site Phosphorylation From A Rock-i:rhoe Complex Structure Length = 406

Iteration: 1
 Score = 51.6 bits (122), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 34/100 (34%), Positives = 53/100 (53%), Gaps = 6/100 (6%)
Query: 387 TIGIARGLEYLHLGCSTRILHFDIKPHNILLDEDFCPKISDFGLAKICNRKESIISMTGA 446
           T  +   L+ +H   S   +H D+KP N+LLD+    K++DFG     N KE ++    A
Sbjct: 179 TAEVVLALDAIH---SMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMN-KEGMVRCDTA 234
Query: 447 RGTVGYIAPEVFCRNIGEVSY--KSDVYNYGMMIFEMTGG 484
            GT  YI+PEV     G+  Y  + D ++ G+ ++EM  G
Sbjct: 235 VGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVG 274

>pdb|1MUO|A Chain A, Crystal Structure Of Aurora-2, An Oncogenic Serine- Threonine Kinase Length = 297

Iteration: 1
 Score = 51.6 bits (122), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 52/201 (25%), Positives = 83/201 (41%), Gaps = 49/201 (24%)
Query: 321 LGQGGYGSVY-----KGKLLDGSNVAVKVLNDSKGNGKEFINEVASISRTSHVNVVAL-- 373
           LG+G +G+VY     + K +    V  K   +  G   +   EV   S   H N++ L  
Sbjct: 33  LGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYG 92
Query: 374 ----------------LGFCLRVAEELSS---------TIGIARGLEYLHLGCSTRILHF 408
                           LG   R  ++LS             +A  L Y H   S R++H 
Sbjct: 93  YFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCH---SKRVIHR 149
Query: 409 DIKPHNILLDEDFCPKISDFGLAKICNRKESIISMTGAR----GTVGYIAPEVFCRNIGE 464
           DIKP N+LL      KI+DFG         S+ + +  R    GT+ Y+ PE+    + +
Sbjct: 150 DIKPENLLLGSAGELKIADFGW--------SVHAPSSRRTTLCGTLDYLPPEMIEGRMHD 201
Query: 465 VSYKSDVYNYGMMIFEMTGGR 485
              K D+++ G++ +E   G+
Sbjct: 202 E--KVDLWSLGVLCYEFLVGK 220

>pdb|3G0F|A Chain A, Kit Kinase Domain Mutant D816h In Complex With Sunitinib Length = 336

Iteration: 1
 Score = 51.6 bits (122), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 60/243 (24%), Positives = 98/243 (40%), Gaps = 62/243 (25%)
Query: 296 NYRSLSPKRYGY---ADIKKMTNSFKYKLGQGGYGSVYKG------KLLDGSNVAVKVLN 346
           NY  + P +  Y    +  +   SF   LG G +G V +       K      VAVK+L 
Sbjct: 26  NYVYIDPTQLPYDHKWEFPRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLK 85
Query: 347 DSK--GNGKEFINEVASISRT-SHVNVVALLGFC------LRVAE--------------- 382
            S      +  ++E+  +S   +H+N+V LLG C      L + E               
Sbjct: 86  PSAHLTEREALMSELKVLSYLGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKR 145
Query: 383 ------------------------ELSSTIGIARGLEYLHLGCSTRILHFDIKPHNILLD 418
                                    LS +  +A+G+ +L    S   +H D+   NILL 
Sbjct: 146 DSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFL---ASKNCIHRDLAARNILLT 202
Query: 419 EDFCPKISDFGLAKICNRKESIISMTGARGTVGYIAPEVFCRNIGEVSYKSDVYNYGMMI 478
                KI DFGLA+      + +    AR  V ++APE     +   +++SDV++YG+ +
Sbjct: 203 HGRITKICDFGLARHIKNDSNYVVKGNARLPVKWMAPESIFNCV--YTFESDVWSYGIFL 260
Query: 479 FEM 481
           +E+
Sbjct: 261 WEL 263

>pdb|3DAJ|A Chain A, Crystal Structure Of Aurora A Complexed With An Inhibitor Discovered Through Site-Directed Dynamic Tethering Length = 272

Iteration: 1
 Score = 51.6 bits (122), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 50/198 (25%), Positives = 86/198 (43%), Gaps = 45/198 (22%)
Query: 321 LGQGGYGSVY-----KGKLLDGSNVAVKVLNDSKGNGKEFINEVASISRTSHVNVVALLG 375
           LG+G +G+VY     + K +    V  K   +  G   +   EV   S   H N++ L G
Sbjct: 20  LGKGKFGNVYLARERQSKFILALKVLFKTQLEKAGVEHQLRREVEIQSHLRHPNILRLYG 79
Query: 376 F-------------------------CLRVAEELSST--IGIARGLEYLHLGCSTRILHF 408
           +                           R  E+ ++T    +A  L Y H   S R++H 
Sbjct: 80  YFHDATRVYLILEYAPLGTVYRELQKLSRFDEQRTATYITELANALSYCH---SKRVIHR 136
Query: 409 DIKPHNILLDEDFCPKISDFGLA--KICNRKESIISMTGARGTVGYIAPEVFCRNIGEVS 466
           DIKP N+LL  +   KI+DFG +     +R++++       GT+ Y+ PE+    + +  
Sbjct: 137 DIKPENLLLGSNGELKIADFGWSVHAPSSRRDTLC------GTLDYLPPEMIEGRMHDE- 189
Query: 467 YKSDVYNYGMMIFEMTGG 484
            K D+++ G++ +E   G
Sbjct: 190 -KVDLWSLGVLCYEFLVG 206

>pdb|1RJB|A Chain A, Crystal Structure Of Flt3 Length = 344

Iteration: 1
 Score = 51.6 bits (122), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 58/251 (23%), Positives = 96/251 (38%), Gaps = 75/251 (29%)
Query: 301 SPKRYGYADIKKMTNSFKYK-----------LGQGGYGSVYKGKLLDGS------NVAVK 343
           S   Y Y D ++     K++           LG G +G V        S       VAVK
Sbjct: 22  SDNEYFYVDFREYEYDLKWEFPRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVK 81
Query: 344 VLNDSKGNGKE--FINEVASISRT-SHVNVVALLGFCL---------------------- 378
           +L +   + +    ++E+  +++  SH N+V LLG C                       
Sbjct: 82  MLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACTLSGPIYLIFEYCCYGDLLNYLR 141
Query: 379 -----------------RVAEE-----------LSSTIGIARGLEYLHLGCSTRILHFDI 410
                            R+ EE           L     +A+G+E+L        +H D+
Sbjct: 142 SKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKSC---VHRDL 198
Query: 411 KPHNILLDEDFCPKISDFGLAKICNRKESIISMTGARGTVGYIAPEVFCRNIGEVSYKSD 470
              N+L+      KI DFGLA+      + +    AR  V ++APE     I  +  KSD
Sbjct: 199 AARNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTI--KSD 256
Query: 471 VYNYGMMIFEM 481
           V++YG++++E+
Sbjct: 257 VWSYGILLWEI 267

>pdb|1T46|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C-kit Tyrosine Kinase Length = 313

Iteration: 1
 Score = 51.6 bits (122), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 60/243 (24%), Positives = 98/243 (40%), Gaps = 62/243 (25%)
Query: 296 NYRSLSPKRYGY---ADIKKMTNSFKYKLGQGGYGSVYKG------KLLDGSNVAVKVLN 346
           NY  + P +  Y    +  +   SF   LG G +G V +       K      VAVK+L 
Sbjct: 3   NYVYIDPTQLPYDHKWEFPRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLK 62
Query: 347 DSK--GNGKEFINEVASISRT-SHVNVVALLGFC------LRVAE--------------- 382
            S      +  ++E+  +S   +H+N+V LLG C      L + E               
Sbjct: 63  PSAHLTEREALMSELKVLSYLGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKR 122
Query: 383 ------------------------ELSSTIGIARGLEYLHLGCSTRILHFDIKPHNILLD 418
                                    LS +  +A+G+ +L    S   +H D+   NILL 
Sbjct: 123 DSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFL---ASKNCIHRDLAARNILLT 179
Query: 419 EDFCPKISDFGLAKICNRKESIISMTGARGTVGYIAPEVFCRNIGEVSYKSDVYNYGMMI 478
                KI DFGLA+      + +    AR  V ++APE     +   +++SDV++YG+ +
Sbjct: 180 HGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCV--YTFESDVWSYGIFL 237
Query: 479 FEM 481
           +E+
Sbjct: 238 WEL 240

>pdb|1T45|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C- Kit Tyrosine Kinase Length = 331

Iteration: 1
 Score = 51.2 bits (121), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 60/243 (24%), Positives = 98/243 (40%), Gaps = 62/243 (25%)
Query: 296 NYRSLSPKRYGY---ADIKKMTNSFKYKLGQGGYGSVYKG------KLLDGSNVAVKVLN 346
           NY  + P +  Y    +  +   SF   LG G +G V +       K      VAVK+L 
Sbjct: 21  NYVYIDPTQLPYDHKWEFPRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLK 80
Query: 347 DSK--GNGKEFINEVASISRT-SHVNVVALLGFC------LRVAE--------------- 382
            S      +  ++E+  +S   +H+N+V LLG C      L + E               
Sbjct: 81  PSAHLTEREALMSELKVLSYLGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKR 140
Query: 383 ------------------------ELSSTIGIARGLEYLHLGCSTRILHFDIKPHNILLD 418
                                    LS +  +A+G+ +L    S   +H D+   NILL 
Sbjct: 141 DSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFL---ASKNCIHRDLAARNILLT 197
Query: 419 EDFCPKISDFGLAKICNRKESIISMTGARGTVGYIAPEVFCRNIGEVSYKSDVYNYGMMI 478
                KI DFGLA+      + +    AR  V ++APE     +   +++SDV++YG+ +
Sbjct: 198 HGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCV--YTFESDVWSYGIFL 255
Query: 479 FEM 481
           +E+
Sbjct: 256 WEL 258

>pdb|3G0E|A Chain A, Kit Kinase Domain In Complex With Sunitinib Length = 336

Iteration: 1
 Score = 51.2 bits (121), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 60/243 (24%), Positives = 98/243 (40%), Gaps = 62/243 (25%)
Query: 296 NYRSLSPKRYGY---ADIKKMTNSFKYKLGQGGYGSVYKG------KLLDGSNVAVKVLN 346
           NY  + P +  Y    +  +   SF   LG G +G V +       K      VAVK+L 
Sbjct: 26  NYVYIDPTQLPYDHKWEFPRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLK 85
Query: 347 DSK--GNGKEFINEVASISRT-SHVNVVALLGFC------LRVAE--------------- 382
            S      +  ++E+  +S   +H+N+V LLG C      L + E               
Sbjct: 86  PSAHLTEREALMSELKVLSYLGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKR 145
Query: 383 ------------------------ELSSTIGIARGLEYLHLGCSTRILHFDIKPHNILLD 418
                                    LS +  +A+G+ +L    S   +H D+   NILL 
Sbjct: 146 DSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFL---ASKNCIHRDLAARNILLT 202
Query: 419 EDFCPKISDFGLAKICNRKESIISMTGARGTVGYIAPEVFCRNIGEVSYKSDVYNYGMMI 478
                KI DFGLA+      + +    AR  V ++APE     +   +++SDV++YG+ +
Sbjct: 203 HGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCV--YTFESDVWSYGIFL 260
Query: 479 FEM 481
           +E+
Sbjct: 261 WEL 263

>pdb|1MRV|A Chain A, Crystal Structure Of An Inactive Akt2 Kinase Domain Length = 339

Iteration: 1
 Score = 51.2 bits (121), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 65/215 (30%), Positives = 91/215 (42%), Gaps = 47/215 (21%)
Query: 308 ADIKKMTNSFKYK--LGQGGYGSVYKGK-LLDGSNVAVKVLNDSKGNGKEFINEVASISR 364
           A  K   N F Y   LG+G +G V   +    G   A+K+L       K+ +    + SR
Sbjct: 1   ARAKVTMNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESR 60
Query: 365 ----TSHVNVVAL---------LGFCLRVA----------------EELSSTIG--IARG 393
               T H  + AL         L F +  A                EE +   G  I   
Sbjct: 61  VLQNTRHPFLTALKYAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARFYGAEIVSA 120
Query: 394 LEYLHLGCSTRILHFDIKPHNILLDEDFCPKISDFGLAKICNRKESI---ISMTGARGTV 450
           LEYLH   S  +++ DIK  N++LD+D   KI+DFGL      KE I    +M    GT 
Sbjct: 121 LEYLH---SRDVVYRDIKLENLMLDKDGHIKITDFGLC-----KEGISDGATMKTFCGTP 172
Query: 451 GYIAPEVFCRNIGEVSYKSDVYNYGMMIFEMTGGR 485
            Y+APEV   N  +     D +  G++++EM  GR
Sbjct: 173 EYLAPEVLEDN--DYGRAVDWWGLGVVMYEMMCGR 205

>pdb|2XNG|A Chain A, Structure Of Aurora-A Bound To A Selective Imidazopyrazine Inhibitor Length = 283

Iteration: 1
 Score = 51.2 bits (121), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 50/199 (25%), Positives = 84/199 (42%), Gaps = 45/199 (22%)
Query: 321 LGQGGYGSVY-----KGKLLDGSNVAVKVLNDSKGNGKEFINEVASISRTSHVNVVALLG 375
           LG+G +G+VY     + K +    V  K   +  G   +   EV   S   H N++ L G
Sbjct: 19  LGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYG 78
Query: 376 F------------------CLRVAEELSS---------TIGIARGLEYLHLGCSTRILHF 408
           +                    R  ++LS             +A  L Y H   S R++H 
Sbjct: 79  YFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCH---SKRVIHR 135
Query: 409 DIKPHNILLDEDFCPKISDFGLA--KICNRKESIISMTGARGTVGYIAPEVFCRNIGEVS 466
           DIKP N+LL      KI+DFG +     +R+ ++       GT+ Y+ PE+    + +  
Sbjct: 136 DIKPENLLLGSAGELKIADFGWSVHAPSSRRTTLC------GTLDYLPPEMIEGRMHDE- 188
Query: 467 YKSDVYNYGMMIFEMTGGR 485
            K D+++ G++ +E   G+
Sbjct: 189 -KVDLWSLGVLCYEFLVGK 206

>pdb|2VWI|A Chain A, Structure Of The Osr1 Kinase, A Hypertension Drug Target Length = 303

Iteration: 1
 Score = 51.2 bits (121), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 32/98 (32%), Positives = 51/98 (52%), Gaps = 7/98 (7%)
Query: 390 IARGLEYLHLGCSTRILHFDIKPHNILLDEDFCPKISDFGLAKICNRKESIISMTGARGT 449
           +  GLEYLH       +H D+K  NILL ED   +I+DFG++        I      +  
Sbjct: 130 VLEGLEYLHKNGQ---IHRDVKAGNILLGEDGSVQIADFGVSAFLATGGDITRNKVRKTF 186
Query: 450 VG---YIAPEVFCRNIGEVSYKSDVYNYGMMIFEMTGG 484
           VG   ++APEV  +  G   +K+D++++G+   E+  G
Sbjct: 187 VGTPCWMAPEVMEQVRG-YDFKADIWSFGITAIELATG 223

>pdb|1OL5|A Chain A, Structure Of Aurora-A 122-403, Phosphorylated On Thr287, Thr288 And Bound To Tpx2 1-43 Length = 282

Iteration: 1
 Score = 51.2 bits (121), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 51/201 (25%), Positives = 83/201 (41%), Gaps = 49/201 (24%)
Query: 321 LGQGGYGSVY-----KGKLLDGSNVAVKVLNDSKGNGKEFINEVASISRTSHVNVVALLG 375
           LG+G +G+VY     + K +    V  K   +  G   +   EV   S   H N++ L G
Sbjct: 18  LGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYG 77
Query: 376 F------------------CLRVAEELSS---------TIGIARGLEYLHLGCSTRILHF 408
           +                    R  ++LS             +A  L Y H   S R++H 
Sbjct: 78  YFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCH---SKRVIHR 134
Query: 409 DIKPHNILLDEDFCPKISDFGLAKICNRKESIISMTGAR----GTVGYIAPEVFCRNIGE 464
           DIKP N+LL      KI+DFG         S+ + +  R    GT+ Y+ PE+    + +
Sbjct: 135 DIKPENLLLGSAGELKIADFGW--------SVHAPSSRRXXLCGTLDYLPPEMIEGRMHD 186
Query: 465 VSYKSDVYNYGMMIFEMTGGR 485
              K D+++ G++ +E   G+
Sbjct: 187 E--KVDLWSLGVLCYEFLVGK 205

>pdb|1PKG|A Chain A, Structure Of A C-kit Kinase Product Complex Length = 329

Iteration: 1
 Score = 50.8 bits (120), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 56/220 (25%), Positives = 90/220 (40%), Gaps = 59/220 (26%)
Query: 316 SFKYKLGQGGYGSVYKG------KLLDGSNVAVKVLNDSK--GNGKEFINEVASISRT-S 366
           SF   LG G +G V +       K      VAVK+L  S      +  ++E+  +S   +
Sbjct: 42  SFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGN 101
Query: 367 HVNVVALLGFC------LRVAE-------------------------------------- 382
           H+N+V LLG C      L + E                                      
Sbjct: 102 HMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLE 161
Query: 383 -ELSSTIGIARGLEYLHLGCSTRILHFDIKPHNILLDEDFCPKISDFGLAKICNRKESII 441
             LS +  +A+G+ +L    S   +H D+   NILL      KI DFGLA+      + +
Sbjct: 162 DLLSFSYQVAKGMAFL---ASKNCIHRDLAARNILLTHGRITKICDFGLARDIKNDSNYV 218
Query: 442 SMTGARGTVGYIAPEVFCRNIGEVSYKSDVYNYGMMIFEM 481
               AR  V ++APE     +   +++SDV++YG+ ++E+
Sbjct: 219 VKGNARLPVKWMAPESIFNCV--YTFESDVWSYGIFLWEL 256

>pdb|3FDN|A Chain A, Structure-Based Drug Design Of Novel Aurora Kinase A Inhibitors: Structure Basis For Potency And Specificity Length = 279

Iteration: 1
 Score = 50.8 bits (120), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 51/201 (25%), Positives = 83/201 (41%), Gaps = 49/201 (24%)
Query: 321 LGQGGYGSVY-----KGKLLDGSNVAVKVLNDSKGNGKEFINEVASISRTSHVNVVALLG 375
           LG+G +G+VY     + K +    V  K   +  G   +   EV   S   H N++ L G
Sbjct: 17  LGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYG 76
Query: 376 F------------------CLRVAEELSS---------TIGIARGLEYLHLGCSTRILHF 408
           +                    R  ++LS             +A  L Y H   S R++H 
Sbjct: 77  YFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCH---SKRVIHR 133
Query: 409 DIKPHNILLDEDFCPKISDFGLAKICNRKESIISMTGAR----GTVGYIAPEVFCRNIGE 464
           DIKP N+LL      KI+DFG         S+ + +  R    GT+ Y+ PE+    + +
Sbjct: 134 DIKPENLLLGSAGELKIADFGW--------SVHAPSSRRTDLCGTLDYLPPEMIEGRMHD 185
Query: 465 VSYKSDVYNYGMMIFEMTGGR 485
              K D+++ G++ +E   G+
Sbjct: 186 E--KVDLWSLGVLCYEFLVGK 204

>pdb|3ZUV|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Phosphorylated Map Kinase Erk2 Length = 364

Iteration: 1
 Score = 50.8 bits (120), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 33/97 (34%), Positives = 51/97 (52%), Gaps = 5/97 (5%)
Query: 390 IARGLEYLHLGCSTRILHFDIKPHNILLDEDFCPKISDFGLAKICNRKESIIS-MTGARG 448
           I RGL+Y+H   S  +LH D+KP N+LL+     KI DFGLA++ +        +     
Sbjct: 137 ILRGLKYIH---SANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLXEXVA 193
Query: 449 TVGYIAPEVFCRNIGEVSYKSDVYNYGMMIFEMTGGR 485
           T  Y APE+   + G  +   D+++ G ++ EM   R
Sbjct: 194 TRWYRAPEIMLNSKG-YTKSIDIWSVGCILAEMLSNR 229

>pdb|2J50|A Chain A, Structure Of Aurora-2 In Complex With Pha-739358 Length = 280

Iteration: 1
 Score = 50.8 bits (120), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 50/199 (25%), Positives = 84/199 (42%), Gaps = 45/199 (22%)
Query: 321 LGQGGYGSVY-----KGKLLDGSNVAVKVLNDSKGNGKEFINEVASISRTSHVNVVALLG 375
           LG+G +G+VY     + K +    V  K   +  G   +   EV   S   H N++ L G
Sbjct: 16  LGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYG 75
Query: 376 F------------------CLRVAEELSS---------TIGIARGLEYLHLGCSTRILHF 408
           +                    R  ++LS             +A  L Y H   S R++H 
Sbjct: 76  YFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCH---SKRVIHR 132
Query: 409 DIKPHNILLDEDFCPKISDFGLA--KICNRKESIISMTGARGTVGYIAPEVFCRNIGEVS 466
           DIKP N+LL      KI+DFG +     +R+ ++       GT+ Y+ PE+    + +  
Sbjct: 133 DIKPENLLLGSAGELKIADFGWSVHAPSSRRTTLC------GTLDYLPPEMIEGRMHDE- 185
Query: 467 YKSDVYNYGMMIFEMTGGR 485
            K D+++ G++ +E   G+
Sbjct: 186 -KVDLWSLGVLCYEFLVGK 203

>pdb|2ERK|A Chain A, Phosphorylated Map Kinase Erk2 Length = 365

Iteration: 1
 Score = 50.8 bits (120), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 33/97 (34%), Positives = 51/97 (52%), Gaps = 5/97 (5%)
Query: 390 IARGLEYLHLGCSTRILHFDIKPHNILLDEDFCPKISDFGLAKICNRKESIIS-MTGARG 448
           I RGL+Y+H   S  +LH D+KP N+LL+     KI DFGLA++ +        +     
Sbjct: 138 ILRGLKYIH---SANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLXEXVA 194
Query: 449 TVGYIAPEVFCRNIGEVSYKSDVYNYGMMIFEMTGGR 485
           T  Y APE+   + G  +   D+++ G ++ EM   R
Sbjct: 195 TRWYRAPEIMLNSKG-YTKSIDIWSVGCILAEMLSNR 230

>pdb|2C6D|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With Adpnp Length = 275

Iteration: 1
 Score = 50.8 bits (120), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 51/201 (25%), Positives = 83/201 (41%), Gaps = 49/201 (24%)
Query: 321 LGQGGYGSVY-----KGKLLDGSNVAVKVLNDSKGNGKEFINEVASISRTSHVNVVALLG 375
           LG+G +G+VY     + K +    V  K   +  G   +   EV   S   H N++ L G
Sbjct: 16  LGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYG 75
Query: 376 F------------------CLRVAEELSS---------TIGIARGLEYLHLGCSTRILHF 408
           +                    R  ++LS             +A  L Y H   S R++H 
Sbjct: 76  YFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCH---SKRVIHR 132
Query: 409 DIKPHNILLDEDFCPKISDFGLAKICNRKESIISMTGAR----GTVGYIAPEVFCRNIGE 464
           DIKP N+LL      KI+DFG         S+ + +  R    GT+ Y+ PE+    + +
Sbjct: 133 DIKPENLLLGSAGELKIADFGW--------SVHAPSSRRTDLCGTLDYLPPEMIEGRMHD 184
Query: 465 VSYKSDVYNYGMMIFEMTGGR 485
              K D+++ G++ +E   G+
Sbjct: 185 E--KVDLWSLGVLCYEFLVGK 203

>pdb|2XRU|A Chain A, Aurora-A T288e Complexed With Pha-828300 Length = 280

Iteration: 1
 Score = 50.8 bits (120), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 51/201 (25%), Positives = 83/201 (41%), Gaps = 49/201 (24%)
Query: 321 LGQGGYGSVY-----KGKLLDGSNVAVKVLNDSKGNGKEFINEVASISRTSHVNVVALLG 375
           LG+G +G+VY     + K +    V  K   +  G   +   EV   S   H N++ L G
Sbjct: 16  LGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYG 75
Query: 376 F------------------CLRVAEELSS---------TIGIARGLEYLHLGCSTRILHF 408
           +                    R  ++LS             +A  L Y H   S R++H 
Sbjct: 76  YFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCH---SKRVIHR 132
Query: 409 DIKPHNILLDEDFCPKISDFGLAKICNRKESIISMTGAR----GTVGYIAPEVFCRNIGE 464
           DIKP N+LL      KI+DFG         S+ + +  R    GT+ Y+ PE+    + +
Sbjct: 133 DIKPENLLLGSAGELKIADFGW--------SVHAPSSRRTELCGTLDYLPPEMIEGRMHD 184
Query: 465 VSYKSDVYNYGMMIFEMTGGR 485
              K D+++ G++ +E   G+
Sbjct: 185 E--KVDLWSLGVLCYEFLVGK 203

>pdb|2X6D|A Chain A, Aurora-A Bound To An Inhibitor Length = 285

Iteration: 1
 Score = 50.8 bits (120), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 50/199 (25%), Positives = 84/199 (42%), Gaps = 45/199 (22%)
Query: 321 LGQGGYGSVY-----KGKLLDGSNVAVKVLNDSKGNGKEFINEVASISRTSHVNVVALLG 375
           LG+G +G+VY     + K +    V  K   +  G   +   EV   S   H N++ L G
Sbjct: 21  LGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYG 80
Query: 376 F------------------CLRVAEELSS---------TIGIARGLEYLHLGCSTRILHF 408
           +                    R  ++LS             +A  L Y H   S R++H 
Sbjct: 81  YFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCH---SKRVIHR 137
Query: 409 DIKPHNILLDEDFCPKISDFGLA--KICNRKESIISMTGARGTVGYIAPEVFCRNIGEVS 466
           DIKP N+LL      KI+DFG +     +R+ ++       GT+ Y+ PE+    + +  
Sbjct: 138 DIKPENLLLGSAGELKIADFGWSVHAPSSRRTTLC------GTLDYLPPEMIEGRMHDE- 190
Query: 467 YKSDVYNYGMMIFEMTGGR 485
            K D+++ G++ +E   G+
Sbjct: 191 -KVDLWSLGVLCYEFLVGK 208

>pdb|3DAK|A Chain A, Crystal Structure Of Domain-Swapped Osr1 Kinase Domain Length = 290

Iteration: 1
 Score = 50.8 bits (120), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 32/98 (32%), Positives = 51/98 (52%), Gaps = 7/98 (7%)
Query: 390 IARGLEYLHLGCSTRILHFDIKPHNILLDEDFCPKISDFGLAKICNRKESIISMTGARGT 449
           +  GLEYLH       +H D+K  NILL ED   +I+DFG++        I      +  
Sbjct: 125 VLEGLEYLHKNGQ---IHRDVKAGNILLGEDGSVQIADFGVSAFLATGGDITRNKVRKTF 181
Query: 450 VG---YIAPEVFCRNIGEVSYKSDVYNYGMMIFEMTGG 484
           VG   ++APEV  +  G   +K+D++++G+   E+  G
Sbjct: 182 VGTPCWMAPEVMEQVRG-YDFKADIWSFGITAIELATG 218

>pdb|3D94|A Chain A, Crystal Structure Of The Insulin-Like Growth Factor-1 Receptor Kinase In Complex With Pqip Length = 301

Iteration: 1
 Score = 50.8 bits (120), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 56/210 (26%), Positives = 94/210 (44%), Gaps = 54/210 (25%)
Query: 320 KLGQGGYGSVYKG------KLLDGSNVAVKVLNDSKGNGK--EFINEVASISRTSHVNVV 371
           +LGQG +G VY+G      K    + VA+K +N++    +  EF+NE + +   +  +VV
Sbjct: 19  ELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVV 78
Query: 372 ALLGFC------------------------LRVAEE---------LSSTIG----IARGL 394
            LLG                          LR   E         LS  I     IA G+
Sbjct: 79  RLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLSKMIQMAGEIADGM 138
Query: 395 EYLHLGCSTRILHFDIKPHNILLDEDFCPKISDFGLAKICNRKESIISMTGARG--TVGY 452
            YL+   + + +H D+   N  + EDF  KI DFG+ +  +  E+     G +G   V +
Sbjct: 139 AYLN---ANKFVHRDLAARNCXVAEDFTVKIGDFGMTR--DIYETDYYRKGGKGLLPVRW 193
Query: 453 IAPEVFCRNIGEVSYKSDVYNYGMMIFEMT 482
           ++PE      G  +  SDV+++G++++E+ 
Sbjct: 194 MSPESL--KDGVFTTYSDVWSFGVVLWEIA 221

>pdb|3P23|A Chain A, Crystal Structure Of The Human Kinase And Rnase Domains In Complex With Adp Length = 432

Iteration: 1
 Score = 50.8 bits (120), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 34/94 (36%), Positives = 50/94 (53%), Gaps = 10/94 (10%)
Query: 393 GLEYLHLGCSTRILHFDIKPHNILLDE-----DFCPKISDFGL-AKICNRKESIISMTGA 446
           GL +LH   S  I+H D+KPHNIL+            ISDFGL  K+   + S    +G 
Sbjct: 130 GLAHLH---SLNIVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLAVGRHSFSRRSGV 186
Query: 447 RGTVGYIAPEVFCRNIGE-VSYKSDVYNYGMMIF 479
            GT G+IAPE+   +  E  +Y  D+++ G + +
Sbjct: 187 PGTEGWIAPEMLSEDCKENPTYTVDIFSAGCVFY 220

>pdb|2C6E|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With A 5-Aminopyrimidinyl Quinazoline Inhibitor Length = 283

Iteration: 1
 Score = 50.8 bits (120), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 51/201 (25%), Positives = 83/201 (41%), Gaps = 49/201 (24%)
Query: 321 LGQGGYGSVY-----KGKLLDGSNVAVKVLNDSKGNGKEFINEVASISRTSHVNVVALLG 375
           LG+G +G+VY     + K +    V  K   +  G   +   EV   S   H N++ L G
Sbjct: 21  LGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYG 80
Query: 376 F------------------CLRVAEELSS---------TIGIARGLEYLHLGCSTRILHF 408
           +                    R  ++LS             +A  L Y H   S R++H 
Sbjct: 81  YFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCH---SKRVIHR 137
Query: 409 DIKPHNILLDEDFCPKISDFGLAKICNRKESIISMTGAR----GTVGYIAPEVFCRNIGE 464
           DIKP N+LL      KI+DFG         S+ + +  R    GT+ Y+ PE+    + +
Sbjct: 138 DIKPENLLLGSAGELKIADFGW--------SVHAPSSRRTDLCGTLDYLPPEMIEGRMHD 189
Query: 465 VSYKSDVYNYGMMIFEMTGGR 485
              K D+++ G++ +E   G+
Sbjct: 190 E--KVDLWSLGVLCYEFLVGK 208

>pdb|1GZN|A Chain A, Structure Of Pkb Kinase Domain Length = 335

Iteration: 1
 Score = 50.8 bits (120), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 64/212 (30%), Positives = 90/212 (42%), Gaps = 47/212 (22%)
Query: 311 KKMTNSFKYK--LGQGGYGSVYKGK-LLDGSNVAVKVLNDSKGNGKEFINEVASISR--- 364
           K   N F Y   LG+G +G V   +    G   A+K+L       K+ +    + SR   
Sbjct: 1   KVTMNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQ 60
Query: 365 -TSHVNVVAL---------LGFCLRVA----------------EELSSTIG--IARGLEY 396
            T H  + AL         L F +  A                EE +   G  I   LEY
Sbjct: 61  NTRHPFLTALKYAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEY 120
Query: 397 LHLGCSTRILHFDIKPHNILLDEDFCPKISDFGLAKICNRKESI---ISMTGARGTVGYI 453
           LH   S  +++ DIK  N++LD+D   KI+DFGL      KE I    +M    GT  Y+
Sbjct: 121 LH---SRDVVYRDIKLENLMLDKDGHIKITDFGLC-----KEGISDGATMKTFCGTPEYL 172
Query: 454 APEVFCRNIGEVSYKSDVYNYGMMIFEMTGGR 485
           APEV   N  +     D +  G++++EM  GR
Sbjct: 173 APEVLEDN--DYGRAVDWWGLGVVMYEMMCGR 202

>pdb|3LAU|A Chain A, Crystal Structure Of Aurora2 Kinase In Complex With A Gsk3beta Inhibitor Length = 287

Iteration: 1
 Score = 50.8 bits (120), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 51/201 (25%), Positives = 83/201 (41%), Gaps = 49/201 (24%)
Query: 321 LGQGGYGSVY-----KGKLLDGSNVAVKVLNDSKGNGKEFINEVASISRTSHVNVVALLG 375
           LG+G +G+VY     + K +    V  K   +  G   +   EV   S   H N++ L G
Sbjct: 16  LGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYG 75
Query: 376 F------------------CLRVAEELSS---------TIGIARGLEYLHLGCSTRILHF 408
           +                    R  ++LS             +A  L Y H   S R++H 
Sbjct: 76  YFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCH---SKRVIHR 132
Query: 409 DIKPHNILLDEDFCPKISDFGLAKICNRKESIISMTGAR----GTVGYIAPEVFCRNIGE 464
           DIKP N+LL      KI+DFG         S+ + +  R    GT+ Y+ PE+    + +
Sbjct: 133 DIKPENLLLGSAGELKIADFGW--------SVHAPSSRRTDLCGTLDYLPPEMIEGRMHD 184
Query: 465 VSYKSDVYNYGMMIFEMTGGR 485
              K D+++ G++ +E   G+
Sbjct: 185 E--KVDLWSLGVLCYEFLVGK 203

>pdb|1GZK|A Chain A, Molecular Mechanism For The Regulation Of Protein Kinase B Akt By Hydrophobic Motif Phosphorylation Length = 315

Iteration: 1
 Score = 50.8 bits (120), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 38/99 (38%), Positives = 53/99 (53%), Gaps = 13/99 (13%)
Query: 390 IARGLEYLHLGCSTRILHFDIKPHNILLDEDFCPKISDFGLAKICNRKESI---ISMTGA 446
           I   LEYLH   S  +++ DIK  N++LD+D   KI+DFGL      KE I    +M   
Sbjct: 114 IVSALEYLH---SRDVVYRDIKLENLMLDKDGHIKITDFGLC-----KEGISDGATMKTF 165
Query: 447 RGTVGYIAPEVFCRNIGEVSYKSDVYNYGMMIFEMTGGR 485
            GT  Y+APEV   N  +     D +  G++++EM  GR
Sbjct: 166 CGTPEYLAPEVLEDN--DYGRAVDWWGLGVVMYEMMCGR 202

>pdb|3NRM|A Chain A, Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibitors Length = 283

Iteration: 1
 Score = 50.8 bits (120), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 50/199 (25%), Positives = 84/199 (42%), Gaps = 45/199 (22%)
Query: 321 LGQGGYGSVY-----KGKLLDGSNVAVKVLNDSKGNGKEFINEVASISRTSHVNVVALLG 375
           LG+G +G+VY     + K +    V  K   +  G   +   EV   S   H N++ L G
Sbjct: 19  LGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYG 78
Query: 376 F------------------CLRVAEELSS---------TIGIARGLEYLHLGCSTRILHF 408
           +                    R  ++LS             +A  L Y H   S R++H 
Sbjct: 79  YFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCH---SKRVIHR 135
Query: 409 DIKPHNILLDEDFCPKISDFGLA--KICNRKESIISMTGARGTVGYIAPEVFCRNIGEVS 466
           DIKP N+LL      KI+DFG +     +R+ ++       GT+ Y+ PE+    + +  
Sbjct: 136 DIKPENLLLGSAGELKIADFGWSVHAPSSRRAALC------GTLDYLPPEMIEGRMHDE- 188
Query: 467 YKSDVYNYGMMIFEMTGGR 485
            K D+++ G++ +E   G+
Sbjct: 189 -KVDLWSLGVLCYEFLVGK 206

>pdb|3I7C|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) In Complex With Bumped Kinase Inhibitor Na-Pp2 Length = 484

Iteration: 1
 Score = 50.8 bits (120), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 56/200 (28%), Positives = 87/200 (43%), Gaps = 46/200 (23%)
Query: 321 LGQGGYGSVY--KGKLLDGSNVAVKVLND----SKGNGKEFINEVASISRTSHVNVVALL 374
           LG+G +G V   K K+  G   AVKV++      K + +  + EV  + +  H N+  L 
Sbjct: 34  LGKGSFGEVILCKDKIT-GQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIXKLY 92
Query: 375 ------GFCLRVAEELS--------------STIGIAR-------GLEYLHLGCSTRILH 407
                 G+   V E  +              S +  AR       G+ Y H     +I+H
Sbjct: 93  EFFEDKGYFYLVGEVYTGGELFDEIISRKRFSEVDAARIIRQVLSGITYXH---KNKIVH 149
Query: 408 FDIKPHNILLD---EDFCPKISDFGLAKICNRKESIISMTGARGTVGYIAPEVFCRNIGE 464
            D+KP N+LL+   +D   +I DFGL+      E+        GT  YIAPEV     G 
Sbjct: 150 RDLKPENLLLESKSKDANIRIIDFGLS---THFEASKKXKDKIGTAYYIAPEVLH---GT 203
Query: 465 VSYKSDVYNYGMMIFEMTGG 484
              K DV++ G++++ +  G
Sbjct: 204 YDEKCDVWSTGVILYILLSG 223

>pdb|3CC6|A Chain A, Crystal Structure Of Kinase Domain Of Protein Tyrosine Kinase 2 Beta (ptk2b) Length = 281

Iteration: 1
 Score = 50.8 bits (120), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 51/216 (23%), Positives = 90/216 (41%), Gaps = 42/216 (19%)
Query: 299 SLSPKRYGYADIKKMTNSFKYKLGQGGYGSVYKGKLLDGS----NVAVKVLND--SKGNG 352
           S+   +YG A    + N     LG+G +G VY+G   +      NVAVK      +  N 
Sbjct: 1   SMGGPQYGIAREDVVLNRI---LGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNK 57
Query: 353 KEFINEVASISRTSHVNVVALLGFC---------------------------LRVAEELS 385
           ++F++E   +    H ++V L+G                             L+V   + 
Sbjct: 58  EKFMSEAVIMKNLDHPHIVKLIGIIEEEPTWIIMELYPYGELGHYLERNKNSLKVLTLVL 117
Query: 386 STIGIARGLEYLHLGCSTRILHFDIKPHNILLDEDFCPKISDFGLAKICNRKESIISMTG 445
            ++ I + + YL    S   +H DI   NIL+    C K+ DFGL++     E     + 
Sbjct: 118 YSLQICKAMAYLE---SINCVHRDIAVRNILVASPECVKLGDFGLSRYIE-DEDYYKASV 173
Query: 446 ARGTVGYIAPEVFCRNIGEVSYKSDVYNYGMMIFEM 481
            R  + +++PE    N    +  SDV+ + + ++E+
Sbjct: 174 TRLPIKWMSPESI--NFRRFTTASDVWMFAVCMWEI 207

>pdb|1O6L|A Chain A, Crystal Structure Of An Activated Akt/protein Kinase B (pkb-pif Chimera) Ternary Complex With Amp-pnp And Gsk3 Peptide Length = 337

Iteration: 1
 Score = 50.8 bits (120), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 38/99 (38%), Positives = 53/99 (53%), Gaps = 13/99 (13%)
Query: 390 IARGLEYLHLGCSTRILHFDIKPHNILLDEDFCPKISDFGLAKICNRKESI---ISMTGA 446
           I   LEYLH   S  +++ DIK  N++LD+D   KI+DFGL      KE I    +M   
Sbjct: 114 IVSALEYLH---SRDVVYRDIKLENLMLDKDGHIKITDFGLC-----KEGISDGATMKXF 165
Query: 447 RGTVGYIAPEVFCRNIGEVSYKSDVYNYGMMIFEMTGGR 485
            GT  Y+APEV   N  +     D +  G++++EM  GR
Sbjct: 166 CGTPEYLAPEVLEDN--DYGRAVDWWGLGVVMYEMMCGR 202

>pdb|3GGF|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase Mst4 In Complex With An Quinazolin Length = 301

Iteration: 1
 Score = 50.4 bits (119), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 34/98 (34%), Positives = 54/98 (55%), Gaps = 11/98 (11%)
Query: 390 IARGLEYLHLGCSTRILHFDIKPHNILLDEDFCPKISDFGLAKICNRKESIISMTGARGT 449
           I +GL+YLH   S + +H DIK  N+LL E    K++DFG+A      ++ I      GT
Sbjct: 129 ILKGLDYLH---SEKKIHRDIKAANVLLSEQGDVKLADFGVA--GQLTDTQIKRNTFVGT 183
Query: 450 VGYIAPEVFCRNIGEVSY--KSDVYNYGMMIFEMTGGR 485
             ++APEV    I + +Y  K+D+++ G+   E+  G 
Sbjct: 184 PFWMAPEV----IQQSAYDSKADIWSLGITAIELAKGE 217

>pdb|3E87|A Chain A, Crystal Structures Of The Kinase Domain Of Akt2 In Complex With Atp- Competitive Inhibitors Length = 335

Iteration: 1
 Score = 50.4 bits (119), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 64/212 (30%), Positives = 90/212 (42%), Gaps = 47/212 (22%)
Query: 311 KKMTNSFKYK--LGQGGYGSVYKGK-LLDGSNVAVKVLNDSKGNGKEFINEVASISR--- 364
           K   N F Y   LG+G +G V   +    G   A+K+L       K+ +    + SR   
Sbjct: 1   KVTMNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQ 60
Query: 365 -TSHVNVVAL---------LGFCLRVA----------------EELSSTIG--IARGLEY 396
            T H  + AL         L F +  A                EE +   G  I   LEY
Sbjct: 61  NTRHPFLTALKYAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEY 120
Query: 397 LHLGCSTRILHFDIKPHNILLDEDFCPKISDFGLAKICNRKESI---ISMTGARGTVGYI 453
           LH   S  +++ DIK  N++LD+D   KI+DFGL      KE I    +M    GT  Y+
Sbjct: 121 LH---SRDVVYRDIKLENLMLDKDGHIKITDFGLC-----KEGISDGATMKXFCGTPEYL 172
Query: 454 APEVFCRNIGEVSYKSDVYNYGMMIFEMTGGR 485
           APEV   N  +     D +  G++++EM  GR
Sbjct: 173 APEVLEDN--DYGRAVDWWGLGVVMYEMMCGR 202

>pdb|3D14|A Chain A, Crystal Structure Of Mouse Aurora A (Asn186->gly, Lys240->arg, Met302- >leu) In Complex With 1-{5-[2-(Thieno[3,2-D]pyrimidin-4-Ylamino)- Ethyl]- Thiazol-2-Yl}-3-(3-Trifluoromethyl-Phenyl)-Urea Length = 272

Iteration: 1
 Score = 50.4 bits (119), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 50/198 (25%), Positives = 85/198 (42%), Gaps = 45/198 (22%)
Query: 321 LGQGGYGSVY-----KGKLLDGSNVAVKVLNDSKGNGKEFINEVASISRTSHVNVVALLG 375
           LG+G +G+VY     + K +    V  K   +  G   +   EV   S   H N++ L G
Sbjct: 20  LGKGKFGNVYLARERQSKFILALKVLFKTQLEKAGVEHQLRREVEIQSHLRHPNILRLYG 79
Query: 376 F-------------------------CLRVAEELSST--IGIARGLEYLHLGCSTRILHF 408
           +                           R  E+ ++T    +A  L Y H   S R++H 
Sbjct: 80  YFHDATRVYLILEYAPLGTVYRELQKLSRFDEQRTATYITELANALSYCH---SKRVIHR 136
Query: 409 DIKPHNILLDEDFCPKISDFGLA--KICNRKESIISMTGARGTVGYIAPEVFCRNIGEVS 466
           DIKP N+LL  +   KI+DFG +     +R+ ++       GT+ Y+ PE+    + +  
Sbjct: 137 DIKPENLLLGSNGELKIADFGWSVHAPSSRRTTLC------GTLDYLPPEMIEGRMHDE- 189
Query: 467 YKSDVYNYGMMIFEMTGG 484
            K D+++ G++ +E   G
Sbjct: 190 -KVDLWSLGVLCYEFLVG 206

>pdb|1O6K|A Chain A, Structure Of Activated Form Of Pkb Kinase Domain S474d With Gsk3 Peptide And Amp-Pnp Length = 336

Iteration: 1
 Score = 50.4 bits (119), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 38/99 (38%), Positives = 53/99 (53%), Gaps = 13/99 (13%)
Query: 390 IARGLEYLHLGCSTRILHFDIKPHNILLDEDFCPKISDFGLAKICNRKESI---ISMTGA 446
           I   LEYLH   S  +++ DIK  N++LD+D   KI+DFGL      KE I    +M   
Sbjct: 114 IVSALEYLH---SRDVVYRDIKLENLMLDKDGHIKITDFGLC-----KEGISDGATMKXF 165
Query: 447 RGTVGYIAPEVFCRNIGEVSYKSDVYNYGMMIFEMTGGR 485
            GT  Y+APEV   N  +     D +  G++++EM  GR
Sbjct: 166 CGTPEYLAPEVLEDN--DYGRAVDWWGLGVVMYEMMCGR 202

>pdb|2X4F|A Chain A, The Crystal Structure Of The Human Myosin Light Chain Kinase Loc340156. Length = 373

Iteration: 1
 Score = 50.4 bits (119), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 53/196 (27%), Positives = 90/196 (45%), Gaps = 40/196 (20%)
Query: 321 LGQGGYGSVYK-GKLLDGSNVAVKVLNDSKGNGKEFI-NEVASISRTSHVNVVALLGF-- 376
           LG G +G V+K  +   G  +A K++       KE + NE++ +++  H N++ L     
Sbjct: 97  LGGGRFGQVHKCEETATGLKLAAKIIKTRGMKDKEEVKNEISVMNQLDHANLIQLYDAFE 156
Query: 377 ----CLRVAE-------------------ELSSTI---GIARGLEYLHLGCSTRILHFDI 410
                + V E                   EL + +    I  G+ ++H      ILH D+
Sbjct: 157 SKNDIVLVMEYVDGGELFDRIIDESYNLTELDTILFMKQICEGIRHMH---QMYILHLDL 213
Query: 411 KPHNIL-LDEDFCP-KISDFGLAKICNRKESIISMTGARGTVGYIAPEVFCRNIGEVSYK 468
           KP NIL ++ D    KI DFGLA+    +E    +    GT  ++APEV   N   VS+ 
Sbjct: 214 KPENILCVNRDAKQIKIIDFGLARRYKPRE---KLKVNFGTPEFLAPEVV--NYDFVSFP 268
Query: 469 SDVYNYGMMIFEMTGG 484
           +D+++ G++ + +  G
Sbjct: 269 TDMWSVGVIAYMLLSG 284

>pdb|1S9I|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 2 (Mek2)in A Complex With Ligand And Mgatp Length = 354

Iteration: 1
 Score = 50.4 bits (119), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 38/110 (34%), Positives = 59/110 (53%), Gaps = 12/110 (10%)
Query: 379 RVAEELSSTIGIA--RGLEYLHLGCSTRILHFDIKPHNILLDEDFCPKISDFGLAKICNR 436
           R+ EE+   + IA  RGL YL      +I+H D+KP NIL++     K+ DFG++     
Sbjct: 110 RIPEEILGKVSIAVLRGLAYLR--EKHQIMHRDVKPSNILVNSRGEIKLCDFGVS----- 162
Query: 437 KESIISMTGA-RGTVGYIAPEVFCRNIGEVSYKSDVYNYGMMIFEMTGGR 485
            + I SM  +  GT  Y+APE         S +SD+++ G+ + E+  GR
Sbjct: 163 GQLIDSMANSFVGTRSYMAPERLQGT--HYSVQSDIWSMGLSLVELAVGR 210

>pdb|3LXN|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 318

Iteration: 1
 Score = 50.4 bits (119), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 34/103 (33%), Positives = 51/103 (49%), Gaps = 6/103 (5%)
Query: 380 VAEELSSTIGIARGLEYLHLGCSTRILHFDIKPHNILLDEDFCPKISDFGLAK-ICNRKE 438
           +A+ L     I  G+ YLH   +   +H D+   N+LLD D   KI DFGLAK +    E
Sbjct: 133 LAQLLLFAQQICEGMAYLH---AQHYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHE 189
Query: 439 SIISMTGARGTVGYIAPEVFCRNIGEVSYKSDVYNYGMMIFEM 481
                      V + APE  C    +  Y SDV+++G+ ++E+
Sbjct: 190 XYRVREDGDSPVFWYAPE--CLKEYKFYYASDVWSFGVTLYEL 230

>pdb|3R21|A Chain A, Design, Synthesis, And Biological Evaluation Of Pyrazolopyridine- Sulfonamides As Potent Multiple-Mitotic Kinase (Mmk) Inhibitors (Part I) Length = 271

Iteration: 1
 Score = 50.4 bits (119), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 50/199 (25%), Positives = 84/199 (42%), Gaps = 45/199 (22%)
Query: 321 LGQGGYGSVY-----KGKLLDGSNVAVKVLNDSKGNGKEFINEVASISRTSHVNVVALLG 375
           LG+G +G+VY     + K +    V  K   +  G   +   EV   S   H N++ L G
Sbjct: 19  LGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYG 78
Query: 376 F------------------CLRVAEELSS---------TIGIARGLEYLHLGCSTRILHF 408
           +                    R  ++LS             +A  L Y H   S R++H 
Sbjct: 79  YFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCH---SKRVIHR 135
Query: 409 DIKPHNILLDEDFCPKISDFGLA--KICNRKESIISMTGARGTVGYIAPEVFCRNIGEVS 466
           DIKP N+LL      KI+DFG +     +R++ +       GT+ Y+ PE+    + +  
Sbjct: 136 DIKPENLLLGSAGELKIADFGWSVHAPSSRRDDLC------GTLDYLPPEMIEGRMHDE- 188
Query: 467 YKSDVYNYGMMIFEMTGGR 485
            K D+++ G++ +E   G+
Sbjct: 189 -KVDLWSLGVLCYEFLVGK 206

>pdb|3O50|A Chain A, Crystal Structure Of Benzamide 9 Bound To Auroraa Length = 267

Iteration: 1
 Score = 50.4 bits (119), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 50/199 (25%), Positives = 84/199 (42%), Gaps = 45/199 (22%)
Query: 321 LGQGGYGSVY-----KGKLLDGSNVAVKVLNDSKGNGKEFINEVASISRTSHVNVVALLG 375
           LG+G +G+VY     + K +    V  K   +  G   +   EV   S   H N++ L G
Sbjct: 15  LGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYG 74
Query: 376 F------------------CLRVAEELSS---------TIGIARGLEYLHLGCSTRILHF 408
           +                    R  ++LS             +A  L Y H   S R++H 
Sbjct: 75  YFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCH---SKRVIHR 131
Query: 409 DIKPHNILLDEDFCPKISDFGLA--KICNRKESIISMTGARGTVGYIAPEVFCRNIGEVS 466
           DIKP N+LL      KI+DFG +     +R+ ++       GT+ Y+ PE+    + +  
Sbjct: 132 DIKPENLLLGSAGELKIADFGWSVHAPSSRRTTLC------GTLDYLPPEMIEGRMHDE- 184
Query: 467 YKSDVYNYGMMIFEMTGGR 485
            K D+++ G++ +E   G+
Sbjct: 185 -KVDLWSLGVLCYEFLVGK 202

>pdb|3H0Y|A Chain A, Aurora A In Complex With A Bisanilinopyrimidine Length = 268

Iteration: 1
 Score = 50.4 bits (119), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 50/199 (25%), Positives = 84/199 (42%), Gaps = 45/199 (22%)
Query: 321 LGQGGYGSVY-----KGKLLDGSNVAVKVLNDSKGNGKEFINEVASISRTSHVNVVALLG 375
           LG+G +G+VY     + K +    V  K   +  G   +   EV   S   H N++ L G
Sbjct: 16  LGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYG 75
Query: 376 F------------------CLRVAEELSS---------TIGIARGLEYLHLGCSTRILHF 408
           +                    R  ++LS             +A  L Y H   S R++H 
Sbjct: 76  YFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCH---SKRVIHR 132
Query: 409 DIKPHNILLDEDFCPKISDFGLA--KICNRKESIISMTGARGTVGYIAPEVFCRNIGEVS 466
           DIKP N+LL      KI+DFG +     +R+ ++       GT+ Y+ PE+    + +  
Sbjct: 133 DIKPENLLLGSAGELKIADFGWSVHAPSSRRAALC------GTLDYLPPEMIEGRMHDE- 185
Query: 467 YKSDVYNYGMMIFEMTGGR 485
            K D+++ G++ +E   G+
Sbjct: 186 -KVDLWSLGVLCYEFLVGK 203

>pdb|3FZO|A Chain A, Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosine Kinase Length = 277

Iteration: 1
 Score = 50.4 bits (119), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 46/194 (23%), Positives = 82/194 (42%), Gaps = 39/194 (20%)
Query: 321 LGQGGYGSVYKGKLLDGS----NVAVKVLND--SKGNGKEFINEVASISRTSHVNVVALL 374
           LG+G +G VY+G   +      NVAVK      +  N ++F++E   +    H ++V L+
Sbjct: 16  LGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIVKLI 75
Query: 375 GFC---------------------------LRVAEELSSTIGIARGLEYLHLGCSTRILH 407
           G                             L+V   +  ++ I + + YL    S   +H
Sbjct: 76  GIIEEEPTWIIMELYPYGELGHYLERNKNSLKVLTLVLYSLQICKAMAYLE---SINCVH 132
Query: 408 FDIKPHNILLDEDFCPKISDFGLAKICNRKESIISMTGARGTVGYIAPEVFCRNIGEVSY 467
            DI   NIL+    C K+ DFGL++     E     +  R  + +++PE    N    + 
Sbjct: 133 RDIAVRNILVASPECVKLGDFGLSRYIE-DEDYYKASVTRLPIKWMSPESI--NFRRFTT 189
Query: 468 KSDVYNYGMMIFEM 481
            SDV+ + + ++E+
Sbjct: 190 ASDVWMFAVCMWEI 203

>pdb|1ZRZ|A Chain A, Crystal Structure Of The Catalytic Domain Of Atypical Protein Kinase C-Iota Length = 364

Iteration: 1
 Score = 50.4 bits (119), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 34/102 (33%), Positives = 52/102 (50%), Gaps = 7/102 (6%)
Query: 390 IARGLEYLHLGCSTRILHFDIKPHNILLDEDFCPKISDFGLAKICNRKESIISMTGARGT 449
           I+  L YLH      I++ D+K  N+LLD +   K++D+G+ K   R     S     GT
Sbjct: 130 ISLALNYLH---ERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTTSXFC--GT 184
Query: 450 VGYIAPEVFCRNIGEVSYKSDVYNYGMMIFEMTGGRKNVDVV 491
             YIAPE+      +  +  D +  G+++FEM  GR   D+V
Sbjct: 185 PNYIAPEILRGE--DYGFSVDWWALGVLMFEMMAGRSPFDIV 224

>pdb|2W1C|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275

Iteration: 1
 Score = 50.1 bits (118), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 51/201 (25%), Positives = 83/201 (41%), Gaps = 49/201 (24%)
Query: 321 LGQGGYGSVY-----KGKLLDGSNVAVKVLNDSKGNGKEFINEVASISRTSHVNVVALLG 375
           LG+G +G+VY     + K +    V  K   +  G   +   EV   S   H N++ L G
Sbjct: 19  LGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYG 78
Query: 376 F------------------CLRVAEELSS---------TIGIARGLEYLHLGCSTRILHF 408
           +                    R  ++LS             +A  L Y H   S R++H 
Sbjct: 79  YFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCH---SKRVIHR 135
Query: 409 DIKPHNILLDEDFCPKISDFGLAKICNRKESIISMTGAR----GTVGYIAPEVFCRNIGE 464
           DIKP N+LL      KI+DFG         S+ + +  R    GT+ Y+ PE+    + +
Sbjct: 136 DIKPENLLLGSAGELKIADFGW--------SVHAPSSRRXXLCGTLDYLPPEMIEGRMHD 187
Query: 465 VSYKSDVYNYGMMIFEMTGGR 485
              K D+++ G++ +E   G+
Sbjct: 188 E--KVDLWSLGVLCYEFLVGK 206

>pdb|2W1D|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275

Iteration: 1
 Score = 50.1 bits (118), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 50/199 (25%), Positives = 84/199 (42%), Gaps = 45/199 (22%)
Query: 321 LGQGGYGSVY-----KGKLLDGSNVAVKVLNDSKGNGKEFINEVASISRTSHVNVVALLG 375
           LG+G +G+VY     + K +    V  K   +  G   +   EV   S   H N++ L G
Sbjct: 19  LGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYG 78
Query: 376 F------------------CLRVAEELSS---------TIGIARGLEYLHLGCSTRILHF 408
           +                    R  ++LS             +A  L Y H   S R++H 
Sbjct: 79  YFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCH---SKRVIHR 135
Query: 409 DIKPHNILLDEDFCPKISDFGLA--KICNRKESIISMTGARGTVGYIAPEVFCRNIGEVS 466
           DIKP N+LL      KI+DFG +     +R+ ++       GT+ Y+ PE+    + +  
Sbjct: 136 DIKPENLLLGSAGELKIADFGWSVHAPSSRRTTLC------GTLDYLPPEMIEGRMHDE- 188
Query: 467 YKSDVYNYGMMIFEMTGGR 485
            K D+++ G++ +E   G+
Sbjct: 189 -KVDLWSLGVLCYEFLVGK 206

>pdb|4DC2|A Chain A, Structure Of Pkc In Complex With A Substrate Peptide From Par-3 Length = 396

Iteration: 1
 Score = 50.1 bits (118), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 34/102 (33%), Positives = 52/102 (50%), Gaps = 7/102 (6%)
Query: 390 IARGLEYLHLGCSTRILHFDIKPHNILLDEDFCPKISDFGLAKICNRKESIISMTGARGT 449
           I+  L YLH      I++ D+K  N+LLD +   K++D+G+ K   R     S     GT
Sbjct: 162 ISLALNYLH---ERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTTSTFC--GT 216
Query: 450 VGYIAPEVFCRNIGEVSYKSDVYNYGMMIFEMTGGRKNVDVV 491
             YIAPE+      +  +  D +  G+++FEM  GR   D+V
Sbjct: 217 PNYIAPEILRGE--DYGFSVDWWALGVLMFEMMAGRSPFDIV 256

>pdb|2YA9|A Chain A, Crystal Structure Of The Autoinhibited Form Of Mouse Dapk2 Length = 361

Iteration: 1
 Score = 50.1 bits (118), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 35/108 (32%), Positives = 58/108 (53%), Gaps = 13/108 (12%)
Query: 382 EELSSTIG-IARGLEYLHLGCSTRILHFDIKPHNILLDEDFCP----KISDFGLAKICNR 436
           EE +S I  I  G+ YLH   + +I HFD+KP NI+L +   P    K+ DFGLA   + 
Sbjct: 115 EEATSFIKQILDGVNYLH---TKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLA---HE 168
Query: 437 KESIISMTGARGTVGYIAPEVFCRNIGEVSYKSDVYNYGMMIFEMTGG 484
            E  +      GT  ++APE+   N   +  ++D+++ G++ + +  G
Sbjct: 169 IEDGVEFKNIFGTPEFVAPEIV--NYEPLGLEADMWSIGVITYILLSG 214

>pdb|4H1J|A Chain A, Crystal Structure Of Pyk2 With The Pyrazole 13a Length = 293

Iteration: 1
 Score = 50.1 bits (118), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 50/211 (23%), Positives = 88/211 (41%), Gaps = 42/211 (19%)
Query: 304 RYGYADIKKMTNSFKYKLGQGGYGSVYKGKLLDGS----NVAVKVLND--SKGNGKEFIN 357
           +YG A    + N     LG+G +G VY+G   +      NVAVK      +  N ++F++
Sbjct: 18  QYGIAREDVVLNRI---LGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMS 74
Query: 358 EVASISRTSHVNVVALLGFC---------------------------LRVAEELSSTIGI 390
           E   +    H ++V L+G                             L+V   +  ++ I
Sbjct: 75  EAVIMKNLDHPHIVKLIGIIEEEPTWIIMELYPYGELGHYLERNKNSLKVLTLVLYSLQI 134
Query: 391 ARGLEYLHLGCSTRILHFDIKPHNILLDEDFCPKISDFGLAKICNRKESIISMTGARGTV 450
            + + YL    S   +H DI   NIL+    C K+ DFGL++     E     +  R  +
Sbjct: 135 CKAMAYLE---SINCVHRDIAVRNILVASPECVKLGDFGLSRYIE-DEDYYKASVTRLPI 190
Query: 451 GYIAPEVFCRNIGEVSYKSDVYNYGMMIFEM 481
            +++PE    N    +  SDV+ + + ++E+
Sbjct: 191 KWMSPESI--NFRRFTTASDVWMFAVCMWEI 219

>pdb|3HA6|A Chain A, Crystal Structure Of Aurora A In Complex With Tpx2 And Compound 10 Length = 268

Iteration: 1
 Score = 50.1 bits (118), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 51/201 (25%), Positives = 83/201 (41%), Gaps = 49/201 (24%)
Query: 321 LGQGGYGSVY-----KGKLLDGSNVAVKVLNDSKGNGKEFINEVASISRTSHVNVVALLG 375
           LG+G +G+VY     + K +    V  K   +  G   +   EV   S   H N++ L G
Sbjct: 16  LGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYG 75
Query: 376 F------------------CLRVAEELSS---------TIGIARGLEYLHLGCSTRILHF 408
           +                    R  ++LS             +A  L Y H   S R++H 
Sbjct: 76  YFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCH---SKRVIHR 132
Query: 409 DIKPHNILLDEDFCPKISDFGLAKICNRKESIISMTGAR----GTVGYIAPEVFCRNIGE 464
           DIKP N+LL      KI+DFG         S+ + +  R    GT+ Y+ PE+    + +
Sbjct: 133 DIKPENLLLGSAGELKIADFGW--------SVHAPSSRRXXLCGTLDYLPPEMIEGRMHD 184
Query: 465 VSYKSDVYNYGMMIFEMTGGR 485
              K D+++ G++ +E   G+
Sbjct: 185 E--KVDLWSLGVLCYEFLVGK 203

>pdb|1MQ4|A Chain A, Crystal Structure Of Aurora-A Protein Kinase Length = 272

Iteration: 1
 Score = 50.1 bits (118), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 50/199 (25%), Positives = 84/199 (42%), Gaps = 45/199 (22%)
Query: 321 LGQGGYGSVY-----KGKLLDGSNVAVKVLNDSKGNGKEFINEVASISRTSHVNVVALLG 375
           LG+G +G+VY     + K +    V  K   +  G   +   EV   S   H N++ L G
Sbjct: 20  LGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYG 79
Query: 376 F------------------CLRVAEELSS---------TIGIARGLEYLHLGCSTRILHF 408
           +                    R  ++LS             +A  L Y H   S R++H 
Sbjct: 80  YFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCH---SKRVIHR 136
Query: 409 DIKPHNILLDEDFCPKISDFGLA--KICNRKESIISMTGARGTVGYIAPEVFCRNIGEVS 466
           DIKP N+LL      KI+DFG +     +R+ ++       GT+ Y+ PE+    + +  
Sbjct: 137 DIKPENLLLGSAGELKIADFGWSVHAPSSRRTTLC------GTLDYLPPEMIEGRMHDE- 189
Query: 467 YKSDVYNYGMMIFEMTGGR 485
            K D+++ G++ +E   G+
Sbjct: 190 -KVDLWSLGVLCYEFLVGK 207

>pdb|3A8W|A Chain A, Crystal Structure Of Pkciota Kinase Domain Length = 345

Iteration: 1
 Score = 50.1 bits (118), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 34/102 (33%), Positives = 52/102 (50%), Gaps = 7/102 (6%)
Query: 390 IARGLEYLHLGCSTRILHFDIKPHNILLDEDFCPKISDFGLAKICNRKESIISMTGARGT 449
           I+  L YLH      I++ D+K  N+LLD +   K++D+G+ K   R     S     GT
Sbjct: 119 ISLALNYLH---ERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTTSXFC--GT 173
Query: 450 VGYIAPEVFCRNIGEVSYKSDVYNYGMMIFEMTGGRKNVDVV 491
             YIAPE+      +  +  D +  G+++FEM  GR   D+V
Sbjct: 174 PNYIAPEILRGE--DYGFSVDWWALGVLMFEMMAGRSPFDIV 213

>pdb|2WTW|A Chain A, Aurora-A Inhibitor Structure (2nd Crystal Form) Length = 285

Iteration: 1
 Score = 50.1 bits (118), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 52/201 (25%), Positives = 85/201 (42%), Gaps = 49/201 (24%)
Query: 321 LGQGGYGSVY-----KGKLLDGSNVAVKVLNDSKGNGKEFINEVASISRTSHVNVVALLG 375
           LG+G +G+VY     + K +    V  K   +  G   +   EV   S   H N++ L G
Sbjct: 21  LGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYG 80
Query: 376 F---CLRVA----------------------EELSST--IGIARGLEYLHLGCSTRILHF 408
           +     RV                       E+ ++T    +A  L Y H   S R++H 
Sbjct: 81  YFHDATRVYLILEYAPRGEVYKELQKLSKFDEQRTATYITELANALSYCH---SKRVIHR 137
Query: 409 DIKPHNILLDEDFCPKISDFGLAKICNRKESIISMTGAR----GTVGYIAPEVFCRNIGE 464
           DIKP N+LL      KI+DFG         S+ + +  R    GT+ Y+ PE+    + +
Sbjct: 138 DIKPENLLLGSAGELKIADFGW--------SVHAPSSRRTTLCGTLDYLPPEMIEGRMHD 189
Query: 465 VSYKSDVYNYGMMIFEMTGGR 485
              K D+++ G++ +E   G+
Sbjct: 190 E--KVDLWSLGVLCYEFLVGK 208

>pdb|3E5A|A Chain A, Crystal Structure Of Aurora A In Complex With Vx-680 And Tpx2 Length = 268

Iteration: 1
 Score = 50.1 bits (118), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 51/201 (25%), Positives = 83/201 (41%), Gaps = 49/201 (24%)
Query: 321 LGQGGYGSVY-----KGKLLDGSNVAVKVLNDSKGNGKEFINEVASISRTSHVNVVALLG 375
           LG+G +G+VY     + K +    V  K   +  G   +   EV   S   H N++ L G
Sbjct: 16  LGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYG 75
Query: 376 F------------------CLRVAEELSS---------TIGIARGLEYLHLGCSTRILHF 408
           +                    R  ++LS             +A  L Y H   S R++H 
Sbjct: 76  YFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCH---SKRVIHR 132
Query: 409 DIKPHNILLDEDFCPKISDFGLAKICNRKESIISMTGAR----GTVGYIAPEVFCRNIGE 464
           DIKP N+LL      KI+DFG         S+ + +  R    GT+ Y+ PE+    + +
Sbjct: 133 DIKPENLLLGSAGELKIADFGW--------SVHAPSSRRTXLCGTLDYLPPEMIEGRMHD 184
Query: 465 VSYKSDVYNYGMMIFEMTGGR 485
              K D+++ G++ +E   G+
Sbjct: 185 E--KVDLWSLGVLCYEFLVGK 203

>pdb|4E1Z|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 291

Iteration: 1
 Score = 50.1 bits (118), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 34/106 (32%), Positives = 52/106 (49%), Gaps = 6/106 (5%)
Query: 377 CLRVAEELSSTIGIARGLEYLHLGCSTRILHFDIKPHNILLDEDFCPKISDFGLAK-ICN 435
           C+ +A+ L     I  G+ YLH   +   +H  +   N+LLD D   KI DFGLAK +  
Sbjct: 108 CVGLAQLLLFAQQICEGMAYLH---AQHYIHRALAARNVLLDNDRLVKIGDFGLAKAVPE 164
Query: 436 RKESIISMTGARGTVGYIAPEVFCRNIGEVSYKSDVYNYGMMIFEM 481
             E           V + APE  C    +  Y SDV+++G+ ++E+
Sbjct: 165 GHEYYRVREDGDSPVFWYAPE--CLKECKFYYASDVWSFGVTLYEL 208

>pdb|2JED|A Chain A, The Crystal Structure Of The Kinase Domain Of The Protein Kinase C Theta In Complex With Nvp-Xaa228 At 2.32a Resolution. Length = 352

Iteration: 1
 Score = 50.1 bits (118), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 34/99 (34%), Positives = 57/99 (57%), Gaps = 13/99 (13%)
Query: 390 IARGLEYLHLGCSTRILHFDIKPHNILLDEDFCPKISDFGLAKICNRKESIISMTGAR-- 447
           I  GL++LH   S  I++ D+K  NILLD+D   KI+DFG+      KE+++        
Sbjct: 128 IILGLQFLH---SKGIVYRDLKLDNILLDKDGHIKIADFGMC-----KENMLGDAKTNEF 179
Query: 448 -GTVGYIAPEVFCRNIGEVSYKSDVYNYGMMIFEMTGGR 485
            GT  YIAPE+      + ++  D +++G++++EM  G+
Sbjct: 180 CGTPDYIAPEILLGQ--KYNHSVDWWSFGVLLYEMLIGQ 216

>pdb|4E20|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 290

Iteration: 1
 Score = 50.1 bits (118), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 34/106 (32%), Positives = 52/106 (49%), Gaps = 6/106 (5%)
Query: 377 CLRVAEELSSTIGIARGLEYLHLGCSTRILHFDIKPHNILLDEDFCPKISDFGLAK-ICN 435
           C+ +A+ L     I  G+ YLH   +   +H  +   N+LLD D   KI DFGLAK +  
Sbjct: 107 CVGLAQLLLFAQQICEGMAYLH---AQHYIHRALAARNVLLDNDRLVKIGDFGLAKAVPE 163
Query: 436 RKESIISMTGARGTVGYIAPEVFCRNIGEVSYKSDVYNYGMMIFEM 481
             E           V + APE  C    +  Y SDV+++G+ ++E+
Sbjct: 164 GHEYYRVREDGDSPVFWYAPE--CLKECKFYYASDVWSFGVTLYEL 207

>pdb|1XJD|A Chain A, Crystal Structure Of Pkc-Theta Complexed With Staurosporine At 2a Resolution Length = 345

Iteration: 1
 Score = 50.1 bits (118), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 34/99 (34%), Positives = 57/99 (57%), Gaps = 13/99 (13%)
Query: 390 IARGLEYLHLGCSTRILHFDIKPHNILLDEDFCPKISDFGLAKICNRKESIISMTGAR-- 447
           I  GL++LH   S  I++ D+K  NILLD+D   KI+DFG+      KE+++        
Sbjct: 127 IILGLQFLH---SKGIVYRDLKLDNILLDKDGHIKIADFGMC-----KENMLGDAKTNXF 178
Query: 448 -GTVGYIAPEVFCRNIGEVSYKSDVYNYGMMIFEMTGGR 485
            GT  YIAPE+      + ++  D +++G++++EM  G+
Sbjct: 179 CGTPDYIAPEILLGQ--KYNHSVDWWSFGVLLYEMLIGQ 215

>pdb|2QLU|A Chain A, Crystal Structure Of Activin Receptor Type Ii Kinase Domain From Human Length = 314

Iteration: 1
 Score = 50.1 bits (118), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 41/132 (31%), Positives = 57/132 (43%), Gaps = 18/132 (13%)
Query: 369 NVVALLGFCLRVAEELSSTIGIARGLEYLHL--------GCSTRILHFDIKPHNILLDED 420
           N++     C  VAE +S      RGL YLH         G    I H D K  N+LL  D
Sbjct: 107 NIITWNELC-HVAETMS------RGLSYLHEDVPWCRGEGHKPSIAHRDFKSKNVLLKSD 159
Query: 421 FCPKISDFGLAKICNRKESIISMTGARGTVGYIAPEVFCRNIG---EVSYKSDVYNYGMM 477
               ++DFGLA      +      G  GT  Y+APEV    I    +   + D+Y  G++
Sbjct: 160 LTAVLADFGLAVRFEPGKPPGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLV 219
Query: 478 IFEMTGGRKNVD 489
           ++E+    K  D
Sbjct: 220 LWELVSRCKAAD 231

>pdb|3ZH8|A Chain A, A Novel Small Molecule Apkc Inhibitor Length = 349

Iteration: 1
 Score = 50.1 bits (118), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 34/102 (33%), Positives = 52/102 (50%), Gaps = 7/102 (6%)
Query: 390 IARGLEYLHLGCSTRILHFDIKPHNILLDEDFCPKISDFGLAKICNRKESIISMTGARGT 449
           I+  L YLH      I++ D+K  N+LLD +   K++D+G+ K   R     S     GT
Sbjct: 115 ISLALNYLH---ERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTTSXFC--GT 169
Query: 450 VGYIAPEVFCRNIGEVSYKSDVYNYGMMIFEMTGGRKNVDVV 491
             YIAPE+      +  +  D +  G+++FEM  GR   D+V
Sbjct: 170 PNYIAPEILRGE--DYGFSVDWWALGVLMFEMMAGRSPFDIV 209

>pdb|2WTV|A Chain A, Aurora-A Inhibitor Structure Length = 285

Iteration: 1
 Score = 49.7 bits (117), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 51/199 (25%), Positives = 85/199 (42%), Gaps = 45/199 (22%)
Query: 321 LGQGGYGSVY-----KGKLLDGSNVAVKVLNDSKGNGKEFINEVASISRTSHVNVVALLG 375
           LG+G +G+VY     + K +    V  K   +  G   +   EV   S   H N++ L G
Sbjct: 21  LGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYG 80
Query: 376 F---CLRVA----------------------EELSST--IGIARGLEYLHLGCSTRILHF 408
           +     RV                       E+ ++T    +A  L Y H   S R++H 
Sbjct: 81  YFHDATRVYLILEYAPRGEVYKELQKLSKFDEQRTATYITELANALSYCH---SKRVIHR 137
Query: 409 DIKPHNILLDEDFCPKISDFGLA--KICNRKESIISMTGARGTVGYIAPEVFCRNIGEVS 466
           DIKP N+LL      KI+DFG +     +R+  +       GT+ Y+ PE+    + +  
Sbjct: 138 DIKPENLLLGSAGELKIADFGWSVHAPSSRRXXLX------GTLDYLPPEMIEGRMHDE- 190
Query: 467 YKSDVYNYGMMIFEMTGGR 485
            K D+++ G++ +E   G+
Sbjct: 191 -KVDLWSLGVLCYEFLVGK 208

>pdb|3A7F|A Chain A, Human Mst3 Kinase Length = 303

Iteration: 1
 Score = 49.7 bits (117), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 34/98 (34%), Positives = 54/98 (55%), Gaps = 11/98 (11%)
Query: 390 IARGLEYLHLGCSTRILHFDIKPHNILLDEDFCPKISDFGLAKICNRKESIISMTGARGT 449
           I +GL+YLH   S + +H DIK  N+LL E    K++DFG+A      ++ I      GT
Sbjct: 128 ILKGLDYLH---SEKKIHRDIKAANVLLSEHGEVKLADFGVA--GQLTDTQIKRNXFVGT 182
Query: 450 VGYIAPEVFCRNIGEVSY--KSDVYNYGMMIFEMTGGR 485
             ++APEV    I + +Y  K+D+++ G+   E+  G 
Sbjct: 183 PFWMAPEV----IKQSAYDSKADIWSLGITAIELARGE 216

>pdb|1WMK|A Chain A, Human Death-Associated Kinase Drp-1, Mutant S308d D40 Length = 321

Iteration: 1
 Score = 49.7 bits (117), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 35/108 (32%), Positives = 58/108 (53%), Gaps = 13/108 (12%)
Query: 382 EELSSTIG-IARGLEYLHLGCSTRILHFDIKPHNILLDEDFCP----KISDFGLAKICNR 436
           EE +S I  I  G+ YLH   + +I HFD+KP NI+L +   P    K+ DFGLA   + 
Sbjct: 115 EEATSFIKQILDGVNYLH---TKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLA---HE 168
Query: 437 KESIISMTGARGTVGYIAPEVFCRNIGEVSYKSDVYNYGMMIFEMTGG 484
            E  +      GT  ++APE+   N   +  ++D+++ G++ + +  G
Sbjct: 169 IEDGVEFKNIFGTPEFVAPEIV--NYEPLGLEADMWSIGVITYILLSG 214

>pdb|3CKW|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) Length = 304

Iteration: 1
 Score = 49.7 bits (117), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 34/98 (34%), Positives = 54/98 (55%), Gaps = 11/98 (11%)
Query: 390 IARGLEYLHLGCSTRILHFDIKPHNILLDEDFCPKISDFGLAKICNRKESIISMTGARGT 449
           I +GL+YLH   S + +H DIK  N+LL E    K++DFG+A      ++ I      GT
Sbjct: 113 ILKGLDYLH---SEKKIHRDIKAANVLLSEHGEVKLADFGVA--GQLTDTQIKRNTFVGT 167
Query: 450 VGYIAPEVFCRNIGEVSY--KSDVYNYGMMIFEMTGGR 485
             ++APEV    I + +Y  K+D+++ G+   E+  G 
Sbjct: 168 PFWMAPEV----IKQSAYDSKADIWSLGITAIELARGE 201

>pdb|3CKX|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) In Complex With Staurosporine Length = 304

Iteration: 1
 Score = 49.7 bits (117), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 34/98 (34%), Positives = 54/98 (55%), Gaps = 11/98 (11%)
Query: 390 IARGLEYLHLGCSTRILHFDIKPHNILLDEDFCPKISDFGLAKICNRKESIISMTGARGT 449
           I +GL+YLH   S + +H DIK  N+LL E    K++DFG+A      ++ I      GT
Sbjct: 113 ILKGLDYLH---SEKKIHRDIKAANVLLSEHGEVKLADFGVA--GQLTDTQIKRNXFVGT 167
Query: 450 VGYIAPEVFCRNIGEVSY--KSDVYNYGMMIFEMTGGR 485
             ++APEV    I + +Y  K+D+++ G+   E+  G 
Sbjct: 168 PFWMAPEV----IKQSAYDSKADIWSLGITAIELARGE 201

>pdb|2A2A|A Chain A, High-resolution Crystallographic Analysis Of The Autoinhibited Conformation Of A Human Death-associated Protein Kinase Length = 321

Iteration: 1
 Score = 49.7 bits (117), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 35/108 (32%), Positives = 58/108 (53%), Gaps = 13/108 (12%)
Query: 382 EELSSTIG-IARGLEYLHLGCSTRILHFDIKPHNILLDEDFCP----KISDFGLAKICNR 436
           EE +S I  I  G+ YLH   + +I HFD+KP NI+L +   P    K+ DFGLA   + 
Sbjct: 115 EEATSFIKQILDGVNYLH---TKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLA---HE 168
Query: 437 KESIISMTGARGTVGYIAPEVFCRNIGEVSYKSDVYNYGMMIFEMTGG 484
            E  +      GT  ++APE+   N   +  ++D+++ G++ + +  G
Sbjct: 169 IEDGVEFKNIFGTPEFVAPEIV--NYEPLGLEADMWSIGVITYILLSG 214

>pdb|2WNT|A Chain A, Crystal Structure Of The Human Ribosomal Protein S6 Kinase Length = 330

Iteration: 1
 Score = 49.7 bits (117), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 42/115 (36%), Positives = 61/115 (53%), Gaps = 17/115 (14%)
Query: 376 FCLRVAEELSSTIGIARGLEYLHLGCSTRILHFDIKPHNIL-LDED---FCPKISDFGLA 431
           F  R A  +  TIG  + +EYLH   S  ++H D+KP NIL +DE     C +I DFG A
Sbjct: 118 FSEREASFVLHTIG--KTVEYLH---SQGVVHRDLKPSNILYVDESGNPECLRICDFGFA 172
Query: 432 KICNRKESIISMTGARGTVGYIAPEVFCRNIGEVSYKS--DVYNYGMMIFEMTGG 484
           K   R E+ + MT    T  ++APEV  R      Y    D+++ G++++ M  G
Sbjct: 173 KQL-RAENGLLMTPCY-TANFVAPEVLKRQ----GYDEGCDIWSLGILLYTMLAG 221

>pdb|2JAV|A Chain A, Human Kinase With Pyrrole-Indolinone Ligand Length = 279

Iteration: 1
 Score = 49.7 bits (117), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 30/79 (37%), Positives = 45/79 (56%), Gaps = 8/79 (10%)
Query: 405 ILHFDIKPHNILLDEDFCPKISDFGLAKICNRKESIISMTGARGTVGYIAPEVFCRNIGE 464
           +LH D+KP N+ LD     K+ DFGLA+I N   S        GT  Y++PE   R    
Sbjct: 137 VLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSFAK--AFVGTPYYMSPEQMNR---- 190
Query: 465 VSY--KSDVYNYGMMIFEM 481
           +SY  KSD+++ G +++E+
Sbjct: 191 MSYNEKSDIWSLGCLLYEL 209

>pdb|1Z9X|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 3 Monomers In The Asymmetric Unit Length = 321

Iteration: 1
 Score = 49.7 bits (117), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 35/108 (32%), Positives = 58/108 (53%), Gaps = 13/108 (12%)
Query: 382 EELSSTIG-IARGLEYLHLGCSTRILHFDIKPHNILLDEDFCP----KISDFGLAKICNR 436
           EE +S I  I  G+ YLH   + +I HFD+KP NI+L +   P    K+ DFGLA   + 
Sbjct: 115 EEATSFIKQILDGVNYLH---TKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLA---HE 168
Query: 437 KESIISMTGARGTVGYIAPEVFCRNIGEVSYKSDVYNYGMMIFEMTGG 484
            E  +      GT  ++APE+   N   +  ++D+++ G++ + +  G
Sbjct: 169 IEDGVEFKNIFGTPEFVAPEIV--NYEPLGLEADMWSIGVITYILLSG 214

>pdb|4A4X|A Chain A, Nek2-Ede Bound To Cct248662 Length = 279

Iteration: 1
 Score = 49.7 bits (117), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 30/79 (37%), Positives = 45/79 (56%), Gaps = 8/79 (10%)
Query: 405 ILHFDIKPHNILLDEDFCPKISDFGLAKICNRKESIISMTGARGTVGYIAPEVFCRNIGE 464
           +LH D+KP N+ LD     K+ DFGLA+I N  E         GT  Y++PE   R    
Sbjct: 137 VLHRDLKPANVFLDGKQNVKLGDFGLARILNHDEDFAK--EFVGTPYYMSPEQMNR---- 190
Query: 465 VSY--KSDVYNYGMMIFEM 481
           +SY  KSD+++ G +++E+
Sbjct: 191 MSYNEKSDIWSLGCLLYEL 209

>pdb|3RNY|A Chain A, Crystal Structure Of Human Rsk1 C-Terminal Kinase Domain Length = 346

Iteration: 1
 Score = 49.7 bits (117), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 42/115 (36%), Positives = 61/115 (53%), Gaps = 17/115 (14%)
Query: 376 FCLRVAEELSSTIGIARGLEYLHLGCSTRILHFDIKPHNIL-LDED---FCPKISDFGLA 431
           F  R A  +  TIG  + +EYLH   S  ++H D+KP NIL +DE     C +I DFG A
Sbjct: 118 FSEREASFVLHTIG--KTVEYLH---SQGVVHRDLKPSNILYVDESGNPECLRICDFGFA 172
Query: 432 KICNRKESIISMTGARGTVGYIAPEVFCRNIGEVSYKS--DVYNYGMMIFEMTGG 484
           K   R E+ + MT    T  ++APEV  R      Y    D+++ G++++ M  G
Sbjct: 173 KQL-RAENGLLMTPCY-TANFVAPEVLKRQ----GYDEGCDIWSLGILLYTMLAG 221

>pdb|2A27|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 8 Monomers In The Asymmetric Unit Length = 321

Iteration: 1
 Score = 49.7 bits (117), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 35/108 (32%), Positives = 58/108 (53%), Gaps = 13/108 (12%)
Query: 382 EELSSTIG-IARGLEYLHLGCSTRILHFDIKPHNILLDEDFCP----KISDFGLAKICNR 436
           EE +S I  I  G+ YLH   + +I HFD+KP NI+L +   P    K+ DFGLA   + 
Sbjct: 115 EEATSFIKQILDGVNYLH---TKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLA---HE 168
Query: 437 KESIISMTGARGTVGYIAPEVFCRNIGEVSYKSDVYNYGMMIFEMTGG 484
            E  +      GT  ++APE+   N   +  ++D+++ G++ + +  G
Sbjct: 169 IEDGVEFKNIFGTPEFVAPEIV--NYEPLGLEADMWSIGVITYILLSG 214

>pdb|2DWB|A Chain A, Aurora-A Kinase Complexed With Amppnp Length = 285

Iteration: 1
 Score = 49.7 bits (117), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 53/202 (26%), Positives = 83/202 (41%), Gaps = 51/202 (25%)
Query: 321 LGQGGYGSVY-----KGKLLDGSNVAVKVLNDSKGNGKEFINEVASISRTSHVNVVALLG 375
           LG+G +G+VY     + K +    V  K   +  G   +   EV   S   H N++ L G
Sbjct: 21  LGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYG 80
Query: 376 F------------------CLRVAEELSS---------TIGIARGLEYLHLGCSTRILHF 408
           +                    R  ++LS             +A  L Y H   S R++H 
Sbjct: 81  YFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCH---SKRVIHR 137
Query: 409 DIKPHNILLDEDFCPKISDFGLAKICNRKESIISMTGAR----GTVGYIAPE-VFCRNIG 463
           DIKP N+LL      KI+DFG         S+ + +  R    GT+ Y+ PE +  R   
Sbjct: 138 DIKPENLLLGSAGELKIADFGW--------SVHAPSSRRTTLCGTLDYLPPEXIEGRXHD 189
Query: 464 EVSYKSDVYNYGMMIFEMTGGR 485
           E   K D+++ G++ +E   G+
Sbjct: 190 E---KVDLWSLGVLCYEFLVGK 208

>pdb|4DYM|A Chain A, Crystal Structure Of The Acvr1 Kinase Domain In Complex With The Imidazo[1,2-B]pyridazine Inhibitor K00135 Length = 301

Iteration: 1
 Score = 49.7 bits (117), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 53/205 (25%), Positives = 92/205 (44%), Gaps = 48/205 (23%)
Query: 321 LGQGGYGSVYKGKLLDGSNVAVKVLN--DSKGNGKEFINEVASISRTSHVNVVALLG--- 375
           +G+G YG V++G    G NVAVK+ +  D K   +E   E+ +     H N++  +    
Sbjct: 16  VGKGRYGEVWRGSW-QGENVAVKIFSSRDEKSWFRE--TELYNTVMLRHENILGFIASDM 72
Query: 376 ---------FCLRVAEELSS------------------TIGIARGLEYLHLGC-----ST 403
                    + +    E+ S                   + IA GL +LH+         
Sbjct: 73  TSRHSSTQLWLITHYHEMGSLYDYLQLTTLDTVSCLRIVLSIASGLAHLHIEIFGTQGKP 132
Query: 404 RILHFDIKPHNILLDEDFCPKISDFGLAKICNRKESIISM--TGARGTVGYIAPEVFCRN 461
            I H D+K  NIL+ ++    I+D GLA + ++  + + +      GT  Y+APEV    
Sbjct: 133 AIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQSTNQLDVGNNPRVGTKRYMAPEVLDET 192
Query: 462 IGEV----SYKS-DVYNYGMMIFEM 481
           I +V    SYK  D++ +G++++E+
Sbjct: 193 I-QVDCFDSYKRVDIWAFGLVLWEV 216

>pdb|3ZHP|C Chain C, Human Mst3 (stk24) In Complex With Mo25beta Length = 294

Iteration: 1
 Score = 49.7 bits (117), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 34/98 (34%), Positives = 54/98 (55%), Gaps = 11/98 (11%)
Query: 390 IARGLEYLHLGCSTRILHFDIKPHNILLDEDFCPKISDFGLAKICNRKESIISMTGARGT 449
           I +GL+YLH   S + +H DIK  N+LL E    K++DFG+A      ++ I      GT
Sbjct: 133 ILKGLDYLH---SEKKIHRDIKAANVLLSEHGEVKLADFGVA--GQLTDTQIKRNTFVGT 187
Query: 450 VGYIAPEVFCRNIGEVSY--KSDVYNYGMMIFEMTGGR 485
             ++APEV    I + +Y  K+D+++ G+   E+  G 
Sbjct: 188 PFWMAPEV----IKQSAYDSKADIWSLGITAIELARGE 221

>pdb|3MTF|A Chain A, Crystal Structure Of The Acvr1 Kinase In Complex With A 2- Aminopyridine Inhibitor Length = 301

Iteration: 1
 Score = 49.7 bits (117), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 53/205 (25%), Positives = 92/205 (44%), Gaps = 48/205 (23%)
Query: 321 LGQGGYGSVYKGKLLDGSNVAVKVLN--DSKGNGKEFINEVASISRTSHVNVVALLG--- 375
           +G+G YG V++G    G NVAVK+ +  D K   +E   E+ +     H N++  +    
Sbjct: 16  VGKGRYGEVWRGSW-QGENVAVKIFSSRDEKSWFRE--TELYNTVMLRHENILGFIASDM 72
Query: 376 ---------FCLRVAEELSS------------------TIGIARGLEYLHLGC-----ST 403
                    + +    E+ S                   + IA GL +LH+         
Sbjct: 73  TSRHSSTQLWLITHYHEMGSLYDYLQLTTLDTVSCLRIVLSIASGLAHLHIEIFGTQGKP 132
Query: 404 RILHFDIKPHNILLDEDFCPKISDFGLAKICNRKESIISM--TGARGTVGYIAPEVFCRN 461
            I H D+K  NIL+ ++    I+D GLA + ++  + + +      GT  Y+APEV    
Sbjct: 133 AIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQSTNQLDVGNNPRVGTKRYMAPEVLDET 192
Query: 462 IGEV----SYKS-DVYNYGMMIFEM 481
           I +V    SYK  D++ +G++++E+
Sbjct: 193 I-QVDCFDSYKRVDIWAFGLVLWEV 216

>pdb|3A62|A Chain A, Crystal Structure Of Phosphorylated P70s6k1 Length = 327

Iteration: 1
 Score = 49.7 bits (117), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 55/203 (27%), Positives = 89/203 (43%), Gaps = 49/203 (24%)
Query: 321 LGQGGYGSVYKGKLLDGSNV----AVKVLNDSK--GNGKEFINEVAS---ISRTSHVNVV 371
           LG+GGYG V++ + + G+N     A+KVL  +    N K+  +  A    +    H  +V
Sbjct: 25  LGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVKHPFIV 84
Query: 372 ALL------GFCLRVAEELSS---------------------TIGIARGLEYLHLGCSTR 404
            L+      G    + E LS                         I+  L +LH      
Sbjct: 85  DLIYAFQTGGKLYLILEYLSGGELFMQLEREGIFMEDTACFYLAEISMALGHLH---QKG 141
Query: 405 ILHFDIKPHNILLDEDFCPKISDFGLAKICNRKESIISMTGAR---GTVGYIAPEVFCRN 461
           I++ D+KP NI+L+     K++DFGL      KESI   T      GT+ Y+APE+  R+
Sbjct: 142 IIYRDLKPENIMLNHQGHVKLTDFGLC-----KESIHDGTVTHXFCGTIEYMAPEILMRS 196
Query: 462 IGEVSYKSDVYNYGMMIFEMTGG 484
               +   D ++ G ++++M  G
Sbjct: 197 GHNRAV--DWWSLGALMYDMLTG 217

>pdb|3A60|A Chain A, Crystal Structure Of Unphosphorylated P70s6k1 (Form I) Length = 327

Iteration: 1
 Score = 49.7 bits (117), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 55/203 (27%), Positives = 89/203 (43%), Gaps = 49/203 (24%)
Query: 321 LGQGGYGSVYKGKLLDGSNV----AVKVLNDSK--GNGKEFINEVAS---ISRTSHVNVV 371
           LG+GGYG V++ + + G+N     A+KVL  +    N K+  +  A    +    H  +V
Sbjct: 25  LGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVKHPFIV 84
Query: 372 ALL------GFCLRVAEELSS---------------------TIGIARGLEYLHLGCSTR 404
            L+      G    + E LS                         I+  L +LH      
Sbjct: 85  DLIYAFQTGGKLYLILEYLSGGELFMQLEREGIFMEDTACFYLAEISMALGHLH---QKG 141
Query: 405 ILHFDIKPHNILLDEDFCPKISDFGLAKICNRKESIISMTGAR---GTVGYIAPEVFCRN 461
           I++ D+KP NI+L+     K++DFGL      KESI   T      GT+ Y+APE+  R+
Sbjct: 142 IIYRDLKPENIMLNHQGHVKLTDFGLC-----KESIHDGTVTHTFCGTIEYMAPEILMRS 196
Query: 462 IGEVSYKSDVYNYGMMIFEMTGG 484
               +   D ++ G ++++M  G
Sbjct: 197 GHNRAV--DWWSLGALMYDMLTG 217

>pdb|3FHI|A Chain A, Crystal Structure Of A Complex Between The Catalytic And Regulatory (Ri{alpha}) Subunits Of Pka Length = 350

Iteration: 1
 Score = 49.7 bits (117), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 29/95 (30%), Positives = 49/95 (51%), Gaps = 10/95 (10%)
Query: 390 IARGLEYLHLGCSTRILHFDIKPHNILLDEDFCPKISDFGLAKICNRKESIISMTGARGT 449
           I    EYLH   S  +++ D+KP N+L+D+    +++DFG AK    +   ++     GT
Sbjct: 150 IVLTFEYLH---SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLA-----GT 201
Query: 450 VGYIAPEVFCRNIGEVSYKSDVYNYGMMIFEMTGG 484
             Y+APE+        +   D +  G++I+EM  G
Sbjct: 202 PEYLAPEIILSK--GYNKAVDWWALGVLIYEMAAG 234

>pdb|2WQE|A Chain A, Structure Of S155r Aurora-A Somatic Mutant Length = 262

Iteration: 1
 Score = 49.3 bits (116), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 50/199 (25%), Positives = 84/199 (42%), Gaps = 45/199 (22%)
Query: 321 LGQGGYGSVY-----KGKLLDGSNVAVKVLNDSKGNGKEFINEVASISRTSHVNVVALLG 375
           LG+G +G+VY     + K +    V  K   +  G   +   EV   S   H N++ L G
Sbjct: 13  LGKGKFGNVYLAREKQRKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYG 72
Query: 376 F------------------CLRVAEELSS---------TIGIARGLEYLHLGCSTRILHF 408
           +                    R  ++LS             +A  L Y H   S R++H 
Sbjct: 73  YFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCH---SKRVIHR 129
Query: 409 DIKPHNILLDEDFCPKISDFGLA--KICNRKESIISMTGARGTVGYIAPEVFCRNIGEVS 466
           DIKP N+LL      KI+DFG +     +R+ ++       GT+ Y+ PE+    + +  
Sbjct: 130 DIKPENLLLGSAGELKIADFGWSVHAPSSRRTTLC------GTLDYLPPEMIEGRMHDE- 182
Query: 467 YKSDVYNYGMMIFEMTGGR 485
            K D+++ G++ +E   G+
Sbjct: 183 -KVDLWSLGVLCYEFLVGK 200

>pdb|3COK|A Chain A, Crystal Structure Of Plk4 Kinase Length = 278

Iteration: 1
 Score = 49.3 bits (116), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 39/109 (35%), Positives = 57/109 (52%), Gaps = 15/109 (13%)
Query: 390 IARGLEYLHLGCSTRILHFDIKPHNILLDEDFCPKISDFGLA---KICNRKESIISMTGA 446
           I  G+ YLH   S  ILH D+   N+LL  +   KI+DFGLA   K+ + K   +     
Sbjct: 121 IITGMLYLH---SHGILHRDLTLSNLLLTRNMNIKIADFGLATQLKMPHEKHYTLC---- 173
Query: 447 RGTVGYIAPEVFCRNIGEVSYKSDVYNYGMMIFEMTGGRK--NVDVVDN 493
            GT  YI+PE+  R+   +  +SDV++ G M + +  GR   + D V N
Sbjct: 174 -GTPNYISPEIATRSAHGL--ESDVWSLGCMFYTLLIGRPPFDTDTVKN 219

>pdb|1XH9|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350

Iteration: 1
 Score = 49.3 bits (116), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 30/95 (31%), Positives = 49/95 (51%), Gaps = 10/95 (10%)
Query: 390 IARGLEYLHLGCSTRILHFDIKPHNILLDEDFCPKISDFGLAKICNRKESIISMTGARGT 449
           I    EYLH   S  +++ D+KP N+++D+    K++DFGLAK    +   +      GT
Sbjct: 150 IVLTFEYLH---SLDLIYRDLKPENLMIDQQGYIKVTDFGLAKRVKGRTWXLC-----GT 201
Query: 450 VGYIAPEVFCRNIGEVSYKSDVYNYGMMIFEMTGG 484
             Y+APE+        +   D +  G++I+EM  G
Sbjct: 202 PEYLAPEIILSK--GYNKAVDWWALGVLIYEMAAG 234

>pdb|1ZWS|A Chain A, Crystal Structure Of The Catalytic Domain Of Human Drp-1 Kinase Length = 288

Iteration: 1
 Score = 49.3 bits (116), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 35/108 (32%), Positives = 58/108 (53%), Gaps = 13/108 (12%)
Query: 382 EELSSTIG-IARGLEYLHLGCSTRILHFDIKPHNILLDEDFCP----KISDFGLAKICNR 436
           EE +S I  I  G+ YLH   + +I HFD+KP NI+L +   P    K+ DFGLA   + 
Sbjct: 115 EEATSFIKQILDGVNYLH---TKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLA---HE 168
Query: 437 KESIISMTGARGTVGYIAPEVFCRNIGEVSYKSDVYNYGMMIFEMTGG 484
            E  +      GT  ++APE+   N   +  ++D+++ G++ + +  G
Sbjct: 169 IEDGVEFKNIFGTPEFVAPEIV--NYEPLGLEADMWSIGVITYILLSG 214

>pdb|2Y7J|A Chain A, Structure Of Human Phosphorylase Kinase, Gamma 2 Length = 365

Iteration: 1
 Score = 49.3 bits (116), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 34/111 (30%), Positives = 57/111 (51%), Gaps = 8/111 (7%)
Query: 379 RVAEELSSTIGIARGL-EYLHLGCSTRILHFDIKPHNILLDEDFCPKISDFGLAKICNRK 437
           +VA     T  I R L E +    +  I+H D+KP NILLD++   ++SDFG +      
Sbjct: 194 KVALSEKETRSIMRSLLEAVSFLHANNIVHRDLKPENILLDDNMQIRLSDFGFSCHLEPG 253
Query: 438 ESIISMTGARGTVGYIAPEVFCRNIGEVS----YKSDVYNYGMMIFEMTGG 484
           E +  +    GT GY+APE+   ++ E       + D++  G+++F +  G
Sbjct: 254 EKLRELC---GTPGYLAPEILKCSMDETHPGYGKEVDLWACGVILFTLLAG 301

>pdb|3H9R|A Chain A, Crystal Structure Of The Kinase Domain Of Type I Activin Receptor (Acvr1) In Complex With Fkbp12 And Dorsomorphin Length = 330

Iteration: 1
 Score = 49.3 bits (116), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 54/205 (26%), Positives = 94/205 (45%), Gaps = 48/205 (23%)
Query: 321 LGQGGYGSVYKGKLLDGSNVAVKVLN--DSKGNGKEFINEVASISRTSHVNVVALLG--- 375
           +G+G YG V++G    G NVAVK+ +  D K   +E   E+ +     H N++  +    
Sbjct: 45  VGKGRYGEVWRGSW-QGENVAVKIFSSRDEKSWFRE--TELYNTVMLRHENILGFIASDM 101
Query: 376 ---------FCLRVAEELSS------------------TIGIARGLEYLHL---GCSTR- 404
                    + +    E+ S                   + IA GL +LH+   G   + 
Sbjct: 102 TSRHSSTQLWLITHYHEMGSLYDYLQLTTLDTVSCLRIVLSIASGLAHLHIEIFGTQGKP 161
Query: 405 -ILHFDIKPHNILLDEDFCPKISDFGLAKICNRKESIISM--TGARGTVGYIAPEVFCRN 461
            I H D+K  NIL+ ++    I+D GLA + ++  + + +      GT  Y+APEV    
Sbjct: 162 AIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQSTNQLDVGNNPRVGTKRYMAPEVLDET 221
Query: 462 IGEV----SYKS-DVYNYGMMIFEM 481
           I +V    SYK  D++ +G++++E+
Sbjct: 222 I-QVDCFDSYKRVDIWAFGLVLWEV 245

>pdb|3E3P|A Chain A, Glycogen Synthase Kinase From Leishmania Major Length = 360

Iteration: 1
 Score = 49.3 bits (116), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 55/202 (27%), Positives = 87/202 (43%), Gaps = 44/202 (21%)
Query: 322 GQGGYGSVYKGKLLD-GSNVAVK-VLNDSKGNGKEFINEVASISRTSHVNVVALLGFCLR 379
           GQG +G+V  GK    G +VA+K V+ D +   +E +  +  ++   H N+V L  +   
Sbjct: 32  GQGTFGTVQLGKEKSTGMSVAIKKVIQDPRFRNRE-LQIMQDLAVLHHPNIVQLQSYFYT 90
Query: 380 VAEELSSTIGIARGLEY----LH----------------------------LGC----ST 403
           + E     I +   +EY    LH                            +GC    S 
Sbjct: 91  LGERDRRDIYLNVVMEYVPDTLHRCCRNYYRRQVAPPPILIKVFLFQLIRSIGCLHLPSV 150
Query: 404 RILHFDIKPHNILLDE-DFCPKISDFGLAKICNRKESIISMTGARGTVGYIAPEVFCRNI 462
            + H DIKPHN+L++E D   K+ DFG AK  +  E  ++   +R    Y APE+   N 
Sbjct: 151 NVCHRDIKPHNVLVNEADGTLKLCDFGSAKKLSPSEPNVAYICSR---YYRAPELIFGN- 206
Query: 463 GEVSYKSDVYNYGMMIFEMTGG 484
              +   D+++ G +  EM  G
Sbjct: 207 QHYTTAVDIWSVGCIFAEMMLG 228

>pdb|3NYX|A Chain A, Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-Thiadiazole- Thiophene Inhibitor Length = 302

Iteration: 1
 Score = 49.3 bits (116), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 34/103 (33%), Positives = 51/103 (49%), Gaps = 6/103 (5%)
Query: 380 VAEELSSTIGIARGLEYLHLGCSTRILHFDIKPHNILLDEDFCPKISDFGLAK-ICNRKE 438
           +A+ L     I  G+ YLH   S   +H ++   N+LLD D   KI DFGLAK +    E
Sbjct: 116 LAQLLLFAQQICEGMAYLH---SQHYIHRNLAARNVLLDNDRLVKIGDFGLAKAVPEGHE 172
Query: 439 SIISMTGARGTVGYIAPEVFCRNIGEVSYKSDVYNYGMMIFEM 481
                      V + APE  C    +  Y SDV+++G+ ++E+
Sbjct: 173 YYRVREDGDSPVFWYAPE--CLKEYKFYYASDVWSFGVTLYEL 213

>pdb|2Y4I|C Chain C, Ksr2-Mek1 Heterodimer Length = 395

Iteration: 1
 Score = 48.9 bits (115), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 37/117 (31%), Positives = 61/117 (52%), Gaps = 12/117 (10%)
Query: 379 RVAEELSSTIGIA--RGLEYLHLGCSTRILHFDIKPHNILLDEDFCPKISDFGLAKICNR 436
           R+ E++   + IA  +GL YL      +I+H D+KP NIL++     K+ DFG++     
Sbjct: 162 RIPEQILGKVSIAVIKGLTYLR--EKHKIMHRDVKPSNILVNSRGEIKLCDFGVS----- 214
Query: 437 KESIISMTGA-RGTVGYIAPEVFCRNIGEVSYKSDVYNYGMMIFEMTGGRKNVDVVD 492
            + I SM  +  GT  Y++PE         S +SD+++ G+ + EM  GR  +   D
Sbjct: 215 GQLIDSMANSFVGTRSYMSPERLQGT--HYSVQSDIWSMGLSLVEMAVGRYPIPPPD 269

>pdb|2W5A|A Chain A, Human Nek2 Kinase Adp-Bound Length = 279

Iteration: 1
 Score = 48.9 bits (115), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 30/79 (37%), Positives = 45/79 (56%), Gaps = 8/79 (10%)
Query: 405 ILHFDIKPHNILLDEDFCPKISDFGLAKICNRKESIISMTGARGTVGYIAPEVFCRNIGE 464
           +LH D+KP N+ LD     K+ DFGLA+I N   S        GT  Y++PE   R    
Sbjct: 137 VLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSFAKT--FVGTPYYMSPEQMNR---- 190
Query: 465 VSY--KSDVYNYGMMIFEM 481
           +SY  KSD+++ G +++E+
Sbjct: 191 MSYNEKSDIWSLGCLLYEL 209

>pdb|1OL6|A Chain A, Structure Of Unphosphorylated D274n Mutant Of Aurora-a Length = 282

Iteration: 1
 Score = 48.9 bits (115), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 50/201 (24%), Positives = 83/201 (41%), Gaps = 49/201 (24%)
Query: 321 LGQGGYGSVY-----KGKLLDGSNVAVKVLNDSKGNGKEFINEVASISRTSHVNVVALLG 375
           LG+G +G+VY     + K +    V  K   +  G   +   EV   S   H N++ L G
Sbjct: 18  LGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYG 77
Query: 376 F------------------CLRVAEELSS---------TIGIARGLEYLHLGCSTRILHF 408
           +                    R  ++LS             +A  L Y H   S R++H 
Sbjct: 78  YFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCH---SKRVIHR 134
Query: 409 DIKPHNILLDEDFCPKISDFGLAKICNRKESIISMTGAR----GTVGYIAPEVFCRNIGE 464
           DIKP N+LL      KI++FG         S+ + +  R    GT+ Y+ PE+    + +
Sbjct: 135 DIKPENLLLGSAGELKIANFGW--------SVHAPSSRRTTLCGTLDYLPPEMIEGRMHD 186
Query: 465 VSYKSDVYNYGMMIFEMTGGR 485
              K D+++ G++ +E   G+
Sbjct: 187 E--KVDLWSLGVLCYEFLVGK 205

>pdb|1YRP|A Chain A, Catalytic Domain Of Human Zip Kinase Phosphorylated At Thr265 Length = 278

Iteration: 1
 Score = 48.9 bits (115), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 32/99 (32%), Positives = 54/99 (54%), Gaps = 12/99 (12%)
Query: 390 IARGLEYLHLGCSTRILHFDIKPHNILLDEDFCP----KISDFGLAKICNRKESIISMTG 445
           I  G+ YLH   S RI HFD+KP NI+L +   P    K+ DFG+A   ++ E+      
Sbjct: 124 ILDGVHYLH---SKRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIA---HKIEAGNEFKN 177
Query: 446 ARGTVGYIAPEVFCRNIGEVSYKSDVYNYGMMIFEMTGG 484
             GT  ++APE+   N   +  ++D+++ G++ + +  G
Sbjct: 178 IFGTPEFVAPEIV--NYEPLGLEADMWSIGVITYILLSG 214

>pdb|3BHY|A Chain A, Crystal Structure Of Human Death Associated Protein Kinase 3 (Dapk3) In Complex With A Beta-Carboline Ligand Length = 283

Iteration: 1
 Score = 48.9 bits (115), Expect = 7e-06,   Method: Compositional matrix adjust.
 Identities = 32/99 (32%), Positives = 54/99 (54%), Gaps = 12/99 (12%)
Query: 390 IARGLEYLHLGCSTRILHFDIKPHNILLDEDFCP----KISDFGLAKICNRKESIISMTG 445
           I  G+ YLH   S RI HFD+KP NI+L +   P    K+ DFG+A   ++ E+      
Sbjct: 117 ILDGVHYLH---SKRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIA---HKIEAGNEFKN 170
Query: 446 ARGTVGYIAPEVFCRNIGEVSYKSDVYNYGMMIFEMTGG 484
             GT  ++APE+   N   +  ++D+++ G++ + +  G
Sbjct: 171 IFGTPEFVAPEIV--NYEPLGLEADMWSIGVITYILLSG 207

>pdb|3AMA|A Chain A, Protein Kinase A Sixfold Mutant Model Of Aurora B With Inhibitor Jnj- 7706621 Length = 351

Iteration: 1
 Score = 48.9 bits (115), Expect = 7e-06,   Method: Compositional matrix adjust.
 Identities = 30/95 (31%), Positives = 48/95 (50%), Gaps = 10/95 (10%)
Query: 390 IARGLEYLHLGCSTRILHFDIKPHNILLDEDFCPKISDFGLAKICNRKESIISMTGARGT 449
           I    EYLH   S  +++ D+KP N+L+D+    K++DFG AK    +   +      GT
Sbjct: 151 IVLTFEYLH---SLDLIYRDLKPENLLIDQQGYIKVADFGFAKRVKGRTWXLC-----GT 202
Query: 450 VGYIAPEVFCRNIGEVSYKSDVYNYGMMIFEMTGG 484
             Y+APE+        +   D +  G++I+EM  G
Sbjct: 203 PEYLAPEIILSK--GYNKAVDWWALGVLIYEMAAG 235

>pdb|2J90|A Chain A, Crystal Structure Of Human Zip Kinase In Complex With A Tetracyclic Pyridone Inhibitor (pyridone 6) Length = 304

Iteration: 1
 Score = 48.9 bits (115), Expect = 7e-06,   Method: Compositional matrix adjust.
 Identities = 32/99 (32%), Positives = 54/99 (54%), Gaps = 12/99 (12%)
Query: 390 IARGLEYLHLGCSTRILHFDIKPHNILLDEDFCP----KISDFGLAKICNRKESIISMTG 445
           I  G+ YLH   S RI HFD+KP NI+L +   P    K+ DFG+A   ++ E+      
Sbjct: 138 ILDGVHYLH---SKRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIA---HKIEAGNEFKN 191
Query: 446 ARGTVGYIAPEVFCRNIGEVSYKSDVYNYGMMIFEMTGG 484
             GT  ++APE+   N   +  ++D+++ G++ + +  G
Sbjct: 192 IFGTPEFVAPEIV--NYEPLGLEADMWSIGVITYILLSG 228

>pdb|3EYG|A Chain A, Crystal Structures Of Jak1 And Jak2 Inhibitor Complexes Length = 290

Iteration: 1
 Score = 48.9 bits (115), Expect = 7e-06,   Method: Compositional matrix adjust.
 Identities = 46/199 (23%), Positives = 80/199 (40%), Gaps = 43/199 (21%)
Query: 321 LGQGGYGSVYKGKLL-----DGSNVAVKVLNDSKGNGK--EFINEVASISRTSHVNVVAL 373
           LG+G +G V   +        G  VAVK L    G     +   E+  +    H N+V  
Sbjct: 17  LGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKY 76
Query: 374 LGFC------------------------------LRVAEELSSTIGIARGLEYLHLGCST 403
            G C                              + + ++L   + I +G++YL    S 
Sbjct: 77  KGICTEDGGNGIKLIMEFLPSGSLKEYLPKNKNKINLKQQLKYAVQICKGMDYL---GSR 133
Query: 404 RILHFDIKPHNILLDEDFCPKISDFGLAKICNRKESIISMTGARGT-VGYIAPEVFCRNI 462
           + +H D+   N+L++ +   KI DFGL K     +   ++   R + V + APE  C   
Sbjct: 134 QYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEXXTVKDDRDSPVFWYAPE--CLMQ 191
Query: 463 GEVSYKSDVYNYGMMIFEM 481
            +    SDV+++G+ + E+
Sbjct: 192 SKFYIASDVWSFGVTLHEL 210

>pdb|2GNF|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase With Y- 27632 Length = 350

Iteration: 1
 Score = 48.9 bits (115), Expect = 7e-06,   Method: Compositional matrix adjust.
 Identities = 30/95 (31%), Positives = 48/95 (50%), Gaps = 10/95 (10%)
Query: 390 IARGLEYLHLGCSTRILHFDIKPHNILLDEDFCPKISDFGLAKICNRKESIISMTGARGT 449
           I    EYLH   S  +++ D+KP N+L+D+    K++DFG AK    +   +      GT
Sbjct: 150 IVLTFEYLH---SLDLIYRDLKPENLLIDQQGYIKVADFGFAKRVKGRTWXLC-----GT 201
Query: 450 VGYIAPEVFCRNIGEVSYKSDVYNYGMMIFEMTGG 484
             Y+APE+        +   D +  G++I+EM  G
Sbjct: 202 PEYLAPEIILSK--GYNKAVDWWALGVLIYEMAAG 234

>pdb|2GNG|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase Length = 350

Iteration: 1
 Score = 48.5 bits (114), Expect = 8e-06,   Method: Compositional matrix adjust.
 Identities = 30/95 (31%), Positives = 48/95 (50%), Gaps = 10/95 (10%)
Query: 390 IARGLEYLHLGCSTRILHFDIKPHNILLDEDFCPKISDFGLAKICNRKESIISMTGARGT 449
           I    EYLH   S  +++ D+KP N+L+D+    K++DFG AK    +   +      GT
Sbjct: 150 IVLTFEYLH---SLDLIYRDLKPENLLIDQQGYIKVADFGFAKRVKGRTWXLC-----GT 201
Query: 450 VGYIAPEVFCRNIGEVSYKSDVYNYGMMIFEMTGG 484
             Y+APE+        +   D +  G++I+EM  G
Sbjct: 202 PEYLAPEIILSK--GYNKAVDWWALGVLIYEMAAG 234

>pdb|2GNJ|A Chain A, Pka Three Fold Mutant Model Of Rho-Kinase With Y-27632 Length = 350

Iteration: 1
 Score = 48.5 bits (114), Expect = 8e-06,   Method: Compositional matrix adjust.
 Identities = 30/95 (31%), Positives = 48/95 (50%), Gaps = 10/95 (10%)
Query: 390 IARGLEYLHLGCSTRILHFDIKPHNILLDEDFCPKISDFGLAKICNRKESIISMTGARGT 449
           I    EYLH   S  +++ D+KP N+L+D+    K++DFG AK    +   +      GT
Sbjct: 150 IVLTFEYLH---SLDLIYRDLKPENLLIDQQGYIKVADFGFAKRVKGRTWXLC-----GT 201
Query: 450 VGYIAPEVFCRNIGEVSYKSDVYNYGMMIFEMTGG 484
             Y+APE+        +   D +  G++I+EM  G
Sbjct: 202 PEYLAPEIILSK--GYNKAVDWWALGVLIYEMAAG 234

>pdb|1J3H|A Chain A, Crystal Structure Of Apoenzyme Camp-Dependent Protein Kinase Catalytic Subunit Length = 350

Iteration: 1
 Score = 48.5 bits (114), Expect = 8e-06,   Method: Compositional matrix adjust.
 Identities = 29/95 (30%), Positives = 48/95 (50%), Gaps = 10/95 (10%)
Query: 390 IARGLEYLHLGCSTRILHFDIKPHNILLDEDFCPKISDFGLAKICNRKESIISMTGARGT 449
           I    EYLH   S  +++ D+KP N+L+D+    +++DFG AK    +   +      GT
Sbjct: 150 IVLTFEYLH---SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLX-----GT 201
Query: 450 VGYIAPEVFCRNIGEVSYKSDVYNYGMMIFEMTGG 484
             Y+APE+        +   D +  G++I+EM  G
Sbjct: 202 PEYLAPEIILSK--GYNKAVDWWALGVLIYEMAAG 234

>pdb|3SLS|A Chain A, Crystal Structure Of Human Mek-1 Kinase In Complex With Ucb1353770 And Amppnp Length = 304

Iteration: 1
 Score = 48.5 bits (114), Expect = 8e-06,   Method: Compositional matrix adjust.
 Identities = 36/110 (32%), Positives = 59/110 (53%), Gaps = 12/110 (10%)
Query: 379 RVAEELSSTIGIA--RGLEYLHLGCSTRILHFDIKPHNILLDEDFCPKISDFGLAKICNR 436
           R+ E++   + IA  +GL YL      +I+H D+KP NIL++     K+ DFG++     
Sbjct: 119 RIPEQILGKVSIAVIKGLTYLR--EKHKIMHRDVKPSNILVNSRGEIKLCDFGVS----- 171
Query: 437 KESIISMTGA-RGTVGYIAPEVFCRNIGEVSYKSDVYNYGMMIFEMTGGR 485
            + I SM  +  GT  Y++PE         S +SD+++ G+ + EM  GR
Sbjct: 172 GQLIDSMANSFVGTRSYMSPERLQGT--HYSVQSDIWSMGLSLVEMAVGR 219

>pdb|2GU8|A Chain A, Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel And Potent Inhibitors For Akt: Synthesis And Sar Studies Length = 337

Iteration: 1
 Score = 48.5 bits (114), Expect = 8e-06,   Method: Compositional matrix adjust.
 Identities = 30/95 (31%), Positives = 48/95 (50%), Gaps = 10/95 (10%)
Query: 390 IARGLEYLHLGCSTRILHFDIKPHNILLDEDFCPKISDFGLAKICNRKESIISMTGARGT 449
           I    EYLH   S  +++ D+KP N+L+DE    +++DFG AK    +   +      GT
Sbjct: 137 IVLTFEYLH---SLDLIYRDLKPENLLIDEQGYIQVTDFGFAKRVKGRTWXLC-----GT 188
Query: 450 VGYIAPEVFCRNIGEVSYKSDVYNYGMMIFEMTGG 484
             Y+APE+        +   D +  G++I+EM  G
Sbjct: 189 PEYLAPEIILSK--GYNKAVDWWALGVLIYEMAAG 221

>pdb|4E4L|A Chain A, Jak1 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302

Iteration: 1
 Score = 48.5 bits (114), Expect = 8e-06,   Method: Compositional matrix adjust.
 Identities = 46/199 (23%), Positives = 80/199 (40%), Gaps = 43/199 (21%)
Query: 321 LGQGGYGSVYKGKLL-----DGSNVAVKVLNDSKGNGK--EFINEVASISRTSHVNVVAL 373
           LG+G +G V   +        G  VAVK L    G     +   E+  +    H N+V  
Sbjct: 29  LGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKY 88
Query: 374 LGFC------------------------------LRVAEELSSTIGIARGLEYLHLGCST 403
            G C                              + + ++L   + I +G++YL    S 
Sbjct: 89  KGICTEDGGNGIKLIMEFLPSGSLKEYLPKNKNKINLKQQLKYAVQICKGMDYL---GSR 145
Query: 404 RILHFDIKPHNILLDEDFCPKISDFGLAKICNRKESIISMTGARGT-VGYIAPEVFCRNI 462
           + +H D+   N+L++ +   KI DFGL K     +   ++   R + V + APE  C   
Sbjct: 146 QYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEXXTVKDDRDSPVFWYAPE--CLMQ 203
Query: 463 GEVSYKSDVYNYGMMIFEM 481
            +    SDV+++G+ + E+
Sbjct: 204 SKFYIASDVWSFGVTLHEL 222

>pdb|2XK9|A Chain A, Structural Analysis Of Checkpoint Kinase 2 (Chk2) In Complex With Inhibitor Pv1533 Length = 322

Iteration: 1
 Score = 48.5 bits (114), Expect = 8e-06,   Method: Compositional matrix adjust.
 Identities = 32/92 (34%), Positives = 51/92 (55%), Gaps = 12/92 (13%)
Query: 393 GLEYLHLGCSTRILHFDIKPHNILL---DEDFCPKISDFGLAKICNRKESIISMTGARGT 449
            ++YLH      I+H D+KP N+LL   +ED   KI+DFG +KI      + ++    GT
Sbjct: 125 AVQYLH---ENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLMRTLC---GT 178
Query: 450 VGYIAPEVFCRNIGEVSYKS--DVYNYGMMIF 479
             Y+APEV   ++G   Y    D ++ G+++F
Sbjct: 179 PTYLAPEVLV-SVGTAGYNRAVDCWSLGVILF 209

>pdb|3EQC|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Ternary Complex With Compound 1, Atp-Gs And Mg2p Length = 360

Iteration: 1
 Score = 48.5 bits (114), Expect = 8e-06,   Method: Compositional matrix adjust.
 Identities = 36/110 (32%), Positives = 59/110 (53%), Gaps = 12/110 (10%)
Query: 379 RVAEELSSTIGIA--RGLEYLHLGCSTRILHFDIKPHNILLDEDFCPKISDFGLAKICNR 436
           R+ E++   + IA  +GL YL      +I+H D+KP NIL++     K+ DFG++     
Sbjct: 127 RIPEQILGKVSIAVIKGLTYLR--EKHKIMHRDVKPSNILVNSRGEIKLCDFGVS----- 179
Query: 437 KESIISMTGA-RGTVGYIAPEVFCRNIGEVSYKSDVYNYGMMIFEMTGGR 485
            + I SM  +  GT  Y++PE         S +SD+++ G+ + EM  GR
Sbjct: 180 GQLIDSMANSFVGTRSYMSPERLQGT--HYSVQSDIWSMGLSLVEMAVGR 227

>pdb|2YCR|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv976 Length = 323

Iteration: 1
 Score = 48.5 bits (114), Expect = 9e-06,   Method: Compositional matrix adjust.
 Identities = 32/92 (34%), Positives = 51/92 (55%), Gaps = 12/92 (13%)
Query: 393 GLEYLHLGCSTRILHFDIKPHNILL---DEDFCPKISDFGLAKICNRKESIISMTGARGT 449
            ++YLH      I+H D+KP N+LL   +ED   KI+DFG +KI      + ++    GT
Sbjct: 126 AVQYLH---ENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLMRTLC---GT 179
Query: 450 VGYIAPEVFCRNIGEVSYKS--DVYNYGMMIF 479
             Y+APEV   ++G   Y    D ++ G+++F
Sbjct: 180 PTYLAPEVLV-SVGTAGYNRAVDCWSLGVILF 210

>pdb|2W0J|A Chain A, Crystal Structure Of Chk2 In Complex With Nsc 109555, A Specific Inhibitor Length = 323

Iteration: 1
 Score = 48.5 bits (114), Expect = 9e-06,   Method: Compositional matrix adjust.
 Identities = 32/92 (34%), Positives = 51/92 (55%), Gaps = 12/92 (13%)
Query: 393 GLEYLHLGCSTRILHFDIKPHNILL---DEDFCPKISDFGLAKICNRKESIISMTGARGT 449
            ++YLH      I+H D+KP N+LL   +ED   KI+DFG +KI      + ++    GT
Sbjct: 126 AVQYLH---ENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLMRTLC---GT 179
Query: 450 VGYIAPEVFCRNIGEVSYKS--DVYNYGMMIF 479
             Y+APEV   ++G   Y    D ++ G+++F
Sbjct: 180 PTYLAPEVLV-SVGTAGYNRAVDCWSLGVILF 210

>pdb|2YCF|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv1531 Length = 322

Iteration: 1
 Score = 48.5 bits (114), Expect = 9e-06,   Method: Compositional matrix adjust.
 Identities = 32/92 (34%), Positives = 51/92 (55%), Gaps = 12/92 (13%)
Query: 393 GLEYLHLGCSTRILHFDIKPHNILL---DEDFCPKISDFGLAKICNRKESIISMTGARGT 449
            ++YLH      I+H D+KP N+LL   +ED   KI+DFG +KI      + ++    GT
Sbjct: 126 AVQYLH---ENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLMRTLC---GT 179
Query: 450 VGYIAPEVFCRNIGEVSYKS--DVYNYGMMIF 479
             Y+APEV   ++G   Y    D ++ G+++F
Sbjct: 180 PTYLAPEVLV-SVGTAGYNRAVDCWSLGVILF 210

>pdb|2XNE|A Chain A, Structure Of Aurora-A Bound To An Imidazopyrazine Inhibitor Length = 272

Iteration: 1
 Score = 48.5 bits (114), Expect = 9e-06,   Method: Compositional matrix adjust.
 Identities = 49/199 (24%), Positives = 84/199 (42%), Gaps = 45/199 (22%)
Query: 321 LGQGGYGSVY-----KGKLLDGSNVAVKVLNDSKGNGKEFINEVASISRTSHVNVVALLG 375
           LG+G +G+VY     + K +    V  K   +  G   +   EV   S   H N++ L G
Sbjct: 19  LGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYG 78
Query: 376 F------------------CLRVAEELSS---------TIGIARGLEYLHLGCSTRILHF 408
           +                    R  ++LS             +A  L Y H   S R++H 
Sbjct: 79  YFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCH---SKRVIHR 135
Query: 409 DIKPHNILLDEDFCPKISDFGLA--KICNRKESIISMTGARGTVGYIAPEVFCRNIGEVS 466
           DIKP N+LL      KI++FG +     +R+ ++       GT+ Y+ PE+    + +  
Sbjct: 136 DIKPENLLLGSAGELKIANFGWSVHAPSSRRTTLC------GTLDYLPPEMIEGRMHDE- 188
Query: 467 YKSDVYNYGMMIFEMTGGR 485
            K D+++ G++ +E   G+
Sbjct: 189 -KVDLWSLGVLCYEFLVGK 206

>pdb|2CN5|A Chain A, Crystal Structure Of Human Chk2 In Complex With Adp Length = 329

Iteration: 1
 Score = 48.5 bits (114), Expect = 9e-06,   Method: Compositional matrix adjust.
 Identities = 32/92 (34%), Positives = 51/92 (55%), Gaps = 12/92 (13%)
Query: 393 GLEYLHLGCSTRILHFDIKPHNILL---DEDFCPKISDFGLAKICNRKESIISMTGARGT 449
            ++YLH      I+H D+KP N+LL   +ED   KI+DFG +KI      + ++    GT
Sbjct: 132 AVQYLH---ENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLMRTLC---GT 185
Query: 450 VGYIAPEVFCRNIGEVSYKS--DVYNYGMMIF 479
             Y+APEV   ++G   Y    D ++ G+++F
Sbjct: 186 PTYLAPEVLV-SVGTAGYNRAVDCWSLGVILF 216

>pdb|2JAM|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase I G Length = 304

Iteration: 1
 Score = 48.5 bits (114), Expect = 9e-06,   Method: Compositional matrix adjust.
 Identities = 56/198 (28%), Positives = 81/198 (40%), Gaps = 49/198 (24%)
Query: 312 KMTNSFKYKLGQGGYGSVYKGKL-LDGSNVAVKVLNDSKG-NGKEFINEVASISRTSHVN 369
           + T  F   LG G +  V+  K  L G   A+K +  S         NE+A + +  H N
Sbjct: 8   RKTFIFMEVLGSGAFSEVFLVKQRLTGKLFALKCIKKSPAFRDSSLENEIAVLKKIKHEN 67
Query: 370 VVAL-----------LGFCLRVAEELSSTI----------------GIARGLEYLHLGCS 402
           +V L           L   L    EL   I                 +   ++YLH    
Sbjct: 68  IVTLEDIYESTTHYYLVMQLVSGGELFDRILERGVYTEKDASLVIQQVLSAVKYLH---E 124
Query: 403 TRILHFDIKPHNILL---DEDFCPKISDFGLAKICNRKESIISMTGARGTVGYIAPEVF- 458
             I+H D+KP N+L    +E+    I+DFGL+K+    E    M+ A GT GY+APEV  
Sbjct: 125 NGIVHRDLKPENLLYLTPEENSKIMITDFGLSKM----EQNGIMSTACGTPGYVAPEVLA 180
Query: 459 ---------CRNIGEVSY 467
                    C +IG ++Y
Sbjct: 181 QKPYSKAVDCWSIGVITY 198

>pdb|3O96|A Chain A, Crystal Structure Of Human Akt1 With An Allosteric Inhibitor Length = 446

Iteration: 1
 Score = 48.5 bits (114), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 33/96 (34%), Positives = 52/96 (54%), Gaps = 6/96 (6%)
Query: 390 IARGLEYLHLGCSTRILHFDIKPHNILLDEDFCPKISDFGLAKICNRKESIISMTGARGT 449
           I   L+YLH      +++ D+K  N++LD+D   KI+DFGL K   +  +  +M    GT
Sbjct: 260 IVSALDYLH--SEKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGA--TMKTFCGT 315
Query: 450 VGYIAPEVFCRNIGEVSYKSDVYNYGMMIFEMTGGR 485
             Y+APEV   N  +     D +  G++++EM  GR
Sbjct: 316 PEYLAPEVLEDN--DYGRAVDWWGLGVVMYEMMCGR 349

>pdb|4EJN|A Chain A, Crystal Structure Of Autoinhibited Form Of Akt1 In Complex With N-(4- (5-(3-Acetamidophenyl)-2-(2-Aminopyridin-3-Yl)-3h- Imidazo[4,5- B]pyridin-3-Yl)benzyl)-3-Fluorobenzamide Length = 446

Iteration: 1
 Score = 48.1 bits (113), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 33/96 (34%), Positives = 52/96 (54%), Gaps = 6/96 (6%)
Query: 390 IARGLEYLHLGCSTRILHFDIKPHNILLDEDFCPKISDFGLAKICNRKESIISMTGARGT 449
           I   L+YLH      +++ D+K  N++LD+D   KI+DFGL K   +  +  +M    GT
Sbjct: 257 IVSALDYLH--SEKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGA--TMKTFCGT 312
Query: 450 VGYIAPEVFCRNIGEVSYKSDVYNYGMMIFEMTGGR 485
             Y+APEV   N  +     D +  G++++EM  GR
Sbjct: 313 PEYLAPEVLEDN--DYGRAVDWWGLGVVMYEMMCGR 346

>pdb|4EC8|A Chain A, Structure Of Full Length Cdk9 In Complex With Cyclint And Drb Length = 373

Iteration: 1
 Score = 48.1 bits (113), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 54/205 (26%), Positives = 85/205 (41%), Gaps = 49/205 (23%)
Query: 320 KLGQGGYGSVYKGKLLD-GSNVAVKVL---NDSKGNGKEFINEVASISRTSHVNVVALLG 375
           K+GQG +G V+K +    G  VA+K +   N+ +G     + E+  +    H NVV L+ 
Sbjct: 25  KIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIE 84
Query: 376 FCLRVAEELSSTIG-----------------------------------IARGLEYLHLG 400
            C   A   +   G                                   +  GL Y+H  
Sbjct: 85  ICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLVKFTLSEIKRVMQMLLNGLYYIH-- 142
Query: 401 CSTRILHFDIKPHNILLDEDFCPKISDFGLAKICN-RKESIISMTGAR-GTVGYIAPEVF 458
              +ILH D+K  N+L+  D   K++DFGLA+  +  K S  +    R  T+ Y  PE+ 
Sbjct: 143 -RNKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYXNRVVTLWYRPPELL 201
Query: 459 CRNIGEVSYKS--DVYNYGMMIFEM 481
              +GE  Y    D++  G ++ EM
Sbjct: 202 ---LGERDYGPPIDLWGAGCIMAEM 223

>pdb|3LM0|A Chain A, Crystal Structure Of Human SerineTHREONINE KINASE 17B (STK17B) Length = 327

Iteration: 1
 Score = 48.1 bits (113), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 35/118 (29%), Positives = 57/118 (48%), Gaps = 19/118 (16%)
Query: 390 IARGLEYLHLGCSTRILHFDIKPHNILLDEDFC---PKISDFGLAK----ICNRKESIIS 442
           I  G+ YLH      I+H D+KP NILL   +     KI DFG+++     C  +E +  
Sbjct: 140 ILEGVYYLH---QNNIVHLDLKPQNILLSSIYPLGDIKIVDFGMSRKIGHACELREIM-- 194
Query: 443 MTGARGTVGYIAPEVFCRNIGEVSYKSDVYNYGMMIFEMTGGRKNVDVVDNGSTALDL 500
                GT  Y+APE+   N   ++  +D++N G++ + +          DN  T L++
Sbjct: 195 -----GTPEYLAPEIL--NYDPITTATDMWNIGIIAYMLLTHTSPFVGEDNQETYLNI 245

>pdb|3ORN|A Chain A, Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In Complex With Ch4987655 And Mgamp-Pnp Length = 307

Iteration: 1
 Score = 48.1 bits (113), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 36/110 (32%), Positives = 59/110 (53%), Gaps = 12/110 (10%)
Query: 379 RVAEELSSTIGIA--RGLEYLHLGCSTRILHFDIKPHNILLDEDFCPKISDFGLAKICNR 436
           R+ E++   + IA  +GL YL      +I+H D+KP NIL++     K+ DFG++     
Sbjct: 100 RIPEQILGKVSIAVIKGLTYLR--EKHKIMHRDVKPSNILVNSRGEIKLCDFGVS----- 152
Query: 437 KESIISMTGA-RGTVGYIAPEVFCRNIGEVSYKSDVYNYGMMIFEMTGGR 485
            + I SM  +  GT  Y++PE         S +SD+++ G+ + EM  GR
Sbjct: 153 GQLIDSMANSFVGTRSYMSPERLQGT--HYSVQSDIWSMGLSLVEMAVGR 200

>pdb|3NZ0|A Chain A, Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 302

Iteration: 1
 Score = 48.1 bits (113), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 33/103 (32%), Positives = 51/103 (49%), Gaps = 6/103 (5%)
Query: 380 VAEELSSTIGIARGLEYLHLGCSTRILHFDIKPHNILLDEDFCPKISDFGLAK-ICNRKE 438
           +A+ L     I  G+ YLH   +   +H ++   N+LLD D   KI DFGLAK +    E
Sbjct: 116 LAQLLLFAQQICEGMAYLH---AQHYIHRNLAARNVLLDNDRLVKIGDFGLAKAVPEGHE 172
Query: 439 SIISMTGARGTVGYIAPEVFCRNIGEVSYKSDVYNYGMMIFEM 481
                      V + APE  C    +  Y SDV+++G+ ++E+
Sbjct: 173 YYRVREDGDSPVFWYAPE--CLKEYKFYYASDVWSFGVTLYEL 213

>pdb|3CQU|A Chain A, Crystal Structure Of Akt-1 Complexed With Substrate Peptide And Inhibitor Length = 342

Iteration: 1
 Score = 48.1 bits (113), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 33/96 (34%), Positives = 52/96 (54%), Gaps = 6/96 (6%)
Query: 390 IARGLEYLHLGCSTRILHFDIKPHNILLDEDFCPKISDFGLAKICNRKESIISMTGARGT 449
           I   L+YLH      +++ D+K  N++LD+D   KI+DFGL K   +  +  +M    GT
Sbjct: 119 IVSALDYLH--SEKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGA--TMKXFCGT 174
Query: 450 VGYIAPEVFCRNIGEVSYKSDVYNYGMMIFEMTGGR 485
             Y+APEV   N  +     D +  G++++EM  GR
Sbjct: 175 PEYLAPEVLEDN--DYGRAVDWWGLGVVMYEMMCGR 208

>pdb|4GV1|A Chain A, Pkb Alpha In Complex With Azd5363 Length = 340

Iteration: 1
 Score = 48.1 bits (113), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 33/96 (34%), Positives = 52/96 (54%), Gaps = 6/96 (6%)
Query: 390 IARGLEYLHLGCSTRILHFDIKPHNILLDEDFCPKISDFGLAKICNRKESIISMTGARGT 449
           I   L+YLH      +++ D+K  N++LD+D   KI+DFGL K   +  +  +M    GT
Sbjct: 117 IVSALDYLH--SEKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGA--TMKXFCGT 172
Query: 450 VGYIAPEVFCRNIGEVSYKSDVYNYGMMIFEMTGGR 485
             Y+APEV   N  +     D +  G++++EM  GR
Sbjct: 173 PEYLAPEVLEDN--DYGRAVDWWGLGVVMYEMMCGR 206

>pdb|1SMH|A Chain A, Protein Kinase A Variant Complex With Completely Ordered N- Terminal Helix Length = 350

Iteration: 1
 Score = 48.1 bits (113), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 29/95 (30%), Positives = 49/95 (51%), Gaps = 10/95 (10%)
Query: 390 IARGLEYLHLGCSTRILHFDIKPHNILLDEDFCPKISDFGLAKICNRKESIISMTGARGT 449
           I    EYLH   S  +++ D+KP N+++D+    +++DFGLAK    +   +      GT
Sbjct: 150 IVLTFEYLH---SLDLIYRDLKPENLMIDQQGYIQVTDFGLAKRVKGRTWXLC-----GT 201
Query: 450 VGYIAPEVFCRNIGEVSYKSDVYNYGMMIFEMTGG 484
             Y+APE+        +   D +  G++I+EM  G
Sbjct: 202 PEYLAPEIILSK--GYNKAVDWWALGVLIYEMAAG 234

>pdb|2P55|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 333

Iteration: 1
 Score = 48.1 bits (113), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 36/110 (32%), Positives = 59/110 (53%), Gaps = 12/110 (10%)
Query: 379 RVAEELSSTIGIA--RGLEYLHLGCSTRILHFDIKPHNILLDEDFCPKISDFGLAKICNR 436
           R+ E++   + IA  +GL YL      +I+H D+KP NIL++     K+ DFG++     
Sbjct: 100 RIPEQILGKVSIAVIKGLTYLR--EKHKIMHRDVKPSNILVNSRGEIKLCDFGVS----- 152
Query: 437 KESIISMTGA-RGTVGYIAPEVFCRNIGEVSYKSDVYNYGMMIFEMTGGR 485
            + I SM  +  GT  Y++PE         S +SD+++ G+ + EM  GR
Sbjct: 153 GQLIDSMANSFVGTRSYMSPERLQGT--HYSVQSDIWSMGLSLVEMAVGR 200

>pdb|1S9J|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 341

Iteration: 1
 Score = 48.1 bits (113), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 36/110 (32%), Positives = 59/110 (53%), Gaps = 12/110 (10%)
Query: 379 RVAEELSSTIGIA--RGLEYLHLGCSTRILHFDIKPHNILLDEDFCPKISDFGLAKICNR 436
           R+ E++   + IA  +GL YL      +I+H D+KP NIL++     K+ DFG++     
Sbjct: 100 RIPEQILGKVSIAVIKGLTYLR--EKHKIMHRDVKPSNILVNSRGEIKLCDFGVS----- 152
Query: 437 KESIISMTGA-RGTVGYIAPEVFCRNIGEVSYKSDVYNYGMMIFEMTGGR 485
            + I SM  +  GT  Y++PE         S +SD+++ G+ + EM  GR
Sbjct: 153 GQLIDSMANSFVGTRSYMSPERLQGT--HYSVQSDIWSMGLSLVEMAVGR 200

>pdb|2F2U|A Chain A, Crystal Structure Of The Rho-Kinase Kinase Domain Length = 402

Iteration: 1
 Score = 48.1 bits (113), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 33/102 (32%), Positives = 54/102 (52%), Gaps = 10/102 (9%)
Query: 387 TIGIARGLEYLHLGCSTRILHFDIKPHNILLDEDFCPKISDFGLAKICNRKES--IISMT 444
           T  +   L+ +H   S  ++H D+KP N+LLD+    K++DFG    C + +   ++   
Sbjct: 180 TAEVVLALDAIH---SMGLIHRDVKPDNMLLDKHGHLKLADFG---TCMKMDETGMVHCD 233
Query: 445 GARGTVGYIAPEVFCRNIGEVSY--KSDVYNYGMMIFEMTGG 484
            A GT  YI+PEV     G+  Y  + D ++ G+ +FEM  G
Sbjct: 234 TAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVG 275

>pdb|3I6W|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 443

Iteration: 1
 Score = 48.1 bits (113), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 32/92 (34%), Positives = 51/92 (55%), Gaps = 12/92 (13%)
Query: 393 GLEYLHLGCSTRILHFDIKPHNILL---DEDFCPKISDFGLAKICNRKESIISMTGARGT 449
            ++YLH      I+H D+KP N+LL   +ED   KI+DFG +KI      + ++    GT
Sbjct: 265 AVQYLH---ENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLMRTLC---GT 318
Query: 450 VGYIAPEVFCRNIGEVSYKS--DVYNYGMMIF 479
             Y+APEV   ++G   Y    D ++ G+++F
Sbjct: 319 PTYLAPEVLV-SVGTAGYNRAVDCWSLGVILF 349

>pdb|3OCB|A Chain A, Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor Length = 341

Iteration: 1
 Score = 48.1 bits (113), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 33/96 (34%), Positives = 52/96 (54%), Gaps = 6/96 (6%)
Query: 390 IARGLEYLHLGCSTRILHFDIKPHNILLDEDFCPKISDFGLAKICNRKESIISMTGARGT 449
           I   L+YLH      +++ D+K  N++LD+D   KI+DFGL K   +  +  +M    GT
Sbjct: 118 IVSALDYLH--SEKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGA--TMKXFCGT 173
Query: 450 VGYIAPEVFCRNIGEVSYKSDVYNYGMMIFEMTGGR 485
             Y+APEV   N  +     D +  G++++EM  GR
Sbjct: 174 PEYLAPEVLEDN--DYGRAVDWWGLGVVMYEMMCGR 207

>pdb|3COH|A Chain A, Crystal Structure Of Aurora-A In Complex With A Pentacyclic Inhibitor Length = 268

Iteration: 1
 Score = 48.1 bits (113), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 49/199 (24%), Positives = 83/199 (41%), Gaps = 45/199 (22%)
Query: 321 LGQGGYGSVY-----KGKLLDGSNVAVKVLNDSKGNGKEFINEVASISRTSHVNVVALLG 375
           LG+G +G+VY       K +    V  K   +  G   +   EV   S   H N++ L G
Sbjct: 16  LGKGKFGNVYLAREKNSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYG 75
Query: 376 F------------------CLRVAEELSS---------TIGIARGLEYLHLGCSTRILHF 408
           +                    R  ++LS             +A  L Y H   S +++H 
Sbjct: 76  YFHDSTRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCH---SKKVIHR 132
Query: 409 DIKPHNILLDEDFCPKISDFGLA--KICNRKESIISMTGARGTVGYIAPEVFCRNIGEVS 466
           DIKP N+LL      KI+DFG +     +R+ ++       GT+ Y+ PE+    + +  
Sbjct: 133 DIKPENLLLGSAGELKIADFGWSVHAPSSRRAALC------GTLDYLPPEMIEGRMHDE- 185
Query: 467 YKSDVYNYGMMIFEMTGGR 485
            K D+++ G++ +E   G+
Sbjct: 186 -KVDLWSLGVLCYEFLVGK 203

>pdb|3I6U|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 419

Iteration: 1
 Score = 48.1 bits (113), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 32/92 (34%), Positives = 51/92 (55%), Gaps = 12/92 (13%)
Query: 393 GLEYLHLGCSTRILHFDIKPHNILL---DEDFCPKISDFGLAKICNRKESIISMTGARGT 449
            ++YLH      I+H D+KP N+LL   +ED   KI+DFG +KI      + ++    GT
Sbjct: 251 AVQYLH---ENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLMRTLC---GT 304
Query: 450 VGYIAPEVFCRNIGEVSYKS--DVYNYGMMIF 479
             Y+APEV   ++G   Y    D ++ G+++F
Sbjct: 305 PTYLAPEVLV-SVGTAGYNRAVDCWSLGVILF 335

>pdb|2VO0|A Chain A, Structure Of Pka-Pkb Chimera Complexed With C-(4-(4- Chlorophenyl)-1-(7h-Pyrrolo(2, 3-D)pyrimidin-4-Yl)piperidin- 4-Yl)methylamine Length = 351

Iteration: 1
 Score = 48.1 bits (113), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 29/95 (30%), Positives = 48/95 (50%), Gaps = 10/95 (10%)
Query: 390 IARGLEYLHLGCSTRILHFDIKPHNILLDEDFCPKISDFGLAKICNRKESIISMTGARGT 449
           I    EYLH   S  +++ D+KP N+++D+    K++DFG AK    +   +      GT
Sbjct: 151 IVLTFEYLH---SLDLIYRDLKPENLMIDQQGYIKVTDFGFAKRVKGRTWXLC-----GT 202
Query: 450 VGYIAPEVFCRNIGEVSYKSDVYNYGMMIFEMTGG 484
             Y+APE+        +   D +  G++I+EM  G
Sbjct: 203 PEYLAPEIILSK--GYNKAVDWWALGVLIYEMAAG 235

>pdb|2UVY|A Chain A, Structure Of Pka-pkb Chimera Complexed With Methyl-(4-(9h- Purin-6-yl)-benzyl)-amine Length = 351

Iteration: 1
 Score = 48.1 bits (113), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 29/95 (30%), Positives = 48/95 (50%), Gaps = 10/95 (10%)
Query: 390 IARGLEYLHLGCSTRILHFDIKPHNILLDEDFCPKISDFGLAKICNRKESIISMTGARGT 449
           I    EYLH   S  +++ D+KP N+++D+    K++DFG AK    +   +      GT
Sbjct: 151 IVLTFEYLH---SLDLIYRDLKPENLMIDQQGYIKVTDFGFAKRVKGRTWXLC-----GT 202
Query: 450 VGYIAPEVFCRNIGEVSYKSDVYNYGMMIFEMTGG 484
             Y+APE+        +   D +  G++I+EM  G
Sbjct: 203 PEYLAPEIILSK--GYNKAVDWWALGVLIYEMAAG 235

>pdb|2XUU|A Chain A, Crystal Structure Of A Dap-Kinase 1 Mutant Length = 334

Iteration: 1
 Score = 48.1 bits (113), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 32/99 (32%), Positives = 53/99 (53%), Gaps = 12/99 (12%)
Query: 390 IARGLEYLHLGCSTRILHFDIKPHNILLDEDFCP----KISDFGLAKICNRKESIISMTG 445
           I  G+ YLH   S +I HFD+KP NI+L +   P    KI DFGLA   +      ++  
Sbjct: 123 ILNGVYYLH---SLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIF- 178
Query: 446 ARGTVGYIAPEVFCRNIGEVSYKSDVYNYGMMIFEMTGG 484
             GT  ++APE+   N   +  ++D+++ G++ + +  G
Sbjct: 179 --GTPAFVAPEIV--NYEPLGLEADMWSIGVITYILLSG 213

>pdb|2JDT|A Chain A, Structure Of Pka-Pkb Chimera Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 351

Iteration: 1
 Score = 48.1 bits (113), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 29/95 (30%), Positives = 48/95 (50%), Gaps = 10/95 (10%)
Query: 390 IARGLEYLHLGCSTRILHFDIKPHNILLDEDFCPKISDFGLAKICNRKESIISMTGARGT 449
           I    EYLH   S  +++ D+KP N+++D+    K++DFG AK    +   +      GT
Sbjct: 151 IVLTFEYLH---SLDLIYRDLKPENLMIDQQGYIKVTDFGFAKRVKGRTWXLC-----GT 202
Query: 450 VGYIAPEVFCRNIGEVSYKSDVYNYGMMIFEMTGG 484
             Y+APE+        +   D +  G++I+EM  G
Sbjct: 203 PEYLAPEIILSK--GYNKAVDWWALGVLIYEMAAG 235

>pdb|1Q61|A Chain A, Pka Triple Mutant Model Of Pkb Length = 350

Iteration: 1
 Score = 48.1 bits (113), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 29/95 (30%), Positives = 48/95 (50%), Gaps = 10/95 (10%)
Query: 390 IARGLEYLHLGCSTRILHFDIKPHNILLDEDFCPKISDFGLAKICNRKESIISMTGARGT 449
           I    EYLH   S  +++ D+KP N+++D+    K++DFG AK    +   +      GT
Sbjct: 150 IVLTFEYLH---SLDLIYRDLKPENLMIDQQGYIKVTDFGFAKRVKGRTWXLC-----GT 201
Query: 450 VGYIAPEVFCRNIGEVSYKSDVYNYGMMIFEMTGG 484
             Y+APE+        +   D +  G++I+EM  G
Sbjct: 202 PEYLAPEIILSK--GYNKAVDWWALGVLIYEMAAG 234

>pdb|1SZM|A Chain A, Dual Binding Mode Of Bisindolylmaleimide 2 To Protein Kinase A (Pka) Length = 350

Iteration: 1
 Score = 47.8 bits (112), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 29/95 (30%), Positives = 48/95 (50%), Gaps = 10/95 (10%)
Query: 390 IARGLEYLHLGCSTRILHFDIKPHNILLDEDFCPKISDFGLAKICNRKESIISMTGARGT 449
           I    EYLH   S  +++ D+KP N+++D+    K++DFG AK    +   +      GT
Sbjct: 150 IVLTFEYLH---SLDLIYRDLKPENLMIDQQGYIKVTDFGFAKRVKGRTWXLC-----GT 201
Query: 450 VGYIAPEVFCRNIGEVSYKSDVYNYGMMIFEMTGG 484
             Y+APE+        +   D +  G++I+EM  G
Sbjct: 202 PEYLAPEIILSK--GYNKAVDWWALGVLIYEMAAG 234

>pdb|3MBL|A Chain A, Crystal Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek 1) In Complex With Ligand And Mgadp Length = 328

Iteration: 1
 Score = 47.8 bits (112), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 36/110 (32%), Positives = 59/110 (53%), Gaps = 12/110 (10%)
Query: 379 RVAEELSSTIGIA--RGLEYLHLGCSTRILHFDIKPHNILLDEDFCPKISDFGLAKICNR 436
           R+ E++   + IA  +GL YL      +I+H D+KP NIL++     K+ DFG++     
Sbjct: 100 RIPEQILGKVSIAVIKGLTYLR--EKHKIMHRDVKPSNILVNSRGEIKLCDFGVS----- 152
Query: 437 KESIISMTGA-RGTVGYIAPEVFCRNIGEVSYKSDVYNYGMMIFEMTGGR 485
            + I SM  +  GT  Y++PE         S +SD+++ G+ + EM  GR
Sbjct: 153 GQLIDSMANSFVGTRSYMSPERLQGT--HYSVQSDIWSMGLSLVEMAVGR 200

>pdb|3DV3|A Chain A, Mek1 With Pf-04622664 Bound Length = 322

Iteration: 1
 Score = 47.8 bits (112), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 36/110 (32%), Positives = 59/110 (53%), Gaps = 12/110 (10%)
Query: 379 RVAEELSSTIGIA--RGLEYLHLGCSTRILHFDIKPHNILLDEDFCPKISDFGLAKICNR 436
           R+ E++   + IA  +GL YL      +I+H D+KP NIL++     K+ DFG++     
Sbjct: 100 RIPEQILGKVSIAVIKGLTYLR--EKHKIMHRDVKPSNILVNSRGEIKLCDFGVS----- 152
Query: 437 KESIISMTGA-RGTVGYIAPEVFCRNIGEVSYKSDVYNYGMMIFEMTGGR 485
            + I SM  +  GT  Y++PE         S +SD+++ G+ + EM  GR
Sbjct: 153 GQLIDSMANSFVGTRSYMSPERLQGT--HYSVQSDIWSMGLSLVEMAVGR 200

>pdb|3L9M|A Chain A, Crystal Structure Of Pkab3 (Pka Triple Mutant V123a, L173m, Q181k) With Compound 18 Length = 351

Iteration: 1
 Score = 47.8 bits (112), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 29/95 (30%), Positives = 48/95 (50%), Gaps = 10/95 (10%)
Query: 390 IARGLEYLHLGCSTRILHFDIKPHNILLDEDFCPKISDFGLAKICNRKESIISMTGARGT 449
           I    EYLH   S  +++ D+KP N+++D+    K++DFG AK    +   +      GT
Sbjct: 151 IVLTFEYLH---SLDLIYRDLKPENLMIDQQGYIKVTDFGFAKRVKGRTWXLC-----GT 202
Query: 450 VGYIAPEVFCRNIGEVSYKSDVYNYGMMIFEMTGG 484
             Y+APE+        +   D +  G++I+EM  G
Sbjct: 203 PEYLAPEIILSK--GYNKAVDWWALGVLIYEMAAG 235

>pdb|3VUL|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 47.8 bits (112), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 35/94 (37%), Positives = 51/94 (54%), Gaps = 12/94 (12%)
Query: 393 GLEYLHLGCSTRILHFDIKPHNILLDEDFCPKISDFGLAKICNRKESIISMTGARGTVGY 452
           G+++LH   S  I+H D+KP NI++  D   KI DFGLA+      +   MT    T  Y
Sbjct: 138 GIKHLH---SAGIIHRDLKPSNIVVKSDATLKILDFGLARTAG---TSFMMTPYVVTRYY 191
Query: 453 IAPEVFCRNIGEVSYKS--DVYNYGMMIFEMTGG 484
            APEV    I  + YK   D+++ G+++ EM  G
Sbjct: 192 RAPEV----ILGMGYKENVDIWSVGVIMGEMIKG 221

>pdb|3VUM|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M7 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 47.8 bits (112), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 35/94 (37%), Positives = 51/94 (54%), Gaps = 12/94 (12%)
Query: 393 GLEYLHLGCSTRILHFDIKPHNILLDEDFCPKISDFGLAKICNRKESIISMTGARGTVGY 452
           G+++LH   S  I+H D+KP NI++  D   KI DFGLA+      +   MT    T  Y
Sbjct: 138 GIKHLH---SAGIIHRDLKPSNIVVKSDATLKILDFGLARTAG---TSFMMTPYVVTRYY 191
Query: 453 IAPEVFCRNIGEVSYKS--DVYNYGMMIFEMTGG 484
            APEV    I  + YK   D+++ G+++ EM  G
Sbjct: 192 RAPEV----ILGMGYKENVDIWSVGVIMGEMIKG 221

>pdb|3MI9|A Chain A, Crystal Structure Of Hiv-1 Tat Complexed With Human P-Tefb Length = 351

Iteration: 1
 Score = 47.8 bits (112), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 54/205 (26%), Positives = 85/205 (41%), Gaps = 49/205 (23%)
Query: 320 KLGQGGYGSVYKGKLLD-GSNVAVKVL---NDSKGNGKEFINEVASISRTSHVNVVALLG 375
           K+GQG +G V+K +    G  VA+K +   N+ +G     + E+  +    H NVV L+ 
Sbjct: 24  KIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIE 83
Query: 376 FCLRVAEELSSTIG-----------------------------------IARGLEYLHLG 400
            C   A   +   G                                   +  GL Y+H  
Sbjct: 84  ICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLVKFTLSEIKRVMQMLLNGLYYIH-- 141
Query: 401 CSTRILHFDIKPHNILLDEDFCPKISDFGLAKICN-RKESIISMTGAR-GTVGYIAPEVF 458
              +ILH D+K  N+L+  D   K++DFGLA+  +  K S  +    R  T+ Y  PE+ 
Sbjct: 142 -RNKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYXNRVVTLWYRPPELL 200
Query: 459 CRNIGEVSYKS--DVYNYGMMIFEM 481
              +GE  Y    D++  G ++ EM
Sbjct: 201 ---LGERDYGPPIDLWGAGCIMAEM 222

>pdb|2QUR|A Chain A, Crystal Structure Of F327aK285P MUTANT OF CAMP-Dependent Protein Kinase Length = 350

Iteration: 1
 Score = 47.8 bits (112), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 29/95 (30%), Positives = 48/95 (50%), Gaps = 10/95 (10%)
Query: 390 IARGLEYLHLGCSTRILHFDIKPHNILLDEDFCPKISDFGLAKICNRKESIISMTGARGT 449
           I    EYLH   S  +++ D+KP N+L+D+    +++DFG AK    +   +      GT
Sbjct: 150 IVLTFEYLH---SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLC-----GT 201
Query: 450 VGYIAPEVFCRNIGEVSYKSDVYNYGMMIFEMTGG 484
             Y+APE+        +   D +  G++I+EM  G
Sbjct: 202 PEYLAPEIILSK--GYNKAVDWWALGVLIYEMAAG 234

>pdb|2F7E|E Chain E, Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoquinolin-6- Yl-Pyridin-3-Yloxymethyl-Etylamine Length = 351

Iteration: 1
 Score = 47.8 bits (112), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 29/95 (30%), Positives = 48/95 (50%), Gaps = 10/95 (10%)
Query: 390 IARGLEYLHLGCSTRILHFDIKPHNILLDEDFCPKISDFGLAKICNRKESIISMTGARGT 449
           I    EYLH   S  +++ D+KP N+L+D+    +++DFG AK    +   +      GT
Sbjct: 151 IVLTFEYLH---SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWTLC-----GT 202
Query: 450 VGYIAPEVFCRNIGEVSYKSDVYNYGMMIFEMTGG 484
             Y+APE+        +   D +  G++I+EM  G
Sbjct: 203 PEYLAPEIILSK--GYNKAVDWWALGVLIYEMAAG 235

>pdb|3BLH|A Chain A, Crystal Structure Of Human Cdk9CYCLINT1 Length = 331

Iteration: 1
 Score = 47.8 bits (112), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 54/205 (26%), Positives = 85/205 (41%), Gaps = 49/205 (23%)
Query: 320 KLGQGGYGSVYKGKLLD-GSNVAVKVL---NDSKGNGKEFINEVASISRTSHVNVVALLG 375
           K+GQG +G V+K +    G  VA+K +   N+ +G     + E+  +    H NVV L+ 
Sbjct: 25  KIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIE 84
Query: 376 FCLRVAEELSSTIG-----------------------------------IARGLEYLHLG 400
            C   A   +   G                                   +  GL Y+H  
Sbjct: 85  ICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLVKFTLSEIKRVMQMLLNGLYYIH-- 142
Query: 401 CSTRILHFDIKPHNILLDEDFCPKISDFGLAKICN-RKESIISMTGAR-GTVGYIAPEVF 458
              +ILH D+K  N+L+  D   K++DFGLA+  +  K S  +    R  T+ Y  PE+ 
Sbjct: 143 -RNKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYXNRVVTLWYRPPELL 201
Query: 459 CRNIGEVSYKS--DVYNYGMMIFEM 481
              +GE  Y    D++  G ++ EM
Sbjct: 202 ---LGERDYGPPIDLWGAGCIMAEM 223

>pdb|3QAL|E Chain E, Crystal Structure Of Arg280ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350

Iteration: 1
 Score = 47.8 bits (112), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 29/95 (30%), Positives = 48/95 (50%), Gaps = 10/95 (10%)
Query: 390 IARGLEYLHLGCSTRILHFDIKPHNILLDEDFCPKISDFGLAKICNRKESIISMTGARGT 449
           I    EYLH   S  +++ D+KP N+L+D+    +++DFG AK    +   +      GT
Sbjct: 150 IVLTFEYLH---SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLC-----GT 201
Query: 450 VGYIAPEVFCRNIGEVSYKSDVYNYGMMIFEMTGG 484
             Y+APE+        +   D +  G++I+EM  G
Sbjct: 202 PEYLAPEIILSK--GYNKAVDWWALGVLIYEMAAG 234

>pdb|1FMO|E Chain E, Crystal Structure Of A Polyhistidine-Tagged Recombinant Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With The Peptide Inhibitor Pki(5-24) And Adenosine Length = 350

Iteration: 1
 Score = 47.8 bits (112), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 29/95 (30%), Positives = 48/95 (50%), Gaps = 10/95 (10%)
Query: 390 IARGLEYLHLGCSTRILHFDIKPHNILLDEDFCPKISDFGLAKICNRKESIISMTGARGT 449
           I    EYLH   S  +++ D+KP N+L+D+    +++DFG AK    +   +      GT
Sbjct: 150 IVLTFEYLH---SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLC-----GT 201
Query: 450 VGYIAPEVFCRNIGEVSYKSDVYNYGMMIFEMTGG 484
             Y+APE+        +   D +  G++I+EM  G
Sbjct: 202 PEYLAPEIILSK--GYNKAVDWWALGVLIYEMAAG 234

>pdb|1APM|E Chain E, 2.0 Angstrom Refined Crystal Structure Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With A Peptide Inhibitor And Detergent Length = 350

Iteration: 1
 Score = 47.8 bits (112), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 29/95 (30%), Positives = 48/95 (50%), Gaps = 10/95 (10%)
Query: 390 IARGLEYLHLGCSTRILHFDIKPHNILLDEDFCPKISDFGLAKICNRKESIISMTGARGT 449
           I    EYLH   S  +++ D+KP N+L+D+    +++DFG AK    +   +      GT
Sbjct: 150 IVLTFEYLH---SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLC-----GT 201
Query: 450 VGYIAPEVFCRNIGEVSYKSDVYNYGMMIFEMTGG 484
             Y+APE+        +   D +  G++I+EM  G
Sbjct: 202 PEYLAPEIILSK--GYNKAVDWWALGVLIYEMAAG 234

>pdb|2QCS|A Chain A, A Complex Structure Between The Catalytic And Regulatory Subunit Of Protein Kinase A That Represents The Inhibited State Length = 350

Iteration: 1
 Score = 47.8 bits (112), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 29/95 (30%), Positives = 48/95 (50%), Gaps = 10/95 (10%)
Query: 390 IARGLEYLHLGCSTRILHFDIKPHNILLDEDFCPKISDFGLAKICNRKESIISMTGARGT 449
           I    EYLH   S  +++ D+KP N+L+D+    +++DFG AK    +   +      GT
Sbjct: 150 IVLTFEYLH---SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLC-----GT 201
Query: 450 VGYIAPEVFCRNIGEVSYKSDVYNYGMMIFEMTGG 484
             Y+APE+        +   D +  G++I+EM  G
Sbjct: 202 PEYLAPEIILSK--GYNKAVDWWALGVLIYEMAAG 234

>pdb|1BKX|A Chain A, A Binary Complex Of The Catalytic Subunit Of Camp-Dependent Protein Kinase And Adenosine Further Defines Conformational Flexibility Length = 350

Iteration: 1
 Score = 47.8 bits (112), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 29/95 (30%), Positives = 48/95 (50%), Gaps = 10/95 (10%)
Query: 390 IARGLEYLHLGCSTRILHFDIKPHNILLDEDFCPKISDFGLAKICNRKESIISMTGARGT 449
           I    EYLH   S  +++ D+KP N+L+D+    +++DFG AK    +   +      GT
Sbjct: 150 IVLTFEYLH---SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLC-----GT 201
Query: 450 VGYIAPEVFCRNIGEVSYKSDVYNYGMMIFEMTGG 484
             Y+APE+        +   D +  G++I+EM  G
Sbjct: 202 PEYLAPEIILSK--GYNKAVDWWALGVLIYEMAAG 234

>pdb|2ERZ|E Chain E, Crystal Structure Of C-amp Dependent Kinase (pka) Bound To Hydroxyfasudil Length = 351

Iteration: 1
 Score = 47.8 bits (112), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 29/95 (30%), Positives = 48/95 (50%), Gaps = 10/95 (10%)
Query: 390 IARGLEYLHLGCSTRILHFDIKPHNILLDEDFCPKISDFGLAKICNRKESIISMTGARGT 449
           I    EYLH   S  +++ D+KP N+L+D+    +++DFG AK    +   +      GT
Sbjct: 151 IVLTFEYLH---SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLC-----GT 202
Query: 450 VGYIAPEVFCRNIGEVSYKSDVYNYGMMIFEMTGG 484
             Y+APE+        +   D +  G++I+EM  G
Sbjct: 203 PEYLAPEIILSK--GYNKAVDWWALGVLIYEMAAG 235

>pdb|1L3R|E Chain E, Crystal Structure Of A Transition State Mimic Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Length = 350

Iteration: 1
 Score = 47.8 bits (112), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 29/95 (30%), Positives = 48/95 (50%), Gaps = 10/95 (10%)
Query: 390 IARGLEYLHLGCSTRILHFDIKPHNILLDEDFCPKISDFGLAKICNRKESIISMTGARGT 449
           I    EYLH   S  +++ D+KP N+L+D+    +++DFG AK    +   +      GT
Sbjct: 150 IVLTFEYLH---SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLC-----GT 201
Query: 450 VGYIAPEVFCRNIGEVSYKSDVYNYGMMIFEMTGG 484
             Y+APE+        +   D +  G++I+EM  G
Sbjct: 202 PEYLAPEIILSK--GYNKAVDWWALGVLIYEMAAG 234

>pdb|1JBP|E Chain E, Crystal Structure Of The Catalytic Subunit Of Camp- Dependent Protein Kinase Complexed With A Substrate Peptide, Adp And Detergent Length = 350

Iteration: 1
 Score = 47.8 bits (112), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 29/95 (30%), Positives = 48/95 (50%), Gaps = 10/95 (10%)
Query: 390 IARGLEYLHLGCSTRILHFDIKPHNILLDEDFCPKISDFGLAKICNRKESIISMTGARGT 449
           I    EYLH   S  +++ D+KP N+L+D+    +++DFG AK    +   +      GT
Sbjct: 150 IVLTFEYLH---SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLC-----GT 201
Query: 450 VGYIAPEVFCRNIGEVSYKSDVYNYGMMIFEMTGG 484
             Y+APE+        +   D +  G++I+EM  G
Sbjct: 202 PEYLAPEIILSK--GYNKAVDWWALGVLIYEMAAG 234

>pdb|4DFX|E Chain E, Crystal Structure Of Myristoylated K7c Catalytic Subunit Of Camp- Dependent Protein Kinase In Complex With Sp20 And Amp-Pnp Length = 350

Iteration: 1
 Score = 47.4 bits (111), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 29/95 (30%), Positives = 48/95 (50%), Gaps = 10/95 (10%)
Query: 390 IARGLEYLHLGCSTRILHFDIKPHNILLDEDFCPKISDFGLAKICNRKESIISMTGARGT 449
           I    EYLH   S  +++ D+KP N+L+D+    +++DFG AK    +   +      GT
Sbjct: 150 IVLTFEYLH---SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLC-----GT 201
Query: 450 VGYIAPEVFCRNIGEVSYKSDVYNYGMMIFEMTGG 484
             Y+APE+        +   D +  G++I+EM  G
Sbjct: 202 PEYLAPEIILSK--GYNKAVDWWALGVLIYEMAAG 234

>pdb|4DG3|E Chain E, Crystal Structure Of R336a Mutant Of Camp-dependent Protein Kinase With Unphosphorylated Turn Motif Length = 371

Iteration: 1
 Score = 47.4 bits (111), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 29/95 (30%), Positives = 48/95 (50%), Gaps = 10/95 (10%)
Query: 390 IARGLEYLHLGCSTRILHFDIKPHNILLDEDFCPKISDFGLAKICNRKESIISMTGARGT 449
           I    EYLH   S  +++ D+KP N+L+D+    +++DFG AK    +   +      GT
Sbjct: 171 IVLTFEYLH---SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLC-----GT 222
Query: 450 VGYIAPEVFCRNIGEVSYKSDVYNYGMMIFEMTGG 484
             Y+APE+        +   D +  G++I+EM  G
Sbjct: 223 PEYLAPEIILSK--GYNKAVDWWALGVLIYEMAAG 255

>pdb|3MY0|A Chain A, Crystal Structure Of The Acvrl1 (Alk1) Kinase Domain Bound To Ldn- 193189 Length = 305

Iteration: 1
 Score = 47.4 bits (111), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 50/203 (24%), Positives = 84/203 (41%), Gaps = 42/203 (20%)
Query: 321 LGQGGYGSVYKGKLLDGSNVAVKVLNDSKGNGKEFINEVASISRTSHVNVV--------- 371
           +G+G YG V++G L  G +VAVK+ +           E+ +     H N++         
Sbjct: 16  VGKGRYGEVWRG-LWHGESVAVKIFSSRDEQSWFRETEIYNTVLLRHDNILGFIASDMTS 74
Query: 372 -----------------ALLGFCLRVAEE----LSSTIGIARGLEYLHLGC-----STRI 405
                            +L  F  R   E    L   +  A GL +LH+          I
Sbjct: 75  RNSSTQLWLITHYHEHGSLYDFLQRQTLEPHLALRLAVSAACGLAHLHVEIFGTQGKPAI 134
Query: 406 LHFDIKPHNILLDEDFCPKISDFGLAKICNRKESIISM--TGARGTVGYIAPEVFCRNIG 463
            H D K  N+L+  +    I+D GLA + ++    + +      GT  Y+APEV    I 
Sbjct: 135 AHRDFKSRNVLVKSNLQCCIADLGLAVMHSQGSDYLDIGNNPRVGTKRYMAPEVLDEQIR 194
Query: 464 E---VSYK-SDVYNYGMMIFEMT 482
                SYK +D++ +G++++E+ 
Sbjct: 195 TDCFESYKWTDIWAFGLVLWEIA 217

>pdb|1CTP|E Chain E, Structure Of The Mammalian Catalytic Subunit Of Camp-Dependent Protein Kinase And An Inhibitor Peptide Displays An Open Conformation Length = 350

Iteration: 1
 Score = 47.4 bits (111), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 29/95 (30%), Positives = 48/95 (50%), Gaps = 10/95 (10%)
Query: 390 IARGLEYLHLGCSTRILHFDIKPHNILLDEDFCPKISDFGLAKICNRKESIISMTGARGT 449
           I    EYLH   S  +++ D+KP N+L+D+    +++DFG AK    +   +      GT
Sbjct: 150 IVLTFEYLH---SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLC-----GT 201
Query: 450 VGYIAPEVFCRNIGEVSYKSDVYNYGMMIFEMTGG 484
             Y+APE+        +   D +  G++I+EM  G
Sbjct: 202 PEYLAPEIILSK--GYNKAVDWWALGVLIYEMAAG 234

>pdb|1Q8W|A Chain A, The Catalytic Subunit Of Camp-Dependent Protein Kinase In Complex With Rho-Kinase Inhibitor Fasudil (Ha-1077) Length = 350

Iteration: 1
 Score = 47.4 bits (111), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 29/95 (30%), Positives = 48/95 (50%), Gaps = 10/95 (10%)
Query: 390 IARGLEYLHLGCSTRILHFDIKPHNILLDEDFCPKISDFGLAKICNRKESIISMTGARGT 449
           I    EYLH   S  +++ D+KP N+L+D+    +++DFG AK    +   +      GT
Sbjct: 150 IVLTFEYLH---SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLC-----GT 201
Query: 450 VGYIAPEVFCRNIGEVSYKSDVYNYGMMIFEMTGG 484
             Y+APE+        +   D +  G++I+EM  G
Sbjct: 202 PEYLAPEIILSK--GYNKAVDWWALGVLIYEMAAG 234

>pdb|3NX8|A Chain A, Human Camp Dependent Protein Kinase In Complex With Phenol Length = 351

Iteration: 1
 Score = 47.4 bits (111), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 29/95 (30%), Positives = 48/95 (50%), Gaps = 10/95 (10%)
Query: 390 IARGLEYLHLGCSTRILHFDIKPHNILLDEDFCPKISDFGLAKICNRKESIISMTGARGT 449
           I    EYLH   S  +++ D+KP N+L+D+    +++DFG AK    +   +      GT
Sbjct: 151 IVLTFEYLH---SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLC-----GT 202
Query: 450 VGYIAPEVFCRNIGEVSYKSDVYNYGMMIFEMTGG 484
             Y+APE+        +   D +  G++I+EM  G
Sbjct: 203 PEYLAPEIILSK--GYNKAVDWWALGVLIYEMAAG 235

>pdb|1STC|E Chain E, Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With Staurosporine Length = 350

Iteration: 1
 Score = 47.4 bits (111), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 29/95 (30%), Positives = 48/95 (50%), Gaps = 10/95 (10%)
Query: 390 IARGLEYLHLGCSTRILHFDIKPHNILLDEDFCPKISDFGLAKICNRKESIISMTGARGT 449
           I    EYLH   S  +++ D+KP N+L+D+    +++DFG AK    +   +      GT
Sbjct: 150 IVLTFEYLH---SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLC-----GT 201
Query: 450 VGYIAPEVFCRNIGEVSYKSDVYNYGMMIFEMTGG 484
             Y+APE+        +   D +  G++I+EM  G
Sbjct: 202 PEYLAPEIILSK--GYNKAVDWWALGVLIYEMAAG 234

>pdb|1B6C|B Chain B, Crystal Structure Of The Cytoplasmic Domain Of The Type I Tgf-Beta Receptor In Complex With Fkbp12 Length = 342

Iteration: 1
 Score = 47.4 bits (111), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 48/210 (22%), Positives = 84/210 (40%), Gaps = 42/210 (20%)
Query: 314 TNSFKYKLGQGGYGSVYKGKLLDGSNVAVKVLNDSKGNGKEFINEVASISRTSHVNVVAL 373
           T   +  +G+G +G V++GK   G  VAVK+ +  +        E+       H N++  
Sbjct: 43  TIVLQESIGKGRFGEVWRGKW-RGEEVAVKIFSSREERSWFREAEIYQTVMLRHENILGF 101
Query: 374 LG------------------------------FCLRVAEELSSTIGIARGLEYLHL---G 400
           +                               + + V   +   +  A GL +LH+   G
Sbjct: 102 IAADNKDNGTWTQLWLVSDYHEHGSLFDYLNRYTVTVEGMIKLALSTASGLAHLHMEIVG 161
Query: 401 CSTR--ILHFDIKPHNILLDEDFCPKISDFGLAKICNRKESIISMTGAR--GTVGYIAPE 456
              +  I H D+K  NIL+ ++    I+D GLA   +     I +      GT  Y+APE
Sbjct: 162 TQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPE 221
Query: 457 VFCRNIGEVSYKS----DVYNYGMMIFEMT 482
           V   +I    ++S    D+Y  G++ +E+ 
Sbjct: 222 VLDDSINMKHFESFKRADIYAMGLVFWEIA 251

>pdb|1SVH|A Chain A, Crystal Structure Of Protein Kinase A In Complex With Azepane Derivative 8 Length = 350

Iteration: 1
 Score = 47.4 bits (111), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 29/95 (30%), Positives = 48/95 (50%), Gaps = 10/95 (10%)
Query: 390 IARGLEYLHLGCSTRILHFDIKPHNILLDEDFCPKISDFGLAKICNRKESIISMTGARGT 449
           I    EYLH   S  +++ D+KP N+L+D+    +++DFG AK    +   +      GT
Sbjct: 150 IVLTFEYLH---SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLC-----GT 201
Query: 450 VGYIAPEVFCRNIGEVSYKSDVYNYGMMIFEMTGG 484
             Y+APE+        +   D +  G++I+EM  G
Sbjct: 202 PEYLAPEIILSK--GYNKAVDWWALGVLIYEMAAG 234

>pdb|1CDK|A Chain A, Camp-Dependent Protein Kinase Catalytic Subunit (E.C.2.7.1.37) (Protein Kinase A) Complexed With Protein Kinase Inhibitor Peptide Fragment 5-24 (Pki(5-24) Isoelectric Variant Ca) And Mn2+ Adenylyl Imidodiphosphate (Mnamp-Pnp) At Ph 5.6 And 7c And 4c Length = 350

Iteration: 1
 Score = 47.4 bits (111), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 29/95 (30%), Positives = 48/95 (50%), Gaps = 10/95 (10%)
Query: 390 IARGLEYLHLGCSTRILHFDIKPHNILLDEDFCPKISDFGLAKICNRKESIISMTGARGT 449
           I    EYLH   S  +++ D+KP N+L+D+    +++DFG AK    +   +      GT
Sbjct: 150 IVLTFEYLH---SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLC-----GT 201
Query: 450 VGYIAPEVFCRNIGEVSYKSDVYNYGMMIFEMTGG 484
             Y+APE+        +   D +  G++I+EM  G
Sbjct: 202 PEYLAPEIILSK--GYNKAVDWWALGVLIYEMAAG 234

>pdb|3PVB|A Chain A, Crystal Structure Of (73-244)ria:c Holoenzyme Of Camp-Dependent Protein Kinase Length = 345

Iteration: 1
 Score = 47.4 bits (111), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 29/95 (30%), Positives = 48/95 (50%), Gaps = 10/95 (10%)
Query: 390 IARGLEYLHLGCSTRILHFDIKPHNILLDEDFCPKISDFGLAKICNRKESIISMTGARGT 449
           I    EYLH   S  +++ D+KP N+L+D+    +++DFG AK    +   +      GT
Sbjct: 145 IVLTFEYLH---SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLC-----GT 196
Query: 450 VGYIAPEVFCRNIGEVSYKSDVYNYGMMIFEMTGG 484
             Y+APE+        +   D +  G++I+EM  G
Sbjct: 197 PEYLAPEIILSK--GYNKAVDWWALGVLIYEMAAG 229

>pdb|3AGM|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-670 Length = 351

Iteration: 1
 Score = 47.4 bits (111), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 29/95 (30%), Positives = 48/95 (50%), Gaps = 10/95 (10%)
Query: 390 IARGLEYLHLGCSTRILHFDIKPHNILLDEDFCPKISDFGLAKICNRKESIISMTGARGT 449
           I    EYLH   S  +++ D+KP N+L+D+    +++DFG AK    +   +      GT
Sbjct: 151 IVLTFEYLH---SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLC-----GT 202
Query: 450 VGYIAPEVFCRNIGEVSYKSDVYNYGMMIFEMTGG 484
             Y+APE+        +   D +  G++I+EM  G
Sbjct: 203 PEYLAPEIILSK--GYNKAVDWWALGVLIYEMAAG 235

>pdb|1CMK|E Chain E, Crystal Structures Of The Myristylated Catalytic Subunit Of Camp- Dependent Protein Kinase Reveal Open And Closed Conformations Length = 350

Iteration: 1
 Score = 47.4 bits (111), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 29/95 (30%), Positives = 48/95 (50%), Gaps = 10/95 (10%)
Query: 390 IARGLEYLHLGCSTRILHFDIKPHNILLDEDFCPKISDFGLAKICNRKESIISMTGARGT 449
           I    EYLH   S  +++ D+KP N+L+D+    +++DFG AK    +   +      GT
Sbjct: 150 IVLTFEYLH---SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLC-----GT 201
Query: 450 VGYIAPEVFCRNIGEVSYKSDVYNYGMMIFEMTGG 484
             Y+APE+        +   D +  G++I+EM  G
Sbjct: 202 PEYLAPEIILSK--GYNKAVDWWALGVLIYEMAAG 234

>pdb|2C1A|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With Isoquinoline-5-Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl)amide Length = 351

Iteration: 1
 Score = 47.4 bits (111), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 29/95 (30%), Positives = 48/95 (50%), Gaps = 10/95 (10%)
Query: 390 IARGLEYLHLGCSTRILHFDIKPHNILLDEDFCPKISDFGLAKICNRKESIISMTGARGT 449
           I    EYLH   S  +++ D+KP N+L+D+    +++DFG AK    +   +      GT
Sbjct: 151 IVLTFEYLH---SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLC-----GT 202
Query: 450 VGYIAPEVFCRNIGEVSYKSDVYNYGMMIFEMTGG 484
             Y+APE+        +   D +  G++I+EM  G
Sbjct: 203 PEYLAPEIILSK--GYNKAVDWWALGVLIYEMAAG 235

>pdb|4AE6|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit Calpha 2 Length = 343

Iteration: 1
 Score = 47.4 bits (111), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 29/95 (30%), Positives = 48/95 (50%), Gaps = 10/95 (10%)
Query: 390 IARGLEYLHLGCSTRILHFDIKPHNILLDEDFCPKISDFGLAKICNRKESIISMTGARGT 449
           I    EYLH   S  +++ D+KP N+L+D+    +++DFG AK    +   +      GT
Sbjct: 143 IVLTFEYLH---SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLC-----GT 194
Query: 450 VGYIAPEVFCRNIGEVSYKSDVYNYGMMIFEMTGG 484
             Y+APE+        +   D +  G++I+EM  G
Sbjct: 195 PEYLAPEIILSK--GYNKAVDWWALGVLIYEMAAG 227

>pdb|2UZT|A Chain A, Pka Structures Of Akt, Indazole-Pyridine Inhibitors Length = 336

Iteration: 1
 Score = 47.4 bits (111), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 29/95 (30%), Positives = 48/95 (50%), Gaps = 10/95 (10%)
Query: 390 IARGLEYLHLGCSTRILHFDIKPHNILLDEDFCPKISDFGLAKICNRKESIISMTGARGT 449
           I    EYLH   S  +++ D+KP N+L+D+    +++DFG AK    +   +      GT
Sbjct: 136 IVLTFEYLH---SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWTLC-----GT 187
Query: 450 VGYIAPEVFCRNIGEVSYKSDVYNYGMMIFEMTGG 484
             Y+APE+        +   D +  G++I+EM  G
Sbjct: 188 PEYLAPEIILSK--GYNKAVDWWALGVLIYEMAAG 220

>pdb|2JDS|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With A- 443654 Length = 351

Iteration: 1
 Score = 47.4 bits (111), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 29/95 (30%), Positives = 48/95 (50%), Gaps = 10/95 (10%)
Query: 390 IARGLEYLHLGCSTRILHFDIKPHNILLDEDFCPKISDFGLAKICNRKESIISMTGARGT 449
           I    EYLH   S  +++ D+KP N+L+D+    +++DFG AK    +   +      GT
Sbjct: 151 IVLTFEYLH---SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLC-----GT 202
Query: 450 VGYIAPEVFCRNIGEVSYKSDVYNYGMMIFEMTGG 484
             Y+APE+        +   D +  G++I+EM  G
Sbjct: 203 PEYLAPEIILSK--GYNKAVDWWALGVLIYEMAAG 235

>pdb|3AGL|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-1039 Length = 351

Iteration: 1
 Score = 47.4 bits (111), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 29/95 (30%), Positives = 48/95 (50%), Gaps = 10/95 (10%)
Query: 390 IARGLEYLHLGCSTRILHFDIKPHNILLDEDFCPKISDFGLAKICNRKESIISMTGARGT 449
           I    EYLH   S  +++ D+KP N+L+D+    +++DFG AK    +   +      GT
Sbjct: 151 IVLTFEYLH---SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLC-----GT 202
Query: 450 VGYIAPEVFCRNIGEVSYKSDVYNYGMMIFEMTGG 484
             Y+APE+        +   D +  G++I+EM  G
Sbjct: 203 PEYLAPEIILSK--GYNKAVDWWALGVLIYEMAAG 235

>pdb|1YDT|E Chain E, Structure Of Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With H89 Protein Kinase Inhibitor N-[2- (4-Bromocinnamylamino)ethyl]-5-Isoquinoline Length = 350

Iteration: 1
 Score = 47.4 bits (111), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 29/95 (30%), Positives = 48/95 (50%), Gaps = 10/95 (10%)
Query: 390 IARGLEYLHLGCSTRILHFDIKPHNILLDEDFCPKISDFGLAKICNRKESIISMTGARGT 449
           I    EYLH   S  +++ D+KP N+L+D+    +++DFG AK    +   +      GT
Sbjct: 150 IVLTFEYLH---SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLC-----GT 201
Query: 450 VGYIAPEVFCRNIGEVSYKSDVYNYGMMIFEMTGG 484
             Y+APE+        +   D +  G++I+EM  G
Sbjct: 202 PEYLAPEIILSK--GYNKAVDWWALGVLIYEMAAG 234

>pdb|3DND|A Chain A, Camp-Dependent Protein Kinase Pka Catalytic Subunit With Pki-5-24 Length = 350

Iteration: 1
 Score = 47.4 bits (111), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 29/95 (30%), Positives = 48/95 (50%), Gaps = 10/95 (10%)
Query: 390 IARGLEYLHLGCSTRILHFDIKPHNILLDEDFCPKISDFGLAKICNRKESIISMTGARGT 449
           I    EYLH   S  +++ D+KP N+L+D+    +++DFG AK    +   +      GT
Sbjct: 150 IVLTFEYLH---SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLC-----GT 201
Query: 450 VGYIAPEVFCRNIGEVSYKSDVYNYGMMIFEMTGG 484
             Y+APE+        +   D +  G++I+EM  G
Sbjct: 202 PEYLAPEIILSK--GYNKAVDWWALGVLIYEMAAG 234

>pdb|1XH7|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350

Iteration: 1
 Score = 47.4 bits (111), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 29/95 (30%), Positives = 48/95 (50%), Gaps = 10/95 (10%)
Query: 390 IARGLEYLHLGCSTRILHFDIKPHNILLDEDFCPKISDFGLAKICNRKESIISMTGARGT 449
           I    EYLH   S  +++ D+KP N+L+D+    +++DFG AK    +   +      GT
Sbjct: 150 IVLTFEYLH---SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLC-----GT 201
Query: 450 VGYIAPEVFCRNIGEVSYKSDVYNYGMMIFEMTGG 484
             Y+APE+        +   D +  G++I+EM  G
Sbjct: 202 PEYLAPEIILSK--GYNKAVDWWALGVLIYEMAAG 234

>pdb|4BCF|A Chain A, Structure Of Cdk9 In Complex With Cyclin T And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 331

Iteration: 1
 Score = 47.4 bits (111), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 54/205 (26%), Positives = 87/205 (42%), Gaps = 49/205 (23%)
Query: 320 KLGQGGYGSVYKGKLLD-GSNVAVKVL---NDSKGNGKEFINEVASISRTSHVNVVALLG 375
           K+GQG +G V+K +    G  VA+K +   N+ +G     + E+  +    H NVV L+ 
Sbjct: 25  KIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIE 84
Query: 376 FCLRVA------------------EELSSTIG-----------------IARGLEYLHLG 400
            C   A                   +L+  +                  +  GL Y+H  
Sbjct: 85  ICRTKASPYNRCKASIYLVFDFCEHDLAGLLSNVLVKFTLSEIKRVMQMLLNGLYYIH-- 142
Query: 401 CSTRILHFDIKPHNILLDEDFCPKISDFGLAKICN-RKESIISMTGAR-GTVGYIAPEVF 458
              +ILH D+K  N+L+  D   K++DFGLA+  +  K S  +    R  T+ Y  PE+ 
Sbjct: 143 -RNKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYXNRVVTLWYRPPELL 201
Query: 459 CRNIGEVSYKS--DVYNYGMMIFEM 481
              +GE  Y    D++  G ++ EM
Sbjct: 202 ---LGERDYGPPIDLWGAGCIMAEM 223

>pdb|3MVJ|A Chain A, Human Cyclic Amp-Dependent Protein Kinase Pka Inhibitor Complex Length = 371

Iteration: 1
 Score = 47.4 bits (111), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 29/95 (30%), Positives = 48/95 (50%), Gaps = 10/95 (10%)
Query: 390 IARGLEYLHLGCSTRILHFDIKPHNILLDEDFCPKISDFGLAKICNRKESIISMTGARGT 449
           I    EYLH   S  +++ D+KP N+L+D+    +++DFG AK    +   +      GT
Sbjct: 171 IVLTFEYLH---SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLC-----GT 222
Query: 450 VGYIAPEVFCRNIGEVSYKSDVYNYGMMIFEMTGG 484
             Y+APE+        +   D +  G++I+EM  G
Sbjct: 223 PEYLAPEIILSK--GYNKAVDWWALGVLIYEMAAG 255

>pdb|4AE9|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit C Alpha 2 Length = 343

Iteration: 1
 Score = 47.4 bits (111), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 29/95 (30%), Positives = 48/95 (50%), Gaps = 10/95 (10%)
Query: 390 IARGLEYLHLGCSTRILHFDIKPHNILLDEDFCPKISDFGLAKICNRKESIISMTGARGT 449
           I    EYLH   S  +++ D+KP N+L+D+    +++DFG AK    +   +      GT
Sbjct: 143 IVLTFEYLH---SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLC-----GT 194
Query: 450 VGYIAPEVFCRNIGEVSYKSDVYNYGMMIFEMTGG 484
             Y+APE+        +   D +  G++I+EM  G
Sbjct: 195 PEYLAPEIILSK--GYNKAVDWWALGVLIYEMAAG 227

>pdb|2PML|X Chain X, Crystal Structure Of Pfpk7 In Complex With An Atp Analogue Length = 348

Iteration: 1
 Score = 47.4 bits (111), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 28/93 (30%), Positives = 48/93 (51%), Gaps = 6/93 (6%)
Query: 389 GIARGLEYLHLGCSTRILHFDIKPHNILLDEDFCPKISDFGLAKICNRKESIISMTGARG 448
            +     Y+H      I H D+KP NIL+D++   K+SDFG ++    K+    + G+RG
Sbjct: 159 SVLNSFSYIH--NEKNICHRDVKPSNILMDKNGRVKLSDFGESEYMVDKK----IKGSRG 212
Query: 449 TVGYIAPEVFCRNIGEVSYKSDVYNYGMMIFEM 481
           T  ++ PE F         K D+++ G+ ++ M
Sbjct: 213 TYEFMPPEFFSNESSYNGAKVDIWSLGICLYVM 245

>pdb|3KK8|A Chain A, Camkii Substrate Complex A Length = 284

Iteration: 1
 Score = 47.4 bits (111), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 55/198 (27%), Positives = 87/198 (43%), Gaps = 36/198 (18%)
Query: 318 KYKLGQGGYGSVYK-GKLLDGSNVAVKVLNDSKGNGKEF--INEVASISRT-SHVNVVAL 373
           K +LG+G +  V +      G   A K++N  K + ++F  +   A I R   H N+V L
Sbjct: 11  KEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRL 70
Query: 374 -----------LGFCLRVAEELSSTIG-------------IARGLEYLHLGCSTRILHFD 409
                      L F L    EL   I              I + LE +    S  I+H +
Sbjct: 71  HDSIQEESFHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQILESIAYCHSNGIVHRN 130
Query: 410 IKPHNILLD---EDFCPKISDFGLAKICNRKESIISMTGARGTVGYIAPEVFCRNIGEVS 466
           +KP N+LL    +    K++DFGLA   N  E+     G  GT GY++PEV  ++    S
Sbjct: 131 LKPENLLLASKAKGAAVKLADFGLAIEVNDSEA---WHGFAGTPGYLSPEVLKKD--PYS 185
Query: 467 YKSDVYNYGMMIFEMTGG 484
              D++  G++++ +  G
Sbjct: 186 KPVDIWACGVILYILLVG 203

>pdb|1RW8|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Atp Site Inhibitor Length = 301

Iteration: 1
 Score = 47.4 bits (111), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 47/203 (23%), Positives = 82/203 (40%), Gaps = 42/203 (20%)
Query: 321 LGQGGYGSVYKGKLLDGSNVAVKVLNDSKGNGKEFINEVASISRTSHVNVVALLG----- 375
           +G+G +G V++GK   G  VAVK+ +  +        E+       H N++  +      
Sbjct: 12  IGKGRFGEVWRGKW-RGEEVAVKIFSSREERSWFREAEIYQTVMLRHENILGFIAADNKD 70
Query: 376 -------------------------FCLRVAEELSSTIGIARGLEYLHL---GCSTR--I 405
                                    + + V   +   +  A GL +LH+   G   +  I
Sbjct: 71  NGTWTQLWLVSDYHEHGSLFDYLNRYTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAI 130
Query: 406 LHFDIKPHNILLDEDFCPKISDFGLAKICNRKESIISMTGAR--GTVGYIAPEVFCRNIG 463
            H D+K  NIL+ ++    I+D GLA   +     I +      GT  Y+APEV   +I 
Sbjct: 131 AHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSIN 190
Query: 464 EVSYKS----DVYNYGMMIFEMT 482
              ++S    D+Y  G++ +E+ 
Sbjct: 191 MKHFESFKRADIYAMGLVFWEIA 213

>pdb|2QR8|A Chain A, 2.0a X-ray Structure Of C-terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 (rsk2) Length = 342

Iteration: 1
 Score = 47.4 bits (111), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 35/99 (35%), Positives = 56/99 (56%), Gaps = 11/99 (11%)
Query: 390 IARGLEYLHLGCSTRILHFDIKPHNIL-LDEDFCP---KISDFGLAKICNRKESIISMTG 445
           I + +EYLH   +  ++H D+KP NIL +DE   P   +I DFG AK   R E+ + MT 
Sbjct: 125 ITKTVEYLH---AQGVVHRDLKPSNILYVDESGNPESIRICDFGFAKQL-RAENGLLMTP 180
Query: 446 ARGTVGYIAPEVFCRNIGEVSYKSDVYNYGMMIFEMTGG 484
              T  ++APEV  R   + +   D+++ G++++ M  G
Sbjct: 181 CY-TANFVAPEVLERQGYDAA--CDIWSLGVLLYTMLTG 216

>pdb|1PY5|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Inhibitor Length = 326

Iteration: 1
 Score = 47.4 bits (111), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 48/210 (22%), Positives = 84/210 (40%), Gaps = 42/210 (20%)
Query: 314 TNSFKYKLGQGGYGSVYKGKLLDGSNVAVKVLNDSKGNGKEFINEVASISRTSHVNVVAL 373
           T   +  +G+G +G V++GK   G  VAVK+ +  +        E+       H N++  
Sbjct: 30  TIVLQESIGKGRFGEVWRGKW-RGEEVAVKIFSSREERSWFREAEIYQTVMLRHENILGF 88
Query: 374 LG------------------------------FCLRVAEELSSTIGIARGLEYLHL---G 400
           +                               + + V   +   +  A GL +LH+   G
Sbjct: 89  IAADNKDNGTWTQLWLVSDYHEHGSLFDYLNRYTVTVEGMIKLALSTASGLAHLHMEIVG 148
Query: 401 CSTR--ILHFDIKPHNILLDEDFCPKISDFGLAKICNRKESIISMTGAR--GTVGYIAPE 456
              +  I H D+K  NIL+ ++    I+D GLA   +     I +      GT  Y+APE
Sbjct: 149 TQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPE 208
Query: 457 VFCRNIGEVSYKS----DVYNYGMMIFEMT 482
           V   +I    ++S    D+Y  G++ +E+ 
Sbjct: 209 VLDDSINMKHFESFKRADIYAMGLVFWEIA 238

>pdb|3KK9|A Chain A, Camkii Substrate Complex B Length = 282

Iteration: 1
 Score = 47.4 bits (111), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 55/198 (27%), Positives = 87/198 (43%), Gaps = 36/198 (18%)
Query: 318 KYKLGQGGYGSVYK-GKLLDGSNVAVKVLNDSKGNGKEF--INEVASISRT-SHVNVVAL 373
           K +LG+G +  V +      G   A K++N  K + ++F  +   A I R   H N+V L
Sbjct: 10  KEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRL 69
Query: 374 -----------LGFCLRVAEELSSTIG-------------IARGLEYLHLGCSTRILHFD 409
                      L F L    EL   I              I + LE +    S  I+H +
Sbjct: 70  HDSIQEESFHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQILESIAYCHSNGIVHRN 129
Query: 410 IKPHNILLD---EDFCPKISDFGLAKICNRKESIISMTGARGTVGYIAPEVFCRNIGEVS 466
           +KP N+LL    +    K++DFGLA   N  E+     G  GT GY++PEV  ++    S
Sbjct: 130 LKPENLLLASKAKGAAVKLADFGLAIEVNDSEA---WHGFAGTPGYLSPEVLKKD--PYS 184
Query: 467 YKSDVYNYGMMIFEMTGG 484
              D++  G++++ +  G
Sbjct: 185 KPVDIWACGVILYILLVG 202

>pdb|1VJY|A Chain A, Crystal Structure Of A Naphthyridine Inhibitor Of Human Tgf- Beta Type I Receptor Length = 303

Iteration: 1
 Score = 47.4 bits (111), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 47/203 (23%), Positives = 82/203 (40%), Gaps = 42/203 (20%)
Query: 321 LGQGGYGSVYKGKLLDGSNVAVKVLNDSKGNGKEFINEVASISRTSHVNVVALLG----- 375
           +G+G +G V++GK   G  VAVK+ +  +        E+       H N++  +      
Sbjct: 11  IGKGRFGEVWRGKW-RGEEVAVKIFSSREERSWFREAEIYQTVMLRHENILGFIAADNKD 69
Query: 376 -------------------------FCLRVAEELSSTIGIARGLEYLHL---GCSTR--I 405
                                    + + V   +   +  A GL +LH+   G   +  I
Sbjct: 70  NGTWTQLWLVSDYHEHGSLFDYLNRYTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAI 129
Query: 406 LHFDIKPHNILLDEDFCPKISDFGLAKICNRKESIISMTGAR--GTVGYIAPEVFCRNIG 463
            H D+K  NIL+ ++    I+D GLA   +     I +      GT  Y+APEV   +I 
Sbjct: 130 AHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSIN 189
Query: 464 EVSYKS----DVYNYGMMIFEMT 482
              ++S    D+Y  G++ +E+ 
Sbjct: 190 MKHFESFKRADIYAMGLVFWEIA 212

>pdb|3KL8|A Chain A, Camkiintide Inhibitor Complex Length = 269

Iteration: 1
 Score = 47.4 bits (111), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 55/198 (27%), Positives = 87/198 (43%), Gaps = 36/198 (18%)
Query: 318 KYKLGQGGYGSVYK-GKLLDGSNVAVKVLNDSKGNGKEF--INEVASISRT-SHVNVVAL 373
           K +LG+G +  V +      G   A K++N  K + ++F  +   A I R   H N+V L
Sbjct: 11  KEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRL 70
Query: 374 -----------LGFCLRVAEELSSTIG-------------IARGLEYLHLGCSTRILHFD 409
                      L F L    EL   I              I + LE +    S  I+H +
Sbjct: 71  HDSIQEESFHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQILESIAYCHSNGIVHRN 130
Query: 410 IKPHNILLD---EDFCPKISDFGLAKICNRKESIISMTGARGTVGYIAPEVFCRNIGEVS 466
           +KP N+LL    +    K++DFGLA   N  E+     G  GT GY++PEV  ++    S
Sbjct: 131 LKPENLLLASKAKGAAVKLADFGLAIEVNDSEA---WHGFAGTPGYLSPEVLKKD--PYS 185
Query: 467 YKSDVYNYGMMIFEMTGG 484
              D++  G++++ +  G
Sbjct: 186 KPVDIWACGVILYILLVG 203

>pdb|3IW4|A Chain A, Crystal Structure Of Pkc Alpha In Complex With Nvp-Aeb071 Length = 360

Iteration: 1
 Score = 47.0 bits (110), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 34/107 (31%), Positives = 53/107 (49%), Gaps = 13/107 (12%)
Query: 390 IARGLEYLHLGCSTRILHFDIKPHNILLDEDFCPKISDFGLAKICNRKESIISMTGAR-- 447
           I+ GL +LH      I++ D+K  N++LD +   KI+DFG+      KE ++     R  
Sbjct: 129 ISIGLFFLH---KRGIIYRDLKLDNVMLDSEGHIKIADFGMC-----KEHMMDGVTTREF 180
Query: 448 -GTVGYIAPEVFCRNIGEVSYKSDVYNYGMMIFEMTGGRKNVDVVDN 493
            GT  YIAPE+            D + YG++++EM  G+   D  D 
Sbjct: 181 CGTPDYIAPEIIAYQ--PYGKSVDWWAYGVLLYEMLAGQPPFDGEDE 225

>pdb|2BDW|A Chain A, Crystal Structure Of The Auto-Inhibited Kinase Domain Of CalciumCALMODULIN ACTIVATED KINASE II Length = 362

Iteration: 1
 Score = 47.0 bits (110), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 55/198 (27%), Positives = 87/198 (43%), Gaps = 36/198 (18%)
Query: 318 KYKLGQGGYGSVYK-GKLLDGSNVAVKVLNDSKGNGKEF--INEVASISRT-SHVNVVAL 373
           K +LG+G +  V +      G   A K++N  K + ++F  +   A I R   H N+V L
Sbjct: 34  KEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRL 93
Query: 374 -----------LGFCLRVAEELSSTIG-------------IARGLEYLHLGCSTRILHFD 409
                      L F L    EL   I              I + LE +    S  I+H +
Sbjct: 94  HDSIQEESFHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQILESIAYCHSNGIVHRN 153
Query: 410 IKPHNILLD---EDFCPKISDFGLAKICNRKESIISMTGARGTVGYIAPEVFCRNIGEVS 466
           +KP N+LL    +    K++DFGLA   N  E+     G  GT GY++PEV  ++    S
Sbjct: 154 LKPENLLLASKAKGAAVKLADFGLAIEVNDSEA---WHGFAGTPGYLSPEVLKKD--PYS 208
Query: 467 YKSDVYNYGMMIFEMTGG 484
              D++  G++++ +  G
Sbjct: 209 KPVDIWACGVILYILLVG 226

>pdb|2X0G|A Chain A, X-ray Structure Of A Dap-kinase Calmodulin Complex Length = 334

Iteration: 1
 Score = 47.0 bits (110), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 32/99 (32%), Positives = 53/99 (53%), Gaps = 12/99 (12%)
Query: 390 IARGLEYLHLGCSTRILHFDIKPHNILLDEDFCP----KISDFGLAKICNRKESIISMTG 445
           I  G+ YLH   S +I HFD+KP NI+L +   P    KI DFGLA   +      ++  
Sbjct: 123 ILNGVYYLH---SLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIF- 178
Query: 446 ARGTVGYIAPEVFCRNIGEVSYKSDVYNYGMMIFEMTGG 484
             GT  ++APE+   N   +  ++D+++ G++ + +  G
Sbjct: 179 --GTPEFVAPEIV--NYEPLGLEADMWSIGVITYILLSG 213

>pdb|2WOT|A Chain A, Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl)-3- Pyridyl)oxy)-N-(3,4,5-Trimethoxyphenyl)pyridin-2-Amine Length = 306

Iteration: 1
 Score = 47.0 bits (110), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 47/203 (23%), Positives = 82/203 (40%), Gaps = 42/203 (20%)
Query: 321 LGQGGYGSVYKGKLLDGSNVAVKVLNDSKGNGKEFINEVASISRTSHVNVVALLG----- 375
           +G+G +G V++GK   G  VAVK+ +  +        E+       H N++  +      
Sbjct: 14  IGKGRFGEVWRGKW-RGEEVAVKIFSSREERSWFREAEIYQTVMLRHENILGFIAADNKD 72
Query: 376 -------------------------FCLRVAEELSSTIGIARGLEYLHL---GCSTR--I 405
                                    + + V   +   +  A GL +LH+   G   +  I
Sbjct: 73  NGTWTQLWLVSDYHEHGSLFDYLNRYTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAI 132
Query: 406 LHFDIKPHNILLDEDFCPKISDFGLAKICNRKESIISMTGAR--GTVGYIAPEVFCRNIG 463
            H D+K  NIL+ ++    I+D GLA   +     I +      GT  Y+APEV   +I 
Sbjct: 133 AHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSIN 192
Query: 464 EVSYKS----DVYNYGMMIFEMT 482
              ++S    D+Y  G++ +E+ 
Sbjct: 193 MKHFESFKRADIYAMGLVFWEIA 215

>pdb|3TZM|A Chain A, Tgf-Beta Receptor Type 1 In Complex With Sb431542 Length = 309

Iteration: 1
 Score = 47.0 bits (110), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 47/203 (23%), Positives = 82/203 (40%), Gaps = 42/203 (20%)
Query: 321 LGQGGYGSVYKGKLLDGSNVAVKVLNDSKGNGKEFINEVASISRTSHVNVVALLG----- 375
           +G+G +G V++GK   G  VAVK+ +  +        E+       H N++  +      
Sbjct: 17  IGKGRFGEVWRGKW-RGEEVAVKIFSSREERSWFREAEIYQTVMLRHENILGFIAADNKD 75
Query: 376 -------------------------FCLRVAEELSSTIGIARGLEYLHL---GCSTR--I 405
                                    + + V   +   +  A GL +LH+   G   +  I
Sbjct: 76  NGTWTQLWLVSDYHEHGSLFDYLNRYTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAI 135
Query: 406 LHFDIKPHNILLDEDFCPKISDFGLAKICNRKESIISMTGAR--GTVGYIAPEVFCRNIG 463
            H D+K  NIL+ ++    I+D GLA   +     I +      GT  Y+APEV   +I 
Sbjct: 136 AHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSIN 195
Query: 464 EVSYKS----DVYNYGMMIFEMT 482
              ++S    D+Y  G++ +E+ 
Sbjct: 196 MKHFESFKRADIYAMGLVFWEIA 218

>pdb|3DLS|A Chain A, Crystal Structure Of Human Pas Kinase Bound To Adp Length = 335

Iteration: 1
 Score = 47.0 bits (110), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 51/179 (28%), Positives = 72/179 (40%), Gaps = 44/179 (24%)
Query: 321 LGQGGYGSVYKGKLLD-GSNVAVKVLNDSKGNGKEFIN---------EVASISRTSHVNV 370
           LG G +G V+     +    V VK +   K     +I          E+A +SR  H N+
Sbjct: 32  LGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVEHANI 91
Query: 371 VALL------GFCL--------------------RVAEELSSTI--GIARGLEYLHLGCS 402
           + +L      GF                      R+ E L+S I   +   + YL L   
Sbjct: 92  IKVLDIFENQGFFQLVMEKHGSGLDLFAFIDRHPRLDEPLASYIFRQLVSAVGYLRL--- 148
Query: 403 TRILHFDIKPHNILLDEDFCPKISDFGLAKICNRKESIISMTGARGTVGYIAPEVFCRN 461
             I+H DIK  NI++ EDF  K+ DFG A    R +   +     GT+ Y APEV   N
Sbjct: 149 KDIIHRDIKDENIVIAEDFTIKLIDFGSAAYLERGKLFYTFC---GTIEYCAPEVLMGN 204

>pdb|3H4J|B Chain B, Crystal Structure Of Pombe Ampk Kdaid Fragment Length = 336

Iteration: 1
 Score = 47.0 bits (110), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 32/97 (32%), Positives = 52/97 (53%), Gaps = 7/97 (7%)
Query: 393 GLEYLHLGCSTRILHFDIKPHNILLDEDFCPKISDFGLAKICNRKESIISMTGARGTVGY 452
            +EY H     +I+H D+KP N+LLD++   KI+DFGL+ I         +  + G+  Y
Sbjct: 120 AIEYCH---RHKIVHRDLKPENLLLDDNLNVKIADFGLSNIMTDGN---FLKTSCGSPNY 173
Query: 453 IAPEVFCRNIGEVSYKSDVYNYGMMIFEMTGGRKNVD 489
            APEV    +     + DV++ G++++ M  GR   D
Sbjct: 174 AAPEVINGKL-YAGPEVDVWSCGIVLYVMLVGRLPFD 209

>pdb|3KMW|A Chain A, Crystal Structure Of The IlkALPHA-Parvin Core Complex (Mgatp) Length = 271

Iteration: 1
 Score = 47.0 bits (110), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 47/238 (19%), Positives = 103/238 (43%), Gaps = 48/238 (20%)
Query: 304 RYGYADIKKMTNSFKYKLGQGGYGSVYKGKLLDGSNVAVKVL---NDSKGNGKEFINEVA 360
           ++   D K++  +F  KL +   G ++KG+   G+++ VKVL   + S    ++F  E  
Sbjct: 3   KHSGIDFKQL--NFLTKLNENHSGELWKGRW-QGNDIVVKVLKVRDWSTRKSRDFNEECP 59
Query: 361 SISRTSHVNVVALLG-------------------------------FCLRVAEELSSTIG 389
            +   SH NV+ +LG                               F +  ++ +   + 
Sbjct: 60  RLRIFSHPNVLPVLGACQSPPAPHPTLITHWMPYGSLYNVLHEGTNFVVDQSQAVKFALD 119
Query: 390 IARGLEYLHLGCSTRILHFDIKPHNILLDEDFCPKISDFGLAKICNRKESIISMTGARGT 449
           +ARG+ +LH      I    +   ++++DED   +IS      + + K S  S  G    
Sbjct: 120 MARGMAFLH-TLEPLIPRHALNSRSVMIDEDMTARIS------MADVKFSFQS-PGRMYA 171
Query: 450 VGYIAPEVFCRNIGEVSYKS-DVYNYGMMIFEMTGGRKNVDVVDNGSTALDLQASRKG 506
             ++APE   +   + + +S D++++ ++++E+    + V   D  +  + ++ + +G
Sbjct: 172 PAWVAPEALQKKPEDTNRRSADMWSFAVLLWELVT--REVPFADLSNMEIGMKVALEG 227

>pdb|1P4F|A Chain A, Death Associated Protein Kinase Catalytic Domain With Bound Inhibitor Fragment Length = 293

Iteration: 1
 Score = 46.6 bits (109), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 32/99 (32%), Positives = 53/99 (53%), Gaps = 12/99 (12%)
Query: 390 IARGLEYLHLGCSTRILHFDIKPHNILLDEDFCP----KISDFGLAKICNRKESIISMTG 445
           I  G+ YLH   S +I HFD+KP NI+L +   P    KI DFGLA   +      ++  
Sbjct: 122 ILNGVYYLH---SLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIF- 177
Query: 446 ARGTVGYIAPEVFCRNIGEVSYKSDVYNYGMMIFEMTGG 484
             GT  ++APE+   N   +  ++D+++ G++ + +  G
Sbjct: 178 --GTPEFVAPEIV--NYEPLGLEADMWSIGVITYILLSG 212

>pdb|1IG1|A Chain A, 1.8a X-Ray Structure Of Ternary Complex Of A Catalytic Domain Of Death-Associated Protein Kinase With Atp Analogue And Mn. Length = 294

Iteration: 1
 Score = 46.6 bits (109), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 32/99 (32%), Positives = 53/99 (53%), Gaps = 12/99 (12%)
Query: 390 IARGLEYLHLGCSTRILHFDIKPHNILLDEDFCP----KISDFGLAKICNRKESIISMTG 445
           I  G+ YLH   S +I HFD+KP NI+L +   P    KI DFGLA   +      ++  
Sbjct: 122 ILNGVYYLH---SLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIF- 177
Query: 446 ARGTVGYIAPEVFCRNIGEVSYKSDVYNYGMMIFEMTGG 484
             GT  ++APE+   N   +  ++D+++ G++ + +  G
Sbjct: 178 --GTPEFVAPEIV--NYEPLGLEADMWSIGVITYILLSG 212

>pdb|4DFY|A Chain A, Crystal Structure Of R194a Mutant Of Camp-Dependent Protein Kinase With Unphosphorylated Activation Loop Length = 371

Iteration: 1
 Score = 46.6 bits (109), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 31/99 (31%), Positives = 49/99 (49%), Gaps = 18/99 (18%)
Query: 390 IARGLEYLHLGCSTRILHFDIKPHNILLDEDFCPKISDFGLAKICNRKESIISMTGAR-- 447
           I    EYLH   S  +++ D+KP N+L+D+    +++DFG AK          + GA   
Sbjct: 171 IVLTFEYLH---SLDLIYRDLKPENLLIDQQGYIQVTDFGFAK---------RVKGATWT 218
Query: 448 --GTVGYIAPEVFCRNIGEVSYKSDVYNYGMMIFEMTGG 484
             GT  Y+APE+        +   D +  G++I+EM  G
Sbjct: 219 LCGTPEYLAPEIILSK--GYNKAVDWWALGVLIYEMAAG 255

>pdb|2XZS|A Chain A, Death Associated Protein Kinase 1 Residues 1-312 Length = 312

Iteration: 1
 Score = 46.6 bits (109), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 32/99 (32%), Positives = 53/99 (53%), Gaps = 12/99 (12%)
Query: 390 IARGLEYLHLGCSTRILHFDIKPHNILLDEDFCP----KISDFGLAKICNRKESIISMTG 445
           I  G+ YLH   S +I HFD+KP NI+L +   P    KI DFGLA   +      ++  
Sbjct: 123 ILNGVYYLH---SLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIF- 178
Query: 446 ARGTVGYIAPEVFCRNIGEVSYKSDVYNYGMMIFEMTGG 484
             GT  ++APE+   N   +  ++D+++ G++ + +  G
Sbjct: 179 --GTPEFVAPEIV--NYEPLGLEADMWSIGVITYILLSG 213

>pdb|1Q24|A Chain A, Pka Double Mutant Model Of Pkb In Complex With Mgatp Length = 350

Iteration: 1
 Score = 46.6 bits (109), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 28/95 (29%), Positives = 48/95 (50%), Gaps = 10/95 (10%)
Query: 390 IARGLEYLHLGCSTRILHFDIKPHNILLDEDFCPKISDFGLAKICNRKESIISMTGARGT 449
           I    EYLH   S  +++ D+KP N+++D+    +++DFG AK    +   +      GT
Sbjct: 150 IVLTFEYLH---SLDLIYRDLKPENLMIDQQGYIQVTDFGFAKRVKGRTWXLC-----GT 201
Query: 450 VGYIAPEVFCRNIGEVSYKSDVYNYGMMIFEMTGG 484
             Y+APE+        +   D +  G++I+EM  G
Sbjct: 202 PEYLAPEIILSK--GYNKAVDWWALGVLIYEMAAG 234

>pdb|3F5U|A Chain A, Crystal Structure Of The Death Associated Protein Kinase In Complex With Amppnp And Mg2+ Length = 295

Iteration: 1
 Score = 46.6 bits (109), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 32/99 (32%), Positives = 53/99 (53%), Gaps = 12/99 (12%)
Query: 390 IARGLEYLHLGCSTRILHFDIKPHNILLDEDFCP----KISDFGLAKICNRKESIISMTG 445
           I  G+ YLH   S +I HFD+KP NI+L +   P    KI DFGLA   +      ++  
Sbjct: 123 ILNGVYYLH---SLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIF- 178
Query: 446 ARGTVGYIAPEVFCRNIGEVSYKSDVYNYGMMIFEMTGG 484
             GT  ++APE+   N   +  ++D+++ G++ + +  G
Sbjct: 179 --GTPEFVAPEIV--NYEPLGLEADMWSIGVITYILLSG 213

>pdb|3GU8|A Chain A, Crystal Structure Of Dapkl93g With N6-Cyclopentyladenosine Length = 295

Iteration: 1
 Score = 46.6 bits (109), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 32/99 (32%), Positives = 53/99 (53%), Gaps = 12/99 (12%)
Query: 390 IARGLEYLHLGCSTRILHFDIKPHNILLDEDFCP----KISDFGLAKICNRKESIISMTG 445
           I  G+ YLH   S +I HFD+KP NI+L +   P    KI DFGLA   +      ++  
Sbjct: 123 ILNGVYYLH---SLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIF- 178
Query: 446 ARGTVGYIAPEVFCRNIGEVSYKSDVYNYGMMIFEMTGG 484
             GT  ++APE+   N   +  ++D+++ G++ + +  G
Sbjct: 179 --GTPEFVAPEIV--NYEPLGLEADMWSIGVITYILLSG 213

>pdb|3GU4|A Chain A, Crystal Structure Of Dapkq23v-Amppnp Length = 295

Iteration: 1
 Score = 46.6 bits (109), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 32/99 (32%), Positives = 53/99 (53%), Gaps = 12/99 (12%)
Query: 390 IARGLEYLHLGCSTRILHFDIKPHNILLDEDFCP----KISDFGLAKICNRKESIISMTG 445
           I  G+ YLH   S +I HFD+KP NI+L +   P    KI DFGLA   +      ++  
Sbjct: 123 ILNGVYYLH---SLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIF- 178
Query: 446 ARGTVGYIAPEVFCRNIGEVSYKSDVYNYGMMIFEMTGG 484
             GT  ++APE+   N   +  ++D+++ G++ + +  G
Sbjct: 179 --GTPEFVAPEIV--NYEPLGLEADMWSIGVITYILLSG 213

>pdb|3S95|A Chain A, Crystal Structure Of The Human Limk1 Kinase Domain In Complex With Staurosporine Length = 310

Iteration: 1
 Score = 46.6 bits (109), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 50/211 (23%), Positives = 88/211 (41%), Gaps = 48/211 (22%)
Query: 321 LGQGGYGSVYKGKLLDGSNVAV--KVLNDSKGNGKEFINEVASISRTSHVNVVALLGFCL 378
           LG+G +G   K    +   V V  +++   +   + F+ EV  +    H NV+  +G   
Sbjct: 18  LGKGCFGQAIKVTHRETGEVMVMKELIRFDEETQRTFLKEVKVMRCLEHPNVLKFIGVLY 77
Query: 379 R----------------------------VAEELSSTIGIARGLEYLHLGCSTRILHFDI 410
           +                             ++ +S    IA G+ YLH   S  I+H D+
Sbjct: 78  KDKRLNFITEYIKGGTLRGIIKSMDSQYPWSQRVSFAKDIASGMAYLH---SMNIIHRDL 134
Query: 411 KPHNILLDEDFCPKISDFGLAKIC----NRKESIISMTGAR--------GTVGYIAPEVF 458
             HN L+ E+    ++DFGLA++      + E + S+            G   ++APE+ 
Sbjct: 135 NSHNCLVRENKNVVVADFGLARLMVDEKTQPEGLRSLKKPDRKKRYTVVGNPYWMAPEMI 194
Query: 459 CRNIGEVSYKSDVYNYGMMIFEMTGGRKNVD 489
             N      K DV+++G+++ E+  GR N D
Sbjct: 195 --NGRSYDEKVDVFSFGIVLCEII-GRVNAD 222

>pdb|2W4K|A Chain A, X-Ray Structure Of A Dap-Kinase 2-302 Length = 302

Iteration: 1
 Score = 46.6 bits (109), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 32/99 (32%), Positives = 53/99 (53%), Gaps = 12/99 (12%)
Query: 390 IARGLEYLHLGCSTRILHFDIKPHNILLDEDFCP----KISDFGLAKICNRKESIISMTG 445
           I  G+ YLH   S +I HFD+KP NI+L +   P    KI DFGLA   +      ++  
Sbjct: 123 ILNGVYYLH---SLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIF- 178
Query: 446 ARGTVGYIAPEVFCRNIGEVSYKSDVYNYGMMIFEMTGG 484
             GT  ++APE+   N   +  ++D+++ G++ + +  G
Sbjct: 179 --GTPEFVAPEIV--NYEPLGLEADMWSIGVITYILLSG 213

>pdb|3DFC|B Chain B, Crystal Structure Of A Glycine-Rich Loop Mutant Of The Death Associated Protein Kinase Catalytic Domain With Amppnp Length = 295

Iteration: 1
 Score = 46.6 bits (109), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 32/99 (32%), Positives = 53/99 (53%), Gaps = 12/99 (12%)
Query: 390 IARGLEYLHLGCSTRILHFDIKPHNILLDEDFCP----KISDFGLAKICNRKESIISMTG 445
           I  G+ YLH   S +I HFD+KP NI+L +   P    KI DFGLA   +      ++  
Sbjct: 123 ILNGVYYLH---SLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIF- 178
Query: 446 ARGTVGYIAPEVFCRNIGEVSYKSDVYNYGMMIFEMTGG 484
             GT  ++APE+   N   +  ++D+++ G++ + +  G
Sbjct: 179 --GTPEFVAPEIV--NYEPLGLEADMWSIGVITYILLSG 213

>pdb|2Y0A|A Chain A, Structure Of Dapk1 Construct Residues 1-304 Length = 326

Iteration: 1
 Score = 46.6 bits (109), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 32/99 (32%), Positives = 53/99 (53%), Gaps = 12/99 (12%)
Query: 390 IARGLEYLHLGCSTRILHFDIKPHNILLDEDFCP----KISDFGLAKICNRKESIISMTG 445
           I  G+ YLH   S +I HFD+KP NI+L +   P    KI DFGLA   +      ++  
Sbjct: 123 ILNGVYYLH---SLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIF- 178
Query: 446 ARGTVGYIAPEVFCRNIGEVSYKSDVYNYGMMIFEMTGG 484
             GT  ++APE+   N   +  ++D+++ G++ + +  G
Sbjct: 179 --GTPEFVAPEIV--NYEPLGLEADMWSIGVITYILLSG 213

>pdb|3O7L|B Chain B, Crystal Structure Of Phospholamban (1-19):pka C-Subunit:amp-Pnp:mg2+ Complex Length = 350

Iteration: 1
 Score = 46.6 bits (109), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 28/95 (29%), Positives = 48/95 (50%), Gaps = 10/95 (10%)
Query: 390 IARGLEYLHLGCSTRILHFDIKPHNILLDEDFCPKISDFGLAKICNRKESIISMTGARGT 449
           I    EYLH   S  +++ D+KP N+++D+    +++DFG AK    +   +      GT
Sbjct: 150 IVLTFEYLH---SLDLIYRDLKPENLIIDQQGYIQVTDFGFAKRVKGRTWXLC-----GT 201
Query: 450 VGYIAPEVFCRNIGEVSYKSDVYNYGMMIFEMTGG 484
             Y+APE+        +   D +  G++I+EM  G
Sbjct: 202 PEYLAPEIIISK--GYNKAVDWWALGVLIYEMAAG 234

>pdb|2YAK|A Chain A, Structure Of Death-Associated Protein Kinase 1 (Dapk1) In Complex With A Ruthenium Octasporine Ligand (Osv) Length = 285

Iteration: 1
 Score = 46.6 bits (109), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 32/99 (32%), Positives = 53/99 (53%), Gaps = 12/99 (12%)
Query: 390 IARGLEYLHLGCSTRILHFDIKPHNILLDEDFCP----KISDFGLAKICNRKESIISMTG 445
           I  G+ YLH   S +I HFD+KP NI+L +   P    KI DFGLA   +      ++  
Sbjct: 123 ILNGVYYLH---SLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIF- 178
Query: 446 ARGTVGYIAPEVFCRNIGEVSYKSDVYNYGMMIFEMTGG 484
             GT  ++APE+   N   +  ++D+++ G++ + +  G
Sbjct: 179 --GTPEFVAPEIV--NYEPLGLEADMWSIGVITYILLSG 213

>pdb|2QNJ|A Chain A, Kinase And Ubiquitin-Associated Domains Of Mark3PAR-1 Length = 328

Iteration: 1
 Score = 46.6 bits (109), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 45/195 (23%), Positives = 83/195 (42%), Gaps = 38/195 (19%)
Query: 321 LGQGGYGSVYKGK-LLDGSNVAVKVLNDSKGNG---KEFINEVASISRTSHVNVVALLGF 376
           +G+G +  V   + +L G  VA+K+++ ++ N    ++   EV  +   +H N+V L   
Sbjct: 20  IGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVKLFEV 79
Query: 377 C---------------------------LRVAEELSSTIGIARGLEYLHLGCSTRILHFD 409
                                       ++  E  S    I   ++Y H     RI+H D
Sbjct: 80  IETEKTLYLIMEYASGGEVFDYLVAHGRMKEKEARSKFRQIVSAVQYCH---QKRIVHRD 136
Query: 410 IKPHNILLDEDFCPKISDFGLAKICNRKESIISMTGARGTVGYIAPEVFCRNIGEVSYKS 469
           +K  N+LLD D   KI+DFG +        + +     G+  Y APE+F     +   + 
Sbjct: 137 LKAENLLLDADMNIKIADFGFSNEFTVGGKLDTFC---GSPPYAAPELFQGKKYD-GPEV 192
Query: 470 DVYNYGMMIFEMTGG 484
           DV++ G++++ +  G
Sbjct: 193 DVWSLGVILYTLVSG 207

>pdb|2W4J|A Chain A, X-Ray Structure Of A Dap-Kinase 2-277 Length = 277

Iteration: 1
 Score = 46.6 bits (109), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 32/99 (32%), Positives = 53/99 (53%), Gaps = 12/99 (12%)
Query: 390 IARGLEYLHLGCSTRILHFDIKPHNILLDEDFCP----KISDFGLAKICNRKESIISMTG 445
           I  G+ YLH   S +I HFD+KP NI+L +   P    KI DFGLA   +      ++  
Sbjct: 123 ILNGVYYLH---SLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIF- 178
Query: 446 ARGTVGYIAPEVFCRNIGEVSYKSDVYNYGMMIFEMTGG 484
             GT  ++APE+   N   +  ++D+++ G++ + +  G
Sbjct: 179 --GTPEFVAPEIV--NYEPLGLEADMWSIGVITYILLSG 213

>pdb|1WVW|A Chain A, Crystal Structures Of Kinase Domain Of Dap Kinase In Complex With Small Molecular Inhibitors Length = 278

Iteration: 1
 Score = 46.6 bits (109), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 32/99 (32%), Positives = 53/99 (53%), Gaps = 12/99 (12%)
Query: 390 IARGLEYLHLGCSTRILHFDIKPHNILLDEDFCP----KISDFGLAKICNRKESIISMTG 445
           I  G+ YLH   S +I HFD+KP NI+L +   P    KI DFGLA   +      ++  
Sbjct: 123 ILNGVYYLH---SLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIF- 178
Query: 446 ARGTVGYIAPEVFCRNIGEVSYKSDVYNYGMMIFEMTGG 484
             GT  ++APE+   N   +  ++D+++ G++ + +  G
Sbjct: 179 --GTPEFVAPEIV--NYEPLGLEADMWSIGVITYILLSG 213

>pdb|1SYK|A Chain A, Crystal Structure Of E230q Mutant Of Camp-Dependent Protein Kinase Reveals Unexpected Apoenzyme Conformation Length = 350

Iteration: 1
 Score = 46.6 bits (109), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 28/95 (29%), Positives = 48/95 (50%), Gaps = 10/95 (10%)
Query: 390 IARGLEYLHLGCSTRILHFDIKPHNILLDEDFCPKISDFGLAKICNRKESIISMTGARGT 449
           I    EYLH   S  +++ D+KP N+L+D+    +++DFG AK    +   +      GT
Sbjct: 150 IVLTFEYLH---SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLC-----GT 201
Query: 450 VGYIAPEVFCRNIGEVSYKSDVYNYGMMIFEMTGG 484
             Y+APE+        +   D +  G++I++M  G
Sbjct: 202 PEYLAPEIILSK--GYNKAVDWWALGVLIYQMAAG 234

>pdb|4ASZ|A Chain A, Crystal Structure Of Apo Trkb Kinase Domain Length = 299

Iteration: 1
 Score = 46.6 bits (109), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 48/219 (21%), Positives = 84/219 (38%), Gaps = 52/219 (23%)
Query: 310 IKKMTNSFKYKLGQGGYGSVYKGKLL------DGSNVAVKVLNDSKGNG-KEFINEVASI 362
           IK+     K +LG+G +G V+  +        D   VAVK L D+  N  K+F  E   +
Sbjct: 10  IKRHNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELL 69
Query: 363 SRTSHVNVVALLGFC----------------------------------------LRVAE 382
           +   H ++V   G C                                        L  ++
Sbjct: 70  TNLQHEHIVKFYGVCVEGDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNPPTELTQSQ 129
Query: 383 ELSSTIGIARGLEYLHLGCSTRILHFDIKPHNILLDEDFCPKISDFGLAKICNRKESIIS 442
            L     IA G+ YL    S   +H D+   N L+ E+   KI DFG+++     +    
Sbjct: 130 MLHIAQQIAAGMVYL---ASQHFVHRDLATRNCLVGENLLVKIGDFGMSRDVYSTDYYRV 186
Query: 443 MTGARGTVGYIAPEVFCRNIGEVSYKSDVYNYGMMIFEM 481
                  + ++ PE       + + +SDV++ G++++E+
Sbjct: 187 GGHTMLPIRWMPPESIMYR--KFTTESDVWSLGVVLWEI 223

>pdb|2H34|A Chain A, Apoenzyme Crystal Structure Of The Tuberculosis SerineTHREONINE Kinase, Pkne Length = 309

Iteration: 1
 Score = 46.2 bits (108), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 26/78 (33%), Positives = 42/78 (53%), Gaps = 4/78 (5%)
Query: 407 HFDIKPHNILLDEDFCPKISDFGLAKICNRKESIISMTGARGTVGYIAPEVFCRNIGEVS 466
           H D+KP NIL+  D    + DFG+A      E +  +    GT+ Y APE F  +    +
Sbjct: 157 HRDVKPENILVSADDFAYLVDFGIASATT-DEKLTQLGNTVGTLYYXAPERFSES--HAT 213
Query: 467 YKSDVYNYGMMIFE-MTG 483
           Y++D+Y    +++E +TG
Sbjct: 214 YRADIYALTCVLYECLTG 231

>pdb|1QL6|A Chain A, The Catalytic Mechanism Of Phosphorylase Kinase Probed By Mutational Studies Length = 298

Iteration: 1
 Score = 46.2 bits (108), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 28/84 (33%), Positives = 48/84 (57%), Gaps = 7/84 (8%)
Query: 405 ILHFDIKPHNILLDEDFCPKISDFGLAKICNRKESIISMTGARGTVGYIAPEVF--CRNI 462
           I+H D+KP NILLD+D   K++DFG +   +  E + S+    GT  Y+APE+     N 
Sbjct: 145 IVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGEKLRSVC---GTPSYLAPEIIECSMND 201
Query: 463 GEVSY--KSDVYNYGMMIFEMTGG 484
               Y  + D+++ G++++ +  G
Sbjct: 202 NHPGYGKEVDMWSTGVIMYTLLAG 225

>pdb|2WTK|C Chain C, Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo25alpha Complex Length = 305

Iteration: 1
 Score = 46.2 bits (108), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 49/202 (24%), Positives = 87/202 (43%), Gaps = 43/202 (21%)
Query: 321 LGQGGYGSVYKGKLLDGSNVAVKVLNDSKG-------NGKEFIN-EVASISRTSHVNVVA 372
           LG+G YG V   ++LD   +  + +   K        NG+  +  E+  + R  H NV+ 
Sbjct: 13  LGEGSYGKV--KEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNVIQ 70
Query: 373 L---------------LGFCLRVAEELSSTIGIAR---------------GLEYLHLGCS 402
           L               + +C+   +E+  ++   R               GLEYLH   S
Sbjct: 71  LVDVLYNEEKQKMYMVMEYCVCGMQEMLDSVPEKRFPVCQAHGYFCQLIDGLEYLH---S 127
Query: 403 TRILHFDIKPHNILLDEDFCPKISDFGLAKICNRKESIISMTGARGTVGYIAPEVFCRNI 462
             I+H DIKP N+LL      KIS  G+A+  +   +  +   ++G+  +  PE+     
Sbjct: 128 QGIVHKDIKPGNLLLTTGGTLKISALGVAEALHPFAADDTCRTSQGSPAFQPPEIANGLD 187
Query: 463 GEVSYKSDVYNYGMMIFEMTGG 484
               +K D+++ G+ ++ +T G
Sbjct: 188 TFSGFKVDIWSAGVTLYNITTG 209

>pdb|1H4L|A Chain A, Structure And Regulation Of The Cdk5-P25(Nck5a) Complex Length = 292

Iteration: 1
 Score = 46.2 bits (108), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 36/144 (25%), Positives = 65/144 (45%), Gaps = 34/144 (23%)
Query: 320 KLGQGGYGSVYKGKLLDGSNVA----VKVLNDSKGNGKEFINEVASISRTSHVNVVAL-- 373
           K+G+G YG+V+K K  +   +     V++ +D +G     + E+  +    H N+V L  
Sbjct: 9   KIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHD 68
Query: 374 -----------LGFCLRVAEEL--------------SSTIGIARGLEYLHLGCSTRILHF 408
                        FC +  ++               S    + +GL + H   S  +LH 
Sbjct: 69  VLHSDKKLTLVFEFCDQDLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCH---SRNVLHR 125
Query: 409 DIKPHNILLDEDFCPKISDFGLAK 432
           D+KP N+L++ +   K++DFGLA+
Sbjct: 126 DLKPQNLLINRNGELKLADFGLAR 149

>pdb|1ZMW|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: T208aS212A INACTIVE DOUBLE MUTANT Length = 327

Iteration: 1
 Score = 46.2 bits (108), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 45/195 (23%), Positives = 82/195 (42%), Gaps = 38/195 (19%)
Query: 321 LGQGGYGSVYKGK-LLDGSNVAVKVLNDSKGNG---KEFINEVASISRTSHVNVVALLGF 376
           +G+G +  V   + +L G  VAVK+++ ++ N    ++   EV  +   +H N+V L   
Sbjct: 22  IGKGNFAKVKLARHILTGKEVAVKIIDKTQLNSSSLQKLFREVRIMKVLNHPNIVKLFEV 81
Query: 377 C---------------------------LRVAEELSSTIGIARGLEYLHLGCSTRILHFD 409
                                       ++  E  +    I   ++Y H      I+H D
Sbjct: 82  IETEKTLYLVMEYASGGEVFDYLVAHGRMKEKEARAKFRQIVSAVQYCH---QKFIVHRD 138
Query: 410 IKPHNILLDEDFCPKISDFGLAKICNRKESIISMTGARGTVGYIAPEVFCRNIGEVSYKS 469
           +K  N+LLD D   KI+DFG +        + +  GA     Y APE+F     +   + 
Sbjct: 139 LKAENLLLDADMNIKIADFGFSNEFTFGNKLDAFCGAP---PYAAPELFQGKKYD-GPEV 194
Query: 470 DVYNYGMMIFEMTGG 484
           DV++ G++++ +  G
Sbjct: 195 DVWSLGVILYTLVSG 209

>pdb|4AGU|A Chain A, Crystal Structure Of The Human Cdkl1 Kinase Domain Length = 311

Iteration: 1
 Score = 46.2 bits (108), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 50/196 (25%), Positives = 82/196 (41%), Gaps = 37/196 (18%)
Query: 320 KLGQGGYGSVYKGKLLD-GSNVAVKVLNDSKGN---GKEFINEVASISRTSHVNVVALLG 375
           K+G+G YG V+K +  D G  VA+K   +S+ +    K  + E+  + +  H N+V LL 
Sbjct: 10  KIGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVIKKIALREIRMLKQLKHPNLVNLLE 69
Query: 376 FCLR-------------------------VAEELSSTIGIARGLEYLHLGCSTRILHFDI 410
              R                         V E L  +I   + L+ ++       +H D+
Sbjct: 70  VFRRKRRLHLVFEYCDHTVLHELDRYQRGVPEHLVKSI-TWQTLQAVNFCHKHNCIHRDV 128
Query: 411 KPHNILLDEDFCPKISDFGLAKICNRKESIISMTGARGTVGYIAPEVFCRNIGEVSY--K 468
           KP NIL+ +    K+ DFG A++            A  T  Y +PE+    +G+  Y   
Sbjct: 129 KPENILITKHSVIKLCDFGFARLLTGPSDYYDDEVA--TRWYRSPELL---VGDTQYGPP 183
Query: 469 SDVYNYGMMIFEMTGG 484
            DV+  G +  E+  G
Sbjct: 184 VDVWAIGCVFAELLSG 199

>pdb|3VUH|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M3 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 46.2 bits (108), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 35/94 (37%), Positives = 50/94 (53%), Gaps = 12/94 (12%)
Query: 393 GLEYLHLGCSTRILHFDIKPHNILLDEDFCPKISDFGLAKICNRKESIISMTGARGTVGY 452
           G+++LH   S  I+H D+KP NI++  D   KI DFGLA+      +   MT    T  Y
Sbjct: 138 GIKHLH---SAGIIHRDLKPSNIVVKSDATLKILDFGLARTAG---TSFMMTPYVVTRYY 191
Query: 453 IAPEVFCRNIGEVSYKS--DVYNYGMMIFEMTGG 484
            APEV    I  + YK   D+++ G ++ EM  G
Sbjct: 192 RAPEV----ILGMGYKENVDIWSVGCIMGEMIKG 221

>pdb|3VUI|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 45.8 bits (107), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 35/94 (37%), Positives = 50/94 (53%), Gaps = 12/94 (12%)
Query: 393 GLEYLHLGCSTRILHFDIKPHNILLDEDFCPKISDFGLAKICNRKESIISMTGARGTVGY 452
           G+++LH   S  I+H D+KP NI++  D   KI DFGLA+      +   MT    T  Y
Sbjct: 138 GIKHLH---SAGIIHRDLKPSNIVVKSDATLKILDFGLARTAG---TSFMMTPYVVTRYY 191
Query: 453 IAPEVFCRNIGEVSYKS--DVYNYGMMIFEMTGG 484
            APEV    I  + YK   D+++ G ++ EM  G
Sbjct: 192 RAPEV----ILGMGYKENVDIWSVGCIMGEMIKG 221

>pdb|3V3V|A Chain A, Structural And Functional Analysis Of Quercetagetin, A Natural Jnk1 Inhibitor Length = 379

Iteration: 1
 Score = 45.8 bits (107), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 35/94 (37%), Positives = 50/94 (53%), Gaps = 12/94 (12%)
Query: 393 GLEYLHLGCSTRILHFDIKPHNILLDEDFCPKISDFGLAKICNRKESIISMTGARGTVGY 452
           G+++LH   S  I+H D+KP NI++  D   KI DFGLA+      +   MT    T  Y
Sbjct: 138 GIKHLH---SAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAG---TSFMMTPEVVTRYY 191
Query: 453 IAPEVFCRNIGEVSYKS--DVYNYGMMIFEMTGG 484
            APEV    I  + YK   D+++ G ++ EM  G
Sbjct: 192 RAPEV----ILGMGYKENVDIWSVGCIMGEMIKG 221

>pdb|3HYH|A Chain A, Crystal Structure Of The Protein Kinase Domain Of Yeast Amp-Activated Protein Kinase Snf1 Length = 275

Iteration: 1
 Score = 45.8 bits (107), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 31/92 (33%), Positives = 49/92 (53%), Gaps = 7/92 (7%)
Query: 390 IARGLEYLHLGCSTRILHFDIKPHNILLDEDFCPKISDFGLAKICNRKESIISMTGARGT 449
           I   +EY H     +I+H D+KP N+LLDE    KI+DFGL+ I         +  + G+
Sbjct: 121 IISAVEYCH---RHKIVHRDLKPENLLLDEHLNVKIADFGLSNIMTDGN---FLKTSCGS 174
Query: 450 VGYIAPEVFCRNIGEVSYKSDVYNYGMMIFEM 481
             Y APEV    +     + DV++ G++++ M
Sbjct: 175 PNYAAPEVISGKL-YAGPEVDVWSCGVILYVM 205

>pdb|3VUK|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M5 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 45.8 bits (107), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 35/94 (37%), Positives = 50/94 (53%), Gaps = 12/94 (12%)
Query: 393 GLEYLHLGCSTRILHFDIKPHNILLDEDFCPKISDFGLAKICNRKESIISMTGARGTVGY 452
           G+++LH   S  I+H D+KP NI++  D   KI DFGLA+      +   MT    T  Y
Sbjct: 138 GIKHLH---SAGIIHRDLKPSNIVVKSDATLKILDFGLARTAG---TSFMMTPYVVTRYY 191
Query: 453 IAPEVFCRNIGEVSYKS--DVYNYGMMIFEMTGG 484
            APEV    I  + YK   D+++ G ++ EM  G
Sbjct: 192 RAPEV----ILGMGYKENVDIWSVGCIMGEMIKG 221

>pdb|4AN2|A Chain A, Crystal Structures Of Human Mek1 With Carboxamide-Based Allosteric Inhibitor Xl518 (Gdc-0973), Or Related Analogs. Length = 301

Iteration: 1
 Score = 45.8 bits (107), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 35/110 (31%), Positives = 57/110 (51%), Gaps = 12/110 (10%)
Query: 379 RVAEELSSTIGIA--RGLEYLHLGCSTRILHFDIKPHNILLDEDFCPKISDFGLAKICNR 436
           R+ E++   + IA  +GL YL      +I+H D+KP NIL++     K+ DFG++     
Sbjct: 103 RIPEQILGKVSIAVIKGLTYLR--EKHKIMHRDVKPSNILVNSRGEIKLCDFGVS----- 155
Query: 437 KESIISMTGA-RGTVGYIAPEVFCRNIGEVSYKSDVYNYGMMIFEMTGGR 485
            + I  M     GT  Y++PE         S +SD+++ G+ + EM  GR
Sbjct: 156 GQLIDEMANEFVGTRSYMSPERLQGT--HYSVQSDIWSMGLSLVEMAVGR 203

>pdb|3DAE|A Chain A, Crystal Structure Of Phosphorylated Snf1 Kinase Domain Length = 283

Iteration: 1
 Score = 45.8 bits (107), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 31/92 (33%), Positives = 49/92 (53%), Gaps = 7/92 (7%)
Query: 390 IARGLEYLHLGCSTRILHFDIKPHNILLDEDFCPKISDFGLAKICNRKESIISMTGARGT 449
           I   +EY H     +I+H D+KP N+LLDE    KI+DFGL+ I         +  + G+
Sbjct: 122 IISAVEYCH---RHKIVHRDLKPENLLLDEHLNVKIADFGLSNIMTDGN---FLKTSCGS 175
Query: 450 VGYIAPEVFCRNIGEVSYKSDVYNYGMMIFEM 481
             Y APEV    +     + DV++ G++++ M
Sbjct: 176 PNYAAPEVISGKL-YAGPEVDVWSCGVILYVM 206

>pdb|2FH9|A Chain A, Structure And Dimerization Of The Kinase Domain From Yeast Snf1 Length = 274

Iteration: 1
 Score = 45.8 bits (107), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 31/92 (33%), Positives = 49/92 (53%), Gaps = 7/92 (7%)
Query: 390 IARGLEYLHLGCSTRILHFDIKPHNILLDEDFCPKISDFGLAKICNRKESIISMTGARGT 449
           I   +EY H     +I+H D+KP N+LLDE    KI+DFGL+ I         +  + G+
Sbjct: 116 IISAVEYCH---RHKIVHRDLKPENLLLDEHLNVKIADFGLSNIMTDGN---FLKTSCGS 169
Query: 450 VGYIAPEVFCRNIGEVSYKSDVYNYGMMIFEM 481
             Y APEV    +     + DV++ G++++ M
Sbjct: 170 PNYAAPEVISGKL-YAGPEVDVWSCGVILYVM 200

>pdb|3MN3|A Chain A, An Inhibited Conformation For The Protein Kinase Domain Of The Saccharomyces Cerevisiae Ampk Homolog Snf1 Length = 271

Iteration: 1
 Score = 45.8 bits (107), Expect = 6e-05,   Method: Compositional matrix adjust.
 Identities = 33/100 (33%), Positives = 51/100 (51%), Gaps = 7/100 (7%)
Query: 390 IARGLEYLHLGCSTRILHFDIKPHNILLDEDFCPKISDFGLAKICNRKESIISMTGARGT 449
           I   +EY H     +I+H D+KP N+LLDE    KI+DFGL+ I         +  + G+
Sbjct: 112 IISAVEYCH---RHKIVHRDLKPENLLLDEHLNVKIADFGLSNIMTDGN---FLKTSCGS 165
Query: 450 VGYIAPEVFCRNIGEVSYKSDVYNYGMMIFEMTGGRKNVD 489
             Y APEV    +     + DV++ G++++ M   R   D
Sbjct: 166 PNYAAPEVISGKL-YAGPEVDVWSCGVILYVMLCRRLPFD 204

>pdb|2IWI|A Chain A, Crystal Structure Of The Human Pim2 In Complex With A Ruthenium Organometallic Ligand Ru1 Length = 312

Iteration: 1
 Score = 45.4 bits (106), Expect = 7e-05,   Method: Compositional matrix adjust.
 Identities = 54/202 (26%), Positives = 88/202 (43%), Gaps = 43/202 (21%)
Query: 321 LGQGGYGSVYKG-KLLDGSNVAVKVLNDSKGNGKEFIN-------EVASISRTS----HV 368
           LG+GG+G+V+ G +L D   VA+KV+  ++  G   ++       EVA + +      H 
Sbjct: 39  LGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGHP 98
Query: 369 NVVALL-------GFCLRVAEELSSTIGIARGLEYLHLG-----------------CSTR 404
            V+ LL       GF L +   L +        E   LG                 C +R
Sbjct: 99  GVIRLLDWFETQEGFMLVLERPLPAQDLFDYITEKGPLGEGPSRCFFGQVVAAIQHCHSR 158
Query: 405 -ILHFDIKPHNILLD-EDFCPKISDFGLAKICNRKESIISMTGARGTVGYIAPEVFCRNI 462
            ++H DIK  NIL+D    C K+ DFG   + + +      T   GT  Y  PE   R+ 
Sbjct: 159 GVVHRDIKDENILIDLRRGCAKLIDFGSGALLHDE----PYTDFDGTRVYSPPEWISRHQ 214
Query: 463 GEVSYKSDVYNYGMMIFEMTGG 484
              +  + V++ G+++++M  G
Sbjct: 215 YH-ALPATVWSLGILLYDMVCG 235

>pdb|1KOB|A Chain A, Twitchin Kinase Fragment (Aplysia), Autoregulated Protein Kinase Domain Length = 387

Iteration: 1
 Score = 45.4 bits (106), Expect = 7e-05,   Method: Compositional matrix adjust.
 Identities = 39/142 (27%), Positives = 69/142 (48%), Gaps = 10/142 (7%)
Query: 345 LNDSKGNGKEFINEVASISRTSHVNVVALLGFCLRVAEELSSTIGIARGLEYLHLGCSTR 404
           L+D+  +  E +  +  +S     + +A   + +  AE ++       GL+++H      
Sbjct: 113 LHDAFEDKYEMVLILEFLSGGELFDRIAAEDYKMSEAEVINYMRQACEGLKHMH---EHS 169
Query: 405 ILHFDIKPHNILLDEDFCP--KISDFGLAKICNRKESIISMTGARGTVGYIAPEVFCRNI 462
           I+H DIKP NI+ +       KI DFGLA   N  E I+ +T A  T  + APE+  R  
Sbjct: 170 IVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDE-IVKVTTA--TAEFAAPEIVDRE- 225
Query: 463 GEVSYKSDVYNYGMMIFEMTGG 484
             V + +D++  G++ + +  G
Sbjct: 226 -PVGFYTDMWAIGVLGYVLLSG 246

>pdb|2I6L|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 6 (Mapk6) Length = 320

Iteration: 1
 Score = 45.4 bits (106), Expect = 7e-05,   Method: Compositional matrix adjust.
 Identities = 36/112 (32%), Positives = 55/112 (49%), Gaps = 15/112 (13%)
Query: 335 LDGSNVAVKVLNDSKGNGKEFINEVASISRTSHVNVVAL-----LGFCLRVAEELSS--- 386
           LD  N+ VKV      +G +  ++V S++  + V +V       L   L     L     
Sbjct: 65  LDHDNI-VKVFEILGPSGSQLTDDVGSLTELNSVYIVQEYMETDLANVLEQGPLLEEHAR 123
Query: 387 --TIGIARGLEYLHLGCSTRILHFDIKPHNILLD-EDFCPKISDFGLAKICN 435
                + RGL+Y+H   S  +LH D+KP N+ ++ ED   KI DFGLA+I +
Sbjct: 124 LFMYQLLRGLKYIH---SANVLHRDLKPANLFINTEDLVLKIGDFGLARIMD 172

>pdb|3VN9|A Chain A, Rifined Crystal Structure Of Non-Phosphorylated Map2k6 In A Putative Auto-Inhibition State Length = 340

Iteration: 1
 Score = 45.4 bits (106), Expect = 7e-05,   Method: Compositional matrix adjust.
 Identities = 28/98 (28%), Positives = 51/98 (52%), Gaps = 7/98 (7%)
Query: 387 TIGIARGLEYLHLGCSTRILHFDIKPHNILLDEDFCPKISDFGLAKICNRKESIISMTGA 446
            + I + LE+LH   S  ++H D+KP N+L++     K+ DFG++         ++ T  
Sbjct: 159 AVSIVKALEHLHSKLS--VIHRDVKPSNVLINALGQVKMCDFGISGYLVDS---VAKTID 213
Query: 447 RGTVGYIAPEVFCRNIGEVSY--KSDVYNYGMMIFEMT 482
            G   Y+APE     + +  Y  KSD+++ G+ + E+ 
Sbjct: 214 AGCKPYMAPERINPELNQKGYSVKSDIWSLGITMIELA 251

>pdb|1UKH|A Chain A, Structural Basis For The Selective Inhibition Of Jnk1 By The Scaffolding Protein Jip1 And Sp600125 Length = 369

Iteration: 1
 Score = 45.4 bits (106), Expect = 8e-05,   Method: Compositional matrix adjust.
 Identities = 35/94 (37%), Positives = 50/94 (53%), Gaps = 12/94 (12%)
Query: 393 GLEYLHLGCSTRILHFDIKPHNILLDEDFCPKISDFGLAKICNRKESIISMTGARGTVGY 452
           G+++LH   S  I+H D+KP NI++  D   KI DFGLA+      +   MT    T  Y
Sbjct: 138 GIKHLH---SAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAG---TSFMMTPYVVTRYY 191
Query: 453 IAPEVFCRNIGEVSYKS--DVYNYGMMIFEMTGG 484
            APEV    I  + YK   D+++ G ++ EM  G
Sbjct: 192 RAPEV----ILGMGYKENVDIWSVGCIMGEMIKG 221

>pdb|2XRW|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 371

Iteration: 1
 Score = 45.4 bits (106), Expect = 8e-05,   Method: Compositional matrix adjust.
 Identities = 35/94 (37%), Positives = 50/94 (53%), Gaps = 12/94 (12%)
Query: 393 GLEYLHLGCSTRILHFDIKPHNILLDEDFCPKISDFGLAKICNRKESIISMTGARGTVGY 452
           G+++LH   S  I+H D+KP NI++  D   KI DFGLA+      +   MT    T  Y
Sbjct: 139 GIKHLH---SAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAG---TSFMMTPYVVTRYY 192
Query: 453 IAPEVFCRNIGEVSYKS--DVYNYGMMIFEMTGG 484
            APEV    I  + YK   D+++ G ++ EM  G
Sbjct: 193 RAPEV----ILGMGYKENVDIWSVGCIMGEMIKG 222

>pdb|3VUD|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 45.4 bits (106), Expect = 8e-05,   Method: Compositional matrix adjust.
 Identities = 35/94 (37%), Positives = 50/94 (53%), Gaps = 12/94 (12%)
Query: 393 GLEYLHLGCSTRILHFDIKPHNILLDEDFCPKISDFGLAKICNRKESIISMTGARGTVGY 452
           G+++LH   S  I+H D+KP NI++  D   KI DFGLA+      +   MT    T  Y
Sbjct: 138 GIKHLH---SAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAG---TSFMMTPYVVTRYY 191
Query: 453 IAPEVFCRNIGEVSYKS--DVYNYGMMIFEMTGG 484
            APEV    I  + YK   D+++ G ++ EM  G
Sbjct: 192 RAPEV----ILGMGYKENVDIWSVGCIMGEMIKG 221

>pdb|2H6D|A Chain A, Protein Kinase Domain Of The Human 5'-Amp-Activated Protein Kinase Catalytic Subunit Alpha-2 (Ampk Alpha-2 Chain) Length = 276

Iteration: 1
 Score = 45.4 bits (106), Expect = 8e-05,   Method: Compositional matrix adjust.
 Identities = 49/196 (25%), Positives = 87/196 (44%), Gaps = 39/196 (19%)
Query: 321 LGQGGYGSVYKGK-LLDGSNVAVKVLNDSKGNGKEFI----NEVASISRTSHVNVVALL- 374
           LG G +G V  G+  L G  VAVK+LN  K    + +     E+ ++    H +++ L  
Sbjct: 19  LGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKLYQ 78
Query: 375 ------GFCL------------------RVAEELSSTI--GIARGLEYLHLGCSTRILHF 408
                  F +                  RV E  +  +   I   ++Y H      ++H 
Sbjct: 79  VISTPTDFFMVMEYVSGGELFDYICKHGRVEEMEARRLFQQILSAVDYCH---RHMVVHR 135
Query: 409 DIKPHNILLDEDFCPKISDFGLAKICNRKESIISMTGARGTVGYIAPEVFCRNIGEVSYK 468
           D+KP N+LLD     KI+DFGL+ + +  E + +   + G+  Y APEV    +     +
Sbjct: 136 DLKPENVLLDAHMNAKIADFGLSNMMSDGEFLRT---SCGSPNYAAPEVISGRL-YAGPE 191
Query: 469 SDVYNYGMMIFEMTGG 484
            D+++ G++++ +  G
Sbjct: 192 VDIWSCGVILYALLCG 207

>pdb|3QAM|E Chain E, Crystal Structure Of Glu208ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350

Iteration: 1
 Score = 45.4 bits (106), Expect = 8e-05,   Method: Compositional matrix adjust.
 Identities = 28/95 (29%), Positives = 47/95 (49%), Gaps = 10/95 (10%)
Query: 390 IARGLEYLHLGCSTRILHFDIKPHNILLDEDFCPKISDFGLAKICNRKESIISMTGARGT 449
           I    EYLH   S  +++ D+KP N+L+D+    +++DFG AK    +   +      GT
Sbjct: 150 IVLTFEYLH---SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLC-----GT 201
Query: 450 VGYIAPEVFCRNIGEVSYKSDVYNYGMMIFEMTGG 484
             Y+AP +        +   D +  G++I+EM  G
Sbjct: 202 PEYLAPAIILSK--GYNKAVDWWALGVLIYEMAAG 234

>pdb|2YZA|A Chain A, Crystal Structure Of Kinase Domain Of Human 5'-Amp-Activated Protein Kinase Alpha-2 Subunit Mutant (T172d) Length = 276

Iteration: 1
 Score = 45.4 bits (106), Expect = 8e-05,   Method: Compositional matrix adjust.
 Identities = 49/196 (25%), Positives = 86/196 (43%), Gaps = 39/196 (19%)
Query: 321 LGQGGYGSVYKGK-LLDGSNVAVKVLNDSKGNGKEFI----NEVASISRTSHVNVVALL- 374
           LG G +G V  G+  L G  VAVK+LN  K    + +     E+ ++    H +++ L  
Sbjct: 19  LGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKLYQ 78
Query: 375 ------GFCL------------------RVAEELSSTI--GIARGLEYLHLGCSTRILHF 408
                  F +                  RV E  +  +   I   ++Y H      ++H 
Sbjct: 79  VISTPTDFFMVMEYVSGGELFDYICKHGRVEEMEARRLFQQILSAVDYCH---RHMVVHR 135
Query: 409 DIKPHNILLDEDFCPKISDFGLAKICNRKESIISMTGARGTVGYIAPEVFCRNIGEVSYK 468
           D+KP N+LLD     KI+DFGL+ + +  E    +  + G+  Y APEV    +     +
Sbjct: 136 DLKPENVLLDAHMNAKIADFGLSNMMSDGE---FLRDSCGSPNYAAPEVISGRL-YAGPE 191
Query: 469 SDVYNYGMMIFEMTGG 484
            D+++ G++++ +  G
Sbjct: 192 VDIWSCGVILYALLCG 207

>pdb|3VUG|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 45.1 bits (105), Expect = 8e-05,   Method: Compositional matrix adjust.
 Identities = 35/94 (37%), Positives = 50/94 (53%), Gaps = 12/94 (12%)
Query: 393 GLEYLHLGCSTRILHFDIKPHNILLDEDFCPKISDFGLAKICNRKESIISMTGARGTVGY 452
           G+++LH   S  I+H D+KP NI++  D   KI DFGLA+      +   MT    T  Y
Sbjct: 138 GIKHLH---SAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAG---TSFMMTPYVVTRYY 191
Query: 453 IAPEVFCRNIGEVSYKS--DVYNYGMMIFEMTGG 484
            APEV    I  + YK   D+++ G ++ EM  G
Sbjct: 192 RAPEV----ILGMGYKENVDIWSVGCIMGEMIKG 221

>pdb|3MDY|A Chain A, Crystal Structure Of The Cytoplasmic Domain Of The Bone Morp Protein Receptor Type-1b (Bmpr1b) In Complex With Fkbp12 An 193189 Length = 337

Iteration: 1
 Score = 45.1 bits (105), Expect = 9e-05,   Method: Compositional matrix adjust.
 Identities = 52/204 (25%), Positives = 88/204 (43%), Gaps = 42/204 (20%)
Query: 320 KLGQGGYGSVYKGKLLDGSNVAVKVLNDSKGNGKEFINEVASISRTSHVNVVALLGFCLR 379
           ++G+G YG V+ GK   G  VAVKV   ++        E+       H N++  +   ++
Sbjct: 44  QIGKGRYGEVWMGKW-RGEKVAVKVFFTTEEASWFRETEIYQTVLMRHENILGFIAADIK 102
Query: 380 -------------------VAEELSSTIGIAR-----------GLEYLHLGC-STR---- 404
                              + + L ST   A+           GL +LH    ST+    
Sbjct: 103 GTGSWTQLYLITDYHENGSLYDYLKSTTLDAKSMLKLAYSSVSGLCHLHTEIFSTQGKPA 162
Query: 405 ILHFDIKPHNILLDEDFCPKISDFGLAK--ICNRKESIISMTGARGTVGYIAPEVFCRNI 462
           I H D+K  NIL+ ++    I+D GLA   I +  E  I      GT  Y+ PEV   ++
Sbjct: 163 IAHRDLKSKNILVKKNGTCCIADLGLAVKFISDTNEVDIPPNTRVGTKRYMPPEVLDESL 222
Query: 463 GEVSYKS----DVYNYGMMIFEMT 482
               ++S    D+Y++G++++E+ 
Sbjct: 223 NRNHFQSYIMADMYSFGLILWEVA 246

>pdb|2R5T|A Chain A, Crystal Structure Of Inactive Serum And Glucocorticoid- Regulated Kinase 1 In Complex With Amp-Pnp Length = 373

Iteration: 1
 Score = 45.1 bits (105), Expect = 9e-05,   Method: Compositional matrix adjust.
 Identities = 38/110 (34%), Positives = 53/110 (48%), Gaps = 13/110 (11%)
Query: 390 IARGLEYLHLGCSTRILHFDIKPHNILLDEDFCPKISDFGLAKICNRKESIISMTGARGT 449
           IA  L YLH   S  I++ D+KP NILLD      ++DFGL K      S  S     GT
Sbjct: 148 IASALGYLH---SLNIVYRDLKPENILLDSQGHIVLTDFGLCKENIEHNSTTSTFC--GT 202
Query: 450 VGYIAPEVFCRNIGEVSYKSDVYNYGMMIFEMTGG------RKNVDVVDN 493
             Y+APEV  +   + +   D +  G +++EM  G      R   ++ DN
Sbjct: 203 PEYLAPEVLHKQPYDRTV--DWWCLGAVLYEMLYGLPPFYSRNTAEMYDN 250

>pdb|3FI2|A Chain A, Crystal Structure Of Jnk3 With Amino-Pyrazole Inhibitor, Sr- 3451 Length = 353

Iteration: 1
 Score = 45.1 bits (105), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 58/229 (25%), Positives = 90/229 (39%), Gaps = 68/229 (29%)
Query: 292 TFLRNYRSLSPKRYGYADIKKMTNSFKYKLGQGGYGSV---YKGKLLDGSNVAVKVLN-- 346
           T L+ Y++L P                  +G G  G V   Y   L    NVA+K L+  
Sbjct: 21  TVLKRYQNLKP------------------IGSGAQGIVCAAYDAVL--DRNVAIKKLSRP 60
Query: 347 -DSKGNGKEFINEVASISRTSHVNVVALLGFCL--RVAEELSSTIGIAR----------- 392
             ++ + K    E+  +   +H N+++LL      +  EE      +             
Sbjct: 61  FQNQTHAKRAYRELVLMKXVNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQ 120
Query: 393 -----------------GLEYLHLGCSTRILHFDIKPHNILLDEDFCPKISDFGLAKICN 435
                            G+++LH   S  I+H D+KP NI++  D   KI DFGLA+   
Sbjct: 121 MELDHERMSYLLYQMLCGIKHLH---SAGIIHRDLKPSNIVVKSDXTLKILDFGLARTAG 177
Query: 436 RKESIISMTGARGTVGYIAPEVFCRNIGEVSYKS--DVYNYGMMIFEMT 482
              +   MT    T  Y APEV    I  + YK   D+++ G ++ EM 
Sbjct: 178 ---TSFMMTPYVVTRYYRAPEV----ILGMGYKENVDIWSVGCIMGEMV 219

>pdb|2XS0|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 386

Iteration: 1
 Score = 45.1 bits (105), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 33/94 (35%), Positives = 49/94 (52%), Gaps = 12/94 (12%)
Query: 393 GLEYLHLGCSTRILHFDIKPHNILLDEDFCPKISDFGLAKICNRKESIISMTGARGTVGY 452
           G+++LH   S  I+H D+KP NI++  D   KI DFGLA+       ++     R    Y
Sbjct: 140 GIKHLH---SAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMVPFVVTR---YY 193
Query: 453 IAPEVFCRNIGEVSYKS--DVYNYGMMIFEMTGG 484
            APEV    I  + YK   D+++ G ++ EM  G
Sbjct: 194 RAPEV----ILGMGYKENVDIWSVGCIMGEMIKG 223

>pdb|2R0I|A Chain A, Crystal Structure Of A Kinase Mark2PAR-1 Mutant Length = 327

Iteration: 1
 Score = 45.1 bits (105), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 44/195 (22%), Positives = 82/195 (42%), Gaps = 38/195 (19%)
Query: 321 LGQGGYGSVYKGK-LLDGSNVAVKVLNDSKGNG---KEFINEVASISRTSHVNVVALLGF 376
           +G+G +  V   + +L G  VAVK+++ ++ N    ++   EV  +   +H N+V L   
Sbjct: 22  IGKGNFAKVKLARHILTGKEVAVKIIDKTQLNSSSLQKLFREVRIMKVLNHPNIVKLFEV 81
Query: 377 C---------------------------LRVAEELSSTIGIARGLEYLHLGCSTRILHFD 409
                                       ++  E  +    I   ++Y H      I+H D
Sbjct: 82  IETEKTLYLVMEYASGGEVFDYLVAHGRMKEKEARAKFRQIVSAVQYCH---QKFIVHRD 138
Query: 410 IKPHNILLDEDFCPKISDFGLAKICNRKESIISMTGARGTVGYIAPEVFCRNIGEVSYKS 469
           +K  N+LLD D   KI+DFG +        + +     G+  Y APE+F     +   + 
Sbjct: 139 LKAENLLLDADMNIKIADFGFSNEFTFGNKLDTFC---GSPPYAAPELFQGKKYD-GPEV 194
Query: 470 DVYNYGMMIFEMTGG 484
           DV++ G++++ +  G
Sbjct: 195 DVWSLGVILYTLVSG 209

>pdb|3FV8|A Chain A, Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Length = 355

Iteration: 1
 Score = 45.1 bits (105), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 58/229 (25%), Positives = 90/229 (39%), Gaps = 68/229 (29%)
Query: 292 TFLRNYRSLSPKRYGYADIKKMTNSFKYKLGQGGYGSV---YKGKLLDGSNVAVKVLN-- 346
           T L+ Y++L P                  +G G  G V   Y   L    NVA+K L+  
Sbjct: 21  TVLKRYQNLKP------------------IGSGAQGIVCAAYDAVL--DRNVAIKKLSRP 60
Query: 347 -DSKGNGKEFINEVASISRTSHVNVVALLGFCL--RVAEELSSTIGIAR----------- 392
             ++ + K    E+  +   +H N+++LL      +  EE      +             
Sbjct: 61  FQNQTHAKRAYRELVLMKXVNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDANLXQVIQ 120
Query: 393 -----------------GLEYLHLGCSTRILHFDIKPHNILLDEDFCPKISDFGLAKICN 435
                            G+++LH   S  I+H D+KP NI++  D   KI DFGLA+   
Sbjct: 121 MELDHERMSYLLYQMLCGIKHLH---SAGIIHRDLKPSNIVVKSDXTLKILDFGLARTAG 177
Query: 436 RKESIISMTGARGTVGYIAPEVFCRNIGEVSYKS--DVYNYGMMIFEMT 482
              +   MT    T  Y APEV    I  + YK   D+++ G ++ EM 
Sbjct: 178 ---TSFMMTPYVVTRYYRAPEV----ILGMGYKENVDIWSVGCIMGEMV 219

>pdb|3GBZ|A Chain A, Structure Of The Cmgc Cdk Kinase From Giardia Lamblia Length = 329

Iteration: 1
 Score = 45.1 bits (105), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 55/199 (27%), Positives = 83/199 (41%), Gaps = 45/199 (22%)
Query: 320 KLGQGGYGSVYKG-KLLDGSNVAVKVL---NDSKGNGKEFINEVASISRTSHVNVVAL-- 373
           KLG+G YG VYK    +    VA+K +   ++ +G     I EV+ +    H N++ L  
Sbjct: 41  KLGEGTYGEVYKAIDTVTNETVAIKRIRLEHEEEGVPGTAIREVSLLKELQHRNIIELKS 100
Query: 374 -------LGFCLRVAE-----------ELSSTI------GIARGLEYLHLGCSTRILHFD 409
                  L      AE           ++S  +       +  G+ + H   S R LH D
Sbjct: 101 VIHHNHRLHLIFEYAENDLKKYMDKNPDVSMRVIKSFLYQLINGVNFCH---SRRCLHRD 157
Query: 410 IKPHNILL---DEDFCP--KISDFGLAKICNRKESIISMTGARGTVGYIAPEVFCRNIGE 464
           +KP N+LL   D    P  KI DFGLA+       I   T    T+ Y  PE+    +G 
Sbjct: 158 LKPQNLLLSVSDASETPVLKIGDFGLARAFGI--PIRQFTHEIITLWYRPPEIL---LGS 212
Query: 465 VSYKS--DVYNYGMMIFEM 481
             Y +  D+++   +  EM
Sbjct: 213 RHYSTSVDIWSIACIWAEM 231

>pdb|1PHK|A Chain A, Two Structures Of The Catalytic Domain Of Phosphorylase, Kinase: An Active Protein Kinase Complexed With Nucleotide, Substrate-Analogue And Product Length = 298

Iteration: 1
 Score = 45.1 bits (105), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 27/84 (32%), Positives = 47/84 (55%), Gaps = 7/84 (8%)
Query: 405 ILHFDIKPHNILLDEDFCPKISDFGLAKICNRKESIISMTGARGTVGYIAPEVF--CRNI 462
           I+H D+KP NILLD+D   K++DFG +   +  E +  +    GT  Y+APE+     N 
Sbjct: 145 IVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGEKLREVC---GTPSYLAPEIIECSMND 201
Query: 463 GEVSY--KSDVYNYGMMIFEMTGG 484
               Y  + D+++ G++++ +  G
Sbjct: 202 NHPGYGKEVDMWSTGVIMYTLLAG 225

>pdb|1ZMU|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Wild Type Length = 327

Iteration: 1
 Score = 44.7 bits (104), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 44/195 (22%), Positives = 82/195 (42%), Gaps = 38/195 (19%)
Query: 321 LGQGGYGSVYKGK-LLDGSNVAVKVLNDSKGNG---KEFINEVASISRTSHVNVVALLGF 376
           +G+G +  V   + +L G  VAVK+++ ++ N    ++   EV  +   +H N+V L   
Sbjct: 22  IGKGNFAKVKLARHILTGKEVAVKIIDKTQLNSSSLQKLFREVRIMKVLNHPNIVKLFEV 81
Query: 377 C---------------------------LRVAEELSSTIGIARGLEYLHLGCSTRILHFD 409
                                       ++  E  +    I   ++Y H      I+H D
Sbjct: 82  IETEKTLYLVMEYASGGEVFDYLVAHGRMKEKEARAKFRQIVSAVQYCH---QKFIVHRD 138
Query: 410 IKPHNILLDEDFCPKISDFGLAKICNRKESIISMTGARGTVGYIAPEVFCRNIGEVSYKS 469
           +K  N+LLD D   KI+DFG +        + +     G+  Y APE+F     +   + 
Sbjct: 139 LKAENLLLDADMNIKIADFGFSNEFTFGNKLDTFC---GSPPYAAPELFQGKKYD-GPEV 194
Query: 470 DVYNYGMMIFEMTGG 484
           DV++ G++++ +  G
Sbjct: 195 DVWSLGVILYTLVSG 209

>pdb|2PHK|A Chain A, The Crystal Structure Of A Phosphorylase Kinase Peptide Substrate Complex: Kinase Substrate Recognition Length = 277

Iteration: 1
 Score = 44.7 bits (104), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 27/84 (32%), Positives = 47/84 (55%), Gaps = 7/84 (8%)
Query: 405 ILHFDIKPHNILLDEDFCPKISDFGLAKICNRKESIISMTGARGTVGYIAPEVF--CRNI 462
           I+H D+KP NILLD+D   K++DFG +   +  E +  +    GT  Y+APE+     N 
Sbjct: 132 IVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGEKLREVC---GTPSYLAPEIIECSMND 188
Query: 463 GEVSY--KSDVYNYGMMIFEMTGG 484
               Y  + D+++ G++++ +  G
Sbjct: 189 NHPGYGKEVDMWSTGVIMYTLLAG 212

>pdb|3FI3|A Chain A, Crystal Structure Of Jnk3 With Indazole Inhibitor, Sr-3737 Length = 364

Iteration: 1
 Score = 44.7 bits (104), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 58/229 (25%), Positives = 90/229 (39%), Gaps = 68/229 (29%)
Query: 292 TFLRNYRSLSPKRYGYADIKKMTNSFKYKLGQGGYGSV---YKGKLLDGSNVAVKVLN-- 346
           T L+ Y++L P                  +G G  G V   Y   L    NVA+K L+  
Sbjct: 21  TVLKRYQNLKP------------------IGSGAQGIVCAAYDAVL--DRNVAIKKLSRP 60
Query: 347 -DSKGNGKEFINEVASISRTSHVNVVALLGFCL--RVAEELSSTIGIAR----------- 392
             ++ + K    E+  +   +H N+++LL      +  EE      +             
Sbjct: 61  FQNQTHAKRAYRELVLMKXVNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDANLXQVIQ 120
Query: 393 -----------------GLEYLHLGCSTRILHFDIKPHNILLDEDFCPKISDFGLAKICN 435
                            G+++LH   S  I+H D+KP NI++  D   KI DFGLA+   
Sbjct: 121 MELDHERMSYLLYQMLXGIKHLH---SAGIIHRDLKPSNIVVKSDXTLKILDFGLARTAG 177
Query: 436 RKESIISMTGARGTVGYIAPEVFCRNIGEVSYKS--DVYNYGMMIFEMT 482
              +   MT    T  Y APEV    I  + YK   D+++ G ++ EM 
Sbjct: 178 ---TSFMMTPYVVTRYYRAPEV----ILGMGYKENVDIWSVGCIMGEMV 219

>pdb|3E7O|A Chain A, Crystal Structure Of Jnk2 Length = 360

Iteration: 1
 Score = 44.7 bits (104), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 61/244 (25%), Positives = 96/244 (39%), Gaps = 68/244 (27%)
Query: 292 TFLRNYRSLSPKRYGYADIKKMTNSFKYKLGQGGYGSVYKG-KLLDGSNVAVKVLN---D 347
           T L+ Y+ L P                  +G G  G V      + G NVAVK L+    
Sbjct: 19  TVLKRYQQLKP------------------IGSGAQGIVCAAFDTVLGINVAVKKLSRPFQ 60
Query: 348 SKGNGKEFINEVASISRTSHVNVVALLGFCL--RVAEELSSTIGIAR------------- 392
           ++ + K    E+  +   +H N+++LL      +  EE      +               
Sbjct: 61  NQTHAKRAYRELVLLKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIHME 120
Query: 393 ---------------GLEYLHLGCSTRILHFDIKPHNILLDEDFCPKISDFGLAKICNRK 437
                          G+++LH   S  I+H D+KP NI++  D   KI DFGLA+  +  
Sbjct: 121 LDHERMSYLLYQMLCGIKHLH---SAGIIHRDLKPSNIVVKSDCTLKILDFGLARTASTN 177
Query: 438 ESIISMTGARGTVGYIAPEVFCRNIGEVSYKS--DVYNYGMMIFEMTGGRKNVDVVDNGS 495
                MT    T  Y APEV    I  + YK   D+++ G ++ E+  G     V+  G+
Sbjct: 178 ---FMMTPYVVTRYYRAPEV----ILGMGYKENVDIWSVGCIMGELVKG----SVIFQGT 226
Query: 496 TALD 499
             +D
Sbjct: 227 DHID 230

>pdb|3OZ6|A Chain A, Crystal Structure Of Mapk From Cryptosporidium Parvum, Cgd2_1960 Length = 388

Iteration: 1
 Score = 44.7 bits (104), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 44/146 (30%), Positives = 68/146 (46%), Gaps = 37/146 (25%)
Query: 320 KLGQGGYGSVYKG-KLLDGSNVAVKVLNDSKGN---GKEFINEVASISRTS-HVNVVALL 374
           KLG+G YG V+K      G  VAVK + D+  N    +    E+  ++  S H N+V LL
Sbjct: 16  KLGKGAYGIVWKSIDRRTGEVVAVKKIFDAFQNSTDAQRTFREIMILTELSGHENIVNLL 75
Query: 375 GFCLR-------------VAEELSSTI---------------GIARGLEYLHLGCSTRIL 406
              LR             +  +L + I                + + ++YLH G    +L
Sbjct: 76  N-VLRADNDRDVYLVFDYMETDLHAVIRANILEPVHKQYVVYQLIKVIKYLHSGG---LL 131
Query: 407 HFDIKPHNILLDEDFCPKISDFGLAK 432
           H D+KP NILL+ +   K++DFGL++
Sbjct: 132 HRDMKPSNILLNAECHVKVADFGLSR 157

>pdb|2W4O|A Chain A, Crystal Structure Of Human Camk4 In Complex With 4-Amino( Sulfamoyl-Phenylamino)-Triazole-Carbothioic Acid (2,6- Difluoro-Phenyl)-Amide) Length = 349

Iteration: 1
 Score = 44.7 bits (104), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 56/198 (28%), Positives = 82/198 (41%), Gaps = 44/198 (22%)
Query: 320 KLGQGGYGSVYKGKLLDGSN-VAVKVLNDSKGNGKEFINEVASISRTSHVNVVAL----- 373
           +LG+G    VY+ K        A+KVL  +  + K    E+  + R SH N++ L     
Sbjct: 60  ELGRGATSIVYRCKQKGTQKPYALKVLKKTV-DKKIVRTEIGVLLRLSHPNIIKLKEIFE 118
Query: 374 ------LGFCLRVAEELSSTI----------------GIARGLEYLHLGCSTRILHFDIK 411
                 L   L    EL   I                 I   + YLH      I+H D+K
Sbjct: 119 TPTEISLVLELVTGGELFDRIVEKGYYSERDAADAVKQILEAVAYLH---ENGIVHRDLK 175
Query: 412 PHNILLDE---DFCPKISDFGLAKICNRKESIISMTGARGTVGYIAPEVF--CRNIGEVS 466
           P N+L      D   KI+DFGL+KI   +   + M    GT GY APE+   C    EV 
Sbjct: 176 PENLLYATPAPDAPLKIADFGLSKIVEHQ---VLMKTVCGTPGYCAPEILRGCAYGPEV- 231
Query: 467 YKSDVYNYGMMIFEMTGG 484
              D+++ G++ + +  G
Sbjct: 232 ---DMWSVGIITYILLCG 246

>pdb|3IEC|A Chain A, Helicobacter Pylori Caga Inhibits Par1MARK FAMILY KINASES BY Mimicking Host Substrates Length = 319

Iteration: 1
 Score = 44.7 bits (104), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 44/195 (22%), Positives = 82/195 (42%), Gaps = 38/195 (19%)
Query: 321 LGQGGYGSVYKGK-LLDGSNVAVKVLNDSKGNG---KEFINEVASISRTSHVNVVALLGF 376
           +G+G +  V   + +L G  VAVK+++ ++ N    ++   EV  +   +H N+V L   
Sbjct: 15  IGKGNFAKVKLARHILTGKEVAVKIIDKTQLNSSSLQKLFREVRIMKVLNHPNIVKLFEV 74
Query: 377 C---------------------------LRVAEELSSTIGIARGLEYLHLGCSTRILHFD 409
                                       ++  E  +    I   ++Y H      I+H D
Sbjct: 75  IETEKTLYLVMEYASGGEVFDYLVAHGWMKEKEARAKFRQIVSAVQYCH---QKFIVHRD 131
Query: 410 IKPHNILLDEDFCPKISDFGLAKICNRKESIISMTGARGTVGYIAPEVFCRNIGEVSYKS 469
           +K  N+LLD D   KI+DFG +        + +  G+     Y APE+F     +   + 
Sbjct: 132 LKAENLLLDADMNIKIADFGFSNEFTFGNKLDTFCGSP---PYAAPELFQGKKYD-GPEV 187
Query: 470 DVYNYGMMIFEMTGG 484
           DV++ G++++ +  G
Sbjct: 188 DVWSLGVILYTLVSG 202

>pdb|2R9S|A Chain A, C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Quinoline Inhibitor Length = 356

Iteration: 1
 Score = 44.7 bits (104), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 34/92 (36%), Positives = 49/92 (53%), Gaps = 12/92 (13%)
Query: 393 GLEYLHLGCSTRILHFDIKPHNILLDEDFCPKISDFGLAKICNRKESIISMTGARGTVGY 452
           G+++LH   S  I+H D+KP NI++  D   KI DFGLA+      +   MT    T  Y
Sbjct: 131 GIKHLH---SAGIIHRDLKPSNIVVKSDXTLKILDFGLARTAG---TSFMMTPYVVTRYY 184
Query: 453 IAPEVFCRNIGEVSYKS--DVYNYGMMIFEMT 482
            APEV    I  + YK   D+++ G ++ EM 
Sbjct: 185 RAPEV----ILGMGYKENVDIWSVGCIMGEMV 212

>pdb|3KVX|A Chain A, Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Length = 364

Iteration: 1
 Score = 44.7 bits (104), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 34/92 (36%), Positives = 49/92 (53%), Gaps = 12/92 (13%)
Query: 393 GLEYLHLGCSTRILHFDIKPHNILLDEDFCPKISDFGLAKICNRKESIISMTGARGTVGY 452
           G+++LH   S  I+H D+KP NI++  D   KI DFGLA+      +   MT    T  Y
Sbjct: 138 GIKHLH---SAGIIHRDLKPSNIVVKSDXTLKILDFGLARTAG---TSFMMTPYVVTRYY 191
Query: 453 IAPEVFCRNIGEVSYKS--DVYNYGMMIFEMT 482
            APEV    I  + YK   D+++ G ++ EM 
Sbjct: 192 RAPEV----ILGMGYKENVDIWSVGCIMGEMV 219

>pdb|1LUF|A Chain A, Crystal Structure Of The Musk Tyrosine Kinase: Insights Into Receptor Autoregulation Length = 343

Iteration: 1
 Score = 44.3 bits (103), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 49/220 (22%), Positives = 87/220 (39%), Gaps = 64/220 (29%)
Query: 321 LGQGGYGSVYKGK---LLDG---SNVAVKVLND--SKGNGKEFINEVASISRTSHVNVVA 372
           +G+G +G V++ +   LL     + VAVK+L +  S     +F  E A ++   + N+V 
Sbjct: 55  IGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVK 114
Query: 373 LLGFC---------------------------------------------------LRVA 381
           LLG C                                                   L  A
Sbjct: 115 LLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCA 174
Query: 382 EELSSTIGIARGLEYLHLGCSTRILHFDIKPHNILLDEDFCPKISDFGLAKICNRKESII 441
           E+L     +A G+ YL      + +H D+   N L+ E+   KI+DFGL++     +   
Sbjct: 175 EQLCIARQVAAGMAYLS---ERKFVHRDLATRNCLVGENMVVKIADFGLSRNIYSADYYK 231
Query: 442 SMTGARGTVGYIAPEVFCRNIGEVSYKSDVYNYGMMIFEM 481
           +       + ++ PE    N    + +SDV+ YG++++E+
Sbjct: 232 ADGNDAIPIRWMPPESIFYN--RYTTESDVWAYGVVLWEI 269

>pdb|2HAK|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark1PAR-1 Length = 328

Iteration: 1
 Score = 44.3 bits (103), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 45/198 (22%), Positives = 85/198 (42%), Gaps = 44/198 (22%)
Query: 321 LGQGGYGSVYKGK-LLDGSNVAVKVLNDSKGNG---KEFINEVASISRTSHVNVVALLGF 376
           +G+G +  V   + +L G  VAVK+++ ++ N    ++   EV  +   +H N+V L   
Sbjct: 23  IGKGNFAKVKLARHVLTGREVAVKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVKLFEV 82
Query: 377 C---------------------------LRVAEELSSTIGIARGLEYLHLGCSTRILHFD 409
                                       ++  E  +    I   ++Y H      I+H D
Sbjct: 83  IETEKTLYLVMEYASGGEVFDYLVAHGRMKEKEARAKFRQIVSAVQYCH---QKYIVHRD 139
Query: 410 IKPHNILLDEDFCPKISDFGLA---KICNRKESIISMTGARGTVGYIAPEVFCRNIGEVS 466
           +K  N+LLD D   KI+DFG +    + N+ ++        G+  Y APE+F     +  
Sbjct: 140 LKAENLLLDGDMNIKIADFGFSNEFTVGNKLDTFC------GSPPYAAPELFQGKKYD-G 192
Query: 467 YKSDVYNYGMMIFEMTGG 484
            + DV++ G++++ +  G
Sbjct: 193 PEVDVWSLGVILYTLVSG 210

>pdb|1RDQ|E Chain E, Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of Camp-Dependent Protein Kinase Length = 350

Iteration: 1
 Score = 44.3 bits (103), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 28/95 (29%), Positives = 47/95 (49%), Gaps = 10/95 (10%)
Query: 390 IARGLEYLHLGCSTRILHFDIKPHNILLDEDFCPKISDFGLAKICNRKESIISMTGARGT 449
           I    EYLH   S  +++ D+KP N+L+D+    +++DFG AK    +   +      GT
Sbjct: 150 IVLTFEYLH---SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLC-----GT 201
Query: 450 VGYIAPEVFCRNIGEVSYKSDVYNYGMMIFEMTGG 484
              +APE+        +   D +  G++I+EM  G
Sbjct: 202 PEALAPEIILSK--GYNKAVDWWALGVLIYEMAAG 234

>pdb|1UNG|A Chain A, Structural Mechanism For The Inhibition Of Cdk5-P25 By Roscovitine, Aloisine And Indirubin. Length = 292

Iteration: 1
 Score = 44.3 bits (103), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 35/144 (24%), Positives = 65/144 (45%), Gaps = 34/144 (23%)
Query: 320 KLGQGGYGSVYKGKLLDGSNVA----VKVLNDSKGNGKEFINEVASISRTSHVNVVAL-- 373
           K+G+G YG+V+K K  +   +     V++ +D +G     + E+  +    H N+V L  
Sbjct: 9   KIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHD 68
Query: 374 -----------LGFCLRVAEEL--------------SSTIGIARGLEYLHLGCSTRILHF 408
                        FC +  ++               S    + +GL + H   S  +LH 
Sbjct: 69  VLHSDKKLTLVFEFCDQDLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCH---SRNVLHR 125
Query: 409 DIKPHNILLDEDFCPKISDFGLAK 432
           D+KP N+L++ +   K+++FGLA+
Sbjct: 126 DLKPQNLLINRNGELKLANFGLAR 149

>pdb|3PFQ|A Chain A, Crystal Structure And Allosteric Activation Of Protein Kinase C Beta Ii Length = 674

Iteration: 1
 Score = 44.3 bits (103), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 32/99 (32%), Positives = 51/99 (51%), Gaps = 13/99 (13%)
Query: 390 IARGLEYLHLGCSTRILHFDIKPHNILLDEDFCPKISDFGLAKICNRKESIISMTGAR-- 447
           IA GL +L    S  I++ D+K  N++LD +   KI+DFG+      KE+I      +  
Sbjct: 451 IAIGLFFLQ---SKGIIYRDLKLDNVMLDSEGHIKIADFGMC-----KENIWDGVTTKXF 502
Query: 448 -GTVGYIAPEVFCRNIGEVSYKSDVYNYGMMIFEMTGGR 485
            GT  YIAPE+            D + +G++++EM  G+
Sbjct: 503 CGTPDYIAPEIIAYQ--PYGKSVDWWAFGVLLYEMLAGQ 539

>pdb|3TTJ|A Chain A, Crystal Structure Of Jnk3 Complexed With Cc-359, A Jnk Inhibitor For The Prevention Of Ischemia-Reperfusion Injury Length = 464

Iteration: 1
 Score = 43.9 bits (102), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 34/92 (36%), Positives = 49/92 (53%), Gaps = 12/92 (13%)
Query: 393 GLEYLHLGCSTRILHFDIKPHNILLDEDFCPKISDFGLAKICNRKESIISMTGARGTVGY 452
           G+++LH   S  I+H D+KP NI++  D   KI DFGLA+      +   MT    T  Y
Sbjct: 176 GIKHLH---SAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAG---TSFMMTPYVVTRYY 229
Query: 453 IAPEVFCRNIGEVSYKS--DVYNYGMMIFEMT 482
            APEV    I  + YK   D+++ G ++ EM 
Sbjct: 230 RAPEV----ILGMGYKENVDIWSVGCIMGEMV 257

>pdb|1ZMV|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: K82r Mutant Length = 327

Iteration: 1
 Score = 43.9 bits (102), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 43/195 (22%), Positives = 82/195 (42%), Gaps = 38/195 (19%)
Query: 321 LGQGGYGSVYKGK-LLDGSNVAVKVLNDSKGNG---KEFINEVASISRTSHVNVVALLGF 376
           +G+G +  V   + +L G  VAV++++ ++ N    ++   EV  +   +H N+V L   
Sbjct: 22  IGKGNFAKVKLARHILTGKEVAVRIIDKTQLNSSSLQKLFREVRIMKVLNHPNIVKLFEV 81
Query: 377 C---------------------------LRVAEELSSTIGIARGLEYLHLGCSTRILHFD 409
                                       ++  E  +    I   ++Y H      I+H D
Sbjct: 82  IETEKTLYLVMEYASGGEVFDYLVAHGRMKEKEARAKFRQIVSAVQYCH---QKFIVHRD 138
Query: 410 IKPHNILLDEDFCPKISDFGLAKICNRKESIISMTGARGTVGYIAPEVFCRNIGEVSYKS 469
           +K  N+LLD D   KI+DFG +        + +     G+  Y APE+F     +   + 
Sbjct: 139 LKAENLLLDADMNIKIADFGFSNEFTFGNKLDTFC---GSPPYAAPELFQGKKYD-GPEV 194
Query: 470 DVYNYGMMIFEMTGG 484
           DV++ G++++ +  G
Sbjct: 195 DVWSLGVILYTLVSG 209

>pdb|4GT5|A Chain A, Crystal Structure Of The Inactive Trka Kinase Domain Length = 306

Iteration: 1
 Score = 43.9 bits (102), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 52/253 (20%), Positives = 103/253 (40%), Gaps = 65/253 (25%)
Query: 310 IKKMTNSFKYKLGQGGYGSVYKGK---LL---DGSNVAVKVLNDSKGNGKE-FINEVASI 362
           IK+     K++LG+G +G V+  +   LL   D   VAVK L ++  + ++ F  E   +
Sbjct: 15  IKRRDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELL 74
Query: 363 SRTSHVNVVALLGFC------------------------------------------LRV 380
           +   H ++V   G C                                          L +
Sbjct: 75  TMLQHQHIVRFFGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGL 134
Query: 381 AEELSSTIGIARGLEYLHLGCSTRILHFDIKPHNILLDEDFCPKISDFGLAKICNRKESI 440
            + L+    +A G+ YL        +H D+   N L+ +    KI DFG+++  +   + 
Sbjct: 135 GQLLAVASQVAAGMVYL---AGLHFVHRDLATRNCLVGQGLVVKIGDFGMSR--DIYSTD 189
Query: 441 ISMTGARGT--VGYIAPEVFCRNIGEVSYKSDVYNYGMMIFEM-TGGRK------NVDVV 491
               G R    + ++ PE       + + +SDV+++G++++E+ T G++      N + +
Sbjct: 190 YYRVGGRTMLPIRWMPPESILYR--KFTTESDVWSFGVVLWEIFTYGKQPWYQLSNTEAI 247
Query: 492 DNGSTALDLQASR 504
           D  +   +L+  R
Sbjct: 248 DCITQGRELERPR 260

>pdb|1JNK|A Chain A, The C-Jun N-Terminal Kinase (Jnk3s) Complexed With Mgamp-Pnp Length = 423

Iteration: 1
 Score = 43.9 bits (102), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 34/92 (36%), Positives = 49/92 (53%), Gaps = 12/92 (13%)
Query: 393 GLEYLHLGCSTRILHFDIKPHNILLDEDFCPKISDFGLAKICNRKESIISMTGARGTVGY 452
           G+++LH   S  I+H D+KP NI++  D   KI DFGLA+      +   MT    T  Y
Sbjct: 176 GIKHLH---SAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAG---TSFMMTPYVVTRYY 229
Query: 453 IAPEVFCRNIGEVSYKS--DVYNYGMMIFEMT 482
            APEV    I  + YK   D+++ G ++ EM 
Sbjct: 230 RAPEV----ILGMGYKENVDIWSVGCIMGEMV 257

>pdb|4F0I|A Chain A, Crystal Structure Of Apo Trka Length = 300

Iteration: 1
 Score = 43.9 bits (102), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 52/253 (20%), Positives = 103/253 (40%), Gaps = 65/253 (25%)
Query: 310 IKKMTNSFKYKLGQGGYGSVYKGK---LL---DGSNVAVKVLNDSKGNGKE-FINEVASI 362
           IK+     K++LG+G +G V+  +   LL   D   VAVK L ++  + ++ F  E   +
Sbjct: 9   IKRRDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELL 68
Query: 363 SRTSHVNVVALLGFC------------------------------------------LRV 380
           +   H ++V   G C                                          L +
Sbjct: 69  TMLQHQHIVRFFGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGL 128
Query: 381 AEELSSTIGIARGLEYLHLGCSTRILHFDIKPHNILLDEDFCPKISDFGLAKICNRKESI 440
            + L+    +A G+ YL        +H D+   N L+ +    KI DFG+++  +   + 
Sbjct: 129 GQLLAVASQVAAGMVYL---AGLHFVHRDLATRNCLVGQGLVVKIGDFGMSR--DIYSTD 183
Query: 441 ISMTGARGT--VGYIAPEVFCRNIGEVSYKSDVYNYGMMIFEM-TGGRK------NVDVV 491
               G R    + ++ PE       + + +SDV+++G++++E+ T G++      N + +
Sbjct: 184 YYRVGGRTMLPIRWMPPESILYR--KFTTESDVWSFGVVLWEIFTYGKQPWYQLSNTEAI 241
Query: 492 DNGSTALDLQASR 504
           D  +   +L+  R
Sbjct: 242 DCITQGRELERPR 254

>pdb|1KWP|A Chain A, Crystal Structure Of Mapkap2 Length = 400

Iteration: 1
 Score = 43.9 bits (102), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 37/110 (33%), Positives = 56/110 (50%), Gaps = 17/110 (15%)
Query: 375 GFCLRVAEELSSTIGIARGLEYLHLGCSTRILHFDIKPHNILLDE---DFCPKISDFGLA 431
            F  R A E+  +IG A  ++YLH   S  I H D+KP N+L      +   K++DFG A
Sbjct: 157 AFTEREASEIMKSIGEA--IQYLH---SINIAHRDVKPENLLYTSKRPNAILKLTDFGFA 211
Query: 432 KICNRKESIISMTGARGTVGYIAPEVFCRNIGEVSYKS--DVYNYGMMIF 479
           K      S  S+T    T  Y+APEV    +G   Y    D+++ G++++
Sbjct: 212 K---ETTSHNSLTTPCYTPYYVAPEV----LGPEKYDKSCDMWSLGVIMY 254

>pdb|2I0E|A Chain A, Structure Of Catalytic Domain Of Human Protein Kinase C Beta Ii Complexed With A Bisindolylmaleimide Inhibitor Length = 353

Iteration: 1
 Score = 43.9 bits (102), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 32/99 (32%), Positives = 51/99 (51%), Gaps = 13/99 (13%)
Query: 390 IARGLEYLHLGCSTRILHFDIKPHNILLDEDFCPKISDFGLAKICNRKESIISMTGAR-- 447
           IA GL +L    S  I++ D+K  N++LD +   KI+DFG+      KE+I      +  
Sbjct: 130 IAIGLFFLQ---SKGIIYRDLKLDNVMLDSEGHIKIADFGMC-----KENIWDGVTTKXF 181
Query: 448 -GTVGYIAPEVFCRNIGEVSYKSDVYNYGMMIFEMTGGR 485
            GT  YIAPE+            D + +G++++EM  G+
Sbjct: 182 CGTPDYIAPEIIAYQ--PYGKSVDWWAFGVLLYEMLAGQ 218

>pdb|3OXI|A Chain A, Design And Synthesis Of Disubstituted Thiophene And Thiazole Based Inhibitors Of Jnk For The Treatment Of Neurodegenerative Diseases Length = 362

Iteration: 1
 Score = 43.5 bits (101), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 34/92 (36%), Positives = 49/92 (53%), Gaps = 12/92 (13%)
Query: 393 GLEYLHLGCSTRILHFDIKPHNILLDEDFCPKISDFGLAKICNRKESIISMTGARGTVGY 452
           G+++LH   S  I+H D+KP NI++  D   KI DFGLA+      +   MT    T  Y
Sbjct: 137 GIKHLH---SAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAG---TSFMMTPYVVTRYY 190
Query: 453 IAPEVFCRNIGEVSYKS--DVYNYGMMIFEMT 482
            APEV    I  + YK   D+++ G ++ EM 
Sbjct: 191 RAPEV----ILGMGYKENVDIWSVGCIMGEMV 218

>pdb|2JBO|A Chain A, Protein Kinase Mk2 In Complex With An Inhibitor (Crystal Form-1, Soaking) Length = 326

Iteration: 1
 Score = 43.5 bits (101), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 37/110 (33%), Positives = 56/110 (50%), Gaps = 17/110 (15%)
Query: 375 GFCLRVAEELSSTIGIARGLEYLHLGCSTRILHFDIKPHNILLDE---DFCPKISDFGLA 431
            F  R A E+  +IG A  ++YLH   S  I H D+KP N+L      +   K++DFG A
Sbjct: 119 AFTEREASEIMKSIGEA--IQYLH---SINIAHRDVKPENLLYTSKRPNAILKLTDFGFA 173
Query: 432 KICNRKESIISMTGARGTVGYIAPEVFCRNIGEVSYKS--DVYNYGMMIF 479
           K      S  S+T    T  Y+APEV    +G   Y    D+++ G++++
Sbjct: 174 K---ETTSHNSLTTPCYTPYYVAPEV----LGPEKYDKSCDMWSLGVIMY 216

>pdb|1PMN|A Chain A, Crystal Structure Of Jnk3 In Complex With An Imidazole- Pyrimidine Inhibitor Length = 364

Iteration: 1
 Score = 43.5 bits (101), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 34/92 (36%), Positives = 49/92 (53%), Gaps = 12/92 (13%)
Query: 393 GLEYLHLGCSTRILHFDIKPHNILLDEDFCPKISDFGLAKICNRKESIISMTGARGTVGY 452
           G+++LH   S  I+H D+KP NI++  D   KI DFGLA+      +   MT    T  Y
Sbjct: 139 GIKHLH---SAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAG---TSFMMTPYVVTRYY 192
Query: 453 IAPEVFCRNIGEVSYKS--DVYNYGMMIFEMT 482
            APEV    I  + YK   D+++ G ++ EM 
Sbjct: 193 RAPEV----ILGMGYKENVDIWSVGCIMGEMV 220

>pdb|3PTG|A Chain A, Design And Synthesis Of A Novel, Orally Efficacious Tri-Substituted Thiophene Based Jnk Inhibitor Length = 363

Iteration: 1
 Score = 43.5 bits (101), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 34/92 (36%), Positives = 49/92 (53%), Gaps = 12/92 (13%)
Query: 393 GLEYLHLGCSTRILHFDIKPHNILLDEDFCPKISDFGLAKICNRKESIISMTGARGTVGY 452
           G+++LH   S  I+H D+KP NI++  D   KI DFGLA+      +   MT    T  Y
Sbjct: 138 GIKHLH---SAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAG---TSFMMTPYVVTRYY 191
Query: 453 IAPEVFCRNIGEVSYKS--DVYNYGMMIFEMT 482
            APEV    I  + YK   D+++ G ++ EM 
Sbjct: 192 RAPEV----ILGMGYKENVDIWSVGCIMGEMV 219

>pdb|2OK1|A Chain A, Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3- Chlorophenyl)-1h-Pyrazol-3-Yl)-1h-Pyrrole-2-Carboxamide Length = 365

Iteration: 1
 Score = 43.5 bits (101), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 34/92 (36%), Positives = 49/92 (53%), Gaps = 12/92 (13%)
Query: 393 GLEYLHLGCSTRILHFDIKPHNILLDEDFCPKISDFGLAKICNRKESIISMTGARGTVGY 452
           G+++LH   S  I+H D+KP NI++  D   KI DFGLA+      +   MT    T  Y
Sbjct: 139 GIKHLH---SAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAG---TSFMMTPYVVTRYY 192
Query: 453 IAPEVFCRNIGEVSYKS--DVYNYGMMIFEMT 482
            APEV    I  + YK   D+++ G ++ EM 
Sbjct: 193 RAPEV----ILGMGYKENVDIWSVGCIMGEMV 220

>pdb|2PZY|A Chain A, Structure Of Mk2 Complexed With Compound 76 Length = 324

Iteration: 1
 Score = 43.5 bits (101), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 37/110 (33%), Positives = 56/110 (50%), Gaps = 17/110 (15%)
Query: 375 GFCLRVAEELSSTIGIARGLEYLHLGCSTRILHFDIKPHNILLDE---DFCPKISDFGLA 431
            F  R A E+  +IG A  ++YLH   S  I H D+KP N+L      +   K++DFG A
Sbjct: 117 AFTEREASEIMKSIGEA--IQYLH---SINIAHRDVKPENLLYTSKRPNAILKLTDFGFA 171
Query: 432 KICNRKESIISMTGARGTVGYIAPEVFCRNIGEVSYKS--DVYNYGMMIF 479
           K      S  S+T    T  Y+APEV    +G   Y    D+++ G++++
Sbjct: 172 K---ETTSHNSLTTPCYTPYYVAPEV----LGPEKYDKSCDMWSLGVIMY 214

>pdb|2ONL|C Chain C, Crystal Structure Of The P38a-Mapkap Kinase 2 Heterodimer Length = 406

Iteration: 1
 Score = 43.5 bits (101), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 37/110 (33%), Positives = 56/110 (50%), Gaps = 17/110 (15%)
Query: 375 GFCLRVAEELSSTIGIARGLEYLHLGCSTRILHFDIKPHNILLDE---DFCPKISDFGLA 431
            F  R A E+  +IG A  ++YLH   S  I H D+KP N+L      +   K++DFG A
Sbjct: 163 AFTEREASEIMKSIGEA--IQYLH---SINIAHRDVKPENLLYTSKRPNAILKLTDFGFA 217
Query: 432 KICNRKESIISMTGARGTVGYIAPEVFCRNIGEVSYKS--DVYNYGMMIF 479
           K      S  S+T    T  Y+APEV    +G   Y    D+++ G++++
Sbjct: 218 K---ETTSHNSLTTPCYTPYYVAPEV----LGPEKYDKSCDMWSLGVIMY 260

>pdb|1Y8G|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Inactive Double Mutant With Selenomethionine Length = 327

Iteration: 1
 Score = 43.5 bits (101), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 48/195 (24%), Positives = 82/195 (42%), Gaps = 38/195 (19%)
Query: 321 LGQGGYGSVYKGK-LLDGSNVAVKVLNDSKGNG---KEFINEVASISRTSHVNVVALLG- 375
           +G+G +  V   + +L G  VAVK+++ ++ N    ++   EV      +H N+V L   
Sbjct: 22  IGKGNFAKVKLARHILTGKEVAVKIIDKTQLNSSSLQKLFREVRIXKVLNHPNIVKLFEV 81
Query: 376 -------------------FCLRVA-------EELSSTIGIARGLEYLHLGCSTRILHFD 409
                              F   VA       E  +    I   ++Y H      I+H D
Sbjct: 82  IETEKTLYLVXEYASGGEVFDYLVAHGRXKEKEARAKFRQIVSAVQYCH---QKFIVHRD 138
Query: 410 IKPHNILLDEDFCPKISDFGLAKICNRKESIISMTGARGTVGYIAPEVFCRNIGEVSYKS 469
           +K  N+LLD D   KI+DFG +        + +  GA     Y APE+F     +   + 
Sbjct: 139 LKAENLLLDADXNIKIADFGFSNEFTFGNKLDAFCGA---PPYAAPELFQGKKYD-GPEV 194
Query: 470 DVYNYGMMIFEMTGG 484
           DV++ G++++ +  G
Sbjct: 195 DVWSLGVILYTLVSG 209

>pdb|2O0U|A Chain A, Crystal Structure Of Human Jnk3 Complexed With N-{3-Cyano-6-[3-(1- Piperidinyl)propanoyl]-4,5,6,7-Tetrahydrothieno[2, 3-C]pyridin-2-Yl}- 1-Naphthalenecarboxamide Length = 364

Iteration: 1
 Score = 43.5 bits (101), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 34/92 (36%), Positives = 49/92 (53%), Gaps = 12/92 (13%)
Query: 393 GLEYLHLGCSTRILHFDIKPHNILLDEDFCPKISDFGLAKICNRKESIISMTGARGTVGY 452
           G+++LH   S  I+H D+KP NI++  D   KI DFGLA+      +   MT    T  Y
Sbjct: 138 GIKHLH---SAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAG---TSFMMTPYVVTRYY 191
Query: 453 IAPEVFCRNIGEVSYKS--DVYNYGMMIFEMT 482
            APEV    I  + YK   D+++ G ++ EM 
Sbjct: 192 RAPEV----ILGMGYKENVDIWSVGCIMGEMV 219

>pdb|3R2Y|A Chain A, Mk2 Kinase Bound To Compound 1 Length = 319

Iteration: 1
 Score = 43.5 bits (101), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 38/115 (33%), Positives = 58/115 (50%), Gaps = 17/115 (14%)
Query: 375 GFCLRVAEELSSTIGIARGLEYLHLGCSTRILHFDIKPHNILLDE---DFCPKISDFGLA 431
            F  R A E+  +IG A  ++YLH   S  I H D+KP N+L      +   K++DFG A
Sbjct: 112 AFTEREASEIMKSIGEA--IQYLH---SINIAHRDVKPENLLYTSKRPNAILKLTDFGFA 166
Query: 432 KICNRKESIISMTGARGTVGYIAPEVFCRNIGEVSYKS--DVYNYGMMIFEMTGG 484
           K      S  S+T    T  Y+APEV    +G   Y    D+++ G++++ +  G
Sbjct: 167 K---ETTSHNSLTTPCYTPYYVAPEV----LGPEKYDKSCDMWSLGVIMYILLCG 214

>pdb|2B1P|A Chain A, Inhibitor Complex Of Jnk3 Length = 355

Iteration: 1
 Score = 43.5 bits (101), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 34/92 (36%), Positives = 49/92 (53%), Gaps = 12/92 (13%)
Query: 393 GLEYLHLGCSTRILHFDIKPHNILLDEDFCPKISDFGLAKICNRKESIISMTGARGTVGY 452
           G+++LH   S  I+H D+KP NI++  D   KI DFGLA+      +   MT    T  Y
Sbjct: 131 GIKHLH---SAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAG---TSFMMTPYVVTRYY 184
Query: 453 IAPEVFCRNIGEVSYKS--DVYNYGMMIFEMT 482
            APEV    I  + YK   D+++ G ++ EM 
Sbjct: 185 RAPEV----ILGMGYKENVDIWSVGCIMGEMV 212

>pdb|4H36|A Chain A, Crystal Structure Of Jnk3 In Complex With Atf2 Peptide Length = 356

Iteration: 1
 Score = 43.5 bits (101), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 34/92 (36%), Positives = 49/92 (53%), Gaps = 12/92 (13%)
Query: 393 GLEYLHLGCSTRILHFDIKPHNILLDEDFCPKISDFGLAKICNRKESIISMTGARGTVGY 452
           G+++LH   S  I+H D+KP NI++  D   KI DFGLA+      +   MT    T  Y
Sbjct: 132 GIKHLH---SAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAG---TSFMMTPYVVTRYY 185
Query: 453 IAPEVFCRNIGEVSYKS--DVYNYGMMIFEMT 482
            APEV    I  + YK   D+++ G ++ EM 
Sbjct: 186 RAPEV----ILGMGYKENVDIWSVGCIMGEMV 213

>pdb|3R2B|A Chain A, Mk2 Kinase Bound To Compound 5b Length = 318

Iteration: 1
 Score = 43.5 bits (101), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 37/110 (33%), Positives = 56/110 (50%), Gaps = 17/110 (15%)
Query: 375 GFCLRVAEELSSTIGIARGLEYLHLGCSTRILHFDIKPHNILLDE---DFCPKISDFGLA 431
            F  R A E+  +IG A  ++YLH   S  I H D+KP N+L      +   K++DFG A
Sbjct: 111 AFTEREASEIMKSIGEA--IQYLH---SINIAHRDVKPENLLYTSKRPNAILKLTDFGFA 165
Query: 432 KICNRKESIISMTGARGTVGYIAPEVFCRNIGEVSYKS--DVYNYGMMIF 479
           K      S  S+T    T  Y+APEV    +G   Y    D+++ G++++
Sbjct: 166 K---ETTSHNSLTTPCYTPYYVAPEV----LGPEKYDKSCDMWSLGVIMY 208

>pdb|3FPM|A Chain A, Crystal Structure Of A Squarate Inhibitor Bound To Mapkap Kinase-2 Length = 325

Iteration: 1
 Score = 43.5 bits (101), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 37/110 (33%), Positives = 56/110 (50%), Gaps = 17/110 (15%)
Query: 375 GFCLRVAEELSSTIGIARGLEYLHLGCSTRILHFDIKPHNILLDE---DFCPKISDFGLA 431
            F  R A E+  +IG A  ++YLH   S  I H D+KP N+L      +   K++DFG A
Sbjct: 118 AFTEREASEIMKSIGEA--IQYLH---SINIAHRDVKPENLLYTSKRPNAILKLTDFGFA 172
Query: 432 KICNRKESIISMTGARGTVGYIAPEVFCRNIGEVSYKS--DVYNYGMMIF 479
           K      S  S+T    T  Y+APEV    +G   Y    D+++ G++++
Sbjct: 173 K---ETTSHNSLTTPCYTPYYVAPEV----LGPEKYDKSCDMWSLGVIMY 215

>pdb|2OZA|A Chain A, Structure Of P38alpha Complex Length = 356

Iteration: 1
 Score = 43.5 bits (101), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 37/110 (33%), Positives = 56/110 (50%), Gaps = 17/110 (15%)
Query: 375 GFCLRVAEELSSTIGIARGLEYLHLGCSTRILHFDIKPHNILLDE---DFCPKISDFGLA 431
            F  R A E+  +IG A  ++YLH   S  I H D+KP N+L      +   K++DFG A
Sbjct: 113 AFTEREASEIMKSIGEA--IQYLH---SINIAHRDVKPENLLYTSKRPNAILKLTDFGFA 167
Query: 432 KICNRKESIISMTGARGTVGYIAPEVFCRNIGEVSYKS--DVYNYGMMIF 479
           K      S  S+T    T  Y+APEV    +G   Y    D+++ G++++
Sbjct: 168 K---ETTSHNSLTTPCYTPYYVAPEV----LGPEKYDKSCDMWSLGVIMY 210

>pdb|2EXC|X Chain X, Inhibitor Complex Of Jnk3 Length = 356

Iteration: 1
 Score = 43.5 bits (101), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 34/92 (36%), Positives = 49/92 (53%), Gaps = 12/92 (13%)
Query: 393 GLEYLHLGCSTRILHFDIKPHNILLDEDFCPKISDFGLAKICNRKESIISMTGARGTVGY 452
           G+++LH   S  I+H D+KP NI++  D   KI DFGLA+      +   MT    T  Y
Sbjct: 132 GIKHLH---SAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAG---TSFMMTPYVVTRYY 185
Query: 453 IAPEVFCRNIGEVSYKS--DVYNYGMMIFEMT 482
            APEV    I  + YK   D+++ G ++ EM 
Sbjct: 186 RAPEV----ILGMGYKENVDIWSVGCIMGEMV 213

>pdb|3GOK|A Chain A, Binding Site Mapping Of Protein Ligands Length = 334

Iteration: 1
 Score = 43.5 bits (101), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 37/110 (33%), Positives = 56/110 (50%), Gaps = 17/110 (15%)
Query: 375 GFCLRVAEELSSTIGIARGLEYLHLGCSTRILHFDIKPHNILLDE---DFCPKISDFGLA 431
            F  R A E+  +IG A  ++YLH   S  I H D+KP N+L      +   K++DFG A
Sbjct: 127 AFTEREASEIMKSIGEA--IQYLH---SINIAHRDVKPENLLYTSKRPNAILKLTDFGFA 181
Query: 432 KICNRKESIISMTGARGTVGYIAPEVFCRNIGEVSYKS--DVYNYGMMIF 479
           K      S  S+T    T  Y+APEV    +G   Y    D+++ G++++
Sbjct: 182 K---ETTSHNSLTTPCYTPYYVAPEV----LGPEKYDKSCDMWSLGVIMY 224

>pdb|2HW6|A Chain A, Crystal Structure Of Mnk1 Catalytic Domain Length = 307

Iteration: 1
 Score = 43.5 bits (101), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 55/219 (25%), Positives = 96/219 (43%), Gaps = 47/219 (21%)
Query: 307 YADIKKMTNSFKYKLGQGGYGSVYKG-KLLDGSNVAVKVLNDSKGNGKEFI-NEVASISR 364
           + D+ K+T+     LG+G Y  V     L +G   AVK++    G+ +  +  EV ++ +
Sbjct: 10  FEDMYKLTSEL---LGEGAYAKVQGAVSLQNGKEYAVKIIEKQAGHSRSRVFREVETLYQ 66
Query: 365 -TSHVNVVALLGFC------LRVAEELSS---------------------TIGIARGLEY 396
              + N++ L+ F         V E+L                          +A  L++
Sbjct: 67  CQGNKNILELIEFFEDDTRFYLVFEKLQGGSILAHIQKQKHFNEREASRVVRDVAAALDF 126
Query: 397 LHLGCSTRILHFDIKPHNILLD--EDFCP-KISDFGLA---KICNRKESIIS--MTGARG 448
           LH   +  I H D+KP NIL +  E   P KI DF L    K+ N    I +  +T   G
Sbjct: 127 LH---TKGIAHRDLKPENILCESPEKVSPVKICDFDLGSGMKLNNSCTPITTPELTTPCG 183
Query: 449 TVGYIAPEVFCRNIGEVSY---KSDVYNYGMMIFEMTGG 484
           +  Y+APEV      + ++   + D+++ G++++ M  G
Sbjct: 184 SAEYMAPEVVEVFTDQATFYDKRCDLWSLGVVLYIMLSG 222

>pdb|2P3G|X Chain X, Crystal Structure Of A Pyrrolopyridine Inhibitor Bound To Mapkap Kinase-2 Length = 327

Iteration: 1
 Score = 43.5 bits (101), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 37/110 (33%), Positives = 56/110 (50%), Gaps = 17/110 (15%)
Query: 375 GFCLRVAEELSSTIGIARGLEYLHLGCSTRILHFDIKPHNILLDE---DFCPKISDFGLA 431
            F  R A E+  +IG A  ++YLH   S  I H D+KP N+L      +   K++DFG A
Sbjct: 113 AFTEREASEIMKSIGEA--IQYLH---SINIAHRDVKPENLLYTSKRPNAILKLTDFGFA 167
Query: 432 KICNRKESIISMTGARGTVGYIAPEVFCRNIGEVSYKS--DVYNYGMMIF 479
           K      S  S+T    T  Y+APEV    +G   Y    D+++ G++++
Sbjct: 168 K---ETTSHNSLTTPCYTPYYVAPEV----LGPEKYDKSCDMWSLGVIMY 210

>pdb|4AOJ|A Chain A, Human Trka In Complex With The Inhibitor Az-23 Length = 329

Iteration: 1
 Score = 43.5 bits (101), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 50/251 (19%), Positives = 100/251 (39%), Gaps = 61/251 (24%)
Query: 310 IKKMTNSFKYKLGQGGYGSVYKGK---LL---DGSNVAVKVLNDSKGNGKE-FINEVASI 362
           IK+     K++LG+G +G V+  +   LL   D   VAVK L ++  + ++ F  E   +
Sbjct: 38  IKRRDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELL 97
Query: 363 SRTSHVNVVALLGFC------------------------------------------LRV 380
           +   H ++V   G C                                          L +
Sbjct: 98  TMLQHQHIVRFFGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGL 157
Query: 381 AEELSSTIGIARGLEYLHLGCSTRILHFDIKPHNILLDEDFCPKISDFGLAKICNRKESI 440
            + L+    +A G+ YL        +H D+   N L+ +    KI DFG+++     +  
Sbjct: 158 GQLLAVASQVAAGMVYL---AGLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYY 214
Query: 441 ISMTGARGTVGYIAPEVFCRNIGEVSYKSDVYNYGMMIFEM-TGGRK------NVDVVDN 493
                    + ++ PE       + + +SDV+++G++++E+ T G++      N + +D 
Sbjct: 215 RVGGRTMLPIRWMPPESILYR--KFTTESDVWSFGVVLWEIFTYGKQPWYQLSNTEAIDC 272
Query: 494 GSTALDLQASR 504
            +   +L+  R
Sbjct: 273 ITQGRELERPR 283

>pdb|2WZJ|A Chain A, Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82r, T208e Double Mutant Length = 327

Iteration: 1
 Score = 43.1 bits (100), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 43/195 (22%), Positives = 81/195 (41%), Gaps = 38/195 (19%)
Query: 321 LGQGGYGSVYKGK-LLDGSNVAVKVLNDSKGNG---KEFINEVASISRTSHVNVVALLGF 376
           +G+G +  V   + +L G  VAV++++ ++ N    ++   EV  +   +H N+V L   
Sbjct: 22  IGKGNFAKVKLARHILTGKEVAVRIIDKTQLNSSSLQKLFREVRIMKVLNHPNIVKLFEV 81
Query: 377 C---------------------------LRVAEELSSTIGIARGLEYLHLGCSTRILHFD 409
                                       ++  E  +    I   ++Y H      I+H D
Sbjct: 82  IETEKTLYLVMEYASGGEVFDYLVAHGRMKEKEARAKFRQIVSAVQYCH---QKFIVHRD 138
Query: 410 IKPHNILLDEDFCPKISDFGLAKICNRKESIISMTGARGTVGYIAPEVFCRNIGEVSYKS 469
           +K  N+LLD D   KI+DFG +        +       G+  Y APE+F     +   + 
Sbjct: 139 LKAENLLLDADMNIKIADFGFSNEFTFGNKLDEFC---GSPPYAAPELFQGKKYD-GPEV 194
Query: 470 DVYNYGMMIFEMTGG 484
           DV++ G++++ +  G
Sbjct: 195 DVWSLGVILYTLVSG 209

>pdb|3KA0|A Chain A, Mk2 Complex With Inhibitor 6-(5-(2-Aminopyrimidin-4-Ylamino)-2- Hydroxyphenyl)-N-Methylbenzo[b]thiophene-2-Carboxamide Length = 320

Iteration: 1
 Score = 43.1 bits (100), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 37/110 (33%), Positives = 56/110 (50%), Gaps = 17/110 (15%)
Query: 375 GFCLRVAEELSSTIGIARGLEYLHLGCSTRILHFDIKPHNILLDE---DFCPKISDFGLA 431
            F  R A E+  +IG A  ++YLH   S  I H D+KP N+L      +   K++DFG A
Sbjct: 111 AFTEREASEIMKSIGEA--IQYLH---SINIAHRDVKPENLLYTSKRPNAILKLTDFGFA 165
Query: 432 KICNRKESIISMTGARGTVGYIAPEVFCRNIGEVSYKS--DVYNYGMMIF 479
           K      S  S+T    T  Y+APEV    +G   Y    D+++ G++++
Sbjct: 166 K---ETTSHNSLTEPCYTPYYVAPEV----LGPEKYDKSCDMWSLGVIMY 208

>pdb|3MFR|A Chain A, Cask-4m Cam Kinase Domain, Native Length = 351

Iteration: 1
 Score = 43.1 bits (100), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 34/98 (34%), Positives = 48/98 (48%), Gaps = 10/98 (10%)
Query: 390 IARGLEYLHLGCSTRILHFDIKPHNILL--DEDFCP-KISDFGLAKICNRKESIISMTGA 446
           I   L Y H      I+H D+KP N+LL   E+  P K+ DFG+A      ES +   G 
Sbjct: 139 ILEALRYCH---DNNIIHRDVKPENVLLASKENSAPVKLGDFGVA--IQLGESGLVAGGR 193
Query: 447 RGTVGYIAPEVFCRNIGEVSYKSDVYNYGMMIFEMTGG 484
            GT  ++APEV  R         DV+  G+++F +  G
Sbjct: 194 VGTPHFMAPEVVKRE--PYGKPVDVWGCGVILFILLSG 229

>pdb|3ELJ|A Chain A, Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine Inhibitor Length = 369

Iteration: 1
 Score = 43.1 bits (100), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 34/92 (36%), Positives = 49/92 (53%), Gaps = 12/92 (13%)
Query: 393 GLEYLHLGCSTRILHFDIKPHNILLDEDFCPKISDFGLAKICNRKESIISMTGARGTVGY 452
           G+++LH   S  I+H D+KP NI++  D   KI DFGLA+      +   MT    T  Y
Sbjct: 143 GIKHLH---SAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAG---TSFMMTPYVVTRYY 196
Query: 453 IAPEVFCRNIGEVSYKS--DVYNYGMMIFEMT 482
            APEV    I  + YK   D+++ G ++ EM 
Sbjct: 197 RAPEV----ILGMGYKENVDLWSVGCIMGEMV 224

>pdb|2DYL|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 7 Activated Mutant (S287d, T291d) Length = 318

Iteration: 1
 Score = 43.1 bits (100), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 32/102 (31%), Positives = 52/102 (50%), Gaps = 8/102 (7%)
Query: 387 TIGIARGLEYLHLGCSTRILHFDIKPHNILLDEDFCPKISDFGLAKICNRKESIISMTGA 446
           T+ I + L YL       ++H D+KP NILLDE    K+ DFG   I  R     +   +
Sbjct: 130 TVAIVKALYYLKEKHG--VIHRDVKPSNILLDERGQIKLCDFG---ISGRLVDDKAKDRS 184
Query: 447 RGTVGYIAPE-VFCRNIGEVSY--KSDVYNYGMMIFEMTGGR 485
            G   Y+APE +   +  +  Y  ++DV++ G+ + E+  G+
Sbjct: 185 AGCAAYMAPERIDPPDPTKPDYDIRADVWSLGISLVELATGQ 226

>pdb|3R1N|A Chain A, Mk3 Kinase Bound To Compound 5b Length = 317

Iteration: 1
 Score = 42.7 bits (99), Expect = 5e-04,   Method: Compositional matrix adjust.
 Identities = 34/110 (30%), Positives = 56/110 (50%), Gaps = 18/110 (16%)
Query: 375 GFCLRVAEELSSTIGIARGLEYLHLGCSTRILHFDIKPHNILL---DEDFCPKISDFGLA 431
            F  R A E+   IG A  +++LH   S  I H D+KP N+L    ++D   K++DFG A
Sbjct: 105 AFTEREAAEIMRDIGTA--IQFLH---SHNIAHRDVKPENLLYTSKEKDAVLKLTDFGFA 159
Query: 432 KICNRKESIISMTGARGTVGYIAPEVFCRNIGEVSYKS--DVYNYGMMIF 479
           K   +     ++     T  Y+APEV    +G   Y    D+++ G++++
Sbjct: 160 KETTQN----ALQTPCYTPYYVAPEV----LGPEKYDKSCDMWSLGVIMY 201

>pdb|1NXK|A Chain A, Crystal Structure Of Staurosporine Bound To Map Kap Kinase 2 Length = 400

Iteration: 1
 Score = 42.7 bits (99), Expect = 5e-04,   Method: Compositional matrix adjust.
 Identities = 38/115 (33%), Positives = 56/115 (48%), Gaps = 17/115 (14%)
Query: 375 GFCLRVAEELSSTIGIARGLEYLHLGCSTRILHFDIKPHNILLDE---DFCPKISDFGLA 431
            F  R A E+  +IG A  ++YLH   S  I H D+KP N+L      +   K++DFG A
Sbjct: 157 AFTEREASEIXKSIGEA--IQYLH---SINIAHRDVKPENLLYTSKRPNAILKLTDFGFA 211
Query: 432 KICNRKESIISMTGARGTVGYIAPEVFCRNIGEVSYKS--DVYNYGMMIFEMTGG 484
           K      S  S+T    T  Y+APEV    +G   Y    D ++ G++ + +  G
Sbjct: 212 K---ETTSHNSLTTPCYTPYYVAPEV----LGPEKYDKSCDXWSLGVIXYILLCG 259

>pdb|1KOA|A Chain A, Twitchin Kinase Fragment (C.Elegans), Autoregulated Protein Kinase And Immunoglobulin Domains Length = 491

Iteration: 1
 Score = 42.7 bits (99), Expect = 5e-04,   Method: Compositional matrix adjust.
 Identities = 47/195 (24%), Positives = 82/195 (42%), Gaps = 36/195 (18%)
Query: 320 KLGQGGYGSVYK-GKLLDGSNVAVKVLNDSKGNGKEFI-NEVASISRTSHVNVVALLG-- 375
           +LG G +G V++  +   G+N A K +     + KE +  E+ ++S   H  +V L    
Sbjct: 58  ELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAF 117
Query: 376 -----------------FCLRVAEELSSTIGIARGLEYLHLGC-------STRILHFDIK 411
                               +VA+E  + +     +EY+   C           +H D+K
Sbjct: 118 EDDNEMVMIYEFMSGGELFEKVADE-HNKMSEDEAVEYMRQVCKGLCHMHENNYVHLDLK 176
Query: 412 PHNILLDEDFCP--KISDFGLAKICNRKESIISMTGARGTVGYIAPEVFCRNIGEVSYKS 469
           P NI+         K+ DFGL    + K+S+   T   GT  + APEV       V Y +
Sbjct: 177 PENIMFTTKRSNELKLIDFGLTAHLDPKQSVKVTT---GTAEFAAPEV--AEGKPVGYYT 231
Query: 470 DVYNYGMMIFEMTGG 484
           D+++ G++ + +  G
Sbjct: 232 DMWSVGVLSYILLSG 246

>pdb|3PZE|A Chain A, Jnk1 In Complex With Inhibitor Length = 358

Iteration: 1
 Score = 42.7 bits (99), Expect = 5e-04,   Method: Compositional matrix adjust.
 Identities = 34/92 (36%), Positives = 49/92 (53%), Gaps = 12/92 (13%)
Query: 393 GLEYLHLGCSTRILHFDIKPHNILLDEDFCPKISDFGLAKICNRKESIISMTGARGTVGY 452
           G+++LH   S  I+H D+KP NI++  D   KI DFGLA+      +   MT    T  Y
Sbjct: 132 GIKHLH---SAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAG---TSFMMTPYVVTRYY 185
Query: 453 IAPEVFCRNIGEVSYKS--DVYNYGMMIFEMT 482
            APEV    I  + YK   D+++ G ++ EM 
Sbjct: 186 RAPEV----ILGMGYKENVDLWSVGCIMGEMV 213

>pdb|4G3D|A Chain A, Crystal Structure Of Human Nf-kappab Inducing Kinase (nik) Length = 371

Iteration: 1
 Score = 42.7 bits (99), Expect = 5e-04,   Method: Compositional matrix adjust.
 Identities = 35/97 (36%), Positives = 49/97 (50%), Gaps = 11/97 (11%)
Query: 393 GLEYLHLGCSTRILHFDIKPHNILLDEDFC-PKISDFGLAKICNRKE----SIISMTGAR 447
           GLEYLH   S RILH D+K  N+LL  D     + DFG A +C + +    S+++     
Sbjct: 197 GLEYLH---SRRILHGDVKADNVLLSSDGSHAALCDFGHA-VCLQPDGLGKSLLTGDYIP 252
Query: 448 GTVGYIAPEVFCRNIGEVSYKSDVYNYGMMIFEMTGG 484
           GT  ++APEV          K DV++   M+  M  G
Sbjct: 253 GTETHMAPEVVLGR--SCDAKVDVWSSCCMMLHMLNG 287

>pdb|2VZ6|A Chain A, Structure Of Human Calcium Calmodulin Dependent Protein Kinase Type Ii Alpha (Camk2a) In Complex With Indirubin E804 Length = 313

Iteration: 1
 Score = 42.7 bits (99), Expect = 5e-04,   Method: Compositional matrix adjust.
 Identities = 52/176 (29%), Positives = 77/176 (43%), Gaps = 39/176 (22%)
Query: 320 KLGQGGYGSVYK-GKLLDGSNVAVKVLNDSKGNGKEF--INEVASISRT-SHVNVVAL-- 373
           +LG+G +  V +  K+L G   A K++N  K + ++   +   A I R   H N+V L  
Sbjct: 29  ELGKGAFSVVRRCVKVLAGQEYAAKIINTKKLSARDHQKLEREARICRLLKHPNIVRLHD 88
Query: 374 ---------LGFCLRVAEELSSTIGIARGLEYLHLG----CSTRIL------------HF 408
                    L F L    EL   I +AR  EY        C  +IL            H 
Sbjct: 89  SISEEGHHYLIFDLVTGGELFEDI-VAR--EYYSEADASHCIQQILEAVLHCHQMGVVHR 145
Query: 409 DIKPHNILLDEDF---CPKISDFGLAKICNRKESIISMTGARGTVGYIAPEVFCRN 461
           D+KP N+LL         K++DFGLA     ++   +  G  GT GY++PEV  ++
Sbjct: 146 DLKPENLLLASKLKGAAVKLADFGLAIEVEGEQQ--AWFGFAGTPGYLSPEVLRKD 199

>pdb|3FHR|A Chain A, High Resolution Crystal Structure Of Mitogen-Activated Protein Kinase-Activated Protein Kinase 3 (Mk3)-Inhibitor Complex Length = 336

Iteration: 1
 Score = 42.7 bits (99), Expect = 5e-04,   Method: Compositional matrix adjust.
 Identities = 34/110 (30%), Positives = 56/110 (50%), Gaps = 18/110 (16%)
Query: 375 GFCLRVAEELSSTIGIARGLEYLHLGCSTRILHFDIKPHNILL---DEDFCPKISDFGLA 431
            F  R A E+   IG A  +++LH   S  I H D+KP N+L    ++D   K++DFG A
Sbjct: 124 AFTEREAAEIMRDIGTA--IQFLH---SHNIAHRDVKPENLLYTSKEKDAVLKLTDFGFA 178
Query: 432 KICNRKESIISMTGARGTVGYIAPEVFCRNIGEVSYKS--DVYNYGMMIF 479
           K   +     ++     T  Y+APEV    +G   Y    D+++ G++++
Sbjct: 179 KETTQN----ALQTPCYTPYYVAPEV----LGPEKYDKSCDMWSLGVIMY 220

>pdb|2QR7|A Chain A, 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2: Se-Met Derivative Length = 342

Iteration: 1
 Score = 42.4 bits (98), Expect = 5e-04,   Method: Compositional matrix adjust.
 Identities = 30/99 (30%), Positives = 52/99 (52%), Gaps = 11/99 (11%)
Query: 390 IARGLEYLHLGCSTRILHFDIKPHNIL-LDEDFCP---KISDFGLAKICNRKESIISMTG 445
           I + +EYLH   +  ++H D+KP NIL +DE   P   +I DFG AK    +  ++    
Sbjct: 125 ITKTVEYLH---AQGVVHRDLKPSNILYVDESGNPESIRICDFGFAKQLRAENGLLXTPC 181
Query: 446 ARGTVGYIAPEVFCRNIGEVSYKSDVYNYGMMIFEMTGG 484
              T  ++APEV  R   + +   D+++ G++++    G
Sbjct: 182 Y--TANFVAPEVLERQGYDAA--CDIWSLGVLLYTXLTG 216

>pdb|3RP9|A Chain A, Crystal Structure Of The Apo Mapk From Toxoplasma Gondii, 25.M01780 Or Tgme49_007820 Length = 458

Iteration: 1
 Score = 42.4 bits (98), Expect = 6e-04,   Method: Compositional matrix adjust.
 Identities = 43/160 (26%), Positives = 71/160 (44%), Gaps = 40/160 (25%)
Query: 316 SFKYKLGQGGYGSVYKG-KLLDGSNVAVK----VLNDSKGNGKEFINEVASISRTSHVNV 370
             ++ +G G YG V +    L+   VA+K    V  D   + K  + E+A ++R +H +V
Sbjct: 56  EIRHLIGTGSYGHVCEAYDKLEKRVVAIKKILRVFEDLI-DCKRILREIAILNRLNHDHV 114
Query: 371 VALLGFCL----RVAEELSSTIGIAR---------------------------GLEYLHL 399
           V +L   +       +EL   + IA                            G++Y+H 
Sbjct: 115 VKVLDIVIPKDVEKFDELYVVLEIADSDFKKLFRTPVYLTELHIKTLLYNLLVGVKYVH- 173
Query: 400 GCSTRILHFDIKPHNILLDEDFCPKISDFGLAKICNRKES 439
             S  ILH D+KP N L+++D   K+ DFGLA+  +  E+
Sbjct: 174 --SAGILHRDLKPANCLVNQDCSVKVCDFGLARTVDYPEN 211

>pdb|3NPC|A Chain A, Crystal Structure Of Jnk2 Complexed With Birb796 Length = 364

Iteration: 1
 Score = 42.4 bits (98), Expect = 6e-04,   Method: Compositional matrix adjust.
 Identities = 57/228 (25%), Positives = 89/228 (39%), Gaps = 62/228 (27%)
Query: 292 TFLRNYRSLSPKRYGYADIKKMTNSFKYKLGQGGYGSVYKG-KLLDGSNVAVKVLN---D 347
           T L+ Y+ L P                  +G G  G V      + G NVAVK L+    
Sbjct: 21  TVLKRYQQLKP------------------IGSGAQGIVCAAFDTVLGINVAVKKLSRPFQ 62
Query: 348 SKGNGKEFINEVASISRTSHVNVVALLGFCL--RVAEELSSTIGIAR------------- 392
           ++ + K    E+  +   +H N+++LL      +  EE      +               
Sbjct: 63  NQTHAKRAYRELVLLKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIHME 122
Query: 393 ---------------GLEYLHLGCSTRILHFDIKPHNILLDEDFCPKISDFGLAKI-CNR 436
                          G+++LH   S  I+H D+KP NI++  D   KI DFGLA+  C  
Sbjct: 123 LDHERMSYLLYQMLCGIKHLH---SAGIIHRDLKPSNIVVKSDCTLKILDFGLARTACTN 179
Query: 437 KESIISMTGARGTVGYIAPEVFCRNIGEVSYKSDVYNYGMMIFEMTGG 484
                 MT    T  Y APEV    +G  +   D+++ G ++ E+  G
Sbjct: 180 ----FMMTPYVVTRYYRAPEVIL-GMGYAA-NVDIWSVGCIMGELVKG 221

>pdb|2F9G|A Chain A, Crystal Structure Of Fus3 Phosphorylated On Tyr182 Length = 353

Iteration: 1
 Score = 42.4 bits (98), Expect = 6e-04,   Method: Compositional matrix adjust.
 Identities = 53/223 (23%), Positives = 90/223 (40%), Gaps = 51/223 (22%)
Query: 302 PKRYGYADIKKMTNSFKYK--LGQGGYGSV-YKGKLLDGSNVAVKVLN--DSKGNGKEFI 356
           PKR  Y     +++ F+ K  LG+G YG V        G  VA+K +   D        +
Sbjct: 2   PKRIVY----NISSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRTL 57
Query: 357 NEVASISRTSHVNVVALLGFC----------LRVAEELSST------------------- 387
            E+  +    H N++ +              + + +EL  T                   
Sbjct: 58  REIKILKHFKHENIITIFNIQRPDSFENFNEVYIIQELMQTDLHRVISTQMLSDDHIQYF 117
Query: 388 -IGIARGLEYLHLGCSTRILHFDIKPHNILLDEDFCPKISDFGLAKICNRKESIIS---- 442
                R ++ LH    + ++H D+KP N+L++ +   K+ DFGLA+I +   +  S    
Sbjct: 118 IYQTLRAVKVLH---GSNVIHRDLKPSNLLINSNCDLKVCDFGLARIIDESAADNSEPTG 174
Query: 443 ----MTGARGTVGYIAPEVFCRNIGEVSYKSDVYNYGMMIFEM 481
               MT    T  Y APEV   +  + S   DV++ G ++ E+
Sbjct: 175 QQSGMTEXVATRWYRAPEVMLTS-AKYSRAMDVWSCGCILAEL 216

>pdb|2WEL|A Chain A, Crystal Structure Of Su6656-Bound CalciumCALMODULIN- Dependent Protein Kinase Ii Delta In Complex With Calmodulin Length = 327

Iteration: 1
 Score = 42.4 bits (98), Expect = 6e-04,   Method: Compositional matrix adjust.
 Identities = 50/185 (27%), Positives = 79/185 (42%), Gaps = 41/185 (22%)
Query: 313 MTNSFKY--KLGQGGYGSVYK-GKLLDGSNVAVKVLNDSKGNGKEF--INEVASISRT-S 366
           MT+ ++   +LG+G +  V +  K+  G   A K++N  K + ++   +   A I R   
Sbjct: 2   MTDEYQLFEELGKGAFSVVRRCMKIPTGQEYAAKIINTKKLSARDHQKLEREARICRLLK 61
Query: 367 HVNVVAL-----------LGFCLRVAEELSSTI----------------GIARGLEYLHL 399
           H N+V L           L F L    EL   I                 I   + + HL
Sbjct: 62  HPNIVRLHDSISEEGFHYLVFDLVTGGELFEDIVAREYYSEADASHCIQQILESVNHCHL 121
Query: 400 GCSTRILHFDIKPHNILL---DEDFCPKISDFGLAKICNRKESIISMTGARGTVGYIAPE 456
                I+H D+KP N+LL    +    K++DFGLA      +   +  G  GT GY++PE
Sbjct: 122 NG---IVHRDLKPENLLLASKSKGAAVKLADFGLAIEVQGDQQ--AWFGFAGTPGYLSPE 176
Query: 457 VFCRN 461
           V  ++
Sbjct: 177 VLRKD 181

>pdb|3UTO|A Chain A, Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-Crd-Ig26) Length = 573

Iteration: 1
 Score = 42.4 bits (98), Expect = 6e-04,   Method: Compositional matrix adjust.
 Identities = 47/195 (24%), Positives = 82/195 (42%), Gaps = 36/195 (18%)
Query: 320 KLGQGGYGSVYK-GKLLDGSNVAVKVLNDSKGNGKEFI-NEVASISRTSHVNVVALLG-- 375
           +LG G +G V++  +   G+N A K +     + KE +  E+ ++S   H  +V L    
Sbjct: 164 ELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAF 223
Query: 376 -----------------FCLRVAEELSSTIGIARGLEYLHLGC-------STRILHFDIK 411
                               +VA+E  + +     +EY+   C           +H D+K
Sbjct: 224 EDDNEMVMIYEFMSGGELFEKVADE-HNKMSEDEAVEYMRQVCKGLCHMHENNYVHLDLK 282
Query: 412 PHNILLDEDFCP--KISDFGLAKICNRKESIISMTGARGTVGYIAPEVFCRNIGEVSYKS 469
           P NI+         K+ DFGL    + K+S+   T   GT  + APEV       V Y +
Sbjct: 283 PENIMFTTKRSNELKLIDFGLTAHLDPKQSVKVTT---GTAEFAAPEVAEGK--PVGYYT 337
Query: 470 DVYNYGMMIFEMTGG 484
           D+++ G++ + +  G
Sbjct: 338 DMWSVGVLSYILLSG 352

>pdb|2VN9|A Chain A, Crystal Structure Of Human Calcium Calmodulin Dependent Protein Kinase Ii Delta Isoform 1, Camkd Length = 301

Iteration: 1
 Score = 42.0 bits (97), Expect = 7e-04,   Method: Compositional matrix adjust.
 Identities = 50/185 (27%), Positives = 79/185 (42%), Gaps = 41/185 (22%)
Query: 313 MTNSFKY--KLGQGGYGSVYK-GKLLDGSNVAVKVLNDSKGNGKEF--INEVASISRT-S 366
           MT+ ++   +LG+G +  V +  K+  G   A K++N  K + ++   +   A I R   
Sbjct: 2   MTDEYQLFEELGKGAFSVVRRCMKIPTGQEYAAKIINTKKLSARDHQKLEREARICRLLK 61
Query: 367 HVNVVAL-----------LGFCLRVAEELSSTI----------------GIARGLEYLHL 399
           H N+V L           L F L    EL   I                 I   + + HL
Sbjct: 62  HPNIVRLHDSISEEGFHYLVFDLVTGGELFEDIVAREYYSEADASHCIQQILESVNHCHL 121
Query: 400 GCSTRILHFDIKPHNILL---DEDFCPKISDFGLAKICNRKESIISMTGARGTVGYIAPE 456
                I+H D+KP N+LL    +    K++DFGLA      +   +  G  GT GY++PE
Sbjct: 122 NG---IVHRDLKPENLLLASKSKGAAVKLADFGLAIEVQGDQQ--AWFGFAGTPGYLSPE 176
Query: 457 VFCRN 461
           V  ++
Sbjct: 177 VLRKD 181

>pdb|2B9F|A Chain A, Crystal Structure Of Non-Phosphorylated Fus3 Length = 353

Iteration: 1
 Score = 42.0 bits (97), Expect = 7e-04,   Method: Compositional matrix adjust.
 Identities = 53/223 (23%), Positives = 90/223 (40%), Gaps = 51/223 (22%)
Query: 302 PKRYGYADIKKMTNSFKYK--LGQGGYGSV-YKGKLLDGSNVAVKVLN--DSKGNGKEFI 356
           PKR  Y     +++ F+ K  LG+G YG V        G  VA+K +   D        +
Sbjct: 2   PKRIVY----NISSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRTL 57
Query: 357 NEVASISRTSHVNVVALLGFC----------LRVAEELSST------------------- 387
            E+  +    H N++ +              + + +EL  T                   
Sbjct: 58  REIKILKHFKHENIITIFNIQRPDSFENFNEVYIIQELMQTDLHRVISTQMLSDDHIQYF 117
Query: 388 -IGIARGLEYLHLGCSTRILHFDIKPHNILLDEDFCPKISDFGLAKICNRKESIIS---- 442
                R ++ LH    + ++H D+KP N+L++ +   K+ DFGLA+I +   +  S    
Sbjct: 118 IYQTLRAVKVLH---GSNVIHRDLKPSNLLINSNCDLKVCDFGLARIIDESAADNSEPTG 174
Query: 443 ----MTGARGTVGYIAPEVFCRNIGEVSYKSDVYNYGMMIFEM 481
               MT    T  Y APEV   +  + S   DV++ G ++ E+
Sbjct: 175 QQSGMTEYVATRWYRAPEVMLTS-AKYSRAMDVWSCGCILAEL 216

>pdb|3FME|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 6 (Mek6) Activated Mutant (S207d, T211d) Length = 290

Iteration: 1
 Score = 42.0 bits (97), Expect = 7e-04,   Method: Compositional matrix adjust.
 Identities = 27/98 (27%), Positives = 50/98 (51%), Gaps = 7/98 (7%)
Query: 387 TIGIARGLEYLHLGCSTRILHFDIKPHNILLDEDFCPKISDFGLAKICNRKESIISMTGA 446
            + I + LE+LH   S  ++H D+KP N+L++     K+ DFG++         ++    
Sbjct: 115 AVSIVKALEHLHSKLS--VIHRDVKPSNVLINALGQVKMCDFGISGYLVDD---VAKDID 169
Query: 447 RGTVGYIAPEVFCRNIGEVSY--KSDVYNYGMMIFEMT 482
            G   Y+APE     + +  Y  KSD+++ G+ + E+ 
Sbjct: 170 AGCKPYMAPERINPELNQKGYSVKSDIWSLGITMIELA 207

>pdb|4DN5|A Chain A, Crystal Structure Of Nf-kb-inducing Kinase (nik) Length = 356

Iteration: 1
 Score = 42.0 bits (97), Expect = 8e-04,   Method: Compositional matrix adjust.
 Identities = 36/97 (37%), Positives = 49/97 (50%), Gaps = 11/97 (11%)
Query: 393 GLEYLHLGCSTRILHFDIKPHNILLDEDFC-PKISDFGLAKICNRKESIIS--MTG--AR 447
           GLEYLH   S RILH D+K  N+LL  D     + DFG A +C + + +    +TG    
Sbjct: 178 GLEYLH---SRRILHGDVKADNVLLSSDGSHAALCDFGHA-VCLQPDGLGKDLLTGDYIP 233
Query: 448 GTVGYIAPEVFCRNIGEVSYKSDVYNYGMMIFEMTGG 484
           GT  ++APEV          K DV++   M+  M  G
Sbjct: 234 GTETHMAPEVVLGR--SCDAKVDVWSSCCMMLHMLNG 268

>pdb|3O17|A Chain A, Crystal Structure Of Jnk1-Alpha1 Isoform Length = 370

Iteration: 1
 Score = 42.0 bits (97), Expect = 8e-04,   Method: Compositional matrix adjust.
 Identities = 33/92 (35%), Positives = 48/92 (52%), Gaps = 12/92 (13%)
Query: 393 GLEYLHLGCSTRILHFDIKPHNILLDEDFCPKISDFGLAKICNRKESIISMTGARGTVGY 452
           G+++LH   S  I+H D+KP NI++  D   KI DFGLA+      +   M     T  Y
Sbjct: 138 GIKHLH---SAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAG---TSFMMEPEVVTRYY 191
Query: 453 IAPEVFCRNIGEVSYKS--DVYNYGMMIFEMT 482
            APEV    I  + YK   D+++ G ++ EM 
Sbjct: 192 RAPEV----ILGMGYKENVDIWSVGCIMGEMV 219

>pdb|1VZO|A Chain A, The Structure Of The N-Terminal Kinase Domain Of Msk1 Reveals A Novel Autoinhibitory Conformation For A Dual Kinase Protein Length = 355

Iteration: 1
 Score = 42.0 bits (97), Expect = 9e-04,   Method: Compositional matrix adjust.
 Identities = 31/98 (31%), Positives = 51/98 (52%), Gaps = 10/98 (10%)
Query: 390 IARGLEYLH-LGCSTRILHFDIKPHNILLDEDFCPKISDFGLAK--ICNRKESIISMTGA 446
           I   LE+LH LG    I++ DIK  NILLD +    ++DFGL+K  + +  E        
Sbjct: 168 IVLALEHLHKLG----IIYRDIKLENILLDSNGHVVLTDFGLSKEFVADETERAYDFC-- 221
Query: 447 RGTVGYIAPEVFCRNIGEVSYKSDVYNYGMMIFEMTGG 484
            GT+ Y+AP++            D ++ G++++E+  G
Sbjct: 222 -GTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTG 258

Structure Templates Detected by RPS-BLAST

Original result of RPS-BLAST against PDB70 database

ID	Length	Definition	E-value
Query	506
3uim_A	326	Brassinosteroid insensitive 1-associated receptor;	1e-71
2qkw_B	321	Protein kinase; three-helix bundle motif, AVRPTO-P	1e-61
2nru_A	307	Interleukin-1 receptor-associated kinase 4; inhibi	1e-56
3p86_A	309	Serine/threonine-protein kinase CTR1; ETR1, ERS1,	2e-48
3soc_A	322	Activin receptor type-2A; structural genomics cons	6e-46
4f0f_A	287	Serine/threonine-protein kinase ROCO4; LRRK2, ATP-	4e-45
2eva_A	307	TAK1 kinase - TAB1 chimera fusion protein; transfe	4e-44
3og7_A	289	AKAP9-BRAF fusion protein; proto-oncogene, V600E,	1e-42
3kmu_A	271	ILK, integrin-linked kinase; cell adhesion, ANK re	5e-42
3dtc_A	271	Mitogen-activated protein kinase kinase kinase 9;	9e-41
3lb7_A	307	RAF proto-oncogene serine/threonine-protein kinas;	2e-40
2y4i_B	319	KSR2, HKSR2, kinase suppressor of RAS 2; transfera	4e-40
3g2f_A	336	Bone morphogenetic protein receptor type-2; kinase	1e-39
3gxj_A	303	TGF-beta receptor type-1; ALK5, kinase, inhibitor,	3e-36
3mdy_A	337	Bone morphogenetic protein receptor type-1B; compl	2e-35
1b6c_B	342	TGF-B superfamily receptor type I; complex (isomer	6e-35
3q4u_A	301	Activin receptor type-1; structural genomics conso	8e-35
3s95_A	310	LIMK-1, LIM domain kinase 1; structural genomics,	1e-31
1zy4_A	303	Serine/threonine-protein kinase GCN2; translation	4e-30
4eqm_A	294	Protein kinase; transferase; HET: ANP; 3.00A {Stap	3e-29
2pzi_A	681	Probable serine/threonine-protein kinase PKNG; ATP	5e-29
3ork_A	311	Serine/threonine protein kinase; structural genomi	4e-28
3lzb_A	327	Epidermal growth factor receptor; epidermal growth	2e-27
1t4h_A	290	Serine/threonine-protein kinase WNK1; protein seri	5e-27
2h34_A	309	Serine/threonine-protein kinase PKNE; apoenzyme, t	2e-26
3p1a_A	311	MYT1 kinase, membrane-associated tyrosine- and thr	4e-26
3p23_A	432	Serine/threonine-protein kinase/endoribonuclease;	4e-26
3poz_A	327	Epidermal growth factor receptor; kinase domain, a	6e-26
3cek_A	313	Dual specificity protein kinase TTK; HMPS1, PYT, E	1e-25
3kex_A	325	Receptor tyrosine-protein kinase ERBB-3; kinase do	1e-25
3dbq_A	343	Dual specificity protein kinase TTK; MPS1 structur	2e-25
4g31_A	299	Eukaryotic translation initiation factor 2-alpha;	2e-25
2a19_B	284	Interferon-induced, double-stranded RNA-activated	3e-25
3cbl_A	377	C-FES, proto-oncogene tyrosine-protein kinase FES/	4e-25
1qcf_A	454	Haematopoetic cell kinase (HCK); tyrosine kinase-i	1e-24
1u59_A	287	Tyrosine-protein kinase ZAP-70; transferase; HET:	2e-24
1qpc_A	279	LCK kinase; alpha beta fold, transferase; HET: PTR	2e-24
4apc_A	350	Serine/threonine-protein kinase NEK1; transferase;	2e-24
2zmd_A	390	Dual specificity protein kinase TTK; MPS1, T686A,	3e-24
2wqm_A	310	Serine/threonine-protein kinase NEK7; ATP-binding,	3e-24
3t9t_A	267	Tyrosine-protein kinase ITK/TSK; kinase domain, al	3e-24
1fmk_A	452	C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros	3e-24
4g3f_A	336	NF-kappa-beta-inducing kinase; non-RD kinase, prot	4e-24
3sxs_A	268	Cytoplasmic tyrosine-protein kinase BMX; transfera	5e-24
2h8h_A	535	Proto-oncogene tyrosine-protein kinase SRC; SRC ki	5e-24
1mp8_A	281	Focal adhesion kinase 1; tyrosine protein kinase,	5e-24
2clq_A	295	Mitogen-activated protein kinase kinase kinase 5;	9e-24
2c30_A	321	Serine/threonine-protein kinase PAK 6; CRIB domain	2e-23
1xbb_A	291	Tyrosine-protein kinase SYK; gleevec, STI-571, ima	2e-23
3kfa_A	288	Tyrosine-protein kinase ABL1; CML, drug resistance	3e-23
3f66_A	298	Hepatocyte growth factor receptor; C-Met, protein	3e-23
1opk_A	495	P150, C-ABL, proto-oncogene tyrosine-protein kinas	3e-23
3pls_A	298	Macrophage-stimulating protein receptor; protein k	4e-23
3gen_A	283	Tyrosine-protein kinase BTK; bruton'S tyrosine kin	5e-23
1u46_A	291	ACK-1, activated CDC42 kinase 1; tyrosine kinase,	7e-23
3mwu_A	486	Calmodulin-domain protein kinase 1; serine/threoni	7e-23
2rio_A	434	Serine/threonine-protein kinase/endoribonuclease I	7e-23
3nyv_A	484	Calmodulin-domain protein kinase 1; serine/threoni	8e-23
3lij_A	494	Calcium/calmodulin dependent protein kinase with A	9e-23
1u5q_A	348	Serine/threonine protein kinase TAO2; transferase;	9e-23
1x8b_A	289	WEE1HU, WEE1-like protein kinase; cell cycle, tran	1e-22
3kul_A	325	Ephrin type-A receptor 8; ATP-binding, kinase, nuc	1e-22
3fxz_A	297	Serine/threonine-protein kinase PAK 1; transferase	1e-22
3c1x_A	373	Hepatocyte growth factor receptor; receptor tyrosi	2e-22
2j7t_A	302	Serine/threonine-protein kinase 10; transferase, A	2e-22
3cc6_A	281	Protein tyrosine kinase 2 beta; focal adhesion kin	2e-22
1mqb_A	333	Ephrin type-A receptor 2; tyrosine protein kinase,	3e-22
2w5a_A	279	Serine/threonine-protein kinase NEK2; Ser/Thr prot	3e-22
2ozo_A	613	Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t	4e-22
3lxp_A	318	Non-receptor tyrosine-protein kinase TYK2; JAK3, i	4e-22
3ugc_A	295	Tyrosine-protein kinase JAK2; small molecule inhib	5e-22
2x7f_A	326	TRAF2 and NCK-interacting protein kinase; serine/t	6e-22
1byg_A	278	CSK, protein (C-terminal SRC kinase); protein kina	6e-22
3lxl_A	327	Tyrosine-protein kinase JAK3; TYK2, inflammation,	8e-22
2j0j_A	656	Focal adhesion kinase 1; cell migration, FERM, tra	9e-22
1k9a_A	450	Carboxyl-terminal SRC kinase; COOH-terminal SRC ki	1e-21
3a7i_A	303	MST3 kinase, serine/threonine kinase 24 (STE20 hom	1e-21
2buj_A	317	Serine/threonine-protein kinase 16; transferase, A	1e-21
4euu_A	319	Serine/threonine-protein kinase TBK1; ATP binding,	1e-21
2owb_A	335	Serine/threonine-protein kinase PLK1; catalytic do	1e-21
3com_A	314	Serine/threonine-protein kinase 4; MST1, STE20-lik	1e-21
2w1i_A	326	JAK2; chromosomal rearrangement, nucleotide-bindin	2e-21
2rku_A	294	Serine/threonine-protein kinase PLK1; structure of	2e-21
2wei_A	287	Calmodulin-domain protein kinase 1, putative; nucl	2e-21
2jam_A	304	Calcium/calmodulin-dependent protein kinase type 1	2e-21
2qol_A	373	Ephrin receptor; receptor tyrosine kinase, juxtame	2e-21
4e5w_A	302	Tyrosine-protein kinase JAK1; kinase domain, trans	3e-21
3is5_A	285	Calcium-dependent protein kinase; CDPK, structural	4e-21
3q5i_A	504	Protein kinase; CDPK, malaria, phosphotransferase,	4e-21
3kk8_A	284	Calcium/calmodulin dependent protein kinase II; AT	4e-21
3fdn_A	279	Serine/threonine-protein kinase 6; aurora kinase i	4e-21
3qup_A	323	Tyrosine-protein kinase receptor TYRO3; protein ki	6e-21
2bdw_A	362	Hypothetical protein K11E8.1D; kinase, calmodulin	8e-21
3cok_A	278	Serine/threonine-protein kinase PLK4; POLO-like ki	9e-21
3brb_A	313	Proto-oncogene tyrosine-protein kinase MER; ATP-bi	1e-20
3c0i_A	351	Peripheral plasma membrane protein CASK; neurexin,	1e-20
3f3z_A	277	Calcium/calmodulin-dependent protein kinase with d	2e-20
3gni_B	389	Strad alpha; kinase fold, pseudokinase, alpha heli	3e-20
2vwi_A	303	Serine/threonine-protein kinase OSR1; STE kinase,	3e-20
4eut_A	396	Serine/threonine-protein kinase TBK1; ATP binding,	4e-20
1kob_A	387	Twitchin; kinase, intrasteric regulation; 2.30A {A	5e-20
2qr7_A	342	Ribosomal protein S6 kinase alpha-3; kinase domain	5e-20
2x4f_A	373	Myosin light chain kinase family member 4; LUNG, b	6e-20
3soa_A	444	Calcium/calmodulin-dependent protein kinase type a	7e-20
3qd2_B	332	Eukaryotic translation initiation factor 2-alpha;	1e-19
3qd2_B	332	Eukaryotic translation initiation factor 2-alpha;	5e-05
3e7e_A	365	HBUB1, BUB1A, mitotic checkpoint serine/threonine-	2e-19
1t46_A	313	HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom	2e-19
1p4o_A	322	Insulin-like growth factor I receptor protein; IGF	3e-19
3bhy_A	283	Death-associated protein kinase 3; death associate	3e-19
1tki_A	321	Titin; serine kinase, muscle, autoinhibition; 2.00	3e-19
2vgo_A	284	Serine/threonine-protein kinase 12-A; nucleotide-b	3e-19
3q60_A	371	ROP5B; pseudokinase, transferase; HET: ATP; 1.72A	4e-19
3q60_A	371	ROP5B; pseudokinase, transferase; HET: ATP; 1.72A	3e-04
2a2a_A	321	Death-associated protein kinase 2; autoinhibition,	4e-19
3uto_A	573	Twitchin; kinase, muscle sarcomere, transferase; H	6e-19
2yab_A	361	Death-associated protein kinase 2; apoptosis, tran	6e-19
1phk_A	298	Phosphorylase kinase; glycogen metabolism, transfe	7e-19
2y0a_A	326	Death-associated protein kinase 1; transferase, ca	7e-19
3eqc_A	360	Dual specificity mitogen-activated protein kinase;	9e-19
3i6u_A	419	CDS1, serine/threonine-protein kinase CHK2; Ser/Th	9e-19
2i1m_A	333	Macrophage colony-stimulating factor 1 receptor; k	1e-18
2y7j_A	365	Phosphorylase B kinase gamma catalytic chain, test	1e-18
1fvr_A	327	Tyrosine-protein kinase TIE-2; tyrosine kinase, tr	1e-18
3qa8_A	676	MGC80376 protein; kinase ubiquitin-like domain, ph	1e-18
3aln_A	327	Dual specificity mitogen-activated protein kinase;	2e-18
4fr4_A	384	YANK1, serine/threonine-protein kinase 32A; struct	2e-18
2pml_X	348	PFPK7, Ser/Thr protein kinase; phosphorylati trans	2e-18
2xir_A	316	Vascular endothelial growth factor receptor 2; ang	2e-18
2ycf_A	322	Serine/threonine-protein kinase CHK2; transferase,	2e-18
3fme_A	290	Dual specificity mitogen-activated protein kinase;	2e-18
3lm5_A	327	Serine/threonine-protein kinase 17B; STK17B, serin	3e-18
2w4o_A	349	Calcium/calmodulin-dependent protein kinase type I	3e-18
4aoj_A	329	High affinity nerve growth factor receptor; transf	3e-18
3an0_A	340	Dual specificity mitogen-activated protein kinase;	3e-18
2yfx_A	327	Tyrosine-protein kinase receptor; nucleotide-bindi	4e-18
3dzo_A	413	Rhoptry kinase domain; parasitic disease, transfer	4e-18
1rjb_A	344	FL cytokine receptor; kinase, structure, autoinhib	5e-18
4e7w_A	394	Glycogen synthase kinase 3; GSK3, PTyr195, transfe	6e-18
2wtk_C	305	Serine/threonine-protein kinase 11; transferase-me	8e-18
4fvq_A	289	Tyrosine-protein kinase JAK2; janus protein kinase	8e-18
2ac3_A	316	MAP kinase-interacting serine/threonine kinase 2;	1e-17
3ll6_A	337	Cyclin G-associated kinase; transferase, protein k	1e-17
3dls_A	335	PAS domain-containing serine/threonine-protein KI;	2e-17
3v5q_A	297	NT-3 growth factor receptor; kinase domain, kinase	2e-17
3tt0_A	382	Basic fibroblast growth factor receptor 1; kinase	2e-17
2pvf_A	334	Fibroblast growth factor receptor 2; kinase domain	2e-17
3l9p_A	367	Anaplastic lymphoma kinase; kinase domain, ATP-bin	2e-17
1j1b_A	420	Glycogen synthase kinase-3 beta; complex, TAU, AMP	2e-17
2psq_A	370	Fibroblast growth factor receptor 2; kinase domain	2e-17
3fhr_A	336	MAP kinase-activated protein kinase 3; kinase-inhi	2e-17
2dyl_A	318	Dual specificity mitogen-activated protein kinase	3e-17
3byv_A	377	Rhoptry kinase; malaria, transferase, structural g	4e-17
3zzw_A	289	Tyrosine-protein kinase transmembrane receptor RO;	6e-17
3kn6_A	325	Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1	6e-17
1nxk_A	400	MAP kinase-activated protein kinase 2; MK2, phosph	1e-16
1ua2_A	346	CAK, cell division protein kinase 7; cell cycle, p	2e-16
3pvu_A	695	Beta-adrenergic receptor kinase 1; transferase, se	3e-16
3nsz_A	330	CK II alpha, casein kinase II subunit alpha; inhib	3e-16
1luf_A	343	Muscle-specific tyrosine kinase receptor MUSK; pho	4e-16
2iwi_A	312	Serine/threonine-protein kinase PIM-2; nucleotide-	6e-16
3hko_A	345	Calcium/calmodulin-dependent protein kinase with d	9e-16
1uu3_A	310	HPDK1, 3-phosphoinositide dependent protein kinase	1e-15
2acx_A	576	G protein-coupled receptor kinase 6; GRK, G transf	2e-15
3c4z_A	543	Rhodopsin kinase; Ser/Thr kinase, RGS homology dom	2e-15
2ivs_A	314	Proto-oncogene tyrosine-protein kinase receptor RE	5e-15
3uc3_A	361	Serine/threonine-protein kinase SRK2I; SNRK2, ABA	5e-15
2zv2_A	298	Calcium/calmodulin-dependent protein kinase kinas;	5e-15
3v8s_A	410	RHO-associated protein kinase 1; dimerization, myo	5e-15
3mi9_A	351	Cell division protein kinase 9; P-TEFB, HIV-1, pro	5e-15
3e3p_A	360	Protein kinase, putative glycogen synthase kinase;	6e-15
3niz_A	311	Rhodanese family protein; structural genomics, str	7e-15
3a99_A	320	Proto-oncogene serine/threonine-protein kinase PI;	1e-14
3g33_A	308	Cell division protein kinase 4; Ser/Thr protein ki	1e-14
2yex_A	276	Serine/threonine-protein kinase CHK1; transferase,	1e-14
3fe3_A	328	MAP/microtubule affinity-regulating kinase 3; seri	2e-14
3o0g_A	292	Cell division protein kinase 5; kinase activator c	3e-14
3tki_A	323	Serine/threonine-protein kinase CHK1; cell checkpo	3e-14
2r3i_A	299	Cell division protein kinase 2; serine/threonine-p	4e-14
1ob3_A	288	PFPK5, cell division control protein 2 homolog; tr	4e-14
4agu_A	311	Cyclin-dependent kinase-like 1; transferase, phosp	4e-14
3uqc_A	286	Probable conserved transmembrane protein; structur	4e-14
2vd5_A	412	DMPK protein; serine/threonine-protein kinase, kin	7e-14
3mtl_A	324	Cell division protein kinase 16; pctaire1, indirub	1e-13
4aaa_A	331	Cyclin-dependent kinase-like 2; transferase, phosp	1e-13
4aw2_A	437	Serine/threonine-protein kinase MRCK alpha; transf	2e-13
3rgf_A	405	Cyclin-dependent kinase 8; protein kinase complex,	3e-13
2pmi_A	317	Negative RE, cyclin-dependent protein kinase PHO85	4e-13
3gbz_A	329	Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-	1e-12
3g51_A	325	Ribosomal protein S6 kinase alpha-3; N-terminal ki	1e-12
1blx_A	326	Cyclin-dependent kinase 6; inhibitor protein, cycl	1e-12
2r5t_A	373	Serine/threonine-protein kinase SGK1; AGC protein	1e-12
1o6l_A	337	RAC-beta serine/threonine protein kinase; protein	2e-12
3txo_A	353	PKC-L, NPKC-ETA, protein kinase C ETA type; phosph	2e-12
3a62_A	327	Ribosomal protein S6 kinase beta-1; kinase domain,	2e-12
3a8x_A	345	Protein kinase C IOTA type; transferase; HET: TPO;	2e-12
3vhe_A	359	Vascular endothelial growth factor receptor 2; kin	2e-12
3vhe_A	359	Vascular endothelial growth factor receptor 2; kin	7e-05
2i0e_A	353	Protein kinase C-beta II; serine/threonine protein	3e-12
1xjd_A	345	Protein kinase C, theta type; PKC-theta, ATP, AMP,	3e-12
2xrw_A	371	Mitogen-activated protein kinase 8; transcription,	4e-12
2h6d_A	276	5'-AMP-activated protein kinase catalytic subunit	4e-12
4dc2_A	396	Protein kinase C IOTA type; kinase, substrate, cel	5e-12
3coi_A	353	Mitogen-activated protein kinase 13; P38D, P38delt	6e-12
3eb0_A	383	Putative uncharacterized protein; kinase cryptospo	6e-12
1rdq_E	350	PKA C-alpha, CAMP-dependent protein kinase, alpha-	7e-12
4ejn_A	446	RAC-alpha serine/threonine-protein kinase; AKT1, a	7e-12
3pg1_A	362	Mitogen-activated protein kinase, putative (MAP K	7e-12
2eue_A	275	Carbon catabolite derepressing protein kinase; kin	8e-12
1cm8_A	367	Phosphorylated MAP kinase P38-gamma; phosphorylati	9e-12
3h4j_B	336	AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin	1e-11
3qyz_A	364	Mitogen-activated protein kinase 1; transferase, s	1e-11
3pfq_A	674	PKC-B, PKC-beta, protein kinase C beta type; phosp	1e-11
2y94_A	476	5'-AMP-activated protein kinase catalytic subunit;	1e-11
2fst_X	367	Mitogen-activated protein kinase 14; active mutant	2e-11
2i6l_A	320	Mitogen-activated protein kinase 6; MAPK6, ERK3, e	2e-11
1vzo_A	355	Ribosomal protein S6 kinase alpha 5; protein kinas	2e-11
1fot_A	318	TPK1 delta, CAMP-dependent protein kinase type 1;	3e-11
3ttj_A	464	Mitogen-activated protein kinase 10; JNK3, protein	4e-11
3m2w_A	299	MAP kinase-activated protein kinase 2; small molec	8e-11
3rp9_A	458	Mitogen-activated protein kinase; structural genom	1e-10
1q8y_A	373	SR protein kinase; transferase; HET: ADP ADE; 2.05	5e-10
2b9h_A	353	MAP kinase FUS3, mitogen-activated protein kinase	5e-10
3n9x_A	432	Phosphotransferase; malaria kinase, structural gen	4e-09
1wak_A	397	Serine/threonine-protein kinase SPRK1; SRPK, trans	6e-09
3oz6_A	388	Mitogen-activated protein kinase 1, serine/threon	1e-08
2izr_A	330	Casein kinase I isoform gamma-3; serine/threonine-	2e-06
3kvw_A	429	DYRK2, dual specificity tyrosine-phosphorylation-r	2e-06
1vt4_I	1221	APAF-1 related killer DARK; drosophila apoptosome,	3e-06
2v62_A	345	Serine/threonine-protein kinase VRK2; transferase,	5e-06
1csn_A	298	Casein kinase-1; phosphotransferase; HET: ATP; 2.0	7e-06
3op5_A	364	Serine/threonine-protein kinase VRK1; adenosine tr	9e-06
3uzp_A	296	CKI-delta, CKID, casein kinase I isoform delta; CK	3e-05
2vx3_A	382	Dual specificity tyrosine-phosphorylation- regula	6e-05
2jii_A	352	Serine/threonine-protein kinase VRK3 molecule: VA	9e-05
3sv0_A	483	Casein kinase I-like; typical kinase domain fold,	3e-04

>3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3tl8_A* Length = 326

 Score =  230 bits (588), Expect = 1e-71
 Identities = 83/225 (36%), Positives = 122/225 (54%), Gaps = 38/225 (16%)

Query: 301 SPKRYGYADIKKMTNSF--KYKLGQGGYGSVYKGKLLDGSNVAVKVL--NDSKGNGKEFI 356
             KR+   +++  +++F  K  LG+GG+G VYKG+L DG+ VAVK L    ++G   +F 
Sbjct: 16  QLKRFSLRELQVASDNFSNKNILGRGGFGKVYKGRLADGTLVAVKRLKEERTQGGELQFQ 75

Query: 357 NEVASISRTSHVNVVALLGFC---------------------LRVAEELSST-------- 387
            EV  IS   H N++ L GFC                     LR   E            
Sbjct: 76  TEVEMISMAVHRNLLRLRGFCMTPTERLLVYPYMANGSVASCLRERPESQPPLDWPKRQR 135

Query: 388 --IGIARGLEYLHLGCSTRILHFDIKPHNILLDEDFCPKISDFGLAKICNRKESIISMTG 445
             +G ARGL YLH  C  +I+H D+K  NILLDE+F   + DFGLAK+ + K++ ++ T 
Sbjct: 136 IALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVT-TA 194

Query: 446 ARGTVGYIAPEVFCRNIGEVSYKSDVYNYGMMIFEMTGGRKNVDV 490
            RGT+G+IAPE      G+ S K+DV+ YG+M+ E+  G++  D+
Sbjct: 195 VRGTIGHIAPEYLST--GKSSEKTDVFGYGVMLLELITGQRAFDL 237

>2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* Length = 321

 Score =  203 bits (519), Expect = 1e-61
 Identities = 81/252 (32%), Positives = 123/252 (48%), Gaps = 53/252 (21%)

Query: 279 SSYNSTASCLNIETFLRNYRSLSPKRYGYADIKKMTNSF--KYKLGQGGYGSVYKGKLLD 336
           S Y+   + +N              R    D+++ TN+F  K+ +G G +G VYKG L D
Sbjct: 3   SKYSKATNSINDALSSSYLVPFESYRVPLVDLEEATNNFDHKFLIGHGVFGKVYKGVLRD 62

Query: 337 GSNVAVKVLNDSKGNG-KEFINEVASISRTSHVNVVALLGFC------------------ 377
           G+ VA+K        G +EF  E+ ++S   H ++V+L+GFC                  
Sbjct: 63  GAKVALKRRTPESSQGIEEFETEIETLSFCRHPHLVSLIGFCDERNEMILIYKYMENGNL 122

Query: 378 -------------------LRVAEELSSTIGIARGLEYLHLGCSTRILHFDIKPHNILLD 418
                              L +       IG ARGL YLH      I+H D+K  NILLD
Sbjct: 123 KRHLYGSDLPTMSMSWEQRLEIC------IGAARGLHYLHTRA---IIHRDVKSINILLD 173

Query: 419 EDFCPKISDFGLAKIC-NRKESIISMTGARGTVGYIAPEVFCRNIGEVSYKSDVYNYGMM 477
           E+F PKI+DFG++K      ++ +S T  +GT+GYI PE F +  G ++ KSDVY++G++
Sbjct: 174 ENFVPKITDFGISKKGTELDQTHLS-TVVKGTLGYIDPEYFIK--GRLTEKSDVYSFGVV 230

Query: 478 IFEMTGGRKNVD 489
           +FE+   R  + 
Sbjct: 231 LFEVLCARSAIV 242

>2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* Length = 307

 Score =  190 bits (484), Expect = 1e-56
 Identities = 70/236 (29%), Positives = 111/236 (47%), Gaps = 52/236 (22%)

Query: 298 RSLSPKRYGYADIKKMTNSFK--------YKLGQGGYGSVYKGKLLDGSNVAVKVLN--- 346
                  + + ++K +TN+F          K+G+GG+G VYKG  ++ + VAVK L    
Sbjct: 8   SDTRFHSFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKG-YVNNTTVAVKKLAAMV 66

Query: 347 --DSKGNGKEFINEVASISRTSHVNVVALLGFCL------------------------RV 380
              ++   ++F  E+  +++  H N+V LLGF                            
Sbjct: 67  DITTEELKQQFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLDG 126

Query: 381 AEELS-ST-----IGIARGLEYLHLGCSTRILHFDIKPHNILLDEDFCPKISDFGLAKIC 434
              LS         G A G+ +LH       +H DIK  NILLDE F  KISDFGLA+  
Sbjct: 127 TPPLSWHMRCKIAQGAANGINFLHENH---HIHRDIKSANILLDEAFTAKISDFGLARAS 183

Query: 435 -NRKESIISMTGARGTVGYIAPEVFCRNIGEVSYKSDVYNYGMMIFEMTGGRKNVD 489
               +++++ +   GT  Y+APE      GE++ KSD+Y++G+++ E+  G   VD
Sbjct: 184 EKFAQTVMT-SRIVGTTAYMAPEAL---RGEITPKSDIYSFGVVLLEIITGLPAVD 235

>3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* Length = 309

 Score =  168 bits (427), Expect = 2e-48
 Identities = 58/201 (28%), Positives = 102/201 (50%), Gaps = 40/201 (19%)

Query: 317 FKYKLGQGGYGSVYKGKLLDGSNVAVKVLNDSKGNG---KEFINEVASISRTSHVNVVAL 373
            K K+G G +G+V++ +   GS+VAVK+L +   +     EF+ EVA + R  H N+V  
Sbjct: 41  IKEKIGAGSFGTVHRAEW-HGSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLF 99

Query: 374 LGFCLR------VAE------------------ELSST------IGIARGLEYLHLGCST 403
           +G   +      V E                  +L           +A+G+ YLH   + 
Sbjct: 100 MGAVTQPPNLSIVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLH-NRNP 158

Query: 404 RILHFDIKPHNILLDEDFCPKISDFGLAKICNRKESIISMTGARGTVGYIAPEVFCRNIG 463
            I+H ++K  N+L+D+ +  K+ DFGL+++  +  + +S   A GT  ++APEV      
Sbjct: 159 PIVHRNLKSPNLLVDKKYTVKVCDFGLSRL--KASTFLSSKSAAGTPEWMAPEVLRDE-- 214

Query: 464 EVSYKSDVYNYGMMIFEM-TG 483
             + KSDVY++G++++E+ T 
Sbjct: 215 PSNEKSDVYSFGVILWELATL 235

>3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 2qlu_A* Length = 322

 Score =  162 bits (411), Expect = 6e-46
 Identities = 55/226 (24%), Positives = 83/226 (36%), Gaps = 43/226 (19%)

Query: 306 GYADIKKMTNSFKY--KLGQGGYGSVYKGKLLDGSNVAVKVLNDSKGNGKEFINEVASIS 363
           G  ++   +   +      +G +G V+K +L     VAVK+         +   EV S+ 
Sbjct: 15  GTENLYFQSMPLQLLEVKARGRFGCVWKAQL-LNEYVAVKIFPIQDKQSWQNEYEVYSLP 73

Query: 364 RTSHVNVVALLGFCLR------------------------------VAEELSSTIGIARG 393
              H N++  +G   R                                E       +ARG
Sbjct: 74  GMKHENILQFIGAEKRGTSVDVDLWLITAFHEKGSLSDFLKANVVSWNELCHIAETMARG 133

Query: 394 LEYLH-------LGCSTRILHFDIKPHNILLDEDFCPKISDFGLAKICNRKESIISMTGA 446
           L YLH        G    I H DIK  N+LL  +    I+DFGLA      +S     G 
Sbjct: 134 LAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNLTACIADFGLALKFEAGKSAGDTHGQ 193

Query: 447 RGTVGYIAPEVFCRNI---GEVSYKSDVYNYGMMIFEMTGGRKNVD 489
            GT  Y+APEV    I    +   + D+Y  G++++E+       D
Sbjct: 194 VGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAAD 239

>4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* Length = 287

 Score =  159 bits (403), Expect = 4e-45
 Identities = 54/205 (26%), Positives = 93/205 (45%), Gaps = 46/205 (22%)

Query: 317 FKYKLGQGGYGSVYKGKLL-DGSNVAVKVLNDSKGNG--------KEFINEVASISRTSH 367
           ++ ++G+GG+G V+KG+L+ D S VA+K L      G        +EF  EV  +S  +H
Sbjct: 23  YEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNH 82

Query: 368 VNVVALLGFCLR----VAE----------------ELSST------IGIARGLEYLHLGC 401
            N+V L G        V E                 +  +      + IA G+EY+    
Sbjct: 83  PNIVKLYGLMHNPPRMVMEFVPCGDLYHRLLDKAHPIKWSVKLRLMLDIALGIEYMQ-NQ 141

Query: 402 STRILHFDIKPHNILLDE-----DFCPKISDFGLAKICNRKESIISMTGARGTVGYIAPE 456
           +  I+H D++  NI L         C K++DFGL++         S++G  G   ++APE
Sbjct: 142 NPPIVHRDLRSPNIFLQSLDENAPVCAKVADFGLSQQSVH-----SVSGLLGNFQWMAPE 196

Query: 457 VFCRNIGEVSYKSDVYNYGMMIFEM 481
                    + K+D Y++ M+++ +
Sbjct: 197 TIGAEEESYTEKADTYSFAMILYTI 221

>2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} Length = 307

 Score =  157 bits (398), Expect = 4e-44
 Identities = 53/194 (27%), Positives = 87/194 (44%), Gaps = 38/194 (19%)

Query: 317 FKYKLGQGGYGSVYKGKLLDGSNVAVKVLNDSKGNGKEFINEVASISRTSHVNVVALLGF 376
            +  +G+G +G V K K     +VA+K +       K FI E+  +SR +H N+V L G 
Sbjct: 12  VEEVVGRGAFGVVCKAKW-RAKDVAIKQIESES-ERKAFIVELRQLSRVNHPNIVKLYGA 69

Query: 377 CL----------------------RVAEELSST------IGIARGLEYLHLGCSTRILHF 408
           CL                            ++       +  ++G+ YLH      ++H 
Sbjct: 70  CLNPVCLVMEYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHSMQPKALIHR 129

Query: 409 DIKPHNILLDEDF-CPKISDFGLAKICNRKESIISMTGARGTVGYIAPEVFCRNIGEVSY 467
           D+KP N+LL       KI DFG A           MT  +G+  ++APEVF  +    S 
Sbjct: 130 DLKPPNLLLVAGGTVLKICDFGTACDIQT-----HMTNNKGSAAWMAPEVFEGS--NYSE 182

Query: 468 KSDVYNYGMMIFEM 481
           K DV+++G++++E+
Sbjct: 183 KCDVFSWGIILWEV 196

>3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} PDB: 3c4c_A* 3c4d_A* 3idp_A* 3ii5_A* 3d4q_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 2fb8_A* 4dbn_A* 1uwj_A* 1uwh_A* 3q96_A* Length = 289

 Score =  152 bits (386), Expect = 1e-42
 Identities = 63/200 (31%), Positives = 101/200 (50%), Gaps = 36/200 (18%)

Query: 317 FKYKLGQGGYGSVYKGKLLDGSNVAVKVLNDSKGNG---KEFINEVASISRTSHVNVVAL 373
              ++G G +G+VYKGK     +VAVK+LN +       + F NEV  + +T HVN++  
Sbjct: 28  VGQRIGSGSFGTVYKGKWHG--DVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLF 85

Query: 374 LGFC--------------------LRVAE---ELSSTIG----IARGLEYLHLGCSTRIL 406
           +G+                     L  +E   E+   I      ARG++YLH   +  I+
Sbjct: 86  MGYSTAPQLAIVTQWCEGSSLYHHLHASETKFEMKKLIDIARQTARGMDYLH---AKSII 142

Query: 407 HFDIKPHNILLDEDFCPKISDFGLAKICNRKESIISMTGARGTVGYIAPEVFC-RNIGEV 465
           H D+K +NI L ED   KI DFGLA   +R           G++ ++APEV   ++    
Sbjct: 143 HRDLKSNNIFLHEDNTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIRMQDSNPY 202

Query: 466 SYKSDVYNYGMMIFEMTGGR 485
           S++SDVY +G++++E+  G+
Sbjct: 203 SFQSDVYAFGIVLYELMTGQ 222

>3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} PDB: 3kmw_A* 3rep_A* Length = 271

 Score =  150 bits (380), Expect = 5e-42
 Identities = 37/201 (18%), Positives = 77/201 (38%), Gaps = 44/201 (21%)

Query: 316 SFKYKLGQGGYGSVYKGKLLDGSNVAVKVLNDSKGNG---KEFINEVASISRTSHVNVVA 372
           +F  KL +   G ++KG+   G+++ VKVL     +    ++F  E   +   SH NV+ 
Sbjct: 13  NFLTKLNENHSGELWKGRW-QGNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPNVLP 71

Query: 373 LLGFCLR--------VAE-----------------------ELSSTIGIARGLEYLHLGC 401
           +LG C          +                          +   + +ARG+ +LH   
Sbjct: 72  VLGACQSPPAPHPTLITHWMPYGSLYNVLHEGTNFVVDQSQAVKFALDMARGMAFLH-TL 130

Query: 402 STRILHFDIKPHNILLDEDFCPKISDFGLAKICNRKESIISMTGARGTVGYIAPEVFC-R 460
              I    +   ++++DED   +IS   +              G      ++APE    +
Sbjct: 131 EPLIPRHALNSRSVMIDEDMTARISMADVKF-------SFQSPGRMYAPAWVAPEALQKK 183

Query: 461 NIGEVSYKSDVYNYGMMIFEM 481
                   +D++++ ++++E+
Sbjct: 184 PEDTNRRSADMWSFAVLLWEL 204

>3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} Length = 271

 Score =  147 bits (372), Expect = 9e-41
 Identities = 59/207 (28%), Positives = 89/207 (42%), Gaps = 47/207 (22%)

Query: 317 FKYKLGQGGYGSVYKGKLLDGSNVAVKVL-----NDSKGNGKEFINEVASISRTSHVNVV 371
            +  +G GG+G VY+     G  VAVK        D     +    E    +   H N++
Sbjct: 11  LEEIIGIGGFGKVYRAFW-IGDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNII 69

Query: 372 ALLGFCLR------VAE--------------------ELSSTIGIARGLEYLHLGCSTRI 405
           AL G CL+      V E                     ++  + IARG+ YLH      I
Sbjct: 70  ALRGVCLKEPNLCLVMEFARGGPLNRVLSGKRIPPDILVNWAVQIARGMNYLHDEAIVPI 129

Query: 406 LHFDIKPHNILLDEDFCP--------KISDFGLAKICNRKESIISMTGARGTVGYIAPEV 457
           +H D+K  NIL+ +            KI+DFGLA    R+    +   A G   ++APEV
Sbjct: 130 IHRDLKSSNILILQKVENGDLSNKILKITDFGLA----REWHRTTKMSAAGAYAWMAPEV 185

Query: 458 FCRNIGEVSYKSDVYNYGMMIFEM-TG 483
              +    S  SDV++YG++++E+ TG
Sbjct: 186 IRAS--MFSKGSDVWSYGVLLWELLTG 210

>2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} Length = 319

 Score =  146 bits (370), Expect = 4e-40
 Identities = 49/210 (23%), Positives = 85/210 (40%), Gaps = 47/210 (22%)

Query: 317 FKYKLGQGGYGSVYKGKLLDGSNVAVKVLN---DSKGNGKEFINEVASISRTSHVNVVAL 373
               +G+G +G VY G+      VA+++++   D++   K F  EV +  +T H NVV  
Sbjct: 37  IGELIGKGRFGQVYHGRWHG--EVAIRLIDIERDNEDQLKAFKREVMAYRQTRHENVVLF 94

Query: 374 LGFCLR------VAE------------------ELSSTIG----IARGLEYLHLGCSTRI 405
           +G C+       +                    +++ T      I +G+ YLH   +  I
Sbjct: 95  MGACMSPPHLAIITSLCKGRTLYSVVRDAKIVLDVNKTRQIAQEIVKGMGYLH---AKGI 151

Query: 406 LHFDIKPHNILLDEDFCPKISDFGLAKI---CNRKESIISMTGARGTVGYIAPEVFCRNI 462
           LH D+K  N+  D      I+DFGL  I            +    G + ++APE+  +  
Sbjct: 152 LHKDLKSKNVFYDNGKV-VITDFGLFSISGVLQAGRREDKLRIQNGWLCHLAPEIIRQLS 210

Query: 463 GEV-------SYKSDVYNYGMMIFEMTGGR 485
            +        S  SDV+  G + +E+    
Sbjct: 211 PDTEEDKLPFSKHSDVFALGTIWYELHARE 240

>3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} Length = 336

 Score =  145 bits (367), Expect = 1e-39
 Identities = 56/216 (25%), Positives = 80/216 (37%), Gaps = 53/216 (24%)

Query: 316 SFKYKLGQGGYGSVYKGKLLDGSNVAVKVLNDSKGNGKEFINE--VASISRTSHVNVVAL 373
                +G+G YG+VYKG L D   VAVKV   S  N + FINE  +  +    H N+   
Sbjct: 16  KLLELIGRGRYGAVYKGSL-DERPVAVKVF--SFANRQNFINEKNIYRVPLMEHDNIARF 72

Query: 374 LGFCLRVAEELSST-------------------------------IGIARGLEYLH---- 398
           +    RV  +                                     + RGL YLH    
Sbjct: 73  IVGDERVTADGRMEYLLVMEYYPNGSLXKYLSLHTSDWVSSCRLAHSVTRGLAYLHTELP 132

Query: 399 --LGCSTRILHFDIKPHNILLDEDFCPKISDFGLAKI------CNRKESIISMTGARGTV 450
                   I H D+   N+L+  D    ISDFGL+            E   +     GT+
Sbjct: 133 RGDHYKPAISHRDLNSRNVLVKNDGTCVISDFGLSMRLTGNRLVRPGEEDNAAISEVGTI 192

Query: 451 GYIAPEVF-----CRNIGEVSYKSDVYNYGMMIFEM 481
            Y+APEV       R+      + D+Y  G++ +E+
Sbjct: 193 RYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEI 228

>3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} Length = 337

 Score =  134 bits (338), Expect = 2e-35
 Identities = 45/205 (21%), Positives = 77/205 (37%), Gaps = 46/205 (22%)

Query: 320 KLGQGGYGSVYKGKLLDGSNVAVKVLNDSKGNGKEFINE--VASISRTSHVNVVALLGFC 377
           ++G+G YG V+ GK   G  VAVKV   +      +  E  +       H N++  +   
Sbjct: 44  QIGKGRYGEVWMGKW-RGEKVAVKVFFTT--EEASWFRETEIYQTVLMRHENILGFIAAD 100

Query: 378 LR------------------------------VAEELSSTIGIARGLEYLH-----LGCS 402
           ++                                  L        GL +LH         
Sbjct: 101 IKGTGSWTQLYLITDYHENGSLYDYLKSTTLDAKSMLKLAYSSVSGLCHLHTEIFSTQGK 160

Query: 403 TRILHFDIKPHNILLDEDFCPKISDFGLAKIC--NRKESIISMTGARGTVGYIAPEVFCR 460
             I H D+K  NIL+ ++    I+D GLA     +  E  I      GT  Y+ PEV   
Sbjct: 161 PAIAHRDLKSKNILVKKNGTCCIADLGLAVKFISDTNEVDIPPNTRVGTKRYMPPEVLDE 220

Query: 461 NI----GEVSYKSDVYNYGMMIFEM 481
           ++     +    +D+Y++G++++E+
Sbjct: 221 SLNRNHFQSYIMADMYSFGLILWEV 245

>1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* Length = 342

 Score =  132 bits (335), Expect = 6e-35
 Identities = 45/205 (21%), Positives = 78/205 (38%), Gaps = 46/205 (22%)

Query: 320 KLGQGGYGSVYKGKLLDGSNVAVKVLNDSKGNGKEFINE--VASISRTSHVNVVALLGFC 377
            +G+G +G V++GK   G  VAVK+ +      + +  E  +       H N++  +   
Sbjct: 49  SIGKGRFGEVWRGKW-RGEEVAVKIFSSR--EERSWFREAEIYQTVMLRHENILGFIAAD 105

Query: 378 LRVAEE------------------------------LSSTIGIARGLEYLH-----LGCS 402
            +                                  +   +  A GL +LH         
Sbjct: 106 NKDNGTWTQLWLVSDYHEHGSLFDYLNRYTVTVEGMIKLALSTASGLAHLHMEIVGTQGK 165

Query: 403 TRILHFDIKPHNILLDEDFCPKISDFGLAKICNRKESI--ISMTGARGTVGYIAPEVFCR 460
             I H D+K  NIL+ ++    I+D GLA   +       I+     GT  Y+APEV   
Sbjct: 166 PAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDD 225

Query: 461 NI----GEVSYKSDVYNYGMMIFEM 481
           +I     E   ++D+Y  G++ +E+
Sbjct: 226 SINMKHFESFKRADIYAMGLVFWEI 250

>3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* Length = 301

 Score =  131 bits (331), Expect = 8e-35
 Identities = 45/205 (21%), Positives = 82/205 (40%), Gaps = 46/205 (22%)

Query: 320 KLGQGGYGSVYKGKLLDGSNVAVKVLNDSKGNGKEFINE--VASISRTSHVNVVALLGFC 377
            +G+G YG V++G    G NVAVK+ +    + K +  E  + +     H N++  +   
Sbjct: 15  CVGKGRYGEVWRGSW-QGENVAVKIFSSR--DEKSWFRETELYNTVMLRHENILGFIASD 71

Query: 378 LRVAEE------------------------------LSSTIGIARGLEYLH-----LGCS 402
           +                                   L   + IA GL +LH         
Sbjct: 72  MTSRHSSTQLWLITHYHEMGSLYDYLQLTTLDTVSCLRIVLSIASGLAHLHIEIFGTQGK 131

Query: 403 TRILHFDIKPHNILLDEDFCPKISDFGLAKIC--NRKESIISMTGARGTVGYIAPEVF-- 458
             I H D+K  NIL+ ++    I+D GLA +   +  +  +      GT  Y+APEV   
Sbjct: 132 PAIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQSTNQLDVGNNPRVGTKRYMAPEVLDE 191

Query: 459 --CRNIGEVSYKSDVYNYGMMIFEM 481
               +  +   + D++ +G++++E+
Sbjct: 192 TIQVDCFDSYKRVDIWAFGLVLWEV 216

>3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} Length = 310

 Score =  122 bits (309), Expect = 1e-31
 Identities = 46/209 (22%), Positives = 80/209 (38%), Gaps = 48/209 (22%)

Query: 320 KLGQGGYGSVYKGKLLD-GSNVAVKVL-NDSKGNGKEFINEVASISRTSHVNVVALLGFC 377
            LG+G +G   K    + G  + +K L    +   + F+ EV  +    H NV+  +G  
Sbjct: 17  VLGKGCFGQAIKVTHRETGEVMVMKELIRFDEETQRTFLKEVKVMRCLEHPNVLKFIGVL 76

Query: 378 ----------------------------LRVAEELSSTIGIARGLEYLHLGCSTRILHFD 409
                                          ++ +S    IA G+ YLH   S  I+H D
Sbjct: 77  YKDKRLNFITEYIKGGTLRGIIKSMDSQYPWSQRVSFAKDIASGMAYLH---SMNIIHRD 133

Query: 410 IKPHNILLDEDFCPKISDFGLAKI------------CNRKESIISMTGARGTVGYIAPEV 457
           +  HN L+ E+    ++DFGLA++              +K          G   ++APE+
Sbjct: 134 LNSHNCLVRENKNVVVADFGLARLMVDEKTQPEGLRSLKKPDRKKRYTVVGNPYWMAPEM 193

Query: 458 FCRNIGEVSYKSDVYNYGMMIFE-MTGGR 485
              N      K DV+++G+++ E +    
Sbjct: 194 I--NGRSYDEKVDVFSFGIVLCEIIGRVN 220

>1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A Length = 303

 Score =  118 bits (298), Expect = 4e-30
 Identities = 59/216 (27%), Positives = 83/216 (38%), Gaps = 58/216 (26%)

Query: 320 KLGQGGYGSVYKGK-LLDGSNVAVKVLNDSKGNGKEFINEVASISRTSHVNVVALLGFCL 378
            LGQG +G V K +  LD    A+K +  ++      ++EV  ++  +H  VV      L
Sbjct: 13  VLGQGAFGQVVKARNALDSRYYAIKKIRHTEEKLSTILSEVMLLASLNHQYVVRYYAAWL 72

Query: 379 RVAE------------------------ELSSTIG-----------------IARGLEYL 397
                                        L   I                  I   L Y+
Sbjct: 73  ERRNFVKPMTAVKKKSTLFIQMEYCENGTLYDLIHSENLNQQRDEYWRLFRQILEALSYI 132

Query: 398 HLGCSTRILHFDIKPHNILLDEDFCPKISDFGLAKICNRKESIIS------------MTG 445
           H   S  I+H D+KP NI +DE    KI DFGLAK  +R   I+             +T 
Sbjct: 133 H---SQGIIHRDLKPMNIFIDESRNVKIGDFGLAKNVHRSLDILKLDSQNLPGSSDNLTS 189

Query: 446 ARGTVGYIAPEVFCRNIGEVSYKSDVYNYGMMIFEM 481
           A GT  Y+A EV     G  + K D+Y+ G++ FEM
Sbjct: 190 AIGTAMYVATEV-LDGTGHYNEKIDMYSLGIIFFEM 224

>4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} Length = 294

 Score =  115 bits (291), Expect = 3e-29
 Identities = 57/199 (28%), Positives = 92/199 (46%), Gaps = 40/199 (20%)

Query: 320 KLGQGGYGSVYKGK-LLDGSNVAVKVLNDSKGNGKEFI----NEVASISRTSHVNVVALL 374
           KLG GG  +VY  +  +    VA+K +       +E +     EV + S+ SH N+V+++
Sbjct: 18  KLGGGGMSTVYLAEDTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQNIVSMI 77

Query: 375 -----------------GFCLR----------VAEELSSTIGIARGLEYLHLGCSTRILH 407
                            G  L           V   ++ T  I  G+++ H     RI+H
Sbjct: 78  DVDEEDDCYYLVMEYIEGPTLSEYIESHGPLSVDTAINFTNQILDGIKHAH---DMRIVH 134

Query: 408 FDIKPHNILLDEDFCPKISDFGLAKICNRKESIISMTGAR-GTVGYIAPEVFCRNIGEVS 466
            DIKP NIL+D +   KI DFG+AK  +  E+ ++ T    GTV Y +PE   +      
Sbjct: 135 RDIKPQNILIDSNKTLKIFDFGIAKALS--ETSLTQTNHVLGTVQYFSPEQ-AKG-EATD 190

Query: 467 YKSDVYNYGMMIFEMTGGR 485
             +D+Y+ G++++EM  G 
Sbjct: 191 ECTDIYSIGIVLYEMLVGE 209

>2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} Length = 681

 Score =  120 bits (302), Expect = 5e-29
 Identities = 45/200 (22%), Positives = 73/200 (36%), Gaps = 47/200 (23%)

Query: 320 KLGQGGYGSVYKGK--LLDGSNVAVKVLNDSKGNG--KEFINEVASISRTSHVNVVA--- 372
            +  GG G +Y      ++G  V +K L  S         + E   ++   H ++V    
Sbjct: 87  CIAHGGLGWIYLALDRNVNGRPVVLKGLVHSGDAEAQAMAMAERQFLAEVVHPSIVQIFN 146

Query: 373 ---------------------------LLGFCLRVAEELSSTIGIARGLEYLHLGCSTRI 405
                                        G  L VAE ++  + I   L YLH   S  +
Sbjct: 147 FVEHTDRHGDPVGYIVMEYVGGQSLKRSKGQKLPVAEAIAYLLEILPALSYLH---SIGL 203

Query: 406 LHFDIKPHNILLDEDFCPKISDFGLAKICNRKESIISMTGARGTVGYIAPEVFCRNIGEV 465
           ++ D+KP NI+L E+   K+ D G     N    +       GT G+ APE+  R     
Sbjct: 204 VYNDLKPENIMLTEEQ-LKLIDLGAVSRINSFGYLY------GTPGFQAPEI-VR--TGP 253

Query: 466 SYKSDVYNYGMMIFEMTGGR 485
           +  +D+Y  G  +  +T   
Sbjct: 254 TVATDIYTVGRTLAALTLDL 273

>3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* Length = 311

 Score =  112 bits (283), Expect = 4e-28
 Identities = 50/203 (24%), Positives = 79/203 (38%), Gaps = 42/203 (20%)

Query: 320 KLGQGGYGSVYKGK-LLDGSNVAVKVLNDSKGNGKEFI----NEVASISRTSHVNVVALL 374
            LG GG   V+  + L D  +VAVKVL         F      E  + +  +H  +VA+ 
Sbjct: 19  ILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVY 78

Query: 375 ---------------------GFCLR----------VAEELSSTIGIARGLEYLHLGCST 403
                                G  LR              +       + L + H     
Sbjct: 79  DTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGPMTPKRAIEVIADACQALNFSH---QN 135

Query: 404 RILHFDIKPHNILLDEDFCPKISDFGLAKICNRKESIISMTGAR-GTVGYIAPEVFCRNI 462
            I+H D+KP NI++      K+ DFG+A+      + ++ T A  GT  Y++PE      
Sbjct: 136 GIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQARG-- 193

Query: 463 GEVSYKSDVYNYGMMIFEMTGGR 485
             V  +SDVY+ G +++E+  G 
Sbjct: 194 DSVDARSDVYSLGCVLYEVLTGE 216

>3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} Length = 327

 Score =  111 bits (280), Expect = 2e-27
 Identities = 55/214 (25%), Positives = 94/214 (43%), Gaps = 46/214 (21%)

Query: 320 KLGQGGYGSVYKGKLLDGSN-----VAVKVLND--SKGNGKEFINEVASISRTSHVNVVA 372
            LG G +G+VYKG  +         VA+K L +  S    KE ++E   ++   + +V  
Sbjct: 22  VLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCR 81

Query: 373 LLGFCLR-----VAE----------------ELSST------IGIARGLEYLHLGCSTRI 405
           LLG CL      + +                 + S       + IA+G+ YL      R+
Sbjct: 82  LLGICLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLE---DRRL 138

Query: 406 LHFDIKPHNILLDEDFCPKISDFGLAKICNRKESIISMTGARGTVGYIAPEVFCRNIGEV 465
           +H D+   N+L+      KI+DFGLAK+   +E      G +  + ++A E         
Sbjct: 139 VHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESI--LHRIY 196

Query: 466 SYKSDVYNYGMMIFE-MTGGRK------NVDVVD 492
           +++SDV++YG+ ++E MT G K        ++  
Sbjct: 197 THQSDVWSYGVTVWELMTFGSKPYDGIPASEISS 230

>1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 3fpq_A Length = 290

 Score =  109 bits (274), Expect = 5e-27
 Identities = 49/201 (24%), Positives = 73/201 (36%), Gaps = 44/201 (21%)

Query: 317 FKYKLGQGGYGSVYKGK-LLDGSNVAVKVLNDSKGNGKE---FINEVASISRTSHVNVVA 372
           F  ++G+G + +VYKG        VA   L D K    E   F  E   +    H N+V 
Sbjct: 30  FDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVR 89

Query: 373 LLGFCLRVAEE---------------LSSTIG----------------IARGLEYLHLGC 401
                    +                L + +                 I +GL++LH   
Sbjct: 90  FYDSWESTVKGKKCIVLVTELMTSGTLKTYLKRFKVMKIKVLRSWCRQILKGLQFLH-TR 148

Query: 402 STRILHFDIKPHNILLD-EDFCPKISDFGLAKICNRKESIISMTGARGTVGYIAPEVFCR 460
           +  I+H D+K  NI +       KI D GLA +              GT  ++APE++  
Sbjct: 149 TPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRAS----FAKAVIGTPEFMAPEMYEE 204

Query: 461 NIGEVSYKSDVYNYGMMIFEM 481
              E     DVY +GM + EM
Sbjct: 205 KYDE---SVDVYAFGMCMLEM 222

>2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} Length = 309

 Score =  108 bits (271), Expect = 2e-26
 Identities = 45/199 (22%), Positives = 81/199 (40%), Gaps = 43/199 (21%)

Query: 320 KLGQGGYGSVYKGK--LLDGSNVAVKVLNDSKGNGKEFI----NEVASISRTSHVNVVA- 372
            +G+GG G VY+ +  + +   VA+K+++++  +   F      E  +  R    +VV  
Sbjct: 41  LVGRGGMGDVYEAEDTVRE-RIVALKLMSETLSSDPVFRTRMQREARTAGRLQEPHVVPI 99

Query: 373 ------------------------LL--GFCLRVAEELSSTIGIARGLEYLHLGCSTRIL 406
                                   +L     L     ++    I   L+  H   +    
Sbjct: 100 HDFGEIDGQLYVDMRLINGVDLAAMLRRQGPLAPPRAVAIVRQIGSALDAAH---AAGAT 156

Query: 407 HFDIKPHNILLDEDFCPKISDFGLAKICNRKESIISMTGAR-GTVGYIAPEVFCRNIGEV 465
           H D+KP NIL+  D    + DFG+A      +  ++  G   GT+ Y+APE F       
Sbjct: 157 HRDVKPENILVSADDFAYLVDFGIASATT--DEKLTQLGNTVGTLYYMAPERFSE--SHA 212

Query: 466 SYKSDVYNYGMMIFEM-TG 483
           +Y++D+Y    +++E  TG
Sbjct: 213 TYRADIYALTCVLYECLTG 231

>3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} Length = 311

 Score =  107 bits (269), Expect = 4e-26
 Identities = 48/199 (24%), Positives = 69/199 (34%), Gaps = 41/199 (20%)

Query: 320 KLGQGGYGSVYKG-KLLDGSNVAVKVLNDSKGNGKE---FINEVASISR-TSHVNVVALL 374
           +LG G YG V+K     DG   AVK         K+    + EV S  +   H   V L 
Sbjct: 64  RLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQHPCCVRLE 123

Query: 375 G-------------FC------------LRVAEELSSTIG--IARGLEYLHLGCSTRILH 407
                          C              + E             L +LH   S  ++H
Sbjct: 124 QAWEEGGILYLQTELCGPSLQQHCEAWGASLPEAQVWGYLRDTLLALAHLH---SQGLVH 180

Query: 408 FDIKPHNILLDEDFCPKISDFGLAKICNRKESIISMTGARGTVGYIAPEVFCRNIGEVSY 467
            D+KP NI L      K+ DFGL        +        G   Y+APE+  +  G    
Sbjct: 181 LDVKPANIFLGPRGRCKLGDFGLLVELGTAGAGEVQE---GDPRYMAPEL-LQ--GSYGT 234

Query: 468 KSDVYNYGMMIFEMTGGRK 486
            +DV++ G+ I E+    +
Sbjct: 235 AADVFSLGLTILEVACNME 253

>3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} Length = 432

 Score =  109 bits (274), Expect = 4e-26
 Identities = 55/214 (25%), Positives = 85/214 (39%), Gaps = 43/214 (20%)

Query: 309 DIKKMTNSFKYKLGQGGYGSVYKGKLLDGSNVAVKVLNDSKGNGKEFINEVASISRTS-- 366
            + K++   K  LG G  G++    + D  +VAVK +     +  +   EV  + R S  
Sbjct: 20  IVGKISFCPKDVLGHGAEGTIVYRGMFDNRDVAVKRILPECFSFAD--REVQ-LLRESDE 76

Query: 367 HVNVVALLGF---------CL-RVAEELSSTI-----------------GIARGLEYLHL 399
           H NV+               +   A  L   +                     GL +LH 
Sbjct: 77  HPNVIRYFCTEKDRQFQYIAIELCAATLQEYVEQKDFAHLGLEPITLLQQTTSGLAHLH- 135

Query: 400 GCSTRILHFDIKPHNILLDE-----DFCPKISDFGLAKICNRKESIIS-MTGARGTVGYI 453
             S  I+H D+KPHNIL+            ISDFGL K         S  +G  GT G+I
Sbjct: 136 --SLNIVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLAVGRHSFSRRSGVPGTEGWI 193

Query: 454 APEVFCRNIGE-VSYKSDVYNYGMMIFEM-TGGR 485
           APE+   +  E  +Y  D+++ G + + + + G 
Sbjct: 194 APEMLSEDCKENPTYTVDIFSAGCVFYYVISEGS 227

>3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* 2jiu_A* ... Length = 327

 Score =  107 bits (269), Expect = 6e-26
 Identities = 54/214 (25%), Positives = 92/214 (42%), Gaps = 46/214 (21%)

Query: 320 KLGQGGYGSVYKGKLLDGSN-----VAVKVLND--SKGNGKEFINEVASISRTSHVNVVA 372
            LG G +G+VYKG  +         VA+K L +  S    KE ++E   ++   + +V  
Sbjct: 22  VLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCR 81

Query: 373 LLGFC---------------------------LRVAEELSSTIGIARGLEYLHLGCSTRI 405
           LLG C                           +     L+  + IA+G+ YL      R+
Sbjct: 82  LLGICLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLE---DRRL 138

Query: 406 LHFDIKPHNILLDEDFCPKISDFGLAKICNRKESIISMTGARGTVGYIAPEVFCRNIGEV 465
           +H D+   N+L+      KI+DFGLAK+   +E      G +  + ++A E         
Sbjct: 139 VHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESI--LHRIY 196

Query: 466 SYKSDVYNYGMMIFE-MTGGRK------NVDVVD 492
           +++SDV++YG+ ++E MT G K        ++  
Sbjct: 197 THQSDVWSYGVTVWELMTFGSKPYDGIPASEISS 230

>3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* Length = 313

 Score =  106 bits (266), Expect = 1e-25
 Identities = 43/206 (20%), Positives = 86/206 (41%), Gaps = 44/206 (21%)

Query: 320 KLGQGGYGSVYKGKLLDGSNVAVKVLNDSKGNGKE---FINEVASISRTSH--VNVVALL 374
           ++G GG   V++         A+K +N  + + +    + NE+A +++       ++ L 
Sbjct: 35  QIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLY 94

Query: 375 GFCLR------VAE----ELSSTIG----------------IARGLEYLHLGCSTRILHF 408
            + +       V E    +L+S +                 +   +  +H      I+H 
Sbjct: 95  DYEITDQYIYMVMECGNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIH---QHGIVHS 151

Query: 409 DIKPHNILLDEDFCPKISDFGLAKICNRKESIISMTGARGTVGYIAPEVF---------C 459
           D+KP N L+ +    K+ DFG+A       + +      GTV Y+ PE            
Sbjct: 152 DLKPANFLIVDGML-KLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENG 210

Query: 460 RNIGEVSYKSDVYNYGMMIFEMTGGR 485
           ++  ++S KSDV++ G +++ MT G+
Sbjct: 211 KSKSKISPKSDVWSLGCILYYMTYGK 236

>3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* Length = 325

 Score =  106 bits (267), Expect = 1e-25
 Identities = 49/214 (22%), Positives = 95/214 (44%), Gaps = 46/214 (21%)

Query: 320 KLGQGGYGSVYKGKLLDGSN-----VAVKVLNDSKG--NGKEFINEVASISRTSHVNVVA 372
            LG G +G+V+KG  +         V +KV+ D  G  + +   + + +I    H ++V 
Sbjct: 20  VLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSLDHAHIVR 79

Query: 373 LLGFCLR-----VAE----------------ELSST------IGIARGLEYLHLGCSTRI 405
           LLG C       V +                 L         + IA+G+ YL       +
Sbjct: 80  LLGLCPGSSLQLVTQYLPLGSLLDHVRQHRGALGPQLLLNWGVQIAKGMYYLE---EHGM 136

Query: 406 LHFDIKPHNILLDEDFCPKISDFGLAKICNRKESIISMTGARGTVGYIAPEVFCRNIGEV 465
           +H ++   N+LL      +++DFG+A +    +  +  + A+  + ++A E    + G+ 
Sbjct: 137 VHRNLAARNVLLKSPSQVQVADFGVADLLPPDDKQLLYSEAKTPIKWMALESI--HFGKY 194

Query: 466 SYKSDVYNYGMMIFE-MTGGRK------NVDVVD 492
           +++SDV++YG+ ++E MT G +        +V D
Sbjct: 195 THQSDVWSYGVTVWELMTFGAEPYAGLRLAEVPD 228

>3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} Length = 343

 Score =  106 bits (266), Expect = 2e-25
 Identities = 43/206 (20%), Positives = 86/206 (41%), Gaps = 44/206 (21%)

Query: 320 KLGQGGYGSVYKGKLLDGSNVAVKVLNDSKGNGKE---FINEVASISRTSH--VNVVALL 374
           ++G GG   V++         A+K +N  + + +    + NE+A +++       ++ L 
Sbjct: 16  QIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLY 75

Query: 375 GFCLR------VAE----ELSSTIG----------------IARGLEYLHLGCSTRILHF 408
            + +       V E    +L+S +                 +   +  +H      I+H 
Sbjct: 76  DYEITDQYIYMVMECGNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIH---QHGIVHS 132

Query: 409 DIKPHNILLDEDFCPKISDFGLAKICNRKESIISMTGARGTVGYIAPEVF---------C 459
           D+KP N L+ +    K+ DFG+A       + +      GTV Y+ PE            
Sbjct: 133 DLKPANFLIVDG-MLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENG 191

Query: 460 RNIGEVSYKSDVYNYGMMIFEMTGGR 485
           ++  ++S KSDV++ G +++ MT G+
Sbjct: 192 KSKSKISPKSDVWSLGCILYYMTYGK 217

>4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* Length = 299

 Score =  105 bits (263), Expect = 2e-25
 Identities = 50/217 (23%), Positives = 86/217 (39%), Gaps = 60/217 (27%)

Query: 320 KLGQGGYGSVYKGK-LLDGSNVAVKV--LNDSKGNGKEFINEVASISRTSHVNVVA---- 372
            LG+GG+G V++ K  +D  N A+K   L + +   ++ + EV ++++  H  +V     
Sbjct: 12  CLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNA 71

Query: 373 ---------------------LLGFC--------------LRVAEE---LSSTIGIARGL 394
                                 +  C              +   E    L   + IA  +
Sbjct: 72  WLEKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHIFLQIAEAV 131

Query: 395 EYLHLGCSTRILHFDIKPHNILLDEDFCPKISDFGLAKI----------CNRKESIISMT 444
           E+LH   S  ++H D+KP NI    D   K+ DFGL                  +    T
Sbjct: 132 EFLH---SKGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYARHT 188

Query: 445 GARGTVGYIAPEVFCRNIGEVSYKSDVYNYGMMIFEM 481
           G  GT  Y++PE         S+K D+++ G+++FE+
Sbjct: 189 GQVGTKLYMSPEQ-IHGNS-YSHKVDIFSLGLILFEL 223

>2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* Length = 284

 Score =  104 bits (261), Expect = 3e-25
 Identities = 45/208 (21%), Positives = 85/208 (40%), Gaps = 57/208 (27%)

Query: 320 KLGQGGYGSVYKGK-LLDGSNVAVKVLNDSKGNGKEFINEVASISRTSHVNVVA------ 372
            +G GG+G V+K K  +DG    +K +  +    ++   EV ++++  HVN+V       
Sbjct: 18  LIGSGGFGQVFKAKHRIDGKTYVIKRVKYNN---EKAEREVKALAKLDHVNIVHYNGCWD 74

Query: 373 -----------------------LLGFC--------------LRVAEELSSTI--GIARG 393
                                   + FC               ++ + L+  +   I +G
Sbjct: 75  GFDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLDKVLALELFEQITKG 134

Query: 394 LEYLHLGCSTRILHFDIKPHNILLDEDFCPKISDFGLAKICNRKESIISMTGARGTVGYI 453
           ++Y+H   S ++++ D+KP NI L +    KI DFGL                 GT+ Y+
Sbjct: 135 VDYIH---SKKLINRDLKPSNIFLVDTKQVKIGDFGLVTSLKNDGKRTRSK---GTLRYM 188

Query: 454 APEVFCRNIGEVSYKSDVYNYGMMIFEM 481
           +PE    +      + D+Y  G+++ E+
Sbjct: 189 SPEQ-ISSQD-YGKEVDLYALGLILAEL 214

>3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* Length = 377

 Score =  105 bits (265), Expect = 4e-25
 Identities = 56/211 (26%), Positives = 89/211 (42%), Gaps = 43/211 (20%)

Query: 320 KLGQGGYGSVYKGKL-LDGSNVAVKVLND--SKGNGKEFINEVASISRTSHVNVVALLGF 376
           ++G+G +G V+ G+L  D + VAVK   +        +F+ E   + + SH N+V L+G 
Sbjct: 121 QIGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGV 180

Query: 377 C----------------------------LRVAEELSSTIGIARGLEYLHLGCSTRILHF 408
           C                            LRV   L      A G+EYL    S   +H 
Sbjct: 181 CTQKQPIYIVMELVQGGDFLTFLRTEGARLRVKTLLQMVGDAAAGMEYLE---SKCCIHR 237

Query: 409 DIKPHNILLDEDFCPKISDFGLAKICNRKESIISMTGARGTVGYIAPEVFCRNIGEVSYK 468
           D+   N L+ E    KISDFG+++         S    +  V + APE    N G  S +
Sbjct: 238 DLAARNCLVTEKNVLKISDFGMSREEADGVYAASGGLRQVPVKWTAPEAL--NYGRYSSE 295

Query: 469 SDVYNYGMMIFE-MTGGR------KNVDVVD 492
           SDV+++G++++E  + G        N    +
Sbjct: 296 SDVWSFGILLWETFSLGASPYPNLSNQQTRE 326

>1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B Length = 454

 Score =  105 bits (264), Expect = 1e-24
 Identities = 51/208 (24%), Positives = 84/208 (40%), Gaps = 41/208 (19%)

Query: 320 KLGQGGYGSVYKGKLLDGSNVAVKVLNDSKGNGKEFINEVASISRTSHVNVVALLGFC-- 377
           KLG G +G V+       + VAVK +     + + F+ E   +    H  +V L      
Sbjct: 195 KLGAGQFGEVWMATYNKHTKVAVKTMKPGSMSVEAFLAEANVMKTLQHDKLVKLHAVVTK 254

Query: 378 ------------------LRVAEELSST--------IGIARGLEYLHLGCSTRILHFDIK 411
                             L+  E               IA G+ ++        +H D++
Sbjct: 255 EPIYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIE---QRNYIHRDLR 311

Query: 412 PHNILLDEDFCPKISDFGLAKICNRKESIISMTGARGTVGYIAPEVFCRNIGEVSYKSDV 471
             NIL+      KI+DFGLA++    E      GA+  + + APE    N G  + KSDV
Sbjct: 312 AANILVSASLVCKIADFGLARVIEDNEYTAR-EGAKFPIKWTAPEAI--NFGSFTIKSDV 368

Query: 472 YNYGMMIFE-MTGGRK------NVDVVD 492
           +++G+++ E +T GR       N +V+ 
Sbjct: 369 WSFGILLMEIVTYGRIPYPGMSNPEVIR 396

>1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 287

 Score =  102 bits (256), Expect = 2e-24
 Identities = 53/215 (24%), Positives = 92/215 (42%), Gaps = 45/215 (20%)

Query: 318 KYKLGQGGYGSVYKGKLLDGSN---VAVKVL--NDSKGNGKEFINEVASISRTSHVNVVA 372
             +LG G +GSV +G          VA+KVL     K + +E + E   + +  +  +V 
Sbjct: 15  DIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVR 74

Query: 373 LLGFCLR-----VAE----------------ELSST------IGIARGLEYLHLGCSTRI 405
           L+G C       V E                E+  +        ++ G++YL        
Sbjct: 75  LIGVCQAEALMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYL---EEKNF 131

Query: 406 LHFDIKPHNILLDEDFCPKISDFGLAKICNRKESIISMT-GARGTVGYIAPEVFCRNIGE 464
           +H D+   N+LL      KISDFGL+K     +S  +     +  + + APE    N  +
Sbjct: 132 VHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPECI--NFRK 189

Query: 465 VSYKSDVYNYGMMIFE-MTGGRK------NVDVVD 492
            S +SDV++YG+ ++E ++ G+K        +V+ 
Sbjct: 190 FSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMA 224

>1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... Length = 279

 Score =  101 bits (255), Expect = 2e-24
 Identities = 53/208 (25%), Positives = 88/208 (42%), Gaps = 41/208 (19%)

Query: 320 KLGQGGYGSVYKGKLLDGSNVAVKVLNDSKGNGKEFINEVASISRTSHVNVVALLGFC-- 377
           +LG G +G V+ G     + VAVK L     +   F+ E   + +  H  +V L      
Sbjct: 20  RLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPDAFLAEANLMKQLQHQRLVRLYAVVTQ 79

Query: 378 ------------------LRVAEELSSTI--------GIARGLEYLHLGCSTRILHFDIK 411
                             L+    +  TI         IA G+ ++        +H D++
Sbjct: 80  EPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIE---ERNYIHRDLR 136

Query: 412 PHNILLDEDFCPKISDFGLAKICNRKESIISMTGARGTVGYIAPEVFCRNIGEVSYKSDV 471
             NIL+ +    KI+DFGLA++    E      GA+  + + APE    N G  + KSDV
Sbjct: 137 AANILVSDTLSCKIADFGLARLIEDNEYTAR-EGAKFPIKWTAPEAI--NYGTFTIKSDV 193

Query: 472 YNYGMMIFE-MTGGRK------NVDVVD 492
           +++G+++ E +T GR       N +V+ 
Sbjct: 194 WSFGILLTEIVTHGRIPYPGMTNPEVIQ 221

>4apc_A Serine/threonine-protein kinase NEK1; transferase; 2.10A {Homo sapiens} Length = 350

 Score =  103 bits (258), Expect = 2e-24
 Identities = 53/202 (26%), Positives = 88/202 (43%), Gaps = 46/202 (22%)

Query: 320 KLGQGGYGSVYKGK-LLDGSNVAVKVLNDSKGNGKE---FINEVASISRTSHVNVVALLG 375
           K+G+G +G     K   DG    +K +N S+ + KE      EVA ++   H N+V    
Sbjct: 31  KIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLANMKHPNIVQYRE 90

Query: 376 F-----CLRV----AE--ELSSTIG------------------IARGLEYLHLGCSTRIL 406
                  L +     E  +L   I                   I   L+++H     +IL
Sbjct: 91  SFEENGSLYIVMDYCEGGDLFKRINAQKGVLFQEDQILDWFVQICLALKHVH---DRKIL 147

Query: 407 HFDIKPHNILLDEDFCPKISDFGLAKICNRKESIISMTGARGTVG---YIAPEVFCRNIG 463
           H DIK  NI L +D   ++ DFG+A++ N    +     AR  +G   Y++PE+ C N  
Sbjct: 148 HRDIKSQNIFLTKDGTVQLGDFGIARVLNSTVEL-----ARACIGTPYYLSPEI-CENKP 201

Query: 464 EVSYKSDVYNYGMMIFEMTGGR 485
             + KSD++  G +++E+   +
Sbjct: 202 -YNNKSDIWALGCVLYELCTLK 222

>2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* Length = 390

 Score =  103 bits (259), Expect = 3e-24
 Identities = 42/206 (20%), Positives = 85/206 (41%), Gaps = 44/206 (21%)

Query: 320 KLGQGGYGSVYKGKLLDGSNVAVKVLNDSKGNGKE---FINEVASISRTSH--VNVVALL 374
           ++G GG   V++         A+K +N  + + +    + NE+A +++       ++ L 
Sbjct: 63  QIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLY 122

Query: 375 GFCLR------VAE----ELSSTIG----------------IARGLEYLHLGCSTRILHF 408
            + +       V E    +L+S +                 +   +  +H      I+H 
Sbjct: 123 DYEITDQYIYMVMECGNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIH---QHGIVHS 179

Query: 409 DIKPHNILLDEDFCPKISDFGLAKICNRKESIISMTGARGTVGYIAPEVF---------C 459
           D+KP N L+ +    K+ DFG+A       + +      G V Y+ PE            
Sbjct: 180 DLKPANFLIVDGML-KLIDFGIANQMQPDTTSVVKDSQVGAVNYMPPEAIKDMSSSRENG 238

Query: 460 RNIGEVSYKSDVYNYGMMIFEMTGGR 485
           ++  ++S KSDV++ G +++ MT G+
Sbjct: 239 KSKSKISPKSDVWSLGCILYYMTYGK 264

>2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* Length = 310

 Score =  102 bits (255), Expect = 3e-24
 Identities = 53/205 (25%), Positives = 88/205 (42%), Gaps = 49/205 (23%)

Query: 320 KLGQGGYGSVYKGK-LLDGSNVAVKVLN-DSKGNGKE---FINEVASISRTSHVNVVALL 374
           K+G+G +  VY+   LLDG  VA+K +      + K     I E+  + + +H NV+   
Sbjct: 39  KIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYY 98

Query: 375 GFCLR------VAE-----ELSSTIG--------------------IARGLEYLHLGCST 403
              +       V E     +LS  I                     +   LE++H   S 
Sbjct: 99  ASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEHMH---SR 155

Query: 404 RILHFDIKPHNILLDEDFCPKISDFGLAKICNRKESIISMTGARGTVG---YIAPEVFCR 460
           R++H DIKP N+ +      K+ D GL +  + K      T A   VG   Y++PE    
Sbjct: 156 RVMHRDIKPANVFITATGVVKLGDLGLGRFFSSK-----TTAAHSLVGTPYYMSPER-IH 209

Query: 461 NIGEVSYKSDVYNYGMMIFEMTGGR 485
             G  ++KSD+++ G +++EM   +
Sbjct: 210 ENG-YNFKSDIWSLGCLLYEMAALQ 233

>3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* Length = 267

 Score =  101 bits (253), Expect = 3e-24
 Identities = 52/212 (24%), Positives = 94/212 (44%), Gaps = 41/212 (19%)

Query: 316 SFKYKLGQGGYGSVYKGKLLDGSNVAVKVLNDSKGNGKEFINEVASISRTSHVNVVALLG 375
           +F  ++G G +G V+ G  L+   VA+K + +   + ++FI E   + + SH  +V L G
Sbjct: 11  TFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAMSEEDFIEEAEVMMKLSHPKLVQLYG 70

Query: 376 FC----------------------------LRVAEELSSTIGIARGLEYLHLGCSTRILH 407
            C                                  L   + +  G+ YL       ++H
Sbjct: 71  VCLEQAPICLVTEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYL---EEACVIH 127

Query: 408 FDIKPHNILLDEDFCPKISDFGLAKICNRKESIISMTGARGTVGYIAPEVFCRNIGEVSY 467
            D+   N L+ E+   K+SDFG+ +     +   S TG +  V + +PEVF  +    S 
Sbjct: 128 RDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSS-TGTKFPVKWASPEVF--SFSRYSS 184

Query: 468 KSDVYNYGMMIFE-MTGGRK------NVDVVD 492
           KSDV+++G++++E  + G+       N +VV+
Sbjct: 185 KSDVWSFGVLMWEVFSEGKIPYENRSNSEVVE 216

>1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... Length = 452

 Score =  104 bits (260), Expect = 3e-24
 Identities = 53/208 (25%), Positives = 87/208 (41%), Gaps = 41/208 (19%)

Query: 320 KLGQGGYGSVYKGKLLDGSNVAVKVLNDSKGNGKEFINEVASISRTSHVNVVALLGFC-- 377
           KLGQG +G V+ G     + VA+K L     + + F+ E   + +  H  +V L      
Sbjct: 191 KLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVSE 250

Query: 378 ------------------LRVAEELSST--------IGIARGLEYLHLGCSTRILHFDIK 411
                             L+                  IA G+ Y+        +H D++
Sbjct: 251 EPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVE---RMNYVHRDLR 307

Query: 412 PHNILLDEDFCPKISDFGLAKICNRKESIISMTGARGTVGYIAPEVFCRNIGEVSYKSDV 471
             NIL+ E+   K++DFGLA++    E      GA+  + + APE      G  + KSDV
Sbjct: 308 AANILVGENLVCKVADFGLARLIEDNEYTAR-QGAKFPIKWTAPEAA--LYGRFTIKSDV 364

Query: 472 YNYGMMIFE-MTGGRK------NVDVVD 492
           +++G+++ E  T GR       N +V+D
Sbjct: 365 WSFGILLTELTTKGRVPYPGMVNREVLD 392

>4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* Length = 336

 Score =  102 bits (255), Expect = 4e-24
 Identities = 48/205 (23%), Positives = 76/205 (37%), Gaps = 51/205 (24%)

Query: 318 KYKLGQGGYGSVYKGKLLD-GSNVAVKV--LNDSKGNGKEFINEVASISRTSHVNVVALL 374
           + ++G+G +G V++ K    G   AVK   L   +      + E+ + +  S   +V L 
Sbjct: 63  QPRVGRGSFGEVHRMKDKQTGFQCAVKKVRLEVFR------VEELVACAGLSSPRIVPLY 116

Query: 375 GFCLRVAEELS-----------------------STIG-----IARGLEYLHLGCSTRIL 406
           G  +R    ++                                   GLEYLH   + RIL
Sbjct: 117 G-AVREGPWVNIFMELLEGGSLGQLIKQMGCLPEDRALYYLGQALEGLEYLH---TRRIL 172

Query: 407 HFDIKPHNILLDEDFCP-KISDFGLAKICNRKESIISMTGA---RGTVGYIAPEVFCRNI 462
           H D+K  N+LL  D     + DFG A          S+       GT  ++APEV    +
Sbjct: 173 HGDVKADNVLLSSDGSRAALCDFGHALCLQPDGLGKSLLTGDYIPGTETHMAPEV----V 228

Query: 463 GEVSY--KSDVYNYGMMIFEMTGGR 485
                  K D+++   M+  M  G 
Sbjct: 229 MGKPCDAKVDIWSSCCMMLHMLNGC 253

>3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} PDB: 3sxr_A* Length = 268

 Score =  100 bits (251), Expect = 5e-24
 Identities = 55/208 (26%), Positives = 93/208 (44%), Gaps = 41/208 (19%)

Query: 320 KLGQGGYGSVYKGKLLDGSNVAVKVLNDSKGNGKEFINEVASISRTSHVNVVALLGFC-- 377
           +LG G +G V  GK     +VAVK++ +   +  EF  E  ++ + SH  +V   G C  
Sbjct: 15  ELGSGQFGVVKLGKWKGQYDVAVKMIKEGSMSEDEFFQEAQTMMKLSHPKLVKFYGVCSK 74

Query: 378 --------------------------LRVAEELSSTIGIARGLEYLHLGCSTRILHFDIK 411
                                     L  ++ L     +  G+ +L    S + +H D+ 
Sbjct: 75  EYPIYIVTEYISNGCLLNYLRSHGKGLEPSQLLEMCYDVCEGMAFLE---SHQFIHRDLA 131

Query: 412 PHNILLDEDFCPKISDFGLAKICNRKESIISMTGARGTVGYIAPEVFCRNIGEVSYKSDV 471
             N L+D D C K+SDFG+ +     + + S  G +  V + APEVF  +  + S KSDV
Sbjct: 132 ARNCLVDRDLCVKVSDFGMTRYVLDDQYVSS-VGTKFPVKWSAPEVF--HYFKYSSKSDV 188

Query: 472 YNYGMMIFE-MTGGRK------NVDVVD 492
           + +G++++E  + G+       N +VV 
Sbjct: 189 WAFGILMWEVFSLGKMPYDLYTNSEVVL 216

>2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 Length = 535

 Score =  104 bits (260), Expect = 5e-24
 Identities = 53/208 (25%), Positives = 87/208 (41%), Gaps = 41/208 (19%)

Query: 320 KLGQGGYGSVYKGKLLDGSNVAVKVLNDSKGNGKEFINEVASISRTSHVNVVALLGFC-- 377
           KLGQG +G V+ G     + VA+K L     + + F+ E   + +  H  +V L      
Sbjct: 274 KLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVSE 333

Query: 378 ------------------LRVAEELSST--------IGIARGLEYLHLGCSTRILHFDIK 411
                             L+                  IA G+ Y+        +H D++
Sbjct: 334 EPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVE---RMNYVHRDLR 390

Query: 412 PHNILLDEDFCPKISDFGLAKICNRKESIISMTGARGTVGYIAPEVFCRNIGEVSYKSDV 471
             NIL+ E+   K++DFGLA++    E      GA+  + + APE      G  + KSDV
Sbjct: 391 AANILVGENLVCKVADFGLARLIEDNEYTAR-QGAKFPIKWTAPEAA--LYGRFTIKSDV 447

Query: 472 YNYGMMIFE-MTGGRK------NVDVVD 492
           +++G+++ E  T GR       N +V+D
Sbjct: 448 WSFGILLTELTTKGRVPYPGMVNREVLD 475

>1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* Length = 281

 Score =  100 bits (252), Expect = 5e-24
 Identities = 48/213 (22%), Positives = 90/213 (42%), Gaps = 46/213 (21%)

Query: 320 KLGQGGYGSVYKGKLLDGSN----VAVKVLND--SKGNGKEFINEVASISRTSHVNVVAL 373
            +G+G +G V++G  +   N    VA+K   +  S    ++F+ E  ++ +  H ++V L
Sbjct: 22  CIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKL 81

Query: 374 LGFC---------------------------LRVAEELSSTIGIARGLEYLHLGCSTRIL 406
           +G                             L +A  +     ++  L YL    S R +
Sbjct: 82  IGVITENPVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLE---SKRFV 138

Query: 407 HFDIKPHNILLDEDFCPKISDFGLAKICNRKESIISMTGARGTVGYIAPEVFCRNIGEVS 466
           H DI   N+L+  + C K+ DFGL++      +    +  +  + ++APE    N    +
Sbjct: 139 HRDIAARNVLVSSNDCVKLGDFGLSRYM-EDSTYYKASKGKLPIKWMAPESI--NFRRFT 195

Query: 467 YKSDVYNYGMMIFE-MTGGRK------NVDVVD 492
             SDV+ +G+ ++E +  G K      N DV+ 
Sbjct: 196 SASDVWMFGVCMWEILMHGVKPFQGVKNNDVIG 228

>2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} Length = 295

 Score =  100 bits (250), Expect = 9e-24
 Identities = 53/199 (26%), Positives = 81/199 (40%), Gaps = 40/199 (20%)

Query: 321 LGQGGYGSVYKGKLLD-GSNVAVK-VLNDSKGNGKEFINEVASISRTSHVNVVALLGFC- 377
           LG+G YG VY G+ L     +A+K +        +    E+A      H N+V  LG   
Sbjct: 30  LGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPLHEEIALHKHLKHKNIVQYLGSFS 89

Query: 378 ---------------------------LRVAEELSSTIG--IARGLEYLHLGCSTRILHF 408
                                      L+  E+        I  GL+YLH     +I+H 
Sbjct: 90  ENGFIKIFMEQVPGGSLSALLRSKWGPLKDNEQTIGFYTKQILEGLKYLH---DNQIVHR 146

Query: 409 DIKPHNILLD-EDFCPKISDFGLAK-ICNRKESIISMTGARGTVGYIAPEVFCRNIGEVS 466
           DIK  N+L++      KISDFG +K +        + TG   T+ Y+APE+  +      
Sbjct: 147 DIKGDNVLINTYSGVLKISDFGTSKRLAGINPCTETFTG---TLQYMAPEIIDKGPRGYG 203

Query: 467 YKSDVYNYGMMIFEMTGGR 485
             +D+++ G  I EM  G+
Sbjct: 204 KAADIWSLGCTIIEMATGK 222

>2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* Length = 321

 Score =  100 bits (250), Expect = 2e-23
 Identities = 57/199 (28%), Positives = 93/199 (46%), Gaps = 47/199 (23%)

Query: 320 KLGQGGYGSVYKGK-LLDGSNVAVKVLNDSKGNGKEFI-NEVASISRTSHVNVVALLG-- 375
           K+G+G  G V   +    G  VAVK+++  K   +E + NEV  +    H NVV +    
Sbjct: 52  KIGEGSTGIVCLAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHFNVVEMYKSY 111

Query: 376 -----------FC-----------LRVAEELSSTI--GIARGLEYLHLGCSTRILHFDIK 411
                      F            +R+ EE  +T+   + + L YLH   +  ++H DIK
Sbjct: 112 LVGEELWVLMEFLQGGALTDIVSQVRLNEEQIATVCEAVLQALAYLH---AQGVIHRDIK 168

Query: 412 PHNILLDEDFCPKISDFG----LAKICNRKESIISMTGARGTVGYIAPEVFCRNIGEVSY 467
             +ILL  D   K+SDFG    ++K   +++S++      GT  ++APEV    I    Y
Sbjct: 169 SDSILLTLDGRVKLSDFGFCAQISKDVPKRKSLV------GTPYWMAPEV----ISRSLY 218

Query: 468 --KSDVYNYGMMIFEMTGG 484
             + D+++ G+M+ EM  G
Sbjct: 219 ATEVDIWSLGIMVIEMVDG 237

>1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* Length = 291

 Score = 99.2 bits (248), Expect = 2e-23
 Identities = 50/213 (23%), Positives = 87/213 (40%), Gaps = 45/213 (21%)

Query: 320 KLGQGGYGSVYKGKLLDGS---NVAVKVL---NDSKGNGKEFINEVASISRTSHVNVVAL 373
           +LG G +G+V KG          VAVK+L    +      E + E   + +  +  +V +
Sbjct: 24  ELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRM 83

Query: 374 LGFC--------------------LRVAEELSST------IGIARGLEYLHLGCSTRILH 407
           +G C                    L+    +           ++ G++YL     +  +H
Sbjct: 84  IGICEAESWMLVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLE---ESNFVH 140

Query: 408 FDIKPHNILLDEDFCPKISDFGLAKICNRKESIISMT-GARGTVGYIAPEVFCRNIGEVS 466
            D+   N+LL      KISDFGL+K     E+        +  V + APE    N  + S
Sbjct: 141 RDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECI--NYYKFS 198

Query: 467 YKSDVYNYGMMIFE-MTGGRK------NVDVVD 492
            KSDV+++G++++E  + G+K        +V  
Sbjct: 199 SKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTA 231

>3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... Length = 288

 Score = 98.9 bits (247), Expect = 3e-23
 Identities = 58/210 (27%), Positives = 89/210 (42%), Gaps = 43/210 (20%)

Query: 320 KLGQGGYGSVYKGKLLDGS-NVAVKVLNDSKGNGKEFINEVASISRTSHVNVVALLGFC- 377
           KLG G YG VY+G     S  VAVK L +     +EF+ E A +    H N+V LLG C 
Sbjct: 20  KLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCT 79

Query: 378 --------------------LRVAEELSSTI--------GIARGLEYLHLGCSTRILHFD 409
                               LR       +          I+  +EYL        +H D
Sbjct: 80  REPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLE---KKNFIHRD 136

Query: 410 IKPHNILLDEDFCPKISDFGLAKICNRKESIISMTGARGTVGYIAPEVFCRNIGEVSYKS 469
           +   N L+ E+   K++DFGL+++    ++  +  GA+  + + APE    N    S KS
Sbjct: 137 LAARNCLVGENHLVKVADFGLSRLMT-GDTYTAHAGAKFPIKWTAPESLAYNK--FSIKS 193

Query: 470 DVYNYGMMIFE-MTGGRK------NVDVVD 492
           DV+ +G++++E  T G           V +
Sbjct: 194 DVWAFGVLLWEIATYGMSPYPGIDLSQVYE 223

>3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 3q6w_A* 3r7o_A* 3q6u_A* 3cth_A* 3ce3_A* 3ctj_A* ... Length = 298

 Score = 98.9 bits (247), Expect = 3e-23
 Identities = 66/228 (28%), Positives = 103/228 (45%), Gaps = 49/228 (21%)

Query: 309 DIKKMTNSFKYKLGQGGYGSVYKGKLLDGSN----VAVKVLND--SKGNGKEFINEVASI 362
               +   F   +G+G +G VY G LLD        AVK LN     G   +F+ E   +
Sbjct: 21  GPSSLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIM 80

Query: 363 SRTSHVNVVALLGFCLR-----------------------------VAEELSSTIGIARG 393
              SH NV++LLG CLR                             V + +   + +A+G
Sbjct: 81  KDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKG 140

Query: 394 LEYLHLGCSTRILHFDIKPHNILLDEDFCPKISDFGLAKICNRKE--SIISMTGARGTVG 451
           ++YL    S + +H D+   N +LDE F  K++DFGLA+    KE  S+ + TGA+  V 
Sbjct: 141 MKYLA---SKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVK 197

Query: 452 YIAPEVFCRNIGEVSYKSDVYNYGMMIFE-MTGGRK------NVDVVD 492
           ++A E         + KSDV+++G++++E MT G          D+  
Sbjct: 198 WMALESLQTQK--FTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITV 243

>1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A Length = 495

 Score =  101 bits (254), Expect = 3e-23
 Identities = 61/290 (21%), Positives = 104/290 (35%), Gaps = 52/290 (17%)

Query: 241 RCHIDDKGNFQCKIEWTGASAFAIGILIFIAFYFKRKLS-SYNSTASCLNIETFLRNYRS 299
           R +    G      E    +     +   +  +                          S
Sbjct: 155 RINTASDGKLYVSSESRFNT-----LAELVHHHSTVADGLITTLHYPAPKRNKPTIYGVS 209

Query: 300 LSPKRYGYADIKKMTNSFKYKLGQGGYGSVYKGKLLDGS-NVAVKVLNDSKGNGKEFINE 358
            +  ++   ++++   + K+KLG G YG VY+G     S  VAVK L +     +EF+ E
Sbjct: 210 PNYDKW---EMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKE 266

Query: 359 VASISRTSHVNVVALLGFC-----------------------------LRVAEELSSTIG 389
            A +    H N+V LLG C                             +     L     
Sbjct: 267 AAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQ 326

Query: 390 IARGLEYLHLGCSTRILHFDIKPHNILLDEDFCPKISDFGLAKICNRKESIISMTGARGT 449
           I+  +EYL        +H ++   N L+ E+   K++DFGL+++           GA+  
Sbjct: 327 ISSAMEYLE---KKNFIHRNLAARNCLVGENHLVKVADFGLSRLMTGDTYTAH-AGAKFP 382

Query: 450 VGYIAPEVFCRNIGEVSYKSDVYNYGMMIFE-MTGGRK------NVDVVD 492
           + + APE    N    S KSDV+ +G++++E  T G           V +
Sbjct: 383 IKWTAPESLAYNK--FSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYE 430

>3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} Length = 298

 Score = 98.5 bits (246), Expect = 4e-23
 Identities = 55/217 (25%), Positives = 94/217 (43%), Gaps = 49/217 (22%)

Query: 320 KLGQGGYGSVYKGKLLDGSN----VAVKVLND--SKGNGKEFINEVASISRTSHVNVVAL 373
            +G+G +G VY G+ +D +      A+K L+        + F+ E   +   +H NV+AL
Sbjct: 28  VIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEAFLREGLLMRGLNHPNVLAL 87

Query: 374 LGFC-----------------------------LRVAEELSSTIGIARGLEYLHLGCSTR 404
           +G                                 V + +S  + +ARG+EYL      +
Sbjct: 88  IGIMLPPEGLPHVLLPYMCHGDLLQFIRSPQRNPTVKDLISFGLQVARGMEYLA---EQK 144

Query: 405 ILHFDIKPHNILLDEDFCPKISDFGLAKICNRKE--SIISMTGARGTVGYIAPEVFCRNI 462
            +H D+   N +LDE F  K++DFGLA+    +E  S+     AR  V + A E      
Sbjct: 145 FVHRDLAARNCMLDESFTVKVADFGLARDILDREYYSVQQHRHARLPVKWTALESL--QT 202

Query: 463 GEVSYKSDVYNYGMMIFE-MTGGRK------NVDVVD 492
              + KSDV+++G++++E +T G          D+  
Sbjct: 203 YRFTTKSDVWSFGVLLWELLTRGAPPYRHIDPFDLTH 239

>3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A Length = 283

 Score = 97.7 bits (244), Expect = 5e-23
 Identities = 51/208 (24%), Positives = 88/208 (42%), Gaps = 41/208 (19%)

Query: 320 KLGQGGYGSVYKGKLLDGSNVAVKVLNDSKGNGKEFINEVASISRTSHVNVVALLGFC-- 377
           +LG G +G V  GK     +VA+K++ +   +  EFI E   +   SH  +V L G C  
Sbjct: 31  ELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSEDEFIEEAKVMMNLSHEKLVQLYGVCTK 90

Query: 378 --------------------------LRVAEELSSTIGIARGLEYLHLGCSTRILHFDIK 411
                                      +  + L     +   +EYL    S + LH D+ 
Sbjct: 91  QRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLE---SKQFLHRDLA 147

Query: 412 PHNILLDEDFCPKISDFGLAKICNRKESIISMTGARGTVGYIAPEVFCRNIGEVSYKSDV 471
             N L+++    K+SDFGL++     E   S  G++  V +  PEV      + S KSD+
Sbjct: 148 ARNCLVNDQGVVKVSDFGLSRYVLDDEYTSS-VGSKFPVRWSPPEVL--MYSKFSSKSDI 204

Query: 472 YNYGMMIFE-MTGGRK------NVDVVD 492
           + +G++++E  + G+       N +  +
Sbjct: 205 WAFGVLMWEIYSLGKMPYERFTNSETAE 232

>1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* Length = 291

 Score = 97.7 bits (244), Expect = 7e-23
 Identities = 52/216 (24%), Positives = 81/216 (37%), Gaps = 48/216 (22%)

Query: 320 KLGQGGYGSVYKGKLLDGSN----VAVKVLN----DSKGNGKEFINEVASISRTSHVNVV 371
           KLG G +G V +G+    S     VAVK L            +FI EV ++    H N++
Sbjct: 25  KLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLI 84

Query: 372 ALLGFCLR-----VAE----------------ELSST------IGIARGLEYLHLGCSTR 404
            L G  L      V E                           + +A G+ YL    S R
Sbjct: 85  RLYGVVLTPPMKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLE---SKR 141

Query: 405 ILHFDIKPHNILLDEDFCPKISDFGLAKICNRKESIISMT-GARGTVGYIAPEVFCRNIG 463
            +H D+   N+LL      KI DFGL +   + +    M    +    + APE       
Sbjct: 142 FIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPESL--KTR 199

Query: 464 EVSYKSDVYNYGMMIFE-MTGGRK------NVDVVD 492
             S+ SD + +G+ ++E  T G++         ++ 
Sbjct: 200 TFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILH 235

>3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* Length = 486

 Score =  100 bits (251), Expect = 7e-23
 Identities = 55/200 (27%), Positives = 86/200 (43%), Gaps = 43/200 (21%)

Query: 316 SFKYKLGQGGYGSVYKGK-LLDGSNVAVKVLNDSKGNGKE---FINEVASISRTSHVNVV 371
           +    LG+G +G V K K  +     AVKV+N +    K+    + EV  + +  H N++
Sbjct: 25  NIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIM 84

Query: 372 ALLGFC-----------------L--------RVAEELSSTIG--IARGLEYLHLGCSTR 404
            L                     L        R +E  ++ I   +  G+ Y+H      
Sbjct: 85  KLFEILEDSSSFYIVGELYTGGELFDEIIKRKRFSEHDAARIIKQVFSGITYMH---KHN 141

Query: 405 ILHFDIKPHNILL---DEDFCPKISDFGLAKICNRKESIISMTGARGTVGYIAPEVFCRN 461
           I+H D+KP NILL   ++D   KI DFGL+    +      M    GT  YIAPEV    
Sbjct: 142 IVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTK---MKDRIGTAYYIAPEVLRGT 198

Query: 462 IGEVSYKSDVYNYGMMIFEM 481
             E   K DV++ G++++ +
Sbjct: 199 YDE---KCDVWSAGVILYIL 215

>2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* Length = 434

 Score = 99.9 bits (249), Expect = 7e-23
 Identities = 50/232 (21%), Positives = 84/232 (36%), Gaps = 61/232 (26%)

Query: 309 DIKKMTNSFKYKLGQGGYGSVYKGKLLDGSNVAVKVLNDSKGNGKEFINEVASISRTS-H 367
            +K +  S K  LG G  G+V       G  VAVK +          + E+  ++ +  H
Sbjct: 12  SLKNLVVSEK-ILGYGSSGTVVFQGSFQGRPVAVKRML--IDFCDIALMEIKLLTESDDH 68

Query: 368 VNVVALLGF-------------------------------CLRVAEELSSTI--GIARGL 394
            NV+                                         E    ++   IA G+
Sbjct: 69  PNVIRYYCSETTDRFLYIALELCNLNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGV 128

Query: 395 EYLHLGCSTRILHFDIKPHNILLD-------------EDFCPKISDFGLAKICNRKESII 441
            +LH   S +I+H D+KP NIL+              E+    ISDFGL K  +  +S  
Sbjct: 129 AHLH---SLKIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDSGQSSF 185

Query: 442 S--MTGARGTVGYIAPEVFCRNIGEV-----SYKSDVYNYGMMIFEM-TGGR 485
              +    GT G+ APE+   +         +   D+++ G + + + + G+
Sbjct: 186 RTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGK 237

>3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* Length = 484

 Score =  100 bits (250), Expect = 8e-23
 Identities = 52/201 (25%), Positives = 85/201 (42%), Gaps = 44/201 (21%)

Query: 316 SFKYKLGQGGYGSVYKGK-LLDGSNVAVKVLNDSKGNGKE----FINEVASISRTSHVNV 370
             +  LG+G +G V   K  + G   AVKV++  +   K      + EV  + +  H N+
Sbjct: 29  KGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNI 88

Query: 371 VALLGF-------------CL------------RVAEELSSTIG--IARGLEYLHLGCST 403
           + L  F                           R +E  ++ I   +  G+ Y+H     
Sbjct: 89  MKLYEFFEDKGYFYLVGEVYTGGELFDEIISRKRFSEVDAARIIRQVLSGITYMH---KN 145

Query: 404 RILHFDIKPHNILL---DEDFCPKISDFGLAKICNRKESIISMTGARGTVGYIAPEVFCR 460
           +I+H D+KP N+LL    +D   +I DFGL+      +    M    GT  YIAPEV   
Sbjct: 146 KIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASKK---MKDKIGTAYYIAPEVLHG 202

Query: 461 NIGEVSYKSDVYNYGMMIFEM 481
              E   K DV++ G++++ +
Sbjct: 203 TYDE---KCDVWSTGVILYIL 220

>3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* Length = 494

 Score =  100 bits (250), Expect = 9e-23
 Identities = 57/205 (27%), Positives = 86/205 (41%), Gaps = 45/205 (21%)

Query: 316 SFKYKLGQGGYGSVYKGK-LLDGSNVAVKVLNDSKGNGKE---FINEVASISRTSHVNVV 371
               KLG G YG V   +  +     A+K++  +  +       + EVA +    H N++
Sbjct: 40  QRVKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSSNSKLLEEVAVLKLLDHPNIM 99

Query: 372 ALLGFC-------LRVAE-----ELSSTIG----------------IARGLEYLHLGCST 403
            L  F        L V E     EL   I                 +  G+ YLH     
Sbjct: 100 KLYDFFEDKRNYYL-VMECYKGGELFDEIIHRMKFNEVDAAVIIKQVLSGVTYLH---KH 155

Query: 404 RILHFDIKPHNILL---DEDFCPKISDFGLAKICNRKESIISMTGARGTVGYIAPEVFCR 460
            I+H D+KP N+LL   ++D   KI DFGL+ +   ++    M    GT  YIAPEV  +
Sbjct: 156 NIVHRDLKPENLLLESKEKDALIKIVDFGLSAVFENQKK---MKERLGTAYYIAPEVLRK 212

Query: 461 NIGEVSYKSDVYNYGMMIFEMTGGR 485
              E   K DV++ G+++F +  G 
Sbjct: 213 KYDE---KCDVWSIGVILFILLAGY 234

>1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* Length = 348

 Score = 98.3 bits (245), Expect = 9e-23
 Identities = 52/195 (26%), Positives = 84/195 (43%), Gaps = 42/195 (21%)

Query: 320 KLGQGGYGSVYKGK-LLDGSNVAVKVLN----DSKGNGKEFINEVASISRTSHVNVVALL 374
           ++G G +G+VY  + + +   VA+K ++     S    ++ I EV  + +  H N +   
Sbjct: 61  EIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYR 120

Query: 375 G-------------FC----LRVAEELSSTIG---IA-------RGLEYLHLGCSTRILH 407
           G             +C      + E     +    IA       +GL YLH   S  ++H
Sbjct: 121 GCYLREHTAWLVMEYCLGSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLH---SHNMIH 177

Query: 408 FDIKPHNILLDEDFCPKISDFGLAKICNRKESIISMTGARGTVGYIAPEV-FCRNIGEVS 466
            D+K  NILL E    K+ DFG A I     S +      GT  ++APEV    + G+  
Sbjct: 178 RDVKAGNILLSEPGLVKLGDFGSASIMAPANSFV------GTPYWMAPEVILAMDEGQYD 231

Query: 467 YKSDVYNYGMMIFEM 481
            K DV++ G+   E+
Sbjct: 232 GKVDVWSLGITCIEL 246

>1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* Length = 289

 Score = 97.0 bits (242), Expect = 1e-22
 Identities = 46/221 (20%), Positives = 73/221 (33%), Gaps = 65/221 (29%)

Query: 320 KLGQGGYGSVYKG-KLLDGSNVAVKVLN---DSKGNGKEFINEVASISRTS-HVNVVALL 374
           K+G G +GSV+K  K LDG   A+K          + +  + EV + +    H +VV   
Sbjct: 18  KIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQHSHVVRYF 77

Query: 375 G-------------FC--------LRVAEELSSTIG----------IARGLEYLHLGCST 403
                         +C        +     + S             + RGL Y+H   S 
Sbjct: 78  SAWAEDDHMLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRYIH---SM 134

Query: 404 RILHFDIKPHNILLDEDFCP-------------------KISDFGLAKICNRKESIISMT 444
            ++H DIKP NI +     P                   KI D G     +  +      
Sbjct: 135 SLVHMDIKPSNIFISRTSIPNAASEEGDEDDWASNKVMFKIGDLGHVTRISSPQVEE--- 191

Query: 445 GARGTVGYIAPEVFCRNIGEVSYKSDVYNYGMMIFEMTGGR 485
              G   ++A EV   N      K+D++   + +    G  
Sbjct: 192 ---GDSRFLANEVLQENYTH-LPKADIFALALTVVCAAGAE 228

>3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} Length = 325

 Score = 97.8 bits (244), Expect = 1e-22
 Identities = 49/215 (22%), Positives = 93/215 (43%), Gaps = 47/215 (21%)

Query: 320 KLGQGGYGSVYKGKLLDGSN----VAVKVLND--SKGNGKEFINEVASISRTSHVNVVAL 373
            +G G  G V  G+L         VA+K L    ++   ++F++E + + +  H N++ L
Sbjct: 56  IIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDFLSEASIMGQFDHPNIIRL 115

Query: 374 LGFCLR------VAE----------------ELSST------IGIARGLEYLHLGCSTRI 405
            G   R      V E                + +         G+  G+ YL        
Sbjct: 116 EGVVTRGRLAMIVTEYMENGSLDTFLRTHDGQFTIMQLVGMLRGVGAGMRYLS---DLGY 172

Query: 406 LHFDIKPHNILLDEDFCPKISDFGLAK-ICNRKESIISMTGARGTVGYIAPEVFCRNIGE 464
           +H D+   N+L+D +   K+SDFGL++ + +  ++  + TG +  + + APE        
Sbjct: 173 VHRDLAARNVLVDSNLVCKVSDFGLSRVLEDDPDAAYTTTGGKIPIRWTAPEAI--AFRT 230

Query: 465 VSYKSDVYNYGMMIFE-MTGGRK------NVDVVD 492
            S  SDV+++G++++E +  G +      N DV+ 
Sbjct: 231 FSSASDVWSFGVVMWEVLAYGERPYWNMTNRDVIS 265

>3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* Length = 297

 Score = 97.0 bits (242), Expect = 1e-22
 Identities = 52/199 (26%), Positives = 89/199 (44%), Gaps = 47/199 (23%)

Query: 320 KLGQGGYGSVYKGK-LLDGSNVAVKVLNDSKGNGKEFI-NEVASISRTSHVNVVALLG-- 375
           K+GQG  G+VY    +  G  VA++ +N  +   KE I NE+  +    + N+V  L   
Sbjct: 27  KIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSY 86

Query: 376 -----------FCL-----------RVAEELSSTI--GIARGLEYLHLGCSTRILHFDIK 411
                      +              + E   + +     + LE+LH   S +++H DIK
Sbjct: 87  LVGDELWVVMEYLAGGSLTDVVTETCMDEGQIAAVCRECLQALEFLH---SNQVIHRDIK 143

Query: 412 PHNILLDEDFCPKISDFG----LAKICNRKESIISMTGARGTVGYIAPEVFCRNIGEVSY 467
             NILL  D   K++DFG    +    +++ +++      GT  ++APEV    +   +Y
Sbjct: 144 SDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMV------GTPYWMAPEV----VTRKAY 193

Query: 468 --KSDVYNYGMMIFEMTGG 484
             K D+++ G+M  EM  G
Sbjct: 194 GPKVDIWSLGIMAIEMIEG 212

>3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 Length = 373

 Score = 97.9 bits (244), Expect = 2e-22
 Identities = 65/228 (28%), Positives = 103/228 (45%), Gaps = 49/228 (21%)

Query: 309 DIKKMTNSFKYKLGQGGYGSVYKGKLLDGSN----VAVKVLND--SKGNGKEFINEVASI 362
               +   F   +G+G +G VY G LLD        AVK LN     G   +F+ E   +
Sbjct: 85  GPSSLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIM 144

Query: 363 SRTSHVNVVALLGFCLR-----------------------------VAEELSSTIGIARG 393
              SH NV++LLG CLR                             V + +   + +A+G
Sbjct: 145 KDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKG 204

Query: 394 LEYLHLGCSTRILHFDIKPHNILLDEDFCPKISDFGLAKICNRKE--SIISMTGARGTVG 451
           +++L    S + +H D+   N +LDE F  K++DFGLA+    KE  S+ + TGA+  V 
Sbjct: 205 MKFLA---SKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVK 261

Query: 452 YIAPEVFCRNIGEVSYKSDVYNYGMMIFE-MTGGRK------NVDVVD 492
           ++A E         + KSDV+++G++++E MT G          D+  
Sbjct: 262 WMALESLQTQK--FTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITV 307

>2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* Length = 302

 Score = 96.6 bits (241), Expect = 2e-22
 Identities = 53/199 (26%), Positives = 87/199 (43%), Gaps = 46/199 (23%)

Query: 320 KLGQGGYGSVYKGK-LLDGSNVAVKVLNDSKGNGKE-FINEVASISRTSHVNVVALLG-- 375
           +LG G +G VYK K    G+  A KV+        E +I E+  ++   H  +V LLG  
Sbjct: 26  ELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYIVEIEILATCDHPYIVKLLGAY 85

Query: 376 -----------FCL-------------RVAEELSSTI--GIARGLEYLHLGCSTRILHFD 409
                      FC               + E     +   +   L +LH   S RI+H D
Sbjct: 86  YHDGKLWIMIEFCPGGAVDAIMLELDRGLTEPQIQVVCRQMLEALNFLH---SKRIIHRD 142

Query: 410 IKPHNILLDEDFCPKISDFG----LAKICNRKESIISMTGARGTVGYIAPEV-FCRNIGE 464
           +K  N+L+  +   +++DFG      K   +++S I      GT  ++APEV  C  + +
Sbjct: 143 LKAGNVLMTLEGDIRLADFGVSAKNLKTLQKRDSFI------GTPYWMAPEVVMCETMKD 196

Query: 465 VSY--KSDVYNYGMMIFEM 481
             Y  K+D+++ G+ + EM
Sbjct: 197 TPYDYKADIWSLGITLIEM 215

>3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* Length = 281

 Score = 96.1 bits (240), Expect = 2e-22
 Identities = 50/218 (22%), Positives = 91/218 (41%), Gaps = 49/218 (22%)

Query: 320 KLGQGGYGSVYKGKLLDGSN----VAVKVLND--SKGNGKEFINEVASISRTSHVNVVAL 373
            LG+G +G VY+G   +       VAVK      +  N ++F++E   +    H ++V L
Sbjct: 19  ILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIVKL 78

Query: 374 LGFC---------------------------LRVAEELSSTIGIARGLEYLHLGCSTRIL 406
           +G                             L+V   +  ++ I + + YL    S   +
Sbjct: 79  IGIIEEEPTWIIMELYPYGELGHYLERNKNSLKVLTLVLYSLQICKAMAYLE---SINCV 135

Query: 407 HFDIKPHNILLDEDFCPKISDFGLAKICNRKESIISMTGARGTVGYIAPEVFCRNIGEVS 466
           H DI   NIL+    C K+ DFGL++     E     +  R  + +++PE    N    +
Sbjct: 136 HRDIAVRNILVASPECVKLGDFGLSRYIE-DEDYYKASVTRLPIKWMSPESI--NFRRFT 192

Query: 467 YKSDVYNYGMMIFE-MTGGRK------NVDV---VDNG 494
             SDV+ + + ++E ++ G++      N DV   ++ G
Sbjct: 193 TASDVWMFAVCMWEILSFGKQPFFWLENKDVIGVLEKG 230

>1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 333

 Score = 96.6 bits (241), Expect = 3e-22
 Identities = 55/216 (25%), Positives = 100/216 (46%), Gaps = 48/216 (22%)

Query: 320 KLGQGGYGSVYKGKLLDGSN-----VAVKVLND--SKGNGKEFINEVASISRTSHVNVVA 372
            +G G +G VYKG L   S      VA+K L    ++    +F+ E   + + SH N++ 
Sbjct: 51  VIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIR 110

Query: 373 LLGFCLR------VAE----------------ELSST------IGIARGLEYLHLGCSTR 404
           L G   +      + E                E S         GIA G++YL    +  
Sbjct: 111 LEGVISKYKPMMIITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAGMKYLA---NMN 167

Query: 405 ILHFDIKPHNILLDEDFCPKISDFGLAK-ICNRKESIISMTGARGTVGYIAPEVFCRNIG 463
            +H D+   NIL++ +   K+SDFGL++ + +  E+  + +G +  + + APE    +  
Sbjct: 168 YVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGGKIPIRWTAPEAI--SYR 225

Query: 464 EVSYKSDVYNYGMMIFE-MTGGRK------NVDVVD 492
           + +  SDV+++G++++E MT G +      N +V+ 
Sbjct: 226 KFTSASDVWSFGIVMWEVMTYGERPYWELSNHEVMK 261

>2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* Length = 279

 Score = 95.4 bits (238), Expect = 3e-22
 Identities = 49/206 (23%), Positives = 78/206 (37%), Gaps = 45/206 (21%)

Query: 320 KLGQGGYGSVYKGK-LLDGSNVAVKVLNDSKGNGKE---FINEVASISRTSHVNVVALLG 375
            +G G YG   K +   DG  +  K L+       E    ++EV  +    H N+V    
Sbjct: 13  TIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYD 72

Query: 376 ---------FCLRVAE-----ELSSTIG--------------------IARGLEYLH--L 399
                      + V E     +L+S I                     +   L+  H   
Sbjct: 73  RIIDRTNTTLYI-VMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRS 131

Query: 400 GCSTRILHFDIKPHNILLDEDFCPKISDFGLAKICNRKESIISMTGARGTVGYIAPEVFC 459
                +LH D+KP N+ LD     K+ DFGLA+I N   S        GT  Y++PE   
Sbjct: 132 DGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSF--AKTFVGTPYYMSPEQ-M 188

Query: 460 RNIGEVSYKSDVYNYGMMIFEMTGGR 485
             +   + KSD+++ G +++E+    
Sbjct: 189 NRMS-YNEKSDIWSLGCLLYELCALM 213

>2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} Length = 613

 Score = 98.9 bits (246), Expect = 4e-22
 Identities = 50/215 (23%), Positives = 90/215 (41%), Gaps = 45/215 (20%)

Query: 318 KYKLGQGGYGSVYKGKLLDGSN---VAVKVL--NDSKGNGKEFINEVASISRTSHVNVVA 372
             +LG G +GSV +G          VA+KVL     K + +E + E   + +  +  +V 
Sbjct: 341 DIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVR 400

Query: 373 LLGFC---------------------------LRVAEELSSTIGIARGLEYLHLGCSTRI 405
           L+G C                           + V+        ++ G++YL        
Sbjct: 401 LIGVCQAEALMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYL---EEKNF 457

Query: 406 LHFDIKPHNILLDEDFCPKISDFGLAKICNRKESIISMT-GARGTVGYIAPEVFCRNIGE 464
           +H ++   N+LL      KISDFGL+K     +S  +     +  + + APE    N  +
Sbjct: 458 VHRNLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPECI--NFRK 515

Query: 465 VSYKSDVYNYGMMIFE-MTGGRK------NVDVVD 492
            S +SDV++YG+ ++E ++ G+K        +V+ 
Sbjct: 516 FSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMA 550

>3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* Length = 318

 Score = 95.9 bits (239), Expect = 4e-22
 Identities = 50/205 (24%), Positives = 75/205 (36%), Gaps = 42/205 (20%)

Query: 320 KLGQGGYGSVYKGKLLD-----GSNVAVKVLNDSKG--NGKEFINEVASISRTSHVNVVA 372
            LG+G +G V            G  VAVK L    G  +   +  E+  +    H +++ 
Sbjct: 38  DLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQHRSGWKQEIDILRTLYHEHIIK 97

Query: 373 LLGFCLRVAEE----------------------------LSSTIGIARGLEYLHLGCSTR 404
             G C                                  L     I  G+ YLH   +  
Sbjct: 98  YKGCCEDAGAASLQLVMEYVPLGSLRDYLPRHSIGLAQLLLFAQQICEGMAYLH---AQH 154

Query: 405 ILHFDIKPHNILLDEDFCPKISDFGLAK-ICNRKESIISMTGARGTVGYIAPEVFCRNIG 463
            +H D+   N+LLD D   KI DFGLAK +    E           V + APE  C    
Sbjct: 155 YIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWYAPE--CLKEY 212

Query: 464 EVSYKSDVYNYGMMIFE-MTGGRKN 487
           +  Y SDV+++G+ ++E +T    +
Sbjct: 213 KFYYASDVWSFGVTLYELLTHCDSS 237

>3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 3q32_A* 3rvg_A* 3tjc_A* 3tjd_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* 3io7_A* 3kck_A* 3jy9_A* Length = 295

 Score = 95.0 bits (237), Expect = 5e-22
 Identities = 53/209 (25%), Positives = 86/209 (41%), Gaps = 43/209 (20%)

Query: 317 FKYKLGQGGYGSVYKGKLL-----DGSNVAVKVL-NDSKGNGKEFINEVASISRTSHVNV 370
           F  +LG+G +GSV   +        G  VAVK L + ++ + ++F  E+  +    H N+
Sbjct: 14  FLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNI 73

Query: 371 VALLGFCLRVAEE------------------------------LSSTIGIARGLEYLHLG 400
           V   G C                                    L  T  I +G+EYL   
Sbjct: 74  VKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLG-- 131

Query: 401 CSTRILHFDIKPHNILLDEDFCPKISDFGLAK-ICNRKESIISMTGARGTVGYIAPEVFC 459
            + R +H D+   NIL++ +   KI DFGL K +   KE           + + APE   
Sbjct: 132 -TKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEFFKVKEPGESPIFWYAPE--S 188

Query: 460 RNIGEVSYKSDVYNYGMMIFE-MTGGRKN 487
               + S  SDV+++G++++E  T   K+
Sbjct: 189 LTESKFSVASDVWSFGVVLYELFTYIEKS 217

>2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} Length = 326

 Score = 95.5 bits (238), Expect = 6e-22
 Identities = 58/206 (28%), Positives = 90/206 (43%), Gaps = 53/206 (25%)

Query: 320 KLGQGGYGSVYKGK-LLDGSNVAVKVLNDSKGNGKEFINEVASISRTS-HVNVVALLG-- 375
            +G G YG VYKG+ +  G   A+KV++ +    +E   E+  + + S H N+    G  
Sbjct: 31  LVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDEEEEIKQEINMLKKYSHHRNIATYYGAF 90

Query: 376 -----------------FC--------------LRVAEELSSTI--GIARGLEYLHLGCS 402
                            FC                + EE  + I   I RGL +LH    
Sbjct: 91  IKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLH---Q 147

Query: 403 TRILHFDIKPHNILLDEDFCPKISDFG----LAKICNRKESIISMTGARGTVGYIAPEVF 458
            +++H DIK  N+LL E+   K+ DFG    L +   R+ + I      GT  ++APEV 
Sbjct: 148 HKVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRRNTFI------GTPYWMAPEVI 201

Query: 459 -CRNIGEVSY--KSDVYNYGMMIFEM 481
            C    + +Y  KSD+++ G+   EM
Sbjct: 202 ACDENPDATYDFKSDLWSLGITAIEM 227

>1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* Length = 278

 Score = 94.6 bits (236), Expect = 6e-22
 Identities = 53/210 (25%), Positives = 87/210 (41%), Gaps = 49/210 (23%)

Query: 320 KLGQGGYGSVYKGKLLDGSNVAVKVLNDSKGNGKEFINEVASISRTSHVNVVALLGFC-- 377
            +G+G +G V  G    G+ VAVK + +     + F+ E + +++  H N+V LLG    
Sbjct: 28  TIGKGEFGDVMLGDY-RGNKVAVKCIKND-ATAQAFLAEASVMTQLRHSNLVQLLGVIVE 85

Query: 378 ----------------------------LRVAEELSSTIGIARGLEYLHLGCSTRILHFD 409
                                       L     L  ++ +   +EYL        +H D
Sbjct: 86  EKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLE---GNNFVHRD 142

Query: 410 IKPHNILLDEDFCPKISDFGLAKICNRKESIISMTGARGTVGYIAPEVFCRNIGEVSYKS 469
           +   N+L+ ED   K+SDFGL      KE+  +    +  V + APE         S KS
Sbjct: 143 LAARNVLVSEDNVAKVSDFGLT-----KEASSTQDTGKLPVKWTAPEALREKK--FSTKS 195

Query: 470 DVYNYGMMIFE-MTGGRK------NVDVVD 492
           DV+++G++++E  + GR         DVV 
Sbjct: 196 DVWSFGILLWEIYSFGRVPYPRIPLKDVVP 225

>3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 3pjc_A* 1yvj_A* Length = 327

 Score = 95.1 bits (237), Expect = 8e-22
 Identities = 52/234 (22%), Positives = 95/234 (40%), Gaps = 46/234 (19%)

Query: 294 LRNYRSLSPKRYGYAD---IKKMTNSFKYKLGQGGYGSVYKGKLL-----DGSNVAVKVL 345
           + ++     + Y   D    ++    +  +LG+G +GSV   +        G+ VAVK L
Sbjct: 1   MGHHHHHHAQLYACQDPTIFEERHLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQL 60

Query: 346 NDSKGNG-KEFINEVASISRTSHVNVVALLGFCLRVAEE--------------------- 383
             S  +  ++F  E+  +       +V   G       +                     
Sbjct: 61  QHSGPDQQRDFQREIQILKALHSDFIVKYRGVSYGPGRQSLRLVMEYLPSGCLRDFLQRH 120

Query: 384 ---------LSSTIGIARGLEYLHLGCSTRILHFDIKPHNILLDEDFCPKISDFGLAK-I 433
                    L  +  I +G+EYL    S R +H D+   NIL++ +   KI+DFGLAK +
Sbjct: 121 RARLDASRLLLYSSQICKGMEYLG---SRRCVHRDLAARNILVESEAHVKIADFGLAKLL 177

Query: 434 CNRKESIISMTGARGTVGYIAPEVFCRNIGEVSYKSDVYNYGMMIFE-MTGGRK 486
              K+  +     +  + + APE    +    S +SDV+++G++++E  T   K
Sbjct: 178 PLDKDYYVVREPGQSPIFWYAPE--SLSDNIFSRQSDVWSFGVVLYELFTYCDK 229

>2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* Length = 656

 Score = 98.0 bits (244), Expect = 9e-22
 Identities = 48/213 (22%), Positives = 90/213 (42%), Gaps = 46/213 (21%)

Query: 320 KLGQGGYGSVYKGKLLDGSN----VAVKVLND--SKGNGKEFINEVASISRTSHVNVVAL 373
            +G+G +G V++G  +   N    VA+K   +  S    ++F+ E  ++ +  H ++V L
Sbjct: 397 CIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKL 456

Query: 374 LGFC---------------------------LRVAEELSSTIGIARGLEYLHLGCSTRIL 406
           +G                             L +A  +     ++  L YL    S R +
Sbjct: 457 IGVITENPVWIIMELCTLGELRSFLQVRKFSLDLASLILYAYQLSTALAYLE---SKRFV 513

Query: 407 HFDIKPHNILLDEDFCPKISDFGLAKICNRKESIISMTGARGTVGYIAPEVFCRNIGEVS 466
           H DI   N+L+  + C K+ DFGL++      +    +  +  + ++APE    N    +
Sbjct: 514 HRDIAARNVLVSSNDCVKLGDFGLSRYM-EDSTYYKASKGKLPIKWMAPESI--NFRRFT 570

Query: 467 YKSDVYNYGMMIFE-MTGGRK------NVDVVD 492
             SDV+ +G+ ++E +  G K      N DV+ 
Sbjct: 571 SASDVWMFGVCMWEILMHGVKPFQGVKNNDVIG 603

>1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A Length = 450

 Score = 96.6 bits (241), Expect = 1e-21
 Identities = 53/213 (24%), Positives = 87/213 (40%), Gaps = 49/213 (23%)

Query: 317 FKYKLGQGGYGSVYKGKLLDGSNVAVKVLNDSKGNGKEFINEVASISRTSHVNVVALLGF 376
               +G+G +G V  G    G+ VAVK + +     + F+ E + +++  H N+V LLG 
Sbjct: 197 LLQTIGKGEFGDVMLGDY-RGNKVAVKCIKNDATA-QAFLAEASVMTQLRHSNLVQLLGV 254

Query: 377 C------------------------------LRVAEELSSTIGIARGLEYLHLGCSTRIL 406
                                          L     L  ++ +   +EYL        +
Sbjct: 255 IVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLE---GNNFV 311

Query: 407 HFDIKPHNILLDEDFCPKISDFGLAKICNRKESIISMTGARGTVGYIAPEVFCRNIGEVS 466
           H D+   N+L+ ED   K+SDFGL      KE+  +    +  V + APE         S
Sbjct: 312 HRDLAARNVLVSEDNVAKVSDFGLT-----KEASSTQDTGKLPVKWTAPEALREKK--FS 364

Query: 467 YKSDVYNYGMMIFE-MTGGRK------NVDVVD 492
            KSDV+++G++++E  + GR         DVV 
Sbjct: 365 TKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVP 397

>3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* Length = 303

 Score = 94.7 bits (236), Expect = 1e-21
 Identities = 50/200 (25%), Positives = 88/200 (44%), Gaps = 48/200 (24%)

Query: 320 KLGQGGYGSVYKGK-LLDGSNVAVKVLNDSKGNGK--EFINEVASISRTSHVNVVALLG- 375
           K+G+G +G V+KG        VA+K+++  +   +  +   E+  +S+     V    G 
Sbjct: 29  KIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGS 88

Query: 376 ------------FCL-----------RVAEELSSTI--GIARGLEYLHLGCSTRILHFDI 410
                       +              + E   +TI   I +GL+YLH   S + +H DI
Sbjct: 89  YLKDTKLWIIMEYLGGGSALDLLEPGPLDETQIATILREILKGLDYLH---SEKKIHRDI 145

Query: 411 KPHNILLDEDFCPKISDFG----LAKICNRKESIISMTGARGTVGYIAPEVFCRNIGEVS 466
           K  N+LL E    K++DFG    L     ++ + +      GT  ++APEV    I + +
Sbjct: 146 KAANVLLSEHGEVKLADFGVAGQLTDTQIKRNTFV------GTPFWMAPEV----IKQSA 195

Query: 467 Y--KSDVYNYGMMIFEMTGG 484
           Y  K+D+++ G+   E+  G
Sbjct: 196 YDSKADIWSLGITAIELARG 215

>2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} Length = 317

 Score = 94.7 bits (236), Expect = 1e-21
 Identities = 50/216 (23%), Positives = 83/216 (38%), Gaps = 52/216 (24%)

Query: 315 NSFKYK----LGQGGYGSVYKGK-LLDGSNVAVKVLNDSKGNGKEFI-NEVASISRTSHV 368
           ++  Y     LG+GG+  V   + L DG   A+K +   +   +E    E       +H 
Sbjct: 27  DNKHYLFIQKLGEGGFSYVDLVEGLHDGHFYALKRILCHEQQDREEAQREADMHRLFNHP 86

Query: 369 NVVALLGFCLRVAE---------------ELSSTI--------------------GIARG 393
           N++ L+ +CLR                   L + I                    GI RG
Sbjct: 87  NILRLVAYCLRERGAKHEAWLLLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRG 146

Query: 394 LEYLHLGCSTRILHFDIKPHNILLDEDFCPKISDFGLAKICNRKESIISMTGA------- 446
           LE +H   +    H D+KP NILL ++  P + D G                        
Sbjct: 147 LEAIH---AKGYAHRDLKPTNILLGDEGQPVLMDLGSMNQACIHVEGSRQALTLQDWAAQ 203

Query: 447 RGTVGYIAPEVF-CRNIGEVSYKSDVYNYGMMIFEM 481
           R T+ Y APE+F  ++   +  ++DV++ G +++ M
Sbjct: 204 RCTISYRAPELFSVQSHCVIDERTDVWSLGCVLYAM 239

>4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} Length = 319

 Score = 94.8 bits (236), Expect = 1e-21
 Identities = 41/211 (19%), Positives = 74/211 (35%), Gaps = 51/211 (24%)

Query: 320 KLGQGGYGSVYKGK-LLDGSNVAVKVLNDSKGNGKE--FINEVASISRTSHVNVVALL-- 374
            LGQG   +V++G+    G   A+KV N+          + E   + + +H N+V L   
Sbjct: 16  ILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAI 75

Query: 375 ----------------------------GFCLRVAEELSSTI--GIARGLEYLHLGCSTR 404
                                            + E     +   +  G+ +L       
Sbjct: 76  EEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLR---ENG 132

Query: 405 ILHFDIKPHNILL----DEDFCPKISDFGLAKICNRKESIISMTGARGTVGYIAPEVFCR 460
           I+H +IKP NI+     D     K++DFG A+     E         GT  Y+ P+++ R
Sbjct: 133 IVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDE---QFVSLYGTEEYLHPDMYER 189

Query: 461 NIGEVSY------KSDVYNYGMMIFEMTGGR 485
            +    +        D+++ G+  +    G 
Sbjct: 190 AVLRKDHQKKYGATVDLWSIGVTFYHAATGS 220

>2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* Length = 335

 Score = 95.1 bits (237), Expect = 1e-21
 Identities = 50/202 (24%), Positives = 82/202 (40%), Gaps = 49/202 (24%)

Query: 321 LGQGGYGSVYKGKLLD-GSNVAVKVLNDSK----GNGKEFINEVASISRTSHVNVVAL-- 373
           LG+GG+   ++    D     A K++  S        ++   E++     +H +VV    
Sbjct: 49  LGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHG 108

Query: 374 -----------LGFCL------------RVAEELSSTI--GIARGLEYLHLGCSTRILHF 408
                      L  C              + E  +      I  G +YLH     R++H 
Sbjct: 109 FFEDNDFVFVVLELCRRRSLLELHKRRKALTEPEARYYLRQIVLGCQYLH---RNRVIHR 165

Query: 409 DIKPHNILLDEDFCPKISDFGLAKICNRKESIISMTGAR-----GTVGYIAPEVFCRNIG 463
           D+K  N+ L+ED   KI DFGLA       + +   G R     GT  YIAPEV  +   
Sbjct: 166 DLKLGNLFLNEDLEVKIGDFGLA-------TKVEYDGERKKVLCGTPNYIAPEVLSKK-- 216

Query: 464 EVSYKSDVYNYGMMIFEMTGGR 485
             S++ DV++ G +++ +  G+
Sbjct: 217 GHSFEVDVWSIGCIMYTLLVGK 238

>3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} Length = 314

 Score = 94.4 bits (235), Expect = 1e-21
 Identities = 58/198 (29%), Positives = 91/198 (45%), Gaps = 49/198 (24%)

Query: 319 YKLGQGGYGSVYKGK-LLDGSNVAVKVLNDSKGNGKEFINEVASISRTSHVNVVALLG-- 375
            KLG+G YGSVYK      G  VA+K +   + + +E I E++ + +    +VV   G  
Sbjct: 35  EKLGEGSYGSVYKAIHKETGQIVAIKQV-PVESDLQEIIKEISIMQQCDSPHVVKYYGSY 93

Query: 376 -----------FC-------------LRVAEELSSTI--GIARGLEYLHLGCSTRILHFD 409
                      +C               + E+  +TI     +GLEYLH     R +H D
Sbjct: 94  FKNTDLWIVMEYCGAGSVSDIIRLRNKTLTEDEIATILQSTLKGLEYLH---FMRKIHRD 150

Query: 410 IKPHNILLDEDFCPKISDFG----LAKICNRKESIISMTGARGTVGYIAPEVFCRNIGEV 465
           IK  NILL+ +   K++DFG    L     ++ ++I      GT  ++APEV    I E+
Sbjct: 151 IKAGNILLNTEGHAKLADFGVAGQLTDTMAKRNTVI------GTPFWMAPEV----IQEI 200

Query: 466 SY--KSDVYNYGMMIFEM 481
            Y   +D+++ G+   EM
Sbjct: 201 GYNCVADIWSLGITAIEM 218

>2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} Length = 326

 Score = 94.4 bits (235), Expect = 2e-21
 Identities = 53/209 (25%), Positives = 86/209 (41%), Gaps = 43/209 (20%)

Query: 317 FKYKLGQGGYGSVYKGKLL-----DGSNVAVKVL-NDSKGNGKEFINEVASISRTSHVNV 370
           F  +LG+G +GSV   +        G  VAVK L + ++ + ++F  E+  +    H N+
Sbjct: 45  FLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNI 104

Query: 371 VALLGFCLRVAEE------------------------------LSSTIGIARGLEYLHLG 400
           V   G C                                    L  T  I +G+EYL   
Sbjct: 105 VKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLG-- 162

Query: 401 CSTRILHFDIKPHNILLDEDFCPKISDFGLAK-ICNRKESIISMTGARGTVGYIAPEVFC 459
            + R +H D+   NIL++ +   KI DFGL K +   KE           + + APE   
Sbjct: 163 -TKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEYYKVKEPGESPIFWYAPE--S 219

Query: 460 RNIGEVSYKSDVYNYGMMIFE-MTGGRKN 487
               + S  SDV+++G++++E  T   K+
Sbjct: 220 LTESKFSVASDVWSFGVVLYELFTYIEKS 248

>2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* Length = 294

 Score = 93.8 bits (234), Expect = 2e-21
 Identities = 50/202 (24%), Positives = 82/202 (40%), Gaps = 49/202 (24%)

Query: 321 LGQGGYGSVYKGKLLD-GSNVAVKVLNDSK----GNGKEFINEVASISRTSHVNVVAL-- 373
           LG+GG+   ++    D     A K++  S        ++   E++     +H +VV    
Sbjct: 23  LGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHG 82

Query: 374 -----------LGFCL------------RVAEELSSTI--GIARGLEYLHLGCSTRILHF 408
                      L  C              + E  +      I  G +YLH     R++H 
Sbjct: 83  FFEDNDFVFVVLELCRRRSLLELHKRRKALTEPEARYYLRQIVLGCQYLH---RNRVIHR 139

Query: 409 DIKPHNILLDEDFCPKISDFGLAKICNRKESIISMTGAR-----GTVGYIAPEVFCRNIG 463
           D+K  N+ L+ED   KI DFGLA       + +   G R     GT  YIAPEV  +   
Sbjct: 140 DLKLGNLFLNEDLEVKIGDFGLA-------TKVEYDGERKKVLCGTPNYIAPEVLSKK-- 190

Query: 464 EVSYKSDVYNYGMMIFEMTGGR 485
             S++ DV++ G +++ +  G+
Sbjct: 191 GHSFEVDVWSIGCIMYTLLVGK 212

>2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* Length = 287

 Score = 93.5 bits (233), Expect = 2e-21
 Identities = 58/216 (26%), Positives = 82/216 (37%), Gaps = 49/216 (22%)

Query: 294 LRNYRSLSPKRYGYADIKKMTN--SFKYKLGQGGYGSVYKGK-LLDGSNVAVKVLNDSKG 350
           + ++   S  R             +    LG+G +G V K K  +     AVKV+N +  
Sbjct: 1   MHHHHHHSSGRENLYFQGTFAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASA 60

Query: 351 NGKE---FINEVASISRTSHVNVVALLGFC-------LRVAE-----ELSSTIGIARG-- 393
             K+    + EV  + +  H N++ L           + V E     EL   I I R   
Sbjct: 61  KNKDTSTILREVELLKKLDHPNIMKLFEILEDSSSFYI-VGELYTGGELFDEI-IKRKRF 118

Query: 394 ---------------LEYLHLGCSTRILHFDIKPHNILL---DEDFCPKISDFGLAKICN 435
                          + Y+H      I+H D+KP NILL   ++D   KI DFGL+    
Sbjct: 119 SEHDAARIIKQVFSGITYMH---KHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQ 175

Query: 436 RKESIISMTGARGTVGYIAPEVFCRNIGEVSYKSDV 471
           +      M    GT  YIAPEV      E   K DV
Sbjct: 176 QNTK---MKDRIGTAYYIAPEVLRGTYDE---KCDV 205

>2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A Length = 304

 Score = 93.4 bits (233), Expect = 2e-21
 Identities = 51/178 (28%), Positives = 75/178 (42%), Gaps = 41/178 (23%)

Query: 317 FKYKLGQGGYGSVYKGK-LLDGSNVAVKVLNDSKGNGKEFI-NEVASISRTSHVNVVALL 374
           F   LG G +  V+  K  L G   A+K +  S       + NE+A + +  H N+V L 
Sbjct: 13  FMEVLGSGAFSEVFLVKQRLTGKLFALKCIKKSPAFRDSSLENEIAVLKKIKHENIVTLE 72

Query: 375 GFC-------LRVAE-----EL---------------SSTIG-IARGLEYLHLGCSTRIL 406
                     L V +     EL               S  I  +   ++YLH      I+
Sbjct: 73  DIYESTTHYYL-VMQLVSGGELFDRILERGVYTEKDASLVIQQVLSAVKYLH---ENGIV 128

Query: 407 HFDIKPHNILL---DEDFCPKISDFGLAKICNRKESIISMTGARGTVGYIAPEVFCRN 461
           H D+KP N+L    +E+    I+DFGL+K+         M+ A GT GY+APEV  + 
Sbjct: 129 HRDLKPENLLYLTPEENSKIMITDFGLSKMEQNGI----MSTACGTPGYVAPEVLAQK 182

>2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... Length = 373

 Score = 94.7 bits (236), Expect = 2e-21
 Identities = 50/215 (23%), Positives = 94/215 (43%), Gaps = 47/215 (21%)

Query: 320 KLGQGGYGSVYKGKLLDGSN----VAVKVLND--SKGNGKEFINEVASISRTSHVNVVAL 373
            +G G +G V  G+L   S     VA+K L    ++   ++F+ E + + +  H N++ L
Sbjct: 52  VVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRL 111

Query: 374 LGFC----------------------------LRVAEELSSTIGIARGLEYLHLGCSTRI 405
            G                                V + +    GIA G++YL        
Sbjct: 112 EGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTVIQLVGMLRGIASGMKYLS---DMGY 168

Query: 406 LHFDIKPHNILLDEDFCPKISDFGLAK-ICNRKESIISMTGARGTVGYIAPEVFCRNIGE 464
           +H D+   NIL++ +   K+SDFGL + + +  E+  +  G +  + + +PE       +
Sbjct: 169 VHRDLAARNILINSNLVCKVSDFGLGRVLEDDPEAAYTTRGGKIPIRWTSPEAI--AYRK 226

Query: 465 VSYKSDVYNYGMMIFE-MTGGRK------NVDVVD 492
            +  SDV++YG++++E M+ G +      N DV+ 
Sbjct: 227 FTSASDVWSYGIVLWEVMSYGERPYWEMSNQDVIK 261

>4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 3eyg_A* 3eyh_A* Length = 302

 Score = 93.1 bits (232), Expect = 3e-21
 Identities = 49/207 (23%), Positives = 77/207 (37%), Gaps = 44/207 (21%)

Query: 320 KLGQGGYGSVYKGKLL-----DGSNVAVKVLNDSKG--NGKEFINEVASISRTSHVNVVA 372
            LG+G +G V   +        G  VAVK L    G  +  +   E+  +    H N+V 
Sbjct: 28  DLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVK 87

Query: 373 LLGFCLRVAEE------------------------------LSSTIGIARGLEYLHLGCS 402
             G C                                    L   + I +G++YL    S
Sbjct: 88  YKGICTEDGGNGIKLIMEFLPSGSLKEYLPKNKNKINLKQQLKYAVQICKGMDYLG---S 144

Query: 403 TRILHFDIKPHNILLDEDFCPKISDFGLAK-ICNRKESIISMTGARGTVGYIAPEVFCRN 461
            + +H D+   N+L++ +   KI DFGL K I   KE           V + APE  C  
Sbjct: 145 RQYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEYYTVKDDRDSPVFWYAPE--CLM 202

Query: 462 IGEVSYKSDVYNYGMMIFE-MTGGRKN 487
             +    SDV+++G+ + E +T    +
Sbjct: 203 QSKFYIASDVWSFGVTLHELLTYCDSD 229

>3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} Length = 285

 Score = 92.3 bits (230), Expect = 4e-21
 Identities = 48/193 (24%), Positives = 71/193 (36%), Gaps = 46/193 (23%)

Query: 316 SFKYKLGQGGYGSVYKGK-LLDGSNVAVKVLNDSKGNGKE--FINEVASISRTSHVNVVA 372
            FK KLG G +G V+  +    G    +K +N  +          E+  +    H N++ 
Sbjct: 25  IFKRKLGSGAFGDVHLVEERSSGLERVIKTINKDRSQVPMEQIEAEIEVLKSLDHPNIIK 84

Query: 373 LLGFC-----------------L--RVAEELSSTIG------------IARGLEYLHLGC 401
           +                     L  R+    +                +   L Y H   
Sbjct: 85  IFEVFEDYHNMYIVMETCEGGELLERIVSAQARGKALSEGYVAELMKQMMNALAYFH--- 141

Query: 402 STRILHFDIKPHNILL---DEDFCPKISDFGLAKICNRKESIISMTGARGTVGYIAPEVF 458
           S  ++H D+KP NIL          KI DFGLA++    E     T A GT  Y+APEVF
Sbjct: 142 SQHVVHKDLKPENILFQDTSPHSPIKIIDFGLAELFKSDEH---STNAAGTALYMAPEVF 198

Query: 459 CRNIGEVSYKSDV 471
            R++     K D+
Sbjct: 199 KRDVTF---KCDI 208

>3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} Length = 504

 Score = 95.2 bits (237), Expect = 4e-21
 Identities = 58/212 (27%), Positives = 83/212 (39%), Gaps = 56/212 (26%)

Query: 316 SFKYKLGQGGYGSVYKGK-LLDGSNVAVKVLN--------------DSKGNGKEFINEVA 360
               KLG G YG V   K     S  A+KV+               + +   +E  NE++
Sbjct: 39  FKVRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEIS 98

Query: 361 SISRTSHVNVVALLGFC-------LRVAE-----ELSSTIG----------------IAR 392
            +    H N++ L           L V E     EL   I                 I  
Sbjct: 99  LLKSLDHPNIIKLFDVFEDKKYFYL-VTEFYEGGELFEQIINRHKFDECDAANIMKQILS 157

Query: 393 GLEYLHLGCSTRILHFDIKPHNILL---DEDFCPKISDFGLAKICNRKESIISMTGARGT 449
           G+ YLH      I+H DIKP NILL   +     KI DFGL+   ++      +    GT
Sbjct: 158 GICYLH---KHNIVHRDIKPENILLENKNSLLNIKIVDFGLSSFFSKDYK---LRDRLGT 211

Query: 450 VGYIAPEVFCRNIGEVSYKSDVYNYGMMIFEM 481
             YIAPEV  +   E   K DV++ G++++ +
Sbjct: 212 AYYIAPEVLKKKYNE---KCDVWSCGVIMYIL 240

>3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* Length = 284

 Score = 92.2 bits (230), Expect = 4e-21
 Identities = 45/179 (25%), Positives = 71/179 (39%), Gaps = 40/179 (22%)

Query: 317 FKYKLGQGGYGSVYKG-KLLDGSNVAVKVLNDSKGNGKE---FINEVASISRTSHVNVVA 372
            K +LG+G +  V +      G   A K++N  K + ++      E     +  H N+V 
Sbjct: 10  VKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVR 69

Query: 373 LLGFC-----LRVAEEL---------------------SSTIG-IARGLEYLHLGCSTRI 405
           L           +  +L                     S  I  I   + Y H   S  I
Sbjct: 70  LHDSIQEESFHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQILESIAYCH---SNGI 126

Query: 406 LHFDIKPHNILL---DEDFCPKISDFGLAKICNRKESIISMTGARGTVGYIAPEVFCRN 461
           +H ++KP N+LL    +    K++DFGLA   N  E   +  G  GT GY++PEV  ++
Sbjct: 127 VHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSE---AWHGFAGTPGYLSPEVLKKD 182

>3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 3lau_A* 2wtv_A* ... Length = 279

 Score = 92.3 bits (230), Expect = 4e-21
 Identities = 51/199 (25%), Positives = 84/199 (42%), Gaps = 45/199 (22%)

Query: 321 LGQGGYGSVYKGKLLD-GSNVAVKVLNDSK----GNGKEFINEVASISRTSHVNVVALLG 375
           LG+G +G+VY  +       +A+KVL  ++    G   +   EV   S   H N++ L G
Sbjct: 17  LGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYG 76

Query: 376 F-------------------------CLRVAEELSSTIG--IARGLEYLHLGCSTRILHF 408
           +                           +  E+ ++T    +A  L Y H   S R++H 
Sbjct: 77  YFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCH---SKRVIHR 133

Query: 409 DIKPHNILLDEDFCPKISDFGLAKICNRKESIISMTGARGTVGYIAPEVFCRNIGEVSY- 467
           DIKP N+LL      KI+DFG +       S        GT+ Y+ PE+    I    + 
Sbjct: 134 DIKPENLLLGSAGELKIADFGWSV---HAPSSRRTDLC-GTLDYLPPEM----IEGRMHD 185

Query: 468 -KSDVYNYGMMIFEMTGGR 485
            K D+++ G++ +E   G+
Sbjct: 186 EKVDLWSLGVLCYEFLVGK 204

>3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} Length = 323

 Score = 92.8 bits (231), Expect = 6e-21
 Identities = 51/226 (22%), Positives = 90/226 (39%), Gaps = 58/226 (25%)

Query: 320 KLGQGGYGSVYKGKLLDGSN----VAVKVLND---SKGNGKEFINEVASISRTSHVNVVA 372
            LG+G +GSV + +L         VAVK+L     +  + +EF+ E A +    H +V  
Sbjct: 30  MLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEFDHPHVAK 89

Query: 373 LLGFC---------------------------------------LRVAEELSSTIGIARG 393
           L+G                                         L +   +   + IA G
Sbjct: 90  LVGVSLRSRAKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIACG 149

Query: 394 LEYLHLGCSTRILHFDIKPHNILLDEDFCPKISDFGLAKICNRKESIISMTGARGTVGYI 453
           +EYL    S   +H D+   N +L ED    ++DFGL++     +       ++  V ++
Sbjct: 150 MEYLS---SRNFIHRDLAARNCMLAEDMTVCVADFGLSRKIYSGDYYRQGCASKLPVKWL 206

Query: 454 APEVFCRNIGEVSYKSDVYNYGMMIFE-MTGGRK------NVDVVD 492
           A E    N+   +  SDV+ +G+ ++E MT G+       N ++ +
Sbjct: 207 ALESLADNL--YTVHSDVWAFGVTMWEIMTRGQTPYAGIENAEIYN 250

>2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B Length = 362

 Score = 92.8 bits (231), Expect = 8e-21
 Identities = 43/181 (23%), Positives = 67/181 (37%), Gaps = 44/181 (24%)

Query: 317 FKYKLGQGGYGSVYKG-KLLDGSNVAVKVLNDSKGNGKE---FINEVASISRTSHVNVVA 372
            K +LG+G +  V +      G   A K++N  K + ++      E     +  H N+V 
Sbjct: 33  VKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVR 92

Query: 373 LLGF-------------CL----------------RVAEELSSTIGIARGLEYLHLGCST 403
           L                                    A      I     + Y H   S 
Sbjct: 93  LHDSIQEESFHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQI--LESIAYCH---SN 147

Query: 404 RILHFDIKPHNILL---DEDFCPKISDFGLAKICNRKESIISMTGARGTVGYIAPEVFCR 460
            I+H ++KP N+LL    +    K++DFGLA   N  E+     G  GT GY++PEV  +
Sbjct: 148 GIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEA---WHGFAGTPGYLSPEVLKK 204

Query: 461 N 461
           +
Sbjct: 205 D 205

>3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} Length = 278

 Score = 91.1 bits (227), Expect = 9e-21
 Identities = 51/203 (25%), Positives = 84/203 (41%), Gaps = 50/203 (24%)

Query: 321 LGQGGYGSVYKGK-LLDGSNVAVKVLNDSK----GNGKEFINEVASISRTSHVNVVALLG 375
           LG+G +  VY+ + +  G  VA+K+++       G  +   NEV    +  H +++ L  
Sbjct: 19  LGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKHPSILELYN 78

Query: 376 F--------------------------CLRVAEELSSTI--GIARGLEYLHLGCSTRILH 407
           +                              +E  +      I  G+ YLH   S  ILH
Sbjct: 79  YFEDSNYVYLVLEMCHNGEMNRYLKNRVKPFSENEARHFMHQIITGMLYLH---SHGILH 135

Query: 408 FDIKPHNILLDEDFCPKISDFGLAKICNRKESIISMTGAR-----GTVGYIAPEVFCRNI 462
            D+   N+LL  +   KI+DFGLA       + + M   +     GT  YI+PE+  R+ 
Sbjct: 136 RDLTLSNLLLTRNMNIKIADFGLA-------TQLKMPHEKHYTLCGTPNYISPEIATRS- 187

Query: 463 GEVSYKSDVYNYGMMIFEMTGGR 485
                +SDV++ G M + +  GR
Sbjct: 188 -AHGLESDVWSLGCMFYTLLIGR 209

>3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* Length = 313

 Score = 91.2 bits (227), Expect = 1e-20
 Identities = 58/225 (25%), Positives = 91/225 (40%), Gaps = 57/225 (25%)

Query: 320 KLGQGGYGSVYKGKLLDGSN----VAVKVLND---SKGNGKEFINEVASISRTSHVNVVA 372
            LG+G +GSV +G L         VAVK +     S+   +EF++E A +   SH NV+ 
Sbjct: 41  ILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSHPNVIR 100

Query: 373 LLGFC--------------------------------------LRVAEELSSTIGIARGL 394
           LLG C                                      + +   L   + IA G+
Sbjct: 101 LLGVCIEMSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALGM 160

Query: 395 EYLHLGCSTRILHFDIKPHNILLDEDFCPKISDFGLAKICNRKESIISMTGARGTVGYIA 454
           EYL    +   LH D+   N +L +D    ++DFGL+K     +       A+  V +IA
Sbjct: 161 EYL---SNRNFLHRDLAARNCMLRDDMTVCVADFGLSKKIYSGDYYRQGRIAKMPVKWIA 217

Query: 455 PEVFCRNIGEVSYKSDVYNYGMMIFE-MTGGRK------NVDVVD 492
            E     +   + KSDV+ +G+ ++E  T G        N ++ D
Sbjct: 218 IESLADRV--YTSKSDVWAFGVTMWEIATRGMTPYPGVQNHEMYD 260

>3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A Length = 351

 Score = 92.0 bits (229), Expect = 1e-20
 Identities = 38/186 (20%), Positives = 62/186 (33%), Gaps = 46/186 (24%)

Query: 317 FKYKLGQGGYGSVYKGK-LLDGSNVAVKVLNDSKGNGKEFI------NEVASISRTSHVN 369
               +G+G +  V +      G   AVK+++ +K      +       E +      H +
Sbjct: 28  LCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPH 87

Query: 370 VVALLGF-------------------CLRVAEELSSTIG------------IARGLEYLH 398
           +V LL                     C  + +   +               I   L Y H
Sbjct: 88  IVELLETYSSDGMLYMVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEALRYCH 147

Query: 399 LGCSTRILHFDIKPHNILL---DEDFCPKISDFGLAKICNRKESIISMTGARGTVGYIAP 455
                 I+H D+KPH +LL   +     K+  FG+A        +    G  GT  ++AP
Sbjct: 148 ---DNNIIHRDVKPHCVLLASKENSAPVKLGGFGVAIQLGESGLV--AGGRVGTPHFMAP 202

Query: 456 EVFCRN 461
           EV  R 
Sbjct: 203 EVVKRE 208

>3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* Length = 277

 Score = 90.3 bits (225), Expect = 2e-20
 Identities = 37/187 (19%), Positives = 59/187 (31%), Gaps = 41/187 (21%)

Query: 317 FKYKLGQGGYGSVYKGK-LLDGSNVAVKVLNDSKGNGKE-FINEVASISRTSHVNVVALL 374
            +  +G+G +G V            A K +        + F  E+  +    H N++ L 
Sbjct: 13  LENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVEDVDRFKQEIEIMKSLDHPNIIRLY 72

Query: 375 GFC-----------------L--------RVAEELSSTI--GIARGLEYLHLGCSTRILH 407
                               L           E  ++ I   +   + Y H      + H
Sbjct: 73  ETFEDNTDIYLVMELCTGGELFERVVHKRVFRESDAARIMKDVLSAVAYCH---KLNVAH 129

Query: 408 FDIKPHNILL---DEDFCPKISDFGLAKICNRKESIISMTGARGTVGYIAPEVFCRNIGE 464
            D+KP N L      D   K+ DFGLA      +    M    GT  Y++P+V     G 
Sbjct: 130 RDLKPENFLFLTDSPDSPLKLIDFGLAARFKPGKM---MRTKVGTPYYVSPQVLEGLYGP 186

Query: 465 VSYKSDV 471
              + D 
Sbjct: 187 ---ECDE 190

>3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* Length = 389

 Score = 91.5 bits (227), Expect = 3e-20
 Identities = 37/206 (17%), Positives = 70/206 (33%), Gaps = 43/206 (20%)

Query: 320 KLGQG--GYGSVYKGK-LLDGSNVAVKVLN---DSKGNGKEFINEVASISRTSHVNVVAL 373
            +G+G     +V   +    G  V V+ +N    S         E+      +H N+V  
Sbjct: 32  VIGKGFEDLMTVNLARYKPTGEYVTVRRINLEACSNEMVTFLQGELHVSKLFNHPNIVPY 91

Query: 374 LG-------------FC--------LRVA------EELSSTI--GIARGLEYLHLGCSTR 404
                          F         +         E   + I  G+ + L+Y+H      
Sbjct: 92  RATFIADNELWVVTSFMAYGSAKDLICTHFMDGMNELAIAYILQGVLKALDYIH---HMG 148

Query: 405 ILHFDIKPHNILLDEDFCPKISDFG----LAKICNRKESIISMTGAR-GTVGYIAPEVFC 459
            +H  +K  +IL+  D    +S       +     R+  +          + +++PEV  
Sbjct: 149 YVHRSVKASHILISVDGKVYLSGLRSNLSMISHGQRQRVVHDFPKYSVKVLPWLSPEVLQ 208

Query: 460 RNIGEVSYKSDVYNYGMMIFEMTGGR 485
           +N+     KSD+Y+ G+   E+  G 
Sbjct: 209 QNLQGYDAKSDIYSVGITACELANGH 234

>2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* Length = 303

 Score = 90.1 bits (224), Expect = 3e-20
 Identities = 50/208 (24%), Positives = 80/208 (38%), Gaps = 47/208 (22%)

Query: 320 KLGQGGYGSVYKGK-LLDGSNVAVKVLNDSKGNGK--EFINEVASISRTSHVNVVALLG- 375
            +G G    V           VA+K +N  K      E + E+ ++S+  H N+V+    
Sbjct: 22  VIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCHHPNIVSYYTS 81

Query: 376 ------------FC--------LRVAEELSSTIG-------IA-------RGLEYLHLGC 401
                                 ++                 IA        GLEYLH   
Sbjct: 82  FVVKDELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYLH--- 138

Query: 402 STRILHFDIKPHNILLDEDFCPKISDFGLAKICNRKESIISMTGARGT-VG---YIAPEV 457
               +H D+K  NILL ED   +I+DFG++         I+    R T VG   ++APEV
Sbjct: 139 KNGQIHRDVKAGNILLGEDGSVQIADFGVSA-FLATGGDITRNKVRKTFVGTPCWMAPEV 197

Query: 458 FCRNIGEVSYKSDVYNYGMMIFEMTGGR 485
             +  G   +K+D++++G+   E+  G 
Sbjct: 198 MEQVRG-YDFKADIWSFGITAIELATGA 224

>4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} Length = 396

 Score = 91.4 bits (227), Expect = 4e-20
 Identities = 42/211 (19%), Positives = 77/211 (36%), Gaps = 51/211 (24%)

Query: 320 KLGQGGYGSVYKGK-LLDGSNVAVKVLNDSKGNGKE--FINEVASISRTSHVNVVALL-- 374
            LGQG   +V++G+    G   A+KV N+          + E   + + +H N+V L   
Sbjct: 16  ILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAI 75

Query: 375 ----------------------------GFCLRVAEELSSTI--GIARGLEYLHLGCSTR 404
                                            + E     +   +  G+ +L       
Sbjct: 76  EEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLR---ENG 132

Query: 405 ILHFDIKPHNILL----DEDFCPKISDFGLAKICNRKESIISMTGARGTVGYIAPEVFCR 460
           I+H +IKP NI+     D     K++DFG A+     E  +S+    GT  Y+ P+++ R
Sbjct: 133 IVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDEQFVSLY---GTEEYLHPDMYER 189

Query: 461 NIGEVSY------KSDVYNYGMMIFEMTGGR 485
            +    +        D+++ G+  +    G 
Sbjct: 190 AVLRKDHQKKYGATVDLWSIGVTFYHAATGS 220

>1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 Length = 387

 Score = 90.9 bits (226), Expect = 5e-20
 Identities = 46/184 (25%), Positives = 72/184 (39%), Gaps = 40/184 (21%)

Query: 320 KLGQGGYGSVYKGK-LLDGSNVAVKVLNDSKGNGKEFI-NEVASISRTSHVNVVALLG-- 375
           +LG G +G V++      G     K +N      K  + NE++ +++  H  ++ L    
Sbjct: 58  ELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAF 117

Query: 376 -----------FCL------RVAEELSS-----TIGIAR----GLEYLHLGCSTRILHFD 409
                      F        R+A E         I   R    GL+++H      I+H D
Sbjct: 118 EDKYEMVLILEFLSGGELFDRIAAEDYKMSEAEVINYMRQACEGLKHMH---EHSIVHLD 174

Query: 410 IKPHNILL--DEDFCPKISDFGLAKICNRKESIISMTGARGTVGYIAPEVFCRNIGEVSY 467
           IKP NI+    +    KI DFGLA   N  E    +     T  + APE+  R    V +
Sbjct: 175 IKPENIMCETKKASSVKIIDFGLATKLNPDE---IVKVTTATAEFAAPEIVDRE--PVGF 229

Query: 468 KSDV 471
            +D+
Sbjct: 230 YTDM 233

>2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A Length = 342

 Score = 90.4 bits (225), Expect = 5e-20
 Identities = 43/178 (24%), Positives = 69/178 (38%), Gaps = 41/178 (23%)

Query: 317 FKYKLGQGGYGSVYKG-KLLDGSNVAVKVLNDSKGNGKEFINEVASISRTS-HVNVVALL 374
            K  +G G Y    +          AVK+++ SK +  E   E+  + R   H N++ L 
Sbjct: 26  VKEDIGVGSYSVCKRCIHKATNMEFAVKIIDKSKRDPTE---EIEILLRYGQHPNIITLK 82

Query: 375 GF-----CLRVAEEL---------------------SSTIG-IARGLEYLHLGCSTRILH 407
                   + V  EL                     S+ +  I + +EYLH   +  ++H
Sbjct: 83  DVYDDGKYVYVVTELMKGGELLDKILRQKFFSEREASAVLFTITKTVEYLH---AQGVVH 139

Query: 408 FDIKPHNILL---DEDFCP-KISDFGLAKICNRKESIISMTGARGTVGYIAPEVFCRN 461
            D+KP NIL      +    +I DFG AK    +  +  +     T  ++APEV  R 
Sbjct: 140 RDLKPSNILYVDESGNPESIRICDFGFAKQLRAENGL--LMTPCYTANFVAPEVLERQ 195

>2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} Length = 373

 Score = 90.5 bits (225), Expect = 6e-20
 Identities = 49/186 (26%), Positives = 81/186 (43%), Gaps = 40/186 (21%)

Query: 318 KYKLGQGGYGSVYKGKLLD-GSNVAVKVLNDSKGNGKEFI-NEVASISRTSHVNVVALLG 375
              LG G +G V+K +    G  +A K++       KE + NE++ +++  H N++ L  
Sbjct: 94  TEILGGGRFGQVHKCEETATGLKLAAKIIKTRGMKDKEEVKNEISVMNQLDHANLIQLYD 153

Query: 376 -------FCL------------RVAEELSS-----TIGIAR----GLEYLHLGCSTRILH 407
                    L            R+ +E  +     TI   +    G+ ++H      ILH
Sbjct: 154 AFESKNDIVLVMEYVDGGELFDRIIDESYNLTELDTILFMKQICEGIRHMH---QMYILH 210

Query: 408 FDIKPHNILL--DEDFCPKISDFGLAKICNRKESIISMTGARGTVGYIAPEVFCRNIGEV 465
            D+KP NIL    +    KI DFGLA+    +E    +    GT  ++APEV   +   V
Sbjct: 211 LDLKPENILCVNRDAKQIKIIDFGLARRYKPRE---KLKVNFGTPEFLAPEVVNYD--FV 265

Query: 466 SYKSDV 471
           S+ +D+
Sbjct: 266 SFPTDM 271

>3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} Length = 444

 Score = 91.2 bits (227), Expect = 7e-20
 Identities = 37/182 (20%), Positives = 65/182 (35%), Gaps = 43/182 (23%)

Query: 316 SFKYKLGQGGYGSVYKGK-LLDGSNVAVKVLNDSKGNGKE---FINEVASISRTSHVNVV 371
               +LG+G +  V +   +L G   A  ++N  K + ++      E        H N+V
Sbjct: 14  QLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREARICRLLKHPNIV 73

Query: 372 ALLG-----------------------------FCLRVAEELSSTIGIARGLEYLHLGCS 402
            L                               +    A      I     + + H    
Sbjct: 74  RLHDSISEEGHHYLIFDLVTGGELFEDIVAREYYSEADASHCIQQI--LEAVLHCH---Q 128

Query: 403 TRILHFDIKPHNILL---DEDFCPKISDFGLAKICNRKESIISMTGARGTVGYIAPEVFC 459
             ++H ++KP N+LL    +    K++DFGLA     ++      G  GT GY++PEV  
Sbjct: 129 MGVVHRNLKPENLLLASKLKGAAVKLADFGLAIEVEGEQQA--WFGFAGTPGYLSPEVLR 186

Query: 460 RN 461
           ++
Sbjct: 187 KD 188

>3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332

 Score = 89.2 bits (221), Expect = 1e-19
 Identities = 32/102 (31%), Positives = 52/102 (50%), Gaps = 15/102 (14%)

Query: 390 IARGLEYLHLGCSTRILHFDIKPHNILLDEDFCPKISDFGLAKICNR----------KES 439
           IA  +E+LH   S  ++H D+KP NI    D   K+ DFGL    ++            +
Sbjct: 173 IAEAVEFLH---SKGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPA 229

Query: 440 IISMTGARGTVGYIAPEVFCRNIGEVSYKSDVYNYGMMIFEM 481
             + TG  GT  Y++PE    N    S+K D+++ G+++FE+
Sbjct: 230 YATHTGQVGTKLYMSPEQIHGN--NYSHKVDIFSLGLILFEL 269

>3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332

 Score = 44.5 bits (105), Expect = 5e-05
 Identities = 21/127 (16%), Positives = 40/127 (31%), Gaps = 5/127 (3%)

Query: 320 KLGQGGYGSVYKGK-LLDGSNVAVKV--LNDSKGNGKEFINEVASISRTSHVNVVALLGF 376
            +G+GG+G V++ K  +D  N A+K   L + +   ++ + EV ++++  H  +V     
Sbjct: 13  CMGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNA 72

Query: 377 CLRVAEELSSTIGIARGLEYLHLGCSTRILHFDIKPH--NILLDEDFCPKISDFGLAKIC 434
            L    E          L+                P      +D                
Sbjct: 73  WLETPPEKWQEEMDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVGQLQPSSP 132

Query: 435 NRKESII 441
                I 
Sbjct: 133 KVYLYIQ 139

>3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} Length = 365

 Score = 89.3 bits (221), Expect = 2e-19
 Identities = 34/221 (15%), Positives = 62/221 (28%), Gaps = 59/221 (26%)

Query: 317 FKYKLGQGGYGSVYKGKLLDGSN------VAVKVLNDSKGNGKEF---INEVASISRTSH 367
             + LG+G +  VY+    D ++        +KV      N  EF      +  +  +  
Sbjct: 69  VHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQK--PANPWEFYIGTQLMERLKPSMQ 126

Query: 368 VNVVALLGFCL------------------------------RVAEELSS--TIGIARGLE 395
              +      L                               + + L     + +   +E
Sbjct: 127 HMFMKFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIE 186

Query: 396 YLHLGCSTRILHFDIKPHNILLDEDFCP-----------KISDFGLAKICNRKESIISMT 444
            +H      I+H DIKP N +L   F              + D G +            T
Sbjct: 187 QVH---DCEIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDMKLFPKGTIFT 243

Query: 445 GARGTVGYIAPEVFCRNIGEVSYKSDVYNYGMMIFEMTGGR 485
               T G+   E+        +Y+ D +     ++ M  G 
Sbjct: 244 AKCETSGFQCVEMLSNK--PWNYQIDYFGVAATVYCMLFGT 282

>1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* Length = 313

 Score = 87.7 bits (218), Expect = 2e-19
 Identities = 57/248 (22%), Positives = 93/248 (37%), Gaps = 63/248 (25%)

Query: 296 NYRSLSPKRYGYAD---IKKMTNSFKYKLGQGGYGSVYKGKLLDGSN------VAVKVLN 346
           NY  + P +  Y       +   SF   LG G +G V +              VAVK+L 
Sbjct: 3   NYVYIDPTQLPYDHKWEFPRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLK 62

Query: 347 D--SKGNGKEFINEVASISR-TSHVNVVALLGFC---------------------LRVAE 382
                   +  ++E+  +S   +H+N+V LLG C                     LR   
Sbjct: 63  PSAHLTEREALMSELKVLSYLGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKR 122

Query: 383 ELSSTIG------------------------IARGLEYLHLGCSTRILHFDIKPHNILLD 418
           +                              +A+G+ +L    S   +H D+   NILL 
Sbjct: 123 DSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLA---SKNCIHRDLAARNILLT 179

Query: 419 EDFCPKISDFGLAKICNRKESIISMTGARGTVGYIAPEVFCRNIGEVSYKSDVYNYGMMI 478
                KI DFGLA+      + +    AR  V ++APE     +   +++SDV++YG+ +
Sbjct: 180 HGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCV--YTFESDVWSYGIFL 237

Query: 479 FE-MTGGR 485
           +E  + G 
Sbjct: 238 WELFSLGS 245

>1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... Length = 322

 Score = 87.7 bits (218), Expect = 3e-19
 Identities = 46/207 (22%), Positives = 85/207 (41%), Gaps = 50/207 (24%)

Query: 320 KLGQGGYGSVYKGKLLDGSN------VAVKVLND--SKGNGKEFINEVASISRTSHVNVV 371
           +LGQG +G VY+G             VA+K +N+  S     EF+NE + +   +  +VV
Sbjct: 32  ELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVV 91

Query: 372 ALLGFC-------------------------------------LRVAEELSSTIGIARGL 394
            LLG                                         +++ +     IA G+
Sbjct: 92  RLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGM 151

Query: 395 EYLHLGCSTRILHFDIKPHNILLDEDFCPKISDFGLAKICNRKESIISMTGARGTVGYIA 454
            YL+   + + +H D+   N ++ EDF  KI DFG+ +     +           V +++
Sbjct: 152 AYLN---ANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMS 208

Query: 455 PEVFCRNIGEVSYKSDVYNYGMMIFEM 481
           PE     +   +  SDV+++G++++E+
Sbjct: 209 PESLKDGV--FTTYSDVWSFGVVLWEI 233

>3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... Length = 283

 Score = 86.8 bits (216), Expect = 3e-19
 Identities = 44/191 (23%), Positives = 69/191 (36%), Gaps = 47/191 (24%)

Query: 320 KLGQGGYGSVYKGK-LLDGSNVAVKVLNDSKGNGKE-------FINEVASISRTSHVNVV 371
           +LG G +  V K +    G   A K +   + +             EV  +    H N++
Sbjct: 12  ELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHPNII 71

Query: 372 ALLGFC-----------------L--RVAEELSST----IGIAR----GLEYLHLGCSTR 404
            L                     L   +AE+ S T        +    G+ YLH   S R
Sbjct: 72  TLHDIFENKTDVVLILELVSGGELFDFLAEKESLTEDEATQFLKQILDGVHYLH---SKR 128

Query: 405 ILHFDIKPHNILL----DEDFCPKISDFGLAKICNRKESIISMTGARGTVGYIAPEVFCR 460
           I HFD+KP NI+L      +   K+ DFG+A                GT  ++APE+   
Sbjct: 129 IAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEAGN---EFKNIFGTPEFVAPEIVNY 185

Query: 461 NIGEVSYKSDV 471
               +  ++D+
Sbjct: 186 E--PLGLEADM 194

>1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 Length = 321

 Score = 87.3 bits (217), Expect = 3e-19
 Identities = 37/183 (20%), Positives = 62/183 (33%), Gaps = 39/183 (21%)

Query: 320 KLGQGGYGSVYKGK-LLDGSNVAVKVLNDSKGNGKEFINEVASISRTSHVNVVALLG--- 375
            LG+G +G V++            K +     +      E++ ++   H N++ L     
Sbjct: 12  DLGRGEFGIVHRCVETSSKKTYMAKFVKVKGTDQVLVKKEISILNIARHRNILHLHESFE 71

Query: 376 ----------FCL------RVAEELSS-----TIGIAR----GLEYLHLGCSTRILHFDI 410
                     F        R+            +         L++LH   S  I HFDI
Sbjct: 72  SMEELVMIFEFISGLDIFERINTSAFELNEREIVSYVHQVCEALQFLH---SHNIGHFDI 128

Query: 411 KPHNILL--DEDFCPKISDFGLAKICNRKESIISMTGARGTVGYIAPEVFCRNIGEVSYK 468
           +P NI+         KI +FG A+     +   +         Y APEV   +   VS  
Sbjct: 129 RPENIIYQTRRSSTIKIIEFGQARQLKPGD---NFRLLFTAPEYYAPEVHQHD--VVSTA 183

Query: 469 SDV 471
           +D+
Sbjct: 184 TDM 186

>2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... Length = 284

 Score = 86.9 bits (216), Expect = 3e-19
 Identities = 49/199 (24%), Positives = 83/199 (41%), Gaps = 45/199 (22%)

Query: 321 LGQGGYGSVYKGKLLD-GSNVAVKVLNDSK----GNGKEFINEVASISRTSHVNVVALLG 375
           LG+G +G+VY  +       +A+KVL  S+    G   +   E+   S   H N++ +  
Sbjct: 22  LGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHPNILRMYN 81

Query: 376 F-------------------------CLRVAEELSSTIG--IARGLEYLHLGCSTRILHF 408
           +                           R  E+ S+T    +A  L Y H     +++H 
Sbjct: 82  YFHDRKRIYLMLEFAPRGELYKELQKHGRFDEQRSATFMEELADALHYCH---ERKVIHR 138

Query: 409 DIKPHNILLDEDFCPKISDFGLAKICNRKESIISMTGARGTVGYIAPEVFCRNIGEVSY- 467
           DIKP N+L+      KI+DFG +       S+   T   GT+ Y+ PE+    I   ++ 
Sbjct: 139 DIKPENLLMGYKGELKIADFGWSVH---APSLRRRTMC-GTLDYLPPEM----IEGKTHD 190

Query: 468 -KSDVYNYGMMIFEMTGGR 485
            K D++  G++ +E   G 
Sbjct: 191 EKVDLWCAGVLCYEFLVGM 209

>3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* Length = 371

 Score = 88.2 bits (218), Expect = 4e-19
 Identities = 14/96 (14%), Positives = 29/96 (30%), Gaps = 8/96 (8%)

Query: 390 IARGLEYLHLGCSTRILHFDIKPHNILLDEDFCPKISDFGLAKICNRKESIISMTGARGT 449
           + R    L    S  ++H    P N+ +  D    + D         +    S       
Sbjct: 203 LIRLAANLQ---SKGLVHGHFTPDNLFIMPDGRLMLGDVSALWKVGTRGPASS-----VP 254

Query: 450 VGYIAPEVFCRNIGEVSYKSDVYNYGMMIFEMTGGR 485
           V Y   E    +    ++  + +  G+ I+ +    
Sbjct: 255 VTYAPREFLNASTATFTHALNAWQLGLSIYRVWCLF 290

>3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* Length = 371

 Score = 42.0 bits (98), Expect = 3e-04
 Identities = 8/62 (12%), Positives = 18/62 (29%), Gaps = 5/62 (8%)

Query: 321 LGQGGYGSVYKGKLLD-GSNVAVKVLNDSKGNG----KEFINEVASISRTSHVNVVALLG 375
           L  G    V+  + ++   + A+KV      N     +       + +R    +      
Sbjct: 70  LRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLLGESPEEARD 129

Query: 376 FC 377
             
Sbjct: 130 RR 131

>2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A Length = 321

 Score = 87.3 bits (217), Expect = 4e-19
 Identities = 41/191 (21%), Positives = 69/191 (36%), Gaps = 47/191 (24%)

Query: 320 KLGQGGYGSVYKGK-LLDGSNVAVKVLNDSKGNGKE-------FINEVASISRTSHVNVV 371
           +LG G +  V K +    G   A K +   +               EV+ + +  H NV+
Sbjct: 19  ELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVI 78

Query: 372 ALLG-------------FCL------RVAEELSST----IGIAR----GLEYLHLGCSTR 404
            L                         +A++ S +        +    G+ YLH   + +
Sbjct: 79  TLHDVYENRTDVVLILELVSGGELFDFLAQKESLSEEEATSFIKQILDGVNYLH---TKK 135

Query: 405 ILHFDIKPHNILL---DEDFCP-KISDFGLAKICNRKESIISMTGARGTVGYIAPEVFCR 460
           I HFD+KP NI+L   +      K+ DFGLA                GT  ++APE+   
Sbjct: 136 IAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGV---EFKNIFGTPEFVAPEIVNY 192

Query: 461 NIGEVSYKSDV 471
               +  ++D+
Sbjct: 193 E--PLGLEADM 201

>3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A Length = 573

 Score = 89.1 bits (221), Expect = 6e-19
 Identities = 46/184 (25%), Positives = 74/184 (40%), Gaps = 40/184 (21%)

Query: 320 KLGQGGYGSVYKGK-LLDGSNVAVKVLNDSKGNGKEFI-NEVASISRTSHVNVVALLGFC 377
           +LG G +G V++      G+N A K +     + KE +  E+ ++S   H  +V L    
Sbjct: 164 ELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAF 223

Query: 378 -----------------L--RVAEELSS-----TIGIAR----GLEYLHLGCSTRILHFD 409
                            L  +VA+E +       +   R    GL ++H       +H D
Sbjct: 224 EDDNEMVMIYEFMSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMH---ENNYVHLD 280

Query: 410 IKPHNILL--DEDFCPKISDFGLAKICNRKESIISMTGARGTVGYIAPEVFCRNIGEVSY 467
           +KP NI+         K+ DFGL    + K+   S+    GT  + APEV       V Y
Sbjct: 281 LKPENIMFTTKRSNELKLIDFGLTAHLDPKQ---SVKVTTGTAEFAAPEVA--EGKPVGY 335

Query: 468 KSDV 471
            +D+
Sbjct: 336 YTDM 339

>2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* Length = 361

 Score = 87.4 bits (217), Expect = 6e-19
 Identities = 41/191 (21%), Positives = 70/191 (36%), Gaps = 47/191 (24%)

Query: 320 KLGQGGYGSVYKGK-LLDGSNVAVKVLNDSKGNGKE-------FINEVASISRTSHVNVV 371
           +LG G +  V K +    G   A K +   +               EV+ + +  H N++
Sbjct: 19  ELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVLHPNII 78

Query: 372 ALLG-------------FCL------RVAEELSST----IGIAR----GLEYLHLGCSTR 404
            L                         +A++ S +        +    G+ YLH   + +
Sbjct: 79  TLHDVYENRTDVVLILELVSGGELFDFLAQKESLSEEEATSFIKQILDGVNYLH---TKK 135

Query: 405 ILHFDIKPHNILLDEDFCP----KISDFGLAKICNRKESIISMTGARGTVGYIAPEVFCR 460
           I HFD+KP NI+L +   P    K+ DFGLA                GT  ++APE+   
Sbjct: 136 IAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGV---EFKNIFGTPEFVAPEIVNY 192

Query: 461 NIGEVSYKSDV 471
               +  ++D+
Sbjct: 193 E--PLGLEADM 201

>1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* Length = 298

 Score = 86.2 bits (214), Expect = 7e-19
 Identities = 39/189 (20%), Positives = 70/189 (37%), Gaps = 49/189 (25%)

Query: 317 FKYKLGQGGYGSVYKGK-LLDGSNVAVKVLN----------DSKGNGKEFINEVASISRT 365
            K  LG+G    V +          AVK+++          + +   +  + EV  + + 
Sbjct: 21  PKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKV 80

Query: 366 S-HVNVVALLGFC-----------------L------------RVAEELSSTIGIARGLE 395
           S H N++ L                     L            +   ++   +     + 
Sbjct: 81  SGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEKVTLSEKETRKIMRAL--LEVIC 138

Query: 396 YLHLGCSTRILHFDIKPHNILLDEDFCPKISDFGLAKICNRKESIISMTGARGTVGYIAP 455
            LH      I+H D+KP NILLD+D   K++DFG +   +  E    +    GT  Y+AP
Sbjct: 139 ALH---KLNIVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGE---KLREVCGTPSYLAP 192

Query: 456 EVFCRNIGE 464
           E+   ++ +
Sbjct: 193 EIIECSMND 201

>2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} Length = 326

 Score = 86.5 bits (215), Expect = 7e-19
 Identities = 45/191 (23%), Positives = 68/191 (35%), Gaps = 47/191 (24%)

Query: 320 KLGQGGYGSVYKGK-LLDGSNVAVKVLNDSKGNGKE-------FINEVASISRTSHVNVV 371
           +LG G +  V K +    G   A K +   +               EV+ +    H NV+
Sbjct: 18  ELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVI 77

Query: 372 ALLG-------------FCL------RVAEELSST----IGIAR----GLEYLHLGCSTR 404
            L                         +AE+ S T        +    G+ YLH   S +
Sbjct: 78  TLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLH---SLQ 134

Query: 405 ILHFDIKPHNILL----DEDFCPKISDFGLAKICNRKESIISMTGARGTVGYIAPEVFCR 460
           I HFD+KP NI+L          KI DFGLA   +            GT  ++APE+   
Sbjct: 135 IAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGN---EFKNIFGTPEFVAPEIVNY 191

Query: 461 NIGEVSYKSDV 471
               +  ++D+
Sbjct: 192 E--PLGLEADM 200

>3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* Length = 360

 Score = 86.8 bits (215), Expect = 9e-19
 Identities = 48/197 (24%), Positives = 81/197 (41%), Gaps = 40/197 (20%)

Query: 320 KLGQGGYGSVYKGKLL-DGSNVAVKV--LNDSKGNGKEFINEVASISRTSHVNVVALLG- 375
           +LG G  G V+K      G  +A K+  L        + I E+  +   +   +V   G 
Sbjct: 40  ELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGA 99

Query: 376 ------------FC------------LRVAEELSSTI--GIARGLEYLHLGCSTRILHFD 409
                                      R+ E++   +   + +GL YL      +I+H D
Sbjct: 100 FYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLR--EKHKIMHRD 157

Query: 410 IKPHNILLDEDFCPKISDFGLAKICNRKESIISMTGAR-GTVGYIAPEVFCRNIGEVSYK 468
           +KP NIL++     K+ DFG++      + I SM  +  GT  Y++PE         S +
Sbjct: 158 VKPSNILVNSRGEIKLCDFGVS-----GQLIDSMANSFVGTRSYMSPERLQGT--HYSVQ 210

Query: 469 SDVYNYGMMIFEMTGGR 485
           SD+++ G+ + EM  GR
Sbjct: 211 SDIWSMGLSLVEMAVGR 227

>3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A Length = 419

 Score = 87.4 bits (217), Expect = 9e-19
 Identities = 47/222 (21%), Positives = 79/222 (35%), Gaps = 55/222 (24%)

Query: 293 FLRNYRSLSPKRYGYADIKKMTNSFKY----KLGQGGYGSVYKGK-LLDGSNVAVKVLND 347
           F+    ++  +      ++      +Y     LG G  G V           VA+++++ 
Sbjct: 116 FVFFDLTVDDQSVYPKALRD-----EYIMSKTLGSGACGEVKLAFERKTCKKVAIRIISK 170

Query: 348 SKGNGKE---------FINEVASISRTSHVNVVALLGFC----------------L---- 378
            K                 E+  + + +H  ++ +  F                 L    
Sbjct: 171 RKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDAEDYYIVLELMEGGELFDKV 230

Query: 379 ----RVAEELSSTI--GIARGLEYLHLGCSTRILHFDIKPHNILL---DEDFCPKISDFG 429
               R+ E         +   ++YLH      I+H D+KP N+LL   +ED   KI+DFG
Sbjct: 231 VGNKRLKEATCKLYFYQMLLAVQYLH---ENGIIHRDLKPENVLLSSQEEDCLIKITDFG 287

Query: 430 LAKICNRKESIISMTGARGTVGYIAPEVFCRNIGEVSYKSDV 471
            +KI         M    GT  Y+APEV   ++G   Y   V
Sbjct: 288 HSKILGETS---LMRTLCGTPTYLAPEVL-VSVGTAGYNRAV 325

>2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* Length = 333

 Score = 86.2 bits (214), Expect = 1e-18
 Identities = 61/268 (22%), Positives = 100/268 (37%), Gaps = 62/268 (23%)

Query: 273 YFKRKLSSYNSTASCLNIETFLRN-YRSLSPKRYGYAD---IKKMTNSFKYKLGQGGYGS 328
           Y  ++   Y        IE++  N Y  + P +  Y +     +    F   LG G +G 
Sbjct: 4   YKYKQKPKYQVRWK--IIESYEGNSYTFIDPTQLPYNEKWEFPRNNLQFGKTLGAGAFGK 61

Query: 329 VYKGKLLDGSN------VAVKVLND--SKGNGKEFINEVASISR-TSHVNVVALLGFC-- 377
           V +              VAVK+L         +  ++E+  +S    H N+V LLG C  
Sbjct: 62  VVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHENIVNLLGACTH 121

Query: 378 -------------------LR--------------VAEELSST------IGIARGLEYLH 398
                              LR                   S+         +A+G+ +L 
Sbjct: 122 GGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSSQVAQGMAFLA 181

Query: 399 LGCSTRILHFDIKPHNILLDEDFCPKISDFGLAKICNRKESIISMTGARGTVGYIAPEVF 458
              S   +H D+   N+LL      KI DFGLA+      + I    AR  V ++APE  
Sbjct: 182 ---SKNCIHRDVAARNVLLTNGHVAKIGDFGLARDIMNDSNYIVKGNARLPVKWMAPESI 238

Query: 459 CRNIGEVSYKSDVYNYGMMIFE-MTGGR 485
              +   + +SDV++YG++++E  + G 
Sbjct: 239 FDCV--YTVQSDVWSYGILLWEIFSLGL 264

>2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A Length = 365

 Score = 86.7 bits (215), Expect = 1e-18
 Identities = 41/187 (21%), Positives = 72/187 (38%), Gaps = 46/187 (24%)

Query: 317 FKYKLGQGGYGSVYKGK-LLDGSNVAVKVLNDSKGNGKE---------FINEVASISRTS 366
            K  +G+G    V +      G   AVK++  +                  E   + + +
Sbjct: 98  PKDVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVA 157

Query: 367 -HVNVVALLGFC-------LRVAE-----EL---------------SSTIG-IARGLEYL 397
            H +++ L+          L V +     EL                S +  +   + +L
Sbjct: 158 GHPHIITLIDSYESSSFMFL-VFDLMRKGELFDYLTEKVALSEKETRSIMRSLLEAVSFL 216

Query: 398 HLGCSTRILHFDIKPHNILLDEDFCPKISDFGLAKICNRKESIISMTGARGTVGYIAPEV 457
           H   +  I+H D+KP NILLD++   ++SDFG +      E    +    GT GY+APE+
Sbjct: 217 H---ANNIVHRDLKPENILLDDNMQIRLSDFGFSCHLEPGE---KLRELCGTPGYLAPEI 270

Query: 458 FCRNIGE 464
              ++ E
Sbjct: 271 LKCSMDE 277

>1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* Length = 327

 Score = 86.2 bits (214), Expect = 1e-18
 Identities = 54/223 (24%), Positives = 95/223 (42%), Gaps = 72/223 (32%)

Query: 320 KLGQGGYGSVYKGKLLDGS---NVAVKVLND--SKGNGKEFINEVASI--SRTSHVNVVA 372
            +G+G +G V K ++       + A+K + +  SK + ++F  E   +      H N++ 
Sbjct: 32  VIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGE-LEVLCKLGHHPNIIN 90

Query: 373 LLGFC---------------------LR----------------VAEELSST------IG 389
           LLG C                     LR                 A  LSS         
Sbjct: 91  LLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAAD 150

Query: 390 IARGLEYLHLGCSTRILHFDIKPHNILLDEDFCPKISDFGLAKICNRKESI-ISMTGARG 448
           +ARG++YL      + +H D+   NIL+ E++  KI+DFGL+    R + + +  T  R 
Sbjct: 151 VARGMDYL---SQKQFIHRDLAARNILVGENYVAKIADFGLS----RGQEVYVKKTMGRL 203

Query: 449 TVGYIAPE-----VFCRNIGEVSYKSDVYNYGMMIFE-MTGGR 485
            V ++A E     V+       +  SDV++YG++++E ++ G 
Sbjct: 204 PVRWMAIESLNYSVY-------TTNSDVWSYGVLLWEIVSLGG 239

>3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* Length = 676

 Score = 88.2 bits (218), Expect = 1e-18
 Identities = 54/210 (25%), Positives = 82/210 (39%), Gaps = 54/210 (25%)

Query: 320 KLGQGGYGSVYKGK-LLDGSNVAVKVLND--SKGNGKEFINEVASISRTSHVNVVALL-- 374
           +LG GG+G V +      G  VA+K      S  N + +  E+  + + +H NVV+    
Sbjct: 21  RLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKLNHPNVVSAREV 80

Query: 375 --------------------------------GFCLRVAEELSSTI--GIARGLEYLHLG 400
                                             C  + E    T+   I+  L YLH  
Sbjct: 81  PDGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISSALRYLH-- 138

Query: 401 CSTRILHFDIKPHNILLD---EDFCPKISDFGLAKICNRKESIISMTGARGTVGYIAPEV 457
              RI+H D+KP NI+L    +    KI D G AK  ++ E     T   GT+ Y+APE+
Sbjct: 139 -ENRIIHRDLKPENIVLQPGPQRLIHKIIDLGYAKELDQGE---LCTEFVGTLQYLAPEL 194

Query: 458 FCRNIGEVSY--KSDVYNYGMMIFEMTGGR 485
             +      Y    D +++G + FE   G 
Sbjct: 195 LEQK----KYTVTVDYWSFGTLAFECITGF 220

>3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* Length = 327

 Score = 85.5 bits (212), Expect = 2e-18
 Identities = 53/203 (26%), Positives = 81/203 (39%), Gaps = 42/203 (20%)

Query: 320 KLGQGGYGSVYKGKLL-DGSNVAVKV--LNDSKGNGKEFINEVASISRTS-HVNVVALLG 375
           ++G+G YGSV K      G  +AVK       +   K+ + ++  + R+S    +V   G
Sbjct: 29  EIGRGAYGSVNKMVHKPSGQIMAVKRIRSTVDEKEQKQLLMDLDVVMRSSDCPYIVQFYG 88

Query: 376 -------------FC--------LRVAEELSSTIG------IAR----GLEYLHLGCSTR 404
                                    V   L   I       I       L +L    + +
Sbjct: 89  ALFREGDCWICMELMSTSFDKFYKYVYSVLDDVIPEEILGKITLATVKALNHLK--ENLK 146

Query: 405 ILHFDIKPHNILLDEDFCPKISDFGLAKICNRKESIISMTGARGTVGYIAPEVFCRNIGE 464
           I+H DIKP NILLD     K+ DFG   I  +    I+ T   G   Y+APE    +   
Sbjct: 147 IIHRDIKPSNILLDRSGNIKLCDFG---ISGQLVDSIAKTRDAGCRPYMAPERIDPSASR 203

Query: 465 VSY--KSDVYNYGMMIFEMTGGR 485
             Y  +SDV++ G+ ++E+  GR
Sbjct: 204 QGYDVRSDVWSLGITLYELATGR 226

>4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} Length = 384

 Score = 86.2 bits (214), Expect = 2e-18
 Identities = 53/211 (25%), Positives = 85/211 (40%), Gaps = 65/211 (30%)

Query: 321 LGQGGYGSVYKGKLLDGSNV-AVKVLNDSKGNGKEFI---NEVASI-------SRTSHVN 369
           +G+G +G V   +  D   + A+K +N      K+     NEV ++           H  
Sbjct: 23  IGKGSFGKVCIVQKNDTKKMYAMKYMN------KQKCVERNEVRNVFKELQIMQGLEHPF 76

Query: 370 VVAL---------------------LGFCLR-------------VAEELSSTIGIARGLE 395
           +V L                     L + L+             + E       +   L+
Sbjct: 77  LVNLWYSFQDEEDMFMVVDLLLGGDLRYHLQQNVHFKEETVKLFICE-------LVMALD 129

Query: 396 YLHLGCSTRILHFDIKPHNILLDEDFCPKISDFGLAKICNRKESIISMTGARGTVGYIAP 455
           YL    + RI+H D+KP NILLDE     I+DF +A +  R+  I +M    GT  Y+AP
Sbjct: 130 YLQ---NQRIIHRDMKPDNILLDEHGHVHITDFNIAAMLPRETQITTMA---GTKPYMAP 183

Query: 456 EVFCRNIGEVSYKS-DVYNYGMMIFEMTGGR 485
           E+F    G     + D ++ G+  +E+  GR
Sbjct: 184 EMFSSRKGAGYSFAVDWWSLGVTAYELLRGR 214

>2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* Length = 348

 Score = 85.9 bits (213), Expect = 2e-18
 Identities = 47/252 (18%), Positives = 86/252 (34%), Gaps = 62/252 (24%)

Query: 289 NIETFLRNYRSLSPKRYGYADIKKMTNSFKY--KLGQGGYGSVYKGKLLDGSNVAVKVLN 346
           +++  L NY +L        +  K  N ++    L QG +  +   +  D    A+K   
Sbjct: 5   SMKDILSNYSNLIYLNKYVKEKDKYINDYRIIRTLNQGKFNKIILCEK-DNKFYALKKYE 63

Query: 347 ------------------DSKGNGKEFINEVASISRTSHVNVVALLGF------------ 376
                               K    +F NE+  I+   +   +   G             
Sbjct: 64  KSLLEKKRDFTKSNNDKISIKSKYDDFKNELQIITDIKNEYCLTCEGIITNYDEVYIIYE 123

Query: 377 ---------------------CLRVAEELSSTI--GIARGLEYLHLGCSTRILHFDIKPH 413
                                   +  ++   I   +     Y+H      I H D+KP 
Sbjct: 124 YMENDSILKFDEYFFVLDKNYTCFIPIQVIKCIIKSVLNSFSYIH--NEKNICHRDVKPS 181

Query: 414 NILLDEDFCPKISDFGLAKICNRKESIISMTGARGTVGYIAPEVFCRNIGEVSYKSDVYN 473
           NIL+D++   K+SDFG ++    K+    + G+RGT  ++ PE F         K D+++
Sbjct: 182 NILMDKNGRVKLSDFGESEYMVDKK----IKGSRGTYEFMPPEFFSNESSYNGAKVDIWS 237

Query: 474 YGMMIFEMTGGR 485
            G+ ++ M    
Sbjct: 238 LGICLYVMFYNV 249

>2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... Length = 316

 Score = 85.0 bits (211), Expect = 2e-18
 Identities = 51/224 (22%), Positives = 87/224 (38%), Gaps = 59/224 (26%)

Query: 316 SFKYKLGQGGYGSVYKGKLLDGSN------VAVKVLND--SKGNGKEFINEVASISR-TS 366
                LG+G +G V +              VAVK+L +  +    +  ++E+  +     
Sbjct: 30  KLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGH 89

Query: 367 HVNVVALLGFC----------------------LRVAEELSSTIG--------------- 389
           H+NVV LLG C                      LR                         
Sbjct: 90  HLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEH 149

Query: 390 -------IARGLEYLHLGCSTRILHFDIKPHNILLDEDFCPKISDFGLAKICNRKESIIS 442
                  +A+G+E+L    S + +H D+   NILL E    KI DFGLA+   +    + 
Sbjct: 150 LICYSFQVAKGMEFLA---SRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVR 206

Query: 443 MTGARGTVGYIAPEVFCRNIGEVSYKSDVYNYGMMIFE-MTGGR 485
              AR  + ++APE     +   + +SDV+++G++++E  + G 
Sbjct: 207 KGDARLPLKWMAPETIFDRV--YTIQSDVWSFGVLLWEIFSLGA 248

>2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* Length = 322

 Score = 85.0 bits (211), Expect = 2e-18
 Identities = 42/178 (23%), Positives = 64/178 (35%), Gaps = 45/178 (25%)

Query: 320 KLGQGGYGSVYKGK-LLDGSNVAVKVLNDSKGNGKE---------FINEVASISRTSHVN 369
            LG G  G V           VA+K+++  K                 E+  + + +H  
Sbjct: 17  TLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPC 76

Query: 370 VVALLGF------------CL------------RVAEELSSTI--GIARGLEYLHLGCST 403
           ++ +  F                          R+ E         +   ++YLH     
Sbjct: 77  IIKIKNFFDAEDYYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLLAVQYLH---EN 133

Query: 404 RILHFDIKPHNILL---DEDFCPKISDFGLAKICNRKESIISMTGARGTVGYIAPEVF 458
            I+H D+KP N+LL   +ED   KI+DFG +KI         M    GT  Y+APEV 
Sbjct: 134 GIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETS---LMRTLCGTPTYLAPEVL 188

>3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A Length = 290

 Score = 84.2 bits (209), Expect = 2e-18
 Identities = 46/202 (22%), Positives = 80/202 (39%), Gaps = 41/202 (20%)

Query: 320 KLGQGGYGSVYKGKLL-DGSNVAVKV--LNDSKGNGKEFINEVASISRTS-HVNVVALLG 375
           +LG+G YG V K + +  G  +AVK      +    K  + ++    RT      V   G
Sbjct: 14  ELGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISMRTVDCPFTVTFYG 73

Query: 376 -------------FC---------------LRVAEELSSTI--GIARGLEYLHLGCSTRI 405
                                           + E++   I   I + LE+LH      +
Sbjct: 74  ALFREGDVWICMELMDTSLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLH--SKLSV 131

Query: 406 LHFDIKPHNILLDEDFCPKISDFGLAKICNRKESIISMTGARGTVGYIAPEVFCRNIGEV 465
           +H D+KP N+L++     K+ DFG++      + +     A G   Y+APE     + + 
Sbjct: 132 IHRDVKPSNVLINALGQVKMCDFGISG--YLVDDVAKDIDA-GCKPYMAPERINPELNQK 188

Query: 466 SY--KSDVYNYGMMIFEMTGGR 485
            Y  KSD+++ G+ + E+   R
Sbjct: 189 GYSVKSDIWSLGITMIELAILR 210

>3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* Length = 327

 Score = 85.0 bits (211), Expect = 3e-18
 Identities = 42/200 (21%), Positives = 70/200 (35%), Gaps = 45/200 (22%)

Query: 309 DIKKMTNSFKYKLGQGGYGSVYKGK-LLDGSNVAVKVLNDSKGNGK---EFINEVASISR 364
           +          +LG+G +  V +      G   A K L   +       E ++E+A +  
Sbjct: 25  NFNNFYILTSKELGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQDCRAEILHEIAVLEL 84

Query: 365 TSHV-NVVALLG-------FCL------------RVAEELSS------TIGIAR----GL 394
                 V+ L           L                EL+        I + +    G+
Sbjct: 85  AKSCPRVINLHEVYENTSEIILILEYAAGGEIFSLCLPELAEMVSENDVIRLIKQILEGV 144

Query: 395 EYLHLGCSTRILHFDIKPHNILL---DEDFCPKISDFGLAKICNRKESIISMTGARGTVG 451
            YLH      I+H D+KP NILL         KI DFG+++          +    GT  
Sbjct: 145 YYLH---QNNIVHLDLKPQNILLSSIYPLGDIKIVDFGMSRKIGHAC---ELREIMGTPE 198

Query: 452 YIAPEVFCRNIGEVSYKSDV 471
           Y+APE+   +   ++  +D+
Sbjct: 199 YLAPEILNYD--PITTATDM 216

>2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} Length = 349

 Score = 85.1 bits (211), Expect = 3e-18
 Identities = 50/176 (28%), Positives = 71/176 (40%), Gaps = 40/176 (22%)

Query: 317 FKYKLGQGGYGSVYKGKLLD-GSNVAVKVLNDSKGNGKEFINEVASISRTSHVNVVALLG 375
            + +LG+G    VY+ K        A+KVL  +  + K    E+  + R SH N++ L  
Sbjct: 57  VESELGRGATSIVYRCKQKGTQKPYALKVLKKTV-DKKIVRTEIGVLLRLSHPNIIKLKE 115

Query: 376 FC-------LRVAE-----EL---------------SSTIG-IARGLEYLHLGCSTRILH 407
                    L V E     EL               +  +  I   + YLH      I+H
Sbjct: 116 IFETPTEISL-VLELVTGGELFDRIVEKGYYSERDAADAVKQILEAVAYLH---ENGIVH 171

Query: 408 FDIKPHNILL---DEDFCPKISDFGLAKICNRKESIISMTGARGTVGYIAPEVFCR 460
            D+KP N+L      D   KI+DFGL+KI   +     M    GT GY APE+   
Sbjct: 172 RDLKPENLLYATPAPDAPLKIADFGLSKIVEHQVL---MKTVCGTPGYCAPEILRG 224

>4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} Length = 329

 Score = 84.7 bits (210), Expect = 3e-18
 Identities = 48/275 (17%), Positives = 101/275 (36%), Gaps = 64/275 (23%)

Query: 278 LSSYNSTASCLNIETFLRNYRSLSPKRYGYADIKKMTNS---FKYKLGQGGYGSVYKGKL 334
           + S +S +      + L+ +   +P+ +  A +  +       K++LG+G +G V+  + 
Sbjct: 3   MGSGSSLSPTEGKGSGLQGHIIENPQYFSDACVHHIKRRDIVLKWELGEGAFGKVFLAEC 62

Query: 335 LDGSN------VAVKVLND-SKGNGKEFINEVASISRTSHVNVVALLGFC---------- 377
            +         VAVK L + S+   ++F  E   ++   H ++V   G C          
Sbjct: 63  HNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIVRFFGVCTEGRPLLMVF 122

Query: 378 --------------------------------LRVAEELSSTIGIARGLEYLHLGCSTRI 405
                                           L + + L+    +A G+ YL        
Sbjct: 123 EYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLA---GLHF 179

Query: 406 LHFDIKPHNILLDEDFCPKISDFGLAKICNRKESIISMTGARGTVGYIAPEVFCRNIGEV 465
           +H D+   N L+ +    KI DFG+++     +           + ++ PE         
Sbjct: 180 VHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRK--F 237

Query: 466 SYKSDVYNYGMMIFE-MT------GGRKNVDVVDN 493
           + +SDV+++G++++E  T          N + +D 
Sbjct: 238 TTESDVWSFGVVLWEIFTYGKQPWYQLSNTEAIDC 272

>2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* Length = 327

 Score = 84.7 bits (210), Expect = 4e-18
 Identities = 54/225 (24%), Positives = 89/225 (39%), Gaps = 57/225 (25%)

Query: 320 KLGQGGYGSVYKGKLLDGSN------VAVKVLND--SKGNGKEFINEVASISRTSHVNVV 371
            LG G +G VY+G++    N      VAVK L +  S+ +  +F+ E   IS+ +H N+V
Sbjct: 37  GLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIV 96

Query: 372 ALLGFC----------------------------------LRVAEELSSTIGIARGLEYL 397
             +G                                    L + + L     IA G +YL
Sbjct: 97  RCIGVSLQSLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYL 156

Query: 398 HLGCSTRILHFDIKPHNILLD---EDFCPKISDFGLAKICNRKESIISMTGARGTVGYIA 454
                   +H DI   N LL         KI DFG+A+   R         A   V ++ 
Sbjct: 157 E---ENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAMLPVKWMP 213

Query: 455 PEVFCRNIGEVSYKSDVYNYGMMIFEMT-------GGRKNVDVVD 492
           PE F   I   + K+D +++G++++E+          + N +V++
Sbjct: 214 PEAFMEGI--FTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEVLE 256

>3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} Length = 413

 Score = 85.5 bits (211), Expect = 4e-18
 Identities = 20/112 (17%), Positives = 41/112 (36%), Gaps = 9/112 (8%)

Query: 378 LRVAEELSSTIGIARGLEYLHLGCSTRILHFDIKPHNILLDEDFCPKISDFGLAKICNRK 437
           L     L  T+ + R L  LH      ++H  ++P +I+LD+     ++ F         
Sbjct: 208 LVHHARLQLTLQVIRLLASLH---HYGLVHTYLRPVDIVLDQRGGVFLTGFEHLVRDG-- 262

Query: 438 ESIISMTGAR-GTVGYIAPEVFCR---NIGEVSYKSDVYNYGMMIFEMTGGR 485
            S +S  G         A  +      +   +++  D +  G+ I+ +    
Sbjct: 263 ASAVSPIGRGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGLAIYWIWCAD 314

>1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 Length = 344

 Score = 84.3 bits (209), Expect = 5e-18
 Identities = 58/253 (22%), Positives = 93/253 (36%), Gaps = 68/253 (26%)

Query: 296 NYRSLSPKRYGYAD---IKKMTNSFKYKLGQGGYGSVYKGKLLDGSN------VAVKVLN 346
            Y  +  + Y Y       +    F   LG G +G V        S       VAVK+L 
Sbjct: 25  EYFYVDFREYEYDLKWEFPRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLK 84

Query: 347 D--SKGNGKEFINEVASISR-TSHVNVVALLGFC---------------------LRVAE 382
           +       +  ++E+  +++  SH N+V LLG C                     LR   
Sbjct: 85  EKADSSEREALMSELKMMTQLGSHENIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKR 144

Query: 383 ELSSTIG-----------------------------IARGLEYLHLGCSTRILHFDIKPH 413
           E  S                                +A+G+E+L        +H D+   
Sbjct: 145 EKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLE---FKSCVHRDLAAR 201

Query: 414 NILLDEDFCPKISDFGLAKICNRKESIISMTGARGTVGYIAPEVFCRNIGEVSYKSDVYN 473
           N+L+      KI DFGLA+      + +    AR  V ++APE     I   + KSDV++
Sbjct: 202 NVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGI--YTIKSDVWS 259

Query: 474 YGMMIFE-MTGGR 485
           YG++++E  + G 
Sbjct: 260 YGILLWEIFSLGV 272

>4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} Length = 394

 Score = 84.7 bits (210), Expect = 6e-18
 Identities = 56/205 (27%), Positives = 77/205 (37%), Gaps = 70/205 (34%)

Query: 298 RSLSPKRYGYADIKKMTNSFKYKLGQGGYGSVYKGKLLDGSNVAVK-VLNDSKGNGKEFI 356
           ++   +   Y + K         +G G +G V++ KL++   VA+K VL D     K F 
Sbjct: 33  KTGEQREIAYTNCKV--------IGNGSFGVVFQAKLVESDEVAIKKVLQD-----KRFK 79

Query: 357 N-EVASISRTSHVNVVALLGF--------------------------CLRVAEELSSTIG 389
           N E+  +    H NVV L  F                            R   +L  T+ 
Sbjct: 80  NRELQIMRIVKHPNVVDLKAFFYSNGDKKDEVFLNLVLEYVPETVYRASRHYAKLKQTMP 139

Query: 390 ----------IARGLEYLHLGCSTRILHFDIKPHNILLDEDFCP-KISDFGLAKICNRKE 438
                     + R L Y+H   S  I H DIKP N+LLD      K+ DFG AKI    E
Sbjct: 140 MLLIKLYMYQLLRSLAYIH---SIGICHRDIKPQNLLLDPPSGVLKLIDFGSAKILIAGE 196

Query: 439 SIISMTGARGTVGYI------APEV 457
             +S         YI      APE+
Sbjct: 197 PNVS---------YICSRYYRAPEL 212

>2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} Length = 305

 Score = 83.1 bits (206), Expect = 8e-18
 Identities = 53/208 (25%), Positives = 88/208 (42%), Gaps = 43/208 (20%)

Query: 318 KYK----LGQGGYGSVYKGK-LLDGSNVAVKVLNDSK----GNGKEFIN-EVASISRTSH 367
           KY     LG+G YG V +          AVK+L   K     NG+  +  E+  + R  H
Sbjct: 6   KYLMGDLLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRH 65

Query: 368 VNVVAL---------------LGFCLRVAEELSSTI-------GIAR--------GLEYL 397
            NV+ L               + +C+   +E+  ++         A         GLEYL
Sbjct: 66  KNVIQLVDVLYNEEKQKMYMVMEYCVCGMQEMLDSVPEKRFPVCQAHGYFCQLIDGLEYL 125

Query: 398 HLGCSTRILHFDIKPHNILLDEDFCPKISDFGLAKICNRKESIISMTGARGTVGYIAPEV 457
           H   S  I+H DIKP N+LL      KIS  G+A+  +   +  +   ++G+  +  PE+
Sbjct: 126 H---SQGIVHKDIKPGNLLLTTGGTLKISALGVAEALHPFAADDTCRTSQGSPAFQPPEI 182

Query: 458 FCRNIGEVSYKSDVYNYGMMIFEMTGGR 485
                    +K D+++ G+ ++ +T G 
Sbjct: 183 ANGLDTFSGFKVDIWSAGVTLYNITTGL 210

>4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* Length = 289

 Score = 82.7 bits (205), Expect = 8e-18
 Identities = 39/229 (17%), Positives = 84/229 (36%), Gaps = 62/229 (27%)

Query: 316 SFKYKLGQGGYGSVYKGKLLDGSN--------VAVKVLN-DSKGNGKEFINEVASISRTS 366
            F   LGQG +  ++KG   +  +        V +KVL+   +   + F    + +S+ S
Sbjct: 11  IFNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFEAASMMSKLS 70

Query: 367 HVNVVALLGFC----------------------------LRVAEELSSTIGIARGLEYLH 398
           H ++V   G C                            + +  +L     +A  + +L 
Sbjct: 71  HKHLVLNYGVCVCGDENILVQEFVKFGSLDTYLKKNKNCINILWKLEVAKQLAAAMHFLE 130

Query: 399 LGCSTRILHFDIKPHNILLDEDFCP--------KISDFGLAKICNRKESIISMTGARGTV 450
                 ++H ++   NILL  +           K+SD G++        ++     +  +
Sbjct: 131 ---ENTLIHGNVCAKNILLIREEDRKTGNPPFIKLSDPGISIT------VLPKDILQERI 181

Query: 451 GYIAPEVFCRNIGEVSYKSDVYNYGMMIFE-MTGGRK------NVDVVD 492
            ++ PE    N   ++  +D +++G  ++E  +GG K      +   + 
Sbjct: 182 PWVPPECI-ENPKNLNLATDKWSFGTTLWEICSGGDKPLSALDSQRKLQ 229

>2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A Length = 316

 Score = 83.1 bits (206), Expect = 1e-17
 Identities = 45/185 (24%), Positives = 68/185 (36%), Gaps = 41/185 (22%)

Query: 318 KYKLGQGGYGSVYKGK-LLDGSNVAVKVLNDSKGNGKE-FINEVASISR-TSHVNVVALL 374
           +  LG+G +  V     L+     AVK++    G+ +     EV  + +   H NV+ L+
Sbjct: 18  EDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLELI 77

Query: 375 GF------CLRVAE-----ELSSTI----------------GIARGLEYLHLGCSTRILH 407
            F         V E      + S I                 +A  L++LH   +  I H
Sbjct: 78  EFFEEEDRFYLVFEKMRGGSILSHIHKRRHFNELEASVVVQDVASALDFLH---NKGIAH 134

Query: 408 FDIKPHNILL---DEDFCPKISDFGLAKICN-----RKESIISMTGARGTVGYIAPEVFC 459
            D+KP NIL    ++    KI DF L             S   +    G+  Y+APEV  
Sbjct: 135 RDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPISTPELLTPCGSAEYMAPEVVE 194

Query: 460 RNIGE 464
               E
Sbjct: 195 AFSEE 199

>3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} Length = 337

 Score = 83.3 bits (206), Expect = 1e-17
 Identities = 42/225 (18%), Positives = 74/225 (32%), Gaps = 62/225 (27%)

Query: 315 NSFKYK----LGQGGYGSVYKGK-LLDGSNVAVKVLN-DSKGNGKEFINEVASISR-TSH 367
              + +    L +GG+  VY+ + +  G   A+K L  + +   +  I EV  + + + H
Sbjct: 26  GELRLRVRRVLAEGGFAFVYEAQDVGSGREYALKRLLSNEEEKNRAIIQEVCFMKKLSGH 85

Query: 368 VNVVALLGFCLRVAEELSSTIG-------------------------------------I 390
            N+V          EE  +                                         
Sbjct: 86  PNIVQFCSAASIGKEESDTGQAEFLLLTELCKGQLVEFLKKMESRGPLSCDTVLKIFYQT 145

Query: 391 ARGLEYLHLGCSTRILHFDIKPHNILLDEDFCPKISDFGLAKICNRKESIISMTGAR--- 447
            R ++++H      I+H D+K  N+LL      K+ DFG A   +           R   
Sbjct: 146 CRAVQHMH-RQKPPIIHRDLKVENLLLSNQGTIKLCDFGSATTISHYPDYSWSAQRRALV 204

Query: 448 -------GTVGYIAPEVF----CRNIGEVSYKSDVYNYGMMIFEM 481
                   T  Y  PE+        IGE   K D++  G +++ +
Sbjct: 205 EEEITRNTTPMYRTPEIIDLYSNFPIGE---KQDIWALGCILYLL 246

>3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} Length = 335

 Score = 82.8 bits (205), Expect = 2e-17
 Identities = 49/176 (27%), Positives = 67/176 (38%), Gaps = 44/176 (25%)

Query: 321 LGQGGYGSVYKGK-LLDGSNVAVKVLNDSKGNGKEFIN---------EVASISRTSHVNV 370
           LG G +G V+          V VK +   K     +I          E+A +SR  H N+
Sbjct: 32  LGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVEHANI 91

Query: 371 VALL------------------GFCL--------RVAEELSSTI--GIARGLEYLHLGCS 402
           + +L                  G  L        R+ E L+S I   +   + YL     
Sbjct: 92  IKVLDIFENQGFFQLVMEKHGSGLDLFAFIDRHPRLDEPLASYIFRQLVSAVGYLR---L 148

Query: 403 TRILHFDIKPHNILLDEDFCPKISDFGLAKICNRKESIISMTGARGTVGYIAPEVF 458
             I+H DIK  NI++ EDF  K+ DFG A      E         GT+ Y APEV 
Sbjct: 149 KDIIHRDIKDENIVIAEDFTIKLIDFGSA---AYLERGKLFYTFCGTIEYCAPEVL 201

>3v5q_A NT-3 growth factor receptor; kinase domain, kinase, phosphorylation, transferase-transfer inhibitor complex; HET: 0F4; 2.20A {Homo sapiens} Length = 297

 Score = 81.9 bits (203), Expect = 2e-17
 Identities = 50/235 (21%), Positives = 88/235 (37%), Gaps = 62/235 (26%)

Query: 316 SFKYKLGQGGYGSVYKGKLLDGSN------VAVKVLND-SKGNGKEFINEVASISRTSHV 368
             K +LG+G +G V+  +  + S       VAVK L D +    K+F  E   ++   H 
Sbjct: 18  VLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHE 77

Query: 369 NVVALLGFC---------------------LR----------------VAEELSST---- 387
           ++V   G C                     LR                   EL  +    
Sbjct: 78  HIVKFYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLH 137

Query: 388 --IGIARGLEYLHLGCSTRILHFDIKPHNILLDEDFCPKISDFGLAKICNRKESIISMTG 445
               IA G+ YL    S   +H D+   N L+  +   KI DFG+++     +       
Sbjct: 138 IASQIASGMVYLA---SQHFVHRDLATRNCLVGANLLVKIGDFGMSRDVYSTDYYRVGGH 194

Query: 446 ARGTVGYIAPEVFCRNIGEVSYKSDVYNYGMMIFE-MTGGR------KNVDVVDN 493
               + ++ PE         + +SDV+++G++++E  T G+       N +V++ 
Sbjct: 195 TMLPIRWMPPESIMYRK--FTTESDVWSFGVILWEIFTYGKQPWFQLSNTEVIEC 247

>3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} Length = 382

 Score = 83.2 bits (206), Expect = 2e-17
 Identities = 54/225 (24%), Positives = 93/225 (41%), Gaps = 60/225 (26%)

Query: 316 SFKYKLGQGGYGSVYKGKLLDGSN--------VAVKVLND--SKGNGKEFINEVASISR- 364
                LG+G +G V   + +            VAVK+L    ++ +  + I+E+  +   
Sbjct: 72  VLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMI 131

Query: 365 TSHVNVVALLGFC-------------------------------------------LRVA 381
             H N++ LLG C                                           L   
Sbjct: 132 GKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSK 191

Query: 382 EELSSTIGIARGLEYLHLGCSTRILHFDIKPHNILLDEDFCPKISDFGLAKICNRKESII 441
           + +S    +ARG+EYL    S + +H D+   N+L+ ED   KI+DFGLA+  +  +   
Sbjct: 192 DLVSCAYQVARGMEYLA---SKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYK 248

Query: 442 SMTGARGTVGYIAPEVFCRNIGEVSYKSDVYNYGMMIFE-MTGGR 485
             T  R  V ++APE     I   +++SDV+++G++++E  T G 
Sbjct: 249 KTTNGRLPVKWMAPEALFDRI--YTHQSDVWSFGVLLWEIFTLGG 291

>2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... Length = 334

 Score = 82.3 bits (204), Expect = 2e-17
 Identities = 54/221 (24%), Positives = 96/221 (43%), Gaps = 60/221 (27%)

Query: 320 KLGQGGYGSVYKGKLLDGSN--------VAVKVLND--SKGNGKEFINEVASISR-TSHV 368
            LG+G +G V   + +            VAVK+L D  ++ +  + ++E+  +     H 
Sbjct: 42  PLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHK 101

Query: 369 NVVALLGFC---------------------LR----------------VAEELSST---- 387
           N++ LLG C                     LR                  E+++      
Sbjct: 102 NIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVS 161

Query: 388 --IGIARGLEYLHLGCSTRILHFDIKPHNILLDEDFCPKISDFGLAKICNRKESIISMTG 445
               +ARG+EYL    S + +H D+   N+L+ E+   KI+DFGLA+  N  +     T 
Sbjct: 162 CTYQLARGMEYLA---SQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTTN 218

Query: 446 ARGTVGYIAPEVFCRNIGEVSYKSDVYNYGMMIFE-MTGGR 485
            R  V ++APE     +   +++SDV+++G++++E  T G 
Sbjct: 219 GRLPVKWMAPEALFDRV--YTHQSDVWSFGVLMWEIFTLGG 257

>3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} Length = 367

 Score = 82.8 bits (205), Expect = 2e-17
 Identities = 54/225 (24%), Positives = 89/225 (39%), Gaps = 57/225 (25%)

Query: 320 KLGQGGYGSVYKGKLLDGSN------VAVKVLND--SKGNGKEFINEVASISRTSHVNVV 371
            LG G +G VY+G++    N      VAVK L +  S+ +  +F+ E   IS+ +H N+V
Sbjct: 78  GLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIV 137

Query: 372 ALLGFC----------------------------------LRVAEELSSTIGIARGLEYL 397
             +G                                    L + + L     IA G +YL
Sbjct: 138 RCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYL 197

Query: 398 HLGCSTRILHFDIKPHNILLD---EDFCPKISDFGLAKICNRKESIISMTGARGTVGYIA 454
                   +H DI   N LL         KI DFG+A+   R         A   V ++ 
Sbjct: 198 E---ENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRAGYYRKGGCAMLPVKWMP 254

Query: 455 PEVFCRNIGEVSYKSDVYNYGMMIFEMT-------GGRKNVDVVD 492
           PE F   I   + K+D +++G++++E+          + N +V++
Sbjct: 255 PEAFMEGI--FTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEVLE 297

>1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... Length = 420

 Score = 83.2 bits (206), Expect = 2e-17
 Identities = 64/214 (29%), Positives = 85/214 (39%), Gaps = 68/214 (31%)

Query: 320 KLGQGGYGSVYKGKLLD-GSNVAVK-VLNDSKGNGKEFIN-EVASISRTSHVNVVALLGF 376
            +G G +G VY+ KL D G  VA+K VL D     K F N E+  + +  H N+V L  F
Sbjct: 61  VIGNGSFGVVYQAKLCDSGELVAIKKVLQD-----KRFKNRELQIMRKLDHCNIVRLRYF 115

Query: 377 --------------------------CLRVAEELSSTIG----------IARGLEYLHLG 400
                                       R       T+           + R L Y+H  
Sbjct: 116 FYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIH-- 173

Query: 401 CSTRILHFDIKPHNILLDEDFCP-KISDFGLAKICNRKESIISMTGARGTVGYI------ 453
            S  I H DIKP N+LLD D    K+ DFG AK   R E  +S         YI      
Sbjct: 174 -SFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVS---------YICSRYYR 223

Query: 454 APEVFCRNIGEVSYKS--DVYNYGMMIFEMTGGR 485
           APE+     G   Y S  DV++ G ++ E+  G+
Sbjct: 224 APELI---FGATDYTSSIDVWSAGCVLAELLLGQ 254

>2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A Length = 370

 Score = 82.8 bits (205), Expect = 2e-17
 Identities = 54/224 (24%), Positives = 96/224 (42%), Gaps = 60/224 (26%)

Query: 317 FKYKLGQGGYGSVYKGKLLDGSN--------VAVKVLND--SKGNGKEFINEVASISR-T 365
               LG+G +G V   + +            VAVK+L D  ++ +  + ++E+  +    
Sbjct: 85  LGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIG 144

Query: 366 SHVNVVALLGFC---------------------LR----------------VAEELSST- 387
            H N++ LLG C                     LR                  E+++   
Sbjct: 145 KHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKD 204

Query: 388 -----IGIARGLEYLHLGCSTRILHFDIKPHNILLDEDFCPKISDFGLAKICNRKESIIS 442
                  +ARG+EYL    S + +H D+   N+L+ E+   KI+DFGLA+  N  +    
Sbjct: 205 LVSCTYQLARGMEYLA---SQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKK 261

Query: 443 MTGARGTVGYIAPEVFCRNIGEVSYKSDVYNYGMMIFE-MTGGR 485
            T  R  V ++APE     +   +++SDV+++G++++E  T G 
Sbjct: 262 TTNGRLPVKWMAPEALFDRV--YTHQSDVWSFGVLMWEIFTLGG 303

>3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* Length = 336

 Score = 82.4 bits (204), Expect = 2e-17
 Identities = 51/202 (25%), Positives = 78/202 (38%), Gaps = 52/202 (25%)

Query: 297 YRSLSPKRYGYADIKKMTNSFKYKLGQGGYGSVYKG-KLLDGSNVAVKVLNDSKGNGKEF 355
           ++   PK+Y   D  +++   K  LG G  G V +      G   A+K+L DS    +E 
Sbjct: 16  FQGPEPKKYAVTDDYQLS---KQVLGLGVNGKVLECFHRRTGQKCALKLLYDSPKARQE- 71

Query: 356 INEVASISRTS-HVNVVALLGFC----------LRVAE-----ELSSTIG---------- 389
              V    + S   ++V +L             L + E     EL S I           
Sbjct: 72  ---VDHHWQASGGPHIVCILDVYENMHHGKRCLLIIMECMEGGELFSRIQERGDQAFTER 128

Query: 390 --------IARGLEYLHLGCSTRILHFDIKPHNILL---DEDFCPKISDFGLAKICNRKE 438
                   I   +++LH   S  I H D+KP N+L    ++D   K++DFG AK   +  
Sbjct: 129 EAAEIMRDIGTAIQFLH---SHNIAHRDVKPENLLYTSKEKDAVLKLTDFGFAKETTQNA 185

Query: 439 SIISMTGARGTVGYIAPEVFCR 460
               +     T  Y+APEV   
Sbjct: 186 ----LQTPCYTPYYVAPEVLGP 203

>2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} Length = 318

 Score = 81.6 bits (202), Expect = 3e-17
 Identities = 46/200 (23%), Positives = 84/200 (42%), Gaps = 39/200 (19%)

Query: 320 KLGQGGYGSVYKGKLL-DGSNVAVKV--LNDSKGNGKEFINEVASISRTS-HVNVVA--- 372
           ++G G  G V+K +    G  +AVK    + +K   K  + ++  + ++     +V    
Sbjct: 32  EMGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNKEENKRILMDLDVVLKSHDCPYIVQCFG 91

Query: 373 -------------LLGFCL---------RVAEELSSTI--GIARGLEYLHLGCSTRILHF 408
                        L+G C           + E +   +   I + L YL       ++H 
Sbjct: 92  TFITNTDVFIAMELMGTCAEKLKKRMQGPIPERILGKMTVAIVKALYYLK--EKHGVIHR 149

Query: 409 DIKPHNILLDEDFCPKISDFGLAKICNRKESIISMTGARGTVGYIAPEVF-CRNIGEVSY 467
           D+KP NILLDE    K+ DFG++    R     +   + G   Y+APE     +  +  Y
Sbjct: 150 DVKPSNILLDERGQIKLCDFGISG---RLVDDKAKDRSAGCAAYMAPERIDPPDPTKPDY 206

Query: 468 --KSDVYNYGMMIFEMTGGR 485
             ++DV++ G+ + E+  G+
Sbjct: 207 DIRADVWSLGISLVELATGQ 226

>3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A Length = 377

 Score = 82.0 bits (202), Expect = 4e-17
 Identities = 19/111 (17%), Positives = 42/111 (37%), Gaps = 18/111 (16%)

Query: 384 LSSTIGIARGLEYLHLGCSTRILHFDIKPHNILLDEDFCPKISDFGLAKICNRKESIISM 443
           L  T+ + R L  LH      ++H  ++P +I+LD+     ++ F        +      
Sbjct: 209 LQLTLQVIRLLASLH---HYGLVHTYLRPVDIVLDQRGGVFLTGFEHLVRDGARVVS--- 262

Query: 444 TGARGTVGYIAPEVFCRNIGE---------VSYKSDVYNYGMMIFEMTGGR 485
                + G+  PE+  R             +++  D +  G++I+ +    
Sbjct: 263 ---SVSRGFEPPELEARRATISYHRDRRTLMTFSFDAWALGLVIYWIWCAD 310

>3zzw_A Tyrosine-protein kinase transmembrane receptor RO; transferase, neurotrophic tyrosine kinase, receptor-related NTRKR2; 2.90A {Homo sapiens} Length = 289

 Score = 80.3 bits (199), Expect = 6e-17
 Identities = 57/235 (24%), Positives = 91/235 (38%), Gaps = 63/235 (26%)

Query: 316 SFKYKLGQGGYGSVYKGKLLDGSN------VAVKVLND--SKGNGKEFINEVASISRTSH 367
            F  +LG+  +G VYKG L   +       VA+K L D       +EF +E    +R  H
Sbjct: 12  RFMEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEAMLRARLQH 71

Query: 368 VNVVALLGFC-------------------------------------------LRVAEEL 384
            NVV LLG                                             L   + +
Sbjct: 72  PNVVCLLGVVTKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFV 131

Query: 385 SSTIGIARGLEYLHLGCSTRILHFDIKPHNILLDEDFCPKISDFGLAKICNRKESIISMT 444
                IA G+EYL    S  ++H D+   N+L+ +    KISD GL +     +    + 
Sbjct: 132 HLVAQIAAGMEYLS---SHHVVHKDLATRNVLVYDKLNVKISDLGLFREVYAADYYKLLG 188

Query: 445 GARGTVGYIAPEVFCRNIGEVSYKSDVYNYGMMIFE-MTGGRK------NVDVVD 492
            +   + ++APE         S  SD+++YG++++E  + G +      N DVV+
Sbjct: 189 NSLLPIRWMAPEAIMYGK--FSIDSDIWSYGVVLWEVFSYGLQPYCGYSNQDVVE 241

>3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A Length = 325

 Score = 80.8 bits (200), Expect = 6e-17
 Identities = 36/175 (20%), Positives = 63/175 (36%), Gaps = 41/175 (23%)

Query: 320 KLGQGGYGSVYKG-KLLDGSNVAVKVLNDSKGNGKEFINEVASISRTS-HVNVVALLGFC 377
            LG+G +    K          AVK+++       +   E+ ++     H N+V L    
Sbjct: 18  PLGEGSFSICRKCVHKKSNQAFAVKIISKRMEANTQ--KEITALKLCEGHPNIVKLHEVF 75

Query: 378 ------LRVAE-----ELSSTIGIARG-----------------LEYLHLGCSTRILHFD 409
                   V E     EL   I   +                  + ++H      ++H D
Sbjct: 76  HDQLHTFLVMELLNGGELFERI-KKKKHFSETEASYIMRKLVSAVSHMH---DVGVVHRD 131

Query: 410 IKPHNILL---DEDFCPKISDFGLAKICNRKESIISMTGARGTVGYIAPEVFCRN 461
           +KP N+L    +++   KI DFG A++         +     T+ Y APE+  +N
Sbjct: 132 LKPENLLFTDENDNLEIKIIDFGFARLKPPDNQP--LKTPCFTLHYAAPELLNQN 184

>1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C Length = 400

 Score = 80.5 bits (199), Expect = 1e-16
 Identities = 53/196 (27%), Positives = 70/196 (35%), Gaps = 55/196 (28%)

Query: 309 DIKKMTNSFKYK-----LGQGGYGSVYKG-KLLDGSNVAVKVLNDSKGNGKEFINEVASI 362
            IKK      YK     LG G  G V +          A+K+L D      +   EV   
Sbjct: 53  QIKKNAIIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDCP----KARREVELH 108

Query: 363 SRTS-HVNVVALLGFC----------LRVAE-----ELSSTIGIARG------------- 393
            R S   ++V ++             L V E     EL S I   RG             
Sbjct: 109 WRASQCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRI-QDRGDQAFTEREASEIM 167

Query: 394 ------LEYLHLGCSTRILHFDIKPHNILL---DEDFCPKISDFGLAKICNRKESIISMT 444
                 ++YLH   S  I H D+KP N+L      +   K++DFG AK         S+T
Sbjct: 168 KSIGEAIQYLH---SINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHN---SLT 221

Query: 445 GARGTVGYIAPEVFCR 460
               T  Y+APEV   
Sbjct: 222 TPCYTPYYVAPEVLGP 237

>1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 Length = 346

 Score = 79.5 bits (197), Expect = 2e-16
 Identities = 44/147 (29%), Positives = 68/147 (46%), Gaps = 37/147 (25%)

Query: 320 KLGQGGYGSVYKGK-LLDGSNVAVK-VLNDSKGNGKEFIN-----EVASISRTSHVNVVA 372
            LG+G + +VYK +       VA+K +    +   K+ IN     E+  +   SH N++ 
Sbjct: 17  FLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIG 76

Query: 373 LLG-------------FCL----RVAEELSSTIGIA----------RGLEYLHLGCSTRI 405
           LL              F       + ++ S  +  +          +GLEYLH      I
Sbjct: 77  LLDAFGHKSNISLVFDFMETDLEVIIKDNSLVLTPSHIKAYMLMTLQGLEYLH---QHWI 133

Query: 406 LHFDIKPHNILLDEDFCPKISDFGLAK 432
           LH D+KP+N+LLDE+   K++DFGLAK
Sbjct: 134 LHRDLKPNNLLLDENGVLKLADFGLAK 160

>3pvu_A Beta-adrenergic receptor kinase 1; transferase, serine/threonine-protein kinase, ATP-binding, I membrane; HET: QRW; 2.48A {Bos taurus} PDB: 3psc_A* 3pvw_A* 1omw_A 1ym7_A 2bcj_A* 3cik_A 3krw_A* 3krx_A* 1bak_A Length = 695

 Score = 81.1 bits (200), Expect = 3e-16
 Identities = 35/99 (35%), Positives = 52/99 (52%), Gaps = 14/99 (14%)

Query: 390 IARGLEYLHLGCSTRILHFDIKPHNILLDEDFCPKISDFGLAKICNRKESIISMTGAR-G 448
           I  GLE++H   +  +++ D+KP NILLDE    +ISD GLA      +       A  G
Sbjct: 301 IILGLEHMH---NRFVVYRDLKPANILLDEHGHVRISDLGLAC-----DFSKKKPHASVG 352

Query: 449 TVGYIAPEVFCRNIGEVSYKSDV--YNYGMMIFEMTGGR 485
           T GY+APEV  + +    Y S    ++ G M+F++  G 
Sbjct: 353 THGYMAPEVLQKGVA---YDSSADWFSLGCMLFKLLRGH 388

>3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3mb7_A* 3mb6_A* 3owj_A* 3owk_A* ... Length = 330

 Score = 78.8 bits (195), Expect = 3e-16
 Identities = 46/222 (20%), Positives = 86/222 (38%), Gaps = 48/222 (21%)

Query: 303 KRYGYADIKKMTNSF----KY----KLGQGGYGSVYKGK-LLDGSNVAVKVLNDSKGNGK 353
           +   Y D +     +     Y    KLG+G Y  V++   + +   V VK+L   K   K
Sbjct: 18  RPREYWDYESHVVEWGNQDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVKK--K 75

Query: 354 EFINEVASISR--TSHVNVVALL-------GFCLR-VAEELSST-----IG--------- 389
           +   E+  I        N++ L              V E +++T                
Sbjct: 76  KIKREI-KILENLRGGPNIITLADIVKDPVSRTPALVFEHVNNTDFKQLYQTLTDYDIRF 134

Query: 390 ----IARGLEYLHLGCSTRILHFDIKPHNILLDEDFCP-KISDFGLAKICNRKESIISMT 444
               I + L+Y H   S  I+H D+KPHN+++D +    ++ D+GLA+  +  +      
Sbjct: 135 YMYEILKALDYCH---SMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQ---EYN 188

Query: 445 GARGTVGYIAPEVFCRNIGEVSYKSDVYNYGMMIFEMTGGRK 486
               +  +  PE+   +     Y  D+++ G M+  M   ++
Sbjct: 189 VRVASRYFKGPELLV-DYQMYDYSLDMWSLGCMLASMIFRKE 229

>1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 Length = 343

 Score = 78.5 bits (194), Expect = 4e-16
 Identities = 47/225 (20%), Positives = 85/225 (37%), Gaps = 64/225 (28%)

Query: 316 SFKYKLGQGGYGSVYKGKLLDGSN------VAVKVLND--SKGNGKEFINEVASISRTSH 367
            +   +G+G +G V++ +            VAVK+L +  S     +F  E A ++   +
Sbjct: 50  EYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDN 109

Query: 368 VNVVALLGFC-------------------------------------------------- 377
            N+V LLG C                                                  
Sbjct: 110 PNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPP 169

Query: 378 -LRVAEELSSTIGIARGLEYLHLGCSTRILHFDIKPHNILLDEDFCPKISDFGLAKICNR 436
            L  AE+L     +A G+ YL      + +H D+   N L+ E+   KI+DFGL++    
Sbjct: 170 PLSCAEQLCIARQVAAGMAYLS---ERKFVHRDLATRNCLVGENMVVKIADFGLSRNIYS 226

Query: 437 KESIISMTGARGTVGYIAPEVFCRNIGEVSYKSDVYNYGMMIFEM 481
            +   +       + ++ PE    N    + +SDV+ YG++++E+
Sbjct: 227 ADYYKADGNDAIPIRWMPPESIFYNR--YTTESDVWAYGVVLWEI 269

>2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} Length = 312

 Score = 77.7 bits (192), Expect = 6e-16
 Identities = 43/179 (24%), Positives = 68/179 (37%), Gaps = 48/179 (26%)

Query: 321 LGQGGYGSVYKGK-LLDGSNVAVKVLNDSKGNGKEFINEVASISR-----------TSHV 368
           LG+GG+G+V+ G  L D   VA+KV+  ++  G   +++  +                H 
Sbjct: 39  LGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGHP 98

Query: 369 NVVALL-------GFCL-------------------RVAEELSSTI--GIARGLEYLHLG 400
            V+ LL       GF L                    + E  S      +   +++ H  
Sbjct: 99  GVIRLLDWFETQEGFMLVLERPLPAQDLFDYITEKGPLGEGPSRCFFGQVVAAIQHCH-- 156

Query: 401 CSTRILHFDIKPHNILLDEDFCP-KISDFGLAKICNRKESIISMTGARGTVGYIAPEVF 458
            S  ++H DIK  NIL+D      K+ DFG   + + +      T   GT  Y  PE  
Sbjct: 157 -SRGVVHRDIKDENILIDLRRGCAKLIDFGSGALLHDEP----YTDFDGTRVYSPPEWI 210

>3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} Length = 345

 Score = 77.6 bits (191), Expect = 9e-16
 Identities = 32/100 (32%), Positives = 47/100 (47%), Gaps = 7/100 (7%)

Query: 390 IARGLEYLHLGCSTRILHFDIKPHNILL--DEDFCPKISDFGLAKICNRKES--IISMTG 445
           I   L YLH   +  I H DIKP N L   ++ F  K+ DFGL+K   +  +     MT 
Sbjct: 177 IFSALHYLH---NQGICHRDIKPENFLFSTNKSFEIKLVDFGLSKEFYKLNNGEYYGMTT 233

Query: 446 ARGTVGYIAPEVFCRNIGEVSYKSDVYNYGMMIFEMTGGR 485
             GT  ++APEV          K D ++ G+++  +  G 
Sbjct: 234 KAGTPYFVAPEVLNTTNESYGPKCDAWSAGVLLHLLLMGA 273

>1uu3_A HPDK1, 3-phosphoinositide dependent protein kinase-1; PKB, inhibitor, LY333531, diabetes, cancer, transferase, serine/threonine-protein kinase; HET: SEP LY4; 1.7A {Homo sapiens} SCOP: d.144.1.7 PDB: 1okz_A* 1oky_A* 1uu7_A* 1uu8_A* 2biy_A* 3rwp_A* 2xch_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* ... Length = 310

 Score = 76.9 bits (190), Expect = 1e-15
 Identities = 64/233 (27%), Positives = 94/233 (40%), Gaps = 62/233 (26%)

Query: 295 RNYRSLSPKRYGYADIKKMTNSFKYK--LGQGGYGSVYKGKLLDGSNV-AVKVLNDSKGN 351
                  P++    D       FK+   LG+G + +V   + L  S   A+K+L      
Sbjct: 17  HAQPPPQPRKKRPED-------FKFGKILGEGSFSTVVLARELATSREYAIKILE----- 64

Query: 352 GKEFI---NEVASI-------SRTSHVNVVALLG---------FCLRVAE--ELSSTIG- 389
            K  I   N+V  +       SR  H   V L           F L  A+  EL   I  
Sbjct: 65  -KRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRK 123

Query: 390 ---------------IARGLEYLHLGCSTRILHFDIKPHNILLDEDFCPKISDFGLAKIC 434
                          I   LEYLH      I+H D+KP NILL+ED   +I+DFG AK+ 
Sbjct: 124 IGSFDETCTRFYTAEIVSALEYLH---GKGIIHRDLKPENILLNEDMHIQITDFGTAKVL 180

Query: 435 NRKESIISMTGARGTVGYIAPEVFCRNIGEVSY-KS-DVYNYGMMIFEMTGGR 485
           + +          GT  Y++PE+    + E S  KS D++  G +I+++  G 
Sbjct: 181 SPESKQARANSFVGTAQYVSPEL----LTEKSACKSSDLWALGCIIYQLVAGL 229

>2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* Length = 576

 Score = 78.3 bits (193), Expect = 2e-15
 Identities = 37/98 (37%), Positives = 51/98 (52%), Gaps = 12/98 (12%)

Query: 390 IARGLEYLHLGCSTRILHFDIKPHNILLDEDFCPKISDFGLAKICNRKESIISMTGARGT 449
           I  GLE LH     RI++ D+KP NILLD+    +ISD GLA      ++I       GT
Sbjct: 295 ICCGLEDLH---RERIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQTIKGRV---GT 348

Query: 450 VGYIAPEVFCRNIGEVSYKSDV--YNYGMMIFEMTGGR 485
           VGY+APEV    +    Y      +  G +++EM  G+
Sbjct: 349 VGYMAPEV----VKNERYTFSPDWWALGCLLYEMIAGQ 382

>3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B Length = 543

 Score = 77.9 bits (192), Expect = 2e-15
 Identities = 35/101 (34%), Positives = 51/101 (50%), Gaps = 17/101 (16%)

Query: 390 IARGLEYLHLGCSTRILHFDIKPHNILLDEDFCPKISDFGLAKICNRKESIISMTGAR-- 447
           I  GLE+LH      I++ D+KP N+LLD+D   +ISD GLA      E     T  +  
Sbjct: 298 IVSGLEHLH---QRNIIYRDLKPENVLLDDDGNVRISDLGLA-----VELKAGQTKTKGY 349

Query: 448 -GTVGYIAPEVFCRNIGEVSYKSDV--YNYGMMIFEMTGGR 485
            GT G++APE+    +    Y   V  +  G+ ++EM   R
Sbjct: 350 AGTPGFMAPEL----LLGEEYDFSVDYFALGVTLYEMIAAR 386

>2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* Length = 314

 Score = 75.0 bits (185), Expect = 5e-15
 Identities = 51/223 (22%), Positives = 88/223 (39%), Gaps = 59/223 (26%)

Query: 320 KLGQGGYGSVYKGKLLDGSN------VAVKVLND--SKGNGKEFINEVASISRTSHVNVV 371
            LG+G +G V K              VAVK+L +  S    ++ ++E   + + +H +V+
Sbjct: 30  TLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQVNHPHVI 89

Query: 372 ALLGFC---------------------LR--------------VAEELSSTIGIARGLEY 396
            L G C                     LR                   S      R L  
Sbjct: 90  KLYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTM 149

Query: 397 LHL---------GC----STRILHFDIKPHNILLDEDFCPKISDFGLAKICNRKESIISM 443
             L         G       +++H D+   NIL+ E    KISDFGL++    ++S +  
Sbjct: 150 GDLISFAWQISQGMQYLAEMKLVHRDLAARNILVAEGRKMKISDFGLSRDVYEEDSYVKR 209

Query: 444 TGARGTVGYIAPEVFCRNIGEVSYKSDVYNYGMMIFE-MTGGR 485
           +  R  V ++A E    +I   + +SDV+++G++++E +T G 
Sbjct: 210 SQGRIPVKWMAIESLFDHI--YTTQSDVWSFGVLLWEIVTLGG 250

>3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A Length = 361

 Score = 75.5 bits (186), Expect = 5e-15
 Identities = 60/227 (26%), Positives = 86/227 (37%), Gaps = 57/227 (25%)

Query: 301 SPKRYGYADIKKMTNSFKYK----LGQGGYGSVYKGK-LLDGSNVAVKVLNDSKGNGKEF 355
           +P   G  D+  M +S +Y     +G G +G     +  L    VAVK +       +  
Sbjct: 4   APVTTGPLDMPIMHDSDRYDFVKDIGSGNFGVARLMRDKLTKELVAVKYIERGAAIDENV 63

Query: 356 INEVASISRTSHVNVVAL---------LGFCLRVAE--ELSSTI--------GIAR---- 392
             E+ +     H N+V           L   +  A   EL   I          AR    
Sbjct: 64  QREIINHRSLRHPNIVRFKEVILTPTHLAIIMEYASGGELYERICNAGRFSEDEARFFFQ 123

Query: 393 ----GLEYLHLGCSTRILHFDIKPHNILLDEDFCP--KISDFGLAKICNRKESIISMTGA 446
               G+ Y H   S +I H D+K  N LLD    P  KI DFG +K         S+  +
Sbjct: 124 QLLSGVSYCH---SMQICHRDLKLENTLLDGSPAPRLKICDFGYSK--------SSVLHS 172

Query: 447 R-----GTVGYIAPEVFCRNIGEVSY---KSDVYNYGMMIFEMTGGR 485
           +     GT  YIAPEV  R      Y    +DV++ G+ ++ M  G 
Sbjct: 173 QPKSTVGTPAYIAPEVLLRQ----EYDGKIADVWSCGVTLYVMLVGA 215

>2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} Length = 298

 Score = 74.6 bits (184), Expect = 5e-15
 Identities = 51/229 (22%), Positives = 88/229 (38%), Gaps = 66/229 (28%)

Query: 318 KYK----LGQGGYGSVYKGK-LLDGSNVAVKVLNDSK--------------------GNG 352
           +Y     +G+G YG V       D +  A+KVL+  K                    G  
Sbjct: 14  QYTLKDEIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGC 73

Query: 353 KEFINEVASISR-------TSHVNVVALL-------------------GFCL-------R 379
            +    +  + +         H NVV L+                      +        
Sbjct: 74  IQPRGPIEQVYQEIAILKKLDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPVMEVPTLKP 133

Query: 380 VAEELSSTI--GIARGLEYLHLGCSTRILHFDIKPHNILLDEDFCPKISDFGLAKICNRK 437
           ++E+ +      + +G+EYLH     +I+H DIKP N+L+ ED   KI+DFG++      
Sbjct: 134 LSEDQARFYFQDLIKGIEYLH---YQKIIHRDIKPSNLLVGEDGHIKIADFGVSNEFKGS 190

Query: 438 ESIISMTGARGTVGYIAPEVFCRNIGEVS-YKSDVYNYGMMIFEMTGGR 485
           ++++S T   GT  ++APE         S    DV+  G+ ++    G+
Sbjct: 191 DALLSNTV--GTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQ 237

>3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* Length = 410

 Score = 75.9 bits (187), Expect = 5e-15
 Identities = 55/232 (23%), Positives = 96/232 (41%), Gaps = 42/232 (18%)

Query: 289 NIETFLRNYRSLSPKRYGYADIKKMTNSFKYK--LGQGGYGSVYKGKLLDGSNV-AVKVL 345
           NI+ FL  Y+    K     D++     ++    +G+G +G V   +      V A+K+L
Sbjct: 46  NIDNFLSRYKDTINK---IRDLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLL 102

Query: 346 NDS----KGNGKEFINEVASISRTSHVNVVAL---------LGFCL-------------- 378
           +      + +   F  E   ++  +   VV L         L   +              
Sbjct: 103 SKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQDDRYLYMVMEYMPGGDLVNLMSN 162

Query: 379 -RVAEELSS--TIGIARGLEYLHLGCSTRILHFDIKPHNILLDEDFCPKISDFGLAKICN 435
             V E+ +   T  +   L+ +H   S   +H D+KP N+LLD+    K++DFG     N
Sbjct: 163 YDVPEKWARFYTAEVVLALDAIH---SMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMN 219

Query: 436 RKESIISMTGARGTVGYIAPEVFCRNIGEVSYKSDV--YNYGMMIFEMTGGR 485
           ++  +   T A GT  YI+PEV     G+  Y  +   ++ G+ ++EM  G 
Sbjct: 220 KEGMVRCDT-AVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGD 270

>3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* Length = 351

 Score = 75.3 bits (186), Expect = 5e-15
 Identities = 50/201 (24%), Positives = 78/201 (38%), Gaps = 48/201 (23%)

Query: 302 PKRYGYADIKKMTNSFKY----KLGQGGYGSVYKGK-LLDGSNVAVK-VLNDSKGNGKEF 355
            K+Y   +        KY    K+GQG +G V+K +    G  VA+K VL +++  G   
Sbjct: 2   AKQYDSVECPFCDEVSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPI 61

Query: 356 --INEVASISRTSHVNVVALLGFCLRVAEELSSTIG------------------------ 389
             + E+  +    H NVV L+  C   A   +   G                        
Sbjct: 62  TALREIKILQLLKHENVVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLVKF 121

Query: 390 -----------IARGLEYLHLGCSTRILHFDIKPHNILLDEDFCPKISDFGLAKICN--R 436
                      +  GL Y+H     +ILH D+K  N+L+  D   K++DFGLA+  +  +
Sbjct: 122 TLSEIKRVMQMLLNGLYYIH---RNKILHRDMKAANVLITRDGVLKLADFGLARAFSLAK 178

Query: 437 KESIISMTGARGTVGYIAPEV 457
                  T    T+ Y  PE+
Sbjct: 179 NSQPNRYTNRVVTLWYRPPEL 199

>3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} Length = 360

 Score = 75.4 bits (186), Expect = 6e-15
 Identities = 54/214 (25%), Positives = 83/214 (38%), Gaps = 62/214 (28%)

Query: 320 KLGQGGYGSVYKGKLLD-GSNVAVK-VLNDSKGNGKEFINEVASISRTSHVNVVALLGF- 376
             GQG +G+V  GK    G +VA+K V+ D +   +E +  +  ++   H N+V L  + 
Sbjct: 30  MAGQGTFGTVQLGKEKSTGMSVAIKKVIQDPRFRNRE-LQIMQDLAVLHHPNIVQLQSYF 88

Query: 377 -----------CLRVAEEL-----------SSTIG--------------IARGLEYLHLG 400
                       L V  E                               + R +  LHL 
Sbjct: 89  YTLGERDRRDIYLNVVMEYVPDTLHRCCRNYYRRQVAPPPILIKVFLFQLIRSIGCLHLP 148

Query: 401 CSTRILHFDIKPHNILLDEDFCP-KISDFGLAKICNRKESIISMTGARGTVGYI------ 453
            S  + H DIKPHN+L++E     K+ DFG AK  +  E  ++         YI      
Sbjct: 149 -SVNVCHRDIKPHNVLVNEADGTLKLCDFGSAKKLSPSEPNVA---------YICSRYYR 198

Query: 454 APEVFCRNIGEVSYKS--DVYNYGMMIFEMTGGR 485
           APE+     G   Y +  D+++ G +  EM  G 
Sbjct: 199 APELI---FGNQHYTTAVDIWSVGCIFAEMMLGE 229

>3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} PDB: 2qkr_A* Length = 311

 Score = 74.5 bits (184), Expect = 7e-15
 Identities = 43/143 (30%), Positives = 69/143 (48%), Gaps = 33/143 (23%)

Query: 320 KLGQGGYGSVYKGKLLDGSNVAVKVLN-DSKGNGKEF--INEVASISRTSHVNVVALL-- 374
           K+G+G YG VYK K   G  VA+K +  D++  G     I E++ +    H N+V+L+  
Sbjct: 28  KVGEGTYGVVYKAKDSQGRIVALKRIRLDAEDEGIPSTAIREISLLKELHHPNIVSLIDV 87

Query: 375 -----------GFCL----RVAEELSSTIGIA----------RGLEYLHLGCSTRILHFD 409
                       F      +V +E  + +  +          RG+ + H     RILH D
Sbjct: 88  IHSERCLTLVFEFMEKDLKKVLDENKTGLQDSQIKIYLYQLLRGVAHCH---QHRILHRD 144

Query: 410 IKPHNILLDEDFCPKISDFGLAK 432
           +KP N+L++ D   K++DFGLA+
Sbjct: 145 LKPQNLLINSDGALKLADFGLAR 167

>3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... Length = 320

 Score = 73.9 bits (182), Expect = 1e-14
 Identities = 44/177 (24%), Positives = 66/177 (37%), Gaps = 46/177 (25%)

Query: 321 LGQGGYGSVYKGK-LLDGSNVAVKVLNDSKGNGKEFIN-------EVASISRTSHV--NV 370
           LG GG+GSVY G  + D   VA+K +   + +    +        EV  + + S     V
Sbjct: 51  LGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGV 110

Query: 371 VALL-------GFCL-------------------RVAEELSSTIG--IARGLEYLHLGCS 402
           + LL        F L                    + EEL+ +    +   + + H   +
Sbjct: 111 IRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHCH---N 167

Query: 403 TRILHFDIKPHNILLDEDFCP-KISDFGLAKICNRKESIISMTGARGTVGYIAPEVF 458
             +LH DIK  NIL+D +    K+ DFG   +          T   GT  Y  PE  
Sbjct: 168 CGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTV----YTDFDGTRVYSPPEWI 220

>3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} Length = 308

 Score = 73.4 bits (181), Expect = 1e-14
 Identities = 44/156 (28%), Positives = 65/156 (41%), Gaps = 46/156 (29%)

Query: 320 KLGQGGYGSVYKGK-LLDGSNVAVK-VLNDSKGNGKEFIN-----EVA---SISRTSHVN 369
           ++G G YG+VYK +    G  VA+K V   + G G   +      EVA    +    H N
Sbjct: 16  EIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLRRLEAFEHPN 75

Query: 370 VVALLG------------------FC---LRVAEELSSTIGIA------------RGLEY 396
           VV L+                        LR   + +   G+             RGL++
Sbjct: 76  VVRLMDVCATSRTDREIKVTLVFEHVDQDLRTYLDKAPPPGLPAETIKDLMRQFLRGLDF 135

Query: 397 LHLGCSTRILHFDIKPHNILLDEDFCPKISDFGLAK 432
           LH   +  I+H D+KP NIL+      K++DFGLA+
Sbjct: 136 LH---ANCIVHRDLKPENILVTSGGTVKLADFGLAR 168

>2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... Length = 276

 Score = 73.0 bits (180), Expect = 1e-14
 Identities = 50/174 (28%), Positives = 67/174 (38%), Gaps = 41/174 (23%)

Query: 321 LGQGGYGSVYKGK-LLDGSNVAVKVLNDSK--GNGKEFINEVASISRTSHVNVVALLGFC 377
           LG+G YG V      +    VAVK+++  +     +    E+      +H NVV   G  
Sbjct: 15  LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYG-- 72

Query: 378 LRVAE---------------ELSSTI--------GIAR--------GLEYLHLGCSTRIL 406
                               EL   I          A+        G+ YLH      I 
Sbjct: 73  --HRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLH---GIGIT 127

Query: 407 HFDIKPHNILLDEDFCPKISDFGLAKICNRKESIISMTGARGTVGYIAPEVFCR 460
           H DIKP N+LLDE    KISDFGLA +         +    GT+ Y+APE+  R
Sbjct: 128 HRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKR 181

>3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A Length = 328

 Score = 73.5 bits (181), Expect = 2e-14
 Identities = 51/208 (24%), Positives = 83/208 (39%), Gaps = 55/208 (26%)

Query: 282 NSTASCLNIETFLRNYRSLSPKRYGYADIKKMTNSFKYKLGQGGYGSVYKGK-LLDGSNV 340
           NS ASC + +  + NYR           + K        +G+G +  V   + +L G  V
Sbjct: 2   NSIASCADEQPHIGNYR-----------LLKT-------IGKGNFAKVKLARHILTGREV 43

Query: 341 AVKVLNDSKGNGKEFIN---EVASISRTSHVNVVALL-----------------GFCL-- 378
           A+K+++ ++ N         EV  +   +H N+V L                  G  +  
Sbjct: 44  AIKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVKLFEVIETEKTLYLIMEYASGGEVFD 103

Query: 379 ------RVAEELSSTIG--IARGLEYLHLGCSTRILHFDIKPHNILLDEDFCPKISDFGL 430
                 R+ E+ + +    I   ++Y H     RI+H D+K  N+LLD D   KI+DFG 
Sbjct: 104 YLVAHGRMKEKEARSKFRQIVSAVQYCH---QKRIVHRDLKAENLLLDADMNIKIADFGF 160

Query: 431 AKICNRKESIISMTGARGTVGYIAPEVF 458
           +           +    G   Y APE+F
Sbjct: 161 SNEFTVGG---KLDAFCGAPPYAAPELF 185

>3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A Length = 292

 Score = 72.2 bits (178), Expect = 3e-14
 Identities = 36/144 (25%), Positives = 62/144 (43%), Gaps = 34/144 (23%)

Query: 320 KLGQGGYGSVYKGK-LLDGSNVAVKVLN-DSKGNGKEF--INEVASISRTSHVNVVALLG 375
           K+G+G YG+V+K K       VA+K +  D    G     + E+  +    H N+V L  
Sbjct: 9   KIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHD 68

Query: 376 -------------FCL----RVAEELSSTIGIA----------RGLEYLHLGCSTRILHF 408
                        FC     +  +  +  +             +GL + H   S  +LH 
Sbjct: 69  VLHSDKKLTLVFEFCDQDLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCH---SRNVLHR 125

Query: 409 DIKPHNILLDEDFCPKISDFGLAK 432
           D+KP N+L++ +   K+++FGLA+
Sbjct: 126 DLKPQNLLINRNGELKLANFGLAR 149

>3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* Length = 323

 Score = 72.3 bits (178), Expect = 3e-14
 Identities = 47/173 (27%), Positives = 66/173 (38%), Gaps = 43/173 (24%)

Query: 321 LGQGGYGSVYKGK-LLDGSNVAVKVLNDSK--GNGKEFINEVASISRTSHVNVVALLGFC 377
           LG+G YG V      +    VAVK+++  +     +    E+      +H NVV   G  
Sbjct: 15  LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYG-- 72

Query: 378 LRVAEELSSTIGI------------------------AR--------GLEYLHLGCSTRI 405
                E  +   +                        A+        G+ YLH      I
Sbjct: 73  --HRRE-GNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLH---GIGI 126

Query: 406 LHFDIKPHNILLDEDFCPKISDFGLAKICNRKESIISMTGARGTVGYIAPEVF 458
            H DIKP N+LLDE    KISDFGLA +         +    GT+ Y+APE+ 
Sbjct: 127 THRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELL 179

>2r3i_A Cell division protein kinase 2; serine/threonine-protein kinase, cell cycle, inhibition, cyclin-dependent kinase, cancer, ATP-binding; HET: SCF; 1.28A {Homo sapiens} PDB: 2r3j_A* 2r3k_A* 2r3l_A* 2r3m_A* 2r3n_A* 2r3o_A* 2r3p_A* 2r3q_A* 1jvp_P* 1buh_A 1ckp_A* 1di8_A* 1dm2_A* 1f5q_A 1fin_A* 1fq1_B* 1fvt_A* 1fvv_A* 1g5s_A* 1gih_A* ... Length = 299

 Score = 72.2 bits (178), Expect = 4e-14
 Identities = 45/145 (31%), Positives = 71/145 (48%), Gaps = 35/145 (24%)

Query: 320 KLGQGGYGSVYKGK-LLDGSNVAVKVLN-DSKGNGKEF--INEVASISRTSHVNVVALLG 375
           K+G+G YG VYK +  L G  VA+K +  D++  G     I E++ +   +H N+V LL 
Sbjct: 10  KIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLD 69

Query: 376 -------------FC---LRVAEELSSTIGIA------------RGLEYLHLGCSTRILH 407
                        F    L+   + S+  GI             +GL + H   S R+LH
Sbjct: 70  VIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCH---SHRVLH 126

Query: 408 FDIKPHNILLDEDFCPKISDFGLAK 432
            D+KP N+L++ +   K++DFGLA+
Sbjct: 127 RDLKPQNLLINTEGAIKLADFGLAR 151

>1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A Length = 288

 Score = 71.8 bits (177), Expect = 4e-14
 Identities = 37/143 (25%), Positives = 61/143 (42%), Gaps = 33/143 (23%)

Query: 320 KLGQGGYGSVYKGKLLDGSNVAVKVLN-DSKGNGKEF--INEVASISRTSHVNVVALL-- 374
           K+G+G YG VYK +   G   A+K +  + +  G     I E++ +    H N+V L   
Sbjct: 9   KIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDV 68

Query: 375 -----GFCL----------RVAEELSSTIGIA----------RGLEYLHLGCSTRILHFD 409
                   L          ++ +     +              G+ Y H     R+LH D
Sbjct: 69  IHTKKRLVLVFEHLDQDLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCH---DRRVLHRD 125

Query: 410 IKPHNILLDEDFCPKISDFGLAK 432
           +KP N+L++ +   KI+DFGLA+
Sbjct: 126 LKPQNLLINREGELKIADFGLAR 148

>4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} Length = 311

 Score = 72.2 bits (178), Expect = 4e-14
 Identities = 34/143 (23%), Positives = 55/143 (38%), Gaps = 34/143 (23%)

Query: 320 KLGQGGYGSVYKGK-LLDGSNVAVK-VLNDSKGNGKEFIN--EVASISRTSHVNVVALLG 375
           K+G+G YG V+K +    G  VA+K  L        + I   E+  + +  H N+V LL 
Sbjct: 10  KIGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVIKKIALREIRMLKQLKHPNLVNLLE 69

Query: 376 -------------FC----LRVAEELSSTIGIA----------RGLEYLHLGCSTRILHF 408
                        +C    L   +     +             + + + H       +H 
Sbjct: 70  VFRRKRRLHLVFEYCDHTVLHELDRYQRGVPEHLVKSITWQTLQAVNFCH---KHNCIHR 126

Query: 409 DIKPHNILLDEDFCPKISDFGLA 431
           D+KP NIL+ +    K+ DFG A
Sbjct: 127 DVKPENILITKHSVIKLCDFGFA 149

>3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A Length = 286

 Score = 71.7 bits (176), Expect = 4e-14
 Identities = 24/198 (12%), Positives = 47/198 (23%), Gaps = 68/198 (34%)

Query: 320 KLGQGGYGSVYKGK--LLDGSNVAVKVLNDSKGNG----KEFINEVASISRTSHVNVVAL 373
             G       ++     LD   VA+  ++          +E ++    +SR     V  +
Sbjct: 38  FHGGVPPLQFWQALDTALD-RQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPGVARV 96

Query: 374 L------GFCLRVAE-----ELSSTI--------------GIARGLEYLH-LGCSTRILH 407
           L         L VAE      L                   +A   +  H  G    +  
Sbjct: 97  LDVVHTRAGGLVVAEWIRGGSLQEVADTSPSPVGAIRAMQSLAAAADAAHRAG----VAL 152

Query: 408 FDIKPHNILLDEDFCPKISDFGLAKICNRKESIISMTGARGTVGYIAPEVFCRNIGEVSY 467
               P  + +  D        G   +                   +            + 
Sbjct: 153 SIDHPSRVRVSID--------GDVVL--------------AYPATMPD---------ANP 181

Query: 468 KSDVYNYGMMIFEMTGGR 485
           + D+   G  ++ +   R
Sbjct: 182 QDDIRGIGASLYALLVNR 199

>2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} Length = 412

 Score = 72.4 bits (178), Expect = 7e-14
 Identities = 47/243 (19%), Positives = 87/243 (35%), Gaps = 59/243 (24%)

Query: 289 NIETFLRNYRSLSPKRYGYADIKKMTNSFKYK--LGQGGYGSVYKGKLLDGSNV-AVKVL 345
            +  FL+    +  +     +++   + F+    +G+G +  V   K+     V A+K++
Sbjct: 38  YVADFLQWAEPIVVRL---KEVRLQRDDFEILKVIGRGAFSEVAVVKMKQTGQVYAMKIM 94

Query: 346 NDSKGNGKEFI---NEVASI-------SRTSHVNVVAL---------LGFCL-------- 378
           N      K  +    EV+                +  L         L   +        
Sbjct: 95  N------KWDMLKRGEVSCFREERDVLVNGDRRWITQLHFAFQDENYLYLVMEYYVGGDL 148

Query: 379 ---------RVAEELSS--TIGIARGLEYLHLGCSTRILHFDIKPHNILLDEDFCPKISD 427
                    R+  E++      I   ++ +H       +H DIKP NILLD     +++D
Sbjct: 149 LTLLSKFGERIPAEMARFYLAEIVMAIDSVH---RLGYVHRDIKPDNILLDRCGHIRLAD 205

Query: 428 FGLAKICNRKESIISMTGARGTVGYIAPEVFCRNIGEVSYKS-----DVYNYGMMIFEMT 482
           FG         ++ S+  A GT  Y++PE+     G     S     D +  G+  +EM 
Sbjct: 206 FGSCLKLRADGTVRSLV-AVGTPDYLSPEILQAVGGGPGTGSYGPECDWWALGVFAYEMF 264

Query: 483 GGR 485
            G+
Sbjct: 265 YGQ 267

>3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} Length = 324

 Score = 71.1 bits (175), Expect = 1e-13
 Identities = 43/143 (30%), Positives = 66/143 (46%), Gaps = 33/143 (23%)

Query: 320 KLGQGGYGSVYKGK-LLDGSNVAVKV--LNDSKGNGKEFINEVASISRTSHVNVVALLG- 375
           KLG+G Y +VYKGK  L  + VA+K   L   +G     I EV+ +    H N+V L   
Sbjct: 9   KLGEGTYATVYKGKSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDI 68

Query: 376 ------------FCL----RVAEELSSTIGIA----------RGLEYLHLGCSTRILHFD 409
                       +      +  ++  + I +           RGL Y H     ++LH D
Sbjct: 69  IHTEKSLTLVFEYLDKDLKQYLDDCGNIINMHNVKLFLFQLLRGLAYCH---RQKVLHRD 125

Query: 410 IKPHNILLDEDFCPKISDFGLAK 432
           +KP N+L++E    K++DFGLA+
Sbjct: 126 LKPQNLLINERGELKLADFGLAR 148

>4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} Length = 331

 Score = 70.7 bits (174), Expect = 1e-13
 Identities = 39/143 (27%), Positives = 56/143 (39%), Gaps = 34/143 (23%)

Query: 320 KLGQGGYGSVYKGK-LLDGSNVAVK-VLNDSKGNGKEFIN--EVASISRTSHVNVVALLG 375
            +G+G YG V K +    G  VA+K  L        + I   E+  + +  H N+V LL 
Sbjct: 32  LVGEGSYGMVMKCRNKDTGRIVAIKKFLESDDDKMVKKIAMREIKLLKQLRHENLVNLLE 91

Query: 376 -------------FC----LRVAEELSSTIG----------IARGLEYLHLGCSTRILHF 408
                        F     L   E   + +           I  G+ + H   S  I+H 
Sbjct: 92  VCKKKKRWYLVFEFVDHTILDDLELFPNGLDYQVVQKYLFQIINGIGFCH---SHNIIHR 148

Query: 409 DIKPHNILLDEDFCPKISDFGLA 431
           DIKP NIL+ +    K+ DFG A
Sbjct: 149 DIKPENILVSQSGVVKLCDFGFA 171

>4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* Length = 437

 Score = 70.9 bits (174), Expect = 2e-13
 Identities = 27/99 (27%), Positives = 48/99 (48%), Gaps = 7/99 (7%)

Query: 390 IARGLEYLHLGCSTRILHFDIKPHNILLDEDFCPKISDFGLAKICNRKESIISMTGARGT 449
           +   ++ +H       +H DIKP NIL+D +   +++DFG         ++ S   A GT
Sbjct: 184 MVIAIDSVH---QLHYVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGTVQSSV-AVGT 239

Query: 450 VGYIAPEVF-CRNIGEVSYKSDV--YNYGMMIFEMTGGR 485
             YI+PE+      G+  Y  +   ++ G+ ++EM  G 
Sbjct: 240 PDYISPEILQAMEGGKGRYGPECDWWSLGVCMYEMLYGE 278

>3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} Length = 405

 Score = 70.2 bits (172), Expect = 3e-13
 Identities = 46/200 (23%), Positives = 80/200 (40%), Gaps = 56/200 (28%)

Query: 308 ADIKKMTNSFKY---KLGQGGYGSVYKGKLLDGSN---VAVKVLNDSKGNGKEFINEVAS 361
           ++ +++ + F+Y   K+G+G YG VYK K  DG +    A+K +  + G       E+A 
Sbjct: 13  SERERVEDLFEYEGCKVGRGTYGHVYKAKRKDGKDDKDYALKQIEGT-GISMSACREIAL 71

Query: 362 ISRTSHVNVVALLG---------------FC----------LRVAEELSSTIGIA----- 391
           +    H NV++L                 +            R ++     + +      
Sbjct: 72  LRELKHPNVISLQKVFLSHADRKVWLLFDYAEHDLWHIIKFHRASKANKKPVQLPRGMVK 131

Query: 392 -------RGLEYLHLGCSTRILHFDIKPHNILLDEDF----CPKISDFGLAKICNRKESI 440
                   G+ YLH   +  +LH D+KP NIL+  +       KI+D G A++ N    +
Sbjct: 132 SLLYQILDGIHYLH---ANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFN--SPL 186

Query: 441 ISMTGARG---TVGYIAPEV 457
             +        T  Y APE+
Sbjct: 187 KPLADLDPVVVTFWYRAPEL 206

>2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* Length = 317

 Score = 69.2 bits (170), Expect = 4e-13
 Identities = 42/158 (26%), Positives = 67/158 (42%), Gaps = 42/158 (26%)

Query: 313 MTNSFKY----KLGQGGYGSVYKGK-LLDGSNVAVKV--LNDSKGNGKEFINEVASISRT 365
           M++S ++    KLG G Y +VYKG     G  VA+K   L+  +G     I E++ +   
Sbjct: 1   MSSSSQFKQLEKLGNGTYATVYKGLNKTTGVYVALKEVKLDSEEGTPSTAIREISLMKEL 60

Query: 366 SHVNVVALL-------------GFC-------LRVAEELSSTIGIA------------RG 393
            H N+V L               F        +      ++  G+             +G
Sbjct: 61  KHENIVRLYDVIHTENKLTLVFEFMDNDLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQG 120

Query: 394 LEYLHLGCSTRILHFDIKPHNILLDEDFCPKISDFGLA 431
           L + H     +ILH D+KP N+L+++    K+ DFGLA
Sbjct: 121 LAFCH---ENKILHRDLKPQNLLINKRGQLKLGDFGLA 155

>3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* Length = 329

 Score = 68.0 bits (167), Expect = 1e-12
 Identities = 39/148 (26%), Positives = 58/148 (39%), Gaps = 38/148 (25%)

Query: 320 KLGQGGYGSVYKGK-LLDGSNVAVKVLN-DSKGNGKEF--INEVASISRTSHVNVVALLG 375
           KLG+G YG VYK    +    VA+K +  + +  G     I EV+ +    H N++ L  
Sbjct: 41  KLGEGTYGEVYKAIDTVTNETVAIKRIRLEHEEEGVPGTAIREVSLLKELQHRNIIELKS 100

Query: 376 -------------FC-------------LRVAEELSSTIGIARGLEYLHLGCSTRILHFD 409
                        +              + +    S    +  G+ + H   S R LH D
Sbjct: 101 VIHHNHRLHLIFEYAENDLKKYMDKNPDVSMRVIKSFLYQLINGVNFCH---SRRCLHRD 157

Query: 410 IKPHNILLDEDFCP-----KISDFGLAK 432
           +KP N+LL           KI DFGLA+
Sbjct: 158 LKPQNLLLSVSDASETPVLKIGDFGLAR 185

>3g51_A Ribosomal protein S6 kinase alpha-3; N-terminal kinase domain of P90 ribosomal S6 kinase 2, ATP- binding, nucleotide-binding, phosphoprotein; HET: ANP; 1.80A {Mus musculus} PDB: 2z7q_A* 2z7r_A* 2z7s_A* Length = 325

 Score = 67.6 bits (166), Expect = 1e-12
 Identities = 38/101 (37%), Positives = 57/101 (56%), Gaps = 17/101 (16%)

Query: 390 IARGLEYLHLGCSTRILHFDIKPHNILLDEDFCPKISDFGLAKICNRKESIISMTGAR-- 447
           +A  L++LH   S  I++ D+KP NILLDE+   K++DFGL+     KESI     A   
Sbjct: 135 LALALDHLH---SLGIIYRDLKPENILLDEEGHIKLTDFGLS-----KESIDHEKKAYSF 186

Query: 448 -GTVGYIAPEVFCRNIGEVSYKSDV--YNYGMMIFEMTGGR 485
            GTV Y+APEV    +    +      +++G+++FEM  G 
Sbjct: 187 CGTVEYMAPEV----VNRRGHTQSADWWSFGVLMFEMLTGT 223

>1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B Length = 326

 Score = 67.6 bits (166), Expect = 1e-12
 Identities = 42/154 (27%), Positives = 63/154 (40%), Gaps = 44/154 (28%)

Query: 320 KLGQGGYGSVYKGK--LLDGSNVAVK-VLNDSKGNGKEF--INEVA---SISRTSHVNVV 371
           ++G+G YG V+K +     G  VA+K V   +   G     I EVA    +    H NVV
Sbjct: 18  EIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVV 77

Query: 372 ALLGFCLRVAEELSSTIGIA---------------------------------RGLEYLH 398
            L   C     +  + + +                                  RGL++LH
Sbjct: 78  RLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLH 137

Query: 399 LGCSTRILHFDIKPHNILLDEDFCPKISDFGLAK 432
              S R++H D+KP NIL+      K++DFGLA+
Sbjct: 138 ---SHRVVHRDLKPQNILVTSSGQIKLADFGLAR 168

>2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* Length = 373

 Score = 68.1 bits (167), Expect = 1e-12
 Identities = 36/101 (35%), Positives = 50/101 (49%), Gaps = 17/101 (16%)

Query: 390 IARGLEYLHLGCSTRILHFDIKPHNILLDEDFCPKISDFGLAKICNRKESIISMTGAR-- 447
           IA  L YLH   S  I++ D+KP NILLD      ++DFGL      KE+I   +     
Sbjct: 148 IASALGYLH---SLNIVYRDLKPENILLDSQGHIVLTDFGLC-----KENIEHNSTTSTF 199

Query: 448 -GTVGYIAPEVFCRNIGEVSYKSDV--YNYGMMIFEMTGGR 485
            GT  Y+APEV    + +  Y   V  +  G +++EM  G 
Sbjct: 200 CGTPEYLAPEV----LHKQPYDRTVDWWCLGAVLYEMLYGL 236

>1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... Length = 337

 Score = 67.6 bits (166), Expect = 2e-12
 Identities = 37/101 (36%), Positives = 53/101 (52%), Gaps = 17/101 (16%)

Query: 390 IARGLEYLHLGCSTRILHFDIKPHNILLDEDFCPKISDFGLAKICNRKESIISMTGAR-- 447
           I   LEYLH   S  +++ DIK  N++LD+D   KI+DFGL      KE I      +  
Sbjct: 114 IVSALEYLH---SRDVVYRDIKLENLMLDKDGHIKITDFGLC-----KEGISDGATMKTF 165

Query: 448 -GTVGYIAPEVFCRNIGEVSYKSDV--YNYGMMIFEMTGGR 485
            GT  Y+APEV    + +  Y   V  +  G++++EM  GR
Sbjct: 166 CGTPEYLAPEV----LEDNDYGRAVDWWGLGVVMYEMMCGR 202

>3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} Length = 353

 Score = 67.3 bits (165), Expect = 2e-12
 Identities = 32/101 (31%), Positives = 51/101 (50%), Gaps = 17/101 (16%)

Query: 390 IARGLEYLHLGCSTRILHFDIKPHNILLDEDFCPKISDFGLAKICNRKESIISMTGAR-- 447
           I   L +LH      I++ D+K  N+LLD +   K++DFG+      KE I +       
Sbjct: 133 IISALMFLH---DKGIIYRDLKLDNVLLDHEGHCKLADFGMC-----KEGICNGVTTATF 184

Query: 448 -GTVGYIAPEVFCRNIGEVSY-KS-DVYNYGMMIFEMTGGR 485
            GT  YIAPE+    + E+ Y  + D +  G++++EM  G 
Sbjct: 185 CGTPDYIAPEI----LQEMLYGPAVDWWAMGVLLYEMLCGH 221

>3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* Length = 327

 Score = 67.2 bits (165), Expect = 2e-12
 Identities = 31/101 (30%), Positives = 51/101 (50%), Gaps = 17/101 (16%)

Query: 390 IARGLEYLHLGCSTRILHFDIKPHNILLDEDFCPKISDFGLAKICNRKESIISMTGAR-- 447
           I+  L +LH      I++ D+KP NI+L+     K++DFGL      KESI   T     
Sbjct: 130 ISMALGHLH---QKGIIYRDLKPENIMLNHQGHVKLTDFGLC-----KESIHDGTVTHTF 181

Query: 448 -GTVGYIAPEVFCRNIGEVSYKSDV--YNYGMMIFEMTGGR 485
            GT+ Y+APE+    +    +   V  ++ G ++++M  G 
Sbjct: 182 CGTIEYMAPEI----LMRSGHNRAVDWWSLGALMYDMLTGA 218

>3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* Length = 345

 Score = 67.3 bits (165), Expect = 2e-12
 Identities = 33/101 (32%), Positives = 50/101 (49%), Gaps = 17/101 (16%)

Query: 390 IARGLEYLHLGCSTRILHFDIKPHNILLDEDFCPKISDFGLAKICNRKESIISMTGAR-- 447
           I+  L YLH      I++ D+K  N+LLD +   K++D+G+      KE +         
Sbjct: 119 ISLALNYLH---ERGIIYRDLKLDNVLLDSEGHIKLTDYGMC-----KEGLRPGDTTSTF 170

Query: 448 -GTVGYIAPEVFCRNIGEVSY-KS-DVYNYGMMIFEMTGGR 485
            GT  YIAPE+    +    Y  S D +  G+++FEM  GR
Sbjct: 171 CGTPNYIAPEI----LRGEDYGFSVDWWALGVLMFEMMAGR 207

>3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359

 Score = 67.3 bits (164), Expect = 2e-12
 Identities = 40/193 (20%), Positives = 80/193 (41%), Gaps = 17/193 (8%)

Query: 289 NIETFLRNYRSLSPKRYGYADIKKMTNSFKYKLGQGGYGSVYKGKLLDGSNVAVKVLNDS 348
           N+ T+LR+ R+            +    +   +       +        S  +  V   S
Sbjct: 113 NLSTYLRSKRNEFVPYKTKGARFRQGKDYVGAIPVDLKRRLDSITSSQSSASSGFVEEKS 172

Query: 349 KGNGKEFINEVASISRTSHVNVVALLGFCLRVAEELSSTIGIARGLEYLHLGCSTRILHF 408
             + +E   E         + +  L+ +  +          +A+G+E+L    S + +H 
Sbjct: 173 LSDVEE--EEAPEDLYKDFLTLEHLICYSFQ----------VAKGMEFL---ASRKCIHR 217

Query: 409 DIKPHNILLDEDFCPKISDFGLAKICNRKESIISMTGARGTVGYIAPEVFCRNIGEVSYK 468
           D+   NILL E    KI DFGLA+   +    +    AR  + ++APE     +   + +
Sbjct: 218 DLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVY--TIQ 275

Query: 469 SDVYNYGMMIFEM 481
           SDV+++G++++E+
Sbjct: 276 SDVWSFGVLLWEI 288

>3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359

 Score = 44.2 bits (104), Expect = 7e-05
 Identities = 24/118 (20%), Positives = 41/118 (34%), Gaps = 15/118 (12%)

Query: 316 SFKYKLGQGGYGSVYKGKLLD------GSNVAVKVLNDSKGNG--KEFINEVAS-ISRTS 366
                LG+G +G V +              VAVK+L +   +   +  ++E+   I    
Sbjct: 25  KLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGH 84

Query: 367 HVNVVALLGFCLRVAEELSSTIGIARGLEYLHLGCSTRILHFDIKPHNILLDEDFCPK 424
           H+NVV LLG C +    L         +E+   G  +  L            +    +
Sbjct: 85  HLNVVNLLGACTKPGGPLM------VIVEFCKFGNLSTYLRSKRNEFVPYKTKGARFR 136

>2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* Length = 353

 Score = 66.9 bits (164), Expect = 3e-12
 Identities = 36/101 (35%), Positives = 55/101 (54%), Gaps = 17/101 (16%)

Query: 390 IARGLEYLHLGCSTRILHFDIKPHNILLDEDFCPKISDFGLAKICNRKESIISMTGAR-- 447
           IA GL +L    S  I++ D+K  N++LD +   KI+DFG+      KE+I      +  
Sbjct: 130 IAIGLFFLQ---SKGIIYRDLKLDNVMLDSEGHIKIADFGMC-----KENIWDGVTTKTF 181

Query: 448 -GTVGYIAPEVFCRNIGEVSY-KS-DVYNYGMMIFEMTGGR 485
            GT  YIAPE+    I    Y KS D + +G++++EM  G+
Sbjct: 182 CGTPDYIAPEI----IAYQPYGKSVDWWAFGVLLYEMLAGQ 218

>1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* Length = 345

 Score = 66.9 bits (164), Expect = 3e-12
 Identities = 36/102 (35%), Positives = 57/102 (55%), Gaps = 19/102 (18%)

Query: 390 IARGLEYLHLGCSTRILHFDIKPHNILLDED-FCPKISDFGLAKICNRKESIISMTGAR- 447
           I  GL++LH   S  I++ D+K  NILLD+D    KI+DFG+      KE+++       
Sbjct: 127 IILGLQFLH---SKGIVYRDLKLDNILLDKDGHI-KIADFGMC-----KENMLGDAKTNT 177

Query: 448 --GTVGYIAPEVFCRNIGEVSY-KS-DVYNYGMMIFEMTGGR 485
             GT  YIAPE+    +    Y  S D +++G++++EM  G+
Sbjct: 178 FCGTPDYIAPEI----LLGQKYNHSVDWWSFGVLLYEMLIGQ 215

>2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... Length = 371

 Score = 66.6 bits (163), Expect = 4e-12
 Identities = 32/96 (33%), Positives = 47/96 (48%), Gaps = 8/96 (8%)

Query: 390 IARGLEYLHLGCSTRILHFDIKPHNILLDEDFCPKISDFGLAKICNRKESIISMTGARGT 449
           +  G+++LH   S  I+H D+KP NI++  D   KI DFGLA+      +   MT    T
Sbjct: 136 MLCGIKHLH---SAGIIHRDLKPSNIVVKSDCTLKILDFGLARTA---GTSFMMTPYVVT 189

Query: 450 VGYIAPEVFCRNIGEVSYKSDVYNYGMMIFEMTGGR 485
             Y APEV            D+++ G ++ EM  G 
Sbjct: 190 RYYRAPEVILGM--GYKENVDIWSVGCIMGEMIKGG 223

>2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* Length = 276

 Score = 65.7 bits (161), Expect = 4e-12
 Identities = 51/206 (24%), Positives = 84/206 (40%), Gaps = 57/206 (27%)

Query: 321 LGQGGYGSVYKGK-LLDGSNVAVKVLNDSKGNGKEFIN----EVASISRTSHVNVVALL- 374
           LG G +G V  G+  L G  VAVK+LN  K    + +     E+ ++    H +++ L  
Sbjct: 19  LGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKLYQ 78

Query: 375 ----------------GFCL--------RVAEELSSTI--GIARGLEYLHLGCSTRILHF 408
                           G  L        RV E  +  +   I   ++Y H      ++H 
Sbjct: 79  VISTPTDFFMVMEYVSGGELFDYICKHGRVEEMEARRLFQQILSAVDYCH---RHMVVHR 135

Query: 409 DIKPHNILLDEDFCPKISDFGLAKICNRKESIISMTGAR------GTVGYIAPEVFCRNI 462
           D+KP N+LLD     KI+DFGL+ +         M+         G+  Y APEV     
Sbjct: 136 DLKPENVLLDAHMNAKIADFGLSNM---------MSDGEFLRTSCGSPNYAAPEVISGR- 185

Query: 463 GEVSY---KSDVYNYGMMIFEMTGGR 485
               Y   + D+++ G++++ +  G 
Sbjct: 186 ---LYAGPEVDIWSCGVILYALLCGT 208

>4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} Length = 396

 Score = 66.6 bits (163), Expect = 5e-12
 Identities = 33/101 (32%), Positives = 50/101 (49%), Gaps = 17/101 (16%)

Query: 390 IARGLEYLHLGCSTRILHFDIKPHNILLDEDFCPKISDFGLAKICNRKESIISMTGAR-- 447
           I+  L YLH      I++ D+K  N+LLD +   K++D+G+      KE +         
Sbjct: 162 ISLALNYLH---ERGIIYRDLKLDNVLLDSEGHIKLTDYGMC-----KEGLRPGDTTSTF 213

Query: 448 -GTVGYIAPEVFCRNIGEVSY-KS-DVYNYGMMIFEMTGGR 485
            GT  YIAPE+    +    Y  S D +  G+++FEM  GR
Sbjct: 214 CGTPNYIAPEI----LRGEDYGFSVDWWALGVLMFEMMAGR 250

>3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} Length = 353

 Score = 66.2 bits (162), Expect = 6e-12
 Identities = 33/96 (34%), Positives = 53/96 (55%), Gaps = 9/96 (9%)

Query: 390 IARGLEYLHLGCSTRILHFDIKPHNILLDEDFCPKISDFGLAKICNRKESIISMTGARGT 449
           + +GL+Y+H   S  ++H D+KP N+ ++ED   KI DFGLA+  +       MTG   T
Sbjct: 135 MLKGLKYIH---SAGVVHRDLKPGNLAVNEDCELKILDFGLARHADA-----EMTGYVVT 186

Query: 450 VGYIAPEVFCRNIGEVSYKSDVYNYGMMIFEMTGGR 485
             Y APEV   +    +   D+++ G ++ EM  G+
Sbjct: 187 RWYRAPEVIL-SWMHYNQTVDIWSVGCIMAEMLTGK 221

>3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} Length = 383

 Score = 66.3 bits (162), Expect = 6e-12
 Identities = 29/105 (27%), Positives = 46/105 (43%), Gaps = 24/105 (22%)

Query: 390 IARGLEYLHLGCSTRILHFDIKPHNILLDEDFCP-KISDFGLAKICNRKESIISMTGARG 448
           + R + ++H   S  I H DIKP N+L++      K+ DFG AK     E  ++      
Sbjct: 150 LFRAVGFIH---SLGICHRDIKPQNLLVNSKDNTLKLCDFGSAKKLIPSEPSVA------ 200

Query: 449 TVGYI------APEVFCRNIGEVSYKS--DVYNYGMMIFEMTGGR 485
              YI      APE+     G   Y    D+++ G +  E+  G+
Sbjct: 201 ---YICSRFYRAPELML---GATEYTPSIDLWSIGCVFGELILGK 239

>1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... Length = 350

 Score = 65.8 bits (161), Expect = 7e-12
 Identities = 51/235 (21%), Positives = 85/235 (36%), Gaps = 63/235 (26%)

Query: 291 ETFLRNYRSLSPKRYGYADIKKMTNSFKYKLGQGGYGSVYKGKLLDGSNV-AVKVLNDSK 349
           E FL+ + + S                   LG G +G V   K  +  N  A+K+L+   
Sbjct: 24  EDFLKKWETPSQNTAQLDQFD-----RIKTLGTGSFGRVMLVKHKESGNHYAMKILD--- 75

Query: 350 GNGKEFI---NEVASI-------SRTSHVNVVALLG-------------FC--------L 378
              K+ +    ++             +   +V L               +         L
Sbjct: 76  ---KQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHL 132

Query: 379 RVAEELSSTIG------IARGLEYLHLGCSTRILHFDIKPHNILLDEDFCPKISDFGLAK 432
           R     S          I    EYLH   S  +++ D+KP N+L+D+    +++DFG AK
Sbjct: 133 RRIGRFSEPHARFYAAQIVLTFEYLH---SLDLIYRDLKPENLLIDQQGYIQVTDFGFAK 189

Query: 433 ICNRKESIISMTGARGTVGYIAPEVFCRNIGEVSY-KS-DVYNYGMMIFEMTGGR 485
               +   +      GT   +APE+    I    Y K+ D +  G++I+EM  G 
Sbjct: 190 RVKGRTWTLC-----GTPEALAPEI----ILSKGYNKAVDWWALGVLIYEMAAGY 235

>4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* Length = 446

 Score = 66.3 bits (162), Expect = 7e-12
 Identities = 56/208 (26%), Positives = 84/208 (40%), Gaps = 60/208 (28%)

Query: 321 LGQGGYGSVYKGKLLDGSNV-AVKVLNDSKGNGKEFI---NEVASI-------SRTSHVN 369
           LG+G +G V   K        A+K+L       KE I   +EVA           + H  
Sbjct: 156 LGKGTFGKVILVKEKATGRYYAMKILK------KEVIVAKDEVAHTLTENRVLQNSRHPF 209

Query: 370 VVAL---------LGFCL----------------RVAEELSS--TIGIARGLEYLHLGCS 402
           + AL         L F +                  +E+ +      I   L+YLH   +
Sbjct: 210 LTALKYSFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRARFYGAEIVSALDYLHSEKN 269

Query: 403 TRILHFDIKPHNILLDEDFCPKISDFGLAKICNRKESIISMTGAR---GTVGYIAPEVFC 459
             +++ D+K  N++LD+D   KI+DFGL      KE I      +   GT  Y+APEV  
Sbjct: 270 --VVYRDLKLENLMLDKDGHIKITDFGLC-----KEGIKDGATMKTFCGTPEYLAPEVLE 322

Query: 460 RNIGEVSYKSDV--YNYGMMIFEMTGGR 485
            N     Y   V  +  G++++EM  GR
Sbjct: 323 DN----DYGRAVDWWGLGVVMYEMMCGR 346

>3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} Length = 362

 Score = 65.8 bits (161), Expect = 7e-12
 Identities = 45/211 (21%), Positives = 73/211 (34%), Gaps = 53/211 (25%)

Query: 320 KLGQGGYGSVYKGKLLDGSNVAVKVLNDSKGNGKE---FINEVASISRT----------S 366
            +  G YG+V  G   +G  VA+K + ++  +G+      +      R            
Sbjct: 29  FISSGSYGAVCAGVDSEGIPVAIKRVFNTVSDGRTVNILSDSFLCK-RVLREIRLLNHFH 87

Query: 367 HVNVVALL---------GFC-LRVAEELSST-----IG-----------------IARGL 394
           H N++ L              L +  EL  T     I                  I  GL
Sbjct: 88  HPNILGLRDIFVHFEEPAMHKLYLVTELMRTDLAQVIHDQRIVISPQHIQYFMYHILLGL 147

Query: 395 EYLHLGCSTRILHFDIKPHNILLDEDFCPKISDFGLAKICNRKESIISMTGARGTVGYIA 454
             LH      ++H D+ P NILL ++    I DF LA+         + T       Y A
Sbjct: 148 HVLH---EAGVVHRDLHPGNILLADNNDITICDFNLAREDTADA---NKTHYVTHRWYRA 201

Query: 455 PEVFCRNIGEVSYKSDVYNYGMMIFEMTGGR 485
           PE+        +   D+++ G ++ EM   +
Sbjct: 202 PELVM-QFKGFTKLVDMWSAGCVMAEMFNRK 231

>1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 Length = 367

 Score = 65.4 bits (160), Expect = 9e-12
 Identities = 34/96 (35%), Positives = 52/96 (54%), Gaps = 9/96 (9%)

Query: 390 IARGLEYLHLGCSTRILHFDIKPHNILLDEDFCPKISDFGLAKICNRKESIISMTGARGT 449
           + +GL Y+H   +  I+H D+KP N+ ++ED   KI DFGLA+  +       MTG   T
Sbjct: 137 MLKGLRYIH---AAGIIHRDLKPGNLAVNEDCELKILDFGLARQADS-----EMTGYVVT 188

Query: 450 VGYIAPEVFCRNIGEVSYKSDVYNYGMMIFEMTGGR 485
             Y APEV   N    +   D+++ G ++ EM  G+
Sbjct: 189 RWYRAPEVIL-NWMRYTQTVDIWSVGCIMAEMITGK 223

>3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} Length = 336

 Score = 65.0 bits (159), Expect = 1e-11
 Identities = 47/202 (23%), Positives = 80/202 (39%), Gaps = 50/202 (24%)

Query: 321 LGQGGYGSVYKGK-LLDGSNVAVKVLNDSKGNGKEFIN----EVASISRTSHVNVVAL-- 373
           LG+G +G V           VA+K ++       +       E++ +    H +++ L  
Sbjct: 17  LGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHPHIIKLYD 76

Query: 374 -------LGFCL---------------RVAEELSSTI--GIARGLEYLHLGCSTRILHFD 409
                  +   +               R+ E+        I   +EY H     +I+H D
Sbjct: 77  VITTPTDIVMVIEYAGGELFDYIVEKKRMTEDEGRRFFQQIICAIEYCH---RHKIVHRD 133

Query: 410 IKPHNILLDEDFCPKISDFGLAKICNRKESIISMTGAR------GTVGYIAPEVFCRNIG 463
           +KP N+LLD++   KI+DFGL+ I         MT         G+  Y APEV      
Sbjct: 134 LKPENLLLDDNLNVKIADFGLSNI---------MTDGNFLKTSCGSPNYAAPEVI-NGKL 183

Query: 464 EVSYKSDVYNYGMMIFEMTGGR 485
               + DV++ G++++ M  GR
Sbjct: 184 YAGPEVDVWSCGIVLYVMLVGR 205

>3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3o71_A 3r63_A 3c9w_A* 2y9q_A* 3sa0_A* 1wzy_A* 2e14_A* 1tvo_A* 2ojg_A* 2oji_A* ... Length = 364

 Score = 65.4 bits (160), Expect = 1e-11
 Identities = 49/199 (24%), Positives = 82/199 (41%), Gaps = 38/199 (19%)

Query: 321 LGQGGYGSVYKGK-LLDGSNVAVKVLN--DSKGNGKEFINEVASISRTSHVNVVALLGFC 377
           +G+G YG V      L+   VA+K ++  + +   +  + E+  + R  H N++ +    
Sbjct: 35  IGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDII 94

Query: 378 LRVAEE---------------LSSTIG---------------IARGLEYLHLGCSTRILH 407
                E               L   +                I RGL+Y+H   S  +LH
Sbjct: 95  RAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLKYIH---SANVLH 151

Query: 408 FDIKPHNILLDEDFCPKISDFGLAKIC-NRKESIISMTGARGTVGYIAPEVFCRNIGEVS 466
            D+KP N+LL+     KI DFGLA++     +    +T    T  Y APE+   N    +
Sbjct: 152 RDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIML-NSKGYT 210

Query: 467 YKSDVYNYGMMIFEMTGGR 485
              D+++ G ++ EM   R
Sbjct: 211 KSIDIWSVGCILAEMLSNR 229

>3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A Length = 674

 Score = 66.2 bits (161), Expect = 1e-11
 Identities = 36/101 (35%), Positives = 55/101 (54%), Gaps = 17/101 (16%)

Query: 390 IARGLEYLHLGCSTRILHFDIKPHNILLDEDFCPKISDFGLAKICNRKESIISMTGAR-- 447
           IA GL +L    S  I++ D+K  N++LD +   KI+DFG+      KE+I      +  
Sbjct: 451 IAIGLFFLQ---SKGIIYRDLKLDNVMLDSEGHIKIADFGMC-----KENIWDGVTTKTF 502

Query: 448 -GTVGYIAPEVFCRNIGEVSY-KS-DVYNYGMMIFEMTGGR 485
            GT  YIAPE+    I    Y KS D + +G++++EM  G+
Sbjct: 503 CGTPDYIAPEI----IAYQPYGKSVDWWAFGVLLYEMLAGQ 539

>2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} Length = 476

 Score = 65.6 bits (160), Expect = 1e-11
 Identities = 48/180 (26%), Positives = 71/180 (39%), Gaps = 58/180 (32%)

Query: 321 LGQGGYGSVYKGK-LLDGSNVAVKVLNDSKGNGKEFIN----EVASISRTSHVNVVALLG 375
           LG G +G V  GK  L G  VAVK+LN  K    + +     E+ ++    H +++ L  
Sbjct: 24  LGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHIIKLY- 82

Query: 376 FCLRVAE---------------ELSSTI--------GIAR--------GLEYLHLGCSTR 404
              +V                 EL   I          +R        G++Y H      
Sbjct: 83  ---QVISTPSDIFMVMEYVSGGELFDYICKNGRLDEKESRRLFQQILSGVDYCH---RHM 136

Query: 405 ILHFDIKPHNILLDEDFCPKISDFGLAKICNRKESIISMTGAR------GTVGYIAPEVF 458
           ++H D+KP N+LLD     KI+DFGL+ +         M+         G+  Y APEV 
Sbjct: 137 VVHRDLKPENVLLDAHMNAKIADFGLSNM---------MSDGEFLRTSCGSPNYAAPEVI 187

>2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... Length = 367

 Score = 64.7 bits (158), Expect = 2e-11
 Identities = 36/96 (37%), Positives = 52/96 (54%), Gaps = 9/96 (9%)

Query: 390 IARGLEYLHLGCSTRILHFDIKPHNILLDEDFCPKISDFGLAKICNRKESIISMTGARGT 449
           I RGL+Y+H   S  I+H D+KP N+ ++ED   KI DFGLA+          MTG   T
Sbjct: 141 ILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLARHTAD-----EMTGYVAT 192

Query: 450 VGYIAPEVFCRNIGEVSYKSDVYNYGMMIFEMTGGR 485
             Y APE+   N    +   D+++ G ++ E+  GR
Sbjct: 193 RWYRAPEIML-NWMHYNQTVDIWSVGCIMAELLTGR 227

>2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} Length = 320

 Score = 64.2 bits (157), Expect = 2e-11
 Identities = 27/98 (27%), Positives = 48/98 (48%), Gaps = 6/98 (6%)

Query: 390 IARGLEYLHLGCSTRILHFDIKPHNILLDEDFCP-KISDFGLAK-ICNRKESIISMTGAR 447
           + RGL+Y+H   S  +LH D+KP N+ ++ +    KI DFGLA+ +         ++   
Sbjct: 129 LLRGLKYIH---SANVLHRDLKPANLFINTEDLVLKIGDFGLARIMDPHYSHKGHLSEGL 185

Query: 448 GTVGYIAPEVFCRNIGEVSYKSDVYNYGMMIFEMTGGR 485
            T  Y +P +   +    +   D++  G +  EM  G+
Sbjct: 186 VTKWYRSPRLLL-SPNNYTKAIDMWAAGCIFAEMLTGK 222

>1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 Length = 355

 Score = 64.2 bits (157), Expect = 2e-11
 Identities = 29/96 (30%), Positives = 49/96 (51%), Gaps = 4/96 (4%)

Query: 390 IARGLEYLHLGCSTRILHFDIKPHNILLDEDFCPKISDFGLAKICNRKESIISMTGARGT 449
           I   LE+LH      I++ DIK  NILLD +    ++DFGL+K     E+  +     GT
Sbjct: 168 IVLALEHLH---KLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFVADETERAYDFC-GT 223

Query: 450 VGYIAPEVFCRNIGEVSYKSDVYNYGMMIFEMTGGR 485
           + Y+AP++            D ++ G++++E+  G 
Sbjct: 224 IEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGA 259

>1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 Length = 318

 Score = 63.7 bits (156), Expect = 3e-11
 Identities = 40/98 (40%), Positives = 55/98 (56%), Gaps = 14/98 (14%)

Query: 390 IARGLEYLHLGCSTRILHFDIKPHNILLDEDFCPKISDFGLAKICNRKESIISMTGARGT 449
           +   LEYLH   S  I++ D+KP NILLD++   KI+DFG AK         + T   GT
Sbjct: 115 VCLALEYLH---SKDIIYRDLKPENILLDKNGHIKITDFGFAKYVPDV----TYT-LCGT 166

Query: 450 VGYIAPEVFCRNIGEVSY-KS-DVYNYGMMIFEMTGGR 485
             YIAPEV    +    Y KS D +++G++I+EM  G 
Sbjct: 167 PDYIAPEV----VSTKPYNKSIDWWSFGILIYEMLAGY 200

>3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* Length = 464

 Score = 63.7 bits (155), Expect = 4e-11
 Identities = 34/98 (34%), Positives = 51/98 (52%), Gaps = 12/98 (12%)

Query: 390 IARGLEYLHLGCSTRILHFDIKPHNILLDEDFCPKISDFGLAKICNRKESIISMTGARGT 449
           +  G+++LH   S  I+H D+KP NI++  D   KI DFGLA+      +   MT    T
Sbjct: 173 MLCGIKHLH---SAGIIHRDLKPSNIVVKSDCTLKILDFGLARTA---GTSFMMTPYVVT 226

Query: 450 VGYIAPEVFCRNIGEVSYKS--DVYNYGMMIFEMTGGR 485
             Y APEV    I  + YK   D+++ G ++ EM   +
Sbjct: 227 RYYRAPEV----ILGMGYKENVDIWSVGCIMGEMVRHK 260

>3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* Length = 299

 Score = 61.9 bits (151), Expect = 8e-11
 Identities = 40/155 (25%), Positives = 55/155 (35%), Gaps = 47/155 (30%)

Query: 317 FKYKLGQGGYGSVYKGK-LLDGSNVAVKVLNDSKGNGKEFINEVASISRTS-HVNVVALL 374
               LG G  G V +          A+K+L D      +   EV    R S   ++V ++
Sbjct: 22  TSQVLGLGINGKVLQIFNKRTQEKFALKMLQDCP----KARREVELHWRASQCPHIVRIV 77

Query: 375 GFC----------LRVAE-----ELSSTIGIARG-------------------LEYLHLG 400
                        L V E     EL S I   RG                   ++YLH  
Sbjct: 78  DVYENLYAGRKCLLIVMECLDGGELFSRI-QDRGDQAFTEREASEIMKSIGEAIQYLH-- 134

Query: 401 CSTRILHFDIKPHNILL---DEDFCPKISDFGLAK 432
            S  I H D+KP N+L      +   K++DFG AK
Sbjct: 135 -SINIAHRDVKPENLLYTSKRPNAILKLTDFGFAK 168

>3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} Length = 458

 Score = 62.5 bits (152), Expect = 1e-10
 Identities = 39/147 (26%), Positives = 62/147 (42%), Gaps = 38/147 (25%)

Query: 320 KLGQGGYGSVYKGK-LLDGSNVAVKVLND---SKGNGKEFINEVASISRTSHVNVVALL- 374
            +G G YG V +    L+   VA+K +        + K  + E+A ++R +H +VV +L 
Sbjct: 60  LIGTGSYGHVCEAYDKLEKRVVAIKKILRVFEDLIDCKRILREIAILNRLNHDHVVKVLD 119

Query: 375 --------GF----------------CLRVAEELSS------TIGIARGLEYLHLGCSTR 404
                    F                  R    L+          +  G++Y+H   S  
Sbjct: 120 IVIPKDVEKFDELYVVLEIADSDFKKLFRTPVYLTELHIKTLLYNLLVGVKYVH---SAG 176

Query: 405 ILHFDIKPHNILLDEDFCPKISDFGLA 431
           ILH D+KP N L+++D   K+ DFGLA
Sbjct: 177 ILHRDLKPANCLVNQDCSVKVCDFGLA 203

>1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A Length = 373

 Score = 60.5 bits (147), Expect = 5e-10
 Identities = 51/217 (23%), Positives = 91/217 (41%), Gaps = 64/217 (29%)

Query: 320 KLGQGGYGSVYKGK-LLDGSNVAVKVLNDSKGNGKEFINEV--------ASISRTSHV-- 368
           KLG G + +V+  K +++ ++VA+K++   K   +   +E+        A  ++   +  
Sbjct: 26  KLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVYTEAAEDEIKLLQRVNDADNTKEDSMGA 85

Query: 369 -NVVALLGF-----------CLRVAEELSSTI------------------GIAR----GL 394
            +++ LL              + V E L   +                   I++    GL
Sbjct: 86  NHILKLLDHFNHKGPNGVHVVM-VFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLLGL 144

Query: 395 EYLHLGCSTRILHFDIKPHNILLDEDFCP------KISDFGLAKICNRKESIISMTGARG 448
           +Y+H  C   I+H DIKP N+L++    P      KI+D G A  C   E   +    R 
Sbjct: 145 DYMHRRC--GIIHTDIKPENVLMEIVDSPENLIQIKIADLGNA--CWYDEHYTNSIQTR- 199

Query: 449 TVGYIAPEVFCRNIG-EVSYKSDVYNYGMMIFEM-TG 483
              Y +PEV    +G      +D+++   +IFE+ TG
Sbjct: 200 --EYRSPEVL---LGAPWGCGADIWSTACLIFELITG 231

>2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* Length = 353

 Score = 60.0 bits (146), Expect = 5e-10
 Identities = 47/207 (22%), Positives = 77/207 (37%), Gaps = 45/207 (21%)

Query: 320 KLGQGGYGSVYKGK-LLDGSNVAVKVLN--DSKGNGKEFINEVASISRTSHVNVVALLGF 376
            LG+G YG V        G  VA+K +   D        + E+  +    H N++ +   
Sbjct: 18  LLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRTLREIKILKHFKHENIITIFNI 77

Query: 377 CLRVAEE---------------LSSTIG---------------IARGLEYLHLGCSTRIL 406
               + E               L   I                  R ++ LH    + ++
Sbjct: 78  QRPDSFENFNEVYIIQELMQTDLHRVISTQMLSDDHIQYFIYQTLRAVKVLH---GSNVI 134

Query: 407 HFDIKPHNILLDEDFCPKISDFGLAKICNRKESIIS--------MTGARGTVGYIAPEVF 458
           H D+KP N+L++ +   K+ DFGLA+I +   +  S        M     T  Y APEV 
Sbjct: 135 HRDLKPSNLLINSNCDLKVCDFGLARIIDESAADNSEPTGQQSGMVEFVATRWYRAPEVM 194

Query: 459 CRNIGEVSYKSDVYNYGMMIFEMTGGR 485
                + S   DV++ G ++ E+   R
Sbjct: 195 L-TSAKYSRAMDVWSCGCILAELFLRR 220

>3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* Length = 432

 Score = 57.8 bits (140), Expect = 4e-09
 Identities = 34/147 (23%), Positives = 56/147 (38%), Gaps = 38/147 (25%)

Query: 320 KLGQGGYGSVYKGK-LLDGSNVAVKVLND---SKGNGKEFINEVASISRTSHVNVVALL- 374
            +G+G YG VY         NVA+K +N       + K  + E+  ++R     ++ L  
Sbjct: 33  LIGRGSYGYVYLAYDKNTEKNVAIKKVNRMFEDLIDCKRILREITILNRLKSDYIIRLYD 92

Query: 375 --------GF----------------CLRVAEELSS------TIGIARGLEYLHLGCSTR 404
                    F                  +    L+          +  G  ++H    + 
Sbjct: 93  LIIPDDLLKFDELYIVLEIADSDLKKLFKTPIFLTEEHIKTILYNLLLGENFIH---ESG 149

Query: 405 ILHFDIKPHNILLDEDFCPKISDFGLA 431
           I+H D+KP N LL++D   K+ DFGLA
Sbjct: 150 IIHRDLKPANCLLNQDCSVKVCDFGLA 176

>1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* Length = 397

 Score = 56.8 bits (137), Expect = 6e-09
 Identities = 50/256 (19%), Positives = 81/256 (31%), Gaps = 99/256 (38%)

Query: 320 KLGQGGYGSVYKGK-LLDGSNVAVKVLNDSKGNGKEFINEVA-----SISRTSHVN---- 369
           KLG G + +V+    +     VA+KV+  ++   +  ++E+        S  +  N    
Sbjct: 44  KLGWGHFSTVWLSWDIQGKKFVAMKVVKSAEHYTETALDEIRLLKSVRNSDPNDPNREMV 103

Query: 370 -------------------VVALLGFCLRVAEELSSTIGI------------ARGLEYLH 398
                              V  +LG  L      S+  G+             +GL+YLH
Sbjct: 104 VQLLDDFKISGVNGTHICMVFEVLGHHLLKWIIKSNYQGLPLPCVKKIIQQVLQGLDYLH 163

Query: 399 LGCSTRILHFDIKPHNILL----------------------------------------- 417
             C  RI+H DIKP NILL                                         
Sbjct: 164 TKC--RIIHTDIKPENILLSVNEQYIRRLAAEATEWQRSGAPPPSGSAVSTAPATAGNFL 221

Query: 418 --------DEDFCPKISDFGLAKICNRKESIISMTGARGTVGYIAPEVFCRNIGEVSYKS 469
                    E    KI+D G A   ++  +    T       Y + EV   +    +  +
Sbjct: 222 VNPLEPKNAEKLKVKIADLGNACWVHKHFTEDIQT-----RQYRSLEVLIGS--GYNTPA 274

Query: 470 DVYNYGMMIFEMTGGR 485
           D+++   M FE+  G 
Sbjct: 275 DIWSTACMAFELATGD 290

>3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} Length = 388

 Score = 56.2 bits (136), Expect = 1e-08
 Identities = 26/115 (22%), Positives = 50/115 (43%), Gaps = 23/115 (20%)

Query: 390 IARGLEYLHLGCSTRILHFDIKPHNILLDEDFCPKISDFGLAKICNRKESIISMTGARGT 449
           + + ++YLH   S  +LH D+KP NILL+ +   K++DFGL++       + +       
Sbjct: 118 LIKVIKYLH---SGGLLHRDMKPSNILLNAECHVKVADFGLSRSFVNIRRVTNNIPLSIN 174

Query: 450 VG-------------------YIAPEVFCRNIGEVSYKSDVYNYGMMIFEMTGGR 485
                                Y APE+      + +   D+++ G ++ E+  G+
Sbjct: 175 ENTENFDDDQPILTDYVATRWYRAPEILL-GSTKYTKGIDMWSLGCILGEILCGK 228

>2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* Length = 330

 Score = 48.9 bits (117), Expect = 2e-06
 Identities = 38/152 (25%), Positives = 57/152 (37%), Gaps = 48/152 (31%)

Query: 320 KLGQGGYGSVYKGK-LLDGSNVAVKVL-NDSKG-------------NGKEFINEVASISR 364
           K+G G +G +  GK L     VA+K+    S+                 + I +V     
Sbjct: 16  KIGCGNFGELRLGKNLYTNEYVAIKLEPMKSRAPQLHLEYRFYKQLGSGDGIPQVYYFGP 75

Query: 365 TSHVNVVA--LLG--------FC---------LRVAEELSSTIGIARGLEYLHLGCSTRI 405
               N +   LLG         C         L +A +L     I+R +EY+H   S  +
Sbjct: 76  CGKYNAMVLELLGPSLEDLFDLCDRTFSLKTVLMIAIQL-----ISR-MEYVH---SKNL 126

Query: 406 LHFDIKPHNILLDEDFCPK-----ISDFGLAK 432
           ++ D+KP N L+            I DF LAK
Sbjct: 127 IYRDVKPENFLIGRPGNKTQQVIHIIDFALAK 158

>3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* Length = 429

 Score = 49.0 bits (117), Expect = 2e-06
 Identities = 46/203 (22%), Positives = 80/203 (39%), Gaps = 52/203 (25%)

Query: 321 LGQGGYGSVYKGK-LLDGSNVAVKVLNDSKGNGKEFINEVASISR------TSHVNVVAL 373
           +G+G +G V K        +VA+K++ + K   ++   E+  +         + +NV+ +
Sbjct: 105 IGKGSFGQVVKAYDHKVHQHVALKMVRNEKRFHRQAAEEIRILEHLRKQDKDNTMNVIHM 164

Query: 374 LGF-------CLRVAEELSS----------------------TIGIARGLEYLHLGCSTR 404
           L         C+   E LS                          I + L+ LH     R
Sbjct: 165 LENFTFRNHICM-TFELLSMNLYELIKKNKFQGFSLPLVRKFAHSILQCLDALH---KNR 220

Query: 405 ILHFDIKPHNILLDEDFCP--KISDFGLAKICNRKES-IISMTGARGTVGYIAPEVFCRN 461
           I+H D+KP NILL +      K+ DFG +   +++    I       +  Y APEV    
Sbjct: 221 IIHCDLKPENILLKQQGRSGIKVIDFGSSCYEHQRVYTYIQ------SRFYRAPEVILG- 273

Query: 462 IGEVSYKSDVYNYGMMIFEM-TG 483
                   D+++ G ++ E+ TG
Sbjct: 274 -ARYGMPIDMWSLGCILAELLTG 295

>1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221

 Score = 49.1 bits (116), Expect = 3e-06
 Identities = 59/374 (15%), Positives = 109/374 (29%), Gaps = 130/374 (34%)

Query: 48  FTDPKHPECGLMAVDNCIEPVQRIRLGKAGPFYN---ILNIAQDVSITLEDQVFQNHLNE 104
                +  C L+ + N    VQ  +   A  F     IL   +   +T  D +       
Sbjct: 238 LKSKPYENC-LLVLLN----VQNAKAWNA--FNLSCKILLTTRFKQVT--DFLSAATTTH 288

Query: 105 RSCESF-ENLT------------------LPTSAS------LSFRIKSNLSLFRCTDKLD 139
            S +     LT                  LP          LS  I  ++     T   D
Sbjct: 289 ISLDHHSMTLTPDEVKSLLLKYLDCRPQDLPREVLTTNPRRLSI-IAESIRDGLAT--WD 345

Query: 140 N----NFISFNSTCNSSSFIYYNH--PDD------DLPSILPPN--------CSL----- 174
           N    N     +   SS     N   P +       L S+ PP+          +     
Sbjct: 346 NWKHVNCDKLTTIIESS----LNVLEPAEYRKMFDRL-SVFPPSAHIPTILLSLIWFDVI 400

Query: 175 ---IQLPVNKTRKSG----DLFNMLTSVFSLQVE----------VHRVCYECRWRGGQCQ 217
              + + VNK  K             S+ S+ +E          +HR   +         
Sbjct: 401 KSDVMVVVNKLHKYSLVEKQPKESTISIPSIYLELKVKLENEYALHRSIVDH-------- 452

Query: 218 SDSEGNFQCAETRECNDCLKKR---------GRCHIDDKGNFQCKIEWTGASAFAIGILI 268
                 +   +T + +D +            G  H+ +  +              +  ++
Sbjct: 453 ------YNIPKTFDSDDLIPPYLDQYFYSHIGH-HLKNIEH---------PERMTLFRMV 496

Query: 269 FIAFYF-KRKL----SSYNSTASCLNIETFLRNYRS-LSPKRYGYADIKKMTNSFKYKLG 322
           F+ F F ++K+    +++N++ S LN    L+ Y+  +      Y  +      F  K+ 
Sbjct: 497 FLDFRFLEQKIRHDSTAWNASGSILNTLQQLKFYKPYICDNDPKYERLVNAILDFLPKIE 556

Query: 323 QGGYGSVYKGKLLD 336
           +    ++   K  D
Sbjct: 557 E----NLICSKYTD 566

>2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} Length = 345

 Score = 47.4 bits (113), Expect = 5e-06
 Identities = 28/161 (17%), Positives = 52/161 (32%), Gaps = 51/161 (31%)

Query: 320 KLGQGGYGSVYKGK-LLDGSNVAVKVLN-DSKGN--------------GKEFINEVASIS 363
           K+G GG+G +Y           A  V+  + + N               K+ I +     
Sbjct: 44  KIGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPLFSELKFYQRVAKKDCIKKWIERK 103

Query: 364 RTSHVNVVALLGFCLRVAEE--------------------------LSSTIGIA----RG 393
           +  ++ +    G  L   +                            S+ + +       
Sbjct: 104 QLDYLGIPLFYGSGLTEFKGRSYRFMVMERLGIDLQKISGQNGTFKKSTVLQLGIRMLDV 163

Query: 394 LEYLHLGCSTRILHFDIKPHNILLDEDFCPKI--SDFGLAK 432
           LEY+H       +H DIK  N+LL      ++  +D+GL+ 
Sbjct: 164 LEYIH---ENEYVHGDIKAANLLLGYKNPDQVYLADYGLSY 201

>1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* Length = 298

 Score = 47.0 bits (112), Expect = 7e-06
 Identities = 33/152 (21%), Positives = 57/152 (37%), Gaps = 48/152 (31%)

Query: 320 KLGQGGYGSVYKGK-LLDGSNVAVKV-LNDSKG-------------NGKEFINEVASISR 364
           ++G+G +G +++G  LL+   VA+K     S                G   I  V    +
Sbjct: 17  RIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSDAPQLRDEYRTYKLLAGCTGIPNVYYFGQ 76

Query: 365 TSHVNVVA--LLG--------FC---------LRVAEELSSTIGIARGLEYLHLGCSTRI 405
               NV+   LLG         C            A+++     +AR ++ +H      +
Sbjct: 77  EGLHNVLVIDLLGPSLEDLLDLCGRKFSVKTVAMAAKQM-----LAR-VQSIH---EKSL 127

Query: 406 LHFDIKPHNILLDEDFCPK-----ISDFGLAK 432
           ++ DIKP N L+            + DFG+ K
Sbjct: 128 VYRDIKPDNFLIGRPNSKNANMIYVVDFGMVK 159

>3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A Length = 364

 Score = 46.7 bits (111), Expect = 9e-06
 Identities = 27/170 (15%), Positives = 50/170 (29%), Gaps = 66/170 (38%)

Query: 320 KLGQGGYGSVYKGKLLDGSNVAVKVLNDSK------------------GNGKEFINEVAS 361
            +GQGG+G +Y   +    +V        K                      E I +   
Sbjct: 42  PIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQIQKWIR 101

Query: 362 ISRTSHVN--------------------VVALLG--------FC---------LRVAEEL 384
             +  ++                     ++   G                   L+++  +
Sbjct: 102 TRKLKYLGVPKYWGSGLHDKNGKSYRFMIMDRFGSDLQKIYEANAKRFSRKTVLQLSLRI 161

Query: 385 SSTIGIARGLEYLHLGCSTRILHFDIKPHNILLDEDFCPKI--SDFGLAK 432
                +   LEY+H       +H DIK  N+LL+     ++   D+GLA 
Sbjct: 162 -----LDI-LEYIH---EHEYVHGDIKASNLLLNYKNPDQVYLVDYGLAY 202

>3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A Length = 296

 Score = 45.1 bits (107), Expect = 3e-05
 Identities = 41/150 (27%), Positives = 60/150 (40%), Gaps = 46/150 (30%)

Query: 320 KLGQGGYGSVYKGK-LLDGSNVAVKV-LNDSKG-------------NGKEFINEVASISR 364
           K+G G +G +Y G  +  G  VA+K+    +K               G   I  +     
Sbjct: 16  KIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKHPQLHIESKIYKMMQGGVGIPTIRWCGA 75

Query: 365 TSHVNVVA--LLG--------FC---------LRVAEELSSTIGIARGLEYLHLGCSTRI 405
               NV+   LLG        FC         L +A+++     I+R +EY+H   S   
Sbjct: 76  EGDYNVMVMELLGPSLEDLFNFCSRKFSLKTVLLLADQM-----ISR-IEYIH---SKNF 126

Query: 406 LHFDIKPHNILLDEDFCPK---ISDFGLAK 432
           +H D+KP N L+          I DFGLAK
Sbjct: 127 IHRDVKPDNFLMGLGKKGNLVYIIDFGLAK 156

>2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* Length = 382

 Score = 44.3 bits (105), Expect = 6e-05
 Identities = 51/209 (24%), Positives = 76/209 (36%), Gaps = 60/209 (28%)

Query: 320 KLGQGGYGSVYKGK-LLDGSNVAVKVLNDSKGNGKEF----INEVASISR------TSHV 368
            +G+G +G V K    ++   VA+K++     N K F      EV  +            
Sbjct: 61  LIGKGSFGQVVKAYDRVEQEWVAIKIIK----NKKAFLNQAQIEVRLLELMNKHDTEMKY 116

Query: 369 NVVALLGF-------CLRVAEELSS----------------------TIGIARGLEYLHL 399
            +V L          CL V E LS                          +   L +L  
Sbjct: 117 YIVHLKRHFMFRNHLCL-VFEMLSYNLYDLLRNTNFRGVSLNLTRKFAQQMCTALLFLAT 175

Query: 400 GCSTRILHFDIKPHNILLDEDFCP--KISDFGLAKICNRKESIISMTGARGTVGYIAPEV 457
                I+H D+KP NILL        KI DFG +  C   + I     +R    Y +PEV
Sbjct: 176 P-ELSIIHCDLKPENILLCNPKRSAIKIVDFGSS--CQLGQRIYQYIQSR---FYRSPEV 229

Query: 458 FCRNIGEVSY--KSDVYNYGMMIFEM-TG 483
               +  + Y    D+++ G ++ EM TG
Sbjct: 230 ----LLGMPYDLAIDMWSLGCILVEMHTG 254

>2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} Length = 352

 Score = 43.6 bits (103), Expect = 9e-05
 Identities = 22/167 (13%), Positives = 48/167 (28%), Gaps = 60/167 (35%)

Query: 320 KLGQGGYGSVYKGK---------LLDGSNVAVKVLNDSKGNGKEF--------------I 356
              +   G +Y+                  ++K+      +G+ F              +
Sbjct: 49  FQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKL---DAKDGRLFNEQNFFQRAAKPLQV 105

Query: 357 NEVASISRTSHVN-----------------VVALLG--------FCLRVAEELSSTIGIA 391
           N+   +  T  +                  V+  LG           +      S + +A
Sbjct: 106 NKWKKLYSTPLLAIPTCMGFGVHQDKYRFLVLPSLGRSLQSALDVSPKHVLSERSVLQVA 165

Query: 392 ----RGLEYLHLGCSTRILHFDIKPHNILLDEDFCPKI--SDFGLAK 432
                 LE+LH       +H ++   NI +D +   ++  + +G A 
Sbjct: 166 CRLLDALEFLH---ENEYVHGNVTAENIFVDPEDQSQVTLAGYGFAF 209

>3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} Length = 483

 Score = 41.9 bits (98), Expect = 3e-04
 Identities = 42/150 (28%), Positives = 58/150 (38%), Gaps = 46/150 (30%)

Query: 320 KLGQGGYGSVYKGK-LLDGSNVAVKV-LNDSKG-------------NGKEFINEVASISR 364
           K+G G +G +Y G  +     VA+K+    +K               G   I  V     
Sbjct: 14  KIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQLLYESKIYRILQGGTGIPNVRWFGV 73

Query: 365 TSHVNVVA--LLG--------FC---------LRVAEELSSTIGIARGLEYLHLGCSTRI 405
               NV+   LLG        FC         L +A+++     I R +E++H   S   
Sbjct: 74  EGDYNVLVMDLLGPSLEDLFNFCSRKLSLKTVLMLADQM-----INR-VEFVH---SKSF 124

Query: 406 LHFDIKPHNILLDEDFCPK---ISDFGLAK 432
           LH DIKP N L+          I DFGLAK
Sbjct: 125 LHRDIKPDNFLMGLGRRANQVYIIDFGLAK 154

Structure Templates Detected by HHsearch

Original result of HHsearch against PDB70 database

ID	Length	Definition	Probability
Query	506
4gt4_A	308	Tyrosine-protein kinase transmembrane receptor RO;	100.0
3omv_A	307	RAF proto-oncogene serine/threonine-protein kinas;	100.0
4asz_A	299	BDNF/NT-3 growth factors receptor; transferase, TR	100.0
4aoj_A	329	High affinity nerve growth factor receptor; transf	100.0
4aw0_A	311	HPDK1, 3-phosphoinositide-dependent protein kinase	100.0
4fih_A	346	Serine/threonine-protein kinase PAK 4; kinase doma	100.0
3fpq_A	290	Serine/threonine-protein kinase WNK1; protein seri	100.0
4b9d_A	350	Serine/threonine-protein kinase NEK1; transferase,	100.0
3hyh_A	275	Carbon catabolite-derepressing protein kinase; kin	100.0
4g3f_A	336	NF-kappa-beta-inducing kinase; non-RD kinase, prot	100.0
4fie_A	423	Serine/threonine-protein kinase PAK 4; kinase doma	100.0
3ubd_A	304	Ribosomal protein S6 kinase alpha-3; kinase-inhibi	100.0
3hmm_A	303	TGF-beta receptor type-1; ALK5, kinase, inhibitor,	100.0
4ase_A	353	Vascular endothelial growth factor receptor 2; tra	100.0
4g31_A	299	Eukaryotic translation initiation factor 2-alpha;	100.0
4b99_A	398	Mitogen-activated protein kinase 7; transferase, i	100.0
4f9c_A	361	Cell division cycle 7-related protein kinase; Ser/	100.0
3v5w_A	689	G-protein coupled receptor kinase 2; inhibitor com	100.0
3uto_A	573	Twitchin; kinase, muscle sarcomere, transferase; H	100.0
4aw2_A	437	Serine/threonine-protein kinase MRCK alpha; transf	100.0
3niz_A	311	Rhodanese family protein; structural genomics, str	100.0
2c30_A	321	Serine/threonine-protein kinase PAK 6; CRIB domain	100.0
3fe3_A	328	MAP/microtubule affinity-regulating kinase 3; seri	100.0
3v8s_A	410	RHO-associated protein kinase 1; dimerization, myo	100.0
3fxz_A	297	Serine/threonine-protein kinase PAK 1; transferase	99.98
1o6l_A	337	RAC-beta serine/threonine protein kinase; protein	99.98
3soc_A	322	Activin receptor type-2A; structural genomics cons	99.98
3zgw_A	347	Maternal embryonic leucine zipper kinase; transfer	99.98
1ob3_A	288	PFPK5, cell division control protein 2 homolog; tr	99.98
2qkw_B	321	Protein kinase; three-helix bundle motif, AVRPTO-P	99.98
2nru_A	307	Interleukin-1 receptor-associated kinase 4; inhibi	99.98
4fr4_A	384	YANK1, serine/threonine-protein kinase 32A; struct	99.98
3tki_A	323	Serine/threonine-protein kinase CHK1; cell checkpo	99.98
2pmi_A	317	Negative RE, cyclin-dependent protein kinase PHO85	99.98
3txo_A	353	PKC-L, NPKC-ETA, protein kinase C ETA type; phosph	99.98
3o0g_A	292	Cell division protein kinase 5; kinase activator c	99.98
1fot_A	318	TPK1 delta, CAMP-dependent protein kinase type 1;	99.98
3uim_A	326	Brassinosteroid insensitive 1-associated receptor;	99.98
2vd5_A	412	DMPK protein; serine/threonine-protein kinase, kin	99.98
3sxs_A	268	Cytoplasmic tyrosine-protein kinase BMX; transfera	99.98
2yab_A	361	Death-associated protein kinase 2; apoptosis, tran	99.97
3h4j_B	336	AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin	99.97
2psq_A	370	Fibroblast growth factor receptor 2; kinase domain	99.97
1qcf_A	454	Haematopoetic cell kinase (HCK); tyrosine kinase-i	99.97
3p86_A	309	Serine/threonine-protein kinase CTR1; ETR1, ERS1,	99.97
4dc2_A	396	Protein kinase C IOTA type; kinase, substrate, cel	99.97
3ttj_A	464	Mitogen-activated protein kinase 10; JNK3, protein	99.97
3oz6_A	388	Mitogen-activated protein kinase 1, serine/threon	99.97
1j1b_A	420	Glycogen synthase kinase-3 beta; complex, TAU, AMP	99.97
1xjd_A	345	Protein kinase C, theta type; PKC-theta, ATP, AMP,	99.97
2zv2_A	298	Calcium/calmodulin-dependent protein kinase kinas;	99.97
1tki_A	321	Titin; serine kinase, muscle, autoinhibition; 2.00	99.97
4hcu_A	269	Tyrosine-protein kinase ITK/TSK; transferase-trans	99.97
3g33_A	308	Cell division protein kinase 4; Ser/Thr protein ki	99.97
4eqm_A	294	Protein kinase; transferase; HET: ANP; 3.00A {Stap	99.97
3a62_A	327	Ribosomal protein S6 kinase beta-1; kinase domain,	99.97
3e7e_A	365	HBUB1, BUB1A, mitotic checkpoint serine/threonine-	99.97
2y0a_A	326	Death-associated protein kinase 1; transferase, ca	99.97
3poz_A	327	Epidermal growth factor receptor; kinase domain, a	99.97
2bdw_A	362	Hypothetical protein K11E8.1D; kinase, calmodulin	99.97
3lb7_A	307	RAF proto-oncogene serine/threonine-protein kinas;	99.97
1rdq_E	350	PKA C-alpha, CAMP-dependent protein kinase, alpha-	99.97
3gen_A	283	Tyrosine-protein kinase BTK; bruton'S tyrosine kin	99.97
3s95_A	310	LIMK-1, LIM domain kinase 1; structural genomics,	99.97
4euu_A	319	Serine/threonine-protein kinase TBK1; ATP binding,	99.97
3kex_A	325	Receptor tyrosine-protein kinase ERBB-3; kinase do	99.97
2i0e_A	353	Protein kinase C-beta II; serine/threonine protein	99.97
2izr_A	330	Casein kinase I isoform gamma-3; serine/threonine-	99.97
3rp9_A	458	Mitogen-activated protein kinase; structural genom	99.97
4f0f_A	287	Serine/threonine-protein kinase ROCO4; LRRK2, ATP-	99.97
3a8x_A	345	Protein kinase C IOTA type; transferase; HET: TPO;	99.97
3cbl_A	377	C-FES, proto-oncogene tyrosine-protein kinase FES/	99.97
3soa_A	444	Calcium/calmodulin-dependent protein kinase type a	99.97
1u5q_A	348	Serine/threonine protein kinase TAO2; transferase;	99.97
3uc3_A	361	Serine/threonine-protein kinase SRK2I; SNRK2, ABA	99.97
1opk_A	495	P150, C-ABL, proto-oncogene tyrosine-protein kinas	99.97
4e7w_A	394	Glycogen synthase kinase 3; GSK3, PTyr195, transfe	99.97
1cm8_A	367	Phosphorylated MAP kinase P38-gamma; phosphorylati	99.97
3kul_A	325	Ephrin type-A receptor 8; ATP-binding, kinase, nuc	99.97
3mi9_A	351	Cell division protein kinase 9; P-TEFB, HIV-1, pro	99.97
1fmk_A	452	C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros	99.97
2x4f_A	373	Myosin light chain kinase family member 4; LUNG, b	99.97
3ork_A	311	Serine/threonine protein kinase; structural genomi	99.97
3dbq_A	343	Dual specificity protein kinase TTK; MPS1 structur	99.97
3p1a_A	311	MYT1 kinase, membrane-associated tyrosine- and thr	99.97
1qpc_A	279	LCK kinase; alpha beta fold, transferase; HET: PTR	99.97
3c0i_A	351	Peripheral plasma membrane protein CASK; neurexin,	99.97
3llt_A	360	Serine/threonine kinase-1, pflammer; lammer kinase	99.97
2zmd_A	390	Dual specificity protein kinase TTK; MPS1, T686A,	99.97
3qd2_B	332	Eukaryotic translation initiation factor 2-alpha;	99.97
2acx_A	576	G protein-coupled receptor kinase 6; GRK, G transf	99.97
1k9a_A	450	Carboxyl-terminal SRC kinase; COOH-terminal SRC ki	99.97
3dls_A	335	PAS domain-containing serine/threonine-protein KI;	99.97
2r5t_A	373	Serine/threonine-protein kinase SGK1; AGC protein	99.97
3rgf_A	405	Cyclin-dependent kinase 8; protein kinase complex,	99.97
3op5_A	364	Serine/threonine-protein kinase VRK1; adenosine tr	99.97
3mtl_A	324	Cell division protein kinase 16; pctaire1, indirub	99.97
3og7_A	289	AKAP9-BRAF fusion protein; proto-oncogene, V600E,	99.97
2fst_X	367	Mitogen-activated protein kinase 14; active mutant	99.97
4ejn_A	446	RAC-alpha serine/threonine-protein kinase; AKT1, a	99.97
3c4z_A	543	Rhodopsin kinase; Ser/Thr kinase, RGS homology dom	99.97
3gni_B	389	Strad alpha; kinase fold, pseudokinase, alpha heli	99.97
3n9x_A	432	Phosphotransferase; malaria kinase, structural gen	99.97
4agu_A	311	Cyclin-dependent kinase-like 1; transferase, phosp	99.97
1vzo_A	355	Ribosomal protein S6 kinase alpha 5; protein kinas	99.97
2eue_A	275	Carbon catabolite derepressing protein kinase; kin	99.97
1ua2_A	346	CAK, cell division protein kinase 7; cell cycle, p	99.97
3qyz_A	364	Mitogen-activated protein kinase 1; transferase, s	99.97
2w4o_A	349	Calcium/calmodulin-dependent protein kinase type I	99.97
3eb0_A	383	Putative uncharacterized protein; kinase cryptospo	99.97
2y94_A	476	5'-AMP-activated protein kinase catalytic subunit;	99.97
3qup_A	323	Tyrosine-protein kinase receptor TYRO3; protein ki	99.97
3l9p_A	367	Anaplastic lymphoma kinase; kinase domain, ATP-bin	99.97
3pfq_A	674	PKC-B, PKC-beta, protein kinase C beta type; phosp	99.97
3lzb_A	327	Epidermal growth factor receptor; epidermal growth	99.97
3f3z_A	277	Calcium/calmodulin-dependent protein kinase with d	99.97
3t9t_A	267	Tyrosine-protein kinase ITK/TSK; kinase domain, al	99.97
1kob_A	387	Twitchin; kinase, intrasteric regulation; 2.30A {A	99.97
2yex_A	276	Serine/threonine-protein kinase CHK1; transferase,	99.97
2xrw_A	371	Mitogen-activated protein kinase 8; transcription,	99.97
3i6u_A	419	CDS1, serine/threonine-protein kinase CHK2; Ser/Th	99.97
2h8h_A	535	Proto-oncogene tyrosine-protein kinase SRC; SRC ki	99.97
3kfa_A	288	Tyrosine-protein kinase ABL1; CML, drug resistance	99.97
2a2a_A	321	Death-associated protein kinase 2; autoinhibition,	99.97
3hko_A	345	Calcium/calmodulin-dependent protein kinase with d	99.97
3kn6_A	325	Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1	99.97
2qol_A	373	Ephrin receptor; receptor tyrosine kinase, juxtame	99.97
1csn_A	298	Casein kinase-1; phosphotransferase; HET: ATP; 2.0	99.97
1mp8_A	281	Focal adhesion kinase 1; tyrosine protein kinase,	99.97
3kvw_A	429	DYRK2, dual specificity tyrosine-phosphorylation-r	99.97
3pg1_A	362	Mitogen-activated protein kinase, putative (MAP K	99.97
3ugc_A	295	Tyrosine-protein kinase JAK2; small molecule inhib	99.97
3tt0_A	382	Basic fibroblast growth factor receptor 1; kinase	99.97
3gbz_A	329	Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-	99.97
4aaa_A	331	Cyclin-dependent kinase-like 2; transferase, phosp	99.97
3q4u_A	301	Activin receptor type-1; structural genomics conso	99.97
2ivs_A	314	Proto-oncogene tyrosine-protein kinase receptor RE	99.97
3e3p_A	360	Protein kinase, putative glycogen synthase kinase;	99.97
3kk8_A	284	Calcium/calmodulin dependent protein kinase II; AT	99.97
3vhe_A	359	Vascular endothelial growth factor receptor 2; kin	99.97
1wak_A	397	Serine/threonine-protein kinase SPRK1; SRPK, trans	99.97
2wtk_C	305	Serine/threonine-protein kinase 11; transferase-me	99.97
3is5_A	285	Calcium-dependent protein kinase; CDPK, structural	99.97
3nsz_A	330	CK II alpha, casein kinase II subunit alpha; inhib	99.97
4exu_A	371	Mitogen-activated protein kinase 13; P38 kinase, t	99.97
2eva_A	307	TAK1 kinase - TAB1 chimera fusion protein; transfe	99.97
1luf_A	343	Muscle-specific tyrosine kinase receptor MUSK; pho	99.97
1rjb_A	344	FL cytokine receptor; kinase, structure, autoinhib	99.97
3bhy_A	283	Death-associated protein kinase 3; death associate	99.97
3dtc_A	271	Mitogen-activated protein kinase kinase kinase 9;	99.97
3c1x_A	373	Hepatocyte growth factor receptor; receptor tyrosi	99.97
1t46_A	313	HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom	99.97
2i1m_A	333	Macrophage colony-stimulating factor 1 receptor; k	99.97
3fdn_A	279	Serine/threonine-protein kinase 6; aurora kinase i	99.97
4eut_A	396	Serine/threonine-protein kinase TBK1; ATP binding,	99.97
1t4h_A	290	Serine/threonine-protein kinase WNK1; protein seri	99.97
2rku_A	294	Serine/threonine-protein kinase PLK1; structure of	99.97
3mwu_A	486	Calmodulin-domain protein kinase 1; serine/threoni	99.97
1u59_A	287	Tyrosine-protein kinase ZAP-70; transferase; HET:	99.97
2b9h_A	353	MAP kinase FUS3, mitogen-activated protein kinase	99.97
2ozo_A	613	Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t	99.97
1nxk_A	400	MAP kinase-activated protein kinase 2; MK2, phosph	99.97
2r3i_A	299	Cell division protein kinase 2; serine/threonine-p	99.97
3cok_A	278	Serine/threonine-protein kinase PLK4; POLO-like ki	99.97
2qr7_A	342	Ribosomal protein S6 kinase alpha-3; kinase domain	99.97
2owb_A	335	Serine/threonine-protein kinase PLK1; catalytic do	99.97
2vgo_A	284	Serine/threonine-protein kinase 12-A; nucleotide-b	99.97
3nyv_A	484	Calmodulin-domain protein kinase 1; serine/threoni	99.97
3brb_A	313	Proto-oncogene tyrosine-protein kinase MER; ATP-bi	99.97
2pvf_A	334	Fibroblast growth factor receptor 2; kinase domain	99.97
2ycf_A	322	Serine/threonine-protein kinase CHK2; transferase,	99.97
3lij_A	494	Calcium/calmodulin dependent protein kinase with A	99.97
3cc6_A	281	Protein tyrosine kinase 2 beta; focal adhesion kin	99.97
2y7j_A	365	Phosphorylase B kinase gamma catalytic chain, test	99.97
3coi_A	353	Mitogen-activated protein kinase 13; P38D, P38delt	99.97
3q5i_A	504	Protein kinase; CDPK, malaria, phosphotransferase,	99.97
2v62_A	345	Serine/threonine-protein kinase VRK2; transferase,	99.97
3pls_A	298	Macrophage-stimulating protein receptor; protein k	99.97
3f66_A	298	Hepatocyte growth factor receptor; C-Met, protein	99.97
4fl3_A	635	Tyrosine-protein kinase SYK; transferase; HET: ANP	99.96
1p4o_A	322	Insulin-like growth factor I receptor protein; IGF	99.96
2ac3_A	316	MAP kinase-interacting serine/threonine kinase 2;	99.96
4e5w_A	302	Tyrosine-protein kinase JAK1; kinase domain, trans	99.96
1byg_A	278	CSK, protein (C-terminal SRC kinase); protein kina	99.96
4hgt_A	296	Casein kinase I isoform delta; CK1D, inhibitor, tr	99.96
3lm5_A	327	Serine/threonine-protein kinase 17B; STK17B, serin	99.96
2jam_A	304	Calcium/calmodulin-dependent protein kinase type 1	99.96
3com_A	314	Serine/threonine-protein kinase 4; MST1, STE20-lik	99.96
3g2f_A	336	Bone morphogenetic protein receptor type-2; kinase	99.96
3byv_A	377	Rhoptry kinase; malaria, transferase, structural g	99.96
2xir_A	316	Vascular endothelial growth factor receptor 2; ang	99.96
3a7i_A	303	MST3 kinase, serine/threonine kinase 24 (STE20 hom	99.96
2h34_A	309	Serine/threonine-protein kinase PKNE; apoenzyme, t	99.96
3mdy_A	337	Bone morphogenetic protein receptor type-1B; compl	99.96
3uzp_A	296	CKI-delta, CKID, casein kinase I isoform delta; CK	99.96
3q60_A	371	ROP5B; pseudokinase, transferase; HET: ATP; 1.72A	99.96
2clq_A	295	Mitogen-activated protein kinase kinase kinase 5;	99.96
1xbb_A	291	Tyrosine-protein kinase SYK; gleevec, STI-571, ima	99.96
1blx_A	326	Cyclin-dependent kinase 6; inhibitor protein, cycl	99.96
3kmu_A	271	ILK, integrin-linked kinase; cell adhesion, ANK re	99.96
2i6l_A	320	Mitogen-activated protein kinase 6; MAPK6, ERK3, e	99.96
3ll6_A	337	Cyclin G-associated kinase; transferase, protein k	99.96
2a19_B	284	Interferon-induced, double-stranded RNA-activated	99.96
1mqb_A	333	Ephrin type-A receptor 2; tyrosine protein kinase,	99.96
2x7f_A	326	TRAF2 and NCK-interacting protein kinase; serine/t	99.96
4fvq_A	289	Tyrosine-protein kinase JAK2; janus protein kinase	99.96
1z57_A	339	Dual specificity protein kinase CLK1; protein tyro	99.96
3fme_A	290	Dual specificity mitogen-activated protein kinase;	99.96
3eqc_A	360	Dual specificity mitogen-activated protein kinase;	99.96
2w5a_A	279	Serine/threonine-protein kinase NEK2; Ser/Thr prot	99.96
3lxp_A	318	Non-receptor tyrosine-protein kinase TYK2; JAK3, i	99.96
2h6d_A	276	5'-AMP-activated protein kinase catalytic subunit	99.96
3cek_A	313	Dual specificity protein kinase TTK; HMPS1, PYT, E	99.96
3an0_A	340	Dual specificity mitogen-activated protein kinase;	99.96
3lxl_A	327	Tyrosine-protein kinase JAK3; TYK2, inflammation,	99.96
2eu9_A	355	Dual specificity protein kinase CLK3; kinase domai	99.96
3sv0_A	483	Casein kinase I-like; typical kinase domain fold,	99.96
1u46_A	291	ACK-1, activated CDC42 kinase 1; tyrosine kinase,	99.96
2jii_A	352	Serine/threonine-protein kinase VRK3 molecule: VA	99.96
3a99_A	320	Proto-oncogene serine/threonine-protein kinase PI;	99.96
2vx3_A	382	Dual specificity tyrosine-phosphorylation- regula	99.96
1phk_A	298	Phosphorylase kinase; glycogen metabolism, transfe	99.96
2yfx_A	327	Tyrosine-protein kinase receptor; nucleotide-bindi	99.96
1q8y_A	373	SR protein kinase; transferase; HET: ADP ADE; 2.05	99.96
2wqm_A	310	Serine/threonine-protein kinase NEK7; ATP-binding,	99.96
1x8b_A	289	WEE1HU, WEE1-like protein kinase; cell cycle, tran	99.96
2j7t_A	302	Serine/threonine-protein kinase 10; transferase, A	99.96
2pml_X	348	PFPK7, Ser/Thr protein kinase; phosphorylati trans	99.96
2vwi_A	303	Serine/threonine-protein kinase OSR1; STE kinase,	99.96
1b6c_B	342	TGF-B superfamily receptor type I; complex (isomer	99.96
2wei_A	287	Calmodulin-domain protein kinase 1, putative; nucl	99.96
2w1i_A	326	JAK2; chromosomal rearrangement, nucleotide-bindin	99.96
2rio_A	434	Serine/threonine-protein kinase/endoribonuclease I	99.96
2buj_A	317	Serine/threonine-protein kinase 16; transferase, A	99.96
3aln_A	327	Dual specificity mitogen-activated protein kinase;	99.96
2iwi_A	312	Serine/threonine-protein kinase PIM-2; nucleotide-	99.96
1fvr_A	327	Tyrosine-protein kinase TIE-2; tyrosine kinase, tr	99.96
3p23_A	432	Serine/threonine-protein kinase/endoribonuclease;	99.96
2j0j_A	656	Focal adhesion kinase 1; cell migration, FERM, tra	99.96
2dyl_A	318	Dual specificity mitogen-activated protein kinase	99.96
3dzo_A	413	Rhoptry kinase domain; parasitic disease, transfer	99.96
2y4i_B	319	KSR2, HKSR2, kinase suppressor of RAS 2; transfera	99.96
1zy4_A	303	Serine/threonine-protein kinase GCN2; translation	99.96
3gxj_A	303	TGF-beta receptor type-1; ALK5, kinase, inhibitor,	99.95
3fhr_A	336	MAP kinase-activated protein kinase 3; kinase-inhi	99.95
3qa8_A	676	MGC80376 protein; kinase ubiquitin-like domain, ph	99.95
2pzi_A	681	Probable serine/threonine-protein kinase PKNG; ATP	99.95
2vuw_A	336	Serine/threonine-protein kinase haspin; cell cycle	99.94
3uqc_A	286	Probable conserved transmembrane protein; structur	99.94
3m2w_A	299	MAP kinase-activated protein kinase 2; small molec	99.93
4azs_A	569	Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15	99.88
3en9_A	540	Glycoprotease, O-sialoglycoprotein endopeptidase/p	99.85
1zar_A	282	RIO2 kinase; serine kinase, winged-helix, RIO doma	99.78
1zth_A	258	RIO1 serine protein kinase; ribosome biogenesis, r	99.62
4gyi_A	397	RIO2 kinase; protein kinase, ADP complex, phosphoa	99.4
3tm0_A	263	Aminoglycoside 3'-phosphotransferase; protein kina	98.6
1nd4_A	264	Aminoglycoside 3'-phosphotransferase; protein kina	98.55
3dxp_A	359	Putative acyl-COA dehydrogenase; protein kinase-li	98.35
3sg8_A	304	APH(2'')-ID; antibiotic resistance enzyme, transfe	98.17
3d1u_A	288	Putative fructosamine-3-kinase; YP_290396.1, struc	97.45
3r70_A	320	Aminoglycoside phosphotransferase; structural geno	97.34
3ovc_A	362	Hygromycin-B 4-O-kinase; aminoglycoside phosphotra	96.98
2olc_A	397	MTR kinase, methylthioribose kinase; kinase ADP-2H	96.89
3f7w_A	288	Putative fructosamine-3-kinase; YP_290396.1, struc	96.84
3tdw_A	306	Gentamicin resistance protein; kinase, phosphoryl	96.8
4gkh_A	272	Aminoglycoside 3'-phosphotransferase APHA1-IAB; py	96.72
3ats_A	357	Putative uncharacterized protein; hypothetical pro	96.19
3dxq_A	301	Choline/ethanolamine kinase family protein; NP_106	95.96
1nw1_A	429	Choline kinase (49.2 KD); phospholipid synthesis,	95.81
2qg7_A	458	Ethanolamine kinase PV091845; malaria, SGC, struct	95.76
3c5i_A	369	Choline kinase; choline, kinase, malaria, transfer	95.24
3feg_A	379	Choline/ethanolamine kinase; non-protein kinase, c	95.01
2ppq_A	322	HSK, HK, homoserine kinase; structural genomics, M	94.78
2l2t_A	44	Receptor tyrosine-protein kinase ERBB-4; transmemb	94.13
1zyl_A	328	Hypothetical protein YIHE; putative protein kinase	94.04
2ks1_B	44	Epidermal growth factor receptor; ERBB1, ERBB2, tr	94.04
3jr1_A	312	Putative fructosamine-3-kinase; YP_719053.1, struc	93.78
2q83_A	346	YTAA protein; 2635576, structural genomics, joint	93.69
2jwa_A	44	Receptor tyrosine-protein kinase ERBB-2; transmemb	92.56
2pyw_A	420	Uncharacterized protein; 5-methylthioribose kinase	91.32
3f2s_A	401	CK, chetk-alpha, choline kinase alpha; non-protein	91.14
3mes_A	424	Choline kinase; malaria, structural genomics, stru	90.41
2yle_A	229	Protein spire homolog 1; actin-binding protein, ac	89.49
3csv_A	333	Aminoglycoside phosphotransferase; YP_614837.1, ph	88.4
3cxl_A	463	N-chimerin; SH2, RHO-GAP, structural genomics cons	80.49
3i1a_A	339	Spectinomycin phosphotransferase; protein kinase,	80.29

>4gt4_A Tyrosine-protein kinase transmembrane receptor RO; ATP binding, phosphorylation, transferase; 2.41A {Homo sapiens} PDB: 3zzw_A

Probab=100.00  E-value=6e-43  Score=343.14  Aligned_cols=183  Identities=30%  Similarity=0.458  Sum_probs=152.0

Q ss_pred             HHHHHHhhhccccCccCceEEEEEEEc------CCCEEEEEEeccCC--CCchhhHHHHHHhhccCccceeEEEEEee--
Q 039231          309 DIKKMTNSFKYKLGQGGYGSVYKGKLL------DGSNVAVKVLNDSK--GNGKEFINEVASISRTSHVNVVALLGFCL--  378 (506)
Q Consensus       309 el~~~~~~~~~~ig~G~~g~V~~~~~~------~~~~vavK~l~~~~--~~~~~~~~E~~~l~~l~h~niv~l~g~~~--  378 (506)
                      |+...+..|.++||+|+||+||+|++.      +++.||||+++...  ...++|.+|+.++++++|||||+++|+|.  
T Consensus        22 ei~~~~~~~~~~lG~G~fG~Vykg~~~~~~~~~~~~~VAvK~l~~~~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~~  101 (308)
T 4gt4_A           22 EISLSAVRFMEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEAMLRARLQHPNVVCLLGVVTKD  101 (308)
T ss_dssp             BCCGGGEEEEEEEEECSSCEEEEEEEC-------CEEEEEEECCC-CCC-CHHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred             cCCHHHCeEeeEeccCCCcEEEEEEEcCCccCCCCeEEEEEEECcccChHHHHHHHHHHHHHHhCCCCCCCCcceEEEEC
Confidence            344445567889999999999999863      46789999997543  23478999999999999999999999982  


Q ss_pred             -----------------------------------------ccchhhhHHHHHHHHHHHHhhcCCCCeEecCcCCCcEEE
Q 039231          379 -----------------------------------------RVAEELSSTIGIARGLEYLHLGCSTRILHFDIKPHNILL  417 (506)
Q Consensus       379 -----------------------------------------~~~~~l~i~~~i~~gl~~LH~~~~~~ivH~dlkp~Nill  417 (506)
                                                               ++.+++.++.|||+||+|||   +++||||||||+||||
T Consensus       102 ~~~~lV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH---~~~iiHRDLK~~NILl  178 (308)
T 4gt4_A          102 QPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVAQIAAGMEYLS---SHHVVHKDLATRNVLV  178 (308)
T ss_dssp             SSCEEEEECCSSCBHHHHHHTTCSSCCCC-----CCEECCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEE
T ss_pred             CEEEEEEEcCCCCcHHHHHHhhCccccccccccccccccCCCHHHHHHHHHHHHHHHHHHH---hCCCCCCCccccceEE
Confidence                                                     12235679999999999999   8999999999999999


Q ss_pred             CCCCcEEEeecCCCccccCCCcceecccCCCCcccccccccccccCCCCccccHHHHHHHHHHHHc-CCCCCCCCCCCcc
Q 039231          418 DEDFCPKISDFGLAKICNRKESIISMTGARGTVGYIAPEVFCRNIGEVSYKSDVYNYGMMIFEMTG-GRKNVDVVDNGST  496 (506)
Q Consensus       418 ~~~~~~ki~dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~s~~~Dv~s~G~il~ellt-g~~pf~~~~~~~~  496 (506)
                      ++++.+||+|||+++.....+.........||+.|||||++.+.  .++.++|||||||+||||+| |+.||...+..+.
T Consensus       179 ~~~~~~Ki~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~--~~s~ksDVwSfGvvl~El~t~g~~Pf~~~~~~~~  256 (308)
T 4gt4_A          179 YDKLNVKISDLGLFREVYAADYYKLLGNSLLPIRWMAPEAIMYG--KFSIDSDIWSYGVVLWEVFSYGLQPYCGYSNQDV  256 (308)
T ss_dssp             CGGGCEEECCSCCBCGGGGGGCBCSSSSSCBCGGGCCHHHHHHC--CCCHHHHHHHHHHHHHHHHTTTCCTTTTCCHHHH
T ss_pred             CCCCCEEECCcccceeccCCCceeEecccccCCcccCHHHHhCC--CCCccchhhhHHHHHHHHHhCCCCCCCCCCHHHH
Confidence            99999999999999877655443334557899999999999654  89999999999999999998 8999987665443

>3omv_A RAF proto-oncogene serine/threonine-protein kinas; serine/threonine-protein kinase, transferase; HET: SM5; 4.00A {Homo sapiens}

Probab=100.00  E-value=4.4e-42  Score=335.74  Aligned_cols=176  Identities=34%  Similarity=0.617  Sum_probs=143.2

Q ss_pred             hhccccCccCceEEEEEEEcCCCEEEEEEeccCCCC---chhhHHHHHHhhccCccceeEEEEEe---------------
Q 039231          316 SFKYKLGQGGYGSVYKGKLLDGSNVAVKVLNDSKGN---GKEFINEVASISRTSHVNVVALLGFC---------------  377 (506)
Q Consensus       316 ~~~~~ig~G~~g~V~~~~~~~~~~vavK~l~~~~~~---~~~~~~E~~~l~~l~h~niv~l~g~~---------------  377 (506)
                      .+.++||+|+||+||+|++++  .||||+++.....   .++|.+|++++++++|||||+++|++               
T Consensus        39 ~l~~~iG~G~fG~Vy~~~~~~--~vAvK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~~~~~iVmEy~~gG  116 (307)
T 3omv_A           39 MLSTRIGSGSFGTVYKGKWHG--DVAVKILKVVDPTPEQFQAFRNEVAVLRKTRHVNILLFMGYMTKDNLAIVTQWCEGS  116 (307)
T ss_dssp             CEEEECCCCSSSEEEEEESSS--EEEEEECCCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSCEEEEECCSSC
T ss_pred             EEeeEEeeCCCcEEEEEEECC--cEEEEEEEecCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEECCeEEEEEEcCCCC
Confidence            456789999999999998743  6999999754332   36789999999999999999999988               


Q ss_pred             ------------eccchhhhHHHHHHHHHHHHhhcCCCCeEecCcCCCcEEECCCCcEEEeecCCCccccCCCcceeccc
Q 039231          378 ------------LRVAEELSSTIGIARGLEYLHLGCSTRILHFDIKPHNILLDEDFCPKISDFGLAKICNRKESIISMTG  445 (506)
Q Consensus       378 ------------~~~~~~l~i~~~i~~gl~~LH~~~~~~ivH~dlkp~Nill~~~~~~ki~dfg~a~~~~~~~~~~~~~~  445 (506)
                                  +++.+++.|+.||++||+|||   +++||||||||+||||++++.+||+|||+|+.............
T Consensus       117 sL~~~l~~~~~~l~~~~~~~i~~qia~gL~yLH---~~~IiHRDlKp~NILl~~~~~~Ki~DFGla~~~~~~~~~~~~~~  193 (307)
T 3omv_A          117 SLYKHLHVQETKFQMFQLIDIARQTAQGMDYLH---AKNIIHRDMKSNNIFLHEGLTVKIGDFGLATVKSRWSGSQQVEQ  193 (307)
T ss_dssp             BHHHHHHTSCCCCCHHHHHHHHHHHHHHHHHHH---HTTCBCSCCCSSSEEEETTEEEEECCCSSCBC------------
T ss_pred             CHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHH---HCCccCCccCHHHEEECCCCcEEEeeccCceecccCCcceeecc
Confidence                        344557889999999999999   89999999999999999999999999999987665443333456


Q ss_pred             CCCCcccccccccccc-cCCCCccccHHHHHHHHHHHHcCCCCCCCCCCCcc
Q 039231          446 ARGTVGYIAPEVFCRN-IGEVSYKSDVYNYGMMIFEMTGGRKNVDVVDNGST  496 (506)
Q Consensus       446 ~~gt~~y~aPE~l~~~-~~~~s~~~Dv~s~G~il~elltg~~pf~~~~~~~~  496 (506)
                      ..||+.|||||++... .+.++.++|||||||+||||+||+.||...++.+.
T Consensus       194 ~~GT~~ymAPE~l~~~~~~~y~~ksDVwS~Gvvl~Elltg~~Pf~~~~~~~~  245 (307)
T 3omv_A          194 PTGSVLWMAPEVIRMQDNNPFSFQSDVYSYGIVLYELMTGELPYSHINNRDQ  245 (307)
T ss_dssp             CCCCTTSCCHHHHHCCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHH
T ss_pred             cccCCCccCHHHhhccCCCCCCcHHHhHhHHHHHHHHHHCCCCCCCCChHHH
Confidence            7899999999998543 34689999999999999999999999987665443

>4asz_A BDNF/NT-3 growth factors receptor; transferase, TRKA, TRKB; 1.70A {Homo sapiens} PDB: 4at3_A* 4at4_A* 4at5_A* 3v5q_A*

Probab=100.00  E-value=4.5e-42  Score=335.49  Aligned_cols=179  Identities=26%  Similarity=0.436  Sum_probs=148.4

Q ss_pred             hhccccCccCceEEEEEEEc------CCCEEEEEEeccCCC-CchhhHHHHHHhhccCccceeEEEEEee----------
Q 039231          316 SFKYKLGQGGYGSVYKGKLL------DGSNVAVKVLNDSKG-NGKEFINEVASISRTSHVNVVALLGFCL----------  378 (506)
Q Consensus       316 ~~~~~ig~G~~g~V~~~~~~------~~~~vavK~l~~~~~-~~~~~~~E~~~l~~l~h~niv~l~g~~~----------  378 (506)
                      .+.++||+|+||+||+|++.      ++..||||+++.... ..++|.+|+++|++++|||||+++|++.          
T Consensus        16 ~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~~~~~~lV~E   95 (299)
T 4asz_A           16 VLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKFYGVCVEGDPLIMVFE   95 (299)
T ss_dssp             EEEEEEEC--CCCEEEEEECSCC----CEEEEEEEECSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSEEEEEE
T ss_pred             EEeeEEeeCCCcEEEEEEECCcccCCCCEEEEEEEeCCCChHHHHHHHHHHHHHHhCCCCCCccEEEEEeeCCEEEEEEE
Confidence            45678999999999999864      377899999976433 3467999999999999999999999982          


Q ss_pred             ------------------------------ccchhhhHHHHHHHHHHHHhhcCCCCeEecCcCCCcEEECCCCcEEEeec
Q 039231          379 ------------------------------RVAEELSSTIGIARGLEYLHLGCSTRILHFDIKPHNILLDEDFCPKISDF  428 (506)
Q Consensus       379 ------------------------------~~~~~l~i~~~i~~gl~~LH~~~~~~ivH~dlkp~Nill~~~~~~ki~df  428 (506)
                                                    ++.+++.++.||++||+|||   +++|+||||||+||||++++.+||+||
T Consensus        96 y~~~G~L~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH---~~~iiHRDlKp~NILl~~~~~~Ki~DF  172 (299)
T 4asz_A           96 YMKHGDLNKFLRAHGPDAVLMAEGNPPTELTQSQMLHIAQQIAAGMVYLA---SQHFVHRDLATRNCLVGENLLVKIGDF  172 (299)
T ss_dssp             CCTTCBHHHHHHHTSHHHHHC----CCCCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEECGGGCEEECCC
T ss_pred             cCCCCcHHHHHHhcCcccccccccCCCCCCCHHHHHHHHHHHHHHHHHHH---hCCcccCccCHhhEEECCCCcEEECCc
Confidence                                          23346779999999999999   899999999999999999999999999


Q ss_pred             CCCccccCCCcceecccCCCCcccccccccccccCCCCccccHHHHHHHHHHHHc-CCCCCCCCCCCcchhh
Q 039231          429 GLAKICNRKESIISMTGARGTVGYIAPEVFCRNIGEVSYKSDVYNYGMMIFEMTG-GRKNVDVVDNGSTALD  499 (506)
Q Consensus       429 g~a~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~s~~~Dv~s~G~il~ellt-g~~pf~~~~~~~~~~~  499 (506)
                      |+|+...............||+.|||||++.+.  .++.++|||||||+||||+| |+.||...+..+....
T Consensus       173 Gla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~--~~~~k~DVwS~Gvvl~Ellt~G~~Pf~~~~~~~~~~~  242 (299)
T 4asz_A          173 GMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYR--KFTTESDVWSLGVVLWEIFTYGKQPWYQLSNNEVIEC  242 (299)
T ss_dssp             SCHHHHTGGGCEEETTTEEECGGGCCHHHHHHC--CCCHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHH
T ss_pred             ccceecCCCCceeecCceecChhhcCHHHHcCC--CCCchhhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHH
Confidence            999877655443333445689999999999654  79999999999999999999 9999987765544333

>4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens}

Probab=100.00  E-value=1.3e-41  Score=336.73  Aligned_cols=178  Identities=23%  Similarity=0.437  Sum_probs=140.5

Q ss_pred             hhccccCccCceEEEEEEEc------CCCEEEEEEeccCCC-CchhhHHHHHHhhccCccceeEEEEEee----------
Q 039231          316 SFKYKLGQGGYGSVYKGKLL------DGSNVAVKVLNDSKG-NGKEFINEVASISRTSHVNVVALLGFCL----------  378 (506)
Q Consensus       316 ~~~~~ig~G~~g~V~~~~~~------~~~~vavK~l~~~~~-~~~~~~~E~~~l~~l~h~niv~l~g~~~----------  378 (506)
                      .+.++||+|+||.||+|+++      +++.||||+++.... ..++|.+|+++|++++|||||+++|+|.          
T Consensus        44 ~l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~~~~~~lV~E  123 (329)
T 4aoj_A           44 VLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIVRFFGVCTEGRPLLMVFE  123 (329)
T ss_dssp             EEEEEEEECSSEEEEEEEESSSCC---CEEEEEEEESCCSHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSEEEEEE
T ss_pred             EEEEEEccCCCcEEEEEEECCcccCCCCeEEEEEEECcCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEE
Confidence            34678999999999999874      378899999976433 3467999999999999999999999982          


Q ss_pred             --------------------------------ccchhhhHHHHHHHHHHHHhhcCCCCeEecCcCCCcEEECCCCcEEEe
Q 039231          379 --------------------------------RVAEELSSTIGIARGLEYLHLGCSTRILHFDIKPHNILLDEDFCPKIS  426 (506)
Q Consensus       379 --------------------------------~~~~~l~i~~~i~~gl~~LH~~~~~~ivH~dlkp~Nill~~~~~~ki~  426 (506)
                                                      ++.+++.++.||++||+|||   +++|+||||||+||||++++.+||+
T Consensus       124 y~~~G~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH---~~~iiHRDLKp~NILl~~~~~~Ki~  200 (329)
T 4aoj_A          124 YMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLA---GLHFVHRDLATRNCLVGQGLVVKIG  200 (329)
T ss_dssp             CCTTCBHHHHHHTSSCC-----------CCSCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEEETTTEEEEC
T ss_pred             cCCCCcHHHHHHhcCcccccccccccccCCCCCHHHHHHHHHHHHHHHHHHh---cCCeecccccHhhEEECCCCcEEEc
Confidence                                            22346789999999999999   8999999999999999999999999


Q ss_pred             ecCCCccccCCCcceecccCCCCcccccccccccccCCCCccccHHHHHHHHHHHHc-CCCCCCCCCCCcchh
Q 039231          427 DFGLAKICNRKESIISMTGARGTVGYIAPEVFCRNIGEVSYKSDVYNYGMMIFEMTG-GRKNVDVVDNGSTAL  498 (506)
Q Consensus       427 dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~s~~~Dv~s~G~il~ellt-g~~pf~~~~~~~~~~  498 (506)
                      |||+++...............||+.|||||++.+.  .++.++|||||||+||||+| |+.||......+...
T Consensus       201 DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~--~~~~~sDvwS~Gvvl~Ellt~G~~Pf~~~~~~~~~~  271 (329)
T 4aoj_A          201 DFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYR--KFTTESDVWSFGVVLWEIFTYGKQPWYQLSNTEAID  271 (329)
T ss_dssp             CCC----------------CCCCGGGCCHHHHTTC--CCCHHHHHHHHHHHHHHHHTTSCCTTCSSCHHHHHH
T ss_pred             ccccceeccCCCcceecCcccccccccChhhhcCC--CCCccccccchHHHHHHHHcCCCCCCCCCCHHHHHH
Confidence            99999977554443333456799999999999654  78999999999999999999 999998766544433

>4aw0_A HPDK1, 3-phosphoinositide-dependent protein kinase 1; transferase, allosteric regulation, allosteric site, phosphorylation, AGC protein kinase; HET: SEP ATP MJF; 1.43A {Homo sapiens} PDB: 3hrc_A* 3hrf_A* 4a06_A* 4a07_A* 3rcj_A* 4aw1_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* 1uu3_A* ...

Probab=100.00  E-value=2e-41  Score=330.45  Aligned_cols=178  Identities=28%  Similarity=0.419  Sum_probs=152.1

Q ss_pred             hhhccccCccCceEEEEEEEc-CCCEEEEEEeccC----CCCchhhHHHHHHhhccCccceeEEEEEe------------
Q 039231          315 NSFKYKLGQGGYGSVYKGKLL-DGSNVAVKVLNDS----KGNGKEFINEVASISRTSHVNVVALLGFC------------  377 (506)
Q Consensus       315 ~~~~~~ig~G~~g~V~~~~~~-~~~~vavK~l~~~----~~~~~~~~~E~~~l~~l~h~niv~l~g~~------------  377 (506)
                      +.+.++||+|+||+||+|+.. +|+.||||++.+.    ....+.+.+|+++|++++|||||++++++            
T Consensus        34 y~i~~~lG~G~fg~V~~a~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~yivmEy  113 (311)
T 4aw0_A           34 FKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGLSY  113 (311)
T ss_dssp             EEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEECC
T ss_pred             cEEEEEEecccCeEEEEEEECCCCCEEEEEEEEHHHCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEEec
Confidence            455678999999999999975 5899999999642    33457799999999999999999999887            


Q ss_pred             ---------------eccchhhhHHHHHHHHHHHHhhcCCCCeEecCcCCCcEEECCCCcEEEeecCCCccccCCCccee
Q 039231          378 ---------------LRVAEELSSTIGIARGLEYLHLGCSTRILHFDIKPHNILLDEDFCPKISDFGLAKICNRKESIIS  442 (506)
Q Consensus       378 ---------------~~~~~~l~i~~~i~~gl~~LH~~~~~~ivH~dlkp~Nill~~~~~~ki~dfg~a~~~~~~~~~~~  442 (506)
                                     +++.+...++.||+.||+|||   +++|+||||||+|||+++++.+||+|||+|+.+........
T Consensus       114 ~~gG~L~~~i~~~~~l~e~~~~~~~~qi~~al~ylH---~~~IiHRDlKPeNILl~~~g~vKl~DFGla~~~~~~~~~~~  190 (311)
T 4aw0_A          114 AKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLH---GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQAR  190 (311)
T ss_dssp             CTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECTTSCEEECCCTTCEECCTTTTCCC
T ss_pred             CCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHH---HCCCccCCCCHHHeEEcCCCCEEEEEcCCceecCCCCCccc
Confidence                           334456779999999999999   89999999999999999999999999999998765444333


Q ss_pred             cccCCCCcccccccccccccCCCCccccHHHHHHHHHHHHcCCCCCCCCCCCcch
Q 039231          443 MTGARGTVGYIAPEVFCRNIGEVSYKSDVYNYGMMIFEMTGGRKNVDVVDNGSTA  497 (506)
Q Consensus       443 ~~~~~gt~~y~aPE~l~~~~~~~s~~~Dv~s~G~il~elltg~~pf~~~~~~~~~  497 (506)
                      .....||+.|||||++.+.  .++.++||||+||+||||++|+.||...+..+..
T Consensus       191 ~~~~~GTp~YmAPEvl~~~--~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~~~  243 (311)
T 4aw0_A          191 ANSFVGTAQYVSPELLTEK--SACKSSDLWALGCIIYQLVAGLPPFRAGNEGLIF  243 (311)
T ss_dssp             BCCCCSCGGGCCHHHHHHS--CBCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHH
T ss_pred             ccCcccCcccCCHHHHcCC--CCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHH
Confidence            4567899999999999664  7899999999999999999999999876544433

>4fih_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP; 1.97A {Homo sapiens} PDB: 4fig_A* 4fif_A* 4fii_A* 4fij_A*

Probab=100.00  E-value=6.1e-41  Score=331.88  Aligned_cols=171  Identities=26%  Similarity=0.365  Sum_probs=147.8

Q ss_pred             ccccCccCceEEEEEEEc-CCCEEEEEEeccC-CCCchhhHHHHHHhhccCccceeEEEEEe------------------
Q 039231          318 KYKLGQGGYGSVYKGKLL-DGSNVAVKVLNDS-KGNGKEFINEVASISRTSHVNVVALLGFC------------------  377 (506)
Q Consensus       318 ~~~ig~G~~g~V~~~~~~-~~~~vavK~l~~~-~~~~~~~~~E~~~l~~l~h~niv~l~g~~------------------  377 (506)
                      .++||+|+||+||+|+.. +|+.||||+++.. ....+.+.+|+++|++++|||||++++++                  
T Consensus        79 ~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~ivmEy~~gg~L  158 (346)
T 4fih_A           79 FIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLEGGAL  158 (346)
T ss_dssp             EEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCSSGGGGHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEECCCTTEEH
T ss_pred             eEEeecCcCeEEEEEEECCCCCEEEEEEEecCchhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEeCCCCCcH
Confidence            467999999999999985 5899999999654 33446789999999999999999999987                  


Q ss_pred             --------eccchhhhHHHHHHHHHHHHhhcCCCCeEecCcCCCcEEECCCCcEEEeecCCCccccCCCcceecccCCCC
Q 039231          378 --------LRVAEELSSTIGIARGLEYLHLGCSTRILHFDIKPHNILLDEDFCPKISDFGLAKICNRKESIISMTGARGT  449 (506)
Q Consensus       378 --------~~~~~~l~i~~~i~~gl~~LH~~~~~~ivH~dlkp~Nill~~~~~~ki~dfg~a~~~~~~~~~~~~~~~~gt  449 (506)
                              +++.+...++.||+.||+|||   +++|+||||||+||||++++.+||+|||+|+........  .....||
T Consensus       159 ~~~l~~~~l~e~~~~~~~~qi~~aL~ylH---~~~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~~~~--~~~~~GT  233 (346)
T 4fih_A          159 TDIVTHTRMNEEQIAAVCLAVLQALSVLH---AQGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPR--RKSLVGT  233 (346)
T ss_dssp             HHHHHHSCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTTCCEEECCCTTCEECCSSSCC--BCCCCSC
T ss_pred             HHHHHcCCCCHHHHHHHHHHHHHHHHHHH---HCCcccccCCHHHEEECCCCCEEEecCcCceecCCCCCc--ccccccC
Confidence                    344457789999999999999   899999999999999999999999999999977654332  3567899


Q ss_pred             cccccccccccccCCCCccccHHHHHHHHHHHHcCCCCCCCCCCCc
Q 039231          450 VGYIAPEVFCRNIGEVSYKSDVYNYGMMIFEMTGGRKNVDVVDNGS  495 (506)
Q Consensus       450 ~~y~aPE~l~~~~~~~s~~~Dv~s~G~il~elltg~~pf~~~~~~~  495 (506)
                      +.|||||++.+.  .++.++|||||||++|||++|+.||...+..+
T Consensus       234 p~YmAPEvl~~~--~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~  277 (346)
T 4fih_A          234 PYWMAPELISRL--PYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLK  277 (346)
T ss_dssp             GGGCCHHHHTTC--CBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHH
T ss_pred             cCcCCHHHHCCC--CCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHH
Confidence            999999999654  78999999999999999999999998655433

>3fpq_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase, ATP-BIND kinase, nucleotide-binding, phosphoprotein; 1.80A {Rattus norvegicus}

Probab=100.00  E-value=1.4e-40  Score=322.78  Aligned_cols=169  Identities=28%  Similarity=0.420  Sum_probs=141.6

Q ss_pred             hhccccCccCceEEEEEEEc-CCCEEEEEEeccCCC---CchhhHHHHHHhhccCccceeEEEEEee-------------
Q 039231          316 SFKYKLGQGGYGSVYKGKLL-DGSNVAVKVLNDSKG---NGKEFINEVASISRTSHVNVVALLGFCL-------------  378 (506)
Q Consensus       316 ~~~~~ig~G~~g~V~~~~~~-~~~~vavK~l~~~~~---~~~~~~~E~~~l~~l~h~niv~l~g~~~-------------  378 (506)
                      .|.++||+|+||+||+|++. ++..||+|++.....   ..+.+.+|+++|++++|||||++++++.             
T Consensus        29 ~~~~~iG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~~lvm  108 (290)
T 3fpq_A           29 KFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLVT  108 (290)
T ss_dssp             EEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEEETTEEEEEEEE
T ss_pred             EeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEeeccCCCcEEEEEE
Confidence            35667999999999999985 488999999975432   2356899999999999999999998752             


Q ss_pred             ------------------ccchhhhHHHHHHHHHHHHhhcCCCC--eEecCcCCCcEEEC-CCCcEEEeecCCCccccCC
Q 039231          379 ------------------RVAEELSSTIGIARGLEYLHLGCSTR--ILHFDIKPHNILLD-EDFCPKISDFGLAKICNRK  437 (506)
Q Consensus       379 ------------------~~~~~l~i~~~i~~gl~~LH~~~~~~--ivH~dlkp~Nill~-~~~~~ki~dfg~a~~~~~~  437 (506)
                                        ++.+...++.||+.||+|||   +++  |+||||||+||||+ .++.+||+|||+|+.....
T Consensus       109 Ey~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~ylH---~~~~~IiHRDlKp~NILl~~~~g~vKl~DFGla~~~~~~  185 (290)
T 3fpq_A          109 ELMTSGTLKTYLKRFKVMKIKVLRSWCRQILKGLQFLH---TRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRAS  185 (290)
T ss_dssp             ECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHH---TSSSCCCCCCCCGGGEEESSTTSCEEECCTTGGGGCCTT
T ss_pred             eCCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH---HCCCCEEecccChhheeEECCCCCEEEEeCcCCEeCCCC
Confidence                              23335678999999999999   777  99999999999997 4789999999999865433


Q ss_pred             CcceecccCCCCcccccccccccccCCCCccccHHHHHHHHHHHHcCCCCCCCCCCC
Q 039231          438 ESIISMTGARGTVGYIAPEVFCRNIGEVSYKSDVYNYGMMIFEMTGGRKNVDVVDNG  494 (506)
Q Consensus       438 ~~~~~~~~~~gt~~y~aPE~l~~~~~~~s~~~Dv~s~G~il~elltg~~pf~~~~~~  494 (506)
                      .    .....||+.|||||++.   +.++.++|||||||+||||+||+.||....+.
T Consensus       186 ~----~~~~~GTp~YmAPE~~~---~~y~~~~DiwSlGvilyelltg~~Pf~~~~~~  235 (290)
T 3fpq_A          186 F----AKAVIGTPEFMAPEMYE---EKYDESVDVYAFGMCMLEMATSEYPYSECQNA  235 (290)
T ss_dssp             S----BEESCSSCCCCCGGGGG---TCCCTHHHHHHHHHHHHHHHHSSCTTTTCSSH
T ss_pred             c----cCCcccCccccCHHHcC---CCCCcHHHHHHHHHHHHHHHHCCCCCCCCCcH
Confidence            2    24568999999999984   36899999999999999999999999765443

>4b9d_A Serine/threonine-protein kinase NEK1; transferase, inhibitor; HET: CK7; 1.90A {Homo sapiens} PDB: 4apc_A*

Probab=100.00  E-value=6.3e-41  Score=332.30  Aligned_cols=177  Identities=27%  Similarity=0.385  Sum_probs=142.2

Q ss_pred             hhccccCccCceEEEEEEEc-CCCEEEEEEeccCCCC---chhhHHHHHHhhccCccceeEEEEEee-------------
Q 039231          316 SFKYKLGQGGYGSVYKGKLL-DGSNVAVKVLNDSKGN---GKEFINEVASISRTSHVNVVALLGFCL-------------  378 (506)
Q Consensus       316 ~~~~~ig~G~~g~V~~~~~~-~~~~vavK~l~~~~~~---~~~~~~E~~~l~~l~h~niv~l~g~~~-------------  378 (506)
                      .+.++||+|+||+||+|+.. +|+.||||+++.....   .+.+.+|+++|++++|||||++++++.             
T Consensus        27 ~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~yiVmEy~~  106 (350)
T 4b9d_A           27 VRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLANMKHPNIVQYRESFEENGSLYIVMDYCE  106 (350)
T ss_dssp             EEEEEC------CEEEEEETTTCCEEEEEEEECTTSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECCT
T ss_pred             EEeEEEecCCCeEEEEEEECCCCCEEEEEEEehHHCCHHHHHHHHHHHHHHHHCCCCCCCcEEEEEEECCEEEEEEeCCC
Confidence            34568999999999999975 5899999999765432   357889999999999999999999871             


Q ss_pred             ----------------ccchhhhHHHHHHHHHHHHhhcCCCCeEecCcCCCcEEECCCCcEEEeecCCCccccCCCccee
Q 039231          379 ----------------RVAEELSSTIGIARGLEYLHLGCSTRILHFDIKPHNILLDEDFCPKISDFGLAKICNRKESIIS  442 (506)
Q Consensus       379 ----------------~~~~~l~i~~~i~~gl~~LH~~~~~~ivH~dlkp~Nill~~~~~~ki~dfg~a~~~~~~~~~~~  442 (506)
                                      ++.+.+.++.||+.||+|||   +++|+||||||+||||++++.+||+|||+|+........  
T Consensus       107 gg~L~~~i~~~~~~~~~e~~~~~~~~qi~~aL~ylH---~~~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~~~~--  181 (350)
T 4b9d_A          107 GGDLFKRINAQKGVLFQEDQILDWFVQICLALKHVH---DRKILHRDIKSQNIFLTKDGTVQLGDFGIARVLNSTVEL--  181 (350)
T ss_dssp             TCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHH---HTTCEETTCCGGGEEECTTCCEEECSTTEESCCCHHHHH--
T ss_pred             CCcHHHHHHHcCCCCCCHHHHHHHHHHHHHHHHHHH---HCCeeeccCCHHHEEECCCCCEEEcccccceeecCCccc--
Confidence                            23346678999999999999   899999999999999999999999999999876543211  


Q ss_pred             cccCCCCcccccccccccccCCCCccccHHHHHHHHHHHHcCCCCCCCCCCCcchhh
Q 039231          443 MTGARGTVGYIAPEVFCRNIGEVSYKSDVYNYGMMIFEMTGGRKNVDVVDNGSTALD  499 (506)
Q Consensus       443 ~~~~~gt~~y~aPE~l~~~~~~~s~~~Dv~s~G~il~elltg~~pf~~~~~~~~~~~  499 (506)
                      .....||+.|||||++.+.  .++.++|||||||+||||++|+.||...+..+....
T Consensus       182 ~~~~~GT~~YmAPE~l~~~--~y~~~~DiwSlGvilyemltG~~PF~~~~~~~~~~~  236 (350)
T 4b9d_A          182 ARACIGTPYYLSPEICENK--PYNNKSDIWALGCVLYELCTLKHAFEAGSMKNLVLK  236 (350)
T ss_dssp             HHHHHSCCTTCCHHHHTTC--CCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHH
T ss_pred             ccccCCCccccCHHHHCCC--CCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHH
Confidence            2346799999999999664  789999999999999999999999987655444333

>3hyh_A Carbon catabolite-derepressing protein kinase; kinase domain, transferase, ATP-binding, carbohydrate metabo kinase, membrane; 2.20A {Saccharomyces cerevisiae} PDB: 3dae_A 2fh9_A 3mn3_A

Probab=100.00  E-value=2.4e-40  Score=318.40  Aligned_cols=172  Identities=27%  Similarity=0.414  Sum_probs=133.6

Q ss_pred             hhhccccCccCceEEEEEEEc-CCCEEEEEEeccCC----CCchhhHHHHHHhhccCccceeEEEEEe------------
Q 039231          315 NSFKYKLGQGGYGSVYKGKLL-DGSNVAVKVLNDSK----GNGKEFINEVASISRTSHVNVVALLGFC------------  377 (506)
Q Consensus       315 ~~~~~~ig~G~~g~V~~~~~~-~~~~vavK~l~~~~----~~~~~~~~E~~~l~~l~h~niv~l~g~~------------  377 (506)
                      +.+.+.||+|+||+||+|+.. +|+.||||++++..    ...+.+.+|++++++++|||||++++++            
T Consensus        15 Y~i~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~ivmEy   94 (275)
T 3hyh_A           15 YQIVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHPHIIKLYDVIKSKDEIIMVIEY   94 (275)
T ss_dssp             CEEEEEEEC---CCEEEEECTTTCCEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEEC
T ss_pred             eEEEEEEecCcCeEEEEEEECCCCCEEEEEEEeHHHcCCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEEEEeC
Confidence            445678999999999999874 58999999997532    2335789999999999999999999987            


Q ss_pred             --------------eccchhhhHHHHHHHHHHHHhhcCCCCeEecCcCCCcEEECCCCcEEEeecCCCccccCCCcceec
Q 039231          378 --------------LRVAEELSSTIGIARGLEYLHLGCSTRILHFDIKPHNILLDEDFCPKISDFGLAKICNRKESIISM  443 (506)
Q Consensus       378 --------------~~~~~~l~i~~~i~~gl~~LH~~~~~~ivH~dlkp~Nill~~~~~~ki~dfg~a~~~~~~~~~~~~  443 (506)
                                    +++.+...++.||+.||+|||   +++|+||||||+|||+++++.+||+|||+|+.......   .
T Consensus        95 ~~g~L~~~l~~~~~l~e~~~~~~~~qi~~al~ylH---~~~IiHRDiKP~NILl~~~~~vkl~DFGla~~~~~~~~---~  168 (275)
T 3hyh_A           95 AGNELFDYIVQRDKMSEQEARRFFQQIISAVEYCH---RHKIVHRDLKPENLLLDEHLNVKIADFGLSNIMTDGNF---L  168 (275)
T ss_dssp             CCEEHHHHHHHSCSCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCTTTEEECTTCCEEECCSSCC------------
T ss_pred             CCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHH---HCCcccccCChHHeEECCCCCEEEeecCCCeecCCCCc---c
Confidence                          344457789999999999999   89999999999999999999999999999987654332   2


Q ss_pred             ccCCCCcccccccccccccCCCCccccHHHHHHHHHHHHcCCCCCCCCCC
Q 039231          444 TGARGTVGYIAPEVFCRNIGEVSYKSDVYNYGMMIFEMTGGRKNVDVVDN  493 (506)
Q Consensus       444 ~~~~gt~~y~aPE~l~~~~~~~s~~~Dv~s~G~il~elltg~~pf~~~~~  493 (506)
                      ....||+.|||||++.+. ..++.++||||+||++|||++|+.||...+.
T Consensus       169 ~~~~GT~~Y~APE~~~~~-~y~~~~~DiwSlGvily~lltg~~PF~~~~~  217 (275)
T 3hyh_A          169 KTSCGSPNYAAPEVISGK-LYAGPEVDVWSCGVILYVMLCRRLPFDDESI  217 (275)
T ss_dssp             ------CTTSCHHHHSSS-SCCCTHHHHHHHHHHHHHHHHSSCSSCCSSH
T ss_pred             CCeeECcccCChhhhcCC-CCCCChhhhHHHHHHHHHHHHCCCCCCCCCH
Confidence            456899999999999664 3456899999999999999999999976543

>4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A*

Probab=100.00  E-value=5.7e-40  Score=323.96  Aligned_cols=176  Identities=28%  Similarity=0.320  Sum_probs=144.8

Q ss_pred             hccccCccCceEEEEEEEc-CCCEEEEEEeccCCCCchhhHHHHHHhhccCccceeEEEEEe------------------
Q 039231          317 FKYKLGQGGYGSVYKGKLL-DGSNVAVKVLNDSKGNGKEFINEVASISRTSHVNVVALLGFC------------------  377 (506)
Q Consensus       317 ~~~~ig~G~~g~V~~~~~~-~~~~vavK~l~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~------------------  377 (506)
                      +.++||+|+||.||+|++. +|+.||||+++...    ...+|++++++++|||||++++++                  
T Consensus        62 ~~~~lG~G~fG~Vy~a~~~~~g~~vAiK~i~~~~----~~~~E~~il~~l~HpnIV~l~~~~~~~~~~~ivmEy~~gg~L  137 (336)
T 4g3f_A           62 HQPRVGRGSFGEVHRMKDKQTGFQCAVKKVRLEV----FRVEELVACAGLSSPRIVPLYGAVREGPWVNIFMELLEGGSL  137 (336)
T ss_dssp             EEEEEEEETTEEEEEEEETTTCCEEEEEEEETTT----CCTHHHHTTTTCCCTTBCCEEEEEEETTEEEEEECCCTTCBH
T ss_pred             eCcEeccCCCeEEEEEEECCCCCEEEEEEECHHH----hHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEeccCCCcH
Confidence            3467999999999999985 48999999997543    235799999999999999999987                  


Q ss_pred             ---------eccchhhhHHHHHHHHHHHHhhcCCCCeEecCcCCCcEEECCCC-cEEEeecCCCccccCCCcce---ecc
Q 039231          378 ---------LRVAEELSSTIGIARGLEYLHLGCSTRILHFDIKPHNILLDEDF-CPKISDFGLAKICNRKESII---SMT  444 (506)
Q Consensus       378 ---------~~~~~~l~i~~~i~~gl~~LH~~~~~~ivH~dlkp~Nill~~~~-~~ki~dfg~a~~~~~~~~~~---~~~  444 (506)
                               +++.+.+.++.||+.||+|||   +++|+||||||+||||+.++ .+||+|||+|+.........   ...
T Consensus       138 ~~~l~~~~~l~e~~~~~~~~qi~~aL~ylH---~~~IiHRDlKp~NILl~~~g~~vKl~DFGla~~~~~~~~~~~~~~~~  214 (336)
T 4g3f_A          138 GQLIKQMGCLPEDRALYYLGQALEGLEYLH---TRRILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDGLGKSLLTGD  214 (336)
T ss_dssp             HHHHHHHSSCCHHHHHHHHHHHHHHHHHHH---TTTEECSCCCGGGEEECTTSCCEEECCCTTCEEC------------C
T ss_pred             HHHHHHcCCCCHHHHHHHHHHHHHHHHHHH---HCCceecccCHHHEEEeCCCCEEEEeeCCCCeEccCCCcccceecCC
Confidence                     344557789999999999999   99999999999999999987 69999999999875443211   123


Q ss_pred             cCCCCcccccccccccccCCCCccccHHHHHHHHHHHHcCCCCCCCCCCCcchhhhh
Q 039231          445 GARGTVGYIAPEVFCRNIGEVSYKSDVYNYGMMIFEMTGGRKNVDVVDNGSTALDLQ  501 (506)
Q Consensus       445 ~~~gt~~y~aPE~l~~~~~~~s~~~Dv~s~G~il~elltg~~pf~~~~~~~~~~~~~  501 (506)
                      ...||+.|||||++.+.  .++.++|||||||++|||++|+.||...+..+....+.
T Consensus       215 ~~~GT~~YmAPE~~~~~--~y~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~i~  269 (336)
T 4g3f_A          215 YIPGTETHMAPEVVMGK--PCDAKVDIWSSCCMMLHMLNGCHPWTQYFRGPLCLKIA  269 (336)
T ss_dssp             CCCCCGGGCCHHHHTTC--CCCTHHHHHHHHHHHHHHHHSSCSSTTTCCSCCHHHHH
T ss_pred             ccccCccccCHHHHCCC--CCCcHHHHHHHHHHHHHHHHCcCCCCCCCHHHHHHHHH
Confidence            35799999999999764  78999999999999999999999998877666555443

>4fie_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP ANP; 3.11A {Homo sapiens}

Probab=100.00  E-value=6.5e-40  Score=332.43  Aligned_cols=172  Identities=27%  Similarity=0.360  Sum_probs=147.9

Q ss_pred             hccccCccCceEEEEEEEc-CCCEEEEEEeccCC-CCchhhHHHHHHhhccCccceeEEEEEe-----------------
Q 039231          317 FKYKLGQGGYGSVYKGKLL-DGSNVAVKVLNDSK-GNGKEFINEVASISRTSHVNVVALLGFC-----------------  377 (506)
Q Consensus       317 ~~~~ig~G~~g~V~~~~~~-~~~~vavK~l~~~~-~~~~~~~~E~~~l~~l~h~niv~l~g~~-----------------  377 (506)
                      +.++||+|+||.||+|+.. +|+.||||++.... ...+.+.+|+++|++++|||||++++++                 
T Consensus       155 ~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~iVmEy~~gG~  234 (423)
T 4fie_A          155 NFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLEGGA  234 (423)
T ss_dssp             EEEEEEECSSCEEEEEEETTTCCEEEEEEEESTTCSSGGGHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECCTTEE
T ss_pred             eeeEeccCcCcEEEEEEECCCCCEEEEEEEeccchhHHHHHHHHHHHHHhCCCCCCCceEEEEEECCEEEEEEeCCCCCc
Confidence            3467999999999999985 58999999997543 3446789999999999999999999987                 


Q ss_pred             ---------eccchhhhHHHHHHHHHHHHhhcCCCCeEecCcCCCcEEECCCCcEEEeecCCCccccCCCcceecccCCC
Q 039231          378 ---------LRVAEELSSTIGIARGLEYLHLGCSTRILHFDIKPHNILLDEDFCPKISDFGLAKICNRKESIISMTGARG  448 (506)
Q Consensus       378 ---------~~~~~~l~i~~~i~~gl~~LH~~~~~~ivH~dlkp~Nill~~~~~~ki~dfg~a~~~~~~~~~~~~~~~~g  448 (506)
                               +.+.+...++.||+.||+|||   +++|+||||||+||||+.++.+||+|||+|+........  .....|
T Consensus       235 L~~~i~~~~l~e~~~~~~~~qil~aL~ylH---~~~IiHRDiKp~NILl~~~g~vKl~DFGla~~~~~~~~~--~~~~~G  309 (423)
T 4fie_A          235 LTDIVTHTRMNEEQIAAVCLAVLQALSVLH---AQGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPR--RKSLVG  309 (423)
T ss_dssp             HHHHHHHSCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSTTTEEECTTCCEEECCCTTCEECCSSCCC--BCCCEE
T ss_pred             HHHHHhccCCCHHHHHHHHHHHHHHHHHHH---HCCeecccCCHHHEEEcCCCCEEEecCccceECCCCCcc--cccccc
Confidence                     334456779999999999999   899999999999999999999999999999877554332  255789


Q ss_pred             CcccccccccccccCCCCccccHHHHHHHHHHHHcCCCCCCCCCCCc
Q 039231          449 TVGYIAPEVFCRNIGEVSYKSDVYNYGMMIFEMTGGRKNVDVVDNGS  495 (506)
Q Consensus       449 t~~y~aPE~l~~~~~~~s~~~Dv~s~G~il~elltg~~pf~~~~~~~  495 (506)
                      |+.|||||++.+.  .|+.++|||||||++|||++|+.||...+..+
T Consensus       310 Tp~YmAPEvl~~~--~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~  354 (423)
T 4fie_A          310 TPYWMAPELISRL--PYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLK  354 (423)
T ss_dssp             CTTTCCHHHHTTC--CBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHH
T ss_pred             CcCcCCHHHHCCC--CCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHH
Confidence            9999999999654  78999999999999999999999997654433

>3ubd_A Ribosomal protein S6 kinase alpha-3; kinase-inhibitor complex, induced FIT, transferase-transfera inhibitor complex; HET: SL0; 1.53A {Mus musculus} PDB: 4el9_A* 3g51_A* 2z7q_A* 2z7r_A* 2z7s_A*

Probab=100.00  E-value=3e-40  Score=322.03  Aligned_cols=177  Identities=31%  Similarity=0.368  Sum_probs=140.4

Q ss_pred             hhhccccCccCceEEEEEEEc----CCCEEEEEEeccCC---CCchhhHHHHHHhhccCccceeEEEEEe----------
Q 039231          315 NSFKYKLGQGGYGSVYKGKLL----DGSNVAVKVLNDSK---GNGKEFINEVASISRTSHVNVVALLGFC----------  377 (506)
Q Consensus       315 ~~~~~~ig~G~~g~V~~~~~~----~~~~vavK~l~~~~---~~~~~~~~E~~~l~~l~h~niv~l~g~~----------  377 (506)
                      +.+.++||+|+||+||+|+..    .++.||||+++...   .....+.+|+++|++++|||||++++++          
T Consensus        26 Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~ivm  105 (304)
T 3ubd_A           26 FELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDILVEVNHPFIVKLHYAFQTEGKLYLIL  105 (304)
T ss_dssp             EEEEEEEECGGGCEEEEEEECSSTTTTCEEEEEEEESEEEEEEECC------CCCCCCCCTTEECEEEEEEETTEEEEEE
T ss_pred             cEEEEEEecCCCeEEEEEEEccCCCCCEEEEEEEEehHHcChHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEEEE
Confidence            345678999999999999863    36889999997532   2235688999999999999999999987          


Q ss_pred             -----------------eccchhhhHHHHHHHHHHHHhhcCCCCeEecCcCCCcEEECCCCcEEEeecCCCccccCCCcc
Q 039231          378 -----------------LRVAEELSSTIGIARGLEYLHLGCSTRILHFDIKPHNILLDEDFCPKISDFGLAKICNRKESI  440 (506)
Q Consensus       378 -----------------~~~~~~l~i~~~i~~gl~~LH~~~~~~ivH~dlkp~Nill~~~~~~ki~dfg~a~~~~~~~~~  440 (506)
                                       +++.+...++.||+.||+|||   +++|+||||||+|||+++++.+||+|||+|+........
T Consensus       106 Ey~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~ylH---~~~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~~~~  182 (304)
T 3ubd_A          106 DFLRGGDLFTRLSKEVMFTEEDVKFYLAELALALDHLH---SLGIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKK  182 (304)
T ss_dssp             CCCTTCEEHHHHHHHCCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSSCCGGGEEECTTSCEEEESSEEEEC-----CC
T ss_pred             EcCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH---HCCCcCCCCCHHHeEEcCCCCEEecccccceeccCCCcc
Confidence                             334456779999999999999   899999999999999999999999999999865443322


Q ss_pred             eecccCCCCcccccccccccccCCCCccccHHHHHHHHHHHHcCCCCCCCCCCCcchh
Q 039231          441 ISMTGARGTVGYIAPEVFCRNIGEVSYKSDVYNYGMMIFEMTGGRKNVDVVDNGSTAL  498 (506)
Q Consensus       441 ~~~~~~~gt~~y~aPE~l~~~~~~~s~~~Dv~s~G~il~elltg~~pf~~~~~~~~~~  498 (506)
                        .....||+.|||||++.+.  .++.++||||+||++|||++|+.||...+..+...
T Consensus       183 --~~~~~GT~~YmAPE~~~~~--~y~~~~DiwSlGvilyemltG~~PF~~~~~~~~~~  236 (304)
T 3ubd_A          183 --AYSFCGTVEYMAPEVVNRR--GHTQSADWWSFGVLMFEMLTGTLPFQGKDRKETMT  236 (304)
T ss_dssp             --CCSCCCCGGGCCHHHHHTS--CCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHH
T ss_pred             --ccccccCcccCCHHHhccC--CCCCCCcccchHHHHHHHHhCCCCCCCcCHHHHHH
Confidence              2457899999999999654  78999999999999999999999998765544433

>3hmm_A TGF-beta receptor type-1; ALK5, kinase, inhibitor, quinazoline, aortic aneurysm, ATP-binding, craniosynostosis, disease mutation, disulfide bond; HET: 855; 1.70A {Homo sapiens} PDB: 1vjy_A* 3gxl_A* 3tzm_A* 2wot_A* 2wou_A* 1py5_A* 1rw8_A*

Probab=100.00  E-value=1.2e-39  Score=319.95  Aligned_cols=176  Identities=26%  Similarity=0.386  Sum_probs=137.8

Q ss_pred             hhccccCccCceEEEEEEEcCCCEEEEEEeccCCCCchhhHHHHHHhhccCccceeEEEEEee-----------------
Q 039231          316 SFKYKLGQGGYGSVYKGKLLDGSNVAVKVLNDSKGNGKEFINEVASISRTSHVNVVALLGFCL-----------------  378 (506)
Q Consensus       316 ~~~~~ig~G~~g~V~~~~~~~~~~vavK~l~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~-----------------  378 (506)
                      .+.++||+|+||+||+|++ +|+.||||+++..........+|+..+.+++|||||+++|++.                 
T Consensus         6 ~L~~~iG~G~fG~Vy~~~~-~g~~VAvK~l~~~~~~~~~~e~Ei~~~~~l~HpNIv~l~g~~~~~~~~~~~~~lV~Ey~~   84 (303)
T 3hmm_A            6 VLQESIGKGRFGEVWRGKW-RGEEVAVKIFSSREERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWLVSDYHE   84 (303)
T ss_dssp             EEEEEEEECSSSEEEEEEE-TTEEEEEEEECGGGHHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEEEECCT
T ss_pred             EEEEEEeeCCCeEEEEEEE-CCEEEEEEEECccchhhHHHHHHHHHHhcCCCCCCCcEEEEEEecCCCceEEEEEecCCC
Confidence            3467899999999999998 6899999999754333233445677778899999999999873                 


Q ss_pred             -------------ccchhhhHHHHHHHHHHHHhhc-----CCCCeEecCcCCCcEEECCCCcEEEeecCCCccccCCCcc
Q 039231          379 -------------RVAEELSSTIGIARGLEYLHLG-----CSTRILHFDIKPHNILLDEDFCPKISDFGLAKICNRKESI  440 (506)
Q Consensus       379 -------------~~~~~l~i~~~i~~gl~~LH~~-----~~~~ivH~dlkp~Nill~~~~~~ki~dfg~a~~~~~~~~~  440 (506)
                                   ++.+++.++.|+++||+|||+.     ..++|+||||||+||||++++.+||+|||+|+........
T Consensus        85 ~gsL~~~l~~~~l~~~~~~~i~~~ia~gl~ylH~~~~~~~~~~~IiHRDlKp~NILl~~~~~~Ki~DFGla~~~~~~~~~  164 (303)
T 3hmm_A           85 HGSLFDYLNRYTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDT  164 (303)
T ss_dssp             TCBHHHHHHHCCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCCEECSCCCGGGEEECTTSCEEECCCTTCEEEETTTTE
T ss_pred             CCcHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCEeeccCCcccEEECCCCCEEEEeCCCCccccCCCCc
Confidence                         3344678999999999999932     1239999999999999999999999999999877654432


Q ss_pred             ee--cccCCCCccccccccccccc----CCCCccccHHHHHHHHHHHHcCCCCCCCCC
Q 039231          441 IS--MTGARGTVGYIAPEVFCRNI----GEVSYKSDVYNYGMMIFEMTGGRKNVDVVD  492 (506)
Q Consensus       441 ~~--~~~~~gt~~y~aPE~l~~~~----~~~s~~~Dv~s~G~il~elltg~~pf~~~~  492 (506)
                      ..  .....||+.|||||++.+..    +.++.++|||||||+||||+||+.||....
T Consensus       165 ~~~~~~~~~GT~~ymAPE~l~~~~~~~~~~~~~k~DVwS~Gvvl~El~tg~~~~~~~~  222 (303)
T 3hmm_A          165 IDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHE  222 (303)
T ss_dssp             ESCC-----CCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCC
T ss_pred             eeeecccccccccccCHHHhcccccccCCccChhHhhhhHHHHHHHHHHCCCCCCccc
Confidence            21  23457999999999985431    246789999999999999999988776543

>4ase_A Vascular endothelial growth factor receptor 2; transferase, angiogenesis, signaling protein, phosphorylatio receptor, inhibitor; HET: AV9; 1.83A {Homo sapiens} PDB: 4agd_A* 4asd_A* 4agc_A*

Probab=100.00  E-value=7.7e-40  Score=326.66  Aligned_cols=184  Identities=27%  Similarity=0.478  Sum_probs=151.7

Q ss_pred             HHHHhhhccccCccCceEEEEEEEcC------CCEEEEEEeccCCC--CchhhHHHHHHhhccCc-cceeEEEEEeec--
Q 039231          311 KKMTNSFKYKLGQGGYGSVYKGKLLD------GSNVAVKVLNDSKG--NGKEFINEVASISRTSH-VNVVALLGFCLR--  379 (506)
Q Consensus       311 ~~~~~~~~~~ig~G~~g~V~~~~~~~------~~~vavK~l~~~~~--~~~~~~~E~~~l~~l~h-~niv~l~g~~~~--  379 (506)
                      ....+.+.++||+|+||.||+|++..      ++.||||+++....  ..+++.+|+++|.+++| ||||+++|+|.+  
T Consensus        62 ~~~~~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~k~VAvK~l~~~~~~~~~~~~~~E~~il~~l~hhpnIV~l~g~~~~~~  141 (353)
T 4ase_A           62 PRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPG  141 (353)
T ss_dssp             CGGGEEEEEEEEECSSEEEEEEEEETSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECCTT
T ss_pred             cHHHeEEeeEEecCCCeEEEEEEEcCCCcccCCeEEEEEEEccccChHHHHHHHHHHHHHHHcCCCCcEEEEEEEEEecC
Confidence            33444556889999999999998643      35799999976443  23678999999999975 899999998822  


Q ss_pred             ------------------------------------------cchhhhHHHHHHHHHHHHhhcCCCCeEecCcCCCcEEE
Q 039231          380 ------------------------------------------VAEELSSTIGIARGLEYLHLGCSTRILHFDIKPHNILL  417 (506)
Q Consensus       380 ------------------------------------------~~~~l~i~~~i~~gl~~LH~~~~~~ivH~dlkp~Nill  417 (506)
                                                                +.+++.++.|||+||+|||   +++||||||||+|||+
T Consensus       142 ~~~~iV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~yLH---~~~iiHRDLK~~NILl  218 (353)
T 4ase_A          142 GPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLA---SRKCIHRDLAARNILL  218 (353)
T ss_dssp             SCCEEEEECCTTEEHHHHHHHTGGGBCCC-------CTTCBCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEE
T ss_pred             CEEEEEEEcCCCCCHHHHHHhcccccccccccchhhccccCCHHHHHHHHHHHHHHHHhHh---hCCeecCccCccceee
Confidence                                                      2234568899999999999   8999999999999999


Q ss_pred             CCCCcEEEeecCCCccccCCCcceecccCCCCcccccccccccccCCCCccccHHHHHHHHHHHHc-CCCCCCCCCCCcc
Q 039231          418 DEDFCPKISDFGLAKICNRKESIISMTGARGTVGYIAPEVFCRNIGEVSYKSDVYNYGMMIFEMTG-GRKNVDVVDNGST  496 (506)
Q Consensus       418 ~~~~~~ki~dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~s~~~Dv~s~G~il~ellt-g~~pf~~~~~~~~  496 (506)
                      ++++.+||+|||+|+...............||+.|||||++.+.  .++.++|||||||+||||+| |+.||......+.
T Consensus       219 ~~~~~vKi~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~--~y~~ksDVwS~Gv~l~El~t~G~~Pf~~~~~~~~  296 (353)
T 4ase_A          219 SEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDR--VYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEE  296 (353)
T ss_dssp             CGGGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHC--CCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCSHH
T ss_pred             CCCCCEEECcchhhhhcccCCCceeeccccccccccCHHHHhcC--CCCCcccEeehHHHHHHHHhCCCCCCCCCCHHHH
Confidence            99999999999999987665554444567789999999999654  79999999999999999998 9999988765554


Q ss_pred             hhh
Q 039231          497 ALD  499 (506)
Q Consensus       497 ~~~  499 (506)
                      ...
T Consensus       297 ~~~  299 (353)
T 4ase_A          297 FCR  299 (353)
T ss_dssp             HHH
T ss_pred             HHH
Confidence            443

>4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A*

Probab=100.00  E-value=4.3e-38  Score=307.69  Aligned_cols=166  Identities=30%  Similarity=0.481  Sum_probs=128.6

Q ss_pred             hccccCccCceEEEEEEEc-CCCEEEEEEeccCCC--CchhhHHHHHHhhccCccceeEEEEEeecc-------------
Q 039231          317 FKYKLGQGGYGSVYKGKLL-DGSNVAVKVLNDSKG--NGKEFINEVASISRTSHVNVVALLGFCLRV-------------  380 (506)
Q Consensus       317 ~~~~ig~G~~g~V~~~~~~-~~~~vavK~l~~~~~--~~~~~~~E~~~l~~l~h~niv~l~g~~~~~-------------  380 (506)
                      +.+.||+|+||+||+|+.. +|+.||||+++....  ..+.+.+|+++|++++|||||++++++.+.             
T Consensus         9 ~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~~~~~~~   88 (299)
T 4g31_A            9 PIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLEKNTTEKLQPSSPKV   88 (299)
T ss_dssp             EEEEEEECC--EEEEEEETTTCCEEEEEEEEECSSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEEC----------CE
T ss_pred             EeeEEecCCCeEEEEEEECCCCCEEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEecCccccccccCCCc
Confidence            4578999999999999975 589999999975433  235789999999999999999999865211             


Q ss_pred             -----------------------------chhhhHHHHHHHHHHHHhhcCCCCeEecCcCCCcEEECCCCcEEEeecCCC
Q 039231          381 -----------------------------AEELSSTIGIARGLEYLHLGCSTRILHFDIKPHNILLDEDFCPKISDFGLA  431 (506)
Q Consensus       381 -----------------------------~~~l~i~~~i~~gl~~LH~~~~~~ivH~dlkp~Nill~~~~~~ki~dfg~a  431 (506)
                                                   ...+.++.||++||+|||   +++|+||||||+|||++.++.+||+|||+|
T Consensus        89 ~l~ivmE~~~gg~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~ylH---~~~IiHRDlKp~NILl~~~~~vKl~DFGla  165 (299)
T 4g31_A           89 YLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHIFLQIAEAVEFLH---SKGLMHRDLKPSNIFFTMDDVVKVGDFGLV  165 (299)
T ss_dssp             EEEEEEECCCSCCHHHHHHTCCSGGGSCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEECTTCCEEECCCCCC
T ss_pred             EEEEEEecCCCCcHHHHHHhcCCCChhHHHHHHHHHHHHHHHHHHHH---HCcCccccCcHHHeEECCCCcEEEccCccc
Confidence                                         114568899999999999   899999999999999999999999999999


Q ss_pred             ccccCCCcce----------ecccCCCCcccccccccccccCCCCccccHHHHHHHHHHHHcCCCCCCC
Q 039231          432 KICNRKESII----------SMTGARGTVGYIAPEVFCRNIGEVSYKSDVYNYGMMIFEMTGGRKNVDV  490 (506)
Q Consensus       432 ~~~~~~~~~~----------~~~~~~gt~~y~aPE~l~~~~~~~s~~~Dv~s~G~il~elltg~~pf~~  490 (506)
                      +.........          ......||+.|||||++.+.  .++.++|||||||++|||++   ||..
T Consensus       166 ~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~--~y~~~~DiwSlGvilyell~---Pf~~  229 (299)
T 4g31_A          166 TAMDQDEEEQTVLTPMPAYARHTGQVGTKLYMSPEQIHGN--SYSHKVDIFSLGLILFELLY---PFST  229 (299)
T ss_dssp             --------------------------CCCTTSCHHHHTTC--CCCTHHHHHHHHHHHHHHHS---CCSS
T ss_pred             eecCCCccccccccccccccccCCcccCccccCHHHHcCC--CCCCHHHHHHHHHHHHHHcc---CCCC
Confidence            8875443211          12335799999999999654  78999999999999999996   8764

>4b99_A Mitogen-activated protein kinase 7; transferase, inhibitor; HET: R4L; 2.80A {Homo sapiens}

Probab=100.00  E-value=6.5e-38  Score=318.03  Aligned_cols=179  Identities=26%  Similarity=0.362  Sum_probs=147.0

Q ss_pred             hhccccCccCceEEEEEEEc-CCCEEEEEEeccCCCC---chhhHHHHHHhhccCccceeEEEEEe--------------
Q 039231          316 SFKYKLGQGGYGSVYKGKLL-DGSNVAVKVLNDSKGN---GKEFINEVASISRTSHVNVVALLGFC--------------  377 (506)
Q Consensus       316 ~~~~~ig~G~~g~V~~~~~~-~~~~vavK~l~~~~~~---~~~~~~E~~~l~~l~h~niv~l~g~~--------------  377 (506)
                      .+.++||+|+||.||+|+.. +|+.||||+++.....   .+.+.+|+++|++++|||||++++++              
T Consensus        57 ~~~~~lG~G~fG~V~~a~~~~t~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~~~~~~i  136 (398)
T 4b99_A           57 EIIETIGNGAYGVVSSARRRLTGQQVAIKKIPNAFDVVTNAKRTLRELKILKHFKHDNIIAIKDILRPTVPYGEFKSVYV  136 (398)
T ss_dssp             EEEEEEEECSSCEEEEEEETTTCCEEEEEEETTTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSSCTTTCCCEEE
T ss_pred             EEEEEEecccCeEEEEEEECCCCCEEEEEEECccccchHHHHHHHHHHHHHHhcCCCCcceEeeeeecccccccCCEEEE
Confidence            34568999999999999975 5999999999765433   25688999999999999999999864              


Q ss_pred             ------------------eccchhhhHHHHHHHHHHHHhhcCCCCeEecCcCCCcEEECCCCcEEEeecCCCccccCCCc
Q 039231          378 ------------------LRVAEELSSTIGIARGLEYLHLGCSTRILHFDIKPHNILLDEDFCPKISDFGLAKICNRKES  439 (506)
Q Consensus       378 ------------------~~~~~~l~i~~~i~~gl~~LH~~~~~~ivH~dlkp~Nill~~~~~~ki~dfg~a~~~~~~~~  439 (506)
                                        +++.+...++.||+.||+|||   +++|+||||||+|||++.++.+||+|||+|+.+.....
T Consensus       137 vmE~~~g~L~~~i~~~~~l~~~~~~~~~~qil~al~ylH---~~~iiHRDlKP~NIl~~~~~~~Ki~DFGla~~~~~~~~  213 (398)
T 4b99_A          137 VLDLMESDLHQIIHSSQPLTLEHVRYFLYQLLRGLKYMH---SAQVIHRDLKPSNLLVNENCELKIGDFGMARGLCTSPA  213 (398)
T ss_dssp             EEECCSEEHHHHHTSSSCCCHHHHHHHHHHHHHHHHHHH---HTTCBCCCCCGGGEEECTTCCEEECCCTTCBCC-----
T ss_pred             EEeCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH---HCcCcCCCcCccccccCCCCCEEEeecceeeecccCcc
Confidence                              233446779999999999999   89999999999999999999999999999987643221


Q ss_pred             --ceecccCCCCcccccccccccccCCCCccccHHHHHHHHHHHHcCCCCCCCCCCCcchh
Q 039231          440 --IISMTGARGTVGYIAPEVFCRNIGEVSYKSDVYNYGMMIFEMTGGRKNVDVVDNGSTAL  498 (506)
Q Consensus       440 --~~~~~~~~gt~~y~aPE~l~~~~~~~s~~~Dv~s~G~il~elltg~~pf~~~~~~~~~~  498 (506)
                        ........||+.|||||++.+. ..++.++||||+||++|||++|+.||...+..+...
T Consensus       214 ~~~~~~~~~~GT~~Y~APEv~~~~-~~~~~~~DiWSlG~il~ell~G~~pF~g~~~~~~l~  273 (398)
T 4b99_A          214 EHQYFMTEYVATRWYRAPELMLSL-HEYTQAIDLWSVGCIFGEMLARRQLFPGKNYVHQLQ  273 (398)
T ss_dssp             --CCCCCSSCCCCTTCCHHHHTTC-SCCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHHHHH
T ss_pred             ccccccccceeChHhcCHHHhcCC-CCCCChhheehhHHHHHHHHHCCCCCCCCCHHHHHH
Confidence              1123457899999999998664 467999999999999999999999998766544433

>4f9c_A Cell division cycle 7-related protein kinase; Ser/Thr protein kinase, transferase, phosphorylation, cell C cell division, mitosis, S phase; HET: 0SX; 2.08A {Homo sapiens} PDB: 4f99_A* 4f9b_A* 4f9a_A*

Probab=100.00  E-value=7.2e-37  Score=307.01  Aligned_cols=177  Identities=23%  Similarity=0.344  Sum_probs=142.8

Q ss_pred             hhccccCccCceEEEEEEEc----CCCEEEEEEeccCCCCchhhHHHHHHhhcc-CccceeEEEEEe-------------
Q 039231          316 SFKYKLGQGGYGSVYKGKLL----DGSNVAVKVLNDSKGNGKEFINEVASISRT-SHVNVVALLGFC-------------  377 (506)
Q Consensus       316 ~~~~~ig~G~~g~V~~~~~~----~~~~vavK~l~~~~~~~~~~~~E~~~l~~l-~h~niv~l~g~~-------------  377 (506)
                      .+.++||+|+||+||+|+.+    .++.||||++.... ...++.+|+++|.++ +|||||++++++             
T Consensus        24 ~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~-~~~~~~~E~~~l~~~~~h~nIv~l~~~~~~~~~~~lvmE~~  102 (361)
T 4f9c_A           24 KIEDKIGEGTFSSVYLATAQLQVGPEEKIALKHLIPTS-HPIRIAAELQCLTVAGGQDNVMGVKYCFRKNDHVVIAMPYL  102 (361)
T ss_dssp             EEEEEEEECSSEEEEEEEEEBTTSCEEEEEEEEECTTS-CHHHHHHHHHHHHHTCSBTTBCCCSEEEEETTEEEEEEECC
T ss_pred             EEEEEEecccCcEEEEEEEcccCCCCCEEEEEEEcccc-CHHHHHHHHHHHHHhcCCCCCceEEEEEEECCEEEEEEeCC
Confidence            34578999999999999863    36789999986543 346788999999998 699999998876             


Q ss_pred             -----------eccchhhhHHHHHHHHHHHHhhcCCCCeEecCcCCCcEEECCC-CcEEEeecCCCccccCCCcc-----
Q 039231          378 -----------LRVAEELSSTIGIARGLEYLHLGCSTRILHFDIKPHNILLDED-FCPKISDFGLAKICNRKESI-----  440 (506)
Q Consensus       378 -----------~~~~~~l~i~~~i~~gl~~LH~~~~~~ivH~dlkp~Nill~~~-~~~ki~dfg~a~~~~~~~~~-----  440 (506)
                                 +++.+...++.||+.||+|||   +++|+||||||+|||++.+ +.+||+|||+|+........     
T Consensus       103 ~g~~L~~~~~~l~~~~~~~~~~qll~al~ylH---~~gIiHRDiKPeNiLl~~~~~~~kl~DFGla~~~~~~~~~~~~~~  179 (361)
T 4f9c_A          103 EHESFLDILNSLSFQEVREYMLNLFKALKRIH---QFGIVHRDVKPSNFLYNRRLKKYALVDFGLAQGTHDTKIELLKFV  179 (361)
T ss_dssp             CCCCHHHHHTTCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEEETTTTEEEECCCTTCEECTTCSCGGGGGC
T ss_pred             CcccHHHHHcCCCHHHHHHHHHHHHHHHHHHH---HCCeEeCcCCHHHeEEeCCCCeEEECcCCCCcccCCccccccccc
Confidence                       334456779999999999999   8999999999999999876 79999999999865432210     


Q ss_pred             ---------------------eecccCCCCcccccccccccccCCCCccccHHHHHHHHHHHHcCCCCCCCCCCCcch
Q 039231          441 ---------------------ISMTGARGTVGYIAPEVFCRNIGEVSYKSDVYNYGMMIFEMTGGRKNVDVVDNGSTA  497 (506)
Q Consensus       441 ---------------------~~~~~~~gt~~y~aPE~l~~~~~~~s~~~Dv~s~G~il~elltg~~pf~~~~~~~~~  497 (506)
                                           .......||+.|+|||++.+. ..++.++||||+||++|||++|+.||....++...
T Consensus       180 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~-~~y~~~~DiWSlG~il~ell~G~~Pf~~~~~~~~~  256 (361)
T 4f9c_A          180 QSEAQQERCSQNKCSICLSRRQQVAPRAGTPGFRAPEVLTKC-PNQTTAIDMWSAGVIFLSLLSGRYPFYKASDDLTA  256 (361)
T ss_dssp             --------------------------CCCCGGGCCHHHHTTC-SCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHH
T ss_pred             cccccccccccccccccccccccccccccCccccCHHHHcCC-CCCCCccchhhhHHHHHHHHHCCCCCCCCCCHHHH
Confidence                                 012345799999999998654 35899999999999999999999999766554433

>3v5w_A G-protein coupled receptor kinase 2; inhibitor complex, protein kinase, beta propeller, RGS homol domain; HET: 8PR; 2.07A {Homo sapiens} PDB: 3cik_A* 3krw_A* 3krx_A* 1omw_A 1ym7_A 2bcj_A* 3uzs_A 3uzt_A 3pvu_A* 3psc_A* 3pvw_A* 1bak_A

Probab=100.00  E-value=9.9e-36  Score=315.21  Aligned_cols=169  Identities=29%  Similarity=0.408  Sum_probs=140.7

Q ss_pred             ccccCccCceEEEEEEEc-CCCEEEEEEeccC----CCCchhhHH---HHHHhhccCccceeEEEEEe------------
Q 039231          318 KYKLGQGGYGSVYKGKLL-DGSNVAVKVLNDS----KGNGKEFIN---EVASISRTSHVNVVALLGFC------------  377 (506)
Q Consensus       318 ~~~ig~G~~g~V~~~~~~-~~~~vavK~l~~~----~~~~~~~~~---E~~~l~~l~h~niv~l~g~~------------  377 (506)
                      .++||+|+||.||+|+.. +|+.||||++++.    ......+.+   +++++..++|||||++++++            
T Consensus       194 ~k~LG~G~fG~V~la~~~~tg~~~AiK~i~K~~i~~~~~~~~~~~E~~~l~ll~~~~HP~IV~l~~~f~~~~~lylVmEy  273 (689)
T 3v5w_A          194 HRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLSFILDL  273 (689)
T ss_dssp             EEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSSEEEEEECC
T ss_pred             EEEEecccCeEEEEEEECCCCCEEEEEEEeHHHcchhhhHHHHHHHHHHHHHHhhCCCCCEeEEEEEEEECCEEEEEEec
Confidence            467999999999999985 4899999999642    222233333   46677788999999999877            


Q ss_pred             ---------------eccchhhhHHHHHHHHHHHHhhcCCCCeEecCcCCCcEEECCCCcEEEeecCCCccccCCCccee
Q 039231          378 ---------------LRVAEELSSTIGIARGLEYLHLGCSTRILHFDIKPHNILLDEDFCPKISDFGLAKICNRKESIIS  442 (506)
Q Consensus       378 ---------------~~~~~~l~i~~~i~~gl~~LH~~~~~~ivH~dlkp~Nill~~~~~~ki~dfg~a~~~~~~~~~~~  442 (506)
                                     +++.+...++.||+.||+|||   +++||||||||+||||+.+|++||+|||+|+.......   
T Consensus       274 ~~GGdL~~~l~~~~~l~E~~a~~y~~qIl~aL~yLH---~~gIiHRDLKPeNILld~~G~vKL~DFGlA~~~~~~~~---  347 (689)
T 3v5w_A          274 MNGGDLHYHLSQHGVFSEADMRFYAAEIILGLEHMH---NRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKP---  347 (689)
T ss_dssp             CCSCBHHHHHHHHCCCCHHHHHHHHHHHHHHHHHHH---TTTEECCCCSGGGEEECTTSCEEECCCTTCEECSSCCC---
T ss_pred             CCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH---HCCccccCCchHHeEEeCCCCEEecccceeeecCCCCC---
Confidence                           344456779999999999999   99999999999999999999999999999987765432   


Q ss_pred             cccCCCCcccccccccccccCCCCccccHHHHHHHHHHHHcCCCCCCCCCCC
Q 039231          443 MTGARGTVGYIAPEVFCRNIGEVSYKSDVYNYGMMIFEMTGGRKNVDVVDNG  494 (506)
Q Consensus       443 ~~~~~gt~~y~aPE~l~~~~~~~s~~~Dv~s~G~il~elltg~~pf~~~~~~  494 (506)
                       ....||+.|||||++.+. ..++.++||||+||+||||++|+.||...+..
T Consensus       348 -~t~~GTp~YmAPEvl~~~-~~y~~~vDiWSLGvilYEmLtG~~PF~~~~~~  397 (689)
T 3v5w_A          348 -HASVGTHGYMAPEVLQKG-VAYDSSADWFSLGCMLFKLLRGHSPFRQHKTK  397 (689)
T ss_dssp             -CSCCSCGGGCCHHHHSTT-CCCCTHHHHHHHHHHHHHHHHSSCTTCGGGCC
T ss_pred             -CCccCCcCccCHHHHhCC-CCCCcHHHHHHHHHHHHHHHhCCCCCCCCChH
Confidence             456899999999998542 36899999999999999999999999865443

>3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A

Probab=100.00  E-value=2.6e-35  Score=313.05  Aligned_cols=177  Identities=24%  Similarity=0.392  Sum_probs=149.0

Q ss_pred             hhhccccCccCceEEEEEEEc-CCCEEEEEEeccCCC-CchhhHHHHHHhhccCccceeEEEEEe---------------
Q 039231          315 NSFKYKLGQGGYGSVYKGKLL-DGSNVAVKVLNDSKG-NGKEFINEVASISRTSHVNVVALLGFC---------------  377 (506)
Q Consensus       315 ~~~~~~ig~G~~g~V~~~~~~-~~~~vavK~l~~~~~-~~~~~~~E~~~l~~l~h~niv~l~g~~---------------  377 (506)
                      +.+.++||+|+||.||+|+.+ +|+.||||++..... ..+.+.+|+++|+.++|||||++++++               
T Consensus       159 Y~i~~~lG~G~fg~V~~~~~~~tg~~~AiK~i~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~iv~E~~~g  238 (573)
T 3uto_A          159 YDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEFMSG  238 (573)
T ss_dssp             EEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHHHTCCTTBCCEEEEEECSSEEEEEEECCCC
T ss_pred             cEEEEEEeeccCeEEEEEEECCCCCEEEEEEEeccchhhHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEeecCC
Confidence            345678999999999999985 589999999976443 346788999999999999999999887               


Q ss_pred             -------------eccchhhhHHHHHHHHHHHHhhcCCCCeEecCcCCCcEEECCC--CcEEEeecCCCccccCCCccee
Q 039231          378 -------------LRVAEELSSTIGIARGLEYLHLGCSTRILHFDIKPHNILLDED--FCPKISDFGLAKICNRKESIIS  442 (506)
Q Consensus       378 -------------~~~~~~l~i~~~i~~gl~~LH~~~~~~ivH~dlkp~Nill~~~--~~~ki~dfg~a~~~~~~~~~~~  442 (506)
                                   +++.+...++.||+.||+|||   +++|+||||||+|||++.+  +.+||+|||+|+.+......  
T Consensus       239 g~L~~~i~~~~~~l~e~~~~~~~~qi~~al~ylH---~~~iiHRDlKp~Nill~~~~~~~vKl~DFG~a~~~~~~~~~--  313 (573)
T 3uto_A          239 GELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMH---ENNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQSV--  313 (573)
T ss_dssp             CBHHHHHTCTTSCEEHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEESSSSCCCEEECCCSSCEECCTTSEE--
T ss_pred             CcHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHH---HCCeeeccCChhhccccCCCCCCEEEeeccceeEccCCCce--
Confidence                         233346678999999999999   8999999999999999854  89999999999987655432  


Q ss_pred             cccCCCCcccccccccccccCCCCccccHHHHHHHHHHHHcCCCCCCCCCCCcchhh
Q 039231          443 MTGARGTVGYIAPEVFCRNIGEVSYKSDVYNYGMMIFEMTGGRKNVDVVDNGSTALD  499 (506)
Q Consensus       443 ~~~~~gt~~y~aPE~l~~~~~~~s~~~Dv~s~G~il~elltg~~pf~~~~~~~~~~~  499 (506)
                       ....||+.|||||++.+.  .++.++||||+||++|||++|+.||...+..+....
T Consensus       314 -~~~~GT~~y~APEv~~~~--~y~~~~DiWSlGvilyeml~G~~Pf~~~~~~~~~~~  367 (573)
T 3uto_A          314 -KVTTGTAEFAAPEVAEGK--PVGYYTDMWSVGVLSYILLSGLSPFGGENDDETLRN  367 (573)
T ss_dssp             -EEECSSGGGCCHHHHTTC--CBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHH
T ss_pred             -eeeEECccccCHHHhCCC--CCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHH
Confidence             446799999999999765  789999999999999999999999987665444333

>4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A*

Probab=100.00  E-value=1.4e-33  Score=290.44  Aligned_cols=184  Identities=22%  Similarity=0.282  Sum_probs=149.3

Q ss_pred             HHhhh--ccccCccCceEEEEEEEcC-CCEEEEEEecc----CCCCchhhHHHHHHhhccCccceeEEEEEee-------
Q 039231          313 MTNSF--KYKLGQGGYGSVYKGKLLD-GSNVAVKVLND----SKGNGKEFINEVASISRTSHVNVVALLGFCL-------  378 (506)
Q Consensus       313 ~~~~~--~~~ig~G~~g~V~~~~~~~-~~~vavK~l~~----~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~-------  378 (506)
                      .+.+|  .++||+|+||+||+|+..+ ++.||+|++++    .......+.+|..++..++||||+++++++.       
T Consensus        72 ~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~~~~~~~l  151 (437)
T 4aw2_A           72 HREDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDSKWITTLHYAFQDDNNLYL  151 (437)
T ss_dssp             CGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTTTCCHHHHHHHHHHSCTTTBCCEEEEEECSSEEEE
T ss_pred             ChhheEEEEEEEeCCCEEEEEEEEcCCCcEEEEEEEEHHHhhhHHHHHHHHHHHHHHHhCCCCCEEEEEEEEeeCCEEEE
Confidence            33444  4689999999999999865 78999999964    2233456899999999999999999998872       


Q ss_pred             ---------------------ccchhhhHHHHHHHHHHHHhhcCCCCeEecCcCCCcEEECCCCcEEEeecCCCccccCC
Q 039231          379 ---------------------RVAEELSSTIGIARGLEYLHLGCSTRILHFDIKPHNILLDEDFCPKISDFGLAKICNRK  437 (506)
Q Consensus       379 ---------------------~~~~~l~i~~~i~~gl~~LH~~~~~~ivH~dlkp~Nill~~~~~~ki~dfg~a~~~~~~  437 (506)
                                           ++.....++.||+.||+|||   +++|+||||||+|||++.++.+||+|||+++.....
T Consensus       152 V~Ey~~gg~L~~~l~~~~~~l~e~~~~~~~~qi~~aL~~LH---~~giiHrDLKp~NILl~~~g~vkL~DFGla~~~~~~  228 (437)
T 4aw2_A          152 VMDYYVGGDLLTLLSKFEDRLPEEMARFYLAEMVIAIDSVH---QLHYVHRDIKPDNILMDMNGHIRLADFGSCLKLMED  228 (437)
T ss_dssp             EECCCTTCBHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTTSCEEECCCTTCEECCTT
T ss_pred             EEecCCCCcHHHHHHHccCCCCHHHHHHHHHHHHHHHHHHH---hCCeEecccCHHHeeEcCCCCEEEcchhhhhhcccC
Confidence                                 23335668999999999999   899999999999999999999999999999876554


Q ss_pred             CcceecccCCCCccccccccccc---ccCCCCccccHHHHHHHHHHHHcCCCCCCCCCCCcchhhh
Q 039231          438 ESIISMTGARGTVGYIAPEVFCR---NIGEVSYKSDVYNYGMMIFEMTGGRKNVDVVDNGSTALDL  500 (506)
Q Consensus       438 ~~~~~~~~~~gt~~y~aPE~l~~---~~~~~s~~~Dv~s~G~il~elltg~~pf~~~~~~~~~~~~  500 (506)
                      ... ......||+.|+|||++..   ..+.++.++|||||||++|||++|+.||...+..+....+
T Consensus       229 ~~~-~~~~~~GT~~Y~APE~l~~~~~~~~~~~~~~DvwSlGvil~elltG~~Pf~~~~~~~~~~~i  293 (437)
T 4aw2_A          229 GTV-QSSVAVGTPDYISPEILQAMEGGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKI  293 (437)
T ss_dssp             SCE-ECCSCCSCGGGCCHHHHHHHHTSCCEECTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHH
T ss_pred             CCc-ccccccCCcCeeChHHHhhcccCCCCCCCcCeeHHHHHHHHHHHhCCCCCCCCChhHHHHhh
Confidence            432 2244679999999999862   1246899999999999999999999999876554443333

>3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} SCOP: d.144.1.7 PDB: 2qkr_A*

Probab=100.00  E-value=4.1e-33  Score=275.08  Aligned_cols=178  Identities=29%  Similarity=0.404  Sum_probs=146.9

Q ss_pred             hccccCccCceEEEEEEEcCCCEEEEEEeccCCCC---chhhHHHHHHhhccCccceeEEEEEe----------------
Q 039231          317 FKYKLGQGGYGSVYKGKLLDGSNVAVKVLNDSKGN---GKEFINEVASISRTSHVNVVALLGFC----------------  377 (506)
Q Consensus       317 ~~~~ig~G~~g~V~~~~~~~~~~vavK~l~~~~~~---~~~~~~E~~~l~~l~h~niv~l~g~~----------------  377 (506)
                      +.++||+|+||.||+|+..+++.||+|++......   .+.+.+|++++++++||||+++++++                
T Consensus        25 ~~~~lG~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~~  104 (311)
T 3niz_A           25 KLEKVGEGTYGVVYKAKDSQGRIVALKRIRLDAEDEGIPSTAIREISLLKELHHPNIVSLIDVIHSERCLTLVFEFMEKD  104 (311)
T ss_dssp             EEEEEEECSSCEEEEEEETTSCEEEEEEEC------CHHHHHHHHHHHHHHCCCTTBCCEEEEECCSSCEEEEEECCSEE
T ss_pred             hhhhccCCCCeEEEEEEECCCCEEEEEEEecccccchhhHHHHHHHHHHHHcCCCCEeeeeeEEccCCEEEEEEcCCCCC
Confidence            34679999999999999988999999999754322   26788999999999999999999987                


Q ss_pred             -----------eccchhhhHHHHHHHHHHHHhhcCCCCeEecCcCCCcEEECCCCcEEEeecCCCccccCCCcceecccC
Q 039231          378 -----------LRVAEELSSTIGIARGLEYLHLGCSTRILHFDIKPHNILLDEDFCPKISDFGLAKICNRKESIISMTGA  446 (506)
Q Consensus       378 -----------~~~~~~l~i~~~i~~gl~~LH~~~~~~ivH~dlkp~Nill~~~~~~ki~dfg~a~~~~~~~~~~~~~~~  446 (506)
                                 +++.+.+.++.|++.||+|||   +++|+||||||+|||++.++.+||+|||+++........  ....
T Consensus       105 l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH---~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~~~~--~~~~  179 (311)
T 3niz_A          105 LKKVLDENKTGLQDSQIKIYLYQLLRGVAHCH---QHRILHRDLKPQNLLINSDGALKLADFGLARAFGIPVRS--YTHE  179 (311)
T ss_dssp             HHHHHHTCTTCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEECTTCCEEECCCTTCEETTSCCC-----CC
T ss_pred             HHHHHHhccCCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCchHhEEECCCCCEEEccCcCceecCCCccc--ccCC
Confidence                       223346678999999999999   899999999999999999999999999999876543322  2446


Q ss_pred             CCCcccccccccccccCCCCccccHHHHHHHHHHHHcCCCCCCCCCCCcchhhh
Q 039231          447 RGTVGYIAPEVFCRNIGEVSYKSDVYNYGMMIFEMTGGRKNVDVVDNGSTALDL  500 (506)
Q Consensus       447 ~gt~~y~aPE~l~~~~~~~s~~~Dv~s~G~il~elltg~~pf~~~~~~~~~~~~  500 (506)
                      .+|+.|+|||++.+. ..++.++||||||+++|||++|+.||....+.+....+
T Consensus       180 ~~t~~y~aPE~~~~~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i  232 (311)
T 3niz_A          180 VVTLWYRAPDVLMGS-KKYSTSVDIWSIGCIFAEMITGKPLFPGVTDDDQLPKI  232 (311)
T ss_dssp             CCCCTTCCHHHHTTC-CSCCTHHHHHHHHHHHHHHHHSSCSCCCSSTTTHHHHH
T ss_pred             cccCCcCCHHHhcCC-CCCCchHHhHHHHHHHHHHHhCCCCCCCCChHHHHHHH
Confidence            789999999998653 46899999999999999999999999887766654444

>2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A*

Probab=100.00  E-value=5.5e-33  Score=275.46  Aligned_cols=186  Identities=27%  Similarity=0.360  Sum_probs=155.0

Q ss_pred             CCCccCHHHHHHHHhhh------------ccccCccCceEEEEEEEc-CCCEEEEEEeccCCC-CchhhHHHHHHhhccC
Q 039231          301 SPKRYGYADIKKMTNSF------------KYKLGQGGYGSVYKGKLL-DGSNVAVKVLNDSKG-NGKEFINEVASISRTS  366 (506)
Q Consensus       301 ~~~~~~~~el~~~~~~~------------~~~ig~G~~g~V~~~~~~-~~~~vavK~l~~~~~-~~~~~~~E~~~l~~l~  366 (506)
                      .+..++++++++++...            .+.||+|+||.||+|+.. +|+.||||++..... ..+.+.+|+.++++++
T Consensus        21 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lg~G~~g~V~~a~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~  100 (321)
T 2c30_A           21 QSGVVTHEQFKAALRMVVDQGDPRLLLDSYVKIGEGSTGIVCLAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQ  100 (321)
T ss_dssp             ----CCHHHHHHHHHTTSCSSCHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCSHHHHHHHHHHHTTCC
T ss_pred             cCCcCcHHHHHHHHhhccCCCCchhhhhccEEeccCCCeEEEEEEECCCCcEEEEEEEeccchhHHHHHHHHHHHHHhCC
Confidence            34568899998888642            347999999999999986 699999999975443 3467889999999999


Q ss_pred             ccceeEEEEEe--------------------------eccchhhhHHHHHHHHHHHHhhcCCCCeEecCcCCCcEEECCC
Q 039231          367 HVNVVALLGFC--------------------------LRVAEELSSTIGIARGLEYLHLGCSTRILHFDIKPHNILLDED  420 (506)
Q Consensus       367 h~niv~l~g~~--------------------------~~~~~~l~i~~~i~~gl~~LH~~~~~~ivH~dlkp~Nill~~~  420 (506)
                      ||||+++++++                          +++.+++.++.|++.||+|||   +.+|+||||||+||+++.+
T Consensus       101 h~niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~l~~~~~~~i~~qi~~~L~~LH---~~~ivH~Dlkp~NIll~~~  177 (321)
T 2c30_A          101 HFNVVEMYKSYLVGEELWVLMEFLQGGALTDIVSQVRLNEEQIATVCEAVLQALAYLH---AQGVIHRDIKSDSILLTLD  177 (321)
T ss_dssp             CTTBCCEEEEEEETTEEEEEECCCCSCBHHHHHTTCCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTT
T ss_pred             CCCcceEEEEEEECCEEEEEEecCCCCCHHHHHHhcCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHEEECCC
Confidence            99999999887                          234446779999999999999   8999999999999999999


Q ss_pred             CcEEEeecCCCccccCCCcceecccCCCCcccccccccccccCCCCccccHHHHHHHHHHHHcCCCCCCCCCC
Q 039231          421 FCPKISDFGLAKICNRKESIISMTGARGTVGYIAPEVFCRNIGEVSYKSDVYNYGMMIFEMTGGRKNVDVVDN  493 (506)
Q Consensus       421 ~~~ki~dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~s~~~Dv~s~G~il~elltg~~pf~~~~~  493 (506)
                      +.+||+|||+++........  .....||+.|+|||++.+.  .++.++||||||+++|||++|+.||.....
T Consensus       178 ~~~kl~Dfg~~~~~~~~~~~--~~~~~gt~~y~aPE~~~~~--~~~~~~Dv~slG~il~el~~g~~pf~~~~~  246 (321)
T 2c30_A          178 GRVKLSDFGFCAQISKDVPK--RKSLVGTPYWMAPEVISRS--LYATEVDIWSLGIMVIEMVDGEPPYFSDSP  246 (321)
T ss_dssp             CCEEECCCTTCEECCSSSCC--BCCCCSCGGGCCHHHHTTC--CBCTHHHHHHHHHHHHHHHHSSCTTTTSCH
T ss_pred             CcEEEeeeeeeeecccCccc--cccccCCccccCHhhhcCC--CCCchhhHHHHHHHHHHHHhCCCCCCCCCH
Confidence            99999999999876544322  2456799999999998553  789999999999999999999999976543

>3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A

Probab=100.00  E-value=4.6e-33  Score=276.66  Aligned_cols=171  Identities=27%  Similarity=0.447  Sum_probs=144.4

Q ss_pred             hccccCccCceEEEEEEE-cCCCEEEEEEeccCCCC---chhhHHHHHHhhccCccceeEEEEEe---------------
Q 039231          317 FKYKLGQGGYGSVYKGKL-LDGSNVAVKVLNDSKGN---GKEFINEVASISRTSHVNVVALLGFC---------------  377 (506)
Q Consensus       317 ~~~~ig~G~~g~V~~~~~-~~~~~vavK~l~~~~~~---~~~~~~E~~~l~~l~h~niv~l~g~~---------------  377 (506)
                      +.+.||+|+||.||+|++ .+|+.||||++......   .+.+.+|++++++++||||+++++++               
T Consensus        19 ~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~e~~~~   98 (328)
T 3fe3_A           19 LLKTIGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVKLFEVIETEKTLYLIMEYASG   98 (328)
T ss_dssp             EEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEECCCTT
T ss_pred             EEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhhcCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEEEEEEECCCC
Confidence            356799999999999998 46999999999764332   35688999999999999999999987               


Q ss_pred             ------------eccchhhhHHHHHHHHHHHHhhcCCCCeEecCcCCCcEEECCCCcEEEeecCCCccccCCCcceeccc
Q 039231          378 ------------LRVAEELSSTIGIARGLEYLHLGCSTRILHFDIKPHNILLDEDFCPKISDFGLAKICNRKESIISMTG  445 (506)
Q Consensus       378 ------------~~~~~~l~i~~~i~~gl~~LH~~~~~~ivH~dlkp~Nill~~~~~~ki~dfg~a~~~~~~~~~~~~~~  445 (506)
                                  +++.+...++.|++.||+|||   +++|+||||||+|||++.++.+||+|||+++.......   ...
T Consensus        99 ~~L~~~l~~~~~l~~~~~~~~~~qi~~al~~lH---~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~~---~~~  172 (328)
T 3fe3_A           99 GEVFDYLVAHGRMKEKEARSKFRQIVSAVQYCH---QKRIVHRDLKAENLLLDADMNIKIADFGFSNEFTVGGK---LDA  172 (328)
T ss_dssp             CBHHHHHHHHCCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEECTTSCEEECSTTCCGGGSSSCG---GGT
T ss_pred             CcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHH---HCCEeccCCCHHHEEEcCCCCEEEeeccCceecCCCCc---ccc
Confidence                        223345678999999999999   89999999999999999999999999999987654432   255


Q ss_pred             CCCCcccccccccccccCCCCccccHHHHHHHHHHHHcCCCCCCCCCCC
Q 039231          446 ARGTVGYIAPEVFCRNIGEVSYKSDVYNYGMMIFEMTGGRKNVDVVDNG  494 (506)
Q Consensus       446 ~~gt~~y~aPE~l~~~~~~~s~~~Dv~s~G~il~elltg~~pf~~~~~~  494 (506)
                      ..||+.|+|||++.+. ...+.++||||+|+++|||++|+.||+..+..
T Consensus       173 ~~gt~~y~aPE~~~~~-~~~~~~~DiwslG~il~ell~g~~pf~~~~~~  220 (328)
T 3fe3_A          173 FCGAPPYAAPELFQGK-KYDGPEVDVWSLGVILYTLVSGSLPFDGQNLK  220 (328)
T ss_dssp             TSSSGGGCCHHHHHTC-CCCSHHHHHHHHHHHHHHHHHSSCSSCCSSHH
T ss_pred             ccCCcceeCcccccCC-CcCCchhhhhhhHHHHHHHHhCCCCCCCCCHH
Confidence            6799999999998654 23458999999999999999999999876543

>3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3twj_A* 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A*

Probab=100.00  E-value=4e-33  Score=284.91  Aligned_cols=179  Identities=25%  Similarity=0.299  Sum_probs=147.6

Q ss_pred             ccccCccCceEEEEEEEcC-CCEEEEEEecc----CCCCchhhHHHHHHhhccCccceeEEEEEee--------------
Q 039231          318 KYKLGQGGYGSVYKGKLLD-GSNVAVKVLND----SKGNGKEFINEVASISRTSHVNVVALLGFCL--------------  378 (506)
Q Consensus       318 ~~~ig~G~~g~V~~~~~~~-~~~vavK~l~~----~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~--------------  378 (506)
                      .++||+|+||.||+|+... ++.||+|++++    .....+.+.+|+++++.++|||||++++++.              
T Consensus        74 ~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~lV~E~~~g  153 (410)
T 3v8s_A           74 VKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQDDRYLYMVMEYMPG  153 (410)
T ss_dssp             EEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTCCCSTHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEECCCTT
T ss_pred             EEEEEcCCCEEEEEEEECCCCcEEEEEEEehhhhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEeCCCC
Confidence            4679999999999999864 88999999964    2334467889999999999999999998872              


Q ss_pred             ------------ccchhhhHHHHHHHHHHHHhhcCCCCeEecCcCCCcEEECCCCcEEEeecCCCccccCCCcceecccC
Q 039231          379 ------------RVAEELSSTIGIARGLEYLHLGCSTRILHFDIKPHNILLDEDFCPKISDFGLAKICNRKESIISMTGA  446 (506)
Q Consensus       379 ------------~~~~~l~i~~~i~~gl~~LH~~~~~~ivH~dlkp~Nill~~~~~~ki~dfg~a~~~~~~~~~~~~~~~  446 (506)
                                  ++.....++.||+.||+|||   +++|+||||||+|||++.++.+||+|||+++........ .....
T Consensus       154 g~L~~~l~~~~~~e~~~~~~~~qi~~aL~~LH---~~givHrDLKp~NILl~~~g~ikL~DFG~a~~~~~~~~~-~~~~~  229 (410)
T 3v8s_A          154 GDLVNLMSNYDVPEKWARFYTAEVVLALDAIH---SMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMV-RCDTA  229 (410)
T ss_dssp             EEHHHHHHHCCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTTSCEEECCCTTCEECCTTSEE-ECCSC
T ss_pred             CcHHHHHHcCCCCHHHHHHHHHHHHHHHHHHH---HCCeEeccCCHHHeeECCCCCEEEeccceeEeeccCCcc-cccCC
Confidence                        23335678899999999999   899999999999999999999999999999876554322 22457


Q ss_pred             CCCcccccccccccccC--CCCccccHHHHHHHHHHHHcCCCCCCCCCCCcchhhh
Q 039231          447 RGTVGYIAPEVFCRNIG--EVSYKSDVYNYGMMIFEMTGGRKNVDVVDNGSTALDL  500 (506)
Q Consensus       447 ~gt~~y~aPE~l~~~~~--~~s~~~Dv~s~G~il~elltg~~pf~~~~~~~~~~~~  500 (506)
                      .||+.|+|||++.+..+  .++.++||||||+++|||++|+.||...+..+....+
T Consensus       230 ~gt~~Y~APE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i  285 (410)
T 3v8s_A          230 VGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKI  285 (410)
T ss_dssp             CSCGGGCCHHHHHTTTTTCEEETHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHH
T ss_pred             cCCccccCHHHhhccCCCcCCCCcceEecchHHHHHHHhCCCCCCCCChhhHHHHH
Confidence            89999999999965421  2788999999999999999999999876554443333

>3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} SCOP: d.144.1.7 PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A*

Probab=99.98  E-value=1.1e-32  Score=270.32  Aligned_cols=171  Identities=29%  Similarity=0.401  Sum_probs=145.5

Q ss_pred             hccccCccCceEEEEEEE-cCCCEEEEEEeccCC-CCchhhHHHHHHhhccCccceeEEEEEe-----------------
Q 039231          317 FKYKLGQGGYGSVYKGKL-LDGSNVAVKVLNDSK-GNGKEFINEVASISRTSHVNVVALLGFC-----------------  377 (506)
Q Consensus       317 ~~~~ig~G~~g~V~~~~~-~~~~~vavK~l~~~~-~~~~~~~~E~~~l~~l~h~niv~l~g~~-----------------  377 (506)
                      +.+.||+|+||.||+|+. .+++.||||++.... ...+.+.+|+.++++++||||+++++++                 
T Consensus        24 ~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~~~  103 (297)
T 3fxz_A           24 RFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYLAGGS  103 (297)
T ss_dssp             CCEEEEEETTEEEEEEEBTTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECCTTCB
T ss_pred             eeeeeccCCCeEEEEEEECCCCcEEEEEEeecccccHHHHHHHHHHHHhcCCCCCCCeEeEEEEECCEEEEEEECCCCCC
Confidence            346799999999999986 458999999996543 3446788999999999999999999876                 


Q ss_pred             ---------eccchhhhHHHHHHHHHHHHhhcCCCCeEecCcCCCcEEECCCCcEEEeecCCCccccCCCcceecccCCC
Q 039231          378 ---------LRVAEELSSTIGIARGLEYLHLGCSTRILHFDIKPHNILLDEDFCPKISDFGLAKICNRKESIISMTGARG  448 (506)
Q Consensus       378 ---------~~~~~~l~i~~~i~~gl~~LH~~~~~~ivH~dlkp~Nill~~~~~~ki~dfg~a~~~~~~~~~~~~~~~~g  448 (506)
                               +++.+.+.++.|++.||+|||   +++|+||||||+|||++.++.+||+|||++.........  .....|
T Consensus       104 L~~~~~~~~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~--~~~~~g  178 (297)
T 3fxz_A          104 LTDVVTETCMDEGQIAAVCRECLQALEFLH---SNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSK--RSTMVG  178 (297)
T ss_dssp             HHHHHHHSCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTTCCEEECCCTTCEECCSTTCC--BCCCCS
T ss_pred             HHHHHhhcCCCHHHHHHHHHHHHHHHHHHH---hCCceeCCCCHHHEEECCCCCEEEeeCCCceecCCcccc--cCCccC
Confidence                     233346778999999999999   899999999999999999999999999999876554432  245679


Q ss_pred             CcccccccccccccCCCCccccHHHHHHHHHHHHcCCCCCCCCCCC
Q 039231          449 TVGYIAPEVFCRNIGEVSYKSDVYNYGMMIFEMTGGRKNVDVVDNG  494 (506)
Q Consensus       449 t~~y~aPE~l~~~~~~~s~~~Dv~s~G~il~elltg~~pf~~~~~~  494 (506)
                      |+.|+|||.+.+.  .++.++||||||+++|||++|+.||...+..
T Consensus       179 t~~y~aPE~~~~~--~~~~~~DiwslG~il~ell~g~~pf~~~~~~  222 (297)
T 3fxz_A          179 TPYWMAPEVVTRK--AYGPKVDIWSLGIMAIEMIEGEPPYLNENPL  222 (297)
T ss_dssp             CGGGCCHHHHHCS--CBCTHHHHHHHHHHHHHHHHSSCTTTTSCHH
T ss_pred             CcCccChhhhcCC--CCCcHHHHHHHHHHHHHHHhCCCCCCCCCHH
Confidence            9999999998654  7899999999999999999999999766543

>1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ...

Probab=99.98  E-value=8.7e-33  Score=275.59  Aligned_cols=171  Identities=30%  Similarity=0.380  Sum_probs=144.2

Q ss_pred             hccccCccCceEEEEEEEc-CCCEEEEEEeccC----CCCchhhHHHHHHhhccCccceeEEEEEee-------------
Q 039231          317 FKYKLGQGGYGSVYKGKLL-DGSNVAVKVLNDS----KGNGKEFINEVASISRTSHVNVVALLGFCL-------------  378 (506)
Q Consensus       317 ~~~~ig~G~~g~V~~~~~~-~~~~vavK~l~~~----~~~~~~~~~E~~~l~~l~h~niv~l~g~~~-------------  378 (506)
                      +.+.||+|+||.||+|+.. +|+.||+|++++.    ....+.+.+|++++++++||||+++++++.             
T Consensus         9 ~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~~~~lv~E~~~   88 (337)
T 1o6l_A            9 YLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVMEYAN   88 (337)
T ss_dssp             EEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEEEEEECCT
T ss_pred             EEEEEecCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhCCCCcCcceEEEEEeCCEEEEEEeCCC
Confidence            3568999999999999985 5899999999652    344567899999999999999999998772             


Q ss_pred             --------------ccchhhhHHHHHHHHHHHHhhcCCCCeEecCcCCCcEEECCCCcEEEeecCCCccccCCCcceecc
Q 039231          379 --------------RVAEELSSTIGIARGLEYLHLGCSTRILHFDIKPHNILLDEDFCPKISDFGLAKICNRKESIISMT  444 (506)
Q Consensus       379 --------------~~~~~l~i~~~i~~gl~~LH~~~~~~ivH~dlkp~Nill~~~~~~ki~dfg~a~~~~~~~~~~~~~  444 (506)
                                    ++.+...++.||+.||+|||   +++|+||||||+|||++.++.+||+|||+++.......  ...
T Consensus        89 gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH---~~~ivHrDlkp~NIll~~~g~vkL~DFG~a~~~~~~~~--~~~  163 (337)
T 1o6l_A           89 GGELFFHLSRERVFTEERARFYGAEIVSALEYLH---SRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGA--TMK  163 (337)
T ss_dssp             TCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHH---HTTCBCCCCCGGGEEECTTSCEEECCCTTCBCSCCTTC--CBC
T ss_pred             CCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH---HCCeecCcCCHHHEEECCCCCEEEeeccchhhcccCCC--ccc
Confidence                          23345678899999999999   89999999999999999999999999999986433222  124


Q ss_pred             cCCCCcccccccccccccCCCCccccHHHHHHHHHHHHcCCCCCCCCCCC
Q 039231          445 GARGTVGYIAPEVFCRNIGEVSYKSDVYNYGMMIFEMTGGRKNVDVVDNG  494 (506)
Q Consensus       445 ~~~gt~~y~aPE~l~~~~~~~s~~~Dv~s~G~il~elltg~~pf~~~~~~  494 (506)
                      ...||+.|+|||++.+.  .++.++||||||+++|||++|+.||...+..
T Consensus       164 ~~~gt~~y~aPE~~~~~--~~~~~~DiwslG~il~ell~g~~Pf~~~~~~  211 (337)
T 1o6l_A          164 TFCGTPEYLAPEVLEDN--DYGRAVDWWGLGVVMYEMMCGRLPFYNQDHE  211 (337)
T ss_dssp             CCEECGGGCCGGGGSSS--CBCTTHHHHHHHHHHHHHHHSSCSSCCSSHH
T ss_pred             ccccChhhCChhhhcCC--CCCchhhcccchhHHHHHhcCCCCCCCCCHH
Confidence            56789999999998654  7899999999999999999999999765443

>3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 4asx_A* 2qlu_A*

Probab=99.98  E-value=3.7e-33  Score=276.80  Aligned_cols=173  Identities=31%  Similarity=0.428  Sum_probs=144.6

Q ss_pred             hccccCccCceEEEEEEEcCCCEEEEEEeccCCCCchhhHHHHHHhhccCccceeEEEEEee------------------
Q 039231          317 FKYKLGQGGYGSVYKGKLLDGSNVAVKVLNDSKGNGKEFINEVASISRTSHVNVVALLGFCL------------------  378 (506)
Q Consensus       317 ~~~~ig~G~~g~V~~~~~~~~~~vavK~l~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~------------------  378 (506)
                      +.++||+|+||.||+|+.. ++.||||++...........+|+.++.+++||||+++++++.                  
T Consensus        28 ~~~~lg~G~~g~Vy~~~~~-~~~vavK~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~lv~e~~~~  106 (322)
T 3soc_A           28 LLEVKARGRFGCVWKAQLL-NEYVAVKIFPIQDKQSWQNEYEVYSLPGMKHENILQFIGAEKRGTSVDVDLWLITAFHEK  106 (322)
T ss_dssp             EEEEEECSTTCEEEEEEET-TEEEEEEEECGGGHHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEEEECCTT
T ss_pred             hhheecccCceEEEEEEEC-CCEEEEEEeecCchHHHHHHHHHHHHhcCCCCCchhhcceeccCCCCCceEEEEEecCCC
Confidence            4567999999999999884 799999999765555566777999999999999999998762                  


Q ss_pred             ------------ccchhhhHHHHHHHHHHHHhhcCCC----------CeEecCcCCCcEEECCCCcEEEeecCCCccccC
Q 039231          379 ------------RVAEELSSTIGIARGLEYLHLGCST----------RILHFDIKPHNILLDEDFCPKISDFGLAKICNR  436 (506)
Q Consensus       379 ------------~~~~~l~i~~~i~~gl~~LH~~~~~----------~ivH~dlkp~Nill~~~~~~ki~dfg~a~~~~~  436 (506)
                                  ++.+.+.++.|++.||+|||   +.          +|+||||||+|||++.++.+||+|||+++....
T Consensus       107 g~L~~~l~~~~~~~~~~~~i~~qi~~al~~LH---~~~~~l~~~~~~~ivH~Dlkp~Nill~~~~~~kL~DFg~a~~~~~  183 (322)
T 3soc_A          107 GSLSDFLKANVVSWNELCHIAETMARGLAYLH---EDIPGLKDGHKPAISHRDIKSKNVLLKNNLTACIADFGLALKFEA  183 (322)
T ss_dssp             CBHHHHHHHCCBCHHHHHHHHHHHHHHHHHHT---CCEEEETTEEECEEECSCCSGGGEEECTTCCEEECCCTTCEEECT
T ss_pred             CCHHHHHHhcCCCHHHHHHHHHHHHHHHHHHH---hhccccccccCCCEEeCCCChHhEEECCCCeEEEccCCccccccc
Confidence                        23346778999999999999   78          999999999999999999999999999987765


Q ss_pred             CCcceecccCCCCccccccccccccc---CCCCccccHHHHHHHHHHHHcCCCCCCCCCC
Q 039231          437 KESIISMTGARGTVGYIAPEVFCRNI---GEVSYKSDVYNYGMMIFEMTGGRKNVDVVDN  493 (506)
Q Consensus       437 ~~~~~~~~~~~gt~~y~aPE~l~~~~---~~~s~~~Dv~s~G~il~elltg~~pf~~~~~  493 (506)
                      ...........||+.|+|||++.+..   ..++.++||||||+++|||++|+.||....+
T Consensus       184 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~  243 (322)
T 3soc_A          184 GKSAGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGPVD  243 (322)
T ss_dssp             TSCCCCCTTCCCCGGGCCHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHTTBTTSSSCCC
T ss_pred             ccCccccccCccCccccCHhhcccccccCcCCCccchhHHHHHHHHHHHhCCCCCCCCcc
Confidence            54433334567999999999986421   2456788999999999999999999987554

>1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A

Probab=99.98  E-value=4.7e-33  Score=271.47  Aligned_cols=174  Identities=29%  Similarity=0.409  Sum_probs=142.3

Q ss_pred             hccccCccCceEEEEEEEcCCCEEEEEEeccCC---CCchhhHHHHHHhhccCccceeEEEEEee---------------
Q 039231          317 FKYKLGQGGYGSVYKGKLLDGSNVAVKVLNDSK---GNGKEFINEVASISRTSHVNVVALLGFCL---------------  378 (506)
Q Consensus       317 ~~~~ig~G~~g~V~~~~~~~~~~vavK~l~~~~---~~~~~~~~E~~~l~~l~h~niv~l~g~~~---------------  378 (506)
                      +.+.||+|+||.||+|+..+++.||+|++....   ...+.+.+|++++++++||||+++++++.               
T Consensus         6 ~~~~lg~G~~g~V~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~   85 (288)
T 1ob3_A            6 GLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVFEHLDQD   85 (288)
T ss_dssp             EEEEEEEETTEEEEEEEETTSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEEEECCSEE
T ss_pred             hhhhcccCCCEEEEEEEcCCCCEEEEEEEeccccccccchhHHHHHHHHHhcCCCCEeeeeeEEccCCeEEEEEEecCCC
Confidence            456899999999999999889999999996543   23367889999999999999999999872               


Q ss_pred             ------------ccchhhhHHHHHHHHHHHHhhcCCCCeEecCcCCCcEEECCCCcEEEeecCCCccccCCCcceecccC
Q 039231          379 ------------RVAEELSSTIGIARGLEYLHLGCSTRILHFDIKPHNILLDEDFCPKISDFGLAKICNRKESIISMTGA  446 (506)
Q Consensus       379 ------------~~~~~l~i~~~i~~gl~~LH~~~~~~ivH~dlkp~Nill~~~~~~ki~dfg~a~~~~~~~~~~~~~~~  446 (506)
                                  ++.+.+.++.|++.||+|||   +++|+||||||+||+++.++.+||+|||+++........  ....
T Consensus        86 l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~--~~~~  160 (288)
T 1ob3_A           86 LKKLLDVCEGGLESVTAKSFLLQLLNGIAYCH---DRRVLHRDLKPQNLLINREGELKIADFGLARAFGIPVRK--YTHE  160 (288)
T ss_dssp             HHHHHHTSTTCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEECTTSCEEECCTTHHHHHCC----------
T ss_pred             HHHHHHhcccCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHEEEcCCCCEEEeECccccccCccccc--cccc
Confidence                        22335678999999999999   899999999999999999999999999999876433221  2345


Q ss_pred             CCCcccccccccccccCCCCccccHHHHHHHHHHHHcCCCCCCCCCCCcc
Q 039231          447 RGTVGYIAPEVFCRNIGEVSYKSDVYNYGMMIFEMTGGRKNVDVVDNGST  496 (506)
Q Consensus       447 ~gt~~y~aPE~l~~~~~~~s~~~Dv~s~G~il~elltg~~pf~~~~~~~~  496 (506)
                      .+|+.|+|||++.+. ..++.++||||||+++|||++|+.||...+..+.
T Consensus       161 ~~t~~y~aPE~~~~~-~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~  209 (288)
T 1ob3_A          161 IVTLWYRAPDVLMGS-KKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQ  209 (288)
T ss_dssp             -CCCTTCCHHHHTTC-CSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHH
T ss_pred             cccccccCchheeCC-CCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHH
Confidence            689999999998653 3689999999999999999999999987654433

>2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A*

Probab=99.98  E-value=2.2e-32  Score=270.91  Aligned_cols=186  Identities=40%  Similarity=0.698  Sum_probs=151.2

Q ss_pred             ccCHHHHHHHHhhh--ccccCccCceEEEEEEEcCCCEEEEEEeccCCC-CchhhHHHHHHhhccCccceeEEEEEe---
Q 039231          304 RYGYADIKKMTNSF--KYKLGQGGYGSVYKGKLLDGSNVAVKVLNDSKG-NGKEFINEVASISRTSHVNVVALLGFC---  377 (506)
Q Consensus       304 ~~~~~el~~~~~~~--~~~ig~G~~g~V~~~~~~~~~~vavK~l~~~~~-~~~~~~~E~~~l~~l~h~niv~l~g~~---  377 (506)
                      ++++.++...+.+|  .+.||+|+||.||+|++++++.||||++..... ..+.+.+|++++++++||||+++++++   
T Consensus        28 ~~~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~  107 (321)
T 2qkw_B           28 RVPLVDLEEATNNFDHKFLIGHGVFGKVYKGVLRDGAKVALKRRTPESSQGIEEFETEIETLSFCRHPHLVSLIGFCDER  107 (321)
T ss_dssp             --CCSCCCCCCCCCSCCCCSCBCSSSEEEEEECTTCCEEEEEECCSCCSSHHHHHHHHHHGGGSCCCTTBCCEEEECCCT
T ss_pred             eecHHHHHHHHhccCccceeecCCCeeEEEEEECCCCEEEEEEecccChHHHHHHHHHHHHHHhCCCCCEeeEEEEEcCC
Confidence            34444455555555  367999999999999988899999999876433 346789999999999999999999987   


Q ss_pred             ----------------------------eccchhhhHHHHHHHHHHHHhhcCCCCeEecCcCCCcEEECCCCcEEEeecC
Q 039231          378 ----------------------------LRVAEELSSTIGIARGLEYLHLGCSTRILHFDIKPHNILLDEDFCPKISDFG  429 (506)
Q Consensus       378 ----------------------------~~~~~~l~i~~~i~~gl~~LH~~~~~~ivH~dlkp~Nill~~~~~~ki~dfg  429 (506)
                                                  +++.+++.++.|++.||+|||   +++|+||||||+||+++.++.+||+|||
T Consensus       108 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH---~~~ivH~dlkp~Nil~~~~~~~kl~Dfg  184 (321)
T 2qkw_B          108 NEMILIYKYMENGNLKRHLYGSDLPTMSMSWEQRLEICIGAARGLHYLH---TRAIIHRDVKSINILLDENFVPKITDFG  184 (321)
T ss_dssp             TCCEEEEECCTTCBTGGGSSSSCCCSCCCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCCSTTEEECTTCCEEECCCT
T ss_pred             CeEEEEEEcCCCCcHHHHHhccCCCccccCHHHHHHHHHHHHHHHHHhc---CCCeecCCCCHHHEEECCCCCEEEeecc
Confidence                                        122346779999999999999   8999999999999999999999999999


Q ss_pred             CCccccCCCcceecccCCCCcccccccccccccCCCCccccHHHHHHHHHHHHcCCCCCCCCCCC
Q 039231          430 LAKICNRKESIISMTGARGTVGYIAPEVFCRNIGEVSYKSDVYNYGMMIFEMTGGRKNVDVVDNG  494 (506)
Q Consensus       430 ~a~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~s~~~Dv~s~G~il~elltg~~pf~~~~~~  494 (506)
                      +++...............||+.|+|||.+.+.  .++.++||||||+++|||++|+.||......
T Consensus       185 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~~Di~slG~il~ell~g~~p~~~~~~~  247 (321)
T 2qkw_B          185 ISKKGTELDQTHLSTVVKGTLGYIDPEYFIKG--RLTEKSDVYSFGVVLFEVLCARSAIVQSLPR  247 (321)
T ss_dssp             TCEECSSSSCCCCBCCCEEETTTCCHHHHHHC--BCCTHHHHHHHHHHHHHHHHCCTTCSCSSSS
T ss_pred             cccccccccccccccccCCCccccCHHHhcCC--CCCcccchHhHHHHHHHHHhCCCcccccCcH
Confidence            99875543322222345689999999998654  7899999999999999999999999865543

>2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A*

Probab=99.98  E-value=4.4e-32  Score=266.87  Aligned_cols=188  Identities=36%  Similarity=0.612  Sum_probs=158.0

Q ss_pred             CCccCHHHHHHHHhhhc--------cccCccCceEEEEEEEcCCCEEEEEEeccCC-----CCchhhHHHHHHhhccCcc
Q 039231          302 PKRYGYADIKKMTNSFK--------YKLGQGGYGSVYKGKLLDGSNVAVKVLNDSK-----GNGKEFINEVASISRTSHV  368 (506)
Q Consensus       302 ~~~~~~~el~~~~~~~~--------~~ig~G~~g~V~~~~~~~~~~vavK~l~~~~-----~~~~~~~~E~~~l~~l~h~  368 (506)
                      ...|++.++.+++.+|.        +.||+|+||.||+|+. +++.||||++....     ...+.+.+|++++++++||
T Consensus        12 ~~~~~~~~l~~~~~~f~~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~   90 (307)
T 2nru_A           12 FHSFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYV-NNTTVAVKKLAAMVDITTEELKQQFDQEIKVMAKCQHE   90 (307)
T ss_dssp             CEECCHHHHHHHTTTTCCSBTTTTCCEEEECSSEEEEEEES-SSCEEEEEEECCCTTSCTTTHHHHHHHHHHHHHHCCCT
T ss_pred             CCcccHHHHHHHHcccccccccccCCccccCCCeEEEEEEE-CCceEEEEEEecccCcchHHHHHHHHHHHHHHHhcCCC
Confidence            46789999999999986        4599999999999987 68899999986532     2236788999999999999


Q ss_pred             ceeEEEEEee------------------------------ccchhhhHHHHHHHHHHHHhhcCCCCeEecCcCCCcEEEC
Q 039231          369 NVVALLGFCL------------------------------RVAEELSSTIGIARGLEYLHLGCSTRILHFDIKPHNILLD  418 (506)
Q Consensus       369 niv~l~g~~~------------------------------~~~~~l~i~~~i~~gl~~LH~~~~~~ivH~dlkp~Nill~  418 (506)
                      ||+++++++.                              ++...+.++.|++.||+|||   +++|+||||||+||+++
T Consensus        91 ~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lH---~~~i~H~dlkp~Nili~  167 (307)
T 2nru_A           91 NLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLDGTPPLSWHMRCKIAQGAANGINFLH---ENHHIHRDIKSANILLD  167 (307)
T ss_dssp             TBCCEEEEECSSSSCEEEEECCTTCBHHHHHHTGGGCCCCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCCGGGEEEC
T ss_pred             CeEEEEEEEecCCceEEEEEecCCCcHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHh---cCCeecCCCCHHHEEEc
Confidence            9999999872                              22335678999999999999   89999999999999999


Q ss_pred             CCCcEEEeecCCCccccCCCcceecccCCCCcccccccccccccCCCCccccHHHHHHHHHHHHcCCCCCCCCCCCcc
Q 039231          419 EDFCPKISDFGLAKICNRKESIISMTGARGTVGYIAPEVFCRNIGEVSYKSDVYNYGMMIFEMTGGRKNVDVVDNGST  496 (506)
Q Consensus       419 ~~~~~ki~dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~s~~~Dv~s~G~il~elltg~~pf~~~~~~~~  496 (506)
                      +++.+||+|||+++...............||+.|+|||.+.+   .++.++||||||+++|||++|+.||......+.
T Consensus       168 ~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~---~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~  242 (307)
T 2nru_A          168 EAFTAKISDFGLARASEKFAQTVMTSRIVGTTAYMAPEALRG---EITPKSDIYSFGVVLLEIITGLPAVDEHREPQL  242 (307)
T ss_dssp             TTCCEEECCCTTCEECCSCSSCEECSSCCSCGGGCCHHHHTT---EECTHHHHHHHHHHHHHHHHCCCSBCTTBSSSB
T ss_pred             CCCcEEEeecccccccccccccccccccCCCcCcCChHHhcC---CCCccchhHHHHHHHHHHHHCCCCcccCcchHH
Confidence            999999999999987655433333344678999999998843   578899999999999999999999987665443

>4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens}

Probab=99.98  E-value=3.2e-32  Score=275.79  Aligned_cols=173  Identities=27%  Similarity=0.417  Sum_probs=145.9

Q ss_pred             hhccccCccCceEEEEEEEcC-CCEEEEEEeccC----CCCchhhHHHHHHhhccCccceeEEEEEe-------------
Q 039231          316 SFKYKLGQGGYGSVYKGKLLD-GSNVAVKVLNDS----KGNGKEFINEVASISRTSHVNVVALLGFC-------------  377 (506)
Q Consensus       316 ~~~~~ig~G~~g~V~~~~~~~-~~~vavK~l~~~----~~~~~~~~~E~~~l~~l~h~niv~l~g~~-------------  377 (506)
                      .+.+.||+|+||.||+|+... ++.||+|++...    ....+.+.+|++++++++|||||++++++             
T Consensus        18 ~i~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~lv~e~~   97 (384)
T 4fr4_A           18 EILRAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLEHPFLVNLWYSFQDEEDMFMVVDLL   97 (384)
T ss_dssp             EEEEEEECCTTCCEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEECCC
T ss_pred             EEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehhhcccHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEEEEecC
Confidence            345789999999999999754 889999999642    33457789999999999999999999887             


Q ss_pred             --------------eccchhhhHHHHHHHHHHHHhhcCCCCeEecCcCCCcEEECCCCcEEEeecCCCccccCCCcceec
Q 039231          378 --------------LRVAEELSSTIGIARGLEYLHLGCSTRILHFDIKPHNILLDEDFCPKISDFGLAKICNRKESIISM  443 (506)
Q Consensus       378 --------------~~~~~~l~i~~~i~~gl~~LH~~~~~~ivH~dlkp~Nill~~~~~~ki~dfg~a~~~~~~~~~~~~  443 (506)
                                    +++.+...++.||+.||+|||   +++|+||||||+|||++.++.+||+|||+++.......   .
T Consensus        98 ~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~LH---~~givHrDlkp~NIll~~~g~vkL~DFG~a~~~~~~~~---~  171 (384)
T 4fr4_A           98 LGGDLRYHLQQNVHFKEETVKLFICELVMALDYLQ---NQRIIHRDMKPDNILLDEHGHVHITDFNIAAMLPRETQ---I  171 (384)
T ss_dssp             TTEEHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTTSCEEECCCTTCEECCTTCC---B
T ss_pred             CCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH---HCCceeccCcHHHeEECCCCCEEEeccceeeeccCCCc---e
Confidence                          233346678999999999999   89999999999999999999999999999987654432   2


Q ss_pred             ccCCCCcccccccccccc-cCCCCccccHHHHHHHHHHHHcCCCCCCCCCCC
Q 039231          444 TGARGTVGYIAPEVFCRN-IGEVSYKSDVYNYGMMIFEMTGGRKNVDVVDNG  494 (506)
Q Consensus       444 ~~~~gt~~y~aPE~l~~~-~~~~s~~~Dv~s~G~il~elltg~~pf~~~~~~  494 (506)
                      ....||+.|+|||++... ...++.++||||||+++|||++|+.||......
T Consensus       172 ~~~~gt~~Y~aPE~~~~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~  223 (384)
T 4fr4_A          172 TTMAGTKPYMAPEMFSSRKGAGYSFAVDWWSLGVTAYELLRGRRPYHIRSST  223 (384)
T ss_dssp             CCCCSCGGGCCGGGTCCCSSCCBCTTHHHHHHHHHHHHHHHSSCSSCCCTTS
T ss_pred             eccCCCccccCCeeeccCCCCCCCccceeechHHHHHHHHhCCCCCCCCCCc
Confidence            557799999999998643 235889999999999999999999999865443

>3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A*

Probab=99.98  E-value=1.9e-32  Score=271.75  Aligned_cols=175  Identities=30%  Similarity=0.407  Sum_probs=144.7

Q ss_pred             hccccCccCceEEEEEEEc-CCCEEEEEEeccCC--CCchhhHHHHHHhhccCccceeEEEEEe----------------
Q 039231          317 FKYKLGQGGYGSVYKGKLL-DGSNVAVKVLNDSK--GNGKEFINEVASISRTSHVNVVALLGFC----------------  377 (506)
Q Consensus       317 ~~~~ig~G~~g~V~~~~~~-~~~~vavK~l~~~~--~~~~~~~~E~~~l~~l~h~niv~l~g~~----------------  377 (506)
                      +.+.||+|+||.||+|+.. +++.||||++....  ...+.+.+|+.++++++||||+++++++                
T Consensus        11 i~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~~~~~   90 (323)
T 3tki_A           11 LVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLEYCSGG   90 (323)
T ss_dssp             EEEEEEEETTEEEEEEEETTTCCEEEEEEEECC-------CHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEECCTTE
T ss_pred             eeeEEecCCCEEEEEEEECCCCcEEEEEEEEcccccchHHHHHHHHHHHHhCCCCCCCeEEEEEecCCeEEEEEEcCCCC
Confidence            3567999999999999986 68999999996443  2336789999999999999999999887                


Q ss_pred             -----------eccchhhhHHHHHHHHHHHHhhcCCCCeEecCcCCCcEEECCCCcEEEeecCCCccccCCCcceecccC
Q 039231          378 -----------LRVAEELSSTIGIARGLEYLHLGCSTRILHFDIKPHNILLDEDFCPKISDFGLAKICNRKESIISMTGA  446 (506)
Q Consensus       378 -----------~~~~~~l~i~~~i~~gl~~LH~~~~~~ivH~dlkp~Nill~~~~~~ki~dfg~a~~~~~~~~~~~~~~~  446 (506)
                                 +++.+.+.++.|++.||+|||   +++|+||||||+|||++.++.+||+|||+++..............
T Consensus        91 ~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH---~~givH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~  167 (323)
T 3tki_A           91 ELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLH---GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKM  167 (323)
T ss_dssp             EGGGGSBTTTBCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECTTCCEEECCCTTCEECEETTEECCBCSC
T ss_pred             cHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHH---HCCccccccchHHEEEeCCCCEEEEEeeccceeccCCcccccCCC
Confidence                       223346789999999999999   899999999999999999999999999999876544333333457


Q ss_pred             CCCcccccccccccccCCCCccccHHHHHHHHHHHHcCCCCCCCCCCCc
Q 039231          447 RGTVGYIAPEVFCRNIGEVSYKSDVYNYGMMIFEMTGGRKNVDVVDNGS  495 (506)
Q Consensus       447 ~gt~~y~aPE~l~~~~~~~s~~~Dv~s~G~il~elltg~~pf~~~~~~~  495 (506)
                      .||+.|+|||++.+. ...+.++||||||+++|||++|+.||.......
T Consensus       168 ~gt~~y~aPE~~~~~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~  215 (323)
T 3tki_A          168 CGTLPYVAPELLKRR-EFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSC  215 (323)
T ss_dssp             CSCGGGSCHHHHHCS-SBCHHHHHHHHHHHHHHHHHHSSCSCSSSCTTS
T ss_pred             ccCcCccCcHHhccC-CCCCCcccHHHHHHHHHHHHhCCCCCCCCchHH
Confidence            799999999998654 234778999999999999999999998766543

>2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A*

Probab=99.98  E-value=3e-32  Score=269.60  Aligned_cols=174  Identities=28%  Similarity=0.398  Sum_probs=136.2

Q ss_pred             hccccCccCceEEEEEEEc-CCCEEEEEEeccCC--CCchhhHHHHHHhhccCccceeEEEEEeec--------------
Q 039231          317 FKYKLGQGGYGSVYKGKLL-DGSNVAVKVLNDSK--GNGKEFINEVASISRTSHVNVVALLGFCLR--------------  379 (506)
Q Consensus       317 ~~~~ig~G~~g~V~~~~~~-~~~~vavK~l~~~~--~~~~~~~~E~~~l~~l~h~niv~l~g~~~~--------------  379 (506)
                      +.++||+|+||.||+|+.. +++.||+|+++...  ...+.+.+|++++++++||||+++++++..              
T Consensus         9 ~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~~   88 (317)
T 2pmi_A            9 QLEKLGNGTYATVYKGLNKTTGVYVALKEVKLDSEEGTPSTAIREISLMKELKHENIVRLYDVIHTENKLTLVFEFMDND   88 (317)
T ss_dssp             ----------CEEEEEECSSSCCEEEEEEEECCSTTCSCHHHHHHHHHHTTCCBTTBCCEEEEECCTTEEEEEEECCCCB
T ss_pred             EeeEECCCCCEEEEEEEECCCCcEEEEEEeecccccccHHHHHHHHHHHHhcCCCCcceEEEEEEECCeEEEEEEecCCC
Confidence            3467999999999999875 58999999997543  334778999999999999999999998721              


Q ss_pred             ------------------cchhhhHHHHHHHHHHHHhhcCCCCeEecCcCCCcEEECCCCcEEEeecCCCccccCCCcce
Q 039231          380 ------------------VAEELSSTIGIARGLEYLHLGCSTRILHFDIKPHNILLDEDFCPKISDFGLAKICNRKESII  441 (506)
Q Consensus       380 ------------------~~~~l~i~~~i~~gl~~LH~~~~~~ivH~dlkp~Nill~~~~~~ki~dfg~a~~~~~~~~~~  441 (506)
                                        +.....++.||+.||+|||   +++|+||||||+|||++.++.+||+|||+++........ 
T Consensus        89 L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH---~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~-  164 (317)
T 2pmi_A           89 LKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGLAFCH---ENKILHRDLKPQNLLINKRGQLKLGDFGLARAFGIPVNT-  164 (317)
T ss_dssp             HHHHHHHHHSSSCCCCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEECTTCCEEECCCSSCEETTSCCCC-
T ss_pred             HHHHHHhccccccccCCCHHHHHHHHHHHHHHHHHHH---HCCeeeCCCChHHeEEcCCCCEEECcCccceecCCCccc-
Confidence                              1224567889999999999   899999999999999999999999999999876543221 


Q ss_pred             ecccCCCCcccccccccccccCCCCccccHHHHHHHHHHHHcCCCCCCCCCCCcc
Q 039231          442 SMTGARGTVGYIAPEVFCRNIGEVSYKSDVYNYGMMIFEMTGGRKNVDVVDNGST  496 (506)
Q Consensus       442 ~~~~~~gt~~y~aPE~l~~~~~~~s~~~Dv~s~G~il~elltg~~pf~~~~~~~~  496 (506)
                       .....+|+.|+|||++.+. ..++.++||||||+++|||++|+.||...++.+.
T Consensus       165 -~~~~~~t~~y~aPE~~~~~-~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~  217 (317)
T 2pmi_A          165 -FSSEVVTLWYRAPDVLMGS-RTYSTSIDIWSCGCILAEMITGKPLFPGTNDEEQ  217 (317)
T ss_dssp             -CCCCCSCCTTCCHHHHTTC-CCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHH
T ss_pred             -CCCCcccccccCchHhhCC-CCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHH
Confidence             2446789999999998653 3689999999999999999999999987655443

>3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens}

Probab=99.98  E-value=6.2e-33  Score=278.43  Aligned_cols=175  Identities=26%  Similarity=0.349  Sum_probs=141.9

Q ss_pred             hhccccCccCceEEEEEEEc-CCCEEEEEEeccC----CCCchhhHHHHHHhhcc-CccceeEEEEEe------------
Q 039231          316 SFKYKLGQGGYGSVYKGKLL-DGSNVAVKVLNDS----KGNGKEFINEVASISRT-SHVNVVALLGFC------------  377 (506)
Q Consensus       316 ~~~~~ig~G~~g~V~~~~~~-~~~~vavK~l~~~----~~~~~~~~~E~~~l~~l-~h~niv~l~g~~------------  377 (506)
                      .+.++||+|+||.||+|+.. +++.||||+++..    ....+.+.+|.+++..+ +||||+++++++            
T Consensus        26 ~~~~~lG~G~fg~V~~~~~~~~~~~~AvK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~~~~lv~E~  105 (353)
T 3txo_A           26 EFIRVLGKGSFGKVMLARVKETGDLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLFCCFQTPDRLFFVMEF  105 (353)
T ss_dssp             EEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHHTTHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEEEC
T ss_pred             EEEEEEeeCCCEEEEEEEEcCCCCEEEEEEEEHHHhcchhHHHHHHHHHHHHHhccCCCceeeEEEEEEeCCEEEEEEeC
Confidence            44578999999999999975 4899999999753    23446788999999988 699999999887            


Q ss_pred             ---------------eccchhhhHHHHHHHHHHHHhhcCCCCeEecCcCCCcEEECCCCcEEEeecCCCccccCCCccee
Q 039231          378 ---------------LRVAEELSSTIGIARGLEYLHLGCSTRILHFDIKPHNILLDEDFCPKISDFGLAKICNRKESIIS  442 (506)
Q Consensus       378 ---------------~~~~~~l~i~~~i~~gl~~LH~~~~~~ivH~dlkp~Nill~~~~~~ki~dfg~a~~~~~~~~~~~  442 (506)
                                     +++.+...++.||+.||+|||   +++|+||||||+|||++.++.+||+|||+++.......  .
T Consensus       106 ~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH---~~givHrDlkp~NILl~~~g~ikL~DFG~a~~~~~~~~--~  180 (353)
T 3txo_A          106 VNGGDLMFHIQKSRRFDEARARFYAAEIISALMFLH---DKGIIYRDLKLDNVLLDHEGHCKLADFGMCKEGICNGV--T  180 (353)
T ss_dssp             CCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHH---HTTCBCCCCCGGGEEECTTSCEEECCCTTCBCSCC------
T ss_pred             CCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHH---HCCCcccCCCHHHEEECCCCCEEEccccceeecccCCc--c
Confidence                           233346678999999999999   89999999999999999999999999999986433222  1


Q ss_pred             cccCCCCcccccccccccccCCCCccccHHHHHHHHHHHHcCCCCCCCCCCCcch
Q 039231          443 MTGARGTVGYIAPEVFCRNIGEVSYKSDVYNYGMMIFEMTGGRKNVDVVDNGSTA  497 (506)
Q Consensus       443 ~~~~~gt~~y~aPE~l~~~~~~~s~~~Dv~s~G~il~elltg~~pf~~~~~~~~~  497 (506)
                      .....||+.|+|||++.+.  .++.++||||||+++|||++|+.||...+..+..
T Consensus       181 ~~~~~gt~~y~aPE~~~~~--~~~~~~DiwslG~il~ell~G~~Pf~~~~~~~~~  233 (353)
T 3txo_A          181 TATFCGTPDYIAPEILQEM--LYGPAVDWWAMGVLLYEMLCGHAPFEAENEDDLF  233 (353)
T ss_dssp             -----CCGGGCCHHHHHHH--HCTTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHH
T ss_pred             ccccCCCcCeEChhhcCCC--CcCCccCCCcchHHHHHHHhCCCCCCCCCHHHHH
Confidence            2456799999999998654  6899999999999999999999999876554433

>3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} SCOP: d.144.1.7 PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A

Probab=99.98  E-value=3.1e-32  Score=266.15  Aligned_cols=171  Identities=25%  Similarity=0.347  Sum_probs=142.8

Q ss_pred             hccccCccCceEEEEEEEc-CCCEEEEEEeccCCCC---chhhHHHHHHhhccCccceeEEEEEe---------------
Q 039231          317 FKYKLGQGGYGSVYKGKLL-DGSNVAVKVLNDSKGN---GKEFINEVASISRTSHVNVVALLGFC---------------  377 (506)
Q Consensus       317 ~~~~ig~G~~g~V~~~~~~-~~~~vavK~l~~~~~~---~~~~~~E~~~l~~l~h~niv~l~g~~---------------  377 (506)
                      +.++||+|+||+||+|+.. +++.||||++......   .+.+.+|++++++++||||+++++++               
T Consensus         6 ~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~   85 (292)
T 3o0g_A            6 KLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFEFCDQ   85 (292)
T ss_dssp             EEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEECCSE
T ss_pred             eeeEecCCCCeEEEEEEECCCCceEEEEeeeccCCcCCcchHHHHHHHHHhcCCCCCEeeEEeEEEeCCEEEEEEecCCC
Confidence            4568999999999999985 4899999999754332   26788999999999999999999987               


Q ss_pred             ------------eccchhhhHHHHHHHHHHHHhhcCCCCeEecCcCCCcEEECCCCcEEEeecCCCccccCCCcceeccc
Q 039231          378 ------------LRVAEELSSTIGIARGLEYLHLGCSTRILHFDIKPHNILLDEDFCPKISDFGLAKICNRKESIISMTG  445 (506)
Q Consensus       378 ------------~~~~~~l~i~~~i~~gl~~LH~~~~~~ivH~dlkp~Nill~~~~~~ki~dfg~a~~~~~~~~~~~~~~  445 (506)
                                  +++.+.+.++.|++.||+|||   +++|+||||||+|||++.++.+||+|||+++........  ...
T Consensus        86 ~l~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH---~~~ivH~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~--~~~  160 (292)
T 3o0g_A           86 DLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCH---SRNVLHRDLKPQNLLINRNGELKLANFGLARAFGIPVRC--YSA  160 (292)
T ss_dssp             EHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTTSCEEECCCTTCEECCSCCSC--CCS
T ss_pred             CHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEEcCCCCEEEeecccceecCCcccc--ccC
Confidence                        223346778999999999999   899999999999999999999999999999876543322  244


Q ss_pred             CCCCcccccccccccccCCCCccccHHHHHHHHHHHHcCCCCCCCCCC
Q 039231          446 ARGTVGYIAPEVFCRNIGEVSYKSDVYNYGMMIFEMTGGRKNVDVVDN  493 (506)
Q Consensus       446 ~~gt~~y~aPE~l~~~~~~~s~~~Dv~s~G~il~elltg~~pf~~~~~  493 (506)
                      ..+|+.|+|||.+.+. ..++.++||||||+++|||++|..||....+
T Consensus       161 ~~~t~~y~aPE~~~~~-~~~~~~~DiwslG~il~~l~~~~~p~~~~~~  207 (292)
T 3o0g_A          161 EVVTLWYRPPDVLFGA-KLYSTSIDMWSAGCIFAELANAGRPLFPGND  207 (292)
T ss_dssp             CCSCGGGCCHHHHTTC-SCCCTHHHHHHHHHHHHHHTTTSCCSCCCSS
T ss_pred             CccccCCcChHHHcCC-CCcCchHHHHHHHHHHHHHHHcCCCCcCCCC
Confidence            6789999999998654 3479999999999999999998888654433

>1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7

Probab=99.98  E-value=2.4e-32  Score=270.28  Aligned_cols=169  Identities=30%  Similarity=0.384  Sum_probs=143.8

Q ss_pred             hccccCccCceEEEEEEEc-CCCEEEEEEeccC----CCCchhhHHHHHHhhccCccceeEEEEEee-------------
Q 039231          317 FKYKLGQGGYGSVYKGKLL-DGSNVAVKVLNDS----KGNGKEFINEVASISRTSHVNVVALLGFCL-------------  378 (506)
Q Consensus       317 ~~~~ig~G~~g~V~~~~~~-~~~~vavK~l~~~----~~~~~~~~~E~~~l~~l~h~niv~l~g~~~-------------  378 (506)
                      +.+.||+|+||.||+|+.. +|+.||+|+++..    ....+.+.+|+.+++.++||||+++++++.             
T Consensus        10 ~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lv~e~~~   89 (318)
T 1fot_A           10 ILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFMIMDYIE   89 (318)
T ss_dssp             EEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEEEEECCCC
T ss_pred             EEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhhCCCCCCceEeEEEEeCCEEEEEEeCCC
Confidence            4568999999999999985 5899999999653    234467889999999999999999998872             


Q ss_pred             --------------ccchhhhHHHHHHHHHHHHhhcCCCCeEecCcCCCcEEECCCCcEEEeecCCCccccCCCcceecc
Q 039231          379 --------------RVAEELSSTIGIARGLEYLHLGCSTRILHFDIKPHNILLDEDFCPKISDFGLAKICNRKESIISMT  444 (506)
Q Consensus       379 --------------~~~~~l~i~~~i~~gl~~LH~~~~~~ivH~dlkp~Nill~~~~~~ki~dfg~a~~~~~~~~~~~~~  444 (506)
                                    ++.....++.||+.||+|||   +++|+||||||+|||++.++.+||+|||+++......     .
T Consensus        90 gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH---~~~ivHrDlkp~NIll~~~g~~kL~Dfg~a~~~~~~~-----~  161 (318)
T 1fot_A           90 GGELFSLLRKSQRFPNPVAKFYAAEVCLALEYLH---SKDIIYRDLKPENILLDKNGHIKITDFGFAKYVPDVT-----Y  161 (318)
T ss_dssp             SCBHHHHHHHTSSCCHHHHHHHHHHHHHHHHHHH---TTTEECCCCCGGGEEECTTSCEEECCCSSCEECSSCB-----C
T ss_pred             CCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHH---HCCccccCCChheEEEcCCCCEEEeecCcceecCCcc-----c
Confidence                          23335668899999999999   9999999999999999999999999999998754322     3


Q ss_pred             cCCCCcccccccccccccCCCCccccHHHHHHHHHHHHcCCCCCCCCCCCc
Q 039231          445 GARGTVGYIAPEVFCRNIGEVSYKSDVYNYGMMIFEMTGGRKNVDVVDNGS  495 (506)
Q Consensus       445 ~~~gt~~y~aPE~l~~~~~~~s~~~Dv~s~G~il~elltg~~pf~~~~~~~  495 (506)
                      ...||+.|+|||++.+.  .++.++||||||+++|||++|+.||...+..+
T Consensus       162 ~~~gt~~y~aPE~~~~~--~~~~~~DiwslG~il~ell~g~~pf~~~~~~~  210 (318)
T 1fot_A          162 TLCGTPDYIAPEVVSTK--PYNKSIDWWSFGILIYEMLAGYTPFYDSNTMK  210 (318)
T ss_dssp             CCCSCTTTCCHHHHTTC--CBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHH
T ss_pred             cccCCccccCHhHhcCC--CCCcccchhhhHHHHHHHHhCCCCCCCCCHHH
Confidence            46789999999998654  78999999999999999999999998655433

>3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3ulz_A* 3tl8_A*

Probab=99.98  E-value=7.9e-33  Score=274.65  Aligned_cols=186  Identities=42%  Similarity=0.762  Sum_probs=155.1

Q ss_pred             CCCccCHHHHHHHHhhhc--cccCccCceEEEEEEEcCCCEEEEEEeccCC--CCchhhHHHHHHhhccCccceeEEEEE
Q 039231          301 SPKRYGYADIKKMTNSFK--YKLGQGGYGSVYKGKLLDGSNVAVKVLNDSK--GNGKEFINEVASISRTSHVNVVALLGF  376 (506)
Q Consensus       301 ~~~~~~~~el~~~~~~~~--~~ig~G~~g~V~~~~~~~~~~vavK~l~~~~--~~~~~~~~E~~~l~~l~h~niv~l~g~  376 (506)
                      ..+.+++.++.....+|.  +.||+|+||.||+|+..+++.||||++....  .....+.+|++++++++||||++++++
T Consensus        16 ~~~~~~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~   95 (326)
T 3uim_A           16 QLKRFSLRELQVASDNFSNKNILGRGGFGKVYKGRLADGTLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGF   95 (326)
T ss_dssp             CCEECCTHHHHTTTTSSCSTTEEECCSSSEEEEECCSSSCCEEEEECCC-----CCCHHHHHHHGGGTCCCTTBCCCCEE
T ss_pred             ccceecHHHHHHHhhccccceeEecCCCcEEEEEEecCCCEEEEEEeccccCchHHHHHHHHHHHHHhccCCCccceEEE
Confidence            346788999998888875  6799999999999998889999999997543  233578999999999999999999998


Q ss_pred             ee-------------------------------ccchhhhHHHHHHHHHHHHhhcCCCCeEecCcCCCcEEECCCCcEEE
Q 039231          377 CL-------------------------------RVAEELSSTIGIARGLEYLHLGCSTRILHFDIKPHNILLDEDFCPKI  425 (506)
Q Consensus       377 ~~-------------------------------~~~~~l~i~~~i~~gl~~LH~~~~~~ivH~dlkp~Nill~~~~~~ki  425 (506)
                      +.                               ++..++.++.|++.||+|||+.+..+|+||||||+|||+++++.+||
T Consensus        96 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~Nil~~~~~~~kl  175 (326)
T 3uim_A           96 CMTPTERLLVYPYMANGSVASCLRERPESQPPLDWPKRQRIALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVV  175 (326)
T ss_dssp             ECCSSCCEEEEECCTTCBHHHHHHCCSTTCCCCCHHHHHHHHHHHHHHHHHHHHSSSSCEECCCCSGGGEEECTTCCEEE
T ss_pred             EecCCceEEEEEeccCCCHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCchhhEEECCCCCEEe
Confidence            72                               22345779999999999999322239999999999999999999999


Q ss_pred             eecCCCccccCCCcceecccCCCCcccccccccccccCCCCccccHHHHHHHHHHHHcCCCCCC
Q 039231          426 SDFGLAKICNRKESIISMTGARGTVGYIAPEVFCRNIGEVSYKSDVYNYGMMIFEMTGGRKNVD  489 (506)
Q Consensus       426 ~dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~s~~~Dv~s~G~il~elltg~~pf~  489 (506)
                      +|||+++......... .....||+.|+|||.+.+.  .++.++||||||+++|||++|+.||+
T Consensus       176 ~Dfg~~~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~--~~~~~~Di~slG~il~~l~~g~~pf~  236 (326)
T 3uim_A          176 GDFGLAKLMDYKDTHV-TTAVRGTIGHIAPEYLSTG--KSSEKTDVFGYGVMLLELITGQRAFD  236 (326)
T ss_dssp             CCCSSCEECCSSSSCE-ECCCCSCGGGCCHHHHHHS--EECHHHHHHHHHHHHHHHHHCCCSBC
T ss_pred             ccCccccccCcccccc-cccccCCcCccCHHHhccC--CCCccccchhHHHHHHHHHhCCCccc
Confidence            9999998775444322 2446699999999998554  68999999999999999999999996

>2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens}

Probab=99.98  E-value=6.6e-33  Score=283.46  Aligned_cols=179  Identities=22%  Similarity=0.267  Sum_probs=146.9

Q ss_pred             ccccCccCceEEEEEEEc-CCCEEEEEEeccC----CCCchhhHHHHHHhhccCccceeEEEEEee--------------
Q 039231          318 KYKLGQGGYGSVYKGKLL-DGSNVAVKVLNDS----KGNGKEFINEVASISRTSHVNVVALLGFCL--------------  378 (506)
Q Consensus       318 ~~~ig~G~~g~V~~~~~~-~~~~vavK~l~~~----~~~~~~~~~E~~~l~~l~h~niv~l~g~~~--------------  378 (506)
                      .+.||+|+||.||+|+.+ +++.||||++++.    ....+.+.+|.+++.+++||||+++++++.              
T Consensus        66 ~~~lG~G~fG~V~~~~~~~~~~~vAiK~l~k~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~~~~~~~lVmE~~~g  145 (412)
T 2vd5_A           66 LKVIGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRGEVSCFREERDVLVNGDRRWITQLHFAFQDENYLYLVMEYYVG  145 (412)
T ss_dssp             EEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHGGGCCHHHHHHHHHHSCTTTBCCEEEEEECSSEEEEEECCCCS
T ss_pred             EEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhcCCCCeeeEEEEEeeCCEEEEEEcCCCC
Confidence            367999999999999985 5899999999642    223456889999999999999999998772              


Q ss_pred             --------------ccchhhhHHHHHHHHHHHHhhcCCCCeEecCcCCCcEEECCCCcEEEeecCCCccccCCCcceecc
Q 039231          379 --------------RVAEELSSTIGIARGLEYLHLGCSTRILHFDIKPHNILLDEDFCPKISDFGLAKICNRKESIISMT  444 (506)
Q Consensus       379 --------------~~~~~l~i~~~i~~gl~~LH~~~~~~ivH~dlkp~Nill~~~~~~ki~dfg~a~~~~~~~~~~~~~  444 (506)
                                    ++.....++.||+.||+|||   +++|+||||||+|||++.++.+||+|||+++........ ...
T Consensus       146 g~L~~~l~~~~~~l~~~~~~~~~~qi~~aL~~LH---~~giiHrDLKp~NILld~~g~vkL~DFGla~~~~~~~~~-~~~  221 (412)
T 2vd5_A          146 GDLLTLLSKFGERIPAEMARFYLAEIVMAIDSVH---RLGYVHRDIKPDNILLDRCGHIRLADFGSCLKLRADGTV-RSL  221 (412)
T ss_dssp             CBHHHHHHHHSSCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTTSCEEECCCTTCEECCTTSCE-ECS
T ss_pred             CcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH---HCCeeecccCHHHeeecCCCCEEEeechhheeccCCCcc-ccc
Confidence                          22335668899999999999   899999999999999999999999999999877554432 123


Q ss_pred             cCCCCcccccccccccc-----cCCCCccccHHHHHHHHHHHHcCCCCCCCCCCCcchhhh
Q 039231          445 GARGTVGYIAPEVFCRN-----IGEVSYKSDVYNYGMMIFEMTGGRKNVDVVDNGSTALDL  500 (506)
Q Consensus       445 ~~~gt~~y~aPE~l~~~-----~~~~s~~~Dv~s~G~il~elltg~~pf~~~~~~~~~~~~  500 (506)
                      ...||+.|+|||++...     .+.++.++|||||||++|||++|+.||...+..+....+
T Consensus       222 ~~~Gt~~Y~APE~l~~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~i  282 (412)
T 2vd5_A          222 VAVGTPDYLSPEILQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQTPFYADSTAETYGKI  282 (412)
T ss_dssp             SCCSCGGGCCHHHHHHHHTCTTCSEECTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHH
T ss_pred             eeccccCcCCHHHHhhcccCcCCCCCChHHhhhHHhHHHHHHHhCCCCCCCCCHHHHHHHH
Confidence            46799999999998632     236889999999999999999999999876654443333

>3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} SCOP: d.144.1.7 PDB: 3sxr_A*

Probab=99.98  E-value=9.6e-33  Score=266.15  Aligned_cols=176  Identities=31%  Similarity=0.561  Sum_probs=149.9

Q ss_pred             hhhccccCccCceEEEEEEEcCCCEEEEEEeccCCCCchhhHHHHHHhhccCccceeEEEEEe-----------------
Q 039231          315 NSFKYKLGQGGYGSVYKGKLLDGSNVAVKVLNDSKGNGKEFINEVASISRTSHVNVVALLGFC-----------------  377 (506)
Q Consensus       315 ~~~~~~ig~G~~g~V~~~~~~~~~~vavK~l~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~-----------------  377 (506)
                      +.+.+.||+|+||.||+|+..++..||+|+++......+++.+|++++.+++||||+++++++                 
T Consensus        10 y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~   89 (268)
T 3sxs_A           10 ITLLKELGSGQFGVVKLGKWKGQYDVAVKMIKEGSMSEDEFFQEAQTMMKLSHPKLVKFYGVCSKEYPIYIVTEYISNGC   89 (268)
T ss_dssp             EEEEEEEEEETTEEEEEEEETTTEEEEEEEECBTTBCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSEEEEEECCTTCB
T ss_pred             eeeeeeeccCCCceEEEEEecCceeEEEEEeccCCCcHHHHHHHHHHHHhCCCCCEeeEEEEEccCCceEEEEEccCCCc
Confidence            344578999999999999998888999999988776778899999999999999999999987                 


Q ss_pred             -----------eccchhhhHHHHHHHHHHHHhhcCCCCeEecCcCCCcEEECCCCcEEEeecCCCccccCCCcceecccC
Q 039231          378 -----------LRVAEELSSTIGIARGLEYLHLGCSTRILHFDIKPHNILLDEDFCPKISDFGLAKICNRKESIISMTGA  446 (506)
Q Consensus       378 -----------~~~~~~l~i~~~i~~gl~~LH~~~~~~ivH~dlkp~Nill~~~~~~ki~dfg~a~~~~~~~~~~~~~~~  446 (506)
                                 +++.+.+.++.|++.||+|||   +++++||||||+||+++.++.+||+|||+++........ .....
T Consensus        90 L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH---~~~i~H~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~~~-~~~~~  165 (268)
T 3sxs_A           90 LLNYLRSHGKGLEPSQLLEMCYDVCEGMAFLE---SHQFIHRDLAARNCLVDRDLCVKVSDFGMTRYVLDDQYV-SSVGT  165 (268)
T ss_dssp             HHHHHHHHGGGCCHHHHHHHHHHHHHHHHHHH---HTTEEESSCSGGGEEECTTCCEEECCTTCEEECCTTCEE-ECCSC
T ss_pred             HHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCcCcceEEECCCCCEEEccCccceecchhhhh-cccCC
Confidence                       223346778999999999999   899999999999999999999999999999876554332 22445


Q ss_pred             CCCcccccccccccccCCCCccccHHHHHHHHHHHHc-CCCCCCCCCCCcc
Q 039231          447 RGTVGYIAPEVFCRNIGEVSYKSDVYNYGMMIFEMTG-GRKNVDVVDNGST  496 (506)
Q Consensus       447 ~gt~~y~aPE~l~~~~~~~s~~~Dv~s~G~il~ellt-g~~pf~~~~~~~~  496 (506)
                      .+|+.|+|||.+.+.  .++.++||||||+++|||++ |+.||+.....+.
T Consensus       166 ~~~~~y~aPE~~~~~--~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~  214 (268)
T 3sxs_A          166 KFPVKWSAPEVFHYF--KYSSKSDVWAFGILMWEVFSLGKMPYDLYTNSEV  214 (268)
T ss_dssp             CCCGGGCCHHHHHHS--EEETTHHHHHHHHHHHHHHTTTCCTTTTSCHHHH
T ss_pred             CcCcccCCHHHHhcc--CCchhhhhHHHHHHHHHHHcCCCCCccccChHHH
Confidence            667889999998553  68899999999999999999 9999986654443

>2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A*

Probab=99.97  E-value=3.3e-32  Score=273.92  Aligned_cols=172  Identities=26%  Similarity=0.409  Sum_probs=145.2

Q ss_pred             hhccccCccCceEEEEEEEc-CCCEEEEEEeccCCC-------CchhhHHHHHHhhccCccceeEEEEEe----------
Q 039231          316 SFKYKLGQGGYGSVYKGKLL-DGSNVAVKVLNDSKG-------NGKEFINEVASISRTSHVNVVALLGFC----------  377 (506)
Q Consensus       316 ~~~~~ig~G~~g~V~~~~~~-~~~~vavK~l~~~~~-------~~~~~~~E~~~l~~l~h~niv~l~g~~----------  377 (506)
                      .+.+.||+|+||.||+|+.. +|+.||+|+++....       ..+.+.+|++++.+++||||+++++++          
T Consensus        15 ~~~~~LG~G~fg~V~~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lv~   94 (361)
T 2yab_A           15 DIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVLHPNIITLHDVYENRTDVVLIL   94 (361)
T ss_dssp             EEEEEEEEETTEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             EEeeEEeeCcCEEEEEEEECCCCCEEEEEEEEccccccccchhHHHHHHHHHHHHHhCCCcCCCcEEEEEEeCCEEEEEE
Confidence            44578999999999999985 589999999975432       235788999999999999999999987          


Q ss_pred             -----------------eccchhhhHHHHHHHHHHHHhhcCCCCeEecCcCCCcEEECCCC----cEEEeecCCCccccC
Q 039231          378 -----------------LRVAEELSSTIGIARGLEYLHLGCSTRILHFDIKPHNILLDEDF----CPKISDFGLAKICNR  436 (506)
Q Consensus       378 -----------------~~~~~~l~i~~~i~~gl~~LH~~~~~~ivH~dlkp~Nill~~~~----~~ki~dfg~a~~~~~  436 (506)
                                       +++.+.+.++.||+.||+|||   +++|+||||||+|||++.++    .+||+|||+++....
T Consensus        95 e~~~gg~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH---~~givHrDlkp~NIll~~~~~~~~~vkl~DFG~a~~~~~  171 (361)
T 2yab_A           95 ELVSGGELFDFLAQKESLSEEEATSFIKQILDGVNYLH---TKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIED  171 (361)
T ss_dssp             ECCCSCBHHHHHTTCSCCBHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEESCTTSSSCCEEECCCSSCEECCT
T ss_pred             EcCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCHHHEEEeCCCCCccCEEEEecCCceEcCC
Confidence                             233446779999999999999   89999999999999998777    799999999987655


Q ss_pred             CCcceecccCCCCcccccccccccccCCCCccccHHHHHHHHHHHHcCCCCCCCCCCCc
Q 039231          437 KESIISMTGARGTVGYIAPEVFCRNIGEVSYKSDVYNYGMMIFEMTGGRKNVDVVDNGS  495 (506)
Q Consensus       437 ~~~~~~~~~~~gt~~y~aPE~l~~~~~~~s~~~Dv~s~G~il~elltg~~pf~~~~~~~  495 (506)
                      ...   .....||+.|+|||++.+.  .++.++||||||+++|||++|..||...+..+
T Consensus       172 ~~~---~~~~~gt~~y~aPE~~~~~--~~~~~~DiwslGvil~~ll~g~~Pf~~~~~~~  225 (361)
T 2yab_A          172 GVE---FKNIFGTPEFVAPEIVNYE--PLGLEADMWSIGVITYILLSGASPFLGDTKQE  225 (361)
T ss_dssp             TCC---CCCCCSCGGGCCHHHHTTC--CCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHH
T ss_pred             CCc---cccCCCCccEECchHHcCC--CCCccccHHHHHHHHHHHHhCCCCCCCCCHHH
Confidence            432   2456799999999998654  78999999999999999999999998765443

>3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe}

Probab=99.97  E-value=2.9e-32  Score=271.59  Aligned_cols=172  Identities=26%  Similarity=0.390  Sum_probs=145.2

Q ss_pred             hhccccCccCceEEEEEEE-cCCCEEEEEEeccC----CCCchhhHHHHHHhhccCccceeEEEEEe-------------
Q 039231          316 SFKYKLGQGGYGSVYKGKL-LDGSNVAVKVLNDS----KGNGKEFINEVASISRTSHVNVVALLGFC-------------  377 (506)
Q Consensus       316 ~~~~~ig~G~~g~V~~~~~-~~~~~vavK~l~~~----~~~~~~~~~E~~~l~~l~h~niv~l~g~~-------------  377 (506)
                      .+.+.||+|+||.||+|+. .+++.||||++...    ....+.+.+|+++++.++||||+++++++             
T Consensus        12 ~i~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~E~~   91 (336)
T 3h4j_B           12 IIRETLGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHPHIIKLYDVITTPTDIVMVIEYA   91 (336)
T ss_dssp             EEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCSHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEECCC
T ss_pred             EEEEEEecCCCeEEEEEEECCCCCEEEEEEEehHHccchhHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEEECC
Confidence            3457899999999999997 46899999998642    23346789999999999999999999987             


Q ss_pred             -------------eccchhhhHHHHHHHHHHHHhhcCCCCeEecCcCCCcEEECCCCcEEEeecCCCccccCCCcceecc
Q 039231          378 -------------LRVAEELSSTIGIARGLEYLHLGCSTRILHFDIKPHNILLDEDFCPKISDFGLAKICNRKESIISMT  444 (506)
Q Consensus       378 -------------~~~~~~l~i~~~i~~gl~~LH~~~~~~ivH~dlkp~Nill~~~~~~ki~dfg~a~~~~~~~~~~~~~  444 (506)
                                   +++.+.+.++.|++.||+|||   +.+|+||||||+|||+++++.+||+|||++........   ..
T Consensus        92 ~g~l~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH---~~givH~Dlkp~NIll~~~~~~kl~DFG~s~~~~~~~~---~~  165 (336)
T 3h4j_B           92 GGELFDYIVEKKRMTEDEGRRFFQQIICAIEYCH---RHKIVHRDLKPENLLLDDNLNVKIADFGLSNIMTDGNF---LK  165 (336)
T ss_dssp             CEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHH---HHTCCCCCCSTTTEEECTTCCEEECCSSCTBTTTTSBT---TC
T ss_pred             CCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHH---HCCeEecCCchhhEEEcCCCCEEEEEeccceeccCCcc---cc
Confidence                         234446779999999999999   89999999999999999999999999999987655432   24


Q ss_pred             cCCCCcccccccccccccCCCCccccHHHHHHHHHHHHcCCCCCCCCCCC
Q 039231          445 GARGTVGYIAPEVFCRNIGEVSYKSDVYNYGMMIFEMTGGRKNVDVVDNG  494 (506)
Q Consensus       445 ~~~gt~~y~aPE~l~~~~~~~s~~~Dv~s~G~il~elltg~~pf~~~~~~  494 (506)
                      ...||+.|+|||.+.+. ...+.++||||||+++|||++|+.||+.....
T Consensus       166 ~~~gt~~y~aPE~~~~~-~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~  214 (336)
T 3h4j_B          166 TSCGSPNYAAPEVINGK-LYAGPEVDVWSCGIVLYVMLVGRLPFDDEFIP  214 (336)
T ss_dssp             CCTTSTTTSCGGGSCCS-GGGCHHHHHHHHHHHHHHHHHSSCSSBCSSST
T ss_pred             cccCCcCcCCHHHHcCC-CCCCCccchhHHHHHHHHHHhCCCCCCCccHH
Confidence            56789999999999654 23478999999999999999999999875443

>2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A

Probab=99.97  E-value=3e-32  Score=275.45  Aligned_cols=175  Identities=30%  Similarity=0.515  Sum_probs=144.2

Q ss_pred             hhccccCccCceEEEEEEEc--------CCCEEEEEEeccCCC--CchhhHHHHHHhhcc-CccceeEEEEEeec-----
Q 039231          316 SFKYKLGQGGYGSVYKGKLL--------DGSNVAVKVLNDSKG--NGKEFINEVASISRT-SHVNVVALLGFCLR-----  379 (506)
Q Consensus       316 ~~~~~ig~G~~g~V~~~~~~--------~~~~vavK~l~~~~~--~~~~~~~E~~~l~~l-~h~niv~l~g~~~~-----  379 (506)
                      .+.+.||+|+||.||+|++.        ++..||||+++....  ..+++.+|+++++++ +||||+++++++.+     
T Consensus        84 ~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~~~~~  163 (370)
T 2psq_A           84 TLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDGPLY  163 (370)
T ss_dssp             EEEEEESCCSSSEEEEEEEETCSTTCTTCEEEEEEEECCTTCBHHHHHHHHHHHHHHHHSCCCTTBCCEEEEECSSSSCE
T ss_pred             EeeeEEeeCCCeeEEEEEEecccCcCcCcceeEEEEEecCCcCHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEccCCCEE
Confidence            44578999999999999863        345799999976432  235789999999999 89999999998721     


Q ss_pred             --------------------------------------cchhhhHHHHHHHHHHHHhhcCCCCeEecCcCCCcEEECCCC
Q 039231          380 --------------------------------------VAEELSSTIGIARGLEYLHLGCSTRILHFDIKPHNILLDEDF  421 (506)
Q Consensus       380 --------------------------------------~~~~l~i~~~i~~gl~~LH~~~~~~ivH~dlkp~Nill~~~~  421 (506)
                                                            +.+.+.++.||+.||+|||   +++|+||||||+|||++.++
T Consensus       164 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH---~~~ivHrDlkp~NIll~~~~  240 (370)
T 2psq_A          164 VIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLA---SQKCIHRDLAARNVLVTENN  240 (370)
T ss_dssp             EEEECCTTCBHHHHHHHTCCC-----------CCCCCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCCGGGEEECTTC
T ss_pred             EEEEcCCCCCHHHHHHhhCCccccccccccccccccCCHHHHHHHHHHHHHHHHHHH---hCCeeccccchhhEEECCCC
Confidence                                                  1224568899999999999   89999999999999999999


Q ss_pred             cEEEeecCCCccccCCCcceecccCCCCcccccccccccccCCCCccccHHHHHHHHHHHHc-CCCCCCCCCCCc
Q 039231          422 CPKISDFGLAKICNRKESIISMTGARGTVGYIAPEVFCRNIGEVSYKSDVYNYGMMIFEMTG-GRKNVDVVDNGS  495 (506)
Q Consensus       422 ~~ki~dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~s~~~Dv~s~G~il~ellt-g~~pf~~~~~~~  495 (506)
                      .+||+|||+++...............+|+.|+|||++.+.  .++.++||||||+++|||++ |+.||......+
T Consensus       241 ~~kl~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~--~~~~~~DvwslG~il~ellt~g~~p~~~~~~~~  313 (370)
T 2psq_A          241 VMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDR--VYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEE  313 (370)
T ss_dssp             CEEECCCSSCEETTCCCTTCTTTTTTSCGGGCCHHHHHTC--CCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGG
T ss_pred             CEEEccccCCcccCcccceecccCCCcccceECHhHhcCC--CCCcHHHHHHHHHHHHHHHcCCCCCCCCCCHHH
Confidence            9999999999876654433333445678899999998654  78999999999999999999 999998765444

>1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B

Probab=99.97  E-value=1.3e-32  Score=285.75  Aligned_cols=176  Identities=26%  Similarity=0.464  Sum_probs=148.6

Q ss_pred             HhhhccccCccCceEEEEEEEcCCCEEEEEEeccCCCCchhhHHHHHHhhccCccceeEEEEEee---------------
Q 039231          314 TNSFKYKLGQGGYGSVYKGKLLDGSNVAVKVLNDSKGNGKEFINEVASISRTSHVNVVALLGFCL---------------  378 (506)
Q Consensus       314 ~~~~~~~ig~G~~g~V~~~~~~~~~~vavK~l~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~---------------  378 (506)
                      .+.+.++||+|+||.||+|+++++..||||+++......+++.+|++++++++|||||++++++.               
T Consensus       189 ~~~~~~~lG~G~fg~V~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~lv~e~~~~g~  268 (454)
T 1qcf_A          189 SLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPGSMSVEAFLAEANVMKTLQHDKLVKLHAVVTKEPIYIITEFMAKGS  268 (454)
T ss_dssp             GEEEEEEEECCSSEEEEEEEETTTEEEEEEEECTTSBCHHHHHHHHHHHTTCCCTTBCCEEEEECSSSCEEEECCCTTCB
T ss_pred             HeEEEEEcccCCceEEEEEEECCccEEEEEEecCCCccHHHHHHHHHHHhhCCCCCEeeEEEEEeCCccEEEEeecCCCc
Confidence            34456789999999999999988899999999877666788999999999999999999999871               


Q ss_pred             -------------ccchhhhHHHHHHHHHHHHhhcCCCCeEecCcCCCcEEECCCCcEEEeecCCCccccCCCcceeccc
Q 039231          379 -------------RVAEELSSTIGIARGLEYLHLGCSTRILHFDIKPHNILLDEDFCPKISDFGLAKICNRKESIISMTG  445 (506)
Q Consensus       379 -------------~~~~~l~i~~~i~~gl~~LH~~~~~~ivH~dlkp~Nill~~~~~~ki~dfg~a~~~~~~~~~~~~~~  445 (506)
                                   ++.+.+.++.||+.||+|||   +++|+||||||+|||+++++.+||+|||+++........ ....
T Consensus       269 L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH---~~~ivHrDlkp~Nill~~~~~~kl~DFG~a~~~~~~~~~-~~~~  344 (454)
T 1qcf_A          269 LLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIE---QRNYIHRDLRAANILVSASLVCKIADFGLARVIEDNEYT-AREG  344 (454)
T ss_dssp             HHHHHHSHHHHTCCHHHHHHHHHHHHHHHHHHH---HTTCCCSSCSGGGEEECTTCCEEECSTTGGGGBCCHHHH-TTCS
T ss_pred             HHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHH---hCCccCCCCCHHHEEECCCCcEEEeeCCCceEcCCCcee-ccCC
Confidence                         12235678999999999999   899999999999999999999999999999876433211 1233


Q ss_pred             CCCCcccccccccccccCCCCccccHHHHHHHHHHHHc-CCCCCCCCCCCc
Q 039231          446 ARGTVGYIAPEVFCRNIGEVSYKSDVYNYGMMIFEMTG-GRKNVDVVDNGS  495 (506)
Q Consensus       446 ~~gt~~y~aPE~l~~~~~~~s~~~Dv~s~G~il~ellt-g~~pf~~~~~~~  495 (506)
                      ..+++.|+|||.+..  +.++.++||||||+++|||++ |+.||......+
T Consensus       345 ~~~~~~y~aPE~~~~--~~~~~~~DvwslG~~l~el~t~g~~P~~~~~~~~  393 (454)
T 1qcf_A          345 AKFPIKWTAPEAINF--GSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPE  393 (454)
T ss_dssp             SSSCGGGSCHHHHHH--CCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHH
T ss_pred             CcccccccCHHHhcc--CCCCcHHHHHhHHHHHHHHHhCCCCCCCCCCHHH
Confidence            456789999999854  378999999999999999999 999998765443

>3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A*

Probab=99.97  E-value=3e-32  Score=268.68  Aligned_cols=172  Identities=33%  Similarity=0.580  Sum_probs=135.1

Q ss_pred             hhccccCccCceEEEEEEEcCCCEEEEEEeccCCCCc---hhhHHHHHHhhccCccceeEEEEEee--------------
Q 039231          316 SFKYKLGQGGYGSVYKGKLLDGSNVAVKVLNDSKGNG---KEFINEVASISRTSHVNVVALLGFCL--------------  378 (506)
Q Consensus       316 ~~~~~ig~G~~g~V~~~~~~~~~~vavK~l~~~~~~~---~~~~~E~~~l~~l~h~niv~l~g~~~--------------  378 (506)
                      .+.+.||+|+||.||+|+. +++.||||++.......   +++.+|++++++++||||+++++++.              
T Consensus        40 ~i~~~lG~G~~g~V~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~  118 (309)
T 3p86_A           40 NIKEKIGAGSFGTVHRAEW-HGSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFMGAVTQPPNLSIVTEYLSR  118 (309)
T ss_dssp             EEEEEEEECSSEEEEEEEE-TTEEEEEEEECCCCCSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSTTCCEEEEECCTT
T ss_pred             eeeeEeecCCCeEEEEEEE-CCCcEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCceEEEEecCCC
Confidence            3457899999999999987 68899999997654332   56889999999999999999999872              


Q ss_pred             ----------------ccchhhhHHHHHHHHHHHHhhcCCCC--eEecCcCCCcEEECCCCcEEEeecCCCccccCCCcc
Q 039231          379 ----------------RVAEELSSTIGIARGLEYLHLGCSTR--ILHFDIKPHNILLDEDFCPKISDFGLAKICNRKESI  440 (506)
Q Consensus       379 ----------------~~~~~l~i~~~i~~gl~~LH~~~~~~--ivH~dlkp~Nill~~~~~~ki~dfg~a~~~~~~~~~  440 (506)
                                      ++.+++.++.|++.||+|||   +++  |+||||||+||+++.++.+||+|||+++....... 
T Consensus       119 ~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~aL~~LH---~~~~~ivH~Dikp~NIll~~~~~~kL~Dfg~a~~~~~~~~-  194 (309)
T 3p86_A          119 GSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLH---NRNPPIVHRNLKSPNLLVDKKYTVKVCDFGLSRLKASTFL-  194 (309)
T ss_dssp             CBHHHHHHSTTHHHHSCHHHHHHHHHHHHHHHHHHH---TSSSCCCCTTCCGGGEEECTTCCEEECCCC-----------
T ss_pred             CcHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHH---cCCCCEECCCCChhhEEEeCCCcEEECCCCCCcccccccc-
Confidence                            22235678999999999999   888  99999999999999999999999999986544322 


Q ss_pred             eecccCCCCcccccccccccccCCCCccccHHHHHHHHHHHHcCCCCCCCCCCCc
Q 039231          441 ISMTGARGTVGYIAPEVFCRNIGEVSYKSDVYNYGMMIFEMTGGRKNVDVVDNGS  495 (506)
Q Consensus       441 ~~~~~~~gt~~y~aPE~l~~~~~~~s~~~Dv~s~G~il~elltg~~pf~~~~~~~  495 (506)
                       ......||+.|+|||.+.+.  .++.++||||||+++|||++|+.||...+..+
T Consensus       195 -~~~~~~gt~~y~aPE~~~~~--~~~~~~DiwslG~il~elltg~~Pf~~~~~~~  246 (309)
T 3p86_A          195 -SSKSAAGTPEWMAPEVLRDE--PSNEKSDVYSFGVILWELATLQQPWGNLNPAQ  246 (309)
T ss_dssp             --------CCTTSCHHHHTTC--CCCTTHHHHHHHHHHHHHHHCCCTTTTSCHHH
T ss_pred             -ccccCCCCccccChhhhcCC--CCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH
Confidence             12446789999999998654  68899999999999999999999998765443

>4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus}

Probab=99.97  E-value=3.2e-32  Score=276.73  Aligned_cols=169  Identities=27%  Similarity=0.400  Sum_probs=141.3

Q ss_pred             hhccccCccCceEEEEEEEcC-CCEEEEEEeccCC----CCchhhHHHHHHhhcc-CccceeEEEEEe------------
Q 039231          316 SFKYKLGQGGYGSVYKGKLLD-GSNVAVKVLNDSK----GNGKEFINEVASISRT-SHVNVVALLGFC------------  377 (506)
Q Consensus       316 ~~~~~ig~G~~g~V~~~~~~~-~~~vavK~l~~~~----~~~~~~~~E~~~l~~l-~h~niv~l~g~~------------  377 (506)
                      .+.++||+|+||.||+|+... ++.+|+|++++..    ...+.+.+|..++.++ +|||||++++++            
T Consensus        55 ~~~~~LG~G~fG~V~~~~~~~~~~~~AvK~~~k~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~~~~lV~E~  134 (396)
T 4dc2_A           55 DLLRVIGRGSYAKVLLVRLKKTDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFVIEY  134 (396)
T ss_dssp             EEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGTC----CCHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEEEEEC
T ss_pred             EEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhcCCCCCcCeeEEEEEECCEEEEEEEc
Confidence            345789999999999999864 7899999997532    2335688999999887 899999999987            


Q ss_pred             ---------------eccchhhhHHHHHHHHHHHHhhcCCCCeEecCcCCCcEEECCCCcEEEeecCCCccccCCCccee
Q 039231          378 ---------------LRVAEELSSTIGIARGLEYLHLGCSTRILHFDIKPHNILLDEDFCPKISDFGLAKICNRKESIIS  442 (506)
Q Consensus       378 ---------------~~~~~~l~i~~~i~~gl~~LH~~~~~~ivH~dlkp~Nill~~~~~~ki~dfg~a~~~~~~~~~~~  442 (506)
                                     +++.+...++.||+.||+|||   +++|+||||||+|||++.++.+||+|||+++.......  .
T Consensus       135 ~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~LH---~~givHrDLKp~NILl~~~g~ikL~DFGla~~~~~~~~--~  209 (396)
T 4dc2_A          135 VNGGDLMFHMQRQRKLPEEHARFYSAEISLALNYLH---ERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGD--T  209 (396)
T ss_dssp             CTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHH---HTTCBCCCCCGGGEEECTTSCEEECCCTTCBCCCCTTC--C
T ss_pred             CCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHH---HCCEEeccCCHHHEEECCCCCEEEeecceeeecccCCC--c
Confidence                           233346678999999999999   89999999999999999999999999999986332222  1


Q ss_pred             cccCCCCcccccccccccccCCCCccccHHHHHHHHHHHHcCCCCCCCC
Q 039231          443 MTGARGTVGYIAPEVFCRNIGEVSYKSDVYNYGMMIFEMTGGRKNVDVV  491 (506)
Q Consensus       443 ~~~~~gt~~y~aPE~l~~~~~~~s~~~Dv~s~G~il~elltg~~pf~~~  491 (506)
                      .....||+.|+|||++.+.  .++.++||||||+++|||++|+.||...
T Consensus       210 ~~~~~gt~~Y~aPE~l~~~--~~~~~~DiwslGvllyell~G~~Pf~~~  256 (396)
T 4dc2_A          210 TSTFCGTPNYIAPEILRGE--DYGFSVDWWALGVLMFEMMAGRSPFDIV  256 (396)
T ss_dssp             BCCCCBCGGGCCHHHHTTC--CBCTHHHHHHHHHHHHHHHHSSCSSTTT
T ss_pred             cccccCCcccCCchhhcCC--CCChHHHHHHHHHHHHHHHhCCCCCccc
Confidence            2457899999999999664  7899999999999999999999999754

>3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A*

Probab=99.97  E-value=1.5e-32  Score=285.79  Aligned_cols=173  Identities=27%  Similarity=0.272  Sum_probs=140.0

Q ss_pred             hccccCccCceEEEEEEEc-CCCEEEEEEeccCC---CCchhhHHHHHHhhccCccceeEEEEEee--------------
Q 039231          317 FKYKLGQGGYGSVYKGKLL-DGSNVAVKVLNDSK---GNGKEFINEVASISRTSHVNVVALLGFCL--------------  378 (506)
Q Consensus       317 ~~~~ig~G~~g~V~~~~~~-~~~~vavK~l~~~~---~~~~~~~~E~~~l~~l~h~niv~l~g~~~--------------  378 (506)
                      +.++||+|+||.||+|+.. +++.||||++....   ...+++.+|++++++++||||+++++++.              
T Consensus        66 ~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~~~~~lv  145 (464)
T 3ttj_A           66 NLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQDVYLV  145 (464)
T ss_dssp             EEEEEEECSSCEEEEEEETTTTEEEEEEEEESGGGSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTCCEEEEE
T ss_pred             EEEEeecCCCeEEEEEEECCCCCEEEEEEECccccChHHHHHHHHHHHHHHhCCCCCCCcEEEEEccCCccccCCeEEEE
Confidence            3467999999999999875 48899999997542   22367889999999999999999998762              


Q ss_pred             ----------------ccchhhhHHHHHHHHHHHHhhcCCCCeEecCcCCCcEEECCCCcEEEeecCCCccccCCCccee
Q 039231          379 ----------------RVAEELSSTIGIARGLEYLHLGCSTRILHFDIKPHNILLDEDFCPKISDFGLAKICNRKESIIS  442 (506)
Q Consensus       379 ----------------~~~~~l~i~~~i~~gl~~LH~~~~~~ivH~dlkp~Nill~~~~~~ki~dfg~a~~~~~~~~~~~  442 (506)
                                      ++.++..++.||+.||+|||   +++|+||||||+|||++.++.+||+|||+++.......   
T Consensus       146 ~E~~~~~l~~~~~~~l~~~~~~~~~~qil~aL~~lH---~~~iiHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~~---  219 (464)
T 3ttj_A          146 MELMDANLCQVIQMELDHERMSYLLYQMLCGIKHLH---SAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFM---  219 (464)
T ss_dssp             EECCSEEHHHHHTSCCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEECTTSCEEECCCCCC-----CCC---
T ss_pred             EeCCCCCHHHHHhhcCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCChHhEEEeCCCCEEEEEEEeeeecCCCcc---
Confidence                            22335668999999999999   89999999999999999999999999999987654322   


Q ss_pred             cccCCCCcccccccccccccCCCCccccHHHHHHHHHHHHcCCCCCCCCCCCcch
Q 039231          443 MTGARGTVGYIAPEVFCRNIGEVSYKSDVYNYGMMIFEMTGGRKNVDVVDNGSTA  497 (506)
Q Consensus       443 ~~~~~gt~~y~aPE~l~~~~~~~s~~~Dv~s~G~il~elltg~~pf~~~~~~~~~  497 (506)
                      .....||+.|+|||++.+.  .++.++||||+||++|||++|+.||...+..+..
T Consensus       220 ~~~~~gt~~y~aPE~~~~~--~~~~~~DiwSlG~il~ell~g~~pF~g~~~~~~~  272 (464)
T 3ttj_A          220 MTPYVVTRYYRAPEVILGM--GYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQW  272 (464)
T ss_dssp             C----CCCTTCCHHHHTTC--CCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHH
T ss_pred             cCCCcccccccCHHHHcCC--CCCHHHHHHHHHHHHHHHHhCCCCCCCCCHHHHH
Confidence            2456789999999999764  7899999999999999999999999876544433

>3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II}

Probab=99.97  E-value=3e-32  Score=277.34  Aligned_cols=179  Identities=27%  Similarity=0.371  Sum_probs=136.1

Q ss_pred             hhccccCccCceEEEEEEEc-CCCEEEEEEeccCCC---CchhhHHHHHHhhccC-ccceeEEEEEeec-----------
Q 039231          316 SFKYKLGQGGYGSVYKGKLL-DGSNVAVKVLNDSKG---NGKEFINEVASISRTS-HVNVVALLGFCLR-----------  379 (506)
Q Consensus       316 ~~~~~ig~G~~g~V~~~~~~-~~~~vavK~l~~~~~---~~~~~~~E~~~l~~l~-h~niv~l~g~~~~-----------  379 (506)
                      .+.+.||+|+||.||+|++. +++.||||++.....   ..+.+.+|+.++.++. ||||+++++++..           
T Consensus        12 ~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~lv~e   91 (388)
T 3oz6_A           12 ELVKKLGKGAYGIVWKSIDRRTGEVVAVKKIFDAFQNSTDAQRTFREIMILTELSGHENIVNLLNVLRADNDRDVYLVFD   91 (388)
T ss_dssp             EEEEC-------CEEEEEETTTCCEEEEEEECC--CCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECTTSSCEEEEEE
T ss_pred             EEEEEeeeCCCeEEEEEEECCCCCEEEEEEecccccChHHHHHHHHHHHHHHhccCCCCCCeeeeEEecCCCCEEEEEec
Confidence            34578999999999999875 589999999965432   2356789999999998 9999999998732           


Q ss_pred             ----------------cchhhhHHHHHHHHHHHHhhcCCCCeEecCcCCCcEEECCCCcEEEeecCCCccccCCC-----
Q 039231          380 ----------------VAEELSSTIGIARGLEYLHLGCSTRILHFDIKPHNILLDEDFCPKISDFGLAKICNRKE-----  438 (506)
Q Consensus       380 ----------------~~~~l~i~~~i~~gl~~LH~~~~~~ivH~dlkp~Nill~~~~~~ki~dfg~a~~~~~~~-----  438 (506)
                                      ......++.||+.||+|||   +.+|+||||||+|||++.++.+||+|||+++......     
T Consensus        92 ~~~~~L~~~~~~~~~~~~~~~~i~~qi~~~L~~LH---~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~~~~~~  168 (388)
T 3oz6_A           92 YMETDLHAVIRANILEPVHKQYVVYQLIKVIKYLH---SGGLLHRDMKPSNILLNAECHVKVADFGLSRSFVNIRRVTNN  168 (388)
T ss_dssp             CCSEEHHHHHHHTCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEECTTCCEEECCCTTCEESSSCCCCCCC
T ss_pred             ccCcCHHHHHHcCCCCHHHHHHHHHHHHHHHHHHH---hCCEEeCCCCHHHeEEcCCCCEEecCCccccccccccccccc
Confidence                            2224568899999999999   8999999999999999999999999999998654311     


Q ss_pred             --------------cceecccCCCCcccccccccccccCCCCccccHHHHHHHHHHHHcCCCCCCCCCCCcchh
Q 039231          439 --------------SIISMTGARGTVGYIAPEVFCRNIGEVSYKSDVYNYGMMIFEMTGGRKNVDVVDNGSTAL  498 (506)
Q Consensus       439 --------------~~~~~~~~~gt~~y~aPE~l~~~~~~~s~~~Dv~s~G~il~elltg~~pf~~~~~~~~~~  498 (506)
                                    .........||+.|+|||++.+. ..++.++||||+||++|||++|+.||...+..+...
T Consensus       169 ~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~  241 (388)
T 3oz6_A          169 IPLSINENTENFDDDQPILTDYVATRWYRAPEILLGS-TKYTKGIDMWSLGCILGEILCGKPIFPGSSTMNQLE  241 (388)
T ss_dssp             GGGCCC---------------CCCGGGGCCHHHHTTC-CCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHH
T ss_pred             ccccccccccccccccccccCCcccCCcCCHHHhcCC-CCCCChhhHHHHHHHHHHHHhCCCCCCCCCHHHHHH
Confidence                          01112446799999999998653 468999999999999999999999998766544433

>1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ...

Probab=99.97  E-value=4.3e-32  Score=279.00  Aligned_cols=175  Identities=30%  Similarity=0.371  Sum_probs=142.4

Q ss_pred             hhccccCccCceEEEEEEEc-CCCEEEEEEeccCCCCchhhHHHHHHhhccCccceeEEEEEeec---------------
Q 039231          316 SFKYKLGQGGYGSVYKGKLL-DGSNVAVKVLNDSKGNGKEFINEVASISRTSHVNVVALLGFCLR---------------  379 (506)
Q Consensus       316 ~~~~~ig~G~~g~V~~~~~~-~~~~vavK~l~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~---------------  379 (506)
                      ...+.||+|+||.||+|++. +++.||||++....   +...+|++++++++|||||++++++..               
T Consensus        57 ~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~---~~~~~E~~il~~l~hpniv~l~~~~~~~~~~~~~~~~~lv~e  133 (420)
T 1j1b_A           57 TDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDK---RFKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLD  133 (420)
T ss_dssp             EEEEEEEECSSEEEEEEEETTTCCEEEEEEEECCT---TSCCHHHHHHHTCCCTTBCCEEEEEEEEETTTTEEEEEEEEE
T ss_pred             EeeeEEeeCCCEEEEEEEECCCCcEEEEEEecccc---hhHHHHHHHHHHcCCCCccceeeEEeccCCCCcceeEEeehh
Confidence            34567999999999999985 48999999986543   334579999999999999999877621               


Q ss_pred             ---------------------cchhhhHHHHHHHHHHHHhhcCCCCeEecCcCCCcEEECCC-CcEEEeecCCCccccCC
Q 039231          380 ---------------------VAEELSSTIGIARGLEYLHLGCSTRILHFDIKPHNILLDED-FCPKISDFGLAKICNRK  437 (506)
Q Consensus       380 ---------------------~~~~l~i~~~i~~gl~~LH~~~~~~ivH~dlkp~Nill~~~-~~~ki~dfg~a~~~~~~  437 (506)
                                           +...+.++.||++||+|||   +++|+||||||+|||++.+ +.+||+|||+++.....
T Consensus       134 ~~~~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH---~~~ivHrDlkp~NILl~~~~~~~kl~DFG~a~~~~~~  210 (420)
T 1j1b_A          134 YVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIH---SFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRG  210 (420)
T ss_dssp             CCCEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHH---TTTEECSCCSGGGEEEETTTTEEEECCCTTCEECCTT
T ss_pred             cccccHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHH---HCCccccCCChhhEEEeCCCCeEEeccchhhhhcccC
Confidence                                 1124557889999999999   9999999999999999955 67899999999876544


Q ss_pred             CcceecccCCCCcccccccccccccCCCCccccHHHHHHHHHHHHcCCCCCCCCCCCcchhhh
Q 039231          438 ESIISMTGARGTVGYIAPEVFCRNIGEVSYKSDVYNYGMMIFEMTGGRKNVDVVDNGSTALDL  500 (506)
Q Consensus       438 ~~~~~~~~~~gt~~y~aPE~l~~~~~~~s~~~Dv~s~G~il~elltg~~pf~~~~~~~~~~~~  500 (506)
                      ...   ....+|+.|+|||++.+. ..++.++|||||||++|||++|+.||...+..+...++
T Consensus       211 ~~~---~~~~~t~~y~aPE~~~~~-~~~~~~~DiwSlG~il~ell~G~~pf~~~~~~~~l~~i  269 (420)
T 1j1b_A          211 EPN---VSYICSRYYRAPELIFGA-TDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEI  269 (420)
T ss_dssp             CCC---CSCCSCTTSCCHHHHTTC-SSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHH
T ss_pred             CCc---eeeeeCCCcCCHHHHcCC-CCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHH
Confidence            322   346789999999998653 36899999999999999999999999876655444443

>1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A*

Probab=99.97  E-value=2.4e-32  Score=273.25  Aligned_cols=173  Identities=26%  Similarity=0.384  Sum_probs=144.5

Q ss_pred             hhccccCccCceEEEEEEEc-CCCEEEEEEeccC----CCCchhhHHHHHHhhcc-CccceeEEEEEe------------
Q 039231          316 SFKYKLGQGGYGSVYKGKLL-DGSNVAVKVLNDS----KGNGKEFINEVASISRT-SHVNVVALLGFC------------  377 (506)
Q Consensus       316 ~~~~~ig~G~~g~V~~~~~~-~~~~vavK~l~~~----~~~~~~~~~E~~~l~~l-~h~niv~l~g~~------------  377 (506)
                      .+.+.||+|+||.||+|+.+ +++.||||+++..    ....+.+.+|.+++..+ +||||+++++++            
T Consensus        20 ~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~iv~l~~~~~~~~~~~lv~E~   99 (345)
T 1xjd_A           20 ILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKENLFFVMEY   99 (345)
T ss_dssp             EEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEEEEEC
T ss_pred             EEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhHHhhhhhhHHHHHHHHHHHHhcCCCCCCCcEEEEEEeCCEEEEEEeC
Confidence            34578999999999999985 4889999999753    33446788899999887 899999999877            


Q ss_pred             ---------------eccchhhhHHHHHHHHHHHHhhcCCCCeEecCcCCCcEEECCCCcEEEeecCCCccccCCCccee
Q 039231          378 ---------------LRVAEELSSTIGIARGLEYLHLGCSTRILHFDIKPHNILLDEDFCPKISDFGLAKICNRKESIIS  442 (506)
Q Consensus       378 ---------------~~~~~~l~i~~~i~~gl~~LH~~~~~~ivH~dlkp~Nill~~~~~~ki~dfg~a~~~~~~~~~~~  442 (506)
                                     +++.+...++.||+.||+|||   +++|+||||||+|||++.++.+||+|||+++........  
T Consensus       100 ~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH---~~~ivHrDlkp~NIll~~~g~vkL~DFG~a~~~~~~~~~--  174 (345)
T 1xjd_A          100 LNGGDLMYHIQSCHKFDLSRATFYAAEIILGLQFLH---SKGIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAK--  174 (345)
T ss_dssp             CTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHH---HTTCBCCCCCGGGEEECTTSCEEECCCTTCBCCCCTTCC--
T ss_pred             CCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHH---HCCeEeCCCChhhEEECCCCCEEEeEChhhhhcccCCCc--
Confidence                           223345678999999999999   899999999999999999999999999999865332221  


Q ss_pred             cccCCCCcccccccccccccCCCCccccHHHHHHHHHHHHcCCCCCCCCCCCc
Q 039231          443 MTGARGTVGYIAPEVFCRNIGEVSYKSDVYNYGMMIFEMTGGRKNVDVVDNGS  495 (506)
Q Consensus       443 ~~~~~gt~~y~aPE~l~~~~~~~s~~~Dv~s~G~il~elltg~~pf~~~~~~~  495 (506)
                      .....||+.|+|||++.+.  .++.++||||||+++|||++|+.||...+..+
T Consensus       175 ~~~~~gt~~y~aPE~~~~~--~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~  225 (345)
T 1xjd_A          175 TNTFCGTPDYIAPEILLGQ--KYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEE  225 (345)
T ss_dssp             BCCCCSCGGGCCHHHHTTC--CBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH
T ss_pred             ccCCCCCcccCChhhhcCC--CCCChhhhHHHHHHHHHHhcCCCCCCCCCHHH
Confidence            2456799999999999654  68999999999999999999999998665433

>2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens}

Probab=99.97  E-value=4.6e-32  Score=265.71  Aligned_cols=172  Identities=28%  Similarity=0.405  Sum_probs=139.7

Q ss_pred             hhccccCccCceEEEEEEEc-CCCEEEEEEeccCCC---------------------------CchhhHHHHHHhhccCc
Q 039231          316 SFKYKLGQGGYGSVYKGKLL-DGSNVAVKVLNDSKG---------------------------NGKEFINEVASISRTSH  367 (506)
Q Consensus       316 ~~~~~ig~G~~g~V~~~~~~-~~~~vavK~l~~~~~---------------------------~~~~~~~E~~~l~~l~h  367 (506)
                      .+.+.||+|+||.||+|+.. +++.||||++.....                           ..+.+.+|++++++++|
T Consensus        16 ~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h   95 (298)
T 2zv2_A           16 TLKDEIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGPIEQVYQEIAILKKLDH   95 (298)
T ss_dssp             EEEEEEEC--CCEEEEEEETTTTEEEEEEEEECC-------------------------------CHHHHHHHHHHTCCC
T ss_pred             EEEeEEeecCCEEEEEEEECCCCcEEEEEEeehhhhhhhcccccccccccccccccccccccchHHHHHHHHHHHHhCCC
Confidence            34578999999999999875 588999999965321                           12568899999999999


Q ss_pred             cceeEEEEEee----------------------------ccchhhhHHHHHHHHHHHHhhcCCCCeEecCcCCCcEEECC
Q 039231          368 VNVVALLGFCL----------------------------RVAEELSSTIGIARGLEYLHLGCSTRILHFDIKPHNILLDE  419 (506)
Q Consensus       368 ~niv~l~g~~~----------------------------~~~~~l~i~~~i~~gl~~LH~~~~~~ivH~dlkp~Nill~~  419 (506)
                      |||+++++++.                            ++.+.+.++.|++.||+|||   +++|+||||||+|||++.
T Consensus        96 ~~iv~~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~lH---~~~ivH~Dlkp~Nil~~~  172 (298)
T 2zv2_A           96 PNVVKLVEVLDDPNEDHLYMVFELVNQGPVMEVPTLKPLSEDQARFYFQDLIKGIEYLH---YQKIIHRDIKPSNLLVGE  172 (298)
T ss_dssp             TTBCCEEEEEECSSSSEEEEEEECCTTCBSCCSSCSSCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEECT
T ss_pred             CCCCeEEEEEEcCCCCEEEEEEecCCCCcHHHHhhcCCCCHHHHHHHHHHHHHHHHHHH---HCCeeccCCCHHHEEECC
Confidence            99999998863                            22336678999999999999   899999999999999999


Q ss_pred             CCcEEEeecCCCccccCCCcceecccCCCCcccccccccccccC-CCCccccHHHHHHHHHHHHcCCCCCCCCC
Q 039231          420 DFCPKISDFGLAKICNRKESIISMTGARGTVGYIAPEVFCRNIG-EVSYKSDVYNYGMMIFEMTGGRKNVDVVD  492 (506)
Q Consensus       420 ~~~~ki~dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~-~~s~~~Dv~s~G~il~elltg~~pf~~~~  492 (506)
                      ++.+||+|||+++........  .....||+.|+|||.+.+... ..+.++||||||+++|||++|+.||....
T Consensus       173 ~~~~kl~Dfg~~~~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~  244 (298)
T 2zv2_A          173 DGHIKIADFGVSNEFKGSDAL--LSNTVGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQCPFMDER  244 (298)
T ss_dssp             TSCEEECCCTTCEECSSSSCE--ECCCCSCGGGCCGGGCCTTCCCEESHHHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred             CCCEEEecCCCcccccccccc--ccCCcCCccccChhhhccCCCCCCCchhhhHhHHHHHHHHHHCCCCCCCcc
Confidence            999999999999876554332  245679999999999865421 14778999999999999999999997643

>1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7

Probab=99.97  E-value=1.7e-32  Score=271.93  Aligned_cols=172  Identities=24%  Similarity=0.332  Sum_probs=145.9

Q ss_pred             hhccccCccCceEEEEEEEc-CCCEEEEEEeccCCCCchhhHHHHHHhhccCccceeEEEEEe-----------------
Q 039231          316 SFKYKLGQGGYGSVYKGKLL-DGSNVAVKVLNDSKGNGKEFINEVASISRTSHVNVVALLGFC-----------------  377 (506)
Q Consensus       316 ~~~~~ig~G~~g~V~~~~~~-~~~~vavK~l~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~-----------------  377 (506)
                      .+.+.||+|+||.||+|+.. +++.+|+|+++........+.+|++++.+++||||+++++++                 
T Consensus         8 ~~~~~lG~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~~~g~~   87 (321)
T 1tki_A            8 MIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGTDQVLVKKEISILNIARHRNILHLHESFESMEELVMIFEFISGLD   87 (321)
T ss_dssp             EEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCTHHHHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEEEEECCCCCCB
T ss_pred             EeeeEEecCCCeEEEEEEECCCCcEEEEEEEecCcccHHHHHHHHHHHHhCCCCCCCeEeEEEecCCEEEEEEEeCCCCC
Confidence            34578999999999999985 488999999976655556788999999999999999999887                 


Q ss_pred             -----------eccchhhhHHHHHHHHHHHHhhcCCCCeEecCcCCCcEEECC--CCcEEEeecCCCccccCCCcceecc
Q 039231          378 -----------LRVAEELSSTIGIARGLEYLHLGCSTRILHFDIKPHNILLDE--DFCPKISDFGLAKICNRKESIISMT  444 (506)
Q Consensus       378 -----------~~~~~~l~i~~~i~~gl~~LH~~~~~~ivH~dlkp~Nill~~--~~~~ki~dfg~a~~~~~~~~~~~~~  444 (506)
                                 +++.+.+.++.|++.||+|||   +++|+||||||+|||++.  ++.+||+|||+++.......   ..
T Consensus        88 L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH---~~givH~Dlkp~NIl~~~~~~~~~kl~Dfg~a~~~~~~~~---~~  161 (321)
T 1tki_A           88 IFERINTSAFELNEREIVSYVHQVCEALQFLH---SHNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDN---FR  161 (321)
T ss_dssp             HHHHHTSSSCCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEESSSSCCCEEECCCTTCEECCTTCE---EE
T ss_pred             HHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH---HCCCCcCCCCHHHEEEccCCCCCEEEEECCCCeECCCCCc---cc
Confidence                       223346778999999999999   899999999999999987  78999999999987755432   23


Q ss_pred             cCCCCcccccccccccccCCCCccccHHHHHHHHHHHHcCCCCCCCCCCCc
Q 039231          445 GARGTVGYIAPEVFCRNIGEVSYKSDVYNYGMMIFEMTGGRKNVDVVDNGS  495 (506)
Q Consensus       445 ~~~gt~~y~aPE~l~~~~~~~s~~~Dv~s~G~il~elltg~~pf~~~~~~~  495 (506)
                      ...+|+.|+|||++.+.  .++.++||||||+++|||++|+.||......+
T Consensus       162 ~~~gt~~y~aPE~~~~~--~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~  210 (321)
T 1tki_A          162 LLFTAPEYYAPEVHQHD--VVSTATDMWSLGTLVYVLLSGINPFLAETNQQ  210 (321)
T ss_dssp             EEESCGGGSCHHHHTTC--EECHHHHHHHHHHHHHHHHHSSCTTCCSSHHH
T ss_pred             cccCChhhcCcHHhcCC--CCCchhhHHHHHHHHHHHHhCCCCCcCCCHHH
Confidence            45689999999998654  67899999999999999999999998765443

>4hcu_A Tyrosine-protein kinase ITK/TSK; transferase-transferase inhibitor complex; HET: 13L; 1.43A {Homo sapiens} PDB: 4hct_A* 4hcv_A* 3t9t_A* 1sm2_A* 1snu_A* 1snx_A 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A*

Probab=99.97  E-value=1.5e-32  Score=265.04  Aligned_cols=175  Identities=29%  Similarity=0.540  Sum_probs=148.5

Q ss_pred             hhccccCccCceEEEEEEEcCCCEEEEEEeccCCCCchhhHHHHHHhhccCccceeEEEEEee-----------------
Q 039231          316 SFKYKLGQGGYGSVYKGKLLDGSNVAVKVLNDSKGNGKEFINEVASISRTSHVNVVALLGFCL-----------------  378 (506)
Q Consensus       316 ~~~~~ig~G~~g~V~~~~~~~~~~vavK~l~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~-----------------  378 (506)
                      .+.+.||+|+||.||+|+..+++.||+|++.......+++.+|++++++++||||+++++++.                 
T Consensus        13 ~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L   92 (269)
T 4hcu_A           13 TFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAMSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFEFMEHGCL   92 (269)
T ss_dssp             EEEEEEEECSSCEEEEEEETTTEEEEEEEECTTSBCHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEEEEECCTTCBH
T ss_pred             eeeheecCCCccEEEEEEecCCCeEEEEEecccccCHHHHHHHHHHHHhCCCCCEeeEEEEEecCCceEEEEEeCCCCcH
Confidence            345689999999999999988999999999887767788999999999999999999999872                 


Q ss_pred             -----------ccchhhhHHHHHHHHHHHHhhcCCCCeEecCcCCCcEEECCCCcEEEeecCCCccccCCCcceecccCC
Q 039231          379 -----------RVAEELSSTIGIARGLEYLHLGCSTRILHFDIKPHNILLDEDFCPKISDFGLAKICNRKESIISMTGAR  447 (506)
Q Consensus       379 -----------~~~~~l~i~~~i~~gl~~LH~~~~~~ivH~dlkp~Nill~~~~~~ki~dfg~a~~~~~~~~~~~~~~~~  447 (506)
                                 ++...+.++.|++.||+|||   +.+|+||||||+||+++.++.+||+|||+++........ ......
T Consensus        93 ~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH---~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~-~~~~~~  168 (269)
T 4hcu_A           93 SDYLRTQRGLFAAETLLGMCLDVCEGMAYLE---EACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYT-SSTGTK  168 (269)
T ss_dssp             HHHHHTTTTCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEECGGGCEEECCTTGGGGBCCHHHH-STTSTT
T ss_pred             HHHHHhcCcccCHHHHHHHHHHHHHHHHHHH---hCCeecCCcchheEEEcCCCCEEeccccccccccccccc-cccCcc
Confidence                       23335678999999999999   899999999999999999999999999999866443221 123455


Q ss_pred             CCcccccccccccccCCCCccccHHHHHHHHHHHHc-CCCCCCCCCCCcc
Q 039231          448 GTVGYIAPEVFCRNIGEVSYKSDVYNYGMMIFEMTG-GRKNVDVVDNGST  496 (506)
Q Consensus       448 gt~~y~aPE~l~~~~~~~s~~~Dv~s~G~il~ellt-g~~pf~~~~~~~~  496 (506)
                      +++.|+|||.+...  .++.++||||+|+++|||++ |+.||......+.
T Consensus       169 ~~~~y~aPE~~~~~--~~~~~~Di~slG~~l~~ll~~g~~p~~~~~~~~~  216 (269)
T 4hcu_A          169 FPVKWASPEVFSFS--RYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEV  216 (269)
T ss_dssp             CCGGGCCHHHHHHC--CCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHH
T ss_pred             cccccCCHHHhcCC--CCCchhhhHHHHHHHHHHhcCCCCCCCCCCHHHH
Confidence            67889999998544  78999999999999999999 9999987654443

>3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens}

Probab=99.97  E-value=2.8e-32  Score=268.49  Aligned_cols=178  Identities=30%  Similarity=0.407  Sum_probs=145.1

Q ss_pred             HhhhccccCccCceEEEEEEE-cCCCEEEEEEeccCC------CCchhhHHHHHHhhccC---ccceeEEEEEee-----
Q 039231          314 TNSFKYKLGQGGYGSVYKGKL-LDGSNVAVKVLNDSK------GNGKEFINEVASISRTS---HVNVVALLGFCL-----  378 (506)
Q Consensus       314 ~~~~~~~ig~G~~g~V~~~~~-~~~~~vavK~l~~~~------~~~~~~~~E~~~l~~l~---h~niv~l~g~~~-----  378 (506)
                      .+.+.++||+|+||+||+|+. .+++.||||++....      .....+.+|++++++++   ||||+++++++.     
T Consensus        10 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~niv~~~~~~~~~~~~   89 (308)
T 3g33_A           10 RYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLRRLEAFEHPNVVRLMDVCATSRTD   89 (308)
T ss_dssp             CCEEEEEECCSSSCCEEEEECTTTCCEEEEEEEEEECCCTTSSCCCHHHHHHHHHHHHHHHHCCTTBCCEEEEEEECCSS
T ss_pred             ceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEecccccccccccchhHHHHHHHHHHHhhcCCCCeEEeeeeeeccCCC
Confidence            445567899999999999997 458999999986322      22356778888877775   999999998762     


Q ss_pred             ----------------------------ccchhhhHHHHHHHHHHHHhhcCCCCeEecCcCCCcEEECCCCcEEEeecCC
Q 039231          379 ----------------------------RVAEELSSTIGIARGLEYLHLGCSTRILHFDIKPHNILLDEDFCPKISDFGL  430 (506)
Q Consensus       379 ----------------------------~~~~~l~i~~~i~~gl~~LH~~~~~~ivH~dlkp~Nill~~~~~~ki~dfg~  430 (506)
                                                  ++.+++.++.|++.||+|||   +++|+||||||+|||++.++.+||+|||+
T Consensus        90 ~~~~~~lv~e~~~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~al~~lH---~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~  166 (308)
T 3g33_A           90 REIKVTLVFEHVDQDLRTYLDKAPPPGLPAETIKDLMRQFLRGLDFLH---ANCIVHRDLKPENILVTSGGTVKLADFGL  166 (308)
T ss_dssp             SEEEEEEEEECCCCBHHHHHHTCCTTCSCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCTTTEEECTTSCEEECSCSC
T ss_pred             CceeEEEEehhhhcCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCHHHEEEcCCCCEEEeeCcc
Confidence                                        22335678999999999999   89999999999999999999999999999


Q ss_pred             CccccCCCcceecccCCCCcccccccccccccCCCCccccHHHHHHHHHHHHcCCCCCCCCCCCcchhh
Q 039231          431 AKICNRKESIISMTGARGTVGYIAPEVFCRNIGEVSYKSDVYNYGMMIFEMTGGRKNVDVVDNGSTALD  499 (506)
Q Consensus       431 a~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~s~~~Dv~s~G~il~elltg~~pf~~~~~~~~~~~  499 (506)
                      ++.......   .....+|+.|+|||++.+.  .++.++||||||+++|||++|+.||......+....
T Consensus       167 a~~~~~~~~---~~~~~gt~~y~aPE~~~~~--~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~  230 (308)
T 3g33_A          167 ARIYSYQMA---LTPVVVTLWYRAPEVLLQS--TYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGK  230 (308)
T ss_dssp             TTTSTTCCC---SGGGGCCCSSCCHHHHHTS--CCCSTHHHHHHHHHHHHTTTSSCSCCCSSHHHHHHH
T ss_pred             ccccCCCcc---cCCccccccccCchHHcCC--CCCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHH
Confidence            987654332   2446789999999998654  689999999999999999999999987665544333

>4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp}

Probab=99.97  E-value=3.6e-32  Score=266.16  Aligned_cols=172  Identities=32%  Similarity=0.434  Sum_probs=138.9

Q ss_pred             hhccccCccCceEEEEEEEc-CCCEEEEEEeccCCCC----chhhHHHHHHhhccCccceeEEEEEe-------------
Q 039231          316 SFKYKLGQGGYGSVYKGKLL-DGSNVAVKVLNDSKGN----GKEFINEVASISRTSHVNVVALLGFC-------------  377 (506)
Q Consensus       316 ~~~~~ig~G~~g~V~~~~~~-~~~~vavK~l~~~~~~----~~~~~~E~~~l~~l~h~niv~l~g~~-------------  377 (506)
                      .+.+.||+|+||.||+|+.. +++.||+|++......    .+.+.+|++++.+++||||+++++++             
T Consensus        14 ~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~   93 (294)
T 4eqm_A           14 KIVDKLGGGGMSTVYLAEDTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQNIVSMIDVDEEDDCYYLVMEYI   93 (294)
T ss_dssp             EEEEEEEEETTEEEEEEEETTTCSEEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCBTTBCCEEEEEECSSEEEEEEECC
T ss_pred             EEEEEEccCCCEEEEEEEECCCCCeEEEEEeccCccccHHHHHHHHHHHHHHhcCCCCCCceEEEeeeeCCeEEEEEeCC
Confidence            34568999999999999975 5899999998654332    25688999999999999999999887             


Q ss_pred             --------------eccchhhhHHHHHHHHHHHHhhcCCCCeEecCcCCCcEEECCCCcEEEeecCCCccccCCCcceec
Q 039231          378 --------------LRVAEELSSTIGIARGLEYLHLGCSTRILHFDIKPHNILLDEDFCPKISDFGLAKICNRKESIISM  443 (506)
Q Consensus       378 --------------~~~~~~l~i~~~i~~gl~~LH~~~~~~ivH~dlkp~Nill~~~~~~ki~dfg~a~~~~~~~~~~~~  443 (506)
                                    +++.+.+.++.|++.||+|||   +++|+||||||+||+++.++.+||+|||+++........ ..
T Consensus        94 ~g~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~-~~  169 (294)
T 4eqm_A           94 EGPTLSEYIESHGPLSVDTAINFTNQILDGIKHAH---DMRIVHRDIKPQNILIDSNKTLKIFDFGIAKALSETSLT-QT  169 (294)
T ss_dssp             CSCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEECTTSCEEECCCSSSTTC---------
T ss_pred             CCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCHHHEEECCCCCEEEEeCCCcccccccccc-cc
Confidence                          233446778999999999999   899999999999999999999999999999876543321 12


Q ss_pred             ccCCCCcccccccccccccCCCCccccHHHHHHHHHHHHcCCCCCCCCCC
Q 039231          444 TGARGTVGYIAPEVFCRNIGEVSYKSDVYNYGMMIFEMTGGRKNVDVVDN  493 (506)
Q Consensus       444 ~~~~gt~~y~aPE~l~~~~~~~s~~~Dv~s~G~il~elltg~~pf~~~~~  493 (506)
                      ....||+.|+|||.+.+.  .++.++||||||+++|||++|+.||.....
T Consensus       170 ~~~~gt~~y~aPE~~~~~--~~~~~~Di~slG~~l~~ll~g~~pf~~~~~  217 (294)
T 4eqm_A          170 NHVLGTVQYFSPEQAKGE--ATDECTDIYSIGIVLYEMLVGEPPFNGETA  217 (294)
T ss_dssp             -----CCSSCCHHHHHTC--CCCTTHHHHHHHHHHHHHHHSSCSSCSSCH
T ss_pred             CccccCccccCHhHhcCC--CCCchHhHHHHHHHHHHHHhCCCCCCCCCh
Confidence            345689999999998654  678999999999999999999999987654

>3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A*

Probab=99.97  E-value=3.9e-32  Score=270.01  Aligned_cols=174  Identities=25%  Similarity=0.360  Sum_probs=135.5

Q ss_pred             hhhccccCccCceEEEEEEE----cCCCEEEEEEeccCC-----CCchhhHHHHHHhhccCccceeEEEEEee-------
Q 039231          315 NSFKYKLGQGGYGSVYKGKL----LDGSNVAVKVLNDSK-----GNGKEFINEVASISRTSHVNVVALLGFCL-------  378 (506)
Q Consensus       315 ~~~~~~ig~G~~g~V~~~~~----~~~~~vavK~l~~~~-----~~~~~~~~E~~~l~~l~h~niv~l~g~~~-------  378 (506)
                      +.+.+.||+|+||.||+|+.    .+++.||+|+++...     .....+.+|++++++++||||+++++++.       
T Consensus        19 y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~l   98 (327)
T 3a62_A           19 FELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVKHPFIVDLIYAFQTGGKLYL   98 (327)
T ss_dssp             EEEEEEEEEETTEEEEEEEECSSTTTTCEEEEEEECCC--------------HHHHHHHCCCTTBCCEEEEEECSSCEEE
T ss_pred             eEEEEEEEeCCCEEEEEEEEeccCCCCcEEEEEEEEHHHhhhhhhHHHHHHHHHHHHHhCCCCCccceeEEEEcCCEEEE
Confidence            34457899999999999987    468999999997542     23356788999999999999999998872       


Q ss_pred             --------------------ccchhhhHHHHHHHHHHHHhhcCCCCeEecCcCCCcEEECCCCcEEEeecCCCccccCCC
Q 039231          379 --------------------RVAEELSSTIGIARGLEYLHLGCSTRILHFDIKPHNILLDEDFCPKISDFGLAKICNRKE  438 (506)
Q Consensus       379 --------------------~~~~~l~i~~~i~~gl~~LH~~~~~~ivH~dlkp~Nill~~~~~~ki~dfg~a~~~~~~~  438 (506)
                                          .+.+.+.++.||+.||+|||   +++|+||||||+|||++.++.+||+|||+++......
T Consensus        99 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~al~~lH---~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~  175 (327)
T 3a62_A           99 ILEYLSGGELFMQLEREGIFMEDTACFYLAEISMALGHLH---QKGIIYRDLKPENIMLNHQGHVKLTDFGLCKESIHDG  175 (327)
T ss_dssp             EEECCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCTTTEEECTTSCEEECCCSCC-------
T ss_pred             EEeCCCCCcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHH---hCCEEcccCCHHHeEECCCCcEEEEeCCcccccccCC
Confidence                                22335668899999999999   8999999999999999999999999999997644332


Q ss_pred             cceecccCCCCcccccccccccccCCCCccccHHHHHHHHHHHHcCCCCCCCCCCCc
Q 039231          439 SIISMTGARGTVGYIAPEVFCRNIGEVSYKSDVYNYGMMIFEMTGGRKNVDVVDNGS  495 (506)
Q Consensus       439 ~~~~~~~~~gt~~y~aPE~l~~~~~~~s~~~Dv~s~G~il~elltg~~pf~~~~~~~  495 (506)
                      ..  .....||+.|+|||.+.+.  .++.++||||||+++|||++|+.||...+..+
T Consensus       176 ~~--~~~~~gt~~y~aPE~~~~~--~~~~~~DiwslG~il~el~~g~~pf~~~~~~~  228 (327)
T 3a62_A          176 TV--THTFCGTIEYMAPEILMRS--GHNRAVDWWSLGALMYDMLTGAPPFTGENRKK  228 (327)
T ss_dssp             -----CTTSSCCTTSCHHHHTTS--CCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHH
T ss_pred             cc--ccccCCCcCccCHhhCcCC--CCCCcccchhHHHHHHHHHHCCCCCCCCCHHH
Confidence            21  2346789999999998654  68999999999999999999999998765443

>3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens}

Probab=99.97  E-value=4e-32  Score=274.13  Aligned_cols=171  Identities=19%  Similarity=0.227  Sum_probs=141.4

Q ss_pred             hhccccCccCceEEEEEE------EcCCCEEEEEEeccCCCCchhhHHHHHHhhccC---ccceeEEEEEe---------
Q 039231          316 SFKYKLGQGGYGSVYKGK------LLDGSNVAVKVLNDSKGNGKEFINEVASISRTS---HVNVVALLGFC---------  377 (506)
Q Consensus       316 ~~~~~ig~G~~g~V~~~~------~~~~~~vavK~l~~~~~~~~~~~~E~~~l~~l~---h~niv~l~g~~---------  377 (506)
                      .+.++||+|+||.||+|.      ..+++.||||+++..  ...++.+|++++.+++   |+||+++++++         
T Consensus        68 ~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~--~~~~~~~e~~~~~~l~~~~~~~iv~~~~~~~~~~~~~lv  145 (365)
T 3e7e_A           68 YVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPA--NPWEFYIGTQLMERLKPSMQHMFMKFYSAHLFQNGSVLV  145 (365)
T ss_dssp             EEEEEEEECSSEEEEEEEC-------CCCCEEEEEESSC--CHHHHHHHHHHHHHSCGGGGGGBCCEEEEEECSSCEEEE
T ss_pred             EEEEEeeccCCEEEEEEEecCCcccccCcEEEEEEeCCC--ChhHHHHHHHHHHHhhhhhhhhhhhhheeeecCCCcEEE
Confidence            345679999999999994      345889999999653  3467888888888887   99999999876         


Q ss_pred             -----------------------eccchhhhHHHHHHHHHHHHhhcCCCCeEecCcCCCcEEECC-----------CCcE
Q 039231          378 -----------------------LRVAEELSSTIGIARGLEYLHLGCSTRILHFDIKPHNILLDE-----------DFCP  423 (506)
Q Consensus       378 -----------------------~~~~~~l~i~~~i~~gl~~LH~~~~~~ivH~dlkp~Nill~~-----------~~~~  423 (506)
                                             +++.+++.++.||+.||+|||   +++|+||||||+|||++.           ++.+
T Consensus       146 ~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~lH---~~~ivHrDiKp~NIll~~~~~~~~~~~~~~~~~  222 (365)
T 3e7e_A          146 GELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVH---DCEIIHGDIKPDNFILGNGFLEQDDEDDLSAGL  222 (365)
T ss_dssp             ECCCCSCBHHHHHHHHHTSTTCSCCHHHHHHHHHHHHHHHHHHH---TTTEECCCCSGGGEEECGGGTCC------CTTE
T ss_pred             EeccCCCcHHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHh---hCCeecCCCCHHHEEecccccCccccccccCCE
Confidence                                   122336779999999999999   899999999999999998           8999


Q ss_pred             EEeecCCCccccCCCcceecccCCCCcccccccccccccCCCCccccHHHHHHHHHHHHcCCCCCCCCCC
Q 039231          424 KISDFGLAKICNRKESIISMTGARGTVGYIAPEVFCRNIGEVSYKSDVYNYGMMIFEMTGGRKNVDVVDN  493 (506)
Q Consensus       424 ki~dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~s~~~Dv~s~G~il~elltg~~pf~~~~~  493 (506)
                      ||+|||+++...............||+.|+|||++.+.  .++.++||||||+++|||++|+.||.....
T Consensus       223 kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~~DiwslG~il~elltg~~pf~~~~~  290 (365)
T 3e7e_A          223 ALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNK--PWNYQIDYFGVAATVYCMLFGTYMKVKNEG  290 (365)
T ss_dssp             EECCCTTCEEGGGSCTTEEECCSSCTTSCCCHHHHTTC--CBSTHHHHHHHHHHHHHHHHSSCCCEEEET
T ss_pred             EEeeCchhhhhhccCCCceeeeecCCCCCCChHHhcCC--CCCccccHHHHHHHHHHHHhCCCccccCCC
Confidence            99999999866533333334567899999999999664  689999999999999999999999976544

>2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens}

Probab=99.97  E-value=9.6e-32  Score=267.07  Aligned_cols=173  Identities=27%  Similarity=0.386  Sum_probs=145.6

Q ss_pred             HhhhccccCccCceEEEEEEEc-CCCEEEEEEeccCCC-------CchhhHHHHHHhhccCccceeEEEEEe--------
Q 039231          314 TNSFKYKLGQGGYGSVYKGKLL-DGSNVAVKVLNDSKG-------NGKEFINEVASISRTSHVNVVALLGFC--------  377 (506)
Q Consensus       314 ~~~~~~~ig~G~~g~V~~~~~~-~~~~vavK~l~~~~~-------~~~~~~~E~~~l~~l~h~niv~l~g~~--------  377 (506)
                      .+.+.+.||+|+||.||+|+.. +++.||+|+++....       ..+.+.+|++++++++||||+++++++        
T Consensus        12 ~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~l   91 (326)
T 2y0a_A           12 YYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDVIL   91 (326)
T ss_dssp             HEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEBCCSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEE
T ss_pred             ceEeceEEeeCCCeEEEEEEECCCCcEEEEEEEEccccccccchhhHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEE
Confidence            3455678999999999999985 489999999975322       236788999999999999999999887        


Q ss_pred             -------------------eccchhhhHHHHHHHHHHHHhhcCCCCeEecCcCCCcEEECCCC----cEEEeecCCCccc
Q 039231          378 -------------------LRVAEELSSTIGIARGLEYLHLGCSTRILHFDIKPHNILLDEDF----CPKISDFGLAKIC  434 (506)
Q Consensus       378 -------------------~~~~~~l~i~~~i~~gl~~LH~~~~~~ivH~dlkp~Nill~~~~----~~ki~dfg~a~~~  434 (506)
                                         +++.+.+.++.||+.||+|||   +++|+||||||+|||++.++    .+||+|||+++..
T Consensus        92 v~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~lH---~~~ivH~Dlkp~NIll~~~~~~~~~~kl~Dfg~a~~~  168 (326)
T 2y0a_A           92 ILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLH---SLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKI  168 (326)
T ss_dssp             EEECCCSCBHHHHHTTSSCCBHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEESCSSSSSCCEEECCCTTCEEC
T ss_pred             EEEcCCCCCHHHHHHhcCCcCHHHHHHHHHHHHHHHHHHH---HCCeEcCCCCHHHEEEecCCCCCCCEEEEECCCCeEC
Confidence                               233446779999999999999   89999999999999998887    7999999999876


Q ss_pred             cCCCcceecccCCCCcccccccccccccCCCCccccHHHHHHHHHHHHcCCCCCCCCCCC
Q 039231          435 NRKESIISMTGARGTVGYIAPEVFCRNIGEVSYKSDVYNYGMMIFEMTGGRKNVDVVDNG  494 (506)
Q Consensus       435 ~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~s~~~Dv~s~G~il~elltg~~pf~~~~~~  494 (506)
                      .....   .....||+.|+|||++...  .++.++||||||+++|||++|+.||......
T Consensus       169 ~~~~~---~~~~~gt~~y~aPE~~~~~--~~~~~~DiwslG~il~~ll~g~~pf~~~~~~  223 (326)
T 2y0a_A          169 DFGNE---FKNIFGTPEFVAPEIVNYE--PLGLEADMWSIGVITYILLSGASPFLGDTKQ  223 (326)
T ss_dssp             CTTSC---CCCCCSCTTTCCHHHHTTC--CCCTHHHHHHHHHHHHHHHHSCCSSCCSSHH
T ss_pred             CCCCc---cccccCCcCcCCceeecCC--CCCcHHHHHHHHHHHHHHHHCcCCCCCCCHH
Confidence            54332   2446789999999998543  7899999999999999999999999765443

>3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 4g5j_A* 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* ...

Probab=99.97  E-value=1.7e-32  Score=272.55  Aligned_cols=175  Identities=31%  Similarity=0.532  Sum_probs=139.2

Q ss_pred             hhccccCccCceEEEEEEEcC-CC----EEEEEEeccCC--CCchhhHHHHHHhhccCccceeEEEEEee----------
Q 039231          316 SFKYKLGQGGYGSVYKGKLLD-GS----NVAVKVLNDSK--GNGKEFINEVASISRTSHVNVVALLGFCL----------  378 (506)
Q Consensus       316 ~~~~~ig~G~~g~V~~~~~~~-~~----~vavK~l~~~~--~~~~~~~~E~~~l~~l~h~niv~l~g~~~----------  378 (506)
                      .+.++||+|+||.||+|++.. ++    .||+|.+....  ...+++.+|++++++++||||+++++++.          
T Consensus        18 ~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~v~e~   97 (327)
T 3poz_A           18 KKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTSTVQLITQL   97 (327)
T ss_dssp             EEEEEEEEETTEEEEEEEECC----CCEEEEEEEC-------CHHHHHHHHHHHHHCCBTTBCCEEEEEESSSEEEEEEC
T ss_pred             ccceEEeeCCCeEEEEEEEcCCCceEEEEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEEEEe
Confidence            345689999999999998643 43    36888886432  34478999999999999999999999872          


Q ss_pred             -----------------ccchhhhHHHHHHHHHHHHhhcCCCCeEecCcCCCcEEECCCCcEEEeecCCCccccCCCcce
Q 039231          379 -----------------RVAEELSSTIGIARGLEYLHLGCSTRILHFDIKPHNILLDEDFCPKISDFGLAKICNRKESII  441 (506)
Q Consensus       379 -----------------~~~~~l~i~~~i~~gl~~LH~~~~~~ivH~dlkp~Nill~~~~~~ki~dfg~a~~~~~~~~~~  441 (506)
                                       .+.+.+.++.|++.||+|||   +++|+||||||+|||++.++.+||+|||+++.........
T Consensus        98 ~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~LH---~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~  174 (327)
T 3poz_A           98 MPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLE---DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEY  174 (327)
T ss_dssp             CTTCBHHHHHHHSTTSCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEEEETTEEEECCTTHHHHHTTTCC--
T ss_pred             cCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHh---hCCeeCCCCChheEEECCCCCEEEccCcceeEccCCcccc
Confidence                             23346779999999999999   8999999999999999999999999999998876554433


Q ss_pred             ecccCCCCcccccccccccccCCCCccccHHHHHHHHHHHHc-CCCCCCCCCCCc
Q 039231          442 SMTGARGTVGYIAPEVFCRNIGEVSYKSDVYNYGMMIFEMTG-GRKNVDVVDNGS  495 (506)
Q Consensus       442 ~~~~~~gt~~y~aPE~l~~~~~~~s~~~Dv~s~G~il~ellt-g~~pf~~~~~~~  495 (506)
                      ......+|+.|+|||.+.+.  .++.++||||||+++|||++ |+.||+.....+
T Consensus       175 ~~~~~~~t~~y~aPE~~~~~--~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~  227 (327)
T 3poz_A          175 HAEGGKVPIKWMALESILHR--IYTHQSDVWSYGVTVWELMTFGSKPYDGIPASE  227 (327)
T ss_dssp             -----CCCGGGSCHHHHHHC--CCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGG
T ss_pred             cccCCCccccccChHHhccC--CCCchhhhhhhHHHHHHHHhcCCCCccCCCHHH
Confidence            33455678899999998654  78999999999999999999 999998765544

>2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B

Probab=99.97  E-value=7.2e-32  Score=271.85  Aligned_cols=172  Identities=28%  Similarity=0.408  Sum_probs=144.1

Q ss_pred             HhhhccccCccCceEEEEEEEc-CCCEEEEEEeccCCCC---chhhHHHHHHhhccCccceeEEEEEe------------
Q 039231          314 TNSFKYKLGQGGYGSVYKGKLL-DGSNVAVKVLNDSKGN---GKEFINEVASISRTSHVNVVALLGFC------------  377 (506)
Q Consensus       314 ~~~~~~~ig~G~~g~V~~~~~~-~~~~vavK~l~~~~~~---~~~~~~E~~~l~~l~h~niv~l~g~~------------  377 (506)
                      .+.+.+.||+|+||.||+|+.. +++.||+|++......   .+.+.+|++++++++||||+++++++            
T Consensus        30 ~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~lv~e~  109 (362)
T 2bdw_A           30 NYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVFDL  109 (362)
T ss_dssp             HEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEECC
T ss_pred             CeEEeeEEecCCCeEEEEEEECCCCCEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEEec
Confidence            3455678999999999999975 5899999999765432   25688999999999999999999877            


Q ss_pred             ---------------eccchhhhHHHHHHHHHHHHhhcCCCCeEecCcCCCcEEECCC---CcEEEeecCCCccccCCCc
Q 039231          378 ---------------LRVAEELSSTIGIARGLEYLHLGCSTRILHFDIKPHNILLDED---FCPKISDFGLAKICNRKES  439 (506)
Q Consensus       378 ---------------~~~~~~l~i~~~i~~gl~~LH~~~~~~ivH~dlkp~Nill~~~---~~~ki~dfg~a~~~~~~~~  439 (506)
                                     +++.+.+.++.||+.||+|||   +++|+||||||+|||++.+   +.+||+|||+++.......
T Consensus       110 ~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~al~~lH---~~~ivH~Dlkp~NIll~~~~~~~~~kl~DfG~a~~~~~~~~  186 (362)
T 2bdw_A          110 VTGGELFEDIVAREFYSEADASHCIQQILESIAYCH---SNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEA  186 (362)
T ss_dssp             CCSCBHHHHHTTCSCCCHHHHHHHHHHHHHHHHHHH---HTTCBCCCCSGGGEEESCSSTTCCEEECCCTTCBCCTTCCS
T ss_pred             CCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHH---HCCeEeccCchHHEEEecCCCCCCEEEeecCcceEecCCcc
Confidence                           223346678999999999999   8999999999999999765   4599999999987654332


Q ss_pred             ceecccCCCCcccccccccccccCCCCccccHHHHHHHHHHHHcCCCCCCCCCC
Q 039231          440 IISMTGARGTVGYIAPEVFCRNIGEVSYKSDVYNYGMMIFEMTGGRKNVDVVDN  493 (506)
Q Consensus       440 ~~~~~~~~gt~~y~aPE~l~~~~~~~s~~~Dv~s~G~il~elltg~~pf~~~~~  493 (506)
                         .....||+.|+|||++.+.  .++.++||||||+++|||++|+.||...+.
T Consensus       187 ---~~~~~gt~~y~aPE~~~~~--~~~~~~DiwslG~il~~ll~g~~Pf~~~~~  235 (362)
T 2bdw_A          187 ---WHGFAGTPGYLSPEVLKKD--PYSKPVDIWACGVILYILLVGYPPFWDEDQ  235 (362)
T ss_dssp             ---CCCSCSCTTTCCHHHHTTC--CCCTHHHHHHHHHHHHHHHHSSCSSCCSSH
T ss_pred             ---cccCCCCccccCHHHHccC--CCCchhhHHHHHHHHHHHHHCCCCCCCCCH
Confidence               2446789999999998654  789999999999999999999999976544

>1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ...

Probab=99.97  E-value=3.8e-32  Score=272.49  Aligned_cols=168  Identities=25%  Similarity=0.312  Sum_probs=143.7

Q ss_pred             hccccCccCceEEEEEEEc-CCCEEEEEEeccC----CCCchhhHHHHHHhhccCccceeEEEEEe--------------
Q 039231          317 FKYKLGQGGYGSVYKGKLL-DGSNVAVKVLNDS----KGNGKEFINEVASISRTSHVNVVALLGFC--------------  377 (506)
Q Consensus       317 ~~~~ig~G~~g~V~~~~~~-~~~~vavK~l~~~----~~~~~~~~~E~~~l~~l~h~niv~l~g~~--------------  377 (506)
                      +.+.||+|+||.||+|+.. +|+.||||+++..    ....+.+.+|++++++++||||+++++++              
T Consensus        45 ~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~  124 (350)
T 1rdq_E           45 RIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVA  124 (350)
T ss_dssp             EEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEECCT
T ss_pred             EEEEeecCcCcEEEEEEECCCCCEEEEEEEEhHHhccHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEcCCEEEEEEcCCC
Confidence            3467999999999999985 5899999999643    23446788999999999999999999876              


Q ss_pred             -------------eccchhhhHHHHHHHHHHHHhhcCCCCeEecCcCCCcEEECCCCcEEEeecCCCccccCCCcceecc
Q 039231          378 -------------LRVAEELSSTIGIARGLEYLHLGCSTRILHFDIKPHNILLDEDFCPKISDFGLAKICNRKESIISMT  444 (506)
Q Consensus       378 -------------~~~~~~l~i~~~i~~gl~~LH~~~~~~ivH~dlkp~Nill~~~~~~ki~dfg~a~~~~~~~~~~~~~  444 (506)
                                   +++.+.+.++.||+.||+|||   +++|+||||||+|||++.++.+||+|||+++......     .
T Consensus       125 gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH---~~~ivHrDlkp~NIll~~~g~~kL~DFg~a~~~~~~~-----~  196 (350)
T 1rdq_E          125 GGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLH---SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRT-----W  196 (350)
T ss_dssp             TCBHHHHHHHHCCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTTSCEEECCCTTCEECSSCB-----C
T ss_pred             CCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHH---HCCcccccCccceEEECCCCCEEEcccccceeccCCc-----c
Confidence                         233346678999999999999   8999999999999999999999999999998765432     3


Q ss_pred             cCCCCcccccccccccccCCCCccccHHHHHHHHHHHHcCCCCCCCCCCC
Q 039231          445 GARGTVGYIAPEVFCRNIGEVSYKSDVYNYGMMIFEMTGGRKNVDVVDNG  494 (506)
Q Consensus       445 ~~~gt~~y~aPE~l~~~~~~~s~~~Dv~s~G~il~elltg~~pf~~~~~~  494 (506)
                      ...||+.|+|||++.+.  .++.++||||||+++|||++|+.||...+..
T Consensus       197 ~~~gt~~y~aPE~~~~~--~~~~~~DiwslG~il~ell~g~~Pf~~~~~~  244 (350)
T 1rdq_E          197 TLCGTPEALAPEIILSK--GYNKAVDWWALGVLIYEMAAGYPPFFADQPI  244 (350)
T ss_dssp             CCEECGGGCCHHHHTTC--CBCTHHHHHHHHHHHHHHHHSSCSSCCSSHH
T ss_pred             cccCCccccCHHHhcCC--CCCCcCCEecccHhHhHHhhCCCCCCCCCHH
Confidence            45689999999998654  6899999999999999999999999865543

>3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A

Probab=99.97  E-value=4e-32  Score=263.94  Aligned_cols=177  Identities=31%  Similarity=0.522  Sum_probs=146.7

Q ss_pred             hhhccccCccCceEEEEEEEcCCCEEEEEEeccCCCCchhhHHHHHHhhccCccceeEEEEEe-----------------
Q 039231          315 NSFKYKLGQGGYGSVYKGKLLDGSNVAVKVLNDSKGNGKEFINEVASISRTSHVNVVALLGFC-----------------  377 (506)
Q Consensus       315 ~~~~~~ig~G~~g~V~~~~~~~~~~vavK~l~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~-----------------  377 (506)
                      +.+.+.||+|+||.||+|++.++..||+|+++......+++.+|++++.+++||||+++++++                 
T Consensus        26 y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~  105 (283)
T 3gen_A           26 LTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEYMANGC  105 (283)
T ss_dssp             EEEEEECC---CEEEEEEEETTTEEEEEEEECTTSBCHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEEEECCCTTCB
T ss_pred             HHhHhhcCCCCCceEEEEEEcCCCeEEEEEecCCCCCHHHHHHHHHHHhcCCCCCEeeEEEEEecCCCeEEEEeccCCCc
Confidence            344578999999999999998888999999987776778899999999999999999999987                 


Q ss_pred             -----------eccchhhhHHHHHHHHHHHHhhcCCCCeEecCcCCCcEEECCCCcEEEeecCCCccccCCCcceecccC
Q 039231          378 -----------LRVAEELSSTIGIARGLEYLHLGCSTRILHFDIKPHNILLDEDFCPKISDFGLAKICNRKESIISMTGA  446 (506)
Q Consensus       378 -----------~~~~~~l~i~~~i~~gl~~LH~~~~~~ivH~dlkp~Nill~~~~~~ki~dfg~a~~~~~~~~~~~~~~~  446 (506)
                                 +++.+.+.++.|++.||+|||   +++|+||||||+||++++++.+||+|||+++........ .....
T Consensus       106 L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH---~~~i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~~~-~~~~~  181 (283)
T 3gen_A          106 LLNYLREMRHRFQTQQLLEMCKDVCEAMEYLE---SKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYT-SSVGS  181 (283)
T ss_dssp             HHHHHHCGGGCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSSCSGGGEEECTTSCEEECSTTGGGGBCCHHHH-STTST
T ss_pred             HHHHHHHhccCCCHHHHHHHHHHHHHHHHHHH---HCCccCCCCccceEEEcCCCCEEEccccccccccccccc-cccCC
Confidence                       223346778999999999999   899999999999999999999999999999866443221 12345


Q ss_pred             CCCcccccccccccccCCCCccccHHHHHHHHHHHHc-CCCCCCCCCCCcch
Q 039231          447 RGTVGYIAPEVFCRNIGEVSYKSDVYNYGMMIFEMTG-GRKNVDVVDNGSTA  497 (506)
Q Consensus       447 ~gt~~y~aPE~l~~~~~~~s~~~Dv~s~G~il~ellt-g~~pf~~~~~~~~~  497 (506)
                      .+|+.|+|||.+.+.  .++.++||||||+++|||++ |+.||......+..
T Consensus       182 ~~~~~y~aPE~~~~~--~~~~~~Dv~slG~~l~~l~t~g~~p~~~~~~~~~~  231 (283)
T 3gen_A          182 KFPVRWSPPEVLMYS--KFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETA  231 (283)
T ss_dssp             TSCGGGCCHHHHHHC--CCSHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHHH
T ss_pred             ccCcccCCHHHhccC--CCCchhhHHHHHHHHHHHHhCCCCCccccChhHHH
Confidence            567889999998654  68999999999999999998 99999876554433

>3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens}

Probab=99.97  E-value=1.1e-31  Score=264.59  Aligned_cols=173  Identities=26%  Similarity=0.392  Sum_probs=142.7

Q ss_pred             hccccCccCceEEEEEEEc-CCCEEEEEEeccCC-CCchhhHHHHHHhhccCccceeEEEEEee----------------
Q 039231          317 FKYKLGQGGYGSVYKGKLL-DGSNVAVKVLNDSK-GNGKEFINEVASISRTSHVNVVALLGFCL----------------  378 (506)
Q Consensus       317 ~~~~ig~G~~g~V~~~~~~-~~~~vavK~l~~~~-~~~~~~~~E~~~l~~l~h~niv~l~g~~~----------------  378 (506)
                      +.++||+|+||.||+|++. +++.||+|++.... ...+.+.+|++++++++||||+++++++.                
T Consensus        14 ~~~~lG~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~~~   93 (310)
T 3s95_A           14 HGEVLGKGCFGQAIKVTHRETGEVMVMKELIRFDEETQRTFLKEVKVMRCLEHPNVLKFIGVLYKDKRLNFITEYIKGGT   93 (310)
T ss_dssp             EEEEEECCSSEEEEEEEETTTCCEEEEEEESCCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEECCTTCB
T ss_pred             ccceecCCCCEEEEEEEECCCCcEEEEEEeccCCHHHHHHHHHHHHHHHhCCCcCcccEEEEEecCCeeEEEEEecCCCc
Confidence            4568999999999999985 48999999886533 33467899999999999999999999872                


Q ss_pred             ------------ccchhhhHHHHHHHHHHHHhhcCCCCeEecCcCCCcEEECCCCcEEEeecCCCccccCCCccee----
Q 039231          379 ------------RVAEELSSTIGIARGLEYLHLGCSTRILHFDIKPHNILLDEDFCPKISDFGLAKICNRKESIIS----  442 (506)
Q Consensus       379 ------------~~~~~l~i~~~i~~gl~~LH~~~~~~ivH~dlkp~Nill~~~~~~ki~dfg~a~~~~~~~~~~~----  442 (506)
                                  ++.+.+.++.|+++||+|||   +++|+||||||+||+++.++.+||+|||+++..........    
T Consensus        94 L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH---~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~  170 (310)
T 3s95_A           94 LRGIIKSMDSQYPWSQRVSFAKDIASGMAYLH---SMNIIHRDLNSHNCLVRENKNVVVADFGLARLMVDEKTQPEGLRS  170 (310)
T ss_dssp             HHHHHHHCCTTSCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSTTSEEECTTSCEEECCCTTCEECC-----------
T ss_pred             HHHHHHhccCCCCHHHHHHHHHHHHHHHHHHH---hCCccCCCCCcCeEEECCCCCEEEeecccceeccccccccccccc
Confidence                        23346779999999999999   89999999999999999999999999999987654332110    


Q ss_pred             --------cccCCCCcccccccccccccCCCCccccHHHHHHHHHHHHcCCCCCCCCCCC
Q 039231          443 --------MTGARGTVGYIAPEVFCRNIGEVSYKSDVYNYGMMIFEMTGGRKNVDVVDNG  494 (506)
Q Consensus       443 --------~~~~~gt~~y~aPE~l~~~~~~~s~~~Dv~s~G~il~elltg~~pf~~~~~~  494 (506)
                              .....||+.|+|||.+.+.  .++.++||||||+++|||++|..||......
T Consensus       171 ~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~~Di~slG~~l~el~~g~~~~~~~~~~  228 (310)
T 3s95_A          171 LKKPDRKKRYTVVGNPYWMAPEMINGR--SYDEKVDVFSFGIVLCEIIGRVNADPDYLPR  228 (310)
T ss_dssp             ---------CCCCSCGGGCCHHHHTTC--CCCTHHHHHHHHHHHHHHHHTCCSSTTTSCB
T ss_pred             ccccccccccccCCCcceeCHHHhcCC--CCCcHHHHHHHHHHHHHHhcCCCCCcchhhh
Confidence                    1145789999999999654  7899999999999999999999999875443

>4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens}

Probab=99.97  E-value=8e-32  Score=266.71  Aligned_cols=174  Identities=24%  Similarity=0.381  Sum_probs=144.8

Q ss_pred             hhccccCccCceEEEEEEEcC-CCEEEEEEeccCC--CCchhhHHHHHHhhccCccceeEEEEEee--------------
Q 039231          316 SFKYKLGQGGYGSVYKGKLLD-GSNVAVKVLNDSK--GNGKEFINEVASISRTSHVNVVALLGFCL--------------  378 (506)
Q Consensus       316 ~~~~~ig~G~~g~V~~~~~~~-~~~vavK~l~~~~--~~~~~~~~E~~~l~~l~h~niv~l~g~~~--------------  378 (506)
                      .+.++||+|+||.||+|+... ++.||||+++...  ...+.+.+|++++++++||||+++++++.              
T Consensus        12 ~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~e~~   91 (319)
T 4euu_A           12 LLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHKVLIMEFC   91 (319)
T ss_dssp             EEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGGSCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCCEEEEEECC
T ss_pred             EEEEEecCCCCeEEEEEEECCCCcEEEEEEeccccccchHHHHHHHHHHHHhcCCCCcceEEEEeecCCCceEEEEEeCC
Confidence            345689999999999999864 8999999997533  33467889999999999999999998762              


Q ss_pred             ------------------ccchhhhHHHHHHHHHHHHhhcCCCCeEecCcCCCcEEE----CCCCcEEEeecCCCccccC
Q 039231          379 ------------------RVAEELSSTIGIARGLEYLHLGCSTRILHFDIKPHNILL----DEDFCPKISDFGLAKICNR  436 (506)
Q Consensus       379 ------------------~~~~~l~i~~~i~~gl~~LH~~~~~~ivH~dlkp~Nill----~~~~~~ki~dfg~a~~~~~  436 (506)
                                        ++.+.+.++.|++.||+|||   +++|+||||||+|||+    +.++.+||+|||+++....
T Consensus        92 ~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~L~~LH---~~~ivH~Dlkp~NIll~~~~~~~~~~kL~Dfg~a~~~~~  168 (319)
T 4euu_A           92 PCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLR---ENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELED  168 (319)
T ss_dssp             TTCBHHHHHHSGGGTTCCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEEEECTTSCEEEEECCCTTCEECCT
T ss_pred             CCCCHHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHH---HCCEecCCCCHHHEEEeccCCCCceEEEccCCCceecCC
Confidence                              22335678999999999999   8999999999999999    7888899999999987765


Q ss_pred             CCcceecccCCCCcccccccccccc------cCCCCccccHHHHHHHHHHHHcCCCCCCCCCCCc
Q 039231          437 KESIISMTGARGTVGYIAPEVFCRN------IGEVSYKSDVYNYGMMIFEMTGGRKNVDVVDNGS  495 (506)
Q Consensus       437 ~~~~~~~~~~~gt~~y~aPE~l~~~------~~~~s~~~Dv~s~G~il~elltg~~pf~~~~~~~  495 (506)
                      ....   ....||+.|+|||++...      ...++.++||||||+++|||++|+.||.......
T Consensus       169 ~~~~---~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~  230 (319)
T 4euu_A          169 DEQF---VSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPR  230 (319)
T ss_dssp             TCCB---CCCCSCGGGCCHHHHHHHTSCCCCCCCBCTTHHHHHHHHHHHHHHHSSCSEECTTCGG
T ss_pred             CCce---eecccCCCccCHHHhhhccccccccCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCccc
Confidence            4432   346789999999998521      2478899999999999999999999998665543

>3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A*

Probab=99.97  E-value=7.8e-32  Score=267.59  Aligned_cols=175  Identities=25%  Similarity=0.450  Sum_probs=142.5

Q ss_pred             hccccCccCceEEEEEEEcC-CCE----EEEEEeccCC--CCchhhHHHHHHhhccCccceeEEEEEe------------
Q 039231          317 FKYKLGQGGYGSVYKGKLLD-GSN----VAVKVLNDSK--GNGKEFINEVASISRTSHVNVVALLGFC------------  377 (506)
Q Consensus       317 ~~~~ig~G~~g~V~~~~~~~-~~~----vavK~l~~~~--~~~~~~~~E~~~l~~l~h~niv~l~g~~------------  377 (506)
                      +.+.||+|+||.||+|++.. ++.    ||+|.+....  ...+.+.+|+.++.+++||||+++++++            
T Consensus        17 ~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~v~e~~   96 (325)
T 3kex_A           17 KLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSLDHAHIVRLLGLCPGSSLQLVTQYL   96 (325)
T ss_dssp             EEEEEECCSSCEEEEEEECCTTCSCCEEEEEEEECCTTSCSCBCSCCHHHHHHHTCCCTTBCCEEEEECBSSEEEEEECC
T ss_pred             eeeeeeecCCceEEEEEEcCCCceEEEEEEEEeccccccHHHHHHHHHHHHHHhcCCCCCcCeEEEEEcCCccEEEEEeC
Confidence            34679999999999998743 443    7888875432  3346788999999999999999999987            


Q ss_pred             ---------------eccchhhhHHHHHHHHHHHHhhcCCCCeEecCcCCCcEEECCCCcEEEeecCCCccccCCCccee
Q 039231          378 ---------------LRVAEELSSTIGIARGLEYLHLGCSTRILHFDIKPHNILLDEDFCPKISDFGLAKICNRKESIIS  442 (506)
Q Consensus       378 ---------------~~~~~~l~i~~~i~~gl~~LH~~~~~~ivH~dlkp~Nill~~~~~~ki~dfg~a~~~~~~~~~~~  442 (506)
                                     +++...+.++.|++.||+|||   +.+|+||||||+|||++.++.+||+|||+++..........
T Consensus        97 ~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH---~~~ivH~Dikp~Nil~~~~~~~kl~Dfg~a~~~~~~~~~~~  173 (325)
T 3kex_A           97 PLGSLLDHVRQHRGALGPQLLLNWGVQIAKGMYYLE---EHGMVHRNLAARNVLLKSPSQVQVADFGVADLLPPDDKQLL  173 (325)
T ss_dssp             TTCBSHHHHHSSGGGSCTTHHHHHHHHHHHHHHHHH---HTTCCCSCCSSTTEEESSSSCEEECSCSGGGGSCCCTTCCC
T ss_pred             CCCCHHHHHHHccccCCHHHHHHHHHHHHHHHHHHH---hCCCCCCccchheEEECCCCeEEECCCCcccccCccccccc
Confidence                           223446778999999999999   89999999999999999999999999999998765544333


Q ss_pred             cccCCCCcccccccccccccCCCCccccHHHHHHHHHHHHc-CCCCCCCCCCCcc
Q 039231          443 MTGARGTVGYIAPEVFCRNIGEVSYKSDVYNYGMMIFEMTG-GRKNVDVVDNGST  496 (506)
Q Consensus       443 ~~~~~gt~~y~aPE~l~~~~~~~s~~~Dv~s~G~il~ellt-g~~pf~~~~~~~~  496 (506)
                      .....++..|+|||.+.+.  .++.++||||||+++|||++ |+.||......+.
T Consensus       174 ~~~~~~~~~y~aPE~~~~~--~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~  226 (325)
T 3kex_A          174 YSEAKTPIKWMALESIHFG--KYTHQSDVWSYGVTVWELMTFGAEPYAGLRLAEV  226 (325)
T ss_dssp             -----CCTTTSCHHHHHHC--CCCHHHHHHHHHHHHHHHHTTSCCTTTTSCTTHH
T ss_pred             ccCCCCcccccChHHhccC--CCChhhHhHHhHHHHHHHHhCCCCCccccCHHHH
Confidence            3556788899999998653  78999999999999999999 9999987665443

>2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A*

Probab=99.97  E-value=5e-32  Score=271.75  Aligned_cols=173  Identities=25%  Similarity=0.356  Sum_probs=144.5

Q ss_pred             hhccccCccCceEEEEEEEcC-CCEEEEEEeccC----CCCchhhHHHHHHhhcc-CccceeEEEEEe------------
Q 039231          316 SFKYKLGQGGYGSVYKGKLLD-GSNVAVKVLNDS----KGNGKEFINEVASISRT-SHVNVVALLGFC------------  377 (506)
Q Consensus       316 ~~~~~ig~G~~g~V~~~~~~~-~~~vavK~l~~~----~~~~~~~~~E~~~l~~l-~h~niv~l~g~~------------  377 (506)
                      .+.+.||+|+||.||+|+... ++.||||+++..    ....+.+.+|.+++..+ +||||+++++++            
T Consensus        23 ~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~~~lv~E~  102 (353)
T 2i0e_A           23 NFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYFVMEY  102 (353)
T ss_dssp             EEEEEEEEETTEEEEEEEETTEEEEEEEEEEEHHHHHHTTCHHHHHHHHHHHTCTTCCTTBCCEEEEEECSSEEEEEEEC
T ss_pred             EEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhcchHHHHHHHHHHHHHhcCCCCEEeeEEEEEEcCCEEEEEEeC
Confidence            345789999999999999865 789999999753    33446788999999988 799999999876            


Q ss_pred             ---------------eccchhhhHHHHHHHHHHHHhhcCCCCeEecCcCCCcEEECCCCcEEEeecCCCccccCCCccee
Q 039231          378 ---------------LRVAEELSSTIGIARGLEYLHLGCSTRILHFDIKPHNILLDEDFCPKISDFGLAKICNRKESIIS  442 (506)
Q Consensus       378 ---------------~~~~~~l~i~~~i~~gl~~LH~~~~~~ivH~dlkp~Nill~~~~~~ki~dfg~a~~~~~~~~~~~  442 (506)
                                     +++.+.+.++.||+.||+|||   +++|+||||||+|||++.++.+||+|||+++.......  .
T Consensus       103 ~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH---~~givHrDlkp~NIll~~~g~vkL~DFG~a~~~~~~~~--~  177 (353)
T 2i0e_A          103 VNGGDLMYHIQQVGRFKEPHAVFYAAEIAIGLFFLQ---SKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENIWDGV--T  177 (353)
T ss_dssp             CCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHH---HTTCBCCCCCGGGEEECTTSCEEECCCTTCBCCCCTTC--C
T ss_pred             CCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH---HCCEEeccCCHHHEEEcCCCcEEEEeCCcccccccCCc--c
Confidence                           233346678999999999999   89999999999999999999999999999986433222  1


Q ss_pred             cccCCCCcccccccccccccCCCCccccHHHHHHHHHHHHcCCCCCCCCCCCc
Q 039231          443 MTGARGTVGYIAPEVFCRNIGEVSYKSDVYNYGMMIFEMTGGRKNVDVVDNGS  495 (506)
Q Consensus       443 ~~~~~gt~~y~aPE~l~~~~~~~s~~~Dv~s~G~il~elltg~~pf~~~~~~~  495 (506)
                      .....||+.|+|||++.+.  .++.++||||||+++|||++|+.||...+..+
T Consensus       178 ~~~~~gt~~y~aPE~~~~~--~~~~~~DiwslG~il~ell~G~~Pf~~~~~~~  228 (353)
T 2i0e_A          178 TKTFCGTPDYIAPEIIAYQ--PYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDE  228 (353)
T ss_dssp             BCCCCSCGGGCCHHHHTTC--CBSTHHHHHHHHHHHHHHHHSSCSSCCSSHHH
T ss_pred             cccccCCccccChhhhcCC--CcCCcccccchHHHHHHHHcCCCCCCCCCHHH
Confidence            2456799999999998654  68999999999999999999999998765443

>2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A*

Probab=99.97  E-value=7.1e-32  Score=268.43  Aligned_cols=174  Identities=22%  Similarity=0.270  Sum_probs=144.7

Q ss_pred             hccccCccCceEEEEEEE-cCCCEEEEEEeccCCCCchhhHHHHHHhhcc-CccceeEEEEEe-----------------
Q 039231          317 FKYKLGQGGYGSVYKGKL-LDGSNVAVKVLNDSKGNGKEFINEVASISRT-SHVNVVALLGFC-----------------  377 (506)
Q Consensus       317 ~~~~ig~G~~g~V~~~~~-~~~~~vavK~l~~~~~~~~~~~~E~~~l~~l-~h~niv~l~g~~-----------------  377 (506)
                      +.+.||+|+||.||+|+. .+++.||||++.... ..+.+.+|+++++++ +||||+++++++                 
T Consensus        13 ~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~lv~e~~~~~L   91 (330)
T 2izr_A           13 VGKKIGCGNFGELRLGKNLYTNEYVAIKLEPMKS-RAPQLHLEYRFYKQLGSGDGIPQVYYFGPCGKYNAMVLELLGPSL   91 (330)
T ss_dssp             EEEECCC-CTTSEEEEEETTTTEEEEEEEEETTC-SSCCHHHHHHHHHHHCSCTTSCCEEEEEEETTEEEEEEECCCCBH
T ss_pred             EEEEeeccCCceEEEEEECCCCcEEEEEEecccc-chHHHHHHHHHHHHhhCCCCCCEEEEEEecCCccEEEEEeCCCCH
Confidence            356899999999999997 468999999987543 336789999999999 899999999876                 


Q ss_pred             ----------eccchhhhHHHHHHHHHHHHhhcCCCCeEecCcCCCcEEECCCCc-----EEEeecCCCccccCCCcce-
Q 039231          378 ----------LRVAEELSSTIGIARGLEYLHLGCSTRILHFDIKPHNILLDEDFC-----PKISDFGLAKICNRKESII-  441 (506)
Q Consensus       378 ----------~~~~~~l~i~~~i~~gl~~LH~~~~~~ivH~dlkp~Nill~~~~~-----~ki~dfg~a~~~~~~~~~~-  441 (506)
                                +++.+.+.++.|++.||+|||   +.+|+||||||+|||++.++.     +||+|||+++......... 
T Consensus        92 ~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH---~~~iiHrDlkp~Nill~~~~~~~~~~~kl~DFg~a~~~~~~~~~~~  168 (330)
T 2izr_A           92 EDLFDLCDRTFSLKTVLMIAIQLISRMEYVH---SKNLIYRDVKPENFLIGRPGNKTQQVIHIIDFALAKEYIDPETKKH  168 (330)
T ss_dssp             HHHHHHTTTCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEECCGGGTCTTSEEECCCTTCEESBCTTTCCB
T ss_pred             HHHHHHcCCCCCHHHHHHHHHHHHHHHHHHH---hCCeeccCCCHHHeeeccCCCCCCceEEEEEcccceeeecCCCCcc
Confidence                      233446779999999999999   899999999999999998887     9999999998765433211 


Q ss_pred             ----ecccCCCCcccccccccccccCCCCccccHHHHHHHHHHHHcCCCCCCCCCCCcc
Q 039231          442 ----SMTGARGTVGYIAPEVFCRNIGEVSYKSDVYNYGMMIFEMTGGRKNVDVVDNGST  496 (506)
Q Consensus       442 ----~~~~~~gt~~y~aPE~l~~~~~~~s~~~Dv~s~G~il~elltg~~pf~~~~~~~~  496 (506)
                          ......||+.|+|||.+.+.  .++.++||||||+++|||++|+.||......+.
T Consensus       169 ~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~~Di~slG~il~ell~g~~Pf~~~~~~~~  225 (330)
T 2izr_A          169 IPYREHKSLTGTARYMSINTHLGK--EQSRRDDLEALGHMFMYFLRGSLPWQGLKADTL  225 (330)
T ss_dssp             CCCCCCCCCCSCTTTCCHHHHTTC--CCCHHHHHHHHHHHHHHHHHSSCTTTTCCCSSH
T ss_pred             ccccccCCcCCCccccChHHHcCC--CCCchhHHHHHHHHHHHHhcCCCCccccccccH
Confidence                12356799999999998654  789999999999999999999999998755443

>3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii}

Probab=99.97  E-value=9.9e-32  Score=279.58  Aligned_cols=173  Identities=27%  Similarity=0.375  Sum_probs=129.2

Q ss_pred             hhhccccCccCceEEEEEEEc-CCCEEEEEEeccCCCC---chhhHHHHHHhhccCccceeEEEEEee------------
Q 039231          315 NSFKYKLGQGGYGSVYKGKLL-DGSNVAVKVLNDSKGN---GKEFINEVASISRTSHVNVVALLGFCL------------  378 (506)
Q Consensus       315 ~~~~~~ig~G~~g~V~~~~~~-~~~~vavK~l~~~~~~---~~~~~~E~~~l~~l~h~niv~l~g~~~------------  378 (506)
                      +.+.+.||+|+||.||+|+.. +++.||||++......   .+++.+|+++|++++|||||++++++.            
T Consensus        55 y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~l  134 (458)
T 3rp9_A           55 YEIRHLIGTGSYGHVCEAYDKLEKRVVAIKKILRVFEDLIDCKRILREIAILNRLNHDHVVKVLDIVIPKDVEKFDELYV  134 (458)
T ss_dssp             EEECCC-------CEEEEEECC--CEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCCCEEE
T ss_pred             eEEeeEeeecCCeEEEEEEECCCCcEEEEEEechhhcCHHHHHHHHHHHHHHHhCCCCCCCceEEEEecCCcccCceEEE
Confidence            344578999999999999875 5899999999754332   357889999999999999999998762            


Q ss_pred             -------------------ccchhhhHHHHHHHHHHHHhhcCCCCeEecCcCCCcEEECCCCcEEEeecCCCccccCCCc
Q 039231          379 -------------------RVAEELSSTIGIARGLEYLHLGCSTRILHFDIKPHNILLDEDFCPKISDFGLAKICNRKES  439 (506)
Q Consensus       379 -------------------~~~~~l~i~~~i~~gl~~LH~~~~~~ivH~dlkp~Nill~~~~~~ki~dfg~a~~~~~~~~  439 (506)
                                         ++.+...++.||+.||+|||   +.+|+||||||+|||++.++.+||+|||+++.......
T Consensus       135 v~e~~~~~L~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH---~~~iiHrDlKp~NILl~~~~~~kl~DFGla~~~~~~~~  211 (458)
T 3rp9_A          135 VLEIADSDFKKLFRTPVYLTELHIKTLLYNLLVGVKYVH---SAGILHRDLKPANCLVNQDCSVKVCDFGLARTVDYPEN  211 (458)
T ss_dssp             EECCCSEEHHHHHHSSCCCCHHHHHHHHHHHHHHHHHHH---HTTCBCCCCCGGGEEECTTCCEEECCCTTCBCTTSCTT
T ss_pred             EEeccccchhhhcccCCCCCHHHHHHHHHHHHHHHHHHH---hCCcCCCCCChhhEEECCCCCEeecccccchhccCccc
Confidence                               23336678999999999999   89999999999999999999999999999987643221


Q ss_pred             c-------------------------eecccCCCCcccccccccccccCCCCccccHHHHHHHHHHHHc-----------
Q 039231          440 I-------------------------ISMTGARGTVGYIAPEVFCRNIGEVSYKSDVYNYGMMIFEMTG-----------  483 (506)
Q Consensus       440 ~-------------------------~~~~~~~gt~~y~aPE~l~~~~~~~s~~~Dv~s~G~il~ellt-----------  483 (506)
                      .                         .......||+.|+|||++... ..++.++|||||||++|||++           
T Consensus       212 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~-~~~~~~~DiwSlG~il~elltg~~~~~~~~~~  290 (458)
T 3rp9_A          212 GNSQLPISPREDDMNLVTFPHTKNLKRQLTGHVVTRWYRAPELILLQ-ENYTEAIDVWSIGCIFAELLNMIKENVAYHAD  290 (458)
T ss_dssp             CCCCCC---------------------------CCCTTCCHHHHTTC-CCCCTHHHHHHHHHHHHHHHTTSTTTCSSGGG
T ss_pred             cccccccCccccccccccccccccccccccCCcccccccChHHhhCC-CCCCcHhHHHHHHHHHHHHHHhcccccccccc
Confidence            1                         112446789999999987443 468999999999999999999           


Q ss_pred             CCCCCCCC
Q 039231          484 GRKNVDVV  491 (506)
Q Consensus       484 g~~pf~~~  491 (506)
                      |+++|...
T Consensus       291 ~~p~f~g~  298 (458)
T 3rp9_A          291 RGPLFPGS  298 (458)
T ss_dssp             CCCSCC--
T ss_pred             ccccCCCC
Confidence            66666543

>4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A*

Probab=99.97  E-value=2.6e-31  Score=258.70  Aligned_cols=172  Identities=31%  Similarity=0.538  Sum_probs=143.3

Q ss_pred             hhccccCccCceEEEEEEEc-CCCEEEEEEeccCCCC--------chhhHHHHHHhhccCccceeEEEEEe---------
Q 039231          316 SFKYKLGQGGYGSVYKGKLL-DGSNVAVKVLNDSKGN--------GKEFINEVASISRTSHVNVVALLGFC---------  377 (506)
Q Consensus       316 ~~~~~ig~G~~g~V~~~~~~-~~~~vavK~l~~~~~~--------~~~~~~E~~~l~~l~h~niv~l~g~~---------  377 (506)
                      .+.+.||+|+||.||+|++. +++.||+|++......        .+.+.+|++++++++||||+++++++         
T Consensus        22 ~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~lv~e  101 (287)
T 4f0f_A           22 EYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHPNIVKLYGLMHNPPRMVME  101 (287)
T ss_dssp             EEEEECCCCSSSCEEEEEETTTCCEEEEEECCCCTTTCCHHHHCCSHHHHHHHHHHTTCCCTTBCCEEEEETTTTEEEEE
T ss_pred             eehhccccCCceeEEEEEEcCCceEEEEEEeeccccccchhHHHHHHHHHHHHHHHHhCCCCCchhhheeecCCCeEEEE
Confidence            44578999999999999984 6899999998643322        15788999999999999999999987         


Q ss_pred             -----------------eccchhhhHHHHHHHHHHHHhhcCCCC--eEecCcCCCcEEECCCCc-----EEEeecCCCcc
Q 039231          378 -----------------LRVAEELSSTIGIARGLEYLHLGCSTR--ILHFDIKPHNILLDEDFC-----PKISDFGLAKI  433 (506)
Q Consensus       378 -----------------~~~~~~l~i~~~i~~gl~~LH~~~~~~--ivH~dlkp~Nill~~~~~-----~ki~dfg~a~~  433 (506)
                                       +++...+.++.|++.||+|||   +++  |+||||||+||+++.++.     +||+|||+++.
T Consensus       102 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~~l~~~l~~lH---~~~~~ivH~dikp~Nil~~~~~~~~~~~~kl~Dfg~~~~  178 (287)
T 4f0f_A          102 FVPCGDLYHRLLDKAHPIKWSVKLRLMLDIALGIEYMQ---NQNPPIVHRDLRSPNIFLQSLDENAPVCAKVADFGLSQQ  178 (287)
T ss_dssp             CCTTCBHHHHHHCTTSCCCHHHHHHHHHHHHHHHHHHH---TSSSCCBCSCCSGGGEEESCCCTTCSCCEEECCCTTCBC
T ss_pred             ecCCCCHHHHHhcccCCccHHHHHHHHHHHHHHHHHHH---hCCCCeecCCCCcceEEEeccCCCCceeEEeCCCCcccc
Confidence                             223346779999999999999   888  999999999999988776     99999999975


Q ss_pred             ccCCCcceecccCCCCcccccccccccccCCCCccccHHHHHHHHHHHHcCCCCCCCCCCCc
Q 039231          434 CNRKESIISMTGARGTVGYIAPEVFCRNIGEVSYKSDVYNYGMMIFEMTGGRKNVDVVDNGS  495 (506)
Q Consensus       434 ~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~s~~~Dv~s~G~il~elltg~~pf~~~~~~~  495 (506)
                      ....     .....+|+.|+|||.+......++.++||||||+++|||++|+.||......+
T Consensus       179 ~~~~-----~~~~~g~~~y~aPE~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~  235 (287)
T 4f0f_A          179 SVHS-----VSGLLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFDEYSYGK  235 (287)
T ss_dssp             CSSC-----EECCCCCCTTSCGGGSSCSSCEECHHHHHHHHHHHHHHHHHSSCTTTTCCCCH
T ss_pred             cccc-----ccccCCCccccCchhhccCCCCcCchhhHHHHHHHHHHHHcCCCCCccccccH
Confidence            4332     24467899999999985444467899999999999999999999998765543

>3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A*

Probab=99.97  E-value=1.3e-31  Score=268.21  Aligned_cols=168  Identities=27%  Similarity=0.388  Sum_probs=141.1

Q ss_pred             hccccCccCceEEEEEEEc-CCCEEEEEEeccCCCC----chhhHHHHHHhhcc-CccceeEEEEEee------------
Q 039231          317 FKYKLGQGGYGSVYKGKLL-DGSNVAVKVLNDSKGN----GKEFINEVASISRT-SHVNVVALLGFCL------------  378 (506)
Q Consensus       317 ~~~~ig~G~~g~V~~~~~~-~~~~vavK~l~~~~~~----~~~~~~E~~~l~~l-~h~niv~l~g~~~------------  378 (506)
                      +.+.||+|+||.||+|+.. +++.||+|+++.....    .+.+.+|..++.++ +||||+++++++.            
T Consensus        13 ~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~~~lv~e~~   92 (345)
T 3a8x_A           13 LLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFVIEYV   92 (345)
T ss_dssp             EEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGSCSHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEECCC
T ss_pred             EEEEEEecCCeEEEEEEECCCCCEEEEEEEEhHHhcchHHHHHHHHHHHHHHhcCCCCccCeEEEEEEeCCEEEEEEeCC
Confidence            4568999999999999986 4889999999764322    24578899999988 8999999999872            


Q ss_pred             ---------------ccchhhhHHHHHHHHHHHHhhcCCCCeEecCcCCCcEEECCCCcEEEeecCCCccccCCCcceec
Q 039231          379 ---------------RVAEELSSTIGIARGLEYLHLGCSTRILHFDIKPHNILLDEDFCPKISDFGLAKICNRKESIISM  443 (506)
Q Consensus       379 ---------------~~~~~l~i~~~i~~gl~~LH~~~~~~ivH~dlkp~Nill~~~~~~ki~dfg~a~~~~~~~~~~~~  443 (506)
                                     ++.+.+.++.||+.||+|||   +++|+||||||+|||++.++.+||+|||+++.......  ..
T Consensus        93 ~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~LH---~~~ivHrDlkp~NIll~~~g~~kL~DFG~a~~~~~~~~--~~  167 (345)
T 3a8x_A           93 NGGDLMFHMQRQRKLPEEHARFYSAEISLALNYLH---ERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGD--TT  167 (345)
T ss_dssp             CSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHH---HTTCBCCCCCGGGEEECTTSCEEECCGGGCBCSCCTTC--CB
T ss_pred             CCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHH---HCCceecCCCHHHEEECCCCCEEEEeccccccccCCCC--cc
Confidence                           23345678899999999999   89999999999999999999999999999986433222  12


Q ss_pred             ccCCCCcccccccccccccCCCCccccHHHHHHHHHHHHcCCCCCCCC
Q 039231          444 TGARGTVGYIAPEVFCRNIGEVSYKSDVYNYGMMIFEMTGGRKNVDVV  491 (506)
Q Consensus       444 ~~~~gt~~y~aPE~l~~~~~~~s~~~Dv~s~G~il~elltg~~pf~~~  491 (506)
                      ....||+.|+|||++.+.  .++.++||||||+++|||++|+.||...
T Consensus       168 ~~~~gt~~y~aPE~~~~~--~~~~~~DiwslG~il~ell~g~~pf~~~  213 (345)
T 3a8x_A          168 STFCGTPNYIAPEILRGE--DYGFSVDWWALGVLMFEMMAGRSPFDIV  213 (345)
T ss_dssp             CCCCSCGGGCCHHHHTTC--CBCTHHHHHHHHHHHHHHHHSSCTTTTT
T ss_pred             cccCCCccccCccccCCC--CCChHHhHHHHHHHHHHHHhCCCCcCCc
Confidence            456799999999999654  6899999999999999999999999753

>3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A*

Probab=99.97  E-value=2.6e-32  Score=276.76  Aligned_cols=174  Identities=31%  Similarity=0.473  Sum_probs=142.7

Q ss_pred             hhccccCccCceEEEEEEEc-CCCEEEEEEeccCCC--CchhhHHHHHHhhccCccceeEEEEEee--------------
Q 039231          316 SFKYKLGQGGYGSVYKGKLL-DGSNVAVKVLNDSKG--NGKEFINEVASISRTSHVNVVALLGFCL--------------  378 (506)
Q Consensus       316 ~~~~~ig~G~~g~V~~~~~~-~~~~vavK~l~~~~~--~~~~~~~E~~~l~~l~h~niv~l~g~~~--------------  378 (506)
                      .+.+.||+|+||.||+|++. +++.||||+++....  ..+++.+|++++++++||||+++++++.              
T Consensus       117 ~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~~~  196 (377)
T 3cbl_A          117 VLGEQIGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIVMELVQG  196 (377)
T ss_dssp             EEEEEEEEETTEEEEEEEETTTCCEEEEEECCTTSCHHHHTTTTHHHHHHTTCCCTTBCCEEEEECSSSSCEEEEECCTT
T ss_pred             EEeeEeccCCCCeEEEEEEecCCeEEEEEEccccCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEecCCCcEEEEEcCCC
Confidence            44578999999999999986 689999999975432  2257889999999999999999999872              


Q ss_pred             --------------ccchhhhHHHHHHHHHHHHhhcCCCCeEecCcCCCcEEECCCCcEEEeecCCCccccCCCcceecc
Q 039231          379 --------------RVAEELSSTIGIARGLEYLHLGCSTRILHFDIKPHNILLDEDFCPKISDFGLAKICNRKESIISMT  444 (506)
Q Consensus       379 --------------~~~~~l~i~~~i~~gl~~LH~~~~~~ivH~dlkp~Nill~~~~~~ki~dfg~a~~~~~~~~~~~~~  444 (506)
                                    ++.+.+.++.|++.||+|||   +++|+||||||+|||+++++.+||+|||+++............
T Consensus       197 g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~LH---~~~ivHrDlkp~Nil~~~~~~~kl~DfG~s~~~~~~~~~~~~~  273 (377)
T 3cbl_A          197 GDFLTFLRTEGARLRVKTLLQMVGDAAAGMEYLE---SKCCIHRDLAARNCLVTEKNVLKISDFGMSREEADGVYAASGG  273 (377)
T ss_dssp             CBHHHHHHHHGGGCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECTTCCEEECCGGGCEECTTSEEECCSS
T ss_pred             CCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH---HCCcCCcccCHHHEEEcCCCcEEECcCCCceecCCCceeecCC
Confidence                          22335678999999999999   8999999999999999999999999999998654332211111


Q ss_pred             cCCCCcccccccccccccCCCCccccHHHHHHHHHHHHc-CCCCCCCCCCC
Q 039231          445 GARGTVGYIAPEVFCRNIGEVSYKSDVYNYGMMIFEMTG-GRKNVDVVDNG  494 (506)
Q Consensus       445 ~~~gt~~y~aPE~l~~~~~~~s~~~Dv~s~G~il~ellt-g~~pf~~~~~~  494 (506)
                      ...+++.|+|||.+..  +.++.++||||||+++|||++ |+.||......
T Consensus       274 ~~~~~~~y~aPE~~~~--~~~~~~~DvwslG~il~el~t~g~~p~~~~~~~  322 (377)
T 3cbl_A          274 LRQVPVKWTAPEALNY--GRYSSESDVWSFGILLWETFSLGASPYPNLSNQ  322 (377)
T ss_dssp             CCEEEGGGSCHHHHHH--CEEEHHHHHHHHHHHHHHHHTTSCCSSTTSCHH
T ss_pred             CCCCCcCcCCHhHhcc--CCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHH
Confidence            2335778999999854  368899999999999999998 99999876543

>3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens}

Probab=99.97  E-value=1.2e-31  Score=276.84  Aligned_cols=174  Identities=23%  Similarity=0.338  Sum_probs=143.4

Q ss_pred             hhhccccCccCceEEEEEEEc-CCCEEEEEEeccCCC---CchhhHHHHHHhhccCccceeEEEEEe-------------
Q 039231          315 NSFKYKLGQGGYGSVYKGKLL-DGSNVAVKVLNDSKG---NGKEFINEVASISRTSHVNVVALLGFC-------------  377 (506)
Q Consensus       315 ~~~~~~ig~G~~g~V~~~~~~-~~~~vavK~l~~~~~---~~~~~~~E~~~l~~l~h~niv~l~g~~-------------  377 (506)
                      +.+.+.||+|+||.||+|... +|+.+|+|++.....   ..+.+.+|++++++++||||+++++++             
T Consensus        13 Y~i~~~LG~G~fg~V~~~~~~~~~~~~a~K~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lv~E~~   92 (444)
T 3soa_A           13 YQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREARICRLLKHPNIVRLHDSISEEGHHYLIFDLV   92 (444)
T ss_dssp             EEEEEEEEEC--CEEEEEEETTTTEEEEEEEEESCSCHHHHHHHHHHHHHHHHHCCBTTBCCEEEEEECSSEEEEEECCC
T ss_pred             eEEEEEeccCCCeEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCcCCCeEEEEEEECCEEEEEEEeC
Confidence            445678999999999999874 589999999976543   235688999999999999999999987             


Q ss_pred             --------------eccchhhhHHHHHHHHHHHHhhcCCCCeEecCcCCCcEEEC---CCCcEEEeecCCCccccCCCcc
Q 039231          378 --------------LRVAEELSSTIGIARGLEYLHLGCSTRILHFDIKPHNILLD---EDFCPKISDFGLAKICNRKESI  440 (506)
Q Consensus       378 --------------~~~~~~l~i~~~i~~gl~~LH~~~~~~ivH~dlkp~Nill~---~~~~~ki~dfg~a~~~~~~~~~  440 (506)
                                    +++.+...++.||+.||+|||   +++|+||||||+|||++   +++.+||+|||+++........
T Consensus        93 ~gg~L~~~i~~~~~~~e~~~~~i~~qil~aL~~lH---~~givHrDlKp~NIll~~~~~~~~vkL~DFG~a~~~~~~~~~  169 (444)
T 3soa_A           93 TGGELFEDIVAREYYSEADASHCIQQILEAVLHCH---QMGVVHRNLKPENLLLASKLKGAAVKLADFGLAIEVEGEQQA  169 (444)
T ss_dssp             BCCBHHHHHHHCSCCCHHHHHHHHHHHHHHHHHHH---HTTCBCCCCSSTTEEESBSSTTCCEEECCCSSCBCCCTTCCB
T ss_pred             CCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHH---HCCccccCCCHHHEEEeccCCCCcEEEccCceeEEecCCCce
Confidence                          233346678999999999999   89999999999999998   5678999999999876554322


Q ss_pred             eecccCCCCcccccccccccccCCCCccccHHHHHHHHHHHHcCCCCCCCCCCCc
Q 039231          441 ISMTGARGTVGYIAPEVFCRNIGEVSYKSDVYNYGMMIFEMTGGRKNVDVVDNGS  495 (506)
Q Consensus       441 ~~~~~~~gt~~y~aPE~l~~~~~~~s~~~Dv~s~G~il~elltg~~pf~~~~~~~  495 (506)
                        .....||+.|+|||++.+.  .++.++||||+|+++|||++|+.||...+..+
T Consensus       170 --~~~~~gt~~Y~APE~l~~~--~~~~~~DIwSlGvilyell~G~~Pf~~~~~~~  220 (444)
T 3soa_A          170 --WFGFAGTPGYLSPEVLRKD--PYGKPVDLWACGVILYILLVGYPPFWDEDQHR  220 (444)
T ss_dssp             --CCCSCSCGGGCCHHHHTTC--CBCTHHHHHHHHHHHHHHHHSSCSCCCSSHHH
T ss_pred             --eecccCCcccCCHHHhcCC--CCCCccccHHHHHHHHHHHhCCCCCCCccHHH
Confidence              2456799999999998654  78999999999999999999999997655433

>1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A*

Probab=99.97  E-value=1.3e-31  Score=268.40  Aligned_cols=170  Identities=31%  Similarity=0.427  Sum_probs=142.8

Q ss_pred             hhccccCccCceEEEEEEE-cCCCEEEEEEeccCCCC----chhhHHHHHHhhccCccceeEEEEEee------------
Q 039231          316 SFKYKLGQGGYGSVYKGKL-LDGSNVAVKVLNDSKGN----GKEFINEVASISRTSHVNVVALLGFCL------------  378 (506)
Q Consensus       316 ~~~~~ig~G~~g~V~~~~~-~~~~~vavK~l~~~~~~----~~~~~~E~~~l~~l~h~niv~l~g~~~------------  378 (506)
                      ...+.||+|+||.||+|+. .+++.||||++......    .+++.+|++++++++||||+++++++.            
T Consensus        57 ~~~~~lG~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~  136 (348)
T 1u5q_A           57 SDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVMEYC  136 (348)
T ss_dssp             EEEEEEEECSSEEEEEEEETTTTEEEEEEEEESCSSCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred             eeeeEEccCCCEEEEEEEEccCCeEEEEEEEccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCeEEEEEecC
Confidence            3346799999999999997 46899999999754322    256889999999999999999999872            


Q ss_pred             ---------------ccchhhhHHHHHHHHHHHHhhcCCCCeEecCcCCCcEEECCCCcEEEeecCCCccccCCCcceec
Q 039231          379 ---------------RVAEELSSTIGIARGLEYLHLGCSTRILHFDIKPHNILLDEDFCPKISDFGLAKICNRKESIISM  443 (506)
Q Consensus       379 ---------------~~~~~l~i~~~i~~gl~~LH~~~~~~ivH~dlkp~Nill~~~~~~ki~dfg~a~~~~~~~~~~~~  443 (506)
                                     ++.+.+.++.|++.||+|||   +++|+||||||+|||+++++.+||+|||+++.....      
T Consensus       137 ~g~l~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH---~~~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~~------  207 (348)
T 1u5q_A          137 LGSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLH---SHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPA------  207 (348)
T ss_dssp             SEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHH---HTTCBCCCCSGGGEEEETTTEEEECCCTTCBSSSSB------
T ss_pred             CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH---hCCeeeCCCCHHHEEECCCCCEEEeeccCceecCCC------
Confidence                           23346678999999999999   899999999999999999999999999999865432      


Q ss_pred             ccCCCCccccccccccc-ccCCCCccccHHHHHHHHHHHHcCCCCCCCCCCC
Q 039231          444 TGARGTVGYIAPEVFCR-NIGEVSYKSDVYNYGMMIFEMTGGRKNVDVVDNG  494 (506)
Q Consensus       444 ~~~~gt~~y~aPE~l~~-~~~~~s~~~Dv~s~G~il~elltg~~pf~~~~~~  494 (506)
                      ....||+.|+|||++.. ..+.++.++||||||+++|||++|+.||...+..
T Consensus       208 ~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~  259 (348)
T 1u5q_A          208 NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAM  259 (348)
T ss_dssp             CCCCSCGGGCCHHHHHTTSSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHH
T ss_pred             CcccCCcceeCHhhhccccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChH
Confidence            34568999999999853 2246899999999999999999999999765543

>3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A

Probab=99.97  E-value=1.2e-31  Score=270.23  Aligned_cols=175  Identities=26%  Similarity=0.332  Sum_probs=135.7

Q ss_pred             hhhccccCccCceEEEEEEEc-CCCEEEEEEeccCCCCchhhHHHHHHhhccCccceeEEEEEe----------------
Q 039231          315 NSFKYKLGQGGYGSVYKGKLL-DGSNVAVKVLNDSKGNGKEFINEVASISRTSHVNVVALLGFC----------------  377 (506)
Q Consensus       315 ~~~~~~ig~G~~g~V~~~~~~-~~~~vavK~l~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~----------------  377 (506)
                      +.+.+.||+|+||.||+++.. +++.||||++.......+.+.+|+.++++++||||+++++++                
T Consensus        22 y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~~~~  101 (361)
T 3uc3_A           22 YDFVKDIGSGNFGVARLMRDKLTKELVAVKYIERGAAIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIIMEYASGG  101 (361)
T ss_dssp             EEEEEEESSSTTSSEEEEEETTTCCEEEEEEEESSTTSCHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEECCCSC
T ss_pred             EEEEEEeccCCCEEEEEEEECCCCcEEEEEEEecCccccHHHHHHHHHHHhCCCCCCCcEEEEEeeCCEEEEEEEeCCCC
Confidence            344578999999999999986 589999999987766668899999999999999999999987                


Q ss_pred             -----------eccchhhhHHHHHHHHHHHHhhcCCCCeEecCcCCCcEEECCCCc--EEEeecCCCccccCCCcceecc
Q 039231          378 -----------LRVAEELSSTIGIARGLEYLHLGCSTRILHFDIKPHNILLDEDFC--PKISDFGLAKICNRKESIISMT  444 (506)
Q Consensus       378 -----------~~~~~~l~i~~~i~~gl~~LH~~~~~~ivH~dlkp~Nill~~~~~--~ki~dfg~a~~~~~~~~~~~~~  444 (506)
                                 +++.+.+.++.|++.||+|||   +++|+||||||+|||++.++.  +||+|||+++.......   ..
T Consensus       102 ~L~~~l~~~~~~~~~~~~~i~~ql~~~L~~LH---~~~ivH~Dlkp~Nill~~~~~~~~kl~Dfg~a~~~~~~~~---~~  175 (361)
T 3uc3_A          102 ELYERICNAGRFSEDEARFFFQQLLSGVSYCH---SMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQ---PK  175 (361)
T ss_dssp             BHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHH---HTTCCSCCCCGGGEEECSSSSCCEEECCCCCC-------------
T ss_pred             CHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCHHHEEEcCCCCceEEEeecCccccccccCC---CC
Confidence                       223346778999999999999   899999999999999987765  99999999975433222   23


Q ss_pred             cCCCCcccccccccccccCCCC-ccccHHHHHHHHHHHHcCCCCCCCCCCCcch
Q 039231          445 GARGTVGYIAPEVFCRNIGEVS-YKSDVYNYGMMIFEMTGGRKNVDVVDNGSTA  497 (506)
Q Consensus       445 ~~~gt~~y~aPE~l~~~~~~~s-~~~Dv~s~G~il~elltg~~pf~~~~~~~~~  497 (506)
                      ...||+.|+|||++.+.  .++ .++||||||+++|||++|+.||.........
T Consensus       176 ~~~gt~~y~aPE~~~~~--~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~  227 (361)
T 3uc3_A          176 STVGTPAYIAPEVLLRQ--EYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPRDY  227 (361)
T ss_dssp             -----CTTSCHHHHHCS--SCCHHHHHHHHHHHHHHHHHHSSCSCC----CCCH
T ss_pred             CCcCCCCcCChhhhcCC--CCCCCeeeeehhHHHHHHHHhCCCCCCCCccHHHH
Confidence            45789999999998654  444 4489999999999999999999876654433

>1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A

Probab=99.97  E-value=3.1e-32  Score=285.78  Aligned_cols=178  Identities=31%  Similarity=0.531  Sum_probs=149.9

Q ss_pred             HHHhhhccccCccCceEEEEEEEcC-CCEEEEEEeccCCCCchhhHHHHHHhhccCccceeEEEEEee------------
Q 039231          312 KMTNSFKYKLGQGGYGSVYKGKLLD-GSNVAVKVLNDSKGNGKEFINEVASISRTSHVNVVALLGFCL------------  378 (506)
Q Consensus       312 ~~~~~~~~~ig~G~~g~V~~~~~~~-~~~vavK~l~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~------------  378 (506)
                      ...+.+.++||+|+||.||+|++.. +..||||+++......+++.+|+++|++++|||||++++++.            
T Consensus       219 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~E~~  298 (495)
T 1opk_A          219 RTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFM  298 (495)
T ss_dssp             GGGEEEEEESGGGTTSSEEEEEEGGGTEEEEEEECCSSSSCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECC
T ss_pred             HHHceeeeEecCCCCeEEEEEEEcCCCeEEEEEEecCcccchHHHHHHHHHHHhcCCCCEeeEEEEEecCCcEEEEEEcc
Confidence            3344556789999999999999865 889999999877667788999999999999999999999882            


Q ss_pred             -----------------ccchhhhHHHHHHHHHHHHhhcCCCCeEecCcCCCcEEECCCCcEEEeecCCCccccCCCcce
Q 039231          379 -----------------RVAEELSSTIGIARGLEYLHLGCSTRILHFDIKPHNILLDEDFCPKISDFGLAKICNRKESII  441 (506)
Q Consensus       379 -----------------~~~~~l~i~~~i~~gl~~LH~~~~~~ivH~dlkp~Nill~~~~~~ki~dfg~a~~~~~~~~~~  441 (506)
                                       ++...+.++.||+.||+|||   +++|+||||||+|||+++++.+||+|||+++........ 
T Consensus       299 ~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~LH---~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~~~-  374 (495)
T 1opk_A          299 TYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLE---KKNFIHRNLAARNCLVGENHLVKVADFGLSRLMTGDTYT-  374 (495)
T ss_dssp             TTCBHHHHHHHSCTTTSCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECGGGCEEECCTTCEECCTTCCEE-
T ss_pred             CCCCHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCChhhEEECCCCcEEEeecccceeccCCcee-
Confidence                             12235678899999999999   899999999999999999999999999999876543321 


Q ss_pred             ecccCCCCcccccccccccccCCCCccccHHHHHHHHHHHHc-CCCCCCCCCCCc
Q 039231          442 SMTGARGTVGYIAPEVFCRNIGEVSYKSDVYNYGMMIFEMTG-GRKNVDVVDNGS  495 (506)
Q Consensus       442 ~~~~~~gt~~y~aPE~l~~~~~~~s~~~Dv~s~G~il~ellt-g~~pf~~~~~~~  495 (506)
                      ......+++.|+|||.+...  .++.++||||||+++|||++ |+.||...+..+
T Consensus       375 ~~~~~~~~~~y~aPE~~~~~--~~~~~sDvwSlG~~l~el~t~g~~p~~~~~~~~  427 (495)
T 1opk_A          375 AHAGAKFPIKWTAPESLAYN--KFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQ  427 (495)
T ss_dssp             CCTTCCCCGGGCCHHHHHHC--EECHHHHHHHHHHHHHHHHTTSCCSSTTCCGGG
T ss_pred             ecCCCcCCcceeCHhHHhcC--CCCcHHhHHhHHHHHHHHHhCCCCCCCCCCHHH
Confidence            22345567899999998543  68999999999999999999 999998765443

>4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis}

Probab=99.97  E-value=1.2e-31  Score=273.43  Aligned_cols=177  Identities=27%  Similarity=0.337  Sum_probs=144.7

Q ss_pred             hhhccccCccCceEEEEEEEcCCCEEEEEEeccCCCCchhhHHHHHHhhccCccceeEEEEEeec---------------
Q 039231          315 NSFKYKLGQGGYGSVYKGKLLDGSNVAVKVLNDSKGNGKEFINEVASISRTSHVNVVALLGFCLR---------------  379 (506)
Q Consensus       315 ~~~~~~ig~G~~g~V~~~~~~~~~~vavK~l~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~---------------  379 (506)
                      +.+.++||+|+||.||+|+..++..+|+|++.....   ...+|+++++.++||||+++++++..               
T Consensus        42 Y~~~~~lG~G~~g~V~~a~~~~~~~~aikk~~~~~~---~~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~~~~~lv~e  118 (394)
T 4e7w_A           42 YTNCKVIGNGSFGVVFQAKLVESDEVAIKKVLQDKR---FKNRELQIMRIVKHPNVVDLKAFFYSNGDKKDEVFLNLVLE  118 (394)
T ss_dssp             EEEEEEEEEETTEEEEEEEETTTEEEEEEEEECCTT---SCCHHHHHHHTCCCTTBCCEEEEEEEESSSSSCEEEEEEEE
T ss_pred             EEEeEEEeeCCCeEEEEEEECCCCeEEEEEEecCcc---hHHHHHHHHHhCCCCCcceEEEEEEecCCCCCceEEEEEee
Confidence            344578999999999999998777799998865432   23479999999999999999987621               


Q ss_pred             ---------------------cchhhhHHHHHHHHHHHHhhcCCCCeEecCcCCCcEEEC-CCCcEEEeecCCCccccCC
Q 039231          380 ---------------------VAEELSSTIGIARGLEYLHLGCSTRILHFDIKPHNILLD-EDFCPKISDFGLAKICNRK  437 (506)
Q Consensus       380 ---------------------~~~~l~i~~~i~~gl~~LH~~~~~~ivH~dlkp~Nill~-~~~~~ki~dfg~a~~~~~~  437 (506)
                                           +.....++.||++||+|||   +++|+||||||+|||++ .++.+||+|||+++.....
T Consensus       119 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH---~~~ivHrDlkp~Nill~~~~~~~kL~DFG~a~~~~~~  195 (394)
T 4e7w_A          119 YVPETVYRASRHYAKLKQTMPMLLIKLYMYQLLRSLAYIH---SIGICHRDIKPQNLLLDPPSGVLKLIDFGSAKILIAG  195 (394)
T ss_dssp             CCSEEHHHHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEEETTTTEEEECCCTTCEECCTT
T ss_pred             ccCccHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHH---HCCccCCCCCHHHEEEcCCCCcEEEeeCCCcccccCC
Confidence                                 1124567889999999999   89999999999999998 7999999999999876544


Q ss_pred             CcceecccCCCCcccccccccccccCCCCccccHHHHHHHHHHHHcCCCCCCCCCCCcchhhhh
Q 039231          438 ESIISMTGARGTVGYIAPEVFCRNIGEVSYKSDVYNYGMMIFEMTGGRKNVDVVDNGSTALDLQ  501 (506)
Q Consensus       438 ~~~~~~~~~~gt~~y~aPE~l~~~~~~~s~~~Dv~s~G~il~elltg~~pf~~~~~~~~~~~~~  501 (506)
                      ...   ....+|+.|+|||++.+. ..++.++|||||||++|||++|+.||...+..+...++.
T Consensus       196 ~~~---~~~~~t~~y~aPE~~~~~-~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~l~~i~  255 (394)
T 4e7w_A          196 EPN---VSYICSRYYRAPELIFGA-TNYTTNIDIWSTGCVMAELMQGQPLFPGESGIDQLVEII  255 (394)
T ss_dssp             CCC---CSSCSCGGGCCHHHHTTC-SSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHH
T ss_pred             CCC---cccccCcCccCHHHHcCC-CCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHH
Confidence            332   346789999999998653 368999999999999999999999998776555444443

>1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7

Probab=99.97  E-value=1.1e-31  Score=270.95  Aligned_cols=171  Identities=30%  Similarity=0.390  Sum_probs=138.0

Q ss_pred             hccccCccCceEEEEEEEc-CCCEEEEEEeccCCCC---chhhHHHHHHhhccCccceeEEEEEeec-------------
Q 039231          317 FKYKLGQGGYGSVYKGKLL-DGSNVAVKVLNDSKGN---GKEFINEVASISRTSHVNVVALLGFCLR-------------  379 (506)
Q Consensus       317 ~~~~ig~G~~g~V~~~~~~-~~~~vavK~l~~~~~~---~~~~~~E~~~l~~l~h~niv~l~g~~~~-------------  379 (506)
                      ..+.||+|+||.||+|+.. +|+.||||++......   .+++.+|++++++++||||+++++++..             
T Consensus        29 ~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~~~~~lv  108 (367)
T 1cm8_A           29 DLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFTDFYLV  108 (367)
T ss_dssp             EEEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTCCCCEEE
T ss_pred             EeEEeeecCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCcCCCCceeeEecCCccccCceEEEE
Confidence            3467999999999999984 5899999999654332   3568899999999999999999987632             


Q ss_pred             ------------------cchhhhHHHHHHHHHHHHhhcCCCCeEecCcCCCcEEECCCCcEEEeecCCCccccCCCcce
Q 039231          380 ------------------VAEELSSTIGIARGLEYLHLGCSTRILHFDIKPHNILLDEDFCPKISDFGLAKICNRKESII  441 (506)
Q Consensus       380 ------------------~~~~l~i~~~i~~gl~~LH~~~~~~ivH~dlkp~Nill~~~~~~ki~dfg~a~~~~~~~~~~  441 (506)
                                        +.+...++.||++||+|||   +.+|+||||||+|||++.++.+||+|||+++.....    
T Consensus       109 ~e~~~~~L~~~~~~~~l~~~~~~~~~~qi~~~L~~LH---~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~----  181 (367)
T 1cm8_A          109 MPFMGTDLGKLMKHEKLGEDRIQFLVYQMLKGLRYIH---AAGIIHRDLKPGNLAVNEDCELKILDFGLARQADSE----  181 (367)
T ss_dssp             EECCSEEHHHHHHHCCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEECTTCCEEECCCTTCEECCSS----
T ss_pred             EecCCCCHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH---HCCccccCcCHHHEEEcCCCCEEEEeeecccccccc----
Confidence                              2235568899999999999   899999999999999999999999999999875433    


Q ss_pred             ecccCCCCcccccccccccccCCCCccccHHHHHHHHHHHHcCCCCCCCCCCCcc
Q 039231          442 SMTGARGTVGYIAPEVFCRNIGEVSYKSDVYNYGMMIFEMTGGRKNVDVVDNGST  496 (506)
Q Consensus       442 ~~~~~~gt~~y~aPE~l~~~~~~~s~~~Dv~s~G~il~elltg~~pf~~~~~~~~  496 (506)
                       .....+|+.|+|||++.+. ..++.++||||+||++|||++|+.||...+..+.
T Consensus       182 -~~~~~~t~~y~aPE~~~~~-~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~  234 (367)
T 1cm8_A          182 -MTGYVVTRWYRAPEVILNW-MRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQ  234 (367)
T ss_dssp             -CCSSCSCGGGCCTHHHHTT-TCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHH
T ss_pred             -cCcCcCCCCcCCHHHHhCC-CCCChhhhHHHHHHHHHHHHhCCCCCCCCCHHHH
Confidence             2456789999999998653 4689999999999999999999999987655443

>3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens}

Probab=99.97  E-value=8.6e-32  Score=267.32  Aligned_cols=176  Identities=25%  Similarity=0.476  Sum_probs=141.2

Q ss_pred             hhccccCccCceEEEEEEEc----CCCEEEEEEeccCCC--CchhhHHHHHHhhccCccceeEEEEEee-----------
Q 039231          316 SFKYKLGQGGYGSVYKGKLL----DGSNVAVKVLNDSKG--NGKEFINEVASISRTSHVNVVALLGFCL-----------  378 (506)
Q Consensus       316 ~~~~~ig~G~~g~V~~~~~~----~~~~vavK~l~~~~~--~~~~~~~E~~~l~~l~h~niv~l~g~~~-----------  378 (506)
                      .+.+.||+|+||.||+|++.    .+..||||+++....  ..+.+.+|++++++++||||+++++++.           
T Consensus        52 ~i~~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~  131 (325)
T 3kul_A           52 HIEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDFLSEASIMGQFDHPNIIRLEGVVTRGRLAMIVTEY  131 (325)
T ss_dssp             EEEEEEEETTTEEEEEEEECCTTSCCEEEEEEEECTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECGGGCCEEEEEC
T ss_pred             EEeeEEEeCCCcEEEEEEEecCCCCCceEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCccEEEeeC
Confidence            33467999999999999984    345699999976432  2367899999999999999999999872           


Q ss_pred             -----------------ccchhhhHHHHHHHHHHHHhhcCCCCeEecCcCCCcEEECCCCcEEEeecCCCccccCCCcc-
Q 039231          379 -----------------RVAEELSSTIGIARGLEYLHLGCSTRILHFDIKPHNILLDEDFCPKISDFGLAKICNRKESI-  440 (506)
Q Consensus       379 -----------------~~~~~l~i~~~i~~gl~~LH~~~~~~ivH~dlkp~Nill~~~~~~ki~dfg~a~~~~~~~~~-  440 (506)
                                       ++.+++.++.|++.||+|||   +.+|+||||||+|||++.++.+||+|||+++........ 
T Consensus       132 ~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~LH---~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~  208 (325)
T 3kul_A          132 MENGSLDTFLRTHDGQFTIMQLVGMLRGVGAGMRYLS---DLGYVHRDLAARNVLVDSNLVCKVSDFGLSRVLEDDPDAA  208 (325)
T ss_dssp             CTTCBHHHHHHTTTTCSCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECTTCCEEECCCSSCEECC----CC
T ss_pred             CCCCcHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHH---HCCeeCCCCCcceEEECCCCCEEECCCCcccccccCccce
Confidence                             23346778999999999999   899999999999999999999999999999876543321 


Q ss_pred             eecccCCCCcccccccccccccCCCCccccHHHHHHHHHHHHc-CCCCCCCCCCCcc
Q 039231          441 ISMTGARGTVGYIAPEVFCRNIGEVSYKSDVYNYGMMIFEMTG-GRKNVDVVDNGST  496 (506)
Q Consensus       441 ~~~~~~~gt~~y~aPE~l~~~~~~~s~~~Dv~s~G~il~ellt-g~~pf~~~~~~~~  496 (506)
                      .......+|+.|+|||.+.+.  .++.++||||||+++|||++ |+.||......+.
T Consensus       209 ~~~~~~~~t~~y~aPE~~~~~--~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~~  263 (325)
T 3kul_A          209 YTTTGGKIPIRWTAPEAIAFR--TFSSASDVWSFGVVMWEVLAYGERPYWNMTNRDV  263 (325)
T ss_dssp             EECC---CCGGGSCHHHHHHC--EECHHHHHHHHHHHHHHHHTTSCCTTTTSCHHHH
T ss_pred             eeccCCCCcccccCHhHhcCC--CCCcHHHHHHHHHHHHHHHcCCCCCcccCCHHHH
Confidence            122334567889999998543  78999999999999999999 9999977654443

>3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 4ec9_A* 4ec8_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* 4bch_A* 4bci_A* 4bcj_A* 4bcf_A*

Probab=99.97  E-value=2.2e-31  Score=267.18  Aligned_cols=176  Identities=27%  Similarity=0.366  Sum_probs=145.0

Q ss_pred             hhccccCccCceEEEEEEEc-CCCEEEEEEeccCC---CCchhhHHHHHHhhccCccceeEEEEEee-------------
Q 039231          316 SFKYKLGQGGYGSVYKGKLL-DGSNVAVKVLNDSK---GNGKEFINEVASISRTSHVNVVALLGFCL-------------  378 (506)
Q Consensus       316 ~~~~~ig~G~~g~V~~~~~~-~~~~vavK~l~~~~---~~~~~~~~E~~~l~~l~h~niv~l~g~~~-------------  378 (506)
                      .+.++||+|+||.||+|+.. +|+.||||++....   .....+.+|++++++++||||+++++++.             
T Consensus        20 ~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~~   99 (351)
T 3mi9_A           20 EKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRCKGSI   99 (351)
T ss_dssp             EEEEECSSCSTTSEEEEEETTTCCEEEEEECCCSSCSSSSCHHHHHHHHHHHHCCCTTBCCEEEEEEEC--------CEE
T ss_pred             eEEEEEecCCCcEEEEEEECCCCCEEEEEEEecccccccchHHHHHHHHHHHhccCCCcccHhheeeccccccccCCceE
Confidence            34578999999999999984 68999999986533   23357889999999999999999998652             


Q ss_pred             ----------------------ccchhhhHHHHHHHHHHHHhhcCCCCeEecCcCCCcEEECCCCcEEEeecCCCccccC
Q 039231          379 ----------------------RVAEELSSTIGIARGLEYLHLGCSTRILHFDIKPHNILLDEDFCPKISDFGLAKICNR  436 (506)
Q Consensus       379 ----------------------~~~~~l~i~~~i~~gl~~LH~~~~~~ivH~dlkp~Nill~~~~~~ki~dfg~a~~~~~  436 (506)
                                            ++.+++.++.|++.||+|||   +++|+||||||+|||++.++.+||+|||+++....
T Consensus       100 ~lv~e~~~~~l~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH---~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~a~~~~~  176 (351)
T 3mi9_A          100 YLVFDFCEHDLAGLLSNVLVKFTLSEIKRVMQMLLNGLYYIH---RNKILHRDMKAANVLITRDGVLKLADFGLARAFSL  176 (351)
T ss_dssp             EEEEECCSEEHHHHHHCTTSCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTTSCEEECCCTTCEECCC
T ss_pred             EEEEeccCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHH---HCCeeCCCCCHHHEEEcCCCCEEEccchhcccccc
Confidence                                  22336678999999999999   89999999999999999999999999999987653


Q ss_pred             CCc--ceecccCCCCcccccccccccccCCCCccccHHHHHHHHHHHHcCCCCCCCCCCCc
Q 039231          437 KES--IISMTGARGTVGYIAPEVFCRNIGEVSYKSDVYNYGMMIFEMTGGRKNVDVVDNGS  495 (506)
Q Consensus       437 ~~~--~~~~~~~~gt~~y~aPE~l~~~~~~~s~~~Dv~s~G~il~elltg~~pf~~~~~~~  495 (506)
                      ...  ........||+.|+|||++.+. ..++.++||||||+++|||++|+.||......+
T Consensus       177 ~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~  236 (351)
T 3mi9_A          177 AKNSQPNRYTNRVVTLWYRPPELLLGE-RDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQH  236 (351)
T ss_dssp             CSSSSCCCCCSSCSCGGGCCHHHHTTC-CSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHH
T ss_pred             cccccccccCCcccccCccCchhhcCC-CCCCcHhHHHHHHHHHHHHHhCCCCCCCCChHH
Confidence            221  1122446789999999998653 367999999999999999999999998765443

>1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ...

Probab=99.97  E-value=5.6e-32  Score=280.77  Aligned_cols=175  Identities=29%  Similarity=0.502  Sum_probs=142.8

Q ss_pred             hhhccccCccCceEEEEEEEcCCCEEEEEEeccCCCCchhhHHHHHHhhccCccceeEEEEEee----------------
Q 039231          315 NSFKYKLGQGGYGSVYKGKLLDGSNVAVKVLNDSKGNGKEFINEVASISRTSHVNVVALLGFCL----------------  378 (506)
Q Consensus       315 ~~~~~~ig~G~~g~V~~~~~~~~~~vavK~l~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~----------------  378 (506)
                      +.+.++||+|+||.||+|+++++..||||+++......+++.+|++++++++||||+++++++.                
T Consensus       186 ~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~iv~e~~~~gsL  265 (452)
T 1fmk_A          186 LRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVSEEPIYIVTEYMSKGSL  265 (452)
T ss_dssp             EEEEEEEEECSSCEEEEEEETTTEEEEEEECCTTSSCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSCEEEECCCTTCBH
T ss_pred             ceeeeeecCCCCeEEEEEEECCCceEEEEEeccCCCCHHHHHHHHHHHHhCCCCCEeeEEEEEcCCceEEEehhhcCCCH
Confidence            3456789999999999999988888999999876666688999999999999999999999872                


Q ss_pred             ------------ccchhhhHHHHHHHHHHHHhhcCCCCeEecCcCCCcEEECCCCcEEEeecCCCccccCCCcceecccC
Q 039231          379 ------------RVAEELSSTIGIARGLEYLHLGCSTRILHFDIKPHNILLDEDFCPKISDFGLAKICNRKESIISMTGA  446 (506)
Q Consensus       379 ------------~~~~~l~i~~~i~~gl~~LH~~~~~~ivH~dlkp~Nill~~~~~~ki~dfg~a~~~~~~~~~~~~~~~  446 (506)
                                  ++.+.+.++.||+.||+|||   +++|+||||||+|||+++++.+||+|||+++........ .....
T Consensus       266 ~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH---~~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~-~~~~~  341 (452)
T 1fmk_A          266 LDFLKGETGKYLRLPQLVDMAAQIASGMAYVE---RMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYT-ARQGA  341 (452)
T ss_dssp             HHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEECGGGCEEECCCCTTC--------------
T ss_pred             HHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHH---hCCeeCCCCChhhEEECCCCCEEECCCccceecCCCcee-cccCC
Confidence                        22335678999999999999   899999999999999999999999999999876543221 12334


Q ss_pred             CCCcccccccccccccCCCCccccHHHHHHHHHHHHc-CCCCCCCCCCCc
Q 039231          447 RGTVGYIAPEVFCRNIGEVSYKSDVYNYGMMIFEMTG-GRKNVDVVDNGS  495 (506)
Q Consensus       447 ~gt~~y~aPE~l~~~~~~~s~~~Dv~s~G~il~ellt-g~~pf~~~~~~~  495 (506)
                      .+++.|+|||.+..  +.++.++||||||+++|||++ |+.||......+
T Consensus       342 ~~~~~y~aPE~~~~--~~~~~~sDvwslG~~l~el~t~g~~P~~~~~~~~  389 (452)
T 1fmk_A          342 KFPIKWTAPEAALY--GRFTIKSDVWSFGILLTELTTKGRVPYPGMVNRE  389 (452)
T ss_dssp             -CCGGGSCHHHHHH--CCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHH
T ss_pred             cccccccCHhHHhc--CCCCccccHHhHHHHHHHHHhCCCCCCCCCCHHH
Confidence            56889999999864  378999999999999999999 999998765443

>2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens}

Probab=99.97  E-value=1.4e-31  Score=270.69  Aligned_cols=170  Identities=28%  Similarity=0.424  Sum_probs=138.2

Q ss_pred             cccCccCceEEEEEEEc-CCCEEEEEEeccCC-CCchhhHHHHHHhhccCccceeEEEEEee------------------
Q 039231          319 YKLGQGGYGSVYKGKLL-DGSNVAVKVLNDSK-GNGKEFINEVASISRTSHVNVVALLGFCL------------------  378 (506)
Q Consensus       319 ~~ig~G~~g~V~~~~~~-~~~~vavK~l~~~~-~~~~~~~~E~~~l~~l~h~niv~l~g~~~------------------  378 (506)
                      +.||+|+||.||+|+.. +|+.||+|+++... ...+++.+|++++++++||||+++++++.                  
T Consensus        95 ~~lG~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~E~~~~~~L~  174 (373)
T 2x4f_A           95 EILGGGRFGQVHKCEETATGLKLAAKIIKTRGMKDKEEVKNEISVMNQLDHANLIQLYDAFESKNDIVLVMEYVDGGELF  174 (373)
T ss_dssp             EECC-----CEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEECCTTCEEH
T ss_pred             eEEecCcCEEEEEEEEcCCCcEEEEEEEcccccccHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEeCCCCCcHH
Confidence            46999999999999875 58999999997643 23467899999999999999999999872                  


Q ss_pred             ----------ccchhhhHHHHHHHHHHHHhhcCCCCeEecCcCCCcEEE--CCCCcEEEeecCCCccccCCCcceecccC
Q 039231          379 ----------RVAEELSSTIGIARGLEYLHLGCSTRILHFDIKPHNILL--DEDFCPKISDFGLAKICNRKESIISMTGA  446 (506)
Q Consensus       379 ----------~~~~~l~i~~~i~~gl~~LH~~~~~~ivH~dlkp~Nill--~~~~~~ki~dfg~a~~~~~~~~~~~~~~~  446 (506)
                                ++.+.+.++.||+.||+|||   +.+|+||||||+|||+  +.++.+||+|||+++.......   ....
T Consensus       175 ~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH---~~~ivH~Dlkp~NIll~~~~~~~~kl~DFG~a~~~~~~~~---~~~~  248 (373)
T 2x4f_A          175 DRIIDESYNLTELDTILFMKQICEGIRHMH---QMYILHLDLKPENILCVNRDAKQIKIIDFGLARRYKPREK---LKVN  248 (373)
T ss_dssp             HHHHHTGGGCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEEEETTTTEEEECCCSSCEECCTTCB---CCCC
T ss_pred             HHHHhcCCCCCHHHHHHHHHHHHHHHHHHH---HCCcccccCCHHHEEEecCCCCcEEEEeCCCceecCCccc---cccc
Confidence                      22335668899999999999   8999999999999999  6678999999999987655432   2345


Q ss_pred             CCCcccccccccccccCCCCccccHHHHHHHHHHHHcCCCCCCCCCCCcc
Q 039231          447 RGTVGYIAPEVFCRNIGEVSYKSDVYNYGMMIFEMTGGRKNVDVVDNGST  496 (506)
Q Consensus       447 ~gt~~y~aPE~l~~~~~~~s~~~Dv~s~G~il~elltg~~pf~~~~~~~~  496 (506)
                      .||+.|+|||++..  ..++.++||||||+++|||++|+.||...++.+.
T Consensus       249 ~gt~~y~aPE~~~~--~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~  296 (373)
T 2x4f_A          249 FGTPEFLAPEVVNY--DFVSFPTDMWSVGVIAYMLLSGLSPFLGDNDAET  296 (373)
T ss_dssp             CSSCTTCCHHHHTT--CBCCHHHHHHHHHHHHHHHHHSSCTTCCSSHHHH
T ss_pred             cCCCcEeChhhccC--CCCCcHHhHHHHHHHHHHHHhCCCCCCCCCHHHH
Confidence            68999999999854  3789999999999999999999999987654443

>3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A*

Probab=99.97  E-value=6.1e-32  Score=266.61  Aligned_cols=175  Identities=26%  Similarity=0.389  Sum_probs=137.2

Q ss_pred             hhccccCccCceEEEEEEE-cCCCEEEEEEeccCCCCc----hhhHHHHHHhhccCccceeEEEEEe-------------
Q 039231          316 SFKYKLGQGGYGSVYKGKL-LDGSNVAVKVLNDSKGNG----KEFINEVASISRTSHVNVVALLGFC-------------  377 (506)
Q Consensus       316 ~~~~~ig~G~~g~V~~~~~-~~~~~vavK~l~~~~~~~----~~~~~E~~~l~~l~h~niv~l~g~~-------------  377 (506)
                      .+.+.||+|+||.||+|+. .+++.||||+++......    +.+.+|++++.+++||||+++++++             
T Consensus        15 ~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~~~~~lv   94 (311)
T 3ork_A           15 ELGEILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPLPYIV   94 (311)
T ss_dssp             EEEEEEEECSSEEEEEEEETTTTEEEEEEEECTTTTTSHHHHHHHHHHHTTCCCCCCTTBCCEEEEEEEEETTEEEEEEE
T ss_pred             EEEEEEccCCCEEEEEEEECCCCceEEEEEeCccccCCHHHHHHHHHHHHHHHcCCCCCcceEEEeeeccCCCCcccEEE
Confidence            4457899999999999997 468999999997643322    4678999999999999999999764             


Q ss_pred             ------------------eccchhhhHHHHHHHHHHHHhhcCCCCeEecCcCCCcEEECCCCcEEEeecCCCccccCCCc
Q 039231          378 ------------------LRVAEELSSTIGIARGLEYLHLGCSTRILHFDIKPHNILLDEDFCPKISDFGLAKICNRKES  439 (506)
Q Consensus       378 ------------------~~~~~~l~i~~~i~~gl~~LH~~~~~~ivH~dlkp~Nill~~~~~~ki~dfg~a~~~~~~~~  439 (506)
                                        +++.+.+.++.|++.||+|||   +++|+||||||+|||++.++.+||+|||+++.......
T Consensus        95 ~e~~~g~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH---~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~~~  171 (311)
T 3ork_A           95 MEYVDGVTLRDIVHTEGPMTPKRAIEVIADACQALNFSH---QNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGN  171 (311)
T ss_dssp             EECCCEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEEETTSCEEECCCSCC--------
T ss_pred             EecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH---HCCCCcCCCCHHHEEEcCCCCEEEeeccCccccccccc
Confidence                              223346778999999999999   89999999999999999999999999999987654332


Q ss_pred             ce-ecccCCCCcccccccccccccCCCCccccHHHHHHHHHHHHcCCCCCCCCCCCc
Q 039231          440 II-SMTGARGTVGYIAPEVFCRNIGEVSYKSDVYNYGMMIFEMTGGRKNVDVVDNGS  495 (506)
Q Consensus       440 ~~-~~~~~~gt~~y~aPE~l~~~~~~~s~~~Dv~s~G~il~elltg~~pf~~~~~~~  495 (506)
                      .. ......||+.|+|||++.+.  .++.++||||||+++|||++|+.||......+
T Consensus       172 ~~~~~~~~~gt~~y~aPE~~~~~--~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~  226 (311)
T 3ork_A          172 SVTQTAAVIGTAQYLSPEQARGD--SVDARSDVYSLGCVLYEVLTGEPPFTGDSPVS  226 (311)
T ss_dssp             ----------CCTTCCHHHHHTC--CCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHH
T ss_pred             ccccccccCcCcccCCHHHhcCC--CCCchHhHHHHHHHHHHHHhCCCCCCCCChHH
Confidence            21 12345689999999998654  78999999999999999999999998765433

>3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens}

Probab=99.97  E-value=1.1e-31  Score=268.51  Aligned_cols=173  Identities=25%  Similarity=0.383  Sum_probs=137.4

Q ss_pred             hhccccCccCceEEEEEEEcCCCEEEEEEeccCCCCc---hhhHHHHHHhhccCc--cceeEEEEEe-------------
Q 039231          316 SFKYKLGQGGYGSVYKGKLLDGSNVAVKVLNDSKGNG---KEFINEVASISRTSH--VNVVALLGFC-------------  377 (506)
Q Consensus       316 ~~~~~ig~G~~g~V~~~~~~~~~~vavK~l~~~~~~~---~~~~~E~~~l~~l~h--~niv~l~g~~-------------  377 (506)
                      .+.+.||+|+||.||++...+++.||||++.......   +.+.+|++++.+++|  +||+++++++             
T Consensus        12 ~i~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~~~~~~lv~e~~   91 (343)
T 3dbq_A           12 SILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMVMECG   91 (343)
T ss_dssp             EEEEEESCCSSEEEEEEECTTSCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEECCC
T ss_pred             EEEEEEecCCCeEEEEEEeCCCCEEEEEEeeccccchHHHHHHHHHHHHHHhhhhcCCceEEEeeeEeeCCEEEEEEeCC
Confidence            3456899999999999999889999999997544332   568899999999987  9999999987             


Q ss_pred             -------------eccchhhhHHHHHHHHHHHHhhcCCCCeEecCcCCCcEEECCCCcEEEeecCCCccccCCCcceecc
Q 039231          378 -------------LRVAEELSSTIGIARGLEYLHLGCSTRILHFDIKPHNILLDEDFCPKISDFGLAKICNRKESIISMT  444 (506)
Q Consensus       378 -------------~~~~~~l~i~~~i~~gl~~LH~~~~~~ivH~dlkp~Nill~~~~~~ki~dfg~a~~~~~~~~~~~~~  444 (506)
                                   +++.+++.++.||+.||+|||   +++|+||||||+|||++ ++.+||+|||+++............
T Consensus        92 ~~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~lH---~~~iiHrDikp~NIll~-~~~~kl~DFG~a~~~~~~~~~~~~~  167 (343)
T 3dbq_A           92 NIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIH---QHGIVHSDLKPANFLIV-DGMLKLIDFGIANQMQPDTTSVVKD  167 (343)
T ss_dssp             SEEHHHHHHHSCCCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEEE-TTEEEECCCSSSCCC----------
T ss_pred             CCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCcceEEEE-CCcEEEeecccccccCcccccccCC
Confidence                         233346778999999999999   89999999999999997 5789999999998776544332334


Q ss_pred             cCCCCccccccccccc---------ccCCCCccccHHHHHHHHHHHHcCCCCCCCCC
Q 039231          445 GARGTVGYIAPEVFCR---------NIGEVSYKSDVYNYGMMIFEMTGGRKNVDVVD  492 (506)
Q Consensus       445 ~~~gt~~y~aPE~l~~---------~~~~~s~~~Dv~s~G~il~elltg~~pf~~~~  492 (506)
                      ...||+.|+|||++.+         ....++.++||||||+++|||++|+.||....
T Consensus       168 ~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~  224 (343)
T 3dbq_A          168 SQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQII  224 (343)
T ss_dssp             --CCCCSSCCHHHHHHCC-----------CCHHHHHHHHHHHHHHHHHSSCTTTTCC
T ss_pred             CCcCCcCcCCHHHHhhccccccccccccCCCchhhHHHHHHHHHHHHhCCCcchhhh
Confidence            5679999999999853         11468899999999999999999999997643

>3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens}

Probab=99.97  E-value=2.5e-31  Score=262.31  Aligned_cols=174  Identities=26%  Similarity=0.301  Sum_probs=139.2

Q ss_pred             HHHHHHHhhhccccCccCceEEEEEEEc-CCCEEEEEEeccCCCCc---hhhHHHHHHhhcc-CccceeEEEEEe-----
Q 039231          308 ADIKKMTNSFKYKLGQGGYGSVYKGKLL-DGSNVAVKVLNDSKGNG---KEFINEVASISRT-SHVNVVALLGFC-----  377 (506)
Q Consensus       308 ~el~~~~~~~~~~ig~G~~g~V~~~~~~-~~~~vavK~l~~~~~~~---~~~~~E~~~l~~l-~h~niv~l~g~~-----  377 (506)
                      .++....+...++||+|+||+||+|++. +++.||||++.......   .+..+|+..+.++ +||||+++++++     
T Consensus        52 ~~~~~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~~~~~~~h~~iv~l~~~~~~~~~  131 (311)
T 3p1a_A           52 ESFFQQSFQRLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQHPCCVRLEQAWEEGGI  131 (311)
T ss_dssp             SCHHHHHEEEEEEEEEETTEEEEEEEETTTSCEEEEEEESSSCCSHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTE
T ss_pred             cchhhhheeeeheeccCCCeEEEEEEECCCCeEEEEEEecccccChHHHHHHHHHHHHHHHhcCCCcEEEEEEEEEeCCE
Confidence            3444455555678999999999999986 68999999987544332   3455566666555 899999999987     


Q ss_pred             ----------------------eccchhhhHHHHHHHHHHHHhhcCCCCeEecCcCCCcEEECCCCcEEEeecCCCcccc
Q 039231          378 ----------------------LRVAEELSSTIGIARGLEYLHLGCSTRILHFDIKPHNILLDEDFCPKISDFGLAKICN  435 (506)
Q Consensus       378 ----------------------~~~~~~l~i~~~i~~gl~~LH~~~~~~ivH~dlkp~Nill~~~~~~ki~dfg~a~~~~  435 (506)
                                            +++.+++.++.|++.||+|||   +++|+||||||+|||++.++.+||+|||+++...
T Consensus       132 ~~lv~e~~~~~L~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH---~~~ivH~Dikp~NIll~~~~~~kl~DFG~a~~~~  208 (311)
T 3p1a_A          132 LYLQTELCGPSLQQHCEAWGASLPEAQVWGYLRDTLLALAHLH---SQGLVHLDVKPANIFLGPRGRCKLGDFGLLVELG  208 (311)
T ss_dssp             EEEEEECCCCBHHHHHHHHCSCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECGGGCEEECCCTTCEECC
T ss_pred             EEEEEeccCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH---HCCEecCCCCHHHEEECCCCCEEEccceeeeecc
Confidence                                  334456779999999999999   8999999999999999999999999999998765


Q ss_pred             CCCcceecccCCCCcccccccccccccCCCCccccHHHHHHHHHHHHcCCCCCCC
Q 039231          436 RKESIISMTGARGTVGYIAPEVFCRNIGEVSYKSDVYNYGMMIFEMTGGRKNVDV  490 (506)
Q Consensus       436 ~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~s~~~Dv~s~G~il~elltg~~pf~~  490 (506)
                      ....   .....||+.|+|||++.+   .++.++||||||+++|||++|..|+..
T Consensus       209 ~~~~---~~~~~gt~~y~aPE~~~~---~~~~~~DiwslG~il~el~~g~~~~~~  257 (311)
T 3p1a_A          209 TAGA---GEVQEGDPRYMAPELLQG---SYGTAADVFSLGLTILEVACNMELPHG  257 (311)
T ss_dssp             ---------CCCCCGGGCCGGGGGT---CCSTHHHHHHHHHHHHHHHHTCCCCSS
T ss_pred             cCCC---CcccCCCccccCHhHhcC---CCCchhhHHHHHHHHHHHHhCCCCCCC
Confidence            4432   244568999999999853   689999999999999999999777654

>1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ...

Probab=99.97  E-value=1.4e-31  Score=259.64  Aligned_cols=174  Identities=28%  Similarity=0.490  Sum_probs=147.6

Q ss_pred             hhhccccCccCceEEEEEEEcCCCEEEEEEeccCCCCchhhHHHHHHhhccCccceeEEEEEe-----------------
Q 039231          315 NSFKYKLGQGGYGSVYKGKLLDGSNVAVKVLNDSKGNGKEFINEVASISRTSHVNVVALLGFC-----------------  377 (506)
Q Consensus       315 ~~~~~~ig~G~~g~V~~~~~~~~~~vavK~l~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~-----------------  377 (506)
                      +.+.+.||+|+||.||+|+..++..||+|+++......+.+.+|++++++++||||+++++++                 
T Consensus        15 y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~v~e~~~~~~L   94 (279)
T 1qpc_A           15 LKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPDAFLAEANLMKQLQHQRLVRLYAVVTQEPIYIITEYMENGSL   94 (279)
T ss_dssp             EEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTSSCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSCEEEEECCTTCBH
T ss_pred             hhheeeecCCCCeEEEEEEEcCCcEEEEEEecCCcccHHHHHHHHHHHHhCCCcCcceEEEEEcCCCcEEEEecCCCCCH
Confidence            344578999999999999998888999999987766678899999999999999999999976                 


Q ss_pred             -----------eccchhhhHHHHHHHHHHHHhhcCCCCeEecCcCCCcEEECCCCcEEEeecCCCccccCCCcceecccC
Q 039231          378 -----------LRVAEELSSTIGIARGLEYLHLGCSTRILHFDIKPHNILLDEDFCPKISDFGLAKICNRKESIISMTGA  446 (506)
Q Consensus       378 -----------~~~~~~l~i~~~i~~gl~~LH~~~~~~ivH~dlkp~Nill~~~~~~ki~dfg~a~~~~~~~~~~~~~~~  446 (506)
                                 +++.+.+.++.|++.||+|||   +++++||||||+||++++++.+||+|||+++........ .....
T Consensus        95 ~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH---~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~-~~~~~  170 (279)
T 1qpc_A           95 VDFLKTPSGIKLTINKLLDMAAQIAEGMAFIE---ERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYT-AREGA  170 (279)
T ss_dssp             HHHTTSHHHHTCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECTTSCEEECCCTTCEECSSSCEE-CCTTC
T ss_pred             HHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHH---HCCeeccCCCHhhEEEcCCCCEEECCCcccccccCcccc-cccCC
Confidence                       223345678999999999999   899999999999999999999999999999876544322 12345


Q ss_pred             CCCcccccccccccccCCCCccccHHHHHHHHHHHHc-CCCCCCCCCCC
Q 039231          447 RGTVGYIAPEVFCRNIGEVSYKSDVYNYGMMIFEMTG-GRKNVDVVDNG  494 (506)
Q Consensus       447 ~gt~~y~aPE~l~~~~~~~s~~~Dv~s~G~il~ellt-g~~pf~~~~~~  494 (506)
                      .+++.|+|||.+.+  +.++.++||||||+++|||++ |+.||......
T Consensus       171 ~~~~~y~aPE~~~~--~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~  217 (279)
T 1qpc_A          171 KFPIKWTAPEAINY--GTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNP  217 (279)
T ss_dssp             CCCTTTSCHHHHHH--CEECHHHHHHHHHHHHHHHHTTTCCSSTTCCHH
T ss_pred             CCccCccChhhhcc--CCCCchhhhHHHHHHHHHHHhCCCCCCcccCHH
Confidence            56889999999854  368899999999999999999 99999865543

>3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A

Probab=99.97  E-value=3.2e-31  Score=266.07  Aligned_cols=172  Identities=24%  Similarity=0.322  Sum_probs=143.0

Q ss_pred             HHhhhccccCccCceEEEEEEEc-CCCEEEEEEeccC------CCCchhhHHHHHHhhccCccceeEEEEEee-------
Q 039231          313 MTNSFKYKLGQGGYGSVYKGKLL-DGSNVAVKVLNDS------KGNGKEFINEVASISRTSHVNVVALLGFCL-------  378 (506)
Q Consensus       313 ~~~~~~~~ig~G~~g~V~~~~~~-~~~~vavK~l~~~------~~~~~~~~~E~~~l~~l~h~niv~l~g~~~-------  378 (506)
                      ..+.+.+.||+|+||.||+|+.. +++.||||++...      ....+.+.+|++++++++||||+++++++.       
T Consensus        24 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~l  103 (351)
T 3c0i_A           24 DVYELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIVELLETYSSDGMLYM  103 (351)
T ss_dssp             HHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHTSSSCCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEE
T ss_pred             cceEEeeEEeeCCCEEEEEEEECCCCCEEEEEEEEhhhccccccchHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEE
Confidence            34556678999999999999875 5899999998531      123467899999999999999999998771       


Q ss_pred             ------------------------ccchhhhHHHHHHHHHHHHhhcCCCCeEecCcCCCcEEECCCCc---EEEeecCCC
Q 039231          379 ------------------------RVAEELSSTIGIARGLEYLHLGCSTRILHFDIKPHNILLDEDFC---PKISDFGLA  431 (506)
Q Consensus       379 ------------------------~~~~~l~i~~~i~~gl~~LH~~~~~~ivH~dlkp~Nill~~~~~---~ki~dfg~a  431 (506)
                                              ++.+.+.++.||+.||+|||   +++|+||||||+|||++.++.   +||+|||++
T Consensus       104 v~e~~~g~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH---~~~ivHrDlkp~NIl~~~~~~~~~vkl~Dfg~a  180 (351)
T 3c0i_A          104 VFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEALRYCH---DNNIIHRDVKPHCVLLASKENSAPVKLGGFGVA  180 (351)
T ss_dssp             EEECCSSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECSSSTTCCEEECCCTTC
T ss_pred             EEeCCCCCCHHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHH---HCCceeccCChHHeEEecCCCCCcEEEecCcce
Confidence                                    22235568899999999999   899999999999999976654   999999999


Q ss_pred             ccccCCCcceecccCCCCcccccccccccccCCCCccccHHHHHHHHHHHHcCCCCCCCC
Q 039231          432 KICNRKESIISMTGARGTVGYIAPEVFCRNIGEVSYKSDVYNYGMMIFEMTGGRKNVDVV  491 (506)
Q Consensus       432 ~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~s~~~Dv~s~G~il~elltg~~pf~~~  491 (506)
                      +........  .....||+.|+|||++.+.  .++.++||||||+++|||++|+.||...
T Consensus       181 ~~~~~~~~~--~~~~~gt~~y~aPE~~~~~--~~~~~~DiwslG~il~~ll~g~~pf~~~  236 (351)
T 3c0i_A          181 IQLGESGLV--AGGRVGTPHFMAPEVVKRE--PYGKPVDVWGCGVILFILLSGCLPFYGT  236 (351)
T ss_dssp             EECCTTSCB--CCCCCSCGGGCCHHHHTTC--CBCTHHHHHHHHHHHHHHHHSSCSSCSS
T ss_pred             eEecCCCee--ecCCcCCcCccCHHHHcCC--CCCchHhhHHHHHHHHHHHHCCCCCCCc
Confidence            877654321  2446799999999998654  6899999999999999999999999764

>3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7}

Probab=99.97  E-value=1.4e-31  Score=269.43  Aligned_cols=171  Identities=26%  Similarity=0.345  Sum_probs=144.4

Q ss_pred             hhhccccCccCceEEEEEEEc-CCCEEEEEEeccCCCCchhhHHHHHHhhccC-----ccceeEEEEEee----------
Q 039231          315 NSFKYKLGQGGYGSVYKGKLL-DGSNVAVKVLNDSKGNGKEFINEVASISRTS-----HVNVVALLGFCL----------  378 (506)
Q Consensus       315 ~~~~~~ig~G~~g~V~~~~~~-~~~~vavK~l~~~~~~~~~~~~E~~~l~~l~-----h~niv~l~g~~~----------  378 (506)
                      +.+.++||+|+||.||+|+.. +++.||||+++......+.+.+|++++++++     ||||+++++++.          
T Consensus        37 y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~e~~~l~~l~~~~~~h~~iv~~~~~~~~~~~~~lv~e  116 (360)
T 3llt_A           37 FLVIRKMGDGTFGRVLLCQHIDNKKYYAVKVVRNIKKYTRSAKIEADILKKIQNDDINNNNIVKYHGKFMYYDHMCLIFE  116 (360)
T ss_dssp             EEEEEEEEECSSEEEEEEEETTTCCEEEEEEECSCHHHHHHHHHHHHHHHHTCCCSTTGGGBCCEEEEEEETTEEEEEEC
T ss_pred             EEEEEEEcccCCeEEEEEEECCCCeEEEEEEeccchhhhhhhHHHHHHHHHhcccCCCCCCeecccceeeECCeeEEEEc
Confidence            344578999999999999984 5899999999865555567888999999986     999999998762          


Q ss_pred             ------------------ccchhhhHHHHHHHHHHHHhhcCCCCeEecCcCCCcEEECC---------------------
Q 039231          379 ------------------RVAEELSSTIGIARGLEYLHLGCSTRILHFDIKPHNILLDE---------------------  419 (506)
Q Consensus       379 ------------------~~~~~l~i~~~i~~gl~~LH~~~~~~ivH~dlkp~Nill~~---------------------  419 (506)
                                        +..+.+.++.||+.||+|||   +++|+||||||+|||++.                     
T Consensus       117 ~~~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH---~~~ivHrDlkp~NIll~~~~~~~~~~~~~~~~~~~~~~~  193 (360)
T 3llt_A          117 PLGPSLYEIITRNNYNGFHIEDIKLYCIEILKALNYLR---KMSLTHTDLKPENILLDDPYFEKSLITVRRVTDGKKIQI  193 (360)
T ss_dssp             CCCCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEESCTTCCEEEEEEECTTTCCEEEE
T ss_pred             CCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHH---HCCeeeCCCCcccEEEccccccccccchhcccccccccc
Confidence                              23346678999999999999   899999999999999975                     


Q ss_pred             ----CCcEEEeecCCCccccCCCcceecccCCCCcccccccccccccCCCCccccHHHHHHHHHHHHcCCCCCCCCCCCc
Q 039231          420 ----DFCPKISDFGLAKICNRKESIISMTGARGTVGYIAPEVFCRNIGEVSYKSDVYNYGMMIFEMTGGRKNVDVVDNGS  495 (506)
Q Consensus       420 ----~~~~ki~dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~s~~~Dv~s~G~il~elltg~~pf~~~~~~~  495 (506)
                          ++.+||+|||+++......     ....||+.|+|||++.+.  .++.++||||||+++|||++|+.||...+..+
T Consensus       194 ~~~~~~~~kl~DFG~a~~~~~~~-----~~~~gt~~y~aPE~~~~~--~~~~~~DiwslG~il~ell~g~~pf~~~~~~~  266 (360)
T 3llt_A          194 YRTKSTGIKLIDFGCATFKSDYH-----GSIINTRQYRAPEVILNL--GWDVSSDMWSFGCVLAELYTGSLLFRTHEHME  266 (360)
T ss_dssp             EEESCCCEEECCCTTCEETTSCC-----CSCCSCGGGCCHHHHTTC--CCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHH
T ss_pred             cccCCCCEEEEeccCceecCCCC-----cCccCcccccCcHHHcCC--CCCCccchHHHHHHHHHHHHCCCCCCCCcHHH
Confidence                7899999999998654432     346789999999999654  78999999999999999999999998765443

>2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A*

Probab=99.97  E-value=1.7e-31  Score=271.89  Aligned_cols=174  Identities=24%  Similarity=0.357  Sum_probs=139.0

Q ss_pred             hhhccccCccCceEEEEEEEcCCCEEEEEEeccCCCC---chhhHHHHHHhhccC--ccceeEEEEEee-----------
Q 039231          315 NSFKYKLGQGGYGSVYKGKLLDGSNVAVKVLNDSKGN---GKEFINEVASISRTS--HVNVVALLGFCL-----------  378 (506)
Q Consensus       315 ~~~~~~ig~G~~g~V~~~~~~~~~~vavK~l~~~~~~---~~~~~~E~~~l~~l~--h~niv~l~g~~~-----------  378 (506)
                      +.+.+.||+|+||.||+|...+++.||||++......   .+.+.+|++++.+++  ||||+++++++.           
T Consensus        58 y~~~~~LG~G~fg~Vy~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~~~~~~iv~~~~~~~~~~~~~lv~E~  137 (390)
T 2zmd_A           58 YSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMVMEC  137 (390)
T ss_dssp             EEEEEEEECCSSEEEEEEECTTCCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEEEC
T ss_pred             eEEEEEEccCCCeEEEEEEcCCCCEEEEEEEecccccHHHHHHHHHHHHHHHHcccCCCeEEEEEEEEecCCEEEEEEec
Confidence            3445789999999999999888999999999754332   367889999999997  599999998762           


Q ss_pred             ---------------ccchhhhHHHHHHHHHHHHhhcCCCCeEecCcCCCcEEECCCCcEEEeecCCCccccCCCcceec
Q 039231          379 ---------------RVAEELSSTIGIARGLEYLHLGCSTRILHFDIKPHNILLDEDFCPKISDFGLAKICNRKESIISM  443 (506)
Q Consensus       379 ---------------~~~~~l~i~~~i~~gl~~LH~~~~~~ivH~dlkp~Nill~~~~~~ki~dfg~a~~~~~~~~~~~~  443 (506)
                                     ++.+++.++.||+.||+|||   +++|+||||||+|||++ ++.+||+|||+++...........
T Consensus       138 ~~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~lH---~~~ivHrDlkp~NIll~-~~~~kl~DFG~a~~~~~~~~~~~~  213 (390)
T 2zmd_A          138 GNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIH---QHGIVHSDLKPANFLIV-DGMLKLIDFGIANQMQPDTTSVVK  213 (390)
T ss_dssp             CSEEHHHHHHHCSSCCHHHHHHHHHHHHHHHHHHH---TTTCCCCCCCGGGEEES-SSCEEECCCSSSCCC---------
T ss_pred             CCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH---HCCeeecCCCHHHEEEE-CCeEEEEecCccccccCCCccccC
Confidence                           23346778999999999999   89999999999999996 578999999999877554433223


Q ss_pred             ccCCCCcccccccccccc---------cCCCCccccHHHHHHHHHHHHcCCCCCCCCC
Q 039231          444 TGARGTVGYIAPEVFCRN---------IGEVSYKSDVYNYGMMIFEMTGGRKNVDVVD  492 (506)
Q Consensus       444 ~~~~gt~~y~aPE~l~~~---------~~~~s~~~Dv~s~G~il~elltg~~pf~~~~  492 (506)
                      ....||+.|+|||++.+.         ...++.++|||||||++|||++|+.||....
T Consensus       214 ~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~  271 (390)
T 2zmd_A          214 DSQVGAVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQII  271 (390)
T ss_dssp             CCSCCCGGGCCHHHHHCC------------CCHHHHHHHHHHHHHHHHHSSCTTTTCC
T ss_pred             CCCCcCCCccChHHhhhccccccccccccCCCChhhHHHHHHHHHHHHHCCCcchhhh
Confidence            456799999999998541         1368899999999999999999999997654

>3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus}

Probab=99.97  E-value=2.4e-31  Score=264.06  Aligned_cols=169  Identities=30%  Similarity=0.469  Sum_probs=138.0

Q ss_pred             hhccccCccCceEEEEEEEc-CCCEEEEEEeccCCC--CchhhHHHHHHhhccCccceeEEEEEeeccc-----------
Q 039231          316 SFKYKLGQGGYGSVYKGKLL-DGSNVAVKVLNDSKG--NGKEFINEVASISRTSHVNVVALLGFCLRVA-----------  381 (506)
Q Consensus       316 ~~~~~ig~G~~g~V~~~~~~-~~~~vavK~l~~~~~--~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~-----------  381 (506)
                      .+.+.||+|+||.||+|+.. +++.||||+++....  ..+.+.+|++++++++||||+++++++.+..           
T Consensus         9 ~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~~~~~   88 (332)
T 3qd2_B            9 EPIQCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLETPPEKWQEEMDEI   88 (332)
T ss_dssp             EEEEEEECC-CSEEEEEEETTTCCEEEEEEEECCSTTTHHHHHHHHHHHHTSCCCTTBCCEEEEEEECCSCHHHHHHHC-
T ss_pred             ceeeEecCCCCeEEEEEEEcCCCcEEEEEEeecCCchhHHHHHHHHHHHHHhCCCCCEeeEEEEEEEeccchhhhhhhhh
Confidence            34578999999999999986 689999999975432  3367899999999999999999998752211           


Q ss_pred             ----------------------------------------------------------------------------hhhh
Q 039231          382 ----------------------------------------------------------------------------EELS  385 (506)
Q Consensus       382 ----------------------------------------------------------------------------~~l~  385 (506)
                                                                                                  ..+.
T Consensus        89 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~  168 (332)
T 3qd2_B           89 WLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVGQLQPSSPKVYLYIQMQLCRKENLKDWMNRRCSLEDREHGVCLH  168 (332)
T ss_dssp             -------------------------------------------CCCEEEEEEECCCSSCHHHHHHTCCSGGGSCHHHHHH
T ss_pred             hhccccccccccCCCcccccccceeeccccCcccccccccCCCCCceEEEEEEecCCCCHHHHHhcccCccchhhHHHHH
Confidence                                                                                        1467


Q ss_pred             HHHHHHHHHHHHhhcCCCCeEecCcCCCcEEECCCCcEEEeecCCCccccCCCcc----------eecccCCCCcccccc
Q 039231          386 STIGIARGLEYLHLGCSTRILHFDIKPHNILLDEDFCPKISDFGLAKICNRKESI----------ISMTGARGTVGYIAP  455 (506)
Q Consensus       386 i~~~i~~gl~~LH~~~~~~ivH~dlkp~Nill~~~~~~ki~dfg~a~~~~~~~~~----------~~~~~~~gt~~y~aP  455 (506)
                      ++.||+.||+|||   +++|+||||||+|||++.++.+||+|||+++........          .......||+.|+||
T Consensus       169 i~~qi~~aL~~LH---~~~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aP  245 (332)
T 3qd2_B          169 IFIQIAEAVEFLH---SKGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQVGTKLYMSP  245 (332)
T ss_dssp             HHHHHHHHHHHHH---HTTEECCCCCGGGEEECTTCCEEECCCTTCEECSCC--------------CCCSCC-CGGGSCH
T ss_pred             HHHHHHHHHHHHH---hCCeeecCCCcccEEEeCCCCEEEeecCcccccccchhhccccccccccccccccCCCcCccCh
Confidence            8999999999999   899999999999999999999999999999877654321          112345699999999


Q ss_pred             cccccccCCCCccccHHHHHHHHHHHHcCCCCCC
Q 039231          456 EVFCRNIGEVSYKSDVYNYGMMIFEMTGGRKNVD  489 (506)
Q Consensus       456 E~l~~~~~~~s~~~Dv~s~G~il~elltg~~pf~  489 (506)
                      |.+.+.  .++.++||||||+++|||++|..|+.
T Consensus       246 E~~~~~--~~~~~~Di~slG~il~el~~~~~~~~  277 (332)
T 3qd2_B          246 EQIHGN--NYSHKVDIFSLGLILFELLYSFSTQM  277 (332)
T ss_dssp             HHHHCC--CCCTHHHHHHHHHHHHHHHSCCCCHH
T ss_pred             HHhcCC--CCcchhhHHHHHHHHHHHHHcCCChh
Confidence            998654  78999999999999999999987763

>2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A*

Probab=99.97  E-value=2e-31  Score=281.36  Aligned_cols=169  Identities=31%  Similarity=0.461  Sum_probs=144.4

Q ss_pred             ccccCccCceEEEEEEEc-CCCEEEEEEeccC----CCCchhhHHHHHHhhccCccceeEEEEEe---------------
Q 039231          318 KYKLGQGGYGSVYKGKLL-DGSNVAVKVLNDS----KGNGKEFINEVASISRTSHVNVVALLGFC---------------  377 (506)
Q Consensus       318 ~~~ig~G~~g~V~~~~~~-~~~~vavK~l~~~----~~~~~~~~~E~~~l~~l~h~niv~l~g~~---------------  377 (506)
                      .+.||+|+||.||+|+.. +|+.||||++...    ......+.+|+++|++++|||||++++++               
T Consensus       189 ~~~LG~G~fG~Vy~a~~~~tg~~vAvK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~lVmEy~~g  268 (576)
T 2acx_A          189 YRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLTLMNG  268 (576)
T ss_dssp             EEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEECCCCS
T ss_pred             EEEEeeCCCEEEEEEEECCCCCEEEEEEEEhHhhhhhHHHHHHHHHHHHHHHcCCCCEeeEEEEEeeCCEEEEEEEcCCC
Confidence            367999999999999985 5899999999642    23446688999999999999999999876               


Q ss_pred             --------------eccchhhhHHHHHHHHHHHHhhcCCCCeEecCcCCCcEEECCCCcEEEeecCCCccccCCCcceec
Q 039231          378 --------------LRVAEELSSTIGIARGLEYLHLGCSTRILHFDIKPHNILLDEDFCPKISDFGLAKICNRKESIISM  443 (506)
Q Consensus       378 --------------~~~~~~l~i~~~i~~gl~~LH~~~~~~ivH~dlkp~Nill~~~~~~ki~dfg~a~~~~~~~~~~~~  443 (506)
                                    +++.+.+.++.||+.||+|||   +++|+||||||+|||++.++.+||+|||+++.......   .
T Consensus       269 g~L~~~l~~~~~~~l~e~~~~~i~~qIl~aL~yLH---~~gIvHrDLKPeNILld~~g~vKL~DFGla~~~~~~~~---~  342 (576)
T 2acx_A          269 GDLKFHIYHMGQAGFPEARAVFYAAEICCGLEDLH---RERIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQT---I  342 (576)
T ss_dssp             CBHHHHHHSSSSCCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEECTTSCEEECCCTTCEECCTTCC---E
T ss_pred             CcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHH---HCCEeccCCchheEEEeCCCCeEEEecccceecccCcc---c
Confidence                          223335678899999999999   89999999999999999999999999999987765443   2


Q ss_pred             ccCCCCcccccccccccccCCCCccccHHHHHHHHHHHHcCCCCCCCCCCC
Q 039231          444 TGARGTVGYIAPEVFCRNIGEVSYKSDVYNYGMMIFEMTGGRKNVDVVDNG  494 (506)
Q Consensus       444 ~~~~gt~~y~aPE~l~~~~~~~s~~~Dv~s~G~il~elltg~~pf~~~~~~  494 (506)
                      ....||+.|+|||++.+.  .++.++|||||||++|||++|+.||......
T Consensus       343 ~~~~GT~~Y~APEvl~~~--~~~~~~DiwSLGvilyeLltG~~PF~~~~~~  391 (576)
T 2acx_A          343 KGRVGTVGYMAPEVVKNE--RYTFSPDWWALGCLLYEMIAGQSPFQQRKKK  391 (576)
T ss_dssp             ECCCSCGGGCCHHHHTTC--EESSHHHHHHHHHHHHHHHHSSCSSSCSSSC
T ss_pred             cccCCCccccCHHHHcCC--CCCccchHHHHHHHHHHHHhCCCCCcccccc
Confidence            346799999999999654  6899999999999999999999999876544

>1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A

Probab=99.97  E-value=2.7e-31  Score=275.50  Aligned_cols=170  Identities=28%  Similarity=0.520  Sum_probs=142.7

Q ss_pred             hccccCccCceEEEEEEEcCCCEEEEEEeccCCCCchhhHHHHHHhhccCccceeEEEEEeec-----------------
Q 039231          317 FKYKLGQGGYGSVYKGKLLDGSNVAVKVLNDSKGNGKEFINEVASISRTSHVNVVALLGFCLR-----------------  379 (506)
Q Consensus       317 ~~~~ig~G~~g~V~~~~~~~~~~vavK~l~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~-----------------  379 (506)
                      +.++||+|+||.||+|++. ++.||||+++... ..+.+.+|++++++++||||+++++++.+                 
T Consensus       197 ~~~~lG~G~fg~V~~~~~~-~~~vavK~~~~~~-~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~iv~e~~~~g~L  274 (450)
T 1k9a_A          197 LLQTIGKGEFGDVMLGDYR-GNKVAVKCIKNDA-TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSL  274 (450)
T ss_dssp             EEEEEEECSSEEEEEEEET-TEEEEEEEESSCT-TSHHHHHHHHHHHTCCCTTBCCEEEEEECTTSCEEEEEECCTTCBH
T ss_pred             EEeeecCcCCeeEEEEEec-CCeEEEEEeCCch-HHHHHHHHHHHHHhccCCCEEEEEEEEEcCCCceEEEEEecCCCcH
Confidence            4568999999999999984 7899999998654 55789999999999999999999998622                 


Q ss_pred             -------------cchhhhHHHHHHHHHHHHhhcCCCCeEecCcCCCcEEECCCCcEEEeecCCCccccCCCcceecccC
Q 039231          380 -------------VAEELSSTIGIARGLEYLHLGCSTRILHFDIKPHNILLDEDFCPKISDFGLAKICNRKESIISMTGA  446 (506)
Q Consensus       380 -------------~~~~l~i~~~i~~gl~~LH~~~~~~ivH~dlkp~Nill~~~~~~ki~dfg~a~~~~~~~~~~~~~~~  446 (506)
                                   ....+.++.||+.||+|||   +++|+||||||+|||+++++.+||+|||+++......     ...
T Consensus       275 ~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH---~~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~-----~~~  346 (450)
T 1k9a_A          275 VDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLE---GNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQ-----DTG  346 (450)
T ss_dssp             HHHHHHHCTTTCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCCGGGEEECTTSCEEECCCTTCEECC-----------
T ss_pred             HHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHH---hCCeeCCCCCHhhEEECCCCCEEEeeCCCcccccccc-----cCC
Confidence                         2235678999999999999   8999999999999999999999999999998644322     223


Q ss_pred             CCCcccccccccccccCCCCccccHHHHHHHHHHHHc-CCCCCCCCCCCcchh
Q 039231          447 RGTVGYIAPEVFCRNIGEVSYKSDVYNYGMMIFEMTG-GRKNVDVVDNGSTAL  498 (506)
Q Consensus       447 ~gt~~y~aPE~l~~~~~~~s~~~Dv~s~G~il~ellt-g~~pf~~~~~~~~~~  498 (506)
                      .+++.|+|||.+...  .++.++||||||+++|||++ |+.||......+...
T Consensus       347 ~~~~~y~aPE~~~~~--~~~~~sDvwslG~~l~el~t~g~~P~~~~~~~~~~~  397 (450)
T 1k9a_A          347 KLPVKWTAPEALREK--KFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVP  397 (450)
T ss_dssp             CCCTTTSCHHHHHSS--CCCHHHHHHHHHHHHHHHHTTTCCSSTTSCTTTHHH
T ss_pred             CCCcceeCHHHhcCC--CCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHH
Confidence            568899999998653  78999999999999999998 999998876655443

>3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens}

Probab=99.97  E-value=2e-31  Score=265.71  Aligned_cols=168  Identities=26%  Similarity=0.362  Sum_probs=141.8

Q ss_pred             hccccCccCceEEEEEEEc-CCCEEEEEEeccCCC---------CchhhHHHHHHhhccCccceeEEEEEe---------
Q 039231          317 FKYKLGQGGYGSVYKGKLL-DGSNVAVKVLNDSKG---------NGKEFINEVASISRTSHVNVVALLGFC---------  377 (506)
Q Consensus       317 ~~~~ig~G~~g~V~~~~~~-~~~~vavK~l~~~~~---------~~~~~~~E~~~l~~l~h~niv~l~g~~---------  377 (506)
                      +.+.||+|+||.||+|+.. +++.||||+++....         ..+.+.+|++++++++||||+++++++         
T Consensus        28 ~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~~~~lv  107 (335)
T 3dls_A           28 TMSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVEHANIIKVLDIFENQGFFQLV  107 (335)
T ss_dssp             EEEECSSSSSCSEEEEEETTTTEEEEEEEEESTTSCTTSEEEETTTEEEEHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred             EEeEEEecCCEEEEEEEECCCCcEEEEEEEehhhcccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEeeCCEEEEE
Confidence            3467999999999999874 588999999976432         335688999999999999999999987         


Q ss_pred             -------------------eccchhhhHHHHHHHHHHHHhhcCCCCeEecCcCCCcEEECCCCcEEEeecCCCccccCCC
Q 039231          378 -------------------LRVAEELSSTIGIARGLEYLHLGCSTRILHFDIKPHNILLDEDFCPKISDFGLAKICNRKE  438 (506)
Q Consensus       378 -------------------~~~~~~l~i~~~i~~gl~~LH~~~~~~ivH~dlkp~Nill~~~~~~ki~dfg~a~~~~~~~  438 (506)
                                         +++..++.++.|++.||+|||   +++|+||||||+|||++.++.+||+|||+++......
T Consensus       108 ~e~~~~g~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH---~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~~  184 (335)
T 3dls_A          108 MEKHGSGLDLFAFIDRHPRLDEPLASYIFRQLVSAVGYLR---LKDIIHRDIKDENIVIAEDFTIKLIDFGSAAYLERGK  184 (335)
T ss_dssp             EECCTTSCBHHHHHHTCCCCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECTTSCEEECCCTTCEECCTTC
T ss_pred             EEeCCCCccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH---hCCeEEeccCHHHEEEcCCCcEEEeecccceECCCCC
Confidence                               223335678999999999999   8999999999999999999999999999998776544


Q ss_pred             cceecccCCCCcccccccccccccCCCCccccHHHHHHHHHHHHcCCCCCCCC
Q 039231          439 SIISMTGARGTVGYIAPEVFCRNIGEVSYKSDVYNYGMMIFEMTGGRKNVDVV  491 (506)
Q Consensus       439 ~~~~~~~~~gt~~y~aPE~l~~~~~~~s~~~Dv~s~G~il~elltg~~pf~~~  491 (506)
                      ..   ....||+.|+|||++.+. ...+.++||||||+++|||++|+.||...
T Consensus       185 ~~---~~~~gt~~y~aPE~~~~~-~~~~~~~DiwslG~il~el~~g~~pf~~~  233 (335)
T 3dls_A          185 LF---YTFCGTIEYCAPEVLMGN-PYRGPELEMWSLGVTLYTLVFEENPFCEL  233 (335)
T ss_dssp             CB---CEECSCGGGCCHHHHTTC-CBCSHHHHHHHHHHHHHHHHHSSCSCSSG
T ss_pred             ce---eccCCCccccChhhhcCC-CCCCCcccchhHHHHHHHHHhCCCchhhH
Confidence            32   345689999999998654 23488999999999999999999999764

>2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A*

Probab=99.97  E-value=9.7e-32  Score=271.60  Aligned_cols=174  Identities=28%  Similarity=0.340  Sum_probs=135.5

Q ss_pred             hhhccccCccCceEEEEEEEcC-CCEEEEEEeccCC----CCchhhHHHHHH-hhccCccceeEEEEEee----------
Q 039231          315 NSFKYKLGQGGYGSVYKGKLLD-GSNVAVKVLNDSK----GNGKEFINEVAS-ISRTSHVNVVALLGFCL----------  378 (506)
Q Consensus       315 ~~~~~~ig~G~~g~V~~~~~~~-~~~vavK~l~~~~----~~~~~~~~E~~~-l~~l~h~niv~l~g~~~----------  378 (506)
                      +.+.+.||+|+||.||+|+... ++.||||++++..    ...+.+.+|..+ ++.++||||+++++++.          
T Consensus        40 y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~e~~~ll~~~~hp~Iv~l~~~~~~~~~~~lv~E  119 (373)
T 2r5t_A           40 FHFLKVIGKGSFGKVLLARHKAEEVFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYFVLD  119 (373)
T ss_dssp             EEEEEEEECCTTCEEEEEEETTTCCEEEEEEEEGGGBC-------------CCBCCCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred             eEEEEEEeeCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHHhCCCCCCCCEEEEEEeCCEEEEEEe
Confidence            3445789999999999999864 8899999997542    233556777776 57789999999998772          


Q ss_pred             -----------------ccchhhhHHHHHHHHHHHHhhcCCCCeEecCcCCCcEEECCCCcEEEeecCCCccccCCCcce
Q 039231          379 -----------------RVAEELSSTIGIARGLEYLHLGCSTRILHFDIKPHNILLDEDFCPKISDFGLAKICNRKESII  441 (506)
Q Consensus       379 -----------------~~~~~l~i~~~i~~gl~~LH~~~~~~ivH~dlkp~Nill~~~~~~ki~dfg~a~~~~~~~~~~  441 (506)
                                       .+.+...++.||+.||+|||   +++|+||||||+|||++.++.+||+|||+++.......  
T Consensus       120 ~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH---~~givHrDlkp~NIll~~~g~ikL~DFG~a~~~~~~~~--  194 (373)
T 2r5t_A          120 YINGGELFYHLQRERCFLEPRARFYAAEIASALGYLH---SLNIVYRDLKPENILLDSQGHIVLTDFGLCKENIEHNS--  194 (373)
T ss_dssp             CCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEECTTSCEEECCCCBCGGGBCCCC--
T ss_pred             CCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH---HCCceecCCCHHHEEECCCCCEEEeeCccccccccCCC--
Confidence                             22335668899999999999   89999999999999999999999999999986433222  


Q ss_pred             ecccCCCCcccccccccccccCCCCccccHHHHHHHHHHHHcCCCCCCCCCCCc
Q 039231          442 SMTGARGTVGYIAPEVFCRNIGEVSYKSDVYNYGMMIFEMTGGRKNVDVVDNGS  495 (506)
Q Consensus       442 ~~~~~~gt~~y~aPE~l~~~~~~~s~~~Dv~s~G~il~elltg~~pf~~~~~~~  495 (506)
                      ......||+.|+|||++.+.  .++.++||||||+++|||++|+.||...+..+
T Consensus       195 ~~~~~~gt~~y~aPE~~~~~--~~~~~~DiwslG~il~ell~G~~Pf~~~~~~~  246 (373)
T 2r5t_A          195 TTSTFCGTPEYLAPEVLHKQ--PYDRTVDWWCLGAVLYEMLYGLPPFYSRNTAE  246 (373)
T ss_dssp             CCCSBSCCCCCCCHHHHTTC--CCCTHHHHHHHHHHHHHHHHSSCTTCCSBHHH
T ss_pred             ccccccCCccccCHHHhCCC--CCCchhhhHHHHHHHHHHHcCCCCCCCCCHHH
Confidence            12456799999999998654  78999999999999999999999998655433

>3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens}

Probab=99.97  E-value=2e-31  Score=272.82  Aligned_cols=171  Identities=28%  Similarity=0.381  Sum_probs=130.4

Q ss_pred             ccccCccCceEEEEEEEc---CCCEEEEEEeccCCCCchhhHHHHHHhhccCccceeEEEEEeec---------------
Q 039231          318 KYKLGQGGYGSVYKGKLL---DGSNVAVKVLNDSKGNGKEFINEVASISRTSHVNVVALLGFCLR---------------  379 (506)
Q Consensus       318 ~~~ig~G~~g~V~~~~~~---~~~~vavK~l~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~---------------  379 (506)
                      .++||+|+||.||+|+..   +++.||||++.... ....+.+|+++|++++||||+++++++..               
T Consensus        26 g~~lG~G~~g~Vy~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~lv~e~~~~  104 (405)
T 3rgf_A           26 GCKVGRGTYGHVYKAKRKDGKDDKDYALKQIEGTG-ISMSACREIALLRELKHPNVISLQKVFLSHADRKVWLLFDYAEH  104 (405)
T ss_dssp             SCCCC-----EEEEEEESSSSCCCCEEEEECSSSS-CCHHHHHHHHHHHHCCCTTBCCCCEEEEETTTTEEEEEEECCSE
T ss_pred             CcEeeecCCeEEEEEEEccCCCCeEEEEEEECCCC-CCHHHHHHHHHHHhcCCCCeeeEeeEEecCCCCeEEEEEeCCCC
Confidence            357999999999999975   47899999997543 33678899999999999999999988722               


Q ss_pred             ----------------------cchhhhHHHHHHHHHHHHhhcCCCCeEecCcCCCcEEE----CCCCcEEEeecCCCcc
Q 039231          380 ----------------------VAEELSSTIGIARGLEYLHLGCSTRILHFDIKPHNILL----DEDFCPKISDFGLAKI  433 (506)
Q Consensus       380 ----------------------~~~~l~i~~~i~~gl~~LH~~~~~~ivH~dlkp~Nill----~~~~~~ki~dfg~a~~  433 (506)
                                            +..++.++.||+.||+|||   +.+|+||||||+|||+    +.++.+||+|||+++.
T Consensus       105 ~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH---~~~ivH~Dlkp~NIll~~~~~~~~~~kl~Dfg~a~~  181 (405)
T 3rgf_A          105 DLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLH---ANWVLHRDLKPANILVMGEGPERGRVKIADMGFARL  181 (405)
T ss_dssp             EHHHHHHHHHHHC-------CCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEECCSSTTTTCEEECCTTCCC-
T ss_pred             CHHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHH---hCCEeCCCcCHHHeEEecCCCCCCcEEEEECCCcee
Confidence                                  2225668899999999999   8999999999999999    7788999999999987


Q ss_pred             ccCCCcc-eecccCCCCcccccccccccccCCCCccccHHHHHHHHHHHHcCCCCCCCCCC
Q 039231          434 CNRKESI-ISMTGARGTVGYIAPEVFCRNIGEVSYKSDVYNYGMMIFEMTGGRKNVDVVDN  493 (506)
Q Consensus       434 ~~~~~~~-~~~~~~~gt~~y~aPE~l~~~~~~~s~~~Dv~s~G~il~elltg~~pf~~~~~  493 (506)
                      ....... .......||+.|+|||++.+. ..++.++|||||||++|||++|+.||.....
T Consensus       182 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~~DiwSlG~il~ell~g~~pf~~~~~  241 (405)
T 3rgf_A          182 FNSPLKPLADLDPVVVTFWYRAPELLLGA-RHYTKAIDIWAIGCIFAELLTSEPIFHCRQE  241 (405)
T ss_dssp             ---------------CCCTTCCHHHHTTC-CSCCHHHHHHHHHHHHHHHHHSSCTTCCCC-
T ss_pred             cCCCCcccccCCCceecCcccCchhhcCC-CcccchhhhHHHHHHHHHHHhCCCCCCCccc
Confidence            6543211 122446789999999998653 3589999999999999999999999976544

>3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A

Probab=99.97  E-value=2.5e-31  Score=268.17  Aligned_cols=175  Identities=22%  Similarity=0.260  Sum_probs=138.7

Q ss_pred             hhhccccCccCceEEEEEEEcC------CCEEEEEEeccCCC------------CchhhHHHHHHhhccCccceeEEEEE
Q 039231          315 NSFKYKLGQGGYGSVYKGKLLD------GSNVAVKVLNDSKG------------NGKEFINEVASISRTSHVNVVALLGF  376 (506)
Q Consensus       315 ~~~~~~ig~G~~g~V~~~~~~~------~~~vavK~l~~~~~------------~~~~~~~E~~~l~~l~h~niv~l~g~  376 (506)
                      +.+.+.||+|+||.||+|++..      ++.||||++.....            ....+.+|+..+..++||||++++++
T Consensus        37 y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~  116 (364)
T 3op5_A           37 WKVGLPIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQIQKWIRTRKLKYLGVPKYWGS  116 (364)
T ss_dssp             EEEEEECCCC-CCEEEEEEECCSSCCCTTCSEEEEEEETTCHHHHHHHHHHHHHCCHHHHHHHHHHTTCSCCCSCCEEEE
T ss_pred             EEEEEEEecCCCeEEEEeeecCccccccccceEEEEeeccchhHHHHHHHHHhhhhhHHHHHHHHHhhccCCCCCeEEee
Confidence            3445789999999999998855      47899999865431            11234456667778889999999987


Q ss_pred             ee-------------------------------ccchhhhHHHHHHHHHHHHhhcCCCCeEecCcCCCcEEEC--CCCcE
Q 039231          377 CL-------------------------------RVAEELSSTIGIARGLEYLHLGCSTRILHFDIKPHNILLD--EDFCP  423 (506)
Q Consensus       377 ~~-------------------------------~~~~~l~i~~~i~~gl~~LH~~~~~~ivH~dlkp~Nill~--~~~~~  423 (506)
                      +.                               ++.+++.++.||+.||+|||   +++|+||||||+|||++  .++.+
T Consensus       117 ~~~~~~~~~~~~lv~e~~g~~L~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lH---~~~iiHrDlkp~Nill~~~~~~~~  193 (364)
T 3op5_A          117 GLHDKNGKSYRFMIMDRFGSDLQKIYEANAKRFSRKTVLQLSLRILDILEYIH---EHEYVHGDIKASNLLLNYKNPDQV  193 (364)
T ss_dssp             EEEEETTEEEEEEEEECEEEEHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEEESSCTTCE
T ss_pred             eeeccCCcceEEEEEeCCCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHH---HCCeEEecCCHHHEEEecCCCCeE
Confidence            62                               23346779999999999999   89999999999999998  88999


Q ss_pred             EEeecCCCccccCCCccee-----cccCCCCcccccccccccccCCCCccccHHHHHHHHHHHHcCCCCCCCCCCC
Q 039231          424 KISDFGLAKICNRKESIIS-----MTGARGTVGYIAPEVFCRNIGEVSYKSDVYNYGMMIFEMTGGRKNVDVVDNG  494 (506)
Q Consensus       424 ki~dfg~a~~~~~~~~~~~-----~~~~~gt~~y~aPE~l~~~~~~~s~~~Dv~s~G~il~elltg~~pf~~~~~~  494 (506)
                      ||+|||+++..........     .....||+.|+|||++.+.  .++.++||||||+++|||++|+.||......
T Consensus       194 kl~DFG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~~Di~slG~~l~el~~g~~Pf~~~~~~  267 (364)
T 3op5_A          194 YLVDYGLAYRYCPEGVHKAYAADPKRCHDGTIEFTSIDAHNGV--APSRRGDLEILGYCMIQWLTGHLPWEDNLKD  267 (364)
T ss_dssp             EECCCTTCEESSGGGCCCCSSCCSSCCCCCCTTTCCHHHHTTC--CCCHHHHHHHHHHHHHHHHHSCCTTGGGTTC
T ss_pred             EEEECCcceecccCCcccccccCcccccCCCCCccCHHHhCCC--CCCchhhHHHHHHHHHHHHhCCCCccccccC
Confidence            9999999987654332211     1234599999999998654  6899999999999999999999999965443

>3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens}

Probab=99.97  E-value=8.8e-32  Score=267.11  Aligned_cols=175  Identities=28%  Similarity=0.392  Sum_probs=138.3

Q ss_pred             hccccCccCceEEEEEEEc-CCCEEEEEEeccCCC--CchhhHHHHHHhhccCccceeEEEEEee---------------
Q 039231          317 FKYKLGQGGYGSVYKGKLL-DGSNVAVKVLNDSKG--NGKEFINEVASISRTSHVNVVALLGFCL---------------  378 (506)
Q Consensus       317 ~~~~ig~G~~g~V~~~~~~-~~~~vavK~l~~~~~--~~~~~~~E~~~l~~l~h~niv~l~g~~~---------------  378 (506)
                      +.++||+|+||.||+|+.. +++.||+|++.....  ....+.+|++++++++||||+++++++.               
T Consensus         6 ~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~   85 (324)
T 3mtl_A            6 KLDKLGEGTYATVYKGKSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTLVFEYLDKD   85 (324)
T ss_dssp             EEEEEEECSSEEEEEEEETTTCCEEEEEEECC------CCCCCCCHHHHSCCCCTTBCCEEEEEECSSCEEEEEECCSEE
T ss_pred             EEEEEcCCCCEEEEEEEECCCCcEEEEEEEecccccccchhHHHHHHHHHhcCCCCCCeeeeEEeeCCEEEEEecccccC
Confidence            3567999999999999986 589999999975432  2246778999999999999999999872               


Q ss_pred             ------------ccchhhhHHHHHHHHHHHHhhcCCCCeEecCcCCCcEEECCCCcEEEeecCCCccccCCCcceecccC
Q 039231          379 ------------RVAEELSSTIGIARGLEYLHLGCSTRILHFDIKPHNILLDEDFCPKISDFGLAKICNRKESIISMTGA  446 (506)
Q Consensus       379 ------------~~~~~l~i~~~i~~gl~~LH~~~~~~ivH~dlkp~Nill~~~~~~ki~dfg~a~~~~~~~~~~~~~~~  446 (506)
                                  ++.+...++.|++.||+|||   +.+|+||||||+|||++.++.+||+|||+++........  ....
T Consensus        86 l~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH---~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~~~~--~~~~  160 (324)
T 3mtl_A           86 LKQYLDDCGNIINMHNVKLFLFQLLRGLAYCH---RQKVLHRDLKPQNLLINERGELKLADFGLARAKSIPTKT--YDNE  160 (324)
T ss_dssp             HHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHH---HTTEEESSCCGGGEEECTTCCEEECSSSEEECC------------
T ss_pred             HHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH---HCCccCCCcCHHHEEECCCCCEEEccCcccccccCCccc--cccc
Confidence                        22335678899999999999   899999999999999999999999999999865433221  2345


Q ss_pred             CCCcccccccccccccCCCCccccHHHHHHHHHHHHcCCCCCCCCCCCcch
Q 039231          447 RGTVGYIAPEVFCRNIGEVSYKSDVYNYGMMIFEMTGGRKNVDVVDNGSTA  497 (506)
Q Consensus       447 ~gt~~y~aPE~l~~~~~~~s~~~Dv~s~G~il~elltg~~pf~~~~~~~~~  497 (506)
                      .+|+.|+|||.+.+. ..++.++||||||+++|||++|+.||...+..+..
T Consensus       161 ~~t~~y~aPE~~~~~-~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~  210 (324)
T 3mtl_A          161 VVTLWYRPPDILLGS-TDYSTQIDMWGVGCIFYEMATGRPLFPGSTVEEQL  210 (324)
T ss_dssp             --CGGGCCHHHHTTC-CCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHH
T ss_pred             cCcccccChhhhcCC-CCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHH
Confidence            689999999998653 46899999999999999999999999876554433

>3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} SCOP: d.144.1.7 PDB: 4fk3_A* 3c4c_A* 3c4d_A* 3idp_A* 4g9r_A* 3ii5_A* 4e26_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 3d4q_A* 4e4x_A* 4g9c_A* ...

Probab=99.97  E-value=6.1e-32  Score=263.73  Aligned_cols=182  Identities=33%  Similarity=0.581  Sum_probs=137.0

Q ss_pred             HHHhhhccccCccCceEEEEEEEcCCCEEEEEEeccCCCC---chhhHHHHHHhhccCccceeEEEEEe-----------
Q 039231          312 KMTNSFKYKLGQGGYGSVYKGKLLDGSNVAVKVLNDSKGN---GKEFINEVASISRTSHVNVVALLGFC-----------  377 (506)
Q Consensus       312 ~~~~~~~~~ig~G~~g~V~~~~~~~~~~vavK~l~~~~~~---~~~~~~E~~~l~~l~h~niv~l~g~~-----------  377 (506)
                      ...+.+.++||+|+||.||+|+..  ..+|+|+++.....   .+.+.+|++++++++||||++++++.           
T Consensus        23 ~~~y~~~~~lG~G~~g~Vy~~~~~--~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~lv~e~  100 (289)
T 3og7_A           23 DGQITVGQRIGSGSFGTVYKGKWH--GDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYSTAPQLAIVTQW  100 (289)
T ss_dssp             TTSCEEEEEEEECSSEEEEEEESS--SEEEEEEESCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSCEEEEEC
T ss_pred             ccceeeeeEecCCCCeEEEEEEEc--CceEEEEEeccCCCHHHHHHHHHHHHHHHhCCCCcEEEEEeeccCCccEEEEEe
Confidence            334455678999999999999864  36999999754433   25688999999999999999999876           


Q ss_pred             ----------------eccchhhhHHHHHHHHHHHHhhcCCCCeEecCcCCCcEEECCCCcEEEeecCCCccccCCCcce
Q 039231          378 ----------------LRVAEELSSTIGIARGLEYLHLGCSTRILHFDIKPHNILLDEDFCPKISDFGLAKICNRKESII  441 (506)
Q Consensus       378 ----------------~~~~~~l~i~~~i~~gl~~LH~~~~~~ivH~dlkp~Nill~~~~~~ki~dfg~a~~~~~~~~~~  441 (506)
                                      +++.+.+.++.|++.||+|||   +++|+||||||+||+++.++.+||+|||+++.........
T Consensus       101 ~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~lH---~~~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~  177 (289)
T 3og7_A          101 CEGSSLYHHLHASETKFEMKKLIDIARQTARGMDYLH---AKSIIHRDLKSNNIFLHEDNTVKIGDFGLATEKSRWSGSH  177 (289)
T ss_dssp             CCEEEHHHHHTTC---CCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEEETTTEEEECCCC------------
T ss_pred             cCCCcHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHH---hCCcccccCccceEEECCCCCEEEccceeccccccccccc
Confidence                            223346789999999999999   8999999999999999999999999999998665433322


Q ss_pred             ecccCCCCcccccccccccc-cCCCCccccHHHHHHHHHHHHcCCCCCCCCCCCcchh
Q 039231          442 SMTGARGTVGYIAPEVFCRN-IGEVSYKSDVYNYGMMIFEMTGGRKNVDVVDNGSTAL  498 (506)
Q Consensus       442 ~~~~~~gt~~y~aPE~l~~~-~~~~s~~~Dv~s~G~il~elltg~~pf~~~~~~~~~~  498 (506)
                      ......||+.|+|||.+... ...++.++||||||+++|||++|+.||......+...
T Consensus       178 ~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~  235 (289)
T 3og7_A          178 QFEQLSGSILWMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQII  235 (289)
T ss_dssp             ------CCCTTCCHHHHC----CCSCHHHHHHHHHHHHHHHHHSSCTTSSCCCHHHHH
T ss_pred             cccccCCCccccCchhhcccCCCCCCcccchHHHHHHHHHHHHCCCCccccchHHHHH
Confidence            33456789999999998521 2467889999999999999999999998766554433

>2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ...

Probab=99.97  E-value=1.2e-31  Score=270.61  Aligned_cols=171  Identities=32%  Similarity=0.407  Sum_probs=130.4

Q ss_pred             hccccCccCceEEEEEEEc-CCCEEEEEEeccCCCC---chhhHHHHHHhhccCccceeEEEEEee--------------
Q 039231          317 FKYKLGQGGYGSVYKGKLL-DGSNVAVKVLNDSKGN---GKEFINEVASISRTSHVNVVALLGFCL--------------  378 (506)
Q Consensus       317 ~~~~ig~G~~g~V~~~~~~-~~~~vavK~l~~~~~~---~~~~~~E~~~l~~l~h~niv~l~g~~~--------------  378 (506)
                      ..+.||+|+||.||+|+.. +|+.||||++......   .+.+.+|++++++++||||+++++++.              
T Consensus        33 ~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~~~~~lv  112 (367)
T 2fst_X           33 NLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLV  112 (367)
T ss_dssp             EEEECC----CCEEEEEETTTTEEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGCCCCEEE
T ss_pred             EeeEEeecCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCCccccCCeEEEE
Confidence            3467999999999999874 5899999999754332   357889999999999999999998762              


Q ss_pred             -----------------ccchhhhHHHHHHHHHHHHhhcCCCCeEecCcCCCcEEECCCCcEEEeecCCCccccCCCcce
Q 039231          379 -----------------RVAEELSSTIGIARGLEYLHLGCSTRILHFDIKPHNILLDEDFCPKISDFGLAKICNRKESII  441 (506)
Q Consensus       379 -----------------~~~~~l~i~~~i~~gl~~LH~~~~~~ivH~dlkp~Nill~~~~~~ki~dfg~a~~~~~~~~~~  441 (506)
                                       ++.+.+.++.||++||+|||   +.+|+||||||+|||++.++.+||+|||+++.....    
T Consensus       113 ~e~~~~~L~~~~~~~~l~~~~~~~i~~qi~~aL~~LH---~~givH~Dlkp~NIll~~~~~~kL~DFG~a~~~~~~----  185 (367)
T 2fst_X          113 THLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLARHTADE----  185 (367)
T ss_dssp             EECCCEECC-----CCCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEECTTCCEEECC--------------
T ss_pred             ecccCCCHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH---HCCeeeCCCCHhhEEECCCCCEEEeecccccccccc----
Confidence                             22335678999999999999   899999999999999999999999999999865432    


Q ss_pred             ecccCCCCcccccccccccccCCCCccccHHHHHHHHHHHHcCCCCCCCCCCCcc
Q 039231          442 SMTGARGTVGYIAPEVFCRNIGEVSYKSDVYNYGMMIFEMTGGRKNVDVVDNGST  496 (506)
Q Consensus       442 ~~~~~~gt~~y~aPE~l~~~~~~~s~~~Dv~s~G~il~elltg~~pf~~~~~~~~  496 (506)
                       .....+|+.|+|||++.+. ..++.++||||||+++|||++|+.||...+..+.
T Consensus       186 -~~~~~~t~~y~aPE~~~~~-~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~  238 (367)
T 2fst_X          186 -MTGYVATRWYRAPEIMLNW-MHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQ  238 (367)
T ss_dssp             ------CCCTTCCHHHHTTC-CSCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHH
T ss_pred             -CCCcCcCcCccChHHHcCC-cCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHH
Confidence             2446789999999998653 4689999999999999999999999987655433

>4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A*

Probab=99.97  E-value=8.6e-32  Score=279.04  Aligned_cols=172  Identities=29%  Similarity=0.384  Sum_probs=134.6

Q ss_pred             hhccccCccCceEEEEEEEc-CCCEEEEEEeccC----CCCchhhHHHHHHhhccCccceeEEEEEe-------------
Q 039231          316 SFKYKLGQGGYGSVYKGKLL-DGSNVAVKVLNDS----KGNGKEFINEVASISRTSHVNVVALLGFC-------------  377 (506)
Q Consensus       316 ~~~~~ig~G~~g~V~~~~~~-~~~~vavK~l~~~----~~~~~~~~~E~~~l~~l~h~niv~l~g~~-------------  377 (506)
                      .+.+.||+|+||.||+|+.. +++.||||+++..    ......+.+|++++++++||||+++++++             
T Consensus       151 ~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~~~lv~e~~  230 (446)
T 4ejn_A          151 EYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFVMEYA  230 (446)
T ss_dssp             EEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHC-------------CCCCCSCTTSCCEEEEEEETTEEEEEECCC
T ss_pred             EEeEEEeeCcCEEEEEEEEcCCCCEEEEEEEEhhhhhhhHHHHHHHHHHHHHHhCCCCeEeeEEEEEeeCCEEEEEEeeC
Confidence            34578999999999999975 5899999999742    33446788999999999999999999887             


Q ss_pred             --------------eccchhhhHHHHHHHHHHHHhhcCC-CCeEecCcCCCcEEECCCCcEEEeecCCCccccCCCccee
Q 039231          378 --------------LRVAEELSSTIGIARGLEYLHLGCS-TRILHFDIKPHNILLDEDFCPKISDFGLAKICNRKESIIS  442 (506)
Q Consensus       378 --------------~~~~~~l~i~~~i~~gl~~LH~~~~-~~ivH~dlkp~Nill~~~~~~ki~dfg~a~~~~~~~~~~~  442 (506)
                                    +++.+...++.||+.||+|||   + ++|+||||||+|||++.++.+||+|||+++.......  .
T Consensus       231 ~~~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH---~~~giiHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~~--~  305 (446)
T 4ejn_A          231 NGGELFFHLSRERVFSEDRARFYGAEIVSALDYLH---SEKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGA--T  305 (446)
T ss_dssp             SSCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHH---HHTCCCCCCCCGGGEEECSSSCEEECCCCCCCTTCC------
T ss_pred             CCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHh---hcCCEEECCCCHHHEEECCCCCEEEccCCCceeccCCCc--c
Confidence                          233346678999999999999   6 8999999999999999999999999999986443322  2


Q ss_pred             cccCCCCcccccccccccccCCCCccccHHHHHHHHHHHHcCCCCCCCCCCC
Q 039231          443 MTGARGTVGYIAPEVFCRNIGEVSYKSDVYNYGMMIFEMTGGRKNVDVVDNG  494 (506)
Q Consensus       443 ~~~~~gt~~y~aPE~l~~~~~~~s~~~Dv~s~G~il~elltg~~pf~~~~~~  494 (506)
                      .....||+.|+|||++.+.  .++.++||||||+++|||++|+.||...+..
T Consensus       306 ~~~~~gt~~y~aPE~~~~~--~~~~~~DiwslG~il~ell~g~~Pf~~~~~~  355 (446)
T 4ejn_A          306 MKTFCGTPEYLAPEVLEDN--DYGRAVDWWGLGVVMYEMMCGRLPFYNQDHE  355 (446)
T ss_dssp             -CCSSSCGGGCCHHHHHTS--CCCTHHHHHHHHHHHHHHHHSSCSSCCSSHH
T ss_pred             cccccCCccccCHhhcCCC--CCCCccchhhhHHHHHHHhhCCCCCCCCCHH
Confidence            3457899999999998553  7899999999999999999999999766543

>3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B

Probab=99.97  E-value=3.1e-31  Score=279.10  Aligned_cols=169  Identities=29%  Similarity=0.439  Sum_probs=143.4

Q ss_pred             cccCccCceEEEEEEEc-CCCEEEEEEeccC----CCCchhhHHHHHHhhccCccceeEEEEEee---------------
Q 039231          319 YKLGQGGYGSVYKGKLL-DGSNVAVKVLNDS----KGNGKEFINEVASISRTSHVNVVALLGFCL---------------  378 (506)
Q Consensus       319 ~~ig~G~~g~V~~~~~~-~~~~vavK~l~~~----~~~~~~~~~E~~~l~~l~h~niv~l~g~~~---------------  378 (506)
                      +.||+|+||.||+|+.. +|+.||+|++...    ....+.+.+|++++++++||||+++++++.               
T Consensus       191 ~~LG~G~fG~Vy~a~~~~tg~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~lVmE~~~gg  270 (543)
T 3c4z_A          191 RVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRFIVSLAYAFETKTDLCLVMTIMNGG  270 (543)
T ss_dssp             EEEEECSSSEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEECCCTTC
T ss_pred             EEEeeCCCeEEEEEEECCCCcEEEEEEEEhHHhhhhHHHHHHHHHHHHHHhcCCCCEeeEEEEEeeCCEEEEEEEeccCC
Confidence            56999999999999985 5899999999643    234467889999999999999999998761               


Q ss_pred             ----------------ccchhhhHHHHHHHHHHHHhhcCCCCeEecCcCCCcEEECCCCcEEEeecCCCccccCCCccee
Q 039231          379 ----------------RVAEELSSTIGIARGLEYLHLGCSTRILHFDIKPHNILLDEDFCPKISDFGLAKICNRKESIIS  442 (506)
Q Consensus       379 ----------------~~~~~l~i~~~i~~gl~~LH~~~~~~ivH~dlkp~Nill~~~~~~ki~dfg~a~~~~~~~~~~~  442 (506)
                                      ++...+.++.||+.||+|||   +++|+||||||+|||++.++.+||+|||+++........  
T Consensus       271 ~L~~~l~~~~~~~~~l~e~~~~~~~~qi~~aL~~LH---~~gIvHrDLKP~NILl~~~g~vkL~DFGla~~~~~~~~~--  345 (543)
T 3c4z_A          271 DIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLH---QRNIIYRDLKPENVLLDDDGNVRISDLGLAVELKAGQTK--  345 (543)
T ss_dssp             BHHHHHHTSSTTSCSCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEECTTSCEEECCCTTCEECCTTCCC--
T ss_pred             CHHHHHHHhhcccccccHHHHHHHHHHHHHHHHHHH---HcCCcccCCChHHEEEeCCCCEEEeecceeeeccCCCcc--
Confidence                            12235567899999999999   899999999999999999999999999999876544322  


Q ss_pred             cccCCCCcccccccccccccCCCCccccHHHHHHHHHHHHcCCCCCCCCCCC
Q 039231          443 MTGARGTVGYIAPEVFCRNIGEVSYKSDVYNYGMMIFEMTGGRKNVDVVDNG  494 (506)
Q Consensus       443 ~~~~~gt~~y~aPE~l~~~~~~~s~~~Dv~s~G~il~elltg~~pf~~~~~~  494 (506)
                      .....||+.|+|||++.+.  .++.++|||||||++|||++|+.||......
T Consensus       346 ~~~~~GT~~Y~APE~l~~~--~~~~~~DiwSlGvilyelltG~~PF~~~~~~  395 (543)
T 3c4z_A          346 TKGYAGTPGFMAPELLLGE--EYDFSVDYFALGVTLYEMIAARGPFRARGEK  395 (543)
T ss_dssp             BCCCCSCTTTSCHHHHTTC--CBCTHHHHHHHHHHHHHHHHSSCSSCCTTCC
T ss_pred             cccccCCccccChhhhcCC--CCChHHhcCcchHHHHHHHhCCCCCCCCccc
Confidence            2345799999999999654  7899999999999999999999999876543

>3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B*

Probab=99.97  E-value=3e-31  Score=270.02  Aligned_cols=181  Identities=18%  Similarity=0.213  Sum_probs=146.6

Q ss_pred             hhccccCcc--CceEEEEEEEc-CCCEEEEEEeccCCCC---chhhHHHHHHhhccCccceeEEEEEee-----------
Q 039231          316 SFKYKLGQG--GYGSVYKGKLL-DGSNVAVKVLNDSKGN---GKEFINEVASISRTSHVNVVALLGFCL-----------  378 (506)
Q Consensus       316 ~~~~~ig~G--~~g~V~~~~~~-~~~~vavK~l~~~~~~---~~~~~~E~~~l~~l~h~niv~l~g~~~-----------  378 (506)
                      .+.++||+|  +||.||+|+.. +++.||||+++.....   .+.+.+|++++++++|||||++++++.           
T Consensus        28 ~~~~~lG~G~~~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~  107 (389)
T 3gni_B           28 ELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEACSNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELWVVTSF  107 (389)
T ss_dssp             EEEEEEEEETTTTEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred             EEEecccCCcCCceEEEEEEEcCCCCEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCCCcEeEEEEECCEEEEEEEc
Confidence            345789999  99999999986 5899999999754322   256788999999999999999999872           


Q ss_pred             ------------------ccchhhhHHHHHHHHHHHHhhcCCCCeEecCcCCCcEEECCCCcEEEeecCCCccccCCCcc
Q 039231          379 ------------------RVAEELSSTIGIARGLEYLHLGCSTRILHFDIKPHNILLDEDFCPKISDFGLAKICNRKESI  440 (506)
Q Consensus       379 ------------------~~~~~l~i~~~i~~gl~~LH~~~~~~ivH~dlkp~Nill~~~~~~ki~dfg~a~~~~~~~~~  440 (506)
                                        ++.+.+.++.||+.||+|||   +++|+||||||+|||++.++.+||+|||.+.........
T Consensus       108 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH---~~~ivHrDlkp~NIll~~~~~~kl~dfg~~~~~~~~~~~  184 (389)
T 3gni_B          108 MAYGSAKDLICTHFMDGMNELAIAYILQGVLKALDYIH---HMGYVHRSVKASHILISVDGKVYLSGLRSNLSMISHGQR  184 (389)
T ss_dssp             CTTCBHHHHHHHTCTTCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTTCCEEECCGGGCEECEETTEE
T ss_pred             cCCCCHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEEcCCCCEEEcccccceeecccccc
Confidence                              22335678999999999999   899999999999999999999999999988654322111


Q ss_pred             e-----ecccCCCCcccccccccccccCCCCccccHHHHHHHHHHHHcCCCCCCCCCCCcchhh
Q 039231          441 I-----SMTGARGTVGYIAPEVFCRNIGEVSYKSDVYNYGMMIFEMTGGRKNVDVVDNGSTALD  499 (506)
Q Consensus       441 ~-----~~~~~~gt~~y~aPE~l~~~~~~~s~~~Dv~s~G~il~elltg~~pf~~~~~~~~~~~  499 (506)
                      .     ......||+.|+|||++.+....++.++|||||||++|||++|+.||...+..+...+
T Consensus       185 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~  248 (389)
T 3gni_B          185 QRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQMLLE  248 (389)
T ss_dssp             CSCBCCCCTTCTTTGGGSCHHHHSTTSSCBCTHHHHHHHHHHHHHHHHSSCTTTTCCSTTHHHH
T ss_pred             ccccccccccccccccccCHHHHhccCCCCCcHhHHHHHHHHHHHHHHCCCCCCCCCHHHHHHH
Confidence            0     1123478999999999976434789999999999999999999999987665554433

>3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A*

Probab=99.97  E-value=3.1e-31  Score=273.70  Aligned_cols=170  Identities=25%  Similarity=0.371  Sum_probs=136.3

Q ss_pred             hhccccCccCceEEEEEEEc-CCCEEEEEEeccCCCC---chhhHHHHHHhhccCccceeEEEEEee-------------
Q 039231          316 SFKYKLGQGGYGSVYKGKLL-DGSNVAVKVLNDSKGN---GKEFINEVASISRTSHVNVVALLGFCL-------------  378 (506)
Q Consensus       316 ~~~~~ig~G~~g~V~~~~~~-~~~~vavK~l~~~~~~---~~~~~~E~~~l~~l~h~niv~l~g~~~-------------  378 (506)
                      .+.+.||+|+||.||+|+.. +++.||||+++.....   .+.+.+|++++++++||||+++++++.             
T Consensus        29 ~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~~~~lv  108 (432)
T 3n9x_A           29 IIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVNRMFEDLIDCKRILREITILNRLKSDYIIRLYDLIIPDDLLKFDELYIV  108 (432)
T ss_dssp             EEEEEEEEETTEEEEEEEETTTTEEEEEEEECSTTTSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCCCEEEE
T ss_pred             EEEEEEeecCCEEEEEEEECCCCcEEEEEEeCchhcChHHHHHHHHHHHHHHHcCCCCcceEEEEEecCCCCcCCeEEEE
Confidence            34568999999999999975 4789999999764333   367889999999999999999998762             


Q ss_pred             ------------------ccchhhhHHHHHHHHHHHHhhcCCCCeEecCcCCCcEEECCCCcEEEeecCCCccccCCCcc
Q 039231          379 ------------------RVAEELSSTIGIARGLEYLHLGCSTRILHFDIKPHNILLDEDFCPKISDFGLAKICNRKESI  440 (506)
Q Consensus       379 ------------------~~~~~l~i~~~i~~gl~~LH~~~~~~ivH~dlkp~Nill~~~~~~ki~dfg~a~~~~~~~~~  440 (506)
                                        ++.+.+.++.||+.||+|||   +.+|+||||||+|||++.++.+||+|||+++........
T Consensus       109 ~e~~~~~L~~~~~~~~~l~~~~~~~i~~qil~aL~~LH---~~givHrDlkp~NILl~~~~~~kL~DFGla~~~~~~~~~  185 (432)
T 3n9x_A          109 LEIADSDLKKLFKTPIFLTEEHIKTILYNLLLGENFIH---ESGIIHRDLKPANCLLNQDCSVKVCDFGLARTINSEKDT  185 (432)
T ss_dssp             EECCSEEHHHHHHSSCCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEECTTCCEEECCCTTCEEC------
T ss_pred             EecCCcCHHHHHhccCCCCHHHHHHHHHHHHHHHHHHH---HCCCCCCCCCHHHeEECCCCCEEEccCCCcccccccccc
Confidence                              23346678999999999999   899999999999999999999999999999876543221


Q ss_pred             --------------------eecccCCCCcccccccccccccCCCCccccHHHHHHHHHHHHcCCCCCC
Q 039231          441 --------------------ISMTGARGTVGYIAPEVFCRNIGEVSYKSDVYNYGMMIFEMTGGRKNVD  489 (506)
Q Consensus       441 --------------------~~~~~~~gt~~y~aPE~l~~~~~~~s~~~Dv~s~G~il~elltg~~pf~  489 (506)
                                          .......||+.|+|||++... ..++.++||||+||++|||++|..||.
T Consensus       186 ~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~-~~~~~~~DiwSlG~il~ell~g~~p~~  253 (432)
T 3n9x_A          186 NIVNDLEENEEPGPHNKNLKKQLTSHVVTRWYRAPELILLQ-ENYTKSIDIWSTGCIFAELLNMLQSHI  253 (432)
T ss_dssp             -------------------------CCCCCTTCCHHHHTTC-SCCCTHHHHHHHHHHHHHHHTTCTTTC
T ss_pred             cccccccccccccccccchhccccCCCCCccccCHHHHhcC-CCCCcccccchHHHHHHHHHhcccccc
Confidence                                113557789999999987443 468999999999999999998555443

>4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens}

Probab=99.97  E-value=2.8e-31  Score=261.65  Aligned_cols=176  Identities=25%  Similarity=0.349  Sum_probs=140.8

Q ss_pred             hccccCccCceEEEEEEEcC-CCEEEEEEeccCCCC---chhhHHHHHHhhccCccceeEEEEEe---------------
Q 039231          317 FKYKLGQGGYGSVYKGKLLD-GSNVAVKVLNDSKGN---GKEFINEVASISRTSHVNVVALLGFC---------------  377 (506)
Q Consensus       317 ~~~~ig~G~~g~V~~~~~~~-~~~vavK~l~~~~~~---~~~~~~E~~~l~~l~h~niv~l~g~~---------------  377 (506)
                      +.++||+|+||.||+|+... ++.||||++......   .+.+.+|++++++++||||+++++++               
T Consensus         7 ~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~   86 (311)
T 4agu_A            7 KIGKIGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVIKKIALREIRMLKQLKHPNLVNLLEVFRRKRRLHLVFEYCDH   86 (311)
T ss_dssp             EEEEEEECSSEEEEEEEETTTCCEEEEEEECCCCC-HHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECCSE
T ss_pred             EeeEEeecCCeEEEEEEeCCCCcEEEEEEeeccccchHHHHHHHHHHHHHHhCCCCCccchhheeecCCeEEEEEEeCCC
Confidence            35689999999999999864 899999998665433   25678999999999999999999987               


Q ss_pred             ------------eccchhhhHHHHHHHHHHHHhhcCCCCeEecCcCCCcEEECCCCcEEEeecCCCccccCCCcceeccc
Q 039231          378 ------------LRVAEELSSTIGIARGLEYLHLGCSTRILHFDIKPHNILLDEDFCPKISDFGLAKICNRKESIISMTG  445 (506)
Q Consensus       378 ------------~~~~~~l~i~~~i~~gl~~LH~~~~~~ivH~dlkp~Nill~~~~~~ki~dfg~a~~~~~~~~~~~~~~  445 (506)
                                  +++...+.++.|++.||+|||   +++|+||||||+||+++.++.+||+|||+++........  ...
T Consensus        87 ~~l~~~~~~~~~~~~~~~~~i~~~l~~~l~~lH---~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~--~~~  161 (311)
T 4agu_A           87 TVLHELDRYQRGVPEHLVKSITWQTLQAVNFCH---KHNCIHRDVKPENILITKHSVIKLCDFGFARLLTGPSDY--YDD  161 (311)
T ss_dssp             EHHHHHHHTSSCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTTSCEEECCCTTCEECC----------
T ss_pred             chHHHHHhhhcCCCHHHHHHHHHHHHHHHHHHH---HCCCcCCCCChhhEEEcCCCCEEEeeCCCchhccCcccc--cCC
Confidence                        223336678999999999999   899999999999999999999999999999876543322  234


Q ss_pred             CCCCcccccccccccccCCCCccccHHHHHHHHHHHHcCCCCCCCCCCCcchh
Q 039231          446 ARGTVGYIAPEVFCRNIGEVSYKSDVYNYGMMIFEMTGGRKNVDVVDNGSTAL  498 (506)
Q Consensus       446 ~~gt~~y~aPE~l~~~~~~~s~~~Dv~s~G~il~elltg~~pf~~~~~~~~~~  498 (506)
                      ..+|+.|+|||.+.+. ..++.++||||||+++|||++|+.||......+...
T Consensus       162 ~~~~~~y~aPE~~~~~-~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~  213 (311)
T 4agu_A          162 EVATRWYRSPELLVGD-TQYGPPVDVWAIGCVFAELLSGVPLWPGKSDVDQLY  213 (311)
T ss_dssp             ----GGGCCHHHHHTC-SCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHH
T ss_pred             CcCCccccChHHHhcC-CCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHH
Confidence            5789999999998653 467999999999999999999999998776554443

>1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7

Probab=99.97  E-value=1.6e-31  Score=268.72  Aligned_cols=178  Identities=25%  Similarity=0.294  Sum_probs=143.8

Q ss_pred             hhccccCccCceEEEEEEE----cCCCEEEEEEeccC-----CCCchhhHHHHHHhhcc-CccceeEEEEEe--------
Q 039231          316 SFKYKLGQGGYGSVYKGKL----LDGSNVAVKVLNDS-----KGNGKEFINEVASISRT-SHVNVVALLGFC--------  377 (506)
Q Consensus       316 ~~~~~ig~G~~g~V~~~~~----~~~~~vavK~l~~~-----~~~~~~~~~E~~~l~~l-~h~niv~l~g~~--------  377 (506)
                      .+.+.||+|+||.||+|+.    .+++.||||+++..     ....+.+.+|++++.++ +||||+++++++        
T Consensus        57 ~~~~~lG~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~l  136 (355)
T 1vzo_A           57 ELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTETKLHL  136 (355)
T ss_dssp             EEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEETTEEEE
T ss_pred             EEEEEeccCCCEEEEEEEEcccCCCCeEEEEEEEeHHHhhhhhhHHHHHHHHHHHHHHccCCCceeEEEEEEeeCceEEE
Confidence            4457899999999999987    36899999998643     23346788899999999 699999999876        


Q ss_pred             -------------------eccchhhhHHHHHHHHHHHHhhcCCCCeEecCcCCCcEEECCCCcEEEeecCCCccccCCC
Q 039231          378 -------------------LRVAEELSSTIGIARGLEYLHLGCSTRILHFDIKPHNILLDEDFCPKISDFGLAKICNRKE  438 (506)
Q Consensus       378 -------------------~~~~~~l~i~~~i~~gl~~LH~~~~~~ivH~dlkp~Nill~~~~~~ki~dfg~a~~~~~~~  438 (506)
                                         +++.+.+.++.||+.||+|||   +++|+||||||+|||++.++.+||+|||+++......
T Consensus       137 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH---~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~~~  213 (355)
T 1vzo_A          137 ILDYINGGELFTHLSQRERFTEHEVQIYVGEIVLALEHLH---KLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFVADE  213 (355)
T ss_dssp             EECCCCSCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEECTTSCEEESCSSEEEECCGGG
T ss_pred             EeecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCHHHEEECCCCcEEEeeCCCCeecccCC
Confidence                               223335678899999999999   8999999999999999999999999999998664333


Q ss_pred             cceecccCCCCcccccccccccccCCCCccccHHHHHHHHHHHHcCCCCCCCCCCCcch
Q 039231          439 SIISMTGARGTVGYIAPEVFCRNIGEVSYKSDVYNYGMMIFEMTGGRKNVDVVDNGSTA  497 (506)
Q Consensus       439 ~~~~~~~~~gt~~y~aPE~l~~~~~~~s~~~Dv~s~G~il~elltg~~pf~~~~~~~~~  497 (506)
                      .. ......||+.|+|||++.+....++.++||||||+++|||++|+.||.........
T Consensus       214 ~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~  271 (355)
T 1vzo_A          214 TE-RAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQ  271 (355)
T ss_dssp             GG-GGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCCH
T ss_pred             CC-cccCcccCcCccChhhhcCCCCCCCchhhHHHHHHHHHHHHHCCCCCccCCccchH
Confidence            22 12345789999999999654345789999999999999999999999876554443

>1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7

Probab=99.97  E-value=2.4e-31  Score=266.41  Aligned_cols=176  Identities=28%  Similarity=0.339  Sum_probs=144.2

Q ss_pred             hhccccCccCceEEEEEEEc-CCCEEEEEEeccCCC------CchhhHHHHHHhhccCccceeEEEEEe-----------
Q 039231          316 SFKYKLGQGGYGSVYKGKLL-DGSNVAVKVLNDSKG------NGKEFINEVASISRTSHVNVVALLGFC-----------  377 (506)
Q Consensus       316 ~~~~~ig~G~~g~V~~~~~~-~~~~vavK~l~~~~~------~~~~~~~E~~~l~~l~h~niv~l~g~~-----------  377 (506)
                      .+.+.||+|+||.||+|+.. +|+.||||+++....      ..+.+.+|++++++++||||+++++++           
T Consensus        13 ~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e   92 (346)
T 1ua2_A           13 EKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSNISLVFD   92 (346)
T ss_dssp             CEEEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTTCCEEEEE
T ss_pred             EEEeEEeecCCEEEEEEEECCCCcEEEEEEEecCCcchhhhhhhHHHHHHHHHHhhCCCCCCCeEEEEEeeCCceEEEEE
Confidence            34578999999999999975 489999999964321      135688999999999999999999987           


Q ss_pred             ----------------eccchhhhHHHHHHHHHHHHhhcCCCCeEecCcCCCcEEECCCCcEEEeecCCCccccCCCcce
Q 039231          378 ----------------LRVAEELSSTIGIARGLEYLHLGCSTRILHFDIKPHNILLDEDFCPKISDFGLAKICNRKESII  441 (506)
Q Consensus       378 ----------------~~~~~~l~i~~~i~~gl~~LH~~~~~~ivH~dlkp~Nill~~~~~~ki~dfg~a~~~~~~~~~~  441 (506)
                                      +++.+.+.++.|++.||+|||   +.+|+||||||+|||++.++.+||+|||+++........ 
T Consensus        93 ~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH---~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~~~~-  168 (346)
T 1ua2_A           93 FMETDLEVIIKDNSLVLTPSHIKAYMLMTLQGLEYLH---QHWILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNRA-  168 (346)
T ss_dssp             CCSEEHHHHHTTCCSSCCSSHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEECTTCCEEECCCGGGSTTTSCCCC-
T ss_pred             cCCCCHHHHHHhcCcCCCHHHHHHHHHHHHHHHHHHH---HCCEECCCCCHHHEEEcCCCCEEEEecccceeccCCccc-
Confidence                            234456789999999999999   899999999999999999999999999999876543321 


Q ss_pred             ecccCCCCcccccccccccccCCCCccccHHHHHHHHHHHHcCCCCCCCCCCCcch
Q 039231          442 SMTGARGTVGYIAPEVFCRNIGEVSYKSDVYNYGMMIFEMTGGRKNVDVVDNGSTA  497 (506)
Q Consensus       442 ~~~~~~gt~~y~aPE~l~~~~~~~s~~~Dv~s~G~il~elltg~~pf~~~~~~~~~  497 (506)
                       .....+|+.|+|||.+.+. ..++.++||||||+++|||++|..||...++.+..
T Consensus       169 -~~~~~~t~~y~aPE~~~~~-~~~~~~~DiwslG~il~ell~g~~~~~~~~~~~~~  222 (346)
T 1ua2_A          169 -YTHQVVTRWYRAPELLFGA-RMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQL  222 (346)
T ss_dssp             -CCCSCCCCTTCCHHHHTTC-SCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHH
T ss_pred             -CCcccccccccCchHhhCC-CCCCchhhhHhHHHHHHHHHHCCCCCCCCCHHHHH
Confidence             2446789999999998643 35789999999999999999999999876544433

>3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 4gsb_A* 4gt3_A* 4gva_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3zu7_A 3zuv_A* 3o71_A 3r63_A 3c9w_A* 2y9q_A* 4fmq_A* ...

Probab=99.97  E-value=3e-31  Score=267.58  Aligned_cols=181  Identities=25%  Similarity=0.341  Sum_probs=147.9

Q ss_pred             hhccccCccCceEEEEEEEc-CCCEEEEEEeccCCCC--chhhHHHHHHhhccCccceeEEEEEee--------------
Q 039231          316 SFKYKLGQGGYGSVYKGKLL-DGSNVAVKVLNDSKGN--GKEFINEVASISRTSHVNVVALLGFCL--------------  378 (506)
Q Consensus       316 ~~~~~ig~G~~g~V~~~~~~-~~~~vavK~l~~~~~~--~~~~~~E~~~l~~l~h~niv~l~g~~~--------------  378 (506)
                      .+.+.||+|+||.||+|+.. +++.||||++......  .+.+.+|++++.+++||||+++++++.              
T Consensus        30 ~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~iv~  109 (364)
T 3qyz_A           30 TNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDVYIVQ  109 (364)
T ss_dssp             EEEEEEEECSSEEEEEEEETTTTEEEEEEEECCTTCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCCEEEEE
T ss_pred             EEEEEeecCCCeEEEEEEECCCCeEEEEEEeccccCcHHHHHHHHHHHHHHhcCCCCCccceeEEecCCccccceEEEEE
Confidence            34568999999999999875 5889999999754322  267889999999999999999988762              


Q ss_pred             ----------------ccchhhhHHHHHHHHHHHHhhcCCCCeEecCcCCCcEEECCCCcEEEeecCCCccccCCCccee
Q 039231          379 ----------------RVAEELSSTIGIARGLEYLHLGCSTRILHFDIKPHNILLDEDFCPKISDFGLAKICNRKESIIS  442 (506)
Q Consensus       379 ----------------~~~~~l~i~~~i~~gl~~LH~~~~~~ivH~dlkp~Nill~~~~~~ki~dfg~a~~~~~~~~~~~  442 (506)
                                      ++.+.+.++.|++.||+|||   +++|+||||||+|||++.++.+||+|||+++..........
T Consensus       110 e~~~~~L~~~l~~~~~~~~~~~~i~~qi~~aL~~LH---~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~~~~~~  186 (364)
T 3qyz_A          110 DLMETDLYKLLKTQHLSNDHICYFLYQILRGLKYIH---SANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTG  186 (364)
T ss_dssp             ECCSEEHHHHHHHCCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEECTTCCEEECCCTTCEECCGGGCBCC
T ss_pred             cccCcCHHHHHHhCCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCChHhEEECCCCCEEEEeCcceEecCCCCCccc
Confidence                            23346678999999999999   89999999999999999999999999999987654332211


Q ss_pred             -cccCCCCcccccccccccccCCCCccccHHHHHHHHHHHHcCCCCCCCCCCCcchhhh
Q 039231          443 -MTGARGTVGYIAPEVFCRNIGEVSYKSDVYNYGMMIFEMTGGRKNVDVVDNGSTALDL  500 (506)
Q Consensus       443 -~~~~~gt~~y~aPE~l~~~~~~~s~~~Dv~s~G~il~elltg~~pf~~~~~~~~~~~~  500 (506)
                       .....||+.|+|||++.+. ..++.++||||||+++|||++|+.||...+..+....+
T Consensus       187 ~~~~~~gt~~y~aPE~~~~~-~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i  244 (364)
T 3qyz_A          187 FLTEYVATRWYRAPEIMLNS-KGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHI  244 (364)
T ss_dssp             TTCCCCSCGGGCCHHHHHTB-CSCSTHHHHHHHHHHHHHHHHSSCSSCCSSGGGHHHHH
T ss_pred             cccccccccCCCCCHHhcCC-CCCCcchhHHHHHHHHHHHHHCCCCCCCCChHHHHHHH
Confidence             2345789999999987543 35899999999999999999999999877655544433

>2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens}

Probab=99.97  E-value=1.9e-31  Score=267.53  Aligned_cols=171  Identities=28%  Similarity=0.416  Sum_probs=128.5

Q ss_pred             hhccccCccCceEEEEEEEcC-CCEEEEEEeccCCCCchhhHHHHHHhhccCccceeEEEEEe-----------------
Q 039231          316 SFKYKLGQGGYGSVYKGKLLD-GSNVAVKVLNDSKGNGKEFINEVASISRTSHVNVVALLGFC-----------------  377 (506)
Q Consensus       316 ~~~~~ig~G~~g~V~~~~~~~-~~~vavK~l~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~-----------------  377 (506)
                      .+.+.||+|+||.||+|+... ++.||||+++... ..+.+.+|++++++++||||+++++++                 
T Consensus        56 ~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~-~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~~  134 (349)
T 2w4o_A           56 EVESELGRGATSIVYRCKQKGTQKPYALKVLKKTV-DKKIVRTEIGVLLRLSHPNIIKLKEIFETPTEISLVLELVTGGE  134 (349)
T ss_dssp             EEEEEEEECSSEEEEEEEETTTCCEEEEEEEEC-----------CHHHHHCCCTTBCCEEEEEECSSEEEEEECCCCSCB
T ss_pred             EEeeEEeeCCCEEEEEEEECCCCcEEEEEEeccch-hHHHHHHHHHHHHhCCCCCCcceeeeEecCCeEEEEEEeCCCCC
Confidence            345689999999999999864 7899999997653 346788999999999999999999987                 


Q ss_pred             ----------eccchhhhHHHHHHHHHHHHhhcCCCCeEecCcCCCcEEECC---CCcEEEeecCCCccccCCCcceecc
Q 039231          378 ----------LRVAEELSSTIGIARGLEYLHLGCSTRILHFDIKPHNILLDE---DFCPKISDFGLAKICNRKESIISMT  444 (506)
Q Consensus       378 ----------~~~~~~l~i~~~i~~gl~~LH~~~~~~ivH~dlkp~Nill~~---~~~~ki~dfg~a~~~~~~~~~~~~~  444 (506)
                                +++.+.+.++.|++.||+|||   +.+|+||||||+|||++.   ++.+||+|||+++.......   ..
T Consensus       135 L~~~l~~~~~~~~~~~~~i~~qi~~~L~~LH---~~~ivH~Dikp~NIll~~~~~~~~~kl~Dfg~a~~~~~~~~---~~  208 (349)
T 2w4o_A          135 LFDRIVEKGYYSERDAADAVKQILEAVAYLH---ENGIVHRDLKPENLLYATPAPDAPLKIADFGLSKIVEHQVL---MK  208 (349)
T ss_dssp             HHHHHTTCSSCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEESSSSTTCCEEECCCC---------------
T ss_pred             HHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH---HCCeEecCCCcccEEEecCCCCCCEEEccCccccccCcccc---cc
Confidence                      233346778999999999999   899999999999999975   88999999999987654322   23


Q ss_pred             cCCCCcccccccccccccCCCCccccHHHHHHHHHHHHcCCCCCCCCCCCc
Q 039231          445 GARGTVGYIAPEVFCRNIGEVSYKSDVYNYGMMIFEMTGGRKNVDVVDNGS  495 (506)
Q Consensus       445 ~~~gt~~y~aPE~l~~~~~~~s~~~Dv~s~G~il~elltg~~pf~~~~~~~  495 (506)
                      ...||+.|+|||++.+.  .++.++||||||+++|||++|+.||......+
T Consensus       209 ~~~gt~~y~aPE~~~~~--~~~~~~DiwslG~il~ell~g~~pf~~~~~~~  257 (349)
T 2w4o_A          209 TVCGTPGYCAPEILRGC--AYGPEVDMWSVGIITYILLCGFEPFYDERGDQ  257 (349)
T ss_dssp             ----CGGGSCHHHHTTC--CCCTHHHHHHHHHHHHHHHHSSCTTCCTTCHH
T ss_pred             cccCCCCccCHHHhcCC--CCCcccchHHHHHHHHHHHhCCCCCCCCcccH
Confidence            46789999999998654  68999999999999999999999997665443

>3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II}

Probab=99.97  E-value=3.5e-31  Score=268.99  Aligned_cols=175  Identities=24%  Similarity=0.292  Sum_probs=142.8

Q ss_pred             hhccccCccCceEEEEEEE-cCCCEEEEEEeccCCCCchhhHHHHHHhhccCccceeEEEEEeec---------------
Q 039231          316 SFKYKLGQGGYGSVYKGKL-LDGSNVAVKVLNDSKGNGKEFINEVASISRTSHVNVVALLGFCLR---------------  379 (506)
Q Consensus       316 ~~~~~ig~G~~g~V~~~~~-~~~~~vavK~l~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~---------------  379 (506)
                      .+.+.||+|+||.||+|+. .+|+.||||++....   +...+|++++++++||||+++++++..               
T Consensus        10 ~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~~~~~~---~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~~~~~~~~~~~   86 (383)
T 3eb0_A           10 SLGKTLGTGSFGIVCEVFDIESGKRFALKKVLQDP---RYKNRELDIMKVLDHVNIIKLVDYFYTTGDEEPKPPQPPDDH   86 (383)
T ss_dssp             EEEEEEECC-CEEEEEEEETTTCCEEEEEEEECCT---TSCCHHHHHHTTCCCTTBCCEEEEEEEC--------------
T ss_pred             EEEEEEEeccCEEEEEEEECCCCCEEEEEEEecCc---chHHHHHHHHHHcCCCCccchhheeeecCccccccccccccc
Confidence            3457899999999999987 468999999987543   334579999999999999999987622               


Q ss_pred             -----------------------------------------------------cchhhhHHHHHHHHHHHHhhcCCCCeE
Q 039231          380 -----------------------------------------------------VAEELSSTIGIARGLEYLHLGCSTRIL  406 (506)
Q Consensus       380 -----------------------------------------------------~~~~l~i~~~i~~gl~~LH~~~~~~iv  406 (506)
                                                                           +.....++.||++||+|||   +.+|+
T Consensus        87 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH---~~gi~  163 (383)
T 3eb0_A           87 NKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVPDTLHKVLKSFIRSGRSIPMNLISIYIYQLFRAVGFIH---SLGIC  163 (383)
T ss_dssp             -----------------------CCEEEEEECCCSEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHH---TTTEE
T ss_pred             ccccccccccccccccccccCCCceEEEEEEecCCccHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH---HCcCc
Confidence                                                                 1124557889999999999   99999


Q ss_pred             ecCcCCCcEEEC-CCCcEEEeecCCCccccCCCcceecccCCCCcccccccccccccCCCCccccHHHHHHHHHHHHcCC
Q 039231          407 HFDIKPHNILLD-EDFCPKISDFGLAKICNRKESIISMTGARGTVGYIAPEVFCRNIGEVSYKSDVYNYGMMIFEMTGGR  485 (506)
Q Consensus       407 H~dlkp~Nill~-~~~~~ki~dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~s~~~Dv~s~G~il~elltg~  485 (506)
                      ||||||+|||++ .++.+||+|||+++........   ....+|+.|+|||.+.+. ..++.++||||+|+++|||++|+
T Consensus       164 H~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~~~~~---~~~~~t~~y~aPE~~~~~-~~~~~~~DiwslG~il~ell~g~  239 (383)
T 3eb0_A          164 HRDIKPQNLLVNSKDNTLKLCDFGSAKKLIPSEPS---VAYICSRFYRAPELMLGA-TEYTPSIDLWSIGCVFGELILGK  239 (383)
T ss_dssp             CSCCCGGGEEEETTTTEEEECCCTTCEECCTTSCC---CCCCCCSSCCCHHHHTTC-SSCCTHHHHHHHHHHHHHHHHSS
T ss_pred             cCccCHHHEEEcCCCCcEEEEECCCCcccCCCCCC---cCcccCCCccCHHHhcCC-CCCCcchhhhhHHHHHHHHHhCC
Confidence            999999999997 6889999999999876544432   446789999999998653 35899999999999999999999


Q ss_pred             CCCCCCCCCcchhhh
Q 039231          486 KNVDVVDNGSTALDL  500 (506)
Q Consensus       486 ~pf~~~~~~~~~~~~  500 (506)
                      .||...+..+...++
T Consensus       240 ~pf~~~~~~~~~~~i  254 (383)
T 3eb0_A          240 PLFSGETSIDQLVRI  254 (383)
T ss_dssp             CSSCCSSHHHHHHHH
T ss_pred             CCCCCCChHHHHHHH
Confidence            999877655544444

>2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus}

Probab=99.97  E-value=3.3e-31  Score=275.53  Aligned_cols=173  Identities=28%  Similarity=0.425  Sum_probs=145.8

Q ss_pred             hhccccCccCceEEEEEEEc-CCCEEEEEEeccC----CCCchhhHHHHHHhhccCccceeEEEEEe-------------
Q 039231          316 SFKYKLGQGGYGSVYKGKLL-DGSNVAVKVLNDS----KGNGKEFINEVASISRTSHVNVVALLGFC-------------  377 (506)
Q Consensus       316 ~~~~~ig~G~~g~V~~~~~~-~~~~vavK~l~~~----~~~~~~~~~E~~~l~~l~h~niv~l~g~~-------------  377 (506)
                      .+.+.||+|+||.||+|+.. +|+.||||++...    ....+.+.+|+++++.++||||+++++++             
T Consensus        19 ~l~~~LG~G~fg~V~~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~lv~E~~   98 (476)
T 2y94_A           19 ILGDTLGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHIIKLYQVISTPSDIFMVMEYV   98 (476)
T ss_dssp             EEEEEEECCSSSCEEEEEETTTCCEEEEEEEEHHHHHHTTTHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEECC
T ss_pred             EEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEeCC
Confidence            34567999999999999986 6899999999643    23346789999999999999999999887             


Q ss_pred             --------------eccchhhhHHHHHHHHHHHHhhcCCCCeEecCcCCCcEEECCCCcEEEeecCCCccccCCCcceec
Q 039231          378 --------------LRVAEELSSTIGIARGLEYLHLGCSTRILHFDIKPHNILLDEDFCPKISDFGLAKICNRKESIISM  443 (506)
Q Consensus       378 --------------~~~~~~l~i~~~i~~gl~~LH~~~~~~ivH~dlkp~Nill~~~~~~ki~dfg~a~~~~~~~~~~~~  443 (506)
                                    +++.+.+.++.||+.||+|||   +.+|+||||||+|||++.++.+||+|||+++.......   .
T Consensus        99 ~gg~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH---~~givHrDLkp~NIll~~~~~vkL~DFG~a~~~~~~~~---~  172 (476)
T 2y94_A           99 SGGELFDYICKNGRLDEKESRRLFQQILSGVDYCH---RHMVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEF---L  172 (476)
T ss_dssp             SSEEHHHHTTSSSSCCHHHHHHHHHHHHHHHHHHH---TTTEECSCCSGGGEEECTTCCEEECCCSSCEECCTTCC---B
T ss_pred             CCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH---HCCCCcccccHHHEEEecCCCeEEEeccchhhcccccc---c
Confidence                          233446779999999999999   99999999999999999999999999999987655432   2


Q ss_pred             ccCCCCcccccccccccccCCCCccccHHHHHHHHHHHHcCCCCCCCCCCCc
Q 039231          444 TGARGTVGYIAPEVFCRNIGEVSYKSDVYNYGMMIFEMTGGRKNVDVVDNGS  495 (506)
Q Consensus       444 ~~~~gt~~y~aPE~l~~~~~~~s~~~Dv~s~G~il~elltg~~pf~~~~~~~  495 (506)
                      ....||+.|+|||++.+. ...+.++||||||+++|||++|+.||+..+..+
T Consensus       173 ~~~~gt~~y~aPE~~~~~-~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~  223 (476)
T 2y94_A          173 RTSCGSPNYAAPEVISGR-LYAGPEVDIWSSGVILYALLCGTLPFDDDHVPT  223 (476)
T ss_dssp             CCCCSCSTTCCHHHHTTC-CBCSHHHHHHHHHHHHHHHHHSSCSSCCSSSHH
T ss_pred             cccCCCcCeEChhhccCC-CCCCCcceehhhHHHHHHHhhCCCCCCCCCHHH
Confidence            456799999999998654 234789999999999999999999998665433

>3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus}

Probab=99.97  E-value=1.2e-31  Score=265.78  Aligned_cols=178  Identities=28%  Similarity=0.444  Sum_probs=133.2

Q ss_pred             hhhccccCccCceEEEEEEEcCC----CEEEEEEeccCC---CCchhhHHHHHHhhccCccceeEEEEEee---------
Q 039231          315 NSFKYKLGQGGYGSVYKGKLLDG----SNVAVKVLNDSK---GNGKEFINEVASISRTSHVNVVALLGFCL---------  378 (506)
Q Consensus       315 ~~~~~~ig~G~~g~V~~~~~~~~----~~vavK~l~~~~---~~~~~~~~E~~~l~~l~h~niv~l~g~~~---------  378 (506)
                      +.+.+.||+|+||.||+|++...    ..||||+++...   ...+++.+|++++++++||||+++++++.         
T Consensus        25 y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~  104 (323)
T 3qup_A           25 FTLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEFDHPHVAKLVGVSLRSRAKGRLP  104 (323)
T ss_dssp             CEEEEEEEEETTEEEEEEEC-------CEEEEEEC------CHHHHHHHHHHHHHTTCCCTTBCCCCEEEECC-------
T ss_pred             eEEeceecccCCeEEEEEEEcccCCcceeEEEEEecccccCHHHHHHHHHHHHHHHHCCCCceehhhceeeccccccCCC
Confidence            34467899999999999987543    279999997542   23367899999999999999999988651         


Q ss_pred             ------------------------------ccchhhhHHHHHHHHHHHHhhcCCCCeEecCcCCCcEEECCCCcEEEeec
Q 039231          379 ------------------------------RVAEELSSTIGIARGLEYLHLGCSTRILHFDIKPHNILLDEDFCPKISDF  428 (506)
Q Consensus       379 ------------------------------~~~~~l~i~~~i~~gl~~LH~~~~~~ivH~dlkp~Nill~~~~~~ki~df  428 (506)
                                                    ++.+.+.++.|++.||+|||   +++|+||||||+|||+++++.+||+||
T Consensus       105 ~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH---~~~ivH~Dikp~NIli~~~~~~kl~Df  181 (323)
T 3qup_A          105 IPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIACGMEYLS---SRNFIHRDLAARNCMLAEDMTVCVADF  181 (323)
T ss_dssp             CEEEEEECCTTCBHHHHHHHHHC---CCCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEECTTSCEEECCC
T ss_pred             ccEEEEEeccCCcHHHHHHhhhccccccccCHHHHHHHHHHHHHHHHHHH---cCCcccCCCCcceEEEcCCCCEEEeec
Confidence                                          12235678999999999999   899999999999999999999999999


Q ss_pred             CCCccccCCCcceecccCCCCcccccccccccccCCCCccccHHHHHHHHHHHHc-CCCCCCCCCCCcch
Q 039231          429 GLAKICNRKESIISMTGARGTVGYIAPEVFCRNIGEVSYKSDVYNYGMMIFEMTG-GRKNVDVVDNGSTA  497 (506)
Q Consensus       429 g~a~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~s~~~Dv~s~G~il~ellt-g~~pf~~~~~~~~~  497 (506)
                      |+++...............+++.|+|||.+.+.  .++.++||||||+++|||++ |+.||......+..
T Consensus       182 g~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~--~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~~~  249 (323)
T 3qup_A          182 GLSRKIYSGDYYRQGCASKLPVKWLALESLADN--LYTVHSDVWAFGVTMWEIMTRGQTPYAGIENAEIY  249 (323)
T ss_dssp             CC-----------------CCGGGCCHHHHHHC--CCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHH
T ss_pred             cccccccccccccccccccCcccccCchhhcCC--CCCCccchhhHHHHHHHHHhCCCCCccccChHHHH
Confidence            999876554433333445678899999998654  78999999999999999999 99999876654443

>3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens}

Probab=99.97  E-value=6.9e-32  Score=272.58  Aligned_cols=177  Identities=29%  Similarity=0.438  Sum_probs=142.0

Q ss_pred             HhhhccccCccCceEEEEEEEc------CCCEEEEEEeccCCC--CchhhHHHHHHhhccCccceeEEEEEeec------
Q 039231          314 TNSFKYKLGQGGYGSVYKGKLL------DGSNVAVKVLNDSKG--NGKEFINEVASISRTSHVNVVALLGFCLR------  379 (506)
Q Consensus       314 ~~~~~~~ig~G~~g~V~~~~~~------~~~~vavK~l~~~~~--~~~~~~~E~~~l~~l~h~niv~l~g~~~~------  379 (506)
                      .+.+.++||+|+||.||+|++.      +++.||||+++....  ...++.+|+.++++++||||+++++++.+      
T Consensus        72 ~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~l  151 (367)
T 3l9p_A           72 NITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQSLPRFI  151 (367)
T ss_dssp             GEEEEEECCCCSSSCEEEEEECC-----CCEEEEEEECCSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEE
T ss_pred             HeEEeeEeeeCCCEEEEEEEEccCCCCCcceeEEEEecccccChhhHHHHHHHHHHHHhCCCCCCCeEEEEEecCCCCEE
Confidence            3445678999999999999853      367899999975432  23568899999999999999999998721      


Q ss_pred             ----------------------------cchhhhHHHHHHHHHHHHhhcCCCCeEecCcCCCcEEECCCC---cEEEeec
Q 039231          380 ----------------------------VAEELSSTIGIARGLEYLHLGCSTRILHFDIKPHNILLDEDF---CPKISDF  428 (506)
Q Consensus       380 ----------------------------~~~~l~i~~~i~~gl~~LH~~~~~~ivH~dlkp~Nill~~~~---~~ki~df  428 (506)
                                                  +.+.+.++.||+.||+|||   +++|+||||||+|||++.++   .+||+||
T Consensus       152 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH---~~~ivHrDlkp~NIll~~~~~~~~~kL~DF  228 (367)
T 3l9p_A          152 LLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLE---ENHFIHRDIAARNCLLTCPGPGRVAKIGDF  228 (367)
T ss_dssp             EEECCTTEEHHHHHHHHSCCSSSCCCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEESCSSTTCCEEECCC
T ss_pred             EEEeCCCCCHHHHHHhhccccCccccccHHHHHHHHHHHHHHHHHHH---hCCeeCCCCChhhEEEecCCCCceEEECCC
Confidence                                        2235678999999999999   89999999999999999554   5999999


Q ss_pred             CCCccccCCCcceecccCCCCcccccccccccccCCCCccccHHHHHHHHHHHHc-CCCCCCCCCCCc
Q 039231          429 GLAKICNRKESIISMTGARGTVGYIAPEVFCRNIGEVSYKSDVYNYGMMIFEMTG-GRKNVDVVDNGS  495 (506)
Q Consensus       429 g~a~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~s~~~Dv~s~G~il~ellt-g~~pf~~~~~~~  495 (506)
                      |+++...............+|+.|+|||++.+.  .++.++||||||+++|||++ |+.||......+
T Consensus       229 G~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~--~~~~~~DvwslG~il~ellt~g~~pf~~~~~~~  294 (367)
T 3l9p_A          229 GMARDIYRAGYYRKGGCAMLPVKWMPPEAFMEG--IFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQE  294 (367)
T ss_dssp             HHHHHHHHHSSCTTCCGGGSCGGGCCHHHHHHC--CCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHH
T ss_pred             ccccccccccccccCCCcCCcccEECHHHhcCC--CCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHH
Confidence            999865433222222345678999999998654  78999999999999999998 999998765443

>3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A

Probab=99.97  E-value=2.4e-31  Score=288.46  Aligned_cols=176  Identities=24%  Similarity=0.340  Sum_probs=146.3

Q ss_pred             hhccccCccCceEEEEEEEc-CCCEEEEEEeccC----CCCchhhHHHHHHhhcc-CccceeEEEEEe------------
Q 039231          316 SFKYKLGQGGYGSVYKGKLL-DGSNVAVKVLNDS----KGNGKEFINEVASISRT-SHVNVVALLGFC------------  377 (506)
Q Consensus       316 ~~~~~ig~G~~g~V~~~~~~-~~~~vavK~l~~~----~~~~~~~~~E~~~l~~l-~h~niv~l~g~~------------  377 (506)
                      .+.++||+|+||.||+|+.. +++.||||+++..    ....+.+.+|.+++..+ +||+|+++++++            
T Consensus       344 ~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~l~~~~~~~~~~~lV~E~  423 (674)
T 3pfq_A          344 NFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYFVMEY  423 (674)
T ss_dssp             EEEEESSBTTTBCEEEEEESSSCCEEEEEEEEHHHHHHTTTTHHHHHHHHHHTCTTCCTTBCCEEEECBCSSEEEEEEEC
T ss_pred             EEEEEEccCCCEEEEEEEECCCCcEEEEEEEeccccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEEEeCCEEEEEEeC
Confidence            34578999999999999975 4889999999742    34456788999999988 699999998876            


Q ss_pred             ---------------eccchhhhHHHHHHHHHHHHhhcCCCCeEecCcCCCcEEECCCCcEEEeecCCCccccCCCccee
Q 039231          378 ---------------LRVAEELSSTIGIARGLEYLHLGCSTRILHFDIKPHNILLDEDFCPKISDFGLAKICNRKESIIS  442 (506)
Q Consensus       378 ---------------~~~~~~l~i~~~i~~gl~~LH~~~~~~ivH~dlkp~Nill~~~~~~ki~dfg~a~~~~~~~~~~~  442 (506)
                                     +++.+++.++.||+.||+|||   +++|+||||||+||||+.++.+||+|||+++.......  .
T Consensus       424 ~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH---~~gIiHrDLKp~NILl~~~g~ikL~DFGla~~~~~~~~--~  498 (674)
T 3pfq_A          424 VNGGDLMYHIQQVGRFKEPHAVFYAAEIAIGLFFLQ---SKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENIWDGV--T  498 (674)
T ss_dssp             CCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHH---HTSEECCCCCSTTEEECSSSCEEECCCTTCEECCCTTC--C
T ss_pred             cCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH---hCCeEeccCChhhEEEcCCCcEEEeecceeeccccCCc--c
Confidence                           233446778999999999999   89999999999999999999999999999986433322  2


Q ss_pred             cccCCCCcccccccccccccCCCCccccHHHHHHHHHHHHcCCCCCCCCCCCcchh
Q 039231          443 MTGARGTVGYIAPEVFCRNIGEVSYKSDVYNYGMMIFEMTGGRKNVDVVDNGSTAL  498 (506)
Q Consensus       443 ~~~~~gt~~y~aPE~l~~~~~~~s~~~Dv~s~G~il~elltg~~pf~~~~~~~~~~  498 (506)
                      .....||+.|+|||++.+.  .++.++||||||++||||++|+.||...+..+...
T Consensus       499 ~~~~~GT~~Y~APE~l~~~--~~~~~~DvwSlGvilyelltG~~Pf~~~~~~~~~~  552 (674)
T 3pfq_A          499 TKTFCGTPDYIAPEIIAYQ--PYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQ  552 (674)
T ss_dssp             BCCCCSCSSSCCHHHHTCC--CBSTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHH
T ss_pred             cccccCCCcccCHhhhcCC--CCCccceEechHHHHHHHHcCCCCCCCCCHHHHHH
Confidence            3457899999999999654  78999999999999999999999998765544333

>3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens}

Probab=99.97  E-value=1.7e-31  Score=265.36  Aligned_cols=176  Identities=31%  Similarity=0.530  Sum_probs=135.6

Q ss_pred             hhccccCccCceEEEEEEEcC-CCE----EEEEEeccC--CCCchhhHHHHHHhhccCccceeEEEEEee----------
Q 039231          316 SFKYKLGQGGYGSVYKGKLLD-GSN----VAVKVLNDS--KGNGKEFINEVASISRTSHVNVVALLGFCL----------  378 (506)
Q Consensus       316 ~~~~~ig~G~~g~V~~~~~~~-~~~----vavK~l~~~--~~~~~~~~~E~~~l~~l~h~niv~l~g~~~----------  378 (506)
                      .+.++||+|+||.||+|++.. ++.    ||+|.+...  ....+++.+|++++++++||||+++++++.          
T Consensus        18 ~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~iK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~v~~~   97 (327)
T 3lzb_A           18 KKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTSTVQLITQL   97 (327)
T ss_dssp             EEEEEEEECSSEEEEEEEECCTTCSCCEEEEEEEECCCSSCCCHHHHHHHHHHHTTCCBTTBCCCCEEEESSSEEEEECC
T ss_pred             eEEEEeeeCCCeEEEEEEEcCCCceEEEEEEEEeeccccCHHHHHHHHHHHHHHHhCCCCCeeEEEEEEecCCceEEEEe
Confidence            335679999999999998743 443    577777543  234478999999999999999999999872          


Q ss_pred             -----------------ccchhhhHHHHHHHHHHHHhhcCCCCeEecCcCCCcEEECCCCcEEEeecCCCccccCCCcce
Q 039231          379 -----------------RVAEELSSTIGIARGLEYLHLGCSTRILHFDIKPHNILLDEDFCPKISDFGLAKICNRKESII  441 (506)
Q Consensus       379 -----------------~~~~~l~i~~~i~~gl~~LH~~~~~~ivH~dlkp~Nill~~~~~~ki~dfg~a~~~~~~~~~~  441 (506)
                                       .+.+.+.++.|++.||+|||   +++|+||||||+|||++.++.+||+|||+++.........
T Consensus        98 ~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH---~~~ivH~Dikp~NIl~~~~~~~kL~DfG~a~~~~~~~~~~  174 (327)
T 3lzb_A           98 MPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLE---DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEY  174 (327)
T ss_dssp             CSSCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEEEETTEEEECCTTC-----------
T ss_pred             cCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHh---hCCCcCCCCCHHHEEEcCCCCEEEccCcceeEccCccccc
Confidence                             23346778999999999999   8999999999999999999999999999998775544333


Q ss_pred             ecccCCCCcccccccccccccCCCCccccHHHHHHHHHHHHc-CCCCCCCCCCCcc
Q 039231          442 SMTGARGTVGYIAPEVFCRNIGEVSYKSDVYNYGMMIFEMTG-GRKNVDVVDNGST  496 (506)
Q Consensus       442 ~~~~~~gt~~y~aPE~l~~~~~~~s~~~Dv~s~G~il~ellt-g~~pf~~~~~~~~  496 (506)
                      ......+|+.|+|||.+.+.  .++.++||||||+++|||++ |+.||......+.
T Consensus       175 ~~~~~~~t~~y~aPE~~~~~--~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~~  228 (327)
T 3lzb_A          175 HAEGGKVPIKWMALESILHR--IYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEI  228 (327)
T ss_dssp             -----CCCGGGSCHHHHHHC--CCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGH
T ss_pred             cccCCCccccccCHHHHcCC--CCChHHHHHHHHHHHHHHHHCCCCCCCCCCHHHH
Confidence            33445678899999998654  78999999999999999999 9999987655443

>3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A*

Probab=99.97  E-value=7.3e-31  Score=254.23  Aligned_cols=173  Identities=21%  Similarity=0.330  Sum_probs=146.3

Q ss_pred             hhhccccCccCceEEEEEEEcC-CCEEEEEEeccC-CCCchhhHHHHHHhhccCccceeEEEEEe---------------
Q 039231          315 NSFKYKLGQGGYGSVYKGKLLD-GSNVAVKVLNDS-KGNGKEFINEVASISRTSHVNVVALLGFC---------------  377 (506)
Q Consensus       315 ~~~~~~ig~G~~g~V~~~~~~~-~~~vavK~l~~~-~~~~~~~~~E~~~l~~l~h~niv~l~g~~---------------  377 (506)
                      +.+.+.||+|+||.||+|+... +..+|+|++... ....+.+.+|++++++++||||+++++++               
T Consensus        11 y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~   90 (277)
T 3f3z_A           11 YTLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVEDVDRFKQEIEIMKSLDHPNIIRLYETFEDNTDIYLVMELCTG   90 (277)
T ss_dssp             EEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEECCCS
T ss_pred             EEeeeEEeecCCEEEEEEEeCCCCcEEEEEeehhhccchHHHHHHHHHHHHhCCCCCEeeEEEEEecCCeEEEEEeccCC
Confidence            4456789999999999999865 778999999754 34457899999999999999999999987               


Q ss_pred             ------------eccchhhhHHHHHHHHHHHHhhcCCCCeEecCcCCCcEEE---CCCCcEEEeecCCCccccCCCccee
Q 039231          378 ------------LRVAEELSSTIGIARGLEYLHLGCSTRILHFDIKPHNILL---DEDFCPKISDFGLAKICNRKESIIS  442 (506)
Q Consensus       378 ------------~~~~~~l~i~~~i~~gl~~LH~~~~~~ivH~dlkp~Nill---~~~~~~ki~dfg~a~~~~~~~~~~~  442 (506)
                                  +++.+.+.++.|++.||+|||   +++|+||||||+||++   +.++.+||+|||++........   
T Consensus        91 ~~L~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH---~~~i~H~dlkp~Nil~~~~~~~~~~~l~Dfg~~~~~~~~~~---  164 (277)
T 3f3z_A           91 GELFERVVHKRVFRESDAARIMKDVLSAVAYCH---KLNVAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKPGKM---  164 (277)
T ss_dssp             CBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEESSSSTTCCEEECCCTTCEECCTTSC---
T ss_pred             CcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHH---HCCccCCCCCHHHEEEecCCCCCcEEEEecccceeccCccc---
Confidence                        233446779999999999999   8999999999999999   7889999999999987654432   


Q ss_pred             cccCCCCcccccccccccccCCCCccccHHHHHHHHHHHHcCCCCCCCCCCCcc
Q 039231          443 MTGARGTVGYIAPEVFCRNIGEVSYKSDVYNYGMMIFEMTGGRKNVDVVDNGST  496 (506)
Q Consensus       443 ~~~~~gt~~y~aPE~l~~~~~~~s~~~Dv~s~G~il~elltg~~pf~~~~~~~~  496 (506)
                      .....+|+.|+|||.+.+   .++.++||||||+++|||++|+.||....+.+.
T Consensus       165 ~~~~~~t~~y~aPE~~~~---~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~  215 (277)
T 3f3z_A          165 MRTKVGTPYYVSPQVLEG---LYGPECDEWSAGVMMYVLLCGYPPFSAPTDSEV  215 (277)
T ss_dssp             BCCCCSCTTTCCHHHHTT---CBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHH
T ss_pred             hhccCCCCCccChHHhcc---cCCchhhehhHHHHHHHHHHCCCCCCCCCHHHH
Confidence            244678999999999843   589999999999999999999999987654443

>3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A*

Probab=99.97  E-value=1.5e-31  Score=257.42  Aligned_cols=174  Identities=29%  Similarity=0.543  Sum_probs=147.0

Q ss_pred             hhccccCccCceEEEEEEEcCCCEEEEEEeccCCCCchhhHHHHHHhhccCccceeEEEEEee-----------------
Q 039231          316 SFKYKLGQGGYGSVYKGKLLDGSNVAVKVLNDSKGNGKEFINEVASISRTSHVNVVALLGFCL-----------------  378 (506)
Q Consensus       316 ~~~~~ig~G~~g~V~~~~~~~~~~vavK~l~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~-----------------  378 (506)
                      .+.+.||+|+||.||+|+..+++.||+|++.......+++.+|++++++++||||+++++++.                 
T Consensus        11 ~~~~~lg~G~~g~V~~~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L   90 (267)
T 3t9t_A           11 TFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAMSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVTEFMEHGCL   90 (267)
T ss_dssp             EEEEEEEEETTEEEEEEEETTTEEEEEEEECTTTBCHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSCEEEECCCTTCBH
T ss_pred             eeeeEecCCCceeEEEEEecCCCeEEEEEccccCCCHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCeEEEEeCCCCCcH
Confidence            345679999999999999988899999999877666688999999999999999999999872                 


Q ss_pred             -----------ccchhhhHHHHHHHHHHHHhhcCCCCeEecCcCCCcEEECCCCcEEEeecCCCccccCCCcceecccCC
Q 039231          379 -----------RVAEELSSTIGIARGLEYLHLGCSTRILHFDIKPHNILLDEDFCPKISDFGLAKICNRKESIISMTGAR  447 (506)
Q Consensus       379 -----------~~~~~l~i~~~i~~gl~~LH~~~~~~ivH~dlkp~Nill~~~~~~ki~dfg~a~~~~~~~~~~~~~~~~  447 (506)
                                 ++.+.+.++.|++.||+|||   +++++|+||||+||+++.++.+||+|||+++........ ......
T Consensus        91 ~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~~~~~-~~~~~~  166 (267)
T 3t9t_A           91 SDYLRTQRGLFAAETLLGMCLDVCEGMAYLE---EACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYT-SSTGTK  166 (267)
T ss_dssp             HHHHHHTTTCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSSCCGGGEEECGGGCEEECCTTGGGGBCCHHHH-STTSTT
T ss_pred             HHHHhhCcccCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCchheEEECCCCCEEEccccccccccccccc-cccccc
Confidence                       23335678999999999999   899999999999999999999999999999865432211 123455


Q ss_pred             CCcccccccccccccCCCCccccHHHHHHHHHHHHc-CCCCCCCCCCCc
Q 039231          448 GTVGYIAPEVFCRNIGEVSYKSDVYNYGMMIFEMTG-GRKNVDVVDNGS  495 (506)
Q Consensus       448 gt~~y~aPE~l~~~~~~~s~~~Dv~s~G~il~ellt-g~~pf~~~~~~~  495 (506)
                      +++.|+|||.+...  .++.++||||||+++|||++ |+.||......+
T Consensus       167 ~~~~y~aPE~~~~~--~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~  213 (267)
T 3t9t_A          167 FPVKWASPEVFSFS--RYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSE  213 (267)
T ss_dssp             CCGGGCCHHHHHHC--CCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHH
T ss_pred             ccccccChhhhcCC--CccchhchhhhHHHHHHHhccCCCCCCCCCHHH
Confidence            67899999998543  68999999999999999999 999998755433

>1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7

Probab=99.97  E-value=2.8e-31  Score=269.56  Aligned_cols=171  Identities=26%  Similarity=0.398  Sum_probs=143.6

Q ss_pred             hhhccccCccCceEEEEEEEc-CCCEEEEEEeccCCC-CchhhHHHHHHhhccCccceeEEEEEe---------------
Q 039231          315 NSFKYKLGQGGYGSVYKGKLL-DGSNVAVKVLNDSKG-NGKEFINEVASISRTSHVNVVALLGFC---------------  377 (506)
Q Consensus       315 ~~~~~~ig~G~~g~V~~~~~~-~~~~vavK~l~~~~~-~~~~~~~E~~~l~~l~h~niv~l~g~~---------------  377 (506)
                      +.+.+.||+|+||.||+|+.. +++.+|+|++..... ....+.+|++++.+++||||+++++++               
T Consensus        53 y~i~~~LG~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~lv~E~~~g  132 (387)
T 1kob_A           53 YDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILEFLSG  132 (387)
T ss_dssp             EEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCSTTBCCEEEEEECSSEEEEEEECCCC
T ss_pred             eEEEEEEecCCCEEEEEEEECCCCCEEEEEEecccchhhHHHHHHHHHHHHhCCCcCCCeEEEEEEeCCEEEEEEEcCCC
Confidence            344578999999999999985 588999999975432 335788999999999999999999987               


Q ss_pred             -------------eccchhhhHHHHHHHHHHHHhhcCCCCeEecCcCCCcEEECC--CCcEEEeecCCCccccCCCccee
Q 039231          378 -------------LRVAEELSSTIGIARGLEYLHLGCSTRILHFDIKPHNILLDE--DFCPKISDFGLAKICNRKESIIS  442 (506)
Q Consensus       378 -------------~~~~~~l~i~~~i~~gl~~LH~~~~~~ivH~dlkp~Nill~~--~~~~ki~dfg~a~~~~~~~~~~~  442 (506)
                                   +++.+.+.++.||+.||+|||   +++|+||||||+|||++.  ++.+||+|||+++........  
T Consensus       133 g~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH---~~givHrDlkp~NIll~~~~~~~vkL~DFG~a~~~~~~~~~--  207 (387)
T 1kob_A          133 GELFDRIAAEDYKMSEAEVINYMRQACEGLKHMH---EHSIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDEIV--  207 (387)
T ss_dssp             CBHHHHTTCTTCCBCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEESSTTCCCEEECCCTTCEECCTTSCE--
T ss_pred             CcHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHH---hCCeeecccchHHeEEecCCCCceEEEecccceecCCCcce--
Confidence                         223346778999999999999   899999999999999974  577999999999877654332  


Q ss_pred             cccCCCCcccccccccccccCCCCccccHHHHHHHHHHHHcCCCCCCCCCC
Q 039231          443 MTGARGTVGYIAPEVFCRNIGEVSYKSDVYNYGMMIFEMTGGRKNVDVVDN  493 (506)
Q Consensus       443 ~~~~~gt~~y~aPE~l~~~~~~~s~~~Dv~s~G~il~elltg~~pf~~~~~  493 (506)
                       ....||+.|+|||++.+.  .++.++||||||+++|||++|+.||...+.
T Consensus       208 -~~~~gt~~y~aPE~~~~~--~~~~~~DiwSlG~il~elltg~~Pf~~~~~  255 (387)
T 1kob_A          208 -KVTTATAEFAAPEIVDRE--PVGFYTDMWAIGVLGYVLLSGLSPFAGEDD  255 (387)
T ss_dssp             -EEECSSGGGCCHHHHTTC--CBCHHHHHHHHHHHHHHHHHSCCSSCCSSH
T ss_pred             -eeeccCCCccCchhccCC--CCCCcccEeeHhHHHHHHHhCCCCCCCCCH
Confidence             335689999999998654  689999999999999999999999987544

>2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ...

Probab=99.97  E-value=9.6e-31  Score=253.02  Aligned_cols=177  Identities=29%  Similarity=0.387  Sum_probs=146.5

Q ss_pred             hhhccccCccCceEEEEEEEc-CCCEEEEEEeccCC--CCchhhHHHHHHhhccCccceeEEEEEee-------------
Q 039231          315 NSFKYKLGQGGYGSVYKGKLL-DGSNVAVKVLNDSK--GNGKEFINEVASISRTSHVNVVALLGFCL-------------  378 (506)
Q Consensus       315 ~~~~~~ig~G~~g~V~~~~~~-~~~~vavK~l~~~~--~~~~~~~~E~~~l~~l~h~niv~l~g~~~-------------  378 (506)
                      +.+.+.||+|+||.||+|+.. +++.||||++....  ...+.+.+|++++++++||||+++++++.             
T Consensus         9 y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~   88 (276)
T 2yex_A            9 WDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLEYCS   88 (276)
T ss_dssp             EEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGCTTHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEECCT
T ss_pred             eEEEEEeecCCCcEEEEEEECCCCcEEEEEEeeeccchhhhHHHHHHHHHHHhcCCCCceeeeeEEEcCCEEEEEEEecC
Confidence            344578999999999999986 58999999996543  23367899999999999999999998772             


Q ss_pred             --------------ccchhhhHHHHHHHHHHHHhhcCCCCeEecCcCCCcEEECCCCcEEEeecCCCccccCCCcceecc
Q 039231          379 --------------RVAEELSSTIGIARGLEYLHLGCSTRILHFDIKPHNILLDEDFCPKISDFGLAKICNRKESIISMT  444 (506)
Q Consensus       379 --------------~~~~~l~i~~~i~~gl~~LH~~~~~~ivH~dlkp~Nill~~~~~~ki~dfg~a~~~~~~~~~~~~~  444 (506)
                                    +..+.+.++.|++.||+|||   +++++|+||||+||+++.++.+||+|||++.............
T Consensus        89 ~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~  165 (276)
T 2yex_A           89 GGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLH---GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLN  165 (276)
T ss_dssp             TEEGGGGSBTTTBCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECTTCCEEECCCTTCEECEETTEECCBC
T ss_pred             CCcHHHHHhhccCCCHHHHHHHHHHHHHHHHHHH---hCCeeccCCChHHEEEccCCCEEEeeCCCccccCCCcchhccc
Confidence                          23346779999999999999   8999999999999999999999999999998765433222234


Q ss_pred             cCCCCcccccccccccccCCCCccccHHHHHHHHHHHHcCCCCCCCCCCCc
Q 039231          445 GARGTVGYIAPEVFCRNIGEVSYKSDVYNYGMMIFEMTGGRKNVDVVDNGS  495 (506)
Q Consensus       445 ~~~gt~~y~aPE~l~~~~~~~s~~~Dv~s~G~il~elltg~~pf~~~~~~~  495 (506)
                      ...+++.|+|||.+.+. ...+.++||||||+++|||++|+.||.......
T Consensus       166 ~~~~~~~y~aPE~~~~~-~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~  215 (276)
T 2yex_A          166 KMCGTLPYVAPELLKRR-EFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSC  215 (276)
T ss_dssp             CCCSCGGGCCGGGGTCS-SBCHHHHHHHHHHHHHHHHHHSSCCCSCSCTTS
T ss_pred             CCccccCccChHHHhcC-CCCCCcchHHHHHHHHHHHHhCCCCCCCCchHH
Confidence            56789999999998653 234778999999999999999999998766543

>2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ...

Probab=99.97  E-value=2.6e-31  Score=268.76  Aligned_cols=171  Identities=29%  Similarity=0.301  Sum_probs=134.7

Q ss_pred             hccccCccCceEEEEEEEc-CCCEEEEEEeccCCCC---chhhHHHHHHhhccCccceeEEEEEee--------------
Q 039231          317 FKYKLGQGGYGSVYKGKLL-DGSNVAVKVLNDSKGN---GKEFINEVASISRTSHVNVVALLGFCL--------------  378 (506)
Q Consensus       317 ~~~~ig~G~~g~V~~~~~~-~~~~vavK~l~~~~~~---~~~~~~E~~~l~~l~h~niv~l~g~~~--------------  378 (506)
                      +.+.||+|+||.||+|+.. +++.||||++......   .+.+.+|+.++++++||||+++++++.              
T Consensus        29 ~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~~~lv  108 (371)
T 2xrw_A           29 NLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQDVYIV  108 (371)
T ss_dssp             EEEEEEECSSEEEEEEEETTTTEEEEEEEEECTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSCCSTTTCCEEEEE
T ss_pred             EeeeeEecCCEEEEEEEECCCCceEEEEEeccccCChHHHHHHHHHHHHHHhcCCCCccceEEeeccccccccccceEEE
Confidence            3567999999999999875 5889999999764332   256889999999999999999998762              


Q ss_pred             ----------------ccchhhhHHHHHHHHHHHHhhcCCCCeEecCcCCCcEEECCCCcEEEeecCCCccccCCCccee
Q 039231          379 ----------------RVAEELSSTIGIARGLEYLHLGCSTRILHFDIKPHNILLDEDFCPKISDFGLAKICNRKESIIS  442 (506)
Q Consensus       379 ----------------~~~~~l~i~~~i~~gl~~LH~~~~~~ivH~dlkp~Nill~~~~~~ki~dfg~a~~~~~~~~~~~  442 (506)
                                      ++.+...++.||+.||+|||   +++|+||||||+|||++.++.+||+|||+++.......   
T Consensus       109 ~e~~~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH---~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~a~~~~~~~~---  182 (371)
T 2xrw_A          109 MELMDANLCQVIQMELDHERMSYLLYQMLCGIKHLH---SAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFM---  182 (371)
T ss_dssp             EECCSEEHHHHHHSCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEECTTSCEEECCCCC------------
T ss_pred             EEcCCCCHHHHHhhccCHHHHHHHHHHHHHHHHHHH---HCCeecccCCHHHEEEcCCCCEEEEEeecccccccccc---
Confidence                            22335678999999999999   89999999999999999999999999999987654321   


Q ss_pred             cccCCCCcccccccccccccCCCCccccHHHHHHHHHHHHcCCCCCCCCCCCc
Q 039231          443 MTGARGTVGYIAPEVFCRNIGEVSYKSDVYNYGMMIFEMTGGRKNVDVVDNGS  495 (506)
Q Consensus       443 ~~~~~gt~~y~aPE~l~~~~~~~s~~~Dv~s~G~il~elltg~~pf~~~~~~~  495 (506)
                      .....||+.|+|||++.+.  .++.++||||||+++|||++|+.||...+..+
T Consensus       183 ~~~~~gt~~y~aPE~~~~~--~~~~~~DiwslG~il~el~~g~~pf~~~~~~~  233 (371)
T 2xrw_A          183 MTPYVVTRYYRAPEVILGM--GYKENVDIWSVGCIMGEMIKGGVLFPGTDHID  233 (371)
T ss_dssp             -------CTTCCHHHHTTC--CCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHH
T ss_pred             cCCceecCCccCHHHhcCC--CCCchHhHHHHHHHHHHHHhCCCCCCCCCHHH
Confidence            2446789999999999654  68999999999999999999999998765443

>3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A

Probab=99.97  E-value=2.9e-31  Score=272.76  Aligned_cols=177  Identities=24%  Similarity=0.372  Sum_probs=136.5

Q ss_pred             HhhhccccCccCceEEEEEEEc-CCCEEEEEEeccCC---------CCchhhHHHHHHhhccCccceeEEEEEe------
Q 039231          314 TNSFKYKLGQGGYGSVYKGKLL-DGSNVAVKVLNDSK---------GNGKEFINEVASISRTSHVNVVALLGFC------  377 (506)
Q Consensus       314 ~~~~~~~ig~G~~g~V~~~~~~-~~~~vavK~l~~~~---------~~~~~~~~E~~~l~~l~h~niv~l~g~~------  377 (506)
                      .+.+.++||+|+||.||+|+.. +++.||||++....         .....+.+|++++++++||||+++++++      
T Consensus       136 ~y~~~~~LG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~  215 (419)
T 3i6u_A          136 EYIMSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDAEDYY  215 (419)
T ss_dssp             TEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGGTTC--------CCHHHHHHHHHHCCCTTBCCCCEEEESSEEE
T ss_pred             cEEEEeEEeeCCCeEEEEEEECCCCcEEEEEEEEechhcccccccchhHHHHHHHHHHHHhCCCCCEeeEEEEEecCceE
Confidence            3445678999999999999875 47999999986432         1224588999999999999999999876      


Q ss_pred             --------------------eccchhhhHHHHHHHHHHHHhhcCCCCeEecCcCCCcEEECCC---CcEEEeecCCCccc
Q 039231          378 --------------------LRVAEELSSTIGIARGLEYLHLGCSTRILHFDIKPHNILLDED---FCPKISDFGLAKIC  434 (506)
Q Consensus       378 --------------------~~~~~~l~i~~~i~~gl~~LH~~~~~~ivH~dlkp~Nill~~~---~~~ki~dfg~a~~~  434 (506)
                                          +.+.+.+.++.|++.||+|||   +++|+||||||+|||++.+   ..+||+|||+++..
T Consensus       216 lv~e~~~~g~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH---~~~ivHrDlkp~NIll~~~~~~~~~kl~DFG~a~~~  292 (419)
T 3i6u_A          216 IVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLLAVQYLH---ENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKIL  292 (419)
T ss_dssp             EEEECCTTCBGGGGTSSSCCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEESSSSSSCCEEECCSSTTTSC
T ss_pred             EEEEcCCCCcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHH---HCCccccCCChHhEEEecCCCcceEEEeecccceec
Confidence                                233346778999999999999   8999999999999999654   45999999999876


Q ss_pred             cCCCcceecccCCCCccccccccccc-ccCCCCccccHHHHHHHHHHHHcCCCCCCCCCCCcc
Q 039231          435 NRKESIISMTGARGTVGYIAPEVFCR-NIGEVSYKSDVYNYGMMIFEMTGGRKNVDVVDNGST  496 (506)
Q Consensus       435 ~~~~~~~~~~~~~gt~~y~aPE~l~~-~~~~~s~~~Dv~s~G~il~elltg~~pf~~~~~~~~  496 (506)
                      .....   .....||+.|+|||++.. ....++.++||||||+++|||++|+.||........
T Consensus       293 ~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~  352 (419)
T 3i6u_A          293 GETSL---MRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVS  352 (419)
T ss_dssp             C--------------CTTCCTTTTC----CTTHHHHHHHHHHHHHHHHHHSSCSSCCCSSSCC
T ss_pred             CCCcc---ccccCCCCCccCceeeecCCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCcchHH
Confidence            54332   244678999999999853 224678899999999999999999999987655443

>2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7

Probab=99.97  E-value=1.3e-31  Score=283.62  Aligned_cols=176  Identities=29%  Similarity=0.502  Sum_probs=148.3

Q ss_pred             HhhhccccCccCceEEEEEEEcCCCEEEEEEeccCCCCchhhHHHHHHhhccCccceeEEEEEee---------------
Q 039231          314 TNSFKYKLGQGGYGSVYKGKLLDGSNVAVKVLNDSKGNGKEFINEVASISRTSHVNVVALLGFCL---------------  378 (506)
Q Consensus       314 ~~~~~~~ig~G~~g~V~~~~~~~~~~vavK~l~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~---------------  378 (506)
                      .+.+.++||+|+||.||+|++.++..||||+++......+++.+|+++|++++||||+++++++.               
T Consensus       268 ~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~lv~e~~~~gs  347 (535)
T 2h8h_A          268 SLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVSEEPIYIVTEYMSKGS  347 (535)
T ss_dssp             GEEEEEEEEECSSEEEEEEEETTTEEEEEEEECTTSSCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSCEEEECCCTTEE
T ss_pred             hhhhheecccCCCeEEEEEEECCCceEEEEEeCCCCCCHHHHHHHHHHHHhCCCCCEeeEEEEEeeccceEeeehhcCCc
Confidence            34456789999999999999988888999999876666688999999999999999999999871               


Q ss_pred             -------------ccchhhhHHHHHHHHHHHHhhcCCCCeEecCcCCCcEEECCCCcEEEeecCCCccccCCCcceeccc
Q 039231          379 -------------RVAEELSSTIGIARGLEYLHLGCSTRILHFDIKPHNILLDEDFCPKISDFGLAKICNRKESIISMTG  445 (506)
Q Consensus       379 -------------~~~~~l~i~~~i~~gl~~LH~~~~~~ivH~dlkp~Nill~~~~~~ki~dfg~a~~~~~~~~~~~~~~  445 (506)
                                   .+.+.+.++.||+.||+|||   +++|+||||||+|||+++++.+||+|||+++........ ....
T Consensus       348 L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH---~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~~~-~~~~  423 (535)
T 2h8h_A          348 LLDFLKGETGKYLRLPQLVDMAAQIASGMAYVE---RMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYT-ARQG  423 (535)
T ss_dssp             HHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEECGGGCEEECCTTSTTTCCCHHHH-TTCS
T ss_pred             HHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHH---hCCeeCCCCCHhhEEEcCCCcEEEcccccceecCCCcee-cccC
Confidence                         22335678999999999999   899999999999999999999999999999876532211 1133


Q ss_pred             CCCCcccccccccccccCCCCccccHHHHHHHHHHHHc-CCCCCCCCCCCc
Q 039231          446 ARGTVGYIAPEVFCRNIGEVSYKSDVYNYGMMIFEMTG-GRKNVDVVDNGS  495 (506)
Q Consensus       446 ~~gt~~y~aPE~l~~~~~~~s~~~Dv~s~G~il~ellt-g~~pf~~~~~~~  495 (506)
                      ..++..|+|||.+..  +.++.++||||||++||||++ |+.||......+
T Consensus       424 ~~~~~~y~aPE~~~~--~~~~~~sDvwSlGv~l~el~t~g~~P~~~~~~~~  472 (535)
T 2h8h_A          424 AKFPIKWTAPEAALY--GRFTIKSDVWSFGILLTELTTKGRVPYPGMVNRE  472 (535)
T ss_dssp             TTSCGGGSCHHHHHH--CCCCHHHHHHHHHHHHHHHTTTTCCSSTTCCHHH
T ss_pred             CcCcccccCHHHhcc--CCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHH
Confidence            456789999999864  378999999999999999999 999998765443

>3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} SCOP: d.144.1.7 PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ...

Probab=99.97  E-value=1e-31  Score=261.70  Aligned_cols=177  Identities=32%  Similarity=0.534  Sum_probs=148.9

Q ss_pred             HHhhhccccCccCceEEEEEEEcC-CCEEEEEEeccCCCCchhhHHHHHHhhccCccceeEEEEEee-------------
Q 039231          313 MTNSFKYKLGQGGYGSVYKGKLLD-GSNVAVKVLNDSKGNGKEFINEVASISRTSHVNVVALLGFCL-------------  378 (506)
Q Consensus       313 ~~~~~~~~ig~G~~g~V~~~~~~~-~~~vavK~l~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~-------------  378 (506)
                      ..+.+.+.||+|+||.||+|++.+ +..||+|++.......+++.+|++++++++||||+++++++.             
T Consensus        13 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~   92 (288)
T 3kfa_A           13 TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMT   92 (288)
T ss_dssp             GGEEEEEESGGGTTCSEEEEEEGGGTEEEEEEEECSCSTHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSEEEEEECCT
T ss_pred             cceeEEeecCCCCceeEEEeEecCCCEEEEEEecCcCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCEEEEEEcCC
Confidence            334456789999999999999865 889999999877666688999999999999999999999872             


Q ss_pred             ----------------ccchhhhHHHHHHHHHHHHhhcCCCCeEecCcCCCcEEECCCCcEEEeecCCCccccCCCccee
Q 039231          379 ----------------RVAEELSSTIGIARGLEYLHLGCSTRILHFDIKPHNILLDEDFCPKISDFGLAKICNRKESIIS  442 (506)
Q Consensus       379 ----------------~~~~~l~i~~~i~~gl~~LH~~~~~~ivH~dlkp~Nill~~~~~~ki~dfg~a~~~~~~~~~~~  442 (506)
                                      ++...+.++.|++.||+|||   +++|+|+||||+||+++.++.+||+|||++......... .
T Consensus        93 ~~~L~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH---~~~i~H~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~~~-~  168 (288)
T 3kfa_A           93 YGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLE---KKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYT-A  168 (288)
T ss_dssp             TEEHHHHHHHCCTTTSCHHHHHHHHHHHHHHHHHHH---HHTCCCSCCSGGGEEECGGGCEEECCCCGGGTSCSSSSE-E
T ss_pred             CCcHHHHHHhcccCCccHhHHHHHHHHHHHHHHHHH---HCCccCCCCCcceEEEcCCCCEEEccCccceeccCCccc-c
Confidence                            22235678899999999999   899999999999999999999999999999876654432 2


Q ss_pred             cccCCCCcccccccccccccCCCCccccHHHHHHHHHHHHc-CCCCCCCCCCCc
Q 039231          443 MTGARGTVGYIAPEVFCRNIGEVSYKSDVYNYGMMIFEMTG-GRKNVDVVDNGS  495 (506)
Q Consensus       443 ~~~~~gt~~y~aPE~l~~~~~~~s~~~Dv~s~G~il~ellt-g~~pf~~~~~~~  495 (506)
                      .....+++.|+|||.+.+.  .++.++||||||+++|||++ |+.||...+..+
T Consensus       169 ~~~~~~~~~y~aPE~~~~~--~~~~~~Di~slG~il~~ll~~g~~p~~~~~~~~  220 (288)
T 3kfa_A          169 HAGAKFPIKWTAPESLAYN--KFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQ  220 (288)
T ss_dssp             ETTEEECGGGCCHHHHHHC--CCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGG
T ss_pred             ccCCccccCcCChhhhccC--CCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHH
Confidence            2345568889999998554  78999999999999999999 999998765443

>2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A

Probab=99.97  E-value=8.9e-31  Score=259.46  Aligned_cols=173  Identities=27%  Similarity=0.405  Sum_probs=145.7

Q ss_pred             HhhhccccCccCceEEEEEEEc-CCCEEEEEEeccCCC-------CchhhHHHHHHhhccCccceeEEEEEe--------
Q 039231          314 TNSFKYKLGQGGYGSVYKGKLL-DGSNVAVKVLNDSKG-------NGKEFINEVASISRTSHVNVVALLGFC--------  377 (506)
Q Consensus       314 ~~~~~~~ig~G~~g~V~~~~~~-~~~~vavK~l~~~~~-------~~~~~~~E~~~l~~l~h~niv~l~g~~--------  377 (506)
                      .+.+.+.||+|+||.||+|+.. +|+.||+|+++....       ..+++.+|++++++++||||+++++++        
T Consensus        13 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l   92 (321)
T 2a2a_A           13 FYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVITLHDVYENRTDVVL   92 (321)
T ss_dssp             HEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSSSCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEE
T ss_pred             cEEEeeEeeecCCEEEEEEEECCCCeEEEEEEEecccccccccchhHHHHHHHHHHHHhCCCCCcceEEEEEecCCEEEE
Confidence            3455678999999999999985 589999999975332       235689999999999999999999887        


Q ss_pred             -------------------eccchhhhHHHHHHHHHHHHhhcCCCCeEecCcCCCcEEECCCC----cEEEeecCCCccc
Q 039231          378 -------------------LRVAEELSSTIGIARGLEYLHLGCSTRILHFDIKPHNILLDEDF----CPKISDFGLAKIC  434 (506)
Q Consensus       378 -------------------~~~~~~l~i~~~i~~gl~~LH~~~~~~ivH~dlkp~Nill~~~~----~~ki~dfg~a~~~  434 (506)
                                         +++.+.+.++.|++.||+|||   +++|+||||||+||+++.++    .+||+|||+++..
T Consensus        93 v~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~lH---~~~ivH~dikp~NIl~~~~~~~~~~~kl~Dfg~~~~~  169 (321)
T 2a2a_A           93 ILELVSGGELFDFLAQKESLSEEEATSFIKQILDGVNYLH---TKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEI  169 (321)
T ss_dssp             EECCCCSCBHHHHHHTCSCEEHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEESCTTSSSCCEEECCCTTCEEC
T ss_pred             EEEcCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCChHHEEEecCCCCcCCEEEccCccceec
Confidence                               233446789999999999999   89999999999999999888    7999999999876


Q ss_pred             cCCCcceecccCCCCcccccccccccccCCCCccccHHHHHHHHHHHHcCCCCCCCCCCC
Q 039231          435 NRKESIISMTGARGTVGYIAPEVFCRNIGEVSYKSDVYNYGMMIFEMTGGRKNVDVVDNG  494 (506)
Q Consensus       435 ~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~s~~~Dv~s~G~il~elltg~~pf~~~~~~  494 (506)
                      .....   .....||+.|+|||.+.+.  .++.++||||||+++|||++|+.||......
T Consensus       170 ~~~~~---~~~~~gt~~y~aPE~~~~~--~~~~~~Di~slG~il~~l~~g~~pf~~~~~~  224 (321)
T 2a2a_A          170 EDGVE---FKNIFGTPEFVAPEIVNYE--PLGLEADMWSIGVITYILLSGASPFLGDTKQ  224 (321)
T ss_dssp             CTTCC---CCCCCSCGGGCCHHHHTTC--CCCTHHHHHHHHHHHHHHHHSCCSSCCSSHH
T ss_pred             Ccccc---ccccCCCCCccCcccccCC--CCCCccccHHHHHHHHHHHHCCCCCCCCCHH
Confidence            55432   2446789999999998543  7899999999999999999999999765443

>3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II}

Probab=99.97  E-value=4.4e-31  Score=264.11  Aligned_cols=180  Identities=27%  Similarity=0.326  Sum_probs=143.1

Q ss_pred             hhhccccCccCceEEEEEEEc-CCCEEEEEEeccC------CCCchhhHHHHHHhhccCccceeEEEEEeec--------
Q 039231          315 NSFKYKLGQGGYGSVYKGKLL-DGSNVAVKVLNDS------KGNGKEFINEVASISRTSHVNVVALLGFCLR--------  379 (506)
Q Consensus       315 ~~~~~~ig~G~~g~V~~~~~~-~~~~vavK~l~~~------~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~--------  379 (506)
                      +.+.+.||+|+||.||+|+.. ++..||+|++...      ....+.+.+|++++++++||||+++++++.+        
T Consensus        28 y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~  107 (345)
T 3hko_A           28 YHLKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLHHPNIARLYEVYEDEQYICLVM  107 (345)
T ss_dssp             EEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHC---CHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             eeecceeeecCCeEEEEEEECCCCceEEEeehhhhhhcccCHHHHHHHHHHHHHHHhCCCCCcceeehhhccCCeEEEEE
Confidence            344578999999999999874 5889999998642      2334678999999999999999999998721        


Q ss_pred             -----------------------------------------------------------cchhhhHHHHHHHHHHHHhhc
Q 039231          380 -----------------------------------------------------------VAEELSSTIGIARGLEYLHLG  400 (506)
Q Consensus       380 -----------------------------------------------------------~~~~l~i~~~i~~gl~~LH~~  400 (506)
                                                                                 +...+.++.||+.||+|||  
T Consensus       108 e~~~gg~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH--  185 (345)
T 3hko_A          108 ELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAINGSIHGFRESLDFVQREKLISNIMRQIFSALHYLH--  185 (345)
T ss_dssp             ECCCSCBHHHHEEEEEETTTTEEEEEEECCCCCCSHHHHHHHHHSCC--CEEECCHHHHHHHHHHHHHHHHHHHHHHH--
T ss_pred             eCCCCCcHHHHHHHhhcccccccccccccccccccccccccccccccccccccccccccHHHHHHHHHHHHHHHHHHH--
Confidence                                                                       1123458899999999999  


Q ss_pred             CCCCeEecCcCCCcEEECCCC--cEEEeecCCCccccCCCcc--eecccCCCCcccccccccccccCCCCccccHHHHHH
Q 039231          401 CSTRILHFDIKPHNILLDEDF--CPKISDFGLAKICNRKESI--ISMTGARGTVGYIAPEVFCRNIGEVSYKSDVYNYGM  476 (506)
Q Consensus       401 ~~~~ivH~dlkp~Nill~~~~--~~ki~dfg~a~~~~~~~~~--~~~~~~~gt~~y~aPE~l~~~~~~~s~~~Dv~s~G~  476 (506)
                       +++|+||||||+||+++.++  .+||+|||+++........  .......||+.|+|||.+.+....++.++||||||+
T Consensus       186 -~~~ivH~Dlkp~NIll~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~  264 (345)
T 3hko_A          186 -NQGICHRDIKPENFLFSTNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNESYGPKCDAWSAGV  264 (345)
T ss_dssp             -HTTEECCCCCGGGEEESCSSSCCEEECCCTTCEEGGGTTCC--------CCCGGGCCHHHHTCSSSCCCTHHHHHHHHH
T ss_pred             -HCCccccCCChhhEEEecCCCceEEEeeccccccccccCccccccccccCCCccccCchhhccCCCCCCcHHHHHHHHH
Confidence             89999999999999998776  8999999999865432211  122456789999999998654457899999999999


Q ss_pred             HHHHHHcCCCCCCCCCCCcch
Q 039231          477 MIFEMTGGRKNVDVVDNGSTA  497 (506)
Q Consensus       477 il~elltg~~pf~~~~~~~~~  497 (506)
                      ++|||++|+.||......+..
T Consensus       265 il~el~~g~~pf~~~~~~~~~  285 (345)
T 3hko_A          265 LLHLLLMGAVPFPGVNDADTI  285 (345)
T ss_dssp             HHHHHHHSSCSSCCSSHHHHH
T ss_pred             HHHHHHHCCCCCCCCChHHHH
Confidence            999999999999876554433

>3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A

Probab=99.97  E-value=6.8e-31  Score=260.81  Aligned_cols=166  Identities=22%  Similarity=0.366  Sum_probs=121.9

Q ss_pred             cccCccCceEEEEEEEc-CCCEEEEEEeccCCCCchhhHHHHHHhhccC-ccceeEEEEEe-------------------
Q 039231          319 YKLGQGGYGSVYKGKLL-DGSNVAVKVLNDSKGNGKEFINEVASISRTS-HVNVVALLGFC-------------------  377 (506)
Q Consensus       319 ~~ig~G~~g~V~~~~~~-~~~~vavK~l~~~~~~~~~~~~E~~~l~~l~-h~niv~l~g~~-------------------  377 (506)
                      +.||+|+||.||+|+.. +++.||||++...  ....+.+|++++.++. ||||+++++++                   
T Consensus        17 ~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~--~~~~~~~e~~~l~~l~~h~niv~~~~~~~~~~~~~lv~e~~~~~~L~   94 (325)
T 3kn6_A           17 KPLGEGSFSICRKCVHKKSNQAFAVKIISKR--MEANTQKEITALKLCEGHPNIVKLHEVFHDQLHTFLVMELLNGGELF   94 (325)
T ss_dssp             CCSEEETTEEEEEEEETTTCCEEEEEEEEGG--GHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEECCCCSCBHH
T ss_pred             CccccCCCeEEEEEEECCCCCEEEEEEEChh--hhhhHHHHHHHHHHhcCCCCeeEEEEEEEcCCEEEEEEEccCCCcHH
Confidence            56999999999999985 5899999999643  3467789999999997 99999999987                   


Q ss_pred             --------eccchhhhHHHHHHHHHHHHhhcCCCCeEecCcCCCcEEECCCC---cEEEeecCCCccccCCCcceecccC
Q 039231          378 --------LRVAEELSSTIGIARGLEYLHLGCSTRILHFDIKPHNILLDEDF---CPKISDFGLAKICNRKESIISMTGA  446 (506)
Q Consensus       378 --------~~~~~~l~i~~~i~~gl~~LH~~~~~~ivH~dlkp~Nill~~~~---~~ki~dfg~a~~~~~~~~~~~~~~~  446 (506)
                              +++.+.+.++.|++.||+|||   +++|+||||||+|||++.++   .+||+|||+++........  ....
T Consensus        95 ~~l~~~~~~~~~~~~~i~~qi~~~l~~LH---~~~ivH~Dlkp~NIll~~~~~~~~~kl~Dfg~a~~~~~~~~~--~~~~  169 (325)
T 3kn6_A           95 ERIKKKKHFSETEASYIMRKLVSAVSHMH---DVGVVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPDNQP--LKTP  169 (325)
T ss_dssp             HHHHHCSCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEEEC----CEEEECCCTTCEECCC----------
T ss_pred             HHHHhcCCCCHHHHHHHHHHHHHHHHHHH---HCCCeecCCCHHHEEEecCCCcccEEEeccccceecCCCCCc--cccc
Confidence                    233446779999999999999   89999999999999997665   8999999999876543322  2446


Q ss_pred             CCCcccccccccccccCCCCccccHHHHHHHHHHHHcCCCCCCCCCC
Q 039231          447 RGTVGYIAPEVFCRNIGEVSYKSDVYNYGMMIFEMTGGRKNVDVVDN  493 (506)
Q Consensus       447 ~gt~~y~aPE~l~~~~~~~s~~~Dv~s~G~il~elltg~~pf~~~~~  493 (506)
                      .+|+.|+|||++.+.  .++.++||||||+++|||++|+.||...+.
T Consensus       170 ~~t~~y~aPE~~~~~--~~~~~~DiwslG~il~~ll~g~~pf~~~~~  214 (325)
T 3kn6_A          170 CFTLHYAAPELLNQN--GYDESCDLWSLGVILYTMLSGQVPFQSHDR  214 (325)
T ss_dssp             --------------C--CCCHHHHHHHHHHHHHHHHHSSCTTC----
T ss_pred             CCCcCccCHHHhcCC--CCCCccchHHHHHHHHHHHhCCCCCCCCcc
Confidence            689999999998654  789999999999999999999999987544

>2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ...

Probab=99.97  E-value=1.3e-31  Score=271.11  Aligned_cols=174  Identities=26%  Similarity=0.506  Sum_probs=130.7

Q ss_pred             hhccccCccCceEEEEEEEc----CCCEEEEEEeccCCC--CchhhHHHHHHhhccCccceeEEEEEee-----------
Q 039231          316 SFKYKLGQGGYGSVYKGKLL----DGSNVAVKVLNDSKG--NGKEFINEVASISRTSHVNVVALLGFCL-----------  378 (506)
Q Consensus       316 ~~~~~ig~G~~g~V~~~~~~----~~~~vavK~l~~~~~--~~~~~~~E~~~l~~l~h~niv~l~g~~~-----------  378 (506)
                      .+.+.||+|+||.||+|++.    ++..||||+++....  ..+++.+|++++++++||||+++++++.           
T Consensus        48 ~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~  127 (373)
T 2qol_A           48 SIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRLEGVVTKSKPVMIVTEY  127 (373)
T ss_dssp             CCCEEEEECSSSEEEEC-CBCTTSCBCCEEEEECCTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSCEEEEEC
T ss_pred             eeeeEEeeCCCeEEEEEEEecCCCCceeEEEEEecCccCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCceEEEEeC
Confidence            34568999999999999875    477899999975432  2367899999999999999999999872           


Q ss_pred             -----------------ccchhhhHHHHHHHHHHHHhhcCCCCeEecCcCCCcEEECCCCcEEEeecCCCccccCCCcce
Q 039231          379 -----------------RVAEELSSTIGIARGLEYLHLGCSTRILHFDIKPHNILLDEDFCPKISDFGLAKICNRKESII  441 (506)
Q Consensus       379 -----------------~~~~~l~i~~~i~~gl~~LH~~~~~~ivH~dlkp~Nill~~~~~~ki~dfg~a~~~~~~~~~~  441 (506)
                                       ++.+.+.++.||+.||+|||   +++|+||||||+|||++.++.+||+|||+++.........
T Consensus       128 ~~~~sL~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH---~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~  204 (373)
T 2qol_A          128 MENGSLDSFLRKHDAQFTVIQLVGMLRGIASGMKYLS---DMGYVHRDLAARNILINSNLVCKVSDFGLGRVLEDDPEAA  204 (373)
T ss_dssp             CTTCBHHHHHHTTTTCSCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEECTTCCEEECCC-------------
T ss_pred             CCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHH---HCCeeCCCCCcceEEEcCCCCEEECcCccccccccCCccc
Confidence                             23346778999999999999   8999999999999999999999999999998765433211


Q ss_pred             -ecccCCCCcccccccccccccCCCCccccHHHHHHHHHHHHc-CCCCCCCCCCC
Q 039231          442 -SMTGARGTVGYIAPEVFCRNIGEVSYKSDVYNYGMMIFEMTG-GRKNVDVVDNG  494 (506)
Q Consensus       442 -~~~~~~gt~~y~aPE~l~~~~~~~s~~~Dv~s~G~il~ellt-g~~pf~~~~~~  494 (506)
                       ......+++.|+|||.+...  .++.++||||||+++|||++ |+.||......
T Consensus       205 ~~~~~~~~~~~y~aPE~~~~~--~~~~~~Dv~SlG~il~ellt~g~~P~~~~~~~  257 (373)
T 2qol_A          205 YTTRGGKIPIRWTSPEAIAYR--KFTSASDVWSYGIVLWEVMSYGERPYWEMSNQ  257 (373)
T ss_dssp             ---------CTTSCHHHHHHC--CCCHHHHHHHHHHHHHHHHTTC-CTTTTCCHH
T ss_pred             eeccCCCcCCCccChhhhccC--CcCchhcHHHHHHHHHHHHhCCCCCCCCCCHH
Confidence             11223457789999998653  78999999999999999998 99999766543

>1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A*

Probab=99.97  E-value=9.6e-31  Score=255.96  Aligned_cols=173  Identities=17%  Similarity=0.289  Sum_probs=143.9

Q ss_pred             hhccccCccCceEEEEEEE-cCCCEEEEEEeccCCCCchhhHHHHHHhhcc-CccceeEEEEEe----------------
Q 039231          316 SFKYKLGQGGYGSVYKGKL-LDGSNVAVKVLNDSKGNGKEFINEVASISRT-SHVNVVALLGFC----------------  377 (506)
Q Consensus       316 ~~~~~ig~G~~g~V~~~~~-~~~~~vavK~l~~~~~~~~~~~~E~~~l~~l-~h~niv~l~g~~----------------  377 (506)
                      .+.+.||+|+||.||+|+. .+++.||||++.... ..+.+.+|++.+.++ +|+|++++++++                
T Consensus        13 ~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~lv~e~~~~~   91 (298)
T 1csn_A           13 KVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRS-DAPQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNVLVIDLLGPS   91 (298)
T ss_dssp             EEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCT-TSCCHHHHHHHHHHTTTCTTCCCEEEEEEETTEEEEEEECCCCB
T ss_pred             EEEEEEeecCCEEEEEEEECCCCcEEEEEEeccCC-ccHHHHHHHHHHHHHhcCCCCCeEEeecCCCceeEEEEEecCCC
Confidence            3456799999999999997 468999999986543 346789999999999 799999998876                


Q ss_pred             -----------eccchhhhHHHHHHHHHHHHhhcCCCCeEecCcCCCcEEECCCCc-----EEEeecCCCccccCCCcce
Q 039231          378 -----------LRVAEELSSTIGIARGLEYLHLGCSTRILHFDIKPHNILLDEDFC-----PKISDFGLAKICNRKESII  441 (506)
Q Consensus       378 -----------~~~~~~l~i~~~i~~gl~~LH~~~~~~ivH~dlkp~Nill~~~~~-----~ki~dfg~a~~~~~~~~~~  441 (506)
                                 +++.+.+.++.|++.||+|||   +++|+||||||+||+++.++.     +||+|||+++.........
T Consensus        92 L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH---~~~ivH~Dlkp~NIl~~~~~~~~~~~~kl~Dfg~~~~~~~~~~~~  168 (298)
T 1csn_A           92 LEDLLDLCGRKFSVKTVAMAAKQMLARVQSIH---EKSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQ  168 (298)
T ss_dssp             HHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHH---TTTEECCCCCGGGEEECCSSSTTTTCEEECCCTTCEESBCTTTCC
T ss_pred             HHHHHHHhccCCCHHHHHHHHHHHHHHHHHHH---hCCEecCCCCHHHEEeccCCCCCCCeEEEEECccccccccccccc
Confidence                       233446789999999999999   999999999999999987776     9999999998765443211


Q ss_pred             -----ecccCCCCcccccccccccccCCCCccccHHHHHHHHHHHHcCCCCCCCCCCC
Q 039231          442 -----SMTGARGTVGYIAPEVFCRNIGEVSYKSDVYNYGMMIFEMTGGRKNVDVVDNG  494 (506)
Q Consensus       442 -----~~~~~~gt~~y~aPE~l~~~~~~~s~~~Dv~s~G~il~elltg~~pf~~~~~~  494 (506)
                           ......||+.|+|||.+.+.  .++.++||||||+++|||++|+.||......
T Consensus       169 ~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~~Di~slG~il~el~~g~~pf~~~~~~  224 (298)
T 1csn_A          169 HIPYREKKNLSGTARYMSINTHLGR--EQSRRDDLEALGHVFMYFLRGSLPWQGLKAA  224 (298)
T ss_dssp             BCCCCCCCCCCSCTTTCCHHHHTTC--CCCHHHHHHHHHHHHHHHHHSSCTTSSCCSC
T ss_pred             cccccCccCCCCCcccCCchhhcCC--CCChHHHHHHHHHHHHHHHcCCCCcchhhcc
Confidence                 12446789999999998654  6899999999999999999999999886544

>1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A*

Probab=99.97  E-value=3e-31  Score=257.68  Aligned_cols=177  Identities=25%  Similarity=0.453  Sum_probs=133.6

Q ss_pred             hhhccccCccCceEEEEEEEcC----CCEEEEEEeccCCC--CchhhHHHHHHhhccCccceeEEEEEe-----------
Q 039231          315 NSFKYKLGQGGYGSVYKGKLLD----GSNVAVKVLNDSKG--NGKEFINEVASISRTSHVNVVALLGFC-----------  377 (506)
Q Consensus       315 ~~~~~~ig~G~~g~V~~~~~~~----~~~vavK~l~~~~~--~~~~~~~E~~~l~~l~h~niv~l~g~~-----------  377 (506)
                      +.+.+.||+|+||.||+|+...    +..||+|+++....  ..+.+.+|+.++++++||||+++++++           
T Consensus        17 y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~lv~e~   96 (281)
T 1mp8_A           17 IELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVITENPVWIIMEL   96 (281)
T ss_dssp             EEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTTSHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSCEEEEEC
T ss_pred             eEEEeEeeecCCeeEEEEEEecCCCCceEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCccceEEEEEccCccEEEEec
Confidence            3456789999999999998743    45799999875432  235788999999999999999999986           


Q ss_pred             ----------------eccchhhhHHHHHHHHHHHHhhcCCCCeEecCcCCCcEEECCCCcEEEeecCCCccccCCCcce
Q 039231          378 ----------------LRVAEELSSTIGIARGLEYLHLGCSTRILHFDIKPHNILLDEDFCPKISDFGLAKICNRKESII  441 (506)
Q Consensus       378 ----------------~~~~~~l~i~~~i~~gl~~LH~~~~~~ivH~dlkp~Nill~~~~~~ki~dfg~a~~~~~~~~~~  441 (506)
                                      +++.+.+.++.|++.||+|||   +++|+||||||+||+++.++.+||+|||+++........ 
T Consensus        97 ~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~-  172 (281)
T 1mp8_A           97 CTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLE---SKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYY-  172 (281)
T ss_dssp             CTTEEHHHHHHHTTTTSCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEEEETTEEEECC--------------
T ss_pred             CCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH---hCCeecccccHHHEEECCCCCEEECccccccccCccccc-
Confidence                            223335678899999999999   899999999999999999999999999999876543322 


Q ss_pred             ecccCCCCcccccccccccccCCCCccccHHHHHHHHHHHHc-CCCCCCCCCCCcch
Q 039231          442 SMTGARGTVGYIAPEVFCRNIGEVSYKSDVYNYGMMIFEMTG-GRKNVDVVDNGSTA  497 (506)
Q Consensus       442 ~~~~~~gt~~y~aPE~l~~~~~~~s~~~Dv~s~G~il~ellt-g~~pf~~~~~~~~~  497 (506)
                      ......+++.|+|||.+...  .++.++||||||+++|||++ |+.||......+..
T Consensus       173 ~~~~~~~~~~y~aPE~~~~~--~~~~~~Di~slG~~l~ell~~g~~pf~~~~~~~~~  227 (281)
T 1mp8_A          173 KASKGKLPIKWMAPESINFR--RFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVI  227 (281)
T ss_dssp             ------CCGGGCCHHHHHHC--CCSHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHH
T ss_pred             ccccCCCcccccChhhcccC--CCCCccCchHHHHHHHHHHhcCCCCCCcCCHHHHH
Confidence            12334567899999998543  78999999999999999996 99999876655433

>3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* 4azf_A*

Probab=99.97  E-value=2.6e-31  Score=273.88  Aligned_cols=175  Identities=24%  Similarity=0.313  Sum_probs=145.0

Q ss_pred             hhhccccCccCceEEEEEEEcC-CCEEEEEEeccCCCCchhhHHHHHHhhcc------CccceeEEEEEe----------
Q 039231          315 NSFKYKLGQGGYGSVYKGKLLD-GSNVAVKVLNDSKGNGKEFINEVASISRT------SHVNVVALLGFC----------  377 (506)
Q Consensus       315 ~~~~~~ig~G~~g~V~~~~~~~-~~~vavK~l~~~~~~~~~~~~E~~~l~~l------~h~niv~l~g~~----------  377 (506)
                      +.+.++||+|+||.||+|+... ++.||||+++......+++.+|++++..+      +|+||+++++++          
T Consensus        99 y~~~~~LG~G~fg~V~~a~~~~~~~~vAvK~~~~~~~~~~~~~~E~~~l~~l~~~~~~~~~~iv~~~~~~~~~~~~~lv~  178 (429)
T 3kvw_A           99 YEVLKVIGKGSFGQVVKAYDHKVHQHVALKMVRNEKRFHRQAAEEIRILEHLRKQDKDNTMNVIHMLENFTFRNHICMTF  178 (429)
T ss_dssp             EEEEEEEEESSSEEEEEEEETTTTEEEEEEEECSCHHHHHHHHHHHHHHHHHHTTCTTSCSCBCCEEEEEEETTEEEEEE
T ss_pred             EEEEEEcccCccEEEEEEEECCCCcEEEEEEECCccchHHHHHHHHHHHHHHhhccccCCcCEEEEEeecccCCeEEEEE
Confidence            3445789999999999998754 88999999986654456778888888877      577999999876          


Q ss_pred             ------------------eccchhhhHHHHHHHHHHHHhhcCCCCeEecCcCCCcEEECCCCc--EEEeecCCCccccCC
Q 039231          378 ------------------LRVAEELSSTIGIARGLEYLHLGCSTRILHFDIKPHNILLDEDFC--PKISDFGLAKICNRK  437 (506)
Q Consensus       378 ------------------~~~~~~l~i~~~i~~gl~~LH~~~~~~ivH~dlkp~Nill~~~~~--~ki~dfg~a~~~~~~  437 (506)
                                        +++..++.++.||+.||+|||   +++|+||||||+|||++.++.  +||+|||++......
T Consensus       179 e~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~aL~~LH---~~~ivHrDlKp~NILl~~~~~~~vkL~DFG~a~~~~~~  255 (429)
T 3kvw_A          179 ELLSMNLYELIKKNKFQGFSLPLVRKFAHSILQCLDALH---KNRIIHCDLKPENILLKQQGRSGIKVIDFGSSCYEHQR  255 (429)
T ss_dssp             CCCCCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHH---HHTEECSCCSGGGEEESSTTSCCEEECCCTTCEETTCC
T ss_pred             eccCCCHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHeEEccCCCcceEEeecccceecCCc
Confidence                              223346679999999999999   889999999999999999887  999999999765432


Q ss_pred             CcceecccCCCCcccccccccccccCCCCccccHHHHHHHHHHHHcCCCCCCCCCCCcchhh
Q 039231          438 ESIISMTGARGTVGYIAPEVFCRNIGEVSYKSDVYNYGMMIFEMTGGRKNVDVVDNGSTALD  499 (506)
Q Consensus       438 ~~~~~~~~~~gt~~y~aPE~l~~~~~~~s~~~Dv~s~G~il~elltg~~pf~~~~~~~~~~~  499 (506)
                      .     ....+|+.|+|||++.+.  .++.++|||||||++|||++|+.||...++.+....
T Consensus       256 ~-----~~~~gt~~y~aPE~~~~~--~~~~~~DiwSlG~il~elltG~~pf~~~~~~~~l~~  310 (429)
T 3kvw_A          256 V-----YTYIQSRFYRAPEVILGA--RYGMPIDMWSLGCILAELLTGYPLLPGEDEGDQLAC  310 (429)
T ss_dssp             C-----CSSCSCGGGCCHHHHHTB--CCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHH
T ss_pred             c-----cccCCCCCccChHHHhCC--CCCchHHHHhHHHHHHHHHhCCCCCCCCCHHHHHHH
Confidence            2     346789999999999654  689999999999999999999999987765544433

>3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} PDB: 3uib_A*

Probab=99.97  E-value=3.1e-31  Score=267.17  Aligned_cols=182  Identities=23%  Similarity=0.298  Sum_probs=140.7

Q ss_pred             HHHHHHHHhhh--ccccCccCceEEEEEEEcCCCEEEEEEeccCCCC------------chhhHHHHHHhhccCccceeE
Q 039231          307 YADIKKMTNSF--KYKLGQGGYGSVYKGKLLDGSNVAVKVLNDSKGN------------GKEFINEVASISRTSHVNVVA  372 (506)
Q Consensus       307 ~~el~~~~~~~--~~~ig~G~~g~V~~~~~~~~~~vavK~l~~~~~~------------~~~~~~E~~~l~~l~h~niv~  372 (506)
                      ..++......|  .+.||+|+||.||+|+..+++.||||++......            .+.+.+|++++++++||||++
T Consensus        14 ~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~   93 (362)
T 3pg1_A           14 IAELHAMQSPYTVQRFISSGSYGAVCAGVDSEGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRLLNHFHHPNILG   93 (362)
T ss_dssp             HHHHHHTTCSCEEEEEEEEETTEEEEEEECTTSCEEEEEEECEECCTTSCEEGGGSHHHHHHHHHHHHHHHHCCCTTBCC
T ss_pred             HHHHHHhccceEEeEEeccCCCEEEEEEECCCCCeEEEEeccccCCccchhhhhhhhhHHHHHHHHHHHHHhCCCcCccc
Confidence            34444444444  4689999999999999888999999999643221            156889999999999999999


Q ss_pred             EEEEee--------------------------------ccchhhhHHHHHHHHHHHHhhcCCCCeEecCcCCCcEEECCC
Q 039231          373 LLGFCL--------------------------------RVAEELSSTIGIARGLEYLHLGCSTRILHFDIKPHNILLDED  420 (506)
Q Consensus       373 l~g~~~--------------------------------~~~~~l~i~~~i~~gl~~LH~~~~~~ivH~dlkp~Nill~~~  420 (506)
                      +++++.                                ++.+.+.++.||+.||+|||   +++|+||||||+||+++.+
T Consensus        94 ~~~~~~~~~~~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH---~~~ivH~Dlkp~NIl~~~~  170 (362)
T 3pg1_A           94 LRDIFVHFEEPAMHKLYLVTELMRTDLAQVIHDQRIVISPQHIQYFMYHILLGLHVLH---EAGVVHRDLHPGNILLADN  170 (362)
T ss_dssp             CSEEEEECCTTTCCEEEEEEECCSEEHHHHHHCTTSCCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEECTT
T ss_pred             eeeeEEeccCCCcceEEEEEccCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHH---HCcCEecCCChHHEEEcCC
Confidence            988762                                23336678999999999999   8999999999999999999


Q ss_pred             CcEEEeecCCCccccCCCcceecccCCCCcccccccccccccCCCCccccHHHHHHHHHHHHcCCCCCCCCCCCc
Q 039231          421 FCPKISDFGLAKICNRKESIISMTGARGTVGYIAPEVFCRNIGEVSYKSDVYNYGMMIFEMTGGRKNVDVVDNGS  495 (506)
Q Consensus       421 ~~~ki~dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~s~~~Dv~s~G~il~elltg~~pf~~~~~~~  495 (506)
                      +.+||+|||+++.......   .....+|+.|+|||.+.+. ..++.++||||||+++|||++|+.||......+
T Consensus       171 ~~~kl~Dfg~~~~~~~~~~---~~~~~~t~~y~aPE~~~~~-~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~  241 (362)
T 3pg1_A          171 NDITICDFNLAREDTADAN---KTHYVTHRWYRAPELVMQF-KGFTKLVDMWSAGCVMAEMFNRKALFRGSTFYN  241 (362)
T ss_dssp             CCEEECCTTC------------------CGGGCCHHHHTTC-TTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHH
T ss_pred             CCEEEEecCcccccccccc---cceecccceecCcHHhcCC-CCCCcHhHHHhHHHHHHHHHhCCCCCCCCCHHH
Confidence            9999999999986544332   2445789999999998653 468999999999999999999999998765433

>3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 4e4m_A* 4f08_A* 4f09_A* 3q32_A* 3rvg_A* 4hge_A* 3tjc_A* 3tjd_A* 4bbe_A* 4bbf_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* ...

Probab=99.97  E-value=1.3e-31  Score=261.97  Aligned_cols=172  Identities=29%  Similarity=0.476  Sum_probs=137.6

Q ss_pred             hhhccccCccCceEEEEEEE-----cCCCEEEEEEeccCCC-CchhhHHHHHHhhccCccceeEEEEEee----------
Q 039231          315 NSFKYKLGQGGYGSVYKGKL-----LDGSNVAVKVLNDSKG-NGKEFINEVASISRTSHVNVVALLGFCL----------  378 (506)
Q Consensus       315 ~~~~~~ig~G~~g~V~~~~~-----~~~~~vavK~l~~~~~-~~~~~~~E~~~l~~l~h~niv~l~g~~~----------  378 (506)
                      +.+.++||+|+||.||+|++     .+++.||||++..... ..+.+.+|++++++++||||+++++++.          
T Consensus        12 ~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv   91 (295)
T 3ugc_A           12 LKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLKLI   91 (295)
T ss_dssp             EEEEEEEEECSSEEEEEEEECTTCSSCCEEEEEEEESCCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECHHHHTSCEEE
T ss_pred             hhhhheeeccCCEEEEEEEEecccCCCCcEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCCceEEE
Confidence            34567899999999999985     2588999999975432 3367899999999999999999999762          


Q ss_pred             --------------------ccchhhhHHHHHHHHHHHHhhcCCCCeEecCcCCCcEEECCCCcEEEeecCCCccccCCC
Q 039231          379 --------------------RVAEELSSTIGIARGLEYLHLGCSTRILHFDIKPHNILLDEDFCPKISDFGLAKICNRKE  438 (506)
Q Consensus       379 --------------------~~~~~l~i~~~i~~gl~~LH~~~~~~ivH~dlkp~Nill~~~~~~ki~dfg~a~~~~~~~  438 (506)
                                          ++.+.+.++.|++.||+|||   +++|+||||||+||+++.++.+||+|||+++......
T Consensus        92 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH---~~~ivH~Dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~  168 (295)
T 3ugc_A           92 MEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLG---TKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDK  168 (295)
T ss_dssp             EECCTTCBHHHHHHHCGGGCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEEEETTEEEECCCCSCC------
T ss_pred             EEeCCCCCHHHHHHhcccccCHHHHHHHHHHHHHHHHHHh---cCCcccCCCCHhhEEEcCCCeEEEccCcccccccCCc
Confidence                                22235678999999999999   8999999999999999999999999999998765443


Q ss_pred             cce-ecccCCCCcccccccccccccCCCCccccHHHHHHHHHHHHcCCCCCCCC
Q 039231          439 SII-SMTGARGTVGYIAPEVFCRNIGEVSYKSDVYNYGMMIFEMTGGRKNVDVV  491 (506)
Q Consensus       439 ~~~-~~~~~~gt~~y~aPE~l~~~~~~~s~~~Dv~s~G~il~elltg~~pf~~~  491 (506)
                      ... ......++..|+|||.+.+.  .++.++||||||+++|||++|..|+...
T Consensus       169 ~~~~~~~~~~~~~~y~aPE~~~~~--~~~~~~Di~slG~~l~~l~~g~~~~~~~  220 (295)
T 3ugc_A          169 EFFKVKEPGESPIFWYAPESLTES--KFSVASDVWSFGVVLYELFTYIEKSKSP  220 (295)
T ss_dssp             -------CTTCGGGGCCHHHHHHC--CCCHHHHHHHHHHHHHHHHHTTCTTCSH
T ss_pred             ceeeeccCCCCccceeCcHHhcCC--CCChHHHHHHHHHHHHHHHhcccccCCC
Confidence            221 12334577889999998654  7899999999999999999999998653

>3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens}

Probab=99.97  E-value=2.3e-31  Score=270.20  Aligned_cols=179  Identities=29%  Similarity=0.472  Sum_probs=146.6

Q ss_pred             HHHHhhhccccCccCceEEEEEEEc--------CCCEEEEEEeccCCCC--chhhHHHHHHhhcc-CccceeEEEEEee-
Q 039231          311 KKMTNSFKYKLGQGGYGSVYKGKLL--------DGSNVAVKVLNDSKGN--GKEFINEVASISRT-SHVNVVALLGFCL-  378 (506)
Q Consensus       311 ~~~~~~~~~~ig~G~~g~V~~~~~~--------~~~~vavK~l~~~~~~--~~~~~~E~~~l~~l-~h~niv~l~g~~~-  378 (506)
                      ....+.+.++||+|+||.||+|+..        ++..||||+++.....  .+++.+|+++++++ +||||+++++++. 
T Consensus        67 ~~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~  146 (382)
T 3tt0_A           67 PRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQ  146 (382)
T ss_dssp             CGGGEEEEEEEEECSSEEEEEEEEETSSTTCTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS
T ss_pred             chhheEeeeEEecCCCeEEEEEEEccccccccccceEEEEEeeccccCHHHHHHHHHHHHHHHHhcCCchhhhheeeecc
Confidence            3334455678999999999999863        2357999999765332  26788999999999 8999999999871 


Q ss_pred             ------------------------------------------ccchhhhHHHHHHHHHHHHhhcCCCCeEecCcCCCcEE
Q 039231          379 ------------------------------------------RVAEELSSTIGIARGLEYLHLGCSTRILHFDIKPHNIL  416 (506)
Q Consensus       379 ------------------------------------------~~~~~l~i~~~i~~gl~~LH~~~~~~ivH~dlkp~Nil  416 (506)
                                                                ++.+++.++.||+.||+|||   +++|+||||||+|||
T Consensus       147 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH---~~~ivH~Dlkp~NIl  223 (382)
T 3tt0_A          147 DGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLA---SKKCIHRDLAARNVL  223 (382)
T ss_dssp             SSSCEEEEECCTTCBHHHHHHHTCCSSSSSCCCCCSSCCCCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEE
T ss_pred             CCceEEEEEecCCCcHHHHHHHhcccccccccccccccccccCHHHHHHHHHHHHHHHHHHH---hCCEecCCCCcceEE
Confidence                                                      12235678999999999999   899999999999999


Q ss_pred             ECCCCcEEEeecCCCccccCCCcceecccCCCCcccccccccccccCCCCccccHHHHHHHHHHHHc-CCCCCCCCCCC
Q 039231          417 LDEDFCPKISDFGLAKICNRKESIISMTGARGTVGYIAPEVFCRNIGEVSYKSDVYNYGMMIFEMTG-GRKNVDVVDNG  494 (506)
Q Consensus       417 l~~~~~~ki~dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~s~~~Dv~s~G~il~ellt-g~~pf~~~~~~  494 (506)
                      +++++.+||+|||+++...............+|+.|+|||++.+.  .++.++||||||+++|||++ |+.||......
T Consensus       224 l~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~--~~~~~~DiwslG~il~ellt~g~~p~~~~~~~  300 (382)
T 3tt0_A          224 VTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDR--IYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVE  300 (382)
T ss_dssp             ECTTCCEEECSCSCCCCSSCCCTTCCCTTCCCGGGGSCHHHHHSC--CCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHH
T ss_pred             EcCCCcEEEcccCcccccccccccccccCCCCCcceeCHHHhcCC--CCCchhHHHHHHHHHHHHHhCCCCCCCCCCHH
Confidence            999999999999999877654433333456678899999998653  78999999999999999999 99999866543

>3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A*

Probab=99.97  E-value=2.2e-31  Score=264.82  Aligned_cols=178  Identities=27%  Similarity=0.310  Sum_probs=137.0

Q ss_pred             hhccccCccCceEEEEEEEc-CCCEEEEEEeccCCC---CchhhHHHHHHhhccCccceeEEEEEe--------------
Q 039231          316 SFKYKLGQGGYGSVYKGKLL-DGSNVAVKVLNDSKG---NGKEFINEVASISRTSHVNVVALLGFC--------------  377 (506)
Q Consensus       316 ~~~~~ig~G~~g~V~~~~~~-~~~~vavK~l~~~~~---~~~~~~~E~~~l~~l~h~niv~l~g~~--------------  377 (506)
                      .+.++||+|+||.||+|+.. +++.||||+++....   ..+.+.+|++++++++||||+++++++              
T Consensus        37 ~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~  116 (329)
T 3gbz_A           37 RRITKLGEGTYGEVYKAIDTVTNETVAIKRIRLEHEEEGVPGTAIREVSLLKELQHRNIIELKSVIHHNHRLHLIFEYAE  116 (329)
T ss_dssp             EEEEEEEECSSSEEEEEEETTTTEEEEEEECCCCC--------CHHHHHHGGGCCCTTBCCEEEEEEETTEEEEEEECCS
T ss_pred             EEEEEEEecCCeEEEEEEECCCCceEEEEEEcccccccccchhHHHHHHHHHHcCCCCcceEEEEEecCCEEEEEEecCC
Confidence            34578999999999999875 589999999975432   235688999999999999999999987              


Q ss_pred             ------------eccchhhhHHHHHHHHHHHHhhcCCCCeEecCcCCCcEEE-----CCCCcEEEeecCCCccccCCCcc
Q 039231          378 ------------LRVAEELSSTIGIARGLEYLHLGCSTRILHFDIKPHNILL-----DEDFCPKISDFGLAKICNRKESI  440 (506)
Q Consensus       378 ------------~~~~~~l~i~~~i~~gl~~LH~~~~~~ivH~dlkp~Nill-----~~~~~~ki~dfg~a~~~~~~~~~  440 (506)
                                  +++.+.+.++.||+.||+|||   +++|+||||||+|||+     ++++.+||+|||+++........
T Consensus       117 ~~L~~~~~~~~~~~~~~~~~i~~ql~~~l~~LH---~~~ivH~Dlkp~NIll~~~~~~~~~~~kl~Dfg~a~~~~~~~~~  193 (329)
T 3gbz_A          117 NDLKKYMDKNPDVSMRVIKSFLYQLINGVNFCH---SRRCLHRDLKPQNLLLSVSDASETPVLKIGDFGLARAFGIPIRQ  193 (329)
T ss_dssp             EEHHHHHHHCTTCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEEEC-----CCEEEECCTTHHHHHC-----
T ss_pred             CCHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHH---hCCEECCCCCHHHEEEecCCCCccceEEECcCCCccccCCcccc
Confidence                        223346678999999999999   8999999999999999     45566999999999876533221


Q ss_pred             eecccCCCCcccccccccccccCCCCccccHHHHHHHHHHHHcCCCCCCCCCCCcchhh
Q 039231          441 ISMTGARGTVGYIAPEVFCRNIGEVSYKSDVYNYGMMIFEMTGGRKNVDVVDNGSTALD  499 (506)
Q Consensus       441 ~~~~~~~gt~~y~aPE~l~~~~~~~s~~~Dv~s~G~il~elltg~~pf~~~~~~~~~~~  499 (506)
                        .....+|+.|+|||++.+. ..++.++||||||+++|||++|+.||......+....
T Consensus       194 --~~~~~~t~~y~aPE~~~~~-~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~  249 (329)
T 3gbz_A          194 --FTHEIITLWYRPPEILLGS-RHYSTSVDIWSIACIWAEMLMKTPLFPGDSEIDQLFK  249 (329)
T ss_dssp             --------CCTTCCHHHHTTC-CCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHH
T ss_pred             --cCCCcCCccccCHHHhcCC-CCCCcHHHHHHHHHHHHHHHHCCCCcCCCCHHHHHHH
Confidence              2445679999999998653 3589999999999999999999999987655444333

>4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} PDB: 4bbm_A*

Probab=99.97  E-value=5.6e-31  Score=262.03  Aligned_cols=176  Identities=28%  Similarity=0.382  Sum_probs=140.9

Q ss_pred             hccccCccCceEEEEEEEcC-CCEEEEEEeccCCCCc---hhhHHHHHHhhccCccceeEEEEEe---------------
Q 039231          317 FKYKLGQGGYGSVYKGKLLD-GSNVAVKVLNDSKGNG---KEFINEVASISRTSHVNVVALLGFC---------------  377 (506)
Q Consensus       317 ~~~~ig~G~~g~V~~~~~~~-~~~vavK~l~~~~~~~---~~~~~E~~~l~~l~h~niv~l~g~~---------------  377 (506)
                      +.+.||+|+||.||+|+... ++.||||++.......   +.+.+|++++++++||||+++++++               
T Consensus        29 ~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~  108 (331)
T 4aaa_A           29 NLGLVGEGSYGMVMKCRNKDTGRIVAIKKFLESDDDKMVKKIAMREIKLLKQLRHENLVNLLEVCKKKKRWYLVFEFVDH  108 (331)
T ss_dssp             EEEEGGGGTTSSEEEEEETTTCCEEEEEEEESCSSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECCSE
T ss_pred             eeeEEeecCCEEEEEEEECCCCceEEEEEEecCCCchHHHHHHHHHHHHHhhCCCCCEeeEEEEeecCCEEEEEEecCCc
Confidence            34679999999999999864 8999999987554332   4577999999999999999999987               


Q ss_pred             ------------eccchhhhHHHHHHHHHHHHhhcCCCCeEecCcCCCcEEECCCCcEEEeecCCCccccCCCcceeccc
Q 039231          378 ------------LRVAEELSSTIGIARGLEYLHLGCSTRILHFDIKPHNILLDEDFCPKISDFGLAKICNRKESIISMTG  445 (506)
Q Consensus       378 ------------~~~~~~l~i~~~i~~gl~~LH~~~~~~ivH~dlkp~Nill~~~~~~ki~dfg~a~~~~~~~~~~~~~~  445 (506)
                                  +++...+.++.|++.||+|||   +.+|+||||||+||+++.++.+||+|||+++........  ...
T Consensus       109 ~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH---~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~--~~~  183 (331)
T 4aaa_A          109 TILDDLELFPNGLDYQVVQKYLFQIINGIGFCH---SHNIIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGEV--YDD  183 (331)
T ss_dssp             EHHHHHHHSTTCCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEECTTSCEEECCCTTC--------------
T ss_pred             chHHHHHhhccCCCHHHHHHHHHHHHHHHHHHH---HCCEEccCcChheEEEcCCCcEEEEeCCCceeecCCccc--cCC
Confidence                        223346678999999999999   899999999999999999999999999999876543321  244


Q ss_pred             CCCCcccccccccccccCCCCccccHHHHHHHHHHHHcCCCCCCCCCCCcchh
Q 039231          446 ARGTVGYIAPEVFCRNIGEVSYKSDVYNYGMMIFEMTGGRKNVDVVDNGSTAL  498 (506)
Q Consensus       446 ~~gt~~y~aPE~l~~~~~~~s~~~Dv~s~G~il~elltg~~pf~~~~~~~~~~  498 (506)
                      ..+++.|+|||.+.+. ..++.++||||||+++|||++|+.||....+.+...
T Consensus       184 ~~~t~~y~aPE~~~~~-~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~  235 (331)
T 4aaa_A          184 EVATRWYRAPELLVGD-VKYGKAVDVWAIGCLVTEMFMGEPLFPGDSDIDQLY  235 (331)
T ss_dssp             CCCCCTTCCHHHHTTC-TTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHH
T ss_pred             CcCCccccCcccccCC-CCcchHHHHHHHHHHHHHHHhCCCCCCCCCcHHHHH
Confidence            6789999999998553 367899999999999999999999998776544433

>3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A*

Probab=99.97  E-value=2.5e-31  Score=260.47  Aligned_cols=176  Identities=27%  Similarity=0.455  Sum_probs=138.6

Q ss_pred             hhccccCccCceEEEEEEEcCCCEEEEEEeccCCCCchhhHHHHHHhhc--cCccceeEEEEEe----------------
Q 039231          316 SFKYKLGQGGYGSVYKGKLLDGSNVAVKVLNDSKGNGKEFINEVASISR--TSHVNVVALLGFC----------------  377 (506)
Q Consensus       316 ~~~~~ig~G~~g~V~~~~~~~~~~vavK~l~~~~~~~~~~~~E~~~l~~--l~h~niv~l~g~~----------------  377 (506)
                      .+.+.||+|+||.||+|+. +++.||||++...  ..+.+.+|.+++..  ++||||+++++++                
T Consensus        11 ~~~~~lg~G~~g~V~~~~~-~~~~vavK~~~~~--~~~~~~~e~~~~~~~~l~h~niv~~~~~~~~~~~~~~~~~lv~e~   87 (301)
T 3q4u_A           11 TLLECVGKGRYGEVWRGSW-QGENVAVKIFSSR--DEKSWFRETELYNTVMLRHENILGFIASDMTSRHSSTQLWLITHY   87 (301)
T ss_dssp             EEEEEEEECSSEEEEEEEE-TTEEEEEEEECGG--GHHHHHHHHHHHHHTCCCCTTBCCEEEEEEEEETTEEEEEEEECC
T ss_pred             EEEEeeccCCCcEEEEEEE-CCEEEEEEEeccc--cchhhHHHHHHHHHhhccCcCeeeEEEeeccccCCCceeEEehhh
Confidence            3457899999999999998 7899999999653  23455666666666  7999999999875                


Q ss_pred             --------------eccchhhhHHHHHHHHHHHHhhcC-----CCCeEecCcCCCcEEECCCCcEEEeecCCCccccCCC
Q 039231          378 --------------LRVAEELSSTIGIARGLEYLHLGC-----STRILHFDIKPHNILLDEDFCPKISDFGLAKICNRKE  438 (506)
Q Consensus       378 --------------~~~~~~l~i~~~i~~gl~~LH~~~-----~~~ivH~dlkp~Nill~~~~~~ki~dfg~a~~~~~~~  438 (506)
                                    +++.+.+.++.|++.||+|||...     +++|+||||||+|||++.++.+||+|||+++......
T Consensus        88 ~~~g~L~~~l~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~  167 (301)
T 3q4u_A           88 HEMGSLYDYLQLTTLDTVSCLRIVLSIASGLAHLHIEIFGTQGKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQST  167 (301)
T ss_dssp             CTTCBHHHHHTTCCBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCEEECSCCCGGGEEECTTSCEEECCCTTCEEEETTT
T ss_pred             ccCCCHHHHHhhcccCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCeecCCCChHhEEEcCCCCEEEeeCCCeeeccccc
Confidence                          223346779999999999999322     5799999999999999999999999999998765543


Q ss_pred             ccee--cccCCCCcccccccccccccC----CCCccccHHHHHHHHHHHHcC----------CCCCCCCCCC
Q 039231          439 SIIS--MTGARGTVGYIAPEVFCRNIG----EVSYKSDVYNYGMMIFEMTGG----------RKNVDVVDNG  494 (506)
Q Consensus       439 ~~~~--~~~~~gt~~y~aPE~l~~~~~----~~s~~~Dv~s~G~il~elltg----------~~pf~~~~~~  494 (506)
                      ....  .....||+.|+|||.+.+...    .++.++||||||+++|||++|          +.||......
T Consensus       168 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DvwslG~il~el~tg~~~~~~~~~~~~pf~~~~~~  239 (301)
T 3q4u_A          168 NQLDVGNNPRVGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDYKPPFYDVVPN  239 (301)
T ss_dssp             TEEECCCCCCCCCGGGCCHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTTTTSCS
T ss_pred             ccccccccccccccceeChhhhcCcCCCCcccCCchhhHHHHHHHHHHHHhhhcCccccccccccccccCCC
Confidence            3221  233578999999999855311    344789999999999999999          8888765443

>2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A*

Probab=99.97  E-value=5.5e-31  Score=259.64  Aligned_cols=175  Identities=26%  Similarity=0.477  Sum_probs=145.1

Q ss_pred             hhccccCccCceEEEEEEEc------CCCEEEEEEeccCCC--CchhhHHHHHHhhccCccceeEEEEEee---------
Q 039231          316 SFKYKLGQGGYGSVYKGKLL------DGSNVAVKVLNDSKG--NGKEFINEVASISRTSHVNVVALLGFCL---------  378 (506)
Q Consensus       316 ~~~~~ig~G~~g~V~~~~~~------~~~~vavK~l~~~~~--~~~~~~~E~~~l~~l~h~niv~l~g~~~---------  378 (506)
                      .+.+.||+|+||.||+|+..      ++..||||+++....  ..+++.+|++++++++||||+++++++.         
T Consensus        26 ~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~  105 (314)
T 2ivs_A           26 VLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQVNHPHVIKLYGACSQDGPLLLIV  105 (314)
T ss_dssp             EEEEEEEECSSSEEEEEEEETGGGCSSEEEEEEEECCTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSCEEEE
T ss_pred             eeeeeecccCCeeEEEEEEeccCcccCcceEEEEeccCCCCHHHHHHHHHHHHHHhhCCCCceeeEEEEEecCCceEEEE
Confidence            34578999999999999862      357899999975432  2367889999999999999999999761         


Q ss_pred             ------------------------------------------ccchhhhHHHHHHHHHHHHhhcCCCCeEecCcCCCcEE
Q 039231          379 ------------------------------------------RVAEELSSTIGIARGLEYLHLGCSTRILHFDIKPHNIL  416 (506)
Q Consensus       379 ------------------------------------------~~~~~l~i~~~i~~gl~~LH~~~~~~ivH~dlkp~Nil  416 (506)
                                                                ++.+.+.++.||++||+|||   +++|+||||||+||+
T Consensus       106 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH---~~~ivH~dikp~NIl  182 (314)
T 2ivs_A          106 EYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYLA---EMKLVHRDLAARNIL  182 (314)
T ss_dssp             ECCTTCBHHHHHHHTTTSTTEEC----------------CEECHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEE
T ss_pred             eecCCCCHHHHHHHHhhccCCcccccccccccccccccccCcCHHHHHHHHHHHHHHHHHHH---HCCCcccccchheEE
Confidence                                                      11235678999999999999   899999999999999


Q ss_pred             ECCCCcEEEeecCCCccccCCCcceecccCCCCcccccccccccccCCCCccccHHHHHHHHHHHHc-CCCCCCCCCCCc
Q 039231          417 LDEDFCPKISDFGLAKICNRKESIISMTGARGTVGYIAPEVFCRNIGEVSYKSDVYNYGMMIFEMTG-GRKNVDVVDNGS  495 (506)
Q Consensus       417 l~~~~~~ki~dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~s~~~Dv~s~G~il~ellt-g~~pf~~~~~~~  495 (506)
                      +++++.+||+|||+++...............+++.|+|||.+.+.  .++.++||||||+++|||++ |+.||......+
T Consensus       183 i~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~--~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~  260 (314)
T 2ivs_A          183 VAEGRKMKISDFGLSRDVYEEDSYVKRSQGRIPVKWMAIESLFDH--IYTTQSDVWSFGVLLWEIVTLGGNPYPGIPPER  260 (314)
T ss_dssp             EETTTEEEECCCTTCEECTTTSCEECSSCCCSCGGGCCHHHHHHC--EECHHHHHHHHHHHHHHHHTTSCCSSTTCCGGG
T ss_pred             EcCCCCEEEccccccccccccccceeccCCCCcccccChhhhcCC--CcCchhhHHHHHHHHHHHHhCCCCCCCCCCHHH
Confidence            999999999999999877655444333456678899999998653  68999999999999999999 999998765544

>3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major}

Probab=99.97  E-value=7.1e-31  Score=264.15  Aligned_cols=178  Identities=26%  Similarity=0.337  Sum_probs=137.6

Q ss_pred             ccccCccCceEEEEEEEc-CCCEEEEEEeccCCCCchhhHHHHHHhhccCccceeEEEEEeecc----------------
Q 039231          318 KYKLGQGGYGSVYKGKLL-DGSNVAVKVLNDSKGNGKEFINEVASISRTSHVNVVALLGFCLRV----------------  380 (506)
Q Consensus       318 ~~~ig~G~~g~V~~~~~~-~~~~vavK~l~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~----------------  380 (506)
                      .+.||+|+||.||+|+.. +++.||||++...........+|++.+..++||||+++++++...                
T Consensus        28 ~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~~~lv~e~  107 (360)
T 3e3p_A           28 ERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQDPRFRNRELQIMQDLAVLHHPNIVQLQSYFYTLGERDRRDIYLNVVMEY  107 (360)
T ss_dssp             C----------CEEEEETTTCCEEEEEEEECCTTCCCHHHHHHHHHHHHCCTTBCCEEEEEEEECSSCTTCEEEEEEEEC
T ss_pred             EEEEecCCCeEEEEEEECCCCCEEEEEEEecCccccHHHHHHHHHHHhcCCCCcccHHHhhhccccccccceeEEEEeec
Confidence            578999999999999985 589999999977666667788899999999999999999876221                


Q ss_pred             ---------------------chhhhHHHHHHHHHHHHhhcCCCCeEecCcCCCcEEECC-CCcEEEeecCCCccccCCC
Q 039231          381 ---------------------AEELSSTIGIARGLEYLHLGCSTRILHFDIKPHNILLDE-DFCPKISDFGLAKICNRKE  438 (506)
Q Consensus       381 ---------------------~~~l~i~~~i~~gl~~LH~~~~~~ivH~dlkp~Nill~~-~~~~ki~dfg~a~~~~~~~  438 (506)
                                           .....++.|++.||.|||.. +++|+||||||+|||++. ++.+||+|||+++......
T Consensus       108 ~~~~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~-~~~ivH~Dlkp~NIll~~~~~~~kl~Dfg~a~~~~~~~  186 (360)
T 3e3p_A          108 VPDTLHRCCRNYYRRQVAPPPILIKVFLFQLIRSIGCLHLP-SVNVCHRDIKPHNVLVNEADGTLKLCDFGSAKKLSPSE  186 (360)
T ss_dssp             CSCBHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHTST-TTCCBCSCCCGGGEEEETTTTEEEECCCTTCBCCCTTS
T ss_pred             ccccHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhCC-CCCeecCcCCHHHEEEeCCCCcEEEeeCCCceecCCCC
Confidence                                 11356789999999999932 689999999999999996 8999999999998766544


Q ss_pred             cceecccCCCCcccccccccccccCCCCccccHHHHHHHHHHHHcCCCCCCCCCCCcchhhh
Q 039231          439 SIISMTGARGTVGYIAPEVFCRNIGEVSYKSDVYNYGMMIFEMTGGRKNVDVVDNGSTALDL  500 (506)
Q Consensus       439 ~~~~~~~~~gt~~y~aPE~l~~~~~~~s~~~Dv~s~G~il~elltg~~pf~~~~~~~~~~~~  500 (506)
                      ..   ....+|+.|+|||++.+. ..++.++||||||+++|||++|+.||...+..+....+
T Consensus       187 ~~---~~~~gt~~y~aPE~~~~~-~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~~~  244 (360)
T 3e3p_A          187 PN---VAYICSRYYRAPELIFGN-QHYTTAVDIWSVGCIFAEMMLGEPIFRGDNSAGQLHEI  244 (360)
T ss_dssp             CC---CSTTSCGGGCCHHHHTTC-SSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHH
T ss_pred             Cc---ccccCCcceeCHHHHcCC-CCCCcHHHHHHHHHHHHHHHhCCCCcCCCChHHHHHHH
Confidence            32   345789999999998553 35899999999999999999999999876655444333

>3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A*

Probab=99.97  E-value=1e-30  Score=254.06  Aligned_cols=170  Identities=28%  Similarity=0.405  Sum_probs=142.4

Q ss_pred             hccccCccCceEEEEEEEc-CCCEEEEEEeccCCCC---chhhHHHHHHhhccCccceeEEEEEe---------------
Q 039231          317 FKYKLGQGGYGSVYKGKLL-DGSNVAVKVLNDSKGN---GKEFINEVASISRTSHVNVVALLGFC---------------  377 (506)
Q Consensus       317 ~~~~ig~G~~g~V~~~~~~-~~~~vavK~l~~~~~~---~~~~~~E~~~l~~l~h~niv~l~g~~---------------  377 (506)
                      +.+.||+|+||.||+|... +++.||+|++......   .+.+.+|++++++++||||+++++++               
T Consensus        10 ~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~   89 (284)
T 3kk8_A           10 VKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVFDLVTG   89 (284)
T ss_dssp             EEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEECCCCS
T ss_pred             hhhhhcCcCCeEEEEEEEcCCCceEEEEEeecccCCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEcCCEEEEEEecCCC
Confidence            3568999999999999975 4899999999754432   25678999999999999999999987               


Q ss_pred             ------------eccchhhhHHHHHHHHHHHHhhcCCCCeEecCcCCCcEEECCCCc---EEEeecCCCccccCCCccee
Q 039231          378 ------------LRVAEELSSTIGIARGLEYLHLGCSTRILHFDIKPHNILLDEDFC---PKISDFGLAKICNRKESIIS  442 (506)
Q Consensus       378 ------------~~~~~~l~i~~~i~~gl~~LH~~~~~~ivH~dlkp~Nill~~~~~---~ki~dfg~a~~~~~~~~~~~  442 (506)
                                  +++.+.+.++.|++.||+|||   +.+|+||||||+||+++.++.   +||+|||++........   
T Consensus        90 ~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dikp~Nil~~~~~~~~~~kl~Dfg~~~~~~~~~~---  163 (284)
T 3kk8_A           90 GELFEDIVAREFYSEADASHCIQQILESIAYCH---SNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEA---  163 (284)
T ss_dssp             CBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCCGGGEEESSSSTTCCEEECCCTTCEECCSSCB---
T ss_pred             CCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH---HCCcCcCCCCHHHEEEecCCCCCcEEEeeceeeEEcccCcc---
Confidence                        223346678999999999999   899999999999999976655   99999999987654432   


Q ss_pred             cccCCCCcccccccccccccCCCCccccHHHHHHHHHHHHcCCCCCCCCCCC
Q 039231          443 MTGARGTVGYIAPEVFCRNIGEVSYKSDVYNYGMMIFEMTGGRKNVDVVDNG  494 (506)
Q Consensus       443 ~~~~~gt~~y~aPE~l~~~~~~~s~~~Dv~s~G~il~elltg~~pf~~~~~~  494 (506)
                      .....+|+.|+|||.+.+.  .++.++||||||+++|||++|+.||...+..
T Consensus       164 ~~~~~~~~~y~aPE~~~~~--~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~  213 (284)
T 3kk8_A          164 WHGFAGTPGYLSPEVLKKD--PYSKPVDIWACGVILYILLVGYPPFWDEDQH  213 (284)
T ss_dssp             CCCSCSCGGGCCHHHHTTC--CBCTHHHHHHHHHHHHHHHHSSCSSCCSSHH
T ss_pred             ccCCCCCcCCcCchhhcCC--CCCcccchHHHHHHHHHHHHCCCCCCCCchh
Confidence            2446789999999998654  6899999999999999999999999765443

>3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vhk_A* 3vid_A* 3hng_A*

Probab=99.97  E-value=8.9e-32  Score=270.64  Aligned_cols=177  Identities=28%  Similarity=0.500  Sum_probs=144.1

Q ss_pred             hhccccCccCceEEEEEEEc------CCCEEEEEEeccCCCC--chhhHHHHHHhhcc-CccceeEEEEEeecc------
Q 039231          316 SFKYKLGQGGYGSVYKGKLL------DGSNVAVKVLNDSKGN--GKEFINEVASISRT-SHVNVVALLGFCLRV------  380 (506)
Q Consensus       316 ~~~~~ig~G~~g~V~~~~~~------~~~~vavK~l~~~~~~--~~~~~~E~~~l~~l-~h~niv~l~g~~~~~------  380 (506)
                      .+.+.||+|+||.||+|++.      +++.||||+++.....  .+.+.+|++++.++ +||||+++++++.+.      
T Consensus        25 ~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpniv~~~~~~~~~~~~~~i  104 (359)
T 3vhe_A           25 KLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGGPLMV  104 (359)
T ss_dssp             EEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSTTSCCEE
T ss_pred             eeceeecCCCCceEEEEEeccccccccceEEEEEEecCcCCHHHHHHHHHHHHHHHhhcCCcceeeeeeeeecCCCceEE
Confidence            34578999999999999842      3578999999764332  25689999999999 799999999986221      


Q ss_pred             --------------------------------------------------------------------------------
Q 039231          381 --------------------------------------------------------------------------------  380 (506)
Q Consensus       381 --------------------------------------------------------------------------------  380 (506)
                                                                                                      
T Consensus       105 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  184 (359)
T 3vhe_A          105 IVEFCKFGNLSTYLRSKRNEFVPYKTKGARFRQGKDYVGAIPVDLKRRLDSITSSQSSASSGFVEEKSLSDVEEEEAPED  184 (359)
T ss_dssp             EEECCTTEEHHHHHHTTTTSBCSCC------------------------------------------------------C
T ss_pred             EEEecCCCcHHHHHHhccccccccccccchhhcccccccccchhhhccccccCccccccccccccccccchhhhcccccc
Confidence                                                                                            


Q ss_pred             --------chhhhHHHHHHHHHHHHhhcCCCCeEecCcCCCcEEECCCCcEEEeecCCCccccCCCcceecccCCCCccc
Q 039231          381 --------AEELSSTIGIARGLEYLHLGCSTRILHFDIKPHNILLDEDFCPKISDFGLAKICNRKESIISMTGARGTVGY  452 (506)
Q Consensus       381 --------~~~l~i~~~i~~gl~~LH~~~~~~ivH~dlkp~Nill~~~~~~ki~dfg~a~~~~~~~~~~~~~~~~gt~~y  452 (506)
                              .+.+.++.|++.||+|||   +++|+||||||+|||++.++.+||+|||+++...............+|+.|
T Consensus       185 ~~~~~l~~~~~~~~~~ql~~aL~~LH---~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~t~~y  261 (359)
T 3vhe_A          185 LYKDFLTLEHLICYSFQVAKGMEFLA---SRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKW  261 (359)
T ss_dssp             TTTTCBCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEECGGGCEEECCCGGGSCTTSCTTCEEC--CEECGGG
T ss_pred             hhccccCHHHHHHHHHHHHHHHHHHH---HCCcccCCCChhhEEEcCCCcEEEEeccceeeecccccchhccccCCCcee
Confidence                    123458889999999999   899999999999999999999999999999876554443334556788999


Q ss_pred             ccccccccccCCCCccccHHHHHHHHHHHHc-CCCCCCCCCCCcch
Q 039231          453 IAPEVFCRNIGEVSYKSDVYNYGMMIFEMTG-GRKNVDVVDNGSTA  497 (506)
Q Consensus       453 ~aPE~l~~~~~~~s~~~Dv~s~G~il~ellt-g~~pf~~~~~~~~~  497 (506)
                      +|||++.+.  .++.++||||||+++|||++ |+.||......+..
T Consensus       262 ~aPE~~~~~--~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~  305 (359)
T 3vhe_A          262 MAPETIFDR--VYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEF  305 (359)
T ss_dssp             CCHHHHHHC--CCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCSHHH
T ss_pred             EChhhhcCC--CCCchhhhhhHHHHHHHHHhcCCCCCCccchhHHH
Confidence            999998653  78999999999999999998 99999876655433

>1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A*

Probab=99.97  E-value=1.7e-31  Score=272.00  Aligned_cols=182  Identities=25%  Similarity=0.297  Sum_probs=148.7

Q ss_pred             ccCHHHHHHHHhhhccccCccCceEEEEEEEc-CCCEEEEEEeccCCCCchhhHHHHHHhhccC--------ccceeEEE
Q 039231          304 RYGYADIKKMTNSFKYKLGQGGYGSVYKGKLL-DGSNVAVKVLNDSKGNGKEFINEVASISRTS--------HVNVVALL  374 (506)
Q Consensus       304 ~~~~~el~~~~~~~~~~ig~G~~g~V~~~~~~-~~~~vavK~l~~~~~~~~~~~~E~~~l~~l~--------h~niv~l~  374 (506)
                      .+...++....+.+.++||+|+||.||+|+.. +++.||||+++......+.+.+|++++++++        |+||++++
T Consensus        28 ~~~~g~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~~~~~~~~~~~~iv~~~  107 (397)
T 1wak_A           28 LVKIGDLFNGRYHVIRKLGWGHFSTVWLSWDIQGKKFVAMKVVKSAEHYTETALDEIRLLKSVRNSDPNDPNREMVVQLL  107 (397)
T ss_dssp             SSCTTCEETTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSCHHHHHHHHHHHHHHHHHHHSCTTCGGGGGBCCEE
T ss_pred             EEehhhhcCCeEEEEEEeeecCCeeEEEEEecCCCeEEEEEEEecCCcchHHHHHHHHHHHHHhhcCCCCCCcceeeeee
Confidence            34444444444555678999999999999874 5889999999765545577889999999986        78899999


Q ss_pred             EEee--------------------------------ccchhhhHHHHHHHHHHHHhhcCCC-CeEecCcCCCcEEECCCC
Q 039231          375 GFCL--------------------------------RVAEELSSTIGIARGLEYLHLGCST-RILHFDIKPHNILLDEDF  421 (506)
Q Consensus       375 g~~~--------------------------------~~~~~l~i~~~i~~gl~~LH~~~~~-~ivH~dlkp~Nill~~~~  421 (506)
                      +++.                                ++.+.+.++.||+.||+|||   ++ +|+||||||+|||++.++
T Consensus       108 ~~~~~~~~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH---~~~givHrDikp~NIll~~~~  184 (397)
T 1wak_A          108 DDFKISGVNGTHICMVFEVLGHHLLKWIIKSNYQGLPLPCVKKIIQQVLQGLDYLH---TKCRIIHTDIKPENILLSVNE  184 (397)
T ss_dssp             EEEEEEETTEEEEEEEECCCCCBHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHH---HTTCEECCCCSGGGEEECCCH
T ss_pred             cceeecCCCCceEEEEEeccCccHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHH---HhCCEecCCCCHHHeeEeccc
Confidence            8752                                22336779999999999999   77 999999999999998775


Q ss_pred             -------------------------------------------------cEEEeecCCCccccCCCcceecccCCCCccc
Q 039231          422 -------------------------------------------------CPKISDFGLAKICNRKESIISMTGARGTVGY  452 (506)
Q Consensus       422 -------------------------------------------------~~ki~dfg~a~~~~~~~~~~~~~~~~gt~~y  452 (506)
                                                                       .+||+|||+++......     ....||+.|
T Consensus       185 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DfG~a~~~~~~~-----~~~~gt~~y  259 (397)
T 1wak_A          185 QYIRRLAAEATEWQRSGAPPPSGSAVSTAPATAGNFLVNPLEPKNAEKLKVKIADLGNACWVHKHF-----TEDIQTRQY  259 (397)
T ss_dssp             HHHHHHHHHHC---------------------CCTTSCCTTSGGGGGGCCEEECCGGGCEETTBCS-----CSCCSCGGG
T ss_pred             hhhhhhhhhhHHHhhcCCCCCCCCccccCCcccccccccccccccccccceEeccccccccccccC-----ccCCCCCcc
Confidence                                                             79999999998765432     445789999


Q ss_pred             ccccccccccCCCCccccHHHHHHHHHHHHcCCCCCCCCCCCc
Q 039231          453 IAPEVFCRNIGEVSYKSDVYNYGMMIFEMTGGRKNVDVVDNGS  495 (506)
Q Consensus       453 ~aPE~l~~~~~~~s~~~Dv~s~G~il~elltg~~pf~~~~~~~  495 (506)
                      +|||++.+.  .++.++||||||+++|||++|+.||...+..+
T Consensus       260 ~aPE~~~~~--~~~~~~DiwslG~il~elltg~~pf~~~~~~~  300 (397)
T 1wak_A          260 RSLEVLIGS--GYNTPADIWSTACMAFELATGDYLFEPHSGEE  300 (397)
T ss_dssp             CCHHHHHTS--CCCTHHHHHHHHHHHHHHHHSSCSCCCCCCSS
T ss_pred             cCChhhcCC--CCCcHHHHHHHHHHHHHHhhCCCCCCCCcccc
Confidence            999999654  68999999999999999999999998765543

>2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens}

Probab=99.97  E-value=6.5e-31  Score=258.14  Aligned_cols=175  Identities=26%  Similarity=0.342  Sum_probs=144.7

Q ss_pred             hhccccCccCceEEEEEEEc-CCCEEEEEEeccC-----CCCchhhHHHHHHhhccCccceeEEEEEee-----------
Q 039231          316 SFKYKLGQGGYGSVYKGKLL-DGSNVAVKVLNDS-----KGNGKEFINEVASISRTSHVNVVALLGFCL-----------  378 (506)
Q Consensus       316 ~~~~~ig~G~~g~V~~~~~~-~~~~vavK~l~~~-----~~~~~~~~~E~~~l~~l~h~niv~l~g~~~-----------  378 (506)
                      .+.+.||+|+||.||+|+.. +++.+|+|+++..     ....+.+.+|++++++++||||+++++++.           
T Consensus         8 ~i~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~lv~   87 (305)
T 2wtk_C            8 LMGDLLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNVIQLVDVLYNEEKQKMYMVM   87 (305)
T ss_dssp             CCCCEEEECSSCEEEEEEBTTTCCEEEEEEECHHHHHHSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECC---CEEEEE
T ss_pred             eEeeEEecCCCeEEEEEEECCCCcEEEEEEeccccccccchhHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCCeEEEEe
Confidence            34578999999999999975 5889999999643     233467899999999999999999999862           


Q ss_pred             -------------------ccchhhhHHHHHHHHHHHHhhcCCCCeEecCcCCCcEEECCCCcEEEeecCCCccccCCCc
Q 039231          379 -------------------RVAEELSSTIGIARGLEYLHLGCSTRILHFDIKPHNILLDEDFCPKISDFGLAKICNRKES  439 (506)
Q Consensus       379 -------------------~~~~~l~i~~~i~~gl~~LH~~~~~~ivH~dlkp~Nill~~~~~~ki~dfg~a~~~~~~~~  439 (506)
                                         ++.+.+.++.|++.||+|||   +++|+||||||+||+++.++.+||+|||++........
T Consensus        88 e~~~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH---~~~i~H~dlkp~NIl~~~~~~~kl~dfg~~~~~~~~~~  164 (305)
T 2wtk_C           88 EYCVCGMQEMLDSVPEKRFPVCQAHGYFCQLIDGLEYLH---SQGIVHKDIKPGNLLLTTGGTLKISALGVAEALHPFAA  164 (305)
T ss_dssp             ECCSEEHHHHHHHSTTCSCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECTTCCEEECCCTTCEECCTTCS
T ss_pred             hhccCCHHHHHHhCcccccCHHHHHHHHHHHHHHHHHHH---HCCeeecCCCcccEEEcCCCcEEeeccccccccCcccc
Confidence                               12235668899999999999   89999999999999999999999999999987654333


Q ss_pred             ceecccCCCCcccccccccccccCCCCccccHHHHHHHHHHHHcCCCCCCCCCC
Q 039231          440 IISMTGARGTVGYIAPEVFCRNIGEVSYKSDVYNYGMMIFEMTGGRKNVDVVDN  493 (506)
Q Consensus       440 ~~~~~~~~gt~~y~aPE~l~~~~~~~s~~~Dv~s~G~il~elltg~~pf~~~~~  493 (506)
                      ........+++.|+|||.+.+.....+.++||||||+++|||++|+.||...+.
T Consensus       165 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~  218 (305)
T 2wtk_C          165 DDTCRTSQGSPAFQPPEIANGLDTFSGFKVDIWSAGVTLYNITTGLYPFEGDNI  218 (305)
T ss_dssp             SCEECCCCSCGGGCCHHHHTCCSCEESHHHHHHHHHHHHHHHHHSSCSCCCSSH
T ss_pred             ccccccCCCCCCCcChhhccCcccCCcchhhHHHHHHHHHHHHhCCCCCCCchH
Confidence            333345678999999999865433457899999999999999999999986543

>3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii}

Probab=99.97  E-value=8.6e-31  Score=255.08  Aligned_cols=171  Identities=28%  Similarity=0.430  Sum_probs=138.9

Q ss_pred             HhhhccccCccCceEEEEEEEc-CCCEEEEEEeccCC--CCchhhHHHHHHhhccCccceeEEEEEee------------
Q 039231          314 TNSFKYKLGQGGYGSVYKGKLL-DGSNVAVKVLNDSK--GNGKEFINEVASISRTSHVNVVALLGFCL------------  378 (506)
Q Consensus       314 ~~~~~~~ig~G~~g~V~~~~~~-~~~~vavK~l~~~~--~~~~~~~~E~~~l~~l~h~niv~l~g~~~------------  378 (506)
                      .+.+.++||+|+||.||+|+.. ++..+|+|++....  ...+.+.+|++++++++||||+++++++.            
T Consensus        23 ~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~  102 (285)
T 3is5_A           23 LFIFKRKLGSGAFGDVHLVEERSSGLERVIKTINKDRSQVPMEQIEAEIEVLKSLDHPNIIKIFEVFEDYHNMYIVMETC  102 (285)
T ss_dssp             HEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCCSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEECCC
T ss_pred             heeecceeccCCCeEEEEEEEccCCceEEEEEeeccccchhHHHHHHHHHHHHhCCCchHHhHHHheecCCeEEEEEEeC
Confidence            4455688999999999999975 58899999997543  33478899999999999999999999872            


Q ss_pred             -------------------ccchhhhHHHHHHHHHHHHhhcCCCCeEecCcCCCcEEE---CCCCcEEEeecCCCccccC
Q 039231          379 -------------------RVAEELSSTIGIARGLEYLHLGCSTRILHFDIKPHNILL---DEDFCPKISDFGLAKICNR  436 (506)
Q Consensus       379 -------------------~~~~~l~i~~~i~~gl~~LH~~~~~~ivH~dlkp~Nill---~~~~~~ki~dfg~a~~~~~  436 (506)
                                         ++...+.++.|++.||+|||   +++|+||||||+||++   +.++.+||+|||+++....
T Consensus       103 ~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH---~~~ivH~dikp~NIl~~~~~~~~~~kl~Dfg~a~~~~~  179 (285)
T 3is5_A          103 EGGELLERIVSAQARGKALSEGYVAELMKQMMNALAYFH---SQHVVHKDLKPENILFQDTSPHSPIKIIDFGLAELFKS  179 (285)
T ss_dssp             SCCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCSGGGEEESSSSTTCCEEECCCCCCCC---
T ss_pred             CCCcHHHHHHhhhhcccCCCHHHHHHHHHHHHHHHHHHH---hCCEEECCCCHHHEEEecCCCCCCEEEEeeecceecCC
Confidence                               22235678999999999999   8999999999999999   4567899999999987654


Q ss_pred             CCcceecccCCCCcccccccccccccCCCCccccHHHHHHHHHHHHcCCCCCCCCCC
Q 039231          437 KESIISMTGARGTVGYIAPEVFCRNIGEVSYKSDVYNYGMMIFEMTGGRKNVDVVDN  493 (506)
Q Consensus       437 ~~~~~~~~~~~gt~~y~aPE~l~~~~~~~s~~~Dv~s~G~il~elltg~~pf~~~~~  493 (506)
                      ...   .....+|+.|+|||.+.   +.++.++||||||+++|||++|+.||.....
T Consensus       180 ~~~---~~~~~~t~~y~aPE~~~---~~~~~~~Di~slG~il~~ll~g~~pf~~~~~  230 (285)
T 3is5_A          180 DEH---STNAAGTALYMAPEVFK---RDVTFKCDIWSAGVVMYFLLTGCLPFTGTSL  230 (285)
T ss_dssp             ----------CTTGGGCCHHHHT---TCCCHHHHHHHHHHHHHHHHHSSCSSCCSSH
T ss_pred             ccc---CcCcccccCcCChHHhc---cCCCcccCeehHHHHHHHHHhCCCCCCCCCH
Confidence            332   24467899999999984   3688999999999999999999999986543

>3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} SCOP: d.144.1.7 PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3u9c_A* 4fbx_A* 3mb7_A* 3mb6_A* ...

Probab=99.97  E-value=1.2e-30  Score=259.30  Aligned_cols=170  Identities=22%  Similarity=0.362  Sum_probs=142.9

Q ss_pred             hhccccCccCceEEEEEEE-cCCCEEEEEEeccCCCCchhhHHHHHHhhccC-ccceeEEEEEeec--------------
Q 039231          316 SFKYKLGQGGYGSVYKGKL-LDGSNVAVKVLNDSKGNGKEFINEVASISRTS-HVNVVALLGFCLR--------------  379 (506)
Q Consensus       316 ~~~~~ig~G~~g~V~~~~~-~~~~~vavK~l~~~~~~~~~~~~E~~~l~~l~-h~niv~l~g~~~~--------------  379 (506)
                      .+.++||+|+||.||+|+. .+++.||||+++..  ..+.+.+|++++++++ ||||+++++++.+              
T Consensus        39 ~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~--~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~lv~e~~~  116 (330)
T 3nsz_A           39 QLVRKLGRGKYSEVFEAINITNNEKVVVKILKPV--KKKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALVFEHVN  116 (330)
T ss_dssp             EEEEEEEECSSEEEEEEEETTTCCEEEEEEECSC--CHHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCCEEEEEECCC
T ss_pred             EEEEEecccCCeEEEEEEECCCCcEEEEEEeccc--chHHHHHHHHHHHHcCCCCCEEEeeeeeccCCCCceEEEEeccC
Confidence            3457899999999999987 45899999999743  3477899999999997 9999999988732              


Q ss_pred             ------------cchhhhHHHHHHHHHHHHhhcCCCCeEecCcCCCcEEECCCC-cEEEeecCCCccccCCCcceecccC
Q 039231          380 ------------VAEELSSTIGIARGLEYLHLGCSTRILHFDIKPHNILLDEDF-CPKISDFGLAKICNRKESIISMTGA  446 (506)
Q Consensus       380 ------------~~~~l~i~~~i~~gl~~LH~~~~~~ivH~dlkp~Nill~~~~-~~ki~dfg~a~~~~~~~~~~~~~~~  446 (506)
                                  ..+.+.++.|++.||+|||   +++|+||||||+|||++.++ .+||+|||+++.......   ....
T Consensus       117 ~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH---~~~ivH~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~~~~---~~~~  190 (330)
T 3nsz_A          117 NTDFKQLYQTLTDYDIRFYMYEILKALDYCH---SMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQE---YNVR  190 (330)
T ss_dssp             CCCHHHHGGGCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEEETTTTEEEECCCTTCEECCTTCC---CCSC
T ss_pred             chhHHHHHHhCCHHHHHHHHHHHHHHHHHHH---hCCeeeCCCCHHHEEEcCCCCEEEEEeCCCceEcCCCCc---cccc
Confidence                        2335678999999999999   89999999999999999776 899999999987654433   2446


Q ss_pred             CCCcccccccccccccCCCCccccHHHHHHHHHHHHcCCCCCCCCCCC
Q 039231          447 RGTVGYIAPEVFCRNIGEVSYKSDVYNYGMMIFEMTGGRKNVDVVDNG  494 (506)
Q Consensus       447 ~gt~~y~aPE~l~~~~~~~s~~~Dv~s~G~il~elltg~~pf~~~~~~  494 (506)
                      .++..|+|||.+.+. ..++.++||||||+++|||++|+.||......
T Consensus       191 ~~~~~y~aPE~~~~~-~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~  237 (330)
T 3nsz_A          191 VASRYFKGPELLVDY-QMYDYSLDMWSLGCMLASMIFRKEPFFHGHDN  237 (330)
T ss_dssp             CSCGGGCCHHHHTTC-CCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSH
T ss_pred             cccccccChhhhcCC-CcCCchhhHHHHHHHHHHHHhCCCCcccCCch
Confidence            789999999998653 46899999999999999999999999665443

>4exu_A Mitogen-activated protein kinase 13; P38 kinase, transferase; 1.70A {Homo sapiens} PDB: 4eyj_A* 4eym_A* 3coi_A

Probab=99.97  E-value=6.4e-31  Score=265.93  Aligned_cols=171  Identities=30%  Similarity=0.389  Sum_probs=140.5

Q ss_pred             hccccCccCceEEEEEEEc-CCCEEEEEEeccCCCC---chhhHHHHHHhhccCccceeEEEEEee--------------
Q 039231          317 FKYKLGQGGYGSVYKGKLL-DGSNVAVKVLNDSKGN---GKEFINEVASISRTSHVNVVALLGFCL--------------  378 (506)
Q Consensus       317 ~~~~ig~G~~g~V~~~~~~-~~~~vavK~l~~~~~~---~~~~~~E~~~l~~l~h~niv~l~g~~~--------------  378 (506)
                      +.+.||+|+||.||+|+.. +|+.||||++......   .+.+.+|++++++++||||+++++++.              
T Consensus        46 ~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~~lv  125 (371)
T 4exu_A           46 SPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNFYDFYLV  125 (371)
T ss_dssp             EEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSSTTCCCCEEE
T ss_pred             EEeEEecCCCeEEEEEEECCCCCEEEEEEecccccchhHHHHHHHHHHHHHhcCCCCchhhhhheeccCCcccceeEEEE
Confidence            3567999999999999875 5899999999764333   367889999999999999999998762              


Q ss_pred             ----------------ccchhhhHHHHHHHHHHHHhhcCCCCeEecCcCCCcEEECCCCcEEEeecCCCccccCCCccee
Q 039231          379 ----------------RVAEELSSTIGIARGLEYLHLGCSTRILHFDIKPHNILLDEDFCPKISDFGLAKICNRKESIIS  442 (506)
Q Consensus       379 ----------------~~~~~l~i~~~i~~gl~~LH~~~~~~ivH~dlkp~Nill~~~~~~ki~dfg~a~~~~~~~~~~~  442 (506)
                                      ++.+.+.++.|++.||+|||   +++|+||||||+|||++.++.+||+|||+++......    
T Consensus       126 ~e~~~~~l~~~~~~~~~~~~~~~i~~qi~~aL~~LH---~~~ivH~Dikp~NIll~~~~~~kL~Dfg~a~~~~~~~----  198 (371)
T 4exu_A          126 MPFMQTDLQKIMGMEFSEEKIQYLVYQMLKGLKYIH---SAGVVHRDLKPGNLAVNEDCELKILDFGLARHADAEM----  198 (371)
T ss_dssp             EECCCEEHHHHTTSCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEECTTCCEEECSTTCC-----------
T ss_pred             EccccccHHHHhhcCCCHHHHHHHHHHHHHHHHHHH---HCCCcCCCcCHHHeEECCCCCEEEEecCcccccccCc----
Confidence                            23346678999999999999   8999999999999999999999999999998654332    


Q ss_pred             cccCCCCcccccccccccccCCCCccccHHHHHHHHHHHHcCCCCCCCCCCCcc
Q 039231          443 MTGARGTVGYIAPEVFCRNIGEVSYKSDVYNYGMMIFEMTGGRKNVDVVDNGST  496 (506)
Q Consensus       443 ~~~~~gt~~y~aPE~l~~~~~~~s~~~Dv~s~G~il~elltg~~pf~~~~~~~~  496 (506)
                       ....+|+.|+|||++.+. ..++.++||||||+++|||++|+.||...+..+.
T Consensus       199 -~~~~~t~~y~aPE~~~~~-~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~  250 (371)
T 4exu_A          199 -TGYVVTRWYRAPEVILSW-MHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQ  250 (371)
T ss_dssp             --CTTCCCTTSCHHHHSCC-SCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHH
T ss_pred             -CCcccCccccCHHHhcCC-CCCCcHHhHHHHHHHHHHHHhCCCCCCCCChHHH
Confidence             446789999999998652 4789999999999999999999999987654433

>2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens}

Probab=99.97  E-value=7.4e-31  Score=258.41  Aligned_cols=168  Identities=34%  Similarity=0.568  Sum_probs=133.4

Q ss_pred             hccccCccCceEEEEEEEcCCCEEEEEEeccCCCCchhhHHHHHHhhccCccceeEEEEEee------------------
Q 039231          317 FKYKLGQGGYGSVYKGKLLDGSNVAVKVLNDSKGNGKEFINEVASISRTSHVNVVALLGFCL------------------  378 (506)
Q Consensus       317 ~~~~ig~G~~g~V~~~~~~~~~~vavK~l~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~------------------  378 (506)
                      +.+.||+|+||.||+|+. .++.||||++... ...+.+.+|++++++++||||+++++++.                  
T Consensus        12 ~~~~lg~G~~g~V~~~~~-~~~~vavK~~~~~-~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~lv~e~~~~~~L~~~   89 (307)
T 2eva_A           12 VEEVVGRGAFGVVCKAKW-RAKDVAIKQIESE-SERKAFIVELRQLSRVNHPNIVKLYGACLNPVCLVMEYAEGGSLYNV   89 (307)
T ss_dssp             EEEEEECCSSSEEEEEEE-TTEEEEEEECSST-THHHHHHHHHHHHHHCCCTTBCCEEEBCTTTTEEEEECCTTCBHHHH
T ss_pred             eeeEeecCCCceEEEEEE-CCeeEEEEEecCh-hHHHHHHHHHHHHhcCCCCCcCeEEEEEcCCcEEEEEcCCCCCHHHH
Confidence            456899999999999998 4788999998643 23467899999999999999999998751                  


Q ss_pred             ----------ccchhhhHHHHHHHHHHHHhhcCCCCeEecCcCCCcEEECCCCc-EEEeecCCCccccCCCcceecccCC
Q 039231          379 ----------RVAEELSSTIGIARGLEYLHLGCSTRILHFDIKPHNILLDEDFC-PKISDFGLAKICNRKESIISMTGAR  447 (506)
Q Consensus       379 ----------~~~~~l~i~~~i~~gl~~LH~~~~~~ivH~dlkp~Nill~~~~~-~ki~dfg~a~~~~~~~~~~~~~~~~  447 (506)
                                ...+.+.++.|+++||+|||+...++|+||||||+||+++.++. +||+|||++.......     ....
T Consensus        90 l~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~~kl~Dfg~~~~~~~~~-----~~~~  164 (307)
T 2eva_A           90 LHGAEPLPYYTAAHAMSWCLQCSQGVAYLHSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTACDIQTHM-----TNNK  164 (307)
T ss_dssp             HHCSSSEECCCHHHHHHHHHHHHHHHHHHHTCSSSCCCCCCCSGGGEEEETTTTEEEECCCCC-----------------
T ss_pred             HhccCCCCccCHHHHHHHHHHHHHHHHHHHhCCCCCeecCCCChhHEEEeCCCCEEEEccccccccccccc-----ccCC
Confidence                      22335678899999999999322289999999999999988876 7999999997654322     3356


Q ss_pred             CCcccccccccccccCCCCccccHHHHHHHHHHHHcCCCCCCCCCC
Q 039231          448 GTVGYIAPEVFCRNIGEVSYKSDVYNYGMMIFEMTGGRKNVDVVDN  493 (506)
Q Consensus       448 gt~~y~aPE~l~~~~~~~s~~~Dv~s~G~il~elltg~~pf~~~~~  493 (506)
                      ||+.|+|||.+.+.  .++.++||||||+++|||++|+.||+....
T Consensus       165 gt~~y~aPE~~~~~--~~~~~~Di~slG~il~el~~g~~p~~~~~~  208 (307)
T 2eva_A          165 GSAAWMAPEVFEGS--NYSEKCDVFSWGIILWEVITRRKPFDEIGG  208 (307)
T ss_dssp             CCTTSSCHHHHTCC--CCCTHHHHHHHHHHHHHHHHTCCTTTTTCS
T ss_pred             CCCceEChhhhCCC--CCCcHHHHHHHHHHHHHHHHCCCCchhhCc
Confidence            89999999998653  789999999999999999999999986543

>1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7

Probab=99.97  E-value=3.3e-31  Score=264.66  Aligned_cols=174  Identities=26%  Similarity=0.472  Sum_probs=141.9

Q ss_pred             hccccCccCceEEEEEEEcC------CCEEEEEEeccCCC--CchhhHHHHHHhhccCccceeEEEEEeec---------
Q 039231          317 FKYKLGQGGYGSVYKGKLLD------GSNVAVKVLNDSKG--NGKEFINEVASISRTSHVNVVALLGFCLR---------  379 (506)
Q Consensus       317 ~~~~ig~G~~g~V~~~~~~~------~~~vavK~l~~~~~--~~~~~~~E~~~l~~l~h~niv~l~g~~~~---------  379 (506)
                      +.+.||+|+||.||+|+..+      ++.||||+++....  ..+.+.+|++++++++||||+++++++..         
T Consensus        51 ~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e  130 (343)
T 1luf_A           51 YVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLGVCAVGKPMCLLFE  130 (343)
T ss_dssp             EEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSCEEEEE
T ss_pred             eeeeeeecCCeeEEEEEecCcCCCCCceeEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEccCCceEEEEe
Confidence            35679999999999999753      47899999975432  23678999999999999999999998721         


Q ss_pred             ------------------------------------------cchhhhHHHHHHHHHHHHhhcCCCCeEecCcCCCcEEE
Q 039231          380 ------------------------------------------VAEELSSTIGIARGLEYLHLGCSTRILHFDIKPHNILL  417 (506)
Q Consensus       380 ------------------------------------------~~~~l~i~~~i~~gl~~LH~~~~~~ivH~dlkp~Nill  417 (506)
                                                                +.+.+.++.||++||+|||   +++|+||||||+||++
T Consensus       131 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH---~~~ivH~Dlkp~NIl~  207 (343)
T 1luf_A          131 YMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLS---ERKFVHRDLATRNCLV  207 (343)
T ss_dssp             CCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEE
T ss_pred             cCCCCcHHHHHHHhCcccccccccccccccccccccCCCCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCcceEEE
Confidence                                                      1224558999999999999   8999999999999999


Q ss_pred             CCCCcEEEeecCCCccccCCCcceecccCCCCcccccccccccccCCCCccccHHHHHHHHHHHHc-CCCCCCCCCCCc
Q 039231          418 DEDFCPKISDFGLAKICNRKESIISMTGARGTVGYIAPEVFCRNIGEVSYKSDVYNYGMMIFEMTG-GRKNVDVVDNGS  495 (506)
Q Consensus       418 ~~~~~~ki~dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~s~~~Dv~s~G~il~ellt-g~~pf~~~~~~~  495 (506)
                      ++++.+||+|||+++...............+|+.|+|||.+.+.  .++.++||||||+++|||++ |+.||......+
T Consensus       208 ~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~--~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~  284 (343)
T 1luf_A          208 GENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYN--RYTTESDVWAYGVVLWEIFSYGLQPYYGMAHEE  284 (343)
T ss_dssp             CGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHC--CCCHHHHHHHHHHHHHHHHTTTCCTTTTSCHHH
T ss_pred             CCCCeEEEeecCCCcccccCccccccCCCcccceecChhhhccC--CcCcccccHHHHHHHHHHHhcCCCcCCCCChHH
Confidence            99999999999999876544332223446678999999998654  78999999999999999999 999998765443

>1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7

Probab=99.97  E-value=6.7e-31  Score=262.74  Aligned_cols=180  Identities=28%  Similarity=0.466  Sum_probs=146.0

Q ss_pred             HhhhccccCccCceEEEEEEEc------CCCEEEEEEeccC--CCCchhhHHHHHHhhcc-CccceeEEEEEee------
Q 039231          314 TNSFKYKLGQGGYGSVYKGKLL------DGSNVAVKVLNDS--KGNGKEFINEVASISRT-SHVNVVALLGFCL------  378 (506)
Q Consensus       314 ~~~~~~~ig~G~~g~V~~~~~~------~~~~vavK~l~~~--~~~~~~~~~E~~~l~~l-~h~niv~l~g~~~------  378 (506)
                      .+.+.+.||+|+||.||+|+..      ++..||||+++..  ....+.+.+|++++.++ +||||+++++++.      
T Consensus        46 ~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~  125 (344)
T 1rjb_A           46 NLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACTLSGPIY  125 (344)
T ss_dssp             GEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCE
T ss_pred             HceeeeeecCCCCceeEEeeeeccccCCcceEEEEEecccccCHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEeeCCccE
Confidence            3344578999999999999862      3568999999753  23447899999999999 8999999999871      


Q ss_pred             --------------------------------------------ccchhhhHHHHHHHHHHHHhhcCCCCeEecCcCCCc
Q 039231          379 --------------------------------------------RVAEELSSTIGIARGLEYLHLGCSTRILHFDIKPHN  414 (506)
Q Consensus       379 --------------------------------------------~~~~~l~i~~~i~~gl~~LH~~~~~~ivH~dlkp~N  414 (506)
                                                                  ++.+++.++.||+.||+|||   +++|+||||||+|
T Consensus       126 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH---~~~ivH~Dikp~N  202 (344)
T 1rjb_A          126 LIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLE---FKSCVHRDLAARN  202 (344)
T ss_dssp             EEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHH---HTTEEETTCSGGG
T ss_pred             EEEecCCCCcHHHHHhhccccccccccchhhhcccccccccccCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCChhh
Confidence                                                        12224568999999999999   8999999999999


Q ss_pred             EEECCCCcEEEeecCCCccccCCCcceecccCCCCcccccccccccccCCCCccccHHHHHHHHHHHHc-CCCCCCCCCC
Q 039231          415 ILLDEDFCPKISDFGLAKICNRKESIISMTGARGTVGYIAPEVFCRNIGEVSYKSDVYNYGMMIFEMTG-GRKNVDVVDN  493 (506)
Q Consensus       415 ill~~~~~~ki~dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~s~~~Dv~s~G~il~ellt-g~~pf~~~~~  493 (506)
                      ||++.++.+||+|||++................+|+.|+|||.+.+.  .++.++||||||+++|||++ |+.||.....
T Consensus       203 Ill~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~--~~~~~~Di~slG~il~el~t~g~~p~~~~~~  280 (344)
T 1rjb_A          203 VLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEG--IYTIKSDVWSYGILLWEIFSLGVNPYPGIPV  280 (344)
T ss_dssp             EEEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHC--CCCHHHHHHHHHHHHHHHTTTSCCSSTTCCC
T ss_pred             EEEcCCCcEEeCCCccCcccccCccceeccCccCccCccCHHHhccC--CCChhHhHHHHHHHHHHHHcCCCCCcccCCc
Confidence            99999999999999999876554443333445678899999998653  78999999999999999998 9999988765


Q ss_pred             Ccchh
Q 039231          494 GSTAL  498 (506)
Q Consensus       494 ~~~~~  498 (506)
                      .+...
T Consensus       281 ~~~~~  285 (344)
T 1rjb_A          281 DANFY  285 (344)
T ss_dssp             SHHHH
T ss_pred             HHHHH
Confidence            54433

>3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ...

Probab=99.97  E-value=1.6e-30  Score=252.62  Aligned_cols=173  Identities=26%  Similarity=0.410  Sum_probs=142.1

Q ss_pred             HhhhccccCccCceEEEEEEEc-CCCEEEEEEeccCCC-------CchhhHHHHHHhhccCccceeEEEEEe--------
Q 039231          314 TNSFKYKLGQGGYGSVYKGKLL-DGSNVAVKVLNDSKG-------NGKEFINEVASISRTSHVNVVALLGFC--------  377 (506)
Q Consensus       314 ~~~~~~~ig~G~~g~V~~~~~~-~~~~vavK~l~~~~~-------~~~~~~~E~~~l~~l~h~niv~l~g~~--------  377 (506)
                      .+.+.+.||+|+||.||+|+.. +++.||+|+++....       ..+.+.+|++++++++||||+++++++        
T Consensus         6 ~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~l   85 (283)
T 3bhy_A            6 HYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHPNIITLHDIFENKTDVVL   85 (283)
T ss_dssp             HEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEE
T ss_pred             hhhhHHhhcccCceEEEEEEEcCCCCeeehHHhhhccccccccchHHHHHHHHHHHHHhCCCCCeeehhheecCCCeEEE
Confidence            4455678999999999999986 589999999865321       236789999999999999999999987        


Q ss_pred             -------------------eccchhhhHHHHHHHHHHHHhhcCCCCeEecCcCCCcEEECCCC----cEEEeecCCCccc
Q 039231          378 -------------------LRVAEELSSTIGIARGLEYLHLGCSTRILHFDIKPHNILLDEDF----CPKISDFGLAKIC  434 (506)
Q Consensus       378 -------------------~~~~~~l~i~~~i~~gl~~LH~~~~~~ivH~dlkp~Nill~~~~----~~ki~dfg~a~~~  434 (506)
                                         +++.+.+.++.|++.||+|||   +++++|+||||+||+++.++    .+||+|||++...
T Consensus        86 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dl~p~Nil~~~~~~~~~~~kl~dfg~~~~~  162 (283)
T 3bhy_A           86 ILELVSGGELFDFLAEKESLTEDEATQFLKQILDGVHYLH---SKRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKI  162 (283)
T ss_dssp             EEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEESCSSSSSCCEEECCCTTCEEC
T ss_pred             EEeecCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH---hCCccCCCCChHHEEEecCCCCCCceEEEecccceec
Confidence                               233346779999999999999   89999999999999998877    8999999999876


Q ss_pred             cCCCcceecccCCCCcccccccccccccCCCCccccHHHHHHHHHHHHcCCCCCCCCCCC
Q 039231          435 NRKESIISMTGARGTVGYIAPEVFCRNIGEVSYKSDVYNYGMMIFEMTGGRKNVDVVDNG  494 (506)
Q Consensus       435 ~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~s~~~Dv~s~G~il~elltg~~pf~~~~~~  494 (506)
                      .....   .....+++.|+|||.+...  .++.++||||||+++|||++|+.||......
T Consensus       163 ~~~~~---~~~~~~~~~y~aPE~~~~~--~~~~~~Di~slG~il~~l~~g~~p~~~~~~~  217 (283)
T 3bhy_A          163 EAGNE---FKNIFGTPEFVAPEIVNYE--PLGLEADMWSIGVITYILLSGASPFLGETKQ  217 (283)
T ss_dssp             C-----------CCCGGGCCHHHHTTC--CCCTHHHHHHHHHHHHHHHHSSCTTCCSSHH
T ss_pred             cCCCc---ccccCCCcCccCcceecCC--CCCcchhhhhHHHHHHHHHHCCCCCCCcchH
Confidence            54332   2345689999999998543  7889999999999999999999999875443

>3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} SCOP: d.144.1.0

Probab=99.97  E-value=6e-31  Score=253.89  Aligned_cols=169  Identities=33%  Similarity=0.535  Sum_probs=132.6

Q ss_pred             hhccccCccCceEEEEEEEcCCCEEEEEEeccCC-----CCchhhHHHHHHhhccCccceeEEEEEe-------------
Q 039231          316 SFKYKLGQGGYGSVYKGKLLDGSNVAVKVLNDSK-----GNGKEFINEVASISRTSHVNVVALLGFC-------------  377 (506)
Q Consensus       316 ~~~~~ig~G~~g~V~~~~~~~~~~vavK~l~~~~-----~~~~~~~~E~~~l~~l~h~niv~l~g~~-------------  377 (506)
                      .+.+.||+|+||.||+|++ .++.+|||+++...     ...+.+.+|++++++++||||+++++++             
T Consensus        10 ~~~~~lg~G~~g~V~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~   88 (271)
T 3dtc_A           10 TLEEIIGIGGFGKVYRAFW-IGDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNIIALRGVCLKEPNLCLVMEFA   88 (271)
T ss_dssp             EEEEEEEEETTEEEEEEEE-TTEEEEEEEC----------CHHHHHHHHHHHHHCCCTTBCCEEEEECCC--CEEEEECC
T ss_pred             eeeeeeccCCCeEEEEEEE-cCCeEEEEEEecCCcccHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEecCCceEEEEEcC
Confidence            3457899999999999997 48899999986532     2236788999999999999999999987             


Q ss_pred             -------------eccchhhhHHHHHHHHHHHHhhcCCCC---eEecCcCCCcEEECC--------CCcEEEeecCCCcc
Q 039231          378 -------------LRVAEELSSTIGIARGLEYLHLGCSTR---ILHFDIKPHNILLDE--------DFCPKISDFGLAKI  433 (506)
Q Consensus       378 -------------~~~~~~l~i~~~i~~gl~~LH~~~~~~---ivH~dlkp~Nill~~--------~~~~ki~dfg~a~~  433 (506)
                                   +++.+.+.++.|++.||+|||   +++   |+||||||+||+++.        ++.+||+|||+++.
T Consensus        89 ~~~~L~~~~~~~~~~~~~~~~i~~~l~~~l~~lH---~~~~~~i~H~dikp~Nil~~~~~~~~~~~~~~~kl~Dfg~~~~  165 (271)
T 3dtc_A           89 RGGPLNRVLSGKRIPPDILVNWAVQIARGMNYLH---DEAIVPIIHRDLKSSNILILQKVENGDLSNKILKITDFGLARE  165 (271)
T ss_dssp             TTEEHHHHHTSSCCCHHHHHHHHHHHHHHHHHHH---HSSSSCCCCSCCSGGGEEESSCCSSSCCSSCCEEECCCCC---
T ss_pred             CCCCHHHHhhcCCCCHHHHHHHHHHHHHHHHHHH---hCCCCceeecCCchHHEEEecccccccccCcceEEccCCcccc
Confidence                         223346778999999999999   677   999999999999986        67899999999986


Q ss_pred             ccCCCcceecccCCCCcccccccccccccCCCCccccHHHHHHHHHHHHcCCCCCCCCCCC
Q 039231          434 CNRKESIISMTGARGTVGYIAPEVFCRNIGEVSYKSDVYNYGMMIFEMTGGRKNVDVVDNG  494 (506)
Q Consensus       434 ~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~s~~~Dv~s~G~il~elltg~~pf~~~~~~  494 (506)
                      ......    ....+|+.|+|||.+.+.  .++.++||||||+++|||++|+.||...+..
T Consensus       166 ~~~~~~----~~~~~~~~y~aPE~~~~~--~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~  220 (271)
T 3dtc_A          166 WHRTTK----MSAAGAYAWMAPEVIRAS--MFSKGSDVWSYGVLLWELLTGEVPFRGIDGL  220 (271)
T ss_dssp             --------------CCGGGSCHHHHHHC--CCSHHHHHHHHHHHHHHHHHCCCTTTTSCHH
T ss_pred             cccccc----cCCCCccceeCHHHhccC--CCCchhhHHHHHHHHHHHHhCCCCCCCCCHH
Confidence            654332    345689999999998654  6899999999999999999999999876543

>3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7

Probab=99.97  E-value=5.1e-31  Score=266.56  Aligned_cols=177  Identities=35%  Similarity=0.589  Sum_probs=133.0

Q ss_pred             hccccCccCceEEEEEEEcC--C--CEEEEEEeccCCC--CchhhHHHHHHhhccCccceeEEEEEeec-----------
Q 039231          317 FKYKLGQGGYGSVYKGKLLD--G--SNVAVKVLNDSKG--NGKEFINEVASISRTSHVNVVALLGFCLR-----------  379 (506)
Q Consensus       317 ~~~~ig~G~~g~V~~~~~~~--~--~~vavK~l~~~~~--~~~~~~~E~~~l~~l~h~niv~l~g~~~~-----------  379 (506)
                      +.+.||+|+||.||+|++.+  +  ..||+|.++....  ..+++.+|+.++++++||||+++++++.+           
T Consensus        93 ~~~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~lv~e~  172 (373)
T 3c1x_A           93 FNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPY  172 (373)
T ss_dssp             EEEEEECCSSSEEEEEEEEETTTEEEEEEEEECCSCSCSHHHHHHHHHHTTSTTCCCTTBCCCCEEECCCSSCCEEEEEC
T ss_pred             cCcEeeeCCCeEEEEEEEECCCCcEEEEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCCCeEEEEEC
Confidence            45689999999999998642  2  4689999875432  33678999999999999999999998621           


Q ss_pred             ------------------cchhhhHHHHHHHHHHHHhhcCCCCeEecCcCCCcEEECCCCcEEEeecCCCccccCCCcce
Q 039231          380 ------------------VAEELSSTIGIARGLEYLHLGCSTRILHFDIKPHNILLDEDFCPKISDFGLAKICNRKESII  441 (506)
Q Consensus       380 ------------------~~~~l~i~~~i~~gl~~LH~~~~~~ivH~dlkp~Nill~~~~~~ki~dfg~a~~~~~~~~~~  441 (506)
                                        +.+.+.++.||++||+|||   +++|+||||||+|||+++++.+||+|||+++.........
T Consensus       173 ~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH---~~~ivHrDlkp~NIll~~~~~~kL~DFG~a~~~~~~~~~~  249 (373)
T 3c1x_A          173 MKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLA---SKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDS  249 (373)
T ss_dssp             CTTCBHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEECTTCCEEECCC-------------
T ss_pred             CCCCCHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHH---HCCEecCccchheEEECCCCCEEEeecccccccccccccc
Confidence                              2235678899999999999   8999999999999999999999999999998664332211


Q ss_pred             --ecccCCCCcccccccccccccCCCCccccHHHHHHHHHHHHc-CCCCCCCCCCCcchh
Q 039231          442 --SMTGARGTVGYIAPEVFCRNIGEVSYKSDVYNYGMMIFEMTG-GRKNVDVVDNGSTAL  498 (506)
Q Consensus       442 --~~~~~~gt~~y~aPE~l~~~~~~~s~~~Dv~s~G~il~ellt-g~~pf~~~~~~~~~~  498 (506)
                        ......+++.|+|||.+.+.  .++.++||||||+++|||++ |..||...+..+...
T Consensus       250 ~~~~~~~~~~~~y~aPE~~~~~--~~~~~~DvwSlG~il~ellt~~~~p~~~~~~~~~~~  307 (373)
T 3c1x_A          250 VHNKTGAKLPVKWMALESLQTQ--KFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITV  307 (373)
T ss_dssp             --------CCGGGSCHHHHHHC--CCCHHHHHHHHHHHHHHHHTTSCCSCTTSCSSCHHH
T ss_pred             ccccCCCCCcccccChHHhcCC--CCCcHHHHHHHHHHHHHHHhCcCCCCCCCCHHHHHH
Confidence              12335578899999998653  78999999999999999999 788887766554433

>1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A*

Probab=99.97  E-value=7.4e-31  Score=258.60  Aligned_cols=178  Identities=31%  Similarity=0.495  Sum_probs=146.9

Q ss_pred             hhhccccCccCceEEEEEEE------cCCCEEEEEEeccCCC--CchhhHHHHHHhhcc-CccceeEEEEEee-------
Q 039231          315 NSFKYKLGQGGYGSVYKGKL------LDGSNVAVKVLNDSKG--NGKEFINEVASISRT-SHVNVVALLGFCL-------  378 (506)
Q Consensus       315 ~~~~~~ig~G~~g~V~~~~~------~~~~~vavK~l~~~~~--~~~~~~~E~~~l~~l-~h~niv~l~g~~~-------  378 (506)
                      +.+.+.||+|+||.||+|+.      .+++.||||+++....  ..+.+.+|++++.++ +||||+++++++.       
T Consensus        25 y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~l  104 (313)
T 1t46_A           25 LSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACTIGGPTLV  104 (313)
T ss_dssp             EEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEE
T ss_pred             hhHHHhhCccCCcceEEEEEeeccccchhhhhHHHhcCcchhHHHHHHHHHHHHHHhhcccCCCeeeEEEEEecCCCcEE
Confidence            34567899999999999985      2467899999976543  236789999999999 8999999999871       


Q ss_pred             --------------------------------------ccchhhhHHHHHHHHHHHHhhcCCCCeEecCcCCCcEEECCC
Q 039231          379 --------------------------------------RVAEELSSTIGIARGLEYLHLGCSTRILHFDIKPHNILLDED  420 (506)
Q Consensus       379 --------------------------------------~~~~~l~i~~~i~~gl~~LH~~~~~~ivH~dlkp~Nill~~~  420 (506)
                                                            ++.+.+.++.|++.||+|||   +++|+||||||+||+++++
T Consensus       105 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dlkp~Nil~~~~  181 (313)
T 1t46_A          105 ITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLA---SKNCIHRDLAARNILLTHG  181 (313)
T ss_dssp             EEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEEETT
T ss_pred             EEecCCCCCHHHHHHhcccccccccccccccccccccCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCccceEEEcCC
Confidence                                                  12235668899999999999   8999999999999999999


Q ss_pred             CcEEEeecCCCccccCCCcceecccCCCCcccccccccccccCCCCccccHHHHHHHHHHHHc-CCCCCCCCCCCcch
Q 039231          421 FCPKISDFGLAKICNRKESIISMTGARGTVGYIAPEVFCRNIGEVSYKSDVYNYGMMIFEMTG-GRKNVDVVDNGSTA  497 (506)
Q Consensus       421 ~~~ki~dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~s~~~Dv~s~G~il~ellt-g~~pf~~~~~~~~~  497 (506)
                      +.+||+|||+++...............+|+.|+|||.+.+.  .++.++||||||+++|||++ |+.||......+..
T Consensus       182 ~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~--~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~  257 (313)
T 1t46_A          182 RITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNC--VYTFESDVWSYGIFLWELFSLGSSPYPGMPVDSKF  257 (313)
T ss_dssp             TEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHC--CCCHHHHHHHHHHHHHHHHTTTCCSSTTCCSSHHH
T ss_pred             CCEEEccccccccccccccceeccCCCCcceeeChHHhcCC--CCChHHHHHHHHHHHHHHHhCCCCCCCcccchhHH
Confidence            99999999999877655443333445678899999998653  78999999999999999999 99999877655433

>2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A*

Probab=99.97  E-value=1.7e-31  Score=265.76  Aligned_cols=179  Identities=29%  Similarity=0.464  Sum_probs=145.6

Q ss_pred             hhhccccCccCceEEEEEEEcC------CCEEEEEEeccCCC--CchhhHHHHHHhhcc-CccceeEEEEEee-------
Q 039231          315 NSFKYKLGQGGYGSVYKGKLLD------GSNVAVKVLNDSKG--NGKEFINEVASISRT-SHVNVVALLGFCL-------  378 (506)
Q Consensus       315 ~~~~~~ig~G~~g~V~~~~~~~------~~~vavK~l~~~~~--~~~~~~~E~~~l~~l-~h~niv~l~g~~~-------  378 (506)
                      +.+.+.||+|+||.||+|+...      ...||+|+++....  ..+.+.+|+++++++ +||||+++++++.       
T Consensus        48 ~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~l  127 (333)
T 2i1m_A           48 LQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHENIVNLLGACTHGGPVLV  127 (333)
T ss_dssp             EEEEEEEEECSSEEEEEEEETTCSSSCCCCEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEE
T ss_pred             ceeeeEeccCCCcceEEEEecCCCcccchhHHHHHhcccccChHHHHHHHHHHHHHHhhcCCCCeeeEEEEEecCCceEE
Confidence            3445789999999999998743      24799999976532  236788999999999 8999999999871       


Q ss_pred             ----------------------------------ccchhhhHHHHHHHHHHHHhhcCCCCeEecCcCCCcEEECCCCcEE
Q 039231          379 ----------------------------------RVAEELSSTIGIARGLEYLHLGCSTRILHFDIKPHNILLDEDFCPK  424 (506)
Q Consensus       379 ----------------------------------~~~~~l~i~~~i~~gl~~LH~~~~~~ivH~dlkp~Nill~~~~~~k  424 (506)
                                                        ++.+.+.++.|++.||+|||   +++|+||||||+|||+++++.+|
T Consensus       128 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH---~~~ivH~Dlkp~NIl~~~~~~~k  204 (333)
T 2i1m_A          128 ITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSSQVAQGMAFLA---SKNCIHRDVAARNVLLTNGHVAK  204 (333)
T ss_dssp             EEECCTTEEHHHHHHHHHHHHSCC-------CCCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGCEEEGGGEEE
T ss_pred             EEecCCCCcHHHHHHHhcccccccccccccccccCHHHHHHHHHHHHHHHHHHh---cCCcccCCcccceEEECCCCeEE
Confidence                                              22234568899999999999   89999999999999999999999


Q ss_pred             EeecCCCccccCCCcceecccCCCCcccccccccccccCCCCccccHHHHHHHHHHHHc-CCCCCCCCCCCcchh
Q 039231          425 ISDFGLAKICNRKESIISMTGARGTVGYIAPEVFCRNIGEVSYKSDVYNYGMMIFEMTG-GRKNVDVVDNGSTAL  498 (506)
Q Consensus       425 i~dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~s~~~Dv~s~G~il~ellt-g~~pf~~~~~~~~~~  498 (506)
                      |+|||+++...............+|+.|+|||.+.+.  .++.++||||||+++|||++ |..||......+...
T Consensus       205 l~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~--~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~~~  277 (333)
T 2i1m_A          205 IGDFGLARDIMNDSNYIVKGNARLPVKWMAPESIFDC--VYTVQSDVWSYGILLWEIFSLGLNPYPGILVNSKFY  277 (333)
T ss_dssp             BCCCGGGCCGGGCTTSEECSSCEECGGGSCHHHHHHC--CCCHHHHHHHHHHHHHHHTTTSCCSSTTCCSSHHHH
T ss_pred             ECccccccccccccceeecCCCCCCccccCHHHhccC--CCChHHHHHHHHHHHHHHHcCCCCCCcccchhHHHH
Confidence            9999999876554433333445678899999998654  78999999999999999998 999998766554433

>3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 4dea_A* 4deb_A* ...

Probab=99.97  E-value=1.1e-30  Score=253.33  Aligned_cols=169  Identities=28%  Similarity=0.434  Sum_probs=139.0

Q ss_pred             hccccCccCceEEEEEEEcC-CCEEEEEEeccC----CCCchhhHHHHHHhhccCccceeEEEEEee-------------
Q 039231          317 FKYKLGQGGYGSVYKGKLLD-GSNVAVKVLNDS----KGNGKEFINEVASISRTSHVNVVALLGFCL-------------  378 (506)
Q Consensus       317 ~~~~ig~G~~g~V~~~~~~~-~~~vavK~l~~~----~~~~~~~~~E~~~l~~l~h~niv~l~g~~~-------------  378 (506)
                      +.+.||+|+||.||+|+... +..||+|++...    ....+.+.+|++++++++||||+++++++.             
T Consensus        13 ~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~   92 (279)
T 3fdn_A           13 IGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAP   92 (279)
T ss_dssp             EEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEECCCT
T ss_pred             EeeEEecCCCeEEEEEEEccCCcEEEEEEEeccccchhhHHHHHHHHHHHHHcCCCCCCcchhheEecCCEEEEEEecCC
Confidence            35679999999999998754 779999998542    233467889999999999999999999872             


Q ss_pred             --------------ccchhhhHHHHHHHHHHHHhhcCCCCeEecCcCCCcEEECCCCcEEEeecCCCccccCCCcceecc
Q 039231          379 --------------RVAEELSSTIGIARGLEYLHLGCSTRILHFDIKPHNILLDEDFCPKISDFGLAKICNRKESIISMT  444 (506)
Q Consensus       379 --------------~~~~~l~i~~~i~~gl~~LH~~~~~~ivH~dlkp~Nill~~~~~~ki~dfg~a~~~~~~~~~~~~~  444 (506)
                                    ++.+.+.++.|++.||+|||   +++|+||||||+||+++.++.+||+|||++........    .
T Consensus        93 ~~~l~~~l~~~~~~~~~~~~~~~~qi~~~l~~LH---~~~i~H~dlkp~Nili~~~~~~~l~Dfg~~~~~~~~~~----~  165 (279)
T 3fdn_A           93 LGTVYRELQKLSKFDEQRTATYITELANALSYCH---SKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRR----T  165 (279)
T ss_dssp             TEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHH---TTTCEECCCCGGGEEECTTSCEEECSCCEESCC----------
T ss_pred             CCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH---hCCEecccCChHhEEEcCCCCEEEEeccccccCCcccc----c
Confidence                          23346678999999999999   89999999999999999999999999998865443321    3


Q ss_pred             cCCCCcccccccccccccCCCCccccHHHHHHHHHHHHcCCCCCCCCCCC
Q 039231          445 GARGTVGYIAPEVFCRNIGEVSYKSDVYNYGMMIFEMTGGRKNVDVVDNG  494 (506)
Q Consensus       445 ~~~gt~~y~aPE~l~~~~~~~s~~~Dv~s~G~il~elltg~~pf~~~~~~  494 (506)
                      ...+++.|+|||.+.+.  .++.++||||||+++|||++|+.||......
T Consensus       166 ~~~~~~~y~aPE~~~~~--~~~~~~Di~slG~il~~l~~g~~p~~~~~~~  213 (279)
T 3fdn_A          166 DLCGTLDYLPPEMIEGR--MHDEKVDLWSLGVLCYEFLVGKPPFEANTYQ  213 (279)
T ss_dssp             --CCCCTTCCHHHHTTC--CCCTTHHHHHHHHHHHHHHHSSCTTCCSSHH
T ss_pred             ccCCCCCccCHhHhccC--CCCccchhHhHHHHHHHHHHCCCCCCCCcHH
Confidence            45789999999998654  6789999999999999999999999865443

>4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens}

Probab=99.97  E-value=4.7e-31  Score=269.24  Aligned_cols=173  Identities=24%  Similarity=0.384  Sum_probs=143.3

Q ss_pred             hhccccCccCceEEEEEEEcC-CCEEEEEEeccCC--CCchhhHHHHHHhhccCccceeEEEEEee--------------
Q 039231          316 SFKYKLGQGGYGSVYKGKLLD-GSNVAVKVLNDSK--GNGKEFINEVASISRTSHVNVVALLGFCL--------------  378 (506)
Q Consensus       316 ~~~~~ig~G~~g~V~~~~~~~-~~~vavK~l~~~~--~~~~~~~~E~~~l~~l~h~niv~l~g~~~--------------  378 (506)
                      .+.++||+|+||.||+|++.. ++.||||+++...  ...+.+.+|++++++++||||+++++++.              
T Consensus        12 ~i~~~LG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~lv~e~~   91 (396)
T 4eut_A           12 LLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHKVLIMEFC   91 (396)
T ss_dssp             EEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGGSCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCCEEEEECCC
T ss_pred             EEEEEEEcCCCeEEEEEEECCCCcEEEEEEeccccccchHHHHHHHHHHHHhcCCCCCCeEEEeeccCCCCeeEEEEecC
Confidence            345689999999999999864 8999999997533  33467889999999999999999998762              


Q ss_pred             ------------------ccchhhhHHHHHHHHHHHHhhcCCCCeEecCcCCCcEEE----CCCCcEEEeecCCCccccC
Q 039231          379 ------------------RVAEELSSTIGIARGLEYLHLGCSTRILHFDIKPHNILL----DEDFCPKISDFGLAKICNR  436 (506)
Q Consensus       379 ------------------~~~~~l~i~~~i~~gl~~LH~~~~~~ivH~dlkp~Nill----~~~~~~ki~dfg~a~~~~~  436 (506)
                                        ++.+.+.++.|++.||+|||   +++|+||||||+|||+    +.++.+||+|||+++....
T Consensus        92 ~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH---~~~ivH~Dlkp~NIll~~~~~~~~~~kL~DFG~a~~~~~  168 (396)
T 4eut_A           92 PCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLR---ENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELED  168 (396)
T ss_dssp             TTEEHHHHTTSGGGTTCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEEEECTTSCEEEEECCGGGCEECCC
T ss_pred             CCCCHHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHHH---HCCEEECCcCHHHEEEeecCCCceeEEEecCCCceEccC
Confidence                              22335678999999999999   8999999999999999    7788899999999987655


Q ss_pred             CCcceecccCCCCcccccccccccc------cCCCCccccHHHHHHHHHHHHcCCCCCCCCCCC
Q 039231          437 KESIISMTGARGTVGYIAPEVFCRN------IGEVSYKSDVYNYGMMIFEMTGGRKNVDVVDNG  494 (506)
Q Consensus       437 ~~~~~~~~~~~gt~~y~aPE~l~~~------~~~~s~~~Dv~s~G~il~elltg~~pf~~~~~~  494 (506)
                      ...   .....||+.|+|||++.+.      ...++.++||||||+++|||++|+.||......
T Consensus       169 ~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwSlG~il~el~tg~~Pf~~~~~~  229 (396)
T 4eut_A          169 DEQ---FVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGP  229 (396)
T ss_dssp             GGG---SSCSSSCCTTCCHHHHHHHCC--CHHHHHHHHHHHHHHHHHHHHHHHSSCSEECTTCT
T ss_pred             CCc---cccccCCccccCHHHhhccccccccccCCCcHHHHHHHHHHHHHHHHCCCCCCCCCcc
Confidence            432   2446789999999998541      135678999999999999999999999865543

>1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} PDB: 3fpq_A

Probab=99.97  E-value=3e-30  Score=251.72  Aligned_cols=168  Identities=29%  Similarity=0.426  Sum_probs=140.0

Q ss_pred             hccccCccCceEEEEEEEc-CCCEEEEEEeccCCC---CchhhHHHHHHhhccCccceeEEEEEee--------------
Q 039231          317 FKYKLGQGGYGSVYKGKLL-DGSNVAVKVLNDSKG---NGKEFINEVASISRTSHVNVVALLGFCL--------------  378 (506)
Q Consensus       317 ~~~~ig~G~~g~V~~~~~~-~~~~vavK~l~~~~~---~~~~~~~E~~~l~~l~h~niv~l~g~~~--------------  378 (506)
                      +.+.||+|+||.||+|... ++..||+|++.....   ..+.+.+|++++++++||||+++++++.              
T Consensus        30 ~~~~lg~G~~g~Vy~~~~~~~~~~va~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~lv~e  109 (290)
T 1t4h_A           30 FDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLVTE  109 (290)
T ss_dssp             EEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEEEEEEEE
T ss_pred             eeeeccCCCCeEEEEeEecCCceEEEEEEecchhhCHHHHHHHHHHHHHHHhCCCCCeeeeeeeeccccCCCceEEEEEE
Confidence            4567999999999999875 478999999975432   2356889999999999999999998652              


Q ss_pred             -----------------ccchhhhHHHHHHHHHHHHhhcCCCC--eEecCcCCCcEEEC-CCCcEEEeecCCCccccCCC
Q 039231          379 -----------------RVAEELSSTIGIARGLEYLHLGCSTR--ILHFDIKPHNILLD-EDFCPKISDFGLAKICNRKE  438 (506)
Q Consensus       379 -----------------~~~~~l~i~~~i~~gl~~LH~~~~~~--ivH~dlkp~Nill~-~~~~~ki~dfg~a~~~~~~~  438 (506)
                                       ++...+.++.|++.||+|||   +.+  |+|+||||+||+++ +++.+||+|||++.......
T Consensus       110 ~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH---~~~~~i~H~dikp~Nil~~~~~~~~kl~Dfg~~~~~~~~~  186 (290)
T 1t4h_A          110 LMTSGTLKTYLKRFKVMKIKVLRSWCRQILKGLQFLH---TRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRASF  186 (290)
T ss_dssp             CCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHH---TSSSCCCCSCCCGGGEEESSTTSCEEECCTTGGGGCCTTS
T ss_pred             ecCCCCHHHHHHHccCCCHHHHHHHHHHHHHHHHHHH---cCCCCEEECCCCHHHEEEECCCCCEEEeeCCCcccccccc
Confidence                             22335678999999999999   888  99999999999997 78999999999997654432


Q ss_pred             cceecccCCCCcccccccccccccCCCCccccHHHHHHHHHHHHcCCCCCCCCCCC
Q 039231          439 SIISMTGARGTVGYIAPEVFCRNIGEVSYKSDVYNYGMMIFEMTGGRKNVDVVDNG  494 (506)
Q Consensus       439 ~~~~~~~~~gt~~y~aPE~l~~~~~~~s~~~Dv~s~G~il~elltg~~pf~~~~~~  494 (506)
                      .    ....+|+.|+|||.+.   +.++.++||||||+++|||++|+.||......
T Consensus       187 ~----~~~~~t~~y~aPE~~~---~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~  235 (290)
T 1t4h_A          187 A----KAVIGTPEFMAPEMYE---EKYDESVDVYAFGMCMLEMATSEYPYSECQNA  235 (290)
T ss_dssp             B----EESCSSCCCCCGGGGG---TCCCTHHHHHHHHHHHHHHHHSSCTTTTCSSH
T ss_pred             c----ccccCCcCcCCHHHHh---ccCCCcchHHHHHHHHHHHHhCCCCCCCcCcH
Confidence            2    3456899999999884   35899999999999999999999999875443

>2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A*

Probab=99.97  E-value=2.2e-30  Score=253.21  Aligned_cols=171  Identities=29%  Similarity=0.407  Sum_probs=143.8

Q ss_pred             hccccCccCceEEEEEEEcC-CCEEEEEEeccCCC----CchhhHHHHHHhhccCccceeEEEEEe--------------
Q 039231          317 FKYKLGQGGYGSVYKGKLLD-GSNVAVKVLNDSKG----NGKEFINEVASISRTSHVNVVALLGFC--------------  377 (506)
Q Consensus       317 ~~~~ig~G~~g~V~~~~~~~-~~~vavK~l~~~~~----~~~~~~~E~~~l~~l~h~niv~l~g~~--------------  377 (506)
                      ..+.||+|+||.||+|+..+ ++.+|+|++.....    ..+.+.+|++++++++||||+++++++              
T Consensus        19 ~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~   98 (294)
T 2rku_A           19 RGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFVVLELCR   98 (294)
T ss_dssp             EEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEECCT
T ss_pred             EEEEEeecCCEEEEEEEECCCCceEEEEEechhhccCHHHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCEEEEEEecCC
Confidence            35679999999999999864 78999999865432    235688999999999999999999987              


Q ss_pred             -------------eccchhhhHHHHHHHHHHHHhhcCCCCeEecCcCCCcEEECCCCcEEEeecCCCccccCCCcceecc
Q 039231          378 -------------LRVAEELSSTIGIARGLEYLHLGCSTRILHFDIKPHNILLDEDFCPKISDFGLAKICNRKESIISMT  444 (506)
Q Consensus       378 -------------~~~~~~l~i~~~i~~gl~~LH~~~~~~ivH~dlkp~Nill~~~~~~ki~dfg~a~~~~~~~~~~~~~  444 (506)
                                   +++.+.+.++.|+++||+|||   +.+++||||||+||+++.++.+||+|||+++........  ..
T Consensus        99 ~~~L~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH---~~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~~--~~  173 (294)
T 2rku_A           99 RRSLLELHKRRKALTEPEARYYLRQIVLGCQYLH---RNRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGER--KK  173 (294)
T ss_dssp             TCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEECTTCCEEECCCTTCEECCSTTCC--BC
T ss_pred             CCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH---HCCccccCCChHhEEEcCCCCEEEEeccCceecccCccc--cc
Confidence                         233446778999999999999   899999999999999999999999999999876543322  23


Q ss_pred             cCCCCcccccccccccccCCCCccccHHHHHHHHHHHHcCCCCCCCCCCC
Q 039231          445 GARGTVGYIAPEVFCRNIGEVSYKSDVYNYGMMIFEMTGGRKNVDVVDNG  494 (506)
Q Consensus       445 ~~~gt~~y~aPE~l~~~~~~~s~~~Dv~s~G~il~elltg~~pf~~~~~~  494 (506)
                      ...+++.|+|||.+.+.  .++.++||||||+++|||++|+.||......
T Consensus       174 ~~~~~~~y~aPE~~~~~--~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~  221 (294)
T 2rku_A          174 VLCGTPNYIAPEVLSKK--GHSFEVDVWSIGCIMYTLLVGKPPFETSCLK  221 (294)
T ss_dssp             CCCSCCSSCCHHHHTTS--CBCTHHHHHHHHHHHHHHHHSSCTTCCSSHH
T ss_pred             cccCCCCcCCcchhccC--CCCchhhHHHHHHHHHHHHhCCCCCCCCCHH
Confidence            46789999999998653  6789999999999999999999999876543

>3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A*

Probab=99.97  E-value=1.6e-30  Score=272.45  Aligned_cols=174  Identities=29%  Similarity=0.449  Sum_probs=144.4

Q ss_pred             HHhhhccccCccCceEEEEEEEc-CCCEEEEEEecc---CCCCchhhHHHHHHhhccCccceeEEEEEe-----------
Q 039231          313 MTNSFKYKLGQGGYGSVYKGKLL-DGSNVAVKVLND---SKGNGKEFINEVASISRTSHVNVVALLGFC-----------  377 (506)
Q Consensus       313 ~~~~~~~~ig~G~~g~V~~~~~~-~~~~vavK~l~~---~~~~~~~~~~E~~~l~~l~h~niv~l~g~~-----------  377 (506)
                      ..+.+.++||+|+||.||+|+.. +++.||||++..   .....+.+.+|++++++++||||+++++++           
T Consensus        22 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e  101 (486)
T 3mwu_A           22 ERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILEDSSSFYIVGE  101 (486)
T ss_dssp             HHEEEEEEEECCSSSEEEEEEETTTCCEEEEEEEEHHHHBCSCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEC
T ss_pred             cceEEeEEEeecCCEEEEEEEECCCCCEEEEEEEecccccchHHHHHHHHHHHHHhCCCCCcCeEEEEEEcCCEEEEEEE
Confidence            34556688999999999999985 589999999964   233457889999999999999999999887           


Q ss_pred             ----------------eccchhhhHHHHHHHHHHHHhhcCCCCeEecCcCCCcEEEC---CCCcEEEeecCCCccccCCC
Q 039231          378 ----------------LRVAEELSSTIGIARGLEYLHLGCSTRILHFDIKPHNILLD---EDFCPKISDFGLAKICNRKE  438 (506)
Q Consensus       378 ----------------~~~~~~l~i~~~i~~gl~~LH~~~~~~ivH~dlkp~Nill~---~~~~~ki~dfg~a~~~~~~~  438 (506)
                                      +++.+.+.++.||+.||+|||   +++|+||||||+|||++   .++.+||+|||+++......
T Consensus       102 ~~~~~~L~~~~~~~~~~~~~~~~~i~~qi~~al~~lH---~~~ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~~~~~  178 (486)
T 3mwu_A          102 LYTGGELFDEIIKRKRFSEHDAARIIKQVFSGITYMH---KHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNT  178 (486)
T ss_dssp             CCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEESSSSTTCCEEECSCSCTTTBCCC-
T ss_pred             cCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH---HCCeEeccCchHHEEEecCCCCCCEEEEECCcCeECCCCC
Confidence                            233446779999999999999   89999999999999995   45679999999998765443


Q ss_pred             cceecccCCCCcccccccccccccCCCCccccHHHHHHHHHHHHcCCCCCCCCCCCc
Q 039231          439 SIISMTGARGTVGYIAPEVFCRNIGEVSYKSDVYNYGMMIFEMTGGRKNVDVVDNGS  495 (506)
Q Consensus       439 ~~~~~~~~~gt~~y~aPE~l~~~~~~~s~~~Dv~s~G~il~elltg~~pf~~~~~~~  495 (506)
                      .   .....||+.|+|||++.+   .++.++||||+|+++|||++|+.||......+
T Consensus       179 ~---~~~~~gt~~y~aPE~~~~---~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~  229 (486)
T 3mwu_A          179 K---MKDRIGTAYYIAPEVLRG---TYDEKCDVWSAGVILYILLSGTPPFYGKNEYD  229 (486)
T ss_dssp             ------CCTTGGGGCCGGGGGS---CCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHH
T ss_pred             c---cCCCcCCCCCCCHHHhCC---CCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH
Confidence            2   245679999999999843   58999999999999999999999997765433

>1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7

Probab=99.97  E-value=1.6e-30  Score=253.35  Aligned_cols=172  Identities=28%  Similarity=0.494  Sum_probs=143.3

Q ss_pred             cccCccCceEEEEEEEc---CCCEEEEEEeccCCC--CchhhHHHHHHhhccCccceeEEEEEe----------------
Q 039231          319 YKLGQGGYGSVYKGKLL---DGSNVAVKVLNDSKG--NGKEFINEVASISRTSHVNVVALLGFC----------------  377 (506)
Q Consensus       319 ~~ig~G~~g~V~~~~~~---~~~~vavK~l~~~~~--~~~~~~~E~~~l~~l~h~niv~l~g~~----------------  377 (506)
                      +.||+|+||.||+|++.   ++..||||+++....  ..+++.+|++++++++||||+++++++                
T Consensus        16 ~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~lv~e~~~~~~   95 (287)
T 1u59_A           16 IELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQAEALMLVMEMAGGGP   95 (287)
T ss_dssp             EEEECCTTEEEEEEEEC---CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEESSSEEEEEECCTTEE
T ss_pred             ccccccCceeEEEeEeccCCCcceEEEEecCCccchhHHHHHHHHHHHHHhCCCCCEeEEEEEecCCCcEEEEEeCCCCC
Confidence            37999999999999864   578899999976432  336789999999999999999999986                


Q ss_pred             -----------eccchhhhHHHHHHHHHHHHhhcCCCCeEecCcCCCcEEECCCCcEEEeecCCCccccCCCccee-ccc
Q 039231          378 -----------LRVAEELSSTIGIARGLEYLHLGCSTRILHFDIKPHNILLDEDFCPKISDFGLAKICNRKESIIS-MTG  445 (506)
Q Consensus       378 -----------~~~~~~l~i~~~i~~gl~~LH~~~~~~ivH~dlkp~Nill~~~~~~ki~dfg~a~~~~~~~~~~~-~~~  445 (506)
                                 +++.+.+.++.|++.||+|||   +.+|+||||||+||++++++.+||+|||+++.......... ...
T Consensus        96 L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~  172 (287)
T 1u59_A           96 LHKFLVGKREEIPVSNVAELLHQVSMGMKYLE---EKNFVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSA  172 (287)
T ss_dssp             HHHHHTTCTTTSCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEEEETTEEEECCCTTCEECTTCSCEECCCCS
T ss_pred             HHHHHHhCCccCCHHHHHHHHHHHHHHHHHHH---HCCEeeCCCchheEEEcCCCCEEECcccceeeeccCcceeecccc
Confidence                       223346779999999999999   89999999999999999999999999999987754433221 233


Q ss_pred             CCCCcccccccccccccCCCCccccHHHHHHHHHHHHc-CCCCCCCCCCCc
Q 039231          446 ARGTVGYIAPEVFCRNIGEVSYKSDVYNYGMMIFEMTG-GRKNVDVVDNGS  495 (506)
Q Consensus       446 ~~gt~~y~aPE~l~~~~~~~s~~~Dv~s~G~il~ellt-g~~pf~~~~~~~  495 (506)
                      ..+|+.|+|||.+.+.  .++.++||||||+++|||++ |+.||......+
T Consensus       173 ~~~~~~y~aPE~~~~~--~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~  221 (287)
T 1u59_A          173 GKWPLKWYAPECINFR--KFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPE  221 (287)
T ss_dssp             SCCCGGGCCHHHHHHC--EECHHHHHHHHHHHHHHHHTTSCCTTTTCCTHH
T ss_pred             ccccccccCHHHhccC--CCCchhhHHHHHHHHHHHHcCCCCCcccCCHHH
Confidence            4568899999998543  68899999999999999998 999998765544

>2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A*

Probab=99.97  E-value=1.2e-30  Score=261.87  Aligned_cols=173  Identities=25%  Similarity=0.348  Sum_probs=141.1

Q ss_pred             hccccCccCceEEEEEEEc-CCCEEEEEEeccCCC--CchhhHHHHHHhhccCccceeEEEEEee---------------
Q 039231          317 FKYKLGQGGYGSVYKGKLL-DGSNVAVKVLNDSKG--NGKEFINEVASISRTSHVNVVALLGFCL---------------  378 (506)
Q Consensus       317 ~~~~ig~G~~g~V~~~~~~-~~~~vavK~l~~~~~--~~~~~~~E~~~l~~l~h~niv~l~g~~~---------------  378 (506)
                      +.+.||+|+||.||+|+.. +|+.||||++.....  ....+.+|++++++++||||+++++++.               
T Consensus        15 ~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~lv~e   94 (353)
T 2b9h_A           15 LKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRTLREIKILKHFKHENIITIFNIQRPDSFENFNEVYIIQE   94 (353)
T ss_dssp             EEEEEEECSSEEEEEEEETTTTEEEEEEEECCCSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCSTTCCCEEEEEC
T ss_pred             EeeEEcCCCCeEEEEEEECCCCcEEEEEeecccccchHHHHHHHHHHHHHhCcCCCcCCeeeeecccccCccceEEEEEe
Confidence            3567999999999999985 589999999965432  2356789999999999999999998752               


Q ss_pred             ---------------ccchhhhHHHHHHHHHHHHhhcCCCCeEecCcCCCcEEECCCCcEEEeecCCCccccCCCcce--
Q 039231          379 ---------------RVAEELSSTIGIARGLEYLHLGCSTRILHFDIKPHNILLDEDFCPKISDFGLAKICNRKESII--  441 (506)
Q Consensus       379 ---------------~~~~~l~i~~~i~~gl~~LH~~~~~~ivH~dlkp~Nill~~~~~~ki~dfg~a~~~~~~~~~~--  441 (506)
                                     ++.+.+.++.|++.||+|||   +++|+||||||+|||++.++.+||+|||+++.........  
T Consensus        95 ~~~~~L~~~~~~~~~~~~~~~~~~~qi~~~L~~LH---~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~~~~~~~  171 (353)
T 2b9h_A           95 LMQTDLHRVISTQMLSDDHIQYFIYQTLRAVKVLH---GSNVIHRDLKPSNLLINSNCDLKVCDFGLARIIDESAADNSE  171 (353)
T ss_dssp             CCSEEHHHHHHHCCCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCCGGGEEECTTCCEEECCCTTCEECC--------
T ss_pred             ccCccHHHHHhhcCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHeEEcCCCcEEEEecccccccccccccccC
Confidence                           23346678999999999999   8999999999999999999999999999998765332111  


Q ss_pred             ------ecccCCCCcccccccccccccCCCCccccHHHHHHHHHHHHcCCCCCCCCCC
Q 039231          442 ------SMTGARGTVGYIAPEVFCRNIGEVSYKSDVYNYGMMIFEMTGGRKNVDVVDN  493 (506)
Q Consensus       442 ------~~~~~~gt~~y~aPE~l~~~~~~~s~~~Dv~s~G~il~elltg~~pf~~~~~  493 (506)
                            ......||+.|+|||++.+. ..++.++||||||+++|||++|+.||...+.
T Consensus       172 ~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~~Di~slG~il~~l~~g~~pf~~~~~  228 (353)
T 2b9h_A          172 PTGQQSGMVEFVATRWYRAPEVMLTS-AKYSRAMDVWSCGCILAELFLRRPIFPGRDY  228 (353)
T ss_dssp             --------CCCCCCGGGCCHHHHHSC-CCCCHHHHHHHHHHHHHHHHHSSCSCCCSSH
T ss_pred             ccccccchhhccccccccCCeeeccC-CCccchhhHHHHHHHHHHHHhCCCCCCCCCc
Confidence                  11235689999999987543 4689999999999999999999999987653

>2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens}

Probab=99.97  E-value=7.7e-31  Score=281.82  Aligned_cols=173  Identities=27%  Similarity=0.487  Sum_probs=139.6

Q ss_pred             ccCccCceEEEEEEEc---CCCEEEEEEeccCC--CCchhhHHHHHHhhccCccceeEEEEEe-----------------
Q 039231          320 KLGQGGYGSVYKGKLL---DGSNVAVKVLNDSK--GNGKEFINEVASISRTSHVNVVALLGFC-----------------  377 (506)
Q Consensus       320 ~ig~G~~g~V~~~~~~---~~~~vavK~l~~~~--~~~~~~~~E~~~l~~l~h~niv~l~g~~-----------------  377 (506)
                      +||+|+||.||+|.+.   ++..||||+++...  ...+++.+|+++|++++|||||++++++                 
T Consensus       343 ~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~~~~~lv~E~~~~g~L  422 (613)
T 2ozo_A          343 ELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQAEALMLVMEMAGGGPL  422 (613)
T ss_dssp             EEEECSSSEEEEEEEECSSCEEEEEEEECCCCCSSTTHHHHHHHHHHHTTCCCTTBCCEEEEEESSSEEEEEECCTTCBH
T ss_pred             EEecCCCcEEEEEEEecCCCcEEEEEEEcCCCCChHHHHHHHHHHHHHHhCCCCCEeeEEEEeccCCeEEEEEeCCCCcH
Confidence            6999999999999874   45679999997643  3447899999999999999999999987                 


Q ss_pred             ----------eccchhhhHHHHHHHHHHHHhhcCCCCeEecCcCCCcEEECCCCcEEEeecCCCccccCCCccee-cccC
Q 039231          378 ----------LRVAEELSSTIGIARGLEYLHLGCSTRILHFDIKPHNILLDEDFCPKISDFGLAKICNRKESIIS-MTGA  446 (506)
Q Consensus       378 ----------~~~~~~l~i~~~i~~gl~~LH~~~~~~ivH~dlkp~Nill~~~~~~ki~dfg~a~~~~~~~~~~~-~~~~  446 (506)
                                +++.+.+.++.||+.||+|||   +++|+||||||+|||+++++.+||+|||+++.......... ....
T Consensus       423 ~~~l~~~~~~l~~~~~~~i~~qi~~~L~~LH---~~~iiHrDlkp~NILl~~~~~vkL~DFGla~~~~~~~~~~~~~~~~  499 (613)
T 2ozo_A          423 HKFLVGKREEIPVSNVAELLHQVSMGMKYLE---EKNFVHRNLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAG  499 (613)
T ss_dssp             HHHHTTCTTTSCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEEEETTEEEECCCSTTTTCC------------
T ss_pred             HHHHhhccCCCCHHHHHHHHHHHHHHHHHHH---HCCEEcCcCCHHHEEEcCCCcEEEeeccCcccccCCCceeeeccCC
Confidence                      223346778999999999999   89999999999999999999999999999987654332211 1234


Q ss_pred             CCCcccccccccccccCCCCccccHHHHHHHHHHHHc-CCCCCCCCCCCcch
Q 039231          447 RGTVGYIAPEVFCRNIGEVSYKSDVYNYGMMIFEMTG-GRKNVDVVDNGSTA  497 (506)
Q Consensus       447 ~gt~~y~aPE~l~~~~~~~s~~~Dv~s~G~il~ellt-g~~pf~~~~~~~~~  497 (506)
                      .+++.|+|||++..  +.++.++||||||+++|||++ |+.||...+..+..
T Consensus       500 ~~~~~y~APE~~~~--~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~~~~~  549 (613)
T 2ozo_A          500 KWPLKWYAPECINF--RKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVM  549 (613)
T ss_dssp             --CCTTSCHHHHHH--CCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCSHHHH
T ss_pred             CCccceeCHhhhcC--CCCCcHHHHHHHHHHHHHHHHCCCCCCCCCCHHHHH
Confidence            45789999999854  478999999999999999998 99999887665443

>1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C

Probab=99.97  E-value=3e-30  Score=263.46  Aligned_cols=164  Identities=26%  Similarity=0.339  Sum_probs=131.7

Q ss_pred             cccCccCceEEEEEEEc-CCCEEEEEEeccCCCCchhhHHHHHHhhc-cCccceeEEEEEe-------------------
Q 039231          319 YKLGQGGYGSVYKGKLL-DGSNVAVKVLNDSKGNGKEFINEVASISR-TSHVNVVALLGFC-------------------  377 (506)
Q Consensus       319 ~~ig~G~~g~V~~~~~~-~~~~vavK~l~~~~~~~~~~~~E~~~l~~-l~h~niv~l~g~~-------------------  377 (506)
                      +.||+|+||.||+|+.. +++.||||+++.    ...+.+|++++.+ .+||||+++++++                   
T Consensus        68 ~~LG~G~~g~V~~~~~~~~~~~vAiK~~~~----~~~~~~E~~~~~~~~~hp~iv~l~~~~~~~~~~~~~~~lv~E~~~g  143 (400)
T 1nxk_A           68 QVLGLGINGKVLQIFNKRTQEKFALKMLQD----CPKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLLIVMECLDG  143 (400)
T ss_dssp             EEEEEETTEEEEEEEETTTCCEEEEEEEEC----SHHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEEEEEECCCS
T ss_pred             ceeeeccCeEEEEEEECCCCCEEEEEEeCc----chhHHHHHHHHHHhcCCCCcceEeEEEeecccCCcEEEEEEEeCCC
Confidence            57999999999999975 589999999964    2567889988754 5799999998765                   


Q ss_pred             --------------eccchhhhHHHHHHHHHHHHhhcCCCCeEecCcCCCcEEECC---CCcEEEeecCCCccccCCCcc
Q 039231          378 --------------LRVAEELSSTIGIARGLEYLHLGCSTRILHFDIKPHNILLDE---DFCPKISDFGLAKICNRKESI  440 (506)
Q Consensus       378 --------------~~~~~~l~i~~~i~~gl~~LH~~~~~~ivH~dlkp~Nill~~---~~~~ki~dfg~a~~~~~~~~~  440 (506)
                                    +++.+.+.++.||+.||+|||   +.+|+||||||+|||++.   ++.+||+|||+++....... 
T Consensus       144 g~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH---~~~ivHrDlkp~Nill~~~~~~~~~kl~DFG~a~~~~~~~~-  219 (400)
T 1nxk_A          144 GELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLH---SINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNS-  219 (400)
T ss_dssp             EEHHHHHHCC---CCBHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEESSSSTTCCEEECCCTTCEECC-----
T ss_pred             CcHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHH---HCCccccCcCcceEEEecCCCCccEEEEecccccccCCCCc-
Confidence                          123335678999999999999   899999999999999987   78999999999987654332 


Q ss_pred             eecccCCCCcccccccccccccCCCCccccHHHHHHHHHHHHcCCCCCCCCCCC
Q 039231          441 ISMTGARGTVGYIAPEVFCRNIGEVSYKSDVYNYGMMIFEMTGGRKNVDVVDNG  494 (506)
Q Consensus       441 ~~~~~~~gt~~y~aPE~l~~~~~~~s~~~Dv~s~G~il~elltg~~pf~~~~~~  494 (506)
                        .....||+.|+|||++.+.  .++.++|||||||++|||++|+.||......
T Consensus       220 --~~~~~gt~~y~aPE~~~~~--~~~~~~DiwslG~il~ell~g~~pf~~~~~~  269 (400)
T 1nxk_A          220 --LTTPCYTPYYVAPEVLGPE--KYDKSCDMWSLGVIMYILLCGYPPFYSNHGL  269 (400)
T ss_dssp             ---------CTTCCGGGSCCC--CSSSHHHHHHHHHHHHHHHHSSCSCCCCTTC
T ss_pred             --cccCCCCCCccCHhhcCCC--CCCCcccHHHHHHHHHHHHhCCCCCCCCccc
Confidence              2456789999999998553  7899999999999999999999999876543

>3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens}

Probab=99.97  E-value=1.9e-30  Score=251.46  Aligned_cols=171  Identities=30%  Similarity=0.447  Sum_probs=124.7

Q ss_pred             hccccCccCceEEEEEEE-cCCCEEEEEEeccC----CCCchhhHHHHHHhhccCccceeEEEEEe--------------
Q 039231          317 FKYKLGQGGYGSVYKGKL-LDGSNVAVKVLNDS----KGNGKEFINEVASISRTSHVNVVALLGFC--------------  377 (506)
Q Consensus       317 ~~~~ig~G~~g~V~~~~~-~~~~~vavK~l~~~----~~~~~~~~~E~~~l~~l~h~niv~l~g~~--------------  377 (506)
                      +.+.||+|+||.||+|+. .+++.||||++...    ....+.+.+|++++.+++||||+++++++              
T Consensus        15 ~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~   94 (278)
T 3cok_A           15 VGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKHPSILELYNYFEDSNYVYLVLEMCH   94 (278)
T ss_dssp             EEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTBCCTTBCCEEEEEECSSEEEEEEECCT
T ss_pred             eeeeecCCCceEEEEEEEccCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHhCCCCCeEeEEEEEccCCeEEEEEecCC
Confidence            356799999999999997 46899999999643    22346789999999999999999999887              


Q ss_pred             --------------eccchhhhHHHHHHHHHHHHhhcCCCCeEecCcCCCcEEECCCCcEEEeecCCCccccCCCcceec
Q 039231          378 --------------LRVAEELSSTIGIARGLEYLHLGCSTRILHFDIKPHNILLDEDFCPKISDFGLAKICNRKESIISM  443 (506)
Q Consensus       378 --------------~~~~~~l~i~~~i~~gl~~LH~~~~~~ivH~dlkp~Nill~~~~~~ki~dfg~a~~~~~~~~~~~~  443 (506)
                                    +++.+.+.++.|+++||+|||   +.+++|+||||+||+++.++.+||+|||++.........  .
T Consensus        95 ~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~~~~~--~  169 (278)
T 3cok_A           95 NGEMNRYLKNRVKPFSENEARHFMHQIITGMLYLH---SHGILHRDLTLSNLLLTRNMNIKIADFGLATQLKMPHEK--H  169 (278)
T ss_dssp             TEEHHHHHHTCSSCCCHHHHHHHHHHHHHHHHHHH---HTTEECSSCCGGGEEECTTCCEEECCCTTCEECC--------
T ss_pred             CCcHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHEEEcCCCCEEEEeecceeeccCCCCc--c
Confidence                          223346778999999999999   899999999999999999999999999999876533221  1


Q ss_pred             ccCCCCcccccccccccccCCCCccccHHHHHHHHHHHHcCCCCCCCCCCC
Q 039231          444 TGARGTVGYIAPEVFCRNIGEVSYKSDVYNYGMMIFEMTGGRKNVDVVDNG  494 (506)
Q Consensus       444 ~~~~gt~~y~aPE~l~~~~~~~s~~~Dv~s~G~il~elltg~~pf~~~~~~  494 (506)
                      ....+|+.|+|||.+.+.  .++.++||||||+++|||++|+.||......
T Consensus       170 ~~~~~~~~y~aPE~~~~~--~~~~~~Di~slG~il~~l~~g~~p~~~~~~~  218 (278)
T 3cok_A          170 YTLCGTPNYISPEIATRS--AHGLESDVWSLGCMFYTLLIGRPPFDTDTVK  218 (278)
T ss_dssp             ------------------------CTHHHHHHHHHHHHHHSSCSSCCCSCC
T ss_pred             eeccCCCCcCCcchhcCC--CCCchhhHHHHHHHHHHHHhCCCCCCChhHH
Confidence            345689999999998654  6788999999999999999999999875543

>2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A

Probab=99.97  E-value=1.3e-30  Score=260.64  Aligned_cols=168  Identities=26%  Similarity=0.423  Sum_probs=138.6

Q ss_pred             hhhccccCccCceEEEEEEEc-CCCEEEEEEeccCCCCchhhHHHHHHhhcc-CccceeEEEEEe---------------
Q 039231          315 NSFKYKLGQGGYGSVYKGKLL-DGSNVAVKVLNDSKGNGKEFINEVASISRT-SHVNVVALLGFC---------------  377 (506)
Q Consensus       315 ~~~~~~ig~G~~g~V~~~~~~-~~~~vavK~l~~~~~~~~~~~~E~~~l~~l-~h~niv~l~g~~---------------  377 (506)
                      +.+.+.||+|+||.||+|+.. +++.||||+++....   ...+|++++.++ +||||+++++++               
T Consensus        24 y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~---~~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~E~~~g  100 (342)
T 2qr7_A           24 YEVKEDIGVGSYSVCKRCIHKATNMEFAVKIIDKSKR---DPTEEIEILLRYGQHPNIITLKDVYDDGKYVYVVTELMKG  100 (342)
T ss_dssp             EEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTTC---CCHHHHHHHHHHTTSTTBCCEEEEEECSSEEEEEECCCCS
T ss_pred             EEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEcccC---ChHHHHHHHHHhcCCCCcCeEEEEEEcCCEEEEEEeCCCC
Confidence            444578999999999999985 488999999976543   356789999888 799999999987               


Q ss_pred             ------------eccchhhhHHHHHHHHHHHHhhcCCCCeEecCcCCCcEEECCC----CcEEEeecCCCccccCCCcce
Q 039231          378 ------------LRVAEELSSTIGIARGLEYLHLGCSTRILHFDIKPHNILLDED----FCPKISDFGLAKICNRKESII  441 (506)
Q Consensus       378 ------------~~~~~~l~i~~~i~~gl~~LH~~~~~~ivH~dlkp~Nill~~~----~~~ki~dfg~a~~~~~~~~~~  441 (506)
                                  +++.+...++.||+.||+|||   +++|+||||||+|||+.++    +.+||+|||+++........ 
T Consensus       101 g~L~~~i~~~~~~~~~~~~~~~~qi~~al~~lH---~~givHrDlkp~NIl~~~~~~~~~~~kl~Dfg~a~~~~~~~~~-  176 (342)
T 2qr7_A          101 GELLDKILRQKFFSEREASAVLFTITKTVEYLH---AQGVVHRDLKPSNILYVDESGNPESIRICDFGFAKQLRAENGL-  176 (342)
T ss_dssp             CBHHHHHHTCTTCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCCGGGEEESSSSCSGGGEEECCCTTCEECBCTTCC-
T ss_pred             CcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHH---HCCcEeccCCHHHEEEecCCCCcCeEEEEECCCcccCcCCCCc-
Confidence                        233346678999999999999   8999999999999998433    35999999999876544322 


Q ss_pred             ecccCCCCcccccccccccccCCCCccccHHHHHHHHHHHHcCCCCCCCCC
Q 039231          442 SMTGARGTVGYIAPEVFCRNIGEVSYKSDVYNYGMMIFEMTGGRKNVDVVD  492 (506)
Q Consensus       442 ~~~~~~gt~~y~aPE~l~~~~~~~s~~~Dv~s~G~il~elltg~~pf~~~~  492 (506)
                       .....+|+.|+|||++.+.  .++.++||||||+++|||++|+.||....
T Consensus       177 -~~~~~gt~~y~aPE~~~~~--~~~~~~DiwslG~il~ell~g~~Pf~~~~  224 (342)
T 2qr7_A          177 -LMTPCYTANFVAPEVLERQ--GYDAACDIWSLGVLLYTMLTGYTPFANGP  224 (342)
T ss_dssp             -BCCSSCCSSCCCHHHHHHH--HHHHHHHHHHHHHHHHHHHHSSCSSCSST
T ss_pred             -eeccCCCccccCHHHhcCC--CCCCccCeeeHhHHHHHHhcCCCCCCCCC
Confidence             2456789999999998654  57889999999999999999999998643

>2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A*

Probab=99.97  E-value=2.3e-30  Score=258.05  Aligned_cols=171  Identities=29%  Similarity=0.407  Sum_probs=144.0

Q ss_pred             hccccCccCceEEEEEEEcC-CCEEEEEEeccCCC----CchhhHHHHHHhhccCccceeEEEEEe--------------
Q 039231          317 FKYKLGQGGYGSVYKGKLLD-GSNVAVKVLNDSKG----NGKEFINEVASISRTSHVNVVALLGFC--------------  377 (506)
Q Consensus       317 ~~~~ig~G~~g~V~~~~~~~-~~~vavK~l~~~~~----~~~~~~~E~~~l~~l~h~niv~l~g~~--------------  377 (506)
                      +.+.||+|+||.||+++..+ ++.+|+|++.....    ..+.+.+|++++++++||||+++++++              
T Consensus        45 ~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~  124 (335)
T 2owb_A           45 RGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFVVLELCR  124 (335)
T ss_dssp             EEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEECCCT
T ss_pred             EEEEEeeCCCeEEEEEEECCCCCEEEEEEechhhhcCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCCeEEEEEecCC
Confidence            35679999999999999864 78999999865432    235688999999999999999999987              


Q ss_pred             -------------eccchhhhHHHHHHHHHHHHhhcCCCCeEecCcCCCcEEECCCCcEEEeecCCCccccCCCcceecc
Q 039231          378 -------------LRVAEELSSTIGIARGLEYLHLGCSTRILHFDIKPHNILLDEDFCPKISDFGLAKICNRKESIISMT  444 (506)
Q Consensus       378 -------------~~~~~~l~i~~~i~~gl~~LH~~~~~~ivH~dlkp~Nill~~~~~~ki~dfg~a~~~~~~~~~~~~~  444 (506)
                                   +.+.+.+.++.|++.||+|||   +++|+||||||+||+++.++.+||+|||+++........  ..
T Consensus       125 ~~~L~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH---~~~ivH~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~--~~  199 (335)
T 2owb_A          125 RRSLLELHKRRKALTEPEARYYLRQIVLGCQYLH---RNRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGER--KK  199 (335)
T ss_dssp             TCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCCGGGEEECTTCCEEECCCTTCEECCSTTCC--BC
T ss_pred             CCCHHHHHhccCCCCHHHHHHHHHHHHHHHHHHH---HCCCEecCCCchhEEEcCCCCEEEeeccCceecccCccc--cc
Confidence                         233346778999999999999   899999999999999999999999999999876543321  24


Q ss_pred             cCCCCcccccccccccccCCCCccccHHHHHHHHHHHHcCCCCCCCCCCC
Q 039231          445 GARGTVGYIAPEVFCRNIGEVSYKSDVYNYGMMIFEMTGGRKNVDVVDNG  494 (506)
Q Consensus       445 ~~~gt~~y~aPE~l~~~~~~~s~~~Dv~s~G~il~elltg~~pf~~~~~~  494 (506)
                      ...+++.|+|||.+.+.  .++.++||||||+++|||++|+.||......
T Consensus       200 ~~~gt~~y~aPE~~~~~--~~~~~~Di~slG~il~~l~~g~~pf~~~~~~  247 (335)
T 2owb_A          200 VLCGTPNYIAPEVLSKK--GHSFEVDVWSIGCIMYTLLVGKPPFETSCLK  247 (335)
T ss_dssp             CCCSCCSSCCHHHHHTS--CBCTHHHHHHHHHHHHHHHHSSCTTCCSSHH
T ss_pred             ccCCCccccCHHHhccC--CCCchhhHHHHHHHHHHHHHCcCCCCCCCHH
Confidence            46789999999998654  6789999999999999999999999875543

>2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ...

Probab=99.97  E-value=2.6e-30  Score=251.30  Aligned_cols=170  Identities=25%  Similarity=0.388  Sum_probs=143.3

Q ss_pred             hhccccCccCceEEEEEEEc-CCCEEEEEEeccC----CCCchhhHHHHHHhhccCccceeEEEEEee------------
Q 039231          316 SFKYKLGQGGYGSVYKGKLL-DGSNVAVKVLNDS----KGNGKEFINEVASISRTSHVNVVALLGFCL------------  378 (506)
Q Consensus       316 ~~~~~ig~G~~g~V~~~~~~-~~~~vavK~l~~~----~~~~~~~~~E~~~l~~l~h~niv~l~g~~~------------  378 (506)
                      .+.+.||+|+||.||+|+.. +++.||+|++...    ....+.+.+|++++++++||||+++++++.            
T Consensus        17 ~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~   96 (284)
T 2vgo_A           17 DIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHPNILRMYNYFHDRKRIYLMLEFA   96 (284)
T ss_dssp             EEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEECCC
T ss_pred             eeeheecCCCCeEEEEEEEcCCCcEEEEEEEcccccchHHHHHHHHHHHHHHhcCCCCCEeeEEEEEEcCCEEEEEEEeC
Confidence            34568999999999999986 4788999998642    233467899999999999999999999872            


Q ss_pred             ---------------ccchhhhHHHHHHHHHHHHhhcCCCCeEecCcCCCcEEECCCCcEEEeecCCCccccCCCcceec
Q 039231          379 ---------------RVAEELSSTIGIARGLEYLHLGCSTRILHFDIKPHNILLDEDFCPKISDFGLAKICNRKESIISM  443 (506)
Q Consensus       379 ---------------~~~~~l~i~~~i~~gl~~LH~~~~~~ivH~dlkp~Nill~~~~~~ki~dfg~a~~~~~~~~~~~~  443 (506)
                                     ++.+.+.++.|++.||+|||   +.+++|+||||+||+++.++.+||+|||++........    
T Consensus        97 ~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~~~~~----  169 (284)
T 2vgo_A           97 PRGELYKELQKHGRFDEQRSATFMEELADALHYCH---ERKVIHRDIKPENLLMGYKGELKIADFGWSVHAPSLRR----  169 (284)
T ss_dssp             TTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHH---TTTEECCCCSGGGEEECTTCCEEECCCTTCEECSSSCB----
T ss_pred             CCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH---HCCceecCCCHHHEEEcCCCCEEEecccccccCccccc----
Confidence                           23345678999999999999   99999999999999999999999999999976544321    


Q ss_pred             ccCCCCcccccccccccccCCCCccccHHHHHHHHHHHHcCCCCCCCCCCC
Q 039231          444 TGARGTVGYIAPEVFCRNIGEVSYKSDVYNYGMMIFEMTGGRKNVDVVDNG  494 (506)
Q Consensus       444 ~~~~gt~~y~aPE~l~~~~~~~s~~~Dv~s~G~il~elltg~~pf~~~~~~  494 (506)
                      ....+++.|+|||.+.+.  .++.++||||||+++|||++|+.||......
T Consensus       170 ~~~~~~~~y~aPE~~~~~--~~~~~~Di~slG~il~~l~~g~~pf~~~~~~  218 (284)
T 2vgo_A          170 RTMCGTLDYLPPEMIEGK--THDEKVDLWCAGVLCYEFLVGMPPFDSPSHT  218 (284)
T ss_dssp             CCCCSCGGGCCHHHHTTC--CBCTTHHHHHHHHHHHHHHHSSCTTCCSSHH
T ss_pred             ccccCCCCcCCHHHhccC--CCCcccchhhHHHHHHHHHHCCCCCCCCCHh
Confidence            346789999999998654  6889999999999999999999999865443

>3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A*

Probab=99.97  E-value=8.1e-31  Score=274.62  Aligned_cols=174  Identities=28%  Similarity=0.460  Sum_probs=146.3

Q ss_pred             HHhhhccccCccCceEEEEEEEc-CCCEEEEEEeccC----CCCchhhHHHHHHhhccCccceeEEEEEe----------
Q 039231          313 MTNSFKYKLGQGGYGSVYKGKLL-DGSNVAVKVLNDS----KGNGKEFINEVASISRTSHVNVVALLGFC----------  377 (506)
Q Consensus       313 ~~~~~~~~ig~G~~g~V~~~~~~-~~~~vavK~l~~~----~~~~~~~~~E~~~l~~l~h~niv~l~g~~----------  377 (506)
                      ..+.+.++||+|+||.||+|+.. +++.||||++...    ....+.+.+|++++++++||||+++++++          
T Consensus        26 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~  105 (484)
T 3nyv_A           26 DRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMKLYEFFEDKGYFYLVG  105 (484)
T ss_dssp             HHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCBSSCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             CceEEeeEEecCCCEEEEEEEECCCCCEEEEEEEEhhhcccchHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEEEE
Confidence            34555678999999999999986 6899999999653    23346789999999999999999999987          


Q ss_pred             -----------------eccchhhhHHHHHHHHHHHHhhcCCCCeEecCcCCCcEEE---CCCCcEEEeecCCCccccCC
Q 039231          378 -----------------LRVAEELSSTIGIARGLEYLHLGCSTRILHFDIKPHNILL---DEDFCPKISDFGLAKICNRK  437 (506)
Q Consensus       378 -----------------~~~~~~l~i~~~i~~gl~~LH~~~~~~ivH~dlkp~Nill---~~~~~~ki~dfg~a~~~~~~  437 (506)
                                       +++.+.+.++.||+.||+|||   +++|+||||||+|||+   +.++.+||+|||+++.....
T Consensus       106 e~~~~~~L~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH---~~~ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~~~~  182 (484)
T 3nyv_A          106 EVYTGGELFDEIISRKRFSEVDAARIIRQVLSGITYMH---KNKIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEAS  182 (484)
T ss_dssp             CCCCSCBHHHHHHTCSCCBHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEESSSSTTCCEEECCTTHHHHBCCC
T ss_pred             ecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH---HCCeeeCCCCHHHEEEecCCCCCcEEEEeeeeeEEcccc
Confidence                             233346779999999999999   8999999999999999   56789999999999876554


Q ss_pred             CcceecccCCCCcccccccccccccCCCCccccHHHHHHHHHHHHcCCCCCCCCCCCc
Q 039231          438 ESIISMTGARGTVGYIAPEVFCRNIGEVSYKSDVYNYGMMIFEMTGGRKNVDVVDNGS  495 (506)
Q Consensus       438 ~~~~~~~~~~gt~~y~aPE~l~~~~~~~s~~~Dv~s~G~il~elltg~~pf~~~~~~~  495 (506)
                      ..   .....||+.|+|||++.+   .++.++||||+|+++|||++|+.||...+..+
T Consensus       183 ~~---~~~~~gt~~y~aPE~~~~---~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~  234 (484)
T 3nyv_A          183 KK---MKDKIGTAYYIAPEVLHG---TYDEKCDVWSTGVILYILLSGCPPFNGANEYD  234 (484)
T ss_dssp             CS---HHHHTTGGGTCCHHHHHT---CCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH
T ss_pred             cc---cccCCCCccccCceeecC---CCCCcceeHHHHHHHHHHHHCCCCCCCCCHHH
Confidence            32   244578999999999843   68999999999999999999999998765443

>3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A*

Probab=99.97  E-value=1.2e-30  Score=257.44  Aligned_cols=175  Identities=32%  Similarity=0.487  Sum_probs=133.0

Q ss_pred             hhccccCccCceEEEEEEEcC----CCEEEEEEeccCCCC---chhhHHHHHHhhccCccceeEEEEEeec---------
Q 039231          316 SFKYKLGQGGYGSVYKGKLLD----GSNVAVKVLNDSKGN---GKEFINEVASISRTSHVNVVALLGFCLR---------  379 (506)
Q Consensus       316 ~~~~~ig~G~~g~V~~~~~~~----~~~vavK~l~~~~~~---~~~~~~E~~~l~~l~h~niv~l~g~~~~---------  379 (506)
                      .+.+.||+|+||.||+|+...    +..||+|+++.....   .+.+.+|++++++++||||+++++++.+         
T Consensus        37 ~~~~~lg~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~  116 (313)
T 3brb_A           37 ILGKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSHPNVIRLLGVCIEMSSQGIPKP  116 (313)
T ss_dssp             EEEEEEEC-CCCCEEEEEEECTTSCEEEEEEEEC---CCCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEC-------CE
T ss_pred             eeccceeecCCeEEEEEEEeccCCceeEEEEEEEeccccchhHHHHHHHHHHHHhcCCCCCeeeeeEEEeeccccCCccc
Confidence            345679999999999998643    458999999754332   2568899999999999999999987522         


Q ss_pred             -----------------------------cchhhhHHHHHHHHHHHHhhcCCCCeEecCcCCCcEEECCCCcEEEeecCC
Q 039231          380 -----------------------------VAEELSSTIGIARGLEYLHLGCSTRILHFDIKPHNILLDEDFCPKISDFGL  430 (506)
Q Consensus       380 -----------------------------~~~~l~i~~~i~~gl~~LH~~~~~~ivH~dlkp~Nill~~~~~~ki~dfg~  430 (506)
                                                   +.+.+.++.|++.||+|||   +++|+||||||+||++++++.+||+|||+
T Consensus       117 ~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH---~~~ivH~dikp~NIli~~~~~~kl~Dfg~  193 (313)
T 3brb_A          117 MVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALGMEYLS---NRNFLHRDLAARNCMLRDDMTVCVADFGL  193 (313)
T ss_dssp             EEEEECCTTCBHHHHHHHTTBTTSCCCCCHHHHHHHHHHHHHHHHHHH---TTTCCCCCCSGGGEEECTTSCEEECSCSC
T ss_pred             EEEEecccCCCHHHHHHHhhhhcCCccCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCCcceEEEcCCCcEEEeecCc
Confidence                                         2235678999999999999   89999999999999999999999999999


Q ss_pred             CccccCCCcceecccCCCCcccccccccccccCCCCccccHHHHHHHHHHHHc-CCCCCCCCCCCc
Q 039231          431 AKICNRKESIISMTGARGTVGYIAPEVFCRNIGEVSYKSDVYNYGMMIFEMTG-GRKNVDVVDNGS  495 (506)
Q Consensus       431 a~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~s~~~Dv~s~G~il~ellt-g~~pf~~~~~~~  495 (506)
                      ++...............+++.|+|||.+.+.  .++.++||||||+++|||++ |+.||......+
T Consensus       194 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~--~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~  257 (313)
T 3brb_A          194 SKKIYSGDYYRQGRIAKMPVKWIAIESLADR--VYTSKSDVWAFGVTMWEIATRGMTPYPGVQNHE  257 (313)
T ss_dssp             C----------------CCGGGSCHHHHHSS--CCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGG
T ss_pred             ceecccccccCcccccCCCccccCchhhcCC--CccchhhhHHHHHHHHHHHhcCCCCCccCCHHH
Confidence            9876544332223445678899999998553  78999999999999999999 999998765544

>2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ...

Probab=99.97  E-value=6.7e-31  Score=261.82  Aligned_cols=176  Identities=30%  Similarity=0.506  Sum_probs=144.1

Q ss_pred             HHhhhccccCccCceEEEEEEEc--------CCCEEEEEEeccCCC--CchhhHHHHHHhhcc-CccceeEEEEEeec--
Q 039231          313 MTNSFKYKLGQGGYGSVYKGKLL--------DGSNVAVKVLNDSKG--NGKEFINEVASISRT-SHVNVVALLGFCLR--  379 (506)
Q Consensus       313 ~~~~~~~~ig~G~~g~V~~~~~~--------~~~~vavK~l~~~~~--~~~~~~~E~~~l~~l-~h~niv~l~g~~~~--  379 (506)
                      ..+.+.+.||+|+||.||+|+..        ++..||||+++....  ..+++.+|+++++++ +||||+++++++..  
T Consensus        35 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~  114 (334)
T 2pvf_A           35 DKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDG  114 (334)
T ss_dssp             GGEEEEEEEEECSSCEEEEEEETTCSTTCC---CEEEEEECCTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSS
T ss_pred             hHeEEeeEEeecCceeEEEeEeccccccccccceEEEEeeeccCCcHHHHHHHHHHHHHHHHhhcCCCEeeEEEEEccCC
Confidence            34455678999999999999863        467899999975432  235788999999999 89999999998711  


Q ss_pred             -----------------------------------------cchhhhHHHHHHHHHHHHhhcCCCCeEecCcCCCcEEEC
Q 039231          380 -----------------------------------------VAEELSSTIGIARGLEYLHLGCSTRILHFDIKPHNILLD  418 (506)
Q Consensus       380 -----------------------------------------~~~~l~i~~~i~~gl~~LH~~~~~~ivH~dlkp~Nill~  418 (506)
                                                               +.+.+.++.||+.||+|||   +.+|+||||||+||+++
T Consensus       115 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH---~~~ivH~Dlkp~NIll~  191 (334)
T 2pvf_A          115 PLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLA---SQKCIHRDLAARNVLVT  191 (334)
T ss_dssp             CCEEEEECCTTCBHHHHHHTTSCTTCCSCC--------CCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEEC
T ss_pred             ceEEEEECCCCCcHHHHHHHhccccccccccccccccccCCHHHHHHHHHHHHHHHHHHH---hCCeeCCCCccceEEEc
Confidence                                                     1234668899999999999   89999999999999999


Q ss_pred             CCCcEEEeecCCCccccCCCcceecccCCCCcccccccccccccCCCCccccHHHHHHHHHHHHc-CCCCCCCCCC
Q 039231          419 EDFCPKISDFGLAKICNRKESIISMTGARGTVGYIAPEVFCRNIGEVSYKSDVYNYGMMIFEMTG-GRKNVDVVDN  493 (506)
Q Consensus       419 ~~~~~ki~dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~s~~~Dv~s~G~il~ellt-g~~pf~~~~~  493 (506)
                      .++.+||+|||+++...............+++.|+|||.+.+.  .++.++||||||+++|||++ |+.||.....
T Consensus       192 ~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~--~~~~~~Di~slG~il~ellt~g~~p~~~~~~  265 (334)
T 2pvf_A          192 ENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDR--VYTHQSDVWSFGVLMWEIFTLGGSPYPGIPV  265 (334)
T ss_dssp             TTCCEEECCCTTCEECTTTSSEECCSCCCCCGGGCCHHHHHHC--EECHHHHHHHHHHHHHHHHTTSCCSSTTCCH
T ss_pred             CCCCEEEccccccccccccccccccCCCCcccceeChHHhcCC--CcChHHHHHHHHHHHHHHHhCCCCCcCcCCH
Confidence            9999999999999877655433333445678899999998653  68899999999999999999 9999986543

>2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A*

Probab=99.97  E-value=2.1e-30  Score=256.86  Aligned_cols=178  Identities=25%  Similarity=0.357  Sum_probs=142.4

Q ss_pred             HHhhhccccCccCceEEEEEEEc-CCCEEEEEEeccCC---------CCchhhHHHHHHhhccCccceeEEEEEe-----
Q 039231          313 MTNSFKYKLGQGGYGSVYKGKLL-DGSNVAVKVLNDSK---------GNGKEFINEVASISRTSHVNVVALLGFC-----  377 (506)
Q Consensus       313 ~~~~~~~~ig~G~~g~V~~~~~~-~~~~vavK~l~~~~---------~~~~~~~~E~~~l~~l~h~niv~l~g~~-----  377 (506)
                      ..+.+.+.||+|+||.||+|+.. +++.||||++....         .....+.+|++++++++||||+++++++     
T Consensus        10 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~   89 (322)
T 2ycf_A           10 DEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDAEDY   89 (322)
T ss_dssp             HHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECC---------------CHHHHHHHHHHCCCTTBCCEEEEEESSSE
T ss_pred             hceeEeeEEecCCCEEEEEEEEcCCCcEEEEEEeehhhhhhcccccchhhhhHHHHHHHHHhCCCCCCceEeeEEcCCce
Confidence            34555688999999999999975 47899999986432         1224688999999999999999999886     


Q ss_pred             ---------------------eccchhhhHHHHHHHHHHHHhhcCCCCeEecCcCCCcEEECCCCc---EEEeecCCCcc
Q 039231          378 ---------------------LRVAEELSSTIGIARGLEYLHLGCSTRILHFDIKPHNILLDEDFC---PKISDFGLAKI  433 (506)
Q Consensus       378 ---------------------~~~~~~l~i~~~i~~gl~~LH~~~~~~ivH~dlkp~Nill~~~~~---~ki~dfg~a~~  433 (506)
                                           +++.+.+.++.||+.||+|||   +++|+||||||+||+++.++.   +||+|||+++.
T Consensus        90 ~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH---~~~ivH~dlkp~NIl~~~~~~~~~~kl~Dfg~~~~  166 (322)
T 2ycf_A           90 YIVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLLAVQYLH---ENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKI  166 (322)
T ss_dssp             EEEEECCTTEETHHHHSTTCCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEESSSSSSCCEEECCCTTCEE
T ss_pred             EEEEecCCCCcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHH---HCCeeccCCCHHHEEEecCCCCCeEEEccCcccee
Confidence                                 223345678999999999999   899999999999999987654   99999999987


Q ss_pred             ccCCCcceecccCCCCccccccccccc-ccCCCCccccHHHHHHHHHHHHcCCCCCCCCCCCcc
Q 039231          434 CNRKESIISMTGARGTVGYIAPEVFCR-NIGEVSYKSDVYNYGMMIFEMTGGRKNVDVVDNGST  496 (506)
Q Consensus       434 ~~~~~~~~~~~~~~gt~~y~aPE~l~~-~~~~~s~~~Dv~s~G~il~elltg~~pf~~~~~~~~  496 (506)
                      ......   .....||+.|+|||++.. ....++.++||||||+++|||++|+.||........
T Consensus       167 ~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~  227 (322)
T 2ycf_A          167 LGETSL---MRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVS  227 (322)
T ss_dssp             CCCCHH---HHHHHSCCTTCCHHHHHHTTTTTCTTHHHHHHHHHHHHHHHHSSCSSCSTTCSSC
T ss_pred             cccccc---cccccCCcCccCchhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCCcccchHHH
Confidence            654321   133568999999999742 224688999999999999999999999987665543

>3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A*

Probab=99.97  E-value=2.4e-30  Score=271.62  Aligned_cols=173  Identities=29%  Similarity=0.464  Sum_probs=141.3

Q ss_pred             HhhhccccCccCceEEEEEEEc-CCCEEEEEEeccC---CCCchhhHHHHHHhhccCccceeEEEEEee-----------
Q 039231          314 TNSFKYKLGQGGYGSVYKGKLL-DGSNVAVKVLNDS---KGNGKEFINEVASISRTSHVNVVALLGFCL-----------  378 (506)
Q Consensus       314 ~~~~~~~ig~G~~g~V~~~~~~-~~~~vavK~l~~~---~~~~~~~~~E~~~l~~l~h~niv~l~g~~~-----------  378 (506)
                      .+.+.++||+|+||.||+|+.. ++..+|+|++...   ......+.+|++++++++||||+++++++.           
T Consensus        38 ~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~  117 (494)
T 3lij_A           38 MYQRVKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSSNSKLLEEVAVLKLLDHPNIMKLYDFFEDKRNYYLVMEC  117 (494)
T ss_dssp             HEEEEEEEECC---EEEEEEETTTCCEEEEEEEEC-----CTTHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEEC
T ss_pred             CeEEeeEEecCCCEEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEEec
Confidence            3455678999999999999986 5889999999753   233477899999999999999999999872           


Q ss_pred             ----------------ccchhhhHHHHHHHHHHHHhhcCCCCeEecCcCCCcEEECC---CCcEEEeecCCCccccCCCc
Q 039231          379 ----------------RVAEELSSTIGIARGLEYLHLGCSTRILHFDIKPHNILLDE---DFCPKISDFGLAKICNRKES  439 (506)
Q Consensus       379 ----------------~~~~~l~i~~~i~~gl~~LH~~~~~~ivH~dlkp~Nill~~---~~~~ki~dfg~a~~~~~~~~  439 (506)
                                      ++.+.+.++.||+.||+|||   +++|+||||||+|||++.   ++.+||+|||+++.......
T Consensus       118 ~~~g~L~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH---~~~ivH~Dlkp~Nil~~~~~~~~~~kl~DfG~a~~~~~~~~  194 (494)
T 3lij_A          118 YKGGELFDEIIHRMKFNEVDAAVIIKQVLSGVTYLH---KHNIVHRDLKPENLLLESKEKDALIKIVDFGLSAVFENQKK  194 (494)
T ss_dssp             CCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEESCSSTTCCEEECCCTTCEECBTTBC
T ss_pred             CCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHH---HCCceeccCChhhEEEeCCCCCCcEEEEECCCCeECCCCcc
Confidence                            23345678999999999999   899999999999999976   45599999999987655432


Q ss_pred             ceecccCCCCcccccccccccccCCCCccccHHHHHHHHHHHHcCCCCCCCCCCCc
Q 039231          440 IISMTGARGTVGYIAPEVFCRNIGEVSYKSDVYNYGMMIFEMTGGRKNVDVVDNGS  495 (506)
Q Consensus       440 ~~~~~~~~gt~~y~aPE~l~~~~~~~s~~~Dv~s~G~il~elltg~~pf~~~~~~~  495 (506)
                         .....||+.|+|||++.   +.++.++||||+|+++|||++|+.||......+
T Consensus       195 ---~~~~~gt~~y~aPE~l~---~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~  244 (494)
T 3lij_A          195 ---MKERLGTAYYIAPEVLR---KKYDEKCDVWSIGVILFILLAGYPPFGGQTDQE  244 (494)
T ss_dssp             ---BCCCCSCTTTCCHHHHT---TCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH
T ss_pred             ---ccccCCCcCeeCHHHHc---ccCCCchhHHHHHHHHHHHHhCCCCCCCCCHHH
Confidence               24567999999999984   368999999999999999999999998765443

>3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A*

Probab=99.97  E-value=1.2e-30  Score=253.44  Aligned_cols=175  Identities=26%  Similarity=0.466  Sum_probs=140.0

Q ss_pred             hhccccCccCceEEEEEEEcC----CCEEEEEEeccCCC--CchhhHHHHHHhhccCccceeEEEEEe------------
Q 039231          316 SFKYKLGQGGYGSVYKGKLLD----GSNVAVKVLNDSKG--NGKEFINEVASISRTSHVNVVALLGFC------------  377 (506)
Q Consensus       316 ~~~~~ig~G~~g~V~~~~~~~----~~~vavK~l~~~~~--~~~~~~~E~~~l~~l~h~niv~l~g~~------------  377 (506)
                      .+.+.||+|+||.||+|+..+    +..||+|+++....  ..+.+.+|++++++++||||+++++++            
T Consensus        15 ~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~v~e~~   94 (281)
T 3cc6_A           15 VLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIVKLIGIIEEEPTWIIMELY   94 (281)
T ss_dssp             EEEEEEEECSSSEEEEEEEECTTCCEEEEEEEECCTTSCHHHHHHHHHHHHHHHHHCCTTBCCEEEEECSSSCEEEEECC
T ss_pred             EEEEEEEecCCeeEEEeEEcCCCCCcceEEEEecccccCchHHHHHHHHHHHHHhCCCCCcceEEEEEcCCCCEEEEecC
Confidence            345789999999999998643    34699999976432  336789999999999999999999987            


Q ss_pred             ---------------eccchhhhHHHHHHHHHHHHhhcCCCCeEecCcCCCcEEECCCCcEEEeecCCCccccCCCccee
Q 039231          378 ---------------LRVAEELSSTIGIARGLEYLHLGCSTRILHFDIKPHNILLDEDFCPKISDFGLAKICNRKESIIS  442 (506)
Q Consensus       378 ---------------~~~~~~l~i~~~i~~gl~~LH~~~~~~ivH~dlkp~Nill~~~~~~ki~dfg~a~~~~~~~~~~~  442 (506)
                                     +++.+.+.++.|++.||+|||   +++|+||||||+||+++.++.+||+|||+++........ .
T Consensus        95 ~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~-~  170 (281)
T 3cc6_A           95 PYGELGHYLERNKNSLKVLTLVLYSLQICKAMAYLE---SINCVHRDIAVRNILVASPECVKLGDFGLSRYIEDEDYY-K  170 (281)
T ss_dssp             TTCBHHHHHHHHTTTCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCSGGGEEEEETTEEEECCCCGGGCC--------
T ss_pred             CCCCHHHHHHhccccCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCccceEEECCCCcEEeCccCCCccccccccc-c
Confidence                           222335678899999999999   899999999999999999999999999999876543321 1


Q ss_pred             cccCCCCcccccccccccccCCCCccccHHHHHHHHHHHHc-CCCCCCCCCCCcc
Q 039231          443 MTGARGTVGYIAPEVFCRNIGEVSYKSDVYNYGMMIFEMTG-GRKNVDVVDNGST  496 (506)
Q Consensus       443 ~~~~~gt~~y~aPE~l~~~~~~~s~~~Dv~s~G~il~ellt-g~~pf~~~~~~~~  496 (506)
                      .....+++.|+|||.+...  .++.++||||||+++|||++ |+.||......+.
T Consensus       171 ~~~~~~~~~y~aPE~~~~~--~~~~~~Di~slG~il~~llt~g~~p~~~~~~~~~  223 (281)
T 3cc6_A          171 ASVTRLPIKWMSPESINFR--RFTTASDVWMFAVCMWEILSFGKQPFFWLENKDV  223 (281)
T ss_dssp             --CCCCCGGGCCHHHHHHC--CCCHHHHHHHHHHHHHHHHTTTCCTTTTSCGGGH
T ss_pred             cccCCCCcceeCchhhccC--CCCchhccHHHHHHHHHHHhCCCCCcccCChHHH
Confidence            2345678899999998543  78999999999999999998 9999986655443

>2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A

Probab=99.97  E-value=3.1e-30  Score=260.29  Aligned_cols=169  Identities=25%  Similarity=0.395  Sum_probs=142.1

Q ss_pred             ccccCccCceEEEEEEEc-CCCEEEEEEeccCCCC---------chhhHHHHHHhhcc-CccceeEEEEEe---------
Q 039231          318 KYKLGQGGYGSVYKGKLL-DGSNVAVKVLNDSKGN---------GKEFINEVASISRT-SHVNVVALLGFC---------  377 (506)
Q Consensus       318 ~~~ig~G~~g~V~~~~~~-~~~~vavK~l~~~~~~---------~~~~~~E~~~l~~l-~h~niv~l~g~~---------  377 (506)
                      .+.||+|+||.||+|++. +|+.||||++......         .+.+.+|++++.++ +||||+++++++         
T Consensus        99 ~~~lg~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~lv  178 (365)
T 2y7j_A           99 KDVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHPHIITLIDSYESSSFMFLV  178 (365)
T ss_dssp             EEEEEECSSEEEEEEEETTTCCEEEEEEEETTSSCCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEEBSSEEEEE
T ss_pred             ceEEecCCCEEEEEEEECCCCcEEEEEEEEccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeEEEEEEeeCCEEEEE
Confidence            478999999999999986 6999999999754321         24578899999999 799999999887         


Q ss_pred             ------------------eccchhhhHHHHHHHHHHHHhhcCCCCeEecCcCCCcEEECCCCcEEEeecCCCccccCCCc
Q 039231          378 ------------------LRVAEELSSTIGIARGLEYLHLGCSTRILHFDIKPHNILLDEDFCPKISDFGLAKICNRKES  439 (506)
Q Consensus       378 ------------------~~~~~~l~i~~~i~~gl~~LH~~~~~~ivH~dlkp~Nill~~~~~~ki~dfg~a~~~~~~~~  439 (506)
                                        +.+...+.++.||+.||+|||   +.+++|+||||+||+++.++.+||+|||++........
T Consensus       179 ~e~~~g~~L~~~l~~~~~l~~~~~~~i~~qi~~~L~~LH---~~gi~H~Dlkp~NIl~~~~~~ikl~DfG~~~~~~~~~~  255 (365)
T 2y7j_A          179 FDLMRKGELFDYLTEKVALSEKETRSIMRSLLEAVSFLH---ANNIVHRDLKPENILLDDNMQIRLSDFGFSCHLEPGEK  255 (365)
T ss_dssp             ECCCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECTTCCEEECCCTTCEECCTTCC
T ss_pred             EEeCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEECCCCCEEEEecCcccccCCCcc
Confidence                              223346678999999999999   89999999999999999999999999999987665432


Q ss_pred             ceecccCCCCcccccccccccc----cCCCCccccHHHHHHHHHHHHcCCCCCCCCC
Q 039231          440 IISMTGARGTVGYIAPEVFCRN----IGEVSYKSDVYNYGMMIFEMTGGRKNVDVVD  492 (506)
Q Consensus       440 ~~~~~~~~gt~~y~aPE~l~~~----~~~~s~~~Dv~s~G~il~elltg~~pf~~~~  492 (506)
                         .....||+.|+|||++.+.    ...++.++||||||+++|||++|+.||....
T Consensus       256 ---~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~  309 (365)
T 2y7j_A          256 ---LRELCGTPGYLAPEILKCSMDETHPGYGKEVDLWACGVILFTLLAGSPPFWHRR  309 (365)
T ss_dssp             ---BCCCCSCGGGCCHHHHHHTTCTTSCCBCTTHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred             ---cccCCCCCCccChhhccccccccCcCCCchhhHHhHHHHHHHHHHCCCCCCCCC
Confidence               2456789999999998532    2357889999999999999999999997654

>3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens}

Probab=99.97  E-value=1.5e-30  Score=261.33  Aligned_cols=169  Identities=30%  Similarity=0.393  Sum_probs=139.5

Q ss_pred             hccccCccCceEEEEEEEc-CCCEEEEEEeccCCCC---chhhHHHHHHhhccCccceeEEEEEee--------------
Q 039231          317 FKYKLGQGGYGSVYKGKLL-DGSNVAVKVLNDSKGN---GKEFINEVASISRTSHVNVVALLGFCL--------------  378 (506)
Q Consensus       317 ~~~~ig~G~~g~V~~~~~~-~~~~vavK~l~~~~~~---~~~~~~E~~~l~~l~h~niv~l~g~~~--------------  378 (506)
                      +.+.||+|+||.||+|+.. +|+.||||++......   .+.+.+|+.++++++||||+++++++.              
T Consensus        28 ~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~lv  107 (353)
T 3coi_A           28 SPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNFYDFYLV  107 (353)
T ss_dssp             EEEEEEECSSEEEEEEEETTTTEEEEEEEESSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGCCCCEEE
T ss_pred             EeeeEecCCCeEEEEEEECCCCCEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCcccHhheEecccccccceeEEEE
Confidence            3467999999999999975 5899999999764333   256889999999999999999998762              


Q ss_pred             ----------------ccchhhhHHHHHHHHHHHHhhcCCCCeEecCcCCCcEEECCCCcEEEeecCCCccccCCCccee
Q 039231          379 ----------------RVAEELSSTIGIARGLEYLHLGCSTRILHFDIKPHNILLDEDFCPKISDFGLAKICNRKESIIS  442 (506)
Q Consensus       379 ----------------~~~~~l~i~~~i~~gl~~LH~~~~~~ivH~dlkp~Nill~~~~~~ki~dfg~a~~~~~~~~~~~  442 (506)
                                      ++.+.+.++.||+.||+|||   +++|+||||||+||++++++.+||+|||+++......    
T Consensus       108 ~e~~~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH---~~~ivH~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~----  180 (353)
T 3coi_A          108 MPFMQTDLQKIMGLKFSEEKIQYLVYQMLKGLKYIH---SAGVVHRDLKPGNLAVNEDCELKILDFGLARHADAEM----  180 (353)
T ss_dssp             EECCSEEGGGTTTSCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSSCCGGGEEECTTCCEEECSTTCTTC---------
T ss_pred             eccccCCHHHHhcCCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCHHHEeECCCCcEEEeecccccCCCCCc----
Confidence                            22335678999999999999   8999999999999999999999999999998654322    


Q ss_pred             cccCCCCcccccccccccccCCCCccccHHHHHHHHHHHHcCCCCCCCCCCC
Q 039231          443 MTGARGTVGYIAPEVFCRNIGEVSYKSDVYNYGMMIFEMTGGRKNVDVVDNG  494 (506)
Q Consensus       443 ~~~~~gt~~y~aPE~l~~~~~~~s~~~Dv~s~G~il~elltg~~pf~~~~~~  494 (506)
                       ....+|+.|+|||.+.+. ..++.++||||||+++|||++|+.||...+..
T Consensus       181 -~~~~~t~~y~aPE~~~~~-~~~~~~~Di~slG~il~el~~g~~pf~~~~~~  230 (353)
T 3coi_A          181 -TGYVVTRWYRAPEVILSW-MHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYL  230 (353)
T ss_dssp             ----CCSBCCSCHHHHSCC-SCCCTTHHHHHHHHHHHHHHHSSCSSBSSCHH
T ss_pred             -cccccCcCcCCHHHHhCc-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH
Confidence             345789999999998652 46889999999999999999999999876543

>3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei}

Probab=99.97  E-value=2.7e-30  Score=271.90  Aligned_cols=172  Identities=31%  Similarity=0.454  Sum_probs=141.9

Q ss_pred             hhccccCccCceEEEEEEEc-CCCEEEEEEeccCC--------------CCchhhHHHHHHhhccCccceeEEEEEe---
Q 039231          316 SFKYKLGQGGYGSVYKGKLL-DGSNVAVKVLNDSK--------------GNGKEFINEVASISRTSHVNVVALLGFC---  377 (506)
Q Consensus       316 ~~~~~ig~G~~g~V~~~~~~-~~~~vavK~l~~~~--------------~~~~~~~~E~~~l~~l~h~niv~l~g~~---  377 (506)
                      .+.++||+|+||.||+|+.. +++.+|||+++...              ...+.+.+|++++++++||||+++++++   
T Consensus        39 ~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~  118 (504)
T 3q5i_A           39 FKVRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKSLDHPNIIKLFDVFEDK  118 (504)
T ss_dssp             EEEEEEEC--CEEEEEEEETTTCCEEEEEEEEC----------------CTHHHHHHHHHHHHTCCCTTBCCEEEEEECS
T ss_pred             EEEeEecccCCeEEEEEEECCCCcEEEEEEEEhhhcccccccccchhhHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEcC
Confidence            34578999999999999985 47899999997532              2236788999999999999999999987   


Q ss_pred             ------------------------eccchhhhHHHHHHHHHHHHhhcCCCCeEecCcCCCcEEECCCC---cEEEeecCC
Q 039231          378 ------------------------LRVAEELSSTIGIARGLEYLHLGCSTRILHFDIKPHNILLDEDF---CPKISDFGL  430 (506)
Q Consensus       378 ------------------------~~~~~~l~i~~~i~~gl~~LH~~~~~~ivH~dlkp~Nill~~~~---~~ki~dfg~  430 (506)
                                              +++.+++.++.||+.||+|||   +++|+||||||+|||++.++   .+||+|||+
T Consensus       119 ~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH---~~~ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~  195 (504)
T 3q5i_A          119 KYFYLVTEFYEGGELFEQIINRHKFDECDAANIMKQILSGICYLH---KHNIVHRDIKPENILLENKNSLLNIKIVDFGL  195 (504)
T ss_dssp             SEEEEEEECCTTCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEESSTTCCSSEEECCCTT
T ss_pred             CEEEEEEecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHH---HCCeEeCCCcHHHEEEecCCCCccEEEEECCC
Confidence                                    233446779999999999999   89999999999999998775   699999999


Q ss_pred             CccccCCCcceecccCCCCcccccccccccccCCCCccccHHHHHHHHHHHHcCCCCCCCCCCCcc
Q 039231          431 AKICNRKESIISMTGARGTVGYIAPEVFCRNIGEVSYKSDVYNYGMMIFEMTGGRKNVDVVDNGST  496 (506)
Q Consensus       431 a~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~s~~~Dv~s~G~il~elltg~~pf~~~~~~~~  496 (506)
                      ++.......   .....||+.|+|||++.   +.++.++||||+|+++|||++|+.||...+..+.
T Consensus       196 a~~~~~~~~---~~~~~gt~~y~aPE~~~---~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~  255 (504)
T 3q5i_A          196 SSFFSKDYK---LRDRLGTAYYIAPEVLK---KKYNEKCDVWSCGVIMYILLCGYPPFGGQNDQDI  255 (504)
T ss_dssp             CEECCTTSC---BCCCCSCTTTCCHHHHT---TCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHH
T ss_pred             CEEcCCCCc---cccccCCcCCCCHHHhc---cCCCchHHHHHHHHHHHHHHhCCCCCCCCCHHHH
Confidence            987765432   24567999999999984   3689999999999999999999999987655443

>2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens}

Probab=99.97  E-value=2.1e-30  Score=259.41  Aligned_cols=174  Identities=22%  Similarity=0.280  Sum_probs=136.0

Q ss_pred             HhhhccccCccCceEEEEEEEc----CCCEEEEEEeccCCC------------CchhhHHHHHHhhccCccceeEEEEEe
Q 039231          314 TNSFKYKLGQGGYGSVYKGKLL----DGSNVAVKVLNDSKG------------NGKEFINEVASISRTSHVNVVALLGFC  377 (506)
Q Consensus       314 ~~~~~~~ig~G~~g~V~~~~~~----~~~~vavK~l~~~~~------------~~~~~~~E~~~l~~l~h~niv~l~g~~  377 (506)
                      .+.+.+.||+|+||.||+|+..    .+..+|||++.....            ..+.+.+|+..+..++||||+++++++
T Consensus        38 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~ni~~~~~~~  117 (345)
T 2v62_A           38 QWVLGKKIGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPLFSELKFYQRVAKKDCIKKWIERKQLDYLGIPLFYGSG  117 (345)
T ss_dssp             EEEEEEEC------CEEEEEESSSCGGGCCEEEEEEECC-CHHHHHHHHHHHHCCHHHHHHHHHHHTCSCCCCCCEEEEE
T ss_pred             eEEEEeeEeecCCeEEEEEEecCCCCccceEEEEeeecCCcchHHHHHHHHHHhhhHHHHHHHhhccccccCcceeeccc
Confidence            3455678999999999999985    578899999875432            123467888999999999999999876


Q ss_pred             ec------------------------------cchhhhHHHHHHHHHHHHhhcCCCCeEecCcCCCcEEECCCC--cEEE
Q 039231          378 LR------------------------------VAEELSSTIGIARGLEYLHLGCSTRILHFDIKPHNILLDEDF--CPKI  425 (506)
Q Consensus       378 ~~------------------------------~~~~l~i~~~i~~gl~~LH~~~~~~ivH~dlkp~Nill~~~~--~~ki  425 (506)
                      ..                              +.+++.++.||+.||+|||   +++|+||||||+|||++.++  .+||
T Consensus       118 ~~~~~~~~~~~lv~e~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH---~~~ivH~Dlkp~NIll~~~~~~~~kL  194 (345)
T 2v62_A          118 LTEFKGRSYRFMVMERLGIDLQKISGQNGTFKKSTVLQLGIRMLDVLEYIH---ENEYVHGDIKAANLLLGYKNPDQVYL  194 (345)
T ss_dssp             EEESSSCEEEEEEEECEEEEHHHHCBGGGBCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEEESSSTTSEEE
T ss_pred             ccccCCCcEEEEEEeccCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH---hCCeeCCCcCHHHEEEccCCCCcEEE
Confidence            33                              3346779999999999999   89999999999999998877  9999


Q ss_pred             eecCCCccccCCCcce-----ecccCCCCcccccccccccccCCCCccccHHHHHHHHHHHHcCCCCCCCCC
Q 039231          426 SDFGLAKICNRKESII-----SMTGARGTVGYIAPEVFCRNIGEVSYKSDVYNYGMMIFEMTGGRKNVDVVD  492 (506)
Q Consensus       426 ~dfg~a~~~~~~~~~~-----~~~~~~gt~~y~aPE~l~~~~~~~s~~~Dv~s~G~il~elltg~~pf~~~~  492 (506)
                      +|||+++.........     ......||+.|+|||++.+.  .++.++||||||+++|||++|+.||....
T Consensus       195 ~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~~Di~slG~il~ell~g~~pf~~~~  264 (345)
T 2v62_A          195 ADYGLSYRYCPNGNHKQYQENPRKGHNGTIEFTSLDAHKGV--ALSRRSDVEILGYCMLRWLCGKLPWEQNL  264 (345)
T ss_dssp             CCCTTCEESSGGGCCCCCCCCGGGCSCSCTTTCCHHHHHTC--CCCHHHHHHHHHHHHHHHHHSSCTTGGGT
T ss_pred             EeCCCceecccccccccchhccccccCCCccccCHHHhcCC--CCCchhhHHHHHHHHHHHHhCCCCccccc
Confidence            9999998764332111     11345789999999998654  78999999999999999999999997543

>3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} SCOP: d.144.1.7

Probab=99.97  E-value=2.4e-30  Score=253.08  Aligned_cols=169  Identities=31%  Similarity=0.489  Sum_probs=136.8

Q ss_pred             ccccCccCceEEEEEEEcC-C---CEEEEEEeccCCC--CchhhHHHHHHhhccCccceeEEEEEee-------------
Q 039231          318 KYKLGQGGYGSVYKGKLLD-G---SNVAVKVLNDSKG--NGKEFINEVASISRTSHVNVVALLGFCL-------------  378 (506)
Q Consensus       318 ~~~ig~G~~g~V~~~~~~~-~---~~vavK~l~~~~~--~~~~~~~E~~~l~~l~h~niv~l~g~~~-------------  378 (506)
                      .++||+|+||.||+|++.+ +   ..+|+|++.....  ..+.+.+|++++++++||||+++++++.             
T Consensus        26 ~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~v~e~~  105 (298)
T 3pls_A           26 DRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEAFLREGLLMRGLNHPNVLALIGIMLPPEGLPHVLLPYM  105 (298)
T ss_dssp             EEEEEEETTEEEEEEEEECSSSCEEEEEEEEETTCCSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSSCCEEEECCC
T ss_pred             CceeccCCCceEEEEEEecCCCceeeeeeeeccccccHHHHHHHHHHHHHHHhCCCCCeeeEEEEEecCCCCcEEEEecc
Confidence            4679999999999998643 2   3799999975433  2367889999999999999999999872             


Q ss_pred             ----------------ccchhhhHHHHHHHHHHHHhhcCCCCeEecCcCCCcEEECCCCcEEEeecCCCccccCCCcc--
Q 039231          379 ----------------RVAEELSSTIGIARGLEYLHLGCSTRILHFDIKPHNILLDEDFCPKISDFGLAKICNRKESI--  440 (506)
Q Consensus       379 ----------------~~~~~l~i~~~i~~gl~~LH~~~~~~ivH~dlkp~Nill~~~~~~ki~dfg~a~~~~~~~~~--  440 (506)
                                      ++.+.+.++.|++.||+|||   +++++||||||+||++++++.+||+|||+++........  
T Consensus       106 ~~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH---~~~i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~~  182 (298)
T 3pls_A          106 CHGDLLQFIRSPQRNPTVKDLISFGLQVARGMEYLA---EQKFVHRDLAARNCMLDESFTVKVADFGLARDILDREYYSV  182 (298)
T ss_dssp             TTCBHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEECTTCCEEECCTTSSCTTTTGGGGCS
T ss_pred             cCCCHHHHHhccccCCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCCcceEEEcCCCcEEeCcCCCcccccCCccccc
Confidence                            22335678899999999999   899999999999999999999999999999865443211  


Q ss_pred             eecccCCCCcccccccccccccCCCCccccHHHHHHHHHHHHcCCCCCCCC
Q 039231          441 ISMTGARGTVGYIAPEVFCRNIGEVSYKSDVYNYGMMIFEMTGGRKNVDVV  491 (506)
Q Consensus       441 ~~~~~~~gt~~y~aPE~l~~~~~~~s~~~Dv~s~G~il~elltg~~pf~~~  491 (506)
                      .......+++.|+|||.+.+.  .++.++||||||+++|||++|..|+...
T Consensus       183 ~~~~~~~~~~~y~aPE~~~~~--~~~~~~Di~slG~il~~l~~g~~~~~~~  231 (298)
T 3pls_A          183 QQHRHARLPVKWTALESLQTY--RFTTKSDVWSFGVLLWELLTRGAPPYRH  231 (298)
T ss_dssp             CCSSCTTCGGGGSCHHHHTTC--CCCHHHHHHHHHHHHHHHHHTSCCTTTT
T ss_pred             ccCcCCCCCccccChhhhccC--CCChhhchhhHHHHHHHHhhCCCCCCcc
Confidence            112345678999999998553  7899999999999999999965554443

>3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 4deg_A* 4deh_A* 4dei_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 4aoi_A* 4ap7_A* 3q6w_A* ...

Probab=99.97  E-value=1.8e-30  Score=254.21  Aligned_cols=177  Identities=34%  Similarity=0.573  Sum_probs=139.7

Q ss_pred             hhccccCccCceEEEEEEEcC----CCEEEEEEeccCCC--CchhhHHHHHHhhccCccceeEEEEEee-----------
Q 039231          316 SFKYKLGQGGYGSVYKGKLLD----GSNVAVKVLNDSKG--NGKEFINEVASISRTSHVNVVALLGFCL-----------  378 (506)
Q Consensus       316 ~~~~~ig~G~~g~V~~~~~~~----~~~vavK~l~~~~~--~~~~~~~E~~~l~~l~h~niv~l~g~~~-----------  378 (506)
                      .+.+.||+|+||.||+|++.+    ...+|+|.++....  ..+.+.+|++++++++||||+++++++.           
T Consensus        28 ~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~v~e  107 (298)
T 3f66_A           28 HFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLP  107 (298)
T ss_dssp             EEEEEEEEETTEEEEEEEEC-----CEEEEEEEETTCCSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSSCCEEEEE
T ss_pred             hhcceeeecCCceEEEEEEecCCCceeEEEEEecccCCCHHHHHHHHHHHHHHHhCCCCCEeeeeeEEEcCCCceEEEEe
Confidence            345789999999999998643    23689999876433  2367889999999999999999999862           


Q ss_pred             ------------------ccchhhhHHHHHHHHHHHHhhcCCCCeEecCcCCCcEEECCCCcEEEeecCCCccccCCCcc
Q 039231          379 ------------------RVAEELSSTIGIARGLEYLHLGCSTRILHFDIKPHNILLDEDFCPKISDFGLAKICNRKESI  440 (506)
Q Consensus       379 ------------------~~~~~l~i~~~i~~gl~~LH~~~~~~ivH~dlkp~Nill~~~~~~ki~dfg~a~~~~~~~~~  440 (506)
                                        ++.+.+.++.|++.||+|||   +++|+||||||+||++++++.+||+|||+++........
T Consensus       108 ~~~~~~L~~~l~~~~~~~~~~~~~~i~~ql~~~l~~lH---~~~i~H~dikp~Nil~~~~~~~kl~Dfg~a~~~~~~~~~  184 (298)
T 3f66_A          108 YMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYLA---SKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYY  184 (298)
T ss_dssp             CCTTCBHHHHHHCTTCCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEECTTCCEEECSCGGGCCCSCGGGC
T ss_pred             CCCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHH---hCCccCCCCchheEEECCCCCEEECcccccccccccchh
Confidence                              22335678899999999999   899999999999999999999999999999866443221


Q ss_pred             --eecccCCCCcccccccccccccCCCCccccHHHHHHHHHHHHc-CCCCCCCCCCCcch
Q 039231          441 --ISMTGARGTVGYIAPEVFCRNIGEVSYKSDVYNYGMMIFEMTG-GRKNVDVVDNGSTA  497 (506)
Q Consensus       441 --~~~~~~~gt~~y~aPE~l~~~~~~~s~~~Dv~s~G~il~ellt-g~~pf~~~~~~~~~  497 (506)
                        .......+|+.|+|||.+.+.  .++.++||||||+++|||++ |.+||...+..+..
T Consensus       185 ~~~~~~~~~~~~~y~aPE~~~~~--~~~~~~Di~slG~il~~l~~~~~~~~~~~~~~~~~  242 (298)
T 3f66_A          185 SVHNKTGAKLPVKWMALESLQTQ--KFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDIT  242 (298)
T ss_dssp             BC-----CCBCGGGSCHHHHHHC--CCCHHHHHHHHHHHHHHHHTTSCCSSTTSCTTTHH
T ss_pred             ccccccCCCCCccccChHHhcCC--CCChHHHHHHHHHHHHHHHhCCCCCCccCCHHHHH
Confidence              112345678899999998554  78999999999999999999 66677665554443

>4fl3_A Tyrosine-protein kinase SYK; transferase; HET: ANP; 1.90A {Homo sapiens} PDB: 4fl2_A* 1a81_A* 1csy_A* 1csz_A*

Probab=99.96  E-value=7e-31  Score=282.92  Aligned_cols=173  Identities=28%  Similarity=0.476  Sum_probs=139.4

Q ss_pred             cccCccCceEEEEEEEc---CCCEEEEEEeccCCC---CchhhHHHHHHhhccCccceeEEEEEe---------------
Q 039231          319 YKLGQGGYGSVYKGKLL---DGSNVAVKVLNDSKG---NGKEFINEVASISRTSHVNVVALLGFC---------------  377 (506)
Q Consensus       319 ~~ig~G~~g~V~~~~~~---~~~~vavK~l~~~~~---~~~~~~~E~~~l~~l~h~niv~l~g~~---------------  377 (506)
                      ++||+|+||.||+|.+.   .++.||||+++....   ..+++.+|++++.+++|||||++++++               
T Consensus       375 ~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~lv~E~~~~g  454 (635)
T 4fl3_A          375 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEAESWMLVMEMAELG  454 (635)
T ss_dssp             EEEEECSSEEEEEEEEECSSCEEEEEEEEECGGGGCGGGHHHHHHHHHHHHHCCCTTBCCEEEEEESSSEEEEEECCTTE
T ss_pred             CEeccCCCEEEEEEEEcCCCcceEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCEEEEEEccCCC
Confidence            36999999999999763   367899999976432   236799999999999999999999987               


Q ss_pred             -----------eccchhhhHHHHHHHHHHHHhhcCCCCeEecCcCCCcEEECCCCcEEEeecCCCccccCCCcce-eccc
Q 039231          378 -----------LRVAEELSSTIGIARGLEYLHLGCSTRILHFDIKPHNILLDEDFCPKISDFGLAKICNRKESII-SMTG  445 (506)
Q Consensus       378 -----------~~~~~~l~i~~~i~~gl~~LH~~~~~~ivH~dlkp~Nill~~~~~~ki~dfg~a~~~~~~~~~~-~~~~  445 (506)
                                 +.+.+++.++.||+.||+|||   +++|+||||||+|||+++++.+||+|||+++......... ....
T Consensus       455 ~L~~~l~~~~~l~~~~~~~i~~qi~~~L~yLH---~~~iiHrDLkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~  531 (635)
T 4fl3_A          455 PLNKYLQQNRHVKDKNIIELVHQVSMGMKYLE---ESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTH  531 (635)
T ss_dssp             EHHHHHHHCTTCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEEEETTEEEECCTTHHHHTTC----------
T ss_pred             CHHHHHhhCCCCCHHHHHHHHHHHHHHHHHHH---HCCEeCCCCChHhEEEeCCCCEEEEEcCCccccccCccccccccC
Confidence                       233346779999999999999   8999999999999999999999999999998765443221 1233


Q ss_pred             CCCCcccccccccccccCCCCccccHHHHHHHHHHHHc-CCCCCCCCCCCcc
Q 039231          446 ARGTVGYIAPEVFCRNIGEVSYKSDVYNYGMMIFEMTG-GRKNVDVVDNGST  496 (506)
Q Consensus       446 ~~gt~~y~aPE~l~~~~~~~s~~~Dv~s~G~il~ellt-g~~pf~~~~~~~~  496 (506)
                      ..+|+.|+|||++..  ..++.++||||||+++|||++ |+.||......+.
T Consensus       532 ~~~t~~y~APE~~~~--~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~~~~  581 (635)
T 4fl3_A          532 GKWPVKWYAPECINY--YKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEV  581 (635)
T ss_dssp             ---CGGGSCHHHHHH--CCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHH
T ss_pred             CCCceeeeChhhhcC--CCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHHH
Confidence            456789999999954  378999999999999999998 9999987665443

>1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ...

Probab=99.96  E-value=1.1e-30  Score=258.56  Aligned_cols=175  Identities=26%  Similarity=0.461  Sum_probs=143.8

Q ss_pred             hhhccccCccCceEEEEEEEc------CCCEEEEEEeccCCC--CchhhHHHHHHhhccCccceeEEEEEee--------
Q 039231          315 NSFKYKLGQGGYGSVYKGKLL------DGSNVAVKVLNDSKG--NGKEFINEVASISRTSHVNVVALLGFCL--------  378 (506)
Q Consensus       315 ~~~~~~ig~G~~g~V~~~~~~------~~~~vavK~l~~~~~--~~~~~~~E~~~l~~l~h~niv~l~g~~~--------  378 (506)
                      +.+.+.||+|+||.||+|+..      +++.||||++.....  ...++.+|++++++++||||+++++++.        
T Consensus        27 y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv  106 (322)
T 1p4o_A           27 ITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQPTLVI  106 (322)
T ss_dssp             EEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSCHHHHHHHHHHHHHGGGCCCTTBCCEEEEECSSSSCEEE
T ss_pred             eeeeeEeccCCceEEEeeeecCccCCCCceEEEEEecccccCHHHHHHHHHHHHHHHhcCCCCEeeeEEEEccCCccEEE
Confidence            344578999999999999864      367899999975433  2246889999999999999999999871        


Q ss_pred             -----------------------------ccchhhhHHHHHHHHHHHHhhcCCCCeEecCcCCCcEEECCCCcEEEeecC
Q 039231          379 -----------------------------RVAEELSSTIGIARGLEYLHLGCSTRILHFDIKPHNILLDEDFCPKISDFG  429 (506)
Q Consensus       379 -----------------------------~~~~~l~i~~~i~~gl~~LH~~~~~~ivH~dlkp~Nill~~~~~~ki~dfg  429 (506)
                                                   .+.+.+.++.|++.||+|||   +++|+||||||+||++++++.+||+|||
T Consensus       107 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH---~~~i~H~dikp~NIli~~~~~~kl~Dfg  183 (322)
T 1p4o_A          107 MELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLN---ANKFVHRDLAARNCMVAEDFTVKIGDFG  183 (322)
T ss_dssp             EECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHH---HTTCBCSCCSGGGEEECTTCCEEECCTT
T ss_pred             EEeCCCCcHHHHHHHhchhhccCCCCCCcCHHHHHHHHHHHHHHHHHHH---HCCCccCCCccceEEEcCCCeEEECcCc
Confidence                                         22335668899999999999   8999999999999999999999999999


Q ss_pred             CCccccCCCcceecccCCCCcccccccccccccCCCCccccHHHHHHHHHHHHc-CCCCCCCCCCC
Q 039231          430 LAKICNRKESIISMTGARGTVGYIAPEVFCRNIGEVSYKSDVYNYGMMIFEMTG-GRKNVDVVDNG  494 (506)
Q Consensus       430 ~a~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~s~~~Dv~s~G~il~ellt-g~~pf~~~~~~  494 (506)
                      +++...............+|+.|+|||.+.+.  .++.++||||||+++|||++ |+.||......
T Consensus       184 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~--~~~~~~Di~slG~il~el~~~g~~p~~~~~~~  247 (322)
T 1p4o_A          184 MTRDIYETDYYRKGGKGLLPVRWMSPESLKDG--VFTTYSDVWSFGVVLWEIATLAEQPYQGLSNE  247 (322)
T ss_dssp             CCCGGGGGGCEEGGGSSEECGGGCCHHHHHHC--CCCHHHHHHHHHHHHHHHHHTSCCTTTTSCHH
T ss_pred             cccccccccccccccCCCCCCCccChhhhccC--CCCchhhHHHHHHHHHHHHhcCCCccccCCHH
Confidence            99876544433323345568899999998653  78999999999999999999 89999876443

>2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A

Probab=99.96  E-value=3.9e-30  Score=253.95  Aligned_cols=173  Identities=25%  Similarity=0.338  Sum_probs=136.0

Q ss_pred             cccCccCceEEEEEEEc-CCCEEEEEEeccCCC-CchhhHHHHHHhhcc-CccceeEEEEEee-----------------
Q 039231          319 YKLGQGGYGSVYKGKLL-DGSNVAVKVLNDSKG-NGKEFINEVASISRT-SHVNVVALLGFCL-----------------  378 (506)
Q Consensus       319 ~~ig~G~~g~V~~~~~~-~~~~vavK~l~~~~~-~~~~~~~E~~~l~~l-~h~niv~l~g~~~-----------------  378 (506)
                      +.||+|+||.||+|+.. +++.||||++..... ..+.+.+|++++.++ +||||+++++++.                 
T Consensus        19 ~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L   98 (316)
T 2ac3_A           19 DVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLELIEFFEEEDRFYLVFEKMRGGSI   98 (316)
T ss_dssp             CCCCCCSSEEEEEEECSSSCCEEEEEEEECCSSCCHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEECCTTCBH
T ss_pred             ceecCCceEEEEEEEEcCCCcEEEEEEEeeCcchhHHHHHHHHHHHHHhcCCCCeeeEEEEEeeCCEEEEEEEcCCCCcH
Confidence            56999999999999864 689999999976543 346789999999985 7999999999872                 


Q ss_pred             ----------ccchhhhHHHHHHHHHHHHhhcCCCCeEecCcCCCcEEECCCCc---EEEeecCCCccccCCCcc-----
Q 039231          379 ----------RVAEELSSTIGIARGLEYLHLGCSTRILHFDIKPHNILLDEDFC---PKISDFGLAKICNRKESI-----  440 (506)
Q Consensus       379 ----------~~~~~l~i~~~i~~gl~~LH~~~~~~ivH~dlkp~Nill~~~~~---~ki~dfg~a~~~~~~~~~-----  440 (506)
                                ++.+.+.++.|++.||+|||   +++|+||||||+|||++.++.   +||+|||+++........     
T Consensus        99 ~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH---~~~ivH~dlkp~Nil~~~~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~  175 (316)
T 2ac3_A           99 LSHIHKRRHFNELEASVVVQDVASALDFLH---NKGIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPIST  175 (316)
T ss_dssp             HHHHHHHSSCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEESCSSSSCSEEECCTTCCC-------------
T ss_pred             HHHHhccCCCCHHHHHHHHHHHHHHHHHHH---hCCceeCCCCHHHEEEccCCCcCceEEEEccCccccccCCccccccc
Confidence                      23346678999999999999   899999999999999988776   999999999765432211     


Q ss_pred             eecccCCCCcccccccccccc---cCCCCccccHHHHHHHHHHHHcCCCCCCCCCCC
Q 039231          441 ISMTGARGTVGYIAPEVFCRN---IGEVSYKSDVYNYGMMIFEMTGGRKNVDVVDNG  494 (506)
Q Consensus       441 ~~~~~~~gt~~y~aPE~l~~~---~~~~s~~~Dv~s~G~il~elltg~~pf~~~~~~  494 (506)
                      .......||+.|+|||++...   ...++.++||||||+++|||++|+.||......
T Consensus       176 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~  232 (316)
T 2ac3_A          176 PELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGS  232 (316)
T ss_dssp             ------CCSGGGCCHHHHHHTSHHHHHHTTTHHHHHHHHHHHHHHHSSCSCCCCCCS
T ss_pred             cccccccCCcCccChHHhhcccccccCCCcccccHhHHHHHHHHHHCCCCCcccccc
Confidence            112235689999999998541   135788999999999999999999999876543

>4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 4ehz_A* 4ei4_A* 4fk6_A* 3eyg_A* 3eyh_A*

Probab=99.96  E-value=8.7e-31  Score=256.85  Aligned_cols=172  Identities=25%  Similarity=0.420  Sum_probs=141.5

Q ss_pred             HHhhhccccCccCceEEEEEEE-----cCCCEEEEEEeccCC--CCchhhHHHHHHhhccCccceeEEEEEeec------
Q 039231          313 MTNSFKYKLGQGGYGSVYKGKL-----LDGSNVAVKVLNDSK--GNGKEFINEVASISRTSHVNVVALLGFCLR------  379 (506)
Q Consensus       313 ~~~~~~~~ig~G~~g~V~~~~~-----~~~~~vavK~l~~~~--~~~~~~~~E~~~l~~l~h~niv~l~g~~~~------  379 (506)
                      ..+...++||+|+||.||+|++     .+++.||+|+++...  ...+.+.+|++++++++||||+++++++..      
T Consensus        21 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~  100 (302)
T 4e5w_A           21 RFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNGI  100 (302)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEECTTSSSCSEEEEEEEEC-----CCHHHHHHHHHHHHTCCCTTBCCEEEEEEC---CCE
T ss_pred             hhhhhhhccCCCCceEEEEEEEccccCccCeEEEEEEecccccchhHHHHHHHHHHHHhCCCCCeeeeeeEEecCCCceE
Confidence            3344567899999999999984     358899999997543  334778999999999999999999988722      


Q ss_pred             ------------------------cchhhhHHHHHHHHHHHHhhcCCCCeEecCcCCCcEEECCCCcEEEeecCCCcccc
Q 039231          380 ------------------------VAEELSSTIGIARGLEYLHLGCSTRILHFDIKPHNILLDEDFCPKISDFGLAKICN  435 (506)
Q Consensus       380 ------------------------~~~~l~i~~~i~~gl~~LH~~~~~~ivH~dlkp~Nill~~~~~~ki~dfg~a~~~~  435 (506)
                                              +.+.+.++.|++.||+|||   +++|+||||||+||+++.++.+||+|||+++...
T Consensus       101 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~  177 (302)
T 4e5w_A          101 KLIMEFLPSGSLKEYLPKNKNKINLKQQLKYAVQICKGMDYLG---SRQYVHRDLAARNVLVESEHQVKIGDFGLTKAIE  177 (302)
T ss_dssp             EEEEECCTTCBHHHHHHHHTTTCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEEEETTEEEECCCTTCEECC
T ss_pred             EEEEEeCCCCcHHHHHHhccccCCHHHHHHHHHHHHHHHHHhh---cCCcccCCCchheEEEcCCCCEEECccccccccc
Confidence                                    2235678999999999999   8999999999999999999999999999998776


Q ss_pred             CCCccee-cccCCCCcccccccccccccCCCCccccHHHHHHHHHHHHcCCCCCC
Q 039231          436 RKESIIS-MTGARGTVGYIAPEVFCRNIGEVSYKSDVYNYGMMIFEMTGGRKNVD  489 (506)
Q Consensus       436 ~~~~~~~-~~~~~gt~~y~aPE~l~~~~~~~s~~~Dv~s~G~il~elltg~~pf~  489 (506)
                      ....... .....+|..|+|||.+.+.  .++.++||||||+++|||++|+.|+.
T Consensus       178 ~~~~~~~~~~~~~~~~~y~aPE~~~~~--~~~~~~Di~slG~il~~l~~g~~p~~  230 (302)
T 4e5w_A          178 TDKEYYTVKDDRDSPVFWYAPECLMQS--KFYIASDVWSFGVTLHELLTYCDSDS  230 (302)
T ss_dssp             TTCCEEECCCCTTCCGGGCCHHHHHHC--EEEHHHHHHHHHHHHHHHHTTTCGGG
T ss_pred             CCCcceeccCCCCCCccccCCeeecCC--CCCcchhHHHHHHHHHHHHHccCCCc
Confidence            5443222 2346688889999998654  67889999999999999999999864

>1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A*

Probab=99.96  E-value=2.3e-30  Score=250.92  Aligned_cols=168  Identities=29%  Similarity=0.532  Sum_probs=135.2

Q ss_pred             hhccccCccCceEEEEEEEcCCCEEEEEEeccCCCCchhhHHHHHHhhccCccceeEEEEEee-----------------
Q 039231          316 SFKYKLGQGGYGSVYKGKLLDGSNVAVKVLNDSKGNGKEFINEVASISRTSHVNVVALLGFCL-----------------  378 (506)
Q Consensus       316 ~~~~~ig~G~~g~V~~~~~~~~~~vavK~l~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~-----------------  378 (506)
                      .+.+.||+|+||.||+|+. +++.||||+++... ..+.+.+|++++++++||||+++++++.                 
T Consensus        24 ~~~~~lg~G~~g~V~~~~~-~~~~vavK~~~~~~-~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~lv~e~~~~~~  101 (278)
T 1byg_A           24 KLLQTIGKGEFGDVMLGDY-RGNKVAVKCIKNDA-TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAKGS  101 (278)
T ss_dssp             EEEEEEEECSSCEEEEEEE-TTEEEEEEECCCCC---HHHHHTHHHHTTCCCTTBCCEEEEECCC--CCEEEECCCTTEE
T ss_pred             eEEeEEecCCCceEEEEEE-cCCEEEEEEecchh-HHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCCceEEEEecCCCCC
Confidence            3456799999999999987 58899999997543 4578999999999999999999999862                 


Q ss_pred             -------------ccchhhhHHHHHHHHHHHHhhcCCCCeEecCcCCCcEEECCCCcEEEeecCCCccccCCCcceeccc
Q 039231          379 -------------RVAEELSSTIGIARGLEYLHLGCSTRILHFDIKPHNILLDEDFCPKISDFGLAKICNRKESIISMTG  445 (506)
Q Consensus       379 -------------~~~~~l~i~~~i~~gl~~LH~~~~~~ivH~dlkp~Nill~~~~~~ki~dfg~a~~~~~~~~~~~~~~  445 (506)
                                   ++.+.+.++.|++.||+|||   +++++||||||+||+++.++.+||+|||+++......     ..
T Consensus       102 L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~~-----~~  173 (278)
T 1byg_A          102 LVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLE---GNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQ-----DT  173 (278)
T ss_dssp             HHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEECTTSCEEECCCCC---------------
T ss_pred             HHHHHHhcccccCCHHHHHHHHHHHHHHHHHHH---hCCccccCCCcceEEEeCCCcEEEeeccccccccccc-----cC
Confidence                         22235678899999999999   8999999999999999999999999999998654332     23


Q ss_pred             CCCCcccccccccccccCCCCccccHHHHHHHHHHHHc-CCCCCCCCCCCc
Q 039231          446 ARGTVGYIAPEVFCRNIGEVSYKSDVYNYGMMIFEMTG-GRKNVDVVDNGS  495 (506)
Q Consensus       446 ~~gt~~y~aPE~l~~~~~~~s~~~Dv~s~G~il~ellt-g~~pf~~~~~~~  495 (506)
                      ..+++.|+|||.+.+.  .++.++||||||+++|||++ |+.||......+
T Consensus       174 ~~~~~~y~aPE~~~~~--~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~~  222 (278)
T 1byg_A          174 GKLPVKWTAPEALREK--KFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKD  222 (278)
T ss_dssp             --CCTTTSCHHHHHHC--CCCHHHHHHHHHHHHHHHHTTSCCSCTTSCGGG
T ss_pred             CCccccccCHHHhCCC--CCCchhcHHHHHHHHHHHHhCCCCCCCCCCHHH
Confidence            4568899999998543  78999999999999999998 999998765443

>4hgt_A Casein kinase I isoform delta; CK1D, inhibitor, transferase-transferase inhibitor C; HET: 15G; 1.80A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 3uzp_A* 4hnf_A* 1cki_A 1ckj_A 4hni_A* 4hok_A

Probab=99.96  E-value=3.1e-30  Score=252.00  Aligned_cols=175  Identities=22%  Similarity=0.308  Sum_probs=142.7

Q ss_pred             hhhccccCccCceEEEEEEE-cCCCEEEEEEeccCCCCchhhHHHHHHhhccCccceeEEEEEe----------------
Q 039231          315 NSFKYKLGQGGYGSVYKGKL-LDGSNVAVKVLNDSKGNGKEFINEVASISRTSHVNVVALLGFC----------------  377 (506)
Q Consensus       315 ~~~~~~ig~G~~g~V~~~~~-~~~~~vavK~l~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~----------------  377 (506)
                      +.+.+.||+|+||.||+|+. .+++.||||++..... .+++.+|++++.+++|++++..++.+                
T Consensus        11 y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~lv~e~~~~   89 (296)
T 4hgt_A           11 YRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTK-HPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVMELLGP   89 (296)
T ss_dssp             CEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEC----CCCHHHHHHHHHHHTTSTTCCCEEEEEEETTEEEEEEECCCC
T ss_pred             eEEeeeecCCCCeEEEEEEEcCCCceEEEEeeccccc-chHHHHHHHHHHHhcCCCCCCeeeeecCCCCceEEEEEccCC
Confidence            34457899999999999997 4689999998765432 35688999999999998877766654                


Q ss_pred             ------------eccchhhhHHHHHHHHHHHHhhcCCCCeEecCcCCCcEEE---CCCCcEEEeecCCCccccCCCcce-
Q 039231          378 ------------LRVAEELSSTIGIARGLEYLHLGCSTRILHFDIKPHNILL---DEDFCPKISDFGLAKICNRKESII-  441 (506)
Q Consensus       378 ------------~~~~~~l~i~~~i~~gl~~LH~~~~~~ivH~dlkp~Nill---~~~~~~ki~dfg~a~~~~~~~~~~-  441 (506)
                                  +++.+.+.++.|++.||+|||   +++|+||||||+|||+   ++++.+||+|||+++......... 
T Consensus        90 ~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH---~~~ivH~Dlkp~NIl~~~~~~~~~~kL~Dfg~a~~~~~~~~~~~  166 (296)
T 4hgt_A           90 SLEDLFNFCSRKFSLKTVLLLADQMISRIEYIH---SKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQH  166 (296)
T ss_dssp             BHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECCGGGTTCEEECCCTTCEECBCTTTCCB
T ss_pred             CHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHeeeeccCCCCeEEEecCccceeccCcccCcc
Confidence                        233446779999999999999   8999999999999999   788999999999998765543211 


Q ss_pred             ----ecccCCCCcccccccccccccCCCCccccHHHHHHHHHHHHcCCCCCCCCCCCc
Q 039231          442 ----SMTGARGTVGYIAPEVFCRNIGEVSYKSDVYNYGMMIFEMTGGRKNVDVVDNGS  495 (506)
Q Consensus       442 ----~~~~~~gt~~y~aPE~l~~~~~~~s~~~Dv~s~G~il~elltg~~pf~~~~~~~  495 (506)
                          ......||+.|+|||.+.+.  .++.++||||||+++|||++|+.||......+
T Consensus       167 ~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~  222 (296)
T 4hgt_A          167 IPYRENKNLTGTARYASINTHLGI--EQSRRDDLESLGYVLMYFNLGSLPWQGLKAAT  222 (296)
T ss_dssp             CCCCCSCCCCSCGGGCCHHHHTTC--CCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSS
T ss_pred             CCCCcccccCCCccccchHHhcCC--CCCchhHHHHHHHHHHHHhcCCCCCcccchhh
Confidence                12346789999999998654  68999999999999999999999998765543

>3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A*

Probab=99.96  E-value=3.2e-30  Score=256.15  Aligned_cols=180  Identities=24%  Similarity=0.365  Sum_probs=143.3

Q ss_pred             HHHHHHhhhc-cccCccCceEEEEEEEc-CCCEEEEEEeccCCC---CchhhHHHHHHhhccC-ccceeEEEEEe-----
Q 039231          309 DIKKMTNSFK-YKLGQGGYGSVYKGKLL-DGSNVAVKVLNDSKG---NGKEFINEVASISRTS-HVNVVALLGFC-----  377 (506)
Q Consensus       309 el~~~~~~~~-~~ig~G~~g~V~~~~~~-~~~~vavK~l~~~~~---~~~~~~~E~~~l~~l~-h~niv~l~g~~-----  377 (506)
                      +.....+.+. +.||+|+||.||+|+.. +++.||+|+++....   ...++.+|+.++.+++ ||||+++++++     
T Consensus        24 ~~~~~~y~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~iv~~~~~~~~~~~  103 (327)
T 3lm5_A           24 ENFNNFYILTSKELGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQDCRAEILHEIAVLELAKSCPRVINLHEVYENTSE  103 (327)
T ss_dssp             HHHHHHEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESEETTEECHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSE
T ss_pred             HhhhhEEeeccceeCCCCCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHhccCCCCEEEEEEEEEeCCe
Confidence            3333333443 78999999999999976 489999999975332   3367889999999995 69999999876     


Q ss_pred             ------------------------eccchhhhHHHHHHHHHHHHhhcCCCCeEecCcCCCcEEECC---CCcEEEeecCC
Q 039231          378 ------------------------LRVAEELSSTIGIARGLEYLHLGCSTRILHFDIKPHNILLDE---DFCPKISDFGL  430 (506)
Q Consensus       378 ------------------------~~~~~~l~i~~~i~~gl~~LH~~~~~~ivH~dlkp~Nill~~---~~~~ki~dfg~  430 (506)
                                              +++.+.+.++.|++.||+|||   +++|+||||||+|||++.   ++.+||+|||+
T Consensus       104 ~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~ql~~~L~~LH---~~givH~Dikp~NIl~~~~~~~~~~kL~Dfg~  180 (327)
T 3lm5_A          104 IILILEYAAGGEIFSLCLPELAEMVSENDVIRLIKQILEGVYYLH---QNNIVHLDLKPQNILLSSIYPLGDIKIVDFGM  180 (327)
T ss_dssp             EEEEEECCTTEEGGGGGSSCC-CCCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCCGGGEEESCBTTBCCEEECCGGG
T ss_pred             EEEEEEecCCCcHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHH---HCCeecCcCChHHEEEecCCCCCcEEEeeCcc
Confidence                                    223346779999999999999   899999999999999987   78999999999


Q ss_pred             CccccCCCcceecccCCCCcccccccccccccCCCCccccHHHHHHHHHHHHcCCCCCCCCCCCcc
Q 039231          431 AKICNRKESIISMTGARGTVGYIAPEVFCRNIGEVSYKSDVYNYGMMIFEMTGGRKNVDVVDNGST  496 (506)
Q Consensus       431 a~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~s~~~Dv~s~G~il~elltg~~pf~~~~~~~~  496 (506)
                      ++.......   .....||+.|+|||++.+.  .++.++||||||+++|||++|+.||...+..+.
T Consensus       181 a~~~~~~~~---~~~~~gt~~y~aPE~~~~~--~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~  241 (327)
T 3lm5_A          181 SRKIGHACE---LREIMGTPEYLAPEILNYD--PITTATDMWNIGIIAYMLLTHTSPFVGEDNQET  241 (327)
T ss_dssp             CEEC------------CCCGGGCCHHHHTTC--CCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHH
T ss_pred             ccccCCccc---cccccCCcCccCCeeecCC--CCCchhhHHHHHHHHHHHHhCCCCCCCCCchHH
Confidence            987654432   2346789999999998554  789999999999999999999999987655443

>2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A

Probab=99.96  E-value=2.5e-30  Score=254.13  Aligned_cols=171  Identities=29%  Similarity=0.436  Sum_probs=141.3

Q ss_pred             HhhhccccCccCceEEEEEEEc-CCCEEEEEEeccCCC-CchhhHHHHHHhhccCccceeEEEEEe--------------
Q 039231          314 TNSFKYKLGQGGYGSVYKGKLL-DGSNVAVKVLNDSKG-NGKEFINEVASISRTSHVNVVALLGFC--------------  377 (506)
Q Consensus       314 ~~~~~~~ig~G~~g~V~~~~~~-~~~~vavK~l~~~~~-~~~~~~~E~~~l~~l~h~niv~l~g~~--------------  377 (506)
                      .+.+.+.||+|+||.||+|+.. +|+.||+|+++.... ..+.+.+|++++++++||||+++++++              
T Consensus        10 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~   89 (304)
T 2jam_A           10 TFIFMEVLGSGAFSEVFLVKQRLTGKLFALKCIKKSPAFRDSSLENEIAVLKKIKHENIVTLEDIYESTTHYYLVMQLVS   89 (304)
T ss_dssp             HEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECC------HHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEECCCC
T ss_pred             cceeeeeccCCCCceEEEEEECCCCCEEEEEEEecccccchHHHHHHHHHHHhCCCCCeeehhhhcccCCEEEEEEEcCC
Confidence            3445678999999999999985 589999999976433 346788999999999999999999877              


Q ss_pred             -------------eccchhhhHHHHHHHHHHHHhhcCCCCeEecCcCCCcEEE---CCCCcEEEeecCCCccccCCCcce
Q 039231          378 -------------LRVAEELSSTIGIARGLEYLHLGCSTRILHFDIKPHNILL---DEDFCPKISDFGLAKICNRKESII  441 (506)
Q Consensus       378 -------------~~~~~~l~i~~~i~~gl~~LH~~~~~~ivH~dlkp~Nill---~~~~~~ki~dfg~a~~~~~~~~~~  441 (506)
                                   +++.+.+.++.|++.||+|||   +.+|+||||||+||++   ++++.+||+|||+++......   
T Consensus        90 ~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dikp~NIl~~~~~~~~~~kl~Dfg~~~~~~~~~---  163 (304)
T 2jam_A           90 GGELFDRILERGVYTEKDASLVIQQVLSAVKYLH---ENGIVHRDLKPENLLYLTPEENSKIMITDFGLSKMEQNGI---  163 (304)
T ss_dssp             SCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHH---HTTCCCCSCCGGGCEESSSSTTCCEEBCSCSTTCCCCCBT---
T ss_pred             CccHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHH---HCCccccCCCHHHEEEecCCCCCCEEEccCCcceecCCCc---
Confidence                         223345678999999999999   8999999999999999   788999999999997654322   


Q ss_pred             ecccCCCCcccccccccccccCCCCccccHHHHHHHHHHHHcCCCCCCCCCC
Q 039231          442 SMTGARGTVGYIAPEVFCRNIGEVSYKSDVYNYGMMIFEMTGGRKNVDVVDN  493 (506)
Q Consensus       442 ~~~~~~gt~~y~aPE~l~~~~~~~s~~~Dv~s~G~il~elltg~~pf~~~~~  493 (506)
                       .....+++.|+|||.+.+.  .++.++||||||+++|||++|+.||.....
T Consensus       164 -~~~~~~~~~y~aPE~~~~~--~~~~~~Di~slG~il~~l~~g~~pf~~~~~  212 (304)
T 2jam_A          164 -MSTACGTPGYVAPEVLAQK--PYSKAVDCWSIGVITYILLCGYPPFYEETE  212 (304)
T ss_dssp             -THHHHSCCCBCCTTTBSSC--SCCHHHHHHHHHHHHHHHHHSSCTTTTSCH
T ss_pred             -cccccCCCCccChHHhccC--CCCchhhHHHHHHHHHHHHHCCCCCCCCCH
Confidence             1334589999999998653  789999999999999999999999976543

>3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens}

Probab=99.96  E-value=6.3e-30  Score=252.27  Aligned_cols=171  Identities=30%  Similarity=0.422  Sum_probs=140.8

Q ss_pred             hhhccccCccCceEEEEEEEcC-CCEEEEEEeccCCCCchhhHHHHHHhhccCccceeEEEEEee---------------
Q 039231          315 NSFKYKLGQGGYGSVYKGKLLD-GSNVAVKVLNDSKGNGKEFINEVASISRTSHVNVVALLGFCL---------------  378 (506)
Q Consensus       315 ~~~~~~ig~G~~g~V~~~~~~~-~~~vavK~l~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~---------------  378 (506)
                      +.+.+.||+|+||.||+|+... |+.||+|++.... ..+++.+|++++.+++||||+++++++.               
T Consensus        31 y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~-~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~  109 (314)
T 3com_A           31 FDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPVES-DLQEIIKEISIMQQCDSPHVVKYYGSYFKNTDLWIVMEYCGAG  109 (314)
T ss_dssp             EEEEEECC----CEEEEEEETTTCCEEEEEEEETTS-CCHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEECCTTE
T ss_pred             hhhheeeccCCCeEEEEEEECCCCCEEEEEecCchH-HHHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEEEEeecCCCC
Confidence            3345789999999999999864 8999999997643 4578999999999999999999998762               


Q ss_pred             -------------ccchhhhHHHHHHHHHHHHhhcCCCCeEecCcCCCcEEECCCCcEEEeecCCCccccCCCcceeccc
Q 039231          379 -------------RVAEELSSTIGIARGLEYLHLGCSTRILHFDIKPHNILLDEDFCPKISDFGLAKICNRKESIISMTG  445 (506)
Q Consensus       379 -------------~~~~~l~i~~~i~~gl~~LH~~~~~~ivH~dlkp~Nill~~~~~~ki~dfg~a~~~~~~~~~~~~~~  445 (506)
                                   ++.+.+.++.|++.||+|||   +.+++|+||||+||+++.++.+||+|||++.........  ...
T Consensus       110 ~L~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH---~~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~~--~~~  184 (314)
T 3com_A          110 SVSDIIRLRNKTLTEDEIATILQSTLKGLEYLH---FMRKIHRDIKAGNILLNTEGHAKLADFGVAGQLTDTMAK--RNT  184 (314)
T ss_dssp             EHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTTCCEEECCCTTCEECBTTBSC--BCC
T ss_pred             CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH---hCCCcCCCcCHHHEEECCCCCEEEeecccchhhhhhccc--cCc
Confidence                         23335678999999999999   899999999999999999999999999999876543221  244


Q ss_pred             CCCCcccccccccccccCCCCccccHHHHHHHHHHHHcCCCCCCCCCC
Q 039231          446 ARGTVGYIAPEVFCRNIGEVSYKSDVYNYGMMIFEMTGGRKNVDVVDN  493 (506)
Q Consensus       446 ~~gt~~y~aPE~l~~~~~~~s~~~Dv~s~G~il~elltg~~pf~~~~~  493 (506)
                      ..+++.|+|||.+.+.  .++.++||||||+++|||++|+.||...+.
T Consensus       185 ~~~~~~y~aPE~~~~~--~~~~~~Di~slG~il~~l~~g~~p~~~~~~  230 (314)
T 3com_A          185 VIGTPFWMAPEVIQEI--GYNCVADIWSLGITAIEMAEGKPPYADIHP  230 (314)
T ss_dssp             CCSCGGGCCHHHHSSS--CBCTTHHHHHHHHHHHHHHHSSCTTTTSCH
T ss_pred             cCCCCCccChhhcCCC--CCCccccHHHHHHHHHHHHhCCCCCCCCCh
Confidence            6789999999998654  688999999999999999999999986543

>3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens}

Probab=99.96  E-value=1.2e-30  Score=260.06  Aligned_cols=171  Identities=29%  Similarity=0.414  Sum_probs=132.4

Q ss_pred             hccccCccCceEEEEEEEcCCCEEEEEEeccCCCCchhhHH--HHHHhhccCccceeEEEEEe-----------------
Q 039231          317 FKYKLGQGGYGSVYKGKLLDGSNVAVKVLNDSKGNGKEFIN--EVASISRTSHVNVVALLGFC-----------------  377 (506)
Q Consensus       317 ~~~~ig~G~~g~V~~~~~~~~~~vavK~l~~~~~~~~~~~~--E~~~l~~l~h~niv~l~g~~-----------------  377 (506)
                      +.+.||+|+||.||+|+. +++.||||++.....  +.+.+  |+..+..++||||+++++.+                 
T Consensus        17 ~~~~lg~G~~g~Vy~~~~-~~~~vavK~~~~~~~--~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~~lv~e~   93 (336)
T 3g2f_A           17 LLELIGRGRYGAVYKGSL-DERPVAVKVFSFANR--QNFINEKNIYRVPLMEHDNIARFIVGDERVTADGRMEYLLVMEY   93 (336)
T ss_dssp             EEEEEEECSSEEEEEEEE-TTEEEEEEEEEGGGH--HHHHHHHHHHTSTTCCCTTBCCEEEEEEEECTTSCEEEEEEECC
T ss_pred             eeeecccCCCeEEEEEEE-CCeEEEEEEeeccch--hhHHHHHHHHHHHhccCcchhhheecccccccCCCceEEEEEec
Confidence            356799999999999987 789999999975432  33444  44445568999999998633                 


Q ss_pred             --------------eccchhhhHHHHHHHHHHHHhhcCCC---------CeEecCcCCCcEEECCCCcEEEeecCCCccc
Q 039231          378 --------------LRVAEELSSTIGIARGLEYLHLGCST---------RILHFDIKPHNILLDEDFCPKISDFGLAKIC  434 (506)
Q Consensus       378 --------------~~~~~~l~i~~~i~~gl~~LH~~~~~---------~ivH~dlkp~Nill~~~~~~ki~dfg~a~~~  434 (506)
                                    .++.+.+.++.||++||+|||   +.         +|+||||||+|||++.++.+||+|||+++..
T Consensus        94 ~~~g~L~~~l~~~~~~~~~~~~i~~qi~~~L~~LH---~~~~~~~~~~~~ivH~Dikp~Nill~~~~~~kL~DFG~a~~~  170 (336)
T 3g2f_A           94 YPNGSLXKYLSLHTSDWVSSCRLAHSVTRGLAYLH---TELPRGDHYKPAISHRDLNSRNVLVKNDGTCVISDFGLSMRL  170 (336)
T ss_dssp             CTTCBHHHHHHHCCBCHHHHHHHHHHHHHHHHHHH---CCBCCGGGCBCCEECSSCSGGGEEECTTSCEEECCCTTCEEC
T ss_pred             CCCCcHHHHHhhcccchhHHHHHHHHHHHHHHHHH---hhhccccccccceeecccccceEEEcCCCcEEEeeccceeec
Confidence                          122335678999999999999   77         9999999999999999999999999999876


Q ss_pred             cCCCc------ceecccCCCCcccccccccccc-----cCCCCccccHHHHHHHHHHHHcCCCCCCCCCC
Q 039231          435 NRKES------IISMTGARGTVGYIAPEVFCRN-----IGEVSYKSDVYNYGMMIFEMTGGRKNVDVVDN  493 (506)
Q Consensus       435 ~~~~~------~~~~~~~~gt~~y~aPE~l~~~-----~~~~s~~~Dv~s~G~il~elltg~~pf~~~~~  493 (506)
                      .....      ........||+.|+|||++.+.     ...++.++||||||+++|||++|..||.....
T Consensus       171 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~  240 (336)
T 3g2f_A          171 TGNRLVRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRCTDLFPGES  240 (336)
T ss_dssp             SSSSCC---------CCTTSCGGGCCHHHHTTCCCGGGHHHHHHHHHHHHHHHHHHHHHTTBGGGSTTSC
T ss_pred             ccccccCccccccccccCCCccceeCchhhcCCcccccccccccccchHHHHHHHHHHHhcCCcCCCccc
Confidence            54321      1112345699999999998641     12456789999999999999999877755433

>3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A

Probab=99.96  E-value=4.5e-31  Score=267.65  Aligned_cols=170  Identities=16%  Similarity=0.167  Sum_probs=132.0

Q ss_pred             ccccCccCceEEEEEEE-cCCCEEEEEEeccCC----CCchhhHHHH---HHhhccCccceeEEE-------EE------
Q 039231          318 KYKLGQGGYGSVYKGKL-LDGSNVAVKVLNDSK----GNGKEFINEV---ASISRTSHVNVVALL-------GF------  376 (506)
Q Consensus       318 ~~~ig~G~~g~V~~~~~-~~~~~vavK~l~~~~----~~~~~~~~E~---~~l~~l~h~niv~l~-------g~------  376 (506)
                      .+.||+|+||.||+|+. .+|+.||||++....    ...+.+.+|+   +.+++++|||||+++       ++      
T Consensus        78 ~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~hpniv~~~~~~~~~~~~~~~~~~  157 (377)
T 3byv_A           78 GTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDLVKDPQK  157 (377)
T ss_dssp             EEEEEEETTEEEEEEEC-CCCCEEEEEEEEECC-CCTTHHHHHHHHHHGGGGSTTCCSHHHHHHHHCBCCCSEEEECTTS
T ss_pred             cceeecCCCEEEEEEEECCCCcEEEEEEEeeccccchHHHHHHHHHHHHHHhccccCCHHHHHHHhhhhhhhhhhhccCC
Confidence            46799999999999996 458999999997432    2336788999   556666899998776       21      


Q ss_pred             ------------------e-------------------ec-------cchhhhHHHHHHHHHHHHhhcCCCCeEecCcCC
Q 039231          377 ------------------C-------------------LR-------VAEELSSTIGIARGLEYLHLGCSTRILHFDIKP  412 (506)
Q Consensus       377 ------------------~-------------------~~-------~~~~l~i~~~i~~gl~~LH~~~~~~ivH~dlkp  412 (506)
                                        +                   +.       +..++.++.||+.||+|||   +++|+||||||
T Consensus       158 ~~~~~~~~~~~~~~i~~~~lv~E~~~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH---~~~ivHrDikp  234 (377)
T 3byv_A          158 KKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLH---HYGLVHTYLRP  234 (377)
T ss_dssp             CSEEEC------CEEESEEEEEECCSEEHHHHHHHHHHTTTTTHHHHHHHHHHHHHHHHHHHHHHH---HTTEECSCCCG
T ss_pred             ccccccccCCCceEEEEEEEEEeccCCCHHHHHHhccccccccccccHHHHHHHHHHHHHHHHHHH---hCCeecCCCCH
Confidence                              1                   01       1335568999999999999   89999999999


Q ss_pred             CcEEECCCCcEEEeecCCCccccCCCcceecccCCCCcccccccccccc---------cCCCCccccHHHHHHHHHHHHc
Q 039231          413 HNILLDEDFCPKISDFGLAKICNRKESIISMTGARGTVGYIAPEVFCRN---------IGEVSYKSDVYNYGMMIFEMTG  483 (506)
Q Consensus       413 ~Nill~~~~~~ki~dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~---------~~~~s~~~Dv~s~G~il~ellt  483 (506)
                      +|||++.++.+||+|||+++.....     .....| +.|+|||++.+.         ...++.++||||||+++|||++
T Consensus       235 ~NIll~~~~~~kL~DFG~a~~~~~~-----~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DvwSlG~il~ellt  308 (377)
T 3byv_A          235 VDIVLDQRGGVFLTGFEHLVRDGAR-----VVSSVS-RGFEPPELEARRATISYHRDRRTLMTFSFDAWALGLVIYWIWC  308 (377)
T ss_dssp             GGEEECTTCCEEECCGGGCEETTCE-----EECCCC-TTCCCHHHHHHHTSTHHHHCCEEECCHHHHHHHHHHHHHHHHH
T ss_pred             HHEEEcCCCCEEEEechhheecCCc-----ccCCCC-cCccChhhhcccccccccccccccCChhhhHHHHHHHHHHHHH
Confidence            9999999999999999999864331     244567 999999998543         0158999999999999999999


Q ss_pred             CCCCCCCCCCCcc
Q 039231          484 GRKNVDVVDNGST  496 (506)
Q Consensus       484 g~~pf~~~~~~~~  496 (506)
                      |+.||......+.
T Consensus       309 g~~Pf~~~~~~~~  321 (377)
T 3byv_A          309 ADLPITKDAALGG  321 (377)
T ss_dssp             SSCCC------CC
T ss_pred             CCCCCcccccccc
Confidence            9999987655443

>2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ...

Probab=99.96  E-value=1.8e-30  Score=256.23  Aligned_cols=176  Identities=28%  Similarity=0.508  Sum_probs=144.5

Q ss_pred             hhccccCccCceEEEEEEE------cCCCEEEEEEeccCCCC--chhhHHHHHHhhcc-CccceeEEEEEeec-------
Q 039231          316 SFKYKLGQGGYGSVYKGKL------LDGSNVAVKVLNDSKGN--GKEFINEVASISRT-SHVNVVALLGFCLR-------  379 (506)
Q Consensus       316 ~~~~~ig~G~~g~V~~~~~------~~~~~vavK~l~~~~~~--~~~~~~E~~~l~~l-~h~niv~l~g~~~~-------  379 (506)
                      .+.+.||+|+||.||+|+.      .+++.||||+++.....  .+.+.+|++++.++ +||||+++++++..       
T Consensus        30 ~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~~l  109 (316)
T 2xir_A           30 KLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGGPLMV  109 (316)
T ss_dssp             EEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECCTTSCCEE
T ss_pred             eeeeEEcCCCceeEEEEEEecCCccccceEEEEEecccCCCcHHHHHHHHHHHHHHhcccCCCeeeEEEEEecCCCceEE
Confidence            3457899999999999985      24688999999764432  35688999999999 69999999998621       


Q ss_pred             -------------------------------------cchhhhHHHHHHHHHHHHhhcCCCCeEecCcCCCcEEECCCCc
Q 039231          380 -------------------------------------VAEELSSTIGIARGLEYLHLGCSTRILHFDIKPHNILLDEDFC  422 (506)
Q Consensus       380 -------------------------------------~~~~l~i~~~i~~gl~~LH~~~~~~ivH~dlkp~Nill~~~~~  422 (506)
                                                           +.+.+.++.|++.||+|||   +++|+||||||+||+++.++.
T Consensus       110 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH---~~~i~H~dikp~Nil~~~~~~  186 (316)
T 2xir_A          110 IVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLA---SRKCIHRDLAARNILLSEKNV  186 (316)
T ss_dssp             EEECCTTEEHHHHHHTCTTSEECC-------CTTCEEHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEECGGGC
T ss_pred             EEEcCCCCcHHHHHHhcccccccccccchhhhccccCHHHHHHHHHHHHHHHHHHH---hCCcccccCccceEEECCCCC
Confidence                                                 1234568899999999999   899999999999999999999


Q ss_pred             EEEeecCCCccccCCCcceecccCCCCcccccccccccccCCCCccccHHHHHHHHHHHHc-CCCCCCCCCCCcc
Q 039231          423 PKISDFGLAKICNRKESIISMTGARGTVGYIAPEVFCRNIGEVSYKSDVYNYGMMIFEMTG-GRKNVDVVDNGST  496 (506)
Q Consensus       423 ~ki~dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~s~~~Dv~s~G~il~ellt-g~~pf~~~~~~~~  496 (506)
                      +||+|||+++...............+|+.|+|||.+.+.  .++.++||||||+++|||++ |+.||......+.
T Consensus       187 ~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~--~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~~~  259 (316)
T 2xir_A          187 VKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDR--VYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEE  259 (316)
T ss_dssp             EEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHC--CCCHHHHHHHHHHHHHHHHTTSCCSSTTCCCSHH
T ss_pred             EEECCCccccccccCccceeccCCCcceeecCchhhccc--cccchhHHHHHHHHHHHHHhCCCCCCcccchhHH
Confidence            999999999876554433333445678899999998653  78999999999999999998 9999987665443

>3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A*

Probab=99.96  E-value=6.1e-30  Score=251.11  Aligned_cols=170  Identities=27%  Similarity=0.396  Sum_probs=144.5

Q ss_pred             hccccCccCceEEEEEEEc-CCCEEEEEEeccCC--CCchhhHHHHHHhhccCccceeEEEEEee---------------
Q 039231          317 FKYKLGQGGYGSVYKGKLL-DGSNVAVKVLNDSK--GNGKEFINEVASISRTSHVNVVALLGFCL---------------  378 (506)
Q Consensus       317 ~~~~ig~G~~g~V~~~~~~-~~~~vavK~l~~~~--~~~~~~~~E~~~l~~l~h~niv~l~g~~~---------------  378 (506)
                      ..+.||+|+||.||+|+.. +++.||||++....  ...+.+.+|+.++++++||||+++++++.               
T Consensus        26 ~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~  105 (303)
T 3a7i_A           26 KLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIMEYLGGG  105 (303)
T ss_dssp             EEEEEEECSSSEEEEEEETTTCCEEEEEEEETTTCSTTHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECCTTE
T ss_pred             HhhhhcccCCeEEEEEEECCCCcEEEEEEecccccHHHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEEEEEeCCCC
Confidence            3467999999999999875 58999999997543  33478899999999999999999999772               


Q ss_pred             -----------ccchhhhHHHHHHHHHHHHhhcCCCCeEecCcCCCcEEECCCCcEEEeecCCCccccCCCcceecccCC
Q 039231          379 -----------RVAEELSSTIGIARGLEYLHLGCSTRILHFDIKPHNILLDEDFCPKISDFGLAKICNRKESIISMTGAR  447 (506)
Q Consensus       379 -----------~~~~~l~i~~~i~~gl~~LH~~~~~~ivH~dlkp~Nill~~~~~~ki~dfg~a~~~~~~~~~~~~~~~~  447 (506)
                                 ++.+.+.++.|++.||+|||   +.+|+|+||||+||+++.++.+||+|||++.........  .....
T Consensus       106 ~L~~~~~~~~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~~~~~~--~~~~~  180 (303)
T 3a7i_A          106 SALDLLEPGPLDETQIATILREILKGLDYLH---SEKKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIK--RNTFV  180 (303)
T ss_dssp             EHHHHHTTSCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTTSCEEECCCTTCEECBTTBCC--BCCCC
T ss_pred             cHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH---HCCCccCCCChheEEECCCCCEEEeecccceecCccccc--cCccC
Confidence                       33446779999999999999   899999999999999999999999999999876543321  24467


Q ss_pred             CCcccccccccccccCCCCccccHHHHHHHHHHHHcCCCCCCCCCC
Q 039231          448 GTVGYIAPEVFCRNIGEVSYKSDVYNYGMMIFEMTGGRKNVDVVDN  493 (506)
Q Consensus       448 gt~~y~aPE~l~~~~~~~s~~~Dv~s~G~il~elltg~~pf~~~~~  493 (506)
                      +++.|+|||.+.+.  .++.++||||||+++|||++|+.||.....
T Consensus       181 ~~~~y~aPE~~~~~--~~~~~~Di~slG~il~~l~~g~~p~~~~~~  224 (303)
T 3a7i_A          181 GTPFWMAPEVIKQS--AYDSKADIWSLGITAIELARGEPPHSELHP  224 (303)
T ss_dssp             SCGGGCCHHHHTTC--CBCTHHHHHHHHHHHHHHHHSSCTTTTSCH
T ss_pred             CCcCccCHHHHhcC--CCCchhhhHHHHHHHHHHccCCCCCCCcCH
Confidence            89999999998653  688999999999999999999999986543

>2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis}

Probab=99.96  E-value=3.8e-30  Score=253.53  Aligned_cols=171  Identities=25%  Similarity=0.429  Sum_probs=133.0

Q ss_pred             hhccccCccCceEEEEEEEc-CCCEEEEEEeccCCCC----chhhHHHHHHhhccCccceeEEEEEe-------------
Q 039231          316 SFKYKLGQGGYGSVYKGKLL-DGSNVAVKVLNDSKGN----GKEFINEVASISRTSHVNVVALLGFC-------------  377 (506)
Q Consensus       316 ~~~~~ig~G~~g~V~~~~~~-~~~~vavK~l~~~~~~----~~~~~~E~~~l~~l~h~niv~l~g~~-------------  377 (506)
                      .+.+.||+|+||.||+|+.. +++.||+|++......    .+.+.+|++++.+++||||+++++++             
T Consensus        37 ~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~  116 (309)
T 2h34_A           37 RLRRLVGRGGMGDVYEAEDTVRERIVALKLMSETLSSDPVFRTRMQREARTAGRLQEPHVVPIHDFGEIDGQLYVDMRLI  116 (309)
T ss_dssp             EEEEEEEECSSSEEEEEEETTTTEEEEEEECGGGGGGSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred             EEEEEEcCCCCeeEEEEEEcCCCeEEEEEecCcccccCHHHHHHHHHHHHHHhhcCCCCeeEEEEEEeeCCeEEEEEEec
Confidence            34568999999999999975 5889999999754322    26688999999999999999999887             


Q ss_pred             --------------eccchhhhHHHHHHHHHHHHhhcCCCCeEecCcCCCcEEECCCCcEEEeecCCCccccCCCcceec
Q 039231          378 --------------LRVAEELSSTIGIARGLEYLHLGCSTRILHFDIKPHNILLDEDFCPKISDFGLAKICNRKESIISM  443 (506)
Q Consensus       378 --------------~~~~~~l~i~~~i~~gl~~LH~~~~~~ivH~dlkp~Nill~~~~~~ki~dfg~a~~~~~~~~~~~~  443 (506)
                                    +++.+.+.++.|++.||+|||   +.+|+|+||||+||+++.++.+||+|||++......... ..
T Consensus       117 ~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH---~~~i~H~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~-~~  192 (309)
T 2h34_A          117 NGVDLAAMLRRQGPLAPPRAVAIVRQIGSALDAAH---AAGATHRDVKPENILVSADDFAYLVDFGIASATTDEKLT-QL  192 (309)
T ss_dssp             CCEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEECTTSCEEECSCCC-------------
T ss_pred             CCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH---HCcCCcCCCChHHEEEcCCCCEEEecCccCccccccccc-cc
Confidence                          223346779999999999999   899999999999999999999999999999866543221 12


Q ss_pred             ccCCCCcccccccccccccCCCCccccHHHHHHHHHHHHcCCCCCCCCC
Q 039231          444 TGARGTVGYIAPEVFCRNIGEVSYKSDVYNYGMMIFEMTGGRKNVDVVD  492 (506)
Q Consensus       444 ~~~~gt~~y~aPE~l~~~~~~~s~~~Dv~s~G~il~elltg~~pf~~~~  492 (506)
                      ....+++.|+|||.+.+.  .++.++||||||+++|||++|+.||....
T Consensus       193 ~~~~~~~~y~aPE~~~~~--~~~~~~Di~slG~il~~l~~g~~pf~~~~  239 (309)
T 2h34_A          193 GNTVGTLYYMAPERFSES--HATYRADIYALTCVLYECLTGSPPYQGDQ  239 (309)
T ss_dssp             ----CCGGGCCGGGTCC------CCCHHHHHHHHHHHHHHSSCSSCSCH
T ss_pred             cccCCCcCccCHHHHcCC--CCCchHhHHHHHHHHHHHHHCCCCCCCch
Confidence            345689999999998654  78899999999999999999999997653

>3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} SCOP: d.144.1.7

Probab=99.96  E-value=6.3e-30  Score=254.63  Aligned_cols=179  Identities=24%  Similarity=0.362  Sum_probs=135.7

Q ss_pred             HHHHHHHHhhhccccCccCceEEEEEEEcCCCEEEEEEeccCCCCchhhHHHHHHhhc--cCccceeEEEEEeec-----
Q 039231          307 YADIKKMTNSFKYKLGQGGYGSVYKGKLLDGSNVAVKVLNDSKGNGKEFINEVASISR--TSHVNVVALLGFCLR-----  379 (506)
Q Consensus       307 ~~el~~~~~~~~~~ig~G~~g~V~~~~~~~~~~vavK~l~~~~~~~~~~~~E~~~l~~--l~h~niv~l~g~~~~-----  379 (506)
                      ..+.....+.+.++||+|+||.||+|+.. ++.||||++....  .....+|.+++..  ++||||+++++++..     
T Consensus        31 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~~-~~~vavK~~~~~~--~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~~~  107 (337)
T 3mdy_A           31 VQRTIAKQIQMVKQIGKGRYGEVWMGKWR-GEKVAVKVFFTTE--EASWFRETEIYQTVLMRHENILGFIAADIKGTGSW  107 (337)
T ss_dssp             HHTTHHHHCEEEEEEEEETTEEEEEEEET-TEEEEEEEEEGGG--HHHHHHHHHHHTSTTCCCTTBCCEEEEEEESCGGG
T ss_pred             cccccccceEEEeEeecCCCeEEEEEEEC-CceEEEEEEeccc--cchhhhHHHHHHHHhhcCCCeeeEEEEEccCCCCC
Confidence            33444445556688999999999999985 8999999996543  2344555555555  489999999987632     


Q ss_pred             -------------------------cchhhhHHHHHHHHHHHHhhcCCC--------CeEecCcCCCcEEECCCCcEEEe
Q 039231          380 -------------------------VAEELSSTIGIARGLEYLHLGCST--------RILHFDIKPHNILLDEDFCPKIS  426 (506)
Q Consensus       380 -------------------------~~~~l~i~~~i~~gl~~LH~~~~~--------~ivH~dlkp~Nill~~~~~~ki~  426 (506)
                                               +.+.+.++.|++.||+|||   +.        +|+||||||+|||++.++.+||+
T Consensus       108 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~i~~~i~~~l~~lH---~~~~~~~~~~~ivH~Dikp~Nill~~~~~~kl~  184 (337)
T 3mdy_A          108 TQLYLITDYHENGSLYDYLKSTTLDAKSMLKLAYSSVSGLCHLH---TEIFSTQGKPAIAHRDLKSKNILVKKNGTCCIA  184 (337)
T ss_dssp             CEEEEEECCCTTCBHHHHHHHCCBCHHHHHHHHHHHHHHHHHHH---SCBCSTTCBCCEECSCCCGGGEEECTTSCEEEC
T ss_pred             CceEEEEeccCCCcHHHHhhccCCCHHHHHHHHHHHHHHHHHHH---HhhhhhccCCCEEecccchHHEEECCCCCEEEE
Confidence                                     2335678999999999999   77        99999999999999999999999


Q ss_pred             ecCCCccccCCCccee--cccCCCCcccccccccccccCCCCc------cccHHHHHHHHHHHHcC----------CCCC
Q 039231          427 DFGLAKICNRKESIIS--MTGARGTVGYIAPEVFCRNIGEVSY------KSDVYNYGMMIFEMTGG----------RKNV  488 (506)
Q Consensus       427 dfg~a~~~~~~~~~~~--~~~~~gt~~y~aPE~l~~~~~~~s~------~~Dv~s~G~il~elltg----------~~pf  488 (506)
                      |||+++..........  .....||+.|+|||++.+.  ..+.      ++||||||+++|||++|          +.||
T Consensus       185 Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~~~~~~~~DiwslG~il~el~tg~~~~~~~~~~~~p~  262 (337)
T 3mdy_A          185 DLGLAVKFISDTNEVDIPPNTRVGTKRYMPPEVLDES--LNRNHFQSYIMADMYSFGLILWEVARRCVSGGIVEEYQLPY  262 (337)
T ss_dssp             CCTTCEECC---------CCSSCSCGGGCCHHHHTTC--CCTTCTHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTT
T ss_pred             eCCCceeeccccccccCCCCCCccCcceeChhhcccc--cCCccccCccccchHHHHHHHHHHHhccCcccccccccccH
Confidence            9999987654332211  1245789999999998654  3333      39999999999999999          7777


Q ss_pred             CCCCC
Q 039231          489 DVVDN  493 (506)
Q Consensus       489 ~~~~~  493 (506)
                      .....
T Consensus       263 ~~~~~  267 (337)
T 3mdy_A          263 HDLVP  267 (337)
T ss_dssp             TTTSC
T ss_pred             hhhcC
Confidence            65433

>3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A

Probab=99.96  E-value=3.9e-30  Score=251.39  Aligned_cols=172  Identities=22%  Similarity=0.313  Sum_probs=141.9

Q ss_pred             hccccCccCceEEEEEEE-cCCCEEEEEEeccCCCCchhhHHHHHHhhccCccceeEEEEEe------------------
Q 039231          317 FKYKLGQGGYGSVYKGKL-LDGSNVAVKVLNDSKGNGKEFINEVASISRTSHVNVVALLGFC------------------  377 (506)
Q Consensus       317 ~~~~ig~G~~g~V~~~~~-~~~~~vavK~l~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~------------------  377 (506)
                      +.+.||+|+||.||+|+. .+++.||||++..... .+++.+|++++.+++|++++..++++                  
T Consensus        13 ~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~lv~e~~~~~L   91 (296)
T 3uzp_A           13 LGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTK-HPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVMELLGPSL   91 (296)
T ss_dssp             EEEEEEEETTEEEEEEEETTTTEEEEEEEEESCSS-CCHHHHHHHHHHHHTTSTTCCCEEEEEEETTEEEEEEECCCCBH
T ss_pred             EEEEEccCCCeEEEEEEEcCCCcEEEEEEecCCcc-hhHHHHHHHHHHHhhcCCCCCccccccCCCCceEEEEEecCCCH
Confidence            356799999999999997 5689999999876443 36789999999999998877666544                  


Q ss_pred             ----------eccchhhhHHHHHHHHHHHHhhcCCCCeEecCcCCCcEEE---CCCCcEEEeecCCCccccCCCcce---
Q 039231          378 ----------LRVAEELSSTIGIARGLEYLHLGCSTRILHFDIKPHNILL---DEDFCPKISDFGLAKICNRKESII---  441 (506)
Q Consensus       378 ----------~~~~~~l~i~~~i~~gl~~LH~~~~~~ivH~dlkp~Nill---~~~~~~ki~dfg~a~~~~~~~~~~---  441 (506)
                                +++.+.+.++.|++.||+|||   +++|+||||||+|||+   ++++.+||+|||+++.........   
T Consensus        92 ~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH---~~~ivH~dlkp~NIl~~~~~~~~~~kl~Dfg~~~~~~~~~~~~~~~  168 (296)
T 3uzp_A           92 EDLFNFCSRKFSLKTVLLLADQMISRIEYIH---SKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIP  168 (296)
T ss_dssp             HHHHHHTTTCCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCCGGGEEECCGGGTTCEEECCCTTCEECBCTTTCCBCC
T ss_pred             HHHHHhhccCCCHHHHHHHHHHHHHHHHHHH---hCCeeeCCCCHHHeEEecCCCCCeEEEeeCCCcccccccccccccc
Confidence                      233346779999999999999   8999999999999999   488899999999998766543311   


Q ss_pred             --ecccCCCCcccccccccccccCCCCccccHHHHHHHHHHHHcCCCCCCCCCCC
Q 039231          442 --SMTGARGTVGYIAPEVFCRNIGEVSYKSDVYNYGMMIFEMTGGRKNVDVVDNG  494 (506)
Q Consensus       442 --~~~~~~gt~~y~aPE~l~~~~~~~s~~~Dv~s~G~il~elltg~~pf~~~~~~  494 (506)
                        ......||+.|+|||.+.+.  .++.++||||||+++|||++|+.||......
T Consensus       169 ~~~~~~~~gt~~y~aPE~~~~~--~~~~~~Di~slG~il~~l~~g~~pf~~~~~~  221 (296)
T 3uzp_A          169 YRENKNLTGTARYASINTHLGI--EQSRRDDLESLGYVLMYFNLGSLPWQGLKAA  221 (296)
T ss_dssp             CCCSCCCCSCTTTCCHHHHTTC--CCCHHHHHHHHHHHHHHHHHSSCTTSSCCCS
T ss_pred             cccccccccccccCChhhhcCC--CCCcchhhHHHHHHHHHHHhCCCCCCCcCch
Confidence              12346789999999998654  6899999999999999999999999875443

>3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A*

Probab=99.96  E-value=1.4e-30  Score=263.41  Aligned_cols=168  Identities=13%  Similarity=0.100  Sum_probs=126.1

Q ss_pred             hccccCccCceEEEEEEEc-CCCEEEEEEeccCCC----CchhhHHHH---HHhhccCccceeEEEE-------------
Q 039231          317 FKYKLGQGGYGSVYKGKLL-DGSNVAVKVLNDSKG----NGKEFINEV---ASISRTSHVNVVALLG-------------  375 (506)
Q Consensus       317 ~~~~ig~G~~g~V~~~~~~-~~~~vavK~l~~~~~----~~~~~~~E~---~~l~~l~h~niv~l~g-------------  375 (506)
                      +.+.||+|+||.||+|++. +++.||||++.....    ..+.+.+|+   +.|+. +||||++++.             
T Consensus        66 ~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~~~~l~~-~hp~iv~~~~~~~~p~d~~~~~~  144 (371)
T 3q60_A           66 LVEPLRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLLG-ESPEEARDRRRLLLPSDAVAVQS  144 (371)
T ss_dssp             EEEEEEECSSEEEEEEEETTTTEEEEEEEEECCSTTHHHHHHHHHHHHHHHHHHHC-----------CBCCCCEEEEETT
T ss_pred             eeeeccCCCCEEEEEEEECCCCceeEEEEEEecccccccHHHHHHHHHHHHHHhcc-cChhhhhhceeEEeeehheecCC
Confidence            4568999999999999975 689999999987543    224567775   45555 6999887431             


Q ss_pred             ------------------Ee--------------------eccchh------hhHHHHHHHHHHHHhhcCCCCeEecCcC
Q 039231          376 ------------------FC--------------------LRVAEE------LSSTIGIARGLEYLHLGCSTRILHFDIK  411 (506)
Q Consensus       376 ------------------~~--------------------~~~~~~------l~i~~~i~~gl~~LH~~~~~~ivH~dlk  411 (506)
                                        ++                    +....+      +.++.||+.||+|||   +++|+|||||
T Consensus       145 ~~~~~~~~~~~~~~~~~~~~lv~e~~~~~L~~~l~~~~~~~~~~~~~~~~vk~~i~~qi~~aL~~LH---~~~ivHrDik  221 (371)
T 3q60_A          145 QPPFAQLSPGQDDYAVANYLLLMPAASVDLELLFSTLDFVYVFRGDEGILALHILTAQLIRLAANLQ---SKGLVHGHFT  221 (371)
T ss_dssp             SCSSSBCSCC---CCEEEEEEEECCCSEEHHHHHHHHHHSCCCCHHHHHHHHHHHHHHHHHHHHHHH---HTTEEETTCS
T ss_pred             CCCeeeccCCcccceeeeEEEEecCCCCCHHHHHHHhccccchhhhhhhhhHHHHHHHHHHHHHHHH---HCCCccCcCC
Confidence                              11                    111223      567799999999999   8999999999


Q ss_pred             CCcEEECCCCcEEEeecCCCccccCCCcceecccCCCCcccccccccccccCCCCccccHHHHHHHHHHHHcCCCCCCCC
Q 039231          412 PHNILLDEDFCPKISDFGLAKICNRKESIISMTGARGTVGYIAPEVFCRNIGEVSYKSDVYNYGMMIFEMTGGRKNVDVV  491 (506)
Q Consensus       412 p~Nill~~~~~~ki~dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~s~~~Dv~s~G~il~elltg~~pf~~~  491 (506)
                      |+|||++.++.+||+|||+++......     ....+|+.|+|||++.+....++.++||||||+++|||++|+.||...
T Consensus       222 p~NIll~~~~~~kL~DFG~a~~~~~~~-----~~~~~t~~y~aPE~~~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~  296 (371)
T 3q60_A          222 PDNLFIMPDGRLMLGDVSALWKVGTRG-----PASSVPVTYAPREFLNASTATFTHALNAWQLGLSIYRVWCLFLPFGLV  296 (371)
T ss_dssp             GGGEEECTTSCEEECCGGGEEETTCEE-----EGGGSCGGGCCHHHHTCSEEECCHHHHHHHHHHHHHHHHHSSCSTTBC
T ss_pred             HHHEEECCCCCEEEEecceeeecCCCc-----cCccCCcCCcChhhccCCCCCcCccccHHHHHHHHHHHHhCCCCCCCc
Confidence            999999999999999999998664322     234567999999999653347899999999999999999999999877


Q ss_pred             CC
Q 039231          492 DN  493 (506)
Q Consensus       492 ~~  493 (506)
                      ..
T Consensus       297 ~~  298 (371)
T 3q60_A          297 TP  298 (371)
T ss_dssp             CT
T ss_pred             Cc
Confidence            43

>2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens}

Probab=99.96  E-value=7.2e-30  Score=249.35  Aligned_cols=170  Identities=30%  Similarity=0.439  Sum_probs=139.0

Q ss_pred             cccCccCceEEEEEEEc-CCCEEEEEEeccCCC-CchhhHHHHHHhhccCccceeEEEEEeec-----------------
Q 039231          319 YKLGQGGYGSVYKGKLL-DGSNVAVKVLNDSKG-NGKEFINEVASISRTSHVNVVALLGFCLR-----------------  379 (506)
Q Consensus       319 ~~ig~G~~g~V~~~~~~-~~~~vavK~l~~~~~-~~~~~~~E~~~l~~l~h~niv~l~g~~~~-----------------  379 (506)
                      ..||+|+||.||+|+.. +++.||||++..... ..+.+.+|+.++++++||||+++++++.+                 
T Consensus        28 ~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~  107 (295)
T 2clq_A           28 VVLGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPLHEEIALHKHLKHKNIVQYLGSFSENGFIKIFMEQVPGGSLS  107 (295)
T ss_dssp             CEEEECSSSEEEEEEETTTCCEEEEEEEECCCC---HHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEECCSEEEHH
T ss_pred             EEEeecCcEEEEEEEECCCCeEEEEEEccCCchHHHHHHHHHHHHHHhCCCCCEeeEeeEEEeCCcEEEEEEeCCCCCHH
Confidence            36999999999999974 588999999976433 34778999999999999999999988721                 


Q ss_pred             -------------cchhhhHHHHHHHHHHHHhhcCCCCeEecCcCCCcEEECC-CCcEEEeecCCCccccCCCcceeccc
Q 039231          380 -------------VAEELSSTIGIARGLEYLHLGCSTRILHFDIKPHNILLDE-DFCPKISDFGLAKICNRKESIISMTG  445 (506)
Q Consensus       380 -------------~~~~l~i~~~i~~gl~~LH~~~~~~ivH~dlkp~Nill~~-~~~~ki~dfg~a~~~~~~~~~~~~~~  445 (506)
                                   +...+.++.|++.||+|||   +++++|+||||+||+++. ++.+||+|||+++........  ...
T Consensus       108 ~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dl~p~Nil~~~~~~~~kl~Dfg~~~~~~~~~~~--~~~  182 (295)
T 2clq_A          108 ALLRSKWGPLKDNEQTIGFYTKQILEGLKYLH---DNQIVHRDIKGDNVLINTYSGVLKISDFGTSKRLAGINPC--TET  182 (295)
T ss_dssp             HHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEEETTTCCEEECCTTTCEESCC-------CC
T ss_pred             HHHHhhccCCCccHHHHHHHHHHHHHHHHHHH---hCCEEccCCChhhEEEECCCCCEEEeecccccccCCCCCc--ccc
Confidence                         2224557899999999999   899999999999999987 899999999999876543221  234


Q ss_pred             CCCCcccccccccccccCCCCccccHHHHHHHHHHHHcCCCCCCCCCC
Q 039231          446 ARGTVGYIAPEVFCRNIGEVSYKSDVYNYGMMIFEMTGGRKNVDVVDN  493 (506)
Q Consensus       446 ~~gt~~y~aPE~l~~~~~~~s~~~Dv~s~G~il~elltg~~pf~~~~~  493 (506)
                      ..+++.|+|||.+.+....++.++||||||+++|||++|+.||.....
T Consensus       183 ~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~  230 (295)
T 2clq_A          183 FTGTLQYMAPEIIDKGPRGYGKAADIWSLGCTIIEMATGKPPFYELGE  230 (295)
T ss_dssp             CCCCGGGCCHHHHHHGGGGCSHHHHHHHHHHHHHHHHHTSCTTGGGSS
T ss_pred             cCCCccccChhhhcCCCCCCCcHHHHHHHHHHHHHHHHCCCCccCCCc
Confidence            578999999999865433478999999999999999999999976543

>1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A*

Probab=99.96  E-value=2.7e-30  Score=252.17  Aligned_cols=170  Identities=28%  Similarity=0.501  Sum_probs=137.9

Q ss_pred             ccCccCceEEEEEEEc---CCCEEEEEEeccCCCC---chhhHHHHHHhhccCccceeEEEEEe----------------
Q 039231          320 KLGQGGYGSVYKGKLL---DGSNVAVKVLNDSKGN---GKEFINEVASISRTSHVNVVALLGFC----------------  377 (506)
Q Consensus       320 ~ig~G~~g~V~~~~~~---~~~~vavK~l~~~~~~---~~~~~~E~~~l~~l~h~niv~l~g~~----------------  377 (506)
                      .||+|+||.||+|.+.   .++.||||+++.....   .+++.+|++++++++||||+++++++                
T Consensus        24 ~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~lv~e~~~~~~  103 (291)
T 1xbb_A           24 ELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEAESWMLVMEMAELGP  103 (291)
T ss_dssp             EEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEEESSSEEEEEECCTTEE
T ss_pred             ccccccCeeeEeeeecCCCceeeEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCEEEEEEEECCCCcEEEEEeCCCCC
Confidence            7999999999999653   3688999999764322   36789999999999999999999987                


Q ss_pred             ----------eccchhhhHHHHHHHHHHHHhhcCCCCeEecCcCCCcEEECCCCcEEEeecCCCccccCCCccee-cccC
Q 039231          378 ----------LRVAEELSSTIGIARGLEYLHLGCSTRILHFDIKPHNILLDEDFCPKISDFGLAKICNRKESIIS-MTGA  446 (506)
Q Consensus       378 ----------~~~~~~l~i~~~i~~gl~~LH~~~~~~ivH~dlkp~Nill~~~~~~ki~dfg~a~~~~~~~~~~~-~~~~  446 (506)
                                +++.+.+.++.|++.||+|||   +.+|+||||||+||+++.++.+||+|||+++.......... ....
T Consensus       104 L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH---~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~  180 (291)
T 1xbb_A          104 LNKYLQQNRHVKDKNIIELVHQVSMGMKYLE---ESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHG  180 (291)
T ss_dssp             HHHHHHHCTTCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEEEETTEEEECCCTTCEECCTTCSEEEC----
T ss_pred             HHHHHHhCcCCCHHHHHHHHHHHHHHHHHHH---hCCeEcCCCCcceEEEeCCCcEEEccCCcceeeccCCCcccccccC
Confidence                      223346779999999999999   89999999999999999999999999999987655443221 2234


Q ss_pred             CCCcccccccccccccCCCCccccHHHHHHHHHHHHc-CCCCCCCCCCC
Q 039231          447 RGTVGYIAPEVFCRNIGEVSYKSDVYNYGMMIFEMTG-GRKNVDVVDNG  494 (506)
Q Consensus       447 ~gt~~y~aPE~l~~~~~~~s~~~Dv~s~G~il~ellt-g~~pf~~~~~~  494 (506)
                      .+++.|+|||.+.+.  .++.++||||||+++|||++ |+.||......
T Consensus       181 ~~~~~y~aPE~~~~~--~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~  227 (291)
T 1xbb_A          181 KWPVKWYAPECINYY--KFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGS  227 (291)
T ss_dssp             CCCGGGCCHHHHHHC--EEEHHHHHHHHHHHHHHHHTTTCCSSTTCCHH
T ss_pred             CCCceeeChHHhccC--CCChhhhHHHHHHHHHHHHhcCCCCCCCCCHH
Confidence            567899999998553  67889999999999999999 99999876543

>1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B

Probab=99.96  E-value=4.5e-30  Score=254.58  Aligned_cols=171  Identities=31%  Similarity=0.455  Sum_probs=141.0

Q ss_pred             hccccCccCceEEEEEEE--cCCCEEEEEEeccCC---CCchhhHHHHHHhhcc---CccceeEEEEEee----------
Q 039231          317 FKYKLGQGGYGSVYKGKL--LDGSNVAVKVLNDSK---GNGKEFINEVASISRT---SHVNVVALLGFCL----------  378 (506)
Q Consensus       317 ~~~~ig~G~~g~V~~~~~--~~~~~vavK~l~~~~---~~~~~~~~E~~~l~~l---~h~niv~l~g~~~----------  378 (506)
                      +.+.||+|+||.||+|+.  .+++.||+|+++...   .....+.+|+++++++   +||||+++++++.          
T Consensus        15 ~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~~~~~~~   94 (326)
T 1blx_A           15 CVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTDRETKL   94 (326)
T ss_dssp             EEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEECSSEEEE
T ss_pred             eeeeecccccEEEEEEEecCCCCEEEEEEEeccCcccccCCchhhHHHHHHHhhhccCCCCeEeeeeeeeecccCCCceE
Confidence            356899999999999998  357899999986432   2335677888877776   8999999998762          


Q ss_pred             -----------------------ccchhhhHHHHHHHHHHHHhhcCCCCeEecCcCCCcEEECCCCcEEEeecCCCcccc
Q 039231          379 -----------------------RVAEELSSTIGIARGLEYLHLGCSTRILHFDIKPHNILLDEDFCPKISDFGLAKICN  435 (506)
Q Consensus       379 -----------------------~~~~~l~i~~~i~~gl~~LH~~~~~~ivH~dlkp~Nill~~~~~~ki~dfg~a~~~~  435 (506)
                                             ++.+.+.++.|++.||+|||   +.+|+||||||+||+++.++.+||+|||+++...
T Consensus        95 ~lv~e~~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~lH---~~gi~H~dlkp~Nili~~~~~~kl~Dfg~~~~~~  171 (326)
T 1blx_A           95 TLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLH---SHRVVHRDLKPQNILVTSSGQIKLADFGLARIYS  171 (326)
T ss_dssp             EEEEECCSCBHHHHHHHSCTTCSCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEECTTCCEEECSCCSCCCCC
T ss_pred             EEEEecCCCCHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHH---HCCceeccCCHHHeEEcCCCCEEEecCccccccc
Confidence                                   12235678999999999999   8999999999999999999999999999998765


Q ss_pred             CCCcceecccCCCCcccccccccccccCCCCccccHHHHHHHHHHHHcCCCCCCCCCCCc
Q 039231          436 RKESIISMTGARGTVGYIAPEVFCRNIGEVSYKSDVYNYGMMIFEMTGGRKNVDVVDNGS  495 (506)
Q Consensus       436 ~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~s~~~Dv~s~G~il~elltg~~pf~~~~~~~  495 (506)
                      ....   .....+|+.|+|||.+.+.  .++.++||||||+++|||++|+.||......+
T Consensus       172 ~~~~---~~~~~~~~~y~aPE~~~~~--~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~  226 (326)
T 1blx_A          172 FQMA---LTSVVVTLWYRAPEVLLQS--SYATPVDLWSVGCIFAEMFRRKPLFRGSSDVD  226 (326)
T ss_dssp             GGGG---GCCCCCCCTTCCHHHHTTC--CCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHH
T ss_pred             CCCC---ccccccccceeCHHHHhcC--CCCcchhHHHHHHHHHHHHcCCCCCCCCCHHH
Confidence            4322   2456789999999998654  68999999999999999999999998765443

>3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} SCOP: d.144.1.0 PDB: 3kmw_A* 3rep_A*

Probab=99.96  E-value=3.4e-30  Score=248.22  Aligned_cols=169  Identities=22%  Similarity=0.439  Sum_probs=139.4

Q ss_pred             hhccccCccCceEEEEEEEcCCCEEEEEEeccCCCC---chhhHHHHHHhhccCccceeEEEEEee--------------
Q 039231          316 SFKYKLGQGGYGSVYKGKLLDGSNVAVKVLNDSKGN---GKEFINEVASISRTSHVNVVALLGFCL--------------  378 (506)
Q Consensus       316 ~~~~~ig~G~~g~V~~~~~~~~~~vavK~l~~~~~~---~~~~~~E~~~l~~l~h~niv~l~g~~~--------------  378 (506)
                      .+.+.||+|+||.||+|++ +++.+|||+++.....   .+.+.+|++++++++||||+++++++.              
T Consensus        13 ~~~~~lg~G~~g~V~~~~~-~~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~e~~   91 (271)
T 3kmu_A           13 NFLTKLNENHSGELWKGRW-QGNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPNVLPVLGACQSPPAPHPTLITHWM   91 (271)
T ss_dssp             EEEEEEEEETTEEEEEEEE-TTEEEEEEEECCTTCCHHHHHHHHHHGGGGCCCSCTTEECEEEEECTTTSSSCEEEEECC
T ss_pred             HHHHHhcCCCcceEEEEEE-CCeeEEEEEecccccCHHHHHHHHHHHHHHHhcCCCchhheEEEEccCCCCCeEeeeccc
Confidence            3456899999999999998 4889999999765432   356899999999999999999999872              


Q ss_pred             -----------------ccchhhhHHHHHHHHHHHHhhcCCCC--eEecCcCCCcEEECCCCcEEEeecCCCccccCCCc
Q 039231          379 -----------------RVAEELSSTIGIARGLEYLHLGCSTR--ILHFDIKPHNILLDEDFCPKISDFGLAKICNRKES  439 (506)
Q Consensus       379 -----------------~~~~~l~i~~~i~~gl~~LH~~~~~~--ivH~dlkp~Nill~~~~~~ki~dfg~a~~~~~~~~  439 (506)
                                       ++.+.+.++.|++.||+|||   +++  ++||||||+||++++++.++|.|||++.....   
T Consensus        92 ~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH---~~~~~i~H~dikp~Nil~~~~~~~~l~~~~~~~~~~~---  165 (271)
T 3kmu_A           92 PYGSLYNVLHEGTNFVVDQSQAVKFALDMARGMAFLH---TLEPLIPRHALNSRSVMIDEDMTARISMADVKFSFQS---  165 (271)
T ss_dssp             TTCBHHHHHHSCSSCCCCHHHHHHHHHHHHHHHHHHT---TSSSCCTTCCCSGGGEEECTTSCEEEEGGGSCCTTSC---
T ss_pred             CCCcHHHHHhhcccCCCCHHHHHHHHHHHHHHHHHHh---cCCCceecCCCccceEEEcCCcceeEEeccceeeecc---
Confidence                             23346778999999999999   888  99999999999999999999999988764322   


Q ss_pred             ceecccCCCCccccccccccccc-CCCCccccHHHHHHHHHHHHcCCCCCCCCCCCc
Q 039231          440 IISMTGARGTVGYIAPEVFCRNI-GEVSYKSDVYNYGMMIFEMTGGRKNVDVVDNGS  495 (506)
Q Consensus       440 ~~~~~~~~gt~~y~aPE~l~~~~-~~~s~~~Dv~s~G~il~elltg~~pf~~~~~~~  495 (506)
                          ....+|+.|+|||.+.+.. ..++.++||||||+++|||++|+.||......+
T Consensus       166 ----~~~~~t~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~  218 (271)
T 3kmu_A          166 ----PGRMYAPAWVAPEALQKKPEDTNRRSADMWSFAVLLWELVTREVPFADLSNME  218 (271)
T ss_dssp             ----TTCBSCGGGSCHHHHHSCGGGSCHHHHHHHHHHHHHHHHHHCSCTTTTSCHHH
T ss_pred             ----cCccCCccccChhhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCccccChHH
Confidence                3356799999999986531 233448999999999999999999998765443

>2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens}

Probab=99.96  E-value=3.1e-30  Score=254.77  Aligned_cols=174  Identities=28%  Similarity=0.388  Sum_probs=135.4

Q ss_pred             ccccCccCceEEEEEEEcC-CCEEEEEEeccCC-CCchhhHHHHHHhhccCccceeEEEEEe------------------
Q 039231          318 KYKLGQGGYGSVYKGKLLD-GSNVAVKVLNDSK-GNGKEFINEVASISRTSHVNVVALLGFC------------------  377 (506)
Q Consensus       318 ~~~ig~G~~g~V~~~~~~~-~~~vavK~l~~~~-~~~~~~~~E~~~l~~l~h~niv~l~g~~------------------  377 (506)
                      .+.||+|+||.||+|+... ++.||+|++.... ...+++.+|++++++++||||+++++++                  
T Consensus        16 ~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~~~~~~   95 (320)
T 2i6l_A           16 LKPLGCGGNGLVFSAVDNDCDKRVAIKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVFEILGPSGSQLTDDVGSLTELN   95 (320)
T ss_dssp             EEECC-----CEEEEEETTTTEEEEEEEEECCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEECTTSCBCCC----CCSCS
T ss_pred             EEEeccCCCeEEEEEEECCCCeEEEEEEEecCChHHHHHHHHHHHHHHhcCCCCeeEEEEeccccccccccccccccccC
Confidence            4679999999999999865 8999999987543 2336788999999999999999998764                  


Q ss_pred             ---------------------eccchhhhHHHHHHHHHHHHhhcCCCCeEecCcCCCcEEEC-CCCcEEEeecCCCcccc
Q 039231          378 ---------------------LRVAEELSSTIGIARGLEYLHLGCSTRILHFDIKPHNILLD-EDFCPKISDFGLAKICN  435 (506)
Q Consensus       378 ---------------------~~~~~~l~i~~~i~~gl~~LH~~~~~~ivH~dlkp~Nill~-~~~~~ki~dfg~a~~~~  435 (506)
                                           +...+.+.++.|++.||+|||   +++|+||||||+||+++ +++.+||+|||+++...
T Consensus        96 ~~~lv~e~~~~~L~~~~~~~~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dlkp~Nil~~~~~~~~kl~Dfg~~~~~~  172 (320)
T 2i6l_A           96 SVYIVQEYMETDLANVLEQGPLLEEHARLFMYQLLRGLKYIH---SANVLHRDLKPANLFINTEDLVLKIGDFGLARIMD  172 (320)
T ss_dssp             EEEEEEECCSEEHHHHHTTCCCCHHHHHHHHHHHHHHHHHHH---HTTCBCCCCSGGGEEEETTTTEEEECCCTTCBCC-
T ss_pred             ceeEEeeccCCCHHHHhhcCCccHHHHHHHHHHHHHHHHHHH---hCCEecCCCCHHHEEEcCCCCeEEEccCccccccC
Confidence                                 122335678999999999999   89999999999999997 56799999999998764


Q ss_pred             CCCcc-eecccCCCCcccccccccccccCCCCccccHHHHHHHHHHHHcCCCCCCCCCCCc
Q 039231          436 RKESI-ISMTGARGTVGYIAPEVFCRNIGEVSYKSDVYNYGMMIFEMTGGRKNVDVVDNGS  495 (506)
Q Consensus       436 ~~~~~-~~~~~~~gt~~y~aPE~l~~~~~~~s~~~Dv~s~G~il~elltg~~pf~~~~~~~  495 (506)
                      ..... .......++..|+|||.+.+. ..++.++||||||+++|||++|+.||......+
T Consensus       173 ~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~  232 (320)
T 2i6l_A          173 PHYSHKGHLSEGLVTKWYRSPRLLLSP-NNYTKAIDMWAAGCIFAEMLTGKTLFAGAHELE  232 (320)
T ss_dssp             -------CCCGGGSCCTTCCHHHHHCT-TCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHH
T ss_pred             CCcccccccccccccccccCcHHhcCc-ccCCchhhhHhHHHHHHHHHhCCCCCCCCCHHH
Confidence            32211 112335578999999988543 468999999999999999999999998765443

>3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens}

Probab=99.96  E-value=4.5e-30  Score=255.47  Aligned_cols=175  Identities=22%  Similarity=0.321  Sum_probs=126.8

Q ss_pred             hhhccccCccCceEEEEEEEc-CCCEEEEEEeccCCC-CchhhHHHHHHhhccC-ccceeEEEEEe--------------
Q 039231          315 NSFKYKLGQGGYGSVYKGKLL-DGSNVAVKVLNDSKG-NGKEFINEVASISRTS-HVNVVALLGFC--------------  377 (506)
Q Consensus       315 ~~~~~~ig~G~~g~V~~~~~~-~~~~vavK~l~~~~~-~~~~~~~E~~~l~~l~-h~niv~l~g~~--------------  377 (506)
                      +.+.++||+|+||.||+|+.. +++.||||++..... ..+.+.+|+.++.++. ||||+++++++              
T Consensus        30 y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~~~~~~~~~~  109 (337)
T 3ll6_A           30 LRVRRVLAEGGFAFVYEAQDVGSGREYALKRLLSNEEEKNRAIIQEVCFMKKLSGHPNIVQFCSAASIGKEESDTGQAEF  109 (337)
T ss_dssp             EEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEESSHHHHHHHHHHHHHHHHHTTSTTBCCEEEEEEECTTTSTTSSEEE
T ss_pred             EEEEEEEccCCceEEEEEEECCCCcEEEEEEecCCchHHHHHHHHHHHHHHHhccCCChhhccccccccccccccCCceE
Confidence            344678999999999999975 589999999865432 3367889999999996 99999998776              


Q ss_pred             -----------------------eccchhhhHHHHHHHHHHHHhhcCCCC--eEecCcCCCcEEECCCCcEEEeecCCCc
Q 039231          378 -----------------------LRVAEELSSTIGIARGLEYLHLGCSTR--ILHFDIKPHNILLDEDFCPKISDFGLAK  432 (506)
Q Consensus       378 -----------------------~~~~~~l~i~~~i~~gl~~LH~~~~~~--ivH~dlkp~Nill~~~~~~ki~dfg~a~  432 (506)
                                             +++.+.+.++.||+.||+|||   +.+  |+||||||+|||++.++.+||+|||+++
T Consensus       110 ~lv~e~~~g~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH---~~~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~~~  186 (337)
T 3ll6_A          110 LLLTELCKGQLVEFLKKMESRGPLSCDTVLKIFYQTCRAVQHMH---RQKPPIIHRDLKVENLLLSNQGTIKLCDFGSAT  186 (337)
T ss_dssp             EEEEECCSEEHHHHHHHHHTTCSCCHHHHHHHHHHHHHHHHHHH---TSSSCCBCCCCCGGGCEECTTSCEEBCCCTTCB
T ss_pred             EEEEEecCCCHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHH---hCCCCEEEccCCcccEEECCCCCEEEecCccce
Confidence                                   122336678999999999999   888  9999999999999999999999999998


Q ss_pred             cccCCCcce----------ecccCCCCccccccccccc-ccCCCCccccHHHHHHHHHHHHcCCCCCCCCC
Q 039231          433 ICNRKESII----------SMTGARGTVGYIAPEVFCR-NIGEVSYKSDVYNYGMMIFEMTGGRKNVDVVD  492 (506)
Q Consensus       433 ~~~~~~~~~----------~~~~~~gt~~y~aPE~l~~-~~~~~s~~~Dv~s~G~il~elltg~~pf~~~~  492 (506)
                      .........          ......+|+.|+|||++.. ....++.++||||||+++|||++|+.||....
T Consensus       187 ~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~  257 (337)
T 3ll6_A          187 TISHYPDYSWSAQRRALVEEEITRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQHPFEDGA  257 (337)
T ss_dssp             CCSSCC-------------------------------CCTTSCSSHHHHHHHHHHHHHHHHHSSCCC----
T ss_pred             eccccCcccccccccccchhhccccCCCCcCChhhhhccccCCCChHHhHHHHHHHHHHHHhCCCCCcchh
Confidence            765432211          0113458999999999832 22467899999999999999999999997644

>2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B*

Probab=99.96  E-value=8.1e-30  Score=247.46  Aligned_cols=166  Identities=28%  Similarity=0.454  Sum_probs=140.5

Q ss_pred             HHhhhccccCccCceEEEEEEEc-CCCEEEEEEeccCCCCchhhHHHHHHhhccCccceeEEEEEee-------------
Q 039231          313 MTNSFKYKLGQGGYGSVYKGKLL-DGSNVAVKVLNDSKGNGKEFINEVASISRTSHVNVVALLGFCL-------------  378 (506)
Q Consensus       313 ~~~~~~~~ig~G~~g~V~~~~~~-~~~~vavK~l~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~-------------  378 (506)
                      ..+...+.||+|+||.||+|+.. +++.||+|+++...   +.+.+|++++++++||||+++++++.             
T Consensus        11 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~~~   87 (284)
T 2a19_B           11 MDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNN---EKAEREVKALAKLDHVNIVHYNGCWDGFDYDPETSSKNS   87 (284)
T ss_dssp             HHEEEEEEEECSSSCCEEEEEETTTCCEEEEEEEECCS---GGGHHHHHHHHHCCCTTBCCEEEEEEEEEEC--------
T ss_pred             cccceeeeeccCCceEEEEEEEcCCCeEEEEEEecccc---HHHHHHHHHHHhCCCCCEEEEeeeEeccccCcccccccc
Confidence            34445578999999999999986 68999999997543   56889999999999999999987541             


Q ss_pred             --------------------------------ccchhhhHHHHHHHHHHHHhhcCCCCeEecCcCCCcEEECCCCcEEEe
Q 039231          379 --------------------------------RVAEELSSTIGIARGLEYLHLGCSTRILHFDIKPHNILLDEDFCPKIS  426 (506)
Q Consensus       379 --------------------------------~~~~~l~i~~~i~~gl~~LH~~~~~~ivH~dlkp~Nill~~~~~~ki~  426 (506)
                                                      ++...+.++.|++.||+|||   +++|+|+||||+||++++++.+||+
T Consensus        88 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH---~~~i~H~dlkp~Nil~~~~~~~kl~  164 (284)
T 2a19_B           88 SRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLDKVLALELFEQITKGVDYIH---SKKLINRDLKPSNIFLVDTKQVKIG  164 (284)
T ss_dssp             -CCEEEEEEEEECCCCSCBHHHHHHHGGGSCCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEEEETTEEEEC
T ss_pred             cccCcceEEEEEeccCCCCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHH---hCCeeeccCCHHHEEEcCCCCEEEC
Confidence                                            12225668899999999999   8999999999999999999999999


Q ss_pred             ecCCCccccCCCcceecccCCCCcccccccccccccCCCCccccHHHHHHHHHHHHcCCCCCC
Q 039231          427 DFGLAKICNRKESIISMTGARGTVGYIAPEVFCRNIGEVSYKSDVYNYGMMIFEMTGGRKNVD  489 (506)
Q Consensus       427 dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~s~~~Dv~s~G~il~elltg~~pf~  489 (506)
                      |||+++.......   .....+++.|+|||.+.+.  .++.++||||||+++|||++|..|+.
T Consensus       165 Dfg~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~--~~~~~~Di~slG~il~~l~~~~~~~~  222 (284)
T 2a19_B          165 DFGLVTSLKNDGK---RTRSKGTLRYMSPEQISSQ--DYGKEVDLYALGLILAELLHVCDTAF  222 (284)
T ss_dssp             CCTTCEESSCCSC---CCCCCSCCTTSCHHHHHCS--CCCTHHHHHHHHHHHHHHHSCCSSHH
T ss_pred             cchhheecccccc---ccccCCcccccChhhhccC--CCcchhhhHHHHHHHHHHHhcCCcch
Confidence            9999987655432   2345689999999998653  68999999999999999999999885

>1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7

Probab=99.96  E-value=4.3e-30  Score=255.95  Aligned_cols=172  Identities=28%  Similarity=0.519  Sum_probs=133.7

Q ss_pred             ccccCccCceEEEEEEEcC-----CCEEEEEEeccCCC--CchhhHHHHHHhhccCccceeEEEEEe-------------
Q 039231          318 KYKLGQGGYGSVYKGKLLD-----GSNVAVKVLNDSKG--NGKEFINEVASISRTSHVNVVALLGFC-------------  377 (506)
Q Consensus       318 ~~~ig~G~~g~V~~~~~~~-----~~~vavK~l~~~~~--~~~~~~~E~~~l~~l~h~niv~l~g~~-------------  377 (506)
                      .+.||+|+||.||+|+...     +..||||+++....  ...++.+|++++++++||||+++++++             
T Consensus        49 ~~~lG~G~~g~Vy~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~  128 (333)
T 1mqb_A           49 QKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYKPMMIITEYM  128 (333)
T ss_dssp             EEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEEEEECC
T ss_pred             ccEEecCCCeEEEEEEEecCCCCccccEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCCCcEEEEeCC
Confidence            4679999999999998653     24699999975432  235688999999999999999999987             


Q ss_pred             ---------------eccchhhhHHHHHHHHHHHHhhcCCCCeEecCcCCCcEEECCCCcEEEeecCCCccccCCCcc-e
Q 039231          378 ---------------LRVAEELSSTIGIARGLEYLHLGCSTRILHFDIKPHNILLDEDFCPKISDFGLAKICNRKESI-I  441 (506)
Q Consensus       378 ---------------~~~~~~l~i~~~i~~gl~~LH~~~~~~ivH~dlkp~Nill~~~~~~ki~dfg~a~~~~~~~~~-~  441 (506)
                                     +++.+.+.++.|++.||+|||   +++|+||||||+||+++.++.+||+|||+++........ .
T Consensus       129 ~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH---~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~  205 (333)
T 1mqb_A          129 ENGALDKFLREKDGEFSVLQLVGMLRGIAAGMKYLA---NMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATY  205 (333)
T ss_dssp             TTEEHHHHHHHTTTCSCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEECTTCCEEECCCCC------------
T ss_pred             CCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHH---hCCeeCCCCChheEEECCCCcEEECCCCcchhhcccccccc
Confidence                           223346778999999999999   899999999999999999999999999999876543221 1


Q ss_pred             ecccCCCCcccccccccccccCCCCccccHHHHHHHHHHHHc-CCCCCCCCCCC
Q 039231          442 SMTGARGTVGYIAPEVFCRNIGEVSYKSDVYNYGMMIFEMTG-GRKNVDVVDNG  494 (506)
Q Consensus       442 ~~~~~~gt~~y~aPE~l~~~~~~~s~~~Dv~s~G~il~ellt-g~~pf~~~~~~  494 (506)
                      ......+++.|+|||.+...  .++.++||||||+++|||++ |+.||......
T Consensus       206 ~~~~~~~~~~y~aPE~~~~~--~~~~~~Di~slG~il~ellt~g~~pf~~~~~~  257 (333)
T 1mqb_A          206 TTSGGKIPIRWTAPEAISYR--KFTSASDVWSFGIVMWEVMTYGERPYWELSNH  257 (333)
T ss_dssp             -----CCCGGGSCHHHHHSC--CCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHH
T ss_pred             ccCCCCccccccCchhcccC--CCCchhhhHHHHHHHHHHHcCCCCCcccCCHH
Confidence            12234567899999998543  78999999999999999999 99999765443

>2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens}

Probab=99.96  E-value=6.8e-30  Score=253.41  Aligned_cols=171  Identities=29%  Similarity=0.442  Sum_probs=136.7

Q ss_pred             ccccCccCceEEEEEEEc-CCCEEEEEEeccCCCCchhhHHHHHHhhcc-CccceeEEEEEeec----------------
Q 039231          318 KYKLGQGGYGSVYKGKLL-DGSNVAVKVLNDSKGNGKEFINEVASISRT-SHVNVVALLGFCLR----------------  379 (506)
Q Consensus       318 ~~~ig~G~~g~V~~~~~~-~~~~vavK~l~~~~~~~~~~~~E~~~l~~l-~h~niv~l~g~~~~----------------  379 (506)
                      .+.||+|+||.||+|+.. +++.||||++.......+.+.+|++++.++ +||||+++++++..                
T Consensus        29 ~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~~~~~lv~e~  108 (326)
T 2x7f_A           29 VELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDEEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGMDDQLWLVMEF  108 (326)
T ss_dssp             EEEEEEETTEEEEEEEETTTCCEEEEEEEECCSSTTHHHHHHHHHHHHHCCSTTBCCEEEEEEECC--CCCCEEEEEEEC
T ss_pred             EEEeccCCCEEEEEEEECCCCCeEEEEEEecCcccHHHHHHHHHHHHhccCCCCeeeeeeEEeeccCccccceEEEEEEc
Confidence            467999999999999984 689999999987766778899999999999 79999999988632                


Q ss_pred             -------------------cchhhhHHHHHHHHHHHHhhcCCCCeEecCcCCCcEEECCCCcEEEeecCCCccccCCCcc
Q 039231          380 -------------------VAEELSSTIGIARGLEYLHLGCSTRILHFDIKPHNILLDEDFCPKISDFGLAKICNRKESI  440 (506)
Q Consensus       380 -------------------~~~~l~i~~~i~~gl~~LH~~~~~~ivH~dlkp~Nill~~~~~~ki~dfg~a~~~~~~~~~  440 (506)
                                         ....+.++.||+.||+|||   +.+|+|+||||+||+++.++.+||+|||++.........
T Consensus       109 ~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH---~~~ivH~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~  185 (326)
T 2x7f_A          109 CGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLH---QHKVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGR  185 (326)
T ss_dssp             CTTEEHHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCSGGGEEECTTCCEEECCCTTTC--------
T ss_pred             CCCCcHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHH---HCCccccCCcHHHEEEcCCCCEEEeeCcCceecCcCccc
Confidence                               1124568899999999999   899999999999999999999999999999866433211


Q ss_pred             eecccCCCCcccccccccccc---cCCCCccccHHHHHHHHHHHHcCCCCCCCCCC
Q 039231          441 ISMTGARGTVGYIAPEVFCRN---IGEVSYKSDVYNYGMMIFEMTGGRKNVDVVDN  493 (506)
Q Consensus       441 ~~~~~~~gt~~y~aPE~l~~~---~~~~s~~~Dv~s~G~il~elltg~~pf~~~~~  493 (506)
                        .....+++.|+|||++...   ...++.++||||||+++|||++|+.||.....
T Consensus       186 --~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~  239 (326)
T 2x7f_A          186 --RNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHP  239 (326)
T ss_dssp             -------CCGGGCCHHHHC--------CCTTHHHHHHHHHHHHHHHSSCTTTTSCH
T ss_pred             --cccccCCccccChhhhccccccCcCCCccchHHHHHHHHHHHHhCCCCCCCCcH
Confidence              2345689999999998521   24688999999999999999999999976544

>4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A*

Probab=99.96  E-value=8.5e-31  Score=255.28  Aligned_cols=166  Identities=23%  Similarity=0.416  Sum_probs=135.4

Q ss_pred             hhhccccCccCceEEEEEEEcC-C-------CEEEEEEeccCC-CCchhhHHHHHHhhccCccceeEEEEEee-------
Q 039231          315 NSFKYKLGQGGYGSVYKGKLLD-G-------SNVAVKVLNDSK-GNGKEFINEVASISRTSHVNVVALLGFCL-------  378 (506)
Q Consensus       315 ~~~~~~ig~G~~g~V~~~~~~~-~-------~~vavK~l~~~~-~~~~~~~~E~~~l~~l~h~niv~l~g~~~-------  378 (506)
                      +.+.+.||+|+||.||+|+... +       ..||+|++.... ...+.+.+|++++++++||||+++++++.       
T Consensus        10 y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l   89 (289)
T 4fvq_A           10 LIFNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFEAASMMSKLSHKHLVLNYGVCVCGDENIL   89 (289)
T ss_dssp             EEEEEEEEEETTEEEEEEEEEEECGGGCEEEEEEEEEEECGGGGGGHHHHHHHHHHHHTSCCTTBCCEEEEECCTTCCEE
T ss_pred             eeeeeeeccCCCceEEEEEEecccccccccchhhhhhhcccccHHHHHHHHHHHHHHHhCCCCCEeEEEEEEEeCCCCEE
Confidence            3456789999999999998653 3       479999996543 34467899999999999999999999872       


Q ss_pred             ---------------------ccchhhhHHHHHHHHHHHHhhcCCCCeEecCcCCCcEEECCCCc--------EEEeecC
Q 039231          379 ---------------------RVAEELSSTIGIARGLEYLHLGCSTRILHFDIKPHNILLDEDFC--------PKISDFG  429 (506)
Q Consensus       379 ---------------------~~~~~l~i~~~i~~gl~~LH~~~~~~ivH~dlkp~Nill~~~~~--------~ki~dfg  429 (506)
                                           ++...+.++.|++.||+|||   +++|+||||||+|||++.++.        +||+|||
T Consensus        90 v~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~LH---~~~ivH~Dlkp~NIll~~~~~~~~~~~~~~kl~Dfg  166 (289)
T 4fvq_A           90 VQEFVKFGSLDTYLKKNKNCINILWKLEVAKQLAAAMHFLE---ENTLIHGNVCAKNILLIREEDRKTGNPPFIKLSDPG  166 (289)
T ss_dssp             EEECCTTCBHHHHHHHTGGGCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEEEECCBGGGTBCCEEEECCCC
T ss_pred             EEECCCCCCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHh---hCCeECCCcCcceEEEecCCcccccccceeeeccCc
Confidence                                 22335678999999999999   899999999999999988887        9999999


Q ss_pred             CCccccCCCcceecccCCCCcccccccccccccCCCCccccHHHHHHHHHHHHcCCCCCCC
Q 039231          430 LAKICNRKESIISMTGARGTVGYIAPEVFCRNIGEVSYKSDVYNYGMMIFEMTGGRKNVDV  490 (506)
Q Consensus       430 ~a~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~s~~~Dv~s~G~il~elltg~~pf~~  490 (506)
                      ++......      ....+++.|+|||.+.+. ..++.++||||||+++|||++|..|+..
T Consensus       167 ~~~~~~~~------~~~~~~~~y~aPE~~~~~-~~~~~~~DiwslG~il~el~~g~~~~~~  220 (289)
T 4fvq_A          167 ISITVLPK------DILQERIPWVPPECIENP-KNLNLATDKWSFGTTLWEICSGGDKPLS  220 (289)
T ss_dssp             SCTTTSCH------HHHHHTTTTSCHHHHHCG-GGCCHHHHHHHHHHHHHHHHTTTCCTTT
T ss_pred             ccccccCc------cccCCcCcccCHHHhCCC-CCCCchhHHHHHHHHHHHHHcCCCCCcc
Confidence            98755332      223468899999998652 4689999999999999999995544443

>1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A*

Probab=99.96  E-value=3.7e-30  Score=256.15  Aligned_cols=171  Identities=25%  Similarity=0.361  Sum_probs=143.0

Q ss_pred             hhhccccCccCceEEEEEEE-c-CCCEEEEEEeccCCCCchhhHHHHHHhhccCccc------eeEEEEEe---------
Q 039231          315 NSFKYKLGQGGYGSVYKGKL-L-DGSNVAVKVLNDSKGNGKEFINEVASISRTSHVN------VVALLGFC---------  377 (506)
Q Consensus       315 ~~~~~~ig~G~~g~V~~~~~-~-~~~~vavK~l~~~~~~~~~~~~E~~~l~~l~h~n------iv~l~g~~---------  377 (506)
                      +.+.+.||+|+||.||+|.. . +++.||||+++......+.+.+|++++++++|++      ++++++++         
T Consensus        16 y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~i~~~~~~~~~~~~~~lv   95 (339)
T 1z57_A           16 YEIVDTLGEGAFGKVVECIDHKAGGRHVAVKIVKNVDRYCEAARSEIQVLEHLNTTDPNSTFRCVQMLEWFEHHGHICIV   95 (339)
T ss_dssp             EEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSSHHHHHHHHHHHHHHHHHHHHCTTCTTCBCCEEEEEEETTEEEEE
T ss_pred             eEEEEEEecCCCeEEEEEEecCCCCcEEEEEEEecCCchhHHHHHHHHHHHHhhhcCCCCceeeEeeecccccCCcEEEE
Confidence            34467899999999999987 3 5889999999765545577889999999998775      89988876         


Q ss_pred             -------------------eccchhhhHHHHHHHHHHHHhhcCCCCeEecCcCCCcEEECC-------------------
Q 039231          378 -------------------LRVAEELSSTIGIARGLEYLHLGCSTRILHFDIKPHNILLDE-------------------  419 (506)
Q Consensus       378 -------------------~~~~~~l~i~~~i~~gl~~LH~~~~~~ivH~dlkp~Nill~~-------------------  419 (506)
                                         +++.+.+.++.|++.||+|||   +++|+||||||+|||++.                   
T Consensus        96 ~e~~~~~l~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~lH---~~~ivH~Dlkp~Nil~~~~~~~~~~~~~~~~~~~~~~  172 (339)
T 1z57_A           96 FELLGLSTYDFIKENGFLPFRLDHIRKMAYQICKSVNFLH---SNKLTHTDLKPENILFVQSDYTEAYNPKIKRDERTLI  172 (339)
T ss_dssp             EECCCCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEESCCCEEEEEC----CEEEEES
T ss_pred             EcCCCCCHHHHHHhcCCCCCcHHHHHHHHHHHHHHHHHHH---HCCCcCCCCCHHHEEEeccccccccCCcccccccccc
Confidence                               123346779999999999999   899999999999999987                   


Q ss_pred             CCcEEEeecCCCccccCCCcceecccCCCCcccccccccccccCCCCccccHHHHHHHHHHHHcCCCCCCCCCCCc
Q 039231          420 DFCPKISDFGLAKICNRKESIISMTGARGTVGYIAPEVFCRNIGEVSYKSDVYNYGMMIFEMTGGRKNVDVVDNGS  495 (506)
Q Consensus       420 ~~~~ki~dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~s~~~Dv~s~G~il~elltg~~pf~~~~~~~  495 (506)
                      ++.+||+|||+++......     ....||+.|+|||.+.+.  .++.++||||||+++|||++|+.||...+..+
T Consensus       173 ~~~~kl~Dfg~~~~~~~~~-----~~~~gt~~y~aPE~~~~~--~~~~~~Di~slG~il~el~~g~~pf~~~~~~~  241 (339)
T 1z57_A          173 NPDIKVVDFGSATYDDEHH-----STLVSTRHYRAPEVILAL--GWSQPCDVWSIGCILIEYYLGFTVFPTHDSKE  241 (339)
T ss_dssp             CCCEEECCCSSCEETTSCC-----CSSCSCGGGCCHHHHTTS--CCCTHHHHHHHHHHHHHHHHSSCSCCCSCHHH
T ss_pred             CCCceEeeCcccccCcccc-----ccccCCccccChHHhhCC--CCCcchhhHHHHHHHHHHHhCCCCCCCCChHH
Confidence            6689999999998654332     345789999999998654  68999999999999999999999998765544

>3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A

Probab=99.96  E-value=3.3e-30  Score=251.07  Aligned_cols=171  Identities=26%  Similarity=0.326  Sum_probs=126.8

Q ss_pred             hhccccCccCceEEEEEEEc-CCCEEEEEEeccCCCCc---hhhHHHHHHhhccCccceeEEEEEee-------------
Q 039231          316 SFKYKLGQGGYGSVYKGKLL-DGSNVAVKVLNDSKGNG---KEFINEVASISRTSHVNVVALLGFCL-------------  378 (506)
Q Consensus       316 ~~~~~ig~G~~g~V~~~~~~-~~~~vavK~l~~~~~~~---~~~~~E~~~l~~l~h~niv~l~g~~~-------------  378 (506)
                      .+.+.||+|+||.||+|+.. +++.||+|+++......   +.+.++...++.++||||+++++++.             
T Consensus        10 ~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~iv~~~~~~~~~~~~~lv~e~~~   89 (290)
T 3fme_A           10 EPIMELGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISMRTVDCPFTVTFYGALFREGDVWICMELMD   89 (290)
T ss_dssp             EEEEEEEECSSEEEEEEEETTTTEEEEEEEEC---CHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSSEEEEEECCS
T ss_pred             hhHHhcCCCCCeEEEEEEecCCCeEEEEEEeecccCcHHHHHHHHHHHHHHHhCCCCeEEEEeeeeeccCCEEEEEehhc
Confidence            34568999999999999974 68999999997543222   23445555688899999999999872             


Q ss_pred             -----------------ccchhhhHHHHHHHHHHHHhhcCCC-CeEecCcCCCcEEECCCCcEEEeecCCCccccCCCcc
Q 039231          379 -----------------RVAEELSSTIGIARGLEYLHLGCST-RILHFDIKPHNILLDEDFCPKISDFGLAKICNRKESI  440 (506)
Q Consensus       379 -----------------~~~~~l~i~~~i~~gl~~LH~~~~~-~ivH~dlkp~Nill~~~~~~ki~dfg~a~~~~~~~~~  440 (506)
                                       ++.+.+.++.|++.||+|||   ++ +|+||||||+||+++.++.+||+|||+++........
T Consensus        90 ~~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH---~~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~  166 (290)
T 3fme_A           90 TSLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLH---SKLSVIHRDVKPSNVLINALGQVKMCDFGISGYLVDDVAK  166 (290)
T ss_dssp             EEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHH---HHSCCCCCCCSGGGCEECTTCCEEBCCC------------
T ss_pred             cchHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHh---hcCCeecCCCCHHHEEECCCCCEEEeecCCcccccccccc
Confidence                             22335678999999999999   76 9999999999999999999999999999876544321


Q ss_pred             eecccCCCCccccccccccc--ccCCCCccccHHHHHHHHHHHHcCCCCCCCCC
Q 039231          441 ISMTGARGTVGYIAPEVFCR--NIGEVSYKSDVYNYGMMIFEMTGGRKNVDVVD  492 (506)
Q Consensus       441 ~~~~~~~gt~~y~aPE~l~~--~~~~~s~~~Dv~s~G~il~elltg~~pf~~~~  492 (506)
                         ....+|+.|+|||.+..  ....++.++||||||+++|||++|+.||+...
T Consensus       167 ---~~~~~t~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~  217 (290)
T 3fme_A          167 ---DIDAGCKPYMAPERINPELNQKGYSVKSDIWSLGITMIELAILRFPYDSWG  217 (290)
T ss_dssp             ------CCCCCCSCHHHHSCCTTC--CCHHHHHHHHHHHHHHHHHTSCSSCCCS
T ss_pred             ---cccCCCccccChhhcChhhcCcCCCcHHHHHHHHHHHHHHHHCCCCccccC
Confidence               33568999999999731  12468899999999999999999999998643

>3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3v01_A* 3v04_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* ...

Probab=99.96  E-value=2.4e-30  Score=260.54  Aligned_cols=170  Identities=26%  Similarity=0.364  Sum_probs=140.9

Q ss_pred             hhccccCccCceEEEEEEEc-CCCEEEEEEeccCCC--CchhhHHHHHHhhccCccceeEEEEEee--------------
Q 039231          316 SFKYKLGQGGYGSVYKGKLL-DGSNVAVKVLNDSKG--NGKEFINEVASISRTSHVNVVALLGFCL--------------  378 (506)
Q Consensus       316 ~~~~~ig~G~~g~V~~~~~~-~~~~vavK~l~~~~~--~~~~~~~E~~~l~~l~h~niv~l~g~~~--------------  378 (506)
                      .+.+.||+|+||.||+|+.. +++.||+|++.....  ..+.+.+|++++++++||||+++++++.              
T Consensus        36 ~~~~~lg~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~  115 (360)
T 3eqc_A           36 EKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDG  115 (360)
T ss_dssp             EEEEEEEECSSCEEEEEEETTTCCEEEEEEEECCCCHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEETTEEEEEECCCTT
T ss_pred             eeeeeecCCCCeEEEEEEECCCCcEEEEEEeccccCHHHHHHHHHHHHHHHHCCCCCEEEEeEEEEECCEEEEEEECCCC
Confidence            34567999999999999986 589999999976432  2367899999999999999999999872              


Q ss_pred             -------------ccchhhhHHHHHHHHHHHHhhcCCC-CeEecCcCCCcEEECCCCcEEEeecCCCccccCCCcceecc
Q 039231          379 -------------RVAEELSSTIGIARGLEYLHLGCST-RILHFDIKPHNILLDEDFCPKISDFGLAKICNRKESIISMT  444 (506)
Q Consensus       379 -------------~~~~~l~i~~~i~~gl~~LH~~~~~-~ivH~dlkp~Nill~~~~~~ki~dfg~a~~~~~~~~~~~~~  444 (506)
                                   ++.....++.|++.||+|||   ++ +|+||||||+|||++.++.+||+|||+++......    ..
T Consensus       116 ~~L~~~l~~~~~~~~~~~~~i~~~i~~~l~~lh---~~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~----~~  188 (360)
T 3eqc_A          116 GSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLR---EKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSM----AN  188 (360)
T ss_dssp             CBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHH---HHHCCCCSCCSGGGEEECTTCCEEECCCCCCHHHHHHC------
T ss_pred             CCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHH---HhCCEEcCCccHHHEEECCCCCEEEEECCCCccccccc----cc
Confidence                         22335678999999999999   65 89999999999999999999999999997653322    13


Q ss_pred             cCCCCcccccccccccccCCCCccccHHHHHHHHHHHHcCCCCCCCCCCC
Q 039231          445 GARGTVGYIAPEVFCRNIGEVSYKSDVYNYGMMIFEMTGGRKNVDVVDNG  494 (506)
Q Consensus       445 ~~~gt~~y~aPE~l~~~~~~~s~~~Dv~s~G~il~elltg~~pf~~~~~~  494 (506)
                      ...||+.|+|||++.+.  .++.++||||||+++|||++|+.||...+..
T Consensus       189 ~~~gt~~y~aPE~~~~~--~~~~~~Di~slG~il~~l~~g~~pf~~~~~~  236 (360)
T 3eqc_A          189 SFVGTRSYMSPERLQGT--HYSVQSDIWSMGLSLVEMAVGRYPIPPPDAK  236 (360)
T ss_dssp             --CCCCTTCCHHHHTTC--CCSHHHHHHHHHHHHHHHHHTSCCSSCCCHH
T ss_pred             CCCCCCCeECHHHHcCC--CCCchhhHHHHHHHHHHHHhCCCCCCCCCHH
Confidence            45789999999998654  7899999999999999999999999875543

>2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A*

Probab=99.96  E-value=2.3e-30  Score=250.86  Aligned_cols=171  Identities=27%  Similarity=0.393  Sum_probs=139.1

Q ss_pred             hccccCccCceEEEEEEEc-CCCEEEEEEeccCCC---CchhhHHHHHHhhccCccceeEEEEEee--------------
Q 039231          317 FKYKLGQGGYGSVYKGKLL-DGSNVAVKVLNDSKG---NGKEFINEVASISRTSHVNVVALLGFCL--------------  378 (506)
Q Consensus       317 ~~~~ig~G~~g~V~~~~~~-~~~~vavK~l~~~~~---~~~~~~~E~~~l~~l~h~niv~l~g~~~--------------  378 (506)
                      +.+.||+|+||.||+|+.. +++.||+|++.....   ..+.+.+|++++++++||||+++++++.              
T Consensus        10 ~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~lv~e~~   89 (279)
T 2w5a_A           10 VLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYIVMEYC   89 (279)
T ss_dssp             EEEEEEECSSSEEEEEEETTTCCEEEEEEEECTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEEGGGTEEEEEEECC
T ss_pred             eehhccCCCCcEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhcCCCCCCeEEEEEecCCCceEEEEEeCC
Confidence            3567999999999999985 589999999975432   2356889999999999999999998762              


Q ss_pred             -------------------ccchhhhHHHHHHHHHHHHhhcCCCC-----eEecCcCCCcEEECCCCcEEEeecCCCccc
Q 039231          379 -------------------RVAEELSSTIGIARGLEYLHLGCSTR-----ILHFDIKPHNILLDEDFCPKISDFGLAKIC  434 (506)
Q Consensus       379 -------------------~~~~~l~i~~~i~~gl~~LH~~~~~~-----ivH~dlkp~Nill~~~~~~ki~dfg~a~~~  434 (506)
                                         ++.+.+.++.|++.||+|||   +.+     |+||||||+||++++++.+||+|||+++..
T Consensus        90 ~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH---~~~~~~~~ivH~dl~p~NIl~~~~~~~kl~dfg~~~~~  166 (279)
T 2w5a_A           90 EGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECH---RRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARIL  166 (279)
T ss_dssp             TTEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHH---HHC------CCCCCSGGGEEECSSSCEEECCCCHHHHC
T ss_pred             CCCCHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHh---cccCCCCeeEEeccchhhEEEcCCCCEEEecCchheee
Confidence                               12235678999999999999   667     999999999999999999999999999876


Q ss_pred             cCCCcceecccCCCCcccccccccccccCCCCccccHHHHHHHHHHHHcCCCCCCCCCCC
Q 039231          435 NRKESIISMTGARGTVGYIAPEVFCRNIGEVSYKSDVYNYGMMIFEMTGGRKNVDVVDNG  494 (506)
Q Consensus       435 ~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~s~~~Dv~s~G~il~elltg~~pf~~~~~~  494 (506)
                      ......  .....+++.|+|||.+.+.  .++.++||||||+++|||++|+.||...+..
T Consensus       167 ~~~~~~--~~~~~~~~~y~aPE~~~~~--~~~~~~Di~slG~il~~l~~g~~p~~~~~~~  222 (279)
T 2w5a_A          167 NHDTSF--AKTFVGTPYYMSPEQMNRM--SYNEKSDIWSLGCLLYELCALMPPFTAFSQK  222 (279)
T ss_dssp             ---CHH--HHHHHSCCTTCCHHHHHCC---CCHHHHHHHHHHHHHHHHHSSCSSCCSSHH
T ss_pred             cccccc--ccccCCCccccChHHhccC--CCCchhhHHHHHHHHHHHHHCCCCCcccCHH
Confidence            543321  1234679999999998654  6889999999999999999999999876543

>3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* 4e20_A* 4e1z_A*

Probab=99.96  E-value=5.9e-30  Score=253.22  Aligned_cols=171  Identities=28%  Similarity=0.429  Sum_probs=141.4

Q ss_pred             hhccccCccCceEEEEEEEc-----CCCEEEEEEeccCCC--CchhhHHHHHHhhccCccceeEEEEEeec---------
Q 039231          316 SFKYKLGQGGYGSVYKGKLL-----DGSNVAVKVLNDSKG--NGKEFINEVASISRTSHVNVVALLGFCLR---------  379 (506)
Q Consensus       316 ~~~~~ig~G~~g~V~~~~~~-----~~~~vavK~l~~~~~--~~~~~~~E~~~l~~l~h~niv~l~g~~~~---------  379 (506)
                      .+.++||+|+||.||++.+.     +++.||||+++....  ..+.+.+|++++++++||||+++++++.+         
T Consensus        34 ~~~~~lG~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv  113 (318)
T 3lxp_A           34 KKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQHRSGWKQEIDILRTLYHEHIIKYKGCCEDAGAASLQLV  113 (318)
T ss_dssp             EEEEEEEECSSEEEEEEEECSCC--CCEEEEEEEECTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTTTEEEEE
T ss_pred             hhhheecCCCCeEEEEEEEccCCCCCCcEEEEEEeccccChHHHHHHHHHHHHHHhCCCcchhhEEEEEecCCCceEEEE
Confidence            44578999999999998653     578999999976532  23568999999999999999999998732         


Q ss_pred             -------------------cchhhhHHHHHHHHHHHHhhcCCCCeEecCcCCCcEEECCCCcEEEeecCCCccccCCCcc
Q 039231          380 -------------------VAEELSSTIGIARGLEYLHLGCSTRILHFDIKPHNILLDEDFCPKISDFGLAKICNRKESI  440 (506)
Q Consensus       380 -------------------~~~~l~i~~~i~~gl~~LH~~~~~~ivH~dlkp~Nill~~~~~~ki~dfg~a~~~~~~~~~  440 (506)
                                         +.+.+.++.|++.||+|||   +.+|+||||||+||+++.++.+||+|||+++........
T Consensus       114 ~e~~~~~~L~~~l~~~~~~~~~~~~i~~~l~~~l~~LH---~~~ivH~Dikp~Nil~~~~~~~kl~Dfg~a~~~~~~~~~  190 (318)
T 3lxp_A          114 MEYVPLGSLRDYLPRHSIGLAQLLLFAQQICEGMAYLH---AQHYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEY  190 (318)
T ss_dssp             ECCCTTCBHHHHGGGSCCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECTTCCEEECCGGGCEECCTTCSE
T ss_pred             EecccCCcHHHHHhhCCCCHHHHHHHHHHHHHHHHHHH---hCCccCCCCchheEEEcCCCCEEECCccccccccccccc
Confidence                               2335678999999999999   899999999999999999999999999999877654332


Q ss_pred             ee-cccCCCCcccccccccccccCCCCccccHHHHHHHHHHHHcCCCCCCCC
Q 039231          441 IS-MTGARGTVGYIAPEVFCRNIGEVSYKSDVYNYGMMIFEMTGGRKNVDVV  491 (506)
Q Consensus       441 ~~-~~~~~gt~~y~aPE~l~~~~~~~s~~~Dv~s~G~il~elltg~~pf~~~  491 (506)
                      .. .....++..|+|||.+.+.  .++.++||||||+++|||++|+.||...
T Consensus       191 ~~~~~~~~~~~~y~aPE~~~~~--~~~~~~Di~slG~il~~ll~g~~p~~~~  240 (318)
T 3lxp_A          191 YRVREDGDSPVFWYAPECLKEY--KFYYASDVWSFGVTLYELLTHCDSSQSP  240 (318)
T ss_dssp             EEC---CCCCGGGCCHHHHHHC--EEEHHHHHHHHHHHHHHHHTTTCGGGSH
T ss_pred             cccccCCCCCceeeChHHhcCC--CCCcHHHHHHHHHHHHHHHhCCCccccc
Confidence            21 2345678889999998654  6788999999999999999999999754

>2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A*

Probab=99.96  E-value=6.1e-30  Score=247.48  Aligned_cols=170  Identities=26%  Similarity=0.418  Sum_probs=134.5

Q ss_pred             hhccccCccCceEEEEEEEc-CCCEEEEEEeccC----CCCchhhHHHHHHhhccCccceeEEEEEee------------
Q 039231          316 SFKYKLGQGGYGSVYKGKLL-DGSNVAVKVLNDS----KGNGKEFINEVASISRTSHVNVVALLGFCL------------  378 (506)
Q Consensus       316 ~~~~~ig~G~~g~V~~~~~~-~~~~vavK~l~~~----~~~~~~~~~E~~~l~~l~h~niv~l~g~~~------------  378 (506)
                      .+.+.||+|+||.||+|+.. +++.||||++...    ....+.+.+|++.+++++||||+++++++.            
T Consensus        14 ~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~   93 (276)
T 2h6d_A           14 VLGDTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKLYQVISTPTDFFMVMEYV   93 (276)
T ss_dssp             EEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEECC
T ss_pred             EEEeeecCCCCeEEEEEEECCCCceEEEEEeccccccchhHHHHHHHHHHHHhcCCCCCEeEEEEEEecCCeEEEEEecc
Confidence            34567999999999999986 6899999999642    234467899999999999999999998872            


Q ss_pred             ---------------ccchhhhHHHHHHHHHHHHhhcCCCCeEecCcCCCcEEECCCCcEEEeecCCCccccCCCcceec
Q 039231          379 ---------------RVAEELSSTIGIARGLEYLHLGCSTRILHFDIKPHNILLDEDFCPKISDFGLAKICNRKESIISM  443 (506)
Q Consensus       379 ---------------~~~~~l~i~~~i~~gl~~LH~~~~~~ivH~dlkp~Nill~~~~~~ki~dfg~a~~~~~~~~~~~~  443 (506)
                                     ++.+.+.++.|++.||+|||   +++++|+||||+||+++.++.+||+|||++........   .
T Consensus        94 ~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~~---~  167 (276)
T 2h6d_A           94 SGGELFDYICKHGRVEEMEARRLFQQILSAVDYCH---RHMVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEF---L  167 (276)
T ss_dssp             CSCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHH---HHCSSCCCCCGGGEEECTTSCEEECCCCGGGCCCC-------
T ss_pred             CCCcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHH---HCCCccCCCChhhEEECCCCCEEEeecccccccCCCcc---e
Confidence                           23346678999999999999   89999999999999999999999999999987654332   2


Q ss_pred             ccCCCCcccccccccccccCCCCccccHHHHHHHHHHHHcCCCCCCCCC
Q 039231          444 TGARGTVGYIAPEVFCRNIGEVSYKSDVYNYGMMIFEMTGGRKNVDVVD  492 (506)
Q Consensus       444 ~~~~gt~~y~aPE~l~~~~~~~s~~~Dv~s~G~il~elltg~~pf~~~~  492 (506)
                      ....+++.|+|||.+.+. ...+.++||||||+++|||++|+.||+...
T Consensus       168 ~~~~~~~~y~aPE~~~~~-~~~~~~~Di~slG~~l~~l~~g~~p~~~~~  215 (276)
T 2h6d_A          168 RTSCGSPNYAAPEVISGR-LYAGPEVDIWSCGVILYALLCGTLPFDDEH  215 (276)
T ss_dssp             ---------CCTGGGTTS-CCCHHHHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred             ecccCCccccCHHHHcCC-CCCCccchHHHHHHHHHHHHhCCCCCCCCc
Confidence            345689999999998653 234689999999999999999999997654

>3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A*

Probab=99.96  E-value=9.8e-30  Score=250.91  Aligned_cols=172  Identities=24%  Similarity=0.359  Sum_probs=135.4

Q ss_pred             hccccCccCceEEEEEEEcCCCEEEEEEeccCCCC---chhhHHHHHHhhccC--ccceeEEEEEee-------------
Q 039231          317 FKYKLGQGGYGSVYKGKLLDGSNVAVKVLNDSKGN---GKEFINEVASISRTS--HVNVVALLGFCL-------------  378 (506)
Q Consensus       317 ~~~~ig~G~~g~V~~~~~~~~~~vavK~l~~~~~~---~~~~~~E~~~l~~l~--h~niv~l~g~~~-------------  378 (506)
                      +.+.||+|+||.||+++..+++.||||++......   .+.+.+|++++.+++  |+||+++++++.             
T Consensus        32 ~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~~~~~~lv~e~~~  111 (313)
T 3cek_A           32 ILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMVMECGN  111 (313)
T ss_dssp             EEEEEECCSSEEEEEEECTTCCEEEEEEEECSSCCHHHHHHHHHHHHHHHHHGGGCTTBCCEEEEEECSSEEEEEECCCS
T ss_pred             EEEEecCCCCEEEEEEEcCCCcEEEEEEeccccccccchHHHHHHHHHHHhccccCCceEEEEEEeecCCEEEEEEecCC
Confidence            35679999999999999988999999999754332   367889999999998  499999998772             


Q ss_pred             -------------ccchhhhHHHHHHHHHHHHhhcCCCCeEecCcCCCcEEECCCCcEEEeecCCCccccCCCcceeccc
Q 039231          379 -------------RVAEELSSTIGIARGLEYLHLGCSTRILHFDIKPHNILLDEDFCPKISDFGLAKICNRKESIISMTG  445 (506)
Q Consensus       379 -------------~~~~~l~i~~~i~~gl~~LH~~~~~~ivH~dlkp~Nill~~~~~~ki~dfg~a~~~~~~~~~~~~~~  445 (506)
                                   ++.+.+.++.|+++||+|||   +++|+||||||+||++++ +.+||+|||+++.............
T Consensus       112 ~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH---~~~ivH~dlkp~NIl~~~-~~~kL~Dfg~~~~~~~~~~~~~~~~  187 (313)
T 3cek_A          112 IDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIH---QHGIVHSDLKPANFLIVD-GMLKLIDFGIANQMQPDTTSVVKDS  187 (313)
T ss_dssp             EEHHHHHHHCSSCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEEET-TEEEECCCSSSCC------------
T ss_pred             CcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH---HCCceecCCCcccEEEEC-CeEEEeeccccccccCccccccccC
Confidence                         23346778999999999999   899999999999999975 8999999999987655433222234


Q ss_pred             CCCCcccccccccccc---------cCCCCccccHHHHHHHHHHHHcCCCCCCCCC
Q 039231          446 ARGTVGYIAPEVFCRN---------IGEVSYKSDVYNYGMMIFEMTGGRKNVDVVD  492 (506)
Q Consensus       446 ~~gt~~y~aPE~l~~~---------~~~~s~~~Dv~s~G~il~elltg~~pf~~~~  492 (506)
                      ..|++.|+|||.+...         ...++.++||||||+++|||++|+.||....
T Consensus       188 ~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~  243 (313)
T 3cek_A          188 QVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQII  243 (313)
T ss_dssp             --CCGGGCCHHHHTTCC----------CCCHHHHHHHHHHHHHHHHHSSCTTTTCC
T ss_pred             CCCCCCcCCHHHHhhcccccccccccccCCchHHHHHHHHHHHHHHhCCCchhhHH
Confidence            5789999999998541         1367889999999999999999999997654

>3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 4hvd_A* 4hvg_A* 4hvh_A* 4hvi_A* 3pjc_A* 1yvj_A*

Probab=99.96  E-value=2.5e-30  Score=256.81  Aligned_cols=171  Identities=28%  Similarity=0.418  Sum_probs=142.3

Q ss_pred             hhccccCccCceEEEEEEE-----cCCCEEEEEEeccCCC-CchhhHHHHHHhhccCccceeEEEEEee-----------
Q 039231          316 SFKYKLGQGGYGSVYKGKL-----LDGSNVAVKVLNDSKG-NGKEFINEVASISRTSHVNVVALLGFCL-----------  378 (506)
Q Consensus       316 ~~~~~ig~G~~g~V~~~~~-----~~~~~vavK~l~~~~~-~~~~~~~E~~~l~~l~h~niv~l~g~~~-----------  378 (506)
                      .+.+.||+|+||.||+|++     .+++.||||++..... ..+.+.+|++++++++||||+++++++.           
T Consensus        26 ~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~lv~  105 (327)
T 3lxl_A           26 KYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFIVKYRGVSYGPGRQSLRLVM  105 (327)
T ss_dssp             EEEEEEEEETTEEEEEEEECTTSSSCSEEEEEEEESSCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSSCEEEEEE
T ss_pred             hhhhhccCCCCeEEEEEEeccCCCCcceEEEEEEeccCCHHHHHHHHHHHHHHHhcCCCceeEEEEEEecCCCceEEEEE
Confidence            4457899999999999984     3578999999976533 3356899999999999999999998762           


Q ss_pred             -------------------ccchhhhHHHHHHHHHHHHhhcCCCCeEecCcCCCcEEECCCCcEEEeecCCCccccCCCc
Q 039231          379 -------------------RVAEELSSTIGIARGLEYLHLGCSTRILHFDIKPHNILLDEDFCPKISDFGLAKICNRKES  439 (506)
Q Consensus       379 -------------------~~~~~l~i~~~i~~gl~~LH~~~~~~ivH~dlkp~Nill~~~~~~ki~dfg~a~~~~~~~~  439 (506)
                                         ++.+.+.++.|++.||+|||   +++|+||||||+||+++.++.+||+|||+++.......
T Consensus       106 e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH---~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~~~~~~~~~~  182 (327)
T 3lxl_A          106 EYLPSGCLRDFLQRHRARLDASRLLLYSSQICKGMEYLG---SRRCVHRDLAARNILVESEAHVKIADFGLAKLLPLDKD  182 (327)
T ss_dssp             ECCTTCBHHHHHHHHGGGCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEEEETTEEEECCGGGCEECCTTCS
T ss_pred             eecCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHH---hCCccCCCCChhhEEECCCCCEEEcccccceecccCCc
Confidence                               22335678899999999999   89999999999999999999999999999987754433


Q ss_pred             ce-ecccCCCCcccccccccccccCCCCccccHHHHHHHHHHHHcCCCCCCCC
Q 039231          440 II-SMTGARGTVGYIAPEVFCRNIGEVSYKSDVYNYGMMIFEMTGGRKNVDVV  491 (506)
Q Consensus       440 ~~-~~~~~~gt~~y~aPE~l~~~~~~~s~~~Dv~s~G~il~elltg~~pf~~~  491 (506)
                      .. ......+|+.|+|||.+.+.  .++.++||||||+++|||++|+.||...
T Consensus       183 ~~~~~~~~~~~~~y~aPE~~~~~--~~~~~~Di~slG~il~~ll~g~~p~~~~  233 (327)
T 3lxl_A          183 YYVVREPGQSPIFWYAPESLSDN--IFSRQSDVWSFGVVLYELFTYCDKSCSP  233 (327)
T ss_dssp             EEECSSCCCSCGGGSCHHHHHHC--EEEHHHHHHHHHHHHHHHHTTTCGGGSH
T ss_pred             cceeeccCCccccccCHHHhccC--CCChHHhHHHHHHHHHHHHhCCCCCccc
Confidence            22 22345688889999998554  6789999999999999999999998654

>2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A*

Probab=99.96  E-value=7.7e-30  Score=255.68  Aligned_cols=172  Identities=23%  Similarity=0.348  Sum_probs=142.7

Q ss_pred             HhhhccccCccCceEEEEEEEcC-C-CEEEEEEeccCCCCchhhHHHHHHhhccCccc------eeEEEEEe--------
Q 039231          314 TNSFKYKLGQGGYGSVYKGKLLD-G-SNVAVKVLNDSKGNGKEFINEVASISRTSHVN------VVALLGFC--------  377 (506)
Q Consensus       314 ~~~~~~~ig~G~~g~V~~~~~~~-~-~~vavK~l~~~~~~~~~~~~E~~~l~~l~h~n------iv~l~g~~--------  377 (506)
                      .+.+.+.||+|+||.||+|+... + +.||+|+++......+.+.+|++++++++|++      ++.+.+++        
T Consensus        20 ~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~l   99 (355)
T 2eu9_A           20 RYEIVGNLGEGTFGKVVECLDHARGKSQVALKIIRNVGKYREAARLEINVLKKIKEKDKENKFLCVLMSDWFNFHGHMCI   99 (355)
T ss_dssp             TEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSCHHHHHHHHHHHHHHHHHHHHCTTSCSCBCCEEEEEEETTEEEE
T ss_pred             cEEEEEEeeccCCeEEEEEEecCCCceEEEEEEEcccccchhHHHHHHHHHHHHhhcCCCCceeEEEeeeeeeeCCeEEE
Confidence            34456789999999999999753 4 68999999765545577889999999998777      88887755        


Q ss_pred             --------------------eccchhhhHHHHHHHHHHHHhhcCCCCeEecCcCCCcEEE-------------------C
Q 039231          378 --------------------LRVAEELSSTIGIARGLEYLHLGCSTRILHFDIKPHNILL-------------------D  418 (506)
Q Consensus       378 --------------------~~~~~~l~i~~~i~~gl~~LH~~~~~~ivH~dlkp~Nill-------------------~  418 (506)
                                          +++.+.+.++.||+.||+|||   +++|+||||||+|||+                   +
T Consensus       100 v~e~~~~~l~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~lH---~~~ivH~Dlkp~NIll~~~~~~~~~~~~~~~~~~~~  176 (355)
T 2eu9_A          100 AFELLGKNTFEFLKENNFQPYPLPHVRHMAYQLCHALRFLH---ENQLTHTDLKPENILFVNSEFETLYNEHKSCEEKSV  176 (355)
T ss_dssp             EEECCCCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHH---TTTEECCCCCGGGEEESCCCEEEEECCC-CCCEEEE
T ss_pred             EEeccCCChHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCHHHEEEeccccccccccccccccccc
Confidence                                233446779999999999999   8999999999999999                   5


Q ss_pred             CCCcEEEeecCCCccccCCCcceecccCCCCcccccccccccccCCCCccccHHHHHHHHHHHHcCCCCCCCCCCCc
Q 039231          419 EDFCPKISDFGLAKICNRKESIISMTGARGTVGYIAPEVFCRNIGEVSYKSDVYNYGMMIFEMTGGRKNVDVVDNGS  495 (506)
Q Consensus       419 ~~~~~ki~dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~s~~~Dv~s~G~il~elltg~~pf~~~~~~~  495 (506)
                      .++.+||+|||+++......     ....||+.|+|||++.+.  .++.++||||||+++|||++|+.||...+..+
T Consensus       177 ~~~~~kl~Dfg~~~~~~~~~-----~~~~gt~~y~aPE~~~~~--~~~~~~Di~slG~il~el~~g~~pf~~~~~~~  246 (355)
T 2eu9_A          177 KNTSIRVADFGSATFDHEHH-----TTIVATRHYRPPEVILEL--GWAQPCDVWSIGCILFEYYRGFTLFQTHENRE  246 (355)
T ss_dssp             SCCCEEECCCTTCEETTSCC-----CSSCSCGGGCCHHHHTTC--CCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHH
T ss_pred             CCCcEEEeecCccccccccc-----cCCcCCCcccCCeeeecC--CCCCccchHHHHHHHHHHHhCCCCCCCCCHHH
Confidence            67899999999998654332     346789999999998654  78999999999999999999999998765544

>3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group}

Probab=99.96  E-value=2.3e-29  Score=262.16  Aligned_cols=175  Identities=23%  Similarity=0.306  Sum_probs=141.2

Q ss_pred             hhccccCccCceEEEEEEE-cCCCEEEEEEeccCCCCchhhHHHHHHhhccCcccee-EEEEEe----------------
Q 039231          316 SFKYKLGQGGYGSVYKGKL-LDGSNVAVKVLNDSKGNGKEFINEVASISRTSHVNVV-ALLGFC----------------  377 (506)
Q Consensus       316 ~~~~~ig~G~~g~V~~~~~-~~~~~vavK~l~~~~~~~~~~~~E~~~l~~l~h~niv-~l~g~~----------------  377 (506)
                      .+.++||+|+||.||+|+. .+++.||||++..... ..++.+|++++..++|++.+ .+..+.                
T Consensus        10 ~i~~~LG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~-~~~~~~E~~il~~L~~~~~i~~i~~~~~~~~~~~lvme~~g~s   88 (483)
T 3sv0_A           10 RLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTK-HPQLLYESKIYRILQGGTGIPNVRWFGVEGDYNVLVMDLLGPS   88 (483)
T ss_dssp             ECCCCCEECSSCEEEEEEETTTCCEEEEEEEETTCS-SCCHHHHHHHHHHTTTSTTCCCEEEEEEETTEEEEEEECCCCB
T ss_pred             EEEEEEeeCCCEEEEEEEECCCCcEEEEEEeccccc-cHHHHHHHHHHHHhcCCCCCCeEEEEEeeCCEEEEEEECCCCC
Confidence            3457899999999999997 4589999998865433 35688999999999875544 333222                


Q ss_pred             -----------eccchhhhHHHHHHHHHHHHhhcCCCCeEecCcCCCcEEE---CCCCcEEEeecCCCccccCCCcce--
Q 039231          378 -----------LRVAEELSSTIGIARGLEYLHLGCSTRILHFDIKPHNILL---DEDFCPKISDFGLAKICNRKESII--  441 (506)
Q Consensus       378 -----------~~~~~~l~i~~~i~~gl~~LH~~~~~~ivH~dlkp~Nill---~~~~~~ki~dfg~a~~~~~~~~~~--  441 (506)
                                 +.+.+++.++.||+.||+|||   +++|+||||||+||||   +.++.+||+|||+++.........  
T Consensus        89 L~~ll~~~~~~l~~~~~~~i~~qi~~aL~yLH---~~gIvHrDIKP~NILl~~~~~~~~vkL~DFGla~~~~~~~~~~~~  165 (483)
T 3sv0_A           89 LEDLFNFCSRKLSLKTVLMLADQMINRVEFVH---SKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHI  165 (483)
T ss_dssp             HHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEECCGGGTTCEEECCCTTCEECBCTTTCCBC
T ss_pred             HHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHH---HCCEeecccCcceEEEecCCCCCeEEEEeCCcceeccCCcccccc
Confidence                       334457789999999999999   8999999999999999   688999999999998776543321  


Q ss_pred             ---ecccCCCCcccccccccccccCCCCccccHHHHHHHHHHHHcCCCCCCCCCCCcc
Q 039231          442 ---SMTGARGTVGYIAPEVFCRNIGEVSYKSDVYNYGMMIFEMTGGRKNVDVVDNGST  496 (506)
Q Consensus       442 ---~~~~~~gt~~y~aPE~l~~~~~~~s~~~Dv~s~G~il~elltg~~pf~~~~~~~~  496 (506)
                         ......||+.|+|||.+.+.  .++.++||||||++||||++|+.||........
T Consensus       166 ~~~~~~~~~gt~~Y~aPE~~~~~--~~s~~sDvwSlGvil~elltG~~Pf~~~~~~~~  221 (483)
T 3sv0_A          166 PYRENKNLTGTARYASVNTHLGI--EQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTK  221 (483)
T ss_dssp             CCCCCCCCCSCTTTCCHHHHTTC--CCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSH
T ss_pred             ccccccccCCCccccCHHHhcCC--CCChHHHHHHHHHHHHHHHhCCCCCccccchhH
Confidence               11256799999999998654  789999999999999999999999998766443

>1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B*

Probab=99.96  E-value=5.7e-30  Score=249.58  Aligned_cols=174  Identities=28%  Similarity=0.448  Sum_probs=132.7

Q ss_pred             hhccccCccCceEEEEEEEcC--CC--EEEEEEeccCC----CCchhhHHHHHHhhccCccceeEEEEEee---------
Q 039231          316 SFKYKLGQGGYGSVYKGKLLD--GS--NVAVKVLNDSK----GNGKEFINEVASISRTSHVNVVALLGFCL---------  378 (506)
Q Consensus       316 ~~~~~ig~G~~g~V~~~~~~~--~~--~vavK~l~~~~----~~~~~~~~E~~~l~~l~h~niv~l~g~~~---------  378 (506)
                      .+.+.||+|+||.||+|++..  ++  .||||+++...    ...+.+.+|++++++++||||+++++++.         
T Consensus        21 ~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~v~e  100 (291)
T 1u46_A           21 RLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLTPPMKMVTE  100 (291)
T ss_dssp             EEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSCEEEEE
T ss_pred             eeeeeecCCCceeEEEEEeccCCCceeEEEEEEEccCccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEccCCceeeEe
Confidence            445789999999999998632  33  68999987532    22367889999999999999999999872         


Q ss_pred             ------------------ccchhhhHHHHHHHHHHHHhhcCCCCeEecCcCCCcEEECCCCcEEEeecCCCccccCCCcc
Q 039231          379 ------------------RVAEELSSTIGIARGLEYLHLGCSTRILHFDIKPHNILLDEDFCPKISDFGLAKICNRKESI  440 (506)
Q Consensus       379 ------------------~~~~~l~i~~~i~~gl~~LH~~~~~~ivH~dlkp~Nill~~~~~~ki~dfg~a~~~~~~~~~  440 (506)
                                        .+.+.+.++.|++.||+|||   +++++|+||||+||+++.++.+||+|||+++........
T Consensus       101 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~~~  177 (291)
T 1u46_A          101 LAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLE---SKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDH  177 (291)
T ss_dssp             CCTTCBHHHHHHHHGGGSCHHHHHHHHHHHHHHHHHHH---HTTEECSCCCGGGEEEEETTEEEECCCTTCEECCC-CCE
T ss_pred             cccCCCHHHHHHhccCCcCHHHHHHHHHHHHHHHHHHH---hCCcccCCCchheEEEcCCCCEEEccccccccccccccc
Confidence                              22335678999999999999   899999999999999999999999999999877554432


Q ss_pred             ee-cccCCCCcccccccccccccCCCCccccHHHHHHHHHHHHc-CCCCCCCCCCC
Q 039231          441 IS-MTGARGTVGYIAPEVFCRNIGEVSYKSDVYNYGMMIFEMTG-GRKNVDVVDNG  494 (506)
Q Consensus       441 ~~-~~~~~gt~~y~aPE~l~~~~~~~s~~~Dv~s~G~il~ellt-g~~pf~~~~~~  494 (506)
                      .. .....++..|+|||.+.+.  .++.++||||||+++|||++ |+.||...+..
T Consensus       178 ~~~~~~~~~~~~y~aPE~~~~~--~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~  231 (291)
T 1u46_A          178 YVMQEHRKVPFAWCAPESLKTR--TFSHASDTWMFGVTLWEMFTYGQEPWIGLNGS  231 (291)
T ss_dssp             EEC-----CCGGGCCHHHHHHC--EEEHHHHHHHHHHHHHHHHTTSCCTTTTCCHH
T ss_pred             hhhhccCCCCceeeCchhhcCC--CCCchhhHHHHHHHHHHHHhCCCCCcccCCHH
Confidence            21 2335578889999998553  67899999999999999999 99999876543

>2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens}

Probab=99.96  E-value=4e-30  Score=258.12  Aligned_cols=169  Identities=18%  Similarity=0.218  Sum_probs=138.6

Q ss_pred             hhhccccCccCceEEEEEEEcC---------CCEEEEEEeccCCCCchhhHHHHHHhhccCccceeE-------------
Q 039231          315 NSFKYKLGQGGYGSVYKGKLLD---------GSNVAVKVLNDSKGNGKEFINEVASISRTSHVNVVA-------------  372 (506)
Q Consensus       315 ~~~~~~ig~G~~g~V~~~~~~~---------~~~vavK~l~~~~~~~~~~~~E~~~l~~l~h~niv~-------------  372 (506)
                      +.+.+.||+|+||.||+|+...         ++.||||++...    +.+.+|++++++++||||++             
T Consensus        44 y~~~~~lg~G~~g~Vy~~~~~~t~~~~~~~~~~~vavK~~~~~----~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~i  119 (352)
T 2jii_A           44 WKLKSFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKD----GRLFNEQNFFQRAAKPLQVNKWKKLYSTPLLAI  119 (352)
T ss_dssp             EEEEEEEEEETTEEEEEEEECC-----------CEEEEEEETT----STHHHHHHHHHHHCCHHHHHHHHHHTTCTTCSC
T ss_pred             EEEEEEecCCCCeEEEEEeecCCccccccccCceEEEEEeccc----chHHHHHHHHHHhcccchhhhhhhhccCCccCc
Confidence            3445789999999999998764         789999999754    57889999999999999987             


Q ss_pred             --EEEEe-----------------------------eccchhhhHHHHHHHHHHHHhhcCCCCeEecCcCCCcEEECCCC
Q 039231          373 --LLGFC-----------------------------LRVAEELSSTIGIARGLEYLHLGCSTRILHFDIKPHNILLDEDF  421 (506)
Q Consensus       373 --l~g~~-----------------------------~~~~~~l~i~~~i~~gl~~LH~~~~~~ivH~dlkp~Nill~~~~  421 (506)
                        +++++                             +++.+++.++.||+.||+|||   +++|+||||||+|||++.++
T Consensus       120 ~~~~~~~~~~~~~~~lv~e~~~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH---~~~ivH~Dikp~NIl~~~~~  196 (352)
T 2jii_A          120 PTCMGFGVHQDKYRFLVLPSLGRSLQSALDVSPKHVLSERSVLQVACRLLDALEFLH---ENEYVHGNVTAENIFVDPED  196 (352)
T ss_dssp             CCCCEEEEETTTEEEEEEECCCEEHHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHH---HTTCBCSCCCGGGEEEETTE
T ss_pred             cchhhccccCCcEEEEEecCCCcCHHHHHHhCCcCCCCHHHHHHHHHHHHHHHHHHH---hCCccCCCCCHHHEEEcCCC
Confidence              33332                             233446789999999999999   89999999999999999998


Q ss_pred             --cEEEeecCCCccccCCCcce-----ecccCCCCcccccccccccccCCCCccccHHHHHHHHHHHHcCCCCCCCCC
Q 039231          422 --CPKISDFGLAKICNRKESII-----SMTGARGTVGYIAPEVFCRNIGEVSYKSDVYNYGMMIFEMTGGRKNVDVVD  492 (506)
Q Consensus       422 --~~ki~dfg~a~~~~~~~~~~-----~~~~~~gt~~y~aPE~l~~~~~~~s~~~Dv~s~G~il~elltg~~pf~~~~  492 (506)
                        .+||+|||+++.........     ......||+.|+|||.+.+.  .++.++||||||+++|||++|+.||....
T Consensus       197 ~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~~Di~slG~il~el~~g~~pf~~~~  272 (352)
T 2jii_A          197 QSQVTLAGYGFAFRYCPSGKHVAYVEGSRSPHEGDLEFISMDLHKGC--GPSRRSDLQSLGYCMLKWLYGFLPWTNCL  272 (352)
T ss_dssp             EEEEEECCGGGCBCSSGGGCCCCCCTTSSCTTCSCTTTCCHHHHTTC--CCCHHHHHHHHHHHHHHHHHSCCTTGGGT
T ss_pred             CceEEEecCcceeeccCCCccccccccccccccCCccccCHHHHccC--CCCchhhHHHHHHHHHHHHhCCCCcccCC
Confidence              89999999998765432211     11335789999999998654  78999999999999999999999998765

>3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ...

Probab=99.96  E-value=1.1e-29  Score=251.67  Aligned_cols=168  Identities=27%  Similarity=0.370  Sum_probs=139.2

Q ss_pred             hhccccCccCceEEEEEEEc-CCCEEEEEEeccCCC-------CchhhHHHHHHhhccC--ccceeEEEEEee-------
Q 039231          316 SFKYKLGQGGYGSVYKGKLL-DGSNVAVKVLNDSKG-------NGKEFINEVASISRTS--HVNVVALLGFCL-------  378 (506)
Q Consensus       316 ~~~~~ig~G~~g~V~~~~~~-~~~~vavK~l~~~~~-------~~~~~~~E~~~l~~l~--h~niv~l~g~~~-------  378 (506)
                      .+.+.||+|+||.||+|+.. +++.||||+++....       ..+.+.+|++++++++  |+||+++++++.       
T Consensus        46 ~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~i~~~~~~~~~~~~~~l  125 (320)
T 3a99_A           46 QVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPDSFVL  125 (320)
T ss_dssp             EEEEECSSSSSCEEEEEEETTTTEEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEECSSEEEE
T ss_pred             EEEEEEeeCCCeEEEEEEECCCCcEEEEEEEecccchhhhhhhhhhHHHHHHHHHHhhccCCCCceEEEEEEecCCcEEE
Confidence            44578999999999999874 589999999975432       2356889999999996  599999998872       


Q ss_pred             ---------------------ccchhhhHHHHHHHHHHHHhhcCCCCeEecCcCCCcEEEC-CCCcEEEeecCCCccccC
Q 039231          379 ---------------------RVAEELSSTIGIARGLEYLHLGCSTRILHFDIKPHNILLD-EDFCPKISDFGLAKICNR  436 (506)
Q Consensus       379 ---------------------~~~~~l~i~~~i~~gl~~LH~~~~~~ivH~dlkp~Nill~-~~~~~ki~dfg~a~~~~~  436 (506)
                                           ++...+.++.|++.||+|||   +.+|+||||||+|||++ +++.+||+|||+++....
T Consensus       126 v~e~~~~~~~L~~~l~~~~~l~~~~~~~i~~qi~~~L~~LH---~~~ivH~Dlkp~NIll~~~~~~~kL~Dfg~~~~~~~  202 (320)
T 3a99_A          126 ILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHCH---NCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKD  202 (320)
T ss_dssp             EEECCSSEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEEETTTTEEEECCCTTCEECCS
T ss_pred             EEEcCCCCccHHHHHhccCCCCHHHHHHHHHHHHHHHHHHH---HCCcEeCCCCHHHEEEeCCCCCEEEeeCcccccccc
Confidence                                 22335668899999999999   89999999999999998 789999999999987654


Q ss_pred             CCcceecccCCCCcccccccccccccCCCCccccHHHHHHHHHHHHcCCCCCCCC
Q 039231          437 KESIISMTGARGTVGYIAPEVFCRNIGEVSYKSDVYNYGMMIFEMTGGRKNVDVV  491 (506)
Q Consensus       437 ~~~~~~~~~~~gt~~y~aPE~l~~~~~~~s~~~Dv~s~G~il~elltg~~pf~~~  491 (506)
                      ..    .....||+.|+|||++.+. ...+.++||||||+++|||++|+.||...
T Consensus       203 ~~----~~~~~gt~~y~aPE~~~~~-~~~~~~~Di~slG~il~el~~g~~pf~~~  252 (320)
T 3a99_A          203 TV----YTDFDGTRVYSPPEWIRYH-RYHGRSAAVWSLGILLYDMVCGDIPFEHD  252 (320)
T ss_dssp             SC----BCCCCSCGGGSCHHHHHHS-CBCHHHHHHHHHHHHHHHHHHSSCSCCSH
T ss_pred             cc----ccCCCCCccCCChHHhccC-CCCCccchHHhHHHHHHHHHHCCCCCCCh
Confidence            32    2346789999999998553 23478899999999999999999999753

>2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A*

Probab=99.96  E-value=1e-29  Score=258.16  Aligned_cols=175  Identities=22%  Similarity=0.261  Sum_probs=141.5

Q ss_pred             hhccccCccCceEEEEEEEc-CCCEEEEEEeccCCCCchhhHHHHHHhhccC-cc-----ceeEEEEEe-----------
Q 039231          316 SFKYKLGQGGYGSVYKGKLL-DGSNVAVKVLNDSKGNGKEFINEVASISRTS-HV-----NVVALLGFC-----------  377 (506)
Q Consensus       316 ~~~~~ig~G~~g~V~~~~~~-~~~~vavK~l~~~~~~~~~~~~E~~~l~~l~-h~-----niv~l~g~~-----------  377 (506)
                      .+.+.||+|+||.||+|+.. +++.||||+++......+++.+|++++..++ |+     +|+++++++           
T Consensus        57 ~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~iv~~~~~~~~~~~~~lv~e  136 (382)
T 2vx3_A           57 EIDSLIGKGSFGQVVKAYDRVEQEWVAIKIIKNKKAFLNQAQIEVRLLELMNKHDTEMKYYIVHLKRHFMFRNHLCLVFE  136 (382)
T ss_dssp             EEEEEEEEETTEEEEEEEETTTTEEEEEEEECSSHHHHHHHHHHHHHHHHHHHCSSGGGGGBCCEEEEEEETTEEEEEEE
T ss_pred             EEEEEEeecCCEEEEEEEEcCCCcEEEEEEEeccHHHHHHHHHHHHHHHHHHhcccccceeEEEeeeeeccCCceEEEEe
Confidence            34578999999999999875 5789999999865544567778888888875 44     489988876           


Q ss_pred             -----------------eccchhhhHHHHHHHHHHHHhhcCCCCeEecCcCCCcEEEC--CCCcEEEeecCCCccccCCC
Q 039231          378 -----------------LRVAEELSSTIGIARGLEYLHLGCSTRILHFDIKPHNILLD--EDFCPKISDFGLAKICNRKE  438 (506)
Q Consensus       378 -----------------~~~~~~l~i~~~i~~gl~~LH~~~~~~ivH~dlkp~Nill~--~~~~~ki~dfg~a~~~~~~~  438 (506)
                                       +++...+.++.|++.||+|||.. +.+|+||||||+|||++  .++.+||+|||+++......
T Consensus       137 ~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~-~~~ivHrDlkp~NIll~~~~~~~~kL~DFG~a~~~~~~~  215 (382)
T 2vx3_A          137 MLSYNLYDLLRNTNFRGVSLNLTRKFAQQMCTALLFLATP-ELSIIHCDLKPENILLCNPKRSAIKIVDFGSSCQLGQRI  215 (382)
T ss_dssp             CCCCBHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHTST-TTCEECCCCSGGGEEESSTTSCCEEECCCTTCEETTCCC
T ss_pred             cCCCCHHHHHhhcCcCCCCHHHHHHHHHHHHHHHHHhccC-CCCEEcCCCCcccEEEecCCCCcEEEEeccCceeccccc
Confidence                             22334677999999999999932 46899999999999994  57889999999998764432


Q ss_pred             cceecccCCCCcccccccccccccCCCCccccHHHHHHHHHHHHcCCCCCCCCCCCcchh
Q 039231          439 SIISMTGARGTVGYIAPEVFCRNIGEVSYKSDVYNYGMMIFEMTGGRKNVDVVDNGSTAL  498 (506)
Q Consensus       439 ~~~~~~~~~gt~~y~aPE~l~~~~~~~s~~~Dv~s~G~il~elltg~~pf~~~~~~~~~~  498 (506)
                           ....+|+.|+|||++.+.  .++.++|||||||++|||++|+.||...+..+...
T Consensus       216 -----~~~~~t~~y~aPE~~~~~--~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~  268 (382)
T 2vx3_A          216 -----YQYIQSRFYRSPEVLLGM--PYDLAIDMWSLGCILVEMHTGEPLFSGANEVDQMN  268 (382)
T ss_dssp             -----CSSCSCGGGCCHHHHTTC--CCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHH
T ss_pred             -----ccccCCccccChHHHcCC--CCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHH
Confidence                 446789999999999654  68999999999999999999999998766544433

>1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A*

Probab=99.96  E-value=1.5e-29  Score=247.46  Aligned_cols=171  Identities=26%  Similarity=0.360  Sum_probs=142.0

Q ss_pred             hccccCccCceEEEEEEEc-CCCEEEEEEeccCCC----------CchhhHHHHHHhhccC-ccceeEEEEEe-------
Q 039231          317 FKYKLGQGGYGSVYKGKLL-DGSNVAVKVLNDSKG----------NGKEFINEVASISRTS-HVNVVALLGFC-------  377 (506)
Q Consensus       317 ~~~~ig~G~~g~V~~~~~~-~~~~vavK~l~~~~~----------~~~~~~~E~~~l~~l~-h~niv~l~g~~-------  377 (506)
                      +.+.||+|+||.||+|+.. +++.||||+++....          ..+.+.+|+++++++. ||||+++++++       
T Consensus        21 ~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~  100 (298)
T 1phk_A           21 PKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYETNTFFF  100 (298)
T ss_dssp             EEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEE
T ss_pred             eeeeecCCCceEEEEEEEcCcCceEEEEEEecccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeeeeeeeccCCeEE
Confidence            3467999999999999985 589999999975431          1245789999999996 99999999887       


Q ss_pred             --------------------eccchhhhHHHHHHHHHHHHhhcCCCCeEecCcCCCcEEECCCCcEEEeecCCCccccCC
Q 039231          378 --------------------LRVAEELSSTIGIARGLEYLHLGCSTRILHFDIKPHNILLDEDFCPKISDFGLAKICNRK  437 (506)
Q Consensus       378 --------------------~~~~~~l~i~~~i~~gl~~LH~~~~~~ivH~dlkp~Nill~~~~~~ki~dfg~a~~~~~~  437 (506)
                                          +++.+.+.++.|++.||+|||   +.+++|+||||+||+++.++.+||+|||++......
T Consensus       101 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~  177 (298)
T 1phk_A          101 LVFDLMKKGELFDYLTEKVTLSEKETRKIMRALLEVICALH---KLNIVHRDLKPENILLDDDMNIKLTDFGFSCQLDPG  177 (298)
T ss_dssp             EEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECTTCCEEECCCTTCEECCTT
T ss_pred             EEEeccCCCcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCcceEEEcCCCcEEEecccchhhcCCC
Confidence                                223346778999999999999   899999999999999999999999999999876544


Q ss_pred             CcceecccCCCCccccccccccc----ccCCCCccccHHHHHHHHHHHHcCCCCCCCCCC
Q 039231          438 ESIISMTGARGTVGYIAPEVFCR----NIGEVSYKSDVYNYGMMIFEMTGGRKNVDVVDN  493 (506)
Q Consensus       438 ~~~~~~~~~~gt~~y~aPE~l~~----~~~~~s~~~Dv~s~G~il~elltg~~pf~~~~~  493 (506)
                      ..   .....+++.|+|||.+..    ....++.++||||||+++|||++|+.||.....
T Consensus       178 ~~---~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~  234 (298)
T 1phk_A          178 EK---LREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQ  234 (298)
T ss_dssp             CC---BCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSH
T ss_pred             cc---cccccCCccccCHHHhccccccccccCCcccccHhHHHHHHHHHHCCCCCcCccH
Confidence            32   244678999999999852    124678899999999999999999999976543

>2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A*

Probab=99.96  E-value=5.6e-30  Score=254.31  Aligned_cols=176  Identities=29%  Similarity=0.447  Sum_probs=136.9

Q ss_pred             HhhhccccCccCceEEEEEEE------cCCCEEEEEEeccCCC--CchhhHHHHHHhhccCccceeEEEEEeec------
Q 039231          314 TNSFKYKLGQGGYGSVYKGKL------LDGSNVAVKVLNDSKG--NGKEFINEVASISRTSHVNVVALLGFCLR------  379 (506)
Q Consensus       314 ~~~~~~~ig~G~~g~V~~~~~------~~~~~vavK~l~~~~~--~~~~~~~E~~~l~~l~h~niv~l~g~~~~------  379 (506)
                      .+.+.+.||+|+||.||+|++      .++..||||++.....  ...++.+|+.++++++||||+++++++.+      
T Consensus        31 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l  110 (327)
T 2yfx_A           31 NITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQSLPRFI  110 (327)
T ss_dssp             GCEEEEECC--CSSCEEEEEC--------CCEEEEEECCSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEE
T ss_pred             heEEEEEEcCCCCeeEEEEEEcCCCCCCccceEEEEEeccccchhhHHHHHHHHHHHhhCCCCCCCeEEEEEcCCCCcEE
Confidence            344567899999999999984      2477899999965332  33578899999999999999999998721      


Q ss_pred             ----------------------------cchhhhHHHHHHHHHHHHhhcCCCCeEecCcCCCcEEECC---CCcEEEeec
Q 039231          380 ----------------------------VAEELSSTIGIARGLEYLHLGCSTRILHFDIKPHNILLDE---DFCPKISDF  428 (506)
Q Consensus       380 ----------------------------~~~~l~i~~~i~~gl~~LH~~~~~~ivH~dlkp~Nill~~---~~~~ki~df  428 (506)
                                                  +.+.+.++.|++.||+|||   +.+|+||||||+|||++.   +..+||+||
T Consensus       111 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH---~~~i~H~dlkp~NIli~~~~~~~~~kl~Df  187 (327)
T 2yfx_A          111 LMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLE---ENHFIHRDIAARNCLLTCPGPGRVAKIGDF  187 (327)
T ss_dssp             EEECCTTEEHHHHHHHTSCCSSSTTSCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEESCSSTTCCEEECCC
T ss_pred             EEecCCCCcHHHHHHhhcccccccccccHHHHHHHHHHHHHHHHHHh---hCCeecCcCCHhHEEEecCCCcceEEECcc
Confidence                                        1235678999999999999   899999999999999984   456999999


Q ss_pred             CCCccccCCCcceecccCCCCcccccccccccccCCCCccccHHHHHHHHHHHHc-CCCCCCCCCCC
Q 039231          429 GLAKICNRKESIISMTGARGTVGYIAPEVFCRNIGEVSYKSDVYNYGMMIFEMTG-GRKNVDVVDNG  494 (506)
Q Consensus       429 g~a~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~s~~~Dv~s~G~il~ellt-g~~pf~~~~~~  494 (506)
                      |+++...............+++.|+|||.+.+.  .++.++||||||+++|||++ |+.||......
T Consensus       188 g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~--~~~~~~Di~slG~il~ellt~g~~p~~~~~~~  252 (327)
T 2yfx_A          188 GMARDIYRASYYRKGGCAMLPVKWMPPEAFMEG--IFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQ  252 (327)
T ss_dssp             HHHHHHHC------CCGGGSCGGGCCHHHHHHC--CCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHH
T ss_pred             ccccccccccccccCCCcCCCcceeCHhHhcCC--CCCchhhHHHHHHHHHHHHcCCCCCCCCcCHH
Confidence            999765443332222345678999999998553  78999999999999999998 99999865443

>1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A

Probab=99.96  E-value=5.5e-30  Score=258.82  Aligned_cols=170  Identities=25%  Similarity=0.365  Sum_probs=138.0

Q ss_pred             HhhhccccCccCceEEEEEEEc-CCCEEEEEEeccCCCCchhhHHHHHHhhccC-----------ccceeEEEEEee---
Q 039231          314 TNSFKYKLGQGGYGSVYKGKLL-DGSNVAVKVLNDSKGNGKEFINEVASISRTS-----------HVNVVALLGFCL---  378 (506)
Q Consensus       314 ~~~~~~~ig~G~~g~V~~~~~~-~~~~vavK~l~~~~~~~~~~~~E~~~l~~l~-----------h~niv~l~g~~~---  378 (506)
                      .+.+.+.||+|+||.||+|+.. +++.||||++.......+.+.+|++++++++           |+||+++++++.   
T Consensus        20 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~i~~~~~~~~~~~   99 (373)
T 1q8y_A           20 RYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHFNHKG   99 (373)
T ss_dssp             TEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSCHHHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEEEEEE
T ss_pred             eEEEEEeeeecCCeEEEEEEecCCCcEEEEEEecCCccchhhhhHHHHHHHHhhcccccchhccccchHHHHHHHhhccC
Confidence            3445678999999999999974 5899999999765545567889999999887           889999988752   


Q ss_pred             -----------------------------ccchhhhHHHHHHHHHHHHhhcCCC-CeEecCcCCCcEEEC------CCCc
Q 039231          379 -----------------------------RVAEELSSTIGIARGLEYLHLGCST-RILHFDIKPHNILLD------EDFC  422 (506)
Q Consensus       379 -----------------------------~~~~~l~i~~~i~~gl~~LH~~~~~-~ivH~dlkp~Nill~------~~~~  422 (506)
                                                   ++.+.+.++.||+.||+|||   ++ +|+||||||+|||++      ..+.
T Consensus       100 ~~~~~~~lv~e~~~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH---~~~~ivH~Dikp~NIll~~~~~~~~~~~  176 (373)
T 1q8y_A          100 PNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMH---RRCGIIHTDIKPENVLMEIVDSPENLIQ  176 (373)
T ss_dssp             TTEEEEEEEECCCCEEHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHH---HTTCEECSCCSGGGEEEEEEETTTTEEE
T ss_pred             CCCceEEEEEecCCCCHHHHHHHhhccCCcHHHHHHHHHHHHHHHHHHH---hcCCEEecCCChHHeEEeccCCCcCcce
Confidence                                         12235678999999999999   77 999999999999994      4458


Q ss_pred             EEEeecCCCccccCCCcceecccCCCCcccccccccccccCCCCccccHHHHHHHHHHHHcCCCCCCCCCC
Q 039231          423 PKISDFGLAKICNRKESIISMTGARGTVGYIAPEVFCRNIGEVSYKSDVYNYGMMIFEMTGGRKNVDVVDN  493 (506)
Q Consensus       423 ~ki~dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~s~~~Dv~s~G~il~elltg~~pf~~~~~  493 (506)
                      +||+|||+++......     ....+|+.|+|||++.+.  .++.++||||||+++|||++|+.||.....
T Consensus       177 ~kl~Dfg~a~~~~~~~-----~~~~~t~~y~aPE~~~~~--~~~~~~Di~slG~il~el~~g~~pf~~~~~  240 (373)
T 1q8y_A          177 IKIADLGNACWYDEHY-----TNSIQTREYRSPEVLLGA--PWGCGADIWSTACLIFELITGDFLFEPDEG  240 (373)
T ss_dssp             EEECCCTTCEETTBCC-----CSCCSCGGGCCHHHHHTC--CCCTHHHHHHHHHHHHHHHHSSCCC-----
T ss_pred             EEEcccccccccCCCC-----CCCCCCccccCcHHHhCC--CCCchHhHHHHHHHHHHHHhCCCCCCCCcc
Confidence            9999999998765432     345789999999998654  689999999999999999999999987653

>2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A*

Probab=99.96  E-value=2.1e-29  Score=248.10  Aligned_cols=171  Identities=26%  Similarity=0.422  Sum_probs=129.1

Q ss_pred             hhhccccCccCceEEEEEEEc-CCCEEEEEEeccCCC----CchhhHHHHHHhhccCccceeEEEEEee-----------
Q 039231          315 NSFKYKLGQGGYGSVYKGKLL-DGSNVAVKVLNDSKG----NGKEFINEVASISRTSHVNVVALLGFCL-----------  378 (506)
Q Consensus       315 ~~~~~~ig~G~~g~V~~~~~~-~~~~vavK~l~~~~~----~~~~~~~E~~~l~~l~h~niv~l~g~~~-----------  378 (506)
                      +.+.+.||+|+||.||+|+.. +++.||||++.....    ..+++.+|++++++++||||+++++++.           
T Consensus        34 y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~  113 (310)
T 2wqm_A           34 FRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIVLEL  113 (310)
T ss_dssp             EEEEEEEECC--CEEEEEEETTTCCEEEEEEECTTSSCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred             eEEEEeecCCCCceEEEEEEcCCCceEEEEeeehhhccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCcEEEEEec
Confidence            445678999999999999974 689999999975322    2256889999999999999999998872           


Q ss_pred             --------------------ccchhhhHHHHHHHHHHHHhhcCCCCeEecCcCCCcEEECCCCcEEEeecCCCccccCCC
Q 039231          379 --------------------RVAEELSSTIGIARGLEYLHLGCSTRILHFDIKPHNILLDEDFCPKISDFGLAKICNRKE  438 (506)
Q Consensus       379 --------------------~~~~~l~i~~~i~~gl~~LH~~~~~~ivH~dlkp~Nill~~~~~~ki~dfg~a~~~~~~~  438 (506)
                                          +..+.+.++.|++.||+|||   +.+++|+||||+||+++.++.+||+|||+++......
T Consensus       114 ~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH---~~~i~H~dl~p~NIl~~~~~~~kl~Dfg~~~~~~~~~  190 (310)
T 2wqm_A          114 ADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEHMH---SRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKT  190 (310)
T ss_dssp             CCSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEECTTSCEEECCC----------
T ss_pred             CCCCCHHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHh---hCCeeCCCCcHHHEEEcCCCCEEEEeccceeeecCCC
Confidence                                22235678999999999999   8999999999999999999999999999998665433


Q ss_pred             cceecccCCCCcccccccccccccCCCCccccHHHHHHHHHHHHcCCCCCCCCC
Q 039231          439 SIISMTGARGTVGYIAPEVFCRNIGEVSYKSDVYNYGMMIFEMTGGRKNVDVVD  492 (506)
Q Consensus       439 ~~~~~~~~~gt~~y~aPE~l~~~~~~~s~~~Dv~s~G~il~elltg~~pf~~~~  492 (506)
                      ..  .....+++.|+|||.+.+.  .++.++||||||+++|||++|+.||....
T Consensus       191 ~~--~~~~~~~~~y~aPE~~~~~--~~~~~~Dv~slG~il~~l~~g~~p~~~~~  240 (310)
T 2wqm_A          191 TA--AHSLVGTPYYMSPERIHEN--GYNFKSDIWSLGCLLYEMAALQSPFYGDK  240 (310)
T ss_dssp             ----------CCSSCCHHHHTTC--CCCHHHHHHHHHHHHHHHHHSSCTTC---
T ss_pred             cc--ccccCCCeeEeChHHhCCC--CCCchhhHHHHHHHHHHHHhCCCCCcccc
Confidence            21  2345689999999998653  78999999999999999999999997543

>1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A*

Probab=99.96  E-value=3.9e-29  Score=242.85  Aligned_cols=166  Identities=26%  Similarity=0.362  Sum_probs=137.3

Q ss_pred             hhhccccCccCceEEEEEEEc-CCCEEEEEEeccCCC---CchhhHHHHHHhhcc-CccceeEEEEEee-----------
Q 039231          315 NSFKYKLGQGGYGSVYKGKLL-DGSNVAVKVLNDSKG---NGKEFINEVASISRT-SHVNVVALLGFCL-----------  378 (506)
Q Consensus       315 ~~~~~~ig~G~~g~V~~~~~~-~~~~vavK~l~~~~~---~~~~~~~E~~~l~~l-~h~niv~l~g~~~-----------  378 (506)
                      +.+.+.||+|+||.||+|+.. +++.||||+++....   ...++.+|+..+.++ +||||+++++++.           
T Consensus        13 y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~~h~~iv~~~~~~~~~~~~~lv~e~   92 (289)
T 1x8b_A           13 FHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQHSHVVRYFSAWAEDDHMLIQNEY   92 (289)
T ss_dssp             EEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCCTTSHHHHHHHHHHHHHHHSCSCTTBCCEEEEEEETTEEEEEEEC
T ss_pred             hhhhhhhcCCCceEEEEEEEcCCCceEEEEEecccccccHHHHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEEEEEEe
Confidence            344578999999999999986 689999999975432   336788999999999 8999999999871           


Q ss_pred             --------------------ccchhhhHHHHHHHHHHHHhhcCCCCeEecCcCCCcEEECC-------------------
Q 039231          379 --------------------RVAEELSSTIGIARGLEYLHLGCSTRILHFDIKPHNILLDE-------------------  419 (506)
Q Consensus       379 --------------------~~~~~l~i~~~i~~gl~~LH~~~~~~ivH~dlkp~Nill~~-------------------  419 (506)
                                          ++.+.+.++.||+.||+|||   +++|+||||||+||+++.                   
T Consensus        93 ~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH---~~~ivH~Dikp~NIl~~~~~~~~~~~~~~~~~~~~~~  169 (289)
T 1x8b_A           93 CNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRYIH---SMSLVHMDIKPSNIFISRTSIPNAASEEGDEDDWASN  169 (289)
T ss_dssp             CTTCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEEC--------------------
T ss_pred             cCCCcHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHH---hCCEeecCCCHHHEEEcCCCCCcccccccccccccCC
Confidence                                23346678999999999999   899999999999999984                   


Q ss_pred             CCcEEEeecCCCccccCCCcceecccCCCCcccccccccccccCCCCccccHHHHHHHHHHHHcCCCCCCC
Q 039231          420 DFCPKISDFGLAKICNRKESIISMTGARGTVGYIAPEVFCRNIGEVSYKSDVYNYGMMIFEMTGGRKNVDV  490 (506)
Q Consensus       420 ~~~~ki~dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~s~~~Dv~s~G~il~elltg~~pf~~  490 (506)
                      ...+||+|||.+.......      ...+|+.|+|||.+.+. ..++.++||||||+++|||++|..|+..
T Consensus       170 ~~~~kl~Dfg~~~~~~~~~------~~~gt~~y~aPE~~~~~-~~~~~~~Di~slG~il~~l~~~~~~~~~  233 (289)
T 1x8b_A          170 KVMFKIGDLGHVTRISSPQ------VEEGDSRFLANEVLQEN-YTHLPKADIFALALTVVCAAGAEPLPRN  233 (289)
T ss_dssp             CCCEEECCCTTCEETTCSC------CCCCCGGGCCHHHHTTC-CTTHHHHHHHHHHHHHHHHTTCCCCCSS
T ss_pred             ceEEEEcccccccccCCcc------ccCCCccccChhHhcCC-CCCCchhhHHHHHHHHHHHhcCCCCCcc
Confidence            4479999999998765432      24589999999998653 3566899999999999999999988753

>2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A*

Probab=99.96  E-value=5.9e-30  Score=250.94  Aligned_cols=174  Identities=26%  Similarity=0.390  Sum_probs=138.9

Q ss_pred             hhccccCccCceEEEEEEEc-CCCEEEEEEeccCC-CCchhhHHHHHHhhccCccceeEEEEEee---------------
Q 039231          316 SFKYKLGQGGYGSVYKGKLL-DGSNVAVKVLNDSK-GNGKEFINEVASISRTSHVNVVALLGFCL---------------  378 (506)
Q Consensus       316 ~~~~~ig~G~~g~V~~~~~~-~~~~vavK~l~~~~-~~~~~~~~E~~~l~~l~h~niv~l~g~~~---------------  378 (506)
                      .+.+.||+|+||.||+|+.. +++.+|+|++.... ...+.+.+|++++.+++||||+++++++.               
T Consensus        22 ~i~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~  101 (302)
T 2j7t_A           22 EIVGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYIVEIEILATCDHPYIVKLLGAYYHDGKLWIMIEFCPGG  101 (302)
T ss_dssp             EEEEEEECSTTCCEEEEEETTTCCEEEEEEEC----CCHHHHHHHHHHHHHCCCTTBCCEEEEEECC-CEEEEEECCTTE
T ss_pred             eecceeccCCCeEEEEEEEcCCCcEEEEEEecCCCHHHHHHHHHHHHHHhcCCCCCEeeeeeeeeeCCeEEEEEEeCCCC
Confidence            34567999999999999986 48999999987543 34578899999999999999999999872               


Q ss_pred             -------------ccchhhhHHHHHHHHHHHHhhcCCCCeEecCcCCCcEEECCCCcEEEeecCCCccccCCCcceeccc
Q 039231          379 -------------RVAEELSSTIGIARGLEYLHLGCSTRILHFDIKPHNILLDEDFCPKISDFGLAKICNRKESIISMTG  445 (506)
Q Consensus       379 -------------~~~~~l~i~~~i~~gl~~LH~~~~~~ivH~dlkp~Nill~~~~~~ki~dfg~a~~~~~~~~~~~~~~  445 (506)
                                   ++.+.+.++.|++.||+|||   +.+++||||||+||+++.++.+||+|||++........  ....
T Consensus       102 ~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~--~~~~  176 (302)
T 2j7t_A          102 AVDAIMLELDRGLTEPQIQVVCRQMLEALNFLH---SKRIIHRDLKAGNVLMTLEGDIRLADFGVSAKNLKTLQ--KRDS  176 (302)
T ss_dssp             EHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCSGGGEEECTTSCEEECCCHHHHHHHHHHH--C---
T ss_pred             cHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHh---cCCcccCCCCHHHEEECCCCCEEEEECCCCcccccccc--cccc
Confidence                         23335678999999999999   89999999999999999999999999998754322111  1133


Q ss_pred             CCCCccccccccccc---ccCCCCccccHHHHHHHHHHHHcCCCCCCCCCCC
Q 039231          446 ARGTVGYIAPEVFCR---NIGEVSYKSDVYNYGMMIFEMTGGRKNVDVVDNG  494 (506)
Q Consensus       446 ~~gt~~y~aPE~l~~---~~~~~s~~~Dv~s~G~il~elltg~~pf~~~~~~  494 (506)
                      ..+++.|+|||.+..   ....++.++||||||+++|||++|+.||...+..
T Consensus       177 ~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~  228 (302)
T 2j7t_A          177 FIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPM  228 (302)
T ss_dssp             --CCGGGCCHHHHHHHHTTSTTTTTHHHHHHHHHHHHHHHHSSCTTTTSCHH
T ss_pred             ccCChhhcCCeeeccccCCCCCCchhhhHHHHHHHHHHHhcCCCCCccCCHH
Confidence            568999999999842   1246788999999999999999999999876543

>2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X*

Probab=99.96  E-value=1.9e-29  Score=252.47  Aligned_cols=169  Identities=24%  Similarity=0.350  Sum_probs=141.4

Q ss_pred             hhccccCccCceEEEEEEEcCCCEEEEEEeccCCCC----c--------------hhhHHHHHHhhccCccceeEEEEEe
Q 039231          316 SFKYKLGQGGYGSVYKGKLLDGSNVAVKVLNDSKGN----G--------------KEFINEVASISRTSHVNVVALLGFC  377 (506)
Q Consensus       316 ~~~~~ig~G~~g~V~~~~~~~~~~vavK~l~~~~~~----~--------------~~~~~E~~~l~~l~h~niv~l~g~~  377 (506)
                      .+.+.||+|+||.||+|+. +++.||||++......    .              +.+.+|++++.+++||||+++++++
T Consensus        34 ~~~~~lg~G~~g~V~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~  112 (348)
T 2pml_X           34 RIIRTLNQGKFNKIILCEK-DNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQIITDIKNEYCLTCEGII  112 (348)
T ss_dssp             EEEEEEECCSSCCEEEEEE-TTEEEEEEEEEHHHHSSCEEECCCSSSSCCEEEHHHHHHHHHHHHTTCCCTTBCCCSEEE
T ss_pred             EEEEEEcCCCCeEEEEEEc-CCceEEEEEeecccccchhhhccccchhhhHHhHHHHHHHHHHHHHhCCCCCcceEEEEE
Confidence            3456799999999999999 9999999999642111    1              7789999999999999999999876


Q ss_pred             e-----------------------------------ccchhhhHHHHHHHHHHHHhhcCC-CCeEecCcCCCcEEECCCC
Q 039231          378 L-----------------------------------RVAEELSSTIGIARGLEYLHLGCS-TRILHFDIKPHNILLDEDF  421 (506)
Q Consensus       378 ~-----------------------------------~~~~~l~i~~~i~~gl~~LH~~~~-~~ivH~dlkp~Nill~~~~  421 (506)
                      .                                   ++.+.+.++.|++.||+|||   + ++|+|+||||+||+++.++
T Consensus       113 ~~~~~~~lv~e~~~~~~L~~~~~~~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH---~~~~i~H~dl~p~Nil~~~~~  189 (348)
T 2pml_X          113 TNYDEVYIIYEYMENDSILKFDEYFFVLDKNYTCFIPIQVIKCIIKSVLNSFSYIH---NEKNICHRDVKPSNILMDKNG  189 (348)
T ss_dssp             ESSSEEEEEEECCTTCBSSEESSSEESSCSSSCCCCCHHHHHHHHHHHHHHHHHHH---HTSCEECCCCCGGGEEECTTS
T ss_pred             eeCCeEEEEEeccCCCcHHHHHHHhhhhhhccccCCCHHHHHHHHHHHHHHHHHHh---ccCCEeecCCChHhEEEcCCC
Confidence            1                                   11225678999999999999   7 9999999999999999999


Q ss_pred             cEEEeecCCCccccCCCcceecccCCCCcccccccccccccCCCCc-cccHHHHHHHHHHHHcCCCCCCCCCC
Q 039231          422 CPKISDFGLAKICNRKESIISMTGARGTVGYIAPEVFCRNIGEVSY-KSDVYNYGMMIFEMTGGRKNVDVVDN  493 (506)
Q Consensus       422 ~~ki~dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~s~-~~Dv~s~G~il~elltg~~pf~~~~~  493 (506)
                      .+||+|||++......    ......+++.|+|||.+.+. ..++. ++||||||+++|||++|+.||.....
T Consensus       190 ~~kl~dfg~~~~~~~~----~~~~~~~~~~y~aPE~~~~~-~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~  257 (348)
T 2pml_X          190 RVKLSDFGESEYMVDK----KIKGSRGTYEFMPPEFFSNE-SSYNGAKVDIWSLGICLYVMFYNVVPFSLKIS  257 (348)
T ss_dssp             CEEECCCTTCEECBTT----EECSSCSCGGGCCGGGGSSC-CCEEHHHHHHHHHHHHHHHHHHSSCSSCCSSC
T ss_pred             cEEEeccccccccccc----cccCCCCCcCccCchhhcCC-CCCCcchhhHHHHHHHHHHHHhCCCCCCCCCc
Confidence            9999999999876443    22456789999999998653 24445 99999999999999999999987665

>2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A*

Probab=99.96  E-value=4.1e-30  Score=251.94  Aligned_cols=175  Identities=25%  Similarity=0.370  Sum_probs=125.0

Q ss_pred             hhccccCccCceEEEEEEEc-CCCEEEEEEeccC--CCCchhhHHHHHHhhccCccceeEEEEEee--------------
Q 039231          316 SFKYKLGQGGYGSVYKGKLL-DGSNVAVKVLNDS--KGNGKEFINEVASISRTSHVNVVALLGFCL--------------  378 (506)
Q Consensus       316 ~~~~~ig~G~~g~V~~~~~~-~~~~vavK~l~~~--~~~~~~~~~E~~~l~~l~h~niv~l~g~~~--------------  378 (506)
                      .+.+.||+|+||.||+|+.. +++.||||++...  ....+++.+|++++.+++||||+++++++.              
T Consensus        18 ~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~   97 (303)
T 2vwi_A           18 ELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCHHPNIVSYYTSFVVKDELWLVMKLLSG   97 (303)
T ss_dssp             EEEEECC---CCCEEEEEC----CEEEEECCC----------------CCCCCCCTTBCCEEEEEESSSCEEEEEECCTT
T ss_pred             hhhheeccccceEEEEEEECCCCcEEEEEEEEhhhcchhHHHHHHHHHHHhhcCCCCEeeEEEEEeecCCcEEEehhccC
Confidence            34568999999999999864 5899999998653  233467889999999999999999998771              


Q ss_pred             ---------------------ccchhhhHHHHHHHHHHHHhhcCCCCeEecCcCCCcEEECCCCcEEEeecCCCccccCC
Q 039231          379 ---------------------RVAEELSSTIGIARGLEYLHLGCSTRILHFDIKPHNILLDEDFCPKISDFGLAKICNRK  437 (506)
Q Consensus       379 ---------------------~~~~~l~i~~~i~~gl~~LH~~~~~~ivH~dlkp~Nill~~~~~~ki~dfg~a~~~~~~  437 (506)
                                           ++.+.+.++.|++.||+|||   +.+++||||||+||+++.++.+||+|||++......
T Consensus        98 ~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH---~~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~  174 (303)
T 2vwi_A           98 GSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYLH---KNGQIHRDVKAGNILLGEDGSVQIADFGVSAFLATG  174 (303)
T ss_dssp             CBHHHHHHHHHHTTTTTTCSSCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCSGGGEEECTTCCEEECCCHHHHHCC--
T ss_pred             CchHHHHHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHH---hCCCCCCCCChhhEEEcCCCCEEEEeccchheeccC
Confidence                                 12235668899999999999   899999999999999999999999999998765433


Q ss_pred             Ccc---eecccCCCCcccccccccccccCCCCccccHHHHHHHHHHHHcCCCCCCCCCCC
Q 039231          438 ESI---ISMTGARGTVGYIAPEVFCRNIGEVSYKSDVYNYGMMIFEMTGGRKNVDVVDNG  494 (506)
Q Consensus       438 ~~~---~~~~~~~gt~~y~aPE~l~~~~~~~s~~~Dv~s~G~il~elltg~~pf~~~~~~  494 (506)
                      ...   .......+|+.|+|||.+.+. ..++.++||||||+++|||++|+.||......
T Consensus       175 ~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~  233 (303)
T 2vwi_A          175 GDITRNKVRKTFVGTPCWMAPEVMEQV-RGYDFKADIWSFGITAIELATGAAPYHKYPPM  233 (303)
T ss_dssp             -------------CCCTTCCHHHHHHH-HCCCTHHHHHHHHHHHHHHHHSSCTTTTSCGG
T ss_pred             CCccchhhhcccCCCccccCHHHhccc-cCCCchhhHHHHHHHHHHHHhCCCCCccCchh
Confidence            211   111335689999999998542 35789999999999999999999999875543

>1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A*

Probab=99.96  E-value=5.5e-29  Score=248.47  Aligned_cols=186  Identities=25%  Similarity=0.388  Sum_probs=146.0

Q ss_pred             cCHHHHHHHHhhhccccCccCceEEEEEEEcCCCEEEEEEeccCCCCchhhHHHHHHhhc--cCccceeEEEEEeec---
Q 039231          305 YGYADIKKMTNSFKYKLGQGGYGSVYKGKLLDGSNVAVKVLNDSKGNGKEFINEVASISR--TSHVNVVALLGFCLR---  379 (506)
Q Consensus       305 ~~~~el~~~~~~~~~~ig~G~~g~V~~~~~~~~~~vavK~l~~~~~~~~~~~~E~~~l~~--l~h~niv~l~g~~~~---  379 (506)
                      +...+.....+.+.+.||+|+||.||+|+. +++.||||++...  ..+.+.+|++++..  ++||||+++++++..   
T Consensus        34 ~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~-~~~~vavK~~~~~--~~~~~~~e~~~~~~~~l~h~ni~~~~~~~~~~~~  110 (342)
T 1b6c_B           34 LLVQRTIARTIVLQESIGKGRFGEVWRGKW-RGEEVAVKIFSSR--EERSWFREAEIYQTVMLRHENILGFIAADNKDNG  110 (342)
T ss_dssp             HHHHHHHHHHCEEEEEEEEETTEEEEEEEE-TTEEEEEEEECGG--GHHHHHHHHHHHHHSCCCCTTBCCEEEEEECCCS
T ss_pred             eeecccccccEEEEeeecCCCCcEEEEEEE-cCccEEEEEeCch--hHHHHHHHHHHHHHhhcCCCcEEEEEeeecccCC
Confidence            334444555566678999999999999998 5899999999643  33567888888887  789999999988632   


Q ss_pred             ---------------------------cchhhhHHHHHHHHHHHHhhcC-----CCCeEecCcCCCcEEECCCCcEEEee
Q 039231          380 ---------------------------VAEELSSTIGIARGLEYLHLGC-----STRILHFDIKPHNILLDEDFCPKISD  427 (506)
Q Consensus       380 ---------------------------~~~~l~i~~~i~~gl~~LH~~~-----~~~ivH~dlkp~Nill~~~~~~ki~d  427 (506)
                                                 +.+.+.++.|++.||+|||...     +++|+||||||+|||+++++.+||+|
T Consensus       111 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dlkp~NIll~~~~~~kL~D  190 (342)
T 1b6c_B          111 TWTQLWLVSDYHEHGSLFDYLNRYTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIAD  190 (342)
T ss_dssp             SCCCEEEEECCCTTCBHHHHHHHCCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCSGGGEEECTTSCEEECC
T ss_pred             ccceeEEEEeecCCCcHHHHHhccCccHHHHHHHHHHHHHHHHHHHHHHhhhcccCCeeeCCCCHHHEEECCCCCEEEEE
Confidence                                       2335678999999999999321     47999999999999999999999999


Q ss_pred             cCCCccccCCCcce--ecccCCCCcccccccccccccC----CCCccccHHHHHHHHHHHHcC----------CCCCCCC
Q 039231          428 FGLAKICNRKESII--SMTGARGTVGYIAPEVFCRNIG----EVSYKSDVYNYGMMIFEMTGG----------RKNVDVV  491 (506)
Q Consensus       428 fg~a~~~~~~~~~~--~~~~~~gt~~y~aPE~l~~~~~----~~s~~~Dv~s~G~il~elltg----------~~pf~~~  491 (506)
                      ||+++.........  ......||+.|+|||.+.+...    .++.++||||||+++|||++|          +.||...
T Consensus       191 fg~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~el~tg~~~~~~~~~~~~p~~~~  270 (342)
T 1b6c_B          191 LGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDL  270 (342)
T ss_dssp             CTTCEEEETTTTEEEECCCSCCCCGGGCCHHHHTSCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTTTT
T ss_pred             CCCceeccccccccccccccCCcCcccCCHhhhcccccccccccCCcccHHHHHHHHHHHHhccCcCCcccccccCcccc
Confidence            99998765544321  1244578999999999854311    223689999999999999999          7888765


Q ss_pred             CC
Q 039231          492 DN  493 (506)
Q Consensus       492 ~~  493 (506)
                      ..
T Consensus       271 ~~  272 (342)
T 1b6c_B          271 VP  272 (342)
T ss_dssp             SC
T ss_pred             Cc
Confidence            43

>2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A*

Probab=99.96  E-value=2.4e-29  Score=244.94  Aligned_cols=174  Identities=28%  Similarity=0.436  Sum_probs=143.3

Q ss_pred             HHHhhhccccCccCceEEEEEEEc-CCCEEEEEEeccC---CCCchhhHHHHHHhhccCccceeEEEEEe----------
Q 039231          312 KMTNSFKYKLGQGGYGSVYKGKLL-DGSNVAVKVLNDS---KGNGKEFINEVASISRTSHVNVVALLGFC----------  377 (506)
Q Consensus       312 ~~~~~~~~~ig~G~~g~V~~~~~~-~~~~vavK~l~~~---~~~~~~~~~E~~~l~~l~h~niv~l~g~~----------  377 (506)
                      ...+.+.+.||+|+||.||+|+.. +++.||+|++...   ....+.+.+|++++++++||||+++++++          
T Consensus        21 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~  100 (287)
T 2wei_A           21 AERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILEDSSSFYIVG  100 (287)
T ss_dssp             HHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGBSSSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             hhcceeeEEEcCCCCEEEEEEEEcCCCcEEEEEEecccccchHHHHHHHHHHHHHHhccCCCccEEEEEEeCCCeEEEEE
Confidence            344555678999999999999986 5899999999643   23446789999999999999999999887          


Q ss_pred             -----------------eccchhhhHHHHHHHHHHHHhhcCCCCeEecCcCCCcEEECCC---CcEEEeecCCCccccCC
Q 039231          378 -----------------LRVAEELSSTIGIARGLEYLHLGCSTRILHFDIKPHNILLDED---FCPKISDFGLAKICNRK  437 (506)
Q Consensus       378 -----------------~~~~~~l~i~~~i~~gl~~LH~~~~~~ivH~dlkp~Nill~~~---~~~ki~dfg~a~~~~~~  437 (506)
                                       +++.+.+.++.|++.||+|||   +.+++|+||||+||+++.+   +.+||+|||++......
T Consensus       101 e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH---~~~i~H~dl~p~NIlv~~~~~~~~~kL~Dfg~~~~~~~~  177 (287)
T 2wei_A          101 ELYTGGELFDEIIKRKRFSEHDAARIIKQVFSGITYMH---KHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQN  177 (287)
T ss_dssp             CCCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEESCSSTTCCEEECSTTGGGTBCCC
T ss_pred             EccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH---HCCeeccCCChhhEEEecCCCcccEEEeccCcceeecCC
Confidence                             223346778999999999999   8999999999999999754   46999999999876543


Q ss_pred             CcceecccCCCCcccccccccccccCCCCccccHHHHHHHHHHHHcCCCCCCCCCCC
Q 039231          438 ESIISMTGARGTVGYIAPEVFCRNIGEVSYKSDVYNYGMMIFEMTGGRKNVDVVDNG  494 (506)
Q Consensus       438 ~~~~~~~~~~gt~~y~aPE~l~~~~~~~s~~~Dv~s~G~il~elltg~~pf~~~~~~  494 (506)
                      ...   ....+++.|+|||.+.+   .++.++||||||+++|||++|+.||...+..
T Consensus       178 ~~~---~~~~~~~~y~aPE~~~~---~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~  228 (287)
T 2wei_A          178 TKM---KDRIGTAYYIAPEVLRG---TYDEKCDVWSAGVILYILLSGTPPFYGKNEY  228 (287)
T ss_dssp             SSC---SCHHHHHTTCCHHHHTT---CCCTHHHHHHHHHHHHHHHHSSCSSCCSSHH
T ss_pred             Ccc---ccccCcccccChHHhcC---CCCCchhhHhHHHHHHHHHhCCCCCCCCCHH
Confidence            321   23457889999999843   5889999999999999999999999875543

>2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens}

Probab=99.96  E-value=1.6e-29  Score=251.00  Aligned_cols=170  Identities=29%  Similarity=0.486  Sum_probs=141.4

Q ss_pred             hhccccCccCceEEEEEEE-----cCCCEEEEEEeccCCC-CchhhHHHHHHhhccCccceeEEEEEee-----------
Q 039231          316 SFKYKLGQGGYGSVYKGKL-----LDGSNVAVKVLNDSKG-NGKEFINEVASISRTSHVNVVALLGFCL-----------  378 (506)
Q Consensus       316 ~~~~~ig~G~~g~V~~~~~-----~~~~~vavK~l~~~~~-~~~~~~~E~~~l~~l~h~niv~l~g~~~-----------  378 (506)
                      .+.+.||+|+||.||+|+.     .+++.||||++..... ..+.+.+|++++++++||||+++++++.           
T Consensus        44 ~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~  123 (326)
T 2w1i_A           44 KFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIM  123 (326)
T ss_dssp             EEEEEEECCSSEEEEEEEECTTSSSCCEEEEEEEESSCCSHHHHHHHHHHHHHHTCCCTTBCCEEEEECC----CCEEEE
T ss_pred             eeeeeeccCCCeEEEEEEeccccCCCceEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEEecCCCceEEEE
Confidence            4457899999999999984     3588999999976433 3367899999999999999999998762           


Q ss_pred             -------------------ccchhhhHHHHHHHHHHHHhhcCCCCeEecCcCCCcEEECCCCcEEEeecCCCccccCCCc
Q 039231          379 -------------------RVAEELSSTIGIARGLEYLHLGCSTRILHFDIKPHNILLDEDFCPKISDFGLAKICNRKES  439 (506)
Q Consensus       379 -------------------~~~~~l~i~~~i~~gl~~LH~~~~~~ivH~dlkp~Nill~~~~~~ki~dfg~a~~~~~~~~  439 (506)
                                         ++.+.+.++.|++.||+|||   +++|+||||||+||++++++.+||+|||+++.......
T Consensus       124 e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH---~~~ivH~dikp~NIli~~~~~~kL~Dfg~~~~~~~~~~  200 (326)
T 2w1i_A          124 EYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLG---TKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKE  200 (326)
T ss_dssp             CCCTTCBHHHHHHHSTTSSCHHHHHHHHHHHHHHHHHHH---HTTEECSCCCGGGEEEEETTEEEECCCTTCEECCSSCS
T ss_pred             ECCCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHH---hCCEeccCCCcceEEEcCCCcEEEecCcchhhcccccc
Confidence                               22235678999999999999   89999999999999999999999999999987765443


Q ss_pred             cee-cccCCCCcccccccccccccCCCCccccHHHHHHHHHHHHcCCCCCCC
Q 039231          440 IIS-MTGARGTVGYIAPEVFCRNIGEVSYKSDVYNYGMMIFEMTGGRKNVDV  490 (506)
Q Consensus       440 ~~~-~~~~~gt~~y~aPE~l~~~~~~~s~~~Dv~s~G~il~elltg~~pf~~  490 (506)
                      ... .....++..|+|||.+.+.  .++.++||||||+++|||++|+.||..
T Consensus       201 ~~~~~~~~~~~~~y~aPE~~~~~--~~~~~~Di~slG~il~el~tg~~~~~~  250 (326)
T 2w1i_A          201 YYKVKEPGESPIFWYAPESLTES--KFSVASDVWSFGVVLYELFTYIEKSKS  250 (326)
T ss_dssp             EEECSSCCSCCGGGCCHHHHHHC--EEEHHHHHHHHHHHHHHHHHTTCGGGS
T ss_pred             ccccccCCCCceeEECchhhcCC--CCCchhhHHHHHHHHHHHHhcCCCCCC
Confidence            222 2335577889999998654  678999999999999999999999864

>2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A*

Probab=99.96  E-value=2.7e-29  Score=259.19  Aligned_cols=170  Identities=27%  Similarity=0.372  Sum_probs=132.6

Q ss_pred             ccccCccCceEEEEEEEcCCCEEEEEEeccCCCCchhhHHHHHHhhcc-CccceeEEEEEeec-----------------
Q 039231          318 KYKLGQGGYGSVYKGKLLDGSNVAVKVLNDSKGNGKEFINEVASISRT-SHVNVVALLGFCLR-----------------  379 (506)
Q Consensus       318 ~~~ig~G~~g~V~~~~~~~~~~vavK~l~~~~~~~~~~~~E~~~l~~l-~h~niv~l~g~~~~-----------------  379 (506)
                      .+.||+|+||+||.+...+|+.||||++...  ..+.+.+|++++.++ +|||||++++++.+                 
T Consensus        20 ~~~LG~G~~g~V~~~~~~~g~~vAvK~~~~~--~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~~~lv~E~~~gsL~~   97 (434)
T 2rio_A           20 EKILGYGSSGTVVFQGSFQGRPVAVKRMLID--FCDIALMEIKLLTESDDHPNVIRYYCSETTDRFLYIALELCNLNLQD   97 (434)
T ss_dssp             EEEEEECSTTCEEEEEESSSSEEEEEEEEGG--GHHHHHHHHHHHHHHTTSTTBCCEEEEEECSSEEEEEECCCSEEHHH
T ss_pred             cCeEeeCCCeEEEEEEEECCeEEEEEEEcHH--HHHHHHHHHHHHHhccCCCCcCeEEEEEecCCeEEEEEecCCCCHHH
Confidence            3579999999998777778999999998653  235678999999886 89999999987621                 


Q ss_pred             ----------------cchhhhHHHHHHHHHHHHhhcCCCCeEecCcCCCcEEECCC-------------CcEEEeecCC
Q 039231          380 ----------------VAEELSSTIGIARGLEYLHLGCSTRILHFDIKPHNILLDED-------------FCPKISDFGL  430 (506)
Q Consensus       380 ----------------~~~~l~i~~~i~~gl~~LH~~~~~~ivH~dlkp~Nill~~~-------------~~~ki~dfg~  430 (506)
                                      +.+.+.++.||+.||+|||   +++|+||||||+|||++.+             +.+||+|||+
T Consensus        98 ~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH---~~~ivHrDLkp~NILl~~~~~~~~~~~~~~~~~~~kL~DFG~  174 (434)
T 2rio_A           98 LVESKNVSDENLKLQKEYNPISLLRQIASGVAHLH---SLKIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGL  174 (434)
T ss_dssp             HHHTC------------CCHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEEECCHHHHSCCTTCCCSCEEEECCCTT
T ss_pred             HHhccCCCchhhhhccchhHHHHHHHHHHHHHHHH---HCCccccCCChHhEEEecCcccccccccCCCceEEEEccccc
Confidence                            1123568999999999999   8999999999999999654             4899999999


Q ss_pred             CccccCCCcce--ecccCCCCcccccccccccc-----cCCCCccccHHHHHHHHHHHHc-CCCCCCCCC
Q 039231          431 AKICNRKESII--SMTGARGTVGYIAPEVFCRN-----IGEVSYKSDVYNYGMMIFEMTG-GRKNVDVVD  492 (506)
Q Consensus       431 a~~~~~~~~~~--~~~~~~gt~~y~aPE~l~~~-----~~~~s~~~Dv~s~G~il~ellt-g~~pf~~~~  492 (506)
                      ++.........  ......||+.|+|||++.+.     ...++.++|||||||++|||++ |+.||....
T Consensus       175 a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~~~  244 (434)
T 2rio_A          175 CKKLDSGQSSFRTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHPFGDKY  244 (434)
T ss_dssp             CEECCC--------------CCTTSCHHHHSCCCTTSCCCCCCTHHHHHHHHHHHHHHHTTSCCTTCSTT
T ss_pred             ceecCCCCccceeeecCCCCCCCccCHHHhccccccccccCcchhhhhHhHHHHHHHHHhCCCCCCCCch
Confidence            98876543221  12346799999999998641     2468999999999999999999 999997653

>2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens}

Probab=99.96  E-value=1.6e-29  Score=249.71  Aligned_cols=173  Identities=29%  Similarity=0.410  Sum_probs=137.5

Q ss_pred             hhhccccCccCceEEEEEEE-cCCCEEEEEEeccCC-CCchhhHHHHHHhhccCccceeEEEEEee--------------
Q 039231          315 NSFKYKLGQGGYGSVYKGKL-LDGSNVAVKVLNDSK-GNGKEFINEVASISRTSHVNVVALLGFCL--------------  378 (506)
Q Consensus       315 ~~~~~~ig~G~~g~V~~~~~-~~~~~vavK~l~~~~-~~~~~~~~E~~~l~~l~h~niv~l~g~~~--------------  378 (506)
                      +.+.+.||+|+||.||+++. .+++.||||++.... ...+.+.+|++++++++||||+++++++.              
T Consensus        31 y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~lv~e  110 (317)
T 2buj_A           31 YLFIQKLGEGGFSYVDLVEGLHDGHFYALKRILCHEQQDREEAQREADMHRLFNHPNILRLVAYCLRERGAKHEAWLLLP  110 (317)
T ss_dssp             EEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEESSHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEEEETTEEEEEEEEE
T ss_pred             EEEEEEecCCCCeEEEEEEecCCCcEEEEEEEecCCHHHHHHHHHHHHHHhhcCCCCeeeEEEEEEeccCCCceeEEEEE
Confidence            34457899999999999997 568999999986533 33467889999999999999999988763              


Q ss_pred             ---------------------ccchhhhHHHHHHHHHHHHhhcCCCCeEecCcCCCcEEECCCCcEEEeecCCCccccCC
Q 039231          379 ---------------------RVAEELSSTIGIARGLEYLHLGCSTRILHFDIKPHNILLDEDFCPKISDFGLAKICNRK  437 (506)
Q Consensus       379 ---------------------~~~~~l~i~~~i~~gl~~LH~~~~~~ivH~dlkp~Nill~~~~~~ki~dfg~a~~~~~~  437 (506)
                                           ++.+.+.++.|++.||+|||   +++|+||||||+||+++.++.+||+|||+++.....
T Consensus       111 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH---~~~ivH~dlkp~NIl~~~~~~~kl~dfg~~~~~~~~  187 (317)
T 2buj_A          111 FFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGLEAIH---AKGYAHRDLKPTNILLGDEGQPVLMDLGSMNQACIH  187 (317)
T ss_dssp             CCTTCBHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEECTTSCEEECCCSSCEESCEE
T ss_pred             eCCCCcHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCCHHHEEEcCCCCEEEEecCcchhcccc
Confidence                                 12235668999999999999   899999999999999999999999999998765321


Q ss_pred             Ccce-------ecccCCCCccccccccccccc-CCCCccccHHHHHHHHHHHHcCCCCCCC
Q 039231          438 ESII-------SMTGARGTVGYIAPEVFCRNI-GEVSYKSDVYNYGMMIFEMTGGRKNVDV  490 (506)
Q Consensus       438 ~~~~-------~~~~~~gt~~y~aPE~l~~~~-~~~s~~~Dv~s~G~il~elltg~~pf~~  490 (506)
                      ....       ......||+.|+|||.+.... ..++.++||||||+++|||++|+.||+.
T Consensus       188 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~  248 (317)
T 2buj_A          188 VEGSRQALTLQDWAAQRCTISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGPYDM  248 (317)
T ss_dssp             EESHHHHHHHHHHHHHHSCGGGCCGGGSSCCSEEEECTHHHHHHHHHHHHHHHHSSCTTHH
T ss_pred             cccccccccccccccccCCcccCCHhHhccCCCcCCCchhhHHHHHHHHHHHHhCCCChhh
Confidence            1100       012245799999999985431 2368899999999999999999999965

>3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A*

Probab=99.96  E-value=2.7e-29  Score=249.37  Aligned_cols=169  Identities=27%  Similarity=0.387  Sum_probs=119.4

Q ss_pred             ccccCccCceEEEEEEEc-CCCEEEEEEeccCCCC--chhhHHHHH-HhhccCccceeEEEEEeec--------------
Q 039231          318 KYKLGQGGYGSVYKGKLL-DGSNVAVKVLNDSKGN--GKEFINEVA-SISRTSHVNVVALLGFCLR--------------  379 (506)
Q Consensus       318 ~~~ig~G~~g~V~~~~~~-~~~~vavK~l~~~~~~--~~~~~~E~~-~l~~l~h~niv~l~g~~~~--------------  379 (506)
                      .+.||+|+||.||+|+.. +++.||||+++.....  ..++.+|+. +++.++||||+++++++..              
T Consensus        27 ~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~~~~h~niv~~~~~~~~~~~~~lv~e~~~~~  106 (327)
T 3aln_A           27 LGEIGRGAYGSVNKMVHKPSGQIMAVKRIRSTVDEKEQKQLLMDLDVVMRSSDCPYIVQFYGALFREGDCWICMELMSTS  106 (327)
T ss_dssp             -CEEEECSSEEEEEEEETTTTEEEEEEEEECCCCHHHHHHHHHHHHHHHSSCCCTTBCCEEEEEECSSEEEEEECCCSEE
T ss_pred             hheeccCCCEEEEEEEEcCCCCEEEEEEeecccCchHHHHHHHHHHHHHHcCCCCcEeeeeeEEEeCCceEEEEeecCCC
Confidence            467999999999999985 5899999999764322  245566665 6777899999999997722              


Q ss_pred             -----------------cchhhhHHHHHHHHHHHHhhcCCC-CeEecCcCCCcEEECCCCcEEEeecCCCccccCCCcce
Q 039231          380 -----------------VAEELSSTIGIARGLEYLHLGCST-RILHFDIKPHNILLDEDFCPKISDFGLAKICNRKESII  441 (506)
Q Consensus       380 -----------------~~~~l~i~~~i~~gl~~LH~~~~~-~ivH~dlkp~Nill~~~~~~ki~dfg~a~~~~~~~~~~  441 (506)
                                       +...+.++.|++.||.|||   +. +|+||||||+||+++.++.+||+|||+++.......  
T Consensus       107 l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH---~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~--  181 (327)
T 3aln_A          107 FDKFYKYVYSVLDDVIPEEILGKITLATVKALNHLK---ENLKIIHRDIKPSNILLDRSGNIKLCDFGISGQLVDSIA--  181 (327)
T ss_dssp             HHHHHHHHHHTTCCCCCHHHHHHHHHHHHHHHHHHH---HHHSCCCSCCCGGGEEEETTTEEEECCCSSSCC--------
T ss_pred             hHHHHHHHHhhhcccCcHHHHHHHHHHHHHHHHHHh---ccCCEeECCCCHHHEEEcCCCCEEEccCCCceecccccc--
Confidence                             2235578999999999999   77 999999999999999999999999999987654332  


Q ss_pred             ecccCCCCccccccccccc--ccCCCCccccHHHHHHHHHHHHcCCCCCCCCC
Q 039231          442 SMTGARGTVGYIAPEVFCR--NIGEVSYKSDVYNYGMMIFEMTGGRKNVDVVD  492 (506)
Q Consensus       442 ~~~~~~gt~~y~aPE~l~~--~~~~~s~~~Dv~s~G~il~elltg~~pf~~~~  492 (506)
                       .....||+.|+|||.+..  ....++.++||||||+++|||++|+.||....
T Consensus       182 -~~~~~gt~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~  233 (327)
T 3aln_A          182 -KTRDAGCRPYMAPERIDPSASRQGYDVRSDVWSLGITLYELATGRFPYPKWN  233 (327)
T ss_dssp             -------------------------CCSHHHHHHHHHHHHHHHHSCCCSSCC-
T ss_pred             -cccCCCCccccCceeeccccCcCCCCchhhHHHHHHHHHHHHHCCCCCCCcc
Confidence             133468999999999842  12368899999999999999999999998643

>2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens}

Probab=99.96  E-value=1.8e-29  Score=248.89  Aligned_cols=172  Identities=27%  Similarity=0.427  Sum_probs=139.3

Q ss_pred             HHHhhhccccCccCceEEEEEEEc-CCCEEEEEEeccCCC-------CchhhHHHHHHhhcc----CccceeEEEEEe--
Q 039231          312 KMTNSFKYKLGQGGYGSVYKGKLL-DGSNVAVKVLNDSKG-------NGKEFINEVASISRT----SHVNVVALLGFC--  377 (506)
Q Consensus       312 ~~~~~~~~~ig~G~~g~V~~~~~~-~~~~vavK~l~~~~~-------~~~~~~~E~~~l~~l----~h~niv~l~g~~--  377 (506)
                      ...+.+.+.||+|+||.||+|+.. +++.||||++.....       ....+.+|++++.++    +||||+++++++  
T Consensus        30 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~h~~i~~~~~~~~~  109 (312)
T 2iwi_A           30 EAEYRLGPLLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGHPGVIRLLDWFET  109 (312)
T ss_dssp             ---CEEEEEEEEETTEEEEEEECTTTCCEEEEEECCSTTTC--------CCCCHHHHHHHHHHSSCCCSSBCCEEEEC--
T ss_pred             hhceEEeeEEEcCCCEEEEEEEEccCCeEEEEEEEecccccccccchhhHHHHHHHHHHHhhcccCCCCCeeeEEEEEec
Confidence            344555688999999999999874 588999999965432       234577899999998    899999999876  


Q ss_pred             --------------------------eccchhhhHHHHHHHHHHHHhhcCCCCeEecCcCCCcEEEC-CCCcEEEeecCC
Q 039231          378 --------------------------LRVAEELSSTIGIARGLEYLHLGCSTRILHFDIKPHNILLD-EDFCPKISDFGL  430 (506)
Q Consensus       378 --------------------------~~~~~~l~i~~~i~~gl~~LH~~~~~~ivH~dlkp~Nill~-~~~~~ki~dfg~  430 (506)
                                                +.+.+.+.++.|++.||+|||   +.+|+||||||+||+++ +++.+||+|||+
T Consensus       110 ~~~~~~v~e~~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dlkp~Nil~~~~~~~~kl~dfg~  186 (312)
T 2iwi_A          110 QEGFMLVLERPLPAQDLFDYITEKGPLGEGPSRCFFGQVVAAIQHCH---SRGVVHRDIKDENILIDLRRGCAKLIDFGS  186 (312)
T ss_dssp             ---CEEEEECCSSEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHH---HHTEECCCCSGGGEEEETTTTEEEECCCSS
T ss_pred             CCeEEEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH---HCCeeecCCChhhEEEeCCCCeEEEEEcch
Confidence                                      123335678999999999999   88999999999999998 889999999999


Q ss_pred             CccccCCCcceecccCCCCcccccccccccccCCCCccccHHHHHHHHHHHHcCCCCCCCC
Q 039231          431 AKICNRKESIISMTGARGTVGYIAPEVFCRNIGEVSYKSDVYNYGMMIFEMTGGRKNVDVV  491 (506)
Q Consensus       431 a~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~s~~~Dv~s~G~il~elltg~~pf~~~  491 (506)
                      ++......    .....++..|+|||.+.+. ...+.++||||||+++|||++|+.||...
T Consensus       187 ~~~~~~~~----~~~~~~~~~y~aPE~~~~~-~~~~~~~Di~slG~il~~l~~g~~pf~~~  242 (312)
T 2iwi_A          187 GALLHDEP----YTDFDGTRVYSPPEWISRH-QYHALPATVWSLGILLYDMVCGDIPFERD  242 (312)
T ss_dssp             CEECCSSC----BCCCCSCTTTSCHHHHHHS-CBCHHHHHHHHHHHHHHHHHHSSCSCCSH
T ss_pred             hhhcccCc----ccccCCcccccCceeeecC-CCCCccchHHHHHHHHHHHHHCCCCCCCh
Confidence            98765433    2446689999999998653 23355899999999999999999999753

>1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A*

Probab=99.96  E-value=2e-29  Score=250.27  Aligned_cols=172  Identities=28%  Similarity=0.524  Sum_probs=136.3

Q ss_pred             hhhccccCccCceEEEEEEEc-CCCE--EEEEEeccC--CCCchhhHHHHHHhhcc-CccceeEEEEEeec---------
Q 039231          315 NSFKYKLGQGGYGSVYKGKLL-DGSN--VAVKVLNDS--KGNGKEFINEVASISRT-SHVNVVALLGFCLR---------  379 (506)
Q Consensus       315 ~~~~~~ig~G~~g~V~~~~~~-~~~~--vavK~l~~~--~~~~~~~~~E~~~l~~l-~h~niv~l~g~~~~---------  379 (506)
                      +.+.+.||+|+||.||+|+.. ++..  +|+|.++..  ....+.+.+|++++.++ +||||+++++++.+         
T Consensus        27 y~~~~~lg~G~~g~Vy~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~lv~e  106 (327)
T 1fvr_A           27 IKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIE  106 (327)
T ss_dssp             CEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC------CHHHHHHHHHTTCCCCTTBCCEEEEEEETTEEEEEEC
T ss_pred             ccceeeeecCCCceEEEEEEccCCcccceeeeeeccccchHHHHHHHHHHHHHHhccCCCchhhhceeeeeCCceEEEEe
Confidence            345678999999999999875 4554  499998753  33446789999999999 89999999987611         


Q ss_pred             ----------------------------------cchhhhHHHHHHHHHHHHhhcCCCCeEecCcCCCcEEECCCCcEEE
Q 039231          380 ----------------------------------VAEELSSTIGIARGLEYLHLGCSTRILHFDIKPHNILLDEDFCPKI  425 (506)
Q Consensus       380 ----------------------------------~~~~l~i~~~i~~gl~~LH~~~~~~ivH~dlkp~Nill~~~~~~ki  425 (506)
                                                        +.+.+.++.|++.||+|||   +++|+||||||+||+++.++.+||
T Consensus       107 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH---~~~ivH~dlkp~NIl~~~~~~~kL  183 (327)
T 1fvr_A          107 YAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLS---QKQFIHRDLAARNILVGENYVAKI  183 (327)
T ss_dssp             CCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECGGGCEEE
T ss_pred             cCCCCCHHHHHHhcccccccccccccccccccCCHHHHHHHHHHHHHHHHHHH---hCCccCCCCccceEEEcCCCeEEE
Confidence                                              1234668999999999999   899999999999999999999999


Q ss_pred             eecCCCccccCCCcceecccCCCCcccccccccccccCCCCccccHHHHHHHHHHHHc-CCCCCCCCCCC
Q 039231          426 SDFGLAKICNRKESIISMTGARGTVGYIAPEVFCRNIGEVSYKSDVYNYGMMIFEMTG-GRKNVDVVDNG  494 (506)
Q Consensus       426 ~dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~s~~~Dv~s~G~il~ellt-g~~pf~~~~~~  494 (506)
                      +|||+++.......   .....+++.|+|||.+.+.  .++.++||||||+++|||++ |+.||......
T Consensus       184 ~Dfg~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~--~~~~~~Di~slG~il~ellt~g~~pf~~~~~~  248 (327)
T 1fvr_A          184 ADFGLSRGQEVYVK---KTMGRLPVRWMAIESLNYS--VYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCA  248 (327)
T ss_dssp             CCTTCEESSCEECC---C----CCTTTCCHHHHHHC--EECHHHHHHHHHHHHHHHHTTSCCTTTTCCHH
T ss_pred             cccCcCcccccccc---ccCCCCCccccChhhhccc--cCCchhcchHHHHHHHHHHcCCCCCCCCCcHH
Confidence            99999874332211   1334568899999998543  67899999999999999998 99999776543

>3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens}

Probab=99.96  E-value=3.6e-29  Score=257.79  Aligned_cols=170  Identities=29%  Similarity=0.389  Sum_probs=132.1

Q ss_pred             ccccCccCceEEEEEEEcCCCEEEEEEeccCCCCchhhHHHHHHhhcc-CccceeEEEEEeec-----------------
Q 039231          318 KYKLGQGGYGSVYKGKLLDGSNVAVKVLNDSKGNGKEFINEVASISRT-SHVNVVALLGFCLR-----------------  379 (506)
Q Consensus       318 ~~~ig~G~~g~V~~~~~~~~~~vavK~l~~~~~~~~~~~~E~~~l~~l-~h~niv~l~g~~~~-----------------  379 (506)
                      .+.||+|+||+|+.....+++.||||++...  ....+.+|+++++++ +|||||++++++.+                 
T Consensus        29 ~~~LG~G~~G~V~~~~~~~~~~vAvK~~~~~--~~~~~~~E~~~l~~l~~HpnIv~l~~~~~~~~~~~lv~E~~~g~L~~  106 (432)
T 3p23_A           29 KDVLGHGAEGTIVYRGMFDNRDVAVKRILPE--CFSFADREVQLLRESDEHPNVIRYFCTEKDRQFQYIAIELCAATLQE  106 (432)
T ss_dssp             EEEEEECGGGCEEEEEESSSSEEEEEEECTT--TEEECHHHHHHHHHSCCCTTBCCEEEEEEETTEEEEEEECCSEEHHH
T ss_pred             CCeeecCcCEEEEEEEEeCCeEEEEEEECHH--HHHHHHHHHHHHHhccCCCCcCeEEEEEecCCEEEEEEECCCCCHHH
Confidence            4679999999976665668999999999653  234578899999999 79999999987621                 


Q ss_pred             ----------cchhhhHHHHHHHHHHHHhhcCCCCeEecCcCCCcEEECC-----CCcEEEeecCCCccccCCCcc-eec
Q 039231          380 ----------VAEELSSTIGIARGLEYLHLGCSTRILHFDIKPHNILLDE-----DFCPKISDFGLAKICNRKESI-ISM  443 (506)
Q Consensus       380 ----------~~~~l~i~~~i~~gl~~LH~~~~~~ivH~dlkp~Nill~~-----~~~~ki~dfg~a~~~~~~~~~-~~~  443 (506)
                                ..+.+.++.||+.||+|||   +++|+||||||+|||++.     ...+||+|||+++........ ...
T Consensus       107 ~l~~~~~~~~~~~~~~i~~qi~~aL~~LH---~~~ivHrDlKp~NIll~~~~~~~~~~~kL~DFG~a~~~~~~~~~~~~~  183 (432)
T 3p23_A          107 YVEQKDFAHLGLEPITLLQQTTSGLAHLH---SLNIVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLAVGRHSFSRR  183 (432)
T ss_dssp             HHHSSSCCCCSSCHHHHHHHHHHHHHHHH---HTTCCCCCCSTTSEEECCCBTTTBCCEEECCTTEEECC----------
T ss_pred             HHHhcCCCccchhHHHHHHHHHHHHHHHH---HCcCEeCCCCHHHEEEecCCCCCceeEEEecccceeeccCCCcceeec
Confidence                      2235679999999999999   899999999999999943     346889999999876543321 122


Q ss_pred             ccCCCCcccccccccccc-cCCCCccccHHHHHHHHHHHHc-CCCCCCCCC
Q 039231          444 TGARGTVGYIAPEVFCRN-IGEVSYKSDVYNYGMMIFEMTG-GRKNVDVVD  492 (506)
Q Consensus       444 ~~~~gt~~y~aPE~l~~~-~~~~s~~~Dv~s~G~il~ellt-g~~pf~~~~  492 (506)
                      ....||+.|+|||++.+. ...++.++|||||||++|||++ |..||....
T Consensus       184 ~~~~gt~~y~APE~l~~~~~~~~t~~~DiwSlG~il~ellt~g~~pf~~~~  234 (432)
T 3p23_A          184 SGVPGTEGWIAPEMLSEDCKENPTYTVDIFSAGCVFYYVISEGSHPFGKSL  234 (432)
T ss_dssp             --CCSCTTSCCGGGTSCC---CCCTHHHHHHHHHHHHHHHTTSCBTTBSTT
T ss_pred             cccCCCcCccChhhhhcccccCCCcHHHHHHHHHHHHHHHcCCCCCcchhh
Confidence            446799999999998642 2367889999999999999999 999996543

>2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A*

Probab=99.96  E-value=2.3e-29  Score=272.05  Aligned_cols=175  Identities=25%  Similarity=0.470  Sum_probs=139.7

Q ss_pred             hhhccccCccCceEEEEEEEcC----CCEEEEEEeccCCCC--chhhHHHHHHhhccCccceeEEEEEe-----------
Q 039231          315 NSFKYKLGQGGYGSVYKGKLLD----GSNVAVKVLNDSKGN--GKEFINEVASISRTSHVNVVALLGFC-----------  377 (506)
Q Consensus       315 ~~~~~~ig~G~~g~V~~~~~~~----~~~vavK~l~~~~~~--~~~~~~E~~~l~~l~h~niv~l~g~~-----------  377 (506)
                      +.+.+.||+|+||.||+|++..    +..||||+++.....  .+.+.+|+.++++++||||+++++++           
T Consensus       392 y~i~~~LG~G~fG~Vy~a~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~lv~E~  471 (656)
T 2j0j_A          392 IELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVITENPVWIIMEL  471 (656)
T ss_dssp             EEEEEEEECCSSCCEEEEEECCSSSCCEEEEEEECSSTTCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSCEEEEEC
T ss_pred             EEEeeEEeeCCCEEEEEEEEecCCCccEEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCceEEEEEc
Confidence            3445679999999999998743    457999998754322  26789999999999999999999987           


Q ss_pred             ----------------eccchhhhHHHHHHHHHHHHhhcCCCCeEecCcCCCcEEECCCCcEEEeecCCCccccCCCcce
Q 039231          378 ----------------LRVAEELSSTIGIARGLEYLHLGCSTRILHFDIKPHNILLDEDFCPKISDFGLAKICNRKESII  441 (506)
Q Consensus       378 ----------------~~~~~~l~i~~~i~~gl~~LH~~~~~~ivH~dlkp~Nill~~~~~~ki~dfg~a~~~~~~~~~~  441 (506)
                                      +++...+.++.|++.||+|||   +++|+||||||+|||++.++.+||+|||+++........ 
T Consensus       472 ~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH---~~givHrDikp~NILl~~~~~vkL~DFG~a~~~~~~~~~-  547 (656)
T 2j0j_A          472 CTLGELRSFLQVRKFSLDLASLILYAYQLSTALAYLE---SKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYY-  547 (656)
T ss_dssp             CTTCBHHHHHHHTTTTCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEEEETTEEEECCCCCCCSCCC-----
T ss_pred             CCCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHH---hCCccccccchHhEEEeCCCCEEEEecCCCeecCCCcce-
Confidence                            122335678899999999999   899999999999999999999999999999876543322 


Q ss_pred             ecccCCCCcccccccccccccCCCCccccHHHHHHHHHHHHc-CCCCCCCCCCCc
Q 039231          442 SMTGARGTVGYIAPEVFCRNIGEVSYKSDVYNYGMMIFEMTG-GRKNVDVVDNGS  495 (506)
Q Consensus       442 ~~~~~~gt~~y~aPE~l~~~~~~~s~~~Dv~s~G~il~ellt-g~~pf~~~~~~~  495 (506)
                      ......+|+.|+|||.+...  .++.++||||||+++|||++ |..||......+
T Consensus       548 ~~~~~~~t~~y~aPE~~~~~--~~~~~~DiwSlG~il~ellt~g~~Pf~~~~~~~  600 (656)
T 2j0j_A          548 KASKGKLPIKWMAPESINFR--RFTSASDVWMFGVCMWEILMHGVKPFQGVKNND  600 (656)
T ss_dssp             ------CCGGGCCHHHHHHC--CCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHH
T ss_pred             eccCCCCCcceeCHHHhcCC--CCCchhhHHHHHHHHHHHHHcCCCCCCCCCHHH
Confidence            12335567899999998543  78999999999999999997 999998765443

>2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens}

Probab=99.96  E-value=4.6e-29  Score=246.32  Aligned_cols=169  Identities=24%  Similarity=0.376  Sum_probs=122.4

Q ss_pred             ccccCccCceEEEEEEEc-CCCEEEEEEeccCCCCc---hhhHHHHHHhhccCccceeEEEEEee---------------
Q 039231          318 KYKLGQGGYGSVYKGKLL-DGSNVAVKVLNDSKGNG---KEFINEVASISRTSHVNVVALLGFCL---------------  378 (506)
Q Consensus       318 ~~~ig~G~~g~V~~~~~~-~~~~vavK~l~~~~~~~---~~~~~E~~~l~~l~h~niv~l~g~~~---------------  378 (506)
                      .+.||+|+||.||+|+.. +++.||||++.......   +.+.++..+++.++||||+++++++.               
T Consensus        30 ~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~~  109 (318)
T 2dyl_A           30 LGEMGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNKEENKRILMDLDVVLKSHDCPYIVQCFGTFITNTDVFIAMELMGTC  109 (318)
T ss_dssp             EEEC------CEEEEEETTTCCEEEEEEEETTSCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEECCCSEE
T ss_pred             cceeeecCCeeEEEEEEecCCeEEEEEEecccccchHHHHHHHHHHHHHHhcCCCceeeEEEEEecCCcEEEEEeccCCc
Confidence            467999999999999985 58999999997654322   23444556788889999999999872               


Q ss_pred             ------------ccchhhhHHHHHHHHHHHHhhcCCC-CeEecCcCCCcEEECCCCcEEEeecCCCccccCCCcceeccc
Q 039231          379 ------------RVAEELSSTIGIARGLEYLHLGCST-RILHFDIKPHNILLDEDFCPKISDFGLAKICNRKESIISMTG  445 (506)
Q Consensus       379 ------------~~~~~l~i~~~i~~gl~~LH~~~~~-~ivH~dlkp~Nill~~~~~~ki~dfg~a~~~~~~~~~~~~~~  445 (506)
                                  ++...+.++.|++.||+|||   ++ +++|+||||+||+++.++.+||+|||++........   ...
T Consensus       110 ~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH---~~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~---~~~  183 (318)
T 2dyl_A          110 AEKLKKRMQGPIPERILGKMTVAIVKALYYLK---EKHGVIHRDVKPSNILLDERGQIKLCDFGISGRLVDDKA---KDR  183 (318)
T ss_dssp             HHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHH---HHHCCCCCCCCGGGEEECTTSCEEECCCTTC--------------
T ss_pred             HHHHHHHhccCCCHHHHHHHHHHHHHHHHHHH---hhCCEEeCCCCHHHEEECCCCCEEEEECCCchhccCCcc---ccc
Confidence                        22335678999999999999   64 999999999999999999999999999976644332   134


Q ss_pred             CCCCccccccccccc---ccCCCCccccHHHHHHHHHHHHcCCCCCCCCC
Q 039231          446 ARGTVGYIAPEVFCR---NIGEVSYKSDVYNYGMMIFEMTGGRKNVDVVD  492 (506)
Q Consensus       446 ~~gt~~y~aPE~l~~---~~~~~s~~~Dv~s~G~il~elltg~~pf~~~~  492 (506)
                      ..+++.|+|||.+..   ....++.++||||||+++|||++|+.||....
T Consensus       184 ~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~  233 (318)
T 2dyl_A          184 SAGCAAYMAPERIDPPDPTKPDYDIRADVWSLGISLVELATGQFPYKNCK  233 (318)
T ss_dssp             ---CCTTCCHHHHC--------CCTHHHHHHHHHHHHHHHHSSCTTTTCC
T ss_pred             cCCCccccChhhcccccccccCCccccchhhHHHHHHHHHhCCCCCCCCC
Confidence            568999999999853   12467889999999999999999999998643

>3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii}

Probab=99.96  E-value=4.7e-29  Score=255.78  Aligned_cols=169  Identities=18%  Similarity=0.148  Sum_probs=131.5

Q ss_pred             ccccCccCceEEEEEEEc-CCCEEEEEEeccCC----CCchhhHHHHHHhhccCc-cc---------------eeEEE--
Q 039231          318 KYKLGQGGYGSVYKGKLL-DGSNVAVKVLNDSK----GNGKEFINEVASISRTSH-VN---------------VVALL--  374 (506)
Q Consensus       318 ~~~ig~G~~g~V~~~~~~-~~~~vavK~l~~~~----~~~~~~~~E~~~l~~l~h-~n---------------iv~l~--  374 (506)
                      .+.||+|+||.||+|++. +|+.||||+++...    ...+.+.+|+.++..++| +|               ++.+.  
T Consensus        83 ~~~LG~G~fG~Vy~a~~~~~g~~vAvK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~  162 (413)
T 3dzo_A           83 GTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDLVKDPQK  162 (413)
T ss_dssp             EEEEEEETTEEEEEEEETTTCCEEEEEEECCSCC----CCHHHHHHHHGGGGSTTCCSHHHHHHHTCBCCCCEEEECCC-
T ss_pred             ecccccCCCEEEEEEEecCCCCceEEEEEecCCCccHHHHHHHHHHHHHHHhhccCCCHHHHHHhcccccchhhcccCCC
Confidence            467999999999999964 58999999997322    234778999999999987 21               11110  


Q ss_pred             ----E------------Ee--------------------------eccchhhhHHHHHHHHHHHHhhcCCCCeEecCcCC
Q 039231          375 ----G------------FC--------------------------LRVAEELSSTIGIARGLEYLHLGCSTRILHFDIKP  412 (506)
Q Consensus       375 ----g------------~~--------------------------~~~~~~l~i~~~i~~gl~~LH~~~~~~ivH~dlkp  412 (506)
                          .            ++                          +++..++.++.||++||+|||   +++|+||||||
T Consensus       163 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~~ll~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH---~~~iiHrDiKp  239 (413)
T 3dzo_A          163 KKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLH---HYGLVHTYLRP  239 (413)
T ss_dssp             --------------CCSEEEEEECCSEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHH---HTTEECSCCCG
T ss_pred             CccccccCCCccccccceEEEeehhcCCHHHHHHHhhcccccCCCCCHHHHHHHHHHHHHHHHHHH---hCCcccCCccc
Confidence                0            00                          112245678899999999999   89999999999


Q ss_pred             CcEEECCCCcEEEeecCCCccccCCCcceecccCCCCccccccccccc--------ccCCCCccccHHHHHHHHHHHHcC
Q 039231          413 HNILLDEDFCPKISDFGLAKICNRKESIISMTGARGTVGYIAPEVFCR--------NIGEVSYKSDVYNYGMMIFEMTGG  484 (506)
Q Consensus       413 ~Nill~~~~~~ki~dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~l~~--------~~~~~s~~~Dv~s~G~il~elltg  484 (506)
                      +|||++.++.+||+|||+++.....     .....| +.|+|||++..        ....++.++|||||||++|||++|
T Consensus       240 ~NILl~~~~~~kL~DFG~a~~~~~~-----~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~DvwSlGvil~elltg  313 (413)
T 3dzo_A          240 VDIVLDQRGGVFLTGFEHLVRDGAS-----AVSPIG-RGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGLAIYWIWCA  313 (413)
T ss_dssp             GGEEECTTCCEEECCGGGCEETTEE-----ECCCCC-TTTCCHHHHHHHTSTTGGGCCEEECHHHHHHHHHHHHHHHHHS
T ss_pred             ceEEEecCCeEEEEeccceeecCCc-----cccCCC-CceeCchhhhccccccccccCcCCCchhhHHHHHHHHHHHHHC
Confidence            9999999999999999999865433     244567 99999999832        123578899999999999999999


Q ss_pred             CCCCCCCCCCc
Q 039231          485 RKNVDVVDNGS  495 (506)
Q Consensus       485 ~~pf~~~~~~~  495 (506)
                      +.||...+..+
T Consensus       314 ~~Pf~~~~~~~  324 (413)
T 3dzo_A          314 DLPNTDDAALG  324 (413)
T ss_dssp             SCCCCTTGGGS
T ss_pred             CCCCCCcchhh
Confidence            99998765443

>2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens}

Probab=99.96  E-value=2.4e-29  Score=248.56  Aligned_cols=174  Identities=28%  Similarity=0.443  Sum_probs=136.1

Q ss_pred             hhccccCccCceEEEEEEEcCCCEEEEEEeccCC---CCchhhHHHHHHhhccCccceeEEEEEe---------------
Q 039231          316 SFKYKLGQGGYGSVYKGKLLDGSNVAVKVLNDSK---GNGKEFINEVASISRTSHVNVVALLGFC---------------  377 (506)
Q Consensus       316 ~~~~~ig~G~~g~V~~~~~~~~~~vavK~l~~~~---~~~~~~~~E~~~l~~l~h~niv~l~g~~---------------  377 (506)
                      .+.+.||+|+||.||+|+..+  .+|+|+++...   ...+.+.+|++++++++||||+++++++               
T Consensus        36 ~~~~~lg~G~~g~V~~~~~~~--~~avk~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~iv~e~~~~  113 (319)
T 2y4i_B           36 EIGELIGKGRFGQVYHGRWHG--EVAIRLIDIERDNEDQLKAFKREVMAYRQTRHENVVLFMGACMSPPHLAIITSLCKG  113 (319)
T ss_dssp             ECCCBCCCSSSSEEEEEEESS--SEEEEECCCCSCCCCCCCCCCTTGGGGTTCCCTTBCCCCEEEECSSCEEEECBCCCS
T ss_pred             EEeeEeccCCceEEEEEEEcC--eEEEEEeecCCCCHHHHHHHHHHHHHHhcCCCCCEeEEEEEEecCCceEEEeecccC
Confidence            345789999999999998754  59999987532   3346788999999999999999999887               


Q ss_pred             -------------eccchhhhHHHHHHHHHHHHhhcCCCCeEecCcCCCcEEECCCCcEEEeecCCCccccCCCc---ce
Q 039231          378 -------------LRVAEELSSTIGIARGLEYLHLGCSTRILHFDIKPHNILLDEDFCPKISDFGLAKICNRKES---II  441 (506)
Q Consensus       378 -------------~~~~~~l~i~~~i~~gl~~LH~~~~~~ivH~dlkp~Nill~~~~~~ki~dfg~a~~~~~~~~---~~  441 (506)
                                   +++.+.+.++.|++.||+|||   +++++||||||+||+++ ++.+||+|||+++.......   ..
T Consensus       114 ~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH---~~~i~H~dlkp~NIl~~-~~~~~l~Dfg~~~~~~~~~~~~~~~  189 (319)
T 2y4i_B          114 RTLYSVVRDAKIVLDVNKTRQIAQEIVKGMGYLH---AKGILHKDLKSKNVFYD-NGKVVITDFGLFSISGVLQAGRRED  189 (319)
T ss_dssp             EEHHHHTTSSCCCCCSHHHHHHHHHHHHHHHHHH---HTTCCCCCCCSTTEEEC---CCEECCCSCCC----------CC
T ss_pred             CcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH---hCCccccCCChhhEEEe-CCCEEEeecCCcccccccccccccc
Confidence                         233446789999999999999   89999999999999998 67999999999876532211   11


Q ss_pred             ecccCCCCcccccccccccc-------cCCCCccccHHHHHHHHHHHHcCCCCCCCCCCCc
Q 039231          442 SMTGARGTVGYIAPEVFCRN-------IGEVSYKSDVYNYGMMIFEMTGGRKNVDVVDNGS  495 (506)
Q Consensus       442 ~~~~~~gt~~y~aPE~l~~~-------~~~~s~~~Dv~s~G~il~elltg~~pf~~~~~~~  495 (506)
                      ......|++.|+|||.+...       ...++.++||||||+++|||++|+.||......+
T Consensus       190 ~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~  250 (319)
T 2y4i_B          190 KLRIQNGWLCHLAPEIIRQLSPDTEEDKLPFSKHSDVFALGTIWYELHAREWPFKTQPAEA  250 (319)
T ss_dssp             SCBCCSGGGGTSCHHHHSCBSCC--CCCSCCCHHHHHHHHHHHHHHHHHSSCSSSSCCHHH
T ss_pred             ccccCCCcccccChHHhhhccccccccccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH
Confidence            12335689999999998542       2357889999999999999999999998765443

>1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A

Probab=99.96  E-value=3.2e-29  Score=245.32  Aligned_cols=167  Identities=34%  Similarity=0.446  Sum_probs=132.2

Q ss_pred             hhccccCccCceEEEEEEEc-CCCEEEEEEeccCCCCchhhHHHHHHhhccCccceeEEEEEeec---------------
Q 039231          316 SFKYKLGQGGYGSVYKGKLL-DGSNVAVKVLNDSKGNGKEFINEVASISRTSHVNVVALLGFCLR---------------  379 (506)
Q Consensus       316 ~~~~~ig~G~~g~V~~~~~~-~~~~vavK~l~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~---------------  379 (506)
                      .+.+.||+|+||.||+|+.. +++.||||++.......+.+.+|++++++++||||+++++++.+               
T Consensus         9 ~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~~~~~~   88 (303)
T 1zy4_A            9 EEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHTEEKLSTILSEVMLLASLNHQYVVRYYAAWLERRNFVKPMTAVKKKS   88 (303)
T ss_dssp             EEEEEEEECSSEEEEEEEETTTCCEEEEEEEEEEHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEECCCCCC------CEE
T ss_pred             hhhheeccCCcEEEEEEEEcCCCeEEEEEEEeccHHHHHHHHHHHHHHHhcCchHHHHHHHHHHhhcchhhhhcccccCC
Confidence            34578999999999999975 68999999997655555778999999999999999999886421               


Q ss_pred             --------------------------cchhhhHHHHHHHHHHHHhhcCCCCeEecCcCCCcEEECCCCcEEEeecCCCcc
Q 039231          380 --------------------------VAEELSSTIGIARGLEYLHLGCSTRILHFDIKPHNILLDEDFCPKISDFGLAKI  433 (506)
Q Consensus       380 --------------------------~~~~l~i~~~i~~gl~~LH~~~~~~ivH~dlkp~Nill~~~~~~ki~dfg~a~~  433 (506)
                                                ..+.+.++.|++.||+|||   +++|+||||||+||+++.++.+||+|||+++.
T Consensus        89 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH---~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~  165 (303)
T 1zy4_A           89 TLFIQMEYCENGTLYDLIHSENLNQQRDEYWRLFRQILEALSYIH---SQGIIHRDLKPMNIFIDESRNVKIGDFGLAKN  165 (303)
T ss_dssp             EEEEEEECCCSCBHHHHHHHSCGGGCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEECTTSCEEECCCCCCSC
T ss_pred             ceEEEEecCCCCCHHHhhhccccccchHHHHHHHHHHHHHHHHHH---hCCeecccCCHHhEEEcCCCCEEEeeCcchhh
Confidence                                      1224568899999999999   89999999999999999999999999999986


Q ss_pred             ccCCCc------------ceecccCCCCcccccccccccccCCCCccccHHHHHHHHHHHHcCCCCCC
Q 039231          434 CNRKES------------IISMTGARGTVGYIAPEVFCRNIGEVSYKSDVYNYGMMIFEMTGGRKNVD  489 (506)
Q Consensus       434 ~~~~~~------------~~~~~~~~gt~~y~aPE~l~~~~~~~s~~~Dv~s~G~il~elltg~~pf~  489 (506)
                      ......            ........+++.|+|||.+.+. +.++.++||||||+++|||++   ||.
T Consensus       166 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~~Di~slG~il~~l~~---p~~  229 (303)
T 1zy4_A          166 VHRSLDILKLDSQNLPGSSDNLTSAIGTAMYVATEVLDGT-GHYNEKIDMYSLGIIFFEMIY---PFS  229 (303)
T ss_dssp             TTC-------------------------CTTSCHHHHTSC-SCCCTHHHHHHHHHHHHHHHS---CCS
T ss_pred             cccccchhccccccccccccccccCCCcccccCcccccCC-CCCcchhhHHHHHHHHHHHHh---ccC
Confidence            643211            1112345689999999998643 468899999999999999998   554

>3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A*

Probab=99.95  E-value=2.6e-28  Score=243.31  Aligned_cols=164  Identities=26%  Similarity=0.352  Sum_probs=113.0

Q ss_pred             cccCccCceEEEEEEEc-CCCEEEEEEeccCCCCchhhHHHHHHhhccCccceeEEEEEe--------------------
Q 039231          319 YKLGQGGYGSVYKGKLL-DGSNVAVKVLNDSKGNGKEFINEVASISRTSHVNVVALLGFC--------------------  377 (506)
Q Consensus       319 ~~ig~G~~g~V~~~~~~-~~~~vavK~l~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~--------------------  377 (506)
                      +.||+|+||.||+|+.. +++.||||++....   +...+....+..++||||+++++++                    
T Consensus        35 ~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~e~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~lv~e~~~gg  111 (336)
T 3fhr_A           35 QVLGLGVNGKVLECFHRRTGQKCALKLLYDSP---KARQEVDHHWQASGGPHIVCILDVYENMHHGKRCLLIIMECMEGG  111 (336)
T ss_dssp             EEEEEETTEEEEEEEETTTCCEEEEEEEESSH---HHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEEEEEECCTTE
T ss_pred             eeeeeCCCeEEEEEEECCCCCEEEEEEecCcH---HHHHHHHHHHHhcCCCChHHHHHHHhhccCCCceEEEEEeccCCC
Confidence            46999999999999986 58999999996532   2222233345667899999998876                    


Q ss_pred             -------------eccchhhhHHHHHHHHHHHHhhcCCCCeEecCcCCCcEEECC---CCcEEEeecCCCccccCCCcce
Q 039231          378 -------------LRVAEELSSTIGIARGLEYLHLGCSTRILHFDIKPHNILLDE---DFCPKISDFGLAKICNRKESII  441 (506)
Q Consensus       378 -------------~~~~~~l~i~~~i~~gl~~LH~~~~~~ivH~dlkp~Nill~~---~~~~ki~dfg~a~~~~~~~~~~  441 (506)
                                   +++.+.+.++.|++.||+|||   +++|+||||||+||+++.   ++.+||+|||+++......   
T Consensus       112 ~L~~~l~~~~~~~l~~~~~~~i~~ql~~~l~~LH---~~~ivH~dlkp~NIll~~~~~~~~~kl~Dfg~~~~~~~~~---  185 (336)
T 3fhr_A          112 ELFSRIQERGDQAFTEREAAEIMRDIGTAIQFLH---SHNIAHRDVKPENLLYTSKEKDAVLKLTDFGFAKETTQNA---  185 (336)
T ss_dssp             EHHHHHHTC-CCCCBHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEESCSSTTCCEEECCCTTCEEC-------
T ss_pred             CHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEEEecCCCceEEEeccccceeccccc---
Confidence                         223336778999999999999   899999999999999976   4559999999998665332   


Q ss_pred             ecccCCCCcccccccccccccCCCCccccHHHHHHHHHHHHcCCCCCCCCCCC
Q 039231          442 SMTGARGTVGYIAPEVFCRNIGEVSYKSDVYNYGMMIFEMTGGRKNVDVVDNG  494 (506)
Q Consensus       442 ~~~~~~gt~~y~aPE~l~~~~~~~s~~~Dv~s~G~il~elltg~~pf~~~~~~  494 (506)
                       .....+|+.|+|||++...  .++.++||||||+++|||++|+.||......
T Consensus       186 -~~~~~~t~~y~aPE~~~~~--~~~~~~Di~slG~il~~l~~g~~pf~~~~~~  235 (336)
T 3fhr_A          186 -LQTPCYTPYYVAPEVLGPE--KYDKSCDMWSLGVIMYILLCGFPPFYSNTGQ  235 (336)
T ss_dssp             -------------------C--HHHHHHHHHHHHHHHHHHHHSSCCC------
T ss_pred             -cccCCCCcCccChhhhCCC--CCCchhhHHHHHHHHHHHHHCCCCCCCccch
Confidence             2345679999999998543  6788999999999999999999999766543

>3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A*

Probab=99.95  E-value=4.8e-28  Score=258.27  Aligned_cols=170  Identities=30%  Similarity=0.427  Sum_probs=141.4

Q ss_pred             HhhhccccCccCceEEEEEEEc-CCCEEEEEEeccCCC--CchhhHHHHHHhhccCccceeEEEEEe-------------
Q 039231          314 TNSFKYKLGQGGYGSVYKGKLL-DGSNVAVKVLNDSKG--NGKEFINEVASISRTSHVNVVALLGFC-------------  377 (506)
Q Consensus       314 ~~~~~~~ig~G~~g~V~~~~~~-~~~~vavK~l~~~~~--~~~~~~~E~~~l~~l~h~niv~l~g~~-------------  377 (506)
                      .+.+.++||+|+||.||+|+.. +|+.||||+++....  ..+.+.+|++++.+++||||+++++++             
T Consensus        15 rY~i~~~LG~G~fG~Vyla~~~~tg~~VAVKvi~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~v~~~~~~~~~~~~~~   94 (676)
T 3qa8_A           15 PWEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKLNHPNVVSAREVPDGLQKLAPNDLPL   94 (676)
T ss_dssp             --CCCCCCCBCSSSBCCCCCCTTTTCCEEECCCCSCCCHHHHHHHHHHHHHHHHCCBTTBCCEEECCTTTCCCCTTSSCC
T ss_pred             CeEEEEEEeeCCCeEEEEEEECCCCcEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCCCCceeeeecccccccCCCeEE
Confidence            3455678999999999999874 589999999875422  235688999999999999999998874             


Q ss_pred             -----------------------eccchhhhHHHHHHHHHHHHhhcCCCCeEecCcCCCcEEECCCCc---EEEeecCCC
Q 039231          378 -----------------------LRVAEELSSTIGIARGLEYLHLGCSTRILHFDIKPHNILLDEDFC---PKISDFGLA  431 (506)
Q Consensus       378 -----------------------~~~~~~l~i~~~i~~gl~~LH~~~~~~ivH~dlkp~Nill~~~~~---~ki~dfg~a  431 (506)
                                             +++.+.+.++.|++.||+|||   +.+|+||||||+||+++.++.   +||+|||++
T Consensus        95 LVmEy~~ggsL~~~L~~~~~~~~lse~~i~~I~~QLl~aL~yLH---s~gIVHrDLKP~NILl~~~g~~~~vKL~DFG~a  171 (676)
T 3qa8_A           95 LAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISSALRYLH---ENRIIHRDLKPENIVLQPGPQRLIHKIIDLGYA  171 (676)
T ss_dssp             CEEECCSSCBHHHHHHSSSCTTCCCSSHHHHHHHHHHHHHHHHH---HTTBCCCCCCSTTEEEECCSSSCEEEECSCCCC
T ss_pred             EEEEeCCCCCHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHH---HCCCccCCCCHHHeEeecCCCceeEEEcccccc
Confidence                                   123346779999999999999   899999999999999986664   999999999


Q ss_pred             ccccCCCcceecccCCCCcccccccccccccCCCCccccHHHHHHHHHHHHcCCCCCCCC
Q 039231          432 KICNRKESIISMTGARGTVGYIAPEVFCRNIGEVSYKSDVYNYGMMIFEMTGGRKNVDVV  491 (506)
Q Consensus       432 ~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~s~~~Dv~s~G~il~elltg~~pf~~~  491 (506)
                      ........   .....||+.|+|||.+.+  ..++.++||||||+++|||++|+.||...
T Consensus       172 ~~~~~~~~---~~~~~gt~~Y~APE~l~~--~~~s~ksDIwSLGviLyeLltG~~Pf~~~  226 (676)
T 3qa8_A          172 KELDQGEL---CTEFVGTLQYLAPELLEQ--KKYTVTVDYWSFGTLAFECITGFRPFLPN  226 (676)
T ss_dssp             CBTTSCCC---CCCCCSCCTTCSSCSSCC--SCCSTTHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred             cccccccc---cccccCCcccCChHHhcc--CCCCchhHHHHHHHHHHHHHHCCCCCCcc
Confidence            87655432   244678999999999865  37899999999999999999999999653

>2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis}

Probab=99.95  E-value=4.5e-28  Score=263.99  Aligned_cols=163  Identities=27%  Similarity=0.356  Sum_probs=137.9

Q ss_pred             hhccccCccCceEEEEEEEc--CCCEEEEEEeccCCC--CchhhHHHHHHhhccCccceeEEEEEee-------------
Q 039231          316 SFKYKLGQGGYGSVYKGKLL--DGSNVAVKVLNDSKG--NGKEFINEVASISRTSHVNVVALLGFCL-------------  378 (506)
Q Consensus       316 ~~~~~ig~G~~g~V~~~~~~--~~~~vavK~l~~~~~--~~~~~~~E~~~l~~l~h~niv~l~g~~~-------------  378 (506)
                      .+.+.||+|+||.||+|++.  +++.||||++.....  ..+.+.+|++++.+++||||+++++++.             
T Consensus        83 ~i~~~lg~G~~g~Vy~a~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~~~~~~lv  162 (681)
T 2pzi_A           83 EVKGCIAHGGLGWIYLALDRNVNGRPVVLKGLVHSGDAEAQAMAMAERQFLAEVVHPSIVQIFNFVEHTDRHGDPVGYIV  162 (681)
T ss_dssp             EEEEEEEEETTEEEEEEEEGGGTTEEEEEEESCSSCCHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEEECTTSCEEEEEE
T ss_pred             EEEEEEeeCCCeEEEEEEEcCCCCcEEEEEEeCccCCHHHHHHHHHHHHHHHhcCCCCcCeEeeeEeecCCCCCceeEEE
Confidence            44567999999999999985  589999999865432  2256889999999999999999998752             


Q ss_pred             -----------------ccchhhhHHHHHHHHHHHHhhcCCCCeEecCcCCCcEEECCCCcEEEeecCCCccccCCCcce
Q 039231          379 -----------------RVAEELSSTIGIARGLEYLHLGCSTRILHFDIKPHNILLDEDFCPKISDFGLAKICNRKESII  441 (506)
Q Consensus       379 -----------------~~~~~l~i~~~i~~gl~~LH~~~~~~ivH~dlkp~Nill~~~~~~ki~dfg~a~~~~~~~~~~  441 (506)
                                       ++.+++.++.||+.||+|||   +++|+||||||+|||++++ .+||+|||+++.....    
T Consensus       163 ~E~~~g~~L~~~~~~~l~~~~~~~~~~qi~~aL~~lH---~~giiHrDlkp~NIll~~~-~~kl~DFG~a~~~~~~----  234 (681)
T 2pzi_A          163 MEYVGGQSLKRSKGQKLPVAEAIAYLLEILPALSYLH---SIGLVYNDLKPENIMLTEE-QLKLIDLGAVSRINSF----  234 (681)
T ss_dssp             EECCCCEECC----CCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECSS-CEEECCCTTCEETTCC----
T ss_pred             EEeCCCCcHHHHHhCCCCHHHHHHHHHHHHHHHHHHH---HCCCeecccChHHeEEeCC-cEEEEecccchhcccC----
Confidence                             23346779999999999999   8999999999999999986 8999999999876543    


Q ss_pred             ecccCCCCcccccccccccccCCCCccccHHHHHHHHHHHHcCCCCCCCC
Q 039231          442 SMTGARGTVGYIAPEVFCRNIGEVSYKSDVYNYGMMIFEMTGGRKNVDVV  491 (506)
Q Consensus       442 ~~~~~~gt~~y~aPE~l~~~~~~~s~~~Dv~s~G~il~elltg~~pf~~~  491 (506)
                        ....||+.|+|||++.+   .++.++||||||+++|||++|..||...
T Consensus       235 --~~~~gt~~y~aPE~~~~---~~~~~sDi~slG~~l~~l~~g~~~~~~~  279 (681)
T 2pzi_A          235 --GYLYGTPGFQAPEIVRT---GPTVATDIYTVGRTLAALTLDLPTRNGR  279 (681)
T ss_dssp             --SCCCCCTTTSCTTHHHH---CSCHHHHHHHHHHHHHHHHSCCCEETTE
T ss_pred             --CccCCCccccCHHHHcC---CCCCceehhhhHHHHHHHHhCCCCCccc
Confidence              34568999999999854   3488999999999999999999998754

>2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A

Probab=99.94  E-value=8.9e-28  Score=239.41  Aligned_cols=166  Identities=19%  Similarity=0.160  Sum_probs=133.3

Q ss_pred             HHHhhhccccCccCceEEEEEEEcCCCEEEEEEeccCCC---------CchhhHHHHHHhhccC---------ccceeEE
Q 039231          312 KMTNSFKYKLGQGGYGSVYKGKLLDGSNVAVKVLNDSKG---------NGKEFINEVASISRTS---------HVNVVAL  373 (506)
Q Consensus       312 ~~~~~~~~~ig~G~~g~V~~~~~~~~~~vavK~l~~~~~---------~~~~~~~E~~~l~~l~---------h~niv~l  373 (506)
                      ...+.+.++||+|+||.||+|+. +|+.||||+++....         ..+.+.+|++++++++         |||||++
T Consensus        19 ~~~y~~~~~lG~G~~g~V~~~~~-~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~~~~~~~h~niv~l   97 (336)
T 2vuw_A           19 TEKLQRCEKIGEGVFGEVFQTIA-DHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIIISKELSLLSGEVCNRTEGFIGL   97 (336)
T ss_dssp             HHHHHTCEEEEEETTEEEEEEEE-TTEEEEEEEEEESCSSCBTTBCCBCHHHHHHHHHHHHHHHHGGGCSSSBCCCBCCE
T ss_pred             cccchheeeecccCceEEEEEEe-CCceEEEEEEecCCccccccccchhHHHHHHHHHHHHHHHHhhccccccCCchhhh
Confidence            34456678899999999999998 789999999975422         1267889999998886         7777776


Q ss_pred             EEEe--------------------------------------------------------eccchhhhHHHHHHHHHHHH
Q 039231          374 LGFC--------------------------------------------------------LRVAEELSSTIGIARGLEYL  397 (506)
Q Consensus       374 ~g~~--------------------------------------------------------~~~~~~l~i~~~i~~gl~~L  397 (506)
                      .+.+                                                        +++.+.+.++.||+.||+||
T Consensus        98 ~~~~~~~~~~hp~iv~~~~~~~~~~~~~~~~~~~~~~~~~~lv~E~~~~g~ll~~~~~~~~~~~~~~~i~~qi~~aL~~l  177 (336)
T 2vuw_A           98 NSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQLFIVLEFEFGGIDLEQMRTKLSSLATAKSILHQLTASLAVA  177 (336)
T ss_dssp             EEEEEEESSCCHHHHHHHHHHHHHTCCSSCCSCCCCTTCEEEEEEEECCCEETGGGTTTCCCHHHHHHHHHHHHHHHHHH
T ss_pred             cceeEecCCCcHHHHHHHHHHhhhccccccCccccccCeEEEEEEecCCCccHHHHHhcCCCHHHHHHHHHHHHHHHHHH
Confidence            5542                                                        12333677899999999999


Q ss_pred             hhcCCCCeEecCcCCCcEEECCCC--------------------cEEEeecCCCccccCCCcceecccCCCCcccccccc
Q 039231          398 HLGCSTRILHFDIKPHNILLDEDF--------------------CPKISDFGLAKICNRKESIISMTGARGTVGYIAPEV  457 (506)
Q Consensus       398 H~~~~~~ivH~dlkp~Nill~~~~--------------------~~ki~dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~  457 (506)
                      |+  +++|+||||||+|||++.++                    .+||+|||+|+.....       ...||+.|+|||+
T Consensus       178 H~--~~~ivHrDlKp~NILl~~~~~~~~~~~~~~~~~~~~~~~~~vkL~DFG~a~~~~~~-------~~~gt~~y~aPE~  248 (336)
T 2vuw_A          178 EA--SLRFEHRDLHWGNVLLKKTSLKKLHYTLNGKSSTIPSCGLQVSIIDYTLSRLERDG-------IVVFCDVSMDEDL  248 (336)
T ss_dssp             HH--HHCCBCSCCCGGGEEEEECSCSEEEEEETTEEEEEECTTEEEEECCCTTCBEEETT-------EEECCCCTTCSGG
T ss_pred             HH--hCCEeECCCCHHHEEEeccCCcceeeeccCccccccCCCceEEEeeccccEecCCC-------cEEEeecccChhh
Confidence            93  37899999999999999887                    8999999999876532       2468999999999


Q ss_pred             cccccCCCCccccHHHHHHH-HHHHHcCCCCCCC
Q 039231          458 FCRNIGEVSYKSDVYNYGMM-IFEMTGGRKNVDV  490 (506)
Q Consensus       458 l~~~~~~~s~~~Dv~s~G~i-l~elltg~~pf~~  490 (506)
                      +.+.   .+.++||||++++ .+++++|..||..
T Consensus       249 ~~g~---~~~~~Diwsl~~~~~~~~~~g~~p~~~  279 (336)
T 2vuw_A          249 FTGD---GDYQFDIYRLMKKENNNRWGEYHPYSN  279 (336)
T ss_dssp             GCCC---SSHHHHHHHHHHHHHTTCTTSCCTHHH
T ss_pred             hcCC---CccceehhhhhCCCCcccccccCCCcc
Confidence            9654   3889999998766 7788999999954

>3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A

Probab=99.94  E-value=5.6e-27  Score=228.27  Aligned_cols=146  Identities=10%  Similarity=0.052  Sum_probs=123.4

Q ss_pred             hhhccccCccCceEEEEEEEcC-CCEEEEEEeccCCCCc----hhhHHHHHHhhccCccceeEEEEEeec----------
Q 039231          315 NSFKYKLGQGGYGSVYKGKLLD-GSNVAVKVLNDSKGNG----KEFINEVASISRTSHVNVVALLGFCLR----------  379 (506)
Q Consensus       315 ~~~~~~ig~G~~g~V~~~~~~~-~~~vavK~l~~~~~~~----~~~~~E~~~l~~l~h~niv~l~g~~~~----------  379 (506)
                      +.+.+.||+|+||.||+|+... ++.||||++.......    +.+.+|++.+.+++||||+++++++..          
T Consensus        33 y~i~~~lg~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~  112 (286)
T 3uqc_A           33 YRLLIFHGGVPPLQFWQALDTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPGVARVLDVVHTRAGGLVVAEW  112 (286)
T ss_dssp             EEEEEEEEBSTTCEEEEEEETTTTEEEEEEESCTTCCSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred             EEEEEEEcccCCeEEEEEEecCCCceEEEEEECcccccCHHHHHHHHHHHHHHhcCCCCCcceeeEEEEECCcEEEEEEe
Confidence            4456789999999999999864 8999999997654433    678999999999999999999988721          


Q ss_pred             ---------------cchhhhHHHHHHHHHHHHhhcCCCCeEecCcCCCcEEECCCCcEEEeecCCCccccCCCcceecc
Q 039231          380 ---------------VAEELSSTIGIARGLEYLHLGCSTRILHFDIKPHNILLDEDFCPKISDFGLAKICNRKESIISMT  444 (506)
Q Consensus       380 ---------------~~~~l~i~~~i~~gl~~LH~~~~~~ivH~dlkp~Nill~~~~~~ki~dfg~a~~~~~~~~~~~~~  444 (506)
                                     ..+.+.++.|++.||+|||   +++|+||||||+|||++.++.+||++++               
T Consensus       113 ~~g~~L~~~l~~~~~~~~~~~i~~ql~~aL~~lH---~~givH~Dikp~NIll~~~g~~kl~~~~---------------  174 (286)
T 3uqc_A          113 IRGGSLQEVADTSPSPVGAIRAMQSLAAAADAAH---RAGVALSIDHPSRVRVSIDGDVVLAYPA---------------  174 (286)
T ss_dssp             CCEEEHHHHHTTCCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCSGGGEEEETTSCEEECSCC---------------
T ss_pred             cCCCCHHHHHhcCCChHHHHHHHHHHHHHHHHHH---HCCCccCCCCcccEEEcCCCCEEEEecc---------------
Confidence                           1235678999999999999   8999999999999999999999998443               


Q ss_pred             cCCCCcccccccccccccCCCCccccHHHHHHHHHHHHcCCCCCCCCCCC
Q 039231          445 GARGTVGYIAPEVFCRNIGEVSYKSDVYNYGMMIFEMTGGRKNVDVVDNG  494 (506)
Q Consensus       445 ~~~gt~~y~aPE~l~~~~~~~s~~~Dv~s~G~il~elltg~~pf~~~~~~  494 (506)
                             |++         .++.++||||||+++|||++|+.||...+..
T Consensus       175 -------~~~---------~~~~~~Di~slG~il~elltg~~Pf~~~~~~  208 (286)
T 3uqc_A          175 -------TMP---------DANPQDDIRGIGASLYALLVNRWPLPEAGVR  208 (286)
T ss_dssp             -------CCT---------TCCHHHHHHHHHHHHHHHHHSEECSCCCSBC
T ss_pred             -------ccC---------CCCchhHHHHHHHHHHHHHHCCCCCCcCCcc
Confidence                   333         3578999999999999999999999876543

>3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A*

Probab=99.93  E-value=1.6e-25  Score=219.34  Aligned_cols=142  Identities=24%  Similarity=0.319  Sum_probs=118.1

Q ss_pred             cccCccCceEEEEEEEc-CCCEEEEEEeccCCCCchhhHHHHHHh-hccCccceeEEEEEee------------------
Q 039231          319 YKLGQGGYGSVYKGKLL-DGSNVAVKVLNDSKGNGKEFINEVASI-SRTSHVNVVALLGFCL------------------  378 (506)
Q Consensus       319 ~~ig~G~~g~V~~~~~~-~~~~vavK~l~~~~~~~~~~~~E~~~l-~~l~h~niv~l~g~~~------------------  378 (506)
                      +.||+|+||.||+|+.. +++.||+|+++.    ...+.+|++++ +..+||||+++++++.                  
T Consensus        24 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~----~~~~~~e~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~lv~e~~~~   99 (299)
T 3m2w_A           24 QVLGLGINGKVLQIFNKRTQEKFALKMLQD----CPKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLLIVMECLDG   99 (299)
T ss_dssp             EEEEEETTEEEEEEEETTTCCEEEEEEEEC----SHHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEEEEECCCCS
T ss_pred             cccccCCCeEEEEEEEcCCCcEEEEEEecc----cHHHHHHHHHHHHhccCCCchhHHhhhhhhcCCCceEEEEEeecCC
Confidence            56999999999999974 589999999964    35678899888 5568999999988762                  


Q ss_pred             ---------------ccchhhhHHHHHHHHHHHHhhcCCCCeEecCcCCCcEEECC---CCcEEEeecCCCccccCCCcc
Q 039231          379 ---------------RVAEELSSTIGIARGLEYLHLGCSTRILHFDIKPHNILLDE---DFCPKISDFGLAKICNRKESI  440 (506)
Q Consensus       379 ---------------~~~~~l~i~~~i~~gl~~LH~~~~~~ivH~dlkp~Nill~~---~~~~ki~dfg~a~~~~~~~~~  440 (506)
                                     ++.+.+.++.|++.||+|||   +++|+||||||+||+++.   ++.+||+|||++.....    
T Consensus       100 ~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH---~~~i~H~dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~~~----  172 (299)
T 3m2w_A          100 GELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLH---SINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTG----  172 (299)
T ss_dssp             CBHHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEESSSSTTCCEEECCCTTCEECTT----
T ss_pred             CcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCCHHHEEEecCCCCCcEEEecccccccccc----
Confidence                           22235678999999999999   899999999999999998   78999999998864221    


Q ss_pred             eecccCCCCcccccccccccccCCCCccccHHHHHHHHHHHHcCCCCCCCCCC
Q 039231          441 ISMTGARGTVGYIAPEVFCRNIGEVSYKSDVYNYGMMIFEMTGGRKNVDVVDN  493 (506)
Q Consensus       441 ~~~~~~~gt~~y~aPE~l~~~~~~~s~~~Dv~s~G~il~elltg~~pf~~~~~  493 (506)
                                            ..++.++||||||+++|||++|+.||.....
T Consensus       173 ----------------------~~~~~~~DiwslG~il~el~tg~~pf~~~~~  203 (299)
T 3m2w_A          173 ----------------------EKYDKSCDMWSLGVIMYILLCGYPPFYSNHG  203 (299)
T ss_dssp             ----------------------CGGGGHHHHHHHHHHHHHHHHSSCSCCC---
T ss_pred             ----------------------ccCCchhhHHHHHHHHHHHHHCCCCCCCCcc
Confidence                                  2467799999999999999999999976543

>4azs_A Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15A {Escherichia coli} PDB: 4azt_A* 4azv_A* 4azw_A*

Probab=99.88  E-value=2.3e-24  Score=228.98  Aligned_cols=161  Identities=17%  Similarity=0.163  Sum_probs=105.1

Q ss_pred             cccCccCceEEEEEE-EcCCCEEEEEEeccCCC-----------CchhhHHHHHHhhcc-CccceeEEEEEeeccch---
Q 039231          319 YKLGQGGYGSVYKGK-LLDGSNVAVKVLNDSKG-----------NGKEFINEVASISRT-SHVNVVALLGFCLRVAE---  382 (506)
Q Consensus       319 ~~ig~G~~g~V~~~~-~~~~~~vavK~l~~~~~-----------~~~~~~~E~~~l~~l-~h~niv~l~g~~~~~~~---  382 (506)
                      ...+.|+.|.+..++ .--|+.+++|++.....           +.+++.+|+++|+++ .|+||+++++++-+..+   
T Consensus       240 ~~~~~~~~~~h~~~rr~~fg~~~~~K~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~ed~~~~yL  319 (569)
T 4azs_A          240 NQPYAGAGLAHKRSRRYFFGEDYVCKFFYYDMPHGILTAEESQRNKYELHNEIKFLTQPPAGFDAPAVLAHGENAQSGWL  319 (569)
T ss_dssp             CC-C--------CCEEEEECSSEEEEEEESSCSTTCSCHHHHHHHHHHHHHHHHHHHSCCTTCCCCCEEEEEECSSEEEE
T ss_pred             hccccCCcccccccccccccceeEEEEEecccccccchhhhhHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEECCEEEE
Confidence            346677777666654 33488999999965421           125689999999999 69999999998832221   


Q ss_pred             ---------------------hhhHHHHHHHHHHHHhhcCCCCeEecCcCCCcEEECCCCcEEEeecCCCccccCCCcce
Q 039231          383 ---------------------ELSSTIGIARGLEYLHLGCSTRILHFDIKPHNILLDEDFCPKISDFGLAKICNRKESII  441 (506)
Q Consensus       383 ---------------------~l~i~~~i~~gl~~LH~~~~~~ivH~dlkp~Nill~~~~~~ki~dfg~a~~~~~~~~~~  441 (506)
                                           ...|+.||+.||+|||   ++|||||||||+||||++++.+||+|||+|+........ 
T Consensus       320 VMEyv~G~~L~d~i~~~~~l~~~~I~~QIl~AL~ylH---~~GIIHRDIKPeNILL~~dg~vKL~DFGlAr~~~~~~~~-  395 (569)
T 4azs_A          320 VMEKLPGRLLSDMLAAGEEIDREKILGSLLRSLAALE---KQGFWHDDVRPWNVMVDARQHARLIDFGSIVTTPQDCSW-  395 (569)
T ss_dssp             EEECCCSEEHHHHHHTTCCCCHHHHHHHHHHHHHHHH---HTTCEESCCCGGGEEECTTSCEEECCCTTEESCC---CC-
T ss_pred             EEecCCCCcHHHHHHhCCCCCHHHHHHHHHHHHHHHH---HCCceeccCchHhEEECCCCCEEEeecccCeeCCCCCcc-
Confidence                                 3458999999999999   999999999999999999999999999999876554332 


Q ss_pred             ecccCCCCcccccccccccccCCCCccccHHHHHHHHHHHHcCCCC
Q 039231          442 SMTGARGTVGYIAPEVFCRNIGEVSYKSDVYNYGMMIFEMTGGRKN  487 (506)
Q Consensus       442 ~~~~~~gt~~y~aPE~l~~~~~~~s~~~Dv~s~G~il~elltg~~p  487 (506)
                       .....||+.|||||++.+   .+..++|+||+|++++++.++..|
T Consensus       396 -~~t~vGTp~YmAPE~l~g---~~~~~~d~~s~g~~~~~l~~~~~~  437 (569)
T 4azs_A          396 -PTNLVQSFFVFVNELFAE---NKSWNGFWRSAPVHPFNLPQPWSN  437 (569)
T ss_dssp             -SHHHHHHHHHHHHHHC--------------------CCCCTTHHH
T ss_pred             -ccCceechhhccHHHhCC---CCCCcccccccccchhhhccccch
Confidence             244679999999999854   567789999999998877655443

>3en9_A Glycoprotease, O-sialoglycoprotein endopeptidase/protein kinase; endopeptidase activity, protein kinase activity; HET: TBR; 2.67A {Methanocaldococcus jannaschii} PDB: 3enh_A* 2vwb_A*

Probab=99.85  E-value=3.3e-22  Score=211.15  Aligned_cols=166  Identities=16%  Similarity=0.168  Sum_probs=124.6

Q ss_pred             ccccCccCceEEEEEEEcCCCEEEEEEeccCCCC---------chhhHHHHHHhhccCcccee--EEEEEe-------ec
Q 039231          318 KYKLGQGGYGSVYKGKLLDGSNVAVKVLNDSKGN---------GKEFINEVASISRTSHVNVV--ALLGFC-------LR  379 (506)
Q Consensus       318 ~~~ig~G~~g~V~~~~~~~~~~vavK~l~~~~~~---------~~~~~~E~~~l~~l~h~niv--~l~g~~-------~~  379 (506)
                      .+.||+|+||.||+|+. .++.+++|+.......         .+++.+|++++++++||||+  ++++..       ++
T Consensus       341 ~~~LG~G~fg~Vy~~~~-~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~~lVmE  419 (540)
T 3en9_A          341 EHLIGKGAEADIKRDSY-LDFDVIIKERVKKGYRDERLDENIRKSRTAREARYLALVKDFGIPAPYIFDVDLDNKRIMMS  419 (540)
T ss_dssp             -------CCEEEEEEEC-SSCEEEEEEECCCTTSCHHHHHHHHHHHHHHHHHHHHHGGGGTCCCCCEEEEETTTTEEEEE
T ss_pred             CCEEeeCCCEEEEEEEE-CCCeEEEEEEecccccchhhhhHHHHHHHHHHHHHHHhcCCCCcCceEEEEEeCCccEEEEE
Confidence            45799999999999954 6788999987543221         23478999999999999999  554432       11


Q ss_pred             c----------chhhhHHHHHHHHHHHHhhcCCCCeEecCcCCCcEEECCCCcEEEeecCCCccccCCCcce-----ecc
Q 039231          380 V----------AEELSSTIGIARGLEYLHLGCSTRILHFDIKPHNILLDEDFCPKISDFGLAKICNRKESII-----SMT  444 (506)
Q Consensus       380 ~----------~~~l~i~~~i~~gl~~LH~~~~~~ivH~dlkp~Nill~~~~~~ki~dfg~a~~~~~~~~~~-----~~~  444 (506)
                      .          .+.+.++.|+++||+|||   +++|+||||||+|||+++  .+||+|||+++.........     ...
T Consensus       420 ~~~ggsL~~~l~~~~~i~~qi~~aL~~LH---~~gIiHrDiKp~NILl~~--~~kL~DFGla~~~~~~~~~~~~~~~~~~  494 (540)
T 3en9_A          420 YINGKLAKDVIEDNLDIAYKIGEIVGKLH---KNDVIHNDLTTSNFIFDK--DLYIIDFGLGKISNLDEDKAVDLIVFKK  494 (540)
T ss_dssp             CCCSEEHHHHSTTCTHHHHHHHHHHHHHH---HTTEECTTCCTTSEEESS--SEEECCCTTCEECCCHHHHHHHHHHHHH
T ss_pred             CCCCCCHHHHHHHHHHHHHHHHHHHHHHH---HCcCccCCCCHHHEEECC--eEEEEECccCEECCCccccccchhhhhh
Confidence            0          114578999999999999   899999999999999998  99999999999875533211     113


Q ss_pred             cCCCCcccccccccccccCCCCccccHHHHHHHHHHHHcCCCCCC
Q 039231          445 GARGTVGYIAPEVFCRNIGEVSYKSDVYNYGMMIFEMTGGRKNVD  489 (506)
Q Consensus       445 ~~~gt~~y~aPE~l~~~~~~~s~~~Dv~s~G~il~elltg~~pf~  489 (506)
                      ...||+.|||||++......|+..+|+|+..+-..+.+.++.+|.
T Consensus       495 ~~~GT~~y~APEv~~~~~~~Y~~~~d~ws~vl~~l~~v~~r~rY~  539 (540)
T 3en9_A          495 AVLSTHHEKFDEIWERFLEGYKSVYDRWEIILELMKDVERRARYV  539 (540)
T ss_dssp             HHHHHCGGGHHHHHHHHHHHHHHHCTTHHHHHHHHHHHHTCSCCC
T ss_pred             hhcCCCCcCCHHHHHHHHHHHHHHHhHHHHHHHHHHHHHhccccC
Confidence            457899999999996533367888999999999999988888774

>1zar_A RIO2 kinase; serine kinase, winged-helix, RIO domain, ADP-Mn complex, rRNA processing, transferase; HET: ADP; 1.75A {Archaeoglobus fulgidus} SCOP: a.4.5.56 d.144.1.9 PDB: 1tqi_A* 1tqp_A* 1tqm_A* 1zao_A*

Probab=99.78  E-value=3.4e-19  Score=172.64  Aligned_cols=124  Identities=17%  Similarity=0.096  Sum_probs=98.1

Q ss_pred             ccccCccCceEEEEEEEcCCCEEEEEEeccCCC-------------------CchhhHHHHHHhhccCccceeEEEEEe-
Q 039231          318 KYKLGQGGYGSVYKGKLLDGSNVAVKVLNDSKG-------------------NGKEFINEVASISRTSHVNVVALLGFC-  377 (506)
Q Consensus       318 ~~~ig~G~~g~V~~~~~~~~~~vavK~l~~~~~-------------------~~~~~~~E~~~l~~l~h~niv~l~g~~-  377 (506)
                      .+.||+|+||.||+|+..+|+.||||+++....                   ....+.+|++++++++|+++...++.- 
T Consensus        95 ~~~iG~G~~g~Vy~~~~~~g~~valK~~~~~~~~~~~~~~~~~~~~~~w~~~~~~~~~~E~~~l~~l~~~~v~~~~~~~~  174 (282)
T 1zar_A           95 GKLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQGLAVPKVYAWEG  174 (282)
T ss_dssp             EEEEEECSSEEEEEEEETTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTTTSSSCCEEEEET
T ss_pred             cCEeccCCCceEEEEEeCCCCEEEEEEEECCCCchhhhhhhhhhcchhhHHHHHHHHHHHHHHHHhccCCCcCeEEeccc
Confidence            367999999999999997799999999964321                   124578999999999865555544321 


Q ss_pred             ---------------eccchhhhHHHHHHHHHHHHhhcCCCCeEecCcCCCcEEECCCCcEEEeecCCCccccCCCccee
Q 039231          378 ---------------LRVAEELSSTIGIARGLEYLHLGCSTRILHFDIKPHNILLDEDFCPKISDFGLAKICNRKESIIS  442 (506)
Q Consensus       378 ---------------~~~~~~l~i~~~i~~gl~~LH~~~~~~ivH~dlkp~Nill~~~~~~ki~dfg~a~~~~~~~~~~~  442 (506)
                                     +...+...++.|++.||+|||   +.+|+||||||+|||++ ++.+||+|||+++.         
T Consensus       175 ~~lvmE~~~g~~L~~l~~~~~~~i~~qi~~~l~~lH---~~giiHrDlkp~NILl~-~~~vkl~DFG~a~~---------  241 (282)
T 1zar_A          175 NAVLMELIDAKELYRVRVENPDEVLDMILEEVAKFY---HRGIVHGDLSQYNVLVS-EEGIWIIDFPQSVE---------  241 (282)
T ss_dssp             TEEEEECCCCEEGGGCCCSCHHHHHHHHHHHHHHHH---HTTEECSCCSTTSEEEE-TTEEEECCCTTCEE---------
T ss_pred             eEEEEEecCCCcHHHcchhhHHHHHHHHHHHHHHHH---HCCCEeCCCCHHHEEEE-CCcEEEEECCCCeE---------
Confidence                           112345679999999999999   89999999999999999 99999999999863         


Q ss_pred             cccCCCCccccccccccc
Q 039231          443 MTGARGTVGYIAPEVFCR  460 (506)
Q Consensus       443 ~~~~~gt~~y~aPE~l~~  460 (506)
                            +..++|||++.+
T Consensus       242 ------~~~~~a~e~l~r  253 (282)
T 1zar_A          242 ------VGEEGWREILER  253 (282)
T ss_dssp             ------TTSTTHHHHHHH
T ss_pred             ------CCCCCHHHHHHH
Confidence                  335789998843

>1zth_A RIO1 serine protein kinase; ribosome biogenesis, rRNA, ADP, manganese, transferase; HET: ADP; 1.89A {Archaeoglobus fulgidus} PDB: 1zp9_A* 1ztf_A*

Probab=99.62  E-value=1.3e-15  Score=145.43  Aligned_cols=114  Identities=17%  Similarity=0.141  Sum_probs=86.8

Q ss_pred             hccccCccCceEEEEEEE-cCCCE--EEEEEeccCCCCc-------------------------hhhHHHHHHhhccCcc
Q 039231          317 FKYKLGQGGYGSVYKGKL-LDGSN--VAVKVLNDSKGNG-------------------------KEFINEVASISRTSHV  368 (506)
Q Consensus       317 ~~~~ig~G~~g~V~~~~~-~~~~~--vavK~l~~~~~~~-------------------------~~~~~E~~~l~~l~h~  368 (506)
                      +.+.||+|+||.||+|+. .+|+.  ||||+++......                         ..+.+|++.+.+++|+
T Consensus        51 i~~~ig~G~~g~Vy~a~~~~~g~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~  130 (258)
T 1zth_A           51 MGGVISTGKEANVFYADGVFDGKPVAMAVKIYRIETSEFDKMDEYLYGDERFDMRRISPKEKVFIWTEKEFRNLERAKEA  130 (258)
T ss_dssp             EEEEEEECSSEEEEEEEEEETTEEEEEEEEEECCC-------GGGTTTCTTSCC----CHHHHHHHHHHHHHHHHHHHHT
T ss_pred             hCCEEeecceEEEEEEEEcCCCcEeeEEEEEEECCccchhhHHHhhcccchhhhhccChHHHHHHHHHHHHHHHHHHHhC
Confidence            346799999999999998 67888  9999975432110                         2578899999998776


Q ss_pred             ce--eEEE---------EEee--------------c--cchhhhHHHHHHHHHHHHhhcCCCCeEecCcCCCcEEECCCC
Q 039231          369 NV--VALL---------GFCL--------------R--VAEELSSTIGIARGLEYLHLGCSTRILHFDIKPHNILLDEDF  421 (506)
Q Consensus       369 ni--v~l~---------g~~~--------------~--~~~~l~i~~~i~~gl~~LH~~~~~~ivH~dlkp~Nill~~~~  421 (506)
                      ++  ..++         .++-              .  +.+...++.|++.||.|||.  +.+|+||||||.|||+++  
T Consensus       131 ~i~~p~~~~~~~~~lVmE~~g~~g~~~~~L~~~~~~~~~~~~~~i~~qi~~~l~~lH~--~~givHrDlkp~NILl~~--  206 (258)
T 1zth_A          131 GVSVPQPYTYMKNVLLMEFIGEDELPAPTLVELGRELKELDVEGIFNDVVENVKRLYQ--EAELVHADLSEYNIMYID--  206 (258)
T ss_dssp             TCCCCCEEEEETTEEEEECCEETTEECCBHHHHGGGGGGSCHHHHHHHHHHHHHHHHH--TSCEECSSCSTTSEEESS--
T ss_pred             CCCCCeEEEcCCCEEEEEecCCCCCccccHHHHhhccChHHHHHHHHHHHHHHHHHHH--HCCEEeCCCCHHHEEEcC--
Confidence            42  2222         2220              0  12456789999999999995  579999999999999998  


Q ss_pred             cEEEeecCCCccc
Q 039231          422 CPKISDFGLAKIC  434 (506)
Q Consensus       422 ~~ki~dfg~a~~~  434 (506)
                      .++|+|||+|...
T Consensus       207 ~~~liDFG~a~~~  219 (258)
T 1zth_A          207 KVYFIDMGQAVTL  219 (258)
T ss_dssp             SEEECCCTTCEET
T ss_pred             cEEEEECcccccC
Confidence            8999999999754

>4gyi_A RIO2 kinase; protein kinase, ADP complex, phosphoaspartate, acyl-phosphat ribosome biogenesis, Ser/Thr protein kinase; HET: PHD ADP; 2.20A {Chaetomium thermophilum} PDB: 4gyg_A

Probab=99.40  E-value=1.9e-13  Score=136.16  Aligned_cols=114  Identities=17%  Similarity=0.151  Sum_probs=82.0

Q ss_pred             hccccCccCceEEEEEEEcCCCEEEEEEeccCCCC---------------chh--------hHHHHHHhhccCccce--e
Q 039231          317 FKYKLGQGGYGSVYKGKLLDGSNVAVKVLNDSKGN---------------GKE--------FINEVASISRTSHVNV--V  371 (506)
Q Consensus       317 ~~~~ig~G~~g~V~~~~~~~~~~vavK~l~~~~~~---------------~~~--------~~~E~~~l~~l~h~ni--v  371 (506)
                      +...||+|++|.||+|...+|+.||||+++.....               ...        ..+|...|.++.+..+  .
T Consensus        99 I~~~IG~Gk~a~VY~a~d~~G~~vAvKi~r~~~~sfr~v~~~r~~~~~~~~~~~~~~~rl~A~kE~~nL~rL~~~gv~vp  178 (397)
T 4gyi_A           99 VGSRIGVGKESDIMIVADEKGKQKVLKIHRLGRISFRTVKANRDYLRNRSTGSWMYLSRLAAIKEFAFMKALYEEGFPVP  178 (397)
T ss_dssp             EEEEEEECSSEEEEEEECTTCCEEEEEEECTTEECCCCCC--CEECTTSCHHHHHHHHHHHHHHHHHHHHHHHHTTCSCC
T ss_pred             ecCEeeeCCceEEEEEECCCCCEEEEEEEecccccHHHHHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHHhcCCCCC
Confidence            34679999999999999989999999998532110               001        1245666666644332  1


Q ss_pred             E---------EEEEe--------eccchhhhHHHHHHHHHHHHhhcCCCCeEecCcCCCcEEECCCC----------cEE
Q 039231          372 A---------LLGFC--------LRVAEELSSTIGIARGLEYLHLGCSTRILHFDIKPHNILLDEDF----------CPK  424 (506)
Q Consensus       372 ~---------l~g~~--------~~~~~~l~i~~~i~~gl~~LH~~~~~~ivH~dlkp~Nill~~~~----------~~k  424 (506)
                      .         ++.++        .+..+...++.|++.+|.+||   +.+||||||||.|||+++++          .+.
T Consensus       179 ~p~~~~~~~LVME~i~G~~L~~l~~~~~~~~l~~qll~~l~~lH---~~gIVHrDLKp~NILl~~dgd~~d~~~~~~~~~  255 (397)
T 4gyi_A          179 EPIAQSRHTIVMSLVDALPMRQVSSVPDPASLYADLIALILRLA---KHGLIHGDFNEFNILIREEKDAEDPSSITLTPI  255 (397)
T ss_dssp             CEEEEETTEEEEECCSCEEGGGCCCCSCHHHHHHHHHHHHHHHH---HTTEECSCCSTTSEEEEEEECSSCTTSEEEEEE
T ss_pred             eeeeccCceEEEEecCCccHhhhcccHHHHHHHHHHHHHHHHHH---HCCCcCCCCCHHHEEEeCCCCcccccccccceE
Confidence            1         11221        223345678899999999999   89999999999999998776          389


Q ss_pred             EeecCCCcc
Q 039231          425 ISDFGLAKI  433 (506)
Q Consensus       425 i~dfg~a~~  433 (506)
                      |+||+-+..
T Consensus       256 iID~~Q~V~  264 (397)
T 4gyi_A          256 IIXFPQMVS  264 (397)
T ss_dssp             ECCCTTCEE
T ss_pred             EEEeCCccc
Confidence            999998754

>3tm0_A Aminoglycoside 3'-phosphotransferase; protein kinase, phosphorylation, transferase-antibiotic COMP; HET: ANP B31; 2.10A {Enterococcus faecalis} SCOP: d.144.1.6 PDB: 2b0q_A* 1l8t_A* 3q2j_A* 1j7i_A* 1j7u_A* 3h8p_A* 1j7l_A* 2bkk_A*

Probab=98.60  E-value=1.1e-07  Score=90.11  Aligned_cols=115  Identities=16%  Similarity=0.072  Sum_probs=84.7

Q ss_pred             ccccCccCceEEEEEEEcCCCEEEEEEeccCC-CCchhhHHHHHHhhccC-ccceeEEEEEeec----------------
Q 039231          318 KYKLGQGGYGSVYKGKLLDGSNVAVKVLNDSK-GNGKEFINEVASISRTS-HVNVVALLGFCLR----------------  379 (506)
Q Consensus       318 ~~~ig~G~~g~V~~~~~~~~~~vavK~l~~~~-~~~~~~~~E~~~l~~l~-h~niv~l~g~~~~----------------  379 (506)
                      ...++.|+.+.||+... +++.+++|+..... .....+.+|+++++.+. |..+.+++++...                
T Consensus        19 ~~~~~g~s~~~v~~~~~-~~~~~vlK~~~~~~~~~~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~~~lv~e~i~G~~l   97 (263)
T 3tm0_A           19 VKDTEGMSPAKVYKLVG-ENENLYLKMTDSRYKGTTYDVEREKDMMLWLEGKLPVPKVLHFERHDGWSNLLMSEADGVLC   97 (263)
T ss_dssp             EECCSCCSSSEEEEEEC-SSCEEEEEEECGGGTTSTTCHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEEECCSSEEH
T ss_pred             EeeccCCCCCeEEEEEC-CCCcEEEEeCCcccCCCHHHHHHHHHHHHHHhcCCCCCeEEEEEecCCceEEEEEecCCeeh
Confidence            44577778889999985 46899999986532 23357889999999885 5566667655411                


Q ss_pred             ------cchhhhHHHHHHHHHHHHhhc-----------------------------------------------------
Q 039231          380 ------VAEELSSTIGIARGLEYLHLG-----------------------------------------------------  400 (506)
Q Consensus       380 ------~~~~l~i~~~i~~gl~~LH~~-----------------------------------------------------  400 (506)
                            ..+...++.+++++|..||..                                                     
T Consensus        98 ~~~~~~~~~~~~~~~~l~~~l~~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~~  177 (263)
T 3tm0_A           98 SEEYEDEQSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCENWEEDTPFKDPRELYDFLKTE  177 (263)
T ss_dssp             HHHCCTTTCHHHHHHHHHHHHHHHHHSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCSGGGGSTTCSSSSHHHHHHHHHHC
T ss_pred             hhccCCcccHHHHHHHHHHHHHHHhCCCcccCCCcchHHHHHHHHHHHHhccccccccccccccccCCCHHHHHHHHHhc
Confidence                  112346788999999999961                                                     


Q ss_pred             ---CCCCeEecCcCCCcEEECCCCcEEEeecCCCcc
Q 039231          401 ---CSTRILHFDIKPHNILLDEDFCPKISDFGLAKI  433 (506)
Q Consensus       401 ---~~~~ivH~dlkp~Nill~~~~~~ki~dfg~a~~  433 (506)
                         ....++|+|++|.||+++++..+.|+||+.+..
T Consensus       178 ~~~~~~~l~HgDl~~~Nil~~~~~~~~lIDwe~a~~  213 (263)
T 3tm0_A          178 KPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSGR  213 (263)
T ss_dssp             CCCCCEEEECSSCCTTSEEEETTEEEEECCCTTCEE
T ss_pred             CCCCCceEECCCCCcCcEEEECCcEEEEEEchhccc
Confidence               014589999999999998766677999998754

>1nd4_A Aminoglycoside 3'-phosphotransferase; protein kinase, ATPase, kanamycin; HET: KAN; 2.10A {Klebsiella pneumoniae} SCOP: d.144.1.6

Probab=98.55  E-value=1.9e-07  Score=88.17  Aligned_cols=111  Identities=17%  Similarity=0.102  Sum_probs=80.3

Q ss_pred             cC-ccCceEEEEEEEcCCCEEEEEEeccCCCCchhhHHHHHHhhccCccce--eEEEEEeecc-----------------
Q 039231          321 LG-QGGYGSVYKGKLLDGSNVAVKVLNDSKGNGKEFINEVASISRTSHVNV--VALLGFCLRV-----------------  380 (506)
Q Consensus       321 ig-~G~~g~V~~~~~~~~~~vavK~l~~~~~~~~~~~~E~~~l~~l~h~ni--v~l~g~~~~~-----------------  380 (506)
                      ++ .|..+.||+....+|..+++|+....  ....+.+|++.++.+.+.++  .+++++....                 
T Consensus        27 ~~~gg~~~~v~~~~~~~g~~~vlK~~~~~--~~~~~~~E~~~l~~l~~~~~~vP~~~~~~~~~~~~~~v~e~i~G~~l~~  104 (264)
T 1nd4_A           27 QTIGCSDAAVFRLSAQGRPVLFVKTDLSG--ALNELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLLLGEVPGQDLLS  104 (264)
T ss_dssp             CSCTTSSCEEEEEECTTSCCEEEEEECSC--TTSCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEEEECCSSEETTT
T ss_pred             cccCCCCceEEEEecCCCCeEEEEeCCcc--cchhhhHHHHHHHHHHhCCCCCCeEEEeccCCCCCEEEEEecCCcccCc
Confidence            44 55569999998777888999997654  33568889999988865443  3455543110                 


Q ss_pred             --chhhhHHHHHHHHHHHHhhcC-------------------------------------------------------CC
Q 039231          381 --AEELSSTIGIARGLEYLHLGC-------------------------------------------------------ST  403 (506)
Q Consensus       381 --~~~l~i~~~i~~gl~~LH~~~-------------------------------------------------------~~  403 (506)
                        .+...++.++++.|..||...                                                       ..
T Consensus       105 ~~~~~~~~~~~l~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~  184 (264)
T 1nd4_A          105 SHLAPAEKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDLDEEHQGLAPAELFARLKARMPDGEDL  184 (264)
T ss_dssp             SCCCHHHHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCCGGGTTCCHHHHHHHHHHTCCSSCCE
T ss_pred             CcCCHhHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhcCCccchhhhhhccCccHHHHHHHHHHhcCCCCCe
Confidence              011257889999999999521                                                       01


Q ss_pred             CeEecCcCCCcEEECCCCcEEEeecCCCcc
Q 039231          404 RILHFDIKPHNILLDEDFCPKISDFGLAKI  433 (506)
Q Consensus       404 ~ivH~dlkp~Nill~~~~~~ki~dfg~a~~  433 (506)
                      .++|+|++|.||+++++..++|+||+.+..
T Consensus       185 ~l~HgDl~~~Nil~~~~~~~~liD~~~a~~  214 (264)
T 1nd4_A          185 VVTHGDACLPNIMVENGRFSGFIDCGRLGV  214 (264)
T ss_dssp             EEECSSCCGGGEEEETTEEEEECCCTTCEE
T ss_pred             EEECCCCCCCcEEEECCcEEEEEcchhccc
Confidence            299999999999998876677999998764

>3dxp_A Putative acyl-COA dehydrogenase; protein kinase-like fold, structural genomics, joint center structural genomics, JCSG; 2.32A {Ralstonia eutropha JMP134}

Probab=98.35  E-value=9.1e-07  Score=88.03  Aligned_cols=115  Identities=17%  Similarity=0.194  Sum_probs=81.6

Q ss_pred             cccCccCceEEEEEEEcCCCEEEEEEec--cCC--CCchhhHHHHHHhhccC--ccceeEEEEEeec-------------
Q 039231          319 YKLGQGGYGSVYKGKLLDGSNVAVKVLN--DSK--GNGKEFINEVASISRTS--HVNVVALLGFCLR-------------  379 (506)
Q Consensus       319 ~~ig~G~~g~V~~~~~~~~~~vavK~l~--~~~--~~~~~~~~E~~~l~~l~--h~niv~l~g~~~~-------------  379 (506)
                      +.++.|.++.||+.... +..+++|+..  ...  .....+.+|+++++.+.  +..+.+++.++.+             
T Consensus        44 ~~l~~G~sn~~y~v~~~-~~~~vlr~~~~p~~~~~~~~~~~~~E~~~l~~L~~~~vpvP~~~~~~~~~~~~g~~~~vme~  122 (359)
T 3dxp_A           44 EQFKGGQSNPTFKLVTP-GQTYVMRAKPGPKSKLLPSAHAIEREYRVMDALAGTDVPVAKMYALCEDESVIGRAFYIMEF  122 (359)
T ss_dssp             EECCC-CCSCEEEEECS-SCEEEEECCCC----------CHHHHHHHHHHHTTSSSCCCCEEEEECCTTTTSSCEEEEEC
T ss_pred             EEcCCcccceEEEEEEC-CceEEEEeCCCCCCCCCCcHHHHHHHHHHHHHhhcCCCCCCcEEEECCCCCccCCeEEEEEe
Confidence            35889999999999875 4678888776  332  22357889999999887  3445666655411             


Q ss_pred             ---------------cchhhhHHHHHHHHHHHHhhcC-------------------------------------------
Q 039231          380 ---------------VAEELSSTIGIARGLEYLHLGC-------------------------------------------  401 (506)
Q Consensus       380 ---------------~~~~l~i~~~i~~gl~~LH~~~-------------------------------------------  401 (506)
                                     ..++..++.++++.|+.||...                                           
T Consensus       123 v~G~~l~~~~~~~l~~~~~~~~~~~l~~~La~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  202 (359)
T 3dxp_A          123 VSGRVLWDQSLPGMSPAERTAIYDEMNRVIAAMHTVDYQAIGLGDYGKPGNYFQRQIERWTKQYKLSETESIPAMDSLMD  202 (359)
T ss_dssp             CCCBCCCCTTCTTCCHHHHHHHHHHHHHHHHHHHHSCTTTTTCTTSSCCSCHHHHHHHHHHHHHHHHCCSCCHHHHHHHH
T ss_pred             cCCeecCCCccccCCHHHHHHHHHHHHHHHHHHhCCCchhccccccCCCCCchHHHHHHHHHHHHhcCCcCChHHHHHHH
Confidence                           1224557889999999999620                                           


Q ss_pred             ------------CCCeEecCcCCCcEEECCCCc--EEEeecCCCccc
Q 039231          402 ------------STRILHFDIKPHNILLDEDFC--PKISDFGLAKIC  434 (506)
Q Consensus       402 ------------~~~ivH~dlkp~Nill~~~~~--~ki~dfg~a~~~  434 (506)
                                  ...++|+|+++.||+++.++.  +.|+||+.+...
T Consensus       203 ~l~~~~~~~~~~~~~lvHgD~~~~Nil~~~~~~~v~~viDwe~a~~g  249 (359)
T 3dxp_A          203 WLPQHIPQEDADLTSIVHGDYRLDNLMFHPTEPRVLAVLDWELSTLG  249 (359)
T ss_dssp             HGGGCCCSTTSSCCEEECSSCSGGGEEECSSSSCEEEECCCTTCEEE
T ss_pred             HHHhcCCCccCCCceEEeCCCCCCcEEEeCCCCcEEEEECccccccC
Confidence                        257999999999999987653  689999998753

>3sg8_A APH(2'')-ID; antibiotic resistance enzyme, transferase, aminoglycoside, phosphorylation, transferase-antibiotic complex; HET: TOY; 1.80A {Enterococcus casseliflavus} PDB: 3sg9_A* 3n4v_A 3n4t_A 3n4u_A 3r81_A* 3r80_A* 3r7z_A* 3r82_A* 3vcq_A* 4dbx_A 4de4_A* 4dfb_A* 4dfu_A* 4dt9_A* 4dt8_A* 4dtb_A* 3sgc_A 4dta_A* 3lzh_A

Probab=98.17  E-value=9e-07  Score=85.93  Aligned_cols=162  Identities=20%  Similarity=0.226  Sum_probs=98.8

Q ss_pred             ccCccCceEEEEEEEcCCCEEEEEEeccCCCCchhhHHHHHHhhccC-ccc--eeEEEEEe-------------------
Q 039231          320 KLGQGGYGSVYKGKLLDGSNVAVKVLNDSKGNGKEFINEVASISRTS-HVN--VVALLGFC-------------------  377 (506)
Q Consensus       320 ~ig~G~~g~V~~~~~~~~~~vavK~l~~~~~~~~~~~~E~~~l~~l~-h~n--iv~l~g~~-------------------  377 (506)
                      .++.|....||+..    ..+++|+.... .....+.+|.+.++.+. +..  +.+++...                   
T Consensus        27 ~~~~G~~n~v~~v~----~~~vlR~~~~~-~~~~~~~~E~~~l~~l~~~~~v~vP~~~~~~~~~~~~~~~~~vm~~i~G~  101 (304)
T 3sg8_A           27 ISGEGNDCIAYEIN----RDFIFKFPKHS-RGSTNLFNEVNILKRIHNKLPLPIPEVVFTGMPSETYQMSFAGFTKIKGV  101 (304)
T ss_dssp             EEEECSSEEEEEST----TSEEEEEESSH-HHHHHHHHHHHHHHHHTTSSSSCCCCEEEECCCCSSCSCSCEEEECCCCE
T ss_pred             ecCCCCcceEEEEC----CEEEEEecCCc-chHHHHHHHHHHHHHHHhcCCCCCCceEeecCCCCCCCcceEEEcccCCe
Confidence            47889999999763    56888886432 22357889999998873 322  22333221                   


Q ss_pred             -e--------ccchhhhHHHHHHHHHHHHhhc------------------------------------------------
Q 039231          378 -L--------RVAEELSSTIGIARGLEYLHLG------------------------------------------------  400 (506)
Q Consensus       378 -~--------~~~~~l~i~~~i~~gl~~LH~~------------------------------------------------  400 (506)
                       +        +..++..++.++++.|+.||..                                                
T Consensus       102 ~l~~~~~~~l~~~~~~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~l  181 (304)
T 3sg8_A          102 PLTPLLLNNLPKQSQNQAAKDLARFLSELHSINISGFKSNLVLDFREKINEDNKKIKKLLSRELKGPQMKKVDDFYRDIL  181 (304)
T ss_dssp             ECCHHHHHTSCHHHHHHHHHHHHHHHHHHHHSCCTTSCGGGBCCHHHHHHHHHHHHHHHHTTTSCHHHHHHHHHHHHHHH
T ss_pred             ECCccccccCCHHHHHHHHHHHHHHHHHHHcCCCCCCCccchhhHHHHHHHHHHHHHHHhcccCCcccHHHHHHHHHHHH
Confidence             1        1112346788899999999851                                                


Q ss_pred             -------CCCCeEecCcCCCcEEECC--CCcEEEeecCCCccccCCCcceecccCCCCcccccccccc---cccCC----
Q 039231          401 -------CSTRILHFDIKPHNILLDE--DFCPKISDFGLAKICNRKESIISMTGARGTVGYIAPEVFC---RNIGE----  464 (506)
Q Consensus       401 -------~~~~ivH~dlkp~Nill~~--~~~~ki~dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~l~---~~~~~----  464 (506)
                             ....++|+|++|.||++++  ...+.|+||+.+................   .-..|+...   ...+.    
T Consensus       182 ~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~iD~~~~~~~~~~~Dl~~~~~~~---~~~~~~~~~~~l~~Y~~~~~~  258 (304)
T 3sg8_A          182 ENEIYFKYYPCLIHNDFSSDHILFDTEKNTICGIIDFGDAAISDPDNDFISLMEDD---EEYGMEFVSKILNHYKHKDIP  258 (304)
T ss_dssp             TCGGGTCCCCEEECSCCCGGGEEEETTTTEEEEECCCTTCEEECTTHHHHTTCCTT---TSCCHHHHHHHHHHHTCSCHH
T ss_pred             hccccccCCceeEeCCCCcccEEEeCCCCCEEEEEeCCCCccCChHHHHHHHHhhc---cccCHHHHHHHHHHcCCCCcH
Confidence                   0135899999999999988  5568899999987543221110000000   001222111   10011    


Q ss_pred             -----CCccccHHHHHHHHHHHHcCCCCCC
Q 039231          465 -----VSYKSDVYNYGMMIFEMTGGRKNVD  489 (506)
Q Consensus       465 -----~s~~~Dv~s~G~il~elltg~~pf~  489 (506)
                           .....+.|+++.++|++.+|..+|-
T Consensus       259 ~~~~r~~~~~~~~~l~~~~~~~~~g~~~~~  288 (304)
T 3sg8_A          259 TVLEKYRMKEKYWSFEKIIYGKEYGYMDWY  288 (304)
T ss_dssp             HHHHHHHHHHHHHHHHHHHHHHHTTCHHHH
T ss_pred             HHHHHHHHHHHHHHHHHHHHHHHcCCHHHH
Confidence                 1122689999999999999998873

>2olc_A MTR kinase, methylthioribose kinase; kinase ADP-2HO complex, transferase; HET: CPS ADP; 2.00A {Bacillus subtilis} SCOP: d.144.1.6 PDB: 2pu8_A* 2pui_A* 2pul_A* 2pun_A* 2pup_A*

Probab=96.89  E-value=0.0042  Score=62.17  Aligned_cols=48  Identities=13%  Similarity=0.054  Sum_probs=33.0

Q ss_pred             cccCccCceEEEEEEEc-CCCEEEEEEeccCC--------CCchhhHHHHHHhhccC
Q 039231          319 YKLGQGGYGSVYKGKLL-DGSNVAVKVLNDSK--------GNGKEFINEVASISRTS  366 (506)
Q Consensus       319 ~~ig~G~~g~V~~~~~~-~~~~vavK~l~~~~--------~~~~~~~~E~~~l~~l~  366 (506)
                      +.||.|..+.||+++.. +++.++||......        ...+.+..|.+.++.+.
T Consensus        36 ~~lg~G~~n~vyrv~~~~~~~~~vvK~~~~~~r~~~~~~~~~~~r~~~E~~~L~~l~   92 (397)
T 2olc_A           36 QEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQG   92 (397)
T ss_dssp             EECCSSSSEEEEEEEC----CEEEEEEECCC-------CCCCTTHHHHHHHHHHHHH
T ss_pred             EECCCCceEEEEEEEECCCCcEEEEEecchhhcccCCCCcCcHHHHHHHHHHHHHhh
Confidence            35899999999999764 46889999864321        12345678888888764

>3f7w_A Putative fructosamine-3-kinase; YP_290396.1, structural GENO joint center for structural genomics, JCSG, protein structu initiative, PSI-2; 1.85A {Thermobifida fusca YX}

Probab=96.84  E-value=0.0034  Score=59.85  Aligned_cols=47  Identities=23%  Similarity=0.293  Sum_probs=37.5

Q ss_pred             ccCccCceEEEEEEEcCCCEEEEEEeccCCCC-chhhHHHHHHhhccC
Q 039231          320 KLGQGGYGSVYKGKLLDGSNVAVKVLNDSKGN-GKEFINEVASISRTS  366 (506)
Q Consensus       320 ~ig~G~~g~V~~~~~~~~~~vavK~l~~~~~~-~~~~~~E~~~l~~l~  366 (506)
                      .+|.|..+.||+.++.+|+.+.+|+....... ...+.+|++.|+.+.
T Consensus        22 ~~g~G~~~~vyrv~l~DG~~~~vK~~~~~~~~~~~~~~~Ea~~L~~L~   69 (288)
T 3f7w_A           22 ERGHSHRWHLYRVELADGTPLFVKALPDDAPALDGLFRAEALGLDWLG   69 (288)
T ss_dssp             EEEEETTEEEEEEEETTSCEEEEEECCTTCCCCTTHHHHHHHHHHHHT
T ss_pred             ecCCCCCeEEEEEEECCCCEEEEEEeCCCCcchhhHHHHHHHHHHHHH
Confidence            48899999999999999999999987644332 245778998888774

>3tdw_A Gentamicin resistance protein; kinase, phosphoryl transfer, antibiotic resistance, transfer; HET: GDP; 1.70A {Enterococcus gallinarum} PDB: 3tdv_A*

Probab=96.80  E-value=0.0022  Score=61.85  Aligned_cols=111  Identities=17%  Similarity=0.174  Sum_probs=72.9

Q ss_pred             ccCccCceEEEEEEEcCCCEEEEEEeccCCCCchhhHHHHHHhhccCcc---ceeEEEEEee------------------
Q 039231          320 KLGQGGYGSVYKGKLLDGSNVAVKVLNDSKGNGKEFINEVASISRTSHV---NVVALLGFCL------------------  378 (506)
Q Consensus       320 ~ig~G~~g~V~~~~~~~~~~vavK~l~~~~~~~~~~~~E~~~l~~l~h~---niv~l~g~~~------------------  378 (506)
                      .++.|....||+.    +..+++|+... ......+.+|.++|..+.+.   .+.+.+.+..                  
T Consensus        26 ~l~~G~~n~v~~v----g~~~VlR~~~~-~~~~~~~~~E~~~L~~L~~~~~v~VP~~~~~~~~~~g~~~~v~e~i~G~~l  100 (306)
T 3tdw_A           26 SLGEGFRNYAILV----NGDWVFRFPKS-QQGADELNKEIQLLPLLVGCVKVNIPQYVYIGKRSDGNPFVGYRKVQGQIL  100 (306)
T ss_dssp             EEEECSSEEEEEE----TTTEEEEEESS-HHHHHHHHHHHHHHHHHTTTCSSBCCCEEEEEECTTSCEEEEEECCCSEEC
T ss_pred             ecCCCcceeEEEE----CCEEEEEecCC-chHHHHHHHHHHHHHHHHhcCCCCCCCeEeecccCCCceEEEEeccCCeEC
Confidence            3777888889987    57788888532 12235788999999998642   1223332221                  


Q ss_pred             --------ccchhhhHHHHHHHHHHHHhhc--------------------------------------------------
Q 039231          379 --------RVAEELSSTIGIARGLEYLHLG--------------------------------------------------  400 (506)
Q Consensus       379 --------~~~~~l~i~~~i~~gl~~LH~~--------------------------------------------------  400 (506)
                              +..+...++.++++.|..||..                                                  
T Consensus       101 ~~~~~~~l~~~~~~~~~~~lg~~La~LH~~~~~~~~~~g~p~~~w~~~~~~~~~~~~~~~~~~l~~~~~~~l~~~~~~~l  180 (306)
T 3tdw_A          101 GEDGMAVLPDDAKDRLALQLAEFMNELSAFPVETAISAGVPVTNLKNKILLLSEAVEDQVFPLLDESLRDYLTLRFQSYM  180 (306)
T ss_dssp             HHHHHTTSCHHHHHHHHHHHHHHHHHHHHSCHHHHHHTTCCBCCHHHHHHHHHHHHHHHTGGGSCHHHHHHHHHHHHHHH
T ss_pred             chhhhhhCCHHHHHHHHHHHHHHHHHHhcCCcccccccCCChHHHHHHHHHHHHHHHHhcccccchhhHHHHHHHHHHHH
Confidence                    1112334566777777777742                                                  


Q ss_pred             -------CCCCeEecCcCCCcEEECC---CCc-EEEeecCCCcccc
Q 039231          401 -------CSTRILHFDIKPHNILLDE---DFC-PKISDFGLAKICN  435 (506)
Q Consensus       401 -------~~~~ivH~dlkp~Nill~~---~~~-~ki~dfg~a~~~~  435 (506)
                             ....++|+|++|.||+++.   ++. ..|+||+.+....
T Consensus       181 ~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~~~iD~~~a~~gd  226 (306)
T 3tdw_A          181 THPVYTRYTPRLIHGDLSPDHFLTNLNSRQTPLTGIIDFGDAAISD  226 (306)
T ss_dssp             HCHHHHCCCCEEECSCCSGGGEEECTTCSSCCEEEECCCTTCEEEC
T ss_pred             hCcccccCCCeeEeCCCCcccEEEecCCCCCceEEEEehhhcCCCC
Confidence                   1235699999999999987   355 5899999887543

>4gkh_A Aminoglycoside 3'-phosphotransferase APHA1-IAB; pyrazolopyrimidine, 1-Na-PP1, bumped kinase inhibitor, BKI, kinase inhibitor; HET: KAN 0J9; 1.86A {Acinetobacter baumannii} PDB: 4feu_A* 4few_A* 4fex_A* 4fev_A* 4gki_A* 4ej7_A* 3r78_A*

Probab=96.72  E-value=0.0046  Score=58.13  Aligned_cols=112  Identities=17%  Similarity=0.140  Sum_probs=73.0

Q ss_pred             cCccCce-EEEEEEEc-CCCEEEEEEeccCCCCchhhHHHHHHhhccC-ccceeEEEEEeec------------------
Q 039231          321 LGQGGYG-SVYKGKLL-DGSNVAVKVLNDSKGNGKEFINEVASISRTS-HVNVVALLGFCLR------------------  379 (506)
Q Consensus       321 ig~G~~g-~V~~~~~~-~~~~vavK~l~~~~~~~~~~~~E~~~l~~l~-h~niv~l~g~~~~------------------  379 (506)
                      +..|..+ .||+.... ++..+++|+-...  ...++.+|...|+.+. +--+-++++++-+                  
T Consensus        32 ~~~G~S~~~v~rl~~~~~~~~~~lk~~~~~--~~~~~~~E~~~l~~l~~~vPVP~v~~~~~~~~~~~lvme~l~G~~~~~  109 (272)
T 4gkh_A           32 DNVGQSGATIYRLYGKPNAPELFLKHGKGS--VANDVTDEMVRLNWLTAFMPLPTIKHFIRTPDDAWLLTTAIPGKTAFQ  109 (272)
T ss_dssp             EECSSSSCEEEEEECCTTCCCEEEEEEETH--HHHHHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEEECCCSEEHHH
T ss_pred             ccCCCcCCeEEEEEecCCCeEEEEEECCCC--CHhHHHHHHHHHHHhccCCCcCeEEEEEEECCeEEEEEEeeCCccccc
Confidence            4445544 68988764 4678899976532  3456888999888774 2223344443311                  


Q ss_pred             -----cchhhhHHHHHHHHHHHHhhcC-----------------------------------------------------
Q 039231          380 -----VAEELSSTIGIARGLEYLHLGC-----------------------------------------------------  401 (506)
Q Consensus       380 -----~~~~l~i~~~i~~gl~~LH~~~-----------------------------------------------------  401 (506)
                           ..+...+..+++..|.-||...                                                     
T Consensus       110 ~~~~~~~~~~~~~~~l~~~L~~Lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~  189 (272)
T 4gkh_A          110 VLEEYPDSGENIVDALAVFLRRLHSIPVCNCPFNSDRVFRLAQAQSRMNNGLVDASDFDDERNGWPVEQVWKEMHKLLPF  189 (272)
T ss_dssp             HHHHCGGGHHHHHHHHHHHHHHHHTSCGGGCCBBCCHHHHHHHHHHHHHTTCCCGGGCCGGGTTCCHHHHHHHHHTTCCC
T ss_pred             cccCCHHHHHHHHHHHHHHHHHhcCCCcccCCcCcccccchhhHHHHHHHhhhhhhhccccccchHHHHHHHHHHhcccc
Confidence                 1123345667777777777310                                                     


Q ss_pred             --CCCeEecCcCCCcEEECCCCcEEEeecCCCccc
Q 039231          402 --STRILHFDIKPHNILLDEDFCPKISDFGLAKIC  434 (506)
Q Consensus       402 --~~~ivH~dlkp~Nill~~~~~~ki~dfg~a~~~  434 (506)
                        ...++|+|+++.|||+++++.+-|+||+.+...
T Consensus       190 ~~~~~l~HGDl~~~Nil~~~~~~~~viDwe~a~~g  224 (272)
T 4gkh_A          190 SPDSVVTHGDFSLDNLIFDEGKLIGCIDVGRVGIA  224 (272)
T ss_dssp             CCCEEEECSCCCTTSEEEETTEEEEECCCTTCEEE
T ss_pred             cCCcEEEcCCCCCCeEEEECCeEEEEEECcccccC
Confidence              113799999999999998877789999988643

>3ats_A Putative uncharacterized protein; hypothetical protein, putative aminoglycoside phosphortransf transferase; 1.67A {Mycobacterium tuberculosis} PDB: 3att_A*

Probab=96.19  E-value=0.0085  Score=58.90  Aligned_cols=33  Identities=15%  Similarity=0.156  Sum_probs=27.4

Q ss_pred             CCCeEecCcCCCcEEECCCCcEEEeecCCCccc
Q 039231          402 STRILHFDIKPHNILLDEDFCPKISDFGLAKIC  434 (506)
Q Consensus       402 ~~~ivH~dlkp~Nill~~~~~~ki~dfg~a~~~  434 (506)
                      ...++|+|+++.||+++++..+.|+||+.+...
T Consensus       221 ~~~l~HgDl~~~Nil~~~~~~~~vIDwe~a~~g  253 (357)
T 3ats_A          221 EPVLLWGDARVGNVLYRDFQPVAVLDWEMVALG  253 (357)
T ss_dssp             CCEEECSSCSGGGEEEETTEEEEECCGGGCEEE
T ss_pred             CceEEeCCCCCCeEEEeCCcEEEEEcccccccC
Confidence            357899999999999996555789999988643

>3dxq_A Choline/ethanolamine kinase family protein; NP_106042.1, STR genomics, joint center for structural genomics, JCSG, prote structure initiative; HET: MSE; 2.55A {Mesorhizobium loti}

Probab=95.96  E-value=0.017  Score=55.28  Aligned_cols=110  Identities=15%  Similarity=0.106  Sum_probs=68.6

Q ss_pred             cccCccCceEEEEEEEcCCCEEEEEEeccCCCCchhhHHHHHHhhccCccce-eEEEEEe----------e-ccc-----
Q 039231          319 YKLGQGGYGSVYKGKLLDGSNVAVKVLNDSKGNGKEFINEVASISRTSHVNV-VALLGFC----------L-RVA-----  381 (506)
Q Consensus       319 ~~ig~G~~g~V~~~~~~~~~~vavK~l~~~~~~~~~~~~E~~~l~~l~h~ni-v~l~g~~----------~-~~~-----  381 (506)
                      +.|..|....+|+.     ..+++|+............+|+..++.+....+ .+++++.          + +..     
T Consensus        24 ~~l~gG~tN~~~~~-----~~~vlR~~~~~~~~~~~r~~E~~~l~~l~~~g~~P~~~~~~~~~~~~v~e~i~~g~~l~~~   98 (301)
T 3dxq_A           24 LERLGGLTNLVFRA-----GDLCLRIPGKGTEEYINRANEAVAAREAAKAGVSPEVLHVDPATGVMVTRYIAGAQTMSPE   98 (301)
T ss_dssp             EEEESCSSEEEEEE-----TTEEEEEECC----CCCHHHHHHHHHHHHHTTSSCCEEEECTTTCCEEEECCTTCEECCHH
T ss_pred             eEcCCcccccccee-----eeEEEECCCCCccceeCHHHHHHHHHHHHHcCCCCceEEEECCCCEEEEeecCCCccCCHh
Confidence            34778888999998     568889886543222344567777766642111 1222222          1 110     


Q ss_pred             hh---hhHHHHHHHHHHHHhhcC--------------------------------------------------CCCeEec
Q 039231          382 EE---LSSTIGIARGLEYLHLGC--------------------------------------------------STRILHF  408 (506)
Q Consensus       382 ~~---l~i~~~i~~gl~~LH~~~--------------------------------------------------~~~ivH~  408 (506)
                      ..   -.+..++++.|+-||...                                                  ...++|+
T Consensus        99 ~~~~~~~~~~~~~~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~l~~~l~~~~~~~~l~Hg  178 (301)
T 3dxq_A           99 KFKTRPGSPARAGEAFRKLHGSGAVFPFRFELFAMIDDYLKVLSTKNVTLPAGYHDVVREAGGVRSALAAHPLPLAACHC  178 (301)
T ss_dssp             HHHHSTTHHHHHHHHHHHHHTSCCCCSSBCCHHHHHHHHHHHHC--CCCCCTTHHHHHHHHHHHHHHHHSSCCCCEEECS
T ss_pred             hHhhhHHHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHhhcCCCchhhHHHHHHHHHHHHHHHHhcCCCceeecc
Confidence            11   235677888888888521                                                  1127999


Q ss_pred             CcCCCcEEECCCCcEEEeecCCCccc
Q 039231          409 DIKPHNILLDEDFCPKISDFGLAKIC  434 (506)
Q Consensus       409 dlkp~Nill~~~~~~ki~dfg~a~~~  434 (506)
                      |+.+.||+ ..++.+.|+||..+...
T Consensus       179 Dl~~~Nil-~~~~~~~lID~e~a~~g  203 (301)
T 3dxq_A          179 DPLCENFL-DTGERMWIVDWEYSGMN  203 (301)
T ss_dssp             CCCGGGEE-ECSSCEEECCCTTCEEE
T ss_pred             CCCcCCEE-ECCCCEEEEecccccCC
Confidence            99999999 55667899999988653

>1nw1_A Choline kinase (49.2 KD); phospholipid synthesis, protein kinase fold, transferase; 2.02A {Caenorhabditis elegans} SCOP: d.144.1.8

Probab=95.81  E-value=0.035  Score=56.14  Aligned_cols=55  Identities=15%  Similarity=0.253  Sum_probs=37.9

Q ss_pred             ccCccCceEEEEEEEcC--------CCEEEEEEeccCCCCc-hhhHHHHHHhhccCccce-eEEEEE
Q 039231          320 KLGQGGYGSVYKGKLLD--------GSNVAVKVLNDSKGNG-KEFINEVASISRTSHVNV-VALLGF  376 (506)
Q Consensus       320 ~ig~G~~g~V~~~~~~~--------~~~vavK~l~~~~~~~-~~~~~E~~~l~~l~h~ni-v~l~g~  376 (506)
                      .|+.|....+|+....+        +..+++|+....  .. ..+.+|..++..+...++ .++++.
T Consensus        80 ~l~gG~tN~~y~v~~~~~~~~~~~~~~~~vlRi~~~~--~~~~~li~E~~~l~~L~~~g~~P~l~~~  144 (429)
T 1nw1_A           80 RIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFNP--ETESHLVAESVIFTLLSERHLGPKLYGI  144 (429)
T ss_dssp             EECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECSC--CCHHHHHHHHHHHHHHHHTTSSSCEEEE
T ss_pred             EeCCCcccceEEEEeCCCccccCCCCceEEEEEeCCC--CcHHHHHHHHHHHHHHHhCCCCCcEEEE
Confidence            47788889999998753        578999988432  23 567789988888753333 344443

>2qg7_A Ethanolamine kinase PV091845; malaria, SGC, structural genomics consortium, transferase; 2.41A {Plasmodium vivax}

Probab=95.76  E-value=0.063  Score=54.68  Aligned_cols=58  Identities=10%  Similarity=0.006  Sum_probs=36.3

Q ss_pred             ccCccCceEEEEEEEcC-CCEEEEEEeccCCCCchhhHHHHHHhhccCccce-eEEEEEe
Q 039231          320 KLGQGGYGSVYKGKLLD-GSNVAVKVLNDSKGNGKEFINEVASISRTSHVNV-VALLGFC  377 (506)
Q Consensus       320 ~ig~G~~g~V~~~~~~~-~~~vavK~l~~~~~~~~~~~~E~~~l~~l~h~ni-v~l~g~~  377 (506)
                      .|..|-...+|+....+ +..+++|+........-+..+|..++..+...++ .++++.+
T Consensus       115 ~lsgG~tN~~y~v~~~~~~~~~vLRi~g~~~~~~idR~~E~~vl~~L~~~gl~P~ll~~~  174 (458)
T 2qg7_A          115 IINGGITNILIKVKDMSKQAKYLIRLYGPKTDEIINREREKKISCILYNKNIAKKIYVFF  174 (458)
T ss_dssp             EECC--CEEEEEEEETTTTEEEEEEEECC-CCSCSCHHHHHHHHHHHTTSSSBCCEEEEE
T ss_pred             EcCCCeEeEEEEEEECCCCceEEEEECCCChhhhcCHHHHHHHHHHHHhcCCCCCEEEEe
Confidence            47788889999998865 4788899875432222233588888888864444 3444433

>3c5i_A Choline kinase; choline, kinase, malaria, transferase, structural genomics, structural genomics consortium; 2.20A {Plasmodium knowlesi} PDB: 3fi8_A*

Probab=95.24  E-value=0.039  Score=54.44  Aligned_cols=30  Identities=20%  Similarity=0.346  Sum_probs=25.0

Q ss_pred             CCeEecCcCCCcEEECCCCcEEEeecCCCcc
Q 039231          403 TRILHFDIKPHNILLDEDFCPKISDFGLAKI  433 (506)
Q Consensus       403 ~~ivH~dlkp~Nill~~~~~~ki~dfg~a~~  433 (506)
                      ..++|+|+++.|||++++. +.|+||..+..
T Consensus       212 ~~l~HgDl~~~Nil~~~~~-~~lID~e~a~~  241 (369)
T 3c5i_A          212 IVFCHNDLQENNIINTNKC-LRLIDFEYSGF  241 (369)
T ss_dssp             EEEECSCCCGGGEEECC-C-EEECCCTTCEE
T ss_pred             eEEEeCCCCcccEEecCCc-EEEEEecCCCC
Confidence            3589999999999998665 89999998864

>3feg_A Choline/ethanolamine kinase; non-protein kinase, choline kinase, structural genomics CONS SGC, hemicholinium-3, phosphorylation; HET: HC7 ADP AMP; 1.30A {Homo sapiens} PDB: 3lq3_A* 2ig7_A*

Probab=95.01  E-value=0.086  Score=52.22  Aligned_cols=47  Identities=9%  Similarity=0.107  Sum_probs=28.9

Q ss_pred             ccCccCceEEEEEEEc--------CCCEEEEEEeccCCCCchhhHHHHHHhhccC
Q 039231          320 KLGQGGYGSVYKGKLL--------DGSNVAVKVLNDSKGNGKEFINEVASISRTS  366 (506)
Q Consensus       320 ~ig~G~~g~V~~~~~~--------~~~~vavK~l~~~~~~~~~~~~E~~~l~~l~  366 (506)
                      .+..|-...+|+....        +++.+++|+..........+.+|.++++.+.
T Consensus        57 ~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlR~~g~~~~~~~~~~rE~~vl~~L~  111 (379)
T 3feg_A           57 PVSGGLSNLLFRCSLPDHLPSVGEEPREVLLRLYGAILQGVDSLVLESVMFAILA  111 (379)
T ss_dssp             EC-----CCEEEEECCTTSCCCSSCCSEEEEEECC---CCHHHHHHHHHHHHHHH
T ss_pred             EcCCcccccEEEEEeCCCccccCCCCCeEEEEECCCccchHHHHHHHHHHHHHHH
Confidence            3666777889998864        2478999987443334466778999888774

>2ppq_A HSK, HK, homoserine kinase; structural genomics, MCSG, PSI-2, protein structure initiative; 2.00A {Agrobacterium tumefaciens str} SCOP: d.144.1.6

Probab=94.78  E-value=0.086  Score=50.66  Aligned_cols=32  Identities=22%  Similarity=0.274  Sum_probs=27.3

Q ss_pred             CCCeEecCcCCCcEEECCCCcEEEeecCCCcc
Q 039231          402 STRILHFDIKPHNILLDEDFCPKISDFGLAKI  433 (506)
Q Consensus       402 ~~~ivH~dlkp~Nill~~~~~~ki~dfg~a~~  433 (506)
                      ...++|+|+++.|||++++..+.|+||+.+..
T Consensus       186 ~~~liHgDl~~~Nil~~~~~~~~lIDf~~a~~  217 (322)
T 2ppq_A          186 PAGVIHADLFQDNVFFLGDELSGLIDFYFACN  217 (322)
T ss_dssp             CEEEECSCCCGGGEEEETTEEEEECCCTTCEE
T ss_pred             CcccCCCCCCccCEEEeCCceEEEecchhccC
Confidence            35789999999999999876668999998864

>2l2t_A Receptor tyrosine-protein kinase ERBB-4; transmembrane dimer, membrane domain, membrane protei; NMR {Homo sapiens}

Probab=94.13  E-value=0.096  Score=33.82  Aligned_cols=13  Identities=31%  Similarity=0.483  Sum_probs=6.2

Q ss_pred             HHHHHHHHhcccC
Q 039231          268 IFIAFYFKRKLSS  280 (506)
Q Consensus       268 i~l~~~~rrk~~~  280 (506)
                      +.+++|+|||+.+
T Consensus        28 ~~~~~~~RRRr~~   40 (44)
T 2l2t_A           28 LTFAVYVRRKSIK   40 (44)
T ss_dssp             HHHHHHHHTTCSS
T ss_pred             HHHHHHhhhhhhh
Confidence            3444555555443

>1zyl_A Hypothetical protein YIHE; putative protein kinase, structural genomics, PSI, protein structure initiative; 2.80A {Escherichia coli} SCOP: d.144.1.6

Probab=94.04  E-value=0.17  Score=48.74  Aligned_cols=45  Identities=16%  Similarity=0.095  Sum_probs=33.0

Q ss_pred             cCccCceEEEEEEEcCCCEEEEEEeccCCCCchhhHHHHHHhhccC
Q 039231          321 LGQGGYGSVYKGKLLDGSNVAVKVLNDSKGNGKEFINEVASISRTS  366 (506)
Q Consensus       321 ig~G~~g~V~~~~~~~~~~vavK~l~~~~~~~~~~~~E~~~l~~l~  366 (506)
                      ++ |....||+....+|+.+++|+..........+..|...+..+.
T Consensus        34 l~-g~~n~~y~v~~~~g~~~vlK~~~~~~~~~~~~~~E~~~~~~L~   78 (328)
T 1zyl_A           34 LN-SYENRVYQFQDEDRRRFVVKFYRPERWTADQILEEHQFALQLV   78 (328)
T ss_dssp             EC-CSSSEEEEECCTTCCCEEEEEECTTTSCHHHHHHHHHHHHHHH
T ss_pred             ec-CcccceEEEEcCCCCEEEEEEcCCCCCCHHHHHHHHHHHHHHH
Confidence            55 7778999988777878999998754334456777887777663

>2ks1_B Epidermal growth factor receptor; ERBB1, ERBB2, transmembrane, heterodimer, complex, tyrosine receptor, bicelles, transferase; NMR {Homo sapiens}

Probab=94.04  E-value=0.095  Score=33.91  Aligned_cols=13  Identities=15%  Similarity=0.416  Sum_probs=6.1

Q ss_pred             HHHHHHHHhcccC
Q 039231          268 IFIAFYFKRKLSS  280 (506)
Q Consensus       268 i~l~~~~rrk~~~  280 (506)
                      +.+++|+|||+.+
T Consensus        29 ~~~~~~~RRr~~~   41 (44)
T 2ks1_B           29 LGIGLFMRRRHIV   41 (44)
T ss_dssp             HHHHHHHHTTTCC
T ss_pred             HHHHHHhhhhHhh
Confidence            4444555555433

>3jr1_A Putative fructosamine-3-kinase; YP_719053.1, structural genomics, joint center for structural genomics, JCSG; HET: MSE UNL; 2.32A {Haemophilus somnus 129PT}

Probab=93.78  E-value=0.2  Score=48.13  Aligned_cols=44  Identities=20%  Similarity=0.175  Sum_probs=33.6

Q ss_pred             ccCccCceEEEEEEEcCCCEEEEEEeccCCCCchhhHHHHHHhhccC
Q 039231          320 KLGQGGYGSVYKGKLLDGSNVAVKVLNDSKGNGKEFINEVASISRTS  366 (506)
Q Consensus       320 ~ig~G~~g~V~~~~~~~~~~vavK~l~~~~~~~~~~~~E~~~l~~l~  366 (506)
                      .|+.|....+|+... ++..+++|+....  ....+.+|.+.|+.+.
T Consensus        43 ~l~gG~~n~~y~v~~-~~~~~vlK~~~~~--~~~~~~~E~~~L~~L~   86 (312)
T 3jr1_A           43 KLYSGEMNEIWLIND-EVQTVFVKINERS--YRSMFRAEADQLALLA   86 (312)
T ss_dssp             EECCSSSSEEEEEES-SSCEEEEEEEEGG--GHHHHHHHHHHHHHHH
T ss_pred             EeCCccceeeeEEEE-CCCeEEEEeCCcc--cHHHHHHHHHHHHHHH
Confidence            488999999999986 5678889987543  2456788888887774

>2q83_A YTAA protein; 2635576, structural genomics, joint center for structu genomics, JCSG, protein structure initiative, PSI-2, transf; HET: ADN CIT UNL; 2.50A {Bacillus subtilis}

Probab=93.69  E-value=0.055  Score=52.40  Aligned_cols=32  Identities=25%  Similarity=0.227  Sum_probs=29.0

Q ss_pred             CCCeEecCcCCCcEEECCCCcEEEeecCCCcc
Q 039231          402 STRILHFDIKPHNILLDEDFCPKISDFGLAKI  433 (506)
Q Consensus       402 ~~~ivH~dlkp~Nill~~~~~~ki~dfg~a~~  433 (506)
                      ...++|+|+++.||+++.++.+.|+||+.+..
T Consensus       221 ~~~l~HgD~~~~Nil~~~~~~~~lIDfe~a~~  252 (346)
T 2q83_A          221 SPNLCHQDYGTGNTLLGENEQIWVIDLDTVSF  252 (346)
T ss_dssp             SCCEECSSCSTTSEEECGGGCEEECCCTTCEE
T ss_pred             cCceecCCCCcccEEEeCCCcEEEEehhhccc
Confidence            67899999999999998888899999998854

>2jwa_A Receptor tyrosine-protein kinase ERBB-2; transmembrane helix dimer, protein kinase receptor membrane domain, ATP-binding, glycoprotein; NMR {Homo sapiens} PDB: 2ks1_A

Probab=92.56  E-value=0.24  Score=31.89  Aligned_cols=9  Identities=22%  Similarity=0.434  Sum_probs=4.2

Q ss_pred             HHHHHhccc
Q 039231          271 AFYFKRKLS  279 (506)
Q Consensus       271 ~~~~rrk~~  279 (506)
                      .+|+|||+.
T Consensus        32 ~~~~RRR~~   40 (44)
T 2jwa_A           32 GILIKRRQQ   40 (44)
T ss_dssp             HHHHHHHCS
T ss_pred             Hhheehhhh
Confidence            345555443

>2pyw_A Uncharacterized protein; 5-methylthioribose kinase, plant methionine recycling, refol transferase; HET: SR1 ADP; 1.90A {Arabidopsis thaliana}

Probab=91.32  E-value=0.17  Score=50.86  Aligned_cols=33  Identities=12%  Similarity=0.255  Sum_probs=29.3

Q ss_pred             CCCeEecCcCCCcEEECCCCcEEEeecCCCcccc
Q 039231          402 STRILHFDIKPHNILLDEDFCPKISDFGLAKICN  435 (506)
Q Consensus       402 ~~~ivH~dlkp~Nill~~~~~~ki~dfg~a~~~~  435 (506)
                      ...++|+|++|.|||++.++ ++|+||+.+....
T Consensus       231 ~~~liHGDl~~~Nil~~~~~-~~lID~e~a~~G~  263 (420)
T 2pyw_A          231 AQALIHGDLHTGSVMVTQDS-TQVIDPEFSFYGP  263 (420)
T ss_dssp             CCEEECSCCSGGGEEECSSC-EEECCCTTCEEEC
T ss_pred             CCeEEecCCCCCcEEEeCCC-CEEEeCcccccCc
Confidence            78999999999999998876 9999999887543

>3mes_A Choline kinase; malaria, structural genomics, structural genomics consortium, SGC, transferase; HET: ADP DME PT3; 2.35A {Cryptosporidium parvum}

Probab=90.41  E-value=0.95  Score=45.37  Aligned_cols=30  Identities=20%  Similarity=0.346  Sum_probs=26.6

Q ss_pred             CCeEecCcCCCcEEECCCCcEEEeecCCCcc
Q 039231          403 TRILHFDIKPHNILLDEDFCPKISDFGLAKI  433 (506)
Q Consensus       403 ~~ivH~dlkp~Nill~~~~~~ki~dfg~a~~  433 (506)
                      ..++|+|+.+.||+ +.++.+.|+||..+..
T Consensus       262 ~~~~H~D~~~~N~l-~~~~~~~~IDwe~a~~  291 (424)
T 3mes_A          262 LVFAHNDLQENNLL-QTQNNIRMIDYEYSAI  291 (424)
T ss_dssp             EEEECSCCCGGGEE-ECSSCEEECCCTTCEE
T ss_pred             ceEECCCCCcccee-cCCCcEEEEecccCCc
Confidence            45899999999999 7788999999999864

>2yle_A Protein spire homolog 1; actin-binding protein, actin polymerization; 1.80A {Homo sapiens} PDB: 2ylf_A 3r7g_A 3rbw_A

Probab=89.49  E-value=0.22  Score=44.88  Aligned_cols=93  Identities=9%  Similarity=-0.013  Sum_probs=58.4

Q ss_pred             EEEeeccchhhhHHHHHHHHHHHHhhcCCCCeEecCcCCCcEEECCCCcEEEeecCCCccccCCCcceecccCCCCcccc
Q 039231          374 LGFCLRVAEELSSTIGIARGLEYLHLGCSTRILHFDIKPHNILLDEDFCPKISDFGLAKICNRKESIISMTGARGTVGYI  453 (506)
Q Consensus       374 ~g~~~~~~~~l~i~~~i~~gl~~LH~~~~~~ivH~dlkp~Nill~~~~~~ki~dfg~a~~~~~~~~~~~~~~~~gt~~y~  453 (506)
                      ++-.+.++++|.++.|.+.+|.-+-.  ...-..+=+.|..|++..+|.+.+.+ ..+.              .....+.
T Consensus        42 ~~~PlsEEqaWALc~Qc~~~L~~~~~--~~~~~~~i~~~~~i~l~~dG~V~f~~-~~s~--------------~~~~~~~  104 (229)
T 2yle_A           42 YNQPINEEQAWAVCYQCCGSLRAAAR--RRQPRHRVRSAAQIRVWRDGAVTLAP-AADD--------------AGEPPPV  104 (229)
T ss_dssp             HTSCCCHHHHHHHHHHHHHHHHHHHH--TTCCCCCCCSGGGEEEETTSCEEECC-C------------------------
T ss_pred             cCCCcCHHHHHHHHHHHHHHHHhhhh--cccCCceecCCcceEEecCCceeccc-cccc--------------ccccCCC
Confidence            33448899999999999999877621  11112334557899999999987764 1110              1123467


Q ss_pred             cccccccccCCCCccccHHHHHHHHHHHHcCCC
Q 039231          454 APEVFCRNIGEVSYKSDVYNYGMMIFEMTGGRK  486 (506)
Q Consensus       454 aPE~l~~~~~~~s~~~Dv~s~G~il~elltg~~  486 (506)
                      |||...   ...+.+.=|||+|++||..+-=..
T Consensus       105 ~pe~~~---~~~te~~~IysLG~tLY~ALDygL  134 (229)
T 2yle_A          105 AGKLGY---SQCMETEVIESLGIIIYKALDYGL  134 (229)
T ss_dssp             --CCSS---SSSCHHHHHHHHHHHHHHHHTTTC
T ss_pred             Chhhcc---ccchHHHHHHHHHHHHHHHhhcCC
Confidence            888762   245788899999999999885333

>3csv_A Aminoglycoside phosphotransferase; YP_614837.1, phosphotransferase enzyme family, structural genomics, JOIN for structural genomics, JCSG; HET: MSE; 2.15A {Silicibacter SP}

Probab=88.40  E-value=0.42  Score=46.03  Aligned_cols=34  Identities=24%  Similarity=0.272  Sum_probs=29.3

Q ss_pred             CCCeEecCcCCCcEEECCC----CcEEEeecCCCcccc
Q 039231          402 STRILHFDIKPHNILLDED----FCPKISDFGLAKICN  435 (506)
Q Consensus       402 ~~~ivH~dlkp~Nill~~~----~~~ki~dfg~a~~~~  435 (506)
                      ...++|+|+.+.|||++.+    ..+.|+||+.+....
T Consensus       182 ~~~lvHgD~~~~Nil~~~~~~~~~~~~lIDf~~a~~G~  219 (333)
T 3csv_A          182 DMVFVHRDFHAQNLLWLPEREGLARVGVIDFQDAKLGH  219 (333)
T ss_dssp             CCEEECSCCSGGGEEECTTSCGGGGEEECCCTTCEEEC
T ss_pred             CCeeEeCCcCcccEEeccCcCCCCCeEEEeCCCcCcCC
Confidence            5789999999999999874    679999999887543

>3cxl_A N-chimerin; SH2, RHO-GAP, structural genomics consortium, SGC, gtpas activation, metal-binding, phorbol-ester binding, SH2 domai finger; 2.60A {Homo sapiens} PDB: 1xa6_A

Probab=80.49  E-value=0.17  Score=51.66  Aligned_cols=57  Identities=7%  Similarity=0.051  Sum_probs=16.3

Q ss_pred             ccccCccCceEEEEEEEcC-CCEEEE------EEeccC---CCCchhhHHHHHHhhccCccceeEEEEEe
Q 039231          318 KYKLGQGGYGSVYKGKLLD-GSNVAV------KVLNDS---KGNGKEFINEVASISRTSHVNVVALLGFC  377 (506)
Q Consensus       318 ~~~ig~G~~g~V~~~~~~~-~~~vav------K~l~~~---~~~~~~~~~E~~~l~~l~h~niv~l~g~~  377 (506)
                      .++||   ||.||+|.+.. ..+|||      |..+..   ......+.+|..++..++|||+++..++.
T Consensus       147 ~~~lG---fG~v~~g~~~~~~~~Vav~~~~~~K~~~~~~~~~e~~~~~~rea~l~~~~~H~niv~~h~f~  213 (463)
T 3cxl_A          147 YEHVG---YTTLNREPAYKKHMPVLKETHDERDSTGQDGVSEKRLTSLVRRATLKENEQIPKYEKIHNFK  213 (463)
T ss_dssp             TTTSS---BCCC---------CCBGGGC-----------------------------------CBCCCEE
T ss_pred             cccCC---chhhhcccccccCCchhhhhccCccccccccccccccccccccccccccccccccCCCcceE
Confidence            34566   99999999854 468888      766542   22335688899999999999999988765

>3i1a_A Spectinomycin phosphotransferase; protein kinase, aminoglycoside phosphotransferase, antibiotic resistance; HET: MES PG4; 1.70A {Legionella pneumophila} PDB: 3i0q_A* 3i0o_A* 3q2m_A*

Probab=80.29  E-value=0.65  Score=44.99  Aligned_cols=34  Identities=21%  Similarity=0.256  Sum_probs=29.3

Q ss_pred             CCCeEecCcCCCcEEECCCCcEEEeecCCCcccc
Q 039231          402 STRILHFDIKPHNILLDEDFCPKISDFGLAKICN  435 (506)
Q Consensus       402 ~~~ivH~dlkp~Nill~~~~~~ki~dfg~a~~~~  435 (506)
                      ...++|+|+.+.||++++++.+.|+||+.+....
T Consensus       205 ~~~~~HgD~~~~N~l~~~~~~~~~iD~e~~~~~~  238 (339)
T 3i1a_A          205 KYVLCHSDIHAGNVLVGNEESIYIIDWDEPMLAP  238 (339)
T ss_dssp             GCEEECSCCCGGGEEECGGGCEEECCCSSCEEEC
T ss_pred             CceeEeCCCCcCCEEEeCCCeEEEEECCCCeeCC
Confidence            4679999999999999988889999998876543

---

Homologous Structure Domains

Structure Domains Detected by RPS-BLAST

Original result of RPS-BLAST against SCOP70(version1.75) database

ID	Length	Definition	E-value
Query	506
d1uwha_	276	d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens)	1e-44
d1qpca_	272	d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Hom	2e-40
d1fmka3	285	d.144.1.7 (A:249-533) c-src tyrosine kinase {Human	4e-40
d1sm2a_	263	d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Hu	2e-39
d1k2pa_	258	d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Hum	2e-38
d1u5ra_	309	d.144.1.7 (A:) Serine/threonine protein kinase TAO	2e-38
d1vjya_	303	d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human	2e-38
d1s9ja_	322	d.144.1.7 (A:) Dual specificity mitogen-activated	2e-37
d1t4ha_	270	d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sa	4e-36
d1opja_	287	d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mou	7e-36
d2jfla1	288	d.144.1.7 (A:21-308) STE20-like serine/threonine-p	7e-36
d1nvra_	271	d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {	1e-35
d2j4za1	263	d.144.1.7 (A:126-388) Aurora-related kinase 1 (aur	2e-35
d1byga_	262	d.144.1.7 (A:) Carboxyl-terminal src kinase (csk)	2e-35
d1r0pa_	311	d.144.1.7 (A:) Hepatocyte growth factor receptor,	3e-35
d2java1	269	d.144.1.7 (A:3-271) Serine/threonine-protein kinas	4e-35
d1xbba_	277	d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human	2e-34
d1jpaa_	299	d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mou	3e-34
d1u59a_	285	d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Hum	8e-34
d1yhwa1	293	d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [	4e-33
d1rjba_	325	d.144.1.7 (A:) Fl cytokine receptor {Human (Homo s	8e-33
d1xkka_	317	d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-	1e-32
d1mqba_	283	d.144.1.7 (A:) epha2 receptor tyrosine kinase {Hum	3e-32
d1uu3a_	288	d.144.1.7 (A:) 3-phosphoinositide dependent protei	1e-31
d1mp8a_	273	d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Huma	6e-31
d1lufa_	301	d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus n	6e-31
d1u46a_	273	d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Hum	7e-31
d1koaa2	350	d.144.1.7 (A:5915-6264) Twitchin, kinase domain {C	2e-30
d1t46a_	311	d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens	7e-30
d1pmea_	345	d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapien	1e-29
d1fvra_	309	d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [	1e-28
d1fota_	316	d.144.1.7 (A:) cAMP-dependent PK, catalytic subuni	4e-28
d1ywna1	299	d.144.1.7 (A:818-1166) Vascular endothelial growth	4e-28
d1ob3a_	286	d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmod	7e-28
d1csna_	293	d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast	2e-27
d1omwa3	364	d.144.1.7 (A:186-549) G-protein coupled receptor k	3e-27
d1q5ka_	350	d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gs	3e-27
d1ua2a_	299	d.144.1.7 (A:) Cell division protein kinase 7, CDK	4e-27
d1koba_	352	d.144.1.7 (A:) Twitchin, kinase domain {California	4e-27
d1gz8a_	298	d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (H	8e-27
d1a06a_	307	d.144.1.7 (A:) Calmodulin-dependent protein kinase	1e-26
d1tkia_	321	d.144.1.7 (A:) Titin, kinase domain {Human (Homo s	1e-26
d1o6ya_	277	d.144.1.7 (A:) Mycobacterial protein kinase PknB,	2e-26
d1ckia_	299	d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus n	3e-26
d1blxa_	305	d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (H	3e-26
d3blha1	318	d.144.1.7 (A:8-325) Cell division protein kinase 9	3e-26
d1phka_	277	d.144.1.7 (A:) gamma-subunit of glycogen phosphory	4e-26
d1xjda_	320	d.144.1.7 (A:) Protein kinase C, theta type {Human	6e-26
d1p4oa_	308	d.144.1.7 (A:) Insulin-like growth factor 1 recept	8e-26
d1unla_	292	d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (H	1e-25
d1o6la_	337	d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sap	2e-25
d1fgka_	299	d.144.1.7 (A:) Fibroblast growth factor receptor 1	7e-25
d1cm8a_	346	d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo s	1e-23
d1rdqe_	350	d.144.1.7 (E:) cAMP-dependent PK, catalytic subuni	1e-23
d1jksa_	293	d.144.1.7 (A:) Death-associated protein kinase, Da	2e-23
d1xwsa_	273	d.144.1.7 (A:) Proto-oncogene serine/threonine-pro	2e-23
d2ozaa1	335	d.144.1.7 (A:51-385) MAP kinase activated protein	3e-23
d1vzoa_	322	d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5	6e-22
d3bqca1	328	d.144.1.7 (A:3-330) Protein kinase CK2, alpha subu	7e-22
d2gfsa1	348	d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sa	2e-21
d1q8ya_	362	d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces	2e-21
d2b1pa1	355	d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3	2e-20
d1zara2	191	d.144.1.9 (A:91-281) Rio2 serine protein kinase C-	2e-16

>d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 276

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: B-Raf kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  156 bits (395), Expect = 1e-44
 Identities = 58/198 (29%), Positives = 98/198 (49%), Gaps = 36/198 (18%)

Query: 320 KLGQGGYGSVYKGKLLDGSNVAVKVLNDSKGNG---KEFINEVASISRTSHVNVVALLGF 376
           ++G G +G+VYKGK     +VAVK+LN +       + F NEV  + +T HVN++  +G+
Sbjct: 15  RIGSGSFGTVYKGKW--HGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGY 72

Query: 377 C---------------------------LRVAEELSSTIGIARGLEYLHLGCSTRILHFD 409
                                         + + +      A+G++YLH      I+H D
Sbjct: 73  STAPQLAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLHAKS---IIHRD 129

Query: 410 IKPHNILLDEDFCPKISDFGLAKICNRKESIISMTGARGTVGYIAPEVF-CRNIGEVSYK 468
           +K +NI L ED   KI DFGLA + +R           G++ ++APEV   ++    S++
Sbjct: 130 LKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQDKNPYSFQ 189

Query: 469 SDVYNYGMMIFEMTGGRK 486
           SDVY +G++++E+  G+ 
Sbjct: 190 SDVYAFGIVLYELMTGQL 207

>d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} Length = 272

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Lymphocyte kinase (lck)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  144 bits (365), Expect = 2e-40
 Identities = 49/195 (25%), Positives = 83/195 (42%), Gaps = 35/195 (17%)

Query: 320 KLGQGGYGSVYKGKLLDGSNVAVKVLNDSKGNGKEFINEVASISRTSHVNVVALLGFC-- 377
           +LG G +G V+ G     + VAVK L     +   F+ E   + +  H  +V L      
Sbjct: 20  RLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPDAFLAEANLMKQLQHQRLVRLYAVVTQ 79

Query: 378 --------------------------LRVAEELSSTIGIARGLEYLHLGCSTRILHFDIK 411
                                     L + + L     IA G+ ++        +H D++
Sbjct: 80  EPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIE---ERNYIHRDLR 136

Query: 412 PHNILLDEDFCPKISDFGLAKICNRKESIISMTGARGTVGYIAPEVFCRNIGEVSYKSDV 471
             NIL+ +    KI+DFGLA++    E   +  GA+  + + APE      G  + KSDV
Sbjct: 137 AANILVSDTLSCKIADFGLARLIEDNEY-TAREGAKFPIKWTAPEAINY--GTFTIKSDV 193

Query: 472 YNYGMMIFEM-TGGR 485
           +++G+++ E+ T GR
Sbjct: 194 WSFGILLTEIVTHGR 208

>d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 285

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-src tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  144 bits (364), Expect = 4e-40
 Identities = 51/198 (25%), Positives = 88/198 (44%), Gaps = 35/198 (17%)

Query: 317 FKYKLGQGGYGSVYKGKLLDGSNVAVKVLNDSKGNGKEFINEVASISRTSHVNVVALLGF 376
            + KLGQG +G V+ G     + VA+K L     + + F+ E   + +  H  +V L   
Sbjct: 21  LEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAV 80

Query: 377 C----------------------------LRVAEELSSTIGIARGLEYLHLGCSTRILHF 408
                                        LR+ + +     IA G+ Y+        +H 
Sbjct: 81  VSEEPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVE---RMNYVHR 137

Query: 409 DIKPHNILLDEDFCPKISDFGLAKICNRKESIISMTGARGTVGYIAPEVFCRNIGEVSYK 468
           D++  NIL+ E+   K++DFGLA++    E   +  GA+  + + APE      G  + K
Sbjct: 138 DLRAANILVGENLVCKVADFGLARLIEDNEY-TARQGAKFPIKWTAPEAALY--GRFTIK 194

Query: 469 SDVYNYGMMIFEM-TGGR 485
           SDV+++G+++ E+ T GR
Sbjct: 195 SDVWSFGILLTELTTKGR 212

>d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} Length = 263

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase Itk/Tsk
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  141 bits (357), Expect = 2e-39
 Identities = 50/198 (25%), Positives = 90/198 (45%), Gaps = 35/198 (17%)

Query: 317 FKYKLGQGGYGSVYKGKLLDGSNVAVKVLNDSKGNGKEFINEVASISRTSHVNVVALLGF 376
           F  ++G G +G V+ G  L+   VA+K + +   + ++FI E   + + SH  +V L G 
Sbjct: 9   FVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAMSEEDFIEEAEVMMKLSHPKLVQLYGV 68

Query: 377 CLR------VAEELSS----------------------TIGIARGLEYLHLGCSTRILHF 408
           CL       V E +                         + +  G+ YL       ++H 
Sbjct: 69  CLEQAPICLVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYL---EEACVIHR 125

Query: 409 DIKPHNILLDEDFCPKISDFGLAKICNRKESIISMTGARGTVGYIAPEVFCRNIGEVSYK 468
           D+   N L+ E+   K+SDFG+ +     +   S  G +  V + +PEVF       S K
Sbjct: 126 DLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSST-GTKFPVKWASPEVFSF--SRYSSK 182

Query: 469 SDVYNYGMMIFEM-TGGR 485
           SDV+++G++++E+ + G+
Sbjct: 183 SDVWSFGVLMWEVFSEGK 200

>d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} Length = 258

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Bruton's tyrosine kinase (Btk)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  139 bits (350), Expect = 2e-38
 Identities = 51/198 (25%), Positives = 87/198 (43%), Gaps = 35/198 (17%)

Query: 317 FKYKLGQGGYGSVYKGKLLDGSNVAVKVLNDSKGNGKEFINEVASISRTSHVNVVALLGF 376
           F  +LG G +G V  GK     +VA+K++ +   +  EFI E   +   SH  +V L G 
Sbjct: 8   FLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSEDEFIEEAKVMMNLSHEKLVQLYGV 67

Query: 377 C----------------------------LRVAEELSSTIGIARGLEYLHLGCSTRILHF 408
           C                             +  + L     +   +EYL    S + LH 
Sbjct: 68  CTKQRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLE---SKQFLHR 124

Query: 409 DIKPHNILLDEDFCPKISDFGLAKICNRKESIISMTGARGTVGYIAPEVFCRNIGEVSYK 468
           D+   N L+++    K+SDFGL++     E   S  G++  V +  PEV      + S K
Sbjct: 125 DLAARNCLVNDQGVVKVSDFGLSRYVLDDEY-TSSVGSKFPVRWSPPEVLMY--SKFSSK 181

Query: 469 SDVYNYGMMIFEM-TGGR 485
           SD++ +G++++E+ + G+
Sbjct: 182 SDIWAFGVLMWEIYSLGK 199

>d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 309

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine protein kinase TAO2
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  140 bits (353), Expect = 2e-38
 Identities = 53/199 (26%), Positives = 83/199 (41%), Gaps = 42/199 (21%)

Query: 320 KLGQGGYGSVYKGKLL-DGSNVAVKVLNDSKGNGKE----FINEVASISRTSHVNVVALL 374
           ++G G +G+VY  + + +   VA+K ++ S     E     I EV  + +  H N +   
Sbjct: 22  EIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYR 81

Query: 375 GFC---------------------------LRVAEELSSTIGIARGLEYLHLGCSTRILH 407
           G                             L+  E  + T G  +GL YLH   S  ++H
Sbjct: 82  GCYLREHTAWLVMEYCLGSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLH---SHNMIH 138

Query: 408 FDIKPHNILLDEDFCPKISDFGLAKICNRKESIISMTGARGTVGYIAPEVF-CRNIGEVS 466
            D+K  NILL E    K+ DFG A I     S +      GT  ++APEV    + G+  
Sbjct: 139 RDVKAGNILLSEPGLVKLGDFGSASIMAPANSFV------GTPYWMAPEVILAMDEGQYD 192

Query: 467 YKSDVYNYGMMIFEMTGGR 485
            K DV++ G+   E+   +
Sbjct: 193 GKVDVWSLGITCIELAERK 211

>d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} Length = 303

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Type I TGF-beta receptor R4
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  139 bits (352), Expect = 2e-38
 Identities = 46/208 (22%), Positives = 79/208 (37%), Gaps = 42/208 (20%)

Query: 320 KLGQGGYGSVYKGKLLDGSNVAVKVLNDSKGNGKEFINEVASISRTSHVNVVALLGFC-- 377
            +G+G +G V++GK   G  VAVK+ +  +        E+       H N++  +     
Sbjct: 10  SIGKGRFGEVWRGKW-RGEEVAVKIFSSREERSWFREAEIYQTVMLRHENILGFIAADNK 68

Query: 378 ----------------------------LRVAEELSSTIGIARGLEYLHLGC-----STR 404
                                       + V   +   +  A GL +LH+          
Sbjct: 69  DNGTWTQLWLVSDYHEHGSLFDYLNRYTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPA 128

Query: 405 ILHFDIKPHNILLDEDFCPKISDFGLAKICNRKES--IISMTGARGTVGYIAPEVFCRNI 462
           I H D+K  NIL+ ++    I+D GLA   +       I+     GT  Y+APEV   +I
Sbjct: 129 IAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSI 188

Query: 463 ----GEVSYKSDVYNYGMMIFEMTGGRK 486
                E   ++D+Y  G++ +E+     
Sbjct: 189 NMKHFESFKRADIYAMGLVFWEIARRCS 216

>d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  137 bits (347), Expect = 2e-37
 Identities = 47/217 (21%), Positives = 83/217 (38%), Gaps = 38/217 (17%)

Query: 320 KLGQGGYGSVYKGKLL-DGSNVAVKVLNDSKGNG--KEFINEVASISRTSHVNVVALLGF 376
           +LG G  G V+K      G  +A K+++         + I E+  +   +   +V   G 
Sbjct: 13  ELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGA 72

Query: 377 CL-------------------------RVAEELSSTI--GIARGLEYLHLGCSTRILHFD 409
                                      R+ E++   +   + +GL YL      +I+H D
Sbjct: 73  FYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKH--KIMHRD 130

Query: 410 IKPHNILLDEDFCPKISDFGLAKICNRKESIISMTGARGTVGYIAPEVFCRNIGEVSYKS 469
           +KP NIL++     K+ DFG++       +        GT  Y++PE         S +S
Sbjct: 131 VKPSNILVNSRGEIKLCDFGVSGQLIDSMA----NSFVGTRSYMSPERLQG--THYSVQS 184

Query: 470 DVYNYGMMIFEMTGGRKNVDVVDNGSTALDLQASRKG 506
           D+++ G+ + EM  GR  +   D     L      +G
Sbjct: 185 DIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEG 221

>d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 270

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase wnk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  133 bits (335), Expect = 4e-36
 Identities = 47/206 (22%), Positives = 75/206 (36%), Gaps = 44/206 (21%)

Query: 317 FKYKLGQGGYGSVYKGKLLD-GSNVAVKVLND---SKGNGKEFINEVASISRTSHVNVVA 372
           F  ++G+G + +VYKG   +    VA   L D   +K   + F  E   +    H N+V 
Sbjct: 13  FDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVR 72

Query: 373 LLGFC-------------------------------LRVAEELSSTIGIARGLEYLHLGC 401
                                               +++    S    I +GL++LH   
Sbjct: 73  FYDSWESTVKGKKCIVLVTELMTSGTLKTYLKRFKVMKIKVLRSWCRQILKGLQFLHT-R 131

Query: 402 STRILHFDIKPHNILL-DEDFCPKISDFGLAKICNRKESIISMTGARGTVGYIAPEVFCR 460
           +  I+H D+K  NI +       KI D GLA +              GT  ++APE++  
Sbjct: 132 TPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRASF----AKAVIGTPEFMAPEMYE- 186

Query: 461 NIGEVSYKSDVYNYGMMIFEMTGGRK 486
              +     DVY +GM + EM     
Sbjct: 187 --EKYDESVDVYAFGMCMLEMATSEY 210

>d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} Length = 287

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Abelsone tyrosine kinase (abl)
species: Mouse (Mus musculus) [TaxId: 10090]

 Score =  132 bits (334), Expect = 7e-36
 Identities = 55/220 (25%), Positives = 94/220 (42%), Gaps = 38/220 (17%)

Query: 299 SLSPKRYGYAD--IKKMTNSFKYKLGQGGYGSVYKGKLLD-GSNVAVKVLNDSKGNGKEF 355
           ++ P    Y    +++   + K+KLG G YG VY+G        VAVK L +     +EF
Sbjct: 1   AMDPSSPNYDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEF 60

Query: 356 INEVASISRTSHVNVVALLGFC-----------------------------LRVAEELSS 386
           + E A +    H N+V LLG C                             +     L  
Sbjct: 61  LKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYM 120

Query: 387 TIGIARGLEYLHLGCSTRILHFDIKPHNILLDEDFCPKISDFGLAKICNRKESIISMTGA 446
              I+  +EYL        +H D+   N L+ E+   K++DFGL+++    ++  +  GA
Sbjct: 121 ATQISSAMEYLE---KKNFIHRDLAARNCLVGENHLVKVADFGLSRLMT-GDTYTAHAGA 176

Query: 447 RGTVGYIAPEVFCRNIGEVSYKSDVYNYGMMIFEMTGGRK 486
           +  + + APE       + S KSDV+ +G++++E+     
Sbjct: 177 KFPIKWTAPESLAY--NKFSIKSDVWAFGVLLWEIATYGM 214

>d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} Length = 288

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: STE20-like serine/threonine-protein kinase, SLK
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  132 bits (334), Expect = 7e-36
 Identities = 48/199 (24%), Positives = 79/199 (39%), Gaps = 38/199 (19%)

Query: 320 KLGQGGYGSVYKGKLLD-GSNVAVKVLN-DSKGNGKEFINEVASISRTSHVNVVALLGFC 377
           +LG G +G VYK +  +     A KV++  S+   ++++ E+  ++   H N+V LL   
Sbjct: 19  ELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAF 78

Query: 378 ----------------------------LRVAEELSSTIGIARGLEYLHLGCSTRILHFD 409
                                       L  ++           L YLH     +I+H D
Sbjct: 79  YYENNLWILIEFCAGGAVDAVMLELERPLTESQIQVVCKQTLDALNYLH---DNKIIHRD 135

Query: 410 IKPHNILLDEDFCPKISDFGLAKICNRKESIISMTGARGTVGYIAPEVF---CRNIGEVS 466
           +K  NIL   D   K++DFG++    R           GT  ++APEV            
Sbjct: 136 LKAGNILFTLDGDIKLADFGVSAKNTRTIQ--RRDSFIGTPYWMAPEVVMCETSKDRPYD 193

Query: 467 YKSDVYNYGMMIFEMTGGR 485
           YK+DV++ G+ + EM    
Sbjct: 194 YKADVWSLGITLIEMAEIE 212

>d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 271

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell cycle checkpoint kinase chk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  132 bits (332), Expect = 1e-35
 Identities = 52/200 (26%), Positives = 76/200 (38%), Gaps = 34/200 (17%)

Query: 320 KLGQGGYGSVYKGKLL-DGSNVAVKVLNDSKGNG--KEFINEVASISRTSHVNVVALLGF 376
            LG+G YG V           VAVK+++  +     +    E+      +H NVV   G 
Sbjct: 12  TLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGH 71

Query: 377 C---------------------------LRVAEELSSTIGIARGLEYLHLGCSTRILHFD 409
                                       +   +       +  G+ YLH      I H D
Sbjct: 72  RREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLH---GIGITHRD 128

Query: 410 IKPHNILLDEDFCPKISDFGLAKICNRKESIISMTGARGTVGYIAPEVFCRNIGEVSYKS 469
           IKP N+LLDE    KISDFGLA +         +    GT+ Y+APE+  R     +   
Sbjct: 129 IKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRR-EFHAEPV 187

Query: 470 DVYNYGMMIFEMTGGRKNVD 489
           DV++ G+++  M  G    D
Sbjct: 188 DVWSCGIVLTAMLAGELPWD 207

>d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 263

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Aurora-related kinase 1 (aurora-2)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  131 bits (330), Expect = 2e-35
 Identities = 49/198 (24%), Positives = 81/198 (40%), Gaps = 41/198 (20%)

Query: 320 KLGQGGYGSVYKGKLL-DGSNVAVKVLNDSKGNG----KEFINEVASISRTSHVNVVALL 374
            LG+G +G+VY  +       +A+KVL  ++        +   EV   S   H N++ L 
Sbjct: 13  PLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLY 72

Query: 375 GFCL-------------------------RVAEELSSTI--GIARGLEYLHLGCSTRILH 407
           G+                           +  E+ ++T    +A  L Y H   S R++H
Sbjct: 73  GYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCH---SKRVIH 129

Query: 408 FDIKPHNILLDEDFCPKISDFGLAKICNRKESIISMTGARGTVGYIAPEVFCRNIGEVSY 467
            DIKP N+LL      KI+DFG +            T   GT+ Y+ PE+          
Sbjct: 130 RDIKPENLLLGSAGELKIADFGWSVHAPSSR----RTTLCGTLDYLPPEMIEG--RMHDE 183

Query: 468 KSDVYNYGMMIFEMTGGR 485
           K D+++ G++ +E   G+
Sbjct: 184 KVDLWSLGVLCYEFLVGK 201

>d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} Length = 262

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Carboxyl-terminal src kinase (csk)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  130 bits (328), Expect = 2e-35
 Identities = 49/197 (24%), Positives = 85/197 (43%), Gaps = 43/197 (21%)

Query: 320 KLGQGGYGSVYKGKLLDGSNVAVKVLNDSKGNGKEFINEVASISRTSHVNVVALLGFC-- 377
            +G+G +G V  G    G+ VAVK + +     + F+ E + +++  H N+V LLG    
Sbjct: 14  TIGKGEFGDVMLGDY-RGNKVAVKCIKNDA-TAQAFLAEASVMTQLRHSNLVQLLGVIVE 71

Query: 378 ----------------------------LRVAEELSSTIGIARGLEYLHLGCSTRILHFD 409
                                       L     L  ++ +   +EYL        +H D
Sbjct: 72  EKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLE---GNNFVHRD 128

Query: 410 IKPHNILLDEDFCPKISDFGLAKICNRKESIISMTGARGTVGYIAPEVFCRNIGEVSYKS 469
           +   N+L+ ED   K+SDFGL K  +      +    +  V + APE       + S KS
Sbjct: 129 LAARNVLVSEDNVAKVSDFGLTKEASS-----TQDTGKLPVKWTAPEALRE--KKFSTKS 181

Query: 470 DVYNYGMMIFEM-TGGR 485
           DV+++G++++E+ + GR
Sbjct: 182 DVWSFGILLWEIYSFGR 198

>d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} Length = 311

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Hepatocyte growth factor receptor, c-MET
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  131 bits (331), Expect = 3e-35
 Identities = 64/233 (27%), Positives = 104/233 (44%), Gaps = 37/233 (15%)

Query: 288 LNIETFLRNYRSLSPKRYGYADIKKMTNSFKYKLGQGGYGSVYKGKLLDGSN----VAVK 343
           ++I+    N   +   ++       +   F   +G+G +G VY G LLD        AVK
Sbjct: 2   VHIDLSALNPELVQAVQHVVIGPSSLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVK 61

Query: 344 VLNDSKGNG--KEFINEVASISRTSHVNVVALLGFCLR-------VAEELSST------- 387
            LN     G   +F+ E   +   SH NV++LLG CLR       V   +          
Sbjct: 62  SLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIR 121

Query: 388 -----------IGIARG-LEYLHLGCSTRILHFDIKPHNILLDEDFCPKISDFGLAKICN 435
                      IG      + +    S + +H D+   N +LDE F  K++DFGLA+   
Sbjct: 122 NETHNPTVKDLIGFGLQVAKGMKFLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMY 181

Query: 436 RKE--SIISMTGARGTVGYIAPEVFCRNIGEVSYKSDVYNYGMMIFEM-TGGR 485
            KE  S+ + TGA+  V ++A E       + + KSDV+++G++++E+ T G 
Sbjct: 182 DKEFDSVHNKTGAKLPVKWMALESLQT--QKFTTKSDVWSFGVLLWELMTRGA 232

>d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} Length = 269

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine-protein kinase Nek2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  130 bits (327), Expect = 4e-35
 Identities = 48/208 (23%), Positives = 73/208 (35%), Gaps = 43/208 (20%)

Query: 317 FKYKLGQGGYGSVYKGKLL-DGSNVAVKVLNDSKGNGKE---FINEVASISRTSHVNVVA 372
             Y +G G YG   K +   DG  +  K L+       E    ++EV  +    H N+V 
Sbjct: 8   VLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVR 67

Query: 373 LLGFC---------------------------------LRVAEELSSTIGIARGLEYLHL 399
                                                 L     L     +   L+  H 
Sbjct: 68  YYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHR 127

Query: 400 --GCSTRILHFDIKPHNILLDEDFCPKISDFGLAKICNRKESIISMTGARGTVGYIAPEV 457
                  +LH D+KP N+ LD     K+ DFGLA+I N   S        GT  Y++PE 
Sbjct: 128 RSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSF--AKAFVGTPYYMSPEQ 185

Query: 458 FCRNIGEVSYKSDVYNYGMMIFEMTGGR 485
             R     + KSD+++ G +++E+    
Sbjct: 186 MNR--MSYNEKSDIWSLGCLLYELCALM 211

>d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} Length = 277

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase SYK
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  128 bits (322), Expect = 2e-34
 Identities = 52/214 (24%), Positives = 93/214 (43%), Gaps = 40/214 (18%)

Query: 307 YADIKKMTNSFKYKLGQGGYGSVYKGKLLD---GSNVAVKVLNDSKGNG---KEFINEVA 360
           Y D K +T   K +LG G +G+V KG          VAVK+L +   +     E + E  
Sbjct: 2   YLDRKLLTLEDK-ELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEAN 60

Query: 361 SISRTSHVNVVALLGFC--------------------------LRVAEELSSTIGIARGL 394
            + +  +  +V ++G C                          ++    +     ++ G+
Sbjct: 61  VMQQLDNPYIVRMIGICEAESWMLVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGM 120

Query: 395 EYLHLGCSTRILHFDIKPHNILLDEDFCPKISDFGLAK-ICNRKESIISMTGARGTVGYI 453
           +YL     +  +H D+   N+LL      KISDFGL+K +   +    + T  +  V + 
Sbjct: 121 KYLE---ESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWY 177

Query: 454 APEVFCRNIGEVSYKSDVYNYGMMIFEM-TGGRK 486
           APE       + S KSDV+++G++++E  + G+K
Sbjct: 178 APECINY--YKFSSKSDVWSFGVLMWEAFSYGQK 209

>d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: ephb2 receptor tyrosine kinase
species: Mouse (Mus musculus) [TaxId: 10090]

 Score =  128 bits (323), Expect = 3e-34
 Identities = 50/231 (21%), Positives = 94/231 (40%), Gaps = 54/231 (23%)

Query: 305 YGYADIKKMTNSFKY-----------KLGQGGYGSVYKGKLLDGSN----VAVKVLND-- 347
           + + D  +    F              +G G +G V  G L         VA+K L    
Sbjct: 7   FTFEDPNEAVREFAKEIDISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGY 66

Query: 348 SKGNGKEFINEVASISRTSHVNVVALLGFCLR---------------------------- 379
           ++   ++F++E + + +  H NV+ L G   +                            
Sbjct: 67  TEKQRRDFLSEASIMGQFDHPNVIHLEGVVTKSTPVMIITEFMENGSLDSFLRQNDGQFT 126

Query: 380 VAEELSSTIGIARGLEYLHLGCSTRILHFDIKPHNILLDEDFCPKISDFGLAKICNRKES 439
           V + +    GIA G++YL        +H D+   NIL++ +   K+SDFGL++      S
Sbjct: 127 VIQLVGMLRGIAAGMKYLADMN---YVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTS 183

Query: 440 IISMT---GARGTVGYIAPEVFCRNIGEVSYKSDVYNYGMMIFEM-TGGRK 486
             + T   G +  + + APE       + +  SDV++YG++++E+ + G +
Sbjct: 184 DPTYTSALGGKIPIRWTAPEAIQY--RKFTSASDVWSYGIVMWEVMSYGER 232

>d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} Length = 285

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase ZAP-70
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  127 bits (319), Expect = 8e-34
 Identities = 48/202 (23%), Positives = 85/202 (42%), Gaps = 39/202 (19%)

Query: 318 KYKLGQGGYGSVYKGKLLDGSN---VAVKVLND--SKGNGKEFINEVASISRTSHVNVVA 372
             +LG G +GSV +G          VA+KVL     K + +E + E   + +  +  +V 
Sbjct: 14  DIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVR 73

Query: 373 LLGFC---------------------------LRVAEELSSTIGIARGLEYLHLGCSTRI 405
           L+G C                           + V+        ++ G++YL        
Sbjct: 74  LIGVCQAEALMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLE---EKNF 130

Query: 406 LHFDIKPHNILLDEDFCPKISDFGLAKICNRKES-IISMTGARGTVGYIAPEVFCRNIGE 464
           +H D+   N+LL      KISDFGL+K     +S   + +  +  + + APE       +
Sbjct: 131 VHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPECINF--RK 188

Query: 465 VSYKSDVYNYGMMIFEM-TGGR 485
            S +SDV++YG+ ++E  + G+
Sbjct: 189 FSSRSDVWSYGVTMWEALSYGQ 210

>d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} Length = 293

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: pak1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  125 bits (315), Expect = 4e-33
 Identities = 54/194 (27%), Positives = 84/194 (43%), Gaps = 35/194 (18%)

Query: 320 KLGQGGYGSVYKGK-LLDGSNVAVKVLNDSKGNGKE-FINEVASISRTSHVNVVALLGFC 377
           K+GQG  G+VY    +  G  VA++ +N  +   KE  INE+  +    + N+V  L   
Sbjct: 27  KIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSY 86

Query: 378 L------------------------RVAEELSSTI--GIARGLEYLHLGCSTRILHFDIK 411
           L                         + E   + +     + LE+LH   S +++H DIK
Sbjct: 87  LVGDELWVVMEYLAGGSLTDVVTETCMDEGQIAAVCRECLQALEFLH---SNQVIHRDIK 143

Query: 412 PHNILLDEDFCPKISDFGLAKICNRKESIISMTGARGTVGYIAPEVFCRNIGEVSYKSDV 471
             NILL  D   K++DFG       ++S    +   GT  ++APEV  R       K D+
Sbjct: 144 SDNILLGMDGSVKLTDFGFCAQITPEQS--KRSTMVGTPYWMAPEVVTR--KAYGPKVDI 199

Query: 472 YNYGMMIFEMTGGR 485
           ++ G+M  EM  G 
Sbjct: 200 WSLGIMAIEMIEGE 213

>d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 325

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fl cytokine receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  125 bits (314), Expect = 8e-33
 Identities = 57/256 (22%), Positives = 95/256 (37%), Gaps = 76/256 (29%)

Query: 301 SPKRYGYADIKKMTNSFKY-----------KLGQGGYGSVYKGKLLDGSN------VAVK 343
           S   Y Y D ++     K+            LG G +G V        S       VAVK
Sbjct: 14  SDNEYFYVDFREYEYDLKWEFPRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVK 73

Query: 344 VLNDSKGNG--KEFINEVASISR-TSHVNVVALLGFC----------------------- 377
           +L +   +   +  ++E+  +++  SH N+V LLG C                       
Sbjct: 74  MLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACTLSGPIYLIFEYCCYGDLLNYLR 133

Query: 378 ---------------------------LRVAEELSSTIGIARGLEYLHLGCSTRILHFDI 410
                                      L   + L     +A+G+E+L        +H D+
Sbjct: 134 SKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLE---FKSCVHRDL 190

Query: 411 KPHNILLDEDFCPKISDFGLAKICNRKESIISMTGARGTVGYIAPEVFCRNIGEVSYKSD 470
              N+L+      KI DFGLA+      + +    AR  V ++APE      G  + KSD
Sbjct: 191 AARNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFE--GIYTIKSD 248

Query: 471 VYNYGMMIFEM-TGGR 485
           V++YG++++E+ + G 
Sbjct: 249 VWSYGILLWEIFSLGV 264

>d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 317

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: EGF receptor tyrosine kinase, Erbb-1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  124 bits (313), Expect = 1e-32
 Identities = 53/201 (26%), Positives = 89/201 (44%), Gaps = 40/201 (19%)

Query: 320 KLGQGGYGSVYKGKLLDGSN-----VAVKVLND--SKGNGKEFINEVASISRTSHVNVVA 372
            LG G +G+VYKG  +         VA+K L +  S    KE ++E   ++   + +V  
Sbjct: 16  VLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCR 75

Query: 373 LLGFCLR---------------------------VAEELSSTIGIARGLEYLHLGCSTRI 405
           LLG CL                                L+  + IA+G+ YL      R+
Sbjct: 76  LLGICLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYL---EDRRL 132

Query: 406 LHFDIKPHNILLDEDFCPKISDFGLAKICNRKESIISMTGARGTVGYIAPEVFCRNIGEV 465
           +H D+   N+L+      KI+DFGLAK+   +E      G +  + ++A E         
Sbjct: 133 VHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILH--RIY 190

Query: 466 SYKSDVYNYGMMIFEM-TGGR 485
           +++SDV++YG+ ++E+ T G 
Sbjct: 191 THQSDVWSYGVTVWELMTFGS 211

>d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 283

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: epha2 receptor tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  123 bits (308), Expect = 3e-32
 Identities = 48/216 (22%), Positives = 93/216 (43%), Gaps = 41/216 (18%)

Query: 321 LGQGGYGSVYKGKLLDGSN-----VAVKVLND--SKGNGKEFINEVASISRTSHVNVVAL 373
           +G G +G VYKG L   S      VA+K L    ++    +F+ E   + + SH N++ L
Sbjct: 15  IGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRL 74

Query: 374 LGFC----------------------------LRVAEELSSTIGIARGLEYLHLGCSTRI 405
            G                                V + +    GIA G++YL    +   
Sbjct: 75  EGVISKYKPMMIITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAGMKYLA---NMNY 131

Query: 406 LHFDIKPHNILLDEDFCPKISDFGLAKIC-NRKESIISMTGARGTVGYIAPEVFCRNIGE 464
           +H D+   NIL++ +   K+SDFGL+++  +  E+  + +G +  + + APE       +
Sbjct: 132 VHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGGKIPIRWTAPEAISY--RK 189

Query: 465 VSYKSDVYNYGMMIFEMTGGRKNVDVVDNGSTALDL 500
            +  SDV+++G++++E+    +      +    +  
Sbjct: 190 FTSASDVWSFGIVMWEVMTYGERPYWELSNHEVMKA 225

>d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 288

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: 3-phosphoinositide dependent protein kinase-1 Pdk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  121 bits (304), Expect = 1e-31
 Identities = 48/207 (23%), Positives = 76/207 (36%), Gaps = 35/207 (16%)

Query: 311 KKMTNSFKY--KLGQGGYGSVYKGK-LLDGSNVAVKVLN----DSKGNGKEFINEVASIS 363
           KK    FK+   LG+G + +V   + L      A+K+L       +        E   +S
Sbjct: 4   KKRPEDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMS 63

Query: 364 RTSHVNVVALLGFCL-------------------------RVAEELSSTIGIARGLEYLH 398
           R  H   V L                                 E  +     A  +  L 
Sbjct: 64  RLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFY-TAEIVSALE 122

Query: 399 LGCSTRILHFDIKPHNILLDEDFCPKISDFGLAKICNRKESIISMTGARGTVGYIAPEVF 458
                 I+H D+KP NILL+ED   +I+DFG AK+ + +          GT  Y++PE+ 
Sbjct: 123 YLHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPELL 182

Query: 459 CRNIGEVSYKSDVYNYGMMIFEMTGGR 485
                     SD++  G +I+++  G 
Sbjct: 183 TE--KSACKSSDLWALGCIIYQLVAGL 207

>d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} Length = 273

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Focal adhesion kinase 1 (fak)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  119 bits (298), Expect = 6e-31
 Identities = 44/200 (22%), Positives = 85/200 (42%), Gaps = 40/200 (20%)

Query: 320 KLGQGGYGSVYKGKLLDGSN----VAVKVLNDSKGNG--KEFINEVASISRTSHVNVVAL 373
            +G+G +G V++G  +   N    VA+K   +   +   ++F+ E  ++ +  H ++V L
Sbjct: 14  CIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKL 73

Query: 374 LGFC---------------------------LRVAEELSSTIGIARGLEYLHLGCSTRIL 406
           +G                             L +A  +     ++  L YL    S R +
Sbjct: 74  IGVITENPVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLE---SKRFV 130

Query: 407 HFDIKPHNILLDEDFCPKISDFGLAKICNRKESIISMTGARGTVGYIAPEVFCRNIGEVS 466
           H DI   N+L+  + C K+ DFGL++         +  G +  + ++APE    N    +
Sbjct: 131 HRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKG-KLPIKWMAPESI--NFRRFT 187

Query: 467 YKSDVYNYGMMIFEM-TGGR 485
             SDV+ +G+ ++E+   G 
Sbjct: 188 SASDVWMFGVCMWEILMHGV 207

>d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 301

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Musk tyrosine kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  119 bits (299), Expect = 6e-31
 Identities = 52/248 (20%), Positives = 96/248 (38%), Gaps = 70/248 (28%)

Query: 300 LSPKRYGYADIKKMTNSFKY--KLGQGGYGSVYKGKLL------DGSNVAVKVLNDSKGN 351
           L+PK      ++   N+ +Y   +G+G +G V++ +          + VAVK+L +    
Sbjct: 1   LNPK---LLSLEYPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASA 57

Query: 352 G--KEFINEVASISRTSHVNVVALLGFC-------------------------------- 377
               +F  E A ++   + N+V LLG C                                
Sbjct: 58  DMQADFQREAALMAEFDNPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCS 117

Query: 378 -------------------LRVAEELSSTIGIARGLEYLHLGCSTRILHFDIKPHNILLD 418
                              L  AE+L     +A G+ YL      + +H D+   N L+ 
Sbjct: 118 LSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLS---ERKFVHRDLATRNCLVG 174

Query: 419 EDFCPKISDFGLAKICNRKESIISMTGARGTVGYIAPEVFCRNIGEVSYKSDVYNYGMMI 478
           E+   KI+DFGL++     +   +       + ++ PE    N    + +SDV+ YG+++
Sbjct: 175 ENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYN--RYTTESDVWAYGVVL 232

Query: 479 FEM-TGGR 485
           +E+ + G 
Sbjct: 233 WEIFSYGL 240

>d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Activated CDC42 kinase 1, ACK1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  118 bits (297), Expect = 7e-31
 Identities = 49/203 (24%), Positives = 78/203 (38%), Gaps = 42/203 (20%)

Query: 320 KLGQGGYGSVYKGKLLDGSN----VAVKVLNDSKGNG----KEFINEVASISRTSHVNVV 371
           KLG G +G V +G+    S     VAVK L     +      +FI EV ++    H N++
Sbjct: 15  KLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLI 74

Query: 372 ALLGFC---------------------------LRVAEELSSTIGIARGLEYLHLGCSTR 404
            L G                               +       + +A G+ YL    S R
Sbjct: 75  RLYGVVLTPPMKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLE---SKR 131

Query: 405 ILHFDIKPHNILLDEDFCPKISDFGLAK-ICNRKESIISMTGARGTVGYIAPEVFCRNIG 463
            +H D+   N+LL      KI DFGL + +    +  +     +    + APE       
Sbjct: 132 FIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPESLKT--R 189

Query: 464 EVSYKSDVYNYGMMIFEM-TGGR 485
             S+ SD + +G+ ++EM T G+
Sbjct: 190 TFSHASDTWMFGVTLWEMFTYGQ 212

>d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} Length = 350

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: Caenorhabditis elegans, pjk4 [TaxId: 6239]

 Score =  119 bits (299), Expect = 2e-30
 Identities = 44/198 (22%), Positives = 77/198 (38%), Gaps = 40/198 (20%)

Query: 320 KLGQGGYGSVYKGK-LLDGSNVAVKVLNDSKGNGKE-FINEVASISRTSHVNVVALLGFC 377
           +LG G +G V++      G+N A K +     + KE    E+ ++S   H  +V L    
Sbjct: 33  ELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAF 92

Query: 378 ----------------------------LRVAEELSSTIGIARGLEYLHLGCSTRILHFD 409
                                       +   E +     + +GL ++H       +H D
Sbjct: 93  EDDNEMVMIYEFMSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMH---ENNYVHLD 149

Query: 410 IKPHNILLDEDFCP--KISDFGLAKICNRKESIISMTGARGTVGYIAPEVFCRNIGEVSY 467
           +KP NI+         K+ DFGL    + K+S+   TG      + APEV       V Y
Sbjct: 150 LKPENIMFTTKRSNELKLIDFGLTAHLDPKQSVKVTTGTA---EFAAPEVAEG--KPVGY 204

Query: 468 KSDVYNYGMMIFEMTGGR 485
            +D+++ G++ + +  G 
Sbjct: 205 YTDMWSVGVLSYILLSGL 222

>d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 311

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-KIT receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  116 bits (292), Expect = 7e-30
 Identities = 59/249 (23%), Positives = 97/249 (38%), Gaps = 63/249 (25%)

Query: 295 RNYRSLSPKRYGYAD---IKKMTNSFKYKLGQGGYGSVYKGKLL------DGSNVAVKVL 345
            NY  + P +  Y       +   SF   LG G +G V +              VAVK+L
Sbjct: 2   NNYVYIDPTQLPYDHKWEFPRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKML 61

Query: 346 NDSKGNG--KEFINEVASISR-TSHVNVVALLGFC------------------------- 377
             S      +  ++E+  +S   +H+N+V LLG C                         
Sbjct: 62  KPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRK 121

Query: 378 --------------------LRVAEELSSTIGIARGLEYLHLGCSTRILHFDIKPHNILL 417
                               L + + LS +  +A+G+ +L    S   +H D+   NILL
Sbjct: 122 RDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLA---SKNCIHRDLAARNILL 178

Query: 418 DEDFCPKISDFGLAKICNRKESIISMTGARGTVGYIAPEVFCRNIGEVSYKSDVYNYGMM 477
                 KI DFGLA+      + +    AR  V ++APE         +++SDV++YG+ 
Sbjct: 179 THGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFN--CVYTFESDVWSYGIF 236

Query: 478 IFEM-TGGR 485
           ++E+ + G 
Sbjct: 237 LWELFSLGS 245

>d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} Length = 345

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase Erk2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  117 bits (293), Expect = 1e-29
 Identities = 47/200 (23%), Positives = 81/200 (40%), Gaps = 38/200 (19%)

Query: 320 KLGQGGYGSVYKGK-LLDGSNVAVKVLN--DSKGNGKEFINEVASISRTSHVNVVALLGF 376
            +G+G YG V      ++   VA+K ++  + +   +  + E+  + R  H N++ +   
Sbjct: 15  YIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDI 74

Query: 377 C------------------------------LRVAEELSSTIGIARGLEYLHLGCSTRIL 406
                                          L           I RGL+Y+H   S  +L
Sbjct: 75  IRAPTIEQMKDVYLVTHLMGADLYKLLKTQHLSNDHICYFLYQILRGLKYIH---SANVL 131

Query: 407 HFDIKPHNILLDEDFCPKISDFGLAKICNRKE-SIISMTGARGTVGYIAPEVFCRNIGEV 465
           H D+KP N+LL+     KI DFGLA++ +        +T    T  Y APE+   + G  
Sbjct: 132 HRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKG-Y 190

Query: 466 SYKSDVYNYGMMIFEMTGGR 485
           +   D+++ G ++ EM   R
Sbjct: 191 TKSIDIWSVGCILAEMLSNR 210

>d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 309

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tie2 kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  113 bits (283), Expect = 1e-28
 Identities = 49/220 (22%), Positives = 90/220 (40%), Gaps = 57/220 (25%)

Query: 316 SFKYKLGQGGYGSVYKGKLLDGSN---VAVKVLND--SKGNGKEFINEVASISR-TSHVN 369
            F+  +G+G +G V K ++         A+K + +  SK + ++F  E+  + +   H N
Sbjct: 13  KFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPN 72

Query: 370 VVALLGFC-------------------------------------------LRVAEELSS 386
           ++ LLG C                                           L   + L  
Sbjct: 73  IINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHF 132

Query: 387 TIGIARGLEYLHLGCSTRILHFDIKPHNILLDEDFCPKISDFGLAKICNRKESIISMTGA 446
              +ARG++YL      + +H D+   NIL+ E++  KI+DFGL++     E  +  T  
Sbjct: 133 AADVARGMDYL---SQKQFIHRDLAARNILVGENYVAKIADFGLSRGQ---EVYVKKTMG 186

Query: 447 RGTVGYIAPEVFCRNIGEVSYKSDVYNYGMMIFEMTGGRK 486
           R  V ++A E         +  SDV++YG++++E+     
Sbjct: 187 RLPVRWMAIESLNY--SVYTTNSDVWSYGVLLWEIVSLGG 224

>d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 316

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

 Score =  112 bits (280), Expect = 4e-28
 Identities = 47/196 (23%), Positives = 74/196 (37%), Gaps = 36/196 (18%)

Query: 320 KLGQGGYGSVYKGKLL-DGSNVAVKVLNDSKGNG----KEFINEVASISRTSHVNVVALL 374
            LG G +G V+  +   +G   A+KVL           +   +E   +S  +H  ++ + 
Sbjct: 11  TLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMW 70

Query: 375 GFCL------------------------RVAEELSSTIGIARGLEYLHLGCSTRILHFDI 410
           G                           +      +    A     L    S  I++ D+
Sbjct: 71  GTFQDAQQIFMIMDYIEGGELFSLLRKSQRFPNPVAKFYAAEVCLALEYLHSKDIIYRDL 130

Query: 411 KPHNILLDEDFCPKISDFGLAKICNRKESIISMTGARGTVGYIAPEVFCRNIGEVSYKSD 470
           KP NILLD++   KI+DFG AK               GT  YIAPEV        +   D
Sbjct: 131 KPENILLDKNGHIKITDFGFAKYVPDV-----TYTLCGTPDYIAPEVVST--KPYNKSID 183

Query: 471 VYNYGMMIFEMTGGRK 486
            +++G++I+EM  G  
Sbjct: 184 WWSFGILIYEMLAGYT 199

>d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Vascular endothelial growth factor receptor 2 (kdr)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  111 bits (278), Expect = 4e-28
 Identities = 49/215 (22%), Positives = 87/215 (40%), Gaps = 58/215 (26%)

Query: 320 KLGQGGYGSVYKGKLL------DGSNVAVKVLNDSKGNG--KEFINEVASISRTSH-VNV 370
            LG+G +G V +              VAVK+L +   +   +  ++E+  +    H +NV
Sbjct: 20  PLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNV 79

Query: 371 VALLGFC--------------------------------------------LRVAEELSS 386
           V LLG C                                            L +   +  
Sbjct: 80  VNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICY 139

Query: 387 TIGIARGLEYLHLGCSTRILHFDIKPHNILLDEDFCPKISDFGLAKICNRKESIISMTGA 446
           +  +A+G+E+L    S + +H D+   NILL E    KI DFGLA+   +    +    A
Sbjct: 140 SFQVAKGMEFLA---SRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDA 196

Query: 447 RGTVGYIAPEVFCRNIGEVSYKSDVYNYGMMIFEM 481
           R  + ++APE         + +SDV+++G++++E+
Sbjct: 197 RLPLKWMAPETIFD--RVYTIQSDVWSFGVLLWEI 229

>d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} Length = 286

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: (Plasmodium falciparum) [TaxId: 5833]

 Score =  110 bits (276), Expect = 7e-28
 Identities = 50/196 (25%), Positives = 80/196 (40%), Gaps = 36/196 (18%)

Query: 320 KLGQGGYGSVYKGKLLDGSNVAVKVLN---DSKGNGKEFINEVASISRTSHVNVVALLGF 376
           K+G+G YG VYK +   G   A+K +    + +G     I E++ +    H N+V L   
Sbjct: 9   KIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDV 68

Query: 377 C---------------------------LRVAEELSSTIGIARGLEYLHLGCSTRILHFD 409
                                       L      S  + +  G+ Y H     R+LH D
Sbjct: 69  IHTKKRLVLVFEHLDQDLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCH---DRRVLHRD 125

Query: 410 IKPHNILLDEDFCPKISDFGLAKICNRKESIISMTGARGTVGYIAPEVFCRNIGEVSYKS 469
           +KP N+L++ +   KI+DFGLA+           T    T+ Y AP+V   +  + S   
Sbjct: 126 LKPQNLLINREGELKIADFGLARAFGIPVR--KYTHEIVTLWYRAPDVLMGS-KKYSTTI 182

Query: 470 DVYNYGMMIFEMTGGR 485
           D+++ G +  EM  G 
Sbjct: 183 DIWSVGCIFAEMVNGT 198

>d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 293

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]

 Score =  109 bits (273), Expect = 2e-27
 Identities = 30/221 (13%), Positives = 68/221 (30%), Gaps = 45/221 (20%)

Query: 320 KLGQGGYGSVYKGK-LLDGSNVAVKVLNDSKGNGKEFINEVASISRTSHVNVVALLGFC- 377
           ++G+G +G +++G  LL+   VA+K     + +  +  +E  +    +    +  + +  
Sbjct: 12  RIGEGSFGVIFEGTNLLNNQQVAIKFEP-RRSDAPQLRDEYRTYKLLAGCTGIPNVYYFG 70

Query: 378 ---------------------------LRVAEELSSTIGIARGLEYLHLGCSTRILHFDI 410
                                        V     +   +   ++ +H      +++ DI
Sbjct: 71  QEGLHNVLVIDLLGPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIH---EKSLVYRDI 127

Query: 411 KPHNILLDEDFCP-----KISDFGLAKICNRKES-----IISMTGARGTVGYIAPEVFCR 460
           KP N L+            + DFG+ K      +             GT  Y++      
Sbjct: 128 KPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKNLSGTARYMSINTHLG 187

Query: 461 NIGEVSYKSDVYNYGMMIFEMTGGRKNVDVVDNGSTALDLQ 501
              E S + D+   G +      G      +   +     +
Sbjct: 188 R--EQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYE 226

>d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} Length = 364

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: G-protein coupled receptor kinase 2
species: Cow (Bos taurus) [TaxId: 9913]

 Score =  110 bits (276), Expect = 3e-27
 Identities = 50/201 (24%), Positives = 85/201 (42%), Gaps = 43/201 (21%)

Query: 320 KLGQGGYGSVYKGKLLD-GSNVAVKVLNDSKGNGKE-------FINEVASISRTSHVNVV 371
            +G+GG+G VY  +  D G   A+K L+  +   K+           ++ +S      +V
Sbjct: 11  IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIV 70

Query: 372 ALLGFCL---------------------------RVAEELSSTIGIARGLEYLHLGCSTR 404
            +                                  A+       I  GLE++H   +  
Sbjct: 71  CMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEADMRFYAAEIILGLEHMH---NRF 127

Query: 405 ILHFDIKPHNILLDEDFCPKISDFGLAKICNRKESIISMTGARGTVGYIAPEVFCRNIGE 464
           +++ D+KP NILLDE    +ISD GLA   ++K+   S+    GT GY+APEV  + +  
Sbjct: 128 VVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHASV----GTHGYMAPEVLQKGVA- 182

Query: 465 VSYKSDVYNYGMMIFEMTGGR 485
               +D ++ G M+F++  G 
Sbjct: 183 YDSSADWFSLGCMLFKLLRGH 203

>d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} Length = 350

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Glycogen synthase kinase-3 beta (Gsk3b)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  110 bits (275), Expect = 3e-27
 Identities = 59/222 (26%), Positives = 85/222 (38%), Gaps = 56/222 (25%)

Query: 302 PKRYGYADIKKMTNSFKYKLGQGGYGSVYKGKLLD-GSNVAVKVLNDSKGNGKEFINEVA 360
           P+   Y D K         +G G +G VY+ KL D G  VA+K +   K   +    E+ 
Sbjct: 17  PQEVSYTDTKV--------IGNGSFGVVYQAKLCDSGELVAIKKVLQDK---RFKNRELQ 65

Query: 361 SISRTSHVNVVALLGFCLRVAEELSS---------------------------------- 386
            + +  H N+V L  F     E+                                     
Sbjct: 66  IMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVK 125

Query: 387 --TIGIARGLEYLHLGCSTRILHFDIKPHNILLDED-FCPKISDFGLAKICNRKESIISM 443
                + R L Y+H   S  I H DIKP N+LLD D    K+ DFG AK   R E  +S 
Sbjct: 126 LYMYQLFRSLAYIH---SFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSY 182

Query: 444 TGARGTVGYIAPEVFCRNIGEVSYKSDVYNYGMMIFEMTGGR 485
             +R    Y APE+        +   DV++ G ++ E+  G+
Sbjct: 183 ICSR---YYRAPELIFGATD-YTSSIDVWSAGCVLAELLLGQ 220

>d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 7, CDK7
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  108 bits (271), Expect = 4e-27
 Identities = 49/200 (24%), Positives = 79/200 (39%), Gaps = 40/200 (20%)

Query: 320 KLGQGGYGSVYKGKLL-DGSNVAVKVLNDSKGNG------KEFINEVASISRTSHVNVVA 372
            LG+G + +VYK +       VA+K +     +       +  + E+  +   SH N++ 
Sbjct: 5   FLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIG 64

Query: 373 LLGFC---------------------------LRVAEELSSTIGIARGLEYLHLGCSTRI 405
           LL                              L  +   +  +   +GLEYLH      I
Sbjct: 65  LLDAFGHKSNISLVFDFMETDLEVIIKDNSLVLTPSHIKAYMLMTLQGLEYLH---QHWI 121

Query: 406 LHFDIKPHNILLDEDFCPKISDFGLAKICNRKESIISMTGARGTVGYIAPEVFCRNIGEV 465
           LH D+KP+N+LLDE+   K++DFGLAK         + T    T  Y APE+        
Sbjct: 122 LHRDLKPNNLLLDENGVLKLADFGLAKSFG--SPNRAYTHQVVTRWYRAPELLFGARM-Y 178

Query: 466 SYKSDVYNYGMMIFEMTGGR 485
               D++  G ++ E+    
Sbjct: 179 GVGVDMWAVGCILAELLLRV 198

>d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} Length = 352

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]

 Score =  109 bits (274), Expect = 4e-27
 Identities = 45/198 (22%), Positives = 77/198 (38%), Gaps = 40/198 (20%)

Query: 320 KLGQGGYGSVYKGK-LLDGSNVAVKVLNDSKGNGKE-FINEVASISRTSHVNVVALLGFC 377
           +LG G +G V++      G     K +N      K    NE++ +++  H  ++ L    
Sbjct: 36  ELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAF 95

Query: 378 ----------------------------LRVAEELSSTIGIARGLEYLHLGCSTRILHFD 409
                                       +  AE ++       GL+++H      I+H D
Sbjct: 96  EDKYEMVLILEFLSGGELFDRIAAEDYKMSEAEVINYMRQACEGLKHMH---EHSIVHLD 152

Query: 410 IKPHNILLDEDFCP--KISDFGLAKICNRKESIISMTGARGTVGYIAPEVFCRNIGEVSY 467
           IKP NI+ +       KI DFGLA   N  E +   T    T  + APE+  R    V +
Sbjct: 153 IKPENIMCETKKASSVKIIDFGLATKLNPDEIVKVTT---ATAEFAAPEIVDR--EPVGF 207

Query: 468 KSDVYNYGMMIFEMTGGR 485
            +D++  G++ + +  G 
Sbjct: 208 YTDMWAIGVLGYVLLSGL 225

>d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} Length = 298

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  108 bits (269), Expect = 8e-27
 Identities = 51/198 (25%), Positives = 84/198 (42%), Gaps = 38/198 (19%)

Query: 320 KLGQGGYGSVYKGK-LLDGSNVAVKVLN---DSKGNGKEFINEVASISRTSHVNVVALLG 375
           K+G+G YG VYK +  L G  VA+K +    +++G     I E++ +   +H N+V LL 
Sbjct: 9   KIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLD 68

Query: 376 FC----------------------------LRVAEELSSTIGIARGLEYLHLGCSTRILH 407
                                         + +    S    + +GL +     S R+LH
Sbjct: 69  VIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFC---HSHRVLH 125

Query: 408 FDIKPHNILLDEDFCPKISDFGLAKICNRKESIISMTGARGTVGYIAPEVFCRNIGEVSY 467
            D+KP N+L++ +   K++DFGLA+           T    T+ Y APE+        S 
Sbjct: 126 RDLKPQNLLINTEGAIKLADFGLARAFGVPVRT--YTHEVVTLWYRAPEILLGC-KYYST 182

Query: 468 KSDVYNYGMMIFEMTGGR 485
             D+++ G +  EM   R
Sbjct: 183 AVDIWSLGCIFAEMVTRR 200

>d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 307

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Calmodulin-dependent protein kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  107 bits (268), Expect = 1e-26
 Identities = 46/199 (23%), Positives = 72/199 (36%), Gaps = 35/199 (17%)

Query: 317 FKYKLGQGGYGSVYKGK-LLDGSNVAVKVLNDSKGNGKE--FINEVASISRTSHVNVVAL 373
           F+  LG G +  V   +       VA+K +      GKE    NE+A + +  H N+VAL
Sbjct: 13  FRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSMENEIAVLHKIKHPNIVAL 72

Query: 374 LGFC---------------------------LRVAEELSSTIGIARGLEYLHLGCSTRIL 406
                                              +       +   ++YLH        
Sbjct: 73  DDIYESGGHLYLIMQLVSGGELFDRIVEKGFYTERDASRLIFQVLDAVKYLHDLGIVHRD 132

Query: 407 HFDIKPHNILLDEDFCPKISDFGLAKICNRKESIISMTGARGTVGYIAPEVFCRNIGEVS 466
                     LDED    ISDFGL+K+ +       ++ A GT GY+APEV  +     S
Sbjct: 133 LKPENLLYYSLDEDSKIMISDFGLSKMEDPGS---VLSTACGTPGYVAPEVLAQ--KPYS 187

Query: 467 YKSDVYNYGMMIFEMTGGR 485
              D ++ G++ + +  G 
Sbjct: 188 KAVDCWSIGVIAYILLCGY 206

>d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} Length = 321

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Titin, kinase domain
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  107 bits (269), Expect = 1e-26
 Identities = 40/197 (20%), Positives = 70/197 (35%), Gaps = 39/197 (19%)

Query: 320 KLGQGGYGSVYKGKLL-DGSNVAVKVLNDSKGNGKEFINEVASISRTSHVNVVALLGFC- 377
            LG+G +G V++            K +     +      E++ ++   H N++ L     
Sbjct: 12  DLGRGEFGIVHRCVETSSKKTYMAKFVKVKGTDQVLVKKEISILNIARHRNILHLHESFE 71

Query: 378 ---------------------------LRVAEELSSTIGIARGLEYLHLGCSTRILHFDI 410
                                      L   E +S    +   L++LH   S  I HFDI
Sbjct: 72  SMEELVMIFEFISGLDIFERINTSAFELNEREIVSYVHQVCEALQFLH---SHNIGHFDI 128

Query: 411 KPHNILLDEDFCP--KISDFGLAKICNRKESIISMTGARGTVGYIAPEVFCRNIGEVSYK 468
           +P NI+         KI +FG A+     +   +         Y APEV       VS  
Sbjct: 129 RPENIIYQTRRSSTIKIIEFGQARQLKPGD---NFRLLFTAPEYYAPEVHQH--DVVSTA 183

Query: 469 SDVYNYGMMIFEMTGGR 485
           +D+++ G +++ +  G 
Sbjct: 184 TDMWSLGTLVYVLLSGI 200

>d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} Length = 277

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Mycobacterial protein kinase PknB, catalytic domain
species: Mycobacterium tuberculosis [TaxId: 1773]

 Score =  106 bits (265), Expect = 2e-26
 Identities = 45/203 (22%), Positives = 75/203 (36%), Gaps = 42/203 (20%)

Query: 320 KLGQGGYGSVYKGK-LLDGSNVAVKVLNDSKGNGKE----FINEVASISRTSHVNVVALL 374
            LG GG   V+  + L    +VAVKVL             F  E  + +  +H  +VA+ 
Sbjct: 14  ILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVY 73

Query: 375 GFC-------------------------------LRVAEELSSTIGIARGLEYLHLGCST 403
                                             +     +       + L +       
Sbjct: 74  DTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGPMTPKRAIEVIADACQALNFS---HQN 130

Query: 404 RILHFDIKPHNILLDEDFCPKISDFGLAKICNRKESIISMTGAR-GTVGYIAPEVFCRNI 462
            I+H D+KP NI++      K+ DFG+A+      + ++ T A  GT  Y++PE      
Sbjct: 131 GIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQARG-- 188

Query: 463 GEVSYKSDVYNYGMMIFEMTGGR 485
             V  +SDVY+ G +++E+  G 
Sbjct: 189 DSVDARSDVYSLGCVLYEVLTGE 211

>d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  106 bits (265), Expect = 3e-26
 Identities = 38/203 (18%), Positives = 63/203 (31%), Gaps = 43/203 (21%)

Query: 320 KLGQGGYGSVYKGK-LLDGSNVAVKVLNDSKGNGKEFINEVASISRTSHVNVVALLGFC- 377
           K+G G +G +Y G  +  G  VA+K+      +  +   E            +  + +C 
Sbjct: 14  KIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKH-PQLHIESKIYKMMQGGVGIPTIRWCG 72

Query: 378 ---------------------------LRVAEELSSTIGIARGLEYLHLGCSTRILHFDI 410
                                        +   L     +   +EY+H   S   +H D+
Sbjct: 73  AEGDYNVMVMELLGPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIH---SKNFIHRDV 129

Query: 411 KPHNIL---LDEDFCPKISDFGLAKICNRKES-----IISMTGARGTVGYIAPEVFCRNI 462
           KP N L     +     I DFGLAK      +             GT  Y +        
Sbjct: 130 KPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYASINTHLG-- 187

Query: 463 GEVSYKSDVYNYGMMIFEMTGGR 485
            E S + D+ + G ++     G 
Sbjct: 188 IEQSRRDDLESLGYVLMYFNLGS 210

>d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} Length = 305

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK6
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  106 bits (265), Expect = 3e-26
 Identities = 54/207 (26%), Positives = 89/207 (42%), Gaps = 49/207 (23%)

Query: 320 KLGQGGYGSVYKGKLL--DGSNVAVKVLN---DSKGNGKEFINEVA---SISRTSHVNVV 371
           ++G+G YG V+K + L   G  VA+K +      +G     I EVA    +    H NVV
Sbjct: 14  EIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVV 73

Query: 372 ALLGFCLRVAEELSSTIGI---------------------------------ARGLEYLH 398
            L   C     +  + + +                                  RGL++LH
Sbjct: 74  RLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLH 133

Query: 399 LGCSTRILHFDIKPHNILLDEDFCPKISDFGLAKICNRKESIISMTGARGTVGYIAPEVF 458
              S R++H D+KP NIL+      K++DFGLA+I + + ++ S+     T+ Y APEV 
Sbjct: 134 ---SHRVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMALTSV---VVTLWYRAPEVL 187

Query: 459 CRNIGEVSYKSDVYNYGMMIFEMTGGR 485
            +     +   D+++ G +  EM   +
Sbjct: 188 LQ--SSYATPVDLWSVGCIFAEMFRRK 212

>d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} Length = 318

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 9, CDK9
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  106 bits (265), Expect = 3e-26
 Identities = 47/204 (23%), Positives = 79/204 (38%), Gaps = 39/204 (19%)

Query: 320 KLGQGGYGSVYKGKLL-DGSNVAVKVL---NDSKGNGKEFINEVASISRTSHVNVVALLG 375
           K+GQG +G V+K +    G  VA+K +   N+ +G     + E+  +    H NVV L+ 
Sbjct: 17  KIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIE 76

Query: 376 FCLRVAEELSSTIG--------------------------------IARGLEYLHLGCST 403
            C   A   +   G                                +   L  L+     
Sbjct: 77  ICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLVKFTLSEIKRVMQMLLNGLYYIHRN 136

Query: 404 RILHFDIKPHNILLDEDFCPKISDFGLAKICNRKES--IISMTGARGTVGYIAPEVFCRN 461
           +ILH D+K  N+L+  D   K++DFGLA+  +  ++      T    T+ Y  PE+    
Sbjct: 137 KILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYTNRVVTLWYRPPELL-LG 195

Query: 462 IGEVSYKSDVYNYGMMIFEMTGGR 485
             +     D++  G ++ EM    
Sbjct: 196 ERDYGPPIDLWGAGCIMAEMWTRS 219

>d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} Length = 277

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: gamma-subunit of glycogen phosphorylase kinase (Phk)
species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]

 Score =  105 bits (263), Expect = 4e-26
 Identities = 44/209 (21%), Positives = 77/209 (36%), Gaps = 49/209 (23%)

Query: 320 KLGQGGYGSVYKGK-LLDGSNVAVKVLNDSKGNG----------KEFINEVASISRTS-H 367
            LG+G    V +          AVK+++ + G            +  + EV  + + S H
Sbjct: 10  ILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGH 69

Query: 368 VNVVALLGFC---------------------------LRVAEELSSTIGIARGLEYLHLG 400
            N++ L                               L   E       +   +  LH  
Sbjct: 70  PNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEKVTLSEKETRKIMRALLEVICALH-- 127

Query: 401 CSTRILHFDIKPHNILLDEDFCPKISDFGLAKICNRKESIISMTGARGTVGYIAPEVF-- 458
               I+H D+KP NILLD+D   K++DFG +   +  E    +    GT  Y+APE+   
Sbjct: 128 -KLNIVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGE---KLREVCGTPSYLAPEIIEC 183

Query: 459 --CRNIGEVSYKSDVYNYGMMIFEMTGGR 485
               N      + D+++ G++++ +  G 
Sbjct: 184 SMNDNHPGYGKEVDMWSTGVIMYTLLAGS 212

>d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} Length = 320

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase C, theta type
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  105 bits (264), Expect = 6e-26
 Identities = 43/199 (21%), Positives = 77/199 (38%), Gaps = 40/199 (20%)

Query: 320 KLGQGGYGSVYKGKLL-DGSNVAVKVLNDSKGNGKE----FINEVASISRT-SHVNVVAL 373
            LG+G +G V+  +        A+K L        +     + E   +S    H  +  +
Sbjct: 9   MLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHM 68

Query: 374 LGFC---------------------------LRVAEELSSTIGIARGLEYLHLGCSTRIL 406
                                            ++        I  GL++L    S  I+
Sbjct: 69  FCTFQTKENLFFVMEYLNGGDLMYHIQSCHKFDLSRATFYAAEIILGLQFL---HSKGIV 125

Query: 407 HFDIKPHNILLDEDFCPKISDFGLAKICNRKESIISMTGARGTVGYIAPEVFCRNIGEVS 466
           + D+K  NILLD+D   KI+DFG+ K     ++        GT  YIAPE+      + +
Sbjct: 126 YRDLKLDNILLDKDGHIKIADFGMCKENMLGDA--KTNTFCGTPDYIAPEILLG--QKYN 181

Query: 467 YKSDVYNYGMMIFEMTGGR 485
           +  D +++G++++EM  G+
Sbjct: 182 HSVDWWSFGVLLYEMLIGQ 200

>d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 308

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Insulin-like growth factor 1 receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  105 bits (262), Expect = 8e-26
 Identities = 47/212 (22%), Positives = 86/212 (40%), Gaps = 51/212 (24%)

Query: 320 KLGQGGYGSVYKGKL------LDGSNVAVKVLNDSKGNG--KEFINEVASISRTSHVNVV 371
           +LGQG +G VY+G           + VA+K +N++       EF+NE + +   +  +VV
Sbjct: 27  ELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVV 86

Query: 372 ALLGFC-------------------------------------LRVAEELSSTIGIARGL 394
            LLG                                         +++ +     IA G+
Sbjct: 87  RLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGM 146

Query: 395 EYLHLGCSTRILHFDIKPHNILLDEDFCPKISDFGLAKICNRKESIISMTGARGTVGYIA 454
            YL    + + +H D+   N ++ EDF  KI DFG+ +     +           V +++
Sbjct: 147 AYL---NANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMS 203

Query: 455 PEVFCRNIGEVSYKSDVYNYGMMIFEM-TGGR 485
           PE      G  +  SDV+++G++++E+ T   
Sbjct: 204 PESLKD--GVFTTYSDVWSFGVVLWEIATLAE 233

>d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} Length = 292

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK5
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  104 bits (260), Expect = 1e-25
 Identities = 44/195 (22%), Positives = 76/195 (38%), Gaps = 32/195 (16%)

Query: 320 KLGQGGYGSVYKGKLL-DGSNVAVKVLN---DSKGNGKEFINEVASISRTSHVNVVALLG 375
           K+G+G YG+V+K K       VA+K +    D +G     + E+  +    H N+V L  
Sbjct: 9   KIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHD 68

Query: 376 FCL------------------------RVAEELSSTIGIARGLEYLHLGCSTRILHFDIK 411
                                         +       + + L+ L    S  +LH D+K
Sbjct: 69  VLHSDKKLTLVFEFCDQDLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCHSRNVLHRDLK 128

Query: 412 PHNILLDEDFCPKISDFGLAKICNRKESIISMTGARGTVGYIAPEVFCRNIGEVSYKSDV 471
           P N+L++ +   K+++FGLA+         S      T+ Y  P+V        S   D+
Sbjct: 129 PQNLLINRNGELKLANFGLARAFGIPVRCYSAEV--VTLWYRPPDVLFGA-KLYSTSIDM 185

Query: 472 YNYGMMIFEM-TGGR 485
           ++ G +  E+   GR
Sbjct: 186 WSAGCIFAELANAGR 200

>d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 337

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Pkb kinase (Akt-2)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  104 bits (261), Expect = 2e-25
 Identities = 48/196 (24%), Positives = 75/196 (38%), Gaps = 35/196 (17%)

Query: 320 KLGQGGYGSVYKGK-LLDGSNVAVKVLNDSKGNGKE----FINEVASISRTSHVNVVALL 374
            LG+G +G V   +    G   A+K+L       K+     + E   +  T H  + AL 
Sbjct: 12  LLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALK 71

Query: 375 GFCL-------------------------RVAEELSSTIGIARGLEYLHLGCSTRILHFD 409
                                           EE +     A  +  L    S  +++ D
Sbjct: 72  YAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARFY-GAEIVSALEYLHSRDVVYRD 130

Query: 410 IKPHNILLDEDFCPKISDFGLAKICNRKESIISMTGARGTVGYIAPEVFCRNIGEVSYKS 469
           IK  N++LD+D   KI+DFGL K      +  +M    GT  Y+APEV      +     
Sbjct: 131 IKLENLMLDKDGHIKITDFGLCKEGISDGA--TMKTFCGTPEYLAPEVLED--NDYGRAV 186

Query: 470 DVYNYGMMIFEMTGGR 485
           D +  G++++EM  GR
Sbjct: 187 DWWGLGVVMYEMMCGR 202

>d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fibroblast growth factor receptor 1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  102 bits (254), Expect = 7e-25
 Identities = 53/221 (23%), Positives = 94/221 (42%), Gaps = 60/221 (27%)

Query: 320 KLGQGGYGSVYKGKLL--------DGSNVAVKVLND--SKGNGKEFINEVASISR-TSHV 368
            LG+G +G V   + +          + VAVK+L    ++ +  + I+E+  +     H 
Sbjct: 20  PLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHK 79

Query: 369 NVVALLGFC-------------------------------------------LRVAEELS 385
           N++ LLG C                                           L   + +S
Sbjct: 80  NIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVS 139

Query: 386 STIGIARGLEYLHLGCSTRILHFDIKPHNILLDEDFCPKISDFGLAKICNRKESIISMTG 445
               +ARG+EYL    S + +H D+   N+L+ ED   KI+DFGLA+  +  +     T 
Sbjct: 140 CAYQVARGMEYLA---SKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTN 196

Query: 446 ARGTVGYIAPEVFCRNIGEVSYKSDVYNYGMMIFEM-TGGR 485
            R  V ++APE         +++SDV+++G++++E+ T G 
Sbjct: 197 GRLPVKWMAPEALFD--RIYTHQSDVWSFGVLLWEIFTLGG 235

>d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} Length = 346

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38-gamma
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 99.9 bits (248), Expect = 1e-23
 Identities = 53/201 (26%), Positives = 80/201 (39%), Gaps = 44/201 (21%)

Query: 320 KLGQGGYGSVYKGK-LLDGSNVAVKVLN---DSKGNGKEFINEVASISRTSHVNVVALLG 375
            +G G YG+V        G+ VA+K L     S+   K    E+  +    H NV+ LL 
Sbjct: 25  PVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLD 84

Query: 376 FC-------------------------------LRVAEELSSTIGIARGLEYLHLGCSTR 404
                                            L           + +GL Y+H   +  
Sbjct: 85  VFTPDETLDDFTDFYLVMPFMGTDLGKLMKHEKLGEDRIQFLVYQMLKGLRYIH---AAG 141

Query: 405 ILHFDIKPHNILLDEDFCPKISDFGLAKICNRKESIISMTGARGTVGYIAPEVFCRNIGE 464
           I+H D+KP N+ ++ED   KI DFGLA+  + +     MTG   T  Y APEV   N   
Sbjct: 142 IIHRDLKPGNLAVNEDCELKILDFGLARQADSE-----MTGYVVTRWYRAPEVI-LNWMR 195

Query: 465 VSYKSDVYNYGMMIFEMTGGR 485
            +   D+++ G ++ EM  G+
Sbjct: 196 YTQTVDIWSVGCIMAEMITGK 216

>d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} Length = 350

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Mouse (Mus musculus) [TaxId: 10090]

 Score = 99.5 bits (247), Expect = 1e-23
 Identities = 43/198 (21%), Positives = 72/198 (36%), Gaps = 42/198 (21%)

Query: 320 KLGQGGYGSVYKGK-LLDGSNVAVKVLNDSKGNGKE----FINEVASISRTSHVNVVALL 374
            LG G +G V   K    G++ A+K+L+  K    +     +NE   +   +   +V L 
Sbjct: 48  TLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLE 107

Query: 375 GFC---------------------------LRVAEELSSTIGIARGLEYLHLGCSTRILH 407
                                                     I    EYLH   S  +++
Sbjct: 108 FSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLH---SLDLIY 164

Query: 408 FDIKPHNILLDEDFCPKISDFGLAKICNRKESIISMTGARGTVGYIAPEVFCRNIGEVSY 467
            D+KP N+L+D+    +++DFG AK    +          GT   +APE+        + 
Sbjct: 165 RDLKPENLLIDQQGYIQVTDFGFAKRVKGR-----TWTLCGTPEALAPEIILS--KGYNK 217

Query: 468 KSDVYNYGMMIFEMTGGR 485
             D +  G++I+EM  G 
Sbjct: 218 AVDWWALGVLIYEMAAGY 235

>d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} Length = 293

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Death-associated protein kinase, Dap
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 97.9 bits (243), Expect = 2e-23
 Identities = 43/202 (21%), Positives = 76/202 (37%), Gaps = 41/202 (20%)

Query: 320 KLGQGGYGSVYKGKLL-DGSNVAVKVLNDSKGNG-------KEFINEVASISRTSHVNVV 371
           +LG G +  V K +    G   A K +   +          ++   EV+ +    H NV+
Sbjct: 17  ELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVI 76

Query: 372 ALLGFCL------------------------RVAEELSSTIGIARGLEYLHLGCSTRILH 407
            L                                 E  +T  + + L  ++   S +I H
Sbjct: 77  TLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLHSLQIAH 136

Query: 408 FDIKPHNILLDEDFCP----KISDFGLAKICNRKESIISMTGARGTVGYIAPEVFCRNIG 463
           FD+KP NI+L +   P    KI DFGLA   +            GT  ++APE+      
Sbjct: 137 FDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGN---EFKNIFGTPEFVAPEIVNY--E 191

Query: 464 EVSYKSDVYNYGMMIFEMTGGR 485
            +  ++D+++ G++ + +  G 
Sbjct: 192 PLGLEADMWSIGVITYILLSGA 213

>d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Proto-oncogene serine/threonine-protein kinase Pim-1
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 97.5 bits (242), Expect = 2e-23
 Identities = 47/205 (22%), Positives = 74/205 (36%), Gaps = 47/205 (22%)

Query: 320 KLGQGGYGSVYKGK-LLDGSNVAVKVLNDSK-------GNGKEFINEVASISRTS--HVN 369
            LG GG+GSVY G  + D   VA+K +   +        NG     EV  + + S     
Sbjct: 11  LLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSG 70

Query: 370 VVALLGFC----------------------------LRVAEELSSTIGIARGLEYLHLGC 401
           V+ LL +                             L+     S    +   + +     
Sbjct: 71  VIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHC---H 127

Query: 402 STRILHFDIKPHNILLDED-FCPKISDFGLAKICNRKESIISMTGARGTVGYIAPEVFCR 460
           +  +LH DIK  NIL+D +    K+ DFG   +          T   GT  Y  PE   R
Sbjct: 128 NCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTV----YTDFDGTRVYSPPEWI-R 182

Query: 461 NIGEVSYKSDVYNYGMMIFEMTGGR 485
                   + V++ G+++++M  G 
Sbjct: 183 YHRYHGRSAAVWSLGILLYDMVCGD 207

>d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} Length = 335

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase activated protein kinase 2, mapkap2
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 98.6 bits (245), Expect = 3e-23
 Identities = 45/203 (22%), Positives = 72/203 (35%), Gaps = 50/203 (24%)

Query: 321 LGQGGYGSVYKGK-LLDGSNVAVKVLNDSKGNGKEFINEVASISRTS-HVNVVALLGFC- 377
           LG G  G V +          A+K+L D      +   EV    R S   ++V ++    
Sbjct: 20  LGLGINGKVLQIFNKRTQEKFALKMLQDCP----KARREVELHWRASQCPHIVRIVDVYE 75

Query: 378 ------------------------------LRVAEELSSTI--GIARGLEYLHLGCSTRI 405
                                             E  +S I   I   ++YLH   S  I
Sbjct: 76  NLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLH---SINI 132

Query: 406 LHFDIKPHNILLDEDFCP---KISDFGLAKICNRKESIISMTGARGTVGYIAPEVFCRNI 462
            H D+KP N+L          K++DFG AK      S+ +      T  Y+APEV     
Sbjct: 133 AHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTP---CYTPYYVAPEVLGP-- 187

Query: 463 GEVSYKSDVYNYGMMIFEMTGGR 485
            +     D+++ G++++ +  G 
Sbjct: 188 EKYDKSCDMWSLGVIMYILLCGY 210

>d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Ribosomal protein S6 kinase alpha 5, Msk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 94.5 bits (234), Expect = 6e-22
 Identities = 41/200 (20%), Positives = 71/200 (35%), Gaps = 35/200 (17%)

Query: 320 KLGQGGYGSVYKGKLL----DGSNVAVKVLNDSKGNGKE-----FINEVASISRTSHVNV 370
            LG G YG V+  + +     G   A+KVL  +    K         E   +        
Sbjct: 31  VLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPF 90

Query: 371 VALLGFCLRVAE-------------------------ELSSTIGIARGLEYLHLGCSTRI 405
           +  L +  +                            E    I +   +  L       I
Sbjct: 91  LVTLHYAFQTETKLHLILDYINGGELFTHLSQRERFTEHEVQIYVGEIVLALEHLHKLGI 150

Query: 406 LHFDIKPHNILLDEDFCPKISDFGLAKICNRKESIISMTGARGTVGYIAPEVFCRNIGEV 465
           ++ DIK  NILLD +    ++DFGL+K     E+  +     GT+ Y+AP++        
Sbjct: 151 IYRDIKLENILLDSNGHVVLTDFGLSKEFVADETERAYDF-CGTIEYMAPDIVRGGDSGH 209

Query: 466 SYKSDVYNYGMMIFEMTGGR 485
               D ++ G++++E+  G 
Sbjct: 210 DKAVDWWSLGVLMYELLTGA 229

>d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} Length = 328

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase CK2, alpha subunit
species: Rattus norvegicus [TaxId: 10116]

 Score = 94.5 bits (234), Expect = 7e-22
 Identities = 39/195 (20%), Positives = 74/195 (37%), Gaps = 38/195 (19%)

Query: 320 KLGQGGYGSVYKGK-LLDGSNVAVKVLNDSKGNGKEFINEVASISRTS-HVNVVALLGFC 377
           KLG+G Y  V++   + +   V VK+L       K+   E+  +       N++ L    
Sbjct: 42  KLGRGKYSEVFEAINITNNEKVVVKILK--PVKKKKIKREIKILENLRGGPNIITLADIV 99

Query: 378 --------------------------LRVAEELSSTIGIARGLEYLHLGCSTRILHFDIK 411
                                     L   +       I + L+Y H   S  I+H D+K
Sbjct: 100 KDPVSRTPALVFEHVNNTDFKQLYQTLTDYDIRFYMYEILKALDYCH---SMGIMHRDVK 156

Query: 412 PHNILLDEDFCP-KISDFGLAKICNRKESIISMTGARGTVGYIAPEVFCRNIGEVSYKSD 470
           PHN+++D +    ++ D+GLA+  +  +          +  +  PE+   +     Y  D
Sbjct: 157 PHNVMIDHEHRKLRLIDWGLAEFYHPGQ---EYNVRVASRYFKGPEL-LVDYQMYDYSLD 212

Query: 471 VYNYGMMIFEMTGGR 485
           +++ G M+  M   +
Sbjct: 213 MWSLGCMLASMIFRK 227

>d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} Length = 348

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 93.4 bits (231), Expect = 2e-21
 Identities = 56/201 (27%), Positives = 80/201 (39%), Gaps = 44/201 (21%)

Query: 320 KLGQGGYGSVYKGK-LLDGSNVAVKVLN---DSKGNGKEFINEVASISRTSHVNVVALLG 375
            +G G YGSV        G  VAVK L+    S  + K    E+  +    H NV+ LL 
Sbjct: 25  PVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLD 84

Query: 376 FC-------------------------------LRVAEELSSTIGIARGLEYLHLGCSTR 404
                                            L           I RGL+Y+H   S  
Sbjct: 85  VFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIH---SAD 141

Query: 405 ILHFDIKPHNILLDEDFCPKISDFGLAKICNRKESIISMTGARGTVGYIAPEVFCRNIGE 464
           I+H D+KP N+ ++ED   KI DFGLA+  + +     MTG   T  Y APE+       
Sbjct: 142 IIHRDLKPSNLAVNEDCELKILDFGLARHTDDE-----MTGYVATRWYRAPEIMLNW-MH 195

Query: 465 VSYKSDVYNYGMMIFEMTGGR 485
            +   D+++ G ++ E+  GR
Sbjct: 196 YNQTVDIWSVGCIMAELLTGR 216

>d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 362

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Sky1p
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

 Score = 93.6 bits (231), Expect = 2e-21
 Identities = 39/211 (18%), Positives = 76/211 (36%), Gaps = 49/211 (23%)

Query: 320 KLGQGGYGSVYKGK-LLDGSNVAVKVLNDSKGNGKEFINEVASISRTSHVNVVALLGFCL 378
           KLG G + +V+  K +++ ++VA+K++   K   +   +E+  + R +  +         
Sbjct: 20  KLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVYTEAAEDEIKLLQRVNDADNTKEDSMGA 79

Query: 379 R-------------------------------------------VAEELSSTIGIARGLE 395
                                                       +      +  +  GL+
Sbjct: 80  NHILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLLGLD 139

Query: 396 YLHLGCSTRILHFDIKPHNILLD-EDFCPKISDFGLAKICNRKESIISMTGARGTVGYIA 454
           Y+H  C   I+H DIKP N+L++  D    +    +A + N        T +  T  Y +
Sbjct: 140 YMHRRCG--IIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDEHYTNSIQTREYRS 197

Query: 455 PEVFCRNIGEVSYKSDVYNYGMMIFEMTGGR 485
           PEV           +D+++   +IFE+  G 
Sbjct: 198 PEVLLG--APWGCGADIWSTACLIFELITGD 226

>d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} Length = 355

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-jun N-terminal kinase (jnk3s)
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 90.4 bits (223), Expect = 2e-20
 Identities = 48/200 (24%), Positives = 78/200 (39%), Gaps = 42/200 (21%)

Query: 320 KLGQGGYGSVYKGK-LLDGSNVAVKVLN---DSKGNGKEFINEVASISRTSHVNVVALLG 375
            +G G  G V      +   NVA+K L+    ++ + K    E+  +   +H N+++LL 
Sbjct: 24  PIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLN 83

Query: 376 FC-----------LRVAEELSS-------------------TIGIARGLEYLHLGCSTRI 405
                        + +  EL                        +  G+++LH   S  I
Sbjct: 84  VFTPQKTLEEFQDVYLVMELMDANLCQVIQMELDHERMSYLLYQMLCGIKHLH---SAGI 140

Query: 406 LHFDIKPHNILLDEDFCPKISDFGLAKICNRKESIISMTGARGTVGYIAPEVFCRNIGEV 465
           +H D+KP NI++  D   KI DFGLA+          MT    T  Y APEV        
Sbjct: 141 IHRDLKPSNIVVKSDCTLKILDFGLARTAGTSF---MMTPYVVTRYYRAPEVILGM--GY 195

Query: 466 SYKSDVYNYGMMIFEMTGGR 485
               D+++ G ++ EM   +
Sbjct: 196 KENVDIWSVGCIMGEMVRHK 215

>d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} Length = 191

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: RIO1-like kinases
domain: Rio2 serine protein kinase C-terminal domain
species: Archaeoglobus fulgidus [TaxId: 2234]

 Score = 75.6 bits (185), Expect = 2e-16
 Identities = 23/204 (11%), Positives = 49/204 (24%), Gaps = 62/204 (30%)

Query: 320 KLGQGGYGSVYKGKLLDGSNVAVKVLNDSKGNGK-----------EFINEVASISRTSHV 368
            +G+G   +V+           VK       + K            F       +R    
Sbjct: 7   LMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFR 66

Query: 369 NVVALLGFCLRVAEELSSTI------------------------GIARGLEYLHLGCSTR 404
            +  L G  +                                   I   +   +      
Sbjct: 67  ALQKLQGLAVPKVYAWEGNAVLMELIDAKELYRVRVENPDEVLDMILEEVAKFY---HRG 123

Query: 405 ILHFDIKPHNILLDEDFCPKISDFGLAKICNRKESIISMTGARGTVGYIAPEVFCRNIGE 464
           I+H D+  +N+L+  +    I DF  +     +                  E+  R++  
Sbjct: 124 IVHGDLSQYNVLVS-EEGIWIIDFPQSVEVGEEG---------------WREILERDVRN 167

Query: 465 V--------SYKSDVYNYGMMIFE 480
           +          + D+ +    I +
Sbjct: 168 IITYFSRTYRTEKDINSAIDRILQ 191

Homologous Domains Detected by HHsearch

Original result of HHsearch against SCOP70(version1.75) database

ID	Length	Definition	Probability
Query	506
d1nvra_	271	Cell cycle checkpoint kinase chk1 {Human (Homo sap	100.0
d1qpca_	272	Lymphocyte kinase (lck) {Human (Homo sapiens) [Tax	100.0
d1uwha_	276	B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]}	100.0
d2j4za1	263	Aurora-related kinase 1 (aurora-2) {Human (Homo sa	100.0
d1k2pa_	258	Bruton's tyrosine kinase (Btk) {Human (Homo sapien	100.0
d1sm2a_	263	Tyrosine-protein kinase Itk/Tsk {Human (Homo sapie	100.0
d1opja_	287	Abelsone tyrosine kinase (abl) {Mouse (Mus musculu	100.0
d1yhwa1	293	pak1 {Human (Homo sapiens) [TaxId: 9606]}	100.0
d1jpaa_	299	ephb2 receptor tyrosine kinase {Mouse (Mus musculu	100.0
d1uu3a_	288	3-phosphoinositide dependent protein kinase-1 Pdk1	100.0
d1t4ha_	270	Protein kinase wnk1 {Human (Homo sapiens) [TaxId:	100.0
d2jfla1	288	STE20-like serine/threonine-protein kinase, SLK {H	100.0
d1s9ja_	322	Dual specificity mitogen-activated protein kinase	100.0
d1u5ra_	309	Serine/threonine protein kinase TAO2 {Rat (Rattus	100.0
d2java1	269	Serine/threonine-protein kinase Nek2 {Human (Homo	100.0
d1xbba_	277	Tyrosine-protein kinase SYK {Human (Homo sapiens)	100.0
d1fmka3	285	c-src tyrosine kinase {Human (Homo sapiens) [TaxId	100.0
d1u59a_	285	Tyrosine-protein kinase ZAP-70 {Human (Homo sapien	100.0
d1fota_	316	cAMP-dependent PK, catalytic subunit {Baker's yeas	100.0
d1mqba_	283	epha2 receptor tyrosine kinase {Human (Homo sapien	100.0
d1xkka_	317	EGF receptor tyrosine kinase, Erbb-1 {Human (Homo	100.0
d1rjba_	325	Fl cytokine receptor {Human (Homo sapiens) [TaxId:	100.0
d1rdqe_	350	cAMP-dependent PK, catalytic subunit {Mouse (Mus m	100.0
d1a06a_	307	Calmodulin-dependent protein kinase {Rat (Rattus n	100.0
d1o6la_	337	Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9	100.0
d1koaa2	350	Twitchin, kinase domain {Caenorhabditis elegans, p	100.0
d1ua2a_	299	Cell division protein kinase 7, CDK7 {Human (Homo	100.0
d1jksa_	293	Death-associated protein kinase, Dap {Human (Homo	100.0
d1koba_	352	Twitchin, kinase domain {California sea hare (Aply	100.0
d1mp8a_	273	Focal adhesion kinase 1 (fak) {Human (Homo sapiens	100.0
d1lufa_	301	Musk tyrosine kinase {Rat (Rattus norvegicus) [Tax	100.0
d1byga_	262	Carboxyl-terminal src kinase (csk) {Human (Homo sa	100.0
d1u46a_	273	Activated CDC42 kinase 1, ACK1 {Human (Homo sapien	100.0
d1o6ya_	277	Mycobacterial protein kinase PknB, catalytic domai	100.0
d1omwa3	364	G-protein coupled receptor kinase 2 {Cow (Bos taur	100.0
d1ob3a_	286	Cyclin-dependent PK, CDK2 {(Plasmodium falciparum)	100.0
d1gz8a_	298	Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [T	100.0
d1r0pa_	311	Hepatocyte growth factor receptor, c-MET {Human (H	100.0
d1xjda_	320	Protein kinase C, theta type {Human (Homo sapiens)	100.0
d1blxa_	305	Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [T	100.0
d1xwsa_	273	Proto-oncogene serine/threonine-protein kinase Pim	100.0
d1vjya_	303	Type I TGF-beta receptor R4 {Human (Homo sapiens)	100.0
d1ywna1	299	Vascular endothelial growth factor receptor 2 (kdr	100.0
d1phka_	277	gamma-subunit of glycogen phosphorylase kinase (Ph	100.0
d1tkia_	321	Titin, kinase domain {Human (Homo sapiens) [TaxId:	100.0
d1t46a_	311	c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]	100.0
d2ozaa1	335	MAP kinase activated protein kinase 2, mapkap2 {Hu	100.0
d1q5ka_	350	Glycogen synthase kinase-3 beta (Gsk3b) {Human (Ho	100.0
d1p4oa_	308	Insulin-like growth factor 1 receptor {Human (Homo	100.0
d3blha1	318	Cell division protein kinase 9, CDK9 {Human (Homo	100.0
d1pmea_	345	MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606	100.0
d1cm8a_	346	MAP kinase p38-gamma {Human (Homo sapiens) [TaxId:	100.0
d1fgka_	299	Fibroblast growth factor receptor 1 {Human (Homo s	100.0
d1fvra_	309	Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]}	100.0
d1unla_	292	Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [T	100.0
d1csna_	293	Casein kinase-1, CK1 {Fission yeast (Schizosacchar	100.0
d1ckia_	299	Casein kinase-1, CK1 {Rat (Rattus norvegicus) [Tax	100.0
d1vzoa_	322	Ribosomal protein S6 kinase alpha 5, Msk1 {Human (	100.0
d3bqca1	328	Protein kinase CK2, alpha subunit {Rattus norvegic	100.0
d2b1pa1	355	c-jun N-terminal kinase (jnk3s) {Human (Homo sapie	99.98
d2gfsa1	348	MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]	99.98
d1q8ya_	362	Sky1p {Baker's yeast (Saccharomyces cerevisiae) [T	99.96
d1zara2	191	Rio2 serine protein kinase C-terminal domain {Arch	99.84
d1j7la_	263	Type IIIa 3',5"-aminoglycoside phosphotransferase	96.99
d1zyla1	325	RdoA {Escherichia coli [TaxId: 562]}	96.61
d2ppqa1	316	Homoserine kinase ThrB {Agrobacterium tumefaciens	96.17
d2pula1	392	Methylthioribose kinase MtnK {Bacillus subtilis [T	96.16
d1nd4a_	255	Aminoglycoside 3'-phosphotransferase IIa (Kanamyci	96.01
d1nw1a_	395	Choline kinase {Caenorhabditis elegans [TaxId: 623	95.16

>d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell cycle checkpoint kinase chk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.3e-40  Score=317.11  Aligned_cols=178  Identities=29%  Similarity=0.401  Sum_probs=148.0

Q ss_pred             hhccccCccCceEEEEEEEc-CCCEEEEEEeccCC--CCchhhHHHHHHhhccCccceeEEEEEe---------------
Q 039231          316 SFKYKLGQGGYGSVYKGKLL-DGSNVAVKVLNDSK--GNGKEFINEVASISRTSHVNVVALLGFC---------------  377 (506)
Q Consensus       316 ~~~~~ig~G~~g~V~~~~~~-~~~~vavK~l~~~~--~~~~~~~~E~~~l~~l~h~niv~l~g~~---------------  377 (506)
                      .+.++||+|+||+||+|+.+ +|+.||||+++...  ...+.+.+|++++++++|||||++++++               
T Consensus         8 ~~~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~~~~~~~~~~~~~ivmEy~~g   87 (271)
T d1nvra_           8 DLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLEYCSG   87 (271)
T ss_dssp             EEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC-------CHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEECCTT
T ss_pred             EEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHhCCCCCEeeEeeeeccCceeEEEEeccCC
Confidence            34578999999999999985 58999999996543  2346789999999999999999999987               


Q ss_pred             ------------eccchhhhHHHHHHHHHHHHhhcCCCCeEecCcCCCcEEECCCCcEEEeecCCCccccCCCcceeccc
Q 039231          378 ------------LRVAEELSSTIGIARGLEYLHLGCSTRILHFDIKPHNILLDEDFCPKISDFGLAKICNRKESIISMTG  445 (506)
Q Consensus       378 ------------~~~~~~l~i~~~i~~gl~~LH~~~~~~ivH~dlkp~Nill~~~~~~ki~dfg~a~~~~~~~~~~~~~~  445 (506)
                                  +++.+...++.||++||+|||   +++|+||||||+|||+++++.+||+|||+|+.............
T Consensus        88 g~L~~~l~~~~~l~e~~~~~i~~qi~~al~ylH---~~~IiHrDiKp~NILl~~~~~~KL~DFG~a~~~~~~~~~~~~~~  164 (271)
T d1nvra_          88 GELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLH---GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNK  164 (271)
T ss_dssp             EEGGGGSBTTTBCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCCGGGEEECTTCCEEECCCTTCEECEETTEECCBCC
T ss_pred             CcHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH---HcCCccCcccHHHEEECCCCCEEEccchhheeeccCCccccccc
Confidence                        334456789999999999999   89999999999999999999999999999998765543333456


Q ss_pred             CCCCcccccccccccccCCCCccccHHHHHHHHHHHHcCCCCCCCCCCCcch
Q 039231          446 ARGTVGYIAPEVFCRNIGEVSYKSDVYNYGMMIFEMTGGRKNVDVVDNGSTA  497 (506)
Q Consensus       446 ~~gt~~y~aPE~l~~~~~~~s~~~Dv~s~G~il~elltg~~pf~~~~~~~~~  497 (506)
                      ..||+.|||||++.+. ..++.++||||+||++|||++|+.||....+....
T Consensus       165 ~~GT~~Y~APE~~~~~-~~~~~~~DiwSlGvilyeml~G~~pf~~~~~~~~~  215 (271)
T d1nvra_         165 MCGTLPYVAPELLKRR-EFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQE  215 (271)
T ss_dssp             CCSCGGGSCTHHHHCS-SBCHHHHHHHHHHHHHHHHHHSSCSCSSSSTTSHH
T ss_pred             eeeCcCccCHhHhcCC-CCCCCceeeeHhHHHHHHHHhCCCCCCCCChHHHH
Confidence            7899999999998654 23567899999999999999999999876655443

>d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Lymphocyte kinase (lck)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.2e-40  Score=320.04  Aligned_cols=171  Identities=27%  Similarity=0.462  Sum_probs=148.4

Q ss_pred             hhhccccCccCceEEEEEEEcCCCEEEEEEeccCCCCchhhHHHHHHhhccCccceeEEEEEe-----------------
Q 039231          315 NSFKYKLGQGGYGSVYKGKLLDGSNVAVKVLNDSKGNGKEFINEVASISRTSHVNVVALLGFC-----------------  377 (506)
Q Consensus       315 ~~~~~~ig~G~~g~V~~~~~~~~~~vavK~l~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~-----------------  377 (506)
                      +.+.++||+|+||.||+|++++++.||||+++......+++.+|++++++++|||||+++|++                 
T Consensus        15 ~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~iv~Ey~~~g~L   94 (272)
T d1qpca_          15 LKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPDAFLAEANLMKQLQHQRLVRLYAVVTQEPIYIITEYMENGSL   94 (272)
T ss_dssp             EEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTSSCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSCEEEEECCTTCBH
T ss_pred             eEEeEEEecCCCcEEEEEEECCCCEEEEEEEccCcCCHHHHHHHHHHHHhCCCCCEeEEEeeeccCCeEEEEEeCCCCcH
Confidence            345678999999999999998889999999987777778899999999999999999999987                 


Q ss_pred             -----------eccchhhhHHHHHHHHHHHHhhcCCCCeEecCcCCCcEEECCCCcEEEeecCCCccccCCCcceecccC
Q 039231          378 -----------LRVAEELSSTIGIARGLEYLHLGCSTRILHFDIKPHNILLDEDFCPKISDFGLAKICNRKESIISMTGA  446 (506)
Q Consensus       378 -----------~~~~~~l~i~~~i~~gl~~LH~~~~~~ivH~dlkp~Nill~~~~~~ki~dfg~a~~~~~~~~~~~~~~~  446 (506)
                                 +++.+++.++.||++||+|||   +++|+||||||+||||++++.+||+|||+|+........ .....
T Consensus        95 ~~~~~~~~~~~l~~~~~~~i~~qi~~gl~~lH---~~~ivHrDiKp~NIll~~~~~~Kl~DFGla~~~~~~~~~-~~~~~  170 (272)
T d1qpca_          95 VDFLKTPSGIKLTINKLLDMAAQIAEGMAFIE---ERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYT-AREGA  170 (272)
T ss_dssp             HHHTTSHHHHTCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECTTSCEEECCCTTCEECSSSCEE-CCTTC
T ss_pred             HHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHH---hCCcccCccchhheeeecccceeeccccceEEccCCccc-ccccc
Confidence                       344557889999999999999   899999999999999999999999999999987654432 23456


Q ss_pred             CCCcccccccccccccCCCCccccHHHHHHHHHHHHcCCCCCCCC
Q 039231          447 RGTVGYIAPEVFCRNIGEVSYKSDVYNYGMMIFEMTGGRKNVDVV  491 (506)
Q Consensus       447 ~gt~~y~aPE~l~~~~~~~s~~~Dv~s~G~il~elltg~~pf~~~  491 (506)
                      .||+.|+|||++..  +.++.++|||||||++|||+||..|+...
T Consensus       171 ~gt~~y~APE~~~~--~~~~~~sDvwS~Gvvl~ellt~~~~~~~~  213 (272)
T d1qpca_         171 KFPIKWTAPEAINY--GTFTIKSDVWSFGILLTEIVTHGRIPYPG  213 (272)
T ss_dssp             CCCTTTSCHHHHHH--CEECHHHHHHHHHHHHHHHHTTTCCSSTT
T ss_pred             CCcccccChHHHhC--CCCCchhhhhhhHHHHHHHHhCCCCCCCC
Confidence            78999999999864  37899999999999999999965555443

>d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: B-Raf kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.3e-40  Score=318.26  Aligned_cols=177  Identities=33%  Similarity=0.618  Sum_probs=142.4

Q ss_pred             hhccccCccCceEEEEEEEcCCCEEEEEEeccCC---CCchhhHHHHHHhhccCccceeEEEEEe---------------
Q 039231          316 SFKYKLGQGGYGSVYKGKLLDGSNVAVKVLNDSK---GNGKEFINEVASISRTSHVNVVALLGFC---------------  377 (506)
Q Consensus       316 ~~~~~ig~G~~g~V~~~~~~~~~~vavK~l~~~~---~~~~~~~~E~~~l~~l~h~niv~l~g~~---------------  377 (506)
                      .+.++||+|+||+||+|+++  ..||||+++...   ...+.+.+|++++++++|||||+++|++               
T Consensus        11 ~~~~~lG~G~fg~Vy~~~~~--~~vAvK~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~~~~~lv~Ey~~~g   88 (276)
T d1uwha_          11 TVGQRIGSGSFGTVYKGKWH--GDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYSTAPQLAIVTQWCEGS   88 (276)
T ss_dssp             CCCSEEEECSSCEEEEEESS--SEEEEEECCCSSCCTTHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSCEEEEECCCEE
T ss_pred             EEEEEEeeCCCcEEEEEEEC--CEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeeeeEEEeccEEEEEEecCCCC
Confidence            34578999999999999864  369999997532   2336788999999999999999999987               


Q ss_pred             ------------eccchhhhHHHHHHHHHHHHhhcCCCCeEecCcCCCcEEECCCCcEEEeecCCCccccCCCcceeccc
Q 039231          378 ------------LRVAEELSSTIGIARGLEYLHLGCSTRILHFDIKPHNILLDEDFCPKISDFGLAKICNRKESIISMTG  445 (506)
Q Consensus       378 ------------~~~~~~l~i~~~i~~gl~~LH~~~~~~ivH~dlkp~Nill~~~~~~ki~dfg~a~~~~~~~~~~~~~~  445 (506)
                                  +++.+++.++.||++||+|||   +++|+||||||+|||+++++.+||+|||+|+.............
T Consensus        89 ~L~~~l~~~~~~~~~~~~~~i~~qi~~gl~yLH---~~~ivHrDlKp~NiLl~~~~~~Kl~DFGla~~~~~~~~~~~~~~  165 (276)
T d1uwha_          89 SLYHHLHIIETKFEMIKLIDIARQTAQGMDYLH---AKSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQ  165 (276)
T ss_dssp             EHHHHHHTSCCCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEEETTSSEEECCCCCSCC------------
T ss_pred             CHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHh---cCCEeccccCHHHEEEcCCCCEEEccccceeeccccCCcccccc
Confidence                        334457889999999999999   89999999999999999999999999999987765444334456


Q ss_pred             CCCCcccccccccccc-cCCCCccccHHHHHHHHHHHHcCCCCCCCCCCCcch
Q 039231          446 ARGTVGYIAPEVFCRN-IGEVSYKSDVYNYGMMIFEMTGGRKNVDVVDNGSTA  497 (506)
Q Consensus       446 ~~gt~~y~aPE~l~~~-~~~~s~~~Dv~s~G~il~elltg~~pf~~~~~~~~~  497 (506)
                      ..||+.|||||++... .+.++.++|||||||+||||+||+.||......+..
T Consensus       166 ~~gt~~y~APE~l~~~~~~~~~~~sDiwS~Gv~l~el~tg~~Pf~~~~~~~~~  218 (276)
T d1uwha_         166 LSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQI  218 (276)
T ss_dssp             CCCCGGGCCHHHHTTCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHHH
T ss_pred             cccCcccCCHHHHhcccCCCCCchhhhhhhHHHHHHHHHCCCCCCCCChHHHH
Confidence            7899999999998543 235799999999999999999999999876655443

>d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Aurora-related kinase 1 (aurora-2)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=5.8e-40  Score=313.07  Aligned_cols=172  Identities=28%  Similarity=0.424  Sum_probs=147.3

Q ss_pred             hhhccccCccCceEEEEEEEc-CCCEEEEEEecc----CCCCchhhHHHHHHhhccCccceeEEEEEe------------
Q 039231          315 NSFKYKLGQGGYGSVYKGKLL-DGSNVAVKVLND----SKGNGKEFINEVASISRTSHVNVVALLGFC------------  377 (506)
Q Consensus       315 ~~~~~~ig~G~~g~V~~~~~~-~~~~vavK~l~~----~~~~~~~~~~E~~~l~~l~h~niv~l~g~~------------  377 (506)
                      +.+.+.||+|+||.||+|+.+ +++.||+|++..    .....+.+.+|++++++++|||||++++++            
T Consensus         8 y~i~~~iG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~ivmEy   87 (263)
T d2j4za1           8 FEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLILEY   87 (263)
T ss_dssp             EEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEEC
T ss_pred             eEEEEEEecCCCcEEEEEEECCCCcEEEEEEEchHHccChHHHHHHHHHHHHHHhcCCCCCCeEEEEEEECCEEEEEEee
Confidence            345678999999999999985 589999999863    233446789999999999999999999988            


Q ss_pred             ---------------eccchhhhHHHHHHHHHHHHhhcCCCCeEecCcCCCcEEECCCCcEEEeecCCCccccCCCccee
Q 039231          378 ---------------LRVAEELSSTIGIARGLEYLHLGCSTRILHFDIKPHNILLDEDFCPKISDFGLAKICNRKESIIS  442 (506)
Q Consensus       378 ---------------~~~~~~l~i~~~i~~gl~~LH~~~~~~ivH~dlkp~Nill~~~~~~ki~dfg~a~~~~~~~~~~~  442 (506)
                                     +++.+...++.||++||+|||   +++|+||||||+|||+++++.+||+|||+|+.......   
T Consensus        88 ~~~g~L~~~l~~~~~l~e~~~~~i~~qi~~al~~lH---~~~ivHrDiKp~Nill~~~~~~kl~DFG~a~~~~~~~~---  161 (263)
T d2j4za1          88 APLGTVYRELQKLSKFDEQRTATYITELANALSYCH---SKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRR---  161 (263)
T ss_dssp             CTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEECTTSCEEECCCCSCSCCCCCCC---
T ss_pred             cCCCcHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHH---HCCeeeeeeccccceecCCCCEeecccceeeecCCCcc---
Confidence                           344457779999999999999   89999999999999999999999999999987654432   


Q ss_pred             cccCCCCcccccccccccccCCCCccccHHHHHHHHHHHHcCCCCCCCCCCCc
Q 039231          443 MTGARGTVGYIAPEVFCRNIGEVSYKSDVYNYGMMIFEMTGGRKNVDVVDNGS  495 (506)
Q Consensus       443 ~~~~~gt~~y~aPE~l~~~~~~~s~~~Dv~s~G~il~elltg~~pf~~~~~~~  495 (506)
                       ....||+.|+|||++.+.  .++.++|||||||++|||++|+.||+..+..+
T Consensus       162 -~~~~Gt~~Y~APE~~~~~--~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~  211 (263)
T d2j4za1         162 -TTLCGTLDYLPPEMIEGR--MHDEKVDLWSLGVLCYEFLVGKPPFEANTYQE  211 (263)
T ss_dssp             -EETTEEGGGCCHHHHTTC--CCCTTHHHHHHHHHHHHHHHSSCTTCCSSHHH
T ss_pred             -cccCCCCcccCHHHHcCC--CCCchhhhhhHhHHHHHHhcCCCCCCCCCHHH
Confidence             346799999999999664  68999999999999999999999997655433

>d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Bruton's tyrosine kinase (Btk)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.3e-39  Score=309.91  Aligned_cols=179  Identities=30%  Similarity=0.516  Sum_probs=155.0

Q ss_pred             hhccccCccCceEEEEEEEcCCCEEEEEEeccCCCCchhhHHHHHHhhccCccceeEEEEEee-----------------
Q 039231          316 SFKYKLGQGGYGSVYKGKLLDGSNVAVKVLNDSKGNGKEFINEVASISRTSHVNVVALLGFCL-----------------  378 (506)
Q Consensus       316 ~~~~~ig~G~~g~V~~~~~~~~~~vavK~l~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~-----------------  378 (506)
                      .|.++||+|+||+||+|++++++.||||+++......+++.+|++++++++|||||+++|++.                 
T Consensus         7 ~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~l~~~~~~~~~~~~Ev~~~~~l~HpnIv~~~g~~~~~~~~~iv~Ey~~~g~l   86 (258)
T d1k2pa_           7 TFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEYMANGCL   86 (258)
T ss_dssp             CCCCCCCEETTEEEEEEEETTTEEEEEEEEESSSSCHHHHHHHHHHHHTCCCTTBCCEEEEECCSSSEEEEEECCTTEEH
T ss_pred             EEeEEEecCCCeEEEEEEECCCCEEEEEEECcCcCCHHHHHHHHHHHHhcCCCceeeEEEEEeeCCceEEEEEccCCCcH
Confidence            356789999999999999988889999999987777789999999999999999999999982                 


Q ss_pred             -----------ccchhhhHHHHHHHHHHHHhhcCCCCeEecCcCCCcEEECCCCcEEEeecCCCccccCCCcceecccCC
Q 039231          379 -----------RVAEELSSTIGIARGLEYLHLGCSTRILHFDIKPHNILLDEDFCPKISDFGLAKICNRKESIISMTGAR  447 (506)
Q Consensus       379 -----------~~~~~l~i~~~i~~gl~~LH~~~~~~ivH~dlkp~Nill~~~~~~ki~dfg~a~~~~~~~~~~~~~~~~  447 (506)
                                 .+..++.++.|+++||+|||   +++|+||||||+|||+++++.+||+|||+++........ ......
T Consensus        87 ~~~~~~~~~~~~~~~~~~i~~qi~~gl~~LH---~~~iiH~dlk~~Nill~~~~~~kl~DfG~a~~~~~~~~~-~~~~~~  162 (258)
T d1k2pa_          87 LNYLREMRHRFQTQQLLEMCKDVCEAMEYLE---SKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYT-SSVGSK  162 (258)
T ss_dssp             HHHHHSGGGCCCHHHHHHHHHHHHHHHHHHH---HTTBCCSCCSGGGEEECTTCCEEECCCSSCCBCSSSSCC-CCCCSC
T ss_pred             HHhhhccccCCcHHHHHHHHHHHHHHHHHHh---hcCcccccccceeEEEcCCCcEEECcchhheeccCCCce-eecccC
Confidence                       23346789999999999999   899999999999999999999999999999876654432 234567


Q ss_pred             CCcccccccccccccCCCCccccHHHHHHHHHHHHc-CCCCCCCCCCCcchhhh
Q 039231          448 GTVGYIAPEVFCRNIGEVSYKSDVYNYGMMIFEMTG-GRKNVDVVDNGSTALDL  500 (506)
Q Consensus       448 gt~~y~aPE~l~~~~~~~s~~~Dv~s~G~il~ellt-g~~pf~~~~~~~~~~~~  500 (506)
                      +|+.|+|||.+.+.  .++.++||||||+++|||+| |+.||+.....+....+
T Consensus       163 ~t~~y~aPE~~~~~--~~~~ksDiwS~G~~l~el~t~g~~Pf~~~~~~~~~~~i  214 (258)
T d1k2pa_         163 FPVRWSPPEVLMYS--KFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHI  214 (258)
T ss_dssp             CCGGGCCHHHHHHC--CCCHHHHHHHHHHHHHHHHTTSCCTTTTSCHHHHHHHH
T ss_pred             CCCCcCCcHHhcCC--CCCcceeecccchhhHhHHhcCCCCCCCCCHHHHHHHH
Confidence            89999999999654  78999999999999999998 89999887665544433

>d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase Itk/Tsk
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=5.9e-40  Score=313.63  Aligned_cols=170  Identities=28%  Similarity=0.520  Sum_probs=136.4

Q ss_pred             hhccccCccCceEEEEEEEcCCCEEEEEEeccCCCCchhhHHHHHHhhccCccceeEEEEEe------------------
Q 039231          316 SFKYKLGQGGYGSVYKGKLLDGSNVAVKVLNDSKGNGKEFINEVASISRTSHVNVVALLGFC------------------  377 (506)
Q Consensus       316 ~~~~~ig~G~~g~V~~~~~~~~~~vavK~l~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~------------------  377 (506)
                      .+.++||+|+||+||+|++.+++.||||+++......+++.+|++++++++|||||+++|++                  
T Consensus         8 ~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~i~~~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~lv~E~~~~g~L   87 (263)
T d1sm2a_           8 TFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAMSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFEFMEHGCL   87 (263)
T ss_dssp             EEEEEEECCSSCCEEEEEETTTEEEEEEECCSSSSCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECCTTCBH
T ss_pred             EEEEEEeeCCCeEEEEEEECCCCEEEEEEECCCcCcHHHHHHHHHHHHhcCCCCcccccceeccCCceEEEEEecCCCcH
Confidence            34578999999999999998889999999988777778899999999999999999999998                  


Q ss_pred             ----------eccchhhhHHHHHHHHHHHHhhcCCCCeEecCcCCCcEEECCCCcEEEeecCCCccccCCCcceecccCC
Q 039231          378 ----------LRVAEELSSTIGIARGLEYLHLGCSTRILHFDIKPHNILLDEDFCPKISDFGLAKICNRKESIISMTGAR  447 (506)
Q Consensus       378 ----------~~~~~~l~i~~~i~~gl~~LH~~~~~~ivH~dlkp~Nill~~~~~~ki~dfg~a~~~~~~~~~~~~~~~~  447 (506)
                                +++..++.++.||++||+|||   +++|+||||||+|||+++++.+||+|||+++......... .....
T Consensus        88 ~~~l~~~~~~~~~~~~~~i~~qia~gl~~lH---~~~iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~~~~~~~-~~~~~  163 (263)
T d1sm2a_          88 SDYLRTQRGLFAAETLLGMCLDVCEGMAYLE---EACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTS-STGTK  163 (263)
T ss_dssp             HHHHHTTTTCCCHHHHHHHHHHHHHHHHHHH---HTTCCCTTCSGGGEEECGGGCEEECSCC------------------
T ss_pred             HHHhhccccCCCHHHHHHHHHHHHHHHHhhh---ccceeecccchhheeecCCCCeEecccchheeccCCCcee-eccee
Confidence                      234446789999999999999   8999999999999999999999999999998775543322 23467


Q ss_pred             CCcccccccccccccCCCCccccHHHHHHHHHHHHcC-CCCCCCC
Q 039231          448 GTVGYIAPEVFCRNIGEVSYKSDVYNYGMMIFEMTGG-RKNVDVV  491 (506)
Q Consensus       448 gt~~y~aPE~l~~~~~~~s~~~Dv~s~G~il~elltg-~~pf~~~  491 (506)
                      ||+.|+|||++.+.  .++.++|||||||++|||+|+ ++||...
T Consensus       164 gt~~y~aPE~l~~~--~~~~k~DVwS~Gvil~el~t~~~~~~~~~  206 (263)
T d1sm2a_         164 FPVKWASPEVFSFS--RYSSKSDVWSFGVLMWEVFSEGKIPYENR  206 (263)
T ss_dssp             -CTTSCCHHHHTTC--CCCHHHHHHHHHHHHHHHHTTSCCTTCSC
T ss_pred             cCcccCChHHhcCC--CCCchhhhcchHHHHHHHHHCCCCCCCCC
Confidence            89999999999654  789999999999999999995 5555443

>d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Abelsone tyrosine kinase (abl)
species: Mouse (Mus musculus) [TaxId: 10090]

Probab=100.00  E-value=4.1e-40  Score=318.49  Aligned_cols=180  Identities=31%  Similarity=0.490  Sum_probs=151.7

Q ss_pred             HhhhccccCccCceEEEEEEEcC-CCEEEEEEeccCCCCchhhHHHHHHhhccCccceeEEEEEe---------------
Q 039231          314 TNSFKYKLGQGGYGSVYKGKLLD-GSNVAVKVLNDSKGNGKEFINEVASISRTSHVNVVALLGFC---------------  377 (506)
Q Consensus       314 ~~~~~~~ig~G~~g~V~~~~~~~-~~~vavK~l~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~---------------  377 (506)
                      .+.+.++||+|+||+||+|++.+ ++.||||+++.+....+++.+|+++|++++|||||+++|++               
T Consensus        18 ~~~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~iv~E~~~~   97 (287)
T d1opja_          18 DITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTY   97 (287)
T ss_dssp             GEEEEEETTTTTTSSEEEEEEGGGTEEEEEEECCTTCSCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECCTT
T ss_pred             HeEEeeEEeeCCCeEEEEEEECCCCeEEEEEEECCccchHHHHHHHHHHHHhCCCCCEecCCccEeeCCeeEEEeecccC
Confidence            34456789999999999999864 88999999988777778899999999999999999999988               


Q ss_pred             --------------eccchhhhHHHHHHHHHHHHhhcCCCCeEecCcCCCcEEECCCCcEEEeecCCCccccCCCcceec
Q 039231          378 --------------LRVAEELSSTIGIARGLEYLHLGCSTRILHFDIKPHNILLDEDFCPKISDFGLAKICNRKESIISM  443 (506)
Q Consensus       378 --------------~~~~~~l~i~~~i~~gl~~LH~~~~~~ivH~dlkp~Nill~~~~~~ki~dfg~a~~~~~~~~~~~~  443 (506)
                                    +++..++.++.||++||+|||   +++|+||||||+||||++++.+||+|||+|+......... .
T Consensus        98 g~l~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH---~~~iiHrDlKp~NILl~~~~~~Kl~DFG~a~~~~~~~~~~-~  173 (287)
T d1opja_          98 GNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLE---KKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTA-H  173 (287)
T ss_dssp             CBHHHHHHHSCTTTSCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEECGGGCEEECCCCCTTTCCSSSSEE-E
T ss_pred             cchHHHhhhccccchHHHHHHHHHHHHHHHHHHHH---HCCcccCccccCeEEECCCCcEEEccccceeecCCCCcee-e
Confidence                          233346778999999999999   8999999999999999999999999999999876544332 2


Q ss_pred             ccCCCCcccccccccccccCCCCccccHHHHHHHHHHHHcCCCCCCCCCCCcchhh
Q 039231          444 TGARGTVGYIAPEVFCRNIGEVSYKSDVYNYGMMIFEMTGGRKNVDVVDNGSTALD  499 (506)
Q Consensus       444 ~~~~gt~~y~aPE~l~~~~~~~s~~~Dv~s~G~il~elltg~~pf~~~~~~~~~~~  499 (506)
                      ....|++.|+|||++.+.  .++.++|||||||++|||++|..||....+.....+
T Consensus       174 ~~~~g~~~y~aPE~~~~~--~~~~k~DiwS~Gv~l~ell~~~~p~~~~~~~~~~~~  227 (287)
T d1opja_         174 AGAKFPIKWTAPESLAYN--KFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYE  227 (287)
T ss_dssp             TTEEECGGGCCHHHHHHC--CCSHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHH
T ss_pred             ccccccccccChHHHcCC--CCCchhhhhhHHHHHHHHHhCCCCCCCcchHHHHHH
Confidence            445688999999998654  789999999999999999998777765544443333

>d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: pak1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.6e-39  Score=313.08  Aligned_cols=173  Identities=29%  Similarity=0.404  Sum_probs=148.2

Q ss_pred             hhccccCccCceEEEEEEEc-CCCEEEEEEeccCC-CCchhhHHHHHHhhccCccceeEEEEEe----------------
Q 039231          316 SFKYKLGQGGYGSVYKGKLL-DGSNVAVKVLNDSK-GNGKEFINEVASISRTSHVNVVALLGFC----------------  377 (506)
Q Consensus       316 ~~~~~ig~G~~g~V~~~~~~-~~~~vavK~l~~~~-~~~~~~~~E~~~l~~l~h~niv~l~g~~----------------  377 (506)
                      .+.++||+|+||+||+|+.. +|+.||||+++... ...+.+.+|++++++++|||||++++++                
T Consensus        23 ~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivmEy~~gg  102 (293)
T d1yhwa1          23 TRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYLAGG  102 (293)
T ss_dssp             CSCEECCCSSSCEEEEEEBTTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECCTTC
T ss_pred             EEEEEEecCcCcEEEEEEECCCCCEEEEEEEecccChHHHHHHHHHHHHHhCCCCCEeeEeEEEEECCEEEEEEEecCCC
Confidence            33567999999999999874 58999999997543 3446789999999999999999999987                


Q ss_pred             ----------eccchhhhHHHHHHHHHHHHhhcCCCCeEecCcCCCcEEECCCCcEEEeecCCCccccCCCcceecccCC
Q 039231          378 ----------LRVAEELSSTIGIARGLEYLHLGCSTRILHFDIKPHNILLDEDFCPKISDFGLAKICNRKESIISMTGAR  447 (506)
Q Consensus       378 ----------~~~~~~l~i~~~i~~gl~~LH~~~~~~ivH~dlkp~Nill~~~~~~ki~dfg~a~~~~~~~~~~~~~~~~  447 (506)
                                +++.+...++.||+.||+|||   +++|+||||||+|||++.++.+||+|||+|+........  .....
T Consensus       103 ~L~~~~~~~~l~~~~~~~i~~qi~~aL~yLH---~~~iiHrDiKp~NILl~~~~~vkl~DFG~a~~~~~~~~~--~~~~~  177 (293)
T d1yhwa1         103 SLTDVVTETCMDEGQIAAVCRECLQALEFLH---SNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSK--RSTMV  177 (293)
T ss_dssp             BHHHHHHHSCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTTCCEEECCCTTCEECCSTTCC--BCCCC
T ss_pred             cHHHHhhccCCCHHHHHHHHHHHHHHHHHHH---HCCCcccCCcHHHeEECCCCcEeeccchhheeecccccc--ccccc
Confidence                      344457789999999999999   899999999999999999999999999999877554332  24567


Q ss_pred             CCcccccccccccccCCCCccccHHHHHHHHHHHHcCCCCCCCCCCCc
Q 039231          448 GTVGYIAPEVFCRNIGEVSYKSDVYNYGMMIFEMTGGRKNVDVVDNGS  495 (506)
Q Consensus       448 gt~~y~aPE~l~~~~~~~s~~~Dv~s~G~il~elltg~~pf~~~~~~~  495 (506)
                      ||+.|+|||++.+.  .++.++||||+||++|||++|+.||...+..+
T Consensus       178 gt~~Y~aPE~~~~~--~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~  223 (293)
T d1yhwa1         178 GTPYWMAPEVVTRK--AYGPKVDIWSLGIMAIEMIEGEPPYLNENPLR  223 (293)
T ss_dssp             SCGGGCCHHHHSSS--CBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHH
T ss_pred             cCCCccChhhhcCC--CCCchhceehHhHHHHHHhhCCCCCCCCCHHH
Confidence            99999999999654  78999999999999999999999997655443

>d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: ephb2 receptor tyrosine kinase
species: Mouse (Mus musculus) [TaxId: 10090]

Probab=100.00  E-value=1.1e-39  Score=317.47  Aligned_cols=189  Identities=27%  Similarity=0.485  Sum_probs=143.3

Q ss_pred             CccCHHHHHHHHhhhc-----------cccCccCceEEEEEEEcC-C---CEEEEEEeccCCC--CchhhHHHHHHhhcc
Q 039231          303 KRYGYADIKKMTNSFK-----------YKLGQGGYGSVYKGKLLD-G---SNVAVKVLNDSKG--NGKEFINEVASISRT  365 (506)
Q Consensus       303 ~~~~~~el~~~~~~~~-----------~~ig~G~~g~V~~~~~~~-~---~~vavK~l~~~~~--~~~~~~~E~~~l~~l  365 (506)
                      ..++++++.+++.+|.           +.||+|+||+||+|+++. +   ..||||++.....  ..+++.+|+++|+++
T Consensus         5 d~~t~~d~~~a~~~f~~~i~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l   84 (299)
T d1jpaa_           5 DPFTFEDPNEAVREFAKEIDISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQF   84 (299)
T ss_dssp             CGGGSSSHHHHHHHHSCBCCGGGEEEEEEEEECSSSEEEEEEECC---CCEEEEEEECCSSCCHHHHHHHHHHHHHHTTC
T ss_pred             CCCCHHHHHHHHhhhchhhChhhcEEeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEECcccCHHHHHHHHHHHHHHHhC
Confidence            3466777777777663           469999999999998753 2   3589998865433  336799999999999


Q ss_pred             CccceeEEEEEe----------------------------eccchhhhHHHHHHHHHHHHhhcCCCCeEecCcCCCcEEE
Q 039231          366 SHVNVVALLGFC----------------------------LRVAEELSSTIGIARGLEYLHLGCSTRILHFDIKPHNILL  417 (506)
Q Consensus       366 ~h~niv~l~g~~----------------------------~~~~~~l~i~~~i~~gl~~LH~~~~~~ivH~dlkp~Nill  417 (506)
                      +|||||+++|++                            +++.+++.++.||++||+|||   +++|+||||||+||||
T Consensus        85 ~HpnIv~l~g~~~~~~~~~iv~Ey~~~g~L~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH---~~~iiHrDlKp~NILl  161 (299)
T d1jpaa_          85 DHPNVIHLEGVVTKSTPVMIITEFMENGSLDSFLRQNDGQFTVIQLVGMLRGIAAGMKYLA---DMNYVHRDLAARNILV  161 (299)
T ss_dssp             CCTTBCCEEEEECSSSSCEEEEECCTTEEHHHHHHTTTTCSCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEE
T ss_pred             CCCCCccEEEEEeeCCEEEEEEEecCCCcceeeeccccCCCCHHHHHHHHHHHHHHHHHHh---hCCCccCccccceEEE
Confidence            999999999998                            344557889999999999999   8999999999999999


Q ss_pred             CCCCcEEEeecCCCccccCCCccee---cccCCCCcccccccccccccCCCCccccHHHHHHHHHHHHc-CCCCCCCCCC
Q 039231          418 DEDFCPKISDFGLAKICNRKESIIS---MTGARGTVGYIAPEVFCRNIGEVSYKSDVYNYGMMIFEMTG-GRKNVDVVDN  493 (506)
Q Consensus       418 ~~~~~~ki~dfg~a~~~~~~~~~~~---~~~~~gt~~y~aPE~l~~~~~~~s~~~Dv~s~G~il~ellt-g~~pf~~~~~  493 (506)
                      ++++.+||+|||+++..........   .....+|+.|+|||.+.+  +.++.++|||||||++|||+| |+.||.....
T Consensus       162 ~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~--~~~~~~sDvwS~Gvvl~el~t~g~~Pf~~~~~  239 (299)
T d1jpaa_         162 NSNLVCKVSDFGLSRFLEDDTSDPTYTSALGGKIPIRWTAPEAIQY--RKFTSASDVWSYGIVMWEVMSYGERPYWDMTN  239 (299)
T ss_dssp             CTTCCEEECCC-----------------------CGGGSCHHHHHS--CCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCH
T ss_pred             CCCCcEEECCcccceEccCCCCcceeeecccccCCccccCHHHHhc--CCCCcccccccchHHHHHHHhCCCCCCCCCCH
Confidence            9999999999999987765433221   123567999999999854  478999999999999999998 8999987655


Q ss_pred             Ccc
Q 039231          494 GST  496 (506)
Q Consensus       494 ~~~  496 (506)
                      .+.
T Consensus       240 ~~~  242 (299)
T d1jpaa_         240 QDV  242 (299)
T ss_dssp             HHH
T ss_pred             HHH
Confidence            443

>d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: 3-phosphoinositide dependent protein kinase-1 Pdk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.5e-39  Score=314.15  Aligned_cols=177  Identities=28%  Similarity=0.405  Sum_probs=146.2

Q ss_pred             hhhccccCccCceEEEEEEEc-CCCEEEEEEeccC----CCCchhhHHHHHHhhccCccceeEEEEEe------------
Q 039231          315 NSFKYKLGQGGYGSVYKGKLL-DGSNVAVKVLNDS----KGNGKEFINEVASISRTSHVNVVALLGFC------------  377 (506)
Q Consensus       315 ~~~~~~ig~G~~g~V~~~~~~-~~~~vavK~l~~~----~~~~~~~~~E~~~l~~l~h~niv~l~g~~------------  377 (506)
                      +.+.+.||+|+||+||+|+.. +|+.||||+++..    ....+.+.+|++++++++|||||++++++            
T Consensus        10 y~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~ivmEy   89 (288)
T d1uu3a_          10 FKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGLSY   89 (288)
T ss_dssp             EEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCSTTBCCEEEEEECSSEEEEEECC
T ss_pred             CEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccCHHHHHHHHHHHHHHHHcCCCCeeEEEEEEEECCEEEEEEEc
Confidence            345678999999999999985 5899999999642    33446789999999999999999999987            


Q ss_pred             ---------------eccchhhhHHHHHHHHHHHHhhcCCCCeEecCcCCCcEEECCCCcEEEeecCCCccccCCCccee
Q 039231          378 ---------------LRVAEELSSTIGIARGLEYLHLGCSTRILHFDIKPHNILLDEDFCPKISDFGLAKICNRKESIIS  442 (506)
Q Consensus       378 ---------------~~~~~~l~i~~~i~~gl~~LH~~~~~~ivH~dlkp~Nill~~~~~~ki~dfg~a~~~~~~~~~~~  442 (506)
                                     +++.+...++.|++.||+|||   +++|+||||||+|||+++++.+||+|||+|+..........
T Consensus        90 ~~gg~L~~~~~~~~~l~e~~~~~~~~qi~~al~ylH---~~~iiHrDiKp~NIll~~~~~vkl~DFG~a~~~~~~~~~~~  166 (288)
T d1uu3a_          90 AKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLH---GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQAR  166 (288)
T ss_dssp             CTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECTTSCEEECCCTTCEECC-------
T ss_pred             cCCCCHHHhhhccCCCCHHHHHHHHHHHHHHHHhhc---cccEEcCcCCccccccCCCceEEecccccceecccCCcccc
Confidence                           334446779999999999999   89999999999999999999999999999998765443333


Q ss_pred             cccCCCCcccccccccccccCCCCccccHHHHHHHHHHHHcCCCCCCCCCCCcc
Q 039231          443 MTGARGTVGYIAPEVFCRNIGEVSYKSDVYNYGMMIFEMTGGRKNVDVVDNGST  496 (506)
Q Consensus       443 ~~~~~gt~~y~aPE~l~~~~~~~s~~~Dv~s~G~il~elltg~~pf~~~~~~~~  496 (506)
                      .....||+.|+|||++.+.  .++.++||||+||++|||++|+.||...+..+.
T Consensus       167 ~~~~~GT~~Y~APE~~~~~--~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~~  218 (288)
T d1uu3a_         167 ANSFVGTAQYVSPELLTEK--SACKSSDLWALGCIIYQLVAGLPPFRAGNEYLI  218 (288)
T ss_dssp             ---CCCCGGGCCHHHHHTC--CCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHH
T ss_pred             cccccCCccccCceeeccC--CCCcccceehhhHHHHHHhhCCCCCCCcCHHHH
Confidence            3556799999999999654  789999999999999999999999987654433

>d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase wnk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=6.4e-39  Score=306.98  Aligned_cols=170  Identities=28%  Similarity=0.426  Sum_probs=142.1

Q ss_pred             hhccccCccCceEEEEEEEc-CCCEEEEEEeccCCC---CchhhHHHHHHhhccCccceeEEEEEee-------------
Q 039231          316 SFKYKLGQGGYGSVYKGKLL-DGSNVAVKVLNDSKG---NGKEFINEVASISRTSHVNVVALLGFCL-------------  378 (506)
Q Consensus       316 ~~~~~ig~G~~g~V~~~~~~-~~~~vavK~l~~~~~---~~~~~~~E~~~l~~l~h~niv~l~g~~~-------------  378 (506)
                      .|.++||+|+||+||+|++. +++.||+|++.....   ..+.+.+|+++|++++|||||++++++.             
T Consensus        12 ~~~~~iG~G~fg~Vy~~~~~~~~~~va~K~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~~~ivm   91 (270)
T d1t4ha_          12 KFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLVT   91 (270)
T ss_dssp             EEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEEEEEEE
T ss_pred             EeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEeeccccCCEEEEEE
Confidence            45668999999999999985 488999999875432   2356889999999999999999998762             


Q ss_pred             ------------------ccchhhhHHHHHHHHHHHHhhcCCCC--eEecCcCCCcEEEC-CCCcEEEeecCCCccccCC
Q 039231          379 ------------------RVAEELSSTIGIARGLEYLHLGCSTR--ILHFDIKPHNILLD-EDFCPKISDFGLAKICNRK  437 (506)
Q Consensus       379 ------------------~~~~~l~i~~~i~~gl~~LH~~~~~~--ivH~dlkp~Nill~-~~~~~ki~dfg~a~~~~~~  437 (506)
                                        ++.+.+.++.||++||+|||   +++  |+||||||+|||++ +++.+||+|||+|+.....
T Consensus        92 E~~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~gl~yLH---~~~~~IiHrDiKp~NILl~~~~~~~Kl~DFGla~~~~~~  168 (270)
T d1t4ha_          92 ELMTSGTLKTYLKRFKVMKIKVLRSWCRQILKGLQFLH---TRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRAS  168 (270)
T ss_dssp             ECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHH---TSSSCCCCSCCCGGGEEESSTTSCEEECCTTGGGGCCTT
T ss_pred             eCCCCCcHHHHHhccccccHHHHHHHHHHHHHHHHHHH---HCCCCEEeCCcChhhceeeCCCCCEEEeecCcceeccCC
Confidence                              23335678999999999999   777  99999999999996 5789999999999865443


Q ss_pred             CcceecccCCCCcccccccccccccCCCCccccHHHHHHHHHHHHcCCCCCCCCCCCc
Q 039231          438 ESIISMTGARGTVGYIAPEVFCRNIGEVSYKSDVYNYGMMIFEMTGGRKNVDVVDNGS  495 (506)
Q Consensus       438 ~~~~~~~~~~gt~~y~aPE~l~~~~~~~s~~~Dv~s~G~il~elltg~~pf~~~~~~~  495 (506)
                      ..    ....||+.|+|||++.+   .++.++|||||||++|||++|+.||....+.+
T Consensus       169 ~~----~~~~GT~~Y~aPE~~~~---~~~~~~DIwSlGvilyel~~g~~Pf~~~~~~~  219 (270)
T d1t4ha_         169 FA----KAVIGTPEFMAPEMYEE---KYDESVDVYAFGMCMLEMATSEYPYSECQNAA  219 (270)
T ss_dssp             SB----EESCSSCCCCCGGGGGT---CCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHH
T ss_pred             cc----CCcccCccccCHHHhCC---CCCCcCchhhHHHHHHHHHHCCCCCCCcccHH
Confidence            32    35679999999999843   58999999999999999999999997655443

>d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: STE20-like serine/threonine-protein kinase, SLK
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4.1e-39  Score=311.28  Aligned_cols=181  Identities=27%  Similarity=0.382  Sum_probs=150.4

Q ss_pred             hhccccCccCceEEEEEEEc-CCCEEEEEEeccC-CCCchhhHHHHHHhhccCccceeEEEEEe----------------
Q 039231          316 SFKYKLGQGGYGSVYKGKLL-DGSNVAVKVLNDS-KGNGKEFINEVASISRTSHVNVVALLGFC----------------  377 (506)
Q Consensus       316 ~~~~~ig~G~~g~V~~~~~~-~~~~vavK~l~~~-~~~~~~~~~E~~~l~~l~h~niv~l~g~~----------------  377 (506)
                      .+.++||+|+||.||+|+.. +++.||||+++.. ....+.+.+|+++|++++|||||++++++                
T Consensus        15 ~i~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lvmEy~~~g   94 (288)
T d2jfla1          15 EIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEFCAGG   94 (288)
T ss_dssp             EEEEEEEEETTEEEEEEEETTTCCEEEEEEEECSSSGGGGGTHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECCTTE
T ss_pred             EEeEEEeeCCCcEEEEEEECCCCeEEEEEEECcCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCeEEEEEecCCCC
Confidence            34567999999999999985 5899999999754 34457899999999999999999999987                


Q ss_pred             ------------eccchhhhHHHHHHHHHHHHhhcCCCCeEecCcCCCcEEECCCCcEEEeecCCCccccCCCcceeccc
Q 039231          378 ------------LRVAEELSSTIGIARGLEYLHLGCSTRILHFDIKPHNILLDEDFCPKISDFGLAKICNRKESIISMTG  445 (506)
Q Consensus       378 ------------~~~~~~l~i~~~i~~gl~~LH~~~~~~ivH~dlkp~Nill~~~~~~ki~dfg~a~~~~~~~~~~~~~~  445 (506)
                                  +++.++..++.||+.||+|||   +++|+||||||+|||++.++.+||+|||+|+.......  ....
T Consensus        95 ~L~~~~~~~~~~l~e~~~~~i~~qi~~gL~ylH---~~~ivHrDiKp~NIll~~~~~~Kl~DFG~a~~~~~~~~--~~~~  169 (288)
T d2jfla1          95 AVDAVMLELERPLTESQIQVVCKQTLDALNYLH---DNKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQ--RRDS  169 (288)
T ss_dssp             EHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTTSCEEECCCTTCEECHHHHH--HHTC
T ss_pred             cHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH---HCCEEEeecChhheeECCCCCEEEEechhhhccCCCcc--cccc
Confidence                        334446789999999999999   89999999999999999999999999999976543221  1245


Q ss_pred             CCCCccccccccccc---ccCCCCccccHHHHHHHHHHHHcCCCCCCCCCCCcchhhhh
Q 039231          446 ARGTVGYIAPEVFCR---NIGEVSYKSDVYNYGMMIFEMTGGRKNVDVVDNGSTALDLQ  501 (506)
Q Consensus       446 ~~gt~~y~aPE~l~~---~~~~~s~~~Dv~s~G~il~elltg~~pf~~~~~~~~~~~~~  501 (506)
                      ..||+.|+|||++..   ....++.++|||||||++|||++|+.||...+..+....+.
T Consensus       170 ~~Gt~~y~APE~l~~~~~~~~~y~~k~DiwSlGvilyemltg~~Pf~~~~~~~~~~~i~  228 (288)
T d2jfla1         170 FIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPPHHELNPMRVLLKIA  228 (288)
T ss_dssp             CCSCCTTCCHHHHTTCSTTTSSTTTHHHHHHHHHHHHHHHHSSCTTTTSCGGGHHHHHH
T ss_pred             cccccccCCHHHHhhcccCCCCCChhhhHHHHHHHHHHHhhCCCCCCCCCHHHHHHHHH
Confidence            779999999999843   22467899999999999999999999998776655544433

>d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.3e-39  Score=320.49  Aligned_cols=170  Identities=26%  Similarity=0.373  Sum_probs=143.7

Q ss_pred             hccccCccCceEEEEEEEc-CCCEEEEEEeccCCC--CchhhHHHHHHhhccCccceeEEEEEe----------------
Q 039231          317 FKYKLGQGGYGSVYKGKLL-DGSNVAVKVLNDSKG--NGKEFINEVASISRTSHVNVVALLGFC----------------  377 (506)
Q Consensus       317 ~~~~ig~G~~g~V~~~~~~-~~~~vavK~l~~~~~--~~~~~~~E~~~l~~l~h~niv~l~g~~----------------  377 (506)
                      +.++||+|+||+||+|+.. +|+.||+|+++....  ..+++.+|+++|++++|||||++++++                
T Consensus        10 ~~~~iG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~iVmEy~~gg   89 (322)
T d1s9ja_          10 KISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGG   89 (322)
T ss_dssp             EEEEEECCSSCCEEEEEETTTTEEEEEEEEECCCCTTHHHHHHHHGGGGGGCCCTTBCCEEEEEECSSEEEEEEECCTTE
T ss_pred             EEEEEecCCCeEEEEEEECCCCcEEEEEEEChhhCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEEcCCCC
Confidence            3468999999999999975 589999999975432  236789999999999999999999988                


Q ss_pred             -----------eccchhhhHHHHHHHHHHHHhhcCC-CCeEecCcCCCcEEECCCCcEEEeecCCCccccCCCcceeccc
Q 039231          378 -----------LRVAEELSSTIGIARGLEYLHLGCS-TRILHFDIKPHNILLDEDFCPKISDFGLAKICNRKESIISMTG  445 (506)
Q Consensus       378 -----------~~~~~~l~i~~~i~~gl~~LH~~~~-~~ivH~dlkp~Nill~~~~~~ki~dfg~a~~~~~~~~~~~~~~  445 (506)
                                 +++.+...++.|++.||+|||   + ++|+||||||+|||+++++.+||+|||+|+.......    ..
T Consensus        90 ~L~~~l~~~~~l~~~~~~~~~~qil~aL~yLH---~~~~IiHRDiKP~NILl~~~~~vkl~DFGla~~~~~~~~----~~  162 (322)
T d1s9ja_          90 SLDQVLKKAGRIPEQILGKVSIAVIKGLTYLR---EKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMA----NS  162 (322)
T ss_dssp             EHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHH---HHHCCCCSCCSGGGEEECTTCCEEECCCCCCHHHHHHTC------
T ss_pred             cHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHH---HhCCEEccccCHHHeeECCCCCEEEeeCCCccccCCCcc----cc
Confidence                       233446678999999999999   5 4899999999999999999999999999987654322    44


Q ss_pred             CCCCcccccccccccccCCCCccccHHHHHHHHHHHHcCCCCCCCCCCCc
Q 039231          446 ARGTVGYIAPEVFCRNIGEVSYKSDVYNYGMMIFEMTGGRKNVDVVDNGS  495 (506)
Q Consensus       446 ~~gt~~y~aPE~l~~~~~~~s~~~Dv~s~G~il~elltg~~pf~~~~~~~  495 (506)
                      ..||+.|+|||++.+.  .++.++||||+||++|||++|+.||...+..+
T Consensus       163 ~~GT~~Y~APEvl~~~--~y~~~~DiWSlGvil~ell~G~~Pf~~~~~~~  210 (322)
T d1s9ja_         163 FVGTRSYMSPERLQGT--HYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKE  210 (322)
T ss_dssp             -CCSSCCCCHHHHHCS--CCCTTHHHHHHHHHHHHHHHSSCCSSCCCTTH
T ss_pred             ccCCccccCchHHcCC--CCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHH
Confidence            6899999999999764  79999999999999999999999998765543

>d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine protein kinase TAO2
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=8.3e-39  Score=312.11  Aligned_cols=173  Identities=31%  Similarity=0.418  Sum_probs=146.3

Q ss_pred             hhhccccCccCceEEEEEEEc-CCCEEEEEEeccCCCC----chhhHHHHHHhhccCccceeEEEEEe------------
Q 039231          315 NSFKYKLGQGGYGSVYKGKLL-DGSNVAVKVLNDSKGN----GKEFINEVASISRTSHVNVVALLGFC------------  377 (506)
Q Consensus       315 ~~~~~~ig~G~~g~V~~~~~~-~~~~vavK~l~~~~~~----~~~~~~E~~~l~~l~h~niv~l~g~~------------  377 (506)
                      +...++||+|+||.||+|+.. +++.||||+++.....    .+.+.+|+++|++++|||||++++++            
T Consensus        17 y~~l~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~iv~E~   96 (309)
T d1u5ra_          17 FSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVMEY   96 (309)
T ss_dssp             EEEEEEEEECSSSEEEEEEETTTTEEEEEEEEECCSSCHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred             cEeeEEEecCCCeEEEEEEECCCCcEEEEEEEchhhccCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEECCEEEEEEEe
Confidence            334567999999999999875 5889999999764432    24688999999999999999999987            


Q ss_pred             ---------------eccchhhhHHHHHHHHHHHHhhcCCCCeEecCcCCCcEEECCCCcEEEeecCCCccccCCCccee
Q 039231          378 ---------------LRVAEELSSTIGIARGLEYLHLGCSTRILHFDIKPHNILLDEDFCPKISDFGLAKICNRKESIIS  442 (506)
Q Consensus       378 ---------------~~~~~~l~i~~~i~~gl~~LH~~~~~~ivH~dlkp~Nill~~~~~~ki~dfg~a~~~~~~~~~~~  442 (506)
                                     +++.+++.++.||+.||+|||   +++|+||||||+|||+++++.+||+|||+|+.....     
T Consensus        97 ~~~g~l~~~~~~~~~l~e~~~~~i~~qi~~aL~yLH---~~~iiHrDiKp~NILl~~~~~~Kl~DFG~a~~~~~~-----  168 (309)
T d1u5ra_          97 CLGSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLH---SHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPA-----  168 (309)
T ss_dssp             CSEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHH---HTTCBCCCCSGGGEEEETTTEEEECCCTTCBSSSSB-----
T ss_pred             cCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHH---hCCEeccCCCcceEEECCCCCEEEeecccccccCCC-----
Confidence                           344557789999999999999   899999999999999999999999999999865432     


Q ss_pred             cccCCCCcccccccccccc-cCCCCccccHHHHHHHHHHHHcCCCCCCCCCCCcc
Q 039231          443 MTGARGTVGYIAPEVFCRN-IGEVSYKSDVYNYGMMIFEMTGGRKNVDVVDNGST  496 (506)
Q Consensus       443 ~~~~~gt~~y~aPE~l~~~-~~~~s~~~Dv~s~G~il~elltg~~pf~~~~~~~~  496 (506)
                       ....||+.|+|||++.+. .+.++.++|||||||++|||++|+.||......+.
T Consensus       169 -~~~~GT~~Y~APE~~~~~~~~~y~~~~DiwSlGvilyel~~g~~Pf~~~~~~~~  222 (309)
T d1u5ra_         169 -NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSA  222 (309)
T ss_dssp             -CCCCSCGGGCCHHHHTTTTSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHH
T ss_pred             -CccccCccccCHHHHhccCCCCcCchhhhhhHHHHHHHHHHCCCCCCCCCHHHH
Confidence             346799999999998542 24689999999999999999999999986654443

>d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine-protein kinase Nek2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.5e-39  Score=309.82  Aligned_cols=176  Identities=26%  Similarity=0.380  Sum_probs=134.4

Q ss_pred             hhccccCccCceEEEEEEEc-CCCEEEEEEeccCCCC---chhhHHHHHHhhccCccceeEEEEEee-------------
Q 039231          316 SFKYKLGQGGYGSVYKGKLL-DGSNVAVKVLNDSKGN---GKEFINEVASISRTSHVNVVALLGFCL-------------  378 (506)
Q Consensus       316 ~~~~~ig~G~~g~V~~~~~~-~~~~vavK~l~~~~~~---~~~~~~E~~~l~~l~h~niv~l~g~~~-------------  378 (506)
                      .+.+.||+|+||+||+|+.. +|+.||||+++.....   .+.+.+|++++++++|||||++++++.             
T Consensus         7 ~~~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~ivmEy   86 (269)
T d2java1           7 EVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYIVMEY   86 (269)
T ss_dssp             EEEEEEEECSSEEEEEEEETTTCCEEEEEEECCTTSCHHHHHHHHHHHHHTTSCCCTTBCCEEEEEEC----CEEEEEEC
T ss_pred             EEeEEEecCCCeEEEEEEECCCCCEEEEEEEChhhCCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEeCCCCEEEEEEec
Confidence            34578999999999999875 5899999999765432   256889999999999999999998762             


Q ss_pred             --------------------ccchhhhHHHHHHHHHHHHhhcC--CCCeEecCcCCCcEEECCCCcEEEeecCCCccccC
Q 039231          379 --------------------RVAEELSSTIGIARGLEYLHLGC--STRILHFDIKPHNILLDEDFCPKISDFGLAKICNR  436 (506)
Q Consensus       379 --------------------~~~~~l~i~~~i~~gl~~LH~~~--~~~ivH~dlkp~Nill~~~~~~ki~dfg~a~~~~~  436 (506)
                                          ++.+++.++.||+.||+|||+..  ..+|+||||||+|||++.++.+||+|||+++....
T Consensus        87 ~~~g~L~~~i~~~~~~~~~l~e~~~~~i~~qi~~al~ylH~~~~~~~~IiHrDiKp~NIll~~~~~vkl~DFG~a~~~~~  166 (269)
T d2java1          87 CEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNH  166 (269)
T ss_dssp             CTTEEHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHHCC---------CCGGGEEECTTSCEEECCHHHHHHC--
T ss_pred             CCCCcHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHhcCCCCCEEeCcCchhhcCcCCCCcEEEeeccceeeccc
Confidence                                22336678999999999999421  23599999999999999999999999999988755


Q ss_pred             CCcceecccCCCCcccccccccccccCCCCccccHHHHHHHHHHHHcCCCCCCCCCCCc
Q 039231          437 KESIISMTGARGTVGYIAPEVFCRNIGEVSYKSDVYNYGMMIFEMTGGRKNVDVVDNGS  495 (506)
Q Consensus       437 ~~~~~~~~~~~gt~~y~aPE~l~~~~~~~s~~~Dv~s~G~il~elltg~~pf~~~~~~~  495 (506)
                      ....  .....||+.|+|||++.+.  .++.++|||||||++|||++|+.||...+..+
T Consensus       167 ~~~~--~~~~~gt~~Y~APE~l~~~--~~~~~~DIwSlGvilyel~tg~~Pf~~~~~~~  221 (269)
T d2java1         167 DTSF--AKAFVGTPYYMSPEQMNRM--SYNEKSDIWSLGCLLYELCALMPPFTAFSQKE  221 (269)
T ss_dssp             -----------CCCSCCCHHHHTTC--CCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHH
T ss_pred             CCCc--cccCCCCcccCCHHHHcCC--CCChHHHHHhhCHHHHHHhhCCCCCCCCCHHH
Confidence            4332  2457799999999999654  78999999999999999999999998765444

>d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase SYK
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=5.8e-39  Score=308.74  Aligned_cols=172  Identities=28%  Similarity=0.491  Sum_probs=141.9

Q ss_pred             cccCccCceEEEEEEEcC---CCEEEEEEeccCCCC---chhhHHHHHHhhccCccceeEEEEEe---------------
Q 039231          319 YKLGQGGYGSVYKGKLLD---GSNVAVKVLNDSKGN---GKEFINEVASISRTSHVNVVALLGFC---------------  377 (506)
Q Consensus       319 ~~ig~G~~g~V~~~~~~~---~~~vavK~l~~~~~~---~~~~~~E~~~l~~l~h~niv~l~g~~---------------  377 (506)
                      ++||+|+||+||+|.+++   ++.||||+++.....   .+++.+|+++|++++|||||+++|++               
T Consensus        13 k~iG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~g~~~~~~~~lvmE~~~~g   92 (277)
T d1xbba_          13 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEAESWMLVMEMAELG   92 (277)
T ss_dssp             EEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEEESSSEEEEEECCTTE
T ss_pred             CCcccCCCeEEEEEEEccCCcCeEEEEEEEChhhCCHHHHHHHHHHHHHHHhCCCCCCceEEEEeccCCEEEEEEcCCCC
Confidence            469999999999998753   468999999754322   35799999999999999999999988               


Q ss_pred             -----------eccchhhhHHHHHHHHHHHHhhcCCCCeEecCcCCCcEEECCCCcEEEeecCCCccccCCCccee-ccc
Q 039231          378 -----------LRVAEELSSTIGIARGLEYLHLGCSTRILHFDIKPHNILLDEDFCPKISDFGLAKICNRKESIIS-MTG  445 (506)
Q Consensus       378 -----------~~~~~~l~i~~~i~~gl~~LH~~~~~~ivH~dlkp~Nill~~~~~~ki~dfg~a~~~~~~~~~~~-~~~  445 (506)
                                 +++.+++.++.||+.||+|||   +++|+||||||+|||++.++.+||+|||+++.......... ...
T Consensus        93 ~L~~~l~~~~~l~~~~~~~i~~qi~~gl~ylH---~~~iiHrDlKp~Nill~~~~~~kl~DFGla~~~~~~~~~~~~~~~  169 (277)
T d1xbba_          93 PLNKYLQQNRHVKDKNIIELVHQVSMGMKYLE---ESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTH  169 (277)
T ss_dssp             EHHHHHHHCTTCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEEEETTEEEECCCTTCEECCTTCSEEEC---
T ss_pred             cHHHHHhhccCCCHHHHHHHHHHHHHHHhhHH---hCCcccCCCcchhhcccccCcccccchhhhhhccccccccccccc
Confidence                       344557889999999999999   89999999999999999999999999999987765443322 234


Q ss_pred             CCCCcccccccccccccCCCCccccHHHHHHHHHHHHc-CCCCCCCCCCCc
Q 039231          446 ARGTVGYIAPEVFCRNIGEVSYKSDVYNYGMMIFEMTG-GRKNVDVVDNGS  495 (506)
Q Consensus       446 ~~gt~~y~aPE~l~~~~~~~s~~~Dv~s~G~il~ellt-g~~pf~~~~~~~  495 (506)
                      ..||+.|+|||.+.+.  .++.++|||||||++|||+| |+.||......+
T Consensus       170 ~~gt~~y~APE~l~~~--~~~~~sDiwS~Gv~l~ellt~g~~Pf~~~~~~~  218 (277)
T d1xbba_         170 GKWPVKWYAPECINYY--KFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSE  218 (277)
T ss_dssp             -CCCGGGCCHHHHHHC--EEEHHHHHHHHHHHHHHHHTTTCCSSTTCCHHH
T ss_pred             cCCCceecCchhhcCC--CCCchhhhccchhhhhHHhhCCCCCCCCCCHHH
Confidence            6789999999998654  78999999999999999998 899998765444

>d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-src tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.1e-39  Score=311.45  Aligned_cols=180  Identities=28%  Similarity=0.478  Sum_probs=146.7

Q ss_pred             HhhhccccCccCceEEEEEEEcCCCEEEEEEeccCCCCchhhHHHHHHhhccCccceeEEEEEe----------------
Q 039231          314 TNSFKYKLGQGGYGSVYKGKLLDGSNVAVKVLNDSKGNGKEFINEVASISRTSHVNVVALLGFC----------------  377 (506)
Q Consensus       314 ~~~~~~~ig~G~~g~V~~~~~~~~~~vavK~l~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~----------------  377 (506)
                      .+.+.+.||+|+||.||+|++++++.||||+++......+.+.+|+.++++++|||||+++|++                
T Consensus        18 ~~~i~~~iG~G~fg~Vy~~~~~~~~~vAiK~l~~~~~~~~~~~~E~~~l~~l~h~nIv~~~g~~~~~~~~lv~Ey~~~g~   97 (285)
T d1fmka3          18 SLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVSEEPIYIVTEYMSKGS   97 (285)
T ss_dssp             GEEEEEEEEECSSCEEEEEEETTTEEEEEEECCTTSSCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSCEEEECCCTTCB
T ss_pred             HEEEeeEEeeCCCeEEEEEEECCCCEEEEEEECcccCCHHHHHHHHHHHHhcccCCEeEEEEEEecCCeEEEEEecCCCc
Confidence            3456678999999999999998888999999987777778899999999999999999999988                


Q ss_pred             ------------eccchhhhHHHHHHHHHHHHhhcCCCCeEecCcCCCcEEECCCCcEEEeecCCCccccCCCcceeccc
Q 039231          378 ------------LRVAEELSSTIGIARGLEYLHLGCSTRILHFDIKPHNILLDEDFCPKISDFGLAKICNRKESIISMTG  445 (506)
Q Consensus       378 ------------~~~~~~l~i~~~i~~gl~~LH~~~~~~ivH~dlkp~Nill~~~~~~ki~dfg~a~~~~~~~~~~~~~~  445 (506)
                                  +++.+++.++.||+.||+|||   +++|+||||||+||||++++.+||+|||+++........ ....
T Consensus        98 l~~~~~~~~~~~l~~~~~~~i~~~i~~gl~~LH---~~~ivH~DlKp~NIll~~~~~~kl~DfGla~~~~~~~~~-~~~~  173 (285)
T d1fmka3          98 LLDFLKGETGKYLRLPQLVDMAAQIASGMAYVE---RMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYT-ARQG  173 (285)
T ss_dssp             HHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEECGGGCEEECCCCTTC-------------
T ss_pred             hhhhhhhcccccchHHHHHHHHHHHHHHHHHHh---hhheecccccceEEEECCCCcEEEcccchhhhccCCCce-eecc
Confidence                        445568889999999999999   899999999999999999999999999999876544332 2244


Q ss_pred             CCCCcccccccccccccCCCCccccHHHHHHHHHHHHcCCCCCCCCCCCcchhh
Q 039231          446 ARGTVGYIAPEVFCRNIGEVSYKSDVYNYGMMIFEMTGGRKNVDVVDNGSTALD  499 (506)
Q Consensus       446 ~~gt~~y~aPE~l~~~~~~~s~~~Dv~s~G~il~elltg~~pf~~~~~~~~~~~  499 (506)
                      ..+|+.|+|||++..  +.++.++||||||+++|||++|..|+.........++
T Consensus       174 ~~gt~~y~aPE~~~~--~~~~~ksDI~S~Giil~el~t~~~p~~~~~~~~~~~~  225 (285)
T d1fmka3         174 AKFPIKWTAPEAALY--GRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLD  225 (285)
T ss_dssp             --CCGGGSCHHHHHH--CCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHH
T ss_pred             ccccccccChHHHhC--CCCCcHHhhhcchHHHHHHHhCCCCCCCCCCHHHHHH
Confidence            678999999999965  4789999999999999999997766665544443333

>d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase ZAP-70
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.7e-38  Score=306.52  Aligned_cols=173  Identities=28%  Similarity=0.491  Sum_probs=145.7

Q ss_pred             ccCccCceEEEEEEEc---CCCEEEEEEeccCCC--CchhhHHHHHHhhccCccceeEEEEEe-----------------
Q 039231          320 KLGQGGYGSVYKGKLL---DGSNVAVKVLNDSKG--NGKEFINEVASISRTSHVNVVALLGFC-----------------  377 (506)
Q Consensus       320 ~ig~G~~g~V~~~~~~---~~~~vavK~l~~~~~--~~~~~~~E~~~l~~l~h~niv~l~g~~-----------------  377 (506)
                      +||+|+||.||+|.++   ++..||||+++....  ..+++.+|+++|++++|||||+++|++                 
T Consensus        16 ~iG~G~fg~Vy~~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~~~~~lvmE~~~~g~L   95 (285)
T d1u59a_          16 ELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQAEALMLVMEMAGGGPL   95 (285)
T ss_dssp             EEECCTTEEEEEEEEC---CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEESSSEEEEEECCTTEEH
T ss_pred             EEecccCeEEEEEEEecCCCcEEEEEEEEChhcCHHHHHHHHHHHHHHHhCCCCCEeeEeeeeccCeEEEEEEeCCCCcH
Confidence            4999999999999764   355799999975432  336799999999999999999999988                 


Q ss_pred             ----------eccchhhhHHHHHHHHHHHHhhcCCCCeEecCcCCCcEEECCCCcEEEeecCCCccccCCCccee-cccC
Q 039231          378 ----------LRVAEELSSTIGIARGLEYLHLGCSTRILHFDIKPHNILLDEDFCPKISDFGLAKICNRKESIIS-MTGA  446 (506)
Q Consensus       378 ----------~~~~~~l~i~~~i~~gl~~LH~~~~~~ivH~dlkp~Nill~~~~~~ki~dfg~a~~~~~~~~~~~-~~~~  446 (506)
                                +++.+++.++.||++||+|||   +++|+||||||+|||+++++.+||+|||+++.......... ....
T Consensus        96 ~~~l~~~~~~l~~~~~~~i~~qi~~gL~ylH---~~~iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~  172 (285)
T d1u59a_          96 HKFLVGKREEIPVSNVAELLHQVSMGMKYLE---EKNFVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAG  172 (285)
T ss_dssp             HHHHTTCTTTSCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEEEETTEEEECCCTTCEECTTCSCEECCCCSS
T ss_pred             HHHhhccccCCCHHHHHHHHHHHHHHHHHHH---hCCeecCcCchhheeeccCCceeeccchhhhccccccccccccccc
Confidence                      334457789999999999999   89999999999999999999999999999998765443322 2345


Q ss_pred             CCCcccccccccccccCCCCccccHHHHHHHHHHHHc-CCCCCCCCCCCcch
Q 039231          447 RGTVGYIAPEVFCRNIGEVSYKSDVYNYGMMIFEMTG-GRKNVDVVDNGSTA  497 (506)
Q Consensus       447 ~gt~~y~aPE~l~~~~~~~s~~~Dv~s~G~il~ellt-g~~pf~~~~~~~~~  497 (506)
                      .||+.|+|||++...  .++.++|||||||++|||+| |+.||......+..
T Consensus       173 ~gt~~y~aPE~~~~~--~~~~ksDVwS~Gv~l~E~lt~G~~Pf~~~~~~~~~  222 (285)
T d1u59a_         173 KWPLKWYAPECINFR--KFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVM  222 (285)
T ss_dssp             CCCGGGCCHHHHHHC--EECHHHHHHHHHHHHHHHHTTSCCTTTTCCTHHHH
T ss_pred             ccCccccChHHHhCC--CCCccchhhcchHHHHHHHhCCCCCCCCCCHHHHH
Confidence            689999999998554  78999999999999999998 99999877655433

>d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

Probab=100.00  E-value=2.2e-38  Score=310.16  Aligned_cols=171  Identities=30%  Similarity=0.385  Sum_probs=146.3

Q ss_pred             hhccccCccCceEEEEEEEc-CCCEEEEEEeccC----CCCchhhHHHHHHhhccCccceeEEEEEee------------
Q 039231          316 SFKYKLGQGGYGSVYKGKLL-DGSNVAVKVLNDS----KGNGKEFINEVASISRTSHVNVVALLGFCL------------  378 (506)
Q Consensus       316 ~~~~~ig~G~~g~V~~~~~~-~~~~vavK~l~~~----~~~~~~~~~E~~~l~~l~h~niv~l~g~~~------------  378 (506)
                      .+.++||+|+||+||+|+.+ +|+.||||+++..    ....+.+.+|+.++++++|||||++++++.            
T Consensus         7 ~i~~~lG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivmE~~   86 (316)
T d1fota_           7 QILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFMIMDYI   86 (316)
T ss_dssp             EEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEEEEECCC
T ss_pred             EEEEEEecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHhccCcChhheeeeEeeCCeeeeEeeec
Confidence            34578999999999999985 5899999999642    334577899999999999999999999872            


Q ss_pred             ---------------ccchhhhHHHHHHHHHHHHhhcCCCCeEecCcCCCcEEECCCCcEEEeecCCCccccCCCcceec
Q 039231          379 ---------------RVAEELSSTIGIARGLEYLHLGCSTRILHFDIKPHNILLDEDFCPKISDFGLAKICNRKESIISM  443 (506)
Q Consensus       379 ---------------~~~~~l~i~~~i~~gl~~LH~~~~~~ivH~dlkp~Nill~~~~~~ki~dfg~a~~~~~~~~~~~~  443 (506)
                                     .......++.||+.||+|||   +++|+||||||+|||+++++.+||+|||+|+......     
T Consensus        87 ~gg~l~~~~~~~~~~~~~~~~~~~~qi~~al~~lH---~~~iiHrDiKp~NILl~~~g~vkL~DFG~a~~~~~~~-----  158 (316)
T d1fota_          87 EGGELFSLLRKSQRFPNPVAKFYAAEVCLALEYLH---SKDIIYRDLKPENILLDKNGHIKITDFGFAKYVPDVT-----  158 (316)
T ss_dssp             CSCBHHHHHHHTSSCCHHHHHHHHHHHHHHHHHHH---TTTEECCCCCGGGEEECTTSCEEECCCSSCEECSSCB-----
T ss_pred             CCccccccccccccccccHHHHHHHHHHHhhhhhc---cCcEEccccCchheeEcCCCCEEEecCccceEecccc-----
Confidence                           22335668899999999999   9999999999999999999999999999998765432     


Q ss_pred             ccCCCCcccccccccccccCCCCccccHHHHHHHHHHHHcCCCCCCCCCCCcc
Q 039231          444 TGARGTVGYIAPEVFCRNIGEVSYKSDVYNYGMMIFEMTGGRKNVDVVDNGST  496 (506)
Q Consensus       444 ~~~~gt~~y~aPE~l~~~~~~~s~~~Dv~s~G~il~elltg~~pf~~~~~~~~  496 (506)
                      ....||+.|+|||++.+.  .++.++||||+||++|||++|+.||...+..+.
T Consensus       159 ~~~~Gt~~Y~APE~l~~~--~y~~~~DiwSlGvilyemltG~~Pf~~~~~~~~  209 (316)
T d1fota_         159 YTLCGTPDYIAPEVVSTK--PYNKSIDWWSFGILIYEMLAGYTPFYDSNTMKT  209 (316)
T ss_dssp             CCCCSCTTTCCHHHHTTC--CBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHH
T ss_pred             ccccCcccccCHHHHcCC--CCCchhhccccchhHHHHHhCCCCCCCcCHHHH
Confidence            456799999999999654  689999999999999999999999987654443

>d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: epha2 receptor tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.4e-38  Score=307.38  Aligned_cols=173  Identities=27%  Similarity=0.470  Sum_probs=134.7

Q ss_pred             hccccCccCceEEEEEEEcCC-----CEEEEEEeccCCCC--chhhHHHHHHhhccCccceeEEEEEe------------
Q 039231          317 FKYKLGQGGYGSVYKGKLLDG-----SNVAVKVLNDSKGN--GKEFINEVASISRTSHVNVVALLGFC------------  377 (506)
Q Consensus       317 ~~~~ig~G~~g~V~~~~~~~~-----~~vavK~l~~~~~~--~~~~~~E~~~l~~l~h~niv~l~g~~------------  377 (506)
                      +.+.||+|+||.||+|+++..     ..||||+++.....  .+++.+|++++++++|||||+++|++            
T Consensus        11 ~~~~iG~G~fG~Vy~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~il~~l~H~nIv~~~g~~~~~~~~~~v~e~   90 (283)
T d1mqba_          11 RQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYKPMMIITEY   90 (283)
T ss_dssp             EEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEEEEEC
T ss_pred             eeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEEECcccChHHHHHHHHHHHHHHhcCCCCEeeeeEEEecCCceEEEEEe
Confidence            456799999999999987542     47999999654332  35689999999999999999999988            


Q ss_pred             ----------------eccchhhhHHHHHHHHHHHHhhcCCCCeEecCcCCCcEEECCCCcEEEeecCCCccccCCCcc-
Q 039231          378 ----------------LRVAEELSSTIGIARGLEYLHLGCSTRILHFDIKPHNILLDEDFCPKISDFGLAKICNRKESI-  440 (506)
Q Consensus       378 ----------------~~~~~~l~i~~~i~~gl~~LH~~~~~~ivH~dlkp~Nill~~~~~~ki~dfg~a~~~~~~~~~-  440 (506)
                                      +++.+++.++.||+.||+|||   +++|+||||||+||||++++.+||+|||+++........ 
T Consensus        91 ~~~~~l~~~~~~~~~~~~~~~~~~i~~~i~~gl~~lH---~~~iiHrDlKp~NILl~~~~~~Kl~DFGla~~~~~~~~~~  167 (283)
T d1mqba_          91 MENGALDKFLREKDGEFSVLQLVGMLRGIAAGMKYLA---NMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEAT  167 (283)
T ss_dssp             CTTEEHHHHHHHTTTCSCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEECTTCCEEECCCCC-----------
T ss_pred             cccCcchhhhhcccccccHHHHHHHHHHHHHhhhhcc---ccccccCccccceEEECCCCeEEEcccchhhcccCCCccc
Confidence                            334457789999999999999   899999999999999999999999999999876543322 


Q ss_pred             eecccCCCCcccccccccccccCCCCccccHHHHHHHHHHHHcCCCCCCCCCCC
Q 039231          441 ISMTGARGTVGYIAPEVFCRNIGEVSYKSDVYNYGMMIFEMTGGRKNVDVVDNG  494 (506)
Q Consensus       441 ~~~~~~~gt~~y~aPE~l~~~~~~~s~~~Dv~s~G~il~elltg~~pf~~~~~~  494 (506)
                      .......||+.|+|||++.+  +.++.++|||||||++|||++|..|+......
T Consensus       168 ~~~~~~~gt~~Y~APE~l~~--~~~~~~sDI~S~Gvil~el~t~~~~~~~~~~~  219 (283)
T d1mqba_         168 YTTSGGKIPIRWTAPEAISY--RKFTSASDVWSFGIVMWEVMTYGERPYWELSN  219 (283)
T ss_dssp             ------CCCGGGSCHHHHHS--CCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCH
T ss_pred             eEeccCCCCccccCHHHHcc--CCCCCcccccccHHHHHHHHhCCCCccccCCH
Confidence            12234568999999999855  47899999999999999999976666544433

>d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: EGF receptor tyrosine kinase, Erbb-1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2e-38  Score=311.33  Aligned_cols=176  Identities=30%  Similarity=0.524  Sum_probs=143.1

Q ss_pred             hhccccCccCceEEEEEEEcC-CC----EEEEEEeccC--CCCchhhHHHHHHhhccCccceeEEEEEe-----------
Q 039231          316 SFKYKLGQGGYGSVYKGKLLD-GS----NVAVKVLNDS--KGNGKEFINEVASISRTSHVNVVALLGFC-----------  377 (506)
Q Consensus       316 ~~~~~ig~G~~g~V~~~~~~~-~~----~vavK~l~~~--~~~~~~~~~E~~~l~~l~h~niv~l~g~~-----------  377 (506)
                      .+.++||+|+||+||+|++.. |+    .||+|+++..  ....+++.+|++++++++|||||+++|++           
T Consensus        12 ~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~~~~~v~e~   91 (317)
T d1xkka_          12 KKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTSTVQLITQL   91 (317)
T ss_dssp             EEEEEEEECSSEEEEEEEECC----CCEEEEEEEECC----CTHHHHHHHHHHHHHCCCTTBCCEEEEEESSSEEEEEEC
T ss_pred             EEeeEEecCCCeEEEEEEEcCCCCEEEEEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCeeEEEEe
Confidence            345689999999999998743 43    5899988653  33447899999999999999999999998           


Q ss_pred             ----------------eccchhhhHHHHHHHHHHHHhhcCCCCeEecCcCCCcEEECCCCcEEEeecCCCccccCCCcce
Q 039231          378 ----------------LRVAEELSSTIGIARGLEYLHLGCSTRILHFDIKPHNILLDEDFCPKISDFGLAKICNRKESII  441 (506)
Q Consensus       378 ----------------~~~~~~l~i~~~i~~gl~~LH~~~~~~ivH~dlkp~Nill~~~~~~ki~dfg~a~~~~~~~~~~  441 (506)
                                      +++.+++.++.||++||+|||   +++|+||||||+|||++.++.+||+|||+++.........
T Consensus        92 ~~~~~l~~~~~~~~~~~~~~~~~~i~~qi~~gl~yLH---~~~iiHrDlKp~NIll~~~~~~kl~DFGla~~~~~~~~~~  168 (317)
T d1xkka_          92 MPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLE---DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEY  168 (317)
T ss_dssp             CTTCBHHHHHHHTSSSCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEEEETTEEEECCCSHHHHTTTTCC--
T ss_pred             ccCCcccccccccccCCCHHHHHHHHHHHHHHHHHHH---HcCcccCcchhhcceeCCCCCeEeeccccceecccccccc
Confidence                            334457789999999999999   8999999999999999999999999999999876655544


Q ss_pred             ecccCCCCcccccccccccccCCCCccccHHHHHHHHHHHHc-CCCCCCCCCCCcc
Q 039231          442 SMTGARGTVGYIAPEVFCRNIGEVSYKSDVYNYGMMIFEMTG-GRKNVDVVDNGST  496 (506)
Q Consensus       442 ~~~~~~gt~~y~aPE~l~~~~~~~s~~~Dv~s~G~il~ellt-g~~pf~~~~~~~~  496 (506)
                      ......||+.|+|||.+.+.  .++.++|||||||++|||+| |+.||+.....+.
T Consensus       169 ~~~~~~gt~~y~APE~l~~~--~~~~~sDvwS~Gvil~el~t~g~~p~~~~~~~~~  222 (317)
T d1xkka_         169 HAEGGKVPIKWMALESILHR--IYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEI  222 (317)
T ss_dssp             ------CCTTTSCHHHHHHC--CCCHHHHHHHHHHHHHHHHTTSCCTTTTSCGGGH
T ss_pred             cccccccCccccChHHHhcC--CCChhhhhhhHHHHHHHHHHCCCCCCCCCCHHHH
Confidence            44556789999999998654  78999999999999999998 8999987665543

>d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fl cytokine receptor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.5e-38  Score=311.56  Aligned_cols=183  Identities=28%  Similarity=0.469  Sum_probs=149.3

Q ss_pred             HhhhccccCccCceEEEEEEEcC-C-----CEEEEEEeccC--CCCchhhHHHHHHhhcc-CccceeEEEEEee------
Q 039231          314 TNSFKYKLGQGGYGSVYKGKLLD-G-----SNVAVKVLNDS--KGNGKEFINEVASISRT-SHVNVVALLGFCL------  378 (506)
Q Consensus       314 ~~~~~~~ig~G~~g~V~~~~~~~-~-----~~vavK~l~~~--~~~~~~~~~E~~~l~~l-~h~niv~l~g~~~------  378 (506)
                      .+.+.++||+|+||+||+|++.. +     ..||+|++...  ....+.+.+|+.++.++ +|||||+++|++.      
T Consensus        38 ~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~l~~~~~~~~~~~  117 (325)
T d1rjba_          38 NLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACTLSGPIY  117 (325)
T ss_dssp             GEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCE
T ss_pred             HeEEeeEEeeCCCeEEEEEEEcCCCcccceeEEEEEEeccccCHHHHHHHHHHHHHHHHhcCCCcEeEEEEEEeeCCeEE
Confidence            34456889999999999998753 2     36899998643  33446789999999998 8999999999882      


Q ss_pred             --------------------------------------------ccchhhhHHHHHHHHHHHHhhcCCCCeEecCcCCCc
Q 039231          379 --------------------------------------------RVAEELSSTIGIARGLEYLHLGCSTRILHFDIKPHN  414 (506)
Q Consensus       379 --------------------------------------------~~~~~l~i~~~i~~gl~~LH~~~~~~ivH~dlkp~N  414 (506)
                                                                  ++.+++.++.||++||+|||   +++|+||||||+|
T Consensus       118 lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~yLH---~~~IiHRDlKp~N  194 (325)
T d1rjba_         118 LIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLE---FKSCVHRDLAARN  194 (325)
T ss_dssp             EEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHH---HTTEEETTCSGGG
T ss_pred             EEEEcCCCCcHHHHHHhccCCCcchhhhhccccccccccccCCCCHHHHHHHHHHHHHHHHHHH---hCCeeeccCchhc
Confidence                                                        12235668999999999999   8999999999999


Q ss_pred             EEECCCCcEEEeecCCCccccCCCcceecccCCCCcccccccccccccCCCCccccHHHHHHHHHHHHc-CCCCCCCCCC
Q 039231          415 ILLDEDFCPKISDFGLAKICNRKESIISMTGARGTVGYIAPEVFCRNIGEVSYKSDVYNYGMMIFEMTG-GRKNVDVVDN  493 (506)
Q Consensus       415 ill~~~~~~ki~dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~s~~~Dv~s~G~il~ellt-g~~pf~~~~~  493 (506)
                      ||++.++.+||+|||+|+...............||+.|||||.+.+.  .++.++|||||||++|||+| |+.||.....
T Consensus       195 ill~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~--~~~~~~DiwS~Gvil~emlt~g~~Pf~~~~~  272 (325)
T d1rjba_         195 VLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEG--IYTIKSDVWSYGILLWEIFSLGVNPYPGIPV  272 (325)
T ss_dssp             EEEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHC--CCCHHHHHHHHHHHHHHHTTTSCCSSTTCCC
T ss_pred             cccccCCeEEEeeccccccccCCCceeeeccccCCCccCChHHHcCC--CCCcceeccchhHHHHHHHhCCCCCCCCCCH
Confidence            99999999999999999887665544444556789999999998654  78999999999999999998 8999988766


Q ss_pred             Ccchhhhh
Q 039231          494 GSTALDLQ  501 (506)
Q Consensus       494 ~~~~~~~~  501 (506)
                      .+...++.
T Consensus       273 ~~~~~~~~  280 (325)
T d1rjba_         273 DANFYKLI  280 (325)
T ss_dssp             SHHHHHHH
T ss_pred             HHHHHHHH
Confidence            65555443

>d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Mouse (Mus musculus) [TaxId: 10090]

Probab=100.00  E-value=5.6e-38  Score=311.56  Aligned_cols=168  Identities=25%  Similarity=0.322  Sum_probs=145.4

Q ss_pred             hhccccCccCceEEEEEEEc-CCCEEEEEEeccC----CCCchhhHHHHHHhhccCccceeEEEEEe-------------
Q 039231          316 SFKYKLGQGGYGSVYKGKLL-DGSNVAVKVLNDS----KGNGKEFINEVASISRTSHVNVVALLGFC-------------  377 (506)
Q Consensus       316 ~~~~~ig~G~~g~V~~~~~~-~~~~vavK~l~~~----~~~~~~~~~E~~~l~~l~h~niv~l~g~~-------------  377 (506)
                      .+.++||+|+||.||+|+++ +|+.||||+++..    ....+.+.+|+++|++++|||||++++++             
T Consensus        44 ~i~~~lG~G~fg~Vy~a~~~~~g~~~AvK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~v~e~~  123 (350)
T d1rdqe_          44 DRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYV  123 (350)
T ss_dssp             EEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEECC
T ss_pred             EEEEEeecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHHcCCCcEeecccccccccccccccccc
Confidence            33468999999999999985 5999999998642    33446789999999999999999999887             


Q ss_pred             --------------eccchhhhHHHHHHHHHHHHhhcCCCCeEecCcCCCcEEECCCCcEEEeecCCCccccCCCcceec
Q 039231          378 --------------LRVAEELSSTIGIARGLEYLHLGCSTRILHFDIKPHNILLDEDFCPKISDFGLAKICNRKESIISM  443 (506)
Q Consensus       378 --------------~~~~~~l~i~~~i~~gl~~LH~~~~~~ivH~dlkp~Nill~~~~~~ki~dfg~a~~~~~~~~~~~~  443 (506)
                                    +++.+...++.||+.||+|||   +++|+||||||+|||++.++.+||+|||+|+......     
T Consensus       124 ~~g~l~~~l~~~~~l~e~~~~~i~~qi~~aL~yLH---~~~iiHRDIKP~NILl~~~g~ikL~DFG~a~~~~~~~-----  195 (350)
T d1rdqe_         124 AGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLH---SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRT-----  195 (350)
T ss_dssp             TTCBHHHHHHHHCCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTTSCEEECCCTTCEECSSCB-----
T ss_pred             cccchhhhHhhcCCCCHHHHHHHHHHHHHHHHHHH---hCCEecCcCCHHHcccCCCCCEEeeeceeeeeccccc-----
Confidence                          344457789999999999999   8999999999999999999999999999998775432     


Q ss_pred             ccCCCCcccccccccccccCCCCccccHHHHHHHHHHHHcCCCCCCCCCC
Q 039231          444 TGARGTVGYIAPEVFCRNIGEVSYKSDVYNYGMMIFEMTGGRKNVDVVDN  493 (506)
Q Consensus       444 ~~~~gt~~y~aPE~l~~~~~~~s~~~Dv~s~G~il~elltg~~pf~~~~~  493 (506)
                      ....||+.|||||++.+.  .++.++|||||||++|||++|+.||...+.
T Consensus       196 ~~~~Gt~~Y~APE~~~~~--~~~~~~DiwSlGvilyemltG~~Pf~~~~~  243 (350)
T d1rdqe_         196 WTLCGTPEALAPEIILSK--GYNKAVDWWALGVLIYEMAAGYPPFFADQP  243 (350)
T ss_dssp             CCCEECGGGCCHHHHTTC--CBCTHHHHHHHHHHHHHHHHSSCSSCCSSH
T ss_pred             ccccCccccCCHHHHcCC--CCCccccccchhHHHHHHHhCCCCCCCcCH
Confidence            346789999999999664  789999999999999999999999976543

>d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Calmodulin-dependent protein kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=3.8e-38  Score=307.26  Aligned_cols=173  Identities=28%  Similarity=0.432  Sum_probs=130.8

Q ss_pred             hhhccccCccCceEEEEEEEc-CCCEEEEEEeccCC--CCchhhHHHHHHhhccCccceeEEEEEe--------------
Q 039231          315 NSFKYKLGQGGYGSVYKGKLL-DGSNVAVKVLNDSK--GNGKEFINEVASISRTSHVNVVALLGFC--------------  377 (506)
Q Consensus       315 ~~~~~~ig~G~~g~V~~~~~~-~~~~vavK~l~~~~--~~~~~~~~E~~~l~~l~h~niv~l~g~~--------------  377 (506)
                      +.+.+.||+|+||+||+|+.. +++.||||++....  ...+.+.+|+++|++++|||||++++++              
T Consensus        11 Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lvmE~~~   90 (307)
T d1a06a_          11 YDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSMENEIAVLHKIKHPNIVALDDIYESGGHLYLIMQLVS   90 (307)
T ss_dssp             EEEEEESBSGGGGGEEEEEETTTCCEEEEEEEEC----------CHHHHHHHTCCCTTBCCEEEEEECSSEEEEEECCCC
T ss_pred             eEEEEEEeeccCeEEEEEEECCCCCEEEEEEEchHHhhhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEeccC
Confidence            455678999999999999985 58999999997543  2335688999999999999999999987              


Q ss_pred             -------------eccchhhhHHHHHHHHHHHHhhcCCCCeEecCcCCCcEEEC---CCCcEEEeecCCCccccCCCcce
Q 039231          378 -------------LRVAEELSSTIGIARGLEYLHLGCSTRILHFDIKPHNILLD---EDFCPKISDFGLAKICNRKESII  441 (506)
Q Consensus       378 -------------~~~~~~l~i~~~i~~gl~~LH~~~~~~ivH~dlkp~Nill~---~~~~~ki~dfg~a~~~~~~~~~~  441 (506)
                                   +++.+...++.||+.||+|||   +++|+||||||+|||+.   +++.+||+|||+++.......  
T Consensus        91 gg~L~~~l~~~~~l~e~~~~~~~~qi~~al~ylH---~~~iiHrDiKp~Nil~~~~~~~~~vkl~DFG~a~~~~~~~~--  165 (307)
T d1a06a_          91 GGELFDRIVEKGFYTERDASRLIFQVLDAVKYLH---DLGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPGSV--  165 (307)
T ss_dssp             SCBHHHHHHTCSCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEESSSSTTCCEEECCC-------------
T ss_pred             CCcHHHhhhcccCCCHHHHHHHHHHHHHHHHhhh---hceeeeEEecccceeecccCCCceEEEeccceeEEccCCCe--
Confidence                         344456779999999999999   89999999999999994   578999999999987654432  


Q ss_pred             ecccCCCCcccccccccccccCCCCccccHHHHHHHHHHHHcCCCCCCCCCCCc
Q 039231          442 SMTGARGTVGYIAPEVFCRNIGEVSYKSDVYNYGMMIFEMTGGRKNVDVVDNGS  495 (506)
Q Consensus       442 ~~~~~~gt~~y~aPE~l~~~~~~~s~~~Dv~s~G~il~elltg~~pf~~~~~~~  495 (506)
                       .....||+.|+|||++.+.  .++.++|||||||++|||++|+.||......+
T Consensus       166 -~~~~~GT~~y~APE~~~~~--~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~  216 (307)
T d1a06a_         166 -LSTACGTPGYVAPEVLAQK--PYSKAVDCWSIGVIAYILLCGYPPFYDENDAK  216 (307)
T ss_dssp             --------CTTSCHHHHTTC--CCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHH
T ss_pred             -eeeeeeCccccCcHHHcCC--CCCcHHHhhhhhHHHHHHHhCCCCCCCCCHHH
Confidence             2446799999999999654  78999999999999999999999998655443

>d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Pkb kinase (Akt-2)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1e-37  Score=307.71  Aligned_cols=173  Identities=30%  Similarity=0.379  Sum_probs=147.8

Q ss_pred             hhccccCccCceEEEEEEEc-CCCEEEEEEeccC----CCCchhhHHHHHHhhccCccceeEEEEEe-------------
Q 039231          316 SFKYKLGQGGYGSVYKGKLL-DGSNVAVKVLNDS----KGNGKEFINEVASISRTSHVNVVALLGFC-------------  377 (506)
Q Consensus       316 ~~~~~ig~G~~g~V~~~~~~-~~~~vavK~l~~~----~~~~~~~~~E~~~l~~l~h~niv~l~g~~-------------  377 (506)
                      .+.+.||+|+||.||+|+.. +|+.||||++++.    ....+.+.+|+++|++++|||||++++++             
T Consensus         8 ~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~iv~ey~   87 (337)
T d1o6la_           8 DYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVMEYA   87 (337)
T ss_dssp             EEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEEEEEECC
T ss_pred             EEEEEEecCcCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhCCCCCEEEEEeeeccccccccceecc
Confidence            34578999999999999974 5899999999642    33457789999999999999999999977             


Q ss_pred             --------------eccchhhhHHHHHHHHHHHHhhcCCCCeEecCcCCCcEEECCCCcEEEeecCCCccccCCCcceec
Q 039231          378 --------------LRVAEELSSTIGIARGLEYLHLGCSTRILHFDIKPHNILLDEDFCPKISDFGLAKICNRKESIISM  443 (506)
Q Consensus       378 --------------~~~~~~l~i~~~i~~gl~~LH~~~~~~ivH~dlkp~Nill~~~~~~ki~dfg~a~~~~~~~~~~~~  443 (506)
                                    +++.+...++.||+.||+|||   +++|+||||||+|||+++++.+||+|||+|+........  .
T Consensus        88 ~gg~L~~~~~~~~~~~e~~~~~~~~qil~al~ylH---~~~iiHRDlKP~NILl~~~g~vkl~DFG~a~~~~~~~~~--~  162 (337)
T d1o6la_          88 NGGELFFHLSRERVFTEERARFYGAEIVSALEYLH---SRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGAT--M  162 (337)
T ss_dssp             TTCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHH---HTTCBCCCCCGGGEEECTTSCEEECCCTTCBCSCCTTCC--B
T ss_pred             CCCchhhhhhcccCCcHHHHHHHHHHHhhhhhhhh---hcCccccccCHHHeEecCCCCEEEeecccccccccCCcc--c
Confidence                          334446778999999999999   899999999999999999999999999999876543322  2


Q ss_pred             ccCCCCcccccccccccccCCCCccccHHHHHHHHHHHHcCCCCCCCCCCCc
Q 039231          444 TGARGTVGYIAPEVFCRNIGEVSYKSDVYNYGMMIFEMTGGRKNVDVVDNGS  495 (506)
Q Consensus       444 ~~~~gt~~y~aPE~l~~~~~~~s~~~Dv~s~G~il~elltg~~pf~~~~~~~  495 (506)
                      ....||+.|+|||++.+.  .++.++||||+||++|||++|+.||...+..+
T Consensus       163 ~~~~GT~~Y~aPE~~~~~--~y~~~~DiwSlGvilyeml~G~~pf~~~~~~~  212 (337)
T d1o6la_         163 KTFCGTPEYLAPEVLEDN--DYGRAVDWWGLGVVMYEMMCGRLPFYNQDHER  212 (337)
T ss_dssp             CCCEECGGGCCGGGGSSS--CBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHH
T ss_pred             ccceeCHHHhhhhhccCC--CCChhhcccchhhHHHHHHHCCCCCCCcCHHH
Confidence            456799999999999664  78999999999999999999999998765443

>d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: Caenorhabditis elegans, pjk4 [TaxId: 6239]

Probab=100.00  E-value=1.4e-37  Score=308.50  Aligned_cols=175  Identities=25%  Similarity=0.398  Sum_probs=147.7

Q ss_pred             hhhccccCccCceEEEEEEEc-CCCEEEEEEeccCCC-CchhhHHHHHHhhccCccceeEEEEEe---------------
Q 039231          315 NSFKYKLGQGGYGSVYKGKLL-DGSNVAVKVLNDSKG-NGKEFINEVASISRTSHVNVVALLGFC---------------  377 (506)
Q Consensus       315 ~~~~~~ig~G~~g~V~~~~~~-~~~~vavK~l~~~~~-~~~~~~~E~~~l~~l~h~niv~l~g~~---------------  377 (506)
                      +.+.+.||+|+||.||+|+.. +|+.||||++..... ..+.+.+|+++|++++|||||++++++               
T Consensus        28 Y~i~~~lG~G~fg~Vy~~~~~~~g~~vAvK~i~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivmE~~~g  107 (350)
T d1koaa2          28 YDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEFMSG  107 (350)
T ss_dssp             EEEEEEEEEETTEEEEEEEETTTTEEEEEEEECCCSHHHHHHHHHHHHHHHHTCCTTBCCEEEEEEETTEEEEEECCCCS
T ss_pred             eEEEEEEecCcCeEEEEEEECCCCCEEEEEEEcccchhhHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEEcCCC
Confidence            445678999999999999975 589999999975433 336788999999999999999999987               


Q ss_pred             -------------eccchhhhHHHHHHHHHHHHhhcCCCCeEecCcCCCcEEEC--CCCcEEEeecCCCccccCCCccee
Q 039231          378 -------------LRVAEELSSTIGIARGLEYLHLGCSTRILHFDIKPHNILLD--EDFCPKISDFGLAKICNRKESIIS  442 (506)
Q Consensus       378 -------------~~~~~~l~i~~~i~~gl~~LH~~~~~~ivH~dlkp~Nill~--~~~~~ki~dfg~a~~~~~~~~~~~  442 (506)
                                   +++.+++.++.||+.||+|||   +++|+||||||+|||++  .++.+||+|||+++........  
T Consensus       108 g~L~~~l~~~~~~l~e~~~~~i~~qi~~aL~ylH---~~~iiHrDiKp~NIll~~~~~~~vkL~DFG~a~~~~~~~~~--  182 (350)
T d1koaa2         108 GELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMH---ENNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQSV--  182 (350)
T ss_dssp             CBHHHHHTCTTSCBCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEESSTTSCCEEECCCTTCEECCTTSCE--
T ss_pred             CCHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHH---hcCCeeeeechhHeeeccCCCCeEEEeecchheeccccccc--
Confidence                         334456789999999999999   89999999999999995  4678999999999987655432  


Q ss_pred             cccCCCCcccccccccccccCCCCccccHHHHHHHHHHHHcCCCCCCCCCCCcch
Q 039231          443 MTGARGTVGYIAPEVFCRNIGEVSYKSDVYNYGMMIFEMTGGRKNVDVVDNGSTA  497 (506)
Q Consensus       443 ~~~~~gt~~y~aPE~l~~~~~~~s~~~Dv~s~G~il~elltg~~pf~~~~~~~~~  497 (506)
                       ....||+.|||||++.+.  .++.++|||||||++|||++|+.||...+..+..
T Consensus       183 -~~~~gT~~Y~aPEv~~~~--~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~  234 (350)
T d1koaa2         183 -KVTTGTAEFAAPEVAEGK--PVGYYTDMWSVGVLSYILLSGLSPFGGENDDETL  234 (350)
T ss_dssp             -EEECSCTTTCCHHHHHTC--CBCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHH
T ss_pred             -ceecCcccccCHHHHcCC--CCChhHhhhhhhHHHHHHHhCCCCCCCCCHHHHH
Confidence             446789999999999654  7899999999999999999999999866544433

>d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 7, CDK7
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.3e-37  Score=301.50  Aligned_cols=172  Identities=28%  Similarity=0.360  Sum_probs=143.4

Q ss_pred             cccCccCceEEEEEEEc-CCCEEEEEEeccCCC------CchhhHHHHHHhhccCccceeEEEEEe--------------
Q 039231          319 YKLGQGGYGSVYKGKLL-DGSNVAVKVLNDSKG------NGKEFINEVASISRTSHVNVVALLGFC--------------  377 (506)
Q Consensus       319 ~~ig~G~~g~V~~~~~~-~~~~vavK~l~~~~~------~~~~~~~E~~~l~~l~h~niv~l~g~~--------------  377 (506)
                      ++||+|+||+||+|+.. +|+.||||+++....      ..+.+.+|++++++++|||||++++++              
T Consensus         4 ~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~~~~~~~~~ivmE~~~   83 (299)
T d1ua2a_           4 DFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSNISLVFDFME   83 (299)
T ss_dssp             EEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTTCCEEEEECCS
T ss_pred             eEeccCcCeEEEEEEECCCCcEEEEEEEehhhhhhhhHHHHHHHHHHHHHHHhCCCCCEeEEEeeeccCCceeehhhhhc
Confidence            46999999999999975 589999999864321      135688999999999999999999988              


Q ss_pred             -------------eccchhhhHHHHHHHHHHHHhhcCCCCeEecCcCCCcEEECCCCcEEEeecCCCccccCCCcceecc
Q 039231          378 -------------LRVAEELSSTIGIARGLEYLHLGCSTRILHFDIKPHNILLDEDFCPKISDFGLAKICNRKESIISMT  444 (506)
Q Consensus       378 -------------~~~~~~l~i~~~i~~gl~~LH~~~~~~ivH~dlkp~Nill~~~~~~ki~dfg~a~~~~~~~~~~~~~  444 (506)
                                   +++.+...++.||+.||+|||   +++|+||||||+|||+++++.+||+|||+++........  ..
T Consensus        84 ~~~~~~~~~~~~~l~~~~~~~~~~qil~aL~~lH---~~~iiHrDiKp~NIli~~~~~~KL~DFG~a~~~~~~~~~--~~  158 (299)
T d1ua2a_          84 TDLEVIIKDNSLVLTPSHIKAYMLMTLQGLEYLH---QHWILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNRA--YT  158 (299)
T ss_dssp             EEHHHHHTTCCSSCCSSHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEECTTCCEEECCCGGGSTTTSCCCC--CC
T ss_pred             chHHhhhhhcccCCCHHHHHHHHHHHHHHHHHhh---ccceecccCCcceEEecCCCccccccCccccccCCCccc--cc
Confidence                         344557789999999999999   899999999999999999999999999999876554322  24


Q ss_pred             cCCCCcccccccccccccCCCCccccHHHHHHHHHHHHcCCCCCCCCCCCcc
Q 039231          445 GARGTVGYIAPEVFCRNIGEVSYKSDVYNYGMMIFEMTGGRKNVDVVDNGST  496 (506)
Q Consensus       445 ~~~gt~~y~aPE~l~~~~~~~s~~~Dv~s~G~il~elltg~~pf~~~~~~~~  496 (506)
                      ...||+.|+|||++... ..++.++|||||||++|||++|+.||....+.+.
T Consensus       159 ~~~gt~~y~aPE~~~~~-~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~~  209 (299)
T d1ua2a_         159 HQVVTRWYRAPELLFGA-RMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQ  209 (299)
T ss_dssp             CSCCCCTTCCHHHHTTC-SCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHH
T ss_pred             ceecChhhccHHHHccC-CCCChhhhhhhcchHHHHHHhCcCCCCCCCHHHH
Confidence            46789999999998543 3679999999999999999999999987655443

>d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Death-associated protein kinase, Dap
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4.3e-37  Score=298.43  Aligned_cols=174  Identities=27%  Similarity=0.393  Sum_probs=146.7

Q ss_pred             hhhccccCccCceEEEEEEEc-CCCEEEEEEeccCCC-------CchhhHHHHHHhhccCccceeEEEEEe---------
Q 039231          315 NSFKYKLGQGGYGSVYKGKLL-DGSNVAVKVLNDSKG-------NGKEFINEVASISRTSHVNVVALLGFC---------  377 (506)
Q Consensus       315 ~~~~~~ig~G~~g~V~~~~~~-~~~~vavK~l~~~~~-------~~~~~~~E~~~l~~l~h~niv~l~g~~---------  377 (506)
                      +.+.++||+|+||+||+|+.. +|+.||||+++....       ..+.+.+|+++|++++|||||++++++         
T Consensus        12 Y~~~~~lG~G~fg~Vy~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~iv   91 (293)
T d1jksa_          12 YDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDVILI   91 (293)
T ss_dssp             EEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred             EEEeEEEecCCCeEEEEEEECCCCCEEEEEEEEhhhcchhhhhHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEE
Confidence            445678999999999999985 589999999964321       235789999999999999999999988         


Q ss_pred             ------------------eccchhhhHHHHHHHHHHHHhhcCCCCeEecCcCCCcEEECCCC----cEEEeecCCCcccc
Q 039231          378 ------------------LRVAEELSSTIGIARGLEYLHLGCSTRILHFDIKPHNILLDEDF----CPKISDFGLAKICN  435 (506)
Q Consensus       378 ------------------~~~~~~l~i~~~i~~gl~~LH~~~~~~ivH~dlkp~Nill~~~~----~~ki~dfg~a~~~~  435 (506)
                                        +++.+.+.++.|++.||+|||   +++|+||||||+|||++.++    .+||+|||+++...
T Consensus        92 ~E~~~gg~L~~~i~~~~~l~~~~~~~~~~qi~~al~yLH---~~~ivHrDiKp~Nill~~~~~~~~~vkl~DfG~a~~~~  168 (293)
T d1jksa_          92 LELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLH---SLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKID  168 (293)
T ss_dssp             EECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEESCSSSSSCCEEECCCTTCEECT
T ss_pred             EEcCCCccccchhccccccchhHHHHHHHHHHHHHHhhh---hcceeecccccceEEEecCCCcccceEecchhhhhhcC
Confidence                              334446779999999999999   89999999999999998776    49999999998775


Q ss_pred             CCCcceecccCCCCcccccccccccccCCCCccccHHHHHHHHHHHHcCCCCCCCCCCCcc
Q 039231          436 RKESIISMTGARGTVGYIAPEVFCRNIGEVSYKSDVYNYGMMIFEMTGGRKNVDVVDNGST  496 (506)
Q Consensus       436 ~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~s~~~Dv~s~G~il~elltg~~pf~~~~~~~~  496 (506)
                      ....   .....+|+.|+|||++.+.  .++.++|||||||++|||++|+.||...+..+.
T Consensus       169 ~~~~---~~~~~~t~~y~APE~~~~~--~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~~  224 (293)
T d1jksa_         169 FGNE---FKNIFGTPEFVAPEIVNYE--PLGLEADMWSIGVITYILLSGASPFLGDTKQET  224 (293)
T ss_dssp             TSCB---CSCCCCCGGGCCHHHHTTC--CBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHH
T ss_pred             CCcc---ccccCCCCcccCHHHHcCC--CCCCcccchhhhHHHHHHHcCCCCCCCCCHHHH
Confidence            5443   2456789999999999654  789999999999999999999999987654443

>d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]

Probab=100.00  E-value=2.2e-37  Score=307.34  Aligned_cols=175  Identities=26%  Similarity=0.386  Sum_probs=148.7

Q ss_pred             hhhccccCccCceEEEEEEEc-CCCEEEEEEeccCCC-CchhhHHHHHHhhccCccceeEEEEEe---------------
Q 039231          315 NSFKYKLGQGGYGSVYKGKLL-DGSNVAVKVLNDSKG-NGKEFINEVASISRTSHVNVVALLGFC---------------  377 (506)
Q Consensus       315 ~~~~~~ig~G~~g~V~~~~~~-~~~~vavK~l~~~~~-~~~~~~~E~~~l~~l~h~niv~l~g~~---------------  377 (506)
                      +.+.++||+|+||.||+|+.. +|+.||||+++.... ..+.+.+|+++|++++|||||++++++               
T Consensus        31 Y~i~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~ivmE~~~g  110 (352)
T d1koba_          31 YDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILEFLSG  110 (352)
T ss_dssp             EEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCSTTBCCEEEEEECSSEEEEEEECCCC
T ss_pred             eEEEEEEecCCCeEEEEEEECCCCCEEEEEEECCcchhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEEcCCC
Confidence            445678999999999999974 599999999976432 335678999999999999999999987               


Q ss_pred             -------------eccchhhhHHHHHHHHHHHHhhcCCCCeEecCcCCCcEEEC--CCCcEEEeecCCCccccCCCccee
Q 039231          378 -------------LRVAEELSSTIGIARGLEYLHLGCSTRILHFDIKPHNILLD--EDFCPKISDFGLAKICNRKESIIS  442 (506)
Q Consensus       378 -------------~~~~~~l~i~~~i~~gl~~LH~~~~~~ivH~dlkp~Nill~--~~~~~ki~dfg~a~~~~~~~~~~~  442 (506)
                                   +++.+.+.++.||+.||+|||   +++|+||||||+||||+  .++.+||+|||+|+........  
T Consensus       111 g~L~~~~~~~~~~l~e~~~~~i~~qi~~aL~ylH---~~~iiHRDiKp~NILl~~~~~~~vkL~DFGla~~~~~~~~~--  185 (352)
T d1koba_         111 GELFDRIAAEDYKMSEAEVINYMRQACEGLKHMH---EHSIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDEIV--  185 (352)
T ss_dssp             CBHHHHTTCTTCCBCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEESSTTCCCEEECCCTTCEECCTTSCE--
T ss_pred             ChHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH---HCCeeecccccccccccccCCCeEEEeecccceecCCCCce--
Confidence                         344456789999999999999   89999999999999997  6789999999999987665432  


Q ss_pred             cccCCCCcccccccccccccCCCCccccHHHHHHHHHHHHcCCCCCCCCCCCcch
Q 039231          443 MTGARGTVGYIAPEVFCRNIGEVSYKSDVYNYGMMIFEMTGGRKNVDVVDNGSTA  497 (506)
Q Consensus       443 ~~~~~gt~~y~aPE~l~~~~~~~s~~~Dv~s~G~il~elltg~~pf~~~~~~~~~  497 (506)
                       ....||+.|+|||++.+.  .++.++||||+||++|||++|+.||...+..+..
T Consensus       186 -~~~~gt~~y~aPE~~~~~--~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~  237 (352)
T d1koba_         186 -KVTTATAEFAAPEIVDRE--PVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLETL  237 (352)
T ss_dssp             -EEECSSGGGCCHHHHTTC--CBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHHHH
T ss_pred             -eeccCcccccCHHHHcCC--CCCCccchHHHHHHHHHHHhCCCCCCCCCHHHHH
Confidence             446789999999999654  7899999999999999999999999876554433

>d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Focal adhesion kinase 1 (fak)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.1e-37  Score=299.50  Aligned_cols=179  Identities=25%  Similarity=0.444  Sum_probs=136.9

Q ss_pred             hhhccccCccCceEEEEEEEcC----CCEEEEEEeccCCCC--chhhHHHHHHhhccCccceeEEEEEe-----------
Q 039231          315 NSFKYKLGQGGYGSVYKGKLLD----GSNVAVKVLNDSKGN--GKEFINEVASISRTSHVNVVALLGFC-----------  377 (506)
Q Consensus       315 ~~~~~~ig~G~~g~V~~~~~~~----~~~vavK~l~~~~~~--~~~~~~E~~~l~~l~h~niv~l~g~~-----------  377 (506)
                      +.+.+.||+|+||.||+|++..    +..||||+++.....  .+.+.+|++++++++|||||+++|++           
T Consensus         9 ~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~iv~E~   88 (273)
T d1mp8a_           9 IELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVITENPVWIIMEL   88 (273)
T ss_dssp             EEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTTSHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSCEEEEEC
T ss_pred             eEEEEEEeeCCCcEEEEEEEecCCceeEEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCeEEEEEEe
Confidence            4456789999999999998743    356899998654332  35789999999999999999999988           


Q ss_pred             ----------------eccchhhhHHHHHHHHHHHHhhcCCCCeEecCcCCCcEEECCCCcEEEeecCCCccccCCCcce
Q 039231          378 ----------------LRVAEELSSTIGIARGLEYLHLGCSTRILHFDIKPHNILLDEDFCPKISDFGLAKICNRKESII  441 (506)
Q Consensus       378 ----------------~~~~~~l~i~~~i~~gl~~LH~~~~~~ivH~dlkp~Nill~~~~~~ki~dfg~a~~~~~~~~~~  441 (506)
                                      +++.+++.++.||++||+|||   +++|+||||||+||++++++.+||+|||+++.........
T Consensus        89 ~~~g~l~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH---~~~iiHrDlKp~NIll~~~~~~Kl~DfG~a~~~~~~~~~~  165 (273)
T d1mp8a_          89 CTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLE---SKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYK  165 (273)
T ss_dssp             CTTEEHHHHHHHTTTTSCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEEEETTEEEECC--------------
T ss_pred             ccCCcHHhhhhccCCCCCHHHHHHHHHHHHHHhhhhc---ccCeeccccchhheeecCCCcEEEccchhheeccCCccee
Confidence                            334457789999999999999   8999999999999999999999999999998765443322


Q ss_pred             ecccCCCCcccccccccccccCCCCccccHHHHHHHHHHHHc-CCCCCCCCCCCcchhh
Q 039231          442 SMTGARGTVGYIAPEVFCRNIGEVSYKSDVYNYGMMIFEMTG-GRKNVDVVDNGSTALD  499 (506)
Q Consensus       442 ~~~~~~gt~~y~aPE~l~~~~~~~s~~~Dv~s~G~il~ellt-g~~pf~~~~~~~~~~~  499 (506)
                       .....||+.|+|||.+.+.  .++.++|||||||++|||++ |..||......+....
T Consensus       166 -~~~~~gt~~y~apE~l~~~--~~~~~~DiwSlGvil~e~lt~g~~P~~~~~~~~~~~~  221 (273)
T d1mp8a_         166 -ASKGKLPIKWMAPESINFR--RFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGR  221 (273)
T ss_dssp             ------CCGGGCCHHHHHHC--CCSHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHH
T ss_pred             -ccceecCcccchhhHhccC--CCCCccccccchHHHHHHHhcCCCCCCCCCHHHHHHH
Confidence             2446789999999999654  78999999999999999998 8999987766554433

>d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Musk tyrosine kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=1.8e-37  Score=302.26  Aligned_cols=178  Identities=25%  Similarity=0.443  Sum_probs=145.4

Q ss_pred             hccccCccCceEEEEEEEc------CCCEEEEEEeccCCCC--chhhHHHHHHhhccCccceeEEEEEee----------
Q 039231          317 FKYKLGQGGYGSVYKGKLL------DGSNVAVKVLNDSKGN--GKEFINEVASISRTSHVNVVALLGFCL----------  378 (506)
Q Consensus       317 ~~~~ig~G~~g~V~~~~~~------~~~~vavK~l~~~~~~--~~~~~~E~~~l~~l~h~niv~l~g~~~----------  378 (506)
                      +.++||+|+||+||+|+.+      +++.||||+++.....  .+++.+|++++++++||||+++++++.          
T Consensus        17 ~~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~~~v~e   96 (301)
T d1lufa_          17 YVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLGVCAVGKPMCLLFE   96 (301)
T ss_dssp             EEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSCEEEEE
T ss_pred             EeEEEeeCCCeEEEEEEECCCccCCCCeEEEEEEEChhcChHHHHHHHHHHHHHHhcCCCCcccceeeeccCCceEEEEE
Confidence            3578999999999999864      3578999999754332  367999999999999999999999872          


Q ss_pred             -----------------------------------------ccchhhhHHHHHHHHHHHHhhcCCCCeEecCcCCCcEEE
Q 039231          379 -----------------------------------------RVAEELSSTIGIARGLEYLHLGCSTRILHFDIKPHNILL  417 (506)
Q Consensus       379 -----------------------------------------~~~~~l~i~~~i~~gl~~LH~~~~~~ivH~dlkp~Nill  417 (506)
                                                               ++.+++.++.|++.||+|||   +++|+||||||+|||+
T Consensus        97 ~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~ylH---~~~ivHrDlKp~NILl  173 (301)
T d1lufa_          97 YMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLS---ERKFVHRDLATRNCLV  173 (301)
T ss_dssp             CCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEE
T ss_pred             ecCCCcHHHHHHhcCccccccccccccchhhhccccCCCCCCHHHHHHHHHHHHHHhhhcc---cCCeEeeEEcccceEE
Confidence                                                     22346778999999999999   8999999999999999


Q ss_pred             CCCCcEEEeecCCCccccCCCcceecccCCCCcccccccccccccCCCCccccHHHHHHHHHHHHcCC-CCCCCCCCCcc
Q 039231          418 DEDFCPKISDFGLAKICNRKESIISMTGARGTVGYIAPEVFCRNIGEVSYKSDVYNYGMMIFEMTGGR-KNVDVVDNGST  496 (506)
Q Consensus       418 ~~~~~~ki~dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~s~~~Dv~s~G~il~elltg~-~pf~~~~~~~~  496 (506)
                      +.++.+||+|||+++...............+++.|+|||.+.+.  .++.++|||||||++|||++|. .||...++.+.
T Consensus       174 d~~~~~Kl~DFGls~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~--~~t~ksDVwS~Gvvl~ell~~~~~p~~~~~~~e~  251 (301)
T d1lufa_         174 GENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYN--RYTTESDVWAYGVVLWEIFSYGLQPYYGMAHEEV  251 (301)
T ss_dssp             CGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHC--CCCHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHH
T ss_pred             CCCCcEEEccchhheeccCCccccccCCCCcCcCcCCHHHHccC--CCChhhhhccchhhHHHHHccCCCCCCCCCHHHH
Confidence            99999999999999877555443333456789999999999654  7999999999999999999985 57776655544


Q ss_pred             hhh
Q 039231          497 ALD  499 (506)
Q Consensus       497 ~~~  499 (506)
                      ...
T Consensus       252 ~~~  254 (301)
T d1lufa_         252 IYY  254 (301)
T ss_dssp             HHH
T ss_pred             HHH
Confidence            333

>d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Carboxyl-terminal src kinase (csk)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=6.4e-37  Score=291.70  Aligned_cols=173  Identities=28%  Similarity=0.515  Sum_probs=139.7

Q ss_pred             hhccccCccCceEEEEEEEcCCCEEEEEEeccCCCCchhhHHHHHHhhccCccceeEEEEEee-----------------
Q 039231          316 SFKYKLGQGGYGSVYKGKLLDGSNVAVKVLNDSKGNGKEFINEVASISRTSHVNVVALLGFCL-----------------  378 (506)
Q Consensus       316 ~~~~~ig~G~~g~V~~~~~~~~~~vavK~l~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~-----------------  378 (506)
                      .+.+.||+|+||.||+|++ .|+.||||+++++. ..+++.+|++++++++|||||+++|++.                 
T Consensus        10 ~~~~~lG~G~fg~Vy~~~~-~~~~vAvK~i~~~~-~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~lv~ey~~~g~   87 (262)
T d1byga_          10 KLLQTIGKGEFGDVMLGDY-RGNKVAVKCIKNDA-TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAKGS   87 (262)
T ss_dssp             EEEEEEEECSSCEEEEEEE-TTEEEEEEECCCCC---HHHHHTHHHHTTCCCTTBCCEEEEECCC--CCEEEECCCTTEE
T ss_pred             EEeEEEecCCCeEEEEEEE-CCeEEEEEEECcHH-HHHHHHHHHHHHHhCCCCCEeeEEEEEEecCCcEEEEEeccCCCC
Confidence            3567899999999999998 57899999997643 4478999999999999999999999873                 


Q ss_pred             -------------ccchhhhHHHHHHHHHHHHhhcCCCCeEecCcCCCcEEECCCCcEEEeecCCCccccCCCcceeccc
Q 039231          379 -------------RVAEELSSTIGIARGLEYLHLGCSTRILHFDIKPHNILLDEDFCPKISDFGLAKICNRKESIISMTG  445 (506)
Q Consensus       379 -------------~~~~~l~i~~~i~~gl~~LH~~~~~~ivH~dlkp~Nill~~~~~~ki~dfg~a~~~~~~~~~~~~~~  445 (506)
                                   ++..++.++.||+.||+|||   +.+|+||||||+|||++.++.+||+|||+++......     ..
T Consensus        88 L~~~l~~~~~~~l~~~~~~~i~~~i~~al~ylH---~~~ivH~dlkp~Nil~~~~~~~kl~dfg~s~~~~~~~-----~~  159 (262)
T d1byga_          88 LVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLE---GNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQ-----DT  159 (262)
T ss_dssp             HHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEECTTSCEEECCCCC---------------
T ss_pred             HHHHHHhcCCCCCCHHHHHHHHHHHHhhccccc---cCceeccccchHhheecCCCCEeecccccceecCCCC-----cc
Confidence                         33446789999999999999   8999999999999999999999999999998765433     33


Q ss_pred             CCCCcccccccccccccCCCCccccHHHHHHHHHHHHc-CCCCCCCCCCCcchhhh
Q 039231          446 ARGTVGYIAPEVFCRNIGEVSYKSDVYNYGMMIFEMTG-GRKNVDVVDNGSTALDL  500 (506)
Q Consensus       446 ~~gt~~y~aPE~l~~~~~~~s~~~Dv~s~G~il~ellt-g~~pf~~~~~~~~~~~~  500 (506)
                      ..+++.|+|||.+.+.  .++.++||||||+++|||+| |+.||......+....+
T Consensus       160 ~~~~~~y~aPE~l~~~--~~t~~sDIwSfG~il~el~t~~~~p~~~~~~~~~~~~i  213 (262)
T d1byga_         160 GKLPVKWTAPEALREK--KFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRV  213 (262)
T ss_dssp             --CCTTTSCHHHHHHC--CCCHHHHHHHHHHHHHHHHTTSCCSCTTSCGGGHHHHH
T ss_pred             ccccccCCChHHHhCC--CCChHHHHHhHHHHHHHHHHCCCCCCCCCCHHHHHHHH
Confidence            5678999999998654  78999999999999999998 78888876655544443

>d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Activated CDC42 kinase 1, ACK1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.8e-37  Score=296.28  Aligned_cols=180  Identities=27%  Similarity=0.427  Sum_probs=138.3

Q ss_pred             hhccccCccCceEEEEEEEcC--C--CEEEEEEeccCC----CCchhhHHHHHHhhccCccceeEEEEEe----------
Q 039231          316 SFKYKLGQGGYGSVYKGKLLD--G--SNVAVKVLNDSK----GNGKEFINEVASISRTSHVNVVALLGFC----------  377 (506)
Q Consensus       316 ~~~~~ig~G~~g~V~~~~~~~--~--~~vavK~l~~~~----~~~~~~~~E~~~l~~l~h~niv~l~g~~----------  377 (506)
                      .+.+.||+|+||.||+|+++.  +  ..||||+++...    ...+++.+|+++|++++|||||+++|++          
T Consensus        11 ~~~~~iG~G~fg~Vy~~~~~~~~~~~~~vAiK~l~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~~~g~~~~~~~~lv~e   90 (273)
T d1u46a_          11 RLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLTPPMKMVTE   90 (273)
T ss_dssp             EEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSCEEEEE
T ss_pred             EEEEEEecCCCeEEEEEEEECCCCcEEEEEEEEEChhhcCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEeecchheeee
Confidence            345689999999999998643  2  378999987532    2236789999999999999999999988          


Q ss_pred             -----------------eccchhhhHHHHHHHHHHHHhhcCCCCeEecCcCCCcEEECCCCcEEEeecCCCccccCCCcc
Q 039231          378 -----------------LRVAEELSSTIGIARGLEYLHLGCSTRILHFDIKPHNILLDEDFCPKISDFGLAKICNRKESI  440 (506)
Q Consensus       378 -----------------~~~~~~l~i~~~i~~gl~~LH~~~~~~ivH~dlkp~Nill~~~~~~ki~dfg~a~~~~~~~~~  440 (506)
                                       +++.+++.++.||+.||+|||   +++|+||||||+||+++.++.+||+|||+++........
T Consensus        91 ~~~~~~l~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH---~~~iiHrDikp~NIll~~~~~vkl~DfGl~~~~~~~~~~  167 (273)
T d1u46a_          91 LAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLE---SKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDH  167 (273)
T ss_dssp             CCTTCBHHHHHHHHGGGSCHHHHHHHHHHHHHHHHHHH---HTTEECSCCCGGGEEEEETTEEEECCCTTCEECCC-CCE
T ss_pred             eecCcchhhhhhcccCCCCHHHHHHHHHHHHHHHHHhh---hCCEeeeeecHHHhccccccceeeccchhhhhcccCCCc
Confidence                             334457789999999999999   899999999999999999999999999999987655433


Q ss_pred             ee-cccCCCCcccccccccccccCCCCccccHHHHHHHHHHHHc-CCCCCCCCCCCcchhhh
Q 039231          441 IS-MTGARGTVGYIAPEVFCRNIGEVSYKSDVYNYGMMIFEMTG-GRKNVDVVDNGSTALDL  500 (506)
Q Consensus       441 ~~-~~~~~gt~~y~aPE~l~~~~~~~s~~~Dv~s~G~il~ellt-g~~pf~~~~~~~~~~~~  500 (506)
                      .. .....++..|+|||.+.+.  .++.++||||||+++|||+| |+.||...+..+....+
T Consensus       168 ~~~~~~~~~~~~~~aPE~~~~~--~~~~~~Di~S~Gvil~emlt~G~~Pf~~~~~~~~~~~i  227 (273)
T d1u46a_         168 YVMQEHRKVPFAWCAPESLKTR--TFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKI  227 (273)
T ss_dssp             EEC-----CCGGGCCHHHHHHC--EEEHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHH
T ss_pred             ceecCccccCcccCCHHHHhCC--CCCcchhhhhhHHHHHHHHhCCCCCCCCcCHHHHHHHH
Confidence            22 2335678899999999654  78999999999999999998 89999876555544333

>d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Mycobacterial protein kinase PknB, catalytic domain
species: Mycobacterium tuberculosis [TaxId: 1773]

Probab=100.00  E-value=1.3e-36  Score=292.75  Aligned_cols=177  Identities=25%  Similarity=0.363  Sum_probs=139.7

Q ss_pred             hhhccccCccCceEEEEEEEc-CCCEEEEEEeccCCCC----chhhHHHHHHhhccCccceeEEEEEe------------
Q 039231          315 NSFKYKLGQGGYGSVYKGKLL-DGSNVAVKVLNDSKGN----GKEFINEVASISRTSHVNVVALLGFC------------  377 (506)
Q Consensus       315 ~~~~~~ig~G~~g~V~~~~~~-~~~~vavK~l~~~~~~----~~~~~~E~~~l~~l~h~niv~l~g~~------------  377 (506)
                      +.+.+.||+|+||.||+|+.. +|+.||||+++.....    .+.+.+|++++++++|||||++++++            
T Consensus         9 Y~i~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~~l~~~~hpniv~~~~~~~~~~~~~~~~~l   88 (277)
T d1o6ya_           9 YELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPLPYI   88 (277)
T ss_dssp             EEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTTTCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEECSSSEEEEE
T ss_pred             eEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhcCCCCCCcccceeeeccCCCceEEE
Confidence            345678999999999999974 6899999999764332    24688999999999999999999875            


Q ss_pred             -------------------eccchhhhHHHHHHHHHHHHhhcCCCCeEecCcCCCcEEECCCCcEEEeecCCCccccCCC
Q 039231          378 -------------------LRVAEELSSTIGIARGLEYLHLGCSTRILHFDIKPHNILLDEDFCPKISDFGLAKICNRKE  438 (506)
Q Consensus       378 -------------------~~~~~~l~i~~~i~~gl~~LH~~~~~~ivH~dlkp~Nill~~~~~~ki~dfg~a~~~~~~~  438 (506)
                                         +++.+.+.++.||+.||+|||   +++|+||||||+|||++.++..+|+|||.++......
T Consensus        89 vmE~~~g~~L~~~~~~~~~l~~~~~~~i~~qi~~al~~lH---~~~iiHrDiKP~NIll~~~~~~~l~d~~~~~~~~~~~  165 (277)
T d1o6ya_          89 VMEYVDGVTLRDIVHTEGPMTPKRAIEVIADACQALNFSH---QNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSG  165 (277)
T ss_dssp             EEECCCEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEEETTSCEEECCCTTCEECC---
T ss_pred             EEECCCCCEehhhhcccCCCCHHHHHHHHHHHHHHHHHHH---hCCccCccccCcccccCccccceeehhhhhhhhcccc
Confidence                               334447789999999999999   8999999999999999999999999999987654332


Q ss_pred             cc-eecccCCCCcccccccccccccCCCCccccHHHHHHHHHHHHcCCCCCCCCCCCcc
Q 039231          439 SI-ISMTGARGTVGYIAPEVFCRNIGEVSYKSDVYNYGMMIFEMTGGRKNVDVVDNGST  496 (506)
Q Consensus       439 ~~-~~~~~~~gt~~y~aPE~l~~~~~~~s~~~Dv~s~G~il~elltg~~pf~~~~~~~~  496 (506)
                      .. .......||+.|+|||++.+.  .++.++|||||||++|||+||+.||...+..+.
T Consensus       166 ~~~~~~~~~~Gt~~Y~aPE~~~~~--~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~  222 (277)
T d1o6ya_         166 NSVTQTAAVIGTAQYLSPEQARGD--SVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSV  222 (277)
T ss_dssp             -------------TTCCHHHHTTC--CCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHH
T ss_pred             ccccccccccCcccccCHHHHcCC--CCCcceecccchHHHHHHHhCCCCCCCcCHHHH
Confidence            21 123456799999999998654  789999999999999999999999986654433

>d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: G-protein coupled receptor kinase 2
species: Cow (Bos taurus) [TaxId: 9913]

Probab=100.00  E-value=2.3e-36  Score=301.49  Aligned_cols=172  Identities=29%  Similarity=0.407  Sum_probs=141.9

Q ss_pred             hhccccCccCceEEEEEEEc-CCCEEEEEEeccC----CCCchhhHH---HHHHhhccCccceeEEEEEe----------
Q 039231          316 SFKYKLGQGGYGSVYKGKLL-DGSNVAVKVLNDS----KGNGKEFIN---EVASISRTSHVNVVALLGFC----------  377 (506)
Q Consensus       316 ~~~~~ig~G~~g~V~~~~~~-~~~~vavK~l~~~----~~~~~~~~~---E~~~l~~l~h~niv~l~g~~----------  377 (506)
                      .+.++||+|+||.||+|+.. +|+.||||++...    ......+.+   |+++++.++|||||++++++          
T Consensus         7 ~i~~~lG~G~fg~Vy~~~~~~t~~~vAiK~i~~~~~~~~~~~~~~~~e~~~~~~l~~~~hpnIv~l~~~~~~~~~~~ivm   86 (364)
T d1omwa3           7 SVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLSFIL   86 (364)
T ss_dssp             EEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSSEEEEEE
T ss_pred             eeeeEEecCCCeEEEEEEECCCCCEEEEEEEchHHcchhhHHHHHHHHHHHHHHHhcCCCCcEEEEEEEEEECCEEEEEE
Confidence            34578999999999999975 5899999998632    122233444   47778888999999999987          


Q ss_pred             -----------------eccchhhhHHHHHHHHHHHHhhcCCCCeEecCcCCCcEEECCCCcEEEeecCCCccccCCCcc
Q 039231          378 -----------------LRVAEELSSTIGIARGLEYLHLGCSTRILHFDIKPHNILLDEDFCPKISDFGLAKICNRKESI  440 (506)
Q Consensus       378 -----------------~~~~~~l~i~~~i~~gl~~LH~~~~~~ivH~dlkp~Nill~~~~~~ki~dfg~a~~~~~~~~~  440 (506)
                                       +.+.+...++.||+.||+|||   +++|+||||||+|||+++++.+||+|||+|+....... 
T Consensus        87 E~~~gg~L~~~l~~~~~~~e~~~~~~~~qi~~aL~ylH---~~~iiHrDlKP~NILl~~~g~iKl~DFGla~~~~~~~~-  162 (364)
T d1omwa3          87 DLMNGGDLHYHLSQHGVFSEADMRFYAAEIILGLEHMH---NRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKP-  162 (364)
T ss_dssp             CCCCSCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECSSSCEEECCCTTCEECSSSCC-
T ss_pred             EecCCCcHHHHHHhcccccHHHHHHHHHHHHHHHHHHH---HCCccceeeccceeEEcCCCcEEEeeeceeeecCCCcc-
Confidence                             233446778999999999999   89999999999999999999999999999987765432 


Q ss_pred             eecccCCCCcccccccccccccCCCCccccHHHHHHHHHHHHcCCCCCCCCCCCc
Q 039231          441 ISMTGARGTVGYIAPEVFCRNIGEVSYKSDVYNYGMMIFEMTGGRKNVDVVDNGS  495 (506)
Q Consensus       441 ~~~~~~~gt~~y~aPE~l~~~~~~~s~~~Dv~s~G~il~elltg~~pf~~~~~~~  495 (506)
                         ....||+.|+|||++.+. ..++.++|||||||++|||++|+.||......+
T Consensus       163 ---~~~~GT~~y~APE~~~~~-~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~  213 (364)
T d1omwa3         163 ---HASVGTHGYMAPEVLQKG-VAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKD  213 (364)
T ss_dssp             ---CSCCSCGGGCCHHHHSTT-CCCCTHHHHHHHHHHHHHHHHSSCSSCSSCSSC
T ss_pred             ---cccccccccchhHHhhcC-CCCCcccchhHHHHHHHHHHhCCCCCCCCCHHH
Confidence               456799999999998543 368999999999999999999999998765443

>d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: (Plasmodium falciparum) [TaxId: 5833]

Probab=100.00  E-value=9.7e-37  Score=295.11  Aligned_cols=172  Identities=30%  Similarity=0.435  Sum_probs=144.0

Q ss_pred             ccccCccCceEEEEEEEcCCCEEEEEEeccCC---CCchhhHHHHHHhhccCccceeEEEEEe-----------------
Q 039231          318 KYKLGQGGYGSVYKGKLLDGSNVAVKVLNDSK---GNGKEFINEVASISRTSHVNVVALLGFC-----------------  377 (506)
Q Consensus       318 ~~~ig~G~~g~V~~~~~~~~~~vavK~l~~~~---~~~~~~~~E~~~l~~l~h~niv~l~g~~-----------------  377 (506)
                      -++||+|+||+||+|++++|+.||||+++...   ...+.+.+|+.+|++++|||||++++++                 
T Consensus         7 ~~~iG~G~fg~Vy~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~i~~e~~~~~~   86 (286)
T d1ob3a_           7 LEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVFEHLDQDL   86 (286)
T ss_dssp             EEEEEEETTEEEEEEEETTSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEEEECCSEEH
T ss_pred             ccEEecCCCcEEEEEEeCCCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEeeeeecccCCceeEEEEeehhhh
Confidence            46799999999999999999999999996542   2347899999999999999999999887                 


Q ss_pred             ----------eccchhhhHHHHHHHHHHHHhhcCCCCeEecCcCCCcEEECCCCcEEEeecCCCccccCCCcceecccCC
Q 039231          378 ----------LRVAEELSSTIGIARGLEYLHLGCSTRILHFDIKPHNILLDEDFCPKISDFGLAKICNRKESIISMTGAR  447 (506)
Q Consensus       378 ----------~~~~~~l~i~~~i~~gl~~LH~~~~~~ivH~dlkp~Nill~~~~~~ki~dfg~a~~~~~~~~~~~~~~~~  447 (506)
                                +++.+...++.||+.||+|||   +++|+||||||+|||++.++.+||+|||.+.........  .....
T Consensus        87 ~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH---~~~IvHrDiKp~NIll~~~~~~kl~DfG~a~~~~~~~~~--~~~~~  161 (286)
T d1ob3a_          87 KKLLDVCEGGLESVTAKSFLLQLLNGIAYCH---DRRVLHRDLKPQNLLINREGELKIADFGLARAFGIPVRK--YTHEI  161 (286)
T ss_dssp             HHHHHTSTTCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEECTTSCEEECCTTHHHHHCC-----------
T ss_pred             HHHHHhhcCCcchhhhHHHHHHHHHHHHHhc---cCcEEecCCCCceeeEcCCCCEEecccccceecccCccc--cceec
Confidence                      344557789999999999999   899999999999999999999999999999876543321  23456


Q ss_pred             CCcccccccccccccCCCCccccHHHHHHHHHHHHcCCCCCCCCCCCc
Q 039231          448 GTVGYIAPEVFCRNIGEVSYKSDVYNYGMMIFEMTGGRKNVDVVDNGS  495 (506)
Q Consensus       448 gt~~y~aPE~l~~~~~~~s~~~Dv~s~G~il~elltg~~pf~~~~~~~  495 (506)
                      +++.|+|||.+.+. ..++.++||||+||++|||++|+.||...++.+
T Consensus       162 ~~~~y~~pE~~~~~-~~~~~~~DiwslGv~l~el~~G~~pf~~~~~~~  208 (286)
T d1ob3a_         162 VTLWYRAPDVLMGS-KKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEAD  208 (286)
T ss_dssp             CCCTTCCHHHHTTC-CSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHH
T ss_pred             ccchhhhHHHHhCC-CCCCcceeehhcCcHHHHHHHCCCCCCCCCHHH
Confidence            89999999998654 467999999999999999999999998665443

>d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.3e-36  Score=295.89  Aligned_cols=172  Identities=30%  Similarity=0.412  Sum_probs=145.4

Q ss_pred             ccccCccCceEEEEEEEc-CCCEEEEEEeccCC---CCchhhHHHHHHhhccCccceeEEEEEe----------------
Q 039231          318 KYKLGQGGYGSVYKGKLL-DGSNVAVKVLNDSK---GNGKEFINEVASISRTSHVNVVALLGFC----------------  377 (506)
Q Consensus       318 ~~~ig~G~~g~V~~~~~~-~~~~vavK~l~~~~---~~~~~~~~E~~~l~~l~h~niv~l~g~~----------------  377 (506)
                      .++||+|+||+||+|+.. +|+.||||+++...   ...+++.+|+++|++++|||||++++++                
T Consensus         7 ~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~Hp~Iv~~~~~~~~~~~~~iv~e~~~~~   86 (298)
T d1gz8a_           7 VEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLHQD   86 (298)
T ss_dssp             EEEEEECSSSEEEEEEETTTCCEEEEEEEC-------CCHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEECCSEE
T ss_pred             ccEEecCcCeEEEEEEECCCCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEEeccccccccceeEEEeecCCc
Confidence            467999999999999974 58999999996432   2347789999999999999999999987                


Q ss_pred             ------------eccchhhhHHHHHHHHHHHHhhcCCCCeEecCcCCCcEEECCCCcEEEeecCCCccccCCCcceeccc
Q 039231          378 ------------LRVAEELSSTIGIARGLEYLHLGCSTRILHFDIKPHNILLDEDFCPKISDFGLAKICNRKESIISMTG  445 (506)
Q Consensus       378 ------------~~~~~~l~i~~~i~~gl~~LH~~~~~~ivH~dlkp~Nill~~~~~~ki~dfg~a~~~~~~~~~~~~~~  445 (506)
                                  +++.+...++.||+.||+|||   +++|+||||||+|||++.++.+||+|||+|+.......  ....
T Consensus        87 ~~~~~~~~~~~~l~e~~~~~~~~qil~~L~yLH---~~~IiHrDiKpeNIl~~~~~~~kl~DFG~a~~~~~~~~--~~~~  161 (298)
T d1gz8a_          87 LKKFMDASALTGIPLPLIKSYLFQLLQGLAFCH---SHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVR--TYTH  161 (298)
T ss_dssp             HHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEECTTSCEEECSTTHHHHHCCCSB--CTTC
T ss_pred             hhhhhhhhcccCCCHHHHHHHHHHHHHHHHHhh---cCCEEccccCchheeecccCcceeccCCcceeccCCcc--ccee
Confidence                        344557789999999999999   89999999999999999999999999999987654332  2345


Q ss_pred             CCCCcccccccccccccCCCCccccHHHHHHHHHHHHcCCCCCCCCCCCc
Q 039231          446 ARGTVGYIAPEVFCRNIGEVSYKSDVYNYGMMIFEMTGGRKNVDVVDNGS  495 (506)
Q Consensus       446 ~~gt~~y~aPE~l~~~~~~~s~~~Dv~s~G~il~elltg~~pf~~~~~~~  495 (506)
                      ..||+.|+|||.+... ..++.++||||+||++|||++|+.||...+..+
T Consensus       162 ~~gt~~y~apE~~~~~-~~~~~~~DiwSlGvily~m~~G~~Pf~~~~~~~  210 (298)
T d1gz8a_         162 EVVTLWYRAPEILLGC-KYYSTAVDIWSLGCIFAEMVTRRALFPGDSEID  210 (298)
T ss_dssp             CBCCCTTCCHHHHTTC-SSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHH
T ss_pred             ecccceeeehhhhccc-cCCCccccccccchhhhHHhhCCCCCCCCCHHH
Confidence            6799999999988654 456889999999999999999999998665433

>d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Hepatocyte growth factor receptor, c-MET
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.9e-36  Score=295.83  Aligned_cols=173  Identities=35%  Similarity=0.559  Sum_probs=141.5

Q ss_pred             hhccccCccCceEEEEEEEcCC----CEEEEEEeccCCC--CchhhHHHHHHhhccCccceeEEEEEeec----------
Q 039231          316 SFKYKLGQGGYGSVYKGKLLDG----SNVAVKVLNDSKG--NGKEFINEVASISRTSHVNVVALLGFCLR----------  379 (506)
Q Consensus       316 ~~~~~ig~G~~g~V~~~~~~~~----~~vavK~l~~~~~--~~~~~~~E~~~l~~l~h~niv~l~g~~~~----------  379 (506)
                      +|+++||+|+||+||+|++.++    ..||||+++....  ..+++.+|+++|++++|||||+++|++.+          
T Consensus        30 ~~~~~iG~G~fg~Vyk~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~lv~E  109 (311)
T d1r0pa_          30 HFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLP  109 (311)
T ss_dssp             EEEEEEEEETTEEEEEEEECC----CEEEEEEEECCCCCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEETTTEEEEEEE
T ss_pred             ccceEEeecCCeEEEEEEEECCCCEEEEEEEEEECcccCHHHHHHHHHHHHHHHhCCCCCEeEEeEEEEecCCceEEEEE
Confidence            4567899999999999997542    3689999975332  33679999999999999999999998732          


Q ss_pred             -------------------cchhhhHHHHHHHHHHHHhhcCCCCeEecCcCCCcEEECCCCcEEEeecCCCccccCCCcc
Q 039231          380 -------------------VAEELSSTIGIARGLEYLHLGCSTRILHFDIKPHNILLDEDFCPKISDFGLAKICNRKESI  440 (506)
Q Consensus       380 -------------------~~~~l~i~~~i~~gl~~LH~~~~~~ivH~dlkp~Nill~~~~~~ki~dfg~a~~~~~~~~~  440 (506)
                                         +.+++.++.|++.||.|||   +++|+||||||+|||+++++.+||+|||+++........
T Consensus       110 ~~~~g~l~~~~~~~~~~~~~~~~~~i~~qia~gL~~lH---~~~iiHrDLK~~NILl~~~~~~kL~DFG~~~~~~~~~~~  186 (311)
T d1r0pa_         110 YMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLA---SKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFD  186 (311)
T ss_dssp             CCTTCBHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEECTTCCEEECSSGGGCCTTTTTCC
T ss_pred             EeecCchhhhhccccccchHHHHHHHHHHHHHhhhhhc---ccCcccCCccHHhEeECCCCCEEEecccchhhccccccc
Confidence                               2336789999999999999   899999999999999999999999999999876544322


Q ss_pred             e--ecccCCCCcccccccccccccCCCCccccHHHHHHHHHHHHcCCCCCCCCCC
Q 039231          441 I--SMTGARGTVGYIAPEVFCRNIGEVSYKSDVYNYGMMIFEMTGGRKNVDVVDN  493 (506)
Q Consensus       441 ~--~~~~~~gt~~y~aPE~l~~~~~~~s~~~Dv~s~G~il~elltg~~pf~~~~~  493 (506)
                      .  ......||+.|+|||.+..  +.++.++||||||+++|||++|+.||.....
T Consensus       187 ~~~~~~~~~gt~~y~aPE~~~~--~~~~~ksDI~SfGivl~El~t~~~p~~~~~~  239 (311)
T d1r0pa_         187 SVHNKTGAKLPVKWMALESLQT--QKFTTKSDVWSFGVLLWELMTRGAPPYPDVN  239 (311)
T ss_dssp             CTTCTTCSSCCGGGSCHHHHHH--CCCCHHHHHHHHHHHHHHHHTTSCCSCC---
T ss_pred             cceecccccccccccChHHHhc--CCCCChhHhhhhHHHHHHHHHCCCCCCCCCC
Confidence            1  1234578999999999865  4789999999999999999998888765443

>d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase C, theta type
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.5e-36  Score=296.07  Aligned_cols=174  Identities=26%  Similarity=0.374  Sum_probs=145.8

Q ss_pred             hhccccCccCceEEEEEEEc-CCCEEEEEEeccC----CCCchhhHHHHHHhh-ccCccceeEEEEEe------------
Q 039231          316 SFKYKLGQGGYGSVYKGKLL-DGSNVAVKVLNDS----KGNGKEFINEVASIS-RTSHVNVVALLGFC------------  377 (506)
Q Consensus       316 ~~~~~ig~G~~g~V~~~~~~-~~~~vavK~l~~~----~~~~~~~~~E~~~l~-~l~h~niv~l~g~~------------  377 (506)
                      .+.++||+|+||+||+|+.. +++.||||++++.    ....+.+.+|..++. .++|||||++++++            
T Consensus         5 ~i~~~iG~G~fg~Vy~~~~~~t~~~vAvK~i~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~~~~~~~~~~~~yivmEy   84 (320)
T d1xjda_           5 ILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKENLFFVMEY   84 (320)
T ss_dssp             EEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEEEEEC
T ss_pred             EEeeEEecCCCcEEEEEEECCCCCEEEEEEEchhhccChHHHHHHHHHHHHHHHhCCCCcEEEEEEEEccCCceeEEEee
Confidence            45678999999999999985 5899999999642    334456777777765 68999999999987            


Q ss_pred             ---------------eccchhhhHHHHHHHHHHHHhhcCCCCeEecCcCCCcEEECCCCcEEEeecCCCccccCCCccee
Q 039231          378 ---------------LRVAEELSSTIGIARGLEYLHLGCSTRILHFDIKPHNILLDEDFCPKISDFGLAKICNRKESIIS  442 (506)
Q Consensus       378 ---------------~~~~~~l~i~~~i~~gl~~LH~~~~~~ivH~dlkp~Nill~~~~~~ki~dfg~a~~~~~~~~~~~  442 (506)
                                     +++.+.+.++.||+.||+|||   +++|+||||||+|||+++++.+||+|||+++........  
T Consensus        85 ~~~g~L~~~i~~~~~~~e~~~~~~~~qi~~al~ylH---~~~iiHrDikp~NiL~~~~~~~kl~DFG~a~~~~~~~~~--  159 (320)
T d1xjda_          85 LNGGDLMYHIQSCHKFDLSRATFYAAEIILGLQFLH---SKGIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAK--  159 (320)
T ss_dssp             CTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHH---HTTCBCCCCCGGGEEECTTSCEEECCCTTCBCCCCTTCC--
T ss_pred             cCCCcHHHHhhccCCCCHHHHHHHHHHHHHHHHHHH---hCCeeeccCcccceeecCCCceeccccchhhhccccccc--
Confidence                           334457789999999999999   899999999999999999999999999999876544332  


Q ss_pred             cccCCCCcccccccccccccCCCCccccHHHHHHHHHHHHcCCCCCCCCCCCcc
Q 039231          443 MTGARGTVGYIAPEVFCRNIGEVSYKSDVYNYGMMIFEMTGGRKNVDVVDNGST  496 (506)
Q Consensus       443 ~~~~~gt~~y~aPE~l~~~~~~~s~~~Dv~s~G~il~elltg~~pf~~~~~~~~  496 (506)
                      .....||+.|+|||++.+.  .++.++||||+||++|||++|+.||...+..+.
T Consensus       160 ~~~~~gt~~y~aPE~~~~~--~~~~~~DiwSlGvilyemltG~~PF~~~~~~~~  211 (320)
T d1xjda_         160 TNTFCGTPDYIAPEILLGQ--KYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEEL  211 (320)
T ss_dssp             BCCCCSCGGGCCHHHHTTC--CBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHH
T ss_pred             ccccCCCCCcCCHHHHcCC--CCCchhhhhhhhHHHHHHHhCCCCCCCCCHHHH
Confidence            2456799999999999654  789999999999999999999999987654443

>d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK6
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.8e-36  Score=294.62  Aligned_cols=172  Identities=31%  Similarity=0.472  Sum_probs=141.4

Q ss_pred             hccccCccCceEEEEEEEc-C-CCEEEEEEeccC---CCCchhhHHHHHHhhcc---CccceeEEEEEee----------
Q 039231          317 FKYKLGQGGYGSVYKGKLL-D-GSNVAVKVLNDS---KGNGKEFINEVASISRT---SHVNVVALLGFCL----------  378 (506)
Q Consensus       317 ~~~~ig~G~~g~V~~~~~~-~-~~~vavK~l~~~---~~~~~~~~~E~~~l~~l---~h~niv~l~g~~~----------  378 (506)
                      +.++||+|+||+||+|++. + ++.||||+++..   ......+.+|+++++.+   +||||+++++++.          
T Consensus        11 i~~~LG~G~fg~V~~a~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~~l~~l~~~~HpnIv~~~~~~~~~~~~~~~~~   90 (305)
T d1blxa_          11 CVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTDRETKL   90 (305)
T ss_dssp             EEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEECSSEEEE
T ss_pred             EEEEEecccCeEEEEEEEECCCCEEEEEEEEehhhccchHHHHHHHHHHHHHHHhhcCCCCcceeeeeecccccccCceE
Confidence            3467999999999999974 3 567999998643   22335677888877666   7999999998762          


Q ss_pred             -----------------------ccchhhhHHHHHHHHHHHHhhcCCCCeEecCcCCCcEEECCCCcEEEeecCCCcccc
Q 039231          379 -----------------------RVAEELSSTIGIARGLEYLHLGCSTRILHFDIKPHNILLDEDFCPKISDFGLAKICN  435 (506)
Q Consensus       379 -----------------------~~~~~l~i~~~i~~gl~~LH~~~~~~ivH~dlkp~Nill~~~~~~ki~dfg~a~~~~  435 (506)
                                             ++.....++.|++.||+|||   +++|+||||||+|||+++++.+||+|||+++...
T Consensus        91 ~~~~e~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH---~~~ivHrDiKp~NILi~~~~~~kl~dfg~~~~~~  167 (305)
T d1blxa_          91 TLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLH---SHRVVHRDLKPQNILVTSSGQIKLADFGLARIYS  167 (305)
T ss_dssp             EEEEECCSCBHHHHHHHSCTTCSCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEECTTCCEEECSCCSCCCCC
T ss_pred             EEEEEeccCCchhhhhhccCCCCCHHHHHHHHHHHHHHHHHHH---hCCEEecCCCccEEEEcCCCCeeecchhhhhhhc
Confidence                                   22235678999999999999   8999999999999999999999999999998654


Q ss_pred             CCCcceecccCCCCcccccccccccccCCCCccccHHHHHHHHHHHHcCCCCCCCCCCCcc
Q 039231          436 RKESIISMTGARGTVGYIAPEVFCRNIGEVSYKSDVYNYGMMIFEMTGGRKNVDVVDNGST  496 (506)
Q Consensus       436 ~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~s~~~Dv~s~G~il~elltg~~pf~~~~~~~~  496 (506)
                      ....   .....||+.|+|||++.+.  .++.++||||+||++|||++|+.||...++.+.
T Consensus       168 ~~~~---~~~~~gT~~Y~APE~~~~~--~y~~~~DiwSlG~il~ell~g~~pf~~~~~~~~  223 (305)
T d1blxa_         168 FQMA---LTSVVVTLWYRAPEVLLQS--SYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQ  223 (305)
T ss_dssp             GGGG---GCCCCCCCTTCCHHHHTTC--CCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHH
T ss_pred             cccc---CCCcccChhhcCcchhcCC--CCChhehhhchHHHHHHHHHCCCCCCCCCHHHH
Confidence            4332   3567899999999998654  789999999999999999999999987654443

>d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Proto-oncogene serine/threonine-protein kinase Pim-1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2e-36  Score=290.62  Aligned_cols=169  Identities=28%  Similarity=0.377  Sum_probs=140.6

Q ss_pred             hhhccccCccCceEEEEEEEc-CCCEEEEEEeccCC-------CCchhhHHHHHHhhccC--ccceeEEEEEe-------
Q 039231          315 NSFKYKLGQGGYGSVYKGKLL-DGSNVAVKVLNDSK-------GNGKEFINEVASISRTS--HVNVVALLGFC-------  377 (506)
Q Consensus       315 ~~~~~~ig~G~~g~V~~~~~~-~~~~vavK~l~~~~-------~~~~~~~~E~~~l~~l~--h~niv~l~g~~-------  377 (506)
                      +.+.++||+|+||+||+|+.. +|+.||||+++...       ....++.+|++++++++  |||||++++++       
T Consensus         6 Y~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~~~h~nIv~~~~~~~~~~~~~   85 (273)
T d1xwsa_           6 YQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPDSFV   85 (273)
T ss_dssp             EEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEECSSEEE
T ss_pred             EEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccchhhhhHHHHHHHHHHHHHHhccCCCCccEEEEEEeeCCeEE
Confidence            344678999999999999975 58999999986432       12345789999999997  89999999987       


Q ss_pred             ---------------------eccchhhhHHHHHHHHHHHHhhcCCCCeEecCcCCCcEEECC-CCcEEEeecCCCcccc
Q 039231          378 ---------------------LRVAEELSSTIGIARGLEYLHLGCSTRILHFDIKPHNILLDE-DFCPKISDFGLAKICN  435 (506)
Q Consensus       378 ---------------------~~~~~~l~i~~~i~~gl~~LH~~~~~~ivH~dlkp~Nill~~-~~~~ki~dfg~a~~~~  435 (506)
                                           +++.+...++.||++||+|||   +++|+||||||+|||++. ++.+||+|||+|+...
T Consensus        86 lv~e~~~~~~~l~~~~~~~~~l~e~~~~~~~~qi~~al~~lH---~~~iiHrDiKp~NIll~~~~~~vkl~DFG~a~~~~  162 (273)
T d1xwsa_          86 LILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHCH---NCGVLHRDIKDENILIDLNRGELKLIDFGSGALLK  162 (273)
T ss_dssp             EEEECCSSEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEEETTTTEEEECCCTTCEECC
T ss_pred             EEEEeccCcchHHHHHhccCCCCHHHHHHHHHHHHHHHHHHH---HCCCccccCcccceEEecCCCeEEECccccceecc
Confidence                                 334446779999999999999   899999999999999985 4799999999998754


Q ss_pred             CCCcceecccCCCCcccccccccccccCCCCccccHHHHHHHHHHHHcCCCCCCCC
Q 039231          436 RKESIISMTGARGTVGYIAPEVFCRNIGEVSYKSDVYNYGMMIFEMTGGRKNVDVV  491 (506)
Q Consensus       436 ~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~s~~~Dv~s~G~il~elltg~~pf~~~  491 (506)
                      ...    .....||+.|+|||++.+. ..++.++||||+||++|||++|+.||...
T Consensus       163 ~~~----~~~~~GT~~y~aPE~~~~~-~~~~~~~DiwSlGvilyell~g~~Pf~~~  213 (273)
T d1xwsa_         163 DTV----YTDFDGTRVYSPPEWIRYH-RYHGRSAAVWSLGILLYDMVCGDIPFEHD  213 (273)
T ss_dssp             SSC----BCCCCSCGGGSCHHHHHHS-CBCHHHHHHHHHHHHHHHHHHSSCSCCSH
T ss_pred             ccc----ccccccCCCcCCHHHHcCC-CCCCcccccccceeeehhHhhCCCCCCCc
Confidence            432    2456799999999998654 24567899999999999999999999754

>d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Type I TGF-beta receptor R4
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.6e-36  Score=294.09  Aligned_cols=175  Identities=26%  Similarity=0.390  Sum_probs=138.4

Q ss_pred             hccccCccCceEEEEEEEcCCCEEEEEEeccCCCCchhhHHHHHHhhccCccceeEEEEEee------------------
Q 039231          317 FKYKLGQGGYGSVYKGKLLDGSNVAVKVLNDSKGNGKEFINEVASISRTSHVNVVALLGFCL------------------  378 (506)
Q Consensus       317 ~~~~ig~G~~g~V~~~~~~~~~~vavK~l~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~------------------  378 (506)
                      +.++||+|+||.||+|++ +|+.||||+++...........|+..+.+++|||||+++|++.                  
T Consensus         7 l~~~iG~G~fg~Vy~~~~-~g~~vAvK~~~~~~~~~~~~e~ei~~~~~~~HpnIv~~~~~~~~~~~~~~~~~lv~Ey~~~   85 (303)
T d1vjya_           7 LQESIGKGRFGEVWRGKW-RGEEVAVKIFSSREERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWLVSDYHEH   85 (303)
T ss_dssp             EEEEEECCSSSEEEEEEE-TTEEEEEEEECGGGHHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEEEECCTT
T ss_pred             EEEEEeeCCCeEEEEEEE-CCEEEEEEEECccchhHHHHHHHHHHHhhCCCCcCcceEEEEEeCCCcceEEEEEEecccC
Confidence            467899999999999997 6889999999654332222344666667889999999999883                  


Q ss_pred             ------------ccchhhhHHHHHHHHHHHHhhc-----CCCCeEecCcCCCcEEECCCCcEEEeecCCCccccCCCcce
Q 039231          379 ------------RVAEELSSTIGIARGLEYLHLG-----CSTRILHFDIKPHNILLDEDFCPKISDFGLAKICNRKESII  441 (506)
Q Consensus       379 ------------~~~~~l~i~~~i~~gl~~LH~~-----~~~~ivH~dlkp~Nill~~~~~~ki~dfg~a~~~~~~~~~~  441 (506)
                                  ++.+++.++.|++.||+|||+.     .+++|+||||||+||||+.++.+||+|||+++.........
T Consensus        86 g~L~~~l~~~~l~~~~~~~~~~~ia~gl~~lH~~~~~~~~~~~IvHrDlKp~NILl~~~~~~Kl~DFGl~~~~~~~~~~~  165 (303)
T d1vjya_          86 GSLFDYLNRYTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTI  165 (303)
T ss_dssp             CBHHHHHHHCCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCCGGGEEECTTSCEEECCCTTCEEEETTTTEE
T ss_pred             CCHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCeeccccCccceEEcCCCCeEEEecCccccccCCCcce
Confidence                        3444678999999999999942     13699999999999999999999999999999876544322


Q ss_pred             e--cccCCCCccccccccccccc----CCCCccccHHHHHHHHHHHHcCCCCCCCCC
Q 039231          442 S--MTGARGTVGYIAPEVFCRNI----GEVSYKSDVYNYGMMIFEMTGGRKNVDVVD  492 (506)
Q Consensus       442 ~--~~~~~gt~~y~aPE~l~~~~----~~~s~~~Dv~s~G~il~elltg~~pf~~~~  492 (506)
                      .  .....||+.|+|||++....    ..++.++|||||||+||||+||..||....
T Consensus       166 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~k~Di~S~Gvvl~el~tg~~~~~~~~  222 (303)
T d1vjya_         166 DIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHE  222 (303)
T ss_dssp             CC----CCSCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCC
T ss_pred             eccccceecccCcCChhhccccccccCCCcCcchhhhhhHHHHHHHhhCCCCCCccc
Confidence            2  23467999999999985431    125778999999999999999999886544

>d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Vascular endothelial growth factor receptor 2 (kdr)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.3e-36  Score=296.09  Aligned_cols=180  Identities=27%  Similarity=0.464  Sum_probs=137.8

Q ss_pred             HhhhccccCccCceEEEEEEEcC------CCEEEEEEeccCCC--CchhhHHHHHHhhcc-CccceeEEEEEee------
Q 039231          314 TNSFKYKLGQGGYGSVYKGKLLD------GSNVAVKVLNDSKG--NGKEFINEVASISRT-SHVNVVALLGFCL------  378 (506)
Q Consensus       314 ~~~~~~~ig~G~~g~V~~~~~~~------~~~vavK~l~~~~~--~~~~~~~E~~~l~~l-~h~niv~l~g~~~------  378 (506)
                      .+.+.++||+|+||.||+|++..      ++.||||+++....  ..+.+.+|.+.+.++ +|+|||++++++.      
T Consensus        14 ~y~~~~~iG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~~~~~   93 (299)
T d1ywna1          14 RLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGGPL   93 (299)
T ss_dssp             GEEEEEEEEECSSCEEEEEEEESTTSSSCEEEEEEEEC----CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSTTSCC
T ss_pred             HEEEeeEEeecCCeEEEEEEEcCCCcccCCeEEEEEEEccccCcHHHHHHHHHHHHHHhhcCCCeEEEeeeeeccCCCeE
Confidence            34456789999999999998642      46899999975432  235678888888887 5889999988761      


Q ss_pred             --------------------------------------ccchhhhHHHHHHHHHHHHhhcCCCCeEecCcCCCcEEECCC
Q 039231          379 --------------------------------------RVAEELSSTIGIARGLEYLHLGCSTRILHFDIKPHNILLDED  420 (506)
Q Consensus       379 --------------------------------------~~~~~l~i~~~i~~gl~~LH~~~~~~ivH~dlkp~Nill~~~  420 (506)
                                                            ++.+++.++.||++||+|||   +++|+||||||+||||+++
T Consensus        94 ~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH---~~~ivHrDlKp~NILl~~~  170 (299)
T d1ywna1          94 MVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLA---SRKCIHRDLAARNILLSEK  170 (299)
T ss_dssp             EEEEECCTTCBHHHHHHHTGGGBCC-----------CBCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEECGG
T ss_pred             EEEEEecCCCcHHHHHHhccccccccccchhhhhcccCCHHHHHHHHHHHHHHHHHHH---hCCCcCCcCCccceeECCC
Confidence                                                  12335678999999999999   8999999999999999999


Q ss_pred             CcEEEeecCCCccccCCCcceecccCCCCcccccccccccccCCCCccccHHHHHHHHHHHHcC-CCCCCCCCCCcchh
Q 039231          421 FCPKISDFGLAKICNRKESIISMTGARGTVGYIAPEVFCRNIGEVSYKSDVYNYGMMIFEMTGG-RKNVDVVDNGSTAL  498 (506)
Q Consensus       421 ~~~ki~dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~s~~~Dv~s~G~il~elltg-~~pf~~~~~~~~~~  498 (506)
                      +.+||+|||+|+...............||+.|+|||.+.+.  .++.++|||||||++|||++| ..||......+...
T Consensus       171 ~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~--~~~~~sDiwS~Gvil~ellt~~~~p~~~~~~~~~~~  247 (299)
T d1ywna1         171 NVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDR--VYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFC  247 (299)
T ss_dssp             GCEEECC------CCSCTTSCCTTSCCCGGGGCCHHHHHHC--CCCHHHHHHHHHHHHHHHHTTSCCSSTTCCCSHHHH
T ss_pred             CcEEEccCcchhhccccccccccCceeeCccccchhHhhcC--CCCcccceeehHHHHHHHHhCCCCCCCCCCHHHHHH
Confidence            99999999999877655544444567899999999999654  789999999999999999986 56787665554433

>d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: gamma-subunit of glycogen phosphorylase kinase (Phk)
species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]

Probab=100.00  E-value=8.4e-36  Score=286.25  Aligned_cols=175  Identities=25%  Similarity=0.341  Sum_probs=147.0

Q ss_pred             hhccccCccCceEEEEEEEc-CCCEEEEEEeccCCCC----------chhhHHHHHHhhccC-ccceeEEEEEe------
Q 039231          316 SFKYKLGQGGYGSVYKGKLL-DGSNVAVKVLNDSKGN----------GKEFINEVASISRTS-HVNVVALLGFC------  377 (506)
Q Consensus       316 ~~~~~ig~G~~g~V~~~~~~-~~~~vavK~l~~~~~~----------~~~~~~E~~~l~~l~-h~niv~l~g~~------  377 (506)
                      .+.+.||+|+||+||+|+.. +|+.||||+++.....          .+.+.+|++++++++ |||||++++++      
T Consensus         6 ~~~~~iG~G~~g~V~~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~~~~   85 (277)
T d1phka_           6 EPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYETNTFF   85 (277)
T ss_dssp             EEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEE
T ss_pred             EEceEEecCcCeEEEEEEECCCCCEEEEEEEecccccchhHHHHHHHHHHHHHHHHHHHHhcCCCCeEEEEeecccCcce
Confidence            34578999999999999974 6899999999754321          135789999999997 99999999988      


Q ss_pred             ---------------------eccchhhhHHHHHHHHHHHHhhcCCCCeEecCcCCCcEEECCCCcEEEeecCCCccccC
Q 039231          378 ---------------------LRVAEELSSTIGIARGLEYLHLGCSTRILHFDIKPHNILLDEDFCPKISDFGLAKICNR  436 (506)
Q Consensus       378 ---------------------~~~~~~l~i~~~i~~gl~~LH~~~~~~ivH~dlkp~Nill~~~~~~ki~dfg~a~~~~~  436 (506)
                                           +++.+.+.++.||++||+|||   +++|+||||||+|||+++++.+||+|||+++....
T Consensus        86 ~ivmE~~~~g~L~~~l~~~~~l~e~~~~~~~~qi~~al~~lH---~~~ivHrDlkp~Nill~~~~~~kl~DFG~a~~~~~  162 (277)
T d1phka_          86 FLVFDLMKKGELFDYLTEKVTLSEKETRKIMRALLEVICALH---KLNIVHRDLKPENILLDDDMNIKLTDFGFSCQLDP  162 (277)
T ss_dssp             EEEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECTTCCEEECCCTTCEECCT
T ss_pred             EEEEEcCCCchHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH---HcCCcccccccceEEEcCCCCeEEccchheeEccC
Confidence                                 345557889999999999999   89999999999999999999999999999988765


Q ss_pred             CCcceecccCCCCcccccccccccc----cCCCCccccHHHHHHHHHHHHcCCCCCCCCCCCcc
Q 039231          437 KESIISMTGARGTVGYIAPEVFCRN----IGEVSYKSDVYNYGMMIFEMTGGRKNVDVVDNGST  496 (506)
Q Consensus       437 ~~~~~~~~~~~gt~~y~aPE~l~~~----~~~~s~~~Dv~s~G~il~elltg~~pf~~~~~~~~  496 (506)
                      ...   .....||+.|+|||.+...    ...++.++||||+||++|||++|+.||...+..+.
T Consensus       163 ~~~---~~~~~gt~~y~~PE~~~~~~~~~~~~~~~~~DiwslGvilyeml~g~~Pf~~~~~~~~  223 (277)
T d1phka_         163 GEK---LREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLM  223 (277)
T ss_dssp             TCC---BCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHH
T ss_pred             CCc---eeeeeccCCCCCHHHhhccccccCCCCCchheEcccchhhhhhccCCCCCCCCCHHHH
Confidence            432   2456799999999998532    23568899999999999999999999987665443

>d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Titin, kinase domain
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.4e-36  Score=295.41  Aligned_cols=177  Identities=23%  Similarity=0.322  Sum_probs=148.5

Q ss_pred             hhccccCccCceEEEEEEEc-CCCEEEEEEeccCCCCchhhHHHHHHhhccCccceeEEEEEe-----------------
Q 039231          316 SFKYKLGQGGYGSVYKGKLL-DGSNVAVKVLNDSKGNGKEFINEVASISRTSHVNVVALLGFC-----------------  377 (506)
Q Consensus       316 ~~~~~ig~G~~g~V~~~~~~-~~~~vavK~l~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~-----------------  377 (506)
                      .+.++||+|+||+||+|+.. +++.||||+++........+.+|+++|++++|||||++++++                 
T Consensus         8 ~i~~~lG~G~fg~Vy~~~~~~~~~~~AiK~i~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~lvmE~~~gg~   87 (321)
T d1tkia_           8 MIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGTDQVLVKKEISILNIARHRNILHLHESFESMEELVMIFEFISGLD   87 (321)
T ss_dssp             EEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCTHHHHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEEEEECCCCCCB
T ss_pred             EEEEEEecCCCeEEEEEEECCCCcEEEEEEEcCCcccHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEecCCCCc
Confidence            44578999999999999985 588999999987655556788999999999999999999987                 


Q ss_pred             -----------eccchhhhHHHHHHHHHHHHhhcCCCCeEecCcCCCcEEECCC--CcEEEeecCCCccccCCCcceecc
Q 039231          378 -----------LRVAEELSSTIGIARGLEYLHLGCSTRILHFDIKPHNILLDED--FCPKISDFGLAKICNRKESIISMT  444 (506)
Q Consensus       378 -----------~~~~~~l~i~~~i~~gl~~LH~~~~~~ivH~dlkp~Nill~~~--~~~ki~dfg~a~~~~~~~~~~~~~  444 (506)
                                 +++.+...++.||+.||+|||   +++|+||||||+|||++.+  ..+||+|||+++........   .
T Consensus        88 L~~~i~~~~~~l~e~~~~~i~~qi~~al~yLH---~~~iiHrDlKp~NIll~~~~~~~ikl~DFG~~~~~~~~~~~---~  161 (321)
T d1tkia_          88 IFERINTSAFELNEREIVSYVHQVCEALQFLH---SHNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDNF---R  161 (321)
T ss_dssp             HHHHHTSSSCCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEESSSSCCCEEECCCTTCEECCTTCEE---E
T ss_pred             HHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH---HcCCCcccccccceeecCCCceEEEEcccchhhccccCCcc---c
Confidence                       334456779999999999999   8999999999999999754  58999999999877554432   3


Q ss_pred             cCCCCcccccccccccccCCCCccccHHHHHHHHHHHHcCCCCCCCCCCCcchhhh
Q 039231          445 GARGTVGYIAPEVFCRNIGEVSYKSDVYNYGMMIFEMTGGRKNVDVVDNGSTALDL  500 (506)
Q Consensus       445 ~~~gt~~y~aPE~l~~~~~~~s~~~Dv~s~G~il~elltg~~pf~~~~~~~~~~~~  500 (506)
                      ...+|+.|+|||.+.+.  .++.++||||+||++|||++|+.||...+..+....+
T Consensus       162 ~~~~t~~y~ape~~~~~--~~~~~~DiWSlGvily~ll~G~~Pf~~~~~~~~~~~i  215 (321)
T d1tkia_         162 LLFTAPEYYAPEVHQHD--VVSTATDMWSLGTLVYVLLSGINPFLAETNQQIIENI  215 (321)
T ss_dssp             EEESCGGGSCHHHHTTC--EECHHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHH
T ss_pred             ccccccccccchhccCC--CCCchhhcccHHHHHHHHHhCCCCCCCCCHHHHHHHH
Confidence            45689999999998654  7899999999999999999999999876654443333

>d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-KIT receptor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.7e-36  Score=294.23  Aligned_cols=187  Identities=29%  Similarity=0.482  Sum_probs=151.7

Q ss_pred             HHHHHhhhccccCccCceEEEEEEEc------CCCEEEEEEeccCCC--CchhhHHHHHHhhcc-CccceeEEEEEee--
Q 039231          310 IKKMTNSFKYKLGQGGYGSVYKGKLL------DGSNVAVKVLNDSKG--NGKEFINEVASISRT-SHVNVVALLGFCL--  378 (506)
Q Consensus       310 l~~~~~~~~~~ig~G~~g~V~~~~~~------~~~~vavK~l~~~~~--~~~~~~~E~~~l~~l-~h~niv~l~g~~~--  378 (506)
                      +....+.+.++||+|+||.||+|++.      +++.||||+++....  ...++.+|+.+++++ +|||||+++|++.  
T Consensus        20 ~~~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~~~~~l~~HpnIv~~~g~~~~~   99 (311)
T d1t46a_          20 FPRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACTIG   99 (311)
T ss_dssp             CCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred             CCHHHeEEeeEEeecCCeEEEEEEEeccccCCCCeEEEEEEECcccCHHHHHHHHHHHHHHHhccCCCCEEEEEEEEeeC
Confidence            33344556788999999999999862      357899999976443  235688999999999 6999999999881  


Q ss_pred             -------------------------------------------ccchhhhHHHHHHHHHHHHhhcCCCCeEecCcCCCcE
Q 039231          379 -------------------------------------------RVAEELSSTIGIARGLEYLHLGCSTRILHFDIKPHNI  415 (506)
Q Consensus       379 -------------------------------------------~~~~~l~i~~~i~~gl~~LH~~~~~~ivH~dlkp~Ni  415 (506)
                                                                 ++.+++.++.||++||+|||   +++++||||||+||
T Consensus       100 ~~~~lvmE~~~~g~l~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~~LH---~~~ivHrDLKp~NI  176 (311)
T d1t46a_         100 GPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLA---SKNCIHRDLAARNI  176 (311)
T ss_dssp             SSCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGE
T ss_pred             CEEEEEEEcCCCCCHHHHHHhccccccccccccccccccccCCCHHHHHHHHHHHHHHHHHHH---hCCeeecccccccc
Confidence                                                       12346678999999999999   89999999999999


Q ss_pred             EECCCCcEEEeecCCCccccCCCcceecccCCCCcccccccccccccCCCCccccHHHHHHHHHHHHc-CCCCCCCCCCC
Q 039231          416 LLDEDFCPKISDFGLAKICNRKESIISMTGARGTVGYIAPEVFCRNIGEVSYKSDVYNYGMMIFEMTG-GRKNVDVVDNG  494 (506)
Q Consensus       416 ll~~~~~~ki~dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~s~~~Dv~s~G~il~ellt-g~~pf~~~~~~  494 (506)
                      +++.++.+||+|||+++...............||+.|+|||.+.+  +.++.++||||||+++|||+| |.+||......
T Consensus       177 l~~~~~~~ki~DfG~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~~DIwS~G~~l~ellt~g~p~~~~~~~~  254 (311)
T d1t46a_         177 LLTHGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFN--CVYTFESDVWSYGIFLWELFSLGSSPYPGMPVD  254 (311)
T ss_dssp             EEETTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHH--CCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCSS
T ss_pred             cccccCcccccccchheeccCCCcceEeeecccChHHcCHHHhcC--CCCCCcccccchHHHHHHHHhCCCCCCCCCCHH
Confidence            999999999999999998776555555566789999999999854  478999999999999999999 55556555555


Q ss_pred             cchhhhh
Q 039231          495 STALDLQ  501 (506)
Q Consensus       495 ~~~~~~~  501 (506)
                      +...++.
T Consensus       255 ~~~~~~i  261 (311)
T d1t46a_         255 SKFYKMI  261 (311)
T ss_dssp             HHHHHHH
T ss_pred             HHHHHHH
Confidence            5444443

>d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase activated protein kinase 2, mapkap2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.6e-35  Score=292.06  Aligned_cols=165  Identities=26%  Similarity=0.337  Sum_probs=139.5

Q ss_pred             cccCccCceEEEEEEE-cCCCEEEEEEeccCCCCchhhHHHHHHhhcc-CccceeEEEEEe-------------------
Q 039231          319 YKLGQGGYGSVYKGKL-LDGSNVAVKVLNDSKGNGKEFINEVASISRT-SHVNVVALLGFC-------------------  377 (506)
Q Consensus       319 ~~ig~G~~g~V~~~~~-~~~~~vavK~l~~~~~~~~~~~~E~~~l~~l-~h~niv~l~g~~-------------------  377 (506)
                      +.||+|+||+||+|+. .+++.||||++++    ...+.+|++++.++ +|||||++++++                   
T Consensus        18 ~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~----~~~~~~E~~~~~~~~~hpnIv~l~~~~~~~~~~~~~~~ivmEy~~g   93 (335)
T d2ozaa1          18 QVLGLGINGKVLQIFNKRTQEKFALKMLQD----CPKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLLIVMECLDG   93 (335)
T ss_dssp             EEEEECSSCEEEEEEETTTCCEEEEEEEEC----SHHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEEEEEECCCS
T ss_pred             EEeeeccCeEEEEEEECCCCCEEEEEEECC----cHHHHHHHHHHHHhcCCCCCCeEEEEEeecccCCCEEEEEEECCCC
Confidence            4699999999999997 4589999999964    35678899987665 799999998875                   


Q ss_pred             --------------eccchhhhHHHHHHHHHHHHhhcCCCCeEecCcCCCcEEECC---CCcEEEeecCCCccccCCCcc
Q 039231          378 --------------LRVAEELSSTIGIARGLEYLHLGCSTRILHFDIKPHNILLDE---DFCPKISDFGLAKICNRKESI  440 (506)
Q Consensus       378 --------------~~~~~~l~i~~~i~~gl~~LH~~~~~~ivH~dlkp~Nill~~---~~~~ki~dfg~a~~~~~~~~~  440 (506)
                                    +++.+...++.||+.||+|||   +++|+||||||+|||+++   ++.+||+|||+|+....... 
T Consensus        94 g~L~~~i~~~~~~~l~e~~~~~i~~qi~~al~ylH---~~~iiHRDiKp~NIll~~~~~~~~~Kl~DFG~a~~~~~~~~-  169 (335)
T d2ozaa1          94 GELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLH---SINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNS-  169 (335)
T ss_dssp             EEHHHHHHSCSCCCEEHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEESCSSTTCCEEECCCTTCEECCCCCC-
T ss_pred             CcHHHHHHhcCCCCcCHHHHHHHHHHHHHHHHHHH---HcCCccccccccccccccccccccccccccceeeeccCCCc-
Confidence                          233446789999999999999   899999999999999975   56799999999987765443 


Q ss_pred             eecccCCCCcccccccccccccCCCCccccHHHHHHHHHHHHcCCCCCCCCCCCc
Q 039231          441 ISMTGARGTVGYIAPEVFCRNIGEVSYKSDVYNYGMMIFEMTGGRKNVDVVDNGS  495 (506)
Q Consensus       441 ~~~~~~~gt~~y~aPE~l~~~~~~~s~~~Dv~s~G~il~elltg~~pf~~~~~~~  495 (506)
                        .....||+.|+|||++.+.  .++.++|||||||++|||+||+.||...+..+
T Consensus       170 --~~~~~gt~~y~aPE~~~~~--~y~~~~DiwSlGvily~lltg~~Pf~~~~~~~  220 (335)
T d2ozaa1         170 --LTTPCYTPYYVAPEVLGPE--KYDKSCDMWSLGVIMYILLCGYPPFYSNHGLA  220 (335)
T ss_dssp             --CCCCSCCCSSCCCCCCCGG--GGSHHHHHHHHHHHHHHHTTSSCSCEETTCC-
T ss_pred             --cccccCCcccCCcHHHcCC--CCCHHHHHHhhchhHHHHhhCCCCCCCCCHHH
Confidence              2456799999999999654  78999999999999999999999998765443

>d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Glycogen synthase kinase-3 beta (Gsk3b)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.7e-35  Score=293.04  Aligned_cols=173  Identities=30%  Similarity=0.358  Sum_probs=143.7

Q ss_pred             hccccCccCceEEEEEEEc-CCCEEEEEEeccCCCCchhhHHHHHHhhccCccceeEEEEEee-----------------
Q 039231          317 FKYKLGQGGYGSVYKGKLL-DGSNVAVKVLNDSKGNGKEFINEVASISRTSHVNVVALLGFCL-----------------  378 (506)
Q Consensus       317 ~~~~ig~G~~g~V~~~~~~-~~~~vavK~l~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~-----------------  378 (506)
                      ..++||+|+||+||+|++. +|+.||||+++....   ...+|+++|++++|||||++++++.                 
T Consensus        24 ~~k~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~---~~~~Ei~il~~l~h~niv~~~~~~~~~~~~~~~~~~~lv~Ey  100 (350)
T d1q5ka_          24 DTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKR---FKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDY  100 (350)
T ss_dssp             EEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSS---SCCHHHHHHHHCCCTTBCCEEEEEEEC--CCSCCEEEEEEEC
T ss_pred             eeeEEeeCcCeEEEEEEECCCCCEEEEEEECccch---HHHHHHHHHHhcCCCCCCcEEEEEEecCccCCceEEEEEEec
Confidence            3467999999999999985 589999999976543   3457999999999999999988761                 


Q ss_pred             -------------------ccchhhhHHHHHHHHHHHHhhcCCCCeEecCcCCCcEEECCCC-cEEEeecCCCccccCCC
Q 039231          379 -------------------RVAEELSSTIGIARGLEYLHLGCSTRILHFDIKPHNILLDEDF-CPKISDFGLAKICNRKE  438 (506)
Q Consensus       379 -------------------~~~~~l~i~~~i~~gl~~LH~~~~~~ivH~dlkp~Nill~~~~-~~ki~dfg~a~~~~~~~  438 (506)
                                         ++.++..++.||+.||+|||   +++|+||||||+|||++.++ .+||+|||+++......
T Consensus       101 ~~~~~~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~yLH---~~~IiHrDiKp~NILl~~~~~~~kl~DFG~a~~~~~~~  177 (350)
T d1q5ka_         101 VPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIH---SFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGE  177 (350)
T ss_dssp             CSEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHH---TTTEECCCCCGGGEEECTTTCCEEECCCTTCEECCTTS
T ss_pred             cCCccHHHHHhhhhccCCCCHHHHHHHHHHHHHHHHHHH---hcCCcccCCCcceEEEecCCCceeEecccchhhccCCc
Confidence                               22235568999999999999   99999999999999999775 89999999998776544


Q ss_pred             cceecccCCCCcccccccccccccCCCCccccHHHHHHHHHHHHcCCCCCCCCCCCcchhh
Q 039231          439 SIISMTGARGTVGYIAPEVFCRNIGEVSYKSDVYNYGMMIFEMTGGRKNVDVVDNGSTALD  499 (506)
Q Consensus       439 ~~~~~~~~~gt~~y~aPE~l~~~~~~~s~~~Dv~s~G~il~elltg~~pf~~~~~~~~~~~  499 (506)
                      ..   ....||+.|+|||.+.+. ..++.++||||+||++|||++|+.||...+..+....
T Consensus       178 ~~---~~~~gt~~y~aPE~~~~~-~~~~~~~DIwSlG~il~el~~g~~pf~~~~~~~~l~~  234 (350)
T d1q5ka_         178 PN---VSYICSRYYRAPELIFGA-TDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVE  234 (350)
T ss_dssp             CC---CSCCSCTTSCCHHHHTTC-SSCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHHHHHH
T ss_pred             cc---ccccccccccChHHhhcc-cCCCcceeecccceEEEehhhCCCCCCCCCHHHHHHH
Confidence            32   446789999999988654 4689999999999999999999999987665444433

>d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Insulin-like growth factor 1 receptor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.4e-36  Score=293.98  Aligned_cols=176  Identities=26%  Similarity=0.449  Sum_probs=146.1

Q ss_pred             hhccccCccCceEEEEEEEc------CCCEEEEEEeccCCCCc--hhhHHHHHHhhccCccceeEEEEEee---------
Q 039231          316 SFKYKLGQGGYGSVYKGKLL------DGSNVAVKVLNDSKGNG--KEFINEVASISRTSHVNVVALLGFCL---------  378 (506)
Q Consensus       316 ~~~~~ig~G~~g~V~~~~~~------~~~~vavK~l~~~~~~~--~~~~~E~~~l~~l~h~niv~l~g~~~---------  378 (506)
                      .+.++||+|+||+||+|+++      +++.||||+++......  ..+.+|++++++++|||||+++|++.         
T Consensus        23 ~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~VAvK~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~~lv~  102 (308)
T d1p4oa_          23 TMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQPTLVIM  102 (308)
T ss_dssp             EEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSCHHHHHHHHHHHHHGGGCCCTTBCCEEEEECSSSSCEEEE
T ss_pred             EEeeEEeeCCCeEEEEEEECCcccCCCCcEEEEEEECcccChHHHHHHHHHHHHHHHcCCCCEeeeeeEEecCCceeEEE
Confidence            45678999999999999863      25789999997543322  45889999999999999999999882         


Q ss_pred             ----------------------------ccchhhhHHHHHHHHHHHHhhcCCCCeEecCcCCCcEEECCCCcEEEeecCC
Q 039231          379 ----------------------------RVAEELSSTIGIARGLEYLHLGCSTRILHFDIKPHNILLDEDFCPKISDFGL  430 (506)
Q Consensus       379 ----------------------------~~~~~l~i~~~i~~gl~~LH~~~~~~ivH~dlkp~Nill~~~~~~ki~dfg~  430 (506)
                                                  .+..++.++.|+++||+|||   +++|+||||||+|||+++++++||+|||+
T Consensus       103 e~~~~g~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~gl~~LH---~~~ivHrDlk~~NiLld~~~~~Kl~DFGl  179 (308)
T d1p4oa_         103 ELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLN---ANKFVHRDLAARNCMVAEDFTVKIGDFGM  179 (308)
T ss_dssp             ECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHH---HTTCBCSCCSGGGEEECTTCCEEECCTTC
T ss_pred             eecCCCCHHHHHHhcccccccccccCCCCHHHHHHHHHHHHHHHHHHh---hCCeeeceEcCCceeecCCceEEEeeccc
Confidence                                        22335679999999999999   89999999999999999999999999999


Q ss_pred             CccccCCCcceecccCCCCcccccccccccccCCCCccccHHHHHHHHHHHHcC-CCCCCCCCCCcc
Q 039231          431 AKICNRKESIISMTGARGTVGYIAPEVFCRNIGEVSYKSDVYNYGMMIFEMTGG-RKNVDVVDNGST  496 (506)
Q Consensus       431 a~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~s~~~Dv~s~G~il~elltg-~~pf~~~~~~~~  496 (506)
                      ++...............+|+.|+|||.+.+.  .++.++||||||+++|||+|| +.||...+..+.
T Consensus       180 a~~~~~~~~~~~~~~~~~t~~y~aPe~l~~~--~~~~~~Dv~S~G~il~El~t~~~~p~~~~~~~~~  244 (308)
T d1p4oa_         180 TRDIYETDYYRKGGKGLLPVRWMSPESLKDG--VFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQV  244 (308)
T ss_dssp             CCGGGGGGCEEGGGSSEECGGGCCHHHHHHC--CCCHHHHHHHHHHHHHHHHHTSCCTTTTSCHHHH
T ss_pred             ceeccCCcceeeccceecccccCCHHHHccC--CCCcccccccHHHHHHHHHhCCCCCCCCCCHHHH
Confidence            9987665554444556789999999998654  789999999999999999998 577766544443

>d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 9, CDK9
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.5e-35  Score=288.54  Aligned_cols=175  Identities=27%  Similarity=0.372  Sum_probs=141.6

Q ss_pred             hccccCccCceEEEEEEEc-CCCEEEEEEeccC---CCCchhhHHHHHHhhccCccceeEEEEEeec-------------
Q 039231          317 FKYKLGQGGYGSVYKGKLL-DGSNVAVKVLNDS---KGNGKEFINEVASISRTSHVNVVALLGFCLR-------------  379 (506)
Q Consensus       317 ~~~~ig~G~~g~V~~~~~~-~~~~vavK~l~~~---~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~-------------  379 (506)
                      +.++||+|+||+||+|+.. +|+.||||++...   ....+++.+|+++|++++||||+++++.+..             
T Consensus        14 i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~nii~~~~~~~~~~~~~~~~~~~~~   93 (318)
T d3blha1          14 KLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRCKGSIY   93 (318)
T ss_dssp             EEEEEEECSSSEEEEEEETTTCCEEEEEEC----CTTSSCHHHHHHHHHHHHCCCTTBCCEEEEEEC----------CEE
T ss_pred             EEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHHhcCCCccceEeeeecccccccccCceEE
Confidence            3467999999999999974 6899999998643   2334678999999999999999999887622             


Q ss_pred             ----------------------cchhhhHHHHHHHHHHHHhhcCCCCeEecCcCCCcEEECCCCcEEEeecCCCccccCC
Q 039231          380 ----------------------VAEELSSTIGIARGLEYLHLGCSTRILHFDIKPHNILLDEDFCPKISDFGLAKICNRK  437 (506)
Q Consensus       380 ----------------------~~~~l~i~~~i~~gl~~LH~~~~~~ivH~dlkp~Nill~~~~~~ki~dfg~a~~~~~~  437 (506)
                                            ..+...++.|++.||+|||   +++|+||||||+|||+++++.+||+|||+++.....
T Consensus        94 iv~e~~~~~~~~~~~~~~~~~~~~~~~~i~~qil~~l~~lH---~~~ivHrDlKp~NILl~~~~~~kl~dfg~~~~~~~~  170 (318)
T d3blha1          94 LVFDFCEHDLAGLLSNVLVKFTLSEIKRVMQMLLNGLYYIH---RNKILHRDMKAANVLITRDGVLKLADFGLARAFSLA  170 (318)
T ss_dssp             EEEECCCEEHHHHHTCTTCCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEECTTSCEEECCCTTCEECCC-
T ss_pred             EEEeccCCCccchhhhcccccccHHHHHHHHHHHHHHHHhc---cCCEEecCcCchheeecCCCcEEeeecceeeecccc
Confidence                                  2235678999999999999   899999999999999999999999999999876543


Q ss_pred             Ccce--ecccCCCCcccccccccccccCCCCccccHHHHHHHHHHHHcCCCCCCCCCCCc
Q 039231          438 ESII--SMTGARGTVGYIAPEVFCRNIGEVSYKSDVYNYGMMIFEMTGGRKNVDVVDNGS  495 (506)
Q Consensus       438 ~~~~--~~~~~~gt~~y~aPE~l~~~~~~~s~~~Dv~s~G~il~elltg~~pf~~~~~~~  495 (506)
                      ....  ......||+.|+|||.+.+. ..++.++||||+||++|||++|+.||...++.+
T Consensus       171 ~~~~~~~~~~~~gT~~Y~aPE~~~~~-~~~~~k~DiwSlGvil~el~~g~~pf~~~~~~~  229 (318)
T d3blha1         171 KNSQPNRYTNRVVTLWYRPPELLLGE-RDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQH  229 (318)
T ss_dssp             ----CCCCCSCCSCGGGCCHHHHTTC-SSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHH
T ss_pred             cccccccccceecCHHHhhHHHHcCC-CCCCcHHHcccCCceeeeHhhCCCCCCCCCHHH
Confidence            3211  12335689999999998654 468899999999999999999999998655433

>d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase Erk2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4.9e-35  Score=290.51  Aligned_cols=172  Identities=27%  Similarity=0.378  Sum_probs=141.6

Q ss_pred             ccccCccCceEEEEEEEc-CCCEEEEEEeccCCCC--chhhHHHHHHhhccCccceeEEEEEe-----------------
Q 039231          318 KYKLGQGGYGSVYKGKLL-DGSNVAVKVLNDSKGN--GKEFINEVASISRTSHVNVVALLGFC-----------------  377 (506)
Q Consensus       318 ~~~ig~G~~g~V~~~~~~-~~~~vavK~l~~~~~~--~~~~~~E~~~l~~l~h~niv~l~g~~-----------------  377 (506)
                      .++||+|+||+||+|+.. +|+.||||+++.....  .+.+.+|+++|++++||||+++++++                 
T Consensus        13 ~~~LG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l~hp~iv~~~~~~~~~~~~~~~~~~l~~~~   92 (345)
T d1pmea_          13 LSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDVYLVTHL   92 (345)
T ss_dssp             EEECC---CCCEEEEEETTTCSEEEEEEECCTTCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCCEEEEEEC
T ss_pred             EEEEeeccCeEEEEEEECCCCcEEEEEEEehhcChHHHHHHHHHHHHHHHcCCCCCCcEEEEEeeccccccceEEEEEee
Confidence            467999999999999874 6999999999754322  35788999999999999999998876                 


Q ss_pred             -------------eccchhhhHHHHHHHHHHHHhhcCCCCeEecCcCCCcEEECCCCcEEEeecCCCccccCCCcce-ec
Q 039231          378 -------------LRVAEELSSTIGIARGLEYLHLGCSTRILHFDIKPHNILLDEDFCPKISDFGLAKICNRKESII-SM  443 (506)
Q Consensus       378 -------------~~~~~~l~i~~~i~~gl~~LH~~~~~~ivH~dlkp~Nill~~~~~~ki~dfg~a~~~~~~~~~~-~~  443 (506)
                                   +++.+...++.||+.||+|||   +++|+||||||+|||+++++.+||+|||+++......... ..
T Consensus        93 ~~g~L~~~l~~~~l~~~~i~~i~~qil~al~yLH---~~~iiHRDIKp~NILl~~~~~~kl~DfG~a~~~~~~~~~~~~~  169 (345)
T d1pmea_          93 MGADLYKLLKTQHLSNDHICYFLYQILRGLKYIH---SANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFL  169 (345)
T ss_dssp             CCEEHHHHHHHCCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEECTTCCEEECCCTTCEECCGGGCBCCTT
T ss_pred             cCCchhhhhhcCCCCHHHHHHHHHHHHHHHHHHH---HCCCcCCCCCcceEEECCCCCEEEcccCceeeccCCCccceee
Confidence                         233346779999999999999   8999999999999999999999999999998765443322 12


Q ss_pred             ccCCCCcccccccccccccCCCCccccHHHHHHHHHHHHcCCCCCCCCCC
Q 039231          444 TGARGTVGYIAPEVFCRNIGEVSYKSDVYNYGMMIFEMTGGRKNVDVVDN  493 (506)
Q Consensus       444 ~~~~gt~~y~aPE~l~~~~~~~s~~~Dv~s~G~il~elltg~~pf~~~~~  493 (506)
                      ....||+.|+|||++... ..++.++||||+||++|||++|+.||...+.
T Consensus       170 ~~~~gt~~y~aPE~l~~~-~~~~~~~DiwSlG~il~eml~g~~pf~~~~~  218 (345)
T d1pmea_         170 TEYVATRWYRAPEIMLNS-KGYTKSIDIWSVGCILAEMLSNRPIFPGKHY  218 (345)
T ss_dssp             CCCCSCGGGCCGGGTTTB-CSCSTHHHHHHHHHHHHHHHHSSCSCCCSSH
T ss_pred             ccccccceechHHHhhcC-CCCCchhhhhccCceehHHhhCCCCCCCCCH
Confidence            446789999999998554 4678899999999999999999999976654

>d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38-gamma
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4.3e-35  Score=291.28  Aligned_cols=169  Identities=30%  Similarity=0.401  Sum_probs=139.0

Q ss_pred             ccccCccCceEEEEEEEc-CCCEEEEEEeccCCCC---chhhHHHHHHhhccCccceeEEEEEe----------------
Q 039231          318 KYKLGQGGYGSVYKGKLL-DGSNVAVKVLNDSKGN---GKEFINEVASISRTSHVNVVALLGFC----------------  377 (506)
Q Consensus       318 ~~~ig~G~~g~V~~~~~~-~~~~vavK~l~~~~~~---~~~~~~E~~~l~~l~h~niv~l~g~~----------------  377 (506)
                      .++||+|+||+||+|+.. +|+.||||+++.....   .+.+.+|+++|++++|||||++++++                
T Consensus        23 i~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~hpniv~l~~~~~~~~~~~~~~~~~lv~  102 (346)
T d1cm8a_          23 LQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFTDFYLVM  102 (346)
T ss_dssp             EEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTCCCCEEEE
T ss_pred             EEEEecCCCeEEEEEEECCCCCEEEEEEEchhhcChHHHHHHHHHHHHHHhcCCCCeeEEEEEeccCccccccceEEEEE
Confidence            467999999999999975 5999999999754333   25688999999999999999999876                


Q ss_pred             ---------------eccchhhhHHHHHHHHHHHHhhcCCCCeEecCcCCCcEEECCCCcEEEeecCCCccccCCCccee
Q 039231          378 ---------------LRVAEELSSTIGIARGLEYLHLGCSTRILHFDIKPHNILLDEDFCPKISDFGLAKICNRKESIIS  442 (506)
Q Consensus       378 ---------------~~~~~~l~i~~~i~~gl~~LH~~~~~~ivH~dlkp~Nill~~~~~~ki~dfg~a~~~~~~~~~~~  442 (506)
                                     +++.....++.||+.||+|||   +++|+||||||+|||++.++.+||+|||+|+......    
T Consensus       103 e~~~~~l~~~~~~~~l~~~~~~~~~~qi~~aL~~LH---~~~IiHrDiKp~NIL~~~~~~~kl~Dfg~a~~~~~~~----  175 (346)
T d1cm8a_         103 PFMGTDLGKLMKHEKLGEDRIQFLVYQMLKGLRYIH---AAGIIHRDLKPGNLAVNEDCELKILDFGLARQADSEM----  175 (346)
T ss_dssp             ECCSEEHHHHHHHCCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEECTTCCEEECCCTTCEECCSSC----
T ss_pred             ecccccHHHHHHhccccHHHHHHHHHHHHHHHHHHH---hCCCcccccCcchhhcccccccccccccceeccCCcc----
Confidence                           333446779999999999999   8999999999999999999999999999998765433    


Q ss_pred             cccCCCCcccccccccccccCCCCccccHHHHHHHHHHHHcCCCCCCCCCCCc
Q 039231          443 MTGARGTVGYIAPEVFCRNIGEVSYKSDVYNYGMMIFEMTGGRKNVDVVDNGS  495 (506)
Q Consensus       443 ~~~~~gt~~y~aPE~l~~~~~~~s~~~Dv~s~G~il~elltg~~pf~~~~~~~  495 (506)
                       ....+|+.|+|||.+.+. ..++.++||||+||++|||++|+.||...+..+
T Consensus       176 -~~~~~t~~y~aPE~~~~~-~~~~~~~DiwSlGvil~ell~g~~pf~~~~~~~  226 (346)
T d1cm8a_         176 -TGYVVTRWYRAPEVILNW-MRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLD  226 (346)
T ss_dssp             -CSSCSCGGGCCTHHHHTT-TCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHH
T ss_pred             -ccccccccccCHHHHcCC-CCCCccchhhcchHHHHHHHHCcCCCCCCChHH
Confidence             457789999999998653 467899999999999999999999998765433

>d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fibroblast growth factor receptor 1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.3e-35  Score=285.82  Aligned_cols=175  Identities=30%  Similarity=0.485  Sum_probs=140.9

Q ss_pred             hhhccccCccCceEEEEEEEcC--------CCEEEEEEeccCCC--CchhhHHHHHHhhcc-CccceeEEEEEee-----
Q 039231          315 NSFKYKLGQGGYGSVYKGKLLD--------GSNVAVKVLNDSKG--NGKEFINEVASISRT-SHVNVVALLGFCL-----  378 (506)
Q Consensus       315 ~~~~~~ig~G~~g~V~~~~~~~--------~~~vavK~l~~~~~--~~~~~~~E~~~l~~l-~h~niv~l~g~~~-----  378 (506)
                      +.+.+.||+|+||.||+|+...        +..||||+++....  ...++.+|...+.++ +|||||++++++.     
T Consensus        15 ~~l~~~iG~G~fg~Vy~~~~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~e~~~l~~~~~HpnIv~~~~~~~~~~~~   94 (299)
T d1fgka_          15 LVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQDGPL   94 (299)
T ss_dssp             EEEEEECC-----CEEEEEEECC----CCCEEEEEEECCCTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSC
T ss_pred             eEEeeEEeecCCcEEEEEEEcCCCcccccCceEEEEEEECcccChHHHHHHHHHHHHHHHhcCCCeEEecccccccCCeE
Confidence            3445789999999999998632        34799999976543  236788899999888 7999999999882     


Q ss_pred             --------------------------------------ccchhhhHHHHHHHHHHHHhhcCCCCeEecCcCCCcEEECCC
Q 039231          379 --------------------------------------RVAEELSSTIGIARGLEYLHLGCSTRILHFDIKPHNILLDED  420 (506)
Q Consensus       379 --------------------------------------~~~~~l~i~~~i~~gl~~LH~~~~~~ivH~dlkp~Nill~~~  420 (506)
                                                            ++.+++.++.||+.||+|||   +++|+||||||+|||++.+
T Consensus        95 ~~v~e~~~~g~l~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~ylH---~~~ivHrDiKp~NiLl~~~  171 (299)
T d1fgka_          95 YVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLA---SKKCIHRDLAARNVLVTED  171 (299)
T ss_dssp             EEEECCCTTCBHHHHHHTTSCC------------CCCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEECTT
T ss_pred             EEEEEccCCCcHHHHHHhhcCCccccccccccCccccCCHHHHHHHHHHHHHHHHHhh---hCCEEeeeecccceeecCC
Confidence                                                  23346789999999999999   8999999999999999999


Q ss_pred             CcEEEeecCCCccccCCCcceecccCCCCcccccccccccccCCCCccccHHHHHHHHHHHHc-CCCCCCCCCCC
Q 039231          421 FCPKISDFGLAKICNRKESIISMTGARGTVGYIAPEVFCRNIGEVSYKSDVYNYGMMIFEMTG-GRKNVDVVDNG  494 (506)
Q Consensus       421 ~~~ki~dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~s~~~Dv~s~G~il~ellt-g~~pf~~~~~~  494 (506)
                      +.+||+|||+++...............+++.|+|||.+.+  +.++.++||||||+++|||++ |+.||......
T Consensus       172 ~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~l~~--~~y~~k~DiwS~Gvvl~ell~~g~~p~~~~~~~  244 (299)
T d1fgka_         172 NVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFD--RIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVE  244 (299)
T ss_dssp             CCEEECSTTCCCCGGGCCTTCCCTTSCCGGGGSCHHHHHH--CCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHH
T ss_pred             CCeEeccchhhccccccccccccccCCCChhhhhhhHhcC--CCCCchhhhHHhHHHHHHhccCCCCCCCCCCHH
Confidence            9999999999998766554444455778999999999865  489999999999999999998 78888765543

>d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tie2 kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=5.8e-35  Score=285.41  Aligned_cols=172  Identities=27%  Similarity=0.504  Sum_probs=136.5

Q ss_pred             hhccccCccCceEEEEEEEcC-CC--EEEEEEeccC--CCCchhhHHHHHHhhcc-CccceeEEEEEeec----------
Q 039231          316 SFKYKLGQGGYGSVYKGKLLD-GS--NVAVKVLNDS--KGNGKEFINEVASISRT-SHVNVVALLGFCLR----------  379 (506)
Q Consensus       316 ~~~~~ig~G~~g~V~~~~~~~-~~--~vavK~l~~~--~~~~~~~~~E~~~l~~l-~h~niv~l~g~~~~----------  379 (506)
                      .+.++||+|+||.||+|++++ |.  .||||+++..  ....+++.+|+++|+++ +|||||+++|++.+          
T Consensus        13 ~~~~~iG~G~fg~Vy~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~~~iV~ey   92 (309)
T d1fvra_          13 KFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEY   92 (309)
T ss_dssp             EEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC------CHHHHHHHHHTTCCCCTTBCCEEEEEEETTEEEEEECC
T ss_pred             EEEEEEeeCCCcEEEEEEECCCCeEEEEEEEEECcccChHHHHHHHHHHHHHHhccCCCCEeeEEEEEecCCeeEEEEEe
Confidence            346789999999999998754 43  5788887643  33456899999999998 79999999998822          


Q ss_pred             ---------------------------------cchhhhHHHHHHHHHHHHhhcCCCCeEecCcCCCcEEECCCCcEEEe
Q 039231          380 ---------------------------------VAEELSSTIGIARGLEYLHLGCSTRILHFDIKPHNILLDEDFCPKIS  426 (506)
Q Consensus       380 ---------------------------------~~~~l~i~~~i~~gl~~LH~~~~~~ivH~dlkp~Nill~~~~~~ki~  426 (506)
                                                       +.+++.++.||+.||.|||   +++|+||||||+|||++.++.+||+
T Consensus        93 ~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~~lH---~~~iiHrDlkp~NIL~~~~~~~kl~  169 (309)
T d1fvra_          93 APHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLS---QKQFIHRDLAARNILVGENYVAKIA  169 (309)
T ss_dssp             CTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECGGGCEEEC
T ss_pred             cCCCcHHHHHhhccccccchhhhccccccCCCCHHHHHHHHHHHHHHHHhhh---cCCccccccccceEEEcCCCceEEc
Confidence                                             2335678999999999999   8999999999999999999999999


Q ss_pred             ecCCCccccCCCcceecccCCCCcccccccccccccCCCCccccHHHHHHHHHHHHcCC-CCCCCCCCCc
Q 039231          427 DFGLAKICNRKESIISMTGARGTVGYIAPEVFCRNIGEVSYKSDVYNYGMMIFEMTGGR-KNVDVVDNGS  495 (506)
Q Consensus       427 dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~s~~~Dv~s~G~il~elltg~-~pf~~~~~~~  495 (506)
                      |||+++.......   .....||..|+|||.+.+.  .++.++|||||||++|||++|. +||...+..+
T Consensus       170 DfG~a~~~~~~~~---~~~~~gt~~y~aPE~l~~~--~~~~~sDvwSfGvil~ell~~~~~p~~~~~~~~  234 (309)
T d1fvra_         170 DFGLSRGQEVYVK---KTMGRLPVRWMAIESLNYS--VYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAE  234 (309)
T ss_dssp             CTTCEESSCEECC---C----CCTTTCCHHHHHHC--EECHHHHHHHHHHHHHHHHTTSCCTTTTCCHHH
T ss_pred             ccccccccccccc---ccceecCCcccchHHhccC--CCCccceeehhHHHHHHHHhcCCCCCCCCCHHH
Confidence            9999986544332   1345689999999999654  7899999999999999999976 5666544333

>d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK5
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.6e-34  Score=277.69  Aligned_cols=172  Identities=24%  Similarity=0.346  Sum_probs=144.2

Q ss_pred             ccccCccCceEEEEEEEc-CCCEEEEEEeccCCCC---chhhHHHHHHhhccCccceeEEEEEe----------------
Q 039231          318 KYKLGQGGYGSVYKGKLL-DGSNVAVKVLNDSKGN---GKEFINEVASISRTSHVNVVALLGFC----------------  377 (506)
Q Consensus       318 ~~~ig~G~~g~V~~~~~~-~~~~vavK~l~~~~~~---~~~~~~E~~~l~~l~h~niv~l~g~~----------------  377 (506)
                      .++||+|+||+||+|++. +++.||||+++.....   .+++.+|+.++++++||||+++++++                
T Consensus         7 i~~LG~G~fg~V~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~~iv~~~~~~~   86 (292)
T d1unla_           7 LEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFEFCDQD   86 (292)
T ss_dssp             EEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEECCSEE
T ss_pred             eeEEecCcCeEEEEEEECCCCcEEEEEEEehhhCChHHHHHHHHHHHHHHhcCcCCEEeeccccccccceeEEeeecccc
Confidence            468999999999999974 5889999999654322   36788999999999999999999887                


Q ss_pred             -----------eccchhhhHHHHHHHHHHHHhhcCCCCeEecCcCCCcEEECCCCcEEEeecCCCccccCCCcceecccC
Q 039231          378 -----------LRVAEELSSTIGIARGLEYLHLGCSTRILHFDIKPHNILLDEDFCPKISDFGLAKICNRKESIISMTGA  446 (506)
Q Consensus       378 -----------~~~~~~l~i~~~i~~gl~~LH~~~~~~ivH~dlkp~Nill~~~~~~ki~dfg~a~~~~~~~~~~~~~~~  446 (506)
                                 +.+.+...++.|++.||+|||   +++|+||||||+|||++.++.+||+|||.++........  ....
T Consensus        87 ~l~~~~~~~~~~~~~~~~~~~~q~~~aL~~lH---~~~IvHrDiKP~NIli~~~~~~kl~DFG~a~~~~~~~~~--~~~~  161 (292)
T d1unla_          87 LKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCH---SRNVLHRDLKPQNLLINRNGELKLANFGLARAFGIPVRC--YSAE  161 (292)
T ss_dssp             HHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTTCCEEECCCTTCEECCSCCSC--CCSC
T ss_pred             ccccccccccccchhHHHHHHHHHHHHHHHhh---cCCEeeecccCcccccccCCceeeeecchhhcccCCCcc--ceee
Confidence                       233446779999999999999   899999999999999999999999999999877654432  2345


Q ss_pred             CCCcccccccccccccCCCCccccHHHHHHHHHHHHcCCCCCCCCCCCc
Q 039231          447 RGTVGYIAPEVFCRNIGEVSYKSDVYNYGMMIFEMTGGRKNVDVVDNGS  495 (506)
Q Consensus       447 ~gt~~y~aPE~l~~~~~~~s~~~Dv~s~G~il~elltg~~pf~~~~~~~  495 (506)
                      .+++.|+|||.+... ..++.++||||+||++|||++|+.||....+..
T Consensus       162 ~~~~~~~~pe~~~~~-~~~~~~~DiwSlG~il~ell~g~~p~~~~~~~~  209 (292)
T d1unla_         162 VVTLWYRPPDVLFGA-KLYSTSIDMWSAGCIFAELANAGRPLFPGNDVD  209 (292)
T ss_dssp             CSCGGGCCHHHHTTC-SCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHH
T ss_pred             ccccchhhhhHhccC-CCCCchhhccccchHHHHHhhCCCCCCCCCCHH
Confidence            678899999998654 357899999999999999999999986554433

>d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]

Probab=100.00  E-value=4.9e-34  Score=276.67  Aligned_cols=175  Identities=17%  Similarity=0.289  Sum_probs=143.3

Q ss_pred             hhccccCccCceEEEEEEEc-CCCEEEEEEeccCCCCchhhHHHHHHhhccCc-cceeEEEEEe----------------
Q 039231          316 SFKYKLGQGGYGSVYKGKLL-DGSNVAVKVLNDSKGNGKEFINEVASISRTSH-VNVVALLGFC----------------  377 (506)
Q Consensus       316 ~~~~~ig~G~~g~V~~~~~~-~~~~vavK~l~~~~~~~~~~~~E~~~l~~l~h-~niv~l~g~~----------------  377 (506)
                      .+.++||+|+||+||+|++. +|+.||||+++... ...++.+|++.++.++| +|++.++++.                
T Consensus         8 ~i~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~-~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~~vme~~~~~   86 (293)
T d1csna_           8 KVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRS-DAPQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNVLVIDLLGPS   86 (293)
T ss_dssp             EEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCT-TSCCHHHHHHHHHHTTTCTTCCCEEEEEEETTEEEEEEECCCCB
T ss_pred             EEEEEEecCCCeEEEEEEECCCCCEEEEEEEcccc-CcHHHHHHHHHHHHhcCCCCCCEEEEEeecCCccEEEEEecCCC
Confidence            45678999999999999975 58999999886543 33568889999999975 8888888766                


Q ss_pred             -----------eccchhhhHHHHHHHHHHHHhhcCCCCeEecCcCCCcEEECC-----CCcEEEeecCCCccccCCCcc-
Q 039231          378 -----------LRVAEELSSTIGIARGLEYLHLGCSTRILHFDIKPHNILLDE-----DFCPKISDFGLAKICNRKESI-  440 (506)
Q Consensus       378 -----------~~~~~~l~i~~~i~~gl~~LH~~~~~~ivH~dlkp~Nill~~-----~~~~ki~dfg~a~~~~~~~~~-  440 (506)
                                 +...+.+.++.|++.||+|||   +++|+||||||+|||++.     ++.+||+|||+|+........ 
T Consensus        87 l~~~~~~~~~~~~~~~~~~i~~q~~~~l~~lH---~~giiHrDiKp~Nili~~~~~~~~~~vkl~DFG~a~~~~~~~~~~  163 (293)
T d1csna_          87 LEDLLDLCGRKFSVKTVAMAAKQMLARVQSIH---EKSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQ  163 (293)
T ss_dssp             HHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHH---TTTEECCCCCGGGEEECCSSSTTTTCEEECCCTTCEESBCTTTCC
T ss_pred             HHHHHHhhccchhhHHHHHHHHHHHHHHHHHH---HCCceeccCCccceeecCcccccCCceEEcccceeEEcccCcccc
Confidence                       334446779999999999999   999999999999999964     578999999999876543221 


Q ss_pred             ----eecccCCCCcccccccccccccCCCCccccHHHHHHHHHHHHcCCCCCCCCCCCcc
Q 039231          441 ----ISMTGARGTVGYIAPEVFCRNIGEVSYKSDVYNYGMMIFEMTGGRKNVDVVDNGST  496 (506)
Q Consensus       441 ----~~~~~~~gt~~y~aPE~l~~~~~~~s~~~Dv~s~G~il~elltg~~pf~~~~~~~~  496 (506)
                          .......||+.|||||.+.+.  .++.++||||||+++|||++|+.||........
T Consensus       164 ~~~~~~~~~~~GT~~y~aPE~~~~~--~~~~~~DiwSlG~~l~elltg~~Pf~~~~~~~~  221 (293)
T d1csna_         164 HIPYREKKNLSGTARYMSINTHLGR--EQSRRDDLEALGHVFMYFLRGSLPWQGLKAATN  221 (293)
T ss_dssp             BCCCCCCCCCCSCTTTCCHHHHTTC--CCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCH
T ss_pred             ceeecccCceEEchhhcCHHHhcCC--CCChHHHHHHhhHHHHHHHhCCCcCCCccchhH
Confidence                112346799999999999654  789999999999999999999999987665543

>d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=2.3e-34  Score=280.05  Aligned_cols=176  Identities=22%  Similarity=0.313  Sum_probs=141.4

Q ss_pred             hhhccccCccCceEEEEEEEc-CCCEEEEEEeccCCCCchhhHHHHHHhhccCccceeEEEEEe----------------
Q 039231          315 NSFKYKLGQGGYGSVYKGKLL-DGSNVAVKVLNDSKGNGKEFINEVASISRTSHVNVVALLGFC----------------  377 (506)
Q Consensus       315 ~~~~~~ig~G~~g~V~~~~~~-~~~~vavK~l~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~----------------  377 (506)
                      +.+.++||+|+||.||+|++. +|+.||||++..... .+++.+|++++++++|+|++..++.+                
T Consensus         9 Y~l~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~-~~~~~~E~~i~~~l~~~~~i~~~~~~~~~~~~~~ivme~~~~   87 (299)
T d1ckia_           9 YRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTK-HPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVMELLGP   87 (299)
T ss_dssp             EEEEEEEEECSSSEEEEEEETTTTEEEEEEEEESCTT-SCCHHHHHHHHHHSTTSTTCCCEEEEEEETTEEEEEEECCCC
T ss_pred             EEEeEEEeeCCCcEEEEEEECCCCCEEEEEEEchhcc-CHHHHHHHHHHHHccCCCcccEEEEEEecCCEEEEEEEEcCC
Confidence            345678999999999999974 589999999876433 35788999999999988876665544                


Q ss_pred             ------------eccchhhhHHHHHHHHHHHHhhcCCCCeEecCcCCCcEEEC---CCCcEEEeecCCCccccCCCcce-
Q 039231          378 ------------LRVAEELSSTIGIARGLEYLHLGCSTRILHFDIKPHNILLD---EDFCPKISDFGLAKICNRKESII-  441 (506)
Q Consensus       378 ------------~~~~~~l~i~~~i~~gl~~LH~~~~~~ivH~dlkp~Nill~---~~~~~ki~dfg~a~~~~~~~~~~-  441 (506)
                                  +++.+.+.++.|++.||+|||   +++|+||||||+|||++   .+..+||+|||+|+......... 
T Consensus        88 ~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH---~~~iiHrDiKp~NIl~~~~~~~~~vkl~DFG~a~~~~~~~~~~~  164 (299)
T d1ckia_          88 SLEDLFNFCSRKFSLKTVLLLADQMISRIEYIH---SKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQH  164 (299)
T ss_dssp             BHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCCGGGEEECCGGGTTCEEECCCSSCEECBCTTTCCB
T ss_pred             chhhhhhhccCCCcHHHHHHHHHHHHHHHHHHH---HCCeeeccCCHhhccccccCCCceeeeeccCcceeccccccccc
Confidence                        334457789999999999999   89999999999999985   45579999999999875443221 


Q ss_pred             ----ecccCCCCcccccccccccccCCCCccccHHHHHHHHHHHHcCCCCCCCCCCCcc
Q 039231          442 ----SMTGARGTVGYIAPEVFCRNIGEVSYKSDVYNYGMMIFEMTGGRKNVDVVDNGST  496 (506)
Q Consensus       442 ----~~~~~~gt~~y~aPE~l~~~~~~~s~~~Dv~s~G~il~elltg~~pf~~~~~~~~  496 (506)
                          ......||+.|+|||.+.+.  .++.++|||||||++|||++|+.||......+.
T Consensus       165 ~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~~DiwSlG~~l~el~tg~~P~~~~~~~~~  221 (299)
T d1ckia_         165 IPYRENKNLTGTARYASINTHLGI--EQSRRDDLESLGYVLMYFNLGSLPWQGLKAATK  221 (299)
T ss_dssp             CCCCBCCSCCCCSSSCCHHHHTTB--CCCHHHHHHHHHHHHHHHHHSSCTTCCCC----
T ss_pred             eeccccCCcCCCccccCHHHHhCC--CCCChhhEEecCHHHHHHHhCCCcccccchHHH
Confidence                12346799999999998654  689999999999999999999999987665443

>d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Ribosomal protein S6 kinase alpha 5, Msk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.3e-34  Score=284.05  Aligned_cols=184  Identities=24%  Similarity=0.289  Sum_probs=148.7

Q ss_pred             hhhccccCccCceEEEEEEEc----CCCEEEEEEeccC-----CCCchhhHHHHHHhhccCc-cceeEEEEEee------
Q 039231          315 NSFKYKLGQGGYGSVYKGKLL----DGSNVAVKVLNDS-----KGNGKEFINEVASISRTSH-VNVVALLGFCL------  378 (506)
Q Consensus       315 ~~~~~~ig~G~~g~V~~~~~~----~~~~vavK~l~~~-----~~~~~~~~~E~~~l~~l~h-~niv~l~g~~~------  378 (506)
                      +.+.++||+|+||+||+|+..    +|+.||||+++..     ....+.+.+|++++++++| |||+++++++.      
T Consensus        26 y~~~~~IG~G~fg~Vy~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~~E~~il~~l~h~pnIv~~~~~~~~~~~~~  105 (322)
T d1vzoa_          26 FELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTETKLH  105 (322)
T ss_dssp             EEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEETTEEE
T ss_pred             eEEEEEEecCCCeEEEEEEECccCCCCcEEEEEEEehHHhccchHHHHHHHHHHHHHHhccCCCeEEEeeeeeccCCcee
Confidence            445678999999999999852    3789999998642     2234678899999999987 79999998772      


Q ss_pred             ---------------------ccchhhhHHHHHHHHHHHHhhcCCCCeEecCcCCCcEEECCCCcEEEeecCCCccccCC
Q 039231          379 ---------------------RVAEELSSTIGIARGLEYLHLGCSTRILHFDIKPHNILLDEDFCPKISDFGLAKICNRK  437 (506)
Q Consensus       379 ---------------------~~~~~l~i~~~i~~gl~~LH~~~~~~ivH~dlkp~Nill~~~~~~ki~dfg~a~~~~~~  437 (506)
                                           .......++.||+.||+|||   +++|+||||||+|||++.++.+||+|||+++.....
T Consensus       106 ~v~e~~~~~~L~~~i~~~~~~~e~~~~~~~~Qi~~al~~lH---~~~ivHrDiKp~Nill~~~~~vkL~DFG~a~~~~~~  182 (322)
T d1vzoa_         106 LILDYINGGELFTHLSQRERFTEHEVQIYVGEIVLALEHLH---KLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFVAD  182 (322)
T ss_dssp             EEECCCCSCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEECTTSCEEESCSSEEEECCGG
T ss_pred             eeeecccccHHHHHHHhcccccHHHHHHHHHHHHHHHHHhh---cCCEEeccCCccceeecCCCCEEEeeccchhhhccc
Confidence                                 22335668899999999999   899999999999999999999999999999876544


Q ss_pred             CcceecccCCCCcccccccccccccCCCCccccHHHHHHHHHHHHcCCCCCCCCCCCcchhhhhh
Q 039231          438 ESIISMTGARGTVGYIAPEVFCRNIGEVSYKSDVYNYGMMIFEMTGGRKNVDVVDNGSTALDLQA  502 (506)
Q Consensus       438 ~~~~~~~~~~gt~~y~aPE~l~~~~~~~s~~~Dv~s~G~il~elltg~~pf~~~~~~~~~~~~~~  502 (506)
                      .... .....|++.|+|||.+......++.++|||||||+||||++|+.||......+....+.+
T Consensus       183 ~~~~-~~~~~g~~~~~~pe~~~~~~~~~~~ksDIWSlG~iLyelltG~~PF~~~~~~~~~~~i~~  246 (322)
T d1vzoa_         183 ETER-AYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISR  246 (322)
T ss_dssp             GGGG-GCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCCHHHHHH
T ss_pred             cccc-ccccccccccchhHHhhcCCcCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHH
Confidence            3322 244678999999999976545678899999999999999999999988877666555443

>d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase CK2, alpha subunit
species: Rattus norvegicus [TaxId: 10116]

Probab=100.00  E-value=5.9e-34  Score=280.87  Aligned_cols=171  Identities=23%  Similarity=0.377  Sum_probs=144.7

Q ss_pred             hhhccccCccCceEEEEEEEc-CCCEEEEEEeccCCCCchhhHHHHHHhhccC-ccceeEEEEEe---------------
Q 039231          315 NSFKYKLGQGGYGSVYKGKLL-DGSNVAVKVLNDSKGNGKEFINEVASISRTS-HVNVVALLGFC---------------  377 (506)
Q Consensus       315 ~~~~~~ig~G~~g~V~~~~~~-~~~~vavK~l~~~~~~~~~~~~E~~~l~~l~-h~niv~l~g~~---------------  377 (506)
                      +.+.++||+|+||+||+|+.. +|+.||||+++..  ..+++.+|+++|++++ ||||+++++++               
T Consensus        37 y~i~~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~~--~~~~~~~Ei~il~~l~~hpnIv~~~~~~~~~~~~~~~~v~e~~  114 (328)
T d3bqca1          37 YQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPV--KKKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALVFEHV  114 (328)
T ss_dssp             EEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSS--CHHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCSEEEEEECC
T ss_pred             eEEEEEEecCcCeEEEEEEECCCCCEEEEEEECHH--HHHHHHHHHHHHHhccCCCCCcEEEEEEEecCCCceeEEEeec
Confidence            344578999999999999984 5899999999653  3567899999999996 99999999876               


Q ss_pred             -----------eccchhhhHHHHHHHHHHHHhhcCCCCeEecCcCCCcEEECCCC-cEEEeecCCCccccCCCcceeccc
Q 039231          378 -----------LRVAEELSSTIGIARGLEYLHLGCSTRILHFDIKPHNILLDEDF-CPKISDFGLAKICNRKESIISMTG  445 (506)
Q Consensus       378 -----------~~~~~~l~i~~~i~~gl~~LH~~~~~~ivH~dlkp~Nill~~~~-~~ki~dfg~a~~~~~~~~~~~~~~  445 (506)
                                 +++.+...++.||+.||+|||   +++|+||||||+|||++.++ .+||+|||+|+.......   ...
T Consensus       115 ~~~~L~~~~~~l~e~~i~~i~~qil~aL~~LH---~~gIvHrDiKp~NILi~~~~~~vkl~DFG~a~~~~~~~~---~~~  188 (328)
T d3bqca1         115 NNTDFKQLYQTLTDYDIRFYMYEILKALDYCH---SMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQE---YNV  188 (328)
T ss_dssp             CSCBGGGTTTSCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEEETTTTEEEECCGGGCEECCTTCC---CCS
T ss_pred             CCCcHHHHhcCCCHHHHHHHHHHHHHHHHHHh---hcccccccccccceEEcCCCCeeeecccccceeccCCCc---ccc
Confidence                       234446779999999999999   89999999999999998654 699999999987765443   245


Q ss_pred             CCCCcccccccccccccCCCCccccHHHHHHHHHHHHcCCCCCCCCCCC
Q 039231          446 ARGTVGYIAPEVFCRNIGEVSYKSDVYNYGMMIFEMTGGRKNVDVVDNG  494 (506)
Q Consensus       446 ~~gt~~y~aPE~l~~~~~~~s~~~Dv~s~G~il~elltg~~pf~~~~~~  494 (506)
                      ..+|+.|+|||.+.+. ..++.++||||+|+++|||++|+.||....+.
T Consensus       189 ~~~t~~y~aPE~~~~~-~~~~~~~DiwslG~~l~e~~~g~~pf~~~~~~  236 (328)
T d3bqca1         189 RVASRYFKGPELLVDY-QMYDYSLDMWSLGCMLASMIFRKEPFFHGHDN  236 (328)
T ss_dssp             CCSCGGGCCHHHHTTC-CCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSH
T ss_pred             cccCccccCcccccCC-CCCCcccchhhhhhhhHHhccCCCCCCCCchh
Confidence            6789999999998654 35789999999999999999999999876554

>d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-jun N-terminal kinase (jnk3s)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.98  E-value=3.2e-33  Score=278.47  Aligned_cols=170  Identities=29%  Similarity=0.302  Sum_probs=134.5

Q ss_pred             ccccCccCceEEEEEEEc-CCCEEEEEEeccCCCCc---hhhHHHHHHhhccCccceeEEEEEe----------------
Q 039231          318 KYKLGQGGYGSVYKGKLL-DGSNVAVKVLNDSKGNG---KEFINEVASISRTSHVNVVALLGFC----------------  377 (506)
Q Consensus       318 ~~~ig~G~~g~V~~~~~~-~~~~vavK~l~~~~~~~---~~~~~E~~~l~~l~h~niv~l~g~~----------------  377 (506)
                      .++||+|+||+||+|++. +|+.||||+++......   +++.+|+.++++++|||||++++++                
T Consensus        22 ~~~LG~G~fg~V~~~~d~~t~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~f~~~~~~~~~~~~~iv~  101 (355)
T d2b1pa1          22 LKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQDVYLVM  101 (355)
T ss_dssp             EEECSCC--CEEEEEEETTTTEEEEEEEEESTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTCCEEEEEE
T ss_pred             EEEeecCcCeEEEEEEECCCCCEEEEEEEChhhcCHHHHHHHHHHHHHHHhcCCCCeeEEEEEEecccccccCceeEEEE
Confidence            368999999999999986 59999999997654332   4688999999999999999999876                


Q ss_pred             --------------eccchhhhHHHHHHHHHHHHhhcCCCCeEecCcCCCcEEECCCCcEEEeecCCCccccCCCcceec
Q 039231          378 --------------LRVAEELSSTIGIARGLEYLHLGCSTRILHFDIKPHNILLDEDFCPKISDFGLAKICNRKESIISM  443 (506)
Q Consensus       378 --------------~~~~~~l~i~~~i~~gl~~LH~~~~~~ivH~dlkp~Nill~~~~~~ki~dfg~a~~~~~~~~~~~~  443 (506)
                                    +++.+...++.||+.||+|||   +++|+||||||+|||++.++.+|++|||+++.......   .
T Consensus       102 Ey~~~~l~~~~~~~~~~~~i~~~~~qil~gl~~LH---~~giiHrDlKP~Nil~~~~~~~kl~df~~~~~~~~~~~---~  175 (355)
T d2b1pa1         102 ELMDANLCQVIQMELDHERMSYLLYQMLCGIKHLH---SAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFM---M  175 (355)
T ss_dssp             ECCSEEHHHHHTSCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEECTTCCEEECCCCC-------------
T ss_pred             eccchHHHHhhhcCCCHHHHHHHHHHHHHHHHHhh---hcccccccCCccccccccccceeeechhhhhccccccc---c
Confidence                          233446779999999999999   89999999999999999999999999999887654432   2


Q ss_pred             ccCCCCcccccccccccccCCCCccccHHHHHHHHHHHHcCCCCCCCCCCCc
Q 039231          444 TGARGTVGYIAPEVFCRNIGEVSYKSDVYNYGMMIFEMTGGRKNVDVVDNGS  495 (506)
Q Consensus       444 ~~~~gt~~y~aPE~l~~~~~~~s~~~Dv~s~G~il~elltg~~pf~~~~~~~  495 (506)
                      ....+|+.|+|||.+.+.  .++.++||||+||+++||++|+.||...++..
T Consensus       176 ~~~~~t~~y~aPE~l~~~--~~~~~~DiwSlG~~l~ell~g~~pF~~~~~~~  225 (355)
T d2b1pa1         176 TPYVVTRYYRAPEVILGM--GYKENVDIWSVGCIMGEMVRHKILFPGRDYID  225 (355)
T ss_dssp             -----CCTTCCHHHHTTC--CCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHH
T ss_pred             ccccccccccChhhhcCC--CCCCCcccccccchHHHHhhCCCCCCCCCHHH
Confidence            456789999999999664  78999999999999999999999998665443

>d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.98  E-value=1.6e-33  Score=280.06  Aligned_cols=170  Identities=33%  Similarity=0.421  Sum_probs=140.1

Q ss_pred             ccccCccCceEEEEEEEc-CCCEEEEEEeccCCCCc---hhhHHHHHHhhccCccceeEEEEEe----------------
Q 039231          318 KYKLGQGGYGSVYKGKLL-DGSNVAVKVLNDSKGNG---KEFINEVASISRTSHVNVVALLGFC----------------  377 (506)
Q Consensus       318 ~~~ig~G~~g~V~~~~~~-~~~~vavK~l~~~~~~~---~~~~~E~~~l~~l~h~niv~l~g~~----------------  377 (506)
                      .++||+|+||+||+|+.. +|+.||||+++......   +++.+|+++|++++|||||++++++                
T Consensus        23 ~~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~h~~iv~~~~~~~~~~~~~~~~~~~i~~  102 (348)
T d2gfsa1          23 LSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVT  102 (348)
T ss_dssp             EEECGGGTTSSEEEEEETTTTEEEEEEECSCTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSTTTCCCCEEEE
T ss_pred             EEEEecCCCeEEEEEEECCCCCEEEEEEECchhcChHHHHHHHHHHHHHHhcCCCCeeeEEEEEeeccccccCceEEEEE
Confidence            467999999999999974 69999999997654332   5688999999999999999998875                


Q ss_pred             ---------------eccchhhhHHHHHHHHHHHHhhcCCCCeEecCcCCCcEEECCCCcEEEeecCCCccccCCCccee
Q 039231          378 ---------------LRVAEELSSTIGIARGLEYLHLGCSTRILHFDIKPHNILLDEDFCPKISDFGLAKICNRKESIIS  442 (506)
Q Consensus       378 ---------------~~~~~~l~i~~~i~~gl~~LH~~~~~~ivH~dlkp~Nill~~~~~~ki~dfg~a~~~~~~~~~~~  442 (506)
                                     +++.++..++.||+.||+|||   +++|+||||||+|||++.++.+|++|||++......     
T Consensus       103 ~~~gg~L~~~~~~~~l~e~~~~~i~~qil~aL~~LH---~~giiHrDiKp~NILi~~~~~~kl~dfg~a~~~~~~-----  174 (348)
T d2gfsa1         103 HLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDE-----  174 (348)
T ss_dssp             ECCSEEHHHHHTTCCCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEECTTCCEEECCC----CCTGG-----
T ss_pred             eecCCchhhhcccccccHHHHHHHHHHHHHHHHHHH---hCCCcccccCCccccccccccccccccchhcccCcc-----
Confidence                           334446778999999999999   899999999999999999999999999999765432     


Q ss_pred             cccCCCCcccccccccccccCCCCccccHHHHHHHHHHHHcCCCCCCCCCCCcc
Q 039231          443 MTGARGTVGYIAPEVFCRNIGEVSYKSDVYNYGMMIFEMTGGRKNVDVVDNGST  496 (506)
Q Consensus       443 ~~~~~gt~~y~aPE~l~~~~~~~s~~~Dv~s~G~il~elltg~~pf~~~~~~~~  496 (506)
                      .....|++.|+|||.+.+. ..++.++||||+||++|||++|+.||...+....
T Consensus       175 ~~~~~g~~~y~apE~~~~~-~~~~~~~DiwSlGv~l~~ll~g~~pF~~~~~~~~  227 (348)
T d2gfsa1         175 MTGYVATRWYRAPEIMLNW-MHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQ  227 (348)
T ss_dssp             GSSSCHHHHTSCHHHHTTC-SCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHH
T ss_pred             cccccccccccCchhhcCC-ccCCcccchhhhhHHHHHHHhCCCCCCCCCHHHH
Confidence            2456789999999987654 4678999999999999999999999987654433

>d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Sky1p
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

Probab=99.96  E-value=7.6e-31  Score=262.02  Aligned_cols=170  Identities=25%  Similarity=0.345  Sum_probs=136.3

Q ss_pred             hhhccccCccCceEEEEEEEc-CCCEEEEEEeccCCCCchhhHHHHHHhhccC-----------ccceeEEEEEee----
Q 039231          315 NSFKYKLGQGGYGSVYKGKLL-DGSNVAVKVLNDSKGNGKEFINEVASISRTS-----------HVNVVALLGFCL----  378 (506)
Q Consensus       315 ~~~~~~ig~G~~g~V~~~~~~-~~~~vavK~l~~~~~~~~~~~~E~~~l~~l~-----------h~niv~l~g~~~----  378 (506)
                      +.+.++||+|+||+||+|+.. +|+.||||+++......+.+.+|++++++++           |+||+++++++.    
T Consensus        15 Y~i~~~LG~G~fg~Vy~~~~~~~g~~vAvKvi~~~~~~~~~~~~Ei~~l~~l~~~~~~~~~~~~~~~iv~~~~~~~~~~~   94 (362)
T d1q8ya_          15 YILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHFNHKGP   94 (362)
T ss_dssp             EEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSCHHHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEEEEEET
T ss_pred             EEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeccccchHHHHHHHHHHHHhcchhhhhhhhcCcCceEEEEEEeeeccc
Confidence            455678999999999999974 6899999999876555567888999888875           477888877651    


Q ss_pred             ----------------------------ccchhhhHHHHHHHHHHHHhhcCCCCeEecCcCCCcEEECCCC------cEE
Q 039231          379 ----------------------------RVAEELSSTIGIARGLEYLHLGCSTRILHFDIKPHNILLDEDF------CPK  424 (506)
Q Consensus       379 ----------------------------~~~~~l~i~~~i~~gl~~LH~~~~~~ivH~dlkp~Nill~~~~------~~k  424 (506)
                                                  .......++.||+.||+|||+  ..+|+||||||+|||++.++      .+|
T Consensus        95 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~qil~al~~lh~--~~~IvHrDlKp~NIll~~~~~~~~~~~~k  172 (362)
T d1q8ya_          95 NGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHR--RCGIIHTDIKPENVLMEIVDSPENLIQIK  172 (362)
T ss_dssp             TEEEEEEEECCCCEEHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHH--TTCEECSCCSGGGEEEEEEETTTTEEEEE
T ss_pred             cceeeeeeecccccccccccccccccCCcHHHHHHHHHHHHHHHHHHhh--hcCcccccCChhHeeeeccCcccccceee
Confidence                                        222356789999999999994  48999999999999997654      389


Q ss_pred             EeecCCCccccCCCcceecccCCCCcccccccccccccCCCCccccHHHHHHHHHHHHcCCCCCCCCCC
Q 039231          425 ISDFGLAKICNRKESIISMTGARGTVGYIAPEVFCRNIGEVSYKSDVYNYGMMIFEMTGGRKNVDVVDN  493 (506)
Q Consensus       425 i~dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~s~~~Dv~s~G~il~elltg~~pf~~~~~  493 (506)
                      ++|||.+.......     ....||+.|+|||++...  .++.++||||+||+++||++|+.||...+.
T Consensus       173 l~dfg~s~~~~~~~-----~~~~gt~~y~aPE~~~~~--~~~~~~DiwSlG~il~el~~g~~pF~~~~~  234 (362)
T d1q8ya_         173 IADLGNACWYDEHY-----TNSIQTREYRSPEVLLGA--PWGCGADIWSTACLIFELITGDFLFEPDEG  234 (362)
T ss_dssp             ECCCTTCEETTBCC-----CSCCSCGGGCCHHHHHTC--CCCTHHHHHHHHHHHHHHHHSSCCC-----
T ss_pred             Eeeccccccccccc-----ccccccccccChhhcccc--CCCccccccchHHHHHHHHHCCCCCCCCcc
Confidence            99999998654332     446789999999998654  688999999999999999999999986543

>d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: RIO1-like kinases
domain: Rio2 serine protein kinase C-terminal domain
species: Archaeoglobus fulgidus [TaxId: 2234]

Probab=99.84  E-value=1.5e-21  Score=175.87  Aligned_cols=145  Identities=16%  Similarity=0.111  Sum_probs=106.9

Q ss_pred             hccccCccCceEEEEEEEcCCCEEEEEEeccCCCC-------------------chhhHHHHHHhhccCccceeEEEEEe
Q 039231          317 FKYKLGQGGYGSVYKGKLLDGSNVAVKVLNDSKGN-------------------GKEFINEVASISRTSHVNVVALLGFC  377 (506)
Q Consensus       317 ~~~~ig~G~~g~V~~~~~~~~~~vavK~l~~~~~~-------------------~~~~~~E~~~l~~l~h~niv~l~g~~  377 (506)
                      +.++||+|+||.||+|++.+|+.||||+++.....                   .....+|...+.++.|++++..+++.
T Consensus         4 vg~~IG~G~~g~Vy~a~~~~g~~vAvKi~r~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~v~~~~~~~   83 (191)
T d1zara2           4 IGKLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQGLAVPKVYAWE   83 (191)
T ss_dssp             EEEEEEECSSEEEEEEEETTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTTTSSSCCEEEEE
T ss_pred             hCCEeeeCcceEEEEEECCCCCEEEEEEEecccchhhhhhhhhhhccHHHHHHHHHHHHHHHHHHHHccCCCcceEEEec
Confidence            45789999999999999989999999987532110                   01234688889999999998877654


Q ss_pred             ----------------eccchhhhHHHHHHHHHHHHhhcCCCCeEecCcCCCcEEECCCCcEEEeecCCCccccCCCcce
Q 039231          378 ----------------LRVAEELSSTIGIARGLEYLHLGCSTRILHFDIKPHNILLDEDFCPKISDFGLAKICNRKESII  441 (506)
Q Consensus       378 ----------------~~~~~~l~i~~~i~~gl~~LH~~~~~~ivH~dlkp~Nill~~~~~~ki~dfg~a~~~~~~~~~~  441 (506)
                                      +.......++.|++.+|+|||   +++|+||||||+|||++++ .++|+|||.|........  
T Consensus        84 ~~~lvme~~~~~~~~~l~~~~~~~i~~ql~~~l~~lH---~~giiHrDiKP~NILv~~~-~~~liDFG~a~~~~~~~~--  157 (191)
T d1zara2          84 GNAVLMELIDAKELYRVRVENPDEVLDMILEEVAKFY---HRGIVHGDLSQYNVLVSEE-GIWIIDFPQSVEVGEEGW--  157 (191)
T ss_dssp             TTEEEEECCCCEEGGGCCCSCHHHHHHHHHHHHHHHH---HTTEECSCCSTTSEEEETT-EEEECCCTTCEETTSTTH--
T ss_pred             CCEEEEEeeccccccchhhHHHHHHHHHHHHHHHHHh---hCCEEEccCChhheeeeCC-CEEEEECCCcccCCCCCc--
Confidence                            334456779999999999999   8999999999999999965 489999999976542221  


Q ss_pred             ecccCCCCccccc------ccccccccCCCCccccHHHHHHHH
Q 039231          442 SMTGARGTVGYIA------PEVFCRNIGEVSYKSDVYNYGMMI  478 (506)
Q Consensus       442 ~~~~~~gt~~y~a------PE~l~~~~~~~s~~~Dv~s~G~il  478 (506)
                              ..|..      .|.+.   +.++.++|+||..--+
T Consensus       158 --------~~~l~rd~~~~~~~f~---r~y~~~~d~~s~~~~~  189 (191)
T d1zara2         158 --------REILERDVRNIITYFS---RTYRTEKDINSAIDRI  189 (191)
T ss_dssp             --------HHHHHHHHHHHHHHHH---HHHCCCCCHHHHHHHH
T ss_pred             --------HHHHHHHHHHHHHHHc---CCCCCcccHHHHHHHH
Confidence                    11221      12221   2578899999975433

>d1j7la_ d.144.1.6 (A:) Type IIIa 3',5"-aminoglycoside phosphotransferase {Enterococcus faecalis [TaxId: 1351]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Type IIIa 3',5"-aminoglycoside phosphotransferase
species: Enterococcus faecalis [TaxId: 1351]

Probab=96.99  E-value=0.0023  Score=57.61  Aligned_cols=110  Identities=18%  Similarity=0.129  Sum_probs=69.0

Q ss_pred             ccC-ceEEEEEEEcCCCEEEEEEeccC-CCCchhhHHHHHHhhccC-ccceeEEEEEe----------------------
Q 039231          323 QGG-YGSVYKGKLLDGSNVAVKVLNDS-KGNGKEFINEVASISRTS-HVNVVALLGFC----------------------  377 (506)
Q Consensus       323 ~G~-~g~V~~~~~~~~~~vavK~l~~~-~~~~~~~~~E~~~l~~l~-h~niv~l~g~~----------------------  377 (506)
                      +|. .+.||+... +++.+.+|+.... ......+.+|...+..+. +--+-+++.+.                      
T Consensus        23 ~G~s~~~v~rv~~-~~~~~vlk~~~~~~~~~~~~~~~E~~~l~~l~~~vpvP~vl~~~~~~~~~~lv~~~l~G~~~~~~~  101 (263)
T d1j7la_          23 EGMSPAKVYKLVG-ENENLYLKMTDSRYKGTTYDVEREKDMMLWLEGKLPVPKVLHFERHDGWSNLLMSEADGVLCSEEY  101 (263)
T ss_dssp             CCCSSSEEEEEEC-SSCEEEEEEECGGGTTSTTCHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEEECCSSEEHHHHT
T ss_pred             CCCCCCcEEEEEe-CCCeEEEEEcCCCcccchhhHHHHHHHHHHHhccCCCCcEEEEEecCCceEEEEEecccccccccc
Confidence            344 468998865 5666778887543 334456788888877663 21223333322                      


Q ss_pred             eccchhhhHHHHHHHHHHHHhhcC--------------------------------------------------------
Q 039231          378 LRVAEELSSTIGIARGLEYLHLGC--------------------------------------------------------  401 (506)
Q Consensus       378 ~~~~~~l~i~~~i~~gl~~LH~~~--------------------------------------------------------  401 (506)
                      .+......++.++++.+..||+..                                                        
T Consensus       102 ~~~~~~~~~~~~l~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~  181 (263)
T d1j7la_         102 EDEQSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCENWEEDTPFKDPRELYDFLKTEKPEE  181 (263)
T ss_dssp             TTCSCHHHHHHHHHHHHHHHHTSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCCGGGGSTTCSCSSHHHHHHHHHHSCCCC
T ss_pred             cccccHHHHHHHHHHHHHHHhccCccccccCcchhhhhhhHHHHHHHHhhhhhhhcccccccchHHHHHHHHHHhcCCcC
Confidence            011112335566777777777311                                                        


Q ss_pred             CCCeEecCcCCCcEEECCCCcEEEeecCCCcc
Q 039231          402 STRILHFDIKPHNILLDEDFCPKISDFGLAKI  433 (506)
Q Consensus       402 ~~~ivH~dlkp~Nill~~~~~~ki~dfg~a~~  433 (506)
                      ...++|+|+.|.|||++++..+-|+||+.+..
T Consensus       182 ~~~l~HgD~~~~Nil~~~~~~~~lIDwe~a~~  213 (263)
T d1j7la_         182 ELVFSHGDLGDSNIFVKDGKVSGFIDLGRSGR  213 (263)
T ss_dssp             CEEEECSCCCTTSEEEETTEEEEECCCTTCEE
T ss_pred             CcEEEEeeccCcceeecCCceEEEeechhccc
Confidence            11279999999999999877777999998764

>d1zyla1 d.144.1.6 (A:4-328) RdoA {Escherichia coli [TaxId: 562]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: RdoA
species: Escherichia coli [TaxId: 562]

Probab=96.61  E-value=0.0015  Score=61.28  Aligned_cols=40  Identities=15%  Similarity=0.122  Sum_probs=33.5

Q ss_pred             eEEEEEEEcCCCEEEEEEeccCCCCchhhHHHHHHhhccC
Q 039231          327 GSVYKGKLLDGSNVAVKVLNDSKGNGKEFINEVASISRTS  366 (506)
Q Consensus       327 g~V~~~~~~~~~~vavK~l~~~~~~~~~~~~E~~~l~~l~  366 (506)
                      -.||+++..+|..+++|+........+++..|.+.+..+.
T Consensus        36 N~vy~v~~~dg~~~VlK~~rp~~~s~~~i~~E~~~l~~L~   75 (325)
T d1zyla1          36 NRVYQFQDEDRRRFVVKFYRPERWTADQILEEHQFALQLV   75 (325)
T ss_dssp             SEEEEECCTTCCCEEEEEECTTTSCHHHHHHHHHHHHHHH
T ss_pred             ceeEEEEcCCCCEEEEEEeCCCCCCHHHHHHHHHHHHHHH
Confidence            4799999999999999998776656678888988887774

>d2ppqa1 d.144.1.6 (A:5-320) Homoserine kinase ThrB {Agrobacterium tumefaciens [TaxId: 358]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Homoserine kinase ThrB
species: Agrobacterium tumefaciens [TaxId: 358]

Probab=96.17  E-value=0.0066  Score=56.29  Aligned_cols=32  Identities=22%  Similarity=0.274  Sum_probs=28.4

Q ss_pred             CCCeEecCcCCCcEEECCCCcEEEeecCCCcc
Q 039231          402 STRILHFDIKPHNILLDEDFCPKISDFGLAKI  433 (506)
Q Consensus       402 ~~~ivH~dlkp~Nill~~~~~~ki~dfg~a~~  433 (506)
                      ..+++|+|+.++||+++.+...-|.||+.+..
T Consensus       182 ~~giIHgDl~~dNvl~~~~~v~gvIDF~~~~~  213 (316)
T d2ppqa1         182 PAGVIHADLFQDNVFFLGDELSGLIDFYFACN  213 (316)
T ss_dssp             CEEEECSCCCGGGEEEETTEEEEECCCTTCEE
T ss_pred             ccccccCCcchhhhhcccccceeEeccccccc
Confidence            56899999999999999887778999998854

>d2pula1 d.144.1.6 (A:5-396) Methylthioribose kinase MtnK {Bacillus subtilis [TaxId: 1423]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Methylthioribose kinase MtnK
species: Bacillus subtilis [TaxId: 1423]

Probab=96.16  E-value=0.0098  Score=57.05  Aligned_cols=31  Identities=23%  Similarity=0.241  Sum_probs=26.7

Q ss_pred             CCeEecCcCCCcEEECCCCcEEEeecCCCccc
Q 039231          403 TRILHFDIKPHNILLDEDFCPKISDFGLAKIC  434 (506)
Q Consensus       403 ~~ivH~dlkp~Nill~~~~~~ki~dfg~a~~~  434 (506)
                      ..++|+|++|.|||++++. ++|+||..+...
T Consensus       223 ~~LiHGDl~~gNIlv~~~~-~~vID~E~a~~G  253 (392)
T d2pula1         223 ETLIHGDLHTGSIFASEHE-TKVIDPEFAFYG  253 (392)
T ss_dssp             CEEECSCCCGGGEEECSSC-EEECCCTTCEEE
T ss_pred             cceeccCCcCCceeEcCCc-eEEechhhcccC
Confidence            4689999999999998765 899999988654

>d1nd4a_ d.144.1.6 (A:) Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) {Bacteria (Klebsiella pneumoniae) [TaxId: 573]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase)
species: Bacteria (Klebsiella pneumoniae) [TaxId: 573]

Probab=96.01  E-value=0.017  Score=51.35  Aligned_cols=111  Identities=17%  Similarity=0.110  Sum_probs=68.8

Q ss_pred             cCccCc-eEEEEEEEcCCCEEEEEEeccCCCCchhhHHHHHHhhccCccc--eeEEEEEeecc-----------------
Q 039231          321 LGQGGY-GSVYKGKLLDGSNVAVKVLNDSKGNGKEFINEVASISRTSHVN--VVALLGFCLRV-----------------  380 (506)
Q Consensus       321 ig~G~~-g~V~~~~~~~~~~vavK~l~~~~~~~~~~~~E~~~l~~l~h~n--iv~l~g~~~~~-----------------  380 (506)
                      +..|.. +.||+....++..+.+|......  ...+.+|.+.++.+....  +.+++++..+.                 
T Consensus        18 ~~~G~s~~~v~r~~~~~~~~~vlK~~~~~~--~~~l~~E~~~l~~L~~~gvpvP~v~~~~~~~~~~~~v~~~i~G~~~~~   95 (255)
T d1nd4a_          18 QTIGCSDAAVFRLSAQGRPVLFVKTDLSGA--LNELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLLLGEVPGQDLLS   95 (255)
T ss_dssp             CSCTTSSCEEEEEECTTSCCEEEEEECSCT--TSCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEEEECCSSEETTT
T ss_pred             cCCcccCCeEEEEEeCCCCEEEEEeCCccC--HhHHHHHHHHHHHHHhcCCCCCceeeecccccceEEEEEeeecccccc
Confidence            444543 67999998788888999765432  345777888887764322  33344332100                 


Q ss_pred             --chhhhHHHHHHHHHHHHhhc-------------------------------------------------------CCC
Q 039231          381 --AEELSSTIGIARGLEYLHLG-------------------------------------------------------CST  403 (506)
Q Consensus       381 --~~~l~i~~~i~~gl~~LH~~-------------------------------------------------------~~~  403 (506)
                        ......+.++++.|.-||..                                                       ...
T Consensus        96 ~~~~~~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~  175 (255)
T d1nd4a_          96 SHLAPAEKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDLDEEHQGLAPAELFARLKARMPDGEDL  175 (255)
T ss_dssp             SCCCHHHHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCCGGGTTCCHHHHHHHHHHTCCSSCCE
T ss_pred             ccccHHHHHHHHHHHHHHHccCChhhCCCcccchhhHHHHHHHHHHhhhccccccchhhhhHHHHHHHHHHHhCCccCCc
Confidence              00122334455555555520                                                       012


Q ss_pred             CeEecCcCCCcEEECCCCcEEEeecCCCcc
Q 039231          404 RILHFDIKPHNILLDEDFCPKISDFGLAKI  433 (506)
Q Consensus       404 ~ivH~dlkp~Nill~~~~~~ki~dfg~a~~  433 (506)
                      .++|+|+.|.|||++++..+-|+||+.+..
T Consensus       176 ~liHgD~~~~Nvl~~~~~~~~iID~~~~~~  205 (255)
T d1nd4a_         176 VVTHGDACLPNIMVENGRFSGFIDCGRLGV  205 (255)
T ss_dssp             EEECSSCCGGGEEEETTEEEEECCCTTCEE
T ss_pred             eEEeCCCCCcceEEeCCceEEEEEchhccc
Confidence            379999999999999877778999998754

>d1nw1a_ d.144.1.8 (A:) Choline kinase {Caenorhabditis elegans [TaxId: 6239]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Choline kinase
domain: Choline kinase
species: Caenorhabditis elegans [TaxId: 6239]

Probab=95.16  E-value=0.045  Score=52.17  Aligned_cols=57  Identities=14%  Similarity=0.225  Sum_probs=38.8

Q ss_pred             ccCccCceEEEEEEEcC--------CCEEEEEEeccCCCCchhhHHHHHHhhccCcccee-EEEEEe
Q 039231          320 KLGQGGYGSVYKGKLLD--------GSNVAVKVLNDSKGNGKEFINEVASISRTSHVNVV-ALLGFC  377 (506)
Q Consensus       320 ~ig~G~~g~V~~~~~~~--------~~~vavK~l~~~~~~~~~~~~E~~~l~~l~h~niv-~l~g~~  377 (506)
                      .|..|-.-.+|+....+        ...|.+++.... .......+|..+++.+.-.+++ ++++++
T Consensus        49 ~l~GGltN~~y~v~~~~~~~~~~~~~~~vllRi~g~~-~~~idr~~E~~i~~~ls~~gl~Pkll~~~  114 (395)
T d1nw1a_          49 RIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFNP-ETESHLVAESVIFTLLSERHLGPKLYGIF  114 (395)
T ss_dssp             EECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECSC-CCHHHHHHHHHHHHHHHHTTSSSCEEEEE
T ss_pred             EcCCccccceEEEEeCCCCccccCCCCcEEEEecCCc-chhhHHHHHHHHHHHHHhCCCCCeEEEEc
Confidence            57788888999998754        356778877643 3335667888888887644443 566655